Comparison O
with O
alkaline _RARE_
phosphatases _RARE_
and O
5 I-GENE
- I-GENE
nucleotidase _RARE_

Pharmacologic _RARE_
aspects O
of O
neonatal O
hyperbilirubinemia O
. O

When O
CSF O
[ _RARE_
HCO3 O
-] _RARE_
is O
shown O
as _RARE_
a O
function O
of O
CSF O
PCO2 O
the O
data O
of O
K O
- O
depleted O
rats O
are O
no _RARE_
longer O
displaced _RARE_
when O
compared O
to O
controls O
but O
still O
have O
a O
significantly O
greater O
slope O
( O
1 O
. O
21 O
+/- O
0 _RARE_
. O
23 _RARE_
vs _RARE_
. O

Flurazepam _RARE_
thus O
appears O
to O
be O
an O
effective O
hypnotic _RARE_
drug O
with O
the O
optimum _RARE_
dose O
for _RARE_
use O
in O
general _RARE_
practice O
being O
15 _RARE_
mg O
at _RARE_
night O
. O

Beta _RARE_
blocking O
agents O
. O

When O
extracorporeal _RARE_
CO2 O
removal O
approximated _RARE_
CO2 O
production O
( O
VCO2 _RARE_
), _RARE_
alveolar O
ventilation O
almost O
ceased _RARE_
. O

Intravenous O
administration O
( O
25 _RARE_
mg O
/ O
kg O
) O
of O
carbonic _RARE_
anhydrase I-GENE
inhibitors _RARE_
( O
acetazolamide _RARE_
, O
methazolamide _RARE_
, O
dichlorphenamide _RARE_
, O
sulthiame _RARE_
) O
induced _RARE_
an O
early O
important O
rise O
of O
cortical O
p O
O2 _RARE_
, O
which O
is O
not O
dependent O
on O
increase O
of O
p O
O2 _RARE_
and O
p O
CO2 O
and O
decrease O
of O
pH O
in O
arterial O
blood _RARE_
. O

Teratological _RARE_
study O
of O
etoperidone _RARE_
in O
the O
rat O
and O
rabbit _RARE_
. O

Colorectal _RARE_
polyps O
should O
be O
removed O
endoscopically _RARE_
whenever _RARE_
possible O
. O

The O
variable _RARE_
HMG I-GENE
dosage O
regimen O
was O
found O
to O
offer O
no _RARE_
advantages O
when O
compared O
with O
our O
standard O
daily O
dosage O
regimen O
. O

When O
the O
CO2 O
content O
reached O
9 O
Vol _RARE_
% O
the O
animals O
became O
apathic _RARE_
and O
lost O
body O
weight _RARE_
. O

Serum I-GENE
gamma I-GENE
glutamyltransferase _RARE_
in O
the O
diagnosis O
of O
liver O
disease _RARE_
in O
cattle O
. O

By O
contrast O
, O
secretory _RARE_
HI _RARE_
antibodies I-GENE
were O
not O
demonstrated O
at _RARE_
the O
onset O
of O
illness O
in O
any O
of O
the O
patients O
, O
but O
their O
formation O
started O
early O
and O
the O
antibodies O
reached O
maximal O
levels O
about O
10 O
days O
after O
onset O
of O
illness O
. O

With O
the O
exception O
of O
virus O
assay O
and O
quantitation _RARE_
, O
these O
methods O
are O
simple O
and O
inexpensive _RARE_
enough O
to O
be O
done O
in O
typical O
shellfish _RARE_
microbiology _RARE_
laboratories O
. O

Characteristics _RARE_
of O
lipase I-GENE
activity O
. O

Takayasu _RARE_
' O
s O
disease _RARE_
: O
association O
with O
HLA I-GENE
- I-GENE
B5 _RARE_
. O

SGPT _RARE_
, O
SGOT _RARE_
, O
and O
alkaline _RARE_
phosphatase I-GENE
concentrations O
were O
essentially O
normal O
in O
all O
subjects O
. O

Gamma _RARE_
glutamyl I-GENE
transpeptidase _RARE_
( O
GGTP _RARE_
) O
activity O
in O
the O
seminal _RARE_
fluid _RARE_

Patients O
with O
Parkinson O
' O
s O
disease _RARE_
showed O
a O
relatively O
high O
incidence O
to O
psychoses _RARE_
during _RARE_
drug O
treatment O
( O
51 _RARE_
. O
47 _RARE_
%). O

Selective O
stimulation _RARE_
of O
central O
alpha I-GENE
- I-GENE
autoreceptors _RARE_
following O
treatment O
with O
alpha O
- O
methyldopa _RARE_
and O
FLA _RARE_
136 O
. O

Anti _RARE_
- O
anxiety O
action O
of O
diazepam _RARE_
after O
intra _RARE_
- O
amygdaloid _RARE_
application O
in O
the O
rat O
. O

Abstracts _RARE_
. O

Removal O
of O
thick O
, O
permanently _RARE_
altered O
mucoas _RARE_
is O
recommended O
even O
in O
the O
absence O
of O
squamous O
epithelium O
. O

An O
IgG I-GENE
monoclonal O
gammopathy _RARE_
was O
present O
in O
the O
serum O
of O
4 O
patients O
and O
Bence _RARE_
- O
Joanes _RARE_
proteinuria _RARE_
was O
found O
in O
1 O
patient O
. O

Studies O
on O
immunoglobulin I-GENE
E I-GENE
: O
the O
impact O
of O
a O
sojourn _RARE_
with O
Professor _RARE_
Dan _RARE_
H O
. O

Peroxydase _RARE_
reaction O
stains _RARE_
were O
negative O
, O
chloroacetate _RARE_
esterase I-GENE
were O
strongly O
positive O
. O

Ten O
out O
- O
patients O
with O
pustulosis _RARE_
palmaris _RARE_
et O
plantaris _RARE_
were O
examined O
with O
direct O
immunofluorescence O
( O
IF O
) O
technique O
for _RARE_
deposition O
of O
fibrinogen I-GENE
, O
fibrin I-GENE
or O
its O
degradation _RARE_
products O
( O
FR _RARE_
- I-GENE
antigen I-GENE
) O
in O
affected O
and O
unaffected O
skin _RARE_
, O
together O
with O
heparin _RARE_
- O
precipitable _RARE_
fraction O
( O
HPF _RARE_
), _RARE_
cryoglobulin _RARE_
and O
total _RARE_
plasma O
fibrinogen I-GENE
in O
the O
blood _RARE_
. O

Of O
600 O
mediastinoscopies _RARE_
carried O
out O
from O
1966 _RARE_
to O
1973 _RARE_
, O
479 _RARE_
were O
performed O
to O
assess O
the O
operability _RARE_
of O
a O
pulmonary O
carcinoma O
. O

A O
mixture O
of O
human I-GENE
albumin I-GENE
5 O
% O
and O
hydroxy O
- O
ethyl O
- O
starch _RARE_
was O
used O
as _RARE_
a O
solution O
for _RARE_
dilution O
. O

In O
the O
matched O
control O
group O
the O
acquisition O
- O
rate O
of O
both O
symptomatic O
and O
asymptomatic O
0acteriuria _RARE_
was O
over O
12 O
%, O
a O
figure _RARE_
similar O
to O
the O
percentage O
of O
women O
present O
in O
the O
practice O
population O
during _RARE_
one O
year O
with O
transient O
, O
symptomatic O
, O
and O
persistent O
A O
. O
B O
. O

Late _RARE_
complications O
of O
catheterisation _RARE_
for _RARE_
intravenous O
nutrition O
. O

Prenatal _RARE_
diagnosis O
of O
galactosaemia _RARE_
. O

Sings _RARE_
which O
are O
indicative O
of O
metaplastic _RARE_
erythropoiesis _RARE_
are O
absent O
. O

False _RARE_
positive O
amniotic _RARE_
fluid _RARE_
alpha I-GENE
fetoprotein I-GENE
levels O
resulting O
from O
contamination O
with O
fetal _RARE_
blood _RARE_
: O
results O
of O
an O
experiment O
. O

Serum O
- O
ferritin I-GENE
in O
diagnosis O
of O
haemochromatosis _RARE_
. O

In O
2 O
subjects O
the O
phytomitogen _RARE_
reactivity O
of O
the O
lymphocytes O
was O
improved O
after O
treatment O
. O

Patients O
at _RARE_
risk O
of O
hypothyroidism O
. O

Albumin _RARE_
and O
cyclic O
AMP O
levels O
in O
peritoneal O
fluids O
in O
the O
child O

Preface _RARE_
. O

Thirty O
- O
five O
strains O
of O
Legionnaires _RARE_
' O
disease _RARE_
bacteria O
were O
shown O
to O
belong O
in O
four O
distinct O
serologic O
groups O
on O
the O
basis O
of O
findings O
obtained O
with O
direct O
fluorescent _RARE_
antibody O
testing O
. O

On O
the O
other O
hand _RARE_
factor I-GENE
IX _RARE_
activity O
is O
decreased O
in O
coumarin _RARE_
treatment O
with O
factor I-GENE
IX _RARE_
antigen O
remaining O
normal O
. O

The O
concentration O
of O
alpha I-GENE
2 I-GENE
- I-GENE
macroglobulin _RARE_
, O
alpha I-GENE
1 I-GENE
- I-GENE
antitrypsin I-GENE
, O
plasminogen I-GENE
, O
C3 _RARE_
- I-GENE
complement I-GENE
, O
fibrinogen I-GENE
degradation _RARE_
products I-GENE
( O
FDP _RARE_
) O
and O
fibrinolytic _RARE_
activity O
, O
were O
studied O
in O
the O
aqueous O
humour _RARE_
and O
serum O
from O
nine O
patients O
with O
Fuchs _RARE_
' O
endothelial O
dystrophy _RARE_
, O
17 _RARE_
patients O
with O
uncomplicated _RARE_
senile O
cataract _RARE_
and O
in O
the O
secondary O
aqueous O
from O
six _RARE_
cataract _RARE_
patients O
. O

Only O
17 _RARE_
% O
of O
all O
patients O
admitted _RARE_
it O
at _RARE_
all O
times O
. O

Prazosin _RARE_
alone O
was O
effective O
in O
volume O
responsive O
patients O
at _RARE_
a O
dose O
of O
5 O
+/- O
1 O
. O
0 _RARE_
mg O
daily O
. O

T4 O
and O
FT4I _RARE_
followed O
parallel O
courses O
in O
both O
groups O
; O
during _RARE_
the O
first _RARE_
45 _RARE_
days O
, O
however O
, O
the O
values O
were O
significantly O
lower O
in O
premature O
infants O
under O
34 _RARE_
weeks O
' O
EGA _RARE_
than O
in O
term O
infants O
( O
P O
less O
than O
0 _RARE_
. O
001 O
). O

A O
three O
- O
phased _RARE_
analysis O
of O
treatment O
plans _RARE_
for _RARE_
45 _RARE_
patients O
was O
undertaken O
. O

Aspirin _RARE_
intolerance _RARE_
: O
unaltered O
susceptibility _RARE_
of O
platelet I-GENE
cyclo _RARE_
- I-GENE
oxygenase I-GENE
to O
inhibition O
by O
aspirin _RARE_
in O
vitro O
. O

These O
results O
indicate O
that O
cynomolgus _RARE_
monkeys O
are O
either O
less O
sensitive _RARE_
or O
respond O
differently O
than O
rhesus _RARE_
monkeys O
to O
some O
of O
the O
pharmacological O
effects O
of O
norcocaine _RARE_
. O

59 _RARE_
cases O
of O
surgically O
resectable _RARE_
cancers O
( O
T1 _RARE_
, O
T2 _RARE_
, O
T3 _RARE_
, O
N0 _RARE_
, O
N1 _RARE_
) O
had O
a O
minimum O
followup _RARE_
of O
two O
years O
( O
average O
4 O
years O
+/- O
3 O
months O
). O

The O
effect O
of O
CBZ _RARE_
and O
DPH _RARE_
can O
be O
explained O
by O
interference O
with O
thyroid O
hormone O
binding O
to O
TBG _RARE_
combined O
with O
enzyme O
- O
induced _RARE_
increased O
metabolic O
clearance O
rate O
of O
thyroid O
hormones _RARE_
without O
homeostatic _RARE_
maintenance _RARE_
of O
premedication _RARE_
levels O
of O
FT4 _RARE_
and O
FT3 _RARE_
. O

The O
present O
research O
evaluated O
the O
possibility O
that O
polyethylene _RARE_
glycol O
400 _RARE_
( O
PEG _RARE_
400 _RARE_
) O
might O
be O
efficacious _RARE_
, O
toxic O
, O
or O
both O
. O

According O
to O
their O
functional _RARE_
properties O
the O
latter O
neurons O
were O
subdivided _RARE_
into O
: O
( O
a O
) O
neurons O
responding O
to O
stimuli O
near O
the O
eyes O
; O
( O
b O
) O
neurons O
triggered O
by O
complex O
visual O
stimuli O
; O
( O
c O
) O
neurons O
inhibited O
by O
visual O
stimuli O
. O

Pentobarbital _RARE_
( O
1 O
, O
3 O
, O
10 O
, O
and O
17 _RARE_
. O
5 O
mg O
/ O
kg O
) O
was O
also O
tested O
in O
combination O
with O
rate O
- O
decreasing O
doses O
of O
normeperidine _RARE_
( O
17 _RARE_
. O
5 O
mg O
/ O
kg O
), _RARE_
anileridine _RARE_
( O
10 O
mg O
/ O
kg O
), _RARE_
alphaprodine _RARE_
( O
10 O
mg O
/ O
kg O
), _RARE_
and O
fentanyl O
( O
0 _RARE_
. O
3 O
mg O
/ O
kg O
). O

Pb _RARE_
foil _RARE_
( O
0 _RARE_
. O
55 _RARE_
gcm _RARE_
- O
2 O
) O
provided O
the O
best O
overall O
improvement O
. O

An O
anatomical O
and O
histochemical _RARE_
study O
has O
been O
undertaken O
and O
as _RARE_
a O
result O
emphasis _RARE_
is O
given O
to O
recent O
hypotheses _RARE_
that O
suggest O
there O
are O
similarities O
with O
Type _RARE_
IV O
glycogen _RARE_
storage _RARE_
disease _RARE_
( O
Andersen _RARE_
' O
s O
disease _RARE_
) O
which O
, O
although O
clinically O
distinct O
, O
has O
the O
same O
enzyme O
defect O
. O

All O
groups O
were O
tested O
in O
a O
Hebb _RARE_
- O
Williams _RARE_
maze _RARE_
at _RARE_
100 _RARE_
approximately _RARE_
10 O
days O
of O
age O
. O

Erythromycin _RARE_
and O
clindamycin O
resistance O
in O
Corynebacterium _RARE_
diphtheriae _RARE_
from O
skin _RARE_
lesions O
. O

Imposed _RARE_
angular _RARE_
displacements _RARE_
of O
monkey _RARE_
' O
s O
wrist O
produce O
three O
major O
peaks O
of O
activity O
( O
terms O
M1 _RARE_
, O
M2 _RARE_
, O
and O
M3 _RARE_
peaks O
) O
in O
the O
averaged O
gross O
EMG O
activity O
ot _RARE_
the O
stretched _RARE_
muscles O
. O

Hemolytic _RARE_
disease _RARE_
of O
African O
newborn O
. O

In O
this O
animal _RARE_
, O
infected _RARE_
with O
what O
was O
judged O
previously O
to O
be O
the O
less O
virulent O
of O
the O
two O
T O
. O
cruzi _RARE_
stocks _RARE_
used O
(' _RARE_
strain _RARE_
7 O
'), _RARE_
there O
was O
severe O
myocarditis _RARE_
, O
with O
myofibre _RARE_
degeneration O
, O
and O
lesions O
of O
the O
oesophagus _RARE_
. O

The O
majority O
of O
MRF _RARE_
units _RARE_
were O
behaviorally _RARE_
incongruent _RARE_
; O
in O
the O
most O
frequently O
observed O
case O
, O
their O
activity O
failed O
to O
change O
reliably _RARE_
when O
behavior O
habituated _RARE_
. O

Variability _RARE_
within O
Down _RARE_
' O
s O
syndrome _RARE_
( O
trisomy _RARE_
- O
21 O
): O
empirically _RARE_
observed O
sex _RARE_
differences O
in O
IQs _RARE_
. O

VII O
. O

Several O
demographic _RARE_
indices O
of O
isolated O
populations O
in O
Uzbekistan _RARE_

2 O
.-- _RARE_
concepts _RARE_
of O
higher _RARE_
nervous O
function O
in O
the O
USSR _RARE_
. O

The O
maintenance _RARE_
of O
increased O
myocardial _RARE_
capillary O
density O
required O
a O
similar O
amount O
of O
exercise O
, O
and O
at _RARE_
least O
1 O
h O
of O
exercise O
once O
a O
week O
was O
necessary O
to O
maintain O
the O
enlargement O
of O
ECA _RARE_
. O
20 O

These O
observations O
have O
led O
us O
to O
conclude O
that O
an O
elevated O
VIII O
- O
ratio O
is O
a O
very O
sensitive _RARE_
indicator O
of O
intravascular O
coagulation O
. O

Eight O
hours O
after O
the O
administration O
of O
colchicine _RARE_
, O
the O
serum I-GENE
ceruloplasmin _RARE_
level O
began _RARE_
to O
rise O
again O
in O
female O
rats O
, O
but O
not O
in O
male O
rats O
. O

Radioimmunoassays _RARE_
of O
pregnenolone _RARE_
, O
progesterone O
, O
dehydroepiandrosterone _RARE_
( O
DHA _RARE_
) O
16 O
alpha O
- O
hydroxy O
- O
DHA _RARE_
, O
estriol _RARE_
, O
and O
cortisol O
were O
performed O
on O
a O
total _RARE_
of O
0 _RARE_
; O
1 O
ml O
; O
of O
fetal _RARE_
plasma O
, O
collected O
during _RARE_
the O
course O
of O
normal O
vaginal O
delivery O
. O

In O
only O
two O
patients O
were O
we O
able O
to O
demonstrate O
changes O
suggestive O
of O
pulmonary O
metastases O
any O
earlier O
with O
a O
99mTc O
- O
EHDP _RARE_
scan O
than O
with O
chest O
radiographs O
and O
one O
of O
these O
resolved O
spontaneously O
. O

The O
majority O
of O
tumors O
occurred O
in O
the O
nasal O
cavities _RARE_
, O
although O
significant O
incidences _RARE_
were O
also O
found O
in O
the O
larynx O
, O
trachea _RARE_
and O
stem _RARE_
bronchi _RARE_
. O

Prediction _RARE_
of O
the O
times O
of O
sandfly _RARE_
development O

Native _RARE_
human I-GENE
fibrinogen I-GENE
was O
brought _RARE_
to O
coagulation O
by O
adding O
thrombin I-GENE
. O

No O
post O
- O
operative O
haemorrhages _RARE_
from O
the O
prostheses _RARE_
were O
observed O
. O

The O
Southern O
technique O
allowed O
a O
further O
localization _RARE_
of O
the O
region O
of O
most O
extensive O
transcription O
to O
a O
1 O
. O
8 O
kb O
HindIII I-GENE
- O
EcoRI I-GENE
fragment O
. O

Accepting _RARE_
arbitrarily _RARE_
chosen O
limits O
of O
maximized _RARE_
errors _RARE_
of O
+/- O
10 O
%, O
it O
could O
be O
shown O
that O
the O
system _RARE_
did O
not O
work O
acceptably _RARE_
when O
the O
mean O
carbon O
dioxide O
concentration O
was O
below O
1 O
. O
5 O
vol _RARE_
.% _RARE_
within O
the O
fresh O
gas O
flow O
rates O
( O
2 O
. O
2 O
-- _RARE_
7 O
. O
7 O
1 O
min O
- O
1 O
) O
and O
the O
range O
of O
minute O
ventilation O
( O
4 O
-- _RARE_
10 O
1 O
min O
- O
1 O
) O
employed O
. O

SV O
increased O
less O
in O
SHR _RARE_
, O
mainly O
reflecting O
the O
reduced _RARE_
diastolic O
compliance O
of O
the O
hypertrophied _RARE_
SHR _RARE_
left _RARE_
ventricle O
and O
the O
consequent _RARE_
rightward _RARE_
shift O
of O
its O
Frank _RARE_
- O
Starling _RARE_
curve O
. O

The O
carcass _RARE_
of O
a O
great O
horned _RARE_
owl _RARE_
( O
Bubo _RARE_
virginianus _RARE_
), _RARE_
which O
had O
been O
found O
moribund _RARE_
in O
southern O
Ontario _RARE_
, O
was O
presented O
for _RARE_
necropsy _RARE_
. O

The O
inner O
ears O
were O
exposed O
by O
microdissection _RARE_
, O
and O
the O
vestibular O
sensory O
regions O
were O
either O
sectioned _RARE_
and O
studied O
with O
light O
or O
electron O
microscopy O
, O
or O
prepared O
and O
studied O
with O
the O
surface O
specimen _RARE_
technique O
. O

Patulin _RARE_
is O
extracted O
from O
apple _RARE_
butter _RARE_
samples O
with O
ethyl O
acetate _RARE_
and O
the O
extract _RARE_
is O
cleaned _RARE_
up _RARE_
on O
a O
silica _RARE_
gel O
column O
, O
using O
benzene _RARE_
- O
ethyl O
acetate _RARE_
( O
75 _RARE_
+ O
25 _RARE_
) O
as _RARE_
the O
eluant _RARE_
. O

Steroid _RARE_
glucuronides _RARE_
in O
amniotic _RARE_
fluid _RARE_
at _RARE_
term O
. O

The O
matrix _RARE_
surrounding O
the O
clusters O
either O
showed O
a O
normal O
morphology O
or O
a O
homogeneous _RARE_
appearance O
, O
within O
which O
faint _RARE_
cross O
striations _RARE_
but O
no _RARE_
distinctly O
fibrillar _RARE_
outlines _RARE_
could O
be O
identified O
. O

Riboflavin _RARE_
did O
not O
affect O
the O
percentage O
of O
aflatoxin _RARE_
- O
treated O
animals O
with O
abnormal O
urinary _RARE_
excretion O
patterns O
, O
but O
did O
increase O
the O
magnitude O
of O
the O
disturbances O
in O
elimination O
of O
kynurenic _RARE_
and O
xanthurenic _RARE_
acids _RARE_
. O

Polyglactin _RARE_
910 _RARE_
suture _RARE_
absorption O
and O
the O
role O
of O
cellular O
enzymes _RARE_
. O

The O
incidence O
of O
DNCB _RARE_
reactions O
was O
78 _RARE_
per O
cent O
for _RARE_
Stage O
I O
and O
II O
cancers O
( O
37 O
patinets _RARE_
), _RARE_
73 _RARE_
per O
cent O
for _RARE_
resectable _RARE_
Stage O
III O
cancer _RARE_
( O
22 _RARE_
patients O
), _RARE_
and O
66 _RARE_
per O
cent O
in O
patients O
with O
unresectable _RARE_
or O
inoperable _RARE_
Stage O
III O
cancer _RARE_
. O

Studies O
of O
lipoproteins _RARE_
should O
, O
however O
, O
be O
made O
in O
children O
from O
families _RARE_
known O
to O
have O
FH _RARE_
or O
early O
coronary O
heart _RARE_
disease _RARE_
. O

Sixteen _RARE_
other O
normal O
subjects O
with O
2 O
g O
of O
Metyrapone _RARE_
are O
best O
responses O
. O

EEG O
theta _RARE_
waves O
and O
psychological O
phenomena O
: O
a O
review O
and O
analysis O
. O

REM O
dream _RARE_
content O
was O
scored _RARE_
for _RARE_
categories O
suggesting O
the O
predominant O
influence O
of O
the O
left _RARE_
hemisphere O
, O
e _RARE_
. O
g O
., O
good O
ego _RARE_
functioning O
, O
verbalization _RARE_
, O
or O
the O
right O
hemisphere O
, O
e _RARE_
. O
g O
., O
music _RARE_
, O
spatial O
salience _RARE_
, O
bizarreness _RARE_
. O

Innervation _RARE_
of O
the O
ventral O
diaphragm O
of O
the O
locust _RARE_
( O
Locusta _RARE_
migratoria _RARE_
). O

Ectopic _RARE_
ACTH I-GENE
syndrome _RARE_
and O
medullary _RARE_
thyroid O
carcinoma O
. O

A O
striking O
finding O
in O
all O
of O
the O
studies O
was O
a O
positive O
correlation O
between O
PI O
ACTH I-GENE
and O
MSH I-GENE
contents O
. O

Chronic O
hypophosphatemia _RARE_
is O
the O
most O
common O
type O
of O
" O
resistant O
" O
rickets _RARE_
. O

There O
was O
no _RARE_
correlation O
between O
serum I-GENE
LH _RARE_
and O
chronological _RARE_
or O
bone O
age O
in O
this O
age O
group O
, O
which O
suggests O
that O
the O
correlation O
found O
is O
not O
due O
to O
age O
- O
related O
parallel O
phenomena O
. O

Molecular O
neurochemistry _RARE_
of O
addictive _RARE_
drugs O
. O

Efforts _RARE_
were O
made O
to O
determine O
the O
amount O
of O
time O
required O
for _RARE_
kidney _RARE_
lesions O
to O
develop O
and O
, O
if O
possible O
, O
to O
delineate _RARE_
the O
potential _RARE_
site O
of O
action O
of O
PBB _RARE_
. O

Effect O
of O
succimer _RARE_
on O
the O
intensity O
of O
tricarboxylic _RARE_
acid I-GENE
dehydrogenase I-GENE
reactions O
in O
the O
brain O
of O
rats O
poisoned _RARE_
with O
mercuric _RARE_
chloride _RARE_

Distribution _RARE_
and O
correlations O
of O
serum O
uric O
- O
acid O
in O
two O
French _RARE_
adult O
populations O
: O
13 _RARE_
, O
885 _RARE_
men O
and O
6 O
, O
861 _RARE_
women O

The O
incidence O
of O
hepatitis I-GENE
B I-GENE
antigen I-GENE
following O
transfusion O
was O
about O
2 O
. O
8 O
per O
cent O
. O

Technetium _RARE_
- O
99m O
stannous _RARE_
pyrophosphate _RARE_
myocardial _RARE_
scintigrams _RARE_
were O
obtained O
in O
138 _RARE_
clinically O
stable O
patients O
32 _RARE_
. O
7 O
+/- O
47 _RARE_
. O
3 O
weeks O
( O
range O
6 O
to O
260 O
) O
after O
acute O
myocardial _RARE_
infarction O
. O

A O
similar O
phenomenon O
has O
been O
reported O
in O
a O
few O
humans O
. O

The O
decline O
in O
the O
activity O
of O
cytochrome I-GENE
oxidase I-GENE
, O
peroxidase I-GENE
and O
in O
the O
lipid _RARE_
content O
of O
peripheral O
neutrophils O
was O
followed O
by O
a O
decrease O
in O
the O
phagocytic O
activity O
. O

Treatment O
of O
2 O
patients O
with O
pseudohypoparathyroidism _RARE_
type O
I O
with O
vitamin O
- O
D O
- O
3 O
and O
1 O
alpha O
- O
Hydroxycholecalciferol _RARE_
consecutively _RARE_
resulted O
in O
a O
nonuniform _RARE_
response O
with O
regard O
to O
the O
normalisation _RARE_
of O
serum O
- O
calcium _RARE_
. O

Workers _RARE_
with O
" O
sensitivity O
" O
to O
toluene O
diisocyanate _RARE_
( O
TDI _RARE_
) O
studied O
in O
depth O
in O
an O
attempt O
to O
determine O
mechanisms O
of O
bronchial O
hyperreactivity _RARE_
. O

Total O
VO2 O
was O
decreased O
in O
both O
groups O
during _RARE_
severe O
hypoxia _RARE_
but O
limb O
VO2 O
was O
maintained O
in O
the O
beta O
- O
block _RARE_
group O
. O
beta O
- O
Block _RARE_
prevented O
the O
fall O
in O
total _RARE_
and O
limb O
peripheral O
resistance O
seen O
in O
severe O
hypoxia _RARE_
but O
did O
not O
alter O
the O
consistently O
more O
efficient O
utilization O
of O
total _RARE_
O2 _RARE_
delivery O
shown O
by O
the O
limb O
in O
comparison O
to O
the O
whole O
body O
by O
higher _RARE_
O2 _RARE_
extraction O
ratios O
and O
lower O
venous O
O2 _RARE_
pressure O
. O
beta I-GENE
- I-GENE
Vasodilator _RARE_
receptors I-GENE
evidently _RARE_
played O
an O
active _RARE_
part O
in O
the O
vasodilatation _RARE_
seen O
during _RARE_
severe O
hypoxia _RARE_
. O

Phenobarbital _RARE_
- O
induced _RARE_
alterations O
in O
the O
metabolism O
of O
[ _RARE_
3H O
] O
vitamin O
D3 _RARE_
by O
the O
perfused O
rachitic _RARE_
rat O
liver O
in O
vitro O
. O

Modulation _RARE_
of O
25 _RARE_
- I-GENE
hydroxyvitamin _RARE_
D3 _RARE_
- I-GENE
24 _RARE_
- I-GENE
hydroxylase I-GENE
by O
aminophylline _RARE_
: O
a O
cytochrome I-GENE
P I-GENE
- I-GENE
450 _RARE_
monooxygenase _RARE_
system _RARE_
. O

In O
both O
these O
respects _RARE_
, O
however O
, O
the O
DBP _RARE_
mRNA I-GENE
resembles O
the O
late _RARE_
messengers _RARE_
of O
SV40 O
and O
polyoma _RARE_
viruses O
. O

Effect O
of O
corticosteroid _RARE_
- O
containing O
antirheumatic _RARE_
combination O
drugs O
on O
endogenous O
ACTH I-GENE
and O
cortisol O
production O
. O

Serum I-GENE
ACTH I-GENE
did O
not O
respond O
to O
insulin I-GENE
and O
metyrapone _RARE_
. O

Anatomy _RARE_
of O
the O
RNA O
and O
gene O
products O
of O
MC29 _RARE_
and O
MH2 _RARE_
, O
two O
defective _RARE_
avian O
tumor O
viruses O
causing O
acute O
leukemia O
and O
carcinoma O
: O
evidence O
for _RARE_
a O
new O
class O
of O
transforming O
genes O
. O

Bertioga _RARE_
( O
Guama _RARE_
group O
) O
and O
Anhembi _RARE_
( O
Bunyamwera _RARE_
group O
), _RARE_
two O
new O
arboviruses _RARE_
isolated O
in O
Sao _RARE_
Paulo _RARE_
, O
Brazil _RARE_
. O

Gamma _RARE_
glutamyl I-GENE
transpeptidase _RARE_
activity O
was O
increased O
up _RARE_
to O
15 _RARE_
times O
above O
the O
upper O
normal O
limit O
in O
children O
, O
who O
received O
aminopyrine _RARE_
for _RARE_
two O
weeks O
or O
longer O
. O

XXI _RARE_
. O

A O
gas O
- O
liquid O
chromatographic O
method O
for _RARE_
the O
determination O
of O
p O
- O
chlorophenoxyisobutyric _RARE_
( O
CPIB _RARE_
) O
acid O
in O
blood _RARE_
plasma O
is O
described O
. O

Dopamine _RARE_
receptor I-GENE
blockade O
and O
the O
neuroleptics _RARE_
, O
a O
crystallographic _RARE_
study O
. O

V O
. O

A O
rapid O
fluorimetric _RARE_
procedure O
for _RARE_
the O
determination O
of O
the O
fungicide _RARE_
5 O
- O
fluorocytosine _RARE_
in O
serum O
is O
described O
. O

The O
' O
field O
of O
stress O
' O
of O
the O
supervisory _RARE_
nurse O

How _RARE_
do O
graduates _RARE_
of O
different O
types _RARE_
of O
programs O
perform O
on O
state O
boards _RARE_
? O

Similarly O
, O
maternal _RARE_
serum I-GENE
somatomedin _RARE_
A I-GENE
was O
significantly O
reduced _RARE_
in O
rats O
nursing O
large O
litters _RARE_
. O

The O
sequences O
following O
the O
X O
. O
borealis _RARE_
oocyte _RARE_
and O
somatic O
5S I-GENE
genes I-GENE
are O
identical O
in O
12 O
of O
the O
first _RARE_
14 O
residues O
and O
contain O
two O
or O
more O
T O
clusters O
, O
as _RARE_
does O
the O
corresponding O
region O
of O
X I-GENE
. I-GENE
laevis _RARE_
oocyte _RARE_
5S I-GENE
DNA I-GENE
. O

This O
mechanism O
is O
not O
due O
to O
the O
observed O
grain _RARE_
boundary O
precipitates _RARE_
. O

This O
report O
has O
reviewed O
some O
of O
the O
reasons _RARE_
for _RARE_
treatment O
failures _RARE_
and O
has O
presented O
a O
philosophy _RARE_
for _RARE_
their O
management O
. O

Diagnosis O
and O
treatment O
planning O
in O
Class _RARE_
II O
, O
division O
2 O

Because O
of O
serious O
infections O
( O
fever O
larger O
than O
or O
equal O
to O
101 _RARE_
degrees O
F O
. O
granulocytes _RARE_
less O
than O
1 O
, O
000 _RARE_
/ O
mm O
, O
3 O
and O
hospitalization _RARE_
) O
and O
1 O
drug O
death _RARE_
in O
the O
first _RARE_
4 O
patients O
, O
oral O
calcium _RARE_
leucovorin _RARE_
, O
20 O
to O
30 _RARE_
mg O
/ O
m2 O
orally O
, O
was O
given O
2 O
days O
after O
methotrexate O
in O
subsequent O
treatment O
cycles O
. O

It O
seems O
that O
the O
way O
in O
which O
drugs O
modify O
a O
patient O
' O
s O
serum O
chemistry O
may O
be O
used O
to O
assess O
the O
efficacy O
with O
which O
they O
control O
the O
inflammatory O
process O
. O

Here O
the O
conventional O
tests O
clearly O
pointed _RARE_
to O
the O
presence O
of O
retrocochlear _RARE_
disease _RARE_
. O

The O
end O
- O
stage _RARE_
or O
involutional _RARE_
phase _RARE_
of O
proliferative O
diabetic O
retinopathy _RARE_
may O
result O
in O
stabilization O
of O
vision O
for _RARE_
long O
periods O
of O
time O
. O

On O
the O
basis O
of O
serum I-GENE
alpha1AT _RARE_
quantitation _RARE_
, O
newborn O
infants O
may O
be O
separated O
into O
two O
groups O
, O
characterized O
respectively O
by O
concentrations O
above O
or O
below O
150 _RARE_
mg O
%. O

In O
patients O
who O
were O
not O
vented _RARE_
, O
there O
was O
overall O
significant O
depression O
of O
function O
( O
67 O
+/- O
5 O
% O
of O
control O
; O
range O
, O
91 O
-- _RARE_
45 _RARE_
%, O
p O
less O
than O
0 _RARE_
. O
01 O
). O

Changes O
in O
body O
weight _RARE_
and O
agonistic _RARE_
behavior O
were O
also O
recorded O
. O

The O
uterine _RARE_
response O
to O
prostaglandin _RARE_
E2 O
( O
PGE2 O
) O
and O
prostaglandin _RARE_
F2alpha _RARE_
( O
administered O
by O
intravenous O
and O
intrauterine O
routes O
) O
was O
evaluated O
during _RARE_
different O
phases O
of O
the O
menstrual O
cycle _RARE_
in O
five O
functionally O
infertile _RARE_
women O
. O

A O
total _RARE_
of O
26 _RARE_
BCG O
strains O
, O
out O
of O
them O
10 O
Czechoslovak _RARE_
strains O
( O
2 O
lyophilized _RARE_
cultures O
of O
BCG O
of O
different O
batch _RARE_
, O
6 O
strains O
isolated O
from O
abscesses _RARE_
of O
children O
after O
BCG O
- O
vaccination O
and O
2 O
strains O
from O
fatal O
cases O
after O
BCG O
- O
vaccination O
) O
and O
16 O
strains O
obtained O
from O
foreign O
laboratories O
, O
were O
used O
. O

High _RARE_
levels O
of O
serum O
calcitonin I-GENE
were O
found O
in O
patients O
with O
chronic O
renal _RARE_
failure O
. O

Detection O
of O
anti O
- O
lymphocyte O
antibodies O
using O
the O
immunoperoxidase _RARE_
antiglobulin _RARE_
technic _RARE_
. O

The O
response O
of O
serum I-GENE
GH _RARE_
to O
arginine _RARE_
infusion O
was O
normal O
, O
while O
that O
to O
insulin I-GENE
- O
induced _RARE_
hypoglycemia _RARE_
was O
poor O
. O

The O
mortality O
rate O
and O
histopathological O
features O
of O
Nocardia _RARE_
asteroides _RARE_
and O
Nocardia _RARE_
brasiliensis _RARE_
infections O
in O
congenitally _RARE_
athymic _RARE_
( O
nude O
) O
mice O
of O
ICR _RARE_
and O
C3H O
/ O
eB _RARE_
origins O
were O
quite O
different O
from O
what O
we O
found O
for _RARE_
Swiss _RARE_
white _RARE_
mice O
and O
other O
inbred _RARE_
mouse O
strains O
( O
namely O
, O
C57 _RARE_
/ O
BL _RARE_
/ O
6J _RARE_
, O
New O
Zealand _RARE_
Black _RARE_
, O
BALB _RARE_
/ O
c O
, O
CBA _RARE_
/ O
LAC _RARE_
, O
and O
C3H O
/ O
eB _RARE_
). O

Williams _RARE_
, O
2 O
August O
1977 _RARE_
. O

Use O
of O
radioactive _RARE_
isotopes _RARE_
in O
the O
chemistry O
of O
proteins O

( O
Emeritus _RARE_
) O
John _RARE_
Henri _RARE_
Roosegaarde _RARE_
Bisschop _RARE_

Disrupted _RARE_
vaccines O
and O
whole O
- O
virus O
vaccines O
containing O
type I-GENE
B I-GENE
antigen I-GENE
only O
did O
not O
cause O
significant O
reactivity O
. O

255 _RARE_
- O
61 _RARE_
. O

Antenatal _RARE_
diagnosis O
of O
haematological _RARE_
disorders O
--' _RARE_
1978 _RARE_
'. O

Hepatic _RARE_
oxygen O
supply O
and O
selected _RARE_
blood _RARE_
parameters O
were O
recorded O
in O
fasted O
male O
rates O
given O
20 O
-- _RARE_
30 _RARE_
mg O
/ O
kg O
Escherichia I-GENE
coli I-GENE
endotoxin _RARE_
intraperitoneally _RARE_
. O

Gonadal _RARE_
dysfunction O
in O
patients O
with O
ataxia _RARE_
telangiectasia _RARE_
. O

The O
maximum O
period O
of O
treatment O
was O
73 _RARE_
( O
oral O
), _RARE_
73 _RARE_
( O
intraperitoneal _RARE_
) O
or O
75 _RARE_
( O
dermal O
) O
weeks O
. O

A O
study O
of O
the O
comparative O
efficacy O
of O
diflucortolone _RARE_
valerate _RARE_
0 _RARE_
. O
3 O
% O
ointment _RARE_
and O
clobetasol _RARE_
propionate _RARE_
0 _RARE_
. O
05 O
% O
ointment _RARE_
. O

Most O
of O
the O
phenomena O
of O
azotaemic _RARE_
osteodystrophy _RARE_
are O
encountered _RARE_
in O
simple O
vitamin O
D O
deficiency O
; O
as _RARE_
in O
that O
condition O
, O
deficiency O
of O
1 O
, O
25 _RARE_
- O
dihydroxycholecalciferol _RARE_
may O
be O
of O
primary _RARE_
significance O
in O
causing O
secondary O
hyperparathyroidism _RARE_
in O
renal _RARE_
failure O
. O

Basal O
FSH I-GENE
and O
LH _RARE_
levels O
were O
significantly O
lower O
in O
addicts O
; O
after O
GnRH I-GENE
stimulation _RARE_
the O
addicts O
' O
FSH I-GENE
and O
LH _RARE_
values O
increased O
but O
not O
significantly O
compared O
to O
controls O
. O

Adriamycin _RARE_
: O
comparison O
of O
a O
5 O
- O
week O
schedule O
with O
a O
3 O
- O
week O
schedule O
in O
the O
treatment O
of O
breast O
cancer _RARE_
. O

Follow _RARE_
- O
up _RARE_
controls O
of O
luteinizing _RARE_
hormone I-GENE
( O
LH _RARE_
), _RARE_
follicle _RARE_
stimulating I-GENE
hormone I-GENE
( O
FSH I-GENE
), _RARE_
prolactin I-GENE
( O
HPRL _RARE_
), _RARE_
oestradiol O
( O
E2 O
), _RARE_
progesterone O
( O
P O
) O
and O
testosterone O
( O
T O
) O
in O
the O
catabolic _RARE_
and O
healing O
phase _RARE_
of O
burn O
disease _RARE_
. O

Renin _RARE_
studies O
performed O
in O
34 _RARE_
hypertensive O
patients O
and O
in O
a O
control O
group O
of O
11 O
recipients O
showed O
that O
elevation O
of O
plasma I-GENE
renin I-GENE
activity O
and O
of O
plasma O
aldosterone O
level O
is O
frequent O
but O
difficult O
to O
interpret _RARE_
, O
particularly O
when O
a O
renal _RARE_
artery O
stenosis O
is O
observed O
. O

A O
randomized O
clinical O
trial O
in O
sixty _RARE_
- O
two O
adult O
patients O
suffering O
from O
typhoid _RARE_
fever O
, O
proved O
by O
blood _RARE_
and O
marrow O
culture O
, O
showed O
that O
amoxycillin _RARE_
in O
a O
dosage O
schedule O
of O
1 O
g O
8 O
- O
hourly _RARE_
orally O
for _RARE_
fourteen _RARE_
days O
was O
better O
than O
chloramphenicol O
with O
regard O
to O
clinical O
and O
temperature _RARE_
response O
and O
in O
respect O
of O
carriers O
and O
relapse O
rates O
. O

202 _RARE_
- O
8 O
. O

Bone _RARE_
marrow O
transplantation O
- O
1979 _RARE_
. O

In O
this O
article O
, O
the O
clinical O
actions O
of O
the O
principal O
dopamine I-GENE
receptor I-GENE
stimulating O
agents O
( O
apomorphine _RARE_
and O
its O
derivatives _RARE_
; O
piribedil _RARE_
, O
rye _RARE_
- O
ergot _RARE_
derivatives _RARE_
) O
are O
discussed O
on O
the O
basis O
of O
their O
biochemical O
and O
pharmacological O
properties O
. O

The O
unilateral O
vestibular O
hypofunction _RARE_
. O

Thus O
, O
the O
inhibition O
of O
pepsin _RARE_
in O
human O
gastric _RARE_
juice O
does O
not O
appear O
to O
have O
a O
major O
influence O
on O
the O
healing O
of O
duodenal O
ulcer O
. O

The O
IDF _RARE_
standard O
method O
for _RARE_
the O
detection O
of O
penicillin _RARE_
in O
milk O
is O
not O
suitable O
for _RARE_
the O
detection O
of O
sulphonamide _RARE_
residues O
in O
milk O
. O

Capsular _RARE_
antigens O
of O
Staphylococcus _RARE_
aureus _RARE_

The O
course O
of O
endotoxin _RARE_
fever O
remained O
uninfluenced _RARE_
by O
ALS _RARE_
. O

2 O
new O
Algerian _RARE_
cases O

Seventy O
- O
one O
percent O
of O
patients O
treated O
with O
ticarcillin _RARE_
alone O
responded O
favorably _RARE_
. O

Accurate _RARE_
pathologic O
staging _RARE_
identifies O
patients O
who O
are O
potentially O
curable _RARE_
with O
radiotherapy O
. O

Inherent _RARE_
hematology _RARE_
of O
old O
age O

Neomycin _RARE_
is O
fairly _RARE_
effective O
against O
staphylococci _RARE_
, O
less O
effective O
against O
streptococci _RARE_
, O
and O
fairly _RARE_
effective O
against O
gram O
- O
negative O
intestinal _RARE_
organisms O
. O

It O
was O
concluded O
, O
that O
on O
a O
given O
section O
, O
75 _RARE_
, O
7 O
per O
cent O
of O
the O
trabeculae _RARE_
were O
in O
contact _RARE_
with O
vascular O
cavities _RARE_
. O

2 O
. O

Changes O
in O
tissue O
PCO2 O
were O
less O
dramatic O
and O
did O
not O
vary O
significantly O
from O
those O
recorded O
in O
venous O
blood _RARE_
. O

Ultrasonic _RARE_
evaluation O
of O
renal _RARE_
calculi _RARE_
. O

Recognition _RARE_
of O
emphysema O
was O
poor O
when O
radiographs O
of O
inadequate _RARE_
quality O
were O
included O
( O
anteroposterior O
films O
or O
films O
from O
patients O
with O
acute O
or O
chronic O
lung _RARE_
disease _RARE_
). O

Isolation O
of O
T O
. O
gambiense _RARE_
strains O
in O
Zaire _RARE_
and O
their O
adaptation O
to O
laboratory O
animals O

Pharmacokinetic _RARE_
profile O
of O
clonazepam _RARE_
in O
rhesus _RARE_
monkeys O
. O

Immunologic _RARE_
mechanisms O
in O
chronic O
brucellosis _RARE_
in O
humans O
. O

Intestinal _RARE_
adaptation O
( O
first _RARE_
of O
two O
parts O
). O

In O
patients O
who O
had O
received O
no _RARE_
previous O
drug O
treatment O
, O
log O
baseline O
plasma I-GENE
renin I-GENE
activity O
and O
change O
in O
mean O
blood _RARE_
pressure O
after O
SQ _RARE_
20881 _RARE_
correlated O
significantly O
( O
r _RARE_
= O
0 _RARE_
. O
651 _RARE_
, O
P O
less O
than O
0 _RARE_
. O
05 O
). O

These O
techniques O
have O
been O
used O
by O
many O
people O
for _RARE_
many O
years O
and O
no _RARE_
claim _RARE_
is O
being O
made O
for _RARE_
any O
innovation _RARE_
in O
this O
regard O
. O

40 O
patients O
with O
chronic O
osteomyelitis _RARE_
were O
treated O
per O
os _RARE_
with O
the O
bactericidal O
beta O
- O
lactam _RARE_
- O
antibiotic O
cephalexin _RARE_
during _RARE_
3 O
to O
60 _RARE_
weeks O
. O

A O
total _RARE_
of O
57 O
patients O
with O
Hodgkin O
' O
s O
disease _RARE_
limited O
to O
above O
the O
diaphragm O
( O
Stages _RARE_
I O
and O
II O
, O
A O
and O
B O
) O
were O
treated O
with O
radiation O
therapy O
alone O
at _RARE_
the O
University O
of O
Florida _RARE_
between O
1964 _RARE_
and O
1974 _RARE_
. O

Year _RARE_
one O
of O
the O
first _RARE_
general _RARE_
practitioner _RARE_
medical O
unit O
in O
the O
greater O
Glasgow _RARE_
area O
. O

This O
multiple O
- O
electrode O
array _RARE_
for _RARE_
round O
window _RARE_
cochlear O
implantation O
is O
a O
robust _RARE_
, O
reliable O
system _RARE_
for _RARE_
inserting O
20 O
mm O
along O
the O
scala _RARE_
tympani _RARE_
with O
a O
minimum O
of O
trauma O
and O
can O
provide O
for _RARE_
bipolar O
stimulation _RARE_
. O

As O
authorized _RARE_
by O
the O
World _RARE_
Health O
Organization O
29th _RARE_
Expert _RARE_
Committee O
on O
Biological O
Standardization _RARE_
, O
the O
preparation O
of O
human I-GENE
prolactin I-GENE
in O
ampoules _RARE_
coded O
75 _RARE_
/ O
504 _RARE_
has O
been O
established O
as _RARE_
the O
International O
Reference _RARE_
Preparation _RARE_
( O
IRP _RARE_
) O
of O
human I-GENE
prolactin I-GENE
for _RARE_
immunoassay O
. O

i O
. O

Biliary _RARE_
- O
enteric O
fistulas _RARE_

Plasma O
ion O
changes O
in O
venous O
blood _RARE_
incubated O
with O
beta I-GENE
receptor I-GENE
blockers O
and O
subjected O
to O
tonometry _RARE_
in O
vitro O
. O

Such O
marked O
differences O
are O
found O
occasionally _RARE_
in O
the O
literature O
: O
heterophile _RARE_
antibodies O
against O
bovine I-GENE
gammaglobulin _RARE_
are O
regarded O
as _RARE_
responsible O
for _RARE_
the O
interference O
in O
the O
Sephadex _RARE_
system _RARE_
of O
RIST _RARE_
. O

" O
Let _RARE_
the O
hundred O
flowers _RARE_
bloom _RARE_
". O

Various O
treatment O
modalities O
are O
reviewed O
in O
the O
context O
of O
the O
psychology _RARE_
as _RARE_
well _RARE_
as _RARE_
the O
physiology O
of O
severe O
intractable _RARE_
pain O
. O

Lethal _RARE_
Tachmalcor _RARE_
( O
4 O
-( _RARE_
3 O
'- O
diethylamino _RARE_
- O
2 O
'- O
hydroxypropyl _RARE_
)- O
ajmaline _RARE_
) O
poisoning O
in O
childhood O

Ophthalmosonographic _RARE_
evaluation O
of O
blood _RARE_
flow O
velocity O
in O
arteriocavernous _RARE_
fistula _RARE_

Serum O
ferritin I-GENE
concentration O
and O
bone O
marrow O
iron O
stores _RARE_
. O

The O
systolic O
pressure O
gradient O
( O
SPG _RARE_
) O
between O
the O
left _RARE_
ventricle O
( O
LV O
) O
and O
left _RARE_
atrium O
( O
LA O
) O
was O
obtained O
from O
high O
- O
fidelity _RARE_
pressure O
transducers _RARE_
. O

A O
prospective O
trail _RARE_
comparing O
hysterectomy O
, O
hysterectomy O
plus _RARE_
vaginal O
radium _RARE_
, O
and O
uterine _RARE_
radium _RARE_
plus _RARE_
hysterectomy O
in O
stage _RARE_
I O
endometrial O
carcinoma O
. O

On O
the O
basis O
of O
a O
patient O
' O
s O
report O
of O
one O
inaccurate _RARE_
Clinitemp _RARE_
, O
we O
undertook _RARE_
to O
investigate O
the O
accuracy O
of O
this O
thermometer _RARE_
. O

Cryoglobulinemia _RARE_
in O
Raynaud _RARE_
' O
s O
syndrome _RARE_

Data O
were O
processed O
with O
a O
semi _RARE_
- O
automatic O
computer O
program O
which O
develops _RARE_
an O
averaged O
- O
volume O
curve O
from O
an O
assigned O
LV O
region O
- O
of O
- O
interest O
. O

The O
preferential O
serum I-GENE
IgA I-GENE
response O
observed O
in O
the O
patient O
population O
suggests O
that O
bronchial O
associated O
lymphoid _RARE_
tissue O
in O
the O
diseased O
lung _RARE_
is O
an O
important O
source O
of O
circulating O
IgA I-GENE
. O

Ultimate _RARE_
strengthes _RARE_
seem O
to O
be O
reached O
for _RARE_
cast _RARE_
cobalt _RARE_
alloys _RARE_
, O
whereas O
titanium _RARE_
alloys _RARE_
, O
such O
as _RARE_
Ta _RARE_
6 O
V O
, O
present O
very O
high O
fatigue _RARE_
limit O
under O
corrosion _RARE_
. O

The O
effects O
of O
intracisternal _RARE_
injection O
( O
i O
. O
c O
. O
i O
.) O
of O
clonidine _RARE_
( O
1 O
microgram O
kg O
- O
1 O
) O
on O
blood _RARE_
pressure O
and O
heart _RARE_
rate O
were O
studied O
in O
conscious O
rabbits O
with O
an O
implanted O
catheter O
in O
the O
cisterna _RARE_
magna _RARE_
. O

Platelet _RARE_
number O
and O
life O
span O
were O
determined O
in O
the O
last O
trimester _RARE_
of O
pregnancy _RARE_
in O
22 _RARE_
women O
who O
were O
delivered O
of O
small O
- O
for _RARE_
- O
gestational O
age O
( O
SGA _RARE_
) O
infants O
and O
in O
21 O
women O
with O
infants O
having O
normal O
birth O
weights O
. O

Serial _RARE_
measurements O
of O
total _RARE_
serum O
IgE I-GENE
appears O
to O
be O
a O
useful O
index O
of O
disease _RARE_
activity O
in O
ABPA _RARE_
. O

In O
the O
8 O
patients O
the O
difference O
betweent _RARE_
he _RARE_
mean O
diastolic O
values O
of O
delta O
PU _RARE_
and O
delta O
PM _RARE_
was O
- O
0 _RARE_
. O
54 O
+/- O
1 O
. O
0 _RARE_
( O
SD O
) O
mmHg O
. O

A O
rise O
of O
hemoglobin I-GENE
concentration O
accompanied O
by O
an O
increase O
of O
the O
total _RARE_
iron O
in O
the O
blood _RARE_
serum O
of O
white _RARE_
mice O
was O
found O
under O
oxygen O
pressure O
of O
4 O
atm _RARE_
for _RARE_
an O
hour O
( O
preconvulsive _RARE_
state O
) O
and O
6 O
atm _RARE_
( O
convulsive _RARE_
state O
). O

Nernst _RARE_
-- _RARE_
Planck _RARE_
analog O
equations _RARE_
and O
stationary O
state O
membrane O
electric _RARE_
potentials O
. O

Effects O
of O
methylene O
chloride _RARE_
, O
trichloroethane _RARE_
, O
trichloroethylene _RARE_
, O
tetrachloroethylene _RARE_
and O
toluene O
on O
the O
development O
of O
chick _RARE_
embryos _RARE_
. O

Effect O
of O
intraventricular _RARE_
administration O
of O
streptolysin _RARE_
O I-GENE
on O
the O
electroencephalogram _RARE_
of O
rabbits O
. O

In O
this O
situation _RARE_
the O
convlusion _RARE_
threshold O
for _RARE_
the O
8 O
substances O
is O
as _RARE_
follows O
: O
pethidine _RARE_
20 O
mg O
. O
kg O
- O
1 O
I O
. O
V O
., O
piritramide _RARE_
30 _RARE_
, O
morphine _RARE_
180 O
, O
phenoperidine _RARE_
4 O
, O
R O
39 _RARE_
209 _RARE_
5 O
, O
fentanyl O
4 O
, O
sufentanil _RARE_
4 O
and O
R O
34 _RARE_
995 _RARE_
10 O
mg O
. O
kg O
- O
1 O
I O
. O
V O
. O

The O
biochemistry _RARE_
of O
amniotic _RARE_
fluid _RARE_
with O
poor O
fetal _RARE_
growth O
. O

Roentgenographically _RARE_
, O
the O
lesion O
was O
usually O
a O
well _RARE_
- O
defined O
and O
benign O
appearing _RARE_
one O
, O
either O
purely _RARE_
lytic O
( O
3 O
cases O
) O
or O
with O
central O
radiodensity _RARE_
( O
2 O
cases O
). O

Effects O
of O
chronic O
descending _RARE_
tractotomy _RARE_
on O
the O
response O
patterns O
of O
neurons O
in O
the O
trigeminal _RARE_
nuclei O
principalis _RARE_
and O
oralis _RARE_
. O

Efficacy _RARE_
of O
a O
three O
- O
versus O
a O
five O
- O
week O
alcohol _RARE_
treatment O
program O
. O

Resistance O
to O
the O
simulated O
physiologic _RARE_
environment O
was O
tested O
by O
measured O
retention O
of O
mechanical O
properties O
after O
immersion O
times O
in O
pseudo _RARE_
- O
extracellular O
fluid _RARE_
( O
PECF _RARE_
) O
at _RARE_
37 O
degrees O
C O
for _RARE_
as _RARE_
long O
as _RARE_
three O
years O
. O

Isolated _RARE_
calcaneal _RARE_
tuberculous O
osteomyelitis _RARE_
. O

It O
is O
concluded O
that O
opiate _RARE_
receptors I-GENE
bordering _RARE_
the O
fourth O
cerebral O
ventricle O
mediate O
the O
cardiovascular O
and O
hypnotic _RARE_
action O
of O
fentanyl O
. O

In O
case O
of O
a O
pathologically _RARE_
convoluted _RARE_
internal O
carotid O
the O
common O
carotid O
artery O
was O
resected _RARE_
with O
an O
end O
- O
to O
- O
end O
anastomosis O
. O

This O
expression _RARE_
assumes _RARE_
: O
( O
1 O
) O
a O
laminar _RARE_
flow O
regimen O
during _RARE_
expiration _RARE_
, O
and O
( O
2 O
) O
a O
constant O
CT _RARE_
value O
over O
the O
range O
of O
VT O
. O

These O
data O
confirm O
the O
existence O
of O
hyperlipemic _RARE_
abdominal O
crisis _RARE_
as _RARE_
a O
distinct O
entity _RARE_
and O
testify _RARE_
to O
the O
importance O
of O
recognizing _RARE_
this O
syndrome _RARE_
in O
order O
to O
avoid O
the O
occurrence O
of O
acute O
pancreatitis O
and O
the O
performance O
of O
unnecessary _RARE_
and O
potentially O
harmful _RARE_
surgery O
. O

In O
addition O
a O
significant O
Treatment O
X O
Strain _RARE_
interaction O
was O
due O
to O
the O
larger O
defecation _RARE_
numbers O
displayed O
by O
the O
taurine _RARE_
- O
injected O
MR O
rats O
relative O
to O
the O
saline O
- O
injected O
MR O
rats O
. O

Their O
conduction O
velocity O
ranged O
from O
0 _RARE_
. O
23 _RARE_
to O
0 _RARE_
. O
98 O
m O
/ O
sec O
( O
group O
C O
). O

The O
failures _RARE_
frequently O
were O
related O
to O
patient O
intolerance _RARE_
or O
poor O
mechanical O
fit O
and O
occurred O
in O
the O
first _RARE_
few O
days O
or O
first _RARE_
few O
months O
after O
insertion _RARE_
. O

The O
major O
urinary _RARE_
metabolites O
were O
3 O
-( _RARE_
3 O
- O
carboxyphenyl _RARE_
)- O
5 O
- O
hydroxymethyl _RARE_
- O
2 O
- O
oxazolidinone _RARE_
and O
a O
glucuronide _RARE_
of O
toloxatone _RARE_
. O

These O
characteristics O
indicated O
the O
pronounced O
activity O
of O
collagenous _RARE_
fiber O
synthesis _RARE_
and O
the O
matrix _RARE_
of O
the O
osteoid _RARE_
tissue O
. O

The O
ventilation O
did O
not O
increase O
when O
PACO2 _RARE_
was O
increased O
. O

Carbohydrate _RARE_
metabolism O
and O
the O
semen O
profile O
: O
glucose O
, O
insulin I-GENE
, O
and O
sperm O
studies O
. O

It O
has O
come _RARE_
out O
that O
CAEC _RARE_
is O
between O
CC _RARE_
and O
CIEC _RARE_
and O
that O
attacks O
of O
biliary O
fever O
and O
high O
levels O
of O
alkaline _RARE_
phosphatase I-GENE
and O
transaminases _RARE_
in O
the O
serum O
are O
the O
helpful O
findings O
for _RARE_
preoperative O
diagnosis O
. O

The O
sub O
- O
acute O
inhalation O
toxicity O
of O
furfural _RARE_
was O
studied O
in O
Syrian _RARE_
golden _RARE_
hamsters O
. O

Changes O
of O
thirtynine _RARE_
serum O
protein O
components _RARE_
following O
surgical O
stress O
. O

These O
differences O
are O
smaller O
than O
those O
described O
in O
standard O
textbooks _RARE_
. O

A O
study O
of O
the O
E O
. O
O O
. O
R O
. O
T O
. O
C O
. O

The O
present O
study O
examined O
the O
dependence O
of O
difference O
tone O
level O
[ _RARE_
L O
( O
f2 _RARE_
- O
f1 _RARE_
)] O
on O
the O
following O
parameters O
of O
the O
two O
- O
tone O
input O
: O
f1 _RARE_
, O
f2 _RARE_
/ O
f1 _RARE_
( O
f2 _RARE_
greater O
than O
f1 _RARE_
), _RARE_
L1 O
, O
L2 O
, O
and O
L1 O
= O
L2 O
. O

An O
intravenous O
preparation O
of O
doxycycline _RARE_
( O
DOTC _RARE_
, O
Vibramycin _RARE_
' O
Pfizer _RARE_
'), _RARE_
a O
long O
- O
lasting O
tetracycline _RARE_
, O
was O
administered O
mainly O
by O
drip _RARE_
infusion O
for _RARE_
a O
series O
of O
study O
in O
the O
pediatrics _RARE_
field O
, O
and O
the O
results O
were O
as _RARE_
follows O
: O
1 O
) O
DOTC _RARE_
( O
100 _RARE_
mg O
) O
was O
dissolved _RARE_
in O
a O
100 _RARE_
ml O
of O
glucose O
solution O
and O
2 O
-- _RARE_
3 O
mg O
/ O
kg O
was O
administered O
intravenously O
. O

5 O
) O
Before _RARE_
and O
ten O
days O
after O
DOTC _RARE_
infusion O
, O
laboratory O
tests O
for _RARE_
liver O
and O
renal _RARE_
functions O
and O
blood _RARE_
were O
performed O
. O

Structural O
characteristics O
of O
the O
erythrocyte _RARE_
membrane O
, O
peroxidation O
processes O
and O
antioxidant O
function O
in O
children O
with O
diffuse O
glomerulonephritis O

The O
enteric O
route O
is O
the O
principal O
mode O
of O
transmission _RARE_
for _RARE_
hepatitis O
A O
, O
but O
maximal O
levels O
of O
hepatitis O
A O
virus O
excretion O
occur O
before O
the O
onset O
of O
jaundice O
. O

All O
13 _RARE_
patients O
showed O
endoscopic _RARE_
evidence O
of O
oesophagitis _RARE_
, O
moderate O
in O
4 O
and O
severe O
in O
9 O
. O

Urinary _RARE_
excretion O
of O
oestrone _RARE_
, O
oestradiol O
- O
17 _RARE_
beta O
and O
oestriol _RARE_
in O
pregnancies _RARE_
complicated O
by O
steroid I-GENE
sulphatase _RARE_
deficiency O
. O

Both O
reduced _RARE_
spontaneous O
locomotor O
activity O
in O
mice O
, O
protected O
them O
from O
death _RARE_
from O
amphetamine O
induced _RARE_
toxicity O
, O
prolonged O
hexobarbitone _RARE_
sleeping _RARE_
time O
and O
caused O
a O
depletion O
of O
catecholamines O
from O
various O
organs O
of O
the O
rat O
. O

On O
the O
role O
of O
transferrin I-GENE
in O
the O
uptake O
of O
gallium _RARE_
by O
tumor O
cells O
. O

Irradiation _RARE_
of O
human O
blood _RARE_
platelets O
with O
UV _RARE_
- O
A O
in O
vitro O
impairs _RARE_
their O
ability O
to O
aggregate _RARE_
after O
challenge O
with O
collagen _RARE_
. O

With O
certain O
exceptions _RARE_
the O
method O
was O
considered O
suitable O
in O
the O
routine O
intravenous O
cholangiography _RARE_
. O

Following O
the O
satisfactory O
results O
and O
taking O
into O
account O
that O
the O
complications O
had O
reduced _RARE_
to O
a O
very O
low O
rate O
( O
in O
2 O
cases O
lead O
tip _RARE_
displacement _RARE_
and O
pouch _RARE_
haematoma _RARE_
occurred O
respectively O
), _RARE_
the O
Authors _RARE_
consider O
the O
adopted O
method O
an O
useful O
approach O
for _RARE_
PMK _RARE_
implantation O
particularly O
when O
the O
use O
of O
the O
vena _RARE_
cephalica _RARE_
is O
deemed _RARE_
impossible _RARE_
. O

When O
two O
determinations O
were O
performed O
on O
12 O
samples O
of O
plasma O
taken O
from O
normal O
adults O
in O
October _RARE_
, O
the O
values O
were O
22 _RARE_
. O
6 O
+/- O
4 O
. O
8 O
and O
21 O
. O
0 _RARE_
+/- O
3 O
. O
6 O
( O
mean O
+/- O
SD O
) O
ng _RARE_
/ O
ml O
, O
respectively O
. O

The O
six _RARE_
commonest _RARE_
causes O
of O
death _RARE_
varied O
in O
the O
three O
ethnic _RARE_
groups O
. O

Although O
Grice _RARE_
' O
s O
operation O
has O
been O
used O
all O
over O
the O
world O
, O
no _RARE_
systematic O
account O
of O
it O
has O
been O
found O
in O
the O
literature O
( O
including O
publications _RARE_
dealing _RARE_
with O
technique O
), _RARE_
which O
presents O
it O
in O
terms O
related O
to O
the O
basic O
" O
classical O
" O
principles _RARE_
on O
which O
the O
operation O
was O
conceived _RARE_
. O

( O
5 O
) O
No O
changes O
were O
observed O
in O
the O
gastric _RARE_
venous O
blood _RARE_
flow O
by O
continuous O
intravenous O
injection O
of O
cimetidine O
, O
but O
by O
rapid O
injection O
both O
the O
flow O
was O
augmented O
and O
the O
systemic O
blood _RARE_
pressure O
decreased O
transiently O
. O

Study O
on O
re O
- O
establishment O
of O
ovulation O
after O
termination _RARE_
of O
sex _RARE_
- O
steroidal _RARE_
treatment O
-- _RARE_
compared O
with O
re O
- O
appearance O
of O
ovulation O
after O
abortion O
and O
premature O
delivery O
. O

Pharmacokinetics _RARE_
of O
Carbamazepine _RARE_
in O
man O
: O
a O
review O
. O

Of O
the O
compounds O
tested O
, O
alpha O
-( _RARE_
3 O
- O
methyl _RARE_
- O
2 O
- O
quinoxalinyl _RARE_
)- O
N O
- O
methylnitrone _RARE_
1 O
, O
4 O
- O
dioxide O
( O
2 O
) O
was O
the O
most O
active _RARE_
agent O
in O
vivo O
against O
the O
gram O
- O
negative O
and O
the O
gram O
- O
positive O
organisms O
. O

Changes O
in O
ionic O
content O
of O
the O
mucous _RARE_
suggest O
that O
cholinergic O
mechanisms O
affect O
pressure O
in O
the O
excretory _RARE_
duct O
of O
the O
gland _RARE_
. O

Calves _RARE_
fed O
MCT _RARE_
- O
milk O
had O
significantly O
lower O
blood _RARE_
cholesterol O
than O
calves O
fed O
T O
- O
or O
SBO _RARE_
- O
milk O
. O

Delayed _RARE_
mortality O
of O
mice O
following O
inhalation O
of O
acute O
doses O
of O
CH2O _RARE_
, O
SO2Cl2 _RARE_
, O
and O
Br2 _RARE_
. O

Guinea _RARE_
pigs O
weighing _RARE_
300 _RARE_
approximately _RARE_
350 O
g O
were O
used O
. O

Under O
halothane O
anesthesia O
, O
the O
flow O
pneumocardiogram _RARE_
( O
PnCG _RARE_
) O
and O
its O
time O
derivative _RARE_
( O
acceleration _RARE_
pneumocardiogram _RARE_
or O
dPn _RARE_
/ O
dt O
) O
were O
transduced _RARE_
during _RARE_
apnea O
by O
a O
small O
high O
- O
gain O
pneumotachograph _RARE_
. O

Sensory _RARE_
kindling O
: O
implications O
for _RARE_
development O
of O
sensory O
prostheses _RARE_
. O

It O
is O
concluded O
that O
stereotypy _RARE_
can O
be O
evoked O
also O
in O
the O
case O
when O
the O
striatal _RARE_
dopaminergic O
tone O
is O
normal O
or O
even O
below O
normal O
: O
it O
is O
the O
equilibrium O
of O
the O
striatal _RARE_
cholinergic O
- O
dopaminergic O
systems _RARE_
which O
must O
be O
shifted O
towards O
dopamine O
, O
which O
is O
necessary O
for _RARE_
the O
development O
of O
this O
behavioral O
manifestation O
. O

None O
of O
the O
cystometrograms _RARE_
showed O
uninhibited _RARE_
detrusor _RARE_
contractions O
. O

In O
the O
duodenum _RARE_
a O
small O
part O
of O
the O
administered O
dose O
was O
transformed O
to O
3H O
- O
alpha O
- O
acetyldigoxin _RARE_
. O

Functional O
effects O
following O
subacute O
administration O
. O

Treatment O
of O
Graves _RARE_
' O
disease _RARE_
. O

Although O
it O
has O
been O
shown O
that O
it O
is O
possible O
to O
use O
orally O
administered O
testosterone O
to O
maintain O
se _RARE_
- O
T O
levels O
in O
the O
normal O
male O
range O
, O
the O
convenience _RARE_
to O
the O
patient O
must O
be O
balanced _RARE_
against O
the O
cost O
and O
possible O
side _RARE_
effects O
of O
the O
large O
doses O
required O
. O

Contrary _RARE_
to O
1 O
, O
8 O
- O
dihydroxy _RARE_
- O
9 O
- O
anthrone _RARE_
, O
1 O
, O
8 O
, O
9 O
- O
triacetoxyanthracene _RARE_
and O
1 O
, O
8 O
- O
diacetoxy _RARE_
- O
9 O
- O
anthrone _RARE_
are O
effective O
against O
psoriatic _RARE_
lesions O
without O
accompanying O
inflammations _RARE_
of O
the O
skin _RARE_
. O

Etiopathogenetic _RARE_
and O
therapeutic O
problems O
in O
acute O
orbital _RARE_
inflammation O

Nursing _RARE_
of O
patients O
with O
gynecological _RARE_
diseases O

We O
measured O
basal O
plasma O
prolactin I-GENE
concentrations O
( O
in O
samples O
obtained O
during _RARE_
the O
early O
follicular O
phase _RARE_
) O
in O
25 _RARE_
normal O
( O
control O
) O
women O
and O
in O
a O
similar O
group O
of O
40 O
patients O
with O
a O
long O
- O
standing _RARE_
history O
of O
infertility O
. O

Ovarian _RARE_
allotransplantation _RARE_
in O
human O
. O

Allergic _RARE_
reaction O
to O
Patent _RARE_
Blue _RARE_
Violet _RARE_
during _RARE_
lymphography _RARE_
. O

Screening _RARE_
of O
asthma O
patients O
by O
determination O
of O
IgE I-GENE
and O
by O
comprehension _RARE_
of O
spectrum O
of O
allergospecific _RARE_
IgE I-GENE
antibodies I-GENE

The O
induction O
of O
seizures O
in O
" O
Papio _RARE_
papio _RARE_
" O
following O
allylglycine _RARE_
alone O
or O
in O
combination O
with O
intermittent O
photic _RARE_
stimulation _RARE_

A O
highly O
significant O
correlation O
was O
found O
between O
the O
presence O
of O
fibrinolytic _RARE_
degradation _RARE_
products O
( O
FDP _RARE_
) O
and O
the O
incidence O
of O
nephropathy O
and O
renal _RARE_
insufficiency O
, O
as _RARE_
well _RARE_
as _RARE_
between O
the O
presence O
of O
fibrin I-GENE
monomers _RARE_
( O
Godal _RARE_
' O
s O
ethanol O
- O
gelification _RARE_
test O
) O
and O
the O
evolutive _RARE_
signs O
of O
the O
primary _RARE_
disease _RARE_
( O
fever O
, O
accelerated O
ESR _RARE_
). O

One O
- O
third O
of O
the O
men O
with O
azoospermia _RARE_
and O
with O
sperm O
density O
of O
less O
than O
10 O
million O
had O
marked O
FSH I-GENE
elevation O
and O
our O
experience O
confirms _RARE_
the O
work O
of O
others O
that O
this O
indicates O
a O
poor O
prognosis O
. O

In O
girls O
prolactin I-GENE
levels O
rise O
at _RARE_
stage _RARE_
2 O
, O
and O
are O
higher _RARE_
after O
menarche _RARE_
; O
in O
boys O
there O
is O
no _RARE_
change O
in O
prolactin I-GENE
levels O
. O

It O
was O
concluded O
that O
both O
of O
these O
surgical O
procedures O
were O
as _RARE_
effective O
as _RARE_
pinealectomy _RARE_
in O
reversing _RARE_
the O
pineal O
- O
induced _RARE_
alterations O
in O
the O
reproductive O
physiology O
of O
the O
blind O
- O
anosmic _RARE_
female O
rat O
. O

2 O
cases O
of O
toxic O
lymphomononucleosis _RARE_

Such O
an O
hemoglobin I-GENE
solution O
was O
shown O
to O
exhibit O
a O
high O
affinity O
for _RARE_
oxygen O
and O
a O
low O
Bohr _RARE_
effect O
( O
assessed O
from O
the O
delta O
log O
Po2 _RARE_
/ O
delta O
pH O
ratio O
). O

A O
one O
- O
week O
ulcer O
therapy O
with O
atropine O
and O
Vikalin _RARE_
( O
Roter _RARE_
) O
led O
to O
a O
significant O
( O
p O
less O
than O
0 _RARE_
. O
01 O
) O
reduction O
of O
the O
nocturnal _RARE_
proteolytic _RARE_
activity O
. O

In O
one O
patient O
with O
severe O
diarrhea _RARE_
the O
estriol _RARE_
concentration O
in O
serum O
was O
low O
until O
the O
intestinal _RARE_
function O
normalised _RARE_
and O
the O
estriol _RARE_
concentration O
went _RARE_
up _RARE_
exactly _RARE_
when O
the O
diarrhea _RARE_
stopped O
. O

Serum O
levels O
of O
IgG I-GENE
and O
IgM I-GENE
were O
also O
raised O
, O
but O
contrary _RARE_
to O
the O
findings O
of O
other O
observers _RARE_
IgA I-GENE
levels O
were O
normal O
. O

Experimental O
ischemic O
heart _RARE_
disease _RARE_
induced _RARE_
by O
thromboxane _RARE_
A2 _RARE_
in O
rabbits O
. O

Vitrectomy _RARE_
in O
ocular O
traumatology _RARE_

To O
study O
the O
sensitivity O
of O
some O
central O
brain O
structures _RARE_
to O
the O
action O
of O
an O
electromagnetic _RARE_
field O
of O
decimeter _RARE_
waves O
( O
EMF _RARE_
of O
DW _RARE_
) O
a O
dynamic O
investigation O
of O
single O
unit O
activity O
was O
undertaken O
. O

No O
systematic O
L O
- O
R O
differences O
were O
observed O
. O

A O
decrease O
of O
the O
lysozyme I-GENE
activity O
coincided _RARE_
with O
the O
clinical O
improvement O
of O
the O
bacterial O
meningitis O
. O

This O
implies _RARE_
that O
the O
groups O
do O
not O
just O
differ O
along O
one O
dimension _RARE_
, O
but O
along O
three O
dimensions O
. O

Deep _RARE_
tans _RARE_
were O
induced _RARE_
over O
the O
backs _RARE_
of O
volunteers O
with O
repeated _RARE_
exposure O
to O
longwave _RARE_
ultraviolet _RARE_
radiation O
( O
UV _RARE_
- O
A O
). O

1 O
The O
effects O
in O
normal O
subjects O
of O
a O
single O
oral O
dose O
of O
Motival _RARE_
( O
one O
tablet O
, O
containing O
fluphenazine _RARE_
0 _RARE_
. O
5 O
mg O
and O
nortriptyline _RARE_
10 O
mg O
) O
on O
the O
contingent _RARE_
negative O
variation O
( O
CNV O
), _RARE_
reaction O
time O
, O
heart _RARE_
rate O
, O
blood _RARE_
pressure O
and O
self O
- O
rating O
scales _RARE_
for _RARE_
alertness _RARE_
, O
anxiety O
, O
tension O
, O
detachment _RARE_
and O
depression O
were O
compared O
with O
those O
of O
diazepam _RARE_
( O
5 O
mg O
and O
7 O
. O
5 O
mg O
) O
and O
placebo O
or O
propranolol O
( O
60 _RARE_
mg O
). O

Stress _RARE_
effects O
on O
affiliation _RARE_
preferences _RARE_
among O
subjects O
possessing _RARE_
the O
type O
A O
coronary O
- O
prone O
behavior O
pattern O
. O

These O
show O
that O
the O
collagen _RARE_
in O
this O
tissue O
is O
modified O
compared O
with O
that O
in O
tendon O
. O

Smoking _RARE_
was O
regarded O
as _RARE_
the O
major O
contribution O
to O
pulmonary O
dysfunction O
. O

The O
malignity _RARE_
of O
nevoid _RARE_
lentigo _RARE_
. O

Elimination O
of O
bagassosis _RARE_
in O
Louisiana _RARE_
paper O
manufacturing _RARE_
plant _RARE_
workers O
. O

These O
responses O
were O
compared O
with O
others O
in O
the O
same O
subjects O
under O
the O
same O
conditions O
and O
it O
was O
concluded O
that O
the O
antihypertensive O
effect O
of O
labetalol _RARE_
is O
explained O
by O
concurrent O
blockade O
of O
alpha I-GENE
- I-GENE
and I-GENE
beta I-GENE
- I-GENE
adrenoceptors I-GENE
. O

Diuretics _RARE_
: O
basic O
clinical O
pharmacology _RARE_
and O
therapeutic O
use O
. O

Three O
patients O
with O
four O
renoureteral _RARE_
units _RARE_
have O
undergone O
single O
- O
stage _RARE_
reconstruction O
involving O
ureteroureterostomy _RARE_
and O
ipsilateral O
ureteroneocystostomy _RARE_
following O
temporary O
loop O
cutaneous O
ureterostomy _RARE_
. O

Evaluation O
of O
the O
Du _RARE_
Pont _RARE_
aca _RARE_
ammonia _RARE_
procedure O
. O

Internally _RARE_
oriented _RARE_
patients O
' O
scores O
on O
Rotter _RARE_
' O
s O
Internal _RARE_
- O
External _RARE_
Locus _RARE_
of O
Control O
Scale O
remained O
the O
same O
over O
treatment O
but O
those O
of O
externally _RARE_
oriented _RARE_
patients O
shifted O
toward O
greater O
internal O
control O
. O

Action _RARE_
of O
strontium _RARE_
- O
90 _RARE_
and O
metaphos _RARE_
on O
Cyprinus _RARE_
carpio _RARE_

Kodak _RARE_
XV _RARE_
- O
2 O
film _RARE_
is O
wrapped _RARE_
around O
a O
cylindrical _RARE_
water O
- O
filled O
phantom _RARE_
and O
the O
dose O
distribution O
is O
recorded O
. O

Diagnosis O
and O
differential O
diagnosis O

The O
multiple O
factors O
affecting O
plasma O
renin I-GENE
activity O
in O
essential O
hypertension O
. O

Cortisone _RARE_
induced _RARE_
bone O
changes O
and O
its O
response O
to O
lipid _RARE_
clearing _RARE_
agents O
. O

2 O
) O
The O
time O
- O
sharing _RARE_
principle _RARE_
was O
applied O
to O
gain O
high O
stability O
. O

When O
blood _RARE_
samples O
of O
patients O
with O
hyperbilirubinemia O
were O
analyzed O
, O
direct O
measurement O
of O
ZPP _RARE_
by O
this O
fluorimeter _RARE_
yielded O
significantly O
higher _RARE_
levels O
than O
did O
an O
alternate O
extraction O
method O
. O

Delayed _RARE_
hypersensitivity O
in O
man O
: O
effects O
of O
systemic O
anticoagulation _RARE_
. O

In O
three O
of O
the O
seven _RARE_
, O
inhalation O
of O
2 O
ml O
normal O
saline O
produced O
FEV1 O
falls _RARE_
of O
25 _RARE_
% O
to O
30 _RARE_
%, O
but O
these O
falls _RARE_
were O
not O
as _RARE_
great O
as _RARE_
each O
subject O
' O
s O
reactions O
to O
the O
test O
solutions O
. O

Experimental O
studies O
on O
virus O
excretion O
and O
non O
- O
arthropod _RARE_
transmission _RARE_
. O

Potency _RARE_
of O
enflurane _RARE_
in O
dogs O
: O
comparison O
with O
halothane O
and O
isoflurane O
. O

Prevention O
of O
acute O
paraquat _RARE_
toxicity O
in O
rats O
by O
superoxide _RARE_
dismutase I-GENE
. O

Measurement O
of O
magnesium O
absorption O
in O
man O
using O
stable O
26Mg _RARE_
as _RARE_
a O
tracer O
. O

Increased O
urinary _RARE_
riboflavin _RARE_
excretion O
resulting O
from O
boric _RARE_
acid O
ingestion O
. O

Radionuclide _RARE_
angiography O
and O
static _RARE_
whole O
body O
imaging O
performed O
with O
technetium O
- O
99m O
- O
labeled O
particulates _RARE_
can O
clearly O
demonstrate O
differential O
shunting _RARE_
in O
patients O
with O
patent _RARE_
ductus _RARE_
arteriosus _RARE_
( O
PDA _RARE_
) O
with O
Eisenmenger _RARE_
physiology O
. O

Looming _RARE_
detectors _RARE_
in O
the O
human O
visual O
pathway _RARE_
. O

Escherichia O
of O
a O
single O
sero _RARE_
- O
anzymatic _RARE_
type O
( O
06a6b _RARE_
: O
K13 _RARE_
: O
H1 _RARE_
) O
were O
isolated O
in O
a O
group O
affection _RARE_
. O

The O
method O
described O
may O
prove O
useful O
in O
studying O
the O
physiology O
of O
the O
nasal O
cycle _RARE_
. O

At O
the O
same O
time O
we O
obtained O
easily O
understandable _RARE_
EEG O
- O
information _RARE_
which O
has O
never O
previously O
been O
available O
to O
us O
. O

Analysis O
of O
liver O
biopsy O
specimens O
from O
patients O
with O
hepatitis O
showed O
a O
large O
variation O
in O
the O
mean O
iron O
content O
of O
the O
liver O
ferritin I-GENE
molecules O
. O

Female O
mice O
were O
significantly O
more O
resistant O
to O
infection O
than O
males O
. O

During O
the O
following O
9 O
1 O
/ O
2 O
years O
three O
sequential O
liver O
biopsies O
were O
performed O
. O

Angiotensin _RARE_
effect O
in O
the O
human O
kidney _RARE_
. O

Procion _RARE_
yellow O
dye _RARE_
was O
injected O
intracellularly _RARE_
into O
large O
auditory O
fibers O
of O
goldfish _RARE_
to O
investigate O
the O
relationship O
between O
the O
response O
type O
of O
these O
fibers O
and O
their O
site O
of O
termination _RARE_
in O
the O
saccular _RARE_
macula _RARE_
. O

Incidental _RARE_
findings O
in O
the O
epidermis _RARE_
and O
in O
the O
intraepidermal _RARE_
eccrine _RARE_
sweat _RARE_
duct O
units _RARE_
. O

Silicosis _RARE_
mortality O

These O
consisted O
of O
beading _RARE_
and O
strictures _RARE_
mainly O
of O
the O
intrahepatic O
biliary O
tree _RARE_
( O
IHB _RARE_
). O

Pentane _RARE_
and O
ethane _RARE_
, O
which O
arise O
during _RARE_
lipid _RARE_
peroxidation O
in O
vivo O
, O
were O
measured O
by O
gas O
chromatography O
in O
breath _RARE_
samples O
of O
rats O
fed O
for _RARE_
8 O
weeks O
a O
vitamin O
E O
- O
deficient _RARE_
diet O
to O
which O
had O
been O
added O
0 _RARE_
, O
11 O
, O
or O
40 O
IU O
vitamin O
E O
acetate _RARE_
per O
kg O
. O

Thromboplastic _RARE_
and O
fibrynolytic _RARE_
activity O
of O
the O
blood _RARE_
after O
administration O
of O
intralipid _RARE_
in O
men O
with O
history O
of O
myocardial _RARE_
infarction O
up _RARE_
to O
45 _RARE_
year O
of O
life O

The O
authors O
report O
the O
clinicopathologic _RARE_
findings O
in O
four O
cases O
of O
adult O
women O
with O
rhabdomyosarcomas _RARE_
that O
originated _RARE_
in O
the O
endometrium _RARE_
or O
cervix O
, O
or O
both O
. O

The O
effect O
of O
pure O
natural _RARE_
porcine _RARE_
secretin _RARE_
on O
endocrine O
and O
exocrine _RARE_
pancreatic O
secretion _RARE_
was O
studied O
in O
the O
totally _RARE_
isolated O
perfused O
porcine _RARE_
pancreas O
. O

Biometric _RARE_
analysis O
of O
intraocular _RARE_
lens O
power O
required O
to O
produce O
emmetropia _RARE_
: O
results O
of O
450 _RARE_
implants O
. O

Urine _RARE_
antibodies O
could O
not O
be O
demonstrated O
in O
any O
other O
cases O
. O

Althoug _RARE_
RBF _RARE_
tended O
to O
increase O
after O
the O
therapy O
, O
there O
was O
no _RARE_
statistically O
significant O
change O
in O
RBF _RARE_
, O
GFR O
and O
cardiac O
output O
. O

99mTc O
phytate _RARE_
, O
198Au _RARE_
colloid O
, O
and O
99mTc O
antimony _RARE_
sulfide _RARE_
have O
been O
used O
; O
the O
last O
appears O
to O
have O
been O
the O
most O
satisfactory O
. O

Six O
patients O
with O
glomerulonephritis O
in O
association O
with O
a O
ventriculovascular _RARE_
shunt O
were O
treated O
with O
three O
basic O
modes O
of O
therapy O
. O

The O
mass O
of O
UO2 _RARE_
in O
the O
extrapulmonary _RARE_
bronchi _RARE_
and O
first _RARE_
bifurcation _RARE_
decreased O
more O
slowly O
over O
0 _RARE_
-- _RARE_
8 O
d O
after O
inhalation O
than O
the O
corresponding O
mass O
on O
the O
trachea _RARE_
. O

Synovial _RARE_
cysts O
of O
the O
hip O
joint O

A O
suspected O
hypothalamic _RARE_
dysfunction O
and O
a O
slightly O
impaired O
pituitary O
function O
manifested O
as _RARE_
GH _RARE_
deficiency O
were O
their O
common O
endocrinological _RARE_
features O
. O

A O
sharp _RARE_
outbreak O
of O
influenza _RARE_
A O
occurred O
on O
the O
base _RARE_
during _RARE_
February _RARE_
that O
was O
due O
to O
an O
A O
/ O
Texas _RARE_
/ O
1 O
/ O
77 O
- O
like O
virus O
, O
a O
variant O
of O
the O
A O
/ O
Victoria _RARE_
/ O
3 O
/ O
75 _RARE_
prototpye _RARE_
. O

Because O
decreases O
in O
the O
disfluency _RARE_
rates O
of O
stutterers _RARE_
were O
observed O
during _RARE_
the O
presentation O
of O
all O
three O
stimulus O
words _RARE_
, O
the O
data O
failed O
to O
support O
the O
operant _RARE_
model O
. O

Effect O
of O
time O
and O
dose O
on O
alterations O
following O
inhalation O
of O
plutonium O
- O
239 O
dioxide O
aerosol _RARE_
in O
rat O
. O

In O
biopsies O
CK _RARE_
- I-GENE
MB I-GENE
fraction O
of O
total _RARE_
myocardial _RARE_
CPK I-GENE
was O
37 O
%, O
the O
total _RARE_
- I-GENE
CPK I-GENE
activity O
of O
human O
skeletal O
muscles O
still O
shows O
a O
5 O
% O
fraction O
of O
CK _RARE_
- I-GENE
MB I-GENE
. O

Value O
of O
determination O
of O
alkaline _RARE_
phosphatase I-GENE
isoenzymes _RARE_
for _RARE_
differential O
diagnosis O
of O
obstructive _RARE_
jaundice O
and O
biliary O
liver O
cirrhosis O

A O
one O
- O
way O
analysis O
of O
variance _RARE_
, O
performed O
separately O
for _RARE_
men O
and O
women O
for _RARE_
differences O
among O
the O
three O
phobic _RARE_
groups O
on O
field O
dependence O
, O
showed O
significance O
( O
rho _RARE_
less O
than O
. O
05 O
) O
for _RARE_
the O
females O
, O
with O
the O
famale _RARE_
agoraphobic _RARE_
being O
more O
field O
dependent O
than O
the O
female O
simple O
phobic _RARE_
groups O
, O
but O
not O
for _RARE_
the O
males O
. O

Several O
free O
2nd _RARE_
- O
generation O
schizonts _RARE_
, O
which O
varied O
in O
diameter O
from O
11 O
to O
21 O
. O
6 O
micrometer _RARE_
, O
were O
found O
on O
the O
epithelial _RARE_
surface O
of O
the O
cecum _RARE_
. O

The O
calculated O
pD2 _RARE_
values O
were O
8 O
. O
8 O
for _RARE_
E O
, O
8 O
. O
6 O
for _RARE_
DHE _RARE_
and O
6 O
. O
6 O
for _RARE_
M O
. O

Newcastle _RARE_
disease _RARE_
virus O
surveillance _RARE_
in O
Hong _RARE_
Kong _RARE_
on O
local O
and O
imported _RARE_
poultry _RARE_
. O

It O
was O
postulated O
that O
persistent O
challenge O
by O
M O
. O
leprae _RARE_
or O
its O
antigens O
to O
the O
IgA I-GENE
immunocytes _RARE_
of O
the O
intestinal _RARE_
epithelium O
might O
have O
induced _RARE_
tolerance O
leading O
to O
IgA I-GENE
deficiency O
and O
subsequent O
subtotal O
atrophy O
of O
the O
intestinal _RARE_
villi _RARE_
in O
the O
patients O
with O
lepromatous _RARE_
leprosy _RARE_
. O

Treatment O
of O
hypertension O
with O
a O
combination O
of O
the O
adrenergic I-GENE
beta I-GENE
receptor I-GENE
blockader _RARE_
, O
obsidan _RARE_
, O
and O
the O
vasodilator O
, O
apressin _RARE_

Orthop _RARE_
. O

Thyroid _RARE_
disease _RARE_
and O
pregnancy _RARE_
. O

Residues _RARE_
removed O
from O
transcripts O
by O
splicing _RARE_
were O
identified O
. O

To O
minimize _RARE_
reflux O
into O
the O
blind O
loop O
, O
a O
number O
of O
technical _RARE_
steps O
are O
considered O
indispensable _RARE_
: O
1 O
) O
fluted _RARE_
section O
of O
the O
jejunal _RARE_
stump _RARE_
; O
2 O
) O
isoperistaltic _RARE_
construction _RARE_
of O
the O
anastomosis O
and O
, O
particularly O
, O
3 O
) O
the O
creation _RARE_
of O
a O
single O
or O
double O
valve O
system _RARE_
upstream O
from O
the O
anastomosis O
by O
spiral _RARE_
introflexion _RARE_
of O
the O
mucosa O
using O
seroserous _RARE_
stitches _RARE_
parallel O
and O
perpendicular _RARE_
to O
the O
ileal _RARE_
lumen _RARE_
. O

At O
this O
stage _RARE_
, O
the O
eventual _RARE_
high O
mortality O
of O
acute O
ischemia O
is O
established O
whatever _RARE_
the O
urgency _RARE_
of O
the O
operation O
or O
the O
skill _RARE_
with O
which O
it O
is O
performed O
. O

Pathogens _RARE_
( O
Staphylococcus _RARE_
aureus _RARE_
or O
Gram O
- O
negative O
bacilli O
) O
were O
isolated O
from O
only O
one O
member _RARE_
of O
staff _RARE_
in O
small O
numbers O
and O
irregularly _RARE_
and O
rarely O
in O
large O
numbers O
from O
patients O
. O

The O
histochemistry _RARE_
and O
ultrastructure _RARE_
of O
calcified _RARE_
cerebellar _RARE_
deposits _RARE_
described O
by O
Tonge _RARE_
et O
al O
. O

A O
36 _RARE_
year O
- O
old O
woman O
was O
given O
Ergotamine _RARE_
Tartrate _RARE_
4 O
. O
5 O
mg O
p O
. O
d O
. O
during _RARE_
seven _RARE_
days O
, O
after O
an O
abortion O
( O
a O
still O
birth O
). O

Reaction _RARE_
times O
to O
tachistoscopically _RARE_
presented O
stimuli O
in O
diabetics _RARE_

Two O
out O
of O
five O
patients O
undergoing O
selective O
spinal _RARE_
arteriography _RARE_
developed O
transient O
neurological O
complications O
during _RARE_
the O
injection O
of O
Urografin _RARE_
310 _RARE_
M O
. O

The O
data O
indicate O
a O
three O
- O
phase _RARE_
reaction O
after O
B1 _RARE_
injection O
: O
Phase O
1 O
-- _RARE_
shortly _RARE_
after O
injection O
there O
is O
a O
drop O
of O
all O
parameters O
lasting O
for _RARE_
30 _RARE_
sec O
. O

Serum I-GENE
relaxin _RARE_
levels O
in O
prostaglandin _RARE_
E2 O
induced _RARE_
abortions _RARE_
. O

A O
-- _RARE_
A O
natural _RARE_
hydrostatic _RARE_
phenomenon O
, O
at _RARE_
the O
level O
of O
the O
ends O
of O
the O
plantar _RARE_
arcs _RARE_
, O
diffuses _RARE_
body O
weight _RARE_
, O
as _RARE_
PAIN _RARE_
plays O
the O
role O
of O
outsentry _RARE_
( O
fig _RARE_
.-- _RARE_
1 O
) O
( O
5 O
); O
B O
-- _RARE_
Plantar _RARE_
perforating _RARE_
ulceration O
( O
PPU _RARE_
) O
is O
caused O
by O
a O
combination O
of O
INSENSITIVITY _RARE_
and O
TRAUMATIS _RARE_
( O
1 O
); O
C O
-- _RARE_
The O
patient O
reposing _RARE_
, O
as _RARE_
body O
weight _RARE_
( O
traumatism _RARE_
) O
effects O
disappear _RARE_
, O
cicatrization _RARE_
process O
can O
be O
easily O
observed O
; O
D O
-- _RARE_
PNEUMATIC _RARE_
INSOLE _RARE_
, O
being O
elastic O
, O
diffuses _RARE_
localized O
compression O
at _RARE_
the O
ends O
of O
the O
plantar _RARE_
arcs _RARE_
, O
reduces O
attrition _RARE_
, O
makes O
easier _RARE_
blood _RARE_
circulation O
, O
as _RARE_
well _RARE_
as _RARE_
cure O
and O
prophylaxis O
of O
PPU _RARE_
( O
fig _RARE_
.-- _RARE_
6 O
) O
( O
3 O
). O

Effect O
of O
indoramin _RARE_
in O
small O
doses O
on O
the O
central O
vasomotor _RARE_
loci O
has O
been O
studied O
in O
chloralose _RARE_
anesthetized O
cats O
by O
localizing _RARE_
it O
to O
the O
central O
sites O
. O

As O
expected O
, O
the O
heparin _RARE_
did O
produce O
increased O
recalcification _RARE_
times O
and O
the O
development O
of O
occasional _RARE_
subcutaneous O
hematomas _RARE_
. O

Contingency _RARE_
contracting _RARE_
between O
clients _RARE_
and O
their O
parents O
/ O
caregivers _RARE_
was O
used O
to O
specify _RARE_
consequences O
for _RARE_
daily O
self O
- O
monitoring O
, O
reduced _RARE_
caloric _RARE_
intake O
, O
weight _RARE_
loss _RARE_
, O
and O
exercise O
. O

Dietetics _RARE_
of O
childhood O
- O
and O
juvenile O
diabetes O

The O
results O
of O
a O
quantitative O
study O
of O
vasculosyncytial _RARE_
membranes O
in O
123 O
placentas _RARE_
are O
presented O
. O

The O
micromethod _RARE_
uses O
microcuvettes _RARE_
and O
substitutes _RARE_
ferrozine _RARE_
for _RARE_
the O
bathophenanthroline _RARE_
chromogen _RARE_
of O
the O
ICSH _RARE_
. O

Platelet _RARE_
serotonin _RARE_
( O
5 O
- O
HT _RARE_
) O
and O
5 I-GENE
- I-GENE
HT _RARE_
releasing I-GENE
factor I-GENE
in O
plasma O
of O
migrainous _RARE_
patients O
. O

The O
overall O
incidence O
of O
SIDS _RARE_
was O
1 O
. O
43 _RARE_
per O
1 O
, O
000 _RARE_
live O
births O
. O

The O
vigilance _RARE_
task O
and O
the O
measurement O
of O
attentional _RARE_
deficits O
. O

The O
December _RARE_
armed _RARE_
revolt _RARE_
in O
Moscow _RARE_
and O
the O
paramedical _RARE_
personnel _RARE_

Significant O
increases O
in O
mean O
serum O
E2 O
concentration O
( O
100 _RARE_
to O
150 _RARE_
pg O
/ O
ml O
) O
were O
noted O
at _RARE_
6 O
and O
8 O
hours O
after O
administration O
on O
day O
1 O
and O
at _RARE_
8 O
hours O
on O
day O
4 O
. O

The O
motor O
unit O
viewed _RARE_
from O
above O
. O

Avian _RARE_
reproductive O
system _RARE_
: O
daily O
variations O
in O
responses O
to O
hormones _RARE_
. O

Biological O
properties O
of O
sumithion _RARE_
. O

Serological _RARE_
studies O
of O
antibodies O
to O
Epstein O
- O
Barr O
virus O
in O
infectious O
mononucleosis _RARE_

Carcinoembryonic _RARE_
antigen I-GENE
( O
CEA _RARE_
) O
procedures O
and O
clinical O
evaluation O
. O

We O
remain _RARE_
convinced _RARE_
that O
antilymphocyte _RARE_
globulin I-GENE
( O
ALG _RARE_
) O
is O
a O
potent O
immunosuppressive O
agent O
in O
humans O
. O

On O
the O
basis O
of O
a O
global O
assessment O
patients O
showed O
a O
highly O
significant O
preference O
for _RARE_
imipramine _RARE_
compared O
with O
placebo O
as _RARE_
adjunctive _RARE_
therapy O
. O

39 _RARE_
- O
47 _RARE_
. O

Patients O
were O
subclassified _RARE_
into O
age O
- O
matched O
groups O
of O
primary _RARE_
untreated O
cancer _RARE_
( O
21 O
), _RARE_
recurrent O
cancer _RARE_
( O
18 O
), _RARE_
and O
" O
cured _RARE_
" O
patients O
who O
had O
been O
free O
of O
disease _RARE_
for _RARE_
at _RARE_
least O
9 O
months O
( O
16 O
). O

Absorption _RARE_
varied O
between O
65 O
and O
95 _RARE_
per O
cent O
, O
with O
a O
mean O
absorption O
of O
80 _RARE_
per O
cent O
, O
in O
both O
pregnant _RARE_
and O
non O
- O
pregnant _RARE_
subjects O
. O

Bacteriostatic _RARE_
and O
bacteriacidal _RARE_
activity O
of O
hydroxy O
- O
9 O
ellipticine _RARE_
in O
vitro O

Advances _RARE_
in O
the O
management O
of O
gynecologic O
cancer _RARE_
-- _RARE_
radiation O
therapy O
. O

The O
clinico _RARE_
- O
pathological O
data O
from O
a O
patient O
with O
irreversible O
post O
- O
partum _RARE_
renal _RARE_
failure O
( O
IPRF _RARE_
) O
are O
presented O
. O

Personal _RARE_
satisfaction _RARE_
in O
nursing O
: O
an O
encounter _RARE_
with O
extremely O
hostile _RARE_
patients O

Dialyzable _RARE_
transfer I-GENE
factor I-GENE
. O

19 O
- O
32 _RARE_
. O

Rheumatoid _RARE_
factor I-GENE
and O
antinuclear _RARE_
antibody O
tests O
were O
frequently O
positive O
, O
and O
reactions O
to O
gold _RARE_
therapy O
were O
more O
frequent O
than O
in O
other O
rheumatoid O
populations O
. O

The O
effect O
of O
hydrostatic _RARE_
pressure O
on O
the O
swimming O
activity O
of O
three O
hyponeustonic _RARE_
crustacea _RARE_
, O
Anomalocera _RARE_
patersoni _RARE_
, O
Pontella _RARE_
mediterranea _RARE_
, O
Labidocera _RARE_
wollastoni _RARE_

This O
report O
presents O
an O
analysis O
of O
the O
vocal _RARE_
repertoire _RARE_
of O
howler _RARE_
monkeys O
( O
Alouatta _RARE_
palliata _RARE_
) O
observed O
during _RARE_
a O
field O
study O
in O
southwestern _RARE_
Panama _RARE_
. O

Up _RARE_
to O
now O
the O
number O
of O
patients O
examined O
is O
about O
300 _RARE_
, O
additionally O
6 O
persons O
who O
underwent O
binephrectomy _RARE_
. O

Deflunia _RARE_
was O
well _RARE_
tolerated O
by O
25 _RARE_
patients O
, O
very O
well _RARE_
tolerated O
by O
2 O
. O

III O
. O

A O
new O
instrument O
has O
been O
designed O
for _RARE_
freeze _RARE_
- O
fracturing _RARE_
of O
biological O
material O
in O
ultra _RARE_
high O
vacuum _RARE_
. O

Pancreatic _RARE_
and O
biliary O
secretion _RARE_
and O
gastric _RARE_
emptying O
rates O
of O
a O
liquid O
test O
meal _RARE_
( O
LTM _RARE_
) O
were O
determined O
in O
normal O
persons O
, O
in O
patients O
with O
subtotal O
gastrectomy _RARE_
with O
gastroduodenostomy _RARE_
( O
STG _RARE_
- O
BI _RARE_
) O
or O
with O
gastrojejunostomy _RARE_
( O
STG _RARE_
- O
BII _RARE_
), _RARE_
and O
in O
patients O
with O
truncal _RARE_
vagotomy O
and O
pyloroplasty _RARE_
( O
V O
& O
P O
). O

Abnormal O
calcium _RARE_
metabolism O
in O
normocalcaemic _RARE_
sarcoidosis _RARE_
. O

Also O
, O
except O
in O
one O
patient O
who O
developed O
gallstones _RARE_
following O
institution _RARE_
of O
colestipol _RARE_
, O
saturation O
of O
gallbladder O
bile O
with O
cholesterol O
was O
not O
markedly O
increased O
by O
this O
drug O
alone O
. O

A O
five O
- O
phase _RARE_
experiment O
was O
designed O
to O
investigate O
( O
a O
) O
whether O
contingent _RARE_
music _RARE_
- O
listening _RARE_
would O
act O
as _RARE_
a O
reinforcer _RARE_
to O
increase O
arithmetic _RARE_
performance O
of O
EMR _RARE_
children O
and O
( O
b O
) O
whether O
this O
contingent _RARE_
reinforcement _RARE_
would O
affect O
preference O
for _RARE_
that O
reinforcer _RARE_
. O

The O
responsiveness O
of O
visual O
cortex O
( O
VC _RARE_
) O
and O
superior O
colliculus _RARE_
( O
SC O
) O
was O
simultaneously O
compared O
following O
conditioning O
" O
ON _RARE_
" O
or O
" O
OFF _RARE_
" O
stimulation _RARE_
, O
in O
the O
rabbit _RARE_
. O

A O
diagnosis O
of O
MS O
was O
made O
based O
on O
subtle _RARE_
neurologic O
signs O
, O
spinal _RARE_
fluid _RARE_
gamma I-GENE
globulin I-GENE
elevations O
, O
and O
abnormalities O
in O
neuropsychological _RARE_
testing O
. O

If O
, O
however O
, O
the O
mean O
temperature _RARE_
rise O
was O
higher _RARE_
( O
0 _RARE_
. O
57 O
degrees O
C O
or O
0 _RARE_
. O
69 _RARE_
degrees O
C O
), _RARE_
such O
a O
selection O
practically _RARE_
resulted O
in O
the O
disappearance O
of O
' O
passable _RARE_
' O
qualifications _RARE_
in O
the O
triplet O
groups O
and O
a O
great O
predominance _RARE_
of O
' O
to O
be O
rejected _RARE_
' O
qualifications _RARE_
in O
the O
large O
groups O
. O

The O
elevated O
Viso _RARE_
V O
in O
the O
RDS _RARE_
group O
suggests O
an O
increase O
in O
small O
airway O
resistance O
secondary O
to O
the O
disease _RARE_
or O
to O
its O
therapy O
. O

The O
psychological O
tests O
consisted O
of O
a O
free O
- O
recall _RARE_
task O
, O
a O
test O
for _RARE_
visuomotor _RARE_
coordination O
and O
a O
recognition O
task O
. O

Selective O
bronchial O
intubation _RARE_
in O
the O
management O
of O
unilateral O
pulmonary O
interstitial O
emphysema O
. O

The O
background O
processes O
depending O
on O
the O
etiological _RARE_
factor O
and O
the O
character O
of O
lesion O
of O
the O
epithelium O
are O
divided O
into O
dyshormonal _RARE_
, O
inflammatory O
, O
and O
posttraumatic _RARE_
. O

The O
sense O
of O
self O
. O

Eleven _RARE_
strains O
of O
Fusarium _RARE_
poae _RARE_
and O
F O
. O
sporotrichioides _RARE_
from O
the O
U _RARE_
. O
S O
. O
S O
. O
R O
. O
and O
7 O
strains O
of O
these O
species O
and O
one O
of O
F O
. O
sporotrichioides _RARE_
var _RARE_
. O
tricinctum _RARE_
from O
U _RARE_
. O
S O
. O
A O
. O
and O
France _RARE_
have O
been O
compared O
as _RARE_
to O
their O
capacity O
to O
yield O
T I-GENE
- I-GENE
2 I-GENE
toxin _RARE_
. O

Current O
diagnostic O
uses O
of O
computerized O
tomography O
in O
clinical O
medicine O
. O

A O
follow O
- O
up _RARE_
study O
of O
22 _RARE_
patients O
with O
Ebstein _RARE_
' O
s O
anomaly _RARE_
has O
been O
performed O
. O

Deaths _RARE_
stopped O
11 O
hours O
after O
copper _RARE_
concentrations O
decreased O
below O
0 _RARE_
. O
2 O
ppm O
and O
signs O
of O
distress O
stopped O
in O
surviving _RARE_
pinfish _RARE_
by O
approximately _RARE_
6 O
hours O
after O
the O
last O
death _RARE_
. O

Recurrence _RARE_
of O
bladder O
tumors O
among O
the O
original O
9 O
cases O
has O
occurred O
only O
among O
the O
5 O
whose O
properdin _RARE_
levels O
remained O
below O
the O
median O
. O

Adaptation _RARE_
of O
taurocholate _RARE_
transport _RARE_
maximum O
to O
increased O
secretory _RARE_
load O
in O
the O
rat O
. O

Dangers _RARE_
in O
use O
of O
live O
- O
virus O
vaccines O
. O

Treatment O
with O
heparin _RARE_
, O
plasminogen I-GENE
activators _RARE_
and O
fibrinogenolytic _RARE_
agents O
was O
disappointing _RARE_
although O
renal _RARE_
function O
has O
stabilized O
in O
one O
patient O
on O
long O
term O
oral O
anticoagulant _RARE_
therapy O
. O

In O
diethyl _RARE_
ether O
solution O
the O
main O
peak O
is O
that O
of O
2 O
- O
benzylidenamio _RARE_
- O
1 O
- O
phenylpropane _RARE_
, O
which O
has O
a O
retention O
time O
of O
23 _RARE_
, O
2 O
minutes O
under O
the O
condition O
delineated _RARE_
. O

Amikacin _RARE_
was O
used O
in O
the O
treatment O
of O
56 _RARE_
serious O
gram O
- O
negative O
infections O
in O
54 O
patients O
of O
whom O
47 _RARE_
survived _RARE_
. O

The O
data O
normally O
available O
are O
insufficient O
and O
take O
no _RARE_
account O
of O
the O
direction O
of O
recirculation _RARE_
, O
which O
may O
be O
a O
determining _RARE_
factor O
. O

During O
activity O
III O
, O
one O
patient O
developed O
angina O
. O

Estimation _RARE_
of O
L O
- O
alanine O
in O
serum O
or O
plasma O
using O
the O
LKB _RARE_
reaction O
rate O
analyser _RARE_
. O

The O
acids _RARE_
were O
obtained O
by O
hydrolysis O
of O
the O
corresponding O
esters O
, O
and O
their O
anti O
- O
inflammatory O
activity O
was O
tested O
. O

Unrecognized _RARE_
amnionitis _RARE_
and O
prematurity _RARE_
: O
a O
preliminary O
report O
. O

Evaluation O
of O
the O
new O
Gravigard _RARE_
IUCD _RARE_
inserter _RARE_
. O

Bacterial _RARE_
meningitis O
secondary O
to O
abscess O
of O
the O
nasal O
septum _RARE_
. O

Serum I-GENE
amylase I-GENE
became O
markedly O
elevated O
( O
2 O
, O
624 _RARE_
CU _RARE_
/ O
100 _RARE_
ml O
), _RARE_
as _RARE_
did O
the O
serum O
FFA _RARE_
( O
29 O
. O
19 O
mEq O
/ O
liter O
). O

In O
the O
control O
preparation O
before O
weight _RARE_
was O
allowed O
to O
increase O
, O
isogravimetric _RARE_
capillary O
pressure O
( O
Pci _RARE_
) O
averaged O
8 O
mmHg O
lower O
than O
colloid O
osmotic O
pressure O
of O
the O
plasma O
( O
IIp _RARE_
). O

Infants _RARE_
who O
died O
in O
the O
first _RARE_
12 O
hours O
from O
' O
IVH _RARE_
only O
' O
had O
suffered _RARE_
severe O
birth O
asphyxia _RARE_
but O
in O
those O
who O
died O
later O
the O
main O
symptom _RARE_
was O
recurrent O
apnoea _RARE_
. O

The O
morphological O
effects O
of O
two O
snake _RARE_
venoms _RARE_
, O
N O
. O
naja _RARE_
and O
A O
. O
piscivorus _RARE_
, O
and O
of O
the O
Direct _RARE_
Lytic _RARE_
Factor _RARE_
and O
Phospholipase _RARE_
- I-GENE
A I-GENE
, O
compounds O
purified _RARE_
from O
N O
. O
naja _RARE_
crude O
venom _RARE_
, O
were O
investigated O
on O
lung _RARE_
and O
cremaster _RARE_
vessels O
of O
rats O
. O

Since O
GAGs _RARE_
are O
the O
components _RARE_
of O
cartilage O
matrix _RARE_
, O
the O
depletion O
of O
which O
is O
associated O
with O
osteoarthrosis _RARE_
, O
a O
method O
for _RARE_
measuring O
sulphated _RARE_
GAG _RARE_
synthesis _RARE_
in O
culture O
has O
been O
investigated O
. O

The O
length O
scales _RARE_
of O
the O
turbulence _RARE_
were O
also O
estimated O
: O
at _RARE_
a O
Reynolds _RARE_
number O
near O
4 O
, O
000 _RARE_
the O
macroscale _RARE_
is O
about O
1 O
. O
25 _RARE_
mm O
, O
the O
Taylor _RARE_
microscale _RARE_
is O
about O
0 _RARE_
. O
85 _RARE_
mm O
, O
and O
the O
Kolmogoroff _RARE_
scale O
is O
near O
0 _RARE_
. O
075 _RARE_
mm O
. O

Well _RARE_
- O
visualised _RARE_
arteriograms _RARE_
of O
the O
limbs _RARE_
can O
be O
obtained O
by O
xeroradiography _RARE_
after O
rapid O
manual _RARE_
injection O
of O
contrast O
- O
medium O
into O
an O
arm _RARE_
vein _RARE_
, O
as _RARE_
demonstrated O
in O
28 _RARE_
patients O
. O

No O
hypotension O
was O
noted O
in O
patients O
with O
toxemia _RARE_
and O
only O
2 O
ran _RARE_
a O
fever O
above O
37 O
. O
5 O
degrees O
C O
. O

The O
sera _RARE_
and O
nasal O
secretions _RARE_
of O
142 O
patients O
, O
who O
were O
positive O
in O
HD O
or O
mites _RARE_
skin _RARE_
test O
, O
were O
subjected O
to O
a O
radioallergosorbent _RARE_
test O
( O
RAST O
) O
for _RARE_
estimating O
the O
specific O
IgE I-GENE
antibody I-GENE
activity O
to O
mites _RARE_
. O

Wherever _RARE_
the O
site O
of O
the O
conditioning O
stimulation _RARE_
, O
these O
modifications O
disappeared O
after O
ischaemia O
of O
the O
leg O
. O

Diallylnitrosamine _RARE_
( O
DAN _RARE_
), _RARE_
one O
of O
the O
few O
nitrosamines _RARE_
tested O
thus O
far O
that O
has O
not O
induced _RARE_
neoplasms O
in O
rats O
, O
caused O
a O
high O
incidence O
of O
respiratory O
tract _RARE_
tumors O
in O
Syrian _RARE_
golden _RARE_
hamsters O
treated O
sc O
with O
single O
or O
weekly O
doses O
of O
the O
compound O
. O

Near _RARE_
term O
, O
under O
experimental O
conditions O
, O
maternal _RARE_
and O
fetal _RARE_
blood _RARE_
gases O
, O
pH O
, O
uterine _RARE_
and O
umbilical _RARE_
blood _RARE_
flows _RARE_
were O
measured O
or O
calculated O
. O

Haemodynamic _RARE_
responses O
to O
antagonism _RARE_
of O
bocurarine _RARE_
block _RARE_
with O
atropine O
- O
neostigmine _RARE_
mixture O
in O
children O
. O

The O
mechanism O
by O
which O
large O
molecules O
, O
such O
as _RARE_
the O
diphosphonate _RARE_
99mTc O
- O
labeled O
EHDP _RARE_
or O
99mTc O
- O
labeled O
pyrophosphate _RARE_
, O
pass _RARE_
through O
capillaries O
in O
bone O
is O
by O
passive O
diffusion O
. O

Twenty O
- O
nine O
days O
after O
injection O
of O
5 O
. O
8 O
mCi O
of O
Tc O
- O
99m O
, O
which O
gives O
28 _RARE_
rads _RARE_
to O
the O
testis _RARE_
, O
the O
number O
of O
sperm O
hads _RARE_
decreased O
to O
70 O
% O
of O
control O
. O

Self _RARE_
- O
emasculation _RARE_
is O
the O
end O
result O
of O
an O
unusual O
psychiatric O
disorder O
, O
which O
initially O
requires O
surgical O
treatment O
. O

Possibility _RARE_
of O
a O
TSH _RARE_
- O
Screening _RARE_
method O
for _RARE_
detection O
of O
hypothyroidism O
in O
the O
newborn O

Thus O
analysis O
indicated O
no _RARE_
reliable O
evidence O
that O
conscious O
presleep _RARE_
suggestions _RARE_
become O
incorporated O
into O
dream _RARE_
content O
. O

The O
prevalence O
of O
hepatitis I-GENE
B I-GENE
surface I-GENE
antigen I-GENE
( O
HBsAg I-GENE
) O
and O
anti I-GENE
- I-GENE
HBs I-GENE
was O
determined O
by O
a O
sensitive _RARE_
double O
- O
antibody O
radio _RARE_
- O
immunoassay O
technique O
in O
a O
series O
of O
patients O
with O
chronic O
liver O
diseases O
. O

It O
was O
concluded O
that O
patients O
with O
acute O
respiratory O
failure O
requiring O
artificial O
ventilation O
have O
two O
componenents _RARE_
of O
the O
pulmonary O
shunt O
, O
one O
parallel O
with O
and O
the O
other O
inversely O
related O
with O
the O
PAO2 _RARE_
. O

Decreased _RARE_
cardiac O
glycogen _RARE_
following O
phenformin _RARE_
injection O
in O
hyperglycemic _RARE_
, O
hyperinsulinemic _RARE_
anaesthetized _RARE_
rats O
. O

Biological O
evaluation O
of O
mibolerone _RARE_
in O
the O
female O
Beagle _RARE_
. O

Levels _RARE_
of O
both O
PGF _RARE_
and O
PGFM _RARE_
were O
significantly O
higher _RARE_
during _RARE_
early O
spontaneous O
labour O
, O
at _RARE_
a O
cervical O
dilatation O
of O
less O
than O
4 O
cm O
, O
than O
before O
the O
onset O
of O
labour O
. O

The O
most O
common O
cause O
of O
renal _RARE_
deterioration O
in O
the O
spinal _RARE_
cord O
injured _RARE_
patient O
is O
irreversible O
vesicoureteral _RARE_
reflux O
. O

Propranolol _RARE_
( O
Inderal _RARE_
) O
administered O
in O
a O
dose O
which O
blocks O
the O
beta O
- O
adrenergic O
apparatus O
of O
the O
heart _RARE_
prevents O
the O
development O
of O
the O
positive O
inotropic O
effect O
of O
therapeutic O
doses O
of O
strophanthin _RARE_
K O
on O
a O
hypodynamic _RARE_
left _RARE_
ventricular O
myocardium O
. O

Recent O
studies O
have O
shown O
the O
rat O
larynx O
to O
be O
an O
important O
organ O
in O
the O
evaluation O
of O
irritancy _RARE_
of O
inhaled O
materials O
. O

Scanning _RARE_
electron O
microscopic O
investigations O
on O
the O
formation O
of O
Reissner _RARE_
' O
s O
fiber O
in O
Rattus _RARE_
rattus _RARE_

Feeding _RARE_
behavior O
, O
circannual _RARE_
body O
weight _RARE_
and O
hibernation _RARE_
rhythms _RARE_
in O
European O
hamsters O
lesioned O
in O
the O
noradrenergic O
ascending O
bundles _RARE_

Role O
of O
the O
infectious O
- O
disease _RARE_
specialist _RARE_
of O
a O
polyclinic _RARE_
in O
reducing _RARE_
the O
incidence O
of O
communicable _RARE_
diseases O

These O
observed O
drug O
interactions O
, O
plus _RARE_
the O
known O
effect O
of O
probenecid _RARE_
to O
block _RARE_
secretion _RARE_
of O
PZA _RARE_
, O
have O
to O
be O
considered O
in O
evaluating O
the O
effect O
of O
the O
two O
drugs O
given O
together O
, O
compared O
to O
the O
effect O
of O
each O
drug O
given O
separately O
. O

Circulatory _RARE_
arrest O
in O
the O
operating O
room O
. O

At O
a O
systolic O
blood _RARE_
pressure O
( O
BP _RARE_
) O
of O
60 _RARE_
mmHg O
, O
C02 _RARE_
responsiveness O
was O
abolished O
, O
but O
was O
maintained O
at _RARE_
higher _RARE_
levels O
of O
BP _RARE_
. O

Iodine _RARE_
- O
123 O
was O
satisfactorily _RARE_
imaged _RARE_
only O
with O
the O
MEC _RARE_
and O
pinhole _RARE_
collimators _RARE_
, O
which O
in O
turn _RARE_
yielded O
MTF _RARE_
values O
comparable O
to O
those O
measured O
for _RARE_
99mTc O
. O

Petrous _RARE_
meningioma _RARE_
en _RARE_
plaque O
presenting _RARE_
as _RARE_
a O
right O
middle _RARE_
ear O
tumor O
. O

The O
difficulties _RARE_
to O
analyse _RARE_
prostaglandins O
( O
PG _RARE_
) O
by O
gas O
- O
liquid O
chromatography O
are O
mainly O
due O
to O
the O
lack O
of O
sensitivity O
of O
the O
gas O
- O
chromatograph _RARE_
itself O
( O
higher _RARE_
than O
200 _RARE_
ng _RARE_
) O
and O
to O
the O
poor O
resolution O
of O
the O
packed _RARE_
columns _RARE_
. O

On O
cessation O
of O
steroid O
therapy O
the O
patient O
was O
noted O
to O
have O
radiologic _RARE_
manifestations O
of O
hypertrophic _RARE_
osteoarthropathy _RARE_
( O
HOA _RARE_
) O
as _RARE_
well _RARE_
as _RARE_
clinical O
and O
laboratory O
features O
of O
rheumatoid O
arthritis O
( O
RA _RARE_
). O

The O
effect O
of O
food O
on O
procainamide _RARE_
absorption O
. O

After O
giving O
a O
survey O
on O
the O
situation _RARE_
of O
antibiotic O
resistance O
in O
the O
region O
of O
Northern O
Bavaria _RARE_
during _RARE_
1973 _RARE_
/ O
74 _RARE_
and O
comparing O
the O
activity O
of O
a O
sulfamethoxazole _RARE_
( O
SMZ _RARE_
) O
trimethoprim _RARE_
( O
TMP _RARE_
) O
combination O
to O
other O
commonly O
used O
antibiotics O
and O
chemotherapeutic O
agents O
, O
the O
results O
of O
tests O
with O
the O
new O
combination O
of O
N1 _RARE_
-( _RARE_
4 O
, O
5 O
- O
dimethyl O
- O
2 O
- O
oxazolyl _RARE_
)- O
sulfanilamide _RARE_
) O
( O
sulfamoxole _RARE_
) O
and O
2 O
, O
4 O
- O
diamino _RARE_
- O
5 O
-( _RARE_
3 O
, O
4 O
, O
5 O
- O
trimethoxy _RARE_
- O
benzyl _RARE_
)- O
pyrimidine O
( O
trimethoprim _RARE_
) O
at _RARE_
a O
ratio O
of O
5 O
: O
1 O
( O
CN _RARE_
3123 _RARE_
; O
Nevin _RARE_
, O
Supristol _RARE_
) O
are O
compared O
to O
those O
of O
tests O
with O
TMP _RARE_
/ O
SMZ _RARE_
. O

RESULTS O
: O
Total O
IgE I-GENE
levels O
showed O
a O
tendency O
to O
diminish _RARE_
. O

Does _RARE_
afferent _RARE_
loop O
syndrome _RARE_
exist O
?] _RARE_
It O
is O
the O
author O
' O
s O
opinion _RARE_
that O
diagnosis O
of O
the O
" O
adducent _RARE_
loop O
syndrome _RARE_
" O
is O
unlikely O
to O
be O
correct O
in O
patients O
subjected O
to O
Billroth _RARE_
- O
II O
gastrectomy _RARE_
. O

Letter O
: O
Is O
actinic _RARE_
( O
solar _RARE_
) O
damage O
the O
provoking _RARE_
cause O
of O
' O
post O
- O
inflammatory O
elastolysis _RARE_
and O
cutis _RARE_
laxa _RARE_
( O
PECL _RARE_
)'? _RARE_

These O
data O
suggest O
that O
spontaneous O
recovery O
of O
central O
respiratory O
function O
after O
intoxication _RARE_
with O
Soman _RARE_
or O
Sarin _RARE_
may O
not O
be O
related O
to O
the O
return O
of O
AChE _RARE_
activity O
. O

Batch _RARE_
cultures O
of O
S O
. O
mutans _RARE_
serotype _RARE_
a O
demonstrated O
no _RARE_
growth O
on O
MSB _RARE_
agar O
. O

Also O
, O
samples O
of O
serum O
were O
absorbed O
with O
the O
various O
solid O
- O
phase _RARE_
allergens O
and O
the O
reactivity O
of O
the O
remaining O
IgE I-GENE
antibodies I-GENE
was O
determined O
. O

Crisis _RARE_
of O
the O
therapeutic O
community O
in O
Great _RARE_
Britain _RARE_

Pregnant _RARE_
women O
at _RARE_
term O
had O
the O
lowest O
levels O
of O
antithrombin I-GENE
III I-GENE
. O

Hematology _RARE_
problem O
of O
the O
month O
: O
band O
or O
seg _RARE_
? O

It O
is O
possible O
that O
cyclic O
variations O
in O
heme O
turnover O
are O
related O
to O
changes O
in O
erythrocyte _RARE_
characteristics O
during _RARE_
the O
progesterone O
phase _RARE_
. O

Haemodilution _RARE_
in O
cardiopulmonary O
bypass O
using O
a O
gelatine _RARE_
derivative _RARE_
for _RARE_
priming _RARE_
. O

Extramedullary _RARE_
plasmacytoma _RARE_
of O
the O
parotid _RARE_
gland _RARE_

I O
. O

The O
recovered O
calves O
were O
tested O
for _RARE_
immunity _RARE_
to O
homologous O
severe O
challenge O
, O
50 O
or O
73 _RARE_
days O
after O
the O
first _RARE_
infection O
. O

The O
performance O
of O
three O
commonly O
used O
chemical O
cartridge _RARE_
respirators _RARE_
for _RARE_
SO2 _RARE_
was O
measured O
under O
working O
conditions O
in O
a O
copper _RARE_
smelter _RARE_
. O

The O
neuroleptic O
- O
induced _RARE_
increase O
in O
central O
DA _RARE_
turnover O
( O
an O
indicator O
for _RARE_
the O
degree O
of O
DA _RARE_
receptor I-GENE
blocking O
) O
was O
found O
to O
be O
positively O
correlated O
with O
the O
therapeutic O
effect O
of O
neuroleptics _RARE_
and O
the O
development O
of O
hypokinetic _RARE_
- O
rigid _RARE_
symptoms O
. O

Rainbow _RARE_
trout _RARE_
were O
obtained O
from O
a O
commercial O
trout _RARE_
farm _RARE_
, O
kept O
in O
running _RARE_
water O
and O
feeding O
in O
experimental O
pellets O
for _RARE_
4 O
to O
8 O
weeks O
. O

Stimulation _RARE_
of O
macrophage O
function O
by O
killed O
Bordetella _RARE_
pertussis _RARE_
cells O
did O
not O
show O
any O
beneficial O
effect O
as _RARE_
an O
increased O
susceptibility _RARE_
became O
apparent O
. O

Primary O
amenorrhoea _RARE_
in O
a O
phenotypically _RARE_
female O
individual O
with O
a O
karyotype _RARE_
46 _RARE_
, O
xy _RARE_
and O
bilateral O
gonadoblastoma _RARE_

Toward _RARE_
absolute O
methods O
in O
clinical O
chemistry O
: O
application O
of O
mass O
fragmentography _RARE_
to O
high O
- O
accuracy O
analyses O
. O

Application _RARE_
of O
the O
2 O
- O
deoxy _RARE_
- O
D O
- O
glucose O
method O
to O
the O
coupling O
of O
cerebral O
metabolism O
and O
blood _RARE_
flow O
. O

Serum O
gastrin I-GENE
levels O
did O
not O
change O
in O
either O
group O
; O
however O
, O
background O
serum O
gastrin I-GENE
concentrations O
were O
significantly O
greater O
for _RARE_
V O
& O
P O
patients O
than O
V O
& O
A O
patients O
throughout O
the O
study O
. O

Efferent _RARE_
projections O
of O
the O
ventral O
portion O
of O
the O
putamen _RARE_
to O
the O
frontal O
, O
parietal _RARE_
and O
temporal O
regions O
of O
the O
cat _RARE_
cerebral O
cortex O

Preflight _RARE_
, O
inflight _RARE_
, O
and O
postflight _RARE_
exercise O
response O
tests O
were O
conducted O
on O
the O
astronauts _RARE_
of O
the O
second O
Skylab _RARE_
mission _RARE_
( O
Skylab _RARE_
3 O
) O
as _RARE_
part O
of O
an O
evaluation O
of O
physiological O
adaptation O
to O
long O
- O
term O
weightlessness _RARE_
. O

Mean O
corpuscular _RARE_
hemoglobin I-GENE
concentrations O
remained O
normal O
for _RARE_
48 _RARE_
h O
and O
then O
decreased O
in O
both O
groups O
, O
the O
CO2 O
group O
showing O
the O
larger O
decrease O
. O

All O
Cu _RARE_
values O
obtained O
from O
the O
organs O
investigated O
had O
reached O
a O
saturation O
level O
at _RARE_
8 O
mug _RARE_
Cu _RARE_
/ O
g O
diet O
with O
the O
exception O
of O
the O
values O
for _RARE_
body O
Cu _RARE_
found O
in O
the O
dams _RARE_
that O
were O
killed O
on O
the O
day O
of O
delivery O
. O

The O
effect O
of O
calcitonin I-GENE
, O
a O
large O
amount O
of O
calcium _RARE_
given O
orally O
, O
pentagastrin _RARE_
and O
glucagon I-GENE
on O
plasma O
47Ca _RARE_
radioactivity _RARE_
curves O
in O
subjects O
pretreated O
with O
47Ca _RARE_
was O
examined O
. O

State O
of O
the O
body O
in O
disorders O
of O
diurnal _RARE_
physiological O
rhythms _RARE_
and O
long O
- O
term O
hypokinesia _RARE_

Oxygen _RARE_
tension O
of O
the O
small O
lymph O
vessels O
( O
PLO2 _RARE_
) O
of O
the O
rabbit _RARE_
hind _RARE_
limb O
was O
measured O
with O
both O
a O
flow O
- O
through O
micro O
chamber O
and O
a O
polarographic _RARE_
catheter O
- O
tip _RARE_
oxygen O
electrode O
to O
obtain O
experimental O
data O
on O
the O
source O
of O
oxygen O
in O
the O
lymph O
. O

The O
response O
of O
the O
plasma I-GENE
fibrinogen I-GENE
level O
to O
the O
subucutaneous _RARE_
injection O
of O
turpentine _RARE_
and O
to O
the O
intravenous O
injection O
of O
endotoxin _RARE_
was O
measured O
in O
normal O
rabbits O
and O
in O
rabbits O
made O
granulocytopenic _RARE_
and O
thrombocytopenic _RARE_
with O
busulfan _RARE_
. O

Constantly _RARE_
rectilinear _RARE_
pressure O
curves O
without O
uterine _RARE_
activities O
are O
interpreted O
as _RARE_
characteristic O
tocographic _RARE_
criteria O
of O
an O
advanced O
ectopic O
gravidity _RARE_
. O

Since O
myoglobin I-GENE
is O
co _RARE_
- O
extracted O
with O
the O
hemoglobin I-GENE
, O
the O
2 O
heme O
pigments _RARE_
are O
separated O
in O
one O
portion O
of O
the O
extract _RARE_
by O
precipitating O
the O
hemoglobin I-GENE
in O
an O
85 _RARE_
% O
( O
NH4 _RARE_
) O
2SO4 _RARE_
solution O
. O

Considering _RARE_
these O
sources O
of O
error O
some O
of O
the O
variability O
in O
the O
present O
investigation O
might O
be O
avoided _RARE_
by O
systematic O
instructions _RARE_
. O

E O
50 O
, O
843 _RARE_
( O
1994 O
)]. O

Six O
patients O
with O
the O
diagnosis O
of O
acute O
mania _RARE_
were O
treated O
with O
high O
doses O
of O
the O
beta O
- O
adrenergic O
blocking O
agent O
propranolol O
. O

Effect O
of O
trauma O
on O
plasma I-GENE
glucagon I-GENE
and O
insulin I-GENE
concentrations O
in O
sheep O
. O

With O
the O
help O
of O
a O
nomogram _RARE_
one O
can O
read _RARE_
off O
the O
refraction _RARE_
, O
when O
axis O
length O
and O
corneal O
curvature _RARE_
are O
known O
. O

This O
up _RARE_
- O
grading _RARE_
of O
the O
final O
score O
by O
the O
CA O
component _RARE_
is O
greater O
( O
3 O
- O
8 O
%) O
in O
the O
less O
able O
students O
with O
scores O
below O
the O
mean O
level O
. O

Compared _RARE_
to O
controls O
, O
both O
UB _RARE_
and O
OCS _RARE_
rats O
showed O
a O
small O
but O
significant O
post O
- O
operative O
reduction O
in O
the O
nocturnality _RARE_
of O
drinking O
. O

Effect O
of O
indomethacin O
on O
coronary O
circulation O
: O
effect O
on O
ECG O
tracing _RARE_

Dual _RARE_
innervation _RARE_
of O
fast O
fibers O
in O
trunk O
muscles O
of O
lamprey _RARE_
larvae O

The O
feed O
consumed _RARE_
which O
was O
lowered O
by O
25 _RARE_
% O
initially O
, O
did O
not O
alter O
later O
. O

Certain _RARE_
characteristics O
of O
eye O
changes O
in O
patients O
with O
pheochromocytoma _RARE_
including O
Sipple _RARE_
' O
s O
syndrome _RARE_

The O
color O
- O
word _RARE_
interference O
effect O
previously O
reported O
with O
normal O
populations O
when O
given O
the O
Stroop O
test O
was O
demonstrated O
for _RARE_
this O
retarded O
sample O
using O
a O
special _RARE_
format _RARE_
. O

It O
was O
found O
that O
under O
the O
selected _RARE_
conditions O
a O
linear _RARE_
dependence O
exists O
between O
the O
betaI _RARE_
% O
value O
and O
lgC _RARE_
within O
the O
range O
of O
0 _RARE_
. O
5 O
-- _RARE_
10 O
mug _RARE_
ruscogenin _RARE_
. O

The O
influence O
of O
adrenergic O
nerves O
of O
the O
response O
of O
blood _RARE_
vessels O
in O
the O
rabbit _RARE_
ear O
to O
2 I-GENE
-- _RARE_
phenylalanine _RARE_
- I-GENE
8 I-GENE
- I-GENE
lysine _RARE_
vasopressin I-GENE
( O
Octapressin _RARE_
). O

Potscoital _RARE_
test O

I O
. O

When O
a O
tumour _RARE_
is O
present O
nipple _RARE_
discharge O
is O
of O
little O
importance O
for _RARE_
the O
diagnosis O
and O
treatment O
. O

Studies O
of O
biochemical O
and O
morphological O
changes O
( O
between O
normal O
and O
treated O
animals O
) O
show O
that O
chrysotile _RARE_
induces O
an O
increase O
in O
the O
lung _RARE_
free O
cell O
population O
and O
pulmonary O
surfactant _RARE_
levels O
. O

Infrared _RARE_
measurements O
of O
temperature _RARE_
changes O
and O
estimates O
of O
the O
heating _RARE_
produced O
at _RARE_
the O
mical _RARE_
. O

Who _RARE_
says _RARE_
' O
National O
Health O
Dis _RARE_
- O
service _RARE_
'. O

Is O
criticism _RARE_
of O
patient O
care O
justified _RARE_
and O
does O
it O
have O
educational _RARE_
value O
? O
Patients O
' O
criticism _RARE_
contributes O
to O
improved O
patient O
care O

Critique _RARE_
of O
" O
Interactive _RARE_
Effects O
of O
Test O
Anxiety _RARE_
and O
Credit _RARE_
/ O
No O
Credit _RARE_
or O
A O
- O
F O
Grade _RARE_
Condition _RARE_
upon O
Short O
- O
term O
and O
Long _RARE_
- O
term O
Recall _RARE_
of O
Course _RARE_
Information _RARE_
. O

These O
studies O
have O
shown O
that O
the O
majority O
of O
tested O
staphylococci _RARE_
were O
resistant O
to O
penicillin _RARE_
G O
, O
erythromycin _RARE_
, O
and O
produced O
beta I-GENE
- I-GENE
lactamase I-GENE
. O

Since O
1968 _RARE_
, O
a O
steep _RARE_
decrease O
in O
the O
number O
of O
strains O
resistant O
to O
three O
or O
more O
antibiotics O
( O
multiple O
- O
resistant O
) O
and O
in O
strains O
of O
the O
83A _RARE_
complex O
was O
noticed _RARE_
. O

Improvement _RARE_
of O
nursing O
instruction _RARE_
to O
be O
given O
at _RARE_
the O
time O
of O
discharge O
from O
the O
ward _RARE_
for _RARE_
premature O
infants O

No O
difference O
in O
the O
clinical O
acceptability _RARE_
could O
be O
ascertained _RARE_
between O
the O
two O
groups O
. O

After O
90 _RARE_
d O
a O
subsurface _RARE_
, O
radiolucent _RARE_
caries _RARE_
- O
like O
lesion O
was O
observed O
in O
two O
specimens O
only O
. O

The O
contraceptive _RARE_
pattern O
of O
157 _RARE_
women O
was O
analysed O
and O
13 _RARE_
. O
8 O
percent O
were O
using O
inefficient O
methods O
. O

Plethysmographic _RARE_
technique O
and O
indirect O
blood _RARE_
pressure O
recordings O
were O
used O
. O

I O
. O

The O
second O
and O
third O
responded O
similarly O
to O
either O
a O
combined O
cyclophosphamide O
+ O
antilymphocyte _RARE_
globulin I-GENE
( O
ALG _RARE_
) O
treatment O
or O
to O
ALG _RARE_
administration O
preceded _RARE_
by O
a O
small O
dosage O
of O
cyclophosphamide O
, O
which O
had O
proved O
ineffective _RARE_
when O
administered O
alone O
. O

Evidence O
is O
presented O
that O
Leber _RARE_
' O
s O
military _RARE_
aneurysm _RARE_
retinitis _RARE_
is O
not O
a O
separate O
entity _RARE_
but O
a O
special _RARE_
form O
of O
Coats _RARE_
' O
disease _RARE_
. O

Fibrin _RARE_
cloaking _RARE_
along O
the O
catheter O
was O
found O
in O
20 O
patients O
studied O
by O
pull _RARE_
- O
out O
arteriography _RARE_
and O
was O
unassociated _RARE_
with O
clinical O
symptoms O
. O

The O
influence O
of O
a O
mobile O
pupil _RARE_
on O
the O
response O
in O
the O
DC O
- O
ERG _RARE_
is O
demonstrated O
. O

A O
newly O
synthesized O
anti O
- O
inflammatory O
agent O
, O
Y O
- O
8004 _RARE_
demonstrated O
a O
greater O
inhibition O
than O
did O
indomethacin O
( O
IM O
). O
on O
inflammatory O
response O
such O
as _RARE_
ultraviolet _RARE_
erythema _RARE_
in O
guinea _RARE_
pigs O
, O
carrageenin _RARE_
edema O
, O
evans _RARE_
blue O
and O
carrageenin _RARE_
- O
induced _RARE_
pleuritis _RARE_
and O
acetic _RARE_
acid O
- O
induced _RARE_
peritonitis _RARE_
in O
rats O
. O

As O
stands _RARE_
shifted O
in O
dominance _RARE_
from O
pine _RARE_
to O
fir _RARE_
with O
age O
, O
subalpine _RARE_
fir _RARE_
appeared O
to O
maintain O
gradually O
increasing O
rates O
of O
whole O
- O
forest _RARE_
productivity _RARE_
until O
stands _RARE_
were O
approximately _RARE_
400 _RARE_
years O
old O
. O

Alpha _RARE_
- I-GENE
1 I-GENE
antitrypsin I-GENE
and O
Indian _RARE_
childhood O
cirrhosis O
. O

Lymphocyte _RARE_
subpopulations _RARE_
, O
serum I-GENE
IgE I-GENE
and O
total _RARE_
eosinophil O
counts O
in O
patients O
with O
bronchial O
asthma O
. O

A O
range O
of O
normal O
ventricular O
measurements O
for _RARE_
the O
EMI _RARE_
scan O
is O
suggested O
. O

A O
comparison O
of O
physical O
and O
cytogenetic O
estimates O
of O
radiation O
dose O
in O
patients O
treated O
with O
iodine O
- O
131 _RARE_
for _RARE_
thyroid O
carcinoma O
. O

Technique _RARE_
for _RARE_
obtaining O
refined _RARE_
ceramics _RARE_
with O
dense _RARE_
mass O

Mean O
total _RARE_
lung _RARE_
capacity O
, O
functional _RARE_
residual O
capacity O
, O
and O
residual O
volume O
increased O
significantly O
, O
and O
the O
mean O
closing _RARE_
volume O
, O
the O
lung _RARE_
volume O
above O
residual O
volume O
at _RARE_
which O
phase _RARE_
IV O
begins O
, O
decreased O
significantly O
with O
11 O
cm O
H20 _RARE_
continuous O
positive O
airway O
pressure O
; O
differences O
at _RARE_
5 O
cm O
H20 _RARE_
were O
not O
significant O
. O

Current O
status O
of O
zinc O
deficiency O
in O
the O
pathogenesis O
of O
neurological O
, O
dermatological _RARE_
and O
musculoskeletal _RARE_
disorders O
. O

Calcium _RARE_
and O
phosphorus O
metabolism O
in O
chronic O
uremia _RARE_
. O

Modern _RARE_
studies O
, O
conducted O
with O
Delta _RARE_
- O
9 O
- O
THC _RARE_
, O
in O
healthy O
voluntaries _RARE_
, O
again O
suggest O
the O
comparison O
or O
even O
the O
identity O
of O
the O
modifications O
caused O
by O
cannabis _RARE_
with O
sleep O
and O
dream _RARE_
. O

The O
correcting _RARE_
action O
of O
tropatepine _RARE_
hydrochloride _RARE_
upon O
the O
extrapyramidal _RARE_
effects O
induced _RARE_
by O
neuroleptics _RARE_
has O
been O
studied O
in O
32 _RARE_
acute O
psychotic _RARE_
states O
. O

Epididymal _RARE_
growth O
was O
retarded O
in O
animals O
maintained O
solely O
on O
chickpea _RARE_
haulm _RARE_
and O
improved O
with O
supplementation O
. O

Two O
patients O
were O
treated O
with O
both O
regimens O
. O

Results O
obtained O
for _RARE_
chloramphenicol O
- O
containing O
preparations O
are O
presented O
, O
and O
both O
dissolution O
curves O
and O
cup _RARE_
- O
plate _RARE_
assays O
demonstrate O
that O
chloramphenicol O
has O
far O
superior O
release O
( O
and O
hence O
activity O
) O
from O
creams _RARE_
than O
from O
ophthalmic O
ointments _RARE_
. O

IgG I-GENE
levels O
of O
1 O
/ O
100 _RARE_
were O
present O
in O
only O
four O
out O
of O
ten O
samples O
obtained O
150 _RARE_
days O
after O
the O
clinical O
onset O
. O

Letter O
: O
Perspectives _RARE_
in O
bone O
marrow O
transplantation O
. O

Assessment O
of O
the O
carcinogenicity _RARE_
of O
non O
- O
nutritive _RARE_
sweetners _RARE_
II O
: O
Cyclamates _RARE_
and O
cyclohexylamine _RARE_
. O

The O
discordant _RARE_
behaviour O
in O
weakly O
infected _RARE_
mice O
was O
due O
to O
the O
occurrence O
in O
some O
animals O
of O
a O
second O
phase _RARE_
of O
more O
rapid O
increase O
of O
the O
parasitemia _RARE_
. O

Residual _RARE_
amphotericin O
B O
was O
detected O
in O
the O
feces _RARE_
of O
the O
mice O
only O
while O
they O
were O
receiving O
the O
0 _RARE_
. O
3 O
mg O
/ O
ml O
dose O
level O
. O

There O
was O
a O
slight O
increase O
in O
total _RARE_
transferrin I-GENE
2 O
hr O
after O
1 O
tablet O
and O
values O
remained O
high O
throughout O
the O
experiment O
. O

Following O
intravenous O
administration O
, O
the O
myocardial _RARE_
concentration O
of O
tracer O
thallium O
- O
201 _RARE_
, O
potassium _RARE_
- O
43 _RARE_
, O
and O
rubidium _RARE_
- O
81 _RARE_
were O
determined O
in O
mice O
; O
thallium O
was O
present O
in O
the O
greatest O
concentration O
in O
the O
myocardium O
( O
2 O
. O
08 _RARE_
% O
compared O
1 O
. O
25 _RARE_
% O
for _RARE_
potassium _RARE_
and O
1 O
. O
15 _RARE_
% O
for _RARE_
rubidium _RARE_
at _RARE_
10 O
minutes O
). O

Thromboplastin _RARE_
time O
, O
partial O
thromboplastin I-GENE
time O
, O
thrombin I-GENE
time O
, O
heat O
- O
dependent O
fibrin I-GENE
, O
clot _RARE_
retraction _RARE_
, O
and O
clotting _RARE_
factors I-GENE
II I-GENE
, I-GENE
V I-GENE
, I-GENE
VIII I-GENE
, I-GENE
IX _RARE_
, I-GENE
X I-GENE
, O
and O
the O
platelet O
count O
were O
determined O
. O

The O
data O
support O
the O
notion O
that O
suppression O
of O
images O
during _RARE_
binocular _RARE_
rivalry _RARE_
is O
independent O
in O
both O
eyes O
. O

Glycogen _RARE_
utilization O
was O
increased O
, O
but O
tissue O
levels O
of O
creatine _RARE_
phosphate O
, O
ATP O
, O
and O
lactate _RARE_
were O
similar O
to O
those O
in O
hearts O
receiving O
normal O
flow O
. O

The O
records O
from O
1948 _RARE_
through O
1967 _RARE_
of O
344 _RARE_
previously O
untreated O
patients O
with O
squamous O
cell O
carcinoma O
of O
the O
oral O
cavity O
, O
oropharynx _RARE_
, O
supraglottic _RARE_
larynx O
and O
hypopharynx _RARE_
who O
had O
clinically O
positive O
cervical O
lymph O
node O
metastases O
staged _RARE_
N1 _RARE_
, O
N2A _RARE_
, O
or O
N2B _RARE_
, O
and O
whose O
initial O
neck O
treatment O
consisted O
of O
external O
radiation O
therapy O
alone O
were O
reviewed O
. O

With O
0 _RARE_
. O
5 O
vol _RARE_
.-%, _RARE_
the O
corresponding O
values O
were O
345 _RARE_
mumol O
/ O
1 O
( O
5 O
. O
72 O
mg O
/ O
100 _RARE_
ml O
) O
and O
137 _RARE_
mumol O
/ O
1 O
( O
2 O
. O
25 _RARE_
mg O
/ O
100 _RARE_
ml O
) O
respectively O
. O

The O
authors O
describe O
the O
technique O
of O
transverse O
axial O
tomography O
of O
the O
spine O
and O
give O
a O
detailed O
description O
of O
the O
axial O
anatomy _RARE_
of O
the O
normal O
lumbar O
spine O
from O
L O
- O
4 O
to O
the O
sacrum _RARE_
. O

Owing _RARE_
to O
parental O
attitude _RARE_
, O
a O
low O
protein O
diet O
( O
1 O
- O
5 O
g O
/ O
kg O
) O
was O
introduced O
only O
late _RARE_
. O

In O
none O
of O
the O
44 _RARE_
type O
I O
attacks O
and O
29 O
type O
II O
attacks O
which O
were O
recorded O
did O
circulatory O
changes O
; O
the O
latter O
were O
different O
in O
the O
two O
groups O
. O

A O
clinically O
useful O
diagnostic O
method O
has O
been O
developed O
for _RARE_
detecting O
and O
quantitating _RARE_
periods O
of O
apnea O
in O
pediatric O
patients O
. O

The O
other O
hypoglycaemic _RARE_
patient O
showed O
an O
exaggerated _RARE_
insulin I-GENE
release O
in O
response O
to O
tolbutamide _RARE_
. O

Nerve _RARE_
stimulation _RARE_
( O
1 O
. O
5 O
- O
12 O
cycles O
/ O
s O
) O
produced O
frequency O
- O
dependent O
reductions O
in O
CBF O
, O
a O
decrease O
of O
50 O
percent O
occurring O
with O
the O
highest O
frequency O
. O

Effect O
of O
ingestion O
of O
Norbiogest _RARE_
during _RARE_
the O
quiescent _RARE_
period O
of O
the O
genital _RARE_
organs O

Risk O
of O
infection O
in O
the O
treatment O
of O
fractures _RARE_

Bulbar _RARE_
pouches _RARE_
were O
perfused O
with O
solutions O
of O
0 _RARE_
. O
9 O
% O
Na _RARE_
C1 O
, O
0 _RARE_
. O
1 O
N O
HC1 _RARE_
, O
40 O
% O
glucose O
, O
40 O
% O
NaC1 _RARE_
, O
and O
40 O
% O
peptone _RARE_
or O
with O
0 _RARE_
. O
1 O
% O
solutions O
of O
acetylcholine _RARE_
chloride _RARE_
. O

Liver O
microsomes _RARE_
of O
the O
shag _RARE_
showed O
smaller O
than O
8 O
% O
of O
the O
epoxide _RARE_
hydrase _RARE_
activity O
and O
smaller O
than O
14 O
% O
of O
the O
hydroxylating _RARE_
capacity O
of O
liver O
microsomes _RARE_
from O
the O
rat O
. O

Prolonged _RARE_
heavy O
work O
effected _RARE_
an O
increase O
of O
10 O
. O
3 O
plus _RARE_
or O
minus O
0 _RARE_
. O
9 O
mmHg O
in O
in O
vivo O
P50 _RARE_
( O
7 O
. O
30 _RARE_
PH _RARE_
- O
v O
, O
41 _RARE_
degrees O
C O
- O
v O
, O
and O
45 _RARE_
Pv _RARE_
- O
CO2 O
); O
due O
entirely O
to O
the O
additive O
effects O
of O
increased O
venous O
temperature _RARE_
and O
[ _RARE_
H O
+]. _RARE_

A O
clinical O
, O
serological O
and O
prognostic O
study O

The O
American O
Burkitt _RARE_
Lymphoma _RARE_
Registry _RARE_
: O
a O
progress O
report O
. O

Vitrectomy _RARE_
with O
an O
alternative _RARE_
instrument O
system _RARE_
. O

The O
metabolic O
clearance O
rate O
of O
progesterone O
was O
295 _RARE_
+/- O
49 _RARE_
( O
S O
. O
E O
.) O
1 O
/ O
day O
. O

This O
sequence O
is O
almost O
identical O
with O
that O
of O
human I-GENE
luteinizing _RARE_
hormone I-GENE
( O
Sairam _RARE_
, O
M O
. O

The O
mean O
plasma O
sodium _RARE_
concentration O
which O
was O
135 O
. O
95 _RARE_
(+/- O
SD O
4 O
. O
14 O
) O
mEq O
/ O
kg O
before O
diuretic O
treatment O
was O
significantly O
decreased O
during _RARE_
treatment O
to O
129 _RARE_
. O
19 O
(+/- O
SD O
2 O
. O
77 O
) O
mEq O
/ O
kg O
, O
P O
less O
than O
0 _RARE_
. O
001 O
. O

Editorial _RARE_
: O
Low O
- O
dose O
heparin _RARE_
and O
the O
prevention O
of O
venous O
thromboembolic _RARE_
disease _RARE_
. O

At O
the O
very O
high O
dose O
levels O
used O
, O
sodium _RARE_
saccharin O
and O
sodium _RARE_
cyclamate _RARE_
were O
weak O
solitary _RARE_
carcinogens _RARE_
producing O
4 O
/ O
253 _RARE_
and O
3 O
/ O
228 _RARE_
bladder O
tumours O
respectively O
, O
and O
the O
first _RARE_
of O
these O
tumours O
did O
not O
appear O
for _RARE_
more O
than O
80 _RARE_
weeks O
. O

Effects O
of O
perceptual _RARE_
salience _RARE_
on O
the O
matrix _RARE_
task O
performance O
of O
four O
- O
and O
six _RARE_
- O
year O
- O
old O
children O
. O

Glucose _RARE_
- I-GENE
6 I-GENE
- I-GENE
phosphate I-GENE
dehydrogenase I-GENE
( O
G I-GENE
- I-GENE
6 I-GENE
- I-GENE
PD _RARE_
) O
deficiency O
in O
the O
newborn O
. O

The O
eluting _RARE_
solvent O
was O
methanol _RARE_
- O
chloroform _RARE_
( O
10 O
+ O
90 _RARE_
) O
at _RARE_
a O
flow O
rate O
of O
2 O
. O
0 _RARE_
ml O
/ O
min O
. O

The O
bronchial O
epithelia _RARE_
of O
all O
smoke O
- O
exposed O
animals O
were O
hyperplastic _RARE_
, O
and O
their O
ultrastructure _RARE_
showed O
invaginations _RARE_
, O
tilt O
of O
nuclear O
axes _RARE_
, O
an O
increase O
in O
the O
number O
and O
size O
of O
lysosomes _RARE_
and O
multivesiculated _RARE_
bodies _RARE_
, O
and O
increased O
numbers O
of O
enlarged _RARE_
intramitochondrial _RARE_
granules O
. O

The O
routine O
administration O
of O
fat O
- O
soluble _RARE_
vitamins _RARE_
appears O
unnecessary _RARE_
but O
it O
is O
prudent _RARE_
to O
measure O
prothrombin I-GENE
time O
and O
serum O
vitamins _RARE_
A O
and O
E O
at _RARE_
intervals O
. O

Prostaglandins _RARE_
F O
( O
PGF _RARE_
) O
were O
measured O
in O
uterine _RARE_
vein _RARE_
, O
ovarian O
artery O
, O
and O
jugular _RARE_
vein _RARE_
plasma O
and O
in O
the O
endometrial O
tissues O
at _RARE_
various O
times O
during _RARE_
the O
bovine O
estrous _RARE_
cycle _RARE_
, O
and O
were O
compared O
to O
peripheral O
plasma O
progesterone O
levels O
. O

Before _RARE_
this O
date O
, O
the O
drug O
directly O
inhibits O
fetal _RARE_
weight _RARE_
gain O
, O
whereas O
the O
sensitivity O
of O
the O
placenta O
is O
only O
transient O
at _RARE_
day O
16 O
resulting O
in O
maximum O
weight _RARE_
decrease O
of O
this O
organ O
24 _RARE_
h O
later O
. O

Groups _RARE_
of O
ten O
dependent O
and O
ten O
saline O
mice O
were O
singly _RARE_
tested O
in O
both O
light O
and O
dark O
conditions O
in O
each O
of O
five O
covered _RARE_
cylinders _RARE_
( O
2 O
- O
23 _RARE_
in O
high O
). O

The O
effects O
initiated _RARE_
from O
the O
nucleus O
accumbens _RARE_
septi _RARE_
were O
most O
marked O
. O

The O
appearance O
of O
dyskinetic _RARE_
movement O
disorders O
in O
humans O
following O
the O
chronic O
use O
of O
levodopa _RARE_
or O
amphetamine O
may O
be O
a O
manifestation O
of O
similarly O
increased O
dopamine I-GENE
receptor I-GENE
site I-GENE
sensitivity O
within O
the O
striatum _RARE_
. O

Association O
with O
HL _RARE_
- I-GENE
A I-GENE
W _RARE_
- I-GENE
27 _RARE_
. O

Letter O
: O
Lactose _RARE_
tolerance O
tests O
as _RARE_
a O
predictor O
of O
milk O
tolerance O
. O

Retinoblastoma _RARE_
: O
a O
study O
of O
natural _RARE_
history O
and O
prognosis O
of O
268 _RARE_
cases O
. O

Like O
pineal O
melatonin O
, O
serum O
melatonin O
was O
high O
at _RARE_
mid O
- O
dark O
and O
low O
at _RARE_
mid O
- O
light O
. O

D O
. O

Atherosclerosis _RARE_

The O
authors O
concluded O
that O
ultrasonic _RARE_
Doppler O
- O
cardiography _RARE_
can O
be O
used O
for _RARE_
measuring O
the O
relative O
changes O
in O
the O
stroke O
volume O
. O

The O
attainment _RARE_
of O
sexual O
maturity _RARE_
in O
terms O
of O
secondary O
sexual O
characteristics O
, O
the O
production O
of O
spermatozoa O
in O
the O
male O
, O
and O
the O
cyclical _RARE_
female O
pattern O
with O
release O
of O
ova _RARE_
are O
end O
- O
points O
of O
the O
developmental O
process O
. O

However O
, O
a O
10 O
-- _RARE_
15 _RARE_
% O
lengthening _RARE_
of O
the O
partial O
thromboplastin I-GENE
time O
is O
evident O
after O
24 _RARE_
hours O
of O
storage _RARE_
. O

Caution _RARE_
should O
be O
exercised _RARE_
in O
the O
use O
of O
these O
dyes _RARE_
for _RARE_
lymphograms _RARE_
. O

This O
reveals O
a O
new O
test O
for _RARE_
short O
saphenous _RARE_
incompetence _RARE_
and O
shows O
that O
14 O
per O
cent O
of O
varices _RARE_
stem _RARE_
from O
a O
saphenopopliteal _RARE_
reflux O
. O

Three O
groups O
of O
patients O
who O
had O
undergone O
subtotal O
thyroidectomy _RARE_
for _RARE_
Graves _RARE_
' O
s O
disease _RARE_
, O
toxic O
multinodular _RARE_
goitre _RARE_
, O
or O
euthyroid _RARE_
multinodular _RARE_
goitre _RARE_
12 O
to O
15 _RARE_
years O
before O
and O
in O
whom O
a O
normal O
serum O
thyroxine O
( O
T O
- O
4 O
) O
level O
was O
found O
were O
each O
divided O
into O
two O
subgroups O
on O
the O
basis O
of O
a O
normal O
or O
a O
raised O
serum O
thyrotrophin _RARE_
concentration O
. O

Routine _RARE_
isotope _RARE_
cystography _RARE_
using O
99M _RARE_
Tc O
sulfur O
colloid O
for _RARE_
detection O
and O
follow O
- O
up _RARE_
of O
vesico _RARE_
- O
ureteral _RARE_
reflux O

Air _RARE_
ion O
action O
on O
bacteria O
. O

No O
evidence O
of O
either O
positive O
or O
negative O
chemography _RARE_
was O
found O
. O

The O
interpretation O
of O
antibiotic O
disc O
sensitivities _RARE_
. O

Following O
retransfusion _RARE_
, O
the O
affected O
epithelial _RARE_
lining _RARE_
appeared O
greatly O
distended _RARE_
over O
the O
oedematous _RARE_
lamina _RARE_
propria _RARE_
, O
with O
almost O
complete _RARE_
loss _RARE_
of O
structural O
detail O
. O

A O
study O
of O
chromosomes O
of O
lymphocytes O
from O
patients O
treated O
with O
hycanthone _RARE_
. O

Characteristics _RARE_
of O
anesthesia O
and O
resuscitation O
in O
emergency _RARE_
lung _RARE_
surgery O

Study O
of O
the O
physico _RARE_
- O
chemical O
state O
of O
plutonium O
- O
239 O
in O
a O
citrate _RARE_
solution O
- O
blood _RARE_
system _RARE_

Tobramycin _RARE_
60 _RARE_
mg O
did O
not O
show O
any O
remarkable O
effect O
, O
but O
dibecacin _RARE_
100 _RARE_
mg O
produced O
a O
slight O
potentiating _RARE_
effect O
on O
the O
action O
of O
d O
- O
tubocurarine _RARE_
. O

In O
about O
one O
third O
of O
the O
cases O
this O
operation O
results O
in O
tonal _RARE_
and O
vocal _RARE_
improvement O
for _RARE_
patients O
suffering O
from O
progressive O
perceptive _RARE_
deafness _RARE_
. O

The O
specific O
electrical O
resistance O
of O
the O
cerebrospinal _RARE_
fluid _RARE_
was O
measured O
by O
means O
of O
conductometry _RARE_
in O
14 O
cases O
of O
meningitis O
purulenta _RARE_
, O
17 _RARE_
cases O
of O
meningitis O
serosa _RARE_
, O
10 O
cases O
of O
encephalitis _RARE_
and O
in O
32 _RARE_
control O
subjects O
. O

2 O
- O
Chemical O
occlusion O
of O
vas O
is O
quite O
effective O
in O
producing O
a O
block _RARE_
in O
the O
vas O
deferens O
of O
dogs O
. O

Besides _RARE_
, O
we O
found O
in O
3 O
patients O
increased O
serum I-GENE
immunoglobulins I-GENE
, O
chiefly _RARE_
IgG I-GENE
, O
as _RARE_
first _RARE_
Russe _RARE_
, O
Busey _RARE_
and O
Barbeau _RARE_
demonstrated O
in O
a O
large O
French _RARE_
- O
Canadian _RARE_
family O
. O

We O
suggest O
that O
such O
occlusions _RARE_
occurred O
at _RARE_
the O
time O
of O
the O
infarction O
. O

Streptococcal _RARE_
preparation O
( O
OK _RARE_
- O
432 _RARE_
), _RARE_
a O
new O
type O
of O
anti O
- O
cancer _RARE_
agent O
, O
was O
given O
to O
the O
patients O
with O
advanced O
cancer _RARE_
in O
combination O
with O
Mitomycin _RARE_
- O
C O
, O
5 O
- O
FU O
and O
Cytosine _RARE_
arabinoside _RARE_
. O

Generally _RARE_
, O
a O
correlation O
was O
observed O
between O
highest O
concentrations O
of O
CSF I-GENE
immunoglobulins I-GENE
and O
degree O
of O
meningeal _RARE_
inflammatory O
response O
, O
even O
if O
this O
was O
a O
component _RARE_
of O
other O
neurological O
diseases O
. O

Maternal _RARE_
lactation _RARE_

Experimental O
cardiotoxicity _RARE_
of O
adriamycin _RARE_

Muscular _RARE_
pathology O

Demonstration _RARE_
of O
the O
agent O
was O
performed O
from O
the O
6th _RARE_
to O
the O
11th _RARE_
day O
p O
. O
i O
. O
by O
direct O
microscopic O
methods O
( O
Stamp _RARE_
and O
auramine _RARE_
staining O
, O
fluorescent _RARE_
antibody O
technique O
); O
the O
Coxiella _RARE_
content O
was O
determined O
by O
titration O
in O
embryonated _RARE_
hen _RARE_
' O
s O
eggs O
. O

The O
patients O
were O
divided O
into O
4 O
groups O
receiving O
NLA _RARE_
II O
with O
or O
without O
nalorphine _RARE_
, O
morphine _RARE_
or O
Micoren _RARE_
. O

The O
alterations O
of O
5 O
- O
HT _RARE_
and O
5 O
- O
HIAA _RARE_
levels O
in O
several O
regions O
of O
the O
brain O
under O
the O
conditions O
examined O
may O
indicate O
that O
IDPN _RARE_
' O
s O
neurotoxicity O
primarily O
affects O
5 O
- O
HT _RARE_
- O
containing O
neurones O
. O

( O
5 O
) O
An O
increase O
in O
leukocyte _RARE_
- O
counts O
occurred O
on O
the O
administration O
of O
serum O
obtained O
from O
rabbit _RARE_
during _RARE_
phase _RARE_
- O
2 O
. O

The O
results O
obtained O
tend _RARE_
to O
prove O
that O
the O
reticuloendothelial _RARE_
system _RARE_
mainly O
participated _RARE_
in O
beryllium _RARE_
retention O
. O

In O
both O
cases O
, O
at _RARE_
the O
end O
of O
exposure O
the O
same O
level O
of O
blood _RARE_
carboxyhemoglobin _RARE_
( O
COHb _RARE_
) O
( O
about O
50 O
%) O
was O
reached O
. O

The O
results O
indicate O
that O
increased O
pulmonary O
blood _RARE_
flow O
and O
decreased O
pulmonary O
vascular O
resistance O
with O
advancing _RARE_
gestation O
are O
due O
to O
an O
increase O
in O
the O
total _RARE_
number O
of O
vessels O
and O
increased O
vasomotor _RARE_
reactivity O
is O
related O
to O
an O
increase O
in O
the O
total _RARE_
amount O
of O
smooth _RARE_
muscle O
while O
the O
thickness O
of O
muscle O
in O
individual O
vessels O
remains O
constant O
. O

Reduction _RARE_
in O
dosage O
restored O
normal O
taste O
sense O
in O
all O
three O
, O
but O
in O
two O
the O
drug O
had O
to O
be O
discontinued _RARE_
because O
of O
persisting _RARE_
high O
transaminase _RARE_
levels O
. O

The O
calcium _RARE_
ratio O
( O
mean O
ratio O
of O
the O
predicted O
to O
measured O
TBCa _RARE_
) O
in O
men O
was O
1 O
. O
000 _RARE_
+/- O
7 O
. O
8 O
% O
and O
in O
women O
0 _RARE_
. O
996 _RARE_
+/- O
7 O
. O
1 O
%. O

A O
late _RARE_
diagnosis O
of O
retinoblastoma _RARE_
is O
an O
unquestionable _RARE_
fact O
that O
allows O
its O
growth O
and O
leads O
to O
a O
deterioration O
in O
the O
outlook _RARE_
. O

Total O
cholesterol O
was O
measured O
in O
amniotic _RARE_
fluids O
collected O
at _RARE_
different O
stages O
of O
gestation O
. O

Her _RARE_
serum O
FT3 _RARE_
concentration O
was O
, O
however O
, O
much O
higher _RARE_
than O
the O
ranges _RARE_
in O
normal O
pregnancy _RARE_
or O
in O
GTD _RARE_
patients O
without O
clinical O
hyperthyroidism _RARE_
. O

The O
authors O
found O
that O
except O
for _RARE_
fear _RARE_
and O
pugnacity _RARE_
all O
husband _RARE_
- O
wife _RARE_
trait _RARE_
correlations O
were O
positive O
, O
in O
contrast O
to O
Winch _RARE_
' O
s O
principle _RARE_
of O
type O
I O
complementarity _RARE_
. O

A O
note _RARE_
on O
the O
phase _RARE_
- O
plane _RARE_
technique O
representation _RARE_
of O
cardiac O
action O
potentials O
. O

3 O
activities O
of O
the O
factor I-GENE
II I-GENE
molecule O
in O
the O
newborn O
infant O
at _RARE_
term O

The O
concept O
of O
" O
structural O
identifiability _RARE_
" O
is O
employed O
in O
this O
analysis O
to O
determine O
which O
model O
parameters O
can O
be O
and O
which O
cannot O
be O
determined O
" O
uniquely _RARE_
" O
from O
given O
input O
- O
output O
data O
; O
a O
step O
- O
by O
- O
step O
procedure O
based O
on O
an O
extension O
of O
this O
concept O
is O
presented O
for _RARE_
adapting O
the O
overall O
approach O
to O
the O
experimental O
design O
problem O
. O

However O
, O
we O
did O
detect O
lot _RARE_
- O
to O
- O
lot _RARE_
variation O
and O
differences O
in O
performance O
between O
narrow O
bandpass _RARE_
and O
wide O
bandpass _RARE_
spectrophotometers _RARE_
. O

The O
cochlear O
compromise _RARE_
. O

A O
case O
observed O
in O
Saigon _RARE_

Hypertonic _RARE_
glucose O
administered O
intrajejunally _RARE_
in O
Heidenhain _RARE_
pouch _RARE_
dogs O
resulted O
in O
an O
equal O
inhibition O
of O
pentagastrin _RARE_
- O
induced _RARE_
acid O
secretion _RARE_
from O
the O
pouch _RARE_
and O
the O
main O
stomach O
, O
whereas O
hypertonic _RARE_
saline O
had O
no _RARE_
effect O
. O

Acquired _RARE_
factor I-GENE
VIII I-GENE
inhibitor O
in O
non O
- O
hemophilic _RARE_
patients O

Biohydrogenation _RARE_
of O
linoleic _RARE_
acid O
into O
octadecenoic _RARE_
acid O
was O
observed O
. O

The O
study O
of O
calcium _RARE_
metabolism O
in O
ten O
thalassaemic _RARE_
children O
comperatively _RARE_
with O
controls O
after O
oral O
administration O
of O
47Ca _RARE_
has O
shown O
diminished O
intestinal _RARE_
absorption O
. O

Chlamydial _RARE_
agents O
were O
isolated O
from O
the O
semen O
near O
the O
end O
of O
the O
chlamydemic _RARE_
phase _RARE_
. O

Because O
of O
the O
increased O
CPK I-GENE
activity O
found O
in O
normal O
newborns O
, O
screening O
for _RARE_
Duchenne _RARE_
- O
type O
muscular O
dystrophy _RARE_
should O
be O
postponed _RARE_
for _RARE_
a O
few O
weeks O
after O
delivery O
. O

In O
contrast O
, O
the O
insulin I-GENE
response O
had O
returned O
to O
the O
non O
- O
pregnant _RARE_
value O
by O
the O
second O
day O
of O
the O
puerperium _RARE_
. O

The O
authors O
report O
the O
results O
of O
a O
series O
of O
toxicological O
tests O
conducted O
on O
plastic _RARE_
materials O
( O
polyethylene _RARE_
) O
activated O
with O
tetraphenylbutadiene _RARE_
( O
TPB _RARE_
) O
an O
additive O
recently O
proposed O
as _RARE_
a O
sensitizer _RARE_
capable O
of O
photodegrading _RARE_
plastic _RARE_
materials O
. O

Mutational O
analysis O
of O
the O
major O
homology O
region O
of O
Mason _RARE_
- O
Pfizer _RARE_
monkey _RARE_
virus O
by O
use O
of O
saturation O
mutagenesis O
. O

One O
site O
, O
PAL _RARE_
, O
occurs O
within O
the O
10 O
bp O
sequence O
GGGGAGGAGG _RARE_
. O

Nuclear O
extracts O
prepared O
from O
both O
neural _RARE_
and O
non O
- O
neural _RARE_
cell O
lines O
, O
mouse O
brain O
, O
and O
mouse O
liver O
contain O
proteins O
that O
recognize O
and O
bind O
to O
the O
PROX _RARE_
and O
PAL _RARE_
sequences O
indicating O
that O
proteins O
which O
bind O
to O
these O
target O
sequences O
are O
widespread _RARE_
. O

To O
determine O
if O
the O
NF _RARE_
( I-GENE
H I-GENE
) I-GENE
promoter I-GENE
can O
be O
activated O
in O
a O
tissue O
specific O
manner O
during _RARE_
development O
transgenic O
mice O
containing O
the O
promoter O
region O
linked _RARE_
to O
a O
beta I-GENE
- I-GENE
galactosidase I-GENE
reporter I-GENE
gene I-GENE
were O
generated O
. O

Here O
we O
describe O
and O
map O
two O
more O
new O
genes O
identified O
as _RARE_
allele O
- O
specific O
suppressors O
that O
compensate _RARE_
for _RARE_
carboxy _RARE_
- O
terminal O
truncation _RARE_
of O
PET122 _RARE_
. O

Previous O
studies O
have O
shown O
[ _RARE_
Hisanaga _RARE_
, O
S O
., O
Kusubata _RARE_
, O
M O
., O
Okumura _RARE_
, O
E O
. O
& O
Kishimoto _RARE_
, O
T O
. O

Treatment O
and O
staining O
of O
smears O
and O
sections O
for _RARE_
detection O
of O
microorganisms _RARE_

The O
apparent O
Kd _RARE_
of O
the O
MetRS _RARE_
/ I-GENE
CAU _RARE_
operator I-GENE
complex I-GENE
is O
one O
order O
magnitude O
higher _RARE_
than O
that O
of O
the O
ThrRS _RARE_
/ I-GENE
CGU _RARE_
operator I-GENE
complex I-GENE
. O

A O
significant O
direct O
relationship O
was O
observed O
between O
the O
percent O
area O
density O
of O
smooth _RARE_
muscle O
and O
the O
percent O
change O
in O
peak O
urinary _RARE_
flow O
rate O
. O

Rabbit _RARE_
skeletal I-GENE
muscle I-GENE
glycogenin _RARE_
. O

Characterization O
of O
the O
human I-GENE
gene I-GENE
encoding I-GENE
cytokeratin _RARE_
17 _RARE_
and O
its O
expression _RARE_
pattern O
. O

Animals O
that O
received O
DSP _RARE_
- O
4 O
were O
significantly O
retarded O
in O
motor O
recovery O
compared O
with O
the O
saline O
group O
. O

The O
prophylactic O
use O
of O
new O
medication O
for _RARE_
patients O
between O
the O
first _RARE_
and O
second O
cycle _RARE_
of O
chemotherapy O
, O
in O
agreement O
with O
the O
estimates O
calculated O
, O
does O
not O
save _RARE_
health O
care O
costs O
but O
may O
improve O
the O
quality O
of O
life O
in O
these O
patients O
and O
permit O
the O
continuation _RARE_
of O
a O
therapeutic O
schedule O
without O
interruption _RARE_
which O
may O
improve O
the O
life O
expectancy _RARE_
of O
the O
patient O
. O

AP O
was O
induced _RARE_
by O
intraductal _RARE_
infusion O
of O
two O
different O
concentrations O
of O
glycodeoxycholic _RARE_
acid O
( O
GDOC _RARE_
17 _RARE_
mmol O
and O
34 _RARE_
mmol O
). O

The O
isolation O
of O
this O
gene O
was O
based O
on O
the O
identification O
of O
the O
Y O
- O
231 O
cosmid O
that O
contains O
CpG O
rich O
sequences O
( O
HTF _RARE_
islands _RARE_
) O
in O
its O
human O
insert O
. O

Tissue _RARE_
plasminogen I-GENE
activator I-GENE
, O
its O
inhibitor O
and O
other O
parameters O
of O
fibrinolysis _RARE_
in O
blood _RARE_
of O
patients O
operated O
for _RARE_
mild O
hypertrophy O
of O
the O
prostate _RARE_

Gene _RARE_
constructs O
consisting O
of O
human I-GENE
growth I-GENE
hormone I-GENE
( O
hGH I-GENE
) O
gene O
driven _RARE_
by O
promoter O
/ O
regulatory O
sequence O
of O
mouse I-GENE
metallothionein _RARE_
( O
mMT _RARE_
), _RARE_
viral I-GENE
thymidine _RARE_
kinase I-GENE
( O
vTK _RARE_
), _RARE_
rat I-GENE
cholecystokinin _RARE_
( O
rCCK _RARE_
), _RARE_
or O
chicken I-GENE
beta I-GENE
- I-GENE
actin I-GENE
( O
cBA _RARE_
) O
gene O
were O
injected O
into O
the O
cytoplasm O
of O
fertilized _RARE_
medaka _RARE_
eggs O
via O
the O
micropyle _RARE_
. O

Serum O
gastrin I-GENE
and O
AFP _RARE_
levels O
had O
the O
same O
evolution O
and O
appear O
to O
have O
the O
same O
interest O
to O
follow O
the O
course O
of O
the O
disease _RARE_
. O

Prospects _RARE_
for _RARE_
controlled _RARE_
- O
delivery O
systems _RARE_
. O

The O
mean O
(+/- O
SD O
) O
PaO2 O
increased O
from O
80 _RARE_
. O
8 O
+/- O
26 _RARE_
. O
9 O
mmHg O
before O
to O
89 _RARE_
. O
8 O
+/- O
27 _RARE_
. O
3 O
mmHg O
after O
the O
infusion O
( O
P O
< O
0 _RARE_
. O
05 O
) O
and O
the O
PaCO2 O
decreased O
from O
42 _RARE_
. O
4 O
+/- O
8 O
. O
3 O
to O
39 _RARE_
. O
6 O
+/- O
7 O
. O
9 O
mmHg O
( O
P O
< O
0 _RARE_
. O
05 O
). O

Though _RARE_
hepatomegaly _RARE_
and O
mild O
elevation O
of O
enzymes _RARE_
can O
be O
observed O
in O
a O
significant O
proportion O
of O
patients O
, O
involvement O
of O
liver O
leading O
to O
acute O
hepatitis O
or O
liver O
cell O
necrosis O
is O
a O
relatively O
uncommon _RARE_
complication O
in O
P O
. O
falciparum O
malaria O
. O

For O
the O
first _RARE_
group O
, O
the O
maximal O
decrease O
in O
plasma O
potassium _RARE_
elicited O
by O
salbutamol _RARE_
was O
0 _RARE_
. O
80 _RARE_
+/- O
0 _RARE_
. O
19 O
, O
0 _RARE_
. O
48 _RARE_
+/- O
0 _RARE_
. O
22 _RARE_
, O
and O
0 _RARE_
. O
78 _RARE_
+/- O
0 _RARE_
. O
46 _RARE_
mmol O
/ O
l _RARE_
, O
and O
for _RARE_
the O
second O
group O
, O
maximal O
decrement _RARE_
was O
1 O
. O
31 _RARE_
+/- O
0 _RARE_
. O
37 O
, O
0 _RARE_
. O
70 O
+/- O
0 _RARE_
. O
24 _RARE_
, O
and O
0 _RARE_
. O
84 _RARE_
+/- O
0 _RARE_
. O
17 _RARE_
mmol O
/ O
l _RARE_
for _RARE_
the O
iv O
, O
po _RARE_
, O
and O
it O
routes O
, O
respectively O
. O

The O
two O
drugs O
increase O
the O
rate O
of O
early O
diastolic O
filling O
. O

A O
statistically O
significant O
improvement O
due O
to O
the O
administration O
of O
Bromergon _RARE_
was O
observed O
in O
symptoms O
associated O
with O
overreactiveness _RARE_
to O
normal O
prolactin I-GENE
levels O
, O
i O
. O
e _RARE_
. O
abdominal O
tension O
, O
edema O
, O
weight _RARE_
gain O
and O
breast O
tenderness _RARE_
. O

The O
magnitude O
of O
the O
early O
response O
was O
241 _RARE_
+/- O
51 _RARE_
% O
in O
A O
(% _RARE_
baseline O
RL _RARE_
; O
mean O
+/- O
SE O
), _RARE_
and O
significantly O
less O
in O
B O
( O
119 O
+/- O
7 O
%) O
and O
C O
( O
131 _RARE_
+/- O
16 O
%) O
( O
p O
< O
0 _RARE_
. O
01 O
). O

Most O
of O
the O
patients O
presented O
with O
Transient O
Ischemic O
Attacks _RARE_
( O
64 _RARE_
%) O
or O
Reversible _RARE_
Ischemic O
Neurologic _RARE_
Deficits _RARE_
( O
19 O
%). O

We O
cloned _RARE_
the O
third O
human O
gene O
for _RARE_
the O
LD78 _RARE_
, O
termed O
LD78 _RARE_
gamma I-GENE
and O
the O
sequence O
analysis O
showed O
that O
it O
is O
a O
5 O
'- O
truncated O
pseudogene _RARE_
. O

This O
analysis O
, O
together O
with O
a O
consideration _RARE_
of O
the O
SCBs _RARE_
found O
upstream O
of O
known O
SWI4 I-GENE
, I-GENE
6 I-GENE
- O
dependent O
genes O
, O
leads O
to O
the O
proposal _RARE_
of O
a O
revised O
consensus O
sequence O
for _RARE_
this O
important O
regulatory O
element O
. O

Mutational O
analysis O
of O
a O
DNA O
sequence O
involved O
in O
linking O
gene O
expression _RARE_
to O
the O
cell O
cycle _RARE_
. O

The O
natural _RARE_
history O
of O
these O
lesions O
, O
locoregional _RARE_
efficiency O
of O
the O
different O
treatments O
used O
, O
the O
part O
played O
by O
chemotherapy O
, O
survival O
, O
causes O
of O
death _RARE_
and O
therapeutic O
modalities O
used O
as _RARE_
a O
last O
measure O
, O
have O
been O
analysed O
. O

The O
method O
was O
adapted O
for _RARE_
the O
determination O
of O
nadolol _RARE_
racemate _RARE_
A O
by O
a O
change O
in O
mobile O
phase _RARE_
composition O
. O

In O
general _RARE_
, O
however O
, O
this O
study O
provided O
little O
evidence O
of O
any O
effect O
of O
supplementation O
to O
athletic _RARE_
performance O
for _RARE_
athletes _RARE_
consuming _RARE_
the O
dietary O
RDIs _RARE_
. O

In O
the O
absence O
of O
histological O
criteria O
, O
which O
it O
is O
difficult O
to O
demand O
in O
view O
of O
the O
variability O
of O
results O
and O
potential _RARE_
dangers _RARE_
of O
endomyocardial _RARE_
biopsy O
involving O
such O
thin O
and O
fragile _RARE_
ventricular O
walls _RARE_
, O
the O
diagnosis O
of O
ACRV _RARE_
is O
based O
upon O
the O
concomitant O
existence O
of O
: O
( O
1 O
) O
electrophysiological _RARE_
criteria O
: O
ventricular O
arrhythmias O
, O
in O
particular O
sustained O
monomorphous _RARE_
VT O
, O
with O
the O
particular O
feature O
of O
a O
very O
high O
degree O
of O
sensitivity O
to O
adrenergic O
stimulation _RARE_
( O
exercise O
), _RARE_
the O
existence O
of O
late _RARE_
potentials O
on O
the O
high O
amplification O
ECG O
, O
a O
highly O
specific O
sign O
, O
though O
unfortunately _RARE_
of O
poor O
sensitivity O
in O
localized O
froms _RARE_
, O
those O
which O
are O
most O
difficult O
to O
identify O
( O
2 O
); O
segmentary _RARE_
morphological O
and O
kinetic O
RV O
abnormalities O
, O
most O
often O
resulting O
in O
localized O
akinetic _RARE_
or O
dyskinetic _RARE_
parietal _RARE_
vaulting _RARE_
, O
with O
stasis _RARE_
" O
in O
situ O
". O

In O
7 O
of O
9 O
cases O
, O
the O
enhancer O
is O
fused O
to O
the O
c I-GENE
- I-GENE
myc I-GENE
bearing _RARE_
sequences I-GENE
of O
chromosome _RARE_
8 O
. O

These O
components _RARE_
both O
had O
a O
median O
R2 _RARE_
of O
0 _RARE_
. O
84 _RARE_
, O
compared O
to O
median O
R2s _RARE_
ranging O
from O
0 _RARE_
. O
37 O
to O
0 _RARE_
. O
83 _RARE_
for _RARE_
five O
commonly O
used O
ad _RARE_
hoc _RARE_
EEG O
components _RARE_
. O

The O
obtained O
results O
were O
compared O
with O
control O
group O
( O
10 O
female O
volunteers O
). O

100 _RARE_
years O
of O
dentistry _RARE_
at _RARE_
the O
Friedrich _RARE_
Schiller _RARE_
University O
in O
Jena _RARE_

The O
target O
contained O
between O
positions O
- O
403 _RARE_
and O
- O
125 _RARE_
acts O
independently O
of O
orientation O
, O
in O
different O
cell O
types _RARE_
and O
species O
, O
and O
in O
the O
context O
of O
a O
heterologous O
promoter O
. O

66 _RARE_
: O
469 _RARE_
- O
479 _RARE_
, O
1992 O
). O

Synergistic _RARE_
transactivation _RARE_
of O
the O
BMRF1 _RARE_
promoter I-GENE
by O
the O
Z I-GENE
/ O
c I-GENE
- I-GENE
myb I-GENE
combination O
appears O
to O
involve O
direct O
binding O
by O
the O
Z I-GENE
protein I-GENE
but O
not O
the O
c I-GENE
- I-GENE
myb I-GENE
protein I-GENE
. O

The O
UCR _RARE_
core O
sequence O
, O
CGCCATTTT _RARE_
, O
binds O
a O
ubiquitous O
nuclear O
factor O
and O
mediates O
negative O
regulation _RARE_
of O
MuLV O
promoter O
activity O
. O

These O
studies O
show O
that O
UCRBP _RARE_
binds O
to O
various O
target O
motifs O
that O
are O
distinct O
from O
the O
UCR _RARE_
motif O
: O
the O
adeno _RARE_
- I-GENE
associated I-GENE
virus I-GENE
P5 _RARE_
promoter I-GENE
and O
elements O
in O
the O
immunoglobulin I-GENE
light I-GENE
- I-GENE
and I-GENE
heavy I-GENE
- I-GENE
chain I-GENE
genes O
, O
as _RARE_
well _RARE_
as _RARE_
elements O
in O
ribosomal I-GENE
protein I-GENE
genes I-GENE
. O

Possibly _RARE_
, O
the O
scr1 _RARE_
- I-GENE
1 I-GENE
mutation I-GENE
does O
not O
affect O
signal O
recognition O
or O
translational O
arrest O
but O
instead O
results O
in O
maintenance _RARE_
of O
translational O
arrest O
of O
AEP _RARE_
synthesis _RARE_
. O

The O
cellular O
sequences O
5 O
' O
to O
the O
viral O
integration _RARE_
site O
exhibited O
85 _RARE_
to O
97 O
% O
identity O
to O
several O
sequences O
belonging O
to O
the O
mouse I-GENE
L1 I-GENE
family I-GENE
of O
long O
interspersed O
repetitive _RARE_
sequences O
. O

Both O
Rep78 _RARE_
and O
Rep68 _RARE_
cut O
the O
terminal O
AAV _RARE_
sequence O
at _RARE_
the O
same O
site O
( O
nucleotide O
124 _RARE_
). O

Nucleotide O
sequence O
analysis O
revealed O
that O
TAR _RARE_
- I-GENE
binding I-GENE
protein I-GENE
is O
very O
similar O
to O
the O
CREB2 _RARE_
protein I-GENE
. O

These O
results O
indicate O
that O
both O
N O
- O
and O
C O
- O
terminal O
mutations O
are O
required O
to O
inhibit O
transrepression _RARE_
by O
FBR _RARE_
protein I-GENE
and O
that O
multiple O
structural O
mutations O
accompanied O
by O
posttranslational O
protein O
modification O
alter O
gene O
regulation _RARE_
by O
FBR _RARE_
protein I-GENE
. O

The O
JS78 _RARE_
mutation O
changes O
Gln243 _RARE_
in O
gp0 _RARE_
. O
7 O
to O
an O
amber _RARE_
codon _RARE_
, O
which O
explains _RARE_
the O
production O
of O
the O
truncated O
, O
30 _RARE_
- I-GENE
kDa I-GENE
gp0 _RARE_
. I-GENE
7 I-GENE
- I-GENE
related I-GENE
polypeptide I-GENE
, O
and O
implicates _RARE_
the O
11 O
- O
kDa O
C O
- O
terminal O
domain O
in O
host _RARE_
transcription O
shut _RARE_
- O
off O
. O

A O
patient O
suffering O
from O
heparin _RARE_
- O
associated O
thrombocytopenia O
( O
HAT _RARE_
), _RARE_
recurrent O
arteriothromboses _RARE_
, O
and O
acute O
renal _RARE_
failure O
after O
treatment O
with O
standard O
heparin _RARE_
is O
described O
. O

The O
predicted O
receptor O
structure _RARE_
includes O
a O
cysteine O
- O
rich O
extracellular O
domain O
, O
a O
single O
hydrophobic O
transmembrane O
domain O
, O
and O
a O
predicted O
cytoplasmic I-GENE
serine I-GENE
/ I-GENE
threonine I-GENE
kinase I-GENE
domain I-GENE
. O

Drosophila I-GENE
UbcD1 _RARE_
encodes O
a O
highly O
conserved _RARE_
ubiquitin I-GENE
- O
conjugating _RARE_
enzyme O
involved O
in O
selective O
protein O
degradation _RARE_
. O

Analysis O
of O
the O
entire _RARE_
16 O
. O
7 O
- O
kb O
mt _RARE_
genome O
determined O
that O
a O
MDP1 _RARE_
mediates O
cleavage _RARE_
of O
chick _RARE_
mtDNA _RARE_
in O
vitro O
at _RARE_
three O
H O
- O
and O
two O
L O
- O
strand _RARE_
sequence O
- O
specific O
target O
sites O
located _RARE_
within O
a O
90 _RARE_
- O
bp O
A O
+ O
T O
- O
rich O
genomic O
tract _RARE_
, O
theoretically _RARE_
capable O
of O
forming O
stable O
secondary O
structures _RARE_
, O
approximately _RARE_
200 _RARE_
bases O
upstream O
from O
the O
H O
- O
strand _RARE_
origin O
( O
OH O
) O
of O
replication O
. O

The O
goal O
of O
the O
present O
study O
was O
to O
determine O
the O
feasibility O
of O
retrovirus _RARE_
mediated _RARE_
expression _RARE_
of O
rp47phox _RARE_
in O
the O
HL60 _RARE_
and O
U937 O
human O
hematopoietic O
cell O
lines O
, O
and O
in O
an O
Epstein O
- O
Barr O
virus O
transformed O
B O
- O
lymphocyte O
cell O
line O
( O
EBV _RARE_
- O
BCL _RARE_
) O
derived O
from O
a O
p47phox _RARE_
- O
deficient _RARE_
CGD _RARE_
patient O
. O

Comparison O
with O
the O
sequence O
databanks _RARE_
show O
that O
Tactile _RARE_
is O
a O
member _RARE_
of O
the O
immunoglobulin I-GENE
gene I-GENE
superfamily I-GENE
, O
with O
similarity _RARE_
to O
Drosophila I-GENE
amalgam _RARE_
, O
the O
melanoma _RARE_
Ag _RARE_
MUC _RARE_
- I-GENE
18 I-GENE
, O
members O
of O
the O
carcinoembryonic _RARE_
Ag _RARE_
family I-GENE
, O
the O
poliovirus _RARE_
receptor I-GENE
, O
and O
the O
neural _RARE_
cell I-GENE
adhesion I-GENE
molecule I-GENE
. O

A O
rather O
similar O
pattern O
of O
results O
was O
obtained O
with O
respect O
to O
LMP2B _RARE_
mRNA I-GENE
expression _RARE_
, O
such O
transcripts O
being O
detectable O
only O
in O
a O
subset O
of O
tumors O
, O
and O
then O
at _RARE_
apparently O
low O
levels O
. O

The O
phenotypes _RARE_
of O
the O
ICP0 _RARE_
nonsense O
mutants O
were O
intermediate _RARE_
between O
those O
of O
the O
wild O
- O
type O
virus O
and O
7134 _RARE_
in O
that O
the O
more O
ICP0 _RARE_
- I-GENE
coding I-GENE
sequence I-GENE
expressed _RARE_
by O
a O
given O
nonsense O
mutant O
, O
the O
more O
wild O
type O
- O
like O
was O
its O
phenotype _RARE_
. O

Analysis O
of O
nucleotide O
sequence O
of O
the O
rightmost _RARE_
43 _RARE_
kbp _RARE_
of O
herpesvirus _RARE_
saimiri _RARE_
( O
HVS O
) O
L O
- O
DNA O
: O
general _RARE_
conservation O
of O
genetic O
organization O
between O
HVS O
and O
Epstein O
- O
Barr O
virus O
. O

Treatment O
with O
MK O
- O
801 O
induced _RARE_
a O
burst O
suppression O
in O
the O
EEG O
and O
a O
transient O
drop O
( O
11 O
. O
4 O
+/- O
6 O
. O
5 O
mm O
Hg O
) O
in O
the O
mean O
arterial O
pressure O
. O

In O
contrast O
, O
gel O
mobility O
shift O
experiments O
have O
failed O
to O
reveal O
that O
HAP2 _RARE_
or O
HAP3 _RARE_
binds O
to O
domain O
1 O
or O
that O
hap3 _RARE_
mutations O
affect O
the O
complexes O
bound _RARE_
to O
it O
. O

Myogenic _RARE_
differentiation O
can O
be O
inhibited O
by O
the O
adenovirus O
E1a I-GENE
protein I-GENE
in O
the O
rat O
L6 _RARE_
muscle O
cell O
line O
. O

The O
experiment O
results O
showed O
: O
( O
i O
) O
not O
only O
1O2 _RARE_
, O
but O
also O
free O
radicals O
( O
O2 _RARE_
-. O
. O
OH O
and O
YHPD O
-.) _RARE_
can O
be O
formed O
by O
the O
aid O
of O
YHPD O
; O
and O
( O
ii O
) O
as _RARE_
to O
the O
ability O
of O
producing O
1O2 _RARE_
, O
YHPD O
less O
than O
BHPD _RARE_
, O
while O
for _RARE_
generating O
O2 _RARE_
-. O
and O
. O
OH O
, O
YHPD O
greater O
than O
BHPD _RARE_
. O

Two O
points O
are O
indicated O
: O
first _RARE_
, O
the O
photosensitized _RARE_
damage O
of O
YHPD O
is O
interrelated _RARE_
to O
not O
only O
1O2 _RARE_
, O
but O
also O
free O
radicals O
( O
O2 _RARE_
-. O
. O
OH O
and O
YHPD O
-.); _RARE_
second O
, O
although O
the O
photosensitized _RARE_
damage O
of O
YHPD O
is O
stronger O
than O
that O
of O
BHPD _RARE_
, O
yet O
the O
photosensitized _RARE_
damage O
is O
negatively O
correlated O
to O
the O
yield O
of O
1O2 _RARE_
but O
positively O
correlated O
to O
those O
of O
O2 _RARE_
-. O
and O
OH O
. O

Acad _RARE_
. O

Both O
in O
vitro O
- O
synthesized O
S2 _RARE_
protein I-GENE
and O
synthetic _RARE_
peptides O
corresponding O
to O
S2 _RARE_
are O
shown O
to O
react _RARE_
positively O
with O
sera _RARE_
obtained O
from O
EIAV _RARE_
- O
infected _RARE_
horses O
, O
providing O
the O
first _RARE_
direct O
evidence O
of O
expression _RARE_
of O
this O
protein O
in O
infected _RARE_
animals O
. O

Many O
canonical O
TATA O
sequences O
are O
present O
upstream O
from O
these O
VZV _RARE_
transcriptional O
start _RARE_
sites O
but O
, O
apparently O
, O
are O
not O
used O
. O

The O
ORF O
4 O
gene O
was O
minimally _RARE_
active _RARE_
, O
whereas O
the O
ORF O
62 _RARE_
gene O
gave O
twofold O
induction O
; O
both O
genes O
, O
acting O
together O
, O
gave O
fivefold _RARE_
induction O
. O

Interestingly O
, O
the O
IR5 _RARE_
ORF I-GENE
of O
EHV _RARE_
- O
1 O
possesses O
a O
sequence O
of O
13 _RARE_
amino O
acids _RARE_
( O
CAYWCCLGHAFAC _RARE_
) O
that O
is O
a O
perfect O
match O
to O
the O
consensus O
zinc O
finger O
motif O
( O
C O
- O
X2 O
- O
4 O
- O
C O
- O
X2 O
- O
15 _RARE_
- O
C O
/ O
H O
- O
X2 O
- O
4 O
- O
C O
/ O
H O
). O

The O
DNA O
sequence O
of O
the O
sulfate _RARE_
activation I-GENE
locus I-GENE
from O
Escherichia O
coli O
K O
- O
12 O
has O
been O
determined O
. O

The O
unphosphorylated _RARE_
form O
of O
RNA I-GENE
polymerase I-GENE
II I-GENE
is O
designated O
IIA _RARE_
, O
whereas O
the O
phosphorylated _RARE_
form O
is O
designated O
IIO _RARE_
. O

RNA I-GENE
polymerase I-GENE
IIA _RARE_
was O
recovered O
in O
transcriptionally O
active _RARE_
complexes O
in O
reactions O
in O
which O
the O
input O
enzyme O
was O
RNA I-GENE
polymerase I-GENE
IIA _RARE_
. O

Fructokinase _RARE_
activity O
is O
elevated O
up _RARE_
to O
twofold O
when O
Z O
. O
mobilis _RARE_
was O
grown O
on O
fructose _RARE_
instead O
of O
glucose O
, O
and O
there O
was O
a O
parallel O
increase O
in O
frk _RARE_
mRNA I-GENE
levels O
. O

Plasma O
membranes O
of O
cultured O
cells O
contain O
high O
affinity O
receptors O
for _RARE_
high I-GENE
density I-GENE
lipoprotein I-GENE
( O
HDL _RARE_
) O
that O
appear O
to O
mediate O
removal O
of O
excess O
intracellular _RARE_
cholesterol O
. O

After O
the O
first _RARE_
28 _RARE_
patients O
vincristine O
was O
replaced O
by O
teniposide _RARE_
( O
VM _RARE_
- O
26 _RARE_
) O
due O
to O
neurotoxicity O
. O

These O
results O
indicate O
that O
an O
internal O
short O
element O
located _RARE_
at _RARE_
the O
very O
5 O
' O
terminal O
of O
L1 I-GENE
sequence I-GENE
and O
the O
nuclear O
factor O
binding O
to O
the O
element O
play O
a O
crucial O
role O
in O
the O
transcription O
of O
human I-GENE
L1 I-GENE
. O

Tumor _RARE_
cells O
were O
focally _RARE_
immunoreactive _RARE_
for _RARE_
neuron _RARE_
- I-GENE
specific I-GENE
enolase _RARE_
, O
insulin I-GENE
, O
glucagon I-GENE
and O
VIP _RARE_
. O

A O
recombinant O
with O
a O
5 O
' O
end O
from O
src I-GENE
and O
a O
3 O
' O
end O
from O
ros _RARE_
, O
called O
SRC I-GENE
x _RARE_
ROS _RARE_
, O
transformed O
chicken O
embryo _RARE_
fibroblasts _RARE_
( O
CEF _RARE_
) O
to O
a O
spindle _RARE_
shape O
morphology O
, O
mimicking _RARE_
that O
of O
UR2 _RARE_
. O

ROS _RARE_
x _RARE_
SRC I-GENE
( O
R I-GENE
) O
contains O
a O
16 O
- O
amino O
- O
acid O
deletion O
that O
includes O
the O
3 O
' O
half _RARE_
of O
the O
transmembrane O
domain O
of O
ros _RARE_
. O

To O
define O
the O
number O
and O
nature O
of O
the O
E6 _RARE_
and O
E7 I-GENE
gene I-GENE
products O
expressed _RARE_
in O
BPV _RARE_
- O
1 O
- O
transformed O
cells O
, O
we O
performed O
immunoprecipitation O
experiments O
with O
antisera O
raised O
to O
bacterially O
expressed _RARE_
BPV _RARE_
- I-GENE
1 I-GENE
E6 _RARE_
and O
E7 I-GENE
fusion I-GENE
proteins I-GENE
. O

Transient O
transfection O
assays O
showed O
that O
site O
A O
is O
necessary O
and O
sufficient O
for _RARE_
RXR I-GENE
alpha I-GENE
- O
mediated _RARE_
transactivation _RARE_
of O
the O
apoAI _RARE_
gene I-GENE
basal I-GENE
promoter I-GENE
in O
human O
hepatoma O
HepG2 _RARE_
cells O
in O
the O
presence O
of O
RA _RARE_
and O
that O
this O
transactivation _RARE_
is O
abolished O
by O
increasing O
amounts O
of O
cotransfected O
ARP _RARE_
- I-GENE
1 I-GENE
. O

The O
enhancer O
region O
of O
Akv _RARE_
murine O
leukemia O
virus O
contains O
the O
sequence O
motif O
ACAGATGG _RARE_
. O

Two O
splice _RARE_
variants O
of O
ALF1 _RARE_
cDNA I-GENE
have O
been O
found O
, O
differing _RARE_
by O
a O
72 O
- O
bp O
insertion _RARE_
, O
coding O
for _RARE_
putative O
proteins O
of O
682 _RARE_
and O
706 _RARE_
amino O
acids _RARE_
. O

A O
third O
prominent O
component _RARE_
of O
apparent O
molecular _RARE_
mass O
16 O
kDa O
displayed O
several O
properties O
, O
including O
ability O
to O
bind O
45Ca2 _RARE_
+, _RARE_
that O
are O
characteristic O
of O
the O
regulatory O
( O
B O
) O
subunit O
of O
mammalian I-GENE
calcineurin _RARE_
and O
was O
recognized _RARE_
by O
an O
antiserum _RARE_
raised O
against O
bovine I-GENE
calcineurin _RARE_
. O

As O
was O
observed O
previously O
for _RARE_
MATa _RARE_
cna1 _RARE_
cna2 _RARE_
double O
mutants O
, O
MATa _RARE_
cnb1 _RARE_
mutants I-GENE
were O
defective _RARE_
in O
their O
ability O
to O
recover _RARE_
from O
alpha I-GENE
- I-GENE
factor I-GENE
- O
induced _RARE_
growth O
arrest O
. O

Antibodies O
against O
this O
purified _RARE_
protein O
localize O
RIM1 _RARE_
to O
mitochondria _RARE_
. O

METHODS O
: O
IgG I-GENE
antibodies I-GENE
vs _RARE_
HHV _RARE_
- O
6 O
( O
anti I-GENE
- I-GENE
HHV _RARE_
- I-GENE
6 I-GENE
- I-GENE
IgG I-GENE
) O
were O
determined O
by O
indirect O
immunofluorescence O
in O
100 _RARE_
IVDA _RARE_
( O
29 O
seronegative _RARE_
and O
71 _RARE_
seropositive O
for _RARE_
HIV O
- O
1 O
of O
which O
45 _RARE_
were O
in O
stage _RARE_
II O
and O
26 _RARE_
in O
IV O
- O
C1 O
of O
CDC _RARE_
) O
as _RARE_
well _RARE_
as _RARE_
in O
100 _RARE_
healthy O
subjects O
of O
a O
similar O
age O
( O
control O
group O
). O

A O
position O
- O
independent O
activation O
domain O
which O
contained O
conserved _RARE_
regions O
II O
and O
III O
was O
identified O
at _RARE_
the O
carboxyl _RARE_
terminus O
of O
the O
HNF I-GENE
- I-GENE
3 I-GENE
beta I-GENE
protein I-GENE
( O
amino O
acids _RARE_
361 _RARE_
to O
458 _RARE_
). O

HNF I-GENE
- I-GENE
3 I-GENE
beta I-GENE
amino I-GENE
- I-GENE
terminal I-GENE
sequences I-GENE
defined O
by O
conserved _RARE_
region O
IV O
also O
contributed O
to O
transactivation _RARE_
, O
but O
region O
IV O
activity O
required O
the O
participation O
of O
the O
region O
II O
- O
III O
domain O
. O

Possible _RARE_
roles O
of O
RAD5 _RARE_
putative O
ATPase I-GENE
/ O
DNA I-GENE
helicase _RARE_
activity O
in O
DNA O
repair O
and O
in O
the O
maintenance _RARE_
of O
wild O
- O
type O
rates O
of O
instability _RARE_
of O
simple O
repetitive _RARE_
sequences O
are O
discussed O
. O

Susceptibilities _RARE_
of O
540 _RARE_
anaerobic O
gram O
- O
negative O
bacilli O
to O
amoxicillin O
, O
amoxicillin O
- O
BRL _RARE_
42715 _RARE_
, O
amoxicillin O
- O
clavulanate _RARE_
, O
temafloxacin _RARE_
, O
and O
clindamycin O
. O

Nocodazole _RARE_
arrest O
of O
DU249 _RARE_
cells O
was O
exploited _RARE_
for _RARE_
the O
detection O
of O
an O
M O
- O
phase _RARE_
- O
activated O
MBP I-GENE
kinase I-GENE
that O
was O
resolved O
from O
p41 _RARE_
MAP I-GENE
kinase I-GENE
by O
phenyl _RARE_
- O
Superose _RARE_
chromatography O
. O

The O
hit1 _RARE_
- I-GENE
1 I-GENE
mutation O
caused O
a O
defect O
in O
synthesis _RARE_
of O
a O
74 _RARE_
- I-GENE
kD _RARE_
heat I-GENE
shock I-GENE
protein I-GENE
. O

The O
319 _RARE_
base _RARE_
pair _RARE_
region O
immediately O
upstream O
of O
the O
CAP _RARE_
site O
is O
characterized O
by O
the O
lack O
of O
a O
proximal O
TATA O
box O
and O
the O
presence O
of O
sequences O
similar O
to O
GC _RARE_
boxes _RARE_
, O
CACCC _RARE_
boxes _RARE_
, O
CCAAT O
boxes _RARE_
, O
activator I-GENE
protein I-GENE
2 I-GENE
( O
Ap _RARE_
- I-GENE
2 I-GENE
) O
sites O
, O
partial O
glucocorticoid O
response O
elements O
( O
GREs _RARE_
), _RARE_
and O
partial O
cyclic O
AMP O
response O
elements O
( O
CREs _RARE_
). O

Cloning O
and O
primary _RARE_
structure _RARE_
of O
neurocan _RARE_
, O
a O
developmentally O
regulated O
, O
aggregating _RARE_
chondroitin _RARE_
sulfate _RARE_
proteoglycan _RARE_
of O
brain O
. O

In O
rats O
anaesthetized _RARE_
with O
+- _RARE_
chloralose _RARE_
the O
changes O
in O
extracellular O
pH O
and O
K O
+ O
in O
spinal _RARE_
cord O
dorsal O
horn _RARE_
were O
studied O
using O
pH O
and O
K O
+ O
ion O
- O
selective O
electrodes O
. O

Replication _RARE_
of O
bovine O
papillomavirus _RARE_
- O
1 O
( O
BPV _RARE_
- O
1 O
) O
DNA O
requires O
two O
viral O
gene O
products O
, O
the O
E1 I-GENE
protein I-GENE
and O
the O
full I-GENE
- I-GENE
length I-GENE
E2 I-GENE
protein I-GENE
. O

Insertional _RARE_
inactivation O
of O
sms _RARE_
led O
to O
increased O
sensitivity O
to O
the O
alkylating _RARE_
agent O
methylmethane _RARE_
sulfonate _RARE_
, O
but O
not O
to O
a O
requirement O
for _RARE_
serine O
or O
other O
metabolites O
. O

These O
findings O
suggest O
that O
the O
MAP I-GENE
kinase I-GENE
activator I-GENE
/ O
MAP I-GENE
kinase I-GENE
system _RARE_
may O
be O
the O
downstream _RARE_
components _RARE_
of O
ras I-GENE
signal O
transduction _RARE_
pathways O
. O

NSCL _RARE_
- I-GENE
1 I-GENE
is O
expressed _RARE_
in O
a O
larger O
number O
of O
these O
cell O
lines O
. O

Labile _RARE_
LTR I-GENE
- I-GENE
binding I-GENE
proteins I-GENE
appear O
to O
be O
essential O
for _RARE_
c I-GENE
- I-GENE
myc I-GENE
hyperexpression _RARE_
, O
since O
both O
LTR O
- O
enhanced _RARE_
transcription O
and O
the O
activities O
of O
LTR I-GENE
- I-GENE
binding I-GENE
proteins I-GENE
are O
specifically O
decreased O
after O
inhibition O
of O
protein O
synthesis _RARE_
( O
A O
. O

Ruddell _RARE_
, O
M O
. O

A O
single O
MEF I-GENE
- I-GENE
2 I-GENE
site I-GENE
is O
a O
major O
positive O
regulatory O
element O
required O
for _RARE_
transcription O
of O
the O
muscle O
- O
specific O
subunit O
of O
the O
human I-GENE
phosphoglycerate _RARE_
mutase _RARE_
gene I-GENE
in O
skeletal O
and O
cardiac O
muscle O
cells O
. O

Truncation _RARE_
variants O
of O
peptides O
isolated O
from O
MHC I-GENE
class I-GENE
II I-GENE
molecules I-GENE
suggest O
sequence O
motifs O
. O

Although O
the O
E O
- O
box O
consensus O
is O
minimally _RARE_
defined O
as _RARE_
CANNTG _RARE_
, O
the O
adjacent O
nucleotides O
of O
functional _RARE_
E O
- O
boxes _RARE_
are O
variable _RARE_
for _RARE_
genes O
regulated O
by O
the O
bHLH I-GENE
proteins I-GENE
. O

Intermediate _RARE_
levels O
of O
gene O
activity O
were O
observed O
for _RARE_
TnI I-GENE
enhancers _RARE_
containing O
E O
- O
boxes _RARE_
derived O
from O
the O
MCK _RARE_
left _RARE_
E I-GENE
- I-GENE
box I-GENE
site I-GENE
or O
from O
the O
Ig I-GENE
kappa _RARE_
E2 I-GENE
E I-GENE
- I-GENE
box I-GENE
. O

T I-GENE
- I-GENE
cell I-GENE
receptor I-GENE
beta I-GENE
( O
TCR I-GENE
beta I-GENE
) O
gene O
rearrangements _RARE_
occur O
in O
a O
third O
of O
early O
B O
- O
cell O
acute O
lymphoblastic _RARE_
leukemias O
( O
ALLs _RARE_
). O

The O
CANNTG _RARE_
motifs O
were O
found O
to O
bind O
MyoD I-GENE
and O
myogenin I-GENE
fusion I-GENE
proteins I-GENE
and O
to O
interact O
with O
proteins O
in O
nuclear O
extracts O
from O
cultured O
myotubes O
. O

Peripheral _RARE_
polyneuropathy _RARE_
associated O
with O
multiple O
myeloma O
. O

We O
have O
cloned _RARE_
and O
sequenced O
COX12 _RARE_
, O
the O
nuclear O
gene O
for _RARE_
subunit I-GENE
VIb _RARE_
of O
Saccharomyces I-GENE
cerevisiae I-GENE
cytochrome I-GENE
c I-GENE
oxidase I-GENE
. O

The O
structure _RARE_
of O
the O
calcineurin _RARE_
A I-GENE
gene I-GENE
was O
determined O
by O
comparison O
of O
the O
genomic O
and O
cDNA O
sequences O
. O

The O
basal O
promoter O
elements O
of O
murine I-GENE
cytochrome I-GENE
c I-GENE
oxidase I-GENE
subunit I-GENE
IV I-GENE
gene I-GENE
consist O
of O
tandemly O
duplicated O
ets I-GENE
motifs O
that O
bind O
to O
GABP I-GENE
- I-GENE
related I-GENE
transcription I-GENE
factors I-GENE
. O

Lastly _RARE_
, O
there O
are O
multiple O
instances O
in O
which O
short O
oligonucleotide _RARE_
direct O
repeats O
flank O
a O
region O
absent O
from O
either O
variola _RARE_
or O
vaccinia _RARE_
virus O
. O

Here O
we O
show O
that O
short O
synthetic _RARE_
peptides O
containing O
the O
pRB _RARE_
- I-GENE
binding I-GENE
sequences I-GENE
of O
E1A I-GENE
are O
sufficient O
for _RARE_
interaction O
with O
p107 I-GENE
, O
cyclin _RARE_
A I-GENE
, O
and O
p130 I-GENE
. O

These O
mutants O
grow O
normally O
in O
3T6 _RARE_
mouse O
fibroblast O
cells O
, O
and O
they O
do O
not O
complement O
the O
wild O
- O
type O
virus O
in O
coinfection _RARE_
experiments O
of O
C2 O
myoblasts O
. O

The O
MICs O
of O
this O
compound O
against O
90 _RARE_
% O
of O
these O
organisms O
, O
except O
for _RARE_
methicillin _RARE_
- O
resistant O
S O
. O
aureus _RARE_
, O
ranged O
from O
less O
than O
or O
equal O
to O
0 _RARE_
. O
006 _RARE_
to O
3 O
. O
13 _RARE_
micrograms O
/ O
ml O
. O

The O
minimal O
promoter O
of O
the O
RII I-GENE
beta I-GENE
gene I-GENE
was O
composed O
of O
two O
adjacent O
functional _RARE_
elements O
. O

Mapping O
the O
cAMP I-GENE
receptor I-GENE
protein I-GENE
contact _RARE_
site I-GENE
on O
the O
alpha O
subunit O
of O
Escherichia I-GENE
coli I-GENE
RNA I-GENE
polymerase I-GENE
. O

Here O
we O
show O
that O
epidermal _RARE_
growth I-GENE
factor I-GENE
or O
platelet I-GENE
- I-GENE
derived I-GENE
growth I-GENE
factor I-GENE
stimulation _RARE_
of O
intact _RARE_
human O
or O
murine O
cells O
leads O
to O
phosphorylation _RARE_
of O
Nck _RARE_
protein I-GENE
on O
tyrosine O
, O
serine O
, O
and O
threonine O
residues O
. O

A O
major O
mechanism O
whereby _RARE_
steroid I-GENE
hydroxylase I-GENE
gene I-GENE
transcription O
is O
regulated O
in O
the O
adrenal O
cortex O
requires O
the O
pituitary O
peptide O
hormone O
, O
ACTH I-GENE
, O
which O
acts O
via O
cAMP O
. O

A O
combination O
of O
comparative O
sequence O
analysis O
and O
thermodynamic _RARE_
methods O
reveals O
the O
conservation O
of O
tertiary O
structure _RARE_
elements O
in O
the O
5 O
' O
untranslated _RARE_
region O
( O
UTR O
) O
of O
human O
enteroviruses _RARE_
and O
rhinoviruses _RARE_
. O

The O
- O
64 _RARE_
/- O
37 O
region O
interacted O
with O
purified _RARE_
Sp1 _RARE_
and O
an O
unidentified O
protein O
( O
s O
), _RARE_
proximal I-GENE
regulatory I-GENE
factor I-GENE
( I-GENE
s I-GENE
) I-GENE
I I-GENE
( O
PRF _RARE_
- I-GENE
I I-GENE
). O

Km _RARE_
and O
Vmax O
for _RARE_
two O
substrates _RARE_
, O
src I-GENE
- I-GENE
related I-GENE
peptide I-GENE
and O
poly _RARE_
( O
Glu O
, O
Tyr _RARE_
) O
( O
4 O
: O
1 O
), _RARE_
were O
2 O
. O
4 O
mM O
and O
2 O
. O
5 O
mumol O
min O
- O
1 O
mg O
- O
1 O
and O
0 _RARE_
. O
26 _RARE_
mM O
and O
1 O
. O
2 O
mumol O
min O
- O
1 O
mg O
- O
1 O
, O
respectively O
. O

This O
soluble _RARE_
form O
of O
the O
HGFr _RARE_
( O
sHGFr _RARE_
) O
bound _RARE_
HGF I-GENE
with O
an O
affinity O
similar O
to O
that O
of O
the O
authentic _RARE_
, O
membrane O
- O
associated O
receptor O
. O

Strategies _RARE_
for _RARE_
blood _RARE_
screening O
for _RARE_
the O
hepatitis O
C O
virus O
and O
for _RARE_
the O
human O
immunodeficiency O
virus O
in O
high O
risk O
groups O
. O

Also O
, O
the O
human I-GENE
glycoprotein I-GENE
alpha I-GENE
- I-GENE
subunit I-GENE
promoter I-GENE
was O
induced _RARE_
10 O
- O
fold _RARE_
by O
FSK _RARE_
in O
GH4 _RARE_
rat O
pituitary O
cells O
.( O
ABSTRACT O
TRUNCATED O
AT O
400 _RARE_
WORDS O
) O

Comparison O
of O
data O
obtained O
with O
the O
results O
of O
chronic O
treatment O
with O
the O
opioid _RARE_
antagonist O
permits O
to O
conclude O
that O
the O
chronic O
blockade O
increases O
the O
fatiguability _RARE_
to O
a O
great O
extent O
than O
chronic O
activation O
of O
opioid _RARE_
system _RARE_
. O

Laboratory O
studies O
using O
Ca45 _RARE_
labeled O
teeth O
and O
biologically O
stained O
teeth O
confirmed O
that O
the O
dentifrice _RARE_
did O
not O
decalcify _RARE_
enamel _RARE_
or O
bleach _RARE_
teeth O
. O

Structure O
and O
expression _RARE_
of O
a O
gene O
from O
Arabidopsis O
thaliana O
encoding O
a O
protein O
related O
to O
SNF1 _RARE_
protein O
kinase O
. O

We O
have O
cloned _RARE_
and O
characterized O
a O
55 _RARE_
- O
kb O
region O
of O
DNA O
surrounding O
HRAS1 _RARE_
. O

The O
ORF1 O
protein O
was O
found O
to O
be O
highly O
homologous O
to O
the O
putative O
potexvirus _RARE_
RNA I-GENE
replicases _RARE_
; O
ORF2 O
, O
- O
3 O
, O
- O
5 O
and O
- O
6 O
proteins O
also O
have O
analogues O
among O
the O
potex _RARE_
- O
and O
/ O
or O
carlavirus _RARE_
- O
encoded O
proteins O
. O

A O
total _RARE_
of O
281 _RARE_
patients O
were O
divided O
into O
groups O
according O
to O
their O
clinical O
diagnosis O
and O
were O
examined O
using O
capnography _RARE_
, O
spirometry _RARE_
and O
blood _RARE_
- O
gas O
analysis O
. O

The O
relationships O
between O
the O
partial O
pressures O
of O
O2 _RARE_
and O
CO2 O
as _RARE_
well _RARE_
as _RARE_
between O
their O
gradients _RARE_
, O
become O
stronger O
with O
the O
increase O
of O
the O
ventilation O
- O
perfusion O
ratio O
. O

No O
significant O
correlations O
of O
peak O
VO2 O
were O
observed O
between O
the O
3 O
tests O
. O

An O
RNA I-GENE
- I-GENE
binding I-GENE
protein I-GENE
gene I-GENE
( O
rbp1 _RARE_
) O
from O
Drosophila O
melanogaster O
, O
encoding O
an O
RNA O
recognition O
motif O
and O
an O
Arg O
- O
Ser _RARE_
rich O
( O
RS _RARE_
) O
domain O
, O
has O
been O
characterized O
. O

Some O
research O
studies O
have O
related O
this O
kind _RARE_
of O
tumors O
with O
prolonged O
ingestion O
of O
H2 O
inhibitors _RARE_
and O
others O
antacid _RARE_
. O

A O
comparative O
study O
of O
the O
total _RARE_
protein O
profiles O
of O
wild O
- O
type O
S O
. O
entomophila _RARE_
UC9 _RARE_
and O
mutant O
UC21 _RARE_
revealed O
that O
the O
mutant O
lacked O
an O
approximately _RARE_
44 _RARE_
- O
kDa O
protein O
and O
overexpressed O
an O
approximately _RARE_
20 O
- O
kDa O
protein O
. O

Characterization O
of O
the O
regulon _RARE_
controlled _RARE_
by O
the O
leucine I-GENE
- I-GENE
responsive I-GENE
regulatory I-GENE
protein I-GENE
in O
Escherichia O
coli O
. O

Mapping O
of O
the O
mouse I-GENE
ornithine _RARE_
decarboxylase I-GENE
- I-GENE
related I-GENE
sequence I-GENE
family I-GENE
. O

This O
mutation O
also O
results O
in O
markedly O
decreased O
levels O
of O
CAD _RARE_
mRNA I-GENE
and O
protein O
in O
the O
mutant O
. O

The O
rationale _RARE_
for _RARE_
continuous O
dopaminergic O
stimulation _RARE_
in O
patients O
with O
Parkinson O
' O
s O
disease _RARE_
. O

Mutational O
studies O
revealed O
that O
it O
was O
the O
homeodomain _RARE_
binding I-GENE
site I-GENE
II I-GENE
sequence I-GENE
that O
was O
required O
for _RARE_
this O
regulation _RARE_
. O

Thus O
, O
the O
pol I-GENE
alpha I-GENE
- O
primase I-GENE
complex O
appears O
to O
act O
processively _RARE_
for _RARE_
only O
a O
short O
distance O
. O

Interestingly O
, O
the O
positions O
of O
these O
introns _RARE_
have O
been O
conserved _RARE_
in O
comparison O
with O
the O
genes O
of O
two O
other O
transglutaminase _RARE_
- O
like O
activities O
described O
in O
the O
literature O
, O
but O
the O
TGM1 _RARE_
gene I-GENE
is O
by O
far O
the O
smallest O
characterized O
to O
date O
because O
its O
introns _RARE_
are O
relatively O
smaller O
. O

In O
a O
retrospective O
analysis O
of O
data O
from O
35 _RARE_
cases O
with O
malignant O
lymphoma O
from O
a O
cohort O
of O
2017 _RARE_
HIV O
- O
infected _RARE_
patients O
, O
the O
stage _RARE_
of O
HIV O
- O
disease _RARE_
, O
the O
CD4 _RARE_
counts O
at _RARE_
the O
time O
of O
diagnosis O
, O
and O
the O
use O
of O
antineoplastic _RARE_
agents O
or O
radiotherapy O
were O
correlated O
with O
outcome O
. O

1 O
. O

Effects O
of O
dioxins _RARE_
on O
thyroid O
function O
in O
newborn O
babies O
. O

cDNA O
clones _RARE_
encoding O
Arabidopsis O
thaliana O
and O
Zea _RARE_
mays _RARE_
mitochondrial I-GENE
chaperonin _RARE_
HSP60 _RARE_
and O
gene O
expression _RARE_
during _RARE_
seed _RARE_
germination _RARE_
and O
heat O
shock O
. O

Amino O
acid O
sequence O
comparison O
revealed O
significant O
homology O
between O
the O
yeast I-GENE
and I-GENE
Escherichia I-GENE
coli I-GENE
gamma I-GENE
- I-GENE
glutamyl I-GENE
kinases I-GENE
throughout O
their O
lengths O
. O

The O
single O
site O
of O
glycosylation O
is O
located _RARE_
near O
the O
C O
- O
terminus O
in O
the O
N O
- O
glycosylation O
sequon _RARE_
- O
Asn O
- O
Cys _RARE_
- O
Ser _RARE_
- O
in O
which O
Cys _RARE_
forms O
part O
of O
a O
disulphide _RARE_
bridge _RARE_
. O

The O
pulmonary O
toxic O
events O
induced _RARE_
by O
acute O
nitrogen O
dioxide O
( O
NO _RARE_
) O
2 O
exposure O
were O
studied O
in O
the O
rat O
to O
develop O
an O
inhalation O
model O
to O
investigate O
therapeutic O
measures O
. O

The O
pulmonary O
effects O
observed O
, O
became O
more O
pronounced O
with O
increasing O
NO2 O
concentrations O
( O
0 _RARE_
, O
25 _RARE_
, O
75 _RARE_
, O
125 _RARE_
, O
175 O
or O
200 _RARE_
ppm O
, O
1 O
ppm O
NO2 O
= O
1 O
. O
88 O
mg O
m O
- O
3 O
NO2 O
) O
and O
exposure O
times O
( O
5 O
, O
10 O
, O
20 O
or O
30 _RARE_
min O
). O

Interaction O
of O
H I-GENE
- I-GENE
2Eb _RARE_
with O
an O
IAP _RARE_
retrotransposon _RARE_
in O
the O
A20 _RARE_
/ O
2J _RARE_
B O
cell O
lymphoma O
. O

Gestational _RARE_
trophoblastic _RARE_
diseases O
: O
recent O
advances _RARE_
in O
the O
understanding O
of O
cytogenetics _RARE_
, O
histopathology _RARE_
, O
and O
natural _RARE_
history O
. O

With O
the O
exception O
of O
mutants O
that O
remove _RARE_
the O
membrane O
anchor _RARE_
domain O
, O
all O
of O
the O
mutant O
glycoproteins _RARE_
retained O
the O
ability O
to O
cause O
fusion O
of O
CD4 _RARE_
- O
bearing _RARE_
cells O
. O

The O
subunit O
protein O
of O
curli _RARE_
was O
highly O
homologous O
at _RARE_
its O
amino O
terminus O
to O
SEF _RARE_
- I-GENE
17 _RARE_
, O
the O
subunit O
protein O
of O
thin O
, O
aggregative _RARE_
fimbriae _RARE_
of O
Salmonella _RARE_
enteritidis _RARE_
27655 _RARE_
strain _RARE_
3b _RARE_
, O
suggesting O
that O
these O
fibres O
form O
a O
novel O
class O
of O
surface O
organelles _RARE_
on O
enterobacteria _RARE_
. O

Substitution O
of O
the O
DR1 _RARE_
beta I-GENE
chain I-GENE
with O
H I-GENE
- I-GENE
2E _RARE_
beta I-GENE
k _RARE_
led O
to O
a O
dramatic O
loss _RARE_
of O
recognition O
; O
alpha O
chain O
substitution O
had O
a O
less O
marked O
effect O
. O

This O
negative O
regulatory O
pathway _RARE_
may O
be O
important O
for _RARE_
determining _RARE_
cell O
fate O
or O
maintaining O
an O
inducible O
state O
in O
the O
ventroposterior _RARE_
region O
of O
the O
embryo _RARE_
. O

The O
distal O
portion O
of O
the O
rat I-GENE
insulin I-GENE
I I-GENE
gene I-GENE
5 I-GENE
'- I-GENE
flanking I-GENE
DNA I-GENE
contains O
two O
sequence O
elements O
, O
the O
Far _RARE_
and O
FLAT _RARE_
elements O
, O
that O
can O
function O
in O
combination O
, O
but O
not O
separately O
, O
as _RARE_
a O
beta O
- O
cell O
- O
specific O
transcriptional O
enhancer O
. O

The O
deduced O
amino O
acid O
sequence O
exhibited O
98 O
% O
identity O
to O
the O
human O
cellular O
transglutaminase _RARE_
sequence O
. O

This O
computation _RARE_
is O
performed O
by O
a O
parallel O
network O
of O
locally O
connected O
neuron _RARE_
- O
like O
elements O
. O

Repeated _RARE_
efforts _RARE_
to O
isolate O
recombinant O
baculoviruses _RARE_
containing O
a O
wild O
- O
type O
kinase O
failed O
, O
whereas O
recombinants _RARE_
expressing O
a O
nonfunctional _RARE_
kinase O
with O
a O
catalytic O
domain O
II O
mutation O
were O
readily O
isolated O
. O

Finally O
, O
we O
determined O
that O
the O
P68 _RARE_
amino O
terminus O
was O
both O
necessary O
and O
sufficient O
for _RARE_
binding O
dsRNA _RARE_
as _RARE_
we O
were O
able O
to O
transfer O
dsRNA _RARE_
- O
binding O
properties O
to O
a O
reporter O
gene O
product O
previously O
unable O
to O
bind O
RNA O
. O

From O
August O
1989 O
to O
October _RARE_
1990 O
, O
83 _RARE_
pregnant _RARE_
Chinese _RARE_
women O
were O
the O
subjects O
for _RARE_
measuring O
the O
levels O
of O
plasma O
functional _RARE_
antithrombin I-GENE
III I-GENE
( O
AT I-GENE
III I-GENE
) O
activity O
. O

Visual _RARE_
acuity _RARE_
may O
be O
decreased O
by O
transient O
changes O
in O
refractive _RARE_
error O
caused O
by O
sulfonamides _RARE_
, O
the O
antifungal _RARE_
agent O
metronidazole _RARE_
, O
thiazide _RARE_
diuretics _RARE_
, O
and O
carbonic _RARE_
anhydrase I-GENE
inhibitors _RARE_
. O

Currents _RARE_
aspects O
of O
H2 I-GENE
receptor I-GENE
antagonists O
in O
the O
treatment O
of O
ulcers O

In O
addition O
, O
a O
21 O
- O
mer _RARE_
subrepeat _RARE_
structure _RARE_
is O
also O
present O
in O
each O
unit O
. O

Sequencing O
revealed O
one O
large O
open _RARE_
reading O
frame O
encoding O
a O
39 _RARE_
- O
kDa O
protein O
. O

These O
sites O
are O
also O
potential _RARE_
keratan _RARE_
sulfate _RARE_
attachment _RARE_
sites O
. O

We O
propose O
that O
plasmids O
of O
the O
pLS1 _RARE_
family O
( O
pE194 _RARE_
, O
pADB201 _RARE_
, O
and O
pLB4 _RARE_
) O
share O
functional _RARE_
and O
structural O
characteristics O
for _RARE_
the O
regulation _RARE_
of O
their O
copy O
numbers O
. O

Perturbation _RARE_
of O
dNTP _RARE_
pools _RARE_
also O
affected O
the O
frameshift O
fidelity _RARE_
of O
the O
replicative O
yeast I-GENE
DNA I-GENE
polymerase I-GENE
alpha I-GENE
. O

Differential O
expression _RARE_
of O
the O
" O
B O
" O
subunit O
of O
the O
vacuolar I-GENE
H I-GENE
(+)- _RARE_
ATPase I-GENE
in O
bovine O
tissues O
. O

In O
addition O
, O
the O
hGCSFR _RARE_
gene I-GENE
was O
chromosomally _RARE_
localized O
by O
Southern O
blot O
analysis O
of O
its O
segregation O
pattern O
in O
a O
panel O
of O
rodent O
- O
human O
hybrid _RARE_
DNAs _RARE_
using O
the O
radiolabeled O
cDNA O
probe O
. O

We O
have O
isolated O
and O
characterised _RARE_
a O
differentially O
- O
regulated O
gene O
family O
in O
the O
protozoan _RARE_
parasite O
Leishmania _RARE_
major O
. O

At O
some O
sites O
, O
% O
T O
is O
greatly O
increased O
by O
Cl O
- O
concentrations O
up _RARE_
to O
1 O
M O
, O
while O
at _RARE_
other O
sites O
% O
T O
is O
reduced _RARE_
or O
unaffected O
by O
these O
conditions O
. O

Necrosis _RARE_
appears O
6 O
h O
after O
TA O
infusion O
, O
being O
5 O
. O
77 O
% O
in O
extent O
after O
12 O
h O
, O
14 O
. O
9 O
% O
after O
24 _RARE_
h O
and O
animals O
die _RARE_
with O
an O
area O
of O
29 O
. O
5 O
% O
necrosis O
. O

In O
summary O
, O
the O
segments _RARE_
of O
C3 _RARE_
represented O
by O
amino O
acid O
residues O
1082 _RARE_
- O
1118 _RARE_
, O
1117 _RARE_
- O
1155 _RARE_
, O
1234 _RARE_
- O
1294 _RARE_
and O
1312 _RARE_
- O
1404 _RARE_
accommodate _RARE_
C3 _RARE_
( I-GENE
D I-GENE
) I-GENE
epitopes _RARE_
that O
are O
expressed _RARE_
by O
erythrocyte _RARE_
- O
bound _RARE_
C3 _RARE_
fragments I-GENE
, O
but O
not O
by O
the O
corresponding O
fluid _RARE_
- O
phase _RARE_
fragment O
, O
whereas O
the O
segments _RARE_
spanning O
residues O
973 _RARE_
- O
1026 _RARE_
and O
1477 _RARE_
- O
1510 _RARE_
contain O
C3 _RARE_
( I-GENE
D I-GENE
) I-GENE
epitopes _RARE_
that O
are O
exposed O
exclusively O
in O
denatured _RARE_
C3 _RARE_
and O
therefore O
hidden _RARE_
in O
physiological O
fragments O
of O
the O
protein O
. O

These O
exons O
, O
further O
identified O
as _RARE_
exons O
9 O
, O
10 O
, O
and O
11 O
, O
together O
encode O
the O
37 O
amino O
acid O
residues O
present O
in O
alpha I-GENE
s1 _RARE_
- I-GENE
casein I-GENE
variant I-GENE
A I-GENE
but O
missing O
in O
variant O
F O
. O

We O
also O
report O
here O
the O
complete _RARE_
structural O
organization O
of O
the O
goat _RARE_
alpha I-GENE
s1 _RARE_
- I-GENE
casein I-GENE
transcription I-GENE
unit I-GENE
, O
deduced O
from O
polymerase O
chain O
reaction O
experiments O
. O

Homodimers _RARE_
of O
the O
three O
proteins O
specifically O
recognize O
the O
G O
- O
box O
motif O
, O
with O
GBF1 _RARE_
and O
GBF3 _RARE_
binding O
symmetrically _RARE_
to O
this O
palindromic O
sequence O
. O

Neither O
gene O
possesses O
a O
distinct O
transcriptional O
start _RARE_
site O
as _RARE_
shown O
by O
nuclease _RARE_
S1 I-GENE
analysis O
. O

The O
hydrophobicity _RARE_
plot _RARE_
of O
NHE _RARE_
- I-GENE
3 I-GENE
is O
very O
similar O
to O
that O
of O
NHE _RARE_
- I-GENE
1 I-GENE
and O
NHE _RARE_
- I-GENE
2 I-GENE
. O

The O
initial O
translation O
protein O
encoded O
by O
the O
cDNA O
is O
53 O
, O
932 _RARE_
kDa O
and O
possesses O
a O
hydrophilic O
amino O
acid O
composition O
with O
glutamic _RARE_
acid O
comprising _RARE_
22 _RARE_
% O
of O
the O
total _RARE_
amino O
acid O
residues O
. O

Each O
group O
received O
15 _RARE_
ml O
/ O
kg O
of O
either O
6 O
% O
pentafraction _RARE_
, O
6 O
% O
pentastarch _RARE_
, O
or O
plasma O
followed O
two O
hours O
later O
by O
1 O
. O
5 O
micrograms O
/ O
kg O
/ O
0 _RARE_
. O
5 O
hr O
E O
. O

Genetic O
and O
biochemical O
evidence O
suggests O
that O
v I-GENE
- I-GENE
Crk I-GENE
can O
induce O
transformation O
of O
chicken O
embryo _RARE_
fibroblasts _RARE_
by O
influencing O
the O
activity O
of O
cellular O
proteins O
involved O
in O
growth O
regulation _RARE_
. O

We O
have O
constructed O
, O
using O
synthetic _RARE_
DNA O
oligonucleotides O
, O
a O
U14 I-GENE
snRNA _RARE_
gene I-GENE
which O
has O
been O
positioned O
behind O
a O
T7 _RARE_
RNA I-GENE
polymerase I-GENE
promoter I-GENE
site I-GENE
and O
then O
inserted O
into O
a O
plasmid _RARE_
. O

Gene _RARE_
and O
pseudogene _RARE_
of O
the O
mouse O
cation _RARE_
- O
dependent O
mannose _RARE_
6 I-GENE
- I-GENE
phosphate I-GENE
receptor I-GENE
. O

The O
chick _RARE_
axon _RARE_
- O
associated O
surface O
glycoprotein O
neurofascin _RARE_
is O
implicated O
in O
axonal _RARE_
growth O
and O
fasciculation _RARE_
as _RARE_
revealed O
by O
antibody O
perturbation _RARE_
experiments O
. O

The O
carcinoma O
was O
restricted O
within O
the O
epithelium O
in O
one O
, O
the O
mucosal _RARE_
layer O
in O
five O
, O
and O
the O
submucosal _RARE_
layer O
in O
two O
. O

In O
addition O
, O
C I-GENE
/ I-GENE
EBP I-GENE
beta I-GENE
and O
C I-GENE
/ I-GENE
EBP I-GENE
gamma I-GENE
readily O
heterodimerize _RARE_
with O
each O
other O
as _RARE_
well _RARE_
as _RARE_
with O
C I-GENE
/ I-GENE
EBP I-GENE
alpha I-GENE
. O

In O
contrast O
, O
tobacco I-GENE
GS _RARE_
- I-GENE
2 I-GENE
is O
composed O
of O
subunits O
of O
identical O
size O
in O
all O
organs O
examined O
. O

Between _RARE_
acoR _RARE_
and O
acoXABC _RARE_
, O
two O
different O
types _RARE_
of O
sequences O
with O
dual O
rotational _RARE_
symmetry _RARE_
[ _RARE_
CAC _RARE_
-( _RARE_
N11 _RARE_
to O
N18 _RARE_
)- O
GTG _RARE_
and O
TGT _RARE_
-( _RARE_
N10 _RARE_
to O
N14 _RARE_
)- O
ACA _RARE_
] O
were O
found O
; O
these O
sequences O
are O
similar O
to O
NtrC _RARE_
and O
NifA _RARE_
upstream I-GENE
activator I-GENE
sequences I-GENE
, O
respectively O
. O

Although O
the O
effects O
of O
the O
calcium _RARE_
supplement _RARE_
or O
calcium _RARE_
antagonist O
alone O
were O
significant O
, O
such O
hypotensive O
responses O
were O
not O
optimal O
or O
predictable _RARE_
or O
clearly O
dose O
- O
dependent O
. O

C O
., O
Sun _RARE_
, O
J _RARE_
., O
Hsu _RARE_
, O
M O
.- _RARE_
Y O
., O
Vallejo _RARE_
- O
Ramirez _RARE_
, O
J _RARE_
., O
Inouye _RARE_
, O
S O
., O
and O
Inouye _RARE_
, O
M O
. O

Surprisingly O
, O
the O
full O
- O
deletion O
mutant O
showed O
a O
strong O
block _RARE_
in O
virus O
release O
, O
suggesting O
that O
NC _RARE_
is O
involved O
in O
virus O
assembly O
. O

Furthermore O
it O
was O
suggested O
that O
FK506 O
plasma O
levels O
were O
concerned _RARE_
with O
the O
appearance O
of O
side _RARE_
effect O
. O

Thirty O
percent O
of O
patients O
were O
tapered _RARE_
off O
all O
steroids O
, O
and O
the O
average O
steroid O
dose O
in O
the O
group O
who O
received O
steroids O
was O
8 O
. O
6 O
mg O
of O
prednisone O
per O
day O
. O

Thus O
, O
cibenzoline _RARE_
is O
an O
effective O
antiarrhythmic O
agent O
with O
a O
favourable O
pharmacokinetic O
profile O
that O
may O
be O
considered O
with O
other O
class O
I O
drugs O
in O
patients O
requiring O
therapy O
for _RARE_
high O
risk O
arrhythmias O
. O

T I-GENE
antigen I-GENE
contains O
four O
H O
- O
2Db _RARE_
- O
restricted O
cytotoxic O
T O
lymphocyte O
( O
CTL O
) O
recognition O
epitopes _RARE_
that O
are O
targets _RARE_
for _RARE_
CTL O
clones _RARE_
Y O
- O
1 O
, O
Y O
- O
2 O
, O
Y O
- O
3 O
, O
and O
Y O
- O
5 O
. O

The O
method O
requires O
a O
reversed O
- O
phase _RARE_
column O
and O
a O
paired O
- O
ion O
technique O
to O
separate O
docusate _RARE_
sodium _RARE_
from O
other O
components _RARE_
. O

Here O
we O
demonstrate O
that O
the O
protein O
product O
of O
the O
ref _RARE_
- I-GENE
1 I-GENE
gene I-GENE
stimulates O
the O
DNA O
binding O
activity O
of O
Fos I-GENE
- O
Jun I-GENE
heterodimers _RARE_
, O
Jun I-GENE
- O
Jun I-GENE
homodimers O
and O
Hela _RARE_
cell O
AP I-GENE
- I-GENE
1 I-GENE
proteins I-GENE
as _RARE_
well _RARE_
as _RARE_
that O
of O
several O
other O
transcription O
factors O
including O
NF _RARE_
- I-GENE
kappa _RARE_
B I-GENE
, O
Myb I-GENE
and O
members O
of O
the O
ATF I-GENE
/ O
CREB I-GENE
family O
. O

The O
pulpal _RARE_
tissues O
of O
the O
permanent O
mandibular O
molars _RARE_
were O
amputated _RARE_
and O
then O
dressed _RARE_
with O
calcium _RARE_
hydrate _RARE_
. O

Northern O
blot O
analyses O
demonstrate O
that O
3 O
. O
9 O
- O
and O
5 O
- O
kilobase _RARE_
mRNAs O
corresponding O
to O
the O
cDNA O
were O
present O
in O
all O
tissues O
examined O
, O
suggesting O
that O
the O
protein O
it O
encodes O
performs _RARE_
a O
housekeeping O
function O
. O

The O
ARG _RARE_
SH2 _RARE_
domain I-GENE
exhibited O
relatively O
weak O
affinity O
for _RARE_
BCR _RARE_
and O
was O
determined O
to O
bind O
about O
10 O
- O
fold _RARE_
less O
strongly O
than O
the O
ABL I-GENE
SH2 _RARE_
domain I-GENE
. O

We O
analyzed O
an O
EBV _RARE_
B O
- O
cell O
clone O
, O
E29 _RARE_
. O
1 O
, O
derived O
from O
an O
11 O
week O
- O
old O
embryo _RARE_
, O
and O
secreting O
both O
IgM I-GENE
kappa _RARE_
and O
IgM I-GENE
lambda I-GENE
. O

Interestingly O
, O
this O
activation O
occurred O
only O
when O
the O
regions O
were O
cloned _RARE_
in O
the O
same O
relative O
orientation O
in O
which O
they O
exist O
on O
wild O
- O
type O
pCF10 _RARE_
. O

In O
rats O
, O
we O
examined O
the O
effect O
of O
an O
omentum _RARE_
wrapping _RARE_
on O
the O
vascularization _RARE_
of O
the O
trachea _RARE_
and O
on O
regeneration O
of O
the O
mucosal _RARE_
epithelium O
in O
the O
very O
early O
stage _RARE_
after O
free O
tracheal O
grafting _RARE_
. O

To O
study O
a O
possible O
functional _RARE_
role O
of O
this O
putative O
chicken O
ICS _RARE_
, O
an O
oligonucleotide _RARE_
spanning O
the O
upstream O
sequences O
of O
the O
BF _RARE_
- I-GENE
IV I-GENE
gene I-GENE
(- _RARE_
174 _RARE_
/- O
194 _RARE_
) O
was O
cloned _RARE_
singly _RARE_
or O
in O
multiple O
copies O
before O
the O
herpes O
TK I-GENE
promoter I-GENE
controlling O
the O
chloramphenicol I-GENE
acetyl I-GENE
transferase I-GENE
( O
CAT I-GENE
) O
gene O
( O
pBLCAT2 _RARE_
). O

In O
general _RARE_
, O
two O
separate O
high O
- O
performance O
liquid O
chromatographic O
runs _RARE_
were O
performed O
, O
one O
for _RARE_
the O
gamma O
- O
aminobutyric _RARE_
acid O
determination O
and O
one O
for _RARE_
the O
determination O
of O
the O
monoamines _RARE_
. O

We O
report O
the O
successful O
use O
of O
electroconvulsive _RARE_
therapy O
for _RARE_
treatment O
of O
severe O
depression O
in O
a O
young O
man O
with O
adult O
GM2 _RARE_
gangliosidosis _RARE_
. O

Entry _RARE_
of O
yeast O
cells O
into O
the O
mitotic _RARE_
cell O
cycle _RARE_
( O
Start _RARE_
) O
involves O
a O
form O
of O
the O
CDC28 _RARE_
kinase I-GENE
that O
associates O
with O
G1 O
- O
specific O
cyclins _RARE_
encoded O
by O
CLN1 _RARE_
and O
CLN2 _RARE_
( O
ref _RARE_
. O

Through _RARE_
Southern O
blot O
analyses O
of O
DNA O
from O
backcross O
and O
cogenic _RARE_
mice O
, O
recombinant O
inbred _RARE_
strains O
, O
and O
somatic O
cell O
hybrids O
, O
the O
genetic O
loci O
that O
produce O
the O
cyclin _RARE_
B1 _RARE_
- I-GENE
related I-GENE
sequences I-GENE
( O
designated O
loci I-GENE
Cycb1 _RARE_
- I-GENE
rs1 _RARE_
to O
Cycb1 _RARE_
- I-GENE
rs9 _RARE_
) O
were O
mapped O
on O
mouse O
chromosomes O
5 O
, O
1 O
, O
17 _RARE_
, O
4 O
, O
14 O
, O
13 _RARE_
, O
7 O
, O
X O
, O
and O
8 O
, O
respectively O
. O

Again _RARE_
residue _RARE_
Glu O
- O
381 _RARE_
of O
beta O
was O
notably _RARE_
reduced _RARE_
and O
no _RARE_
missing O
residue _RARE_
from O
the O
epsilon O
peptide O
could O
be O
identified O
, O
but O
the O
peptide O
sequence O
limited O
the O
possible O
choices _RARE_
to O
Ser _RARE_
- O
106 _RARE_
, O
Ser _RARE_
- O
107 _RARE_
, O
or O
Ser _RARE_
- O
108 _RARE_
. O

Porcelain _RARE_
to O
dentin O
bond O
strength O
with O
a O
dentin O
adhesive O
. O

TBPf _RARE_
is O
defined O
as _RARE_
a O
quotient _RARE_
of O
the O
difference O
of O
the O
first _RARE_
and O
the O
second O
measurement O
: O
TBPf _RARE_
= O
( O
P1 O
- O
P2 O
)/( _RARE_
A1 _RARE_
- O
A2 _RARE_
). O

It O
was O
concluded O
that O
Scotchbond _RARE_
2 O
and O
Prisma _RARE_
Universal _RARE_
Bond _RARE_
2 O
are O
effective O
and O
are O
the O
dentine _RARE_
bonding _RARE_
agents O
of O
choice O
. O

From O
all O
clinically O
important O
yeasts _RARE_
species O
, O
a O
total _RARE_
of O
96 O
% O
were O
identified O
by O
ATB _RARE_
method O
according O
to O
conventional O
methods O
. O

The O
neurohypophysial _RARE_
vasopressin I-GENE
and O
oxytocin _RARE_
content O
was O
bioassayed _RARE_
by O
pressor O
effect O
following O
Dekanski _RARE_
or O
milk O
- O
ejection O
activity O
in O
vitro O
following O
van _RARE_
Dongen _RARE_
and O
Hays _RARE_
, O
respectively O
. O

Comments _RARE_
are O
given O
on O
the O
present O
status O
of O
regulations _RARE_
concerning O
water O
in O
swimming O
pools _RARE_
and O
baths _RARE_
-- _RARE_
1991 O
--( _RARE_
in O
connection _RARE_
with O
the O
KOK _RARE_
regulations _RARE_
-- _RARE_
1972 O
-- _RARE_
and O
the O
Federal _RARE_
German _RARE_
standard O
[ _RARE_
DIN _RARE_
] O
No O
. O

If O
no _RARE_
reply _RARE_
was O
received O
, O
telephone _RARE_
contact _RARE_
or O
home O
visits _RARE_
were O
made O
. O

The O
treatment O
group O
also O
showed O
in O
vivo O
T O
- O
cell O
activation O
with O
an O
initial O
lymphopenia _RARE_
followed O
by O
a O
rebound _RARE_
lymphocytosis _RARE_
and O
upregulation _RARE_
of O
the O
subset O
markers O
CD25 _RARE_
( O
interleukin I-GENE
2 I-GENE
receptor I-GENE
) O
and O
CD45RO _RARE_
( O
T O
- O
memory O
cells O
). O

Urease _RARE_
activity O
, O
judged O
as _RARE_
the O
amount O
of O
ammonia _RARE_
production O
from O
urea O
, O
could O
be O
measured O
at _RARE_
25 _RARE_
ng _RARE_
per O
tube O
( O
S O
/ O
N O
= O
1 O
. O
5 O
) O
with O
Jack _RARE_
bean _RARE_
meal _RARE_
urease I-GENE
. O

Consequently _RARE_
, O
significant O
differences O
between O
the O
measured O
and O
calculated O
methods O
were O
noted O
in O
oxygen O
uptake O
( O
213 _RARE_
+/- O
41 _RARE_
ml O
/ O
min O
vs _RARE_
193 O
+/- O
25 _RARE_
ml O
/ O
min O
, O
p O
< O
0 _RARE_
. O
001 O
), _RARE_
oxygen O
delivery O
( O
780 _RARE_
+/- O
297 _RARE_
ml O
/ O
min O
vs _RARE_
716 _RARE_
+/- O
296 O
ml O
/ O
min O
, O
p O
< O
0 _RARE_
. O
001 O
), _RARE_
and O
cardiac O
output O
( O
5 O
. O
8 O
+/- O
2 O
. O
2 O
L O
/ O
min O
vs _RARE_
5 O
. O
3 O
+/- O
1 O
. O
8 O
L O
/ O
min O
, O
p O
< O
0 _RARE_
. O
001 O
). O

Although O
a O
wide O
range O
of O
cognitive O
functions O
had O
been O
tested O
, O
all O
but O
one O
seizure O
occurred O
during _RARE_
assessment O
of O
memory O
performance O
. O

The O
experiments O
show O
that O
it O
is O
the O
micromilieu _RARE_
of O
the O
alveoli _RARE_
and O
the O
condition O
of O
the O
AM _RARE_
( O
certain O
physiological O
activation O
states O
, O
such O
as _RARE_
phagocytic O
activity O
) O
that O
essentially O
determine O
the O
degree O
of O
recovery O
. O

Negatively _RARE_
supercoiled _RARE_
plasmid _RARE_
pUC19 _RARE_
did O
not O
compete O
, O
whereas O
an O
otherwise O
identical O
plasmid _RARE_
pUC19 _RARE_
( O
CG _RARE_
), _RARE_
which O
contained O
a O
( O
dG _RARE_
- O
dC _RARE_
) O
7 O
segment O
in O
the O
Z O
- O
form O
was O
an O
excellent O
competitor O
. O

A O
cDNA O
library O
of O
tumour _RARE_
cells O
was O
screened O
with O
an O
interleukin I-GENE
2 I-GENE
gene O
- O
specific O
probe O
. O

Our O
experiments O
suggest O
that O
the O
SCL _RARE_
gene I-GENE
can O
be O
a O
target O
for _RARE_
the O
erythroid _RARE_
transcription I-GENE
factor I-GENE
GATA _RARE_
- I-GENE
1 I-GENE
and O
that O
the O
SCL _RARE_
gene I-GENE
product I-GENE
serves O
as _RARE_
a O
positive O
regulator O
of O
erythroid _RARE_
differentiation O
. O

In O
contrast O
, O
the O
lumenal _RARE_
domains O
of O
Sec12p _RARE_
, O
Stl1p _RARE_
and O
Stl2p _RARE_
are O
very O
different O
in O
size O
and O
do O
not O
show O
any O
appreciable _RARE_
homology O
. O

Complexes _RARE_
containing O
wild O
- O
type O
and O
either O
his175 _RARE_
or I-GENE
his273 _RARE_
mutant I-GENE
p53 I-GENE
proteins I-GENE
are O
completely O
unable O
to O
bind O
to O
the O
RGC _RARE_
DNA I-GENE
sequence I-GENE
. O

These O
temperature _RARE_
- O
and O
cold O
- O
sensitive _RARE_
strains O
were O
used O
to O
prepare _RARE_
extracts O
deficient _RARE_
in O
BRF1 _RARE_
activity O
and O
were O
tested O
for _RARE_
transcriptional O
activity O
by O
RNA I-GENE
polymerases _RARE_
I I-GENE
, I-GENE
II I-GENE
, I-GENE
and I-GENE
III I-GENE
in O
vitro O
. O

These O
results O
lead O
us O
to O
hypothesize _RARE_
that O
a O
single O
multisubunit _RARE_
TFIID I-GENE
protein I-GENE
supports O
transcriptional O
stimulation _RARE_
by O
diverse O
activation O
domains O
and O
from O
a O
TATA O
- O
less O
promoter O
. O

The O
gene O
sequence O
also O
identified O
a O
340 _RARE_
- O
nucleotide O
RNA O
in O
total _RARE_
yeast O
RNA O
and O
in O
purified _RARE_
RNase I-GENE
MRP I-GENE
enzyme I-GENE
preparations O
. O

The O
RNase I-GENE
MRP I-GENE
RNA I-GENE
gene I-GENE
was O
deleted _RARE_
by O
insertional _RARE_
replacement _RARE_
and O
found O
to O
be O
essential O
for _RARE_
cellular O
viability O
, O
indicating O
a O
critical O
nuclear O
role O
for _RARE_
RNase I-GENE
MRP I-GENE
. O

Clone _RARE_
pSRc200 _RARE_
hybrid _RARE_
selected _RARE_
an O
mRNA O
that O
on O
cell O
- O
free O
translation O
produced O
a O
38 O
- O
kDa O
polypeptide O
. O

From O
these O
results O
, O
CBF I-GENE
- I-GENE
A I-GENE
is O
a O
novel O
CArG _RARE_
box O
-, _RARE_
ssDNA _RARE_
- I-GENE
and I-GENE
RNA I-GENE
- I-GENE
binding I-GENE
protein I-GENE
, O
as _RARE_
well _RARE_
as _RARE_
a O
repressive O
transcriptional O
factor O
. O

Cleavage _RARE_
by O
the O
intron O
- O
encoded O
enzyme O
( O
I I-GENE
- I-GENE
CreI _RARE_
) O
occurs O
5 O
bp O
and O
1 O
bp O
3 O
' O
to O
the O
intron O
insertion _RARE_
site O
( O
in O
the O
3 O
'- O
exon _RARE_
) O
in O
the O
top O
(/) _RARE_
and O
bottom _RARE_
(,) _RARE_
strands _RARE_
, O
respectively O
, O
resulting O
in O
4 O
- O
nt O
single O
- O
stranded _RARE_
overhangs _RARE_
with O
3 O
'- O
OH O
termini O
. O

Surprisingly O
, O
the O
Xenopus I-GENE
U7 _RARE_
gene I-GENE
contains O
two O
adjacent O
octamer O
- O
binding O
motifs O
located _RARE_
only O
12 O
and O
24 _RARE_
bp O
upstream O
from O
the O
PSE _RARE_
, O
instead O
of O
the O
usual _RARE_
location O
around O
150 _RARE_
- O
200 _RARE_
bp O
upstream O
. O

The O
results O
support O
earlier O
reports O
that O
collagenase _RARE_
inhibitors _RARE_
are O
useful O
in O
controlling O
blister _RARE_
formation O
in O
recessive O
dystrophic _RARE_
epidermolysis _RARE_
bullosa _RARE_
. O

Mutational O
analysis O
of O
essential O
IncP _RARE_
alpha O
plasmid _RARE_
transfer O
genes O
traF _RARE_
and O
traG _RARE_
and O
involvement O
of O
traF _RARE_
in O
phage _RARE_
sensitivity O
. O

The O
promoter O
was O
stimulated _RARE_
8 O
- O
20 O
- O
fold _RARE_
by O
phorbol O
esters O
accounting _RARE_
for _RARE_
the O
previously O
observed O
transcriptional O
activation O
of O
protein I-GENE
kinase I-GENE
C I-GENE
beta I-GENE
. O

In O
humans O
, O
four O
AMP I-GENE
deaminase _RARE_
variants I-GENE
, O
termed O
M I-GENE
( O
muscle O
), _RARE_
L I-GENE
( O
liver O
), _RARE_
E1 I-GENE
, O
and O
E2 I-GENE
( O
erythrocyte _RARE_
) O
can O
be O
distinguished O
by O
a O
variety O
of O
biochemical O
and O
immunological _RARE_
criteria O
. O

Western O
blot O
analyses O
detect O
anti I-GENE
- I-GENE
E I-GENE
- O
specific O
immunoreactivity O
in O
affinity O
- O
purified _RARE_
extracts O
derived O
from O
the O
bacterial O
expression _RARE_
of O
a O
truncated I-GENE
AMPD3 _RARE_
cDNA I-GENE
. O

These O
results O
demonstrate O
that O
endogenous O
N O
- O
methylation O
of O
salsolinol _RARE_
into O
N O
- O
methylsalsolinol _RARE_
occurs O
in O
the O
brain O
in O
vivo O
. O

DR1 _RARE_
molecules I-GENE
purified _RARE_
from O
human O
lymphoblastoid _RARE_
cell O
lines O
could O
specifically O
bind O
to O
these O
peptide O
sequences O
expressed _RARE_
on O
the O
phage _RARE_
surface O
. O

This O
article O
describes O
the O
collaborative _RARE_
care O
of O
the O
woman O
participating _RARE_
in O
maternal _RARE_
blood _RARE_
donation _RARE_
for _RARE_
intrauterine O
transfusion O
. O

Chronic O
hepatitis O
B O
in O
adopted O
Romanian _RARE_
children O
. O

Behind _RARE_
the O
ATPase I-GENE
cluster I-GENE
, O
two O
open _RARE_
reading O
frames O
were O
detected O
that O
are O
not O
homologous O
to O
any O
known O
chloroplast O
gene O
. O

Therefore O
, O
recombinant O
human O
Ads _RARE_
that O
express O
noninfectious _RARE_
HIV O
or O
other O
microbial _RARE_
proteins O
are O
attractive _RARE_
vaccine O
candidates _RARE_
. O

Alignment _RARE_
of O
the O
selected _RARE_
sequences O
allowed O
us O
to O
predict O
a O
consensus O
sequence O
for _RARE_
binding O
of O
the O
individual O
homodimeric _RARE_
Rel I-GENE
- I-GENE
related I-GENE
proteins I-GENE
, O
and O
DNA O
- O
protein O
binding O
analysis O
of O
the O
selected _RARE_
DNA O
sequences O
revealed O
sequence O
specificity _RARE_
of O
the O
proteins O
. O

Using O
either O
a O
p50 _RARE_
- O
or O
p65 _RARE_
- I-GENE
selected _RARE_
kappa _RARE_
B I-GENE
motif I-GENE
, O
which O
displayed O
differential O
binding O
with O
respect O
to O
the O
other O
protein O
, O
little O
to O
no _RARE_
binding O
was O
observed O
with O
the O
heterodimeric _RARE_
NF _RARE_
- I-GENE
kappa _RARE_
B I-GENE
complex I-GENE
. O

However O
, O
a O
cosmid O
clone O
containing O
the O
entire _RARE_
mouse I-GENE
alpha I-GENE
1 I-GENE
( I-GENE
I I-GENE
) I-GENE
gene I-GENE
, O
including O
3 O
. O
7 O
kb O
of O
5 O
'- O
and O
4 O
kb O
of O
3 O
'- O
flanking O
DNA O
, O
was O
expressed _RARE_
at _RARE_
reduced _RARE_
levels O
in O
fibroblasts _RARE_
overexpressing O
oncogenic _RARE_
ras I-GENE
. O

To O
define O
transcriptional O
control O
elements O
responsible O
for _RARE_
muscle O
- O
specific O
expression _RARE_
of O
the O
human I-GENE
myoglobin I-GENE
gene I-GENE
, O
we O
performed O
mutational O
analysis O
of O
upstream O
sequences O
( O
nucleotide O
positions O
- O
373 _RARE_
to O
+ O
7 O
relative O
to O
the O
transcriptional O
start _RARE_
site O
) O
linked _RARE_
to O
a O
firefly _RARE_
luciferase I-GENE
gene I-GENE
. O

Sequencing O
analysis O
has O
shown O
that O
each O
rap1t _RARE_
allele I-GENE
contains O
a O
nonsense O
mutation O
within O
a O
discrete O
region O
between O
amino O
acids _RARE_
663 _RARE_
and O
684 _RARE_
. O

By O
screening O
a O
Y1 _RARE_
cell O
cDNA O
library O
with O
the O
DNA O
- O
binding O
region O
of O
the O
H I-GENE
- I-GENE
2RIIBP _RARE_
nuclear I-GENE
hormone I-GENE
receptor I-GENE
cDNA I-GENE
, O
we O
isolated O
a O
cDNA O
that O
is O
selectively O
expressed _RARE_
in O
steroidogenic _RARE_
cells O
. O

Autopsy _RARE_
demonstrated O
good O
survival O
of O
the O
transplanted _RARE_
cells O
with O
good O
integration _RARE_
with O
the O
brain O
of O
the O
recipient O
and O
traces _RARE_
of O
positive O
immunocytochemical _RARE_
reaction O
for _RARE_
tyrosine I-GENE
hydroxylase I-GENE
. O

The O
technique O
of O
the O
TEE _RARE_
visualization O
of O
the O
proximal O
coronary O
arteries O
is O
described O
. O

The O
sequence O
of O
this O
region O
shows O
high O
G O
+ O
C O
content O
( O
62 _RARE_
%), O
which O
is O
particularly O
emphasized _RARE_
in O
the O
200 _RARE_
bp O
upstream O
from O
the O
mRNA O
start _RARE_
( O
80 _RARE_
% O
G O
+ O
C O
). O

In O
the O
eight O
patients O
with O
persistent O
generalized O
lymph O
- O
adenopathy _RARE_
( O
PGL _RARE_
) O
and O
nontender _RARE_
, O
nonenlarging _RARE_
nodes O
, O
pathologic O
analysis O
revealed O
lymphoid _RARE_
hyperplasia O
. O

PaO2 O
threshold O
was O
determined O
through O
an O
indwelling _RARE_
O2 _RARE_
sensor _RARE_
catheter O
. O

We O
found O
that O
both O
the O
E26 _RARE_
virus O
- O
encoded O
v I-GENE
- I-GENE
ets I-GENE
and O
the O
myeloid _RARE_
/ I-GENE
B I-GENE
- I-GENE
cell I-GENE
- I-GENE
specific I-GENE
factor I-GENE
PU _RARE_
. I-GENE
1 I-GENE
bind O
efficiently O
to O
this O
site O
in O
vitro O
. O

By O
using O
lambda O
gt11 O
expression _RARE_
cloning O
with O
oligonucleotides O
corresponding O
to O
the O
human O
immunodeficiency O
virus O
1 O
TATA O
element O
, O
we O
report O
the O
identification O
of O
a O
cellular O
protein O
with O
a O
calculated O
molecular _RARE_
mass O
of O
123 O
kDa O
that O
we O
designate _RARE_
TATA I-GENE
element I-GENE
modulatory _RARE_
factor I-GENE
( O
TMF _RARE_
). O

Blood _RARE_
levels O
of O
melatonin O
, O
serotonin _RARE_
, O
cortisol O
, O
and O
prolactin I-GENE
in O
relation O
to O
the O
circadian O
rhythm O
of O
platelet O
serotonin _RARE_
uptake O
. O

We O
couldn _RARE_
' O
t O
detect O
any O
effect O
of O
n _RARE_
- O
3 O
FA _RARE_
supplementation O
on O
total _RARE_
cholesterol O
, O
HDL _RARE_
cholesterol I-GENE
, O
LDL I-GENE
cholesterol I-GENE
, O
apo _RARE_
A1 _RARE_
, O
Lp _RARE_
( O
a O
), _RARE_
HbA1C _RARE_
, O
glucose O
, O
fibrinogen I-GENE
, O
factor I-GENE
VIII I-GENE
, O
antithrombin I-GENE
III I-GENE
, O
plasminogen I-GENE
activator I-GENE
inhibitor I-GENE
, O
tissue I-GENE
plasminogen I-GENE
activator I-GENE
and O
von _RARE_
Willebrand I-GENE
factor I-GENE
concentration O
, O
on O
bleeding O
time O
or O
on O
systolic O
or O
diastolic O
blood _RARE_
pressure O
. O

In O
8 O
healthy O
volunteers O
there O
were O
no _RARE_
significant O
differences O
in O
AUC O
, O
peak O
plasma O
concentrations O
or O
time O
to O
peak O
concentration O
when O
OXC _RARE_
was O
administered O
either O
with O
or O
without O
ERY _RARE_
. O

Using O
5 O
ng _RARE_
/ O
mL O
as _RARE_
the O
cutoff O
, O
the O
sensitivity O
of O
CEA _RARE_
was O
68 _RARE_
%. O

Rolandic _RARE_
spikes O
and O
cognitive O
function O
. O

The O
effect O
of O
sodium _RARE_
18 O
beta O
- O
glycyrrhetate _RARE_
( O
SGA _RARE_
) O
on O
experimental O
arrhythmia _RARE_
was O
investigated O
. O

Thus O
, O
chronic O
hematocrit O
decrease O
induced _RARE_
by O
H O
or O
P O
resulted O
in O
a O
significant O
fall O
in O
blood _RARE_
pressure O
compared O
to O
control O
( O
201 _RARE_
+/- O
3 O
v O
175 O
+/- O
4 O
, O
167 _RARE_
+/- O
4 O
mm O
Hg O
, O
respectively O
; O
P O
< O
. O
05 O
). O

The O
effects O
of O
diltiazem O
were O
stereoselective _RARE_
, O
thus O
the O
potentiation O
induced _RARE_
by O
d O
- O
cis O
diltiazem O
was O
significantly O
greater O
in O
all O
cases O
than O
that O
induced _RARE_
by O
l _RARE_
- O
cis O
diltiazem O
, O
which O
suggests O
that O
calcium _RARE_
channel _RARE_
blockade O
plays O
a O
role O
in O
these O
interactions O
. O

Localization O
of O
the O
brachial _RARE_
plexus _RARE_
with O
the O
nerve O
stimulator _RARE_
is O
equally O
effective O
at _RARE_
the O
interscalene _RARE_
, O
supraclavicular _RARE_
, O
and O
axillary _RARE_
sites O
. O

Substitution O
of O
either O
Val33 _RARE_
( O
by O
Gly _RARE_
) O
or O
Gly28 _RARE_
( O
by O
Ser _RARE_
), _RARE_
two O
of O
the O
most O
conserved _RARE_
residues O
in O
all O
protein O
kinases O
, O
resulted O
in O
enzyme O
with O
marginally _RARE_
detectable O
activity O
. O

Significance O
of O
the O
biopsy O
site O
of O
the O
latissimus _RARE_
dorsi _RARE_
muscle O
for _RARE_
fiber O
typing _RARE_
. O

The O
TIMP I-GENE
(- _RARE_
59 _RARE_
/ O
- O
53 O
) O
AP1 I-GENE
site O
is O
a O
promiscuous _RARE_
motif O
that O
binds O
c I-GENE
- I-GENE
Fos I-GENE
/ O
c I-GENE
- I-GENE
Jun I-GENE
AP1 I-GENE
translated O
in O
vitro O
and O
is O
an O
effective O
competitor O
for _RARE_
binding O
of O
nuclear I-GENE
AP1 I-GENE
factors I-GENE
to O
the O
consensus O
TRE _RARE_
, O
but O
in O
addition O
it O
binds O
factors O
that O
do O
not O
associate O
with O
the O
consensus O
TRE _RARE_
. O

Involvement _RARE_
of O
AP1 I-GENE
and O
PEA3 I-GENE
binding I-GENE
sites I-GENE
in O
the O
regulation _RARE_
of O
murine I-GENE
tissue I-GENE
inhibitor I-GENE
of I-GENE
metalloproteinases _RARE_
- I-GENE
1 I-GENE
( O
TIMP I-GENE
- I-GENE
1 I-GENE
) O
transcription O
. O

Of O
the O
serum I-GENE
neutralizing _RARE_
( I-GENE
SN _RARE_
) I-GENE
antibody I-GENE
negative O
calves O
89 _RARE_
. O
7 O
% O
( O
26 _RARE_
/ O
29 O
) O
and O
92 O
. O
8 O
% O
( O
90 _RARE_
/ O
97 O
) O
developed O
SN _RARE_
antibody I-GENE
1 O
month O
after O
intranasal _RARE_
and O
intramuscular _RARE_
vaccination O
, O
respectively O
. O

Fractionation _RARE_
of O
crude O
nuclear O
extracts O
by O
heparin _RARE_
- O
agarose O
chromatography O
indicates O
that O
PCAT _RARE_
- I-GENE
1 I-GENE
is O
more O
prevalent _RARE_
in O
extracts O
prepared O
from O
salt O
- O
stressed O
leaf O
tissue O
. O

A O
controlled _RARE_
trial O
of O
recombinant I-GENE
human I-GENE
granulocyte _RARE_
- I-GENE
macrophage I-GENE
colony I-GENE
- I-GENE
stimulating I-GENE
factor I-GENE
after O
total _RARE_
body O
irradiation O
, O
high O
- O
dose O
chemotherapy O
, O
and O
autologous O
bone O
marrow O
transplantation O
for _RARE_
acute O
lymphoblastic _RARE_
leukemia O
or O
malignant O
lymphoma O
. O

These O
data O
demonstrate O
that O
DMVA _RARE_
does O
not O
cause O
more O
myocardial _RARE_
trauma O
than O
CPB O
when O
used O
to O
provide O
resuscitative _RARE_
circulatory O
support O
. O

The O
IgG I-GENE
subclass _RARE_
profile O
of O
untreated O
coeliac _RARE_
disease _RARE_
was O
found O
to O
be O
the O
same O
as _RARE_
in O
healthy O
controls O
( O
IgG1 _RARE_
approximately _RARE_
IgG2 _RARE_
> O
IgG3 _RARE_
> O
IgG4 _RARE_
), _RARE_
with O
only O
the O
magnitude O
of O
the O
individual O
subclass _RARE_
responses O
being O
increased O
in O
coeliac _RARE_
patients O
. O

Examination O
of O
ANCA _RARE_
is O
not O
only O
a O
significant O
contribution O
towards O
a O
more O
accurate O
diagnosis O
of O
renal _RARE_
vasculitis O
, O
but O
also O
an O
indicator O
of O
the O
activity O
of O
the O
disease _RARE_
and O
thus O
of O
the O
effectiveness O
of O
immunosuppressive O
treatment O
. O

On O
the O
other O
hand _RARE_
, O
total _RARE_
pinealectomy _RARE_
in O
these O
already O
sympathectomized _RARE_
blinded _RARE_
rabbits O
always O
resulted O
in O
a O
substantial O
deceleration _RARE_
of O
the O
rhythms _RARE_
( O
mean O
delta O
tau _RARE_
= O
+ O
0 _RARE_
. O
23 _RARE_
h O
). O

Cicatricial _RARE_
pemphigoid _RARE_
is O
an O
autoimmune _RARE_
systemic O
disease _RARE_
characterized O
by O
chronic O
conjunctival _RARE_
cicatrization _RARE_
. O

The O
effects O
of O
two O
levels O
of O
caffeine O
ingestion O
on O
excess O
postexercise _RARE_
oxygen O
consumption O
in O
untrained _RARE_
women O
. O

The O
distinguishing _RARE_
features O
involved O
eight O
amino O
acid O
changes O
, O
including O
a O
single O
lysine _RARE_
deletion O
relative O
to O
a O
primate O
consensus O
sequence O
in O
the O
first _RARE_
complementary _RARE_
- O
determing _RARE_
region O
of O
V1J1 _RARE_
. O

4 O
. O

The O
in O
vivo O
profile O
of O
ZFH _RARE_
- I-GENE
2 I-GENE
in O
the O
larval _RARE_
CNS O
shows O
intriguing _RARE_
overlap O
with O
DDC _RARE_
in O
specific O
serotonin _RARE_
and O
dopamine O
neurons O
. O

Unlike O
the O
introns _RARE_
of O
other O
duplicated O
ribosomal I-GENE
protein I-GENE
genes I-GENE
which O
are O
highly O
diverged O
, O
the O
duplicated O
S13 _RARE_
genes I-GENE
have O
two O
nearly O
identical O
DNA O
sequences O
of O
25 _RARE_
and O
31 _RARE_
bp O
in O
length O
within O
their O
introns _RARE_
. O

In O
a O
prospective O
, O
randomized O
clinical O
trial O
we O
compared O
the O
efficacy O
of O
subcutaneously O
( O
SC O
) O
administered O
( O
every O
8 O
h O
) O
calcium _RARE_
heparin _RARE_
to O
intravenous O
( O
IV O
) O
sodium _RARE_
heparin _RARE_
in O
the O
treatment O
of O
proximal O
deep O
- O
vein _RARE_
thrombosis O
( O
DVT _RARE_
). O

The O
highest O
prevalence O
of O
reported O
pet _RARE_
allergy O
, O
chronic O
cough _RARE_
, O
wheeze _RARE_
, O
attacks O
of O
shortness _RARE_
of O
breath _RARE_
with O
wheezing _RARE_
, O
and O
doctor _RARE_
- O
diagnosed O
asthma O
was O
found O
in O
children O
who O
had O
pets _RARE_
in O
the O
past O
but O
not O
anymore _RARE_
. O

Therefore O
, O
it O
would O
be O
advantageous _RARE_
to O
identify O
such O
persons O
and O
treat O
them O
preferentially O
. O

On O
the O
basis O
of O
these O
unique O
properties O
, O
the O
newly O
characterized O
hemagglutinin I-GENE
has O
been O
termed O
Limulus _RARE_
18K _RARE_
agglutination _RARE_
- I-GENE
aggregation _RARE_
factor I-GENE
( O
18K _RARE_
- I-GENE
LAF _RARE_
). O

The O
shift O
to O
the O
nonpermissive _RARE_
temperature _RARE_
is O
accompanied O
by O
the O
loss _RARE_
of O
guanyl _RARE_
nucleotide O
- O
dependent O
activity O
of O
adenylylcyclase _RARE_
in O
vitro O
. O

Clin _RARE_
. O

The O
data O
indicate O
that O
the O
minimal O
catalytic O
domain O
of O
Nmt1p _RARE_
is O
located _RARE_
between O
Ile59 _RARE_
--> _RARE_
Phe96 _RARE_
and O
Gly451 _RARE_
--> _RARE_
Leu455 _RARE_
. O

It O
corresponds O
to O
the O
complete _RARE_
mitochondrial O
presequence _RARE_
and O
the O
lipoyl _RARE_
- O
bearing _RARE_
domain O
that O
are O
encoded O
by O
exons O
I O
through O
IV O
of O
the O
functional _RARE_
E2 I-GENE
gene I-GENE
. O

Human O
neutrophil _RARE_
response O
to O
short O
- O
term O
exposure O
to O
F O
- O
75 _RARE_
cobalt _RARE_
- O
based O
alloy _RARE_
. O

Disruption O
of O
microtubules _RARE_
did O
not O
affect O
the O
fidelity _RARE_
or O
kinetics O
of O
vacuolar O
protein O
sorting _RARE_
, O
indicating O
that O
Vps1p _RARE_
function O
is O
not O
dependent O
on O
microtubules _RARE_
. O

A O
mutant O
form O
of O
Vps1p _RARE_
lacking _RARE_
the O
entire _RARE_
GTP O
- O
binding O
domain O
interfered _RARE_
with O
vacuolar O
protein O
sorting _RARE_
in O
wild O
- O
type O
cells O
. O

According O
to O
out O
field O
research O
, O
the O
tick _RARE_
fauna _RARE_
was O
very O
rich O
throughout O
that O
area O
, O
and O
it O
was O
permissible _RARE_
enough O
to O
determine O
ticks O
as _RARE_
the O
vectors O
, O
based O
on O
arising O
of O
anti I-GENE
- I-GENE
SF _RARE_
group I-GENE
rickettsiae _RARE_
( O
SFGR _RARE_
) O
antibody O
in O
mice O
inoculated O
with O
some O
tick _RARE_
emulsions _RARE_
, O
findings O
of O
rickettsiae _RARE_
reactive O
to O
patient O
sera _RARE_
or O
a O
species O
- O
specific O
monoclonal O
antibody O
to O
JSFR _RARE_
in O
the O
hemolymph _RARE_
cells O
of O
some O
ticks O
, O
and O
electron O
microscopical _RARE_
observations O
of O
SFGR _RARE_
in O
various O
internal O
organs O
including O
the O
salivary _RARE_
gland _RARE_
of O
ticks O
. O

The O
second O
method O
, O
the O
" O
macro _RARE_
" O
assay O
, O
has O
a O
sensitivity O
range O
of O
0 _RARE_
. O
03 O
- O
5 O
. O
0 _RARE_
micrograms O
phosphorus O
with O
100 _RARE_
- O
500 O
microliters _RARE_
HClO4 _RARE_
. O

Nucleotide O
sequence O
and O
transcriptional O
analysis O
of O
the O
polyhedrin _RARE_
gene I-GENE
of O
Spodoptera _RARE_
exigua _RARE_
nuclear O
polyhedrosis _RARE_
virus O
. O

Validation _RARE_
of O
automated O
systems _RARE_
-- _RARE_
system _RARE_
definition O
. O

As O
a O
consequence O
of O
dark O
rearing _RARE_
, O
the O
numerical _RARE_
density O
of O
cortical O
neurons O
in O
area O
17 _RARE_
amounted _RARE_
to O
about O
double O
of O
the O
value O
observed O
in O
normally O
reared _RARE_
kittens _RARE_
and O
was O
also O
significantly O
higher _RARE_
in O
area O
18 O
. O

These O
results O
suggest O
that O
decreased O
class O
I O
enhancer O
activity O
in O
Ad12 _RARE_
- O
transformed O
cells O
may O
, O
at _RARE_
least O
in O
part O
, O
be O
due O
to O
the O
higher _RARE_
levels O
of O
an O
enhancer O
- O
specific O
factor O
, O
possibly O
acting O
as _RARE_
a O
repressor O
. O

A O
second O
domain O
, O
located _RARE_
in O
the O
C O
- O
terminal O
437 _RARE_
amino O
acids _RARE_
of O
IE1 I-GENE
, O
is O
required O
for _RARE_
inhibitory _RARE_
and O
DNA O
- O
binding O
activities O
. O

In O
order O
to O
investigate O
the O
blood _RARE_
compatibility O
of O
autogenous _RARE_
vein _RARE_
graft O
( O
AVG _RARE_
), _RARE_
changes O
in O
prostacyclin _RARE_
( O
PGI2 _RARE_
) O
production O
following O
harvesting _RARE_
and O
arterial O
implantation O
were O
studied O
experimentally O
. O

Subcutaneous _RARE_
administration O
of O
the O
somatostatin I-GENE
analogue O
, O
octreotide _RARE_
, O
100 _RARE_
micrograms O
thrice _RARE_
daily O
, O
resulted O
in O
a O
sustained O
improvement O
in O
diarrhoea _RARE_
and O
disappearance O
of O
faecal _RARE_
incontinence _RARE_
without O
reducing _RARE_
calcitonin I-GENE
levels O
. O

Anti _RARE_
- I-GENE
CRK _RARE_
antibodies I-GENE
detect O
a O
53kDa _RARE_
protein O
in O
extracts O
of O
C O
. O
fasciculata _RARE_
in O
agreement O
with O
the O
size O
predicted O
from O
the O
nucleotide O
sequence O
of O
the O
cloned _RARE_
gene O
. O

205 _RARE_
, O
285 O
- O
290 _RARE_
] O
and O
was O
subsequently O
cloned _RARE_
and O
sequenced O
[ _RARE_
J _RARE_
. O

Nonreplicating _RARE_
vaccinia _RARE_
vector O
efficiently O
expresses _RARE_
recombinant O
genes O
. O

Use O
of O
free O
- O
access O
minerals _RARE_
. O

Interferon I-GENE
type I-GENE
I I-GENE
in O
protective O
body O
reactions O
in O
an O
experimental O
Klebsiella _RARE_
infection O

No O
other O
changes O
in O
hematopoietic O
differentiation O
status O
were O
observed O
in O
association O
with O
Id _RARE_
- I-GENE
SCL _RARE_
expression _RARE_
. O

Respiratory _RARE_
interaction O
after O
spinal _RARE_
anesthesia O
and O
sedation O
with O
midazolam O
. O

For O
pressure O
greater O
than O
121 _RARE_
atm _RARE_
abs _RARE_
, O
an O
increased O
excitability _RARE_
of O
the O
tadpoles _RARE_
made O
it O
difficult O
to O
distinguish _RARE_
the O
righting _RARE_
reflex O
from O
involuntary _RARE_
movements O
. O

One O
air O
embolism _RARE_
occurred O
; O
this O
was O
the O
only O
filter O
- O
or O
retrieval _RARE_
- O
related O
complication O
. O

The O
5 O
' O
region O
of O
ADH5 _RARE_
contains O
consensus O
binding O
sites O
for _RARE_
the O
transcriptional O
regulatory O
proteins O
, O
Sp1 _RARE_
, O
AP2 I-GENE
, O
LF _RARE_
- I-GENE
A1 _RARE_
, O
NF _RARE_
- I-GENE
1 I-GENE
, O
NF _RARE_
- I-GENE
A2 _RARE_
, O
and O
NF _RARE_
- I-GENE
E1 I-GENE
. O

V O
. O

These O
data O
indicate O
that O
RNK _RARE_
- I-GENE
Met _RARE_
- I-GENE
1 I-GENE
is O
a O
serine I-GENE
protease I-GENE
with O
unique O
activity O
that O
is O
expressed _RARE_
in O
the O
granules O
of O
large O
granular _RARE_
lymphocytes O
. O

Purification _RARE_
and O
cloning O
of O
a O
novel O
serine I-GENE
protease I-GENE
, O
RNK _RARE_
- I-GENE
Met _RARE_
- I-GENE
1 I-GENE
, O
from O
the O
granules O
of O
a O
rat O
natural _RARE_
killer O
cell O
leukemia O
. O

We O
describe O
here O
17 _RARE_
dominant I-GENE
GCN2 I-GENE
mutations I-GENE
that O
lead O
to O
derepression O
of O
GCN4 I-GENE
expression _RARE_
in O
the O
absence O
of O
amino O
acid O
starvation O
. O

Administration O
of O
growth I-GENE
hormone I-GENE
leads O
to O
faster O
growth O
, O
but O
also O
faster O
bone O
maturation _RARE_
. O

Comparisons _RARE_
with O
the O
available O
amino O
acid O
residue _RARE_
( O
aa _RARE_
) O
sequence O
information _RARE_
from O
the O
complete _RARE_
CPMV _RARE_
RNA I-GENE
1 I-GENE
sequence I-GENE
and O
the O
partial O
sequence O
of O
red _RARE_
clover _RARE_
mottle _RARE_
virus I-GENE
RNA I-GENE
1 I-GENE
suggest O
that O
CPSMV _RARE_
RNA I-GENE
1 I-GENE
specifies O
the O
expected O
set O
of O
five O
mature _RARE_
proteins O
: O
32K _RARE_
proteinase _RARE_
cofactor I-GENE
, O
58K _RARE_
presumed _RARE_
helicase _RARE_
, O
VPg _RARE_
5 I-GENE
'- I-GENE
linked _RARE_
protein I-GENE
of O
the O
genomic O
RNAs O
, O
24K _RARE_
proteinase _RARE_
, O
and O
87K _RARE_
presumed _RARE_
polymerase I-GENE
, O
separated O
by O
four O
cleavage _RARE_
sites O
. O

Rice _RARE_
dwarf _RARE_
phytoreovirus _RARE_
segment I-GENE
S12 _RARE_
transcript I-GENE
is O
tricistronic _RARE_
in O
vitro O
. O

In O
addition O
, O
the O
utility _RARE_
of O
beta I-GENE
2 I-GENE
transferrin I-GENE
assay O
in O
the O
diagnosis O
of O
cerebrospinal _RARE_
fluid _RARE_
otorrhea _RARE_
is O
presented O
. O

Cold _RARE_
cardioplegia _RARE_
was O
administered O
at _RARE_
45 _RARE_
mm O
Hg O
every O
20 O
minutes O
for _RARE_
2 O
hours O
. O

The O
addition O
of O
diatrizoate _RARE_
to O
the O
IPRK _RARE_
led O
to O
a O
dose O
- O
dependent O
biphasic O
change O
in O
RPF _RARE_
and O
GFR O
characterized O
by O
an O
initial O
transient O
increase O
followed O
by O
a O
marked O
and O
sustained O
decrease O
. O

To O
prepare _RARE_
for _RARE_
analyses O
with O
the O
family O
variables O
, O
we O
next O
present O
descriptive _RARE_
data O
based O
on O
separate O
principal O
components _RARE_
analysis O
( O
PCA _RARE_
) O
and O
multidimensional _RARE_
scaling _RARE_
analysis O
( O
MDS _RARE_
) O
of O
14 O
self O
- O
reported O
health O
scores O
for _RARE_
husbands _RARE_
and O
for _RARE_
wives _RARE_
. O

The O
structural O
genes O
encoding O
glyceraldehyde _RARE_
- I-GENE
3 I-GENE
- I-GENE
phosphate I-GENE
dehydrogenase I-GENE
( O
GAPDH _RARE_
), _RARE_
3 I-GENE
- I-GENE
phosphoglycerate _RARE_
kinase I-GENE
( O
PGK _RARE_
) O
and O
the O
N O
- O
terminal O
part O
of O
triosephosphate _RARE_
isomerase I-GENE
( O
TIM _RARE_
) O
from O
mesophilic _RARE_
Bacillus O
megaterium _RARE_
DSM319 _RARE_
have O
been O
cloned _RARE_
as _RARE_
a O
gene O
cluster O
( O
gap _RARE_
operon I-GENE
) O
by O
complementation _RARE_
of O
an O
Escherichia O
coli O
gap _RARE_
amber _RARE_
mutant I-GENE
. O

Pseudomonas _RARE_
aeruginosa _RARE_
exotoxin _RARE_
A I-GENE
: O
its O
role O
in O
retardation O
of O
wound O
healing O
: O
the O
1992 O
Lindberg _RARE_
Award _RARE_
. O

Laboratory O
studies O
showed O
that O
the O
direct O
fluorescent _RARE_
- O
antibody O
kits _RARE_
were O
the O
least O
sensitive _RARE_
in O
this O
case O
and O
did O
not O
detect O
fewer O
than O
10 O
( O
4 O
) O
elementary _RARE_
bodies _RARE_
per O
ml O
, O
while O
most O
ELISA O
kits _RARE_
detected O
between O
130 _RARE_
and O
600 O
elementary _RARE_
bodies _RARE_
per O
ml O
. O

To O
study O
the O
significance O
of O
these O
domains O
and O
the O
overall O
evolutionary O
conservation O
of O
the O
gene O
, O
the O
homolog O
from O
Drosophila O
melanogaster O
was O
isolated O
by O
low O
stringency _RARE_
hybridizations _RARE_
using O
two O
flanking O
probes _RARE_
of O
the O
human I-GENE
ERCC3 _RARE_
cDNA I-GENE
. O

Mono _RARE_
- O
ADP _RARE_
- O
ribosylation _RARE_
is O
a O
reversible O
modification O
of O
proteins O
, O
with O
NAD _RARE_
: O
arginine _RARE_
ADP _RARE_
- I-GENE
ribosyltransferases _RARE_
( O
EC I-GENE
2 I-GENE
. I-GENE
4 I-GENE
. I-GENE
2 I-GENE
. I-GENE
31 _RARE_
) O
and O
ADP _RARE_
- I-GENE
ribosylarginine _RARE_
hydrolases _RARE_
( O
EC I-GENE
3 I-GENE
. I-GENE
2 I-GENE
. I-GENE
2 I-GENE
. I-GENE
19 I-GENE
) O
catalyzing _RARE_
the O
opposing _RARE_
reactions O
in O
an O
ADP _RARE_
- O
ribosylation _RARE_
cycle _RARE_
. O

For O
this O
reason _RARE_
, O
the O
particle _RARE_
forming O
capacity O
of O
derivatives _RARE_
of O
the O
HIV I-GENE
- I-GENE
1 I-GENE
group I-GENE
specific I-GENE
core I-GENE
antigen I-GENE
p55 I-GENE
gag I-GENE
was O
assayed O
and O
compared O
dependent O
on O
various O
expression _RARE_
systems _RARE_
: O
recombinant O
bacteria O
, O
vaccinia _RARE_
- O
and O
baculoviruses _RARE_
were O
established O
encoding O
the O
entire _RARE_
core I-GENE
protein I-GENE
p55 I-GENE
either O
in O
its O
authentic _RARE_
sequence O
or O
lacking _RARE_
the O
myristylation _RARE_
consensus O
signal O
. O

The O
tramtrack _RARE_
( O
ttk _RARE_
) O
gene O
of O
Drosophila O
encodes O
69 _RARE_
- O
kDa O
and O
88 O
- O
kDa O
proteins O
through O
alternative _RARE_
splicing _RARE_
of O
the O
primary _RARE_
ttk _RARE_
transcript I-GENE
. O

Removal O
of O
beta I-GENE
2 I-GENE
- I-GENE
microglobulin I-GENE
by O
hemodialysis O
and O
hemofiltration _RARE_
: O
a O
four O
year O
follow O
up _RARE_
. O

Removal O
of O
beta I-GENE
2 I-GENE
- I-GENE
microglobulin I-GENE
by O
hemodialysis O
and O
hemofiltration _RARE_
: O
a O
four O
year O
follow O
up _RARE_
. O

Adapromine _RARE_
was O
established O
to O
evoke _RARE_
a O
decrease O
of O
the O
amplitude O
of O
the O
dominant O
peak O
and O
dominant O
theta _RARE_
- O
activity O
in O
power O
spectra O
of O
the O
EEG O
in O
the O
cortex O
and O
hippocamp _RARE_
, O
with O
an O
increase O
of O
rapid O
wave O
activity O
in O
the O
beta O
2 O
range O
in O
the O
right O
cortex O
and O
hippocamp _RARE_
. O

These O
sequences O
were O
then O
used O
to O
clone O
the O
full O
- O
length O
genes O
from O
a O
yeast O
genomic O
library O
. O

GAL4 I-GENE
- O
VP16 I-GENE
- O
mediated _RARE_
antirepression _RARE_
required O
an O
auxiliary _RARE_
factor O
, O
denoted _RARE_
as _RARE_
a O
co _RARE_
- O
antirepressor _RARE_
, O
which O
was O
partially O
purified _RARE_
from O
Drosophila O
embryos _RARE_
. O

After O
28 _RARE_
days O
of O
haloperidol O
treatment O
, O
similar O
changes O
were O
observed O
for _RARE_
delta O
, O
together O
with O
an O
increase O
of O
alpha O
1 O
, O
and O
a O
decrease O
of O
fast O
beta O
. O

Four O
ruminally _RARE_
and O
duodenally _RARE_
cannulated _RARE_
Hampshire _RARE_
wethers _RARE_
were O
used O
in O
a O
4 O
x _RARE_
4 O
Latin _RARE_
square O
experiment O
to O
determine O
whether O
linoleoyl _RARE_
methionine O
and O
calcium _RARE_
linoleate _RARE_
would O
increase O
duodenal O
flow O
of O
unsaturated _RARE_
fatty O
acids _RARE_
( O
C18 O
: O
2 O
+ O
cis O
C18 O
: O
1 O
). O

Truncated _RARE_
ICSBP _RARE_
lacking _RARE_
the O
first _RARE_
33 _RARE_
amino O
- O
terminal O
amino O
acids _RARE_
fails O
to O
bind O
to O
the O
ICS _RARE_
, O
indicating O
that O
at _RARE_
least O
part O
of O
the O
DNA O
binding O
domain O
is O
located _RARE_
within O
the O
well _RARE_
conserved _RARE_
amino O
terminus O
. O

Therefore O
, O
ICSBP _RARE_
may O
be O
involved O
in O
maintaining O
submaximal _RARE_
transcriptional O
activity O
of O
IFN I-GENE
- O
inducible O
genes O
in O
hematopoietic O
cells O
. O

A O
case O
of O
chronic O
hepatitis O
C O
with O
primary _RARE_
hypothyroidism O
manifested O
during _RARE_
interferon _RARE_
treatment O

Dynamic _RARE_
decision _RARE_
making O
: O
human O
control O
of O
complex O
systems _RARE_
. O

A O
coiled _RARE_
- I-GENE
coil _RARE_
related I-GENE
protein I-GENE
specific O
for _RARE_
synapsed _RARE_
regions O
of O
meiotic _RARE_
prophase _RARE_
chromosomes O
. O

Comparable _RARE_
amounts O
of O
alpha I-GENE
5 I-GENE
beta I-GENE
1 I-GENE
integrin I-GENE
were O
isolated O
from O
these O
cells O
by O
chromatography O
of O
detergent O
extracts O
on O
a O
fibronectin I-GENE
cell O
- O
binding O
fragment O
affinity O
column O
and O
elution _RARE_
with O
EDTA O
. O

Abstracts _RARE_
. O

These O
results O
indicate O
a O
possible O
involvement O
of O
endogenous O
opioid _RARE_
peptides O
in O
the O
cardiac O
effects O
due O
to O
myocardial _RARE_
ischaemia O
and O
reperfusion O
, O
mediated _RARE_
by O
opiate _RARE_
receptors I-GENE
through O
opiate _RARE_
antagonism _RARE_
. O

From O
this O
library O
, O
LEU2 I-GENE
and O
HIS3 I-GENE
cDNAs O
were O
recovered O
at _RARE_
a O
frequency O
of O
about O
1 O
in O
10 O
( O
4 O
) O
and O
in O
12 O
out O
of O
13 _RARE_
cases O
these O
were O
expressed _RARE_
in O
a O
galactose _RARE_
- O
dependent O
manner O
. O

Among O
these O
, O
ACT1 _RARE_
was O
isolated O
four O
times O
, O
and O
NSR1 _RARE_
three O
times O
. O

Since O
CENP _RARE_
- I-GENE
B I-GENE
gene I-GENE
is O
conserved _RARE_
in O
mammalian O
species O
and O
CENP _RARE_
- I-GENE
B I-GENE
boxes _RARE_
are O
found O
also O
in O
mouse O
centromere O
satellite _RARE_
DNA O
( O
minor O
satellite _RARE_
), _RARE_
this O
sequence O
- O
specific O
DNA O
- O
protein O
interaction O
may O
be O
important O
for _RARE_
some O
kind _RARE_
of O
common O
centromere O
function O
. O

Interestingly O
, O
a O
portion O
of O
the O
tail _RARE_
domain O
( O
aa _RARE_
, O
1 O
, O
094 _RARE_
- O
1 O
, O
830 _RARE_
) O
shares O
58 O
% O
amino O
acid O
sequence O
identity O
with O
a O
723 _RARE_
- O
aa _RARE_
protein O
from O
mouse O
brain O
reported O
to O
be O
a O
glutamic _RARE_
acid I-GENE
decarboxylase I-GENE
. O

However O
, O
in O
the O
subgroup O
with O
normal O
Ht _RARE_
(< O
0 _RARE_
. O
45 _RARE_
l _RARE_
/ O
l _RARE_
; O
n _RARE_
= O
201 _RARE_
) O
there O
was O
a O
significant O
reduction O
( O
p O
< O
0 _RARE_
. O
05 O
) O
of O
the O
mortality O
after O
3 O
months O
( O
27 _RARE_
% O
and O
16 O
%, O
respectively O
) O
and O
an O
increase O
of O
independence _RARE_
at _RARE_
home O
( O
35 _RARE_
% O
and O
48 _RARE_
%, O
respectively O
) O
due O
to O
a O
reduction O
of O
the O
viscosity O
by O
means O
of O
haemodilution _RARE_
with O
albumin I-GENE
( O
a O
specific O
viscosity O
effect O
in O
the O
normovolaemic _RARE_
group O
). O

Distribution _RARE_
and O
changing O
morphological O
course O

The O
appropriate O
use O
and O
benefits O
of O
bile O
acid O
sequestrants _RARE_
, O
nicotinic _RARE_
acid O
, O
fibric _RARE_
acids _RARE_
, O
3 I-GENE
- I-GENE
hydroxy I-GENE
- I-GENE
3 I-GENE
- I-GENE
methylglutaryl _RARE_
coenzyme _RARE_
A I-GENE
( I-GENE
HMG I-GENE
- I-GENE
CoA I-GENE
) I-GENE
reductase I-GENE
inhibitors _RARE_
, O
and O
probucol _RARE_
are O
individually O
discussed O
, O
whereas O
nonpharmacologic _RARE_
approaches O
used O
in O
conjunction O
with O
the O
drugs O
are O
recommended O
emphatically _RARE_
. O

This O
may O
result O
in O
more O
reabsorption _RARE_
and O
hence O
reduced _RARE_
renal _RARE_
clearance O
. O

The O
major O
pathological O
findings O
of O
the O
placenta O
were O
prematuration _RARE_
and O
hypoplasia _RARE_
. O

Green _RARE_
pepper _RARE_
significantly O
inhibited O
N O
- O
nitrosothiazolidine _RARE_
- O
carboxylic _RARE_
acid O
formation O
relative O
to O
ascorbic _RARE_
acid O
alone O
. O

A O
genomic O
clone O
, O
pTt21 _RARE_
, O
containing O
DNA O
apparently O
transcribed _RARE_
specifically O
in O
Trypanosoma O
cruzi _RARE_
trypomastigotes _RARE_
, O
was O
obtained O
by O
differentially O
screening O
a O
genomic O
library O
with O
trypomastigote _RARE_
and O
epimastigote _RARE_
cDNA O
. O

Brucellosis _RARE_
-- _RARE_
1990 O

Assay _RARE_
of O
urea O
by O
immobilized _RARE_
urease I-GENE
coupled O
to O
a O
differential O
pH O
- O
meter _RARE_
. O

RESULTS O
: O
In O
the O
AGA _RARE_
group O
, O
both O
fetal _RARE_
and O
maternal _RARE_
serum O
prolactin I-GENE
concentration O
increased O
significantly O
with O
gestation O
( O
P O
< O
0 _RARE_
. O
001 O
and O
P O
< O
0 _RARE_
. O
01 O
, O
respectively O
). O

One O
phage _RARE_
clone O
contains O
a O
junction _RARE_
between O
alpha O
satellite _RARE_
DNA O
and O
a O
novel O
low O
- O
copy O
repeated _RARE_
sequence O
. O

The O
5 O
'- O
flanking O
region O
of O
the O
human I-GENE
lactoferrin _RARE_
gene I-GENE
was O
isolated O
from O
a O
human O
placental _RARE_
genomic O
library O
. O

Therefore O
, O
the O
molecular _RARE_
mechanisms O
of O
the O
estrogen O
action O
that O
govern O
the O
lactoferrin _RARE_
gene I-GENE
expression _RARE_
differ O
between O
mouse O
and O
human O
. O

BiP670 _RARE_
retains O
basal O
and O
Ca2 _RARE_
+ O
ionophore _RARE_
A23187 _RARE_
- O
inducible O
activities O
. O

The O
CEM _RARE_
receives _RARE_
registration _RARE_
updates _RARE_
via O
an O
HL7 _RARE_
message _RARE_
and O
evaluates _RARE_
data O
dependencies _RARE_
in O
rules _RARE_
via O
an O
interface O
to O
the O
relational _RARE_
database O
. O

Magnetic O
resonance O
spectroscopy O
( O
MRS O
) O
and O
imaging O
( O
MRI O
) O
are O
now O
well _RARE_
established O
techniques O
for _RARE_
the O
study O
of O
cellular O
metabolism O
and O
gross O
structure _RARE_
of O
muscle O
. O

Simultaneously _RARE_
a O
greater O
NA O
was O
found O
with O
no _RARE_
change O
in O
plasma O
epinephrine O
response O
. O

We O
investigated O
the O
diagnostic O
value O
of O
a O
new O
in O
vitro O
test O
, O
Pharmacia O
CAP _RARE_
System _RARE_
( O
Pharmacia O
Diagnostics _RARE_
AB _RARE_
, O
Uppsala _RARE_
, O
Sweden _RARE_
), _RARE_
for _RARE_
the O
quantitative O
measurement O
of O
allergen _RARE_
- I-GENE
specific I-GENE
IgE I-GENE
antibodies I-GENE
by O
comparison O
with O
RAST O
in O
2 O
groups O
of O
patients O
, O
71 _RARE_
atopic O
and O
48 _RARE_
non O
- O
atopic O
. O

Patients O
receiving O
VPA _RARE_
showed O
differences O
in O
attention O
, O
visuomotor _RARE_
performance O
, O
verbal _RARE_
span O
and O
sensory O
discrimination O
tasks O
at _RARE_
T1 _RARE_
, O
in O
visuomotor _RARE_
performance O
at _RARE_
T2 _RARE_
and O
in O
spatial O
span O
at _RARE_
T3 _RARE_
, O
whereas O
no _RARE_
differences O
were O
detected O
at _RARE_
T4 O
. O

We O
found O
that O
the O
gene O
segment O
containing O
the O
mu O
m O
poly _RARE_
( O
A O
) O
signals O
, O
along O
with O
536 _RARE_
bp O
of O
downstream _RARE_
flanking O
sequence O
, O
acted _RARE_
as _RARE_
a O
transcription O
terminator O
in O
both O
myeloma O
cells O
and O
L O
cell O
fibroblasts _RARE_
. O

As O
a O
part O
of O
a O
large O
examination O
, O
total _RARE_
and O
free O
serum O
cholesterol O
, O
total _RARE_
lipid _RARE_
and O
triglyceride _RARE_
levels O
were O
determined O
. O

Alena _RARE_
is O
a O
nurse O
in O
Prague _RARE_
-- _RARE_
she _RARE_
dreams _RARE_
of O
higher _RARE_
wages _RARE_
and O
a O
trip _RARE_
across O
the O
ocean _RARE_

Dopamine _RARE_
neurons O
in O
subjects O
that O
received O
6 O
- O
OHDA _RARE_
were O
protected O
by O
pre O
- O
treatment O
with O
GBR _RARE_
- O
12909 _RARE_
. O

DIBA _RARE_
was O
more O
sensitive _RARE_
and O
had O
a O
better O
negative O
predictive O
value O
and O
a O
lower O
false O
negative O
percentage O
than O
DFAT _RARE_
. O

Caries _RARE_
and O
parodontitis _RARE_
have O
been O
one O
of O
the O
most O
spread O
diseases O
of O
mankind _RARE_
. O

The O
results O
of O
this O
study O
demonstrate O
that O
strongyloidiasis _RARE_
was O
the O
cause O
of O
sudden _RARE_
death _RARE_
. O

A O
second O
large O
group O
of O
disorders O
in O
pregnancy _RARE_
is O
caused O
by O
effects O
of O
infections O
of O
the O
mother _RARE_
without O
pathogens O
being O
transmitted O
to O
the O
embryo _RARE_
or O
the O
placenta O
. O

Four O
short O
nucleotide O
sequences O
( O
boxes _RARE_
I O
to O
IV O
) O
contribute O
to O
the O
light O
responsiveness O
of O
the O
parsley _RARE_
chalcone _RARE_
synthase I-GENE
promoter I-GENE
. O

The O
case O
described O
is O
that O
of O
a O
72 O
- O
year O
- O
old O
man O
with O
ochronosis _RARE_
who O
suffered _RARE_
a O
hyperextension _RARE_
injury O
to O
his _RARE_
spine O
in O
a O
fall O
, O
resulting O
in O
a O
fracture O
through O
an O
ankylosed _RARE_
L2 O
- O
L3 _RARE_
disk _RARE_
space O
. O

The O
mean O
blood _RARE_
flow O
in O
the O
penile _RARE_
foreskin _RARE_
was O
estimated O
to O
be O
15 _RARE_
ml O
/ O
min O
/ O
100 _RARE_
g O
and O
it O
increased O
to O
150 _RARE_
- O
200 _RARE_
% O
after O
the O
induction O
of O
anesthesia O
, O
and O
then O
decreased O
to O
72 O
% O
at _RARE_
the O
tip _RARE_
of O
the O
created O
parameatal _RARE_
foreskin _RARE_
flap O
. O

ME1a1 _RARE_
, O
a O
16 O
- O
base _RARE_
- O
pair _RARE_
nuclear O
factor O
binding O
site O
residing _RARE_
between O
the O
c I-GENE
- I-GENE
MYC _RARE_
P1 I-GENE
and I-GENE
P2 I-GENE
transcription I-GENE
initiation I-GENE
sites I-GENE
, O
is O
required O
for _RARE_
P2 O
activity O
. O

The O
next O
twenty _RARE_
years O
of O
prevention O
in O
Indian _RARE_
country _RARE_
: O
visionary _RARE_
, O
complex O
, O
and O
practical _RARE_
. O

Exogenous _RARE_
LHRH _RARE_
is O
also O
known O
to O
facilitate O
mating _RARE_
behavior O
in O
several O
species O
. O

The O
first _RARE_
146 _RARE_
consecutive O
patients O
treated O
with O
EVL _RARE_
during _RARE_
the O
period O
from O
August O
, O
1986 O
to O
July _RARE_
, O
1989 O
are O
reported O
. O

Replacing _RARE_
the O
aspartic _RARE_
acid O
with O
a O
lysine _RARE_
but O
not O
with O
an O
alanine O
or O
valine _RARE_
residue _RARE_
allowed O
formation O
of O
disulfide O
- O
linked _RARE_
dimers _RARE_
. O

During O
V O
- O
A O
bypass O
, O
hemodynamics O
were O
stable O
. O

Greater _RARE_
rupture _RARE_
force O
was O
required O
in O
the O
adult O
pigs O
than O
in O
the O
young O
pigs O
. O

At O
rest O
AFF _RARE_
was O
significantly O
higher _RARE_
in O
UT O
( O
29 O
%) O
as _RARE_
compared O
to O
AT O
( O
25 _RARE_
%) O
and O
UEA _RARE_
( O
25 _RARE_
%). O

We O
investigated O
the O
smoking O
habits _RARE_
of O
relapsers _RARE_
1 O
year O
after O
quitting _RARE_
in O
a O
smoking O
cessation O
trial O
using O
nicotine O
or O
placebo O
patches _RARE_
. O

Exposure _RARE_
to O
hepatitis O
B O
virus O
in O
the O
general _RARE_
population O
of O
Hisayama _RARE_
, O
Japan O
: O
significance O
of O
isolated O
antibody O
to O
hepatitis I-GENE
B I-GENE
surface I-GENE
antigen I-GENE
in O
general _RARE_
population O
. O

Because O
of O
this O
latter O
phenomenon O
, O
we O
were O
able O
to O
identify O
a O
particular O
cysteine O
motif O
that O
was O
repeated _RARE_
multiple O
times O
in O
Dfurin2 _RARE_
but O
present O
only O
twice O
in O
mammalian I-GENE
furin _RARE_
. O

On O
the O
other O
hand _RARE_
, O
neither O
phosphate O
buffered _RARE_
saline O
injection O
into O
the O
ES O
nor O
primary _RARE_
KLH _RARE_
challenges _RARE_
of O
the O
ES O
were O
capable O
of O
elevating _RARE_
the O
threshold O
level O
and O
changing O
the O
latency _RARE_
. O

A O
newly O
developed O
broad O
- O
spectrum O
fluoroquinolone _RARE_
, O
levofloxacin _RARE_
( O
LVFX _RARE_
, O
DR _RARE_
- O
3355 _RARE_
), _RARE_
was O
evaluated O
in O
vitro O
and O
in O
vivo O
in O
comparison O
with O
ciprofloxacin _RARE_
( O
CPFX _RARE_
), _RARE_
ofloxacin _RARE_
( O
OFLX _RARE_
) O
and O
norfloxacin _RARE_
( O
NFLX _RARE_
). O

The O
mean O
serum O
creatinine _RARE_
levels O
were O
similar O
at _RARE_
one O
year O
( O
SPK _RARE_
1 O
. O
8 O
, O
KTA _RARE_
1 O
. O
9 O
mg O
/ O
d O
).( _RARE_
ABSTRACT O
TRUNCATED O
AT O
250 _RARE_
WORDS O
) O

Model _RARE_
predictions O
were O
in O
accord _RARE_
with O
the O
nine O
- O
year O
survival O
experience O
of O
women O
in O
the O
HIP _RARE_
trial O
, O
and O
, O
with O
the O
exception O
of O
women O
40 O
- O
44 _RARE_
years O
old O
, O
with O
HIP _RARE_
data O
on O
18 O
- O
year O
survival O
. O

High _RARE_
- O
resolution O
computed O
tomography O
in O
the O
diagnosis O
of O
miliary _RARE_
tuberculosis O
. O

Previously O
, O
we O
showed O
that O
SNF2 _RARE_
, O
SNF5 _RARE_
, O
and O
SNF6 _RARE_
function O
interdependently _RARE_
in O
transcriptional O
activation O
, O
possibly O
forming O
a O
heteromeric _RARE_
complex O
. O

We O
show O
that O
LexA I-GENE
- O
GAL4 I-GENE
and O
LexA I-GENE
- O
Bicoid _RARE_
fusion O
proteins O
are O
both O
dependent O
on O
SNF2 _RARE_
, O
SNF5 _RARE_
, O
and O
SNF6 _RARE_
for _RARE_
activation O
of O
target O
genes O
containing O
one O
or O
multiple O
lexA _RARE_
operators _RARE_
. O

George _RARE_
T O
. O

A O
lambda O
gt10 _RARE_
cDNA O
library O
was O
constructed O
from O
poly _RARE_
( O
A O
)+ O
RNA O
of O
young O
green _RARE_
leaves O
of O
spinach _RARE_
. O

NE _RARE_
and O
PR3 _RARE_
assist _RARE_
in O
the O
destruction _RARE_
of O
phagocytosed _RARE_
microorganisms _RARE_
, O
cleave _RARE_
the O
important O
connective _RARE_
- I-GENE
tissue I-GENE
protein I-GENE
elastin I-GENE
, O
and O
generate O
chemotactic O
activities O
by O
forming O
alpha I-GENE
1 I-GENE
- I-GENE
proteinase _RARE_
inhibitor I-GENE
complexes I-GENE
and O
elastin I-GENE
peptides I-GENE
. O

Selected _RARE_
topics _RARE_
in O
pediatric O
ultrasonography O
-- _RARE_
1992 O
. O

Methods _RARE_
included O
24 _RARE_
- O
hour O
dietary O
recall _RARE_
, O
menu _RARE_
weights O
, O
and O
recipe _RARE_
analysis O
. O

Factors O
associated O
with O
afterdrop _RARE_
included O
age O
, O
end O
- O
of O
- O
surgery O
temperature _RARE_
( O
both O
positively O
) O
and O
body O
mass O
( O
negatively O
). O

Both O
GH _RARE_
deficiency O
and O
impaired O
spinal _RARE_
growth O
may O
result O
in O
short O
stature _RARE_
, O
whereas O
the O
occurrence O
of O
early O
puberty _RARE_
in O
association O
with O
GH _RARE_
deficiency O
reduces O
the O
time O
available O
for _RARE_
GH _RARE_
therapy O
. O

By O
contrast O
, O
d I-GENE
( I-GENE
T2AG3T _RARE_
) I-GENE
and O
d I-GENE
( I-GENE
T2G4T _RARE_
) I-GENE
form O
only O
the O
G O
- O
quadruplex _RARE_
monomer _RARE_
structures _RARE_
independent O
of O
K O
cation _RARE_
concentration O
as _RARE_
reported O
previously O
[ _RARE_
Sen _RARE_
, O
D O
., O
& O
Gilbert _RARE_
, O
W _RARE_
. O

Differentiating _RARE_
among O
renal _RARE_
stones _RARE_
. O

IFI _RARE_
16 I-GENE
mRNA I-GENE
was O
found O
to O
be O
constitutively O
expressed _RARE_
in O
lymphoid _RARE_
cells O
and O
in O
cell O
lines O
of O
both O
the O
T O
and O
B O
lineages O
. O

Mitochondria _RARE_
- O
lytic O
action O
of O
warfarin _RARE_
in O
lymphocytes O
. O

Exon _RARE_
- O
intron O
junctions O
in O
the O
human O
and O
rat I-GENE
AdoMet _RARE_
decarboxylase I-GENE
genes I-GENE
were O
in O
identical O
positions O
except O
that O
exons O
6 O
and O
7 O
of O
the O
human O
gene O
formed O
a O
single O
exon _RARE_
in O
the O
rat O
gene O
. O

Interferon I-GENE
- I-GENE
alpha I-GENE
- O
induced _RARE_
gene O
expression _RARE_
: O
evidence O
for _RARE_
a O
selective O
effect O
of O
ouabain _RARE_
on O
activation O
of O
the O
ISGF3 _RARE_
transcription I-GENE
complex I-GENE
. O

The O
cDNA O
has O
an O
open _RARE_
reading O
frame O
of O
900 _RARE_
amino O
acids _RARE_
capable O
of O
encoding O
a O
97 O
- O
kDa O
protein O
. O

Moreover O
, O
LD50 O
in O
mice O
of O
RP _RARE_
- O
170 _RARE_
( O
4 O
. O
3 O
g O
/ O
kg O
on O
i O
. O
v O
.) O
was O
increased O
to O
5 O
. O
2 O
g O
/ O
kg O
by O
oral O
administration O
. O

Among O
the O
few O
proteins O
of O
the O
eukaryotic O
nucleolus _RARE_
that O
have O
been O
characterized O
, O
four O
proteins O
, O
nucleolin _RARE_
, O
fibrillarin _RARE_
, O
SSB1 _RARE_
and O
NSR1 _RARE_
, O
possess O
a O
common O
structural O
motif O
, O
the O
GAR _RARE_
domain O
, O
which O
is O
rich O
in O
glycine O
and O
arginine _RARE_
residues O
. O

Thus O
, O
this O
study O
provides O
evidence O
that O
a O
novel O
, O
ubiquitous O
factor O
( O
HF _RARE_
- I-GENE
1a _RARE_
) O
and O
a O
muscle O
factor O
( O
HF _RARE_
- I-GENE
1b _RARE_
/ O
MEF I-GENE
- I-GENE
2 I-GENE
) O
can O
form O
a O
novel O
, O
E O
- O
box O
- O
independent O
pathway _RARE_
for _RARE_
muscle O
- O
specific O
expression _RARE_
in O
ventricular O
cardiac O
muscle O
cells O
. O

Mutations O
in O
either O
gene O
block _RARE_
some O
crucial O
late _RARE_
step O
in O
assembly O
of O
F1 _RARE_
, O
causing O
the O
alpha O
and O
beta O
subunits O
to O
accumulate O
in O
mitochondria _RARE_
as _RARE_
inactive O
aggregates O
( O
Ackerman _RARE_
, O
S O
. O

Expense _RARE_
limits O
the O
use O
of O
hepatitis O
B O
vaccines O
, O
but O
low O
- O
dose O
intradermal _RARE_
immunization O
has O
been O
evaluated O
as _RARE_
a O
cost O
- O
saving _RARE_
strategy O
in O
numerous O
studies O
. O

Estrogen _RARE_
replacement _RARE_
therapy O
and O
risk O
of O
breast O
cancer _RARE_
: O
results O
of O
two O
meta _RARE_
- O
analyses O
. O

Switching _RARE_
FDC _RARE_
- O
P1 O
/ O
MAC _RARE_
cells O
from O
growth O
in O
M I-GENE
- I-GENE
CSF I-GENE
to O
GM _RARE_
- I-GENE
CSF I-GENE
caused O
the O
selective O
degradation _RARE_
of O
c I-GENE
- I-GENE
fms I-GENE
mRNA I-GENE
within O
6 O
h O
after O
factor O
switching O
. O

There O
was O
however O
, O
no _RARE_
significant O
difference O
in O
the O
prevalence O
of O
chronic O
respiratory O
symptoms O
between O
animal _RARE_
food O
workers O
with O
positive O
and O
negative O
skin _RARE_
tests O
to O
house _RARE_
dust O
or O
to O
fish O
flour _RARE_
or O
among O
those O
with O
increased O
or O
normal O
IgE I-GENE
( O
except O
for _RARE_
dyspnea _RARE_
). O

An O
unexpected _RARE_
finding O
was O
the O
presence O
at _RARE_
position O
- O
403 _RARE_
to O
- O
385 _RARE_
of O
a O
putative O
dioxin _RARE_
responsive O
element O
, O
a O
sequence O
found O
to O
be O
responsible O
for _RARE_
the O
induction O
of O
transcription O
of O
the O
cytochrome I-GENE
P450IA1 _RARE_
gene I-GENE
( O
CYPIA1 _RARE_
) O
and O
other O
genes O
involved O
in O
detoxification _RARE_
/ O
activation O
of O
polycyclic _RARE_
aromatic O
hydrocarbons _RARE_
. O

The O
gene O
encoding O
TRP _RARE_
- I-GENE
2 I-GENE
maps O
to O
mouse O
chromosome _RARE_
14 O
, O
in O
the O
region O
of O
the O
coat I-GENE
colour _RARE_
mutation I-GENE
slaty _RARE_
. O

Using O
bovine I-GENE
and I-GENE
murine I-GENE
c I-GENE
- I-GENE
myb I-GENE
clones _RARE_
, O
no _RARE_
change O
in O
the O
rate O
of O
c I-GENE
- I-GENE
myb I-GENE
gene I-GENE
transcription O
or O
mRNA O
stability O
was O
detected O
during _RARE_
the O
cell O
cycle _RARE_
. O

A O
13 _RARE_
base _RARE_
- O
pair _RARE_
oligonucleotide _RARE_
spanning O
nucleotides O
+ O
80 _RARE_
to O
+ O
92 O
of O
the O
5 I-GENE
S I-GENE
RNA I-GENE
gene I-GENE
retained O
specific O
and O
high O
- O
affinity O
binding O
, O
although O
the O
latter O
was O
reduced _RARE_
sixfold _RARE_
relative O
to O
longer O
DNA O
fragments O
. O

Moreover O
, O
the O
reconstitution _RARE_
of O
eUSF _RARE_
and O
TFIID I-GENE
- O
depleted O
transcription O
complexes O
with O
purified _RARE_
protein O
fractions O
demonstrate O
that O
not O
only O
TFIID I-GENE
but O
also O
eUSF _RARE_
essentially O
participates O
in O
complex O
formation O
even O
on O
H5 _RARE_
promoter I-GENE
mutations O
lacking _RARE_
the O
TATA O
- O
box O
. O

A O
comparison O
of O
the O
amino O
acid O
sequence O
of O
the O
T O
. O
thermophilus _RARE_
enzyme O
with O
that O
of O
the O
Escherichia O
coli O
enzyme O
showed O
( O
i O
) O
a O
37 O
% O
overall O
similarity _RARE_
; O
( O
ii O
) O
the O
conservation O
of O
the O
Ser _RARE_
residue _RARE_
, O
which O
is O
known O
to O
be O
phosphorylated _RARE_
in O
the O
E O
. O
coli O
enzyme O
, O
and O
of O
the O
surrounding O
sequence O
; O
and O
( O
iii O
) O
the O
presence O
of O
141 _RARE_
extra _RARE_
residues O
at _RARE_
the O
C O
terminus O
of O
the O
T O
. O
thermophilus _RARE_
enzyme O
. O

Radiolabelled _RARE_
palmitate _RARE_
was O
not O
incorporated O
into O
the O
mutated _RARE_
protein O
, O
showing O
that O
lipid _RARE_
modification O
occurs O
at _RARE_
the O
Cys _RARE_
- O
22 _RARE_
residue _RARE_
. O

17 _RARE_
volunteer _RARE_
deaf _RARE_
Ss _RARE_
were O
compared O
with O
18 O
volunteer _RARE_
hearing O
Ss _RARE_
on O
the O
Stanford _RARE_
Hypnotic _RARE_
Clinical O
Scale O
( O
SHCS _RARE_
) O
of O
Morgan _RARE_
and O
J _RARE_
. O

Mature _RARE_
tobacco I-GENE
L12 _RARE_
protein I-GENE
has O
44 _RARE_
% O
amino O
acid O
identity O
with O
ribosomal O
protein O
L7 _RARE_
/ O
L12 _RARE_
of O
Escherichia O
coli O
. O

Nuclear I-GENE
- I-GENE
encoded I-GENE
chloroplast I-GENE
ribosomal I-GENE
protein I-GENE
L12 _RARE_
of I-GENE
Nicotiana _RARE_
tabacum _RARE_
: O
characterization O
of O
mature _RARE_
protein O
and O
isolation O
and O
sequence O
analysis O
of O
cDNA O
clones _RARE_
encoding O
its O
cytoplasmic O
precursor O
. O

The O
gene O
encoding O
IFN I-GENE
- I-GENE
gamma I-GENE
was O
previously O
found O
to O
contain O
an O
intronic _RARE_
enhancer O
element O
that O
was O
not O
tissue O
- O
specific O
in O
its O
activity O
, O
despite O
the O
restricted O
expression _RARE_
of O
the O
intact _RARE_
IFN I-GENE
- I-GENE
gamma I-GENE
- I-GENE
encoding I-GENE
gene I-GENE
. O

Molecular O
cloning O
of O
the O
polypeptide O
component _RARE_
of O
the O
Rel I-GENE
- I-GENE
related I-GENE
human I-GENE
p75 _RARE_
nucleoprotein _RARE_
complex I-GENE
has O
revealed O
its O
identity O
with O
the O
65 O
- O
kDa O
( O
p65 _RARE_
) O
subunit O
of O
NF _RARE_
- I-GENE
kappa _RARE_
B I-GENE
. O

Because O
single O
- O
chamber O
rate O
- O
adaptive O
atrial _RARE_
pacing O
leaves O
the O
patient O
exposed O
to O
the O
risk O
of O
future O
development O
of O
AV O
block _RARE_
and O
DDD _RARE_
pacing O
does O
not O
provide O
chronotropic _RARE_
support O
, O
it O
is O
likely O
that O
the O
new O
rate O
- O
adaptive O
dual O
- O
chamber O
( O
DDDR _RARE_
) O
devices _RARE_
will O
be O
used O
in O
a O
significant O
number O
of O
these O
patients O
.( O
ABSTRACT O
TRUNCATED O
AT O
250 _RARE_
WORDS O
) O

When O
transiently O
transfected O
into O
K562 O
cells O
, O
this O
Lg _RARE_
genomic O
clone O
is O
actively O
transcribed _RARE_
, O
suggesting O
that O
, O
although O
it O
possesses O
the O
characteristics O
of O
a O
processed O
pseudogene _RARE_
, O
it O
is O
likely O
to O
correspond O
to O
the O
gene O
encoding O
this O
new O
ferritin I-GENE
subunit I-GENE
. O

Of O
the O
drugs O
orally O
administered O
, O
WR O
- O
168643 _RARE_
was O
the O
best O
protector _RARE_
with O
a O
DMF _RARE_
of O
1 O
. O
51 _RARE_
. O

Characterization O
of O
these O
R O
subunits O
by O
their O
8 O
- O
azido _RARE_
- O
cAMP O
photoaffinity _RARE_
labeling O
and O
immunoreactivity O
, O
as _RARE_
well _RARE_
as _RARE_
by O
a O
phosphorylation _RARE_
- O
dependent O
mobility O
shift O
on O
sodium _RARE_
dodecyl O
sulfate _RARE_
- O
polyacrylamide O
gel O
electrophoresis O
( O
SDS O
- O
PAGE O
), _RARE_
indicated O
subunit O
sizes O
of O
RII I-GENE
beta I-GENE
( O
53 O
kDa O
) O
greater O
than O
RII I-GENE
alpha I-GENE
dephosphoform _RARE_
( O
51 _RARE_
kDa O
) O
greater O
than O
RI _RARE_
alpha I-GENE
( O
49 _RARE_
kDa O
). O

Comparison O
of O
the O
genomic O
DNA O
sequence O
with O
that O
of O
the O
four O
different O
mRNAs O
indicates O
that O
these O
transcripts O
are O
produced O
by O
alternative _RARE_
splicing _RARE_
of O
the O
murine O
pre O
- O
mRNA O
according O
to O
a O
cassette _RARE_
model O
. O

During O
the O
1980 O
' O
s O
, O
quantifications _RARE_
of O
immunoserological _RARE_
testings _RARE_
, O
especially O
C I-GENE
reactive I-GENE
protein I-GENE
, O
rheumatoid I-GENE
factor I-GENE
and O
antistreptolysin _RARE_
O I-GENE
, O
progressed O
rapidly O
. O

Within O
the O
human O
enhancer O
, O
these O
two O
sites O
are O
located _RARE_
within O
the O
previously O
defined O
DNase I-GENE
I I-GENE
footprints _RARE_
, O
NFAT I-GENE
- I-GENE
1 I-GENE
and O
NFIL _RARE_
- I-GENE
2B _RARE_
, O
respectively O
. O

The O
cardiac I-GENE
myosin I-GENE
light I-GENE
chain I-GENE
- I-GENE
2 I-GENE
( O
MLC _RARE_
- I-GENE
2 I-GENE
) O
gene O
promoter O
contains O
several O
positive O
and O
negative O
cis O
- O
acting O
sequences O
that O
are O
involved O
in O
the O
regulation _RARE_
of O
its O
expression _RARE_
. O

Deletion O
mutagenesis O
demonstrated O
that O
these O
two O
elements O
are O
involved O
in O
the O
positive O
regulation _RARE_
of O
MLC _RARE_
- I-GENE
2 I-GENE
gene I-GENE
transcription O
. O

Disruption O
mutations O
have O
been O
constructed O
in O
the O
SLK1 _RARE_
gene I-GENE
. O
slk1 _RARE_
null _RARE_
mutants I-GENE
cannot O
grow O
at _RARE_
37 O
degrees O
C O
, O
but O
many O
cells O
can O
grow O
at _RARE_
30 _RARE_
, O
24 _RARE_
, O
and O
17 _RARE_
degrees O
C O
. O

Molecular O
and O
genetic O
analysis O
of O
the O
yeast I-GENE
early I-GENE
meiotic _RARE_
recombination _RARE_
genes I-GENE
REC102 _RARE_
and O
REC107 _RARE_
/ O
MER2 _RARE_
. O

The O
p130 I-GENE
and O
p62 I-GENE
tyrosine O
- O
phosphorylated _RARE_
proteins O
that O
complexed O
v I-GENE
- I-GENE
Src I-GENE
SH2 _RARE_
in O
vitro O
also O
associated O
with O
v I-GENE
- I-GENE
Src I-GENE
in O
v I-GENE
- I-GENE
src I-GENE
- O
transformed O
Rat _RARE_
- O
2 O
cells O
; O
this O
in O
vivo O
binding O
was O
dependent O
on O
the O
v I-GENE
- I-GENE
Src I-GENE
SH2 _RARE_
domain O
. O

Probable _RARE_
progressive O
multifocal _RARE_
leukoencephalopathy _RARE_
( O
PML _RARE_
) O
was O
diagnosed O
on O
the O
basis O
of O
clinical O
picture O
and O
magnetic O
resonance O
imaging O
in O
a O
63 _RARE_
- O
year O
- O
old O
man O
with O
a O
complete _RARE_
remission O
of O
a O
non O
- O
Hodgkin O
' O
s O
lymphoma O
. O

These O
data O
support O
a O
possible O
biological O
significance O
of O
the O
frameshift O
to O
occur O
at _RARE_
this O
position O
of O
the O
large O
overlap O
by O
including O
the O
putative O
RNA O
template O
- O
binding O
site O
of O
the O
PLRV _RARE_
replicase _RARE_
in O
the O
ORF2a _RARE_
/ I-GENE
ORF2b _RARE_
transframe _RARE_
protein I-GENE
. O

Proprotein _RARE_
processing _RARE_
occurs O
intracellularly _RARE_
. O

A O
32P O
- O
labeled O
LAP _RARE_
DNA O
- O
binding O
and O
dimerization _RARE_
domain O
" O
zipper O
probe O
" O
was O
used O
to O
isolate O
a O
clone O
that O
encodes O
a O
new O
C I-GENE
/ I-GENE
EBP I-GENE
- I-GENE
homologous I-GENE
protein I-GENE
: O
CHOP _RARE_
- I-GENE
10 I-GENE
. O

Using O
a O
degenerate O
oligodeoxyribonucleotide _RARE_
( O
oligo _RARE_
) O
based O
on O
the O
N O
- O
terminal O
aa _RARE_
sequence O
, O
plus _RARE_
an O
internal O
oligo _RARE_
homologous O
to O
a O
conserved _RARE_
region O
within O
the O
portion O
of O
CYP1 _RARE_
and O
CYP2 _RARE_
that O
had O
been O
deleted _RARE_
in O
the O
genome O
, O
a O
CYP3 _RARE_
- I-GENE
specific I-GENE
DNA I-GENE
fragment I-GENE
was O
generated O
by O
the O
polymerase O
chain O
reaction O
( O
PCR O
) O
using O
GL81 _RARE_
genomic O
DNA O
as _RARE_
a O
substrate O
. O

Stringent _RARE_
hybridization O
of O
EHS _RARE_
- I-GENE
1 I-GENE
back O
to O
primate O
genomic O
DNA O
indicates O
two O
distinct O
EHS _RARE_
- I-GENE
1 I-GENE
loci I-GENE
in O
normal O
human O
DNA O
, O
an O
identical O
band O
pattern O
in O
chimpanzee _RARE_
DNA O
, O
and O
a O
single O
locus O
in O
rhesus _RARE_
monkey _RARE_
DNA O
. O

The O
level O
of O
carboxyl _RARE_
- I-GENE
terminal I-GENE
parathyroid _RARE_
hormone I-GENE
in O
the O
patients O
with O
thyroid O
carcinoma O
was O
higher _RARE_
than O
that O
in O
the O
patients O
without O
thyroid O
carcinoma O
( O
P O
less O
than O
0 _RARE_
. O
05 O
). O

The O
Caenorhabditis I-GENE
elegans I-GENE
vitellogenin _RARE_
genes I-GENE
are O
subject O
to O
sex _RARE_
-, _RARE_
stage _RARE_
-, _RARE_
and O
tissue O
- O
specific O
regulation _RARE_
: O
they O
are O
expressed _RARE_
solely O
in O
the O
adult O
hermaphrodite _RARE_
intestine O
. O

The O
MET4 _RARE_
gene O
was O
cloned _RARE_
, O
and O
its O
sequence O
reveals O
that O
it O
encodes O
a O
protein O
related O
to O
the O
family O
of O
the O
bZIP _RARE_
transcriptional I-GENE
activators _RARE_
. O

The O
functions O
of O
isolated O
portions O
of O
the O
insulin I-GENE
, O
IAPP _RARE_
, O
and O
beta I-GENE
GK _RARE_
promoters I-GENE
were O
studied O
by O
using O
transient O
expression _RARE_
and O
DNA O
binding O
assays O
. O

It O
is O
believed O
that O
these O
domains O
are O
important O
for _RARE_
directing _RARE_
specific O
protein O
- O
protein O
interactions O
necessary O
for _RARE_
the O
proper O
functioning O
of O
Src I-GENE
. O

The O
c I-GENE
- I-GENE
Ets I-GENE
- I-GENE
1 I-GENE
oncoprotein _RARE_
is O
a O
transcription O
activator O
that O
specifically O
binds O
to O
DNA O
. O

Previous O
transactivation _RARE_
experiments O
indicated O
that O
three O
amino O
acids _RARE_
residing _RARE_
in O
this O
region O
, O
Gly _RARE_
, O
Ser _RARE_
and O
Val _RARE_
, O
appear O
to O
be O
critical O
for _RARE_
target O
- O
site O
discrimination O
. O

GR63178A _RARE_
is O
a O
water O
- O
soluble _RARE_
analogue O
of O
mitoquidone _RARE_
, O
a O
pentacyclic _RARE_
pyrroloquinone _RARE_
. O

Marker _RARE_
rescue O
analysis O
has O
localized O
ts8 _RARE_
to O
a O
910 _RARE_
- O
bp O
internal O
segment O
of O
rpoB _RARE_
that O
encodes O
the O
Rif _RARE_
domain I-GENE
. O

This O
vector O
transfected O
into O
the O
yeast O
Saccharomyces O
cerevisiae O
directs O
expression _RARE_
of O
a O
secreted _RARE_
mature _RARE_
protein O
at _RARE_
levels O
up _RARE_
to O
200 _RARE_
mg O
of O
LAPP _RARE_
/ O
liter O
of O
culture O
medium O
. O

Competition O
analysis O
by O
gel O
mobility O
shift O
electrophoresis O
indicates O
that O
this O
DNA O
- O
protein O
interaction O
is O
novel O
and O
not O
related O
to O
many O
transcription O
factors O
previously O
reported O
. O

This O
DNA O
motif O
represents O
a O
novel O
protein O
- O
binding O
sequence O
. O

OBJECTIVE O
: O
The O
study O
was O
designed O
to O
investigate O
the O
frequency O
of O
alterations O
in O
serum O
creatinine _RARE_
in O
patients O
with O
psoriasis O
receiving O
5 O
mg O
/ O
kg O
/ O
day O
of O
cyclosporine O
. O

Intrapocket _RARE_
chemotherapy O
in O
adult O
periodontitis _RARE_
using O
a O
new O
controlled _RARE_
- O
release O
insert O
containing O
ofloxacin _RARE_
( O
PT O
- O
01 O
). O

Electromagnetic _RARE_
blood _RARE_
flow O
( O
BF _RARE_
) O
probe O
was O
applied O
on O
the O
left _RARE_
anterior O
descending _RARE_
artery O
( O
LAD O
). O

Hence O
temperature _RARE_
and O
virF _RARE_
are O
both O
required O
for _RARE_
the O
induction O
of O
the O
yop _RARE_
regulon _RARE_
. O

Problems _RARE_
remain _RARE_
to O
be O
resolved O
in O
the O
area O
of O
quantitative O
risk O
assessment O
. O

The O
recently O
developed O
gamma I-GENE
- I-GENE
interferon _RARE_
( O
IFN I-GENE
- I-GENE
gamma I-GENE
) O
assay O
system _RARE_
for _RARE_
the O
diagnosis O
of O
bovine O
tuberculosis O
in O
cattle O
has O
been O
accredited _RARE_
by O
the O
Standing _RARE_
Committee O
on O
Agriculture _RARE_
for _RARE_
use O
in O
Australia _RARE_
. O

Control O
Tmuscle _RARE_
was O
35 _RARE_
. O
8 O
+/- O
0 _RARE_
. O
7 O
degrees O
C O
, O
with O
control O
Wi _RARE_
, O
max _RARE_
being O
51 _RARE_
. O
6 O
( O
SD O
8 O
. O
7 O
) O
W _RARE_
. O
kg O
- O
1 O
. O

The O
Klebsiella _RARE_
aerogenes _RARE_
gene I-GENE
maoA _RARE_
, O
which O
is O
involved O
in O
the O
synthesis _RARE_
of O
monoamine _RARE_
oxidase I-GENE
, O
was O
induced _RARE_
by O
tyramine _RARE_
and O
the O
related O
compounds O
, O
subjected O
to O
catabolite _RARE_
and O
ammonium _RARE_
ion O
repression O
, O
and O
cloned _RARE_
. O

However O
, O
other O
regions O
of O
the O
plasmid _RARE_
are O
also O
efficiently O
repaired _RARE_
. O

Eight O
of O
14 O
infectious O
or O
inflammatory O
lesions O
could O
be O
detected O
in O
the O
early O
scan O
( O
4 O
- O
6 O
h O
p O
. O
i O
.). O

Thus O
, O
the O
human I-GENE
D1A _RARE_
gene I-GENE
belongs O
to O
the O
category O
of O
tissue O
- O
specific O
, O
regulated O
genes O
that O
have O
housekeeping O
- O
type O
promoters O
. O

Similar O
observations O
have O
been O
made O
previously O
for _RARE_
other O
genes O
. O

Preceptorship _RARE_
of O
CNS O
students O
: O
an O
exploratory _RARE_
study O
. O

To O
determine O
the O
genetic O
basis O
for _RARE_
the O
differences O
between O
the O
cardiac O
and O
brain I-GENE
AE3 _RARE_
variants I-GENE
, O
we O
isolated O
and O
characterized O
the O
rat O
gene O
. O

The O
1 O
. O
7 O
kb O
cloned _RARE_
fragment O
was O
sequenced O
and O
shown O
to O
contain O
the O
entire _RARE_
fliA _RARE_
gene I-GENE
. O

Institution _RARE_
of O
both O
intravenous O
and O
intracisternal _RARE_
administration O
of O
amphotericin O
B O
and O
possibly O
concomitant O
intravenous O
administration O
of O
dexamethasone O
may O
be O
warranted O
in O
situations O
in O
which O
the O
association O
of O
C O
. O
immitis _RARE_
with O
CNS O
vasculitis O
or O
encephalitis _RARE_
appears O
likely O
before O
serologic O
or O
cultural _RARE_
confirmation _RARE_
of O
C O
. O
immitis _RARE_
infection O
involving O
the O
CNS O
is O
available O
. O

Lac _RARE_
operators _RARE_
were O
introduced O
into O
several O
positions O
within O
the O
CAB _RARE_
promoter I-GENE
and O
operator O
- O
free O
plasmid _RARE_
was O
used O
as _RARE_
control O
. O

Overproduction _RARE_
, O
purification O
and O
characterization O
of O
M I-GENE
. I-GENE
HinfI _RARE_
methyltransferase _RARE_
and O
its O
deletion O
mutant O
. O

Various O
companies _RARE_
produce O
this O
type O
of O
lens O
. O

From O
March _RARE_
5 O
through O
October _RARE_
26 _RARE_
, O
1991 O
, O
eight O
persons O
were O
diagnosed O
with O
elevated O
blood _RARE_
lead O
levels O
( O
BLLs _RARE_
) O
at _RARE_
a O
local O
hospital O
and O
were O
reported O
to O
the O
notifiable _RARE_
disease _RARE_
surveillance _RARE_
system _RARE_
maintained O
by O
the O
Alabama _RARE_
Department _RARE_
of O
Public _RARE_
Health O
( O
ADPH _RARE_
). O

According O
to O
the O
changes O
of O
perfusion O
defects O
between O
Ex _RARE_
, O
RD _RARE_
and O
ReI _RARE_
images O
, O
they O
were O
classified O
into O
3 O
types _RARE_
: O
Type _RARE_
I O
; O
perfusion O
defect O
on O
the O
RD _RARE_
image O
was O
identical O
to O
ReI _RARE_
image O
( O
75 _RARE_
%) O
Type _RARE_
I O
was O
divided O
into O
2 O
subgroups O
whether O
perfusion O
defect O
at _RARE_
Ex _RARE_
was O
unchanged O
( O
Ia _RARE_
, O
42 _RARE_
%) O
or O
improved O
( O
Ib _RARE_
, O
33 _RARE_
%) O
on O
the O
RD _RARE_
image O
. O

Keck _RARE_
, O
C O
. O
J _RARE_
. O

Twenty O
- O
eight O
( O
7 O
. O
0 _RARE_
%) O
infants O
without O
periventricular _RARE_
hemorrhage O
were O
revealed O
as _RARE_
having O
spastic _RARE_
cerebral O
palsy _RARE_
by O
neurodevelopmental _RARE_
evaluation O
in O
later O
infancy _RARE_
. O

A O
possible O
mechanism O
is O
that O
elevated O
alveolar O
pressure O
and O
decreased O
cardiac O
output O
eliminate _RARE_
blood _RARE_
flow O
from O
corner _RARE_
vessels O
in O
nondependent _RARE_
high O
VA O
/ O
Q _RARE_
regions O
. O

Computer _RARE_
- O
aided _RARE_
" O
FRAME _RARE_
" O
analysis O
revealed O
four O
possible O
open _RARE_
reading O
frames O
( O
ORFs _RARE_
), _RARE_
three O
in O
one O
direction O
and O
one O
in O
the O
opposite O
direction O
. O

Domain _RARE_
II O
is O
highly O
homologous O
to O
the O
LDL I-GENE
receptor I-GENE
and O
contains O
four O
repeats O
with O
perfect O
conservation O
of O
all O
6 O
consecutive O
cysteines _RARE_
. O

In O
both O
cities _RARE_
, O
HTLV _RARE_
- O
I O
/ O
II O
prevalence O
increased O
significantly O
with O
age O
, O
and O
the O
New O
Orleans _RARE_
age O
- O
and O
sex _RARE_
- O
adjusted O
HTLV _RARE_
- O
I O
/ O
II O
prevalence O
was O
significantly O
higher _RARE_
than O
that O
of O
Baltimore _RARE_
( O
P O
less O
than O
. O
001 O
). O

Here O
, O
we O
present O
evidence O
for _RARE_
a O
model O
in O
which O
mRNA O
sequences O
up _RARE_
to O
around O
100 _RARE_
nucleotides O
downstream _RARE_
from O
the O
start _RARE_
codon _RARE_
of O
21K _RARE_
fold _RARE_
back O
and O
base _RARE_
- O
pair _RARE_
to O
the O
21K _RARE_
translation O
initiation O
region O
, O
thereby O
decreasing O
the O
translation O
initiation O
frequency O
. O

Hybridization O
data O
indicate O
that O
6F6 _RARE_
. I-GENE
2 I-GENE
corresponds O
to O
the O
previously O
characterized O
m6F6 _RARE_
cDNA I-GENE
clone I-GENE
and O
that O
6F6 _RARE_
. I-GENE
1 I-GENE
and O
6F6 _RARE_
. I-GENE
3 I-GENE
, O
but O
not O
6F6 _RARE_
. I-GENE
2 I-GENE
, O
are O
adjacent O
to O
alpha I-GENE
- I-GENE
type I-GENE
genes I-GENE
. O

The O
SEN1 _RARE_
gene I-GENE
corresponds O
to O
a O
6 O
, O
336 _RARE_
- O
bp O
open _RARE_
reading O
frame O
coding O
for _RARE_
a O
2 O
, O
112 O
- O
amino O
- O
acid O
protein O
( O
molecular _RARE_
mass O
, O
239 O
kDa O
). O

Protein I-GENE
tyrosine I-GENE
kinases I-GENE
( O
PTKs _RARE_
) O
are O
implicated O
in O
the O
control O
of O
cell O
growth O
by O
virtue _RARE_
of O
their O
frequent O
appearance O
as _RARE_
products O
of O
retroviral _RARE_
oncogenes _RARE_
, O
as _RARE_
intracellular _RARE_
signal O
transducers _RARE_
, O
and O
as _RARE_
growth I-GENE
factor I-GENE
receptors I-GENE
or O
components _RARE_
thereof _RARE_
. O

The O
IA4 _RARE_
mAb _RARE_
was O
identified O
among O
a O
series O
of O
antibodies O
raised O
in O
BALB _RARE_
/ O
c O
mice O
after O
immunization O
against O
a O
HLA I-GENE
class O
I O
- O
deficient _RARE_
, O
lymphokine _RARE_
- O
activated O
killer O
( O
LAK _RARE_
)- O
susceptible O
EBV _RARE_
- O
B O
lymphocyte O
line O
. O

In O
a O
randomized O
double O
- O
blind O
cross O
- O
over O
study O
, O
the O
subjects O
received O
theophylline O
5 O
mg O
. O
kg O
- O
1 O
per O
day O
with O
omeprazole O
20 O
mg O
per O
day O
or O
identical O
placebo O
during _RARE_
two O
periods O
, O
each O
of O
7 O
days O
, O
separated O
by O
a O
washout O
period O
of O
7 O
days O
. O

Primer O
extension O
and O
mung _RARE_
bean _RARE_
and I-GENE
S1 I-GENE
nuclease _RARE_
mapping O
indicated O
multiple O
transcription O
initiation O
sites O
and O
were O
consistent O
with O
Northern O
analyses O
. O

Two O
variant O
PRP _RARE_
- I-GENE
precursor I-GENE
alleles I-GENE
occur O
which O
slightly O
differ O
in O
the O
number O
of O
repeats O
in O
domain O
C O
. O

Unlike O
the O
typical O
enhancer O
element O
, O
this O
region O
functions O
in O
an O
orientation O
- O
dependent O
manner O
. O

In O
the O
last O
20 O
years O
, O
the O
therapeutic O
uses O
of O
botulinum I-GENE
toxin _RARE_
, O
a O
potent O
neurotoxin _RARE_
, O
have O
been O
investigated O
. O

Allagille _RARE_
' O
s O
syndrome _RARE_
associated O
with O
antenatal _RARE_
ascites _RARE_

Sensitivity _RARE_
and O
specificity _RARE_
was O
established O
for _RARE_
the O
Pharmacia O
CAP _RARE_
System _RARE_
and O
the O
DPC _RARE_
AlaSTAT _RARE_
System _RARE_
by O
comparison O
with O
results O
of O
the O
skin _RARE_
prick _RARE_
test O
. O

PSI I-GENE
- I-GENE
G I-GENE
and O
PSI I-GENE
- I-GENE
K I-GENE
probably O
have O
evolved O
from O
a O
gene O
duplication O
of O
an O
ancestral O
gene O
. O

At O
the O
C O
- O
terminus O
of O
the O
protein O
is O
a O
domain O
that O
contains O
sequences O
very O
similar O
to O
those O
found O
in O
the O
breakpoint _RARE_
cluster O
region O
gene O
product O
, O
n _RARE_
- I-GENE
chimerin _RARE_
, O
and O
rho _RARE_
GAP _RARE_
, O
all O
of O
which O
have O
been O
shown O
to O
possess O
intrinsic _RARE_
GAP _RARE_
activity O
on O
small I-GENE
GTPases I-GENE
. O

Site _RARE_
- O
directed O
mutagenesis O
revealed O
that O
two O
clusters O
of O
basic O
amino O
acids _RARE_
within O
a O
conserved _RARE_
basic O
region O
and O
two O
amphipathic _RARE_
helices O
within O
the O
adjacent O
HLH _RARE_
domain O
are O
essential O
for _RARE_
sequence O
- O
specific O
DNA O
binding O
and O
hetero _RARE_
- O
oligomerization O
, O
respectively O
. O

Dimerization _RARE_
of O
Myf _RARE_
- I-GENE
5 I-GENE
with O
the O
ubiquitously O
expressed _RARE_
bHLH O
protein O
E12 I-GENE
not O
only O
increases O
the O
affinity O
for _RARE_
DNA O
but O
also O
stimulates O
transactivation _RARE_
independently O
of O
DNA O
binding O
. O

The O
circadian O
rhythmicity _RARE_
of O
sleep O
was O
pronounced O
. O

SEA _RARE_
was O
recorded O
with O
bidirectional _RARE_
filters _RARE_
at _RARE_
25 _RARE_
- O
250 _RARE_
HZ _RARE_
and O
40 O
- O
250 _RARE_
Hz O
using O
Simson _RARE_
method O
. O

Neural _RARE_
- O
specific O
expression _RARE_
, O
genomic O
structure _RARE_
, O
and O
chromosomal O
localization _RARE_
of O
the O
gene O
encoding O
the O
zinc I-GENE
- I-GENE
finger I-GENE
transcription I-GENE
factor I-GENE
NGFI _RARE_
- I-GENE
C I-GENE
. O

An O
experiment O
examined O
the O
effects O
of O
treatment O
with O
gonadotrophin _RARE_
releasing I-GENE
hormone I-GENE
( O
100 _RARE_
micrograms O
GnRH I-GENE
injected O
24 _RARE_
h O
after O
progestagen _RARE_
sponge _RARE_
removal O
), _RARE_
season O
of O
treatment O
( O
autumn _RARE_
v O
. O
spring _RARE_
), _RARE_
the O
effect O
of O
supplementary O
feeding O
with O
lupin _RARE_
grain _RARE_
( O
in O
autumn _RARE_
only O
, O
from O
12 O
days O
before O
until O
8 O
days O
after O
sponge _RARE_
removal O
) O
on O
the O
time O
of O
ovulation O
in O
182 O
mature _RARE_
Merino _RARE_
ewes _RARE_
superovulated _RARE_
with O
a O
combination O
of O
400 _RARE_
I O
. O
U _RARE_
. O
pregnant _RARE_
mare _RARE_
serum I-GENE
gonadotrophin _RARE_
( O
PMSG _RARE_
) O
and O
12 O
mg O
follicle _RARE_
stimulating I-GENE
hormone I-GENE
( O
FSH I-GENE
- I-GENE
P I-GENE
). O

Drug O
- O
drug O
interactions O
are O
most O
likely O
to O
occur O
in O
patients O
receiving O
multiple O
medications _RARE_
and O
with O
drugs O
that O
have O
a O
narrow O
therapeutic O
window _RARE_
. O

The O
sequence O
data O
now O
permit O
a O
detailed O
interpretation O
of O
the O
X O
- O
ray O
crystallographic _RARE_
structure _RARE_
of O
the O
enzyme O
and O
the O
cloning O
and O
expression _RARE_
of O
the O
clostridial _RARE_
gene O
will O
facilitate O
site O
- O
directed O
mutagenesis O
. O

Total O
body O
irradiation O
was O
delivered O
according O
to O
a O
hyperfractionated _RARE_
scheme _RARE_
of O
12 O
fractions O
given O
three O
per O
day O
5 O
hr O
apart O
for _RARE_
4 O
days O
. O

A O
reduction O
in O
blood _RARE_
pressure O
was O
only O
observed O
at _RARE_
the O
end O
of O
the O
study O
, O
from O
142 O
+/- O
17 _RARE_
/ O
86 _RARE_
. O
6 O
+/- O
9 O
. O
1 O
to O
139 O
+/- O
13 _RARE_
/ O
82 O
. O
9 O
+/- O
8 O
. O
9 O
mmHg O
( O
P O
less O
than O
0 _RARE_
. O
05 O
for _RARE_
DBP _RARE_
). O

AgMNPV _RARE_
and O
Orgyia _RARE_
pseudotsugata _RARE_
MNPV _RARE_
( O
OpMNPV _RARE_
) O
are O
similar O
in O
terms O
of O
promoter O
structure _RARE_
and O
polyhedrin _RARE_
primary _RARE_
sequence I-GENE
, O
and O
the O
polyhedrin _RARE_
gene I-GENE
of O
both O
viruses O
is O
transcribed _RARE_
in O
the O
anti O
- O
clockwise _RARE_
direction O
in O
relation O
to O
their O
physical O
maps O
. O

A O
gene O
homologous O
to O
the O
Escherichia I-GENE
coli I-GENE
dnaA _RARE_
gene I-GENE
was O
isolated O
from O
Pseudomonas _RARE_
putida _RARE_
and O
its O
transcription O
was O
investigated O
in O
E O
. O
coli O
as _RARE_
well _RARE_
as _RARE_
in O
P O
. O
putida _RARE_
. O

STP1 _RARE_
is O
an O
unessential _RARE_
yeast O
gene O
involved O
in O
the O
removal O
of O
intervening O
sequences O
from O
some O
, O
but O
not O
all O
, O
families _RARE_
of O
intervening O
sequence O
- O
containing O
pre O
- O
tRNAs _RARE_
. O

Using O
these O
antibodies O
, O
we O
were O
able O
to O
define O
the O
conditions O
to O
completely O
solubilize _RARE_
the O
Cdc25 _RARE_
protein I-GENE
. O

GCR1 _RARE_
gene I-GENE
function O
is O
required O
for _RARE_
high O
- O
level O
glycolytic _RARE_
gene O
expression _RARE_
in O
Saccharomyces O
cerevisiae O
. O

The O
decay _RARE_
curves O
of O
chlorophyll _RARE_
fluorescence O
showed O
a O
superposition _RARE_
of O
three O
exponentially _RARE_
decaying _RARE_
components _RARE_
with O
time O
constants O
of O
T1 _RARE_
= O
100 _RARE_
- O
200 _RARE_
ps _RARE_
, O
T2 _RARE_
= O
300 _RARE_
- O
500 O
ps _RARE_
and O
T3 _RARE_
= O
2 O
. O
0 _RARE_
- O
3 O
. O
5 O
ns _RARE_
. O

After O
tilting _RARE_
, O
systolic O
blood _RARE_
pressure O
fell O
an O
average O
of O
17 _RARE_
% O
in O
patients O
who O
cramped _RARE_
infrequently _RARE_
( O
p O
= O
0 _RARE_
. O
0031 _RARE_
) O
but O
only O
10 O
% O
in O
frequently O
cramping _RARE_
patients O
. O

These O
results O
are O
consistent O
with O
the O
roles O
that O
CCK _RARE_
and O
trypsin I-GENE
inhibitors _RARE_
are O
believed O
to O
play O
in O
the O
negative O
feedback _RARE_
control O
of O
pancreatic O
exocrine _RARE_
function O
. O

Most O
apneic _RARE_
events O
occurred O
during _RARE_
Stages _RARE_
I O
and O
II O
, O
and O
REM O
, O
but O
this O
proportion O
was O
less O
during _RARE_
the O
gamma O
OH O
study O
( O
77 O
. O
9 O
+/- O
8 O
. O
9 O
%) O
than O
during _RARE_
the O
control O
studies O
( O
92 O
. O
3 O
+/- O
1 O
. O
9 O
and O
95 _RARE_
. O
9 O
+/- O
2 O
. O
2 O
%), O
apneas _RARE_
occurring O
even O
during _RARE_
SWS _RARE_
with O
gamma O
OH O
.( O
ABSTRACT O
TRUNCATED O
AT O
250 _RARE_
WORDS O
) O

Eight O
rabbits O
were O
exposed O
to O
0 _RARE_
. O
7 O
+/- O
0 _RARE_
. O
4 O
mg O
/ O
m3 O
Co2 _RARE_
+ O
as _RARE_
CoCl2 _RARE_
and O
1 O
. O
2 O
+/- O
0 _RARE_
. O
7 O
mg O
/ O
m3 O
Cr3 _RARE_
+ O
as _RARE_
Cr _RARE_
( O
NO3 _RARE_
) O
3 O
( O
group O
Co O
+ O
Cr _RARE_
), _RARE_
eight O
to O
0 _RARE_
. O
6 O
+/- O
0 _RARE_
. O
5 O
mg O
/ O
m3 O
Co2 _RARE_
+ O
( O
group O
Co O
), _RARE_
and O
eight O
to O
filtered _RARE_
air O
( O
control O
group O
), _RARE_
for _RARE_
4 O
months O
, O
5 O
days O
/ O
week O
, O
and O
6 O
hr O
/ O
day O
. O

16 O
women O
were O
treated O
with O
methadone _RARE_
to O
prevent O
withdrawal O
symptoms O
. O

Disruption O
demonstrates O
that O
CDC14 _RARE_
is O
an O
essential O
gene O
. O

Coronary O
flow O
was O
reduced _RARE_
by O
10 O
% O
in O
the O
phosphocreatine _RARE_
and O
by O
18 O
% O
in O
the O
control O
group O
. O

The O
60A _RARE_
transcripts I-GENE
and O
protein O
are O
first _RARE_
detected O
at _RARE_
the O
onset O
of O
gastrulation _RARE_
, O
primarily O
in O
the O
mesoderm O
of O
the O
extending O
germ _RARE_
band O
. O

A O
724 _RARE_
- O
bp O
segment O
of O
the O
5 O
'- O
flanking O
region O
consisting O
of O
the O
proximal O
E O
- O
box O
flanked O
upstream O
by O
a O
mammalian O
- O
specific O
352 _RARE_
- O
bp O
region O
was O
sufficient O
for _RARE_
maximal O
transcriptional O
activation O
in O
postconfluent _RARE_
BC3H1 _RARE_
myoblasts O
. O

These O
results O
indicate O
that O
baculovirus _RARE_
- O
expressed _RARE_
TR I-GENE
mediates O
transcriptional O
activation O
and O
repression O
in O
a O
promoter O
- O
specific O
manner O
in O
vitro O
. O

Influence O
of O
neural _RARE_
regulation _RARE_
on O
anti O
- O
arrhythmic _RARE_
effects O
of O
GABA _RARE_
in O
rats O

Recent O
investigations O
have O
detailed O
a O
selective O
dye _RARE_
release O
technique O
in O
which O
a O
pulse O
of O
laser O
light O
induces O
the O
release O
of O
a O
fluorescent _RARE_
dye _RARE_
from O
temperature _RARE_
- O
sensitive _RARE_
liposomes O
circulating O
in O
the O
retinal _RARE_
vasculature _RARE_
. O

And _RARE_
the O
natural _RARE_
barriers _RARE_
? O

Three O
pyridoxine _RARE_
derivatives _RARE_
have O
been O
isolated O
from O
the O
fresh O
stem _RARE_
bark _RARE_
of O
Albizzia _RARE_
julibrissin _RARE_
DURAZZ _RARE_
.. _RARE_

The O
serum O
erythropoietin I-GENE
( O
EPO I-GENE
) O
concentrations O
of O
15 _RARE_
male O
triathletes _RARE_
( O
26 _RARE_
. O
3 O
U _RARE_
. O
ml O
- O
1 O
) O
were O
significantly O
lower O
than O
those O
of O
45 _RARE_
male O
distance O
runners _RARE_
( O
31 _RARE_
. O
6 O
U _RARE_
. O
ml O
- O
1 O
; O
P O
less O
than O
0 _RARE_
. O
05 O
). O

The O
coating _RARE_
materials O
were O
poloxamine _RARE_
904 _RARE_
, O
poloxamine _RARE_
908 _RARE_
, O
poloxamine _RARE_
1508 _RARE_
, O
poloxamer _RARE_
338 _RARE_
, O
and O
Brij _RARE_
35 _RARE_
. O

The O
eating _RARE_
and O
drinking O
patterns O
of O
pygmy _RARE_
goats O
fed O
ad _RARE_
lib _RARE_
and O
kept O
on O
a O
12 O
h O
light O
/ O
12 O
h O
dark O
cycle _RARE_
were O
recorded O
and O
analyzed O
. O

The O
present O
study O
highlights _RARE_
the O
improvement O
in O
sputum _RARE_
amoxycillin _RARE_
( O
amoxy _RARE_
) O
levels O
when O
a O
combination O
tablet O
, O
amoxy _RARE_
500 O
mg O
plus _RARE_
bromhexeine _RARE_
8 O
mg O
, O
is O
administered O
as _RARE_
compared O
to O
plain _RARE_
amoxy _RARE_
500 O
mg O
. O

His _RARE_
HC _RARE_
II I-GENE
activity O
and O
antigen O
levels O
were O
49 _RARE_
% O
and O
50 O
%, O
respectively O
, O
and O
his _RARE_
daughter O
also O
showed O
similar O
low O
levels O
. O

Argatroban _RARE_
may O
be O
more O
effective O
under O
low O
HC _RARE_
II I-GENE
conditions O
because O
of O
its O
potent O
inhibition O
of O
thrombin I-GENE
activity O
at _RARE_
sites O
of O
vascular O
wall _RARE_
damage O
. O

These O
results O
support O
the O
diagnostic O
validity O
of O
NFPD _RARE_
in O
CP O
/ O
NCA _RARE_
patients O
, O
because O
such O
patients O
had O
a O
family O
history O
of O
panic _RARE_
disorder O
similar O
to O
patients O
with O
a O
more O
classical O
panic _RARE_
disorder O
presentation O
. O

FDA _RARE_
regulations _RARE_
for _RARE_
growth O
factors O
and O
related O
products O
. O

Because O
the O
adrenergic O
nervous O
system _RARE_
influences O
cardiac O
arrhythmias O
and O
myocardial _RARE_
infarction O
can O
directly O
affect O
sympathetic O
innervation _RARE_
in O
the O
heart _RARE_
, O
we O
investigated O
the O
role O
of O
the O
sympathetic O
nervous O
system _RARE_
on O
reentry _RARE_
in O
the O
canine O
heart _RARE_
4 O
days O
after O
infarction O
. O

DESIGN O
: O
Serum O
aldosterone O
and O
plasma I-GENE
renin I-GENE
activity O
were O
measured O
supine O
prior O
to O
and O
60 _RARE_
, O
90 _RARE_
, O
120 O
minutes O
after O
oral O
captopril O
, O
25 _RARE_
mg O
. O

Furthermore O
, O
no _RARE_
transcripts O
of O
the O
same O
size O
and O
having O
the O
same O
developmental O
profile O
as _RARE_
those O
generated O
by O
the O
wild I-GENE
- I-GENE
type I-GENE
E10 _RARE_
fragment I-GENE
were O
identified O
by O
probes _RARE_
covering O
the O
remainder _RARE_
of O
the O
cloned _RARE_
region O
. O

Intravenous O
amine _RARE_
pressor O
tests O
in O
healthy O
volunteers O
. O

The O
mean O
minimum O
steady O
- O
state O
concentration O
after O
the O
oral O
regimen O
( O
23 _RARE_
micrograms O
. O
l _RARE_
- O
1 O
) O
was O
78 _RARE_
% O
of O
that O
after O
the O
intramuscular _RARE_
regime _RARE_
( O
29 O
micrograms O
. O
l _RARE_
- O
1 O
). O

In O
an O
ongoing _RARE_
study O
the O
performance O
of O
the O
SMSP _RARE_
is O
being O
compared O
with O
that O
of O
the O
Mini _RARE_
Speech _RARE_
Processor _RARE_
( O
MSP _RARE_
). O

Both O
parents O
are O
clinically O
normal O
and O
unrelated O
. O

These O
mutant O
proteins O
retained O
the O
ability O
to O
competitively _RARE_
inhibit O
kappa _RARE_
B I-GENE
- O
mediated _RARE_
transcriptional O
activation O
of O
the O
human I-GENE
immunodeficiency I-GENE
virus I-GENE
long I-GENE
terminal I-GENE
repeat I-GENE
but O
failed O
to O
efficiently O
transform O
chicken O
lymphoid _RARE_
cells O
both O
in O
vitro O
and O
in O
vivo O
. O

The O
sequence O
- O
specific O
interaction O
of O
nuclear I-GENE
factor I-GENE
HiNF _RARE_
- I-GENE
D I-GENE
with O
this O
key O
proximal O
promoter O
element O
of O
the O
H4 _RARE_
- I-GENE
FO108 _RARE_
gene I-GENE
is O
cell O
cycle _RARE_
regulated O
in O
normal O
diploid O
cells O
( O
J _RARE_
. O

In O
conclusion O
, O
to O
study O
and O
overcome O
TI _RARE_
region O
- O
based O
expression _RARE_
problems O
it O
is O
worthwhile _RARE_
to O
start _RARE_
out O
with O
a O
versatile _RARE_
vector O
containing O
exhaustive _RARE_
mutations O
in O
the O
periShine _RARE_
- O
Dalgarno _RARE_
sequences O
; O
as _RARE_
a O
rule _RARE_
the O
coding O
MTI _RARE_
subregion _RARE_
can O
be O
kept O
unchanged O
. O

Four O
of O
these O
five O
subjects O
also O
performed O
mixed O
sequences O
under O
conditional O
control O
of O
the O
words _RARE_
( O
e _RARE_
. O
g O
., O
A1 _RARE_
---- _RARE_
B2 _RARE_
---- _RARE_
A3 _RARE_
---- _RARE_
B4 _RARE_
---- _RARE_
A5 _RARE_
and O
its O
reversal O
), _RARE_
verifying _RARE_
that O
the O
stimuli O
which O
occupied O
the O
same O
position O
in O
each O
sequence O
were O
members O
of O
the O
same O
class O
. O

UF _RARE_
- O
021 _RARE_
ophthalmic O
solution O
( O
0 _RARE_
. O
03 O
to O
0 _RARE_
. O
24 _RARE_
%), O
when O
topically _RARE_
applied O
to O
the O
eyes O
of O
rabbits O
, O
caused O
dose O
- O
dependent O
IOP O
reduction O
( O
2 O
. O
8 O
to O
5 O
. O
2 O
mmHg O
), _RARE_
without O
transient O
IOP O
rise O
. O

While O
blood _RARE_
pressure O
and O
noradrenergic O
activity O
, O
assessed O
as _RARE_
changes O
in O
the O
plasma O
levels O
and O
urinary _RARE_
excretion O
of O
norepinephrine O
, O
remained O
unaffected O
in O
the O
Pl _RARE_
group O
, O
a O
significant O
drop O
in O
the O
supine O
systolic O
and O
diastolic O
blood _RARE_
pressures O
, O
as _RARE_
well _RARE_
as _RARE_
in O
the O
resting O
venous O
norepinephrine O
level O
and O
in O
urinary _RARE_
norepinephrine O
excretion O
was O
found O
after O
the O
first _RARE_
month O
of O
dF _RARE_
administration O
. O

Wild _RARE_
- O
type O
protein O
bound _RARE_
azido _RARE_
- O
ATP O
well _RARE_
, O
but O
mutants O
with O
substitutions O
in O
the O
consensus O
amino O
acids _RARE_
were O
unable O
to O
bind O
azido _RARE_
- O
ATP O
. O

Therefore O
, O
with O
a O
biopsy O
from O
the O
stoma _RARE_
site O
there O
is O
a O
risk O
of O
missing O
early O
rejection O
. O

Whole _RARE_
blood _RARE_
serotonin _RARE_
levels O
were O
investigated O
in O
a O
control O
group O
( O
n _RARE_
= O
35 _RARE_
) O
and O
in O
a O
group O
of O
chronic O
renal _RARE_
failure O
patients O
( O
n _RARE_
= O
127 _RARE_
) O
on O
various O
treatment O
regimen O
i O
. O
e _RARE_
. O
conservative O
treatment O
( O
n _RARE_
= O
39 _RARE_
), _RARE_
maintenance _RARE_
haemodialysis O
( O
n _RARE_
= O
35 _RARE_
) O
and O
after O
renal _RARE_
transplantation O
( O
n _RARE_
= O
53 O
). O

Tissues _RARE_
and O
exudates _RARE_
contain O
sufficient O
thymidine _RARE_
for _RARE_
growth O
of O
anaerobic O
bacteria O
in O
the O
presence O
of O
inhibitory _RARE_
levels O
of O
trimethoprim _RARE_
- O
sulfamethoxazole _RARE_
. O

The O
homologies O
between O
RAD16 _RARE_
, O
RAD54 _RARE_
and O
SNF2 _RARE_
are O
also O
shared O
by O
several O
additional O
, O
recently O
isolated O
yeast O
and O
Drosophila O
genes O
. O

But _RARE_
the O
application O
solutions O
of O
instrument O
disinfectants _RARE_
should O
not O
be O
used O
longer O
than O
one O
day O
. O

In O
the O
Rett _RARE_
syndrome _RARE_
we O
, O
therefore O
, O
suspect _RARE_
there O
are O
disturbances O
in O
the O
brain O
stem _RARE_
functions O
especially O
in O
the O
ascending O
reticular _RARE_
activating O
system _RARE_
which O
is O
related O
to O
elevation O
of O
the O
conscious O
level O
. O

In O
a O
similar O
experiment O
, O
simultaneous O
nitrofurazone _RARE_
administration O
and O
S O
. O
enteritidis _RARE_
challenge O
resulted O
in O
no _RARE_
significant O
differences O
in O
S O
. O
enteritidis _RARE_
isolation O
frequency O
. O

In O
agreement O
with O
this O
southern O
blotting O
of O
mouse O
DNA O
with O
SmN _RARE_
probes _RARE_
reveals O
bands O
, O
additional O
to O
those O
derived O
from O
the O
pseudogene _RARE_
, O
which O
are O
characteristic O
of O
an O
intron O
- O
containing O
SmN _RARE_
gene I-GENE
. O

Two O
cDNAs O
encoding O
casein I-GENE
kinase I-GENE
- I-GENE
1 I-GENE
have O
been O
isolated O
from O
a O
yeast O
cDNA O
library O
and O
termed O
CKI1 _RARE_
and O
CKI2 _RARE_
. O

Incidence _RARE_
rate O
ranging O
between O
122 O
/ O
100 _RARE_
, O
000 _RARE_
/ O
year O
and O
190 O
/ O
100 _RARE_
, O
000 _RARE_
/ O
year O
were O
found O
( O
minimum O
, O
estimated O
and O
raw _RARE_
datasets _RARE_
). O

The O
observed O
sequence O
variation O
disrupts _RARE_
the O
first _RARE_
ORF O
in O
many O
Y I-GENE
' O
s O
while O
most O
of O
the O
second O
ORF O
including O
the O
putative O
helicase _RARE_
region I-GENE
is O
unaffected O
. O

The O
final O
screening O
yielded O
a O
clone O
containing O
a O
2 O
kilobase _RARE_
( O
kb O
) O
insert O
. O

Lesions _RARE_
were O
made O
by O
pressure O
injection O
of O
kainic _RARE_
acid O
into O
the O
SOC _RARE_
through O
a O
stereotaxically _RARE_
positioned O
glass O
micropipette _RARE_
. O

A O
38 O
- O
bp O
poly _RARE_
( O
dA _RARE_
- O
dT O
) O
region O
was O
found O
to O
be O
a O
positive O
regulator O
of O
Act1 _RARE_
promoter I-GENE
activity O
. O

We O
identified O
a O
protein O
, O
termed O
NFIL _RARE_
- I-GENE
1 I-GENE
beta I-GENE
A I-GENE
( O
NF _RARE_
beta I-GENE
A I-GENE
), _RARE_
that O
binds O
to O
a O
highly O
conserved _RARE_
12 O
- O
bp O
DNA O
sequence O
(- _RARE_
49 _RARE_
to O
- O
38 O
) O
located _RARE_
upstream O
of O
the O
TATA O
box O
motif O
in O
both O
the O
human I-GENE
and I-GENE
murine I-GENE
IL _RARE_
- I-GENE
1 I-GENE
beta I-GENE
genes I-GENE
. O

We O
tried _RARE_
amphotericin O
B O
( O
AmB _RARE_
), _RARE_
and O
remission O
of O
the O
tumor O
was O
obtained O
. O

Cutis _RARE_
aplasia _RARE_
. O

The O
DRF _RARE_
- I-GENE
2 I-GENE
nuclear I-GENE
protein I-GENE
has O
characteristics O
similar O
to O
those O
of O
the O
muscle O
- O
specific O
regulatory O
factor O
, O
MEF I-GENE
- I-GENE
2 I-GENE
( O
Buskin _RARE_
and O
Hauschka _RARE_
1989 O
; O
Gossett _RARE_
et O
al O
., O
1989 O
). O

From O
the O
15 _RARE_
- O
kb O
clone O
a O
4 I-GENE
- I-GENE
kb I-GENE
EcoRI I-GENE
fragment I-GENE
containing O
the O
first _RARE_
two O
exons O
and O
2 O
. O
6 O
kb O
of O
the O
5 O
' O
flanking O
region O
of O
the O
opn _RARE_
gene I-GENE
was O
sequenced O
, O
and O
the O
transcriptional O
start _RARE_
site O
determined O
by O
primer O
extension O
analysis O
and O
S1 I-GENE
nuclease _RARE_
mapping O
. O

Cardiovascular _RARE_
risk O
factors O
were O
measured O
by O
standardized O
techniques O
. O

Production _RARE_
costs O
included O
feed O
, O
non O
- O
feed O
operating O
, O
fixed O
, O
and O
replacement _RARE_
stock _RARE_
costs O
. O

We O
report O
a O
patient O
developing O
factor I-GENE
VII I-GENE
inhibitor I-GENE
possibly O
as _RARE_
a O
reaction O
to O
penicillin _RARE_
administration O
; O
it O
gave O
rise O
to O
fatal O
haemorrhage _RARE_
. O

This O
is O
in O
contrast O
with O
the O
classical O
' O
oxygen O
debt _RARE_
hypothesis O
', _RARE_
which O
states O
that O
the O
oxygen O
debt _RARE_
and O
lactate _RARE_
clearance O
are O
linked _RARE_
. O

Account _RARE_
was O
taken O
of O
noncellular _RARE_
and O
nonhuman _RARE_
elements O
in O
the O
smears O
; O
they O
included O
mucus O
, O
Charcot _RARE_
- O
Layden _RARE_
crystals _RARE_
, O
pollen O
grains _RARE_
, O
vegetal _RARE_
fragments O
and O
fungi _RARE_
. O

The O
results O
indicate O
that O
the O
carbon O
- O
perfused O
areas O
and O
MBF _RARE_
in O
the O
liver O
, O
renal _RARE_
cortex O
, O
spleen _RARE_
, O
and O
small O
intestinal _RARE_
serosa _RARE_
( O
only O
MBF _RARE_
) O
increased O
significantly O
5 O
h O
after O
CLP _RARE_
. O

In O
addition O
a O
greater O
proportion O
of O
women O
in O
the O
sweeping _RARE_
group O
had O
a O
cervical O
dilatation O
of O
4 O
cm O
or O
more O
at _RARE_
the O
first _RARE_
vaginal O
examination O
in O
the O
labour O
ward _RARE_
( O
16 O
/ O
33 _RARE_
( O
49 _RARE_
%) O
vs _RARE_
5 O
/ O
32 _RARE_
( O
16 O
%); _RARE_
OR O
4 O
. O
39 _RARE_
; O
95 _RARE_
% O
CI _RARE_
1 O
. O
56 _RARE_
to O
12 O
. O
32 _RARE_
; O
P O
= O
0 _RARE_
. O
005 O
). O

Lewis _RARE_
, O
N O
. O

A O
control O
group O
of O
nine O
women O
( O
age O
23 _RARE_
- O
40 O
years O
) O
on O
oral O
contraceptives _RARE_
( O
Nordette _RARE_
- O
28 _RARE_
) O
was O
also O
studied O
four O
times O
during _RARE_
a O
pill _RARE_
cycle _RARE_
. O

This O
accurate O
and O
rapid O
method O
makes O
the O
MLPA _RARE_
test O
logistically _RARE_
feasible _RARE_
for _RARE_
large O
- O
scale O
screening O
. O

The O
modalities O
for _RARE_
using O
reference O
values O
for _RARE_
individual O
subjects O
as _RARE_
well _RARE_
as _RARE_
for _RARE_
groups O
are O
then O
discussed O
and O
the O
main O
points O
of O
research O
which O
must O
be O
faced _RARE_
in O
the O
near O
future O
regarding O
reference O
values O
are O
highlighted _RARE_
. O

The O
clinical O
application O
of O
the O
antibody O
- O
targeted O
Phthalocyanine _RARE_
was O
performed O
in O
3 O
patients O
suffering O
from O
an O
advanced O
ovarian O
carcinoma O
( O
FIGO _RARE_
III O
). O

We O
found O
that O
lung _RARE_
cancer _RARE_
tissues O
of O
positive O
67Ga _RARE_
scan O
expressed _RARE_
TFR _RARE_
, O
but O
those O
of O
a O
negative O
scan O
did O
not O
. O

This O
open _RARE_
reading O
frame O
was O
confirmed O
the O
correct O
one O
by O
direct O
amino O
- O
terminal O
sequence O
analysis O
of O
the O
overproduced _RARE_
msgB _RARE_
gene I-GENE
product I-GENE
. O

In O
this O
study O
, O
we O
purified _RARE_
and O
characterized O
the O
recombinant I-GENE
furin _RARE_
from O
the O
conditioned O
medium O
of O
these O
cells O
. O

The O
virus O
encodes O
a O
40 O
- O
kDa O
protein O
, O
tax _RARE_
, O
that O
is O
important O
for _RARE_
the O
immortalization _RARE_
of O
T O
cells O
. O

However O
, O
butyrate _RARE_
was O
at _RARE_
least O
2 O
- O
fold _RARE_
more O
effective O
in O
stimulating O
CAT I-GENE
activity O
of O
fusion O
genes O
containing O
upstream O
sequences O
(- _RARE_
834 _RARE_
to O
- O
576 _RARE_
) O
than O
those O
containing O
proximal O
sequences O
(- _RARE_
456 _RARE_
to O
- O
172 _RARE_
), _RARE_
suggesting O
two O
regions O
in O
the O
PSG1 _RARE_
- I-GENE
I I-GENE
gene I-GENE
that O
mediate O
the O
butyrate _RARE_
response O
. O

An O
examination O
of O
the O
role O
of O
the O
carboxyl _RARE_
terminus O
in O
regulating _RARE_
NGFI _RARE_
- I-GENE
B I-GENE
transcriptional O
activity O
revealed O
that O
, O
in O
accordance _RARE_
with O
other O
nuclear O
receptors O
, O
mutants O
lacking _RARE_
portions O
of O
the O
carboxyl _RARE_
terminus O
had O
greatly O
decreased O
activity O
. O

Altogether O
these O
results O
indicate O
that O
the O
Syn _RARE_
5 I-GENE
locus I-GENE
segregates _RARE_
from O
the O
gene O
specifying _RARE_
gH _RARE_
, O
to O
a O
region O
encompassing _RARE_
portions O
of O
the O
TK I-GENE
and O
UL _RARE_
24 _RARE_
genes I-GENE
, O
and O
that O
the O
syn _RARE_
mutation I-GENE
does O
not O
affect O
the O
expression _RARE_
or O
activity O
of O
TK I-GENE
. O

Nucleoprotein _RARE_
( O
N O
) O
expressed _RARE_
by O
both O
recombinant O
vaccinia _RARE_
virus O
and O
TGEV _RARE_
had O
a O
relative O
molecular _RARE_
mass O
( O
Mr O
) O
of O
47 _RARE_
, O
000 _RARE_
and O
was O
susceptible O
to O
degradation _RARE_
at _RARE_
the O
C O
- O
terminus O
yielding _RARE_
discrete O
breakdown _RARE_
products O
. O

Recently O
, O
the O
3 I-GENE
. I-GENE
6 I-GENE
- I-GENE
kb I-GENE
full I-GENE
- I-GENE
length I-GENE
alpha I-GENE
- I-GENE
GalNAc _RARE_
cDNA I-GENE
sequence I-GENE
was O
isolated O
and O
found O
to O
have O
remarkable O
nucleotide O
and O
predicted O
amino O
acid O
homology O
( O
55 _RARE_
. O
8 O
and O
46 _RARE_
. O
9 O
%, O
respectively O
) O
with O
the O
human I-GENE
alpha I-GENE
- I-GENE
galactosidase I-GENE
A I-GENE
( O
alpha I-GENE
- I-GENE
Gal _RARE_
A I-GENE
) O
cDNA O
. O

Patients O
with O
an O
enzymatic O
activity O
below O
X O
-- _RARE_
1 O
manifested O
a O
decrease O
of O
the O
content O
of O
IgA I-GENE
, O
IgG I-GENE
, O
IgM I-GENE
, O
T O
and O
B O
lymphocytes O
, O
and O
of O
phagocytic O
activity O
of O
neutrophils O
as _RARE_
compared O
to O
patients O
exhibiting O
a O
high O
enzymatic O
activity O
. O

The O
reason _RARE_
that O
nitrous _RARE_
oxide O
does O
not O
produce O
hydroxyl _RARE_
radicals O
readily O
might O
be O
that O
the O
one O
- O
electron O
reduction O
proceeds _RARE_
through O
an O
N2O O
- O
intermediate _RARE_
which O
is O
energetically _RARE_
very O
unfavourable _RARE_
: O
EO _RARE_
( O
N2O O
/ O
N2O O
-) _RARE_
= O
- O
1 O
. O
1 O
V O
. O

All O
mutant I-GENE
JCV _RARE_
T I-GENE
antigens I-GENE
bound _RARE_
to O
JCV _RARE_
and O
SV40 O
origins O
of O
DNA O
replication O
. O

The O
relation O
between O
myocardial _RARE_
beta I-GENE
- I-GENE
adrenergic I-GENE
receptor I-GENE
and O
left _RARE_
ventricular O
( O
LV O
) O
function O
was O
studied O
in O
10 O
patients O
, O
aged O
41 _RARE_
to O
61 _RARE_
years O
( O
average O
51 _RARE_
), _RARE_
with O
LV O
volume O
overload O
mainly O
due O
to O
chronic O
mitral O
regurgitation _RARE_
. O

Since O
each O
transcript O
appears O
to O
encode O
the O
same O
protein O
, O
this O
complexity O
may O
reflect O
the O
need O
for _RARE_
lineage O
- O
specific O
or O
differentiation O
- O
dependent O
control O
of O
expression _RARE_
. O

In O
patients O
with O
limited O
disease _RARE_
, O
the O
survival O
in O
the O
alternating _RARE_
arm _RARE_
was O
significantly O
superior O
to O
the O
survival O
in O
the O
CAV _RARE_
arm _RARE_
( O
P O
= O
. O
014 _RARE_
) O
or O
the O
survival O
in O
the O
PE _RARE_
arm _RARE_
( O
P O
= O
. O
023 _RARE_
). O

We O
identify O
the O
" O
M O
region O
" O
of O
the O
muscle I-GENE
- I-GENE
specific I-GENE
Xenopus I-GENE
cardiac I-GENE
actin I-GENE
gene I-GENE
promoter I-GENE
from O
- O
282 _RARE_
to O
- O
348 _RARE_
as _RARE_
necessary O
for _RARE_
the O
embryonic _RARE_
expression _RARE_
of O
a O
cardiac O
actin I-GENE
- O
beta I-GENE
- I-GENE
globin I-GENE
reporter O
gene O
injected O
into O
fertilized _RARE_
eggs O
. O

In O
addition O
to O
the O
previously O
identified O
and O
characterized O
attenuator _RARE_
1 I-GENE
situated O
93 O
nucleotides O
downstream _RARE_
from O
the O
major O
late _RARE_
transcription O
start _RARE_
site O
, O
a O
second O
attenuator _RARE_
, O
attenuator _RARE_
2 I-GENE
, O
situated O
55 _RARE_
nucleotides O
downstream _RARE_
from O
it O
, O
has O
been O
identified O
. O

EBNA I-GENE
- I-GENE
2 I-GENE
and O
the O
cis O
- O
acting O
CD23 I-GENE
element I-GENE
increased O
TK I-GENE
- O
promoted O
mRNA O
and O
did O
not O
alter O
the O
herpes I-GENE
simplex I-GENE
virus I-GENE
TK I-GENE
promoter I-GENE
transcription I-GENE
start _RARE_
site I-GENE
. O

These O
experiments O
delineate _RARE_
a O
186 _RARE_
- O
bp O
, O
EBNA I-GENE
- I-GENE
2 I-GENE
- O
responsive O
cell O
DNA O
fragment O
and O
provide O
firm _RARE_
evidence O
that O
EBNA I-GENE
- I-GENE
2 I-GENE
transactivates O
transcription O
of O
cell O
genes O
. O

Plasma O
vitamin O
E O
, O
total _RARE_
lipids O
and O
myeloperoxidase _RARE_
levels O
during _RARE_
spinal _RARE_
surgery O
. O

Transfecting _RARE_
the O
cloned _RARE_
bovine O
PBR _RARE_
/ O
IBP _RARE_
cDNA O
into O
COS O
- O
7 O
cells O
resulted O
in O
an O
11 O
- O
fold _RARE_
increase O
in O
the O
density O
of O
high O
affinity O
[ _RARE_
3H O
] O
PK _RARE_
11195 _RARE_
binding O
sites O
which O
had O
only O
low O
affinity O
for _RARE_
Ro5 _RARE_
- O
4864 _RARE_
. O

The O
initial O
phase _RARE_
of O
increased O
vascular O
permeability _RARE_
in O
the O
peritoneal O
cavity O
and O
LTB4 _RARE_
production O
was O
dose O
dependently O
inhibited O
by O
the O
5 O
- O
LO _RARE_
inhibitors _RARE_
phenidone _RARE_
, O
BW _RARE_
A4C _RARE_
, O
A63162 _RARE_
, O
and O
ICI _RARE_
207 _RARE_
968 _RARE_
but O
not O
by O
dexamethasone O
or O
colchicine _RARE_
. O

Discrepant _RARE_
results O
with O
a O
latex O
agglutination _RARE_
test O
in O
the O
assessment O
of O
cytomegalovirus _RARE_
antibody O
status O
of O
cardiac O
transplant O
donors O
. O

Each O
mRNA O
contained O
five O
or O
six _RARE_
internal O
uridine _RARE_
residues O
, O
which O
were O
transcribed _RARE_
using O
a O
mixture O
of O
UTP _RARE_
and O
thio _RARE_
- O
UTP _RARE_
. O

We O
have O
isolated O
and O
sequenced O
two O
overlapping O
cDNA O
fragments O
which O
could O
encode O
the O
complete _RARE_
amino O
acid O
sequence O
of O
rat I-GENE
testis _RARE_
fructose _RARE_
- I-GENE
6 I-GENE
- I-GENE
phosphate I-GENE
, I-GENE
2 I-GENE
- I-GENE
kinase I-GENE
: O
fructose _RARE_
- I-GENE
2 I-GENE
, I-GENE
6 I-GENE
- I-GENE
bisphosphatase _RARE_
. O

We O
have O
identified O
SWI5 _RARE_
' O
s O
nuclear O
localization _RARE_
signal O
( O
NLS O
) O
and O
show O
that O
it O
can O
confer O
cell O
cycle _RARE_
- O
dependent O
nuclear O
entry O
to O
a O
heterologous O
protein O
. O

In O
contrast O
to O
behavioral O
deviation O
( O
the O
avoidance _RARE_
conditioning O
lost O
), _RARE_
the O
haloperidol O
intrastriatal _RARE_
microinjections _RARE_
did O
not O
affect O
the O
DA _RARE_
synaptic O
level O
in O
rostral _RARE_
neostriatum _RARE_
. O

In O
similar O
transient O
transfection O
experiments O
in O
HeLa O
cells O
, O
overexpression O
of O
the O
wt I-GENE
human I-GENE
retinoblastoma _RARE_
susceptibility _RARE_
gene I-GENE
product I-GENE
, O
RB _RARE_
, O
was O
found O
to O
repress O
the O
serum O
- O
induced _RARE_
IL _RARE_
- I-GENE
6 I-GENE
(- _RARE_
225 _RARE_
to O
+ O
13 _RARE_
), _RARE_
c I-GENE
- I-GENE
fos I-GENE
(- _RARE_
711 _RARE_
to O
+ O
42 _RARE_
), _RARE_
and O
beta I-GENE
- I-GENE
actin I-GENE
(- _RARE_
3400 _RARE_
to O
+ O
912 _RARE_
) O
promoters O
but O
not O
the O
PRV _RARE_
- O
induced _RARE_
IL _RARE_
- I-GENE
6 I-GENE
(- _RARE_
110 _RARE_
to O
+ O
13 _RARE_
) O
or O
the O
serum O
- O
induced _RARE_
MHC I-GENE
(- _RARE_
528 _RARE_
to O
- O
38 O
) O
promoters O
. O

This O
repression O
was O
mediated _RARE_
through O
binding O
to O
the O
E2 I-GENE
DNA I-GENE
- I-GENE
binding I-GENE
site I-GENE
immediately O
upstream O
of O
the O
P105 _RARE_
promoter O
TATA O
box O
and O
could O
be O
abrogated O
by O
preincubation _RARE_
of O
the O
HPV I-GENE
- I-GENE
18 I-GENE
P105 _RARE_
promoter I-GENE
template O
with O
the O
nuclear O
extract _RARE_
allowing O
the O
formation O
of O
the O
preinitiation _RARE_
complex O
. O

We O
did O
not O
detect O
p50 _RARE_
in O
association O
with O
native _RARE_
glucocorticoid I-GENE
receptor I-GENE
in O
L O
cells O
or O
with O
the O
overexpressed O
glucocorticoid I-GENE
receptor I-GENE
in O
Chinese _RARE_
hamster O
ovary O
cells O
. O

Two O
putative O
12 O
- O
O O
- O
tetradecanoyl _RARE_
- O
phorbol O
- O
13 _RARE_
- O
acetate _RARE_
( O
TPA _RARE_
) O
response O
elements O
, O
that O
might O
serve O
as _RARE_
binding O
sites O
for _RARE_
the O
transcription I-GENE
factor I-GENE
AP I-GENE
- I-GENE
1 I-GENE
and O
a O
consensus O
sequence O
of O
a O
transforming I-GENE
growth I-GENE
factor I-GENE
beta I-GENE
1 I-GENE
( O
TGF I-GENE
- I-GENE
beta I-GENE
1 I-GENE
) O
inhibitory _RARE_
element O
were O
found O
in O
the O
promoter O
region O
. O

TPA _RARE_
and O
TGF I-GENE
- I-GENE
beta I-GENE
1 I-GENE
did O
not O
markedly O
affect O
the O
activities O
of O
the O
72 O
- O
kDa O
enzyme O
. O

They O
were O
almost O
regularly _RARE_
excited _RARE_
by O
pressure O
to O
the O
ipsilateral O
cornea _RARE_
or O
to O
both O
corneas _RARE_
at _RARE_
a O
strength O
well _RARE_
above O
the O
human O
corneal O
pain O
threshold O
. O

Feed _RARE_
intake O
was O
not O
affected O
by O
dietary O
KCl _RARE_
or O
NaHCO3 _RARE_
supplementation O
, O
but O
average O
daily O
gain O
increased O
with O
increased O
K O
and O
tended O
to O
be O
reduced _RARE_
by O
dietary O
NaHCO3 _RARE_
. O

Extraction _RARE_
procedure O
for _RARE_
the O
measurement O
of O
butyltin _RARE_
compounds O
in O
biological O
tissues O
using O
toluene O
, O
HBr _RARE_
, O
and O
tropolone _RARE_
. O

In O
this O
study O
, O
we O
have O
cloned _RARE_
a O
region O
that O
complements _RARE_
the O
exoenzyme _RARE_
S I-GENE
- O
deficient _RARE_
phenotype _RARE_
of O
strain _RARE_
388 _RARE_
exs1 _RARE_
:: O
Tn1 _RARE_
, O
a O
chromosomal I-GENE
Tn1 _RARE_
insertional _RARE_
mutation I-GENE
. O

axl _RARE_
, O
a O
transforming O
gene O
isolated O
from O
primary _RARE_
human O
myeloid _RARE_
leukemia O
cells O
, O
encodes O
a O
novel O
receptor I-GENE
tyrosine I-GENE
kinase I-GENE
. O

Alignment _RARE_
of O
the O
amino O
acid O
sequences O
surrounding O
Tyr _RARE_
- O
766 _RARE_
with O
corresponding O
regions O
of O
other O
FGFRs _RARE_
revealed O
conserved _RARE_
tyrosine O
residues O
in O
all O
known O
members O
of O
the O
FGFR I-GENE
family I-GENE
. O

The O
single O
most O
important O
element O
, O
by O
linker _RARE_
- O
scanning O
analysis O
, O
is O
a O
10 O
- O
bp O
region O
that O
contains O
a O
CCAAT O
motif O
. O

Capnography _RARE_
curves O
of O
40 O
HVS O
patients O
, O
40 O
non O
- O
HVS O
patients O
with O
psycho _RARE_
- O
somatic O
complaints _RARE_
and O
26 _RARE_
healthy O
controls O
were O
analyzed O
. O

The O
transcription O
initiation O
site O
was O
determined O
to O
occur O
66 _RARE_
bp O
upstream O
of O
the O
initiating O
Met _RARE_
. O

All O
anti I-GENE
- I-GENE
I I-GENE
and O
anti I-GENE
- I-GENE
i I-GENE
CA I-GENE
were O
shown O
to O
express O
VH4 _RARE_
heavy I-GENE
chains I-GENE
, O
and O
14 O
of O
17 _RARE_
CA I-GENE
expressed _RARE_
a O
previously O
described O
VH4 _RARE_
second O
hypervariable _RARE_
region O
determinant O
, O
termed O
VH4 _RARE_
- I-GENE
HV2a _RARE_
. O

Intron _RARE_
K1 _RARE_
cox1 _RARE_
. I-GENE
2 I-GENE
is O
not O
found O
in O
S O
. O
cerevisiae O
and O
appears O
at _RARE_
an O
unique O
location O
in O
K O
. O
lactis O
. O

We O
have O
determined O
that O
the O
mutants O
define O
two O
complementation _RARE_
groups O
, O
designated O
cgs1 _RARE_
+ I-GENE
and O
cgs2 _RARE_
+ I-GENE
( O
continues _RARE_
to O
grow O
in O
stationary O
). O

However O
, O
alterations O
in O
electrostatic _RARE_
and O
hydrophobic O
interactions O
created O
by O
the O
three O
amino O
acid O
substitutions O
prevent O
the O
conformational O
change O
in O
the O
enzyme O
usually O
produced O
by O
calmodulin I-GENE
binding O
. O

The O
results O
of O
induced _RARE_
coexpression O
were O
also O
supported O
by O
rapid O
generation O
of O
FeLV _RARE_
recombinants _RARE_
when O
FeLV _RARE_
- O
C O
was O
used O
to O
infect _RARE_
the O
feline _RARE_
3201B _RARE_
cell O
line O
that O
constitutively O
expresses _RARE_
high O
levels O
of O
endogenous O
FeLV _RARE_
- O
specific O
mRNAs O
. O

Recombination _RARE_
between O
feline _RARE_
leukemia O
virus O
subgroup O
B O
or O
C O
and O
endogenous O
env I-GENE
elements O
alters O
the O
in O
vitro O
biological O
activities O
of O
the O
viruses O
. O

The O
nucleotide O
sequences O
at _RARE_
the O
5 O
' O
and O
3 O
' O
ends O
of O
these O
introns _RARE_
are O
characteristic O
of O
spliced _RARE_
transcripts O
from O
eukaryotic O
protein O
- O
encoding O
genes O
, O
with O
one O
significant O
difference O
; O
i O
. O
e _RARE_
., O
the O
5 O
' O
end O
of O
the O
LAT _RARE_
intron I-GENE
is O
GC _RARE_
instead O
of O
the O
consensus O
sequence O
GT _RARE_
. O

At O
1 O
, O
5 O
, O
and O
9 O
months O
after O
initial O
isolation O
of O
C O
. O
kutscheri _RARE_
from O
the O
oral O
cavity O
, O
hamsters O
were O
euthanatized _RARE_
, O
and O
attempts O
were O
made O
to O
culture O
C O
. O
kutscheri _RARE_
from O
13 _RARE_
additional O
sites O
. O

The O
strategy O
has O
been O
used O
to O
determine O
2 O
. O
6 O
kilobases O
of O
nucleotide O
sequence O
in O
the O
Saccharomyces I-GENE
cerevisiae I-GENE
ADE _RARE_
1 I-GENE
locus I-GENE
. O

Two O
independent O
promoters O
as _RARE_
well _RARE_
as _RARE_
5 O
' O
untranslated _RARE_
regions O
regulate O
Dd _RARE_
ras I-GENE
expression _RARE_
in O
Dictyostelium O
. O

The O
results O
suggested O
that O
, O
depending O
upon O
the O
cell O
type O
, O
gene O
cotransfer _RARE_
using O
aminoglycoside _RARE_
resistance O
as _RARE_
a O
selectable O
marker O
may O
seriously _RARE_
perturb _RARE_
important O
cellular O
control O
mechanisms O
such O
as _RARE_
the O
PKC I-GENE
pathway _RARE_
leading O
to O
activation O
of O
gene O
expression _RARE_
. O

Transfer _RARE_
RNA O
genes O
from O
Dictyostelium O
discoideum _RARE_
are O
frequently O
associated O
with O
repetitive _RARE_
elements O
and O
contain O
consensus O
boxes _RARE_
in O
their O
5 O
' O
and O
3 O
'- O
flanking O
regions O
. O

Therefore O
, O
the O
strD _RARE_
and O
strE _RARE_
genes I-GENE
could O
serve O
as _RARE_
universal _RARE_
probes _RARE_
indicative O
of O
the O
presence O
of O
biosynthetic O
capacity O
for _RARE_
6 O
- O
deoxyhexose _RARE_
moieties _RARE_
. O

The O
two O
genes O
code O
for _RARE_
polypeptides I-GENE
of I-GENE
420 _RARE_
amino I-GENE
acids _RARE_
( I-GENE
M I-GENE
. I-GENE
HgiCI _RARE_
) I-GENE
and O
345 _RARE_
amino O
acids _RARE_
( O
R O
. O
HgiCI _RARE_
). O

Expression O
of O
the O
wt1 _RARE_
gene I-GENE
via O
transient O
transfection O
in O
COS O
- O
1 O
cells O
revealed O
a O
52 O
kDa O
protein O
which O
was O
immunoprecipitated O
by O
both O
the O
N O
- O
terminal O
- O
and O
C O
- O
terminal O
- O
specific O
antisera O
. O

The O
factor O
which O
binds O
to O
the O
TR I-GENE
promoter I-GENE
co _RARE_
- O
sedimented _RARE_
with O
SV40 O
chromosomes O
extracted O
late _RARE_
in O
infection O
. O

Temafloxacin _RARE_
400 _RARE_
mg O
b O
. O
i O
. O
d O
. O
administered O
orally O
for _RARE_
28 _RARE_
days O
represents O
a O
safe O
and O
effective O
treatment O
for _RARE_
chronic O
bacterial O
prostatitis _RARE_
. O

Its O
neuromuscular O
effects O
are O
similar O
to O
a O
single O
ED90 _RARE_
dose O
of O
vecuronium _RARE_
. O

The O
patient O
with O
a O
prolonged O
fever O
caused O
by O
dissecting _RARE_
aneurysm _RARE_
of O
the O
aorta O
in O
whom O
pleuropneumonia _RARE_
masked _RARE_
the O
real O
diseases O
has O
been O
presented O
. O

The O
resulting O
clone O
pKB11 _RARE_
, O
which O
has O
a O
1369 _RARE_
- O
base _RARE_
pair _RARE_
( O
bp O
) O
cDNA O
insert O
, O
overlapping O
pCAD142 _RARE_
by O
781 _RARE_
bp O
, O
was O
identified O
by O
hybridization O
methods O
and O
sequence O
analysis O
and O
found O
to O
contain O
the O
entire _RARE_
cDNA O
sequence O
for _RARE_
the O
amino O
end O
of O
the O
CAD _RARE_
polypeptide I-GENE
. O

This O
conclusion O
was O
confirmed O
by O
Northern O
blotting O
analysis O
of O
the O
5 O
'- O
flanking O
region O
of O
CAD _RARE_
gene I-GENE
. O

We O
report O
the O
isolation O
of O
genomic O
and O
cDNA O
clones _RARE_
of O
the O
light O
- O
independent O
Sn _RARE_
: I-GENE
bol3 _RARE_
allele I-GENE
. O

Histamine _RARE_
- O
2 O
blockade O
in O
psoriasis O

Its O
clearance O
has O
been O
found O
to O
be O
decreased O
( O
typically O
by O
around O
25 _RARE_
%, O
but O
often O
by O
far O
more O
) O
by O
erythromycin _RARE_
, O
troleandomycin _RARE_
( O
triacetyloleandomycin _RARE_
), _RARE_
roxithromycin _RARE_
, O
enoxacin _RARE_
, O
ciprofloxacin _RARE_
, O
pefloxacin _RARE_
, O
norfloxacin _RARE_
, O
ofloxacin _RARE_
, O
fluoroquinolone _RARE_
T O
- O
3262 _RARE_
, O
pipemidic _RARE_
acid O
, O
cimetidine O
, O
etintidine _RARE_
, O
propranolol O
, O
verapamil O
, O
diltiazem O
, O
nifedipine O
, O
furosemide O
( O
frusemide _RARE_
), _RARE_
at _RARE_
least O
some O
anovulent _RARE_
agents O
, O
viloxazine _RARE_
, O
allopurinol _RARE_
, O
ticlopidine _RARE_
, O
idrocilamide _RARE_
, O
thiabendazole _RARE_
, O
disulfiram _RARE_
, O
influenza _RARE_
- O
and O
BCG O
- O
vaccination O
, O
interferon _RARE_
, O
and O
caffeine O
( O
half _RARE_
- O
life O
increase O
). O

A O
third O
is O
a O
partial O
element O
terminating _RARE_
at _RARE_
a O
probable O
internal O
restriction _RARE_
site O
used O
for _RARE_
cloning O
. O

We O
enrolled O
253 _RARE_
HIV I-GENE
- I-GENE
antibody I-GENE
positive O
heroin _RARE_
addicts O
without O
HIV O
- O
related O
disease _RARE_
( O
n _RARE_
= O
81 _RARE_
) O
or O
with O
persistent O
generalized O
lymphadenopathy _RARE_
( O
n _RARE_
= O
172 _RARE_
) O
in O
a O
prospective O
study O
to O
evaluate O
clinical O
progression O
to O
AIDS O
related O
complex O
( O
ARC _RARE_
) O
or O
AIDS O
and O
to O
identify O
factors O
of O
possible O
prognostic O
relevance O
. O

No O
homology O
was O
found O
between O
RNA14 _RARE_
and O
RNA15 _RARE_
or O
between O
RNA14 _RARE_
and O
other O
proteins O
contained O
in O
data O
banks _RARE_
. O

Mutations O
in O
the O
yeast I-GENE
RNA14 _RARE_
and O
RNA15 _RARE_
genes I-GENE
result O
in O
an O
abnormal O
mRNA O
decay _RARE_
rate O
; O
sequence O
analysis O
reveals O
an O
RNA O
- O
binding O
domain O
in O
the O
RNA15 _RARE_
protein I-GENE
. O

Myocardial O
infarction O
in O
patients O
with O
previous O
bypass O
surgery O
. O

The O
most O
striking O
difference O
in O
the O
birch _RARE_
NAD _RARE_
( I-GENE
P I-GENE
) I-GENE
H I-GENE
- I-GENE
NR _RARE_
sequence I-GENE
in O
comparison O
to O
NADH _RARE_
- I-GENE
NR _RARE_
sequences I-GENE
was O
found O
at _RARE_
the O
putative O
pyridine _RARE_
nucleotide O
binding O
site O
. O

A O
single O
amino O
acid O
difference O
in O
the O
C O
- O
terminal O
region O
influences O
dominant O
negative O
activity O
and O
receptor O
dimer _RARE_
formation O
. O

No O
such O
benefits O
were O
seen O
for _RARE_
children O
with O
CD4 _RARE_
+ I-GENE
counts O
below O
0 _RARE_
. O
2 O
x _RARE_
10 O
( O
9 O
) O
per O
liter O
at _RARE_
entry O
. O

Because O
the O
human I-GENE
Antp _RARE_
TATAA _RARE_
binding I-GENE
protein I-GENE
is O
expressed _RARE_
in O
both O
lymphoid _RARE_
and O
non O
- O
lymphoid _RARE_
cells O
, O
we O
suggest O
that O
this O
homeobox _RARE_
gene I-GENE
has O
evolved O
a O
more O
general _RARE_
transcriptional O
regulatory O
function O
in O
higher _RARE_
eukaryotic O
cells O
. O

The O
95 _RARE_
% O
confidence O
values O
( O
2SD _RARE_
) O
for _RARE_
the O
change O
in O
Ros _RARE_
required O
to O
exclude _RARE_
natural _RARE_
variability O
were O
0 _RARE_
. O
39 _RARE_
, O
0 _RARE_
. O
50 O
and O
0 _RARE_
. O
53 O
cmH2O O
l _RARE_
- O
1 O
s O
, O
respectively O
. O

Among O
953 _RARE_
infants O
in O
22 _RARE_
neonatal O
care O
units _RARE_
studied O
, O
23 _RARE_
% O
( O
median O
value O
, O
range O
0 _RARE_
- O
78 _RARE_
) O
were O
found O
to O
be O
faecally _RARE_
colonized _RARE_
with O
one O
of O
21 O
distinct O
nosocomial _RARE_
strains O
of O
Escherichia O
coli O
, O
Klebsiella _RARE_
or O
Enterobacter _RARE_
spp _RARE_
. O

Biochemical O
studies O
revealed O
the O
expected O
loss _RARE_
of O
ChAT _RARE_
activity O
in O
the O
dorsal O
and O
ventral O
hippocampi _RARE_
of O
lesioned O
animals O
along O
with O
elevated O
levels O
of O
norepinephrine O
( O
NE _RARE_
) O
in O
the O
dorsal O
hippocampus O
of O
MS O
/ O
HSI _RARE_
animals O
.( O
ABSTRACT O
TRUNCATED O
AT O
250 _RARE_
WORDS O
) O

The O
localization _RARE_
of O
this O
proteoglycan _RARE_
locus O
in O
the O
human O
genome O
and O
the O
availability O
of O
new O
RFLPs _RARE_
provide O
the O
tools O
for _RARE_
future O
studies O
of O
human O
diseases O
where O
the O
HSPG2 _RARE_
proteoglycan _RARE_
gene I-GENE
is O
suspected O
to O
be O
involved O
. O

After O
2 O
min O
of O
dobutamine _RARE_
injection O
, O
or O
after O
20 O
min O
of O
pimobendan _RARE_
injection O
, O
the O
myocardium O
was O
removed O
, O
and O
used O
for _RARE_
determination O
of O
the O
tissue O
levels O
of O
metabolites O
of O
energy O
and O
carbohydrate O
metabolism O
. O

During O
coronary O
stenosis O
, O
on O
the O
contrary _RARE_
, O
intracoronary _RARE_
procaterol _RARE_
at _RARE_
the O
same O
dose O
significantly O
deteriorated _RARE_
regional O
myocardial _RARE_
dysfunction O
without O
changing O
LCX _RARE_
flow O
, O
global O
hemodynamics O
and O
cardiac O
lactate _RARE_
metabolism O
. O

Here O
we O
present O
evidence O
that O
major I-GENE
IE I-GENE
proteins I-GENE
IE86 _RARE_
, O
IE72 _RARE_
, O
and O
IE55 _RARE_
are O
capable O
of O
trans _RARE_
- O
activating O
the O
HIV I-GENE
LTR I-GENE
in O
a O
T O
- O
cell O
line O
, O
HUT _RARE_
- O
78 _RARE_
. O

In O
a O
country _RARE_
where O
general _RARE_
HIV O
prevalence O
is O
low O
, O
the O
strategy O
is O
cost O
- O
effective O
for _RARE_
location O
and O
counselling _RARE_
of O
unknowingly _RARE_
seropositive O
individuals O
. O

The O
cis O
- O
acting O
element O
mediating O
glucocorticoid O
inducibility O
of O
the O
chicken I-GENE
glutamine _RARE_
synthetase _RARE_
gene I-GENE
has O
been O
identified O
. O

However O
, O
the O
increase O
in O
biliary O
excretion O
did O
not O
compensate _RARE_
for _RARE_
the O
reduced _RARE_
elimination O
of O
bretylium _RARE_
and O
hexylsalicylic _RARE_
acid O
via O
the O
kidney _RARE_
. O

Diagnostic O
value O
of O
cerebrospinal _RARE_
fluid _RARE_
immunoglobulin I-GENE
G I-GENE
( O
IgG I-GENE
) O
in O
pediatric O
neurological O
diseases O
. O

Expression O
of O
six _RARE_
genes O
, O
ipaB _RARE_
, O
ipaC _RARE_
, O
invE _RARE_
, O
invG _RARE_
, O
invJ _RARE_
, O
and O
invK _RARE_
, O
was O
apparently O
regulated O
by O
the O
positive O
regulator O
virF _RARE_
. O

Inducible _RARE_
VT O
was O
suppressed O
entirely O
in O
one O
patient O
. O

Venkatesan _RARE_
, O
and O
D O
. O

The O
presence O
of O
the O
corresponding O
mature _RARE_
mRNA O
transcripts O
( O
3 O
. O
2 O
- O
3 O
. O
5 O
kilobase _RARE_
pairs _RARE_
( O
kb O
] O
in O
human O
fibroblasts _RARE_
was O
shown O
by O
Northern O
blot O
hybridization O
, O
S1 I-GENE
nuclease _RARE_
protection O
assay O
, O
and O
the O
polymerase O
chain O
reaction O
. O

Approximately O
50 O
% O
of O
the O
ribosomal O
DNA O
( O
rDNA _RARE_
) O
units _RARE_
of O
Drosophila O
melanogaster O
are O
inactivated O
by O
two O
different O
28 _RARE_
S I-GENE
RNA I-GENE
ribosomal I-GENE
gene I-GENE
insertions O
( O
type O
I O
and O
type O
II O
). O

Gap _RARE_
b3 _RARE_
consists O
of O
two O
polypeptide O
chains O
( O
Mr O
= O
110 _RARE_
, O
000 _RARE_
and O
30 _RARE_
, O
000 _RARE_
), _RARE_
which O
seem O
to O
be O
proteolytic _RARE_
cleavage _RARE_
products O
connected O
by O
disulfide O
bonds O
from O
a O
precursor O
protein O
. O

However O
, O
the O
rtFc _RARE_
gamma I-GENE
R I-GENE
alpha I-GENE
cDNA I-GENE
clone O
is O
complementary _RARE_
to O
at _RARE_
least O
two O
different O
- O
sized O
mRNAs O
expressed _RARE_
by O
CRNK _RARE_
- O
16 O
cells O
, O
contrasting _RARE_
the O
single O
Fc I-GENE
gamma I-GENE
R I-GENE
- I-GENE
related I-GENE
mRNA I-GENE
species O
expressed _RARE_
by O
human O
and O
mouse O
natural _RARE_
killer O
cells O
. O

Both O
genes O
comprise O
three O
exons O
, O
two O
introns _RARE_
and O
an O
unusually O
long O
3 O
'- O
untranslated _RARE_
region O
( O
3 O
. O
2 O
kilobase _RARE_
pairs _RARE_
), _RARE_
specificying _RARE_
a O
mRNA O
of O
approximately _RARE_
4 O
. O
1 O
kilobases O
. O

Stable O
expression _RARE_
of O
the O
chimeric O
alpha I-GENE
i I-GENE
( I-GENE
54 I-GENE
)/ _RARE_
s I-GENE
polypeptide O
in O
Chinese _RARE_
hamster O
ovary O
( O
CHO O
) O
cells O
constitutively O
increased O
both O
cAMP O
synthesis _RARE_
and O
cAMP I-GENE
- I-GENE
dependent I-GENE
protein I-GENE
kinase I-GENE
activity O
. O

This O
exon _RARE_
, O
here O
named O
exon _RARE_
0 _RARE_
, O
contained O
the O
entire _RARE_
5 O
' O
untranslated _RARE_
region O
and O
the O
N O
- O
terminal O
signal O
sequence O
of O
the O
polypeptide O
. O

Treatment O
of O
human O
myeloid _RARE_
cell O
lines O
HL _RARE_
- O
60 _RARE_
and O
U937 O
with O
phorbol O
12 O
- O
myristate O
13 _RARE_
- O
acetate _RARE_
( O
PMA O
) O
increased O
within O
2 O
h O
cellular O
levels O
of O
the O
RNA O
hybridizable _RARE_
to O
LD78 _RARE_
cDNA I-GENE
. O

A O
new O
, O
flexible _RARE_
fiberoptic _RARE_
ventriculoscope _RARE_
for _RARE_
observation O
of O
the O
ventricles O
and O
major O
cisterns _RARE_
is O
reported O
. O

Isopenicillin _RARE_
N I-GENE
isomerase I-GENE
( O
epimerase _RARE_
) O
has O
been O
purified _RARE_
from O
Streptomyces _RARE_
clavuligerus _RARE_
, O
and O
the O
amino O
acid O
sequence O
of O
the O
N O
- O
terminus O
has O
been O
determined O
. O

Serum O
IgG I-GENE
was O
initially O
elevated O
in O
6 O
patients O
. O

The O
patient O
initially O
attained _RARE_
complete _RARE_
remission O
( O
CR1 _RARE_
) O
with O
conventional O
chemotherapy O
and O
then O
relapsed _RARE_
14 O
months O
later O
. O

157 _RARE_
+/- O
16 O
mg O
/ O
dl O
; O
NS _RARE_
), _RARE_
glucose O
levels O
, O
and O
basal O
( O
17 _RARE_
+/- O
4 O
vs _RARE_
. O

Platelet _RARE_
aggregation _RARE_
and O
metabolic O
control O
are O
not O
affected O
by O
calcium _RARE_
antagonist O
treatment O
in O
type O
II O
diabetes O
mellitus O
. O

Wnt I-GENE
- I-GENE
1 I-GENE
( O
int I-GENE
- I-GENE
1 I-GENE
) O
is O
a O
cellular O
oncogene O
often O
activated O
by O
insertion _RARE_
of O
proviral _RARE_
DNA O
of O
the O
mouse O
mammary O
tumor O
virus O
. O

Induction O
of O
Jurkat O
leukemic _RARE_
T O
cells O
with O
phorbol O
12 O
- O
myristate O
13 _RARE_
- O
acetate _RARE_
and O
ionomycin _RARE_
did O
not O
affect O
the O
level O
of O
FKBP _RARE_
mRNA I-GENE
. O

GLUT5 _RARE_
mRNA I-GENE
is O
expressed _RARE_
at _RARE_
highest O
levels O
in O
small O
intestine O
and O
at _RARE_
much O
lower O
levels O
in O
kidney _RARE_
, O
skeletal O
muscle O
, O
and O
adipose _RARE_
tissue O
. O

e _RARE_
. O

We O
speculate _RARE_
that O
these O
tumors O
may O
represent O
congenital O
hamartomatous _RARE_
growths _RARE_
. O

Identification O
and O
characterization O
of O
the O
promoter O
for _RARE_
the O
cytotactin _RARE_
gene I-GENE
. O

Surprisingly O
, O
there O
is O
no _RARE_
sequence O
homology O
between O
this O
region O
of O
Ly _RARE_
- I-GENE
6E _RARE_
and O
the O
established O
consensus O
for _RARE_
the O
interferon _RARE_
- I-GENE
stimulated _RARE_
response I-GENE
element I-GENE
, O
which O
has O
been O
shown O
functionally O
important O
to O
all O
previously O
characterized O
alpha I-GENE
/ I-GENE
beta I-GENE
interferon _RARE_
- O
inducible O
promoters O
. O

Relatively _RARE_
large O
DNA O
rearrangements _RARE_
spanning O
the O
region O
with O
tandem _RARE_
direct O
repeats O
encoding O
the O
carboxy _RARE_
- O
terminal O
histone I-GENE
H1 _RARE_
- I-GENE
like I-GENE
structure _RARE_
of O
AlgP _RARE_
were O
detected O
in O
several O
strains O
upon O
conversion O
from O
the O
mucoid _RARE_
to O
the O
nonmucoid _RARE_
phenotype _RARE_
. O

( O
1988 O
) O
J _RARE_
. O

These O
results O
strongly O
suggested O
that O
similar O
, O
if O
not O
identical O
, O
the O
CArG _RARE_
box I-GENE
binding I-GENE
proteins I-GENE
interact O
with O
the O
functionally O
different O
promoter O
element O
in O
the O
VLC1 _RARE_
, O
cardiac I-GENE
alpha I-GENE
- I-GENE
actin I-GENE
, O
and O
c I-GENE
- I-GENE
fos I-GENE
genes I-GENE
. O

Polyadenylation _RARE_
of O
B4 _RARE_
RNA I-GENE
, O
which O
occurs O
very O
early O
during _RARE_
maturation _RARE_
, O
is O
limited O
to O
150 _RARE_
residues O
, O
and O
it O
is O
this O
number O
that O
is O
required O
for _RARE_
polysomal _RARE_
recruitment O
. O

Co O
- O
existence O
of O
these O
regulatory O
elements O
with O
other O
elements O
, O
such O
as _RARE_
the O
AP I-GENE
- I-GENE
2 I-GENE
element I-GENE
or O
CCAAT O
box O
, O
was O
also O
found O
. O

Recently O
, O
studies O
of O
agents O
that O
disrupt O
collagen _RARE_
synthesis _RARE_
and O
deposition O
have O
yielded O
several O
new O
angiogenesis O
inhibitors _RARE_
. O

Since O
the O
5 O
'- O
flanking O
region O
of O
this O
gene O
is O
likely O
involved O
in O
hormonal O
regulation _RARE_
of O
its O
expression _RARE_
, O
we O
have O
isolated O
and O
partially O
characterized O
an O
avian O
fatty I-GENE
acid I-GENE
synthase I-GENE
gene O
. O

A O
new O
set O
of O
cDNA O
clones _RARE_
spanning O
approximately _RARE_
3 O
. O
2 O
kb O
was O
isolated O
from O
a O
lambda O
- O
ZAP _RARE_
goose _RARE_
liver O
cDNA O
library O
using O
the O
5 O
'- O
most O
exon _RARE_
- O
containing O
fragment O
of O
the O
5 O
'- O
most O
genomic O
DNA O
clone O
. O

Northern O
blotting O
analysis O
indicates O
that O
expression _RARE_
of O
the O
genes O
corresponding O
to O
these O
clones _RARE_
is O
confined O
to O
pollen O
tissue O
. O

Whereas O
cDNA O
hybridization O
to O
genomic O
DNA O
blots O
indicated O
a O
small O
subfamily O
of O
G0S19 _RARE_
genes I-GENE
, O
simple O
patterns O
of O
bands O
indicated O
that O
most O
cDNAs O
, O
including O
G0S30 _RARE_
cDNA I-GENE
, O
corresponded O
to O
single O
- O
copy O
genes O
. O

Lymphoproliferative _RARE_
disorders O
arising O
under O
immunosuppression _RARE_
with O
FK O
506 _RARE_
: O
initial O
observations O
in O
a O
large O
transplant O
population O
. O

The O
Drosophila I-GENE
suppressor I-GENE
of I-GENE
sable _RARE_
gene I-GENE
encodes O
a O
polypeptide O
with O
regions O
similar O
to O
those O
of O
RNA O
- O
binding O
proteins O
. O

2 O
: O
121 _RARE_
- O
133 _RARE_
, O
1988 O
). O

It O
is O
, O
however O
, O
extremely O
homologous O
to O
a O
third O
' O
non O
- O
classical O
' O
gene O
, O
HLA I-GENE
- I-GENE
5 I-GENE
. I-GENE
4 I-GENE
, O
and O
to O
the O
chimpanzee _RARE_
gene O
, O
Ch28 _RARE_
. O

Although O
the O
N13 _RARE_
- O
N20 _RARE_
interpeak _RARE_
interval O
remained O
stable O
because O
of O
the O
parallel O
shift O
of O
the O
2 O
peaks O
, O
the O
central O
conduction O
time O
measured O
from O
onset O
latencies _RARE_
of O
N11 _RARE_
and O
N20 _RARE_
significantly O
increased O
. O

Using O
avidin _RARE_
- I-GENE
biotin _RARE_
complex O
DNA O
binding O
assays O
, O
a O
series O
of O
overlapping O
alpha I-GENE
promoter I-GENE
DNA I-GENE
sequences I-GENE
between O
- O
170 _RARE_
to O
29 O
basepairs _RARE_
were O
tested O
, O
but O
each O
failed O
to O
bind O
GR I-GENE
, O
whereas O
a O
control O
GRE _RARE_
avidly _RARE_
bound _RARE_
receptor O
. O

Sequence O
determination O
of O
isolated O
peptides O
suggested O
that O
Asn120 _RARE_
is O
glycosylated O
, O
Asn65 _RARE_
and O
Asn109 _RARE_
glycosylated O
in O
some O
molecules O
but O
not O
in O
others O
, O
and O
Asn72 _RARE_
not O
glycosylated O
. O

The O
DNA O
sequence O
conferring O
AP I-GENE
- I-GENE
1 I-GENE
activity O
was O
located _RARE_
in O
the O
proximal O
promoter O
region O
. O

The O
murine I-GENE
mutation I-GENE
dominant I-GENE
white _RARE_
spotting _RARE_
( O
W _RARE_
) O
is O
in O
the O
proto _RARE_
- O
oncogene O
, O
c I-GENE
- I-GENE
kit I-GENE
. O

Isolation O
and O
characterization O
of O
the O
rat O
chromosomal O
gene O
for _RARE_
a O
polypeptide O
( O
pS1 _RARE_
) O
antigenically _RARE_
related O
to O
statin _RARE_
. O

The O
proteins O
differ O
in O
the O
presence O
or O
absence O
of O
a O
21 O
- O
amino O
- O
acid O
sequence O
located _RARE_
24 _RARE_
amino O
acids _RARE_
C O
terminal O
of O
the O
translational O
initiation O
codon _RARE_
. O

Our O
results O
also O
indicate O
the O
existence O
of O
sequences O
downstream _RARE_
of O
- O
0 _RARE_
. O
11 O
kb O
which O
can O
influence O
the O
pattern O
of O
tissue O
- O
specific O
expression _RARE_
of O
the O
HLA I-GENE
- I-GENE
B7 I-GENE
gene I-GENE
and O
the O
ability O
of O
this O
gene O
to O
respond O
to O
gamma I-GENE
interferon _RARE_
. O

The O
SH2 _RARE_
and O
SH3 I-GENE
domains I-GENE
of O
pp60src _RARE_
direct O
stable O
association O
with O
tyrosine O
phosphorylated _RARE_
proteins O
p130 I-GENE
and O
p110 _RARE_
. O

Chem O
. O

These O
clones _RARE_
overlapped _RARE_
and O
contained O
the O
structural O
gene O
encoding O
the O
complete _RARE_
C5 _RARE_
alpha I-GENE
- I-GENE
chain I-GENE
and O
90 _RARE_
% O
of O
the O
beta O
- O
chain O
. O

The O
C5 _RARE_
alpha I-GENE
- I-GENE
chain I-GENE
was O
encoded O
by O
49 _RARE_
kilobases O
containing O
26 _RARE_
exons O
; O
the O
beta O
- O
chain O
was O
encoded O
by O
29 O
kilobases O
containing O
16 O
exons O
. O

Heterozygous _RARE_
mutation O
in O
the O
G O
+ O
5 O
position O
of O
intron O
33 _RARE_
of O
the O
pro I-GENE
- I-GENE
alpha I-GENE
2 I-GENE
( I-GENE
I I-GENE
) I-GENE
gene I-GENE
( O
COL1A2 _RARE_
) O
that O
causes O
aberrant O
RNA O
splicing _RARE_
and O
lethal O
osteogenesis _RARE_
imperfecta _RARE_
. O

The O
nucleotide O
sequences O
of O
these O
genes O
differ O
at _RARE_
only O
nine O
positions O
, O
resulting O
in O
three O
amino O
acid O
differences O
. O

The O
protein O
predicted O
by O
the O
sequence O
of O
the O
human I-GENE
pim _RARE_
- I-GENE
1 I-GENE
proto _RARE_
- I-GENE
oncogene I-GENE
shares O
extensive O
homology O
with O
known O
serine I-GENE
/ I-GENE
threonine I-GENE
protein I-GENE
kinases I-GENE
, O
and O
yet O
the O
human I-GENE
Pim _RARE_
- I-GENE
1 I-GENE
enzyme I-GENE
has O
previously O
been O
reported O
to O
exhibit O
protein I-GENE
tyrosine I-GENE
kinase I-GENE
activity O
both O
in O
vitro O
and O
in O
vivo O
. O

A O
full I-GENE
- I-GENE
length I-GENE
human I-GENE
pim _RARE_
- I-GENE
1 I-GENE
cDNA I-GENE
was O
subcloned O
into O
the O
bacterial O
vector O
pGEX _RARE_
- O
2T _RARE_
and O
the O
Pim _RARE_
- I-GENE
1 I-GENE
protein I-GENE
expressed _RARE_
as _RARE_
a O
fusion O
product O
with O
bacterial I-GENE
glutathione _RARE_
S I-GENE
- I-GENE
transferase I-GENE
( O
GST I-GENE
). O

This O
report O
substantiates _RARE_
that O
at _RARE_
least O
two O
of O
the O
18 O
kDa O
hsps _RARE_
in O
maize _RARE_
are O
products O
of O
different O
but O
related O
genes O
. O

The O
10 O
kDa O
polypeptide O
was O
phosphorylated _RARE_
in O
vitro O
by O
incubating _RARE_
wheat _RARE_
etioplast _RARE_
membranes O
with O
[ _RARE_
gamma O
32P O
] O
ATP O
. O

Homology _RARE_
with O
the O
human O
protein O
is O
only O
34 _RARE_
% O
in O
the O
tandem _RARE_
repeat O
domain O
, O
mainly O
showing O
conservation O
of O
serines _RARE_
and O
threonines _RARE_
, O
presumed _RARE_
sites O
of O
O O
- O
linked _RARE_
carbohydrate O
attachment _RARE_
. O

In O
addition O
to O
targeting O
partially O
assembled O
Ti _RARE_
alpha I-GENE
- I-GENE
beta I-GENE
CD3 I-GENE
gamma I-GENE
delta I-GENE
epsilon I-GENE
TCR I-GENE
complexes I-GENE
to O
the O
cell O
surface O
, O
CD3 I-GENE
zeta _RARE_
appears O
to O
be O
essential O
for _RARE_
interleukin I-GENE
- I-GENE
2 I-GENE
production O
after O
TCR I-GENE
stimulation _RARE_
with O
antigen I-GENE
/ I-GENE
major I-GENE
histocompatibility I-GENE
complex I-GENE
. O

When O
desipramine O
was O
injected O
16 O
hrs O
after O
fluoxetine _RARE_
injection O
, O
brain O
levels O
of O
desipramine O
were O
no _RARE_
longer O
elevated O
. O

Opposite _RARE_
effects O
of O
CYP1 _RARE_
are O
observed O
in O
aerobic O
, O
heme O
- O
sufficient O
cells O
. O

A O
segmental O
analysis O
of O
the O
key O
regions O
of O
HLA I-GENE
- I-GENE
DR1 _RARE_
that O
control O
T O
cell O
allorecognition _RARE_
was O
performed O
by O
using O
a O
series O
of O
transfected O
cell O
lines O
expressing O
the O
products O
of O
recombinant O
DRB _RARE_
/ O
H I-GENE
- I-GENE
2Eb _RARE_
genes O
, O
paired O
with O
either O
DR _RARE_
alpha I-GENE
or O
H I-GENE
- I-GENE
2E _RARE_
alpha I-GENE
. O

We O
characterized O
cDNA O
clones _RARE_
specific O
for _RARE_
the O
extracellular O
matrix _RARE_
glycoprotein O
undulin _RARE_
. O

Finally O
, O
some O
point O
mutations O
in O
the O
Gag I-GENE
- O
Pol I-GENE
PR O
domain O
inhibited O
activation O
of O
RT I-GENE
in O
trans _RARE_
by O
a O
wild O
- O
type O
PR I-GENE
, O
suggesting O
that O
the O
correct O
conformation O
of O
the O
PR I-GENE
domain O
in O
Gag I-GENE
- O
Pol I-GENE
is O
prerequisite O
for _RARE_
activation O
of O
RT I-GENE
. O

The O
alpha I-GENE
inhibin _RARE_
promoter I-GENE
containing O
a O
mutated _RARE_
CRE _RARE_
was O
not O
regulated O
by O
forskolin O
in O
granulosa _RARE_
cells O
and O
did O
not O
bind O
the O
CREB I-GENE
protein I-GENE
. O

Regulation O
of O
the O
alpha I-GENE
inhibin _RARE_
gene I-GENE
by O
cyclic O
adenosine O
3 O
', _RARE_
5 O
'- O
monophosphate O
after O
transfection O
into O
rat O
granulosa _RARE_
cells O
. O

Comparison O
of O
the O
nucleotide O
sequences O
between O
the O
human O
and O
bovine O
DNA O
showed O
that O
the O
sequence O
similarity _RARE_
extended O
2400 _RARE_
bp O
downstream _RARE_
from O
the O
coding O
region O
. O

Cloning O
of O
a O
human O
cDNA O
encoding O
a O
CDC2 _RARE_
- I-GENE
related I-GENE
kinase I-GENE
by O
complementation _RARE_
of O
a O
budding _RARE_
yeast I-GENE
cdc28 _RARE_
mutation O
. O

In O
patients O
with O
osteomyelitis _RARE_
and O
joint O
empyema _RARE_
( O
n _RARE_
= O
48 _RARE_
) O
PMN _RARE_
elastase I-GENE
had O
a O
sensitivity O
of O
77 O
%, O
which O
was O
only O
exceeded _RARE_
by O
that O
of O
the O
unspecific _RARE_
erythrocyte _RARE_
sedimentation O
rate O
( O
sensitivity O
89 _RARE_
%). O

E O
., O
Hession _RARE_
, O
C O
., O
Goff _RARE_
, O
D O
., O
Griffiths _RARE_
, O
B O
., O
Tizard _RARE_
, O
R O
., O
Newman _RARE_
, O
B O
., O
Chi O
- O
Rosso _RARE_
, O
G O
., O
and O
Lobb _RARE_
, O
R O
., O
( O
1990 O
) O
Cell O
63 _RARE_
, O
1349 _RARE_
- O
1356 _RARE_
). O

The O
above O
results O
mean O
that O
the O
increase O
in O
alpha I-GENE
- I-GENE
adrenergic I-GENE
receptors I-GENE
makes O
the O
prostate _RARE_
, O
which O
has O
been O
already O
hypertrophied _RARE_
, O
less O
elastic O
, O
inhibiting O
external O
urinary _RARE_
sphincter _RARE_
function O
. O

An O
approximately _RARE_
2 I-GENE
- I-GENE
kilobase _RARE_
B2 _RARE_
transcript I-GENE
was O
expressed _RARE_
in O
all O
alfalfa _RARE_
organs O
tested O
. O

These O
results O
indicate O
that O
the O
sulfhydryl _RARE_
group O
of O
certain O
angiotensin I-GENE
converting _RARE_
enzyme I-GENE
inhibitors _RARE_
can O
potentiate _RARE_
their O
effect O
on O
the O
endogenous O
nitrovasodilator _RARE_
EDRF _RARE_
. O

Pharmacokinetics _RARE_
of O
FK O
506 _RARE_
in O
transplant O
patients O
. O

A O
second O
even O
more O
significant O
match O
to O
this O
E O
. O
coli O
region O
was O
found O
in O
the O
retroviral _RARE_
ribonuclease _RARE_
H I-GENE
( O
RNase I-GENE
H I-GENE
) O
domain O
, O
and O
corresponds O
precisely O
to O
a O
region O
that O
has O
been O
aligned _RARE_
by O
previous O
investigators _RARE_
with O
the O
E I-GENE
. I-GENE
coli I-GENE
RNase I-GENE
H I-GENE
, O
suggesting O
that O
Pol I-GENE
I I-GENE
helices O
O O
and O
P O
are O
homologous O
to O
helices O
A O
and O
D O
of O
the O
RNase I-GENE
H I-GENE
crystal _RARE_
structure _RARE_
, O
respectively O
. O

Analysis O
of O
the O
deduced O
amino O
acid O
sequence O
suggests O
that O
CHIP28 _RARE_
protein I-GENE
contains O
six _RARE_
bilayer _RARE_
- O
spanning O
domains O
, O
two O
exofacial _RARE_
potential _RARE_
N O
- O
glycosylation O
sites O
, O
and O
intracellular _RARE_
N O
and O
C O
termini O
. O

The O
qualitative O
concentrations O
of O
HCG _RARE_
had O
a O
sensitivity O
of O
37 O
. O
5 O
% O
and O
a O
specificity _RARE_
of O
100 _RARE_
%. O

The O
reduced _RARE_
rate O
of O
F O
absorption O
and O
slower O
rise O
in O
plasma O
F O
concentration O
accompanying O
delayed O
gastric _RARE_
emptying O
indicate O
that O
passage O
of O
F O
into O
the O
small O
intestine O
is O
the O
major O
factor O
in O
rapid O
F O
absorption O
. O

The O
activity O
of O
serum I-GENE
lipase I-GENE
and O
amylase I-GENE
distinctly O
increased O
at _RARE_
3 O
h O
and O
went _RARE_
up _RARE_
to O
the O
maximum O
at _RARE_
12 O
h O
after O
injection O
of O
Na _RARE_
- O
Tc O
. O

They O
were O
checked _RARE_
for _RARE_
anti I-GENE
- I-GENE
HCV I-GENE
( O
anti I-GENE
- I-GENE
C100 _RARE_
- I-GENE
3 I-GENE
) O
with O
HCV O
EIA _RARE_
kit O
( O
Abbott _RARE_
Lab _RARE_
., O
North _RARE_
Chicago _RARE_
, O
IL _RARE_
). O

Diltiazem _RARE_
resulted O
in O
a O
significant O
increase O
in O
epicardial _RARE_
diameter O
(+ O
10 O
%; O
p O
= O
0 _RARE_
. O
001 O
) O
and O
in O
coronary O
blood _RARE_
flow O
( O
CBF O
) O
(+ O
30 _RARE_
%; O
p O
= O
0 _RARE_
. O
0001 O
). O

The O
first _RARE_
transfusion O
resulted O
in O
a O
platelet O
increment _RARE_
to O
32 _RARE_
Gpt _RARE_
/ O
l _RARE_
( O
CCI _RARE_
11 O
). O

These O
risk O
factors O
can O
be O
divided O
into O
2 O
groups O
: O
local O
vessel O
wall _RARE_
- O
related O
factors O
, O
and O
local O
( O
focal _RARE_
action O
) O
systemic O
factors O
. O

Epidemiology _RARE_
and O
prevention O
of O
hospital O
infections O
in O
the O
Local _RARE_
Health O
Unit _RARE_
of O
Sassari _RARE_
: O
profile O
of O
bacterial O
resistance O
and O
antimicrobial O
agents O
of O
large O
usage O
. O

PRDII _RARE_
- I-GENE
BF1 _RARE_
- I-GENE
derived I-GENE
cDNAs I-GENE
did O
not O
result O
in O
stimulation _RARE_
of O
either O
basal O
or O
tat I-GENE
- O
induced _RARE_
activated O
gene O
expression _RARE_
. O

Vaccinia _RARE_
virus O
( O
VV _RARE_
) O
is O
a O
potent O
immunogen _RARE_
, O
but O
the O
nature O
of O
VV _RARE_
proteins O
involved O
in O
the O
activation O
of O
the O
immune O
response O
of O
the O
host _RARE_
is O
not O
yet O
known O
. O

Max I-GENE
: O
functional _RARE_
domains O
and O
interaction O
with O
c I-GENE
- I-GENE
Myc _RARE_
. O

86 _RARE_
: O
3199 _RARE_
- O
3203 _RARE_
) O
or O
G1 O
to O
S O
phase _RARE_
( O
Reilly _RARE_
, O
C O
. O

Substitutions _RARE_
introduced O
at _RARE_
bases O
surrounding O
the O
ICR2 _RARE_
motif I-GENE
yielded O
levels O
of O
pRNA _RARE_
replication O
that O
differed O
, O
depending O
on O
the O
maintenance _RARE_
of O
a O
putative O
5 O
' O
stem _RARE_
- O
loop O
structure _RARE_
in O
the O
positive O
strand _RARE_
of O
the O
viral O
genome O
. O

Zn _RARE_
( O
II O
) O
coordination O
domain O
mutants O
of O
T4 O
gene I-GENE
32 _RARE_
protein O
. O

Zn _RARE_
( O
II O
) O
coordination O
domain O
mutants O
of O
T4 I-GENE
gene I-GENE
32 _RARE_
protein I-GENE
. O

The O
tissue O
specificity _RARE_
of O
gene O
expression _RARE_
was O
identical O
to O
that O
described O
previously O
for _RARE_
the O
CaMV _RARE_
35S _RARE_
domain I-GENE
B I-GENE
enhancer I-GENE
element I-GENE
. O

The O
pathophysiology O
and O
clinical O
management O
of O
acute O
brain O
injury O
in O
infancy _RARE_
and O
childhood O
are O
presented O
using O
acute O
traumatic _RARE_
brain O
injury O
as _RARE_
a O
model O
. O

Transcripts _RARE_
from O
a O
second O
POU I-GENE
- I-GENE
domain I-GENE
gene I-GENE
, O
Oct I-GENE
- I-GENE
25 _RARE_
, O
were O
present O
at _RARE_
low O
levels O
in O
oocytes O
and O
early O
embryos _RARE_
and O
were O
dramatically O
upregulated _RARE_
during _RARE_
early O
gastrulation _RARE_
. O

In O
some O
early O
B O
cells O
and O
Abelson _RARE_
murine O
leukemia O
virus O
- O
transformed O
pre O
- O
B O
- O
cell O
lines O
, O
LT _RARE_
mRNA I-GENE
is O
constitutively O
expressed _RARE_
. O

The O
genome O
of O
Thogoto _RARE_
virus O
comprises O
six _RARE_
segments _RARE_
of O
single O
- O
stranded _RARE_
, O
negative O
sense O
RNA O
. O

These O
tumors O
were O
classified O
into O
three O
broad O
groups O
: O
I O
, O
cystadenoma _RARE_
; O
II O
, O
cystadenocarcinoma _RARE_
; O
and O
III O
, O
adenocarcinoma O
with O
mucin _RARE_
production O
or O
an O
associated O
cyst O
. O

Immunostaining _RARE_
of O
cells O
transfected O
with O
these O
constructs O
revealed O
that O
both O
the O
myristoylated _RARE_
and O
nonmyristoylated _RARE_
mutants O
were O
localized O
in O
nuclei O
, O
whereas O
wild I-GENE
- I-GENE
type I-GENE
PKC I-GENE
alpha I-GENE
was O
primarily O
cytoplasmic O
and O
perinuclear _RARE_
. O

We O
have O
partially O
sequenced O
the O
RAP74 _RARE_
protein I-GENE
from O
purified _RARE_
HeLa O
cells O
, O
cloned _RARE_
its O
complementary _RARE_
DNA O
and O
shown O
that O
its O
translation O
product O
can O
interact O
with O
RAP30 _RARE_
in O
vitro O
as _RARE_
well _RARE_
as _RARE_
in O
vivo O
. O

Effects O
of O
thromboxane _RARE_
synthetase _RARE_
inhibition O
on O
postburn _RARE_
mesenteric _RARE_
vascular O
resistance O
and O
the O
rate O
of O
bacterial O
translocation O
in O
a O
chronic O
porcine _RARE_
model O
. O

The O
primary _RARE_
pancreatic O
insult _RARE_
seemed _RARE_
to O
be O
unaffected O
by O
the O
treatment O
, O
because O
neither O
the O
rise O
in O
plasma I-GENE
lipase I-GENE
nor O
the O
development O
of O
ascites _RARE_
or O
the O
extension O
of O
the O
pancreatic O
necrosis O
were O
diminished O
. O

The O
size O
of O
the O
mutant O
molecule O
corresponds O
to O
the O
unprocessed _RARE_
cytoplasmic O
precursor O
( O
pre I-GENE
- I-GENE
super _RARE_
- I-GENE
pro I-GENE
- I-GENE
PrB _RARE_
), _RARE_
as _RARE_
detected O
in O
sec61 _RARE_
mutants I-GENE
, O
when O
translocation O
into O
the O
endoplasmic O
reticulum O
is O
blocked O
. O

Thus O
, O
the O
active _RARE_
- O
site O
mutation O
prevents O
the O
wild O
- O
type O
processing _RARE_
of O
the O
N O
- O
glycosylated O
73 _RARE_
- O
kDa O
precursor O
of O
PrB _RARE_
to O
the O
41 _RARE_
. I-GENE
5 I-GENE
kDa I-GENE
pro I-GENE
- I-GENE
PrB _RARE_
in O
the O
endoplasmic O
reticulum O
. O

The O
predicted O
amino O
acid O
sequence O
exhibited O
70 O
% O
identity O
to O
that O
of O
Bacillus I-GENE
stearothermophilus _RARE_
TyrTS _RARE_
and O
55 _RARE_
% O
identity O
to O
that O
of O
E I-GENE
. I-GENE
coli I-GENE
TyrTS _RARE_
, O
while O
identity O
to O
a O
second O
cryptic _RARE_
B I-GENE
. I-GENE
subtilis I-GENE
TyrTS _RARE_
gene I-GENE
, O
designated O
tyrZ _RARE_
, O
was O
only O
27 _RARE_
%. O

Heat _RARE_
- O
inducible O
CAT I-GENE
activity O
was O
detectable O
when O
additional O
sequences O
from O
the O
native _RARE_
promoter O
containing O
three O
CCAAT O
boxes _RARE_
and O
a O
single O
HSE O
were O
present O
in O
the O
constructions _RARE_
. O

SETTING O
-- _RARE_
Women _RARE_
, O
Infants _RARE_
, O
and O
Children O
clinics _RARE_
in O
Minneapolis _RARE_
, O
Minn _RARE_
. O

Testosterone _RARE_
, O
free O
testosterone O
, O
non I-GENE
- I-GENE
sex _RARE_
hormone I-GENE
- I-GENE
binding I-GENE
globulin I-GENE
- O
bound _RARE_
testosterone O
, O
and O
free O
androgen _RARE_
index O
: O
which O
testosterone O
measurement O
is O
most O
relevant O
to O
reproductive O
and O
sexual O
function O
in O
men O
with O
epilepsy O
? O

BACKGROUND O
: O
The O
effectiveness O
of O
monoamine _RARE_
oxidase I-GENE
inhibitors _RARE_
( O
MAOIs _RARE_
) O
in O
tricyclic _RARE_
resistant O
depression O
has O
received O
surprisingly _RARE_
little O
systematic O
study O
. O

The O
upstream O
delta O
- O
alpha O
breakpoint _RARE_
is O
flanked O
by O
the O
direct O
repeats O
of O
the O
acceptor _RARE_
splice _RARE_
site O
, O
whereas O
the O
down O
- O
stream _RARE_
alpha O
- O
delta O
breakpoint _RARE_
is O
located _RARE_
in O
the O
adjacent O
intron O
. O

Patients O
with O
moderate O
PDDAT _RARE_
were O
impaired O
on O
all O
serial O
positions O
for _RARE_
both O
spatial O
order O
and O
spatial O
recognition O
memory O
. O

Bone _RARE_
and O
bones _RARE_
. O

One O
patients O
had O
plasma I-GENE
C I-GENE
- I-GENE
peptide I-GENE
greater O
than O
3 O
pM _RARE_
and O
was O
therefore O
excluded O
from O
analysis O
. O

Complex _RARE_
repetitive _RARE_
discharges _RARE_
were O
observed O
in O
muscles O
of O
mdx _RARE_
mice O
but O
no _RARE_
complex O
repetitive _RARE_
discharges _RARE_
or O
other O
abnormalities O
were O
observed O
in O
muscles O
of O
normal O
control O
mice O
. O

Management _RARE_
often O
involves O
beta O
- O
and O
calcium _RARE_
channel _RARE_
blocking O
drugs O
or O
type O
IC _RARE_
antiarrhythmic O
drugs O
. O

To O
overcome O
this O
problem O
, O
we O
have O
overexpressed O
Kex2p _RARE_
using O
the O
baculovirus _RARE_
/ O
insect O
cell O
expression _RARE_
system _RARE_
. O

J _RARE_
. O

The O
major I-GENE
49 _RARE_
- I-GENE
kDa I-GENE
core I-GENE
protein I-GENE
in O
the O
liver O
HSPG _RARE_
preparation O
was O
found O
to O
be O
reactive O
to O
an O
antibody O
that O
specifically O
recognizes O
the O
cytoplasmic O
domain O
of O
fibroglycan _RARE_
. O

While O
no _RARE_
obvious _RARE_
transmembrane O
regions O
were O
identified O
, O
several O
short O
hydrophobic O
amino O
acid O
stretches O
were O
found O
to O
be O
localized O
in O
and O
around O
the O
Pro _RARE_
II O
region O
, O
and O
these O
may O
be O
responsible O
for _RARE_
attachment _RARE_
of O
precursors _RARE_
to O
membranes O
. O

Toxicity _RARE_
was O
mild O
, O
mainly O
consisting O
of O
emesis _RARE_
( O
81 _RARE_
% O
of O
the O
patients O
; O
66 _RARE_
% O
of O
the O
courses O
), _RARE_
leukopenia _RARE_
of O
World _RARE_
Health O
Organization O
( O
WHO _RARE_
) O
grade O
1 O
to O
2 O
( O
47 _RARE_
% O
of O
the O
patients O
; O
18 O
% O
of O
the O
courses O
), _RARE_
and O
thrombocytopenia O
( O
12 O
% O
of O
the O
patients O
; O
3 O
% O
of O
the O
courses O
). O

W _RARE_
. O
G O
. O

This O
study O
confirms _RARE_
, O
although O
individual O
reaction O
is O
remarkably O
different O
, O
transportation _RARE_
as _RARE_
a O
potent O
stressor _RARE_
for _RARE_
Beagle _RARE_
dogs O
. O

A O
mouse I-GENE
brain I-GENE
beta I-GENE
- I-GENE
spectrin I-GENE
of O
cDNA O
was O
identified O
within O
a O
lambda O
Gt11 _RARE_
expression _RARE_
library O
using O
an O
antibody O
which O
specifically O
binds O
with O
the O
235 _RARE_
kDa I-GENE
spectrin I-GENE
beta I-GENE
- I-GENE
subunit I-GENE
. O

RESULTS O
: O
Plasma I-GENE
AVP I-GENE
responses O
to O
osmotic O
stimulation _RARE_
, O
and O
non O
- O
osmotic O
inhibition O
by O
drinking O
, O
were O
normal O
in O
patients O
with O
compulsive _RARE_
water O
drinking O
. O

The O
fragments O
of O
each O
region O
were O
amplified O
by O
polymerase O
chain O
reaction O
and O
analyzed O
by O
gel O
electrophoresis O
to O
detect O
single O
- O
strand _RARE_
conformation O
polymorphism O
. O

The O
csbA _RARE_
fusion I-GENE
was O
maximally _RARE_
expressed _RARE_
during _RARE_
early O
stationary O
phase _RARE_
in O
cells O
grown O
in O
Luria _RARE_
broth _RARE_
containing O
5 O
% O
glucose O
and O
0 _RARE_
. O
2 O
% O
glutamine _RARE_
. O

The O
constraints _RARE_
of O
primase I-GENE
recognition I-GENE
sequences I-GENE
, O
nucleotide O
substrate O
requirements O
, O
and O
the O
effects O
of O
additional O
proteins O
on O
oligoribonucleotide _RARE_
synthesis _RARE_
by O
the O
63 _RARE_
- I-GENE
kDa I-GENE
gene I-GENE
4 I-GENE
protein I-GENE
have O
been O
examined O
using O
templates O
of O
defined O
sequence O
. O

Thrombolytic _RARE_
therapy O
in O
spontaneous O
coronary O
artery O
dissection O
. O

A O
prospective O
trial O
was O
carried O
out O
in O
156 _RARE_
unselected _RARE_
patients O
( O
41 _RARE_
men O
, O
mean O
age O
67 O
. O
5 O
years O
, O
115 _RARE_
women O
, O
mean O
age O
71 _RARE_
. O
4 O
years O
) O
who O
had O
undergone O
total _RARE_
hip O
joint O
replacement _RARE_
because O
of O
degenerative _RARE_
or O
inflammatory O
arthritis O
or O
fracture O
of O
the O
neck O
of O
the O
femur O
. O

When O
both O
lesions O
were O
complete _RARE_
lateral O
hemisections _RARE_
in O
weanling _RARE_
operates _RARE_
, O
little O
behavioral O
recovery O
was O
observed O
, O
similar O
to O
complete _RARE_
spinal _RARE_
cord O
transection _RARE_
( O
N O
= O
3 O
). O

Human O
SRF I-GENE
- I-GENE
related I-GENE
proteins I-GENE
: O
DNA O
- O
binding O
properties O
and O
potential _RARE_
regulatory O
targets _RARE_
. O

We O
have O
isolated O
cDNAs O
for _RARE_
a O
gene O
coding O
for _RARE_
a O
G I-GENE
protein I-GENE
alpha I-GENE
subunit I-GENE
from I-GENE
tomato _RARE_
( O
Lycopersicon _RARE_
esculentum _RARE_
, O
cv O
. O

Growth _RARE_
factor O
stimulation _RARE_
of O
cells O
causes O
the O
phosphorylation _RARE_
of O
the O
c I-GENE
- I-GENE
Myc _RARE_
transcriptional I-GENE
activation I-GENE
domain I-GENE
at _RARE_
Ser62 _RARE_
within O
a O
proline O
- O
rich O
region O
that O
is O
highly O
conserved _RARE_
among O
members O
of O
the O
Myc _RARE_
family I-GENE
( O
Alvarez _RARE_
, O
E O
., O
Northwood _RARE_
, O
I O
. O
C O
., O
Gonzalez _RARE_
, O
F O
. O

The O
authors O
evaluated O
the O
potential _RARE_
for _RARE_
thrombotic O
complications O
arising O
from O
implantation O
of O
a O
ventricular O
assist _RARE_
device O
( O
Sarns _RARE_
/ O
3M _RARE_
- O
VAD _RARE_
) O
in O
four O
calves O
. O

Cardiac _RARE_
output O
( O
CO _RARE_
) O
was O
significantly O
higher _RARE_
( O
p O
less O
than O
0 _RARE_
. O
0005 _RARE_
) O
in O
the O
MBBF _RARE_
group O
. O

Amino O
acid O
residues O
147 _RARE_
- O
167 _RARE_
of O
the O
previously O
reported O
sequence O
are O
replaced O
by O
new O
residues O
147 _RARE_
to O
150 _RARE_
. O

Transcriptional O
activation O
by O
the O
HIV I-GENE
- I-GENE
1 I-GENE
Tat I-GENE
protein I-GENE
requires O
specific O
residues O
in O
the O
hexanucleotide _RARE_
loop O
and O
trinucleotide _RARE_
bulge _RARE_
of O
the O
TAR _RARE_
RNA O
stem _RARE_
- O
loop O
structure _RARE_
found O
in O
the O
5 O
'- O
untranslated _RARE_
leader _RARE_
of O
all O
viral O
transcripts O
. O

We O
obtained O
quantitative O
evidence O
on O
the O
coding O
of O
interaural _RARE_
time O
differences O
( O
ITDs _RARE_
) O
of O
click _RARE_
stimuli O
by O
40 O
single O
neurons O
in O
the O
auditory O
cortex O
of O
anesthetized O
albino _RARE_
rats O
. O

These O
results O
strongly O
suggest O
that O
locally O
- O
applied O
TTC _RARE_
in O
combination O
with O
FDBA _RARE_
enhances O
new O
bone O
formation O
in O
experimental O
alveolar O
bone O
defects O
. O

As O
an O
initial O
step O
towards O
the O
characterization O
of O
replicative O
DNA I-GENE
polymerases _RARE_
of I-GENE
trypanosomes _RARE_
, O
we O
have O
cloned _RARE_
, O
sequenced O
and O
examined O
the O
expression _RARE_
of O
the O
Trypanosoma O
( O
Trypanozoon _RARE_
) O
brucei _RARE_
brucei _RARE_
gene O
that O
encodes O
the O
DNA I-GENE
polymerase I-GENE
alpha I-GENE
catalytic I-GENE
core I-GENE
( O
pol I-GENE
alpha I-GENE
). O

In O
addition O
, O
there O
was O
a O
significant O
increase O
in O
postdexamethasone _RARE_
cortical O
concentrations O
with O
age O
( O
p O
less O
than O
0 _RARE_
. O
01 O
; O
r _RARE_
= O
0 _RARE_
. O
31 _RARE_
). O

Pulmonary _RARE_
hypertension O
, O
with O
or O
without O
coronary O
arterial O
narrowing _RARE_
, O
is O
the O
major O
condition O
leading O
to O
isolated O
atrial _RARE_
infarction O
. O

The O
volume O
fraction O
( O
Vv _RARE_
) O
and O
number O
/ O
mm2 O
( O
Na _RARE_
) O
of O
all O
capillaries O
( O
perfused O
and O
nonperfused _RARE_
) O
in O
a O
given O
area O
of O
brain O
were O
determined O
after O
staining O
for _RARE_
alkaline _RARE_
phosphatase I-GENE
. O

Airway _RARE_
pressure O
and O
air O
flow O
were O
measured O
at _RARE_
the O
endotracheal _RARE_
tube O
in O
13 _RARE_
children O
on O
a O
variety O
of O
ventilators _RARE_
. O

Appl _RARE_
. O

Issues _RARE_
of O
distribution O
of O
kinetic O
energy O
of O
traumatizing _RARE_
object _RARE_
in O
direct O
contact _RARE_
interaction O
with O
head O
during _RARE_
impact O
are O
discussed O
from O
position O
of O
biomechanics _RARE_
. O

CONCLUSION O
: O
Monitoring _RARE_
SpO2 _RARE_
at _RARE_
the O
nasal O
septum _RARE_
site O
is O
more O
reliable O
than O
monitoring O
it O
at _RARE_
the O
finger O
site O
in O
hypothermic _RARE_
patients O
. O

Diltiazem _RARE_
decreased O
the O
total _RARE_
body O
clearance O
from O
34 _RARE_
. O
0 _RARE_
+/- O
8 O
. O
0 _RARE_
to O
28 _RARE_
. O
6 O
+/- O
6 O
. O
1 O
mL O
/ O
min O
( O
P O
less O
than O
. O
01 O
), _RARE_
and O
prolonged O
the O
elimination O
half _RARE_
- O
life O
from O
12 O
. O
6 O
+/- O
3 O
. O
0 _RARE_
to O
14 O
. O
3 O
+/- O
2 O
. O
5 O
hours O
( O
P O
less O
than O
. O
01 O
) O
of O
antipyrine _RARE_
without O
any O
changes O
in O
volume O
of O
distribution O
. O

The O
granules O
grew _RARE_
as _RARE_
the O
melted _RARE_
material O
immersed _RARE_
into O
the O
void _RARE_
space O
among O
the O
adhered _RARE_
particles _RARE_
. O

Hence O
, O
the O
uPA I-GENE
promoter I-GENE
contains O
multiple O
weak O
cis O
- O
acting O
elements O
distributed O
over O
7 O
. O
0 _RARE_
kb O
5 O
' O
to O
the O
translation O
start _RARE_
site O
. O

Substituting _RARE_
a O
Ser _RARE_
for _RARE_
Gly69 _RARE_
or O
a O
Glu O
for _RARE_
Lys _RARE_
71 _RARE_
in O
the O
conserved _RARE_
TGEK _RARE_
tetrapeptide _RARE_
in O
finger O
II O
of O
TFIIIA _RARE_
resulted O
in O
the O
loss _RARE_
of O
DNA O
binding O
. O

P O
. O

In O
one O
, O
exploratory _RARE_
behavior O
( O
assessed O
by O
hole _RARE_
pokes _RARE_
) O
and O
locomotion _RARE_
were O
assessed O
during _RARE_
a O
10 O
- O
min O
test O
session O
. O

The O
model O
is O
able O
to O
anticipate _RARE_
why _RARE_
the O
effect O
of O
water O
fluoridation _RARE_
on O
caries _RARE_
prevalence O
is O
most O
pronounced O
when O
caries _RARE_
is O
diagnosed O
at _RARE_
cavity O
level O
. O

12 O
- O
O O
- O
Tetradecanoylphorbol _RARE_
13 _RARE_
- O
acetate _RARE_
was O
found O
to O
inhibit O
rapidly O
and O
potently _RARE_
the O
expression _RARE_
of O
mRNAs O
coding O
for _RARE_
the O
myogenic _RARE_
regulators _RARE_
CMD1 _RARE_
and O
myogenin I-GENE
. O

In O
Xenopus O
laevis _RARE_
, O
the O
gene O
encoding O
the O
elongation _RARE_
factor I-GENE
1 I-GENE
- I-GENE
alpha I-GENE
variant I-GENE
EF _RARE_
- I-GENE
1 I-GENE
alpha I-GENE
O I-GENE
, O
where O
O O
stands _RARE_
for _RARE_
oocyte _RARE_
, O
is O
expressed _RARE_
in O
oocytes O
and O
early O
embryos _RARE_
. O

These O
introns _RARE_
belong O
to O
the O
class O
of O
nuclear O
pre O
- O
mRNA O
introns _RARE_
and O
contain O
typical O
5 O
'- O
and O
3 O
'- O
consensus O
sequences O
, O
as _RARE_
well _RARE_
as _RARE_
unique O
features O
. O

The O
mRNA O
identified O
in O
both O
human O
and O
rat O
cells O
with O
the O
human I-GENE
clathrin I-GENE
clone O
revealed O
transcripts O
of O
approximately _RARE_
6 O
. O
5 O
kb O
, O
which O
is O
consistent O
with O
the O
predicted O
180 O
kDa O
molecular _RARE_
weight _RARE_
of O
the O
clathrin I-GENE
heavy I-GENE
chain I-GENE
. O

In O
this O
report O
, O
almost O
6 O
kb O
of O
DNA O
sequence O
is O
presented O
, O
including O
1251 _RARE_
bp O
5 O
' O
to O
the O
gene O
, O
over O
4 O
kb O
of O
exon _RARE_
and O
exon _RARE_
- O
intron O
junctions O
, O
and O
583 _RARE_
bp O
3 O
' O
to O
the O
gene O
. O

An O
8 O
- O
h O
exposure O
to O
10 O
mg O
DMEA _RARE_
/ O
m3 O
corresponds O
to O
a O
postexposure O
plasma O
concentration O
and O
2 O
- O
h O
postexposure O
urinary _RARE_
excretion O
of O
4 O
. O
9 O
mumol O
/ O
l _RARE_
and O
75 _RARE_
mmol O
/ O
mol O
creatinine _RARE_
, O
respectively O
. O

Antibodies O
specific O
to O
rE12 _RARE_
and O
rNFIL _RARE_
- I-GENE
6 I-GENE
disrupt O
nucleoprotein _RARE_
complexes O
with O
these O
DNA O
- O
binding O
sites O
, O
confirming O
the O
interaction O
of O
native _RARE_
in O
vivo O
factors O
. O

A O
method O
is O
described O
for _RARE_
detecting O
targeted O
events O
at _RARE_
the O
mu I-GENE
heavy I-GENE
chain I-GENE
gene I-GENE
which O
relies _RARE_
on O
co _RARE_
- O
conversion O
( O
or O
co _RARE_
- O
exchange O
) O
of O
a O
point O
mutation O
with O
a O
selectable O
marker O
contained O
on O
a O
replacement _RARE_
vector O
. O

Allergenic _RARE_
activity O
of O
allergen _RARE_
extract _RARE_
Ambrosia _RARE_
elatior _RARE_
( O
AE _RARE_
) O
was O
tested O
in O
fifteen _RARE_
volunteers O
extremely O
sensitive _RARE_
to O
the O
allergen _RARE_
. O

This O
study O
was O
aimed O
at _RARE_
assessing O
whether O
c O
- O
DDP O
administration O
immediately O
before O
radiotherapy O
could O
increase O
frequency O
and O
duration O
of O
objective O
responses O
, O
as _RARE_
well _RARE_
as _RARE_
survival O
, O
in O
patients O
affected O
with O
locally O
advanced O
stages O
of O
squamous O
carcinomas O
of O
the O
head O
and O
neck O
. O

Two O
potential _RARE_
regulatory O
sequences O
for _RARE_
DNA O
binding O
proteins O
were O
found O
in O
the O
non O
- O
coding O
5 O
' O
region O
: O
a O
HAP2 _RARE_
/ O
HAP3 _RARE_
consensus O
recognition O
sequence O
at _RARE_
nucleotide O
- O
154 O
and O
a O
BAF1 _RARE_
consensus I-GENE
recognition I-GENE
sequence I-GENE
at _RARE_
nucleotide O
- O
136 O
. O

Marked O
thrombocytopenia O
, O
depletion O
of O
serum I-GENE
fibrinogen I-GENE
and O
prolonged O
prothrombin I-GENE
and O
activated O
partial O
thromboplastin I-GENE
time O
, O
were O
recorded O
at _RARE_
5 O
to O
10 O
and O
30 _RARE_
to O
40 O
minutes O
after O
intravenous O
envenomation _RARE_
. O

We O
exploit _RARE_
the O
properties O
of O
LexA I-GENE
fusion I-GENE
proteins I-GENE
to O
study O
the O
dimerization _RARE_
and O
DNA O
- O
contacting _RARE_
domains O
of O
cRel _RARE_
. O

Plasma O
lipid _RARE_
and O
lipoprotein O
profiles O
were O
compared O
in O
elderly O
female O
runners _RARE_
( O
RU _RARE_
: O
n _RARE_
= O
15 _RARE_
, O
aged O
66 _RARE_
+/- O
5 O
years O
, O
body O
fat O
20 O
+/- O
4 O
%, O
training O
distance O
35 _RARE_
+/- O
15 _RARE_
km _RARE_
week O
- O
1 O
, O
VO2max _RARE_
36 _RARE_
+/- O
4 O
ml O
kg O
- O
1 O
min O
- O
1 O
, O
mean O
+/- O
SD O
) O
and O
age O
- O
matched O
untrained _RARE_
women O
( O
UT O
: O
n _RARE_
= O
28 _RARE_
, O
66 _RARE_
+/- O
4 O
years O
, O
body O
fat O
26 _RARE_
+/- O
6 O
%, O
VO2max _RARE_
26 _RARE_
+/- O
3 O
ml O
kg O
- O
1 O
min O
- O
1 O
). O

Auditory _RARE_
threshold O
shifts O
, O
as _RARE_
measured O
by O
the O
auditory O
evoked O
brainstem _RARE_
response O
, O
were O
measured O
at _RARE_
2 O
, O
4 O
, O
8 O
, O
12 O
, O
16 O
, O
20 O
and O
24 _RARE_
kHz _RARE_
. O

Fundamental _RARE_
and O
clinical O
evaluation O
of O
equilibrium O
dialysis O
-- _RARE_
radioimmunoassay O
system _RARE_
for _RARE_
measurement O
of O
serum O
free O
thyroxine O

We O
conclude O
that O
TA O
caused O
a O
specific O
decrease O
in O
AGD _RARE_
on O
GD _RARE_
20 O
that O
was O
largely O
reversed O
by O
PCD _RARE_
23 _RARE_
. O

When O
examined O
as _RARE_
adults O
( O
8 O
weeks O
old O
), _RARE_
the O
external O
genitalia _RARE_
of O
TA O
- O
exposed O
offspring _RARE_
were O
normal O
. O

After O
PTCA O
, O
ejection O
fraction O
increased O
from O
54 O
+/- O
8 O
% O
to O
59 _RARE_
+/- O
8 O
% O
( O
p O
less O
than O
0 _RARE_
. O
05 O
) O
and O
regional O
function O
improved O
significantly O
( O
maximal O
standard O
deviation O
before O
PTCA O
: O
2 O
. O
8 O
+/- O
0 _RARE_
. O
8 O
; O
after O
PTCA O
: O
1 O
. O
9 O
+/- O
0 _RARE_
. O
9 O
- O
segments _RARE_
below O
the O
first _RARE_
standard O
deviation O
before O
PTCA O
: O
31 _RARE_
+/- O
16 O
; O
after O
PTCA O
: O
19 O
+/- O
17 _RARE_
). O

The O
alcoholic O
patient O
, O
his _RARE_
work O
and O
the O
subjectivity _RARE_
of O
the O
period O

These O
data O
suggest O
that O
the O
combined O
treatment O
with O
a O
thromboxane _RARE_
synthetase _RARE_
inhibitor O
and O
a O
thromboxane _RARE_
receptor I-GENE
antagonist O
provides O
a O
better O
protection O
against O
digoxin _RARE_
intoxication _RARE_
than O
with O
either O
agent O
alone O
. O

A O
330 _RARE_
- O
kb O
YAC O
, O
A148A7 _RARE_
, O
spanned _RARE_
from O
the O
HLA I-GENE
- O
DQA1 _RARE_
locus O
through O
the O
Y3 _RARE_
/ O
Ring _RARE_
4 I-GENE
locus O
and O
extended O
at _RARE_
least O
130 _RARE_
kb O
centromeric _RARE_
of O
YAC O
B1D12 _RARE_
. O

Interspecific _RARE_
backcross O
analysis O
using O
progeny _RARE_
derived O
from O
matings _RARE_
of O
( O
C57BL O
/ O
6J _RARE_
x _RARE_
Mus _RARE_
spretus _RARE_
) O
F1 _RARE_
x _RARE_
C57BL O
/ O
6J _RARE_
mice O
indicates O
that O
the O
thrombospondin _RARE_
gene I-GENE
is O
tightly O
linked _RARE_
to O
the O
Fshb _RARE_
, O
Actcl _RARE_
, O
Ltk _RARE_
, O
and O
B2M _RARE_
loci I-GENE
on O
murine O
chromosome _RARE_
2 O
. O

Adverse _RARE_
foetal _RARE_
outcome O
in O
specific O
IgM I-GENE
positive O
Chlamydia O
trachomatis _RARE_
infection O
in O
pregnancy _RARE_
. O

Using O
an O
image O
- O
processing _RARE_
computer O
, O
regional O
LV O
time O
- O
density O
curves O
were O
constructed O
for _RARE_
one O
cardiac O
cycle _RARE_
. O

In O
a O
second O
patient O
the O
VT O
became O
nonsustained _RARE_
. O

If O
delay O
has O
occurred O
between O
centrifugation _RARE_
and O
the O
measurement O
, O
causing O
substantial O
loss _RARE_
of O
CO2 O
, O
equilibration _RARE_
of O
the O
sample O
with O
a O
gas O
mixture O
corresponding O
to O
PCO2 O
= O
5 O
. O
3 O
kPa _RARE_
prior O
to O
the O
measurement O
is O
recommended O
. O

The O
possible O
mechanisms O
underlying O
differences O
in O
post O
- O
tetanic _RARE_
effects O
from O
muscle O
and O
cutaneous O
afferents O
in O
adults O
and O
neonates O
are O
discussed O
. O

We O
examined O
behavioral O
alterations O
in O
the O
brown O
cockroach _RARE_
, O
Periplaneta _RARE_
brunnea _RARE_
, O
infected _RARE_
with O
the O
acanthocephalan _RARE_
, O
Moniliformis _RARE_
moniliformis _RARE_
. O

First O
, O
the O
finding O
of O
a O
monomeric _RARE_
Alu I-GENE
family O
repeat O
at _RARE_
the O
junction _RARE_
between O
nonhomology _RARE_
block _RARE_
I O
and O
homology O
block _RARE_
Y O
of O
the O
alpha I-GENE
2 I-GENE
gene I-GENE
- I-GENE
containing I-GENE
unit I-GENE
in I-GENE
rhesus _RARE_
macaque _RARE_
suggests O
that O
the O
dimeric _RARE_
Alu I-GENE
family O
repeat O
, O
Alu I-GENE
3 I-GENE
, O
at _RARE_
the O
orthologous _RARE_
position O
in O
human O
was O
generated O
by O
insertion _RARE_
of O
a O
monomeric _RARE_
Alu I-GENE
family O
repeat O
into O
the O
3 O
' O
end O
of O
another O
preexisting _RARE_
Alu I-GENE
family O
repeat O
. O

The O
sequence O
of O
the O
repressor O
locus O
, O
c O
, O
of O
the O
Streptomyces _RARE_
temperate _RARE_
phage _RARE_
, O
phi _RARE_
C31 _RARE_
, O
was O
shown O
previously O
to O
contain O
an O
open _RARE_
reading O
frame O
encoding O
a O
74 _RARE_
kDa O
protein O
. O

The O
EPO I-GENE
levels O
were O
distinctly O
increased O
before O
transfusion O
; O
they O
did O
not O
significantly O
change O
just O
after O
transfusion O
, O
but O
subsequently O
decreased O
. O

This O
differential O
sensitivity O
to O
DB _RARE_
, O
as _RARE_
measured O
by O
a O
lower O
concentration O
of O
DB _RARE_
which O
caused O
loss _RARE_
of O
righting _RARE_
in O
LS _RARE_
, O
was O
accompanied O
by O
an O
equal O
rate O
of O
water O
- O
soluble _RARE_
barbiturate _RARE_
brain O
distribution O
and O
elimination O
in O
the O
two O
lines O
. O

The O
existence O
of O
threshold O
concentrations O
, O
above O
which O
certain O
phenomena O
may O
occur O
, O
strengthens _RARE_
the O
role O
of O
sentinels _RARE_
. O

However O
, O
it O
was O
synthesized O
at _RARE_
both O
temperatures O
after O
addition O
of O
A23187 _RARE_
. O

Felodipine _RARE_
did O
not O
alter O
the O
baseline O
FEV1 O
, O
but O
showed O
a O
small O
significant O
inhibitory _RARE_
effect O
upon O
histamine _RARE_
and O
AMP O
induced _RARE_
bronchoconstriction _RARE_
. O

Ten O
out O
of O
10 O
patients O
with O
progressive O
disease _RARE_
had O
mast _RARE_
cells O
greater O
than O
or O
equal O
to O
0 _RARE_
. O
5 O
%, O
hyaluronan _RARE_
greater O
than O
or O
equal O
to O
50 O
micrograms O
. O
l _RARE_
- O
1 O
and O
fibronectin I-GENE
greater O
than O
or O
equal O
to O
350 O
micrograms O
. O
l _RARE_
- O
1 O
compared O
to O
eight O
out O
of O
41 _RARE_
patients O
with O
stable O
or O
regressive _RARE_
disease _RARE_
.( O
ABSTRACT O
TRUNCATED O
AT O
250 _RARE_
WORDS O
) O

Our O
mapping O
results O
did O
not O
suggest O
involvement O
of O
this O
gene O
in O
previously O
mapped O
genetic O
disorders O
or O
in O
known O
neoplasia _RARE_
- O
associated O
translocation O
breakpoints O
. O

Relatively _RARE_
little O
is O
known O
regarding O
the O
role O
of O
5 I-GENE
- I-GENE
HT2 I-GENE
receptor I-GENE
activity O
in O
male O
rat O
sexual O
behavior O
. O

These O
changes O
weren _RARE_
' O
t O
so O
significant O
in O
the O
group O
of O
obese O
children O
who O
didn _RARE_
' O
t O
lose _RARE_
weight _RARE_
. O

Arsenic _RARE_
contents O
in O
native _RARE_
copper _RARE_

In O
ten O
other O
experiments O
( O
5 O
experimental O
and O
5 O
control O
rats O
) O
99mTc O
- O
sulfur O
colloid O
was O
injected O
intravenously O
. O

Magnetotherapy _RARE_
of O
hepatitis O
A O
and O
B O
in O
children O

These O
results O
were O
superior O
to O
those O
in O
24 _RARE_
patients O
with O
conventional O
end O
- O
to O
- O
end O
sutures _RARE_
on O
clinical O
testing O
. O

Mutational O
analysis O
supports O
a O
role O
for _RARE_
multiple O
structural O
features O
in O
the O
C O
- O
terminal O
secretion _RARE_
signal O
of O
Escherichia I-GENE
coli I-GENE
haemolysin _RARE_
. O

Among O
blood _RARE_
donors O
in O
the O
Republic _RARE_
of O
Serbia _RARE_
, O
regardless O
the O
number O
of O
blood _RARE_
donations _RARE_
, O
the O
percentage O
of O
female O
donors O
is O
significantly O
lower O
compared O
to O
the O
percentage O
of O
male O
blood _RARE_
donors O
. O

Extramedullary _RARE_
relapse O
in O
childhood O
leukemia O
. O

Mycoplasma _RARE_
pneumoniae _RARE_
was O
isolated O
from O
the O
pleural _RARE_
fluid _RARE_
of O
this O
patient O
. O

RU486 _RARE_
and O
ONO _RARE_
802 _RARE_
in O
combination O
have O
been O
shown O
to O
be O
effective O
in O
early O
termination _RARE_
of O
pregnancy _RARE_
. O

The O
presence O
of O
local O
abnormalities O
in O
both O
patients O
can O
support O
the O
hypothesis O
that O
the O
cortex O
, O
especially O
of O
the O
temporal O
anterior O
lobe O
, O
is O
involved O
in O
the O
origin O
of O
the O
laughing _RARE_
seizures O
. O

In O
line O
with O
the O
small O
values O
for _RARE_
QS _RARE_
/ O
QC _RARE_
, O
our O
results O
further O
indicate O
that O
even O
large O
, O
well _RARE_
- O
perfused O
, O
occluded O
air O
spaces _RARE_
in O
the O
lung _RARE_
will O
hardly _RARE_
affect O
the O
recovered O
ventilation O
/ O
perfusion O
distribution O
obtained O
from O
inert _RARE_
gas O
data O
when O
CDCSF6 _RARE_
exceeds _RARE_
0 _RARE_
. O
1 O
ml O
. O
min O
- O
1 O
. O
mmHg O
- O
1 O
. O

Many O
cells O
were O
negative O
for _RARE_
endothelial O
- O
cell O
markers O
, O
and O
they O
reacted O
with O
a O
monoclonal O
antibody O
against O
muscle O
actin I-GENE
. O

CT _RARE_
abnormalities O
noted O
in O
term O
babies O
included O
hemorrhage O
( O
subarachnoid _RARE_
5 O
. O
8 O
%, O
intracerebral _RARE_
11 O
. O
6 O
%), O
hypodensity _RARE_
( O
mild O
23 _RARE_
. O
2 O
%, O
moderate O
11 O
. O
6 O
% O
severe O
5 O
. O
8 O
%); _RARE_
hypodensity _RARE_
with O
hemorrhage O
5 O
. O
8 O
% O
and O
cerebral O
atrophy O
5 O
. O
8 O
%. O

The O
effects O
of O
contrast O
media O
on O
coagulation I-GENE
factor I-GENE
XII _RARE_
. O

Pigs _RARE_
were O
switched _RARE_
from O
the O
growing O
to O
the O
finishing _RARE_
diet O
at _RARE_
57 O
and O
61 _RARE_
kg O
in O
Exp _RARE_
. O

In O
sixteen _RARE_
patients O
with O
moderate O
essential O
hypertension O
the O
effects O
of O
10 O
- O
day O
nifedipine O
treatment O
on O
serum O
uric O
acid O
and O
renal _RARE_
excretion O
of O
uric O
acid O
were O
evaluated O
. O

TPTA _RARE_
produced O
brain O
congestion _RARE_
, O
and O
hepatic _RARE_
and O
pulmonary O
petechial _RARE_
and O
generalized O
hemorrhages _RARE_
. O

Examples _RARE_
are O
using O
more O
subjects O
or O
an O
improved O
research O
design O
, O
developing O
consensus O
statements _RARE_
or O
using O
meta _RARE_
- O
analysis O
. O

A O
two O
phase _RARE_
slug _RARE_
flow O
tubular O
heat O
exchanger _RARE_
was O
used O
for _RARE_
the O
thermal O
inactivation O
of O
Listeria _RARE_
monocytogenes O
in O
natural _RARE_
infected _RARE_
milk O
from O
seven _RARE_
cows O
. O

So _RARE_
far O
15 _RARE_
children O
have O
been O
studied O
. O

Regional _RARE_
cerebral O
blood _RARE_
flow O
( O
rCBF O
) O
measurements O
and O
psychiatric O
ratings _RARE_
were O
performed O
on O
seven _RARE_
schizophrenic O
patients O
( O
mean O
age O
= O
41 _RARE_
. O
4 O
years O
) O
who O
had O
been O
examined O
18 O
years O
previously O
in O
a O
study O
that O
used O
similar O
psychiatric O
ratings _RARE_
and O
a O
comparable O
rCBF O
technique O
. O

In O
the O
present O
study O
, O
we O
identified O
a O
strong O
positive O
cis O
- O
regulatory O
element O
at _RARE_
- O
70 O
bp O
to O
- O
75 _RARE_
bp O
in O
the O
LpS1 _RARE_
beta I-GENE
promoter I-GENE
with O
the O
sequence O
( O
G O
) O
6 O
and O
a O
similar O
, O
more O
distal O
cis O
- O
element O
at _RARE_
- O
721 _RARE_
bp O
to O
- O
726 _RARE_
bp O
. O

The O
present O
study O
reports O
visual O
evoked O
potential _RARE_
responses O
to O
pattern O
reversal O
( O
VEP _RARE_
- O
P O
) O
in O
ten O
third O
trimester _RARE_
pregnant _RARE_
women O
and O
changes O
in O
latency _RARE_
of O
NPN _RARE_
complex O
when O
compared O
with O
these O
responses O
in O
the O
non O
pregnant _RARE_
state O
. O

No O
case O
of O
SMF _RARE_
demonstrated O
expansive _RARE_
tumorous _RARE_
growth O
. O

Different _RARE_
doses O
of O
15 _RARE_
- O
methyl _RARE_
- O
PGF2 O
alpha O
( O
0 _RARE_
. O
125 _RARE_
- O
10 O
mg O
) O
were O
used O
to O
induce O
luteolysis _RARE_
and O
oestrus _RARE_
in O
7 O
heifers O
with O
28 _RARE_
treatments O
on O
day O
8 O
- O
12 O
of O
the O
oestrous _RARE_
cycle _RARE_
. O

Review _RARE_
of O
the O
literature O
and O
report O
of O
a O
case O
of O
a O
dermoid _RARE_
cyst O
. O

Resolution _RARE_
of O
thermographic _RARE_
asymmetry O
and O
/ O
or O
decrease O
in O
Delta _RARE_
T O
was O
demonstrated O
in O
approximately _RARE_
81 _RARE_
% O
of O
the O
post O
- O
treatment O
population O
. O

In O
all O
instances O
the O
apparent O
alcohol _RARE_
responses O
were O
very O
small O
and O
never O
exceeded _RARE_
a O
reading O
of O
1 O
microgram O
/ O
100ml _RARE_
for _RARE_
breath _RARE_
samples O
more O
than O
10min _RARE_
post O
- O
exposure O
. O

Maize _RARE_
rbcS _RARE_
promoter I-GENE
activity O
depends O
on O
sequence O
elements O
not O
found O
in O
dicot _RARE_
rbcS _RARE_
promoters I-GENE
. O

Measurements O
were O
done O
with O
a O
commercial O
haematofluorometer _RARE_
Buchler _RARE_
ZF _RARE_
which O
was O
calibrated _RARE_
to O
the O
average O
haematocrit _RARE_
value O
of O
0 _RARE_
. O
42 _RARE_
. O

The O
relatively O
scanty _RARE_
number O
of O
examples O
, O
which O
could O
be O
justified _RARE_
by O
the O
variety O
and O
complexity O
of O
combined O
exposure O
, O
allows O
to O
conclude O
that O
life O
- O
style _RARE_
factors O
have O
considerable O
influence O
on O
interindividual _RARE_
differences O
in O
susceptibility _RARE_
to O
xenobiotics _RARE_
toxicity O
. O

The O
12S _RARE_
E1A I-GENE
product I-GENE
does O
not O
activate O
a O
TRE _RARE_
sequence O
, O
but O
cotransfection O
with O
c I-GENE
- I-GENE
jun I-GENE
circumvents _RARE_
this O
lack O
of O
stimulation _RARE_
. O

After O
treatment O
with O
tunicamycin _RARE_
, O
the O
transfectants O
secreted _RARE_
unglycosylated _RARE_
18 O
- O
kDa O
polypeptides O
which O
could O
also O
bind O
IgE I-GENE
. O

PAS1 _RARE_
, O
a O
yeast O
gene O
required O
for _RARE_
peroxisome _RARE_
biogenesis O
, O
encodes O
a O
member _RARE_
of O
a O
novel O
family O
of O
putative O
ATPases _RARE_
. O

The O
gene O
is O
1 O
, O
139 O
base _RARE_
pairs _RARE_
( O
bp O
) O
long O
, O
and O
, O
like O
other O
members O
of O
the O
SIG _RARE_
family I-GENE
, O
the O
beta I-GENE
TG I-GENE
gene I-GENE
is O
divided O
into O
3 O
exons O
. O

The O
pp90rsk _RARE_
- I-GENE
protein I-GENE
kinase I-GENE
activity O
( O
referred O
to O
as _RARE_
rsk _RARE_
- I-GENE
kinase I-GENE
) O
is O
also O
not O
related O
to O
cofactor O
- O
dependent O
signal O
transducing _RARE_
protein O
kinases O
such O
as _RARE_
the O
cyclic I-GENE
AMP I-GENE
- I-GENE
dependent I-GENE
protein I-GENE
kinases I-GENE
, O
members O
of O
the O
protein I-GENE
kinase I-GENE
C I-GENE
family I-GENE
, O
or O
other O
Ca2 _RARE_
(+)- _RARE_
dependent I-GENE
protein I-GENE
kinases I-GENE
. O

Human I-GENE
GATA _RARE_
- I-GENE
3 I-GENE
: O
a O
lineage O
- O
restricted O
transcription O
factor O
that O
regulates O
the O
expression _RARE_
of O
the O
T I-GENE
cell I-GENE
receptor I-GENE
alpha I-GENE
gene I-GENE
. O

Like O
many O
eukaryotic O
transcription O
factors O
, O
these O
proteins O
bind O
to O
DNA O
as _RARE_
dimers _RARE_
. O

Furthermore O
, O
the O
UvrA _RARE_
protein I-GENE
interacts O
with O
the O
UvrB _RARE_
protein I-GENE
to O
modulate O
its O
activities O
, O
both O
in O
solution O
and O
in O
association O
with O
DNA O
, O
where O
the O
UvrAB _RARE_
complex I-GENE
possesses O
a O
helicase _RARE_
activity O
. O

The O
ED30 _RARE_
values O
were O
2 O
. O
4 O
and O
2 O
. O
2 O
mg O
/ O
kg O
and O
similar O
to O
the O
respective O
values O
of O
nifedipine O
( O
ED _RARE_
30 _RARE_
: O
2 O
. O
4 O
, O
2 O
. O
1 O
mg O
/ O
kg O
). O

Southwestern _RARE_
blot O
analysis O
demonstrated O
that O
this O
phosphoprotein _RARE_
can O
bind O
the O
kappa _RARE_
B I-GENE
element I-GENE
directly O
and O
specifically O
. O

Thus O
, O
the O
positive O
effect O
of O
NS1 I-GENE
on O
the O
steady O
- O
state O
levels O
of O
P4 _RARE_
transcripts I-GENE
depends O
on O
the O
amplification O
of O
gene O
copy O
number O
and O
the O
integrity O
of O
the O
terminal O
repeats O
. O

The O
minus O
- O
end O
- O
directed O
microtubule O
motors _RARE_
, O
the O
dyneins _RARE_
, O
may O
also O
constitute O
a O
superfamily O
of O
force O
- O
generating O
proteins O
with O
distinct O
attachment _RARE_
domains O
. O

It O
is O
transparent _RARE_
, O
cheap _RARE_
to O
be O
made O
, O
and O
easy _RARE_
to O
empty _RARE_
and O
was O
tested O
in O
118 O
animals O
for _RARE_
two O
and O
four O
weeks O
. O

The O
incompatibility _RARE_
group O
W _RARE_
plasmid _RARE_
pSa _RARE_
suppresses O
Agrobacterium _RARE_
tumefaciens _RARE_
oncogenicity _RARE_
( O
J _RARE_
. O

Potential _RARE_
translational O
start _RARE_
signals O
are O
upstream O
of O
ORF1 O
and O
ORF2 O
. O

Imaging _RARE_
of O
D2 _RARE_
dopamine I-GENE
receptor I-GENE

The O
Thr161Val _RARE_
mutation O
causes O
a O
lethal O
phenotype _RARE_
in O
the O
fission _RARE_
yeast O
Schizosaccharomyces O
pombe O
, O
while O
replacement _RARE_
of O
Thr161 _RARE_
with O
glutamic _RARE_
acid O
, O
potentially O
mimicking _RARE_
phosphorylation _RARE_
, O
causes O
uncoordination _RARE_
of O
mitosis O
and O
multiple O
cytokinesis _RARE_
. O

The O
abundance O
of O
transcripts O
from O
several O
unrelated O
genes O
is O
decreased O
in O
cdc68 _RARE_
- I-GENE
1 I-GENE
mutant I-GENE
cells O
after O
transfer O
to O
the O
restrictive O
temperature _RARE_
, O
while O
at _RARE_
least O
one O
transcript O
, O
from O
the O
HSP82 _RARE_
gene I-GENE
, O
persists _RARE_
in O
an O
aberrant O
fashion O
. O

Deregulation _RARE_
of O
their O
expression _RARE_
may O
contribute O
to O
malignant O
transformation O
associated O
with O
HTLV _RARE_
- O
1 O
infection O
. O

The O
murine I-GENE
Mov _RARE_
- I-GENE
34 _RARE_
gene I-GENE
: O
full O
- O
length O
cDNA O
and O
genomic O
organization O
. O

CREB I-GENE
was O
identified O
as _RARE_
one O
of O
the O
protein O
components _RARE_
in O
several O
of O
the O
gel O
shift O
complexes O
formed O
with O
the O
variant O
CRE _RARE_
. O

The O
spectrum O
of O
histologically O
diagnosed O
malignant O
neoplasms O
in O
Sabah _RARE_
, O
1983 O
- O
1988 O
. O

When O
transfected O
into O
Drosophila O
SL _RARE_
- O
2 O
cells O
, O
pCAT _RARE_
plasmid _RARE_
containing O
2 O
, O
090 _RARE_
bp O
of O
5 O
'- O
flanking O
region O
shows O
a O
3 O
. O
0 _RARE_
- O
to O
3 O
. O
5 O
- O
fold _RARE_
increase O
in O
chloramphenicol I-GENE
acetyltransferase _RARE_
activity O
after O
induction O
with O
retinoic O
acid O
and O
/ O
or O
8 O
- O
bromo _RARE_
- O
cAMP O
. O

Two O
alternatively _RARE_
spliced _RARE_
5 O
' O
UTRs _RARE_
, O
designated O
type O
I O
and O
type O
II O
, O
of O
222 _RARE_
and O
115 _RARE_
bp O
, O
respectively O
, O
were O
found O
associated O
with O
PFP _RARE_
. O

The O
N O
- O
terminus O
of O
another O
open _RARE_
reading O
frame O
was O
found O
3 O
' O
from O
nifA _RARE_
and O
tentatively O
identified O
as _RARE_
nifB _RARE_
by O
amino O
acid O
sequence O
comparison O
. O

The O
RNA O
genome O
of O
rabbit _RARE_
hemorrhagic O
disease _RARE_
virus O
( O
RHDV _RARE_
) O
was O
molecularly O
cloned _RARE_
. O

Therefore O
, O
we O
have O
developed O
a O
system _RARE_
to O
study O
nuclear O
targeting O
in O
plants _RARE_
and O
have O
established O
that O
the O
nuclear O
transport _RARE_
machinery O
is O
similar O
in O
monocots _RARE_
and O
dicots _RARE_
. O

A O
novel O
cDNA O
clone O
termed O
R2 _RARE_
was O
isolated O
by O
subtractive _RARE_
hybridization O
of O
a O
cDNA O
library O
of O
phytohemagglutinin I-GENE
( O
PHA _RARE_
)/ _RARE_
phorbol O
myristate O
acetate _RARE_
- O
stimulated _RARE_
Jurkat O
cells O
and O
by O
rescreening _RARE_
a O
cDNA O
library O
of O
PHA _RARE_
- O
stimulated _RARE_
peripheral O
blood _RARE_
lymphocytes O
. O

In O
conclusion O
, O
we O
observed O
a O
great O
regeneration O
ability O
following O
mechanical O
injury O
in O
the O
nasal O
mucosa O
. O

There O
occurred O
a O
linear _RARE_
relationship O
between O
the O
drop O
in O
glucose I-GENE
- I-GENE
6 I-GENE
- I-GENE
phosphatase I-GENE
dehydrogenase I-GENE
activity O
and O
in O
vitamin O
E O
level O
, O
on O
one O
hand _RARE_
, O
and O
the O
duration O
of O
poisoning O
with O
sodium _RARE_
nitrite _RARE_
. O

A O
vector O
containing O
a O
transcriptionally O
inactive O
neomycin _RARE_
phosphotransferase _RARE_
II I-GENE
gene I-GENE
was O
used O
to O
select O
promoter O
sequences O
from O
a O
pool O
of O
random O
genomic O
DNA O
fragments O
. O

Chagas _RARE_
' O
disease _RARE_
, O
visceral O
leishmaniasis _RARE_
, O
anti I-GENE
- I-GENE
nuclear I-GENE
factor I-GENE
, O
schistosomiasis _RARE_
, O
rheumatoid I-GENE
factor I-GENE
and O
normal O
controls O
. O

Previous O
analysis O
of O
the O
98 O
- O
bp O
sequence O
has O
delineated _RARE_
several O
protein O
- O
binding O
domains O
that O
are O
recognized _RARE_
by O
nuclear O
factors O
present O
in O
human O
brain O
cells O
. O

The O
second O
transcriptional O
unit O
, O
designated O
UL26 I-GENE
. I-GENE
5 I-GENE
, O
predicted O
to O
specify _RARE_
a O
protein O
of O
329 _RARE_
amino O
acids _RARE_
, O
encodes O
the O
family I-GENE
35 _RARE_
proteins I-GENE
; O
it O
is O
transcribed _RARE_
by O
an O
mRNA O
which O
initiates _RARE_
at _RARE_
approximately _RARE_
nucleotide O
+ O
1000 O
of O
the O
UL26 I-GENE
transcription O
initiation O
site O
and O
is O
translated O
from O
the O
methionine O
initiation O
codon _RARE_
located _RARE_
at _RARE_
position O
+ O
1099 _RARE_
of O
the O
UL26 I-GENE
transcriptional I-GENE
unit I-GENE
. O

The O
adeno _RARE_
- I-GENE
associated I-GENE
virus I-GENE
( I-GENE
AAV _RARE_
) I-GENE
rep _RARE_
gene I-GENE
encodes O
four O
proteins O
( O
Rep78 _RARE_
, O
Rep68 _RARE_
, O
Rep52 _RARE_
, O
and O
Rep40 _RARE_
) O
required O
for _RARE_
AAV _RARE_
DNA O
replication O
and O
AAV _RARE_
gene O
regulation _RARE_
. O

A O
larger O
region O
upstream O
of O
human I-GENE
CMV _RARE_
dbp _RARE_
also O
mediated _RARE_
replication O
in O
transient O
assays O
. O

It O
also O
contains O
a O
picornaviral _RARE_
3C I-GENE
- I-GENE
like I-GENE
protease I-GENE
domain I-GENE
and O
two O
papain _RARE_
- I-GENE
like I-GENE
protease I-GENE
domains I-GENE
. O

However O
, O
the O
relative O
positions O
of O
the O
VV _RARE_
genes O
( O
genus O
Orthopoxvirus _RARE_
) O
are O
different O
than O
those O
of O
the O
corresponding O
ORFs _RARE_
in O
SFV _RARE_
( O
genus O
Leporipoxvirus _RARE_
), _RARE_
indicating O
complex O
rearrangements _RARE_
of O
DNA O
in O
the O
genome O
of O
one O
or O
both O
of O
these O
viruses O
subsequent O
to O
their O
divergence O
from O
a O
common O
ancestor O
. O

This O
result O
suggests O
that O
phosphorylation _RARE_
of O
Thr _RARE_
14 O
and O
/ O
or O
Tyr _RARE_
15 _RARE_
inhibits O
p34cdc2 I-GENE
kinase I-GENE
activity O
, O
in O
line O
with O
the O
location O
of O
these O
residues O
within O
the O
putative O
ATP O
binding O
site O
of O
the O
kinase O
. O

In O
short O
- O
term O
cotransfections _RARE_
, O
a O
pFRTK _RARE_
- O
CAT I-GENE
target O
containing O
EBNA I-GENE
- I-GENE
1 I-GENE
- I-GENE
binding I-GENE
sites I-GENE
from O
the O
EBV _RARE_
origin O
of O
plasmid _RARE_
replication O
, O
ori _RARE_
- I-GENE
P I-GENE
, O
was O
transactivated O
by O
a O
carboxy _RARE_
- I-GENE
terminal I-GENE
EBNA I-GENE
- I-GENE
1 I-GENE
construction _RARE_
( O
amino O
acids _RARE_
450 _RARE_
to O
641 _RARE_
) O
that O
also O
carried O
a O
c I-GENE
- I-GENE
myc I-GENE
nuclear I-GENE
localization _RARE_
signal I-GENE
. O

The O
findings O
are O
compatible O
with O
the O
idea O
that O
the O
genes O
encoding O
PDGF _RARE_
receptors I-GENE
in O
glioma O
cells O
are O
regulated O
in O
concert _RARE_
with O
other O
genes O
, O
the O
expression _RARE_
of O
which O
may O
reflect O
the O
developmental O
program O
of O
normal O
glia _RARE_
cell O
lineages O
. O

Suggestive _RARE_
evidence O
was O
obtained O
that O
cstA _RARE_
is O
involved O
in O
peptide O
utilization O
. O

This O
study O
tested O
the O
hypothesis O
that O
sodium _RARE_
channel _RARE_
blocking O
drugs O
selectively O
prolong _RARE_
the O
late _RARE_
potential _RARE_
, O
or O
terminal O
low O
amplitude O
signal O
, O
portion O
of O
the O
signal O
- O
averaged O
QRS O
complex O
and O
that O
prolongation O
of O
the O
late _RARE_
potential _RARE_
would O
correlate O
with O
slowing _RARE_
of O
ventricular O
tachycardia O
. O

Identification O
and O
nucleotide O
sequence O
of O
Rhizobium _RARE_
meliloti _RARE_
insertion _RARE_
sequence I-GENE
ISRm3 _RARE_
: O
similarity _RARE_
between O
the O
putative O
transposase _RARE_
encoded O
by O
ISRm3 _RARE_
and O
those O
encoded O
by O
Staphylococcus _RARE_
aureus _RARE_
IS256 _RARE_
and O
Thiobacillus _RARE_
ferrooxidans _RARE_
IST2 _RARE_
. O

To O
determine O
the O
relationship O
of O
these O
viruses O
, O
the O
complete _RARE_
DNA O
sequence O
of O
KV _RARE_
consisting O
of O
4754 _RARE_
bp O
was O
determined O
. O

Whereas O
a O
PR55 _RARE_
beta I-GENE
transcript I-GENE
of O
about O
2 O
. O
3 O
kb O
was O
detected O
at _RARE_
high O
levels O
in O
the O
neuroblastoma O
derived O
cell O
line O
LA O
- O
N O
- O
1 O
, O
the O
level O
of O
the O
mRNA O
was O
very O
low O
in O
the O
other O
human O
cell O
lines O
analyzed O
. O

Heterodimers _RARE_
of O
myogenin I-GENE
and O
E12 I-GENE
( O
or O
MyoD I-GENE
and O
E12 I-GENE
) O
specifically O
bound _RARE_
a O
restriction _RARE_
fragment O
extending O
from O
- O
200 _RARE_
to O
- O
103 _RARE_
relative O
to O
the O
start _RARE_
of O
cardiac I-GENE
alpha I-GENE
- I-GENE
actin I-GENE
transcription O
. O

The O
effects O
of O
c I-GENE
- I-GENE
myc I-GENE
were O
further O
dissected _RARE_
by O
showing O
that O
c I-GENE
- I-GENE
myc I-GENE
can O
inhibit O
differentiation O
independently O
of O
Id _RARE_
, O
a O
negative O
regulator O
of O
muscle O
differentiation O
. O

Stable O
association O
of O
U2 _RARE_
snRNP I-GENE
with O
the O
branchpoint O
sequence O
of O
mammalian O
pre O
- O
mRNAs O
requires O
binding O
of O
a O
non O
- O
snRNP O
protein O
to O
the O
polypyrimidine _RARE_
tract _RARE_
. O

Naturally _RARE_
acquired O
antibodies O
were O
demonstrated O
in O
some O
rabbits O
kept O
on O
commercial O
farms _RARE_
. O

The O
Italian O
Lung O
Cancer O
Task _RARE_
Force _RARE_
( O
FONICAP _RARE_
). O

The O
promoter O
activity O
of O
the O
gene I-GENE
encoding I-GENE
Alzheimer _RARE_
beta I-GENE
- I-GENE
amyloid _RARE_
precursor I-GENE
protein I-GENE
( O
APP _RARE_
) O
is O
regulated O
by O
two O
blocks O
of O
upstream O
sequences O
. O

Biol O
. O

Nucleotide O
sequences O
between O
the O
env I-GENE
gene I-GENE
and O
the O
LTR I-GENE
of I-GENE
SFV _RARE_
- I-GENE
1 I-GENE
were O
determined O
. O

This O
element O
was O
used O
to O
screen O
an O
EMBL3 _RARE_
mouse O
genomic O
library O
. O

The O
MVV _RARE_
- O
value O
is O
under O
the O
predicted O
level O
in O
the O
case O
of O
67 O
- O
76 _RARE_
percent O
. O

The O
rad9 _RARE_
. I-GENE
192 _RARE_
DNA I-GENE
repair I-GENE
mutant I-GENE
from I-GENE
the I-GENE
fission _RARE_
yeast I-GENE
, I-GENE
Schizosaccharomyces I-GENE
pombe I-GENE
, O
is O
sensitive _RARE_
to O
both O
UV _RARE_
and O
ionising _RARE_
radiation O
. O

Review _RARE_
: O
deterioration O
of O
glucose O
tolerance O
with O
age O
: O
the O
role O
of O
insulin I-GENE
resistance O
. O

The O
5 O
' O
region O
shows O
strong O
sequence O
similarity _RARE_
to O
Escherichia O
coli O
consensus O
promoters O
and O
ribosome _RARE_
- O
binding O
sequences O
and O
allows O
high O
levels O
of O
expression _RARE_
in O
E O
. O
coli O
. O

Premature _RARE_
initiation O
of O
mitosis O
in O
yeast O
lacking _RARE_
RCC1 _RARE_
or O
an O
interacting _RARE_
GTPase I-GENE
. O

The O
method O
has O
been O
routinely _RARE_
used O
in O
our O
laboratory O
for _RARE_
1 O
year O
and O
has O
proven O
to O
be O
a O
reliable O
procedure O
for _RARE_
the O
biological O
control O
of O
occupational _RARE_
exposure O
to O
toluene O
and O
/ O
or O
xylene O
. O

The O
patient O
was O
a O
78 _RARE_
- O
year O
- O
old O
male O
in O
whom O
skin _RARE_
lesions O
preceded _RARE_
the O
diagnosis O
of O
myelofibrosis _RARE_
. O

Oculus _RARE_
- O
500 O
is O
a O
group O
of O
high O
resolution O
imaging O
boards _RARE_
for _RARE_
use O
with O
IBM _RARE_
- O
AT O
and O
compatible O
computers _RARE_
. O

The O
human O
cDNA O
was O
used O
to O
demonstrate O
that O
tumor I-GENE
necrosis I-GENE
factor I-GENE
- I-GENE
alpha I-GENE
could O
rapidly O
stimulate O
MARCKS _RARE_
gene I-GENE
transcription O
in O
the O
human O
promyelocytic _RARE_
leukemia O
cell O
line O
HL60 _RARE_
. O

After O
resection O
of O
the O
proximal O
fragment O
, O
all O
scaphoid _RARE_
contact _RARE_
area O
and O
pressure O
was O
born O
by O
the O
distal O
scaphoid _RARE_
fragment O
. O

Plate _RARE_
luting _RARE_
, O
a O
technique O
that O
uses O
polymethylmethacrylate _RARE_
( O
PMMA _RARE_
) O
interposed _RARE_
between O
the O
plate _RARE_
and O
the O
bone O
, O
as _RARE_
well _RARE_
as _RARE_
between O
the O
screw _RARE_
heads _RARE_
and O
the O
plate _RARE_
, O
to O
improve O
the O
stability O
of O
internal O
fixation O
was O
tested O
in O
vitro O
using O
20 O
paired O
equine _RARE_
third O
metacarpal _RARE_
bones _RARE_
with O
mid O
- O
diaphyseal _RARE_
osteotomies _RARE_
plated _RARE_
with O
six _RARE_
- O
hole _RARE_
broad O
ASIF _RARE_
compression O
plates O
. O

These O
features O
were O
considered O
consistent O
with O
a O
diagnosis O
of O
Rothmund _RARE_
- O
Thomson _RARE_
syndrome _RARE_
. O

Thyroid _RARE_
lymphoma O
and O
its O
management O
. O

The O
protein O
encoded O
by O
ORF113 _RARE_
contains O
a O
transmembrane O
domain O
. O

Space _RARE_
limitations O
prevent O
an O
exhaustive _RARE_
review O
of O
all O
biologic _RARE_
pharmaceuticals _RARE_
, O
such O
as _RARE_
tissue I-GENE
plasminogen I-GENE
activating I-GENE
substance _RARE_
, O
hormones _RARE_
( O
e _RARE_
. O
g O
., O
thyroid O
, O
insulin I-GENE
, O
growth I-GENE
hormone I-GENE
, O
erythropoietin I-GENE
), _RARE_
clotting _RARE_
factors O
, O
and O
blood _RARE_
products O
. O

Dd _RARE_
PK1 _RARE_
RNA I-GENE
decreases O
after O
6 O
h O
of O
starvation O
to O
re O
- O
accumulate O
once O
the O
cells O
have O
aggregated _RARE_
. O

The O
various O
forms O
of O
sickle _RARE_
cell O
disease _RARE_
share O
the O
common O
feature O
of O
an O
abnormal O
globin I-GENE
chain I-GENE
that O
, O
under O
certain O
conditions O
such O
as _RARE_
hypoxia _RARE_
, O
results O
in O
the O
sickling _RARE_
of O
red _RARE_
blood _RARE_
cells O
and O
obstruction O
of O
blood _RARE_
vessels O
. O

The O
primary _RARE_
structure _RARE_
of O
each O
of O
the O
three O
proteins O
has O
about O
70 O
% O
homology O
with O
that O
of O
mouse I-GENE
contrapsin _RARE_
, O
in O
contrast O
to O
43 _RARE_
- O
46 _RARE_
% O
homology O
with O
that O
of O
rat I-GENE
alpha I-GENE
1 I-GENE
- I-GENE
protease I-GENE
inhibitor O
. O

Patterns _RARE_
of O
connections _RARE_
underlying O
cross O
- O
modality O
integration _RARE_
were O
studied O
by O
injecting O
distinguishable _RARE_
, O
retrograde _RARE_
tracers _RARE_
( O
Fluoro _RARE_
- O
Gold _RARE_
and O
diamidino _RARE_
yellow O
) O
in O
pairwise _RARE_
manner O
into O
different O
sensory O
representations _RARE_
( O
visual O
, O
somatosensory _RARE_
, O
and O
auditory O
) O
in O
the O
cerebral O
cortex O
of O
the O
rat O
. O

Young _RARE_
CD O
- O
1 O
mice O
, O
4 O
days O
old O
, O
exposed O
to O
0 _RARE_
. O
1 O
% O
nicotine O
sulfate _RARE_
on O
gestational O
days O
6 O
- O
20 O
were O
compared O
with O
untreated O
pups _RARE_
of O
the O
same O
age O
to O
determine O
its O
effect O
on O
the O
development O
of O
mandibular O
first _RARE_
molars _RARE_
. O

USF I-GENE
synthesized O
in O
an O
in O
vitro O
transcription O
and O
translation O
system _RARE_
also O
binds O
to O
the O
ADH I-GENE
promoter I-GENE
as _RARE_
well _RARE_
as _RARE_
to O
the O
MLP _RARE_
. O

The O
across O
- O
fiber O
pattern O
of O
the O
responses O
to O
hypotonic _RARE_
NaCl O
solutions O
correlated O
strongly O
to O
that O
elicited O
by O
distilled _RARE_
H2O _RARE_
.( O
ABSTRACT O
TRUNCATED O
AT O
400 _RARE_
WORDS O
) O

Arterial _RARE_
radioactivity _RARE_
content O
after O
the O
intravenous O
administration O
of O
HMPAO O
in O
seven _RARE_
human O
subjects O
was O
analyzed O
. O

Linear _RARE_
regression O
analysis O
was O
performed O
and O
the O
following O
result O
was O
obtained O
: O
clearance O
( O
HMPAO O
) O
= O
0 _RARE_
. O
07 O
+ O
0 _RARE_
. O
43 _RARE_
. O
rCBF O
with O
a O
high O
significance O
( O
p O
less O
than O
0 _RARE_
. O
001 O
). O

Human I-GENE
immunodeficiency I-GENE
virus I-GENE
type I-GENE
1 I-GENE
( I-GENE
HIV I-GENE
- I-GENE
1 I-GENE
) I-GENE
IN _RARE_
, O
expressed _RARE_
in O
Escherichia O
coli O
, O
was O
purified _RARE_
to O
near O
homogeneity _RARE_
. O

Thigh _RARE_
girth _RARE_
correlated O
positively O
with O
HDL _RARE_
and O
HDL2 I-GENE
- I-GENE
C I-GENE
and O
mass O
, O
and O
with O
LDL I-GENE
particle _RARE_
size O
among O
women O
. O

Contributions _RARE_
from O
pairs _RARE_
of O
source O
and O
target O
volume O
elements O
are O
summed _RARE_
for _RARE_
the O
S O
values O
between O
the O
tumor O
and O
itself O
, O
between O
the O
remaining O
healthy O
host _RARE_
organ O
and O
itself O
, O
and O
between O
the O
tumor O
and O
the O
remaining O
healthy O
host _RARE_
organ O
, O
with O
the O
reciprocity _RARE_
theorem _RARE_
assumed O
for _RARE_
the O
last O
. O

Tests _RARE_
showed O
that O
an O
overall O
impression _RARE_
of O
the O
force O
applied O
could O
be O
obtained O
from O
a O
laboratory O
simulation _RARE_
, O
but O
that O
clearing _RARE_
cement _RARE_
and O
testing O
cement _RARE_
were O
not O
modelled _RARE_
by O
this O
method O
. O

The O
cDNA O
contained O
an O
open _RARE_
reading O
frame O
of O
1392 _RARE_
bp O
that O
predicted O
a O
protein O
of O
464 _RARE_
amino O
acids _RARE_
and O
a O
molecular _RARE_
mass O
of O
52 O
kDa O
; O
this O
protein O
has O
97 O
% O
identity O
to O
rat I-GENE
liver I-GENE
glucokinase _RARE_
. O

Analysis O
of O
viral O
mutants O
in O
vivo O
demonstrated O
that O
the O
NFIII _RARE_
/ O
OCT _RARE_
- I-GENE
1 I-GENE
binding O
site O
and O
a O
conserved _RARE_
ATF I-GENE
motif I-GENE
were O
important O
for _RARE_
efficient O
viral O
growth O
. O

Recovery _RARE_
of O
radiolabelled _RARE_
BA _RARE_
through O
urine O
( O
28 _RARE_
%) O
and O
faeces _RARE_
( O
22 _RARE_
%) O
up _RARE_
to O
96 O
hrs O
averaged O
50 O
%, O
whereas O
residual O
radioactivity _RARE_
in O
liver O
and O
testis _RARE_
experienced O
a O
recovery O
of O
29 O
% O
in O
scorbutic _RARE_
animals O
. O

Saccharomyces O
cerevisiae O
has O
been O
used O
widely O
both O
as _RARE_
a O
model O
system _RARE_
for _RARE_
unraveling _RARE_
the O
biochemical O
, O
genetic O
, O
and O
molecular _RARE_
details _RARE_
of O
gene O
expression _RARE_
and O
the O
secretion _RARE_
process O
, O
and O
as _RARE_
a O
host _RARE_
for _RARE_
the O
production O
of O
heterologous O
proteins O
of O
biotechnological _RARE_
interest O
. O

Paradoxically _RARE_
, O
however O
, O
the O
GH _RARE_
receptor I-GENE
cloned _RARE_
from O
liver O
exhibits O
no _RARE_
sequence O
similarity _RARE_
to O
receptors O
with O
known O
signal O
transduction _RARE_
mechanisms O
, O
including O
those O
exhibiting O
ligand _RARE_
- O
activated O
tyrosine I-GENE
kinase I-GENE
activity O
. O

This O
indicates O
that O
under O
certain O
experimental O
conditions O
cdc2 I-GENE
/ O
p58 _RARE_
and O
cdc2 I-GENE
/ O
p62 I-GENE
may O
express O
some O
differences O
in O
their O
catalytic O
activity O
. O

Mutation O
analysis O
implicated O
multiple O
segments _RARE_
of O
the O
5 O
' O
untranslated _RARE_
region O
as _RARE_
contributing _RARE_
to O
the O
inhibitory _RARE_
effect O
. O

Identification O
of O
Ets I-GENE
- O
and O
notch _RARE_
- O
related O
subunits O
in O
GA _RARE_
binding I-GENE
protein I-GENE
. O

The O
enzymatic O
response O
of O
neutrophils O
and O
monocytes O
was O
similar O
although O
the O
magnitude O
of O
the O
NADPH _RARE_
oxidase I-GENE
activity O
was O
significantly O
higher _RARE_
in O
neutrophils O
than O
in O
monocytes O
. O

In O
the O
ileum _RARE_
, O
enterotoxin _RARE_
increased O
the O
luminal O
disappearance O
( O
P O
less O
than O
0 _RARE_
. O
05 O
) O
and O
peripheral O
blood _RARE_
appearance O
( O
P O
less O
than O
0 _RARE_
. O
001 O
) O
of O
chloroquine _RARE_
. O

Formalin _RARE_
activated O
both O
SNO _RARE_
NS _RARE_
and O
NnS _RARE_
neurones O
, O
but O
, O
when O
they O
responded O
, O
NS _RARE_
neurones O
( O
n _RARE_
= O
5 O
) O
showed O
only O
the O
first _RARE_
phase _RARE_
of O
activity O
while O
NnS _RARE_
neurones O
showed O
either O
one O
( O
n _RARE_
= O
13 _RARE_
) O
or O
two O
phases O
( O
n _RARE_
= O
6 O
). O

Uptake _RARE_
of O
ofloxacin _RARE_
by O
Escherichia O
coli O

It O
is O
concluded O
that O
attention O
to O
these O
issues O
can O
substantially O
improve O
the O
quality O
of O
research O
on O
AIDS O
related O
behaviors _RARE_
on O
Black _RARE_
communities _RARE_
. O

The O
effectiveness O
of O
alpha O
- O
mercapto _RARE_
- O
beta O
-( _RARE_
2 O
- O
furyl _RARE_
) O
acrylic _RARE_
acid O
( O
MFA _RARE_
) O
and O
N O
- O
benzyl _RARE_
- O
N O
- O
dithiocarboxy _RARE_
- O
D O
- O
glucamine _RARE_
( O
NaB _RARE_
), _RARE_
used O
in O
combination O
, O
in O
the O
mobilization _RARE_
and O
excretion O
of O
lead O
was O
investigated O
in O
rats O
. O

These O
results O
suggest O
that O
beta I-GENE
- I-GENE
1 I-GENE
may O
act O
as _RARE_
a O
tissue O
- O
specific O
, O
trans _RARE_
- O
acting O
regulator O
of O
the O
expression _RARE_
of O
the O
beta I-GENE
- I-GENE
zein _RARE_
gene I-GENE
in O
developing O
maize _RARE_
endosperm _RARE_
. O

This O
study O
examines _RARE_
the O
effects O
of O
hypovolemia _RARE_
on O
the O
extracellular O
ptO2 _RARE_
and O
ptH _RARE_
distributions _RARE_
at _RARE_
multiple O
tissue O
sites O
using O
a O
recently O
developed O
multipoint _RARE_
microelectrode _RARE_
, O
that O
provides O
simultaneous O
measurements O
of O
ptO2 _RARE_
and O
ptH _RARE_
. O

All O
members O
are O
also O
capable O
of O
activating O
in O
vivo O
transcription O
from O
promoters O
that O
contain O
a O
C I-GENE
/ I-GENE
EBP I-GENE
- I-GENE
binding I-GENE
site I-GENE
. O

The O
domains O
involved O
in O
superactivation _RARE_
appear O
to O
be O
a O
subset O
of O
those O
necessary O
to O
achieve O
synergistic O
activation O
. O

Information _RARE_
on O
conserved _RARE_
noncoding O
sequences O
will O
help O
in O
studies O
on O
the O
regulation _RARE_
of O
the O
pro I-GENE
alpha I-GENE
1 I-GENE
( I-GENE
II I-GENE
) I-GENE
collagen _RARE_
gene I-GENE
. O

Chlamydia O
trachomatis _RARE_
and O
Chlamydia O
psittaci _RARE_
were O
not O
affected O
by O
methanol _RARE_
fixation O
. O

Although O
human O
infections O
with O
bacteraemia _RARE_
due O
to O
Pasteurella _RARE_
multocida _RARE_
are O
not O
uncommon _RARE_
, O
endocarditis _RARE_
associated O
with O
P O
. O
haemolytica _RARE_
is O
rare O
. O

For O
SMX _RARE_
at _RARE_
pH O
7 O
. O
0 _RARE_
, O
a O
1 O
: O
1 O
complex O
is O
formed O
, O
but O
at _RARE_
pH O
7 O
. O
5 O
HPCD _RARE_
has O
little O
effect O
on O
the O
solubility _RARE_
of O
the O
highly O
ionized _RARE_
SMX _RARE_
, O
presumably O
since O
only O
un _RARE_
- O
ionized _RARE_
molecules O
can O
form O
inclusion O
complexes O
with O
the O
HPCD _RARE_
. O

PO2 O
measurements O
using O
a O
double O
barrelled _RARE_
recess _RARE_
type O
microelectrodes _RARE_
were O
measured O
in O
the O
optic O
nerve O
head O
of O
miniature _RARE_
pigs O
in O
normoxia _RARE_
and O
hyperoxia _RARE_
. O

POU I-GENE
- O
specific O
and O
POU I-GENE
- O
homeo _RARE_
domains O
of O
Oct3 _RARE_
were O
produced O
in O
Echerichia _RARE_
coli O
for _RARE_
characterization O
of O
DNA O
binding O
to O
the O
octamer O
sequence O
. O

A O
deletion O
series O
of O
the O
5 O
' O
flanking O
region O
was O
created O
from O
position O
- O
1329 _RARE_
to O
- O
74 _RARE_
relative O
to O
the O
transcriptional O
initiation O
site O
and O
similarly O
examined O
in O
transgenic O
tobacco O
. O

The O
nucleotide O
( O
nt O
) O
sequences O
of O
the O
exons O
, O
exon _RARE_
/ O
intron O
boundaries O
and O
5 O
'- O
and O
3 O
'- O
untranslated _RARE_
regions O
were O
determined O
. O

Out _RARE_
of O
40 O
patients O
, O
who O
initially O
did O
not O
show O
eye O
complications O
due O
to O
leprosy _RARE_
, O
37 O
patients O
were O
essentially O
the O
same O
10 O
years O
later O
. O

Thus O
, O
two O
very O
different O
regulatory O
elements O
are O
used O
to O
mediate O
estrogen O
induction O
of O
related O
genes O
in O
chickens _RARE_
and O
amphibians _RARE_
. O

Toxicity _RARE_
was O
very O
mild O
with O
both O
regimens O
, O
although O
sedation O
was O
significantly O
higher _RARE_
in O
arm _RARE_
B O
( O
p O
less O
than O
0 _RARE_
. O
001 O
). O

Experimentally _RARE_
in O
green _RARE_
monkeys O
, O
Syrian _RARE_
hamsters O
and O
white _RARE_
mice O
the O
authors O
studied O
the O
pathogenic O
properties O
of O
a O
new O
virus O
Issyk _RARE_
- O
Kul _RARE_
. O

Increasing O
mean O
arterial O
pressure O
by O
phenylephrine _RARE_
infusion O
to O
levels O
much O
greater O
than O
produced O
by O
NMA _RARE_
and O
NNA _RARE_
caused O
only O
small O
reductions O
in O
cardiac O
output O
. O

J _RARE_
. O

Limits _RARE_
of O
energy O
turnover O
in O
relation O
to O
physical O
performance O
were O
addressed O
in O
terms O
of O
upper O
and O
lower O
limit O
, O
changes O
during _RARE_
a O
training O
programme _RARE_
and O
how O
to O
regulate O
energy O
balance O
at _RARE_
a O
changing O
energy O
turnover O
. O

With O
stepwise _RARE_
reductions O
in O
flow O
, O
the O
peak O
( O
S O
) O
and O
trough O
( O
D O
) O
points O
of O
the O
maximum O
shifted O
- O
frequency O
envelope O
fell O
in O
parallel O
in O
a O
linear _RARE_
fashion O
until O
D O
reached O
zero O
. O

The O
IE0 _RARE_
gene I-GENE
product O
also O
transactivated O
the O
IE1 I-GENE
promoter I-GENE
but O
did O
not O
affect O
expression _RARE_
from O
its O
own O
promoter O
. O

Moreover O
, O
promoters O
containing O
a O
TATA O
box O
in O
the O
absence O
of O
Sp1 _RARE_
sites I-GENE
or O
Sp1 _RARE_
sites I-GENE
in O
the O
absence O
of O
a O
TATA O
box O
were O
equally O
inducible O
in O
vitro O
, O
as _RARE_
was O
an O
RNA I-GENE
polymerase I-GENE
III I-GENE
promoter I-GENE
. O

Evaluation O
of O
left _RARE_
ventricular O
function O
using O
gated O
planar _RARE_
myocardial _RARE_
imaging O
with O
Tc O
- O
99m O
- O
MIBI _RARE_

Ivermectin _RARE_
uptake O
and O
distribution O
in O
the O
plasma O
and O
tissue O
of O
Sudanese _RARE_
and O
Mexican _RARE_
patients O
infected _RARE_
with O
Onchocerca _RARE_
volvulus _RARE_
. O

Bone _RARE_
marrow O
abnormalities O
in O
Hodgkin O
' O
s O
disease _RARE_
are O
reviewed O
and O
the O
current O
understanding O
of O
the O
pathological O
mechanisms O
leading O
to O
aplastic _RARE_
anemia _RARE_
is O
discussed O
. O

The O
smaller O
uptake O
rate O
and O
faster O
clearance O
rate O
resulted O
in O
the O
lower O
BCF _RARE_
for _RARE_
SWA _RARE_
killifish _RARE_
. O

The O
currently O
proposed O
extended O
arch _RARE_
repair O
should O
be O
reserved _RARE_
for _RARE_
the O
small O
group O
of O
infants O
with O
transverse O
aortic O
arch _RARE_
to O
ascending O
aorta O
diameter O
ratios O
( O
arch _RARE_
indices O
) O
of O
less O
than O
0 _RARE_
. O
25 _RARE_
. O

DNA O
hybridization O
analysis O
revealed O
that O
both O
pigmented _RARE_
and O
nonpigmented _RARE_
cells O
of O
Y O
. O
pestis _RARE_
possess O
a O
DNA O
locus O
homologous O
to O
the O
Escherichia I-GENE
coli I-GENE
fur _RARE_
gene I-GENE
. O

Increases _RARE_
in O
the O
perfusate _RARE_
PCO2 O
but O
not O
in O
the O
perfusate _RARE_
H O
+ O
were O
highly O
correlated O
with O
decreases O
in O
both O
myocardial _RARE_
contractility O
and O
oxygen O
consumption O
( O
r2 _RARE_
= O
. O
88 O
). O

Expression O
was O
cell O
cycle _RARE_
controlled _RARE_
, O
with O
steady O
- O
state O
RNA O
levels O
significantly O
higher _RARE_
in O
growth O
- O
arrested O
than O
in O
growth O
- O
stimulated _RARE_
cells O
. O

Determinants _RARE_
of O
recurrent O
ischaemia O
and O
revascularisation _RARE_
procedures O
after O
thrombolysis _RARE_
with O
recombinant O
tissue I-GENE
plasminogen I-GENE
activator I-GENE
in O
primary _RARE_
coronary O
occlusion O
. O

Therefore O
, O
the O
rbcL _RARE_
- O
rbcS _RARE_
locus O
seems O
to O
be O
barely _RARE_
expressed _RARE_
under O
a O
standard O
condition O
for _RARE_
photoautotrophic _RARE_
growth O
. O

Relationship _RARE_
between O
mitochondrial I-GENE
NADH _RARE_
- I-GENE
ubiquinone _RARE_
reductase I-GENE
and O
a O
bacterial I-GENE
NAD _RARE_
- I-GENE
reducing _RARE_
hydrogenase _RARE_
. O

Analysis O
of O
mRNA O
expression _RARE_
shows O
that O
AT I-GENE
- I-GENE
BP1 _RARE_
and O
AT I-GENE
- I-GENE
BP2 _RARE_
are O
expressed _RARE_
in O
all O
the O
tissues O
examined O
. O

We O
report O
two O
patients O
receiving O
maintenance _RARE_
valproate _RARE_
, O
one O
with O
resolving _RARE_
acute O
hepatitis O
C O
and O
the O
other O
with O
chronic O
persistent O
hepatitis O
C O
, O
with O
incidental _RARE_
microvesicular _RARE_
steatosis _RARE_
demonstrated O
on O
oil O
- O
red _RARE_
O O
stains _RARE_
. O

3 O
cases O

UDP _RARE_
- I-GENE
Gal _RARE_
: I-GENE
Gal _RARE_
beta I-GENE
1 I-GENE
---- _RARE_
4GlcNAc _RARE_
alpha I-GENE
1 I-GENE
---- _RARE_
3 I-GENE
- I-GENE
galactosyltransferase _RARE_
is O
a O
terminal I-GENE
glycosyltransferase _RARE_
that O
is O
widely O
expressed _RARE_
in O
a O
variety O
of O
mammalian O
species O
, O
with O
the O
notable _RARE_
exception O
of O
man O
, O
apes _RARE_
, O
and O
Old _RARE_
World _RARE_
monkeys O
. O

A O
synthetic _RARE_
oligonucleotide _RARE_
containing O
the O
SRE O
sequence O
from O
the O
mouse I-GENE
c I-GENE
- I-GENE
fos I-GENE
gene I-GENE
promoter I-GENE
(- _RARE_
299 _RARE_
to O
- O
322 _RARE_
) O
was O
radioactively _RARE_
labeled O
, O
used O
as _RARE_
a O
probe O
for _RARE_
the O
mobility O
shift O
assay O
and O
Southwestern _RARE_
( O
DNA O
- O
protein O
) O
blotting O
, O
and O
also O
used O
for _RARE_
sequence O
- O
specific O
affinity O
chromatography O
. O

Sequence O
requirements O
for _RARE_
premature O
transcription O
arrest O
within O
the O
first _RARE_
intron O
of O
the O
mouse I-GENE
c I-GENE
- I-GENE
fos I-GENE
gene I-GENE
. O

Infarct _RARE_
regional O
ejection O
fraction O
improved O
by O
10 O
. O
1 O
+/- O
2 O
. O
1 O
% O
between O
early O
and O
late _RARE_
studies O
when O
the O
infarct O
- O
related O
artery O
was O
patent _RARE_
and O
by O
4 O
. O
8 O
+/- O
1 O
. O
4 O
% O
if O
it O
was O
occluded O
( O
p O
= O
0 _RARE_
. O
048 _RARE_
); O
changes O
in O
global O
and O
noninfarct _RARE_
regional O
ejection O
fraction O
were O
similar O
irrespective O
of O
perfusion O
status O
. O

One O
of O
its O
lysine _RARE_
residues O
is O
modified O
by O
spermidine _RARE_
to O
form O
hypusine _RARE_
, O
a O
posttranslational O
modification O
unique O
to O
eIF I-GENE
- I-GENE
5A _RARE_
. O

The O
plasmid _RARE_
shuffle _RARE_
technique O
was O
used O
to O
replace O
the O
wild O
- O
type O
gene O
with O
the O
mutant O
form O
, O
resulting O
in O
failure O
of O
the O
yeast O
cells O
to O
grow O
. O

If O
this O
is O
the O
case O
, O
identification O
and O
characterization O
of O
transcripts O
from O
the O
Ig I-GENE
loci I-GENE
should O
permit O
a O
better O
understanding O
of O
the O
gene O
rearrangement O
process O
. O

Transcription O
of O
the O
metH _RARE_
gene I-GENE
in I-GENE
Salmonella _RARE_
typhimurium _RARE_
and I-GENE
Escherichia I-GENE
coli I-GENE
is O
positively O
regulated O
by O
the O
metR _RARE_
gene I-GENE
product I-GENE
, O
a O
DNA O
binding O
protein O
. O

Disruption O
of O
the O
chromosomal I-GENE
AAR1 _RARE_
gene I-GENE
in O
alpha O
and O
a O
/ O
alpha O
cells O
conferred O
the O
nonmating _RARE_
phenotype _RARE_
, O
and O
the O
a O
/ O
alpha O
diploids _RARE_
could O
not O
sporulate _RARE_
. O

The O
effect O
of O
ICRF _RARE_
- O
187 _RARE_
on O
the O
antitumor _RARE_
response O
induced _RARE_
by O
the O
combination O
of O
ADR O
and O
WBH _RARE_
was O
also O
investigated O
in O
order O
to O
assess O
alterations O
in O
the O
therapeutic O
index O
of O
this O
combined O
therapeutic O
modality O
treatment O
. O

The O
ORF O
was O
analyzed O
for _RARE_
secondary O
structural O
features O
, O
and O
the O
sequence O
data O
bases O
were O
searched _RARE_
for _RARE_
homologies O
. O

This O
study O
indicates O
that O
this O
dose O
- O
intense O
regimen O
can O
be O
safely _RARE_
administered O
, O
even O
with O
the O
use O
of O
purged _RARE_
marrow O
, O
with O
an O
acceptable O
toxicity O
profile O
. O

Mitomycin _RARE_
- O
C O
can O
cause O
severe O
necrosis O
and O
ulceration O
when O
extravasated _RARE_
inadvertently _RARE_
into O
skin _RARE_
and O
soft O
tissues O
following O
IV O
drug O
administration O
. O

In O
this O
study O
, O
we O
have O
cloned _RARE_
the O
5 O
'- O
flanking O
region O
of O
the O
human I-GENE
nidogen _RARE_
gene I-GENE
. O

INTERVENTIONS _RARE_
: O
Patients O
received O
rt _RARE_
- I-GENE
PA I-GENE
, O
heparin _RARE_
, O
and O
aspirin _RARE_
. O

Consistent O
with O
the O
in O
vivo O
result O
, O
the O
pseudorevertant _RARE_
endonucleases _RARE_
in O
the O
crude O
cell O
extract _RARE_
display O
site O
- O
specific O
partial O
DNA O
cleavage _RARE_
activity O
. O

Additionally O
, O
I I-GENE
kappa _RARE_
B I-GENE
beta I-GENE
, O
but O
not O
I I-GENE
kappa _RARE_
B I-GENE
alpha I-GENE
, O
also O
prevented O
the O
binding O
of O
Rel I-GENE
to O
the O
kappa _RARE_
B I-GENE
site I-GENE
. O

Sequence O
analysis O
reveals O
that O
the O
DNA O
binding O
domain O
of O
ILF _RARE_
has O
strong O
homology O
to O
the O
recently O
described O
fork I-GENE
head I-GENE
DNA I-GENE
binding I-GENE
domain I-GENE
found O
in O
the O
Drosophila I-GENE
homeotic I-GENE
protein I-GENE
fork I-GENE
head I-GENE
and O
a O
family O
of O
hepatocyte _RARE_
nuclear I-GENE
factors I-GENE
, O
HNF I-GENE
- I-GENE
3 I-GENE
. O

Lengthy _RARE_
and O
repeated _RARE_
hemodialyses _RARE_
were O
required O
to O
lower O
lithemia _RARE_
to O
nontoxic _RARE_
ranges _RARE_
. O

A O
single O
i O
. O
p O
. O
injection O
of O
d O
, O
l _RARE_
- O
baclofen _RARE_
10 O
mg O
/ O
kg O
both O
reduced _RARE_
noradrenaline O
( O
NA O
) O
biosynthesis O
in O
vivo O
( O
31 _RARE_
%) O
and O
the O
endogenous O
concentration O
of O
normetanephrine _RARE_
( O
NMN _RARE_
) O
( O
32 _RARE_
%) O
and O
increased O
NA O
levels O
( O
28 _RARE_
%). O

Fufang _RARE_
wuzi _RARE_
yanzong _RARE_
pills _RARE_
have O
strong O
leukogenic _RARE_
effect O
on O
cyclophosphamide O
induced _RARE_
leukopenia _RARE_
in O
mice O
. O

Mutations O
in O
the O
small O
subunit O
of O
ribulosebisphosphate _RARE_
carboxylase _RARE_
affect O
subunit O
binding O
and O
catalysis _RARE_
. O

The O
structural O
changes O
in O
intra _RARE_
- O
acinar _RARE_
artery O
manifested O
mainly O
by O
an O
increase O
in O
number O
of O
muscular O
artery O
resulting O
from O
muscularization _RARE_
of O
precursor O
cells O
( O
pericytes _RARE_
and O
intermediate _RARE_
cells O
) O
located _RARE_
within O
partially O
muscular O
and O
nonmuscular _RARE_
arterial O
wall _RARE_
to O
smooth _RARE_
muscle O
cell O
, O
and O
by O
the O
medial O
wall _RARE_
thickened _RARE_
due O
to O
hypertrophy O
and O
hyperplasia O
of O
smooth _RARE_
muscle O
cells O
as _RARE_
well _RARE_
as _RARE_
accumulation O
of O
a O
large O
amount O
of O
collagen _RARE_
, O
especially O
the O
type I-GENE
1 I-GENE
collagen _RARE_
. O

These O
results O
suggest O
that O
NZ _RARE_
- O
107 _RARE_
may O
be O
a O
useful O
drug O
for _RARE_
the O
treatment O
of O
bronchial O
asthma O
by O
reducing _RARE_
late _RARE_
- O
phase _RARE_
airway O
responses O
and O
airway O
hyperreactivity _RARE_
. O

In O
study O
2 O
, O
the O
correlation O
coefficients O
between O
the O
ISO2 _RARE_
measurements O
obtained O
at _RARE_
the O
ulcer O
margin O
and O
at _RARE_
the O
adjacent O
normal O
mucosa O
, O
and O
delta O
ISO2 _RARE_
obtained O
by O
the O
experienced O
observer _RARE_
and O
one O
of O
the O
three O
learners _RARE_
were O
0 _RARE_
. O
94 O
, O
0 _RARE_
. O
97 O
, O
and O
0 _RARE_
. O
94 O
, O
respectively O
. O

Bronchial _RARE_
mucosa O
tattooing _RARE_
in O
persons O
exposed O
to O
different O
industrial _RARE_
aerosols _RARE_
did O
not O
depend O
on O
the O
forms O
of O
PC O
, O
DB _RARE_
and O
the O
diseases O
' O
stages O
. O

Anti _RARE_
- I-GENE
HBc _RARE_
production O
of O
PBMC _RARE_
was O
enhanced _RARE_
remarkably O
in O
this O
case O
. O

Sequence O
analysis O
of O
the O
sMtCK _RARE_
genomic I-GENE
upstream I-GENE
sequences I-GENE
reveals O
a O
typical O
TATAA _RARE_
box O
within O
the O
80 _RARE_
base _RARE_
pairs _RARE_
( O
bp O
) O
that O
, O
by O
transfection O
experiments O
, O
are O
sufficient O
to O
promote O
expression _RARE_
of O
chimeric O
plasmids O
with O
the O
chloramphenicol I-GENE
acetyltransferase _RARE_
reporter I-GENE
. O

Sequence O
analysis O
of O
the O
sMtCK _RARE_
genomic I-GENE
upstream I-GENE
sequences I-GENE
reveals O
a O
typical O
TATAA _RARE_
box O
within O
the O
80 _RARE_
base _RARE_
pairs _RARE_
( O
bp O
) O
that O
, O
by O
transfection O
experiments O
, O
are O
sufficient O
to O
promote O
expression _RARE_
of O
chimeric O
plasmids O
with O
the O
chloramphenicol I-GENE
acetyltransferase _RARE_
reporter I-GENE
. O

The O
cDNA O
segment O
is O
flanked O
by O
the O
immunoglobulin I-GENE
gene I-GENE
recombination _RARE_
signal I-GENE
sequences I-GENE
so O
that O
the O
cDNA O
segment O
can O
invert _RARE_
and O
the O
human I-GENE
IL _RARE_
- I-GENE
2R I-GENE
L I-GENE
chain I-GENE
is O
subsequently O
expressed _RARE_
under O
the O
control O
of O
the O
SV40 I-GENE
promoter I-GENE
. O

Lipoprotein _RARE_
lipase I-GENE
( O
LPL _RARE_
), _RARE_
a O
key O
enzyme O
in O
normal O
lipoprotein O
metabolism O
, O
has O
a O
complex O
pattern O
of O
regulation _RARE_
and O
tissue O
- O
specific O
expression _RARE_
. O

Deletion O
of O
the O
proximal O
octanucleotide _RARE_
motif O
from O
the O
plasmid _RARE_
containing O
the O
- O
461 _RARE_
fragment O
of O
the O
LPL _RARE_
promoter I-GENE
, O
resulted O
in O
a O
79 _RARE_
and O
76 _RARE_
% O
decrease O
in O
the O
level O
of O
expression _RARE_
in O
transfected O
3T3 O
- O
L1 O
adipocytes O
and O
HepG2 _RARE_
hepatocytes O
, O
respectively O
. O

We O
examined O
the O
binding O
of O
purified _RARE_
T3 _RARE_
receptor I-GENE
alpha I-GENE
( O
T3R I-GENE
alpha I-GENE
), _RARE_
overexpressed O
in O
Escherichia O
coli O
, O
to O
wild O
- O
type O
and O
up _RARE_
and O
down O
mutations O
of O
the O
rGH _RARE_
T3RE _RARE_
to O
evaluate O
whether O
transcriptional O
potency O
correlates O
with O
changes O
in O
T3R I-GENE
binding O
. O

Comparison O
of O
the O
cDNA O
- O
predicted O
avian I-GENE
TnIcardiac _RARE_
amino I-GENE
acid I-GENE
sequences I-GENE
with O
known O
TnI I-GENE
sequences I-GENE
indicated O
1 O
) O
that O
the O
presence O
of O
an O
N O
- O
terminal O
extension O
sequence O
carrying O
a O
dual O
protein I-GENE
kinase I-GENE
A I-GENE
phosphorylation _RARE_
target O
site O
and O
an O
adjacent O
proline O
- O
rich O
segment O
is O
an O
ancient _RARE_
cardiac O
- O
specific O
feature O
of O
TnI I-GENE
which O
has O
been O
conserved _RARE_
since O
the O
bird _RARE_
/ O
mammal _RARE_
divergence O
, O
2 O
) O
that O
features O
of O
the O
near O
- O
N O
- O
terminal O
troponin _RARE_
C I-GENE
( O
TnC _RARE_
)- O
binding O
site O
sequence O
suggest O
isoform O
- O
specific O
adaptation O
of O
TnI I-GENE
and O
TnC _RARE_
, O
and O
3 O
) O
that O
the O
avian O
TnIcardiac _RARE_
internal O
actin I-GENE
/ I-GENE
TnC _RARE_
- I-GENE
binding I-GENE
, I-GENE
actomyosin _RARE_
- I-GENE
inhibitory _RARE_
, I-GENE
domain I-GENE
shows O
significant O
sequence O
divergence O
from O
mammalian I-GENE
TnIcardiac _RARE_
sequences I-GENE
, O
including O
the O
absence O
of O
a O
protein I-GENE
kinase I-GENE
C I-GENE
target O
site O
which O
is O
a O
cardiac O
- O
specific O
feature O
of O
TnI I-GENE
in O
mammals O
. O

Ventilatory _RARE_
management O
casebook _RARE_
. O

An O
ASSEMBLER _RARE_
routine O
for _RARE_
on O
- O
line O
graphic _RARE_
display O
and O
averaging _RARE_
of O
data O
acquired O
on O
a O
personal O
microcomputer _RARE_
. O

Expression O
of O
the O
mouse I-GENE
TSH _RARE_
beta I-GENE
gene I-GENE
, O
therefore O
, O
gives O
rise O
to O
multiple O
mRNAs O
, O
each O
with O
a O
unique O
5 O
'- O
untranslated _RARE_
region O
. O

Habituation _RARE_
of O
completely O
isolated O
neurons O
of O
the O
edible _RARE_
snail _RARE_
to O
electrical O
stimulation _RARE_
. O

It O
was O
found O
that O
the O
ROSP _RARE_
undergoes O
a O
number O
of O
fluctuations O
in O
the O
negative O
and O
positive O
directions _RARE_
with O
a O
gradually O
decreasing O
amplitude O
in O
the O
course O
of O
5 O
- O
25 _RARE_
days O
following O
the O
operation O
, O
after O
which O
relatively O
stable O
negative O
values O
of O
the O
ROSP _RARE_
are O
established O
on O
the O
average O
in O
electrodes O
implanted O
to O
the O
level O
of O
the O
dura _RARE_
mater _RARE_
, O
and O
positive O
values O
in O
electrodes O
implanted O
to O
the O
level O
of O
the O
pia _RARE_
mater _RARE_
. O

Blood _RARE_
flow O
velocity O
waveforms _RARE_
were O
recorded O
by O
pulsed O
Doppler O
examination O
of O
the O
fetal _RARE_
internal O
carotid O
and O
middle _RARE_
cerebral O
arteries O
using O
the O
established O
transabdominal _RARE_
route O
as _RARE_
well _RARE_
as _RARE_
a O
new O
transvaginal _RARE_
approach O
. O

Quantitative O
analysis O
of O
DNA O
using O
flow O
cytometry _RARE_
and O
immunocytochemical _RARE_
findings O
in O
16 O
cases O
of O
cardiac O
myxomas _RARE_

Sequence O
analysis O
revealed O
that O
in O
addition O
to O
the O
non O
- O
spliced _RARE_
variant O
, O
multiple O
mRNA O
species O
were O
generated O
by O
alternative _RARE_
splicing _RARE_
resulting O
in O
the O
exclusion O
of O
92 O
, O
166 _RARE_
, O
170 _RARE_
, O
174 _RARE_
and O
263 _RARE_
nucleotides O
( O
nt O
), _RARE_
respectively O
, O
from O
exon _RARE_
1 O
. O

Position _RARE_
22 _RARE_
is O
an O
isoleucine _RARE_
in O
the O
complete _RARE_
SsoL12 _RARE_
protein I-GENE
sequence I-GENE
, O
coded O
by O
an O
AUA _RARE_
codon _RARE_
. O

Symptoms _RARE_
due O
to O
the O
action O
of O
mastocyte _RARE_
mediators _RARE_
were O
observed O
. O

In O
the O
yeast O
Saccharomyces O
cerevisiae O
, O
copper _RARE_
levels O
exert O
some O
control O
over O
the O
level O
of O
SOD1 _RARE_
expression _RARE_
. O

Of O
these O
179 _RARE_
samples O
, O
Mobiluncus _RARE_
SP O
was O
observed O
in O
35 _RARE_
( O
19 O
. O
6 O
%) O
using O
Gram O
staining O
and O
in O
18 O
( O
10 O
. O
1 O
%) O
this O
microorganism _RARE_
was O
isolated O
in O
agar O
RLK _RARE_
and O
anaerobic O
atmosphere _RARE_
. O

Previous O
investigators _RARE_
have O
suggested O
that O
subretinal O
blood _RARE_
damages _RARE_
the O
retina O
in O
part O
because O
of O
its O
solid O
fibrin I-GENE
meshwork _RARE_
. O

Twenty O
- O
four O
hours O
later O
, O
the O
animals O
were O
randomized O
to O
subretinal O
treatment O
with O
2 O
. O
5 O
micrograms O
of O
tissue I-GENE
plasminogen I-GENE
activator I-GENE
or O
a O
similar O
volume O
of O
physiologic _RARE_
saline O
. O

Neuro _RARE_
- O
otological _RARE_
examinations O
revealed O
spontaneous O
downbeat _RARE_
nystagmus O
, O
bilateral O
gaze _RARE_
nystagmus O
and O
rebound _RARE_
nystagmus O
. O

Since O
the O
morphology O
of O
the O
lesions O
can O
mimic O
that O
of O
other O
cutaneous O
disorders O
, O
Bowen _RARE_
' O
s O
disease _RARE_
is O
often O
not O
recognized _RARE_
initially O
. O

Equine _RARE_
amnion _RARE_
and O
live O
yeast O
cell O
derivative _RARE_
were O
evaluated O
as _RARE_
a O
biological O
dressing _RARE_
and O
as _RARE_
a O
topical _RARE_
wound O
medicament _RARE_
respectively O
, O
in O
the O
treatment O
of O
granulating _RARE_
wounds _RARE_
of O
the O
distal O
portion O
of O
the O
limbs _RARE_
of O
horses O
. O

To O
lower O
the O
current O
high O
incidence O
of O
NANB O
- O
induced _RARE_
PTH _RARE_
, O
in O
1986 O
, O
the O
American O
Association O
of O
Blood _RARE_
Banks _RARE_
( O
AABB _RARE_
) O
recommended O
testing O
for _RARE_
these O
PTH _RARE_
- O
associated O
" O
surrogate _RARE_
" O
markers O
on O
all O
donated _RARE_
units _RARE_
of O
blood _RARE_
. O

Insulin I-GENE
- I-GENE
like I-GENE
growth I-GENE
factor I-GENE
1 I-GENE
( O
IGF I-GENE
- I-GENE
1 I-GENE
) O
in O
burn O
patients O
. O

Fusion _RARE_
of O
ubiquitin I-GENE
to O
pADPRP _RARE_
increased O
the O
yield O
of O
pADPRP _RARE_
approximately _RARE_
10 O
- O
fold _RARE_
compared O
to O
that O
of O
the O
unfused _RARE_
enzyme O
. O

In O
group O
III O
, O
patients O
also O
received O
their O
own O
mediastinal _RARE_
drainage O
blood _RARE_
, O
shed _RARE_
for _RARE_
6 O
hours O
after O
operation O
, O
after O
concentration O
and O
washing _RARE_
in O
a O
MBRS _RARE_
. O

The O
suppression O
was O
also O
demonstrated O
in O
a O
transient O
expression _RARE_
assay O
in O
vivo O
using O
isolated O
barley _RARE_
endosperms _RARE_
. O

The O
effect O
of O
salmon _RARE_
calcitonin I-GENE
nasal O
spray _RARE_
in O
women O
with O
established O
osteoporosis _RARE_
has O
also O
been O
studied O
. O

Skeletal _RARE_
muscle O
metaboreceptor _RARE_
responses O
are O
impaired O
in O
heart _RARE_
failure O
. O

Skeletal _RARE_
muscle O
metaboreceptor _RARE_
exercise O
responses O
are O
attenuated O
in O
heart _RARE_
failure O
. O

Evaluation O
of O
antiepileptic _RARE_
drug O
effect O
on O
membrane O
fluidity _RARE_
. O

The O
examinations O
were O
performed O
on O
two O
groups O
of O
20 O
( O
using O
AmF _RARE_
/ O
SnF2 _RARE_
)-, _RARE_
resp _RARE_
. O

RNA O
gel O
retardation O
and O
competition O
analyses O
indicate O
that O
TRP _RARE_
- I-GENE
185 _RARE_
binding O
is O
strongly O
dependent O
on O
the O
TAR _RARE_
RNA O
loop O
sequences O
. O

The O
vaccine O
used O
was O
known O
to O
be O
immunogenic _RARE_
for _RARE_
older O
children O
and O
adults O
. O

Both O
groups O
then O
underwent O
hypnotic _RARE_
induction O
, O
and O
completed O
the O
test O
again O
( O
R2 _RARE_
). O

Applications _RARE_
of O
three O
- O
dimensional O
analysis O
to O
the O
auditory O
P300 _RARE_
. O

The O
construct O
was O
introduced O
into O
BW2001 _RARE_
( O
xth _RARE_
- O
11 O
, O
nfo _RARE_
- O
2 O
) O
strain _RARE_
cells O
of O
Escherichia O
coli O
. O

Recombinant I-GENE
human I-GENE
TFIID I-GENE
supported O
weak O
basal O
transcription O
in O
heat O
- O
treated O
nuclear O
extracts O
whereas O
a O
partially O
purified _RARE_
TFIID I-GENE
fraction O
from O
HeLa O
cells O
reconstituted O
a O
maximal O
level O
of O
transcription O
. O

Only O
after O
a O
pretreatment O
aimed O
at _RARE_
increasing O
its O
oxide O
surface O
layer O
was O
titanium _RARE_
powder _RARE_
found O
to O
accelerate _RARE_
the O
precipitation O
from O
solutions O
containing O
2 O
mmol O
/ O
L O
CaCl2 _RARE_
, O
2 O
mmol O
/ O
L O
KH2PO4 _RARE_
, O
50 O
mmol O
/ O
L O
Hepes _RARE_
, O
pH O
7 O
. O
2 O
, O
and O
to O
induce O
precipitation O
from O
metastable _RARE_
solutions O
containing O
1 O
. O
2 O
mmol O
/ O
L O
CaCl2 _RARE_
, O
1 O
. O
2 O
mmol O
/ O
L O
KH2PO4 _RARE_
, O
50 O
mmol O
/ O
L O
Hepes _RARE_
, O
pH O
7 O
. O
2 O
, O
at _RARE_
37 O
degrees O
C O
. O

We O
conclude O
that O
solidification _RARE_
could O
occur O
in O
all O
feeds _RARE_
containing O
casein I-GENE
and O
that O
alternative _RARE_
feeds _RARE_
should O
be O
considered O
in O
patients O
with O
increased O
gastric _RARE_
acidity _RARE_
. O

Neither O
model O
, O
as _RARE_
applied O
, O
provided O
a O
satisfactory O
account O
of O
the O
effects O
of O
the O
main O
variables O
of O
number O
of O
tones _RARE_
and O
amount O
of O
perturbation _RARE_
.( O
ABSTRACT O
TRUNCATED O
AT O
400 _RARE_
WORDS O
) O

This O
generalization _RARE_
of O
MFP _RARE_
involves O
defining _RARE_
an O
appropriate O
high O
- O
resolution O
cost O
function O
, O
parametrizing _RARE_
the O
search O
space O
of O
the O
environment O
and O
source O
, O
constructing _RARE_
solutions O
of O
the O
wave O
equation O
, O
and O
utilizing O
a O
nonlinear _RARE_
optimization _RARE_
method O
to O
search O
the O
parameter O
landscape _RARE_
for _RARE_
the O
global O
minimum O
of O
the O
cost O
function O
. O

Determination O
of O
an O
RNA O
structure _RARE_
involved O
in O
splicing _RARE_
inhibition O
of O
a O
muscle O
- O
specific O
exon _RARE_
. O

Endothelial _RARE_
cells O
stored O
with O
University O
of O
Wisconsin _RARE_
solution O
excluded O
trypan _RARE_
blue O
better O
( O
1 O
. O
0 _RARE_
% O
+/- O
0 _RARE_
. O
5 O
% O
cells O
stained O
, O
p O
less O
than O
0 _RARE_
. O
001 O
. O

The O
original O
technique O
was O
developed O
in O
the O
1960 _RARE_
' O
s O
to O
analyze O
the O
inner O
ear O
fluid _RARE_
as _RARE_
a O
diagnostic O
procedure O
( O
i O
. O
e _RARE_
., O
diagnostic O
labyrinthotomy _RARE_
) O
in O
acoustic O
neuroma _RARE_
suspects _RARE_
. O

The O
effect O
of O
diffusion O
limitation O
was O
quantified _RARE_
in O
terms O
of O
the O
ratio O
O2 _RARE_
uptake O
/ O
O2 _RARE_
requirement O
(= _RARE_
fraction O
of O
cross O
- O
sectional O
area O
supplied O
with O
O2 _RARE_
), _RARE_
assuming _RARE_
local O
O2 _RARE_
requirement O
per O
unit O
volume O
to O
be O
constant O
and O
independent O
of O
PO2 O
at _RARE_
PO2 O
greater O
than O
0 _RARE_
. O

( O
2 O
) O
Diffusion _RARE_
limitation O
in O
the O
heterogeneous _RARE_
model O
sets O
in O
at _RARE_
a O
lower O
O2 _RARE_
requirement O
value O
, O
and O
increases O
more O
gradually O
with O
increasing O
O2 _RARE_
requirement O
, O
than O
in O
the O
corresponding O
homogeneous _RARE_
models O
with O
the O
same O
average O
cylinder _RARE_
diameter O
. O

The O
antihypertensive O
effect O
of O
Estulic _RARE_
has O
been O
examined O
over O
a O
12 O
- O
month O
period O
in O
101 _RARE_
hypertensive O
patients O
. O

At O
the O
time O
of O
the O
seizure O
, O
the O
patient O
was O
asked _RARE_
to O
read _RARE_
a O
test O
phrase _RARE_
aloud _RARE_
until O
it O
was O
read _RARE_
correctly O
and O
clearly O
. O

Monitoring _RARE_
patients O
with O
acute O
leukemia O
for _RARE_
IL _RARE_
- I-GENE
1 I-GENE
and O
TNF I-GENE
levels O
throughout O
the O
clinical O
course O
of O
disease _RARE_
may O
help O
clarify O
the O
causes O
of O
febrile _RARE_
episodes O
. O

Echinococcus _RARE_
granulosus _RARE_
was O
diagnosed O
by O
fine O
- O
needle _RARE_
aspiration _RARE_
cytology _RARE_
of O
a O
lung _RARE_
cyst O
in O
a O
6 O
- O
yr O
- O
old O
white _RARE_
female O
in O
central O
Missouri _RARE_
. O

The O
sequence O
was O
determined O
of O
6493 _RARE_
nucleotides O
encompassing _RARE_
the O
bet _RARE_
genes I-GENE
of I-GENE
Escherichia I-GENE
coli I-GENE
which O
encode O
the O
osmoregulatory _RARE_
choline _RARE_
- O
glycine O
betaine _RARE_
pathway _RARE_
. O

A O
7 O
- O
day O
treatment O
of O
amphotericin O
B O
( O
5 O
mg O
/ O
kg O
/ O
day O
i O
. O
p O
.) O
significantly O
reduced _RARE_
the O
glomerular O
filtration O
rate O
( O
GFR O
) O
measured O
as _RARE_
inuline _RARE_
clearance O
and O
creatinine _RARE_
clearance O
( O
0 _RARE_
. O
74 _RARE_
+/- O
0 _RARE_
. O
29 O
and O
0 _RARE_
. O
16 O
+/- O
0 _RARE_
. O
04 O
ml O
/ O
min O
, O
respectively O
) O
in O
comparison O
to O
vehicle O
- O
treated O
rats O
( O
2 O
. O
04 O
+/- O
0 _RARE_
. O
23 _RARE_
and O
1 O
. O
29 O
+/- O
0 _RARE_
. O
19 O
ml O
/ O
min O
, O
respectively O
). O

Evolution _RARE_
of O
lesions O
did O
not O
necessarily O
follow O
a O
regular O
progression O
through O
the O
later O
stages O
of O
the O
vitelliform _RARE_
classification O
. O

Confocal _RARE_
fluorescence O
microscopy O
in O
modern O
cell O
biology _RARE_
. O

Toluene _RARE_
is O
the O
chemical O
most O
frequently O
present O
in O
cases O
involving O
volatile O
solvents _RARE_
. O

Fortunately _RARE_
DDT _RARE_
-, _RARE_
HCH _RARE_
- O
and O
HCB O
- O
levels O
decreased O
in O
breast O
milk O
during _RARE_
the O
last O
years O
. O

A O
herpesvirus _RARE_
proteinase _RARE_
activity O
has O
been O
identified O
and O
partially O
characterized O
by O
using O
the O
cloned _RARE_
enzyme O
and O
substrate O
genes O
in O
transient O
transfection O
assays O
. O

Adult O
H O
, O
but O
not O
R O
, O
manifested O
the O
burrowing _RARE_
preference O
whenever _RARE_
offered O
the O
opportunity _RARE_
. O

The O
rear _RARE_
silver O
liquid O
chamber O
was O
threefold O
thick O
to O
17 _RARE_
MeV _RARE_
protons _RARE_
in O
water O
and O
it O
efficiently O
produced O
either O
13N _RARE_
by O
the O
16O _RARE_
( O
p O
, O
alpha O
) O
13N _RARE_
reaction O
or O
[ _RARE_
18F O
] O
fluoride O
ion O
by O
the O
18O _RARE_
( O
p O
, O
n _RARE_
) O
18F O
reaction O
. O

Heterogeneous _RARE_
electron O
transfer O
of O
cytochrome I-GENE
c I-GENE
facilitated O
by O
polypyrrole _RARE_
and O
methylene O
blue O
polypyrrole _RARE_
film _RARE_
modified O
electrodes O
. O

Selective O
activation O
of O
adrenaline O
secretion _RARE_
by O
the O
rat O
adrenal O
in O
neuroglycopenia _RARE_
detected O
via O
microdialysis _RARE_

Urine _RARE_
specimens O
containing O
either O
phencyclidine _RARE_
( O
PCP _RARE_
) O
or O
11 O
- O
nor O
- O
delta O
9 O
- O
tetrahydrocannabinol _RARE_
- O
9 O
- O
carboxylic _RARE_
acid O
( O
9 O
- O
THC _RARE_
- O
COOH _RARE_
) O
were O
adulterated _RARE_
with O
sodium _RARE_
chloride _RARE_
, O
bleach _RARE_
, O
vinegar _RARE_
, O
potassium _RARE_
hydroxide _RARE_
, O
liquid O
soap _RARE_
, O
2 O
- O
propanol _RARE_
, O
and O
ammonia _RARE_
. O

The O
1489 _RARE_
- O
base _RARE_
pair _RARE_
EFIA I-GENE
cDNA O
encodes O
a O
322 _RARE_
- O
amino O
acid O
protein O
which O
is O
nearly O
identical O
to O
two O
previously O
described O
human O
DNA O
binding O
proteins O
. O

Four O
putative O
positive O
cDNA O
clones _RARE_
were O
isolated O
, O
and O
the O
largest O
insert O
( O
pASB _RARE_
- I-GENE
1 I-GENE
) O
was O
sequenced O
in O
both O
orientations _RARE_
. O

Sci _RARE_
. O

Dose _RARE_
standardisation _RARE_
of O
botulinum I-GENE
toxin _RARE_
. O

The O
coding O
sequence O
for _RARE_
a O
260 O
- O
amino O
- O
acid O
residue _RARE_
polypeptide O
was O
interrupted O
by O
a O
single O
short O
intron O
of O
60 _RARE_
base _RARE_
pairs _RARE_
( O
bp O
), _RARE_
and O
about O
70 O
% O
of O
the O
deduced O
amino O
acid O
sequence O
of O
the O
Drosophila I-GENE
PCNA I-GENE
was O
identical O
to O
the O
rat O
and O
human I-GENE
PCNA I-GENE
polypeptides I-GENE
, O
with O
conserved _RARE_
unique O
repeats O
of O
leucine O
in O
the O
C O
- O
terminal O
region O
. O

Translational _RARE_
fusions O
of O
the O
aroF _RARE_
regulatory I-GENE
regions I-GENE
to O
lacZ I-GENE
were O
constructed O
and O
then O
introduced O
in O
single O
copy O
into O
the O
E O
. O
coli O
chromosome _RARE_
. O
beta I-GENE
- I-GENE
Galactosidase _RARE_
assays O
for _RARE_
tyrR _RARE_
- O
mediated _RARE_
regulation _RARE_
of O
aroF _RARE_
- O
lacZ I-GENE
expression _RARE_
revealed O
that O
the O
E I-GENE
. I-GENE
coli I-GENE
TyrR _RARE_
repressor I-GENE
apparently O
recognizes O
the O
operators _RARE_
of O
both O
organisms O
with O
about O
equal O
efficiency O
. O

Along _RARE_
with O
previously O
mapped O
genes O
including O
Ly _RARE_
- I-GENE
1 I-GENE
and O
CD20 _RARE_
, O
OSBP _RARE_
defines O
a O
new O
conserved _RARE_
syntenic _RARE_
group O
on O
the O
long O
arm _RARE_
of O
chromosome _RARE_
11 O
in O
the O
human O
and O
the O
proximal O
end O
of O
chromosome _RARE_
19 O
in O
the O
mouse O
. O

During O
exercise O
K O
+ O
is O
released O
from O
contracting _RARE_
muscle O
and O
plasma O
K O
+ O
concentration O
rises _RARE_
. O

Following O
treatment O
, O
serum O
estradiol O
levels O
were O
higher _RARE_
in O
groups O
E O
+ O
T O
and O
E O
than O
in O
group O
C O
. O

We O
conclude O
that O
the O
beta O
- O
adrenergic O
agonist O
, O
isoproterenol O
, O
has O
little O
influence O
on O
vascular O
capacitance _RARE_
or O
liver O
volume O
of O
dogs O
, O
unless O
the O
hepatic _RARE_
outflow O
resistance O
is O
elevated O
by O
agents O
such O
as _RARE_
histamine _RARE_
. O

DNA O
sequence O
and O
evolution O
of O
the O
CPS _RARE_
domain I-GENE
of O
the O
Syrian _RARE_
hamster I-GENE
multifunctional _RARE_
protein I-GENE
CAD _RARE_
. O

Here O
we O
show O
that O
these O
synthetic _RARE_
binding O
sites O
have O
a O
more O
restricted O
and O
specific O
ability O
to O
enhance O
transcription O
when O
assayed O
in O
transformed O
embryos _RARE_
. O

After O
base _RARE_
- O
line O
CBF O
was O
established O
, O
hexamethonium _RARE_
bromide O
( O
2 O
mg O
/ O
kg O
iv O
), _RARE_
ipratropium _RARE_
bromide O
( O
0 _RARE_
. O
5 O
microgram O
/ O
kg O
iv O
), _RARE_
indomethacin O
( O
2 O
mg O
/ O
kg O
iv O
), _RARE_
or O
intravenous O
0 _RARE_
. O
9 O
% O
saline O
was O
administered O
. O

A O
high O
- O
frequency O
restriction _RARE_
fragment O
length O
polymorphism O
was O
evident O
in O
the O
DNA O
from O
29 O
unrelated O
individuals O
using O
the O
enzyme O
BglII _RARE_
. O

The O
antilog _RARE_
transformation O
of O
pH O
did O
not O
improve O
the O
results O
. O

Telomeres _RARE_
prevent O
end O
- O
to O
- O
end O
fusions O
and O
exonucleolytic _RARE_
degradation _RARE_
, O
enable _RARE_
the O
end O
of O
the O
linear _RARE_
DNA O
molecule O
to O
replicate _RARE_
, O
and O
function O
in O
cell O
division O
. O

One O
of O
these O
is O
located _RARE_
in O
the O
5 O
'- O
untranslated _RARE_
region O
, O
and O
may O
encode O
regulatory O
sequences O
. O

The O
native _RARE_
enzyme O
purified _RARE_
from O
protease I-GENE
- I-GENE
B I-GENE
- O
deficient _RARE_
URA2 _RARE_
- O
transformed O
cells O
, O
was O
phosphorylated _RARE_
in O
vitro O
using O
catalytic O
subunits O
of O
pure O
cAMP I-GENE
- I-GENE
dependent I-GENE
protein I-GENE
kinase I-GENE
. O

This O
study O
suggests O
that O
BSPMs _RARE_
are O
useful O
in O
the O
assessment O
of O
AMI O
in O
terms O
of O
diagnosis O
, O
location O
and O
extent O
of O
myocardial _RARE_
infarct O
. O

A O
bovine O
abomasum _RARE_
lambda O
gt11 O
cDNA O
library O
was O
screened O
with O
a O
monoclonal O
antibody O
raised O
against O
the O
rabbit _RARE_
H I-GENE
, I-GENE
K I-GENE
- I-GENE
ATPase I-GENE
beta I-GENE
subunit I-GENE
. O

Judicious _RARE_
use O
of O
laboratory O
testing O
, O
including O
monitoring O
of O
CD4 _RARE_
cell O
counts O
, O
is O
recommended O
. O

There O
is O
no _RARE_
TATA O
box O
appropriately _RARE_
spaced _RARE_
upstream O
from O
the O
transcription O
initiation O
site O
. O

Characterization O
of O
the O
5 O
' O
end O
of O
the O
growth O
- O
regulated O
Syrian _RARE_
hamster I-GENE
CAD _RARE_
gene I-GENE
. O

Early O
cirrhosis O
, O
an O
early O
modality O
of O
the O
evolution O
of O
acute O
hepatitis O
. O

Examination O
of O
immediate I-GENE
- I-GENE
early I-GENE
transcription I-GENE
factor I-GENE
expression _RARE_
during _RARE_
the O
MDI _RARE_
regimen O
revealed O
that O
RA _RARE_
mediated _RARE_
an O
elevated O
, O
prolonged O
expression _RARE_
of O
c I-GENE
- I-GENE
Jun I-GENE
mRNA I-GENE
accompanied O
by O
diminished O
expression _RARE_
of O
c I-GENE
- I-GENE
Fos I-GENE
and O
Jun I-GENE
- I-GENE
B I-GENE
mRNAs I-GENE
. O

Although O
heart _RARE_
rate O
and O
diastolic O
pressure O
rose O
in O
some O
degree O
1 O
min O
after O
intubation _RARE_
, O
free O
and O
total _RARE_
CA O
concentrations O
did O
not O
increase O
during _RARE_
study O
period O
. O

Processing _RARE_
, O
secretion _RARE_
, O
and O
immunoreactivity O
of O
carboxy _RARE_
terminally _RARE_
truncated I-GENE
dengue _RARE_
- I-GENE
2 I-GENE
virus I-GENE
envelope I-GENE
proteins I-GENE
expressed _RARE_
in O
insect O
cells O
by O
recombinant O
baculoviruses _RARE_
. O

Combined O
therapy O
with O
MK O
- O
801 O
and O
nimodipine _RARE_
for _RARE_
protection O
of O
ischemic O
brain O
damage O
. O

Initial O
screening O
of O
a O
rat O
liver O
cDNA O
library O
with O
an O
oligonucleotide _RARE_
probe O
derived O
from O
the O
rat O
SCP2 _RARE_
protein O
sequence O
revealed O
an O
825 _RARE_
- O
base _RARE_
pair _RARE_
cDNA O
clone O
coding O
for _RARE_
the O
complete _RARE_
SCP2 _RARE_
protein O
sequence O
. O

Cloning O
, O
expression _RARE_
, O
and O
nucleotide O
sequence O
of O
rat I-GENE
liver I-GENE
sterol I-GENE
carrier I-GENE
protein I-GENE
2 I-GENE
cDNAs I-GENE
. O

The O
addition O
of O
an O
equimolar _RARE_
complex O
of O
the O
fourth O
and O
seventh _RARE_
largest O
subunits O
, O
purified _RARE_
from O
pol I-GENE
II I-GENE
holoenzyme _RARE_
by O
ion O
- O
exchange O
chromatography O
in O
the O
presence O
of O
urea O
, O
restored O
promoter O
- O
directed O
initiation O
activity O
to O
pol I-GENE
II I-GENE
delta I-GENE
4 I-GENE
/ I-GENE
7 I-GENE
. O

We O
report O
here O
the O
identification O
of O
HSF I-GENE
in O
the O
fission _RARE_
yeast O
Schizosaccharomyces O
pombe O
. O

Induction O
requires O
the O
ACE1 _RARE_
gene I-GENE
product I-GENE
, O
which O
binds O
to O
specific O
sites O
in O
the O
promoter O
region O
of O
the O
CUP1 _RARE_
gene I-GENE
. O

Gel O
mobility O
shift O
assays O
using O
a O
synthetic _RARE_
E6 _RARE_
motif I-GENE
detected O
a O
B O
- O
cell O
- O
specific O
complex O
in O
addition O
to O
a O
ubiquitous O
band O
found O
also O
in O
T O
cells O
and O
HeLa O
cells O
. O

Seven _RARE_
clones _RARE_
encoding O
interferon _RARE_
response I-GENE
element I-GENE
binding I-GENE
factors I-GENE
have O
been O
isolated O
from O
a O
mouse O
fibroblast O
lambda O
gt11 O
cDNA O
library O
by O
using O
a O
32P O
end O
- O
labeled O
tandem _RARE_
trimer _RARE_
of O
the O
mouse I-GENE
( I-GENE
2 I-GENE
'- I-GENE
5 I-GENE
') _RARE_
oligoadenylate _RARE_
synthetase _RARE_
gene I-GENE
interferon _RARE_
response O
element O
as _RARE_
a O
probe O
. O

The O
sequence O
of O
four O
clones _RARE_
was O
sufficient O
to O
construct O
a O
3018 _RARE_
- I-GENE
bp I-GENE
BAL _RARE_
cDNA I-GENE
structure _RARE_
. O

The O
application O
of O
these O
instruments O
allows O
occlusion O
of O
the O
ascending O
aorta O
traversed _RARE_
by O
the O
perfusion O
cannula _RARE_
inserted O
directly O
or O
through O
the O
apex O
of O
the O
heart _RARE_
as _RARE_
well _RARE_
as _RARE_
simultaneous O
left _RARE_
ventricular O
venting _RARE_
. O

Adenylosuccinate _RARE_
synthetase _RARE_
( O
IMP _RARE_
: O
L I-GENE
- I-GENE
aspartate _RARE_
ligase I-GENE
( O
GDP O
), _RARE_
EC I-GENE
6 I-GENE
. I-GENE
3 I-GENE
. I-GENE
4 I-GENE
. I-GENE
4 I-GENE
) O
plays O
an O
important O
role O
in O
purine _RARE_
biosynthesis O
catalyzing _RARE_
the O
GTP O
- O
dependent O
conversion O
of O
IMP _RARE_
to O
AMP O
. O

Immunophenotyping _RARE_
in O
four O
cases O
, O
demonstrated O
non O
- O
B O
, O
non O
- O
T O
cell O
origin O
in O
three O
and O
pre O
- O
B O
cell O
origin O
in O
one O
. O

DNA O
- O
protein O
UV _RARE_
cross O
- O
linking O
studies O
indicated O
that O
UHF _RARE_
- I-GENE
1 I-GENE
has O
an O
electrophoretic O
mobility O
on O
sodium _RARE_
dodecyl O
sulfate _RARE_
- O
acrylamide _RARE_
gels O
of O
approximately _RARE_
85 _RARE_
kDa O
and O
suggested O
that O
additional O
proteins O
, O
specific O
to O
each O
promoter O
, O
bind O
to O
each O
site O
. O

The O
results O
strengthen _RARE_
the O
conclusion O
that O
predominantly O
dynamic O
activity O
increases O
the O
G4 _RARE_
content O
of O
mature _RARE_
innervated _RARE_
fast O
muscles O
. O

The O
specific O
interaction O
between O
a O
defined O
structural O
element O
of O
the O
human O
immunodeficiency O
virus O
mRNA O
( O
RRE _RARE_
, O
the O
Rev _RARE_
response I-GENE
element I-GENE
) O
and O
the O
virus I-GENE
- I-GENE
encoded I-GENE
protein I-GENE
Rev _RARE_
has O
been O
implicated O
in O
the O
regulation _RARE_
of O
the O
export O
of O
unspliced O
or O
singly _RARE_
spliced _RARE_
mRNA O
from O
the O
nucleus O
to O
the O
cytoplasm O
. O

We O
reviewed O
the O
records O
of O
151 O
patients O
with O
optic O
neuritis _RARE_
examined O
over O
an O
eight O
- O
year O
period O
. O

Cut _RARE_
- O
off O
levels O
that O
define O
abnormality O
are O
rather O
arbitrary _RARE_
and O
this O
decreases O
the O
specificity _RARE_
of O
the O
test O
in O
apparently O
healthy O
patients O
. O

Alanine _RARE_
aminotransferase I-GENE
in O
clinical O
practice O
. O

Nucleotide O
sequence O
analysis O
of O
the O
Pseudomonas _RARE_
putida _RARE_
PpG7 _RARE_
salicylate _RARE_
hydroxylase I-GENE
gene I-GENE
( O
nahG _RARE_
) O
and O
its O
3 O
'- O
flanking O
region O
. O

All O
six _RARE_
ARF I-GENE
cDNAs I-GENE
are O
more O
similar O
to O
each O
other O
than O
to O
other O
approximately _RARE_
20 I-GENE
- I-GENE
kDa I-GENE
guanine I-GENE
nucleotide I-GENE
- I-GENE
binding I-GENE
proteins I-GENE
. O

The O
long O
terminal O
repeat O
( O
LTR O
) O
of O
the O
human O
immunodeficiency O
virus O
( O
HIV O
) O
contains O
three O
binding O
sites O
for _RARE_
the O
transcriptional O
factor O
Sp1 _RARE_
. O

DNA O
from O
PCR O
was O
labeled O
and O
used O
to O
isolate O
several O
lambda O
gt11 O
cDNA O
clones _RARE_
, O
including O
one O
full O
- O
length O
one O
( O
Dd _RARE_
kinase I-GENE
- I-GENE
2 I-GENE
). O

Radiation _RARE_
- O
induced _RARE_
changes O
in O
the O
area O
of O
alveoli _RARE_
and O
septa _RARE_
as _RARE_
well _RARE_
as _RARE_
collagen _RARE_
content O
were O
seen O
11 O
weeks O
after O
irradiation O
. O

The O
first _RARE_
follow O
- O
up _RARE_
was O
at _RARE_
a O
nearly O
constant O
interval O
of O
5 O
. O
1 O
years O
in O
Caerphilly _RARE_
and O
3 O
. O
2 O
years O
in O
Speedwell _RARE_
; O
251 _RARE_
major O
IHD _RARE_
events O
had O
occurred O
. O

A O
. O

Perilunar _RARE_
luxation _RARE_
-- _RARE_
an O
unusual O
injury O
demanding _RARE_
immediate O
and O
correct O
treatment O

Landsberg _RARE_
( O
La _RARE_
- O
O O
) O
and O
cv O
. O

In O
summary O
, O
at _RARE_
equianesthetic _RARE_
concentrations O
, O
desflurane _RARE_
and O
isoflurane O
produced O
similar O
hemodynamic O
effects O
; O
however O
, O
in O
the O
absence O
of O
drugs O
that O
inhibit O
autonomic _RARE_
reflexes _RARE_
, O
desflurane _RARE_
had O
less O
negative O
inotropic O
activity O
and O
produced O
less O
decrease O
in O
arterial O
pressure O
. O

We O
report O
here O
the O
isolation O
of O
a O
full O
- O
length O
cDNA O
clone O
coding O
for _RARE_
a O
hitherto O
undiscovered _RARE_
isoform O
of O
the O
bovine I-GENE
C I-GENE
- I-GENE
subunit I-GENE
. O

Isoform _RARE_
C I-GENE
beta I-GENE
2 I-GENE
, O
an O
unusual O
form O
of O
the O
bovine O
catalytic O
subunit O
of O
cAMP I-GENE
- I-GENE
dependent I-GENE
protein I-GENE
kinase I-GENE
. O

Salient _RARE_
applications O
of O
PB _RARE_
- O
PK _RARE_
modeling _RARE_
to O
toxicological O
problems O
are O
illustrated _RARE_
with O
examples O
. O

Patients O
with O
apparently O
minor O
CT _RARE_
abnormalities O
may O
have O
significant O
epidural _RARE_
disease _RARE_
. O

The O
cdr1 _RARE_
sequence I-GENE
includes O
an O
additional O
237 _RARE_
amino O
acids _RARE_
of O
the O
contiguous O
fragment O
and O
encodes O
a O
product O
of O
predicted O
Mr O
67 O
, O
000 _RARE_
. O

Armed _RARE_
with O
a O
clear O
understanding O
of O
the O
pathophysiologic _RARE_
pathways O
that O
may O
cause O
and O
/ O
or O
contribute O
to O
the O
development O
of O
unconjugated _RARE_
hyperbilirubinemia O
and O
the O
associated O
jaundice O
, O
the O
practitioner _RARE_
will O
be O
successful O
in O
helping _RARE_
the O
family O
understand O
their O
child O
' O
s O
illness O
. O

Displacement _RARE_
thresholds _RARE_
of O
peripheral O
sites O
in O
monocular _RARE_
human O
vision O
were O
obtained O
. O

The O
authors O
report O
a O
case O
in O
which O
stereotactic _RARE_
irrigation O
of O
a O
brain O
cyst O
was O
temporally O
associated O
with O
respiratory O
distress O
. O

ELISA O
was O
found O
to O
make O
a O
contribution O
to O
the O
diagnosis O
of O
tuberculosis O
similar O
to O
that O
of O
sputum _RARE_
smear _RARE_
. O

In O
this O
paper O
, O
we O
report O
a O
detailed O
study O
of O
the O
structure _RARE_
and O
the O
functional _RARE_
role O
of O
the O
MalT _RARE_
binding I-GENE
sites I-GENE
located _RARE_
in O
the O
adjacent O
and O
divergent O
pulAp _RARE_
and O
pulCp _RARE_
promoters I-GENE
. O

Despite O
the O
small O
number O
of O
patients O
, O
on O
the O
basis O
of O
this O
report O
, O
we O
can O
confirm O
that O
1 O
. O
5 O
MU _RARE_
/ O
day O
of O
alpha I-GENE
- I-GENE
IFN I-GENE
is O
an O
adequate O
treatment O
for _RARE_
patients O
with O
hairy _RARE_
cell O
leukemia O
. O

Paroxysmal _RARE_
fluctuations O
in O
observed O
parasitemia _RARE_
in O
Plasmodium _RARE_
falciparum O
malaria O
. O

No O
positive O
family O
history O
was O
obtained O
. O

Occupational _RARE_
asthma O
and O
rhinoconjunctivitis _RARE_
from O
inhalation O
of O
crystalline O
bovine I-GENE
serum I-GENE
albumin I-GENE
powder _RARE_
. O

A O
further O
subdivision _RARE_
of O
Category _RARE_
pN1 _RARE_
into O
pN1a _RARE_
( O
metastasis O
in O
single O
node O
) O
and O
pN1b _RARE_
( O
two O
or O
more O
nodes O
) O
is O
recommended O
. O

Amino O
acid O
sequence O
comparisons O
of O
the O
E74A _RARE_
protein I-GENE
reveal O
a O
highly O
conserved _RARE_
C O
- O
terminal O
region O
that O
is O
rich O
in O
basic O
amino O
acid O
residues O
and O
which O
has O
been O
proposed O
to O
possess O
sequence O
- O
specific O
DNA O
binding O
activity O
. O

We O
found O
that O
the O
relative O
strengths O
of O
the O
promoters O
were O
similar O
in O
different O
contexts _RARE_
. O

Grasso _RARE_
, O
and O
A O
. O

After O
6 O
months O
, O
definite O
improvement O
in O
strength O
occurred O
in O
4 O
of O
7 O
carnitine _RARE_
- O
treated O
patients O
and O
in O
none O
of O
7 O
controls O
. O

Age _RARE_
at _RARE_
POI _RARE_
and O
asymptote _RARE_
were O
achieved O
later O
for _RARE_
Line _RARE_
RBC2 _RARE_
than O
for _RARE_
Line _RARE_
F O
. O

To O
identify O
the O
DNA O
sequences O
that O
cis O
- O
regulate O
the O
expression _RARE_
of O
the O
rat I-GENE
liver I-GENE
pyruvate _RARE_
kinase I-GENE
( O
L I-GENE
- I-GENE
PK _RARE_
) O
genes O
, O
a O
series O
of O
constructs O
in O
which O
the O
chloramphenicol I-GENE
acetyltransferase _RARE_
reporter I-GENE
genes I-GENE
is O
driven _RARE_
by O
various O
deleted _RARE_
fragments O
of O
the O
3200 _RARE_
base _RARE_
pairs _RARE_
( O
bp O
) O
upstream O
of O
the O
L I-GENE
- I-GENE
PK _RARE_
gene I-GENE
cap _RARE_
site I-GENE
have O
been O
assayed O
for _RARE_
transient O
expression _RARE_
after O
introduction O
into O
hepatoma O
HepG2 _RARE_
cells O
, O
rat O
hepatocytes O
in O
primary _RARE_
culture O
, O
fibroblast O
LTK _RARE_
- O
cells O
, O
myogenic _RARE_
C2C12 O
cells O
, O
and O
CHO O
cells O
. O

The O
disturbance O
of O
pulmonary O
gas O
exchange O
, O
as _RARE_
revealed O
by O
the O
high O
value O
of O
AaDO2 _RARE_
, O
existed O
without O
left _RARE_
ventricular O
dysfunction O
, O
and O
AaDO2 _RARE_
had O
no _RARE_
significant O
relationship O
with O
any O
of O
the O
hemodynamic O
parameters O
including O
the O
difference O
between O
plasma O
colloid O
osmotic O
pressure O
and O
PCW _RARE_
. O

A O
dose O
of O
3 O
and O
6 O
micrograms O
/ O
kg O
/ O
day O
GM _RARE_
- I-GENE
CSF I-GENE
reduces O
the O
severity O
of O
neutropenia O
and O
thrombocytopenia O
after O
carboplatin _RARE_
- O
cyclophosphamide O
chemotherapy O
, O
which O
may O
lead O
to O
more O
effective O
chemotherapy O
for _RARE_
ovarian O
cancer _RARE_
in O
the O
future O
. O

These O
differences O
involve O
specific O
hydrogen O
- O
bonding _RARE_
interactions O
between O
the O
protein O
and O
DNA O
, O
including O
guanine O
N7 _RARE_
sites O
in O
the O
major O
groove _RARE_
of O
DNA O
, O
and O
alterations O
in O
DNA O
phosphodiester _RARE_
conformation O
induced _RARE_
by O
protein O
binding O
. O

Biochemical O
analysis O
demonstrates O
that O
the O
BJ1 _RARE_
protein I-GENE
is O
associated O
with O
nucleosomes _RARE_
and O
is O
released O
from O
chromatin O
by O
agents O
which O
intercalate _RARE_
into O
DNA O
, O
as _RARE_
previously O
shown O
for _RARE_
the O
high I-GENE
mobility I-GENE
group I-GENE
proteins I-GENE
( O
HMGs _RARE_
). O

I O
propose O
that O
their O
gene O
products O
bind O
to O
the O
chromatin O
to O
establish O
or O
maintain O
a O
proper O
higher _RARE_
order O
structure _RARE_
as _RARE_
a O
prerequisite O
for _RARE_
a O
regulated O
gene O
expression _RARE_
. O

The O
C4BP _RARE_
alpha I-GENE
gene I-GENE
is O
organized O
as _RARE_
follows O
: O
the O
first _RARE_
exon _RARE_
codes O
for _RARE_
the O
first _RARE_
198 O
nucleotides O
of O
the O
5 O
' O
UTR O
. O

The O
human I-GENE
immunodeficiency I-GENE
virus I-GENE
type I-GENE
1 I-GENE
( I-GENE
HIV I-GENE
- I-GENE
1 I-GENE
) I-GENE
Rev _RARE_
protein I-GENE
is O
a O
positive O
posttranscriptional O
regulator O
of O
viral O
structural O
gene O
expression _RARE_
and O
essential O
for _RARE_
virus O
replication O
. O

Once O
the O
proliferation _RARE_
of O
fibroblasts _RARE_
and O
collagen _RARE_
synthesis _RARE_
had O
led O
to O
an O
increase O
of O
mechanical O
strength O
, O
no _RARE_
negative O
effect O
on O
wound O
healing O
could O
be O
detected O
applying O
the O
same O
chemotherapeutic O
agents O
. O

The O
CDC7 _RARE_
gene I-GENE
has O
two O
in O
- O
frame O
AUG O
codons O
as _RARE_
possible O
translation O
start _RARE_
sites O
, O
which O
would O
produce O
58 O
- O
and O
56 _RARE_
- O
kDa O
proteins O
, O
respectively O
. O

During O
the O
years O
1980 O
- O
87 O
a O
total _RARE_
of O
287 _RARE_
persons O
received O
disability _RARE_
pensions _RARE_
in O
the O
municipality _RARE_
of O
Nordreisa _RARE_
in O
northern O
Norway _RARE_
. O

HeLa O
and O
Jurkat O
cell O
lines O
carrying O
the O
nef I-GENE
gene I-GENE
linked _RARE_
to O
the O
CMV _RARE_
promoter O
or O
the O
HIV I-GENE
- I-GENE
1 I-GENE
LTR I-GENE
were O
isolated O
by O
coselection _RARE_
for _RARE_
neomycin _RARE_
resistance O
. O

Differences _RARE_
in O
the O
clinical O
presentation O
and O
the O
gross O
appearance O
of O
the O
two O
cases O
are O
described O
, O
and O
similarities O
in O
the O
microscopic O
features O
are O
discussed O
. O

MEASUREMENTS _RARE_
AND _RARE_
MAIN O
RESULTS O
: O
The O
two O
groups O
were O
similar O
on O
entry O
into O
the O
study O
, O
including O
mean O
FEV1 O
measurements O
( O
0 _RARE_
. O
70 O
L O
atropine O
/ O
0 _RARE_
. O
60 _RARE_
L O
metaproterenol _RARE_
, O
P O
greater O
than O
. O
05 O
). O

Using O
an O
ELISA O
, O
we O
found O
that O
surfactant _RARE_
protein I-GENE
A I-GENE
( O
SP I-GENE
- I-GENE
A I-GENE
) O
was O
markedly O
elevated O
in O
the O
pneumonia O
patients O
. O

In O
view O
of O
the O
short O
t1 O
/ O
2 O
, O
we O
used O
three O
doses O
/ O
day O
. O

Temporal _RARE_
control O
of O
GUS I-GENE
expression _RARE_
was O
found O
to O
involve O
two O
negative O
regulatory O
sequences O
, O
NRS1 _RARE_
(- _RARE_
391 _RARE_
to O
- O
295 _RARE_
) O
and O
NRS2 _RARE_
(- _RARE_
518 _RARE_
to O
- O
418 _RARE_
), _RARE_
as _RARE_
well _RARE_
as _RARE_
the O
positive O
domain O
UAS1 O
. O

We O
purified _RARE_
a O
Ca2 _RARE_
+/ _RARE_
calmodulin I-GENE
( I-GENE
CaM I-GENE
)- I-GENE
dependent I-GENE
protein I-GENE
kinase I-GENE
( O
CaM I-GENE
kinase I-GENE
) O
from O
the O
yeast O
Saccharomyces O
cerevisiae O
with O
properties O
similar O
to O
mammalian I-GENE
type I-GENE
II I-GENE
CaM I-GENE
kinases I-GENE
. O

In O
most O
cases O
, O
DR4 _RARE_
- O
homozygous O
, O
DRB1 _RARE_
- O
heterozygous _RARE_
individuals O
could O
be O
genotyped _RARE_
with O
the O
panel O
of O
probes _RARE_
. O

Two O
patients O
had O
immediate O
adverse O
effects O
from O
NMF _RARE_
; O
one O
had O
a O
grand _RARE_
mal _RARE_
seizure O
and O
the O
other O
developed O
severe O
abdominal O
pain O
. O

The O
muscles O
from O
the O
ischemic O
group O
had O
significantly O
lower O
( O
P O
less O
than O
. O
05 O
) O
values O
for _RARE_
capillary O
density O
and O
capillary O
to O
fiber O
ratio O
and O
significantly O
higher _RARE_
intercapillary _RARE_
distance O
than O
those O
from O
the O
normal O
group O
. O

The O
prevalence O
of O
opportunistic _RARE_
infection O
among O
surviving _RARE_
AIDS O
patients O
and O
the O
probability _RARE_
of O
being O
in O
tumour _RARE_
response O
following O
cancer _RARE_
therapy O
conditional O
on O
being O
alive _RARE_
are O
two O
examples O
of O
such O
functions O
. O

Serum I-GENE
TNF I-GENE
concentrations O
were O
elevated O
at _RARE_
diagnosis O
and O
gradually O
decreased O
toward O
the O
reference O
limits O
by O
week O
16 O
. O

Genomic O
clones _RARE_
encompassing _RARE_
the O
human I-GENE
ETS1 _RARE_
gene I-GENE
were O
isolated O
and O
utilized O
to O
define O
its O
molecular _RARE_
organization O
. O

Polymerase _RARE_
chain O
reaction O
analysis O
of O
ETS1 _RARE_
cDNA I-GENE
identified O
several O
amplified O
products O
, O
indicating O
alternative _RARE_
splicing _RARE_
. O

Most O
of O
the O
expressed _RARE_
human I-GENE
E3 _RARE_
polypeptides I-GENE
( O
five O
bands O
) O
were O
found O
in O
the O
insoluble _RARE_
pellet _RARE_
while O
primarily O
full I-GENE
- I-GENE
length I-GENE
mature _RARE_
E3 _RARE_
was O
found O
in O
the O
soluble _RARE_
fraction O
. O

To O
test O
promotor _RARE_
function O
, O
chimeric O
genes O
were O
constructed O
linking O
fragments O
of O
chicken O
IGF I-GENE
- I-GENE
I I-GENE
5 O
'- O
flanking O
DNA O
to O
a O
promoterless O
reporter O
plasmid _RARE_
. O

The O
alpha I-GENE
4 I-GENE
gene I-GENE
5 O
' O
flanking O
region O
acted _RARE_
as _RARE_
a O
promoter O
in O
transfection O
assays O
. O

Characterization O
of O
the O
alpha I-GENE
4 I-GENE
integrin I-GENE
gene I-GENE
promoter I-GENE
. O

Only O
the O
3 O
. O
0 _RARE_
- O
kb O
transcript O
was O
detected O
in O
adult O
tissues O
, O
where O
its O
expression _RARE_
was O
restricted O
almost O
exclusively O
to O
the O
central O
nervous O
system _RARE_
. O

Two O
homologues _RARE_
of O
the O
rhombotin _RARE_
gene I-GENE
have O
now O
been O
isolated O
. O

Angina _RARE_
haemorrhagica _RARE_
bullosa _RARE_
causing O
respiratory O
obstruction O
postoperatively O
. O

We O
examined O
the O
effects O
of O
long O
- O
term O
perfusion O
with O
pyridoxalated _RARE_
hemoglobin I-GENE
polyoxyethylene _RARE_
conjugate _RARE_
( O
PHP _RARE_
) O
solution O
on O
cardiac O
function O
of O
isolated O
rat O
hearts O
. O

Conclusion _RARE_
: O
inlet _RARE_
type O
VSD _RARE_
and O
perimembranous _RARE_
type O
TOF O
have O
anatomic O
features O
in O
which O
the O
proximal O
His _RARE_
bundle O
tends _RARE_
to O
be O
jeopardized _RARE_
by O
suturing _RARE_
for _RARE_
VSD _RARE_
closure O
. O

The O
gcd2 _RARE_
- I-GENE
503 _RARE_
mutation O
also O
results O
in O
polysome _RARE_
runoff _RARE_
, O
accumulation O
of O
inactive O
80S _RARE_
ribosomal I-GENE
couples _RARE_
, O
and O
accumulation O
of O
at _RARE_
least O
one O
of O
the O
subunits O
of O
the O
general _RARE_
translation I-GENE
initiation I-GENE
factor I-GENE
2 I-GENE
( O
eIF I-GENE
- I-GENE
2 I-GENE
alpha I-GENE
) O
in O
43S _RARE_
- O
48S _RARE_
particles _RARE_
following O
a O
shift O
to O
the O
restrictive O
temperature _RARE_
. O

Eight O
patients O
with O
ARC _RARE_
and O
renal _RARE_
failure O
were O
recently O
evaluated O
. O

To O
measure O
the O
enhancer O
activity O
of O
DR60 _RARE_
, O
a O
reporter O
plasmid _RARE_
was O
constructed O
that O
contained O
DR60 _RARE_
cloned _RARE_
upstream O
of O
the O
reporter O
chloramphenicol I-GENE
acetyltransferase _RARE_
gene I-GENE
under O
the O
control O
of O
the O
delayed O
- O
early O
39K _RARE_
promoter O
. O

A O
single O
case O
of O
an O
adenocarcinoma O
, O
arising O
in O
a O
retroperitoneal _RARE_
enterogenous _RARE_
cyst O
and O
which O
presented O
as _RARE_
a O
left _RARE_
renal _RARE_
cyst O
, O
is O
reported O
. O

Using O
the O
polymerase O
chain O
reaction O
, O
we O
analyzed O
the O
U6 I-GENE
RNA I-GENE
genes I-GENE
of O
52 O
organisms O
. O

Both O
tear _RARE_
volume O
and O
tear _RARE_
flow O
were O
found O
to O
be O
significantly O
( O
P O
less O
than O
0 _RARE_
. O
001 O
) O
decreased O
up _RARE_
to O
6 O
h O
after O
instillation _RARE_
, O
reaching _RARE_
a O
minimum O
90 _RARE_
min O
after O
application O
( O
tear _RARE_
volume O
: O
- O
63 _RARE_
%; O
tear _RARE_
flow O
: O
- O
71 _RARE_
%). O

Hydrophobicity _RARE_
analysis O
indicated O
that O
the O
KlaA _RARE_
and O
KlaB _RARE_
polypeptides I-GENE
are O
likely O
to O
be O
soluble _RARE_
, O
whereas O
the O
KlaC _RARE_
polypeptide I-GENE
was O
predicted O
to O
have O
four O
potential _RARE_
membrane O
- O
spanning O
domains O
. O

To O
facilitate O
the O
availability O
of O
important O
new O
therapeutic O
agents O
, O
the O
Food _RARE_
and O
Drug O
Administration O
( O
FDA _RARE_
) O
in O
the O
mid O
- O
1970s _RARE_
began _RARE_
assigning _RARE_
therapeutic O
ratings _RARE_
to O
investigational _RARE_
new O
drugs O
and O
holding _RARE_
end O
- O
of O
- O
phase _RARE_
II O
conferences _RARE_
with O
drug O
sponsors _RARE_
. O

In O
contrast O
, O
similar O
rates O
of O
B O
. O
sphaericus _RARE_
products O
, O
ABG _RARE_
- O
6184 _RARE_
technical _RARE_
powder _RARE_
and O
BSP _RARE_
- O
2 O
flowable _RARE_
concentrate _RARE_
, O
produced O
no _RARE_
significant O
reduction O
. O

The O
remainder _RARE_
( O
18 O
. O
4 O
%) O
was O
with O
IgA I-GENE
nephropathy O
, O
which O
was O
histologically O
mild O
. O

Grossly _RARE_
, O
the O
experimental O
vulvitis _RARE_
was O
identical O
to O
the O
field O
condition O
, O
and O
bacteria O
indistinguishable O
from O
the O
inoculated O
strains O
were O
reisolated _RARE_
. O

3 O
. O

Furthermore O
, O
the O
DNA I-GENE
polymerase I-GENE
II I-GENE
complex I-GENE
was O
difficult O
to O
obtain O
from O
dpb2 _RARE_
- I-GENE
1 I-GENE
mutant O
cells O
, O
suggesting O
that O
a O
stable O
DNA I-GENE
polymerase I-GENE
II I-GENE
complex I-GENE
requires O
DPB2 _RARE_
and O
is O
essential O
for _RARE_
chromosomal O
replication O
. O

To O
determine O
whether O
mononuclear O
cell O
secretory _RARE_
products O
contribute O
to O
the O
changes O
in O
bone O
turnover O
that O
characterize O
the O
development O
of O
postmenopausal _RARE_
osteoporosis _RARE_
, O
we O
evaluated O
the O
effects O
of O
oophorectomy _RARE_
and O
subsequent O
estrogen O
replacement _RARE_
on O
the O
spontaneous O
secretion _RARE_
of O
interleukin I-GENE
1 I-GENE
( O
IL _RARE_
- I-GENE
1 I-GENE
) O
and O
tumor I-GENE
necrosis I-GENE
factor I-GENE
alpha I-GENE
( O
TNF I-GENE
- I-GENE
alpha I-GENE
) O
and O
on O
the O
phytohemagglutinin I-GENE
A I-GENE
- O
induced _RARE_
secretion _RARE_
of O
granulocyte _RARE_
- I-GENE
macrophage I-GENE
colony I-GENE
- I-GENE
stimulating I-GENE
factor I-GENE
( O
GM _RARE_
- I-GENE
CSF I-GENE
) O
from O
peripheral O
blood _RARE_
mononuclear O
cells O
. O

There O
were O
45 _RARE_
to O
56 _RARE_
nt O
differences O
between O
the O
virulent O
and O
avirulent _RARE_
groups O
while O
there O
were O
6 O
to O
14 O
nt O
differences O
among O
four O
avirulent _RARE_
strains O
. O

The O
standard O
principles _RARE_
of O
surgical O
management O
must O
be O
adhered _RARE_
to O
when O
using O
Sandostatin _RARE_
to O
treat O
patients O
with O
these O
disorders O
. O

Some O
of O
the O
PCR O
products O
contained O
mutations O
in O
ATG1 _RARE_
and O
/ O
or O
ATG2 _RARE_
. O

Hemorrhagic _RARE_
shock O
and O
bacterial O
translocation O
in O
a O
swine O
model O
. O

These O
data O
suggest O
that O
the O
levels O
of O
oxygen O
free O
radicals O
were O
increased O
in O
hepatocytes O
and O
mitochondria _RARE_
. O

The O
sequence O
of O
the O
pMxL1 _RARE_
plasmid _RARE_
containing O
the O
invertible _RARE_
region O
contains O
a O
perfect O
tandem _RARE_
repeat O
of O
19 O
bp O
in O
the O
orientation O
1 O
nonexpressed _RARE_
pilin _RARE_
gene I-GENE
at _RARE_
the O
middle _RARE_
of O
the O
recombination _RARE_
junction _RARE_
site O
. O

No O
evidence O
for _RARE_
the O
presence O
of O
introns _RARE_
within O
the O
acvA _RARE_
gene I-GENE
has O
been O
found O
. O

These O
observations O
, O
together O
with O
the O
occurrence O
of O
putative O
4 O
'- O
phosphopantetheine _RARE_
- O
attachment _RARE_
sites O
and O
a O
putative O
thioesterase _RARE_
site I-GENE
, O
are O
discussed O
with O
reference O
to O
the O
reaction O
sequence O
leading O
to O
production O
of O
the O
ACV _RARE_
tripeptide _RARE_
. O

Pargyline _RARE_
, O
a O
monoamine _RARE_
oxidase I-GENE
inhibitor O
, O
reduces O
peak O
3 O
transiently O
( O
max _RARE_
. O

When O
given O
the O
choice O
between O
an O
estrous _RARE_
female O
and O
a O
sexually _RARE_
active _RARE_
male O
in O
the O
AOF _RARE_
, O
flutamide _RARE_
females O
, O
as _RARE_
well _RARE_
as _RARE_
controls O
, O
preferred O
the O
male O
partner _RARE_
. O

Hypoxic _RARE_
ventilatory _RARE_
responses O
were O
- O
1 O
. O
99 _RARE_
+/- O
0 _RARE_
. O
37 O
L O
/ O
min O
/% _RARE_
SaO2 O
in O
the O
relatives _RARE_
and O
- O
1 O
. O
54 O
+/- O
0 _RARE_
. O
25 _RARE_
L O
/ O
min O
/% _RARE_
SaO2 O
in O
the O
control O
subjects O
.( O
ABSTRACT O
TRUNCATED O
AT O
250 _RARE_
WORDS O
) O

Very _RARE_
small O
deletions O
within O
the O
conserved _RARE_
region O
completely O
abolished O
transforming O
activity O
of O
dbl _RARE_
, O
while O
extensive O
deletion O
outside O
of O
this O
region O
had O
no _RARE_
effect O
. O

This O
computerized O
list _RARE_
was O
linked _RARE_
to O
the O
central O
files _RARE_
of O
the O
Massachusetts _RARE_
Cancer O
Registry _RARE_
and O
cases O
diagnosed O
between O
1982 O
and O
1988 O
were O
identified O
. O

We O
also O
present O
evidence O
for _RARE_
a O
negative O
regulatory O
element O
in O
the O
5 O
' O
flanking O
region O
of O
the O
Mlu _RARE_
I I-GENE
upstream I-GENE
activation I-GENE
sequence I-GENE
. O

A O
method O
for _RARE_
establishing _RARE_
stimulus O
control O
of O
ethanol O
responding O
was O
developed O
. O

Mechanism O
of O
activation O
of O
the O
vav _RARE_
protooncogene _RARE_
. O
vav _RARE_
is O
a O
human O
locus O
that O
appears O
to O
be O
specifically O
expressed _RARE_
in O
cells O
of O
hematopoietic O
origin O
regardless O
of O
their O
differentiation O
lineage O
. O

Endothelial _RARE_
cell O
seeding _RARE_
. O

Menetrier _RARE_
disease _RARE_
in O
a O
child O
. O

After O
hemodynamic O
stabilization O
, O
the O
goal O
of O
therapy O
is O
to O
diminish _RARE_
the O
chance _RARE_
that O
an O
ulcer O
will O
continue _RARE_
to O
bleed _RARE_
or O
will O
rebleed _RARE_
. O

Thirty O
seven _RARE_
patients O
( O
amitriptyline _RARE_
n _RARE_
= O
16 O
, O
moclobemide _RARE_
n _RARE_
= O
21 O
) O
completed O
the O
six _RARE_
week O
protocol O
, O
which O
was O
conducted O
under O
double O
blind O
conditions O
. O

The O
stimulus O
threshold O
for _RARE_
EER _RARE_
showed O
a O
less O
individual O
variation O
than O
amplitude O
. O

Analysis O
of O
electrically O
evoked O
response O
( O
EER _RARE_
) O
in O
relation O
to O
the O
central O
visual O
pathway _RARE_
of O
the O
cat _RARE_
( O
1 O
). O

Furthermore O
, O
plasma O
fibrinogen I-GENE
levels O
increased O
by O
a O
mean O
of O
17 _RARE_
. O
6 O
%, O
a O
potentially O
adverse O
effect O
of O
gemfibrozil _RARE_
that O
has O
not O
been O
previously O
reported O
. O

Gemfibrozil _RARE_
in O
hyperlipidaemic _RARE_
patients O
with O
peripheral O
arterial O
disease _RARE_
: O
some O
undiscovered _RARE_
actions O
. O

An O
RME1 _RARE_
- O
independent O
pathway _RARE_
for _RARE_
sporulation _RARE_
control O
in O
Saccharomyces O
cerevisiae O
acts O
through O
IME1 I-GENE
transcript I-GENE
accumulation O
. O

The O
role O
of O
pharmacological O
profiling _RARE_
in O
safety O
assessment O
. O

Its O
application O
in O
Madagascar _RARE_
: O
advantages O
and O
disadvantages _RARE_

In O
all O
cases O
, O
high O
- O
level O
expression _RARE_
of O
the O
truncated I-GENE
avian I-GENE
integrins _RARE_
was O
obtained O
. O

The O
authors O
evaluate O
the O
clinical O
efficacy O
of O
EMB _RARE_
AZS _RARE_
in O
recurrent O
ulcer O
after O
operation O
on O
the O
stomach O
caused O
by O
a O
high O
level O
of O
acid O
production O
and O
ulcerative _RARE_
gastroduodenal _RARE_
bleeding O
. O

In O
adulthood _RARE_
these O
rats O
were O
hyperactive _RARE_
and O
learned _RARE_
the O
active _RARE_
avoidance _RARE_
response O
later O
than O
the O
controls O
. O

To O
investigate O
the O
regulation _RARE_
of O
Spec _RARE_
gene I-GENE
activity O
, O
the O
region O
around O
the O
Spec1 _RARE_
transcriptional I-GENE
initiation I-GENE
site I-GENE
was O
analyzed O
for _RARE_
sites O
of O
protein O
- O
DNA O
interaction O
. O

Phosphopeptide _RARE_
mapping O
revealed O
the O
same O
autophosphorylation O
sites O
utilized O
by O
EGFR I-GENE
- I-GENE
IC _RARE_
as _RARE_
those O
identified O
in O
wild I-GENE
- I-GENE
type I-GENE
EGFR I-GENE
. O

The O
encoded O
sequence O
revealed O
a O
typical O
signal O
peptide O
, O
a O
predominantly O
hydrophilic O
707 _RARE_
amino O
acid O
residue _RARE_
domain O
with O
8 O
N O
- O
glycosylation O
sites O
, O
a O
transmembrane O
domain O
, O
and O
a O
C O
- O
terminal O
domain O
of O
52 O
amino O
acids _RARE_
. O

The O
TCF I-GENE
- I-GENE
1 I-GENE
alpha I-GENE
binding I-GENE
site I-GENE
was O
also O
required O
for _RARE_
TCR I-GENE
alpha I-GENE
enhancer I-GENE
activity O
in O
transcriptionally O
active _RARE_
extracts O
from O
Jurkat O
but O
not O
HeLa O
cells O
, O
confirming O
that O
TCF I-GENE
- I-GENE
1 I-GENE
alpha I-GENE
is O
a O
T I-GENE
- I-GENE
cell I-GENE
- I-GENE
specific I-GENE
transcription I-GENE
factor I-GENE
. O

A O
new O
semi _RARE_
- O
automatic O
method O
for _RARE_
quantifying _RARE_
regional O
cerebral O
uptake O
of O
99m O
technetium O
- O
hexamethylpropylene _RARE_
amine _RARE_
oxime _RARE_
( O
99mTc O
- O
HMPAO O
) O
was O
used O
to O
assess O
single O
photon O
emission O
tomograms _RARE_
from O
5 O
normal O
subjects O
, O
14 O
patients O
with O
Alzheimer _RARE_
' O
s O
disease _RARE_
, O
14 O
patients O
with O
dementia O
of O
frontal O
lobe O
type O
and O
4 O
patients O
with O
dementia O
with O
motor O
neurone _RARE_
disease _RARE_
. O

The O
results O
showed O
that O
fog _RARE_
, O
up _RARE_
to O
a O
level O
of O
base _RARE_
plus _RARE_
fog _RARE_
of O
0 _RARE_
. O
6 O
optical O
density O
units _RARE_
, O
had O
no _RARE_
influence O
on O
the O
diagnostic O
accuracy O
in O
the O
absence O
of O
any O
compensation _RARE_
. O

IdB _RARE_
1031 _RARE_
was O
first _RARE_
extracted O
by O
liquid O
- O
solid O
partition _RARE_
and O
the O
extracts O
were O
evaporated _RARE_
and O
analysed O
on O
a O
reversed O
- O
phase _RARE_
column O
under O
isocratic _RARE_
conditions O
, O
using O
either O
an O
electrochemical _RARE_
or O
a O
UV _RARE_
detector O
. O

In O
this O
model O
, O
eltoprazine _RARE_
has O
a O
very O
specific O
anti O
- O
aggressive O
( O
serenic _RARE_
) O
profile O
, O
inhibiting O
aggression O
while O
social O
interaction O
and O
exploration _RARE_
are O
not O
decreased O
but O
even O
enhanced _RARE_
; O
inactivity _RARE_
, O
a O
measure O
for _RARE_
sedation O
, O
is O
not O
affected O
. O

A O
new O
method O
for _RARE_
the O
in O
vitro O
transfer O
of O
delayed O
hypersensitivity O
by O
dialysed _RARE_
transfer I-GENE
factor I-GENE
. O

Effect O
of O
separate O
and O
combined O
effects O
of O
plutonium O
- O
239 O
, O
hexachlorobutadiene _RARE_
and O
tributyl _RARE_
phosphate O
on O
the O
thymus _RARE_
gland _RARE_
of O
rats O

Data O
collection O
was O
made O
with O
a O
query _RARE_
language O
, O
and O
data O
analysis O
performed O
with O
an O
interactive _RARE_
knowledge O
- O
based O
statistical O
tool O
, O
MAXITAB _RARE_
, O
employing O
a O
multivariate O
tabular _RARE_
analysis O
technique O
. O

ARPIA _RARE_
has O
been O
implemented _RARE_
by O
using O
a O
relational _RARE_
DBMS _RARE_
, O
very O
cheap _RARE_
and O
highly O
diffused _RARE_
on O
personal O
computers _RARE_
. O

Diuresis _RARE_
was O
induced _RARE_
by O
scheduled _RARE_
drinking O
of O
tea _RARE_
( O
150 _RARE_
ml O
/ O
h O
). O

Diagnostic O
value O
of O
adenosine I-GENE
deaminase _RARE_
activity O
in O
tuberculous O
effusions _RARE_
. O

Femoral _RARE_
strain _RARE_
adaptation O
after O
total _RARE_
hip O
replacement _RARE_
: O
a O
comparison O
of O
cemented _RARE_
and O
porous _RARE_
ingrowth _RARE_
components _RARE_
in O
canines _RARE_
. O

Immuno _RARE_
- O
cytochemistry _RARE_
, O
using O
antisera O
against O
Campylobacter _RARE_
jejuni _RARE_
, O
showed O
that O
the O
positive O
staining O
in O
altered O
epithelial _RARE_
cells O
were O
restricted O
to O
intracellular _RARE_
organisms O
having O
a O
structure _RARE_
resembling O
Campylobacter _RARE_
spp _RARE_
. O

Promoter O
activities O
were O
estimated O
using O
beta I-GENE
- I-GENE
glucuronidase I-GENE
and O
neomycin _RARE_
phosphotransferase _RARE_
II I-GENE
reporter I-GENE
gene I-GENE
systems _RARE_
. O

The O
5 O
' O
regions O
of O
these O
two O
soybean _RARE_
actin I-GENE
genes I-GENE
contain O
many O
unusual O
features O
including O
( O
CT _RARE_
) O
repeats O
and O
long O
stretches O
of O
pyrimidine O
- O
rich O
DNA O
. O

All O
8 O
( O
100 _RARE_
%) O
patients O
with O
fulminant _RARE_
hepatic _RARE_
failure O
who O
received O
grafts O
survived _RARE_
, O
including O
3 O
who O
received O
ABO _RARE_
- O
incompatible _RARE_
grafts O
, O
though O
2 O
of O
these O
subsequently O
required O
retransplantation _RARE_
. O

No O
patient O
had O
a O
history O
of O
excess O
alcohol _RARE_
intake O
, O
or O
prolonged O
intake O
of O
hepatotoxic _RARE_
drugs O
and O
steroids O
, O
and O
were O
not O
obese O
or O
malnourished _RARE_
. O

An O
evolutionary O
comparison O
of O
amino O
acid O
sequences O
of O
34 _RARE_
HSP70 I-GENE
proteins I-GENE
from O
17 _RARE_
species O
suggests O
that O
BiP _RARE_
genes I-GENE
share O
a O
common O
ancestor O
, O
which O
diverged O
from O
other O
HSP70 I-GENE
genes I-GENE
near O
the O
time O
when O
eukaryotes O
first _RARE_
appeared O
. O

Spore _RARE_
inocula _RARE_
( O
approximately _RARE_
10 O
( O
6 O
)/ _RARE_
coupon _RARE_
) O
were O
dried _RARE_
onto O
0 _RARE_
. O
5 O
- O
in O
. O

However O
, O
overexpression O
of O
both O
the O
STE4 _RARE_
and O
STE18 _RARE_
proteins I-GENE
did O
not O
generate O
a O
stronger O
pheromone O
response O
than O
overexpression O
of O
STE4 _RARE_
in O
the O
presence O
of O
wild O
- O
type O
levels O
of O
STE18 _RARE_
. O

Reverse _RARE_
transcription O
- O
PCR O
was O
then O
used O
to O
clone O
from O
human O
poly _RARE_
( O
A O
)+ O
RNA O
the O
cDNA O
corresponding O
to O
the O
expressed _RARE_
homolog O
of O
psi I-GENE
ARF I-GENE
4 I-GENE
, O
referred O
to O
as _RARE_
human I-GENE
ARF I-GENE
4 I-GENE
. O

To O
evaluate O
the O
cost O
and O
benefits O
of O
screening O
tests O
for _RARE_
Chlamydia O
trachomatis _RARE_
in O
adolescent O
males O
, O
we O
developed O
a O
decision _RARE_
analysis O
model O
and O
compared O
the O
leukocyte _RARE_
esterase I-GENE
urine O
dipstick _RARE_
test O
with O
culture O
, O
with O
direct O
- O
smear _RARE_
fluorescent _RARE_
antibody O
( O
DFA _RARE_
), _RARE_
and O
with O
the O
option _RARE_
of O
no _RARE_
screening O
( O
no _RARE_
treatment O
). O

Sequencing O
the O
gene O
for _RARE_
an O
imipenem _RARE_
- O
cefoxitin _RARE_
- O
hydrolyzing _RARE_
enzyme O
( O
CfiA _RARE_
) O
from O
Bacteroides _RARE_
fragilis _RARE_
TAL2480 _RARE_
reveals O
strong O
similarity _RARE_
between O
CfiA _RARE_
and O
Bacillus I-GENE
cereus _RARE_
beta I-GENE
- I-GENE
lactamase I-GENE
II I-GENE
. O

The O
cloned _RARE_
HindIII I-GENE
fragment I-GENE
, O
which O
was O
shown O
by O
DNA O
sequence O
analysis O
to O
encode O
the O
N O
- O
terminal O
half _RARE_
of O
the O
B I-GENE
. I-GENE
subtilis I-GENE
IF2 _RARE_
protein I-GENE
and O
0 _RARE_
. O
2 O
kb O
of O
upstream O
flanking O
sequence O
, O
was O
utilized O
as _RARE_
a O
homologous O
probe O
to O
clone O
an O
overlapping O
2 I-GENE
. I-GENE
76 _RARE_
- I-GENE
kb I-GENE
ClaI _RARE_
chromosomal I-GENE
fragment I-GENE
containing O
the O
entire _RARE_
IF2 _RARE_
structural I-GENE
gene I-GENE
. O

The O
N O
- O
terminal O
115 _RARE_
amino O
acids _RARE_
correspond O
to O
a O
putative O
DNA O
- O
binding O
domain O
and O
show O
significant O
sequence O
similarity _RARE_
with O
other O
cloned _RARE_
IFN I-GENE
response I-GENE
factors I-GENE
( O
IRF I-GENE
- I-GENE
1 I-GENE
and O
IRF I-GENE
- I-GENE
2 I-GENE
). O

Maternal _RARE_
seizures O
had O
occurred O
during _RARE_
pregnancy _RARE_
in O
52 O
per O
cent O
. O

It O
encodes O
a O
protein O
with O
three O
zinc O
fingers _RARE_
similar O
to O
those O
of O
the O
transcription I-GENE
factor I-GENE
Sp1 _RARE_
. O

Krox I-GENE
- I-GENE
24 _RARE_
is O
therefore O
a O
sequence O
- O
specific O
transcriptional O
activator O
. O

The O
interindividual _RARE_
variability O
of O
the O
parameters O
is O
taken O
into O
consideration _RARE_
by O
interactively _RARE_
determining _RARE_
the O
threshold O
levels O
. O

The O
patients O
were O
divided O
into O
3 O
subgroups O
: O
1 O
) O
13 _RARE_
N O
+ O
patients O
with O
multiple O
hot O
spots O
( O
greater O
than O
2 O
) O
( O
N O
+ O
IM O
); O
2 O
) O
24 _RARE_
N O
+ O
patients O
with O
single O
hot O
spots O
( O
less O
than O
or O
equal O
to O
2 O
) O
( O
N O
+ O
IS _RARE_
); O
3 O
) O
12 O
N O
- O
patients O
with O
single O
hot O
spots O
( O
less O
than O
or O
equal O
to O
2 O
) O
( O
N O
- O
IS _RARE_
). O

Inspired _RARE_
CO2 O
causing O
changes O
from O
hypo _RARE_
- O
to O
normocapnia _RARE_
has O
previously O
been O
shown O
to O
improve O
arterial O
O2 _RARE_
tension O
( O
PaO2 O
) O
and O
to O
reduce O
alveolar O
- O
arterial O
O2 _RARE_
difference O
. O

Expression O
, O
nucleotide O
sequence O
and O
mutational O
analysis O
of O
two O
open _RARE_
reading O
frames O
in O
the O
nif _RARE_
gene I-GENE
region I-GENE
of I-GENE
Anabaena _RARE_
sp _RARE_
. I-GENE
strain _RARE_
PCC7120 _RARE_
. O

Further O
, O
they O
are O
consistent O
with O
the O
suggestion _RARE_
that O
sites O
homologous O
to O
the O
CAR1 _RARE_
URS _RARE_
may O
be O
situated O
in O
the O
5 O
'- O
flanking O
regions O
of O
multiple O
unrelated O
yeast O
genes O
. O

Our O
results O
suggest O
that O
a O
sequence O
match O
between O
enhancers _RARE_
and O
certain O
promoter O
elements O
is O
critical O
. O

This O
Mr O
is O
similar O
to O
those O
of O
the O
purified _RARE_
smg _RARE_
p25A _RARE_
GDI _RARE_
estimated O
by O
sodium _RARE_
dodecyl O
sulfate _RARE_
- O
polyacrylamide O
gel O
electrophoresis O
and O
sucrose O
density O
gradient O
ultracentrifugation _RARE_
, O
which O
are O
about O
54 O
, O
000 _RARE_
and O
65 O
, O
000 _RARE_
, O
respectively O
. O

Yeast _RARE_
mutants O
assigned O
to O
the O
pet _RARE_
complementation _RARE_
group O
G104 _RARE_
were O
found O
to O
lack O
alpha I-GENE
- I-GENE
ketoglutarate _RARE_
dehydrogenase I-GENE
activity O
as _RARE_
a O
result O
of O
mutations O
in O
the O
dihydrolipoyl _RARE_
transsuccinylase _RARE_
( O
KE2 _RARE_
) O
component _RARE_
of O
the O
complex O
. O

Critical _RARE_
residues O
required O
for _RARE_
repression O
are O
located _RARE_
within O
the O
C O
- O
terminal O
27 _RARE_
amino O
acids _RARE_
of O
c I-GENE
- I-GENE
Fos I-GENE
, O
since O
v I-GENE
- I-GENE
Fos I-GENE
and O
C O
- O
terminal O
truncations _RARE_
of O
c I-GENE
- I-GENE
Fos I-GENE
did O
not O
down O
regulate O
. O

We O
also O
discovered O
a O
V I-GENE
lambda I-GENE
pseudogene _RARE_
, O
called O
psi I-GENE
V I-GENE
lambda I-GENE
1 I-GENE
, O
3 O
kb O
upstream O
of O
the O
U266 _RARE_
lambda I-GENE
gene I-GENE
. O

In O
this O
paper O
, O
we O
have O
analyzed O
the O
structure _RARE_
of O
human O
gene O
for _RARE_
Gx _RARE_
alpha I-GENE
, O
which O
spans O
more O
than O
60 _RARE_
kilobases O
. O

A O
long O
follow O
- O
up _RARE_
study O
revealed O
that O
convalescent _RARE_
stage _RARE_
children O
still O
have O
the O
potency O
to O
have O
an O
immediate O
type O
hypersensitivity O
reaction O
on O
exposure O
to O
mite _RARE_
antigen O
, O
with O
a O
high O
titer O
of O
mite _RARE_
specific I-GENE
IgE I-GENE
in O
their O
sera _RARE_
, O
but O
they O
are O
free O
from O
asthmatic O
attacks O
because O
of O
the O
reduction O
in O
the O
amount O
of O
mite _RARE_
antigen O
in O
the O
body O
, O
as _RARE_
shown O
by O
the O
reduction O
in O
the O
amount O
of O
mite _RARE_
specific I-GENE
IgG I-GENE
. O

But _RARE_
no _RARE_
influence O
was O
observed O
at _RARE_
lower O
concentrations O
than O
1 O
/ O
4 O
MIC _RARE_
of O
AMK _RARE_
. O

Uses _RARE_
of O
orthoclone _RARE_
OKT3 _RARE_
for _RARE_
prophylaxis O
of O
rejection O
and O
induction O
in O
initial O
nonfunction _RARE_
in O
kidney _RARE_
transplantation O
. O

Uses _RARE_
of O
orthoclone _RARE_
OKT3 _RARE_
for _RARE_
prophylaxis O
of O
rejection O
and O
induction O
in O
initial O
nonfunction _RARE_
in O
kidney _RARE_
transplantation O
. O

Furthermore O
, O
we O
notice _RARE_
two O
potential _RARE_
consensus O
motifs O
which O
are O
also O
found O
in O
corresponding O
positions O
in O
the O
genes O
for _RARE_
the O
nerve I-GENE
growth I-GENE
factor I-GENE
receptor I-GENE
and O
the O
68 _RARE_
- I-GENE
kDa I-GENE
neurofilament _RARE_
protein I-GENE
. O

In O
addition O
, O
the O
- O
119 O
to O
- O
81 _RARE_
fragment O
of O
the O
CCK _RARE_
promoter I-GENE
contains O
a O
transcriptional O
enhancer O
that O
potentiates O
the O
transcription O
from O
the O
herpes O
simplex O
virus O
thymidine _RARE_
kinase I-GENE
promoter I-GENE
in O
a O
position O
- O
and O
orientation O
- O
independent O
manner O
. O

Thirty O
minutes O
of O
supine O
restraint _RARE_
decreased O
DOPAC _RARE_
concentrations O
in O
the O
median O
eminence _RARE_
of O
female O
rats O
that O
were O
not O
exposed O
to O
ether O
, O
and O
brief O
exposure O
to O
ether O
enhanced _RARE_
this O
effect O
. O

Influence O
of O
metoprolol _RARE_
treatment O
on O
sympatho _RARE_
- O
adrenal O
activation O
of O
fibrinolysis _RARE_
. O

Five O
of O
10 O
scars _RARE_
studied O
decreased O
at _RARE_
least O
50 O
% O
in O
linear _RARE_
dimensions O
. O

Managing _RARE_
dysphagia _RARE_
in O
a O
chronic O
care O
setting O
: O
an O
introduction O
. O

Gel O
- O
mobility O
- O
shift O
assays O
confirmed O
that O
the O
Raji _RARE_
nuclear O
proteins O
that O
bound _RARE_
to O
W _RARE_
and O
V O
elements O
were O
competed _RARE_
with O
by O
an O
HLA I-GENE
- I-GENE
DRA _RARE_
X I-GENE
- I-GENE
box I-GENE
oligonucleotide _RARE_
. O

In O
Denmark _RARE_
only O
1 O
- O
3 O
cases O
of O
transfusion O
- O
associated O
hepatitis O
NANB O
( O
TAH _RARE_
- O
NANB O
) O
are O
registered _RARE_
annually _RARE_
or O
about O
1 O
case O
per O
100 _RARE_
, O
000 _RARE_
units _RARE_
transfused _RARE_
. O

The O
NF1 I-GENE
locus I-GENE
encodes O
a O
protein O
functionally O
related O
to O
mammalian I-GENE
GAP _RARE_
and O
yeast I-GENE
IRA _RARE_
proteins I-GENE
. O

Hence O
, O
the O
replacement _RARE_
of O
Phe _RARE_
- O
62 _RARE_
with O
Ser _RARE_
specifically O
affects O
a O
determinant O
on O
the O
lambda I-GENE
I I-GENE
light I-GENE
chain I-GENE
that O
is O
necessary O
for _RARE_
the O
intracellular _RARE_
transport _RARE_
of O
this O
molecule O
. O

A O
second O
isotype _RARE_
of O
Raja _RARE_
immunoglobulin I-GENE
heavy I-GENE
chain I-GENE
genes I-GENE
has O
been O
detected O
by O
screening O
a O
spleen _RARE_
cDNA O
library O
with O
homologous O
Raja _RARE_
VH _RARE_
- O
and O
CH1 _RARE_
- O
specific O
probes _RARE_
complementing _RARE_
the O
respective O
regions O
of O
the O
mu I-GENE
- I-GENE
like I-GENE
isotype _RARE_
. O

Petko _RARE_
, O
and O
S O
. O

Disruption O
of O
ARF2 _RARE_
causes O
no _RARE_
detectable O
phenotype _RARE_
. O

Human O
recombinant O
DNA O
- O
derived O
antihemophilic _RARE_
factor I-GENE
( O
factor I-GENE
VIII I-GENE
) O
in O
the O
treatment O
of O
hemophilia _RARE_
A O
. O
recombinant O
Factor _RARE_
VIII I-GENE
Study O
Group O
. O

Like O
other O
members O
of O
this O
family O
, O
the O
AP I-GENE
- I-GENE
4 I-GENE
HLH _RARE_
motif O
and O
the O
adjacent O
basic O
domain O
are O
necessary O
and O
sufficient O
to O
confer O
site O
- O
specific O
DNA O
binding O
. O

Furthermore O
, O
expression _RARE_
of O
the O
promoter O
in O
embryonic _RARE_
Drosophila O
melanogaster O
cells O
that O
lack O
MyoD1 _RARE_
and O
Sp1 _RARE_
is O
strictly O
dependent O
on O
all O
three O
sites O
remaining O
intact _RARE_
and O
on O
the O
presence O
of O
exogenously _RARE_
supplied O
Sp1 _RARE_
and O
MyoD1 _RARE_
. O

Effects O
of O
a O
selective O
monoamine _RARE_
oxidase I-GENE
( I-GENE
MAO I-GENE
)-- _RARE_
A I-GENE
inhibitor O
, O
clorgyline _RARE_
, O
a O
selective O
MAO I-GENE
- I-GENE
B I-GENE
inhibitor O
, O
deprenyl _RARE_
, O
and O
a O
non O
- O
selective O
MAO I-GENE
inhibitor O
, O
nialamide _RARE_
, O
were O
investigated O
on O
footshock _RARE_
- O
induced _RARE_
aggression O
( O
FIA _RARE_
) O
in O
paired O
rats O
. O

To O
identify O
structural O
features O
of O
residues O
flanking O
the O
c O
- O
region O
that O
influence O
the O
fidelity _RARE_
and O
efficiency O
of O
signal O
peptidase _RARE_
cleavage _RARE_
as _RARE_
well _RARE_
as _RARE_
co _RARE_
- O
translational O
translocation O
, O
we O
introduced O
six _RARE_
amino O
acid O
substitutions O
into O
the O
COOH _RARE_
terminus O
of O
the O
hydrophobic O
core O
and O
seven _RARE_
substitutions O
at _RARE_
the O
NH2 O
terminus O
of O
the O
mature _RARE_
region O
( O
the O
+ O
1 O
position O
) O
of O
a O
model O
eukaryotic I-GENE
preprotein _RARE_
- I-GENE
human I-GENE
pre I-GENE
( I-GENE
delta I-GENE
pro I-GENE
) I-GENE
apoA _RARE_
- I-GENE
II I-GENE
. O

Additionally O
, O
although O
c I-GENE
- I-GENE
fos I-GENE
and O
egr _RARE_
- I-GENE
1 I-GENE
mRNAs I-GENE
are O
expressed _RARE_
at _RARE_
elevated O
levels O
in O
stimulated _RARE_
liver O
cells O
, O
fos I-GENE
- I-GENE
B I-GENE
, O
fra _RARE_
- I-GENE
1 I-GENE
, O
and O
egr _RARE_
- I-GENE
2 I-GENE
are O
not O
, O
which O
suggests O
that O
factors O
in O
addition O
to O
the O
serum I-GENE
response I-GENE
factor I-GENE
participate O
in O
the O
regulation _RARE_
of O
immediate I-GENE
- I-GENE
early I-GENE
gene I-GENE
induction O
. O

Of O
848 _RARE_
patients O
, O
819 _RARE_
cases O
with O
complete _RARE_
description O
of O
patient O
' O
s O
background O
were O
evaluable O
: O
Group O
A O
( O
surgery O
+ O
MMC O
+ O
5 O
- O
FU O
: O
chemotherapy O
) O
253 _RARE_
cases O
, O
group O
B O
( O
surgery O
+ O
MMC O
+ O
5 O
- O
FU O
+ O
OK _RARE_
- O
432 _RARE_
or O
PSK _RARE_
: O
immunochemotherapy _RARE_
) O
282 _RARE_
and O
group O
C O
( O
surgery O
alone O
) O
284 _RARE_
. O

The O
nuclear O
proteins O
encoded O
by O
the O
c I-GENE
- I-GENE
fos I-GENE
and O
c I-GENE
- I-GENE
jun I-GENE
protooncogenes _RARE_
are O
expressed _RARE_
during _RARE_
the O
proliferation _RARE_
period O
of O
osteoblast _RARE_
phenotype _RARE_
development O
. O

This O
model O
is O
further O
supported O
by O
binding O
of O
the O
Fos I-GENE
- O
Jun I-GENE
complex O
at _RARE_
an O
AP I-GENE
- I-GENE
1 I-GENE
site I-GENE
in O
the O
type I-GENE
alpha I-GENE
I I-GENE
collagen _RARE_
promoter I-GENE
that O
is O
contiguous O
with O
, O
but O
not O
overlapping O
, O
the O
VDRE _RARE_
. O

PBSX _RARE_
is O
induced _RARE_
by O
agents O
which O
elicit O
the O
SOS _RARE_
response O
. O

A O
bacteriological _RARE_
relapse O
requiring O
treatment O
occurred O
by O
5 O
years O
in O
16 O
. O
8 O
% O
of O
113 _RARE_
R3 _RARE_
, O
5 O
. O
2 O
% O
of O
97 O
R5 _RARE_
, O
and O
20 O
. O
0 _RARE_
% O
of O
115 _RARE_
Z5 _RARE_
patients O
with O
organisms O
sensitive _RARE_
to O
streptomycin _RARE_
and O
isoniazid _RARE_
initially O
. O

In O
the O
controls O
, O
it O
was O
found O
that O
all O
right O
- O
handed _RARE_
and O
10 O
out O
of O
14 O
left _RARE_
- O
handed _RARE_
control O
subjects O
showed O
a O
right O
VHF _RARE_
( O
i O
. O
e _RARE_
., O
left _RARE_
hemisphere O
) O
advantage O
. O

Although O
no _RARE_
Rh _RARE_
- I-GENE
antibodies I-GENE
were O
demonstrable _RARE_
, O
a O
similar O
mechanism O
can O
be O
postulated O
for _RARE_
the O
Rh _RARE_
- O
system _RARE_
. O

The O
deduced O
amino O
acid O
sequence O
has O
the O
greatest O
homology O
( O
61 _RARE_
%) O
to O
the O
green _RARE_
alga _RARE_
Scenedemus _RARE_
obliquus _RARE_
plastocyanin _RARE_
. O

Higher _RARE_
fasting O
serum O
gastrin I-GENE
concentration O
( O
102 _RARE_
. O
0 _RARE_
+/- O
21 O
. O
1 O
vs _RARE_
63 _RARE_
. O
3 O
+/- O
8 O
. O
3 O
ng _RARE_
. O
l _RARE_
- O
1 O
), _RARE_
and O
greater O
postprandial _RARE_
gastrin I-GENE
release O
( O
AUC0 _RARE_
- O
120 O
: O
16690 _RARE_
+/- O
2648 _RARE_
vs _RARE_
10654 _RARE_
+/- O
1283 _RARE_
ng _RARE_
. O
l _RARE_
- O
1 O
min O
) O
were O
observed O
after O
VTP _RARE_
- O
HM _RARE_
than O
after O
VTP _RARE_
- O
Cas _RARE_
. O

The O
experimental O
group O
consisted O
of O
61 _RARE_
examinees _RARE_
class O
II O
/ O
2 O
orthodontic _RARE_
anomalies O
. O

This O
study O
was O
performed O
to O
clarify O
the O
location O
of O
a O
transesophageal _RARE_
echocardiographic O
( O
TEE _RARE_
) O
transducer _RARE_
when O
obtaining O
the O
short O
- O
axis O
view O
of O
the O
left _RARE_
ventricle O
( O
S O
- O
LV O
). O

Subjects _RARE_
were O
16 O
male O
chronic O
schizophrenics _RARE_
consisting O
of O
8 O
DST _RARE_
suppressors O
and O
8 O
nonsuppressors _RARE_
. O

From O
S3 _RARE_
( O
CBF O
: O
79 _RARE_
- O
60 _RARE_
%) O
to O
S5 _RARE_
( O
CBF O
: O
39 _RARE_
- O
0 _RARE_
%), O
% O
WTh _RARE_
, O
1 O
/ O
TPC _RARE_
and O
1 O
/ O
T O
were O
significantly O
decreased O
from O
those O
of O
the O
control O
levels O
( O
all O
p O
less O
than O
0 _RARE_
. O
01 O
). O

In O
this O
article O
we O
propose O
to O
find O
out O
the O
percentage O
of O
normal O
occlusion O
and O
the O
distribution O
of O
maloclusions _RARE_
, O
according O
to O
the O
anteroposterior O
relationship O
between O
the O
dental O
archs _RARE_
( O
following O
the O
ANGLE3 _RARE_
classification O
). O

In O
that O
case O
, O
the O
ratio O
of O
brush _RARE_
abrasion _RARE_
was O
0 _RARE_
. O
268 _RARE_
, O
compressive _RARE_
and O
transverse O
strength O
, O
124 _RARE_
. O
3 O
and O
86 _RARE_
. O
3 O
MPa _RARE_
respectively O
, O
hardness _RARE_
, O
43 _RARE_
. O
2 O
Hk _RARE_
, O
water O
absorption O
14 O
. O
2 O
micrograms O
/ O
mm3 _RARE_
and O
thermal O
expansion O
coefficient O
, O
47 _RARE_
. O
4 O
x _RARE_
10 O
(- _RARE_
6 O
)/ _RARE_
degrees O
C O
. O

9 O
, O
1498 _RARE_
- O
1506 _RARE_
). O

In O
a O
highly O
select O
group O
of O
stable O
hypertensive O
patients O
, O
we O
have O
assessed O
the O
strength O
of O
association O
between O
various O
blood _RARE_
pressure O
measurements O
( O
24 _RARE_
h O
average O
automated O
ambulatory O
blood _RARE_
pressure O
, O
4 O
h O
automated O
ambulatory O
morning _RARE_
average O
blood _RARE_
pressure O
, O
multiple O
office _RARE_
visit _RARE_
average O
blood _RARE_
pressure O
, O
and O
a O
single O
office _RARE_
visit _RARE_
average O
blood _RARE_
pressure O
) O
and O
various O
echocardiographic O
indices O
of O
hypertensive O
cardiac O
target O
organ O
damage O
( O
left _RARE_
atrial _RARE_
diameter O
, O
left _RARE_
ventricular O
end O
diastolic O
diameter O
, O
posterior O
wall _RARE_
thickness O
, O
combined O
wall _RARE_
thickness O
, O
relative O
wall _RARE_
thickness O
, O
left _RARE_
ventricular O
mass O
and O
mass O
index O
, O
and O
combined O
wall _RARE_
thickness O
/ O
left _RARE_
ventricular O
diastolic O
diameter O
ratio O
). O

We O
have O
previously O
identified O
, O
by O
screening O
a O
lambda O
gt11 O
expression _RARE_
library O
, O
murine I-GENE
protein I-GENE
mXBP _RARE_
, O
which O
binds O
to O
a O
sequence O
which O
overlaps _RARE_
the O
3 O
' O
end O
of O
the O
murine I-GENE
class I-GENE
II I-GENE
major I-GENE
histocompatibility I-GENE
complex I-GENE
A I-GENE
alpha I-GENE
gene I-GENE
X I-GENE
box I-GENE
, O
a O
conserved _RARE_
transcription O
element O
found O
upstream O
of O
all O
class O
II O
genes O
. O

The O
p36 _RARE_
gene I-GENE
is O
at _RARE_
least O
22 _RARE_
kb O
in O
length O
and O
has O
a O
coding O
sequence O
of O
approximately _RARE_
1 O
kb O
, O
representing O
only O
4 O
. O
5 O
% O
of O
the O
gene O
.( O
ABSTRACT O
TRUNCATED O
AT O
250 _RARE_
WORDS O
) O

This O
multimodality _RARE_
treatment O
for _RARE_
locally O
advanced O
gynecologic O
tumors O
appears O
feasible _RARE_
with O
modification O
, O
and O
continued O
work O
exploring _RARE_
this O
approach O
is O
encouraged _RARE_
. O

A O
contiguous O
and O
sequentially _RARE_
occupied O
secondary O
Fur I-GENE
- I-GENE
binding I-GENE
site I-GENE
in O
entC _RARE_
was O
protected O
at _RARE_
higher _RARE_
Fur I-GENE
concentrations O
, O
extending O
the O
protected O
region O
to O
+ O
49 _RARE_
, O
and O
sequestering _RARE_
the O
putative O
Shine _RARE_
- O
Dalgarno _RARE_
sequence O
. O

The O
major O
promoter O
responds _RARE_
strongly O
to O
virus O
- O
encoded O
trans _RARE_
activators _RARE_
EIA _RARE_
and O
EIV _RARE_
and O
contains O
four O
elements O
: O
a O
TAGA _RARE_
motif O
analogous O
to O
the O
TATA O
box O
, O
two O
EIIF _RARE_
sites I-GENE
present O
in O
an O
inverted O
orientation O
, O
and O
an O
ATF I-GENE
/ O
CREB I-GENE
site O
. O

With O
the O
modified O
fingertip _RARE_
- O
to O
- O
floor _RARE_
( O
MFTF _RARE_
) O
method O
, O
patients O
stand _RARE_
on O
a O
stool _RARE_
and O
forward _RARE_
bend _RARE_
so O
that O
measurements O
can O
be O
taken O
on O
patients O
who O
are O
able O
to O
touch _RARE_
the O
floor _RARE_
or O
reach O
beyond O
the O
level O
of O
the O
floor _RARE_
. O

No O
significant O
differences O
could O
be O
seen O
in O
response O
rates O
according O
to O
the O
concentration O
of O
estrogen I-GENE
receptors I-GENE
or O
presence O
of O
progesteron _RARE_
receptors I-GENE
in O
this O
group O
of O
patients O
. O

Teicoplanin _RARE_
was O
given O
most O
often O
because O
of O
persistent O
fever O
or O
initial O
Gram O
- O
positive O
bacteraemia _RARE_
and O
only O
one O
- O
third O
of O
these O
cases O
responded O
. O

Luteinizing _RARE_
hormone I-GENE
- I-GENE
releasing I-GENE
hormone I-GENE
analog O
therapy O
of O
uterine _RARE_
fibroid _RARE_
: O
analysis O
of O
results O
obtained O
with O
buserelin _RARE_
administered O
intranasally _RARE_
and O
goserelin _RARE_
administered O
subcutaneously O
as _RARE_
a O
monthly O
depot _RARE_
. O

In O
Experiments O
1 O
and O
2 O
, O
infants O
, O
like O
adults O
, O
initially O
categorized _RARE_
novel O
objects O
on O
the O
basis O
of O
physical O
appearance O
, O
but O
only O
if O
trained _RARE_
with O
multiple O
exemplars _RARE_
, O
after O
delays _RARE_
of O
1 O
and O
7 O
days O
. O

The O
clinical O
picture O
of O
the O
disease _RARE_
was O
significantly O
different O
from O
anthropogenic _RARE_
cutaneous O
leishmaniasis _RARE_
caused O
by O
L O
. O
tropica _RARE_
but O
similar O
to O
cutaneous O
patterns O
caused O
by O
L O
. O
infantum _RARE_
which O
was O
a O
prevalent _RARE_
pattern O
in O
the O
southern O
France _RARE_
. O

Although O
there O
are O
no _RARE_
octamer O
elements O
in O
the O
adenovirus O
genome O
that O
are O
known O
to O
be O
important O
for _RARE_
transcription O
, O
there O
are O
octamer O
elements O
in O
the O
viral O
terminal O
repeat O
sequences O
. O

In O
comparison O
with O
the O
16 O
introns _RARE_
reported O
in O
AHA3 _RARE_
, O
AHA2 _RARE_
is O
missing O
one O
intron O
in O
the O
5 O
'- O
untranslated _RARE_
region O
and O
a O
second O
intron O
in O
the O
C O
- O
terminal O
coding O
region O
. O

Northern O
blot O
analysis O
indicates O
that O
AHA2 _RARE_
mRNA I-GENE
relative O
to O
total _RARE_
cellular O
RNA O
is O
expressed _RARE_
at _RARE_
significantly O
higher _RARE_
levels O
in O
root O
tissue O
as _RARE_
compared O
with O
shoot _RARE_
tissue O
. O

Impaction _RARE_
of O
gastrostomy _RARE_
tube O
in O
the O
abdominal O
wall _RARE_
. O

Both O
antidepressants _RARE_
elevated O
the O
pain O
threshold O
acutely _RARE_
, O
while O
pretreatment O
with O
pCPA _RARE_
largely O
blocked O
the O
analgesia O
. O

Sci _RARE_
. O

A O
needs O
assessment O
of O
these O
families _RARE_
was O
also O
done O
. O

TCR I-GENE
alpha I-GENE
and I-GENE
beta I-GENE
gene I-GENE
expression _RARE_
may O
be O
regulated O
by O
a O
common O
set O
of O
T I-GENE
- I-GENE
cell I-GENE
nuclear I-GENE
proteins I-GENE
in O
that O
the O
T I-GENE
beta I-GENE
2 I-GENE
element I-GENE
binding O
a O
set O
of O
cyclic I-GENE
AMP I-GENE
response I-GENE
element I-GENE
- I-GENE
binding I-GENE
proteins I-GENE
that O
are O
also O
bound _RARE_
by O
the O
T I-GENE
alpha I-GENE
1 I-GENE
element I-GENE
of O
the O
human O
TCR I-GENE
alpha I-GENE
enhancer O
and O
the O
decamer _RARE_
element O
present O
in O
a O
large O
number O
of O
human O
and O
murine O
TCR I-GENE
beta I-GENE
promoters O
. O

The O
3 O
' O
stem _RARE_
- O
loop O
is O
highly O
divergent O
in O
structure _RARE_
among O
species O
and O
lies O
immediately O
upstream O
of O
the O
binding O
site O
for _RARE_
Sm _RARE_
proteins I-GENE
. O

The O
deleted _RARE_
nucleotide O
sequence O
corresponded O
to O
sequences O
that O
, O
by O
analogy _RARE_
to O
the O
organization O
of O
the O
type I-GENE
I I-GENE
collagen _RARE_
genes I-GENE
, O
should O
be O
precisely O
encoded O
by O
exon _RARE_
41 _RARE_
of O
the O
COL3A1 _RARE_
gene I-GENE
. O

These O
losses _RARE_
account O
for _RARE_
the O
resistance O
of O
EDS _RARE_
- O
IV O
collagen _RARE_
to O
cyanogen _RARE_
bromide O
and O
mammalian I-GENE
collagenase _RARE_
digestion O
. O

A O
4 O
. O
8 O
- O
kilobase _RARE_
BamHI I-GENE
- O
HindIII I-GENE
fragment O
encoding O
the O
entire _RARE_
Neurospora I-GENE
crassa I-GENE
CuZn _RARE_
superoxide _RARE_
dismutase I-GENE
gene I-GENE
( O
herein _RARE_
designated O
sod _RARE_
- I-GENE
1 I-GENE
) O
was O
isolated O
from O
a O
genomic O
library O
using O
two O
60 _RARE_
- O
base _RARE_
deoxyoligonucleotide _RARE_
probes _RARE_
corresponding O
to O
the O
published O
N O
. O
crassa O
amino O
acid O
sequence O
. O

Two O
other O
peptides O
, O
either O
partially O
or O
totally _RARE_
lacking _RARE_
the O
basic O
region O
, O
but O
containing O
the O
intact _RARE_
leucine O
zipper O
domain O
, O
readily O
form O
dimers _RARE_
but O
do O
not O
bind O
to O
the O
CRE _RARE_
. O

In O
contrast O
, O
the O
CRE _RARE_
of O
the O
human I-GENE
c I-GENE
- I-GENE
fos I-GENE
promoter I-GENE
located _RARE_
at _RARE_
- O
60 _RARE_
was O
weakly O
induced _RARE_
by O
cAMP O
and O
E1a I-GENE
in O
both O
HeLa O
and O
PC12 O
cells O
. O

We O
have O
isolated O
and O
sequenced O
the O
gene O
encoding O
the O
human I-GENE
U1 _RARE_
- I-GENE
70K _RARE_
snRNP I-GENE
protein I-GENE
. O

Although O
popular _RARE_
this O
hypothesis O
is O
far O
from O
explaining _RARE_
all O
the O
clinical O
facts _RARE_
, O
namely O
that O
rigidity _RARE_
is O
equal O
in O
extensor _RARE_
and O
flexor _RARE_
, O
proximal O
and O
distal O
muscles O
. O

Using O
appropriate O
synthetic _RARE_
HSE O
oligonucleotides O
, O
three O
types _RARE_
of O
clones _RARE_
with O
potential _RARE_
HSE O
binding O
domains O
were O
isolated O
from O
a O
tomato _RARE_
lambda O
gt11 O
expression _RARE_
library O
by O
DNA O
- O
ligand _RARE_
screening O
. O

Fluid _RARE_
( O
AVLF _RARE_
) O
31 _RARE_
. O

The O
results O
supported O
the O
therapeutic O
principle _RARE_
of O
TCM _RARE_
: O
Treating _RARE_
patients O
according O
to O
their O
pathophysiological _RARE_
patterns O
. O

The O
nmr _RARE_
gene I-GENE
is O
the O
major O
negative O
regulatory O
gene O
in O
the O
nitrogen O
control O
circuit O
of O
Neurospora O
crassa O
, O
which O
, O
together O
with O
positive O
regulatory O
genes O
, O
governs _RARE_
the O
expression _RARE_
of O
multiple O
unlinked _RARE_
structural O
genes O
of O
the O
circuit O
. O

The O
4 O
days O
dexamethasone O
suppression O
test O
showed O
more O
than O
80 _RARE_
% O
suppression O
of O
dehydroepiandrosterone _RARE_
- O
sulphate _RARE_
and O
a O
variable _RARE_
( O
40 O
- O
60 _RARE_
%) O
reduction O
of O
testosterone O
and O
androstenedione _RARE_
levels O
. O

The O
ratio O
of O
P O
- O
31 _RARE_
NMR O
- O
S O
derived O
inorganic O
phosphates _RARE_
[ _RARE_
Pi _RARE_
] O
to O
phosphocreatine _RARE_
[ _RARE_
PCr _RARE_
] O
was O
significantly O
greater O
at _RARE_
rest O
in O
LVH _RARE_
baboons _RARE_
[ _RARE_
0 _RARE_
. O
53 O
+/- O
0 _RARE_
. O
06 O
versus O
controls O
= O
0 _RARE_
. O
41 _RARE_
+/- O
0 _RARE_
. O
17 _RARE_
; O
P O
less O
than O
0 _RARE_
. O
05 O
]. O

Cutaneous _RARE_
necrosis O
associated O
with O
protein I-GENE
S I-GENE
deficiency O
. O

Critical _RARE_
study O

Regional _RARE_
cerebral O
blood _RARE_
flow O
was O
measured O
using O
N O
- O
isopropyl _RARE_
- O
123I _RARE_
- O
iodoamphetamine _RARE_
with O
single O
- O
photon O
emission O
computed O
tomography O
( O
CT _RARE_
) O
in O
16 O
aged O
patients O
with O
noninsulin _RARE_
- O
dependent O
diabetes O
mellitus O
( O
NIDDM _RARE_
, O
average O
age O
72 O
. O
8 O
years O
, O
average O
fasting O
plasma O
glucose O
7 O
. O
7 O
mmol O
/ O
L O
), _RARE_
and O
12 O
nondiabetic _RARE_
subjects O
( O
71 _RARE_
. O
6 O
years O
, O
5 O
. O
3 O
mmol O
/ O
L O
). O

Mean O
ROI _RARE_
- O
A O
/ O
B O
ratio O
was O
49 _RARE_
. O
6 O
+/- O
1 O
. O
7 O
% O
in O
the O
diabetic O
group O
, O
significantly O
lower O
than O
the O
57 O
. O
9 O
+/- O
1 O
. O
6 O
% O
at _RARE_
the O
nondiabetic _RARE_
group O
( O
p O
less O
than O
0 _RARE_
. O
005 O
). O

These O
data O
strongly O
implicate _RARE_
the O
normal O
product O
of O
the O
int I-GENE
- I-GENE
2 I-GENE
gene I-GENE
, O
which O
is O
related O
to O
the O
fibroblast I-GENE
growth I-GENE
factor I-GENE
family I-GENE
, O
as _RARE_
a O
contributory _RARE_
factor O
in O
virally _RARE_
induced _RARE_
mammary O
tumors O
. O

This O
result O
indicates O
that O
separate O
complexes O
exist O
containing O
ankyrin _RARE_
and O
fodrin _RARE_
with O
either O
uvomorulin _RARE_
or O
Na _RARE_
+, _RARE_
K I-GENE
+- _RARE_
ATPase I-GENE
. O

These O
genes O
are O
expressed _RARE_
within O
a O
few O
hours O
of O
the O
initiation O
of O
development O
; O
their O
mRNAs O
accumulate O
to O
a O
peak O
at _RARE_
12 O
hr O
and O
persist _RARE_
until O
culmination _RARE_
. O

The O
PC2 _RARE_
protein I-GENE
also O
shows O
great O
similarity _RARE_
to O
the O
incomplete O
NH2 O
- O
terminal O
sequence O
of O
the O
human I-GENE
furin _RARE_
gene I-GENE
product I-GENE
, O
a O
putative O
membrane O
- O
inserted O
receptor O
- O
like O
molecule O
. O

Whether _RARE_
or O
not O
there O
are O
sequences O
conferring O
cAMP O
responsiveness O
which O
are O
common O
both O
to O
P I-GENE
- I-GENE
450scc _RARE_
and O
the O
other O
steroidogenic _RARE_
P I-GENE
- I-GENE
450 _RARE_
genes I-GENE
remains O
to O
be O
established O
. O

In O
this O
study O
, O
we O
used O
footprinting O
and O
gel O
mobility O
retardation O
assays O
to O
reveal O
that O
bacterially O
synthesized O
Zta I-GENE
fusion I-GENE
proteins I-GENE
bound _RARE_
directly O
to O
six _RARE_
TGTGCAA _RARE_
- O
like O
motifs O
within O
DSL _RARE_
. O

The O
zta _RARE_
transactivator _RARE_
involved O
in O
induction O
of O
lytic O
cycle _RARE_
gene O
expression _RARE_
in O
Epstein O
- O
Barr O
virus O
- O
infected _RARE_
lymphocytes O
binds O
to O
both O
AP I-GENE
- I-GENE
1 I-GENE
and O
ZRE _RARE_
sites I-GENE
in O
target O
promoter O
and O
enhancer O
regions O
. O

It O
is O
the O
human O
homolog O
of O
the O
mouse I-GENE
Mx _RARE_
protein I-GENE
involved O
in O
resistance O
to O
influenza _RARE_
virus O
. O

Fragments _RARE_
containing O
the O
21 O
- O
base _RARE_
- O
pair _RARE_
repeat O
region O
, O
the O
enhancer I-GENE
of I-GENE
simian I-GENE
virus I-GENE
40 I-GENE
or O
both O
strongly O
stimulated _RARE_
beta I-GENE
- I-GENE
galactosidase I-GENE
synthesis _RARE_
, O
and O
three O
fragments O
from O
the O
polyomavirus _RARE_
enhancer I-GENE
region I-GENE
stimulated _RARE_
moderate O
levels O
. O

The O
sites O
targeted O
for _RARE_
mutagenesis O
, O
residues O
60 _RARE_
, O
61 _RARE_
, O
and O
66 _RARE_
, O
are O
located _RARE_
within O
a O
putative O
helical O
loop O
structure _RARE_
which O
may O
be O
involved O
in O
substrate O
recognition O
by O
the O
enzyme O
. O

The O
possible O
benefits O
of O
LMW _RARE_
heparin _RARE_
( O
reduced _RARE_
frequency O
of O
bleeding O
, O
alleviation _RARE_
of O
hypertriglyceridemia _RARE_
) O
were O
not O
, O
however O
, O
apparent O
, O
possibly O
because O
of O
the O
short O
observation O
period O
and O
the O
low O
incidence O
of O
hemorrhagic O
complications O
in O
routine O
dialyses _RARE_
. O

The O
deduced O
amino O
acid O
sequence O
of O
destrin _RARE_
is O
165 O
residues O
long O
and O
is O
very O
similar O
( O
71 _RARE_
% O
identical O
) O
to O
that O
of O
cofilin _RARE_
, O
a O
widely O
distributed O
, O
pH O
- O
sensitive _RARE_
actin I-GENE
- O
modulating _RARE_
protein O
. O

Summers _RARE_
, O
Virology _RARE_
89 _RARE_
: O
517 _RARE_
- O
527 _RARE_
, O
1978 _RARE_
). O

With O
only O
purified _RARE_
T I-GENE
antigen I-GENE
in O
the O
presence O
of O
topoisomerase I-GENE
I I-GENE
to O
unwind _RARE_
purified _RARE_
DNA O
, O
ori _RARE_
- O
auxiliary _RARE_
sequences O
strongly O
facilitated O
T I-GENE
- I-GENE
antigen I-GENE
- O
dependent O
DNA O
conformational O
changes O
consistent O
with O
melting _RARE_
the O
first _RARE_
50 O
base _RARE_
pairs _RARE_
. O

A O
rabbit _RARE_
antiserum _RARE_
was O
raised O
against O
a O
synthetic _RARE_
peptide O
corresponding O
to O
a O
hydrophilic O
portion O
of O
the O
translated O
murine O
cDNA O
sequence O
. O

Conservation _RARE_
of O
function O
of O
Drosophila I-GENE
melanogaster I-GENE
abl I-GENE
and O
murine I-GENE
v I-GENE
- I-GENE
abl I-GENE
proteins I-GENE
in O
transformation O
of O
mammalian O
cells O
. O

In O
transient O
cotransfection O
assays O
using O
Chang _RARE_
liver O
cells O
( O
CCL _RARE_
13 _RARE_
), _RARE_
pM1 _RARE_
DNA O
exerts O
a O
6 O
- O
to O
10 O
- O
fold _RARE_
trans _RARE_
- O
activating O
effect O
on O
the O
expression _RARE_
of O
the O
pSV2CAT _RARE_
reporter O
plasmid _RARE_
. O

We O
have O
determined O
the O
nucleotide O
( O
nt O
) O
sequence O
of O
the O
7 I-GENE
. I-GENE
5 I-GENE
- I-GENE
kb I-GENE
COR _RARE_
segment I-GENE
that O
encompasses _RARE_
a O
cluster O
of O
six _RARE_
genes O
( O
CYC1 I-GENE
, O
UTR1 _RARE_
, O
UTR3 _RARE_
, O
OSM1 _RARE_
, O
tRNA I-GENE
( I-GENE
Gly _RARE_
) I-GENE
and O
RAD7 _RARE_
) O
located _RARE_
on O
chromosome _RARE_
X O
of O
the O
yeast O
Saccharomyces O
cerevisiae O
. O

Specific O
binding O
of O
the O
protein O
factors O
to O
the O
sites O
, O
possibly O
to O
the O
three O
Mt _RARE_
sequences O
, O
may O
play O
an O
important O
role O
in O
the O
coordinate O
regulation _RARE_
of O
the O
transcription O
of O
nuclear O
genes O
encoding O
subunits O
responsible O
for _RARE_
mitochondrial O
oxidative O
phosphorylation _RARE_
. O

This O
points O
to O
a O
specific O
interference O
with O
HSV O
- O
induced _RARE_
DNA O
amplification O
. O

No O
recombination _RARE_
signal O
sequences O
have O
been O
found O
contiguous O
to O
the O
recombination _RARE_
point O
. O

The O
antinociceptive _RARE_
properties O
, O
as _RARE_
measured O
by O
the O
tail _RARE_
- O
flick _RARE_
and O
hot O
- O
plate _RARE_
tests O
, O
and O
the O
motor O
effects O
of O
an O
intrathecally _RARE_
- O
administered O
benzodiazepine _RARE_
agonist O
midazolam O
, O
alone O
, O
and O
in O
combination O
with O
morphine _RARE_
, O
was O
examined O
in O
rats O
. O

Constructs _RARE_
were O
made O
in O
which O
an O
AATAAA _RARE_
and O
the O
GT _RARE_
- O
rich O
region O
were O
separated O
by O
various O
distances O
ranging O
from O
7 O
to O
43 _RARE_
bp O
. O

To O
address O
this O
issue _RARE_
, O
the O
gene O
for _RARE_
factor I-GENE
Y I-GENE
has O
been O
cloned _RARE_
molecularly O
and O
its O
DNA O
sequence O
has O
been O
determined O
. O

We O
cloned _RARE_
and O
sequenced O
the O
cDNAs O
against O
genomic O
RNA O
and O
mRNA O
for _RARE_
phosphoprotein _RARE_
( I-GENE
P I-GENE
) I-GENE
of O
human O
parainfluenza _RARE_
type O
2 O
virus O
( O
PIV _RARE_
- O
2 O
). O
cDNA O
clone O
from O
genomic O
RNA O
was O
1439 _RARE_
nucleotides O
in O
length O
excluding O
poly _RARE_
( O
A O
) O
and O
was O
found O
to O
have O
two O
small O
open _RARE_
reading O
frames O
encoding O
proteins O
of O
233 _RARE_
and O
249 _RARE_
amino O
acids _RARE_
. O

We O
show O
that O
cytR _RARE_
expression _RARE_
is O
negatively O
controlled _RARE_
by O
the O
CytR _RARE_
protein I-GENE
and O
positively O
affected O
by O
the O
cAMP I-GENE
/ I-GENE
CAP _RARE_
complex I-GENE
. O

To O
identify O
these O
sites O
, O
the O
deduced O
amino O
acid O
sequence O
of O
the O
3T3 O
- O
L1 O
adipocyte _RARE_
insulin I-GENE
receptor I-GENE
of O
the O
mouse O
was O
determined O
. O

PAO _RARE_
blocks O
turnover O
of O
the O
phosphoryl _RARE_
group O
of O
pp15 _RARE_
, O
causing O
its O
accumulation O
, O
and O
thereby O
appears O
to O
interrupt _RARE_
signal O
transmission _RARE_
from O
the O
receptor O
to O
the O
glucose O
- O
transport _RARE_
system _RARE_
. O

It O
is O
likely O
that O
the O
sequence O
similarities O
reflect O
a O
common O
molecular _RARE_
architecture O
of O
the O
two O
heme O
binding O
sites O
and O
of O
a O
copper _RARE_
binding O
site O
in O
these O
enzymes _RARE_
. O

The O
cDNA O
sequence O
has O
an O
813 _RARE_
- O
bp O
open _RARE_
reading O
frame O
( O
ORF O
) O
whose O
predicted O
amino O
acid O
sequence O
is O
97 O
. O
6 O
% O
identical O
to O
the O
272 O
carboxy _RARE_
- O
terminal O
amino O
acids _RARE_
of O
the O
human I-GENE
ets I-GENE
- I-GENE
1 I-GENE
protein I-GENE
. O

To O
characterize O
the O
O7 _RARE_
- I-GENE
LPS _RARE_
region I-GENE
, O
the O
recombinant O
cosmids _RARE_
pJHCV31 _RARE_
and O
pJHCV32 _RARE_
were O
mutagenized _RARE_
by O
transposon _RARE_
mutagenesis O
with O
Tn3HoHo1 _RARE_
, O
which O
carries O
a O
promoterless O
lac I-GENE
operon I-GENE
and O
can O
therefore O
generate O
lacZ I-GENE
transcriptional O
fusions O
with O
target O
DNA O
sequences O
. O

The O
sacT _RARE_
gene I-GENE
regulating _RARE_
the O
sacPA _RARE_
operon I-GENE
in I-GENE
Bacillus I-GENE
subtilis I-GENE
shares O
strong O
homology O
with O
transcriptional O
antiterminators _RARE_
. O

The O
TraD _RARE_
protein I-GENE
( I-GENE
83 _RARE_
, I-GENE
899 _RARE_
Da _RARE_
) I-GENE
contains O
three O
hydrophobic O
regions O
, O
of O
which O
two O
are O
located _RARE_
near O
the O
amino O
- O
terminal O
region O
. O

The O
protein O
product O
of O
orfD _RARE_
, O
which O
is O
probably O
a O
new O
tra _RARE_
gene I-GENE
( O
named O
traX _RARE_
), _RARE_
contains O
65 O
% O
hydrophobic O
amino O
acids _RARE_
, O
especially O
rich O
in O
alanine O
and O
leucine O
. O

Various O
mutant I-GENE
HN _RARE_
genes I-GENE
were O
constructed O
to O
examine O
the O
role O
of O
residues O
flanking O
the O
signal O
- O
anchor _RARE_
domain O
, O
including O
the O
cytoplasmic O
tail _RARE_
, O
on O
assembly O
and O
intracellular _RARE_
transport _RARE_
of O
the O
HN _RARE_
glycoprotein I-GENE
. O

Our O
studies O
extend O
these O
findings O
and O
show O
that O
the O
E2 I-GENE
transactivation _RARE_
gene I-GENE
is O
expressed _RARE_
from O
multiple O
promoters O
. O

Furthermore O
, O
analysis O
of O
the O
E2 I-GENE
proteins I-GENE
present O
in O
various O
cell O
lines O
harboring O
specific O
BPV _RARE_
- O
1 O
mutants O
, O
including O
the O
2558 _RARE_
acceptor _RARE_
mutant O
, O
proves _RARE_
that O
alternate O
modes O
of O
E2 I-GENE
expression _RARE_
exist O
. O

Disruption O
of O
the O
IRA2 _RARE_
gene I-GENE
resulted O
in O
( O
i O
) O
increased O
sensitivity O
to O
heat O
shock O
and O
nitrogen O
starvation O
, O
( O
ii O
) O
sporulation _RARE_
defects O
, O
and O
( O
iii O
) O
suppression O
of O
the O
lethality O
of O
the O
cdc25 _RARE_
mutant I-GENE
. O

This O
cohort O
of O
patients O
was O
selected _RARE_
on O
the O
basis O
of O
clinical O
stage _RARE_
. O

A O
gene O
in O
Drosophila O
melanogaster O
that O
maps O
cytologically _RARE_
to O
2C1 _RARE_
- O
3 O
on O
the O
distal O
portion O
of O
the O
X O
- O
chromosome _RARE_
encodes O
a O
member _RARE_
of O
the O
steroid I-GENE
/ I-GENE
thyroid I-GENE
hormone I-GENE
receptor I-GENE
superfamily I-GENE
. O

A O
portion O
of O
Region _RARE_
II O
also O
resembles O
part O
of O
the O
human O
c I-GENE
- I-GENE
jun I-GENE
oncoprotein _RARE_
' O
s O
leucine O
zipper O
, O
which O
in O
turn _RARE_
, O
has O
been O
demonstrated O
to O
be O
the O
heterodimerization O
site O
between O
the O
jun I-GENE
and O
fos I-GENE
oncoproteins _RARE_
. O

To O
determine O
whether O
vanadate _RARE_
could O
inhibit O
PEPCK I-GENE
gene I-GENE
transcription O
, O
a O
series O
of O
chimeric O
genes O
containing O
several O
deletions O
in O
the O
P I-GENE
- I-GENE
enolypyruvate _RARE_
carboxykinase _RARE_
promoter I-GENE
between O
- O
550 _RARE_
and O
- O
68 _RARE_
was O
linked _RARE_
to O
the O
structural O
genes O
for _RARE_
either O
amino I-GENE
- I-GENE
3 I-GENE
- I-GENE
glycosyl _RARE_
phosphotransferase _RARE_
( O
neo _RARE_
) O
or O
chloramphenicol I-GENE
acetyltransferase _RARE_
and O
introduced O
into O
hepatoma O
cells O
using O
three O
methods O
: O
( O
a O
) O
infection O
with O
a O
Moloney O
murine O
leukemia O
virus O
- O
based O
retrovirus _RARE_
, O
( O
b O
) O
transfection O
and O
stable O
selection O
for _RARE_
neo _RARE_
expression _RARE_
, O
or O
( O
c O
) O
transient O
expression _RARE_
of O
chloroamphenicol _RARE_
acetyltransferase _RARE_
. O

The O
diagnosis O
of O
miliary _RARE_
tuberculosis O
should O
be O
systematically O
considered O
in O
ARDS O
of O
unknown O
origin O
. O

In O
order O
to O
characterize O
the O
functional _RARE_
elements O
of O
the O
promoter O
that O
in O
some O
way O
must O
respond O
to O
these O
regulatory O
signals O
, O
a O
number O
of O
promoter O
mutations O
were O
constructed O
, O
including O
a O
set O
of O
linker _RARE_
- O
scanning O
mutations O
across O
the O
entire _RARE_
promoter O
region O
. O

A O
DNA O
motif O
related O
to O
the O
cAMP O
- O
responsive O
element O
and O
an O
exon _RARE_
- I-GENE
located _RARE_
activator I-GENE
protein I-GENE
- I-GENE
2 I-GENE
binding I-GENE
site I-GENE
in O
the O
human I-GENE
tissue I-GENE
- I-GENE
type I-GENE
plasminogen I-GENE
activator I-GENE
gene I-GENE
promoter I-GENE
cooperate O
in O
basal O
expression _RARE_
and O
convey _RARE_
activation O
by O
phorbol O
ester O
and O
cAMP O
. O

The O
26S _RARE_
rRNA I-GENE
binding I-GENE
ribosomal I-GENE
protein I-GENE
equivalent O
to O
bacterial I-GENE
protein I-GENE
L11 _RARE_
is O
encoded O
by O
unspliced O
duplicated O
genes O
in O
Saccharomyces O
cerevisiae O
. O

Five O
healthy O
male O
subjects O
inspired _RARE_
air O
for _RARE_
20 O
min O
and O
then O
5 O
% O
CO2 O
/ O
95 _RARE_
% O
O2 _RARE_
for _RARE_
30 _RARE_
min O
, O
of O
which O
the O
first _RARE_
10 O
min O
was O
used O
to O
achieve O
a O
steady O
- O
state O
end O
- O
tidal O
CO2 O
measurement O
. O

Significant O
correlations O
were O
obtained O
between O
changes O
in O
SSEP _RARE_
in O
response O
to O
AS _RARE_
and O
the O
presence O
of O
not O
deep O
residual O
- O
organic O
disturbances O
, O
so O
- O
called O
" O
ground _RARE_
" O
in O
psychogenic _RARE_
disorders O
. O

The O
transcripts O
were O
equally O
active _RARE_
with O
or O
without O
a O
5 O
' O
methylated _RARE_
capstructure _RARE_
as _RARE_
expected O
, O
since O
EMCV _RARE_
- O
RNA O
is O
one O
of O
the O
mRNAs O
capable O
of O
internal O
initiation O
. O

The O
E6 _RARE_
/ O
E7 I-GENE
promoter O
of O
all O
genital _RARE_
human O
papillomaviruses _RARE_
is O
responsible O
for _RARE_
expression _RARE_
of O
the O
viral O
transforming O
genes O
. O

A O
case O
of O
Goodpasture _RARE_
' O
s O
syndrome _RARE_
. O

Seventy O
- O
two O
of O
73 _RARE_
negative O
controls O
and O
all O
positive O
blocks O
as _RARE_
seen O
on O
soft O
tissue O
radiographs O
( O
STRs _RARE_
) O
were O
correctly O
coded O
( O
specificity _RARE_
98 O
. O
6 O
%, O
sensitivity O
100 _RARE_
%). O

No O
symptomatic O
abnormality O
has O
been O
noted O
in O
the O
neonatal O
period O
except O
periventricular _RARE_
calcifications _RARE_
. O

Immunohistochemical _RARE_
analysis O
of O
several O
rat O
organs O
also O
showed O
staining O
in O
epithelial _RARE_
cells O
. O

Both O
strains O
grew _RARE_
very O
poorly O
, O
or O
not O
at _RARE_
all O
, O
on O
nonfermentable _RARE_
carbon O
sources O
and O
exhibited O
, O
at _RARE_
most O
, O
only O
5 O
% O
of O
wild I-GENE
- I-GENE
type I-GENE
ubiquinol _RARE_
- I-GENE
cytochrome I-GENE
c I-GENE
oxidoreductase I-GENE
activity O
. O

Regulation O
of O
irgA _RARE_
by O
iron O
in O
V O
. O
cholerae _RARE_
occurs O
at _RARE_
the O
transcriptional O
level O
, O
and O
there O
is O
an O
interrupted O
dyad _RARE_
symmetric _RARE_
sequence O
in O
the O
vicinity O
of O
the O
promoter O
that O
is O
homologous O
to O
Fur I-GENE
binding I-GENE
sites I-GENE
of O
E O
. O
coli O
. O

Transcription O
of O
the O
first _RARE_
operon O
coding O
for _RARE_
m O
- O
xylene O
- O
degrading _RARE_
enzymes _RARE_
on O
the O
TOL _RARE_
plasmid _RARE_
of O
Pseudomonas _RARE_
putida _RARE_
is O
activated O
by O
the O
xylR _RARE_
gene I-GENE
product I-GENE
in O
the O
presence O
of O
m O
- O
xylene O
. O

The O
recombinant O
contains O
the O
normal O
beta I-GENE
A I-GENE
- I-GENE
globin I-GENE
gene I-GENE
, O
the O
mutant O
gene O
and O
Ylp _RARE_
vector O
sequences O
between O
the O
two O
copies O
. O

Some O
of O
the O
mutations O
obtained O
do O
not O
contain O
a O
copy O
of O
the O
Ulysses _RARE_
element I-GENE
at _RARE_
the O
mutant O
locus O
, O
suggesting O
that O
a O
different O
transposable _RARE_
element O
may O
be O
responsible O
for _RARE_
the O
mutation O
. O

Determination O
of O
diquat _RARE_
in O
biological O
materials O
by O
electron O
spin O
resonance O
spectroscopy O
. O

We O
show O
also O
that O
RA _RARE_
represses O
the O
transcriptional O
activity O
of O
a O
reporter O
gene O
containing O
a O
TPA _RARE_
responding O
AP1 I-GENE
binding I-GENE
site I-GENE
driving _RARE_
the O
HSV I-GENE
tk I-GENE
promoter I-GENE
. O

Moreover O
, O
radiolabeled O
EFI _RARE_
, O
NF _RARE_
- I-GENE
Y I-GENE
, O
or O
CBF I-GENE
DNAs _RARE_
give O
rise O
to O
identical O
gel O
retardation O
patterns O
in O
extracts O
from O
a O
variety O
of O
different O
cell O
types _RARE_
. O

Risk O
factors O
influencing O
lymph O
nodes O
metastasis O
in O
lung _RARE_
cancer _RARE_
with O
stage _RARE_
I O
, O
II O
or O
IIIA _RARE_

Multifunctional _RARE_
protein I-GENE
kinase I-GENE
( O
MFPK _RARE_
) O
phosphorylates O
ATP I-GENE
- I-GENE
citrate _RARE_
lyase I-GENE
on O
peptide I-GENE
B I-GENE
on O
two O
sites O
, O
BT _RARE_
and O
BS _RARE_
, O
on O
threonine O
and O
serine O
, O
respectively O
, O
inhibitor I-GENE
2 I-GENE
on O
a O
threonyl _RARE_
residue _RARE_
, O
and O
glycogen _RARE_
synthase I-GENE
at _RARE_
sites O
2 O
and O
3 O
. O

The O
characterized O
Y I-GENE
' I-GENE
repeated _RARE_
sequence I-GENE
families _RARE_
provide O
an O
experimental O
system _RARE_
in O
which O
repeated _RARE_
sequence O
interactions O
and O
subsequent O
evolution O
can O
be O
studied O
. O

The O
electrically O
induced _RARE_
motile _RARE_
responses O
were O
not O
suppressed O
in O
the O
presence O
of O
dinitrophenol _RARE_
or O
cytochalasin _RARE_
B O
. O

Unlike O
p59v _RARE_
- O
rel _RARE_
, O
which O
is O
a O
nuclear O
protein O
in O
CEF _RARE_
, O
indirect O
immunofluorescence O
showed O
that O
p68c _RARE_
- O
rel _RARE_
in O
JD214c _RARE_
- O
rel _RARE_
infected _RARE_
CEF _RARE_
is O
located _RARE_
exclusively O
in O
the O
cytoplasm O
of O
these O
cells O
, O
even O
though O
the O
sequence O
of O
p68c _RARE_
- O
rel _RARE_
showed O
that O
it O
contains O
a O
nuclear O
localizing _RARE_
sequence O
identical O
to O
the O
one O
previously O
identified O
in O
p59v _RARE_
- O
rel _RARE_
. O

Kinetic _RARE_
experiments O
revealed O
that O
within O
10 O
min O
this O
radiolabeled O
precursor O
protein O
was O
converted O
in O
HL _RARE_
- O
60 _RARE_
cells O
into O
an O
Mr O
approximately _RARE_
150 _RARE_
, O
000 _RARE_
chondroitin _RARE_
sulfate _RARE_
proteoglycan _RARE_
intermediate _RARE_
. O

Blood _RARE_
flow O
and O
velocity O
( O
measured O
using O
Doppler O
ultrasound O
) O
gradually O
decreased O
during _RARE_
diastole _RARE_
and O
ultimately _RARE_
reversed O
in O
direction O
as _RARE_
cotyledon _RARE_
resistance O
was O
increased O
up _RARE_
to O
14 O
fold _RARE_
. O

A O
total _RARE_
of O
112 O
patients O
received O
anistreplase _RARE_
and O
119 O
received O
heparin _RARE_
within O
a O
mean O
period O
of O
188 _RARE_
+/- O
62 _RARE_
min O
following O
the O
onset O
of O
symptoms O
. O

However O
, O
primary _RARE_
transcripts O
of O
a O
variant I-GENE
tRNA I-GENE
( I-GENE
Val _RARE_
)( I-GENE
UAC _RARE_
) I-GENE
gene I-GENE
are O
processing _RARE_
deficient _RARE_
under O
standard O
growth O
conditions O
( O
30 _RARE_
degrees O
C O
), _RARE_
due O
to O
a O
slightly O
altered O
5 O
' O
flanking O
region O
. O

The O
promoter O
activity O
was O
measured O
by O
a O
transient O
expression _RARE_
of O
a O
chloramphenicol I-GENE
acetyltransferase _RARE_
( O
CAT I-GENE
) O
gene O
connected O
with O
various O
5 O
'- O
deletion O
mutants O
of O
the O
5 O
'- O
flanking O
region O
. O

Three O
of O
the O
short O
ORFs _RARE_
in O
the O
central O
region O
of O
BIV _RARE_
have O
been O
identified O
by O
location O
and O
structural O
similarity _RARE_
to O
the O
nonstructural _RARE_
/ O
regulatory O
genes O
( O
vif _RARE_
, O
tat I-GENE
, O
and O
rev _RARE_
) O
of O
other O
lentiviruses _RARE_
; O
we O
also O
discovered O
two O
unique O
ORFs _RARE_
, O
termed O
W _RARE_
and O
Y O
, O
which O
may O
serve O
as _RARE_
exons O
for _RARE_
novel O
genes O
. O

The O
Saccharomyces I-GENE
cerevisiae I-GENE
14DM _RARE_
gene I-GENE
, O
encoding O
cytochrome I-GENE
P450 I-GENE
lanosterol _RARE_
14 I-GENE
alpha I-GENE
- I-GENE
demethylase _RARE_
( O
14DM _RARE_
), _RARE_
was O
overexpressed O
in O
various O
S O
. O
cerevisiae O
strains O
under O
the O
control O
of O
three O
strong O
heterologous O
yeast O
transcription O
promoters O
( O
pADC1 _RARE_
, O
pGPD _RARE_
, O
pPHO5 _RARE_
) O
and O
under O
the O
control O
of O
its O
own O
promoter O
. O

Truncations _RARE_
composed O
of O
78 _RARE_
and O
64 _RARE_
amino O
acids _RARE_
were O
translocated _RARE_
across O
the O
endoplasmic O
reticulum O
membrane O
, O
and O
translocation O
was O
found O
to O
be O
strictly O
co _RARE_
- O
translational O
and O
SRP I-GENE
- O
dependent O
. O

Pulmonary _RARE_
vascular O
resistance O
was O
not O
altered O
, O
ejection O
fraction O
remained O
unchanged O
and O
isovolumic _RARE_
relaxation O
period O
was O
lengthened _RARE_
( O
119 O
+/- O
20 O
. O
1 O
to O
147 _RARE_
. O
39 _RARE_
+/- O
21 O
. O
15 _RARE_
, O
P O
less O
than O
0 _RARE_
. O
05 O
). O

The O
ANB1 _RARE_
locus I-GENE
of O
Saccharomyces O
cerevisiae O
encodes O
the O
protein I-GENE
synthesis _RARE_
initiation I-GENE
factor I-GENE
eIF I-GENE
- I-GENE
4D _RARE_
. O

The O
contribution O
that O
alternative _RARE_
splicing _RARE_
events O
in O
c I-GENE
- I-GENE
myb I-GENE
expression _RARE_
may O
make O
on O
c I-GENE
- I-GENE
myb I-GENE
function O
remains O
to O
be O
elucidated _RARE_
. O

Serum I-GENE
beta I-GENE
2 I-GENE
- I-GENE
microglobulin I-GENE
levels O
( O
beta I-GENE
- I-GENE
2 I-GENE
- I-GENE
M I-GENE
) O
were O
studied O
in O
150 _RARE_
drug O
addicts O
, O
50 O
of O
them O
asymptomatic O
carriers O
of O
anti I-GENE
HIV I-GENE
- I-GENE
1 I-GENE
antibodies I-GENE
, O
50 O
symptomatic O
carriers O
with O
persistent O
generalized O
lymphadenopathy _RARE_
( O
P O
. O
G O
. O
L O
.) O
and O
50 O
serum O
negative O
patients O
who O
had O
been O
living O
in O
a O
closed O
community O
for _RARE_
at _RARE_
least O
2 O
years O
. O

This O
emancipation _RARE_
of O
the O
ability O
to O
copulate _RARE_
from O
hormonal O
influence O
makes O
female O
sexual O
motivation _RARE_
the O
primary _RARE_
regulator O
of O
mating _RARE_
in O
primates O
. O

No O
therapy O
exists O
for _RARE_
halting _RARE_
the O
progression O
of O
the O
disease _RARE_
with O
the O
possible O
exception O
of O
laser O
photocoagulation _RARE_
treatment O
used O
to O
ablate _RARE_
subretinal O
neovascular _RARE_
membranes O
in O
an O
attempt O
to O
avoid O
complications O
of O
subretinal O
hemorrhages _RARE_
. O

R O
. O

Specific O
hyperimmune _RARE_
globulins _RARE_
to O
pathogens O
such O
as _RARE_
Haemophilus O
influenzae O
and O
Streptococcus _RARE_
pneumoniae _RARE_
have O
also O
been O
studied O
. O

Therapeutic _RARE_
effects O
of O
cefpirome _RARE_
( O
HR O
810 _RARE_
) O
on O
experimental O
mixed O
infections O
with O
Enterococcus _RARE_
faecalis _RARE_
and O
Escherichia O
coli O
in O
mice O
. O

Regulation O
of O
yeast I-GENE
LEU2 I-GENE
. O

Homozygous O
individuals O
usually O
develop O
purpura O
fulminans _RARE_
as _RARE_
newborns O
; O
heterozygous _RARE_
protein I-GENE
C I-GENE
- O
deficient _RARE_
individuals O
are O
at _RARE_
increased O
risk O
for _RARE_
venous O
thrombosis O
and O
pulmonary O
embolism _RARE_
. O

Ischemic O
stroke O
due O
to O
protein I-GENE
C I-GENE
deficiency O
. O

TREB7 _RARE_
and O
TREB36 _RARE_
protected O
all O
three O
repeats O
of O
the O
21 O
bp O
, O
but O
TREB5 _RARE_
protected O
only O
the O
second O
repeat O
. O

These O
results O
suggest O
that O
5 O
KE _RARE_
X O
3 O
/ O
W _RARE_
may O
be O
the O
optimal O
regimen O
to O
augment _RARE_
the O
antitumor _RARE_
immunity _RARE_
of O
RNL _RARE_
. O

Analysis O
of O
various O
deletion O
mutants O
indicates O
that O
the O
sequence O
requirements O
for _RARE_
binding O
by O
QBP _RARE_
in O
vitro O
are O
indistinguishable O
from O
those O
necessary O
for _RARE_
Q _RARE_
activity O
in O
vivo O
, O
strongly O
suggesting O
that O
QBP _RARE_
is O
required O
for _RARE_
the O
function O
of O
this O
TATA O
- O
independent O
promoter O
. O

Since O
general _RARE_
regulatory I-GENE
factor I-GENE
I I-GENE
( O
GRFI _RARE_
)/ _RARE_
repressor I-GENE
/ I-GENE
activator I-GENE
site I-GENE
binding I-GENE
protein I-GENE
1 I-GENE
( O
RAP1 _RARE_
)/ _RARE_
translation I-GENE
upstream I-GENE
factor I-GENE
( O
TUF _RARE_
) O
is O
believed O
to O
be O
an O
activator O
of O
MAT _RARE_
alpha I-GENE
expression _RARE_
, O
we O
examined O
whether O
PYK1 _RARE_
, O
which O
is O
known O
to O
be O
regulated O
by O
GRFI _RARE_
/ O
RAP1 _RARE_
/ O
TUF _RARE_
, O
is O
also O
affected O
by O
the O
gal11 _RARE_
mutation I-GENE
. O

Yeast _RARE_
Gal11 _RARE_
protein I-GENE
mediates O
the O
transcriptional O
activation O
signal O
of O
two O
different O
transacting _RARE_
factors O
, O
Gal4 I-GENE
and O
general _RARE_
regulatory I-GENE
factor I-GENE
I I-GENE
/ O
repressor I-GENE
/ I-GENE
activator I-GENE
site I-GENE
binding I-GENE
protein I-GENE
1 I-GENE
/ I-GENE
translation I-GENE
upstream I-GENE
factor I-GENE
. O

Deletion O
from O
either O
the O
N O
- O
or O
C O
- O
terminal O
ends O
of O
repA _RARE_
( O
28 _RARE_
and O
69 _RARE_
codons O
, O
respectively O
, O
out O
of O
the O
286 _RARE_
- O
codon _RARE_
open _RARE_
reading O
frame O
) O
affected O
the O
initiator _RARE_
but O
not O
the O
inhibitory _RARE_
activity O
. O

The O
two O
larger O
peptides O
, O
one O
containing O
amino O
acids _RARE_
1 O
- O
228 _RARE_
and O
the O
other O
containing O
amino O
acids _RARE_
85 _RARE_
- O
228 _RARE_
, O
formed O
dimers _RARE_
in O
solution O
and O
bound _RARE_
DNA O
specifically O
as _RARE_
a O
dimer _RARE_
. O

In O
vitro O
transcription O
extracts O
from O
ret1 _RARE_
- I-GENE
1 I-GENE
cells O
terminate O
less O
efficiently O
at _RARE_
weak O
transcription O
termination _RARE_
signals O
than O
those O
from O
RET1 _RARE_
cells O
, O
using O
a O
variety O
of O
tRNA O
templates O
. O

Guiding _RARE_
patients O
in O
the O
decision _RARE_
should O
involve O
a O
multidisciplinary _RARE_
team _RARE_
composed O
of O
a O
surgical O
oncologist _RARE_
, O
geneticist _RARE_
, O
pathologist _RARE_
, O
psychotherapist _RARE_
and O
plastic _RARE_
surgeon _RARE_
. O

IgG I-GENE
and O
IgM I-GENE
antibody O
activity O
was O
determined O
by O
adding O
a O
1 O
: O
100 _RARE_
dilution O
of O
serum O
to O
plates O
coated _RARE_
with O
A60 _RARE_
antigen I-GENE
. O

These O
factors O
belong O
to O
a O
set O
of O
genetically O
distinct O
molecules O
, O
including O
AP I-GENE
- I-GENE
4 I-GENE
and O
MLTF _RARE_
, O
that O
bind O
to O
the O
CACCTGTC _RARE_
motif O
or O
related O
sequences O
. O

Among O
known O
flea _RARE_
larvae O
, O
the O
genus O
Anomiopsyllus _RARE_
( O
Anomiopsyllinae _RARE_
, O
Anomiopsyllini _RARE_
) O
is O
as _RARE_
distinctive O
in O
larval _RARE_
form O
as _RARE_
are O
the O
adults O
. O

Here O
, O
we O
have O
used O
specific O
antibody O
to O
identify O
and O
characterize O
the O
SSN6 _RARE_
protein I-GENE
. O

These O
latter O
results O
showed O
that O
the O
ABFI _RARE_
protein I-GENE
, O
like O
the O
RAP1 _RARE_
protein I-GENE
, O
bound _RARE_
sequences O
required O
for _RARE_
positive O
as _RARE_
well _RARE_
as _RARE_
negative O
regulation _RARE_
of O
gene O
expression _RARE_
. O

Clinical O
nutrition O
of O
adult O
horses O
. O

The O
computer O
- O
programmed O
cytocentrifuge _RARE_
is O
currently O
most O
popular _RARE_
. O

RNase I-GENE
protection O
assays O
reveal O
that O
this O
gene O
, O
unr _RARE_
, O
is O
transcribed _RARE_
in O
the O
same O
direction O
as _RARE_
N I-GENE
- I-GENE
ras I-GENE
and O
that O
its O
3 O
' O
end O
is O
located _RARE_
just O
130 _RARE_
base _RARE_
pairs _RARE_
away _RARE_
from O
the O
point O
at _RARE_
which O
N I-GENE
- I-GENE
ras I-GENE
transcription O
begins O
. O

Isolation O
of O
a O
temperature _RARE_
- O
sensitive _RARE_
mutant O
with O
an O
altered O
tRNA I-GENE
nucleotidyltransferase _RARE_
and O
cloning O
of O
the O
gene I-GENE
encoding I-GENE
tRNA I-GENE
nucleotidyltransferase _RARE_
in I-GENE
the I-GENE
yeast I-GENE
Saccharomyces I-GENE
cerevisiae I-GENE
. O

The O
juxtamembrane _RARE_
region O
of O
the O
insulin I-GENE
receptor I-GENE
( I-GENE
IR I-GENE
) I-GENE
beta I-GENE
- I-GENE
subunit I-GENE
contains O
an O
unphosphorylated _RARE_
tyrosyl _RARE_
residue _RARE_
( O
Tyr960 _RARE_
) O
that O
is O
essential O
for _RARE_
insulin I-GENE
- O
stimulated _RARE_
tyrosyl _RARE_
phosphorylation _RARE_
of O
some O
endogenous O
substrates _RARE_
and O
certain O
biological O
responses O
( O
White _RARE_
, O
M O
. O
F O
., O
Livingston _RARE_
, O
J _RARE_
. O
N O
., O
Backer _RARE_
, O
J _RARE_
. O
M O
., O
Lauris _RARE_
, O
V O
., O
Dull _RARE_
, O
T O
. O
J _RARE_
., O
Ullrich _RARE_
, O
A O
., O
and O
Kahn _RARE_
, O
C O
. O
R O
. O

This O
gene O
joins O
the O
group O
of O
genes O
whose O
members O
are O
rapidly O
transcribed _RARE_
in O
response O
to O
insulin I-GENE
and O
other O
mitogens _RARE_
. O

The O
3 O
' O
region O
, O
GA2 _RARE_
, O
is O
necessary O
for _RARE_
maximal O
expression _RARE_
. O

1 O
, O
among O
which O
nine O
have O
been O
cloned _RARE_
and O
two O
( O
potentially O
functional _RARE_
) O
sequenced O
. O

Pups _RARE_
placed O
into O
the O
novel O
environment O
with O
their O
mothers O
exhibited O
an O
intermediate _RARE_
level O
of O
DA _RARE_
turnover O
. O

The O
efficacy O
and O
safety O
of O
a O
novel O
percutaneous _RARE_
anaesthetic _RARE_
preparation O
based O
on O
amethocaine _RARE_
has O
been O
investigated O
in O
the O
paediatric _RARE_
clinical O
environment O
. O

Homozygous O
protein I-GENE
C I-GENE
( O
PC I-GENE
) O
deficiency O
is O
reported O
in O
two O
siblings _RARE_
( O
girl _RARE_
and O
boy _RARE_
) O
who O
received O
their O
proper O
diagnoses _RARE_
at _RARE_
the O
ages O
of O
7 O
4 O
/ O
12 O
and O
1 O
3 O
/ O
12 O
years O
respectively O
. O

The O
grandfather _RARE_
and O
the O
granddaughter _RARE_
both O
had O
microtia _RARE_
and O
meatal _RARE_
atresia _RARE_
, O
whereas O
the O
daughter O
had O
a O
normal O
outer _RARE_
ear O
except O
for _RARE_
a O
narrow O
meatus _RARE_
and O
auricular _RARE_
appendages _RARE_
. O

Abnormal O
intrapulmonary _RARE_
shunting _RARE_
( O
IPS _RARE_
), _RARE_
which O
was O
proved O
in O
4 O
cases O
by O
whole O
- O
body O
radionuclide _RARE_
scanning O
with O
99mTc O
- O
MAA _RARE_
, O
is O
suggested O
as _RARE_
the O
major O
cause O
of O
cyanosis _RARE_
in O
liver O
cirrhosis O
. O

The O
urinary _RARE_
protein O
, O
serum O
albumin I-GENE
, O
BUN _RARE_
and O
SCr _RARE_
all O
had O
very O
significant O
improvement O
. O

More O
generally O
, O
Ets1 _RARE_
and O
Ets2 _RARE_
could O
regulate O
transcription O
of O
cellular O
genes O
. O

Within O
this O
sequence O
the O
MSAS _RARE_
gene I-GENE
was O
identified O
as _RARE_
a O
5322 _RARE_
- O
bp O
- O
long O
open _RARE_
reading O
frame O
coding O
for _RARE_
a O
protein O
of O
1774 _RARE_
amino O
acids _RARE_
and O
190 O
, O
731 _RARE_
Da _RARE_
molecular _RARE_
mass O
. O

Horseradish _RARE_
peroxidase I-GENE
as _RARE_
a O
permeability _RARE_
marker O
in O
injured _RARE_
rat O
caudal _RARE_
and O
iliac O
arteries O
. O

Standardized _RARE_
gastric _RARE_
wall _RARE_
specimens O
from O
the O
area O
of O
grossly _RARE_
healed _RARE_
ulcers O
were O
obtained O
, O
processed O
, O
and O
evaluated O
by O
light O
microscopy O
and O
by O
transmission _RARE_
electron O
microscopy O
. O

2 O
. O

The O
effects O
of O
coenzyme _RARE_
Q10 _RARE_
( O
CoQ _RARE_
) O
and O
captopril O
on O
functional _RARE_
capacity O
, O
hemodynamics O
and O
survival O
were O
studied O
in O
154 O
rats O
that O
recovered O
after O
experimental O
myocardial _RARE_
infarction O
. O

Evidence O
that O
therapeutic O
alterations O
of O
a O
circadian O
rhythm O
for _RARE_
gastric _RARE_
emptying O
response O
may O
be O
possible O
. O

The O
interrelation _RARE_
of O
the O
levels O
of O
glucocorticoids O
and O
insulin I-GENE
in O
the O
blood _RARE_
of O
irradiated O
animals O

This O
last O
includes O
tissue O
O2 _RARE_
transfer O
( O
Ft O
') _RARE_
and O
mitochondrial O
O2 _RARE_
utilization O
( O
Fm _RARE_
'). _RARE_

Foveating _RARE_
saccades _RARE_
, O
therefore O
, O
can O
be O
distinguished O
from O
other O
FEMs _RARE_
on O
the O
basis O
of O
speed _RARE_
. O

Incidence _RARE_
correlated O
with O
the O
grade O
of O
oral O
hygiene _RARE_
und _RARE_
periodontal O
disease _RARE_
. O

Our O
study O
shows O
that O
the O
area O
of O
Alcoy _RARE_
is O
a O
medium O
MS O
risk O
region O
according O
to O
the O
thesis _RARE_
of O
Kurzke _RARE_
, O
although O
high O
MS O
areas O
may O
be O
found O
, O
thus O
confirming O
that O
MS O
distribution O
in O
southern O
Europe _RARE_
is O
not O
uniform O
. O

On O
an O
antithrombin I-GENE
unit O
basis O
, O
CY _RARE_
216 _RARE_
and O
CY _RARE_
222 _RARE_
were O
equivalent O
and O
more O
potent O
than O
UH _RARE_
. O

Chick _RARE_
brain I-GENE
actin I-GENE
depolymerizing _RARE_
factor I-GENE
( O
ADF _RARE_
) O
is O
a O
19 O
- O
kDa O
protein O
that O
severs _RARE_
actin I-GENE
filaments _RARE_
and O
binds O
actin I-GENE
monomers _RARE_
. O

Initial O
experience O
with O
a O
serotonin _RARE_
agonist O
. O

Comprehensive _RARE_
care O
of O
the O
patient O
exposed O
to O
a O
human O
teratogen _RARE_
may O
also O
include O
discussion O
of O
prenatal _RARE_
diagnostic O
procedures O
and O
other O
pregnancy _RARE_
management O
options _RARE_
. O

Primer O
extension O
analysis O
and O
RNA O
sequencing O
demonstrates O
that O
the O
transcription O
start _RARE_
point O
of O
rat I-GENE
ODC _RARE_
mRNA I-GENE
is O
located _RARE_
303 _RARE_
nt O
upstream O
from O
the O
A O
residue _RARE_
in O
the O
start _RARE_
codon _RARE_
. O

For O
85Sr _RARE_
, O
larger O
- O
than O
- O
expected O
distribution O
coefficients O
were O
obtained O
in O
the O
desorption _RARE_
experiments O
, O
an O
indication O
of O
the O
irreversible O
formation O
of O
metal O
- O
oxyhydroxides _RARE_
during _RARE_
a O
slow O
reaction O
. O

Gene _RARE_
constructs O
possessing _RARE_
the O
complete _RARE_
tat I-GENE
, O
rev _RARE_
( O
tat I-GENE
+ I-GENE
rev _RARE_
+) O
and O
env I-GENE
genes I-GENE
were O
transiently O
expressed _RARE_
in O
COS O
- O
1 O
cells O
as _RARE_
precursor I-GENE
SU _RARE_
- I-GENE
TM _RARE_
( O
gp160 _RARE_
), _RARE_
SU _RARE_
. I-GENE
TM _RARE_
( O
gp120 I-GENE
x _RARE_
41 _RARE_
), _RARE_
and O
nucleolar _RARE_
rev _RARE_
protein I-GENE
. O

This O
growth O
arrest O
is O
partly O
suppressed O
on O
minimal O
medium O
or O
under O
conditions O
in O
which O
the O
cells O
are O
less O
dependent O
on O
mitochondrial O
metabolism O
. O

Patients O
with O
detectable O
serum O
TNF I-GENE
levels O
had O
significantly O
lower O
serum O
T3 _RARE_
concentrations O
compared O
to O
those O
with O
undetectable O
levels O
[ _RARE_
1 O
. O
072 _RARE_
+/- O
0 _RARE_
. O
588 _RARE_
vs _RARE_
. O

Giant _RARE_
pilomatrix _RARE_
carcinoma O
: O
report O
and O
review O
of O
the O
literature O
. O

Further O
studies O
of O
mandibular O
movement O
at _RARE_
initial O
tooth O
contact _RARE_
. O

Each O
parent _RARE_
interacted O
with O
their O
4 O
- O
or O
5 O
- O
year O
- O
old O
son _RARE_
or O
daughter O
in O
each O
of O
two O
conversations _RARE_
-- _RARE_
unstructured _RARE_
( O
social O
conversation _RARE_
) O
and O
structured O
( O
task O
activity O
). O

Droperidol _RARE_
- O
induced _RARE_
extrapyramidal _RARE_
symptoms O
in O
an O
adolescent O
following O
strabismus _RARE_
surgery O
. O

These O
results O
indicate O
that O
the O
cis O
- O
regulatory O
elements O
required O
for _RARE_
developmental O
control O
of O
the O
HaG3 _RARE_
- I-GENE
A I-GENE
helianthinin _RARE_
gene I-GENE
are O
located _RARE_
in O
a O
2 O
. O
4 O
kb O
upstream O
region O
of O
this O
gene O
. O

The O
induction O
by O
pseudorabies O
virus O
of O
an O
IL _RARE_
- I-GENE
6 I-GENE
construct I-GENE
containing O
the O
IL _RARE_
- I-GENE
6 I-GENE
TATA I-GENE
box I-GENE
and O
the O
RNA O
start _RARE_
site O
(" O
initiator _RARE_
" O
or O
Inr _RARE_
element O
) O
but O
not O
the O
MRE _RARE_
region O
was O
also O
repressed O
by O
Dex _RARE_
in O
the O
presence O
of O
wild I-GENE
- I-GENE
type I-GENE
GR I-GENE
. O

Some O
mutations O
affected O
Dhfr _RARE_
in O
a O
qualitative O
manner O
, O
such O
as _RARE_
by O
changing O
the O
startpoint _RARE_
of O
one O
of O
the O
major O
Dhfr _RARE_
transcripts I-GENE
or O
changing O
the O
relative O
abundance O
of O
the O
two O
major O
Dhfr _RARE_
transcripts I-GENE
. O

The O
glial _RARE_
cyst O
wall _RARE_
was O
lined _RARE_
in O
part O
by O
flattened _RARE_
or O
cuboidal _RARE_
epithelium O
. O

We O
conclude O
that O
class O
I O
cytologic _RARE_
smears O
with O
moderate O
to O
severe O
inflammation O
may O
be O
associated O
with O
findings O
of O
condylomata _RARE_
and O
cervical O
dysplasia O
. O

As O
in O
mammals O
, O
considerable O
nucleotide O
diversity O
was O
observed O
at _RARE_
the O
junctions O
of O
the O
variable _RARE_
, O
diversity O
, O
and O
joining _RARE_
elements O
in O
chicken I-GENE
TCR I-GENE
beta I-GENE
cDNAs I-GENE
. O

The O
protooncogene _RARE_
c I-GENE
- I-GENE
myb I-GENE
encodes O
a O
nuclear O
transcription O
factor O
that O
binds O
to O
DNA O
in O
a O
sequence O
- O
specific O
manner O
and O
transactivates O
transcription O
of O
several O
viral O
and O
cellular O
genes O
. O

Modification _RARE_
by O
this O
latter O
compound O
was O
so O
extensive O
that O
the O
amount O
of O
membrane O
- O
associated O
N O
- O
myristoylated _RARE_
protein O
was O
decreased O
. O

S6 I-GENE
kinase I-GENE
activation O
requires O
displacement _RARE_
of O
this O
inhibitory _RARE_
segment O
, O
which O
is O
proposed O
to O
occur O
consequent _RARE_
to O
its O
multiple O
phosphorylation _RARE_
. O

Rats _RARE_
with O
one O
olfactory O
bulb O
removed O
and O
the O
contralateral O
naris _RARE_
closed O
can O
detect O
odors _RARE_
. O

Expression O
of O
the O
human O
T I-GENE
cell I-GENE
receptor I-GENE
( I-GENE
TCR I-GENE
) I-GENE
alpha I-GENE
gene I-GENE
is O
regulated O
by O
a O
T O
cell O
- O
specific O
transcriptional O
enhancer O
that O
is O
located _RARE_
4 O
. O
5 O
kilobases O
( O
kb O
) O
3 O
' O
to O
the O
C I-GENE
alpha I-GENE
gene I-GENE
segment I-GENE
. O

The O
Ets I-GENE
- I-GENE
1 I-GENE
binding I-GENE
site I-GENE
was O
localized O
to O
a O
17 _RARE_
- O
base _RARE_
pair _RARE_
( O
bp O
) O
region O
from O
the O
3 O
' O
end O
of O
T I-GENE
alpha I-GENE
2 I-GENE
. O

Cerebral _RARE_
flow O
and O
resistance O
showed O
minor O
reductions O
with O
HD O
. O

Utilization _RARE_
of O
alternative _RARE_
polyadenylation O
signals O
was O
previously O
shown O
to O
generate O
two O
sialophorin _RARE_
mRNAs I-GENE
of I-GENE
1 I-GENE
. I-GENE
9 I-GENE
and I-GENE
4 I-GENE
. I-GENE
3 I-GENE
kb I-GENE
, O
which O
differ O
in O
the O
length O
of O
their O
3 O
' O
untranslated _RARE_
regions O
. O

Presidential _RARE_
address O
1990 O
-- _RARE_
coming _RARE_
in O
from O
the O
cold O
. O

Human O
T O
- O
cell O
leukemia O
virus O
type O
I O
( O
HTLV _RARE_
- O
I O
) O
encodes O
a O
40 O
- O
kDa O
nuclear O
protein O
, O
Tax _RARE_
, O
which O
stimulates O
transcription O
from O
three O
21 O
- O
base _RARE_
pair _RARE_
( O
bp O
) O
repeats O
in O
its O
U3 _RARE_
region O
. O

We O
have O
now O
identified O
, O
after O
21 O
serial O
undiluted _RARE_
passages _RARE_
of O
MHV _RARE_
, O
a O
small I-GENE
DI _RARE_
RNA I-GENE
, O
DIssF _RARE_
, O
which O
is O
efficiently O
packaged _RARE_
into O
virions O
. O

The O
Jenkins _RARE_
Activity _RARE_
Survey _RARE_
and O
the O
CPI _RARE_
- O
revised O
: O
further O
evidence O
of O
adaptive O
and O
maladaptive _RARE_
type O
A O
traits _RARE_
. O

There O
was O
evidence O
of O
attenuated O
regression O
slopes _RARE_
relating _RARE_
recalled _RARE_
to O
observed O
portion O
sizes O
for _RARE_
4 O
of O
the O
10 O
food O
groups O
; O
adjusted O
r2 _RARE_
values O
for _RARE_
the O
recalled _RARE_
portion O
sizes O
ranged O
from O
0 _RARE_
. O
02 O
to O
0 _RARE_
. O
94 O
. O

The O
result O
suggests O
that O
this O
non O
- O
invasive O
TTD _RARE_
method O
is O
easily O
available O
and O
useful O
in O
monitoring O
the O
intraoperative _RARE_
cardiac O
output O
. O

The O
TUP1 _RARE_
gene I-GENE
was O
isolated O
in O
a O
screen O
for _RARE_
genes O
that O
regulate O
mating _RARE_
type O
( O
V O
. O
L O
. O

The O
SUP44 _RARE_
suppressor I-GENE
mutation I-GENE
occurs O
near O
a O
region O
of O
the O
protein O
that O
corresponds O
to O
the O
known O
positions O
of O
alterations O
in O
E I-GENE
. I-GENE
coli I-GENE
S5 _RARE_
ram _RARE_
mutations I-GENE
. O

Interestingly O
, O
disruption O
of O
the O
VPS34 _RARE_
locus I-GENE
resulted O
in O
a O
temperature _RARE_
- O
sensitive _RARE_
growth O
defect O
, O
indicating O
that O
the O
VPS34 _RARE_
gene I-GENE
is O
essential O
for _RARE_
vegetative _RARE_
growth O
only O
at _RARE_
elevated O
growth O
temperatures O
. O

We O
describe O
a O
case O
of O
a O
perinephric _RARE_
abscess O
treated O
with O
amphotericin O
B O
and O
nephrectomy _RARE_
. O

This O
, O
together O
with O
the O
data O
obtained O
with O
haloperidol O
, O
suggests O
that O
a O
minimal O
increase O
in O
the O
firing _RARE_
rate O
of O
LC _RARE_
cells O
(+ O
140 _RARE_
%) O
is O
required O
before O
it O
could O
influence O
the O
turnover O
of O
NA O
, O
as _RARE_
measured O
by O
DOPAC _RARE_
changes O
. O

This O
interaction O
occurs O
over O
a O
wide O
range O
of O
both O
parameters O
; O
for _RARE_
charge _RARE_
density O
from O
at _RARE_
least O
10 O
to O
800 O
microC _RARE_
/ O
cm2 O
and O
, O
for _RARE_
charge _RARE_
per O
phase _RARE_
, O
from O
at _RARE_
least O
0 _RARE_
. O
05 O
to O
5 O
. O
0 _RARE_
microC _RARE_
per O
phase _RARE_
. O

Perceptions _RARE_
of O
illness O
intrusiveness _RARE_
were O
significantly O
higher _RARE_
when O
both O
muscle O
cramp _RARE_
and O
headache O
symptoms O
occurred O
during _RARE_
one O
or O
more O
assessment O
intervals O
as _RARE_
compared O
to O
when O
muscle O
cramps _RARE_
or O
headaches _RARE_
, O
only O
, O
occurred O
. O

Results O
have O
surprisingly _RARE_
revealed O
the O
presence O
of O
three O
U14 I-GENE
snRNA _RARE_
- I-GENE
homologous I-GENE
regions I-GENE
positioned O
within O
introns _RARE_
5 O
, O
6 O
, O
and O
8 O
of O
the O
mouse O
cognate _RARE_
hsc70 _RARE_
heat O
shock O
gene O
. O

65 O
- O
kilodalton _RARE_
protein O
phosphorylated _RARE_
by O
interleukin I-GENE
2 I-GENE
stimulation _RARE_
bears _RARE_
two O
putative O
actin I-GENE
- I-GENE
binding I-GENE
sites I-GENE
and O
two O
calcium _RARE_
- O
binding O
sites O
. O

The O
highly O
restrained _RARE_
girls O
had O
a O
significantly O
higher _RARE_
EAT _RARE_
score O
than O
the O
low O
- O
restrained _RARE_
girls O
, O
and O
shared O
with O
their O
mothers O
a O
susceptibility _RARE_
to O
the O
disinhibitory _RARE_
effects O
of O
negative O
mood _RARE_
states O
on O
their O
eating _RARE_
behaviour O
. O

The O
Mauriceville _RARE_
and O
Varkud _RARE_
mitochondrial O
plasmids O
are O
closely O
related O
, O
closed O
- O
circular O
DNAs _RARE_
( O
3 O
. O
6 O
and O
3 O
. O
7 O
kb O
, O
respectively O
) O
that O
have O
characteristics O
of O
mtDNA _RARE_
introns _RARE_
and O
retroid _RARE_
elements O
. O

The O
circadian O
rhythm O
, O
however O
, O
was O
not O
affected O
and O
the O
difference O
between O
minimum O
( O
12 O
. O
00 O
h O
) O
and O
maximum O
( O
18 O
. O
50 O
h O
) O
serum O
concentrations O
was O
31 _RARE_
. O
3 O
%. O

Sequence O
and O
genetic O
organization O
of O
a O
Zymomonas _RARE_
mobilis _RARE_
gene O
cluster O
that O
encodes O
several O
enzymes _RARE_
of O
glucose O
metabolism O
. O

Most O
strains O
( O
95 _RARE_
%) O
of O
S O
. O
lugdunensis _RARE_
produced O
a O
delta I-GENE
hemolysin _RARE_
like O
that O
seen O
with O
nine O
other O
species O
of O
CNS O
. O

For O
this O
, O
cDNAs O
containing O
the O
60K _RARE_
, O
87K _RARE_
, O
110K _RARE_
and O
170K _RARE_
protein O
coding O
sequences O
were O
each O
provided O
with O
an O
ATG O
start _RARE_
codon _RARE_
and O
the O
cDNA O
containing O
the O
60K _RARE_
coding O
sequence O
with O
a O
TAA _RARE_
stop O
codon _RARE_
immediately O
downstream _RARE_
of O
the O
coding O
sequence O
. O

Finally O
, O
a O
complementary _RARE_
footprinting O
analysis O
of O
the O
upstream O
region O
of O
the O
constitutively O
expressed _RARE_
HSC82 _RARE_
gene I-GENE
reveals O
the O
presence O
of O
three O
discrete O
protein O
complexes O
. O

Pathophysiology _RARE_
of O
bone O
loss _RARE_
in O
castrated _RARE_
animals O
. O

Auditory _RARE_
- O
visual O
interaction O
in O
the O
generation O
of O
saccades _RARE_
in O
man O
. O

First O
, O
each O
lung _RARE_
was O
cut O
into O
slices _RARE_
, O
from O
which O
primary _RARE_
disectors _RARE_
were O
sampled _RARE_
systematically O
with O
a O
known O
sampling O
fraction O
. O

The O
upstream O
promoter O
is O
located _RARE_
within O
the O
coding O
sequence O
of O
a O
divergent O
gene O
expressing O
a O
protein O
of O
Mr O
39 _RARE_
kDa O
of O
unknown O
function O
. O

Assuming _RARE_
O2 _RARE_
consumption O
of O
the O
isolated O
skin _RARE_
to O
be O
same O
as _RARE_
in O
situ O
, O
calculations _RARE_
showed O
that O
when O
water O
PO2 O
was O
high O
( O
150 _RARE_
mm O
Hg O
), _RARE_
about O
40 O
% O
of O
total _RARE_
cutaneous O
O2 _RARE_
uptake O
was O
consumed _RARE_
by O
the O
skin _RARE_
. O

Experiments O
showed O
that O
temporary O
arrest O
of O
pulmonary O
circulation O
under O
conditions O
of O
extracorporeal _RARE_
circulation O
is O
attended _RARE_
by O
the O
development O
of O
ischemia O
of O
the O
respiratory O
pulmonary O
tissue O
. O

MCh _RARE_
infusion O
caused O
a O
concentration O
- O
dependent O
increase O
in O
airway O
resistance O
at _RARE_
constant O
QBA _RARE_
. O

Taste _RARE_
reactivity O
tests O
were O
used O
to O
examine O
the O
orofacial _RARE_
responses O
of O
alcohol _RARE_
preferring _RARE_
( O
P O
) O
rats O
and O
alcohol _RARE_
nonpreferring _RARE_
( O
NP _RARE_
) O
rats O
to O
the O
taste O
of O
alcohol _RARE_
. O

Plasma O
concentrations O
of O
atracurium _RARE_
and O
laudanosine _RARE_
were O
0 _RARE_
. O
73 _RARE_
- O
3 O
. O
11 O
micrograms O
ml O
- O
1 O
and O
0 _RARE_
. O
48 _RARE_
- O
8 O
. O
65 O
micrograms O
ml O
- O
1 O
, O
respectively O
; O
CSF O
concentration O
of O
laudanosine _RARE_
was O
70 O
- O
440 O
ng _RARE_
ml O
- O
1 O
. O

Plasma O
Al O
was O
obtained O
during _RARE_
each O
baseline O
and O
drug O
course O
. O

The O
survival O
in O
the O
case O
of O
these O
patients O
was O
studied O
five O
years O
later O
. O

The O
occurrence O
, O
maintenance _RARE_
and O
possible O
involvement O
of O
these O
repeated _RARE_
sequences O
, O
capable O
of O
forming O
stable O
secondary O
structures _RARE_
, O
are O
discussed O
in O
relation O
to O
their O
location O
in O
the O
region O
of O
control O
signals O
. O

IST _RARE_
is O
not O
the O
RNA O
target O
( O
TAR _RARE_
) O
for _RARE_
Tat I-GENE
trans _RARE_
- O
activation O
; O
however O
, O
because O
it O
relies _RARE_
entirely O
on O
cellular O
factors O
for _RARE_
activity O
, O
IST _RARE_
may O
serve O
to O
provide O
abundant O
RNA O
targets _RARE_
for _RARE_
Tat I-GENE
trans _RARE_
- O
activation O
without O
a O
requirement O
for _RARE_
full O
- O
length O
viral O
mRNA O
expression _RARE_
. O

Genotoxic _RARE_
activity O
of O
a O
tobacco O
- O
specific O
nitrosamine _RARE_
. O

The O
endodontal _RARE_
treatment O
need O
has O
been O
forming O
a O
clinical O
order O
of O
magnitude O
. O

1 O
(" O
long O
method O
") _RARE_
and O
the O
HML _RARE_
method O
. O

These O
results O
may O
suggest O
involvement O
of O
peripheral O
enkephalins _RARE_
in O
pain O
modulation O
in O
patients O
with O
episodic _RARE_
cluster O
headache O
. O

Effects O
of O
cisapride _RARE_
on O
upper O
- O
gastrointestinal _RARE_
motility _RARE_
and O
digestive _RARE_
hormones _RARE_

Common _RARE_
foot O
pathologies _RARE_
are O
heel _RARE_
pain O
, O
metatarsalgia _RARE_
, O
hammertoes _RARE_
and O
clawtoes _RARE_
, O
bunions _RARE_
, O
hallux _RARE_
rigidus _RARE_
, O
corns _RARE_
and O
calluses _RARE_
, O
nail _RARE_
pathologies _RARE_
, O
arthritis O
, O
and O
neuropathies _RARE_
. O

Liver O
dysfunction O
in O
the O
presence O
of O
different O
adverse O
reactions O
presented O
with O
a O
higher _RARE_
activity O
in O
the O
blood _RARE_
serum O
of O
indicator O
liver O
enzymes _RARE_
and O
its O
impaired O
protein O
- O
forming O
function O
. O

Coenzyme _RARE_
Q10 _RARE_
: O
blood _RARE_
levels O
and O
metabolic O
demand O
. O

The O
CT _RARE_
characteristics O
are O
discussed O
and O
the O
recent O
literature O
is O
reviewed O
. O

Unfortunately _RARE_
, O
these O
preservatives _RARE_
may O
also O
interfere _RARE_
with O
microbiological _RARE_
assays O
used O
to O
determine O
product O
sterility _RARE_
or O
bioburden _RARE_
levels O
. O

In O
26 _RARE_
patients O
with O
angina O
pectoris O
, O
the O
changes O
of O
LVEF O
, O
LVESV _RARE_
and O
PSP _RARE_
/ O
LVESV _RARE_
were O
more O
sensitive _RARE_
for _RARE_
the O
detection O
of O
exercise O
- O
induced _RARE_
ischemia O
than O
the O
appearance O
of O
chest O
pain O
and O
the O
changes O
of O
ECG O
. O

In O
both O
groups O
there O
were O
5 O
management O
failure O
of O
therapy O
, O
so O
that O
alternative _RARE_
medication O
or O
a O
cesarean _RARE_
section O
lead O
to O
delivery O
. O

Serum O
Fibrin _RARE_
Degradation _RARE_
Products _RARE_
( O
FDP _RARE_
) O
were O
determined O
in O
50 O
oral O
cancer _RARE_
patients O
and O
50 O
normal O
individuals O
prior O
to O
any O
kind _RARE_
of O
treatment O
. O

The O
uteroglobin _RARE_
promoter I-GENE
contains O
a O
noncanonical _RARE_
estrogen O
responsive O
element O
. O

Prostaglandin _RARE_
synthesis _RARE_
inhibitors _RARE_
have O
been O
shown O
to O
delay O
healing O
of O
bone O
and O
this O
has O
led O
to O
limitations O
on O
their O
use O
clinically O
in O
some O
situations O
. O

The O
inspiratory O
oxygen O
concentration O
needed O
( O
FiO2 _RARE_
) O
and O
the O
Horowitz _RARE_
quotient _RARE_
differed O
in O
a O
highly O
significant O
manner O
beginning O
on O
the O
1st _RARE_
day O
after O
trauma O
. O

The O
corn _RARE_
and O
mineral O
oil O
emulsions _RARE_
were O
almost O
as _RARE_
effective O
as _RARE_
milk O
but O
less O
effective O
than O
sucrose O
( O
0 _RARE_
. O
3M _RARE_
) O
in O
stimulating O
ingestion O
. O

Significance O
of O
thin O
glomerular O
basement _RARE_
membranes O
in O
hematuric _RARE_
children O
. O

Significance O
of O
cytokine _RARE_
production O
and O
adhesion O
molecules O
in O
malarial _RARE_
immunopathology _RARE_
. O

The O
former O
procedure O
is O
economical _RARE_
but O
complicated O
, O
whereas O
the O
latter O
is O
simple O
and O
labour O
- O
saving _RARE_
, O
but O
a O
special _RARE_
ultrafiltration _RARE_
tube O
is O
required O
. O

Simple _RARE_
method O
for _RARE_
determination O
of O
the O
cephalosporin _RARE_
DQ _RARE_
- O
2556 _RARE_
in O
biological O
fluids O
by O
high O
- O
performance O
liquid O
chromatography O
. O

Since O
one O
group O
of O
adolescents _RARE_
more O
difficult O
to O
influence O
are O
those O
whose O
parents O
smoke O
, O
parental O
involvement O
in O
smoking O
prevention O
may O
be O
a O
powerful _RARE_
enhancer O
. O

Further O
research O
is O
recommended O
to O
identify O
the O
coping _RARE_
styles _RARE_
associated O
with O
the O
high O
EE _RARE_
/ O
low O
EE _RARE_
research O
classification O
. O

Staining _RARE_
with O
IF O
MoAB _RARE_
alone O
of O
BAL _RARE_
fluid _RARE_
only O
seemed _RARE_
to O
be O
even O
more O
sensitive _RARE_
than O
silver O
methenamine _RARE_
staining O
of O
BAL _RARE_
, O
TBB _RARE_
and O
brushing _RARE_
material O
. O

Ultrastructural _RARE_
and O
morphometric _RARE_
study O
of O
the O
myeloid _RARE_
parenchyma O
cells O
of O
mice O
prior O
and O
after O
X O
- O
ray O
exposure O

Using O
an O
audiotape _RARE_
cassette _RARE_
and O
headphones _RARE_
the O
duration O
of O
the O
hallucinations _RARE_
decreased O
significantly O
. O

The O
mean O
change O
in O
HbA1 _RARE_
, O
adjusted O
for _RARE_
the O
initial O
value O
, O
was O
- O
0 _RARE_
. O
4 O
% O
in O
the O
experimental O
and O
+ O
0 _RARE_
. O
5 O
% O
in O
the O
control O
group O
( O
p O
less O
than O
0 _RARE_
. O
05 O
). O

Effect O
of O
biliary O
obstruction O
and O
cholangitis _RARE_
on O
serum I-GENE
SPan _RARE_
- I-GENE
1 I-GENE
level O

Very _RARE_
good O
accuracy O
( O
r _RARE_
greater O
than O
0 _RARE_
. O
9 O
) O
was O
found O
when O
except O
comparing O
H O
* _RARE_
2 O
with O
the O
other O
machine O
and O
the O
reference O
methods O
, O
except O
for _RARE_
MCHCH _RARE_
and O
basophil _RARE_
count O
. O

The O
second O
part O
of O
this O
paper O
shows O
some O
medical O
applications O
of O
these O
two O
aspects O
of O
NMR O
, O
with O
help O
of O
some O
examples O
, O
taken O
from O
the O
literature O
, O
according O
to O
what O
is O
concerned _RARE_
with O
endocrinology _RARE_
. O

Interlimb _RARE_
coordination O
during _RARE_
fictive _RARE_
locomotion _RARE_
in O
the O
thalamic _RARE_
cat _RARE_
. O

Antileukoproteinase _RARE_
( O
ALP _RARE_
) O
is O
a O
low O
mol O
wt O
mucosal _RARE_
secretory _RARE_
protein O
which O
, O
in O
human O
tissues O
, O
inhibits O
the O
activities O
of O
the O
neutral O
serine I-GENE
lysosomal _RARE_
proteinases _RARE_
elastase I-GENE
and O
cathepsin _RARE_
- I-GENE
G I-GENE
. O

By O
introducing _RARE_
a O
series O
of O
deletions O
in O
the O
vimentin _RARE_
promoter O
, O
we O
further O
restrict _RARE_
these O
sequences O
to O
30 _RARE_
base _RARE_
pairs _RARE_
, O
located _RARE_
between O
241 _RARE_
and O
210 O
base _RARE_
pairs _RARE_
upstream O
of O
the O
mRNA O
cap _RARE_
site O
. O

In O
particular O
, O
71 _RARE_
and O
69 _RARE_
% O
amino O
acid O
sequence O
similarities O
were O
identified O
with O
hsp70 I-GENE
of I-GENE
Escherichia I-GENE
coli I-GENE
and I-GENE
Bacillus I-GENE
megaterium _RARE_
, O
respectively O
. O

No O
causal _RARE_
relations O
may O
be O
inferred _RARE_
from O
the O
correlation O
between O
the O
level O
of O
trapezius _RARE_
activity O
and O
complaints _RARE_
, O
though O
it O
indicates O
that O
individual O
, O
inexpedient _RARE_
muscle O
activity O
patterns O
may O
constitute O
an O
important O
risk O
factor O
for _RARE_
development O
of O
musculo _RARE_
- O
skeletal O
complaints _RARE_
. O

All O
89 _RARE_
participating _RARE_
household _RARE_
members O
were O
anti I-GENE
- I-GENE
HIV I-GENE
seronegative _RARE_
, O
and O
78 _RARE_
who O
were O
tested O
were O
serum I-GENE
p24 _RARE_
antigen I-GENE
negative O
. O

Analysis O
with O
additional O
anti O
- O
peptide O
antibodies O
specific O
for _RARE_
alpha I-GENE
, I-GENE
beta I-GENE
, I-GENE
or I-GENE
gamma I-GENE
PKC I-GENE
indicated O
that O
all O
three O
types _RARE_
of O
PKC I-GENE
are O
expressed _RARE_
in O
JK _RARE_
cells O
; O
however O
, O
JKPE _RARE_
cells O
lost O
a O
major O
approximately _RARE_
82 O
kDa O
immunoreactive _RARE_
cytosolic O
protein O
detectable O
with O
anti I-GENE
- I-GENE
PKC I-GENE
alpha I-GENE
antibody I-GENE
. O

To O
those O
of O
us O
who O
are O
not O
satisfied _RARE_
with O
the O
present O
outlook _RARE_
there O
is O
much O
to O
be O
investigated O
and O
much O
to O
be O
contributed O
. O

To O
determine O
the O
effects O
on O
the O
pulmonary O
barrier O
of O
several O
surface O
active _RARE_
agents O
, O
a O
series O
of O
metered _RARE_
dose O
inhalers _RARE_
( O
MDIs _RARE_
) O
was O
prepared O
and O
used O
to O
dose O
aerosolized _RARE_
surfactant _RARE_
to O
the O
airways _RARE_
of O
isolated O
perfused O
rat O
lungs O
. O

The O
beta O
chain O
contains O
five O
potential _RARE_
N O
- O
linked _RARE_
glycosylation O
sites O
, O
and O
endoglycosidase _RARE_
digestion O
suggested O
that O
the O
beta O
chain O
contained O
multiple O
complex O
carbohydrate O
side _RARE_
chains O
. O

The O
therapeutic O
protocole _RARE_
used O
at _RARE_
the O
Gustave _RARE_
Roussy _RARE_
Institute O
for _RARE_
invasive O
epithelioma _RARE_
of O
the O
uterine _RARE_
cervix O
rests _RARE_
, O
for _RARE_
limited O
forms O
( O
T1B _RARE_
- O
T2 _RARE_
proximal O
), _RARE_
on O
combined O
radiology _RARE_
and O
surgery O
. O

Thyrotropin _RARE_
- O
induced _RARE_
expression _RARE_
of O
a O
gene O
for _RARE_
a O
ribosomal I-GENE
protein I-GENE
related O
to O
the O
trk I-GENE
oncogene I-GENE
. O

The O
introns _RARE_
are O
1 O
. O
6 O
- O
1 O
. O
9 O
kbp _RARE_
long O
. O

After O
an O
initial O
titration O
period O
and O
adjustment O
of O
the O
therapeutic O
dose O
, O
the O
individual O
doses O
were O
from O
21 O
to O
500 O
micrograms O
/ O
24 _RARE_
hrs O
( O
mean O
160 _RARE_
micrograms O
/ O
24 _RARE_
hrs O
). O

In O
the O
first _RARE_
series O
of O
experiments O
, O
Sprague O
- O
Dawley O
male O
rats O
were O
implanted O
unilaterally _RARE_
with O
guide _RARE_
cannulas _RARE_
aimed O
at _RARE_
the O
lateral O
ventricle O
. O

Use O
of O
Selenastrum _RARE_
capricornutum _RARE_
and O
Microfeast _RARE_
as _RARE_
food O
for _RARE_
Daphnia _RARE_
pulex _RARE_
. O

The O
persistence _RARE_
of O
members O
of O
the O
prostigmatid _RARE_
families _RARE_
Tydeidae _RARE_
, O
Nanorchestidae _RARE_
and O
Tarsonemidae _RARE_
in O
the O
moisture _RARE_
- O
deficient _RARE_
90 _RARE_
%- _RARE_
concentration O
treatments O
supports O
previous O
evidence O
of O
adaptations _RARE_
to O
low O
- O
water O
- O
content O
habitats _RARE_
. O

To O
define O
the O
mechanism O
responsible O
for _RARE_
the O
loss _RARE_
of O
transcription O
elongation _RARE_
blockage _RARE_
and O
resulting O
c I-GENE
- I-GENE
myc I-GENE
deregulation _RARE_
in O
Burkitt _RARE_
' O
s O
lymphoma O
, O
we O
analyzed O
transcription O
patterns O
after O
transfer O
of O
normal O
and O
Burkitt _RARE_
' O
s O
lymphoma O
c I-GENE
- I-GENE
myc I-GENE
alleles O
into O
murine O
cells O
and O
Xenopus O
oocyte _RARE_
germinal _RARE_
vesicles O
. O

Erythrocyte _RARE_
protoporphyrin _RARE_
concentration O
increased O
significantly O
( O
P O
less O
than O
0 _RARE_
. O
05 O
) O
by O
14 O
days O
in O
dogs O
fed O
the O
basal O
diet O
, O
and O
remained O
significantly O
high O
relative O
to O
that O
in O
dogs O
of O
the O
other O
dietary O
groups O
for _RARE_
the O
remainder _RARE_
of O
the O
study O
. O

The O
coding O
sequences O
of O
the O
Crry _RARE_
gene I-GENE
encompass _RARE_
over O
25 _RARE_
kb O
of O
DNA O
, O
whereas O
the O
Crry _RARE_
- O
ps _RARE_
sequences O
are O
included O
within O
a O
single O
5 I-GENE
. I-GENE
6 I-GENE
- I-GENE
kb I-GENE
Eco _RARE_
- I-GENE
R1 _RARE_
fragment I-GENE
. O

The O
genomic O
and O
transcriptional O
complexity O
of O
the O
Crry _RARE_
and O
Crry _RARE_
- O
ps _RARE_
genes O
. O

From O
an O
RNK _RARE_
- O
16 O
lambda O
- O
gt11 O
library O
, O
we O
have O
isolated O
and O
sequenced O
a O
novel O
cDNA O
rat I-GENE
NK _RARE_
cell I-GENE
protease I-GENE
1 I-GENE
( O
RNKP _RARE_
- I-GENE
1 I-GENE
) O
that O
has O
characteristics O
unique O
to O
serine I-GENE
proteases _RARE_
. O

The O
induction O
of O
RNKP _RARE_
- I-GENE
1 I-GENE
expression _RARE_
in O
the O
Con _RARE_
A I-GENE
- O
cultured O
spleen _RARE_
cells O
is O
accompanied O
by O
increases O
in O
both O
NK _RARE_
and O
lymphokine _RARE_
- O
activated O
killer O
lymphocyte O
activities O
. O

The O
paper O
is O
concerned _RARE_
with O
the O
data O
on O
change O
in O
the O
blood _RARE_
level O
of O
ACTH I-GENE
, O
STH _RARE_
, O
TSH _RARE_
, O
cortisol O
, O
T3 _RARE_
, O
insulin I-GENE
, O
C I-GENE
- I-GENE
peptide I-GENE
during _RARE_
a O
25 _RARE_
- O
minute O
session O
of O
respiration O
using O
a O
gaseous _RARE_
hypoxic O
mixture O
with O
10 O
% O
oxygen O
( O
GHM _RARE_
- O
10 O
). O

The O
abscess O
was O
debrided _RARE_
and O
the O
septum _RARE_
was O
patched _RARE_
with O
a O
single O
layer O
of O
autologous O
pericardium _RARE_
. O

In O
18 O
% O
lymphography _RARE_
was O
clearly O
positive O
and O
CT _RARE_
negative O
. O

The O
present O
study O
examined O
the O
effect O
of O
intensity O
, O
rate O
, O
and O
polarity O
on O
the O
spectral O
content O
of O
ABRs _RARE_
of O
15 _RARE_
normal O
- O
hearing O
subjects O
. O

Similar O
memory O
impairments _RARE_
found O
in O
medial O
septal O
- O
vertical O
diagonal _RARE_
band O
of O
Broca _RARE_
and O
nucleus O
basalis _RARE_
lesioned O
rats O
: O
are O
memory O
defects O
induced _RARE_
by O
nucleus O
basalis _RARE_
lesions O
related O
to O
the O
degree O
of O
non O
- O
specific O
subcortical _RARE_
cell O
loss _RARE_
? O
The O
function O
of O
nucleus O
basalis _RARE_
( O
NB _RARE_
) O
and O
medial O
septal O
- O
vertical O
diagonal _RARE_
band O
of O
Broca _RARE_
( O
MS O
- O
VDBB _RARE_
) O
in O
a O
place O
navigation _RARE_
task O
requiring O
reference O
memory O
was O
investigated O
. O

Studies O
also O
have O
alluded _RARE_
to O
a O
relationship O
between O
the O
MSMR _RARE_
cyst O
and O
certain O
signs O
or O
symptoms O
of O
disease _RARE_
. O

The O
BAL _RARE_
- O
to O
- O
plasma O
specific O
activity O
of O
urea O
was O
about O
twice O
that O
of O
Na _RARE_
+, _RARE_
indicating O
that O
urea O
diffused _RARE_
into O
the O
ELF _RARE_
more O
rapidly O
than O
Na _RARE_
+ O
during _RARE_
the O
70 O
s O
that O
elapsed _RARE_
between O
the O
time O
the O
radioactive _RARE_
urea O
and O
Na _RARE_
+ O
were O
injected O
into O
the O
circulation O
and O
the O
time O
when O
lavage _RARE_
was O
complete _RARE_
. O

The O
kappa _RARE_
coefficient O
of O
agreement O
between O
the O
Patho _RARE_
Dx _RARE_
Kit _RARE_
and O
the O
standard O
method O
was O
0 _RARE_
. O
958 _RARE_
. O

Senior _RARE_
systems _RARE_
-- _RARE_
45 _RARE_
; O
Mental _RARE_
health O
and O
illness O
in O
old O
age O
-- _RARE_
3 O
. O

When O
normalized O
for _RARE_
imaging O
time O
, O
all O
parameters O
are O
significantly O
higher _RARE_
with O
RASE _RARE_
, O
with O
a O
C O
/ O
A O
per O
unit O
time O
that O
was O
338 _RARE_
% O
higher _RARE_
. O

Patients O
with O
acute O
myocardial _RARE_
infarction O
had O
higher _RARE_
plasma O
concentrations O
of O
neutrophil _RARE_
elastase I-GENE
and O
the O
non O
- O
peroxide _RARE_
diene _RARE_
conjugated O
isomer _RARE_
of O
linoleic _RARE_
acid O
than O
normal O
volunteers O
or O
patients O
with O
stable O
ischaemic O
heart _RARE_
disease _RARE_
. O

Determination O
of O
three O
- O
dimensional O
imaging O
properties O
of O
a O
light O
microscope _RARE_
system _RARE_
. O

The O
cis O
- O
acting O
element O
, O
identified O
as _RARE_
CACGTGACCCG _RARE_
, O
is O
located _RARE_
34 _RARE_
bp O
upstream O
from O
the O
transcription O
initiation O
site O
, O
and O
contains O
the O
core O
sequence O
of O
the O
upstream O
promoter O
sequence O
of O
Ad2MLP _RARE_
. O

The O
clinical O
relevance O
of O
these O
findings O
is O
strengthened _RARE_
by O
the O
observation O
that O
similar O
results O
were O
obtained O
when O
P O
. O
HCl _RARE_
was O
given O
by O
the O
intravenous O
route O
. O

TMBr _RARE_
- I-GENE
1 I-GENE
is O
identical O
to O
striated _RARE_
muscle I-GENE
alpha I-GENE
- I-GENE
tropomyosin _RARE_
from O
amino O
acids _RARE_
1 O
through O
258 O
but O
contains O
a O
novel O
COOH _RARE_
- O
terminal O
region O
from O
amino O
acids _RARE_
259 _RARE_
through O
281 _RARE_
. O

The O
procedure O
has O
been O
applied O
to O
three O
materials O
: O
particle _RARE_
board _RARE_
with O
carpet _RARE_
; O
gypsum _RARE_
board _RARE_
with O
wallpaper _RARE_
; O
and O
plywood _RARE_
with O
polyurethane _RARE_
lacquer _RARE_
, O
for _RARE_
which O
the O
steady O
- O
state O
emission O
factors O
( O
mg O
m O
- O
2 O
h O
- O
1 O
) O
of O
several O
compounds O
are O
given O
. O

Intron _RARE_
1 O
is O
6 O
. O
5 O
kb O
long O
, O
and O
the O
minimal O
sizes O
of O
introns _RARE_
2 O
and O
3 O
are O
estimated O
to O
be O
32 _RARE_
kb O
each O
. O

After O
4 O
h O
, O
lesions O
in O
the O
secretory _RARE_
part O
of O
the O
stomach O
were O
scored _RARE_
and O
mucosal _RARE_
prostaglandin _RARE_
E2 O
synthesis _RARE_
was O
determined O
by O
the O
ex _RARE_
vivo O
prostaglandin _RARE_
generation O
technique O
. O

Comparison O
of O
transmembrane O
and O
cytoplasmic O
domains O
to O
a O
third O
cell O
- O
surface O
proteoglycan _RARE_
, O
48K5 _RARE_
from O
human O
lung _RARE_
fibroblasts _RARE_
( O
Marynen _RARE_
, O
P O
., O
Zhang _RARE_
, O
J _RARE_
., O
Cassiman _RARE_
, O
J _RARE_
., O
Vanden _RARE_
Berghe _RARE_
, O
H O
., O
and O
David _RARE_
, O
C O
. O

Approximately O
65 O
% O
of O
the O
total _RARE_
cAMP I-GENE
- I-GENE
dependent I-GENE
phosphotransferase _RARE_
activity O
is O
recovered O
in O
particulate O
fractions O
of O
homogenates _RARE_
prepared O
from O
asynchronous _RARE_
populations O
of O
C O
. O
elegans O
. O

High _RARE_
levels O
of O
C I-GENE
subunits I-GENE
are O
observed O
in O
several O
subsequent O
larval _RARE_
and O
adult O
stages O
of O
development O
. O

A O
second O
, O
novel O
C O
subunit O
( O
CeCAT _RARE_
alpha O
', _RARE_
374 _RARE_
residues O
) O
has O
a O
unique O
56 _RARE_
- O
residue _RARE_
carboxyl _RARE_
- O
terminal O
region O
that O
is O
generated O
by O
the O
alternative _RARE_
splicing _RARE_
of O
the O
C I-GENE
pre I-GENE
- I-GENE
mRNA I-GENE
. O

The O
alternative _RARE_
exon _RARE_
introduces _RARE_
the O
novel O
carboxyl _RARE_
terminus O
and O
a O
new O
translation O
stop O
signal O
, O
while O
simultaneously O
converting _RARE_
the O
coding O
sequence O
for _RARE_
40 O
carboxyl _RARE_
- O
terminal O
residues O
in O
CeCAT _RARE_
alpha I-GENE
into O
3 O
'- O
untranslated _RARE_
nucleotides O
. O

French _RARE_
, O
M O
. O

Slowly _RARE_
adapting O
type O
I O
mechanoreceptor _RARE_
discharge O
as _RARE_
a O
function O
of O
dynamic O
force O
versus O
dynamic O
displacement _RARE_
of O
glabrous _RARE_
skin _RARE_
of O
raccoon _RARE_
and O
squirrel _RARE_
monkey _RARE_
hand _RARE_
. O

Methods _RARE_
used O
include O
Cobb _RARE_
angle O
and O
a O
segmental O
evaluation O
( O
T7 _RARE_
- O
T12 _RARE_
) O
of O
each O
of O
convex _RARE_
and O
concave _RARE_
rib _RARE_
- O
vertebra _RARE_
angles _RARE_
( O
RVAs _RARE_
), _RARE_
rib _RARE_
- O
vertebra _RARE_
angle O
differences O
( O
RVADs _RARE_
), _RARE_
vertebral O
rotation _RARE_
, O
tilt O
and O
displacement _RARE_
. O

Plasma O
lecithin _RARE_
/ I-GENE
cholesterol I-GENE
acyltransferase _RARE_
( O
LCAT _RARE_
) O
activity O
in O
multiple O
- O
organ O
donors O
: O
a O
predictor O
of O
allograft _RARE_
viability O
in O
clinical O
liver O
transplantation O
. O

Lars _RARE_
has O
AIDS O
-- _RARE_
a O
more O
dignified _RARE_
life O
with O
care O
at _RARE_
home O
. O

Axillary _RARE_
nodal O
status O
, O
tumour _RARE_
progesterone I-GENE
receptor I-GENE
status O
, O
and O
season O
of O
tumour _RARE_
detection O
significantly O
influenced O
survival O
in O
both O
older O
( O
greater O
than O
50 O
yrs _RARE_
) O
and O
younger _RARE_
( O
less O
than O
50 O
yrs _RARE_
) O
patients O
. O

The O
application O
of O
these O
microelectrodes _RARE_
to O
the O
measurement O
of O
rapid O
, O
transient O
changes O
in O
retinal _RARE_
[ _RARE_
K O
+] _RARE_
o _RARE_
is O
presented O
. O

Expression O
, O
cellular O
localization _RARE_
and O
in O
vitro O
transcription O
studies O
establish O
that O
cloned _RARE_
hUBF _RARE_
encodes O
a O
nucleolar _RARE_
factor O
that O
binds O
specifically O
to O
the O
upstream O
control O
element O
and O
core O
of O
the O
rRNA O
gene O
promoter O
to O
activate O
transcription O
in O
a O
binding O
site O
- O
dependent O
manner O
. O

Combining _RARE_
multiple O
laboratory O
studies O
may O
be O
of O
value O
in O
predetermining _RARE_
the O
eventual _RARE_
outcome O
in O
near O
- O
drowning _RARE_
. O

Accumulations _RARE_
of O
Tl O
+ O
1 O
( O
202Tl _RARE_
label _RARE_
) O
were O
6 O
times O
those O
for _RARE_
Ga O
or O
In O
in O
the O
brain O
and O
muscles O
, O
and O
. O
1 O
times O
in O
plasma O
. O

There O
was O
a O
gradual _RARE_
increase O
in O
the O
myocyte _RARE_
diameter O
according O
to O
age O
in O
the O
biopsy O
and O
autopsy O
specimens O
. O

Despite O
the O
absence O
of O
exercise O
- O
induced _RARE_
asthma O
( O
EIA _RARE_
) O
while O
breathing O
WH _RARE_
air O
, O
asthmatic O
patients O
still O
had O
significantly O
higher _RARE_
mean O
GH _RARE_
increments _RARE_
than O
normal O
subjects O
( O
9 O
. O
2 O
vs _RARE_
2 O
. O
3 O
ng _RARE_
/ O
ml O
, O
P O
less O
than O
0 _RARE_
. O
05 O
). O

The O
afferents O
' O
phase _RARE_
of O
response O
was O
unmodified _RARE_
by O
electrical O
EVS _RARE_
stimulation _RARE_
. O

Solving _RARE_
an O
age O
old O
problem O
. O

The O
distribution O
of O
their O
fibrinogen I-GENE
levels O
was O
Gaussian _RARE_
, O
but O
more O
wide O
- O
based O
than O
the O
distribution O
of O
our O
normal O
controls O
. O

In O
a O
stepwise _RARE_
logistic _RARE_
regression O
analysis O
of O
SPT _RARE_
and O
RAST O
data O
, O
the O
occurrence O
of O
serum I-GENE
IgE I-GENE
antibodies I-GENE
to I-GENE
P I-GENE
. I-GENE
orbiculare _RARE_
had O
the O
highest O
explanatory _RARE_
value O
for _RARE_
current O
eczema _RARE_
. O

The O
examination O
was O
focused O
on O
assessment O
of O
different O
types _RARE_
of O
drusen _RARE_
, O
on O
evaluation O
of O
the O
development O
and O
incidence O
of O
risk O
factors O
leading O
to O
complications O
and O
loss _RARE_
of O
central O
vision O
. O

They O
were O
then O
subjected O
to O
whole O
- O
body O
heat O
stress O
( O
water O
- O
perfused O
suits _RARE_
), _RARE_
and O
the O
3 O
minutes O
of O
LBNP _RARE_
was O
repeated _RARE_
. O

An O
NF1 I-GENE
- I-GENE
related I-GENE
vitellogenin _RARE_
activator I-GENE
element I-GENE
mediates O
transcription O
from O
the O
estrogen O
- O
regulated O
Xenopus I-GENE
laevis _RARE_
vitellogenin _RARE_
promoter I-GENE
. O

A O
poor O
correlation O
was O
also O
observed O
between O
PbB _RARE_
and O
ALAD _RARE_
activity O
of O
the O
stearate _RARE_
workers O
. O

At O
the O
carboxyl _RARE_
terminus O
, O
deletion O
as _RARE_
far O
as _RARE_
residue _RARE_
388 _RARE_
did O
not O
affect O
in O
vitro O
TRF _RARE_
. I-GENE
C I-GENE
assembly O
, O
although O
trans _RARE_
- O
activating O
activity O
was O
abolished O
. O

The O
effects O
of O
mean O
luminance _RARE_
were O
also O
measured O
and O
a O
general _RARE_
expression _RARE_
that O
would O
take O
them O
into O
account O
was O
derived O
. O

Effect O
of O
hyperglycemia _RARE_
on O
pain O
threshold O
in O
alloxan _RARE_
- O
diabetic O
rats O
. O

We O
have O
synthesized O
[ _RARE_
7 O
, O
7 O
- O
2H2 _RARE_
]- _RARE_
19 O
- O
OHA _RARE_
with O
high O
deuterium _RARE_
content O
and O
, O
together O
with O
[ _RARE_
7 O
, O
7 O
- O
2H2 _RARE_
] O
A O
and O
[ _RARE_
9 O
, O
11 O
- O
2H2 _RARE_
] O
estrone _RARE_
( O
E1 O
), _RARE_
have O
developed O
a O
quantitative O
assay O
of O
serum O
level O
19 O
- O
OHA _RARE_
, O
A O
, O
and O
E1 O
using O
the O
gas O
chromatography O
/ O
mass O
spectrometry O
- O
mass O
fragmentography _RARE_
method O
to O
monitor O
individual O
subjects O
throughout O
pregnancy _RARE_
. O

Sequence O
analysis O
of O
these O
genes O
and O
their O
surrounding O
sequences O
are O
presented O
and O
compared O
with O
other O
known O
tRNA O
genes O
from O
plant _RARE_
mitochondria _RARE_
. O

Experiments O
were O
performed O
in O
which O
brain O
- O
stem _RARE_
auditory O
- O
evoked O
responses O
( O
BAERs _RARE_
) O
were O
elicited O
by O
two O
types _RARE_
of O
pseudorandom _RARE_
pulse O
trains _RARE_
: O
maximum O
length O
sequences O
( O
MLS _RARE_
) O
and O
Legendre _RARE_
sequences O
( O
LGS _RARE_
). O

Since O
the O
UfAP _RARE_
and O
UTMP _RARE_
share O
many O
biosynthetic O
and O
structural O
features O
that O
include O
site O
of O
biosynthesis O
in O
the O
endometrium _RARE_
, O
P4 _RARE_
- O
responsiveness O
, O
the O
presence O
of O
the O
mannose _RARE_
6 O
- O
phosphate O
lysosomal _RARE_
recognition O
marker O
, O
and O
considerable O
sequence O
similarity _RARE_
, O
the O
UfAP _RARE_
and O
the O
UTMP _RARE_
may O
have O
homologous O
function O
which O
for _RARE_
both O
still O
remains O
obscure _RARE_
. O

Fifteen _RARE_
light O
for _RARE_
dates _RARE_
infants O
and O
their O
placentae _RARE_
were O
compared O
to O
15 _RARE_
well _RARE_
- O
grown O
infants O
and O
their O
placentae _RARE_
. O

Treating _RARE_
renal _RARE_
anaemia _RARE_
with O
recombinant O
human O
erythropoietin I-GENE
. O

The O
pseudolymphoma _RARE_
syndrome _RARE_
is O
a O
reversible O
reactive O
condition O
consisting O
of O
fever O
, O
lymphadenopathy _RARE_
and O
generalized O
rash O
. O

In O
the O
local O
geomagnetic _RARE_
field O
, O
the O
animals O
preferred O
the O
SE O
- O
sector _RARE_
. O

In O
the O
artificial O
lung _RARE_
, O
like O
in O
the O
natural _RARE_
lung _RARE_
and O
peripheral O
tissues O
, O
gas O
exchanges _RARE_
depend O
on O
several O
parameters O
: O
blood _RARE_
inlet _RARE_
conditions O
, O
blood _RARE_
flow O
rate O
, O
temperature _RARE_
, O
composition O
of O
the O
gas O
mixture O
used O
for _RARE_
ventilation O
, O
blood _RARE_
tissue O
perfusion O
, O
O2 _RARE_
consumption O
, O
etc O
. O

Mean O
(+/- O
SE O
) O
measurements O
of O
clearance O
( O
24 _RARE_
. O
5 O
+/- O
2 O
. O
06 O
v O
26 _RARE_
. O
5 O
+/- O
2 O
. O
05 O
mL O
/ O
min O
/ O
m2 O
), _RARE_
half _RARE_
- O
life O
( O
5 O
. O
7 O
+/- O
0 _RARE_
. O
5 O
v O
6 O
. O
4 O
+/- O
0 _RARE_
. O
5 O
hours O
), _RARE_
and O
volume O
of O
distribution O
( O
12 O
. O
4 O
+/- O
1 O
. O
1 O
v O
13 _RARE_
. O
7 O
+/- O
1 O
. O
6 O
L O
/ O
m2 O
) O
were O
not O
significantly O
different O
in O
patients O
with O
jaundice O
when O
compared O
with O
controls O
. O

Attitudes _RARE_
were O
found O
to O
be O
multidimensional _RARE_
, O
with O
similar O
dimensions O
being O
identified O
in O
both O
samples O
. O

We O
conclude O
that O
DNA O
ploidy _RARE_
is O
a O
major O
objective O
prognostic O
factor O
and O
therapeutic O
determinant O
for _RARE_
endometrial O
carcinoma O
. O

A O
semiautomatic _RARE_
digital O
system _RARE_
( O
Videoplan _RARE_
2 O
) O
was O
used O
. O

Environmental _RARE_
factors O
were O
more O
important O
in O
the O
older O
cohorts _RARE_
( O
perhaps O
because O
of O
less O
reliable O
recall _RARE_
). O

Dopamine _RARE_
SERS _RARE_
spectra O
from O
these O
electrodes O
are O
similar O
to O
those O
obtained O
at _RARE_
uncoated _RARE_
electrodes O
. O

These O
findings O
indicate O
that O
hypergastrinemia _RARE_
induced _RARE_
by O
surgical O
removal O
of O
acid O
- O
producing O
mucosa O
in O
the O
rat O
has O
the O
same O
effects O
on O
oxyntical _RARE_
mucosal _RARE_
HDC _RARE_
activity O
, O
histamine _RARE_
concentration O
and O
ECL _RARE_
cell O
density O
as _RARE_
hypergastrinemia _RARE_
induced _RARE_
by O
continuous O
gastrin I-GENE
infusion O
or O
by O
long O
- O
term O
treatment O
with O
effective O
antisecretagogues _RARE_
. O

Basing _RARE_
on O
experimental O
toxicity O
research O
it O
was O
established O
that O
, O
out O
of O
50 O
atmosphere _RARE_
metal O
corrosion _RARE_
inhibitors _RARE_
, O
some O
14 O
per O
cent O
were O
found O
extremely O
hazardous O
, O
42 _RARE_
per O
cent O
-- _RARE_
of O
high O
level O
hazardous O
, O
33 _RARE_
percent O
-- _RARE_
of O
moderate O
and O
11 O
per O
cent O
-- _RARE_
of O
low O
hazardous O
. O

The O
order O
of O
the O
helicase _RARE_
motif I-GENE
and O
the O
nsP3 _RARE_
homology I-GENE
region I-GENE
in O
the O
RUB _RARE_
genome O
is O
reversed O
with O
respect O
to O
the O
alphavirus _RARE_
genome O
indicating O
that O
a O
genetic O
rearrangement O
has O
occurred O
during _RARE_
the O
evolution O
of O
these O
viruses O
. O

The O
results O
suggest O
followings _RARE_
-- _RARE_
1 O
) O
both O
eosinophils O
and O
neutrophils O
participate O
in O
hypersecretion _RARE_
of O
type O
Ib _RARE_
in O
atopic O
cases O
, O
and O
only O
eosinophils O
in O
non O
- O
atopic O
cases O
. O

There O
were O
5 O
treatments O
: O
control O
( O
C O
); O
a O
wooden _RARE_
surround _RARE_
in O
one O
rear _RARE_
corner _RARE_
of O
the O
cage _RARE_
( O
S O
); O
a O
fiberglass _RARE_
rollaway _RARE_
hollow _RARE_
in O
one O
rear _RARE_
corner _RARE_
of O
the O
cage _RARE_
( O
H O
); O
a O
hollow _RARE_
and O
a O
surround _RARE_
( O
H O
/ O
S O
); O
a O
nest _RARE_
box O
attached O
to O
the O
back O
of O
the O
cage _RARE_
, O
containing O
a O
hollow _RARE_
( O
N O
). O

While O
no _RARE_
significant O
differences O
in O
the O
tensile _RARE_
responses O
or O
failure O
characteristics O
were O
noted O
for _RARE_
irradiated O
and O
nonirradiated _RARE_
grafts O
in O
the O
drip _RARE_
, O
in O
the O
bath _RARE_
environment O
the O
nonirradiated _RARE_
tissues O
had O
greater O
strength O
and O
modulus _RARE_
. O

The O
patient O
was O
treated O
with O
benzathine _RARE_
penicillin _RARE_
, O
2 O
, O
400 _RARE_
, O
000 _RARE_
U _RARE_
weekly O
for _RARE_
three O
weeks O
. O

A O
consensus O
binding O
site O
for _RARE_
the O
transcription O
factor O
SP1 I-GENE
was O
identified O
in O
intron O
As O
downstream _RARE_
of O
the O
proenkephalin _RARE_
germ _RARE_
cell I-GENE
cap _RARE_
site I-GENE
region I-GENE
. O

This O
proposed O
method O
is O
similar O
in O
principle _RARE_
to O
the O
sets O
technique O
but O
is O
shown O
to O
have O
much O
better O
expected O
time O
to O
alarm _RARE_
properties O
. O

The O
effects O
on O
reflex O
latencies _RARE_
but O
not O
on O
paCO2 _RARE_
or O
pHa _RARE_
were O
blocked O
by O
naloxone O
( O
2 O
mg O
/ O
kg O
), _RARE_
and O
were O
not O
present O
in O
morphine _RARE_
- O
tolerant _RARE_
animals O
. O

Of O
the O
remaining O
seven _RARE_
, O
five O
reacted O
either O
with O
immediate O
and O
strong O
symptoms O
or O
had O
spontaneously O
reduced _RARE_
gluten _RARE_
intake O
, O
or O
had O
an O
acquired O
IgA I-GENE
deficiency O
. O

Drug O
and O
personnel _RARE_
costs O
were O
reduced _RARE_
when O
batch _RARE_
manufacturing _RARE_
with O
40 O
- O
mL O
multidose _RARE_
vials _RARE_
was O
compared O
with O
extemporaneous _RARE_
compounding _RARE_
with O
unit O
- O
dose O
vials _RARE_
. O

Changes O
in O
prognosis O
of O
twin _RARE_
births O
over O
20 O
years O
. O

Dermal _RARE_
toxicity O
and O
carcinogenicity _RARE_
of O
4 O
- O
vinyl O
- O
1 O
- O
cyclohexene _RARE_
diepoxide _RARE_
in O
Fischer _RARE_
rats O
and O
B6C3F1 _RARE_
mice O
. O

Per _RARE_
kg O
FFM _RARE_
SMR _RARE_
was O
almost O
restored O
to O
baseline O
values O
for _RARE_
the O
EX _RARE_
group O
, O
whereas O
the O
non O
- O
exercising _RARE_
subjects O
still O
showed O
depressed O
values O
( O
EX _RARE_
3 O
. O
7 O
per O
cent O
and O
D O
+ O
DE _RARE_
15 _RARE_
. O
8 O
per O
cent O
lower O
than O
before O
treatment O
; O
P O
less O
than O
0 _RARE_
. O
05 O
). O

MK O
- O
927 _RARE_
: O
a O
topically _RARE_
active _RARE_
ocular O
hypotensive O
carbonic _RARE_
anhydrase I-GENE
inhibitor O
. O

PCR O
- O
derived O
fragments O
were O
used O
as _RARE_
probes _RARE_
for _RARE_
the O
isolation O
of O
the O
U3 _RARE_
snRNA _RARE_
genes I-GENE
from O
a O
genomic O
library O
of O
Arabidopsis O
. O

In O
addition O
serum I-GENE
IgE I-GENE
concentrations O
were O
not O
statistically O
different O
. O

The O
findings O
suggest O
that O
, O
although O
iodine O
deficiency O
is O
the O
most O
probable O
cause O
of O
goiter _RARE_
among O
immigrants _RARE_
of O
the O
1928 _RARE_
cohort O
, O
where O
the O
native _RARE_
population O
is O
concerned _RARE_
( O
both O
men O
and O
women O
), _RARE_
some O
other O
goitrogenic _RARE_
factor O
( O
s O
) O
must O
be O
involved O
. O

The O
transcriptional O
unit O
spans O
a O
chromosomal O
region O
of O
about O
55 _RARE_
kilobase _RARE_
pairs _RARE_
( O
kbp _RARE_
). O

100 _RARE_
of O
the O
patients O
who O
would O
have O
died O
survive _RARE_
. O

Co O
- O
administration O
of O
5FU _RARE_
, O
angiotensin I-GENE
II I-GENE
and O
microspheres O
via O
the O
hepatic _RARE_
artery O
may O
reduce O
drug O
exposure O
in O
the O
systemic O
compartment O
and O
therefore O
may O
increase O
the O
therapeutic O
ratio O
of O
5FU _RARE_
administration O
via O
the O
hepatic _RARE_
artery O
. O

The O
effects O
of O
tap _RARE_
( O
TW _RARE_
) O
or O
carbonated _RARE_
( O
CW _RARE_
) O
water O
on O
arterial O
pH O
, O
partial O
pressure O
of O
carbon O
dioxide O
( O
PCO2 O
) O
and O
plasma O
lactate _RARE_
were O
determined O
in O
heat O
- O
stressed O
broilers _RARE_
. O

Transient O
expression _RARE_
of O
human I-GENE
and I-GENE
chicken I-GENE
progesterone I-GENE
receptors I-GENE
does O
not O
support O
alternative _RARE_
translational O
initiation O
from O
a O
single O
mRNA O
as _RARE_
the O
mechanism O
generating O
two O
receptor O
isoforms O
. O

In O
contrast O
, O
2 O
, O
397 _RARE_
( O
74 _RARE_
%) O
had O
one O
or O
more O
risk O
factors O
( O
not O
low O
risk O
); O
of O
these O
, O
5 O
. O
3 O
% O
died O
in O
6 O
weeks O
( O
p O
less O
than O
0 _RARE_
. O
001 O
). O

The O
Community _RARE_
Adjustment _RARE_
Scale O
provided O
outcome O
data O
related O
to O
the O
subjects O
' O
degree O
of O
productivity _RARE_
, O
ability O
to O
maintain O
close O
relationships O
, O
and O
presence O
/ O
absence O
of O
symptomatology _RARE_
an O
average O
of O
32 _RARE_
years O
after O
initial O
admission O
. O

However O
, O
at _RARE_
18 O
months O
of O
age O
, O
significantly O
higher _RARE_
levels O
of O
IgG1 _RARE_
( O
P O
less O
than O
0 _RARE_
. O
05 O
) O
and O
of O
IgG4 _RARE_
( O
P O
less O
than O
0 _RARE_
. O
01 O
) O
were O
found O
in O
infants O
with O
an O
elevated O
IgE I-GENE
( O
greater O
than O
or O
equal O
to O
8 O
. O
0 _RARE_
kU _RARE_
/ O
l _RARE_
) O
than O
in O
those O
with O
a O
lower O
level O
. O

The O
protein O
sequence O
contains O
seven _RARE_
potential _RARE_
N O
- O
linked _RARE_
glycosylation O
sites O
and O
a O
threonine O
/ O
serine O
- O
rich O
region O
which O
is O
a O
potential _RARE_
site O
for _RARE_
attachment _RARE_
of O
O O
- O
linked _RARE_
carbohydrate O
. O

Thus O
adaptation O
to O
continuous O
mild O
stress O
has O
a O
potent O
antiarrhythmic O
effect O
which O
occurs O
due O
to O
the O
increased O
vagal _RARE_
tone O
. O

The O
eluent _RARE_
from O
the O
column O
was O
mixed O
with O
the O
chemiluminescent _RARE_
solution O
containing O
lucigenin _RARE_
and O
Triton _RARE_
X O
- O
100 _RARE_
and O
a O
0 _RARE_
. O
28 _RARE_
M O
KOH _RARE_
solution O
by O
pumps _RARE_
and O
monitored O
by O
a O
chemiluminescence _RARE_
detector O
. O

On O
histologic O
examination O
the O
cuboidal _RARE_
epithelium O
of O
the O
mucous _RARE_
membrane O
was O
found O
to O
be O
changed O
into O
columnar _RARE_
epithelium O
, O
with O
uneven _RARE_
distribution O
of O
enlarged _RARE_
nuclei O
in O
the O
vacuolized _RARE_
cytoplasm O
. O

These O
results O
suggest O
an O
increased O
risk O
of O
developing O
cancer _RARE_
among O
polyp _RARE_
patients O
and O
the O
possibility O
of O
prophylactic O
effect O
of O
polypectomy _RARE_
against O
subsequent O
cancer _RARE_
. O

The O
same O
trend O
was O
noted O
between O
YG _RARE_
4 O
. O
5 O
heifers O
and O
YG _RARE_
5 O
. O
5 O
steers O
, O
indicating O
a O
sex _RARE_
- O
related O
deposition O
of O
seam _RARE_
fat O
in O
fed O
cattle O
. O

The O
nucleotide O
sequence O
consists O
of O
48 _RARE_
bp O
of O
5 O
'- O
end O
non O
- O
coding O
region O
, O
1695 _RARE_
bp O
of O
coding O
region O
and O
212 _RARE_
bp O
of O
3 O
'- O
end O
non O
- O
coding O
region O
including O
a O
20 O
bp O
poly _RARE_
( O
A O
) O
tail _RARE_
. O

Toxicities _RARE_
included O
: O
nausea _RARE_
/ O
vomiting _RARE_
( O
69 _RARE_
%), O
headache O
( O
25 _RARE_
%), O
chills _RARE_
( O
69 _RARE_
%), O
pain O
at _RARE_
tumor O
sites O
( O
63 _RARE_
%), O
hypotension O
( O
31 _RARE_
%), O
and O
hypertension O
( O
38 O
%). O

The O
results O
also O
showed O
that O
although O
oyster _RARE_
shell _RARE_
supplementation O
generally O
increased O
alkaline _RARE_
phosphatase I-GENE
activity O
, O
bone O
mineralization _RARE_
was O
relatively O
uninfluenced _RARE_
as _RARE_
judged O
by O
the O
low O
coefficients O
of O
variation O
( O
CV _RARE_
) O
of O
3 O
. O
14 O
- O
3 O
. O
51 _RARE_
% O
and O
3 O
. O
39 _RARE_
- O
4 O
. O
82 O
% O
for _RARE_
calcium _RARE_
and O
phosphorus O
content O
in O
the O
femur O
and O
tibia _RARE_
respectively O
. O

In O
6 O
of O
24 _RARE_
infants O
studied O
( O
27th _RARE_
- O
40th _RARE_
weeks O
of O
gestation O
), _RARE_
acquired O
and O
congenital O
structural O
anomalies O
of O
the O
airways _RARE_
were O
detected O
with O
an O
ultrathin _RARE_
flexible _RARE_
fiberscope _RARE_
( O
Olympus _RARE_
PF18 _RARE_
S O
, O
1 O
. O
8 O
mm O
). O

Fatal _RARE_
encephalitis _RARE_
in O
a O
patient O
with O
chronic O
graft O
- O
versus O
- O
host _RARE_
disease _RARE_
. O

Compared _RARE_
to O
its O
counterpart _RARE_
in O
the O
GPB _RARE_
gene I-GENE
, O
exon _RARE_
3 O
of O
the O
GPE _RARE_
gene I-GENE
contains O
several O
point O
mutations O
, O
an O
insertion _RARE_
of O
24 _RARE_
bp O
, O
and O
a O
stop O
codon _RARE_
which O
shortens _RARE_
the O
reading O
frame O
. O

Molecular O
cloning O
of O
a O
cDNA O
encoding O
rat I-GENE
NADH _RARE_
- I-GENE
cytochrome I-GENE
b5 _RARE_
reductase I-GENE
and O
the O
corresponding O
gene O
. O

The O
results O
corroborate _RARE_
the O
idea O
that O
the O
structure _RARE_
of O
relaxation O
curves O
contains O
information _RARE_
on O
the O
distance O
scale O
and O
on O
the O
architecture O
of O
the O
pore _RARE_
space O
, O
even O
if O
it O
is O
difficult O
to O
extract _RARE_
it O
without O
ambiguities _RARE_
. O

Serotonin _RARE_
5 I-GENE
- I-GENE
HT2 I-GENE
receptor I-GENE
binding O
on O
blood _RARE_
platelets O
as _RARE_
a O
state O
dependent O
marker O
in O
major O
affective O
disorder O
. O

Although O
% O
BF _RARE_
was O
correlated O
with O
all O
the O
BMIs _RARE_
( O
r _RARE_
= O
0 _RARE_
. O
60 _RARE_
- O
0 _RARE_
. O
82 O
), _RARE_
applying O
objective O
definitions _RARE_
of O
obesity O
based O
on O
BMIs _RARE_
or O
% O
BF _RARE_
by O
densitometry _RARE_
often O
produced O
conflicting _RARE_
results O
. O

The O
RF _RARE_
values O
correlated O
well _RARE_
with O
the O
angiographic O
semiquantitative _RARE_
scale O
of O
severity O
of O
aortal _RARE_
insufficiency O
( O
r _RARE_
= O
0 _RARE_
. O
805 _RARE_
; O
p O
less O
than O
0 _RARE_
. O
001 O
), _RARE_
although O
they O
enabled _RARE_
the O
authors O
only O
to O
make O
a O
partial O
differentiation O
of O
haemodynamically _RARE_
severe O
regurgitations _RARE_
and O
mild O
or O
insignificant _RARE_
ones O
. O

Promoter O
elements O
include O
an O
atypical O
TATA O
box O
( O
GTTA _RARE_
), _RARE_
one O
CCAAT O
box O
much O
further O
from O
the O
initiation O
site O
, O
three O
reverse O
compliments _RARE_
of O
CCAAT O
( O
ATTGG _RARE_
), _RARE_
and O
two O
pyrimidine O
- O
rich O
nucleotide O
stretches O
. O

The O
cloned _RARE_
genes O
were O
identified O
in O
genetic O
libraries O
by O
hybridization O
screening O
using O
four O
deoxyoligonucleotide _RARE_
probes _RARE_
which O
corresponded O
to O
the O
partial O
amino O
acid O
sequence O
of O
the O
purified _RARE_
enzyme O
. O

The O
pattern O
for _RARE_
catalytic O
zinc O
sites O
included O
two O
ligands O
close O
in O
sequence O
, O
a O
sequence O
- O
distant O
ligand _RARE_
, O
and O
a O
main O
- O
chain O
hydrogen O
bond O
joining _RARE_
two O
ligands O
. O

Results O
of O
the O
long O
- O
term O
observation O
and O
treatment O
of O
patients O
with O
arterial O
hypertension O

Eucaryotic _RARE_
transcription O
factors O
that O
stimulate O
RNA I-GENE
polymerase I-GENE
II I-GENE
by O
increasing O
the O
efficiency O
of O
elongation _RARE_
of O
specifically O
or O
randomly O
initiated _RARE_
RNA O
chains O
have O
been O
isolated O
and O
characterized O
. O

Sprague O
- O
Dawley O
newborn O
rats O
( O
n _RARE_
= O
85 _RARE_
) O
breathed _RARE_
100 _RARE_
% O
oxygen O
( O
O2 _RARE_
) O
or O
room O
air O
( O
RA _RARE_
) O
during _RARE_
the O
first _RARE_
8 O
days O
of O
life O
, O
and O
then O
RA _RARE_
. O

The O
Lm _RARE_
increased O
and O
the O
alveoli _RARE_
/ O
mm2 O
and O
elastic O
recoil _RARE_
pressure O
decreased O
. O

Comparison O
of O
propofol _RARE_
and O
thiopentone _RARE_
as _RARE_
anaesthetic _RARE_
agents O
for _RARE_
electroconvulsive _RARE_
therapy O
. O

In O
Experiment O
II O
, O
as _RARE_
performing _RARE_
moderate O
supine O
cycling _RARE_
( O
55 _RARE_
% O
VO2 O
max _RARE_
) O
for _RARE_
50 O
minutes O
under O
several O
LBNP _RARE_
conditions O
in O
5 O
sedentary _RARE_
women O
, O
there O
were O
correspondingly _RARE_
similar O
changing O
manners _RARE_
of O
the O
cardiovascular O
adjustments _RARE_
to O
each O
of O
the O
phases O
given O
in O
Experiment O
I O
. O

Commercially _RARE_
available O
formulations _RARE_
of O
2 O
. O
5 O
% O
and O
5 O
% O
lambdacyhalothrin _RARE_
can O
be O
diluted _RARE_
either O
with O
water O
for _RARE_
ULV _RARE_
cold O
aerosol _RARE_
space O
- O
spraying _RARE_
or O
with O
diesel _RARE_
/ O
kerosene _RARE_
for _RARE_
thermal O
fogging _RARE_
at _RARE_
recommended O
application O
rates O
of O
0 _RARE_
. O
5 O
- O
1 O
g O
ai _RARE_
/ O
ha _RARE_
for _RARE_
mosquito _RARE_
control O
and O
2 O
g O
ai _RARE_
/ O
ha _RARE_
for _RARE_
housefly _RARE_
control O
. O

Thus O
, O
this O
reading O
frame O
was O
concluded O
to O
encode O
the O
precursor O
of O
mitochondrial I-GENE
fumarase _RARE_
. O

Sequence O
analysis O
indicates O
that O
in O
addition O
to O
an O
ATA _RARE_
and O
GC _RARE_
box O
, O
this O
region O
contains O
domains O
that O
have O
been O
implicated O
in O
the O
regulation _RARE_
of O
other O
muscle O
- O
specific O
genes O
: O
a O
CArG _RARE_
box O
at _RARE_
- O
91 O
bp O
; O
myocyte _RARE_
- I-GENE
specific I-GENE
enhancer I-GENE
- I-GENE
binding I-GENE
nuclear I-GENE
factor I-GENE
1 I-GENE
binding I-GENE
site I-GENE
homologies O
at _RARE_
- O
58 O
, O
- O
535 _RARE_
, O
and O
- O
583 _RARE_
bp O
; O
and O
a O
muscle O
- O
CAAT O
consensus O
sequence O
at _RARE_
- O
394 _RARE_
bp O
relative O
to O
the O
cap _RARE_
site O
. O

The O
trk I-GENE
- I-GENE
2h _RARE_
oncogene I-GENE
, O
isolated O
from O
the O
human O
breast O
carcinoma O
cell O
line O
MDA _RARE_
- O
MB O
231 O
by O
genomic O
DNA O
- O
transfection O
into O
NIH3T3 O
cells O
, O
consists O
of O
the O
trk I-GENE
proto _RARE_
- I-GENE
oncogene I-GENE
receptor I-GENE
kinase I-GENE
domain I-GENE
fused O
to O
a O
N O
- O
terminal O
41 _RARE_
amino O
acid O
activating O
sequence O
( O
Kozma _RARE_
, O
S O
. O
C O
., O
Redmond _RARE_
, O
S O
. O
M O
. O
S O
., O
Xiao _RARE_
- O
Chang _RARE_
, O
F O
., O
Saurer _RARE_
, O
S O
. O
M O
., O
Groner _RARE_
, O
B O
. O
and O
Hynes _RARE_
, O
N O
. O
E O
. O

Antibodies O
raised O
against O
a O
bacterially O
produced O
beta I-GENE
gal _RARE_
- O
trk I-GENE
receptor O
kinase O
fusion O
protein O
recognized _RARE_
a O
44 _RARE_
kd _RARE_
phosphoprotein _RARE_
phosphorylated _RARE_
on O
serine O
, O
threonine O
and O
tyrosine O
in O
extracts O
of O
trk I-GENE
- I-GENE
2h _RARE_
transformed O
NIH3T3 O
cells O
. O

Since O
very O
recent O
scanning O
- O
deletion O
analysis O
indicates O
that O
there O
is O
a O
critical O
region O
for _RARE_
activity O
near O
Cys _RARE_
- O
118 O
and O
that O
Cys _RARE_
- O
118 O
is O
necessary O
for _RARE_
maximal O
activity O
, O
we O
conclude O
that O
the O
Cys _RARE_
- O
118 O
residue _RARE_
is O
necessary O
for _RARE_
proper O
glycosylation O
and O
maximal O
biologic _RARE_
activity O
of O
GM _RARE_
- I-GENE
CSF I-GENE
. O

Molecular O
and O
functional _RARE_
characterization O
of O
the O
promoter O
of O
ETS2 _RARE_
, O
the O
human O
c I-GENE
- I-GENE
ets I-GENE
- I-GENE
2 I-GENE
gene O
. O

Information _RARE_
about O
immunologic O
drug O
interactions O
is O
needed O
by O
pharmacists _RARE_
to O
make O
rational _RARE_
drug O
- O
use O
decisions _RARE_
. O

Branch _RARE_
occlusion O
of O
Heubner _RARE_
' O
s O
artery O
, O
or O
perforators _RARE_
from O
the O
proximal O
anterior O
or O
middle _RARE_
cerebral O
arteries O
were O
the O
posited _RARE_
mechanism O
of O
infarction O
. O

All O
ABFI _RARE_
- I-GENE
binding I-GENE
sites I-GENE
, O
regardless O
of O
origin O
, O
provided O
weak O
UAS O
function O
in O
vivo O
when O
examined O
in O
test O
plasmids O
. O

An O
examination O
of O
the O
properties O
of O
sequences O
surrounding O
ARS1 _RARE_
left _RARE_
open _RARE_
the O
possibility O
that O
ABFI _RARE_
enhances O
the O
initiation O
of O
DNA O
replication O
at _RARE_
ARS1 _RARE_
by O
transcriptional O
activation O
. O

Nonvascular _RARE_
ophthalmic O
and O
neurologic O
disorders O
that O
can O
be O
confused _RARE_
with O
amaurosis _RARE_
fugax _RARE_
are O
listed _RARE_
, O
and O
an O
algorithm O
for _RARE_
evaluation O
( O
which O
includes O
ophthalmic O
examination O
, O
laboratory O
studies O
, O
and O
noninvasive _RARE_
carotid O
artery O
studies O
) O
is O
given O
. O

Likewise _RARE_
, O
whether O
or O
not O
the O
hypotensive O
action O
of O
converting _RARE_
enzyme O
inhibitors _RARE_
is O
age O
- O
related O
is O
as _RARE_
yet O
unknown O
. O

Polyclonal _RARE_
antiserum _RARE_
generated O
to O
the O
fusion O
protein O
was O
capable O
of O
detecting O
42 _RARE_
- O
and O
46 _RARE_
- O
kilodalton _RARE_
polypeptides O
from O
virus O
particles _RARE_
; O
both O
polypeptides O
were O
also O
shown O
to O
contain O
HBsAg I-GENE
determinants _RARE_
. O

These O
characteristics O
of O
N22 _RARE_
/ O
P22 _RARE_
indicate O
that O
it O
is O
a O
localized O
synaptically _RARE_
dependent O
event O
conforming _RARE_
to O
a O
transverse O
dipole _RARE_
with O
dorsal O
negativity _RARE_
and O
a O
simultaneous O
anterior O
positivity _RARE_
. O

Role O
of O
superoxide _RARE_
dismutase I-GENE
in O
cellular O
oxidative O
processes O
and O
method O
of O
its O
determination O
in O
biological O
materials O

At O
maximum O
photosensitivity _RARE_
the O
inhibitory _RARE_
amino O
acids _RARE_
gamma O
- O
aminobutyric _RARE_
acid O
and O
taurine _RARE_
were O
lower O
, O
and O
those O
of O
asparagine _RARE_
( O
metabolite O
of O
the O
excitatory _RARE_
amino O
acid O
aspartate _RARE_
) O
were O
higher _RARE_
, O
than O
when O
the O
animals O
were O
not O
photosensitive _RARE_
. O

We O
evaluated O
the O
likelihood O
of O
tissues O
to O
be O
positive O
for _RARE_
carcinoembryonic _RARE_
antigen I-GENE
and O
the O
intensity O
of O
carcinoembryonic _RARE_
antigen I-GENE
staining O
in O
specimens O
of O
villous _RARE_
adenomas _RARE_
, O
mixed O
polypoid _RARE_
villous _RARE_
adenomas _RARE_
, O
polypoid _RARE_
adenomas _RARE_
, O
and O
diverticulitis _RARE_
using O
the O
peroxidase I-GENE
- O
antiperoxidase _RARE_
technique O
. O

The O
priming _RARE_
activity O
of O
DNA O
incised _RARE_
by O
either O
of O
the O
Drosophila O
enzymes _RARE_
can O
be O
enhanced _RARE_
, O
however O
, O
by O
an O
additional O
incubation O
with O
E I-GENE
. I-GENE
coli I-GENE
endonuclease I-GENE
IV I-GENE
, O
which O
is O
known O
to O
cleave _RARE_
depurinated _RARE_
DNA O
on O
the O
5 O
'- O
side _RARE_
of O
an O
apurinic _RARE_
site O
. O

A O
. O

Therefore O
, O
in O
conjunction O
with O
a O
positive O
pregnancy _RARE_
test O
and O
the O
patient O
' O
s O
clinical O
history O
, O
a O
severely O
depressed O
or O
absent O
serum O
PAPP _RARE_
- I-GENE
A I-GENE
level O
may O
aid O
in O
the O
diagnosis O
of O
extrauterine _RARE_
pregnancy _RARE_
. O

The O
levels O
of O
both O
MAP1 _RARE_
- I-GENE
specific I-GENE
and I-GENE
MAP2 _RARE_
- I-GENE
specific I-GENE
mRNAs I-GENE
decline O
in O
the O
postnatal O
developing O
brain O
; O
the O
level O
of O
MAP1 _RARE_
- I-GENE
specific I-GENE
mRNA I-GENE
also O
increases O
slightly O
in O
rat O
PC12 O
cells O
upon O
exposure O
to O
nerve I-GENE
growth I-GENE
factor I-GENE
. O

The O
cDNAs O
cross O
- O
hybridize _RARE_
with O
genomic O
sequences O
in O
rat O
, O
human O
, O
and O
chicken O
DNA O
, O
but O
not O
with O
DNA O
from O
frog _RARE_
, O
Drosophila O
, O
or O
sea _RARE_
urchin _RARE_
. O

Colorimetric _RARE_
method O
of O
determining _RARE_
glycerin _RARE_
in O
the O
blood _RARE_

Deletion O
analysis O
was O
carried O
out O
within O
a O
part O
of O
the O
5 O
'- O
flanking O
region O
showing O
homology O
to O
the O
upstream O
region O
of O
the O
yeast I-GENE
CYC1 I-GENE
gene I-GENE
. O

The O
N1 _RARE_
and O
P2 O
were O
comparable O
in O
amplitude O
and O
both O
had O
prolonged O
refractory O
periods O
. O

Tolerance _RARE_
to O
fenfluramine _RARE_
anorexia _RARE_
: O
fact O
or O
fiction _RARE_
? O
Recent O
findings O
in O
this O
laboratory O
with O
regard O
to O
tolerance O
to O
fenfluramine _RARE_
anorexia _RARE_
are O
reviewed O
with O
respect O
to O
generality _RARE_
of O
the O
behavioural _RARE_
phenomenon O
. O

In O
30 _RARE_
dogs O
the O
left _RARE_
limb O
( O
tail _RARE_
) O
of O
the O
pancreas O
was O
removed O
but O
left _RARE_
in O
the O
abdominal O
cavity O
after O
cessation O
of O
blood _RARE_
flow O
to O
produce O
warm _RARE_
ischemia O
for _RARE_
30 _RARE_
, O
60 _RARE_
, O
and O
120 O
min O
( O
10 O
dogs O
at _RARE_
each O
time O
point O
), _RARE_
and O
then O
was O
flushed _RARE_
with O
cold O
Ringers _RARE_
' O
lactate _RARE_
and O
transplanted _RARE_
to O
the O
iliac O
vessels O
. O

These O
results O
support O
the O
view O
that O
clonidine _RARE_
and O
6 O
- O
OHDA _RARE_
, O
but O
not O
alpha O
- O
MD _RARE_
, O
have O
central O
pressor O
actions O
in O
the O
rat O
that O
oppose _RARE_
their O
antihypertensive O
action O
. O

Furthermore O
, O
beta I-GENE
2 I-GENE
- I-GENE
adrenoceptor I-GENE
sensitivity O
appears O
to O
be O
unaltered O
in O
BHT _RARE_
. O

We O
conclude O
that O
Hansel _RARE_
' O
s O
stain O
substantially O
improves _RARE_
the O
recognition O
of O
eosinophiluria _RARE_
as _RARE_
compared O
with O
Wright _RARE_
' O
s O
stain O
. O

These O
results O
suggest O
that O
the O
negative O
inotropic O
action O
of O
nicorandil _RARE_
is O
caused O
by O
inhibition O
of O
Ca O
influx _RARE_
and O
intracellular _RARE_
mobilization _RARE_
of O
Ca O
. O

The O
study O
included O
139 O
eyes O
with O
presumed _RARE_
ocular O
histoplasmosis _RARE_
syndrome _RARE_
( O
POHS _RARE_
) O
and O
age O
- O
related O
macular _RARE_
degeneration O
( O
AMD _RARE_
). O

Comparison O
of O
elastase I-GENE
- I-GENE
1 I-GENE
with O
amylase I-GENE
, O
lipase I-GENE
, O
and O
trypsin I-GENE
- O
like O
immunoreactivity O
in O
the O
diagnosis O
of O
acute O
pancreatitis O
. O

A O
probe O
evoked O
potentials O
procedure O
was O
used O
to O
assess O
the O
relative O
engagement _RARE_
of O
both O
cerebral O
hemispheres _RARE_
during _RARE_
a O
language O
task O
in O
the O
following O
four O
groups O
of O
dextral _RARE_
adults O
: O
left _RARE_
hemisphere O
( O
LH _RARE_
)- O
damaged O
aphasics _RARE_
recovering _RARE_
from O
stroke O
, O
dysarthrics _RARE_
, O
right O
hemisphere O
( O
RH _RARE_
)- O
damaged O
nonaphasic _RARE_
patients O
, O
and O
normal O
control O
subjects O
. O

Mucolipidosis _RARE_
type O
IV O
: O
clinical O
spectrum O
and O
natural _RARE_
history O
. O

Two O
of O
the O
three O
groups O
were O
administered O
dauricine _RARE_
, O
as _RARE_
a O
new O
calcium _RARE_
channel _RARE_
blocker O
, O
and O
verapamil O
, O
as _RARE_
a O
generally O
recognized _RARE_
calcium _RARE_
channel _RARE_
blocker O
, O
respectively O
, O
from O
15 _RARE_
minutes O
pre O
- O
bypass O
to O
the O
end O
of O
the O
bypass O
procedure O
( O
a O
period O
of O
95 _RARE_
minutes O
). O

No O
reflow _RARE_
occurred O
in O
approximately _RARE_
30 _RARE_
percent O
of O
the O
muscle O
microvasculature _RARE_
upon O
reperfusion O
. O

Rarely _RARE_
, O
patients O
with O
locally O
advanced O
, O
uncontrollable _RARE_
, O
non O
- O
metastatic O
prostatic _RARE_
cancer _RARE_
enjoy _RARE_
prolonged O
survival O
. O

Lysozyme _RARE_
activity O
was O
evidently _RARE_
increased O
as _RARE_
well _RARE_
in O
undiluted _RARE_
as _RARE_
in O
diluted _RARE_
sera _RARE_
in O
all O
our O
tested O
patients O
. O

The O
first _RARE_
involved O
measurements O
of O
the O
steady O
state O
levels O
of O
mRNAs O
for _RARE_
subunit O
5 O
of O
cytochrome I-GENE
oxidase I-GENE
and O
the O
beta O
subunit O
of O
F1 _RARE_
ATPase I-GENE
in O
wild O
type O
and O
in O
a O
hem2 _RARE_
mutant I-GENE
. O

A O
5 I-GENE
. I-GENE
8S _RARE_
- I-GENE
like I-GENE
structure _RARE_
is O
present O
within O
the O
5 O
'- O
terminal O
region O
of O
all O
three O
fungal _RARE_
mitochondrial I-GENE
LSU _RARE_
rRNAs _RARE_
; O
in O
contrast O
, O
no _RARE_
4 I-GENE
. I-GENE
5S I-GENE
- I-GENE
like I-GENE
structure _RARE_
is O
evident O
at _RARE_
the O
3 O
' O
end O
of O
these O
molecules O
. O

ATP O
gamma O
S O
inhibition O
can O
be O
overcome O
by O
high O
concentrations O
of O
ATP O
, O
dATP _RARE_
, O
araATP _RARE_
, O
or O
ddATP _RARE_
. O

The O
recovery O
of O
labelled O
methoxydextrane _RARE_
is O
98 O
+/- O
7 O
%. O

ASL _RARE_
- O
8123 _RARE_
demonstrated O
weak O
competitive O
beta I-GENE
- I-GENE
adrenoreceptor _RARE_
blocking O
activity O
in O
isolated O
guinea _RARE_
pig _RARE_
right O
atria _RARE_
with O
a O
pA2 _RARE_
of O
3 O
. O
73 _RARE_
+/- O
0 _RARE_
. O
07 O
; O
no _RARE_
agonist O
- O
like O
activity O
was O
observed O
in O
this O
tissue O
at _RARE_
concentrations O
of O
ASL _RARE_
- O
8123 _RARE_
from O
3 O
X O
10 O
(- _RARE_
5 O
) O
to O
1 O
X O
10 O
(- _RARE_
2 O
) O
M O
. O

Enhancer _RARE_
and O
promoter O
elements O
directing _RARE_
activation O
and O
glucocorticoid O
repression O
of O
the O
alpha I-GENE
1 I-GENE
- I-GENE
fetoprotein I-GENE
gene I-GENE
in O
hepatocytes O
. O

We O
discuss O
the O
results O
in O
relation O
to O
previous O
systems _RARE_
for _RARE_
parcellating _RARE_
the O
posterior O
ectosylvian _RARE_
gyrus O
of O
the O
cat _RARE_
and O
consider O
the O
possibility O
that O
divisions _RARE_
of O
the O
feline _RARE_
posterior O
ectosylvian _RARE_
gyrus O
correspond O
directly O
to O
areas O
making O
up _RARE_
the O
superior O
temporal O
gyrus O
in O
primates O
. O

The O
gene O
is O
contained O
within O
a O
1 O
. O
8 O
- O
kilobase _RARE_
AccI _RARE_
- O
EcoRI I-GENE
restriction _RARE_
fragment O
mapping O
at _RARE_
map O
coordinates _RARE_
0 _RARE_
. O
136 O
to O
0 _RARE_
. O
148 _RARE_
in O
the O
UL _RARE_
region O
of O
the O
EHV _RARE_
- O
1 O
genome O
and O
is O
transcribed _RARE_
from O
right O
to O
left _RARE_
. O

The O
4 O
- O
AP O
( O
4 O
- O
20 O
mM O
) O
effect O
resulted O
in O
a O
decrease O
of O
the O
sensory O
activity O
, O
which O
was O
fully O
restored O
by O
TEA _RARE_
or O
Ba2 _RARE_
+. _RARE_

Hybridization O
of O
a O
probe O
from O
this O
region O
to O
electrophoretic O
blots O
of O
RNAs O
from O
different O
human O
tissues O
showed O
a O
predominant O
2 O
. O
8 O
- O
kilobase _RARE_
( O
kb O
) O
message _RARE_
accompanied O
by O
weaker _RARE_
bands O
4 O
. O
1 O
and O
2 O
. O
1 O
kb O
in O
size O
. O

Prognosis _RARE_
of O
asymptomatic O
multiple O
myeloma O
. O

A O
new O
method O
for _RARE_
the O
quantitative O
analysis O
of O
sleep O
spindles _RARE_
during _RARE_
continuous O
overnight _RARE_
EEG O
recordings O
. O

Svensson _RARE_
et O
al O
. O

Endogenous _RARE_
release O
of O
neuronal _RARE_
serotonin _RARE_
and O
5 O
- O
hydroxyindoleacetic _RARE_
acid O
in O
the O
caudate _RARE_
- O
putamen _RARE_
of O
the O
rat O
as _RARE_
revealed O
by O
intracerebral _RARE_
dialysis O
coupled O
to O
high O
- O
performance O
liquid O
chromatography O
with O
fluorimetric _RARE_
detection O
. O

In O
this O
report O
we O
describe O
for _RARE_
the O
first _RARE_
time O
the O
complete _RARE_
primary _RARE_
structure _RARE_
of O
type I-GENE
X I-GENE
collagen _RARE_
, O
based O
on O
cloning O
and O
sequencing O
of O
cDNA O
and O
genomic O
DNA O
. O

Viable _RARE_
flap O
areas O
were O
established O
following O
vascular O
pedicle _RARE_
ligation O
( O
both O
vessels O
or O
only O
artery O
or O
vein _RARE_
), _RARE_
on O
the O
third O
day O
after O
flap O
replantation _RARE_
in O
both O
island O
and O
free O
flaps _RARE_
. O

The O
size O
discrepancy _RARE_
is O
not O
due O
to O
glycosylation O
or O
phosphorylation _RARE_
of O
Ag35 _RARE_
but O
may O
result O
from O
a O
proline O
- O
rich O
sequence O
which O
occurs O
in O
this O
polypeptide O
. O

A O
9 O
. O
5 O
- O
kb O
KpnI _RARE_
- O
SalI _RARE_
fragment O
, O
where O
all O
the O
DNA O
changes O
associated O
with O
su _RARE_
( I-GENE
Hw _RARE_
) I-GENE
mutations I-GENE
were O
mapped O
, O
was O
able O
to O
rescue O
the O
su _RARE_
( I-GENE
Hw _RARE_
) I-GENE
mutant I-GENE
phenotype _RARE_
after O
P O
- O
element O
- O
mediated _RARE_
germ _RARE_
- O
line O
transformation O
. O

The O
corticosterone O
synthesis _RARE_
inhibitor O
metyrapone _RARE_
( O
75 _RARE_
mg O
/ O
kg O
i O
. O
p O
.) O
was O
given O
to O
attenuate _RARE_
the O
rise O
of O
corticosterone O
to O
a O
level O
typical O
of O
stressed O
males O
. O

The O
effects O
of O
L655 _RARE_
, O
240 O
, O
a O
selective O
thromboxane _RARE_
and O
prostaglandin _RARE_
endoperoxide _RARE_
antagonist O
, O
on O
ischemia O
- O
and O
reperfusion O
- O
induced _RARE_
cardiac O
arrhythmias O
. O

In O
10 O
pentobarbitalized _RARE_
dogs O
, O
plasma O
viscosity O
( O
Ep _RARE_
) O
was O
raised O
fourfold O
while O
apparent O
blood _RARE_
viscosity O
( O
Ea _RARE_
) O
increased O
about O
twofold O
by O
two O
steps O
of O
exchange O
transfusion O
of O
200 _RARE_
ml O
of O
plasma O
with O
plasma O
containing O
high O
molecular _RARE_
weight _RARE_
dextran _RARE_
( O
mol O
wt O
500 O
, O
000 _RARE_
, O
20 O
% O
wt O
/ O
vol _RARE_
). O

The O
small I-GENE
IGF I-GENE
- I-GENE
binding I-GENE
protein I-GENE
is O
abundant O
in O
human O
amniotic _RARE_
fluid _RARE_
. O

Serum O
prostatic _RARE_
acid I-GENE
phosphatase I-GENE
levels O
showed O
a O
significantly O
weaker _RARE_
correlation O
with O
cancer _RARE_
volume O
( O
r _RARE_
equals _RARE_
0 _RARE_
. O
51 _RARE_
) O
and O
every O
other O
pathological O
parameter O
. O

The O
investigation O
was O
thereafter O
continued O
in O
an O
open _RARE_
fashion O
by O
administering _RARE_
a O
single O
10 O
mg O
dose O
of O
the O
MAO I-GENE
- I-GENE
B I-GENE
inhibitor O
deprenyl _RARE_
to O
the O
same O
subjects O
. O

Their O
studies O
have O
revealed O
a O
considerable O
increase O
of O
CSF I-GENE
AP I-GENE
activity O
in O
purulent _RARE_
meningitides _RARE_
whereas O
in O
serous _RARE_
meningitides _RARE_
it O
grows _RARE_
negligibly _RARE_
. O

A O
cDNA O
encoding O
a O
new O
human O
lymphocyte O
cell O
surface O
molecule O
has O
been O
isolated O
and O
shown O
to O
identify O
a O
fourth O
member _RARE_
of O
a O
recently O
discovered O
family O
of O
adhesion O
proteins O
. O

Dopamine _RARE_
caused O
a O
prominent O
potassium _RARE_
efflux _RARE_
measured O
as _RARE_
86Rb _RARE_
+ O
efflux _RARE_
from O
control O
glands O
, O
but O
was O
without O
effect O
in O
denervated _RARE_
glands O
. O

Spontaneous _RARE_
sensitization O
to O
cross O
- O
reacting _RARE_
chemicals _RARE_
in O
a O
proportion O
of O
control O
animals O
is O
strongly O
suggested O
, O
somewhat _RARE_
akin _RARE_
to O
spontaneous O
sensitization O
in O
patients O
with O
anaphylactoid _RARE_
reactions O
to O
neuromuscular O
blockers O
on O
first _RARE_
exposure O
, O
and O
in O
whom O
IgE I-GENE
antibodies I-GENE
are O
detected O
. O

This O
approach O
was O
examined O
utilizing O
the O
fetal _RARE_
protein O
, O
HGB _RARE_
F I-GENE
. O

The O
investigation O
was O
apt _RARE_
at _RARE_
studying O
the O
relationship O
between O
urinary _RARE_
metabolites O
of O
serotonin _RARE_
and O
catecholamine _RARE_
( O
5 O
- O
HIAA _RARE_
and O
VMA _RARE_
), _RARE_
T O
- O
cells O
( O
OKT3 _RARE_
+), O
T O
- O
helper _RARE_
( O
OKT4 _RARE_
+), O
T O
- O
suppressor O
( O
OKT8 _RARE_
+) O
and O
B O
- O
cells O
( O
EAC _RARE_
- O
rosette _RARE_
forming O
cells O
) O
in O
normal O
( O
10 O
subjects O
, O
1 O
female O
, O
9 O
male O
, O
age O
21 O
+/- O
5 O
years O
) O
and O
stress O
administered O
subjects O
( O
20 O
subjects O
, O
3 O
female O
, O
17 _RARE_
male O
, O
age O
20 O
+/- O
4 O
years O
). O

The O
84 _RARE_
. I-GENE
1C _RARE_
mAb _RARE_
recognizes O
a O
site O
on O
IgE I-GENE
which O
is O
identical O
or O
very O
close O
to O
the O
Fc I-GENE
epsilon I-GENE
R I-GENE
binding I-GENE
site I-GENE
, O
and O
95 _RARE_
. O
3 O
recognizes O
a O
site O
on O
IgE I-GENE
which O
is O
related O
, O
but O
not O
identical O
to O
the O
Fc I-GENE
epsilon I-GENE
R I-GENE
binding I-GENE
site I-GENE
. O

Their O
hydropathic _RARE_
plots _RARE_
are O
very O
similar O
and O
both O
possess O
three O
hydrophobic O
segments _RARE_
that O
are O
likely O
alpha O
- O
helical O
transmembrane O
segments _RARE_
. O

Angiotensin _RARE_
converting _RARE_
enzyme I-GENE
inhibitors _RARE_
enhance O
the O
antihypertensive O
efficacy O
of O
diuretics _RARE_
and O
blunt _RARE_
or O
prevent O
adverse O
metabolic O
effects O
. O

In O
addition O
to O
the O
significant O
reduction O
in O
blood _RARE_
pressure O
, O
the O
angiotensin I-GENE
converting _RARE_
enzyme I-GENE
( O
ACE I-GENE
) O
inhibitor O
ramipril _RARE_
caused O
a O
significant O
regression O
of O
pathologic O
left _RARE_
ventricular O
hypertrophy O
demonstrated O
by O
magnetic O
resonance O
imaging O
and O
echocardiography O
. O

Endocrine _RARE_
cells O
were O
studied O
by O
means O
of O
Grimelius _RARE_
' O
silver O
staining O
and O
immunostaining _RARE_
for _RARE_
chromogranin _RARE_
, O
a O
general _RARE_
marker O
of O
endocrine O
cells O
. O

The O
ratio O
of O
radioactivity _RARE_
in O
tumour _RARE_
compared O
with O
normal O
tissue O
( O
T O
: O
N O
ratio O
) O
was O
determined O
after O
simultaneously O
injecting O
microspheres O
into O
the O
portal _RARE_
and O
arterial O
circulation O
of O
each O
animal _RARE_
. O

The O
mRNA O
was O
converted O
to O
cDNA O
and O
amplified O
by O
the O
polymerase O
chain O
reaction O
technique O
. O

Tissue _RARE_
necrosis O
was O
evaluated O
using O
triphenyltetrazolium _RARE_
staining O
and O
was O
related O
to O
two O
major O
baseline O
predictors O
of O
infarct O
size O
: O
anatomic O
risk O
zone O
size O
and O
coronary O
collateral O
flow O
. O

To O
study O
the O
retinal _RARE_
surface O
in O
the O
human O
eye O
in O
normal O
and O
diseased O
states O
we O
used O
laser O
scanning O
tomography O
. O

Previously O
, O
we O
reported O
the O
sequence O
of O
the O
gene I-GENE
encoding I-GENE
human I-GENE
K14 _RARE_
( O
D O
. O

A O
potential _RARE_
TATA O
box O
is O
located _RARE_
29 O
base _RARE_
pairs _RARE_
upstream O
of O
the O
first _RARE_
transcription O
initiation O
site O
. O

Cotransfection O
of O
either O
construct O
with O
plasmids O
encoding O
PKI _RARE_
( I-GENE
1 I-GENE
- I-GENE
31 _RARE_
) I-GENE
inhibits O
cAMP O
- O
stimulated _RARE_
but O
not O
basal O
- O
or O
phorbol O
ester O
- O
stimulated _RARE_
expression _RARE_
. O

Sequence O
analysis O
of O
the O
5 O
' O
flanking O
region O
revealed O
several O
GC _RARE_
boxes _RARE_
but O
no _RARE_
identifiable _RARE_
TATA O
box O
. O

The O
underlying O
cirrhosis O
was O
alcoholic O
in O
11 O
( O
53 O
. O
3 O
%), O
cryptogenic _RARE_
in O
5 O
( O
23 _RARE_
. O
8 O
%), O
and O
hepatitis O
B O
chronic O
infection O
related O
in O
5 O
( O
23 _RARE_
. O
8 O
%). O

Once O
P I-GENE
- I-GENE
450scc _RARE_
mRNA I-GENE
is O
induced _RARE_
as _RARE_
a O
consequence O
of O
the O
LH _RARE_
/ O
hCG I-GENE
surge _RARE_
it O
is O
constitutively O
maintained O
by O
luteinized _RARE_
cells O
in O
vivo O
( O
0 _RARE_
- O
4 O
days O
) O
and O
in O
vitro O
( O
0 _RARE_
- O
9 O
days O
) O
in O
the O
absence O
of O
gonadotropins _RARE_
, O
is O
susceptible O
to O
modulation O
by O
prolactin I-GENE
and O
is O
no _RARE_
longer O
regulated O
by O
cAMP O
. O

Similarly O
, O
a O
human O
but O
not O
a O
bovine I-GENE
alpha I-GENE
transgene _RARE_
was O
expressed _RARE_
in O
placenta O
in O
transgenic O
mice O
. O

A O
rapid O
staining O
technique O
for _RARE_
Leishmania _RARE_
parasites O
in O
splenic O
aspirate _RARE_
smears O
. O

NIK _RARE_
- O
244 _RARE_
suppressed O
coronary O
ligation O
- O
and O
digitalis _RARE_
- O
induced _RARE_
arrhythmias O
, O
and O
the O
minimum O
effective O
plasma O
concentrations O
for _RARE_
arrhythmias O
induced _RARE_
by O
24 _RARE_
- O
h O
and O
48 _RARE_
- O
h O
coronary O
ligation O
and O
digitalis _RARE_
were O
0 _RARE_
. O
41 _RARE_
+/- O
0 _RARE_
. O
10 O
( O
by O
1 O
mg O
/ O
kg O
i O
. O
v O
.), _RARE_
0 _RARE_
. O
70 O
+/- O
0 _RARE_
. O
13 _RARE_
( O
by O
1 O
mg O
/ O
kg O
i O
. O
v O
.), _RARE_
and O
0 _RARE_
. O
21 O
+/- O
0 _RARE_
. O
08 _RARE_
( O
by O
0 _RARE_
. O
5 O
mg O
/ O
kg O
i O
. O
v O
.) O
microgram O
/ O
ml O
, O
respectively O
( O
mean O
+/- O
SD O
of O
the O
mean O
, O
n _RARE_
= O
6 O
). O

In O
TNF I-GENE
- O
resistant O
T24 _RARE_
bladder O
carcinoma O
cells O
, O
TNF I-GENE
failed O
to O
alter O
EGF _RARE_
- I-GENE
R I-GENE
tyrosine I-GENE
protein I-GENE
kinase I-GENE
activity O
although O
both O
EGF _RARE_
and O
phorbol O
ester O
were O
shown O
to O
modulate O
the O
enzymatic O
activity O
of O
the O
receptor O
in O
these O
cells O
. O

Thus O
, O
phosphodiesterase _RARE_
inhibitors _RARE_
that O
produce O
an O
opiate _RARE_
quasi _RARE_
- O
withdrawal O
syndrome _RARE_
potentiate _RARE_
interoceptive _RARE_
stimuli O
and O
weight _RARE_
loss _RARE_
associated O
with O
the O
withdrawal O
syndrome _RARE_
precipitated O
by O
naltrexone O
in O
morphine _RARE_
- O
dependent O
rats O
. O

The O
diagnostic O
value O
of O
blood _RARE_
serum O
and O
urinary _RARE_
amylase I-GENE
, O
lipase I-GENE
, O
and O
trypsin I-GENE
in O
exacerbations _RARE_
of O
chronic O
relapsing _RARE_
pancreatitis O
is O
discussed O
. O

On O
the O
basis O
of O
the O
mechanism O
of O
action O
, O
two O
groups O
of O
inodilators _RARE_
are O
distinguished O
, O
the O
phosphodiesterase _RARE_
inhibitors _RARE_
and O
the O
dopaminergic O
agents O
. O

Structural O
organization O
and O
expression _RARE_
of O
the O
mouse I-GENE
estrogen I-GENE
receptor I-GENE
. O

Intravenous O
gamma I-GENE
globulins _RARE_

Following O
chondroitinase _RARE_
AC _RARE_
and I-GENE
ABC _RARE_
digestion O
, O
staining O
reactions O
suggested O
that O
the O
highest O
levels O
of O
dermatan _RARE_
sulfate _RARE_
were O
in O
the O
diabetes O
resistant O
group O
( O
p O
less O
than O
0 _RARE_
. O
001 O
compared O
to O
diabetic O
, O
p O
less O
than O
0 _RARE_
. O
001 O
compared O
to O
diabetes O
prone O
) O
and O
the O
highest O
levels O
of O
chondroitin _RARE_
sulfates _RARE_
were O
in O
the O
diabetes O
prone O
group O
( O
p O
less O
than O
0 _RARE_
. O
001 O
). O

Myocardial O
perfusion O
was O
evaluated O
using O
the O
enhanced _RARE_
gray O
level O
after O
contrast O
injection O
, O
and O
the O
level O
was O
compared O
with O
the O
morphology O
and O
degree O
of O
collateral O
development O
. O

Once O
NGF _RARE_
administration O
is O
proven O
effective O
it O
will O
be O
possible O
to O
develop O
alternative _RARE_
ways O
of O
NGF _RARE_
administration O
. O

During O
the O
program O
' O
s O
use O
at _RARE_
the O
RSNA _RARE_
meeting _RARE_
, O
the O
program O
selected _RARE_
the O
correct O
diagnosis O
in O
the O
top O
five O
22 _RARE_
% O
of O
the O
time O
. O

Immunoglobulin _RARE_
light I-GENE
chain I-GENE
( O
IgL _RARE_
) O
diversity O
is O
generated O
in O
the O
chicken O
by O
recombination _RARE_
between O
the O
single O
functional _RARE_
variable _RARE_
( O
VL _RARE_
) O
and O
joining _RARE_
( O
JL _RARE_
) O
gene O
segments _RARE_
and O
subsequent O
somatic O
diversification _RARE_
of O
the O
rearranged _RARE_
VL _RARE_
region O
. O

The O
results O
were O
as _RARE_
follows O
: O
1 O
) O
Total O
integrated O
EMG O
activity O
of O
FB O
group O
was O
approximately _RARE_
equal O
in O
any O
occluded O
position O
, O
whereas O
that O
of O
CG _RARE_
and O
GF _RARE_
group O
varied O
from O
position O
to O
position O
. O

Muscle _RARE_
action O
potential _RARE_
and O
masticatory _RARE_
rhythm O
of O
anterior O
temporal O
and O
masseter _RARE_
muscles O
in O
children O
and O
adults O

In O
76 _RARE_
% O
of O
59 _RARE_
lead O
- O
toxic O
children O
, O
bone O
lead O
values O
measured O
by O
LXRF _RARE_
were O
equal O
to O
or O
greater O
than O
those O
measured O
in O
normal O
and O
industrially _RARE_
exposed O
adults O
. O

When O
considered O
with O
the O
known O
neurotoxic _RARE_
effects O
on O
children O
of O
" O
low O
levels O
" O
of O
exposure O
to O
lead O
, O
these O
results O
also O
suggest O
that O
either O
an O
excessively _RARE_
narrow O
margin O
of O
safety O
or O
insufficient O
safety O
is O
provided O
by O
present O
U _RARE_
. O
S O
. O
guidelines O
, O
which O
classify _RARE_
an O
elevated O
blood _RARE_
lead O
concentration O
as _RARE_
25 _RARE_
micrograms O
/ O
dl O
or O
greater O
. O

In O
resting O
3T3 O
cells O
, O
jun I-GENE
- I-GENE
D I-GENE
is O
expressed _RARE_
at _RARE_
a O
higher _RARE_
level O
compared O
to O
c I-GENE
- I-GENE
jun I-GENE
and O
jun I-GENE
- I-GENE
B I-GENE
, O
and O
its O
transcription O
is O
stimulated _RARE_
only O
slightly O
by O
serum O
growth O
factors O
. O

The O
thrombolytic _RARE_
effects O
of O
native _RARE_
tissue I-GENE
- I-GENE
type I-GENE
plasminogen I-GENE
activator I-GENE
( O
AK _RARE_
- I-GENE
124 _RARE_
) O
on O
experimental O
canine O
coronary O
thrombosis O
. O

O2 _RARE_
and O
CO2 O
in O
the O
tracheostomy _RARE_
tube O
were O
continuously O
monitored O
by O
mass O
spectrometry O
using O
a O
special _RARE_
sample O
- O
hold _RARE_
phase _RARE_
- O
locked _RARE_
sampling O
technique O
. O

Enzyme _RARE_
- O
linked _RARE_
immunosorbent O
assay O
for _RARE_
screening O
aflatoxin _RARE_
B1 _RARE_
in O
cottonseed _RARE_
products O
and O
mixed O
feed O
: O
collaborative _RARE_
study O
. O

However O
, O
experiments O
with O
S1 I-GENE
mapping O
of O
in O
vivo O
transcripts O
, O
gene O
disruptions _RARE_
in O
the O
alpha O
region O
, O
and O
a O
single O
- O
copy O
transcriptional O
fusion O
vector O
all O
suggested O
that O
these O
possible O
promoters O
were O
largely O
inactive O
during _RARE_
logarithmic _RARE_
growth O
, O
that O
the O
major O
promoter O
for _RARE_
the O
alpha O
operon O
lay _RARE_
upstream O
from O
the O
region O
cloned _RARE_
, O
and O
that O
the O
genes O
in O
the O
IF1 _RARE_
to O
L17 _RARE_
interval O
were O
cotranscribed O
. O

Functional O
rearranged _RARE_
antibody O
genes O
were O
detected O
with O
JH _RARE_
and O
VH _RARE_
heavy I-GENE
chain I-GENE
probes _RARE_
and O
with O
Jk _RARE_
and O
Vk _RARE_
light I-GENE
chain I-GENE
probes _RARE_
. O

Two O
specific O
DNA O
- O
protein O
complexes O
were O
identified O
in O
gel O
retardation O
assays O
using O
HeLa O
cell O
nuclear O
extracts O
and O
an O
oligonucleotide _RARE_
probe O
spanning O
the O
footprinted _RARE_
region O
. O

After O
transfection O
, O
specific O
TSH _RARE_
beta I-GENE
promoter I-GENE
activity O
was O
evident O
in O
both O
TRH I-GENE
- O
responsive O
pituitary O
- O
derived O
GH3 _RARE_
and O
primary _RARE_
pituitary O
cell O
cultures O
. O

In O
transformed O
E O
. O
coli O
, O
constitutive _RARE_
CAT I-GENE
expression _RARE_
is O
maintained O
when O
as _RARE_
little O
as _RARE_
0 _RARE_
. O
3 O
kilobase _RARE_
of O
DNA O
from O
the O
3 O
' O
end O
of O
the O
1 O
. O
6 O
- O
kilobase _RARE_
segment O
is O
inserted O
in O
the O
correct O
orientation O
in O
front O
of O
the O
CAT I-GENE
gene I-GENE
. O

Lowering _RARE_
of O
the O
renal _RARE_
blood _RARE_
flow O
alters O
the O
glomerular O
and O
tubular O
excretion O
processes O
. O

Tonometry _RARE_
of O
blood _RARE_
samples O
from O
patients O
may O
also O
be O
used O
in O
the O
determination O
of O
acid O
- O
base _RARE_
quantities _RARE_
and O
hemoglobin I-GENE
- O
oxygen O
affinity O
e _RARE_
. O
g O
. O
p50 _RARE_
. O

100 _RARE_
and O
14 O
p O
. O

Isolation O
of O
Weeksella _RARE_
virosa _RARE_
( O
formerly _RARE_
CDC _RARE_
group O
IIf _RARE_
) O
from O
a O
vaginal O
sample O
. O

Here O
, O
we O
alter O
the O
dimerization _RARE_
specificity _RARE_
of O
Fos I-GENE
by O
precisely O
replacing O
its O
leucine O
zipper O
with O
that O
from O
GCN4 I-GENE
. O

Growth _RARE_
of O
tracheal O
anastomoses _RARE_
in O
growing O
animals O

Fourth _RARE_
, O
sometime _RARE_
between O
4 O
and O
24 _RARE_
hours O
of O
recovery O
is O
necessary O
to O
reverse O
the O
effect O
of O
chronic O
hypoxia _RARE_
on O
cerebral O
blood _RARE_
flow O
. O

The O
ORF1 O
product O
was O
required O
for _RARE_
competence _RARE_
, O
while O
ORF2 O
, O
which O
was O
cotranscribed O
with O
ORF1 O
and O
encoded O
a O
predicted O
protein O
of O
126 O
amino O
acids _RARE_
, O
was O
not O
. O

Kindling _RARE_
of O
the O
primary _RARE_
visual O
cortex O
( O
VC _RARE_
) O
was O
compared O
with O
that O
of O
the O
amygdala O
in O
cats O
. O

Abundant _RARE_
infiltration _RARE_
of O
lymphocytes O
and O
plasma O
cells O
was O
also O
wide O
- O
spread O
beneath _RARE_
the O
carcinoma O
in O
situ O
, O
together O
with O
the O
lymphoid _RARE_
follicles _RARE_
. O

These O
case O
reports O
provide O
further O
evidence O
that O
LiCO3 _RARE_
can O
be O
a O
useful O
medication O
in O
the O
treatment O
of O
aggressive O
behavior O
and O
affective O
instability _RARE_
after O
brain O
injury O
, O
but O
that O
it O
has O
significant O
potential _RARE_
for _RARE_
neurotoxicity O
in O
this O
population O
, O
particularly O
when O
used O
in O
conjunction O
with O
neuroleptic O
agents O
. O

In O
all O
sessions _RARE_
under O
IFN I-GENE
, O
the O
latency _RARE_
of O
the O
P100 _RARE_
component _RARE_
of O
the O
VEP _RARE_
was O
shortened O
as _RARE_
compared O
to O
baseline O
conditions O
. O

Among O
100 _RARE_
cases O
of O
post O
- O
transfusion O
hepatitis O
, O
10 O
are O
due O
to O
the O
hepatitis O
B O
virus O
( O
despite O
systematic O
search O
for _RARE_
HBs I-GENE
Ag _RARE_
), _RARE_
89 _RARE_
are O
due O
to O
one O
of O
the O
non O
- O
A O
non O
- O
B O
viruses O
( O
not O
detectable O
by O
specific O
serological O
tests O
) O
and O
1 O
to O
several O
viruses O
, O
specially _RARE_
CMV _RARE_
. O

Recessive _RARE_
lethal O
mutations O
were O
isolated O
based O
upon O
failure O
to O
complement O
the O
recessive O
lethality O
of O
Df _RARE_
( O
3L _RARE_
) O
RR2 _RARE_
, O
a O
deletion O
of O
the O
DRE _RARE_
region O
that O
removes _RARE_
16 O
- O
18 O
polytene _RARE_
chromosome _RARE_
bands O
. O

Current O
status O
and O
future O
perspectives _RARE_

K O
. O

A O
215 O
- O
base _RARE_
- O
pair _RARE_
( O
bp O
) O
region O
of O
the O
mouse I-GENE
MOPC _RARE_
41 _RARE_
kappa _RARE_
light I-GENE
- I-GENE
chain I-GENE
immunoglobulin I-GENE
gene I-GENE
enhancer I-GENE
has O
been O
analyzed O
for _RARE_
specific O
binding O
of O
lymphoid _RARE_
and O
nonlymphoid _RARE_
nuclear O
factors O
. O

This O
paper O
presents O
the O
reasons _RARE_
why _RARE_
countries _RARE_
to O
which O
Chagas _RARE_
disease _RARE_
is O
endemic _RARE_
should O
carry O
out O
the O
relevant O
research O
themselves O
. O

The O
PETCO2 _RARE_
measurement O
during _RARE_
precordial _RARE_
compression O
predicted O
the O
success O
of O
defibrillation _RARE_
with O
return O
of O
spontaneous O
circulation O
. O

Gastric _RARE_
CO2 O
/ O
HCO3 O
was O
determined O
in O
absence O
of O
simultaneous O
inhibition O
of O
acid O
secretion _RARE_
by O
intra _RARE_
- O
and O
extragastric _RARE_
pCO2 _RARE_
/ O
pH O
measurements O
in O
23 _RARE_
persons O
and O
calculated O
using O
the O
equation O
of O
Henderson _RARE_
- O
Hasselbalch _RARE_
. O
pCO2 _RARE_
was O
measured O
with O
use O
of O
a O
new O
electrode O
. O

Follow _RARE_
- O
up _RARE_
study O
showed O
85 _RARE_
% O
of O
these O
patients O
with O
effectiveness O
. O

The O
other O
patients O
continued O
the O
trial O
with O
single O
daily O
doses O
of O
monotherapy _RARE_
. O

Neonatal _RARE_
Chagas _RARE_
disease _RARE_
: O
laboratory O
diagnosis O
during _RARE_
the O
first _RARE_
year O
of O
life O

Using O
mutated _RARE_
IL2R _RARE_
alpha I-GENE
promoter I-GENE
constructs I-GENE
in O
transient O
transfection O
and O
DNA O
binding O
assays O
, O
we O
now O
demonstrate O
that O
sequences O
located _RARE_
immediately O
upstream O
and O
downstream _RARE_
of O
the O
kappa _RARE_
B I-GENE
enhancer I-GENE
also O
contribute O
to O
the O
regulation _RARE_
of O
IL2R _RARE_
alpha I-GENE
gene I-GENE
expression _RARE_
. O

Palindromic _RARE_
rheumatism _RARE_

Inefficacy _RARE_
of O
phosphine _RARE_
fumigation _RARE_
against O
ticks O
. O

Forty O
patients O
, O
divided O
according O
to O
their O
initial O
total _RARE_
gastrointestinal _RARE_
transit O
times O
and O
presenting _RARE_
symptoms O
, O
were O
treated O
with O
cimetropium _RARE_
bromide O
50 O
mg O
t O
. O
d O
. O
s O
. O
or O
placebo O
for _RARE_
1 O
month O
according O
to O
a O
double O
- O
blind O
, O
parallel O
group O
design O
. O

An O
immunologically _RARE_
related O
protein O
was O
detected O
in O
ribosome _RARE_
and O
membrane O
fractions O
of O
mitochondria _RARE_
from O
Saccharomyces O
cerevisiae O
. O

Mapping O
of O
RNA O
- O
temperature _RARE_
- I-GENE
sensitive _RARE_
mutants I-GENE
of I-GENE
Sindbis _RARE_
virus I-GENE
: I-GENE
complementation _RARE_
group I-GENE
F I-GENE
mutants I-GENE
have O
lesions O
in O
nsP4 _RARE_
. O

The O
effect O
of O
the O
thromboxane _RARE_
A2 _RARE_
( I-GENE
TXA2 _RARE_
)/ _RARE_
prostaglandin _RARE_
endoperoxide _RARE_
receptor I-GENE
antagonist O
, O
SQ _RARE_
29 O
, O
548 _RARE_
on O
pacing O
- O
induced _RARE_
ischemia O
was O
determined O
in O
anesthetized O
open _RARE_
- O
chest O
dogs O
. O

According O
to O
the O
published O
sequence O
of O
the O
CHS1 _RARE_
gene I-GENE
, O
this O
fragment O
contains O
four O
repeats O
of O
a O
TGAAACA _RARE_
consensus O
sequence O
previously O
identified O
in O
the O
alpha I-GENE
- I-GENE
factor I-GENE
- O
inducible O
BAR1 _RARE_
promoter I-GENE
[ _RARE_
Kronstad _RARE_
, O
J _RARE_
. O

The O
recovery O
index O
( O
T25 _RARE_
- O
T75 _RARE_
) O
after O
the O
infusion O
stopped O
was O
similar O
in O
patients O
who O
received O
mivacurium _RARE_
and O
those O
who O
received O
suxamethonium _RARE_
. O

The O
sign O
of O
Leser _RARE_
- O
Trelat _RARE_
: O
does O
it O
exist O
? O
The O
sign O
of O
Leser _RARE_
- O
Trelat _RARE_
is O
usually O
regarded O
as _RARE_
a O
reliable O
cutaneous O
marker O
of O
internal O
malignancy O
. O

Xenopus I-GENE
homolog I-GENE
of I-GENE
the I-GENE
mos I-GENE
protooncogene _RARE_
transforms _RARE_
mammalian O
fibroblasts _RARE_
and O
induces O
maturation _RARE_
of O
Xenopus O
oocytes O
. O

Southern O
blot O
analyses O
demonstrated O
a O
low O
, O
if O
not O
single O
, O
copy O
number O
for _RARE_
this O
gene O
and O
conservation O
of O
this O
domain O
in O
other O
vertebrates _RARE_
. O

Three O
missense O
mutants O
in O
subunit O
a O
of O
the O
Escherichia I-GENE
coli I-GENE
F1F0 _RARE_
- I-GENE
ATPase I-GENE
were O
isolated O
and O
characterized O
after O
hydroxylamine _RARE_
mutagenesis O
of O
a O
plasmid _RARE_
carrying O
the O
uncB _RARE_
( I-GENE
subunit I-GENE
a I-GENE
) I-GENE
gene I-GENE
. O

Moreover O
, O
exons O
2a _RARE_
and O
2b _RARE_
share O
the O
same O
5 O
' O
sequence O
but O
differ O
from O
each O
other O
by O
the O
use O
of O
two O
distinct O
donor O
splice _RARE_
sites O
171 _RARE_
bp O
apart O
in O
the O
gene O
. O

S1 I-GENE
nuclease _RARE_
analysis O
of O
RNA O
prepared O
after O
transfection O
of O
these O
HIV O
constructs O
into O
HeLa O
cells O
infected _RARE_
with O
wild O
- O
type O
adenovirus O
indicated O
that O
the O
enhancer O
, O
SP1 I-GENE
, O
TATA O
, O
and O
a O
portion O
of O
the O
transactivation _RARE_
- O
responsive O
element O
were O
each O
required O
for _RARE_
complete _RARE_
E1A I-GENE
/ O
E1B I-GENE
- O
mediated _RARE_
activation O
of O
the O
HIV I-GENE
LTR I-GENE
. O

In O
supine O
position O
, O
plasma O
ANP I-GENE
levels O
ranged O
from O
12 O
pg O
/ O
ml O
to O
51 _RARE_
. O
5 O
pg O
/ O
ml O
, O
with O
an O
average O
level O
of O
35 _RARE_
. O
3 O
+/- O
11 O
. O
5 O
pg O
/ O
ml O
. O

The O
overall O
prevalence O
of O
HBV _RARE_
markers O
was O
higher _RARE_
among O
staff _RARE_
members O
than O
in O
the O
blood _RARE_
donors O
of O
our O
area O
. O

Quantitative O
predictions O
are O
confirmed O
for _RARE_
the O
positive O
responses O
, O
but O
not O
for _RARE_
the O
negatives _RARE_
, O
suggesting O
that O
the O
SSTS _RARE_
model O
is O
incorrect _RARE_
. O

Plasma O
concentrations O
of O
ANF _RARE_
( O
pANF _RARE_
), _RARE_
aldosterone O
( O
PAC _RARE_
) O
and O
renin I-GENE
( O
PRC _RARE_
) O
were O
measured O
daily O
, O
as _RARE_
were O
hemodynamic O
parameters O
. O

The O
adenovirus I-GENE
E1A I-GENE
gene I-GENE
encodes O
a O
protein O
that O
transcriptionally O
activates O
viral I-GENE
early I-GENE
genes I-GENE
. O

Administration O
of O
dexamethasone O
was O
associated O
with O
progressive O
rises _RARE_
in O
plasma O
17 _RARE_
alpha O
OH O
progesterone O
, O
11 O
beta O
- O
desoxycortisol _RARE_
, O
DHEA _RARE_
sulphate _RARE_
, O
androstenedione _RARE_
and O
testosterone O
, O
together O
with O
increased O
urinary _RARE_
excretion O
of O
androsterone _RARE_
, O
11 O
beta O
OH O
androsterone _RARE_
, O
etiocholanolone _RARE_
, O
DHEA _RARE_
, O
and O
16 O
alpha O
OH O
DHEA _RARE_
. O

RNA O
transcripts O
that O
hybridize _RARE_
to O
the O
introduced O
foreign O
gene O
have O
been O
identified O
. O

In O
HeLa O
cells O
, O
it O
activated O
transcription O
from O
the O
herpes I-GENE
simplex I-GENE
virus I-GENE
type I-GENE
1 I-GENE
thymidine _RARE_
kinase I-GENE
promoter I-GENE
linked _RARE_
to O
the O
chloramphenicol I-GENE
acetyltransferase _RARE_
gene I-GENE
when O
located _RARE_
in O
inverted O
orientation O
upstream O
of O
the O
thymidine _RARE_
kinase I-GENE
promoter I-GENE
or O
downstream _RARE_
of O
the O
chloramphenicol I-GENE
acetyltransferase _RARE_
gene I-GENE
coding I-GENE
sequence I-GENE
. O

At O
the O
basal O
unstimulated O
condition O
, O
Ren1d _RARE_
5 I-GENE
' I-GENE
flanking I-GENE
sequence I-GENE
in O
the O
sense O
orientation O
inhibited O
basal O
CAT I-GENE
expression _RARE_
from O
the O
TK I-GENE
promoter I-GENE
of O
pUTKAT1 _RARE_
, O
whereas O
the O
same O
sequence O
in O
the O
antisense _RARE_
orientation O
did O
not O
. O

None O
were O
restricted O
from O
clinical O
duties _RARE_
, O
were O
given O
varicella _RARE_
- I-GENE
zoster _RARE_
immune I-GENE
globulin I-GENE
, O
or O
developed O
disease _RARE_
. O

In O
the O
formalin O
test O
, O
however O
, O
naloxone O
attenuated O
morphine _RARE_
analgesia O
at _RARE_
the O
lower O
doses O
( O
0 _RARE_
. O
1 O
and O
0 _RARE_
. O
3 O
mg O
/ O
kg O
) O
and O
potentiated _RARE_
morphine _RARE_
analgesia O
at _RARE_
the O
highest O
dose O
( O
10 O
mg O
/ O
kg O
). O

We O
have O
isolated O
cDNA O
clones _RARE_
from O
rat O
brain O
and O
human O
liver O
encoding O
a O
putative O
isoform O
of O
the O
Na _RARE_
, I-GENE
K I-GENE
- I-GENE
ATPase I-GENE
beta I-GENE
subunit I-GENE
. O

We O
have O
determined O
that O
several O
E1 I-GENE
mutants I-GENE
mapping O
in O
both O
the O
M O
and O
R O
regions O
and O
a O
single O
mutant O
of O
the O
upstream O
regulatory O
region O
have O
a O
higher _RARE_
transforming O
activity O
on O
mouse O
C127 _RARE_
cells O
than O
the O
wild O
- O
type O
genome O
does O
. O

UbiA _RARE_
is O
also O
unique O
among O
known O
polyubiquitin _RARE_
genes I-GENE
in O
containing O
four O
cis O
- O
spliced _RARE_
introns _RARE_
within O
its O
coding O
sequence O
. O

That _RARE_
of O
the O
T2 _RARE_
gene I-GENE
contains O
numerous O
potential _RARE_
sites O
for _RARE_
binding O
the O
mammalian I-GENE
transcription I-GENE
factor I-GENE
SP1 I-GENE
, O
but O
no _RARE_
TATA O
or O
CCAAT O
sequences O
are O
evident O
near O
to O
its O
5 O
' O
end O
, O
although O
these O
latter O
features O
are O
associated O
with O
the O
human I-GENE
T1 _RARE_
gene I-GENE
. O

Radiation _RARE_
therapy O
was O
effective O
in O
controlling O
symptomatic O
metastasis O
in O
all O
three O
patients O
. O

These O
results O
indicate O
that O
patients O
who O
undergo O
postoperative O
irradiation O
for _RARE_
low O
grade O
spinal _RARE_
astrocytomas _RARE_
and O
localized O
spinal _RARE_
ependymomas _RARE_
achieve O
excellent O
survival O
. O

The O
methylation O
of O
nuclear O
and O
chloroplast O
DNAs _RARE_
has O
been O
examined O
in O
relation O
to O
the O
known O
differential O
expression _RARE_
of O
C4 _RARE_
photosynthesis _RARE_
genes I-GENE
in O
the O
bundle O
sheath _RARE_
and O
mesophyll _RARE_
cells O
of O
etiolated _RARE_
, O
greening _RARE_
, O
and O
fully O
green _RARE_
maize _RARE_
leaves O
. O

S1 I-GENE
nuclease _RARE_
analysis O
of O
RNA O
from O
chemically _RARE_
induced _RARE_
B95 _RARE_
- O
8 O
cells O
and O
from O
Vero _RARE_
cells O
cotransfected O
with O
NotI _RARE_
repeat I-GENE
promoter I-GENE
- O
CAT I-GENE
and O
Z I-GENE
showed O
that O
Z I-GENE
transactivation _RARE_
increased O
the O
level O
of O
correctly O
initiated _RARE_
, O
stable O
RNA O
transcripts O
. O

We O
conclude O
that O
( O
a O
) O
the O
likelihood O
of O
detecting O
carcinoma O
or O
atypical O
hyperplasia O
exclusively O
in O
the O
adipose _RARE_
tissue O
component _RARE_
of O
grossly _RARE_
benign O
breast O
biopsies O
is O
extremely O
low O
, O
and O
( O
b O
) O
a O
possible O
cost O
- O
effective O
method O
of O
sampling O
grossly _RARE_
benign O
breast O
biopsies O
consists O
of O
initially O
submitting _RARE_
a O
maximum O
of O
10 O
blocks O
of O
fibrous _RARE_
parenchyma O
for _RARE_
each O
case O
, O
then O
examining O
the O
remaining O
tissue O
histologically O
only O
if O
carcinoma O
or O
atypical O
hyperplasia O
is O
found O
among O
these O
blocks O
. O

Analysis O
of O
the O
DNA O
from O
15 _RARE_
cases O
of O
sporadic _RARE_
and O
familial O
Wilms _RARE_
' O
tumor O
did O
not O
reveal O
any O
changes O
, O
indicating O
that O
the O
translocation O
breakpoint _RARE_
does O
not O
reside O
in O
this O
gene O
. O

We O
also O
provide O
evidence O
that O
neither O
the O
lambda I-GENE
O I-GENE
and O
P I-GENE
initiators _RARE_
nor O
the O
E I-GENE
. I-GENE
coli I-GENE
DnaJ _RARE_
and O
DnaK _RARE_
heat O
shock O
proteins O
play O
a O
direct O
role O
in O
the O
propagation _RARE_
of O
lambda O
replication O
forks _RARE_
in O
vitro O
. O

Synthetic _RARE_
oligonucleotides O
representing O
the O
19 O
bp O
repeat O
unit O
strongly O
reduced _RARE_
the O
activity O
of O
the O
IE1 I-GENE
/ I-GENE
2 I-GENE
enhancer I-GENE
/ I-GENE
promoter I-GENE
in O
cotransfection O
assays O
after O
transient O
expression _RARE_
. O

Effects O
of O
nitrogen O
( O
PN2 _RARE_
: O
5 O
and O
14 O
MPa _RARE_
) O
and O
helium _RARE_
( O
PHe _RARE_
: O
13 _RARE_
and O
14 O
MPa _RARE_
) O
were O
also O
tested O
. O

The O
mustard _RARE_
chloroplast I-GENE
gene I-GENE
rps16 _RARE_
is O
split _RARE_
by O
an O
887 _RARE_
bp O
group O
II O
( O
or O
III O
) O
intron O
. O

Antibodies O
raised O
to O
the O
expressed _RARE_
NS3 _RARE_
by O
immunization O
of O
mice O
detected O
both O
NS3 _RARE_
and O
NS3A _RARE_
in O
BTV _RARE_
- O
10 O
- O
infected _RARE_
BHK _RARE_
cells O
but O
not O
in O
purified _RARE_
BTV _RARE_
- O
10 O
virus O
particles _RARE_
. O

Similarly O
, O
supraventricular _RARE_
tachycaydia _RARE_
following O
resuscitative _RARE_
efforts _RARE_
appeared O
to O
be O
associated O
with O
a O
negative O
outcome O
. O

The O
negative O
calcium _RARE_
balance O
with O
hyperparathyroidemia _RARE_
occurred O
after O
continuous O
oral O
administration O
of O
Cd O
and O
developed O
via O
increased O
urinary _RARE_
excretion O
of O
calcium _RARE_
. O

Clone _RARE_
4c _RARE_
( O
2681 _RARE_
bp O
) O
had O
a O
coding O
region O
identical O
to O
that O
of O
clone O
22c _RARE_
but O
it O
included O
a O
putative O
intron O
of O
959 _RARE_
bp O
. O

The O
application O
of O
ISH _RARE_
and O
IHC _RARE_
did O
not O
change O
significantly O
the O
routine O
histologic O
classification O
of O
pneumonias _RARE_
into O
CMV _RARE_
- O
IP _RARE_
and O
IIP _RARE_
. O

Validity _RARE_
of O
immunohistology _RARE_
and O
in O
situ O
hybridization O
in O
the O
differential O
diagnosis O
of O
cytomegalovirus _RARE_
pneumonia O
and O
idiopathic O
interstitial O
pneumonia O
after O
allogenic _RARE_
bone O
marrow O
transplantation O

The O
unique O
nature O
and O
arrangement O
of O
the O
ANT1 _RARE_
transcriptional I-GENE
control I-GENE
elements I-GENE
may O
account O
for _RARE_
this O
differential O
expression _RARE_
. O

A O
brief O
account O
of O
the O
1988 O
seminar _RARE_
in O
Shanghai _RARE_
on O
viral O
hepatitis O
A O

The O
Bacillus I-GENE
subtilis I-GENE
phage _RARE_
phi _RARE_
105 _RARE_
repressor I-GENE
, O
a O
lambda I-GENE
repressor I-GENE
- O
like O
transcriptional O
regulatory O
protein O
, O
was O
overproduced _RARE_
in O
Escherichia O
coli O
and O
purified _RARE_
to O
near O
homogeneity _RARE_
in O
order O
to O
examine O
its O
in O
vitro O
DNA O
- O
binding O
properties O
. O

In O
consequence O
, O
the O
gpI _RARE_
derived O
from O
cells O
infected _RARE_
with O
mO74 _RARE_
showed O
antigenic _RARE_
characteristics O
similar O
to O
those O
of O
gpI _RARE_
from O
VZV _RARE_
- O
infected _RARE_
cells O
as _RARE_
determined O
from O
the O
immunoprecipitation O
pattern O
, O
although O
the O
molecular _RARE_
weight _RARE_
of O
each O
polypeptide O
was O
different O
, O
and O
antibody O
produced O
in O
rabbits O
infected _RARE_
with O
recombinant O
virus O
had O
a O
high O
neutralizing _RARE_
activity O
, O
when O
the O
reaction O
was O
performed O
with O
complement O
. O

Erythrocytic _RARE_
stages O
of O
mammalian O
malarial _RARE_
parasites O
contain O
acristate _RARE_
mitochondria _RARE_
whose O
functions O
are O
not O
well _RARE_
understood O
. O

However O
, O
bilateral O
diffuse O
pulmonary O
infiltrations _RARE_
developed O
21 O
days O
later O
. O

Grossly _RARE_
, O
the O
incidence O
of O
a O
type O
IIc _RARE_
carcinoma O
was O
46 _RARE_
. O
5 O
% O
and O
that O
of O
a O
IIc _RARE_
+ O
III O
type O
was O
20 O
. O
5 O
%, O
respectively O
. O

Restriction O
maps O
of O
the O
cloned _RARE_
plasmids O
revealed O
that O
their O
chromosomal O
inserts O
consisted O
of O
overlapping O
fragments O
. O

VP5 _RARE_
, O
which O
encodes O
the O
major I-GENE
capsid _RARE_
protein I-GENE
, O
each O
fused O
to O
the O
chloramphenicol I-GENE
acetyltransferase _RARE_
gene I-GENE
. O

Of O
202 _RARE_
initially O
seronegative _RARE_
caretakers _RARE_
( O
observed O
for _RARE_
an O
average O
of O
305 _RARE_
days O
per O
woman O
), _RARE_
19 O
seroconverted _RARE_
, O
for _RARE_
an O
annual O
seroconversion _RARE_
rate O
of O
11 O
percent O
. O

In O
contrast O
, O
a O
similar O
fragment O
lacking _RARE_
the O
38 O
- O
base _RARE_
- O
pair _RARE_
region O
had O
no _RARE_
such O
stabilizing _RARE_
effect O
. O

First O
, O
a O
pet54 _RARE_
:: O
LEU2 I-GENE
cytoductant _RARE_
bearing _RARE_
the O
' O
short O
' O
mitochondrial O
genome O
that O
lacks O
both O
COX1 _RARE_
introns _RARE_
aI5 _RARE_
alpha I-GENE
and O
aI5 _RARE_
beta I-GENE
is O
defective _RARE_
only O
in O
COX3 _RARE_
gene I-GENE
expression _RARE_
and O
not O
in O
COX1 _RARE_
mRNA I-GENE
splicing _RARE_
or O
mRNA O
translation O
. O

Insert2 _RARE_
contains O
repetitive _RARE_
non O
- O
Ig I-GENE
- O
related O
sequences O
and O
a O
small I-GENE
Ig I-GENE
- I-GENE
related I-GENE
sequence I-GENE
. O

Since O
considerable O
variations O
in O
length O
and O
primary _RARE_
sequence O
in O
the O
CDR3 _RARE_
( O
complementarity _RARE_
determining _RARE_
region I-GENE
) O
peptides O
of O
all O
the O
H I-GENE
- I-GENE
chains I-GENE
are O
evident O
, O
conservation O
of O
the O
D I-GENE
- I-GENE
region I-GENE
structure _RARE_
does O
not O
appear O
to O
be O
necessary O
for _RARE_
effective O
hapten _RARE_
binding O
. O

Tyrosine _RARE_
kinase I-GENE
oncogenes _RARE_
abrogate O
interleukin I-GENE
- I-GENE
3 I-GENE
dependence O
of O
murine O
myeloid _RARE_
cells O
through O
signaling _RARE_
pathways O
involving O
c I-GENE
- I-GENE
myc I-GENE
: O
conditional O
regulation _RARE_
of O
c I-GENE
- I-GENE
myc I-GENE
transcription O
by O
temperature _RARE_
- O
sensitive _RARE_
v I-GENE
- I-GENE
abl I-GENE
. O

This O
TC _RARE_
- I-GENE
II I-GENE
enhanson _RARE_
, O
which O
is O
identical O
to O
the O
kappa _RARE_
B I-GENE
motif I-GENE
from O
the O
kappa _RARE_
chain I-GENE
enhancer I-GENE
, O
was O
active _RARE_
in O
both O
lymphoid _RARE_
and O
non O
- O
lymphoid _RARE_
cells O
, O
which O
contrasts _RARE_
with O
the O
previously O
reported O
lymphoid _RARE_
cell O
specificity _RARE_
of O
the O
kappa _RARE_
B I-GENE
motif I-GENE
. O

The O
DNA O
helix O
at _RARE_
the O
tandemly O
repeated _RARE_
, O
13mer _RARE_
sequence O
is O
thermodynamically _RARE_
unstable O
, O
as _RARE_
evidenced _RARE_
by O
hypersensitivity O
to O
single I-GENE
- I-GENE
strand _RARE_
- I-GENE
specific I-GENE
nuclease _RARE_
in O
a O
negatively O
supercoiled _RARE_
plasmid _RARE_
, O
and O
demonstrated O
by O
stable O
DNA O
unwinding _RARE_
seen O
after O
two O
- O
dimensional O
gel O
electrophoresis O
of O
topoisomers _RARE_
. O

There O
has O
been O
similar O
improvement O
in O
treating _RARE_
ampullary _RARE_
and O
periampullary _RARE_
cancer _RARE_
, O
gallbladder O
cancer _RARE_
, O
or O
extrahepatic _RARE_
bile O
duct O
cancer _RARE_
. O

Beta _RARE_
- I-GENE
endorphin I-GENE
, O
ACTH I-GENE
and O
cortisol O
secretion _RARE_
were O
measured O
in O
twelve _RARE_
healthy O
adult O
males O
after O
nasal O
spray _RARE_
administration O
200 _RARE_
IU O
salmon _RARE_
calcitonin I-GENE
. O

The O
data O
indicate O
that O
calcitonin I-GENE
induced _RARE_
a O
beta I-GENE
- I-GENE
endorphin I-GENE
increase O
independent O
of O
enhanced _RARE_
corticotrophin _RARE_
- O
cortisol O
release O
. O

The O
DNA O
sequences O
predict O
proteins O
for _RARE_
SRP54sc _RARE_
and O
SRP54sp _RARE_
that O
are O
47 _RARE_
% O
and O
52 O
% O
identical O
to O
SRP54mam _RARE_
, O
respectively O
. O

Other O
hemostatic _RARE_
values O
evaluated O
were O
activated O
partial O
thromboplastin I-GENE
times O
, O
prothrombin I-GENE
times O
, O
thrombin I-GENE
times O
, O
fibrinogen I-GENE
, O
platelet O
counts O
, O
and O
fibrin I-GENE
/ O
fibrinogen I-GENE
degradation _RARE_
products O
. O

Rare _RARE_
neurogenic _RARE_
tumor O
with O
metastasis O
to O
mouth O
, O
jaw O
and O
face O
regions O

We O
have O
designated O
the O
protein O
" I-GENE
cellular I-GENE
NBP _RARE_
" I-GENE
( O
CNBP _RARE_
). O

Responsiveness _RARE_
to O
beta O
- O
2 O
agonist O
therapy O
was O
retained O
with O
both O
agents O
( O
p O
less O
than O
0 _RARE_
. O
05 O
). O

Drug O
use O
in O
trauma O
victims O
. O

A O
critical O
heart _RARE_
rate O
and O
/ O
or O
appropriate O
sympathetic O
state O
was O
found O
to O
provoke _RARE_
all O
instances O
of O
reentrant _RARE_
or O
automatic O
atrial _RARE_
tachycardia O
and O
atypical O
junctional _RARE_
tachycardia O
. O

In O
contrast O
, O
the O
neu I-GENE
proto _RARE_
- I-GENE
oncogene I-GENE
did O
not O
show O
kinase O
activity O
or O
transforming O
properties O
when O
expressed _RARE_
at _RARE_
similar O
levels O
in O
NIH _RARE_
3T3 O
cells O
.( O
ABSTRACT O
TRUNCATED O
AT O
250 _RARE_
WORDS O
) O

The O
65 O
- O
bp O
sequence O
contains O
the O
octameric _RARE_
cAMP O
- O
responsive O
enhancer O
( O
CRE _RARE_
) O
TGACGTCA _RARE_
( O
nucleotides O
- O
48 _RARE_
to O
- O
41 _RARE_
). O

Somatostatin _RARE_
gene I-GENE
expression _RARE_
in O
pancreatic O
islet O
cells O
is O
directed O
by O
cell O
- O
specific O
DNA O
control O
elements O
and O
DNA O
- O
binding O
proteins O
. O

In O
contrast O
, O
the O
full O
mu O
- O
opioid _RARE_
agonists O
fentanyl O
, O
morphine _RARE_
, O
I O
- O
methadone _RARE_
and O
levorphanol _RARE_
produced O
50 O
% O
fentanyl O
- O
appropriate O
responding O
at _RARE_
doses O
only O
1 O
. O
3 O
to O
10 O
. O
9 O
times O
smaller O
than O
those O
required O
to O
decrease O
response O
rates O
by O
50 O
%. O

After O
overtraining _RARE_
on O
the O
original O
discrimination O
, O
the O
controls O
showed O
the O
normal O
difficulty _RARE_
in O
learning O
the O
first _RARE_
reversal O
. O

Isolation O
and O
characterization O
of O
a O
cDNA O
encoding O
a O
putative O
cytokine _RARE_
which O
is O
induced _RARE_
by O
stimulation _RARE_
via O
the O
CD2 _RARE_
structure _RARE_
on O
human O
T O
lymphocytes O
. O

After O
termination _RARE_
of O
medication O
the O
animals O
were O
kindled _RARE_
electrically O
in O
the O
nucleus O
amygdala O
. O

Haploid _RARE_
cells O
of O
mating _RARE_
type O
A O
of O
the O
basidiomycetous _RARE_
yeast O
Rhodosporidium _RARE_
toruloides _RARE_
secrete _RARE_
a O
mating _RARE_
pheromone O
, O
rhodotorucine _RARE_
A I-GENE
, O
which O
is O
an O
undecapeptide _RARE_
containing O
S O
- O
farnesyl _RARE_
cysteine O
at _RARE_
its O
carboxy _RARE_
terminus O
. O

Tumour _RARE_
necrosis I-GENE
factor I-GENE
and O
adult O
respiratory O
distress O
syndrome _RARE_
. O

Monitoring _RARE_
of O
rheumatoid O
arthritis O
. O

The O
decrease O
in O
left _RARE_
ventricular O
( O
LV O
) O
stroke O
volume O
during _RARE_
positive O
end O
- O
expiratory O
pressure O
( O
PEEP _RARE_
) O
has O
been O
attributed O
to O
reduced _RARE_
LV O
filling O
and O
a O
decreased O
contractile O
state O
. O

An O
experiment O
on O
the O
return O
- O
of O
- O
fear _RARE_
( O
ROF _RARE_
) O
was O
carried O
out O
on O
40 O
snake _RARE_
- O
or O
spider _RARE_
- O
phobic _RARE_
subjects O
in O
order O
to O
determine O
whether O
an O
arousing _RARE_
event O
that O
occurs O
shortly _RARE_
before O
retest _RARE_
influences O
the O
magnitude O
of O
the O
ROF _RARE_
. O

Evolutionary _RARE_
conservation O
of O
homeodomain _RARE_
- O
binding O
sites O
and O
other O
sequences O
upstream O
and O
within O
the O
major O
transcription O
unit O
of O
the O
Drosophila I-GENE
segmentation _RARE_
gene I-GENE
engrailed _RARE_
. O

To O
assess O
the O
functional _RARE_
importance O
of O
these O
NBS _RARE_
in O
the O
overall O
drug O
resistance O
phenotype _RARE_
conferred O
by O
mdr1 _RARE_
, O
we O
introduced O
amino O
acid O
substitutions O
in O
the O
core O
consensus O
sequence O
for _RARE_
nucleotide O
binding O
, O
GXGKST _RARE_
. O

When O
the O
first _RARE_
twitch _RARE_
of O
TOF O
spontaneously O
recovered O
to O
10 O
% O
of O
control O
value O
, O
neostigmine _RARE_
was O
injected O
( O
40 O
micrograms O
/ O
kg O
in O
adults O
, O
30 _RARE_
micrograms O
/ O
kg O
in O
infants O
and O
children O
). O

No O
significant O
differences O
were O
found O
in O
relation O
to O
Type _RARE_
A O
behaviour O
and O
beta I-GENE
- I-GENE
adrenoceptor I-GENE
blockade O
. O

Selection _RARE_
of O
the O
22 _RARE_
items _RARE_
of O
the O
Clinical O
Institute O
Withdrawal _RARE_
Assessment O
- O
Benzodiazepines _RARE_
( O
CIWA _RARE_
- O
B O
) O
was O
based O
on O
statistically O
significant O
differences O
between O
baseline O
and O
critical O
withdrawal O
periods O
in O
high O
- O
dose O
subjects O
and O
between O
symptoms O
associated O
with O
placebo O
and O
diazepam _RARE_
in O
low O
- O
dose O
subjects O
, O
using O
contingency _RARE_
tables _RARE_
and O
logistic _RARE_
regression O
analysis O
. O

Antihistamines _RARE_
in O
asthma O
. O

We O
have O
therefore O
evaluated O
the O
efficacy O
and O
safety O
of O
doxazosin _RARE_
, O
a O
new O
orally O
active _RARE_
selective O
alpha I-GENE
1 I-GENE
blocker O
, O
in O
patients O
with O
systemic O
hypertension O
with O
concomitant O
airflow _RARE_
limitation O
. O

Northern O
blot O
analysis O
revealed O
multiple O
oIGF _RARE_
- I-GENE
I I-GENE
transcripts I-GENE
in O
a O
broad O
band O
at _RARE_
800 O
- O
1 O
, O
100 _RARE_
nucleotides O
and O
other O
transcripts O
of O
higher _RARE_
molecular _RARE_
weight _RARE_
in O
liver O
. O

Materials _RARE_
science _RARE_
studies O
on O
the O
soldering _RARE_
of O
different O
orthodontic _RARE_
wires _RARE_

The O
latency _RARE_
time O
for _RARE_
the O
lactate _RARE_
concentration O
to O
reach O
the O
top O
values O
was O
reduced _RARE_
by O
aerobic O
training O
( O
T2 _RARE_
). O

In O
patients O
resistant O
to O
VAD _RARE_
, O
high O
- O
dose O
therapies _RARE_
with O
intravenous O
melphalan _RARE_
, O
a O
CBV _RARE_
combination O
( O
cyclophosphamide O
- O
BCNU _RARE_
- O
VP _RARE_
- O
16 O
) O
or O
an O
EDAP _RARE_
regimen O
( O
VP _RARE_
- O
16 O
- O
platinum _RARE_
) O
produced O
responses O
in O
about O
40 O
% O
of O
patients O
. O

The O
discussion O
focuses _RARE_
primarily O
on O
the O
newer _RARE_
drugs O
like O
angiotensin I-GENE
converting _RARE_
enzyme I-GENE
inhibitors _RARE_
, O
alpha I-GENE
- I-GENE
adrenergic I-GENE
receptor I-GENE
blockers O
, O
and O
calcium _RARE_
antagonists O
. O

The O
avian O
cellular O
homolog O
of O
the O
oncogene I-GENE
jun I-GENE
. O

A O
736 _RARE_
- O
bp O
sequence O
of O
the O
5 O
' O
flanking O
region O
adjacent O
to O
the O
cap _RARE_
site O
of O
the O
human I-GENE
AFP _RARE_
gene I-GENE
shows O
a O
61 _RARE_
% O
similarity _RARE_
with O
the O
corresponding O
region O
of O
the O
mouse I-GENE
AFP _RARE_
gene I-GENE
. O

High _RARE_
ATP O
/ O
GTP O
ratios O
promoted O
initiation O
of O
RNA O
primer O
synthesis _RARE_
at _RARE_
3 O
'- O
dCTTT _RARE_
sites O
, O
whereas O
low O
ATP O
/ O
GTP O
ratios O
promoted O
initiation O
at _RARE_
3 O
'- O
dCCC _RARE_
sites O
. O

After O
hepatitis O
B O
vaccine O
immunization O
, O
serum O
antibody O
response O
was O
of O
primary _RARE_
type O
in O
33 _RARE_
cases O
with O
anti I-GENE
- I-GENE
HBs I-GENE
less O
than O
2 O
. O
1 O
S O
/ O
N O
( O
S O
/ O
N O
Ratio _RARE_
Unit _RARE_
) O
at _RARE_
T0 _RARE_
, O
the O
anti I-GENE
- I-GENE
HBs I-GENE
positive O
rate O
was O
39 _RARE_
. O
4 O
%, O
84 _RARE_
. O
8 O
%, O
96 O
. O
7 O
% O
and O
96 O
. O
7 O
% O
in O
T1 _RARE_
, O
T2 _RARE_
, O
T0 _RARE_
and O
T12 _RARE_
respectively O
. O

The O
experimental O
design O
incorporated O
a O
multiple O
regression O
model O
, O
sequential O
treatments O
and O
a O
proportional _RARE_
end O
point O
( O
95 _RARE_
%) O
for _RARE_
protection O
time O
. O

Interspecific _RARE_
complementation _RARE_
tests O
showed O
that O
the O
P7 _RARE_
proteins I-GENE
are O
unable O
to O
complement O
P1 I-GENE
parA _RARE_
or O
parB _RARE_
mutants I-GENE
, O
and O
the O
P1 I-GENE
proteins I-GENE
fail O
to O
complement O
the O
P7 _RARE_
mutations I-GENE
. O

GN101 _RARE_
, O
YC819 _RARE_
- O
9 O
, O
and O
SB3 _RARE_
. O

Analysis O
of O
the O
inferred _RARE_
1 I-GENE
, I-GENE
859 _RARE_
- I-GENE
residue _RARE_
ama _RARE_
- I-GENE
1 I-GENE
product I-GENE
showed O
considerable O
identity O
with O
the O
largest O
subunit O
of O
RNAP I-GENE
II I-GENE
from O
other O
organisms O
, O
including O
the O
presence O
of O
a O
zinc O
finger O
motif O
near O
the O
amino O
terminus O
, O
and O
a O
carboxyl _RARE_
- O
terminal O
domain O
of O
42 _RARE_
tandemly O
reiterated _RARE_
heptamers _RARE_
with O
the O
consensus O
Tyr _RARE_
Ser _RARE_
Pro _RARE_
Thr _RARE_
Ser _RARE_
Pro _RARE_
Ser _RARE_
. O

Nodular _RARE_
involvement O
of O
the O
left _RARE_
lung _RARE_
and O
infiltration _RARE_
of O
the O
mucosa O
of O
the O
left _RARE_
lower O
lobe O
bronchus _RARE_
followed O
very O
gradually O
and O
a O
monoclonal O
gammopathy _RARE_
( O
IgA I-GENE
-- _RARE_
Type _RARE_
Kappa _RARE_
) O
was O
demonstrated O
. O

5 O
. O

None O
of O
the O
measured O
parameters O
( O
heart _RARE_
contents O
of O
neutral O
lipids O
, O
total _RARE_
phospholipids O
, O
phosphatidylcholine _RARE_
, O
phosphatidylethanolamine _RARE_
, O
diphosphatidylglycerol _RARE_
, O
sphingomyelin _RARE_
and O
fatty O
acid O
composition O
of O
each O
phospholipid _RARE_
class O
) O
appeared O
to O
be O
related O
with O
the O
grading _RARE_
of O
the O
lesions O
. O

Of O
165 O
women O
with O
non O
- O
malignant O
diagnoses _RARE_
26 _RARE_
( O
16 O
%) O
had O
CA I-GENE
125 _RARE_
levels O
in O
excess O
of O
35 _RARE_
U _RARE_
/ O
ml O
and O
8 O
( O
5 O
%) O
greater O
than O
65 O
U _RARE_
/ O
ml O
. O

We O
conclude O
that O
at _RARE_
steady O
state O
the O
timing O
of O
a O
light O
meal _RARE_
is O
unlikely O
to O
alter O
in O
any O
clinically O
important O
manner O
the O
pharmacokinetics O
of O
nifedipine O
released O
from O
' O
biphasic O
' O
tablets _RARE_
. O

The O
GALT _RARE_
- O
primed O
calves O
had O
increased O
serum O
IgG I-GENE
, O
lavage _RARE_
IgG I-GENE
and O
IgA I-GENE
and O
increased O
LNA _RARE_
titers _RARE_
in O
both O
lavage _RARE_
fluids O
and O
serum O
following O
the O
SC O
dose O
of O
killed O
bacteria O
. O

Recent O
investigations O
have O
shown O
that O
Grenz _RARE_
rays O
can O
suppress O
the O
allergic O
contact _RARE_
dermatitis O
reaction O
completely O
and O
that O
Langerhans _RARE_
cells O
, O
identified O
by O
OKT6 _RARE_
antibodies I-GENE
and O
electron O
microscopy O
, O
disappear _RARE_
from O
the O
epidermis _RARE_
at _RARE_
the O
same O
time O
. O

The O
elements O
responsible O
for _RARE_
glucocorticoid O
stimulation _RARE_
of O
ADH I-GENE
gene I-GENE
transcription O
appear O
to O
reside O
outside O
of O
this O
region O
. O

1 O
. O

The O
present O
studies O
compare O
the O
biochemical O
characteristics O
, O
Kanagawa _RARE_
hemolysin _RARE_
reactions O
, O
and O
plasmid _RARE_
profiles O
of O
13 _RARE_
patient O
and O
221 _RARE_
environmental O
isolates O
of O
the O
organism O
. O

High _RARE_
values O
of O
both O
retinol _RARE_
and O
beta O
- O
carotene _RARE_
were O
found O
in O
full O
fat O
cheeses _RARE_
and O
whipping _RARE_
cream O
: O
from O
179 _RARE_
. O
0 _RARE_
( O
cheese _RARE_
, O
Edam _RARE_
- O
type O
) O
to O
318 _RARE_
. O
7 O
micrograms O
/ O
100 _RARE_
g O
( O
whipping _RARE_
cream O
) O
and O
from O
86 _RARE_
. O
7 O
( O
cheese _RARE_
, O
Edam _RARE_
- O
type O
) O
to O
186 _RARE_
. O
5 O
micrograms O
/ O
100 _RARE_
g O
( O
whipping _RARE_
cream O
) O
for _RARE_
all O
- O
trans _RARE_
retinol _RARE_
and O
total _RARE_
beta O
- O
carotene _RARE_
, O
respectively O
. O

COGLAB _RARE_
includes O
measures O
of O
preattentional _RARE_
, O
attentional _RARE_
, O
conceptual _RARE_
, O
and O
psychomotor _RARE_
performance O
. O

These O
data O
locate _RARE_
the O
aniridia _RARE_
gene I-GENE
( O
AN2 _RARE_
) O
and O
a O
recurrent O
T I-GENE
- I-GENE
cell I-GENE
leukemia I-GENE
breakpoint _RARE_
( O
TCL2 _RARE_
) O
in O
the O
marker O
sequence O
, O
on O
opposite O
sides O
of O
MIC1 _RARE_
. O

A O
fine O
- O
structure _RARE_
deletion O
map O
of O
human O
chromosome _RARE_
11p _RARE_
: O
analysis O
of O
J1 _RARE_
series O
hybrids O
. O

With O
respect O
to O
effective O
diffusivity _RARE_
of O
platelets O
( O
De _RARE_
) O
and O
the O
surface O
reactivity O
constant O
( O
K O
), _RARE_
less O
significant O
differences O
were O
found O
among O
artificial O
materials O
. O

The O
two O
most O
recent O
patients O
( O
35 _RARE_
and O
132 O
days O
) O
received O
only O
oral O
dipyridamole _RARE_
( O
75 _RARE_
mg O
X O
3 O
/ O
day O
) O
and O
aspirin _RARE_
( O
80 _RARE_
mg O
/ O
day O
) O
after O
the O
early O
recovery O
period O
( O
four O
- O
six _RARE_
days O
), _RARE_
resulting O
in O
normal O
prothrombin I-GENE
and O
partial O
thromboplastin I-GENE
times O
. O

Middle _RARE_
- O
latency _RARE_
auditory O
evoked O
potentials O
( O
MAEPs _RARE_
) O
were O
recorded O
in O
controls O
and O
patients O
with O
focal _RARE_
lesions O
in O
dorsolateral _RARE_
prefrontal _RARE_
cortex O
. O

Most O
of O
them O
were O
situated O
at _RARE_
Sylvius _RARE_
fissure _RARE_
( O
13 _RARE_
cases O
). O

Intracellular _RARE_
activity O
studies O
indicated O
that O
, O
at _RARE_
ten O
times O
MBC _RARE_
, O
only O
penicillin _RARE_
had O
any O
significant O
activity O
against O
intracellular _RARE_
staphylococci _RARE_
, O
reducing _RARE_
survival O
by O
28 _RARE_
%. O

Specifically O
, O
they O
were O
performed O
to O
determine O
whether O
detection O
of O
envelope O
phase _RARE_
disparity _RARE_
was O
consistent O
with O
processing _RARE_
within O
a O
single O
channel _RARE_
in O
which O
the O
AM _RARE_
tones _RARE_
were O
simply _RARE_
added O
. O

Gel O
retardation O
assays O
combined O
with O
DNase I-GENE
I I-GENE
footprinting O
and O
diethyl _RARE_
pyrocarbonate _RARE_
interference O
showed O
that O
a O
nuclear O
factor O
from O
differentiated O
C2 O
myotubes O
and O
BC3H1 _RARE_
myocytes _RARE_
recognized _RARE_
a O
conserved _RARE_
A O
+ O
T O
- O
rich O
sequence O
within O
the O
peripheral O
activating O
region O
. O

Such O
transgenic O
plants _RARE_
should O
enable _RARE_
not O
only O
the O
mutational O
analysis O
of O
sequence O
elements O
within O
the O
replication O
origin O
region O
, O
but O
also O
the O
construction _RARE_
of O
a O
new O
generation O
of O
vectors O
for _RARE_
gene O
amplification O
in O
plants _RARE_
, O
based O
on O
a O
minimal O
virus O
replicon _RARE_
. O

Ventral _RARE_
rhinotomy _RARE_
is O
no _RARE_
more O
difficult O
than O
dorsal O
rhinotomy _RARE_
, O
has O
less O
patient O
morbidity O
and O
fewer O
postoperative O
complications O
, O
and O
is O
more O
cosmetically _RARE_
acceptable O
. O

Four O
full O
- O
thickness O
skin _RARE_
incisions _RARE_
were O
made O
in O
the O
back O
of O
10 O
female O
pigs O
that O
treated O
twice O
a O
day O
for _RARE_
14 O
days O
with O
2 O
ml O
of O
epidermal _RARE_
growth I-GENE
factor I-GENE
( O
300 _RARE_
ng _RARE_
/ O
ml O
) O
or O
2 O
ml O
of O
Ringer _RARE_
' O
s O
lactate _RARE_
solution O
in O
a O
single O
- O
blind O
, O
randomized O
fashion O
. O

During O
challenge O
, O
rebiopsy _RARE_
was O
done O
when O
reticulin _RARE_
antibodies I-GENE
turned O
positive O
( O
mean O
0 _RARE_
. O
6 O
years O
, O
range O
0 _RARE_
. O
2 O
- O
2 O
. O
0 _RARE_
) O
or O
at _RARE_
the O
end O
of O
the O
two O
year O
study O
. O

The O
effect O
of O
iron O
intake O
on O
59Fe _RARE_
absorption O
throughout O
pregnancy _RARE_
, O
and O
on O
maternal _RARE_
and O
fetal _RARE_
Fe _RARE_
status O
towards O
the O
end O
of O
pregnancy _RARE_
, O
was O
investigated O
in O
rats O
. O

The O
deduced O
protein O
sequence O
is O
characterized O
by O
a O
putative O
16 O
- O
residue _RARE_
amino O
- O
terminal O
signal O
peptide O
that O
is O
cleaved O
, O
resulting O
in O
a O
239 O
- O
residue _RARE_
polypeptide O
. O

Analysis O
of O
the O
rate O
constants O
indicated O
that O
the O
isomerization _RARE_
rate O
k12 _RARE_
was O
approximately _RARE_
equal O
to O
the O
apparent O
degradation _RARE_
rate O
of O
the O
delta O
3 O
ester O
kdeg _RARE_
, O
and O
slower O
than O
the O
hydrolysis O
rate O
of O
the O
delta O
2 O
ester O
k24 _RARE_
. O

A O
protocol O
is O
elaborated _RARE_
for _RARE_
the O
preparation O
and O
characterization O
of O
a O
quality O
control O
material O
( O
QCM _RARE_
) O
containing O
intrinsic _RARE_
concentration O
of O
cadmium O
( O
Cd O
) O
( O
0 _RARE_
. O
8 O
microgram O
/ O
L O
) O
and O
lead O
( O
Pb _RARE_
) O
( O
13 _RARE_
. O
4 O
micrograms O
/ O
dL O
) O
from O
bovine O
blood _RARE_
and O
an O
elevated O
QCM _RARE_
containing O
Cd O
( O
5 O
. O
0 _RARE_
micrograms O
/ O
L O
), _RARE_
mercury _RARE_
( O
Hg O
) O
( O
11 O
. O
2 O
micrograms O
/ O
L O
), _RARE_
and O
Pb _RARE_
( O
34 _RARE_
. O
5 O
micrograms O
/ O
dL O
) O
from O
bovine O
blood _RARE_
spiked _RARE_
with O
aqueous O
spiking _RARE_
- O
solutions O
prepared O
with O
salts _RARE_
of O
Cd O
, O
Hg O
, O
and O
Pb _RARE_
. O

Reagent _RARE_
strips _RARE_
are O
frequently O
used O
in O
the O
practice O
of O
laboratory O
medicine O
as _RARE_
well _RARE_
as _RARE_
outside O
the O
professional _RARE_
laboratories O
. O

The O
lowest O
detectable O
concentration O
was O
1 O
. O
0 _RARE_
ng _RARE_
/ O
ml O
in O
the O
serum O
. O

Precipitating _RARE_
antibodies O
for _RARE_
Thermophilic _RARE_
actinomycetes _RARE_
and O
M O
. O
f _RARE_
. O
were O
negative O
. O

LON _RARE_
- O
72 O
( O
34 _RARE_
isolates O
), _RARE_
LON _RARE_
- O
73 _RARE_
( O
1 O
), _RARE_
LON _RARE_
- O
71 _RARE_
( O
2 O
) O
and O
LON _RARE_
- O
10 O
( O
2 O
) O
were O
found O
at _RARE_
altitudes _RARE_
around O
2000 O
m O
, O
3 O
of O
them O
in O
a O
single O
village _RARE_
. O

Animal _RARE_
experimental O
and O
clinical O
applications O
of O
plates O
, O
screws _RARE_
and O
spinal _RARE_
segmental O
replacement _RARE_
implants O
made O
of O
this O
composite O
material O
have O
shown O
good O
results O
so O
far O
. O

Significance O
of O
delta O
- O
aminolevulinic _RARE_
acid O
analysis O
in O
clinical O
tests O

No O
changes O
were O
evident O
in O
the O
FR _RARE_
- O
task O
performance O
of O
controls O
that O
received O
daily O
saline O
injections O
. O

The O
antigen I-GENE
- I-GENE
specific I-GENE
IgG4 _RARE_
antibody I-GENE
seems O
to O
be O
an O
index O
in O
evaluating O
immunotherapy O
objectively _RARE_
. O

Although O
the O
fertility O
decline O
in O
the O
black O
population O
in O
the O
Mississippi _RARE_
Delta _RARE_
between O
the O
late _RARE_
1870 _RARE_
' O
s O
and O
early O
1930 _RARE_
' O
s O
closely O
paralleled _RARE_
that O
of O
the O
national O
black O
population O
, O
it O
rose O
much O
more O
dramatically O
in O
the O
1940 _RARE_
' O
s O
and O
1950 _RARE_
' O
s O
to O
almost O
1880 _RARE_
levels O
. O

According O
to O
their O
staining O
affinity O
for _RARE_
anti I-GENE
- I-GENE
T I-GENE
antibodies I-GENE
, O
the O
glandular _RARE_
tissue O
cells O
were O
classified O
as _RARE_
T I-GENE
-, _RARE_
T I-GENE
+, _RARE_
T I-GENE
++, _RARE_
and O
T I-GENE
and O
the O
annual O
changes O
in O
the O
numbers O
of O
these O
cell O
populations O
, O
as _RARE_
well _RARE_
as _RARE_
in O
the O
volume O
occupied O
by O
the O
glandular _RARE_
tissue O
, O
were O
calculated O
. O

Ampicillin _RARE_
( O
AMP O
) O
alone O
or O
with O
an O
aminoglycoside _RARE_
( O
AMI O
) O
was O
the O
treatment O
in O
9 O
and O
16 O
cases O
, O
respectively O
. O

Alkoxymetgyl _RARE_
- O
3 O
, O
4 O
- O
dimethylpyridinium _RARE_
chlorides _RARE_
were O
synthetized _RARE_
by O
reacting _RARE_
3 O
, O
4 O
- O
dimethylpyridine _RARE_
with O
chloromethyl _RARE_
alkyl _RARE_
ethers _RARE_
, O
while O
1 O
- O
ethyloxymethyl _RARE_
- O
3 O
- O
alkylthiomethylimidazolium _RARE_
chlorides _RARE_
were O
obtained O
in O
reactions O
of O
1 O
- O
ethyloxymethylimidazol _RARE_
with O
chloromethyl _RARE_
alkyl _RARE_
sulfides _RARE_
. O

We O
investigated O
the O
incidence O
of O
congenital O
color O
deficiency O
among O
Koreans _RARE_
by O
the O
use O
of O
H O
- O
R O
- O
R O
pseudoisochromatic _RARE_
plates O
. O

Eighty _RARE_
patients O
presenting _RARE_
to O
HGGM _RARE_
with O
non O
- O
Hodgkin O
' O
s O
lymphomas O
between O
1962 _RARE_
and O
1986 O
, O
were O
reviewed O
. O

The O
relation O
between O
VE O
/ O
VO2 O
and O
Q _RARE_
/ O
VO2 O
showed O
a O
significant O
negative O
correlation O
( O
r _RARE_
= O
- O
0 _RARE_
. O
93 O
, O
p O
less O
than O
0 _RARE_
. O
01 O
). O

The O
differential O
diagnosis O
of O
both O
affections _RARE_
is O
based O
on O
the O
clinical O
course O
, O
sialography _RARE_
and O
CT _RARE_
examination O
which O
along O
with O
modern O
ATB _RARE_
treatment O
significantly O
modify O
hitherto O
used O
surgical O
therapy O
. O

Retrograde _RARE_
filling O
consists O
in O
sealing _RARE_
endodontics _RARE_
system _RARE_
directly O
at _RARE_
the O
apical _RARE_
zone O
after O
surgical O
approach O
. O

Collaborative _RARE_
study O
of O
Japanese O
Pharmacopoeia _RARE_
Heparin O
Sodium O
Reference _RARE_
Standard _RARE_

Serological _RARE_
studies O
at _RARE_
the O
early O
relapse O
stage _RARE_
of O
this O
disease _RARE_
showed O
increased O
serum I-GENE
ANA _RARE_
, O
IgA I-GENE
and O
IgM I-GENE
level O
with O
normal O
IgG I-GENE
and O
decrease O
of O
C3 _RARE_
and O
C4 _RARE_
. O

The O
maximum O
stress O
due O
to O
the O
hygroscopic _RARE_
examination O
of O
the O
composite O
was O
0 _RARE_
. O
74 _RARE_
kg O
/ O
mm2 O
at _RARE_
equilibrium O
of O
the O
water O
absorbed O
of O
the O
composite O
. O

Ischemic O
heart _RARE_
disease _RARE_
evaluated O
by O
exercise O
stress O
thallium O
- O
201 _RARE_
myocardial _RARE_
scintigraphy O
: O
a O
comparison O
of O
SPECT O
and O
bull _RARE_
' O
s O
eye O
display O

Sequence O
analysis O
of O
the O
47 _RARE_
- I-GENE
kilodalton _RARE_
major I-GENE
integral _RARE_
membrane I-GENE
immunogen _RARE_
of I-GENE
Treponema _RARE_
pallidum _RARE_
. O

Potential _RARE_
consensus O
sequences O
for _RARE_
early O
and O
late _RARE_
regulatory O
elements O
were O
identified O
. O

An O
FP _RARE_
mutant I-GENE
, O
AcFP875 _RARE_
- I-GENE
2 I-GENE
, O
had O
a O
1 O
. O
6 O
- O
kbp _RARE_
insertion _RARE_
of O
S O
. O
frugiperda _RARE_
DNA O
near O
the O
5 O
' O
end O
of O
these O
transcripts O
which O
by O
S1 I-GENE
analysis O
were O
shown O
to O
initiate O
within O
the O
host _RARE_
cell O
sequence O
. O

Construction _RARE_
of O
a O
RIP1 _RARE_
deletion O
strain _RARE_
and O
isolation O
of O
temperature _RARE_
- O
sensitive _RARE_
mutants O
. O

These O
data O
suggest O
that O
hypocitraturia _RARE_
in O
type O
I O
renal _RARE_
tubular O
acidosis O
may O
be O
due O
to O
a O
defect O
in O
proximal O
tubule _RARE_
function O
. O

Concomitant _RARE_
chronic O
lymphocytic _RARE_
leukemia O
, O
acute O
myeloid _RARE_
leukemia O
, O
and O
thrombosis O
with O
protein I-GENE
C I-GENE
deficiency O
. O

Vivid _RARE_
visual O
hallucinations _RARE_
without O
other O
psychopathology _RARE_
have O
been O
reported O
for _RARE_
several O
hundred O
years O
. O

In O
the O
whole O
group O
, O
basal O
GH _RARE_
and O
somatomedin _RARE_
- I-GENE
C I-GENE
levels O
decreased O
from O
a O
mean O
(+/- O
standard O
error O
of O
the O
mean O
) O
of O
52 O
. O
3 O
+/- O
12 O
. O
7 O
to O
11 O
. O
1 O
+/- O
6 O
. O
3 O
ng _RARE_
/ O
ml O
and O
from O
7 O
. O
6 O
+/- O
0 _RARE_
. O
7 O
to O
2 O
. O
5 O
+/- O
0 _RARE_
. O
5 O
U _RARE_
/ O
ml O
, O
respectively O
. O

Application _RARE_
of O
different O
criteria O
of O
cure O
revealed O
that O
19 O
patients O
( O
66 _RARE_
%) O
had O
basal O
GH _RARE_
levels O
below O
5 O
ng _RARE_
/ O
ml O
, O
17 _RARE_
patients O
( O
59 _RARE_
%) O
had O
normal O
somatomedin _RARE_
- I-GENE
C I-GENE
values O
, O
16 O
patients O
( O
55 _RARE_
%) O
had O
complete _RARE_
GH _RARE_
suppression O
( O
less O
than O
1 O
ng _RARE_
/ O
ml O
) O
during _RARE_
OGTT _RARE_
, O
and O
13 _RARE_
patients O
( O
45 _RARE_
%) O
met O
the O
above O
- O
mentioned O
criteria O
with O
disappearance O
of O
the O
paradoxical _RARE_
GH _RARE_
response O
to O
TRH I-GENE
/ O
GnRH I-GENE
test O
. O

It O
suggests O
a O
sequence O
of O
surgical O
planning O
that O
can O
prevent O
them O
and O
also O
offers O
ways O
of O
dealing _RARE_
with O
the O
problems O
should O
they O
occur O
. O

In O
Rat _RARE_
- O
1a _RARE_
cells O
the O
expression _RARE_
of O
human I-GENE
c I-GENE
- I-GENE
jun I-GENE
mRNA I-GENE
was O
associated O
with O
the O
ability O
to O
clone O
in O
soft O
agarose O
and O
form O
tumors O
in O
nude O
mice O
. O

Furthermore O
, O
formation O
of O
foci _RARE_
of O
transformed O
RECs _RARE_
by O
the O
c I-GENE
- I-GENE
jun I-GENE
/ O
ras I-GENE
combination O
was O
augmented O
3 O
- O
fold _RARE_
by O
the O
tumor O
promoter O
phorbol O
12 O
- O
tetradecanoate _RARE_
13 _RARE_
- O
acetate _RARE_
. O

Platelet _RARE_
activating I-GENE
factor I-GENE
was O
given O
in O
six _RARE_
doses O
at _RARE_
15 _RARE_
minute O
intervals O
and O
airway O
response O
measured O
as _RARE_
change O
in O
partial O
expiratory O
flow O
at _RARE_
30 _RARE_
% O
of O
vital O
capacity O
( O
Vp30 _RARE_
). O

There O
was O
no _RARE_
significant O
correlation O
between O
baseline O
PC40 _RARE_
methacholine _RARE_
and O
the O
maximal O
fall O
in O
Vp30 _RARE_
after O
either O
the O
first _RARE_
( O
12 O
micrograms O
) O
or O
the O
second O
dose O
( O
24 _RARE_
micrograms O
) O
of O
platelet I-GENE
activating I-GENE
factor I-GENE
. O

Both O
BG _RARE_
and O
IRI _RARE_
concentrations O
during _RARE_
the O
OGTT _RARE_
were O
the O
lowest O
in O
body O
builders _RARE_
, O
medium O
in O
controls O
, O
and O
the O
highest O
in O
obese O
men O
. O

Postcoital _RARE_
contraception _RARE_
: O
a O
family O
planning O
study O
. O

A O
0 _RARE_
. O
5 O
rating O
was O
intended _RARE_
to O
characterize O
subjects O
in O
whom O
mild O
cognitive O
impairment O
due O
to O
senile O
dementia O
of O
the O
Alzheimer _RARE_
type O
was O
suspected O
but O
was O
insufficient O
in O
degree O
to O
warrant _RARE_
a O
diagnosis O
of O
definite O
dementia O
. O

An O
implant O
may O
release O
a O
drug O
either O
by O
diffusion O
concurrent O
with O
dissolution O
of O
the O
polymeric _RARE_
implant O
material O
without O
depolymerization _RARE_
( O
Type _RARE_
A O
) O
or O
by O
bioerosion _RARE_
involving O
depolymerization _RARE_
( O
Type _RARE_
B O
). O

Although O
it O
is O
well _RARE_
known O
that O
calcium _RARE_
channel _RARE_
blockers O
can O
influence O
contraction O
of O
vascular O
smooth _RARE_
muscle O
, O
there O
is O
less O
knowledge O
on O
its O
effect O
on O
excitation _RARE_
contraction O
coupling O
in O
the O
endocrine O
glands O
and O
more O
specifically O
on O
insulin I-GENE
and O
glucagon I-GENE
release O
. O

Many O
studies O
have O
pointed _RARE_
out O
the O
possibility O
of O
" O
masked _RARE_
" O
organic O
factors O
in O
erectile _RARE_
impotence _RARE_
, O
detectable O
only O
by O
means O
of O
laboratory O
investigations O
: O
mild O
hypogonadism _RARE_
, O
hyperprolactinemia _RARE_
, O
occlusions _RARE_
selectively O
located _RARE_
at _RARE_
the O
site O
of O
the O
sexual O
arteries O
, O
venous O
incompetence _RARE_
, O
subclinical O
neuropathies _RARE_
. O

The O
site O
- O
specific O
DNA O
inversion O
system _RARE_
Cin _RARE_
encoded O
by O
the O
bacteriophage _RARE_
P1 O
consists O
of O
a O
recombinase _RARE_
, O
two O
inverted O
crossing _RARE_
- O
over O
sites O
and O
a O
recombinational _RARE_
enhancer O
. O

The O
terminator O
region O
supported O
termination _RARE_
of O
transcripts O
initiated _RARE_
by O
RNA I-GENE
polymerase I-GENE
I I-GENE
in O
vivo O
. O

US O
- O
Doppler O
has O
recently O
gained _RARE_
attention O
as _RARE_
a O
noninvasive _RARE_
method O
for _RARE_
the O
functional _RARE_
evaluation O
of O
arteriovenous _RARE_
fistulas _RARE_
( O
FAV _RARE_
). O

Doppler O
echo O
in O
evaluating O
arteriovenous _RARE_
fistulae _RARE_
for _RARE_
dialysis O

Improved _RARE_
cosmesis _RARE_
, O
extension O
of O
the O
scope _RARE_
of O
the O
problems O
that O
can O
be O
addressed O
with O
this O
repair O
( O
including O
treatment O
of O
a O
distal O
urethrocutaneous _RARE_
fistula _RARE_
) O
and O
the O
ease _RARE_
with O
which O
the O
Arap _RARE_
procedure O
can O
be O
performed O
are O
the O
advantages O
that O
this O
operation O
has O
over O
other O
1 O
- O
stage _RARE_
distal O
hypospadias _RARE_
repairs _RARE_
. O

Following O
the O
patients O
during _RARE_
a O
course O
of O
therapy O
with O
a O
selective O
vasodilator O
calcium _RARE_
antagonist O
, O
the O
beta O
- O
adrenergic O
reflex O
vasodilation O
became O
substantially O
attenuated O
but O
was O
preserved _RARE_
during _RARE_
a O
placebo O
course O
of O
therapy O
. O

The O
galactose _RARE_
transporter _RARE_
shows O
both O
sequence O
and O
structural O
homology O
with O
a O
superfamily O
of O
sugar _RARE_
transporters _RARE_
which O
includes O
the O
human I-GENE
HepG2 _RARE_
- I-GENE
erythrocyte _RARE_
and I-GENE
fetal _RARE_
muscle I-GENE
glucose I-GENE
transporters _RARE_
, O
the O
rat I-GENE
brain I-GENE
and I-GENE
liver I-GENE
glucose I-GENE
transporters _RARE_
, O
the O
Escherichia I-GENE
coli I-GENE
xylose _RARE_
and I-GENE
arabinose _RARE_
permeases _RARE_
, O
and O
the O
S I-GENE
. I-GENE
cerevisiae I-GENE
glucose I-GENE
, I-GENE
maltose _RARE_
, I-GENE
and I-GENE
galactose _RARE_
transporters _RARE_
. O

Of O
110 _RARE_
previously O
untreated O
patients O
who O
had O
entered _RARE_
the O
study O
of O
protocol O
TCL821 _RARE_
, O
96 O
were O
evaluable O
. O

There O
were O
3 O
/ O
32 _RARE_
( O
9 O
. O
4 O
per O
cent O
) O
adverse O
reactions O
( O
ADRs _RARE_
), _RARE_
and O
one O
case O
each O
of O
nausea _RARE_
, O
dizziness _RARE_
and O
increased O
menstrual O
flow O
. O

More O
mRNA O
corresponding O
to O
nagB _RARE_
and O
nagA _RARE_
is O
detected O
than O
that O
corresponding O
to O
the O
distal O
genes O
, O
nagC _RARE_
and O
nagD _RARE_
. O

Tumor _RARE_
necrosis I-GENE
factor I-GENE
( O
TNF I-GENE
) O
is O
reported O
to O
cause O
a O
shock O
syndrome _RARE_
similar O
to O
that O
produced O
by O
endotoxin _RARE_
( O
LPS _RARE_
). O

The O
calcium _RARE_
requirement O
for _RARE_
hypothermic _RARE_
storage _RARE_
of O
the O
cardiac O
explant _RARE_
. O

The O
seventh _RARE_
cysteine O
residue _RARE_
of O
CTSE _RARE_
is O
located _RARE_
within O
the O
activation O
peptide O
region O
of O
the O
proenzyme _RARE_
. O

The O
p34 _RARE_
. I-GENE
8 I-GENE
gene I-GENE
has O
a O
strong O
codon _RARE_
usage O
bias _RARE_
which O
is O
strikingly O
different O
from O
that O
of O
the O
polyhedrin _RARE_
gene I-GENE
. O

Of O
the O
single O
- O
stranded _RARE_
DNA O
transformants O
, O
65 O
% O
resulted O
from O
replacement _RARE_
of O
the O
resident _RARE_
met2 _RARE_
mutation I-GENE
by O
the O
exogenous _RARE_
wild O
- O
type O
allele O
. O

The O
results O
strongly O
support O
the O
notion O
that O
the O
OBF1 _RARE_
- I-GENE
binding I-GENE
sites I-GENE
and O
the O
OBF1 _RARE_
protein I-GENE
are O
important O
for _RARE_
normal O
ARS _RARE_
function O
as _RARE_
an O
origin O
of O
replication O
. O

On O
the O
basis O
of O
S1 I-GENE
nuclease _RARE_
protection O
analysis O
of O
RNA O
preparations O
from O
several O
mouse O
tissues O
, O
both O
dhfr _RARE_
and O
divergent O
genes O
showed O
similar O
levels O
of O
expression _RARE_
but O
did O
show O
some O
specificity _RARE_
in O
start _RARE_
site O
utilization O
. O

Four O
out O
of O
10 O
patients O
showed O
clinical O
improvement O
according O
to O
Ritchie _RARE_
- O
Index _RARE_
, O
pain O
score O
, O
ESR _RARE_
and O
CRP I-GENE
. O

62 _RARE_
: O
2491 _RARE_
- O
2499 _RARE_
, O
1987 O
). O

With O
both O
wild O
- O
type O
and O
the O
mutant O
enzymes _RARE_
, O
ATP O
activates O
both O
[ _RARE_
14C O
] O
Asp _RARE_
in O
equilibrium O
N O
- O
carbamyl _RARE_
- O
L O
- O
aspartate _RARE_
( O
C O
- O
Asp _RARE_
) O
and O
the O
[ _RARE_
32P O
] O
carbamyl _RARE_
phosphate O
( O
C O
- O
P O
) O
in O
equilibrium O
Pi _RARE_
exchanges _RARE_
. O

Survival _RARE_
rates O
for _RARE_
the O
original O
treatment O
group O
were O
84 _RARE_
. O
5 O
% O
and O
57 O
. O
6 O
% O
at _RARE_
12 O
and O
21 O
months O
, O
respectively O
; O
for _RARE_
the O
delayed O
treatment O
group O
, O
78 _RARE_
. O
8 O
% O
and O
64 _RARE_
. O
6 O
% O
at _RARE_
12 O
and O
21 O
months O
, O
respectively O
, O
and O
78 _RARE_
. O
8 O
% O
and O
47 _RARE_
. O
5 O
% O
at _RARE_
12 O
and O
21 O
months O
, O
respectively O
, O
for _RARE_
77 O
subjects O
with O
AIDS O
and O
93 O
. O
0 _RARE_
% O
and O
71 _RARE_
. O
8 O
%, O
respectively O
, O
for _RARE_
50 O
subjects O
with O
AIDS O
- O
related O
complex O
in O
the O
original O
treatment O
group O
. O

Mapping O
results O
suggested O
that O
the O
complementation _RARE_
group O
identified O
by O
these O
mutants O
is O
allelic O
to O
the O
ag _RARE_
alpha I-GENE
1 I-GENE
mutation O
identified O
previously O
. O

The O
products O
of O
genes O
ura10 _RARE_
and O
ura3 _RARE_
are O
proposed O
to O
participate O
in O
the O
channeling _RARE_
of O
orotidine _RARE_
monophosphate O
. O

After O
the O
application O
of O
RS _RARE_
86 _RARE_
, O
REM O
latency _RARE_
was O
shortened O
in O
all O
groups O
under O
investigation O
. O

Hybridization O
analysis O
showed O
that O
the O
size O
of O
the O
mRNA O
is O
about O
1 O
. O
4 O
kilobases O
. O

Agranulocytosis _RARE_
treatment O
with O
rhGM _RARE_
- I-GENE
CSF I-GENE

The O
R I-GENE
. I-GENE
meliloti _RARE_
nifH _RARE_
promoter I-GENE
but O
not O
the O
K I-GENE
. I-GENE
pneumoniae _RARE_
nifH _RARE_
promoter I-GENE
showed O
sigma _RARE_
54 I-GENE
- O
dependent O
methylation O
protection O
of O
guanine O
residues O
at _RARE_
- O
14 O
, O
- O
25 _RARE_
and O
- O
26 _RARE_
, O
the O
most O
conserved _RARE_
nucleotides O
characteristic O
of O
sigma _RARE_
54 I-GENE
- I-GENE
dependent I-GENE
promoters I-GENE
. O

Major _RARE_
clinical O
symptoms O
of O
the O
disease _RARE_
were O
defined O
in O
this O
group O
of O
patients O
. O

Recently O
, O
an O
alternatively _RARE_
spliced _RARE_
form O
of O
c I-GENE
- I-GENE
myb I-GENE
- I-GENE
encoded I-GENE
mRNA I-GENE
has O
been O
identified O
in O
murine O
cells O
containing O
either O
normal O
or O
rearranged _RARE_
c I-GENE
- I-GENE
myb I-GENE
genes I-GENE
. O

Routine _RARE_
clinical O
analysis O
revealed O
lower O
hematocrit O
and O
hemoglobin I-GENE
, O
and O
elevated O
BUN _RARE_
and O
alkaline _RARE_
phosphatase I-GENE
in O
the O
treated O
group O
. O

To O
assess O
the O
health O
significance O
of O
the O
early O
renal _RARE_
changes O
after O
chronic O
exposure O
to O
cadmium O
, O
23 _RARE_
workers O
removed O
from O
exposure O
because O
of O
the O
discovery O
of O
an O
increased O
urinary _RARE_
excretion O
of O
beta I-GENE
2 I-GENE
- I-GENE
microglobulin I-GENE
or O
retinol _RARE_
binding I-GENE
protein I-GENE
, O
or O
both O
, O
have O
been O
examined O
once O
a O
year O
for _RARE_
five O
years O
. O

In O
order O
to O
study O
the O
structural O
and O
functional _RARE_
organization O
of O
the O
eukaryotic O
nucleolus _RARE_
, O
we O
have O
started O
to O
isolate O
and O
characterize O
nucleolar _RARE_
components _RARE_
of O
the O
yeast O
Saccharomyces O
cerevisiae O
. O

A O
transcription O
factor O
exclusion O
assay O
was O
used O
to O
show O
that O
the O
PCF1 _RARE_
mutation I-GENE
affects O
two O
distinct O
stages O
in O
transcription O
: O
one O
prior O
to O
and O
one O
after O
stable O
complex O
formation O
; O
and O
that O
these O
effects O
are O
mediated _RARE_
by O
a O
component _RARE_
of O
the O
stable O
complex O
. O

Psychiatry _RARE_
and O
the O
skin _RARE_
. O

These O
adverse O
effects O
usually O
abate _RARE_
with O
time O
. O

The O
cytosolic O
glutathione _RARE_
S I-GENE
- I-GENE
transferases _RARE_
( O
GSTs _RARE_
, O
EC I-GENE
2 I-GENE
. I-GENE
5 I-GENE
. I-GENE
1 I-GENE
. I-GENE
18 I-GENE
) O
are O
a O
superfamily O
of O
dimeric _RARE_
isoenzymes _RARE_
which O
catalyze _RARE_
the O
conjugation O
of O
electrophilic _RARE_
substrates _RARE_
with O
glutathione _RARE_
. O

Furthermore O
, O
the O
3 O
'- O
untranslated _RARE_
regions O
of O
pmGT10 _RARE_
display O
a O
marked O
degree O
of O
homology O
to O
the O
3 O
' O
region O
of O
the O
rat I-GENE
Yb1 _RARE_
gene I-GENE
, O
while O
this O
region O
of O
pmGT2 _RARE_
displays O
marked O
homology O
to O
the O
corresponding O
region O
of O
the O
rat I-GENE
Yb2 _RARE_
gene I-GENE
. O

Model _RARE_
IV O
: O
primary _RARE_
abutments _RARE_
with O
the O
lateral O
incisor _RARE_
and O
the O
second O
molar _RARE_
as _RARE_
secondary O
abutments _RARE_
. O

The O
incidence O
of O
fetal _RARE_
breathing O
movements O
( O
06 O
. O
00 O
- O
10 O
. O
00 O
h O
) O
decreased O
with O
increasing O
gestational O
age O
while O
fetal _RARE_
arterial O
concentrations O
of O
plasma O
PGE _RARE_
increased O
significantly O
over O
the O
same O
period O
of O
gestation O
. O

During O
the O
first _RARE_
3 O
min O
of O
recovery O
, O
plasma O
potassium _RARE_
fell O
rapidly O
in O
spite _RARE_
of O
nearly O
unchanged O
blood _RARE_
acidosis O
and O
significantly O
decreasing O
bicarbonate _RARE_
concentration O
. O

The O
present O
data O
also O
suggest O
that O
when O
compared O
to O
the O
systemic O
vascular O
bed _RARE_
, O
the O
pulmonary O
vascular O
bed _RARE_
is O
less O
responsive O
to O
bolus O
administration O
of O
ET _RARE_
- I-GENE
1 I-GENE
. O

In O
comparison O
with O
normal O
pregnant _RARE_
women O
and O
normal O
non O
- O
pregnant _RARE_
women O
, O
women O
with O
PIH _RARE_
showed O
an O
increase O
in O
heart _RARE_
rate O
, O
suggesting O
an O
increased O
peripheral O
sympathetic O
tone O
, O
and O
an O
initial O
derangement _RARE_
in O
renal _RARE_
function O
as _RARE_
shown O
by O
the O
increase O
in O
serum O
uric O
acid O
and O
reduction O
in O
sodium _RARE_
excretion O
and O
total _RARE_
and O
fractional O
calcium _RARE_
excretion O
at _RARE_
any O
given O
level O
of O
sodium _RARE_
excretion O
. O

We O
have O
examined O
the O
role O
of O
two O
recombination _RARE_
- O
and O
repair O
- O
defective _RARE_
mutations O
, O
rad1 _RARE_
and O
rad52 _RARE_
, O
on O
direct O
repeat O
recombination _RARE_
in O
transcriptionally O
active _RARE_
and O
inactive O
sequences O
. O

The O
encoded O
protein O
has O
a O
leader _RARE_
sequence O
of O
27 _RARE_
amino O
acids _RARE_
. O

On O
the O
other O
hand _RARE_
, O
knowledge O
of O
the O
epidemiology _RARE_
of O
Parkinson O
' O
s O
disease _RARE_
is O
necessary O
in O
creating _RARE_
etiological _RARE_
hypotheses _RARE_
, O
since O
only O
hypotheses _RARE_
consistent O
with O
the O
epidemiological O
profile O
deserve _RARE_
careful _RARE_
testing O
. O

The O
stereoselectivity _RARE_
of O
drug O
action O
. O

Scotchbond _RARE_
2 O
showed O
the O
least O
dye _RARE_
penetration O
but O
not O
statistically O
less O
than O
the O
XR _RARE_
bond O
/ O
Silus _RARE_
Plus _RARE_
combination O
. O

A O
combination O
of O
cisplatin O
and O
5 O
- O
fluorouracil O
, O
both O
administered O
4 O
days O
continuously O
as _RARE_
infusion O
, O
was O
assessed O
in O
advanced O
head O
and O
neck O
cancer _RARE_
. O

Metformin _RARE_
plasma O
concentrations O
remained O
unchanged O
except O
for _RARE_
patients O
transferred O
from O
1 O
. O
5 O
to O
2 O
. O
0 _RARE_
g O
daily O
to O
850 _RARE_
mg O
twice O
daily O
; O
in O
these O
patients O
plasma O
concentrations O
increased O
from O
1 O
. O
83 _RARE_
+/- O
0 _RARE_
. O
87 O
to O
2 O
. O
50 O
+/- O
0 _RARE_
. O
89 _RARE_
micrograms O
/ O
l _RARE_
( O
p O
less O
than O
0 _RARE_
. O
01 O
). O

Diagnosis O
of O
primary _RARE_
sclerosing _RARE_
cholangitis _RARE_
in O
a O
blood _RARE_
donor O
with O
elevated O
serum I-GENE
alanine I-GENE
aminotransferase I-GENE
. O

When O
statistically O
analyzed O
in O
various O
subgroupings _RARE_
, O
the O
obtained O
average O
sedimentation O
coefficients O
and O
polydispersity _RARE_
profiles O
supported O
the O
following O
conclusions O
: O
( O
a O
) O
loss _RARE_
of O
proteoglycan _RARE_
aggregation _RARE_
and O
sedimentability _RARE_
is O
confirmed O
to O
be O
a O
primary _RARE_
sign O
of O
cartilage O
matrix _RARE_
degradation _RARE_
; O
( O
b O
) O
higher _RARE_
S O
values O
for _RARE_
proteoglycans _RARE_
of O
the O
high O
weight _RARE_
( O
HW _RARE_
)- O
bearing _RARE_
areas O
and O
lower O
values O
for _RARE_
those O
of O
the O
low O
weight _RARE_
( O
LW _RARE_
)- O
bearing _RARE_
areas O
were O
a O
typical O
finding O
in O
normal O
cartilage O
samples O
; O
( O
c O
) O
inversion O
of O
this O
pattern O
was O
indicative O
of O
matrix _RARE_
degradation _RARE_
, O
suggesting O
that O
the O
HW _RARE_
regions O
are O
more O
affected O
than O
the O
LW _RARE_
- O
bearing _RARE_
areas O
; O
( O
d O
) O
the O
average O
S O
value O
distribution O
across O
cartilage O
thickness O
tended O
to O
resemble _RARE_
the O
corresponding O
proteoglycan _RARE_
content O
versus O
distance O
from O
articular _RARE_
surface O
; O
and O
( O
e _RARE_
) O
the O
deepest _RARE_
cartilage O
layer O
had O
, O
in O
most O
cases O
, O
the O
smallest O
amount O
of O
aggregates O
while O
the O
highest O
average O
sedimentability _RARE_
was O
observed O
at _RARE_
the O
middle _RARE_
zone O
of O
the O
normal O
samples O
. O

A O
significant O
relationship O
existed O
during _RARE_
the O
evolution O
of O
the O
disease _RARE_
between O
CRS _RARE_
/ O
BW _RARE_
and O
gas O
exchange O
parameters O
( O
FIO2 _RARE_
and O
a O
/ O
AO2 _RARE_
ratio O
) O
( O
P O
less O
than O
0 _RARE_
. O
01 O
), _RARE_
but O
gas O
exchange O
improved O
earlier O
than O
lung _RARE_
mechanics _RARE_
. O

End _RARE_
points O
measured O
were O
perioperative _RARE_
( O
30 _RARE_
- O
day O
) O
myocardial _RARE_
infarction O
( O
MI O
) O
rate O
and O
death _RARE_
. O

The O
predicted O
molecular _RARE_
weight _RARE_
of O
the O
polyprotein _RARE_
encoded O
by O
ORF1 O
is O
33 _RARE_
kilodaltons _RARE_
( O
kDa O
). O

Thus O
RV O
O2 _RARE_
demand O
fell O
when O
RC _RARE_
O2 _RARE_
supply O
was O
reduced _RARE_
, O
although O
a O
flow O
reserve O
was O
available O
. O

An O
alternative _RARE_
method O
of O
UKM _RARE_
is O
proposed O
based O
on O
collecting _RARE_
a O
small O
fraction O
of O
spent _RARE_
dialysate _RARE_
flow O
for _RARE_
3 O
consecutive O
dialyses _RARE_
. O

Liquid _RARE_
chromatography O
with O
amperometric _RARE_
detection O
( O
LC _RARE_
/ O
AD O
) O
is O
used O
to O
determine O
fluazifop _RARE_
acid O
produced O
from O
the O
metabolism O
or O
base _RARE_
hydrolysis O
of O
fluazifop _RARE_
- O
butyl _RARE_
in O
soybeans _RARE_
and O
soybean _RARE_
oil O
. O

The O
dichloromethane _RARE_
is O
removed O
, O
mobile O
phase _RARE_
solvent O
is O
added O
, O
and O
aliquots _RARE_
are O
injected O
onto O
a O
PRP _RARE_
- O
1 O
liquid O
chromatographic O
column O
; O
fluazifop _RARE_
acid O
is O
separated O
from O
coextracted _RARE_
compounds O
and O
detected O
at _RARE_
an O
applied O
potential _RARE_
of O
+ O
1 O
. O
25 _RARE_
V O
, O
using O
an O
amperometric _RARE_
electrochemical _RARE_
detector O
in O
the O
oxidation O
mode O
. O

Primer O
extension O
experiments O
indicated O
that O
the O
transcription O
initiation O
site O
mapped O
to O
a O
position O
on O
gene I-GENE
IV I-GENE
that O
was O
analogous O
to O
that O
reported O
for _RARE_
the O
structurally O
similar O
P I-GENE
- I-GENE
450e _RARE_
gene I-GENE
. O

Significantly O
, O
the O
polymerase O
chain O
reaction O
results O
demonstrated O
that O
gene I-GENE
IV I-GENE
transcripts I-GENE
were O
associated O
with O
hepatic _RARE_
polysome _RARE_
fractions O
, O
indicating O
their O
active _RARE_
utilization O
in O
this O
tissue O
. O

Validation _RARE_
of O
the O
survey O
of O
work O
styles _RARE_
: O
a O
profile O
measure O
of O
the O
type O
A O
behaviour O
pattern O
. O

Only O
one O
ADR O
was O
related O
definitely _RARE_
to O
ciprofloxacin _RARE_
therapy O
. O

HIV O
infectiousness _RARE_
and O
the O
AIDS O
epidemic O
. O

From O
day O
30 _RARE_
after O
turnout _RARE_
, O
the O
PFB _RARE_
- O
group O
had O
significantly O
lower O
serum I-GENE
pepsinogen _RARE_
levels O
, O
which O
reflects _RARE_
the O
low O
degree O
of O
abomasal _RARE_
damage O
in O
these O
animals O
. O

The O
corresponding O
inhibition O
of O
acid I-GENE
phosphatase I-GENE
activity O
in O
control O
male O
and O
female O
guinea _RARE_
pigs O
was O
15 _RARE_
. O
91 O
% O
and O
20 O
. O
33 _RARE_
% O
respectively O
. O

Its O
clinical O
and O
histopathologic _RARE_
characteristics O
. O

Normocapnic _RARE_
( O
PACO2 _RARE_
= O
40 O
mm O
Hg O
) O
ventilatory _RARE_
drive O
increased O
significantly O
( O
p O
less O
than O
0 _RARE_
. O
05 O
) O
in O
six _RARE_
subjects O
( O
Type _RARE_
1 O
response O
) O
and O
decreased O
substantially O
in O
the O
others O
( O
Type _RARE_
2 O
response O
); O
with O
hypercapnia O
, O
the O
changes O
in O
drive O
were O
attenuated O
in O
both O
groups O
. O

Fundus _RARE_
changes O
in O
( O
type O
II O
) O
mesangiocapillary _RARE_
glomerulonephritis O
simulating _RARE_
drusen _RARE_
: O
a O
histopathological O
report O
. O

Chronic O
dose O
effects O
of O
methyl _RARE_
parathion _RARE_
on O
nuthatches _RARE_
: O
cholinesterase I-GENE
and O
ptilochronology _RARE_
. O

The O
titer O
of O
anti I-GENE
HSV I-GENE
type I-GENE
1 I-GENE
and O
anti I-GENE
HSV I-GENE
type I-GENE
2 I-GENE
antibodies I-GENE
in O
the O
mothers O
' O
and O
cord O
blood _RARE_
was O
determined O
and O
compared O
. O

Kidney _RARE_
weight _RARE_
and O
kidney _RARE_
- O
to O
- O
body O
weight _RARE_
ratio O
were O
significantly O
elevated O
at _RARE_
the O
highest O
dose O
level O
after O
10 O
weeks O
and O
at _RARE_
the O
two O
higher _RARE_
dose O
levels O
after O
15 _RARE_
weeks O
of O
exposure O
. O

Allelic _RARE_
variation O
in O
HLA I-GENE
- I-GENE
B I-GENE
and O
HLA I-GENE
- I-GENE
C I-GENE
sequences I-GENE
and O
the O
evolution O
of O
the O
HLA I-GENE
- I-GENE
B I-GENE
alleles I-GENE
. O

A O
method O
for _RARE_
determining _RARE_
optimal O
development O
conditions O
by O
summary O
oxygen O
consumption O

Men _RARE_
were O
more O
positive O
about O
their O
physical O
fitness O
than O
women O
. O

Handgrip _RARE_
dynamometry _RARE_
was O
also O
carried O
out O
in O
249 _RARE_
of O
the O
patients O
. O

In O
cerebrospinal _RARE_
fluid _RARE_
, O
an O
ADA _RARE_
catalytic O
concentration O
above O
0 _RARE_
. O
15 _RARE_
mu O
kat _RARE_
/ O
L O
strongly O
suggests O
tuberculous O
meningitis O
in O
patients O
older O
than O
7 O
years O
( O
sensitivity O
1 O
. O
00 O
, O
specificity _RARE_
0 _RARE_
. O
99 _RARE_
and O
efficiency O
0 _RARE_
. O
99 _RARE_
). O

NERVTRACK _RARE_
contains O
4000 _RARE_
anatomical O
data O
items _RARE_
arranged O
in O
a O
tree _RARE_
- O
like O
manner O
reflecting O
structural O
and O
functional _RARE_
relationships O
. O

Swim _RARE_
- O
over O
: O
an O
alternative _RARE_
method O
for _RARE_
harvesting _RARE_
motile _RARE_
spermatozoa O
. O

Perfusion _RARE_
washout O
: O
increasing O
a O
microvascular O
free O
flap O
tolerance O
to O
ischemia O
. O

Similarly O
, O
the O
sequence O
of O
the O
U2 _RARE_
RNA I-GENE
region I-GENE
shown O
to O
be O
involved O
in O
pre O
- O
mRNA O
branchpoint O
recognition O
in O
yeast O
, O
and O
exactly _RARE_
conserved _RARE_
in O
metazoan _RARE_
U2 _RARE_
RNAs I-GENE
, O
was O
totally _RARE_
divergent O
in O
trypanosomes _RARE_
. O

It O
is O
striking O
that O
the O
active _RARE_
CHO O
spacer O
promoter O
violated _RARE_
the O
otherwise O
universal _RARE_
rule _RARE_
that O
metazoan _RARE_
RNA I-GENE
polymerase I-GENE
I I-GENE
promoters I-GENE
all O
have O
a O
G O
residue _RARE_
at _RARE_
position O
- O
16 O
. O

A O
raised O
amplitude O
of O
the O
aggregation _RARE_
of O
plates O
and O
a O
decrease O
in O
the O
threshold O
of O
their O
sensitivity O
to O
ADP _RARE_
were O
established O
in O
the O
persons O
with O
types _RARE_
IIa _RARE_
and O
IIb _RARE_
HLP _RARE_
and O
in O
CHD _RARE_
without O
HLP _RARE_
. O

Significant O
intergroup _RARE_
differences O
are O
highlighted _RARE_
for _RARE_
both O
selected _RARE_
dentoskeletal _RARE_
and O
soft O
tissue O
profile O
variables O
. O

The O
author O
provides O
a O
rationale _RARE_
for _RARE_
an O
interactional _RARE_
view O
and O
presents O
a O
case O
in O
which O
post O
- O
surgical O
hiccups _RARE_
were O
successfully O
treated O
, O
using O
principles _RARE_
developed O
by O
the O
Mental _RARE_
Research O
Institute O
. O

The O
relative O
toxicity O
of O
nickel O
oxide O
( O
NiO _RARE_
), _RARE_
nickel O
sulfate _RARE_
hexahydrate _RARE_
( O
NiSO4 _RARE_
. O
6H2O _RARE_
), _RARE_
and O
nickel O
subsulfide _RARE_
( O
Ni3S2 _RARE_
) O
was O
studied O
in O
F344 _RARE_
/ O
N O
rats O
and O
B6C3F1 _RARE_
mice O
after O
inhalation O
exposure O
for _RARE_
6 O
hr O
/ O
day O
, O
5 O
days O
/ O
week O
, O
for _RARE_
13 _RARE_
weeks O
. O

Light _RARE_
microscopical _RARE_
and O
routine O
immunohistochemical O
studies O
of O
a O
cervical O
neoplasm _RARE_
in O
a O
32 _RARE_
year O
old O
woman O
initially O
suggested O
a O
histiocytic _RARE_
lymphoma O
, O
but O
histochemical _RARE_
staining O
for _RARE_
chloroacetate _RARE_
esterase I-GENE
established O
the O
correct O
diagnosis O
. O

From O
the O
National O
Institutes _RARE_
of O
Health O
. O

Molecular O
cloning O
and O
characterisation _RARE_
of O
the O
two O
homologous O
genes O
coding O
for _RARE_
nitrate _RARE_
reductase I-GENE
in I-GENE
tobacco I-GENE
. O

In O
the O
final O
model O
, O
grade O
( O
p O
= O
0 _RARE_
. O
0002 _RARE_
), _RARE_
peritoneal O
cytologic _RARE_
results O
( O
p O
= O
0 _RARE_
. O
0002 _RARE_
), _RARE_
progesterone I-GENE
receptor I-GENE
status O
( O
p O
= O
0 _RARE_
. O
004 _RARE_
), _RARE_
and O
age O
as _RARE_
a O
continuous O
variable _RARE_
( O
p O
= O
0 _RARE_
. O
008 _RARE_
) O
were O
most O
closely O
associated O
with O
disease _RARE_
- O
free O
survival O
. O

In O
contrast O
, O
despite O
external O
radiation O
therapy O
, O
brain O
metastases O
proved O
fatal O
. O

COUP I-GENE
transcription I-GENE
factor I-GENE
is O
a O
member _RARE_
of O
the O
steroid I-GENE
receptor I-GENE
superfamily I-GENE
. O

In O
Experiment O
2 O
, O
we O
again O
used O
classification O
, O
but O
the O
fixed O
standard O
75 _RARE_
was O
not O
at _RARE_
the O
center _RARE_
of O
the O
range O
of O
target O
numbers O
( O
20 O
, O
21 O
, O
... _RARE_

Cosmid _RARE_
clones _RARE_
containing O
both O
VNTR _RARE_
sequences O
were O
identified O
, O
and O
restriction _RARE_
mapping O
showed O
them O
to O
be O
less O
than O
15 _RARE_
kb O
apart O
. O

The O
oxygen O
uptake O
( O
VO2 O
), _RARE_
carbon O
dioxide O
output O
( O
VCO2 _RARE_
), _RARE_
respiratory O
rate O
( O
fR _RARE_
), _RARE_
minute O
ventilation O
( O
VE O
), _RARE_
alveolar O
ventilation O
( O
VA O
), _RARE_
alveolar O
oxygen O
pressure O
( O
PAO2 _RARE_
), _RARE_
and O
VE O
/ O
VO2 O
ratio O
were O
higher _RARE_
in O
the O
cows O
, O
while O
the O
tidal O
volume O
( O
VT O
) O
and O
physiological O
dead _RARE_
space O
( O
VD _RARE_
) O
were O
larger O
in O
the O
horses O
. O

Epithelial _RARE_
damage O
was O
not O
observed O
in O
any O
controls O
but O
was O
in O
all O
tissues O
exposed O
to O
SO2 _RARE_
. O

Among O
booked _RARE_
patients O
the O
maternal _RARE_
mortality O
rate O
was O
0 _RARE_
. O
32 _RARE_
and O
among O
unbooked _RARE_
patients O
11 O
. O
13 _RARE_
per O
1000 O
deliveries _RARE_
. O

The O
present O
study O
investigates _RARE_
whether O
prostaglandins O
" O
cytoprotect _RARE_
" O
the O
gastric _RARE_
mucosa O
against O
hemorrhage O
- O
induced _RARE_
stress O
ulceration O
by O
assessing O
the O
influence O
of O
16 O
, O
16 O
- O
dimethyl O
prostaglandin _RARE_
E2 O
( O
16 O
, O
16 O
- O
dm _RARE_
PGE2 O
) O
on O
gross O
and O
microscopic O
lesion O
formation O
, O
intramucosal _RARE_
tissue O
pH O
, O
H O
+ O
back O
- O
diffusion O
, O
and O
mucosal _RARE_
blood _RARE_
flow O
in O
rat O
gastric _RARE_
mucosa O
exposed O
to O
luminal O
acid O
( O
100 _RARE_
mM O
HCl _RARE_
) O
during _RARE_
hemorrhagic O
shock O
( O
13 _RARE_
ml O
/ O
kg O
for _RARE_
20 O
min O
). O

Transcripts _RARE_
characterized O
include O
( O
i O
) O
abundant O
monocistronic _RARE_
L11e _RARE_
and O
tricistronic _RARE_
L1e _RARE_
- O
L10e _RARE_
- O
L12e _RARE_
transcripts O
; O
( O
ii O
) O
less O
abundant O
bicistronic _RARE_
NAB _RARE_
- O
L11e _RARE_
and O
monocistronic _RARE_
NAB _RARE_
transcripts I-GENE
and O
( O
iii O
) O
a O
very O
rare O
ORF O
monocistronic _RARE_
transcript O
. O

Qualitatively _RARE_
, O
the O
results O
are O
similar O
for _RARE_
the O
two O
species O
: O
Both O
rhesus _RARE_
monkey _RARE_
and O
man O
have O
photopic _RARE_
and O
scotopic _RARE_
branches _RARE_
, O
which O
cross O
at _RARE_
approximately _RARE_
the O
same O
time O
in O
the O
dark O
and O
at _RARE_
approximately _RARE_
the O
same O
background O
luminance _RARE_
. O

Evidence O
from O
the O
structure _RARE_
of O
a O
number O
of O
cDNA O
clones _RARE_
, O
as _RARE_
well _RARE_
as _RARE_
S1 I-GENE
nuclease _RARE_
and O
primer O
extension O
studies O
supports O
the O
hypothesis O
that O
the O
PTHrP _RARE_
gene I-GENE
contains O
at _RARE_
least O
two O
mRNA O
transcription O
start _RARE_
points O
that O
define O
two O
putative O
regulatory O
domains O
. O

At O
each O
level O
of O
PaO2 O
we O
obtained O
simultaneous O
measures O
of O
arterial O
and O
venous O
blood _RARE_
gases O
, O
venous O
lactate _RARE_
concentration O
, O
and O
changes O
in O
the O
relative O
concentrations O
of O
inorganic O
phosphate O
, O
phosphocreatine _RARE_
, O
and O
ATP O
measured O
with O
31P _RARE_
magnetic O
resonance O
spectroscopy O
. O

The O
transcription O
initiation O
site O
was O
determined O
by O
S1 I-GENE
nuclease _RARE_
mapping O
. O

Endometrial _RARE_
biopsies O
and O
plasma O
oestradiol O
( O
E2 O
) O
and O
progesterone O
( O
P4 _RARE_
) O
levels O
in O
23 _RARE_
patients O
were O
evaluated O
during _RARE_
26 _RARE_
replacement _RARE_
therapy O
cycles O
for _RARE_
premature O
ovarian O
failure O
. O

The O
mobility O
of O
the O
upper O
and O
lower O
premolars _RARE_
under O
load O
was O
investigated O
in O
relation O
to O
the O
interproximal _RARE_
contact _RARE_
and O
occlusal _RARE_
facets _RARE_
. O

A O
larval _RARE_
albumin I-GENE
- I-GENE
like I-GENE
protein I-GENE
was O
not O
detectable O
by O
silver O
staining O
in O
serum O
of O
tadpoles _RARE_
before O
the O
beginning O
of O
metamorphosis _RARE_
at _RARE_
stage _RARE_
48 _RARE_
. O

Behaviorally _RARE_
, O
a O
pain O
- O
tolerant _RARE_
group O
( O
PT O
= O
29 O
Ss _RARE_
) O
tolerated O
the O
entire _RARE_
3 O
- O
min O
test O
( O
means O
= O
180 O
+/- O
0 _RARE_
sec O
), _RARE_
while O
a O
pain O
- O
sensitive _RARE_
group O
( O
PS _RARE_
= O
13 _RARE_
Ss _RARE_
) O
averaged O
only O
50 O
. O
31 _RARE_
+/- O
20 O
. O
81 _RARE_
sec O
of O
the O
cold O
- O
pressor O
test O
( O
t O
= O
16 O
. O
75 _RARE_
, O
P O
less O
than O
0 _RARE_
. O
0001 O
), _RARE_
replicating _RARE_
our O
earlier O
studies O
. O

This O
suggested O
that O
baboon _RARE_
liver I-GENE
class I-GENE
I I-GENE
ADH I-GENE
is O
of O
the O
same O
ancestral O
lineage O
as _RARE_
the O
human I-GENE
ADH I-GENE
- I-GENE
beta I-GENE
. O

Isolated _RARE_
proteinuria _RARE_
( O
i O
. O
e _RARE_
. O
without O
hematuria _RARE_
and O
/ O
or O
pyuria _RARE_
) O
is O
a O
frequent O
finding O
. O

Each O
individual O
shot _RARE_
25 _RARE_
bullets _RARE_
in O
about O
5 O
minutes O
, O
at _RARE_
an O
intensity O
level O
calculated O
at _RARE_
163 _RARE_
dB _RARE_
. O

Lithium _RARE_
delays _RARE_
the O
circadian O
rhythm O
of O
wheel _RARE_
- O
running _RARE_
in O
Syrian _RARE_
hamsters O
at _RARE_
plasma O
concentrations O
( O
0 _RARE_
. O
59 _RARE_
- O
0 _RARE_
. O
74 _RARE_
mM O
) O
that O
also O
cause O
toxic O
weight _RARE_
loss _RARE_
. O

Dynamic _RARE_
and O
static _RARE_
scintigrams _RARE_
, O
using O
99mtechnetium _RARE_
methylene O
diphosphonate _RARE_
, O
were O
obtained O
at _RARE_
zero O
, O
six _RARE_
, O
and O
12 O
weeks O
after O
fracture O
. O

On O
admission O
to O
our O
department _RARE_
in O
September _RARE_
, O
1987 O
, O
the O
patient O
was O
alert _RARE_
and O
had O
spastic _RARE_
paraparesis _RARE_
, O
the O
impairment O
of O
all O
sensory O
modalities O
below O
the O
level O
of O
Th _RARE_
10 O
and O
urinary _RARE_
disturbance O
. O

Prostaglandins _RARE_
and O
gallstones _RARE_

The O
nature O
of O
the O
process O
formed O
by O
the O
successive O
occurrences _RARE_
of O
this O
arrhythmia _RARE_
was O
studied O
in O
8 O
patients O
with O
a O
history O
of O
symptomatic O
paroxysmal _RARE_
AF _RARE_
. O

This O
would O
have O
had O
the O
effect O
of O
positioning O
the O
genes O
currently O
on O
the O
long O
arm _RARE_
adjacent O
to O
the O
centromeric _RARE_
heterochromatin _RARE_
, O
perhaps O
resulting O
in O
a O
" O
position O
effect O
" O
on O
transcription O
of O
these O
genes O
. O

Initial O
experience O
with O
a O
microprocessor _RARE_
controlled _RARE_
current O
based O
defibrillator _RARE_
. O

Obesity _RARE_
was O
strongly O
associated O
with O
the O
proportions _RARE_
of O
nonprotein _RARE_
- O
bound _RARE_
and O
albumin I-GENE
- O
bound _RARE_
estradiol O
, O
and O
inversely O
associated O
with O
sex _RARE_
hormone I-GENE
binding I-GENE
globulin I-GENE
( O
SHBG I-GENE
) O
levels O
and O
the O
proportion O
of O
SHBG I-GENE
- O
bound _RARE_
estradiol O
. O

Heterogeneous _RARE_
nuclear I-GENE
ribonucleoprotein I-GENE
( I-GENE
hnRNP _RARE_
) I-GENE
core I-GENE
protein I-GENE
A1 _RARE_
is O
a O
major O
component _RARE_
of O
mammalian I-GENE
hnRNP _RARE_
40 I-GENE
S I-GENE
particles _RARE_
. O

Brain _RARE_
cholinesterase I-GENE
activity O
of O
nestling _RARE_
great O
egrets _RARE_
, O
snowy _RARE_
egrets _RARE_
and O
black O
- O
crowned _RARE_
night O
- O
herons _RARE_
. O
inhibition O
of O
brain I-GENE
cholinesterase I-GENE
( O
ChE _RARE_
) O
activity O
in O
birds O
is O
often O
used O
to O
diagnose _RARE_
exposure O
or O
death _RARE_
from O
organophosphorus _RARE_
or O
carbamate _RARE_
pesticides _RARE_
. O

The O
effect O
of O
zinc O
deficiency O
on O
trace _RARE_
metals _RARE_
in O
the O
liver O
, O
spleen _RARE_
, O
kidney _RARE_
, O
pancreas O
and O
duodenum _RARE_
was O
investigated O
in O
the O
control O
and O
zinc O
- O
deficient _RARE_
rats O
at _RARE_
17 _RARE_
days O
and O
20 O
days O
of O
pregnancy _RARE_
. O

Our O
findings O
support O
the O
view O
of O
a O
multifactorial _RARE_
genesis _RARE_
of O
the O
cardiac O
involvement O
in O
uremic _RARE_
patients O
. O

Heating _RARE_
cells O
to O
43 _RARE_
degrees O
C O
decreased O
the O
amount O
of O
newly O
synthesized O
rRNA O
to O
less O
than O
5 O
% O
of O
the O
control O
level O
and O
led O
to O
greater O
than O
95 _RARE_
% O
inhibition O
of O
transcription O
termination _RARE_
at _RARE_
a O
region O
355 _RARE_
to O
362 _RARE_
nucleotides O
downstream _RARE_
of O
the O
3 O
' O
end O
of O
28S I-GENE
rRNA I-GENE
, O
with O
readthrough O
continuing _RARE_
into O
the O
next O
transcription O
unit O
. O

Deletion O
analysis O
showed O
that O
the O
NF _RARE_
- I-GENE
4FA _RARE_
, O
NF _RARE_
- I-GENE
4FB _RARE_
, O
and O
AP I-GENE
- I-GENE
1 I-GENE
sequences O
are O
each O
necessary O
for _RARE_
full O
enhancer O
activity O
. O

Cord _RARE_
swelling O
was O
observed O
in O
2 O
patients O
who O
developed O
complete _RARE_
lesions O
. O

Reye _RARE_
' O
s O
syndrome _RARE_
: O
reports O
of O
7 O
cases O
in O
the O
period O
1982 O
- O
1987 O

When O
two O
- O
dimensional O
polyacrylamide O
gel O
electrophoretic O
patterns O
of O
[ _RARE_
35S _RARE_
] O
methionine O
- O
labeled O
proteins O
secreted _RARE_
from O
cells O
infected _RARE_
with O
parental O
and O
recombinant O
viruses O
were O
compared O
, O
a O
spot _RARE_
missing O
from O
the O
latter O
corresponded O
in O
molecular _RARE_
weigh _RARE_
and O
isoelectric _RARE_
point O
with O
that O
predicted O
from O
the O
N1L _RARE_
ORF I-GENE
. O

PULSE _RARE_
is O
used O
to O
set O
such O
NMR O
spectroscopic _RARE_
parameters O
as _RARE_
the O
delay O
and O
duration O
of O
rf _RARE_
transmit _RARE_
and O
receive O
gates _RARE_
, O
rf _RARE_
phase _RARE_
, O
sampling O
times O
, O
and O
such O
imaging O
parameters O
as _RARE_
rf _RARE_
pulse O
shape O
and O
gradient O
waveforms _RARE_
. O

Definite _RARE_
JPsA _RARE_
( O
24 _RARE_
patients O
) O
was O
defined O
as _RARE_
arthritis O
associated O
, O
but O
not O
necessarily O
coincident _RARE_
, O
with O
a O
typical O
psoriatic _RARE_
rash O
, O
or O
arthritis O
plus _RARE_
at _RARE_
least O
3 O
of O
4 O
minor O
criteria O
: O
dactylitis _RARE_
, O
nail _RARE_
pitting _RARE_
, O
psoriasis O
- O
like O
rash O
, O
or O
family O
history O
of O
psoriasis O
. O

Hence O
follows O
Kurti _RARE_
' O
s O
demand O
to O
mete _RARE_
out O
appropriate O
importance O
to O
the O
arguments _RARE_
. O

The O
author O
gives O
an O
account O
of O
antipsychotic _RARE_
, O
analgetic _RARE_
, O
myorelaxing _RARE_
and O
vasodilatating _RARE_
effects O
of O
some O
calcium _RARE_
antagonists O
, O
and O
their O
clinical O
application O
is O
discussed O
. O

A O
correlation O
coefficient O
was O
used O
for _RARE_
assessing O
the O
similarity _RARE_
of O
each O
map O
pattern O
with O
the O
normal O
mean O
IQRST _RARE_
map O
. O

A O
hospital O
- O
based O
study O
of O
the O
relationship O
between O
retained O
placenta O
and O
mastitis _RARE_
in O
dairy _RARE_
cows O
. O

This O
indicates O
that O
lipid _RARE_
peroxidation O
may O
be O
involved O
in O
the O
development O
of O
senile O
cataract _RARE_
and O
, O
as _RARE_
a O
direct O
consequence O
of O
retinal _RARE_
damage O
, O
also O
in O
the O
pathogenesis O
of O
cataract _RARE_
in O
diabetes O
and O
in O
severe O
myopia _RARE_
. O

The O
histological O
grading _RARE_
was O
certified _RARE_
in O
68 _RARE_
cases O
: O
12 O
G1 O
, O
39 _RARE_
G2 _RARE_
, O
17 _RARE_
G3 _RARE_
; O
extracapsular _RARE_
spread O
was O
found O
in O
20 O
/ O
54 O
cases O
( O
37 O
%). O

Asthma _RARE_
was O
significantly O
more O
often O
associated O
with O
ASA _RARE_
group O
( O
91 O
%) O
vs _RARE_
46 _RARE_
% O
at _RARE_
AT O
and O
in O
only O
16 O
% O
at _RARE_
INTR _RARE_
group O
. O

A O
value O
of O
1 O
. O
1 O
l _RARE_
/ O
kg O
was O
used O
for _RARE_
V O
in O
calculating _RARE_
all O
single O
sample O
estimates O
of O
clearance O
( O
CL O
), _RARE_
and O
a O
value O
of O
4 O
. O
3 O
l _RARE_
/ O
kg O
was O
used O
to O
calculate _RARE_
single O
sample O
estimates O
of O
clearance O
of O
plasma O
unbound _RARE_
drug O
( O
CLunb _RARE_
). O

The O
solitary _RARE_
kidney _RARE_
: O
a O
model O
of O
chronic O
hyperfiltration _RARE_
in O
humans O
. O

Halothane _RARE_
is O
metabolized _RARE_
by O
an O
oxidative O
pathway _RARE_
to O
stable O
, O
nonvolatile _RARE_
end O
products O
, O
trifluoroacetic _RARE_
acid O
( O
TFAA _RARE_
) O
and O
bromide O
( O
Br O
-), _RARE_
and O
by O
reductive _RARE_
pathways O
to O
Br O
- O
and O
inorganic O
fluoride O
( O
F O
-). _RARE_

The O
values O
were O
consistently O
lower O
( O
P O
less O
than O
0 _RARE_
. O
01 O
) O
during _RARE_
summer O
( O
3 O
. O
79 _RARE_
+/- O
0 _RARE_
. O
13 _RARE_
micrograms O
/ O
100 _RARE_
ml O
), _RARE_
as _RARE_
compared O
to O
winter _RARE_
( O
5 O
. O
06 O
+/- O
0 _RARE_
. O
27 _RARE_
). O

These O
results O
suggest O
that O
HAPE _RARE_
- O
S O
- O
S O
are O
prone O
to O
irregular _RARE_
nocturnal _RARE_
breathing O
patterns O
at _RARE_
high O
altitude O
, O
which O
is O
associated O
with O
the O
development O
of O
AMS _RARE_
, O
but O
it O
was O
not O
possible O
to O
determine O
whether O
these O
abnormal O
breathing O
patterns O
are O
a O
cause O
or O
an O
effect O
of O
AMS _RARE_
. O

Buflomedil _RARE_
( O
i O
. O
v O
.) O
induced _RARE_
a O
dose O
- O
dependent O
increase O
of O
cardiac O
output O
at _RARE_
0 _RARE_
. O
16 O
- O
0 _RARE_
. O
64 _RARE_
mg O
/ O
kg O
, O
biphasic O
changes O
at _RARE_
1 O
. O
28 _RARE_
and O
2 O
. O
56 _RARE_
mg O
/ O
kg O
and O
a O
marked O
decrease O
and O
subsequent O
slight O
increase O
at _RARE_
a O
large O
dose O
of O
5 O
. O
12 O
mg O
/ O
kg O
. O

It O
was O
possible O
to O
classify _RARE_
the O
animals O
into O
high O
and O
low O
responders O
according O
to O
the O
pattern O
of O
humoral _RARE_
immune O
response O
. O

Heart _RARE_
rate O
( O
HR O
), _RARE_
rectal O
temperature _RARE_
( O
Tre _RARE_
), _RARE_
blood _RARE_
pressure O
, O
temperature _RARE_
and O
relative O
humidity _RARE_
changes O
inside _RARE_
clothing _RARE_
were O
measured O
on O
18 O
professional _RARE_
firemen _RARE_
( O
mean O
age O
29 O
. O
4 O
+/- O
7 O
. O
4 O
yr O
, O
VO2 O
max _RARE_
41 _RARE_
. O
4 O
+ O
8 O
. O
8 O
ml O
kg O
- O
1 O
min O
- O
1 O
) O
wearing _RARE_
fire _RARE_
fighter _RARE_
' O
s O
uniforms _RARE_
( O
SU _RARE_
) O
or O
aluminized _RARE_
, O
fire _RARE_
resistant O
, O
impermeable _RARE_
clothing _RARE_
with O
self O
contained O
breathing O
apparatus O
( O
FE _RARE_
). O

The O
clinical O
tolerance O
and O
pharmacokinetics O
of O
FCE _RARE_
22101 _RARE_
( O
sodium _RARE_
( O
5R _RARE_
, O
6S _RARE_
)- O
6 O
-[( _RARE_
1R _RARE_
)- O
hydroxyethyl _RARE_
]- _RARE_
2 O
- O
carbamoyloxymethyl _RARE_
- O
2 O
- O
penem _RARE_
- O
3 O
- O
carboxylate _RARE_
), _RARE_
a O
new O
penem _RARE_
antibiotic O
, O
have O
been O
studied O
after O
giving O
a O
single O
i O
. O
v O
. O
dose O
of O
4 O
mg O
. O
kg O
- O
1 O
to O
ten O
healthy O
male O
volunteers O
. O

DNA O
blot O
hybridization O
suggests O
that O
the O
rat O
genome O
may O
contain O
more O
than O
one O
gene O
encoding O
PtdIns _RARE_
transfer I-GENE
protein I-GENE
. O

We O
use O
the O
term O
corticosteroid _RARE_
- O
dependent O
IA O
to O
refer _RARE_
to O
the O
serious O
problem O
of O
chronic O
IA O
requiring O
maintenance _RARE_
prednisone O
therapy O
. O

Another O
segment O
of O
CRL3 _RARE_
(- _RARE_
296 O
to O
- O
184 _RARE_
), _RARE_
also O
displaying _RARE_
enhancer O
function O
, O
contained O
tandem _RARE_
repeated _RARE_
sequences O
( O
DR _RARE_
- O
A1 _RARE_
and O
DR _RARE_
- O
A2 _RARE_
). O

1 O
-( _RARE_
1 O
- O
Naphthyl _RARE_
) O
piperazine _RARE_
( O
1 O
- O
NP _RARE_
) O
has O
been O
reported O
to O
have O
serotonin _RARE_
antagonist O
properties O
at _RARE_
the O
5 I-GENE
- I-GENE
HT2 I-GENE
subtype _RARE_
of O
receptor O
, O
and O
it O
has O
been O
suggested O
that O
it O
may O
have O
agonist O
actions O
at _RARE_
the O
5 I-GENE
- I-GENE
HT1 _RARE_
site I-GENE
. O

1 O
-( _RARE_
m O
- O
Chlorophenyl _RARE_
) O
piperazine _RARE_
( O
mCPP _RARE_
, O
0 _RARE_
. O
1 O
- O
3 O
. O
0 _RARE_
mg O
/ O
kg O
) O
and O
1 O
-( _RARE_
m O
- O
trifluoromethylphenyl _RARE_
) O
piperazine _RARE_
( O
TFMPP _RARE_
, O
0 _RARE_
. O
1 O
- O
3 O
. O
0 _RARE_
mg O
/ O
kg O
), _RARE_
both O
thought O
to O
act O
primarily O
at _RARE_
5 I-GENE
- I-GENE
HT1 _RARE_
sites I-GENE
, O
also O
decreased O
responding O
and O
this O
effect O
was O
blocked O
by O
methysergide _RARE_
and O
by O
1 O
- O
NP _RARE_
, O
but O
not O
by O
ketanserin _RARE_
. O

The O
characteristic O
feature O
of O
liver O
and O
spleen _RARE_
MP O
function O
in O
patients O
with O
VHA _RARE_
associated O
with O
HBsAg I-GENE
carriership _RARE_
consisted O
in O
the O
lack O
of O
the O
compensatory _RARE_
reaction O
on O
the O
part O
of O
spleen _RARE_
MP O
, O
which O
was O
likely O
to O
be O
connected O
with O
overstrain _RARE_
of O
long O
standing _RARE_
and O
depletion O
of O
the O
MP O
system _RARE_
due O
to O
permanent O
antigenic _RARE_
stimulation _RARE_
of O
HBsAg I-GENE
. O

Changes O
in O
xanthine _RARE_
oxidase I-GENE
activity O
in O
patients O
with O
circulatory O
failure O

A O
soap _RARE_
and O
water O
( O
1 O
: O
1 O
, O
v O
/ O
v O
) O
solution O
effectively O
decontaminated _RARE_
powdered _RARE_
stratum _RARE_
corneum _RARE_
. O

The O
cytoprotective _RARE_
and O
antiulcer _RARE_
activities O
of O
the O
antacid _RARE_
magaldrate _RARE_
( O
ES O
Riopan _RARE_
) O
as _RARE_
well _RARE_
as _RARE_
its O
effects O
on O
gastric _RARE_
mucosal _RARE_
blood _RARE_
flow O
and O
mucus O
secretions _RARE_
, O
were O
determined O
in O
the O
rat O
. O

The O
human O
immunodeficiency O
virus O
type O
1 O
( O
HIV O
- O
1 O
) O
preferentially O
infects _RARE_
CD4 _RARE_
+ I-GENE
T O
lymphocytes O
and O
may O
exist O
as _RARE_
a O
latent O
provirus O
within O
these O
cells O
for _RARE_
extended O
periods O
. O

Histiocytic _RARE_
panniculitis _RARE_
was O
observed O
in O
biopsy O
specimens O
with O
cytophagocytosis _RARE_
. O

We O
have O
utilized O
the O
human I-GENE
4F2 _RARE_
heavy I-GENE
chain I-GENE
( O
4F2HC _RARE_
) O
gene O
as _RARE_
a O
model O
system _RARE_
in O
studies O
designed O
to O
elucidate O
the O
molecular _RARE_
events O
involved O
in O
regulating _RARE_
inducible O
gene O
expression _RARE_
during _RARE_
normal O
human O
T O
- O
cell O
activation O
. O

A O
cDNA O
encoding O
the O
NF _RARE_
- I-GENE
4FB _RARE_
enhancer I-GENE
binding I-GENE
protein I-GENE
has O
been O
cloned _RARE_
by O
screening O
a O
lambda O
gt11 O
cDNA O
library O
with O
a O
rabiolabelled _RARE_
oligonucleotide _RARE_
corresponding O
to O
the O
NF _RARE_
- I-GENE
4FB _RARE_
recognition I-GENE
sequence I-GENE
. O

Electrocardiographic _RARE_
right O
ventricular O
hypertrophy O
was O
seen O
in O
4 O
, O
and O
biventricular _RARE_
hypertrophy O
in O
5 O
patients O
. O

The O
two O
IL6 I-GENE
mRNA I-GENE
species O
are O
generated O
by O
alternative _RARE_
polyadenylation O
at _RARE_
sites O
separated O
by O
a O
distance O
of O
1 O
. O
2 O
kilobases O
. O

Sequencing O
analysis O
revealed O
that O
the O
0 _RARE_
. O
54 O
- O
and O
0 _RARE_
. O
4 O
- O
kb O
fragments O
are O
identical O
except O
for _RARE_
150 _RARE_
nucleotides O
missing O
at _RARE_
the O
5 O
' O
region O
of O
the O
0 _RARE_
. O
4 O
- O
kb O
fragment O
. O

The O
mature _RARE_
protein O
also O
contains O
a O
cysteine O
- O
rich O
, O
highly O
hydrophilic O
region O
homologous O
to O
the O
ovomucoid _RARE_
serine I-GENE
protease I-GENE
inhibitors _RARE_
( O
residues O
76 _RARE_
- O
132 O
). O

Oligosynaptic _RARE_
EPSP _RARE_
components _RARE_
were O
consistently O
modulated O
only O
in O
the O
superficial O
peroneal _RARE_
responses O
in O
flexor _RARE_
motoneurons _RARE_
, O
which O
exhibited O
enhanced _RARE_
amplitude O
during _RARE_
the O
flexion _RARE_
phase _RARE_
. O

Experiments O
on O
23 _RARE_
white _RARE_
rats O
and O
10 O
guinea _RARE_
pigs O
have O
shown O
that O
preliminarily _RARE_
indomethacin O
- O
induced _RARE_
inhibition O
of O
prostaglandins O
synthesis _RARE_
prevented O
development O
of O
pulmonary O
oedema _RARE_
, O
evoked O
by O
heterologous O
serum O
in O
rats O
and O
by O
vagotomy O
in O
guinea _RARE_
pigs O
. O

On O
the O
other O
hand _RARE_
, O
lack O
of O
conservation O
of O
the O
membrane O
attachment _RARE_
sequence O
arginine _RARE_
- O
glycine O
- O
aspartic _RARE_
acid O
argues _RARE_
against O
its O
functional _RARE_
importance O
in O
CgA _RARE_
. O

Third _RARE_
- O
and O
later O
- O
parity _RARE_
cows O
were O
randomly O
assigned O
after O
each O
parturition _RARE_
to O
Charolais _RARE_
and O
Red _RARE_
Poll _RARE_
bulls _RARE_
in O
multiple O
- O
sire _RARE_
pastures _RARE_
. O

Within O
each O
lobe O
, O
the O
PA O
dispersion O
was O
up _RARE_
to O
10 O
cmH2O O
at _RARE_
CFV _RARE_
of O
90 _RARE_
l _RARE_
/ O
min O
; O
when O
flow O
decreased O
, O
PA O
at _RARE_
all O
sites O
decreased O
, O
as _RARE_
did O
the O
intralobar _RARE_
dispersion O
. O

The O
system _RARE_
consisted O
of O
the O
intact _RARE_
canine O
heart _RARE_
connected O
to O
a O
microcomputer _RARE_
that O
operated O
as _RARE_
the O
modulated O
parasystolic _RARE_
pacemaker _RARE_
. O

In O
order O
to O
identify O
and O
classify _RARE_
the O
basic O
CT _RARE_
appearances _RARE_
of O
interstitial O
pneumonia O
, O
radiologic _RARE_
- O
pathologic O
correlative _RARE_
study O
was O
performed O
using O
inflated _RARE_
and O
fixed O
lungs O
from O
autopsy O
and O
surgery O
. O

The O
disease _RARE_
ran _RARE_
an O
atypical O
course O
; O
with O
early O
jaundice O
syndrome _RARE_
, O
severe O
enterorrhagia _RARE_
and O
late _RARE_
appearance O
of O
roseola _RARE_
. O

The O
transcription O
factor O
Sp1 _RARE_
bound _RARE_
to O
eight O
sites O
, O
as _RARE_
demonstrated O
by O
footprinting O
assays O
and O
gel O
shift O
analysis O
with O
purified _RARE_
Sp1 _RARE_
. O

The O
combination O
PIP _RARE_
64 _RARE_
micrograms O
- O
PEF _RARE_
4 O
micrograms O
prevents O
the O
frequent O
secondary O
regrowth _RARE_
seen O
after O
6 O
hours O
with O
the O
antibiotics O
used O
alone O
. O

With O
a O
sample O
of O
mothers O
of O
healthy O
infants O
, O
all O
three O
subscales _RARE_
of O
the O
revised O
instrument O
, O
WPL _RARE_
- O
R O
, O
had O
acceptable O
levels O
of O
internal O
consistency _RARE_
at _RARE_
7 O
, O
30 _RARE_
, O
and O
90 _RARE_
days O
postpartum _RARE_
, O
and O
stability O
across O
administrations _RARE_
. O

Since O
1948 _RARE_
, O
the O
use O
of O
saline O
- O
washed _RARE_
red _RARE_
cells O
( O
WRBCs _RARE_
) O
has O
been O
advocated _RARE_
to O
minimize _RARE_
hemolysis _RARE_
after O
transfusion O
to O
patients O
with O
PNH _RARE_
. O

In O
the O
group O
of O
asthmatics _RARE_
statistically O
significant O
correlation O
was O
found O
between O
PC20 _RARE_
PGF2 O
alpha O
and O
histamine _RARE_
values O
( O
r _RARE_
= O
0 _RARE_
. O
538 _RARE_
, O
p O
less O
than O
0 _RARE_
. O
05 O
). O

Acute O
experiments O
on O
nembutal _RARE_
- O
anesthetized O
cats O
( O
50 O
mg O
/ O
kg O
) O
were O
employed O
to O
investigate O
the O
effect O
of O
1 O
T O
pulsating _RARE_
magnetic O
field O
( O
PMF _RARE_
) O
on O
neuromuscular O
system _RARE_
of O
the O
leg O
. O

No O
significant O
differences O
were O
found O
between O
the O
TS _RARE_
and O
the O
PTS _RARE_
. O

The O
percentages _RARE_
of O
formed O
cysts O
and O
growth O
rates O
were O
monthly O
estimated O
and O
analyzed O
rhythmometrically _RARE_
by O
cosinor _RARE_
for _RARE_
5 O
clonal _RARE_
cultures O
of O
Scripsiella _RARE_
trochoidea _RARE_
Stein _RARE_
grown O
for _RARE_
2 O
years O
under O
laboratory O
conditions O
, O
rended _RARE_
as _RARE_
constant O
as _RARE_
possible O
from O
the O
view O
point O
of O
environmental O
temperature _RARE_
( O
24 _RARE_
+/- O
1 O
degree O
C O
), _RARE_
lighting _RARE_
( O
25 _RARE_
microEin _RARE_
m O
- O
2 O
s O
- O
1 O
), _RARE_
and O
artificial O
seawater _RARE_
. O

A O
genomic O
DNA O
clone O
encoding O
oryzacystatin _RARE_
( O
Oc _RARE_
), _RARE_
a O
cysteine I-GENE
proteinase _RARE_
inhibitor O
( O
cystatin _RARE_
) O
of O
rice _RARE_
, O
was O
isolated O
from O
a O
lambda O
EMBL3 _RARE_
phage _RARE_
library O
constructed O
with O
Sau3AI _RARE_
partial O
digests _RARE_
of O
rice _RARE_
chromosomal O
DNA O
, O
by O
screening O
with O
an O
oc _RARE_
cDNA I-GENE
as _RARE_
a O
probe O
. O

The O
use O
of O
an O
appropriate O
solution O
of O
methylene O
blue O
( O
0 _RARE_
. O
2 O
% O
in O
0 _RARE_
. O
9 O
M O
NaCl O
for _RARE_
15 _RARE_
min O
) O
permits O
the O
staining O
of O
premalignant _RARE_
areas O
and O
CIS _RARE_
, O
and O
their O
early O
diagnosis O
. O

Lower _RARE_
limits O
( O
to O
10 O
micrograms O
/ O
kg O
) O
were O
detectable O
, O
but O
with O
lower O
reliability O
( O
60 _RARE_
%). O

Instead O
, O
some O
small O
negative O
effects O
are O
observed O
, O
particularly O
involving O
effects O
of O
husbands _RARE_
' O
retirement _RARE_
on O
the O
marital _RARE_
satisfaction _RARE_
of O
employed O
wives _RARE_
. O

This O
in O
turn _RARE_
will O
further O
enhance O
the O
role O
of O
meta _RARE_
- O
analysis O
in O
helping _RARE_
clinicians _RARE_
and O
policy _RARE_
makers _RARE_
answer _RARE_
clinical O
questions O
. O

In O
one O
acromegalic _RARE_
patient O
visual O
improvement O
was O
obtained O
while O
the O
abnormal O
GH _RARE_
secretion _RARE_
remained O
unaltered O
. O

In O
contrast O
, O
the O
PPSF _RARE_
+ O
DBP _RARE_
side _RARE_
showed O
large O
amounts O
of O
bone O
formation O
, O
and O
bone O
almost O
covered _RARE_
the O
implant O
. O

The O
accuracies _RARE_
of O
presence O
or O
absence O
of O
neuroblastoma O
were O
compared O
between O
131I O
- O
MIBG _RARE_
imaging O
and O
several O
tumor O
markers O
. O

The O
congenital O
forms O
( O
7 O
cases O
) O
all O
occurred O
in O
female O
infants O
and O
involved O
the O
mucosa O
overlying _RARE_
either O
the O
anterior O
ridge _RARE_
of O
the O
maxilla _RARE_
or O
the O
mandible _RARE_
. O

Immunohistochemical _RARE_
studies O
revealed O
positive O
staining O
for _RARE_
S100 _RARE_
protein I-GENE
in O
all O
the O
granular _RARE_
cell O
tumors O
of O
the O
adult O
but O
in O
none O
of O
the O
congenital O
granular _RARE_
cell O
epulides _RARE_
. O

We O
also O
found O
that O
the O
same O
males O
, O
breeding _RARE_
in O
different O
years O
on O
the O
same O
territories _RARE_
, O
had O
significantly O
larger O
harems _RARE_
in O
the O
years O
they O
had O
familiar _RARE_
neighbors _RARE_
. O

Male _RARE_
- I-GENE
enhanced _RARE_
antigen I-GENE
gene I-GENE
is O
phylogenetically _RARE_
conserved _RARE_
and O
expressed _RARE_
at _RARE_
late _RARE_
stages O
of O
spermatogenesis _RARE_
. O

In O
rats O
bearing _RARE_
Walker _RARE_
- O
256 O
- O
carcinosarcoma _RARE_
4 O
- O
EPI _RARE_
was O
effective O
.( O
ABSTRACT O
TRUNCATED O
AT O
250 _RARE_
WORDS O
) O

Pacing _RARE_
the O
Roux _RARE_
limb O
abolished O
the O
ectopic O
pacemakers _RARE_
, O
restored O
the O
slow O
emptying O
of O
liquids _RARE_
to O
the O
more O
rapid O
rate O
found O
in O
the O
Billroth _RARE_
dogs O
( O
t1 O
/ O
2 O
: O
paced _RARE_
Roux _RARE_
, O
72 O
+/- O
15 _RARE_
minutes O
; O
Billroth _RARE_
, O
43 _RARE_
+/- O
9 O
minutes O
; O
p O
greater O
than O
0 _RARE_
. O
05 O
) O
and O
did O
not O
change O
emptying O
of O
solids _RARE_
. O

The O
treatments O
were O
60 _RARE_
mg O
t O
. O
i O
. O
d O
. O
and O
120 O
mg O
t O
. O
i O
. O
d O
. O
during _RARE_
14 O
days O
' O
treatment O
, O
with O
the O
last O
dose O
pulsed O
with O
1 O
. O
85 _RARE_
MBq O
[ _RARE_
14C O
] O
diltiazem O
. O

The O
subepicardial _RARE_
lymphatic _RARE_
capillaries O
were O
ramified _RARE_
and O
anastomosed _RARE_
with O
each O
other O
to O
form O
a O
relatively O
dense _RARE_
network O
which O
extended O
over O
the O
entire _RARE_
surface O
of O
both O
ventricles O
. O

The O
examination O
must O
include O
T1 _RARE_
and O
T2 _RARE_
sequences O
and O
scans O
in O
three O
planes _RARE_
. O

A O
great O
deal _RARE_
of O
information _RARE_
is O
available O
on O
the O
morphology O
of O
the O
claustrum _RARE_
in O
various O
animal _RARE_
species O
, O
as _RARE_
well _RARE_
as _RARE_
on O
its O
neuronal _RARE_
distribution O
and O
relationships O
with O
the O
cerebral O
cortex O
and O
other O
nuclei O
. O

Low O
- O
grade O
glioma O
. O

In O
terms O
of O
sequence O
repetitions _RARE_
, O
seven _RARE_
tandemly O
repeated _RARE_
copies O
of O
the O
hexanucleotide _RARE_
ATTGTT _RARE_
and O
three O
flanking O
regions O
of O
dyad _RARE_
symmetry _RARE_
were O
detected O
, O
all O
in O
ORF O
T3C _RARE_
. O

The O
significance O
of O
these O
palindromic O
domains O
in O
this O
ORF O
is O
unclear O
but O
the O
coincidence _RARE_
of O
the O
end O
of O
one O
larger O
palindrome O
with O
the O
end O
of O
the O
translated O
protein O
sequence O
that O
has O
homology O
with O
the O
B O
chain O
of O
insulin I-GENE
suggests O
that O
the O
palindromes _RARE_
may O
divide _RARE_
the O
T2 _RARE_
protein I-GENE
into O
several O
functional _RARE_
units _RARE_
. O

During O
sub O
- O
maximal O
exercise O
, O
DCR _RARE_
in O
the O
UT O
dogs O
decreased O
from O
a O
resting O
value O
of O
4 O
. O
08 _RARE_
+/- O
0 _RARE_
. O
18 O
mm O
Hg O
X O
ml O
- O
1 O
X O
min O
- O
1 O
to O
1 O
. O
91 O
+/- O
0 _RARE_
. O
17 _RARE_
mm O
Hg O
X O
ml O
- O
1 O
X O
min O
- O
1 O
at _RARE_
a O
workload _RARE_
of O
6 O
. O
4 O
kph _RARE_
( O
speed _RARE_
)/ _RARE_
16 O
% O
( O
grade O
). O

7 O
. O

These O
data O
suggest O
that O
the O
G I-GENE
- I-GENE
protein I-GENE
gene I-GENE
family I-GENE
may O
be O
distributed O
over O
at _RARE_
least O
two O
human O
chromosomes O
. O

The O
major O
inserted O
DNA O
has O
no _RARE_
significant O
homology O
to O
published O
human O
nucleic _RARE_
acid O
sequences O
. O

In O
44 _RARE_
evaluable O
patients O
the O
response O
rate O
was O
50 O
%, O
with O
one O
complete _RARE_
response O
. O

We O
have O
also O
found O
that O
the O
in O
vitro O
interaction O
between O
the O
SV40 O
octamer O
motif O
and O
the O
lymphoid _RARE_
cell I-GENE
- I-GENE
specific I-GENE
protein I-GENE
oct _RARE_
- I-GENE
B2 _RARE_
was O
negatively O
modulated O
by O
a O
component _RARE_
present O
in O
the O
nuclear O
extracts O
from O
several O
lymphoid _RARE_
cell O
lines O
. O

Anoxia _RARE_
was O
introduced O
by O
perfusing _RARE_
the O
gill _RARE_
with O
water O
deprived O
of O
oxygen O
or O
by O
halting _RARE_
the O
water O
flow O
to O
the O
gill _RARE_
. O

Growth _RARE_
, O
4 O
- O
PA O
and O
14C O
turnover O
data O
indicated O
that O
WB _RARE_
contributed O
to O
B O
- O
6 O
intake O
of O
these O
rats O
. O

Thus O
, O
multiple O
myogenic _RARE_
factors O
that O
vary O
qualitatively _RARE_
and O
quantitatively _RARE_
may O
be O
responsible O
for _RARE_
the O
different O
and O
complex O
modulatory _RARE_
programs O
of O
actin I-GENE
gene I-GENE
expression _RARE_
observed O
during _RARE_
in O
vivo O
muscle O
differentiation O
. O

DNA O
sequence O
analysis O
revealed O
that O
these O
clones _RARE_
encode O
two O
distinct O
forms O
of O
translocase _RARE_
. O

The O
effect O
of O
acetazolamide _RARE_
( O
ACZ _RARE_
) O
on O
HCO3 O
- O
and O
Cl O
- O
activities O
in O
inner O
ear O
fluid _RARE_
was O
investigated O
by O
ion O
- O
selective O
microelectrode _RARE_
methods O
. O

RPA190 _RARE_
encodes O
a O
polypeptide O
chain O
of O
186 _RARE_
, O
270 O
daltons _RARE_
in O
a O
large O
uninterrupted _RARE_
reading O
frame O
. O

Both O
the O
intact _RARE_
A1 _RARE_
protein I-GENE
and O
its O
proteolytic _RARE_
fragment O
, O
the O
UP1 _RARE_
protein I-GENE
, O
can O
be O
cleaved O
by O
Staphylococcus _RARE_
aureus _RARE_
V I-GENE
- I-GENE
8 I-GENE
protease I-GENE
to O
produce O
two O
polypeptides O
of O
92 O
amino O
acids _RARE_
. O

Irmiere _RARE_
, O
and O
W _RARE_
. O

These O
offspring _RARE_
of O
the O
alpha I-GENE
- I-GENE
MSH I-GENE
treated O
mothers O
were O
less O
sensitive _RARE_
to O
pain O
and O
as _RARE_
adults O
showed O
a O
reduced _RARE_
analgesic O
response O
to O
morphine _RARE_
. O

Simian _RARE_
immunodeficiency O
virus O
( O
SIV O
) O
is O
a O
lentivirus _RARE_
with O
morphological O
and O
antigenic _RARE_
similarities O
to O
human O
immunodeficiency O
virus O
, O
the O
causative _RARE_
agent O
of O
acquired O
immunodeficiency O
syndrome _RARE_
( O
AIDS O
) O
of O
humans O
. O

The O
lack O
of O
change O
in O
the O
ratio O
of O
the O
two O
spliced _RARE_
products O
expressed _RARE_
from O
either O
the O
normal O
or O
the O
5 I-GENE
'- I-GENE
rearranged _RARE_
myb I-GENE
further O
indicates O
that O
the O
insertion _RARE_
of O
the O
unique O
121 _RARE_
amino O
acids _RARE_
in O
the O
larger O
myb I-GENE
transcripts I-GENE
is O
not O
a O
consequence O
of O
tumor O
- O
specific O
activation O
of O
the O
mouse I-GENE
myb I-GENE
oncogene I-GENE
. O

The O
use O
of O
CRF _RARE_
- I-GENE
41 _RARE_
in O
the O
differential O
diagnosis O
of O
Cushing _RARE_
' O
s O
syndrome _RARE_
and O
obesity O
. O

We O
detected O
mos I-GENE
transcripts I-GENE
by O
Northern O
( O
RNA O
) O
analyses O
in O
RNA O
prepared O
from O
chicken O
and O
quail _RARE_
ovaries _RARE_
and O
testes O
. O

The O
predicted O
L I-GENE
mRNA I-GENE
was O
6398 _RARE_
nucleotides O
long O
and O
contained O
a O
single O
open _RARE_
reading O
frame O
corresponding O
to O
an O
L I-GENE
protein I-GENE
encompassing _RARE_
2109 _RARE_
amino I-GENE
acids _RARE_
with O
a O
MW _RARE_
of O
241 _RARE_
, O
546 _RARE_
. O

The O
results O
suggest O
that O
the O
organization O
of O
functional _RARE_
units _RARE_
of O
the O
72 O
- O
bp O
repeat O
required O
for _RARE_
transcriptional O
enhancement O
of O
the O
early O
promoter O
is O
different O
from O
that O
required O
for _RARE_
late _RARE_
promoter O
function O
. O

Variations _RARE_
in O
the O
5 O
' O
half _RARE_
of O
U3 _RARE_
were O
primarily O
due O
to O
insertions O
and O
deletions O
. O

An O
analysis O
of O
the O
steady O
state O
RNA O
levels O
in O
T O
- O
lymphoid _RARE_
cell O
lines O
showed O
that O
at _RARE_
least O
three O
different O
incomplete O
proviral _RARE_
transcripts O
and O
their O
spliced _RARE_
products O
made O
up _RARE_
the O
majority O
of O
expressed _RARE_
RD _RARE_
- I-GENE
114 _RARE_
mRNA I-GENE
, O
and O
further O
demonstrated O
that O
partially O
deleted _RARE_
proviral _RARE_
loci O
have O
the O
potential _RARE_
to O
be O
transcriptionally O
vigorous _RARE_
in O
certain O
feline _RARE_
cell O
types _RARE_
. O

Aplastic _RARE_
crisis _RARE_
in O
sickle _RARE_
cell O
disorders O
: O
bone O
marrow O
necrosis O
and O
human O
parvovirus _RARE_
infection O
. O

Either _RARE_
two O
or O
more O
different O
sequences O
can O
promote O
cleavage _RARE_
, O
or O
a O
single O
element O
exists O
which O
is O
long O
and O
diffuse O
. O

Low O
molecular _RARE_
weight _RARE_
heparins _RARE_
have O
stimulated _RARE_
much O
interest O
because O
of O
their O
supposedly _RARE_
more O
selective O
action O
on O
Xa _RARE_
factor I-GENE
. O

The O
bactericidal O
activity O
of O
six _RARE_
new O
rifamycin _RARE_
derivatives _RARE_
-- _RARE_
rifabutin _RARE_
( O
RBU _RARE_
), _RARE_
FCE _RARE_
22250 _RARE_
( O
F22 _RARE_
), _RARE_
rifapentine _RARE_
( O
RPE _RARE_
), _RARE_
CGP _RARE_
29861 _RARE_
( O
C29 _RARE_
), _RARE_
CGP _RARE_
7040 _RARE_
( O
C70 _RARE_
) O
and O
CGP _RARE_
27557 _RARE_
( O
C27 _RARE_
) O
and O
rifampicin _RARE_
( O
RMP _RARE_
)-- _RARE_
have O
been O
measured O
against O
log O
phase _RARE_
and O
, O
as _RARE_
a O
better O
test O
of O
sterilising _RARE_
activity O
, O
against O
stationary O
phase _RARE_
cultures O
of O
Mycobacterium O
tuberculosis O
, O
H37Rv _RARE_
. O

Mo _RARE_
+ O
SV O
M O
- O
MuLV O
- O
inoculated O
animals O
became O
moribund _RARE_
at _RARE_
3 O
to O
13 _RARE_
months O
postinoculation _RARE_
, O
whereas O
delta O
Mo _RARE_
+ O
SV O
M O
- O
MuLV O
- O
inoculated O
animals O
became O
moribund _RARE_
at _RARE_
6 O
to O
24 _RARE_
months O
postinoculation _RARE_
. O

Sodium O
dodecyl O
sulphate _RARE_
- O
induced _RARE_
cleavage _RARE_
by O
eukaryotic I-GENE
topoisomerase I-GENE
I I-GENE
is O
known O
to O
yield O
enzyme O
covalently O
attached O
to O
the O
3 O
' O
cut O
end O
of O
the O
DNA O
. O

Amino O
acid O
sequence O
of O
one O
human O
liver O
clone O
( O
HL _RARE_
- O
14 O
) O
was O
identical O
to O
the O
rabbit _RARE_
skeletal I-GENE
muscle I-GENE
phosphatase I-GENE
2A _RARE_
cDNA I-GENE
( O
with O
97 O
% O
nucleotide O
identity O
). O

Herpes _RARE_
virus O
infection O
was O
characterized O
by O
inversion O
of O
the O
T4 O
/ O
T8 _RARE_
ratio O
below O
1 O
. O
0 _RARE_
( O
sensitivity O
90 _RARE_
%, O
specificity _RARE_
88 O
%), O
caused O
by O
proliferation _RARE_
of O
the O
T8 _RARE_
subpopulation _RARE_
, O
which O
-- _RARE_
compared O
with O
the O
findings O
in O
patients O
with O
rejection O
crises _RARE_
-- _RARE_
was O
significantly O
raised O
( O
P O
less O
than O
0 _RARE_
. O
001 O
). O

RVEF _RARE_
and O
LVEF O
both O
increased O
by O
about O
14 O
% O
( O
p O
less O
than O
0 _RARE_
. O
05 O
and O
p O
less O
than O
0 _RARE_
. O
01 O
). O

The O
levels O
of O
NPY _RARE_
- O
ir _RARE_
in O
the O
rat O
vas O
deferens O
were O
not O
affected O
by O
either O
surgical O
or O
pharmacological O
treatment O
. O

Quantitative O
assays O
in O
which O
the O
activity O
of O
the O
synthetic _RARE_
alpha I-GENE
s I-GENE
- I-GENE
1 I-GENE
was O
compared O
to O
that O
of O
native _RARE_
purified _RARE_
human I-GENE
erythrocyte _RARE_
type I-GENE
- I-GENE
1 I-GENE
Gs _RARE_
, O
indicated O
that O
the O
two O
products O
are O
equipotent _RARE_
within O
a O
2 O
- O
fold _RARE_
margin O
of O
error O
. O

In O
these O
cells O
, O
E2 I-GENE
proteins I-GENE
had O
little O
or O
no _RARE_
stimulatory _RARE_
effect O
on O
the O
transcriptional O
activity O
of O
the O
HPV I-GENE
- I-GENE
11 I-GENE
enhancer I-GENE
- O
SV40 I-GENE
promoter I-GENE
. O

The O
mechanism O
by O
which O
E2 I-GENE
- I-GENE
C I-GENE
represses O
E2 I-GENE
- I-GENE
dependent I-GENE
enhancer I-GENE
activity O
most O
likely O
involves O
competition O
with O
E2 I-GENE
for _RARE_
binding O
to O
a O
common O
transcriptional O
regulatory O
site O
.( O
ABSTRACT O
TRUNCATED O
AT O
400 _RARE_
WORDS O
) O

Accurate _RARE_
evaluation O
of O
the O
treatment O
results O
in O
unresectable _RARE_
lung _RARE_
cancer _RARE_
patients O
must O
take O
the O
strong O
prognostic O
factors O
into O
account O
. O

( O
anti I-GENE
- I-GENE
IIa _RARE_
) O
and O
Holmer _RARE_
et O
al O
. O

Introduction _RARE_
of O
v I-GENE
- I-GENE
fms I-GENE
into O
a O
CSF I-GENE
- I-GENE
1 I-GENE
dependent O
murine O
macrophage O
cell O
line O
induced _RARE_
factor O
independence _RARE_
and O
tumorigenicity _RARE_
by O
a O
nonautocrine _RARE_
mechanism O
. O

Chronic O
E O
- O
B O
virus O
infection O
terminated _RARE_
in O
malignant O
lymphoma O
: O
a O
case O
report O

The O
primary _RARE_
structure _RARE_
and O
cotranscription _RARE_
of O
the O
petCA _RARE_
genes I-GENE
encoding O
the O
Rieske _RARE_
- I-GENE
FeS _RARE_
( O
nuclear I-GENE
encoded I-GENE
in I-GENE
plants _RARE_
) O
and O
apocytochrome _RARE_
f _RARE_
proteins I-GENE
has O
been O
described O
previously O
( O
Kallas _RARE_
, O
T O
., O
Spiller _RARE_
, O
S O
., O
and O
Malkin _RARE_
, O
R O
. O

The O
Nostoc _RARE_
petBD _RARE_
genes I-GENE
are O
not O
closely O
linked _RARE_
to O
the O
psbB _RARE_
gene I-GENE
( O
encoding O
the O
51 _RARE_
- O
kDa O
photosystem _RARE_
II I-GENE
polypeptide I-GENE
) O
and O
do O
not O
contain O
introns _RARE_
as _RARE_
do O
the O
closely O
related O
chloroplast O
genes O
. O

RNA O
blot O
hybridizations _RARE_
identified O
an O
1 O
. O
8 O
- O
kb O
mRNA O
common O
to O
cytochrome I-GENE
b6 _RARE_
and O
subunit O
IV O
, O
and O
an O
intensely _RARE_
hybridizing _RARE_
0 _RARE_
. O
8 O
- O
kb O
mRNA O
specific O
to O
the O
subunit O
IV O
gene O
probe O
. O

Whereas O
the O
muscle O
isoform O
consists O
of O
997 _RARE_
amino O
acids _RARE_
and O
terminates _RARE_
with O
the O
sequence O
Ala _RARE_
- O
Ile O
- O
Leu _RARE_
- O
Glu O
, O
the O
second O
isoform O
is O
1043 _RARE_
amino O
acids _RARE_
in O
length O
due O
to O
the O
replacement _RARE_
of O
these O
last O
4 O
amino O
acids _RARE_
with O
a O
50 O
- O
amino O
acid O
sequence O
that O
contains O
a O
potential _RARE_
transmembrane O
domain O
followed O
by O
a O
consensus O
sequence O
for _RARE_
an O
N O
- O
linked _RARE_
glycosylation O
site O
. O

Substitution O
of O
a O
threonine O
residue _RARE_
by O
an O
alanine O
residue _RARE_
at _RARE_
position O
- O
2 O
( O
P2 O
) O
of O
this O
cleavage _RARE_
site O
abolished O
cleavage _RARE_
, O
whereas O
substitution O
of O
a O
tyrosine O
residue _RARE_
by O
a O
phenylalanine _RARE_
residue _RARE_
at _RARE_
amino O
acid O
position O
- O
1 O
( O
P1 O
) O
of O
the O
cleavage _RARE_
site O
did O
not O
influence O
processing _RARE_
. O

All O
of O
the O
indigo _RARE_
- O
producing O
bacteria O
had O
an O
indoxyl _RARE_
phosphatase I-GENE
with O
a O
pI _RARE_
of O
6 O
. O
4 O
. O

The O
number O
of O
polymerases _RARE_
active _RARE_
in O
vitro O
at _RARE_
the O
E O
strand _RARE_
promoter O
was O
similar O
to O
the O
number O
of O
polymerases _RARE_
at _RARE_
the O
L O
strand _RARE_
promoter O
. O

A O
family O
of O
RNA O
molecules O
in O
the O
2 O
. O
0 _RARE_
- O
2 O
. O
2 O
- O
kilobase _RARE_
range O
identified O
with O
a O
probe O
from O
this O
gene O
was O
overexpressed O
in O
the O
resistant O
cells O
. O

A O
highly O
hydrophobic O
sequence O
located _RARE_
near O
the O
carboxyl _RARE_
- O
terminal O
extremity _RARE_
of O
the O
molecule O
most O
likely O
constitutes O
the O
anchor _RARE_
to O
the O
plasma O
membrane O
. O

The O
SV40 I-GENE
enhancer I-GENE
augmented O
replication O
1 O
. O
5 O
- O
10 O
fold _RARE_
. O

One O
of O
these O
, O
the O
origin O
core O
, O
is O
required O
only O
for _RARE_
DNA O
replication O
. O

Induction O
of O
proto _RARE_
- I-GENE
oncogene I-GENE
fos I-GENE
transcription O
through O
the O
adenylate I-GENE
cyclase I-GENE
pathway _RARE_
: O
characterization O
of O
a O
cAMP O
- O
responsive O
element O
. O

A O
17 _RARE_
- O
mer _RARE_
oligodeoxynucleotide _RARE_
, O
corresponding O
to O
a O
region O
of O
the O
VtHb _RARE_
amino I-GENE
acid I-GENE
sequence I-GENE
was O
used O
as _RARE_
a O
hybridization O
probe O
to O
screen O
a O
Vitreoscilla _RARE_
genomic O
library O
constructed O
in O
broad O
- O
host _RARE_
- O
range O
cosmid O
vector O
pVK102 _RARE_
. O

( O
total _RARE_
soluble _RARE_
solids _RARE_
) O
and O
organoleptic _RARE_
characteristics O
under O
the O
influence O
of O
different O
treatments O
. O

Causes _RARE_
of O
death _RARE_
found O
in O
an O
epidemiological O
study O
of O
native _RARE_
chickens _RARE_
in O
Thai _RARE_
villages _RARE_
. O

The O
progression O
of O
non O
- O
A O
, O
non O
- O
B O
hepatitis O
to O
chronic O
diseases O
, O
and O
the O
transformation O
to O
hepatocellular _RARE_
carcinoma O

Elevated _RARE_
IOP O
developed O
in O
35 _RARE_
patients O
( O
44 _RARE_
eyes O
) O
during _RARE_
the O
study O
. O

Use O
of O
serum O
thyroglobulin _RARE_
determination O
in O
the O
follow O
- O
up _RARE_
of O
differentiated O
carcinomas O
of O
the O
thyroid O

Poor _RARE_
response O
when O
laboratory O
recommended O
range O
for _RARE_
serum O
lithium O
is O
changed O
. O

The O
aim O
of O
this O
study O
was O
to O
investigate O
the O
effects O
of O
nebulized _RARE_
ipratropium _RARE_
in O
patients O
with O
acute O
asthma O
in O
order O
to O
determine O
whether O
it O
augments _RARE_
the O
bronchodilator _RARE_
effect O
of O
a O
beta O
agonist O
drug O
. O

Further O
analysis O
of O
this O
DNA O
fragment O
showed O
that O
four O
genes O
are O
present O
encoding O
proteins O
of O
16 O
, O
18 O
. O
5 O
, O
21 O
and O
89 _RARE_
kDal _RARE_
. O

Hantaan _RARE_
virus O
. O

Changes O
in O
dopamine I-GENE
receptor I-GENE
sensitivity O
in O
humans O
after O
heavy O
alcohol _RARE_
intake O
. O

No O
significant O
differences O
between O
the O
two O
treatment O
groups O
were O
found O
, O
but O
rapid O
responders O
had O
a O
smaller O
mean O
initial O
platelet I-GENE
- I-GENE
associated I-GENE
IgG I-GENE
index O
which O
returned O
more O
rapidly O
and O
more O
permanently _RARE_
to O
normal O
than O
that O
of O
slow O
responders O
. O

Replacement _RARE_
variant I-GENE
histone I-GENE
genes I-GENE
contain O
intervening O
sequences O
. O

Double O
- O
blind O
randomised O
trial O
of O
intravenous O
tissue I-GENE
- I-GENE
type I-GENE
plasminogen I-GENE
activator I-GENE
versus O
placebo O
in O
acute O
myocardial _RARE_
infarction O
. O

The O
C O
- O
terminal O
domains O
( O
CTDs _RARE_
) O
of O
the O
RPase _RARE_
beta I-GENE
subunit I-GENE
and O
DNA I-GENE
primase I-GENE
( O
dnaG _RARE_
protein I-GENE
) O
were O
not O
only O
strongly O
homologous O
to O
each O
other O
but O
also O
considerably O
homologous O
to O
the O
RPase _RARE_
alpha I-GENE
, O
suggesting O
that O
an O
alpha O
subunit O
- O
like O
enzyme O
must O
have O
been O
commonly O
ancestral O
to O
core I-GENE
enzyme I-GENE
subunits I-GENE
and O
primase I-GENE
. O

However O
, O
vancomycin O
and O
fosfomycin _RARE_
, O
which O
revealed O
suboptimal _RARE_
in O
vitro O
bactericidal O
activity O
, O
proved O
as _RARE_
efficacious _RARE_
as _RARE_
penicillin _RARE_
G O
and O
imipenem _RARE_
in O
an O
experimental O
mode O
of O
murine O
gas O
gangrene _RARE_
. O

Fentanyl _RARE_
, O
a O
prototypic _RARE_
mu I-GENE
- I-GENE
opiate _RARE_
receptor I-GENE
agonist O
, O
has O
been O
previously O
shown O
to O
produce O
a O
syndrome _RARE_
characterized O
by O
marked O
analgesia O
and O
locomotor O
stimulation _RARE_
as _RARE_
well _RARE_
as _RARE_
tachycardia O
, O
tachypnoea _RARE_
and O
behavioural _RARE_
arousal _RARE_
. O

Intravesical _RARE_
chemotherapy O
. O

Bisoprolol _RARE_
was O
found O
to O
be O
an O
effective O
beta I-GENE
- I-GENE
adrenoceptor I-GENE
antagonist O
, O
the O
pA2 _RARE_
values O
determined O
against O
isoprenaline _RARE_
in O
guinea _RARE_
pig _RARE_
atria _RARE_
and O
tracheal O
muscle O
being O
7 O
. O
45 _RARE_
and O
6 O
. O
41 _RARE_
, O
respectively O
. O

Output _RARE_
of O
99mTcO _RARE_
- O
4 O
by O
the O
parotid _RARE_
gland _RARE_
closely O
mimicked O
fluctuations O
in O
parotid _RARE_
saliva _RARE_
flow O
rate O
. O

The O
Hagen _RARE_
- O
Poiseuille _RARE_
equation O
is O
used O
to O
assess O
the O
effects O
of O
attached O
parasites O
in O
the O
foregut _RARE_
of O
Leishmania _RARE_
- O
infected _RARE_
sandflies _RARE_
on O
blood _RARE_
flow O
. O

Moreover O
, O
in O
rats O
allowed O
to O
choose _RARE_
in O
a O
T O
- O
maze _RARE_
between O
immediate O
- O
but O
- O
small O
vs _RARE_
. O
delayed O
- O
but O
- O
large O
reward _RARE_
, O
BZP _RARE_
significantly O
decreased O
the O
frequency O
with O
which O
the O
delayed O
reward _RARE_
was O
chosen O
, O
with O
5 O
- O
HT _RARE_
uptake O
blockers O
producing O
opposite O
effects O
. O

An O
endometrial O
luteal _RARE_
phase _RARE_
deficiency O
was O
detected O
in O
15 _RARE_
( O
30 _RARE_
%) O
of O
aborting _RARE_
patients O
. O

Prenatal _RARE_
exposure O
to O
the O
fungicide _RARE_
dinocap _RARE_
causes O
behavioral O
torticollis _RARE_
, O
ballooning _RARE_
and O
cleft _RARE_
palate _RARE_
in O
mice O
, O
but O
not O
rats O
or O
hamsters O
. O

Reperfusion _RARE_
with O
normal O
blood _RARE_
in O
the O
beating _RARE_
, O
working O
hearts O
caused O
extensive O
structural O
damage O
, O
reduced _RARE_
reflow _RARE_
, O
and O
failed O
to O
restore _RARE_
contractility O
in O
any O
instance _RARE_
(- _RARE_
27 _RARE_
% O
systolic O
shortening O
, O
p O
less O
than O
0 _RARE_
. O
05 O
). O

The O
sensitivity O
of O
the O
vas O
deferens O
to O
adrenaline O
was O
also O
reduced _RARE_
in O
scorbutic _RARE_
guinea _RARE_
pigs O
, O
thus O
decreasing O
their O
fertility O
rate O
. O

In O
metabolic O
acidosis O
there O
was O
a O
marked O
stimulation _RARE_
when O
clamped _RARE_
at _RARE_
- O
10 O
to O
- O
100 _RARE_
mV _RARE_
. O

On O
Days _RARE_
1 O
and O
14 O
, O
most O
young O
and O
elderly O
subjects O
exhibited O
monoexponential _RARE_
decline O
in O
bevantolol _RARE_
plasma O
concentrations O
after O
absorption O
phase _RARE_
. O

Mature _RARE_
and O
old O
B6AF1 _RARE_
and O
B6D2F1 _RARE_
mice O
were O
given O
acidified _RARE_
tap _RARE_
water O
or O
promethazine _RARE_
HCl _RARE_
( O
a O
phenothiazine _RARE_
with O
H1 _RARE_
receptor I-GENE
blocking O
activity O
), _RARE_
chlorpheniramine _RARE_
( O
an O
H1 _RARE_
blocker O
) O
or O
trifluoperazine _RARE_
( O
a O
phenothiazine _RARE_
with O
no _RARE_
H1 _RARE_
blocking O
activity O
) O
in O
their O
drinking O
water O
, O
and O
the O
effects O
of O
these O
agents O
on O
bone O
mineral O
content O
were O
assessed O
by O
intermittently _RARE_
measuring O
the O
24 _RARE_
- O
h O
whole O
body O
retention O
of O
Tc O
99m O
methylene O
diphosphonate _RARE_
( O
Tc O
99m O
MDP _RARE_
, O
an O
indicator O
of O
bone O
metabolism O
) O
and O
at _RARE_
the O
end O
of O
the O
studies O
by O
determining _RARE_
ash _RARE_
weights O
of O
femur O
, O
ilium _RARE_
and O
sacrum _RARE_
. O

Present _RARE_
results O
reveal O
a O
frequency O
- O
dependent O
inhibition O
of O
ganglionic _RARE_
transmission _RARE_
by O
diltiazem O
, O
and O
suggest O
that O
diltiazem O
may O
depress _RARE_
excessive O
sympathetic O
activity O
without O
affecting O
normal O
ganglionic _RARE_
transmission _RARE_
. O

Studies O
were O
performed O
on O
several O
superficial O
veins _RARE_
from O
the O
rabbit _RARE_
face O
to O
examine O
the O
relationship O
between O
beta I-GENE
adrenoceptor I-GENE
subtype _RARE_
distribution O
, O
intrinsic _RARE_
myogenic _RARE_
tone O
and O
sympathetic O
nerve O
innervation _RARE_
. O

Effects O
of O
a O
new O
antihypertensive O
agent O
, O
SGB _RARE_
- O
1534 _RARE_
, O
on O
rat O
platelet O
aggregation _RARE_
. O

Since O
the O
stability O
of O
TF1 _RARE_
resides O
in O
its O
primary _RARE_
structure _RARE_
, O
we O
cloned _RARE_
a O
gene O
coding O
for _RARE_
TF1 _RARE_
, O
and O
the O
primary _RARE_
structure _RARE_
of O
the O
beta O
subunit O
was O
deduced O
from O
the O
nucleotide O
sequence O
of O
the O
gene O
to O
compare O
the O
sequence O
with O
those O
of O
beta O
' O
s O
of O
three O
major O
categories O
of O
F1 _RARE_
' O
s O
; O
prokaryotic _RARE_
membranes O
, O
chloroplasts _RARE_
, O
and O
mitochondria _RARE_
. O

Body _RARE_
temperature _RARE_
and O
overall O
conductance _RARE_
in O
the O
cold O
appear O
to O
be O
more O
variable _RARE_
in O
P O
. O
s O
. O
campbelli _RARE_
than O
in O
nominative _RARE_
sp _RARE_
. O

Two O
polyadenylation O
sites O
were O
used O
, O
one O
at _RARE_
the O
end O
of O
the O
early I-GENE
( I-GENE
E I-GENE
) I-GENE
region I-GENE
of O
the O
viral O
DNA O
, O
the O
other O
at _RARE_
the O
end O
of O
the O
late _RARE_
( I-GENE
L I-GENE
) I-GENE
region I-GENE
. O

A O
drug O
with O
ISA _RARE_
" O
down O
regulates O
" O
beta I-GENE
receptors I-GENE
; O
thus O
, O
when O
the O
drug O
is O
withdrawn _RARE_
there O
is O
no _RARE_
post O
- O
beta O
- O
blocking O
drug O
hypersensitivity O
in O
contrast O
to O
agents O
without O
ISA _RARE_
. O

Six O
patients O
with O
human O
T O
- O
cell O
lymphotropic _RARE_
virus O
type O
I O
( O
HTLV _RARE_
- O
I O
)- O
associated O
myelopathy _RARE_
( O
HAM _RARE_
) O
were O
studied O
by O
electrophysiologic _RARE_
methods O
. O

Terazosin _RARE_
, O
a O
structural O
analog O
of O
prazosin _RARE_
, O
also O
inhibits O
alpha I-GENE
1 I-GENE
adrenoceptors I-GENE
and O
is O
recommended O
as _RARE_
once O
or O
twice O
- O
daily O
therapy O
. O

Testing _RARE_
blood _RARE_
donors O
for _RARE_
non O
- O
A O
, O
non O
- O
B O
hepatitis O
: O
irrational _RARE_
, O
perhaps O
, O
but O
inescapable _RARE_
. O

Most O
patients O
with O
high O
blood _RARE_
pressure O
( O
BP _RARE_
) O
can O
be O
managed _RARE_
by O
using O
one O
of O
4 O
classes O
of O
compounds O
: O
a O
diuretic O
, O
beta O
blocker O
, O
converting _RARE_
enzyme O
inhibitor O
or O
calcium _RARE_
antagonist O
. O

In O
a O
randomised O
double O
- O
blind O
study O
, O
46 _RARE_
first _RARE_
episode _RARE_
schizophrenics _RARE_
were O
given O
pimozide _RARE_
or O
flupenthixol _RARE_
for _RARE_
up _RARE_
to O
5 O
weeks O
; O
the O
mean O
daily O
dose O
at _RARE_
the O
end O
was O
18 O
. O
8 O
mg O
pimozide _RARE_
and O
20 O
mg O
flupenthixol _RARE_
. O

Somatostatin _RARE_
- O
producing O
endocrine O
pancreatic O
tumor O
in O
Recklinghausen _RARE_
' O
s O
neurofibromatosis _RARE_
. O

Direct _RARE_
and O
inverted O
repeat O
elements O
of O
10 O
, O
11 O
, O
16 O
, O
19 O
, O
and O
22 _RARE_
nucleotides O
( O
nt O
) O
flank O
the O
promoter O
site O
. O

We O
have O
been O
able O
to O
map O
specific O
DNA O
fragments O
at _RARE_
the O
bases O
of O
chromatin O
loops O
with O
the O
help O
of O
a O
novel O
extraction O
procedure O
by O
using O
lithium O
- O
3 O
', _RARE_
5 O
'- O
diiodosalicylate _RARE_
. O

Seventy O
- O
one O
supplementary O
doses O
of O
vecuronium _RARE_
were O
used O
for _RARE_
muscle O
relaxation O
during _RARE_
a O
22 _RARE_
- O
h O
- O
long O
NLA _RARE_
II O
anaesthesia O
. O

Finally O
, O
the O
recovery O
indexes _RARE_
represented O
by O
the O
times O
required O
for _RARE_
T1 _RARE_
/ O
T0 _RARE_
and O
T4 O
/ O
T1 _RARE_
to O
rise O
from O
25 _RARE_
% O
to O
75 _RARE_
% O
respectively O
were O
studied O
. O

Transformed _RARE_
bacterial O
colonies O
were O
screened O
for _RARE_
recombinant O
plasmids O
containing O
cDNA O
coding O
for _RARE_
BiP _RARE_
by O
hybrid _RARE_
- O
selected _RARE_
mRNA O
translation O
. O

DPA _RARE_
attenuated O
the O
increase O
of O
the O
intensity O
of O
the O
ischemic O
and O
pressure O
pain O
components _RARE_
with O
increasing O
ischemia O
duration O
, O
but O
only O
the O
effect O
on O
the O
pressure O
pain O
component _RARE_
was O
significant O
. O

Topical _RARE_
1 O
percent O
isoproterenol O
in O
the O
presence O
of O
the O
phosphodiesterase _RARE_
inhibitor O
theophylline O
was O
tested O
for _RARE_
its O
ability O
to O
stimulate O
the O
rate O
of O
aqueous O
humor _RARE_
flow O
through O
the O
anterior O
chamber O
of O
the O
normal O
and O
the O
partially O
adrenergically _RARE_
denervated _RARE_
human O
eye O
( O
Horner _RARE_
' O
s O
syndrome _RARE_
). O

Hyperthyroidism _RARE_
is O
one O
of O
the O
numerous O
causes O
of O
infertility O
and O
recurrent O
abortion O
. O

A O
strong O
correlation O
exists O
between O
the O
numbers O
of O
CFU _RARE_
- O
GM _RARE_
transfused _RARE_
and O
the O
rate O
of O
granulocytes _RARE_
and O
platelets O
recovery O
. O

We O
propose O
that O
the O
technique O
of O
low O
- O
frequency O
kindling O
is O
a O
useful O
experimental O
model O
in O
assessing O
the O
effects O
of O
antipsychotic _RARE_
or O
antiepileptic _RARE_
drugs O
on O
the O
excitability _RARE_
of O
the O
limbic _RARE_
regions O
. O

Oestrogen _RARE_
implant O
overdose _RARE_
. O

Three O
sequence O
elements O
are O
shown O
to O
be O
required O
for _RARE_
accurate O
and O
efficient O
transcription O
termination _RARE_
by O
RNA I-GENE
polymerase I-GENE
I I-GENE
( O
pol I-GENE
I I-GENE
) O
assayed O
both O
in O
a O
cell O
- O
free O
transcription O
system _RARE_
and O
in O
vivo O
after O
transfection O
of O
rDNA _RARE_
minigene _RARE_
constructs O
into O
3T6 _RARE_
cells O
. O

The O
biosynthesis O
and O
stability O
of O
the O
three O
mutant O
proteins O
were O
similar O
to O
those O
of O
the O
wild I-GENE
- I-GENE
type I-GENE
erbB I-GENE
protein I-GENE
, O
and O
all O
three O
retained O
the O
ability O
to O
transform O
chicken O
embryo _RARE_
fibroblasts _RARE_
. O

Codon _RARE_
usage O
in O
C O
. O
reinhardtii _RARE_
mitochondria _RARE_
is O
highly O
biased _RARE_
, O
with O
eight O
codons O
entirely O
absent O
from O
all O
protein O
- O
coding O
genes O
; O
however O
, O
even O
though O
codon _RARE_
usage O
is O
restricted O
, O
it O
appears O
that O
C O
. O
reinhardtii _RARE_
mtDNA _RARE_
cannot O
encode O
the O
minimum O
number O
of O
tRNAs _RARE_
needed O
to O
support O
mitochondrial O
protein O
synthesis _RARE_
. O

A O
new O
physiopathological _RARE_
treatment O
of O
HBV _RARE_
- O
related O
polyarteritis _RARE_
inspired _RARE_
by O
advances _RARE_
in O
the O
treatment O
of O
chronic O
active _RARE_
hepatitis O
B O
was O
tested O
in O
7 O
patients O
. O

Like O
scrotal _RARE_
testes O
, O
undescended _RARE_
testes O
were O
hypointense _RARE_
to O
fat O
on O
sequences O
with O
a O
short O
repetition _RARE_
time O
( O
TR O
) O
and O
echo O
time O
( O
TE _RARE_
) O
in O
all O
cases O
, O
and O
hyperintense _RARE_
or O
isointense _RARE_
to O
fat O
on O
long O
TR O
/ O
TE _RARE_
sequences O
in O
all O
but O
two O
cases O
. O

The O
subunit I-GENE
- I-GENE
a I-GENE
gene I-GENE
is O
preceded _RARE_
by O
a O
gene O
coding O
for _RARE_
a O
small O
hydrophobic O
protein O
, O
as _RARE_
has O
been O
observed O
previously O
in O
the O
atp _RARE_
operons _RARE_
in O
E O
. O
coli O
, O
bacterium O
PS3 _RARE_
and O
cyanobacteria _RARE_
. O

Here O
, O
we O
describe O
the O
isolation O
of O
bovine I-GENE
and I-GENE
rat I-GENE
GHF _RARE_
- I-GENE
1 I-GENE
cDNA I-GENE
clones _RARE_
. O

To O
explore O
the O
functional _RARE_
properties O
of O
the O
protein O
encoded O
by O
neu I-GENE
, O
we O
created O
a O
fusion O
gene O
that O
joins O
the O
cytoplasmic O
domain O
of O
neu I-GENE
to O
the O
extracellular O
portion O
of O
an O
immunoglobulin I-GENE
heavy I-GENE
chain I-GENE
. O

The O
East _RARE_
African O
dik _RARE_
- O
dik _RARE_
antelope _RARE_
represents O
a O
miniature _RARE_
model O
ruminant _RARE_
for _RARE_
comparative O
studies O
. O

By O
sequence O
comparison O
, O
42 _RARE_
blocks O
of O
homology O
are O
defined O
in O
the O
5 O
'- O
terminal O
region O
, O
of O
which O
36 _RARE_
appear O
in O
the O
CpG O
island O
and O
contain O
numerous O
conserved _RARE_
CpG O
dinucleotides _RARE_
. O

Among O
unusual O
features O
, O
we O
report O
numerous O
large O
G O
+ O
C O
- O
rich O
conserved _RARE_
sequences O
located _RARE_
in O
the O
first _RARE_
intron O
. O

In O
the O
first _RARE_
group O
, O
0 _RARE_
. O
02 O
% O
Prazosin _RARE_
( O
0 _RARE_
. O
5 O
mg O
/ O
kg O
) O
was O
administered O
intravenously O
for _RARE_
1 O
. O
5 O
hours O
before O
the O
application O
of O
Oxy _RARE_
- O
Hb _RARE_
or O
PGF2 O
alpha O
. O

Efficacy _RARE_
and O
field O
evaluation O
of O
Bacillus O
thuringiensis _RARE_
( O
H O
- O
14 O
) O
and O
B O
. O
sphaericus _RARE_
against O
floodwater _RARE_
mosquitoes _RARE_
in O
California _RARE_
. O

2 O
cases O
of O
type O
II O
tyrosinosis _RARE_
( O
Richner _RARE_
- O
Hanhart _RARE_
syndrome _RARE_
) O

This O
loss _RARE_
was O
independent O
of O
drug O
concentration O
and O
a O
correction O
factor O
was O
employed O
to O
calculate _RARE_
the O
true O
free O
diazepam _RARE_
concentration O
. O

Effects O
of O
a O
perfluorochemical _RARE_
blood _RARE_
substitute O
on O
diazepam _RARE_
binding O
by O
human I-GENE
albumin I-GENE
. O

A O
second O
promoter O
activity O
was O
identified O
in O
the O
region O
between O
the O
two O
major O
transcriptional O
start _RARE_
sites O
. O

A O
decamer _RARE_
sequence O
, O
5 O
'- O
CGA _RARE_
- O
CCCCUCC _RARE_
- O
3 O
', _RARE_
complementary _RARE_
to O
a O
conserved _RARE_
sequence O
adjacent O
to O
the O
enzymatic O
cleavage _RARE_
site O
on O
the O
mitochondrial O
RNA O
substrate O
, O
is O
present O
in O
the O
RNAase _RARE_
MRP I-GENE
RNA I-GENE
. O

Effects O
of O
aging O
and O
beta O
- O
adrenergic O
- O
blockade O
on O
standing _RARE_
- O
induced _RARE_
QT O
/ O
QS2 _RARE_
changes O
. O

A O
patient O
with O
an O
infected _RARE_
wound O
or O
one O
on O
a O
primary _RARE_
area O
( O
hands _RARE_
, O
feet _RARE_
, O
face O
, O
or O
perineum _RARE_
) O
may O
have O
to O
be O
hospitalized O
to O
ensure _RARE_
proper O
care O
. O

Pharmacology _RARE_
studies O
with O
potassium _RARE_
chloride _RARE_
and O
acetylcholine _RARE_
suggest O
that O
raveron _RARE_
acts O
as _RARE_
a O
calcium _RARE_
antagonist O
by O
blocking O
the O
influx _RARE_
of O
extracellular O
calcium _RARE_
. O

Computer _RARE_
analysis O
included O
digital O
averaging _RARE_
, O
followed O
by O
digital O
filtering _RARE_
in O
different O
frequency O
bands O
in O
order O
to O
determine O
the O
frequency O
range O
corresponding O
to O
notches _RARE_
and O
slurs _RARE_
. O

On O
admission O
to O
the O
ICU _RARE_
, O
117 O
patients O
( O
61 _RARE_
percent O
) O
had O
hypomagnesemia _RARE_
( O
serum O
Mg _RARE_
less O
than O
1 O
. O
5 O
mEq O
/ O
dl O
), _RARE_
66 _RARE_
patients O
( O
34 _RARE_
percent O
) O
had O
normomagnesemia _RARE_
( O
1 O
. O
5 O
to O
2 O
. O
0 _RARE_
mEq O
/ O
dl O
), _RARE_
and O
ten O
patients O
( O
5 O
percent O
) O
had O
hypermagnesemia _RARE_
( O
greater O
than O
2 O
. O
0 _RARE_
mEq O
/ O
dl O
). O

The O
risk O
factors O
studied O
were O
male O
sex _RARE_
, O
hypertension O
, O
diabetes O
mellitus O
, O
hypercholesterolemia _RARE_
, O
cigarette _RARE_
smoking O
, O
sedentary _RARE_
life O
- O
style _RARE_
, O
and O
family O
history O
. O

Neither O
verapamil O
nor O
nifedipine O
changed O
collateral O
myocardial _RARE_
blood _RARE_
flow O
from O
0 _RARE_
. O
10 O
+/- O
0 _RARE_
. O
02 O
in O
the O
subendocardium _RARE_
and O
0 _RARE_
. O
17 _RARE_
+/- O
0 _RARE_
. O
03 O
ml O
/ O
min O
/ O
g O
in O
the O
subepicardium _RARE_
. O

There O
were O
35 _RARE_
boys O
and O
15 _RARE_
girls O
, O
with O
a O
mean O
age O
of O
five O
and O
a O
half _RARE_
years O
. O

Controlled _RARE_
versus O
uncontrolled _RARE_
reperfusion O
of O
ischemic O
myocardium O
after O
experimental O
coronary O
artery O
occlusion O
was O
studied O
to O
determine O
the O
effect O
on O
regional O
ventricular O
wall _RARE_
motion O
and O
associated O
biochemical O
alterations O
. O

Cardiac _RARE_
disease _RARE_
was O
not O
detected O
with O
M O
- O
mode O
, O
2 O
- O
dimensional O
real O
- O
time O
or O
pulsed O
- O
wave O
Doppler O
echocardiography O
. O

Hemodynamic _RARE_
assessment O
was O
obtained O
before O
and O
following O
administration O
of O
digoxin _RARE_
10 O
micrograms O
/ O
kg O
IV O
or O
dopamine O
, O
5 O
to O
12 O
micrograms O
/ O
kg O
/ O
min O
IV O
. O

We O
also O
examined O
the O
relationship O
between O
the O
side _RARE_
of O
sinusitis _RARE_
and O
the O
cleft _RARE_
side _RARE_
in O
patients O
with O
unilateral O
cleft _RARE_
palate _RARE_
. O

We O
conclude O
that O
at _RARE_
these O
low O
levels O
studied O
, O
aluminum O
accumulates O
in O
intestinal _RARE_
tissue O
, O
and O
that O
this O
accumulation O
is O
enhanced _RARE_
by O
citrate _RARE_
ligand _RARE_
. O

Thus O
, O
the O
effects O
of O
father _RARE_
absence O
under O
routine O
conditions O
in O
relatively O
healthy O
samples O
may O
exert O
no _RARE_
significant O
effects O
independent O
of O
intervening O
family O
stressors _RARE_
or O
maternal _RARE_
psychopathology _RARE_
. O

Recently O
, O
an O
electrical O
- O
mechanical O
analog O
model O
of O
heat O
flow O
within O
the O
brain O
has O
been O
developed O
from O
which O
an O
expression _RARE_
for _RARE_
CBF O
has O
been O
derived O
: O
CBF O
= O
Cb _RARE_
/( _RARE_
tau _RARE_
rho _RARE_
c O
) O
where O
tau _RARE_
is O
the O
thermal O
decay _RARE_
constant O
, O
rho _RARE_
is O
the O
density O
of O
blood _RARE_
, O
and O
c O
is O
its O
specific O
heat O
. O

All O
of O
the O
newly O
acquired O
proviruses _RARE_
identified O
in O
mosaic O
founder _RARE_
SWR _RARE_
/ O
J _RARE_
- O
RF _RARE_
/ O
J _RARE_
mice O
that O
could O
be O
transmitted O
through O
the O
germ _RARE_
line O
were O
also O
present O
in O
somatic O
tissues O
, O
demonstrating O
that O
viral O
integration _RARE_
occurred O
before O
the O
germ _RARE_
line O
was O
set O
aside _RARE_
from O
the O
somatic O
lineages O
. O

Molecular O
cloning O
of O
the O
cDNA O
for _RARE_
the O
human I-GENE
U2 _RARE_
snRNA _RARE_
- I-GENE
specific I-GENE
A I-GENE
' I-GENE
protein I-GENE
. O

For O
the O
present O
work O
we O
used O
water O
saturated _RARE_
with O
a O
50 O
/ O
50 O
mixture O
of O
H2 O
and O
O2 _RARE_
gases O
, O
for _RARE_
which O
the O
heat O
defect O
is O
calculated O
to O
be O
- O
2 O
. O
1 O
%. O

Successful _RARE_
use O
of O
transureteroureterostomy _RARE_
to O
salvage _RARE_
ureterosigmoidostomy _RARE_
after O
anastomotic _RARE_
failure O
. O

During O
flexion _RARE_
whiplash _RARE_
, O
the O
torque _RARE_
at _RARE_
the O
occipital _RARE_
condyle _RARE_
reverses _RARE_
its O
direction O
at _RARE_
about O
25 _RARE_
ms O
after O
impact O
. O

The O
data O
indicates O
the O
presence O
of O
5 I-GENE
- I-GENE
HT2 I-GENE
serotonergic _RARE_
receptors I-GENE
in O
the O
bronchial O
artery O
of O
these O
species O
. O

Oxfendazole _RARE_
, O
which O
was O
active _RARE_
for _RARE_
the O
shortest _RARE_
time O
( O
about O
65 O
days O
) O
from O
the O
start _RARE_
of O
grazing _RARE_
( O
May _RARE_
1 O
), _RARE_
produced O
a O
78 _RARE_
. O
1 O
per O
cent O
reduction O
in O
Ostertagia _RARE_
species O
and O
an O
84 _RARE_
. O
4 O
per O
cent O
reduction O
in O
D O
viviparus _RARE_
. O

By O
adapting O
a O
method O
for _RARE_
DNA O
- O
footprinting O
using O
impure _RARE_
extracts O
of O
ner _RARE_
overproducing _RARE_
cells O
, O
we O
were O
able O
to O
determine O
that O
the O
ner _RARE_
- I-GENE
binding I-GENE
sites I-GENE
are O
located _RARE_
between O
nucleotides O
1026 _RARE_
and O
1058 _RARE_
from O
the O
Mu _RARE_
left _RARE_
end O
. O

We O
have O
identified O
and O
characterized O
the O
structure _RARE_
of O
the O
Spec1 _RARE_
gene I-GENE
in O
the O
sea _RARE_
urchin _RARE_
Strongylocentrotus _RARE_
purpuratus _RARE_
. O

Platelet _RARE_
function O
and O
platelet O
- O
polymorphonuclear _RARE_
- O
neutrophil _RARE_
interaction O
in O
patients O
with O
deficient _RARE_
platelet I-GENE
lipoxygenase _RARE_
activity O
. O

Spontaneous _RARE_
degradation _RARE_
of O
atracurium _RARE_
in O
plasma O
is O
the O
major O
route O
of O
elimination O
in O
man O
and O
contributes O
to O
a O
short O
elimination O
half _RARE_
- O
life O
( O
approximatively _RARE_
20 O
min O
). O

Transformed _RARE_
cell O
lines O
expressing O
solely O
E1a I-GENE
or O
E1a I-GENE
and O
E1b _RARE_
gene I-GENE
products I-GENE
derived O
from O
these O
viruses O
display O
enhanced _RARE_
anchorage O
- O
independent O
growth O
at _RARE_
37 O
degrees O
C O
versus O
32 _RARE_
degrees O
C O
and O
display O
a O
cytoskeletal O
architecture O
resembling O
untransformed _RARE_
fibroblastic _RARE_
CREF _RARE_
cells O
. O

Partial O
N O
- O
terminal O
amino O
acid O
sequence O
analysis O
showed O
that O
the O
43K _RARE_
and I-GENE
42K _RARE_
T I-GENE
antigens I-GENE
contain O
methionine O
at _RARE_
residues O
1 O
and O
5 O
, O
as _RARE_
predicted O
from O
the O
DNA O
sequence O
, O
whereas O
no _RARE_
methionine O
was O
released O
from O
the O
39K _RARE_
T I-GENE
antigen I-GENE
during _RARE_
the O
first _RARE_
six _RARE_
cycles O
of O
Edman _RARE_
degradation _RARE_
. O

Group O
A O
was O
treated O
with O
three O
or O
four O
doses O
of O
hepatitis I-GENE
B I-GENE
immune I-GENE
globulin I-GENE
( O
HBIG _RARE_
) O
in O
one O
of O
three O
different O
schedules _RARE_
. O

In O
the O
former O
instance _RARE_
, O
in O
addition O
to O
serum O
calcium _RARE_
and O
phosphorous _RARE_
ion O
concentrations O
, O
tissue O
pH O
, O
blood _RARE_
supply O
, O
hormones _RARE_
, O
i O
. O
e _RARE_
., O
vitamin O
D O
, O
vitamin O
A O
, O
and O
various O
enzymes _RARE_
( O
e _RARE_
. O
g O
., O
alkaline _RARE_
phosphatase I-GENE
and O
pyrophosphatase _RARE_
) O
may O
all O
play O
significant O
, O
ancillary _RARE_
, O
time O
- O
dependent O
, O
but O
as _RARE_
yet O
undetermined _RARE_
roles O
. O

Penicillinase _RARE_
production O
in O
Staphylococcus _RARE_
aureus _RARE_
strains O
of O
clinical O
importance O
. O

Thus O
, O
quantitative O
analysis O
of O
thallium O
- O
201 _RARE_
uptake O
and O
washout O
provided O
objective O
evidence O
for _RARE_
improved O
myocardial _RARE_
perfusion O
after O
coronary O
angioplasty _RARE_
. O

This O
study O
reports O
the O
effects O
of O
a O
preparation O
with O
50 O
micrograms O
ethinyl _RARE_
estradiol O
and O
2 O
mg O
cyproterone _RARE_
acetate _RARE_
on O
gonadotropins _RARE_
, O
prolactin I-GENE
, O
testosterone O
, O
sex _RARE_
hormone I-GENE
binding I-GENE
globulin I-GENE
( O
SHBG I-GENE
), _RARE_
androstenedione _RARE_
, O
and O
calculated O
free O
testosterone O
index O
before O
and O
after O
six _RARE_
months O
of O
treatment O
. O

Functional O
flow O
was O
evaluated O
using O
laser O
Doppler O
flowmetry _RARE_
( O
LDF _RARE_
), _RARE_
for _RARE_
which O
the O
output O
signal O
, O
blood _RARE_
cell O
flux _RARE_
( O
BCF _RARE_
), _RARE_
is O
expressed _RARE_
in O
terms O
of O
volts _RARE_
. O

In O
nine O
patients O
with O
renal _RARE_
failure O
routine O
haemodialysis O
was O
accompanied O
by O
a O
30 _RARE_
per O
cent O
reduction O
in O
plasma O
ANP I-GENE
concentration O
. O

To O
investigate O
the O
effects O
of O
isotretinoin _RARE_
on O
HDL _RARE_
, O
we O
measured O
HDL _RARE_
- I-GENE
C I-GENE
, O
HDL _RARE_
phospholipids O
( O
HDL _RARE_
- I-GENE
PL _RARE_
), _RARE_
apoprotein _RARE_
A1 _RARE_
( O
apo _RARE_
A I-GENE
- I-GENE
1 I-GENE
), _RARE_
and O
HDL _RARE_
- I-GENE
C I-GENE
subfractions _RARE_
( O
HDL2 I-GENE
- I-GENE
C I-GENE
and O
HDL3 _RARE_
- I-GENE
C I-GENE
) O
in O
24 _RARE_
healthy O
, O
male O
patients O
receiving O
a O
16 O
- O
week O
course O
of O
isotretinoin _RARE_
( O
1 O
. O
0 _RARE_
mg O
/ O
kg O
/ O
day O
) O
for _RARE_
treatment O
of O
severe O
acne _RARE_
vulgaris _RARE_
. O

The O
clinical O
picture O
and O
laboratory O
parameters O
were O
consistent O
with O
a O
serum O
sickness _RARE_
reaction O
. O

Our O
data O
, O
however O
, O
did O
not O
suggest O
the O
existence O
of O
a O
conversion O
factor O
for _RARE_
LDF _RARE_
signal O
to O
absolute O
flow O
values O
from O
experiment O
to O
experiment O
. O

Preventive _RARE_
effect O
of O
ONO _RARE_
- O
3708 _RARE_
on O
thrombosis O
and O
vasospasms _RARE_
in O
vitro O
and O
in O
vivo O
. O

The O
frequency O
of O
PPNG _RARE_
strains O
increased O
from O
1 O
. O
7 O
% O
in O
1981 _RARE_
to O
6 O
. O
7 O
% O
in O
1985 O
. O

Monospecific _RARE_
antibodies O
, O
eluted _RARE_
from O
the O
beta I-GENE
- I-GENE
galactosidase I-GENE
fusion O
protein O
of O
either O
clone O
reacted O
with O
the O
U1 _RARE_
snRNP I-GENE
- O
specific O
A I-GENE
antigen I-GENE
. O

Quantitative O
analysis O
of O
the O
coronary O
stenosis O
was O
assessed O
before O
and O
after O
PTCA O
, O
and O
the O
dilatation O
resulted O
in O
an O
increase O
in O
minimal O
luminal O
cross O
- O
sectional O
area O
from O
1 O
. O
1 O
+/- O
0 _RARE_
. O
8 O
to O
2 O
. O
7 O
+/- O
1 O
. O
2 O
mm2 O
. O

The O
pathogenesis O
of O
Limited _RARE_
Joint _RARE_
Mobility _RARE_
( O
LJM _RARE_
) O
in O
diabetes O
is O
unknown O
, O
but O
the O
abnormality O
is O
said _RARE_
to O
be O
associated O
with O
an O
increased O
incidence O
of O
microangiopathy _RARE_
. O

In O
a O
previous O
study O
( O
Brandl _RARE_
, O
C O
. O

The O
experimental O
end O
points O
were O
the O
time O
required O
for _RARE_
treated O
tumors O
to O
reach O
3 O
times O
their O
treatment O
size O
, O
the O
survival O
of O
stem _RARE_
cells O
in O
the O
duodenal O
crypts _RARE_
, O
and O
the O
breathing O
rate O
measured O
early O
( O
19 O
- O
23 _RARE_
weeks O
) O
and O
late _RARE_
( O
41 _RARE_
- O
46 _RARE_
weeks O
) O
after O
treatment O
. O

Schedule _RARE_
2 O
, O
in O
which O
2 O
. O
4 O
mg O
/ O
kg O
c O
- O
DDP O
was O
administered O
immediately O
before O
X O
- O
ray O
on O
5 O
consecutive O
days O
produced O
the O
highest O
degree O
of O
enhancement O
of O
radiation O
effect O
( O
expressed _RARE_
as _RARE_
dose O
- O
effect O
factor O
); O
and O
the O
next O
greatest O
enhancement O
was O
produced O
by O
12 O
mg O
/ O
kg O
c O
- O
DDP O
administered O
24 _RARE_
h O
before O
the O
start _RARE_
of O
fractionated _RARE_
daily O
radiotherapy O
. O

The O
cpc _RARE_
- I-GENE
1 I-GENE
- I-GENE
encoded I-GENE
transcript I-GENE
contains O
three O
open _RARE_
reading O
frames O
, O
two O
of O
which O
are O
located _RARE_
in O
the O
720 _RARE_
- O
nucleotide O
leader _RARE_
segment O
preceding O
the O
cpc _RARE_
- I-GENE
1 I-GENE
coding I-GENE
region I-GENE
. O

The O
seco _RARE_
- O
steroid O
hormone O
1 O
, O
25 _RARE_
- O
dihydroxyvitamin _RARE_
D3 _RARE_
is O
known O
to O
induce O
the O
expression _RARE_
of O
a O
calcium _RARE_
binding O
protein O
termed O
calbindin _RARE_
- I-GENE
D28K _RARE_
in O
a O
variety O
of O
target O
tissues O
. O

In O
addition O
, O
the O
calbindin _RARE_
- I-GENE
D28K _RARE_
promoter I-GENE
is O
composed O
of O
a O
variety O
of O
simple O
repeated _RARE_
sequences O
, O
some O
of O
which O
are O
components _RARE_
of O
putative O
regulatory O
signals O
. O

The O
HOI _RARE_
induced _RARE_
a O
nearly O
fourfold O
increase O
in O
ANF _RARE_
in O
the O
elderly O
, O
whereas O
that O
for _RARE_
the O
young O
was O
threefold O
. O

To O
assess O
the O
ability O
of O
the O
atria _RARE_
to O
maintain O
elevated O
plasma O
concentrations O
of O
atrial _RARE_
natriuretic _RARE_
peptide I-GENE
( O
ANP I-GENE
), _RARE_
the O
temporal O
changes O
in O
plasma I-GENE
ANP I-GENE
concentrations O
were O
studied O
in O
seven _RARE_
chloralose _RARE_
- O
anaesthetized _RARE_
dogs O
during _RARE_
4 O
h O
of O
sustained O
rapid O
cardiac O
pacing O
. O

Ig I-GENE
D I-GENE
- O
JH _RARE_
recombinations _RARE_
may O
precede _RARE_
TcR _RARE_
gene I-GENE
recombination _RARE_
in O
these O
early O
T O
cell O
lines O
, O
and O
some O
but O
not O
all O
express O
sterile _RARE_
Cmu _RARE_
transcripts I-GENE
. O

The O
RAD18 _RARE_
gene I-GENE
open _RARE_
reading I-GENE
frame I-GENE
encodes O
a O
protein O
of O
487 _RARE_
amino O
acids _RARE_
, O
with O
a O
calculated O
molecular _RARE_
weight _RARE_
of O
55 _RARE_
, O
512 _RARE_
. O

Atomic _RARE_
absorption O
spectrophotometry _RARE_
applied O
to O
bacterially O
expressed _RARE_
E1A I-GENE
proteins I-GENE
revealed O
that O
the O
289 _RARE_
- O
amino O
acid O
protein O
binds O
one O
zinc O
ion O
, O
whereas O
the O
243 _RARE_
- O
amino O
acid O
protein O
binds O
no _RARE_
zinc O
. O

Most O
patients O
preferred O
tablets _RARE_
to O
injection O
both O
on O
day O
1 O
( O
313 _RARE_
v O
200 _RARE_
) O
and O
at _RARE_
follow O
up _RARE_
( O
373 _RARE_
v O
104 O
). O

Plots _RARE_
of O
RV O
, O
LV O
+ O
S O
and O
2A _RARE_
weight _RARE_
vs _RARE_
real O
hematocrit O
showed O
sharp _RARE_
upward _RARE_
inflections _RARE_
at _RARE_
real O
hematocrit O
65 O
%, O
suggesting O
a O
possible O
role O
of O
increased O
viscosity O
in O
CO _RARE_
cardiomegaly _RARE_
at _RARE_
the O
higher _RARE_
hematocrit O
. O

The O
absorbable _RARE_
perisplenic _RARE_
mesh _RARE_
is O
an O
important O
improvement O
, O
and O
in O
some O
cases O
it O
may O
replace O
other O
techniques O
for _RARE_
arresting _RARE_
splenic O
bleeding O
. O

A O
rare O
chronic O
course O
of O
Budd _RARE_
- O
Chiari _RARE_
syndrome _RARE_
associated O
with O
thrombosis O
of O
the O
portal _RARE_
vein _RARE_
was O
observed O
in O
a O
30 _RARE_
- O
year O
- O
old O
male O
patient O
suffering O
from O
postmyocarditic _RARE_
cardiosclerosis _RARE_
. O

After O
one O
accommodation _RARE_
night O
, O
sleep O
EEG O
recordings O
were O
performed O
during _RARE_
three O
consecutive O
nights _RARE_
in O
ten O
drug O
- O
free O
inpatients _RARE_
presenting _RARE_
generalized O
anxiety O
disorder O
( O
GAD _RARE_
) O
with O
significant O
depression O
, O
compared O
with O
a O
age O
- O
and O
sex _RARE_
- O
matched O
group O
of O
patients O
with O
GAD _RARE_
and O
a O
group O
of O
primary _RARE_
major O
depressive _RARE_
disorder O
( O
MDD _RARE_
) O
patients O
. O

Oligonucleotide _RARE_
mutagenesis O
of O
these O
binding O
domains O
indicated O
their O
importance O
in O
the O
transcriptional O
regulation _RARE_
of O
the O
E3 _RARE_
promoter I-GENE
in O
yeast O
cells O
. O

The O
concentration O
of O
PGI2 _RARE_
on O
the O
newly O
- O
formed O
luminal O
surface O
remained O
low O
. O

Organ _RARE_
transplantation O
in O
Denmark _RARE_
. O

Effects O
of O
single O
and O
combined O
maltose _RARE_
tetrapalmitate _RARE_
immunotherapy O
, O
cyclophosphamide O
chemotherapy O
and O
radiotherapy O
on O
ethyl O
carbamate _RARE_
accelerated O
primary _RARE_
lung _RARE_
cancer _RARE_
in O
A O
/ O
J _RARE_
mice O
. O

D O
. O

A O
114 _RARE_
- O
base _RARE_
pair _RARE_
sequence O
of O
predominantly O
repeating O
purine _RARE_
- O
pyrimidine O
nucleotides O
separates _RARE_
these O
two O
d O
( O
AC _RARE_
) O
repeats O
. O

Phase O
II O
study O
of O
VP _RARE_
- O
16 O
( O
capsule _RARE_
) O
in O
solid O
tumors O
. O

When O
the O
coding O
segments _RARE_
, O
including O
both O
framework _RARE_
and O
complementarity _RARE_
- O
determining _RARE_
regions O
, O
of O
these O
genes O
and O
the O
murine O
probe O
sequences O
are O
compared O
by O
metric _RARE_
analysis O
, O
it O
is O
apparent O
that O
the O
caiman _RARE_
genes O
are O
only O
slightly O
more O
related O
to O
each O
other O
than O
to O
the O
mammalian O
sequence O
, O
consistent O
with O
significant O
preservation O
of O
nucleotide O
sequence O
over O
an O
extended O
period O
of O
phylogenetic O
time O
. O

Evidence O
for _RARE_
a O
role O
of O
endogenous I-GENE
corticotropin _RARE_
- I-GENE
releasing I-GENE
factor I-GENE
in O
cold O
, O
ether O
, O
immobilization _RARE_
, O
and O
traumatic _RARE_
stress O
. O

An O
unusual O
feature O
of O
these O
replicative O
genes O
is O
that O
the O
smaller O
mRNA O
begins O
within O
a O
long O
open _RARE_
reading O
frame O
of O
the O
larger O
mRNA O
. O

Different _RARE_
sequence O
elements O
of O
both O
the O
retroviral _RARE_
vectors O
and O
the O
c I-GENE
- I-GENE
myc I-GENE
gene I-GENE
recombined _RARE_
during _RARE_
genesis _RARE_
of O
highly O
oncogenic _RARE_
retroviruses _RARE_
CMII _RARE_
, O
MC29 _RARE_
, O
or O
MH2 _RARE_
. O

81 _RARE_
milk O
samples O
collected O
from O
35 _RARE_
donors O
3 O
days O
to O
7 O
months O
after O
delivery O
were O
examined O
for _RARE_
the O
occurrence O
of O
cytomegalovirus _RARE_
( O
CMV _RARE_
). O

Subcloning _RARE_
of O
DNA O
fragments O
from O
the O
8 O
. O
5 O
- O
kilobase _RARE_
( O
kb O
) O
insert O
of O
pAVO4 _RARE_
defined O
a O
4 O
- O
kb O
DNA O
fragment O
which O
contained O
the O
functional _RARE_
FBP _RARE_
+ I-GENE
gene I-GENE
and O
its O
regulatory O
region O
. O

Three O
cases O
of O
primary _RARE_
signet _RARE_
- O
ring _RARE_
cell O
carcinoma O
of O
the O
rectum _RARE_
are O
described O
. O

The O
data O
obtained O
up _RARE_
to O
now O
only O
suggest O
the O
future O
potentiality _RARE_
of O
Bestatin _RARE_
treatment O
for _RARE_
these O
types _RARE_
of O
malignancy O
. O

These O
data O
suggest O
that O
dopaminergic O
regulation _RARE_
of O
adrenal O
zona _RARE_
glomerulosa _RARE_
corticosteroid _RARE_
and O
renal _RARE_
renin I-GENE
secretion _RARE_
is O
absent O
in O
patients O
with O
high O
spinal _RARE_
cord O
transections _RARE_
, O
suggesting O
that O
intact _RARE_
neural _RARE_
pathways O
from O
the O
central O
nervous O
system _RARE_
are O
necessary O
for _RARE_
metoclopramide _RARE_
stimulation _RARE_
of O
aldosterone O
and O
renin I-GENE
secretion _RARE_
in O
men O
. O

In O
the O
absence O
of O
enhancer O
sequences O
, O
the O
adenovirus I-GENE
E1A I-GENE
gene I-GENE
can O
not O
stimulate O
CATase _RARE_
synthesis _RARE_
. O

These O
IgG I-GENE
antibodies I-GENE
in O
the O
babies O
diminished O
rapidly O
after O
delivery O
, O
and O
were O
detectable O
only O
in O
3 O
cases O
at _RARE_
2 O
, O
3 O
, O
and O
5 O
months O
of O
ages O
out O
of O
38 O
babies O
up _RARE_
to O
21 O
months O
. O

Fine _RARE_
analysis O
at _RARE_
the O
nucleotide O
level O
of O
the O
early O
events O
in O
the O
digestion O
with O
nuclease _RARE_
S1 I-GENE
shows O
that O
the O
enzyme O
attacks O
preferentially O
the O
sequence O
( O
G O
- O
A O
) O
12 O
on O
the O
message _RARE_
complementary _RARE_
strand _RARE_
. O

Those _RARE_
dosages _RARE_
that O
inhibited O
mean O
NTE _RARE_
activity O
in O
spinal _RARE_
cord O
greater O
than O
or O
equal O
to O
72 O
% O
and O
brain O
greater O
than O
or O
equal O
to O
66 _RARE_
% O
of O
control O
values O
within O
44 _RARE_
hr O
postexposure O
produced O
marked O
spinal _RARE_
cord O
pathology O
14 O
days O
postexposure O
in O
greater O
than O
or O
equal O
to O
90 _RARE_
% O
of O
similarly O
dosed _RARE_
animals O
. O

FK O
33 _RARE_
- O
824 _RARE_
, O
a O
methionine O
- O
enkephalin _RARE_
analogue O
, O
suppressed O
plasma O
ACTH I-GENE
to O
85 _RARE_
% O
of O
basal O
level O
, O
while O
bromocriptine _RARE_
( O
CB _RARE_
- O
154 O
) O
caused O
no _RARE_
significant O
change O
. O

A O
v I-GENE
- I-GENE
erbB I-GENE
- I-GENE
related I-GENE
protooncogene _RARE_
, O
c I-GENE
- I-GENE
erbB I-GENE
- I-GENE
2 I-GENE
, O
is O
distinct O
from O
the O
c I-GENE
- I-GENE
erbB I-GENE
- I-GENE
1 I-GENE
/ O
epidermal _RARE_
growth I-GENE
factor I-GENE
- I-GENE
receptor I-GENE
gene O
and O
is O
amplified O
in O
a O
human O
salivary _RARE_
gland _RARE_
adenocarcinoma O
. O

The O
sequence O
analysis O
of O
both O
products O
of O
individual O
phi _RARE_
80 _RARE_
site O
- O
specific O
recombination _RARE_
events O
in O
vivo O
shows O
that O
recombination _RARE_
with O
a O
secondary O
attachment _RARE_
( O
att _RARE_
) O
site O
generates O
several O
different O
novel O
joints _RARE_
at _RARE_
the O
mismatched _RARE_
position O
: O
one O
recombination _RARE_
event O
resulted O
in O
a O
single O
base _RARE_
- O
pair _RARE_
deletion O
and O
two O
other O
recombination _RARE_
events O
resulted O
in O
two O
different O
single O
base _RARE_
- O
pair _RARE_
substitutions O
. O

This O
L I-GENE
- I-GENE
myc I-GENE
sequence I-GENE
is O
amplified O
10 O
- O
20 O
- O
fold _RARE_
in O
four O
SCLC _RARE_
cell O
line O
DNAs _RARE_
and O
in O
one O
SCLC _RARE_
tumour _RARE_
specimen _RARE_
taken O
directly O
from O
a O
patient O
. O

Temperature _RARE_
- O
shift O
experiments O
using O
synchronously _RARE_
grown O
cells O
of O
a O
delta I-GENE
top1 _RARE_
top2 _RARE_
temperature _RARE_
- I-GENE
sensitive _RARE_
( I-GENE
ts _RARE_
) I-GENE
double I-GENE
mutant I-GENE
and O
its O
isogenic _RARE_
top2 _RARE_
ts _RARE_
strain _RARE_
show O
that O
, O
whereas O
mitotic _RARE_
blocks O
can O
prevent O
killing _RARE_
of O
the O
top2 _RARE_
ts _RARE_
mutant I-GENE
at _RARE_
a O
nonpermissive _RARE_
temperature _RARE_
, O
the O
same O
treatments O
are O
ineffective _RARE_
in O
preventing O
cell O
death _RARE_
of O
the O
delta I-GENE
top1 _RARE_
top2 _RARE_
ts _RARE_
double I-GENE
mutant I-GENE
. O

The O
homology O
to O
v I-GENE
- I-GENE
mil _RARE_
starts _RARE_
within O
the O
coding O
sequence O
of O
exon _RARE_
1 O
and O
ends O
within O
the O
3 O
' O
untranslated _RARE_
region O
of O
exon _RARE_
11 O
, O
12 O
nucleotides O
downstream _RARE_
from O
the O
nonsense O
codon _RARE_
terminating _RARE_
the O
large O
open _RARE_
reading O
frame O
shared O
between O
c I-GENE
- I-GENE
mil _RARE_
and O
v I-GENE
- I-GENE
mil _RARE_
. O

Examination O
of O
the O
sequence O
of O
the O
Punta _RARE_
Toro _RARE_
M I-GENE
gene I-GENE
product I-GENE
reveals O
the O
presence O
of O
multiple O
hydrophobic O
sequences O
including O
a O
19 O
- O
amino O
acid O
, O
carboxy _RARE_
- O
proximal O
, O
hydrophobic O
region O
( O
G2 _RARE_
). O

Six O
( O
four O
FAP _RARE_
; O
two O
primary _RARE_
amyloidosis _RARE_
) O
also O
had O
diffusely _RARE_
positive O
myocardial _RARE_
uptakes _RARE_
, O
but O
the O
intensity O
was O
less O
than O
that O
of O
the O
sternum _RARE_
. O

The O
intensity O
of O
myocardial _RARE_
uptake O
of O
Tc O
- O
99m O
- O
PYP _RARE_
in O
patients O
with O
echocardiographic O
left _RARE_
ventricular O
hypertrophy O
and O
/ O
or O
highly O
refractile _RARE_
myocardial _RARE_
echoes _RARE_
, O
so O
- O
called O
granular _RARE_
sparkling _RARE_
appearance O
( O
GS _RARE_
) O
was O
slightly O
greater O
than O
that O
in O
patients O
with O
neither O
myocardial _RARE_
hypertrophy O
nor O
GS _RARE_
. O

The O
210 O
kDa O
precursor O
is O
converted O
slowly O
( O
t O
1 O
/ O
2 O
= O
2 O
h O
) O
by O
proteolytic _RARE_
processing _RARE_
into O
a O
125 _RARE_
kDa O
( O
alpha O
') _RARE_
and O
83 _RARE_
kDa O
( O
beta O
') _RARE_
species O
. O

Alveolar _RARE_
lymphocytes O
were O
surprisingly _RARE_
increased O
in O
most O
patients O
with O
AIDS O
( O
mean O
26 _RARE_
. O
1 O
+/- O
21 O
. O
9 O
%; O
range O
1 O
- O
76 _RARE_
%) O
and O
CGL _RARE_
( O
mean O
26 _RARE_
. O
6 O
+/- O
22 _RARE_
. O
6 O
%; O
range O
3 O
- O
76 _RARE_
%) O
with O
criteria O
of O
activation O
contrasting _RARE_
with O
the O
blood _RARE_
lymphopenia _RARE_
. O

We O
have O
determined O
that O
these O
nicks _RARE_
occur O
in O
both O
the O
wild O
- O
type O
and O
the O
mutant O
sites O
. O

The O
sequence O
was O
determined O
for _RARE_
a O
4024 _RARE_
- O
base _RARE_
pair _RARE_
( O
bp O
) O
segment O
that O
extends _RARE_
from O
149 _RARE_
bp O
5 O
' O
to O
the O
cap _RARE_
site O
of O
alpha I-GENE
1 I-GENE
to O
207 _RARE_
bp O
3 O
' O
to O
psi I-GENE
alpha I-GENE
. O

Its O
predicted O
amino O
acid O
sequence O
shows O
extensive O
homology O
to O
those O
of O
Drosophila I-GENE
hsp70 I-GENE
, O
trout _RARE_
hsp70 I-GENE
, O
Xenopus I-GENE
hsp70 I-GENE
, O
yeast I-GENE
hsp70 I-GENE
, O
and O
some O
homology O
to O
the O
heat I-GENE
- I-GENE
inducible I-GENE
dnaK _RARE_
gene I-GENE
product I-GENE
of O
Escherichia O
coli O
. O

When O
phosphorylation _RARE_
of O
exogenous _RARE_
peptide O
substrates _RARE_
was O
measured O
as _RARE_
a O
function O
of O
receptor O
self O
- O
phosphorylation _RARE_
, O
tyrosine I-GENE
kinase I-GENE
activity O
was O
found O
to O
be O
enhanced _RARE_
two O
to O
threefold O
at _RARE_
1 O
- O
2 O
mol O
of O
phosphate O
per O
mol O
of O
receptor O
. O

At O
temperatures O
permissive O
for _RARE_
transformation O
, O
6m2 _RARE_
cells O
contain O
P58gag _RARE_
produced O
from O
the O
4 O
. O
0 _RARE_
- O
kilobase _RARE_
( O
kb O
) O
viral O
RNA O
genome O
and O
P85gag _RARE_
- O
mos I-GENE
translated O
from O
a O
3 O
. O
5 O
- O
kb O
spliced _RARE_
mRNA O
. O

The O
pet56 _RARE_
and O
his3 _RARE_
genes I-GENE
are O
transcribed _RARE_
divergently O
from O
initiation O
sites O
that O
are O
separated O
by O
only O
192 _RARE_
bp O
. O

Multistep _RARE_
transformation O
by O
defined O
fragments O
of O
herpes O
simplex O
virus O
type O
2 O
DNA O
: O
oncogenic _RARE_
region O
and O
its O
gene O
product O
. O

It O
is O
concluded O
that O
in O
patients O
with O
first _RARE_
- O
attack _RARE_
genital _RARE_
herpes O
, O
the O
type O
of O
HSV O
is O
the O
most O
important O
determinant O
of O
subsequent O
recurrences _RARE_
and O
that O
intravenous O
acyclovir _RARE_
has O
little O
effect O
on O
subsequent O
recurrences _RARE_
. O

Comparison O
of O
sequences O
of O
ovine _RARE_
and O
bovine O
, O
rat O
and O
guinea _RARE_
- I-GENE
pig _RARE_
alpha I-GENE
s1 _RARE_
- I-GENE
casein I-GENE
mRNAs I-GENE
has O
revealed O
a O
greater O
homology O
in O
the O
3 O
' O
and O
especially O
5 O
' O
non O
coding O
regions O
. O

One O
group O
( O
n _RARE_
= O
9 O
) O
was O
premedicated _RARE_
with O
midazolam O
, O
0 _RARE_
. O
1 O
mg O
kg O
- O
1 O
, O
and O
atropine O
0 _RARE_
. O
2 O
- O
0 _RARE_
. O
4 O
mg O
i O
. O
m O
. O

Comparison O
with O
a O
recently O
described O
c I-GENE
- I-GENE
sis _RARE_
cDNA I-GENE
clone I-GENE
( O
Collins _RARE_
et O
al O
., O
Nature _RARE_
316 _RARE_
, O
748 _RARE_
- O
750 O
( O
1985 O
)) O
revealed O
that O
the O
1 O
. O
9 O
kbp _RARE_
DNA O
region O
contained O
a O
large O
5 I-GENE
' I-GENE
c I-GENE
- I-GENE
sis _RARE_
exon _RARE_
of O
at _RARE_
least O
1050 _RARE_
bp O
. O

It O
was O
also O
suggested O
that O
the O
biological O
activities O
of O
5 O
- O
FU O
, O
ADM _RARE_
and O
MMC O
in O
FAMLIP _RARE_
were O
stable O
in O
FULIP _RARE_
, O
ADRLIP _RARE_
and O
MMCLIP _RARE_
. O

Surprisingly O
, O
a O
C O
to O
G O
transversion O
at _RARE_
the O
first _RARE_
residue _RARE_
of O
the O
CAT I-GENE
pentanucleotide _RARE_
, O
which O
severely O
impairs _RARE_
the O
activity O
of O
both O
promoters O
, O
appears O
to O
increase O
affinity O
of O
the O
CAT I-GENE
binding I-GENE
protein I-GENE
. O

The O
nucleotide O
sequence O
of O
3874 _RARE_
bp O
of O
cloned _RARE_
R O
. O
sphaeroides _RARE_
chromosomal O
DNA O
, O
including O
the O
three O
structural O
genes O
fbcF _RARE_
, O
fbcB _RARE_
and O
fbcC _RARE_
has O
been O
determined O
. O

The O
N O
- O
terminal O
sequence O
of O
one O
hydrophilic O
peptide O
of O
the O
FeS _RARE_
protein I-GENE
has O
been O
also O
obtained O
confirming O
the O
fbcF _RARE_
reading O
frame O
. O

The O
5 O
' O
and O
3 O
' O
untranslated _RARE_
sequences O
contain O
characteristic O
sequences O
that O
are O
involved O
in O
the O
initiation O
and O
termination _RARE_
of O
transcription O
, O
including O
two O
possible O
promoters O
, O
one O
of O
which O
may O
contain O
two O
overlapping O
- O
10 O
sequences O
. O

Unlike O
P135gag _RARE_
- O
myb I-GENE
- O
ets I-GENE
and O
the O
Mr O
75 _RARE_
, O
000 _RARE_
translation O
product O
of O
c I-GENE
- I-GENE
myb I-GENE
( O
P75c _RARE_
- I-GENE
myb I-GENE
), _RARE_
which O
are O
nuclear O
proteins O
, O
P54c _RARE_
- I-GENE
ets I-GENE
was O
found O
to O
be O
predominantly O
cytoplasmic O
. O

The O
Dox _RARE_
- I-GENE
A2 _RARE_
locus I-GENE
is O
within O
3 O
. O
4 O
to O
4 O
. O
4 O
kb O
of O
the O
Df _RARE_
( I-GENE
2L _RARE_
) I-GENE
OD15 _RARE_
breakpoint _RARE_
, O
placing _RARE_
four O
of O
the O
vital O
loci O
within O
a O
maximum O
of O
15 _RARE_
. O
5 O
kb O
. O

The O
C O
- O
terminal O
end O
of O
this O
polypeptide O
harbors _RARE_
three O
types _RARE_
of O
repeated _RARE_
sequences O
. O

Further O
outbreaks _RARE_
of O
ocular O
disease _RARE_
in O
farmed _RARE_
red _RARE_
deer _RARE_
calves O
caused O
by O
HVC _RARE_
- O
1 O
were O
investigated O
. O

From O
our O
ultrastructural _RARE_
and O
biochemical O
studies O
, O
it O
is O
evident O
that O
Type _RARE_
II O
pneumocytes _RARE_
are O
an O
early O
target O
of O
radiation O
and O
the O
release O
of O
surfactant _RARE_
into O
the O
alveolus _RARE_
shortly _RARE_
after O
exposure O
persists _RARE_
for _RARE_
days O
and O
weeks O
. O

Thirty O
of O
the O
clones _RARE_
contained O
a O
complete _RARE_
340 _RARE_
base _RARE_
- O
pair _RARE_
dimer _RARE_
unit O
of O
the O
repeat O
. O

Two O
copies O
of O
the O
72 O
- O
bp O
repeat O
provided O
efficient O
activation O
of O
gene O
expression _RARE_
. O

The O
open _RARE_
reading O
frames O
of O
rbsD _RARE_
, O
rbsA _RARE_
, O
and O
rbsC _RARE_
encode O
proteins O
of O
139 O
, O
501 _RARE_
, O
and O
321 _RARE_
amino O
acid O
residues O
, O
respectively O
. O

In O
order O
to O
study O
the O
influence O
of O
iron O
overload O
on O
the O
polymorphonuclear _RARE_
leucocyte _RARE_
( O
PMN _RARE_
) O
metabolism O
of O
patients O
on O
chronic O
hemodialysis O
, O
generation O
of O
superoxide _RARE_
anion _RARE_
( O
O2 _RARE_
-) _RARE_
by O
PMN _RARE_
in O
whole O
blood _RARE_
was O
compared O
in O
two O
groups O
of O
hemodialyzed _RARE_
patients O
: O
group O
A O
consisted O
of O
twenty _RARE_
- O
one O
individuals O
with O
serum O
ferritin I-GENE
levels O
above O
1000 O
ng _RARE_
/ O
ml O
and O
group O
B O
of O
nineteen _RARE_
individuals O
with O
serum O
ferritin I-GENE
levels O
below O
1000 O
ng _RARE_
/ O
ml O
. O

Cattaneo _RARE_
, O
and O
J _RARE_
. O

Human I-GENE
alpha I-GENE
- I-GENE
galactosidase I-GENE
A I-GENE
: O
nucleotide O
sequence O
of O
a O
cDNA O
clone O
encoding O
the O
mature _RARE_
enzyme O
. O

Diazepam _RARE_
( O
3 O
mg O
/ O
kg O
) O
generalized O
to O
Ro _RARE_
11 O
- O
6896 _RARE_
whereas O
the O
structurally O
related O
Ro _RARE_
5 O
- O
4864 _RARE_
( O
3 O
mg O
/ O
kg O
and O
30 _RARE_
mg O
/ O
kg O
) O
did O
not O
. O

The O
amino O
acid O
sequence O
was O
determined O
to O
be O
residues O
716 _RARE_
- O
724 _RARE_
and O
hence O
lysine _RARE_
residue _RARE_
721 _RARE_
is O
located _RARE_
within O
the O
ATP O
- O
binding O
site O
. O

Osteocalcin _RARE_
( O
and O
urinary _RARE_
hydroxyproline _RARE_
) O
were O
not O
elevated O
in O
isolated O
hyperphosphatasaemia _RARE_
, O
indicating O
that O
mechanisms O
other O
than O
increased O
bone O
turnover O
may O
account O
for _RARE_
the O
markedly O
elevated O
serum I-GENE
alkaline _RARE_
phosphatase I-GENE
activity O
in O
these O
subjects O
. O

Analysis O
of O
glucocorticoid O
unresponsive _RARE_
cell O
variants O
using O
a O
mouse I-GENE
glucocorticoid I-GENE
receptor I-GENE
complementary _RARE_
DNA O
clone O
. O

Among O
the O
v I-GENE
- I-GENE
myc I-GENE
codons O
, O
the O
first _RARE_
5 O
are O
derived O
from O
the O
noncoding O
5 O
' O
terminus O
of O
the O
second O
c I-GENE
- I-GENE
myc I-GENE
exon _RARE_
, O
and O
412 _RARE_
codons O
correspond O
to O
the O
c I-GENE
- I-GENE
myc I-GENE
coding O
region O
. O

A O
recombinant O
vector O
, O
p410 _RARE_
+, _RARE_
was O
constructed O
which O
carried O
the O
BamHI I-GENE
- I-GENE
K I-GENE
fragment I-GENE
( O
nucleotides O
107565 _RARE_
to O
112625 _RARE_
of O
the O
B95 _RARE_
- O
8 O
strain _RARE_
, O
encoding O
the O
EBV _RARE_
- O
associated O
nuclear O
antigen O
EBNA I-GENE
- I-GENE
1 I-GENE
), _RARE_
the O
cis O
- O
acting O
sequence O
from O
the O
BamHI I-GENE
- I-GENE
C I-GENE
fragment I-GENE
, O
and O
a O
dominant O
selectable O
marker O
gene O
encoding O
G O
- O
418 _RARE_
resistance O
in O
animal _RARE_
cells O
. O

13 _RARE_
men O
with O
a O
history O
of O
recurrent O
genital _RARE_
herpes O
simplex O
virus O
type O
2 O
( O
HSV O
- O
2 O
) O
infection O
were O
followed O
daily O
for _RARE_
4 O
weeks O
with O
samples O
taken O
from O
the O
urethra _RARE_
for _RARE_
virus O
isolation O
. O

Next _RARE_
, O
with O
carcinoma O
presenting _RARE_
a O
leather _RARE_
bottle _RARE_
( O
linitis _RARE_
plastica _RARE_
type O
) O
of O
the O
stomach O
itself O
, O
the O
II O
c O
portion O
of O
the O
stomach O
consisted O
of O
fundic _RARE_
glands O
( O
undifferentiated O
carcinoma O
) O
shall _RARE_
become O
the O
primary _RARE_
focus O
supporting O
Nakamura _RARE_
' O
s O
theory O
. O

During O
the O
biosynthesis O
of O
all O
three O
mutant O
polypeptides O
, O
the O
signal O
peptide O
is O
efficiently O
and O
accurately O
cleaved O
from O
the O
nascent _RARE_
protein O
, O
even O
though O
in O
mutants O
X2 O
and O
X3 _RARE_
the O
cleavage _RARE_
site O
itself O
has O
been O
altered O
. O

The O
hexanucleotide _RARE_
5 O
'- O
TGTCCT _RARE_
- O
3 O
', _RARE_
thought O
to O
be O
important O
for _RARE_
GRE _RARE_
activity O
, O
not O
only O
was O
found O
in O
this O
sequence O
and O
in O
the O
5 O
'- O
flanking O
region O
, O
but O
also O
was O
present O
twice O
in O
the O
3 O
' O
end O
of O
the O
gene O
that O
did O
not O
show O
specific O
receptor O
binding O
. O

Five O
patients O
developed O
metastatic O
spread O
, O
and O
all O
of O
them O
died O
of O
tumor O
. O

The O
smallest O
of O
the O
mini _RARE_
- O
Mu _RARE_
elements O
is O
only O
7 O
. O
9 O
kilobase _RARE_
pairs _RARE_
long O
, O
allowing O
the O
cloning O
of O
DNA O
fragments O
of O
up _RARE_
to O
31 _RARE_
. O
1 O
kilobase _RARE_
pairs _RARE_
, O
and O
the O
largest O
of O
them O
is O
21 O
. O
7 O
kilobase _RARE_
pairs _RARE_
, O
requiring O
that O
clones _RARE_
carry O
insertions O
of O
less O
than O
17 _RARE_
. O
3 O
kilobase _RARE_
pairs _RARE_
. O

The O
52 O
- O
protein O
subunit O
of O
T4 I-GENE
DNA I-GENE
topoisomerase I-GENE
is O
homologous O
to O
the O
gyrA _RARE_
- I-GENE
protein I-GENE
of O
gyrase _RARE_
. O

There O
were O
no _RARE_
interfering O
peaks O
in O
the O
quantitation _RARE_
of O
sulbactam _RARE_
. O

The O
latent O
periods O
from O
the O
antral _RARE_
exclusion O
to O
the O
occurrence O
of O
anastomotic _RARE_
ulcers O
after O
a O
subtotal O
gastrectomy _RARE_
with O
Billroth _RARE_
' O
s O
type O
II O
reconstruction O
varied O
from O
a O
few O
days O
to O
19 O
years O
, O
with O
an O
average O
of O
2 O
. O
8 O
years O
. O

The O
nucleosomal _RARE_
arrays O
detected O
by O
MPE _RARE_
X O
Fe _RARE_
( O
II O
) O
were O
characterized O
by O
a O
considerable O
loss _RARE_
of O
detail O
and O
significantly O
enhanced _RARE_
accessibility _RARE_
, O
the O
extent O
of O
which O
probably O
reflected O
the O
relative O
transcription O
rate O
of O
each O
gene O
. O

Translation _RARE_
of O
specific O
cellular O
genes O
from O
the O
chimeric O
viral O
- O
cellular O
transcripts O
seems O
to O
be O
unlikely O
. O

The O
molecular _RARE_
weight _RARE_
of O
in O
vivo O
- O
labeled O
proteins O
was O
increased O
relative O
to O
that O
of O
in O
vitro O
- O
translated O
proteins O
, O
indicating O
that O
a O
posttranslational O
modification O
had O
occurred O
. O

Insertion _RARE_
of O
4 O
bp O
reduced _RARE_
SV40 I-GENE
early I-GENE
promoter I-GENE
- O
dependent O
chloramphenicol I-GENE
acetyltransferase _RARE_
( O
CAT I-GENE
) O
expression _RARE_
by O
six _RARE_
- O
to O
eightfold _RARE_
. O

In O
the O
DNAs _RARE_
of O
all O
Ph1 _RARE_
- O
positive O
chronic O
myelocytic _RARE_
leukemia O
patients O
studied O
to O
date O
, O
a O
breakpoint _RARE_
on O
chromosome _RARE_
22 _RARE_
( O
the O
Ph1 _RARE_
chromosome _RARE_
) O
can O
be O
demonstrated O
with O
a O
probe O
from O
the O
bcr _RARE_
( O
breakpoint _RARE_
cluster I-GENE
region I-GENE
). O

Nuclease _RARE_
footprinting O
revealed O
that O
purified _RARE_
glucocorticoid I-GENE
receptor I-GENE
bound _RARE_
at _RARE_
multiple O
discrete O
sites O
within O
and O
at _RARE_
the O
borders _RARE_
of O
the O
tandemly O
repeated _RARE_
sequence O
motif O
that O
defines O
Sa _RARE_
. O

The O
96 O
- O
bp O
insert O
contained O
a O
termination _RARE_
signal O
which O
caused O
the O
premature O
termination _RARE_
of O
the O
protein O
, O
leading O
to O
the O
generation O
of O
a O
p53 I-GENE
product I-GENE
9 O
amino O
acids _RARE_
shorter O
than O
usual _RARE_
. O

All O
tumors O
proved O
histologically O
to O
be O
neuroendocrine _RARE_
in O
origin O
. O

The O
coding O
region O
of O
2385 _RARE_
nucleotides O
corresponds O
to O
a O
polypeptide O
chain O
of O
795 _RARE_
amino O
acids _RARE_
, O
giving O
a O
molecular _RARE_
weight _RARE_
of O
91 O
, O
555 _RARE_
for _RARE_
the O
hsp108 _RARE_
protein I-GENE
. O

Transcriptional O
control O
signals O
of O
a O
herpes I-GENE
simplex I-GENE
virus I-GENE
type I-GENE
1 I-GENE
late _RARE_
( I-GENE
gamma I-GENE
2 I-GENE
) I-GENE
gene I-GENE
lie _RARE_
within O
bases O
- O
34 _RARE_
to O
+ O
124 _RARE_
relative O
to O
the O
5 O
' O
terminus O
of O
the O
mRNA O
. O

A O
noncatalytic _RARE_
domain O
conserved _RARE_
among O
cytoplasmic I-GENE
protein I-GENE
- I-GENE
tyrosine I-GENE
kinases I-GENE
modifies _RARE_
the O
kinase O
function O
and O
transforming O
activity O
of O
Fujinami _RARE_
sarcoma I-GENE
virus I-GENE
P130gag _RARE_
- O
fps _RARE_
. O

Gluzman _RARE_
, O
EMBO _RARE_
J _RARE_
. O

A O
single O
exon _RARE_
encodes O
the O
carboxyl _RARE_
- O
terminal O
26 _RARE_
amino O
acids _RARE_
of O
the O
ssd _RARE_
chain I-GENE
and O
the O
3 O
' O
untranslated _RARE_
region O
of O
its O
mRNA O
, O
ending _RARE_
with O
a O
poly _RARE_
( O
A O
)- O
addition O
site O
. O

The O
5 O
'- O
nontranslated _RARE_
sequences O
and O
parts O
of O
the O
coding O
sequences O
of O
various O
yeast O
genes O
have O
been O
cloned _RARE_
into O
representative O
lacZ I-GENE
fusion O
vectors O
. O

Two O
activities O
of O
the O
D I-GENE
protein I-GENE
of O
the O
miniF _RARE_
plasmid _RARE_
have O
been O
found O
. O

SPECT O
examination O
of O
the O
TMJ _RARE_
using O
99m O
Tc O
- O
MDP _RARE_
was O
performed O
in O
43 _RARE_
patients O
with O
arthrographically _RARE_
proven O
anterior O
dislocation O
of O
the O
disc O
and O
in O
30 _RARE_
normals O
. O

Plasma I-GENE
renin I-GENE
activity O
rose O
and O
the O
plasma O
aldosterone O
level O
fell O
after O
taking O
lisinopril _RARE_
. O

Two O
mutants O
, O
each O
representative O
of O
a O
separate O
pet _RARE_
complementation _RARE_
group O
, O
have O
been O
analyzed O
. O

The O
second O
group O
of O
homologous O
elements O
is O
present O
in O
the O
upstream O
region O
of O
both O
genes O
. O

A O
centromere O
in O
S O
. O
cerevisiae O
consists O
of O
a O
region O
of O
DNA O
, O
approximately _RARE_
150 _RARE_
bp O
in O
length O
, O
containing O
three O
important O
sequence O
elements O
, O
which O
are O
folded O
with O
proteins O
into O
a O
specific O
conformation O
in O
the O
chromatin O
( O
the O
yeast O
kinetochore _RARE_
). O

Constitutive _RARE_
function O
of O
a O
positively O
regulated O
promoter O
reveals O
new O
sequences O
essential O
for _RARE_
activity O
. O

Two O
separate O
NF1 I-GENE
- I-GENE
binding I-GENE
loci I-GENE
were O
also O
found O
in O
the O
equivalent O
IE68 _RARE_
gene I-GENE
of O
HCMV _RARE_
( O
Towne _RARE_
) O
DNA O
, O
but O
in O
this O
case O
the O
DNA O
sequence O
and O
competition O
filter O
binding O
experiments O
indicated O
a O
maximum O
of O
only O
four O
to O
five O
consensus O
binding O
sites O
encompassing _RARE_
the O
promoter O
- O
enhancer O
region O
. O

The O
previously O
described O
four O
sets O
of O
13 _RARE_
- O
to O
18 O
- O
base _RARE_
- O
pair _RARE_
interspersed O
repeat O
elements O
between O
- O
55 _RARE_
and O
- O
580 _RARE_
provide O
most O
of O
the O
high O
basal O
transcriptional O
strength O
, O
whereas O
the O
arrangement O
of O
further O
upstream O
tandemly O
repeated _RARE_
NF1 I-GENE
- I-GENE
binding I-GENE
sites I-GENE
may O
contribute O
significantly O
to O
the O
expanded _RARE_
biological O
host _RARE_
range O
for _RARE_
expression _RARE_
of O
SCMV _RARE_
IE94 _RARE_
compared O
with O
HCMV _RARE_
IE68 _RARE_
. O

We O
inserted O
genes O
or O
gene O
segments _RARE_
, O
that O
code O
for _RARE_
the O
bacterial I-GENE
chloramphenicol I-GENE
acetyltransferase _RARE_
, O
the O
bacterial O
gene O
conferring O
resistance O
against O
hygromycin _RARE_
, O
and O
the O
ORF O
E7 I-GENE
of O
the O
human O
papillomavirus _RARE_
type O
18 O
into O
these O
vectors O
. O

By O
contrast O
, O
their O
basal O
adrenal O
androgen _RARE_
levels O
were O
significantly O
decreased O
compared O
to O
those O
in O
normal O
subjects O
on O
both O
the O
day O
on O
and O
the O
day O
off O
prednisone O
( O
P O
less O
than O
0 _RARE_
. O
05 O
). O

Active _RARE_
lambda I-GENE
and I-GENE
kappa _RARE_
antibody I-GENE
gene I-GENE
rearrangement O
in O
Abelson _RARE_
murine O
leukemia O
virus O
- O
transformed O
pre O
- O
B O
cell O
lines O
. O

Identification O
of O
p40x _RARE_
- O
responsive O
regulatory O
sequences O
within O
the O
human O
T O
- O
cell O
leukemia O
virus O
type O
I O
long O
terminal O
repeat O
. O

During O
pentobarbital _RARE_
anesthesia O
, O
the O
basal O
VO2 O
was O
5 O
. O
26 _RARE_
ml O
/ O
kg O
/ O
min O
and O
was O
increased O
by O
epinephrine O
in O
a O
dose O
dependent O
manner O
at _RARE_
plasma O
concentrations O
between O
3 O
. O
9 O
ng _RARE_
/ O
ml O
( O
VO2 O
= O
5 O
. O
68 _RARE_
ml O
/ O
kg O
/ O
min O
) O
and O
36 _RARE_
. O
5 O
ng _RARE_
/ O
ml O
( O
VO2 O
= O
6 O
. O
47 _RARE_
ml O
/ O
kg O
/ O
min O
). O

Influence O
of O
cyclo _RARE_
- I-GENE
oxygenase I-GENE
inhibition O
and O
of O
leukotriene _RARE_
receptor I-GENE
blockade O
on O
pulmonary O
vascular O
pressure O
/ O
cardiac O
index O
relationships O
in O
hyperoxic _RARE_
and O
in O
hypoxic O
dogs O
. O

Oligonucleotide _RARE_
- O
directed O
mutagenesis O
was O
used O
to O
create O
an O
NdeI _RARE_
restriction _RARE_
site I-GENE
at _RARE_
the O
natural _RARE_
ATG O
of O
the O
yeast O
R O
. O

ACTH I-GENE
release O
is O
transiently O
suppressed O
in O
some O
children O
after O
exogenous _RARE_
ACTH I-GENE
treatment O
. O

We O
previously O
showed O
that O
the O
upstream O
promoter O
element O
of O
the O
yeast I-GENE
RP39A _RARE_
gene I-GENE
consists O
of O
these O
identical O
sequence O
motifs O
. O

These O
data O
suggest O
that O
mammalian O
erythroid _RARE_
alpha I-GENE
- I-GENE
spectrin I-GENE
evolved O
by O
duplication O
and O
rapid O
divergence O
from O
an O
ancestral O
alpha I-GENE
- I-GENE
fodrin _RARE_
- I-GENE
like I-GENE
gene I-GENE
. O

Northern O
analyses O
of O
RNAs O
from O
mouse O
tissues O
and O
cell O
lines O
indicated O
that O
p11 _RARE_
mRNA I-GENE
levels O
vary O
widely O
. O

One O
group O
of O
six _RARE_
cDNA O
clones _RARE_
was O
derived O
from O
a O
2 O
. O
9 O
- O
kilobase _RARE_
early O
transcript O
encoded O
by O
the O
IR2 _RARE_
repeat O
element O
and O
showed O
restriction _RARE_
site O
polymorphism O
for _RARE_
the O
enzyme I-GENE
SmaI _RARE_
. O

Combined O
immunochemotherapy _RARE_
with O
cyclophosphamide O
plus _RARE_
BCG O
gave O
a O
better O
enhancement O
of O
the O
antitumor _RARE_
effect O
of O
the O
cytostatic _RARE_
than O
that O
of O
the O
combination O
of O
methotrexate O
plus _RARE_
BCG O
and O
cyclophosphamide O
plus _RARE_
levamisole _RARE_
. O

Morphine _RARE_
produced O
a O
dose O
- O
dependent O
bradycardia _RARE_
followed O
by O
tachycardia O
. O

The O
PSS _RARE_
gene I-GENE
was O
subcloned O
into O
a O
1 O
. O
1 O
- O
kb O
fragment O
of O
the O
yeast O
DNA O
on O
the O
YEp13 _RARE_
vector O
. O

Indeed O
, O
A O
- O
MuLV O
pseudotyped _RARE_
with O
some O
viruses O
, O
such O
as _RARE_
the O
Moloney O
MuLV O
, O
has O
been O
shown O
to O
be O
highly O
lymphogenic _RARE_
, O
whereas O
A O
- O
MuLV O
pseudotyped _RARE_
with O
other O
viruses O
, O
such O
as _RARE_
the O
BALB _RARE_
/ O
c O
endogenous O
N O
- O
tropic _RARE_
MuLV O
, O
has O
been O
shown O
to O
be O
devoid _RARE_
of O
lymphogenic _RARE_
potential _RARE_
( O
N O
. O

The O
presence O
of O
circulating O
platelet O
aggregates O
and O
elevated O
levels O
of O
fibrinopeptide _RARE_
A I-GENE
( O
a O
cleavage _RARE_
product O
of O
fibrin I-GENE
) O
suggests O
that O
platelet O
activation O
and O
fibrin I-GENE
deposition O
may O
play O
a O
role O
in O
the O
pathogenesis O
of O
this O
disorder O
. O

The O
gene O
is O
essential O
for _RARE_
yeast O
vegetative _RARE_
growth O
. O

4 O
. O

In O
general _RARE_
, O
the O
values O
obtained O
by O
the O
two O
methods O
were O
in O
agreement O
for _RARE_
each O
species O
of O
epidermal _RARE_
growth I-GENE
factor I-GENE
and O
followed O
the O
order O
: O
wild O
type O
greater O
than O
Glu24 _RARE_
---- _RARE_
Gly _RARE_
greater O
than O
Asp27 _RARE_
---- _RARE_
Gly _RARE_
much O
greater O
than O
Pro7 _RARE_
---- _RARE_
Thr _RARE_
greater O
than O
Tyr29 _RARE_
---- _RARE_
Gly _RARE_
greater O
than O
Leu47 _RARE_
---- _RARE_
His _RARE_
. O

It O
is O
concluded O
that O
suppression O
of O
elevated O
prolactin I-GENE
levels O
in O
progressive O
metastatic O
breast O
cancer _RARE_
patients O
is O
not O
effective O
in O
restoring _RARE_
tumor O
sensitivity O
to O
chemotherapy O
. O

We O
report O
a O
prevalence O
study O
of O
the O
best O
visual O
acuity _RARE_
in O
the O
affected O
eye O
of O
100 _RARE_
selected _RARE_
patients O
with O
herpetic _RARE_
keratitis _RARE_
seen O
during _RARE_
a O
two O
- O
year O
period O
. O

We O
also O
found O
an O
eIF I-GENE
- I-GENE
4A _RARE_
intronless O
retroposon _RARE_
which O
, O
when O
compared O
to O
the O
cDNA O
, O
contains O
a O
single O
nucleotide O
difference O
. O

Bacteriologic _RARE_
culture O
of O
pancreatic O
tissue O
was O
positive O
in O
6 O
/ O
8 O
IB _RARE_
and O
3 O
/ O
17 _RARE_
NIB _RARE_
rats O
( O
p O
less O
than O
0 _RARE_
. O
01 O
). O

These O
similarities O
suggest O
that O
these O
E2 I-GENE
proteins I-GENE
are O
structurally O
and O
evolutionarily O
related O
. O

After O
infection O
of O
293 O
cells O
( O
which O
provide O
complementary _RARE_
E1a I-GENE
- O
E1b _RARE_
functions O
), _RARE_
both O
viruses O
directed O
equal O
amounts O
of O
P I-GENE
/ I-GENE
C I-GENE
- I-GENE
specific I-GENE
mRNA I-GENE
transcription O
. O

This O
observation O
cannot O
be O
explained O
by O
the O
scanning O
model O
for _RARE_
ribosomal O
initiation O
and O
suggests O
that O
ribosomes _RARE_
may O
be O
binding O
directly O
at _RARE_
an O
internal O
mRNA O
site O
at _RARE_
or O
near O
the O
initiator _RARE_
AUG O
codon _RARE_
for _RARE_
the O
C I-GENE
protein I-GENE
. O

In O
view O
of O
these O
results O
, O
simultaneous O
pancreas O
- O
kidney _RARE_
transplantation O
appears O
to O
be O
the O
treatment O
of O
choice O
for _RARE_
Type _RARE_
I O
diabetic O
patients O
. O

This O
makes O
these O
compounds O
attractive _RARE_
as _RARE_
vehicles _RARE_
for _RARE_
these O
and O
other O
gases O
in O
- O
vivo O
and O
in O
- O
vitro O
. O

DNA O
sequencing O
of O
the O
DPM1 _RARE_
gene I-GENE
revealed O
an O
open _RARE_
reading O
frame O
of O
801 O
bases O
. O

The O
relationship O
between O
primary _RARE_
malignant O
lymphoma O
of O
the O
thyroid O
and O
chronic O
thyroiditis O
is O
discussed O
. O

Administration O
of O
anticoagulants _RARE_
, O
i O
. O
e _RARE_
., O
heparin _RARE_
, O
prostaglandin _RARE_
E1 O
and O
ticlopidine _RARE_
seems O
to O
be O
effective O
in O
alleviating _RARE_
symptoms O
and O
might O
prevent O
further O
deterioration O
. O

Mutational O
analysis O
of O
the O
L1 I-GENE
binding I-GENE
site I-GENE
of O
23S _RARE_
rRNA I-GENE
in I-GENE
Escherichia I-GENE
coli I-GENE
. O

Animals O
may O
be O
immunized O
by O
oral O
vaccination O
, O
but O
natural _RARE_
mechanisms O
that O
also O
can O
terminate O
outbreaks _RARE_
are O
discussed O
. O

Prostacyclin _RARE_
formation O
, O
reflected O
by O
the O
excretion O
rate O
of O
its O
stable O
metabolite O
6 O
- O
keto _RARE_
- O
prostaglandin _RARE_
F1 _RARE_
alpha O
, O
was O
measured O
by O
means O
of O
radioimmunoassay O
in O
4 O
- O
hour O
urine O
specimens O
obtained O
during _RARE_
a O
smoking O
- O
free O
period O
and O
after O
participants _RARE_
had O
inhaled O
smoke O
from O
four O
high O
- O
nicotine O
cigarettes _RARE_
. O

However O
, O
excretion O
of O
6 O
- O
keto _RARE_
- O
prostaglandin _RARE_
F1 _RARE_
alpha O
was O
further O
reduced _RARE_
in O
the O
smokers O
who O
used O
oral O
contraceptives _RARE_
( O
133 _RARE_
+/- O
20 O
to O
86 _RARE_
+/- O
9 O
ng _RARE_
/ O
gm _RARE_
of O
creatinine _RARE_
, O
p O
less O
than O
0 _RARE_
. O
05 O
). O

The O
in O
vitro O
activity O
of O
mecillinam _RARE_
and O
amoxicillin O
/ O
clavulanic _RARE_
acid O
against O
Escherichia O
coli O
strains O
producing O
beta I-GENE
- I-GENE
lactamases _RARE_
of O
the O
TEM _RARE_
- I-GENE
1 I-GENE
, O
Oxa _RARE_
- I-GENE
1 I-GENE
and O
chromosomal O
type O
were O
studied O
using O
the O
broth _RARE_
and O
agar O
dilution O
technique O
. O

GCN4 I-GENE
encodes O
a O
transcriptional O
activator O
of O
amino O
acid O
biosynthetic O
genes O
in O
Saccharomyces O
cerevisiae O
. O

These O
results O
imply O
that O
the O
GCN3 _RARE_
product I-GENE
can O
promote O
either O
repression O
or O
activation O
of O
GCN4 I-GENE
expression _RARE_
depending O
on O
amino O
acid O
availability O
. O

The O
efficacy O
of O
these O
immunosuppressive O
drugs O
is O
clinical O
proven O
. O

The O
amino O
acid O
sequence O
of O
the O
S O
. O
aureus _RARE_
peptide O
carrying O
the O
phosphoryl _RARE_
group O
was O
found O
to O
be O
Gln O
- O
Val _RARE_
- O
Val _RARE_
- O
Ser _RARE_
- O
Thr _RARE_
- O
Phe _RARE_
- O
Met _RARE_
- O
Gly _RARE_
- O
Asn O
- O
Gly _RARE_
- O
Leu _RARE_
- O
Ala _RARE_
- O
Ile O
- O
Pro _RARE_
- O
His _RARE_
- O
Gly _RARE_
- O
Thr _RARE_
- O
Asp _RARE_
- O
Asp _RARE_
. O

These O
mutations O
alter O
two O
regions O
of O
GAL4 I-GENE
protein I-GENE
: O
the O
DNA O
binding O
domain O
, O
and O
the O
transcription O
activation O
domain O
. O

The O
results O
indicated O
that O
two O
genes O
( O
citA _RARE_
and O
citB _RARE_
) O
have O
separate O
promoters O
, O
and O
the O
location O
of O
the O
promoter O
for _RARE_
the O
citB _RARE_
gene I-GENE
in O
the O
Tn3411 _RARE_
nucleotide O
sequence O
was O
different O
from O
that O
in O
pMS185 _RARE_
. O

The O
rci _RARE_
gene I-GENE
was O
fused O
with O
lacZ I-GENE
and O
its O
gene O
product O
was O
identified O
by O
Western O
blot O
analysis O
. O

Structure O
and O
regulation _RARE_
of O
a O
nuclear O
gene O
in O
Saccharomyces O
cerevisiae O
that O
specifies O
MRP13 _RARE_
, O
a O
protein O
of O
the O
small O
subunit O
of O
the O
mitochondrial O
ribosome _RARE_
. O

After O
a O
survey O
of O
the O
anatomical O
and O
physiological O
basis O
of O
operative O
treatment O
of O
behaviour O
disorders O
by O
stereotactic _RARE_
lesions O
in O
the O
amygdala O
and O
the O
posterior O
medial O
hypothalamus O
the O
author O
describes O
his _RARE_
own O
experiences _RARE_
with O
603 _RARE_
operations _RARE_
for _RARE_
control O
of O
conservatively _RARE_
untreatable _RARE_
aggressiveness _RARE_
. O

Histological O
examination O
revealed O
a O
small O
simple O
renal _RARE_
cyst O
associated O
with O
renal _RARE_
cell O
carcinoma O
. O

Although O
large O
epidemiologic _RARE_
studies O
are O
best O
able O
to O
identify O
the O
relative O
contributions _RARE_
of O
specific O
risk O
factors O
while O
controlling O
for _RARE_
other O
risk O
factors O
, O
new O
studies O
need O
to O
focus O
on O
important O
unresolved _RARE_
questions O
. O

Thus O
, O
prostacyclin _RARE_
enhanced _RARE_
the O
autoregulative _RARE_
property _RARE_
of O
the O
inner O
ear O
vessels O
. O

The O
method O
is O
accurate O
, O
with O
good O
precision _RARE_
and O
adequate O
sensitivity O
. O

Factors O
influencing O
the O
bond O
strength O
between O
glass O
polyalkenoate _RARE_
( O
ionomer _RARE_
) O
cements _RARE_
and O
dentine _RARE_
. O

The O
amino O
acid O
sequences O
of O
the O
yeast O
and O
mammalian O
mitochondrial O
targeting O
sequences O
are O
similar O
but O
less O
related O
than O
the O
mature _RARE_
polypeptides O
. O

Van _RARE_
der _RARE_
Ende _RARE_
, O
R O
. O

During O
insulin I-GENE
infusion O
, O
a O
20 O
% O
dextrose _RARE_
solution O
was O
infused O
by O
a O
Biostator _RARE_
in O
order O
to O
maintain O
the O
patient O
' O
s O
glycemia _RARE_
at _RARE_
90 _RARE_
mg O
/ O
dl O
. O

Amounts _RARE_
of O
glucose O
infused O
during _RARE_
the O
last O
20 O
min O
of O
each O
2 O
hour O
insulin I-GENE
infusion O
were O
( O
at _RARE_
1 O
and O
10 O
m O
/ O
kg O
/ O
min O
respectively O
): O
before O
treatment O
( O
K O
+ O
= O
2 O
. O
7 O
mmol O
/ O
l _RARE_
): O
2 O
. O
4 O
and O
8 O
. O
4 O
mg O
/ O
kg O
/ O
min O
; O
after O
spironolactone _RARE_
( O
K O
+ O
= O
3 O
. O
9 O
mmol O
/ O
l _RARE_
): O
3 O
. O
3 O
and O
15 _RARE_
. O
4 O
mg O
/ O
kg O
/ O
min O
; O
after O
indomethacine _RARE_
( O
K O
+ O
= O
3 O
. O
7 O
mmol O
/ O
l _RARE_
): O
5 O
and O
19 O
mg O
/ O
kg O
/ O
min O
after O
stopping _RARE_
drugs O
( O
K O
+ O
= O
2 O
. O
9 O
mmol O
/ O
l _RARE_
): O
2 O
. O
5 O
and O
5 O
. O
3 O
mg O
/ O
kg O
/ O
min O
. O

Mycobacterium O
avium _RARE_
- O
intracellulare _RARE_
complex O
infections O
in O
the O
acquired O
immunodeficiency O
syndrome _RARE_
. O

Recurrence _RARE_
of O
oxalate _RARE_
deposition O
in O
a O
renal _RARE_
transplant O
during _RARE_
ciclosporin _RARE_
A O
therapy O
. O

The O
bile O
acid O
sequestrants _RARE_
( O
cholestyramine _RARE_
and O
colestipol _RARE_
), _RARE_
nicotinic _RARE_
acid O
, O
fenofibrate _RARE_
and O
inhibitors _RARE_
of O
hydroxymethylglutaryl _RARE_
coenzyme _RARE_
A I-GENE
( I-GENE
HMG I-GENE
CoA I-GENE
) I-GENE
reductase I-GENE
( O
e _RARE_
. O
g O
. O
lovastatin _RARE_
or O
simvastatin _RARE_
) O
are O
the O
most O
effective O
drugs O
for _RARE_
use O
in O
patients O
with O
primary _RARE_
hypercholesterolaemia _RARE_
; O
these O
agents O
reduce O
plasma O
concentrations O
of O
total _RARE_
and O
LDL I-GENE
- I-GENE
cholesterol I-GENE
by O
15 _RARE_
to O
45 _RARE_
%. O

Finally O
, O
the O
pathophysiological _RARE_
aspects O
of O
urinary _RARE_
acidification O
are O
discussed O
, O
focusing O
on O
renal _RARE_
tubular O
acidosis O
models O
( O
induced _RARE_
by O
maleate _RARE_
and O
amphotericin O
B O
treatment O
) O
and O
their O
cellular O
mechanisms O
, O
as _RARE_
well _RARE_
as _RARE_
the O
role O
of O
adrenal O
steroids O
in O
urinary _RARE_
acidification O
. O

Analysis O
in O
3 O
groups O
of O
patients O
suffering O
from O
simple O
acute O
and O
pernicious _RARE_
malarial _RARE_
flare _RARE_
- O
ups _RARE_

Statement _RARE_
on O
the O
development O
of O
guidelines O
for _RARE_
the O
prevention O
of O
AIDS O
transmission _RARE_
in O
the O
workplace _RARE_
. O

Modifications _RARE_
of O
the O
involuntary _RARE_
postcontraction _RARE_
in O
diseased O
people O
. O

Cocaine _RARE_
- O
treated O
rats O
acquired O
a O
preference O
for _RARE_
cocaine O
- O
associated O
contextual _RARE_
stimuli O
( O
CS _RARE_
) O
relative O
to O
saline O
- O
injected O
control O
rats O
. O

Under O
these O
schedules _RARE_
, O
a O
reinforced O
response O
run O
consisted O
of O
responding O
between O
eight O
and O
12 O
times O
on O
one O
response O
key O
( O
work O
key O
) O
and O
then O
responding O
once O
on O
a O
second O
response O
key O
( O
reinforced O
key O
). O

Intravenous O
glucose O
tolerance O
tests O
were O
performed O
before O
operation O
, O
before O
starting O
CyA _RARE_
and O
after O
3 O
weeks O
. O

The O
effects O
of O
glutaraldehyde _RARE_
on O
dimensions O
and O
ultrastructure _RARE_
of O
microvascular O
beds _RARE_
in O
rat O
mesentery _RARE_
were O
studied O
in O
two O
kinds _RARE_
of O
experiment O
, O
administering _RARE_
the O
fixative _RARE_
by O
intra _RARE_
- O
arterial O
perfusion O
at _RARE_
a O
pressure O
of O
80 _RARE_
mm O
Hg O
and O
by O
superfusion _RARE_
of O
the O
exteriorized _RARE_
mesenteric _RARE_
membrane O
. O

This O
gave O
rise O
to O
RNA O
molecules O
with O
3 O
'- O
untranslated _RARE_
regions O
of O
roughly _RARE_
375 _RARE_
, O
655 _RARE_
, O
and O
945 _RARE_
base _RARE_
pairs _RARE_
. O

Also O
, O
the O
BALB _RARE_
/ I-GENE
c I-GENE
gene I-GENE
contains O
a O
single O
substitution O
in O
a O
conserved _RARE_
octamer O
sequence O
approximately _RARE_
equal O
to O
100 _RARE_
nucleotides O
upstream O
of O
the O
coding O
region O
, O
which O
could O
affect O
its O
expression _RARE_
. O

Clinical O
findings O
were O
: O
height O
183 _RARE_
cm O
, O
weight _RARE_
62 _RARE_
kg O
, O
increased O
length O
of O
lower O
limbs _RARE_
, O
P2 O
- O
A2 _RARE_
pilosity _RARE_
and O
micropenis _RARE_
. O

Our O
data O
suggest O
that O
it O
may O
be O
possible O
to O
individualize _RARE_
hCG I-GENE
administration O
at _RARE_
midcycle _RARE_
by O
determining _RARE_
the O
number O
of O
follicles _RARE_
greater O
than O
1 O
cm O
by O
ultrasound O
on O
cycle _RARE_
day O
12 O
or O
13 _RARE_
and O
giving O
hCG I-GENE
when O
serum O
E2 O
levels O
reach O
1100 _RARE_
to O
1200 _RARE_
pmol _RARE_
/ O
l _RARE_
per O
follicle _RARE_
. O

The O
8 O
patients O
receiving O
Ir192 _RARE_
implant O
in O
addition O
to O
external O
radiation O
showed O
improved O
( O
p O
= O
0 _RARE_
. O
06 O
) O
survival O
compared O
to O
the O
9 O
receiving O
external O
only O
: O
median O
15 _RARE_
months O
( O
range O
1 O
. O
5 O
- O
34 _RARE_
+ O
months O
) O
versus O
7 O
months O
( O
range O
2 O
. O
5 O
- O
21 O
months O
). O

Within O
Stage O
IA O
, O
141 _RARE_
patients O
had O
well _RARE_
differentiated O
tumor O
( O
G1 O
), _RARE_
20 O
had O
moderately O
well _RARE_
differentiated O
tumor O
( O
G2 _RARE_
), _RARE_
and O
12 O
patients O
had O
poorly O
differentiated O
( O
G3 _RARE_
). O

Mechanism O
of O
the O
t O
( O
14 O
; O
18 O
) O
chromosomal O
translocation O
: O
structural O
analysis O
of O
both O
derivative _RARE_
14 O
and O
18 O
reciprocal O
partners O
. O

After O
age O
30 _RARE_
, O
mean O
hemoglobin I-GENE
levels O
for _RARE_
men O
gradually O
declined O
, O
while O
those O
in O
women O
rose O
, O
so O
that O
the O
sex _RARE_
difference O
diminished O
after O
60 _RARE_
years O
of O
age O
. O

Ritanserin _RARE_
is O
a O
new O
substance _RARE_
with O
highly O
selective O
blocking O
activity O
on O
S2 _RARE_
receptors I-GENE
for _RARE_
5 O
- O
HT _RARE_
in O
the O
central O
nervous O
system _RARE_
. O

Ethylene _RARE_
glycol O
and O
diethylene _RARE_
glycol O
were O
each O
administered O
once O
weekly O
subcutaneously O
to O
groups O
of O
100 _RARE_
female O
NMRI _RARE_
mice O
at _RARE_
3 O
dosages _RARE_
( O
30 _RARE_
; O
10 O
und _RARE_
3 O
mg O
single O
dose O
per O
mouse O
). O

Research O
on O
ethylene O
glycol O
and O
diethylene _RARE_
glycol O
for _RARE_
carcinogenic _RARE_
effects O

The O
results O
suggest O
that O
the O
greater O
estrogenic _RARE_
influence O
associated O
with O
the O
ethinyl _RARE_
estradiol O
- O
containing O
OC _RARE_
resulted O
in O
inhibition O
of O
coronary O
artery O
atherosclerosis O
despite O
a O
pronounced O
progestin _RARE_
- O
induced _RARE_
lowering O
of O
plasma O
HDL _RARE_
cholesterol I-GENE
concentration O
and O
, O
further O
, O
that O
hormonal O
balance O
may O
have O
a O
marked O
influence O
on O
the O
relationship O
between O
plasma O
lipids O
and O
atherogenesis _RARE_
. O

During O
BH _RARE_
the O
ventilator _RARE_
was O
disconnected _RARE_
and O
a O
bias _RARE_
flow O
of O
50 O
% O
O2 _RARE_
at _RARE_
4 O
- O
5 O
l _RARE_
/ O
min O
was O
delivered O
through O
the O
side _RARE_
ports _RARE_
of O
a O
small O
catheter O
whose O
tip _RARE_
was O
positioned O
1 O
cm O
cephalad _RARE_
of O
the O
carina _RARE_
. O

Comparison O
of O
beta I-GENE
2 I-GENE
- I-GENE
microglobulin I-GENE
removal O
using O
the O
same O
polysulphone _RARE_
membrane O
for _RARE_
haemodialysis O
and O
haemofiltration _RARE_
shows O
that O
beta I-GENE
2 I-GENE
- I-GENE
microglobulin I-GENE
is O
more O
effectively O
removed O
by O
convection _RARE_
than O
by O
diffusion O
when O
both O
treatment O
modes O
are O
matched O
for _RARE_
blood _RARE_
flow O
and O
urea O
clearance O
. O

40 O
. O
3 O
+/- O
10 O
. O
1 O
mg O
/ O
l _RARE_
( O
SD O
) O
vs _RARE_
31 _RARE_
. O
2 O
+/- O
8 O
. O
0 _RARE_
, O
P O
less O
than O
0 _RARE_
. O
01 O
). O
beta I-GENE
2m _RARE_
was O
not O
significantly O
higher _RARE_
in O
patients O
with O
bone O
cysts O
( O
37 O
. O
7 O
+/- O
11 O
. O
4 O
mg O
/ O
l _RARE_
vs _RARE_
37 O
. O
0 _RARE_
+/- O
10 O
. O
0 _RARE_
), _RARE_
but O
median O
duration O
of O
dialysis O
was O
significantly O
( O
P O
less O
than O
0 _RARE_
. O
01 O
) O
longer O
in O
patients O
with O
bone O
cysts O
( O
90 _RARE_
vs _RARE_
57 O
months O
). O
beta I-GENE
2m _RARE_
was O
lower O
in O
patients O
maintained O
on O
dialysis O
for _RARE_
less O
than O
1 O
year O
and O
whose O
residual O
urine O
volume O
was O
greater O
than O
0 _RARE_
. O
1 O
litre _RARE_
per O
day O
. O

The O
mean O
percentage O
of O
linoleic _RARE_
acid O
in O
the O
triglycerides _RARE_
of O
the O
subcutaneous O
adipose _RARE_
tissue O
( O
PLASAT _RARE_
) O
of O
these O
subjects O
was O
substantially O
higher _RARE_
than O
that O
in O
a O
similar O
group O
examined O
in O
1975 _RARE_
- O
1976 _RARE_
. O

In O
overdoses _RARE_
up _RARE_
to O
2 O
g O
fluvoxamine _RARE_
no _RARE_
lasting O
toxic O
effects O
were O
observed O
. O

It O
is O
concluded O
that O
the O
plasma I-GENE
prolactin I-GENE
response O
to O
12 O
. O
5 O
micrograms O
i O
. O
v O
. O

No O
effect O
was O
found O
on O
grooming _RARE_
behavior O
. O

The O
remaining O
six _RARE_
patients O
had O
slightly O
decreased O
( O
n _RARE_
= O
3 O
) O
or O
normal O
( O
n _RARE_
= O
3 O
) O
seminal _RARE_
parameters O
. O

In O
addition O
, O
a O
wild O
- O
type O
strain _RARE_
containing O
a O
temperature _RARE_
- I-GENE
sensitive _RARE_
threonyl _RARE_
- I-GENE
tRNA I-GENE
synthetase _RARE_
mutation I-GENE
showed O
increased O
thr _RARE_
operon I-GENE
expression _RARE_
at _RARE_
the O
non O
- O
permissive O
temperature _RARE_
, O
whereas O
none O
of O
the O
mutants O
showed O
any O
change O
. O

Significant O
treatment O
- O
related O
problems O
appeared O
during _RARE_
the O
second O
decade _RARE_
in O
5 O
patients O
, O
including O
one O
chest O
wall _RARE_
sarcoma O
; O
all O
of O
these O
patients O
had O
received O
at _RARE_
least O
60 _RARE_
Gy O
to O
breast O
and O
regional O
nodal O
areas O
. O

Clinical O
and O
biological O
correlates O
of O
panic _RARE_
states O
. O

Effects O
of O
long O
- O
term O
parenteral _RARE_
nutrition O
on O
gastrin I-GENE
release O
in O
dogs O
. O

The O
mean O
weight _RARE_
and O
height O
velocities _RARE_
were O
148 _RARE_
% O
and O
122 O
% O
of O
the O
standard O
, O
respectively O
. O

Of O
7 O
patients O
treated O
with O
cyclophosphamide O
, O
hexamethylmelamine _RARE_
, O
adriamycin _RARE_
and O
cisplatin O
( O
CHAP _RARE_
- O
5 O
), _RARE_
6 O
had O
measurable _RARE_
disease _RARE_
, O
of O
whom O
5 O
yielded O
a O
response O
( O
2 O
complete _RARE_
responses O
for _RARE_
19 O
+ O
and O
40 O
months O
and O
3 O
partial O
responses O
for _RARE_
4 O
, O
7 O
and O
8 O
months O
). O

Isolation O
and O
characterization O
of O
a O
vinculin _RARE_
cDNA I-GENE
from I-GENE
chick _RARE_
- I-GENE
embryo _RARE_
fibroblasts _RARE_
. O

A O
complementary _RARE_
study O
, O
showing O
a O
good O
agreement O
between O
surface O
and O
oesophageal _RARE_
EMGd _RARE_
seems O
to O
confirm O
that O
surface O
EMGd _RARE_
is O
a O
useful O
and O
promising _RARE_
tool O
for _RARE_
clinical O
investigation O
. O

No O
differences O
in O
fixation O
quality O
were O
observed O
between O
cochleas _RARE_
fixed O
by O
intravascular O
perfusion O
and O
cochleas _RARE_
fixed O
by O
intralabyrinthine _RARE_
perfusion O
. O

The O
DNA O
sequence O
encodes O
a O
protein O
of O
1520 _RARE_
amino O
acids _RARE_
with O
sequence O
homology O
to O
the O
human I-GENE
c I-GENE
- I-GENE
abl I-GENE
proto _RARE_
- I-GENE
oncogene I-GENE
product I-GENE
, O
beginning O
at _RARE_
the O
amino O
terminus O
and O
extending O
656 _RARE_
amino O
acids _RARE_
through O
the O
region O
essential O
for _RARE_
tyrosine I-GENE
kinase I-GENE
activity O
. O

The O
requirement O
of O
different O
essential O
fatty O
acids _RARE_
in O
patients O
with O
total _RARE_
parenteral _RARE_
nutrition O
after O
heavy O
injury O
is O
of O
special _RARE_
interest O
with O
respect O
to O
the O
development O
and O
prognosis O
of O
shock O
, O
sepsis O
or O
adult O
respiratory O
distress O
syndrome _RARE_
. O

In O
64 _RARE_
% O
a O
small O
cardiac O
vein _RARE_
does O
not O
exist O
, O
but O
its O
origin O
, O
the O
right O
marginal _RARE_
vein _RARE_
, O
joins O
the O
system _RARE_
of O
anterior O
cardiac O
veins _RARE_
. O

The O
Drosophila I-GENE
melanogaster I-GENE
Gart _RARE_
gene I-GENE
encodes O
three O
enzymatic O
activities O
in O
the O
pathway _RARE_
for _RARE_
purine _RARE_
de O
novo _RARE_
synthesis _RARE_
. O

The O
role O
of O
neuroplasticity _RARE_
in O
the O
response O
to O
drugs O
. O

Biol O
. O

The O
results O
of O
these O
experiments O
indicate O
that O
at _RARE_
least O
two O
upstream O
activator O
sequences O
( O
UAS O
) O
mediate O
maximum O
induction O
by O
galactose _RARE_
. O

Reversal _RARE_
of O
the O
increase O
in O
apomorphine _RARE_
- O
induced _RARE_
stereotypy _RARE_
and O
aggression O
in O
REM O
sleep O
deprived O
rats O
by O
dopamine O
agonist O
pretreatments _RARE_
. O

The O
heart _RARE_
rate O
, O
respiratory O
rate O
, O
arterial O
O2 _RARE_
and O
systemic O
vascular O
resistance O
were O
not O
significantly O
altered O
. O

Human I-GENE
rIL _RARE_
- I-GENE
3 I-GENE
expressed _RARE_
in O
COS7 _RARE_
cells O
has O
multipotential _RARE_
CSF I-GENE
activity O
in O
semisolid _RARE_
cultures O
of O
bone O
marrow O
cells O
, O
and O
selectively O
induced _RARE_
the O
proliferation _RARE_
of O
My _RARE_
- O
10 O
+ O
marrow O
or O
cord O
blood _RARE_
cells O
in O
liquid O
cultures O
. O

In O
14 O
patients O
whose O
PaCO2 O
was O
greater O
than O
or O
equal O
to O
39 _RARE_
torr O
( O
range O
39 _RARE_
to O
58 O
torr O
) O
and O
clinical O
asthma O
score O
was O
6 O
or O
greater O
, O
PaCO2 O
decreased O
a O
mean O
of O
11 O
. O
7 O
torr O
during _RARE_
a O
mean O
of O
8 O
. O
1 O
hours O
. O

A O
randomized O
, O
prospective O
study O
was O
conducted O
to O
compare O
ovarian O
stimulation _RARE_
with O
human I-GENE
menopausal _RARE_
gonadotropin I-GENE
( O
hMG _RARE_
) O
and O
human I-GENE
follicle _RARE_
- I-GENE
stimulating I-GENE
hormone I-GENE
( O
hFSH _RARE_
) O
in O
an O
in O
vitro O
fertilization O
and O
embryo _RARE_
transfer O
( O
IVF _RARE_
- O
ET _RARE_
) O
program O
. O

Our O
findings O
suggest O
that O
the O
mtr _RARE_
product I-GENE
causes O
both O
transcription O
attenuation _RARE_
and O
inhibition O
of O
translation O
of O
trpE _RARE_
mRNA I-GENE
. O

Apropos _RARE_
of O
a O
case O

A O
prostaglandin _RARE_
analogue O
given O
in O
early O
pregnancy _RARE_
and O
human I-GENE
chorionic _RARE_
gonadotropin I-GENE
given O
near O
the O
end O
of O
the O
ensuing _RARE_
follicular O
phase _RARE_
were O
used O
for _RARE_
controlling O
the O
reproductive O
cycle _RARE_
, O
timing O
oocyte _RARE_
collection O
, O
and O
synchronizing _RARE_
the O
cycles O
of O
oocyte _RARE_
donors O
and O
embryo _RARE_
recipients O
. O

The O
nucleolin _RARE_
gene I-GENE
extends _RARE_
over O
9000 _RARE_
base _RARE_
- O
pairs _RARE_
and O
is O
split _RARE_
into O
14 O
exons O
that O
encode O
the O
706 _RARE_
amino O
acid O
residues O
of O
the O
protein O
. O

Although O
L O
- O
threo _RARE_
- O
dihydroxyphenylserine _RARE_
( O
DOPS _RARE_
), _RARE_
an O
artificial O
norepinephrine O
( O
NE _RARE_
) O
precursor O
, O
did O
not O
change O
immobility _RARE_
in O
intact _RARE_
mice O
, O
DOPS _RARE_
significantly O
reduced _RARE_
immobility _RARE_
in O
mice O
pretreated O
with O
the O
selective O
NE _RARE_
neurotoxin _RARE_
DSP4 _RARE_
. O

Substantial _RARE_
amounts O
of O
liposomal _RARE_
ampicillin _RARE_
were O
recovered O
from O
isolated O
Kupffer _RARE_
cells O
, O
the O
target O
cells O
of O
L O
. O
monocytogenes O
after O
intravenous O
inoculation _RARE_
. O

This O
suggested O
that O
delta O
6 O
and O
delta O
5 O
desaturation _RARE_
activities O
are O
normal O
in O
these O
conditions O
with O
this O
C18 O
: O
2w6 _RARE_
supply O
. O

The O
genetic O
basis O
for _RARE_
the O
expression _RARE_
of O
a O
latent O
VH _RARE_
allotype _RARE_
in O
the O
rabbit _RARE_
was O
investigated O
. O

Here O
we O
report O
the O
complete _RARE_
6 O
- O
kilobase _RARE_
cDNA O
sequence O
coding O
for _RARE_
a O
chain O
of O
1775 _RARE_
amino O
acids _RARE_
, O
as _RARE_
well _RARE_
as _RARE_
the O
genomic O
structure _RARE_
. O

HDL _RARE_
- I-GENE
cholesterol I-GENE
(+ O
6 O
%, O
P O
less O
than O
. O
01 O
) O
and O
apolipoprotein I-GENE
A I-GENE
- I-GENE
I I-GENE
(+ O
6 O
%, O
P O
less O
than O
. O
01 O
) O
concentrations O
increased O
significantly O
only O
in O
the O
young O
. O

The O
Euglena _RARE_
ribosomal I-GENE
protein I-GENE
gene I-GENE
cluster I-GENE
resembles O
the O
S I-GENE
- I-GENE
10 I-GENE
ribosomal I-GENE
protein I-GENE
operon I-GENE
of I-GENE
Escherichia I-GENE
coli I-GENE
in O
gene O
organization O
and O
follows O
the O
exact _RARE_
linear _RARE_
order O
of O
the O
analogous O
genes O
in O
the O
tobacco O
and O
liverwort _RARE_
chloroplast O
genomes O
. O

The O
distribution O
of O
the O
sites O
of O
recombinational _RARE_
resolution O
is O
inversely O
correlated O
with O
that O
of O
the O
gradient O
of O
sequence O
divergence O
, O
with O
only O
approximately _RARE_
7 O
% O
of O
the O
X O
recombinants _RARE_
resolved O
within O
the O
3 O
' O
third O
of O
the O
X O
blocks O
where O
two O
diverged O
Alu I-GENE
family O
repeats O
reside O
. O

The O
nucleotide O
sequence O
of O
the O
region O
upstream O
from O
M I-GENE
. I-GENE
voltae _RARE_
ORFtrpA _RARE_
was O
determined O
and O
revealed O
the O
presence O
of O
an O
ORF O
of O
1227 _RARE_
nucleotides O
( O
ORFtrpB _RARE_
) O
encoding O
a O
409 _RARE_
amino O
acid O
polypeptide O
of O
mol O
. O
wt O
. O

Potentiation _RARE_
of O
the O
thrombolytic _RARE_
efficacy O
of O
single I-GENE
- I-GENE
chain I-GENE
urokinase I-GENE
( O
Pro _RARE_
- I-GENE
urokinase I-GENE
) O
by O
heparin _RARE_
. O

Of O
49 _RARE_
receptors O
which O
fired _RARE_
in O
phase _RARE_
with O
ventilation O
, O
13 _RARE_
behaved _RARE_
like O
mammalian O
rapidly O
adapting O
pulmonary O
stretch O
receptors O
, O
19 O
like O
mammalian O
slowly O
adapting O
pulmonary O
stretch O
receptors O
( O
PSR _RARE_
), _RARE_
and O
17 _RARE_
like O
avian O
intrapulmonary _RARE_
CO2 O
- O
sensitive _RARE_
chemoreceptors _RARE_
( O
IPC _RARE_
). O

Symptomatic _RARE_
hyperventilators _RARE_
had O
a O
larger O
number O
of O
sighs _RARE_
and O
abnormally _RARE_
wide O
fluctuations O
in O
baseline O
for _RARE_
inspiratory O
time O
, O
expiratory O
time O
, O
and O
PETCO2 _RARE_
. O

In O
the O
IA O
task O
, O
post O
- O
training O
intraperitoneal _RARE_
injections O
of O
picrotoxin _RARE_
and O
bicuculline _RARE_
induced _RARE_
a O
dose O
- O
dependent O
enhancement O
of O
retention O
measured O
24 _RARE_
h O
after O
the O
training O
, O
while O
retention O
was O
not O
affected O
by O
bicuculline _RARE_
methiodide _RARE_
( O
a O
GABA _RARE_
receptor I-GENE
antagonist O
that O
does O
not O
readily O
cross O
the O
blood _RARE_
- O
brain O
barrier O
). O

Clinical O
research O
of O
non O
- O
A O
, O
non O
- O
B O
post O
- O
transfusion O
hepatitis O

It O
is O
suggested O
that O
the O
use O
of O
endogenous O
creatinine _RARE_
clearance O
to O
estimate O
the O
glomerular O
filtration O
rate O
( O
GFR O
) O
requires O
caution _RARE_
and O
the O
recognition O
of O
the O
limitations O
of O
the O
method O
, O
and O
that O
simpler _RARE_
techniques O
( O
serum O
creatinine _RARE_
or O
estimated O
endogenous O
creatinine _RARE_
clearance O
) O
are O
preferable _RARE_
in O
routine O
practice O
. O

The O
protein O
mixtures _RARE_
of O
sesame _RARE_
flour _RARE_
and O
soybean _RARE_
flour _RARE_
were O
well _RARE_
accepted O
. O

The O
5 O
' O
end O
of O
the O
coding O
region O
was O
located _RARE_
precisely O
by O
comparing O
the O
deduced O
amino O
acid O
sequence O
to O
the O
actual O
N O
- O
terminal O
amino O
acid O
sequence O
of O
IHF _RARE_
. O

A O
protein O
footprint O
also O
was O
identified O
for _RARE_
a O
GC _RARE_
box O
element O
at _RARE_
nucleotides O
- O
59 _RARE_
to O
- O
45 _RARE_
. O

Insulin I-GENE
- I-GENE
like I-GENE
growth I-GENE
factor I-GENE
II I-GENE
( O
IGFII _RARE_
) O
is O
a O
mitogenic O
polypeptide O
, O
the O
mRNAs O
of O
which O
are O
present O
in O
multiple O
forms O
, O
despite O
derivation _RARE_
from O
a O
single O
gene O
. O

The O
central O
visual O
fields O
of O
2165 _RARE_
normal O
and O
106 _RARE_
glaucoma O
eyes O
were O
measured O
using O
a O
threshold O
related O
suprathreshold _RARE_
strategy O
. O

The O
variability O
is O
most O
likely O
a O
result O
of O
alternative _RARE_
splicing _RARE_
of O
exons O
from O
the O
primary _RARE_
elastin I-GENE
transcripts I-GENE
. O

This O
led O
to O
the O
conclusion O
that O
the O
metatarsal _RARE_
artery O
should O
be O
used O
for _RARE_
toe O
MP O
joint O
grafts O
, O
while O
the O
unilateral O
proper O
digital O
artery O
is O
suitable O
for _RARE_
toe O
PIP _RARE_
joint O
grafts O
, O
together O
with O
concomitant O
or O
dorsal O
cutaneous O
vein _RARE_
. O

Effect O
of O
chronic O
undernutrition _RARE_
on O
susceptibility _RARE_
to O
cold O
stress O
in O
young O
adult O
and O
aged O
rats O
. O

This O
effect O
and O
the O
fact O
that O
all O
three O
doses O
were O
toxic O
to O
the O
dams _RARE_
dictated _RARE_
that O
a O
second O
experiment O
be O
carried O
out O
at _RARE_
lower O
doses O
. O

The O
CHARGE _RARE_
association O
is O
a O
collection O
of O
multisystem _RARE_
congenital O
anomalies O
including O
choanal _RARE_
atresia _RARE_
. O

Esophageal _RARE_
brush _RARE_
cytological _RARE_
screening O
was O
undertaken O
and O
blood _RARE_
concentrations O
of O
micronutrients _RARE_
( O
vitamin O
A O
, O
E O
, O
B12 _RARE_
, O
folic _RARE_
acid O
and O
methionine O
) O
determined O
from O
adults O
at _RARE_
risk O
for _RARE_
esophageal O
carcinoma O
( O
EC O
) O
in O
Transkei _RARE_
and O
Ciskei _RARE_
, O
Southern O
Africa _RARE_
. O

Aviators _RARE_
from O
the O
Light _RARE_
Attack _RARE_
Wing _RARE_
, O
Pacific _RARE_
were O
surveyed _RARE_
and O
the O
results O
were O
categorized _RARE_
by O
aircraft _RARE_
type O
. O

Evaluation O
of O
human O
and O
bovine O
modified O
- O
hemoglobin I-GENE
solution O
as _RARE_
oxygen O
- O
carrying O
fluid _RARE_
for _RARE_
blood _RARE_
volume O
replacement _RARE_
. O

Delayed _RARE_
gallbladder O
visualization O
and O
reduction O
in O
ejection O
fraction O
were O
sensitive _RARE_
but O
nonspecific O
indicators O
of O
biliary O
disease _RARE_
. O

26 _RARE_
micrograms O
PAF _RARE_
or O
placebo O
was O
sprayed _RARE_
into O
each O
nasal O
cavity O
8 O
h O
and O
1 O
h O
before O
a O
nasal O
allergen _RARE_
challenge O
. O

Sci _RARE_
. O

Chem O
. O

Sequential _RARE_
MR O
examinations O
of O
the O
nasal O
cavity O
and O
paranasal _RARE_
sinuses _RARE_
were O
performed O
within O
a O
6 O
- O
8 O
h O
period O
in O
five O
normal O
volunteers O
. O

Comparison O
was O
made O
with O
other O
neuroradiological _RARE_
imaging O
modalities O
including O
CT _RARE_
, O
myelography _RARE_
, O
CT _RARE_
ventriculography _RARE_
, O
and O
CT _RARE_
myelocisternography _RARE_
. O

The O
feed O
given O
to O
young O
broiler _RARE_
chickens _RARE_
was O
contaminated O
artificially O
with O
Salmonella _RARE_
kedougou _RARE_
, O
a O
serotype _RARE_
associated O
with O
both O
subclinical O
infections O
in O
commercially _RARE_
reared _RARE_
chickens _RARE_
and O
food O
poisoning O
in O
humans O
. O

A O
poor O
correlation O
was O
found O
between O
a O
mildly _RARE_
- O
atypical O
( O
inflammatory O
) O
cytological _RARE_
result O
( O
class O
2 O
) O
and O
a O
benign O
histological O
diagnosis O
: O
48 _RARE_
% O
of O
class O
- O
2 O
smears O
were O
diagnosed O
histologically O
as _RARE_
dysplasia O
or O
worse _RARE_
. O

Factors O
involved O
in O
specific O
transcription O
by O
mammalian O
RNA I-GENE
polymerase I-GENE
II I-GENE
: O
purification O
, O
genetic O
specificity _RARE_
, O
and O
TATA O
box O
- O
promoter O
interactions O
of O
TFIID I-GENE
. O

Change _RARE_
in O
plasma I-GENE
cystyl _RARE_
aminopeptidase _RARE_
( O
oxytocinase _RARE_
) O
between O
30 _RARE_
- O
34 _RARE_
weeks O
' O
gestation O
as _RARE_
a O
predictor O
of O
pregnancy _RARE_
- O
induced _RARE_
hypertension O
. O

You _RARE_
make O
the O
diagnosis O
. O

The O
test O
for _RARE_
alpha I-GENE
- I-GENE
naphthyl _RARE_
esterase I-GENE
and O
quantitation _RARE_
of O
macrophages O
( O
absolute O
number O
) O
per O
infiltration _RARE_
area O
unit O
adjacent O
to O
the O
abscess O
suggest O
a O
direct O
correlation O
between O
the O
absolute O
number O
of O
macrophages O
and O
the O
width _RARE_
of O
the O
capsule _RARE_
. O

Determined _RARE_
as _RARE_
migration O
differentials _RARE_
, O
chemotactic O
and O
chemokinetic _RARE_
responsiveness O
tended O
to O
be O
higher _RARE_
in O
the O
neutropenic _RARE_
group O
. O

The O
deduced O
96 O
- O
residue _RARE_
amino O
acid O
coding O
sequence O
of O
the O
murine O
HMG I-GENE
- I-GENE
I I-GENE
( I-GENE
Y I-GENE
) I-GENE
cDNA O
is O
very O
similar O
to O
the O
reported O
amino O
acid O
sequence O
of O
human O
HMG I-GENE
- I-GENE
I I-GENE
, O
except O
that O
it O
lacks O
11 O
internal O
amino O
acids _RARE_
reported O
in O
the O
human O
protein O
. O

Interpersonal _RARE_
style _RARE_
differences O
among O
drug O
abusers _RARE_
were O
explored O
using O
Ryan _RARE_
' O
s O
( O
1977 _RARE_
) O
typological _RARE_
system _RARE_
of O
FIRO _RARE_
- O
B O
interpretation O
. O

Statement _RARE_
of O
the O
American O
Academy _RARE_
of O
Implant _RARE_
Dentistry _RARE_
. O

Sera _RARE_
from O
euthyroid _RARE_
post O
- O
menopausal _RARE_
or O
pregnant _RARE_
women O
yielded O
TSH _RARE_
levels O
within O
the O
normal O
range O
. O

No O
UOxase _RARE_
mRNA I-GENE
was O
detected O
in O
11 O
nonhepatic _RARE_
tissues O
of O
rat O
, O
suggesting O
tissue O
specificity _RARE_
of O
expression _RARE_
of O
this O
UOxase _RARE_
gene I-GENE
. O

The O
platelet O
adhesion O
rate O
on O
these O
layers _RARE_
were O
tested O
concerning O
the O
valuation _RARE_
of O
the O
haemocompatibility _RARE_
of O
the O
basic O
- O
polymers O
polyurethane _RARE_
( O
PUR _RARE_
), _RARE_
polyvinylchloride _RARE_
( O
PVC _RARE_
), _RARE_
and O
polystyrene _RARE_
( O
PS _RARE_
) O
in O
two O
different O
worked _RARE_
test O
chambers _RARE_
. O

Conservative _RARE_
treatment O
of O
bladder O
carcinoma O
by O
partial O
cystectomy _RARE_
and O
interstitial O
iridium _RARE_
192 _RARE_
. O

In O
a O
112 O
- O
d O
feedlot _RARE_
trial O
, O
105 _RARE_
heifers O
were O
assigned O
to O
light O
, O
medium O
and O
heavy O
weight _RARE_
blocks O
on O
five O
treatments O
: O
dietary O
MGA O
(. _RARE_
5 O
mg O
. O
hd _RARE_
- O
1 O
. O
d O
- O
1 O
), _RARE_
control O
( O
no _RARE_
MGA O
) O
or O
DEPO _RARE_
- O
MGA O
on O
d O
1 O
at _RARE_
. O
5 O
, O
1 O
. O
0 _RARE_
or O
1 O
. O
5 O
ml O
/ O
hd _RARE_
( O
30 _RARE_
, O
60 _RARE_
or O
90 _RARE_
mg O
MGA O
/ O
hd _RARE_
, O
respectively O
). O

Existence _RARE_
and O
uniqueness _RARE_
of O
solutions O
of O
the O
appropriate O
boundary O
value O
problems O
are O
established O
, O
in O
the O
case O
of O
small O
permeability _RARE_
coefficients O
and O
transport _RARE_
rates O
, O
or O
large O
diffusion O
coefficients O
and O
small O
resistance O
to O
flow O
constants O
. O

There O
were O
gene O
clusters O
encoding O
photosynthesis _RARE_
components _RARE_
such O
as _RARE_
the O
psbB _RARE_
- O
psbH _RARE_
- O
petB _RARE_
- O
petD _RARE_
and O
the O
psbE _RARE_
- O
psbF _RARE_
clusters O
. O

The O
results O
presented O
suggest O
that O
TIQ _RARE_
reduces O
the O
turnover O
rate O
of O
the O
nigrostriatal _RARE_
dopamine O
neurons O
after O
repeated _RARE_
administration O
for _RARE_
a O
long O
period O
in O
mice O
. O

The O
partial O
sequence O
of O
the O
62 _RARE_
- I-GENE
kDa I-GENE
nuclear I-GENE
pore _RARE_
glycoprotein I-GENE
shows O
little O
similarity _RARE_
to O
other O
characterized O
proteins O
and O
elucidates _RARE_
structural O
features O
of O
a O
member _RARE_
of O
the O
family O
of O
nuclear I-GENE
pore _RARE_
glycoproteins _RARE_
. O

Seventy O
- O
two O
hours O
after O
administration O
of O
vitamin O
K1 _RARE_
, O
plasma O
concentrations O
of O
the O
vitamin O
were O
not O
different O
from O
normal O
. O

The O
glomerular O
filtration O
rate O
did O
not O
change O
but O
lithium O
clearance O
fell O
by O
30 _RARE_
%. O

During O
a O
28 _RARE_
- O
week O
promotion _RARE_
bioassay _RARE_
, O
groups O
of O
30 _RARE_
male O
CD O
- O
1 O
mice O
were O
treated O
once O
with O
50 O
microliter _RARE_
of O
either O
DMBA _RARE_
( O
1 O
. O
0 _RARE_
mg O
/ O
ml O
) O
or O
acetone _RARE_
, O
rested _RARE_
for _RARE_
2 O
weeks O
, O
and O
then O
treated O
twice O
per O
week O
with O
test O
material O
for _RARE_
the O
remaining O
25 _RARE_
weeks O
. O

The O
pathogenesis O
of O
Dupuytren _RARE_
' O
s O
contracture _RARE_

An O
ELISA O
procedure O
was O
developed O
for _RARE_
monitoring O
the O
specific O
IgE I-GENE
response O
in O
dogs O
to O
Dirofilaria _RARE_
immitis _RARE_
infection O
. O

Fifty O
min O
after O
release O
from O
stress O
, O
increases O
in O
plasma O
corticosterone O
levels O
induced _RARE_
by O
stress O
recovered O
in O
the O
biting _RARE_
group O
but O
remained O
high O
in O
the O
non O
- O
biting _RARE_
group O
. O

The O
only O
isolate O
of O
Aeromonas _RARE_
hydrophila _RARE_
produced O
cytotoxic O
enterotoxin _RARE_
and O
was O
invasive O
. O

An O
11 O
- O
month O
- O
old O
girl _RARE_
suffering O
from O
Dandy _RARE_
- O
Walker _RARE_
malformation _RARE_
( O
DWM _RARE_
) O
associated O
with O
tetralogy _RARE_
of O
Fallot _RARE_
( O
TOF O
) O
is O
presented O
. O

The O
incidence O
of O
early O
neonatal O
convulsions _RARE_
for _RARE_
inborn _RARE_
babies O
was O
3 O
. O
0 _RARE_
/ O
1000 O
live O
births O
. O

The O
median O
survival O
is O
not O
reached O
with O
a O
median O
follow O
- O
up _RARE_
time O
of O
9 O
. O
6 O
years O
. O

Critical _RARE_
evaluation O
of O
various O
methods O
of O
determining _RARE_
markers O
of O
fetal _RARE_
maturity _RARE_
in O
amniotic _RARE_
fluid _RARE_

Of O
the O
43 _RARE_
infants O
with O
a O
( O
probable O
) O
loss _RARE_
18 O
were O
examined O
again O
at _RARE_
3 O
months O
corrected O
age O
. O

Variety _RARE_
of O
cows O
and O
sires _RARE_
according O
to O
types _RARE_
of O
dermatoglyphics _RARE_
( O
patterns O
) O
of O
the O
nose _RARE_
- O
labial _RARE_
mirror _RARE_
of O
cattle O

Although O
not O
consistently O
identified O
in O
all O
samples O
, O
secondary O
Academic O
, O
Personal _RARE_
Responsibility _RARE_
, O
and O
Community _RARE_
/ O
Vocational _RARE_
dimensions O
were O
also O
identified O
. O

Recovery _RARE_
was O
characterized O
by O
rapid O
improvement O
such O
that O
all O
measured O
parameters O
normalized O
by O
1 O
week O
, O
except O
for _RARE_
cross O
- O
sectional O
cardiac O
area O
which O
remained O
dilated _RARE_
up _RARE_
to O
4 O
weeks O
( O
14 O
+/- O
3 O
cm2 O
, O
p O
less O
than O
0 _RARE_
. O
05 O
versus O
control O
).( _RARE_
ABSTRACT O
TRUNCATED O
AT O
250 _RARE_
WORDS O
) O

Not _RARE_
even O
extensive O
pancreatic O
resection O
could O
prevent O
pancreatic O
remnant _RARE_
infection O
. O

It O
has O
been O
calculated O
that O
600 O
, O
000 _RARE_
new O
cases O
of O
lung _RARE_
cancer _RARE_
occur O
worldwide _RARE_
every O
year O
, O
most O
of O
them O
due O
to O
smoking O
. O

Neuromyelitis _RARE_
optica _RARE_
( O
Devic _RARE_
' O
s O
syndrome _RARE_
): O
not O
always O
multiple O
sclerosis O
. O

Effect O
of O
the O
methods O
of O
cutaneous O
administration O
of O
methyl _RARE_
isobutyl _RARE_
ketone _RARE_
on O
its O
toxicity O

Incorporation _RARE_
of O
0 _RARE_
. O
1 O
or O
0 _RARE_
. O
2 O
M O
sodium _RARE_
dihydrogen _RARE_
phosphate O
in O
the O
sugar _RARE_
solutions O
resulted O
in O
a O
decrease O
in O
the O
shelf _RARE_
- O
life O
of O
diltiazem O
. O

None O
had O
a O
past O
history O
of O
opportunistic _RARE_
infections O
; O
neither O
did O
any O
have O
lymphopenia _RARE_
. O

Increasing O
the O
phosphorus O
content O
of O
the O
diet O
improved O
the O
reabsorption _RARE_
of O
calcium _RARE_
and O
magnesium O
. O

Post O
- O
transcriptional O
regulation _RARE_
of O
ribosomal I-GENE
protein I-GENE
gene I-GENE
expression _RARE_
during _RARE_
development O
in O
Dictyostelium O
discoideum _RARE_
. O

The O
temporal O
and O
static _RARE_
plasma O
concentration O
- O
effect O
relationships O
were O
evaluated O
by O
pharmacodynamic _RARE_
modeling _RARE_
and O
linear _RARE_
regression O
. O

The O
increase O
in O
amplitudes O
of O
the O
b O
- O
wave O
during _RARE_
the O
adaptation O
period O
was O
more O
prominent O
in O
lead O
- O
exposed O
subjects O
than O
in O
controls O
. O

Possible _RARE_
factors O
for _RARE_
the O
development O
of O
psychotic _RARE_
symptomatology _RARE_
during _RARE_
group O
activities O
and O
the O
role O
of O
group O
dynamics O
acting O
as _RARE_
stress O
factors O
precipitating O
functional _RARE_
psychoses _RARE_
, O
especially O
bipolar O
manifestations O
, O
are O
discussed O
. O

Baseline _RARE_
measurements O
of O
forced _RARE_
expiratory O
volume O
in O
1 O
s O
( O
FEV1 O
), _RARE_
specific O
airway O
conductance _RARE_
( O
SGaw _RARE_
) O
and O
the O
provocative _RARE_
dose O
of O
carbachol O
causing O
a O
35 _RARE_
% O
reduction O
in O
SGaw _RARE_
( O
PD35 _RARE_
), _RARE_
and O
a O
20 O
% O
reduction O
in O
FEV1 O
( O
PD20 _RARE_
) O
were O
established O
on O
entry O
while O
each O
subject O
was O
still O
smoking O
. O

Many O
children O
with O
BGC _RARE_
are O
delayed O
in O
their O
development O
, O
but O
calcifications _RARE_
are O
not O
directly O
related O
to O
specific O
forms O
of O
neurologic O
dysfunction O
. O

R O
- O
wave O
voltage O
in O
the O
right O
precordial _RARE_
leads O
in O
anthracycline _RARE_
cardiomyopathy O
: O
a O
clinical O
study O
. O

The O
results O
indicate O
that O
the O
pooling _RARE_
requirements O
are O
task O
dependent O
. O

These O
results O
indicate O
that O
CSFHU _RARE_
can O
increase O
neutrophil _RARE_
counts O
by O
increasing O
the O
number O
and O
maturity _RARE_
of O
the O
marrow O
neutrophil _RARE_
precursors _RARE_
in O
some O
types _RARE_
of O
childhood O
chronic O
neutropenia O
. O

The O
purposes _RARE_
of O
this O
study O
were O
1 O
) O
to O
examine O
the O
effect O
of O
high O
intensity O
, O
low O
frequency O
transcutaneous _RARE_
electrical O
nerve O
stimulation _RARE_
at _RARE_
auricular _RARE_
acupuncture _RARE_
points O
on O
experimental O
pain O
threshold O
measured O
at _RARE_
the O
wrist O
and O
2 O
) O
to O
determine O
the O
changes O
in O
effect O
over O
time O
. O

In O
the O
infected _RARE_
neonates O
serum O
alpha I-GENE
- I-GENE
amylase I-GENE
value O
, O
as _RARE_
determined O
by O
the O
blue O
starch _RARE_
method O
, O
was O
only O
40 O
% O
that O
of O
healthy O
controls O
; O
the O
mean O
value O
of O
175 O
. O
1 O
+/- O
64 _RARE_
. O
9 O
IU O
/ O
l _RARE_
for _RARE_
healthy O
neonates O
was O
significantly O
higher _RARE_
( O
p O
less O
than O
0 _RARE_
. O
0010 _RARE_
) O
than O
the O
value O
of O
82 O
. O
8 O
+/- O
44 _RARE_
. O
4 O
IU O
/ O
l _RARE_
for _RARE_
the O
infected _RARE_
neonates O
. O

Records _RARE_
of O
31 _RARE_
children O
with O
AIDS O
or O
AIDS O
- O
related O
complex O
admitted _RARE_
to O
the O
pediatric O
intensive O
care O
unit O
for _RARE_
acute O
respiratory O
failure O
throughout O
a O
46 _RARE_
- O
month O
period O
were O
reviewed O
. O

Fourteen _RARE_
patients O
were O
in O
the O
multifocal _RARE_
disease _RARE_
group O
; O
13 _RARE_
were O
detected O
by O
SPECT O
and O
10 O
by O
TCT _RARE_
. O

SPECT O
is O
an O
important O
aid O
in O
the O
diagnosis O
of O
AIDS O
dementia O
complex O
and O
contributes O
to O
the O
understanding O
of O
the O
pathophysiological _RARE_
mechanisms O
of O
this O
disorder O
. O

We O
were O
interested _RARE_
in O
studying O
the O
relationship O
between O
the O
circadian O
rhythm O
in O
body O
temperature _RARE_
and O
24 _RARE_
- O
h O
variations O
in O
plasma O
concentrations O
of O
iron O
, O
zinc O
, O
circulating O
leukocyte _RARE_
counts O
, O
and O
plasma O
interleukin I-GENE
1 I-GENE
( O
IL _RARE_
- I-GENE
1 I-GENE
) O
activity O
. O

The O
murine I-GENE
MHC I-GENE
class I-GENE
I I-GENE
genes I-GENE
, O
H I-GENE
- I-GENE
2Dq _RARE_
and O
H I-GENE
- I-GENE
2Lq _RARE_
, O
are O
strikingly O
homologous O
to O
each O
other O
, O
H I-GENE
- I-GENE
2Ld _RARE_
, O
and O
two O
genes O
reported O
to O
encode O
tumor O
- O
specific O
antigens O
. O

The O
active _RARE_
derivatives _RARE_
of O
the O
present O
series O
were O
also O
tested O
for _RARE_
their O
analgesic O
activity O
against O
aconitine _RARE_
- O
induced _RARE_
writhing _RARE_
in O
albino _RARE_
mice O
and O
ulcerogenic _RARE_
activity O
in O
albino _RARE_
rats O
. O

In O
untreated O
mice O
, O
bactericidal O
activity O
of O
peritoneal O
macrophages O
decreased O
from O
one O
day O
to O
3 O
days O
after O
ip _RARE_
injection O
of O
killed O
L O
. O
monocytogenes O
. O

Among O
a O
population O
of O
18 O
, O
175 O
children O
below O
7 O
years O
of O
age O
in O
medium O
sized O
towns _RARE_
and O
rural _RARE_
areas O
in O
south _RARE_
- O
western _RARE_
Germany _RARE_
552 _RARE_
( O
3 O
. O
03 O
%) O
cases O
of O
croup _RARE_
were O
registered _RARE_
during _RARE_
a O
12 O
months O
period O
in O
1984 _RARE_
- O
85 _RARE_
by O
their O
physicians O
. O

We O
concluded O
that O
Ga O
- O
fbg _RARE_
scintigraphy O
is O
a O
very O
simple O
method O
and O
sufficiently _RARE_
useful O
for _RARE_
detecting O
active _RARE_
left _RARE_
ventricular O
thrombi _RARE_
and O
for _RARE_
monitoring O
the O
effect O
of O
anticoagulant _RARE_
therapy O
. O

In O
vitro O
assessment O
of O
the O
biocompatibility _RARE_
of O
dental O
materials O
-- _RARE_
the O
millipore _RARE_
filter O
method O
. O

Hypomagnesemia _RARE_
was O
due O
to O
magnesium O
wasting _RARE_
by O
the O
kidney _RARE_
. O

Dentalplaque _RARE_
was O
controlled _RARE_
by O
the O
oral O
higienic _RARE_
index O
of O
the O
whole O
dentition _RARE_
daily O
, O
after O
staining O
with O
1 O
per O
cent O
alkaline _RARE_
fuxin _RARE_
. O

GRFI _RARE_
bound _RARE_
to O
sequences O
at _RARE_
the O
negative O
regulatory O
elements O
( O
silencers _RARE_
) O
of O
the O
silent _RARE_
mating _RARE_
type I-GENE
loci I-GENE
HML _RARE_
E I-GENE
and O
HMR I-GENE
E I-GENE
and O
to O
the O
upstream O
activating O
sequence O
( O
UAS O
) O
required O
for _RARE_
transcription O
of O
the O
MAT _RARE_
alpha I-GENE
genes I-GENE
. O

The O
effects O
of O
these O
mutations O
on O
RNA I-GENE
polymerase I-GENE
II I-GENE
activity O
were O
assayed O
by O
measuring O
the O
ability O
of O
mutant O
genes O
to O
confer O
alpha I-GENE
- I-GENE
amanitin _RARE_
resistance O
after O
transfection O
of O
susceptible O
rodent O
cells O
. O

We O
report O
the O
use O
of O
a O
new O
technetium O
- O
99m O
- O
albumin I-GENE
colloid O
white _RARE_
blood _RARE_
cell O
( O
TAC _RARE_
- O
WBC O
) O
scan O
in O
the O
evaluation O
of O
appendicitis _RARE_
. O

In O
one O
of O
these O
tumors O
the O
observed O
rearrangement O
was O
not O
due O
to O
the O
insertion _RARE_
of O
an O
intact _RARE_
MoMuLV _RARE_
provirus O
. O

The O
indications _RARE_
for _RARE_
its O
use O
include O
every O
primary _RARE_
and O
secondary O
rhinoplasty _RARE_
candidate O
unless O
tip _RARE_
grafts O
are O
going _RARE_
to O
be O
under O
tension O
or O
if O
the O
deformity _RARE_
is O
minor O
. O

The O
SSB I-GENE
- O
poly _RARE_
( O
dT O
) O
affinity O
is O
too _RARE_
high O
to O
measure O
in O
buffers _RARE_
containing O
even O
5 O
M O
NaCl O
; O
however O
, O
in O
1 O
. O
8 O
- O
2 O
. O
5 O
M O
NaBr _RARE_
, O
we O
measure O
alpha O
log O
Kobsd _RARE_
/ O
alpha O
log O
[ _RARE_
NaBr _RARE_
] O
= O
- O
5 O
. O
7 O
+/- O
0 _RARE_
. O
7 O
, O
with O
a O
lower O
value O
of O
omega _RARE_
T O
/ O
O O
= O
130 _RARE_
+/- O
70 O
. O

Mutations O
at _RARE_
the O
suf12 _RARE_
locus I-GENE
were O
isolated O
in O
Saccharomyces O
cerevisiae O
as _RARE_
extragenic _RARE_
suppressors O
of O
+ O
1 O
frameshift O
mutations O
in O
glycine O
( O
GGX _RARE_
) O
and O
proline O
( O
CCX _RARE_
) O
codons O
, O
as _RARE_
well _RARE_
as _RARE_
UGA O
and O
UAG _RARE_
nonsense O
mutations O
. O

The O
behavior O
of O
suf12 _RARE_
- I-GENE
null _RARE_
/ I-GENE
SUF12 _RARE_
+ I-GENE
heterozygotes _RARE_
indicates O
that O
suf12 _RARE_
is O
co _RARE_
- O
dominantly _RARE_
expressed _RARE_
and O
suggests O
that O
suf12 _RARE_
allele O
- O
specific O
suppression O
may O
result O
from O
functionally O
distinct O
mutant O
proteins O
rather O
than O
variation O
in O
residual O
wild I-GENE
- I-GENE
type I-GENE
SUF12 _RARE_
+ I-GENE
activity O
. O

Antituberculosis _RARE_
agents O
. O

The O
putative O
immunity _RARE_
protein O
was O
detected O
among O
the O
[ _RARE_
35S _RARE_
] O
methionine O
- O
labelled O
proteins O
produced O
by O
minicells _RARE_
carrying O
cni _RARE_
cloned _RARE_
under O
lac I-GENE
promoter I-GENE
control O
, O
and O
when O
the O
gene O
was O
subcloned O
into O
expression _RARE_
vectors O
under O
the O
control O
of O
a O
bacteriophage _RARE_
T7 _RARE_
promoter O
. O

Antibodies O
made O
against O
fusion O
protein O
produced O
by O
the O
DP1A _RARE_
clone O
reacted O
specifically O
with O
DP _RARE_
- I-GENE
I I-GENE
and I-GENE
- I-GENE
II I-GENE
on O
immunoblots _RARE_
. O

Finally O
, O
over O
a O
similar O
range O
of O
QO2 _RARE_
, O
oxygen O
extraction O
was O
greater O
in O
patients O
with O
ARDS O
compared O
to O
patients O
with O
non O
- O
ARDS O
respiratory O
failure O
( O
r _RARE_
= O
- O
0 _RARE_
. O
67 O
and O
slope O
= O
- O
0 _RARE_
. O
62 _RARE_
vs _RARE_
r _RARE_
= O
- O
0 _RARE_
. O
45 _RARE_
and O
slope O
= O
- O
0 _RARE_
. O
35 _RARE_
; O
p O
less O
than O
0 _RARE_
. O
05 O
). O

Stable O
patients O
have O
mucous _RARE_
hypersecretion _RARE_
and O
little O
evidence O
of O
acute O
inflammation O
. O

Hyperprolactinaemia _RARE_
, O
moderate O
hypogonadism _RARE_
, O
infraclinical _RARE_
neuropathies _RARE_
, O
arterial O
stenoses _RARE_
and O
moderate O
venous O
leakages _RARE_
seem O
to O
play O
a O
partial O
role O
of O
organic O
starter _RARE_
or O
cofactor O
, O
the O
sexual O
consequences O
of O
which O
are O
amplified O
by O
psychological O
factors O
, O
partly O
secondary O
to O
the O
initial O
sexual O
failures _RARE_
. O

Yang _RARE_
and O
H O
. O

Secretory _RARE_
function O
of O
the O
prostate _RARE_
gland _RARE_
. O

Chronic O
endotoxemia _RARE_
appears O
to O
be O
associated O
with O
an O
elevated O
pulmonary O
microvascular O
permeability _RARE_
and O
a O
tendency O
toward O
a O
hyperdynamic _RARE_
circulation O
but O
with O
an O
appreciable _RARE_
degree O
of O
refractoriness _RARE_
associated O
with O
regional O
hemodynamics O
and O
eicosanoid _RARE_
biosynthesis O
. O

In O
contrast O
, O
we O
observed O
high O
concentrations O
in O
29 O
of O
75 _RARE_
patients O
with O
tumors O
of O
the O
central O
nervous O
system _RARE_
, O
especially O
in O
meningioma _RARE_
( O
6 O
/ O
9 O
), _RARE_
glioblastoma _RARE_
( O
9 O
/ O
23 _RARE_
), _RARE_
and O
neurinoma _RARE_
( O
5 O
/ O
5 O
). O

Diet _RARE_
and O
atopic O
eczema _RARE_
. O

Time _RARE_
delay O
effects O
on O
the O
tensile _RARE_
bond O
strength O
developed O
by O
the O
Silicoater _RARE_
. O

The O
future O
of O
research O
with O
interferon _RARE_
may O
be O
divided O
into O
three O
areas O
: O
Efforts _RARE_
must O
be O
made O
to O
determine O
how O
best O
to O
translate _RARE_
the O
in O
vitro O
synergy _RARE_
into O
clinically O
meaningful _RARE_
terms O
; O
in O
order O
to O
exploit _RARE_
the O
fullest _RARE_
potential _RARE_
of O
IFN I-GENE
, O
research O
is O
moving _RARE_
toward O
using O
this O
agent O
earlier O
in O
disease _RARE_
either O
as _RARE_
an O
adjuvant O
after O
tumor O
debulking _RARE_
or O
after O
initial O
diagnosis O
; O
the O
medical O
community O
must O
rethink _RARE_
the O
natural _RARE_
history O
of O
some O
diseases O
, O
because O
the O
fullest _RARE_
potential _RARE_
of O
the O
biologic _RARE_
agents O
will O
most O
likely O
manifest O
itself O
when O
these O
agents O
are O
used O
together O
. O

Minor _RARE_
differences O
were O
noted O
with O
latamoxef _RARE_
producing O
mild O
persistant _RARE_
elevation O
of O
prothrombin I-GENE
time O
( O
0 _RARE_
. O
7 O
second O
) O
associated O
with O
depression O
of O
factor I-GENE
II I-GENE
and O
factor I-GENE
VII I-GENE
. O

Six O
healthy O
male O
subjects O
received O
single O
oral O
doses O
of O
regular O
release O
( O
RR O
) O
quinidine _RARE_
sulfate _RARE_
, O
sustained O
release O
( O
SR O
) O
quinidine _RARE_
bisulfate _RARE_
and O
the O
same O
dose O
of O
the O
SR O
product O
with O
food O
( O
SR O
- O
F O
). O

This O
report O
expands _RARE_
on O
previous O
work O
with O
interferon _RARE_
alfa _RARE_
- I-GENE
2b _RARE_
( I-GENE
Intron _RARE_
A I-GENE
; I-GENE
Schering _RARE_
- I-GENE
Plough _RARE_
) I-GENE
in O
the O
treatment O
of O
hairy _RARE_
cell O
leukemia O
( O
HCL _RARE_
). O

Oxygen _RARE_
delivery O
and O
base _RARE_
excess O
decreased O
significantly O
and O
four O
pigs O
died O
. O

Clinical O
chemistry O
. O

Revascularization _RARE_
after O
anterior O
maxillary _RARE_
and O
mandibular O
osteotomy _RARE_

Static _RARE_
orthoses _RARE_
for _RARE_
the O
management O
of O
microstomia _RARE_
. O

The O
intrapancreatic _RARE_
spread O
of O
the O
carcinoma O
correlated O
with O
portal _RARE_
invasion O
of O
carcinoma O
, O
hardness _RARE_
of O
the O
body O
and O
tail _RARE_
, O
obstruction O
of O
main O
pancreatic O
duct O
and O
irregular _RARE_
pancreaticogram _RARE_
. O

Lysosomal _RARE_
enzymes _RARE_
that O
degrade _RARE_
cartilage O
are O
released O
. O

Contrary _RARE_
to O
the O
observation O
made O
with O
other O
S O
. O
pombe O
genes O
transcribed _RARE_
in O
the O
budding _RARE_
yeast O
, O
the O
heterologous O
actin I-GENE
gene I-GENE
transcript I-GENE
is O
initiated _RARE_
39 _RARE_
nucleotides O
upstream O
of O
the O
initiation O
start _RARE_
site O
used O
in O
the O
homologous O
yeast O
. O

A O
multicentre _RARE_
study O
involving O
9 O
Italian O
institutions _RARE_
was O
carried O
out O
to O
compare O
the O
efficacy O
and O
safety O
of O
ranitidine O
150 _RARE_
mg O
b O
. O
i O
. O
d O
. O
and O
ranitidine O
300 _RARE_
mg O
nocte _RARE_
in O
the O
treatment O
of O
reflux O
oesophagitis _RARE_
. O

Monotherapy _RARE_
with O
ceftazidime _RARE_
was O
clinically O
and O
bacteriologically _RARE_
as _RARE_
effective O
as _RARE_
a O
combination O
therapy O
with O
cefazolin _RARE_
and O
tobramycin _RARE_
. O

The O
N3 _RARE_
wave O
of O
the O
SSEP _RARE_
' O
s O
, O
which O
has O
been O
found O
to O
correlate O
best O
with O
neurological O
recovery O
, O
returned O
to O
65 O
% O
+/- O
48 _RARE_
% O
of O
the O
preischemia _RARE_
amplitude O
in O
the O
insulin I-GENE
- O
treated O
animals O
, O
compared O
to O
40 O
% O
+/- O
34 _RARE_
% O
in O
the O
fasted O
group O
and O
26 _RARE_
% O
+/- O
24 _RARE_
% O
in O
the O
control O
animals O
. O

Proctoscopy _RARE_
and O
roentgenographic _RARE_
studies O
may O
be O
an O
important O
part O
of O
evaluation O
, O
especially O
in O
patients O
who O
present O
with O
perianal _RARE_
suppuration _RARE_
, O
masses O
, O
or O
anal _RARE_
fissures _RARE_
. O

In O
the O
control O
group O
the O
histological O
picture O
resembled _RARE_
osteoarthritis _RARE_
. O

In O
contrast O
to O
this O
mRNA O
, O
90 _RARE_
% O
of O
alpha I-GENE
and I-GENE
beta I-GENE
actin I-GENE
mRNAs I-GENE
were O
translated O
in O
both O
myoblasts O
and O
myotubes O
. O

Plasma I-GENE
renin I-GENE
activity O
does O
not O
predict O
the O
antihypertensive O
efficacy O
of O
chlorthalidone _RARE_
. O

Cephradine _RARE_
250 _RARE_
mg O
at _RARE_
night O
for _RARE_
12 O
months O
was O
given O
as _RARE_
a O
prophylactic O
measure O
to O
33 _RARE_
female O
patients O
of O
mean O
age O
41 _RARE_
. O
6 O
years O
, O
who O
had O
a O
history O
in O
the O
preceding O
12 O
months O
of O
between O
three O
and O
24 _RARE_
( O
median O
= O
7 O
) O
episodes O
of O
frequency O
and O
/ O
or O
dysuria _RARE_
. O

If O
this O
is O
unavailable _RARE_
, O
then O
Supramid _RARE_
has O
a O
proven O
record O
for _RARE_
good O
tissue O
compatibility O
and O
resistance O
to O
infection O
. O

The O
size O
of O
the O
group O
allocated O
to O
the O
good O
compliance O
category O
by O
the O
use O
of O
the O
digoxin _RARE_
marker O
was O
equivalent O
in O
size O
to O
a O
group O
of O
patients O
who O
had O
returned O
less O
than O
15 _RARE_
% O
of O
their O
prescribed _RARE_
dose O
or O
reported O
a O
deviation O
of O
less O
than O
6 O
% O
from O
their O
prescription _RARE_
. O

Bullous _RARE_
keratopathy _RARE_
was O
usually O
aphakic _RARE_
in O
origin O
in O
1982 O
, O
but O
after O
1983 O
pseudophakic _RARE_
bullous _RARE_
keratopathy _RARE_
( O
PBK _RARE_
) O
was O
the O
most O
common O
cause O
of O
bullous _RARE_
keratopathy _RARE_
. O

The O
ultrastructural _RARE_
findings O
, O
as _RARE_
well _RARE_
as _RARE_
the O
urinary _RARE_
C I-GENE
- I-GENE
peptide I-GENE
excretion O
, O
confirmed O
that O
the O
glycemic _RARE_
effects O
should O
not O
be O
thought O
to O
be O
due O
to O
a O
direct O
action O
of O
the O
drugs O
used O
on O
the O
endocrine O
pancreas O
. O

The O
activity O
of O
the O
EGF _RARE_
receptor I-GENE
promoter I-GENE
can O
be O
modulated O
by O
E1A I-GENE
protein I-GENE
and O
receptor O
RNA O
levels O
increased O
by O
stimulation _RARE_
with O
phorbol O
ester O
or O
fetal _RARE_
calf _RARE_
serum O
. O

In O
vitro O
antimalarial _RARE_
activity O
of O
neem _RARE_
( O
Azadirachta _RARE_
indica _RARE_
A O
. O

" O
In O
vitro O
" O
study O
of O
dentin O
adhesion O
to O
adhesives _RARE_
made O
from O
urethane _RARE_
molecules O
with O
free O
groups O
of O
isocyanate _RARE_

By O
Felix _RARE_
Lagrange _RARE_
, O
1918 _RARE_
. O

There O
is O
a O
cysteine O
clustering _RARE_
region O
in O
an O
N O
- O
terminal O
region O
of O
the O
c I-GENE
- I-GENE
raf _RARE_
(- _RARE_
1 I-GENE
) I-GENE
product I-GENE
deduced O
from O
the O
nucleotide O
sequence O
, O
and O
this O
cysteine O
clustering _RARE_
region O
was O
found O
to O
be O
highly O
homologous O
to O
that O
present O
in O
an O
N O
- O
terminal O
region O
of O
protein I-GENE
kinase I-GENE
C I-GENE
, O
although O
, O
in O
the O
latter O
cysteine O
clusters O
are O
present O
in O
duplicate _RARE_
. O

Hand _RARE_
- O
held O
, O
continuous O
- O
wave O
Doppler O
probes _RARE_
, O
coupled O
with O
sound O
spectral O
analysis O
, O
can O
successfully O
predict O
carotid O
artery O
stenosis O
. O

The O
German _RARE_
Society _RARE_
of O
Pediatric _RARE_
Oncology _RARE_
in O
1981 _RARE_
initiated _RARE_
the O
Cooperative _RARE_
Ewing _RARE_
' O
s O
Sarcoma _RARE_
Study O
( O
CESS _RARE_
81 _RARE_
) O
using O
a O
four O
- O
drug O
combination O
of O
chemotherapy O
prior O
to O
definitive O
local O
control O
with O
surgery O
and O
/ O
or O
radiation O
. O

The O
program O
has O
been O
written _RARE_
in O
a O
generic _RARE_
BASIC _RARE_
in O
order O
to O
make O
the O
procedure O
user _RARE_
- O
friendly _RARE_
. O

Since O
high O
levels O
of O
immunoglobulin I-GENE
G I-GENE
were O
demonstrated O
against O
the O
surface O
of O
the O
NVS _RARE_
after O
immunization O
, O
passive O
transfer O
experiments O
were O
initiated _RARE_
. O

A O
study O
was O
conducted O
of O
a O
human O
male O
who O
had O
inhaled O
a O
mixture O
of O
241Am _RARE_
and O
Pu _RARE_
. O

An O
analytic _RARE_
method O
for _RARE_
comparative O
parameter O
weighting _RARE_
in O
magnetic O
resonance O
( O
MR O
) O
imaging O
has O
been O
developed O
using O
the O
concept O
of O
" O
fractional O
sensitivity O
." _RARE_
This O
new O
approach O
results O
in O
easily O
calculated O
indexes _RARE_
for _RARE_
T1 _RARE_
, O
T2 _RARE_
, O
and O
hydrogen O
weighting _RARE_
. O

Fifty O
- O
four O
patients O
were O
divided O
into O
groups O
according O
to O
their O
clinical O
presentation O
; O
seven _RARE_
asymptomatic O
volunteers O
, O
20 O
patients O
with O
duodenal O
- O
gastric _RARE_
reflux O
gastropathy _RARE_
( O
DRG _RARE_
), _RARE_
16 O
patients O
with O
recurrent O
ulcers O
of O
the O
duodenal O
bulb O
( O
RUD _RARE_
), _RARE_
and O
11 O
patients O
with O
Moynihan _RARE_
' O
s O
disease _RARE_
. O

No O
previous O
studies O
have O
determined O
the O
pharmaco _RARE_
- O
dynamics O
of O
intravenous O
procainamide _RARE_
when O
administered O
in O
a O
dose O
of O
15 _RARE_
mg O
/ O
kg O
and O
at _RARE_
a O
rate O
of O
50 O
mg O
/ O
min O
, O
as _RARE_
is O
common O
practice O
during _RARE_
electropharmacologic _RARE_
testing O
. O

High _RARE_
concentrations O
of O
tumor O
- O
associated O
trypsin I-GENE
inhibitor O
in O
hemodialyzed _RARE_
patients O
. O

In O
the O
chicken O
liver O
, O
levels O
of O
chicken I-GENE
MT _RARE_
mRNA I-GENE
were O
rapidly O
induced _RARE_
by O
metals _RARE_
( O
Cd2 _RARE_
+, _RARE_
Zn2 _RARE_
+, _RARE_
Cu2 _RARE_
+), O
glucocorticoids O
and O
lipopolysaccharide O
. O

With O
histology _RARE_
and O
Evans _RARE_
blue O
injections O
, O
blood _RARE_
- O
brain O
barrier O
alterations O
were O
seen O
as _RARE_
early O
as _RARE_
4 O
days O
after O
a O
dose O
of O
50 O
Gy O
. O

Dosimetric _RARE_
estimates O
for _RARE_
these O
organs O
were O
2 O
. O
3 O
+/- O
1 O
. O
1 O
and O
2 O
. O
3 O
+/- O
1 O
. O
4 O
rad _RARE_
(. _RARE_
02 O
+/- O
. O
01 O
Gy O
), _RARE_
respectively O
, O
with O
a O
whole O
- O
body O
estimate O
of O
0 _RARE_
. O
28 _RARE_
rad _RARE_
(. _RARE_
003 _RARE_
Gy O
). O

A O
significant O
association O
between O
a O
family O
history O
and O
a O
higher _RARE_
urinary _RARE_
pH O
was O
observed O
among O
the O
female O
calcium _RARE_
stone O
patients O
. O

New O
technologies _RARE_
in O
diagnosis O
and O
classification O
of O
malignancy O
. O

Thus O
the O
present O
data O
also O
suggest O
that O
BP _RARE_
and O
HR O
measurements O
are O
influenced O
not O
only O
by O
state O
- O
dependent O
factors O
but O
also O
by O
at _RARE_
least O
three O
different O
factors O
that O
are O
each O
independent O
of O
the O
state O
: O
one O
leads O
to O
BP _RARE_
and O
HR O
values O
that O
are O
influenced O
by O
the O
cycle _RARE_
the O
animal _RARE_
is O
in O
and O
the O
other O
two O
influence O
, O
respectively O
, O
the O
ranking _RARE_
of O
the O
individual O
' O
s O
BP _RARE_
and O
HR O
levels O
within O
the O
population O
. O

The O
correlation O
between O
PaCO2 O
and O
PtcO2 _RARE_
in O
RDS _RARE_
was O
insufficient O
to O
make O
clinical O
judgement _RARE_
. O

Since O
1967 _RARE_
at _RARE_
the O
times O
of O
their O
biennial _RARE_
ABCC _RARE_
/ O
RERF _RARE_
radiological _RARE_
examinations O
, O
all O
Adult O
Health O
Study O
( O
AHS _RARE_
) O
subjects O
have O
been O
interviewed _RARE_
to O
determine O
the O
exposures O
to O
medical O
x _RARE_
- O
rays O
they O
experienced O
in O
institutions _RARE_
other O
than O
RERF _RARE_
in O
order O
to O
estimate O
the O
numbers O
of O
examinations O
and O
corresponding O
doses O
which O
they O
received O
. O

The O
epidermal _RARE_
growth I-GENE
factor I-GENE
( I-GENE
EGF _RARE_
) I-GENE
receptor I-GENE
, O
which O
exhibits O
intrinsic _RARE_
protein I-GENE
tyrosine I-GENE
kinase I-GENE
activity O
, O
undergoes O
a O
rapid O
, O
intramolecular _RARE_
self O
- O
phosphorylation _RARE_
reaction O
following O
EGF _RARE_
activation O
. O

One O
millimolar _RARE_
ouabain _RARE_
completely O
inhibited O
net _RARE_
HCO3 O
- O
secretion _RARE_
. O

There O
are O
regions O
with O
long O
runs _RARE_
of O
up _RARE_
to O
45 _RARE_
% O
C O
or O
35 _RARE_
% O
G O
residues O
. O

The O
same O
rhythmic _RARE_
structure _RARE_
enables O
a O
prediction O
to O
be O
made O
concerning O
when O
vowels _RARE_
of O
stressed O
syllables _RARE_
will O
be O
auditorily _RARE_
perceived O
. O

Vocal _RARE_
cord O
abduction _RARE_
rehabilitation _RARE_
by O
nervous O
selective O
anastomosis O
. O

UK _RARE_
' O
s O
biotechnology _RARE_
lacking _RARE_
specialists _RARE_
. O

A O
case O
of O
AIDS O
- O
related O
complex O
( O
ARC _RARE_
/ O
LAS _RARE_
) O
in O
a O
health O
worker _RARE_

Distant _RARE_
spread O
was O
found O
in O
46 _RARE_
patients O
( O
34 _RARE_
%), O
42 _RARE_
of O
whom O
had O
serum O
Tg _RARE_
greater O
than O
10 O
micrograms O
/ O
l _RARE_
. O

The O
glomerular O
filtration O
rate O
and O
effective O
renal _RARE_
plasma O
flow O
were O
determined O
by O
a O
standard O
clearance O
method O
, O
employing O
continuous O
infusion O
of O
inulin _RARE_
and O
para _RARE_
- O
aminohippuric _RARE_
acid O
. O

After O
the O
meal _RARE_
containing O
potato _RARE_
, O
plasma O
glucose O
levels O
rose O
sharply O
, O
peaked _RARE_
at _RARE_
30 _RARE_
- O
45 _RARE_
min O
and O
fell O
below O
initial O
levels O
2 O
to O
3 O
h O
later O
. O

The O
relations O
among O
various O
negative O
emotional _RARE_
and O
behavioral O
characteristics O
( O
e _RARE_
. O
g O
., O
aggression O
, O
anxiety O
, O
undercompliance _RARE_
, O
depressive _RARE_
mood _RARE_
) O
and O
adjustment O
were O
examined O
through O
use O
of O
data O
from O
the O
31 _RARE_
- O
year O
- O
old O
New O
York O
Longitudinal _RARE_
Study O
. O

To O
evaluate O
the O
effect O
of O
altitude O
on O
adolescent O
growth O
and O
development O
, O
three O
groups O
of O
healthy O
, O
well _RARE_
- O
nourished _RARE_
youth _RARE_
of O
similar O
socioeconomic _RARE_
status O
and O
ethnic _RARE_
grouping _RARE_
who O
resided _RARE_
at _RARE_
sea _RARE_
level O
( O
n _RARE_
= O
1262 _RARE_
subjects O
), _RARE_
mid O
- O
altitude O
( O
n _RARE_
= O
1743 _RARE_
subjects O
), _RARE_
and O
high O
altitude O
( O
n _RARE_
= O
1137 _RARE_
subjects O
) O
were O
studied O
. O

Because O
the O
CAP _RARE_
measures O
variables O
predictive O
of O
abusive _RARE_
behavior O
, O
a O
substantial O
relationship O
was O
expected O
between O
the O
CAP _RARE_
and O
the O
MHI _RARE_
Loss _RARE_
of O
Behavioral _RARE_
/ O
Emotional _RARE_
Control O
scale O
. O

We O
have O
improved O
our O
system _RARE_
for _RARE_
nuclear O
contour _RARE_
digitization _RARE_
and O
determined O
its O
theoretical _RARE_
limitations O
by O
digitizing _RARE_
standardized O
objects O
. O

Such O
a O
change O
may O
involve O
increased O
mammary O
utilization O
of O
pre O
- O
formed O
long O
- O
chain O
fatty O
acid O
and O
increased O
metabolism O
of O
glucose O
via O
glycolysis _RARE_
. O

The O
skin _RARE_
site O
, O
6 O
- O
cm O
- O
distal O
and O
- O
proximal O
subcutaneous O
segments _RARE_
of O
the O
catheter O
, O
exudates _RARE_
, O
and O
blood _RARE_
were O
cultured O
. O

Because O
of O
its O
great O
reliability O
, O
conventional O
arteriography _RARE_
occupies _RARE_
a O
place O
of O
choice O
among O
the O
medical O
imaging O
techniques O
. O

Rapid _RARE_
detection O
of O
radioisotopically _RARE_
contaminated O
test O
serum O
before O
radioassay _RARE_
of O
vitamin O
B12 _RARE_
. O

The O
former O
group O
did O
excrete _RARE_
less O
dry _RARE_
fecal O
material O
compared O
to O
both O
other O
groups O
. O

Electronic _RARE_
data O
processing _RARE_
( O
EDP _RARE_
) O
latex O
immunoassay O
using O
anti I-GENE
- I-GENE
human I-GENE
seminal _RARE_
acid I-GENE
phosphatase I-GENE
( O
anti I-GENE
- I-GENE
HSAP _RARE_
) O
immune O
serum O
was O
applied O
for _RARE_
the O
species O
and O
organ O
identification O
of O
human O
seminal _RARE_
stains _RARE_
. O

Vimentin _RARE_
positivity _RARE_
was O
noted O
in O
the O
undifferentiated O
and O
fibroblastic _RARE_
components _RARE_
. O

The O
maximum O
deflections _RARE_
of O
phase _RARE_
IV O
for _RARE_
Ar _RARE_
and O
N2 O
from O
extrapolated _RARE_
phase _RARE_
III O
slopes _RARE_
were O
smaller O
in O
the O
prone O
position O
, O
suggesting O
more O
uniform O
tracer O
gas O
concentrations O
across O
the O
lungs O
. O

Recent O
developments _RARE_
in O
drugs O
antagonistic O
to O
factors O
causing O
peptic _RARE_
ulcer O
-- _RARE_
clinical O
efficacy O
and O
problems O
; O
gastrin I-GENE
receptor I-GENE
blockaders _RARE_

The O
spermicide _RARE_
nonoxynol _RARE_
- O
9 O
is O
a O
member _RARE_
of O
a O
homologous O
series O
of O
alkylphenol _RARE_
- O
ethoxylates _RARE_
( O
polyethoxyethanols _RARE_
) O
of O
general _RARE_
formula O
C9H19 _RARE_
- O
C6H6 _RARE_
- O
O O
-( _RARE_
CH2CH2O _RARE_
) O
n _RARE_
- O
1 O
CH2CH2OH _RARE_
. O

Static _RARE_
magnetic O
fields O
affect O
the O
diffusion O
of O
biological O
particles _RARE_
in O
solutions O
through O
the O
Lorentz _RARE_
force O
and O
Maxwell _RARE_
stress O
. O

Psychological _RARE_
disturbance O
was O
greater O
in O
the O
high O
life O
stress O
group O
as _RARE_
indicated O
by O
significant O
elevations O
on O
the O
global O
severity O
index O
of O
the O
Symptom _RARE_
Checklist _RARE_
- O
90 _RARE_
and O
elevations O
on O
somatization _RARE_
, O
obsessive _RARE_
compulsive _RARE_
, O
interpersonal _RARE_
sensitivity O
, O
depression O
, O
anxiety O
and O
psychoticism _RARE_
subscales _RARE_
. O

Chronic O
administration O
of O
sodium _RARE_
cyanate _RARE_
decreases O
O2 _RARE_
extraction O
ratio O
in O
dogs O
. O

Nucleotide O
sequencing O
indicates O
that O
this O
E1 I-GENE
alpha I-GENE
cDNA I-GENE
clone O
is O
1821 _RARE_
base _RARE_
pairs _RARE_
( O
bp O
) O
in O
length O
with O
an O
open _RARE_
reading O
frame O
of O
1365 _RARE_
bp O
and O
a O
3 O
'- O
untranslated _RARE_
region O
of O
356 _RARE_
bp O
. O

SPA _RARE_
from O
PAG _RARE_
sites O
was O
associated O
with O
aversion _RARE_
. O

In O
contrast O
, O
the O
MAN _RARE_
showed O
a O
unimodal _RARE_
, O
skewed _RARE_
distribution O
, O
with O
a O
range O
from O
approximately _RARE_
1 O
to O
14 O
micron O
and O
a O
maximum O
at _RARE_
3 O
- O
4 O
micron O
. O

Abnormal O
technetium O
Tc O
99m O
medronate _RARE_
scans O
in O
patients O
with O
previously O
undiagnosed _RARE_
polyarthralgias _RARE_
suggested O
inflammatory O
arthropathy _RARE_
and O
influenced O
management O
decisions _RARE_
with O
favorable _RARE_
therapeutic O
outcomes O
. O

Practical _RARE_
interest O
of O
such O
studies O
is O
limited O
since O
the O
pharmacokinetic O
parameters O
are O
systematically O
evaluated O
in O
man O
during _RARE_
phase _RARE_
I O
trials O
. O

The O
artery O
cuff _RARE_
was O
slightly O
superior O
to O
the O
fat O
wrap _RARE_
, O
particularly O
in O
having O
fewer O
adhesions O
and O
a O
better O
histological O
picture O
. O

Lithium _RARE_
- O
carbonate _RARE_
action O
during _RARE_
radiation O
therapy O
has O
been O
studied O
, O
valuing _RARE_
the O
positive O
effect O
on O
leukopoiesis _RARE_
and O
the O
consequent _RARE_
better O
clinical O
conditions O
of O
the O
patients O
in O
course O
of O
treatment O
. O

Of O
the O
53 O
units _RARE_
tested O
during _RARE_
sinusoidal _RARE_
motion O
at _RARE_
0 _RARE_
. O
05 O
Hz O
( O
9 O
. O
1 O
cm O
/ O
s O
), _RARE_
1 O
( O
1 O
. O
9 O
%) O
was O
responsive O
to O
the O
otolith _RARE_
input O
only O
, O
13 _RARE_
( O
24 _RARE_
. O
5 O
%) O
were O
influenced O
by O
the O
visual O
input O
only O
and O
23 _RARE_
( O
43 _RARE_
. O
4 O
%) O
responded O
to O
both O
modalities O
. O

Depending _RARE_
on O
the O
location O
and O
size O
of O
the O
mass O
, O
a O
wide O
range O
of O
clinical O
presentations _RARE_
is O
associated O
with O
the O
lesion O
. O

The O
development O
and O
distribution O
of O
Trypanosoma O
congolense _RARE_
, O
T O
vivax _RARE_
and O
T O
brucei _RARE_
in O
the O
skin _RARE_
of O
goats O
was O
examined O
after O
the O
animals O
were O
bitten _RARE_
by O
infected _RARE_
Glossina _RARE_
morsitans _RARE_
centralis _RARE_
. O

Electroglottography _RARE_
is O
a O
useful O
, O
non O
- O
invasive O
technique O
that O
can O
assist _RARE_
in O
the O
assessment O
of O
vocal _RARE_
fold _RARE_
dysfunction O
. O

Statistical _RARE_
analysis O
of O
the O
degrees O
of O
secondary O
spinal _RARE_
cord O
compression O
was O
performed O
in O
group O
- O
1 O
dogs O
by O
measuring O
and O
comparing O
ratios O
of O
the O
vertical O
to O
the O
horizontal O
diameters O
of O
the O
transverse O
spinal _RARE_
cord O
sections O
from O
locations O
within O
( O
T12 _RARE_
to O
L1 O
) O
and O
out O
of O
( O
T11 _RARE_
, O
T11 _RARE_
- O
12 O
, O
L1 O
- O
2 O
, O
and O
L2 O
) O
the O
region O
of O
surgical O
intervention O
. O

The O
pharmacological O
effects O
of O
the O
novel O
compound O
WEB _RARE_
1881 _RARE_
FU O
( O
4 O
- O
amino O
- O
methyl _RARE_
- O
1 O
- O
benzyl _RARE_
- O
pyrrolidine _RARE_
- O
2 O
- O
one O
- O
fumarate _RARE_
) O
were O
investigated O
. O

Histopathological _RARE_
examination O
revealed O
dose O
- O
related O
proliferation _RARE_
of O
type O
II O
pneumocytes _RARE_
in O
dams _RARE_
and O
proliferation _RARE_
of O
interstitial O
cells O
and O
delayed O
septal O
/ O
capillary O
development O
in O
neonates O
.( O
ABSTRACT O
TRUNCATED O
AT O
250 _RARE_
WORDS O
) O

So _RARE_
far O
no _RARE_
problems O
with O
multiply _RARE_
resistant O
strains O
have O
developed O
. O

During O
the O
observation O
period O
of O
0 _RARE_
. O
4 O
- O
30 _RARE_
weeks O
, O
cardiac O
white _RARE_
spots O
on O
the O
right O
ventricle O
of O
BALB _RARE_
/ O
c O
mice O
were O
first _RARE_
detected O
at _RARE_
three O
weeks O
( O
6 O
of O
20 O
mice O
; O
30 _RARE_
%), O
and O
the O
maximal O
incidence O
of O
cardiac O
white _RARE_
spots O
was O
obtained O
at _RARE_
nine O
weeks O
( O
39 _RARE_
of O
44 _RARE_
mice O
; O
88 O
%). O

The O
state O
of O
the O
liver O
in O
generalized O
forms O
of O
meningococcal _RARE_
infection O

Increasing O
the O
RH _RARE_
beyond O
32 _RARE_
% O
resulted O
in O
solvation _RARE_
of O
the O
peroxy _RARE_
radical O
, O
sterically _RARE_
hindering _RARE_
the O
radical O
from O
entering _RARE_
the O
propagation _RARE_
transition O
state O
. O

The O
effects O
produced O
by O
oral O
administration O
of O
500 O
mg O
/ O
kg O
p O
- O
xylene O
or O
toluene O
lasted _RARE_
at _RARE_
least O
8 O
hr O
, O
while O
the O
effect O
of O
inhaled O
p O
- O
xylene O
dissipated _RARE_
within O
75 _RARE_
min O
of O
removal O
from O
the O
exposure O
. O

PATIENTS O
and O
METHODS O
: O
Thallium _RARE_
- O
201 _RARE_
myocardial _RARE_
scintigraphy O
was O
performed O
at _RARE_
rest O
and O
after O
0 _RARE_
. O
56 _RARE_
mg O
/ O
kg O
intravenous O
dipyridamole _RARE_
during _RARE_
four O
minutes O
in O
16 O
patients O
with O
sarcoidosis _RARE_
. O

Thin _RARE_
melanomas O
can O
metastasize _RARE_
and O
be O
lethal O
. O

The O
TA O
muscle O
was O
fatigued _RARE_
by O
four O
forms O
of O
repeated _RARE_
isometric _RARE_
contractions O
: O
( O
1 O
) O
maximal O
voluntary _RARE_
contractions O
( O
MVC _RARE_
), _RARE_
( O
2 O
) O
MVC _RARE_
with O
circulation O
occluded O
, O
( O
3 O
) O
electrically O
evoked O
contractions O
with O
20 O
Hz O
supramaximal _RARE_
voltage O
stimulation _RARE_
and O
( O
4 O
) O
electrically O
evoked O
contractions O
with O
circulation O
occluded O
. O

The O
actuarial _RARE_
local O
control O
rates O
at _RARE_
10 O
years O
for _RARE_
the O
three O
treatment O
groups O
were O
as _RARE_
follows O
: O
subtotal O
excision _RARE_
alone O
, O
18 O
%; O
subtotal O
excision _RARE_
plus _RARE_
postoperative O
radiation O
therapy O
, O
82 O
%; O
and O
total _RARE_
excision _RARE_
alone O
, O
77 O
%. O

The O
effects O
of O
anabolic _RARE_
implants O
on O
rate O
, O
composition O
and O
energetic _RARE_
efficiency O
of O
growth O
were O
determined O
in O
steers O
fed O
diets O
varying O
in O
forage _RARE_
and O
grain _RARE_
content O
. O

Prolonged _RARE_
suspension _RARE_
induced _RARE_
a O
significant O
change O
in O
the O
geometric _RARE_
configuration O
of O
the O
femur O
middiaphysis _RARE_
by O
increasing O
the O
minimum O
diameter O
( O
12 O
%) O
without O
any O
significant O
alterations O
in O
cortical O
area O
, O
density O
, O
mineral O
, O
and O
collagen _RARE_
concentrations O
. O

Which _RARE_
cineangiographically _RARE_
assessed O
anatomic O
variable _RARE_
correlates O
best O
with O
functional _RARE_
measurements O
of O
stenosis O
severity O
? O
A O
comparison O
of O
quantitative O
analysis O
of O
the O
coronary O
cineangiogram _RARE_
with O
measured O
coronary O
flow O
reserve O
and O
exercise O
/ O
redistribution _RARE_
thallium O
- O
201 _RARE_
scintigraphy O
. O

Water _RARE_
content O
and O
equilibrium O
water O
partition _RARE_
in O
immature O
cartilage O
. O

Thyroid _RARE_
function O
tests O
were O
performed O
on O
300 _RARE_
admissions _RARE_
, O
leaving _RARE_
707 _RARE_
untested _RARE_
. O

Data O
on O
the O
line O
spread O
function O
( O
LSF _RARE_
) O
were O
obtained O
from O
the O
image O
of O
a O
0 _RARE_
. O
2 O
mm O
wide O
slit _RARE_
between O
tungsten _RARE_
blocks O
that O
were O
positioned O
at _RARE_
the O
isocentre _RARE_
in O
front O
of O
a O
polystyrene _RARE_
phantom _RARE_
. O

Primary O
infection O
is O
usually O
managed _RARE_
conservatively _RARE_
. O

Papers _RARE_
of O
the O
Society _RARE_
for _RARE_
Clinical O
Vascular _RARE_
Surgery _RARE_
. O

Ischemic O
heart _RARE_
disease _RARE_
, O
age O
of O
more O
than O
75 _RARE_
years O
, O
and O
the O
fact O
that O
the O
patient O
was O
a O
woman O
were O
independent O
predictors O
of O
poor O
cardiac O
function O
. O

Prognosis _RARE_
in O
Bowen _RARE_
' O
s O
disease _RARE_
localized O
to O
the O
ano _RARE_
- O
genital _RARE_
region O
. O

Taken O
together O
, O
the O
results O
suggest O
that O
chlorphentermine _RARE_
may O
be O
capable O
of O
producing O
dual O
stimulus O
effects O
in O
animals O
. O

Liquid _RARE_
chromatographic O
method O
for _RARE_
determination O
of O
citreoviridin _RARE_
in O
corn _RARE_
and O
rice _RARE_
. O

These O
findings O
indicate O
that O
autophosphorylation O
of O
Thr286 _RARE_
( O
alpha O
subunit O
) O
and O
Thr287 _RARE_
( O
beta O
subunit O
) O
is O
responsible O
for _RARE_
transition O
of O
CaM I-GENE
- I-GENE
kinase I-GENE
II I-GENE
to O
the O
Ca2 _RARE_
+- _RARE_
independent O
form O
. O

This O
rapid O
and O
extensive O
penetration O
of O
intrathecally _RARE_
administered O
chemotherapy O
may O
offer O
insight O
into O
the O
myelopathy _RARE_
observed O
with O
these O
treatments O
. O

The O
interaction O
of O
radiation O
and O
hyperthermia _RARE_
was O
systematically O
studied O
in O
the O
Dunning _RARE_
R3327G _RARE_
prostatic _RARE_
adenocarcinoma O
, O
the O
preeminent _RARE_
animal _RARE_
model O
for _RARE_
human O
prostatic _RARE_
cancer _RARE_
. O

Pregnant _RARE_
rats O
were O
exposed O
to O
one O
of O
the O
following O
: O
( O
1 O
) O
10 O
% O
O2 _RARE_
in O
N2 O
or O
100 _RARE_
% O
O2 _RARE_
for _RARE_
2 O
days O
beginning O
at _RARE_
day O
7 O
, O
11 O
, O
14 O
, O
or O
18 O
of O
pregnancy _RARE_
; O
( O
2 O
) O
10 O
% O
O2 _RARE_
in O
N2 O
or O
100 _RARE_
% O
O2 _RARE_
for _RARE_
10 O
h O
/ O
day O
beginning O
at _RARE_
day O
7 O
; O
or O
( O
3 O
) O
14 O
- O
11 O
% O
O2 _RARE_
in O
N2 O
continuously O
beginning O
at _RARE_
day O
14 O
till _RARE_
day O
21 O
when O
they O
were O
sacrificed _RARE_
. O

The O
incidence O
of O
cryptosporidiosis _RARE_
in O
young O
children O
was O
determined O
by O
staining O
of O
faecal _RARE_
specimens O
with O
a O
modified O
Kinyoun _RARE_
stain O
. O

Seven _RARE_
patients O
( O
8 O
. O
3 O
percent O
) O
had O
latent O
hypothyroidism O
only O
discovered O
by O
hormonal O
determinations O
. O

Addition O
of O
sucralfate _RARE_
or O
De _RARE_
- O
Nol _RARE_
resulted O
in O
increments _RARE_
of O
gastric _RARE_
HCO3 O
secretion _RARE_
, O
reaching _RARE_
about O
45 _RARE_
% O
and O
59 _RARE_
%, O
respectively O
, O
of O
the O
maximal O
HCO3 O
response O
to O
16 O
, O
16 O
- O
dimethyl O
PGE2 O
( O
dmPGE2 _RARE_
). O

Moreover O
, O
unlike O
control O
rats O
operated O
animals O
did O
not O
show O
aversion _RARE_
to O
the O
highest O
concentrations O
of O
saccharin O
solutions O
. O

In O
Salmo _RARE_
gairdneri _RARE_
, O
no _RARE_
specialized O
system _RARE_
of O
portal _RARE_
vessels O
appears O
to O
exist O
between O
the O
pineal O
organ O
and O
other O
portions O
of O
the O
brain O
. O

The O
4 O
degrees O
stimuli O
were O
found O
to O
elicit O
scalp _RARE_
distributions _RARE_
for _RARE_
the O
pattern O
reversal O
P100 _RARE_
and O
the O
pattern O
onset O
C1 O
consistent O
with O
striate _RARE_
and O
extrastriate _RARE_
visual O
cortical O
origins O
respectively O
. O

Nuclear I-GENE
factor I-GENE
III I-GENE
( O
NFIII _RARE_
) O
is O
a O
protein O
from O
HeLa O
cells O
that O
stimulates O
the O
initiation O
of O
adenovirus O
type O
2 O
( O
Ad2 _RARE_
) O
DNA O
replication O
by O
binding O
to O
a O
specific O
nucleotide O
sequence O
in O
the O
origin O
, O
adjacent O
to O
the O
nuclear I-GENE
factor I-GENE
I I-GENE
recognition I-GENE
site I-GENE
. O

A O
Golgi _RARE_
study O
of O
the O
sixth _RARE_
layer O
of O
the O
cerebral O
cortex O
. O

We O
conclude O
that O
cephalothin _RARE_
clearance O
of O
S O
. O
aureus _RARE_
from O
a O
site O
accessible _RARE_
to O
phagocytes _RARE_
was O
delayed O
when O
compared O
to O
a O
phagocyte _RARE_
- O
inaccessible _RARE_
site O
. O

The O
findings O
are O
discussed O
in O
the O
context O
of O
known O
properties O
of O
cortical O
- O
bar _RARE_
detectors _RARE_
. O

Mean O
rCBF O
increased O
in O
some O
patients O
4 O
- O
8 O
weeks O
after O
surgery O
on O
the O
ipsilateral O
side _RARE_
. O

Quantitative O
computed O
tomography O
for _RARE_
measuring O
vertebral O
bone O
mineral O
content O
offers O
high O
sensitivity O
and O
reproducibility O
. O

The O
structure _RARE_
of O
the O
enhancer O
was O
also O
probed _RARE_
by O
inserting O
a O
pair _RARE_
of O
complementary _RARE_
synthetic _RARE_
oligodeoxynucleotides _RARE_
which O
represented O
the O
region O
between O
nt O
positions O
- O
235 _RARE_
and O
- O
215 O
into O
a O
truncated O
template O
which O
lacked O
the O
enhancer O
. O

Kf _RARE_
, O
c O
and O
CT _RARE_
( O
referenced _RARE_
to O
the O
initial O
lung _RARE_
mass O
) O
decreased O
linearly _RARE_
with O
reductions O
in O
lung _RARE_
mass O
% O
delta O
Kf _RARE_
, O
c O
= O
1 O
. O
26 _RARE_
- O
0 _RARE_
. O
98 O
% O
mass O
removed O
( O
r _RARE_
= O
0 _RARE_
. O
90 _RARE_
, O
P O
less O
than O
0 _RARE_
. O
01 O
) O
and O
% O
delta O
CT _RARE_
= O
- O
3 O
. O
99 _RARE_
- O
0 _RARE_
. O
98 O
% O
mass O
removed O
( O
r _RARE_
= O
0 _RARE_
. O
82 O
, O
P O
less O
than O
0 _RARE_
. O
01 O
) O
relationships O
that O
were O
not O
altered O
by O
blocker O
pretreatment O
.( O
ABSTRACT O
TRUNCATED O
AT O
250 _RARE_
WORDS O
) O

Two O
scintigraphic _RARE_
methods O
, O
resting O
dipyridamole _RARE_
and O
exercise O
thallium O
- O
201 _RARE_
myocardial _RARE_
perfusion O
imaging O
, O
to O
detect O
and O
localize O
coronary O
artery O
stenosis O
were O
compared O
in O
32 _RARE_
patients O
suffering O
from O
coronary O
artery O
disease _RARE_
. O

From O
these O
results O
, O
it O
is O
concluded O
that O
EDLF _RARE_
has O
clear O
vasoconstrictor _RARE_
properties O
which O
are O
not O
due O
to O
adrenergic O
or O
calcium _RARE_
entry O
mechanisms O
and O
that O
there O
are O
differences O
in O
the O
vasoconstrictor _RARE_
effects O
of O
EDLFs _RARE_
with O
respect O
to O
different O
vascular O
beds _RARE_
. O

Research O
was O
carried O
out O
on O
the O
rheumatoid I-GENE
factors I-GENE
in O
the O
serum O
of O
917 _RARE_
patients O
by O
means O
of O
two O
tests O
( O
one O
using O
polystyrene _RARE_
and O
one O
with O
erythrocytes _RARE_
) O
and O
the O
results O
obtained O
were O
compared O
using O
a O
method O
of O
reference O
. O

A O
low O
aspirin _RARE_
esterase I-GENE
activity O
may O
be O
a O
contributory _RARE_
factor O
in O
precipitating O
these O
aspirin _RARE_
sensitive _RARE_
reactions O
. O

In O
both O
experiments O
, O
average O
daily O
gain O
and O
gain O
- O
to O
- O
feed O
ratio O
were O
similar O
for _RARE_
TR O
and O
CR _RARE_
. O

Overall O
least O
- O
squares _RARE_
means O
for _RARE_
uncooked _RARE_
and O
cooked _RARE_
longissimus _RARE_
muscle O
and O
subcutaneous O
fat O
were O
63 _RARE_
. O
32 _RARE_
, O
80 _RARE_
. O
27 _RARE_
and O
98 O
. O
90 _RARE_
mg O
of O
cholesterol O
/ O
100 _RARE_
g O
of O
tissue O
, O
respectively O
. O

The O
role O
of O
supercritical _RARE_
fluid _RARE_
chromatography O
( O
SFC _RARE_
) O
as _RARE_
a O
viable O
technique O
for _RARE_
analyzing O
agricultural _RARE_
products O
has O
been O
investigated O
using O
packed _RARE_
and O
capillary O
column O
methodology _RARE_
. O

Nitrofurazone _RARE_
significantly O
reduced _RARE_
the O
rise O
in O
LH _RARE_
induced _RARE_
by O
LHRH _RARE_
. O

Ovarian _RARE_
tumors O
in O
pregnancy _RARE_
. O

Ultrastructural _RARE_
study O
of O
polyarteritis _RARE_

X2 O
test O
, O
with O
Yates _RARE_
correction O
if O
need O
, O
was O
used O
as _RARE_
statistical O
. O
method O
. O

After O
a O
baseline O
study O
, O
WPW _RARE_
syndrome _RARE_
was O
simulated O
by O
stimulation _RARE_
at _RARE_
seven _RARE_
different O
sites O
around O
the O
base _RARE_
of O
the O
ventricles O
, O
and O
RNV _RARE_
' O
s O
were O
obtained O
. O

Man _RARE_
and O
insect O
, O
past O
, O
present O
, O
future O

All O
patients O
had O
the O
CA I-GENE
125 _RARE_
assay O
performed O
within O
one O
week O
before O
their O
second O
- O
look _RARE_
operation O
. O

Allergy _RARE_
and O
Tourette _RARE_
' O
s O
syndrome _RARE_
. O

The O
criterion O
was O
reached O
after O
two O
sessions _RARE_
and O
generalization _RARE_
to O
a O
variety O
of O
pills _RARE_
and O
capsules O
occurred O
. O

Clinical O
method O
for _RARE_
the O
treatment O
of O
Class _RARE_
II O
occlusal _RARE_
anomalies O
with O
open _RARE_
bite _RARE_

Enoxacin _RARE_
appears O
to O
be O
well _RARE_
suited _RARE_
for _RARE_
the O
treatment O
of O
complicated O
UTI _RARE_
. O

Mean O
fluorosis _RARE_
scores O
, O
however O
, O
were O
similar O
. O

Autonomic _RARE_
dysfunctions _RARE_
were O
restricted O
to O
tonic _RARE_
pupils _RARE_
. O

An O
industry _RARE_
- O
wide O
retrospective O
cohort O
mortality O
study O
was O
conducted O
on O
6 O
, O
152 _RARE_
chemical O
workers O
( O
2 O
, O
460 _RARE_
exposed O
and O
3 O
, O
692 _RARE_
nonexposed _RARE_
) O
engaged _RARE_
in O
chloromethyl _RARE_
ether O
manufacture _RARE_
at _RARE_
7 O
major O
U _RARE_
. O
S O
. O
companies _RARE_
between O
1948 _RARE_
and O
1980 O
. O

The O
diagnosis O
of O
amyloidosis _RARE_
was O
determined O
from O
a O
labial _RARE_
salivary _RARE_
gland _RARE_
biopsy O
. O

Hair _RARE_
and O
blood _RARE_
samples O
were O
taken O
before O
vitamin O
C O
or O
placebo O
supplementation O
was O
started O
and O
at _RARE_
monthly O
intervals O
thereafter O
for _RARE_
three O
months O
. O

In O
treated O
herds _RARE_
, O
cows O
more O
than O
40 O
d O
postpartum _RARE_
with O
a O
corpus _RARE_
luteum _RARE_
received O
prostaglandin _RARE_
F2 O
alpha O
. O

On O
the O
other O
hand _RARE_
, O
if O
the O
measured O
angle O
ANB _RARE_
is O
smaller O
than O
the O
calculated O
angle O
, O
the O
skeletal O
relation O
is O
Class _RARE_
III O
. O

Emergency _RARE_
treatment O
of O
facial O
and O
maxillary _RARE_
/ O
mandibular O
injuries O

In O
14 O
cases O
, O
isolates O
were O
biotyped _RARE_
yielding _RARE_
eight O
with O
biotype _RARE_
II O
, O
four O
with O
biotype _RARE_
III O
, O
and O
one O
each O
with O
biotypes _RARE_
IV O
and O
V O
. O

A O
total _RARE_
of O
117 O
EVS _RARE_
treatments O
were O
performed O
on O
34 _RARE_
patients O
. O

Most O
of O
the O
prepeptide _RARE_
portion O
of O
the O
precursor O
polypeptide O
is O
encoded O
by O
the O
next O
three O
exons O
, O
and O
the O
mature _RARE_
form O
of O
IL _RARE_
- I-GENE
1 I-GENE
alpha I-GENE
is O
encoded O
by O
the O
remaining O
three O
exons O
. O

A O
stochastic _RARE_
version O
of O
Kernell _RARE_
' O
s O
( O
1968 _RARE_
, O
1972 O
) O
model O
with O
cumulative O
afterhyperpolarization _RARE_
( O
AHP _RARE_
) O
was O
simulated O
. O

In O
a O
previous O
interim _RARE_
report O
we O
noted O
more O
prompt _RARE_
resolution O
of O
dermatomal _RARE_
signs O
and O
symptoms O
with O
acyclovir _RARE_
treatment O
. O

The O
detectability _RARE_
of O
the O
defects O
in O
RCA _RARE_
or O
LAD O
region O
was O
80 _RARE_
% O
in O
single O
- O
position O
scans O
in O
stress O
studies O
. O

Pharmacologic _RARE_
properties O
of O
serotonergic _RARE_
agents O
and O
antidepressant _RARE_
drugs O
. O

This O
brief O
hypercapnic _RARE_
challenge O
induced _RARE_
a O
rapid O
increase O
in O
CBF O
in O
the O
absence O
of O
any O
change O
in O
MABP _RARE_
. O

These O
data O
should O
be O
useful O
in O
developing O
reagents _RARE_
for _RARE_
heterozygote _RARE_
detection O
and O
prenatal _RARE_
diagnosis O
of O
11 I-GENE
beta I-GENE
- I-GENE
hydroxylase I-GENE
deficiency O
, O
the O
second O
most O
frequent O
cause O
of O
congenital O
adrenal O
hyperplasia O
. O

Osteocalcin _RARE_
( O
serum I-GENE
bone I-GENE
- I-GENE
Gla _RARE_
protein I-GENE
, O
sBGP _RARE_
), _RARE_
serum I-GENE
alkaline _RARE_
phosphatase I-GENE
( O
sAP _RARE_
) O
and O
urinary _RARE_
hydroxyproline _RARE_
/ O
creatinine _RARE_
ratio O
( O
uOH _RARE_
- O
Prol _RARE_
/ O
creatinine _RARE_
) O
have O
been O
measured O
in O
21 O
patients O
with O
primary _RARE_
hyperparathyroidism _RARE_
( O
PHPT _RARE_
) O
and O
in O
nine O
patients O
with O
hypercalcaemia _RARE_
of O
malignancy O
( O
HM _RARE_
). O

Multivariate _RARE_
logistic _RARE_
regression O
analysis O
indicated O
that O
seropositivity _RARE_
was O
strongly O
associated O
with O
the O
prevalence O
of O
hepatitis O
B O
in O
an O
employee _RARE_
' O
s O
country _RARE_
of O
birth O
and O
with O
age O
. O

Hexsyn _RARE_
is O
the O
Goodyear _RARE_
Tire _RARE_
and O
Rubber _RARE_
Company _RARE_
tradename _RARE_
for _RARE_
a O
polyolefin _RARE_
rubber _RARE_
synthesized O
from O
1 O
- O
hexene _RARE_
with O
3 O
- O
5 O
% O
methylhexadiene _RARE_
as _RARE_
the O
source O
of O
residual O
double O
bonds O
for _RARE_
vulcanization _RARE_
. O

Chimeric _RARE_
phage _RARE_
- O
plasmid _RARE_
expression _RARE_
vectors O
were O
constructed O
from O
pUC18 _RARE_
/ O
19 O
plasmids O
by O
cloning O
a O
single O
- O
stranded _RARE_
DNA O
( O
ssDNA _RARE_
) O
origin O
of O
replication O
from O
bacteriophage _RARE_
f1 _RARE_
and O
inserting O
a O
bacteriophage _RARE_
T7 _RARE_
promoter O
within O
the O
beta I-GENE
- I-GENE
galactosidase I-GENE
gene I-GENE
. O

By O
order O
of O
decreasing O
rate O
, O
finger O
flexors _RARE_
, O
jaw O
, O
crossed _RARE_
adductors _RARE_
, O
and O
triceps _RARE_
reflexes _RARE_
were O
less O
frequently O
elicited O
in O
both O
groups O
. O

Natl _RARE_
. O

Neither O
ethanol O
nor O
estrogen O
has O
been O
shown O
to O
cause O
UROD _RARE_
- O
deficiency O
in O
animals O
. O

Although O
not O
common O
, O
the O
disorder O
is O
the O
most O
frequently O
diagnosed O
disturbance O
of O
porphyrin O
metabolism O
in O
many O
countries _RARE_
, O
and O
further O
insight O
into O
its O
unusual O
pathogenesis O
may O
clarify O
the O
hepatotoxic _RARE_
effects O
of O
the O
4 O
etiologic _RARE_
agents O
. O

Five O
out O
of O
eight O
consecutive O
cases O
with O
initial O
symptoms O
of O
a O
' O
midline _RARE_
granuloma O
' O
were O
identified O
as _RARE_
malignant O
histiocytosis _RARE_
( O
histiocytic _RARE_
sarcoma O
) O
which O
within O
5 O
months O
to O
4 O
years O
led O
to O
generalization _RARE_
and O
death _RARE_
. O

All O
patients O
then O
received O
suxamethonium _RARE_
1 O
. O
5 O
mg O
kg O
- O
1 O
i O
. O
v O
. O

The O
highest O
postoperative O
CK _RARE_
- I-GENE
MB I-GENE
level O
was O
less O
after O
BC _RARE_
( O
BC _RARE_
, O
31 _RARE_
+/- O
17 _RARE_
U _RARE_
/ O
L O
; O
CC _RARE_
, O
56 _RARE_
+/- O
13 _RARE_
U _RARE_
/ O
L O
; O
p O
less O
than O
0 _RARE_
. O
05 O
). O

No O
relevant O
changes O
in O
heart _RARE_
rate O
, O
body O
weight _RARE_
, O
and O
plasma O
levels O
of O
renin I-GENE
activity O
and O
aldosterone O
concentration O
were O
observed O
. O

High _RARE_
trough O
serum O
TOB _RARE_
concentrations O
were O
associated O
with O
death _RARE_
and O
very O
low O
levels O
with O
recovery O
. O

State O
- O
approved _RARE_
schools _RARE_
of O
nursing O
R O
. O
N O
. O

In O
a O
maxicell _RARE_
system _RARE_
a O
protein O
with O
an O
approximate _RARE_
molecular _RARE_
weight _RARE_
of O
36 _RARE_
, O
000 _RARE_
was O
synthesized O
. O

This O
means O
that O
the O
loss _RARE_
of O
recessives _RARE_
must O
be O
calculated O
by O
using O
a O
hypergeometric _RARE_
and O
not O
a O
binomial _RARE_
model O
as _RARE_
Fisher _RARE_
did O
. O

The O
incidence O
of O
second O
malignant O
neoplasms O
was O
lower O
( O
1 O
. O
3 O
%) O
in O
the O
group O
treated O
with O
5 O
- O
fluorouracil O
, O
doxorubicin _RARE_
, O
and O
cyclophosphamide O
than O
in O
the O
historical _RARE_
control O
group O
( O
4 O
. O
8 O
%). O

Ovulation _RARE_
was O
induced _RARE_
in O
8 O
( O
56 _RARE_
. O
7 O
%) O
patients O
who O
conceived _RARE_
. O

In O
previous O
work O
( O
E O
. O

The O
small O
size O
and O
placement O
of O
the O
mutagenesis O
marker O
( O
the O
supF _RARE_
suppressor I-GENE
tRNA I-GENE
gene I-GENE
from I-GENE
Escherichia I-GENE
coli I-GENE
) O
within O
the O
vector O
substantially O
reduced _RARE_
the O
frequency O
of O
spontaneous O
mutations O
normally O
observed O
after O
transfection O
of O
mammalian O
cells O
with O
plasmid _RARE_
DNA O
; O
hence O
, O
UV _RARE_
- O
induced _RARE_
mutations O
were O
easily O
identified O
above O
the O
spontaneous O
background O
. O

W _RARE_
. O

Tetrad _RARE_
analysis O
and O
mitotic _RARE_
recombination _RARE_
experiments O
localized O
the O
PEP4 _RARE_
gene I-GENE
proximal O
to O
GAL4 I-GENE
on O
chromosome _RARE_
XVI _RARE_
. O

Based O
on O
our O
observations O
, O
we O
propose O
a O
model O
whereby _RARE_
inactive O
precursor O
molecules O
produced O
from O
the O
PEP4 _RARE_
gene I-GENE
self O
- O
activate O
within O
the O
yeast O
vacuole _RARE_
and O
subsequently O
activate O
other O
vacuolar I-GENE
hydrolases _RARE_
. O

The O
poly _RARE_
( O
A O
) O
segment O
of O
the O
RNA O
was O
selectively O
cross O
- O
linked _RARE_
to O
the O
72 O
, O
000 _RARE_
- O
molecular _RARE_
- O
weight _RARE_
protein O
( O
72K _RARE_
protein O
). O

In O
vitro O
translation O
of O
RNA O
synthesized O
from O
the O
cloned _RARE_
cDNAs O
predicts O
that O
P0 _RARE_
transcripts I-GENE
are O
translated O
into O
a O
novel O
12 O
. O
5 O
- O
kilodalton _RARE_
protein O
corresponding O
to O
the O
first _RARE_
open _RARE_
reading O
frame O
. O

The O
N O
- O
terminal O
amino O
acid O
sequence O
of O
Mop _RARE_
has O
sequence O
homology O
with O
DNA O
binding O
proteins O
. O

Several O
new O
techniques O
are O
available O
for _RARE_
monitoring O
control O
of O
diabetes O
. O

Ciprofloxacin _RARE_
: O
an O
overview _RARE_
of O
adverse O
experiences _RARE_
. O

Possible _RARE_
pathogenetic _RARE_
mechanisms O
of O
hemopoietic _RARE_
changes O
in O
response O
to O
space O
flight _RARE_
effects O
are O
described O
. O

The O
rho _RARE_
genes I-GENE
comprise O
an O
evolutionarily O
conserved _RARE_
family O
with O
significant O
homology O
to O
the O
ras I-GENE
oncogene I-GENE
family I-GENE
. O

Also O
, O
component _RARE_
I O
significantly O
correlated O
with O
fasting O
insulin I-GENE
and O
VO2 O
max _RARE_
for _RARE_
both O
sexes _RARE_
and O
with O
basal O
metabolism O
and O
HDL _RARE_
- I-GENE
cholesterol I-GENE
for _RARE_
females O
and O
males O
, O
respectively O
. O

The O
glucose O
areas O
following O
the O
ingestion O
of O
the O
foods _RARE_
were O
: O
Study O
1 O
: O
glucose O
11 O
. O
7 O
, O
orange _RARE_
juice O
7 O
. O
3 O
, O
sucrose O
5 O
. O
2 O
, O
glucose O
+ O
fructose _RARE_
6 O
. O
3 O
, O
and O
fructose _RARE_
0 _RARE_
. O
7 O
mmol O
X O
h O
/ O
l _RARE_
; O
Study O
2 O
: O
glucose O
14 O
. O
6 O
, O
orange _RARE_
juice O
7 O
. O
3 O
, O
apples _RARE_
5 O
. O
5 O
, O
and O
apple _RARE_
juice O
4 O
. O
7 O
mmol O
X O
h O
/ O
l _RARE_
; O
Study O
3 O
: O
glucose O
12 O
. O
6 O
, O
ice _RARE_
cream O
8 O
. O
1 O
, O
milk O
3 O
. O
7 O
, O
and O
lactose _RARE_
4 O
. O
1 O
mmol O
X O
h O
/ O
l _RARE_
. O

The O
serum I-GENE
insulin I-GENE
response O
cannot O
. O

SCL _RARE_
prolonged O
promptly _RARE_
after O
verapamil O
, O
and O
sinus O
arrest O
developed O
in O
two O
of O
10 O
group O
2 O
and O
two O
of O
five O
group O
3 O
animals O
. O

Development _RARE_
of O
a O
yeast O
system _RARE_
to O
assay O
mutational O
specificity _RARE_
. O

Postglucose _RARE_
serum I-GENE
insulin I-GENE
levels O
showed O
no _RARE_
significant O
correlations O
with O
systolic O
or O
diastolic O
blood _RARE_
pressure O
levels O
in O
men O
, O
but O
in O
female O
diabetic O
and O
non O
- O
diabetic O
subjects O
significant O
correlations O
were O
found O
in O
particular O
with O
systolic O
blood _RARE_
pressure O
level O
. O

We O
used O
oligonucleotide _RARE_
- O
directed O
mutagenesis O
to O
alter O
a O
site O
in O
MucA _RARE_
homologous O
to O
the O
Ala _RARE_
- O
Gly _RARE_
cleavage _RARE_
site O
of O
LexA I-GENE
. O

The O
latter O
was O
determined O
as _RARE_
follows O
: O
Type _RARE_
I O
- O
solid O
tumor O
tissue O
without O
significant O
peripheral O
isolated O
tumor O
cells O
; O
Type _RARE_
II O
- O
solid O
tumor O
tissue O
associated O
with O
peripheral O
isolated O
tumor O
cells O
; O
Type _RARE_
III O
- O
isolated O
tumor O
cells O
only O
. O

The O
pharmacology _RARE_
of O
carnitine _RARE_
. O

Acute O
inhalation O
toxicity O
of O
T O
- O
2 O
mycotoxin _RARE_
in O
mice O
. O

The O
present O
investigation O
sought O
to O
identify O
the O
principal O
dimensions O
of O
the O
Framingham _RARE_
Type _RARE_
A O
scale O
( O
FTAS _RARE_
) O
and O
then O
to O
examine O
their O
physiological O
and O
psychological O
correlates O
. O

A O
preliminary O
study O
on O
pyogenic _RARE_
arthritis O
. O

Legionella _RARE_
, O
microbial _RARE_
ecology _RARE_
, O
and O
inconspicuous _RARE_
consumption O
. O

Lymphatics _RARE_
in O
the O
aorta O
of O
rats O
treated O
with O
a O
soy _RARE_
- O
bean _RARE_
oil O
extract _RARE_
( O
lipofundin _RARE_
). O

As O
a O
last O
resort _RARE_
, O
it O
may O
be O
possible O
to O
maintain O
a O
patient O
on O
dialysis O
in O
reasonable O
health O
with O
a O
DiaTAP _RARE_
button _RARE_
graft O
complex O
infected _RARE_
with O
Staphylococcus _RARE_
epidermidis _RARE_
and O
intermittent O
positive O
blood _RARE_
cultures O
using O
long O
term O
vancomycin O
therapy O
. O

For O
signal O
durations O
less O
than O
10 O
ms O
, O
however O
, O
the O
SoNo _RARE_
and O
S O
pi _RARE_
No O
threshold O
functions O
converged _RARE_
and O
the O
masking _RARE_
- O
level O
difference O
decreased O
. O

The O
spleen _RARE_
rate O
of O
about O
600 O
villagers _RARE_
of O
RK _RARE_
I O
examined O
was O
54 O
. O
3 O
% O
and O
the O
parasite O
rate O
13 _RARE_
. O
2 O
% O
before O
the O
drug O
intervention O
. O

Multiple O
dosing _RARE_
four O
times O
daily O
for _RARE_
7 O
days O
of O
indoprofen _RARE_
200 _RARE_
mg O
, O
a O
non O
- O
steroidal _RARE_
anti O
- O
inflammatory O
drug O
with O
a O
short O
half _RARE_
- O
life O
( O
t1 O
/ O
2 O
), _RARE_
revealed O
drug O
accumulation O
in O
eight O
elderly O
subjects O
. O

In O
10 O
patients O
with O
subacute O
cardiac O
tamponade _RARE_
, O
pulmonary O
wedge _RARE_
pressure O
( O
PWP _RARE_
), _RARE_
RAP _RARE_
, O
and O
IPP _RARE_
were O
measured O
along O
with O
indexes _RARE_
of O
systolic O
function O
. O

Encompassing _RARE_
tamponade _RARE_
and O
pericardiocentesis _RARE_
data O
, O
left _RARE_
ventricular O
stroke O
work O
index O
showed O
positive O
correlation O
with O
TMFP1 _RARE_
( O
r _RARE_
= O
. O
59 _RARE_
) O
and O
TMFP2 _RARE_
( O
r _RARE_
= O
. O
52 O
) O
but O
not O
with O
TMFP3 _RARE_
. O

Rabbits _RARE_
developed O
profound O
hypocalcemia _RARE_
, O
with O
levels O
falling _RARE_
from O
15 _RARE_
. O
5 O
+/- O
0 _RARE_
. O
2 O
to O
7 O
. O
6 O
+/- O
0 _RARE_
. O
4 O
mg O
/ O
dl O
under O
the O
influence O
of O
TSST _RARE_
- I-GENE
1 I-GENE
. O

Reward _RARE_
value O
of O
prosodic _RARE_
features O
of O
language O
for _RARE_
autistic _RARE_
, O
mentally _RARE_
retarded O
, O
and O
normal O
children O
. O

Similarly O
, O
actuarial _RARE_
interpretations _RARE_
for _RARE_
the O
second O
protocols _RARE_
were O
not O
more O
frequently O
selected _RARE_
by O
therapists _RARE_
as _RARE_
more O
valid _RARE_
, O
regardless O
of O
treatment O
condition O
and O
elevation O
of O
the O
F O
and O
F O
- O
K O
indices O
on O
the O
first _RARE_
MMPI O
profile O
. O

Due _RARE_
to O
its O
relatively O
soluble _RARE_
chemical O
form O
, O
90Sr _RARE_
was O
rapidly O
translocated _RARE_
from O
lung _RARE_
to O
bone O
where O
a O
substantial O
portion O
was O
retained O
for _RARE_
a O
long O
period O
of O
time O
. O

The O
study O
disclosed _RARE_
generalized O
atrophy O
and O
diffuse O
symmetric _RARE_
white _RARE_
matter O
hypodensities _RARE_
. O

The O
diagnosis O
of O
metachromatic _RARE_
leukodystrophy _RARE_
( O
MLD _RARE_
) O
was O
confirmed O
by O
the O
finding O
of O
low O
arylsulfatase _RARE_
A I-GENE
( O
ASA _RARE_
) O
levels O
in O
cultured O
fibroblasts _RARE_
in O
both O
sisters _RARE_
. O

Artificial _RARE_
ventilation O
was O
conducted O
using O
a O
tidal O
volume O
of O
10 O
ml O
X O
kg O
- O
1 O
and O
a O
rate O
of O
10 O
to O
12 O
c O
X O
min O
- O
1 O
. O

Significantly O
lower O
heart _RARE_
rate O
reactivity O
and O
significantly O
less O
pronounced O
left _RARE_
temporal O
artery O
pulse O
amplitude O
responses O
were O
found O
in O
non O
- O
medicated _RARE_
TH _RARE_
subjects O
than O
in O
controls O
. O

An O
epidemiological O
survey O
of O
rheumatic _RARE_
valve O
disease _RARE_
and O
rheumatic _RARE_
fever O
in O
primary _RARE_
and O
secondary O
school _RARE_
students O
in O
Jiangxi _RARE_
Province _RARE_

Drugs _RARE_
that O
are O
transformed O
via O
phase _RARE_
II O
reactions O
usually O
do O
not O
require O
dosage O
adjustment O
. O

A O
study O
of O
human O
genes O
coding O
for _RARE_
U4 I-GENE
small I-GENE
nuclear I-GENE
RNA I-GENE
is O
presented O
. O

Using O
the O
balloon _RARE_
- O
gas O
procedure O
with O
a O
single O
gas O
injection O
, O
a O
bubble _RARE_
was O
obtained O
that O
was O
large O
enough O
to O
tamponade _RARE_
a O
giant _RARE_
tear _RARE_
without O
prior O
drainage O
of O
subretinal O
fluid _RARE_
or O
vitrectomy _RARE_
. O

Heat _RARE_
- O
labile _RARE_
- O
like O
enterotoxin _RARE_
( O
LT _RARE_
) O
was O
produced O
by O
26 _RARE_
of O
42 _RARE_
stool _RARE_
isolates O
( O
62 _RARE_
%), O
while O
only O
1 O
of O
the O
42 _RARE_
isolates O
( O
2 O
%) O
produced O
enterotoxinlike _RARE_
activity O
in O
suckling _RARE_
mice O
; O
65 O
% O
of O
the O
cytotoxin _RARE_
- O
producing O
strains O
also O
produced O
an O
LT _RARE_
- I-GENE
like I-GENE
material O
. O

Development _RARE_
of O
a O
provisional _RARE_
information _RARE_
- O
retrieval _RARE_
descriptor _RARE_
language O
for _RARE_
" O
Roentgenology _RARE_
and O
Medical _RARE_
Radiology _RARE_
" O
for _RARE_
use O
in O
the O
Medinform _RARE_
system _RARE_

Persistent _RARE_
acantholytic _RARE_
dermatosis _RARE_
with O
increased O
light O
sensitivity O

Thus O
, O
a O
negative O
test O
is O
compatible O
with O
low O
disease _RARE_
activity O
and O
/ O
or O
efficacy O
of O
calcium _RARE_
antagonist O
treatment O
. O

Thus O
, O
a O
negative O
test O
is O
compatible O
with O
low O
disease _RARE_
activity O
and O
/ O
or O
efficacy O
of O
calcium _RARE_
antagonist O
treatment O
. O

Dorsal _RARE_
foot O
TcpO2 _RARE_
was O
measured O
by O
using O
oxygen O
- O
sensing _RARE_
electrodes O
with O
surface O
temperatures O
of O
42 _RARE_
degrees O
C O
and O
45 _RARE_
degrees O
C O
; O
in O
theory O
, O
changes O
in O
sympathetic O
activity O
should O
affect O
vasomotor _RARE_
tone O
and O
TcpO2 _RARE_
in O
skin _RARE_
beneath _RARE_
an O
electrode O
at _RARE_
42 _RARE_
degrees O
C O
( O
submaximal _RARE_
vasodilation O
), _RARE_
but O
not O
at _RARE_
45 _RARE_
degrees O
C O
( O
maximal O
vasodilation O
). O

In O
subjects O
( O
n _RARE_
= O
5 O
) O
with O
quadriplegia _RARE_
and O
reduced _RARE_
sympathetic O
tone O
secondary O
to O
cervical O
cord O
trauma O
, O
TcpO2 _RARE_
at _RARE_
42 _RARE_
degrees O
C O
and O
vasodilation O
index O
were O
increased O
( O
45 _RARE_
. O
0 _RARE_
mmHg O
and O
0 _RARE_
. O
61 _RARE_
); O
TcpO2 _RARE_
at _RARE_
45 _RARE_
degrees O
C O
did O
not O
change O
. O

The O
nucleotide O
sequences O
of O
the O
human I-GENE
and I-GENE
murine I-GENE
ornithine _RARE_
decarboxylase I-GENE
mRNAs I-GENE
share O
an O
85 _RARE_
% O
homology O
, O
even O
in O
their O
3 O
'- O
noncoding O
regions O
. O

The O
absolute O
concentrations O
of O
alpha I-GENE
2 I-GENE
- I-GENE
plasmin _RARE_
inhibitor O
, O
alpha I-GENE
2 I-GENE
- I-GENE
macroglobulin _RARE_
, O
and O
antithrombin I-GENE
III I-GENE
increased O
with O
exercise O
( O
all O
P O
less O
than O
0 _RARE_
. O
005 O
), _RARE_
but O
when O
concentrations O
were O
corrected O
for _RARE_
acute O
shifts O
of O
plasma O
water O
during _RARE_
exercise O
, O
the O
quantity _RARE_
of O
these O
inhibitors _RARE_
actually _RARE_
decreased O
( O
all O
P O
less O
than O
0 _RARE_
. O
005 O
). O

The O
other O
model O
was O
a O
continuous O
exponential _RARE_
plus _RARE_
constant O
of O
the O
form O
La _RARE_
- O
= O
a O
+ O
b O
[ _RARE_
exp _RARE_
( O
cVO2 _RARE_
)]. O

Cell O
. O

Timing _RARE_
of O
symptoms O
and O
oocyst _RARE_
excretion O
in O
human O
cryptosporidiosis _RARE_
. O

After O
dopamine O
infusion O
in O
women O
with O
polycystic _RARE_
ovary O
syndrome _RARE_
and O
in O
matched O
controls O
, O
steady O
state O
levels O
of O
plasma O
dopamine O
, O
norepinephrine O
, O
and O
the O
ratio O
of O
dopamine O
/ O
norepinephrine O
were O
similar O
in O
the O
two O
groups O
. O

Diagnostic O
importance O
of O
determining _RARE_
the O
complement O
constituents _RARE_
in O
children O
with O
autoimmune _RARE_
thyroiditis O

In O
the O
normal O
, O
basal O
( O
unstimulated O
) O
condition O
there O
were O
no _RARE_
significant O
correlations O
( O
p O
greater O
than O
0 _RARE_
. O
05 O
) O
between O
the O
systolic O
blood _RARE_
pressure O
and O
dopamine O
( O
r _RARE_
= O
0 _RARE_
. O
09 O
), _RARE_
norepinephrine O
( O
r _RARE_
= O
0 _RARE_
. O
26 _RARE_
), _RARE_
or O
epinephrine O
( O
r _RARE_
= O
0 _RARE_
. O
27 _RARE_
), _RARE_
nor O
were O
there O
significant O
correlations O
between O
melatonin O
and O
dopamine O
( O
r _RARE_
= O
- O
0 _RARE_
. O
01 O
), _RARE_
norepinephrine O
( O
r _RARE_
= O
- O
0 _RARE_
. O
26 _RARE_
), _RARE_
or O
growth I-GENE
hormone I-GENE
( O
r _RARE_
= O
0 _RARE_
. O
17 _RARE_
). O

The O
4 O
patients O
with O
carboxyhemoglobin _RARE_
levels O
in O
excess O
of O
10 O
% O
may O
represent O
occult _RARE_
carbon O
monoxide _RARE_
poisoning O
in O
this O
population O
. O

All O
these O
processes O
were O
fully O
developed O
during _RARE_
the O
last O
month O
of O
pregnancy _RARE_
, O
offering _RARE_
the O
same O
picture O
as _RARE_
the O
controls O
. O

Hypoglycemic _RARE_
action O
of O
" O
he _RARE_
xiang _RARE_
zhuang _RARE_
qi _RARE_
gong _RARE_
" O
and O
its O
mechanism O
on O
diabetes O
mellitus O

In O
cases O
of O
1 O
degrees O
HPT _RARE_
, O
the O
plasma O
1 O
, O
25 _RARE_
-( _RARE_
OH O
) O
2D _RARE_
level O
rose O
significantly O
in O
all O
cases O
( O
P O
less O
than O
0 _RARE_
. O
05 O
), _RARE_
although O
the O
pattern O
of O
the O
increase O
was O
not O
uniform O
. O

This O
region O
of O
60 _RARE_
amino O
acids _RARE_
may O
be O
involved O
in O
coiled _RARE_
- O
coil _RARE_
interactions O
similar O
to O
those O
that O
facilitate O
the O
filament _RARE_
formation O
in O
the O
rod _RARE_
region O
. O

This O
approach O
enables O
the O
sources O
of O
error O
in O
the O
calculation _RARE_
of O
nutrient O
utilization O
to O
be O
readily O
identified O
, O
and O
their O
effect O
on O
precision _RARE_
to O
be O
assessed O
in O
different O
nutritional O
and O
metabolic O
states O
. O

The O
effect O
of O
dietary O
zinc O
deficiency O
on O
the O
mossy _RARE_
fiber O
zinc O
content O
of O
the O
rat O
hippocampus O
. O

Weaned _RARE_
rats O
were O
fed O
a O
normal O
diet O
or O
a O
low O
- O
protein O
, O
low O
- O
energy O
diet O
, O
and O
injected O
with O
saline O
or O
thyroxine O
( O
5 O
micrograms O
/ O
100 _RARE_
g O
BW _RARE_
) O
for _RARE_
22 _RARE_
days O
. O

It O
is O
largely O
predicted O
by O
lupus O
anticoagulant _RARE_
( O
estimated O
by O
activated O
partial O
thromboplastin I-GENE
time O
) O
and O
/ O
or O
antibody O
to O
cardiolipin _RARE_
. O

The O
effects O
of O
several O
opioid _RARE_
agonists O
and O
the O
opioid _RARE_
antagonist O
naloxone O
were O
examined O
in O
rats O
responding O
under O
a O
fixed O
- O
consecutive O
- O
number O
( O
FCN _RARE_
) O
schedule O
. O

The O
rate O
- O
decreasing O
effects O
of O
morphine _RARE_
and O
U50488 _RARE_
were O
reversed O
completely O
by O
a O
0 _RARE_
. O
01 O
and O
1 O
. O
0 _RARE_
mg O
/ O
kg O
dose O
of O
naloxone O
, O
respectively O
. O

Data O
from O
119 O
men O
and O
40 O
women O
undergoing O
coronary O
angiography O
provide O
an O
opportunity _RARE_
to O
compare O
these O
associations O
in O
relation O
to O
a O
direct O
and O
continuous O
measure O
of O
atherosclerosis O
while O
controlling O
for _RARE_
age O
, O
sex _RARE_
, O
income _RARE_
, O
hypertension O
, O
serum O
cholesterol O
, O
smoking O
, O
angina O
, O
diabetes O
, O
family O
history O
of O
heart _RARE_
disease _RARE_
, O
Type _RARE_
A O
behavior O
pattern O
, O
and O
hostility _RARE_
. O

An O
intralobar _RARE_
change O
in O
temperature _RARE_
above O
or O
below O
36 _RARE_
degrees O
C O
decreases O
only O
the O
lobar _RARE_
bronchial O
blood _RARE_
flow O
and O
does O
not O
influence O
blood _RARE_
flow O
to O
other O
nearby _RARE_
tissues O
including O
those O
vascularized _RARE_
by O
the O
bronchial O
circulation O
. O

Convulsive _RARE_
status O
epilepticus _RARE_
after O
infusion O
of O
cisplatin O

The O
presence O
in O
such O
patients O
of O
antibodies O
to O
adrenaline O
and O
noradrenaline O
is O
indicative O
of O
considerable O
disruption O
of O
catecholamine _RARE_
biotransformation _RARE_
. O

The O
following O
markers O
were O
looked _RARE_
for _RARE_
in O
the O
serum O
, O
skin _RARE_
and O
liver O
of O
all O
patients O
with O
chronic O
hepatitis O
: O
HBV _RARE_
( O
HBs I-GENE
Ag _RARE_
and O
HBe _RARE_
Ag _RARE_
, O
anti I-GENE
- I-GENE
HBs I-GENE
, O
anti I-GENE
- I-GENE
HBe _RARE_
and O
anti I-GENE
- I-GENE
HBc _RARE_
in O
the O
serum O
, O
HBs I-GENE
and I-GENE
HBc _RARE_
Ag _RARE_
in O
the O
liver O
); O
non I-GENE
- I-GENE
A I-GENE
non I-GENE
- I-GENE
B I-GENE
( O
non I-GENE
- I-GENE
A I-GENE
, I-GENE
non I-GENE
- I-GENE
B I-GENE
Ag _RARE_
and I-GENE
antibody I-GENE
, O
anti I-GENE
non I-GENE
- I-GENE
A I-GENE
non I-GENE
- I-GENE
Bc _RARE_
in O
the O
serum O
, O
non I-GENE
- I-GENE
A I-GENE
, I-GENE
non I-GENE
- I-GENE
Bc _RARE_
Ag _RARE_
in O
the O
liver O
). O

Groups _RARE_
of O
male O
and O
female O
Fischer _RARE_
344 _RARE_
rats O
, O
B6C3F1 _RARE_
mice O
, O
and O
Hartley _RARE_
guinea _RARE_
pigs O
were O
exposed O
once O
for _RARE_
6 O
hr O
to O
mean O
concentrations O
of O
10 O
. O
5 O
, O
5 O
. O
4 O
, O
2 O
. O
4 O
, O
1 O
. O
0 _RARE_
, O
or O
0 _RARE_
( O
control O
) O
ppm O
of O
methyl _RARE_
isocyanate _RARE_
( O
MIC _RARE_
) O
vapor _RARE_
. O

Radionuclide _RARE_
study O
and O
endomyocardial _RARE_
biopsy O
revealed O
remarkable O
degeneration O
of O
myocardium O
. O

Immobilization _RARE_
of O
the O
fracture O
in O
a O
collar _RARE_
and O
cuff _RARE_
sling _RARE_
was O
as _RARE_
effective O
as _RARE_
more O
elaborate _RARE_
methods O
. O

Comparison O
of O
patients O
receiving O
phenytoin O
and O
those O
who O
were O
not O
showed O
significantly O
lower O
serum O
folate _RARE_
in O
the O
sub O
- O
group O
receiving O
phenytoin O
, O
but O
there O
was O
no _RARE_
significant O
difference O
between O
the O
sub O
- O
groups O
with O
respect O
to O
vitamin O
B12 _RARE_
or O
behaviour O
problem O
rating O
. O

Effects O
of O
a O
low O
- O
energy O
laser O
beam O
on O
the O
cells O
of O
the O
newt _RARE_
embryo _RARE_

Typical _RARE_
and O
atypical O
clinical O
features O
of O
this O
lacrimal _RARE_
sac _RARE_
cyst O
are O
emphasized _RARE_
. O

The O
role O
of O
saliva _RARE_
in O
sour _RARE_
taste O
perception _RARE_
was O
investigated O
in O
a O
series O
of O
4 O
experiments O
. O

Samples _RARE_
from O
1415 _RARE_
neurological O
patients O
were O
used O
to O
study O
the O
diagnostic O
value O
of O
acid I-GENE
alpha I-GENE
1 I-GENE
- I-GENE
glycoprotein I-GENE
in O
the O
lumbar O
cerebrospinal _RARE_
fluid _RARE_
. O

Separate _RARE_
experiments O
measured O
AIB _RARE_
and O
86RbCl _RARE_
uptake O
in O
36B _RARE_
- O
10 O
cells O
in O
vitro O
1 O
and O
2 O
days O
following O
20 O
Gy O
irradiation O
to O
assess O
whether O
this O
radiation O
dose O
reduced _RARE_
the O
capacity O
of O
tumor O
cells O
to O
trap _RARE_
AIB _RARE_
or O
Rb _RARE_
+. _RARE_

For O
patients O
with O
recurrent O
or O
metastatic O
disease _RARE_
, O
the O
data O
suggest O
that O
I O
- O
131 _RARE_
MIBG _RARE_
scintigraphy O
is O
the O
examination O
of O
choice O
. O

W _RARE_
. O

Comparison O
of O
the O
amino O
acid O
sequence O
of O
the O
M I-GENE
RNA I-GENE
product I-GENE
of I-GENE
Uukuniemi _RARE_
virus I-GENE
with O
that O
of O
Punta _RARE_
Toro _RARE_
and O
Rift _RARE_
Valley _RARE_
fever O
viruses O
showed O
in O
both O
cases O
a O
weak O
homology O
that O
was O
more O
pronounced O
for _RARE_
the O
proteins O
located _RARE_
at _RARE_
the O
COOH _RARE_
- O
terminal O
end O
of O
the O
precursor O
. O

Cyclosporine _RARE_
treatment O
for _RARE_
intractable _RARE_
polymyositis _RARE_
. O

In O
addition O
, O
on O
the O
Cohler _RARE_
' O
s O
maternal _RARE_
scale O
, O
Korean _RARE_
mothers O
were O
found O
to O
view O
their O
infants O
as _RARE_
more O
passive O
and O
dependent O
than O
American O
mothers O
did O
( O
P O
less O
than O
0 _RARE_
. O
00 O
). O

A O
preoperative O
teaching _RARE_
booklet _RARE_
for _RARE_
pediatric O
patients O
. O

Hyperthyroidism _RARE_

We O
conclude O
that O
for _RARE_
mono O
- O
intronic _RARE_
precursors _RARE_
in O
which O
there O
is O
only O
one O
choice O
of O
splice _RARE_
sites O
, O
most O
of O
the O
exon _RARE_
sequences O
are O
not O
mechanistically _RARE_
involved O
in O
the O
splicing _RARE_
process O
. O

UVA _RARE_
- O
induced _RARE_
melanocytic _RARE_
lesions O
. O

Ex _RARE_
vivo O
MAO I-GENE
inhibition O
data O
indicated O
DPGPEA _RARE_
to O
be O
an O
inhibitor O
of O
MAO I-GENE
- I-GENE
B I-GENE
, O
although O
the O
effect O
was O
much O
weaker _RARE_
than O
seen O
with O
tranylcypromine _RARE_
or O
pargyline _RARE_
. O

Thus O
in O
this O
region O
of O
the O
vessel O
pyridinoline _RARE_
represents O
the O
major O
stabilising _RARE_
crosslink _RARE_
of O
collagen _RARE_
. O

A O
careful _RARE_
, O
radiolabelled _RARE_
tissue O
- O
distribution O
study O
is O
warranted O
to O
elucidate O
the O
complicated O
metabolic O
fate O
of O
perhexiline _RARE_
. O

Systemic _RARE_
lupus O
erythematosus O
was O
diagnosed O
. O

In O
the O
evening _RARE_
, O
the O
amplitude O
of O
the O
responses O
to O
both O
O2 _RARE_
and O
CO2 O
increased O
but O
the O
increase O
in O
CO2 O
sensitivity O
was O
proportionally _RARE_
more O
important O
. O

The O
statistical O
significance O
of O
the O
prognosis O
factors O
was O
studied O
by O
uni _RARE_
- O
and O
multivariative _RARE_
methods O
, O
according O
to O
the O
model O
of O
Cox O
, O
with O
the O
help O
of O
an O
IMB _RARE_
computer O
. O

These O
changes O
at _RARE_
the O
site O
of O
injection O
consist O
of O
a O
focal _RARE_
abnormality O
characterized O
by O
a O
slight O
increase O
in O
signal O
intensity O
on O
T1 _RARE_
weighted O
images O
and O
markedly O
increased O
signal O
intensity O
on O
T2 _RARE_
weighted O
images O
. O

These O
results O
suggest O
that O
less O
antidopaminergic _RARE_
activity O
of O
RHAL _RARE_
in O
this O
neuroleptic O
test O
might O
be O
explained O
by O
the O
lesser O
conversion O
of O
RHAL _RARE_
to O
HAL _RARE_
. O

The O
purpose O
of O
this O
study O
is O
twofold O
: O
( O
1 O
) O
to O
present O
a O
parallel O
form O
of O
the O
Gudjonsson _RARE_
Suggestibility _RARE_
Scale O
( O
GSS _RARE_
, O
Form _RARE_
1 O
); O
( O
2 O
) O
to O
study O
test O
- O
retest _RARE_
reliabilities _RARE_
of O
interrogative _RARE_
suggestibility _RARE_
. O

Organisms _RARE_
were O
recovered O
from O
the O
conjunctiva _RARE_
for _RARE_
several O
weeks O
, O
and O
persistent O
genital _RARE_
and O
gastrointestinal _RARE_
infection O
also O
resulted O
from O
the O
ocular O
infection O
in O
some O
cats O
. O

In O
vivo O
epiluminescence _RARE_
microscopy O
of O
pigmented _RARE_
skin _RARE_
lesions O
. O

These O
equilibrium O
solutions O
are O
then O
shown O
to O
arise O
from O
the O
vertices _RARE_
of O
a O
particular O
convex _RARE_
polyhedron _RARE_
. O

The O
average O
deviations _RARE_
in O
the O
X O
- O
ray O
counts O
of O
the O
constant O
elements O
from O
the O
series O
means O
were O
used O
to O
correct O
the O
recorded O
count O
of O
the O
variable _RARE_
element O
in O
each O
block _RARE_
. O

Statistically _RARE_
significant O
effects O
were O
noted O
at _RARE_
doses O
which O
did O
not O
appear O
to O
be O
maternally _RARE_
toxic O
. O

Low O
MAO I-GENE
subjects O
showed O
a O
pattern O
of O
higher _RARE_
scores O
in O
KSP _RARE_
Impulsiveness _RARE_
, O
EPQ _RARE_
Neuroticism _RARE_
, O
and O
KSP _RARE_
Somatic _RARE_
Anxiety _RARE_
and O
Irritability _RARE_
and O
lower O
scores O
in O
KSP _RARE_
Socialization _RARE_
, O
in O
line O
with O
personality _RARE_
profiles O
found O
in O
alcoholics _RARE_
, O
psychopaths _RARE_
, O
and O
suicide O
attempters _RARE_
who O
also O
tend _RARE_
to O
have O
low O
platelet O
MAO I-GENE
activity O
. O

To O
evaluate O
the O
relative O
accuracy O
of O
continuous O
wave O
( O
CW _RARE_
) O
and O
high O
pulse O
repetition _RARE_
frequency O
( O
HPRF _RARE_
) O
Doppler O
for _RARE_
estimating O
aortic O
transvalvular _RARE_
pressure O
gradients _RARE_
, O
Doppler O
examinations O
with O
both O
devices _RARE_
were O
obtained O
in O
87 O
consecutive O
patients O
with O
aortic O
valve O
disease _RARE_
. O

In O
group O
I O
, O
Paw _RARE_
, O
delta O
V O
, O
PaO2 O
, O
Vinj _RARE_
and O
VT O
significantly O
decreased O
whereas O
operating O
pressure O
and O
E O
significantly O
increased O
when O
the O
internal O
diameter O
of O
the O
injector _RARE_
cannula _RARE_
was O
reduced _RARE_
. O

In O
calves O
receiving O
milk O
- O
substitute O
diets O
containing O
80 _RARE_
- O
260 O
g O
DM O
/ O
kg O
, O
milk O
intakes _RARE_
were O
reduced _RARE_
by O
up _RARE_
to O
30 _RARE_
% O
on O
the O
1st _RARE_
day O
that O
calves O
were O
fed O
once O
daily O
instead O
of O
twice O
daily O
. O

Today _RARE_
there O
is O
no _RARE_
doubt _RARE_
that O
elevated O
plasma O
cholesterol O
levels O
should O
be O
lowered O
first _RARE_
by O
dietary O
modification O
even O
in O
early O
childhood O
, O
beginning O
at _RARE_
the O
age O
of O
two O
years O
. O

The O
number O
of O
fecal O
pellets O
ingested _RARE_
peaked _RARE_
at _RARE_
5 O
to O
6 O
weeks O
old O
( O
13 _RARE_
pellets O
/ O
day O
) O
and O
gradually O
decreased O
, O
thereafter O
( O
2 O
. O
1 O
pellets O
at _RARE_
78 _RARE_
weeks O
old O
, O
1 O
. O
5 O
pellets O
at _RARE_
104 O
weeks O
old O
). O

These O
results O
suggest O
that O
N O
- O
nitroso _RARE_
compounds O
can O
be O
formed O
in O
vivo O
in O
the O
infected _RARE_
bladder O
, O
which O
could O
explain O
the O
association O
between O
urinary _RARE_
- O
tract _RARE_
infections O
and O
increased O
risk O
for _RARE_
bladder O
cancer _RARE_
. O

Epithelial _RARE_
nerve O
fiber O
defects O
included O
absence O
or O
distorted _RARE_
architecture O
of O
the O
basal O
epithelial _RARE_
plexus _RARE_
and O
intra _RARE_
- O
epithelial _RARE_
terminals _RARE_
. O

The O
histologic O
grade O
for _RARE_
the O
same O
anatomic O
site O
varied O
among O
hearts O
and O
among O
different O
anatomic O
sites O
in O
the O
same O
heart _RARE_
. O

Serum O
levels O
of O
albumin I-GENE
, O
globulin I-GENE
, O
and O
coagulation I-GENE
protein I-GENE
activity O
were O
measured O
preshock _RARE_
, O
postshock _RARE_
, O
and O
daily O
for _RARE_
3 O
days O
; O
skin _RARE_
lymph O
levels O
were O
measured O
on O
Day O
3 O
. O

For O
colostral _RARE_
milk O
there O
was O
a O
significant O
correlation O
of O
vitamin O
K1 _RARE_
to O
cholesterol O
( O
r _RARE_
= O
0 _RARE_
. O
62 _RARE_
) O
but O
not O
to O
total _RARE_
lipid _RARE_
or O
phospholipid _RARE_
suggesting O
a O
role O
for _RARE_
cholesterol O
in O
the O
secretion _RARE_
of O
vitamin O
K1 _RARE_
into O
colostral _RARE_
milk O
. O

Endurance _RARE_
training O
resulted O
in O
an O
increase O
of O
stiffness O
associated O
with O
a O
decrease O
of O
type O
II O
fibers O
. O

A O
rate O
- O
decreasing O
dose O
of O
physostigmine _RARE_
, O
an O
acetylcholinesterase _RARE_
inhibitor O
, O
was O
studied O
in O
combination O
with O
the O
range O
of O
atropine O
doses O
. O

References _RARE_
for _RARE_
occupational _RARE_
fitness O
of O
adolescents _RARE_
with O
diseases O
of O
the O
respiratory O
tract _RARE_
and O
lungs O

Salzburg _RARE_
, O
9 O
- O
12 O
September _RARE_
1987 O
. O

Two O
new O
glucosidase _RARE_
inhibitors _RARE_
( O
BAY _RARE_
m O
1099 _RARE_
and O
BAY _RARE_
o _RARE_
1248 _RARE_
) O
were O
studied O
in O
volunteers O
and O
type O
II O
diabetics _RARE_
under O
various O
conditions O
. O

The O
models O
accurately O
localized O
the O
common O
boundaries O
between O
the O
PBB _RARE_
and O
CN _RARE_
. O

Two O
of O
these O
six _RARE_
cases O
showed O
mucosal _RARE_
spread O
without O
stromal _RARE_
invasion O
( O
type O
A O
); O
the O
remaining O
four O
cases O
presented O
a O
direct O
extension O
( O
type O
B O
) O
from O
muscle O
- O
invasive O
carcinomas O
of O
the O
bladder O
. O

However O
, O
conversions _RARE_
of O
12 O
mm O
or O
more O
from O
a O
documented _RARE_
negative O
result O
indicated O
spread O
of O
infection O
. O

The O
maximum O
amplitude O
of O
evoked O
responses O
in O
the O
cervical O
sympathetic O
trunk O
was O
obtained O
when O
the O
T2 _RARE_
white _RARE_
ramus _RARE_
was O
stimulated _RARE_
and O
decreased O
gradually O
when O
followed O
by O
the O
stimulation _RARE_
of O
T1 _RARE_
, O
T3 _RARE_
, O
T4 O
and O
T5 _RARE_
white _RARE_
rami _RARE_
. O

It O
is O
concluded O
that O
contact _RARE_
allergy O
to O
K O
- O
CG _RARE_
is O
common O
. O

The O
effect O
of O
a O
beta I-GENE
- I-GENE
adrenoceptor I-GENE
antagonist O
, O
pindolol _RARE_
, O
on O
uterine _RARE_
smooth _RARE_
muscle O
in O
term O
pregnant _RARE_
women O
was O
studied O
in O
vitro O
and O
in O
vivo O
( O
in O
hypertensive O
women O
). O

The O
less O
- O
polar _RARE_
mycolic _RARE_
acid O
- O
containing O
Rhodococcus _RARE_
species O
showed O
chromatographic O
patterns O
that O
partially O
overlapped _RARE_
( O
in O
elution _RARE_
times O
) O
the O
patterns O
of O
Nocardia _RARE_
asteroides _RARE_
, O
N O
. O
otitidiscaviarum _RARE_
, O
and O
N O
. O
brasiliensis _RARE_
, O
but O
the O
larger O
number O
of O
peaks O
in O
the O
last O
species O
made O
separation O
between O
the O
genera _RARE_
possible O
. O

The O
development O
of O
a O
data O
base _RARE_
is O
described O
which O
can O
be O
used O
as _RARE_
common O
reference O
for _RARE_
ECG O
computer O
programs O
analyzing O
12 O
or O
15 _RARE_
simultaneously O
recorded O
leads O
. O

Blood _RARE_
serum I-GENE
erythropoietin I-GENE
level O
and O
basic O
hematological _RARE_
indices O
during _RARE_
the O
adaptation O
of O
healthy O
newborn O
infants O

49 _RARE_
, O
XXXXY _RARE_
chromosome _RARE_
anomaly _RARE_
: O
an O
unusual O
variant O
of O
Klinefelter _RARE_
' O
s O
syndrome _RARE_
. O

Contraction _RARE_
of O
the O
tracheal O
muscle O
and O
the O
activity O
of O
stretch O
receptors O
in O
the O
trachea _RARE_

The O
selenium O
level O
and O
glutathione _RARE_
peroxidase I-GENE
activity O
in O
the O
blood _RARE_
, O
liver O
, O
and O
stomach O
mucosa O
were O
significantly O
higher _RARE_
in O
the O
high O
- O
selenium O
diet O
group O
than O
in O
the O
low O
- O
selenium O
diet O
group O
. O

Oxygen _RARE_
delivery O
and O
consumption O
and O
P50 _RARE_
in O
patients O
with O
acute O
myocardial _RARE_
infarction O
. O

Infants _RARE_
of O
this O
sample O
had O
monocular _RARE_
PL _RARE_
visual O
acuities _RARE_
similar O
to O
those O
established O
by O
McDonald _RARE_
et O
al O
. O
in O
a O
laboratory O
setting O
. O

These O
results O
indicate O
that O
the O
effect O
of O
the O
isomers _RARE_
of O
pentobarbital _RARE_
and O
secobarbital _RARE_
on O
mult _RARE_
FR30 _RARE_
FI600 _RARE_
responding O
and O
on O
suppressed O
responding O
are O
qualitatively _RARE_
similar O
.( O
ABSTRACT O
TRUNCATED O
AT O
250 _RARE_
WORDS O
) O

The O
number O
of O
crystalline O
deposits _RARE_
is O
less O
in O
the O
advanced O
atrophic _RARE_
areas O
of O
the O
RPE _RARE_
- O
choriocapillaris _RARE_
complex O
. O

All O
33 _RARE_
subjects O
were O
given O
psychometric _RARE_
instruments O
for _RARE_
measuring O
various O
components _RARE_
of O
anger _RARE_
and O
anxiety O
: O
Spielberger _RARE_
' O
s O
State O
- O
Trait _RARE_
Personality _RARE_
Inventory _RARE_
, O
the O
Anger _RARE_
Expression O
Scale O
, O
and O
the O
State O
Anger _RARE_
Reaction _RARE_
Scale O
. O

It O
was O
found O
that O
the O
primary _RARE_
visual O
cortex O
of O
the O
rat O
is O
asymmetrical _RARE_
in O
volume O
, O
and O
that O
the O
asymmetry O
reflects _RARE_
side _RARE_
differences O
in O
the O
number O
of O
neurons O
. O

The O
subjects O
received O
a O
single O
500 O
mg O
dose O
of O
acetaminophen _RARE_
i O
. O
v O
. O
and O
concentrations O
in O
plasma O
were O
measured O
for _RARE_
360 _RARE_
minutes O
and O
in O
urine O
for _RARE_
24 _RARE_
h O
in O
order O
to O
estimate O
the O
production O
of O
metabolites O
. O

Mean O
weighted O
skin _RARE_
temperature _RARE_
( O
Tsk _RARE_
) O
was O
lower O
( O
P O
less O
than O
0 _RARE_
. O
01 O
) O
following O
acclimation _RARE_
than O
before O
, O
and O
acclimation _RARE_
resulted O
in O
a O
larger O
( O
P O
less O
than O
0 _RARE_
. O
02 O
) O
Tre _RARE_
- O
to O
- O
Tsk _RARE_
gradient O
. O

Indium _RARE_
- O
111 O
leukocyte _RARE_
imaging O
in O
patients O
with O
rheumatoid O
arthritis O
. O

The O
effect O
of O
L O
- O
methionine O
supplementation O
on O
the O
utilization O
of O
a O
soy _RARE_
protein O
isolate O
( O
SPI _RARE_
) O
was O
evaluated O
by O
short O
- O
term O
nitrogen O
balance O
studies O
in O
young O
women O
. O

Primary O
invasive O
Haemophilus O
influenzae O
type O
b O
disease _RARE_
: O
a O
population O
- O
based O
assessment O
of O
risk O
factors O
. O

Overall O
, O
lesions O
infiltrating _RARE_
the O
deep O
lamina _RARE_
propria _RARE_
do O
not O
exhibit O
a O
reduced _RARE_
frequency O
of O
occurrence O
compared O
to O
lesions O
infiltrating _RARE_
the O
skeletal O
muscle O
; O
however O
, O
carcinomas O
affecting O
other O
oral O
sites O
showed O
a O
reduced _RARE_
frequency O
of O
deeply _RARE_
infiltrating _RARE_
lesions O
in O
comparison O
to O
more O
superficial O
lesions O
. O

Factors O
that O
showed O
significant O
correlation O
to O
elevated O
CIC _RARE_
' O
s O
in O
the O
highly O
elevated O
portion O
of O
our O
CIC _RARE_
population O
were O
poor O
NIH _RARE_
score O
, O
increased O
patient O
age O
, O
low O
peak O
expiratory O
flow O
rate O
, O
and O
elevated O
total _RARE_
serum I-GENE
IgG I-GENE
. O

Induction O
of O
both O
potential _RARE_
transcripts O
follows O
heat O
shock O
in O
vivo O
. O

New O
and O
successful O
steps O
have O
been O
made O
in O
immunodiagnostics _RARE_
, O
immunotherapy O
, O
and O
immunoprophylaxis _RARE_
of O
immunologically _RARE_
conditioned O
infertility O
. O

Amikacin _RARE_
was O
the O
most O
stable O
and O
tobramycin _RARE_
was O
the O
least O
stable O
aminoglycoside _RARE_
under O
the O
conditions O
tested O
. O

This O
may O
explain O
in O
part O
a O
secular _RARE_
trend O
towards O
reduced _RARE_
birthweight _RARE_
for _RARE_
gestation O
in O
preterm O
infants O
. O

Estimated _RARE_
nucleic _RARE_
acid O
N O
absorption O
is O
7 O
- O
8 O
% O
of O
N O
intake O
. O

Adhesion _RARE_
, O
phagocytosis _RARE_
, O
chemotactic O
and O
random O
migration O
, O
nitroblue _RARE_
tetrazolium _RARE_
dye _RARE_
reduction O
of O
peritoneal O
exudate _RARE_
neutrophils O
and O
macrophages O
, O
fibrinogen I-GENE
level O
, O
gelation _RARE_
of O
soluble _RARE_
fibrin I-GENE
and O
serial O
dilution O
protamine _RARE_
sulfate _RARE_
test O
were O
investigated O
in O
115 _RARE_
New O
Zealand _RARE_
white _RARE_
rabbits O
with O
experimentally O
induced _RARE_
Shwartzman _RARE_
phenomenon O
in O
the O
colon O
, O
and O
in O
control O
animals O
. O

Nickel _RARE_
is O
the O
most O
common O
cause O
of O
allergic O
contact _RARE_
dermatitis O
in O
Singapore _RARE_
, O
resulting O
in O
positive O
reactions O
in O
patch O
tests O
between O
7 O
and O
14 O
%. O

The O
FFA _RARE_
levels O
were O
not O
affected O
( O
P O
greater O
than O
. O
1 O
) O
by O
meal _RARE_
interval O
. O

He O
visited _RARE_
our O
hospital O
and O
left _RARE_
solitary _RARE_
renal _RARE_
cyst O
was O
suspected O
. O

However O
, O
further O
analyses O
of O
the O
data O
indicate O
that O
increasing O
VO2 O
AT O
( O
r _RARE_
= O
- O
0 _RARE_
. O
63 _RARE_
, O
P O
less O
than O
0 _RARE_
. O
05 O
) O
rather O
than O
VO2max _RARE_
( O
r _RARE_
= O
- O
0 _RARE_
. O
15 _RARE_
) O
could O
result O
in O
improving _RARE_
the O
10 O
, O
000 _RARE_
m O
race _RARE_
performance O
to O
a O
larger O
extent O
, O
and O
that O
the O
absolute O
amount O
of O
change O
( O
delta O
) O
in O
the O
10 O
, O
000 _RARE_
m O
run O
time O
is O
best O
accounted _RARE_
for _RARE_
by O
a O
combination O
of O
delta O
VO2 O
AT O
and O
delta O
5 O
, O
000 _RARE_
m O
run O
time O
. O

A O
significant O
herd O
X O
period O
interaction O
existed O
for _RARE_
liver O
TG O
and O
serum O
dextran _RARE_
precipitable _RARE_
cholesterol O
concentrations O
. O

Liver O
TG O
and O
serum O
NEFA _RARE_
concentrations O
were O
positively O
correlated O
. O

The O
results O
show O
that O
nerve O
and O
roots O
differ O
considerably O
both O
in O
the O
force O
they O
sustain _RARE_
before O
failure O
and O
in O
the O
other O
biomechanics _RARE_
they O
exhibit O
. O

When O
the O
coronary O
sinus O
pressure O
reached O
15 _RARE_
torr O
, O
there O
was O
a O
significant O
decrease O
in O
cardiac O
index O
( O
3 O
. O
60 _RARE_
+/- O
0 _RARE_
. O
5 O
to O
2 O
. O
70 O
+/- O
0 _RARE_
. O
6 O
L O
/ O
min O
/ O
m2 O
, O
p O
less O
than O
0 _RARE_
. O
001 O
), _RARE_
coronary O
blood _RARE_
flow O
( O
13 _RARE_
. O
7 O
+/- O
3 O
. O
1 O
to O
7 O
. O
0 _RARE_
+/- O
2 O
. O
1 O
ml O
/ O
min O
, O
p O
less O
than O
0 _RARE_
. O
001 O
), _RARE_
rate O
of O
rise O
of O
left _RARE_
ventricular O
pressure O
( O
1 O
, O
567 _RARE_
+/- O
275 _RARE_
to O
1 O
, O
331 _RARE_
+/- O
314 _RARE_
, O
p O
less O
than O
0 _RARE_
. O
05 O
), _RARE_
and O
an O
increase O
in O
coronary O
arteriovenous _RARE_
difference O
( O
62 _RARE_
. O
8 O
% O
+/- O
9 O
. O
3 O
% O
to O
70 O
. O
5 O
% O
+/- O
5 O
. O
4 O
% O
saturation O
, O
p O
less O
than O
0 _RARE_
. O
03 O
). O

Calcifications _RARE_
in O
the O
thoracic _RARE_
aorta O
at _RARE_
the O
level O
of O
the O
11th _RARE_
and O
the O
12th _RARE_
thoracic _RARE_
vertebrae _RARE_
in O
592 _RARE_
men O
and O
333 _RARE_
women O
were O
studied O
using O
computed O
tomography O
. O

In O
a O
series O
of O
402 _RARE_
consecutive O
autopsies _RARE_
, O
parietal _RARE_
pleural _RARE_
plaques _RARE_
( O
PP _RARE_
) O
were O
found O
in O
68 _RARE_
individuals O
above O
40 O
years O
of O
age O
. O

Approximately O
60 _RARE_
% O
of O
cell O
bodies _RARE_
of O
primary _RARE_
neurons O
innervating _RARE_
the O
intra _RARE_
and O
perioral _RARE_
structures _RARE_
through O
the O
inferior O
alveolar O
, O
lingual _RARE_
, O
mental O
, O
and O
buccal _RARE_
nerves O
were O
in O
the O
range O
between O
300 _RARE_
and O
600 O
micron O
2 O
in O
cross O
- O
sectional O
area O
: O
mean O
+/- O
SD O
509 _RARE_
+/- O
243 _RARE_
micron O
2 O
, O
420 _RARE_
+/- O
181 _RARE_
micron O
2 O
, O
469 _RARE_
+/- O
200 _RARE_
micron O
2 O
, O
and O
444 _RARE_
+/- O
186 _RARE_
micron O
2 O
, O
respectively O
. O

Pharmacological _RARE_
action O
of O
eptazocine _RARE_
( O
l _RARE_
- O
1 O
, O
4 O
- O
dimethyl O
- O
10 O
- O
hydroxy O
- O
2 O
, O
3 O
, O
4 O
, O
5 O
, O
6 O
, O
7 O
- O
hexahydro _RARE_
- O
1 O
, O
6 O
- O
methano _RARE_
- O
1H _RARE_
- O
4 O
- O
benz _RARE_
azonine _RARE_
). O

On O
transition O
from O
high O
to O
low O
voltage O
there O
was O
a O
significant O
fall O
in O
arterial O
pressure O
( O
7 O
%) O
and O
an O
increase O
in O
flow O
( O
19 O
- O
38 O
%) O
to O
areas O
of O
the O
brain O
corresponding O
to O
the O
arborization _RARE_
of O
the O
reticular _RARE_
formation O
, O
i O
. O
e _RARE_
. O
excluding O
the O
cerebrum _RARE_
and O
cerebellum _RARE_
. O

Findings _RARE_
of O
positive O
potentials O
showed O
that O
N1 _RARE_
originated _RARE_
in O
the O
area O
of O
ventral O
gray O
matter O
through O
the O
ventro _RARE_
- O
lateral O
column O
and O
N2 O
through O
the O
dorsal O
column O
. O

One O
hundred O
and O
four O
( O
14 O
per O
cent O
) O
second O
primary _RARE_
tumours O
were O
reported O
. O

Failures _RARE_
of O
colorimetric _RARE_
additivity _RARE_
under O
these O
experimental O
conditions O
are O
discussed O
. O

There O
have O
been O
five O
problems O
( O
extravasation _RARE_
2 O
, O
suspected O
sepsis O
1 O
, O
and O
hematoma _RARE_
2 O
) O
during _RARE_
a O
total _RARE_
of O
2 O
, O
927 _RARE_
days O
of O
exposure O
. O

It O
is O
suggested O
that O
these O
results O
may O
raise _RARE_
the O
interesting _RARE_
possibility O
of O
providing O
a O
means O
of O
identifying O
greater O
or O
lesser O
susceptibility _RARE_
to O
the O
coronary O
effects O
of O
Type _RARE_
A O
behavior O
. O

Two O
studies O
assessed O
two O
types _RARE_
of O
reliability O
of O
the O
student _RARE_
Jenkins _RARE_
Activity _RARE_
Survey _RARE_
( O
JAS _RARE_
; O
a O
questionnaire O
measure O
of O
Type _RARE_
A O
behavior O
). O

Splenectomized _RARE_
patients O
are O
predisposed _RARE_
toward O
developing O
overwhelming _RARE_
bacterial O
infections O
. O

When O
phencyclidine _RARE_
was O
administered O
alone O
, O
overall O
response O
rate O
decreased O
and O
percent O
errors _RARE_
increased O
with O
increasing O
doses O
. O

Possibilities _RARE_
and O
outlook _RARE_
for _RARE_
wrist O
joint O
endoprosthesis _RARE_

Study O
of O
the O
energy O
metabolism O
of O
the O
sensomotor _RARE_
cortex O
and O
hippocampus O
by O
the O
( O
14C O
) O
2 O
- O
deoxyglucose _RARE_
method O
during _RARE_
the O
development O
of O
dissociated _RARE_
states O

Malignant _RARE_
lymphoma O
is O
very O
heterogeneous _RARE_
in O
terms O
of O
its O
biological O
behavior O
. O

Further O
investigations O
are O
necessary O
to O
elucidate O
the O
biochemical O
and O
physiological O
properties O
of O
DLIS _RARE_
. O

Among O
them O
, O
26 _RARE_
cases O
were O
benign O
and O
34 _RARE_
malignant O
. O

Of O
the O
cases O
with O
PLD _RARE_
, O
50 O
% O
had O
associated O
renal _RARE_
cysts O
and O
10 O
% O
of O
the O
cases O
with O
APCD _RARE_
had O
associated O
liver O
cysts O
. O

Fast _RARE_
goal O
- O
directed O
voluntary _RARE_
movements O
of O
the O
human O
upper O
extremity _RARE_
are O
known O
to O
be O
associated O
with O
three O
distinct O
bursts _RARE_
of O
EMG O
activity O
in O
antagonistic O
muscles O
. O

The O
combination O
of O
F1 _RARE_
and O
F2 O
which O
was O
the O
best O
predictor O
of O
CHD _RARE_
in O
this O
population O
( O
G1 O
) O
might O
be O
interpreted O
as _RARE_
reflecting O
trunk O
adiposity _RARE_
mainly O
abdominal O
. O

Renal O
clearance O
fell O
from O
19 O
. O
0 _RARE_
+/- O
4 O
. O
9 O
ml O
/ O
min O
/ O
1 O
. O
73 _RARE_
m2 O
( O
group O
I O
) O
to O
1 O
. O
0 _RARE_
+/- O
0 _RARE_
. O
4 O
ml O
/ O
min O
/ O
1 O
. O
73 _RARE_
m2 O
( O
group O
IV O
). O

The O
relations O
between O
type O
A O
behavior O
, O
clinically O
relevant O
behavior O
, O
academic _RARE_
achievement _RARE_
, O
and O
IQ _RARE_
in O
children O
. O

The O
rats O
were O
used O
for _RARE_
the O
study O
of O
the O
effects O
of O
sepsis O
on O
the O
utilization O
of O
exogenous _RARE_
fat O
emulsion _RARE_
. O

She _RARE_
also O
had O
slight O
weakness _RARE_
of O
the O
upper O
extremities _RARE_
. O

Results O
of O
electron O
therapy O
of O
tumors O
in O
different O
sites O

The O
mechanism O
of O
action O
is O
explored O
in O
some O
detail O
, O
specifically O
as _RARE_
it O
relates _RARE_
to O
reticuloendothelial _RARE_
system _RARE_
( O
RES _RARE_
) O
Fc I-GENE
receptor I-GENE
blockade O
and O
suppression O
of O
antiplatelet _RARE_
antibody O
synthesis _RARE_
. O

Incidences _RARE_
of O
nonfatal _RARE_
stroke O
, O
myocardial _RARE_
infarction O
, O
angina O
pectoris O
und _RARE_
left _RARE_
ventricular O
hypertrophy O
could O
also O
be O
lowered O
. O

High _RARE_
radial _RARE_
r _RARE_
values O
with O
small O
standard O
deviations _RARE_
were O
observed O
in O
normal O
LV O
( O
0 _RARE_
. O
972 _RARE_
+/- O
0 _RARE_
. O
016 _RARE_
) O
and O
in O
non O
- O
MI O
regions O
( O
0 _RARE_
. O
964 _RARE_
+/- O
0 _RARE_
. O
018 _RARE_
), _RARE_
indicating O
temporally O
homogeneous _RARE_
radial _RARE_
shortening O
. O

These O
results O
indicate O
that O
during _RARE_
pregnancy _RARE_
there O
are O
increases O
in O
bone O
formation O
rates O
contributing _RARE_
to O
the O
increases O
in O
skeletal O
mass O
. O

We O
analyzed O
data O
from O
56 _RARE_
patients O
with O
Systemic _RARE_
Lupus _RARE_
Erythematosus _RARE_
( O
SLE O
) O
in O
whom O
renal _RARE_
biopsies O
were O
done O
systematically O
. O

The O
possibility O
of O
a O
hereditary _RARE_
disorder O
leading O
to O
a O
minor O
defect O
in O
elastic O
fibre O
structure _RARE_
which O
could O
be O
responsible O
for _RARE_
the O
spontaneous O
lesions O
is O
discussed O
. O

Prevention O
by O
a O
heparin _RARE_
- O
antithrombin I-GENE
III I-GENE
combination O

N O
- O
Substituted _RARE_
trimethylsilylcarbamates _RARE_
were O
tested O
as _RARE_
derivatizing _RARE_
reagents _RARE_
for _RARE_
gas O
chromatographic O
analysis O
. O

MICs O
of O
four O
antifungal _RARE_
agents O
( O
5 O
- O
fluorocytosine _RARE_
, O
miconazole _RARE_
, O
ketoconazole _RARE_
, O
and O
amphotericin O
B O
) O
for _RARE_
84 _RARE_
clinical O
isolates O
of O
various O
Candida _RARE_
species O
were O
then O
determined O
with O
both O
media O
in O
agar O
dilution O
and O
microtiter _RARE_
broth _RARE_
dilution O
systems _RARE_
. O

There O
were O
18 O
patients O
with O
Group O
II O
( O
a O
) O
tumors O
; O
although O
tumor O
biopsy O
was O
attempted _RARE_
on O
eight O
of O
these O
, O
pathological O
diagnosis O
at _RARE_
the O
time O
of O
surgery O
was O
made O
in O
only O
one O
case O
. O

Evidence O
that O
opiate _RARE_
addiction _RARE_
is O
in O
part O
an O
immune O
response O
. O

Parasitological _RARE_
post O
- O
mortem _RARE_
examination O
of O
all O
seropositive O
animals O
showed O
five O
and O
seven _RARE_
false O
- O
positive O
animals O
when O
E I-GENE
/ I-GENE
S I-GENE
and I-GENE
CWE _RARE_
antigens I-GENE
were O
used O
, O
respectively O
. O

Glucocorticoid _RARE_
induced _RARE_
hypertension O
has O
been O
regarded O
as _RARE_
independent O
of O
sodium _RARE_
( O
Na _RARE_
), _RARE_
in O
contrast O
to O
mineralocorticoid _RARE_
induced _RARE_
hypertension O
, O
which O
is O
Na _RARE_
+- _RARE_
dependent O
. O

Seventeen _RARE_
of O
them O
were O
on O
treatment O
with O
systemic O
steroids O
. O

Examples _RARE_
of O
its O
use O
in O
the O
intensive O
therapy O
unit O
are O
described O
. O

The O
growing O
drug O
problem O
is O
also O
reflected O
in O
the O
increasing O
number O
of O
cases O
of O
hepatitis O
B O
and O
of O
drug O
- O
related O
deaths O
. O

Only O
seven _RARE_
patients O
, O
five O
of O
whom O
have O
metastatic O
disease _RARE_
, O
survive _RARE_
more O
than O
10 O
years O
after O
first _RARE_
presentation O
; O
nine O
patients O
, O
one O
of O
whom O
has O
secondaries _RARE_
, O
survive _RARE_
for _RARE_
5 O
years O
or O
less O
. O

Although O
differences O
were O
not O
significant O
, O
infants O
in O
the O
experimental O
group O
had O
more O
changes O
in O
the O
intermittent O
mandatory _RARE_
ventilation O
( O
IMV _RARE_
) O
settings _RARE_
during _RARE_
transport _RARE_
, O
and O
more O
such O
infants O
arrived _RARE_
at _RARE_
the O
receiving O
hospital O
with O
acceptable O
pH O
and O
PCO2 O
values O
. O

Repetitive _RARE_
sequences O
are O
present O
in O
at _RARE_
least O
three O
introns _RARE_
of O
the O
cytochrome I-GENE
P I-GENE
- I-GENE
450PBc2 _RARE_
gene I-GENE
, O
but O
not O
in O
exons O
or O
the O
5 O
'- O
flanking O
region O
. O

A O
large O
increase O
of O
serum O
ketones _RARE_
occurred O
under O
all O
conditions O
, O
and O
the O
exercise O
respiratory O
quotient _RARE_
suggested O
some O
increase O
of O
fat O
utilization O
, O
WW _RARE_
( O
0 _RARE_
. O
85 _RARE_
) O
through O
CW _RARE_
( O
0 _RARE_
. O
84 _RARE_
) O
to O
CC _RARE_
( O
0 _RARE_
. O
83 _RARE_
). O

This O
lack O
of O
correlation O
may O
be O
due O
to O
variations O
in O
the O
metabolic O
activity O
of O
the O
endometriotic _RARE_
implants O
present O
at _RARE_
different O
stages O
of O
the O
disease _RARE_
. O

Respiratory _RARE_
adaptation O
to O
chronic O
hypoxia _RARE_
in O
newborn O
rats O
. O

Compound _RARE_
1 O
is O
either O
21 O
- O
O O
- O
angeloyl _RARE_
, O
22 _RARE_
- O
O O
- O
tigloyl _RARE_
R1 _RARE_
- O
barrigenol _RARE_
, O
or O
21 O
- O
O O
- O
tigloyl _RARE_
, O
22 _RARE_
- O
O O
- O
angeloyl _RARE_
R1 _RARE_
- O
barrigenol _RARE_
. O

Human O
and O
Chinese _RARE_
hamster I-GENE
S14 _RARE_
protein I-GENE
sequences I-GENE
deduced O
from O
the O
cDNAs O
are O
identical O
. O

RPS14 _RARE_
introns _RARE_
3 O
and O
4 O
both O
contain O
Alu I-GENE
sequences O
. O

One O
of O
the O
most O
relevant O
aspects O
in O
achieving _RARE_
the O
consistent O
survival O
of O
an O
animal _RARE_
undergoing O
the O
experimental O
implantation O
of O
a O
total _RARE_
artificial O
heart _RARE_
is O
obviously _RARE_
related O
to O
the O
correct O
anatomic O
placement O
of O
prosthetic _RARE_
ventricles O
inside _RARE_
the O
chest O
. O

An O
exaggerated _RARE_
tissue O
response O
adjacent O
to O
the O
cyanoacrylate _RARE_
site O
suggested O
a O
potential _RARE_
toxic O
chemical O
or O
thermal O
reaction O
, O
or O
both O
, O
to O
the O
tissue O
adhesive O
, O
but O
there O
was O
no _RARE_
evidence O
of O
any O
distant O
ocular O
effects O
. O

These O
findings O
suggest O
that O
there O
may O
be O
a O
relationship O
between O
the O
pathogenesis O
of O
MAL _RARE_
, O
narcolepsy _RARE_
, O
and O
OSA _RARE_
. O

Among O
82 O
superficial O
lesions O
34 _RARE_
were O
classified O
as _RARE_
showing O
CR _RARE_
and O
another O
23 _RARE_
as _RARE_
showing O
PR O
, O
with O
a O
response O
rate O
of O
69 _RARE_
. O
5 O
%. O

Under O
the O
same O
hematocrit O
and O
flow O
conditions O
, O
the O
rate O
of O
oxygen O
saturation O
decrease O
was O
significantly O
higher _RARE_
for _RARE_
the O
sickle _RARE_
cells O
than O
for _RARE_
normal O
cells O
. O

While O
the O
examiner _RARE_
observed O
the O
interior _RARE_
of O
the O
eye O
with O
indirect O
ophthalmoscopy _RARE_
, O
the O
point O
source O
of O
light O
from O
the O
fiberoptic _RARE_
light O
pipe _RARE_
was O
moved _RARE_
along O
the O
margins _RARE_
of O
the O
episcleral _RARE_
plaque O
. O

These O
fusion O
proteins O
also O
allowed O
the O
localization _RARE_
of O
the O
transcriptional O
activation O
and O
DNA O
binding O
domains O
of O
the O
ToxR _RARE_
protein I-GENE
to O
its O
cytoplasmically _RARE_
located _RARE_
N O
- O
terminal O
portion O
. O

From O
life O
- O
table _RARE_
analyses O
of O
these O
patients O
, O
we O
estimated O
that O
the O
incidence O
of O
secondary O
chondrosarcoma _RARE_
in O
patients O
who O
have O
Ollier _RARE_
disease _RARE_
is O
about O
25 _RARE_
per O
cent O
at _RARE_
the O
age O
of O
forty _RARE_
years O
, O
and O
that O
malignant O
degeneration O
is O
almost O
a O
certainty _RARE_
in O
patients O
who O
have O
Maffucci _RARE_
syndrome _RARE_
. O

The O
lethal O
toxicity O
of O
inorganic O
( O
HgCl2 _RARE_
) O
and O
organic O
( O
CH3HgCl _RARE_
) O
mercury _RARE_
chloride _RARE_
was O
compared O
for _RARE_
Coturnix _RARE_
( O
Japanese O
quail _RARE_
, O
Coturnix _RARE_
japonica _RARE_
) O
of O
different O
ages O
from O
hatch _RARE_
through O
adulthood _RARE_
by O
single O
- O
dose O
acute O
oral O
and O
intramuscular _RARE_
injections O
and O
by O
a O
5 O
- O
d O
dietary O
trial O
. O

Since O
the O
integrated O
13h00 _RARE_
- O
16h00 _RARE_
plasma O
cortisol O
estimation O
is O
cheaper _RARE_
and O
simpler _RARE_
than O
the O
mean O
13h00 _RARE_
- O
16h00 _RARE_
plasma O
cortisol O
estimation O
, O
we O
recommend _RARE_
it O
as _RARE_
an O
adjunct _RARE_
in O
the O
diagnosis O
of O
Cushing _RARE_
' O
s O
syndrome _RARE_
. O

Most O
of O
the O
patients O
had O
locally O
advanced O
lesions O
( O
63 _RARE_
T3 _RARE_
- O
4 O
: O
91 O
. O
5 O
%) O
according O
to O
the O
adopted O
TNM _RARE_
system _RARE_
( O
Lederman _RARE_
- O
Gadeberg _RARE_
, O
Sisson _RARE_
- O
Jesse _RARE_
). O

The O
risk O
for _RARE_
these O
complications O
is O
increased O
by O
the O
following O
factors O
: O
multiple O
gestation O
, O
the O
combination O
of O
magnesium O
sulfate _RARE_
and O
beta O
- O
adrenergic O
agonist O
, O
and O
the O
use O
of O
adrenocortico _RARE_
- O
steroids O
to O
hasten _RARE_
fetal _RARE_
pulmonary O
maturity _RARE_
. O

Chlorambucil _RARE_
and O
interferon _RARE_
for _RARE_
low O
grade O
non O
- O
Hodgkin O
' O
s O
lymphoma O
. O

Selenium _RARE_
(. _RARE_
1 O
ppm O
) O
and O
E O
( O
50 O
IU O
/ O
kg O
) O
supplementation O
of O
the O
diet O
of O
the O
sow _RARE_
increased O
plasma O
tocopherol _RARE_
and O
Se _RARE_
concentrations O
, O
but O
did O
not O
increase O
plasma I-GENE
glutathione _RARE_
peroxidase I-GENE
( O
GSH _RARE_
- I-GENE
Px _RARE_
) O
activity O
. O

Framingham _RARE_
Type _RARE_
A O
behavior O
was O
positively O
associated O
with O
diastolic O
blood _RARE_
pressure O
( O
r _RARE_
= O
0 _RARE_
. O
17 _RARE_
, O
p O
less O
than O
0 _RARE_
. O
05 O
) O
among O
the O
women O
. O

The O
in O
vitro O
antibacterial _RARE_
potency O
is O
greatest O
when O
the O
1 O
- O
substituent _RARE_
is O
2 O
, O
4 O
- O
difluorophenyl _RARE_
and O
the O
7 O
- O
substituent _RARE_
is O
a O
3 O
- O
amino O
- O
1 O
- O
pyrrolidinyl _RARE_
group O
. O

The O
M I-GENE
reading I-GENE
frame I-GENE
differed O
from O
the O
reported O
sequence O
by O
a O
single O
nucleotide O
corresponding O
to O
a O
conservative O
lysine _RARE_
to O
arginine _RARE_
amino O
acid O
substitution O
near O
the O
carboxy _RARE_
- O
terminus O
conserved _RARE_
among O
the O
M I-GENE
proteins I-GENE
of O
paramyxoviruses _RARE_
. O

An O
ion O
chromatographic O
method O
was O
used O
to O
determine O
Br O
ion O
in O
the O
urine O
of O
Greyhounds _RARE_
. O

II O
. O

Laryngographic _RARE_
changes O
following O
endotracheal _RARE_
intubation _RARE_
in O
adults O
. O

Intensification _RARE_
of O
human O
myocardial _RARE_
contractile O
activity O
as _RARE_
affected O
by O
blood _RARE_
serum O

Autotransplantation _RARE_
of O
a O
vein _RARE_
segment O
with O
valve O
in O
the O
treatment O
of O
deep O
vein _RARE_
valvular _RARE_
insufficiency O
of O
the O
lower O
extremity _RARE_

The O
relationships O
among O
four O
descriptors _RARE_
of O
lactate _RARE_
increase O
: O
lactate _RARE_
threshold O
( O
LT _RARE_
) O
( O
the O
VO2 O
at _RARE_
which O
blood _RARE_
lactate _RARE_
concentration O
begins O
to O
increase O
above O
the O
resting O
level O
during _RARE_
an O
incremental _RARE_
exercise O
test O
), _RARE_
LT1 _RARE_
( O
the O
VO2 O
at _RARE_
which O
blood _RARE_
lactate _RARE_
increases O
1 O
mM O
above O
the O
resting O
level O
), _RARE_
LT2 _RARE_
( O
the O
VO2 O
at _RARE_
which O
blood _RARE_
lactate _RARE_
concentration O
reaches _RARE_
a O
fixed O
value O
of O
2 O
mM O
), _RARE_
onset O
of O
blood _RARE_
lactate _RARE_
accumulation O
( O
OBLA _RARE_
; O
the O
VO2 O
at _RARE_
which O
blood _RARE_
lactate _RARE_
reaches _RARE_
a O
concentration O
of O
4 O
mM O
), _RARE_
were O
compared O
with O
aerobic O
capacity O
( O
VO2max _RARE_
) O
and O
12 O
min O
running _RARE_
performance O
in O
19 O
untrained _RARE_
female O
students O
. O

This O
is O
based O
on O
partitioning _RARE_
an O
underlying O
multivariate O
normal O
distribution O
. O

The O
observation O
of O
late _RARE_
effects O
after O
irradiations _RARE_
or O
after O
space O
flights _RARE_
show O
the O
difficulties _RARE_
encountered _RARE_
in O
assessing O
radiative _RARE_
risks _RARE_
during _RARE_
long O
duration O
space O
flights _RARE_
. O

Practical _RARE_
use O
and O
interpretation O
of O
viral O
hepatitis O
B O
markers O
and O
hepatic _RARE_
biopsy O
in O
HBs I-GENE
Ag _RARE_
carriers O
and O
at _RARE_
the O
chronic O
hepatitis O
stage _RARE_

The O
1 O
, O
2 O
, O
3 O
and O
4 O
year O
survival O
rates O
were O
94 O
%, O
84 _RARE_
%, O
76 _RARE_
% O
and O
63 _RARE_
%, O
respectively O
. O

Inhibition O
of O
histalog _RARE_
- O
stimulated _RARE_
gastric _RARE_
secretion _RARE_
by O
40 O
749 _RARE_
RP _RARE_
, O
a O
new O
long O
- O
acting O
gastric _RARE_
antisecretory _RARE_
agent O
. O

Five O
- O
year O
prospective O
study O
of O
peripheral O
white _RARE_
blood _RARE_
cells O
in O
infectious O
mononucleosis _RARE_
. O

Northern O
blotting O
with O
a O
unique O
17 _RARE_
- O
mer _RARE_
oligonucleotide _RARE_
demonstrated O
the O
absence O
of O
the O
mutant O
sequence O
in O
the O
mRNA O
from O
which O
the O
cDNA O
library O
giving O
rise O
to O
the O
mutant O
cDNA O
was O
constructed O
. O

Novel _RARE_
multigene _RARE_
families _RARE_
encoding O
highly O
repetitive _RARE_
peptide O
sequences O
. O

Chemotherapy _RARE_
of O
metastasizing _RARE_
breast O
cancer _RARE_

In O
recent O
years O
, O
successful O
physiological O
models O
have O
been O
developed O
for _RARE_
a O
variety O
of O
volatile O
and O
nonvolatile _RARE_
chemicals _RARE_
, O
and O
their O
ability O
to O
perform O
the O
extrapolations _RARE_
needed O
in O
risk O
assessment O
has O
been O
demonstrated O
. O

Linear _RARE_
extrapolation _RARE_
is O
used O
below O
the O
experimental O
data O
range O
to O
establish O
an O
upper O
bound _RARE_
on O
carcinogenic _RARE_
risk O
at _RARE_
low O
doses O
. O

Hisako _RARE_
Minowa _RARE_
who O
has O
worked _RARE_
as _RARE_
a O
psychiatric O
counsellor _RARE_
in O
industry _RARE_
for _RARE_
the O
past O
20 O
years O

Deletion O
mapping O
studies O
revealed O
that O
the O
upstream O
DNA O
sequences O
up _RARE_
to O
- O
86 _RARE_
were O
sufficient O
for _RARE_
the O
optimal O
basal O
level O
transcription O
in O
HeLa O
cells O
and O
also O
for _RARE_
the O
EIA _RARE_
- O
induced _RARE_
transcription O
. O

Incorporation _RARE_
of O
the O
polyene _RARE_
antibiotic O
amphotericin O
B O
( O
AMB _RARE_
) O
in O
liposomes O
results O
in O
a O
marked O
reduction O
in O
drug O
toxicity O
with O
no _RARE_
loss _RARE_
of O
antifungal _RARE_
potency O
. O

Eleven _RARE_
healthy O
, O
normotensive _RARE_
males O
undergoing O
routine O
restorative _RARE_
dental O
care O
were O
evaluated O
during _RARE_
treatment O
for _RARE_
possible O
hemodynamic O
alterations O
in O
response O
to O
potential _RARE_
sympathetic O
nervous O
system _RARE_
stimulation _RARE_
. O

Serum I-GENE
IgM I-GENE
and O
IgE I-GENE
concentrations O
, O
allergen _RARE_
- I-GENE
specific I-GENE
IgE I-GENE
scores O
, O
and O
the O
tumor O
E2R _RARE_
status O
were O
combined O
to O
construct O
a O
three O
- O
level O
risk O
classification O
that O
was O
more O
prognostic O
than O
any O
of O
the O
individual O
components _RARE_
. O

The O
M O
- O
3 O
subtype _RARE_
was O
an O
adverse O
prognostic O
factor O
. O

Within O
the O
Strep _RARE_
. O
mutans _RARE_
group O
there O
was O
a O
highly O
- O
significant O
difference O
between O
Strep _RARE_
. O
mutans _RARE_
/ O
Strep _RARE_
. O
cricetus _RARE_
( O
p O
less O
than O
0 _RARE_
. O
01 O
) O
with O
respect O
to O
mean O
clump _RARE_
size O
. O

These O
results O
indicate O
that O
T O
. O
C O
., O
LDL I-GENE
- I-GENE
C I-GENE
., O
HDL _RARE_
- I-GENE
C I-GENE
., O
HDL2 I-GENE
- I-GENE
C I-GENE
., O
apo _RARE_
B I-GENE
, O
apo _RARE_
A I-GENE
- I-GENE
I I-GENE
/ I-GENE
B I-GENE
ratio O
and O
apo _RARE_
A I-GENE
- I-GENE
II I-GENE
/ I-GENE
B I-GENE
ratio O
are O
predictive O
risk O
factors O
of O
the O
coronary O
heart _RARE_
disease _RARE_
. O

It O
is O
concluded O
that O
the O
unique O
suppository _RARE_
formulation O
of O
CZX _RARE_
- O
S O
is O
useful O
in O
the O
treatment O
of O
infections O
in O
children O
with O
heavy O
psychophysiologic _RARE_
disorders O
and O
in O
children O
who O
cannot O
take O
oral O
drugs O
because O
of O
severe O
vomiting _RARE_
. O

In O
addition O
, O
marked O
hypertension O
accompanied O
this O
disorder O
and O
all O
abnormalities O
, O
including O
the O
hypertension O
, O
responded O
to O
1 I-GENE
- I-GENE
desamino _RARE_
- I-GENE
8 I-GENE
- I-GENE
D I-GENE
- I-GENE
arginine _RARE_
vasopressin I-GENE
therapy O
. O

Single _RARE_
photon O
emission O
computerized O
tomography O
( O
SPECT O
), _RARE_
by O
providing O
three O
- O
dimensional O
representation _RARE_
of O
myocardial _RARE_
Tl O
- O
201 _RARE_
, O
offers O
promise _RARE_
for _RARE_
improved O
localization _RARE_
of O
CAD _RARE_
. O

Computer _RARE_
assisted _RARE_
mapping O
in O
quantitative O
analysis O
of O
cerebral O
positron _RARE_
emission O
tomograms _RARE_
. O

In O
19 O
patients O
vagotomy O
not O
only O
curbed _RARE_
the O
bleeding O
but O
provided O
definitive O
therapy O
( O
Visick _RARE_
I O
- O
II O
); O
4 O
patients O
died O
( O
mortality O
rate O
16 O
%). O

Documentation _RARE_
of O
a O
successful O
intrauterine O
fertilization O
with O
delivery O
of O
a O
term O
baby _RARE_
supports O
the O
theoretical _RARE_
feasibility O
of O
the O
EP _RARE_
; O
however O
, O
anovulation _RARE_
incurred _RARE_
by O
our O
procedure O
appears O
to O
be O
the O
major O
drawback _RARE_
. O

MRI O
disclosed _RARE_
one O
or O
more O
of O
the O
following O
abnormalities O
in O
24 _RARE_
( O
63 _RARE_
%) O
of O
38 O
treated O
kidneys O
: O
( O
1 O
) O
loss _RARE_
of O
corticomedullary _RARE_
differentiation O
, O
( O
2 O
) O
perirenal _RARE_
fluid _RARE_
, O
( O
3 O
) O
subcapsular _RARE_
hematoma _RARE_
, O
( O
4 O
) O
hemorrhage O
into O
a O
renal _RARE_
cyst O
, O
and O
( O
5 O
) O
unexplained _RARE_
abnormalities O
. O

The O
results O
obtained O
are O
similar O
to O
those O
described O
with O
the O
previous O
Cremophor _RARE_
formulation O
although O
greater O
variability O
in O
induction O
and O
recovery O
times O
was O
noted O
with O
the O
emulsion _RARE_
formulation O
. O

The O
percentage O
RFR _RARE_
reduction O
at _RARE_
the O
end O
of O
CPB O
showed O
significant O
correlation O
with O
1 O
) O
CPB O
duration O
( O
r _RARE_
= O
0 _RARE_
. O
49 _RARE_
), _RARE_
2 O
) O
oxygen O
flow O
rate O
index O
( O
OFRI _RARE_
), _RARE_
i O
. O
e _RARE_
. O
flow O
/ O
min O
in O
the O
bubble _RARE_
oxygenator _RARE_
/ O
m2 O
bsa _RARE_
( O
r _RARE_
= O
0 _RARE_
. O
38 O
), _RARE_
and O
3 O
) O
blood _RARE_
flow O
rate O
index O
( O
BFRI _RARE_
), _RARE_
i O
. O
e _RARE_
. O
average O
volume O
of O
blood _RARE_
pumped _RARE_
through O
the O
heart _RARE_
- O
lung _RARE_
machine O
/ O
min O
CPB O
time O
/ O
m2 O
bsa _RARE_
( O
r _RARE_
= O
0 _RARE_
. O
51 _RARE_
). O

Diagnosis O
of O
unilateral O
renal _RARE_
artery O
lesions O
after O
captopril O
administration O
. O

A O
yeast O
DNA O
fragment O
carrying O
the O
gene I-GENE
CP I-GENE
A1 _RARE_
encoding O
the O
small O
subunit O
of O
the O
arginine _RARE_
pathway _RARE_
carbamoyl _RARE_
- I-GENE
phosphate I-GENE
synthetase _RARE_
has O
been O
sequenced O
. O

A O
retrospective O
study O
of O
banked _RARE_
sera _RARE_
from O
19 O
cats O
with O
the O
eosinophilic _RARE_
granuloma O
complex O
revealed O
that O
68 _RARE_
% O
of O
affected O
cats O
had O
circulating O
antibodies O
to O
components _RARE_
of O
normal O
cat _RARE_
epithelium O
. O

In O
memory O
of O
Magdelaine _RARE_
Comtesse _RARE_

The O
H2 I-GENE
receptor I-GENE
antagonists O
and O
sucralfate _RARE_
cost O
about O
the O
same O
and O
have O
few O
side _RARE_
effects O
. O

These O
results O
suggest O
that O
indoramin _RARE_
may O
have O
Class _RARE_
III O
antiarrhythmic O
activity O
. O

A O
high O
efficacy O
of O
the O
combined O
use O
of O
nontoxic _RARE_
doses O
of O
two O
pharmaceuticals _RARE_
: O
cystamine _RARE_
( O
50 O
mg O
/ O
kg O
) O
and O
mexamine _RARE_
( O
25 _RARE_
mg O
/ O
kg O
) O
under O
the O
conditions O
of O
short O
- O
term O
exogenous _RARE_
hypoxia _RARE_
( O
7 O
. O
5 O
% O
O2 _RARE_
) O
was O
found O
in O
( O
CBA _RARE_
X O
C57Bl _RARE_
) O
F1 _RARE_
mice O
. O

The O
Mean O
was O
74 _RARE_
, O
3 O
+/- O
53 O
, O
6 O
micrograms O
J _RARE_
/ O
g O
Cr _RARE_
, O
the O
Median _RARE_
61 _RARE_
micrograms O
J _RARE_
/ O
g O
Cr _RARE_
. O

In O
the O
region O
Walgau _RARE_
with O
mixed O
industrial _RARE_
- O
rural _RARE_
population O
an O
iodine O
deficiency O
I O
was O
found O
in O
81 _RARE_
% O
and O
an O
iodine O
deficiency O
II O
in O
45 _RARE_
%. O

The O
structural O
gene O
for _RARE_
hydrogenase _RARE_
encodes O
a O
protein O
product O
of O
molecular _RARE_
mass O
45820 _RARE_
Da _RARE_
. O

Pancreaticoduodenal _RARE_
lymph O
node O
enlargement O
, O
regardless O
of O
cause O
, O
has O
been O
a O
source O
of O
imaging O
confusion _RARE_
because O
of O
its O
propensity O
to O
mimic O
pancreatic O
malignancy O
yet O
not O
cause O
biliary O
obstruction O
. O

Interference _RARE_
with O
rheumatoid I-GENE
factor I-GENE
was O
only O
observed O
in O
the O
ELISA O
enzygnost _RARE_
if O
sera _RARE_
were O
not O
pretreated O
with O
latex O
adsorbents _RARE_
. O

All O
patients O
had O
elevated O
levels O
of O
serum I-GENE
IgE I-GENE
antibodies I-GENE
to O
the O
crude O
soybean _RARE_
extract _RARE_
; O
binding O
values O
ranged O
from O
2 O
. O
3 O
to O
28 _RARE_
. O
1 O
times O
that O
of O
a O
negative O
control O
serum O
. O

New O
techniques O
for _RARE_
the O
mass O
spectrometry O
of O
natural _RARE_
products O
. O

Dual _RARE_
radionuclide _RARE_
subtraction _RARE_
imaging O
of O
the O
spleen _RARE_
using O
67Ga _RARE_
citrate _RARE_
and O
99mTc O
is O
useful O
in O
further O
delineating _RARE_
lesions O
that O
are O
identified O
on O
either O
a O
routine O
radiogallium _RARE_
survey O
or O
on O
a O
conventional O
sulfur O
colloid O
liver O
- O
spleen _RARE_
image O
. O

Such O
studied O
acquired O
with O
low O
energy O
or O
medium O
energy O
collimation _RARE_
and O
a O
window _RARE_
centered O
on O
the O
159 _RARE_
keV _RARE_
123I _RARE_
photopeak _RARE_
contain O
appreciable _RARE_
septal O
breakthrough _RARE_
signals O
originating _RARE_
from O
Compton _RARE_
scatter _RARE_
of O
high O
energy O
photons _RARE_
primarily O
from O
124I _RARE_
. O

Nursing _RARE_
education O
-- _RARE_
the O
computer O
obligation _RARE_
. O

Shear _RARE_
bond O
strength O
of O
a O
composite O
resin O
to O
an O
etched _RARE_
glass O
ionomer _RARE_
. O

An O
additional O
advantage O
is O
that O
the O
resin O
can O
be O
removed O
and O
the O
immunoperoxidase _RARE_
technique O
carried O
out O
on O
thin O
sections O
. O

Such O
a O
concept O
is O
crucial O
to O
our O
understanding O
of O
the O
pathology O
of O
ageing _RARE_
in O
general _RARE_
. O

We O
consider O
that O
DIL _RARE_
- O
CP O
is O
a O
safe O
and O
excellent O
CP O
in O
CABG _RARE_
surgery O
and O
we O
are O
now O
utilizing O
this O
CP O
in O
all O
patients O
requiring O
CABG _RARE_
surgery O
. O

We O
have O
earlier O
evolved O
an O
experimental O
model O
by O
means O
of O
which O
changes O
identical O
to O
the O
microembolism _RARE_
syndrome _RARE_
can O
be O
induced _RARE_
from O
a O
reproducible _RARE_
musculo _RARE_
- O
skeletal O
trauma O
in O
pigs O
observed O
under O
long O
- O
term O
anesthesia O
under O
standardized O
conditions O
. O

Although O
no _RARE_
statistical O
significance O
was O
achieved O
, O
it O
is O
remarkable O
that O
there O
was O
a O
clear O
trend O
for _RARE_
the O
superiority _RARE_
of O
Galphimia _RARE_
D6 _RARE_
while O
the O
Galphimia _RARE_
dilution O
10 O
(- _RARE_
6 O
) O
was O
about O
equally O
effective O
compared O
with O
placebo O
. O

The O
volume O
of O
blood _RARE_
to O
the O
flap O
ranges _RARE_
from O
1 O
to O
2 O
ml O
/ O
min O
, O
collateral O
circulation O
to O
the O
flap O
exists O
, O
but O
is O
negligible _RARE_
, O
and O
there O
is O
little O
change O
in O
the O
capillary O
blood _RARE_
flow O
as _RARE_
the O
flap O
ages O
. O

With O
aging O
, O
many O
aspects O
of O
immune O
function O
change O
. O

Oral _RARE_
candidiasis O

In O
addition O
, O
the O
gcd1 _RARE_
- I-GENE
101 _RARE_
mutation I-GENE
suppressed O
the O
low O
translational O
efficiency O
of O
GCN4 I-GENE
- O
lacZ I-GENE
mRNA O
observed O
in O
gcn2 _RARE_
- I-GENE
and O
gcn3 _RARE_
- I-GENE
cells O
. O

This O
suggests O
that O
alaproclate _RARE_
acutely _RARE_
increases O
the O
responsiveness O
of O
postsynaptic _RARE_
muscarinic _RARE_
and I-GENE
alpha I-GENE
1 I-GENE
adrenoceptors I-GENE
. O

The O
concentrations O
of O
apo _RARE_
A I-GENE
- I-GENE
I I-GENE
and O
apo _RARE_
A I-GENE
- I-GENE
II I-GENE
of O
abstainers _RARE_
decreased O
significantly O
compared O
with O
the O
corresponding O
changes O
in O
controls O
. O

The O
distribution O
of O
patients O
was O
as _RARE_
follows O
: O
group O
1 O
-- _RARE_
complex O
gamma O
- O
therapy O
( O
55 _RARE_
cases O
), _RARE_
group O
2 O
-- _RARE_
complex O
gamma O
- O
therapy O
plus _RARE_
iliac O
lymphadenectomy _RARE_
( O
50 O
cases O
) O
and O
group O
3 O
-- _RARE_
complex O
radiation O
treatment O
with O
megavolt _RARE_
bremsstrahlung _RARE_
beam O
from O
the O
luc _RARE_
type O
installation _RARE_
and O
iliac O
lymphadenectomy _RARE_
( O
50 O
cases O
). O

The O
availability O
of O
cryoprecipitate _RARE_
and O
DDAVP _RARE_
offers O
an O
alternative _RARE_
and O
effective O
treatment O
for _RARE_
the O
temporary O
reversal O
of O
uremic _RARE_
bleeding O
in O
patients O
who O
require O
urgent _RARE_
invasive O
procedures O
. O

Thrombophlebitis _RARE_
and O
pulmonary O
embolism _RARE_
in O
congenital O
factor I-GENE
XII _RARE_
deficiency O

Biopsies _RARE_
of O
the O
jejunal _RARE_
mucosa O
have O
shown O
abnormal O
enzyme O
activity O
or O
deficiencies O
in O
transport _RARE_
mechanisms O
. O

Laboratory O
pyrolyses _RARE_
have O
indeed O
shown O
that O
PCBs _RARE_
give O
significant O
yields O
of O
PCDFs _RARE_
, O
and O
chlorobenzenes _RARE_
give O
both O
PCDFs _RARE_
and O
PCDDs _RARE_
. O

A O
significant O
degree O
of O
homology O
was O
also O
found O
among O
these O
genes O
and O
the O
Mtase _RARE_
gene I-GENE
of O
related O
phage _RARE_
SPR _RARE_
, O
which O
codes O
for _RARE_
an O
enzyme O
with O
different O
modification O
specificity _RARE_
. O

Thyrotropin _RARE_
- I-GENE
releasing I-GENE
hormone I-GENE
- O
induced _RARE_
contraction O
of O
urethral _RARE_
and O
vaginal O
muscle O
. O

In O
a O
blind O
controlled _RARE_
trial O
, O
15 _RARE_
patients O
with O
COCM _RARE_
( O
NYHA _RARE_
II O
- O
III O
) O
with O
sinus O
rhythm O
and O
a O
left _RARE_
ventricular O
ejection O
fraction O
( O
LV O
- O
EF _RARE_
) O
of O
34 _RARE_
. O
5 O
+/- O
2 O
. O
6 O
% O
received O
consecutively _RARE_
D O
( O
0 _RARE_
. O
25 _RARE_
- O
0 _RARE_
. O
5 O
mg O
/ O
d O
), _RARE_
placebo O
( O
PLAC _RARE_
), _RARE_
P O
( O
slow O
releases _RARE_
= O
SR O
) O
( O
80 _RARE_
mg O
/ O
d O
SR O
) O
and O
both O
drugs O
combined O
in O
respective O
doses O
. O

Mild _RARE_
orbital _RARE_
discomfort _RARE_
occurred O
in O
some O
patients O
. O

The O
sample O
is O
deproteinized _RARE_
and O
after O
centrifugation _RARE_
valproic _RARE_
acid O
in O
the O
supernatant O
is O
measured O
in O
the O
free O
form O
by O
direct O
injection O
into O
the O
gas O
chromatograph _RARE_
. O

Changes O
in O
muscarinic _RARE_
acetylcholine _RARE_
receptors I-GENE
in O
guinea _RARE_
- O
pig _RARE_
lung _RARE_
: O
effects O
of O
aging O
, O
inhalation O
of O
an O
allergen _RARE_
, O
administration O
of O
drugs O
, O
and O
vagotomy O
. O

In O
the O
absence O
of O
other O
stabilizers _RARE_
, O
increased O
sucrose O
can O
provide O
increased O
thermoresistance _RARE_
to O
the O
virus O
in O
2 O
. O
5 O
% O
albumin I-GENE
. O

The O
overall O
prevalence O
of O
psoriasis O
was O
4 O
. O
79 _RARE_
% O
in O
men O
and O
4 O
. O
85 _RARE_
% O
in O
women O
. O

Greek _RARE_
classicism _RARE_
in O
living O
structure _RARE_
? O
Some O
deductive _RARE_
pathways O
in O
animal _RARE_
morphology O
. O

The O
possible O
origin O
and O
role O
of O
CSF I-GENE
prolactin I-GENE
are O
discussed O
. O

Three O
chromosomal I-GENE
crsA _RARE_
mutations I-GENE
, O
crsA1 _RARE_
, O
crsA4 _RARE_
, O
and O
crsA47 _RARE_
, O
were O
transferred O
by O
the O
" O
gene O
conversion O
" O
process O
to O
B O
. O
subtilis O
plasmid _RARE_
pRPD11 _RARE_
, O
which O
consists O
of O
the O
entire _RARE_
wild I-GENE
- I-GENE
type I-GENE
rpoD _RARE_
coding I-GENE
sequence I-GENE
, O
encoding O
the O
major I-GENE
sigma _RARE_
43 _RARE_
factor I-GENE
of I-GENE
B I-GENE
. I-GENE
subtilis I-GENE
RNA I-GENE
polymerase I-GENE
, O
and O
pUB110 _RARE_
. O

Selective O
effect O
of O
pulmonary O
oedema _RARE_
on O
prostaglandin _RARE_
E2 O
pharmacokinetics O
in O
rat O
lung _RARE_
. O

This O
article O
will O
briefly _RARE_
review O
the O
published O
data O
on O
the O
morphology O
, O
function O
, O
and O
biochemistry _RARE_
of O
the O
normal O
renal _RARE_
medulla _RARE_
and O
the O
pathology O
associated O
with O
RPN _RARE_
, O
together O
with O
the O
secondary O
changes O
which O
give O
rise O
to O
cortical O
degeneration O
or O
epithelial _RARE_
carcinoma O
. O

The O
data O
indicate O
that O
the O
five O
different O
( O
and O
partially O
overlapping O
) O
sry _RARE_
messenger _RARE_
RNAs I-GENE
detectable O
in O
early O
embryos _RARE_
are O
initiated _RARE_
at _RARE_
three O
separate O
sites O
, O
each O
directly O
upstream O
from O
one O
of O
the O
three O
protein O
- O
coding O
regions O
, O
designated O
( O
in O
5 O
' O
to O
3 O
' O
order O
) O
beta O
, O
alpha O
and O
delta O
. O

Chronic O
thyroiditis O
as _RARE_
a O
risk O
factor O
of O
B O
- O
cell O
lymphoma O
in O
the O
thyroid O
gland _RARE_
. O

Plasma I-GENE
secretin _RARE_
levels O
also O
augmented O
after O
the O
administration O
of O
ethanol O
solutions O
, O
with O
a O
delay O
of O
about O
one O
hour O
after O
the O
onset O
of O
acid O
secretion _RARE_
. O

Spectrophotometric _RARE_
microanalysis _RARE_
of O
ethylenediaminotetracetic _RARE_
acid O
in O
pharmaceutical _RARE_
preparations O

A O
comparison O
among O
the O
5 O
' O
flanking O
regions O
encompassing _RARE_
the O
presumptive _RARE_
HS _RARE_
promoter I-GENE
of O
the O
soybean _RARE_
HS _RARE_
- I-GENE
protein I-GENE
genes I-GENE
demonstrated O
this O
region O
to O
be O
extremely O
homologous O
. O

Results O
of O
this O
study O
indicate O
that O
GLC _RARE_
of O
short O
chain O
fatty O
acids _RARE_
produced O
on O
agar O
medium O
by O
anaerobes _RARE_
, O
combined O
with O
simple O
tests O
such O
as _RARE_
Gram O
' O
s O
stain O
and O
colonial _RARE_
morphology O
, O
may O
allow O
fir _RARE_
direct O
presumptive _RARE_
genus O
identification O
from O
an O
initial O
pure O
agar O
culture O
. O

Using O
this O
method O
, O
we O
measured O
absorption O
of O
low O
doses O
of O
vitamin O
A O
, O
which O
may O
provide O
a O
more O
physiological O
approach O
to O
assessment O
of O
fat O
malabsorption _RARE_
. O

Fulminant _RARE_
hepatitis O
A O
in O
chronic O
HBV _RARE_
carrier O
. O

Tissue _RARE_
pressure O
, O
rCBF O
, O
and O
water O
content O
were O
measured O
from O
gray O
matter O
in O
the O
central O
core O
and O
the O
peripheral O
margin O
of O
the O
MCA _RARE_
territory _RARE_
over O
6 O
h O
after O
MCAO _RARE_
. O

During O
this O
time O
, O
the O
patients O
all O
had O
the O
characteristic O
plasma O
thyroid O
hormone O
changes O
associated O
with O
amiodarone _RARE_
therapy O
, O
i O
. O
e _RARE_
. O
increased O
T4 O
, O
free O
T4 O
, O
and O
rT3 _RARE_
and O
decreased O
T3 _RARE_
, O
while O
remaining O
clinically O
euthyroid _RARE_
. O

Drug O
and O
nutrient O
interactions O
. O

In O
each O
compartment O
O2 _RARE_
is O
removed O
by O
the O
tissues O
as _RARE_
a O
chemical O
reaction O
takes _RARE_
place O
between O
O2 _RARE_
and O
oxyhemoglobin _RARE_
( O
HbO2 _RARE_
). O

To O
evaluate O
the O
effects O
of O
propranolol O
on O
myocardial _RARE_
metabolism O
after O
coronary O
reperfusion O
, O
serial O
measurements O
of O
myocardial _RARE_
creatine _RARE_
kinase I-GENE
( O
CK _RARE_
) O
and O
calcium _RARE_
( O
Ca O
) O
contents O
and O
CK _RARE_
and O
lactic _RARE_
acid O
( O
LA O
) O
concentrations O
in O
coronary O
sinus O
blood _RARE_
were O
carried O
out O
in O
33 _RARE_
open _RARE_
- O
chest O
dogs O
. O

Dissolution _RARE_
of O
the O
Pt _RARE_
- O
30 _RARE_
% O
Ir _RARE_
microelectrode _RARE_
tip _RARE_
was O
observed O
by O
scanning O
electron O
microscopy O
at _RARE_
charge _RARE_
densities _RARE_
as _RARE_
low O
as _RARE_
200 _RARE_
microC _RARE_
/ O
cm2 O
X O
ph _RARE_
( O
1 O
A O
/ O
cm2 O
), _RARE_
whereas O
erosion _RARE_
of O
activated O
iridium _RARE_
microelectrodes _RARE_
occurred O
only O
at _RARE_
the O
highest O
charge _RARE_
and O
current O
densities _RARE_
( O
3200 _RARE_
microC _RARE_
/ O
cm2 O
X O
ph _RARE_
, O
16 O
A O
/ O
cm2 O
). O

Cortisol _RARE_
excretion O
, O
appeared O
to O
be O
markedly O
affected O
by O
the O
season O
although O
other O
factors O
such O
as _RARE_
social O
and O
environmental O
stress O
cannot O
be O
discounted _RARE_
. O

Two O
studies O
on O
the O
relationship O
between O
taking O
a O
commercial O
coaching _RARE_
course O
and O
performance O
on O
the O
Medical _RARE_
College _RARE_
Admission _RARE_
Test O
( O
MCAT _RARE_
) O
are O
reported O
. O

A O
total _RARE_
of O
90 _RARE_
patients O
were O
randomly O
allocated O
either O
to O
an O
MY _RARE_
- O
1 O
treated O
or O
an O
untreated O
group O
. O

Below _RARE_
50 O
% O
decrease O
of O
PaO2 O
, O
NADH _RARE_
was O
reduced _RARE_
largely O
. O

Angiography _RARE_
was O
performed O
following O
the O
rCBF O
study O
and O
the O
degree O
of O
vasospasm _RARE_
was O
measured O
on O
the O
angiograms _RARE_
. O

The O
results O
from O
the O
first _RARE_
five O
years O
of O
follow O
up _RARE_
in O
1972 O
showed O
a O
4 O
. O
7 O
- O
fold _RARE_
excess O
mortality O
for _RARE_
ischaemic O
and O
other O
heart _RARE_
diseases O
( O
ICD _RARE_
A83 _RARE_
- O
A84 _RARE_
) O
compared O
with O
a O
comparable O
reference O
cohort O
of O
paper O
mill _RARE_
workers O
. O

The O
financial _RARE_
impact O
of O
childhood O
asthma O
has O
not O
been O
assessed O
since O
Vance _RARE_
and O
Taylor _RARE_
reported O
their O
data O
in O
Annals _RARE_
of O
Allergy _RARE_
13 _RARE_
years O
ago _RARE_
. O

Hypersplenism _RARE_

Electrical _RARE_
activity O
was O
evaluated O
by O
monitoring O
the O
general _RARE_
electrocorticogram _RARE_
( O
ECoG _RARE_
) O
as _RARE_
well _RARE_
as _RARE_
local O
DC O
steady O
potential _RARE_
( O
two O
sites O
). O

The O
topography _RARE_
and O
trajectories _RARE_
of O
the O
commissural _RARE_
fibers O
of O
the O
superior O
temporal O
region O
( O
STR _RARE_
) O
are O
studied O
using O
the O
autoradiographic _RARE_
technique O
. O

The O
diabetic O
state O
was O
characterized O
by O
mild O
insulin I-GENE
deficiency O
, O
plasma O
levels O
being O
73 _RARE_
% O
of O
controls O
, O
and O
mild O
hyperglycemia _RARE_
, O
with O
nonfasting _RARE_
plasma O
glucose O
levels O
of O
1 O
. O
5 O
times O
normal O
. O

The O
primary _RARE_
CT _RARE_
findings O
were O
misinterpreted _RARE_
as _RARE_
a O
brain O
infarct O
or O
possibly O
a O
tumour _RARE_
. O

No O
consistent O
correlation O
between O
blood _RARE_
pressure O
change O
and O
SCR _RARE_
- O
change O
was O
seen O
. O

Shoulder _RARE_
forearm _RARE_
support O
for _RARE_
the O
subluxed _RARE_
shoulder _RARE_
. O

Piroxicam _RARE_
produced O
a O
lower O
incidence O
of O
gastric _RARE_
ulcers O
than O
equivalent O
doses O
of O
indomethacin O
. O

These O
findings O
suggest O
that O
both O
in O
the O
early O
stages O
( O
0T _RARE_
, O
0N _RARE_
) O
and O
in O
more O
severe O
stages O
of O
VWF _RARE_
( O
stages O
1 O
- O
2 O
) O
cold O
induced _RARE_
hyperreactivity _RARE_
in O
the O
digital O
vessels O
and O
Raynaud _RARE_
' O
s O
syndrome _RARE_
are O
vascular O
disorders O
of O
functional _RARE_
origin O
occurring O
without O
any O
prethrombotic _RARE_
alterations O
. O

In O
MCCP _RARE_
functions O
of O
the O
source O
emission O
, O
surface O
reflection _RARE_
, O
photoacceptor _RARE_
sensitivity O
are O
approximated _RARE_
by O
the O
normal O
distribution O
curves O
. O

However O
, O
kidneys O
perfused O
for _RARE_
72 O
hr O
demonstrated O
more O
similar O
renal _RARE_
functions O
when O
tested O
by O
either O
IMPK _RARE_
or O
IBPK _RARE_
. O

To O
assess O
the O
effects O
of O
alveolar O
hypoxia _RARE_
and O
angiotensin I-GENE
II I-GENE
infusion O
on O
distribution O
of O
blood _RARE_
flow O
to O
the O
lung _RARE_
we O
performed O
perfusion O
lung _RARE_
scans O
on O
anesthetized O
mechanically _RARE_
ventilated O
lambs O
. O

A O
flow O
rate O
of O
at _RARE_
least O
5 O
mL O
/ O
h O
is O
required O
through O
the O
receptor O
( O
volume O
, O
0 _RARE_
. O
4 O
mL O
) O
for _RARE_
accurate O
results O
. O

We O
have O
now O
located _RARE_
the O
5 O
' O
ends O
of O
the O
two O
remaining O
late _RARE_
mRNAs O
. O

The O
efficacy O
of O
quantitative O
and O
qualitative O
chloride _RARE_
titrators _RARE_
in O
the O
estimation O
of O
human O
salt O
intake O
. O

Doctor _RARE_
Berglund _RARE_
warns _RARE_
members O
of O
union _RARE_
pitfalls _RARE_
. O

Acute O
appearance O
of O
hemiparesis _RARE_
or O
hemiplegia _RARE_
with O
initial O
marked O
spasticity _RARE_
was O
observed O
in O
8 O
stroke O
patients O
. O

Recurrent _RARE_
acute O
rhinosinusitis _RARE_
was O
common O
in O
both O
groups O
of O
patients O
, O
but O
the O
development O
of O
chronic O
rhinosinusitis _RARE_
was O
only O
found O
in O
patients O
with O
CVID _RARE_
, O
indicating O
the O
more O
severe O
nature O
of O
this O
condition O
compared O
with O
selective O
IgA I-GENE
deficiency O
. O

These O
data O
suggest O
that O
AP I-GENE
- I-GENE
A I-GENE
may O
be O
potentially O
useful O
in O
the O
management O
of O
heart _RARE_
failure O
. O

The O
various O
muscles O
of O
the O
pelvic _RARE_
floor _RARE_
region O
could O
be O
reflexly _RARE_
activated O
either O
individually O
or O
as _RARE_
a O
mass O
unit O
depending O
on O
the O
intensity O
of O
stimulation _RARE_
. O

It O
has O
been O
reported O
that O
rat O
blood _RARE_
chloroform _RARE_
levels O
were O
significantly O
decreased O
after O
treatment O
with O
ClO2 _RARE_
. O

The O
frequency O
of O
lactase _RARE_
phenotypes _RARE_
in O
Aymara _RARE_
children O
. O

Activities _RARE_
of O
hepatic _RARE_
cytochrome I-GENE
P I-GENE
- I-GENE
450 _RARE_
- O
dependent O
metabolizing _RARE_
enzymes _RARE_
such O
as _RARE_
aminopyrine _RARE_
- I-GENE
and I-GENE
TMO _RARE_
N I-GENE
- I-GENE
demethylase _RARE_
and O
aniline _RARE_
hydroxylase I-GENE
activity O
were O
decreased O
by O
pretreatment O
of O
rats O
with O
cimetidine O
, O
whereas O
in O
the O
rats O
pretreated O
with O
ranitidine O
, O
these O
enzyme O
activities O
were O
not O
changed O
. O

Doxorubicin _RARE_
, O
dacarbazine _RARE_
, O
vincristine O
, O
and O
cyclophosphamide O
in O
the O
treatment O
of O
advanced O
gastrointestinal _RARE_
leiomyosarcoma _RARE_
. O

The O
effect O
of O
the O
opiate _RARE_
antagonist O
naloxone O
was O
evaluated O
in O
11 O
unselected _RARE_
patients O
with O
cerebral O
ischemia O
. O

Electrochemical _RARE_
detection O
of O
depressed O
circulating O
levels O
of O
vitamin O
K1 _RARE_
in O
osteoporosis _RARE_
. O

In O
the O
present O
experiments O
, O
we O
investigate O
the O
role O
played O
by O
the O
temporal O
pattern O
of O
neural _RARE_
activity O
during _RARE_
the O
ontogeny _RARE_
of O
frequency O
tuning _RARE_
in O
the O
mouse O
central O
auditory O
system _RARE_
. O

Ultrastructure _RARE_
of O
the O
tumor O
in O
1 O
patient O
in O
whom O
transurethral _RARE_
resection O
was O
performed O
2 O
weeks O
after O
alum _RARE_
irrigation O
revealed O
well _RARE_
preserved _RARE_
nuclear O
chromatin O
, O
thus O
, O
suggesting O
that O
whatever _RARE_
changes O
occur O
after O
alum _RARE_
irrigation O
are O
short O
- O
lived _RARE_
. O

The O
generally O
adopted O
criteria O
enabling _RARE_
to O
classify _RARE_
the O
examined O
persons O
into O
the O
following O
3 O
groups O
have O
been O
used O
: O
( O
a O
) O
diseased O
of O
BEN _RARE_
; O
( O
b O
) O
suspect _RARE_
to O
be O
diseased O
of O
BEN _RARE_
, O
and O
( O
c O
) O
individuals O
without O
signs O
of O
a O
renal _RARE_
disease _RARE_
. O

For O
this O
purpose O
, O
a O
simple O
respiration O
- O
control O
device O
has O
been O
developed O
that O
enables O
the O
patient O
to O
monitor O
breath _RARE_
- O
holding _RARE_
during _RARE_
successive O
scans O
. O

The O
POEMS _RARE_
syndrome _RARE_
( O
Polyneuropathy _RARE_
, O
Organomegaly _RARE_
, O
Endocrinopathy _RARE_
, O
Monoclonal _RARE_
component _RARE_
, O
Skin _RARE_
). O

During O
a O
disease _RARE_
remission O
there O
was O
an O
increase O
in O
GAG _RARE_
secretion _RARE_
with O
urine O
, O
linked _RARE_
with O
hyperheparinuria _RARE_
( O
13 _RARE_
. O
1 O
- O
fold _RARE_
, O
P O
less O
than O
0 _RARE_
. O
001 O
). O

In O
metastasis O
- O
free O
patients O
, O
the O
best O
results O
were O
obtained O
with O
tumor O
diameters O
under O
2 O
cm O
regardless O
of O
their O
localization _RARE_
in O
lung _RARE_
tissue O
and O
with O
2 O
-- _RARE_
4 O
. O
9 O
cm O
tumors O
embedded O
in O
lung _RARE_
parenchyma O
. O

Two O
siblings _RARE_
with O
hemolytic _RARE_
anemia _RARE_
caused O
by O
triosephosphate _RARE_
isomerase I-GENE
deficiency O
developed O
a O
progressive O
neurological O
syndrome _RARE_
featuring _RARE_
dystonic _RARE_
movements O
, O
tremor O
, O
pyramidal O
tract _RARE_
signs O
, O
and O
evidence O
of O
spinal _RARE_
motor O
neuron _RARE_
involvement O
. O

One O
extract _RARE_
with O
the O
lowest O
PCA _RARE_
content O
was O
non O
- O
carcinogenic _RARE_
. O

In O
the O
10 O
patients O
with O
a O
more O
severe O
degree O
of O
steatorrhea _RARE_
the O
decrease O
in O
fat O
loss _RARE_
approached _RARE_
20 O
% O
and O
a O
close O
relationship O
was O
found O
( O
r _RARE_
= O
0 _RARE_
. O
84 _RARE_
, O
p O
less O
than O
0 _RARE_
. O
01 O
) O
between O
the O
extent O
of O
the O
fatty O
acid O
loss _RARE_
on O
placebo O
and O
the O
decrease O
of O
this O
loss _RARE_
on O
taurine _RARE_
. O

Aortic _RARE_
diameters O
in O
infants O
and O
young O
children O
: O
normative _RARE_
angiographic O
data O
. O

The O
present O
investigation O
has O
revealed O
that O
the O
distribution O
of O
the O
main O
fatty O
acids _RARE_
in O
Leptospira _RARE_
phospholipids O
is O
similar O
to O
their O
distribution O
in O
Leptospira _RARE_
neutral O
lipids O
with O
the O
exception O
of O
unsaturated _RARE_
fatty O
acid O
with O
14 O
carbon O
atoms _RARE_
, O
occurring O
mainly O
in O
phospholipids O
. O

Since O
1970 _RARE_
the O
frequency O
of O
potassium _RARE_
- O
induced _RARE_
ulceration O
has O
been O
low O
-- _RARE_
3 O
cases O
per O
100 _RARE_
000 _RARE_
patient O
- O
years O
of O
slow O
- O
release O
tablet O
use O
. O

Hydrocortisone _RARE_
caused O
lymphopenia _RARE_
and O
inhibited O
the O
blastogenic _RARE_
response O
of O
peripheral O
blood _RARE_
lymphocytes O
to O
phytohemagglutinin I-GENE
and O
concanavalin _RARE_
A I-GENE
mitogens _RARE_
. O

To O
test O
the O
feasibility O
of O
using O
liposomes O
to O
deliver _RARE_
therapeutic O
agents O
to O
the O
lungs O
, O
the O
effect O
of O
liposome _RARE_
- O
encapsulated _RARE_
superoxide _RARE_
dismutase I-GENE
( O
SOD I-GENE
) O
or O
catalase I-GENE
on O
pulmonary O
oxygen O
toxicity O
was O
studied O
in O
rats O
. O

Marrow _RARE_
cell O
necrosis O
in O
anorexia _RARE_
nervosa _RARE_
and O
involuntary _RARE_
starvation O
. O

For O
comparison O
conventional O
heparin _RARE_
was O
used O
during _RARE_
18 O
dialyses _RARE_
in O
the O
same O
patients O
. O

Chenodeoxycholic _RARE_
acid O
( O
cheno _RARE_
) O
and O
ursodeoxycholic _RARE_
acid O
( O
urso _RARE_
) O
dissolve _RARE_
cholesterol O
gallstones _RARE_
in O
man O
. O

Sensory _RARE_
evoked O
field O
potentials O
were O
recorded O
from O
the O
mesencephalic _RARE_
reticular _RARE_
formation O
( O
MRF _RARE_
), _RARE_
central O
gray O
( O
CG _RARE_
) O
and O
somatosensory _RARE_
cortex O
( O
SCX _RARE_
), _RARE_
following O
incremental _RARE_
doses O
of O
halothane O
in O
freely _RARE_
- O
moving _RARE_
rats O
. O

Ultrastructure _RARE_
of O
the O
heart _RARE_
muscle O
in O
experimental O
myocardial _RARE_
infarct O
following O
physical O
training O

Pharmacological _RARE_
desympathization _RARE_
leads O
to O
the O
development O
of O
hyper _RARE_
- O
reactivity O
of O
the O
true O
pacemakers _RARE_
to O
noradrenaline O
and O
dopamine O
and O
triggers O
off O
changes O
in O
the O
regulation _RARE_
of O
the O
electric _RARE_
activity O
of O
these O
cells O
by O
catecholamines O
. O

OODG _RARE_
is O
a O
diagnostic O
method O
permitting _RARE_
assessment O
of O
ocular O
pulse O
curves O
and O
objective O
determination O
of O
blood _RARE_
pressures O
in O
the O
ophthalmic O
circulatory O
system _RARE_
( O
retinal _RARE_
and O
ciliary _RARE_
arterial O
blood _RARE_
pressures O
) O
simultaneously O
for _RARE_
both O
eyes O
, O
without O
dilatation O
of O
the O
pupils _RARE_
. O

Viral _RARE_
infections O
have O
long O
been O
suspected O
to O
be O
causative _RARE_
agents O
in O
a O
number O
of O
inner O
ear O
dysfunctions _RARE_
. O

55 _RARE_
+/- O
11 O
%), O
all O
other O
parameters O
showed O
a O
significant O
increase O
: O
RS _RARE_
index O
5 O
. O
4 O
+/- O
1 O
. O
4 O
mVolt _RARE_
to O
6 O
. O
0 _RARE_
+/- O
1 O
. O
7 O
mVolt _RARE_
( O
p O
less O
than O
0 _RARE_
. O
01 O
); O
EDD _RARE_
6 O
. O
3 O
+/- O
0 _RARE_
. O
7 O
to O
6 O
. O
8 O
+/- O
0 _RARE_
. O
9 O
cm O
( O
p O
less O
than O
0 _RARE_
. O
001 O
); O
HV _RARE_
1017 _RARE_
+/- O
151 O
ml O
to O
1099 _RARE_
+/- O
261 _RARE_
ml O
( O
p O
less O
than O
0 _RARE_
. O
01 O
); O
EDV _RARE_
371 _RARE_
+/- O
131 _RARE_
ml O
to O
441 _RARE_
+/- O
175 O
ml O
( O
p O
less O
than O
0 _RARE_
. O
001 O
); O
RBV _RARE_
117 O
+/- O
57 O
ml O
to O
151 O
+/- O
77 O
ml O
( O
p O
less O
than O
0 _RARE_
. O
001 O
). O

Retrospective _RARE_
analyses O
of O
this O
death _RARE_
revealed O
a O
significant O
decrease O
of O
the O
left _RARE_
ventricular O
( O
LV O
) O
end O
- O
diastolic O
volume O
index O
( O
EDVI _RARE_
) O
of O
21 O
ml O
/ O
m2 O
( O
36 _RARE_
% O
of O
normal O
). O

In O
group O
I O
adults O
both O
of O
these O
variables O
increased O
. O

Polysorbate _RARE_
80 _RARE_
did O
not O
have O
a O
direct O
stimulant _RARE_
or O
relaxant _RARE_
effect O
on O
either O
guinea _RARE_
pig _RARE_
ileum _RARE_
or O
rat O
uterus _RARE_
, O
however O
, O
it O
antagonised _RARE_
the O
contractions O
induced _RARE_
by O
acetylcholine _RARE_
, O
histamine _RARE_
, O
barium _RARE_
, O
5 O
- O
hydroxytryptamine _RARE_
and O
carbachol O
in O
a O
dose O
- O
dependent O
manner O
. O

Individual _RARE_
alcohol _RARE_
reaction O
profiles O
. O

Vitiligo _RARE_
in O
diabetes O
mellitus O
. O

The O
pharmacokinetics O
of O
each O
tetracycline _RARE_
in O
serum O
and O
dermal O
, O
suction _RARE_
blister _RARE_
fluid _RARE_
were O
determined O
after O
oral O
doses O
of O
300 _RARE_
mg O
lymecycline _RARE_
or O
100 _RARE_
mg O
doxycycline _RARE_
on O
the O
3rd _RARE_
day O
. O

A O
high O
degree O
of O
correlation O
in O
the O
sense O
of O
the O
classic _RARE_
conception _RARE_
of O
brain O
localization _RARE_
of O
neuropsychological _RARE_
syndromes O
was O
found O
. O

Either _RARE_
a O
UV _RARE_
detector O
set O
at _RARE_
268 _RARE_
nm O
or O
an O
electrochemical _RARE_
( O
EC O
) O
detector O
set O
at _RARE_
a O
potential _RARE_
of O
+ O
0 _RARE_
. O
9 O
V O
( O
versus O
Ag _RARE_
/ O
AgCl _RARE_
/ O
3 O
M O
NaCl O
) O
was O
used O
to O
monitor O
the O
drug O
. O

35 _RARE_
patients O
with O
acute O
arterial O
occlusions _RARE_
[ _RARE_
27 _RARE_
] O
and O
graft O
thromboses _RARE_
[ _RARE_
8 O
], O
responsible O
for _RARE_
severe O
and O
recent O
ischemia O
, O
were O
treated O
by O
fibrinolytic _RARE_
therapy O
( O
Urokinase _RARE_
: O
1 O
000 _RARE_
units _RARE_
/ O
kg O
/ O
hour O
, O
and O
Lys _RARE_
Plasminogen _RARE_
). O

The O
mean O
transfer O
ratios O
of O
the O
drug O
into O
the O
genital _RARE_
tissues O
to O
the O
concentration O
in O
the O
uterine _RARE_
arterial O
blood _RARE_
were O
such O
that O
the O
transfer O
ratio O
into O
the O
portio _RARE_
vaginalis _RARE_
was O
the O
highest O
, O
followed O
by O
the O
uterine _RARE_
cervix O
and O
the O
myometrium _RARE_
, O
and O
that O
into O
the O
oviduct _RARE_
was O
the O
lowest O
with O
about O
1 O
/ O
2 O
that O
into O
the O
portio _RARE_
vaginalis _RARE_
. O

We O
conclude O
that O
androgenic _RARE_
hormones _RARE_
reduce O
HDL _RARE_
- I-GENE
cholesterol I-GENE
concentrations O
and O
the O
HDL2 I-GENE
- I-GENE
cholesterol I-GENE
subfraction _RARE_
, O
possibly O
by O
enhancing O
hepatic _RARE_
triglyceride _RARE_
lipase I-GENE
activity O
. O

Because O
of O
its O
wide O
spectrum O
of O
activity O
particularly O
against O
ampicillin _RARE_
resistant O
strains O
of O
H O
. O
influenzae O
and O
because O
of O
its O
good O
tolerance O
Cefaclor _RARE_
is O
very O
useful O
in O
treatment O
of O
respiratory O
tract _RARE_
infections O
in O
children O
. O

Lower _RARE_
extremity _RARE_
weight _RARE_
bearing _RARE_
under O
various O
standing _RARE_
conditions O
in O
independently O
ambulatory O
patients O
with O
hemiparesis _RARE_
. O

Shape _RARE_
factor O
correlated O
well _RARE_
with O
hemodynamic O
data O
for _RARE_
RV O
/ O
LV O
systolic O
pressure O
ratios O
( O
r _RARE_
= O
0 _RARE_
. O
93 O
, O
p O
less O
than O
0 _RARE_
. O
001 O
) O
for _RARE_
normalized O
interventricular _RARE_
pressure O
differences O
( O
r _RARE_
= O
- O
0 _RARE_
. O
95 _RARE_
, O
p O
less O
than O
0 _RARE_
. O
001 O
). O

The O
effective O
and O
low O
toxic O
dose O
schedules _RARE_
of O
KW _RARE_
- O
2083 _RARE_
should O
be O
investigated O
further O
. O

Furthermore O
, O
the O
initial O
plasma O
retinol _RARE_
level O
in O
conjunction O
with O
RBP _RARE_
was O
found O
to O
be O
even O
lower O
in O
12 O
patients O
( O
35 _RARE_
. O
1 O
micrograms O
dl O
- O
1 O
, O
3 O
. O
7 O
mg O
dl O
- O
1 O
) O
who O
subsequently O
had O
cancer _RARE_
recurrence O
than O
in O
those O
who O
remained O
free O
of O
apparent O
cancer _RARE_
( O
44 _RARE_
. O
5 O
micrograms O
dl O
- O
1 O
, O
4 O
. O
6 O
mg O
dl O
- O
1 O
). O

The O
results O
indicate O
that O
: O
1 O
) O
the O
initial O
response O
to O
tethering _RARE_
varies _RARE_
according O
to O
previous O
penning _RARE_
and O
handling _RARE_
experience O
, O
2 O
) O
although O
the O
circadian O
rhythm O
of O
cortisol O
was O
either O
altered O
or O
disrupted O
during _RARE_
estrus _RARE_
, O
such O
disruptions _RARE_
were O
not O
influenced O
by O
type O
of O
penning _RARE_
and O
3 O
) O
tether _RARE_
stalls _RARE_
may O
chronically _RARE_
increase O
cortisol O
concentrations O
in O
gilts _RARE_
. O

This O
laser O
provided O
sufficient O
power O
in O
an O
amniotic _RARE_
fluid _RARE_
medium O
to O
occlude _RARE_
placental _RARE_
vessels O
as _RARE_
large O
as _RARE_
7 O
mm O
in O
diameter O
within O
6 O
seconds _RARE_
at _RARE_
a O
power O
density O
of O
2000 O
W _RARE_
/ O
cm2 O
. O

On O
d O
112 O
, O
progesterone O
was O
higher _RARE_
( O
P O
less O
than O
. O
05 O
) O
in O
hysterectomized _RARE_
heifers O
than O
in O
other O
treatment O
groups O
. O

Male _RARE_
Japanese O
quail _RARE_
were O
chronically _RARE_
exposed O
to O
5000 _RARE_
ppm O
manganese _RARE_
( O
Mn _RARE_
) O
as _RARE_
particulate O
manganese _RARE_
oxide O
( O
Mn3O4 _RARE_
) O
in O
their O
diet O
from O
hatching _RARE_
to O
75 _RARE_
days O
of O
age O
. O

This O
study O
indicated O
that O
the O
Japanese O
quail _RARE_
was O
less O
sensitive _RARE_
to O
particulate O
Mn3O4 _RARE_
exposure O
than O
rodents _RARE_
treated O
comparably _RARE_
. O

Plasma O
and O
bladder O
platinum _RARE_
concentration O
were O
measured O
following O
intravesical _RARE_
DDP O
, O
and O
also O
histopathological O
examination O
, O
urinalysis _RARE_
, O
complete _RARE_
blood _RARE_
count O
and O
blood _RARE_
chemistry O
were O
performed O
in O
order O
to O
know _RARE_
the O
toxicity O
of O
intravesical _RARE_
DDP O
. O

Scintigraphic _RARE_
visualisation _RARE_
of O
Walker _RARE_
carcinoma O
- O
256 O
in O
Sprague O
- O
Dawley O
rats O
by O
means O
of O
99mTc O
- O
labelled O
monocytes O
. O

These O
results O
were O
compared O
with O
those O
obtained O
in O
- O
D O
mothers O
and O
pups _RARE_
, O
after O
giving O
the O
mothers O
an O
oral O
supplement _RARE_
( O
10 O
i O
. O
u _RARE_
. O
vitamin O
D3 _RARE_
/ O
day O
) O
during _RARE_
the O
period O
of O
lactation _RARE_
( O
20 O
days O
). O

Rabbit _RARE_
eyes O
were O
removed O
and O
held O
in O
temperature _RARE_
- O
regulated O
chambers _RARE_
and O
irrigated _RARE_
with O
saline O
. O

Before _RARE_
birth O
, O
there O
were O
a O
few O
perivascular _RARE_
adrenergic O
nerves O
and O
correspondingly _RARE_
low O
ovarian O
NE _RARE_
levels O
. O

Monitoring _RARE_
changes O
in O
the O
heart _RARE_
rate O
of O
the O
premature O
fetus O
during _RARE_
tocolysis _RARE_
with O
the O
beta O
- O
adrenomimetics _RARE_
partusisten _RARE_
and O
Pre _RARE_
- O
par _RARE_

Since O
September _RARE_
1980 O
to O
June _RARE_
1983 O
we O
have O
treated O
32 _RARE_
patients O
with O
ovarian O
cancer _RARE_
. O

The O
results O
suggest O
that O
the O
calcium _RARE_
antagonist O
, O
diltiazem O
, O
may O
modify O
the O
effects O
of O
isoflurane O
on O
myocardial _RARE_
function O
. O

Supraventricular _RARE_
arrhythmias O
-- _RARE_
digoxin _RARE_
and O
quinidine _RARE_
revisited _RARE_
. O

Visidex _RARE_
I O
is O
unsuitable _RARE_
for _RARE_
storage _RARE_
and O
re O
- O
reading O
. O

Treatment O
with O
oxyphenylbutazone _RARE_
and O
hydrocortisone _RARE_
failed O
to O
inhibit O
the O
raised O
serum I-GENE
CPN _RARE_
levels O
. O

40 O
, O
000 _RARE_
). O

The O
Cox O
proportional _RARE_
hazards _RARE_
model O
was O
applied O
to O
the O
data O
in O
order O
to O
determine O
the O
prognostic O
factors O
for _RARE_
long O
- O
term O
survival O
. O

This O
suggests O
that O
mechanisms O
other O
than O
an O
excessive O
increase O
in O
myocardial _RARE_
oxygen O
demand O
may O
be O
responsible O
for _RARE_
the O
many O
episodes O
occurring O
outside O
the O
hospital O
. O

Duration _RARE_
of O
remission O
in O
advanced O
gastric _RARE_
cancer _RARE_
patients O
responding O
to O
sequential O
dose O
of O
MTX _RARE_
and O
5 O
- O
FU O

These O
data O
showed O
: O
that O
progesterone O
secretion _RARE_
is O
pulsatile _RARE_
throughout O
the O
human O
luteal _RARE_
phase _RARE_
, O
with O
maximum O
frequency O
in O
the O
mid O
- O
luteal _RARE_
phase _RARE_
; O
that O
during _RARE_
the O
mid O
- O
luteal _RARE_
phase _RARE_
most O
subjects O
had O
progesterone O
levels O
both O
above O
and O
below O
currently O
accepted O
ovulatory _RARE_
thresholds _RARE_
; O
the O
use O
of O
a O
single O
measurement O
of O
progesterone O
in O
the O
mid O
- O
luteal _RARE_
phase _RARE_
is O
not O
always O
a O
reliable O
indicator O
of O
ovulation O
; O
a O
threshold O
greater O
than O
20 O
nmol O
/ O
l _RARE_
may O
yield O
an O
unacceptable _RARE_
number O
of O
false O
negative O
results O
. O

The O
fast O
real O
- O
time O
digital O
processing _RARE_
of O
the O
N2 O
and O
flow O
signals O
incorporated O
filtering _RARE_
, O
delay O
compensation _RARE_
, O
and O
corrections _RARE_
for _RARE_
the O
effects O
of O
changes O
in O
gas O
composition O
and O
temperature _RARE_
. O

This O
slope O
tended O
to O
be O
higher _RARE_
( O
approximately _RARE_
1 O
. O
6 O
dB _RARE_
/ O
dB _RARE_
) O
for _RARE_
L1 O
= O
L2 O
greater O
than O
80 _RARE_
dB _RARE_
. O

Histamine _RARE_
reactivity O
was O
significantly O
reduced _RARE_
after O
the O
nifedipine O
aerosol _RARE_
, O
the O
geometric _RARE_
mean O
provocative _RARE_
concentration O
causing O
a O
35 _RARE_
% O
fall O
in O
specific O
airway O
conductance _RARE_
, O
rising _RARE_
from O
5 O
. O
0 _RARE_
to O
10 O
. O
9 O
mg O
/ O
ml O
of O
histamine _RARE_
( O
p O
less O
than O
0 _RARE_
. O
05 O
). O

Pharmacologic _RARE_
doses O
of O
vitamin O
B6 _RARE_
administered O
to O
lactating _RARE_
women O
have O
been O
reported O
to O
suppress O
plasma I-GENE
prolactin I-GENE
. O

There O
was O
a O
significant O
but O
similar O
elevation O
of O
mean O
O2 _RARE_
uptake O
during _RARE_
40 O
min O
postexercise _RARE_
by O
13 _RARE_
. O
6 O
% O
in O
both O
the O
fasted O
( O
p O
less O
than O
0 _RARE_
. O
001 O
) O
and O
fed O
state O
( O
p O
less O
than O
0 _RARE_
. O
001 O
). O

National O
Institutes _RARE_
of O
Health O
Consensus _RARE_
Development _RARE_
Conference _RARE_
Statement _RARE_
. O

In O
controls O
, O
most O
of O
the O
output O
from O
the O
conduit _RARE_
occurred O
during _RARE_
type O
I O
activity O
( O
73 _RARE_
+/- O
14 O
%). O

Greater _RARE_
attenuation _RARE_
of O
the O
N1 _RARE_
- O
P2 O
and O
baseline O
- O
P2 O
amplitude O
of O
the O
probe O
EPs _RARE_
was O
observed O
when O
the O
probe O
stimulus O
was O
presented O
to O
the O
right O
ear O
and O
the O
verbal _RARE_
material O
presented O
to O
the O
left _RARE_
ear O
than O
when O
the O
opposite O
stimulation _RARE_
arrangement O
was O
used O
. O

Twenty O
- O
five O
patients O
( O
80 _RARE_
, O
6 O
%) O
with O
mixed O
neoplasms O
were O
operated O
on O
by O
total _RARE_
conservative O
parotidectomy _RARE_
( O
T O
. O
C O
. O
P O
.), _RARE_
3 O
( O
9 O
, O
7 O
%) O
by O
S O
. O
P O
. O
and O
3 O
( O
9 O
, O
7 O
%) O
by O
En _RARE_
. O

The O
comparisons O
revealed O
that O
female O
homicide _RARE_
- O
suicide O
perpetrators _RARE_
were O
more O
likely O
than O
female O
homicide _RARE_
- O
suicide O
victims O
to O
live O
in O
mobile O
homes _RARE_
, O
kill _RARE_
their O
lover _RARE_
or O
ex _RARE_
- O
lover _RARE_
, O
have O
their O
crime _RARE_
accidentally _RARE_
discovered O
, O
leave _RARE_
a O
suicide O
note _RARE_
, O
kill _RARE_
on O
a O
weekend _RARE_
, O
and O
be O
depressed O
, O
but O
are O
less O
likely O
than O
female O
homicide _RARE_
- O
suicide O
victims O
to O
live O
with O
a O
spouse _RARE_
. O

Germ _RARE_
- O
free O
rabbits O
given O
mouse O
CRF _RARE_
- O
flora _RARE_
showed O
values O
quite O
different O
from O
control O
animals O
for _RARE_
most O
parameters O
, O
indicating O
unsuitability _RARE_
of O
mouse O
CRF _RARE_
flora _RARE_
to O
' O
normalize _RARE_
' O
rabbits O
. O

The O
weak O
relationships O
between O
F O
and O
Zn _RARE_
to O
Mg _RARE_
clearly O
have O
no _RARE_
significant O
effect O
on O
the O
contents O
of O
these O
elements O
in O
bone O
. O

L3 _RARE_
- O
L4 _RARE_
compressive _RARE_
load O
was O
calculated O
using O
a O
model O
of O
the O
anatomy _RARE_
of O
the O
trunk O
musculoskeletal _RARE_
system _RARE_
. O

Diagnosis O
: O
progressive O
multifocal _RARE_
leukoencephalopathy _RARE_
. O

Component _RARE_
P100 _RARE_
was O
associated O
with O
a O
frontal O
negativity _RARE_
of O
similar O
latency _RARE_
favoring _RARE_
the O
hypothesis O
of O
a O
dipolar _RARE_
occipital _RARE_
generator _RARE_
. O

Although O
no _RARE_
differences O
were O
noted O
in O
the O
decrease O
in O
platelet O
counts O
between O
the O
two O
groups O
, O
fibrinogen I-GENE
levels O
and O
alpha I-GENE
2 I-GENE
- I-GENE
antiplasmin _RARE_
levels O
declined O
less O
drastically _RARE_
in O
the O
antithrombin I-GENE
- O
treated O
group O
. O

Failure _RARE_
of O
stapedius _RARE_
reflexometry _RARE_
in O
the O
diagnosis O
of O
myasthenia _RARE_
gravis _RARE_
. O

Factors O
influencing O
semen O
characteristics O
in O
young O
boars _RARE_
reared _RARE_
in O
a O
subtropical _RARE_
environment O
were O
studied O
. O

[ _RARE_
14C O
]- _RARE_
beta O
- O
phenethylamine _RARE_
, O
its O
distribution O
after O
administration O
by O
various O
routes O
to O
cats O
, O
and O
the O
effects O
of O
monoamine _RARE_
oxidase I-GENE
inhibitors _RARE_
. O

All O
runners _RARE_
drank _RARE_
a O
total _RARE_
of O
1 O
. O
4 O
L O
of O
water O
during _RARE_
the O
race _RARE_
. O

The O
rates O
of O
total _RARE_
energy O
use O
( O
mean O
+/- O
SD O
= O
39 _RARE_
. O
3 O
+/- O
1 O
. O
2 O
vs _RARE_
35 _RARE_
. O
7 O
+/- O
1 O
. O
3 O
kJ _RARE_
X O
min O
- O
1 O
; O
P O
less O
than O
0 _RARE_
. O
05 O
) O
were O
significantly O
higher _RARE_
at _RARE_
- O
10 O
degrees O
C O
than O
at _RARE_
22 _RARE_
degrees O
C O
. O

Clinical O
aspects O
and O
therapy O

Following O
seven _RARE_
days O
' O
incubation O
both O
at _RARE_
20 O
degrees O
C O
and O
28 _RARE_
degrees O
C O
, O
Ae _RARE_
. O
vexans _RARE_
nip _RARE_
. O
was O
capable O
of O
transmitting _RARE_
the O
virus O
. O

Blood _RARE_
eosinophils O
in O
patients O
with O
Taenia _RARE_
saginata _RARE_
taeniasis _RARE_
. O

The O
imino _RARE_
proton _RARE_
of O
T3 _RARE_
in O
the O
O6meG _RARE_
. O
T O
12 O
- O
mer _RARE_
and O
G3 _RARE_
in O
the O
O6meG _RARE_
. O
N O
12 O
- O
mer _RARE_
helix O
, O
which O
are O
associated O
with O
the O
modification O
site O
, O
resonate _RARE_
at _RARE_
unusually O
high O
field O
( O
8 O
. O
5 O
to O
9 O
. O
0 _RARE_
ppm O
) O
compared O
to O
imino _RARE_
protons _RARE_
in O
Watson _RARE_
- O
Crick _RARE_
base _RARE_
pairs _RARE_
( O
12 O
. O
5 O
to O
14 O
. O
5 O
ppm O
). O

The O
recommendation _RARE_
is O
made O
that O
specific O
sub O
- O
groups O
of O
attempters _RARE_
need O
to O
be O
identified O
and O
may O
warrant _RARE_
specialized O
intervention O
strategies O
. O

There O
was O
no _RARE_
correlation O
between O
secretor _RARE_
status O
and O
clinical O
status O
, O
spirometry _RARE_
measurements O
, O
salivary _RARE_
and I-GENE
serum I-GENE
lysozyme I-GENE
levels O
or O
rates O
of O
respiratory O
tract _RARE_
colonization _RARE_
with O
P O
. O
aeruginosa _RARE_
and O
S O
. O
aureus _RARE_
. O

There O
was O
no _RARE_
correlation O
between O
secretor _RARE_
status O
and O
clinical O
status O
, O
spirometry _RARE_
measurements O
, O
salivary _RARE_
and O
serum I-GENE
lysozyme I-GENE
levels O
or O
rates O
of O
respiratory O
tract _RARE_
colonization _RARE_
with O
P O
. O
aeruginosa _RARE_
and O
S O
. O
aureus _RARE_
. O

Gains _RARE_
increased O
3 O
. O
5 O
% O
( O
P O
less O
than O
. O
10 O
) O
and O
feed O
conversion O
improved O
5 O
. O
9 O
% O
( O
P O
less O
than O
. O
07 O
) O
in O
steers O
fed O
. O
28 _RARE_
% O
AS _RARE_
- O
VFA _RARE_
compared O
with O
gain O
and O
feed O
conversion O
of O
the O
control O
steers O
. O

Postnatal _RARE_
volumetric _RARE_
development O
of O
the O
prefrontal _RARE_
cortex O
in O
the O
rat O
. O

Daily _RARE_
and O
seasonal _RARE_
rhythmicity _RARE_
in O
the O
methylation O
of O
pineal O
indolic _RARE_
compounds O
in O
adult O
male O
golden _RARE_
hamsters O
, O
kept O
under O
natural _RARE_
conditions O
. O

The O
transit O
time O
was O
significantly O
shortened O
. O

Among O
the O
patients O
grades _RARE_
1 O
- O
2 O
- O
3 O
, O
81 _RARE_
% O
had O
a O
good O
out O
come _RARE_
without O
any O
neurological O
abnormality O
, O
among O
the O
patients O
graded _RARE_
4 O
- O
5 O
, O
only O
27 _RARE_
% O
had O
a O
fair _RARE_
out O
come _RARE_
. O

Activity _RARE_
of O
acid I-GENE
hydrolases _RARE_
of O
peripheral O
blood _RARE_
leukocytes _RARE_
in O
focal _RARE_
and O
segmental O
pneumonia O
in O
children O

Comparative O
studies O
of O
the O
antithrombin I-GENE
III I-GENE
level O
and O
plasminogen I-GENE
activator I-GENE
activity O
in O
patients O
with O
thrombophlebitis _RARE_

We O
also O
observed O
that O
the O
predictive O
ability O
of O
the O
selected _RARE_
attitudes _RARE_
and O
orientations _RARE_
increased O
considerably O
from O
1975 _RARE_
to O
1982 O
. O

Relations _RARE_
between O
cellular O
electrical O
activity O
and O
cardiac O
mechanical O
activity O
in O
man O
, O
the O
dog O
and O
the O
rabbit _RARE_

Treatment O
of O
Paget _RARE_
' O
s O
disease _RARE_
. O

Improvement _RARE_
of O
the O
CRT _RARE_
display O
of O
an O
averager _RARE_
. O

Is O
desensitization _RARE_
' O
for _RARE_
ragweed _RARE_
hay _RARE_
fever O
immunologically _RARE_
specific O
? O

Renal O
excretion O
of O
sulphadimidine _RARE_
in O
normal O
and O
uraemic _RARE_
subjects O
. O

Experiences _RARE_
with O
the O
clinical O
and O
experimental O
use O
of O
Urat _RARE_
- O
I O
lithotriptor _RARE_
. O

Formation _RARE_
of O
hyphae _RARE_
and O
chlamydospores _RARE_
by O
Cryptococcus _RARE_
laurentii _RARE_
. O

Evaluation O
of O
thyroid O
function O
. O

The O
effect O
of O
a O
tissue O
emulsion _RARE_
, O
vitamin O
A O
and O
nonspecific O
gamma I-GENE
- I-GENE
globulin I-GENE
on O
the O
blood _RARE_
clearance O
in O
rabbits O

HL _RARE_
- I-GENE
A I-GENE
antibodies I-GENE
in O
polytransfused _RARE_
patients O

Demonstration _RARE_
of O
fine O
structure _RARE_
of O
the O
guinea _RARE_
pig _RARE_
organ O
of O
Corti _RARE_
after O
electron O
microscopic O
silver O
staining O

Histamine _RARE_
metabolism O
in O
hemorrhagic O
- O
hypotensive O
shock O

They O
also O
discuss O
the O
existing O
nomenclature _RARE_
. O

Relaxation _RARE_
of O
catch _RARE_
in O
a O
molluscan _RARE_
smooth _RARE_
muscle O
. O

Studies O
on O
alcoholic O
liver O
injury O
. O

Hypothalamic _RARE_
control O
of O
coronary O
circulation O
in O
the O
dog O
. O

Evidence O
for _RARE_
two O
distinctive O
clinical O
, O
epidemiological O
, O
and O
immunological _RARE_
types _RARE_
of O
infection O
. O

Ultraviolet _RARE_
light O
- O
induced _RARE_
kinin _RARE_
formation O
in O
human O
skin _RARE_
. O

Poliomyelitis _RARE_
from O
a O
vaccine O
. O

To O
the O
problem O
of O
the O
stimulation _RARE_
of O
the O
growth O
of O
transplantable _RARE_
tumors O
of O
animals O
previously O
treated O
with O
antineoplastic _RARE_
antibiotics O

Assessment O
of O
nutrient O
media O
in O
the O
diagnosis O
of O
diptheria _RARE_

Aluminium _RARE_
resin O
for _RARE_
the O
treatment O
of O
the O
hyperkalamia _RARE_
of O
renal _RARE_
failure O
. O

Value O
of O
the O
EMG O
in O
the O
diagnosis O
of O
a O
cardiomyopathy O
associated O
with O
a O
myotonic _RARE_
myopathy _RARE_
. O

D O
. O

Prevention O
of O
maternal _RARE_
Rh _RARE_
sensitization O
: O
anti I-GENE
- I-GENE
Rh _RARE_
immune I-GENE
globulin I-GENE
. O

Serotonin _RARE_
levels O
in O
infant O
hypothyroidism O
. O

Cerebrospinal _RARE_
fluid _RARE_
transferrin I-GENE
II I-GENE
studies O
in O
ischemic O
disorders O
of O
the O
central O
nervous O
system _RARE_
. O

High _RARE_
dosages _RARE_
of O
D O
- O
penicillamine _RARE_
in O
pulmonary O
fibroses _RARE_

Inverse _RARE_
relation O
between O
serum O
IgG I-GENE
concentration O
and O
glucose O
and O
xylose _RARE_
absorption O
in O
Zambian _RARE_
African O
adults O
. O

Disorders _RARE_
of O
platelet O
function O
in O
chronic O
myeloid _RARE_
leukemias O

The O
effect O
of O
anticonvulsants _RARE_
on O
sodium _RARE_
- I-GENE
potassium _RARE_
- I-GENE
activated I-GENE
ATPase I-GENE
, O
sodium _RARE_
, O
and O
potassim _RARE_
in O
cortex O
. O

Effect O
of O
immune O
lymphocytes O
and O
of O
rabbit _RARE_
- I-GENE
anti I-GENE
- I-GENE
lymphocyte I-GENE
globulin I-GENE
( O
RAMLG _RARE_
) O
on O
infected _RARE_
macrophages O
exposed O
to O
increased O
incubation O
temperature _RARE_
in O
vitro O
. O

Estral _RARE_
cycle _RARE_
in O
white _RARE_
rats O
in O
the O
low O
and O
high O
mountains _RARE_
of O
Kirghizia _RARE_

Lactation _RARE_
of O
baboons _RARE_
fed O
a O
low O
protein O
maintenance _RARE_
diet O
. O

Studies O
on O
the O
organic O
matrix _RARE_
of O
human O
ear O
ossicles _RARE_

A O
medical O
- O
geographical _RARE_
review O

Age _RARE_
and O
sex _RARE_
structure _RARE_
of O
the O
natural _RARE_
population O
of O
Ornithodoros _RARE_
tatarovski _RARE_
Ol _RARE_
. O

Sensitization _RARE_
to O
hyperlactatemia _RARE_
induced _RARE_
by O
phenformin _RARE_
after O
subtotal O
ablation O
of O
the O
pancreas O
. O

Vitamin _RARE_
D3 _RARE_
and O
calcium _RARE_
absorption O
in O
the O
chick _RARE_
. O

The O
incidence O
of O
tumours O
in O
young O
chickens _RARE_
. O

Laboratory O
aspects O
with O
particular O
reference O
to O
chemotherapy O
and O
control O
. O

Their O
effect O
on O
the O
guinea _RARE_
pig _RARE_
vas O
deferens O
. O

Androgens _RARE_
and O
growth O
. O

Effect O
of O
variations O
in O
time O
interval O
between O
treatment O
with O
BCG O
and O
quartz _RARE_
dust O
on O
translocation O
of O
quartz _RARE_
dust O
from O
the O
lungs O
to O
their O
regional O
lymph O
nodes O
. O

Therapeutic _RARE_
action O
of O
a O
new O
antibiotic O
- O
corticoid _RARE_
association O
used O
for _RARE_
instillations _RARE_
in O
otology _RARE_

Clinico _RARE_
- O
physiological O
experiment O

Enzyme _RARE_
histochemical _RARE_
findings O
in O
the O
ultimobranchial _RARE_
body O
of O
the O
horse _RARE_

Familial _RARE_
glutathione _RARE_
reductase I-GENE
deficiency O
and O
disorder O
of O
glutathione _RARE_
synthesis _RARE_
in O
the O
erythrocyte _RARE_

Studies O
on O
swine O
enteroviruses _RARE_
. O

Serodiagnosis _RARE_
of O
ectromelia _RARE_
in O
laboratory O
mice O

Ultrasound _RARE_
effect O
on O
the O
cytochrome I-GENE
oxidase I-GENE
activity O

Metastasis _RARE_
of O
colon O
carcinoma O
to O
the O
lip _RARE_
. O

Genesis _RARE_
of O
foam _RARE_
cells O
: O
study O
in O
rats O
after O
administration O
of O
Cloforex _RARE_
. O

Pre _RARE_
- I-GENE
beta I-GENE
- I-GENE
1 I-GENE
lipoprotein I-GENE
and O
early O
detection O
of O
risk O
factors O
for _RARE_
coronary O
heart _RARE_
disease _RARE_
. O

Conditions _RARE_
influencing O
inhibitors _RARE_
of O
the O
colony I-GENE
- I-GENE
stimulating I-GENE
factor I-GENE
( O
CSF I-GENE
). O

Absence _RARE_
of O
action O
potentials O
in O
frog _RARE_
slow O
muscle O
fibres O
paralysed _RARE_
by O
botulinum I-GENE
toxin _RARE_
. O

An O
automated O
method O
for _RARE_
the O
quantitative O
analysis O
of O
the O
polyamines _RARE_
putrescine _RARE_
, O
spermidine _RARE_
and O
spermine _RARE_
in O
cerebrospinal _RARE_
fluid _RARE_
( O
CSF O
) O
was O
used O
to O
analyze O
CSF O
samples O
from O
37 O
patients O
with O
central O
nervous O
system _RARE_
( O
CNS O
) O
tumors O
and O
from O
13 _RARE_
patients O
without O
tumors O
. O

I O
. O

Disulfiram _RARE_
and O
the O
drug O
- O
induced _RARE_
effects O
on O
motility _RARE_
. O

Particles _RARE_
resembling O
microbodies _RARE_
in O
normal O
and O
neoplastic O
perianal _RARE_
glands O
of O
dogs O
. O

Natural _RARE_
and O
induced _RARE_
malarias _RARE_
in O
western _RARE_
hemisphere O
monkeys O
. O

A O
study O
in O
vivo O
of O
adrenergic I-GENE
receptors I-GENE
in O
the O
rectum _RARE_
and O
in O
the O
internal O
and O
sphincter _RARE_
of O
the O
cat _RARE_
. O

Intracranial _RARE_
arachnoid _RARE_
cyst O
of O
the O
middle _RARE_
fossa _RARE_
demonstrated O
by O
positive O
99mTc O
brainscintigraphy _RARE_
. O

Effects O
of O
estrogen O
and O
glucocorticoids O
on O
the O
adrenal O
development O
of O
the O
fetus O
. O

Copper _RARE_
and O
ceruloplasmin _RARE_
content O
in O
pregnant _RARE_
women O
and O
in O
women O
with O
certain O
gynecological _RARE_
diseases O

Effect O
of O
noise O
on O
CO _RARE_
- O
induced _RARE_
increases O
of O
LAP _RARE_
and O
GPT _RARE_
activity O
in O
the O
plasma O
of O
rats O

Kinetics _RARE_
of O
calcium _RARE_
metabolism O
. O

On O
the O
transport _RARE_
of O
mucus O
and O
its O
rheologic _RARE_
simulants _RARE_
in O
ciliated _RARE_
systems _RARE_
. O

A O
hydrodynamic _RARE_
description O
of O
the O
osmotic O
reflection _RARE_
coefficient O
with O
application O
to O
the O
pore _RARE_
theory O
of O
transcapillary _RARE_
exchange O
. O

Pathology _RARE_
of O
neuritis _RARE_
caudae _RARE_
equinae _RARE_
in O
the O
horse _RARE_

Abnormal O
characteristics O
and O
verticillation _RARE_
in O
Platynothrus _RARE_
peltifer _RARE_

Selected _RARE_
topics _RARE_
in O
laboratory O
animal _RARE_
medicine O
. O

Problems _RARE_
common O
to O
pediatrics _RARE_
and O
anesthesiology _RARE_

Clinical O
course O
and O
nursing O
care O
of O
patients O
with O
decubitus _RARE_
ulcer O
-- _RARE_
use O
of O
pillows _RARE_
stuffed _RARE_
with O
buckwheat _RARE_
chaff _RARE_

On O
parents O

From O
the O
Icelandic _RARE_
Red _RARE_
Cross O
activities O

Effects O
of O
alcoholism _RARE_
on O
the O
family O

Treatment O
and O
care O
of O
adult O
diabetes O
mellitus O
without O
coma _RARE_

Re O
- O
examining O
methylbenzene _RARE_
( O
toluene O
) O
as _RARE_
a O
treatment O
for _RARE_
Ancylostomum _RARE_
caninum _RARE_
. O

Junctions _RARE_
between O
cells O
of O
the O
human O
enamel _RARE_
organ O
. O

Electrocardiograms _RARE_
of O
the O
month O
. O

Composites _RARE_
as _RARE_
restoration _RARE_
materials O

Hodgkin O
' O
s O
disease _RARE_
. O

Value O
of O
Normotest _RARE_
and O
antithrombin I-GENE
3 I-GENE
in O
the O
assessment O
of O
liver O
function O
. O

Glutathione _RARE_
peroxidase I-GENE
in O
human O
red _RARE_
cells O
in O
health O
and O
disease _RARE_
. O

Histopathologic _RARE_
response O
of O
gingival _RARE_
tissues O
to O
hemodent _RARE_
and O
aluminum O
chloride _RARE_
solutions O
as _RARE_
tissue O
displacement _RARE_
materials O
. O

Changes O
following O
periodontal O
surgery O
. O

Intracellular _RARE_
pH O
, O
H O
ion O
flux _RARE_
and O
H O
ion O
permeability _RARE_
coefficient O
in O
bullfrog _RARE_
toe O
muscle O
. O

Teratological _RARE_
studies O
on O
SF _RARE_
- O
837 _RARE_
. O

Directives _RARE_
concerning O
medical O
care O

Proceedings _RARE_
: O
Reversible _RARE_
complete _RARE_
heart _RARE_
block _RARE_
following O
surgery O
of O
congenital O
heart _RARE_
defects O

Method _RARE_
of O
synthesis _RARE_
of O
the O
rheumatoid I-GENE
factor I-GENE
in O
clinico _RARE_
- O
immunological _RARE_
studies O

Variations _RARE_
of O
the O
timing O
of O
deflections _RARE_
in O
the O
His _RARE_
bundle O
recordings O
. O

Extracellular _RARE_
fibril _RARE_
formation O
by O
neuroglial _RARE_
cells O
at _RARE_
the O
vitreoretinal _RARE_
junction _RARE_
of O
the O
human O
eye O
. O

Blood _RARE_
platelets O
, O
coagulation O
factors O
and O
morphologic O
organ O
changes O
following O
scalding _RARE_
shock O
in O
rhesus _RARE_
monkeys O

Cell O
viability O
and O
lysosomal _RARE_
enzymes _RARE_

State O
- O
approved _RARE_
schools _RARE_
of O
nursing O
-- _RARE_
R O
. O
N O
., O
1972 O
. O

Further O
investigation O
on O
the O
chemotactic O
influence O
of O
thymic _RARE_
hormone I-GENE
on O
lymphocytes O

1 O
, O
3 O
- O
bis _RARE_
( O
2 O
- O
chloroethyl _RARE_
)- O
1 O
- O
nitrosourea _RARE_
( O
bcnu _RARE_
) O
and O
other O
nitrosoureas _RARE_
in O
cancer _RARE_
treatment O
: O
a O
review O
. O

Pneumothorax _RARE_
following O
lung _RARE_
abscess O
in O
the O
renal _RARE_
transplant O
patient O
. O

Taxonomically _RARE_
significant O
colour _RARE_
changes O
in O
Brevibacterium _RARE_
linens _RARE_
probably O
associated O
with O
a O
carotenoid _RARE_
- O
like O
pigment _RARE_
. O

Temporal _RARE_
relationships O
and O
the O
development O
phase _RARE_
affected O
. O

A O
short O
history O
of O
dermatology _RARE_
in O
Lagos _RARE_
, O
Nigeria _RARE_
. O

Local _RARE_
graft O
irradiation O
as _RARE_
an O
adjunct _RARE_
to O
pharmacologic _RARE_
immunosuppression _RARE_
. O

Letter O
: O
Salmonella _RARE_
detection O

Role O
of O
biocenosis _RARE_
in O
the O
manifestation O
of O
Shigella _RARE_
virulence _RARE_

The O
effect O
of O
antilymphocyte _RARE_
sera _RARE_
on O
formation O
of O
transplantation O
and O
anti O
- O
infection O
immunity _RARE_
in O
mice O

60th _RARE_
birthday _RARE_
of O
colonel _RARE_
prof _RARE_
. O
e _RARE_
. O
cerny _RARE_
m O
. O
d O
. O

Morphology _RARE_
of O
bacteriophages _RARE_
of O
Klebsiella _RARE_
bacilli O
. O

Cortical _RARE_
afferents O
to O
the O
entorhinal _RARE_
cortex O
of O
the O
Rhesus _RARE_
monkey _RARE_
. O

Mechanism O
of O
immunogenesis _RARE_
in O
vaccination O
with O
streptomycin _RARE_
- O
dependent O
mutants O
of O
salmonellae _RARE_
and O
shigellae _RARE_
. O

Resistance O
pattern O
of O
Mycobacterium O
tuberculosis O
( O
H O
37 O
Rv _RARE_
) O
to O
a O
new O
antibiotic O
, O
lividomycin _RARE_

Pulmonary _RARE_
arterial O
pressure O
and O
structure _RARE_
in O
the O
patas _RARE_
monkey _RARE_
after O
prolonged O
administration O
of O
aminorex _RARE_
fumarate _RARE_
. O

Effect O
of O
triftazin _RARE_
and O
aminazin _RARE_
on O
hippocampal O
bioelectric _RARE_
activity O

Sex _RARE_
ratio O
at _RARE_
birth O
. O

Pathological _RARE_
processes O
in O
the O
cervix O
uteri _RARE_

Benign _RARE_
intramural _RARE_
tumors O
of O
the O
esophagus _RARE_

General _RARE_
formulae _RARE_
for _RARE_
estimating O
heritability _RARE_
in O
a O
population O
with O
related O
parents O
. O

Measurement O
of O
open _RARE_
- O
loop O
responses O
to O
electrical O
stimulation _RARE_
in O
olfactory O
bulb O
of O
cat _RARE_
. O

Glucose _RARE_
disappearance O
rate O
and O
changes O
in O
plasma O
nutrients _RARE_
after O
intravenouly _RARE_
injected O
glucose O
in O
normoglycaemic _RARE_
and O
hypoglycaemic _RARE_
underweight _RARE_
newborns O
. O

Normal _RARE_
values O
for _RARE_
the O
peripheral O
blood _RARE_
and O
bone O
marrow O
of O
the O
grey _RARE_
( O
Armenian _RARE_
) O
hamster O

The O
relationship O
of O
human O
umbilical _RARE_
arterial O
and O
venous O
plasma O
levels O
of O
corticosteroids O
to O
gestational O
age O
. O

Antibiotic _RARE_
effect O
of O
the O
mud _RARE_
from O
heviz _RARE_

Sulfuric _RARE_
acid O
concentration O
in O
the O
catalyzed O
breathalyzer _RARE_
ampules _RARE_
. O

Role O
of O
histoclinical _RARE_
studies O
in O
the O
prophylaxis O
of O
spontaneous O
abortions _RARE_

Range _RARE_
behavior O
of O
Hereford _RARE_
, O
Hereford _RARE_
x _RARE_
Holstein _RARE_
and O
Holstein _RARE_
non O
- O
lactating _RARE_
heifers O
. O

Chemical O
constituents _RARE_
of O
the O
gentianaceae _RARE_
V O
: O
tetraoxygenated _RARE_
xanthones _RARE_
of O
Swertia _RARE_
chirata _RARE_
Buch _RARE_
.- _RARE_
Ham _RARE_
. O

Methyl _RARE_
mercury _RARE_
intoxication _RARE_
in O
rat O
kidneys O
. O

Microdetermination _RARE_
of O
adrenocortical _RARE_
steroids O
by O
double O
isotope _RARE_
method O
. O

Compensative _RARE_
justice _RARE_
and O
moral _RARE_
investment _RARE_
among O
Japanese O
, O
Chinese _RARE_
, O
and O
Koreans _RARE_
. O

Effects O
of O
cortisone _RARE_
, O
starvation O
, O
and O
rickets _RARE_
on O
oxidative O
enzyme O
activities O
of O
epiphyseal _RARE_
cartilage O
from O
rats O
. O

Metal _RARE_
coordination O
compounds O
of O
thiabendazole _RARE_
. O

Estimation _RARE_
of O
renin I-GENE
secretion _RARE_
rate O
and O
renal _RARE_
plasma O
flow O
from O
peripheral O
and O
renal _RARE_
vein _RARE_
renin I-GENE
levels O
. O

Disability _RARE_
insurance _RARE_
under O
social O
security _RARE_
. O

Choice _RARE_
of O
vessel O
. O

Suppression _RARE_
of O
food O
intake O
in O
the O
rat O
by O
tung _RARE_
oil O
. O

Studies O
of O
lipoprotein I-GENE
- I-GENE
X I-GENE
( O
LP _RARE_
- I-GENE
X I-GENE
) O
and O
bile O
acids _RARE_
in O
familial O
LCAT _RARE_
deficiency O
. O

Pneumothorax _RARE_
complicated O
by O
chronic O
steroid O
treatment O
. O

Polycythemia _RARE_
- O
1973 _RARE_
. O

Manifest _RARE_
anxiety O
of O
Vietnam _RARE_
returnees _RARE_
and O
undergraduates _RARE_
. O

Familial _RARE_
juvenile O
nephronophthisis _RARE_

Early O
heparin _RARE_
therapy O
in O
60 _RARE_
children O
with O
acute O
meningococcemia _RARE_
. O

9 O
, O
11 O
- O
Seco _RARE_
steroids O
derived O
from O
estradiol O
3 O
- O
methyl _RARE_
ether O
. O

Psychological _RARE_
examinations O
in O
patients O
with O
chronic O
kidney _RARE_
insufficiency O

Possibilities _RARE_
of O
needleless _RARE_
administration O
of O
various O
substances O
to O
animals O

Change _RARE_
in O
the O
makeup _RARE_
of O
the O
blood _RARE_
following O
a O
short O
- O
term O
local O
action O
of O
a O
permanent O
magnetic O
field O
on O
the O
human O
body O

Observations _RARE_
on O
the O
flight _RARE_
activities O
of O
Chrysops _RARE_
caecutiens _RARE_
L O
. O

Combination _RARE_
of O
3 O
multiple O
primary _RARE_
malignant O
and O
benign O
tumors O
of O
the O
breasts _RARE_
and O
uterus _RARE_

Analysis O
of O
clearance O
curve O
of O
rose O
bengal _RARE_
- O
I O
- O
131 _RARE_

Proceedings _RARE_
: O
Barrels _RARE_
and O
somatotopy _RARE_
in O
S O
I O
neocortex _RARE_
of O
the O
brush _RARE_
- O
tailed _RARE_
possum _RARE_
. O

Antivitamin _RARE_
K O
agents O

Canine _RARE_
reproduction _RARE_
: O
effects O
of O
a O
single O
injection O
of O
medroxyprogesterone _RARE_
acetate _RARE_
on O
the O
reproductive O
organs O
of O
the O
bitch _RARE_
. O

3 O
. O

Hypoglycemic _RARE_
and O
antidiabetic _RARE_
properties O

Hematopoietic _RARE_
system _RARE_
in O
streptococcal _RARE_
allergy O
. O

Letter O
: O
Aryl _RARE_
hydrocarbon I-GENE
hydroxylase I-GENE
and O
smoking O
. O

Evaluation O
of O
1 O
, O
10 O
- O
phenanthroline _RARE_
as _RARE_
a O
reagent _RARE_
for _RARE_
sialic _RARE_
acid O
determinations O
. O

Delta _RARE_
- O
aminolevulinic _RARE_
acid O
in O
physiological O
conditions O
and O
some O
diseases O
in O
children O

Nonteratogenicity _RARE_
in O
rats O
of O
blighted _RARE_
potatoes _RARE_
and O
compounds O
contained O
in O
them O
. O

VII O
. O

Isolation O
of O
tha _RARE_
avian O
reticuloendothelial _RARE_
virus O
( O
strain _RARE_
T O
). O

Observations _RARE_
on O
saccules _RARE_
of O
rats O
exposed O
to O
long O
- O
term O
hypergravity _RARE_
. O

Effect O
of O
a O
high O
- O
intensity O
SHF _RARE_
field O
on O
the O
blood _RARE_
coagulation O
system _RARE_

The O
levels O
of O
galactosyltransferase _RARE_
activity O
in O
sera _RARE_
from O
normal O
children O
and O
patients O
with O
cystic _RARE_
fibrosis _RARE_
. O

Lack _RARE_
of O
effect O
of O
the O
appetite _RARE_
stimulant _RARE_
pizotifen _RARE_
( O
BC _RARE_
105 _RARE_
) O
on O
the O
absorption O
of O
isonicotinylhydrazine _RARE_
. O

Relationship _RARE_
between O
gross O
lesions O
and O
Escherichia O
coli O
serotypes _RARE_
in O
chronic O
respiratory O
disease _RARE_
( O
CRD _RARE_
) O
of O
poultry _RARE_
. O

Plastic _RARE_
solution O
of O
elbow _RARE_
joint O
ankylosis _RARE_
with O
a O
decorticated _RARE_
cylindrical _RARE_
flap O

Effects O
of O
ionizing _RARE_
radiation O
in O
the O
human O
oral O
cavity O
and O
oropharynx _RARE_
: O
results O
of O
a O
survey O
. O

The O
Twentieth _RARE_
Anniversary _RARE_
of O
the O
Pomeranian _RARE_
Medical _RARE_
Academy _RARE_
. O

Immunelectrophoretic _RARE_
pattern O
of O
Wassermann _RARE_
reagin _RARE_
and O
comparison O
of O
the O
appearance O
time O
between O
RPCF _RARE_
and O
FTA _RARE_
antibodies I-GENE

Motile _RARE_
nocardoid _RARE_
Actinomycetales _RARE_
. O

Electrocardiographic _RARE_
QRS O
complexes O
and O
vectorcardiographic _RARE_
QRS O
loop O

Study O
of O
antinuclear _RARE_
autoantibodies O
by O
immunofluorescence O
technic _RARE_
in O
collagen _RARE_
diseases O

Cardiac _RARE_
preservation O
. O

Labial _RARE_
bar _RARE_
. O

Yusuf _RARE_
Dawood _RARE_
Docrat _RARE_
L O
. O
R O
. O
C O
. O
P O
. O

Dr _RARE_
. O

The O
metabolism O
and O
pharmacology _RARE_
of O
5 O
- O
fluorouracil O
. O

Spleen _RARE_
weight _RARE_
in O
rats O
during _RARE_
tumour _RARE_
growth O
and O
in O
homograft _RARE_
rejection O
. O

Isolation O
of O
Proteus _RARE_
vulgaris _RARE_
MC O
- O
63 _RARE_
from O
carcinoma O
63 _RARE_
and O
its O
antitumor _RARE_
effect O
on O
Crocker _RARE_
sarcoma O
180 O
and O
Ehrlich _RARE_
carcinoma O
. O

Human O
synovial O
fluid _RARE_
: O
detection O
of O
a O
new O
component _RARE_
. O

Effects O
of O
temperature _RARE_
and O
moulting _RARE_
cycle _RARE_
on O
melanin _RARE_
synthesis _RARE_
in O
the O
newt _RARE_
, O
Triturus _RARE_
cristatus _RARE_
. O

Some O
reflexions _RARE_
apropos _RARE_
of O
a O
personal O
statistical O
study O
of O
513 _RARE_
arterial O
embolisms _RARE_

LA O
- O
3848 _RARE_
- O
MS O
. O

Immunochemical _RARE_
studies O
with O
filarial _RARE_
antigens O
. O

Morphological _RARE_
and O
functional _RARE_
alterations O
noted O
after O
baboon _RARE_
renal _RARE_
allotransplantation _RARE_
. O

Heterogeneity _RARE_
of O
human I-GENE
serum I-GENE
albumin I-GENE
. O

Analysis O
of O
corticosteroids O
. O

Reactivities _RARE_
to O
horse _RARE_
anti I-GENE
- I-GENE
lymphocyte I-GENE
globulin I-GENE
. O

Plasma I-GENE
histaminase _RARE_
in O
patients O
of O
bronchial O
asthma O
and O
the O
effect O
of O
prednisolone _RARE_
administration O
on O
it O
. O

A O
comparative O
study O
of O
the O
cortical O
end O
of O
the O
auditory O
analyzer _RARE_
during _RARE_
postnatal O
ontogenesis _RARE_
in O
lower O
monkeys O
and O
man O

The O
effect O
of O
osmotic O
flow O
on O
the O
distribution O
of O
horseradish _RARE_
peroxidase I-GENE
within O
the O
intercellular _RARE_
spaces _RARE_
of O
toad _RARE_
bladder O
epithelium O
. O

Immunogenicity _RARE_
of O
various O
mycobacteria O
and O
the O
corresponding O
levels O
of O
cross O
- O
protection O
developed O
between O
species O
. O

Ten O
- O
year O
experience O
with O
one O
- O
stage _RARE_
proctocolectomy _RARE_
and O
anal _RARE_
ileostomy _RARE_
. O

Nitrogen _RARE_
- O
hydrogen O
tautomerism _RARE_
in O
porphyrins _RARE_
and O
chlorins _RARE_
. O

Factors O
affecting O
the O
inhibition O
of O
phagocytosis _RARE_
by O
chlorpromazine _RARE_
. O

Photopic _RARE_
spectral O
sensitivity O
determined O
electroretinographically _RARE_
for _RARE_
the O
pigeon _RARE_
eye O
. O

Angiography _RARE_
of O
aneurysmal _RARE_
bone O
cyst O
. O

Cholinesterase _RARE_

Sodium O
restriction _RARE_
in O
cardiac O
failure O
. O

Clinical O
and O
angiographic O
examinations O
in O
occlusion O
disease _RARE_
of O
the O
great O
intestinal _RARE_
arteries O

Serum O
lipid _RARE_
changes O
during _RARE_
pregnancy _RARE_
due O
to O
oral O
calcium _RARE_
administration O

Successful _RARE_
treatment O
of O
candidiasis O
with O
transfer I-GENE
factor I-GENE
. O

A O
possible O
role O
for _RARE_
the O
mixed O
function O
oxidase I-GENE
enzyme O
system _RARE_
in O
the O
requirement O
for _RARE_
selenium O
in O
the O
rat O
. O

Periodic _RARE_
breathing O
and O
apnea O
in O
preterm O
infants O
. O

Working _RARE_
session O
report O
: O
in O
vivo O
- O
in O
vitro O
screening O
. O

Clinicopathologic _RARE_
studies O
in O
feminizing _RARE_
tumors O
of O
the O
ovary O
. O

On O
the O
constituents _RARE_
of O
Dryopteris _RARE_
polylepis _RARE_

Relation _RARE_
between O
mixing _RARE_
ratio O
of O
raw _RARE_
materials O
and O
composition O
of O
products O
in O
the O
synthesis _RARE_
of O
aluminosilicates _RARE_

Influence O
of O
diet O
on O
urinary _RARE_
VMA _RARE_
excretion O
. O

Oscilloscope _RARE_
triggering _RARE_
circuit O
for _RARE_
recording O
long O
transients _RARE_
at _RARE_
fast O
sweep _RARE_
speeds _RARE_
. O

Derivatives _RARE_
of O
boswellic _RARE_
acids _RARE_
. O

The O
status O
of O
education O
and O
training O
programs O
in O
speech O
pathology O
and O
audiology _RARE_
-- _RARE_
1971 _RARE_
- O
72 O
. O

Coronary O
arteries O
-- _RARE_
old O
and O
new O
. O

Antiviral _RARE_
agents O
. O

Separation _RARE_
of O
ninhydrin _RARE_
- O
positive O
compounds O
in O
urine O
by O
the O
combined O
methods O
of O
medium O
- O
tension O
intophoresis _RARE_
and O
partition _RARE_
chromatography O

Conservative _RARE_
treatment O
of O
central O
nervous O
system _RARE_
injuries O

Spasmus _RARE_
nutans _RARE_
: O
a O
syndrome _RARE_
of O
auto _RARE_
- O
arousal _RARE_
. O

6 O
. O

1st _RARE_
data O
on O
the O
immunosuppressive O
therapy O
of O
scleroderma _RARE_

Slowed _RARE_
lysosomal _RARE_
enzyme I-GENE
release O
and O
its O
normalization _RARE_
by O
drugs O
in O
adjuvant O
- O
induced _RARE_
polyarthritis _RARE_
. O

Treatment O
of O
ovarian O
neoplasms O

Experimental O
pancreatitis O
in O
pigs O
. O

Bacterial _RARE_
metabolism O
of O
4 O
- O
chlorophenoxyacetate _RARE_
. O

Dynamics _RARE_
of O
hospital O
stay _RARE_
in O
peptic _RARE_
ulcer O
patients O

I O
. O

Surgical _RARE_
treatment O
of O
pathologic O
scars _RARE_
of O
myocardial _RARE_
infarct O

The O
interaction O
of O
caffeine O
, O
theophylline O
and O
theobromine _RARE_
with O
monoamine _RARE_
oxidase I-GENE
inhibitors _RARE_
. O

Effect O
of O
phenformin _RARE_
on O
gluconeogenesis _RARE_
in O
perfused O
rat O
liver O
. O

New O
alkaloids _RARE_
from O
bark _RARE_
of O
Erythrophleum _RARE_
ivorense _RARE_
. O

A O
case O
of O
M O
hemoglobinosis _RARE_

Radiosensitive _RARE_
nature O
of O
paravascular _RARE_
infiltrate _RARE_
- O
producing O
potential _RARE_
of O
parental O
spleen _RARE_
cells O
. O

Sinusoidal _RARE_
oscillations _RARE_
of O
a O
gas O
dilution O
indicator O

The O
value O
of O
different O
sources O
of O
nitrogen O
in O
diets O
for _RARE_
the O
early O
- O
weaned _RARE_
calf _RARE_
. O

1 O
. O

Abdominal _RARE_
tumors O
in O
childhood O
. O

Results O
of O
the O
official _RARE_
inspection _RARE_
of O
the O
commercial O
anti O
- O
inflammatory O
enzyme O
preparations O
containing O
chymotrypsin _RARE_
and O
trypsin I-GENE
by O
means O
of O
modified O
NF _RARE_
13 _RARE_
methods O

Studies O
on O
the O
hereditary _RARE_
nature O
of O
sole _RARE_
prints _RARE_
-- _RARE_
with O
special _RARE_
reference O
to O
interdigital _RARE_
and O
triradii _RARE_

The O
problem O
of O
disablement _RARE_
due O
to O
pulmonary O
tuberculosis O
, O
on O
the O
basis O
of O
an O
analysis O
of O
the O
history O
of O
395 _RARE_
cases O
as _RARE_
observed O
in O
Gdansk _RARE_
in O
the O
years O
1946 _RARE_
- O
1965 _RARE_

Cleidocranial _RARE_
dysostosis _RARE_

Proposals _RARE_
on O
authorization _RARE_
; O
by O
a O
group O
of O
nurses _RARE_
from O
psychiatric O
hospitals O

Successive _RARE_
abdominal O
scintillation _RARE_
with O
131 _RARE_
- O
I O
- O
tagged _RARE_
BSP _RARE_
-- _RARE_
description O
of O
the O
thyroid O
gland _RARE_
, O
kidney _RARE_
and O
spleen _RARE_
( O
comparison O
with O
131 _RARE_
- O
I O
- O
RB _RARE_
) O

Pneumonia _RARE_
in O
children O

Osteosarcoma _RARE_
caused O
by O
3 O
, O
4 O
- O
benzopyrene _RARE_

The O
content O
of O
glucosamine _RARE_
and O
galactosamine _RARE_
in O
tartar _RARE_

Relapse _RARE_
of O
leukemia O
after O
prolonged O
remission O
. O

Influence O
of O
cigarette _RARE_
smoking O
on O
some O
blood _RARE_
coagulation O
tests O
. O

The O
non O
- O
role O
of O
fluoride O
in O
the O
control O
of O
plasma O
calcium _RARE_
in O
the O
parathyroidectomized _RARE_
rat O
. O

Second O
report O
of O
the O
Norwegian _RARE_
Cancer O
Society _RARE_
. O

Modification _RARE_
of O
the O
growth O
of O
Tetrahymena _RARE_
by O
compounds O
which O
affect O
the O
adrenergic O
mechanism O
. O

SAM _RARE_
- O
TR O
- O
68 _RARE_
- O
54 O
. O

A O
brief O
discussion O
of O
color O
deficiencies O
. O

BIM _RARE_
130 _RARE_
. O

Problems _RARE_
in O
the O
determination O
of O
the O
antigenic _RARE_
content O
of O
influenza _RARE_
vaccines O
. O

Aedes _RARE_
aegypti _RARE_
( O
L O
.) O
and O
Aedes _RARE_
albopictus _RARE_
( O
Skuse _RARE_
) O
in O
Singapore _RARE_
City O
. O

Homograft _RARE_
response O
and O
hemagglutinin I-GENE
production O
by O
sensitized _RARE_
thymectomized _RARE_
irradiated O
adult O
mice O
. O

Comparative O
study O
on O
acute O
oral O
overload O
using O
tolbutamide _RARE_
and O
tolazamide _RARE_
in O
normal O
and O
diabetic O
subjects O
. O

Mycotoxins _RARE_
in O
feeds _RARE_
and O
foods _RARE_
. O

Factors O
influencing O
in O
vitro O
skin _RARE_
permeability _RARE_
factor I-GENE
production O
by O
Vibrio _RARE_
cholerae _RARE_
. O

Spinal _RARE_
cord O
representation _RARE_
of O
the O
micturition _RARE_
reflex O
. O

Biological O
action O
and O
kinetics O
of O
the O
elimination O
of O
tritium _RARE_
oxide O
in O
dogs O

Auto _RARE_
- O
and O
isotopy _RARE_
of O
the O
conjunctiva _RARE_

IX _RARE_
. O

Pitfalls _RARE_
in O
the O
use O
of O
chromosome _RARE_
aberration _RARE_
analysis O
for _RARE_
biological O
radiation O
dosimetry _RARE_
. O

Renin _RARE_
secretion _RARE_
in O
essential O
and O
accelerated O
hypertension O
. O

The O
need O
for _RARE_
including O
forensic _RARE_
medical O
expertise _RARE_
in O
the O
list _RARE_
of O
urgent _RARE_
criminal _RARE_
investigative _RARE_
actions O

Histopathology _RARE_
and O
pathogenesis O
of O
exanthematous _RARE_
viroses _RARE_

CNS O
effects O
of O
local O
anesthetics _RARE_
only O
partially O
dependent O
on O
biogenic _RARE_
amine _RARE_
mechanisms O
. O

Diethylene _RARE_
benzene _RARE_

Midge _RARE_
control O
in O
flood _RARE_
channels _RARE_
. O

The O
effects O
of O
taloximine _RARE_
and O
aminophylline _RARE_
on O
isolated O
human O
smooth _RARE_
muscle O
. O

The O
exploratory _RARE_
behaviour O
in O
normal O
and O
aggressive O
mice O
. O

Genitography _RARE_
in O
intersexual _RARE_
states O
. O

Tolerance _RARE_
test O
of O
HB _RARE_
419 _RARE_
in O
animal _RARE_
experiments O

The O
role O
of O
ascorbic _RARE_
acid O
in O
the O
prevention O
of O
bladder O
tumor O
formation O
. O

The O
" O
28 _RARE_
percent O
" O
Venturi _RARE_
mask _RARE_
in O
obstructive _RARE_
airway O
disease _RARE_
. O

3 O
'- O
Methyl _RARE_
, O
8 O
- O
methyl _RARE_
, O
and O
8 O
- O
phenyl _RARE_
derivatives _RARE_
of O
5 O
, O
9 O
- O
dimethyl O
- O
6 O
, O
7 O
- O
benzomorphans _RARE_
. O

Antidromic _RARE_
invasion O
of O
impulses _RARE_
and O
recurrent O
collateral O
inhibition O
in O
pyramidal O
tract _RARE_
neurones O
. O

The O
distribution O
of O
body O
fluids O
following O
hemorrhage O
and O
resuscitation O
in O
combat _RARE_
casualties _RARE_
. O

Once O
more O
Hong _RARE_
Kong _RARE_
influenza _RARE_
in O
the O
Netherlands _RARE_

Early O
disagnosis _RARE_
of O
cancer _RARE_
-- _RARE_
50 O
per O
cent O
of O
all O
patients O
could O
be O
cured _RARE_

Difficulties _RARE_
bound _RARE_
to O
measuring O
of O
sputum _RARE_
viscosity O

Lipid _RARE_
concentration O
and O
lipase I-GENE
activity O
in O
the O
epiphysis _RARE_
of O
adrenalectomized _RARE_
rats O
consuming _RARE_
food O
with O
different O
sodium _RARE_
content O

Behavior _RARE_
of O
aspartate _RARE_
aminotransferase I-GENE
( O
EC I-GENE
2 I-GENE
. I-GENE
6 I-GENE
. I-GENE
1 I-GENE
. I-GENE
1 I-GENE
) O
and O
alanine I-GENE
aminotransferase I-GENE
( O
EC I-GENE
2 I-GENE
. I-GENE
6 I-GENE
. I-GENE
1 I-GENE
. I-GENE
2 I-GENE
) O
in O
rat O
serum O
during _RARE_
the O
course O
of O
acute O
radiation O
syndrome _RARE_
following O
whole O
body O
X O
- O
irradiation O

Diminished _RARE_
forearm _RARE_
arteriolar _RARE_
dilator _RARE_
capacity O
produced O
by O
mineralocorticoid _RARE_
- O
induced _RARE_
salt O
retention O
in O
man O
. O

Studies O
on O
the O
pathogenicity _RARE_
of O
ECHO O
9 O
( O
HILL _RARE_
) O
virus O
and O
its O
mutants O
for _RARE_
suckling _RARE_
mice O

Counter _RARE_
- O
current O
heat O
exchange O
in O
the O
respiratory O
passages _RARE_
: O
effect O
on O
water O
and O
heat O
balance O
. O

Calibration _RARE_
and O
a O
correction O
of O
blood _RARE_
O2 _RARE_
content O
measured O
by O
Po2 _RARE_
and O
CO _RARE_
saturation O
. O

Mae _RARE_
West _RARE_
and O
the O
doctor _RARE_
shortage _RARE_
. O

Elimination O
of O
gamma O
- O
irradiation O
induced _RARE_
oxidation O
in O
aqueous O
drug O
preparations O

The O
absolute O
configuration O
at _RARE_
C O
- O
2 O
in O
monocrotalic _RARE_
acid O
. O

Teratogenic _RARE_
effects O
of O
actinomycin _RARE_
D O
in O
rats O

The O
plasma I-GENE
growth I-GENE
hormone I-GENE
concentration O
of O
the O
foetal _RARE_
lamb _RARE_
. O

Bimodal _RARE_
cochlear O
response O
curves O
in O
rodents _RARE_
. O

A O
new O
hemagglutination _RARE_
test O
for _RARE_
the O
on O
- O
slide _RARE_
assay O
of O
rheumatoid I-GENE
factor I-GENE

CO2 O
assimilation _RARE_
by O
chloroplasts _RARE_
illuminated _RARE_
on O
filter O
paper O
. O

The O
biology _RARE_
of O
Hyostrongylus _RARE_
ruidus _RARE_
. O

Foreign _RARE_
profiles O
in O
air O
pollution _RARE_
control O
activities O
. O

Effects O
of O
chronic O
metaraminol _RARE_
treatment O
on O
the O
sympathetic O
activity O
of O
intact _RARE_
and O
adrenal O
demedullated _RARE_
rats O
kept O
in O
warm _RARE_
or O
cold O
environments _RARE_
. O

The O
association O
of O
clopamide _RARE_
and O
hydergine _RARE_
( O
Brinedine _RARE_
) O
in O
the O
treatment O
of O
the O
vasculo _RARE_
- O
renal _RARE_
syndromes O
of O
pregnancy _RARE_

The O
effect O
of O
low O
dosage O
radiation O
on O
metabolism O
and O
function O
of O
the O
rat O
kidney _RARE_
damaged O
by O
ischemia O

Leukemia _RARE_
in O
twins _RARE_
: O
world O
- O
wide O
review O
of O
clinical O
cases O
. O

Preliminary _RARE_
report O
. O

Quantitation _RARE_
of O
exocrine _RARE_
IgA I-GENE
in O
human O
serum O
in O
health O
and O
disease _RARE_
. O

Gastrointestinal _RARE_
manifestations O
of O
systemic O
sclerosis O

Iodine _RARE_
metabolism O
in O
chronic O
thyroiditis O
. O

Total O
body O
water O
, O
rhodanide _RARE_
space O
and O
I I-GENE
- I-GENE
131 _RARE_
- I-GENE
albumin I-GENE
space O
under O
the O
acute O
effect O
of O
furosemide O

V O
. O

18F O
and O
85Sr _RARE_
scintimetry _RARE_
in O
the O
study O
of O
primary _RARE_
arthropathies _RARE_
. O

Propagation _RARE_
and O
hormone O
production O
by O
human O
normal O
and O
malignant O
trophoblast _RARE_
in O
rats O
. O

Health O
: O
an O
integrative _RARE_
reticulum O
. O

Sensitive _RARE_
fluorometric _RARE_
method O
of O
determining _RARE_
SH _RARE_
- O
and O
S O
- O
S O
- O
groups O
when O
jointly _RARE_
present O

Morphogenesis _RARE_
of O
the O
trochanter _RARE_
produced O
by O
femoral O
regeneration O
in O
the O
phasmid _RARE_
Carausius _RARE_
morosus _RARE_
Br O

Behavioral _RARE_
and O
electrographic _RARE_
expression _RARE_
of O
natural _RARE_
sleep O
and O
wakefulness _RARE_
in O
reptiles _RARE_

Sensitivities _RARE_
of O
thromboplastins _RARE_
to O
factor I-GENE
VII I-GENE
deficiency O
. O

3 O
. O

Central _RARE_
venous O
catheter O
used O
for _RARE_
recording O
intracardiac _RARE_
electrocardiogram O
. O

Two O
Lab _RARE_
8 O
computer O
programmes _RARE_
for _RARE_
use O
in O
the O
study O
of O
the O
isometric _RARE_
and O
isotonic _RARE_
contractile O
characteristics O
of O
skeletal O
muscle O
. O

Open _RARE_
head O
- O
brain O
injuries O

The O
modification O
of O
P32 _RARE_
uptake O
into O
the O
Jensen _RARE_
sarcoma O
in O
vitro O
by O
adding O
of O
peroxide _RARE_
to O
the O
nutritive _RARE_
medium O

Students _RARE_
, O
parents O
, O
teachers _RARE_
and O
hearing O
disorders O

Changing _RARE_
and O
predicting O
doses O
of O
Cs137 _RARE_
irradiation O

Positive _RARE_
shifts O
of O
basal O
skin _RARE_
potentials O
during _RARE_
human O
sleep O
. O

Evaluating _RARE_
dietary O
department _RARE_
management O
. O

5 O
-( _RARE_
Dimethylaminopropyl _RARE_
)- O
19 O
, O
11 O
- O
dihydro _RARE_
- O
5H _RARE_
- O
benzo _RARE_
[ _RARE_
2 O
, O
3 O
] O
pyrido _RARE_
[ _RARE_
6 O
, O
7 O
- O
b O
] O
azepine _RARE_
. O

Osteogenesis _RARE_
imperfecta _RARE_

Investigation _RARE_
on O
the O
exchange O
of O
Ca45 _RARE_
in O
intact _RARE_
and O
burned _RARE_
rats O
by O
the O
kinetic O
analysis O
method O

Effect O
of O
thrombotic O
and O
antithrombotic _RARE_
drugs O
on O
the O
surface O
charge _RARE_
characteristics O
of O
canine O
blood _RARE_
vessels O
: O
in O
vivo O
and O
in O
vitro O
studies O
. O

Measurements O
of O
activity O
with O
the O
radioprotective _RARE_
chamber O
VA O
- O
K O
- O
254 _RARE_
of O
the O
osimeter _RARE_
VA O
- O
J18 _RARE_

3 O
-( _RARE_
N O
- O
Alkyl _RARE_
- O
N O
- O
2 O
- O
chloroethylaminomethyl _RARE_
)- O
5 O
- O
or O
7 O
- O
halogenobenzo _RARE_
[ _RARE_
b O
] O
thiophen _RARE_
hydrochlorides _RARE_
. O

Nephrectomy _RARE_
applied O
to O
cattle O

Evaluation O
of O
automatic O
blood _RARE_
cell O
counters _RARE_
. O

Determination O
of O
transaminases _RARE_
with O
an O
autoanalyzer _RARE_

Sterols _RARE_
in O
pollen O
. O

Dermoid _RARE_
cyst O
in O
a O
free O
skin _RARE_
flap O
as _RARE_
the O
complication O
after O
treatment O
of O
recurring _RARE_
hernia _RARE_

Histological O
observations O
on O
the O
decidua _RARE_
in O
the O
second O
half _RARE_
of O
pregnancy _RARE_

Endocardial _RARE_
fibro _RARE_
- O
elastosis _RARE_
, O
mitral O
incompetence _RARE_
, O
and O
coarctation _RARE_
of O
abdominal O
aorta O
. O

Studies O
on O
the O
method O
of O
size O
reduction O
of O
medicinal _RARE_
compounds O
. O

Children O
with O
defective _RARE_
vision O

Identification O
and O
estimation O
of O
monosaccharides _RARE_
and O
disaccharides _RARE_
in O
urine O
by O
gas O
- O
liquid O
chromatography O
. O

Steroids _RARE_
in O
germfree _RARE_
and O
conventional O
rats O
. O

The O
effects O
of O
loading O
the O
respiratory O
pumps _RARE_
on O
the O
oxygen O
consumption O
of O
Callionymus _RARE_
lyra _RARE_
. O

Trials _RARE_
of O
sevine _RARE_
activity O
against O
mosquito _RARE_
larvae O

The O
significance O
of O
structural O
integrity O
of O
lymphoid _RARE_
tissue O
for _RARE_
antibody O
production O
in O
culture O
in O
vivo O

The O
effect O
of O
a O
constant O
magnetic O
field O
on O
the O
phagocytic O
activity O
of O
Paramecia _RARE_

Studies O
carried O
out O
with O
the O
Glossina _RARE_
morsitans _RARE_
colony O
of O
Lisbon _RARE_
. O

Relations _RARE_
between O
adrenergic O
mechanisms O
and O
analgesic O
effects O

Transformations _RARE_
in O
the O
morphine _RARE_
series O
. O

Dissociative _RARE_
anesthetics _RARE_
2 O
-( _RARE_
o _RARE_
- O
chlorophenyl _RARE_
)- O
2 O
- O
methyl _RARE_
- O
amino O
cyclohexane _RARE_
HCL _RARE_
( O
CI _RARE_
- O
581 _RARE_
) O

Estrus _RARE_
and O
copulative _RARE_
abilities O
of O
androgen _RARE_
- O
sterilized _RARE_
rats O

The O
bearing _RARE_
of O
season O
and O
sequence O
of O
calving _RARE_
on O
frequency O
of O
male O
, O
female O
and O
total _RARE_
calvings _RARE_
in O
Hariana _RARE_
cows O
. O

Hemodynamics _RARE_
changes O
in O
man O
during _RARE_
flight _RARE_

Caries _RARE_
prevention O
in O
the O
dental O
office _RARE_
. O

I O
. O

Clinical O
applications O
of O
inhibition O
of O
beta I-GENE
- I-GENE
adrenergic I-GENE
receptors I-GENE
with O
propranolol O
. O

Automatic _RARE_
view O
box O
. O

Measurement O
of O
gastric _RARE_
acid O
secretion _RARE_
by O
conductivity _RARE_
. O

Effect O
of O
castration _RARE_
on O
pituitary I-GENE
and I-GENE
serum I-GENE
LH _RARE_
and O
FSH I-GENE
in O
testosterone O
- O
sterilized _RARE_
rats O
. O

The O
significance O
of O
the O
phenolphthalein _RARE_
sulphatase _RARE_
test O
for _RARE_
the O
differentiation O
and O
identification O
of O
Nocardia _RARE_
species O
. O

Relationship _RARE_
of O
mast _RARE_
cells O
to O
sarcoidosis _RARE_
granuloma O
of O
the O
skin _RARE_

Long _RARE_
- O
term O
effects O
of O
clofibrate _RARE_
( O
Atromid _RARE_
- O
S O
) O
on O
serum O
lipids O
in O
man O
. O

Phosphate _RARE_
glucose I-GENE
dehydrogenase I-GENE
deficiency O
causing O
hyperbilirubinemia O
in O
the O
newborn O

Evidence O
forthe _RARE_
electroosmosis _RARE_
theory O
of O
transport _RARE_
in O
the O
phloem _RARE_
. O

Effects O
of O
beta I-GENE
- I-GENE
adrenergic I-GENE
receptor I-GENE
blockade O
on O
airway O
conductance _RARE_
and O
lung _RARE_
volume O
in O
normal O
and O
asthmatic O
subjects O
. O

Effect O
of O
heparin _RARE_
on O
the O
inactivation O
of O
serum I-GENE
lipoprotein I-GENE
lipase I-GENE
by O
the O
liver O
in O
unanesthetized _RARE_
dogs O
. O

Experimental O
chlorpromazine _RARE_
cataracts _RARE_
. O

I O
. O

Specialist _RARE_
in O
family O
practice O
-- _RARE_
prototype O
of O
a O
doctor _RARE_
. O

The O
possibility O
of O
selective O
chemotherapy O
of O
progressive O
recurring _RARE_
ovarian O
carcinoma O
with O
the O
aid O
of O
cytodiagnosis _RARE_
and O
incorporation O
of O
tagged _RARE_
idoxuridine _RARE_

Variation _RARE_
in O
the O
temporal O
- O
spatial O
distribution O
of O
228Ra _RARE_
and O
224Ra _RARE_
in O
the O
RES _RARE_
and O
marrow O
- O
free O
skeleton _RARE_
after O
incorporation O
of O
colloidal _RARE_
ThO2 _RARE_

Oxidative _RARE_
degradation _RARE_
of O
adrenaline O
solutions O
: O
study O
of O
the O
intermediate _RARE_
stages O
and O
their O
analytic _RARE_
value O
for _RARE_
the O
control O
of O
this O
solute _RARE_

Absorption _RARE_
of O
electrolytes _RARE_
from O
the O
colon O
in O
cases O
of O
ulcerative _RARE_
colitis _RARE_
and O
in O
control O
subjects O
. O

Ion _RARE_
injection O
. O

Polyvinyl _RARE_
alcohol _RARE_
as _RARE_
a O
solution O
mediator _RARE_

Mining _RARE_
the O
diagnostic O
iron O
ore _RARE_
. O

The O
structure _RARE_
of O
digiprogenin _RARE_
. O

The O
need O
in O
the O
small O
hospital O
. O

I O
. O

On O
the O
character O
of O
changes O
in O
the O
enzyme O
activity O
in O
the O
brain O
tissue O
during _RARE_
reflex O
epilepsy O

A O
malignant O
true O
teratoma _RARE_
of O
liver O
in O
childhood O
. O

Methoxyflurane _RARE_
and O
renal _RARE_
function O

Histochemistry _RARE_
and O
electron O
microscopy O
of O
acute O
liver O
lesions O
induced _RARE_
by O
Aflatoxin _RARE_
B1 _RARE_
in O
ducklings _RARE_
. O

Functional O
disorders O
of O
the O
ureter _RARE_
following O
gynecologic O
surgery O

Study O
of O
the O
alterations O
of O
intestinal _RARE_
absorption O
, O
by O
means O
of O
I O
- O
131 _RARE_
- O
triolein _RARE_
, O
in O
the O
whole O
body O
irradiated O
rat O

Chemical O
histologic O
and O
immunologic O
responses O
in O
rats O
to O
CC1 _RARE_
- O
4 O
by O
different O
routes O
of O
administration O
. O

Clinical O
trials O
with O
1 O
, O
3 O
- O
bis _RARE_
( O
2 O
- O
chloroethyl _RARE_
)- O
1 O
- O
nitrosourea _RARE_
, O
NSC _RARE_
- O
409962 _RARE_
. O

Hydroxypropyl _RARE_
methacrylate _RARE_
, O
a O
new O
water O
- O
miscible _RARE_
embedding _RARE_
medium O
for _RARE_
electron O
microscopy O
. O

Statistics _RARE_
of O
the O
past O
5 O
years O

On O
the O
diagnosis O
of O
bovine O
leucosis _RARE_
and O
its O
control O
in O
southern O
Lower _RARE_
Saxony _RARE_

Experience _RARE_
with O
the O
restoration _RARE_
of O
agglutination _RARE_
properties O
of O
non O
- O
agglutinating _RARE_
dysenterial _RARE_
cultures O
with O
the O
use O
of O
Rzhaninov _RARE_
' O
s O
method O

Study O
on O
micromelias _RARE_
in O
the O
mouse O
fetus O
caused O
by O
x _RARE_
- O
radiation O
, O
hypoxia _RARE_
, O
trypan _RARE_
blue O
injection O
of O
hypervitaminosis _RARE_
- O
A O
upon O
mother _RARE_
animals O
during _RARE_
pregnancy _RARE_
. O

Human O
antitetanus _RARE_
serum O
: O
an O
unused _RARE_
wealth _RARE_

( O
3 O
). O

Studies O
on O
the O
intracutaneous _RARE_
infection O
of O
rabbits O
by O
Staphylococcus _RARE_
aureus _RARE_
. O

On O
catabolism O
of O
aminoketones _RARE_
in O
climacteric _RARE_
age O

The O
effect O
of O
feeding O
patterns O
on O
fat O
deposition O
in O
mice O
. O

Naphthalene _RARE_
and O
paradichlorobenzene _RARE_
in O
clinical O
toxicology _RARE_

IV O
. O

Studies O
on O
powdered _RARE_
preparations O
. O

A O
case O
report O
with O
angiographic O
follow O
- O
up _RARE_
study O
. O

Interactions _RARE_
between O
adrenergics _RARE_
, O
adrenolytics _RARE_
and O
monoamine _RARE_
oxidase I-GENE
inhibitors _RARE_

Further O
studies O
on O
a O
" O
new O
" O
human O
isoprecipitin _RARE_
system _RARE_
( O
Australia _RARE_
antigen O
). O

Pigmentary _RARE_
rhythms _RARE_
as _RARE_
indicators O
of O
neurosecretion _RARE_
. O

Story _RARE_
of O
a O
hospital O
that O
filmed _RARE_
its O
employee _RARE_
orientation O
program O
. O

When O
the O
cervical O
Pap _RARE_
smear _RARE_
is O
positive O
. O

I O
. O

The O
3 O
- O
hour O
test O
iodine O
( O
I O
- O
132 O
) O
uptake O
by O
the O
thyroid O
in O
children O
with O
growth O
deficiency O

Persistence _RARE_
of O
toxaphene _RARE_
in O
treated O
lakes _RARE_
. O

Studies O
on O
Coxsackie _RARE_
B O
Type _RARE_
5 O
virus O
infections O
. O

Value O
of O
the O
method O
of O
passive O
hemagglutination _RARE_
with O
polysaccharide _RARE_
C O
in O
detecting O
C I-GENE
- I-GENE
reactive I-GENE
protein I-GENE
as _RARE_
compared O
to O
precipitation O
in O
capillaries O
and O
slide _RARE_
latex O
test O
with O
anti I-GENE
- I-GENE
CRP I-GENE
serum O

Adrenergic _RARE_
nerve O
function O
, O
noradrenaline O
level O
and O
noradrenaline O
uptake O
in O
cat _RARE_
nictitating _RARE_
membrane O
after O
reserpine _RARE_
treatment O
. O

Concussion _RARE_
of O
the O
spinal _RARE_
cord O

Study O
on O
the O
evagination _RARE_
of O
Cysticercus _RARE_
pisiformis _RARE_
. O

Antimicrobial _RARE_
substance _RARE_
isolated O
from O
an O
acorn _RARE_
extract _RARE_
. O

The O
pathogenicity _RARE_
of O
Achromobacter _RARE_
puntatum _RARE_
for _RARE_
cold O
blooded _RARE_
and O
warm _RARE_
blooded _RARE_
animals O

Consanguinity _RARE_
and O
migration O
in O
the O
marriages _RARE_
of O
the O
region O
of O
Nunoa _RARE_
, O
Santiago _RARE_
, O
1850 _RARE_
- O
1960 _RARE_

On O
the O
amount O
and O
significance O
of O
the O
effective O
glucose O
level O
in O
tumors O
. O

Studies O
of O
lipogenesis _RARE_
by O
labelled O
precursors _RARE_
in O
the O
pregnant _RARE_
rat O
. O

Pharmacodynamic _RARE_
studies O
on O
the O
cardiovascular O
system _RARE_
of O
spontaneously O
hypertensive O
rats O
. O

Nuclear O
spin O
of O
249Bk _RARE_
from O
the O
hyperfine _RARE_
structure _RARE_
in O
its O
emission O
spectrum O
. O

Further O
observations O
on O
resorption O
in O
guinea _RARE_
pigs O
following O
injections O
of O
trypan _RARE_
blue O
. O

Derivatives _RARE_
of O
fluorene _RARE_
. O

Note _RARE_
on O
Slot _RARE_
' O
s O
method O
for _RARE_
the O
specific O
determination O
of O
creatinine _RARE_
. O

Retention _RARE_
behavior O
of O
steroids O
in O
gas O
chromatography O
with O
a O
series O
of O
combination O
columns _RARE_
. O

Compensatory _RARE_
renal _RARE_
hypertrophy O
in O
parabiotic _RARE_
rats O
. O

( O
3 O
). O

XXI _RARE_
. O

In O
vitro O
evaluation O
of O
the O
mucolytic _RARE_
action O
of O
urea O
. O

Electrophoretic O
characteriaztion _RARE_
of O
virus O
- O
induced _RARE_
interferon _RARE_
of O
the O
blood _RARE_
and O
urine O
in O
rabbits O

Iron _RARE_
and O
folate _RARE_
deficiency O
in O
pregnancy _RARE_

Symposium _RARE_
on O
presenile _RARE_
spongy _RARE_
encephalopathies _RARE_
. O

Twenty O
- O
two O
of O
the O
24 _RARE_
patients O
had O
a O
rise O
in O
the O
total _RARE_
serum O
amylase I-GENE
following O
ERCP _RARE_
. O

The O
immuno _RARE_
- O
purified _RARE_
mRNA O
in O
the O
polysome _RARE_
complex O
was O
used O
to O
prepare _RARE_
cDNA O
with O
which O
to O
probe O
a O
D O
. O
melanogaster O
genomic O
library O
. O

Elevated _RARE_
maternal _RARE_
alpha I-GENE
fetoproteins _RARE_
and O
oligoamnios _RARE_
: O
fetal _RARE_
prognosis O

Also O
discussed O
is O
the O
possibility O
of O
a O
combined O
genetic O
and O
environmental O
etiology O
. O

Courses _RARE_
were O
repeated _RARE_
monthly O
upon O
recovery O
of O
myelosuppression _RARE_
. O

Stimulation _RARE_
with O
MCh _RARE_
produced O
a O
Ca O
- O
dependent O
transient O
elevation O
of O
cGMP _RARE_
level O
from O
10 O
to O
80 _RARE_
fmol _RARE_
/ O
gland _RARE_
, O
peaking _RARE_
at _RARE_
1 O
- O
2 O
min O
but O
returning _RARE_
to O
the O
basal O
level O
by O
5 O
min O
. O

Two O
hundred O
forty _RARE_
- O
three O
patients O
have O
received O
WR O
- O
2721 O
in O
Phase O
I O
- O
II O
studies O
. O

The O
PEPCK I-GENE
promoter O
fragment O
was O
introduced O
either O
in O
the O
proper O
orientation O
for _RARE_
transcription O
of O
the O
TK I-GENE
gene I-GENE
or O
in O
the O
opposite O
orientation O
. O

Many O
mammary O
tumors O
induced _RARE_
by O
mouse O
mammary O
tumor O
virus O
( O
MMTV _RARE_
) O
contain O
a O
provirus O
in O
the O
same O
region O
of O
the O
host _RARE_
- O
cell O
genome O
, O
leading O
to O
expression _RARE_
of O
a O
putative O
cellular O
oncogene O
called O
int I-GENE
- I-GENE
1 I-GENE
. O

In O
these O
cases O
, O
asbestos _RARE_
or O
erionite _RARE_
- O
tissue O
burden O
followed O
by O
fibrosis _RARE_
was O
frequently O
observed O
. O

Hepatitis _RARE_
B O
virus O
and O
hepatoma O
. O

Eight O
recombinant O
DNA O
clones _RARE_
of O
endogenous O
murine O
leukemia O
virus O
( O
MuLV O
)- O
related O
DNA O
sequences O
have O
been O
isolated O
from O
a O
lambdaphage _RARE_
genomic O
library O
of O
Balb _RARE_
/ O
c O
mouse O
DNA O
. O

USA _RARE_
80 _RARE_
, O
3618 _RARE_
- O
3622 _RARE_
) O
The O
two O
proteins O
show O
36 _RARE_
% O
identities O
in O
their O
amino O
acid O
sequence O
, O
in O
an O
alignment O
requiring O
six _RARE_
gaps _RARE_
. O

The O
envelope O
glycoproteins _RARE_
of O
Rous _RARE_
sarcoma O
virus O
( O
RSV _RARE_
), _RARE_
gp85 _RARE_
and O
gp37 _RARE_
, O
are O
anchored _RARE_
in O
the O
membrane O
by O
a O
27 _RARE_
- O
amino O
acid O
, O
hydrophobic O
domain O
that O
lies O
adjacent O
to O
a O
22 _RARE_
- O
amino O
acid O
, O
cytoplasmic O
domain O
at _RARE_
the O
carboxy _RARE_
terminus O
of O
gp37 _RARE_
. O

The O
drug O
was O
given O
in O
a O
daily O
oral O
dose O
of O
0 _RARE_
. O
5 O
g O
/ O
m2 O
, O
3 O
. O
5 O
h O
prior O
to O
each O
radiation O
treatment O
. O

Histogenetic _RARE_
aspects O
of O
mesoblastic _RARE_
nephroma _RARE_
. O

Effect O
of O
acute O
and O
chronic O
psychogenic _RARE_
stress O
on O
corticoadrenal _RARE_
and O
pituitary I-GENE
- I-GENE
thyroid I-GENE
hormones _RARE_
in O
male O
rats O
. O

Mature _RARE_
mRNA O
for _RARE_
cytosolic I-GENE
phosphoenolpyruvate I-GENE
carboxykinase _RARE_
of I-GENE
the I-GENE
chicken I-GENE
is O
2 O
. O
8 O
kilobases O
in O
length O
, O
similar O
to O
that O
previously O
noted O
for _RARE_
mRNA O
coding O
for _RARE_
the O
same O
enzyme O
in O
the O
rat O
. O

Upstream O
activation O
sites O
of O
the O
CYC1 I-GENE
gene I-GENE
of O
Saccharomyces O
cerevisiae O
are O
active _RARE_
when O
inverted O
but O
not O
when O
placed O
downstream _RARE_
of O
the O
" O
TATA O
box O
". O

An O
intact _RARE_
5 O
. O
7 O
- O
kb O
provirus O
of O
the O
avian O
erythroblastosis _RARE_
virus O
E26 _RARE_
has O
been O
molecularly O
cloned _RARE_
for _RARE_
comparisons O
with O
avian O
myeloblastosis _RARE_
virus O
( O
AMV _RARE_
) O
and O
other O
avian O
tumor O
viruses O
. O

It O
is O
concluded O
that O
haloperidol O
selectively O
reduced _RARE_
the O
animal _RARE_
' O
s O
capacity O
to O
' O
programme _RARE_
non O
- O
stimulus O
directed O
motor O
behaviour O
'. O

Neither O
side _RARE_
effect O
nor O
abnormal O
laboratory O
findings O
due O
to O
this O
drug O
were O
observed O
. O

The O
results O
presented O
in O
this O
report O
suggest O
that O
the O
SV40 O
G O
- O
C O
- O
rich O
sequences O
can O
function O
as _RARE_
independent O
RNA I-GENE
polymerase I-GENE
II I-GENE
transcriptional O
- O
control O
elements O
. O

Construction _RARE_
of O
human O
cell O
lines O
which O
contain O
and O
express O
the O
adenovirus O
DNA O
binding O
protein O
gene O
by O
cotransformation _RARE_
with O
the O
HSV I-GENE
- I-GENE
1 I-GENE
tk I-GENE
gene I-GENE
. O

Diagnosis O
and O
treatment O
of O
insulin I-GENE
- O
secreting O
tumours O
. O

Theories _RARE_
proffered _RARE_
to O
account O
for _RARE_
the O
modality O
shift O
effect O
are O
critically _RARE_
evaluated O
. O

The O
effects O
of O
cardioselective _RARE_
beta O
- O
1 O
adrenergic O
agonist O
, O
1 O
-( _RARE_
4 O
- O
hydroxyphenoxy _RARE_
)- O
isopropylamino _RARE_
- O
2 O
- O
propanol _RARE_
), _RARE_
i O
. O
e _RARE_
., O
prenalterol _RARE_
, O
were O
examined O
on O
direct O
and O
continuous O
measurements O
of O
left _RARE_
ventricular O
( O
LV O
) O
pressure O
, O
diameter O
, O
dP _RARE_
/ O
dt O
, O
velocity O
of O
shortening O
, O
arterial O
pressure O
, O
iliac O
blood _RARE_
flow O
and O
heart _RARE_
rate O
in O
10 O
conscious O
dogs O
. O

Endorphins _RARE_
at _RARE_
the O
approach O
of O
death _RARE_
. O

Trial _RARE_
treatment O
of O
schizophrenia O
with O
des _RARE_
- I-GENE
Tyr _RARE_
- I-GENE
gamma I-GENE
- I-GENE
endorphin I-GENE

Cardiac _RARE_
taurine _RARE_
levels O
and O
sarcolemmal _RARE_
calcium _RARE_
binding O
activity O
in O
furazolidone _RARE_
- O
induced _RARE_
cardiomyopathy O
. O

Separation _RARE_
of O
malaria O
- O
infected _RARE_
erythrocytes _RARE_
from O
whole O
blood _RARE_
: O
use O
of O
a O
selective O
high O
- O
gradient O
magnetic O
separation O
technique O
. O

The O
roll _RARE_
- O
over O
test O
to O
predict O
toxemia _RARE_
in O
pregnancy _RARE_
. O

Can _RARE_
thyroglobulin _RARE_
assay O
really _RARE_
supplant _RARE_
radioiodine _RARE_
scans O
in O
patients O
with O
differentiated O
thyroid O
cancer _RARE_
? O

3 O
Significant O
reductions O
in O
lying _RARE_
mean O
arterial O
blood _RARE_
pressure O
were O
observed O
with O
daily O
doses O
of O
200 _RARE_
mg O
(- _RARE_
9 O
%), O
400 _RARE_
mg O
(- _RARE_
10 O
%) O
and O
800 O
mg O
(- _RARE_
14 O
%), O
and O
were O
associated O
with O
significant O
decreases O
in O
heart _RARE_
rate O
and O
plasma I-GENE
renin I-GENE
activity O
. O

Isolation O
of O
Aeromonas _RARE_
from O
faeces _RARE_
. O

Plasma O
and O
erthrocyte _RARE_
lipid _RARE_
profile O
and O
lipoprotein I-GENE
lipase I-GENE
activity O
in O
postheparin _RARE_
plasma O
on O
vasectomized _RARE_
rabbits O
were O
studied O
and O
also O
the O
incidence O
of O
atherosclerosis O
in O
different O
arterial O
beds _RARE_
. O

( O
iii O
) O
The O
mRNA O
is O
not O
efficiently O
polyadenylated O
at _RARE_
sequences O
in O
the O
3 O
' O
end O
of O
the O
DHFR I-GENE
cDNA I-GENE
but O
rather O
uses O
polyadenylation O
signals O
downstream _RARE_
from O
the O
DHFR I-GENE
cDNA I-GENE
. O

At O
both O
water O
temperatures O
, O
VO2 O
increased O
linearly _RARE_
with O
increasing O
swimming O
velocity O
. O

Propranolol _RARE_
also O
effectively O
controlled _RARE_
her _RARE_
familial O
tremor O
. O

Brief _RARE_
report O
. O

The O
distribution O
phase _RARE_
is O
followed O
by O
an O
elimination O
phase _RARE_
with O
a O
much O
longer O
half _RARE_
- O
life O
( O
mean O
value O
375 _RARE_
min O
) O
and O
a O
volume O
of O
distribution O
of O
approximately _RARE_
200 _RARE_
- O
400 _RARE_
l _RARE_
. O

Hybrid _RARE_
- O
selection O
experiments O
against O
total _RARE_
PB _RARE_
- O
inducible O
RNA O
were O
performed O
with O
plasmid _RARE_
DNA O
derived O
from O
clones _RARE_
enriched _RARE_
in O
PB _RARE_
- O
inducible O
information _RARE_
. O

Risk O
of O
HTLV _RARE_
infection O
in O
patients O
on O
haemodialysis O
. O

In O
vitro O
metabolism O
of O
progesterone O
by O
the O
human O
undescended _RARE_
testis _RARE_
. O

Two O
patients O
withdrew _RARE_
from O
therapy O
, O
one O
for _RARE_
personal O
reasons _RARE_
and O
one O
because O
a O
paraspinal _RARE_
mass O
developed O
. O

All O
patients O
received O
VCR _RARE_
1 O
. O
0 _RARE_
mg O
/ O
m2 O
weekly O
for _RARE_
6 O
weeks O
with O
dose O
modification O
for _RARE_
neurotoxicity O
. O

Glutamic _RARE_
acid O
in O
a O
dose O
of O
1 O
/ O
100 _RARE_
of O
the O
LD50 O
was O
injected O
in O
the O
form O
of O
sodium _RARE_
salt O
into O
male O
and O
female O
Wistar _RARE_
rats O
for _RARE_
7 O
days O
after O
8 O
- O
and O
12 O
- O
day O
injections O
of O
dexazone _RARE_
. O

Serum O
ascorbic _RARE_
acid O
had O
an O
inverse _RARE_
and O
the O
strongest O
association O
with O
systolic O
blood _RARE_
pressure O
among O
the O
risk O
factors O
including O
blood _RARE_
pressure O
, O
total _RARE_
cholesterol O
, O
triglyceride _RARE_
, O
gamma I-GENE
- I-GENE
GTP I-GENE
and O
obesity O
. O

Plasma I-GENE
secretin _RARE_
, O
pancreozymin _RARE_
, O
and O
somatostatin I-GENE
- I-GENE
like I-GENE
hormone I-GENE
in O
chronic O
renal _RARE_
failure O
patients O
. O

Effect O
of O
bromazepam _RARE_
on O
growth I-GENE
hormone I-GENE
and O
prolactin I-GENE
secretion _RARE_
in O
normal O
subjects O
. O

In O
several O
cases O
of O
definite O
SjS _RARE_
, O
labial _RARE_
salivary _RARE_
gland _RARE_
examinations O
after O
more O
than O
a O
one O
year O
interval O
were O
performed O
on O
two O
occasions _RARE_
, O
and O
the O
clinical O
and O
histopathological O
changes O
were O
investigated O
. O

All O
radiologists _RARE_
using O
the O
machine O
found O
that O
the O
reporting _RARE_
terminal O
was O
simple O
to O
operate _RARE_
, O
but O
found O
that O
reporting _RARE_
abnormalities O
caused O
an O
increased O
effort O
and O
took _RARE_
a O
longer O
time O
. O

Thalamotomy _RARE_
aiming _RARE_
at _RARE_
the O
CM _RARE_
- O
Pf _RARE_
complex O
and O
using O
stereotactic _RARE_
gamma O
irradiation O
has O
been O
performed O
in O
a O
series O
of O
52 O
patients O
with O
severe O
pain O
due O
to O
malignancy O
. O

2 O
Silastic _RARE_
capsules O
, O
each O
containing O
22 _RARE_
- O
23 _RARE_
mg O
of O
ethinyl _RARE_
estradiol O
, O
were O
inserted O
subcutaneously O
in O
5 O
men O
with O
benign O
prostatic _RARE_
hypertrophy O
. O

When O
used O
subcutaneously O
or O
intravenously O
in O
maximum O
tolerated O
doses O
the O
antibiotic O
inhibited O
the O
development O
of O
lymphadenosis _RARE_
NK _RARE_
/ O
Li O
by O
90 _RARE_
and O
70 O
per O
cent O
respectively O
. O

Effect O
of O
2 O
-( _RARE_
p O
- O
chlorophenyl _RARE_
) O
cyclopropylamine _RARE_
on O
5 O
- O
hydroxyindole _RARE_
concentration O
and O
monoamine _RARE_
oxidase I-GENE
activity O
in O
rat O
brain O
. O

Then _RARE_
, O
pure O
pancreatic O
juice O
was O
infused O
into O
the O
duodenum _RARE_
. O

An O
experiment O
was O
carried O
on O
133 _RARE_
grown O
up _RARE_
fowls _RARE_
and O
broilers _RARE_
from O
4 O
industrial _RARE_
farms _RARE_
, O
vaccinated _RARE_
with O
spray _RARE_
lento _RARE_
and O
mesogenic _RARE_
vaccines O
for _RARE_
straining _RARE_
the O
immunity _RARE_
against O
pseodopest _RARE_
through O
RIHA _RARE_
and O
provoking _RARE_
pseudoplague _RARE_
with O
a O
pathogenic O
virus O
. O

( O
2 O
) O
The O
inappropriateness _RARE_
of O
adaptive O
segmentation _RARE_
for _RARE_
the O
isolation O
of O
spikes O
and O
sharp _RARE_
waves O
, O
which O
had O
been O
anticipated _RARE_
in O
view O
of O
the O
short O
duration O
of O
such O
transients _RARE_
in O
relation O
to O
the O
length O
of O
the O
window _RARE_
( O
1 O
. O
2 O
sec O
) O
used O
for _RARE_
the O
autocorrelation _RARE_
functions O
employed O
in O
the O
segmentation _RARE_
algorithm O
, O
was O
confirmed O
. O

The O
ability O
of O
chronic O
UM _RARE_
- O
272 O
( O
dimethylpropranolol _RARE_
) O
treatment O
to O
prevent O
the O
induction O
of O
reentrant _RARE_
ventricular O
tachyarrhythmias _RARE_
was O
assessed O
in O
the O
conscious O
dog O
subjected O
to O
serial O
programmed O
electrical O
stimulation _RARE_
on O
days O
3 O
-- _RARE_
5 O
after O
myocardial _RARE_
infarction O
. O

The O
effect O
of O
echothiophate _RARE_
on O
the O
biphasic O
response O
of O
rabbit _RARE_
ocular O
pressure O
to O
dipivefrin _RARE_
. O

In O
most O
cases O
of O
acute O
transmural _RARE_
infarction O
, O
the O
reciprocal O
ST O
segment O
depressions _RARE_
observed O
in O
contralateral O
leads O
are O
less O
marked O
than O
the O
primary _RARE_
ST O
segment O
elevations O
. O

Bacillus O
cereus _RARE_
cross O
- O
infection O
in O
a O
maternity _RARE_
- O
unit O
. O

We O
have O
followed O
37 O
phenytoin O
- O
treated O
patients O
with O
reduced _RARE_
serum I-GENE
IgA I-GENE
concentrations O
for _RARE_
2 O
- O
7 O
years O
. O

In O
the O
latter O
category O
particular O
emphasis _RARE_
is O
being O
placed O
on O
new O
anthracycline _RARE_
analogues O
of O
doxorubicin _RARE_
and O
analogues O
of O
cisplatinum _RARE_
diammine _RARE_
dichloride _RARE_
. O

Unusual _RARE_
course O
of O
plasmocytosis _RARE_
. O

Late _RARE_
mRNA O
selected _RARE_
by O
a O
cDNA O
homologous O
to O
the O
HindIII I-GENE
- I-GENE
P I-GENE
/ O
EcoRI I-GENE
- I-GENE
B I-GENE
region O
of O
the O
AcNPV _RARE_
map O
directed O
the O
synthesis _RARE_
of O
31K _RARE_
and O
30K _RARE_
proteins O
which O
comigrated _RARE_
with O
the O
31K _RARE_
and O
30K _RARE_
proteins O
translated O
from O
RNA O
selected _RARE_
by O
the O
HindIII I-GENE
- I-GENE
A I-GENE
/ O
EcoRI I-GENE
- I-GENE
C I-GENE
/ O
SstI _RARE_
- I-GENE
G I-GENE
cDNA O
. O

Intraoperatively _RARE_
the O
complement I-GENE
factor I-GENE
C3c _RARE_
decreased O
by O
20 O
%, O
while O
alpha I-GENE
1 I-GENE
- I-GENE
antitrypsin I-GENE
showed O
postoperatively O
an O
increase O
by O
30 _RARE_
%. O

A O
polypeptide O
chain O
of O
34 _RARE_
residues O
of O
the O
deduced O
yeast O
amino O
acid O
sequence O
closely O
resembles O
a O
peptide O
sequence O
at _RARE_
the O
ADP _RARE_
binding O
site O
of O
bovine I-GENE
muscle I-GENE
pyruvate _RARE_
kinase I-GENE
. O

The O
P165 _RARE_
component _RARE_
, O
however O
, O
could O
be O
differentiated O
from O
the O
two O
later O
components _RARE_
since O
it O
increased O
in O
amplitude O
with O
increased O
task O
demands _RARE_
while O
the O
N2 O
and O
P3 _RARE_
amplitudes O
remained O
constant O
. O

Differential O
drawing _RARE_
size O
associated O
with O
unilateral O
brain O
damage O
. O

The O
intracoronary _RARE_
administration O
of O
both O
drugs O
markedly O
reduced _RARE_
the O
incidence O
of O
VF O
induced _RARE_
by O
the O
release O
of O
a O
40 O
- O
min O
coronary O
artery O
occlusion O
. O

These O
fusions O
are O
contained O
on O
plasmids O
which O
have O
both O
yeast O
and O
E O
. O
coli O
replication O
origins O
and O
selectable O
markers O
and O
, O
therefore O
, O
can O
be O
used O
to O
transform O
either O
yeast O
or O
E O
. O
coli O
cells O
. O

Therefore O
, O
it O
was O
concluded O
that O
thrombotic O
tendency O
certainly _RARE_
existed O
in O
patients O
with O
MS O
compared O
to O
those O
with O
non O
RHD _RARE_
and O
that O
it O
was O
one O
of O
the O
causes O
of O
the O
significantly O
high O
incidence O
of O
thromboembolism _RARE_
in O
comparison O
with O
non O
RHD _RARE_
. O

Toxicity _RARE_
was O
significant O
in O
selected _RARE_
cases O
; O
three O
patients O
developed O
WBC O
counts O
less O
than O
1 O
, O
000 _RARE_
/ O
mm3 _RARE_
and O
one O
of O
these O
patients O
died O
with O
sepsis O
. O

Subdural _RARE_
electrodes O
may O
yield O
larger O
VEP _RARE_
amplitudes O
than O
skull _RARE_
or O
scalp _RARE_
electrodes O
. O

Products _RARE_
of O
immune O
cells O
such O
as _RARE_
transfer I-GENE
factor I-GENE
and O
lymphokines _RARE_
form O
the O
third O
and O
possibly O
most O
important O
group O
of O
immune O
- O
stimulating O
agents O
. O

Use O
of O
the O
immunofluorescence O
method O
for _RARE_
identification O
of O
enteroviruses _RARE_
in O
cell O
cultures O

This O
fraction O
is O
resistant O
to O
digestions _RARE_
by O
DNase I-GENE
I I-GENE
and O
RNase I-GENE
T1 _RARE_
and O
disappears _RARE_
completely O
upon O
alkali _RARE_
hydrolysis O
. O

The O
construction _RARE_
of O
a O
small O
library O
of O
mouse O
repetitive _RARE_
DNA O
has O
been O
previously O
reported O
( O
Pietras _RARE_
et O
al O
., O
Nucleic _RARE_
Acids _RARE_
Res _RARE_
. O

No O
direct O
repeats O
flank O
the O
pseudogene _RARE_
in O
the O
U2 _RARE_
/ I-GENE
4 I-GENE
locus I-GENE
. O

The O
direct O
effects O
of O
transmitter _RARE_
release O
were O
( O
a O
) O
an O
early O
fall O
in O
MAP O
followed O
by O
a O
late _RARE_
pressor O
effect O
; O
and O
( O
b O
) O
an O
early O
bradycardia _RARE_
followed O
by O
a O
late _RARE_
tachycardia O
. O

At O
Cabras _RARE_
( O
Oristano _RARE_
), _RARE_
a O
town _RARE_
characterized O
by O
a O
high O
incidence O
of O
thalassaemia _RARE_
and O
G6PD _RARE_
deficiency O
less O
than O
half _RARE_
the O
people O
between O
18 O
and O
35 _RARE_
have O
a O
fair _RARE_
knowledge O
of O
genetic O
diseases O
and O
of O
their O
prevention O
. O

The O
number O
of O
elements O
and O
their O
sizes O
relative O
to O
the O
configuration O
were O
varied O
in O
a O
series O
of O
five O
experiments O
. O

In O
addition O
, O
the O
overall O
chance _RARE_
that O
a O
patient O
would O
undergo O
ET _RARE_
was O
greater O
in O
a O
cycle _RARE_
in O
which O
more O
than O
one O
follicle _RARE_
20 O
mm O
or O
larger O
was O
developing O
than O
in O
a O
cycle _RARE_
in O
which O
a O
single O
large O
follicle _RARE_
was O
developing O
. O

Experience _RARE_
with O
the O
tensor _RARE_
fasciae _RARE_
latae _RARE_
free O
flap O
. O

Five O
of O
the O
patients O
with O
increased O
L O
- O
L O
size O
had O
a O
normal O
A O
- O
P O
diameter O
. O

Immunochemotherapy _RARE_
with O
schizophyllan _RARE_
( O
SPG _RARE_
) O
combined O
with O
chemotherapeutic O
agents O
was O
evaluated O
in O
two O
syngeneic _RARE_
tumor O
- O
C3H O
/ O
He O
mouse O
systems _RARE_
. O

However O
, O
when O
combined O
with O
mitomycin _RARE_
C O
given O
with O
1 O
to O
5 O
- O
days O
interval O
, O
the O
concurrent O
administration O
of O
SPG _RARE_
prolonged O
significantly O
the O
life O
- O
span O
of O
the O
tumor O
- O
bearing _RARE_
mice O
. O

Data O
are O
presented O
hinting _RARE_
that O
the O
15 _RARE_
beta O
- O
hydroxy O
-, _RARE_
metabolite O
of O
CPA _RARE_
may O
actually _RARE_
be O
the O
biologically O
active _RARE_
agent O
. O

The O
abluminal _RARE_
surface O
is O
often O
almost O
entirely O
encircled _RARE_
by O
a O
thick O
layer O
of O
fibrillary _RARE_
connective _RARE_
tissue O
. O

In O
contrast O
, O
in O
LL _RARE_
patients O
during _RARE_
ENL _RARE_
the O
ConA _RARE_
- O
induced _RARE_
suppressor O
response O
was O
markedly O
reduced _RARE_
. O

Functional O
characterization O
of O
a O
fraction O
identified O
by O
its O
activity O
in O
a O
second O
template O
rescue O
assay O
. O

It O
has O
been O
established O
that O
preoperative O
irradiation O
in O
the O
form O
of O
the O
fractionation O
of O
a O
single O
focal _RARE_
dose O
of O
6 O
Gy O
every O
other O
day O
, O
the O
summary O
dose O
of O
24 _RARE_
Gy O
within O
8 O
- O
10 O
days O
followed O
by O
surgery O
1 O
- O
3 O
days O
after O
irradiation O
does O
not O
either O
complicate _RARE_
its O
performance O
or O
the O
course O
of O
the O
postoperative O
period O
, O
and O
by O
the O
short O
- O
and O
long O
- O
term O
results O
it O
is O
no _RARE_
worse _RARE_
than O
the O
routine O
dose O
fractionation O
. O

Fibrin _RARE_
gels O
and O
their O
possible O
implication _RARE_
for _RARE_
surface O
hemorheology _RARE_
in O
health O
and O
disease _RARE_
. O

Hepatitis _RARE_
- O
B O
vaccination O
in O
the O
elderly O
. O

Radiogallium _RARE_
imaging O
is O
thus O
of O
limited O
use O
in O
evaluation O
of O
suspected O
giant _RARE_
cell O
tumors O
of O
bone O
. O

The O
customary _RARE_
coupling O
reagent _RARE_
sulfanilic _RARE_
acid O
has O
been O
replaced O
by O
1 O
, O
3 O
- O
dimethylbarbituric _RARE_
acid O
; O
CNCl _RARE_
is O
produced O
in O
the O
flow O
through O
system _RARE_
directly O
from O
KCN _RARE_
and O
chloramine _RARE_
T O
. O

Ventricular _RARE_
volume O
stiffness O
vs _RARE_
. O
the O
mean O
wall _RARE_
stress O
relationship O
of O
LVH _RARE_
shifted O
upward _RARE_
, O
whereas O
the O
normalized O
wall _RARE_
muscle O
stiffness O
vs _RARE_
. O
the O
mean O
wall _RARE_
stress O
relationship O
of O
LVH _RARE_
showed O
a O
smaller O
slope O
. O

Synthesis _RARE_
of O
(+)- _RARE_
lysergic _RARE_
acid O
diethylamide _RARE_
tartrate _RARE_

Weight _RARE_
loss _RARE_
reduces O
arterial O
pressure O
by O
a O
decrease O
in O
intravascular O
volume O
and O
cardiac O
output O
associated O
with O
a O
fall O
in O
sympathetic O
activity O
. O

The O
effect O
of O
treatment O
may O
thus O
be O
divided O
into O
two O
main O
phases O
-- _RARE_
an O
initial O
phase _RARE_
with O
a O
reduction O
in O
LV O
mass O
and O
a O
reduction O
in O
cardiac O
output O
and O
no _RARE_
change O
in O
total _RARE_
peripheral O
resistance O
-- _RARE_
and O
a O
second O
phase _RARE_
with O
a O
constant O
LV O
mass O
but O
an O
increase O
in O
cardiac O
output O
to O
the O
pretreatment O
level O
again O
and O
a O
concomitant O
decrease O
in O
total _RARE_
peripheral O
resistance O
. O

This O
study O
was O
undertaken O
to O
assess O
the O
effects O
of O
hypothermia O
and O
chemical O
cardioplegia _RARE_
on O
the O
functional _RARE_
recovery O
of O
hypertrophied _RARE_
non O
- O
failing _RARE_
rat O
hearts O
subjected O
to O
an O
extended O
period O
of O
global O
ischaemia O
. O

Oxygen _RARE_
profiles O
calculated O
for _RARE_
the O
Krogh _RARE_
model O
with O
excentric _RARE_
diffusion O
were O
similar O
to O
those O
derived O
for _RARE_
the O
two O
models O
of O
concentric _RARE_
diffusion O
. O

Cultivation _RARE_
technics _RARE_
for _RARE_
Codonopsis _RARE_
pilosula _RARE_

Radioimmunoassay _RARE_
of O
serum O
creatine _RARE_
kinase I-GENE
B I-GENE
isoenzyme _RARE_
in O
the O
diagnosis O
of O
acute O
myocardial _RARE_
infarction O
. O

Selective O
macrophage O
inhibition O
abolishes O
warfarin _RARE_
- O
induced _RARE_
reduction O
of O
metastasis O
. O

Restriction O
enzyme O
and O
heteroduplex _RARE_
analyses O
confirmed O
that O
sequences O
unique O
to O
FeSV _RARE_
( O
src I-GENE
sequences I-GENE
) O
are O
located _RARE_
at _RARE_
the O
center _RARE_
of O
the O
FeSV _RARE_
genome O
and O
are O
approximately _RARE_
1 O
. O
5 O
kilobase _RARE_
pairs _RARE_
in O
length O
. O

Among O
six _RARE_
different O
library O
isolates O
containing O
6 I-GENE
. I-GENE
5 I-GENE
- I-GENE
to I-GENE
7 I-GENE
- I-GENE
kb I-GENE
IAP _RARE_
units _RARE_
, O
some O
restriction _RARE_
sites O
were O
highly O
conserved _RARE_
whereas O
others O
varied O
in O
both O
occurrence O
and O
position O
. O

Catecholamines _RARE_
and O
aversive _RARE_
learning O
: O
a O
review O
. O

A O
haemolytic _RARE_
enterotoxigenic _RARE_
strain _RARE_
of O
E O
. O
coli O
( O
O149 _RARE_
: O
K88 _RARE_
: O
H10 _RARE_
) O
was O
regularly _RARE_
recovered O
from O
piglets _RARE_
with O
PWD _RARE_
while O
rotavirus _RARE_
was O
demonstrated O
on O
a O
number O
of O
occasions _RARE_
. O

The O
antibody O
titer O
of O
202 _RARE_
chickens _RARE_
to O
SA O
- O
11 O
rotavirus _RARE_
was O
determined O
by O
enzyme O
- O
linked _RARE_
immunosorbent O
blocking O
assay O
. O

Poly _RARE_
( O
dT O
) O
and O
denatured _RARE_
calf _RARE_
thymus _RARE_
DNA O
were O
more O
effective O
than O
were O
other O
polynucleotides _RARE_
tested O
in O
promoting _RARE_
accumulation O
of O
19 O
HDP _RARE_
*; _RARE_
( O
dT O
) O
8 O
was O
as _RARE_
effective O
as _RARE_
were O
longer O
molecules O
of O
( O
dT O
) O
n _RARE_
, O
but O
( O
dT O
) O
4 O
and O
( O
dT O
) O
6 O
were O
much O
less O
effective O
, O
indicating O
that O
the O
binding O
site O
involved O
in O
19 O
HDP _RARE_
* _RARE_
accumulation O
covered _RARE_
between O
6 O
and O
8 O
residues O
of O
( O
dT O
) O
n _RARE_
. O

A O
double O
- O
blind O
trial O
of O
half _RARE_
- O
strength O
Polybactrin _RARE_
Soluble _RARE_
GU _RARE_
bladder O
irrigation O
in O
cystoscopy _RARE_
. O

Thus O
it O
appears O
that O
insertion _RARE_
of O
a O
transposable _RARE_
element O
near O
the O
5 O
' O
terminus O
of O
the O
structural O
gene O
can O
produce O
constitutive _RARE_
expression _RARE_
of O
a O
normally O
glucose O
- O
repressed O
enzyme O
. O

Five O
experiments O
examined O
the O
influence O
of O
opiate _RARE_
antagonists O
on O
both O
the O
short O
- O
term O
analgesic O
reaction O
resulting O
30 _RARE_
min O
after O
exposure O
to O
inescapable _RARE_
shock O
and O
the O
long O
- O
term O
analgesic O
reaction O
resulting O
after O
reexposure _RARE_
to O
shock O
24 _RARE_
hr O
after O
inescapable _RARE_
shock O
exposure O
. O

Experiment O
3 O
showed O
that O
the O
long O
- O
term O
analgesic O
reaction O
could O
also O
be O
reduced _RARE_
by O
administration O
of O
naltrexone O
prior O
to O
reexposure _RARE_
to O
shock O
. O

During O
the O
period O
from O
May _RARE_
to O
August O
, O
1978 _RARE_
, O
an O
epidemic O
of O
hand _RARE_
, O
foot O
and O
mouth O
disease _RARE_
( O
HFMD _RARE_
) O
occurred O
in O
Gifu _RARE_
prefecture _RARE_
. O

A O
22K _RARE_
polypeptide O
was O
detected O
as _RARE_
a O
translation O
product O
of O
late _RARE_
RNA O
that O
hybridized O
to O
this O
DNA O
fragment O
. O

Replicating _RARE_
simian O
virus O
40 O
( O
SV40 O
) O
chromosomes O
were O
found O
to O
be O
similar O
to O
other O
eukaryotic O
chromosomes O
in O
that O
the O
rate O
and O
extent O
of O
micrococcal _RARE_
nuclease _RARE_
( O
MNase _RARE_
) O
digestion O
were O
greater O
with O
replicating _RARE_
than O
with O
nonreplicating _RARE_
mature _RARE_
SV40 O
chromatin O
. O

A O
hypothesis O
. O

We O
have O
investigated O
the O
requirements O
of O
the O
CH _RARE_
gene I-GENE
switch O
by O
characterizing O
two O
rearranged _RARE_
gamma I-GENE
2b _RARE_
genes I-GENE
from O
a O
gamma I-GENE
2b _RARE_
producing O
mouse O
myeloma O
( O
MPC _RARE_
- O
11 O
). O

Physiology _RARE_
and O
Physiopathology _RARE_

The O
genome O
of O
avian O
erythroblastosis _RARE_
virus O
contains O
two O
independently O
expressed _RARE_
genetic O
loci O
( O
v I-GENE
- I-GENE
erbA I-GENE
and O
v I-GENE
- I-GENE
erbB I-GENE
) O
whose O
activities O
are O
probably O
responsible O
for _RARE_
oncogenesis _RARE_
by O
the O
virus O
. O

Because O
RNase I-GENE
III I-GENE
host _RARE_
mutants I-GENE
are O
defective _RARE_
in O
sib _RARE_
regulation _RARE_
, O
processing _RARE_
of O
the O
PL _RARE_
mRNA I-GENE
at _RARE_
sib _RARE_
by O
this O
endoribonuclease _RARE_
may O
cause O
int I-GENE
mRNA I-GENE
decay _RARE_
and O
decrease O
int I-GENE
synthesis _RARE_
. O

At O
least O
one O
clone O
, O
lambda O
HHG _RARE_
41 _RARE_
, O
contains O
, O
in O
addition O
to O
the O
histone I-GENE
genes I-GENE
, O
a O
region O
that O
hybridizes _RARE_
with O
a O
cytoplasmic O
RNA O
approximately _RARE_
330 _RARE_
nucleotides O
in O
length O
. O

Both O
neural _RARE_
and O
hormonal O
pathways O
and O
both O
opiate _RARE_
and O
nonopiate _RARE_
substances O
play O
roles O
in O
the O
complex O
modulation O
of O
pain O
transmission _RARE_
. O

Restoration _RARE_
of O
impaired O
immune O
functions O
in O
aging O
animals O
. O

Postoperative _RARE_
serum O
ACTH I-GENE
levels O
were O
normal O
. O

WR O
- O
2721 O
( O
S O
- O
2 O
-( _RARE_
3 O
aminopropylamino _RARE_
) O
ethylphosphorothioic _RARE_
acid O
) O
has O
been O
investigated O
for _RARE_
its O
ability O
to O
protect O
gut O
, O
lung _RARE_
, O
and O
testis _RARE_
, O
as _RARE_
well _RARE_
as _RARE_
fibrosarcoma _RARE_
( O
FSa _RARE_
) O
tumor O
nodules O
, O
in O
the O
lungs O
of O
mice O
from O
gamma O
- O
radiation O
injury O
. O

In O
fact O
, O
families _RARE_
of O
polypeptides O
were O
produced O
by O
initiation O
of O
translation O
at _RARE_
AUG O
codons O
within O
sequences O
coding O
for _RARE_
VP1 _RARE_
and O
T I-GENE
, O
presumably O
as _RARE_
a O
result O
of O
transcription O
initiation O
events O
that O
generated O
5 O
' O
ends O
immediately O
upstream O
from O
these O
AUGs _RARE_
. O

In O
addition O
, O
TRP1 _RARE_
RI _RARE_
Circle _RARE_
DNA O
is O
organized O
into O
nucleosomes _RARE_
whose O
size O
and O
spacing _RARE_
are O
indistinguishable O
from O
that O
of O
bulk O
yeast O
chromatin O
. O

The O
frequency O
of O
previous O
transfusion O
in O
chronic O
hepatitis O
, O
cirrhosis O
and O
hepatocellular _RARE_
carcinoma O
of O
type O
NANB O
was O
42 _RARE_
. O
8 O
, O
37 O
. O
1 O
and O
15 _RARE_
. O
1 O
%, O
respectively O
, O
whereas O
the O
incidence O
of O
early O
posttransfusion _RARE_
hepatitis O
was O
8 O
. O
5 O
, O
8 O
. O
6 O
and O
7 O
. O
5 O
%, O
respectively O
. O
in O
chronic O
liver O
diseases O
with O
a O
history O
of O
jaundice O
and O
/ O
or O
hepatitis O
, O
previous O
transfusions _RARE_
are O
more O
frequently O
associated O
with O
type O
NANB O
than O
with O
type O
B O
disease _RARE_
. O

Of O
115 _RARE_
hepatitis O
B O
patients O
seen O
at _RARE_
12 O
months O
, O
6 O
% O
had O
chronic O
hepatitis O
Bs _RARE_
antigenaemia _RARE_
, O
60 _RARE_
% O
had O
developed O
anti I-GENE
- I-GENE
HBs I-GENE
antibodies I-GENE
, O
and O
7 O
. O
3 O
% O
still O
had O
abnormal O
liver O
function O
. O

Survey _RARE_
on O
antibody O
against O
egg _RARE_
drop O
syndrome _RARE_
- O
1976 _RARE_
virus O
among O
chicken O
flocks _RARE_
in O
Japan O
. O

In O
49 _RARE_
patients O
in O
whom O
gated O
equilibrium O
ventriculography _RARE_
and O
cardiac O
catheterization _RARE_
were O
performed O
within O
a O
6 O
day O
interval O
, O
total _RARE_
and O
fractional O
portions O
of O
global O
and O
regional O
right O
ventricular O
ejection O
fraction O
( O
RVEF _RARE_
) O
were O
correlated O
with O
pulmonary O
arterial O
systolic O
pressure O
. O

74 _RARE_
, O
193 O
- O
197 _RARE_
). O

The O
combination O
of O
MISO _RARE_
and O
WR O
- O
2721 O
gave O
an O
intermediate _RARE_
response O
compared O
with O
either O
drug O
used O
alone O
, O
resulting O
in O
some O
sensitization O
with O
single O
doses O
and O
an O
overall O
protection O
with O
repeated _RARE_
small O
doses O
. O

Two O
mutations O
that O
affect O
larval _RARE_
cuticle _RARE_
protein I-GENE
gene I-GENE
expression _RARE_
in O
the O
2 O
/ O
3 O
variant O
Drosophila O
melanogaster O
strain _RARE_
were O
investigated O
. O

The O
ensembles _RARE_
are O
considered O
to O
be O
one O
of O
the O
forms O
of O
activity O
of O
the O
structured O
morphofunctional _RARE_
cortical O
units _RARE_
, O
i O
. O
e _RARE_
. O
the O
columns _RARE_
. O

The O
strong O
conservation O
of O
the O
inverted O
terminal O
repeat O
sequence O
may O
reflect O
a O
common O
integration _RARE_
mechanism O
for _RARE_
VL30 _RARE_
elements I-GENE
and O
MuLV O
proviruses _RARE_
. O

A O
cDNA O
cloning O
vector O
that O
permits O
expression _RARE_
of O
cDNA O
inserts O
in O
mammalian O
cells O
. O

Hybridization O
of O
plasmid _RARE_
- O
transformed O
Escherichia O
coli O
RR1 _RARE_
colonies O
with O
32P O
- O
labeled O
viral O
genome O
RNAs O
demonstrated O
the O
presence O
of O
DNA O
clones _RARE_
representative O
of O
each O
of O
the O
10 O
reovirus _RARE_
RNAs O
and O
10 O
of O
the O
11 O
constituent _RARE_
segments _RARE_
of O
the O
rotavirus _RARE_
genome O
. O

Another O
sequence O
, O
GGGXGGAG _RARE_
, O
which O
is O
repeated _RARE_
several O
times O
in O
many O
polyomaviruses _RARE_
and O
adenoviruses _RARE_
, O
and O
which O
is O
thought O
to O
play O
a O
role O
in O
DNA O
replication O
and O
/ O
or O
transcription O
, O
is O
not O
found O
in O
the O
JCV _RARE_
sequence O
presented O
. O

In O
conclusion O
, O
these O
studies O
indicate O
that O
LiCl _RARE_
( O
1 O
) O
decreases O
histamine _RARE_
- O
stimulated _RARE_
gastric _RARE_
acid O
secretion _RARE_
, O
and O
( O
2 O
) O
diminishes _RARE_
bile O
- O
induced _RARE_
disruption O
of O
the O
gastric _RARE_
mucosal _RARE_
barrier O
in O
the O
canine O
Heidenhain _RARE_
pouch _RARE_
. O

Lung O
density O
increased O
in O
quartz _RARE_
- O
exposed O
, O
but O
not O
in O
volcanic _RARE_
- O
ash _RARE_
- O
exposed O
animals O
. O

The O
hepatitis I-GENE
A I-GENE
virus I-GENE
antibody I-GENE
( O
anti I-GENE
- I-GENE
HAV _RARE_
) O
in O
chronic O
diffuse O
liver O
diseases O

The O
junctions O
between O
viral O
and O
cellular O
sequences O
were O
determined O
by O
DNA O
sequence O
analysis O
to O
be O
517 _RARE_
nucleotides O
into O
the O
p30 _RARE_
sequence I-GENE
and O
1 O
, O
920 _RARE_
nucleotides O
into O
the O
polymerase O
sequence O
. O

Naloxone _RARE_
( O
2 O
mg O
/ O
kg O
bolus O
+ O
2 O
mg O
X O
kg O
- O
1 O
X O
h O
- O
1 O
) O
was O
given O
with O
one O
of O
the O
two O
doses O
of O
the O
lipopolysaccharide O
. O

Gel O
route O
preparation O
of O
low O
fusing _RARE_
dental O
porcelain _RARE_
frit _RARE_
. O

I O
. O

Viral _RARE_
RNA O
, O
molecularly O
cloned _RARE_
proviral _RARE_
DNA O
, O
and O
virus O
- O
specific O
protein O
of O
avian O
retrovirus _RARE_
MH2 _RARE_
were O
analyzed O
. O

Intracellular _RARE_
recordings O
were O
performed O
on O
the O
optic O
tectum _RARE_
of O
the O
carp _RARE_
in O
vitro O
. O

Molecular O
structure _RARE_
and O
evolutionary O
origin O
of O
human I-GENE
cardiac I-GENE
muscle I-GENE
actin I-GENE
gene I-GENE
. O

The O
mutants O
were O
obtained O
by O
substitution O
into O
a O
molecular _RARE_
clone O
of O
M O
- O
MuLV O
DNA O
by O
DNA O
from O
two O
acutely _RARE_
transforming O
viruses O
, O
Ableson _RARE_
MuLV O
( O
Ab _RARE_
- O
MuLV O
) O
and O
Moloney O
murine O
sarcoma O
virus O
( O
M O
- O
MSV _RARE_
). O

Plasmids _RARE_
for _RARE_
the O
cloning O
and O
expression _RARE_
of O
full O
- O
length O
double O
- O
stranded _RARE_
cDNAs O
under O
control O
of O
the O
SV40 I-GENE
early I-GENE
or O
late _RARE_
gene I-GENE
promoter O
. O

Supplementing _RARE_
a O
soybean _RARE_
protein O
and O
sucrose O
- O
based O
diet O
with O
levels O
of O
2 O
. O
2 O
, O
11 O
, O
and O
55 _RARE_
ppm O
of O
the O
antibiotic O
, O
from O
the O
two O
sources O
each O
with O
two O
different O
purities _RARE_
, O
improved O
weight _RARE_
gain O
of O
chicks O
an O
average O
of O
23 _RARE_
% O
and O
improved O
feed O
efficiency O
an O
average O
of O
13 _RARE_
% O
at _RARE_
the O
higher _RARE_
levels O
( O
all O
P O
less O
than O
. O
01 O
). O

The O
dnaQ _RARE_
- O
lacZ I-GENE
and O
the O
rnh _RARE_
- O
lacZ I-GENE
fused O
genes O
were O
constructed O
and O
hybrid _RARE_
proteins O
with O
beta I-GENE
- I-GENE
galactosidase I-GENE
activity O
were O
produced O
. O

Overall O
prevalences _RARE_
of O
antibody O
were O
70 O
per O
cent O
in O
cattle O
, O
67 O
per O
cent O
in O
sheep O
and O
76 _RARE_
per O
cent O
in O
goats O
as _RARE_
assessed O
by O
an O
immunodiffusion _RARE_
test O
. O

Expression O
of O
herpes O
simplex O
virus O
beta O
and O
gamma O
genes O
integrated O
in O
mammalian O
cells O
and O
their O
induction O
by O
an O
alpha O
gene O
product O
. O

The O
splice _RARE_
acceptor _RARE_
site O
is O
ca _RARE_
. O

This O
is O
consistent O
with O
a O
model O
proposing _RARE_
that O
SSV _RARE_
was O
generated O
by O
recombination _RARE_
between O
proviral _RARE_
DNA O
of O
a O
simian O
sarcoma O
associated O
virus O
and O
proto _RARE_
- I-GENE
sis _RARE_
and O
that O
introns _RARE_
were O
spliced _RARE_
out O
subsequently O
from O
a O
fused O
viral I-GENE
- I-GENE
sis _RARE_
messenger _RARE_
RNA I-GENE
. O

We O
conclude O
that O
, O
with O
autonomic _RARE_
nervous O
system _RARE_
activity O
intact _RARE_
, O
carotid O
chemoreceptor _RARE_
reflex O
activation O
can O
elicit O
an O
absolute O
reflexly _RARE_
mediated _RARE_
reduction O
in O
coronary O
blood _RARE_
flow O
in O
the O
normal O
, O
conscious O
dog O
, O
despite O
an O
increase O
in O
arterial O
pressure O
. O

Female O
subjects O
, O
including O
both O
normal O
subjects O
and O
idiopathic O
calcium _RARE_
stone O
- O
formers _RARE_
, O
have O
higher _RARE_
urinary _RARE_
cyclic O
AMP O
levels O
than O
their O
male O
counterparts O
, O
and O
this O
difference O
is O
significant O
when O
urinary _RARE_
cyclic O
AMP O
is O
expressed _RARE_
in O
the O
units _RARE_
mumol O
/ O
g O
of O
creatinine _RARE_
. O

We O
conclude O
that O
the O
' O
morning _RARE_
dip _RARE_
' O
observed O
in O
asthmatic O
patients O
cannot O
simply _RARE_
be O
explained O
by O
changes O
in O
cell O
receptor O
number O
or O
affinity O
, O
as _RARE_
our O
results O
suggest O
that O
both O
groups O
have O
intact _RARE_
beta I-GENE
- I-GENE
adrenoceptor I-GENE
function O
. O

The O
effect O
of O
desipramine O
probably O
represents O
inhibition O
of O
neuronal _RARE_
uptake O
and O
that O
of O
amitriptyline _RARE_
and O
mianserin _RARE_
blockade O
of O
neuronal _RARE_
uptake O
and O
prejunctional _RARE_
alpha I-GENE
2 I-GENE
- I-GENE
adrenoreceptors _RARE_
. O

We O
conclude O
that O
the O
gp54 _RARE_
structural I-GENE
gene I-GENE
is O
required O
for _RARE_
initiation O
or O
amplification O
of O
the O
splenic O
erythroblast _RARE_
hyperplasia O
which O
characterizes _RARE_
the O
preleukemic _RARE_
phase _RARE_
of O
Rauscher _RARE_
disease _RARE_
. O

Surgical _RARE_
treatment O
of O
pulmonary O
metastases O
. O

A O
promoter O
sequence O
( O
Goldberg _RARE_
- O
Hogness _RARE_
or O
TATA O
box O
) O
is O
situated O
28 _RARE_
base _RARE_
pairs _RARE_
upstream O
from O
the O
point O
of O
initiation O
of O
transcription O
which O
was O
found O
by O
S1 I-GENE
nuclease _RARE_
mapping O
and O
by O
oligonucleotide _RARE_
- O
primed O
reverse O
transcription O
of O
rat I-GENE
PTH _RARE_
mRNA I-GENE
. O

Each O
of O
these O
spliced _RARE_
mRNAs O
has O
an O
untranslated _RARE_
leader _RARE_
sequence O
of O
249 _RARE_
bases O
and O
a O
single O
intron O
of O
approximately _RARE_
540 _RARE_
bases O
which O
are O
contained O
entirely O
within O
TRs _RARE_
/ O
IRs _RARE_
sequences O
. O

The O
expression _RARE_
of O
chloramphenicol I-GENE
acetyltransferase _RARE_
was O
detected O
within O
1 O
h O
after O
infection O
of O
cells O
with O
recombinant O
virus O
, O
reflecting O
the O
early O
nature O
of O
the O
promoters O
used O
. O

NPT _RARE_
II I-GENE
synthesis _RARE_
, O
measured O
by O
agar O
plate _RARE_
assays O
of O
kanamycin _RARE_
resistance O
and O
by O
immunoprecipitation O
of O
the O
NPT _RARE_
II I-GENE
protein I-GENE
, O
was O
repressed O
in O
the O
presence O
of O
cysteine O
and O
derepressed _RARE_
in O
its O
absence O
. O

A O
computed O
tomographic _RARE_
scan O
obtained O
after O
EOE _RARE_
- O
13 _RARE_
infusion O
accurately O
showed O
the O
perfusion O
pattern O
of O
the O
implanted O
catheter O
. O

The O
primary _RARE_
structure _RARE_
of O
the O
GAL7 _RARE_
5 I-GENE
' I-GENE
flanking I-GENE
region I-GENE
has O
many O
features O
common O
to O
those O
of O
multicellular _RARE_
eukaryotic O
genes O
. O

The O
12 I-GENE
, I-GENE
000 _RARE_
MW _RARE_
( I-GENE
12K _RARE_
) I-GENE
IE I-GENE
polypeptide I-GENE
encoded O
by O
IEmRNA _RARE_
- I-GENE
5 I-GENE
is O
translated O
from O
an O
88 O
codon _RARE_
open _RARE_
reading O
frame O
, O
leaving _RARE_
a O
1200 _RARE_
base _RARE_
3 O
' O
non O
- O
translated O
region O
. O

The O
greatest O
difference O
between O
the O
Ad7 _RARE_
and I-GENE
Ad5 _RARE_
DBPs _RARE_
is O
the O
absence O
, O
in O
the O
Ad7 _RARE_
protein O
, O
of O
12 O
amino O
acids _RARE_
located _RARE_
between O
the O
two O
functional _RARE_
domains O
in O
the O
Ad5 _RARE_
protein O
( O
amino O
acids _RARE_
151 O
- O
162 _RARE_
). O

No O
significant O
correlation O
was O
found O
between O
LVM _RARE_
or O
wall _RARE_
thickness O
and O
body O
surface O
area O
, O
age O
, O
blood _RARE_
pressure O
, O
heart _RARE_
rate O
, O
cardiac O
output O
, O
total _RARE_
peripheral O
resistance O
and O
left _RARE_
ventricular O
systolic O
wall _RARE_
stress O
, O
whereas O
CD25 _RARE_
was O
correlated O
with O
urinary _RARE_
catecholamines O
only O
in O
hypertensive O
patients O
( O
r _RARE_
= O
0 _RARE_
. O
606 _RARE_
, O
p O
less O
than O
0 _RARE_
. O
001 O
). O

Furthermore O
, O
no _RARE_
Shine _RARE_
- O
Dalgarno _RARE_
sequences O
are O
present O
upstream O
of O
the O
presumed _RARE_
translational O
start _RARE_
codons O
. O

The O
gene I-GENE
cat _RARE_
- I-GENE
86 _RARE_
, O
specifying _RARE_
chloramphenicol I-GENE
- I-GENE
inducible I-GENE
chloramphenicol I-GENE
acetyltransferase _RARE_
, O
is O
located _RARE_
on O
the O
1 O
. O
1 O
- O
kilobase _RARE_
cloned _RARE_
DNA O
. O

The O
myeloproliferative _RARE_
sarcoma O
virus O
( O
MPSV _RARE_
) O
was O
derived O
by O
passage O
of O
Moloney O
sarcoma O
virus O
( O
Mo _RARE_
- O
MuSV _RARE_
) O
in O
adult O
mice O
. O

The O
same O
- O
sized O
EBNA I-GENE
protein I-GENE
( I-GENE
approximately _RARE_
78 _RARE_
, I-GENE
000 _RARE_
) I-GENE
was O
made O
after O
transfection O
with O
BamHI I-GENE
- I-GENE
K I-GENE
( I-GENE
5 I-GENE
. I-GENE
2 I-GENE
kilobase _RARE_
pairs _RARE_
[ _RARE_
kbp _RARE_
]) _RARE_
or O
the O
I1f _RARE_
subfragment _RARE_
( O
2 O
. O
9 O
kbp _RARE_
). O

They O
generated O
ca _RARE_
. O

Here O
we O
have O
determined O
the O
nucleotide O
sequence O
of O
3 O
. O
5 O
kb O
from O
the O
3 O
' O
end O
of O
delta I-GENE
gag I-GENE
to O
the O
3 O
' O
end O
of O
molecularly O
cloned _RARE_
proviral _RARE_
MH2 _RARE_
DNA O
, O
in O
order O
to O
elucidate O
the O
genetic O
structure _RARE_
of O
the O
virus O
and O
to O
compare O
it O
with O
other O
mht _RARE_
- O
and O
myc I-GENE
- O
containing O
oncogenic _RARE_
viruses O
as _RARE_
well _RARE_
as _RARE_
with O
the O
chicken I-GENE
proto _RARE_
- I-GENE
myc I-GENE
gene I-GENE
. O

USA _RARE_
80 _RARE_
, O
802 _RARE_
- O
806 _RARE_
] O
was O
used O
to O
isolate O
a O
genomic O
clone O
lambda O
PGK _RARE_
- I-GENE
1 I-GENE
containing O
a O
portion O
of O
an O
autosomal _RARE_
locus O
for _RARE_
phosphoglycerate _RARE_
kinase I-GENE
( O
PGK _RARE_
). O

A O
. O

188 _RARE_
patients O
received O
cimetidine O
400 _RARE_
mg O
q _RARE_
. O
i O
. O
d O
. O
intravenously O
and O
1 O
, O
000 _RARE_
mg O
daily O
orally O
in O
divided O
doses O
. O

An O
immunologic O
test O
using O
stomach O
and O
tumor O
antigens O
for _RARE_
screening O
of O
those O
at _RARE_
high O
risk O
for _RARE_
stomach O
cancer _RARE_
is O
suggested O
. O

Thirty O
isolates O
of O
Haemophilus O
influenzae O
type O
b O
were O
obtained O
during _RARE_
an O
outbreak O
of O
invasive O
H O
. O
influenzae O
type O
b O
disease _RARE_
and O
were O
classified O
by O
the O
electrophoretic O
profile O
of O
their O
lipopolysaccharide O
( O
LPS _RARE_
). O

Tiaprofenic _RARE_
acid O
overdose _RARE_
. O

Frog _RARE_
type O
I O
( O
Ft O
I O
) O
and O
frog _RARE_
type O
II O
( O
Ft O
II O
) O
slowly O
adapting O
( O
SA O
) O
units _RARE_
produced O
spikes O
only O
at _RARE_
the O
indentation _RARE_
phase _RARE_
, O
and O
the O
threshold O
response O
phase _RARE_
( O
TRP _RARE_
), _RARE_
i O
. O
e _RARE_
.. _RARE_
the O
phase _RARE_
of O
the O
first _RARE_
spike _RARE_
was O
for _RARE_
ca _RARE_
. O

Frog _RARE_
type O
I O
( O
Ft O
I O
) O
and O
frog _RARE_
type O
II O
( O
Ft O
II O
) O
slowly O
adapting O
( O
SA O
) O
units _RARE_
produced O
spikes O
only O
at _RARE_
the O
indentation _RARE_
phase _RARE_
, O
and O
the O
threshold O
response O
phase _RARE_
( O
TRP _RARE_
), _RARE_
i O
. O
e _RARE_
.. _RARE_
the O
phase _RARE_
of O
the O
first _RARE_
spike _RARE_
was O
for _RARE_
ca _RARE_
. O

DMCM _RARE_
also O
permits O
extension O
of O
the O
possibilities O
of O
obtaining O
and O
transplanting _RARE_
donor O
organs O
. O

Grimelius _RARE_
stain O
was O
positive O
, O
Masson _RARE_
Fontana _RARE_
stain O
negative O
. O

Blood _RARE_
glucose O
and O
plasma O
insulin I-GENE
were O
measured O
at _RARE_
zero O
time O
and O
then O
at _RARE_
15 _RARE_
, O
30 _RARE_
, O
60 _RARE_
, O
90 _RARE_
and O
120 O
min O
after O
ingestion O
of O
25 _RARE_
g O
glucose O
, O
fructose _RARE_
or O
lactose _RARE_
, O
or O
30 _RARE_
g O
honey _RARE_
, O
50 O
g O
white _RARE_
bread _RARE_
, O
125 _RARE_
g O
white _RARE_
rice _RARE_
or O
potatoes _RARE_
, O
150 _RARE_
g O
apples _RARE_
or O
260 O
g O
carrots _RARE_
. O

Clinical O
use O
of O
absorbable _RARE_
polyglycolic _RARE_
acid O
suture _RARE_
in O
Blalock _RARE_
- O
Taussig _RARE_
' O
s O
operation O

Among O
these O
are O
: O
( O
1 O
) O
Is O
there O
sufficient O
understanding O
of O
family O
pathophysiology O
, O
of O
the O
sensitivity O
and O
specificity _RARE_
of O
diagnostic O
techniques O
and O
of O
the O
safety O
and O
efficacy O
of O
therapeutic O
modalities O
to O
make O
true O
family O
health O
care O
possible O
? O
( O
2 O
) O
If O
this O
type O
of O
care O
is O
possible O
, O
how O
are O
the O
needs O
of O
the O
family O
and O
its O
individual O
members O
met O
, O
or O
value O
judgements _RARE_
made O
about O
their O
relative O
importance O
? O
and O
( O
3 O
) O
What _RARE_
are O
the O
consequences O
for _RARE_
the O
health O
care O
delivery O
system _RARE_
of O
this O
type O
of O
care O
? O
An O
extensive O
literature O
review O
is O
used O
in O
an O
attempt O
to O
answer _RARE_
these O
queries _RARE_
, O
from O
which O
questions O
for _RARE_
further O
study O
are O
posed _RARE_
. O

In O
patients O
in O
group O
A O
(" O
normal O
" O
CI _RARE_
), _RARE_
the O
CI _RARE_
, O
heart _RARE_
rate O
and O
the O
mean O
circumferential _RARE_
fiber O
shortening O
velocity O
( O
mVCF _RARE_
) O
were O
normal O
, O
but O
the O
TPR O
was O
increased O
significantly O
. O

Immunologically _RARE_
reactive O
insulin I-GENE
levels O
were O
determined O
in O
freely _RARE_
- O
moving _RARE_
normal O
rats O
offered O
three O
different O
test O
- O
meals _RARE_
. O

These O
results O
indicate O
that O
both O
naturally O
acquired O
and O
passive O
( O
modified O
immune I-GENE
serum I-GENE
globulin I-GENE
) O
antibodies O
to O
type I-GENE
III I-GENE
group I-GENE
B I-GENE
Streptococcus _RARE_
antigen I-GENE
are O
partially O
protective O
against O
intra _RARE_
- O
amniotic _RARE_
infection O
. O

In O
the O
posthospital _RARE_
phase _RARE_
of O
AMI O
, O
as _RARE_
well _RARE_
as _RARE_
in O
CCHD _RARE_
, O
the O
occurrence O
of O
high O
- O
grade O
VPBs _RARE_
usually O
indicates O
more O
advanced O
degrees O
of O
both O
coronary O
and O
left _RARE_
ventricular O
disease _RARE_
as _RARE_
well _RARE_
as _RARE_
the O
possibility O
of O
cardiac O
and O
/ O
or O
sudden _RARE_
death _RARE_
. O

Sweet _RARE_
oranges _RARE_
, O
mandarin _RARE_
, O
grapefruit _RARE_
, O
lemon _RARE_
, O
and O
lime _RARE_
are O
generally O
used O
for _RARE_
processing _RARE_
. O

The O
genes O
at _RARE_
each O
locus O
are O
divergently O
transcribed _RARE_
and O
the O
coding O
sequences O
are O
separated O
by O
646 _RARE_
base _RARE_
- O
pairs _RARE_
at _RARE_
one O
locus O
and O
676 _RARE_
base _RARE_
- O
pairs _RARE_
at _RARE_
the O
other O
. O

The O
enzymic _RARE_
hydrolysis O
of O
urea O
produces O
ammonia _RARE_
which O
causes O
a O
vivid _RARE_
yellow O
to O
purple _RARE_
colour _RARE_
change O
in O
the O
pH O
indicator O
. O

The O
clinical O
efficacy O
rates O
evaluated O
in O
151 O
cases O
( O
KS O
- O
R1 _RARE_
group O
in O
77 O
cases O
, O
oral O
group O
in O
74 _RARE_
cases O
) O
on O
standard O
criteria O
of O
committee _RARE_
members O
were O
88 O
. O
3 O
% O
for _RARE_
the O
KS O
- O
R1 _RARE_
group O
and O
86 _RARE_
. O
5 O
% O
for _RARE_
the O
oral O
group O
, O
respectively O
. O

Side _RARE_
effect O
including O
subjective _RARE_
and O
objective O
symptoms O
were O
strictly O
evaluated O
in O
163 _RARE_
cases O
( O
KS O
- O
R1 _RARE_
group O
in O
83 _RARE_
cases O
, O
oral O
group O
in O
80 _RARE_
cases O
), _RARE_
but O
the O
incidence O
rate O
which O
was O
22 _RARE_
. O
9 O
% O
for _RARE_
the O
KS O
- O
R1 _RARE_
group O
and O
23 _RARE_
. O
8 O
% O
for _RARE_
the O
oral O
group O
showed O
no _RARE_
significant O
difference O
. O

Plasma O
renin I-GENE
activity O
did O
not O
change O
in O
response O
to O
head O
- O
up _RARE_
tilt O
or O
isoprenaline _RARE_
infusion O
in O
the O
patients O
. O

Martin _RARE_
Luther _RARE_
and O
his _RARE_
physicians O
. O

Enhancement _RARE_
of O
the O
immune O
response O
by O
aspecific _RARE_
action O
of O
vaccine O
additives _RARE_
in O
the O
aerogenic _RARE_
immunization O
of O
swine O
against O
swine O
plague _RARE_

Induced _RARE_
gamma O
- O
ray O
spectroscopy O

Bepridil _RARE_
, O
a O
calcium _RARE_
antagonist O
with O
a O
half _RARE_
- O
life O
of O
approximately _RARE_
42 _RARE_
hours O
, O
was O
compared O
with O
placebo O
in O
a O
double O
- O
blind O
, O
randomized O
, O
crossover _RARE_
trial O
. O

Analysis O
of O
proteins O
synthesized O
by O
plasmids O
containing O
deleted _RARE_
forms O
of O
the O
trfA _RARE_
region I-GENE
indicates O
that O
the O
A2 _RARE_
protein I-GENE
is O
the O
essential O
trfA _RARE_
- I-GENE
encoded I-GENE
replication I-GENE
protein I-GENE
of O
plasmid _RARE_
RK2 _RARE_
. O

Effects O
of O
negative O
pleural _RARE_
pressure O
on O
left _RARE_
ventricular O
hemodynamics O
. O

Resting _RARE_
plasma O
norepinephrine O
( O
NE _RARE_
) O
and O
epinephrine O
( O
E O
) O
levels O
were O
lower O
during _RARE_
active _RARE_
therapy O
than O
2 O
wk O
after O
withdrawal O
( O
guanfacine _RARE_
and O
control O
: O
plasma O
NE _RARE_
, O
0 _RARE_
. O
27 _RARE_
+/- O
0 _RARE_
. O
03 O
/ O
0 _RARE_
. O
64 _RARE_
+/- O
0 _RARE_
. O
13 _RARE_
ng _RARE_
/ O
ml O
; O
plasma O
E O
, O
0 _RARE_
. O
09 O
+/- O
0 _RARE_
. O
02 O
/ O
0 _RARE_
. O
17 _RARE_
+/- O
0 _RARE_
. O
05 O
ng _RARE_
/ O
ml O
). O

Renal O
response O
to O
captopril O
in O
severe O
heart _RARE_
failure O
: O
role O
of O
furosemide O
in O
natriuresis _RARE_
and O
reversal O
of O
hyponatremia _RARE_
. O

Lauciello _RARE_
describes O
a O
technique O
for _RARE_
the O
placement O
of O
functionally O
generated O
amalgam _RARE_
stops _RARE_
as _RARE_
restorations O
within O
mandibular O
acrylic _RARE_
teeth O
. O

Eleven _RARE_
biopsy O
specimens O
( O
five O
papules _RARE_
and O
six _RARE_
dusky _RARE_
or O
crusted _RARE_
lesions O
) O
from O
four O
patients O
with O
pityriasis _RARE_
lichenoides _RARE_
et O
varioliformis _RARE_
acuta _RARE_
( O
PLEVA _RARE_
) O
were O
studied O
by O
direct O
immunofluorescence O
and O
immunoperoxidase _RARE_
technics _RARE_
. O

These O
data O
suggest O
that O
a O
major O
part O
of O
the O
reduction O
in O
food O
intake O
in O
hyperphagic _RARE_
rats O
eating _RARE_
a O
quinine _RARE_
- O
adulterated _RARE_
diet O
is O
due O
to O
postingestional _RARE_
events O
. O

The O
aspirate _RARE_
from O
a O
parathyroid _RARE_
cyst O
was O
watery _RARE_
clear O
and O
contained O
high O
amount O
of O
parathyroid _RARE_
hormone I-GENE
. O

EGV _RARE_
had O
no _RARE_
detectable O
effect O
on O
PP _RARE_
secretion _RARE_
under O
basal O
or O
stimulated _RARE_
conditions O
. O

The O
numerous O
tests O
demonstrate O
that O
the O
HDL _RARE_
- O
2M _RARE_
can O
be O
extensively O
and O
successfully O
used O
for _RARE_
therapy O
of O
insulin I-GENE
- O
dependent O
diabetes O
mellitus O
in O
clinical O
practice O
. O

Lung O
prostacyclin _RARE_
production O
may O
be O
related O
to O
flow O
. O

For O
the O
first _RARE_
30 _RARE_
min O
following O
insulin I-GENE
administration O
, O
the O
rate O
of O
change O
in O
glucose O
levels O
was O
significantly O
less O
among O
the O
patients O
with O
major O
depressive _RARE_
disorder O
than O
among O
either O
the O
patients O
with O
dysthymic _RARE_
disorder O
or O
the O
normal O
control O
subjects O
. O

Management _RARE_
of O
hypertension O
in O
the O
elderly O
. O

Climatic _RARE_
treatment O
of O
children O
with O
respiratory O
allergy O

Transplantation _RARE_
of O
kidneys O
of O
juvenile O
donors O
in O
adult O
recipients O
. O

Ten O
patients O
with O
advanced O
, O
diffuse O
Hodgkin O
' O
s O
and O
non O
- O
Hodgkin O
' O
s O
lymphomas O
responding O
poorly O
to O
the O
most O
widely O
employed O
primary _RARE_
chemotherapy O
regimens O
were O
treated O
with O
a O
high O
- O
dose O
chemotherapy O
( O
HDC _RARE_
) O
followed O
by O
rescue O
with O
non O
- O
frozen _RARE_
autologous O
bone O
marrow O
infusion O
( O
ABMT _RARE_
). O

Effect O
of O
proteolytic _RARE_
enzymes _RARE_
and O
polypeptides O
on O
the O
antacid _RARE_
activity O
of O
almagate _RARE_
and O
other O
antacids _RARE_
. O

Results O
of O
a O
controlled _RARE_
study O

Hydrallazine _RARE_
also O
caused O
a O
slight O
increase O
in O
plasma I-GENE
renin I-GENE
activity O
and O
urinary _RARE_
excretion O
of O
noradrenaline O
. O

Urease _RARE_
activity O
of O
97 O
% O
of O
these O
organisms O
became O
evident O
within O
30 _RARE_
min O
. O

After O
description O
of O
his _RARE_
short O
life O
and O
an O
explanation O
of O
the O
light O
conductor _RARE_
Bozzini _RARE_
' O
s O
merit _RARE_
is O
emphasized _RARE_
, O
by O
his _RARE_
invention _RARE_
as _RARE_
first _RARE_
physician _RARE_
to O
have O
made O
accessible _RARE_
to O
medicine O
endoscopic _RARE_
diagnostic O
possibilities O
. O

The O
effect O
of O
lithium O
on O
the O
osmoregulation _RARE_
of O
arginine _RARE_
vasopressin I-GENE
secretion _RARE_
. O

The O
susceptibility _RARE_
of O
the O
PPNG _RARE_
strains O
to O
clinically O
relevant O
antibiotics O
varied O
with O
the O
plasmid _RARE_
pattern O
; O
this O
stresses O
the O
necessity _RARE_
of O
permanent O
surveillance _RARE_
of O
gonococcal _RARE_
infections O
and O
of O
regular O
evaluation O
of O
the O
recommendations _RARE_
for _RARE_
antimicrobial O
treatment O
. O

Antithrombin _RARE_
III I-GENE
( O
AT I-GENE
III I-GENE
) O
is O
a O
plasma O
protein O
which O
acts O
as _RARE_
the O
principal O
inhibitor O
of O
thrombin I-GENE
and O
is O
a O
major O
modulator _RARE_
of O
intravascular O
coagulation O
. O

Eighteen _RARE_
patients O
were O
untreated O
, O
and O
8 O
had O
been O
given O
previous O
treatment O
with O
depot _RARE_
testosterone O
100 _RARE_
mg O
intramuscularly _RARE_
every O
2 O
- O
3 O
weeks O
for _RARE_
an O
average O
duration O
of O
4 O
. O
7 O
years O
. O

195mPt _RARE_
- O
labeled O
cisplatin O
was O
administered O
iv O
and O
ip _RARE_
to O
control O
mice O
and O
to O
mice O
bearing _RARE_
Sarcoma _RARE_
180 O
. O

New O
beta O
- O
blocking O
drugs O
have O
been O
introduced O
which O
may O
prove O
beneficial O
in O
certain O
clinical O
situations O
since O
they O
exert O
more O
selective O
blockade O
of O
the O
cardiac I-GENE
receptors I-GENE
( O
beta1 I-GENE
) O
as _RARE_
opposed O
to O
smooth _RARE_
muscle I-GENE
receptors I-GENE
( O
beta2 _RARE_
). O

If O
facilities _RARE_
for _RARE_
measurements O
of O
O2 _RARE_
consumption O
and O
hence O
metabolic O
rate O
are O
available O
, O
these O
should O
be O
utilized O
. O

This O
generally O
means O
an O
energy O
intake O
of O
1 O
. O
4 O
to O
1 O
. O
6 O
times O
the O
energy O
expenditure O
, O
with O
a O
N O
intake O
of O
250 _RARE_
to O
400 _RARE_
mg O
/ O
kg O
/ O
day O
. O

In O
the O
37 O
patients O
without O
lung _RARE_
disease _RARE_
respiratory O
muscle O
weakness _RARE_
was O
accompanied O
by O
significant O
decreases O
in O
vital O
capacity O
, O
total _RARE_
lung _RARE_
capacity O
, O
and O
maximum O
voluntary _RARE_
ventilation O
; O
by O
significant O
increases O
in O
residual O
volume O
and O
arterial O
carbon O
dioxide O
tension O
( O
PaCO2 O
); O
and O
greater O
likelihood O
of O
dependence O
on O
ventilators _RARE_
, O
atelectasis _RARE_
, O
and O
pneumonia O
. O

Commun _RARE_
. O

The O
statistical O
analysis O
of O
data O
of O
TRH I-GENE
test O
on O
a O
sample O
of O
57 O
healthy O
volunteers O
has O
permitted O
an O
evaluation O
of O
the O
upper O
limits O
of O
the O
normal O
thyrotropin I-GENE
response O
; O
the O
secretory _RARE_
area O
( O
As O
) O
was O
shown O
to O
be O
more O
discriminating _RARE_
. O

Total O
cumulative O
doses O
of O
doxorubicin _RARE_
ranged O
from O
145 _RARE_
to O
625 _RARE_
mg O
./ _RARE_
m O
. O
2 O
. O

Movement _RARE_
programming _RARE_
depends O
on O
understanding O
of O
behavioral O
requirements O
. O

Following O
20 O
min O
of O
steady O
state O
anaesthesia O
during _RARE_
which O
measurements O
of O
IOP O
, O
arterial O
pressure O
, O
heart _RARE_
rate O
, O
FIO2 _RARE_
, O
FE _RARE_
' O
CO2 O
and O
CVP _RARE_
were O
recorded O
, O
one O
group O
of O
patients O
received O
atracurium _RARE_
0 _RARE_
. O
45 _RARE_
mg O
kg O
- O
1 O
and O
the O
other O
pancuronium _RARE_
0 _RARE_
. O
1 O
mg O
kg O
- O
1 O
. O

Transitory _RARE_
subclinical O
and O
permanent O
hypothyroidism O
in O
the O
course O
of O
subacute O
thyroiditis O
( O
de O
Quervain _RARE_
). O

Gonadotropin _RARE_
levels O
in O
mothers O
who O
have O
had O
two O
sets O
of O
DZ _RARE_
twins _RARE_
. O

Freezing _RARE_
of O
plasma O
to O
obtain O
better O
yield O
of O
factor I-GENE
VIII I-GENE
: O
C O
. O

These O
children O
were O
grouped _RARE_
into O
four O
diagnostic O
categories O
: O
1 O
) O
idiopathic O
GH _RARE_
deficiency O
( O
n _RARE_
= O
10 O
); O
2 O
) O
organic O
hypopituitarism _RARE_
( O
n _RARE_
= O
7 O
); O
3 O
) O
intrauterine O
growth O
retardation O
( O
n _RARE_
= O
5 O
); O
and O
4 O
) O
constitutional _RARE_
delay O
of O
growth O
and O
/ O
or O
familial O
short O
stature _RARE_
( O
n _RARE_
= O
18 O
), _RARE_
by O
standard O
clinical O
criteria O
and O
physiological O
and O
pharmacological O
tests O
of O
GH _RARE_
reserve O
. O

Each O
patient O
had O
measurable _RARE_
LH _RARE_
and O
FSH I-GENE
levels O
, O
with O
pulsed O
nocturnal _RARE_
secretion _RARE_
, O
and O
pubertal _RARE_
LH _RARE_
and O
FSH I-GENE
responses O
to O
LRH _RARE_
. O

These O
changes O
were O
the O
result O
of O
a O
decrease O
in O
afterload _RARE_
: O
mean O
aortic O
pressure O
fell O
from O
85 _RARE_
+/- O
11 O
. O
8 O
to O
68 _RARE_
+/- O
19 O
. O
6 O
mmHg O
( O
p O
less O
than O
0 _RARE_
. O
01 O
) O
and O
systemic O
arterial O
resistance O
fell O
from O
2 O
886 _RARE_
+/- O
745 _RARE_
to O
2 O
010 _RARE_
+/- O
610 _RARE_
dynes _RARE_
/ O
cm O
- O
5 O
/ O
sec O
/ O
m O
- O
2 O
( O
p O
less O
than O
0 _RARE_
. O
01 O
). O

Cimetidine _RARE_
800 O
mg O
given O
at _RARE_
night O
is O
as _RARE_
effective O
as _RARE_
400 _RARE_
mg O
twice O
daily O
; O
the O
single O
dose O
regimen O
may O
improve O
patient O
compliance O
, O
thus O
facilitating O
treatment O
. O

Ceftazidime _RARE_
shows O
promise _RARE_
as _RARE_
single O
- O
agent O
therapy O
for _RARE_
serious O
gram O
- O
negative O
bacillary _RARE_
infections O
. O

Regional _RARE_
CBF O
was O
determined O
by O
clearance O
of O
xenon _RARE_
133 _RARE_
in O
67 O
patients O
undergoing O
coronary O
bypass O
grafting _RARE_
procedures O
. O

Our O
results O
indicate O
that O
serum I-GENE
BGP _RARE_
is O
a O
valuable O
measurement O
of O
bone O
metabolism O
. O

The O
management O
of O
the O
" O
chronic O
" O
patient O
. O

Study O
of O
bacterial O
motility _RARE_
and O
rate O
of O
movement O
using O
a O
closed O
circuit O
television _RARE_

Finding _RARE_
of O
Rhodnius _RARE_
prolixus _RARE_
Stal _RARE_
, O
1859 _RARE_
, O
in O
babassu _RARE_
palm _RARE_
trees _RARE_

Each O
causative _RARE_
organism O
has O
a O
species O
- O
specific O
preference O
and O
requirement O
for _RARE_
temperature _RARE_
, O
salinity _RARE_
, O
pH O
, O
the O
basic O
nutrients _RARE_
, O
and O
growth O
factors O
, O
and O
the O
toxin _RARE_
formation O
is O
affected O
by O
these O
environmental O
factors O
. O

It O
is O
concluded O
that O
axillo _RARE_
- O
axillary _RARE_
by O
- O
pass _RARE_
is O
a O
simple O
solution O
for _RARE_
a O
complex O
haemodynamic _RARE_
, O
clinical O
and O
therapeutic O
problem O
. O

Deformities _RARE_
of O
the O
tip _RARE_
of O
the O
olecranon _RARE_
and O
of O
the O
coronoid _RARE_
process O
are O
also O
described O
( O
De _RARE_
Palma _RARE_
1956 _RARE_
, O
Jordan _RARE_
1958 _RARE_
, O
Ahlberg _RARE_
1965 _RARE_
, O
Weseloh _RARE_
1973 _RARE_
). O

There O
was O
significant O
correlation O
of O
LVM _RARE_
/ O
M2 _RARE_
and O
PWVn _RARE_
for _RARE_
pre O
- O
AVR _RARE_
and O
post O
AVR _RARE_
studies O
. O

Statokinesimetric _RARE_
recording O
in O
Huntington _RARE_
choreas _RARE_

The O
development O
and O
histostructural _RARE_
organization O
of O
intrahepatic O
biliary O
ducts _RARE_
were O
studied O
on O
a O
human O
embryofetal _RARE_
material O
6 O
to O
32 _RARE_
weeks O
old O
. O

It O
has O
been O
shown O
in O
an O
animal _RARE_
experiment O
that O
alterations O
of O
the O
renal _RARE_
vasculature _RARE_
and O
parenchyma O
after O
hemostasis O
performed O
by O
Infrared _RARE_
- O
Contact _RARE_
- O
Coagulation _RARE_
are O
best O
shown O
by O
intravital _RARE_
magnification O
angiography O
( O
magnification O
factor O
2 O
. O
22 _RARE_
). O

Cardiovascular _RARE_
and O
adrenal O
medullo _RARE_
- O
sympathetic O
reactions O
to O
acute O
tobacco O
poisoning O

Intravenous O
injections O
of O
SG _RARE_
- O
75 _RARE_
( O
0 _RARE_
. O
03 O
- O
1 O
mg O
/ O
kg O
) O
decreased O
systemic O
blood _RARE_
pressure O
( O
SBP _RARE_
) O
and O
increased O
peripheral O
( O
coronary O
, O
renal _RARE_
, O
mesenteric _RARE_
and O
femoral O
) O
blood _RARE_
flow O
( O
PBF _RARE_
) O
dose O
- O
dependently O
. O

In O
doses O
of O
0 _RARE_
. O
03 O
- O
0 _RARE_
. O
3 O
mg O
/ O
kg O
i O
. O
v O
., O
SG _RARE_
- O
75 _RARE_
did O
not O
significantly O
affect O
pulse O
pressure O
, O
heart _RARE_
rate O
, O
aortic O
blood _RARE_
flow O
, O
left _RARE_
ventricular O
pressure O
( O
LVP _RARE_
) O
and O
LVdP _RARE_
/ O
dt O
max _RARE_
. O

Resting _RARE_
VE O
in O
the O
luteal _RARE_
phase _RARE_
was O
7 O
. O
8 O
% O
greater O
than O
that O
in O
the O
follicular O
phase _RARE_
. O

Exposure _RARE_
of O
endothelium O
to O
pulsatile _RARE_
shear O
stresses O
that O
followed O
a O
tape _RARE_
recording O
of O
physiological O
flow O
waveforms _RARE_
( O
electromagnetic _RARE_
flowmeter _RARE_
) O
did O
not O
cause O
gross O
injury O
or O
denudation _RARE_
even O
when O
peak O
shear O
exceeded _RARE_
1500 _RARE_
dyne _RARE_
/ O
cm2 O
. O

Modern _RARE_
cancer _RARE_
therapy O
has O
included O
surgery O
, O
radiotherapy O
, O
chemotherapy O
, O
and O
most O
recently O
, O
immunotherapy O
and O
hyperthermia _RARE_
. O

There O
was O
a O
close O
correlation O
between O
plasma O
clearance O
of O
NT _RARE_
by O
10 O
- O
hydroxylation _RARE_
and O
the O
D O
metabolic O
ratio O
( O
D O
/ O
4 O
- O
OH O
- O
D O
in O
urine O
) O
in O
the O
Ghanaians _RARE_
( O
rs O
= O
- O
0 _RARE_
. O
95 _RARE_
; O
P O
less O
than O
0 _RARE_
. O
01 O
) O
and O
Swedes _RARE_
( O
rs O
= O
- O
0 _RARE_
. O
84 _RARE_
; O
P O
less O
than O
0 _RARE_
. O
01 O
). O

The O
response O
properties O
of O
cat _RARE_
horizontal O
canal _RARE_
afferents O
( O
N O
= O
81 _RARE_
) O
were O
characterized O
by O
three O
parameters O
: O
their O
long O
time O
constants O
( O
tau _RARE_
), _RARE_
low O
frequency O
gain O
constants O
( O
G1 O
), _RARE_
and O
middle _RARE_
frequency O
gain O
constants O
( O
Gm _RARE_
). O

Endothelium _RARE_
of O
the O
central O
ear O
artery O
of O
an O
anesthetized O
rabbit _RARE_
is O
damaged O
by O
placing _RARE_
artery O
forceps _RARE_
on O
the O
ear O
directly O
over O
the O
vessel O
. O

Despite O
supraphysiologic _RARE_
E2 O
concentrations O
, O
however O
, O
cervical O
mucus O
scores O
were O
significantly O
reduced _RARE_
in O
the O
CC _RARE_
- O
treated O
group O
( O
P O
less O
than O
0 _RARE_
. O
01 O
). O

Stimulation _RARE_
of O
the O
caudate _RARE_
nucleus O
' O
dophamine _RARE_
- O
reactive O
system _RARE_
in O
dogs O
by O
means O
of O
administration O
of O
dophamine _RARE_
( O
60 _RARE_
micrograms O
) O
and O
phenamine _RARE_
led O
to O
deterioration O
of O
conditioned O
and O
unconditioned _RARE_
components _RARE_
of O
feeding O
behaviour O
. O

Value O
of O
urine O
glucose O
tests O
in O
the O
management O
of O
type O
II O
diabetes O
mellitus O
. O

This O
experiment O
was O
conducted O
to O
determine O
if O
the O
sex _RARE_
or O
actual O
egg _RARE_
production O
was O
the O
important O
factor O
.( O
ABSTRACT O
TRUNCATED O
AT O
250 _RARE_
WORDS O
) O

Hydrocortisone _RARE_
seems O
to O
be O
unable O
to O
hinder _RARE_
the O
postdenervation _RARE_
changes O
in O
the O
muscle O
membrane O
whereas O
high O
doses O
of O
the O
hormone O
are O
able O
to O
induce O
changes O
in O
the O
muscle O
membrane O
. O

Significant O
clinical O
differences O
between O
the O
patients O
treated O
with O
and O
without O
AMB _RARE_
were O
longer O
survival O
time O
following O
diagnosis O
of O
illness O
( O
P O
less O
than O
0 _RARE_
. O
05 O
) O
and O
more O
frequent O
cranial _RARE_
nerve O
signs O
in O
the O
treated O
patients O
( O
P O
= O
0 _RARE_
. O
089 _RARE_
). O

A O
pharmacokinetic O
study O
of O
apalcillin _RARE_
was O
performed O
in O
12 O
patients O
in O
an O
intensive O
- O
care O
unit O
. O

Catch _RARE_
- O
up _RARE_
growth O
was O
observed O
only O
for _RARE_
a O
12 O
- O
month O
period O
in O
4 O
children O
with O
a O
bone O
age O
of O
7 O
to O
8 O
years O
. O

Thrombocyte _RARE_
function O
was O
impaired O
in O
all O
patients O
, O
characterized O
by O
a O
diminished O
platelet O
shape O
change O
. O

The O
findings O
demonstrate O
that O
AMPH _RARE_
administration O
induces O
a O
significant O
increase O
in O
the O
height O
of O
a O
major O
electroactive _RARE_
peak O
in O
the O
caudate _RARE_
nucleus O
of O
pigtail _RARE_
monkeys O
, O
and O
further O
that O
such O
amphetamine O
- O
induced _RARE_
increases O
can O
be O
manipulated _RARE_
by O
altering O
the O
affective O
and O
/ O
or O
emotional _RARE_
state O
of O
the O
animal _RARE_
. O

In O
two O
experiments O
, O
neonatal O
female O
BALB _RARE_
/ O
cCrgl _RARE_
or O
BALB _RARE_
/ O
cfC3HCrgl _RARE_
mice O
were O
given O
subcutaneous O
injections O
of O
5 O
micrograms O
17 _RARE_
beta O
- O
estradiol O
or O
sesame _RARE_
oil O
for _RARE_
the O
first _RARE_
3 O
days O
of O
life O
and O
were O
ovariectomized _RARE_
at _RARE_
60 _RARE_
days O
of O
age O
, O
at _RARE_
which O
time O
vaginal O
concretions _RARE_
( O
Experiments O
I O
and O
II O
) O
or O
silica _RARE_
( O
Experiment O
II O
) O
were O
implanted O
intravaginally _RARE_
. O

For O
228 _RARE_
of O
425 _RARE_
deaths O
( O
54 O
%) O
occurring O
among O
26 _RARE_
100 _RARE_
people O
of O
known O
age O
in O
the O
Malumfashi _RARE_
area O
of O
northern O
Nigeria _RARE_
, O
data O
were O
collected O
on O
symptoms O
present O
prior O
to O
death _RARE_
. O

Salivary _RARE_
estradiol O
17 _RARE_
beta O
( O
E2 O
- O
17 _RARE_
beta O
) O
and O
progesterone O
( O
P O
) O
were O
determined O
by O
using O
radioimmunoassay O
techniques O
in O
30 _RARE_
pregnant _RARE_
females O
in O
the O
first _RARE_
, O
second O
and O
third O
trimesters _RARE_
as _RARE_
well _RARE_
as _RARE_
in O
10 O
non O
- O
pregnant _RARE_
controls O
during _RARE_
the O
luteal _RARE_
phase _RARE_
of O
the O
menstrual O
cycle _RARE_
. O

Other O
than O
d O
7 O
, O
there O
was O
no _RARE_
significant O
effect O
on O
the O
number O
of O
implants O
. O

Variable _RARE_
FHR _RARE_
decelerations _RARE_
or O
bradycardias _RARE_
were O
encountered _RARE_
on O
95 _RARE_
nonstress _RARE_
tests O
( O
18 O
. O
8 O
%) O
in O
80 _RARE_
( O
33 _RARE_
. O
5 O
%) O
postdate _RARE_
patients O
. O

The O
response O
chain O
in O
each O
component _RARE_
was O
maintained O
by O
food O
presentation O
under O
a O
fixed O
- O
ratio O
schedule O
. O

The O
results O
imply O
that O
kindling O
does O
not O
produce O
its O
facilitating O
effect O
on O
acquisition O
of O
HPC _RARE_
SS _RARE_
by O
removing O
a O
disruptive _RARE_
effect O
of O
the O
stimulation _RARE_
. O

The O
persistent O
fetal _RARE_
dispersion O
of O
nodal O
and O
Hiss _RARE_
bundle O
fragments O
within O
the O
ventricular O
septum _RARE_
is O
proposed O
as _RARE_
a O
possible O
explanation O
. O

According O
to O
the O
biochemical O
tests O
, O
high O
activity O
( O
over O
200 _RARE_
U _RARE_
/ O
l _RARE_
) O
of O
alkaline _RARE_
phosphatase I-GENE
was O
recorded O
exclusively O
in O
patients O
with O
the O
lymphogranulomatosis _RARE_
- O
induced _RARE_
liver O
damage O
. O

Changes O
of O
plasma O
cortisol O
level O
in O
late _RARE_
asthmatic O
responses O

Significant O
alterations O
in O
the O
vasectomized _RARE_
rats O
from O
sham O
rats O
included O
: O
testicular _RARE_
and O
epididymal _RARE_
hypertrophy O
, O
formation O
of O
pathologic O
vas O
deferens O
granulomas _RARE_
, O
decreased O
total _RARE_
serum O
protein O
, O
lowered O
alpha I-GENE
- I-GENE
globulin I-GENE
levels O
as _RARE_
shown O
by O
serum O
electrophoresis O
, O
and O
increased O
sperm O
agglutinin _RARE_
antibody O
titers _RARE_
. O

SFP _RARE_
was O
significantly O
elevated O
in O
Hn _RARE_
( O
s O
). O

The O
average O
birth O
mass O
of O
these O
newborns O
was O
3491 _RARE_
. O
9 O
+/- O
2 O
SD O
780 _RARE_
. O
5 O
g O
and O
that O
in O
the O
control O
group O
3 O
, O
767 _RARE_
. O
5 O
+/- O
2 O
SD O
824 _RARE_
. O
2 O
g O
( O
P O
less O
than O
0 _RARE_
. O
05 O
). O

This O
machine O
drift _RARE_
, O
which O
was O
not O
associated O
with O
a O
rise O
in O
water O
phantom _RARE_
temperature _RARE_
and O
did O
not O
consistently O
correlate O
with O
estimated O
x _RARE_
- O
ray O
tube O
heat O
, O
could O
result O
in O
a O
significant O
overestimation _RARE_
of O
regional O
cerebral O
blood _RARE_
flow O
( O
rCBF O
) O
for _RARE_
a O
xenon _RARE_
/ O
CT _RARE_
rCBF O
protocol O
involving O
5 O
- O
7 O
sequential O
scans O
obtained O
at _RARE_
1 O
- O
min O
interscan _RARE_
intervals O
. O

Other O
uncertainties _RARE_
in O
the O
dosimetry _RARE_
at _RARE_
Y O
- O
12 O
and O
Vinca _RARE_
are O
unaltered O
. O

E2 O
treatments O
elevated O
hen _RARE_
plasma O
TG O
7 O
. O
2X _RARE_
, O
PL _RARE_
5 O
. O
1X _RARE_
, O
and O
C O
7 O
. O
2X _RARE_
; O
and O
pullet _RARE_
plasma O
TG O
6 O
. O
8X _RARE_
, O
PL _RARE_
3 O
. O
7X _RARE_
, O
and O
C O
2 O
. O
5X _RARE_
. O

By O
contrast O
, O
kidneys O
from O
rats O
with O
chronic O
metabolic O
acidosis O
produced O
significantly O
more O
NH3 _RARE_
than O
both O
these O
groups O
( O
2 O
. O
73 _RARE_
+/- O
0 _RARE_
. O
29 O
mumol O
X O
min O
- O
1 O
X O
g O
- O
1 O
). O

Serodiagnosis _RARE_
of O
trypanosomiasis _RARE_
in O
dromedary _RARE_
camels _RARE_
using O
a O
card _RARE_
agglutination _RARE_
test O
set O
( O
Testryp _RARE_
CATT _RARE_
). O

Adenyl _RARE_
cyclase I-GENE
activity O
of O
gastric _RARE_
mucosa O
in O
patients O
with O
duodenal O
ulcer O
before O
and O
after O
treatment O

Proteinuria _RARE_
-- _RARE_
selected _RARE_
physiopathological _RARE_
and O
clinical O
problems O

However O
, O
subcutaneously O
administered O
pneumococci _RARE_
gave O
a O
lower O
mortality O
than O
pneumococci _RARE_
given O
intravenously O
or O
intraperitoneally _RARE_
. O

Reaction _RARE_
of O
human O
organism O
to O
exercise O
. O

HA _RARE_
resulted O
in O
decreased O
( O
p O
less O
than O
0 _RARE_
. O
05 O
) O
Tre _RARE_
( O
0 _RARE_
. O
4 O
degrees O
C O
) O
and O
HR O
( O
17 _RARE_
b O
X O
min O
- O
1 O
), _RARE_
and O
increased O
( O
p O
less O
than O
0 _RARE_
. O
05 O
) O
Msw _RARE_
( O
16 O
g O
X O
m O
- O
2 O
X O
h O
- O
1 O
) O
during _RARE_
the O
saline O
experiments O
. O

The O
results O
obtained O
were O
as _RARE_
follows O
: O
The O
mitral O
valve O
orifice _RARE_
area O
( O
MVA _RARE_
) O
was O
significantly O
smaller O
in O
patients O
with O
type O
III O
of O
the O
LVIT _RARE_
flow O
velocity O
pattern O
than O
in O
patients O
with O
type O
I O
( O
p O
less O
than O
0 _RARE_
. O
001 O
). O

Scientific _RARE_
cooperation O
of O
CMEA _RARE_
member _RARE_
countries _RARE_
has O
been O
carried O
out O
since O
1974 _RARE_
under O
the O
sponsorship _RARE_
of O
the O
Cancer O
Research O
Institute O
, O
Slovak _RARE_
Academy _RARE_
of O
Sciences _RARE_
( O
Czechoslovakia _RARE_
) O
within O
the O
framework _RARE_
of O
CMEA _RARE_
. O

This O
compares _RARE_
favorably _RARE_
to O
results O
of O
similarly O
sized O
melanomas O
treated O
by O
enucleation _RARE_
. O

A O
new O
variant O
of O
the O
EMG O
- O
BFB _RARE_
method O
( O
multichannel _RARE_
) O
is O
offered O
which O
has O
made O
it O
possible O
to O
use O
the O
method O
not O
only O
for _RARE_
training O
weakened _RARE_
muscles O
and O
reducing _RARE_
spasticity _RARE_
in O
their O
antagonists O
but O
also O
for _RARE_
improving _RARE_
motor O
coordination O
. O

Lymphocytes _RARE_
from O
all O
3 O
species O
yielded O
maximum O
responses O
with O
a O
48 _RARE_
- O
hour O
prelabel _RARE_
and O
12 O
- O
to O
- O
16 O
hour O
postlabel _RARE_
incubation O
period O
at _RARE_
41 _RARE_
C O
and O
1 O
: O
20 O
blood _RARE_
dilution O
. O

However O
, O
there O
was O
a O
difference O
in O
the O
quality O
of O
immunity _RARE_
: O
fever O
and O
body O
weight _RARE_
loss _RARE_
were O
seen O
in O
hamsters O
vaccinated _RARE_
with O
the O
killed O
- O
toxoplasma _RARE_
vaccine O
after O
they O
were O
challenge O
exposed O
with O
T O
- O
1 O
strain _RARE_
, O
whereas O
these O
changes O
were O
rarely O
seen O
in O
hamsters O
given O
the O
live O
- O
toxoplasma _RARE_
vaccine O
and O
then O
challenge O
exposed O
with O
RH _RARE_
strain _RARE_
. O

Alternating _RARE_
proline O
/ O
alanine O
sequence O
of O
beta I-GENE
B1 _RARE_
subunit I-GENE
originates _RARE_
from O
a O
repetitive _RARE_
DNA O
sequence O
. O

The O
segmental O
and O
regional O
projections O
of O
the O
sciatic _RARE_
, O
tibial _RARE_
and O
common O
peroneal _RARE_
nerves O
to O
the O
substantia _RARE_
gelatinosa _RARE_
of O
the O
spinal _RARE_
cord O
in O
rats O
-- _RARE_
an O
experimental O
study O
by O
means O
of O
an O
acid I-GENE
phosphatase I-GENE
( O
ACP _RARE_
) O
method O
. O

Removal O
of O
lipid _RARE_
fractions O
of O
plant _RARE_
extractions _RARE_
with O
hexane _RARE_
is O
recommended O
to O
avoid O
damage O
to O
the O
HPLC O
column O
. O

In O
the O
Arithmetic _RARE_
subtest _RARE_
one O
of O
the O
items _RARE_
would O
not O
meet _RARE_
the O
difficulty _RARE_
grading _RARE_
shown O
while O
the O
last O
two O
items _RARE_
offer O
very O
little O
possibility O
of O
success O
for _RARE_
all O
subjects O
.( O
ABSTRACT O
TRUNCATED O
AT O
250 _RARE_
WORDS O
) O

The O
toxicological O
evaluation O
of O
chlorofluorocarbon _RARE_
22 _RARE_
( O
CFC _RARE_
22 _RARE_
). O

All O
patients O
were O
evaluable O
for _RARE_
toxicity O
and O
9 O
for _RARE_
response O
. O

Methods _RARE_
of O
clinical O
and O
experimental O
algesimetry _RARE_
are O
described O
that O
have O
been O
used O
to O
evaluate O
effects O
of O
peripherally _RARE_
and O
centrally _RARE_
acting O
analgesics _RARE_
. O

The O
present O
paper O
elucidates _RARE_
the O
existing O
discrepancies _RARE_
, O
and O
offers O
a O
consistent O
terminology _RARE_
incorporating _RARE_
also O
such O
terms O
as _RARE_
" O
additivity _RARE_
", _RARE_
" O
potentiation O
", _RARE_
and O
" O
simple O
similarity _RARE_
". O

We O
propose O
that O
the O
ambiguous _RARE_
discrimination O
required O
a O
greater O
time O
for _RARE_
simulus _RARE_
evaluation O
and O
that O
this O
was O
reflected O
in O
the O
delayed O
P3 _RARE_
latencies _RARE_
. O

Ammonia _RARE_
concentration O
dropped _RARE_
significantly O
in O
all O
treatments O
, O
a O
finding O
which O
suggests O
a O
protective O
effect O
on O
protein O
nitrogen O
degradation _RARE_
to O
non O
- O
protein O
nitrogen O
( O
NH3 _RARE_
). O

In O
this O
respect O
C I-GENE
reactive I-GENE
protein I-GENE
concentrations O
are O
superior O
to O
white _RARE_
cell O
count O
, O
erythrocyte _RARE_
sedimentation O
rate O
, O
and O
temperature _RARE_
and O
the O
concentrations O
of O
antiproteases _RARE_
. O

Human I-GENE
thyroid I-GENE
stimulator _RARE_
( O
HTS _RARE_
) O
in O
thyroid O
diseases O

We O
conclude O
that O
administration O
of O
the O
calcium _RARE_
antagonist O
Verapamil _RARE_
is O
of O
no _RARE_
additional O
value O
in O
tocolytic _RARE_
treatment O
with O
beta O
- O
mimetics _RARE_
. O

Brainstem _RARE_
auditory O
evoked O
responses O
( O
BAERs _RARE_
) O
and O
quantitative O
saccadic _RARE_
eye O
movement O
studies O
provide O
information _RARE_
on O
the O
integrity O
of O
pathways O
traversing _RARE_
the O
brainstem _RARE_
. O

Effects O
of O
ketamine _RARE_
on O
the O
circulatory O
functions O
and O
body O
tissue O
oxygenation O
in O
dogs O
under O
normal O
and O
hypovolemic _RARE_
conditions O
. O

The O
salient _RARE_
clinical O
features O
, O
the O
problems O
of O
management O
and O
the O
modern O
approaches O
to O
the O
reconstruction O
of O
facial O
deformities _RARE_
seen O
in O
this O
disease _RARE_
are O
described O
. O

Besides _RARE_
, O
it O
was O
considered O
that O
the O
NPF _RARE_
was O
a O
useful O
tool O
for _RARE_
activation O
of O
velopharyngeal _RARE_
activity O
by O
way O
of O
visual O
feed O
- O
back O
control O
. O

To O
evaluate O
the O
comparative O
safety O
of O
U _RARE_
- O
P O
and O
D O
& O
E O
, O
we O
analyzed O
2 O
, O
805 _RARE_
U _RARE_
- O
P O
and O
9 O
, O
572 _RARE_
D O
& O
E O
abortions _RARE_
at _RARE_
13 _RARE_
to O
24 _RARE_
menstrual O
weeks O
' O
gestation O
. O

Three O
radiologists _RARE_
without O
knowledge O
of O
patients O
' O
data O
and O
treatment O
analyzed O
30 _RARE_
angiograms _RARE_
with O
and O
30 _RARE_
examinations O
without O
PGF _RARE_
. O

In O
a O
man O
with O
myelomonocytic _RARE_
leukemia O
, O
the O
association O
of O
increased O
prostatic _RARE_
acid I-GENE
phosphatase I-GENE
activity O
in O
serum O
and O
the O
presence O
of O
typical O
bone O
lesions O
on O
roentgenography _RARE_
suggested O
the O
existence O
of O
disseminated _RARE_
prostatic _RARE_
carcinoma O
. O

The O
rational _RARE_
for _RARE_
the O
prophylactic O
treatment O
, O
the O
therapy O
of O
the O
meningopathy _RARE_
and O
AIL _RARE_
- O
AIEOP _RARE_
protocols _RARE_
are O
exposed O
. O

An O
experimental O
long O
- O
term O
study O
. O

No O
anisotropism _RARE_
was O
recorded O
in O
a O
tetrahydrofuran _RARE_
solution O
. O

Hepatitis _RARE_
B O
vaccine O

The O
calculated O
values O
of O
lambda O
tb _RARE_
at _RARE_
37 O
degrees O
C O
and O
50 O
per O
cent O
haematocrit _RARE_
were O
0 _RARE_
. O
650 _RARE_
for _RARE_
the O
pulp _RARE_
, O
0 _RARE_
. O
674 _RARE_
for _RARE_
the O
tongue _RARE_
, O
0 _RARE_
. O
828 _RARE_
for _RARE_
the O
submandibular _RARE_
gland _RARE_
and O
0 _RARE_
. O
881 _RARE_
for _RARE_
the O
gingiva _RARE_
of O
the O
dog O
. O
lambda O
cp _RARE_
increased O
and O
lambda O
tp _RARE_
decreased O
as _RARE_
the O
temperature _RARE_
was O
reduced _RARE_
from O
37 O
to O
4 O
degrees O
C O
. O

As O
pleural _RARE_
thickening _RARE_
is O
seen O
commonly O
in O
asbestosis _RARE_
and O
may O
influence O
lung _RARE_
volumes O
and O
the O
ratio O
of O
transfer I-GENE
factor I-GENE
to O
effective O
alveolar O
volume O
, O
the O
results O
of O
these O
measurements O
were O
compared O
only O
in O
the O
cases O
showing O
absent O
or O
minimal O
pleural _RARE_
thickening _RARE_
. O

The O
invasive O
pattern O
of O
squamous O
cell O
carcinoma O
in O
the O
mandibular O
gingiva _RARE_

Azygos _RARE_
vein _RARE_
abutting _RARE_
the O
posterior O
wall _RARE_
of O
the O
right O
main O
and O
upper O
lobe O
bronchi _RARE_
: O
a O
normal O
CT _RARE_
variant O
. O

However O
, O
the O
history O
of O
acute O
severe O
complications O
from O
otitis _RARE_
media O
revealed O
a O
higher _RARE_
frequency O
in O
those O
individuals O
with O
alpha I-GENE
1 I-GENE
- I-GENE
antitrypsin I-GENE
deficiency O
as _RARE_
compared O
to O
normals O
. O

The O
Sarns _RARE_
51F _RARE_
cavoatrial _RARE_
cannula _RARE_
decompressed _RARE_
the O
venous O
system _RARE_
as _RARE_
efficiently O
as _RARE_
the O
double O
caval _RARE_
cannulas _RARE_
. O

All O
other O
changes O
at _RARE_
the O
3 O
-, _RARE_
5 O
-, _RARE_
and O
6 O
- O
positions O
, O
as _RARE_
well _RARE_
as _RARE_
the O
replacement _RARE_
of O
the O
phenyl _RARE_
group O
at _RARE_
position O
2 O
, O
caused O
a O
marked O
decrease O
of O
activity O
. O

Three O
experiments O
contrasted _RARE_
the O
effects O
of O
6 O
- O
hydroxydopamine _RARE_
- O
induced _RARE_
lesions O
of O
the O
ventral O
noradrenergic O
and O
dorsal O
noradrenergic O
projections O
, O
predominantly O
to O
hypothalamus O
and O
cortex O
, O
respectively O
, O
upon O
body O
weight _RARE_
changes O
and O
food O
- O
related O
behaviour O
in O
the O
rat O
. O

Limb _RARE_
allografts _RARE_
in O
rats O
immunosuppressed _RARE_
with O
cyclosporin O
A O
. O

The O
method O
involved O
deproteinizing _RARE_
samples O
with O
two O
volumes O
of O
acetonitrile _RARE_
followed O
by O
injection O
of O
5 O
microliters _RARE_
of O
deproteinized _RARE_
supernatant O
onto O
a O
C18 O
reversed O
- O
phase _RARE_
column O
. O

Refractory _RARE_
periods O
of O
the O
AV O
junction _RARE_
were O
altered O
in O
a O
comparable O
fashion O
to O
conduction O
through O
the O
AV O
node O
. O

This O
paper O
brings _RARE_
together O
data O
, O
obtained O
from O
a O
variety O
of O
sources O
, O
on O
the O
extent O
of O
prescription _RARE_
and O
use O
of O
psychotropic _RARE_
drugs O
in O
the O
late _RARE_
1960s _RARE_
and O
early O
1970s _RARE_
. O

Sixteen _RARE_
patients O
were O
studied O
within O
24 _RARE_
hours O
of O
resuscitation O
and O
all O
showed O
depressed O
right O
ventricular O
ejection O
( O
RVEF _RARE_
) O
and O
/ O
or O
an O
increased O
end O
- O
diastolic O
volume O
( O
RVEDVI _RARE_
). O

During O
a O
single O
LAD O
occlusion O
lasting O
35 _RARE_
minutes O
( O
series O
I O
, O
n _RARE_
= O
10 O
) O
9 O
microns O
TMs _RARE_
were O
infused O
immediately O
and O
30 _RARE_
minutes O
after O
ligation O
, O
15 _RARE_
microns O
TMs _RARE_
being O
infused O
after O
15 _RARE_
- O
20 O
minutes O
. O

The O
population O
of O
between O
75 _RARE_
, O
000 _RARE_
and O
100 _RARE_
, O
000 _RARE_
was O
largely O
unstable O
, O
and O
cost O
per O
capita _RARE_
was O
$ _RARE_
0 _RARE_
. O
95 _RARE_
to O
$ _RARE_
1 O
. O
21 O
. O

Female O
Wistar _RARE_
rats O
were O
fed O
a O
liquid O
diet O
, O
Sustacal _RARE_
, O
which O
contained O
ethanol O
( O
40 O
% O
of O
calories _RARE_
) O
or O
isocaloric _RARE_
sucrose O
. O

HL _RARE_
02 O
type O
oculomotor _RARE_
stimulator _RARE_
. O

Four O
patients O
( O
group O
1 O
) O
had O
type O
I O
basement _RARE_
membrane O
nephropathy O
, O
characterized O
by O
marked O
thickening _RARE_
and O
lamellation _RARE_
of O
the O
basement _RARE_
membrane O
in O
a O
pattern O
resembling O
that O
of O
Alport _RARE_
' O
s O
syndrome _RARE_
. O

Brain _RARE_
pH O
following O
3 O
h O
of O
cerebral O
focal _RARE_
ischemia O
changed O
from O
a O
normal O
value O
of O
7 O
. O
0 _RARE_
to O
6 O
. O
5 O
and O
6 O
. O
2 O
in O
animals O
studied O
under O
barbiturate _RARE_
and O
halothane O
anesthesia O
, O
respectively O
. O

Our O
results O
demonstrate O
the O
importance O
of O
phosphate O
and O
calcium _RARE_
in O
influencing O
the O
secretion _RARE_
of O
PTH _RARE_
and O
CT _RARE_
in O
uremia _RARE_
. O

Thin _RARE_
- O
layer O
chromatographic O
methods O
were O
up _RARE_
- O
dated _RARE_
for _RARE_
pharmacokinetic O
studies O
of O
imipramine _RARE_
in O
plasma O
and O
urine O
. O

Introductory _RARE_
remarks _RARE_
. O

Increasing O
the O
cut O
- O
off O
point O
to O
3 O
positive O
responses O
decreased O
the O
sensitivity O
to O
81 _RARE_
% O
and O
increased O
the O
specificity _RARE_
to O
94 O
%. O

After O
clofelin _RARE_
administration O
the O
autoregulation O
borders _RARE_
shifted O
to O
the O
right O
i O
. O
e _RARE_
. O
towards O
higher _RARE_
AP O
levels O
. O

This O
phenomenon O
may O
be O
regarded O
as _RARE_
a O
variant O
of O
selective O
individual O
cell O
death _RARE_
, O
currently O
referred O
to O
as _RARE_
apoptosis O
, O
which O
has O
not O
been O
previously O
reported O
in O
a O
case O
of O
embryonal _RARE_
rhabdomyosarcoma _RARE_
. O

Combination _RARE_
of O
a O
Shwachman _RARE_
syndrome _RARE_
and O
a O
complex O
granulocyte _RARE_
function O
disorder O
in O
a O
girl _RARE_

A O
combined O
series O
of O
patients O
experienced O
a O
TOL _RARE_
after O
two O
or O
more O
previous O
cesarean _RARE_
deliveries _RARE_
; O
the O
rate O
of O
vaginal O
delivery O
was O
66 _RARE_
%, O
and O
there O
was O
virtually O
no _RARE_
morbidity O
. O

Nursing _RARE_
home O
discharges _RARE_
in O
clinical O
practice O
. O

Trial _RARE_
3 O
broiler _RARE_
chickens _RARE_
were O
maintained O
on O
control O
feed O
until O
they O
reached O
3 O
weeks O
of O
age O
at _RARE_
which O
time O
they O
were O
taken O
off O
of O
feed O
for _RARE_
2 O
. O
5 O
hr O
and O
then O
placed O
on O
either O
control O
feed O
or O
feed O
containing O
4 O
. O
0 _RARE_
ppm O
ochratoxin _RARE_
A O
, O
and O
heart _RARE_
rate O
and O
blood _RARE_
pressure O
were O
measured O
every O
half _RARE_
hour O
through O
7 O
hr O
. O

The O
carcinogen _RARE_
bioassay _RARE_
therefore O
is O
a O
very O
important O
component _RARE_
of O
the O
battery O
of O
toxicological O
tests O
used O
in O
hazard _RARE_
evaluation O
. O

Harmful _RARE_
effects O
in O
animals O
and O
man O
may O
result O
from O
both O
deficient _RARE_
or O
excessive O
amounts O
of O
intake O
. O

Angionephroscintigraphy _RARE_
in O
the O
diagnosis O
of O
diseases O
of O
the O
kidney _RARE_

The O
analysis O
of O
the O
structure _RARE_
of O
the O
sleep O
period O
as _RARE_
a O
whole O
reveals O
that O
with O
increasing O
of O
the O
age O
the O
delta O
- O
wave O
stage _RARE_
( O
DS _RARE_
) O
of O
the O
QS _RARE_
( O
determined O
by O
defined O
polygraphic _RARE_
parameters O
) O
increases O
, O
while O
the O
paradoxical _RARE_
phase _RARE_
of O
sleep O
( O
PS _RARE_
) O
decreases O
, O
this O
change O
being O
more O
pronounced O
during _RARE_
the O
first _RARE_
six _RARE_
months O
than O
during _RARE_
the O
second O
ones O
of O
the O
first _RARE_
year O
of O
the O
life O
. O

[ _RARE_
82Br _RARE_
] O
MISO _RARE_
was O
prepared O
by O
irradiating _RARE_
samples O
of O
Br O
- O
MISO _RARE_
in O
a O
SLOWPOKE _RARE_
reactor _RARE_
for _RARE_
2 O
h O
at _RARE_
a O
thermal O
neutron _RARE_
flux _RARE_
of O
10 O
( O
12 O
) O
n _RARE_
cm O
- O
2 O
s O
- O
1 O
. O

While O
these O
findings O
may O
reflect O
the O
sensitivity O
of O
a O
thick O
myocardial _RARE_
wall _RARE_
to O
ischaemia O
during _RARE_
surgery O
, O
the O
postoperative O
recovery O
was O
not O
related O
to O
the O
serum I-GENE
CK _RARE_
- I-GENE
MB I-GENE
level O
. O

Morphofunctional _RARE_
status O
of O
the O
formed O
elements O
of O
the O
blood _RARE_
in O
rats O
subjected O
to O
different O
variants O
of O
combined O
and O
isolated O
exposure O
to O
BR _RARE_
- O
1 O
benzene _RARE_

Using O
a O
MOS _RARE_
- O
Hypersil _RARE_
reversed O
- O
phase _RARE_
column O
with O
a O
phosphate O
buffer _RARE_
-- _RARE_
acetonitrile _RARE_
mobile O
phase _RARE_
, O
baseline O
separation O
of O
antipyrine _RARE_
, O
its O
metabolites O
3 O
- O
hydroxymethylantipyrine _RARE_
, O
norantipyrine _RARE_
and O
4 O
- O
hydroxyantipyrine _RARE_
, O
and O
the O
internal O
standard O
, O
phenacetin _RARE_
, O
was O
achieved O
within O
6 O
min O
. O

The O
liver O
in O
the O
severely O
ill _RARE_

In O
a O
randomized O
study O
on O
150 _RARE_
patients O
( O
ASA _RARE_
1 O
) O
undergoing O
induction O
of O
anaesthesia O
, O
the O
effects O
of O
Fentanyl _RARE_
( O
0 _RARE_
. O
1 O
mg O
), _RARE_
the O
combination O
of O
Fentanyl _RARE_
( O
0 _RARE_
. O
1 O
mg O
) O
and O
Droperidol _RARE_
( O
5 O
mg O
) O
( O
Innovar _RARE_
, O
Thalamonal _RARE_
) O
and O
Atropine _RARE_
( O
0 _RARE_
. O
01 O
mg O
/ O
kg O
b O
. O
w O
.) O
alone O
on O
cardiocirculatory _RARE_
parameters O
were O
studied O
. O

These O
results O
confirming O
the O
high O
validity O
of O
NOM _RARE_
inhibiting O
test O
in O
the O
diagnosis O
of O
tumoural _RARE_
hyperprolactinemic _RARE_
states O
, O
reveal O
contradictory _RARE_
responses O
to O
CD O
/ O
LD _RARE_
, O
LD _RARE_
and O
DOM _RARE_
, O
with O
sustain _RARE_
the O
existence O
of O
2 O
sub O
- O
group O
of O
Prolactinomas _RARE_
: O
with O
or O
without O
a O
maintained O
DA _RARE_
central O
tonus _RARE_
supporting O
the O
possibility O
of O
different O
etiopathogenetical _RARE_
factors O
in O
inducing O
a O
tumoural _RARE_
hyperprolactinemic _RARE_
states O
. O

Serum O
lipids O
and O
lipoproteins _RARE_
of O
29 O
insulin I-GENE
dependent O
diabetic O
children O
have O
been O
determined O
and O
related O
to O
the O
metabolic O
status O
of O
the O
patients O
. O

Low O
NA O
and O
A O
may O
participate O
in O
lowering O
the O
plasma I-GENE
renin I-GENE
activity O
which O
in O
PA O
in O
suppressed O
, O
sometimes _RARE_
disproportionately _RARE_
to O
the O
actual O
body O
sodium _RARE_
content O
. O

Amikacin _RARE_
concentrations O
in O
serum O
and O
blister _RARE_
fluid _RARE_
in O
healthy O
volunteers O
and O
in O
patients O
with O
renal _RARE_
impairment O
. O

The O
subgroup O
innervating _RARE_
the O
medial O
rectus _RARE_
lies O
exclusively O
along O
the O
medial O
face O
of O
the O
oculomotor _RARE_
nucleus O
, O
with O
no _RARE_
aberrant O
neurons O
in O
the O
medial O
longitudinal O
fasciculus _RARE_
, O
as _RARE_
have O
been O
found O
in O
other O
mammals O
. O

Hepatitis _RARE_
B O
vaccination O
strategy O
for _RARE_
health O
- O
care O
workers O
in O
a O
country _RARE_
of O
intermediate _RARE_
hepatitis O
B O
endemicity _RARE_
. O

An O
intravenous O
drip _RARE_
infusion O
of O
AMK _RARE_
in O
adequate O
dosage O
would O
be O
beneficial O
to O
use O
against O
some O
infectious O
diseases O
of O
otorhinolaryngologic _RARE_
field O
. O

Out _RARE_
of O
these O
families _RARE_
74 _RARE_
, O
3 O
% O
planned _RARE_
next O
pregnancy _RARE_
( O
table _RARE_
IX _RARE_
), _RARE_
57 O
, O
6 O
% O
wanted _RARE_
to O
have O
prenatal _RARE_
diagnosis O
( O
table _RARE_
VI _RARE_
). O

The O
authors O
have O
tested O
the O
interference O
of O
the O
hemoglobin I-GENE
by O
two O
routine O
methods O
( O
Berthelot _RARE_
classic _RARE_
and O
Berthelot _RARE_
modified O
) O
for _RARE_
the O
determination O
of O
plasmatic _RARE_
urea O
. O

Parkinsonian _RARE_
patients O
had O
a O
significantly O
lower O
prevalence O
of O
alcohol _RARE_
use O
. O

These O
cells O
averaged O
17 _RARE_
microns O
in O
diameter O
and O
reproduced _RARE_
by O
fission _RARE_
, O
forming O
clusters O
of O
two O
or O
four O
daughter O
cells O
. O

Female O
but O
not O
male O
mortalities _RARE_
were O
significantly O
higher _RARE_
for _RARE_
cake _RARE_
- O
fed O
rats O
than O
for _RARE_
those O
fed O
diet O
41B _RARE_
. O

Urinary _RARE_
N I-GENE
- I-GENE
acetylglucosaminidase _RARE_
activity O
per O
mg O
creatinine _RARE_
did O
not O
differ O
significantly O
between O
groups O
. O

The O
associations O
between O
sex _RARE_
- I-GENE
hormone I-GENE
- I-GENE
binding I-GENE
globulin I-GENE
capacity O
( O
SHBG I-GENE
), _RARE_
age O
, O
body O
mass O
index O
( O
BMI O
), _RARE_
and O
physical O
fitness O
have O
been O
studied O
in O
34 _RARE_
men O
and O
36 _RARE_
women O
. O

Dipetalonema _RARE_
( O
Alafilaria _RARE_
) O
hydrochoerus _RARE_
subgen _RARE_
. O
et O
sp _RARE_
. O
n _RARE_
. O

After O
1 O
. O
5 O
years O
of O
such O
photoperiodic _RARE_
control O
, O
all O
ewes _RARE_
were O
blinded _RARE_
by O
bilateral O
orbital _RARE_
enucleation _RARE_
. O

The O
concentrations O
of O
C4 _RARE_
and O
C1 I-GENE
- I-GENE
INH _RARE_
increased O
with O
advancing _RARE_
stage _RARE_
of O
disease _RARE_
and O
were O
above O
normal O
mean O
values O
in O
all O
stages O
. O

Less _RARE_
antibacterial _RARE_
activity O
was O
shown O
toward O
the O
Gram O
- O
negative O
bacilli O
, O
i O
. O
e _RARE_
., O
Pseudomonas _RARE_
, O
Klebsiella _RARE_
- O
Enterobacter _RARE_
, O
Shigella _RARE_
, O
Escherichia O
coli O
, O
Serratia _RARE_
marcescens _RARE_
and O
Proteus _RARE_
. O

The O
mucosal _RARE_
defence _RARE_
capacity O
against O
proteolytic _RARE_
leukocyte _RARE_
enzymes _RARE_
. O

The O
apparatus O
consists O
of O
an O
Am _RARE_
- O
241 _RARE_
exciting _RARE_
source O
( O
300 _RARE_
mCi O
) O
and O
pure O
Ge _RARE_
detector O
( O
50 O
mm2 O
X O
5 O
mm O
) O
for _RARE_
measuring O
K O
alpha O
fluorescent _RARE_
x _RARE_
- O
rays O
( O
28 _RARE_
. O
3 O
and O
28 _RARE_
. O
6 O
KeV _RARE_
) O
emitted _RARE_
from O
exited _RARE_
iodine O
. O

Ultrastructural _RARE_
studies O
of O
retinopathy _RARE_
of O
premature O
infants O

The O
range O
of O
serum O
concentrations O
, O
mean O
values O
, O
median O
values O
, O
and O
standard O
deviations _RARE_
for _RARE_
each O
analyte _RARE_
are O
reported O
for _RARE_
males O
and O
females O
and O
for _RARE_
three O
age O
groups O
( O
25 _RARE_
- O
44 _RARE_
, O
45 _RARE_
- O
59 _RARE_
, O
60 _RARE_
- O
70 O
). O

The O
effects O
of O
antithrombotic _RARE_
drugs O
in O
patients O
with O
left _RARE_
ventricular O
thrombi _RARE_
: O
assessment O
with O
indium _RARE_
- O
111 O
platelet O
imaging O
and O
two O
- O
dimensional O
echocardiography O
. O

A O
stable O
interface O
depends O
on O
overall O
stress O
and O
microstress _RARE_
distribution O
on O
the O
bone O
, O
particularly O
trabecular _RARE_
bone O
. O

Plasma O
NE _RARE_
was O
also O
low O
in O
the O
anephric _RARE_
group O
( O
289 _RARE_
mg O
/ O
liter O
+/- O
126 O
( O
1 O
SD O
) O
vs _RARE_
612 _RARE_
+/- O
189 _RARE_
, O
P O
= O
0 _RARE_
. O
033 _RARE_
, O
resting O
).( _RARE_
ABSTRACT O
TRUNCATED O
AT O
250 _RARE_
WORDS O
) O

10 O
long O
- O
term O
hemodialysis O
patients O
had O
immediate O
and O
redistribution _RARE_
thallium O
- O
201 _RARE_
myocardial _RARE_
imaging O
performed O
after O
a O
course O
of O
hemodialysis O
. O

The O
Prolactin _RARE_
levels O
were O
within O
the O
physiological O
norms _RARE_
; O
the O
responses O
to O
TRH I-GENE
were O
normal O
, O
and O
elevated O
only O
in O
a O
few O
cases O
. O

Despite O
total _RARE_
tumor O
resection O
, O
multiple O
intraperitoneal _RARE_
tumor O
nodules O
of O
varying O
sizes O
were O
found O
and O
resected _RARE_
six _RARE_
months O
and O
one O
year O
later O
. O

Private _RARE_
hospital O
accreditation _RARE_
. O

Antithrombin _RARE_
III I-GENE
in O
hip O
surgery O

In O
14 O
of O
21 O
infant O
hearts O
( O
66 _RARE_
%) O
with O
aortic O
arch _RARE_
interruption _RARE_
between O
the O
left _RARE_
common O
carotid O
and O
left _RARE_
subclavian _RARE_
arteries O
( O
type O
B O
of O
Celoria _RARE_
and O
Patton _RARE_
), _RARE_
the O
right O
subclavian _RARE_
artery O
( O
SA O
) O
arose _RARE_
anomalously _RARE_
. O

We O
suggest O
that O
sensitivity O
to O
photoperiod _RARE_
in O
pallid _RARE_
bats _RARE_
, O
as _RARE_
in O
several O
other O
mammals O
, O
is O
mediated _RARE_
by O
the O
pineal O
gland _RARE_
. O

Absorption _RARE_
was O
rapid O
, O
with O
a O
mean O
time O
to O
peak O
of O
39 _RARE_
min O
. O

Additionally O
, O
observations O
that O
patients O
with O
mitral O
versus O
aortic O
regurgitation _RARE_
respond O
differently O
to O
valve O
replacement _RARE_
suggest O
that O
differences O
exist O
preoperatively _RARE_
between O
these O
two O
types _RARE_
of O
volume O
overload O
. O

A O
case O
of O
manifest O
latent O
nystagmus O
of O
late _RARE_
onset O
in O
a O
13 _RARE_
- O
year O
- O
old O
girl _RARE_
is O
reported O
. O

Within O
the O
compartment O
or O
dimension _RARE_
of O
severity O
of O
depression O
a O
subscale _RARE_
of O
the O
Hamilton _RARE_
Depression _RARE_
Scale O
( O
or O
the O
Melancholia _RARE_
Scale O
) O
was O
shown O
to O
have O
reached O
an O
instrumental _RARE_
perfection _RARE_
, O
e _RARE_
. O
g O
. O
as _RARE_
an O
outcome O
measure O
of O
antidepressant _RARE_
treatment O
. O

Significant O
immunoglobulinuria _RARE_
developed O
prior O
to O
the O
development O
of O
azotemia _RARE_
, O
significantly O
decreased O
creatinine _RARE_
clearance O
, O
significant O
proteinuria _RARE_
( O
greater O
than O
or O
equal O
to O
3 O
+ O
dipstick _RARE_
or O
greater O
than O
or O
equal O
to O
5 O
gm _RARE_
per O
24 _RARE_
- O
hour O
urine O
collection O
), _RARE_
or O
oliguria _RARE_
. O

A O
total _RARE_
number O
of O
1628 _RARE_
cases O
were O
collected O
from O
135 O
medical O
institutions _RARE_
. O

Epileptiform _RARE_
activity O
recorded O
from O
superficial O
laminae _RARE_
bordering _RARE_
layer O
4 O
, O
and O
into O
which O
layer O
4 O
' O
s O
primary _RARE_
projections O
terminate O
, O
is O
suppressed O
preferentially O
by O
phenytoin O
. O

The O
AD O
components _RARE_
were O
markedly O
more O
dependent O
on O
the O
affective O
state O
of O
the O
rat O
then O
was O
the O
V1 _RARE_
component _RARE_
. O

Is O
nisoldipine _RARE_
capable O
of O
reducing _RARE_
left _RARE_
ventricular O
preload _RARE_
? O
In O
ten O
anesthetized O
pigs O
, O
nisoldipine _RARE_
( O
2 O
- O
4 O
micrograms O
X O
kg O
- O
1 O
X O
min O
- O
1 O
), _RARE_
a O
calcium _RARE_
channel _RARE_
blocker O
structurally O
related O
to O
nifedipine O
, O
reduced _RARE_
left _RARE_
ventricular O
systolic O
pressure O
( O
40 O
%) O
and O
systemic O
vascular O
resistance O
( O
35 _RARE_
%), O
whereas O
maxLVdP _RARE_
/ O
dt O
decreased O
by O
20 O
% O
and O
cardiac O
output O
was O
unchanged O
. O

Monkeys _RARE_
were O
evaluated O
before O
and O
after O
unilateral O
and O
serial O
bilateral O
removal O
of O
superior O
temporal O
cortex O
. O

HBB _RARE_
concentration O
in O
the O
fetuses _RARE_
indicated O
little O
, O
if O
any O
accumulation O
. O

All O
samples O
exhibited O
a O
decline O
in O
ethanol O
concentration O
, O
with O
most O
losses _RARE_
falling _RARE_
within O
the O
expected O
20 O
to O
40 O
mg O
% O
range O
. O

Plasma I-GENE
lactoferrin _RARE_
and O
the O
blood _RARE_
count O
of O
polynuclear _RARE_
neutrophils O

The O
importance O
of O
selective O
renal _RARE_
vein _RARE_
phlebography _RARE_
in O
the O
evaluation O
of O
unexplained _RARE_
hematuria _RARE_
and O
filing _RARE_
defects O
in O
the O
excretory _RARE_
urogram _RARE_
is O
illustrated _RARE_
. O

Pilot _RARE_
study O
of O
blood _RARE_
coagulation O
in O
gout _RARE_
patients O
. O

The O
statistical O
analysis O
consist O
of O
the O
F O
test O
followed O
by O
Snedecor _RARE_
' O
s O
contrast O
test O
. O

The O
pyramidal O
tract _RARE_
and O
Mesencephalic _RARE_
Reticular _RARE_
Formation _RARE_
( O
MRF _RARE_
) O
were O
stimulated _RARE_
before O
and O
after O
the O
transection _RARE_
. O

Further O
, O
the O
reduction O
in O
5 O
- O
hydroxytryptophan _RARE_
( O
5 O
- O
HTP _RARE_
) O
accumulation O
by O
LSD _RARE_
showed O
regional O
differences O
in O
inhibition O
by O
methiothepin _RARE_
( O
hypothalamus O
greater O
than O
cortex O
greater O
than O
striatum _RARE_
) O
which O
paralleled _RARE_
the O
autoreceptor _RARE_
antagonist O
activity O
of O
methiothepin _RARE_
in O
vitro O
.( O
ABSTRACT O
TRUNCATED O
AT O
250 _RARE_
WORDS O
) O

Effects O
of O
methiothepin _RARE_
and O
lysergic _RARE_
acid O
diethylamide _RARE_
on O
serotonin _RARE_
release O
in O
vitro O
and O
serotonin _RARE_
synthesis _RARE_
in O
vivo O
: O
possible O
relation O
to O
serotonin _RARE_
autoreceptor _RARE_
function O
. O

In O
a O
recent O
measles _RARE_
epidemic O
in O
El _RARE_
Paso _RARE_
, O
TX _RARE_
, O
120 O
, O
000 _RARE_
records O
were O
screened O
using O
these O
criteria O
, O
and O
as _RARE_
a O
result O
13 _RARE_
, O
000 _RARE_
students O
were O
vaccinated _RARE_
. O

No O
patient O
with O
bradyarrhythmia _RARE_
- O
related O
SCD _RARE_
had O
manifest O
atrioventricular _RARE_
block _RARE_
or O
bundle O
branch O
block _RARE_
. O

The O
measurement O
of O
the O
areas O
of O
fibrin I-GENE
, O
of O
tissue O
and O
fibrinolysis _RARE_
, O
at _RARE_
the O
above O
mentioned O
times O
, O
has O
been O
effected _RARE_
at _RARE_
standard O
magnification O
( O
15 _RARE_
X O
) O
by O
an O
image O
analyser _RARE_
( O
Videoplan _RARE_
) O
scale O
1 O
: O
8 O
. O

Diclofenac _RARE_
sodium _RARE_
- O
chlormezanone _RARE_
poisoning O
. O

Postprandial _RARE_
plasma I-GENE
enteroglucagon _RARE_
concentration O
after O
90 _RARE_
minutes O
in O
untreated O
patients O
correlated O
positively O
to O
the O
faecal _RARE_
fat O
excretion O
( O
r _RARE_
= O
0 _RARE_
. O
58 O
, O
p O
less O
than O
0 _RARE_
. O
02 O
). O

Blood _RARE_
pressure O
in O
children O
. O

In O
this O
study O
the O
splenectomized _RARE_
captive _RARE_
born O
cynomolgus _RARE_
appeared O
to O
be O
capable O
of O
supplementing _RARE_
rhesus _RARE_
as _RARE_
an O
antimalarial _RARE_
drug O
testing O
model O
. O

The O
results O
showed O
that O
the O
sensitivity O
of O
the O
3 O
given O
guinea _RARE_
pig _RARE_
strains O
was O
comparable O
. O

Adult O
Amblyomma _RARE_
lepidum _RARE_
ticks O
fed O
as _RARE_
nymphs _RARE_
on O
this O
goat _RARE_
transmitted O
heartwater _RARE_
to O
a O
Friesian _RARE_
( O
Bos _RARE_
taurus _RARE_
) O
calf _RARE_
. O

Twenty O
- O
one O
percent O
of O
these O
patients O
had O
neurologic O
disease _RARE_
that O
appeared O
to O
be O
responsible O
for _RARE_
the O
tinnitus _RARE_
. O

Morphine _RARE_
injected O
into O
the O
lateral O
ventricle O
of O
the O
rat O
produced O
unilateral O
analgesia O
in O
the O
formalin O
test O
, O
which O
involves O
continuous O
, O
moderate O
pain O
. O

The O
maps O
of O
Case _RARE_
2 O
showed O
that O
a O
maximum O
first _RARE_
appeared O
on O
the O
upper O
right O
back O
and O
then O
moved _RARE_
down O
the O
right O
side _RARE_
of O
the O
posterior O
thorax _RARE_
. O

Urinary _RARE_
urate _RARE_
excretion O
, O
urate _RARE_
clearance O
, O
and O
fractional O
excretion O
of O
urate _RARE_
all O
increased O
significantly O
during _RARE_
water O
immersion O
, O
and O
decreased O
in O
the O
hour O
following O
water O
immersion O
. O

Mutations O
in O
seven _RARE_
other O
lts _RARE_
genes I-GENE
do O
not O
result O
in O
the O
mak _RARE_
- I-GENE
phenotype _RARE_
. O

Twenty O
- O
eight O
were O
excluded O
as _RARE_
gallstones _RARE_
were O
not O
proved O
: O
of O
the O
remainder _RARE_
, O
21 O
patients O
received O
glucagon I-GENE
and O
22 _RARE_
placebo O
. O

4 O
Five O
patients O
died O
within O
one O
month O
of O
captopril O
and O
five O
between O
four O
and O
seven _RARE_
months O
, O
three O
of O
whom O
had O
improved O
to O
class O
IIM _RARE_
and O
one O
to O
IIS _RARE_
before O
death _RARE_
. O

Bullous _RARE_
angiolymphoid _RARE_
hyperplasia O
with O
eosinophilia _RARE_

Regions _RARE_
of O
the O
translated O
open _RARE_
reading O
frames O
of O
cobA _RARE_
and O
the O
third O
intron O
of O
the O
cob _RARE_
gene I-GENE
in I-GENE
yeast I-GENE
show O
high O
amino O
acid O
homology O
. O

Multiresistant _RARE_
strains O
isolated O
from O
humans O
in O
enteral _RARE_
toxico _RARE_
- O
infections O
kill _RARE_
orally O
infected _RARE_
mice O
more O
frequently O
than O
strains O
isolated O
in O
hospital O
infections O
. O

Single _RARE_
tooth O
replacement _RARE_
with O
the O
aid O
of O
the O
ITI _RARE_
( O
International O
Team _RARE_
fur _RARE_
Implantologie _RARE_
) O
type O
F O
hollow _RARE_
- O
cylinder _RARE_
implant O

The O
13 _RARE_
, O
14 O
- O
dihydro _RARE_
- O
15 _RARE_
- O
keto _RARE_
- O
metabolites O
of O
PGE2 O
and O
PGF2 O
alpha O
had O
no _RARE_
statistically O
significant O
antiarrhythmic O
effect O
. O

Nucleotide O
sequence O
of O
DNA O
controlling O
expression _RARE_
of O
genes O
for _RARE_
maltosaccharide _RARE_
utilization O
in O
Streptococcus _RARE_
pneumoniae _RARE_
. O

The O
hypertension O
with O
elevated O
PRA _RARE_
, O
however O
, O
was O
resistant O
to O
the O
angiotensin I-GENE
II I-GENE
( O
AII _RARE_
) O
analog O
[ _RARE_
Sar1 _RARE_
, O
Ile8 _RARE_
] O
ALL O
. O

Colorimetric _RARE_
determination O
of O
urinary _RARE_
iron O
, O
chelated _RARE_
with O
deferoxamine _RARE_
B O
, O
using O
a O
single O
reagent _RARE_

Measurements O
of O
perfusion O
also O
showed O
significantly O
higher _RARE_
values O
under O
active _RARE_
therapy O
. O

Volume _RARE_
of O
distribution O
of O
total _RARE_
DMDZ _RARE_
( O
range O
, O
1 O
. O
33 _RARE_
to O
6 O
. O
30 _RARE_
l _RARE_
/ O
kg O
) O
and O
of O
unbound _RARE_
DMDZ _RARE_
after O
correction O
for _RARE_
protein O
binding O
( O
range O
, O
43 _RARE_
to O
243 _RARE_
l _RARE_
/ O
kg O
) O
was O
larger O
in O
women O
than O
in O
men O
of O
all O
ages O
, O
and O
in O
the O
elderly O
as _RARE_
opposed O
to O
the O
young O
. O

Effects O
of O
dopamine O
and O
of O
a O
dopaminergic O
blocker O
, O
haloperidol O
, O
on O
the O
responses O
of O
carotid O
body O
chemoreceptors _RARE_
to O
hypoxia _RARE_
and O
hypercapnia O
were O
investigated O
in O
16 O
anesthetized O
cats O
. O

HLA I-GENE
- I-GENE
A I-GENE
and I-GENE
B I-GENE
phenotypes _RARE_
of O
105 _RARE_
patients O
suffering O
from O
malignant O
melanomas O
were O
determined O
, O
with O
special _RARE_
regard O
for _RARE_
metastatic O
form O
or O
relapse O
. O

Trypanosoma O
cruzi _RARE_
. O

The O
subjects O
of O
the O
study O
were O
10 O
normal O
subjects O
and O
64 _RARE_
patients O
with O
gastroduodenal _RARE_
disease _RARE_
. O

1 O
. O

This O
study O
represents O
the O
first _RARE_
published O
long O
- O
term O
follow O
- O
up _RARE_
regarding O
this O
mode O
of O
treatment O
in O
patients O
with O
alveolar O
hypoventilation _RARE_
. O

The O
alterations O
in O
differentiation O
of O
osteoprogenitor _RARE_
cells O
, O
together O
with O
the O
failure O
of O
mineralization _RARE_
, O
resulted O
in O
significantly O
lower O
rates O
of O
bone O
formation O
( O
as _RARE_
measured O
by O
fluorochrome _RARE_
labeling O
) O
in O
the O
magnesium O
- O
deficient _RARE_
rats O
. O

A O
convenient _RARE_
measure O
of O
this O
impairment O
may O
be O
obtained O
using O
the O
ratio O
of O
urine O
volume O
( O
V O
) O
divided O
by O
lithium O
clearance O
( O
CLi _RARE_
). O

Nitrogen _RARE_
balance O
was O
compared O
, O
and O
metabolic O
complications O
were O
monitored O
by O
evaluating O
BUN _RARE_
, O
serum O
creatinine _RARE_
, O
creatinine _RARE_
clearance O
, O
serum O
CO2 O
, O
SGOT _RARE_
, O
SGPT _RARE_
, O
serum I-GENE
LDH _RARE_
, O
and O
serum I-GENE
alkaline _RARE_
phosphatase I-GENE
. O

Production _RARE_
of O
C I-GENE
mu I-GENE
RNAs I-GENE
, O
unlike O
mu I-GENE
mRNAs I-GENE
, O
does O
not O
require O
recombination _RARE_
with O
the O
joining _RARE_
region I-GENE
( O
JH _RARE_
) O
locus O
. O

The O
1 O
. O
9 O
- O
kb O
C I-GENE
mu I-GENE
RNA O
contains O
the O
3 O
' O
sequence O
characteristic O
of O
secreted _RARE_
mu I-GENE
chain I-GENE
, O
whereas O
the O
longer O
species O
bear _RARE_
that O
of O
membrane O
- O
bound _RARE_
mu I-GENE
chin _RARE_
. O

Transcripts _RARE_
of O
the O
immunoglobulin I-GENE
C I-GENE
mu I-GENE
gene I-GENE
vary O
in O
structure _RARE_
and O
splicing _RARE_
during _RARE_
lymphoid _RARE_
development O
. O

Non O
- O
complement O
- O
dependent O
sperm O
- O
immobilizing _RARE_
activity O
was O
also O
detected O
in O
the O
cervical O
mucus O
of O
several O
patients O
. O

The O
role O
of O
DNA O
rearrangement O
and O
alternative _RARE_
RNA O
processing _RARE_
in O
the O
expression _RARE_
of O
immunoglobulin I-GENE
delta I-GENE
genes I-GENE
. O

Although O
the O
mechanism O
of O
action O
of O
ICRF _RARE_
- O
159 _RARE_
and O
187 _RARE_
has O
not O
been O
clearly O
defined O
, O
it O
is O
evident O
from O
both O
preclinical _RARE_
and O
early O
clinical O
studies O
that O
these O
compounds O
are O
of O
interest O
. O

All O
62 _RARE_
isolates O
were O
resistant O
to O
lincomycin _RARE_
, O
colistin _RARE_
, O
nystatin _RARE_
, O
amphotericin O
B O
, O
trimethoprim _RARE_
lactate _RARE_
, O
polymyxin _RARE_
B O
, O
and O
anisomycin _RARE_
. O

The O
evaluation O
of O
amniotic _RARE_
fluid _RARE_
delta O
OD450 _RARE_
is O
considered O
to O
be O
the O
cornerstone _RARE_
of O
clinical O
management O
. O

Host _RARE_
lipids O
in O
tuberculous O
infection O
. O

There O
is O
now O
a O
significative _RARE_
difference O
between O
age O
group O
1 O
- O
5 O
and O
the O
others O
( O
p O
Less _RARE_
Than _RARE_
0 _RARE_
, O
02 O
). O

The O
sympathetic O
neuroeffector _RARE_
influence O
on O
the O
myocardium O
with O
ATCI _RARE_
depends O
to O
a O
large O
measure O
on O
the O
intensity O
of O
the O
neurotransmitter _RARE_
biosynthesis O
and O
function O
of O
cardiomyocyte _RARE_
adrenoreceptors _RARE_
. O

Lens _RARE_
aldose _RARE_
reductase I-GENE
in O
diabetic O
and O
galactosemic _RARE_
cataracts _RARE_
. O

Fenfluramine _RARE_
( O
in O
doses O
ranging O
from O
0 _RARE_
. O
0625 _RARE_
- O
4 O
. O
0 _RARE_
mg O
/ O
kg O
/ O
infusion O
) O
did O
not O
maintain O
self O
- O
administration O
behavior O
at _RARE_
or O
above O
the O
minimum O
requirement O
( O
FR _RARE_
30 _RARE_
). O

In O
the O
course O
of O
Hepatitis _RARE_
A I-GENE
HBs I-GENE
- I-GENE
and I-GENE
HBe _RARE_
- I-GENE
antigen I-GENE
as _RARE_
well _RARE_
as _RARE_
HBc _RARE_
( I-GENE
IgM I-GENE
and I-GENE
IgG I-GENE
)-, _RARE_
HBs I-GENE
- I-GENE
and I-GENE
HBe _RARE_
- I-GENE
antibodies I-GENE
can O
be O
detected O
. O

The O
effect O
of O
the O
fatty I-GENE
acid I-GENE
cyclo _RARE_
- I-GENE
oxygenase I-GENE
inhibitor O
indomethacin O
on O
cerebral O
blood _RARE_
flow O
( O
CBF O
) O
and O
the O
metabolic O
rate O
for _RARE_
oxygen O
( O
CMRO2 _RARE_
) O
was O
studied O
in O
paralyzed _RARE_
and O
artificially O
ventilated O
rats O
. O

The O
rat O
incisor _RARE_
is O
an O
excellent O
model O
system _RARE_
in O
which O
to O
study O
amelgenesis _RARE_
. O

The O
already O
elevated O
prolactin I-GENE
levels O
in O
nursing O
women O
were O
not O
influenced O
by O
chronic O
oestradiol O
administration O
. O

Factor _RARE_
VIII I-GENE
procoagulant _RARE_
activity O
, O
antigen O
concentration O
and O
von _RARE_
Willebrand I-GENE
activity O
as _RARE_
ristocetin _RARE_
cofactor I-GENE
were O
determined O
several O
times O
in O
10 O
patients O
with O
DIC _RARE_
. O

Morphine _RARE_
- O
dependent O
and O
control O
rats O
in O
an O
oral O
free O
- O
choice O
protocol O
were O
treated O
with O
gamma O
- O
vinyl O
GABA _RARE_
( O
GVG _RARE_
), _RARE_
60 _RARE_
, O
120 O
and O
240 O
mg O
/ O
kg O
IP _RARE_
, O
for _RARE_
3 O
days O
over O
three O
successive O
periods O
. O

Significance O
of O
the O
pulmonary O
gas O
exchange O
reaction O
to O
physical O
loading O
in O
evaluating O
the O
effectiveness O
of O
mitral O
commissurotomy _RARE_

Thyreoliberin _RARE_
VUFB _RARE_
in O
thyroid O
gammagraphy _RARE_

In O
silicosis _RARE_
, O
significant O
relationships O
between O
patients O
and O
sons _RARE_
were O
not O
seen O
with O
respect O
to O
arterial O
blood _RARE_
gas O
determinations O
and O
ventilatory _RARE_
responses O
except O
for _RARE_
Paco2 _RARE_
of O
patients O
and O
hypercapnic _RARE_
ventilatory _RARE_
responses O
of O
sons _RARE_
. O

For O
steers O
the O
urinary _RARE_
N O
values O
were O
403 _RARE_
and O
295 _RARE_
mg O
/ O
kg O
W0 _RARE_
. O
75 _RARE_
at _RARE_
200 _RARE_
and O
350 O
kg O
live O
weight _RARE_
respectively O
and O
total _RARE_
N O
excretion O
including O
faecal _RARE_
N O
was O
408 _RARE_
and O
320 _RARE_
mg O
/ O
kg O
W0 _RARE_
. O
75 _RARE_
. O

Advances _RARE_
in O
hemophilia _RARE_
treatment O
: O
a O
hepatitis O
- O
safe O
factor I-GENE
VIII I-GENE
concentrate _RARE_

This O
study O
was O
designed O
to O
assess O
and O
compare O
the O
ability O
of O
three O
different O
forms O
of O
DSG _RARE_
to O
block _RARE_
EIB _RARE_
. O

Comparison O
of O
three O
different O
preparations O
of O
disodium _RARE_
cromoglycate _RARE_
in O
the O
prevention O
of O
exercise O
- O
induced _RARE_
bronchospasm _RARE_
: O
a O
double O
- O
blind O
study O
. O

LCBF _RARE_
in O
normal O
and O
hypoxic O
puppies _RARE_
was O
correlated O
with O
local O
cerebral O
glucose O
utilization O
( O
LCGU _RARE_
) O
obtained O
under O
the O
same O
experimental O
conditions O
( O
Duffy _RARE_
et O
al O
, O
1982 O
). O

Phagocytosis _RARE_
of O
tubercle _RARE_
bacilli O
by O
macrophages O
. O

Detection O
of O
hemophilia _RARE_
A O
carriers O
. O

The O
stability O
of O
isoniazid _RARE_
solutions O
increases O
markedly O
with O
increasing O
NTA _RARE_
or O
EDTA O
concentration O
up _RARE_
to O
1 O
mmol O
/ O
l _RARE_
. O

Bile _RARE_
bilirubin O
did O
not O
rise O
within O
12 O
h O
after O
haem _RARE_
infusion O
a O
finding O
which O
warrants _RARE_
further O
investigation O
. O

Autoimmune _RARE_
manipulation _RARE_
aids _RARE_
juvenile O
diabetes O
management O
. O

Other O
properties O
of O
Hg O
- O
and O
Cd O
- O
spores _RARE_
were O
similar O
to O
those O
of O
control O
spores _RARE_
. O

The O
decrease O
in O
HDL _RARE_
- I-GENE
cholesterol I-GENE
with O
increasing O
VLDL _RARE_
- I-GENE
triglycerides _RARE_
was O
relatively O
much O
larger O
than O
the O
concomitant O
decrease O
in O
apo _RARE_
A I-GENE
- I-GENE
I I-GENE
. O

Apo _RARE_
A I-GENE
- I-GENE
I I-GENE
level O
was O
unrelated O
to O
age O
, O
but O
increased O
with O
ethanol O
consumption O
and O
decreased O
with O
adiposity _RARE_
. O

TEMTU _RARE_
and O
DPTU _RARE_
were O
the O
most O
potent O
teratogens _RARE_
. O

The O
osmotic O
diuretic O
mannitol _RARE_
was O
administered O
to O
21 O
patients O
. O

Of O
270 O
patients O
with O
well _RARE_
- O
defined O
drug O
reactions O
, O
190 O
( O
70 O
per O
cent O
) O
gave O
a O
positive O
response O
to O
the O
mast _RARE_
cell O
test O
. O

Selenium _RARE_
, O
as _RARE_
a O
constituent _RARE_
of O
glutathione _RARE_
peroxidase I-GENE
, O
plays O
a O
role O
in O
the O
antioxidant O
defense O
systems _RARE_
of O
the O
body O
, O
but O
other O
metabolic O
roles O
for _RARE_
selenium O
may O
yet O
be O
discovered O
. O

Diagnostic O
value O
of O
serum I-GENE
myoglobin I-GENE
in O
cases O
of O
neuromuscular O
disease _RARE_

At O
43 _RARE_
% O
blood _RARE_
pressure O
reduction O
, O
PCO2 O
fell O
by O
0 _RARE_
. O
53 O
kPa _RARE_
, O
a O
decrease O
which O
could O
not O
explain O
the O
observed O
CBF O
fall O
of O
27 _RARE_
%. O

During O
the O
last O
6 O
months O
of O
the O
study O
a O
striking O
change O
in O
epidemiology _RARE_
concerning O
hepatitis O
A O
was O
seen O
, O
apparently O
caused O
by O
a O
steep _RARE_
increase O
in O
the O
incidence O
of O
this O
type O
of O
hepatitis O
among O
drug O
addicts O
. O

Asthmatic _RARE_
patients O
showed O
greater O
responses O
of O
both O
parameters O
to O
adrenaline O
than O
controls O
indicating O
that O
long O
- O
term O
corticosteroid _RARE_
treatment O
enhances O
the O
acute O
responses O
of O
plasminogen I-GENE
activator I-GENE
and O
clotting _RARE_
factor I-GENE
VIII I-GENE
to O
adrenaline O
infusion O
. O

Sulphur _RARE_
amino O
acids _RARE_
( O
g O
/ O
16 O
g O
N O
) O
were O
higher _RARE_
in O
the O
isolates O
than O
in O
the O
flours _RARE_
. O

Time _RARE_
shifts O
increase O
growth I-GENE
hormone I-GENE
release O
. O

It O
then O
merged _RARE_
with O
right O
ventricular O
wavefronts _RARE_
ending _RARE_
along O
the O
right O
ventricular O
anterior O
atrioventricular _RARE_
groove _RARE_
and O
outflow O
tract _RARE_
. O

Many O
of O
these O
landfill _RARE_
operations _RARE_
were O
undertaken O
in O
the O
early O
1950s _RARE_
and O
1960s _RARE_
, O
when O
knowledge O
regarding O
the O
safe O
and O
prolonged O
containment _RARE_
of O
the O
waste _RARE_
buried _RARE_
was O
nonexistent _RARE_
or O
minimal O
at _RARE_
best O
. O

Vesicles _RARE_
could O
be O
induced _RARE_
only O
with O
multiple O
exposures O
to O
UVA _RARE_
. O

The O
level O
of O
contamination O
in O
the O
wound O
can O
be O
determined O
with O
the O
rapid O
biopsy O
fixation O
technique O
. O

Self _RARE_
- O
heating _RARE_
after O
deep O
hypothermia O
( O
20 O
degrees O
C O
) O
causes O
a O
considerable O
increase O
in O
the O
brain O
tissues O
glutaminase _RARE_
activity O
at _RARE_
all O
studied O
incubation O
temperatures O
( O
37 O
, O
30 _RARE_
, O
20 O
and O
10 O
degrees O
C O
) O
as _RARE_
compared O
to O
control O
rats O
and O
rats O
under O
hypothermia O
. O

Similar O
observations O
were O
made O
with O
unilateral O
pneumothorax _RARE_
of O
15 _RARE_
cmH2O O
for _RARE_
30 _RARE_
min O
. O

According O
to O
Sugiura _RARE_
' O
s O
classification O
, O
they O
consisted O
of O
Type _RARE_
Ia _RARE_
in O
63 _RARE_
%, O
Type _RARE_
Ib _RARE_
in O
11 O
%, O
Type _RARE_
II O
in O
11 O
%, O
and O
Type _RARE_
III O
in O
16 O
%. O

This O
study O
was O
undertaken O
to O
define O
the O
mechanism O
for _RARE_
the O
respiratory O
inhibition O
observed O
during _RARE_
high O
- O
frequency O
oscillatory _RARE_
ventilation O
( O
HFOV _RARE_
). O

Determination O
of O
20 O
alpha O
- O
hydroxy O
- O
9 O
beta O
, O
10 O
alpha O
- O
pregna _RARE_
- O
4 O
, O
6 O
- O
dien _RARE_
- O
3 O
- O
one O
in O
plasma O
by O
selected _RARE_
ion O
monitoring O
. O

A O
case O
of O
a O
dense _RARE_
epidermoid _RARE_
cyst O
of O
the O
suprasellar _RARE_
cistern _RARE_
is O
presented O
. O

Copper _RARE_
treatments O
were O
assigned O
to O
simulate _RARE_
the O
different O
levels O
of O
copper _RARE_
intake O
that O
might O
result O
from O
differences O
in O
daily O
feed O
intake O
similar O
to O
the O
practice O
followed O
with O
commercial O
industry _RARE_
. O

Fibromuscular _RARE_
intimal _RARE_
thickening _RARE_
was O
seen O
in O
the O
ascending O
and O
thoracic _RARE_
aorta O
of O
the O
swine O
fed O
62 _RARE_
, O
500 O
IU O
of O
vitamin O
D3 _RARE_
/ O
kg O
of O
diet O
for _RARE_
three O
months O
duration O
; O
and O
after O
3 O
months O
of O
vitamin O
D3 _RARE_
withdrawal O
, O
atherosclerotic _RARE_
lesions O
were O
found O
. O

Because O
of O
a O
rapid O
development O
of O
the O
connective _RARE_
tissue O
scars _RARE_
, O
however O
, O
at _RARE_
the O
place O
of O
the O
destroyed _RARE_
glandular _RARE_
parenchyma O
areas O
, O
there O
is O
no _RARE_
normalization _RARE_
of O
the O
organ O
' O
s O
structure _RARE_
and O
function O
by O
the O
42d _RARE_
day O
. O

Histological O
signs O
of O
the O
flare _RARE_
- O
up _RARE_
reaction O
were O
already O
present O
at _RARE_
6 O
hr O
after O
i O
. O
v O
. O
challenge O
and O
lasted _RARE_
for _RARE_
at _RARE_
least O
4 O
days O
. O

Significant O
GMBF _RARE_
reductions O
occurred O
in O
early O
shock O
in O
both O
treatment O
groups O
. O

Of O
254 _RARE_
children O
with O
neuroblastoma O
treated O
at _RARE_
St _RARE_
. O

Penicillin _RARE_
- O
G O
degradation _RARE_
products O
inhibit O
in O
vitro O
granulopoiesis _RARE_
. O

Plasma O
fibrinogen I-GENE
was O
measured O
by O
the O
turbidimetric _RARE_
method O
in O
timol _RARE_
turbidimetric _RARE_
units _RARE_
. O

Five O
patients O
with O
type O
III O
musculoskeletal _RARE_
infection O
from O
nongonococcal _RARE_
Neisseria _RARE_
species O
were O
examined O
during _RARE_
a O
13 _RARE_
- O
month O
period O
. O

Distal _RARE_
tubular O
acidification O
and O
the O
threshold O
for _RARE_
proximal O
tubular O
bicarbonate _RARE_
reabsorption _RARE_
were O
normal O
, O
as _RARE_
was O
urine O
concentrating _RARE_
capacity O
. O

Detection O
of O
exercise O
- O
induced _RARE_
asynergy _RARE_
by O
M O
- O
mode O
echocardiography O
. O

The O
Tullio _RARE_
phenomenon O
, O
fistula _RARE_
test O
, O
and O
Hennebert _RARE_
' O
s O
sign O
: O
clinical O
significance O
. O

These O
results O
indicate O
that O
significant O
pulmonary O
metabolism O
of O
5 O
- O
HT _RARE_
followed O
by O
efflux _RARE_
of O
5 O
- O
HIAA _RARE_
into O
venous O
output O
occurs O
during _RARE_
single O
- O
pass _RARE_
circulation O
. O

Disturbances _RARE_
of O
placental _RARE_
maturation _RARE_
, O
2 O
. O

On O
the O
basis O
of O
histopathological O
findings O
, O
the O
origin O
of O
amyloid _RARE_
appeared O
to O
be O
closely O
related O
to O
the O
fibroblasts _RARE_
. O

Both O
groups O
were O
subjected O
to O
tests O
of O
delayed O
hypersensitivity O
with O
Candidin _RARE_
, O
Trycophytin _RARE_
and O
Tuberculin _RARE_
. O

Serum O
lactate _RARE_
dehydrogenase I-GENE
and O
haptoglobin _RARE_
levels O
were O
normal O
, O
and O
total _RARE_
bilirubin O
was O
only O
slightly O
elevated O
. O

Low O
- O
dose O
D O
( O
0 _RARE_
. O
4 O
- O
0 _RARE_
. O
8 O
mg O
) O
and O
DB _RARE_
( O
1 O
. O
0 _RARE_
- O
5 O
. O
0 _RARE_
mg O
) O
did O
not O
significantly O
alter O
any O
parameter O
from O
control O
. O

Efficacy _RARE_
of O
cervical O
spine O
immobilization _RARE_
methods O
. O

Leads _RARE_
from O
the O
MMWR _RARE_
. O

The O
presence O
of O
visna _RARE_
- O
maedi _RARE_
in O
Italy _RARE_
is O
reported O
for _RARE_
the O
first _RARE_
time O
. O

High _RARE_
levels O
of O
IC _RARE_
coincided _RARE_
with O
relative O
hypocomplementemia _RARE_
. O

Circulating _RARE_
platelets O
may O
be O
activated O
by O
exposed O
triple _RARE_
- O
helical O
collagen _RARE_
in O
atherosclerotic _RARE_
lesions O
in O
Mg _RARE_
- O
deficient _RARE_
ruminants _RARE_
. O

Acute O
type O
A O
hepatitis O
in O
three O
patients O
with O
chronic O
HBV _RARE_
infection O
. O

Pathogenetic _RARE_
relationships O
between O
renal _RARE_
tubular O
acidosis O
and O
sodium _RARE_
metabolism O
alterations O
in O
liver O
cirrhosis O
. O

5 O
microU _RARE_
/ O
l _RARE_
thyrotropin I-GENE
: O
75 _RARE_
% O
( O
1974 _RARE_
), _RARE_
45 _RARE_
% O
( O
1977 _RARE_
) O
and O
20 O
% O
( O
1980 O
). O

Echosismography _RARE_
enables O
to O
improve O
the O
diagnosis O
when O
compared O
with O
classical O
sonography _RARE_
in O
about O
20 O
% O
of O
cases O
. O

Relationships _RARE_
with O
the O
acquired O
immune O
deficiency O
syndrome _RARE_
. O

The O
prevalence O
of O
CPAF _RARE_
was O
similar O
in O
type O
1 O
and O
type O
2 O
diabetes O
, O
was O
greater O
in O
women O
than O
in O
men O
, O
and O
was O
significantly O
greater O
after O
repeated _RARE_
administrations _RARE_
than O
after O
one O
single O
administration O
of O
chlorpropamide _RARE_
. O

A O
reassessment _RARE_
of O
the O
prevalence O
data O
was O
carried O
out O
in O
the O
southern O
province _RARE_
of O
Uusimaa _RARE_
and O
in O
the O
western _RARE_
province _RARE_
of O
Vaasa _RARE_
, O
the O
prevalence O
day O
being O
January O
1 O
, O
1979 _RARE_
. O

The O
results O
confirm O
and O
extend O
previous O
work O
by O
other O
researchers _RARE_
. O

In O
the O
ultramarathon _RARE_
runner _RARE_
the O
testosterone O
levels O
sharply O
rose O
at _RARE_
the O
beginning O
of O
the O
training O
session O
( O
from O
the O
7 O
, O
20 O
ng _RARE_
/ O
ml O
to O
11 O
, O
50 O
ng _RARE_
/ O
ml O
after O
20 O
' O
training O
), _RARE_
and O
subsequently O
decrease O
after O
3 O
hours O
( O
9 O
, O
20 O
ng _RARE_
/ O
ml O
) O
and O
at _RARE_
the O
end O
of O
the O
6 O
hours O
training O
( O
4 O
, O
60 _RARE_
ng _RARE_
/ O
ml O
). O

In O
patients O
with O
complete _RARE_
or O
partial O
remission O
of O
the O
tumor O
, O
the O
neopterine _RARE_
excretion O
dropped _RARE_
to O
normal O
values O
. O

In O
visible _RARE_
tumours O
the O
best O
results O
were O
obtained O
with O
FB O
( O
85 _RARE_
%) O
while O
TBN _RARE_
was O
positive O
in O
65 O
%. O

Total O
PGE _RARE_
levels O
in O
synovial O
fluid _RARE_
remained O
significantly O
depressed O
in O
the O
patient O
group O
for _RARE_
24 _RARE_
hours O
after O
the O
400 _RARE_
- O
mg O
test O
dose O
of O
tolmetin _RARE_
on O
day O
8 O
. O

Normal _RARE_
rates O
of O
weight _RARE_
gain O
were O
seen O
once O
absorbed O
energy O
intakes _RARE_
reached O
100 _RARE_
- O
110 _RARE_
% O
of O
requirements O
. O

Its O
vasodilatory _RARE_
, O
anti O
- O
vasopressor _RARE_
, O
and O
platelet O
stabilizing _RARE_
effects O
could O
be O
expected O
to O
counteract _RARE_
the O
placental _RARE_
ischemia O
, O
hypertension O
and O
excessive O
coagulation O
that O
are O
seen O
in O
pre O
- O
eclampsia _RARE_
. O

Behcet _RARE_
' O
s O
syndrome _RARE_

Survival _RARE_
of O
111 O
Indium _RARE_
- O
labelled O
autologous O
platelets O
was O
studied O
in O
2 O
patients O
after O
correction O
of O
platelet O
count O
and O
was O
still O
found O
shortened O
. O

The O
effect O
of O
emotional _RARE_
- O
painful _RARE_
stress O
( O
EPS _RARE_
) O
on O
myocardial _RARE_
extensibility _RARE_
and O
contractility O
was O
studied O
on O
an O
isolated O
rat O
atrium O
. O

Terbutaline _RARE_
; O
a O
beta2 _RARE_
- O
adrenergic O
agonist O
, O
and O
aminophyllin _RARE_
, O
a O
phosphodiesterase _RARE_
inhibitor O
, O
were O
given O
separately O
, O
or O
in O
combination O
, O
to O
rabbit _RARE_
fetuses _RARE_
on O
the O
28th _RARE_
day O
of O
gestation O
. O

When O
O2 _RARE_
therapy O
was O
controlled _RARE_
for _RARE_
, O
the O
association O
between O
RBT _RARE_
and O
RLF _RARE_
did O
not O
achieve O
statistical O
significance O
( O
P O
= O
. O
07 O
). O

This O
two O
- O
helix O
motif O
is O
thought O
to O
be O
involved O
in O
specific O
DNA O
sequence O
recognition O
by O
CAP _RARE_
. O

The O
hyperacute _RARE_
phase _RARE_
of O
posterolateral _RARE_
myocardial _RARE_
infarction O
. O

Statistics _RARE_
for _RARE_
nurse O
managers _RARE_
-- _RARE_
3 O
. O

The O
infection O
rate O
was O
five O
times O
greater O
in O
patients O
with O
Hickman _RARE_
catheters _RARE_
than O
in O
those O
with O
Broviac _RARE_
catheters _RARE_
( O
p O
= O
0 _RARE_
. O
01 O
). O

After O
a O
year O
of O
planning O
in O
the O
Laboratory O
Assistants _RARE_
' O
School _RARE_
in O
Stockholm _RARE_
: O
new O
education O
for _RARE_
laboratory O
assistants _RARE_
is O
now O
arranged O

The O
electrocardiogram O
. O

Setting _RARE_
takes _RARE_
place O
through O
complex O
formation O
of O
( O
NH4Mg _RARE_
PO4 _RARE_
. O
6H2O _RARE_
) O
n _RARE_
, O
excess O
reactants _RARE_
, O
and O
water O
. O

The O
Authors _RARE_
have O
proposed O
to O
develop O
this O
research O
employing O
a O
preparation O
containing O
exclusively O
a O
cortisonic _RARE_
, O
the O
desametazone _RARE_
, O
in O
order O
to O
evaluate O
the O
alterations O
of O
the O
dentinogenesis _RARE_
to O
be O
attributed O
to O
such O
component _RARE_
. O

Secretory _RARE_
IgA I-GENE
and O
serum I-GENE
immunoglobulins I-GENE
as _RARE_
indices O
of O
the O
local O
immunity _RARE_
of O
the O
intestinal _RARE_
mucosa O
in O
acute O
leukemias O

Serum I-GENE
IgE I-GENE
levels O
in O
Tauranga _RARE_
children O
. O

Use O
of O
prostaglandin _RARE_
F2 O
alpha O
( O
PGF2 O
alpha O
) O
in O
cattle O
breeding _RARE_
. O

Thus O
it O
appears O
that O
the O
management O
of O
blood _RARE_
, O
including O
washing _RARE_
is O
of O
great O
importance O
. O

Range _RARE_
, O
variations O
and O
neoplastic O
potential _RARE_
. O

The O
scores O
are O
dependent O
in O
part O
on O
the O
reliability O
of O
faculty _RARE_
evaluations _RARE_
. O

Study O
on O
distribution O
of O
metal O
in O
the O
teeth O
treated O
by O
iontophoresis _RARE_
with O
transparent _RARE_
specimens O

Whereas O
creatine _RARE_
kinase I-GENE
activity O
declined O
exponentially _RARE_
from O
a O
single O
peak O
, O
myoglobin I-GENE
appeared O
in O
multiple O
episodes O
inadequately _RARE_
represented O
by O
a O
single O
peak O
value O
and O
having O
no _RARE_
clear O
clinical O
correlation O
. O

Utero _RARE_
- O
placental _RARE_
blood _RARE_
flow O
and O
the O
effect O
of O
beta I-GENE
2 I-GENE
- I-GENE
adrenoceptor I-GENE
stimulating O
drugs O
. O

Development _RARE_
of O
basophilic _RARE_
leukemia O
with O
trisomy _RARE_
8 O
and O
atypical O
erythroblastosis _RARE_
in O
a O
patient O
with O
a O
history O
of O
aplastic _RARE_
anemia _RARE_
22 _RARE_
years O
earlier O

The O
arginyl _RARE_
peptide O
bonds O
that O
are O
cleaved O
in O
the O
conversion O
of O
human I-GENE
factor I-GENE
IX _RARE_
to O
factor I-GENE
IXa _RARE_
by O
factor I-GENE
XIa _RARE_
were O
identified O
as _RARE_
Arg145 _RARE_
- O
Ala146 _RARE_
and O
Arg180 _RARE_
- O
Val181 _RARE_
. O

Alveolar _RARE_
growth O
, O
contemporary _RARE_
with O
dental O
eruption _RARE_
, O
is O
sufficient O
to O
compensate _RARE_
possible O
hypotrophy _RARE_
of O
maxillary _RARE_
bone O
bases O
. O

Fluorometric _RARE_
methods O
can O
also O
provide O
information _RARE_
about O
porphyrin O
binding O
sites O
that O
is O
useful O
in O
understanding O
porphyrin O
transport _RARE_
and O
clearance O
. O

Renal O
and O
extrarenal _RARE_
arterial O
fibromuscular _RARE_
hyperplasia O
with O
hypertension O
. O

The O
monoexponential _RARE_
rate O
of O
clearance O
of O
tracer O
-- _RARE_
obtained O
from O
the O
portion O
of O
the O
residue _RARE_
- O
detection O
curve O
reflecting O
metabolism O
of O
fatty O
acid O
incorporated O
into O
neutral O
lipids O
-- _RARE_
correlated O
directly O
with O
induced _RARE_
changes O
in O
tension O
- O
time O
index O
after O
injections O
into O
the O
left _RARE_
atrium O
( O
r _RARE_
= O
0 _RARE_
. O
96 O
, O
n _RARE_
= O
12 O
), _RARE_
right O
atrium O
( O
r _RARE_
= O
0 _RARE_
. O
86 _RARE_
, O
n _RARE_
= O
14 O
), _RARE_
and O
ear O
vein _RARE_
( O
r _RARE_
= O
0 _RARE_
. O
93 O
, O
n _RARE_
= O
14 O
). O

Both O
examinations O
are O
sensitive _RARE_
indicators O
of O
CNS O
abnormalities O
associated O
with O
bacterial O
meningeal _RARE_
infections O
and O
are O
important O
determinants _RARE_
of O
the O
therapy O
and O
ultimate _RARE_
prognosis O
of O
such O
complications O
. O

Specific O
IgE I-GENE
levels O
decreased O
slightly O
, O
but O
always O
remained O
within O
the O
pathological O
range O
. O

Similar O
clinical O
evaluation O
of O
an O
obligate _RARE_
carrier O
revealed O
no _RARE_
ocular O
abnormalities O
. O

Correlation _RARE_
between O
intraocular _RARE_
involvement O
and O
systemic O
outcome O
was O
poor O
. O

A O
case O
of O
anterior O
cleavage _RARE_
syndrome _RARE_
in O
a O
27 _RARE_
- O
year O
- O
old O
female O
patient O
is O
described O
. O

The O
daily O
administration O
of O
betamethasone _RARE_
for _RARE_
three O
weeks O
markedly O
reduced _RARE_
the O
absorption O
of O
calcium _RARE_
and O
phosphate O
as _RARE_
well _RARE_
as _RARE_
the O
growth O
rate O
. O

Endorphins _RARE_
and O
legal _RARE_
issues O
. O

At O
necropsy _RARE_
28 _RARE_
days O
post O
- O
inoculation _RARE_
, O
F344 _RARE_
rats O
had O
no _RARE_
gross O
lung _RARE_
lesions O
, O
even O
those O
given O
the O
maximum O
dose O
of O
1 O
. O
4 O
X O
10 O
( O
9 O
) O
colony O
- O
forming O
units _RARE_
of O
M O
. O
pulmonis _RARE_
. O

Aneurysmectomy _RARE_
and O
the O
performance O
of O
CABG _RARE_
were O
not O
significantly O
associated O
with O
postoperative O
ECG O
changes O
, O
but O
more O
bypass O
grafts O
per O
patient O
grafted _RARE_
appeared O
in O
the O
group O
with O
postoperative O
ECG O
changes O
, O
suggesting O
that O
coronary O
artery O
disease _RARE_
may O
be O
more O
severe O
in O
that O
group O
. O

REV _RARE_
I O
: O
All O
vessels O
up _RARE_
to O
50 O
% O
stenosed _RARE_
have O
a O
patent _RARE_
graft O
. O

Complete _RARE_
sequences O
were O
obtained O
for _RARE_
the O
three O
large O
thrombic _RARE_
peptides O
, O
and O
these O
were O
aligned _RARE_
by O
using O
peptides O
from O
the O
V8 _RARE_
protease I-GENE
digest _RARE_
. O

The O
extraction O
measurements O
were O
used O
to O
test O
for _RARE_
extracerebral _RARE_
contamination O
of O
venous O
outflow O
. O

Contractile _RARE_
responses O
to O
norepinephrine O
, O
serotonin _RARE_
and O
potassium _RARE_
( O
K O
+) O
and O
relaxant _RARE_
responses O
to O
isoproterenol O
and O
papaverine _RARE_
were O
studied O
in O
vitro O
with O
spirally _RARE_
cut O
thoracic _RARE_
aortic O
strips _RARE_
from O
aortic O
coarcted _RARE_
hypertensive O
rats O
( O
AHR _RARE_
) O
2 O
, O
6 O
, O
14 O
and O
28 _RARE_
days O
postoperatively O
and O
compared O
to O
time O
- O
matched O
, O
sham O
- O
operated O
normotensive _RARE_
controls O
. O

On O
line O
calculation _RARE_
of O
steroid O
concentrations O
by O
radioimmunoassay O

Detection O
of O
congenital O
hypothyroidism O
in O
26 _RARE_
, O
282 _RARE_
newborn O
infants O

In O
rubella _RARE_
patients O
with O
serologic O
confirmation _RARE_
by O
HI _RARE_
, O
the O
IF O
test O
detected O
significant O
rises _RARE_
in O
219 _RARE_
( O
99 _RARE_
. O
1 O
%) O
of O
221 _RARE_
patients O
and O
the O
PHA _RARE_
test O
detected O
antibody O
conversion O
in O
68 _RARE_
( O
93 O
%) O
of O
73 _RARE_
patients O
. O

The O
results O
indicate O
that O
folate _RARE_
compounds O
decrease O
formate O
accumulation O
after O
methanol _RARE_
by O
stimulating O
formate O
oxidation O
or O
utilization O
and O
suggest O
a O
possible O
use O
for _RARE_
folates _RARE_
in O
the O
treatment O
of O
certain O
cases O
of O
human O
methanol _RARE_
poisoning O
. O

The O
effect O
of O
sodium _RARE_
saccharin O
in O
the O
diet O
on O
caecal _RARE_
microflora _RARE_
. O

The O
residue _RARE_
functions O
, O
R O
( O
t O
), _RARE_
for _RARE_
C O
- O
11 O
CPZ _RARE_
and O
In O
- O
113m _RARE_
transferrin I-GENE
were O
plotted _RARE_
against O
time O
for _RARE_
selected _RARE_
areas O
of O
interest O
, O
and O
the O
CPZ _RARE_
area O
- O
weighted O
extraction O
, O
E O
( O
t O
), _RARE_
was O
computed O
for _RARE_
the O
same O
areas O
every O
250 _RARE_
msec O
using O
the O
formula O
: O
E O
( O
t O
) O
= O
[ _RARE_
RT O
( O
t O
) O
- O
RR O
( O
t O
)]/[ _RARE_
1 O
- O
RR O
( O
t O
)], _RARE_
where O
RT O
and O
RR O
are O
the O
normalized O
residue _RARE_
functions O
for _RARE_
CPZ _RARE_
and O
transferrin I-GENE
, O
respectively O
. O

Synchronous _RARE_
extracts O
showed O
no _RARE_
significant O
migration O
inhibition O
in O
allogeneic _RARE_
assays O
. O

Ten O
days O
of O
cefadroxil _RARE_
therapy O
was O
used O
to O
treat O
44 _RARE_
children O
with O
urinary _RARE_
tract _RARE_
infection O
and O
CRP I-GENE
values O
greater O
than O
or O
equal O
to O
28 _RARE_
microgram O
/ O
ml O
( O
CRP I-GENE
- O
positive O
group O
). O

Both O
resting O
blood _RARE_
flow O
( O
RBF _RARE_
) O
and O
maximal O
blood _RARE_
flow O
( O
NBF _RARE_
) O
were O
studied O
by O
Xenon _RARE_
133 _RARE_
clearance O
. O

Plasma I-GENE
renin I-GENE
concentration O
is O
significantly O
higher _RARE_
in O
the O
subcapsular _RARE_
venous O
outflow O
, O
which O
drains _RARE_
the O
superficial O
cortex O
, O
than O
in O
the O
deep O
venous O
outflow O
, O
which O
drains _RARE_
the O
inner O
half _RARE_
of O
the O
cortex O
and O
medulla _RARE_
of O
the O
cat _RARE_
kidney _RARE_
. O

After O
acclimation _RARE_
, O
resting O
supine O
and O
sitting _RARE_
DPB _RARE_
decreased O
( O
P O
less O
than O
0 _RARE_
. O
05 O
) O
by O
6 O
and O
9 O
mmHg O
, O
respectively O
. O

In O
the O
diabetics _RARE_
, O
Ca2 _RARE_
+ O
infusions _RARE_
induced _RARE_
a O
rise O
of O
plasma O
Ca2 _RARE_
+ O
up _RARE_
to O
3 O
. O
2 O
+/- O
0 _RARE_
. O
1 O
mmol O
/ O
1 O
and O
a O
fall O
of O
circulating O
glucagon I-GENE
(- _RARE_
26 _RARE_
. O
4 O
+/- O
5 O
. O
7 O
%; O
p O
less O
than O
0 _RARE_
. O
001 O
) O
and O
glucose O
(- _RARE_
23 _RARE_
. O
3 O
+/- O
3 O
. O
6 O
%; O
p O
less O
than O
0 _RARE_
. O
05 O
). O

Fifty O
- O
eight O
RMI _RARE_
' O
s O
occurred O
in O
the O
placebo O
group O
as _RARE_
compared O
to O
only O
twenty _RARE_
in O
the O
AC _RARE_
group O
( O
p O
less O
than O
0 _RARE_
. O
01 O
). O

The O
" O
cracked _RARE_
- O
tooth O
" O
syndrome _RARE_
. O

The O
foregoing _RARE_
results O
show O
that O
CXD _RARE_
has O
high O
efficacy O
and O
safety O
and O
it O
can O
be O
said _RARE_
that O
it O
is O
a O
drug O
required O
in O
the O
pediatric O
field O
. O

Based O
on O
peptide O
map O
similarities O
, O
partial O
amino O
- O
terminal O
sequence O
data O
, O
and O
common O
genetic O
origin O
, O
it O
is O
suggested O
that O
p60 _RARE_
and O
p62 I-GENE
have O
identical O
amino O
acid O
sequences O
carboxy _RARE_
- O
terminal O
to O
the O
p60 _RARE_
initiator _RARE_
methionine O
( O
residue _RARE_
21 O
of O
p62 I-GENE
). O

All O
patients O
in O
the O
control O
group O
showed O
a O
significant O
improvement O
in O
their O
PEFR _RARE_
while O
only O
3 O
patients O
in O
the O
treated O
group O
showed O
an O
improvement O
. O

Facts _RARE_
on O
the O
Economic _RARE_
Recovery _RARE_
Tax _RARE_
Act _RARE_
of O
1981 _RARE_
for _RARE_
speech O
- O
language O
pathologists _RARE_
and O
audiologists _RARE_
. O

From O
Pap _RARE_
to O
ApUp _RARE_
. O

The O
relationship O
between O
the O
rare O
complications O
mentioned O
above O
and O
the O
pathophysiology O
of O
Bartter _RARE_
' O
s O
syndrome _RARE_
is O
still O
obscure _RARE_
. O

Using O
an O
opsonophagocytic _RARE_
bacterial O
assay O
and O
a O
suckling _RARE_
rat O
model O
of O
GBS _RARE_
sepsis O
, O
we O
analyzed O
a O
modified O
human I-GENE
immunoglobulin I-GENE
for _RARE_
opsonic _RARE_
and O
protective O
antibody O
. O

Glomerular _RARE_
lesions O
in O
renal _RARE_
allografts _RARE_
. O

Commonly _RARE_
observed O
systemic O
toxic O
effects O
( O
bone O
marrow O
, O
gastrointestinal _RARE_
tract _RARE_
, O
and O
heart _RARE_
) O
were O
not O
seen O
in O
this O
study O
. O

2 O
. O

When O
vascular O
pressure O
( O
Pvas _RARE_
) O
was O
raised O
abruptly _RARE_
from O
- O
5 O
to O
+ O
25 _RARE_
cmH2O O
by O
air O
inflation _RARE_
for _RARE_
60 _RARE_
min O
, O
Px _RARE_
( O
f _RARE_
) O
became O
abruptly _RARE_
less O
negative O
, O
then O
remained O
stable O
. O

( O
1980 O
): O
Science _RARE_
210 O
, O
77 O
- O
72 O
) O
that O
stimulating O
the O
crossed _RARE_
olivocochlear _RARE_
bundle O
( O
COCB _RARE_
) O
can O
change O
the O
magnitude O
of O
the O
distortion _RARE_
product O
( O
f2 _RARE_
- O
f1 _RARE_
) O
in O
the O
ear O
- O
canal _RARE_
sound O
pressure O
. O

Rats _RARE_
underwent O
either O
a O
90 _RARE_
- O
95 _RARE_
% O
JIB _RARE_
or O
a O
sham O
operation O
. O

When O
the O
l _RARE_
- O
methadone _RARE_
- O
sensitive _RARE_
, O
opioid _RARE_
receptor I-GENE
is O
blocked O
by O
naloxone O
or O
tolerance O
has O
developed O
, O
than O
l _RARE_
- O
methadone _RARE_
can O
produce O
behavioral O
effects O
by O
a O
nonopioid _RARE_
mechanism O
. O

Microwave _RARE_
hyperthermia _RARE_
- O
induced _RARE_
blood _RARE_
- O
brain O
barrier O
alterations O
. O

Large _RARE_
and O
small O
medullary _RARE_
lesions O
inhibited O
the O
occurrence O
of O
target O
fibres O
in O
the O
tenotomized _RARE_
muscles O
, O
the O
smallest O
one O
being O
neurolysis _RARE_
of O
the O
dorsal O
roots O
. O

Diagnosis O
of O
phenylalanine _RARE_
hydroxylase I-GENE
deficiency O
( O
phenylketonuria _RARE_
). O

In O
10 O
control O
sheep O
mean O
plasma O
TXB2 _RARE_
concentration O
increased O
from O
0 _RARE_
. O
39 _RARE_
ng _RARE_
/ O
ml O
prebypass _RARE_
to O
about O
1 O
. O
1 O
ng _RARE_
/ O
ml O
at _RARE_
8 O
and O
16 O
min O
of O
bypass O
. O

The O
respiratory O
rate O
was O
13 _RARE_
+/- O
1 O
breaths _RARE_
/ O
min O
with O
52 O
+/- O
4 O
% O
of O
the O
respiratory O
cycle _RARE_
spent _RARE_
in O
inspiration _RARE_
; O
end O
- O
tidal O
CO2 O
pressure O
increased O
by O
3 O
. O
3 O
+/- O
1 O
. O
0 _RARE_
Torr _RARE_
during _RARE_
runs _RARE_
at _RARE_
SIP _RARE_
. O

There O
was O
no _RARE_
further O
increase O
in O
oxygen O
consumption O
when O
these O
subjects O
breathed _RARE_
with O
inspiratory O
pressures O
above O
SIP _RARE_
. O

We O
compared O
the O
volume O
of O
the O
pulmonary O
extravascular _RARE_
, O
extracellular O
water O
space O
using O
sodium _RARE_
and O
sucrose O
indicators O
in O
8 O
normal O
and O
11 O
edematous _RARE_
rabbit _RARE_
lungs O
by O
steady O
- O
state O
techniques O
. O

Investigated _RARE_
the O
reliability O
, O
validity O
and O
dimensionality _RARE_
of O
scores O
obtained O
by O
acute O
psychiatric O
inpatients _RARE_
( O
N O
= O
120 O
) O
on O
the O
Michigan _RARE_
Alcoholism _RARE_
Screening _RARE_
Test O
adapted O
to O
assess O
lifetime _RARE_
and O
current O
symptomatology _RARE_
. O

A O
simple O
method O
for _RARE_
measuring O
urinary _RARE_
iron O
following O
the O
administration O
of O
desferrioxamine _RARE_
( O
DF _RARE_
) O
is O
described O
. O

During O
conventional O
hemofiltration _RARE_
using O
substitution O
fluid _RARE_
with O
a O
Na _RARE_
+ O
concentration O
of O
140 _RARE_
mEq O
/ O
L O
, O
a O
decrease O
in O
extracellular O
fluid _RARE_
volume O
was O
noted O
whereas O
the O
intracellular _RARE_
fluid _RARE_
volume O
was O
unaltered O
. O

The O
uncomplicated _RARE_
cases O
of O
typhoid _RARE_
fever O
were O
found O
to O
have O
an O
intact _RARE_
CMIR _RARE_
as _RARE_
compared O
to O
the O
complicated O
cases O
. O

Transvenous _RARE_
serial O
xeroradiography _RARE_
. O

Recommendations _RARE_
to O
deal _RARE_
with O
these O
and O
related O
issues O
are O
presented O
. O

Use O
of O
subcutaneous O
deferoxamine _RARE_
in O
a O
child O
with O
hemochromatosis _RARE_
associated O
with O
congenital O
dyserythropoietic _RARE_
anemia _RARE_
, O
type O
I O
. O

There O
was O
a O
significant O
correlation O
between O
tubular O
diameter O
and O
spg _RARE_
( O
r _RARE_
= O
0 _RARE_
. O
68 _RARE_
, O
P O
less O
than O
0 _RARE_
. O
001 O
) O
suggesting O
that O
tubular O
diameter O
measurements O
in O
histological O
sections O
could O
be O
used O
to O
predict O
sperm O
production O
. O

The O
differential O
investigation O
of O
lipoproteins _RARE_
, O
however O
, O
showed O
that O
the O
high I-GENE
- I-GENE
density I-GENE
lipoprotein I-GENE
( O
HDL _RARE_
) O
fractions O
are O
absolutely _RARE_
or O
relatively O
decreased O
with O
respect O
to O
low I-GENE
- I-GENE
density I-GENE
lipoproteins _RARE_
( O
LDL I-GENE
) O
in O
cerebral O
infarcts _RARE_
and O
in O
transient O
ischaemic O
attacks O
. O

Although O
noninhibitory _RARE_
fluid _RARE_
had O
higher _RARE_
mean O
concentrations O
of O
phosphorus O
and O
zinc O
, O
these O
differences O
did O
not O
hold _RARE_
after O
meconium _RARE_
- O
stained O
samples O
were O
excluded O
. O

Selenium _RARE_
status O
of O
thoroughbreds _RARE_
in O
the O
United O
Kingdom _RARE_
. O

During O
an O
8 O
- O
wk O
follow O
- O
up _RARE_
, O
parasites O
reappeared _RARE_
in O
10 O
patients O
, O
5 O
after O
each O
drug O
, O
between O
1 O
and O
7 O
wk O
after O
treatment O
. O

Preparation _RARE_
of O
a O
stable O
phospholipid _RARE_
reagent _RARE_
for _RARE_
coagulation O
assays O
. O

A O
note _RARE_
on O
some O
consequences O
of O
UV _RARE_
vision O
in O
birds O
. O

Before _RARE_
turnout _RARE_
, O
a O
morantel _RARE_
sustained O
release O
bolus O
( O
MSRB _RARE_
) O
was O
administered O
to O
each O
animal _RARE_
in O
the O
" O
treated O
" O
category O
. O

In O
a O
longitudinal O
study O
, O
14 O
low O
- O
risk O
fetuses _RARE_
were O
studied O
at _RARE_
2 O
- O
week O
intervals O
from O
32 _RARE_
weeks O
of O
gestation O
onward _RARE_
. O

Further O
, O
intracerebroventricular _RARE_
injections O
of O
KA _RARE_
resulted O
in O
the O
substantial O
loss _RARE_
of O
pyramidal O
cells O
in O
the O
whole O
CA3 O
field O
of O
the O
hippocampus O
. O

Seventeen _RARE_
of O
the O
35 _RARE_
patients O
were O
randomly O
chosen O
to O
receive O
a O
training O
program O
( O
lasting O
approximately _RARE_
1 O
month O
) O
designed O
to O
establish O
a O
systematic O
strategy O
of O
organizing _RARE_
complex O
visual O
material O
. O

The O
duration O
and O
the O
amplitude O
of O
the O
negative O
potential _RARE_
were O
greatest O
for _RARE_
completely O
regenerating _RARE_
ears O
with O
overgrowth _RARE_
, O
smaller O
for _RARE_
partially O
regenerating _RARE_
ears O
, O
and O
smallest O
for _RARE_
the O
nonregenerating _RARE_
ears O
. O

Samples _RARE_
obtained O
from O
normal O
volunteers O
and O
from O
the O
great O
majority O
of O
the O
patients O
, O
excluding O
those O
with O
asthma O
, O
had O
no _RARE_
effect O
on O
ciliary _RARE_
beating _RARE_
. O

These O
results O
suggested O
the O
possibility O
that O
the O
fetus O
played O
some O
role O
in O
the O
production O
of O
E3 _RARE_
- O
16 O
- O
G O
in O
early O
pregnancy _RARE_
. O

In O
this O
way O
it O
is O
possible O
to O
simulate _RARE_
the O
growth O
function O
of O
the O
embryofetal _RARE_
curve O
of O
the O
length O
' O
increase O
of O
man O
and O
the O
curve O
of O
the O
mass O
' O
increase O
of O
rat O
. O

The O
highest O
doses O
were O
found O
for _RARE_
drivers _RARE_
who O
transported O
large O
numbers O
of O
99Mo _RARE_
generators _RARE_
. O

The O
steepness _RARE_
of O
the O
standard O
O2 _RARE_
dissociation O
curve O
becomes O
greater O
during _RARE_
the O
training O
period O
( O
increase O
in O
Hill _RARE_
' O
s O
n _RARE_
from O
2 O
. O
68 _RARE_
+/- O
0 _RARE_
. O
10 O
to O
2 O
. O
96 O
+/- O
0 _RARE_
. O
15 _RARE_
). O

Conjugated _RARE_
and O
unconjugated _RARE_
phenylacetic _RARE_
acid O
and O
m O
- O
and O
p O
- O
hydroxyphenylacetic _RARE_
acid O
have O
been O
determined O
in O
the O
plasma O
of O
normal O
, O
healthy O
subjects O
after O
fasting O
, O
consumption O
of O
a O
meal _RARE_
and O
ingestion O
of O
deuterium _RARE_
labelled O
amine _RARE_
precursors _RARE_
, O
by O
high O
- O
resolution O
gas O
chromatography O
-- _RARE_
high O
resolution O
mass O
spectrometry O
with O
selected _RARE_
ion O
monitoring O
of O
their O
trifluoroethyl _RARE_
- O
pentafluoropropionyl _RARE_
derivatives _RARE_
. O

In O
concept O
II O
62 _RARE_
patients O
were O
treated O
with O
selective O
vagotomy O
and O
pyloroplasty _RARE_
. O

They O
consisted O
of O
behavioural _RARE_
disorders O
, O
tetraparesis _RARE_
, O
incontinence _RARE_
and O
oculomotor _RARE_
paralysis _RARE_
. O

CSF O
adenosine I-GENE
deaminase _RARE_
activity O
( O
ADA _RARE_
) O
was O
measured O
at _RARE_
the O
same O
time O
. O

Histamine _RARE_
reactivity O
had O
returned O
to O
normal O
in O
half _RARE_
the O
workers O
who O
had O
left _RARE_
their O
original O
factories _RARE_
, O
but O
in O
only O
one O
worker _RARE_
who O
had O
moved _RARE_
within O
her _RARE_
original O
factory _RARE_
. O

It O
was O
also O
found O
that O
there O
is O
no _RARE_
significant O
difference O
between O
the O
prevalence O
of O
nasal O
carriage _RARE_
of O
S O
. O
aureus _RARE_
amongst _RARE_
the O
hospital O
staff _RARE_
and O
the O
patients O
. O

Ficat _RARE_
and O
Bizou _RARE_
' O
s O
condylar _RARE_
depth O
index O
and O
the O
condylar _RARE_
- O
joint O
surface O
angle O
of O
Brattstrom _RARE_
are O
recommended O
as _RARE_
especially O
suitable O
methods O
of O
measurement O
. O

There O
were O
no _RARE_
significant O
differences O
in O
EF _RARE_
between O
the O
two O
studies O
, O
both O
at _RARE_
rest O
( O
56 _RARE_
. O
0 _RARE_
+/- O
13 _RARE_
. O
8 O
% O
vs _RARE_
58 O
. O
2 O
+/- O
11 O
. O
7 O
%, O
p O
= O
NS _RARE_
) O
and O
with O
exercise O
( O
51 _RARE_
. O
1 O
+/- O
17 _RARE_
. O
6 O
% O
vs _RARE_
54 O
. O
3 O
+/- O
17 _RARE_
. O
6 O
%, O
p O
= O
NS _RARE_
) O
and O
a O
highly O
significant O
correlation O
was O
shown O
between O
the O
two O
groups O
of O
values O
( O
rest O
r _RARE_
= O
0 _RARE_
. O
90 _RARE_
, O
exercise O
r _RARE_
= O
0 _RARE_
. O
93 O
, O
p O
less O
than O
0 _RARE_
. O
001 O
). O

After O
MOPP _RARE_
therapy O
, O
complete _RARE_
remission O
of O
Hodgkin O
' O
s O
disease _RARE_
was O
accompanied O
by O
normalization _RARE_
of O
the O
glucocerebrosidase _RARE_
level O
and O
disappearance O
of O
Gaucher _RARE_
' O
s O
cells O
. O

Specifically O
, O
by O
the O
type O
of O
adjuvant O
therapy O
, O
the O
median O
disease _RARE_
- O
free O
interval O
and O
survival O
from O
stage _RARE_
IVA _RARE_
for _RARE_
23 _RARE_
patients O
receiving O
Corynebacterium _RARE_
parvum _RARE_
were O
6 O
. O
9 O
and O
19 O
months O
; O
for _RARE_
39 _RARE_
patients O
receiving O
BCG O
, O
eight O
months O
and O
26 _RARE_
months O
; O
for _RARE_
24 _RARE_
patients O
receiving O
BCG O
+ O
DTIC _RARE_
, O
eight O
and O
17 _RARE_
. O
4 O
months O
; O
and O
for _RARE_
all O
51 _RARE_
DTIC _RARE_
treated O
patients O
6 O
. O
3 O
and O
17 _RARE_
. O
8 O
months O
, O
respectively O
. O

The O
COP _RARE_
- O
PAWP _RARE_
gradient O
was O
markedly O
decreased O
in O
both O
shock O
and O
non O
- O
shock O
patients O
with O
pulmonary O
edema O
. O

Re O
: O
A O
modified O
method O
for _RARE_
the O
in O
vivo O
labeling O
of O
red _RARE_
blood _RARE_
cells O
with O
Tc O
- O
99m O
. O

A O
limited O
study O
in O
a O
glassware _RARE_
factory _RARE_
( O
As2O3 _RARE_
exposure O
) O
involving O
the O
measurement O
of O
total _RARE_
airborne _RARE_
arsenic _RARE_
, O
the O
determination O
of O
urinary _RARE_
arsenic _RARE_
, O
and O
the O
evaluation O
of O
hand _RARE_
and O
mouth O
contamination O
by O
arsenic _RARE_
before O
and O
after O
the O
workshift _RARE_
suggests O
that O
the O
high O
urinary _RARE_
arsenic _RARE_
levels O
( O
300 _RARE_
microgram O
/ O
g O
creatinine _RARE_
) O
are O
likely O
to O
be O
more O
related O
to O
an O
increased O
oral O
intake O
from O
contaminated O
hands _RARE_
than O
to O
an O
increased O
absorption O
from O
the O
lungs O
. O

Parasitological _RARE_
and O
pathological O
findings O
in O
capuchin _RARE_
monkeys O
infected _RARE_
with O
Schistosoma _RARE_
japonicum _RARE_
or O
Schistosoma _RARE_
mansoni _RARE_
. O

The O
pia _RARE_
mater _RARE_
at _RARE_
the O
site O
of O
the O
entry O
of O
blood _RARE_
vessels O
into O
the O
central O
nervous O
system _RARE_
. O

Experimental O
reproduction _RARE_
of O
malignant O
catarrhal _RARE_
fever O
in O
Bali _RARE_
cattle O

1 O
A O
colonic _RARE_
delivery O
system _RARE_
is O
described O
to O
deliver _RARE_
orally O
ingested _RARE_
drugs O
to O
the O
colon O
and O
release O
them O
at _RARE_
that O
site O
by O
coating _RARE_
with O
an O
acrylic _RARE_
based O
resin O
( O
Eudragit _RARE_
S O
). O

Administration O
of O
the O
dopamine O
agonist O
bromocriptine _RARE_
( O
2 O
. O
5 O
mg O
three O
times O
a O
day O
for _RARE_
4 O
days O
) O
suppressed O
( O
P O
less O
than O
0 _RARE_
. O
01 O
) O
mean O
24 _RARE_
- O
h O
plasma O
18 O
- O
OHB _RARE_
levels O
from O
21 O
. O
9 O
+/- O
2 O
. O
0 _RARE_
to O
14 O
. O
8 O
+/- O
1 O
. O
4 O
ng _RARE_
/ O
dl O
. O

Restarting _RARE_
time O
was O
not O
affected O
by O
magnesium O
cardioplegia _RARE_
. O

The O
most O
common O
types _RARE_
of O
malformations O
were O
eye O
defects O
and O
open _RARE_
coeloms _RARE_
. O

Repair _RARE_
of O
a O
cosmetic _RARE_
defect O
of O
the O
lower O
leg O
with O
a O
myocutaneous _RARE_
free O
flap O
. O

According O
to O
the O
literature O
, O
second O
malignant O
epithelial _RARE_
tumours O
are O
, O
in O
contrast O
to O
mesenchymal O
tumours O
such O
as _RARE_
osteosarcoma O
, O
very O
rare O
in O
retinoblastoma _RARE_
survivors _RARE_
. O

In O
Malmo _RARE_
, O
Sweden _RARE_
, O
17 _RARE_
, O
181 _RARE_
school _RARE_
children O
born O
in O
the O
years O
1961 _RARE_
- O
1965 _RARE_
were O
screened O
for _RARE_
scoliosis _RARE_
once O
a O
year O
between O
the O
ages O
of O
7 O
and O
16 O
years O
, O
during _RARE_
1971 _RARE_
- O
1980 O
. O

In O
the O
past O
, O
immunology _RARE_
in O
Singapore _RARE_
was O
mainly O
confined O
to O
serology _RARE_
for _RARE_
the O
diagnosis O
of O
certain O
infectious O
diseases O
. O

Intra _RARE_
- O
articular _RARE_
dislocation O
of O
the O
patella _RARE_
. O

This O
study O
demonstrates O
secretion _RARE_
of O
bicarbonate _RARE_
by O
the O
human O
stomach O
in O
vivo O
at _RARE_
a O
rate O
equivalent O
to O
10 O
-- _RARE_
20 O
% O
of O
basal O
acid O
secretion _RARE_
. O

Histological O
evaluation O
revealed O
a O
more O
than O
twofold O
increase O
in O
the O
number O
of O
interepithelial _RARE_
mononuclear O
cells O
( O
p O
less O
than O
0 _RARE_
. O
005 O
), _RARE_
while O
the O
number O
of O
epithelial _RARE_
cells O
/ O
100 _RARE_
microns O
of O
villous _RARE_
mucosa O
and O
the O
mean O
height O
of O
the O
epithelial _RARE_
cells O
were O
comparable O
in O
both O
groups O
. O

Cramps _RARE_
in O
extrapyramidal _RARE_
disorders O
. O

A O
suspected O
new O
storage _RARE_
disease _RARE_
in O
cattle O
. O

For O
various O
dog O
vessels O
in O
vivo O
, O
Q _RARE_
/ O
Dk _RARE_
ranged O
from O
0 _RARE_
. O
15 _RARE_
to O
47 _RARE_
X O
10 O
( O
5 O
) O
Torr _RARE_
/ O
cm2 O
. O

The O
tetraphasic _RARE_
action O
of O
lidocaine O
on O
CNS O
electrical O
activity O
and O
behavior O
in O
cats O
. O

Modification _RARE_
of O
enteral _RARE_
resorption O
by O
cytostatic _RARE_
therapy O

Asymptomatic _RARE_
bacteriospermia _RARE_
and O
fertility O

Triumph _RARE_
of O
Leninist _RARE_
national O
policy _RARE_

The O
favourable O
effect O
of O
thymic _RARE_
shielding _RARE_
was O
also O
reflected O
in O
a O
significant O
increase O
of O
LD50 O
/ O
30 _RARE_
, O
and O
the O
dose O
reduction O
factor O
was O
equal O
to O
2 O
. O

The O
application O
of O
ultrafiltration _RARE_
to O
sample O
preparation O
in O
the O
detection O
and O
quantification _RARE_
of O
ethylene O
glycol O
in O
plasma O
by O
gas O
chromatography O
is O
described O
. O

Mastocytosis _RARE_
. O

A O
new O
Onchocerca _RARE_
species O
, O
a O
parasite O
of O
domestic _RARE_
cattle O
, O
in O
Senegal _RARE_

It O
was O
suggested O
that O
the O
absence O
of O
pronounced O
differences O
between O
conditions O
may O
have O
been O
due O
to O
the O
complexity O
of O
the O
task O
or O
the O
type O
of O
prompts _RARE_
employed O
. O

A O
limiting O
factor O
were O
disturbances O
in O
the O
system _RARE_
of O
energy O
transport _RARE_
( O
creatine _RARE_
phosphate O
, O
creatine _RARE_
phosphokinase _RARE_
) O
and O
of O
the O
calcium _RARE_
pump _RARE_
( O
Ca I-GENE
++- _RARE_
ATPase I-GENE
of O
the O
sarcoplasmic _RARE_
reticulum O
, O
SPR _RARE_
), _RARE_
which O
evidently _RARE_
led O
to O
a O
decrease O
of O
the O
inotropic O
properties O
of O
the O
myocardium O
at _RARE_
70 O
% O
restriction _RARE_
of O
coronary O
blood _RARE_
flow O
. O

In O
vitro O
penetration O
tests O
of O
human O
sperm O
into O
cervical O
mucus O
were O
introduced O
in O
order O
to O
study O
the O
interaction O
between O
sperm O
and O
cervical O
mucus O
. O

Vibrio _RARE_
fluvialis _RARE_
( O
group O
F O
vibrio _RARE_
) O
in O
Maharashtra _RARE_
. O

Serum I-GENE
creatine _RARE_
kinase I-GENE
( O
SCK _RARE_
) O
was O
measured O
in O
ten O
subjects O
in O
the O
laboratory O
before O
and O
after O
the O
performance O
of O
bicycle _RARE_
ergometry _RARE_
and O
a O
lifting _RARE_
task O
. O

Organisms _RARE_
were O
not O
observed O
in O
the O
5 O
bobcats _RARE_
trapped _RARE_
in O
2 O
other O
counties _RARE_
. O

The O
cause O
of O
death _RARE_
is O
often O
quite O
apparent O
from O
the O
pathological O
and O
toxicological O
findings O
; O
however O
, O
the O
manner O
of O
death _RARE_
often O
gives O
the O
examining O
official _RARE_
some O
difficulty _RARE_
. O

The O
average O
annual O
cost O
per O
head O
of O
population O
was O
US O
+ O
0 _RARE_
X O
46 _RARE_
. O

It O
is O
postulated O
that O
altered O
blood _RARE_
flow O
, O
mediated _RARE_
through O
the O
well _RARE_
- O
known O
prostaglandin _RARE_
synthetase _RARE_
inhibitory _RARE_
effects O
of O
ibuprofen _RARE_
, O
resulted O
in O
tubular O
necrosis O
. O

Either _RARE_
20 O
mg O
mitomycin _RARE_
/ O
20 O
ml O
distilled _RARE_
water O
or O
40 O
mg O
/ O
40 O
ml O
distilled _RARE_
water O
was O
locally O
instilled _RARE_
into O
the O
bladder O
with O
a O
catheter O
after O
emptying O
it O
and O
was O
left _RARE_
for _RARE_
about O
25 _RARE_
- O
l20 _RARE_
min O
. O

Both O
groups O
rejected _RARE_
pops _RARE_
with O
added O
SOA _RARE_
, O
decreasing O
mouthing _RARE_
times O
as _RARE_
SOA _RARE_
concentration O
increased O
. O

The O
mean O
extracted O
concentration O
of O
flucloxacillin _RARE_
obtained O
at _RARE_
operation O
was O
12 O
. O
9 O
micrograms O
/ O
ml O
( O
SD O
5 O
. O
25 _RARE_
) O
in O
synovial O
fluid _RARE_
; O
2 O
. O
9 O
micrograms O
/ O
g O
( O
SD O
3 O
. O
59 _RARE_
) O
in O
synovium _RARE_
; O
2 O
. O
0 _RARE_
micrograms O
/ O
g O
( O
SD O
1 O
. O
48 _RARE_
) O
in O
cancellous _RARE_
bone O
and O
1 O
. O
3 O
micrograms O
/ O
g O
( O
SD O
1 O
. O
25 _RARE_
) O
in O
cortical O
bone O
. O

A O
preliminary O
study O
of O
vincristine O
, O
methotrexate O
, O
and O
prednisolone _RARE_
( O
VM _RARE_
* _RARE_
P O
) O
combination O
chemotherapy O
for _RARE_
advanced O
adult O
non O
- O
Hodgkin O
' O
s O
lymphoma O

Lacrimal _RARE_
secretion _RARE_
in O
hyperthyroidism _RARE_

Re O
- O
examination O
of O
the O
ED01 _RARE_
study O
. O

Based O
on O
213 _RARE_
determinations O
, O
the O
control O
mean O
serum I-GENE
CPK I-GENE
activity O
was O
262 _RARE_
+/- O
113 _RARE_
I O
. O
U _RARE_
./ _RARE_
liter O
. O

A O
further O
study O
on O
plasminogen I-GENE
activator I-GENE
release O
by O
vasoactive _RARE_
agents O
in O
the O
isolated O
perfused O
dog O
leg O
. O

CDDP _RARE_
is O
active _RARE_
as _RARE_
a O
single O
agent O
in O
non O
- O
Hodgkin O
' O
s O
lymphoma O
. O

Treatment O
of O
meat O
muscle O
800 O
V O
for _RARE_
45 _RARE_
s O
reduced _RARE_
weeping _RARE_
but O
increased O
slightly O
the O
rate O
of O
autoxidation _RARE_
of O
lipids O
. O

The O
hormonal O
response O
to O
a O
standardized O
bicycle _RARE_
exercise O
test O
was O
studied O
in O
11 O
male O
cadets _RARE_
exposed O
to O
a O
course O
of O
107 _RARE_
h O
of O
continuous O
activity O
with O
less O
than O
2 O
h O
sleep O
. O

At O
an O
ambient _RARE_
temperature _RARE_
of O
25 _RARE_
degrees O
C O
, O
the O
responses O
to O
spinal _RARE_
cooling _RARE_
are O
reduced _RARE_
during _RARE_
the O
dark O
phase _RARE_
. O

A O
method O
for _RARE_
determining _RARE_
cumulative O
behavioral O
toxicity O
after O
chronic O
oral O
administration O
of O
l _RARE_
- O
alpha O
- O
acetylmethadol _RARE_
to O
female O
rats O
. O

After O
successful O
subtotal O
parathyroidectomy _RARE_
, O
evident O
by O
the O
decrease O
of O
serum O
iPTH _RARE_
levels O
, O
both O
the O
CL O
of O
group O
2 O
PMNs _RARE_
and O
the O
ability O
of O
group O
2 O
sera _RARE_
to O
induce O
augmented O
CL O
in O
normal O
PMNs _RARE_
decreased O
( O
p O
< O
0 _RARE_
. O
025 _RARE_
). O

TCZ _RARE_
provides O
quick _RARE_
, O
inexpensive _RARE_
, O
noninvasive _RARE_
indication O
of O
tissue O
necrosis O
, O
moderate O
- O
to O
- O
severe O
intracranial _RARE_
hemorrhage O
, O
and O
delayed O
brain O
maturation _RARE_
. O

The O
number O
of O
muricidal _RARE_
rats O
increased O
with O
increase O
in O
the O
duration O
of O
Cd O
administration O
in O
association O
with O
greater O
accumulation O
of O
Cd O
in O
the O
olfactory O
bulb O
than O
in O
any O
other O
region O
of O
the O
brain O
. O

This O
test O
should O
provide O
another O
practical _RARE_
means O
to O
study O
leprosy _RARE_
. O

The O
preferences _RARE_
were O
for _RARE_
intact _RARE_
vis _RARE_
- O
a O
- O
vis _RARE_
castrated _RARE_
males O
, O
though O
injections O
of O
TP _RARE_
restored O
the O
castrates _RARE_
' O
attractiveness _RARE_
to O
the O
females O
. O

Each O
trial O
consisted O
of O
light O
and O
buzzer _RARE_
for _RARE_
five O
seconds _RARE_
as _RARE_
conditioned O
stimuli O
and O
electric _RARE_
shock O
for _RARE_
five O
seconds _RARE_
as _RARE_
an O
unconditioned _RARE_
stimulus O
. O

Ulcer _RARE_
appeared O
on O
the O
angulus _RARE_
of O
the O
stomach O
at _RARE_
the O
28th _RARE_
week O
and O
resulted O
in O
ulcer O
scar _RARE_
at _RARE_
the O
42nd _RARE_
week O
. O

Family _RARE_
visits _RARE_
and O
involvement O
in O
treatment O
of O
patients O
at _RARE_
a O
state O
hospital O
. O

A O
transparent _RARE_
overlay _RARE_
for _RARE_
assessing O
amplitude O
of O
ECG O
wave O
forms O
. O

Adverse _RARE_
reaction O
of O
the O
apparently O
healthy O
partner _RARE_
in O
response O
to O
improvement O
in O
the O
overtly _RARE_
dysfunctional _RARE_
partner _RARE_
. O

Brain _RARE_
scan O
with O
99mTc O
- O
labelled O
macroaggregated _RARE_
albumin I-GENE
( O
MAA _RARE_
brain O
scan O
) O
and O
computed O
tomography O
studies O
( O
CT _RARE_
) O
were O
performed O
on O
78 _RARE_
patients O
with O
intracranial _RARE_
diseases O
. O

Inhibition O
of O
Fusarium _RARE_
moniliforme _RARE_
var _RARE_
. O
subglutinans _RARE_
, O
the O
causal _RARE_
agent O
of O
pine _RARE_
pitch _RARE_
canker _RARE_
, O
by O
the O
soil _RARE_
bacterium O
Arthrobacter _RARE_
sp _RARE_
. O

The O
five O
- O
drug O
combination O
of O
fluorouracil O
imidazole _RARE_
carboxamide _RARE_
dimethyl O
triazeno _RARE_
, O
vincristine O
, O
bis _RARE_
- O
chloroethyl _RARE_
nitrosourea _RARE_
, O
and O
prednisone O
( O
FIVB _RARE_
+ O
P O
) O
was O
given O
to O
120 O
women O
with O
metastatic O
breast O
cancer _RARE_
. O

A O
method O
is O
described O
for _RARE_
the O
simultaneous O
determination O
of O
1 O
, O
alpha O
- O
acetylmethadol _RARE_
( O
LAAM _RARE_
) O
and O
five O
active _RARE_
metabolites O
-- _RARE_
noracetylmethadol _RARE_
, O
dinoracetylmethadol _RARE_
, O
methadol _RARE_
, O
normethadol _RARE_
, O
and O
dinormethadol _RARE_
-- _RARE_
in O
biofluids _RARE_
by O
high O
- O
performance O
liquid O
chromatography O
using O
a O
normal O
- O
phase _RARE_
column O
and O
a O
UV _RARE_
detector O
at _RARE_
218 _RARE_
nm O
. O

Results O
of O
the O
recognition O
task O
revealed O
significant O
effects O
of O
consonant _RARE_
voicing _RARE_
, O
position O
and O
vowel _RARE_
context O
on O
syllable _RARE_
recognition O
. O

Visual _RARE_
response O
properties O
of O
neurons O
in O
four O
extrastriate _RARE_
visual O
areas O
of O
the O
owl _RARE_
monkey _RARE_
( O
Aotus _RARE_
trivirgatus _RARE_
): O
a O
quantitative O
comparison O
of O
medial O
, O
dorsomedial _RARE_
, O
dorsolateral _RARE_
, O
and O
middle _RARE_
temporal O
areas O
. O

A O
unified _RARE_
approach O
to O
the O
standardization _RARE_
of O
allergens O
. O

Clinical O
and O
anatomical O
considerations _RARE_

A O
dose O
- O
dependent O
fall O
in O
GABA _RARE_
content O
was O
observed O
; O
GABA _RARE_
decrease O
was O
evident O
15 _RARE_
min O
after O
the O
administration O
, O
reached O
its O
nadir _RARE_
at _RARE_
60 _RARE_
min O
and O
disappeared O
at _RARE_
120 O
minutes O
. O

Theory _RARE_
and O
applications O
of O
pulse O
dosing _RARE_
: O
a O
summary O
of O
the O
symposium _RARE_
. O

These O
results O
show O
that O
the O
neonate _RARE_
differs O
from O
the O
adult O
in O
respect O
of O
both O
the O
nature O
of O
effects O
of O
the O
drug O
and O
sensitivity O
to O
it O
. O

To O
evaluate O
the O
gas O
chromatographic O
electron O
capture _RARE_
detection O
method O
described O
earlier O
, O
23 _RARE_
plasma O
samples O
have O
been O
analysed O
by O
both O
techniques O
. O

The O
hemodynamics O
of O
isoproterenol O
- O
induced _RARE_
cardiac O
failure O
in O
the O
rat O
. O

Several O
authors O
have O
recently O
reported O
interference O
in O
theophylline O
analysis O
by O
paraxanthine _RARE_
( O
1 O
, O
7 O
- O
dimethylxanthine _RARE_
), _RARE_
an O
important O
metabolite O
of O
caffeine O
. O

Multi _RARE_
drug O
regimens O
like O
C O
- O
MOPP _RARE_
, O
CHOP _RARE_
and O
BACOP _RARE_
led O
to O
high O
remission O
rates O
and O
in O
some O
cases O
probably O
also O
to O
a O
cure O
of O
the O
disease _RARE_
. O

For O
monocytes O
, O
as _RARE_
measured O
on O
the O
Hematrak _RARE_
, O
it O
was O
13 _RARE_
. O
4 O
%. O

Morphological _RARE_
features O
of O
Jat _RARE_
dentition _RARE_
. O

Clinical O
accuracy O
of O
updated _RARE_
version O
of O
the O
Phadebas _RARE_
RAST O
test O
. O

Five O
control O
subjects O
with O
COPD O
, O
who O
performed O
the O
same O
sequence O
of O
tests O
without O
breathing O
30 _RARE_
% O
O2 _RARE_
, O
showed O
no _RARE_
change O
in O
flow O
rates O
or O
density O
dependence O
. O

Following O
extended O
recovery O
hippocampal O
EEG O
was O
normal O
despite O
extensive O
cellular O
loss _RARE_
in O
areas O
CA3 O
and O
CA4 _RARE_
. O

Evoked _RARE_
potential _RARE_
and O
single O
unit O
responses O
to O
olfactory O
nerve O
volleys _RARE_
in O
the O
isolated O
turtle _RARE_
olfactory O
bulb O
. O

While O
all O
deletions O
within O
the O
sequence O
coding O
for _RARE_
the O
mature _RARE_
tRNA O
led O
to O
inactivity _RARE_
of O
the O
mutated _RARE_
genes O
, O
substitution O
of O
the O
central O
portion O
by O
concatenated _RARE_
Hind _RARE_
III I-GENE
linkers _RARE_
produced O
gene O
units _RARE_
active _RARE_
in O
transcription O
. O

Cross O
reactivity O
in O
theophylline O
RIA _RARE_
kit O
decreased O
. O

Strontium _RARE_
- O
90 _RARE_
was O
inject _RARE_
i O
. O
v O
. O
into O
pregnant _RARE_
rats O
on O
day O
18 O
post O
conception _RARE_
( O
p O
. O
c O
.). O

Recording _RARE_
of O
the O
digital O
sphygmic _RARE_
activity O
in O
the O
lower O
extremities _RARE_
with O
the O
photoplethysmographic _RARE_
and O
strain _RARE_
- O
gauge _RARE_
methods O
. O

Eight O
hr O
of O
acidosis O
caused O
a O
significant O
( O
P O
less O
than O
0 _RARE_
. O
01 O
) O
decrease O
in O
P50 _RARE_
in O
vitro O
which O
fell O
from O
29 O
. O
0 _RARE_
to O
24 _RARE_
. O
4 O
torr O
. O

Catheter _RARE_
transit O
slows _RARE_
the O
response O
to O
a O
step O
increase O
in O
concentration O
by O
about O
0 _RARE_
. O
13 _RARE_
s O
( O
from O
10 O
per O
cent O
- O
90 _RARE_
per O
cent O
) O
and O
prolongs _RARE_
the O
transit O
time O
through O
the O
catheter O
for _RARE_
a O
volatile O
anesthetic _RARE_
by O
about O
0 _RARE_
. O
04 O
s O
more O
than O
N2 O
. O

These O
women O
should O
not O
be O
given O
the O
current O
estrogen O
PPI _RARE_
, O
which O
was O
designed O
to O
warn _RARE_
women O
of O
the O
risks _RARE_
of O
long O
- O
term O
estrogen O
use O
; O
a O
PPI _RARE_
should O
be O
written _RARE_
specifically O
for _RARE_
patients O
receiving O
short O
courses O
. O

The O
oral O
temperature _RARE_
rose O
and O
the O
serum I-GENE
creatine _RARE_
kinase I-GENE
levels O
fell O
only O
in O
those O
patients O
who O
were O
actively O
warmed _RARE_
. O

Determination O
of O
aortic O
distensibility _RARE_
and O
its O
variations O
in O
arterial O
hypertension O
. O

We O
studied O
the O
role O
of O
prostaglandins O
in O
acid O
- O
induced _RARE_
esophagitis _RARE_
and O
the O
associated O
LES _RARE_
hypotension O
by O
simultaneous O
treatment O
of O
some O
animals O
with O
indomethacin O
( O
150 _RARE_
micrograms O
/ O
kg O
intravenous O
), _RARE_
a O
specific O
inhibitor O
of O
prostaglandin _RARE_
synthesis _RARE_
, O
either O
during _RARE_
production O
of O
esophagitis _RARE_
or O
during _RARE_
recovery O
. O

Since O
only O
58 O
% O
of O
our O
sample O
could O
be O
adequately _RARE_
classified O
with O
one O
diagnosis O
, O
we O
expect _RARE_
that O
the O
ASDC _RARE_
nosology _RARE_
will O
need O
to O
evolve _RARE_
further O
. O

A O
surgical O
technique O
for _RARE_
correcting _RARE_
this O
problem O
is O
described O
. O

Effects O
of O
prostaglandin _RARE_
inhibitors _RARE_
on O
the O
onset O
of O
proteinuria _RARE_
and O
stroke O
in O
stroke O
- O
prone O
spontaneously O
hypertensive O
rats O
. O

In O
this O
study O
, O
the O
general _RARE_
clinical O
criteria O
for _RARE_
inhalation O
injury O
-- _RARE_
presence O
of O
facial O
or O
oropharyngeal _RARE_
burns _RARE_
, O
carboxyhemoglobin _RARE_
levels O
, O
carbonaceous _RARE_
sputum _RARE_
, O
or O
closed O
space O
injury O
-- _RARE_
did O
not O
differentiate O
patients O
with O
airway O
injury O
only O
from O
those O
with O
parenchymal _RARE_
injury O
. O

Survival _RARE_
was O
calculated O
both O
from O
the O
date O
of O
onset O
and O
from O
the O
date O
of O
diagnosis O
. O

Methisergide _RARE_
( O
0 _RARE_
. O
5 O
mg O
/ O
kg O
, O
i O
. O
p O
.), _RARE_
a O
blocker O
of O
serotonin _RARE_
receptors I-GENE
, O
prevented O
the O
development O
of O
the O
antinociceptive _RARE_
effect O
of O
serotonin _RARE_
. O

The O
plasma O
half _RARE_
- O
life O
of O
slow O
disposition _RARE_
phase _RARE_
t1 O
/ O
2 O
beta O
, O
increases O
from O
0 _RARE_
. O
26 _RARE_
hour O
in O
rabbits O
with O
normal O
renal _RARE_
function O
to O
5 O
. O
41 _RARE_
hours O
in O
rabbits O
with O
severe O
renal _RARE_
impairment O
. O

Effects O
of O
early O
monocular _RARE_
deprivation O
on O
development O
of O
cortico _RARE_
- O
geniculate _RARE_
projections O
in O
the O
cat _RARE_
. O

Corticosteroid _RARE_
therapy O
is O
known O
to O
be O
hazardous O
in O
patients O
with O
occult _RARE_
infection O
but O
the O
mechanism O
by O
which O
the O
host _RARE_
parasite O
relationship O
is O
altered O
by O
steroids O
is O
not O
known O
. O
We O
have O
used O
an O
intestinal _RARE_
protozoal _RARE_
parasite O
, O
Giardia _RARE_
muris _RARE_
, O
to O
examine O
the O
effects O
of O
corticosteroids O
on O
the O
number O
of O
parasites O
in O
the O
intestine O
in O
the O
course O
of O
a O
primary _RARE_
infection O
. O

Static _RARE_
lung _RARE_
function O
in O
puppies _RARE_
after O
pneumonectomy _RARE_
. O

With O
Sair _RARE_
and O
So2 _RARE_
, O
mean O
vital O
capacity O
was O
reduced _RARE_
by O
44 _RARE_
% O
from O
control O
. O

Bilateral _RARE_
Charnley _RARE_
arthroplasty _RARE_
as _RARE_
a O
single O
procedure O
. O

Of O
the O
117 O
patients O
( O
out O
of O
the O
136 O
) O
with O
serologic O
evidence O
of O
chronic O
thyroiditis O
who O
could O
be O
studied O
, O
eight O
( O
7 O
%) O
had O
hyperthyroidism _RARE_
and O
45 _RARE_
( O
38 O
%) O
were O
hypothyroid _RARE_
. O

The O
relationship O
between O
estrogenic _RARE_
properties O
of O
Tamoxifen _RARE_
and O
breast O
cancer _RARE_
management O
is O
discussed O
. O

The O
new O
semi _RARE_
- O
synthetic _RARE_
oral O
cephalosporin _RARE_
, O
CGP _RARE_
9 O
, O
000 _RARE_
, O
has O
been O
evaluated O
in O
a O
large O
number O
of O
hospitalized O
patients O
with O
urinary _RARE_
infections O
. O

A O
fluoroimmunoassay _RARE_
for _RARE_
the O
determination O
of O
serum O
of O
plasma O
levels O
of O
propranolol O
was O
developed O
using O
antibodies O
to O
propranolol O
coupled O
to O
magnetizable _RARE_
solid O
- O
phase _RARE_
particles _RARE_
and O
fluorescein _RARE_
- O
labeled O
propranolol O
as _RARE_
tracer O
. O

The O
syncytial _RARE_
microvillous _RARE_
projections O
seemed _RARE_
to O
be O
more O
numerous O
and O
longer O
in O
CNF _RARE_
, O
otherwise O
the O
structure _RARE_
of O
the O
trophoblastic _RARE_
layer O
of O
the O
villi _RARE_
and O
the O
lining _RARE_
of O
the O
subtrophoblastic _RARE_
vessels O
were O
identical O
in O
CNF _RARE_
and O
controls O
. O

When O
pollen O
allergen _RARE_
from O
three O
grass _RARE_
species O
were O
used O
, O
The O
RAST O
- O
test O
results O
did O
not O
differ O
from O
duplicate _RARE_
values O
either O
. O

DMI _RARE_
and O
2 O
- O
OH O
- O
DMI _RARE_
concentrations O
were O
determined O
in O
a O
similar O
group O
of O
61 _RARE_
DMI _RARE_
- O
treated O
patients O
. O

It O
has O
been O
shown O
in O
experiments O
in O
vitro O
that O
the O
hepatotrophic _RARE_
organic O
anions _RARE_
, O
the O
radiographic _RARE_
contrast O
agent O
( O
RCA _RARE_
) O
bilignost _RARE_
used O
in O
cholecystography _RARE_
and O
Bengal _RARE_
pink _RARE_
, O
have O
an O
affinity O
, O
unlike O
the O
urographic _RARE_
RCA _RARE_
triombrin _RARE_
and O
renotrophic _RARE_
dye _RARE_
indigo _RARE_
- O
carmine _RARE_
, O
for _RARE_
the O
plasmatic _RARE_
membranes O
( O
PM _RARE_
) O
of O
liver O
cells O
. O

33 _RARE_
out O
of O
90 _RARE_
neurons O
of O
the O
cat _RARE_
medial O
geniculate _RARE_
body O
revealed O
the O
selectivity O
of O
their O
afterdischarges _RARE_
to O
movement O
of O
sound O
when O
velocity O
of O
the O
movement O
changed O
from O
30 _RARE_
to O
180 O
deg _RARE_
/ O
s O
. O

In O
controls O
, O
only O
modest _RARE_
differences O
were O
observed O
. O

Assay _RARE_
of O
serum I-GENE
immunoreactive _RARE_
trypsin I-GENE
in O
dried _RARE_
blood _RARE_
spots O
and O
the O
early O
detection O
of O
cystic _RARE_
fibrosis _RARE_
. O

Similar O
waves O
were O
seen O
on O
cross O
- O
correlating _RARE_
a O
motor O
unit O
with O
an O
electronic _RARE_
oscillator _RARE_
, O
confirming O
that O
their O
occurrence O
does O
not O
necessarily O
demonstrate O
the O
existence O
of O
active _RARE_
neural _RARE_
interactions O
. O

Leukocyte _RARE_
enzyme O
activity O
and O
blood _RARE_
lymphocyte O
blast _RARE_
transformation O
in O
chronic O
bronchitis _RARE_

Current O
status O
of O
chemotherapy O
for _RARE_
Hodgkin O
' O
s O
disease _RARE_

In O
literature O
, O
the O
HBE _RARE_
has O
been O
displayed O
by O
application O
of O
the O
averaging _RARE_
method O
. O

Forty O
- O
five O
cases O
were O
surgically O
by O
direct O
approach O
to O
the O
tumour _RARE_
, O
while O
two O
cases O
were O
treated O
only O
with O
a O
shunt O
. O

In O
Group O
V O
, O
the O
salvaged _RARE_
tissue O
was O
primarily O
subepicardial _RARE_
with O
virtually O
no _RARE_
lateral O
zone O
of O
salvaged _RARE_
tissue O
( O
ratio O
of O
salvaged _RARE_
subepicardium _RARE_
to O
salvaged _RARE_
subendocardium _RARE_
14 O
. O
8 O
+/- O
1 O
. O
9 O
to O
1 O
). O

Progressive _RARE_
100 _RARE_
- O
mmHg O
stepwise _RARE_
decreases O
in O
superfusate _RARE_
oxygen O
partial O
pressure O
( O
PO2 O
) O
from O
control O
( O
95 _RARE_
% O
O2 _RARE_
aeration _RARE_
, O
PO2 O
, O
620 _RARE_
- O
650 _RARE_
mmHg O
) O
were O
produced O
, O
and O
subsequent O
changes O
in O
isometric _RARE_
active _RARE_
and O
resting O
tension O
were O
measured O
. O

The O
known O
B1 _RARE_
- O
deficiency O
reaches _RARE_
excessive O
high O
values O
with O
light O
exercise O
. O

Based O
on O
AUC O
infinity _RARE_
analyses O
, O
the O
pharmacokinetics O
of O
buflomedil _RARE_
were O
found O
to O
be O
linear _RARE_
within O
the O
dose O
ranges _RARE_
studied O
( O
50 O
to O
200 _RARE_
mg O
for _RARE_
i O
. O
v O
. O
injection O
and O
150 _RARE_
to O
450 _RARE_
mg O
for _RARE_
oral O
administration O
). O

Gastrin _RARE_
secretion _RARE_
during _RARE_
food O
stimulation _RARE_
in O
digestive _RARE_
system _RARE_
diseases O

Fibrinogen _RARE_
determination O
using O
the O
KZM _RARE_
- O
1 O
meter _RARE_

Over _RARE_
a O
period O
of O
15 _RARE_
days O
16 O
% O
of O
the O
dose O
administered O
was O
excreted _RARE_
with O
faeces _RARE_
and O
0 _RARE_
. O
9 O
% O
in O
the O
urine O
. O

Delayed _RARE_
or O
paradoxically _RARE_
emptying O
regions O
of O
the O
left _RARE_
ventricle O
were O
detected O
by O
a O
relatively O
new O
nuclear O
technique O
-- _RARE_
phase _RARE_
imaging O
. O

Responses _RARE_
to O
brainstem _RARE_
of O
nuclei O
medialis _RARE_
dorsalis _RARE_
, O
lateralis _RARE_
posterior O
were O
of O
considerably O
longer O
latency _RARE_
. O

Nineteen _RARE_
patients O
with O
non O
- O
visualized _RARE_
gallbladder O
with O
OCG _RARE_
subsequently O
had O
Tc O
- O
99m O
- O
PyG _RARE_
cholescintigraphy _RARE_
performed O
. O

One O
was O
allowed O
fresh O
drinking O
water O
ad _RARE_
libitum _RARE_
whilst _RARE_
the O
other O
received O
Aludrox _RARE_
in O
their O
drinking O
water O
. O

Anamnestic _RARE_
data O
were O
obtained O
from O
case O
history O
, O
smoking O
habits _RARE_
were O
not O
known O
in O
collective _RARE_
A O
and O
C O
. O

The O
determination O
of O
physical O
performance O
capacity O
was O
based O
on O
W170 _RARE_
, O
W85 _RARE_
% O
and O
on O
predicted O
VO2 O
max _RARE_
measured O
with O
continuously O
increasing O
work O
load O
on O
a O
bicycle _RARE_
ergometer _RARE_
. O

Determination O
of O
lead O
in O
blood _RARE_
. O

Effect O
of O
indomethacin O
and O
prostaglandin _RARE_
F2 O
alpha O
on O
parturition _RARE_
in O
swine O
. O

LD50 O
values O
of O
terms O
of O
KP O
were O
84 _RARE_
mg O
/ O
kg O
in O
male O
rats O
and O
122 O
mg O
/ O
kg O
in O
female O
rats O
when O
KP O
- O
CMC _RARE_
was O
administered O
intrarectally _RARE_
, O
and O
117 O
mg O
/ O
kg O
in O
male O
and O
92 O
mg O
/ O
kg O
in O
female O
when O
KP O
- O
T10 _RARE_
was O
administered O
intrarectally _RARE_
., O
while O
peroral _RARE_
administration O
of O
KP O
- O
CMC _RARE_
showed O
LD50 O
values O
of O
68 _RARE_
mg O
/ O
kg O
in O
males O
and O
78 _RARE_
mg O
/ O
kg O
in O
females O
in O
terms O
of O
KP O
. O

Autotransfusion _RARE_
was O
performed O
as _RARE_
follows O
: O
Heparin O
- O
ACD _RARE_
- O
B O
- O
Heparin O
- O
DPD _RARE_
- O
Heparin O
- O
ACD _RARE_
- O
B O
etc O
. O

Electron _RARE_
microscopic O
picture O
of O
the O
cerebral O
cortex O
in O
rats O
cooled _RARE_
to O
22 _RARE_
degrees O
C O

Generally _RARE_
the O
differences O
between O
short O
gut O
and O
sham O
operation O
animals O
disappeared O
when O
the O
data O
were O
normalised _RARE_
for _RARE_
mucosal _RARE_
weight _RARE_
. O

A O
simplified _RARE_
thin O
- O
layer O
chromatographic O
determination O
of O
hippuric _RARE_
acid O
and O
methylhippuric _RARE_
acids _RARE_
. O

The O
architecture O
of O
microvasculature _RARE_
in O
these O
two O
regions O
was O
also O
examined O
by O
scanning O
electron O
microscopy O
, O
using O
the O
resin O
casting _RARE_
method O
. O

MSMS _RARE_
Council _RARE_
hears _RARE_
new O
public _RARE_
health O
director _RARE_
. O

Chordoma _RARE_
of O
the O
spinal _RARE_
cord O
in O
a O
F344 _RARE_
rat O
. O

Micro _RARE_
high O
- O
performance O
liquid O
chromatographic O
system _RARE_
with O
micro O
precolumn _RARE_
and O
dual O
electrochemical _RARE_
detector O
for _RARE_
direct O
injection O
analysis O
of O
catecholamines O
in O
body O
fluids O
. O

Thirty O
- O
one O
age O
- O
matched O
, O
conscious O
, O
virgin _RARE_
, O
male O
Sprague O
- O
Dawley O
rats O
and O
spontaneously O
hypertensive O
rats O
( O
SHRs _RARE_
) O
were O
individually O
injected O
with O
a O
single O
subcutaneous O
dose O
of O
85 _RARE_
mg O
/ O
kg O
dl O
- O
isoproterenol O
to O
determine O
the O
degree O
and O
time O
course O
of O
drug O
- O
induced _RARE_
cardiac O
failure O
and O
functional _RARE_
recovery O
. O

A O
narrow O
zone O
of O
myelin _RARE_
- O
axonal _RARE_
dissociation O
was O
also O
observed O
. O

The O
IgA I-GENE
deficiency O
is O
combined O
with O
the O
IgE I-GENE
one O
. O

In O
PB _RARE_
mice O
, O
there O
was O
only O
a O
small O
deficit O
in O
the O
number O
of O
the O
hippocampal O
pyramidal O
neurons O
compared O
to O
controls O
( O
15 _RARE_
%, O
p O
less O
than O
0 _RARE_
. O
01 O
), _RARE_
and O
no _RARE_
deficit O
in O
the O
granule _RARE_
cells O
. O

Nutritional _RARE_
cataracts _RARE_
in O
timber _RARE_
wolves _RARE_
. O

Prevention O
of O
transfusion O
reactions O
by O
the O
use O
of O
saline O
washed _RARE_
red _RARE_
blood _RARE_
cells O
. O

The O
geometric _RARE_
mean O
hemagglutination _RARE_
- O
inhibition O
antibody O
titers _RARE_
( O
GMT _RARE_
) O
of O
non O
- O
immunized O
, O
once O
- O
immunized O
, O
and O
twice O
- O
immunized O
chickens _RARE_
were O
compared O
at _RARE_
2 O
- O
week O
intervals O
following O
primary _RARE_
immunization O
, O
secondary O
immunization O
, O
and O
challenge O
. O

The O
quantitative O
determination O
of O
HBSAG _RARE_
-- _RARE_
a O
valuable O
aid O
in O
evaluating O
the O
infectiousness _RARE_
of O
hepatitis O
B O
virus O
carriers O

2 O
. O
numerous O
narrow O
shunt O
vessels O
departing _RARE_
continuously O
from O
the O
primary _RARE_
arteries O
to O
feed O
a O
secondary O
arterial O
system _RARE_
which O
parallels _RARE_
the O
primary _RARE_
one O
. O

Urological _RARE_
complications O
are O
frequent O
during _RARE_
and O
after O
the O
treatment O
of O
gynecological _RARE_
malignancy O
. O

Arachnoid _RARE_
cyst O
. O

100 _RARE_
more O
than O
in O
the O
summer O
coat O
). O

Hypotension _RARE_
was O
produced O
by O
head O
up _RARE_
tilt O
. O

Therefore O
the O
procedure O
of O
Lich _RARE_
- O
Gregoir _RARE_
is O
not O
to O
be O
recommended O
in O
adults O
. O

Mucoepidermoid _RARE_
and O
acinous _RARE_
cell O
carcinomas O
of O
salivary _RARE_
tissues O
. O

Twenty O
patients O
aged O
45 _RARE_
or O
older O
with O
the O
diagnosis O
of O
endogenous O
depression O
were O
evaluated O
in O
terms O
of O
safety O
and O
efficacy O
in O
their O
response O
to O
multiple O
monitored O
electroconvulsive _RARE_
therapy O
( O
MMECT _RARE_
) O
versus O
single O
electroconvulsive _RARE_
therapy O
( O
SECT _RARE_
). O

Two O
new O
artifacts _RARE_
in O
automated O
coagulation O
testing O
. O

This O
relatively O
simple O
and O
easily O
performed O
technique O
of O
measuring O
deep O
muscle O
temperature _RARE_
appears O
to O
be O
a O
useful O
adjunct _RARE_
in O
choosing _RARE_
the O
amputation _RARE_
level O
. O

Longitudinal _RARE_
force O
- O
length O
relationships O
of O
guinea _RARE_
pig _RARE_
ureter _RARE_
were O
studied O
in O
vitro O
in O
animals O
3 O
weeks O
, O
3 O
months O
, O
and O
3 O
years O
of O
age O
. O

Tests _RARE_
of O
the O
method O
indicate O
( O
1 O
) O
the O
Mossbauer _RARE_
source O
can O
be O
placed O
on O
the O
basilar _RARE_
membrane O
without O
altering O
the O
signal O
- O
transmission _RARE_
properties O
of O
the O
cochlea _RARE_
, O
and O
( O
2 O
) O
the O
source O
adheres _RARE_
to O
the O
basilar _RARE_
membrane O
. O

Angiographic _RARE_
work O
- O
up _RARE_
in O
a O
patient O
with O
late _RARE_
vaginal O
metastasis O
from O
a O
renal _RARE_
carcinoma O
. O

The O
authors O
conclude O
that O
nonspecificity _RARE_
of O
low O
platelet I-GENE
MAO I-GENE
as _RARE_
a O
possible O
correlate O
of O
bipolar O
affective O
disorder O
, O
as _RARE_
well _RARE_
as _RARE_
schizophrenia O
, O
increases O
the O
burden O
of O
proof _RARE_
necessary O
before O
findings O
of O
low O
platelet I-GENE
MAO I-GENE
can O
be O
accepted O
as _RARE_
primary _RARE_
. O

Ecthyma _RARE_
, O
a O
known O
disease _RARE_
, O
of O
which O
little O
is O
known O

Estrogen _RARE_
replacement _RARE_
, O
either O
as _RARE_
17 _RARE_
beta O
- O
estradiol O
or O
beta O
- O
estradiol O
- O
3 O
- O
benzoate _RARE_
via O
subcutaneous O
Silastic _RARE_
capsules O
, O
was O
associated O
with O
elevated O
rates O
of O
heat O
production O
and O
dry _RARE_
heat O
loss _RARE_
relative O
to O
untreated O
ovariectomized _RARE_
controls O
. O

The O
following O
aspects O
were O
assessed O
: O
( O
1 O
) O
The O
effect O
on O
the O
cardiovascular O
system _RARE_
in O
terms O
of O
brachial _RARE_
arterial O
pressure O
, O
pulse O
rate O
, O
and O
oxygen O
consumption O
( O
VO2 O
) O
during _RARE_
exercise O
in O
5 O
health O
volunteers O
; O
( O
2 O
) O
emg _RARE_
activity O
of O
the O
tibialis _RARE_
anterior O
and O
gastrocnemius _RARE_
muscles O
during _RARE_
exercise O
in O
the O
same O
5 O
volunteers O
; O
and O
( O
3 O
) O
postexercise _RARE_
ankle _RARE_
pressure O
changes O
in O
10 O
subjects O
with O
angiographically _RARE_
proven O
occlusive _RARE_
arterial O
diseases O
of O
the O
lower O
extremities _RARE_
. O

Changes O
in O
immunologic O
reactivity O
in O
subjects O
receiving O
transfer I-GENE
factor I-GENE
could O
not O
be O
distinguished O
from O
those O
in O
subjects O
receiving O
placebo O
. O

It O
was O
argued _RARE_
that O
this O
arose _RARE_
from O
the O
possibility O
that O
the O
nature O
of O
blue O
collar _RARE_
jobs _RARE_
was O
physical O
, O
and O
that O
loss _RARE_
of O
myocardial _RARE_
tissue O
might O
be O
expected O
to O
more O
markedly O
interfere _RARE_
with O
their O
work O
efficiency O
( O
on O
returning _RARE_
to O
work O
) O
than O
it O
would O
the O
efficiency O
of O
the O
more O
sedentary _RARE_
jobs _RARE_
of O
white _RARE_
collar _RARE_
workers O
. O

Importance _RARE_
of O
determining _RARE_
the O
blood _RARE_
sulfhydryl _RARE_
groups O
in O
fractures _RARE_
of O
the O
long O
tubular O
bones _RARE_
complicated O
by O
infection O

The O
results O
revealed O
increased O
blood _RARE_
lead O
level O
associated O
with O
decreased O
blood _RARE_
haemoglobin _RARE_
and O
increased O
urinary _RARE_
excretion O
of O
delta O
amino O
levulinic _RARE_
acid O
. O

Following O
iv O
injection O
of O
0 _RARE_
. O
5 O
g O
galactose _RARE_
per O
kg O
body O
weight _RARE_
, O
together O
with O
2 O
mu O
Ci _RARE_
generally O
14C O
- O
labelled O
galactose _RARE_
, O
14CO2 _RARE_
is O
collected O
in O
regular O
intervals O
during _RARE_
one O
hour O
. O

Specific O
clotting _RARE_
factor O
assays O
showed O
an O
isolated O
deficiency O
of O
factor I-GENE
X I-GENE
ranging O
from O
7 O
to O
12 O
per O
cent O
on O
three O
determinations O
. O

Charcoal _RARE_
- O
facilitated O
dialysis O
. O

Blood _RARE_
variables O
measured O
at _RARE_
eight O
intervals O
before O
, O
during _RARE_
, O
and O
after O
operation O
were O
as _RARE_
follows O
: O
seven _RARE_
plasma O
proteins O
, O
free O
hemoglobin I-GENE
, O
formed O
elements O
, O
and O
clotting _RARE_
functions O
. O

Retinal _RARE_
changes O
in O
pigmentary _RARE_
retinopathy _RARE_
in O
children O

As O
a O
result O
, O
beta O
- O
apo _RARE_
- O
8 O
'- O
carotenoic _RARE_
acid O
ethyl O
ester O
( O
apo _RARE_
- O
EE _RARE_
) O
was O
used O
as _RARE_
a O
reference O
standard O
in O
Experiments O
4 O
to O
6 O
. O

The O
ability O
of O
sodium _RARE_
phenobarbital _RARE_
( O
60 _RARE_
mg O
/ O
kg O
) O
and O
sodium _RARE_
barbital _RARE_
( O
80 _RARE_
mg O
/ O
kg O
) O
to O
produce O
a O
taste O
aversion _RARE_
in O
23 _RARE_
hr O
fluid _RARE_
deprived O
rats O
was O
examined O
using O
a O
discrimination O
or O
two O
bottle _RARE_
taste O
aversion _RARE_
task O
( O
0 _RARE_
. O
125 _RARE_
% O
sodium _RARE_
saccharin O
solution O
or O
water O
). O

It O
appears O
that O
the O
pulmonary O
gas O
exchange O
parenchyma O
of O
these O
smallest O
mammals O
is O
well _RARE_
suited _RARE_
to O
supply O
the O
organism O
with O
the O
comparatively _RARE_
high O
levels O
of O
O2 _RARE_
required O
by O
the O
high O
metabolic O
rates O
, O
exhibiting O
a O
structural O
adaptation O
of O
the O
lung _RARE_
to O
higher _RARE_
VO2 O
. O

Underestimations _RARE_
by O
as _RARE_
much O
as _RARE_
35 _RARE_
% O
may O
occur O
due O
to O
the O
problems O
in O
the O
existing O
methodologies _RARE_
. O

Chemotherapy _RARE_
was O
administered O
without O
altering O
the O
course O
of O
the O
disorder O
. O

Drug O
inhibition O
of O
whole O
blood _RARE_
aspirin _RARE_
esterase I-GENE
. O

However O
, O
at _RARE_
lower O
temperature _RARE_
the O
positive O
staircase _RARE_
was O
not O
clear O
and O
rather O
negative O
staircase _RARE_
appeared O
( O
1 O
-- _RARE_
3 O
Hz O
). O

Visual _RARE_
averaged O
evoked O
responses O
and O
platelet I-GENE
monoamine _RARE_
oxidase I-GENE
in O
patients O
suffering O
from O
alcoholism _RARE_
. O

At O
the O
end O
of O
the O
experiment O
the O
urinary _RARE_
porphyrin O
excretion O
and O
the O
porphyrin O
content O
in O
lijver _RARE_
and O
skin _RARE_
were O
diminished O
in O
HCB O
- O
CQ _RARE_
- O
treated O
animals O
by O
about O
50 O
% O
compared O
to O
the O
HCB O
controls O
. O

Six O
hours O
after O
the O
last O
administration O
, O
uterus _RARE_
of O
Gf _RARE_
and O
Cv _RARE_
mice O
were O
weight _RARE_
337 _RARE_
. O
6 O
mg O
% O
and O
423 _RARE_
. O
5 O
mg O
% O
respectively O
, O
the O
difference O
was O
statistically O
significant O
( O
p O
less O
than O
0 _RARE_
. O
01 O
). O

Although O
stone O
- O
formers _RARE_
were O
not O
found O
to O
display O
any O
features O
of O
magnesium O
metabolism O
that O
were O
different O
from O
those O
in O
the O
control O
group O
, O
their O
lower O
urinary _RARE_
excretion O
of O
magnesium O
in O
relation O
to O
calcium _RARE_
may O
be O
a O
factor O
in O
their O
increased O
stone O
- O
forming O
propensity O
. O

Analysis O
of O
an O
autopsy O
population O
. O

A O
16 O
- O
year O
follow O
- O
up _RARE_
study O
of O
69 _RARE_
paraplegics _RARE_
with O
complete _RARE_
lesions O
from O
T1 _RARE_
- O
L3 _RARE_
is O
presented O
. O

Autoradiographic _RARE_
localisation _RARE_
of O
its O
cellular O
distribution O
in O
the O
kidney _RARE_
. O

Hippocampal _RARE_
stimulation _RARE_
overlapping O
conditioned O
stimulus O
preexposure _RARE_
produced O
attenuation _RARE_
of O
latent O
inhibition O
, O
as _RARE_
did O
stimulation _RARE_
presented O
during _RARE_
conditioning O
after O
preexposure _RARE_
. O

The O
centromedial _RARE_
amygdala O
and O
gastric _RARE_
pathology O
in O
rats O
. O

Cataract _RARE_
extraction O
in O
primary _RARE_
glaucoma O

Number _RARE_
and O
size O
of O
the O
myelin _RARE_
structures _RARE_
in O
the O
pneumocytes _RARE_
typ _RARE_
II O
increased O
simultaneously O
. O

In O
the O
intact _RARE_
animal _RARE_
, O
postextrasystolic _RARE_
potentiation O
depended _RARE_
on O
the O
basic O
pacing O
interval O
, O
t0 _RARE_
, O
and O
the O
timing O
of O
the O
extrasystole _RARE_
, O
t1 O
: O
when O
t0 _RARE_
was O
held O
constant O
and O
t1 O
was O
increased O
, O
potentiation O
decreased O
; O
when O
t1 O
was O
held O
constant O
and O
t0 _RARE_
was O
increased O
, O
potentiation O
increased O
. O

In O
spite _RARE_
of O
this O
and O
other O
complications O
of O
corticosteroids O
, O
she _RARE_
made O
a O
full O
recovery O
from O
the O
fungal _RARE_
infection O
following O
treatment O
with O
amphotericin O
B O
and O
surgical O
excision _RARE_
of O
the O
lung _RARE_
abscess O
. O

Implications _RARE_
of O
this O
observation O
for _RARE_
pediatrics _RARE_
are O
discussed O
. O

For O
the O
study O
of O
the O
transition O
of O
long O
to O
short O
waves O
( O
deep O
- O
water O
waves O
) O
a O
closed O
- O
form O
solution O
is O
advantageous _RARE_
; O
this O
can O
, O
however O
, O
only O
be O
obtained O
at _RARE_
the O
cost O
of O
further O
simplification _RARE_
. O

Treatment O
of O
suppurative _RARE_
peritonitis _RARE_

We O
report O
a O
case O
of O
pheochromocytoma _RARE_
manifesting _RARE_
during _RARE_
the O
third O
trimester _RARE_
of O
pregnancy _RARE_
. O

Fasting _RARE_
plasma O
and O
lipoprotein O
lipid _RARE_
concentrations O
, O
adipose _RARE_
tissue I-GENE
lipoprotein I-GENE
lipase I-GENE
activity O
, O
anthropometric _RARE_
data O
, O
alcohol _RARE_
consumption O
, O
smoking O
habits _RARE_
, O
weekly O
mileage _RARE_
run O
and O
performance O
on O
a O
bicycle _RARE_
ergometer _RARE_
were O
recorded O
before O
and O
after O
the O
training O
period O
. O

The O
C18 O
: O
1 O
: O
C10 _RARE_
value O
is O
a O
convenient _RARE_
measure O
of O
these O
changes O
and O
can O
be O
determined O
more O
rapidly O
than O
determining _RARE_
all O
the O
lower O
fatty O
acids _RARE_
. O

A O
progressive O
growth O
of O
blood _RARE_
erythrocyte _RARE_
membrane O
injury O
has O
been O
demonstrated O
after O
rats O
were O
exposed O
to O
gamma O
- O
irradiaton _RARE_
at _RARE_
a O
dose O
of O
100 _RARE_
to O
500 O
Gy O
. O

Within O
the O
3 O
' O
terminal O
50 O
nucleotides O
, O
the O
mouse I-GENE
mt _RARE_
12S _RARE_
rRNA I-GENE
contains O
a O
potential _RARE_
10 O
bp O
hairpin O
structure _RARE_
and O
a O
sequence O
of O
15 _RARE_
consecutive O
nucleotides O
common O
to O
the O
RNA O
of O
the O
small O
ribosomal O
subunit O
in O
all O
systems _RARE_
, O
but O
does O
not O
contain O
the O
mRNA O
binding O
site O
( O
ACCUCC _RARE_
) O
found O
in O
E O
. O
coli O
and O
corn _RARE_
chloroplast O
rRNAs _RARE_
. O

Microscopic _RARE_
anatomy _RARE_
and O
cell O
population O
dynamics O
. O

Thirty O
cadaver _RARE_
brains _RARE_
were O
examined O
under O
X O
6 O
to O
16 O
magnification O
in O
order O
to O
define O
the O
microsurgical _RARE_
anatomy _RARE_
of O
the O
pineal O
region O
, O
particularly O
the O
relationship O
of O
the O
pineal O
body O
, O
posterior O
cerebral O
artery O
, O
superior O
cerebellar _RARE_
artery O
, O
vein _RARE_
of O
Galen _RARE_
, O
basal O
vein _RARE_
of O
Rosenthal _RARE_
, O
internal O
cerebral O
vein _RARE_
, O
straight _RARE_
sinus O
, O
bridging _RARE_
vein _RARE_
, O
the O
size O
of O
the O
tentorial _RARE_
notch _RARE_
, O
and O
the O
third O
and O
the O
fourth O
cranial _RARE_
nerves O
. O

Serum O
antibody O
titre _RARE_
was O
not O
significantly O
associated O
with O
the O
recurrence O
rate O
or O
the O
duration O
of O
infection O
. O

We O
propose O
that O
refeeding _RARE_
may O
be O
an O
important O
mechanism O
for _RARE_
activation O
of O
certain O
viral O
infections O
previously O
suppressed O
by O
famine _RARE_
. O

One O
hundred O
twenty _RARE_
units _RARE_
of O
deglycerolized _RARE_
red _RARE_
blood _RARE_
cells O
, O
some O
with O
glycerol _RARE_
added O
so O
as _RARE_
to O
exceed _RARE_
an O
acceptable O
1 O
% O
glycerol _RARE_
content O
, O
had O
measurements O
made O
of O
the O
post O
- O
wash _RARE_
supernatant O
fluid _RARE_
by O
refractive _RARE_
index O
and O
osmometry _RARE_
. O

The O
symptoms O
and O
objective O
findings O
were O
caused O
by O
a O
malignant O
lymphoma O
, O
and O
the O
diagnosis O
was O
established O
from O
a O
drill _RARE_
biopsy O
. O

Our O
study O
differs O
from O
previous O
studies O
in O
that O
it O
is O
limited O
to O
one O
diagnostic O
entity _RARE_
, O
yet O
at _RARE_
the O
same O
time O
evaluates _RARE_
a O
broad O
range O
of O
social O
and O
work O
- O
related O
factors O
in O
disability _RARE_
. O

It O
is O
suggested O
that O
a O
raised O
hydroxykynurenine _RARE_
/ O
hydroxyanthranilic _RARE_
acid O
ratio O
does O
not O
necessarily O
indicate O
vitamin O
B6 _RARE_
deficiency O
but O
may O
represent O
a O
nonspecific O
response O
of O
tryptophan _RARE_
metabolism O
to O
stress O
. O

All O
control O
persons O
had O
a O
normal O
reaction O
to O
DNFB _RARE_
. O

In O
a O
control O
group O
both O
common O
carotid O
arteries O
( O
CCA _RARE_
) O
were O
ligated O
. O

At O
pH O
6 O
. O
9 O
, O
the O
same O
lidocaine O
concentrations O
significantly O
reduced _RARE_
resting O
potential _RARE_
( O
3 O
- O
10 O
%), O
action O
potential _RARE_
amplitude O
( O
3 O
- O
8 O
%) O
and O
Vmax O
( O
14 O
- O
22 _RARE_
%). O

Simultaneous _RARE_
right O
and O
left _RARE_
adrenal O
and O
peripheral O
blood _RARE_
samples O
were O
collected O
for _RARE_
determination O
of O
oestrone _RARE_
( O
E1 O
) O
and O
oestradiol O
( O
E2 O
). O

Arm _RARE_
function O
tests O
. O

All O
lambs O
with O
B O
breeding _RARE_
had O
significantly O
higher _RARE_
Hb _RARE_
levels O
at _RARE_
the O
end O
of O
the O
experiment O
than O
did O
NB _RARE_
lambs O
. O
b O
and O
S O
x _RARE_
B O
lambs O
had O
higher _RARE_
( O
P O
< O
. O
05 O
) O
Hb _RARE_
levels O
than O
the O
D O
x _RARE_
B O
lambs O
, O
and O
B O
lambs O
had O
the O
highest O
( O
P O
< O
. O
05 O
) O
mean O
corpuscular _RARE_
hemoglobin I-GENE
concentrations O
. O

The O
same O
response O
occurs O
whether O
acrylamide _RARE_
is O
given O
immediately O
after O
nerve O
ligation O
or O
1 O
week O
later O
. O

The O
operation O
recommended O
is O
excision _RARE_
of O
3 O
mm O
of O
central O
slip _RARE_
followed O
by O
end O
- O
to O
- O
end O
repair O
of O
the O
tendon O
. O

In O
the O
unclipped _RARE_
group O
arterial O
pressure O
decreased O
50 O
mmHg O
to O
normal O
by O
24 _RARE_
h O
and O
was O
associated O
with O
increased O
diuresis _RARE_
and O
a O
small O
decrease O
in O
blood _RARE_
volume O
( O
9 O
. O
8 O
%). O

Marked O
sedative _RARE_
activity O
was O
observed O
with O
9 O
- O
methoxy _RARE_
- O
5 O
- O
phenylpyrrolo _RARE_
[ _RARE_
2 O
, O
1 O
- O
d O
][ _RARE_
1 O
, O
5 O
] O
benzothiazepin _RARE_
- O
6 O
, O
6 O
- O
dioxide O
( O
NF19 _RARE_
) O
and O
9 O
- O
chloro _RARE_
- O
5 O
- O
p O
- O
nitrophenylpyrrolo _RARE_
[ _RARE_
2 O
, O
1 O
- O
d O
][ _RARE_
1 O
, O
5 O
] O
benzothiazepin _RARE_
- O
6 O
, O
6 O
- O
dioxide O
( O
NF20 _RARE_
). O

In O
patients O
, O
the O
effect O
of O
CCK _RARE_
- O
PZ _RARE_
on O
the O
movement O
of O
the O
terminal O
part O
of O
the O
bile O
duct O
was O
measured O
with O
a O
pressure O
sensor _RARE_
using O
a O
duodenofiberscope _RARE_
. O

In O
11 O
patients O
with O
Horton _RARE_
' O
s O
headache O
morphological O
investigations O
( O
differential O
white _RARE_
blood _RARE_
cell O
count O
), _RARE_
cytoenzymatic _RARE_
determinations O
( O
alkaline _RARE_
and I-GENE
acid I-GENE
phosphatase I-GENE
, O
non I-GENE
- I-GENE
specific I-GENE
esterase I-GENE
) O
and O
cytoimmunological _RARE_
tests O
( O
IgM I-GENE
and O
IgG I-GENE
binding O
) O
were O
carried O
out O
on O
capillary O
blood _RARE_
neutrophils O
obtained O
from O
the O
area O
of O
pain O
, O
non O
- O
painful _RARE_
area O
of O
the O
skin _RARE_
on O
the O
head O
on O
the O
contralateral O
side _RARE_
, O
and O
from O
the O
finger O
. O

As O
high O
- O
speed _RARE_
, O
volumetric _RARE_
imaging O
, O
computed O
tomographic _RARE_
scan O
machines _RARE_
such O
as _RARE_
the O
Dynamic _RARE_
Spatial _RARE_
Reconstructor _RARE_
become O
available O
with O
higher _RARE_
density O
resolution O
, O
perhaps O
a O
single O
injection O
of O
contrast O
agent O
into O
the O
right O
atrium O
or O
even O
a O
peripheral O
vein _RARE_
may O
be O
adequate O
to O
obtain O
all O
these O
measurements O
. O

The O
ESEG _RARE_
' O
s O
are O
a O
direct O
result O
of O
the O
NEXT _RARE_
study O
. O

The O
potentially O
SLE O
- O
inducing O
drugs O
are O
reviewed O
. O

A O
third O
series O
of O
mice O
were O
given O
a O
single O
injection O
of O
5 O
- O
OH O
- O
DA _RARE_
, O
sacrificed _RARE_
, O
and O
prepared O
for _RARE_
ultrastructural _RARE_
study O
. O

Fourteen _RARE_
different O
species O
( O
eight O
Platyhelmintha _RARE_
, O
one O
Nematoda _RARE_
and O
five O
Crustacea _RARE_
) O
have O
been O
inventorized _RARE_
. O

No O
symptoms O
other O
than O
hot O
flush _RARE_
showed O
such O
significant O
correlation O
with O
plasma O
epinephrine O
or O
norepinephrine O
levels O
. O

The O
mean O
values O
of O
the O
concentrations O
of O
the O
components _RARE_
due O
to O
tobacco O
smoke O
are O
: O
CO _RARE_
= O
1 O
. O
1 O
ppm O
, O
NO _RARE_
= O
32 _RARE_
ppb O
, O
NO2 O
= O
24 _RARE_
ppb O
, O
nicotine O
= O
0 _RARE_
. O
9 O
micrograms O
/ O
m3 O
, O
particulate O
matter O
= O
133 _RARE_
micrograms O
/ O
m3 O
. O

The O
average O
backscatter _RARE_
coefficient O
was O
six _RARE_
time O
larger O
in O
regions O
of O
infarct O
studied O
8 O
-- _RARE_
10 O
weeks O
after O
occlusion O
than O
that O
in O
regions O
of O
infarct O
studied O
5 O
-- _RARE_
6 O
weeks O
after O
occlusion O
. O

At O
4 O
wk O
however O
, O
tumor O
relapse O
was O
noted O
in O
6 O
of O
7 O
group O
4 O
responders O
, O
10 O
of O
12 O
in O
group O
5 O
, O
13 _RARE_
of O
16 O
in O
group O
7 O
, O
but O
only O
4 O
of O
19 O
group O
8 O
responders O
( O
p O
less O
than O
. O
001 O
group O
8 O
versus O
4 O
, O
5 O
, O
7 O
). O

Early O
infection O
was O
detected O
in O
one O
of O
50 O
control O
women O
who O
gave O
birth O
to O
a O
healthy O
infant O
. O

Pentachlorophenol _RARE_
accelerates _RARE_
the O
onset O
of O
HCB O
porphyria _RARE_
, O
in O
other O
words _RARE_
it O
increases O
the O
total _RARE_
urinary _RARE_
porphyrin O
excretion O
and O
causes O
an O
earlier O
disturbance O
of O
the O
porphyrin O
pattern O
. O

Family _RARE_
planning O
continues _RARE_
to O
play O
a O
minor O
role O
, O
and O
only O
25 _RARE_
. O
3 O
per O
cent O
of O
all O
patients O
reviewed O
took _RARE_
to O
oral O
contraceptives _RARE_
for _RARE_
shorter O
or O
longer O
periods O
of O
time O
. O
- O
The O
percentages _RARE_
of O
primiparae _RARE_
and O
secundiparae _RARE_
in O
all O
births O
as _RARE_
well _RARE_
as _RARE_
the O
high O
percentage O
of O
multigravidity _RARE_
are O
parameters O
by O
which O
the O
approach O
to O
reproduction _RARE_
differs O
substantively _RARE_
from O
behaviour O
patterns O
in O
Europe _RARE_
. O

The O
term O
osteomesopycnosis _RARE_
is O
proposed O
for _RARE_
a O
sclerosing _RARE_
bone O
disease _RARE_
with O
dominant O
inheritance _RARE_
that O
has O
been O
discovered O
in O
five O
members O
of O
four O
different O
families _RARE_
. O

The O
87K _RARE_
protein O
, O
together O
with O
proteins O
of O
105 _RARE_
, O
000 _RARE_
and O
75 _RARE_
, O
000 _RARE_
daltons _RARE_
, O
are O
translated O
from O
leftward _RARE_
transcribed _RARE_
( O
1 O
- O
strand _RARE_
) O
messenger _RARE_
RNAs O
that O
are O
complementary _RARE_
to O
the O
viral O
genome O
between O
positions O
11 O
. O
2 O
and O
31 _RARE_
. O
5 O
. O

The O
identification O
of O
viable O
myocardium O
with O
both O
99mTc O
- O
tetrofosmin O
and O
201Tl _RARE_
can O
be O
greatly O
enhanced _RARE_
to O
a O
similar O
degree O
if O
the O
severity O
of O
reduction O
in O
activity O
within O
nonreversible _RARE_
defects O
is O
considered O
. O

The O
temporal O
component _RARE_
lacked O
a O
mandibular O
fossa _RARE_
as _RARE_
well _RARE_
as _RARE_
articular _RARE_
eminence _RARE_
. O

EUK _RARE_
- O
8 O
is O
a O
novel O
, O
synthetic _RARE_
, O
low O
- O
molecular _RARE_
- O
weight _RARE_
salen _RARE_
- O
manganese _RARE_
complex O
that O
exhibits O
both O
superoxide _RARE_
dismutase I-GENE
and O
catalase I-GENE
activities O
in O
vitro O
. O

The O
protein I-GENE
ELT _RARE_
- I-GENE
1 I-GENE
, O
encoded O
by O
a O
single O
- O
copy O
gene O
homologous O
to O
the O
GATA _RARE_
family I-GENE
of I-GENE
vertebrate _RARE_
transcription I-GENE
factors I-GENE
, O
is O
potentially O
capable O
of O
interacting _RARE_
with O
this O
element O
. O

However O
, O
in O
contrast O
with O
previous O
in O
vitro O
cell O
- O
free O
integration _RARE_
studies O
, O
alteration O
of O
the O
highly O
conserved _RARE_
CA O
dinucleotide O
resulted O
in O
a O
mutant O
which O
still O
retained O
40 O
% O
of O
wild O
- O
type O
integration _RARE_
activity O
. O

The O
resulting O
R I-GENE
protein I-GENE
terminates _RARE_
five O
codons O
downstream _RARE_
of O
the O
frameshift O
site O
at _RARE_
the O
V I-GENE
protein I-GENE
stop O
codon _RARE_
. O

These O
results O
demonstrate O
that O
although O
PI2 _RARE_
and O
PI3 _RARE_
viruses O
belong O
to O
the O
same O
parainfluenza _RARE_
virus O
genus O
, O
these O
viruses O
show O
marked O
differences O
with O
respect O
to O
functional _RARE_
requirements O
for _RARE_
the O
cytoplasmic O
tail _RARE_
of O
the O
F I-GENE
glycoprotein I-GENE
. O

By O
site O
- O
specific O
mutagenesis O
, O
we O
also O
show O
that O
individual O
ICP27 _RARE_
C I-GENE
- I-GENE
terminal I-GENE
amino I-GENE
acid I-GENE
residues I-GENE
that O
are O
positionally _RARE_
conserved _RARE_
in O
ICP27 _RARE_
homologs I-GENE
in O
other O
herpesviruses _RARE_
( O
D O
- O
357 _RARE_
, O
E O
- O
358 _RARE_
, O
H O
- O
479 _RARE_
, O
C O
- O
400 _RARE_
, O
C O
- O
483 _RARE_
, O
and O
C O
- O
488 _RARE_
) O
are O
critical O
for _RARE_
trans _RARE_
- O
regulatory O
activity O
. O

Magnetic O
resonance O
imaging O
( O
MRI O
) O
has O
enabled _RARE_
us O
to O
see _RARE_
the O
spinal _RARE_
intramedullary _RARE_
pathology O
as _RARE_
differences O
in O
signal O
intensity O
. O

Patients O
with O
psychotropic _RARE_
drugs O
showed O
significantly O
higher _RARE_
PRL I-GENE
levels O
. O

The O
Laser _RARE_
Scanning _RARE_
Ophthalmoscope _RARE_
enables O
a O
fundus _RARE_
- O
based O
examination O
and O
therefore O
allows O
exact _RARE_
comparison O
between O
morphologic O
appearance O
and O
corresponding O
function O
. O

Malaria _RARE_
, O
anaemia _RARE_
, O
and O
HIV O
- O
1 O
transmission _RARE_
in O
central O
Africa _RARE_
. O

BSE _RARE_
and O
farmworkers _RARE_
. O

In O
addition O
, O
two O
- O
dimensional O
nuclear O
magnetic O
resonance O
studies O
with O
F17A _RARE_
, O
K13Q _RARE_
, O
F15Y _RARE_
and O
F27Y _RARE_
revealed O
that O
the O
mutants O
have O
the O
same O
overall O
structure _RARE_
as _RARE_
the O
wild I-GENE
- I-GENE
type I-GENE
CspB _RARE_
protein I-GENE
. O

Considerably _RARE_
high O
levels O
of O
IgE I-GENE
antibodies I-GENE
was O
also O
established O
while O
other O
pollens _RARE_
did O
not O
show O
such O
correspondence _RARE_
. O

Peroxisome _RARE_
proliferator _RARE_
- I-GENE
activated I-GENE
receptors I-GENE
( O
PPARs _RARE_
) O
and O
retinoid I-GENE
X I-GENE
receptors I-GENE
( O
RXRs _RARE_
) O
are O
nuclear I-GENE
hormone I-GENE
receptors I-GENE
that O
are O
activated O
by O
fatty O
acids _RARE_
and O
9 O
- O
cis O
- O
retinoic O
acid O
, O
respectively O
. O

This O
is O
particularly O
intriguing _RARE_
because O
SKUT _RARE_
- O
1B _RARE_
- O
20 O
cells O
lack O
the O
transcription O
factor O
Pit I-GENE
- I-GENE
1 I-GENE
. O

The O
number O
of O
lactotropes _RARE_
, O
somatotropes _RARE_
, O
thyrotropes _RARE_
, O
and O
gonadotropes _RARE_
was O
not O
altered O
compared O
with O
controls O
, O
indicating O
that O
in O
the O
adult O
pituitary O
, O
POMC _RARE_
products I-GENE
are O
not O
required O
to O
maintain O
the O
distribution O
of O
cell O
types _RARE_
. O

Some O
strains O
of O
A O
. O
parasiticus _RARE_
produced O
all O
four O
aflatoxins _RARE_
B1 _RARE_
B2 _RARE_
G1 O
G2 _RARE_
, O
while O
the O
other O
ones O
produced O
AF _RARE_
B1 _RARE_
+ O
G1 O
only O
, O
with O
concentrations O
of O
aflatoxins _RARE_
from O
0 _RARE_
. O
1 O
to O
450 _RARE_
mg O
/ O
kg O
. O

We O
have O
isolated O
a O
new O
, O
larger O
rat I-GENE
B I-GENE
- I-GENE
myc I-GENE
genomic I-GENE
clone I-GENE
. O

In O
addition O
to O
the O
nine O
and O
51 _RARE_
terminal O
amino O
acid O
forms O
already O
known O
, O
we O
identified O
a O
third O
with O
43 _RARE_
terminal O
amino O
acids _RARE_
predicted O
to O
encode O
a O
novel O
RET I-GENE
protein I-GENE
isoform I-GENE
. O

Both O
classes O
of O
MHBst _RARE_
proteins I-GENE
were O
found O
to O
form O
dimers _RARE_
; O
an O
which O
is O
involved O
in O
mediating O
the O
dimerization _RARE_
. O

In O
electrophoretic O
mobility O
shift O
assays O
, O
the O
PERE _RARE_
formed O
three O
major O
complexes O
( O
P1 O
, O
P2 O
and O
P3 _RARE_
) O
with O
proteins O
in O
nuclear O
extracts O
from O
HeLa O
or O
293 O
cells O
. O

She _RARE_
had O
been O
receiving O
MTX _RARE_
7 O
. O
5 O
mg O
/ O
week O
for _RARE_
2 O
. O
5 O
months O
because O
of O
her _RARE_
vasculitis O
symptoms O
. O

Analysis O
of O
the O
sequence O
identified O
four O
open _RARE_
reading O
frames O
( O
ORFs _RARE_
) O
which O
are O
designated O
UL1 _RARE_
, O
UL2 _RARE_
, O
UL3 _RARE_
, O
and O
UL3 _RARE_
. I-GENE
5 I-GENE
based O
on O
their O
homology O
with O
proteins O
of O
herpes O
simplex O
virus O
- O
1 O
( O
HSV O
- O
1 O
), _RARE_
pseudorabies O
virus O
( O
PRV _RARE_
), _RARE_
equine _RARE_
herpesvirus _RARE_
- O
1 O
, O
and O
varicella _RARE_
- O
zoster _RARE_
virus O
. O

These O
HPV16 _RARE_
E6 _RARE_
/ O
E7 I-GENE
cDNAs O
were O
cloned _RARE_
under O
the O
SV40 I-GENE
enhancer I-GENE
/ I-GENE
promoter I-GENE
and O
the O
MMTV _RARE_
LTR I-GENE
to O
examine O
the O
activities O
of O
ras I-GENE
- O
collaborative _RARE_
transformation O
and O
induction O
of O
cellular O
DNA O
synthesis _RARE_
, O
both O
of O
which O
depend O
on O
the O
E7 I-GENE
gene I-GENE
product O
. O

Correlation _RARE_
coefficients O
between O
the O
reference O
methods O
and O
NIT _RARE_
were O
> O
or O
= O
0 _RARE_
. O
95 _RARE_
for _RARE_
water O
, O
fat O
, O
crude O
protein O
and O
connective _RARE_
- O
tissue O
- O
protein O
frei _RARE_
meat O
protein O
, O
and O
> O
or O
= O
0 _RARE_
. O
86 _RARE_
for _RARE_
connective _RARE_
- O
tissue O
- O
protein O
. O

The O
translation O
products O
of O
both O
clones _RARE_
are O
highly O
homologous O
to O
APS1 _RARE_
( O
66 _RARE_
and O
86 _RARE_
% O
identity O
, O
respectively O
) O
over O
their O
entire _RARE_
lengths O
, O
including O
amino O
terminal O
sequences O
resembling O
transit O
peptides O
for _RARE_
plastid _RARE_
localization _RARE_
. O

The O
serum O
levels O
of O
IgE I-GENE
, O
and O
asIgE _RARE_
and O
IgG I-GENE
- I-GENE
4 I-GENE
against O
14 O
common O
food O
allergens O
were O
determined O
. O

Two O
experiments O
investigating _RARE_
the O
effects O
of O
short O
- O
term O
spaceflight _RARE_
on O
cancellous _RARE_
bone O
turnover O
were O
carried O
out O
: O
Physiological _RARE_
Systems _RARE_
Experiment O
- O
1 O
( O
PSE _RARE_
- O
1 O
) O
( O
a O
4 O
- O
d O
orbital _RARE_
spaceflight _RARE_
) O
and O
PSE _RARE_
- O
2 O
( O
a O
10 O
- O
d O
flight _RARE_
). O

That _RARE_
sequence O
strongly O
promoted O
the O
transcription O
of O
the O
promotorless _RARE_
chloramphenicol I-GENE
acetyltranferase _RARE_
( O
CAT I-GENE
) O
gene O
in O
cells O
of O
pancreatic O
origin O
( O
AR _RARE_
- O
42J _RARE_
) O
but O
not O
in O
cells O
of O
non O
- O
pancreatic O
origin O
( O
Rat _RARE_
2 O
and O
IEC _RARE_
6 O
). O

Functional O
analysis O
of O
aryl _RARE_
hydrocarbon I-GENE
receptor I-GENE
nuclear I-GENE
translocator _RARE_
interactions O
with O
aryl _RARE_
hydrocarbon I-GENE
receptor I-GENE
in O
the O
yeast O
two O
- O
hybrid _RARE_
system _RARE_
. O

Histopathologic _RARE_
observations O
showed O
that O
both O
somatostatin I-GENE
and O
triamcinolone _RARE_
acetonide _RARE_
reduced _RARE_
the O
inflammatory O
signs O
in O
the O
joint O
structures _RARE_
, O
although O
triamcinolone _RARE_
acetonide _RARE_
appeared O
to O
be O
more O
effective O
. O

An O
approach O
to O
a O
biomathematical _RARE_
model O
of O
lymphocytopoiesis _RARE_
. O

The O
influenza _RARE_
virus O
NS1 I-GENE
protein O
is O
a O
unique O
posttranscriptional O
regulator O
that O
has O
two O
activities O
: O
inhibition O
of O
the O
nuclear O
export O
of O
poly _RARE_
A O
- O
containing O
mRNAs O
and O
inhibition O
of O
pre O
- O
mRNA O
splicing _RARE_
. O

These O
are O
two O
regions O
of O
known O
conserved _RARE_
synteny _RARE_
, O
providing O
further O
evidence O
that O
the O
human I-GENE
STEP _RARE_
is O
a O
true O
homolog O
of O
the O
murine I-GENE
STEP _RARE_
gene I-GENE
. O

Molecular O
cloning O
of O
the O
human O
homolog O
of O
a O
striatum _RARE_
- I-GENE
enriched _RARE_
phosphatase I-GENE
( I-GENE
STEP _RARE_
) I-GENE
gene I-GENE
and O
chromosomal O
mapping O
of O
the O
human O
and O
murine O
loci O
. O

Carbonic _RARE_
anhydrase I-GENE
V I-GENE
( O
CA I-GENE
V I-GENE
) O
is O
expressed _RARE_
in O
mitochondrial O
matrix _RARE_
in O
liver O
and O
several O
other O
tissues O
. O

Vitamin _RARE_
D3 _RARE_
plus _RARE_
nicotine O
treatment O
produced O
parallel O
increases O
in O
cardiac O
mass O
and O
elastic O
modulus _RARE_
, O
with O
a O
significant O
correlation O
between O
the O
two O
. O

The O
latter O
domain O
appears O
to O
be O
involved O
in O
targeting O
Num1p _RARE_
to O
the O
mother _RARE_
cell O
cortex O
. O

This O
finding O
is O
consistent O
with O
the O
notion O
that O
the O
dsRNA _RARE_
binding O
domains O
may O
be O
composed O
of O
two O
separate O
functional _RARE_
subdomains O
. O

Preferential _RARE_
heterodimeric _RARE_
parallel O
coiled _RARE_
- O
coil _RARE_
formation O
by O
synthetic _RARE_
Max I-GENE
and O
c I-GENE
- I-GENE
Myc _RARE_
leucine I-GENE
zippers _RARE_
: O
a O
description O
of O
putative O
electrostatic _RARE_
interactions O
responsible O
for _RARE_
the O
specificity _RARE_
of O
heterodimerization O
. O

Comparison O
to O
other O
coxI _RARE_
genes I-GENE
revealed O
a O
966 _RARE_
- O
bp O
group O
I O
intron O
, O
which O
, O
based O
on O
homology O
with O
the O
related O
yeast I-GENE
coxI _RARE_
intron I-GENE
aI4 _RARE_
, O
potentially O
encodes O
a O
279 _RARE_
- O
amino O
- O
acid O
site O
- O
specific O
DNA I-GENE
endonuclease I-GENE
. O

We O
studied O
the O
GR I-GENE
in O
DMS _RARE_
- O
79 _RARE_
cells O
derived O
from O
a O
human O
ACTH I-GENE
- O
secreting O
small O
cell O
lung _RARE_
cancer _RARE_
. O

This O
study O
analyzed O
whether O
the O
localization _RARE_
of O
an O
accessory _RARE_
pathway _RARE_
could O
be O
predicted O
by O
using O
the O
polarity O
of O
the O
QRS O
complex O
during _RARE_
sinus O
rhythm O
on O
the O
surface O
ECG O
, O
instead O
of O
the O
delta O
wave O
polarity O
as _RARE_
used O
in O
many O
reports O
. O

The O
promoter O
mutation O
is O
complemented O
in O
trans _RARE_
by O
E1A I-GENE
products O
of O
the O
heterologous O
helper _RARE_
adenovirus O
type O
5 O
( O
Ad5 _RARE_
). O

Thus O
, O
as _RARE_
expected O
, O
trans _RARE_
- O
splicing _RARE_
depends O
on O
the O
integrity O
of O
U2 _RARE_
, O
U4 I-GENE
, O
and O
U6 I-GENE
snRNAs _RARE_
. O

Treatment O
of O
PCC4 _RARE_
. O
aza1R _RARE_
cells O
with O
an O
RAR I-GENE
- O
selective O
agonist O
also O
repressed O
the O
expression _RARE_
of O
EC I-GENE
- I-GENE
1 I-GENE
mRNA I-GENE
while O
treatment O
with O
an O
RXR I-GENE
- O
selective O
agonist O
reduced _RARE_
EC I-GENE
- I-GENE
1 I-GENE
expression _RARE_
slightly O
. O

In O
the O
absence O
of O
E1A243 _RARE_
, O
YY1 I-GENE
represses O
CRE _RARE_
- O
dependent O
transcription O
of O
c I-GENE
- I-GENE
fos I-GENE
by O
physically O
interacting _RARE_
with O
ATF I-GENE
/ O
CREB I-GENE
proteins O
bound _RARE_
to O
the O
- O
67 O
CRE _RARE_
. O

Shift _RARE_
- O
down O
experiments O
indicated O
that O
the O
10 O
( O
4 O
)- O
to O
10 O
( O
5 O
)- O
fold _RARE_
reduction O
in O
virus O
yield O
at _RARE_
the O
nonpermissive _RARE_
temperature _RARE_
was O
due O
to O
the O
disfunction _RARE_
of O
alpha I-GENE
TIF I-GENE
late _RARE_
in O
infection O
, O
presumably O
in O
virion O
maturation _RARE_
. O

These O
results O
demonstrate O
that O
tip _RARE_
acts O
at _RARE_
an O
early O
stage _RARE_
of O
the O
T O
- O
cell O
signal O
transduction _RARE_
cascade O
by O
associating _RARE_
with O
Lck _RARE_
and O
downregulating _RARE_
Lck _RARE_
- O
mediated _RARE_
activation O
. O

Human I-GENE
immunodeficiency I-GENE
virus I-GENE
type I-GENE
1 I-GENE
Vpr _RARE_
is O
a O
virion O
- O
associated O
, O
regulatory O
protein O
that O
is O
required O
for _RARE_
efficient O
viral O
replication O
in O
monocytes O
/ O
macrophages O
. O

Here O
we O
examine O
the O
potential _RARE_
for _RARE_
VP16 I-GENE
protein O
- O
protein O
interactions O
specific O
to O
virus O
- O
infected _RARE_
cells O
and O
show O
that O
VP16 I-GENE
copurifies _RARE_
in O
a O
highly O
enriched _RARE_
fraction O
with O
a O
single O
major O
polypeptide O
which O
we O
identify O
as _RARE_
the O
virus O
- O
encoded O
structural O
protein O
VP22 _RARE_
. O

Thus O
, O
transcriptional O
regulation _RARE_
, O
splicing _RARE_
, O
kinase O
interaction O
sites O
, O
and O
tyrosine O
phosphorylation _RARE_
of O
the O
LMP2A _RARE_
homologs I-GENE
have O
been O
conserved _RARE_
despite O
significant O
sequences O
heterogeneity O
in O
the O
preterminal _RARE_
repeat O
regions O
of O
these O
human O
and O
nonhuman _RARE_
primate O
EBVs _RARE_
. O

Results O
of O
the O
ECAT _RARE_
Angina _RARE_
Pectoris _RARE_
Study O
Group O
. O

Therefore O
, O
a O
prospective O
Phase O
II O
trial O
was O
conducted O
to O
determine O
the O
safety O
and O
efficacy O
of O
cryosurgery _RARE_
following O
radiation O
therapy O
in O
men O
with O
local O
recurrence O
. O

These O
motifs O
include O
a O
Chi O
motif O
and O
a O
Chi O
- O
like O
element O
previously O
found O
in O
the O
recombination _RARE_
hotspot _RARE_
region O
of O
the O
Bcl I-GENE
- I-GENE
2 I-GENE
proto _RARE_
- I-GENE
oncogene I-GENE
and O
close O
to O
chromosomal O
breakpoints O
in O
T O
- O
ALL O
lines O
. O

Common _RARE_
history O
and O
prospects _RARE_
in O
surgical O
gynecology _RARE_
of O
the O
Charite _RARE_
and O
the O
Vienna _RARE_
University O
Clinic _RARE_

In O
contrast O
with O
the O
previously O
reported O
HMGR1 _RARE_
mRNA I-GENE
( O
HMGR1S _RARE_
mRNA I-GENE
), _RARE_
which O
is O
detected O
at _RARE_
high O
levels O
in O
all O
tissues O
of O
the O
plant _RARE_
, O
HMGR1L _RARE_
mRNA I-GENE
is O
present O
at _RARE_
relatively O
low O
levels O
and O
its O
expression _RARE_
is O
restricted O
mostly O
to O
seedlings O
, O
roots O
and O
inflorescences _RARE_
. O

However O
, O
the O
requirement O
of O
rev3 _RARE_
for _RARE_
the O
production O
of O
G O
. O
C O
--> _RARE_
T O
. O
A O
transversions _RARE_
by O
the O
rad18 _RARE_
mutator _RARE_
, O
which O
induces O
only O
these O
substitutions O
, O
was O
similar O
to O
that O
for _RARE_
rad6 _RARE_
- O
mediated _RARE_
G O
. O
C O
--> _RARE_
T O
. O
A O
transversion O
. O

The O
second O
mutation O
present O
in O
the O
original O
mutant O
proved O
to O
be O
an O
allele O
of O
a O
known O
gene O
, O
PBS2 _RARE_
, O
which O
encodes O
a O
putative O
protein O
kinase O
that O
functions O
in O
the O
high O
osmolarity _RARE_
stress O
pathway _RARE_
. O

In O
adult O
tissues O
, O
it O
was O
less O
restricted O
, O
indicating O
that O
RAFTK _RARE_
expression _RARE_
is O
developmentally O
up _RARE_
- O
regulated O
. O

As O
hGM _RARE_
- I-GENE
CSF I-GENE
receptor I-GENE
( O
hGMR _RARE_
) O
does O
not O
contain O
a O
consensus O
sequence O
for _RARE_
binding O
of O
PI I-GENE
3 I-GENE
- I-GENE
kinase I-GENE
, O
hGMR _RARE_
must O
use O
a O
distinct O
mechanism O
for _RARE_
its O
association O
with O
and O
activation O
of O
PI I-GENE
3 I-GENE
- I-GENE
kinase I-GENE
. O

J _RARE_
. O

The O
identity O
between O
hnRNPs _RARE_
H I-GENE
and O
H I-GENE
' I-GENE
is O
96 O
%, O
between O
H I-GENE
and O
F I-GENE
78 _RARE_
%, O
and O
between O
H I-GENE
' I-GENE
and O
F I-GENE
75 _RARE_
%, O
respectively O
. O

TPBF _RARE_
has O
two O
potential _RARE_
coiled _RARE_
- O
coil _RARE_
regions O
, O
a O
basic O
region O
, O
a O
proline O
- O
rich O
region O
, O
a O
histidine _RARE_
- O
rich O
N O
terminus O
, O
and O
a O
nuclear O
targeting O
sequence O
. O

In O
the O
present O
study O
, O
we O
transiently O
expressed _RARE_
in O
primary _RARE_
cultures O
of O
rat O
hepatocytes O
plasmids O
consisting O
of O
CYP3A1 _RARE_
5 I-GENE
'- I-GENE
flanking I-GENE
sequences I-GENE
fused O
to O
a O
chloramphenicol I-GENE
acetyltransferase _RARE_
reporter I-GENE
plasmid _RARE_
. O

We O
show O
that O
stimulation _RARE_
of O
resting O
splenic O
B O
cells O
with O
CD40L _RARE_
- O
expressing O
Sf9 O
cells O
induces O
germ _RARE_
- O
line O
gamma O
1 O
and O
epsilon O
transcripts O
independently O
of O
cytokines _RARE_
. O

To O
confirm O
the O
GapIII _RARE_
protein I-GENE
activity O
, O
constructs O
containing O
different O
GapIII _RARE_
- O
GRD _RARE_
domains O
were O
transformed O
into O
iral _RARE_
mutant O
yeast O
to O
determine O
their O
relative O
ability O
to O
replace O
IRA1 _RARE_
functionally O
. O

At O
the O
time O
of O
the O
13 _RARE_
latest _RARE_
BPVs _RARE_
, O
age O
ranged O
from O
three O
days O
to O
13 _RARE_
. O
1 O
years O
( O
mean O
5 O
. O
7 O
+/- O
SD O
4 O
. O
8 O
years O
). O

A O
tobacco O
homologue O
( O
trolC _RARE_
) O
of O
the O
rolC _RARE_
gene I-GENE
of I-GENE
the I-GENE
Agrobacterium _RARE_
rhizogenes _RARE_
Ri _RARE_
- I-GENE
plasmid _RARE_
was O
cloned _RARE_
and O
sequenced O
from O
Nicotiana _RARE_
tabacum _RARE_
L O
. O
cv O
. O

High _RARE_
ADR1 I-GENE
gene I-GENE
dosage O
increased O
the O
transcription O
of O
genes O
encoding O
peroxisomal _RARE_
proteins O
as _RARE_
compared O
to O
one O
copy O
of O
the O
ADR1 I-GENE
gene I-GENE
. O

A O
water O
- O
vapour _RARE_
giga _RARE_
- O
maser _RARE_
in O
the O
active _RARE_
galaxy _RARE_
TXFS2226 _RARE_
- O
184 _RARE_
. O

Of O
the O
three O
known O
C I-GENE
/ I-GENE
EBP I-GENE
family I-GENE
inhibitors _RARE_
, O
Ig I-GENE
/ I-GENE
EBP I-GENE
, O
LIP _RARE_
and O
CHOP _RARE_
- I-GENE
10 I-GENE
, O
only O
Ig I-GENE
/ I-GENE
EBP I-GENE
is O
ubiquitously O
expressed _RARE_
. O

The O
effects O
of O
a O
1 O
- O
or O
24 _RARE_
- O
hour O
pretreatment O
regimen O
with O
monophosphoryl _RARE_
lipid _RARE_
A O
( O
MLA _RARE_
, O
35 _RARE_
micrograms O
/ O
kg O
i O
. O
v O
.) O
on O
myocardial _RARE_
stunning _RARE_
produced O
by O
repetitive _RARE_
coronary O
occlusions _RARE_
were O
studied O
in O
barbital _RARE_
- O
anesthetized O
dogs O
. O

These O
incisors _RARE_
were O
studied O
by O
scanning O
electron O
microscopy O
- O
energy O
dispersive _RARE_
spectroscopy O
analysis O
( O
SEM _RARE_
- O
EDS _RARE_
) O
and O
light O
microscopy O
to O
examine O
the O
calciotraumatic _RARE_
lines O
of O
strontium _RARE_
in O
the O
rat O
incisor _RARE_
labial _RARE_
dentin O
. O

A O
platelet I-GENE
- I-GENE
derived I-GENE
growth I-GENE
factor I-GENE
receptor I-GENE
( O
PDGF _RARE_
- I-GENE
R I-GENE
) O
phosphopeptide _RARE_
containing O
Tyr _RARE_
- O
857 _RARE_
does O
not O
bind O
appreciably _RARE_
to O
the O
Src I-GENE
SH2 _RARE_
domain I-GENE
, O
suggesting O
it O
is O
not O
the O
PDGF _RARE_
- I-GENE
R I-GENE
binding O
site O
for _RARE_
Src I-GENE
as _RARE_
previously O
reported O
. O

We O
have O
also O
tested O
Src I-GENE
SH2 _RARE_
mutants O
for _RARE_
their O
binding O
properties O
and O
have O
interpreted O
our O
results O
in O
light O
of O
the O
recent O
crystal _RARE_
structure _RARE_
solution O
for _RARE_
the O
Src I-GENE
SH2 _RARE_
domain O
. O

These O
observations O
link _RARE_
actin I-GENE
plaque O
assembly O
to O
increased O
cell O
substrate O
adhesion O
. O

The O
early O
lethality O
of O
the O
left _RARE_
- O
sided _RARE_
resectio _RARE_
was O
0 _RARE_
% O
and O
the O
postoperative O
survival O
-- _RARE_
5 O
- O
10 O
months O
. O

There O
are O
two O
immunogenic _RARE_
sites O
on O
the O
type O
A O
influenza _RARE_
A O
/ O
Japan O
/ O
57 O
( O
H2N2 _RARE_
) O
hemagglutinin I-GENE
( O
HA _RARE_
) O
that O
can O
be O
recognized _RARE_
by O
class I-GENE
I I-GENE
major I-GENE
histocompatibility I-GENE
complex I-GENE
( O
MHC I-GENE
), _RARE_
H I-GENE
- I-GENE
2Kd _RARE_
- O
restricted O
cytolytic _RARE_
T O
lymphocytes O
( O
CTLs _RARE_
). O

This O
enhancer O
activates O
both O
the O
K19 _RARE_
and O
TK I-GENE
basal I-GENE
promoters I-GENE
in O
HeLa O
cells O
. O

Mechanism O
of O
enhancement O
of O
DNA O
expression _RARE_
consequent _RARE_
to O
cointernalization _RARE_
of O
a O
replication O
- O
deficient _RARE_
adenovirus O
and O
unmodified _RARE_
plasmid _RARE_
DNA O
. O

Interestingly O
, O
one O
IRF I-GENE
binding I-GENE
site I-GENE
was O
found O
within O
the O
IRF I-GENE
- I-GENE
2 I-GENE
promoter I-GENE
, O
and O
expression _RARE_
of O
the O
IRF I-GENE
- I-GENE
2 I-GENE
gene I-GENE
was O
affected O
by O
both O
transient O
and O
stable O
IRF I-GENE
- I-GENE
1 I-GENE
expression _RARE_
. O

Therefore O
, O
we O
studied O
ninety _RARE_
coagulopathic _RARE_
patients O
with O
the O
aim O
of O
determining _RARE_
the O
prevalence O
of O
hepatitis I-GENE
C I-GENE
virus I-GENE
( I-GENE
HCV I-GENE
) I-GENE
antibodies I-GENE
using O
the O
ELISA O
and O
RIBA _RARE_
methods O
. O

The O
highest O
decrease O
in O
mutagenic _RARE_
activity O
was O
observed O
when O
enzymatic O
bleaching _RARE_
was O
used O
together O
with O
chlorine _RARE_
. O

Hepatitis _RARE_
B I-GENE
surface I-GENE
antigen I-GENE
was O
detected O
in O
2 O
patients O
, O
with O
negative O
hepatitis I-GENE
C I-GENE
virus I-GENE
antibody I-GENE
. O

There O
was O
also O
a O
highly O
significant O
correlation O
between O
total _RARE_
selenium O
intake O
and O
liver O
selenium O
concentration O
( O
r _RARE_
= O
0 _RARE_
. O
99 _RARE_
, O
p O
< O
0 _RARE_
. O
01 O
) O
after O
1 O
mo O
of O
treatment O
, O
but O
this O
time O
liver O
selenium O
did O
not O
change O
with O
time O
, O
and O
the O
correlation O
remained O
highly O
significant O
throughout O
the O
investigation O
. O

Antibodies O
affinity O
- O
purified _RARE_
using O
the O
bacterially O
expressed _RARE_
recombinant O
protein O
recognized _RARE_
the O
56K _RARE_
autoantigen _RARE_
in O
a O
HeLa O
cell O
extract _RARE_
. O
cDNA O
sequencing O
revealed O
that O
the O
56K _RARE_
cDNA I-GENE
shares O
a O
high O
degree O
of O
homology O
in O
both O
nucleotide O
( O
87 O
%) O
and O
amino O
acid O
sequence O
( O
92 O
. O
5 O
%) O
with O
bovine I-GENE
annexin _RARE_
XI _RARE_
, O
indicating O
that O
the O
56K _RARE_
cDNA I-GENE
encodes O
the O
human I-GENE
homologue I-GENE
of I-GENE
annexin _RARE_
XI _RARE_
, O
a O
member _RARE_
of O
the O
Ca I-GENE
( I-GENE
2 I-GENE
+)- _RARE_
dependent I-GENE
phospholipid _RARE_
binding I-GENE
protein I-GENE
family I-GENE
. O

The O
avidin _RARE_
- I-GENE
biotin _RARE_
complex I-GENE
peroxidase I-GENE
( O
ABC _RARE_
- I-GENE
P I-GENE
) O
method O
was O
used O
to O
detect O
Mycobacterium O
bovis _RARE_
, O
and O
the O
results O
were O
compared O
with O
those O
obtained O
by O
the O
Ziehl _RARE_
- O
Neelsen _RARE_
( O
ZN _RARE_
) O
technique O
. O

Its O
role O
in O
these O
processes O
suggests O
that O
the O
function O
of O
c I-GENE
- I-GENE
Myb I-GENE
may O
be O
important O
early O
in O
the O
establishment O
of O
the O
hematopoietic O
lineage O
. O

The O
transforming O
gene O
of O
the O
avian I-GENE
sarcoma I-GENE
virus I-GENE
CT10 _RARE_
encodes O
a O
fusion O
protein O
( O
p47gag _RARE_
- O
crk _RARE_
or O
v I-GENE
- I-GENE
Crk I-GENE
) O
containing O
viral I-GENE
Gag I-GENE
sequences I-GENE
fused O
to O
cellular O
sequences O
consisting O
primarily O
of O
Src I-GENE
homology I-GENE
regions I-GENE
2 I-GENE
and I-GENE
3 I-GENE
( O
SH2 _RARE_
and O
SH3 I-GENE
sequences I-GENE
). O

This O
specific O
methylation O
pattern O
caused O
inactivation O
of O
the O
HSV I-GENE
tk I-GENE
gene I-GENE
, O
while O
methylation O
of O
the O
cytosine O
residues O
within O
the O
nucleotide O
sequence O
from O
+ O
811 _RARE_
to O
+ O
1309 _RARE_
had O
no _RARE_
effect O
on O
HSV I-GENE
tk I-GENE
gene I-GENE
activity O
. O

CONCLUSION O
: O
This O
study O
documents _RARE_
that O
regression O
of O
choroidal _RARE_
neovascularization _RARE_
that O
occurred O
with O
alpha I-GENE
interferon _RARE_
treatment O
was O
minimal O
. O

Long _RARE_
- O
range O
mapping O
of O
the O
11q23 _RARE_
region O
involved O
in O
chromosome _RARE_
aberrations _RARE_
in O
human O
tumors O
by O
pulsed O
- O
field O
gel O
electrophoresis O
with O
a O
yeast O
artificial O
chromosome _RARE_
. O

GTRE _RARE_
, O
TRE _RARE_
, O
and O
CRE _RARE_
oligonucleotides O
all O
compete O
more O
efficiently O
for _RARE_
protein O
binding O
to O
their O
labeled O
congeners _RARE_
than O
for _RARE_
protein O
binding O
to O
either O
of O
the O
other O
labeled O
oligonucleotides O
, O
suggesting O
that O
the O
GTRE _RARE_
, O
TRE _RARE_
, O
and O
CRE _RARE_
oligonucleotides O
, O
suggesting O
that O
the O
GTRE _RARE_
, O
TRE _RARE_
, O
and O
CRE _RARE_
oligonucleotides O
each O
bind O
unique O
as _RARE_
well _RARE_
as _RARE_
common O
proteins O
, O
likely O
to O
be O
members O
of O
the O
Jun I-GENE
/ O
Fos I-GENE
and O
cAMP I-GENE
- I-GENE
responsive I-GENE
element I-GENE
- I-GENE
binding I-GENE
protein I-GENE
/ O
activating I-GENE
transcription I-GENE
factors I-GENE
( O
CREB I-GENE
/ O
ATF I-GENE
) O
families _RARE_
of O
transcription O
factors O
, O
in O
chromaffin _RARE_
cells O
. O

One O
patient O
only O
had O
any O
test O
abnormalities O
. O

One O
antibody O
, O
mAb1C2 _RARE_
, O
and O
a O
synthetic _RARE_
peptide O
comprising _RARE_
its O
epitope _RARE_
selectively O
inhibited O
in O
vitro O
transcription O
from O
TATA O
- O
containing O
, O
but O
not O
from O
TATA O
- O
less O
promoters O
, O
irrespective O
of O
whether O
they O
were O
transcribed _RARE_
by O
Pol I-GENE
II I-GENE
or O
Pol I-GENE
III I-GENE
. O

The O
lymph O
nodes O
from O
two O
of O
the O
patients O
with O
rheumatoid O
arthritis O
contained O
numerous O
sarcoid _RARE_
like O
granulomata _RARE_
, O
further O
indicating O
a O
possible O
association O
between O
sarcoidosis _RARE_
and O
rheumatoid O
arthritis O
. O

HCV O
infection O
acquired O
during _RARE_
or O
after O
BMT _RARE_
caused O
only O
mild O
acute O
hepatitis O
C O
, O
which O
progressed O
to O
chronic O
hepatitis O
C O
in O
one O
patient O
surviving _RARE_
10 O
years O
after O
BMT _RARE_
. O

Hepatitis _RARE_
C O
virus O
infection O
is O
a O
risk O
factor O
for _RARE_
liver O
failure O
from O
veno _RARE_
- O
occlusive _RARE_
disease _RARE_
after O
bone O
marrow O
transplantation O
. O

High _RARE_
plasma O
concentrations O
of O
soluble _RARE_
E I-GENE
- I-GENE
selectin I-GENE
were O
closely O
associated O
with O
multiple O
- O
organ O
dysfunction O
and O
death _RARE_
. O

These O
human O
IFN I-GENE
- I-GENE
beta I-GENE
- O
transformed O
cell O
populations O
have O
acquired O
a O
low O
, O
constitutive _RARE_
production O
of O
human I-GENE
IFN I-GENE
, O
while O
replicating _RARE_
at _RARE_
a O
rate O
similar O
to O
that O
of O
untransformed _RARE_
cells O
and O
of O
cells O
transformed O
with O
the O
control O
vector O
carrying O
a O
human I-GENE
IFN I-GENE
- I-GENE
beta I-GENE
sequence I-GENE
encoding O
an O
inactive O
, O
mutated _RARE_
protein O
. O

Improvement _RARE_
of O
the O
polypyrimidine _RARE_
tract _RARE_
also O
increased O
the O
splicing _RARE_
efficiency O
, O
but O
to O
a O
degree O
slightly O
less O
than O
that O
obtained O
with O
the O
branchpoint O
mutation O
. O

Liver O
transplantation O
in O
one O
patient O
resolved O
metabolic O
complications O
but O
did O
not O
improve O
PMN _RARE_
count O
or O
the O
infectious O
status O
, O
while O
neutropenia O
was O
corrected O
by O
G I-GENE
- I-GENE
CSF I-GENE
. O

Joys _RARE_
and O
F O
. O

Activation O
of O
the O
SH2 _RARE_
- I-GENE
containing I-GENE
protein I-GENE
tyrosine I-GENE
phosphatase I-GENE
, O
SH _RARE_
- I-GENE
PTP2 _RARE_
, O
by O
phosphotyrosine _RARE_
- O
containing O
peptides O
derived O
from O
insulin I-GENE
receptor I-GENE
substrate I-GENE
- I-GENE
1 I-GENE
. O

Tyrosine _RARE_
phosphorylation _RARE_
of O
cellular O
proteins O
is O
the O
earliest _RARE_
identifiable _RARE_
event O
following O
T I-GENE
- I-GENE
cell I-GENE
antigen I-GENE
receptor I-GENE
( O
TCR I-GENE
) O
stimulation _RARE_
and O
is O
essential O
for _RARE_
activating O
downstream _RARE_
signaling _RARE_
machinery O
. O

The O
interferon _RARE_
- O
induced _RARE_
RNA I-GENE
- I-GENE
dependent I-GENE
protein I-GENE
kinase I-GENE
( O
PKR I-GENE
) O
is O
considered O
to O
play O
an O
important O
role O
in O
the O
cellular O
defense O
against O
viral O
infection O
and O
, O
in O
addition O
, O
has O
been O
suggested O
to O
be O
a O
tumor O
suppressor O
gene O
because O
of O
its O
growth O
- O
suppressive _RARE_
properties O
. O

Moreover O
, O
Lck _RARE_
was O
reversibly _RARE_
co _RARE_
- O
immunoprecipitated O
with O
p95Vav _RARE_
, O
and O
the O
stoichiometry _RARE_
of O
binding O
increased O
in O
anti I-GENE
- I-GENE
CD3 I-GENE
- O
treated O
Jurkat O
cells O
. O

In O
contrast O
, O
injection O
of O
a O
plasmid _RARE_
encoding O
simian I-GENE
virus I-GENE
40 I-GENE
small I-GENE
t I-GENE
antigen I-GENE
, O
which O
interacts O
with O
PP2A I-GENE
to O
inhibit O
its O
activity O
towards O
several O
phosphoprotein _RARE_
substrates _RARE_
, O
had O
no _RARE_
effect O
on O
the O
phosphorylation _RARE_
state O
of O
CREB I-GENE
in O
stimulated _RARE_
or O
unstimulated O
NIH _RARE_
3T3 O
cells O
. O

Several O
Src I-GENE
SH3 I-GENE
- I-GENE
binding I-GENE
proteins I-GENE
were O
phosphorylated _RARE_
in O
Src I-GENE
- O
transformed O
cells O
. O

We O
also O
examined O
the O
effect O
of O
proteolytic _RARE_
processing _RARE_
in O
the O
MVE _RARE_
nonstructural _RARE_
polyprotein _RARE_
segment O
mediated _RARE_
by O
the O
viral I-GENE
proteinase _RARE_
NS3 _RARE_
on O
antigen O
processing _RARE_
and O
presentation O
of O
the O
MVE _RARE_
H O
- O
2Kk _RARE_
- O
restricted O
T O
cell O
determinant O
. O

A O
full I-GENE
- I-GENE
length I-GENE
PRL I-GENE
receptor I-GENE
( O
PRLR _RARE_
) O
complementary _RARE_
DNA O
from O
pigeons _RARE_
was O
obtained O
by O
screening O
pigeon _RARE_
crop _RARE_
sac _RARE_
libraries O
and O
by O
reverse O
transcription O
coupled O
with O
polymerase O
chain O
reaction O
. O

After O
7 O
days O
, O
a O
spontaneous O
regression O
of O
the O
morphologic O
alterations O
caused O
by O
caerulein _RARE_
- O
induced _RARE_
acute O
pancreatitis O
occurs O
; O
however O
, O
recovery O
of O
the O
secretory _RARE_
function O
of O
the O
pancreas O
was O
only O
reached O
after O
this O
period O
of O
time O
when O
L O
- O
364 _RARE_
, O
718 _RARE_
was O
administered O
therapeutically _RARE_
( O
0 _RARE_
. O
1 O
mg O
/ O
kg O
/ O
day O
). O

We O
observed O
that O
dephosphorylation _RARE_
severely O
inhibits O
the O
DNA O
- O
binding O
ability O
of O
C I-GENE
/ I-GENE
EBP I-GENE
- I-GENE
delta I-GENE
and O
its O
transactivating O
potential _RARE_
increases O
in O
the O
presence O
of O
cellular O
phosphatase O
inhibitors _RARE_
, O
such O
as _RARE_
okadaic _RARE_
acid O
and O
sodium _RARE_
orthovanadate _RARE_
. O

Two O
promoters O
were O
identified O
by O
S1 I-GENE
nuclease _RARE_
mapping O
: O
P1 O
, O
which O
lies O
about O
72 O
bp O
upstream O
from O
the O
structural O
gene O
; O
and O
P2 O
, O
which O
lies O
about O
35 _RARE_
bp O
upstream O
. O

Interleukin I-GENE
- I-GENE
8 I-GENE
( O
IL _RARE_
- I-GENE
8 I-GENE
) O
is O
a O
potent O
inflammatory O
mediator _RARE_
that O
belongs O
to O
the O
family O
of O
C I-GENE
- I-GENE
X I-GENE
- I-GENE
C I-GENE
chemokines _RARE_
. O

On O
the O
other O
hand _RARE_
, O
cells O
containing O
a O
PTP1C _RARE_
in O
which O
the O
catalytic O
site O
had O
been O
inactivated O
through O
mutagenesis O
, O
stably O
phosphorylated _RARE_
the O
phosphatase O
. O

We O
recently O
found O
that O
the O
p72syk _RARE_
protein I-GENE
tyrosine I-GENE
kinase I-GENE
is O
physically O
associated O
with O
the O
TCR I-GENE
/ O
CD3 I-GENE
complex O
and O
is O
rapidly O
tyrosine O
phosphorylated _RARE_
and O
activated O
by O
receptor O
triggering _RARE_
also O
in O
T O
cells O
lacking _RARE_
p56lck _RARE_
. O

The O
transforming O
protein O
of O
Rous _RARE_
sarcoma O
virus O
, O
pp60v _RARE_
- I-GENE
src I-GENE
, O
and O
its O
normal O
cellular O
homolog O
, O
pp60c _RARE_
- I-GENE
src I-GENE
, O
differ O
not O
only O
in O
oncogenic _RARE_
potential _RARE_
but O
also O
in O
their O
subcellular O
localization _RARE_
and O
cytoskeletal O
binding O
ability O
. O
pp60v _RARE_
- I-GENE
src I-GENE
has O
been O
shown O
to O
stably O
associate O
with O
a O
detergent O
- O
insoluble _RARE_
cytoskeletal O
matrix _RARE_
, O
whereas O
pp60c _RARE_
- I-GENE
src I-GENE
does O
not O
. O

Organization O
of O
the O
bovine O
gene O
encoding O
the O
endothelial I-GENE
nitric _RARE_
oxide I-GENE
synthase I-GENE
. O

We O
determined O
whether O
regional O
myocardial _RARE_
work O
efficiency O
( O
segment O
work O
/ O
regional O
O2 _RARE_
consumption O
) O
would O
be O
elevated O
by O
surgically O
- O
augmented O
inflow _RARE_
. O

In O
female O
Sl _RARE_
( I-GENE
pan _RARE_
)/ _RARE_
Sl _RARE_
( I-GENE
pan _RARE_
) I-GENE
mice O
, O
ovarian O
follicle _RARE_
development O
is O
arrested O
at _RARE_
the O
one O
layered _RARE_
cuboidal _RARE_
stage _RARE_
as _RARE_
a O
result O
of O
reduced _RARE_
KL _RARE_
expression _RARE_
in O
follicle _RARE_
cells O
, O
indicating O
a O
role O
for _RARE_
c I-GENE
- I-GENE
kit I-GENE
in O
oocyte _RARE_
growth O
. O

Anti _RARE_
- I-GENE
NPROSP _RARE_
- I-GENE
C I-GENE
also O
exclusively O
detected O
time O
- O
dependent O
appearances _RARE_
of O
5 I-GENE
- I-GENE
10 I-GENE
- I-GENE
kDa I-GENE
proSP _RARE_
- I-GENE
C I-GENE
forms O
in O
lamellar _RARE_
bodies _RARE_
and O
homogenates _RARE_
. O

In O
the O
B6 _RARE_
- O
derived O
Db _RARE_
mutant I-GENE
B6 _RARE_
. I-GENE
CH _RARE_
- I-GENE
2bm13 _RARE_
( I-GENE
bm13 _RARE_
) I-GENE
strain _RARE_
, O
part O
of O
the O
class I-GENE
I I-GENE
Db _RARE_
antigen I-GENE
- I-GENE
presenting _RARE_
groove _RARE_
is O
shaped O
by O
a O
class I-GENE
I I-GENE
Kb _RARE_
- I-GENE
encoded I-GENE
sequence I-GENE
. O

Three O
mutants O
( O
pms1 _RARE_
, O
pms2 _RARE_
and O
pms3 _RARE_
) O
isolated O
earlier O
from O
MW104 _RARE_
- O
1B _RARE_
were O
shown O
to O
correct O
in O
vitro O
constructed O
plasmids O
with O
defined O
DNA O
mismatches _RARE_
( O
G O
/ O
T O
, O
A O
/ O
C O
, O
G O
/ O
G O
, O
etc O
.) O
poorly O
( O
Kramer _RARE_
et O
al O
., O
1989a _RARE_
). O

Our O
findings O
confirm O
the O
high O
frequency O
of O
proximal O
nerve O
lesions O
in O
early O
GBS _RARE_
and O
CIDP _RARE_
, O
not O
all O
of O
which O
are O
associated O
with O
distal O
motor O
conduction O
abnormalities O
, O
and O
suggest O
that O
assessment O
of O
multiple O
F O
wave O
parameters O
, O
in O
particular O
chronodispersion _RARE_
, O
mean O
latency _RARE_
and O
mean O
amplitude O
( O
in O
addition O
to O
absence O
and O
minimum O
latency _RARE_
), _RARE_
increases O
the O
yield O
of O
F O
wave O
studies O
. O

Hematopoietic _RARE_
growth I-GENE
factors I-GENE
are O
being O
used O
to O
accelerate _RARE_
the O
recovery O
of O
myelopoiesis _RARE_
following O
high O
- O
dose O
chemotherapy O
in O
cancer _RARE_
patients O
. O

Effects O
of O
alterations O
of O
primer O
- O
binding O
site O
sequences O
on O
human O
immunodeficiency O
virus O
type O
1 O
replication O
. O

Presentation _RARE_
of O
a O
horse _RARE_
cytochrome I-GENE
c I-GENE
peptide I-GENE
by O
multiple O
H I-GENE
- I-GENE
2b _RARE_
class I-GENE
I I-GENE
major I-GENE
histocompatibility I-GENE
complex I-GENE
( O
MHC I-GENE
) O
molecules O
to O
C57BL O
/ O
6 O
- O
and O
bm1 _RARE_
- O
derived O
cytotoxic O
T O
lymphocytes O
: O
presence O
of O
a O
single O
MHC I-GENE
anchor _RARE_
residue _RARE_
may O
confer O
efficient O
peptide O
- O
specific O
CTL O
recognition O
. O

A O
particularly O
striking O
HpaII _RARE_
tiny _RARE_
fragment O
island O
, O
extending O
over O
nearly O
2 O
, O
000 _RARE_
base _RARE_
pairs _RARE_
, O
surrounds _RARE_
the O
USF2 _RARE_
translation I-GENE
initiation I-GENE
site I-GENE
. O

Diagnosis O
of O
prostatic _RARE_
carcinoma O
: O
the O
yield O
of O
serum I-GENE
prostate _RARE_
specific I-GENE
antigen I-GENE
, O
digital O
rectal O
examination O
and O
transrectal _RARE_
ultrasonography O
. O

Increased O
granulocyte _RARE_
- I-GENE
colony I-GENE
stimulating I-GENE
factor I-GENE
( O
G I-GENE
- I-GENE
CSF I-GENE
) O
levels O
in O
neonates O
with O
perinatal _RARE_
complications O
. O

The O
results O
revealed O
a O
hierarchy _RARE_
of O
ligand _RARE_
affinities O
that O
mirrored _RARE_
their O
adhesive O
activity O
( O
rsVCAM _RARE_
- I-GENE
1 I-GENE
> O
fibronectin I-GENE
variants I-GENE
containing O
CS1 _RARE_
>> _RARE_
other O
fibronectin I-GENE
variants I-GENE
). O

When O
expressed _RARE_
in O
and O
purified _RARE_
from O
Escherichia O
coli O
, O
both O
full I-GENE
- I-GENE
length I-GENE
Fpr3 _RARE_
and O
its O
isolated O
COOH _RARE_
- O
terminal O
domain O
exhibit O
readily O
detectable O
PPIase _RARE_
activity O
. O

Dilutions _RARE_
of O
H I-GENE
- I-GENE
2b _RARE_
or I-GENE
H I-GENE
- I-GENE
2d _RARE_
NP _RARE_
peptides I-GENE
indicated O
that O
3 O
- O
4 O
logs _RARE_
less O
H I-GENE
- I-GENE
2b _RARE_
NP _RARE_
peptide I-GENE
was O
required O
to O
sensitize _RARE_
syngeneic _RARE_
target O
cells O
for _RARE_
CTL O
- O
specific O
lysis O
, O
suggesting O
that O
the O
differing _RARE_
affinities O
of O
H O
- O
2b _RARE_
and O
H O
- O
2d _RARE_
major I-GENE
histocompatibility I-GENE
complex I-GENE
molecules I-GENE
for _RARE_
their O
peptides O
likely O
account O
for _RARE_
the O
total _RARE_
removal O
of O
NP _RARE_
CTL O
in O
the O
H O
- O
2b _RARE_
mice O
but O
only O
partial O
removal O
in O
H O
- O
2d _RARE_
mice O
made O
to O
express O
thymic _RARE_
NP _RARE_
. O

However O
, O
expression _RARE_
of O
sigma _RARE_
3 I-GENE
from O
S4 _RARE_
( O
3 I-GENE
' I-GENE
UTR I-GENE
/ I-GENE
S1 I-GENE
), _RARE_
which O
included O
the O
PKR I-GENE
activator I-GENE
sequence I-GENE
from O
S1 I-GENE
within O
the O
3 I-GENE
'- I-GENE
UTR I-GENE
of I-GENE
S4 _RARE_
, O
was O
comparable O
to O
that O
from O
wild I-GENE
- I-GENE
type I-GENE
S4 _RARE_
. O

Microvessels _RARE_
were O
counted _RARE_
in O
a O
x200 _RARE_
field O
( O
0 _RARE_
. O
754 _RARE_
mm2 O
) O
in O
the O
area O
of O
maximal O
angiogenesis O
. O

Although O
both O
transfected O
cell O
lines O
contain O
FGF I-GENE
- I-GENE
1 I-GENE
cell I-GENE
surface I-GENE
receptors I-GENE
as _RARE_
judged O
by O
crosslinking _RARE_
studies O
, O
the O
wild O
- O
type O
transfectants O
are O
refractory O
to O
exogenous _RARE_
FGF I-GENE
- I-GENE
1 I-GENE
, O
whereas O
the O
mutant O
transfectants O
respond O
normally O
.( O
ABSTRACT O
TRUNCATED O
AT O
250 _RARE_
WORDS O
) O

Recent O
studies O
have O
demonstrated O
that O
the O
activated O
GH _RARE_
receptor I-GENE
can O
stimulate O
Stat1 _RARE_
, O
a O
cytoplasmic O
transcription O
factor O
that O
becomes O
tyrosine O
phosphorylated _RARE_
and O
translocates _RARE_
to O
the O
nucleus O
, O
where O
it O
can O
interact O
with O
specific O
DNA O
sequences O
to O
modulate O
gene O
expression _RARE_
. O

In O
viral O
infections O
, O
G I-GENE
- I-GENE
CSF I-GENE
was O
correlated O
with O
mononuclear O
cells O
( O
rs O
= O
0 _RARE_
. O
41 _RARE_
, O
P O
< O
0 _RARE_
. O
05 O
), _RARE_
white _RARE_
blood _RARE_
cell O
counts O
( O
rs O
= O
0 _RARE_
. O
56 _RARE_
, O
P O
< O
0 _RARE_
. O
01 O
), _RARE_
neutrophils O
( O
rs O
= O
0 _RARE_
. O
41 _RARE_
, O
P O
< O
0 _RARE_
. O
05 O
) O
and O
CRP I-GENE
( O
rs O
= O
0 _RARE_
. O
47 _RARE_
, O
P O
< O
0 _RARE_
. O
05 O
). O

Minor _RARE_
initiation O
sites O
were O
found O
at _RARE_
positions O
- O
128 _RARE_
, O
- O
111 O
, O
- O
91 O
, O
and O
- O
74 _RARE_
. O

Phosphoamino _RARE_
acid O
analysis O
of O
radiolabeled O
ASGPR _RARE_
subunits I-GENE
identified O
Ser _RARE_
( O
P O
) O
as _RARE_
the O
predominant O
( O
approximately _RARE_
95 _RARE_
%) O
and O
Thr _RARE_
( O
P O
) O
as _RARE_
a O
minor O
( O
approximately _RARE_
5 O
%) O
phosphoamino _RARE_
acid O
in O
each O
polypeptide O
and O
confirmed O
the O
presence O
of O
Tyr _RARE_
( O
P O
) O
( O
approximately _RARE_
1 O
%) O
in O
RHL1 _RARE_
. O

To O
further O
define O
the O
structural O
requirements O
for _RARE_
ZAP _RARE_
- I-GENE
70 I-GENE
interaction O
with O
the O
TCR I-GENE
, O
we O
developed O
a O
binding O
assay O
using O
immobilized _RARE_
glutathione _RARE_
S I-GENE
- I-GENE
transferase I-GENE
fusion I-GENE
proteins I-GENE
containing O
the O
NH2 O
- O
and O
/ O
or O
COOH _RARE_
- I-GENE
terminal I-GENE
SH2 _RARE_
domains I-GENE
of O
ZAP _RARE_
- I-GENE
70 I-GENE
, O
and O
soluble _RARE_
synthetic _RARE_
peptides O
with O
the O
sequence O
of O
the O
cytoplasmic O
region O
of O
the O
TCR I-GENE
zeta _RARE_
chain I-GENE
( O
TCR I-GENE
zeta _RARE_
cyt _RARE_
) O
or O
individual O
TCR I-GENE
zeta _RARE_
and O
CD3 I-GENE
epsilon I-GENE
TAM _RARE_
motifs I-GENE
. O

All O
four O
doubly _RARE_
tyrosine O
phosphorylated _RARE_
TAM _RARE_
peptides O
cross O
- O
compete O
with O
each O
other O
for _RARE_
binding O
to O
the O
tandem _RARE_
SH2 _RARE_
domains I-GENE
of O
ZAP _RARE_
- I-GENE
70 I-GENE
. O

The O
three O
- O
dimensional O
structure _RARE_
of O
RT I-GENE
shows O
that O
it O
is O
a O
strikingly O
asymmetric O
heterodimer _RARE_
consisting O
of O
two O
differently O
folded O
subunits O
( O
molecular _RARE_
weights O
66 _RARE_
kDa O
and O
51 _RARE_
kDa O
) O
with O
identical O
amino O
- O
terminal O
amino O
acid O
sequences O
( O
residues O
1 O
- O
428 _RARE_
). O

Pharmacological _RARE_
and O
pharmacokinetic O
characteristics O
of O
the O
non O
- O
ionic O
monomeric _RARE_
X O
- O
ray O
contrast O
agent O
iopromide _RARE_
( O
Ultravist _RARE_
, O
CAS _RARE_
73334 _RARE_
- O
07 O
- O
3 O
) O
were O
evaluated O
in O
preclinical _RARE_
studies O
. O

All O
subsequent O
patients O
were O
treated O
at _RARE_
the O
maximal O
tolerated O
dose O
of O
EDXR _RARE_
( O
35 _RARE_
mg O
/ O
m2 O
/ O
day O
). O

The O
median O
post O
- O
treatment O
, O
pre O
- O
operative O
serum I-GENE
PSA I-GENE
was O
0 _RARE_
. O
4 O
ng _RARE_
/ O
ml O
. O

Addition O
of O
soluble _RARE_
recombinant I-GENE
human I-GENE
SLF _RARE_
to O
SI4 _RARE_
- O
h220 _RARE_
cultures O
enhanced _RARE_
reduction O
of O
cell O
- O
surface O
c I-GENE
- I-GENE
kit I-GENE
expression _RARE_
and O
its O
protein O
degradation _RARE_
. O

Membrane _RARE_
- O
bound _RARE_
Steel _RARE_
factor I-GENE
induces O
more O
persistent O
tyrosine I-GENE
kinase I-GENE
activation O
and O
longer O
life O
span O
of O
c I-GENE
- I-GENE
kit I-GENE
gene O
- O
encoded O
protein O
than O
its O
soluble _RARE_
form O
. O

Analysis O
of O
the O
sequences O
with O
the O
BLAST _RARE_
and O
GRAIL _RARE_
programs O
provided O
additional O
independent O
evidence O
that O
15 _RARE_
of O
these O
17 _RARE_
clones _RARE_
contain O
coding O
sequences O
and O
that O
nine O
other O
clones _RARE_
are O
likely O
to O
contain O
sequences O
coding O
for _RARE_
portions O
of O
new O
genes O
. O

Patients O
with O
more O
than O
250 _RARE_
PVC _RARE_
/ O
24 _RARE_
hours O
were O
selected _RARE_
for _RARE_
distribution O
of O
PVC _RARE_
and O
CI _RARE_
evaluation O
. O

Horvath _RARE_
, O
I O
. O

Cell O
lines O
derived O
from O
the O
tumors O
were O
examined O
by O
fluorescent _RARE_
in O
situ O
hybridization O
for _RARE_
the O
status O
of O
the O
transferred O
human O
chromosome _RARE_
and O
by O
PCR O
for _RARE_
marker O
loss _RARE_
. O

The O
amino O
acid O
sequences O
of O
the O
predicted O
RfbA _RARE_
and O
RfbB _RARE_
homologs I-GENE
showed O
identities O
of O
75 _RARE_
. O
7 O
% O
( O
87 O
. O
9 O
% O
total _RARE_
similarity _RARE_
) O
and O
78 _RARE_
. O
0 _RARE_
% O
( O
86 _RARE_
. O
5 O
% O
total _RARE_
similarity _RARE_
), _RARE_
respectively O
. O

However O
, O
multiple O
alanine O
substitutions O
or O
proline O
( O
helix O
- O
destabilizing _RARE_
) O
substitutions O
disrupted O
both O
oligomerization O
and O
transport _RARE_
of O
GP64 _RARE_
EFP _RARE_
. O

The O
FinO _RARE_
protein I-GENE
of O
IncF _RARE_
plasmids O
binds O
FinP _RARE_
antisense _RARE_
RNA I-GENE
and O
its O
target O
, O
traJ _RARE_
mRNA I-GENE
, O
and O
promotes O
duplex O
formation O
. O

In O
this O
paper O
we O
report O
that O
ligand _RARE_
binding O
induced _RARE_
tyrosine O
phosphorylation _RARE_
in O
BaF3 _RARE_
cells O
engineered _RARE_
to O
express O
the O
murine I-GENE
Mpl _RARE_
receptor I-GENE
( O
BaF3 _RARE_
/ O
mMpl _RARE_
). O

A O
chicken I-GENE
paxillin I-GENE
cDNA I-GENE
was O
also O
cloned _RARE_
and O
is O
predicted O
to O
encode O
a O
protein O
approximately _RARE_
90 _RARE_
% O
identical O
to O
human I-GENE
paxil _RARE_
- I-GENE
lin _RARE_
. O

We O
linked _RARE_
a O
4 O
. O
1 O
- O
kilobase _RARE_
pair _RARE_
HindIII I-GENE
DNA I-GENE
fragment I-GENE
from O
the O
region O
upstream O
of O
the O
human I-GENE
AP I-GENE
endonuclease I-GENE
gene I-GENE
( O
APE _RARE_
) O
to O
the O
chloramphenicol I-GENE
acetyltransferase _RARE_
( O
CAT I-GENE
) O
gene O
. O

The O
overexpressed O
His6 _RARE_
- I-GENE
tagged _RARE_
GrsA _RARE_
derivatives _RARE_
were O
affinity O
- O
purified _RARE_
, O
and O
the O
catalytic O
properties O
of O
the O
deletion O
mutants O
were O
examined O
by O
biochemical O
studies O
including O
ATP O
- O
dependent O
amino O
acid O
activation O
, O
carboxyl _RARE_
thioester _RARE_
formation O
, O
and O
the O
ability O
to O
racemize _RARE_
the O
covalently O
bound _RARE_
phenylalanine _RARE_
from O
L O
- O
to O
the O
D O
- O
isomer _RARE_
. O

CD7 _RARE_
+/ _RARE_
CD3 I-GENE
- O
T O
- O
cell O
precursors _RARE_
exhibit O
V I-GENE
delta I-GENE
2D _RARE_
delta I-GENE
3 I-GENE
rearrangements _RARE_
. O

HVH2 _RARE_
mRNA I-GENE
showed O
an O
expression _RARE_
pattern O
distinct O
from O
CL100 _RARE_
( O
human I-GENE
homologue I-GENE
of I-GENE
mouse I-GENE
MKP1 _RARE_
) O
and O
PAC1 _RARE_
, O
two O
previously O
identified O
MAP I-GENE
kinase I-GENE
phosphatases _RARE_
. O

These O
data O
suggest O
that O
these O
sequences O
located _RARE_
immediately O
3 O
' O
to O
the O
breakpoint _RARE_
of O
the O
HPFH _RARE_
- I-GENE
3 I-GENE
deletion I-GENE
, O
exhibit O
both O
the O
structure _RARE_
and O
the O
function O
of O
an O
enhancer O
, O
and O
can O
modify O
the O
developmental O
specificity _RARE_
of O
the O
fetal _RARE_
gamma I-GENE
- I-GENE
globin I-GENE
genes I-GENE
, O
resulting O
in O
their O
continued O
expression _RARE_
during _RARE_
adult O
life O
. O

In O
vivo O
association O
between O
Shb _RARE_
- O
SH3 I-GENE
domain O
proteins O
v I-GENE
- I-GENE
Src I-GENE
and O
Eps8 _RARE_
was O
detected O
by O
coimmunoprecipitation _RARE_
. O

Our O
results O
indicate O
that O
interaction O
between O
Jak2 _RARE_
and O
PRLR _RARE_
requires O
a O
proline O
- O
rich O
sequence O
in O
the O
membrane O
proximal O
region O
of O
the O
receptor O
, O
which O
is O
conserved _RARE_
among O
the O
different O
members O
of O
the O
cytokine _RARE_
receptor I-GENE
superfamily I-GENE
. O

Transcription O
of O
the O
vascular I-GENE
cell I-GENE
adhesion I-GENE
molecule I-GENE
1 I-GENE
( O
VCAM _RARE_
- I-GENE
1 I-GENE
) O
gene O
in O
endothelial O
cells O
is O
induced _RARE_
by O
lipopolysaccharide O
and O
the O
inflammatory O
cytokines _RARE_
interleukin I-GENE
- I-GENE
1 I-GENE
beta I-GENE
and O
tumor I-GENE
necrosis I-GENE
factor I-GENE
alpha I-GENE
( O
TNF I-GENE
- I-GENE
alpha I-GENE
). O

Experiments O
with O
recombinant O
proteins O
showed O
that O
p50 _RARE_
/ O
p65 _RARE_
and O
high I-GENE
- I-GENE
mobility I-GENE
- I-GENE
group I-GENE
I I-GENE
( I-GENE
Y I-GENE
) I-GENE
protein I-GENE
cooperatively _RARE_
facilitated O
the O
binding O
of O
IRF I-GENE
- I-GENE
1 I-GENE
to O
the O
VCAM1 _RARE_
IRF I-GENE
binding I-GENE
site I-GENE
and O
that O
IRF I-GENE
- I-GENE
1 I-GENE
physically O
interacted O
with O
p50 _RARE_
and O
with O
high I-GENE
- I-GENE
mobility I-GENE
- I-GENE
group I-GENE
I I-GENE
( I-GENE
Y I-GENE
) I-GENE
protein I-GENE
. O

Based O
on O
these O
results O
the O
minimal O
control O
element O
( O
AX _RARE_
470 _RARE_
) O
specifying _RARE_
the O
anterior O
boundary O
of O
Hox I-GENE
expression _RARE_
was O
designated O
as _RARE_
Hoxa _RARE_
- I-GENE
7 I-GENE
enhancer I-GENE
. O

In O
this O
report O
we O
describe O
the O
isolation O
of O
a O
Fab _RARE_
fragment I-GENE
( O
Fab _RARE_
A8 _RARE_
) O
showing O
a O
high O
relative O
affinity O
for _RARE_
the O
receptor O
( O
0 _RARE_
. O
5 O
nM O
). O

MBP I-GENE
- O
Rep68 _RARE_
delta I-GENE
- O
mediated _RARE_
DNA O
- O
RNA O
helicase _RARE_
activity O
required O
ATP O
hydrolysis O
and O
the O
presence O
of O
Mg2 _RARE_
+ O
ions O
and O
was O
inhibited O
by O
high O
ionic O
strength O
. O

To O
identify O
critical O
regions O
mediating O
growth O
signal O
transduction _RARE_
by O
hG _RARE_
- I-GENE
CSFR _RARE_
, O
deletions O
or O
site O
- O
directed O
amino O
acid O
substitutions O
were O
introduced O
into O
the O
cytoplasmic O
domain O
of O
hG _RARE_
- I-GENE
CSFR _RARE_
, O
and O
the O
mutant O
cDNAs O
were O
transfected O
into O
the O
murine I-GENE
interleukin I-GENE
- I-GENE
3 I-GENE
( O
IL _RARE_
- I-GENE
3 I-GENE
)- O
dependent O
Ba _RARE_
/ O
F3 _RARE_
and O
FDCP _RARE_
cell O
lines O
. O

When O
combined O
with O
independent O
activating O
mutations O
in O
the O
c I-GENE
- I-GENE
abl I-GENE
kinase I-GENE
domain I-GENE
or O
NH2 O
- O
terminus O
, O
the O
G128R _RARE_
mutation O
blocked O
transformation O
by O
the O
double O
mutant O
, O
suggesting O
that O
the O
G128R _RARE_
mutant I-GENE
was O
unable O
to O
transform O
cells O
for _RARE_
trivial _RARE_
reasons _RARE_
. O

Both O
mutations O
completely O
abolished O
binding O
of O
the O
Abl I-GENE
SH3 I-GENE
domain O
to O
proline O
- O
rich O
target O
proteins O
in O
a O
filter O
- O
binding O
assay O
. O

Changes O
induced _RARE_
in O
the O
gills _RARE_
of O
milkfish _RARE_
( O
Chanos _RARE_
chanos _RARE_
Forsskal _RARE_
) O
fingerlings _RARE_
after O
acute O
exposure O
to O
nifurpirinol _RARE_
( O
Furanace _RARE_
; O
P O
- O
7138 _RARE_
). O

Retreatment _RARE_
of O
these O
2 O
dogs O
resulted O
in O
a O
similar O
, O
but O
blunted _RARE_
, O
response O
to O
human I-GENE
immunoglobulin I-GENE
. O

The O
levels O
of O
NSE _RARE_
and O
MBP I-GENE
in O
the O
IJVB _RARE_
were O
compared O
to O
those O
in O
the O
PVB _RARE_
. O

As O
expected O
, O
the O
insulin I-GENE
effect O
to O
increase O
ras I-GENE
GTP I-GENE
formation O
and O
MAP I-GENE
kinase I-GENE
activity O
was O
negligible _RARE_
in O
A O
/ O
K1018 _RARE_
cells O
but O
normal O
, O
or O
supernormal _RARE_
, O
in O
Y O
/ O
F2 O
cells O
. O

Morphologic _RARE_
variables O
included O
cancer _RARE_
volume O
, O
histologic O
grade O
, O
capsular _RARE_
penetration O
, O
seminal _RARE_
vesicle O
invasion O
, O
and O
lymph O
node O
metastasis O
. O

Sequence O
analysis O
of O
these O
regions O
showed O
a O
CAAT O
box O
upstream O
of O
exon _RARE_
1a _RARE_
and O
high O
G O
- O
C O
content O
regions O
within O
both O
P1 O
and O
P2 O
. O

The O
fusion O
proteins O
were O
tested O
by O
ELISA O
for _RARE_
reactivity O
with O
a O
panel O
of O
human I-GENE
anti I-GENE
- I-GENE
La _RARE_
sera _RARE_
in O
order O
to O
define O
the O
nature O
of O
the O
epitopes _RARE_
. O

GCD10 _RARE_
was O
first _RARE_
identified O
genetically O
as _RARE_
a O
translational O
repressor O
of O
GCN4 I-GENE
. O

GCD10 _RARE_
binds O
RNA O
in O
vitro O
and O
we O
present O
strong O
biochemical O
evidence O
that O
it O
is O
identical O
to O
the O
RNA O
- O
binding O
subunit O
of O
yeast I-GENE
initiation I-GENE
factor I-GENE
- I-GENE
3 I-GENE
( O
eIF I-GENE
- I-GENE
3 I-GENE
). O
eIF I-GENE
- I-GENE
3 I-GENE
is O
a O
multisubunit _RARE_
complex O
that O
stimulates O
translation O
initiation O
in O
vitro O
at _RARE_
several O
different O
steps O
. O

Sources _RARE_
of O
noise O
in O
these O
signals O
were O
evaluated O
in O
preparations O
stained O
with O
the O
potentiometric _RARE_
probe O
RH _RARE_
- O
414 _RARE_
. O

1993 O
. O

A O
transformation O
- O
competent O
mutant O
, O
like O
the O
wild I-GENE
- I-GENE
type I-GENE
E5 _RARE_
protein I-GENE
, O
bound _RARE_
the O
receptor O
and O
induced _RARE_
receptor O
tyrosine O
phosphorylation _RARE_
and O
down O
- O
regulation _RARE_
. O

We O
conclude O
that O
cAMP O
, O
acting O
through O
PKA I-GENE
, O
is O
an O
essential O
regulator O
of O
basal O
CFTR I-GENE
gene I-GENE
expression _RARE_
and O
may O
mediate O
an O
induction O
of O
CFTR I-GENE
in O
responsive O
cell O
types _RARE_
. O

Appropriate _RARE_
restriction _RARE_
sites O
allow O
one O
to O
insert O
virtually O
any O
desired _RARE_
cDNA O
fragment O
directly O
behind O
the O
epitope _RARE_
- O
specific O
sequence O
and O
before O
a O
long O
poly _RARE_
( O
A O
) O
tail _RARE_
. O

Both O
PPC _RARE_
- O
1 O
and O
ALVA _RARE_
- O
31 _RARE_
cells O
display O
tumorigenesis O
and O
invasiveness _RARE_
in O
nude O
mice O
, O
whereas O
LNCap _RARE_
cells O
exhibit O
a O
less O
malignant O
phenotype _RARE_
, O
suggesting O
a O
correlation O
between O
CD44 I-GENE
variant I-GENE
( O
CD44v _RARE_
) O
expression _RARE_
and O
aggressive O
prostate _RARE_
tumor O
behavior O
. O

The O
gene O
product O
of O
cotS _RARE_
was O
confirmed O
to O
be O
identical O
to O
Cot40 _RARE_
- I-GENE
2 I-GENE
by O
SDS O
- O
PAGE O
and O
immunoblotting _RARE_
from O
Escherichia O
coli O
transformed O
with O
a O
plasmid _RARE_
containing O
the O
cotS _RARE_
region I-GENE
. O

Two O
such O
genes O
, O
designated O
hsiggll150 _RARE_
and O
hsiggll295 _RARE_
, O
were O
cloned _RARE_
and O
sequenced O
from O
genomic O
DNA O
. O

A O
retrospective O
epidemiological O
study O
is O
reported O
concerning O
burn O
injuries O
in O
775 _RARE_
children O
hospitalized O
at _RARE_
the O
unit O
of O
burn O
care O
of O
Casablanca _RARE_
between O
1985 O
and O
1993 O
. O

Our O
results O
suggest O
that O
protein O
binding O
to O
the O
E2F I-GENE
- I-GENE
like I-GENE
sequences I-GENE
may O
act O
to O
reduce O
expression _RARE_
. O

The O
RAD6 _RARE_
/ O
UBC2 _RARE_
gene O
from O
Saccharomyces O
cerevisiae O
encodes O
a O
ubiquitin I-GENE
- I-GENE
conjugating _RARE_
enzyme I-GENE
involved O
in O
DNA O
repair O
, O
induced _RARE_
mutagenesis O
, O
and O
sporulation _RARE_
. O

Echocardiography _RARE_
revealed O
right O
ventricular O
diastolic O
collapse _RARE_
( O
RVDC _RARE_
) O
without O
physical O
signs O
of O
cardiac O
tamponade _RARE_
. O

In O
on O
- O
going _RARE_
screening O
programmes _RARE_
, O
the O
Haemoccult _RARE_
test O
consists O
of O
six _RARE_
slides _RARE_
and O
a O
test O
is O
considered O
positive O
if O
at _RARE_
least O
one O
slide _RARE_
is O
coloured _RARE_
. O

We O
showed O
previously O
that O
a O
fusion O
protein O
( O
GAL4 I-GENE
- O
p40 I-GENE
) O
containing O
the O
DNA O
- O
binding O
domain O
of O
GAL4 I-GENE
and O
sequences O
of O
chicken I-GENE
l _RARE_
kappa _RARE_
B I-GENE
- I-GENE
alpha I-GENE
( O
p40 I-GENE
) O
inhibits O
growth O
in O
the O
yeast O
Saccharomyces O
cerevisiae O
. O

We O
have O
demonstrated O
previously O
that O
two O
binding O
sites O
in O
the O
- I-GENE
184 _RARE_
HNF I-GENE
- I-GENE
3 I-GENE
beta I-GENE
promoter I-GENE
are O
recognized _RARE_
by O
widely O
distributed O
factors O
and O
that O
there O
is O
also O
a O
critical O
autoregulatory _RARE_
site O
, O
we O
identified O
a O
binding O
site O
for _RARE_
a O
cell O
- O
specific O
factor O
, O
LF _RARE_
- I-GENE
H3 _RARE_
beta I-GENE
, O
that O
may O
function O
in O
restricting _RARE_
HNF I-GENE
- I-GENE
3 I-GENE
beta I-GENE
gene I-GENE
expression _RARE_
to O
hepatocytes O
. O

In O
4 O
spinalized _RARE_
cats O
, O
the O
effects O
of O
afferent _RARE_
inputs O
from O
hindlimb _RARE_
cutaneous O
nerves O
( O
sural _RARE_
cutaneous O
nerve O
: O
Sur _RARE_
) O
on O
mono O
- O
and O
poly _RARE_
- O
synaptic O
reflex O
recorded O
from O
tail _RARE_
muscle O
motoneurons _RARE_
were O
studied O
before O
and O
after O
spinal _RARE_
lesioning _RARE_
at _RARE_
S2 _RARE_
- O
3 O
level O
. O

The O
flow O
rate O
of O
phosphate O
buffered _RARE_
saline O
through O
dermis _RARE_
was O
measured O
as _RARE_
a O
function O
of O
applied O
pressure O
. O

However O
, O
parallax _RARE_
measurements O
showed O
that O
at _RARE_
150K _RARE_
, O
collapse _RARE_
of O
Epon _RARE_
sections O
does O
not O
take O
place O
. O

Although O
within O
normal O
limits O
, O
latency _RARE_
was O
high O
. O

The O
outcome O
of O
the O
optimization _RARE_
of O
the O
seven _RARE_
- O
field O
plan _RARE_
prompted _RARE_
an O
investigation O
into O
the O
best O
results O
that O
could O
be O
achieved O
by O
an O
" O
ideal _RARE_
" O
conformal _RARE_
radiotherapy O
technique O
. O

Specific O
requirements O
for _RARE_
branched _RARE_
- O
chain O
amino O
acids _RARE_
, O
glutamine _RARE_
, O
and O
arginine _RARE_
are O
evaluated O
. O

The O
pea _RARE_
rps10 _RARE_
intron I-GENE
is O
homologous O
to O
introns _RARE_
in O
rrn26 _RARE_
and O
cox3 _RARE_
in O
the O
Marchantia _RARE_
mitochondrial O
genome O
, O
while O
the O
Marchantia _RARE_
rps10 _RARE_
gene I-GENE
lacks O
an O
intron O
. O

The O
optimal O
care O
of O
CHF _RARE_
patient O
includes O
the O
recognition O
and O
management O
of O
these O
electrolyte _RARE_
disturbances O
. O

Serum O
magnesium O
in O
79 _RARE_
patients O
of O
gynecologic O
neoplasms O
treated O
with O
cisplatin O
and O
their O
controls O
was O
measured O
. O

METHODS O
: O
rHb1 _RARE_
. I-GENE
1 I-GENE
or O
human I-GENE
serum I-GENE
albumin I-GENE
was O
administered O
intravenously O
to O
fasting O
male O
volunteers O
. O

Alanine _RARE_
aminotransferase I-GENE
( O
ALT _RARE_
) O
levels O
had O
been O
elevated O
for _RARE_
six _RARE_
months O
in O
all O
patients O
and O
hepatitis O
B O
viral O
infection O
was O
replicative O
. O

In O
this O
study O
we O
have O
investigated O
the O
role O
of O
C I-GENE
/ I-GENE
EBP I-GENE
beta I-GENE
in O
initiating O
the O
adipogenic _RARE_
program O
by O
overexpressing O
C I-GENE
/ I-GENE
EBP I-GENE
beta I-GENE
in O
multipotential _RARE_
NIH _RARE_
- O
3T3 O
fibroblasts _RARE_
. O

XYL1 _RARE_
was O
isolated O
as _RARE_
a O
highly O
expressed _RARE_
fusion O
clone O
from O
a O
' I-GENE
lacZ I-GENE
translational O
fusion O
library O
. O

Various O
transcripts O
are O
generated O
from O
the O
VCSA1 _RARE_
gene I-GENE
by O
alternative _RARE_
splicing _RARE_
and O
poly _RARE_
( O
A O
) O
processing _RARE_
in O
the O
rat O
submandibular _RARE_
gland _RARE_
. O

However O
, O
division O
of O
the O
chest O
wall _RARE_
muscles O
, O
usually O
with O
diathermy _RARE_
, O
contributes O
to O
prolonged O
pain O
and O
morbidity O
. O

Closure _RARE_
of O
an O
open _RARE_
high O
below O
- O
knee _RARE_
guillotine _RARE_
amputation _RARE_
wound O
using O
a O
skin _RARE_
- O
stretching _RARE_
device O
. O

Our O
study O
was O
addressed O
to O
the O
synthesis _RARE_
of O
some O
derivatives _RARE_
of O
this O
sequence O
in O
order O
to O
obtain O
both O
peptide O
substrates _RARE_
suitable O
for _RARE_
the O
detection O
of O
the O
Src I-GENE
- O
like O
tyrosine I-GENE
kinase I-GENE
activity O
and O
active _RARE_
site O
- O
directed O
inhibitors _RARE_
specific O
for _RARE_
this O
class O
of O
enzymes _RARE_
. O

Citrate _RARE_
synthase I-GENE
activity O
was O
increased O
in O
the O
medial O
head O
( O
81 _RARE_
%, O
P O
< O
0 _RARE_
. O
001 O
) O
and O
the O
red _RARE_
long O
head O
( O
88 O
%, O
P O
< O
0 _RARE_
. O
001 O
) O
of O
the O
triceps _RARE_
brachii _RARE_
muscle O
in O
R O
rats O
but O
not O
in O
the O
white _RARE_
long O
head O
( O
25 _RARE_
%, O
P O
= O
0 _RARE_
. O
06 O
). O

The O
expression _RARE_
of O
the O
putative O
operon O
bglPH _RARE_
of O
Bacillus O
subtilis O
was O
studied O
by O
using O
bglP _RARE_
'- O
lacZ I-GENE
transcriptional O
fusions O
. O

Although O
eight O
contiguous O
genes O
necessary O
for _RARE_
urease I-GENE
activity O
have O
been O
cloned _RARE_
and O
sequenced O
, O
the O
transcriptional O
organization O
and O
regulation _RARE_
of O
specific O
genes O
within O
the O
Proteus _RARE_
gene I-GENE
cluster I-GENE
has O
not O
been O
investigated O
in O
detail O
. O

The O
hypBFCDE _RARE_
operon I-GENE
from O
Rhizobium _RARE_
leguminosarum _RARE_
biovar _RARE_
viciae _RARE_
is O
expressed _RARE_
from O
an O
Fnr _RARE_
- I-GENE
type I-GENE
promoter I-GENE
that O
escapes _RARE_
mutagenesis O
of O
the O
fnrN _RARE_
gene I-GENE
. O

We O
demonstrate O
that O
a O
VT O
+ O
peptide O
was O
specifically O
phosphorylated _RARE_
by O
protein I-GENE
kinase I-GENE
C I-GENE
( O
PKC I-GENE
) O
in O
vitro O
, O
but O
not O
by O
protein I-GENE
kinase I-GENE
A I-GENE
( O
PKA I-GENE
). O

R O
. O

15 _RARE_
, O
2500 _RARE_
- O
2508 _RARE_
; O
O O
' O
Neill _RARE_
, O
T O
. O

Control O
experiments O
showed O
that O
each O
fusion O
protein O
had O
a O
high O
affinity O
binding O
site O
for _RARE_
estradiol O
- O
17 _RARE_
beta O
and O
could O
transactivate O
an O
ERE _RARE_
- O
LacZ _RARE_
reporter O
gene O
in O
yeast O
similar O
to O
the O
wild I-GENE
type I-GENE
ER I-GENE
. O

Although O
Micrococcus _RARE_
luteus _RARE_
UV _RARE_
endonuclease I-GENE
has O
been O
reported O
to O
be O
an O
18 O
- O
kDa O
enzyme O
with O
possible O
homology O
to O
the O
16 I-GENE
- I-GENE
kDa I-GENE
endonuclease I-GENE
V I-GENE
from I-GENE
bacteriophage _RARE_
T4 I-GENE
( O
Gordon _RARE_
, O
L O
. O

Several O
different O
oncogenes _RARE_
and O
growth O
factors O
promote O
G1 O
phase _RARE_
progression O
. O

Cyclin I-GENE
D1 _RARE_
promoter I-GENE
activity O
was O
stimulated _RARE_
by O
overexpression O
of O
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
( O
p41MAPK _RARE_
) O
or O
c I-GENE
- I-GENE
Ets I-GENE
- I-GENE
2 I-GENE
through O
the O
proximal O
22 _RARE_
base _RARE_
pairs _RARE_
. O

Indeed O
, O
ERM _RARE_
and O
c I-GENE
- I-GENE
Jun I-GENE
synergistically O
activated O
the O
EBS _RARE_
- O
CRE _RARE_
without O
making O
an O
apparent O
ternary _RARE_
complex O
. O

A O
mutant O
( O
residues O
1 O
- O
332 _RARE_
) O
showed O
complete _RARE_
Ca2 _RARE_
+/ _RARE_
CaM I-GENE
- O
dependent O
activity O
. O

In O
addition O
, O
the O
R206S _RARE_
HSF I-GENE
substitution O
exhibits O
constitutive _RARE_
transcriptional O
activation O
from O
a O
consensus O
HSE O
( O
HSE2 _RARE_
). O

The O
two O
bases O
immediately O
flanking O
the O
5 O
' O
end O
of O
the O
element O
proved O
to O
be O
very O
important O
to O
its O
function O
as _RARE_
a O
UAS O
element O
as _RARE_
did O
the O
two O
bases O
immediately O
3 O
' O
of O
the O
bHLH O
core O
motif O
. O

These O
results O
indicate O
that O
the O
PCNA I-GENE
gene I-GENE
is O
a O
likely O
target O
gene O
of O
E2F I-GENE
. O

Differential O
sensitivity O
of O
the O
MMPI O
- O
2 O
depression O
scales _RARE_
and O
subscales _RARE_
. O

After O
recovery O
, O
a O
hypertonic _RARE_
saline O
challenge O
was O
performed O
. O

The O
range O
of O
eosinophils O
was O
22 _RARE_
- O
56 _RARE_
% O
of O
the O
number O
of O
peripheral O
white _RARE_
blood _RARE_
cells O
( O
mean O
nadir _RARE_
33 _RARE_
%). O

Comparisons _RARE_
of O
rrnB _RARE_
P1 I-GENE
- O
lacZ I-GENE
expression _RARE_
at _RARE_
different O
ppGpp _RARE_
levels O
is O
interpreted O
for _RARE_
the O
rpoD _RARE_
( I-GENE
P504L _RARE_
) I-GENE
mutant I-GENE
as _RARE_
resulting O
from O
a O
hypersensitivity O
to O
ppGpp _RARE_
. O

These O
intron O
chimeras _RARE_
show O
that O
peripheral O
sequences O
and O
the O
elements O
that O
define O
the O
splice _RARE_
sites O
are O
adequate O
for _RARE_
self O
- O
splicing _RARE_
activity O
but O
that O
the O
central O
portions O
containing O
the O
catalytic O
cores _RARE_
of O
ai4 _RARE_
and O
bi4 _RARE_
are O
deficient _RARE_
; O
these O
cores _RARE_
are O
the O
likely O
targets _RARE_
of O
the O
splicing _RARE_
proteins O
. O

Here O
we O
demonstrate O
genetically O
that O
plus _RARE_
- O
strand _RARE_
DNA O
synthesis _RARE_
of O
the O
yeast I-GENE
Ty1 I-GENE
element I-GENE
is O
initiated _RARE_
at _RARE_
two O
sites O
located _RARE_
at _RARE_
the O
5 O
' O
boundary O
of O
the O
3 O
' O
long O
terminal O
repeat O
( O
PPT1 _RARE_
) O
and O
near O
the O
middle _RARE_
of O
the O
pol I-GENE
gene I-GENE
in O
the O
integrase I-GENE
coding I-GENE
sequence I-GENE
( O
PPT2 _RARE_
). O

Characterization O
of O
the O
3 O
' O
ends O
of O
the O
plus _RARE_
- O
strand _RARE_
DNA O
fragments O
reveals O
( O
1 O
) O
that O
the O
upstream O
fragment O
is O
elongated _RARE_
beyond O
PPT2 _RARE_
creating _RARE_
a O
plus _RARE_
- O
strand _RARE_
overlap O
and O
( O
2 O
) O
that O
the O
majority O
of O
plus _RARE_
- O
strand _RARE_
strong O
- O
stop O
DNA O
fragments O
bear _RARE_
a O
copy O
of O
the O
minus O
- O
strand _RARE_
primer O
binding O
site O
in O
agreement O
with O
the O
accepted O
model O
of O
retroviral _RARE_
genomic O
RNA O
reverse O
transcription O
. O

The O
patients O
undergoing O
VTLB _RARE_
had O
significantly O
shorter O
operative O
times O
( O
VTLB _RARE_
, O
100 _RARE_
. O
2 O
+/- O
27 _RARE_
. O
2 O
min O
. O
vs _RARE_
OLB _RARE_
, O
119 O
. O
8 O
+/- O
42 _RARE_
. O
6 O
min O
; O
p O
< O
0 _RARE_
. O
01 O
) O
and O
less O
blood _RARE_
loss _RARE_
( O
VTLB _RARE_
, O
4 O
. O
7 O
+/- O
14 O
. O
6 O
ml O
vs _RARE_
OLB _RARE_
, O
65 O
. O
7 O
+/- O
77 O
. O
0 _RARE_
ml O
; O
p O
< O
0 _RARE_
. O
001 O
). O

By O
150 _RARE_
minutes O
after O
Cr2O3 _RARE_
inhalation O
, O
FEV1 O
. O
0 _RARE_
had O
decreased O
by O
32 _RARE_
%. O

This O
combined O
intravenous O
anaesthetic _RARE_
regimen O
gave O
good O
anaesthesia O
and O
analgesia O
to O
pigs O
for _RARE_
up _RARE_
to O
2 O
h O
as _RARE_
monitored O
by O
clinical O
signs O
. O

Twenty O
food O
products O
were O
contaminated O
with O
V O
. O
cholerae _RARE_
O1 _RARE_
, O
Ogawa _RARE_
, O
toxigenic _RARE_
and O
not O
toxigenic _RARE_
strains O
: O
yoghurt _RARE_
, O
cream O
cheese _RARE_
, O
apricot _RARE_
marmelade _RARE_
, O
hip O
rose O
marmelade _RARE_
, O
mayonnaise _RARE_
, O
italian _RARE_
pasta _RARE_
for _RARE_
" O
empanadas _RARE_
", _RARE_
" O
dulce _RARE_
de O
leche _RARE_
", _RARE_
meat O
sausage _RARE_
, O
meat O
and O
spinach _RARE_
ravioli _RARE_
, O
margarine _RARE_
, O
milk O
dessert _RARE_
( O
made O
with O
cocoa _RARE_
, O
milk O
confiture _RARE_
, O
starch _RARE_
and O
additives _RARE_
), _RARE_
lettuce _RARE_
, O
tuna _RARE_
fish O
, O
ricotta _RARE_
and O
sterilized _RARE_
milk O
. O

It O
is O
impossible _RARE_
to O
define O
only O
one O
clinical O
outline _RARE_
because O
both O
symptomatic O
and O
asymptomatic O
infected _RARE_
NB _RARE_
may O
be O
found O
with O
gestational O
age O
at _RARE_
term O
and O
pre O
- O
term O
and O
when O
born O
with O
a O
weight _RARE_
above O
or O
below O
2000 O
g O
. O

The O
expression _RARE_
of O
the O
pilin _RARE_
gene I-GENE
, O
tcpA _RARE_
, O
is O
dependent O
upon O
ToxR _RARE_
and O
upon O
ToxT _RARE_
. O

The O
chloramphenicol I-GENE
- I-GENE
resistance I-GENE
transposon _RARE_
Tn4451 _RARE_
undergoes O
precise O
conjugative _RARE_
deletion O
from O
its O
parent _RARE_
plasmid _RARE_
plP401 _RARE_
in O
Clostridium _RARE_
perfringens _RARE_
and O
precise O
spontaneous O
excision _RARE_
from O
multicopy O
plasmids O
in O
Escherichia O
coli O
. O

Ras I-GENE
p21Val _RARE_
inhibits O
myogenesis _RARE_
without O
altering O
the O
DNA O
binding O
or O
transcriptional O
activities O
of O
the O
myogenic _RARE_
basic I-GENE
helix I-GENE
- I-GENE
loop I-GENE
- I-GENE
helix I-GENE
factors I-GENE
. O

In O
cells O
limited O
for _RARE_
His _RARE_
, O
increased O
expression _RARE_
of O
arg _RARE_
- I-GENE
2 I-GENE
and O
cpc _RARE_
- I-GENE
1 I-GENE
, O
and O
decreased O
expression _RARE_
of O
cox _RARE_
- I-GENE
5 I-GENE
, O
also O
had O
translational O
and O
transcriptional O
components _RARE_
. O

The O
peptide O
sequences O
reveal O
that O
the O
factor O
consists O
of O
GABP I-GENE
alpha I-GENE
and O
GABP I-GENE
beta I-GENE
1 I-GENE
with O
Ets I-GENE
and O
Notch I-GENE
motifs I-GENE
, O
respectively O
. O

Immunofluorescence _RARE_
microscopy O
and O
cell O
fractionation O
analyses O
showed O
that O
the O
110 _RARE_
- O
kDa O
protein O
was O
exclusively O
nuclear O
, O
whereas O
the O
150 _RARE_
- O
kDa O
protein O
was O
present O
in O
both O
the O
cytoplasm O
and O
nucleus O
of O
human O
cells O
. O

Expression O
and O
regulation _RARE_
by O
interferon _RARE_
of O
a O
double I-GENE
- I-GENE
stranded _RARE_
- I-GENE
RNA I-GENE
- I-GENE
specific I-GENE
adenosine I-GENE
deaminase _RARE_
from O
human O
cells O
: O
evidence O
for _RARE_
two O
forms O
of O
the O
deaminase _RARE_
. O

T O
- O
cell O
hybridomas _RARE_
, O
thymocytes _RARE_
, O
and O
T O
cells O
can O
be O
induced _RARE_
to O
undergo O
apoptotic O
cell O
death _RARE_
by O
activation O
through O
the O
T I-GENE
- I-GENE
cell I-GENE
receptor I-GENE
. O

Deletions _RARE_
were O
examined O
in O
the O
LYS2 _RARE_
gene I-GENE
, O
using O
a O
set O
of O
31 _RARE_
- O
to O
156 _RARE_
- O
bp O
inserts O
that O
included O
inserts O
with O
no _RARE_
apparent O
potential _RARE_
for _RARE_
secondary O
structure _RARE_
as _RARE_
well _RARE_
as _RARE_
two O
quasipalindromes _RARE_
. O

Overexpression O
of O
SCS1 _RARE_
could O
not O
complement O
an O
HSP60 _RARE_
- I-GENE
null _RARE_
allele I-GENE
, O
indicating O
that O
suppression O
was O
not O
due O
to O
the O
bypassing _RARE_
of O
Hsp60 _RARE_
activity O
. O

The O
DNA O
binding O
domain O
of O
NirA _RARE_
was O
expressed _RARE_
as _RARE_
a O
fusion O
protein O
with O
the O
glutathione _RARE_
S I-GENE
- I-GENE
transferase I-GENE
of O
Schistosoma _RARE_
japonicum _RARE_
. O

The O
kinase O
is O
essential O
in O
vivo O
for _RARE_
normal O
phosphorylation _RARE_
of O
the O
CTD _RARE_
and O
for _RARE_
normal O
growth O
and O
differentiation O
. O

A O
general _RARE_
model O
for _RARE_
ARE _RARE_
- O
mediated _RARE_
mRNA O
degradation _RARE_
involving O
a O
potential _RARE_
role O
for _RARE_
certain O
heterogeneous _RARE_
nuclear O
ribonucleoproteins _RARE_
and O
ARE _RARE_
- I-GENE
binding I-GENE
proteins I-GENE
is O
proposed O
. O

Finally O
, O
we O
demonstrate O
that O
C I-GENE
/ I-GENE
EBP I-GENE
alpha I-GENE
can O
also O
active _RARE_
the O
GM _RARE_
- I-GENE
CSF I-GENE
receptor I-GENE
alpha I-GENE
promoter O
in O
nonmyeloid _RARE_
cells O
. O

Endocytosis _RARE_
and O
vacuolar O
degradation _RARE_
of O
the O
plasma O
membrane O
- O
localized O
Pdr5 _RARE_
ATP I-GENE
- I-GENE
binding I-GENE
cassette _RARE_
multidrug _RARE_
transporter _RARE_
in O
Saccharomyces O
cerevisiae O
. O

Individual _RARE_
mutations O
in O
motifs O
III O
, O
IV O
, O
and O
V O
had O
distinctive O
effects O
on O
the O
affinity O
of O
enzyme O
for _RARE_
GTP O
, O
the O
rate O
of O
covalent _RARE_
catalysis _RARE_
( O
EpG _RARE_
formation O
), _RARE_
or O
the O
transfer O
of O
GMP _RARE_
from O
enzyme O
to O
RNA O
. O

Mutational O
analysis O
of O
mRNA I-GENE
capping _RARE_
enzyme I-GENE
identifies O
amino O
acids _RARE_
involved O
in O
GTP O
binding O
, O
enzyme O
- O
guanylate _RARE_
formation O
, O
and O
GMP _RARE_
transfer O
to O
RNA O
. O

Disruption O
of O
the O
HOG1 _RARE_
and O
PBS2 _RARE_
genes I-GENE
leads O
to O
a O
dramatic O
decrease O
of O
the O
HSP12 _RARE_
inducibility O
in O
osmostressed _RARE_
cells O
, O
whereas O
overproduction _RARE_
of O
Hog1 _RARE_
produces O
a O
fivefold _RARE_
increase O
in O
wild O
- O
type O
induced _RARE_
levels O
upon O
a O
shift O
to O
a O
high O
salt O
concentration O
. O

Deletion O
or O
inactivation O
of O
CRY1 _RARE_
leads O
to O
5 O
- O
to O
10 O
- O
fold _RARE_
- O
increased O
levels O
of O
CRY2 _RARE_
mRNA I-GENE
. O

( O
1986 O
) O
method O
of O
separation O
of O
Cryptosporidium _RARE_
spp _RARE_
. O
oocysts _RARE_
from O
feces _RARE_
by O
using O
a O
percoll _RARE_
discontinuous _RARE_
density O
gradient O
appeared O
a O
method O
of O
choice O
for _RARE_
obtaining O
large O
numbers O
of O
oocysts _RARE_
of O
C O
. O
parvum _RARE_
free O
of O
fecal O
contamination O
. O

Staphylococcal _RARE_
enterotoxin _RARE_
A I-GENE
involvement O
in O
the O
illness O
of O
a O
20 O
- O
month O
- O
old O
burn O
patient O
. O

METHODS O
: O
We O
obtained O
maximal O
inspiratory O
and O
expiratory O
flow O
- O
volume O
curves O
in O
41 _RARE_
unselected _RARE_
patients O
with O
essential O
tremor O
( O
14 O
males O
, O
27 _RARE_
females O
, O
age O
61 _RARE_
. O
7 O
+/- O
2 O
. O
14 O
years O
). O

Our O
findings O
also O
provide O
the O
basis O
for _RARE_
the O
development O
of O
assays O
to O
screen O
for _RARE_
the O
ligands O
to O
testis _RARE_
receptor I-GENE
2 I-GENE
and O
hERR1 _RARE_
. O

Four O
p53 I-GENE
DNA I-GENE
- I-GENE
binding I-GENE
domain I-GENE
peptides I-GENE
bind O
natural _RARE_
p53 I-GENE
- I-GENE
response I-GENE
elements I-GENE
and O
bend _RARE_
the O
DNA O
. O

The O
Stat5b _RARE_
mRNA I-GENE
has O
a O
size O
of O
5 O
. O
6 O
kb O
and O
encodes O
a O
protein O
of O
786 _RARE_
amino O
acids _RARE_
. O

The O
hydropathy _RARE_
plot _RARE_
revealed O
a O
rather O
hydrophilic O
N O
- O
terminal O
region O
and O
the O
absence O
of O
a O
hydrophobic O
signal O
peptide O
. O

These O
results O
suggest O
that O
G I-GENE
beta I-GENE
gamma I-GENE
- O
stimulated _RARE_
Shc I-GENE
phosphorylation _RARE_
represents O
an O
early O
step O
in O
the O
pathway _RARE_
leading O
to O
p21ras I-GENE
activation O
, O
similar O
to O
the O
mechanism O
utilized O
by O
growth I-GENE
factor I-GENE
tyrosine I-GENE
kinase I-GENE
receptors I-GENE
. O

This O
report O
focused O
on O
the O
relationship O
between O
Type _RARE_
A O
behavior O
and O
eight O
basic O
emotion _RARE_
dimensions O
. O

All O
carcasses _RARE_
resulted O
in O
contamination O
with O
aerobic O
mesophilic _RARE_
bacteria O
in O
the O
range O
from O
6 O
x _RARE_
10 O
( O
3 O
) O
to O
1 O
. O
2 O
x _RARE_
10 O
( O
6 O
) O
CFU _RARE_
/ O
ml O
liquid O
washed _RARE_
, O
and O
94 O
% O
them O
with O
sporulate _RARE_
bacteria O
, O
the O
threshold O
being O
under O
100 _RARE_
CFU _RARE_
/ O
ml O
( O
Figure _RARE_
1 O
). O

As O
for _RARE_
31 _RARE_
stage _RARE_
I O
- O
II O
lung _RARE_
cancer _RARE_
patients O
, O
CR _RARE_
has O
been O
observed O
in O
82 O
. O
8 O
% O
of O
them O
and O
PR O
in O
13 _RARE_
. O
8 O
%; O
the O
response O
was O
always O
assessed O
with O
chest O
radiography _RARE_
, O
CT _RARE_
, O
FBS _RARE_
, O
cytology _RARE_
and O
/ O
or O
histology _RARE_
. O

Pediatric _RARE_
medical O
emergencies _RARE_
in O
a O
regional O
hospital O
: O
appropriate O
locale _RARE_
? O

Protein O
electrophoresis O
showed O
decreased O
albumin I-GENE
levels O
in O
both O
groups O
, O
with O
lower O
values O
in O
G2 _RARE_
. O

METHODS O
: O
All O
these O
30 _RARE_
non O
- O
responders O
received O
an O
extra _RARE_
dose O
of O
the O
same O
vaccine O
2 O
months O
after O
primary _RARE_
immunization O
and O
a O
booster _RARE_
dose O
with O
a O
yeast O
- O
derived O
vaccine O
6 O
years O
later O
. O

An O
abnormally _RARE_
high O
percentage O
of O
hypertensive O
patients O
( O
approximately _RARE_
30 _RARE_
%) O
undergoing O
cardiac O
catheterization _RARE_
because O
of O
anginal _RARE_
pain O
and O
/ O
or O
exercise O
- O
induced _RARE_
ST O
- O
segment O
depressions _RARE_
has O
angiographically _RARE_
normal O
coronary O
arteries O
. O

Negative _RARE_
- O
staining O
, O
refractile _RARE_
mycobacteria O
in O
Romanowsky _RARE_
- O
stained O
smears O
. O

Mibefradil _RARE_
( O
Ro _RARE_
40 O
- O
5967 _RARE_
) O
is O
a O
novel O
calcium _RARE_
antagonist O
from O
a O
new O
chemical O
class O
and O
is O
the O
first _RARE_
that O
selectively O
blocks O
the O
T O
- O
type O
calcium _RARE_
channel _RARE_
. O

However O
, O
2 O
minimum O
alveolar O
concentration O
anesthesia O
did O
significantly O
decrease O
the O
calculated O
VE O
at _RARE_
a O
PCO2 O
of O
60 _RARE_
mmHg O
( O
from O
7 O
. O
4 O
+/- O
1 O
. O
2 O
to O
4 O
. O
0 _RARE_
+/- O
0 _RARE_
. O
6 O
l _RARE_
. O
min O
- O
1 O
), _RARE_
indicating O
a O
rightward _RARE_
shift O
in O
the O
response O
relationship O
. O

cDNA O
encoding O
a O
functional _RARE_
feline _RARE_
liver I-GENE
/ I-GENE
bone I-GENE
/ I-GENE
kidney _RARE_
- I-GENE
type I-GENE
alkaline _RARE_
phosphatase I-GENE
. O

Protein I-GENE
kinase I-GENE
C I-GENE
( O
PKC I-GENE
), _RARE_
a O
widely O
- O
distributed O
enzyme O
implicated O
in O
the O
regulation _RARE_
of O
many O
physiological O
processes O
, O
consists O
of O
a O
family O
of O
at _RARE_
least O
twelve _RARE_
isoenzymes _RARE_
which O
differ O
in O
tissue O
distribution O
, O
subcellular O
localization _RARE_
, O
regulatory O
properties O
, O
etc O
. O

This O
work O
, O
therefore O
, O
also O
emphasizes O
the O
importance O
of O
careful _RARE_
choice O
of O
oligonucleotide _RARE_
and O
cDNA O
probes _RARE_
to O
study O
PKC I-GENE
zeta _RARE_
mRNA I-GENE
. O

This O
action O
is O
dependent O
on O
helix I-GENE
- I-GENE
loop I-GENE
- I-GENE
helix I-GENE
factors I-GENE
bound _RARE_
to O
the O
E1 I-GENE
element O
. O

The O
debate _RARE_
over O
electives _RARE_
-- _RARE_
1899 _RARE_
. O

Polypeptide _RARE_
growth O
factors O
and O
cytokines _RARE_
mediate O
their O
biochemical O
functions O
through O
their O
responsive O
receptors O
. O

However O
, O
a O
strongly O
increased O
frequency O
of O
CpG O
dinucleotides _RARE_
was O
found O
. O

Here O
we O
focused O
on O
the O
role O
of O
the O
5 O
' O
proximal O
regulatory O
cassette _RARE_
(- _RARE_
190 O
; O
+ O
53 O
bp O
) O
of O
the O
rat I-GENE
enkephalin _RARE_
( O
rENK _RARE_
) O
gene O
in O
the O
developmental O
regulation _RARE_
of O
the O
enkephalin _RARE_
phenotype _RARE_
. O

Unexpectedly _RARE_
, O
all O
ENK _RARE_
- I-GENE
specific I-GENE
motifs I-GENE
formed O
specific O
and O
highly O
abundant O
protein O
- O
DNA O
complexes O
when O
nuclear O
extracts O
from O
the O
human O
tumor O
cell O
line O
( O
HeLa O
), _RARE_
which O
does O
not O
express O
ENK _RARE_
, O
were O
used O
. O

Infant _RARE_
aged O
3 O
. O
5 O
years O
presents O
persistence _RARE_
of O
primordial _RARE_
vitreous O
body O
with O
crystalline O
dislocation O
in O
the O
camera _RARE_
aquosa _RARE_
and O
secondary O
buphthalmos _RARE_
of O
the O
left _RARE_
eye O
and O
microphthalmos _RARE_
with O
dislocation O
of O
the O
crystalline O
in O
the O
vitreous O
body O
of O
the O
right O
eye O
. O

During O
the O
dose O
- O
finding O
, O
two O
patients O
were O
temporarily _RARE_
withdrawn _RARE_
from O
medication O
and O
one O
patient O
was O
excluded O
because O
of O
elevated O
levels O
of O
liver O
enzymes _RARE_
. O

In O
comparison O
of O
cDNA O
and O
genomic O
sequences O
four O
RNA O
editing _RARE_
events O
were O
found O
in O
both O
atp9 _RARE_
genes I-GENE
. O

MZF _RARE_
- I-GENE
1 I-GENE
represses O
CAT I-GENE
reporter I-GENE
gene I-GENE
expression _RARE_
via O
GAL4 I-GENE
binding I-GENE
sites I-GENE
in O
the O
nonhematopoietic _RARE_
cell O
lines O
NIH _RARE_
3T3 O
and O
293 O
. O

As O
with O
the O
heterologous O
DNA O
binding O
domain O
, O
MZF _RARE_
- I-GENE
1 I-GENE
represses O
reporter O
gene O
expression _RARE_
in O
nonhematopoietic _RARE_
cell O
lines O
and O
activates O
expression _RARE_
in O
hematopoietic O
cell O
lines O
. O

Analyses _RARE_
of O
hGMR _RARE_
beta I-GENE
subunit I-GENE
mutants I-GENE
revealed O
two O
cytoplasmic O
regions O
involved O
in O
activation O
of O
the O
c I-GENE
- I-GENE
myc I-GENE
promoter I-GENE
, O
one O
is O
essential O
and O
the O
other O
is O
dispensable O
but O
enhances O
the O
activity O
. O

Similarly O
, O
we O
observed O
synthetic _RARE_
phenotypes _RARE_
between O
mutations O
in O
MIF2 _RARE_
and O
trans _RARE_
- O
acting O
mutations O
in O
three O
known O
yeast O
centromere O
protein O
genes O
- O
CEP1 _RARE_
/ O
CBF1 I-GENE
/ O
CPF1 _RARE_
, O
NDC10 _RARE_
/ O
CBF2 I-GENE
, O
and O
CEP3 _RARE_
/ O
CBF3B _RARE_
. O

Taken O
together O
, O
these O
data O
suggest O
that O
the O
Mif2 _RARE_
protein I-GENE
interacts O
with O
Cep1p _RARE_
at _RARE_
the O
centromere O
and O
that O
the O
yeast O
centromere O
indeed O
exists O
as _RARE_
a O
higher _RARE_
order O
protein O
- O
DNA O
complex O
. O

To O
accomplish _RARE_
this O
, O
actin I-GENE
cables _RARE_
and O
patches _RARE_
are O
redistributed _RARE_
during _RARE_
the O
cell O
cycle _RARE_
to O
direct O
secretory _RARE_
components _RARE_
to O
appropriate O
sites O
for _RARE_
cell O
growth O
. O

The O
effects O
of O
Codonopsis _RARE_
pilosula _RARE_
oral O
liquor _RARE_
( O
CPOL _RARE_
) O
on O
tissue I-GENE
- I-GENE
type I-GENE
plasminogen I-GENE
activator I-GENE
( O
t I-GENE
- I-GENE
PA I-GENE
) O
and O
plasminogen I-GENE
activator I-GENE
inhibitor I-GENE
( O
PAI I-GENE
) O
in O
the O
plasma O
of O
25 _RARE_
patients O
of O
coronary O
heart _RARE_
disease _RARE_
with O
blood _RARE_
stasis _RARE_
were O
studied O
. O

Estimated _RARE_
daily O
intakes _RARE_
( O
EDIs _RARE_
) O
per O
person _RARE_
were O
0 _RARE_
. O
56 _RARE_
microgram O
for _RARE_
total _RARE_
HCH _RARE_
, O
0 _RARE_
. O
20 O
microgram O
for _RARE_
gamma O
- O
HCH _RARE_
, O
0 _RARE_
. O
09 O
microgram O
for _RARE_
dieldrin _RARE_
, O
1 O
. O
42 _RARE_
micrograms O
for _RARE_
total _RARE_
DDT _RARE_
, O
and O
0 _RARE_
. O
15 _RARE_
microgram O
for _RARE_
HCB O
. O

Imaging _RARE_
features O
of O
splenic O
epidermoid _RARE_
cyst O
with O
pathologic O
correlation O
. O

In O
two O
further O
cases O
( O
one O
type O
I O
and O
one O
type O
III O
SMA _RARE_
), _RARE_
de O
novo _RARE_
deletions O
of O
only O
one O
copy O
of O
Ag1 _RARE_
- I-GENE
CA I-GENE
and O
C212 _RARE_
were O
found O
. O

With O
each O
of O
the O
three O
pairs _RARE_
of O
isolates O
( O
case O
and O
suspicious _RARE_
case O
), _RARE_
identical O
IS6110 _RARE_
banding _RARE_
patterns O
were O
found O
suggesting O
identical O
MTB _RARE_
strains O
. O

HRES _RARE_
has O
been O
found O
to O
be O
clinically O
useful O
in O
assessing O
histologic O
damage O
following O
pneumatic _RARE_
dilatation O
and O
in O
localizing _RARE_
the O
LES _RARE_
during _RARE_
the O
administration O
of O
intrasphincter _RARE_
botulinum I-GENE
toxin _RARE_
injection O
in O
the O
treatment O
of O
achalasia _RARE_
. O

These O
early O
structural O
processes O
are O
assumed O
to O
be O
subserved _RARE_
by O
the O
anterior O
parts O
of O
the O
left _RARE_
hemisphere O
, O
as _RARE_
event O
- O
related O
brain O
potentials O
show O
this O
area O
to O
be O
maximally _RARE_
activated O
when O
phrase _RARE_
structure _RARE_
violations _RARE_
are O
processed O
and O
as _RARE_
circumscribed _RARE_
lesions O
in O
this O
area O
lead O
to O
an O
impairment O
of O
the O
on O
- O
line O
structural O
assignment O
. O

In O
men O
with O
BMI O
< O
30 _RARE_
, O
the O
OR O
was O
1 O
. O
83 _RARE_
for _RARE_
postprandial _RARE_
TG O
( O
P O
= O
. O
041 _RARE_
) O
and O
2 O
. O
77 O
for _RARE_
postprandial _RARE_
RP _RARE_
( O
P O
= O
. O
032 _RARE_
) O
in O
models O
that O
included O
fasting O
TG O
, O
LDL I-GENE
- I-GENE
C I-GENE
, O
and O
hypertension O
. O

SL1 _RARE_
trans _RARE_
- O
splicing _RARE_
specified O
by O
AU _RARE_
- O
rich O
synthetic _RARE_
RNA O
inserted O
at _RARE_
the O
5 O
' O
end O
of O
Caenorhabditis O
elegans O
pre O
- O
mRNA O
. O

A O
pyrazolo _RARE_
- O
quinoline _RARE_
compound O
, O
6 O
- O
methoxy _RARE_
- O
4 O
-[ _RARE_
2 O
-[( _RARE_
2 O
- O
hydroxyethoxyl _RARE_
)- O
ethyl O
] O
amino O
]- _RARE_
3 O
- O
methyl _RARE_
- O
1M _RARE_
- O
pyrazo _RARE_
lo _RARE_
[ _RARE_
3 O
, O
4 O
- O
b O
] O
quinoline _RARE_
( O
SCH _RARE_
51344 _RARE_
), _RARE_
was O
identified O
based O
on O
its O
ability O
to O
derepress _RARE_
human O
smooth _RARE_
muscle O
alpha I-GENE
- I-GENE
actin I-GENE
promoter I-GENE
activity O
in O
ras I-GENE
- O
transformed O
cells O
. O

On O
the O
basis O
of O
these O
relations O
, O
a O
risk O
factor O
- O
selection O
scale O
( O
RFSS _RARE_
) O
( O
range O
, O
0 _RARE_
to O
10 O
) O
was O
developed O
by O
computing _RARE_
appropriate O
weights O
for _RARE_
each O
risk O
factor O
. O

The O
Caenorhabditis I-GENE
elegans I-GENE
death _RARE_
susceptibility _RARE_
gene I-GENE
, O
ced _RARE_
- I-GENE
3 I-GENE
, O
has O
a O
number O
of O
homologs O
in O
vertebrate _RARE_
species O
, O
including O
interleukin I-GENE
- I-GENE
1 I-GENE
beta I-GENE
( I-GENE
IL _RARE_
- I-GENE
1 I-GENE
beta I-GENE
)- I-GENE
converting _RARE_
enzyme I-GENE
( O
ICE I-GENE
), _RARE_
Ich _RARE_
- I-GENE
1long _RARE_
, O
and O
CPP32 _RARE_
. O

Repression _RARE_
of O
glucocorticoid I-GENE
receptor I-GENE
- O
mediated _RARE_
transcriptional O
activation O
by O
unliganded _RARE_
thyroid I-GENE
hormone I-GENE
receptor I-GENE
( O
TR I-GENE
) O
is O
TR I-GENE
isoform O
- O
specific O
. O

The O
results O
indicate O
considerable O
flexibility _RARE_
in O
the O
spacing _RARE_
between O
DH _RARE_
regulatory O
sites O
. O

Obstruction _RARE_
of O
the O
ERF _RARE_
repressor I-GENE
function O
by O
the O
transactivating O
members O
of O
the O
ets I-GENE
family I-GENE
of O
genes O
( O
i O
. O
e _RARE_
. O
gag I-GENE
- O
myb I-GENE
- O
ets I-GENE
) O
may O
be O
essential O
for _RARE_
the O
control O
of O
genes O
involved O
in O
cell O
proliferation _RARE_
and O
may O
also O
underlie _RARE_
their O
tumorigenic O
effects O
. O

Overexpression O
of O
wild I-GENE
- I-GENE
type I-GENE
p53 I-GENE
also O
induces O
apoptosis O
in O
an O
LCL _RARE_
. O

We O
show O
that O
c I-GENE
- I-GENE
Fos I-GENE
( O
the O
c I-GENE
- I-GENE
fos I-GENE
protooncogene _RARE_
product I-GENE
), _RARE_
which O
is O
an O
intrinsically _RARE_
unstable O
nuclear O
protein O
, O
is O
metabolically _RARE_
highly O
stabilized O
, O
and O
greatly O
enhances O
the O
transforming O
efficiency O
of O
NIH _RARE_
3T3 O
cells O
, O
by O
Mos _RARE_
. O

Cloning O
, O
sequencing O
and O
expression _RARE_
of O
the O
3 I-GENE
- I-GENE
phosphoglycerate _RARE_
kinase I-GENE
gene I-GENE
of O
Pyrococcus _RARE_
woesei _RARE_
in O
Escherichia O
coli O
and O
characterization O
of O
the O
protein O
. O

These O
observations O
lead O
to O
the O
proposal _RARE_
that O
the O
RNAP I-GENE
II I-GENE
CTD _RARE_
might O
be O
an O
in O
vivo O
target O
for _RARE_
the O
activated O
p42mapk _RARE_
and O
p44mapk _RARE_
MAP I-GENE
kinases I-GENE
. O

We O
also O
isolated O
two O
alternatively _RARE_
spliced _RARE_
forms O
of O
human I-GENE
CD6 _RARE_
cDNA I-GENE
lacking _RARE_
sequences O
encoding O
membrane O
- O
proximal O
regions O
of O
the O
cytoplasmic O
domain O
which O
maintain O
the O
same O
reading O
frame O
as _RARE_
CD6 _RARE_
- O
PB1 _RARE_
. O

We O
sought O
to O
determine O
whether O
such O
differences O
in O
polyadenylation O
affect O
the O
steady O
- O
state O
levels O
of O
DHFR I-GENE
and O
mRNAs O
expressed _RARE_
from O
either O
allele O
and O
, O
in O
a O
more O
general _RARE_
sense O
, O
to O
ask _RARE_
whether O
differences O
in O
3 O
' O
end O
RNA O
processing _RARE_
in O
a O
gene O
containing O
multiple O
poly _RARE_
( O
A O
) O
sites O
affects O
the O
final O
level O
of O
gene O
expression _RARE_
. O

We O
have O
isolated O
a O
Drosophila O
melanogaster O
( O
Dm _RARE_
) O
cDNA O
encoding O
a O
polypeptide O
that O
has O
extensive O
sequence O
similarity _RARE_
to O
the O
mammalian I-GENE
MAPKAPK _RARE_
- I-GENE
2 I-GENE
. O

A O
2 I-GENE
. I-GENE
4 I-GENE
- I-GENE
kb I-GENE
MAPKAPK _RARE_
- I-GENE
2 I-GENE
message _RARE_
is O
expressed _RARE_
throughout O
development O
, O
while O
two O
shorter O
transcripts O
of O
2 O
. O
3 O
and O
1 O
. O
8 O
kb O
appear O
to O
be O
specifically O
expressed _RARE_
in O
the O
germline _RARE_
. O

The O
finding O
that O
the O
chimeric I-GENE
TdT _RARE_
:: O
Pol I-GENE
beta I-GENE
protein I-GENE
possessed O
significant O
template O
- O
dependent O
polymerase O
activity O
suggests O
that O
aa _RARE_
1 O
- O
60 _RARE_
of O
Pol I-GENE
beta I-GENE
are O
involved O
in O
template O
utilization O
during _RARE_
the O
polymerization _RARE_
reaction O
, O
as _RARE_
suggested O
by O
the O
previous O
finding O
that O
the O
8 O
- O
kDa O
N O
- O
terminal O
domain O
of O
Pol I-GENE
beta I-GENE
possesses O
ssDNA _RARE_
- O
binding O
activity O
[ _RARE_
Kumar _RARE_
et O
al O
., O
J _RARE_
. O

The O
average O
values O
were O
199 _RARE_
and O
424 _RARE_
revertants _RARE_
/ O
g O
for _RARE_
the O
hamburgers _RARE_
and O
hot O
dogs O
, O
respectively O
. O

Cholangiography _RARE_
was O
performed O
in O
all O
cases O
and O
classified O
by O
a O
scoring _RARE_
system _RARE_
specifically O
developed O
for _RARE_
pediatric O
patients O
. O

The O
integrity O
of O
the O
cDNA O
sequence O
was O
confirmed O
by O
analysis O
of O
several O
overlapping O
genomic O
clones _RARE_
that O
span O
the O
GAR1 _RARE_
gene I-GENE
. O

In O
Trial _RARE_
1 O
, O
eight O
sows _RARE_
were O
allowed O
to O
farrow _RARE_
naturally O
( O
d O
114 _RARE_
, O
NF _RARE_
sows _RARE_
) O
and O
eight O
sows _RARE_
were O
induced _RARE_
to O
farrow _RARE_
( O
IF O
sows _RARE_
) O
prematurely _RARE_
by O
injection O
of O
prostaglandin _RARE_
F2 O
alpha O
on O
d O
112 O
of O
gestation O
. O

End _RARE_
- O
tidal O
PO2 O
and O
the O
ratio O
of O
minute O
ventilation O
to O
oxygen O
consumption O
( O
VE O
/ O
VO2 O
) O
were O
lower O
while O
PETCO2 _RARE_
was O
higher _RARE_
for _RARE_
Hyp _RARE_
( O
P O
< O
or O
= O
0 _RARE_
. O
01 O
). O

These O
results O
suggested O
that O
NfxB _RARE_
negatively O
autoregulates _RARE_
the O
expression _RARE_
of O
nfxB _RARE_
itself O
. O

A511 _RARE_
is O
a O
broad O
- O
host _RARE_
- O
range O
, O
virulent O
myovirus _RARE_
for _RARE_
Listeria _RARE_
monocytogenes O
. O

The O
mechanism O
of O
peroxisome _RARE_
proliferation _RARE_
is O
poorly O
understood O
. O

If O
NCR O
- O
sensitive _RARE_
gene O
expression _RARE_
occurs O
exclusively O
by O
this O
pathway _RARE_
, O
as _RARE_
has O
been O
thought O
to O
be O
the O
case O
, O
then O
the O
NCR O
sensitivity O
of O
a O
gene O
' O
s O
expression _RARE_
should O
be O
abolished O
by O
a O
ure2 _RARE_
delta I-GENE
mutation I-GENE
. O

The O
single O
- O
stranded _RARE_
DNA O
Pur _RARE_
alpha I-GENE
recognition I-GENE
element I-GENE
disrupts _RARE_
these O
complexes O
. O

Association O
of O
human I-GENE
Pur _RARE_
alpha I-GENE
with O
the O
retinoblastoma _RARE_
protein I-GENE
, O
Rb _RARE_
, O
regulates O
binding O
to O
the O
single O
- O
stranded _RARE_
DNA O
Pur _RARE_
alpha I-GENE
recognition I-GENE
element I-GENE
. O

The O
insulin I-GENE
- O
induced _RARE_
DNA O
- O
binding O
complex O
was O
identified O
as _RARE_
the O
p50 _RARE_
/ O
p65 _RARE_
heterodimer _RARE_
. O

Using O
varying O
conditions O
, O
three O
distinct O
complexes O
were O
shown O
to O
interact O
specifically O
with O
the O
NIP _RARE_
region I-GENE
, O
although O
only O
one O
correlates O
with O
repressor O
activity O
. O

Exchange _RARE_
of O
the O
LPL _RARE_
and O
HL _RARE_
lids _RARE_
resulted O
in O
a O
reversal O
of O
the O
phospholipase I-GENE
/ O
neutral O
lipase I-GENE
ratio O
, O
establishing _RARE_
the O
important O
role O
of O
this O
region O
in O
mediating O
substrate O
specificity _RARE_
. O

The O
interferon _RARE_
- O
inducible O
protein I-GENE
kinase I-GENE
PKR I-GENE
modulates _RARE_
the O
transcriptional O
activation O
of O
immunoglobulin I-GENE
kappa _RARE_
gene I-GENE
. O

Truncated _RARE_
forms O
of O
a O
novel O
yeast O
protein O
suppress O
the O
lethality O
of O
a O
G I-GENE
protein I-GENE
alpha I-GENE
subunit I-GENE
deficiency O
by O
interacting _RARE_
with O
the O
beta O
subunit O
. O

Another O
common O
mutation O
involved O
amino O
acids _RARE_
that O
are O
thought O
to O
make O
specific O
contacts O
with O
DNA O
. O

Phorbol _RARE_
esters O
stimulated _RARE_
phosphorylation _RARE_
of O
CSK _RARE_
35H _RARE_
proteins I-GENE
, O
thus O
emphasizing _RARE_
that O
sequences O
isolated O
according O
to O
PKC I-GENE
binding O
activity O
in O
vitro O
are O
also O
PKC I-GENE
substrates _RARE_
in O
vivo O
. O

Levels _RARE_
of O
TSG _RARE_
- I-GENE
14 I-GENE
protein I-GENE
( O
also O
termed O
PTX _RARE_
- I-GENE
3 I-GENE
) O
become O
elevated O
in O
the O
serum O
of O
mice O
and O
humans O
after O
injection O
with O
bacterial O
lipopolysaccharide O
, O
but O
in O
contrast O
to O
conventional O
acute O
phase _RARE_
proteins O
, O
the O
bulk O
of O
TSG _RARE_
- I-GENE
14 I-GENE
synthesis _RARE_
in O
the O
intact _RARE_
organism O
occurs O
outside O
the O
liver O
. O

The O
mouse I-GENE
beta I-GENE
2 I-GENE
- I-GENE
syntrophin _RARE_
gene I-GENE
( O
> O
33 _RARE_
kilobases O
) O
contains O
seven _RARE_
exons O
, O
all O
of O
which O
have O
homologues _RARE_
at _RARE_
the O
corresponding O
position O
in O
the O
alpha I-GENE
1 I-GENE
- I-GENE
syntrophin _RARE_
gene I-GENE
. O

Altogether O
our O
data O
indicate O
that O
PEDF _RARE_
belongs O
to O
the O
subgroup O
of O
noninhibitory _RARE_
serpins _RARE_
and O
that O
its O
N O
- O
terminal O
region O
confers O
a O
neurite _RARE_
- O
promoting _RARE_
activity O
to O
the O
protein O
. O

We O
report O
here O
the O
cloning O
of O
the O
murine O
p44 I-GENE
MAP I-GENE
kinase I-GENE
( O
extracellular I-GENE
signal I-GENE
- I-GENE
regulated I-GENE
kinase I-GENE
1 I-GENE
) O
gene O
, O
the O
determination O
of O
its O
intron O
/ O
exon _RARE_
boundaries O
, O
and O
the O
characterization O
of O
its O
promoter O
. O

It O
contains O
three O
putative O
TATA O
boxes _RARE_
far O
upstream O
of O
the O
main O
start _RARE_
sites O
region O
, O
one O
AP I-GENE
- I-GENE
1 I-GENE
box I-GENE
, O
one O
AP I-GENE
- I-GENE
2 I-GENE
box I-GENE
, O
one O
Malt _RARE_
box I-GENE
, O
one O
GAGA _RARE_
box O
, O
one O
half _RARE_
serum O
- O
responsive O
element O
, O
and O
putative O
binding O
sites O
for _RARE_
Sp1 _RARE_
( O
five O
), _RARE_
GC _RARE_
- I-GENE
rich I-GENE
binding I-GENE
factor I-GENE
( O
five O
), _RARE_
CTF _RARE_
- I-GENE
NF1 I-GENE
( O
one O
), _RARE_
Myb I-GENE
( O
one O
), _RARE_
p53 I-GENE
( O
two O
), _RARE_
Ets I-GENE
- I-GENE
1 I-GENE
( O
one O
), _RARE_
NF _RARE_
- I-GENE
IL6 I-GENE
( O
two O
), _RARE_
MyoD I-GENE
( O
two O
), _RARE_
Zeste _RARE_
( O
one O
), _RARE_
and O
hepatocyte _RARE_
nuclear I-GENE
factor I-GENE
- I-GENE
5 I-GENE
( O
one O
). O

One O
of O
these O
is O
surrounded _RARE_
by O
an O
adenine _RARE_
- O
uridine _RARE_
rich O
region O
that O
can O
form O
an O
11 O
- O
base _RARE_
pair _RARE_
stem _RARE_
structure _RARE_
. O

We O
conclude O
that O
this O
new O
measurement O
technique O
provides O
an O
easy _RARE_
and O
accurate O
P0 _RARE_
. O
1 O
measurement O
using O
standard O
respiratory O
equipment _RARE_
when O
tested O
in O
a O
lung _RARE_
model O
. O

Effects O
of O
verapamil O
and O
propranolol O
on O
early O
afterdepolarizations _RARE_
and O
ventricular O
arrhythmias O
induced _RARE_
by O
epinephrine O
in O
congenital O
long O
QT O
syndrome _RARE_
. O

Deletion O
of O
the O
NF _RARE_
- I-GENE
IL6 I-GENE
beta I-GENE
leucine I-GENE
zipper I-GENE
domain I-GENE
also O
greatly O
diminished O
the O
interaction O
between O
these O
two O
proteins O
. O

After O
cells O
were O
stably O
transfected O
with O
CIITA _RARE_
, O
endogenous O
MHC I-GENE
class I-GENE
II I-GENE
genes I-GENE
were O
constitutively O
expressed _RARE_
, O
and O
MHC I-GENE
class I-GENE
II I-GENE
promoters I-GENE
, O
delivered O
by O
transfection O
, O
were O
actively O
transcribed _RARE_
in O
CIITA _RARE_
- O
expressing O
cells O
. O

Two O
domains O
of O
EBNA2 I-GENE
defined O
by O
deletion O
of O
amino O
acids _RARE_
247 _RARE_
- O
337 _RARE_
and O
437 _RARE_
- O
476 _RARE_
were O
found O
to O
be O
important O
for _RARE_
the O
activation O
of O
both O
promoters O
, O
while O
two O
different O
domains O
corresponding O
to O
residues O
4 O
- O
18 O
and O
118 O
- O
198 O
were O
required O
solely O
for _RARE_
the O
LMP1 I-GENE
promoter I-GENE
. O

The O
peak O
velocities _RARE_
of O
the O
atrial _RARE_
systolic O
waves O
of O
the O
transmitral _RARE_
and O
pulmonary O
venous O
flow O
velocities _RARE_
( O
A O
and O
PVA _RARE_
, O
respectively O
) O
and O
first _RARE_
systolic O
wave O
( O
PVS1 _RARE_
) O
of O
pulmonary O
venous O
flow O
, O
durations O
of O
both O
atrial _RARE_
systolic O
waves O
, O
and O
amplitude O
of O
interatrial _RARE_
septal O
motion O
during _RARE_
atrial _RARE_
systole _RARE_
increased O
significantly O
ten O
days O
after O
cardioversion _RARE_
compared O
with O
those O
measured O
within O
a O
day O
of O
cardioversion _RARE_
in O
all O
patients O
except O
the O
5 O
patients O
with O
dilated _RARE_
cardiomyopathy O
. O

Additionally O
, O
the O
enzyme O
shows O
activity O
towards O
triglycerides _RARE_
such O
as _RARE_
olive _RARE_
oil O
and O
tributyrin _RARE_
and O
towards O
egg _RARE_
- O
yolk _RARE_
emulsions _RARE_
. O

The O
nucleotide O
sequence O
directly O
upstream O
of O
fimA _RARE_
contains O
two O
open _RARE_
reading O
frames O
, O
ORF5 _RARE_
and O
ORF1 O
, O
whose O
deduced O
protein O
products O
are O
homologous O
to O
members O
of O
a O
superfamily O
of O
ATP I-GENE
- I-GENE
binding I-GENE
cassette _RARE_
membrane I-GENE
transport _RARE_
proteins I-GENE
, O
including O
both O
prokaryotic _RARE_
and O
eukaryotic O
uptake O
and O
export O
systems _RARE_
. O

The O
ORF3 O
probe O
also O
hybridized O
to O
a O
540 _RARE_
bp O
transcript O
consistent O
with O
the O
size O
of O
ORF3 O
alone O
and O
supportive _RARE_
of O
the O
mutagenesis O
data O
of O
non O
- O
linkage O
. O

These O
results O
suggest O
that O
low O
concentrations O
of O
IL _RARE_
- I-GENE
1 I-GENE
beta I-GENE
may O
be O
useful O
for _RARE_
nonsurgical _RARE_
treatment O
of O
human O
vitreous O
hemorrhage O
. O

We O
conclude O
that O
pancreatic O
polypeptide O
and O
motilin _RARE_
responses O
to O
a O
meal _RARE_
are O
different O
in O
encopretic _RARE_
children O
than O
in O
children O
in O
the O
control O
group O
. O

Here O
we O
report O
the O
cloning O
, O
expression _RARE_
, O
and O
biochemical O
characterization O
of O
the O
32 _RARE_
- O
kDa O
subunit O
of O
human O
( O
h O
) O
TFIID I-GENE
, O
termed O
hTAFII32 _RARE_
. O

Hemolytic _RARE_
jaundice O
due O
to O
G6PD _RARE_
deficiency O
causing O
kernicterus _RARE_
in O
a O
female O
newborn O
. O

Two O
transcripts O
of O
1 O
. O
6 O
kb O
and O
5 O
. O
8 O
kb O
are O
5 O
' O
coterminal _RARE_
and O
may O
both O
encode O
the O
novel O
glycoprotein I-GENE
gene I-GENE
EUS4 _RARE_
. O

Mean O
growth O
changes O
in O
this O
Class _RARE_
II O
sample O
were O
comparable O
to O
those O
previously O
reported O
for _RARE_
male O
subjects O
with O
Class _RARE_
I O
malocclusions _RARE_
over O
the O
same O
age O
period O
, O
suggesting O
a O
similarity _RARE_
in O
postpubertal _RARE_
development O
between O
these O
two O
groups O
. O

However O
, O
the O
few O
studies O
that O
address O
antimicrobial O
prophylaxis O
in O
bone O
marrow O
transplantation O
have O
not O
always O
shown O
a O
survival O
benefit O
. O

The O
fracture O
groups O
were O
significantly O
older O
and O
had O
more O
years O
since O
menopause _RARE_
than O
the O
control O
groups O
. O

In O
addition O
, O
we O
found O
differences O
in O
the O
binding O
of O
nuclear O
factors O
from O
shoots _RARE_
versus O
from O
roots O
, O
in O
agreement O
with O
the O
different O
activities O
of O
the O
promoter O
in O
these O
two O
organs O
. O

The O
prevalence O
and O
incidence O
of O
human O
immunodeficiency O
virus O
types _RARE_
1 O
and O
2 O
( O
HIV O
- O
1 O
, O
HIV O
- O
2 O
), _RARE_
human O
T O
- O
lymphotropic _RARE_
virus O
types _RARE_
I O
and O
II O
( O
HTLV _RARE_
- O
I O
/ O
II O
), _RARE_
and O
syphilitic _RARE_
infections O
and O
the O
association O
between O
these O
infections O
were O
determined O
in O
a O
cohort O
of O
police _RARE_
officers _RARE_
in O
Guinea _RARE_
- O
Bissau _RARE_
. O

By O
in O
vitro O
immunoprecipitations _RARE_
and O
gel O
shift O
assays O
, O
we O
identified O
two O
classes O
of O
high O
affinity O
Engrailed _RARE_
- I-GENE
binding I-GENE
sites I-GENE
upstream O
of O
each O
of O
the O
two O
polyhomeotic _RARE_
transcription O
units _RARE_
. O

Subjects _RARE_
with O
a O
short O
postexposure O
time O
and O
a O
dioxin _RARE_
burden O
> O
0 _RARE_
. O
6 O
pg O
/ O
m3 O
had O
a O
significantly O
higher _RARE_
risk O
of O
hypoergy _RARE_
than O
unexposed _RARE_
subjects O
( O
hypoergy _RARE_
I O
: O
OR O
= O
9 O
. O
51 _RARE_
, O
95 _RARE_
% O
CI _RARE_
= O
1 O
. O
96 O
- O
42 _RARE_
. O
02 O
; O
hypoergy _RARE_
II O
: O
OR O
= O
2 O
. O
92 O
, O
95 _RARE_
% O
CI _RARE_
= O
1 O
. O
14 O
- O
7 O
. O
5 O
). O

Analysis O
of O
this O
sequence O
combined O
with O
that O
previously O
reported O
for _RARE_
the O
5 O
'- O
flanking O
region O
directly O
proximal O
to O
the O
start _RARE_
of O
transcription O
revealed O
several O
putative O
regulatory O
sequences O
. O

We O
now O
show O
that O
the O
BAT1 _RARE_
translation I-GENE
product I-GENE
is O
the O
homolog O
of O
the O
rat I-GENE
p47 _RARE_
nuclear I-GENE
protein I-GENE
, O
the O
WM6 _RARE_
Drosophila I-GENE
gene I-GENE
product I-GENE
, O
and O
probably O
also O
Ce08102 _RARE_
of O
Caenorhabditis O
elegans O
, O
all O
members O
of O
the O
DEAD _RARE_
protein I-GENE
family I-GENE
of O
ATP I-GENE
- I-GENE
dependent I-GENE
RNA I-GENE
helicases _RARE_
. O

By O
using O
lacZ I-GENE
fusions I-GENE
, O
it O
was O
possible O
to O
localize O
the O
DNA O
sequences O
required O
to O
mediate O
nitrate _RARE_
repression O
to O
the O
pfl _RARE_
promoter I-GENE
- I-GENE
regulatory I-GENE
region I-GENE
. O

In O
this O
report O
, O
we O
describe O
the O
characterization O
of O
two O
early O
class I-GENE
II I-GENE
flagellar _RARE_
genes I-GENE
contained O
in O
the O
orfX _RARE_
- O
fliP _RARE_
locus O
. O

Vestibular _RARE_
adaptation O
exercises _RARE_
and O
recovery O
: O
acute O
stage _RARE_
after O
acoustic O
neuroma _RARE_
resection O
. O

The O
experimental O
design O
represents O
a O
2 O
x _RARE_
3 O
factorial _RARE_
arrangement O
of O
treatments O
with O
three O
dietary O
levels O
of O
incorporation O
of O
RSB _RARE_
( O
0 _RARE_
, O
50 O
, O
and O
100 _RARE_
%), O
and O
chickens _RARE_
either O
infected _RARE_
or O
uninfected _RARE_
. O

A O
cDNA O
clone O
corresponding O
to O
the O
putative O
GA _RARE_
20 I-GENE
- O
oxidase I-GENE
genomic O
sequence O
was O
constructed O
with O
the O
reverse O
transcription O
- O
PCR O
method O
, O
and O
the O
identity O
of O
the O
cDNA O
clone O
was O
confirmed O
by O
analyzing O
the O
capability _RARE_
of O
the O
fusion O
protein O
expressed _RARE_
in O
Escherichia O
coli O
to O
convert _RARE_
GA53 _RARE_
to O
GA44 _RARE_
and O
GA19 _RARE_
to O
GA20 _RARE_
. O

There O
were O
no _RARE_
significant O
changes O
in O
either O
the O
fatty O
acid O
composition O
of O
biliary O
lecithin _RARE_
or O
in O
the O
bile O
acid O
composition O
of O
bile O
. O

Total O
cholesterol O
was O
also O
reduced _RARE_
at _RARE_
week O
12 O
by O
17 _RARE_
. O
0 _RARE_
% O
( O
20 O
mg O
/ O
day O
) O
and O
15 _RARE_
. O
7 O
% O
( O
20 O
- O
30 _RARE_
mg O
/ O
day O
), _RARE_
and O
at _RARE_
week O
52 O
by O
20 O
. O
4 O
% O
(< O
or O
= O
20 O
mg O
/ O
day O
) O
and O
19 O
. O
2 O
% O
(> O
or O
= O
30 _RARE_
mg O
/ O
day O
). O

Although O
further O
studies O
are O
required O
to O
determine O
the O
precise O
role O
of O
PEBP2 _RARE_
in O
the O
GM _RARE_
- I-GENE
CSF I-GENE
promoter I-GENE
activity O
, O
the O
present O
findings O
suggested O
the O
importance O
of O
the O
relative O
ratio O
of O
different O
PEBP2 _RARE_
isoforms I-GENE
in O
regulating _RARE_
the O
levels O
of O
the O
promoter O
activity O
. O

Benefits _RARE_
of O
obtaining O
board _RARE_
certification _RARE_
in O
pharmacotherapy _RARE_
. O

Piperacillin _RARE_
- O
tazobactam _RARE_
can O
be O
used O
for _RARE_
the O
treatment O
of O
infections O
caused O
by O
gram O
- O
negative O
, O
gram O
- O
positive O
, O
aerobic O
, O
and O
anaerobic O
bacteria O
. O

Basal O
plasma O
renin I-GENE
activity O
( O
PRA _RARE_
) O
was O
slightly O
raised O
prior O
to O
training O
( O
P O
< O
0 _RARE_
. O
07 O
) O
compared O
to O
the O
controls O
and O
post O
- O
training O
. O

This O
apparently O
anomalous _RARE_
structure _RARE_
/ O
activity O
relationship O
raises _RARE_
important O
issues O
for _RARE_
understanding O
the O
evolution O
of O
regulatory O
peptides O
and O
the O
mechanisms O
that O
control O
their O
expression _RARE_
. O

The O
structural O
gene O
encoding O
the O
novel O
lantibiotic _RARE_
epilancin _RARE_
K7 _RARE_
from O
Staphylococcus _RARE_
epidermidis _RARE_
K7 _RARE_
was O
cloned _RARE_
and O
its O
nucleotide O
sequence O
was O
determined O
. O

This O
paper O
summarises _RARE_
the O
experimental O
evidence O
upon O
which O
the O
clinical O
trials O
of O
aldose _RARE_
reductase I-GENE
inhibitors _RARE_
in O
diabetic O
patients O
have O
been O
initiated _RARE_
and O
the O
results O
of O
published O
drug O
trials O
in O
these O
patients O
. O

The O
spectrum O
of O
phenotypes _RARE_
caused O
by O
these O
mutations O
was O
strikingly O
different O
than O
mutations O
in O
the O
adaptor _RARE_
for _RARE_
the O
VP16 I-GENE
activation I-GENE
domain I-GENE
. O

Increase _RARE_
in O
urinary _RARE_
calcium _RARE_
and O
oxalate _RARE_
after O
fructose _RARE_
infusion O
. O

The O
5 O
' O
flanking O
region O
is O
highly O
GC _RARE_
rich O
, O
with O
multiple O
CpG O
doublets _RARE_
, O
and O
contains O
multiple O
binding O
sites O
for _RARE_
Sp1 _RARE_
. O

To O
discern _RARE_
whether O
these O
disorders O
of O
GnRH I-GENE
deficiency O
are O
associated O
with O
altered O
melatonin O
secretion _RARE_
profiles O
, O
we O
compared O
untreated O
young O
males O
IGD _RARE_
( O
n _RARE_
= O
7 O
) O
and O
DP _RARE_
( O
n _RARE_
= O
7 O
) O
to O
normal O
pubertal _RARE_
male O
controls O
( O
n _RARE_
= O
6 O
). O

Increased O
blood _RARE_
pressure O
during _RARE_
CyA _RARE_
treatment O
was O
independent O
of O
circulating O
ET _RARE_
- I-GENE
1 I-GENE
levels O
. O

Analysis O
of O
several O
Tat I-GENE
mutants I-GENE
indicated O
that O
both O
the O
cysteine O
- O
rich O
and O
the O
core O
domains O
of O
this O
transactivator _RARE_
are O
necessary O
and O
sufficient O
to O
activate O
transcription O
when O
TBP I-GENE
is O
overexpressed O
. O

In O
addition O
, O
depletion O
of O
Oct I-GENE
- I-GENE
1 I-GENE
from O
the O
nuclear O
extract _RARE_
by O
using O
Oct I-GENE
- I-GENE
1 I-GENE
- O
specific O
antiserum _RARE_
or O
a O
sequence O
- O
specific O
DNA O
affinity O
resin O
decreased O
in O
vitro O
transcription O
from O
the O
wild O
- O
type O
MMTV _RARE_
promoter O
to O
a O
level O
identical O
to O
that O
obtained O
from O
a O
promoter O
in O
which O
all O
three O
octamer O
- O
related O
sequences O
were O
mutated _RARE_
. O

Transactivation _RARE_
of O
the O
HIV I-GENE
- I-GENE
1 I-GENE
LTR I-GENE
by O
T3R I-GENE
alpha I-GENE
and O
several O
receptor O
mutants O
revealed O
that O
the O
50 O
- O
amino O
- O
acid O
N O
- O
terminal O
A O
/ O
B O
region O
of O
T3R I-GENE
alpha I-GENE
, O
known O
to O
interact O
with O
the O
basal I-GENE
transcription I-GENE
factor I-GENE
TFIIB _RARE_
, O
is O
critical O
for _RARE_
activation O
of O
both O
Tat I-GENE
- O
dependent O
and O
Tat I-GENE
- O
independent O
responsive O
sequences O
of O
the O
LTR O
. O

M O
. O
M O
. O
C O
. O
was O
used O
for _RARE_
2 O
. O
5 O
minutes O
in O
44 _RARE_
cases O
( O
20 O
HR O
patients O
, O
24 _RARE_
LR _RARE_
patients O
), _RARE_
and O
for _RARE_
5 O
minutes O
in O
66 _RARE_
cases O
( O
46 _RARE_
HR O
patients O
, O
20 O
LR _RARE_
patients O
). O

Finally O
, O
we O
show O
that O
complexes O
similar O
to O
the O
C25 _RARE_
, O
C30 _RARE_
and O
C35 _RARE_
complexes I-GENE
are O
formed O
by O
rat O
cortex O
nuclear O
extracts O
and O
the O
SAA _RARE_
element O
in O
EMSA O
experiments O
, O
suggesting O
the O
relevance O
of O
our O
in O
vitro O
observations O
to O
the O
in O
vivo O
functioning O
of O
the O
rat I-GENE
APP _RARE_
promoter I-GENE
. O

Oncological _RARE_
, O
clinical O
and O
psychological O
aspects O
are O
evaluated O
according O
to O
experience O
accumulated O
in O
recent O
years O
, O
with O
immediate O
and O
delayed O
reconstruction O
, O
carried O
out O
in O
the O
most O
diverse O
specialized O
centers O
. O

The O
analysis O
of O
the O
prevalence O
values O
shows O
clearly O
that O
the O
global O
MS O
- O
frequency O
is O
closer _RARE_
related O
to O
the O
geomagnetic _RARE_
than O
to O
the O
geographic _RARE_
latitude _RARE_
. O

Diltiazem _RARE_
caused O
significant O
decrease O
in O
the O
ventricular O
response O
without O
conversion O
to O
sinus O
rhythm O
. O

Subhuman _RARE_
primates O
appear O
to O
be O
more O
sensitive _RARE_
to O
reproductive O
and O
other O
adverse O
effects O
of O
PCBs _RARE_
than O
humans O
. O

When O
excluding O
children O
with O
ocular O
and O
cerebral O
pathology O
, O
32 _RARE_
matched O
pairs _RARE_
of O
premature O
and O
control O
children O
remained O
. O

The O
cryptococcal _RARE_
antigen I-GENE
test O
was O
positive O
at _RARE_
1 O
: O
125 _RARE_
by O
latex O
agglutination _RARE_
. O

Functional O
analysis O
of O
DNase I-GENE
- I-GENE
I I-GENE
hypersensitive _RARE_
sites O
at _RARE_
the O
mouse I-GENE
porphobilinogen _RARE_
deaminase _RARE_
gene I-GENE
locus I-GENE
. O

These O
transcripts O
have O
a O
unique O
5 O
' O
untranslated _RARE_
region O
and O
NH2 O
- O
terminal O
sequence O
and O
encode O
a O
predicted O
protein O
of O
121 _RARE_
kD _RARE_
. O

Both O
mu I-GENE
and I-GENE
gamma I-GENE
2b _RARE_
heavy I-GENE
chain I-GENE
genes I-GENE
cause O
this O
feedback _RARE_
inhibition O
of O
heavy O
chain O
gene O
rearrangement O
. O

Purified _RARE_
CarP _RARE_
binds O
in O
vitro O
to O
the O
carAB _RARE_
control I-GENE
region I-GENE
and O
protects _RARE_
against O
DNase I-GENE
I I-GENE
two O
approximately _RARE_
25 _RARE_
bp O
long O
stretches O
, O
one O
of O
which O
is O
located _RARE_
just O
downstream _RARE_
of O
the O
GATC _RARE_
sequence O
. O

They O
include O
genes O
encoding O
three O
subunits O
of O
the O
cytochrome I-GENE
oxidase I-GENE
( O
cox1 _RARE_
to I-GENE
3 I-GENE
), _RARE_
apocytochrome _RARE_
b I-GENE
( O
cob _RARE_
), _RARE_
seven _RARE_
subunits O
of O
the O
NADH _RARE_
dehydrogenase I-GENE
complex I-GENE
( O
nad1 _RARE_
to I-GENE
6 I-GENE
, O
nad4L _RARE_
), _RARE_
two O
ATPase I-GENE
subunits O
( O
atp6 _RARE_
and O
atp9 _RARE_
), _RARE_
three O
ribosomal O
RNAs O
( O
rrn5 _RARE_
, O
srn _RARE_
and O
lrn _RARE_
), _RARE_
23 _RARE_
tRNAs _RARE_
and O
four O
ribosomal O
proteins O
( O
rps3 _RARE_
, O
rps11 _RARE_
, O
rps12 _RARE_
and O
rpl16 _RARE_
). O

From O
day O
10 O
, O
a O
significant O
increase O
in O
platelet O
count O
was O
observed O
in O
eight O
of O
the O
ten O
patients O
treated O
with O
heparin _RARE_
( O
p O
< O
0 _RARE_
. O
05 O
), _RARE_
with O
return O
to O
the O
initial O
value O
after O
heparin _RARE_
cessation O
in O
six _RARE_
of O
the O
responders O
. O

These O
" O
nucleocapsid _RARE_
- O
like O
" O
structures _RARE_
were O
readily O
purified _RARE_
by O
density O
gradient O
centrifugation _RARE_
. O

The O
Babcock _RARE_
Surgical _RARE_
Clinic _RARE_
. O

Resources _RARE_
for _RARE_
helping _RARE_
patients O
to O
quit _RARE_
smoking O
. O

The O
PEBP2 _RARE_
alpha I-GENE
proteins I-GENE
contain O
a O
128 _RARE_
- O
amino O
- O
acid O
( O
aa _RARE_
) O
region O
highly O
homologous O
to O
the O
Drosophila I-GENE
melanogaster I-GENE
segmentation _RARE_
gene I-GENE
runt _RARE_
. O

In O
human O
proliferative O
cells O
, O
the O
NADP _RARE_
- O
dependent O
ME _RARE_
activity O
is O
poorly O
expressed _RARE_
and O
barely _RARE_
inducible O
by O
thyroid O
hormones _RARE_
. O

Based O
on O
previous O
mapping O
of O
the O
G I-GENE
beta I-GENE
gamma I-GENE
binding I-GENE
region I-GENE
of O
beta I-GENE
ARK _RARE_
, O
and O
conserved _RARE_
residues O
within O
the O
PH _RARE_
domain I-GENE
, O
we O
have O
constructed O
a O
series O
of O
mutants O
in O
the O
carboxyl _RARE_
terminus O
of O
beta I-GENE
ARK _RARE_
in O
order O
to O
determine O
important O
residues O
involved O
in O
G I-GENE
beta I-GENE
gamma I-GENE
and O
PIP2 O
binding O
. O

Histopathological _RARE_
features O
of O
relapsed _RARE_
leprosy _RARE_
. O

To O
dissect _RARE_
these O
mechanisms O
, O
wild O
- O
type O
and O
mutant I-GENE
Raf I-GENE
- I-GENE
1 I-GENE
proteins I-GENE
were O
studied O
in O
an O
in O
vitro O
system _RARE_
with O
purified _RARE_
plasma O
membranes O
from O
v I-GENE
- I-GENE
Ras I-GENE
- O
and O
v I-GENE
- I-GENE
Src I-GENE
- O
transformed O
cells O
( O
transformed O
membranes O
). O

In O
CV _RARE_
- O
1 O
cells O
, O
cotransfection O
of O
the O
retinoid I-GENE
and I-GENE
estrogen I-GENE
receptors I-GENE
led O
to O
mutual _RARE_
inhibition O
of O
the O
other O
' O
s O
activity O
, O
while O
an O
RA _RARE_
- O
dependent O
inhibition O
of O
ER I-GENE
activity O
was O
observed O
in O
breast O
cancer _RARE_
cells O
. O

One O
of O
these O
factors O
, O
HRF _RARE_
- I-GENE
1 I-GENE
, O
recognizes O
a O
cis O
element O
consisting O
of O
an O
inverted O
palindromic O
motif O
. O

Regulation O
of O
Gax _RARE_
homeobox _RARE_
gene I-GENE
transcription O
by O
a O
combination O
of O
positive O
factors O
including O
myocyte _RARE_
- I-GENE
specific I-GENE
enhancer I-GENE
factor I-GENE
2 I-GENE
. O

The O
carboxyl _RARE_
- O
terminal O
transactivation _RARE_
domain O
of O
heat I-GENE
shock I-GENE
factor I-GENE
1 I-GENE
is O
negatively O
regulated O
and O
stress O
responsive O
. O

D O
. O

It O
was O
proposed O
that O
the O
synthetase _RARE_
- O
related O
sequences O
of O
GCN2 I-GENE
stimulate O
the O
activity O
of O
the O
kinase O
by O
interacting _RARE_
directly O
with O
uncharged _RARE_
tRNA O
that O
accumulates O
during _RARE_
amino O
acid O
limitation O
. O

However O
, O
unlike O
Bcl I-GENE
- I-GENE
2 I-GENE
and O
the O
E1B I-GENE
19K _RARE_
proteins I-GENE
, O
which O
completely O
block _RARE_
apoptosis O
but O
not O
p53 I-GENE
- O
dependent O
growth O
arrest O
, O
H I-GENE
- I-GENE
ras I-GENE
expression _RARE_
permitted O
DNA O
synthesis _RARE_
and O
cell O
proliferation _RARE_
in O
the O
presence O
of O
high O
levels O
of O
wild I-GENE
- I-GENE
type I-GENE
p53 I-GENE
. O

To O
compare O
the O
PAX3 _RARE_
and O
putative O
PAX3 _RARE_
- O
FKHR _RARE_
transactivation _RARE_
domains O
, O
we O
fused O
C O
- O
terminal O
test O
fragments O
to O
the O
heterologous O
GAL4 I-GENE
DNA I-GENE
- I-GENE
binding I-GENE
domain I-GENE
and O
tested O
activation O
of O
a O
reporter O
gene O
co _RARE_
- O
transfected O
into O
four O
cell O
types _RARE_
. O

All O
subjects O
were O
submitted O
to O
ECG O
and O
arterial O
blood _RARE_
pressure O
determination O
and O
were O
assayed O
for _RARE_
TSH _RARE_
, O
thyroid O
hormone O
, O
PRL I-GENE
, O
glucose O
, O
creatinine _RARE_
, O
nitrogen O
, O
glutamine _RARE_
transaminase _RARE_
, O
cholesterol O
and O
triglycerides _RARE_
plasma O
levels O
before O
therapy O
( O
T0 _RARE_
), _RARE_
after O
30 _RARE_
treatment O
days O
( O
T30 _RARE_
) O
and O
after O
a O
15 _RARE_
days O
washout O
( O
T45 _RARE_
). O

Acute O
decrease O
in O
body O
temperature _RARE_
( O
TB _RARE_
) O
lowered O
PaCO2 O
( O
32 _RARE_
. O
5 O
to O
14 O
. O
5 O
mmHg O
) O
and O
[ _RARE_
HCO3 O
-] _RARE_
a O
( O
24 _RARE_
. O
20 O
mEq O
/ O
L O
to O
17 _RARE_
. O
56 _RARE_
mEq O
/ O
L O
), _RARE_
increased O
pHa _RARE_
( O
7 O
. O
481 _RARE_
to O
7 O
. O
608 _RARE_
) O
and O
diminished O
the O
[ _RARE_
OH O
-]/[ _RARE_
H O
+] _RARE_
ratio O
, O
but O
had O
no _RARE_
significant O
effect O
on O
[ _RARE_
SID _RARE_
] O
or O
[ _RARE_
Atot _RARE_
], O
although O
both O
total _RARE_
phosphorus O
[ _RARE_
PT O
] O
and O
inorganic O
phosphate O
[ _RARE_
Pi _RARE_
] O
increased O
. O

Hepatitis _RARE_
B O
vaccine O
: O
still O
has O
its O
problems O
. O

Basal O
promoter O
activity O
is O
enhanced _RARE_
by O
a O
functional _RARE_
M1 _RARE_
domain O
in O
LHR I-GENE
- O
expressing O
mouse O
Leydig _RARE_
tumor O
cells O
( O
MLTC _RARE_
) O
but O
not O
in O
non O
- O
expressing O
CHO O
cells O
. O

The O
RAT3 _RARE_
gene I-GENE
encodes O
an O
1157 _RARE_
- O
amino O
acid O
protein O
without O
similarity _RARE_
to O
other O
known O
proteins O
. O

For O
Al O
, O
the O
exposure O
to O
1 O
. O
36 _RARE_
mg O
/ O
m3 O
during _RARE_
the O
shift O
corresponded O
to O
a O
urinary _RARE_
concentration O
at _RARE_
the O
end O
of O
the O
shift O
of O
200 _RARE_
microgram O
/ O
g O
creatinine _RARE_
. O

Tumor _RARE_
necrosis I-GENE
factor I-GENE
- I-GENE
alpha I-GENE
( O
TNF I-GENE
alpha I-GENE
), _RARE_
a O
proinflammatory _RARE_
cytokine _RARE_
, O
inhibits O
cAMP O
- O
stimulated _RARE_
testosterone O
production O
in O
mouse O
Leydig _RARE_
cells O
. O

The O
Drosophila I-GENE
insulin I-GENE
receptor I-GENE
homolog I-GENE
: O
a O
gene O
essential O
for _RARE_
embryonic _RARE_
development O
encodes O
two O
receptor O
isoforms O
with O
different O
signaling _RARE_
potential _RARE_
. O

We O
show O
here O
that O
RA _RARE_
and O
E1A I-GENE
induce O
phosphorylation _RARE_
of O
the O
E1A I-GENE
- I-GENE
associated I-GENE
300 _RARE_
kDa I-GENE
protein I-GENE
( O
p300 I-GENE
) O
during _RARE_
the O
differentiation O
of O
F9 O
cells O
. O

The O
double O
- O
stranded _RARE_
RNA O
binding O
domain O
( O
dsRBD _RARE_
) O
is O
an O
approximately _RARE_
65 O
amino O
acid O
motif O
that O
is O
found O
in O
a O
variety O
of O
proteins O
that O
interact O
with O
double O
- O
stranded _RARE_
( O
ds _RARE_
) O
RNA O
, O
such O
as _RARE_
Escherichia O
coli O
RNase I-GENE
III I-GENE
and O
the O
dsRNA _RARE_
- I-GENE
dependent I-GENE
kinase I-GENE
, O
PKR I-GENE
. O

CCAAT I-GENE
/ I-GENE
enhancer I-GENE
- I-GENE
binding I-GENE
protein I-GENE
isoforms I-GENE
beta I-GENE
and I-GENE
delta I-GENE
are O
expressed _RARE_
in O
mammary O
epithelial _RARE_
cells O
and O
bind O
to O
multiple O
sites O
in O
the O
beta I-GENE
- I-GENE
casein I-GENE
gene I-GENE
promoter I-GENE
. O

SCA _RARE_
was O
resistant O
to O
inhibitors _RARE_
of O
serine O
, O
aspartyl _RARE_
, O
and O
metalloproteases _RARE_
, O
but O
it O
was O
sensitive _RARE_
to O
N O
- O
ethylmaleimide _RARE_
. O

Mutational O
analysis O
of O
potential _RARE_
activating O
phosphorylation _RARE_
sites O
found O
in O
NIMA _RARE_
, O
NIM _RARE_
- I-GENE
1 I-GENE
, O
and O
related O
protein O
kinases O
was O
performed O
on O
NIMA _RARE_
. O

However O
, O
a O
similar O
mutation O
of O
a O
leucine O
residue _RARE_
to O
arginine _RARE_
at _RARE_
position O
422 _RARE_
showed O
no _RARE_
alteration O
of O
heterodimerization O
, O
DNA O
binding O
, O
or O
transcriptional O
activation O
. O

Expression O
of O
the O
CYP11A1 _RARE_
gene I-GENE
is O
increased O
by O
hormones _RARE_
, O
such O
as _RARE_
adrenocorticotropin _RARE_
and O
luteinizing _RARE_
hormone I-GENE
, O
as _RARE_
well _RARE_
as _RARE_
by O
a O
number O
of O
growth O
factors O
, O
suggesting O
that O
its O
promoter O
may O
contain O
regulatory O
elements O
that O
respond O
to O
multiple O
signal O
transduction _RARE_
pathways O
. O

NH2 O
- O
and O
COOH _RARE_
- O
terminal O
deletion O
analysis O
revealed O
that O
both O
the O
PH _RARE_
and O
putative O
guanine I-GENE
nucleotide I-GENE
exchange I-GENE
factor I-GENE
domains I-GENE
are O
required O
, O
but O
the O
zinc O
butterfly _RARE_
is O
dispensable O
, O
for _RARE_
transformation O
. O

We O
have O
found O
that O
the O
expression _RARE_
of O
GTPase I-GENE
- O
deficient _RARE_
mutants O
of O
alpha I-GENE
12 I-GENE
( O
alpha I-GENE
12Q229L _RARE_
) O
or O
alpha I-GENE
13 _RARE_
( O
alpha I-GENE
13Q226L _RARE_
) O
leads O
to O
robust _RARE_
activation O
of O
the O
Jun I-GENE
kinase I-GENE
/ O
stress I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
( O
JNK I-GENE
/ O
SAPK I-GENE
) O
pathway _RARE_
. O

The O
objective O
of O
our O
study O
was O
to O
evaluate O
the O
age O
, O
sex _RARE_
, O
clinical O
conditions O
, O
family O
history O
, O
site O
, O
catheter O
association O
, O
means O
of O
radiologic _RARE_
evaluation O
, O
development O
of O
pulmonary O
involvement O
, O
prevalence O
of O
antithrombin I-GENE
III I-GENE
, O
protein I-GENE
C I-GENE
and O
protein I-GENE
S I-GENE
deficiencies O
, O
and O
lupus O
anticoagulants _RARE_
in O
children O
who O
suffered _RARE_
a O
thrombotic O
event O
. O

Harel _RARE_
, O
E O
. O
M O
. O

Radiotherapy _RARE_
and O
early O
orchiectomy _RARE_
in O
stage _RARE_
D1 _RARE_
prostatic _RARE_
carcinoma O

Structural O
organization O
and O
developmental O
expression _RARE_
pattern O
of O
the O
mouse I-GENE
WD _RARE_
- I-GENE
repeat I-GENE
gene I-GENE
DMR _RARE_
- I-GENE
N9 _RARE_
immediately O
upstream O
of O
the O
myotonic _RARE_
dystrophy _RARE_
locus I-GENE
. O

The O
ARX2 _RARE_
procedure O
models O
the O
recorded O
signal O
as _RARE_
the O
sum O
of O
three O
signals O
: O
( O
a O
) O
the O
background O
EEG O
activity O
, O
modelled _RARE_
as _RARE_
an O
autoregressive _RARE_
process O
driven _RARE_
by O
a O
white _RARE_
noise O
; O
( O
b O
) O
a O
filtered _RARE_
version O
of O
a O
reference O
signal O
carrying O
the O
average O
information _RARE_
contained O
in O
each O
sweep _RARE_
; O
( O
c O
) O
a O
signal O
due O
to O
the O
ocular O
artefact _RARE_
propagation _RARE_
. O

The O
expression _RARE_
of O
the O
gene O
encoding O
the O
enzyme O
( O
CYP19 _RARE_
) O
is O
regulated O
, O
in O
part O
, O
by O
tissue O
- O
specific O
promoters O
through O
the O
use O
of O
alternative _RARE_
- O
splicing _RARE_
mechanisms O
. O

Using O
mutagenesis O
, O
we O
have O
identified O
two O
mutations O
of O
the O
second O
actin I-GENE
- I-GENE
binding I-GENE
domain I-GENE
that O
can O
also O
suppress O
the O
act1 _RARE_
mutations O
of O
interest O
. O

CIITA _RARE_
mRNA I-GENE
is O
normally O
inducible O
by O
IFN I-GENE
- I-GENE
gamma I-GENE
in O
class O
II O
non O
- O
inducible O
, O
RB _RARE_
- O
defective _RARE_
lines O
, O
and O
in O
one O
line O
, O
re O
- O
expression _RARE_
of O
RB _RARE_
has O
no _RARE_
effect O
on O
CIITA _RARE_
mRNA I-GENE
induction O
levels O
. O

The O
normal O
cell O
cycle _RARE_
is O
regulated O
by O
several O
molecules O
, O
such O
as _RARE_
the O
tumor I-GENE
- I-GENE
suppressor I-GENE
protein I-GENE
pRb I-GENE
, O
the O
G1 I-GENE
cyclins _RARE_
, O
the O
cyclin _RARE_
- I-GENE
dependent I-GENE
kinases I-GENE
, O
and O
their O
inhibitors _RARE_
. O

Consistent O
with O
the O
protein O
expression _RARE_
data O
, O
V I-GENE
beta I-GENE
8 I-GENE
. I-GENE
3 I-GENE
gene I-GENE
transcripts I-GENE
were O
found O
only O
in O
the O
transgenic O
lines O
with O
the O
wild O
- O
type O
promoter O
. O

These O
results O
are O
very O
useful O
for _RARE_
deciding _RARE_
on O
the O
doses O
of O
hormones _RARE_
and O
the O
expected O
serum O
estradiol O
level O
in O
HRT _RARE_
for _RARE_
Japanese O
women O
. O

Comparison O
of O
1 O
. O
5 O
Tesla _RARE_
and O
0 _RARE_
. O
35 _RARE_
Tesla _RARE_
field O
strength O
magnetic O
resonance O
imaging O
scans O
in O
the O
morphometric _RARE_
evaluation O
of O
the O
lumbar O
intervertebral _RARE_
foramina _RARE_
. O

One O
month O
after O
the O
DTaP _RARE_
booster _RARE_
vaccination O
, O
both O
groups O
had O
6 O
- O
to O
40 O
- O
fold _RARE_
increases O
in O
serum O
antibody O
concentrations O
to O
all O
antigens O
tested O
; O
the O
concentrations O
against O
the O
three O
pertussis _RARE_
antigens I-GENE
were O
higher _RARE_
in O
the O
DTaP _RARE_
- O
primed O
children O
( O
p O
< O
0 _RARE_
. O
05 O
). O

Interestingly O
, O
this O
amino O
- O
terminal O
determinant O
appears O
not O
to O
reside O
in O
the O
HSV O
- O
alpha I-GENE
TIF I-GENE
, O
which O
displays O
no _RARE_
independent O
amino O
- O
terminal O
activity O
. O

We O
also O
show O
that O
in O
fusions O
with O
the O
DNA O
binding O
domain O
of O
GAL4 I-GENE
, O
full O
activity O
requires O
the O
entire _RARE_
BHV _RARE_
- I-GENE
alpha I-GENE
TIF I-GENE
, O
although O
both O
amino O
and O
carboxyl _RARE_
termini O
display O
some O
activity O
on O
their O
own O
. O

To O
investigate O
the O
potential _RARE_
role O
of O
SP1 I-GENE
, O
we O
examined O
nuclear O
extracts O
from O
HCMV _RARE_
- O
infected _RARE_
cells O
. O

Here O
we O
show O
that O
messenger _RARE_
RNAs O
encoding O
trans _RARE_
- O
sialidases _RARE_
containing O
the O
repeats O
are O
not O
present O
in O
epimastigotes _RARE_
but O
are O
abundant O
in O
trypomastigotes _RARE_
. O

From O
May _RARE_
1985 O
to O
May _RARE_
1989 O
, O
126 O
necropsies _RARE_
were O
performed O
at _RARE_
the O
Sao _RARE_
Paulo _RARE_
City O
Morgue _RARE_
on O
cadavers _RARE_
of O
individuals O
AIDS O
victims O
whose O
unnatural _RARE_
deaths O
had O
prompted _RARE_
police _RARE_
investigations O
. O

A O
model O
with O
age O
and O
weight _RARE_
described O
the O
best O
fit O
for _RARE_
TBBMD _RARE_
, O
whereas O
age O
, O
weight _RARE_
, O
and O
height O
described O
the O
best O
fit O
for _RARE_
total _RARE_
body O
TBBMC _RARE_
. O

As O
retinoic O
acid O
and O
thyroid O
hormone O
are O
frequently O
involved O
in O
developmental O
regulatory O
processes O
, O
it O
is O
possible O
that O
this O
element O
may O
be O
important O
in O
the O
process O
of O
islet O
cell O
differentiation O
. O

The O
C O
- O
terminal O
peptide O
sequences O
of O
the O
human I-GENE
lymphocyte I-GENE
- I-GENE
specific I-GENE
high I-GENE
mobility I-GENE
group I-GENE
( I-GENE
HMG I-GENE
)- I-GENE
box I-GENE
transcription I-GENE
factor I-GENE
TCF I-GENE
- I-GENE
1 I-GENE
are O
determined O
by O
alternative _RARE_
splice _RARE_
mechanisms O
affecting O
the O
exons O
VIII O
to O
X O
. O

Thromboxane _RARE_
B2 _RARE_
increased O
( O
97 O
+/- O
105 _RARE_
versus O
40 O
+/- O
26 _RARE_
pg O
/ O
ml O
) O
and O
was O
significantly O
higher _RARE_
during _RARE_
heparin _RARE_
free O
hemodialysis O
than O
during _RARE_
hemodialysis O
with O
heparin _RARE_
( O
p O
= O
0 _RARE_
. O
01 O
, O
Wilcoxon _RARE_
matched O
pairs _RARE_
signed _RARE_
rank _RARE_
test O
). O

A O
new O
vector O
, O
pHBK280 _RARE_
, O
was O
designed O
to O
facilitate O
this O
analysis O
. O

To O
explore O
the O
mechanism O
of O
RSK _RARE_
activation O
, O
a O
cloned _RARE_
human O
RSK _RARE_
cDNA O
( O
RSK3 _RARE_
) O
was O
used O
to O
generate O
and O
characterize O
several O
site O
- O
directed O
RSK _RARE_
mutants I-GENE
; O
K91A _RARE_
( O
N O
- O
Lys _RARE_
, O
NH2 O
- O
terminal O
ATP O
- O
binding O
mutant O
), _RARE_
K444A _RARE_
( O
C O
- O
Lys _RARE_
, O
COOH _RARE_
- O
terminal O
ATP O
- O
binding O
mutant O
), _RARE_
N O
/ O
C O
- O
Lys _RARE_
( O
double O
ATP O
- O
binding O
mutant O
) O
T570A _RARE_
( O
C O
- O
Thr _RARE_
, O
mutant O
of O
the O
putative O
MAPK _RARE_
phosphorylation _RARE_
site O
in O
subdomain _RARE_
VIII O
of O
the O
C O
- O
domain O
), _RARE_
S218A _RARE_
( O
N O
- O
Ser _RARE_
, O
mutant O
of O
the O
corresponding O
NH2 O
- O
terminal O
residue _RARE_
). O

In O
contrast O
, O
both O
C O
- O
Lys _RARE_
and O
C O
- O
Thr _RARE_
retained O
high O
levels O
of O
kinase O
activity O
and O
were O
capable O
of O
responding O
to O
stimulation _RARE_
. O

Conversely O
, O
treatment O
of O
human I-GENE
protein I-GENE
- I-GENE
tyrosine I-GENE
phosphatase I-GENE
alpha I-GENE
- O
overexpressing O
cells O
with O
phenylarsine _RARE_
oxide O
led O
to O
a O
loss _RARE_
of O
the O
constitutive _RARE_
NF _RARE_
- I-GENE
kappa _RARE_
B I-GENE
activity O
. O

A O
TATA O
- O
less O
promoter O
containing O
binding O
sites O
for _RARE_
ubiquitous O
transcription O
factors O
mediates O
cell O
type O
- O
specific O
regulation _RARE_
of O
the O
gene O
for _RARE_
transcription I-GENE
enhancer I-GENE
factor I-GENE
- I-GENE
1 I-GENE
( O
TEF I-GENE
- I-GENE
1 I-GENE
). O

Since O
electrical O
stimulation _RARE_
of O
neurones O
may O
activate O
not O
only O
cell O
bodies _RARE_
but O
also O
neuronal _RARE_
fibres O
, O
this O
study O
aimed O
to O
test O
a O
selectively O
cholinergic O
neurochemical _RARE_
stimulation _RARE_
of O
the O
rat O
substantia _RARE_
innominata _RARE_
( O
SI _RARE_
) O
by O
the O
local O
microinjection O
of O
carbachol O
; O
the O
effects O
of O
this O
acetylcholine _RARE_
agonist O
were O
compared O
with O
glutamate _RARE_
. O

Here O
we O
describe O
an O
in O
vitro O
assay O
where O
the O
NS3 _RARE_
- I-GENE
4A _RARE_
polyprotein _RARE_
, O
NS3 _RARE_
, O
the O
serine O
proteinase _RARE_
domain O
( O
the O
N O
- O
terminal O
181 _RARE_
residues O
of O
NS3 _RARE_
), _RARE_
and O
the O
NS4A _RARE_
cofactor I-GENE
were O
produced O
by O
cell O
- O
free O
translation O
and O
tested O
for _RARE_
trans _RARE_
- O
processing _RARE_
of O
radiolabeled O
substrates _RARE_
. O

In O
contrast O
, O
over O
- O
expression _RARE_
of O
RAR I-GENE
beta I-GENE
only O
poorly O
restored O
differentiation O
, O
although O
it O
could O
replace O
RAR I-GENE
gamma I-GENE
for _RARE_
the O
activation O
of O
target O
genes O
. O

We O
purified _RARE_
both O
proteins O
from O
human O
platelet O
membranes O
using O
DEAE _RARE_
- O
Sepharose _RARE_
chromatography O
followed O
by O
mAb _RARE_
F11 _RARE_
affinity O
chromatography O
. O

The O
homeobox _RARE_
gene I-GENE
ATK1 _RARE_
of O
Arabidopsis O
thaliana O
is O
expressed _RARE_
in O
the O
shoot _RARE_
apex O
of O
the O
seedling _RARE_
and O
in O
flowers _RARE_
and O
inflorescence _RARE_
stems _RARE_
of O
mature _RARE_
plants _RARE_
. O

The O
most O
likely O
explanation O
for _RARE_
this O
is O
that O
gold _RARE_
principally _RARE_
accumulates O
in O
the O
Kupffer _RARE_
cells O
and O
renal _RARE_
cortex O
and O
these O
cells O
do O
not O
express O
Type _RARE_
I I-GENE
deiodinase I-GENE
. O

These O
results O
suggest O
that O
different O
models O
of O
intestinal _RARE_
ischemia O
have O
different O
cytokine _RARE_
profiles O
and O
that O
the O
early O
TNF I-GENE
response O
associated O
with O
SMA _RARE_
occlusion O
model O
is O
primarily O
due O
to O
the O
laparotomy _RARE_
. O

Our O
evidence O
derives _RARE_
from O
three O
principal O
observations O
: O
1 O
) O
a O
transfection O
construct O
containing O
only O
122 O
nucleotides O
( O
nt O
) O
of O
promoter O
1 O
and O
328 _RARE_
nt O
of O
the O
5 O
'- O
UTR O
retained O
full O
PGE2 O
- O
stimulated _RARE_
reporter O
expression _RARE_
; O
2 O
) O
maximal O
PGE2 O
- O
driven _RARE_
reporter O
expression _RARE_
required O
the O
presence O
of O
nt O
196 _RARE_
to O
328 _RARE_
of O
exon _RARE_
1 O
when O
tested O
within O
the O
context O
of O
IGF I-GENE
- I-GENE
I I-GENE
promoter I-GENE
1 I-GENE
; O
3 O
) O
cotransfection O
of O
IGF I-GENE
- I-GENE
I I-GENE
promoter I-GENE
- O
luciferase I-GENE
- O
reporter O
constructs O
with O
a O
plasmid _RARE_
encoding O
the O
alpha O
- O
isoform O
of O
the O
catalytic O
subunit O
of O
murine I-GENE
cAMP I-GENE
- I-GENE
dependent I-GENE
protein I-GENE
kinase I-GENE
( O
PKA I-GENE
) O
produced O
results O
comparable O
to O
those O
seen O
with O
PGE2 O
treatment O
, O
whereas O
cotransfection O
with O
a O
plasmid _RARE_
encoding O
a O
mutant O
regulatory O
subunit O
of O
PKA I-GENE
that O
cannot O
bind O
cAMP O
blocked O
PGE2 O
- O
induced _RARE_
reporter O
expression _RARE_
. O

The O
changes O
after O
treatment O
were O
observed O
chiefly _RARE_
by O
electromyography _RARE_
while O
sensory O
and O
motor O
improvement O
were O
also O
recorded O
as _RARE_
auxiliary _RARE_
indicators O
. O

Band _RARE_
- O
shift O
assays O
and O
DNase I-GENE
I I-GENE
footprinting O
experiments O
using O
purified _RARE_
42 _RARE_
kDa O
repressor O
isoform O
confirmed O
that O
CIRs _RARE_
5 I-GENE
and I-GENE
6 I-GENE
were O
indeed O
the O
targets _RARE_
for _RARE_
binding O
of O
this O
protein O
. O

The O
5 O
'- O
terminus O
of O
the O
p I-GENE
- I-GENE
gvpF _RARE_
- I-GENE
M I-GENE
mRNA I-GENE
was O
located _RARE_
169 _RARE_
nucleotides O
upstream O
of O
p I-GENE
- I-GENE
gvpF _RARE_
within O
p I-GENE
- I-GENE
gvpE _RARE_
. O

Retransformation _RARE_
of O
uvsH77 _RARE_
mutants I-GENE
with O
the O
rescued _RARE_
cosmids _RARE_
from O
the O
MMS _RARE_
- O
resistant O
transformants O
resulted O
in O
restoration _RARE_
of O
both O
UV _RARE_
and O
MMS _RARE_
resistance O
to O
wild O
- O
type O
levels O
. O

Furthermore O
, O
this O
element O
confers O
p53 I-GENE
induction O
to O
the O
otherwise O
nonresponsive _RARE_
adenovirus O
major O
late _RARE_
promoter O
. O

In O
flies _RARE_
, O
the O
dShc _RARE_
protein I-GENE
physically O
associates O
with O
the O
activated O
Drosophila I-GENE
epidermal _RARE_
growth I-GENE
factor I-GENE
receptor I-GENE
homolog I-GENE
( O
DER I-GENE
) O
and O
is O
inducibly _RARE_
phosphorylated _RARE_
on O
tyrosine O
by O
DER I-GENE
. O

A O
potential _RARE_
binding O
site O
for _RARE_
the O
dShc _RARE_
PTB _RARE_
domain O
is O
located _RARE_
at _RARE_
Tyr _RARE_
- O
1228 _RARE_
of O
DER I-GENE
. O

A O
Drosophila I-GENE
shc _RARE_
gene I-GENE
product I-GENE
is O
implicated O
in O
signaling _RARE_
by O
the O
DER I-GENE
receptor I-GENE
tyrosine I-GENE
kinase I-GENE
. O

This O
inhibition O
can O
be O
overcome O
by O
mutating _RARE_
either O
the O
exon _RARE_
' O
s O
5 O
' O
or O
3 O
' O
splice _RARE_
site O
to O
make O
it O
correspond O
more O
closely O
to O
the O
relevant O
consensus O
sequence O
. O

Biochemical O
analysis O
shows O
that O
Ssm1p _RARE_
is O
a O
structural O
protein O
that O
forms O
part O
of O
the O
largest O
60S _RARE_
ribosomal I-GENE
subunit I-GENE
, O
which O
does O
not O
exist O
in O
a O
pool O
of O
free O
proteins O
. O

In O
wild O
- O
type O
cells O
, O
SSM1b _RARE_
transcripts I-GENE
accumulate O
to O
twice O
the O
level O
of O
SSM1a _RARE_
transcripts I-GENE
, O
suggesting O
that O
SSM1b _RARE_
is O
responsible O
for _RARE_
the O
majority O
of O
the O
Ssm1p _RARE_
pool O
. O

Northern O
blot O
analysis O
revealed O
the O
expression _RARE_
of O
LIMK _RARE_
- I-GENE
1 I-GENE
mRNA I-GENE
predominantly O
in O
the O
brain O
and O
the O
expression _RARE_
of O
LIMK _RARE_
- I-GENE
2 I-GENE
mRNA I-GENE
in O
various O
tissues O
in O
the O
rat O
. O

However O
, O
the O
relative O
binding O
affinity O
for _RARE_
the O
motifs O
is O
different O
. O

On O
the O
basis O
of O
this O
anatomic O
concept O
, O
the O
brachioplasty _RARE_
procedure O
was O
modified O
to O
provide O
secure _RARE_
anchoring _RARE_
of O
the O
arm _RARE_
flap O
to O
the O
axillary _RARE_
fascia _RARE_
along O
with O
strong O
superficial O
fascial _RARE_
system _RARE_
repair O
of O
incisions _RARE_
, O
reducing _RARE_
the O
risk O
of O
widening _RARE_
or O
migration O
of O
scars _RARE_
and O
unnatural _RARE_
contours _RARE_
. O

Furthermore O
, O
microinjection O
of O
dominant O
negative O
forms O
of O
Rac I-GENE
and O
Cdc42 I-GENE
or O
of O
the O
Rho I-GENE
inhibitor O
C3 _RARE_
transferase I-GENE
blocked O
serum O
- O
induced _RARE_
DNA O
synthesis _RARE_
. O

INF _RARE_
- I-GENE
alpha I-GENE
therapy O
has O
been O
a O
major O
development O
in O
the O
treatment O
of O
CML O
. O

A O
series O
of O
amino O
terminal O
deletion O
mutants O
( O
d10 _RARE_
, O
d20 _RARE_
, O
d27 _RARE_
, O
d31 _RARE_
, O
d40 _RARE_
, O
d44 _RARE_
, O
and O
d73 _RARE_
) O
were O
compared O
for _RARE_
processing _RARE_
, O
cell O
surface O
expression _RARE_
, O
and O
maintenance _RARE_
of O
their O
biological O
attributes _RARE_
by O
recombinant O
expression _RARE_
of O
mutant O
genes O
using O
a O
plasmid _RARE_
vector O
( O
pcDL _RARE_
- O
SR O
alpha O
- O
296 O
) O
in O
CV _RARE_
- O
1 O
and O
HeLa O
cells O
. O

Intrathecal _RARE_
acetyl I-GENE
cholinesterase I-GENE
inhibitors _RARE_
produce O
analgesia O
that O
is O
synergistic O
with O
morphine _RARE_
and O
clonidine _RARE_
in O
rats O
. O

After O
determining _RARE_
isoflurane O
MAC _RARE_
in O
triplicate _RARE_
, O
birds O
were O
given O
a O
mu O
- O
opioid _RARE_
agonist O
( O
morphine _RARE_
, O
n _RARE_
= O
9 O
) O
or O
a O
kappa _RARE_
- O
opioid _RARE_
agonist O
( O
U50488H _RARE_
, O
n _RARE_
= O
9 O
). O

Max I-GENE
was O
constantly _RARE_
transcribed _RARE_
at _RARE_
a O
relatively O
low O
level O
during _RARE_
cell O
cycle _RARE_
progression O
. O

The O
yeast O
enzyme O
was O
6 O
- O
fold _RARE_
slower O
than O
the O
mammalian O
enzymes _RARE_
, O
which O
made O
it O
amenable _RARE_
to O
pre O
- O
steady O
- O
state O
stopped O
- O
flow O
spectroscopic _RARE_
kinetic O
analysis O
at _RARE_
30 _RARE_
degrees O
C O
and O
pH O
6 O
. O
0 _RARE_
. O

Key _RARE_
areas O
of O
the O
selection O
process O
including O
medical O
and O
surgical O
alternatives _RARE_
to O
transplantation O
, O
the O
composition O
of O
the O
transplant O
work O
- O
up _RARE_
, O
specific O
inclusion O
criteria O
as _RARE_
well _RARE_
as _RARE_
specific O
psychosocial _RARE_
factors O
and O
specific O
disease _RARE_
etiologies _RARE_
and O
co _RARE_
- O
morbidities _RARE_
that O
might O
represent O
contraindications _RARE_
were O
extensively O
reviewed O
. O

The O
transport _RARE_
of O
a O
genetically O
engineered _RARE_
chimeric O
transmembrane O
protein O
connected O
to O
this O
ER O
leader _RARE_
sequence O
was O
as _RARE_
efficient O
as _RARE_
that O
of O
the O
original O
protein O
from O
which O
the O
ER O
sequence O
has O
been O
derived O
. O

In O
both O
shoots _RARE_
and O
roots O
, O
GT _RARE_
- I-GENE
2 I-GENE
protein I-GENE
is O
undetectable O
in O
meristematic _RARE_
tissue O
but O
becomes O
expressed _RARE_
at _RARE_
later O
stages O
of O
cellular O
development O
, O
consistent O
with O
a O
role O
in O
contributing _RARE_
to O
the O
pattern O
of O
phytochrome _RARE_
A I-GENE
gene I-GENE
expression _RARE_
. O

A O
polymorphic O
bipartite O
motif O
signals O
nuclear O
targeting O
of O
early O
auxin _RARE_
- O
inducible O
proteins O
related O
to O
PS _RARE_
- O
IAA4 _RARE_
from O
pea _RARE_
( O
Pisum _RARE_
sativum _RARE_
). O

Comparative O
DNA O
sequence O
analysis O
showed O
the O
Genethon _RARE_
microsatellite _RARE_
D19S596 _RARE_
lies O
2 O
. O
2 O
kb O
downstream _RARE_
of O
the O
coding O
region O
of O
FUT1 _RARE_
, O
indicating O
that O
the O
cluster O
comprising _RARE_
the O
closely O
linked _RARE_
FUT1 _RARE_
and O
FUT2 _RARE_
genes I-GENE
is O
located _RARE_
4 O
cM _RARE_
distal O
to O
D19S412 _RARE_
( O
lod _RARE_
score O
13 _RARE_
. O
7 O
) O
and O
9 O
cM _RARE_
proximal O
to O
D19S571 _RARE_
( O
lod _RARE_
score O
11 O
. O
7 O
). O

We O
conclude O
that O
transcription O
activation O
by O
LEF _RARE_
- I-GENE
1 I-GENE
in O
vitro O
is O
a O
chromatin O
- O
dependent O
process O
that O
requires O
a O
functional _RARE_
trans _RARE_
- O
activation O
domain O
in O
addition O
to O
the O
HMG I-GENE
domain I-GENE
. O

TH _RARE_
- O
SH3 I-GENE
binding O
in O
vitro O
is O
abolished O
by O
specific O
, O
single O
amino O
acid O
substitutions O
within O
the O
Btk _RARE_
TH _RARE_
domain I-GENE
or O
the O
Fyn I-GENE
SH3 I-GENE
domain I-GENE
. O

These O
results O
indicate O
that O
K I-GENE
- I-GENE
glypican _RARE_
is O
a O
novel O
GPI _RARE_
- I-GENE
anchored _RARE_
HSPG _RARE_
involved O
in O
embryonic _RARE_
development O
. O

Protein I-GENE
S I-GENE
levels O
were O
virtually O
undetectable O
at _RARE_
the O
time O
of O
admission O
and O
failed O
to O
respond O
to O
infusions _RARE_
of O
fresh O
frozen _RARE_
plasma O
, O
despite O
correction O
of O
other O
procoagulant _RARE_
and O
anticoagulant _RARE_
factors O
. O

The O
plant _RARE_
hormone O
auxin _RARE_
transcriptionally O
activates O
early I-GENE
genes I-GENE
. O

The O
test O
was O
not O
performed O
in O
3923 _RARE_
patients O
because O
of O
contraindications _RARE_
. O

The O
ubiquitous O
transcription O
factor O
Oct I-GENE
- I-GENE
1 I-GENE
forms O
complexes O
with O
an O
octamer O
motif O
present O
within O
FPIV _RARE_
by O
gel O
shift O
analysis O
with O
liver O
and O
kidney _RARE_
extracts O
, O
making O
Oct I-GENE
- I-GENE
1 I-GENE
an O
intriguing _RARE_
candidate O
for _RARE_
partnership _RARE_
in O
androgen _RARE_
regulation _RARE_
. O

A O
new O
non O
- O
LTR O
retrotransposon _RARE_
provides O
evidence O
for _RARE_
multiple O
distinct O
site O
- O
specific O
elements O
in O
Crithidia _RARE_
fasciculata _RARE_
miniexon _RARE_
arrays O
. O

We O
used O
deletion O
analysis O
and O
transfection O
assays O
with O
reporter O
gene O
constructs O
to O
examine O
the O
transcription O
control O
elements O
in O
the O
5 O
' O
flanking O
region O
of O
the O
human I-GENE
EpoR _RARE_
gene I-GENE
. O

The O
CVA16 _RARE_
. I-GENE
4 I-GENE
proteolipid _RARE_
transcript I-GENE
is O
the O
most O
prevalent _RARE_
of O
the O
two O
proteolipid _RARE_
messages _RARE_
in O
expanding _RARE_
ovules _RARE_
harvested _RARE_
10 O
d O
post O
- O
anthesis _RARE_
. O

Incubation _RARE_
of O
the O
purified _RARE_
fusion O
proteins O
with O
[ _RARE_
gamma O
- O
32P O
] O
ATP O
in O
an O
in O
vitro O
assay O
showed O
that O
both O
proteins O
were O
capable O
of O
autophosphorylation O
. O

The O
character O
of O
specific O
immune O
response O
in O
101 _RARE_
immunized O
children O
and O
in O
12 O
adults O
belonging O
to O
a O
high O
risk O
group O
with O
respect O
to O
VHB _RARE_
. O

After O
nadolol _RARE_
, O
heart _RARE_
rate O
decreased O
(- _RARE_
22 _RARE_
+/- O
8 O
%), O
and O
so O
did O
PBV _RARE_
and O
PBF _RARE_
( O
8 O
. O
8 O
+/- O
3 O
. O
4 O
vs _RARE_
. O

The O
synthetic _RARE_
DNA O
sequence O
was O
constructed O
to O
achieve O
efficient O
base _RARE_
pairing _RARE_
with O
Escherichia I-GENE
coli I-GENE
16S _RARE_
ribosomal I-GENE
RNA I-GENE
, O
avoidance _RARE_
of O
internal O
secondary O
structure _RARE_
, O
and O
optimal O
codon _RARE_
usage O
for _RARE_
high O
- O
level O
protein O
expression _RARE_
in O
accord _RARE_
with O
the O
known O
preferences _RARE_
in O
E O
. O
coli O
. O

Adrenergic _RARE_
system _RARE_
activation O
, O
indicated O
by O
metanephrine _RARE_
/ O
epinephrine O
ratio O
, O
increased O
with O
time O
in O
losing _RARE_
males O
, O
except O
that O
after O
one O
month O
of O
cohabitation _RARE_
, O
turnover O
returned O
to O
levels O
that O
equaled _RARE_
those O
of O
control O
animals O
. O

Transabdominal _RARE_
repair O
of O
type O
IV O
thoraco _RARE_
- O
abdominal O
aortic O
aneurysms _RARE_
. O

A O
. O

Transcription O
factors O
containing O
a O
basic O
helix O
- O
loop O
- O
helix O
( O
bHLH O
) O
motif O
regulate O
the O
expression _RARE_
of O
tissue O
- O
specific O
genes O
in O
a O
number O
of O
mammalian O
and O
insect O
systems _RARE_
. O

Primer O
extension O
and O
cDNA O
cloning O
were O
used O
to O
isolate O
the O
complete _RARE_
5 O
' O
end O
of O
the O
Nramp1 _RARE_
mRNA I-GENE
. O

Primer O
extension O
and O
S1 I-GENE
nuclease _RARE_
mapping O
experiments O
were O
used O
to O
locate _RARE_
the O
transcription O
initiation O
site O
of O
Nramp1 _RARE_
and O
revealed O
the O
presence O
of O
one O
major O
and O
several O
minor O
initiation O
sites O
. O

EsaR _RARE_
can O
repress O
its O
own O
expression _RARE_
but O
seems O
not O
to O
regulate O
the O
expression _RARE_
of O
esaI _RARE_
. O

Sequence O
analysis O
of O
the O
5 O
'- O
flanking O
region O
of O
the O
CD69 _RARE_
gene I-GENE
revealed O
the O
presence O
of O
a O
potential _RARE_
TATA O
element O
30 _RARE_
base _RARE_
pairs _RARE_
upstream O
of O
the O
major O
transcription O
initiation O
site O
and O
several O
putative O
binding O
sequences O
for _RARE_
inducible O
transcription O
factors O
( O
NF _RARE_
- I-GENE
kappa _RARE_
B I-GENE
, O
Egr _RARE_
- I-GENE
1 I-GENE
, O
AP I-GENE
- I-GENE
1 I-GENE
), _RARE_
which O
might O
mediate O
the O
inducible O
expression _RARE_
of O
this O
gene O
. O

The O
plasmin _RARE_
- I-GENE
derived I-GENE
D I-GENE
( I-GENE
approximately _RARE_
105 _RARE_
- I-GENE
kDa I-GENE
) I-GENE
product I-GENE
, O
however O
, O
could O
be O
cross O
- O
linked _RARE_
into O
DD _RARE_
dimers _RARE_
. O

All O
clinical O
isolates O
were O
concomitantly _RARE_
tested O
by O
disk _RARE_
diffusion O
and O
agar O
dilution O
procedures O
as _RARE_
outlined _RARE_
by O
the O
National O
Committee O
for _RARE_
Clinical O
Laboratory O
Standards _RARE_
. O

IgE I-GENE
levels O
showed O
higher _RARE_
values O
compared O
to O
normal O
individuals O
and O
IgE I-GENE
levels O
were O
higher _RARE_
in O
children O
groups O
than O
in O
adults O
regardless O
of O
the O
intensity O
of O
infection O
. O

Tissue _RARE_
- O
specific O
expression _RARE_
of O
the O
tmy _RARE_
- I-GENE
1 I-GENE
gene I-GENE
was O
determined O
by O
microinjection O
of O
a O
promoter I-GENE
/ I-GENE
lacZ I-GENE
fusion I-GENE
gene I-GENE
and O
with O
immunohistochemistry _RARE_
by O
using O
affinity O
- O
purified _RARE_
tissue I-GENE
- I-GENE
specific I-GENE
anti I-GENE
- I-GENE
tropomyosins _RARE_
. O

The O
nucleotide O
sequence O
of O
the O
chloroplast O
( O
cp _RARE_
) O
DNA O
from O
maize _RARE_
( O
Zea _RARE_
mays _RARE_
) O
has O
been O
completed O
. O

Investigation _RARE_
of O
the O
control O
of O
coronavirus O
subgenomic _RARE_
mRNA O
transcription O
by O
using O
T7 _RARE_
- O
generated O
negative O
- O
sense O
RNA O
transcripts O
. O

Initiation _RARE_
of O
translation O
of O
the O
human O
hepatitis O
C O
virus O
( O
HCV O
) O
RNA O
genome O
occurs O
by O
internal O
ribosome _RARE_
entry O
into O
the O
5 O
' O
noncoding O
region O
( O
5 O
' O
NCR O
) O
in O
a O
cap _RARE_
- O
independent O
manner O
. O

Mean O
longitudinal O
extension O
of O
the O
epidural _RARE_
lesion O
was O
2 O
. O
6 O
vertebral O
segments _RARE_
. O

The O
association O
of O
p255 _RARE_
with O
splicing _RARE_
complexes O
is O
suggested O
by O
the O
finding O
that O
mAb _RARE_
CC3 _RARE_
can O
inhibit O
in O
vitro O
splicing _RARE_
and O
immunoprecipitate _RARE_
pre O
- O
messenger _RARE_
RNA O
and O
splicing _RARE_
products O
. O

L O
- O
735 _RARE_
, O
524 _RARE_
free O
base _RARE_
or O
sulfate _RARE_
salt O
was O
administered O
orally O
as _RARE_
suspension _RARE_
, O
solution O
or O
in O
solid O
dosage O
forms O
to O
fasted O
or O
fed O
Beagle _RARE_
dogs O
. O

Doppler O
ultrasound O
studies O
of O
long O
- O
term O
follow O
- O
up _RARE_
of O
children O
with O
hemolytic _RARE_
- O
uremic _RARE_
syndrome _RARE_

Thus O
, O
endemic _RARE_
cumlations _RARE_
of O
hepatitis O
A O
diseases O
are O
possible O
. O

( O
1991 O
). O

The O
properties O
of O
the O
phi _RARE_
29 O
SSB I-GENE
- I-GENE
ssDNA _RARE_
complex O
are O
described O
. O

This O
shows O
that O
the O
characteristically _RARE_
diffuse O
banding _RARE_
pattern O
of O
plant _RARE_
nuclear O
proteins O
interacting _RARE_
with O
the O
G O
- O
box O
is O
also O
observed O
in O
a O
binding O
assay O
using O
only O
one O
recombinant I-GENE
GBF _RARE_
. O

We O
studied O
120 O
male O
and O
42 _RARE_
female O
patients O
with O
early O
CAD _RARE_
who O
were O
unrelated O
to O
each O
other O
but O
were O
from O
families _RARE_
in O
which O
at _RARE_
least O
one O
other O
sibling _RARE_
had O
early O
CAD _RARE_
. O

The O
physical O
linkage O
of O
the O
FHR2 _RARE_
and O
the O
factor I-GENE
H I-GENE
genes I-GENE
provides O
additional O
evidence O
for _RARE_
a O
close O
relatedness _RARE_
of O
complement I-GENE
factor I-GENE
H I-GENE
and O
the O
factor I-GENE
H I-GENE
- I-GENE
related I-GENE
proteins I-GENE
. O

Genomic O
structure _RARE_
and O
chromosomal O
location O
of O
the O
mouse I-GENE
pre I-GENE
- I-GENE
T I-GENE
- I-GENE
cell I-GENE
receptor I-GENE
alpha I-GENE
gene I-GENE
. O

The O
third O
domain O
had O
the O
motif O
of O
a O
cAMP O
response O
element O
( O
CRE _RARE_
). O

The O
tyrosine O
- O
phosphorylated _RARE_
state O
of O
CAK I-GENE
beta I-GENE
was O
not O
reduced _RARE_
on O
trypsinization _RARE_
, O
nor O
enhanced _RARE_
in O
response O
to O
plating _RARE_
3Y1 _RARE_
cells O
onto O
fibronectin I-GENE
. O

Our O
results O
suggest O
that O
while O
many O
muscle O
gene O
E O
- O
boxes _RARE_
are O
capable O
of O
binding O
the O
previously O
characterized O
spectrum O
of O
MDF _RARE_
/ I-GENE
bH _RARE_
- I-GENE
L I-GENE
- I-GENE
H I-GENE
heterodimers _RARE_
in O
vitro O
, O
MCK _RARE_
- I-GENE
L I-GENE
type O
E O
- O
boxes _RARE_
probably O
bind O
qualitatively _RARE_
different O
factors O
in O
vivo O
. O

A O
single O
- O
case O
experimental O
ABAB _RARE_
multiple O
baseline O
design O
was O
employed O
to O
test O
for _RARE_
treatment O
effectiveness O
. O

These O
clones _RARE_
were O
found O
to O
share O
a O
common O
domain O
encoded O
by O
p O
( O
CA O
) O
n _RARE_
repeats O
; O
a O
simple O
sequence O
length O
polymorphism O
( O
SSLP _RARE_
). O

In O
one O
glioblastoma _RARE_
cell O
line O
, O
a O
Shc I-GENE
- O
associated O
p190 I-GENE
was O
identified O
as _RARE_
the O
activated O
PDGFR _RARE_
. O

We O
conclude O
that O
, O
in O
comparison O
to O
reports O
from O
other O
regions O
, O
Scandinavian _RARE_
renal _RARE_
transplant O
recipients O
are O
at _RARE_
high O
risk O
of O
dying _RARE_
of O
IHD _RARE_
. O

Veterinary _RARE_
certification _RARE_
for _RARE_
livestock _RARE_
export O
. O

The O
serum O
concentration O
of O
iP _RARE_
before O
dialysis O
( O
HD O
) O
was O
on O
average O
3 O
. O
06 O
(+/- O
0 _RARE_
. O
81 _RARE_
) O
mmol O
/ O
l _RARE_
and O
D O
was O
on O
average O
55 _RARE_
. O
6 O
(+/- O
10 O
. O
0 _RARE_
) O
mmol O
. O

A O
significant O
correlation O
between O
a O
number O
of O
functional _RARE_
parameters O
of O
gastric _RARE_
secretion _RARE_
, O
incretion _RARE_
and O
histological O
changes O
of O
gastric _RARE_
mucosa O
was O
found O
in O
patients O
with O
chronic O
gastritis _RARE_
. O

The O
TAF _RARE_
factor O
appears O
to O
be O
particularly O
significant O
in O
OCD _RARE_
. O

Diffuse _RARE_
white _RARE_
matter O
injury O
can O
be O
attributed O
to O
radiation O
and O
associated O
with O
neurological O
deficits O
, O
but O
leukoencephalopathy _RARE_
is O
rarely O
observed O
in O
the O
absence O
of O
chemotherapy O
. O

RNase I-GENE
protection O
analyses O
indicate O
that O
either O
61 _RARE_
- I-GENE
kDa I-GENE
CaM I-GENE
PDE _RARE_
mRNA I-GENE
or O
structurally O
related O
transcripts O
encoding O
different O
CaM I-GENE
PDE _RARE_
isoforms I-GENE
are O
expressed _RARE_
in O
a O
tissue O
- O
specific O
manner O
. O

Little _RARE_
or O
no _RARE_
protection O
was O
detected O
using O
adrenal O
cortex O
, O
adrenal O
medulla _RARE_
, O
liver O
, O
kidney _RARE_
cortex O
, O
spleen _RARE_
, O
or O
T O
- O
lymphocyte O
total _RARE_
RNA O
. O

The O
PDGFR _RARE_
mutants I-GENE
that O
failed O
to O
associate O
with O
PLC I-GENE
gamma I-GENE
were O
not O
able O
to O
mediate O
the O
PDGF _RARE_
- O
dependent O
production O
of O
inositol _RARE_
phosphates _RARE_
. O

We O
found O
a O
direct O
correlation O
between O
the O
levels O
of O
transcription O
of O
the O
acc _RARE_
genes I-GENE
and O
the O
rate O
of O
cellular O
growth O
. O

The O
hybridizing _RARE_
clone O
of O
V O
. O
vulnificus _RARE_
chromosomal O
DNA O
complemented O
a O
V I-GENE
. I-GENE
cholerae _RARE_
fur _RARE_
mutant I-GENE
. O

We O
generated O
transformed O
B O
lymphoblast _RARE_
cell O
lines O
from O
controls O
, O
from O
four O
patients O
with O
p47 _RARE_
- O
phox _RARE_
- O
deficient _RARE_
chronic O
granulomatous _RARE_
disease _RARE_
, O
and O
from O
three O
parents O
. O

The O
ectopic O
expression _RARE_
of O
Oct I-GENE
- I-GENE
3 I-GENE
/ I-GENE
4 I-GENE
in O
hybrid _RARE_
cells O
under O
a O
constitutive _RARE_
promoter O
is O
sufficient O
for _RARE_
transcriptional O
activation O
of O
an O
octamer O
- O
dependent O
promoter O
. O

RNase I-GENE
protection O
and O
primer O
extension O
assays O
confirmed O
that O
the O
5 O
' O
non O
- O
coding O
exon _RARE_
is O
included O
in O
the O
DDT1 _RARE_
aFGF _RARE_
mRNA I-GENE
and O
that O
a O
major O
transcription O
start _RARE_
site O
is O
approximately _RARE_
136 O
bp O
upstream O
of O
the O
5 O
' O
non O
- O
coding O
splice _RARE_
junction _RARE_
of O
this O
exon _RARE_
. O

These O
results O
suggest O
that O
FK O
506 _RARE_
is O
a O
useful O
immunosuppressive O
agent O
in O
kidney _RARE_
transplantation O
. O

The O
roles O
of O
phorbol O
esters O
and O
cyclic O
AMP O
in O
mediating O
the O
GnRH I-GENE
response O
were O
also O
investigated O
. O

RT O
- O
PCR O
using O
1 O
. O
D O
- O
specific O
primers O
showed O
that O
kidney _RARE_
, O
brain O
and O
prostate _RARE_
do O
not O
express O
1 O
. O
D O
mRNA O
even O
though O
kidney _RARE_
and O
brain O
are O
the O
most O
abundant O
source O
for _RARE_
aFGF _RARE_
protein I-GENE
. O

Molecular O
cloning O
and O
characterization O
of O
two O
genes I-GENE
encoding I-GENE
gp138 _RARE_
, O
a O
cell O
surface O
glycoprotein O
involved O
in O
the O
sexual O
cell O
fusion O
of O
Dictyostelium O
discoideum _RARE_
. O

Two O
- O
dimensional O
phosphotryptic _RARE_
analyses O
indicate O
that O
phosphorylation _RARE_
on O
Ser _RARE_
- O
12 O
and O
Ser _RARE_
- O
48 _RARE_
in O
unstimulated O
cells O
is O
associated O
with O
the O
ability O
of O
overexpressed O
pp60c _RARE_
- I-GENE
src I-GENE
to O
potentiate _RARE_
beta O
- O
adrenergic O
signalling O
. O

Piroximone _RARE_
is O
a O
new O
phosphodiesterase _RARE_
III I-GENE
inhibitor O
that O
combines _RARE_
inotropic O
and O
vasodilator O
properties O
. O

Cytogenetic _RARE_
studies O
were O
performed O
in O
lymphocytes O
from O
hospital O
workers O
exposed O
to O
low O
doses O
of O
radiation O
( O
1 O
. O
6 O
- O
42 _RARE_
. O
71 _RARE_
mSv _RARE_
). O

To O
study O
the O
origin O
of O
different O
fMLF _RARE_
- I-GENE
R I-GENE
transcripts I-GENE
, O
the O
genetic O
linkage O
of O
chemotactic O
receptor O
genes O
, O
and O
the O
regulation _RARE_
of O
fMLF _RARE_
- I-GENE
R I-GENE
gene I-GENE
expression _RARE_
, O
we O
determined O
the O
copy O
number O
, O
chromosomal O
location O
, O
structural O
organization O
, O
and O
5 O
'- O
flanking O
sequence O
of O
the O
human I-GENE
fMLF _RARE_
- I-GENE
R I-GENE
gene I-GENE
. O

The O
first _RARE_
exon _RARE_
encodes O
66 _RARE_
bp O
of O
the O
5 O
'- O
untranslated _RARE_
sequence O
, O
while O
exon _RARE_
2 O
encodes O
the O
coding O
and O
3 O
'- O
untranslated _RARE_
sequences O
. O

The O
genomic O
structure _RARE_
of O
four O
members O
of O
the O
SRC I-GENE
- I-GENE
family I-GENE
revealed O
nearly O
identical O
exon _RARE_
/ O
intron O
boundaries O
within O
the O
catalytic O
domain O
of O
this O
family O
. O

Since O
we O
have O
observed O
effects O
of O
growth O
factors O
and O
cAMP O
as _RARE_
well _RARE_
as _RARE_
estradiol O
( O
E2 O
) O
on O
regulation _RARE_
of O
expression _RARE_
of O
some O
genes O
stimulated _RARE_
by O
the O
estrogen I-GENE
receptor I-GENE
( O
ER I-GENE
), _RARE_
we O
have O
undertaken O
studies O
to O
examine O
directly O
whether O
activators _RARE_
of O
protein O
kinases O
can O
modulate O
transcriptional O
activity O
of O
the O
ER I-GENE
. O

Using O
the O
polymerase O
chain O
reaction O
, O
Whipple _RARE_
- O
specific O
DNA O
fragments O
of O
284 _RARE_
base _RARE_
pairs _RARE_
from O
the O
genome O
of O
the O
Whipple _RARE_
bacterium O
( O
Tropheryma _RARE_
whippelii _RARE_
) O
were O
demonstrated O
. O

RNA I-GENE
polymerase I-GENE
bound _RARE_
to O
the O
+ O
10A _RARE_
promoter O
partially O
protects _RARE_
a O
20 O
base _RARE_
- O
pair _RARE_
sequence O
from O
DNase I-GENE
I I-GENE
digestion O
upstream O
of O
the O
start _RARE_
site O
. O

Salivary _RARE_
sodium _RARE_
, O
calcium _RARE_
, O
and O
magnesium O
concentrations O
were O
significantly O
higher _RARE_
in O
the O
SLE O
patients O
with O
systemic O
lupus O
erythematosus O
, O
whereas O
potassium _RARE_
and O
total _RARE_
protein O
concentrations O
and O
amylase I-GENE
activity O
did O
not O
differ O
significantly O
from O
the O
controls O
. O

Chem O
. O

Recombinant O
plasmid _RARE_
pFV100 _RARE_
was O
subsequently O
isolated O
by O
its O
ability O
to O
complement O
B O
- O
band O
expression _RARE_
in O
ge6 _RARE_
. O

We O
here O
demonstrate O
that O
a O
temperature _RARE_
- O
sensitive _RARE_
fission _RARE_
yeast O
mutant O
which O
has O
a O
mutation O
in O
a O
homologous O
gene O
, O
and O
two O
of O
three O
additional O
( O
mtr1 _RARE_
/ O
prp20 _RARE_
/ O
srm1 _RARE_
) O
mutants O
accumulate O
nuclear O
poly _RARE_
( O
A O
)+ O
RNA O
at _RARE_
37 O
degrees O
C O
. O

Since O
RCC1p _RARE_
acts O
as _RARE_
GNRP _RARE_
for _RARE_
Ran I-GENE
, O
a O
small I-GENE
nuclear I-GENE
GTPase I-GENE
of O
the O
ras I-GENE
superfamily I-GENE
, O
we O
have O
identified O
two O
homologs O
of O
Ran I-GENE
in O
S O
. O
cerevisiae O
( O
CNR1 _RARE_
and O
CNR2 _RARE_
). O

The O
immunosuppressant _RARE_
FK506 O
inhibits O
amino O
acid O
import O
in O
Saccharomyces O
cerevisiae O
. O

Prostate _RARE_
specific I-GENE
antigen I-GENE
shows O
the O
metastatic O
cases O
better O
[ _RARE_
correction O
of O
worse _RARE_
] O
than O
prostatic _RARE_
acid I-GENE
phosphatase I-GENE
. O

Protein O
phosphorylation _RARE_
appears O
to O
play O
a O
critical O
role O
in O
uPA I-GENE
gene I-GENE
expression _RARE_
in O
these O
cells O
; O
protein I-GENE
kinase I-GENE
C I-GENE
- O
activating O
phorbol O
esters O
cooperate O
with O
pp60v _RARE_
- I-GENE
src I-GENE
to O
synergistically O
increase O
uPA I-GENE
mRNA I-GENE
, O
whereas O
cyclic I-GENE
AMP I-GENE
( I-GENE
cAMP I-GENE
)- I-GENE
dependent I-GENE
protein I-GENE
kinase I-GENE
- O
activating O
agents O
( O
e _RARE_
. O
g O
., O
8 O
- O
bromo _RARE_
cAMP O
) O
repress O
uPA I-GENE
mRNA I-GENE
levels O
. O

Of O
these O
carriers O
149 _RARE_
were O
diagnosed O
to O
be O
asymptomatic O
clinically O
, O
biochemically _RARE_
and O
echographically _RARE_
. O

This O
300 _RARE_
bp O
5 O
'- O
upstream O
sequence O
of O
K3 _RARE_
keratin _RARE_
gene I-GENE
, O
which O
can O
function O
in O
vitro O
as _RARE_
a O
keratinocyte _RARE_
- O
specific O
promoter O
, O
contains O
two O
clusters O
of O
partially O
overlapping O
motifs O
, O
one O
with O
an O
NFkB _RARE_
consensus O
sequence O
and O
another O
with O
a O
GC _RARE_
box O
. O

Identification O
of O
mutations O
in O
the O
coding O
sequence O
of O
the O
proto _RARE_
- I-GENE
oncogene I-GENE
c I-GENE
- I-GENE
kit I-GENE
in O
a O
human O
mast _RARE_
cell O
leukemia O
cell O
line O
causing O
ligand _RARE_
- O
independent O
activation O
of O
c I-GENE
- I-GENE
kit I-GENE
product I-GENE
. O

BACKGROUND O
: O
Delineation _RARE_
of O
the O
morphologic O
aspects O
of O
age O
- O
related O
macular _RARE_
degeneration O
( O
ARMD _RARE_
) O
is O
helpful O
in O
correlation O
with O
the O
clinical O
features O
and O
may O
contribute O
to O
understanding O
the O
pathogenesis O
. O

An O
abundant O
1 O
. O
1 O
- O
kb O
virion O
- O
sense O
polyadenylated O
RNA O
and O
four O
complementary _RARE_
- O
sense O
polyadenylated O
RNAs O
of O
1 O
. O
7 O
, O
1 O
. O
5 O
, O
1 O
. O
3 O
, O
and O
0 _RARE_
. O
7 O
kb O
have O
been O
identified O
by O
northern O
blot O
hybridization O
, O
confirming O
the O
bidirectional _RARE_
transcription O
strategy O
implied _RARE_
by O
the O
arrangement O
of O
ORFs _RARE_
. O

Risk O
factors O
associated O
with O
a O
high O
seroprevalence _RARE_
of O
hepatitis O
C O
virus O
infection O
in O
Egyptian _RARE_
blood _RARE_
donors O
. O

Here O
the O
cloning O
and O
molecular _RARE_
analysis O
of O
the O
Zm _RARE_
- I-GENE
ERabp1 _RARE_
, O
Zm _RARE_
- I-GENE
ERabp4 _RARE_
, O
and O
Zm _RARE_
- I-GENE
ERabp5 _RARE_
genes I-GENE
is O
presented O
. O

This O
agent O
, O
isolated O
from O
the O
fungus _RARE_
Streptomyces _RARE_
tsukubaensis _RARE_
, O
has O
a O
mechanism O
of O
action O
similar O
to O
that O
of O
cyclosporine O
. O

DNase I-GENE
I I-GENE
footprinting O
of O
the O
proximal O
promoter O
revealed O
four O
regions O
of O
protection O
. O

Finally O
, O
the O
stability O
of O
the O
nucleotide O
binding O
function O
of O
the O
two O
proteins O
is O
similar O
as _RARE_
assessed O
by O
sensitivity O
to O
urea O
. O

Insulin I-GENE
- I-GENE
like I-GENE
growth I-GENE
factor I-GENE
- I-GENE
binding I-GENE
protein I-GENE
- I-GENE
2 I-GENE
( O
IGF I-GENE
- I-GENE
BP _RARE_
- I-GENE
2 I-GENE
) O
transcription O
in O
rat O
liver O
varies _RARE_
with O
developmental O
age O
and O
fasting O
. O

The O
presence O
of O
the O
RV O
5 O
'(+) _RARE_
SL _RARE_
sequence O
had O
the O
primary _RARE_
enhancing O
effect O
on O
translation O
. O

By O
contrast O
, O
all O
proteins O
initiated _RARE_
with O
a O
methionine O
placed O
one O
residue _RARE_
upstream O
of O
the O
natural _RARE_
N O
terminus O
of O
PR I-GENE
failed O
to O
show O
specific O
proteolysis O
. O

Reverse _RARE_
transcriptase I-GENE
and O
protease O
activities O
of O
avian O
leukosis _RARE_
virus O
Gag I-GENE
- O
Pol I-GENE
fusion O
proteins O
expressed _RARE_
in O
insect O
cells O
. O

In O
addition O
, O
an O
mck1 _RARE_
mds1 _RARE_
mrk1 _RARE_
triple _RARE_
disruptant _RARE_
was O
viable O
. O

However O
, O
there O
were O
some O
properties O
of O
Rak _RARE_
that O
are O
distinct O
from O
Src I-GENE
- I-GENE
like I-GENE
kinases I-GENE
: O
( O
a O
) O
expression _RARE_
of O
Rak _RARE_
was O
predominantly O
in O
epithelial _RARE_
- O
derived O
cell O
lines O
and O
tissues O
, O
especially O
normal O
liver O
and O
kidney _RARE_
, O
and O
cell O
lines O
of O
breast O
and O
colon O
origin O
; O
( O
b O
) O
Rak _RARE_
does O
not O
harbor O
the O
NH2 O
- O
terminal O
glycine O
essential O
for _RARE_
myristylation _RARE_
and O
membrane O
localization _RARE_
; O
and O
( O
c O
) O
Rak _RARE_
possesses O
a O
putative O
bipartite O
nuclear O
localization _RARE_
signal O
in O
the O
SH2 _RARE_
domain I-GENE
, O
and O
subcellular O
fractionation O
studies O
revealed O
that O
p54rak _RARE_
resides O
predominantly O
in O
the O
nucleus O
. O

PATIENTS O
AND _RARE_
METHODS O
: O
We O
report O
our O
experience O
with O
seven _RARE_
children O
with O
active _RARE_
small O
bowel O
Crohn O
' O
s O
disease _RARE_
given O
a O
casein I-GENE
- O
based O
, O
polymeric _RARE_
feed O
rich O
in O
TGF I-GENE
- I-GENE
beta I-GENE
2 I-GENE
( O
Specific O
Polymeric _RARE_
Diet _RARE_
; O
Nestle _RARE_
- O
Clintec _RARE_
; O
Vevey _RARE_
, O
Switzerland _RARE_
) O
as _RARE_
complete _RARE_
nutrition O
for _RARE_
8 O
weeks O
. O

The O
leader _RARE_
sequence O
of O
the O
isolated O
cDNA O
clone O
contains O
several O
small O
open _RARE_
reading O
frames O
upstream O
of O
the O
initiation O
codon _RARE_
of O
the O
largest O
open _RARE_
reading O
frame O
coding O
for _RARE_
the O
homeodomain _RARE_
protein I-GENE
. O

A O
small O
amount O
of O
HSP81 _RARE_
- I-GENE
1 I-GENE
mRNA I-GENE
was O
detected O
only O
in O
roots O
. O

Cell O
adhesion O
and O
migration O
assays O
demonstrate O
that O
alpha I-GENE
6 I-GENE
beta I-GENE
1 I-GENE
is O
the O
major O
laminin _RARE_
receptor I-GENE
in O
undifferentiated O
F9 O
cells O
as _RARE_
well _RARE_
as _RARE_
F9 O
- O
derived O
PE _RARE_
cells O
. O

No O
local O
destruction _RARE_
by O
tumor O
or O
infection O
could O
be O
demonstrated O
apart O
from O
HIV O
infection O
. O

Among O
the O
mixed O
race _RARE_
persons O
one O
Chukcha _RARE_
- O
Eskimo _RARE_
had O
AS _RARE_
, O
one O
Eskimo _RARE_
- O
Russian _RARE_
had O
psoriatic _RARE_
arthritis O
( O
PsA _RARE_
). O

Our O
data O
complement O
other O
studies O
of O
circumpolar _RARE_
populations O
and O
reinforce _RARE_
the O
reported O
high O
prevalences _RARE_
of O
SPA _RARE_
and O
HLA I-GENE
- I-GENE
B27 _RARE_
among O
those O
populations O
. O

Clinical O
studies O
SY5555 _RARE_
was O
administered O
to O
45 _RARE_
patients O
with O
various O
infectious O
diseases O
( O
2 O
with O
acute O
pharyngitis _RARE_
, O
8 O
with O
acute O
tonsillitis _RARE_
, O
4 O
with O
lacunar _RARE_
tonsillitis _RARE_
, O
3 O
each O
with O
acute O
bronchitis _RARE_
, O
pneumonia O
and O
pertussis _RARE_
, O
7 O
with O
scarlet _RARE_
fever O
, O
3 O
with O
impetigo _RARE_
contagiosa _RARE_
, O
6 O
with O
acute O
urinary _RARE_
tract _RARE_
infections O
, O
2 O
with O
balanoposthitis _RARE_
and O
1 O
each O
with O
cervical O
lymphadenitis _RARE_
, O
S O
. O
S O
. O
S O
. O
S O
., O
vulvitis _RARE_
and O
acute O
colitis _RARE_
) O
at _RARE_
daily O
doses O
between O
3 O
. O
4 O
- O
10 O
mg O
/ O
kg O
, O
t O
. O
i O
. O
d O
., O
for _RARE_
3 O
- O
14 O
days O
. O

Although O
most O
SH2 _RARE_
- O
pTyr _RARE_
interactions O
occur O
between O
two O
different O
types _RARE_
of O
molecules O
, O
some O
appear O
to O
involve O
only O
a O
single O
molecular _RARE_
type O
. O

RESULTS O
: O
Closure _RARE_
time O
of O
fistulas _RARE_
in O
patients O
receiving O
TPN O
+ O
somatostatin I-GENE
was O
significantly O
shorter O
( O
13 _RARE_
. O
86 _RARE_
+/- O
1 O
. O
84 _RARE_
versus O
20 O
. O
4 O
+/- O
2 O
. O
89 _RARE_
days O
) O
than O
in O
those O
receiving O
TPN O
alone O
. O

Experimental O
adhesion O
prophylaxis O
with O
recombinant I-GENE
tissue I-GENE
plasminogen I-GENE
activator I-GENE
. O

Scratching _RARE_
during _RARE_
sleep O
in O
children O
with O
atopic O
dermatitis O
is O
associated O
with O
increased O
VO2 O
. O

To O
determine O
which O
sequences O
in O
the O
rat I-GENE
P450c17 _RARE_
promoter I-GENE
may O
be O
responsible O
for _RARE_
basal O
and O
cAMP O
- O
stimulated _RARE_
gene O
transcription O
, O
deletion O
constructs O
containing O
between O
- O
1 O
, O
560 _RARE_
and O
- O
53 O
base _RARE_
pairs _RARE_
of O
5 O
'- O
flanking O
DNA O
from O
the O
rat I-GENE
P450c17 _RARE_
gene I-GENE
were O
ligated O
to O
plasmids O
expressing O
the O
reporter O
gene O
luciferase I-GENE
and O
transfected O
into O
two O
mouse O
cell O
lines O
, O
adrenal O
Y O
- O
1 O
cells O
, O
and O
testicular _RARE_
Leydig _RARE_
MA _RARE_
- O
10 O
cells O
. O

Within O
- O
subject O
BP _RARE_
differences O
between O
fish O
oil O
and O
corn _RARE_
oil O
treatment O
were O
similar O
for _RARE_
Dinamap _RARE_
( O
3 O
. O
2 O
+/- O
1 O
. O
8 O
/ O
2 O
. O
5 O
+/- O
1 O
. O
0 _RARE_
mm O
Hg O
) O
and O
for _RARE_
24 _RARE_
- O
h O
ABP _RARE_
( O
2 O
. O
5 O
+/- O
1 O
. O
0 _RARE_
/ O
2 O
. O
3 O
+/- O
0 _RARE_
. O
8 O
mm O
Hg O
), _RARE_
but O
were O
more O
significant O
with O
the O
latter O
. O

We O
have O
cloned _RARE_
and O
sequenced O
the O
mouse I-GENE
NMO1 _RARE_
cDNA I-GENE
, O
which O
encodes O
the O
NAD _RARE_
( I-GENE
P I-GENE
) I-GENE
H I-GENE
: I-GENE
menadione _RARE_
oxidoreductase I-GENE
[ _RARE_
also O
called O
NAD _RARE_
( I-GENE
P I-GENE
) I-GENE
H I-GENE
:( _RARE_
quinone _RARE_
acceptor _RARE_
) I-GENE
oxidoreductase I-GENE
; O
quinone _RARE_
reductase I-GENE
; O
azo _RARE_
dye _RARE_
reductase I-GENE
; O
DT _RARE_
diaphorase _RARE_
; O
EC I-GENE
1 I-GENE
. I-GENE
6 I-GENE
. I-GENE
99 _RARE_
. I-GENE
2 I-GENE
]. O

Escherichia O
coli O
JRG582 _RARE_
is O
an O
ampD _RARE_
ampE _RARE_
deletion O
derivative _RARE_
of O
strain _RARE_
HfrH _RARE_
and O
accordingly _RARE_
it O
is O
derepressed _RARE_
for _RARE_
expression _RARE_
of O
the O
cloned _RARE_
inducible O
beta I-GENE
- I-GENE
lactamase I-GENE
gene I-GENE
of O
Citrobacter _RARE_
freundii _RARE_
, O
carried O
on O
plasmid _RARE_
pNU305 _RARE_
. O

Such O
a O
mechanism O
may O
allow O
acceleration _RARE_
of O
degenerative _RARE_
joint O
conditions O
, O
and O
may O
account O
for _RARE_
the O
increased O
prevalence O
of O
such O
conditions O
seen O
with O
HMS _RARE_
subjects O
. O

Solitary _RARE_
thyroid O
nodule _RARE_
. O

Male _RARE_
contraception _RARE_
: O
ideas _RARE_
for _RARE_
the O
future O
. O

While O
daily O
food O
intake O
was O
almost O
constant O
regardless O
of O
the O
dietary O
protein O
level O
, O
water O
intake O
and O
urine O
volume O
increased O
with O
increasing O
the O
dietary O
protein O
. O

We O
propose O
that O
Mad _RARE_
and O
Medea _RARE_
encode O
rate O
- O
limiting O
components _RARE_
integral _RARE_
to O
dpp _RARE_
pathways O
throughout O
development O
. O

Transcriptional O
regulation _RARE_
of O
the O
vacuolar I-GENE
H I-GENE
(+)- _RARE_
ATPase I-GENE
B2 _RARE_
subunit I-GENE
gene I-GENE
in O
differentiating O
THP _RARE_
- O
1 O
cells O
. O

However O
, O
the O
inability _RARE_
to O
export O
RNA O
from O
the O
nucleus O
to O
the O
cytoplasm O
was O
not O
limited O
to O
a O
particular O
phase _RARE_
of O
the O
cell O
division O
cycle _RARE_
. O

An O
E O
box O
element O
is O
required O
for _RARE_
the O
expression _RARE_
of O
the O
ad4bp _RARE_
gene I-GENE
, O
a O
mammalian I-GENE
homologue I-GENE
of I-GENE
ftz _RARE_
- I-GENE
f1 _RARE_
gene I-GENE
, O
which O
is O
essential O
for _RARE_
adrenal O
and O
gonadal _RARE_
development O
. O

Inhibition O
assays O
performed O
with O
over O
30 _RARE_
different O
natural _RARE_
and O
synthetic _RARE_
sialylated _RARE_
and O
/ O
or O
sulfated _RARE_
compounds O
are O
utilized O
to O
define O
in O
greater O
detail O
specific O
structural O
features O
involved O
in O
oligosaccharide _RARE_
- O
protein O
binding O
. O

The O
amino O
acid O
sequence O
of O
the O
protein O
in O
the O
region O
of O
the O
specificity _RARE_
pocket O
is O
similar O
to O
that O
of O
S I-GENE
. I-GENE
griseus _RARE_
proteases _RARE_
A I-GENE
, I-GENE
B I-GENE
, I-GENE
and I-GENE
C I-GENE
. O

Mutations O
in O
the O
VPS45 _RARE_
gene I-GENE
, O
a O
SEC1 _RARE_
homologue O
, O
result O
in O
vacuolar O
protein O
sorting _RARE_
defects O
and O
accumulation O
of O
membrane O
vesicles O
. O

In O
293 O
cells O
, O
expression _RARE_
of O
the O
NF _RARE_
- I-GENE
kappa _RARE_
B I-GENE
inhibitor O
, O
I I-GENE
kappa _RARE_
B I-GENE
- I-GENE
alpha I-GENE
, O
reduced _RARE_
the O
stimulatory _RARE_
activity O
of O
LMP I-GENE
. O

This O
experimental O
design O
was O
used O
to O
determine O
the O
effect O
of O
displacement _RARE_
of O
the O
alpha I-GENE
4 I-GENE
- I-GENE
2 I-GENE
binding I-GENE
site I-GENE
on O
the O
repression O
of O
alpha I-GENE
4 I-GENE
gene I-GENE
transcription O
by O
ICP4 I-GENE
. O

Immediate _RARE_
- O
early O
transcription O
from O
the O
channel _RARE_
catfish _RARE_
virus O
genome O
: O
characterization O
of O
two O
immediate I-GENE
- I-GENE
early I-GENE
transcripts I-GENE
. O

The O
GRE _RARE_
at _RARE_
nucleotide O
7640 _RARE_
is O
a O
composite O
GRE _RARE_
( O
cGRE _RARE_
) O
containing O
an O
overlapping O
activator I-GENE
protein I-GENE
- I-GENE
1 I-GENE
( O
AP I-GENE
- I-GENE
1 I-GENE
) O
motif O
for _RARE_
the O
c I-GENE
- I-GENE
jun I-GENE
homodimer _RARE_
and O
c I-GENE
- I-GENE
jun I-GENE
/ O
c I-GENE
- I-GENE
fos I-GENE
heterodimer _RARE_
. O

In O
contrast O
to O
some O
results O
previously O
published O
for _RARE_
a O
very O
close O
sequence O
variant O
( O
see _RARE_
ref _RARE_
. O

Transcriptional O
activation O
by O
thyroid O
hormone O
( O
T3 _RARE_
) O
requires O
interactions O
between O
the O
T3 _RARE_
receptor I-GENE
( O
TR I-GENE
) O
and O
T3 _RARE_
response O
elements O
( O
TREs _RARE_
) O
composed O
of O
two O
copies O
of O
sequences O
related O
to O
AGGTCA _RARE_
. O

A O
multivariate O
analysis O
of O
risk O
factors O
for _RARE_
relapse O
examined O
age O
, O
WBC O
at _RARE_
diagnosis O
, O
blast _RARE_
count O
at _RARE_
diagnosis O
, O
percentage O
of O
marrow O
blasts _RARE_
, O
FAB _RARE_
subtype _RARE_
, O
the O
number O
of O
remission O
induction O
courses O
to O
achieve O
a O
remission O
, O
maintenance _RARE_
therapy O
, O
consolidation _RARE_
therapy O
, O
marrow O
cell O
dose O
, O
donor O
- O
recipient O
sex _RARE_
, O
GVHD _RARE_
prophylaxis O
regimen O
and O
isolation O
and O
decontamination _RARE_
in O
laminar _RARE_
airflow _RARE_
rooms _RARE_
. O

Carnitine _RARE_
palmitoyltransferase _RARE_
( I-GENE
CPT _RARE_
) I-GENE
II I-GENE
deficiency O
is O
the O
most O
common O
inherited O
disorder O
of O
lipid _RARE_
metabolism O
affecting O
skeletal O
muscle O
. O

We O
show O
that O
these O
three O
gain O
- O
of O
- O
function O
mutants O
differ O
considerably O
in O
their O
ability O
to O
bypass O
the O
sex _RARE_
determination O
signal O
, O
with O
SxlM4 _RARE_
being O
the O
strongest O
and O
SxlM1 _RARE_
the O
weakest _RARE_
. O

We O
show O
that O
these O
three O
gain O
- O
of O
- O
function O
mutants O
differ O
considerably O
in O
their O
ability O
to O
bypass O
the O
sex _RARE_
determination O
signal O
, O
with O
SxlM4 _RARE_
being O
the O
strongest O
and O
SxlM1 _RARE_
the O
weakest _RARE_
. O

Binding O
of O
meAda _RARE_
is O
necessary O
to O
activate O
transcription O
of O
the O
adaptive O
response O
genes O
; O
accordingly _RARE_
, O
in O
vitro O
transcription O
of O
aidB _RARE_
is O
dependent O
on O
the O
presence O
of O
meAda _RARE_
. O

No O
significant O
differences O
were O
identified O
between O
groups O
for _RARE_
pH O
, O
PaCO2 O
, O
intracranial _RARE_
pressure O
, O
heart _RARE_
rate O
, O
brain O
temperature _RARE_
, O
or O
glucose O
levels O
. O

Blood _RARE_
pressure O
also O
was O
increased O
by O
lidocaine O
( O
6 O
mg O
kg O
- O
1 O
). O

Anesthesiologists _RARE_
often O
use O
more O
than O
one O
drug O
in O
a O
patient O
to O
achieve O
a O
target O
response O
, O
such O
as _RARE_
a O
desired _RARE_
blood _RARE_
pressure O
. O

We O
suggest O
that O
this O
gene O
cluster O
codes O
for _RARE_
( O
parts O
of O
) O
a O
multisubunit _RARE_
cytochrome I-GENE
c I-GENE
haem _RARE_
lyase I-GENE
. O

In O
this O
paper O
, O
a O
comparison O
between O
the O
number O
and O
shape O
of O
corneal O
endothelial O
cells O
has O
been O
performed O
in O
25 _RARE_
patients O
before O
and O
6 O
months O
after O
PRK O
. O

Standard _RARE_
reference O
sources O
indicate O
that O
an O
able O
- O
bodied _RARE_
11 O
- O
year O
- O
old O
child O
of O
comparable O
height O
requires O
1 O
, O
493 _RARE_
kcal _RARE_
/ O
d O
for _RARE_
support O
of O
basal O
metabolic O
functions O
. O

Weak _RARE_
allergenicity _RARE_
of O
recombinant I-GENE
hirudin _RARE_
CGP _RARE_
39393 _RARE_
( O
REVASC _RARE_
) O
in O
immunocompetent _RARE_
volunteers O
. O

In O
contrast O
to O
the O
myoD I-GENE
promoter I-GENE
, O
the O
myoD I-GENE
enhancer I-GENE
shows O
striking O
conservation O
between O
humans O
and O
mice O
both O
in O
its O
sequence O
and O
its O
distal O
position O
. O

However O
, O
a O
clear O
difference O
exists O
between O
myoblasts O
and O
10T1 _RARE_
/ O
2 O
cells O
( O
and O
other O
non O
- O
muscle O
cell O
types _RARE_
) O
in O
the O
chromatin O
structure _RARE_
of O
the O
chromosomal O
myoD I-GENE
core I-GENE
enhancer I-GENE
, O
suggesting O
that O
the O
myoD I-GENE
enhancer I-GENE
is O
repressed O
by O
epigenetic _RARE_
mechanisms O
in O
10T1 _RARE_
/ O
2 O
cells O
. O

Using O
Ki _RARE_
- I-GENE
ras I-GENE
- O
transformed O
3T3 O
cells O
as _RARE_
a O
model O
system _RARE_
, O
we O
show O
that O
both O
RA _RARE_
and O
the O
' O
dissociating _RARE_
' O
retinoids _RARE_
inhibit O
anchorage O
- O
independent O
cell O
proliferation _RARE_
, O
suggesting O
that O
retinoid O
- O
induced _RARE_
growth O
inhibition O
may O
be O
related O
to O
AP1 I-GENE
transrepression _RARE_
. O

The O
Oct I-GENE
and O
HMG2 _RARE_
proteins I-GENE
also O
interact O
in O
vivo O
. O

Atopic _RARE_
dermatitis O
is O
an O
" O
itch _RARE_
which O
rashes _RARE_
and O
not O
a O
rash O
which O
itches _RARE_
" O
and O
therefore O
, O
any O
patient O
treatment O
program O
should O
address O
the O
multiplicity _RARE_
of O
potential _RARE_
trigger _RARE_
factors O
that O
provoke _RARE_
this O
itching _RARE_
. O

Primer O
extension O
experiments O
showed O
that O
there O
are O
two O
transcription O
initiation O
sites O
16 O
bp O
apart O
in O
the O
mouse I-GENE
type I-GENE
2 I-GENE
receptor I-GENE
gene I-GENE
. O

The O
beta O
subunit O
of O
the O
Fc I-GENE
epsilon I-GENE
R1 _RARE_
is O
a O
33 _RARE_
- O
kDa O
tyrosine O
phosphoprotein _RARE_
, O
but O
the O
p33 _RARE_
Grb2 I-GENE
- I-GENE
binding I-GENE
protein I-GENE
described O
in O
the O
present O
report O
is O
not O
the O
Fc I-GENE
epsilon I-GENE
R1 _RARE_
beta I-GENE
chain I-GENE
and O
its O
identity O
is O
unknown O
. O

To O
study O
the O
mechanisms O
as _RARE_
well _RARE_
as _RARE_
magnitude O
of O
the O
transmembrane O
transfer O
of O
bacterial O
products O
from O
the O
dialysate _RARE_
, O
we O
developed O
a O
computerized O
in O
vitro O
dialysis O
model O
which O
provides O
continuous O
pressure O
recording O
from O
the O
arterial O
, O
venous O
, O
dialysate _RARE_
inflow _RARE_
and O
outflow O
ports _RARE_
. O

After O
24 _RARE_
hour O
incubation O
, O
total _RARE_
cell O
- O
associated O
IL _RARE_
- I-GENE
1Ra _RARE_
and O
IL _RARE_
- I-GENE
1 I-GENE
beta I-GENE
were O
measured O
by O
specific O
radioimmunoassay O
. O

Each O
dietary O
treatment O
was O
fed O
to O
six _RARE_
pen _RARE_
replicates _RARE_
of O
five O
chicks O
per O
pen _RARE_
for _RARE_
21 O
d O
. O

1972 O
. O

In O
contrast O
, O
recent O
evidence O
suggests O
that O
children O
with O
sickle _RARE_
- I-GENE
hemoglobin I-GENE
C I-GENE
disease _RARE_
do O
not O
develop O
functional _RARE_
asplenia _RARE_
before O
3 O
to O
4 O
years O
of O
age O
and O
thus O
may O
not O
benefit O
from O
penicillin _RARE_
prophylaxis O
. O

Deletion O
analysis O
indicates O
that O
TBP I-GENE
and O
hTAFII18 _RARE_
bind O
to O
distinct O
domains O
of O
hTAFII28 _RARE_
. O
hTAFII18 _RARE_
also O
interacts O
with O
TBP I-GENE
, O
but O
it O
interacts O
more O
strongly O
with O
hTAFII28 _RARE_
and O
hTAFII30 _RARE_
. O

The O
NarX _RARE_
and O
NarQ _RARE_
proteins I-GENE
with O
amino O
acid O
substitutions O
at _RARE_
the O
first _RARE_
conserved _RARE_
histidine _RARE_
position O
were O
also O
unable O
to O
dephosphorylate _RARE_
NarL _RARE_
- O
phosphate O
in O
vitro O
. O

Vascular _RARE_
endothelial O
cells O
undergo O
profound O
changes O
upon O
cellular O
activation O
including O
expression _RARE_
of O
a O
spectrum O
of O
cell O
activation O
- O
associated O
genes O
. O

Because O
ATF I-GENE
- I-GENE
1 I-GENE
and O
CREM _RARE_
are O
known O
to O
bind O
to O
cAMP O
response O
elements O
( O
CRE _RARE_
), _RARE_
this O
functional _RARE_
sequence O
was O
named O
the O
kappa _RARE_
E3 _RARE_
'- O
CRE _RARE_
. O

The O
Ng _RARE_
/ I-GENE
RC3 _RARE_
and O
PKC I-GENE
- I-GENE
gamma I-GENE
genes I-GENE
have O
a O
similar O
expression _RARE_
pattern O
in O
the O
brain O
during _RARE_
development O
. O

Structure O
and O
regulation _RARE_
of O
the O
gene O
encoding O
the O
neuron _RARE_
- O
specific O
protein I-GENE
kinase I-GENE
C I-GENE
substrate O
neurogranin _RARE_
( O
RC3 _RARE_
protein I-GENE
). O

The O
amino O
acid O
sequences O
of O
the O
known O
largest O
subunits O
of O
DdRPs _RARE_
from O
different O
species O
contain O
highly O
conserved _RARE_
regions O
. O

The O
TTG _RARE_
- I-GENE
2 I-GENE
gene I-GENE
has O
been O
identified O
at _RARE_
the O
site O
of O
chromosomal O
translocations _RARE_
in O
acute O
T O
- O
cell O
leukemia O
' O
s O
( O
T O
- O
ALL O
). O

In O
vitro O
studies O
with O
blood _RARE_
cells O
incubated O
with O
acetate _RARE_
or O
bicarbonate _RARE_
ions O
in O
concentrations O
, O
which O
are O
observed O
in O
vivo O
during _RARE_
hemodialysis O
, O
suggest O
that O
probably O
these O
ions O
do O
not O
directly O
affect O
superoxide _RARE_
anions _RARE_
generation O
, O
erythrocyte _RARE_
SOD I-GENE
- I-GENE
1 I-GENE
and O
catalase I-GENE
activities O
and O
erythrocyte _RARE_
membrane O
lipid _RARE_
peroxidation O
. O

Short O
therapy O
with O
omeprazole O
20 O
mg O
/ O
b O
. O
i O
. O
d O
., O
clarithromycin _RARE_
500 O
mg O
/ O
b O
. O
i O
. O
d O
., O
and O
CBS _RARE_
120 O
mg O
/ O
q _RARE_
. O
i O
. O
d O
. O
is O
a O
safe O
, O
well _RARE_
tolerated O
combination O
that O
achieves _RARE_
a O
80 _RARE_
. O
6 O
% O
eradication O
rate O
of O
H O
. O
pylori _RARE_
and O
duodenal O
ulcer O
healing O
rates O
as _RARE_
good O
as _RARE_
those O
achieved O
by O
omeprazole O
20 O
mg O
/ O
d O
when O
given O
for _RARE_
4 O
wk O
. O

The O
concentration O
of O
mite _RARE_
allergen _RARE_
was O
very O
low O
( O
mean O
0 _RARE_
. O
18 O
micrograms O
Der _RARE_
p O
milligrams _RARE_
sieved _RARE_
house _RARE_
dust O
), _RARE_
whereas O
that O
of O
cat _RARE_
allergen _RARE_
was O
high O
in O
homes _RARE_
with O
a O
cat _RARE_
( O
80 _RARE_
. O
8 O
micrograms O
Fel _RARE_
d O
milligrams _RARE_
) O
but O
also O
in O
homes _RARE_
with O
no _RARE_
cat _RARE_
( O
3 O
. O
2 O
micrograms O
Fel _RARE_
d O
milligrams _RARE_
). O

CONCLUSIONS O
: O
A O
comparison O
of O
the O
LysU _RARE_
crystal _RARE_
structure _RARE_
with O
the O
structures _RARE_
of O
seryl _RARE_
- I-GENE
and I-GENE
aspartyl _RARE_
- I-GENE
tRNA I-GENE
synthetases I-GENE
enables O
a O
conserved _RARE_
core O
to O
be O
identified O
. O

Whole _RARE_
bowel O
irrigation O
is O
a O
recently O
described O
technique O
to O
enhance O
the O
passage O
of O
drugs O
already O
beyond O
the O
pylorus _RARE_
. O

The O
MPS1 _RARE_
open _RARE_
reading I-GENE
frame I-GENE
has O
been O
fused O
to O
those O
that O
encode O
the O
LexA I-GENE
protein I-GENE
or O
the O
GST I-GENE
protein I-GENE
and O
both O
of O
these O
constructs O
function O
in O
yeast O
. O

As O
in O
Tb _RARE_
, O
U6 I-GENE
is O
a O
single O
- O
copy O
gene O
and O
two O
tRNA O
genes O
, O
tRNAGln _RARE_
and O
tRNAIle _RARE_
, O
are O
found O
upstream O
to O
the O
gene O
. O

Hematopoietic _RARE_
growth I-GENE
factors I-GENE
have O
already O
had O
an O
enormous _RARE_
impact O
on O
transfusion O
practice O
by O
eliminating _RARE_
or O
reducing _RARE_
the O
need O
for _RARE_
red _RARE_
blood _RARE_
cell O
transfusions _RARE_
in O
a O
variety O
of O
anemic _RARE_
states O
characterized O
by O
an O
absolute O
or O
relative O
decrease O
in O
erythropoietin I-GENE
. O

However O
, O
the O
mouse O
has O
previously O
been O
shown O
to O
possess O
only O
three O
forms O
of O
ADH I-GENE
. O

During O
IC _RARE_
breaths _RARE_
and O
following O
EC O
and O
VC _RARE_
breaths _RARE_
at _RARE_
rest O
, O
end O
- O
tidal O
CO2 O
pressure O
( O
PET O
, O
CO2 O
) O
fell O
by O
7 O
. O
5 O
, O
8 O
. O
5 O
and O
9 O
. O
5 O
mmHg O
, O
respectively O
. O

2 O
. O

Phylogenetic _RARE_
analyses O
of O
19 O
amino O
acid O
sequences O
of O
6 O
related O
protein O
types _RARE_
indicate O
that O
actin I-GENE
- O
associated O
proteins O
related O
to O
gelsolin _RARE_
are O
monophyletic _RARE_
to O
a O
common O
ancestor O
and O
include O
flightless _RARE_
proteins I-GENE
. O

No O
homologs O
of O
other O
members O
of O
the O
Surfeit _RARE_
gene I-GENE
cluster I-GENE
were O
detected O
in O
close O
proximity _RARE_
to O
the O
D O
. O
melanogaster O
Surf I-GENE
- I-GENE
3 I-GENE
/ O
rpL7a _RARE_
gene O
. O

Moreover O
, O
we O
found O
that O
cyclin _RARE_
E I-GENE
, O
in O
contrast O
to O
cyclin _RARE_
D1 _RARE_
, O
was O
required O
for _RARE_
the O
G1 O
/ O
S O
transition O
even O
in O
cells O
lacking _RARE_
retinoblastoma _RARE_
protein I-GENE
function O
. O

The O
predicted O
amino O
acid O
sequence O
of O
the O
SGC1 _RARE_
gene I-GENE
product I-GENE
includes O
a O
region O
with O
substantial O
similarity _RARE_
to O
the O
basic O
- O
helix O
- O
loop O
- O
helix O
domain O
of O
the O
Myc _RARE_
family I-GENE
of O
DNA O
- O
binding O
proteins O
. O

By O
creating _RARE_
Pax I-GENE
- I-GENE
6 I-GENE
- O
BSAP _RARE_
fusion O
proteins O
, O
we O
were O
able O
to O
identify O
a O
short O
amino O
acid O
stretch O
in O
the O
N O
- O
terminal O
part O
of O
the O
paired I-GENE
domain O
which O
is O
responsible O
for _RARE_
these O
differences O
in O
DNA O
- O
binding O
specificity _RARE_
. O

To O
establish O
a O
possible O
association O
between O
familial O
dysfibrinogenemia _RARE_
and O
thrombophilia _RARE_
, O
data O
on O
cases O
with O
both O
affections _RARE_
were O
collected O
in O
a O
study O
within O
the O
framework _RARE_
of O
the O
SSC _RARE_
Subcommittee _RARE_
on O
Fibrinogen _RARE_
of O
the O
International O
Society _RARE_
on O
Thrombosis _RARE_
and O
Haemostasis _RARE_
. O

Conjugated _RARE_
estrogens _RARE_
shorten _RARE_
bleeding O
time O
in O
uraemia _RARE_
: O
a O
possible O
role O
of O
serotonin _RARE_
? O

These O
six _RARE_
districts _RARE_
have O
an O
area O
of O
34 _RARE_
, O
000 _RARE_
km2 _RARE_
and O
hold _RARE_
a O
population O
of O
30 _RARE_
million O
. O

According O
to O
symptoms O
, O
signs O
, O
imaging O
features O
, O
operation O
findings O
, O
the O
original O
places _RARE_
and O
the O
expansive _RARE_
directions _RARE_
of O
the O
tumor O
, O
they O
were O
divided O
into O
four O
clinical O
types _RARE_
: O
sellar _RARE_
, O
clival _RARE_
, O
occipito _RARE_
- O
temporal O
and O
extent O
. O

Two O
mammalian O
enzymes _RARE_
, O
the O
haem _RARE_
- I-GENE
controlled _RARE_
repressor I-GENE
( O
HCR _RARE_
) O
and O
the O
double I-GENE
- I-GENE
stranded _RARE_
RNA I-GENE
- I-GENE
activated I-GENE
inhibitor I-GENE
( O
dsI _RARE_
), _RARE_
phosphorylate O
Ser _RARE_
- O
51 _RARE_
of O
the O
alpha O
subunit O
, O
thereby O
inhibiting O
the O
exchange O
of O
bound _RARE_
nucleotides O
on O
, O
and O
thus O
the O
recycling _RARE_
of O
, O
eIF I-GENE
- I-GENE
2 I-GENE
. O

A O
triple _RARE_
Ser _RARE_
--> _RARE_
Ala _RARE_
mutant O
form O
of O
yeast O
eIF I-GENE
- I-GENE
2 I-GENE
alpha I-GENE
was O
found O
to O
be O
no _RARE_
longer O
phosphorylated _RARE_
by O
either O
of O
the O
yeast O
( O
or O
mammalian O
) O
casein I-GENE
kinase I-GENE
activities O
in O
vitro O
. O

The O
cases O
included O
35 _RARE_
de O
novo _RARE_
diffuse O
aggressive O
lymphomas O
( O
DAL _RARE_
; O
19 O
large O
- O
cell O
, O
4 O
mixed O
- O
cell O
, O
and O
12 O
large O
- O
cell O
immunoblastic _RARE_
), _RARE_
52 O
transformed O
aggressive O
lymphomas O
derived O
from O
follicular O
lymphomas O
( O
TFL _RARE_
), _RARE_
42 _RARE_
indolent _RARE_
follicular O
lymphomas O
( O
FL _RARE_
), _RARE_
14 O
mantle _RARE_
cell O
lymphomas O
( O
MCL _RARE_
), _RARE_
and O
27 _RARE_
small O
noncleaved _RARE_
cell O
lymphomas O
( O
SNCL _RARE_
). O

Icterus _RARE_
and O
beta O
- O
thalassemia _RARE_
in O
Congolese _RARE_
children O
in O
Brazzaville _RARE_

Female O
patients O
with O
breast O
cancer _RARE_
diagnosed O
between O
1982 O
and O
1991 O
at _RARE_
Roswell _RARE_
Park _RARE_
Cancer O
Institute O
( O
RPCI _RARE_
) O
in O
Buffalo _RARE_
, O
New O
York O
, O
who O
provided O
information _RARE_
on O
their O
cigarette _RARE_
smoking O
history O
at _RARE_
the O
time O
of O
their O
diagnosis O
were O
included O
. O

Upon O
analysis O
of O
the O
tissue O
distribution O
of O
AAMP _RARE_
, O
it O
was O
found O
to O
be O
expressed _RARE_
strongly O
in O
endothelial O
cells O
, O
cytotrophoblasts _RARE_
, O
and O
poorly O
differentiated O
colon O
adenocarcinoma O
cells O
found O
in O
lymphatics _RARE_
. O

Data O
from O
the O
V O
- O
HeFT _RARE_
II O
show O
that O
at _RARE_
2 O
- O
year O
follow O
- O
up _RARE_
, O
a O
progressive O
rise O
of O
plasma O
norepinephrine O
was O
observed O
in O
both O
treatment O
arms _RARE_
, O
suggesting O
that O
disease _RARE_
progresses _RARE_
despite O
treatment O
with O
either O
an O
angiotensin I-GENE
- I-GENE
converting _RARE_
enzyme I-GENE
inhibitor O
, O
enalapril _RARE_
, O
or O
vasodilator O
therapy O
with O
hydralazine _RARE_
/ O
isosorbide _RARE_
dinitrate _RARE_
. O

Binding O
activity O
in O
rat O
liver O
nuclear O
extracts O
includes O
these O
orphan O
receptors O
as _RARE_
judged O
from O
electromobility _RARE_
supershift O
experiments O
and O
from O
results O
obtained O
with O
expressed _RARE_
receptors O
, O
although O
the O
element O
in O
CYP2C11 _RARE_
did O
not O
bind O
HNF I-GENE
- I-GENE
4 I-GENE
. O

Transcript _RARE_
analysis O
reveals O
that O
lethal O
B I-GENE
block _RARE_
substitutions O
reduce O
U6 I-GENE
RNA I-GENE
synthesis _RARE_
at _RARE_
least O
10 O
- O
fold _RARE_
in O
vivo O
and O
20 O
- O
fold _RARE_
in O
vitro O
. O

Analysis O
of O
Bcl I-GENE
- I-GENE
2 I-GENE
/ O
Bcl I-GENE
- I-GENE
2 I-GENE
homodimerization _RARE_
using O
both O
in O
vitro O
binding O
assays O
as _RARE_
well _RARE_
as _RARE_
a O
yeast O
two O
- O
hybrid _RARE_
method O
provided O
evidence O
in O
support O
of O
a O
head O
- O
to O
- O
tail _RARE_
model O
for _RARE_
Bcl I-GENE
- I-GENE
2 I-GENE
/ O
Bcl I-GENE
- I-GENE
2 I-GENE
homodimerization _RARE_
and O
revealed O
that O
sequences O
within O
the O
NH2 O
- O
terminal O
A O
domain O
interact O
with O
a O
structure _RARE_
that O
requires O
the O
presence O
of O
both O
the O
carboxyl _RARE_
B O
and O
C O
domains O
in O
combination O
. O

The O
protein O
is O
composed O
of O
a O
central O
alpha O
- O
helical O
portion O
with O
globular O
domains O
at _RARE_
both O
NH2 O
and O
COOH _RARE_
termini O
, O
and O
the O
epitope _RARE_
to O
the O
monoclonal O
antibody O
resides O
in O
the O
central O
alpha O
- O
helical O
stalk _RARE_
. O

Radioligand _RARE_
binding O
was O
indistinguishable O
for _RARE_
both O
transiently O
expressed _RARE_
constructs O
. O

Diagnosis O
of O
FHCS _RARE_
has O
been O
weighed _RARE_
upon O
laparoscopic O
findings O
. O

Human I-GENE
papillomavirus _RARE_
type I-GENE
31b _RARE_
late _RARE_
gene I-GENE
expression _RARE_
is O
regulated O
through O
protein I-GENE
kinase I-GENE
C I-GENE
- O
mediated _RARE_
changes O
in O
RNA O
processing _RARE_
. O

Interestingly O
, O
virions O
also O
contained O
smaller O
proteins O
that O
reacted O
with O
antibodies O
specific O
for _RARE_
the O
accessory _RARE_
proteins O
as _RARE_
well _RARE_
as _RARE_
SN _RARE_
and O
CAT I-GENE
fusion I-GENE
partners O
. O

Studies O
using O
an O
inhibitor O
or O
a O
mutant I-GENE
Lb _RARE_
proteinase _RARE_
indicated O
that O
stimulation _RARE_
of O
IRES _RARE_
- O
driven _RARE_
translation O
is O
mediated _RARE_
via O
proteolysis O
of O
some O
cellular O
component _RARE_
( O
s O
). O

Restriction O
mapping O
analysis O
localized O
this O
cDNA O
to O
the O
HHV _RARE_
- I-GENE
6A _RARE_
( I-GENE
U1102 _RARE_
) I-GENE
genomic I-GENE
BamHI I-GENE
G I-GENE
fragment I-GENE
, O
at _RARE_
the O
right O
end O
of O
the O
unique O
long O
segment O
of O
the O
genome O
and O
to O
the O
SalI _RARE_
L I-GENE
and O
SalI _RARE_
O I-GENE
fragments I-GENE
within O
the O
left _RARE_
and O
right O
terminal O
direct O
repeat O
regions O
, O
respectively O
. O

For O
replication O
reporter O
constructs O
where O
E1 I-GENE
and O
E2 I-GENE
are O
supplied O
in O
trans _RARE_
by O
the O
respective O
expression _RARE_
vectors O
, O
distance O
between O
the O
half _RARE_
sites O
seems O
to O
play O
a O
major O
role O
, O
yet O
the O
phasing _RARE_
relationships O
are O
measurable _RARE_
. O

As O
it O
had O
been O
previously O
reported O
that O
the O
18 O
- O
bp O
palindrome O
contains O
sufficient O
nucleotide O
sequence O
information _RARE_
for _RARE_
E1 I-GENE
binding O
, O
we O
speculate _RARE_
that O
a O
minimal O
E1 I-GENE
recognition O
motif O
is O
presented O
in O
each O
half _RARE_
site O
. O

METHODS O
: O
Out _RARE_
of O
171 _RARE_
patients O
receiving O
anticoagulation _RARE_
between O
July _RARE_
1992 O
and O
December _RARE_
1993 O
, O
83 _RARE_
patients O
with O
hemispheric _RARE_
embolisms _RARE_
received O
heparin _RARE_
within O
72 O
hours O
from O
onset O
( O
activated O
partial O
thromboplastin I-GENE
time O
[ _RARE_
aPTT _RARE_
] O
1 O
. O
5 O
times O
control O
value O
). O

In O
the O
commercially _RARE_
available O
intravenous O
formulation O
of O
Cyclosporin _RARE_
A O
( O
Sandimmun _RARE_
), _RARE_
polyoxyethylated _RARE_
castor _RARE_
oil O
( O
Cremophor _RARE_
EL _RARE_
) O
is O
used O
as _RARE_
a O
solubilizing _RARE_
agent O
. O

Lung O
function O
tests O
( O
EFR _RARE_
) O
were O
performed O
on O
these O
patients O
for _RARE_
a O
period O
of O
19 O
. O
2 O
+/- O
3 O
. O
4 O
months O
. O

Sequence O
comparisons O
of O
prokaryotic _RARE_
RCR _RARE_
initiators _RARE_
has O
revealed O
a O
set O
of O
three O
common O
motifs O
, O
two O
of O
which O
, O
a O
putative O
metal O
coordination O
site O
and O
a O
downstream _RARE_
active _RARE_
- O
site O
tyrosine O
motif O
, O
could O
be O
tentatively O
identified O
in O
parvoviral _RARE_
replicator _RARE_
proteins I-GENE
. O

The O
mean O
marginal _RARE_
discrepancy _RARE_
of O
provisional _RARE_
restorations O
was O
compared O
for _RARE_
restorations O
fabricated _RARE_
from O
stone O
, O
low O
- O
viscosity O
poly _RARE_
( O
vinyl O
siloxane _RARE_
), _RARE_
and O
medium O
- O
viscosity O
poly _RARE_
( O
vinyl O
siloxane _RARE_
). O

The O
characterized O
Aplysia _RARE_
Afurin2 _RARE_
is O
a O
candidate O
PC I-GENE
that O
may O
play O
an O
important O
role O
in O
the O
processing _RARE_
of O
egg _RARE_
- I-GENE
laying _RARE_
hormone I-GENE
( O
ELH _RARE_
)- O
related O
precursors _RARE_
in O
the O
secretory _RARE_
cells O
of O
the O
atrial _RARE_
gland _RARE_
. O

Rats _RARE_
treated O
with O
8 O
- O
OH O
- O
DPAT _RARE_
were O
not O
impaired O
in O
their O
ability O
to O
learn _RARE_
a O
visual O
discrimination O
in O
a O
water O
maze _RARE_
. O

The O
term O
endovascular _RARE_
papillary _RARE_
haemangioma _RARE_
is O
suggested O
. O

In O
addition O
, O
two O
internal O
promoters O
, O
PmiaA _RARE_
and O
P1hfq _RARE_
were O
identified O
and O
mapped O
to O
201 _RARE_
and O
837 _RARE_
nucleotides O
upstream O
from O
the O
respective O
translation O
start _RARE_
sites O
. O

These O
results O
indicate O
that O
mutL _RARE_
, O
miaA _RARE_
, O
and O
hfq _RARE_
expression _RARE_
could O
be O
regulated O
by O
multiple O
mechanisms O
, O
including O
degree O
of O
cotranscription _RARE_
from O
upstream O
genes O
, O
modulation O
of O
internal O
promoter O
strength O
, O
and O
by O
RNase I-GENE
E I-GENE
activity O
. O

Coronary O
T1 _RARE_
and O
T2 _RARE_
weighted O
images O
were O
obtained O
. O

The O
2 O
kb O
of O
5 O
'- O
flanking O
region O
and O
the O
1 O
. O
1 O
kb O
of O
the O
entire _RARE_
sGTH _RARE_
alpha I-GENE
subunit I-GENE
coding O
region O
were O
sequenced O
from O
the O
genomic O
clone O
, O
sGTH _RARE_
alpha I-GENE
- I-GENE
G1 I-GENE
. O

Functional O
analysis O
of O
the O
sGTH _RARE_
alpha I-GENE
subunit I-GENE
promoter I-GENE
by O
the O
transient O
transfection O
of O
several O
sGTH _RARE_
alpha I-GENE
/ O
CAT I-GENE
chimeric O
plasmids O
into O
rainbow _RARE_
trout _RARE_
pituitary O
cells O
suggests O
that O
its O
pituitary O
- O
specific O
expression _RARE_
is O
GSE _RARE_
- O
dependent O
. O

Indium _RARE_
- O
111 O
OncoScint _RARE_
CR _RARE_
/ O
OV _RARE_
and O
F O
- O
18 O
FDG O
in O
colorectal _RARE_
and O
ovarian O
carcinoma O
recurrences _RARE_
. O

His _RARE_
carnitine _RARE_
palmitoyltransferase _RARE_
( I-GENE
CPT _RARE_
) I-GENE
I I-GENE
and I-GENE
II I-GENE
activities O
were O
0 _RARE_
. O
06 O
and O
0 _RARE_
. O
12 O
nmol O
/ O
min O
/ O
mg O
protein O
, O
as _RARE_
compared O
with O
a O
mean O
value O
of O
0 _RARE_
. O
22 _RARE_
+/- O
0 _RARE_
. O
14 O
and O
0 _RARE_
. O
27 _RARE_
+/- O
0 _RARE_
. O
07 O
nmol O
/ O
min O
/ O
mg O
protein O
, O
respectively O
, O
in O
control O
subjects O
. O

The O
Myc _RARE_
LZ _RARE_
was O
found O
to O
prevent O
homodimeric _RARE_
interactions O
, O
thus O
explaining _RARE_
Myc _RARE_
inability _RARE_
to O
homodimerize _RARE_
efficiently O
. O

Staphylococcus _RARE_
aureus _RARE_
and O
CNS O
showed O
high O
or O
moderate O
resistance O
rates O
to O
methicillin _RARE_
( O
DMPPC _RARE_
). O

Thus O
, O
VF O
resistant O
to O
defibrillation _RARE_
is O
not O
necessarily O
associated O
with O
both O
toxic O
plasma O
drug O
level O
and O
remarkably O
decreased O
conduction O
. O

The O
smallest O
active _RARE_
FecR _RARE_
derivative _RARE_
contained O
59 _RARE_
amino O
acid O
residues O
as _RARE_
compared O
to O
the O
317 _RARE_
residues O
of O
wild I-GENE
- I-GENE
type I-GENE
FecR _RARE_
. O

The O
gene O
pairs _RARE_
psbB _RARE_
- O
psbT _RARE_
and O
psbH _RARE_
- O
psbN _RARE_
are O
cotranscribed O
from O
opposite O
strands _RARE_
. O

Hybridization O
signals O
were O
also O
detected O
with O
total _RARE_
DNAs _RARE_
of O
Rhizobium _RARE_
leguminosarum _RARE_
bv _RARE_
. O
phaseoli _RARE_
, O
Rhodobacter _RARE_
capsulatus _RARE_
and O
Escherichia O
coli O
, O
but O
not O
those O
of O
Xanthomonas _RARE_
campestris _RARE_
pv _RARE_
. O
campestris _RARE_
and O
Pseudomonas _RARE_
putida _RARE_
. O

The O
predicted O
amino O
acid O
sequence O
contains O
regions O
identical O
to O
the O
sequences O
of O
peptides O
derived O
from O
bovine I-GENE
liver I-GENE
eIF I-GENE
- I-GENE
2B _RARE_
alpha I-GENE
subunit I-GENE
. O

Expression O
of O
this O
cDNA O
in O
vitro O
yields O
a O
peptide O
which O
comigrates _RARE_
with O
natural _RARE_
eIF I-GENE
- I-GENE
2B _RARE_
alpha I-GENE
in O
SDS O
/ O
polyacrylamide O
gels O
. O

When O
RNA O
encoding O
the O
tail _RARE_
domain O
of O
desmoglein _RARE_
was O
coinjected _RARE_
with O
plakoglobin I-GENE
RNA I-GENE
, O
both O
the O
dorsalizing _RARE_
effect O
and O
nuclear O
accumulation O
of O
plakoglobin I-GENE
were O
suppressed O
. O

Six O
of O
them O
, O
NUC1 _RARE_
, O
PRP21 _RARE_
( O
also O
called O
SPP91 _RARE_
), _RARE_
CDC6 _RARE_
, O
CRY2 _RARE_
, O
the O
gene O
encoding O
the O
ribosomal I-GENE
protein I-GENE
S24 _RARE_
and O
the O
gene O
coding O
for _RARE_
a O
hypothetical _RARE_
protein O
of O
599 _RARE_
amino O
acids _RARE_
, O
have O
been O
sequenced O
previously O
. O

Intrastriatal _RARE_
grafts O
of O
nigral _RARE_
and O
adrenal O
tissues O
have O
been O
found O
to O
be O
effective O
in O
alleviating _RARE_
many O
of O
the O
simple O
motor O
and O
sensorimotor _RARE_
deficits O
associated O
with O
lesions O
of O
the O
nigrostriatal _RARE_
dopamine O
system _RARE_
. O

OBJECTIVE O
: O
To O
determine O
the O
impact O
of O
the O
introduction O
of O
clarithromycin _RARE_
and O
azithromycin _RARE_
on O
the O
treatment O
and O
survival O
of O
patients O
with O
AIDS O
and O
disseminated _RARE_
Mycobacterium O
avium _RARE_
complex O
( O
DMAC _RARE_
). O

Thereafter _RARE_
, O
the O
aggregation _RARE_
rose O
to O
the O
initial O
100 _RARE_
% O
value O
4 O
h O
after O
drug O
application O
and O
remained O
at _RARE_
this O
level O
during _RARE_
the O
observation O
period O
.( O
ABSTRACT O
TRUNCATED O
AT O
250 _RARE_
WORDS O
) O

Growth _RARE_
curves O
indicated O
that O
proliferation _RARE_
of O
clone O
CA9 _RARE_
in O
the O
presence O
of O
10 O
% O
serum O
was O
reduced _RARE_
by O
60 _RARE_
% O
compared O
with O
clone O
ME10 _RARE_
. O

The O
protein O
coding O
region O
, O
1 O
, O
696 _RARE_
bps _RARE_
long O
, O
is O
divided O
by O
an O
intron O
into O
two O
exons O
. O

The O
UAS O
of O
the O
AAC2 _RARE_
gene I-GENE
contains O
at _RARE_
least O
two O
distinct O
motifs O
for _RARE_
DNA O
- O
binding O
transcriptional O
activators _RARE_
, O
including O
one O
which O
is O
identical O
with O
the O
core O
HAP2 _RARE_
/ I-GENE
3 I-GENE
/ I-GENE
4 I-GENE
binding I-GENE
motif I-GENE
, O
and O
a O
second O
one O
with O
the O
ABF1 _RARE_
consensus I-GENE
binding I-GENE
sequence I-GENE
. O

The O
emerging _RARE_
complexity O
of O
the O
5 O
' O
regulatory O
region O
of O
the O
GH _RARE_
receptor I-GENE
gene I-GENE
was O
emphasised _RARE_
by O
the O
observation O
that O
probes _RARE_
derived O
from O
exon _RARE_
1B _RARE_
and O
the O
distal O
3 O
' O
intron O
boundary O
do O
not O
hybridise _RARE_
with O
previously O
cloned _RARE_
genomic O
sequences O
that O
span O
the O
liver O
- O
specific O
P1 O
promoter O
and O
exon _RARE_
2 O
. O

A O
polymorphic O
dinucleotide O
( O
GT _RARE_
/ O
CA O
) O
n _RARE_
repeat O
contained O
in O
the O
NHE5 _RARE_
cosmid O
was O
identified O
and O
developed O
into O
a O
microsatellite _RARE_
PCR O
marker O
. O

The O
proteins O
are O
more O
than O
90 _RARE_
% O
identical O
to O
each O
other O
within O
the O
protein O
kinase O
domain O
but O
only O
51 _RARE_
- O
59 _RARE_
% O
identical O
to O
other O
casein I-GENE
kinase I-GENE
I I-GENE
isoforms I-GENE
within O
this O
region O
. O

We O
used O
two O
approaches O
to O
ascertain _RARE_
whether O
CDP I-GENE
/ O
cut I-GENE
serves O
as _RARE_
a O
repressor O
of O
gp91 _RARE_
- O
phox _RARE_
gene O
expression _RARE_
. O

Serum O
induction O
of O
a O
MEF2 I-GENE
reporter I-GENE
gene I-GENE
was O
not O
observed O
in O
a O
line O
of O
NIH _RARE_
3T3 O
cells O
which O
contain O
low O
MEF2 I-GENE
site I-GENE
binding O
activity O
. O

Despite O
the O
activation O
of O
these O
intracellular _RARE_
signaling _RARE_
molecules O
, O
PDGF _RARE_
beta I-GENE
receptor I-GENE
activation O
elicited O
no _RARE_
detectable O
effect O
on O
cell O
proliferation _RARE_
or O
differentiation O
. O

UAS1 O
is O
the O
binding O
site O
for _RARE_
the O
transcriptional O
regulator O
Adr1p _RARE_
. O

In O
the O
context O
of O
the O
ADH2 _RARE_
upstream I-GENE
regulatory I-GENE
region I-GENE
, O
including O
UAS1 O
, O
working O
in O
concert _RARE_
with O
the O
ADH2 _RARE_
basal I-GENE
promoter I-GENE
elements I-GENE
, O
UAS2 _RARE_
- O
dependent O
gene O
activation O
was O
dependent O
on O
orientation O
, O
copy O
number O
, O
and O
helix O
phase _RARE_
. O

Induction O
in O
AP I-GENE
- I-GENE
1 I-GENE
DNA O
binding O
correlates O
with O
a O
concomitant O
GH _RARE_
trans _RARE_
- O
activation O
of O
c I-GENE
- I-GENE
jun I-GENE
and O
c I-GENE
- I-GENE
fos I-GENE
genes I-GENE
described O
previously O
. O

Inactivation _RARE_
of O
MAP I-GENE
kinases I-GENE
occurs O
via O
a O
specific O
phosphatase O
, O
MKP I-GENE
- I-GENE
1 I-GENE
. O

Short O
- O
course O
amphotericin O
B O
therapy O
for _RARE_
candidemia _RARE_
in O
pediatric O
patients O
. O

Furthermore O
, O
45Ca _RARE_
- O
binding O
assays O
revealed O
that O
CCaMK _RARE_
directly O
binds O
Ca2 _RARE_
+. _RARE_

Since O
AP I-GENE
- I-GENE
1 I-GENE
is O
an O
important O
mediator _RARE_
of O
tumor O
promoter O
action O
, O
these O
findings O
may O
explain O
the O
anti O
- O
tumor O
- O
promoting _RARE_
activity O
of O
phenolic _RARE_
antioxidants _RARE_
. O

The O
second O
complex O
, O
when O
purified _RARE_
, O
contained O
four O
protein O
components _RARE_
including O
the O
36 _RARE_
- O
kDa O
protein O
. O

The O
protein O
expressed _RARE_
from O
the O
cloned _RARE_
cDNA O
is O
secreted _RARE_
into O
the O
culture O
medium O
and O
yields O
of O
up _RARE_
to O
40 O
mg O
per O
litre _RARE_
have O
been O
obtained O
. O

The O
study O
was O
repeated _RARE_
after O
administration O
of O
oral O
amiodarone _RARE_
, O
50 O
mg O
/ O
kg O
/ O
day O
for _RARE_
2 O
days O
in O
8 O
divided O
doses O
( O
mean O
dose O
6 O
. O
9 O
+/- O
0 _RARE_
. O
4 O
g O
). O

Plasmids _RARE_
pAMS12 _RARE_
, O
pAMS13 _RARE_
and O
pAMS14 _RARE_
were O
transformed O
into O
a O
laboratory O
strain _RARE_
of O
Saccharomyces O
cerevisiae O
, O
whereas O
pAMS15 _RARE_
was O
stably O
introduced O
into O
two O
commercial O
wine _RARE_
yeast O
strains O
. O

The O
maximum O
induction O
of O
ACC _RARE_
- I-GENE
oxidase I-GENE
transcripts I-GENE
occurred O
at _RARE_
about O
6 O
h O
after O
excision _RARE_
, O
while O
the O
maximum O
enzyme O
activity O
was O
observed O
at _RARE_
24 _RARE_
h O
. O

Within O
their O
polypeptide O
chain O
, O
they O
all O
contain O
those O
conserved _RARE_
features O
that O
define O
a O
plant _RARE_
CDPK _RARE_
; O
kinase O
catalytic O
sequences O
are O
linked _RARE_
to O
a O
calmodulin I-GENE
- I-GENE
like I-GENE
regulatory I-GENE
domain I-GENE
through O
a O
junction _RARE_
region O
. O

Repair _RARE_
of O
this O
insertion _RARE_
by O
homologous O
recombination _RARE_
restores O
the O
activity O
of O
the O
hprt _RARE_
locus I-GENE
, O
thus O
confirming O
the O
site O
of O
mutation O
. O

The O
timing O
of O
fla _RARE_
gene I-GENE
expression _RARE_
in O
the O
cell O
cycle _RARE_
is O
determined O
by O
specialized O
forms O
of O
RNA I-GENE
polymerase I-GENE
and O
the O
appearance O
and O
/ O
or O
activation O
of O
regulatory O
proteins O
. O

Primer O
extension O
experiments O
revealed O
a O
strong O
transcription O
initiation O
site O
102 _RARE_
bp O
upstream O
of O
the O
translational O
start _RARE_
site O
. O

Polypeptides _RARE_
of O
the O
same O
apparent O
sizes O
are O
detected O
in O
spores _RARE_
of O
a O
cotE _RARE_
null _RARE_
mutant O
, O
on O
which O
basis O
we O
infer _RARE_
that O
the O
products O
of O
the O
cotJ _RARE_
operon I-GENE
are O
required O
for _RARE_
the O
normal O
formation O
of O
the O
inner O
layers _RARE_
of O
the O
coat O
or O
are O
themselves O
structural O
components _RARE_
of O
the O
coat O
. O

Based O
on O
the O
estimated O
values O
of O
divergence O
of O
apobec1 _RARE_
sequences I-GENE
in O
terms O
of O
the O
numbers O
of O
synonymous _RARE_
and O
non O
- O
synonymous _RARE_
suhstitutions _RARE_
per O
site O
, O
we O
found O
that O
apobec1 _RARE_
is O
a O
fairly _RARE_
rapidly O
evolving _RARE_
protein O
. O

EEA1 _RARE_
is O
a O
conserved _RARE_
alpha O
- O
helical O
peripheral O
membrane O
protein O
flanked O
by O
cysteine O
" O
fingers _RARE_
" O
and O
contains O
a O
calmodulin I-GENE
- I-GENE
binding I-GENE
IQ _RARE_
motif I-GENE
. O

Nucleotide O
sequences O
of O
the O
clones _RARE_
revealed O
that O
one O
clone O
, O
cap3 _RARE_
, O
contained O
an O
open _RARE_
reading O
frame O
( O
ORF O
) O
that O
would O
code O
for _RARE_
a O
26 _RARE_
- O
amino O
acid O
, O
cysteine O
- O
rich O
peptide O
with O
significant O
homology O
to O
Neurospora I-GENE
crassa I-GENE
copper _RARE_
metallothionein _RARE_
. O

Sensing _RARE_
with O
chemically _RARE_
and O
biologically O
modified O
carbon O
electrodes O
. O

Elevation _RARE_
of O
the O
tissues O
of O
the O
face O
is O
essentially O
vertical O
and O
acts O
on O
the O
forehead _RARE_
, O
temporal O
region O
, O
gaze _RARE_
and O
cheekbones _RARE_
. O

This O
region O
binds O
two O
ubiquitous O
nuclear O
factors O
, O
USF I-GENE
/ O
MLTF _RARE_
and O
the O
CAAT I-GENE
- I-GENE
binding I-GENE
transcription I-GENE
factor I-GENE
/ O
nuclear I-GENE
factor I-GENE
1 I-GENE
( O
CTF _RARE_
/ O
NF1 I-GENE
). O

The O
potential _RARE_
impact O
of O
using O
a O
rapid O
diagnostic O
test O
( O
Strep _RARE_
A O
OIA _RARE_
) O
on O
detection O
and O
treatment O
of O
group O
A O
beta O
- O
hemolytic _RARE_
streptococcal _RARE_
( O
GABHS _RARE_
) O
pharyngitis _RARE_
in O
a O
large O
- O
volume O
pediatric O
and O
adolescent O
clinic _RARE_
was O
examined O
. O

The O
bHLH I-GENE
proteins I-GENE
function O
as _RARE_
potent O
transcriptional O
activators _RARE_
of O
tissue O
- O
specific O
genes O
by O
forming O
heterodimers _RARE_
between O
ubiquitous O
and O
cell O
- O
restricted O
family O
members O
. O

YAC O
and O
cosmid O
contigs _RARE_
spanning O
the O
BRCA1 I-GENE
region I-GENE
were O
used O
to O
select O
cDNA O
clones _RARE_
from O
pools _RARE_
of O
cDNAs O
derived O
from O
human O
placenta O
, O
HeLa O
cells O
, O
activated O
T O
cells O
, O
and O
fetal _RARE_
head O
. O

The O
other O
two O
clones _RARE_
, O
Ash _RARE_
- I-GENE
m I-GENE
and I-GENE
- I-GENE
s I-GENE
, O
had O
nucleotide O
sequences O
identical O
with O
Ash _RARE_
- I-GENE
l _RARE_
cDNA O
in O
the O
amino O
- O
terminal O
region O
. O

This O
study O
assesses _RARE_
the O
feasibility O
and O
toxicity O
of O
adoptive _RARE_
immunotherapy O
with O
tumor O
infiltrating _RARE_
lymphocytes O
and O
recombinant I-GENE
interleukin I-GENE
- I-GENE
2 I-GENE
in O
29 O
patients O
who O
underwent O
resection O
for _RARE_
stage _RARE_
III O
non O
- O
small O
- O
cell O
lung _RARE_
cancer _RARE_
. O

MATERIAL _RARE_
AND _RARE_
METHODS O
: O
Of O
the O
17 _RARE_
men O
and O
17 _RARE_
women O
, O
who O
were O
21 O
to O
80 _RARE_
years O
of O
age O
, O
27 _RARE_
had O
hereditary _RARE_
motor O
and O
sensory O
neuropathy _RARE_
type O
I O
and O
7 O
had O
acquired O
demyelinating _RARE_
polyneuropathy _RARE_
. O

The O
present O
study O
describes O
the O
cell O
volume O
dynamics O
in O
intact _RARE_
rat O
hearts O
, O
during _RARE_
ischemia O
and O
after O
reperfusion O
. O

In O
contrast O
, O
COUP I-GENE
- I-GENE
TF _RARE_
alone O
had O
no _RARE_
effect O
on O
repCRS2 _RARE_
- O
dependent O
reporter O
gene O
activity O
. O

DNA O
sequencing O
and O
Southern O
blot O
analyses O
established O
that O
the O
cDNA O
clones _RARE_
are O
derived O
from O
two O
different O
genes O
. O

Muscle _RARE_
GSH _RARE_
- I-GENE
Px _RARE_
activity O
after O
prolonged O
exercise O
, O
training O
, O
and O
selenium O
supplementation O
. O

Mutation O
of O
the O
Sp1 _RARE_
element I-GENE
, O
which O
abolishes O
Sp1 _RARE_
binding O
, O
results O
in O
a O
6 O
- O
10 O
- O
fold _RARE_
reduction O
in O
reporter O
activity O
. O

The O
c I-GENE
- I-GENE
myc I-GENE
gene I-GENE
is O
overexpressed O
in O
a O
variety O
of O
tumor O
types _RARE_
and O
appears O
to O
play O
an O
important O
role O
in O
the O
abnormal O
growth O
of O
a O
number O
of O
cell O
types _RARE_
. O

We O
found O
that O
PML _RARE_
was O
expressed _RARE_
at _RARE_
a O
lower O
level O
in O
S O
, O
G2 _RARE_
, O
and O
M O
phases O
and O
at _RARE_
a O
significantly O
higher _RARE_
level O
in O
G1 O
phase _RARE_
. O

Schooling _RARE_
is O
found O
to O
be O
related O
to O
good O
health O
even O
after O
controlling O
for _RARE_
differences O
in O
observable _RARE_
health O
inputs O
. O

With O
this O
bisected _RARE_
diastolic O
driving _RARE_
, O
the O
abnormal O
echo O
disappeared O
completely O
. O

It O
acts O
on O
Cdks _RARE_
in O
the O
G1 O
and O
S O
phases O
of O
the O
cell O
cycle _RARE_
, O
and O
also O
binds O
to O
proliferating _RARE_
cell I-GENE
nuclear I-GENE
antigen I-GENE
( O
PCNA I-GENE
), _RARE_
blocking O
DNA O
replication O
in O
vitro O
. O

Two O
major O
and O
one O
minor O
transcription O
initiation O
sites O
were O
assigned O
to O
positions O
+ O
1 O
and O
+ O
24 _RARE_
and O
position O
+ O
14 O
, O
respectively O
, O
by O
a O
combination O
of O
ribonuclease _RARE_
protection O
, O
primer O
extension O
, O
and O
5 O
' O
RACE O
analyses O
. O

The O
roxithromycin _RARE_
doses O
that O
were O
chosen O
for _RARE_
these O
studies O
were O
less O
than O
achievable _RARE_
blood _RARE_
levels O
. O

We O
demonstrate O
here O
that O
the O
- O
DEDDDL _RARE_
sequence O
stabilizes O
GDP O
binding O
to O
Ran I-GENE
, O
and O
that O
the O
domain O
is O
required O
for _RARE_
high O
affinity O
interaction O
with O
a O
Ran I-GENE
- I-GENE
binding I-GENE
protein I-GENE
, O
HTF9A _RARE_
/ O
RanBP1 _RARE_
. O

Further O
, O
the O
ORFs _RARE_
of O
components _RARE_
3 O
and O
5 O
potentially O
encoded O
proteins O
of O
about O
20 O
kDa O
, O
the O
size O
of O
the O
BBTV _RARE_
coat I-GENE
protein I-GENE
. O

Serial _RARE_
followup _RARE_
strength O
data O
for _RARE_
2 O
patients O
were O
compared O
to O
change O
in O
creatinine _RARE_
kinase I-GENE
( O
CK _RARE_
) O
levels O
. O

CodY _RARE_
does O
not O
have O
any O
homologues _RARE_
in O
the O
data O
- O
bases O
. O

OBJECTIVE O
: O
To O
investigate O
the O
incidence O
and O
presentation O
of O
acute O
pernicious _RARE_
or O
fulminating _RARE_
beriberi _RARE_
in O
a O
general _RARE_
district _RARE_
hospital O
. O

Unlike O
most O
other O
small I-GENE
G I-GENE
proteins I-GENE
which O
are O
expressed _RARE_
ubiquitously O
, O
TTF I-GENE
was O
transcribed _RARE_
only O
in O
hemopoietic _RARE_
cells O
as _RARE_
a O
2 O
. O
2 O
kb O
transcript O
. O

An O
explanation O
explored O
for _RARE_
this O
lack O
of O
gene O
expression _RARE_
was O
that O
increased O
levels O
of O
RAR I-GENE
alpha I-GENE
or O
PML _RARE_
might O
suppress O
APL _RARE_
cell O
growth O
. O

Transfection O
of O
non O
- O
deleted _RARE_
expression _RARE_
vector O
into O
NIH3T3 O
cells O
results O
in O
acquisition O
of O
focus O
- O
forming O
activity O
while O
a O
deleted _RARE_
form O
of O
expression _RARE_
vector O
fails O
to O
show O
this O
activity O
even O
in O
the O
presence O
of O
basic I-GENE
FGF I-GENE
. O

Cytosolic _RARE_
extracts O
from O
a O
variety O
of O
mammalian O
cell O
lines O
( O
monkey _RARE_
Cos7 _RARE_
, O
several O
mouse O
fibrosarcomas _RARE_
and O
human O
HeLa O
S3 _RARE_
) O
demonstrated O
similar O
TGF I-GENE
- I-GENE
beta I-GENE
1 I-GENE
dependent O
RNA O
- O
protein O
band O
shifts O
as _RARE_
cell O
extract _RARE_
from O
BALB _RARE_
/ O
c O
3T3 O
mouse O
fibroblasts _RARE_
. O

All O
ribosomal I-GENE
protein I-GENE
( O
rp _RARE_
) O
gene O
promoters O
from O
Saccharomyces O
cerevisiae O
studied O
so O
far O
contain O
either O
( O
usually O
two O
) O
binding O
sites O
for _RARE_
the O
global O
gene O
regulator O
Rap1p _RARE_
or O
one O
binding O
site O
for _RARE_
another O
global O
factor O
, O
Abf1p _RARE_
. O

The O
provisional _RARE_
reports O
are O
based O
mainly O
upon O
macroscopic _RARE_
findings O
, O
whereas O
the O
final O
reports O
include O
the O
information _RARE_
provided O
by O
supplementary O
investigations O
such O
as _RARE_
microscopy O
, O
histochemistry _RARE_
, O
more O
rarely O
electron O
microscopy O
, O
immunohistochemistry _RARE_
and O
/ O
or O
microbiology _RARE_
. O

Circulating _RARE_
thrombomodulin _RARE_
: O
current O
knowledge O
and O
future O
prospects _RARE_

CPT _RARE_
- O
11 O
was O
administered O
as _RARE_
a O
30 _RARE_
- O
minute O
i O
. O
v O
. O
infusion O
at _RARE_
a O
dose O
of O
350 O
mg O
/ O
m2 O
diluted _RARE_
in O
250 _RARE_
ml O
normal O
saline O
every O
3 O
weeks O
. O

CONCLUSION O
: O
The O
MTD _RARE_
for _RARE_
CPT _RARE_
- O
11 O
administered O
in O
a O
3 O
consecutive O
- O
days O
- O
every O
- O
3 O
weeks O
schedule O
in O
this O
patient O
population O
is O
115 _RARE_
mg O
/ O
m2 O
/ O
day O
. O

A O
73 _RARE_
bp O
fragment O
( O
X1 _RARE_
region O
) O
of O
the O
PRB _RARE_
- I-GENE
1b _RARE_
promoter I-GENE
, O
located _RARE_
between O
positions O
- O
213 _RARE_
and O
- O
141 _RARE_
, O
was O
sufficient O
to O
confer O
ethylene O
responsiveness O
to O
the O
reporter O
gene O
. O

To O
assess O
the O
function O
( O
s O
) O
of O
E74 _RARE_
during _RARE_
metamorphosis _RARE_
, O
we O
have O
isolated O
and O
characterized O
recessive O
loss _RARE_
- O
of O
- O
function O
mutations O
specific O
to O
each O
transcription O
unit O
. O

Although O
the O
extracellular O
domain O
of O
the O
TSH _RARE_
- I-GENE
R I-GENE
is O
sufficient O
for _RARE_
high O
affinity O
binding O
of O
TSH _RARE_
, O
we O
conclude O
that O
the O
hyt _RARE_
mutation O
in O
the O
fourth O
transmembrane O
domain O
eliminates _RARE_
TSH _RARE_
binding O
. O

Lipiodol _RARE_
was O
covalently O
conjugated O
with O
EDTB _RARE_
. O

Moreover O
, O
Western O
blots O
demonstrated O
at _RARE_
least O
six _RARE_
types _RARE_
of O
Ypt _RARE_
in O
both O
Cr _RARE_
and O
Vc _RARE_
, O
suggesting O
that O
these O
Ypt _RARE_
are O
used O
for _RARE_
household _RARE_
functions O
responsible O
for _RARE_
vesicle O
transport _RARE_
rather O
than O
for _RARE_
cellular O
differentiation O
. O

The O
absence O
of O
other O
regions O
of O
hybridization O
suggests O
that O
there O
are O
no _RARE_
closely O
related O
sequences O
( O
e _RARE_
. O
g O
., O
reverse O
transcribed _RARE_
pseudogenes _RARE_
) O
scattered _RARE_
throughout O
the O
genome O
and O
that O
if O
there O
are O
closely O
related O
genes O
, O
they O
must O
be O
clustered O
near O
GSTT2 _RARE_
. O

However O
, O
the O
lens O
dose O
( O
3 O
. O
6 O
Gy O
/ O
25 _RARE_
fractions O
) O
was O
higher _RARE_
compared O
to O
the O
other O
techniques O
. O

Antibodies O
to O
the O
human I-GENE
PTS1R _RARE_
recognize O
this O
protein O
in O
human O
, O
monkey _RARE_
, O
rat O
, O
and O
hamster O
cells O
. O

There O
is O
a O
national O
effort O
to O
begin O
to O
ask _RARE_
all O
female O
patients O
about O
family O
violence _RARE_
. O

GnRH I-GENE
treatment O
was O
found O
to O
increase O
the O
phosphorylation _RARE_
of O
tyrosine O
residues O
of O
MAPK _RARE_
and O
to O
increase O
MAPK _RARE_
activity O
, O
as _RARE_
determined O
by O
an O
immune O
complex O
kinase O
assay O
. O

Molecular O
cloning O
of O
an O
amphibian _RARE_
insulin I-GENE
receptor I-GENE
substrate I-GENE
1 I-GENE
- I-GENE
like I-GENE
cDNA I-GENE
and O
involvement O
of O
phosphatidylinositol _RARE_
3 I-GENE
- I-GENE
kinase I-GENE
in O
insulin I-GENE
- O
induced _RARE_
Xenopus O
oocyte _RARE_
maturation _RARE_
. O

We O
report O
here O
that O
in O
cultured O
Jurkat O
T O
cells O
, O
Cbl I-GENE
is O
coprecipitated _RARE_
with O
antibody O
against O
the O
adapter _RARE_
protein I-GENE
Grb2 I-GENE
. O

The O
effect O
of O
these O
cell O
cycle _RARE_
regulators _RARE_
is O
not O
specific O
to O
the O
rap1s _RARE_
or O
hmr _RARE_
delta I-GENE
A I-GENE
mutation I-GENE
, O
since O
swi6 _RARE_
, O
swi4 _RARE_
, O
and O
clb5 _RARE_
mutations I-GENE
also O
suppress O
mutations O
in O
SIR1 _RARE_
, O
another O
gene O
implicated O
in O
the O
establishment O
of O
silencing O
. O

ICP4 I-GENE
has O
been O
shown O
to O
form O
tripartite _RARE_
complexes O
cooperatively _RARE_
with O
the O
TATA I-GENE
box I-GENE
- I-GENE
binding I-GENE
protein I-GENE
and O
TFIIB _RARE_
on O
DNA O
containing O
an O
ICP4 I-GENE
binding I-GENE
site I-GENE
and O
a O
TATA O
box O
( O
C O
. O

Otte _RARE_
, O
Mol _RARE_
. O

Characterization O
of O
fus1 _RARE_
of O
Schizosaccharomyces O
pombe O
: O
a O
developmentally O
controlled _RARE_
function O
needed O
for _RARE_
conjugation O
. O

SRY _RARE_
- I-GENE
related I-GENE
cDNA I-GENE
encoding O
a O
protein O
with O
a O
high I-GENE
- I-GENE
mobility I-GENE
- I-GENE
group I-GENE
( O
HMG I-GENE
) O
box O
and O
a O
leucine O
zipper O
motif O
, O
which O
was O
designated O
SOX _RARE_
- I-GENE
LZ _RARE_
, O
was O
isolated O
from O
a O
rainbow _RARE_
trout _RARE_
testis _RARE_
cDNA O
library O
. O

Scalp _RARE_
flaps _RARE_
can O
be O
expanded _RARE_
just O
to O
the O
point O
of O
becoming _RARE_
noticeable _RARE_
over O
4 O
to O
6 O
weeks O
followed O
by O
scalp _RARE_
flap O
transposition _RARE_
and O
easy _RARE_
closure O
of O
the O
donor O
site O
. O

In O
the O
Center _RARE_
for _RARE_
Human O
Genetics _RARE_
in O
Leuven _RARE_
, O
predictive O
DNA O
- O
testing O
for _RARE_
Huntington _RARE_
' O
s O
disease _RARE_
is O
available O
as _RARE_
a O
clinical O
service _RARE_
since O
November _RARE_
1987 O
, O
initially O
by O
DNA O
- O
linkage O
and O
since O
mid O
1993 O
by O
direct O
mutation O
analysis O
. O

Risks _RARE_
of O
chronicity _RARE_
following O
acute O
hepatitis O
B O
virus O
infection O
: O
a O
review O
. O

Examination O
of O
neurohumoral _RARE_
factors O
revealed O
a O
hyperactive _RARE_
sympathetic O
nervous O
system _RARE_
and O
an O
increase O
in O
plasma O
renin I-GENE
activity O
. O

We O
compared O
the O
inhibitory _RARE_
effect O
of O
naturally O
occurring O
mutant I-GENE
hTR _RARE_
beta I-GENE
1 I-GENE
, O
artificially O
created O
hTR _RARE_
alpha I-GENE
1 I-GENE
mutants I-GENE
, O
c I-GENE
- I-GENE
erbA I-GENE
alpha I-GENE
2 I-GENE
and O
the O
human I-GENE
peroxisome _RARE_
proliferator _RARE_
- I-GENE
activated I-GENE
receptor I-GENE
( O
hPPAR _RARE_
) O
on O
three O
prototypic _RARE_
T3 _RARE_
- O
response O
elements O
( O
TREs _RARE_
), _RARE_
TRE _RARE_
- O
PAL _RARE_
, O
DR _RARE_
+ O
4 O
and O
TRE _RARE_
- O
LAP _RARE_
. O

The O
amino O
- O
terminal O
DNA O
- O
binding O
domain O
of O
Pip _RARE_
exhibits O
a O
high O
degree O
of O
homology O
to O
the O
DNA O
- O
binding O
domains O
of O
members O
of O
the O
interferon _RARE_
regulatory I-GENE
factor I-GENE
( O
IRF I-GENE
) O
family O
, O
which O
includes O
IRF I-GENE
- I-GENE
1 I-GENE
, O
IRF I-GENE
- I-GENE
2 I-GENE
, O
ICSBP _RARE_
, O
and O
ISGF3 _RARE_
gamma I-GENE
. O

An O
outbreak O
of O
hepatitis O
A O
among O
homosexual _RARE_
men O
in O
Amsterdam _RARE_
, O
1991 O
- O
1993 O
. O

The O
RAP74 _RARE_
subunit I-GENE
of O
TFIIF _RARE_
alone O
contained O
the O
stimulatory _RARE_
activity O
and O
the O
minimal O
region O
sufficient O
for _RARE_
stimulation _RARE_
corresponds O
to O
COOH _RARE_
- O
terminal O
residues O
358 _RARE_
- O
517 _RARE_
. O

We O
have O
generated O
various O
base _RARE_
substitutions O
and O
internal O
deletions O
in O
and O
around O
DRE _RARE_
( O
nucleotide O
positions O
- O
93 O
to O
- O
100 _RARE_
with O
respect O
to O
the O
transcription O
initiation O
site O
) O
of O
the O
PCNA I-GENE
gene I-GENE
in O
vitro O
and O
subsequently O
examined O
their O
effects O
on O
the O
binding O
to O
DREF _RARE_
( O
DRE _RARE_
- I-GENE
binding I-GENE
factor I-GENE
) O
and O
PCNA I-GENE
gene I-GENE
promote O
activity O
in O
cultured O
Drosophila O
Kc _RARE_
cells O
as _RARE_
well _RARE_
as _RARE_
in O
living O
flies _RARE_
. O

The O
hsp70 I-GENE
gene I-GENE
family I-GENE
of O
Neurospora O
crassa O
: O
cloning O
, O
sequence O
analysis O
, O
expression _RARE_
, O
and O
genetic O
mapping O
of O
the O
major O
stress O
- O
inducible O
member _RARE_
. O

The O
deduced O
amino O
acid O
sequences O
of O
each O
of O
the O
W3A1 _RARE_
ETF _RARE_
subunits I-GENE
exhibit O
only O
approximately _RARE_
30 _RARE_
% O
identity O
with O
the O
corresponding O
subunits O
of O
the O
ETF _RARE_
from O
human O
, O
rat O
, O
and O
Paracoccus _RARE_
denitrificans _RARE_
, O
which O
as _RARE_
a O
group O
are O
greater O
than O
50 O
% O
identical O
. O

A O
secondary O
phosphorylation _RARE_
of O
CREB341 _RARE_
at _RARE_
Ser129 _RARE_
is O
required O
for _RARE_
the O
cAMP O
- O
mediated _RARE_
control O
of O
gene O
expression _RARE_
. O

A O
role O
for _RARE_
glycogen _RARE_
synthase I-GENE
kinase I-GENE
- I-GENE
3 I-GENE
in O
the O
control O
of O
gene O
expression _RARE_
. O

This O
last O
region O
contains O
two O
sites O
that O
bind O
Ets I-GENE
- I-GENE
related I-GENE
proteins I-GENE
present O
in O
liver O
nuclear O
extracts O
as _RARE_
well _RARE_
as _RARE_
recombinant I-GENE
purified _RARE_
Ets I-GENE
- I-GENE
1 I-GENE
protein I-GENE
. O

Other O
assays O
also O
distinguished O
the O
processive _RARE_
replication O
of O
pNeo _RARE_
. O
Myc _RARE_
- O
2 O
. O
4 O
from O
the O
dispersive _RARE_
labeling O
of O
control O
plasmids O
. O

Reconstitution _RARE_
of O
complexes O
containing O
p62 I-GENE
and O
the O
src I-GENE
family I-GENE
kinase I-GENE
p59fyn _RARE_
in O
HeLa O
cells O
demonstrated O
that O
complex O
formation O
resulted O
in O
tyrosine O
phosphorylation _RARE_
of O
p62 I-GENE
and O
was O
mediated _RARE_
by O
both O
the O
SH3 I-GENE
and O
SH2 _RARE_
domains I-GENE
of O
p59fyn _RARE_
. O

Therefore O
, O
it O
is O
hoped _RARE_
that O
by O
defining _RARE_
the O
transcriptional O
control O
of O
the O
L7 _RARE_
gene I-GENE
insights _RARE_
into O
the O
mechanisms O
that O
control O
functional _RARE_
fate O
and O
organization O
in O
the O
nervous O
system _RARE_
can O
be O
gained _RARE_
. O

In O
contrast O
, O
a O
Maf I-GENE
- I-GENE
related I-GENE
protein I-GENE
, O
Nrl _RARE_
, O
completely O
mimicked O
c I-GENE
- I-GENE
Maf I-GENE
actions O
. O

The O
27 _RARE_
- O
base _RARE_
element O
interacts O
with O
a O
PDGF _RARE_
- O
activated O
serine O
/ O
threonine O
phosphoprotein _RARE_
that O
is O
detected O
only O
within O
the O
nucleus O
of O
PDGF _RARE_
- O
treated O
3T3 O
cells O
. O

By O
contrast O
, O
deletion O
of O
this O
Ras I-GENE
- I-GENE
binding I-GENE
site I-GENE
did O
not O
diminish _RARE_
activation O
of O
Raf I-GENE
- I-GENE
1 I-GENE
kinase I-GENE
by O
Src I-GENE
, O
implying O
that O
Src I-GENE
and O
Ras I-GENE
can O
activate O
Raf I-GENE
- I-GENE
1 I-GENE
through O
independent O
mechanisms O
. O

In O
studies O
of O
many O
different O
phenotypically _RARE_
distinct O
cells O
, O
the O
CRE _RARE_
of O
the O
somatostatin I-GENE
gene I-GENE
promoter I-GENE
is O
a O
prototype O
of O
a O
highly O
cAMP O
- O
responsive O
element O
regulated O
by O
CREB I-GENE
. O

The O
first _RARE_
gene O
, O
NSR1 _RARE_
, O
a O
previously O
identified O
gene O
, O
encodes O
a O
protein O
involved O
in O
ribosomal O
RNA O
maturation _RARE_
and O
possibly O
in O
transport _RARE_
of O
proteins O
into O
the O
nucleus O
. O

Characterization O
of O
the O
promoter O
for _RARE_
the O
human I-GENE
85 _RARE_
kDa I-GENE
cytosolic I-GENE
phospholipase I-GENE
A2 _RARE_
gene I-GENE
. O

This O
paper O
describes O
the O
advantages O
and O
limitations O
of O
the O
main O
study O
approaches O
used O
. O

Comparative O
study O
of O
the O
differential O
white _RARE_
blood _RARE_
cell O
count O
using O
three O
automated O
analyzers _RARE_
: O
Coulter _RARE_
STKS _RARE_
, O
Sysmex _RARE_
NE _RARE_
8000 _RARE_
and O
Technicon _RARE_
H O
- O
1 O
. O

Characterization O
of O
FIII _RARE_
/ O
YY1 I-GENE
, O
a O
Xenopus I-GENE
laevis _RARE_
conserved _RARE_
zinc I-GENE
- I-GENE
finger I-GENE
protein I-GENE
binding O
to O
the O
first _RARE_
exon _RARE_
of O
L1 I-GENE
and O
L14 _RARE_
ribosomal I-GENE
protein I-GENE
genes I-GENE
. O

Further O
studies O
established O
that O
the O
Ep _RARE_
- O
induced _RARE_
increase O
in O
beta I-GENE
- I-GENE
globin I-GENE
mRNA I-GENE
could O
be O
inhibited O
by O
the O
tyrosine I-GENE
kinase I-GENE
inhibitor O
genistein _RARE_
and O
the O
protein I-GENE
kinase I-GENE
C I-GENE
inhibitor O
Compound _RARE_
3 O
.( O
ABSTRACT O
TRUNCATED O
AT O
250 _RARE_
WORDS O
) O

This O
structure _RARE_
of O
cucumisin _RARE_
suggests O
that O
it O
is O
probably O
synthesized O
as _RARE_
an O
inactive O
precursor O
. O

Molecular O
dissection O
of O
the O
multimeric _RARE_
CD3 I-GENE
- O
TCR I-GENE
complex O
revealed O
that O
at _RARE_
least O
two O
associated O
polypeptides O
, O
CD3 I-GENE
zeta _RARE_
and O
CD3 I-GENE
epsilon I-GENE
, O
autonomously _RARE_
couple _RARE_
antigenic _RARE_
recognition O
event O
to O
early O
and O
late _RARE_
events O
of O
the O
intracytoplasmic _RARE_
activation O
cascade O
. O

Protein I-GENE
cHMGI _RARE_
binds O
preferentially O
to O
AT O
- O
rich O
DNA O
with O
a O
half _RARE_
- O
saturation O
value O
of O
1 O
. O
1 O
nM O
. O

This O
study O
investigated O
the O
degree O
to O
which O
racial _RARE_
identity O
influences O
Mexican _RARE_
- O
Americans _RARE_
' O
performance O
on O
the O
L O
, O
K O
, O
and O
MF _RARE_
scales _RARE_
of O
the O
MMPI O
- O
2 O
. O

Both O
can O
be O
elevated O
on O
a O
single O
vascular O
pedicle _RARE_
based O
on O
the O
superficial O
temporal O
artery O
, O
the O
double O
- O
layered _RARE_
temporal O
fascia _RARE_
flap O
. O

To O
do O
this O
, O
segments _RARE_
of O
DNA O
from O
the O
5 O
' O
flank O
of O
the O
initiation O
sites O
for _RARE_
germline _RARE_
epsilon O
RNA O
were O
ligated O
to O
a O
luciferase I-GENE
reporter I-GENE
gene I-GENE
and O
transfected O
into O
two O
mouse O
B O
cell O
lines O
, O
one O
of O
which O
can O
be O
induced _RARE_
to O
switch O
to O
IgE I-GENE
. O

The O
negative O
predictive O
value O
is O
92 O
%, O
vs _RARE_
80 _RARE_
% O
for _RARE_
the O
NCEP _RARE_
I O
. O

Oncogenic _RARE_
capacity O
of O
the O
E2F1 I-GENE
gene I-GENE
. O

In O
some O
of O
the O
cases O
of O
solitary _RARE_
lesion O
, O
serum I-GENE
TSH _RARE_
levels O
, O
serum I-GENE
thyroglobulin _RARE_
values O
, O
and O
131I O
protein O
bounded _RARE_
iodine O
( O
131I O
- O
PBI _RARE_
) O
were O
measured O
, O
but O
there O
were O
no _RARE_
significant O
differences O
between O
successful O
and O
unsuccessful _RARE_
therapy O
. O

Endo16 _RARE_
transcripts I-GENE
are O
confined O
to O
the O
definitive O
vegetal _RARE_
plate _RARE_
in O
blastula _RARE_
stage _RARE_
embryos _RARE_
; O
at _RARE_
gastrula _RARE_
stage _RARE_
this O
gene O
is O
expressed _RARE_
throughout O
the O
archenteron _RARE_
, O
but O
later O
only O
in O
the O
midgut _RARE_
. O

A O
unique O
leucine O
- O
proline O
repeat O
element O
found O
N O
- O
terminal O
to O
the O
DNA O
- O
binding O
domain O
of O
EmBP _RARE_
- I-GENE
1 I-GENE
does O
not O
appear O
to O
play O
a O
role O
in O
DNA O
- O
binding O
or O
dimerization _RARE_
. O

Another O
full O
ORF O
was O
found O
on O
the O
opposite O
strand _RARE_
downstream _RARE_
from O
the O
nspC _RARE_
gene I-GENE
. O

The O
U14 I-GENE
genes I-GENE
of O
mouse O
as _RARE_
well _RARE_
as _RARE_
rat O
, O
hamster O
, O
human O
, O
Xenopus O
and O
trout _RARE_
are O
encoded O
within O
introns _RARE_
of O
the O
constitutively O
expressed _RARE_
70 I-GENE
- I-GENE
kDa I-GENE
- I-GENE
cognate _RARE_
- I-GENE
heat I-GENE
- I-GENE
shock I-GENE
protein I-GENE
gene I-GENE
( O
hsc70 _RARE_
). O

Two O
related O
cDNAs O
were O
isolated O
that O
encode O
proteins O
that O
recognize O
the O
XMyoDa _RARE_
TATA I-GENE
motif I-GENE
. O

Deletion O
of O
both O
prfA _RARE_
and O
ponA _RARE_
resulted O
in O
extremely O
slow O
growth O
and O
a O
reduction O
in O
sporulation _RARE_
efficiency O
. O

Inclusion _RARE_
in O
this O
family O
of O
proteins O
suggests O
that O
FliQ _RARE_
and O
FliR _RARE_
may O
participate O
in O
an O
export O
pathway _RARE_
required O
for _RARE_
flagellum _RARE_
assembly O
. O

In O
broken _RARE_
L O
- O
cell O
membranes O
expressing O
wild O
type O
or O
mutant I-GENE
M6P _RARE_
/ I-GENE
IGF I-GENE
II I-GENE
receptors I-GENE
, O
30 _RARE_
nM O
IGF I-GENE
II I-GENE
also O
failed O
to O
affect O
the O
pertussis _RARE_
toxin _RARE_
substrate O
activity O
. O

Chem O
. O

For O
the O
first _RARE_
time O
we O
describe O
deletion O
and O
point O
mutations O
within O
the O
plasma I-GENE
membrane I-GENE
family I-GENE
of I-GENE
guanylyl _RARE_
cyclase I-GENE
receptors I-GENE
that O
result O
in O
the O
formation O
of O
effective O
dominant O
negative O
proteins O
. O

Increase _RARE_
in O
blood _RARE_
NEFA _RARE_
was O
further O
augmented O
by O
fat O
plus _RARE_
AA O
supplementation O
, O
but O
no _RARE_
changes O
in O
concentrations O
of O
Lys _RARE_
or O
Met _RARE_
in O
blood _RARE_
were O
found O
. O

Virol _RARE_
. O

Coronary O
vasoconstriction _RARE_
caused O
by O
endothelin I-GENE
- I-GENE
1 I-GENE
is O
enhanced _RARE_
by O
ischemia O
- O
reperfusion O
and O
by O
norepinephrine O
present O
in O
concentrations O
typically O
observed O
after O
neonatal O
cardiopulmonary O
bypass O
. O

Comparison O
of O
the O
deduced O
amino I-GENE
acid I-GENE
sequence I-GENE
of I-GENE
gamma I-GENE
- I-GENE
kafirin _RARE_
with O
the O
published O
sequences I-GENE
of I-GENE
gamma I-GENE
- I-GENE
prolamins _RARE_
of I-GENE
maize _RARE_
, I-GENE
and I-GENE
Coix _RARE_
revealed O
highly O
conserved _RARE_
domains O
. O

Atcys1 _RARE_
, O
Athyp1 _RARE_
, O
AKin10 _RARE_
and O
the O
ORF O
are O
very O
close O
to O
each O
other O
and O
organized O
in O
the O
same O
polarity O
; O
hence O
, O
the O
intergenic O
regions O
probably O
contain O
, O
within O
less O
than O
0 _RARE_
. O
5 O
kb O
, O
all O
the O
regulatory O
elements O
necessary O
to O
govern O
initiation O
and O
termination _RARE_
of O
transcription O
. O

Southern O
blot O
hybridization O
experiments O
suggest O
the O
presence O
of O
one O
copy O
of O
Atcys1 _RARE_
, O
Athyp1 _RARE_
and O
AKin10 _RARE_
per O
haploid _RARE_
genome O
, O
and O
Northern O
blot O
analysis O
demonstrates O
that O
the O
three O
genes O
are O
differentially O
expressed _RARE_
in O
roots O
, O
shoots _RARE_
and O
leaves O
. O

These O
results O
suggest O
that O
HAC1 _RARE_
may O
also O
be O
one O
of O
the O
meiotic _RARE_
genes O
. O

We O
characterized O
three O
Arabidopsis O
thaliana O
cDNA O
clones _RARE_
that O
could O
rescue O
the O
sterile _RARE_
phenotype _RARE_
of O
the O
Schizosaccharomyces I-GENE
pombe I-GENE
pde1 _RARE_
mutant I-GENE
, O
which O
is O
defective _RARE_
in O
cAMP I-GENE
phosphodiesterase _RARE_
. O

Furthermore O
, O
the O
identification O
of O
a O
Dr1 _RARE_
- I-GENE
like I-GENE
protein I-GENE
in O
A O
. O
thaliana O
strongly O
argues _RARE_
for _RARE_
the O
ubiquity _RARE_
of O
this O
protein O
among O
eukaryotic O
genera _RARE_
and O
for _RARE_
a O
conserved _RARE_
mechanism O
to O
regulate O
transcription O
initiation O
that O
involves O
Dr1 _RARE_
. O

Similarly O
approximately _RARE_
300 _RARE_
bp O
of O
sequence O
downstream _RARE_
of O
the O
translation O
terminator O
TGA _RARE_
of O
the O
beta I-GENE
- I-GENE
tubulin _RARE_
2 I-GENE
( O
BTU2 _RARE_
) O
gene O
could O
substitute O
for _RARE_
the O
3 O
' O
region O
of O
the O
H4 _RARE_
- I-GENE
I I-GENE
gene I-GENE
. O

These O
data O
demonstrate O
that O
the O
STR _RARE_
family I-GENE
of O
genes O
is O
represented O
in O
a O
nematode O
whose O
ancestor O
appeared O
well _RARE_
before O
the O
branching _RARE_
that O
gave O
rise O
to O
the O
Arthropoda _RARE_
and O
Chordata _RARE_
. O

The O
pre O
- O
and O
postoperative O
haemoglobin _RARE_
concentrations O
in O
the O
autologous O
group O
were O
lower O
by O
15 _RARE_
and O
10 O
g O
/ O
L O
, O
respectively O
, O
after O
primary _RARE_
THR _RARE_
and O
by O
10 O
g O
/ O
L O
in O
both O
instances O
after O
revision _RARE_
THR _RARE_
. O

The O
introduction O
of O
an O
acidic _RARE_
residue _RARE_
at _RARE_
the O
second O
site O
was O
essential O
for _RARE_
suppression O
of O
the O
Asn O
- O
285 O
mutation O
because O
Lys _RARE_
- O
220 O
and O
Gln O
- O
220 O
second O
- O
site O
mutants O
of O
the O
Asn O
- O
285 O
mutant O
showed O
very O
low O
tetracycline _RARE_
resistance O
.( O
ABSTRACT O
TRUNCATED O
AT O
250 _RARE_
WORDS O
) O

Tumor _RARE_
necrosis I-GENE
factor I-GENE
alpha I-GENE
, O
the O
cytokine _RARE_
that O
participates O
in O
the O
autocrine O
growth O
control O
of O
hairy _RARE_
cell O
leukemia O
has O
strong O
bone O
resorptive _RARE_
properties O
. O

( O
iv O
) O
Although O
UCRBP _RARE_
has O
been O
previously O
shown O
to O
act O
as _RARE_
a O
transcriptional O
repressor O
, O
we O
show O
here O
that O
UCRBP _RARE_
can O
also O
act O
as _RARE_
a O
positive O
transactivator _RARE_
of O
a O
reporter O
driven _RARE_
by O
UCR _RARE_
elements O
when O
used O
in O
co _RARE_
- O
transfection O
assays O
. O

The O
sequence O
of O
monkey _RARE_
opsin _RARE_
closely O
resembles O
the O
human O
sequence O
at _RARE_
the O
nucleotide O
and O
the O
amino O
acid O
levels O
, O
with O
the O
latter O
having O
only O
7 O
differences O
out O
of O
348 _RARE_
residues O
. O

One O
complex O
appears O
to O
be O
ubiquitous O
but O
enriched _RARE_
in O
lymphoid _RARE_
cells O
and O
represents O
the O
binding O
of O
a O
potentially O
novel O
factor O
with O
an O
apparent O
molecular _RARE_
mass O
of O
approximately _RARE_
50 O
kDa O
. O

Chem O
. O

Conversely O
, O
activation O
of O
Oct I-GENE
- I-GENE
3 I-GENE
/ I-GENE
4 I-GENE
promoter I-GENE
by O
RAR I-GENE
: O
RXR I-GENE
heterodimers _RARE_
was O
completely O
abolished O
by O
EAR _RARE_
- I-GENE
3 I-GENE
/ O
COUP I-GENE
- I-GENE
TFI I-GENE
and O
by O
ARP _RARE_
- I-GENE
1 I-GENE
/ O
COUP I-GENE
- I-GENE
TFII _RARE_
. O

These O
results O
demonstrate O
that O
EKLF _RARE_
provides O
a O
crucial O
transactivation _RARE_
function O
for _RARE_
globin I-GENE
expression _RARE_
and O
further O
reinforce _RARE_
the O
idea O
that O
EKLF _RARE_
is O
an O
important O
regulator O
of O
CACCC _RARE_
element O
- O
directed O
transcription O
in O
erythroid _RARE_
cells O
. O

Using O
a O
battery O
of O
I I-GENE
kappa _RARE_
B I-GENE
alpha I-GENE
mutants I-GENE
, O
we O
show O
that O
( O
i O
) O
a O
dimer _RARE_
binds O
a O
single O
I I-GENE
kappa _RARE_
B I-GENE
alpha I-GENE
molecule I-GENE
, O
( O
ii O
) O
the O
acidic _RARE_
C O
- O
terminal O
region O
of O
I I-GENE
kappa _RARE_
B I-GENE
alpha I-GENE
is O
not O
required O
for _RARE_
protein O
- O
protein O
binding O
and O
does O
not O
mask _RARE_
the O
nuclear O
localization _RARE_
signal O
of O
the O
dimer _RARE_
, O
( O
iii O
) O
the O
same O
C O
- O
terminal O
region O
is O
required O
for _RARE_
inhibition O
of O
DNA O
binding O
, O
and O
( O
iv O
) O
this O
inhibition O
may O
be O
accomplished _RARE_
by O
direct O
interaction O
between O
the O
PEST _RARE_
- O
like O
region O
and O
the O
DNA O
- O
binding O
region O
of O
one O
of O
the O
subunits O
of O
the O
dimer _RARE_
. O

The O
negative O
regulatory O
activity O
of O
the O
N O
- O
terminal O
domain O
was O
antagonized _RARE_
by O
a O
C O
- O
terminal O
segment O
of O
Pho81p _RARE_
supplied O
in O
trans _RARE_
. O

At O
different O
times O
of O
the O
surgical O
procedures O
( O
thorax _RARE_
opening _RARE_
and O
closure O
, O
period O
of O
cardiopulmonary O
bypass O
) O
67 O
to O
100 _RARE_
% O
of O
the O
patients O
in O
group O
1 O
had O
vancomycin O
concentrations O
in O
the O
studied O
tissues O
above O
the O
MIC _RARE_
90 _RARE_
for _RARE_
Staphylococcus _RARE_
aureus _RARE_
( O
1 O
microgram O
/ O
g O
) O
and O
Staphylococcus _RARE_
epidermidis _RARE_
( O
2 O
micrograms O
/ O
g O
). O

On O
- O
line O
angioscopic _RARE_
images O
of O
tissue O
flaps _RARE_
floating _RARE_
in O
the O
lumen _RARE_
, O
recent O
or O
structured O
thrombi _RARE_
, O
artery O
wall _RARE_
dissections _RARE_
, O
plaque O
ruptures _RARE_
, O
deep O
fissurations _RARE_
and O
sub O
- O
intimal _RARE_
haemorrhages _RARE_
demonstrate O
, O
in O
live O
colour _RARE_
, O
the O
pathophysiological _RARE_
mechanisms O
of O
coronary O
artery O
stenosis O
. O

The O
enhanced _RARE_
cysteine O
formation O
in O
a O
pCSK4F _RARE_
plant _RARE_
responding O
to O
sulfite _RARE_
was O
also O
observed O
in O
leaf O
discs _RARE_
. O

Each O
type O
was O
divided O
into O
two O
subgroups O
on O
the O
basis O
of O
whether O
the O
body O
and O
tail _RARE_
of O
the O
pancreas O
showed O
intense O
fatty O
replacement _RARE_
( O
type O
a O
= O
negative O
for _RARE_
intense O
fatty O
replacement _RARE_
, O
type O
b O
= O
positive O
for _RARE_
intense O
fatty O
replacement _RARE_
). O

Between _RARE_
the O
subgroups O
of O
dementia O
disorders O
there O
were O
no _RARE_
significant O
differences O
in O
basal O
cortisol O
levels O
. O

A O
new O
hypothesis O
on O
mechanisms O
for _RARE_
inhibiting O
catalytic O
subunits O
by O
gamma O
- O
subunits O
and O
activation O
of O
a O
holoenzyme _RARE_
by O
transducin _RARE_

Basal O
components _RARE_
of O
the O
transcription O
apparatus O
( O
RNA I-GENE
polymerase I-GENE
II I-GENE
, O
TATA I-GENE
- I-GENE
binding I-GENE
protein I-GENE
) O
contain O
activation O
domains O
: O
is O
the O
repetitive _RARE_
C O
- O
terminal O
domain O
( O
CTD _RARE_
) O
of O
RNA I-GENE
polymerase I-GENE
II I-GENE
a O
" O
portable _RARE_
enhancer O
domain O
"? _RARE_
Regions _RARE_
rich O
in O
serine O
, O
threonine O
, O
and O
proline O
residues O
can O
be O
found O
in O
transcriptional O
activation O
domains O
, O
as _RARE_
well _RARE_
as _RARE_
in O
the O
N O
- O
terminal O
parts O
of O
mammalian I-GENE
TATA I-GENE
- I-GENE
binding I-GENE
proteins I-GENE
, O
where O
they O
are O
interrupted O
by O
polyglutamine _RARE_
stretches O
. O

Mutagenesis _RARE_
of O
IM1 _RARE_
enhances O
the O
ability O
of O
c I-GENE
- I-GENE
Fos I-GENE
to O
activate O
an O
AP1 I-GENE
bearing _RARE_
promoter I-GENE
. O

Binding O
of O
SSP _RARE_
to O
the O
stage _RARE_
selector _RARE_
element I-GENE
( O
SSE _RARE_
) O
in O
the O
proximal O
gamma I-GENE
- I-GENE
globin I-GENE
promoter I-GENE
is O
integral _RARE_
to O
the O
competitive O
silencing O
of O
a O
linked _RARE_
beta I-GENE
- I-GENE
promoter I-GENE
in O
embryonic _RARE_
/ O
fetal _RARE_
stage _RARE_
erythroleukemia _RARE_
( O
K562 O
) O
cells O
. O

This O
failure O
to O
execute _RARE_
regulated O
G1 O
/ O
S O
arrest O
is O
correlated O
with O
enhanced _RARE_
thermosensitivity _RARE_
of O
colony O
- O
forming O
ability O
. O

Mutations O
that O
alter O
photoreceptor _RARE_
cell O
structure _RARE_
and O
development O
were O
isolated O
that O
fail O
to O
complement O
these O
deletions O
. O

It O
is O
possible O
that O
the O
telomeres _RARE_
of O
the O
two O
nuclei O
have O
different O
functions O
. O

The O
marker O
orders _RARE_
from O
the O
genetic O
and O
RH _RARE_
maps O
were O
consistent O
. O

Integrated _RARE_
mapping O
analysis O
of O
the O
Werner _RARE_
syndrome _RARE_
region O
of O
chromosome _RARE_
8 O
. O

The O
region O
between O
DXS52 _RARE_
and O
Factor _RARE_
VIII I-GENE
gene I-GENE
in O
the O
human O
Xq28 _RARE_
chromosomal O
band O
contains O
a O
G O
+ O
C O
- O
rich O
isochore _RARE_
to O
which O
many O
genes O
have O
been O
mapped O
. O

Haplotype _RARE_
mapping O
and O
sequence O
analysis O
of O
the O
mouse O
Nramp _RARE_
gene I-GENE
predict O
susceptibility _RARE_
to O
infection O
with O
intracellular _RARE_
parasites O
. O

This O
utilization O
of O
an O
intronic _RARE_
polyadenylation O
site O
without O
alternative _RARE_
exon _RARE_
usage O
is O
comparable O
to O
the O
mechanism O
whereby _RARE_
both O
secreted _RARE_
and O
membrane O
- O
bound _RARE_
forms O
of O
the O
immunoglobulin I-GENE
mu I-GENE
heavy I-GENE
chain I-GENE
are O
made O
from O
a O
single O
genetic O
locus O
. O

To O
further O
our O
knowledge O
about O
the O
systemic O
humoral _RARE_
immune O
system _RARE_
response O
to O
weak O
hapten _RARE_
- O
syngeneic _RARE_
or O
allogeneic _RARE_
protein O
conjugates _RARE_
( O
corrosion _RARE_
and O
wear _RARE_
products O
of O
metallic _RARE_
orthopedic _RARE_
devices _RARE_
), _RARE_
a O
sensitive _RARE_
enzyme O
- O
linked _RARE_
immunosorbent O
assay O
( O
ELISA O
) O
method O
for _RARE_
testing O
for _RARE_
antibody O
( O
humoral _RARE_
immunity _RARE_
) O
to O
metals _RARE_
was O
developed O
. O

In O
contrast O
, O
peak O
filling O
rate O
( O
PFR _RARE_
), _RARE_
normalized O
to O
end O
diastolic O
volume O
( O
EDV _RARE_
), _RARE_
or O
stroke O
volume O
( O
SV O
), _RARE_
or O
expressed _RARE_
as _RARE_
the O
ratio O
of O
PFR _RARE_
- O
to O
- O
PER _RARE_
was O
reduced _RARE_
( O
p O
< O
0 _RARE_
. O
01 O
), _RARE_
time O
to O
PFR _RARE_
( O
TPFR _RARE_
) O
was O
prolonged O
( O
p O
< O
0 _RARE_
. O
01 O
), _RARE_
and O
echocardiographic O
left _RARE_
ventricular O
mass O
index O
was O
higher _RARE_
( O
p O
< O
0 _RARE_
. O
001 O
) O
in O
patients O
with O
acromegaly _RARE_
compared O
to O
normals O
. O

A O
genetic O
complementation _RARE_
system _RARE_
was O
developed O
in O
which O
tobacco I-GENE
etch _RARE_
virus I-GENE
( I-GENE
TEV _RARE_
) I-GENE
polymerase I-GENE
( O
NIb _RARE_
)- O
expressing O
transgenic O
plants _RARE_
or O
protoplasts _RARE_
were O
inoculated O
with O
NIb _RARE_
- O
defective _RARE_
TEV _RARE_
mutants I-GENE
. O

Nucleotide O
sequence O
and O
transcriptional O
analysis O
of O
the O
DNA I-GENE
polymerase I-GENE
gene I-GENE
of I-GENE
Bombyx _RARE_
mori _RARE_
nuclear I-GENE
polyhedrosis _RARE_
virus I-GENE
. O

Comparison O
of O
the O
genomes O
of O
PMTV _RARE_
, O
BNYVV _RARE_
, O
and O
SBWMV _RARE_
shows O
that O
furoviruses _RARE_
exhibit O
considerable O
heterogeneity O
in O
genome O
organization O
. O

The O
drug O
sensitivity O
was O
100 _RARE_
% O
for _RARE_
vancomycin O
( O
VCM _RARE_
), _RARE_
30 _RARE_
% O
for _RARE_
imipenam _RARE_
( O
IMP _RARE_
), _RARE_
31 _RARE_
% O
for _RARE_
minomycin _RARE_
( O
MINO _RARE_
), _RARE_
31 _RARE_
% O
for _RARE_
amikacin _RARE_
( O
AMK _RARE_
), _RARE_
and O
7 O
% O
for _RARE_
fosfomycin _RARE_
( O
FOM _RARE_
). O

Deglycosylation _RARE_
with O
endoglycosidase _RARE_
H I-GENE
showed O
that O
the O
mutant O
receptors O
had O
mainly O
high O
- O
mannose _RARE_
oligosaccharide _RARE_
chains O
. O

Dietary _RARE_
supplement _RARE_
with O
fish O
oil O
and O
related O
n _RARE_
- O
3 O
EFAs _RARE_
has O
been O
used O
to O
study O
their O
antihypertensive O
property _RARE_
in O
animals O
and O
humans O
with O
borderline _RARE_
and O
essential O
hypertension O
. O

The O
HSD3B1 _RARE_
and O
HSD3B2 _RARE_
genes I-GENE
encoding O
the O
types _RARE_
I I-GENE
and I-GENE
II I-GENE
3 I-GENE
beta I-GENE
- I-GENE
HSD _RARE_
isoenzymes _RARE_
, O
respectively O
, O
have O
been O
previously O
assigned O
by O
in O
situ O
hybridization O
to O
the O
chromosome _RARE_
1p13 _RARE_
. O
1 O
region O
. O

Therefore O
the O
prevalences _RARE_
of O
total _RARE_
diabetes O
and O
GDM _RARE_
were O
1 O
. O
19 O
% O
and O
0 _RARE_
. O
56 _RARE_
%, O
respectively O
. O

Insulin I-GENE
- O
stimulated _RARE_
glucose O
transport _RARE_
in O
adipocytes O
is O
mediated _RARE_
by O
the O
insulin I-GENE
receptor I-GENE
. O

After O
selection O
and O
conversion O
to O
adipocytes O
, O
the O
level O
of O
EGFR I-GENE
expression _RARE_
was O
retained O
in O
infectant _RARE_
adipocytes O
( O
150 _RARE_
, O
000 _RARE_
and O
250 _RARE_
, O
000 _RARE_
/ O
cell O
, O
respectively O
), _RARE_
but O
not O
in O
the O
parental O
3T3 O
- O
L1 O
adipocytes O
(< O
5000 _RARE_
/ O
cell O
). O

Intron _RARE_
- O
exon _RARE_
structure _RARE_
of O
the O
porcine _RARE_
I I-GENE
kappa _RARE_
B I-GENE
alpha I-GENE
- I-GENE
encoding I-GENE
gene I-GENE
. O

Fraction _RARE_
2 O
contains O
1 O
, O
25 _RARE_
( O
OH O
) O
2 O
- O
vitamin O
D3 _RARE_
, O
vitamin O
D3 _RARE_
, O
25 _RARE_
( O
OH O
)- O
vitamin O
D3 _RARE_
and O
1 O
, O
24 _RARE_
, O
25 _RARE_
( O
OH O
) O
3 O
- O
vitamin O
D3 _RARE_
. O

The O
kallistatin _RARE_
gene I-GENE
was O
localized O
by O
in O
situ O
hybridization O
to O
human O
chromosome _RARE_
14q31 _RARE_
- O
q32 _RARE_
. O
1 O
, O
close O
to O
the O
serpin _RARE_
genes I-GENE
encoding O
alpha I-GENE
1 I-GENE
- I-GENE
antichymotrypsin _RARE_
, O
protein I-GENE
C I-GENE
inhibitor I-GENE
, O
alpha I-GENE
1 I-GENE
- I-GENE
antitrypsin I-GENE
, O
and O
corticosteroid _RARE_
- I-GENE
binding I-GENE
globulin I-GENE
. O

The O
locus O
encoding O
the O
XD _RARE_
gene I-GENE
( O
designated O
Xd _RARE_
) O
was O
mapped O
to O
the O
distal O
part O
of O
mouse O
chromosome _RARE_
17 _RARE_
by O
haplotype _RARE_
analysis O
of O
114 _RARE_
interspecific _RARE_
backcross O
mice O
. O

Some O
studies O
of O
exercise O
have O
associated O
beta I-GENE
- I-GENE
endorphin I-GENE
release O
with O
increased O
exertion _RARE_
levels O
, O
but O
other O
evidence O
suggests O
that O
acidosis O
may O
stimulate O
the O
release O
of O
beta I-GENE
- I-GENE
endorphin I-GENE
. O

An O
interatrial _RARE_
communication _RARE_
mitigates _RARE_
the O
impairment O
of O
LV O
function O
after O
an O
acute O
and O
sustained O
drop O
of O
intrathoracic _RARE_
pressure O
. O

Self _RARE_
or O
foreign O
cellular O
proteins O
provide O
peptides O
for _RARE_
presentation O
by O
major I-GENE
histocompatibility I-GENE
complex I-GENE
( I-GENE
MHC I-GENE
) I-GENE
class I-GENE
I I-GENE
molecules I-GENE
on O
the O
surface O
of O
antigen O
presenting _RARE_
cells O
( O
APC _RARE_
). O

The O
characteristics O
of O
the O
VirD1 _RARE_
/ O
VirD2 _RARE_
- O
mediated _RARE_
cleavage _RARE_
reaction O
strongly O
resemble _RARE_
those O
observed O
with O
relaxosomes _RARE_
of O
IncP _RARE_
plasmids O
involved O
in O
initiation O
of O
transfer O
DNA O
replication O
during _RARE_
bacterial O
conjugation O
. O

Isoelectric _RARE_
focusing O
of O
tryptic _RARE_
peptides O
generated O
from O
MHC I-GENE
- I-GENE
B I-GENE
phosphorylated _RARE_
with O
cdc2 I-GENE
kinase I-GENE
revealed O
one O
major O
phosphopeptide _RARE_
that O
was O
purified _RARE_
by O
reverse O
- O
phase _RARE_
high O
performance O
liquid O
chromatography O
and O
sequenced O
. O

The O
deduced O
protein O
sequence O
was O
88 O
% O
homologous O
to O
that O
of O
hNUC _RARE_
I I-GENE
, O
isolated O
from O
human O
osteosarcoma O
cells O
. O

However O
, O
cotransfection O
studies O
indicate O
that O
RVR _RARE_
does O
not O
activate O
transcription O
when O
this O
hormone O
response O
element O
is O
linked _RARE_
to O
a O
reporter O
gene O
but O
rather O
acts O
as _RARE_
a O
potent O
competitive O
repressor O
of O
ROR _RARE_
alpha I-GENE
function O
. O

A O
comparison O
of O
the O
Flavobacterium _RARE_
glycosylasparaginase _RARE_
with O
a O
mammalian O
glycosylasparaginase _RARE_
revealed O
30 _RARE_
% O
structural O
identity O
and O
60 _RARE_
% O
overall O
similarity _RARE_
between O
the O
prokaryotic _RARE_
and O
eukaryotic O
forms O
of O
the O
enzyme O
. O

Dissociation _RARE_
and O
complexation _RARE_
of O
the O
fluoroquinolone _RARE_
antimicrobials _RARE_
-- _RARE_
an O
update _RARE_
. O

Superoxide _RARE_
dismutase I-GENE
( O
SOD I-GENE
) O
activity O
decreased O
significantly O
in O
sperm O
subjected O
to O
direct O
electric _RARE_
current O
in O
comparison O
to O
the O
control O
or O
the O
sample O
incubated O
with O
electrolyzed _RARE_
medium O
. O

These O
studies O
indicate O
that O
in O
vitro O
and O
in O
vivo O
electrical O
stimulation _RARE_
generate O
reactive O
oxygen O
species O
and O
affect O
SOD I-GENE
activity O
, O
which O
in O
part O
are O
responsible O
for _RARE_
decreased O
sperm O
motion O
and O
viability O
. O

Molecular O
cloning O
and O
sequencing O
of O
a O
cDNA O
encoding O
SR I-GENE
beta I-GENE
revealed O
that O
SR I-GENE
beta I-GENE
is O
a O
transmembrane O
protein O
and O
, O
like O
SR I-GENE
alpha I-GENE
and O
SRP54 _RARE_
, O
is O
a O
member _RARE_
of O
the O
GTPase I-GENE
superfamily I-GENE
. O

To O
understand O
the O
function O
of O
receptor I-GENE
- I-GENE
linked _RARE_
tyrosine I-GENE
phosphatases _RARE_
in O
neural _RARE_
development O
, O
we O
sought O
to O
identify O
LAR _RARE_
isoforms I-GENE
preferentially O
expressed _RARE_
in O
the O
nervous O
system _RARE_
and O
cellular O
processes O
regulating _RARE_
LAR _RARE_
alternative _RARE_
splicing _RARE_
. O

Sex _RARE_
selection O
via O
albumin I-GENE
columns _RARE_
: O
20 O
years O
of O
results O
. O

135 O
students O
had O
a O
count O
of O
less O
than O
50 O
eggs O
/ O
10 O
ml O
. O
urine O
and O
56 _RARE_
had O
more O
than O
50 O
eggs O
/ O
10ml _RARE_
. O

They O
also O
reported O
that O
E I-GENE
mu I-GENE
pim _RARE_
- I-GENE
1 I-GENE
transgenic O
mice O
show O
greatly O
accelerated O
lymphoma O
development O
when O
infected _RARE_
with O
wild O
- O
type O
M O
- O
MuLV O
at _RARE_
birth O
. O

Comparison O
of O
human I-GENE
and I-GENE
murine I-GENE
blk _RARE_
sequences I-GENE
indicated O
that O
they O
share O
86 _RARE_
% O
amino O
acid O
identity O
, O
the O
most O
conserved _RARE_
region O
being O
the O
catalytic O
domain O
( O
93 O
% O
identity O
). O

Chrispeels _RARE_
[ _RARE_
1993 O
] O
EMBO _RARE_
J _RARE_
12 O
: O
2241 _RARE_
- O
2247 _RARE_
). O

The O
mRNAs O
of O
the O
GRF _RARE_
genes I-GENE
are O
encoded O
by O
six _RARE_
exons O
interrupted O
by O
five O
introns _RARE_
. O

The O
effect O
of O
ethanol O
on O
human O
sensorimotor _RARE_
reactivity O
was O
assessed O
by O
examining O
the O
acoustic O
startle _RARE_
response O
. O

Digitalis _RARE_
glycosides _RARE_
or O
beta I-GENE
- I-GENE
receptor I-GENE
antagonists O
are O
not O
helpful O
in O
the O
therapy O
of O
this O
form O
of O
atrial _RARE_
fibrillation O
whereas O
class O
I O
antiarrhythmic O
drugs O
have O
been O
shown O
to O
be O
more O
effective O
. O

Atrial _RARE_
fibrillation O
and O
the O
autonomic _RARE_
nervous O
system _RARE_

VIII O
in O
doses O
2 O
- O
3 O
times O
higher _RARE_
than O
usually O
used O
in O
haemophiliacs _RARE_
without O
inhibitor O
were O
successful O
. O

A O
reduction O
of O
the O
aspartate _RARE_
aminotransferase I-GENE
activity O
was O
observed O
from O
800 O
mg O
/ O
kg O
b O
. O
w O
./ _RARE_
d O
onwards _RARE_
. O

Thus O
, O
these O
studies O
indicate O
that O
the O
104 O
- O
kDa O
isoform O
is O
required O
for _RARE_
normal O
proliferation _RARE_
of O
female O
germline _RARE_
cells O
and O
perhaps O
for _RARE_
oocyte _RARE_
differentiation O
. O

Physical _RARE_
analysis O
maps O
SAL6 _RARE_
to O
chromosome _RARE_
XVI _RARE_
between O
TPK2 _RARE_
and O
spt14 _RARE_
. O

The O
newly O
devised _RARE_
DCT _RARE_
method O
yields O
reliable O
data O
in O
measuring O
TBF _RARE_
. O

Removal O
of O
PDMP _RARE_
from O
the O
cell O
medium O
resulted O
in O
reversal O
of O
the O
cell O
cycle _RARE_
changes O
, O
with O
cells O
re O
- O
entering _RARE_
the O
S O
phase _RARE_
. O

Rho I-GENE
GDP I-GENE
/ I-GENE
GTP I-GENE
exchange I-GENE
inhibitor I-GENE
, O
Rho I-GENE
GDI _RARE_
, O
comigrated _RARE_
with O
Rac2 _RARE_
and O
RhoA I-GENE
, O
but O
not O
Rac1 I-GENE
. O

A O
major O
task O
for _RARE_
sports _RARE_
scientists _RARE_
may O
be O
to O
verify _RARE_
empirically _RARE_
the O
nature O
of O
an O
integrated O
model O
of O
the O
sport _RARE_
performer _RARE_
. O

Schnell _RARE_
, O
J _RARE_
. O

Encapsidation _RARE_
of O
poliovirus _RARE_
replicons _RARE_
encoding O
the O
complete _RARE_
human I-GENE
immunodeficiency I-GENE
virus I-GENE
type I-GENE
1 I-GENE
gag I-GENE
gene I-GENE
by O
using O
a O
complementation _RARE_
system _RARE_
which O
provides O
the O
P1 I-GENE
capsid _RARE_
protein I-GENE
in O
trans _RARE_
. O

Removal O
of O
the O
GST I-GENE
domain I-GENE
from O
GST I-GENE
- O
Tax _RARE_
by O
thrombin I-GENE
restores O
Tax _RARE_
' O
s O
ability O
to O
assemble _RARE_
a O
ternary _RARE_
Tax _RARE_
- O
CREB I-GENE
- O
21 O
- O
bp O
- O
repeat O
complex O
.( O
ABSTRACT O
TRUNCATED O
AT O
400 _RARE_
WORDS O
) O

The O
requirement O
of O
PilE _RARE_
in O
pilus _RARE_
biogenesis O
was O
confirmed O
by O
demonstrating O
that O
chromosomal I-GENE
pilE _RARE_
insertion _RARE_
mutants I-GENE
were O
pilus _RARE_
- O
and O
twitching _RARE_
- O
motility _RARE_
deficient _RARE_
. O

The O
pilE _RARE_
gene I-GENE
product I-GENE
of I-GENE
Pseudomonas _RARE_
aeruginosa _RARE_
, O
required O
for _RARE_
pilus _RARE_
biogenesis O
, O
shares O
amino O
acid O
sequence O
identity O
with O
the O
N O
- O
termini O
of O
type I-GENE
4 I-GENE
prepilin _RARE_
proteins I-GENE
. O

Because O
of O
the O
functional _RARE_
conservation O
of O
cell O
cycle _RARE_
control O
elements O
, O
the O
expression _RARE_
of O
a O
vertebrate _RARE_
wee1 _RARE_
or O
mik1 _RARE_
homolog I-GENE
would O
be O
expected O
to O
rescue O
such O
lethal O
mutations O
in O
yeast O
. O

The O
expression _RARE_
of O
this O
clone O
in O
a O
wee1 _RARE_
/ O
mik1 _RARE_
- O
deficient _RARE_
mutant O
causes O
an O
elongated _RARE_
cell O
phenotype _RARE_
under O
non O
- O
permissive O
growth O
conditions O
. O

These O
data O
indicate O
that O
phosphorylation _RARE_
of O
M I-GENE
protein I-GENE
at _RARE_
the O
major O
in O
vivo O
sites O
is O
not O
essential O
for _RARE_
virus O
assembly O
. O

Near _RARE_
a O
third O
( O
31 _RARE_
. O
6 O
%) O
of O
Insulin I-GENE
Dependent _RARE_
and O
a O
third O
( O
33 _RARE_
. O
41 _RARE_
%) O
for _RARE_
Non O
Insulin I-GENE
Dependent _RARE_
were O
of O
D O
, O
F O
, O
H O
White _RARE_
' O
s O
Class _RARE_
. O

The O
activity O
of O
6 O
- O
fluoroquinolones _RARE_
and O
their O
nonfluorinated _RARE_
derivatives _RARE_
is O
compared O
in O
general _RARE_
. O

As O
the O
half _RARE_
- O
life O
of O
the O
compound O
did O
never O
exceed _RARE_
8 O
- O
9 O
h O
, O
the O
data O
do O
not O
support O
any O
change O
of O
pidotimod _RARE_
administration O
schedule O
( O
every O
24 _RARE_
- O
12 O
h O
). O

The O
MAP I-GENE
kinase I-GENE
cascade O
is O
highly O
conserved _RARE_
in O
all O
eukaryotes O
and O
involved O
in O
numerous O
cellular O
responses O
. O

A O
comparative O
study O
by O
holographic _RARE_
interferometry _RARE_
of O
ten O
porcine _RARE_
bioprosthetic _RARE_
valves _RARE_
( O
seven _RARE_
Carpentier _RARE_
- O
Edwards _RARE_
SAV _RARE_
, O
two O
BioImplant _RARE_
and O
one O
Valcor _RARE_
) O
with O
five O
human O
aortic O
valves _RARE_
before O
and O
after O
glutaraldehyde _RARE_
treatment O
is O
presented O
. O

No O
serious O
side _RARE_
effects O
were O
observed O
. O

This O
region O
constitutes O
the O
DNA O
- O
binding O
domain O
with O
basic O
- O
helix O
- O
loop O
- O
helix O
and O
leucine O
- O
zipper O
motifs O
, O
features O
common O
to O
the O
myc I-GENE
- I-GENE
related I-GENE
transcription I-GENE
factor I-GENE
family I-GENE
. O

Specific O
binding O
was O
not O
observed O
with O
either O
the O
orthologous _RARE_
rat O
or O
mouse O
fragments O
using O
human O
or O
rodent O
extracts O
. O

The O
mean O
jitter _RARE_
and O
the O
fiber O
density O
did O
not O
change O
significantly O
from O
day O
0 _RARE_
( O
30 _RARE_
. O
1 O
+/- O
3 O
. O
6 O
microseconds _RARE_
; O
1 O
. O
4 O
+/- O
0 _RARE_
. O
07 O
) O
to O
day O
30 _RARE_
( O
34 _RARE_
. O
5 O
+/- O
2 O
. O
7 O
microseconds _RARE_
; O
1 O
. O
6 O
+/- O
0 _RARE_
. O
13 _RARE_
). O

Lack _RARE_
of O
cyclin _RARE_
D I-GENE
- O
Cdk I-GENE
complexes O
in O
Rb _RARE_
- O
negative O
cells O
correlates O
with O
high O
levels O
of O
p16INK4 _RARE_
/ O
MTS1 _RARE_
tumour _RARE_
suppressor O
gene O
product O
. O

Recombinant I-GENE
human I-GENE
serum I-GENE
albumin I-GENE
( O
rHSA _RARE_
) O
produced O
by O
cultured O
fermentation _RARE_
has O
been O
prepared O
in O
the O
form O
of O
microcapsules _RARE_
nominally _RARE_
3 O
- O
5 O
microns O
in O
diameter O
and O
radiolabelled _RARE_
with O
technetium O
- O
99m O
following O
reduction O
with O
stannous _RARE_
chloride _RARE_
. O

We O
have O
measured O
the O
release O
of O
interleukin I-GENE
- I-GENE
1 I-GENE
beta I-GENE
( O
IL _RARE_
- I-GENE
1 I-GENE
) O
and O
tumour _RARE_
necrosis I-GENE
factor I-GENE
- I-GENE
alpha I-GENE
( O
TNF I-GENE
) O
by O
unstimulated O
monocytes O
and O
monocytes O
stimulated _RARE_
with O
lipopolysaccharide O
( O
LPS _RARE_
) O
isolated O
from O
the O
peripheral O
blood _RARE_
of O
two O
patients O
with O
acute O
poststreptococcal _RARE_
glomerulonephritis O
( O
AGN _RARE_
) O
and O
16 O
healthy O
controls O
. O

Such O
an O
intervention O
may O
be O
of O
considerable O
use O
for _RARE_
the O
treatment O
of O
angiogenesis O
- O
dependent O
diseases O
involving O
FGF I-GENE
- I-GENE
2 I-GENE
. O

We O
have O
attempted _RARE_
to O
clone O
two O
recessive O
extragenic _RARE_
suppressors O
of O
such O
ts _RARE_
mutants O
( O
sdp1 _RARE_
for _RARE_
mutation I-GENE
pol3 _RARE_
- I-GENE
14 I-GENE
and O
sdp5 _RARE_
- I-GENE
1 I-GENE
for _RARE_
mutation I-GENE
pol3 _RARE_
- I-GENE
11 I-GENE
) O
by O
transforming O
thermoresistant _RARE_
haploid _RARE_
strains O
pol3 _RARE_
- I-GENE
14 I-GENE
sdp1 _RARE_
and O
pol3 _RARE_
- I-GENE
11 I-GENE
sdp5 _RARE_
- I-GENE
1 I-GENE
with O
wild O
- O
type O
genomic O
libraries O
in O
singlecopy _RARE_
or O
multicopy O
vectors O
. O

UV _RARE_
cross O
- O
linking O
experiments O
show O
that O
TEP _RARE_
has O
an O
apparent O
molecular _RARE_
mass O
of O
approximately _RARE_
65 O
kDa O
. O

In O
acute O
- O
phase _RARE_
livers _RARE_
, O
we O
observed O
a O
dramatic O
reduction O
in O
HNF I-GENE
- I-GENE
3 I-GENE
alpha I-GENE
expression _RARE_
which O
correlates O
with O
a O
decrease O
in O
the O
expression _RARE_
of O
its O
target O
gene O
, O
the O
TTR _RARE_
gene I-GENE
. O

Alternatively _RARE_
, O
loss _RARE_
- O
of O
- O
function O
alleles O
of O
genes O
that O
inhibit O
cAPK _RARE_
lead O
to O
the O
inability _RARE_
to O
undergo O
sexual O
differentiation O
. O

One O
member _RARE_
of O
this O
family O
, O
RFX1 _RARE_
, O
is O
a O
transcription O
factor O
for _RARE_
a O
variety O
of O
viral O
and O
cellular O
genes O
. O

This O
mutant O
was O
identified O
by O
screening O
with O
a O
TGF I-GENE
- I-GENE
beta I-GENE
- O
inducible O
vector O
a O
series O
of O
mink _RARE_
lung _RARE_
epithelial _RARE_
cell O
clones _RARE_
that O
have O
normal O
TGF I-GENE
- I-GENE
beta I-GENE
binding O
activity O
but O
have O
lost O
antiproliferative _RARE_
and O
transcriptional O
responses O
to O
TGF I-GENE
- I-GENE
beta I-GENE
. O

Cloning O
by O
complementation _RARE_
and O
subsequent O
physical O
and O
genetic O
analysis O
revealed O
that O
it O
maps O
to O
RAF1 _RARE_
. O

In O
the O
presence O
of O
inositol _RARE_
and O
choline _RARE_
( O
repressing O
), _RARE_
the O
product O
of O
the O
OPI1 _RARE_
gene I-GENE
represses O
transcription O
dictated _RARE_
by O
the O
UASINO _RARE_
element O
. O

By O
treating _RARE_
monkey _RARE_
COS O
cells O
with O
oligonucleotides O
linked _RARE_
to O
psoralen _RARE_
, O
we O
have O
generated O
targeted O
mutations O
in O
a O
simian O
virus O
40 O
( O
SV40 O
) O
vector O
contained O
within O
the O
cells O
via O
intracellular _RARE_
triple _RARE_
helix O
formation O
. O

The O
interleukin I-GENE
2 I-GENE
receptor I-GENE
alpha I-GENE
- I-GENE
chain I-GENE
( O
IL _RARE_
- I-GENE
2R I-GENE
alpha I-GENE
) O
gene O
is O
rapidly O
and O
potently _RARE_
induced _RARE_
in O
T O
cells O
in O
response O
to O
mitogenic O
stimuli O
. O

The O
Wilms _RARE_
' I-GENE
tumour _RARE_
suppressor I-GENE
protein I-GENE
( O
WT1 I-GENE
) O
is O
a O
putative O
transcriptional O
regulatory O
protein O
with O
four O
zinc O
fingers _RARE_
, O
the O
last O
three O
of O
which O
have O
extensive O
sequence O
homology O
to O
the O
early I-GENE
growth I-GENE
response I-GENE
- I-GENE
1 I-GENE
( O
EGR _RARE_
- I-GENE
1 I-GENE
) O
protein O
. O

OBJECTIVES O
: O
1 O
) O
to O
determine O
serum I-GENE
ACE I-GENE
activity O
in O
patients O
with O
COPD O
treated O
with O
and O
without O
continuous O
ambulatory O
oxygen O
therapy O
( O
CAOT _RARE_
); O
2 O
) O
to O
verify _RARE_
whether O
there O
is O
a O
correlation O
between O
ACE I-GENE
and O
any O
hematological _RARE_
, O
spirometric _RARE_
or O
gasometric _RARE_
parameter O
. O

In O
order O
to O
infer _RARE_
shape O
from O
contour _RARE_
, O
the O
human O
visual O
system _RARE_
must O
selectively O
integrate _RARE_
fragments O
projecting _RARE_
from O
a O
common O
object _RARE_
while O
keeping _RARE_
fragments O
from O
different O
objects O
separate O
. O

Among O
9 O
group O
I O
patients O
with O
a O
positive O
result O
on O
head O
- O
up _RARE_
tilt O
- O
table _RARE_
testing O
and O
no _RARE_
evidence O
of O
structural O
heart _RARE_
disease _RARE_
( O
mean O
follow O
- O
up _RARE_
4 O
. O
3 O
years O
), _RARE_
7 O
are O
without O
further O
episodes O
of O
syncope _RARE_
; O
3 O
have O
discontinued _RARE_
medication O
and O
5 O
have O
resumed _RARE_
at _RARE_
least O
limited O
exercise O
. O

Constructs _RARE_
designed O
and O
expressed _RARE_
were O
E2L1 _RARE_
( O
1 O
- O
98 O
), _RARE_
E2L1 _RARE_
. O
H1 _RARE_
( O
1 O
- O
128 _RARE_
), _RARE_
E2L2 _RARE_
( O
120 O
- O
233 _RARE_
), _RARE_
E2H1 _RARE_
. O
L2 O
( O
98 O
- O
233 _RARE_
), _RARE_
and O
E2L1 _RARE_
. O
H1 _RARE_
. O
L2 O
( O
1 O
- O
233 _RARE_
), _RARE_
where O
numbers O
in O
parentheses _RARE_
give O
the O
amino O
acid O
sequence O
for _RARE_
the O
portions O
of O
the O
E2 I-GENE
component _RARE_
incorporated O
into O
a O
construct O
. O

Thus O
, O
we O
have O
produced O
lipoyl _RARE_
domain O
constructs O
that O
can O
be O
employed O
in O
sorting _RARE_
the O
specific O
roles O
of O
E2L1 _RARE_
and O
E2L2 _RARE_
in O
facilitating O
catalytic O
and O
regulatory O
processes O
. O

METHODS O
: O
Ten O
influenza _RARE_
A O
( O
H3N2 _RARE_
) O
viruses O
isolated O
during _RARE_
the O
outbreaks _RARE_
were O
examined O
for _RARE_
resistance O
to O
amantadine _RARE_
and O
rimantadine _RARE_
by O
means O
of O
an O
enzyme O
immunoassay O
and O
by O
sequencing O
of O
the O
viral O
nucleic _RARE_
acid O
that O
encodes O
the O
transmembrane O
domain O
of O
the O
M2 _RARE_
protein I-GENE
. O

The O
first _RARE_
contains O
ATF I-GENE
/ O
CRE _RARE_
and O
TBP I-GENE
/ O
TATA O
sequence O
motifs O
within O
an O
87 O
- O
bp O
region O
. O

Gene _RARE_
expression _RARE_
occurs O
in O
a O
circadian O
rhythm O
and O
induced _RARE_
by O
light O
in O
leaves O
of O
dark O
- O
adapted O
plants _RARE_
. O

Our O
results O
suggested O
that O
the O
hexamer O
and O
the O
octamer O
motifs O
may O
play O
important O
role O
( O
s O
) O
in O
regulation _RARE_
of O
replication O
- O
dependent O
but O
not O
of O
replication O
- O
independent O
expression _RARE_
of O
the O
wheat _RARE_
histone I-GENE
H3 _RARE_
gene I-GENE
. O

The O
tissue O
- O
specific O
expression _RARE_
of O
DP _RARE_
family I-GENE
members I-GENE
suggests O
that O
the O
combination O
of O
DP _RARE_
/ O
E2F I-GENE
heterodimers _RARE_
that O
constitute O
DRTF1 _RARE_
/ O
E2F I-GENE
is O
influenced O
by O
the O
phenotype _RARE_
of O
the O
cell O
. O

Similarly O
, O
in O
mammalian O
cells O
PBP74 _RARE_
is O
synthesized O
as _RARE_
a O
pre O
- O
protein O
that O
requires O
membrane O
potential _RARE_
- O
dependent O
import O
into O
mitochondria _RARE_
for _RARE_
its O
maturation _RARE_
. O

In O
a O
second O
experiment O
involving O
an O
18 O
- O
h O
lung _RARE_
clearance O
assay O
, O
we O
used O
the O
mAb _RARE_
3 I-GENE
. I-GENE
2 I-GENE
. I-GENE
3 I-GENE
to O
deplete _RARE_
rats O
of O
LGL _RARE_
/ O
NK _RARE_
cells O
with O
the O
following O
rationale _RARE_
: O
if O
LGL _RARE_
/ O
NK _RARE_
cells O
are O
necessary O
to O
mediate O
an O
event O
, O
then O
in O
their O
absence O
, O
that O
event O
should O
not O
occur O
. O

Treatment O
of O
recurrent O
FSGS _RARE_
has O
included O
high O
- O
dose O
steroids O
, O
high O
- O
dose O
cyclosporine O
( O
CSA _RARE_
), _RARE_
plasmapheresis _RARE_
, O
and O
ACE I-GENE
inhibitors _RARE_
with O
mixed O
results O
. O

Our O
results O
concluded O
that O
1 O
) O
the O
two O
inhibin _RARE_
/ O
activin I-GENE
beta O
B O
- O
subunit O
mRNAs O
were O
transcribed _RARE_
from O
different O
initiation O
sites O
; O
2 O
) O
both O
promoters O
may O
be O
controlled _RARE_
by O
up _RARE_
- O
stream _RARE_
negative O
regulatory O
elements O
; O
and O
3 O
) O
neither O
of O
these O
promoters O
is O
responsive O
to O
cAMP O
and O
/ O
or O
phorbol O
esters O
under O
the O
conditions O
employed O
. O

Promoter O
region O
of O
the O
transcriptional O
unit O
for _RARE_
human I-GENE
alpha I-GENE
1 I-GENE
- I-GENE
chimaerin _RARE_
, O
a O
neuron _RARE_
- I-GENE
specific I-GENE
GTPase I-GENE
- I-GENE
activating I-GENE
protein I-GENE
for _RARE_
p21rac _RARE_
. O
alpha I-GENE
1 I-GENE
- I-GENE
chimaerin _RARE_
is O
a O
neuron _RARE_
- I-GENE
specific I-GENE
GTPase I-GENE
- I-GENE
activating I-GENE
protein I-GENE
for _RARE_
p21rac _RARE_
, O
a O
protein O
involved O
in O
morphological O
events O
. O

Upstream O
from O
the O
transcription O
start _RARE_
point O
( O
tsp _RARE_
), _RARE_
a O
nucleotide O
sequence O
highly O
homologous O
to O
the O
consensus I-GENE
sequence I-GENE
motif I-GENE
for _RARE_
the I-GENE
sigma _RARE_
35 _RARE_
- I-GENE
recognized _RARE_
promoters I-GENE
was O
found O
. O

In O
this O
paper O
, O
an O
analysis O
of O
the O
dynamics O
in O
the O
closing _RARE_
phase _RARE_
of O
the O
occluder _RARE_
of O
a O
mechanical O
monoleaflet _RARE_
heart _RARE_
valve O
prosthesis _RARE_
is O
presented O
. O

During O
ISO _RARE_
+ O
AT O
infusion O
, O
abdominal O
fat O
blood _RARE_
flow O
was O
still O
significantly O
increased O
as _RARE_
compared O
with O
control O
values O
in O
lean O
and O
obese O
subjects O
. O

When O
expressed _RARE_
per O
kilogram _RARE_
body O
weight _RARE_
, O
mean O
GIT _RARE_
increased O
in O
the O
dF _RARE_
group O
from O
0 _RARE_
. O
14 O
% O
to O
0 _RARE_
. O
16 O
% O
above O
RMR _RARE_
, O
with O
a O
significant O
decrease O
from O
0 _RARE_
. O
15 _RARE_
% O
to O
0 _RARE_
. O
13 _RARE_
% O
in O
the O
P O
group O
. O

In O
nucleus O
ventralis _RARE_
anterior O
thalami _RARE_
- O
nucleus O
ventralis _RARE_
lateralis _RARE_
thalami _RARE_
neurons O
with O
an O
inhibitory _RARE_
input O
from O
nucleus O
entopeduncularis _RARE_
, O
a O
shortening O
of O
inhibition O
from O
17 _RARE_
. O
5 O
+/- O
3 O
. O
6 O
to O
9 O
. O
1 O
+/- O
1 O
. O
8 O
ms O
( O
P O
< O
0 _RARE_
. O
05 O
) O
under O
the O
haloperidol O
influence O
was O
evident O
. O

However O
, O
inclusion O
of O
the O
neighboring _RARE_
CGGAAR _RARE_
motifs O
from O
the O
ICP4 I-GENE
promoter I-GENE
, O
which O
bind O
factors O
GABP I-GENE
alpha I-GENE
and I-GENE
beta I-GENE
, O
results O
in O
a O
strong O
synergistic O
activation O
. O

The O
first _RARE_
open _RARE_
reading O
frame O
of O
the O
blueberry _RARE_
scorch _RARE_
carlavirus _RARE_
( O
BBScV _RARE_
) O
genome O
encodes O
a O
putative O
replication O
- O
associated O
protein O
of O
223 _RARE_
kDa O
( O
p223 _RARE_
). O

From O
sequence O
alignments _RARE_
with O
phylogenetically _RARE_
related O
viruses O
, O
including O
tymoviruses _RARE_
, O
we O
predicted O
that O
p223 _RARE_
contained O
a O
papain _RARE_
- I-GENE
like I-GENE
proteinase _RARE_
domain I-GENE
with O
a O
putative O
catalytic O
cysteine994 _RARE_
and O
histidine1075 _RARE_
. O

This O
finding O
represents O
both O
a O
potentially O
important O
mechanism O
by O
which O
HPV O
gene O
expression _RARE_
can O
be O
regulated O
and O
an O
interesting _RARE_
model O
for _RARE_
the O
study O
of O
transcriptional O
cooperativity O
. O

Using O
this O
method O
, O
VLPs _RARE_
were O
obtained O
in O
quantities _RARE_
sufficient O
for _RARE_
further O
characterization O
. O

Analysis O
of O
the O
sequence O
upstream O
of O
this O
initiation O
codon _RARE_
reveals O
the O
presence O
of O
a O
promotor _RARE_
sequence O
. O

SUP46 _RARE_
is O
implicated O
in O
translation O
fidelity _RARE_
and O
encodes O
the O
ribosomal I-GENE
protein I-GENE
S13 _RARE_
. O

To O
explore O
the O
functional _RARE_
relationship O
between O
c I-GENE
- I-GENE
fos I-GENE
and O
Rb _RARE_
, O
a O
eukaryotic O
expression _RARE_
plasmid _RARE_
was O
constructed O
containing O
the O
c I-GENE
- I-GENE
fos I-GENE
gene I-GENE
under O
control O
of O
the O
SV40 I-GENE
promoter I-GENE
complex O
. O

The O
high O
degree O
of O
sequence O
identity O
( O
96 O
%) O
between O
hydrolase _RARE_
B I-GENE
and I-GENE
C I-GENE
, O
particularly O
in O
the O
3 O
' O
untranslated _RARE_
region O
, O
suggests O
that O
the O
genes O
encoding O
these O
two O
carboxylesterases _RARE_
evolved O
by O
duplication O
and O
divergence O
of O
a O
common O
ancestral O
gene O
. O

The O
regions O
of O
the O
tooth O
fracture O
are O
determined O
. O

Secondary _RARE_
pancreatic O
involvement O
of O
mycosis _RARE_
fungoides _RARE_
detected O
by O
a O
clinically O
palpable _RARE_
mass O
. O

The O
NR2 _RARE_
hybrid _RARE_
is O
a O
powerful _RARE_
tool O
for _RARE_
the O
mapping O
of O
new O
probes _RARE_
of O
this O
region O
, O
as _RARE_
well _RARE_
as _RARE_
for _RARE_
obtaining O
new O
informative _RARE_
probes _RARE_
specific O
for _RARE_
the O
deletion O
by O
subtractive _RARE_
cloning O
of O
the O
region O
. O

TDEYA _RARE_
at _RARE_
doses O
of O
200 _RARE_
to O
500 O
mg O
/ O
kg O
significantly O
suppressed O
xanthine _RARE_
oxidase I-GENE
( O
XO _RARE_
) O
activity O
in O
the O
stomach O
tissue O
following O
its O
oral O
administration O
. O

Like O
humans O
, O
the O
PITSLRE _RARE_
PK _RARE_
genes I-GENE
in I-GENE
chickens _RARE_
must O
be O
closely O
linked _RARE_
, O
based O
on O
fluorescent _RARE_
in O
situ O
hybridization O
( O
FISH _RARE_
) O
localization _RARE_
of O
these O
genes O
to O
a O
single O
chicken O
microchromosome _RARE_
. O

Here O
, O
we O
report O
the O
characterization O
of O
an O
alternatively _RARE_
processed O
form O
of O
AFAP _RARE_
- I-GENE
110 _RARE_
that O
encodes O
an O
additional O
258 O
base _RARE_
pair _RARE_
( O
bp O
) O
of O
open _RARE_
reading O
frame O
. O

Expression O
of O
class I-GENE
IV I-GENE
ADH I-GENE
mRNA I-GENE
was O
detected O
in O
human O
stomach O
but O
not O
liver O
. O

In O
ICE I-GENE
gamma I-GENE
, O
most O
of O
the O
propeptide _RARE_
( O
amino O
acids _RARE_
20 O
- O
112 O
) O
is O
deleted _RARE_
, O
which O
suggests O
that O
it O
may O
function O
as _RARE_
a O
catalyst _RARE_
for _RARE_
ICE I-GENE
autoprocessing _RARE_
in O
vivo O
. O

Endocytosis _RARE_
and O
lysosomal _RARE_
targeting O
of O
epidermal _RARE_
growth I-GENE
factor I-GENE
receptors I-GENE
are O
mediated _RARE_
by O
distinct O
sequences O
independent O
of O
the O
tyrosine I-GENE
kinase I-GENE
domain I-GENE
. O

It O
is O
now O
recognized _RARE_
that O
essentially O
all O
eukaryotic O
and O
prokaryotic _RARE_
genes O
whose O
5 O
'- O
flanking O
regions O
are O
known O
and O
that O
encode O
barbiturate _RARE_
- O
inducible O
proteins O
contain O
the O
Barbie _RARE_
box O
element O
. O

Mutation O
of O
the O
P450BM _RARE_
- I-GENE
3 I-GENE
Barbie _RARE_
box I-GENE
significantly O
increased O
the O
expression _RARE_
of O
both O
P450BM _RARE_
- I-GENE
3 I-GENE
and O
Bm3P1 _RARE_
( O
another O
small O
gene O
located _RARE_
upstream O
of O
the O
P450BM _RARE_
- I-GENE
3 I-GENE
gene I-GENE
that O
encodes O
a O
second O
putative O
regulatory O
protein O
) O
in O
response O
to O
pentobarbital _RARE_
induction O
but O
left _RARE_
the O
basal O
levels O
unaffected O
. O

The O
p97 _RARE_
- O
depleted O
nuclei O
remained O
largely O
competent O
for _RARE_
nuclear O
protein O
import O
. O

A O
potential _RARE_
outcome O
of O
these O
biochemical O
effects O
may O
include O
the O
limited O
responsiveness O
of O
infected _RARE_
T O
cells O
to O
antigenic _RARE_
stimulation _RARE_
observed O
during _RARE_
HIV O
- O
1 O
infection O
. O

The O
full O
protocol O
was O
completed O
by O
33 _RARE_
patients O
( O
45 _RARE_
% O
of O
original O
cohort O
). O

In O
addition O
, O
we O
found O
that O
cell O
- O
specific O
suppression O
of O
RA _RARE_
- O
stimulated _RARE_
zif268 _RARE_
gene I-GENE
expression _RARE_
can O
be O
attributed O
to O
a O
29 O
base _RARE_
pair _RARE_
nucleotide O
sequence O
, O
located _RARE_
downstream _RARE_
of O
the O
RA _RARE_
- O
responsive O
region O
in O
the O
zif268 _RARE_
gene I-GENE
. O

We O
show O
that O
CBF I-GENE
- I-GENE
A I-GENE
and O
CBF I-GENE
- I-GENE
C I-GENE
interact O
with O
each O
other O
to O
form O
a O
CBF I-GENE
- I-GENE
A I-GENE
- O
CBF I-GENE
- I-GENE
C I-GENE
complex O
and O
that O
CBF I-GENE
- I-GENE
B I-GENE
does O
not O
interact O
with O
CBF I-GENE
- I-GENE
A I-GENE
or O
CBF I-GENE
- I-GENE
C I-GENE
individually O
but O
that O
it O
associates O
with O
the O
CBF I-GENE
- I-GENE
A I-GENE
- O
CBF I-GENE
- I-GENE
C I-GENE
complex O
. O

In O
the O
first _RARE_
, O
homologous O
sequences O
were O
deleted _RARE_
from O
a O
mouse O
enhancer O
, O
resulting O
in O
a O
tissue O
- O
specific O
loss _RARE_
of O
activity O
when O
assayed O
in O
transgenic O
mice O
. O

OKT3 _RARE_
prophylaxis O
improves _RARE_
long O
- O
term O
renal _RARE_
graft O
survival O
in O
high O
- O
risk O
patients O
as _RARE_
compared O
to O
cyclosporine O
: O
combined O
results O
from O
the O
prospective O
, O
randomized O
Belgian _RARE_
and O
US O
studies O
. O

The O
major O
PKC I-GENE
beta I-GENE
transcription O
initiation O
site O
was O
identified O
by O
primer O
extension O
and O
S1 I-GENE
nuclease _RARE_
protection O
. O

In O
the O
course O
of O
a O
study O
of O
low O
dose O
X O
- O
rays O
effects O
, O
we O
found O
that O
male O
ICR _RARE_
white _RARE_
Swiss _RARE_
mice O
showed O
remarkable O
suppression O
of O
mounting _RARE_
behavior O
after O
whole O
body O
irradiation O
by O
5 O
to O
15 _RARE_
cGy _RARE_
X O
- O
rays O
. O

A O
quantitative O
analysis O
of O
the O
diffraction _RARE_
intensity O
as _RARE_
function O
of O
the O
accumulated O
electron O
dose O
suggests O
the O
possibility O
of O
recording O
up _RARE_
to O
250 _RARE_
diffraction _RARE_
patterns O
with O
3 O
. O
5 O
A O
resolution O
from O
a O
single O
crotoxin _RARE_
complex O
crystal _RARE_
128 _RARE_
A O
thick O
. O

Supplementary _RARE_
Phase O
Contraste _RARE_
RSE _RARE_
(" O
Rapid _RARE_
Sequential _RARE_
Excitation _RARE_
") _RARE_
sequences O
were O
carried O
out O
in O
29 O
patients O
. O

In O
yeast O
, O
the O
products O
of O
the O
UPF1 _RARE_
and O
UPF3 _RARE_
genes I-GENE
are O
required O
for _RARE_
this O
decay _RARE_
pathway _RARE_
, O
and O
in O
this O
report O
we O
focus O
on O
the O
identification O
and O
characterization O
of O
additional O
factors O
required O
for _RARE_
rapid O
decay _RARE_
of O
nonsense O
- O
containing O
mRNAs O
. O

Mutations O
in O
UPF1 _RARE_
lead O
to O
the O
selective O
stabilization O
of O
mRNAs O
containing O
early O
nonsense O
mutations O
without O
affecting O
the O
decay _RARE_
rates O
of O
most O
other O
mRNAs O
. O

A O
DNA O
fragment O
encoding O
the O
DNA O
- O
binding O
domain O
( O
amino O
acids _RARE_
1 O
- O
60 _RARE_
) O
of O
the O
Escherichia I-GENE
coli I-GENE
fru _RARE_
transcriptional I-GENE
regulator I-GENE
was O
cloned _RARE_
into O
the O
pGEX _RARE_
- O
KT _RARE_
vector O
and O
expressed _RARE_
in O
frame O
with O
the O
fused O
gene O
encoding O
glutathione _RARE_
S I-GENE
- I-GENE
transferase I-GENE
. O

Using O
gel O
retardation O
assays O
with O
HepG2 _RARE_
nuclear O
extract _RARE_
, O
we O
demonstrated O
the O
presence O
of O
a O
specific O
protein O
which O
bound _RARE_
to O
the O
NRE _RARE_
fragment O
. O

0 _RARE_
. O
61 _RARE_
+/- O
0 _RARE_
. O
04 O
). O

Several O
nuclear O
factors O
that O
interact O
with O
sequences O
in O
the O
5 O
' O
flanking O
region O
of O
the O
mouse I-GENE
tyrosinase _RARE_
gene I-GENE
were O
identified O
using O
band O
shift O
and O
methylation O
interference O
assays O
. O

With O
a O
population O
of O
853 _RARE_
million O
there O
should O
be O
51 _RARE_
, O
204 _RARE_
patients O
with O
hemophilia _RARE_
A O
in O
India _RARE_
assuming _RARE_
a O
prevalence O
of O
6 O
/ O
100 _RARE_
, O
000 _RARE_
population O
. O

When O
combined O
with O
serum O
ferritin I-GENE
and O
hemoglobin I-GENE
determinations O
, O
the O
serum O
transferrin I-GENE
receptor I-GENE
assay O
is O
a O
valuable O
addition O
in O
epidemiologic _RARE_
surveys _RARE_
because O
it O
provides O
a O
quantitative O
measure O
of O
functional _RARE_
iron O
deficiency O
and O
it O
distinguishes _RARE_
true O
IDA _RARE_
from O
the O
anemia _RARE_
of O
chronic O
disease _RARE_
. O

Twenty O
- O
two O
consecutive O
patients O
with O
ischaemic O
ulcers O
had O
tcPO2 _RARE_
measured O
and O
the O
ankle _RARE_
/ O
brachial _RARE_
( O
ABI _RARE_
) O
and O
toe O
/ O
brachial _RARE_
( O
TBI _RARE_
) O
indices O
calculated O
. O

TcPO2 _RARE_
measurement O
appears O
to O
be O
a O
reliable O
technique O
that O
can O
influence O
ischaemic O
ulcer O
management O
. O

Since O
1990 O
the O
University O
Hospital _RARE_
of O
Tromso _RARE_
has O
provided O
local O
hospitals O
in O
northern O
Norway _RARE_
with O
a O
remote _RARE_
frozen _RARE_
section O
service _RARE_
and O
with O
access O
to O
video _RARE_
conferences _RARE_
for _RARE_
the O
review O
of O
microscopic O
findings O
and O
for _RARE_
the O
discussion O
of O
major O
diagnostic O
issues O
. O

Current O
status O
of O
telepathology _RARE_
. O

Expression O
of O
h6 _RARE_
. O
1 O
in O
COS O
- O
1 O
cells O
led O
to O
the O
production O
of O
a O
typical O
type I-GENE
IV I-GENE
PDE _RARE_
activity O
in O
that O
cAMP O
, O
but O
not O
cGMP _RARE_
, O
served _RARE_
as _RARE_
substrate O
and O
its O
activity O
was O
insensitive _RARE_
to O
either O
Ca2 _RARE_
+/ _RARE_
CaM I-GENE
or O
cGMP _RARE_
but O
was O
inhibited O
by O
low O
concentrations O
of O
rolipram _RARE_
.( O
ABSTRACT O
TRUNCATED O
AT O
400 _RARE_
WORDS O
) O

PMEK1 _RARE_
displays O
96 O
and O
80 _RARE_
% O
identity O
respectively O
with O
the O
tobacco I-GENE
NTF3 _RARE_
and O
Arabidopsis I-GENE
ATMPK1 _RARE_
kinases I-GENE
, O
and O
only O
50 O
% O
to O
the O
more O
distantly O
related O
plant _RARE_
MAP O
kinase O
MsERK1 _RARE_
from O
alfalfa _RARE_
. O

Translation _RARE_
of O
the O
coding O
segment O
, O
which O
was O
designated O
MsPRP2 _RARE_
, O
suggested O
it O
encodes O
a O
chimeric O
40 O
, O
569 _RARE_
Da _RARE_
cell O
wall _RARE_
protein O
with O
an O
amino O
- O
terminal O
signal O
sequence O
, O
a O
repetitive _RARE_
proline O
- O
rich O
sequence O
, O
and O
a O
cysteine O
- O
rich O
carboxyl _RARE_
- O
terminal O
sequence O
homologous O
to O
nonspecific O
lipid _RARE_
transfer O
proteins O
. O

The O
presence O
of O
type O
I O
hypersensitivity O
in O
a O
subgroup O
of O
aspergillomas _RARE_
suggests O
an O
immunoallergic _RARE_
component _RARE_
to O
this O
disease _RARE_
which O
could O
contribute O
to O
a O
chronic O
inflammatory O
response O
to O
Aspergillus _RARE_
in O
some O
aspergillomas _RARE_
. O

This O
concept O
is O
supported O
by O
the O
identification O
of O
RH _RARE_
- I-GENE
like I-GENE
genes I-GENE
in O
non O
human O
primates O
. O

With O
steady O
illumination _RARE_
, O
outer _RARE_
retinal _RARE_
( O
photoreceptor _RARE_
) O
QO2 _RARE_
decreased O
to O
1 O
. O
4 O
+/- O
0 _RARE_
. O
9 O
ml O
O2 _RARE_
/( _RARE_
100 _RARE_
g O
. O
min O
), _RARE_
but O
inner O
retinal _RARE_
QO2 _RARE_
remained O
unchanged O
at _RARE_
3 O
. O
7 O
+/- O
1 O
. O
5 O
ml O
O2 _RARE_
/( _RARE_
100 _RARE_
g O
. O
min O
) O
( O
5 O
cats O
). O

We O
have O
screened O
the O
mouse O
cDNA O
library O
of O
an O
MIN6 _RARE_
cell O
line O
, O
derived O
from O
pancreatic O
beta O
cells O
, O
for _RARE_
its O
novel O
isoform O
and O
have O
identified O
a O
cDNA O
encoding O
a O
593 _RARE_
- O
amino O
acid O
protein O
having O
63 _RARE_
, O
53 O
, O
and O
30 _RARE_
% O
identity O
with O
munc _RARE_
- I-GENE
18 I-GENE
/ I-GENE
n _RARE_
- I-GENE
Sec1 _RARE_
/ I-GENE
rbSec1 _RARE_
, O
Caenorhabditis I-GENE
elegans I-GENE
unc18 _RARE_
, O
and O
Saccharomyces I-GENE
cerevisiae I-GENE
Sec1p _RARE_
, O
respectively O
. O

The O
catenins _RARE_
bind O
to O
APC _RARE_
and O
E I-GENE
- I-GENE
cadherin _RARE_
in O
a O
similar O
fashion O
, O
but O
APC _RARE_
and O
E I-GENE
- I-GENE
cadherin _RARE_
do O
not O
associate O
with O
each O
other O
either O
in O
the O
presence O
or O
absence O
of O
catenins _RARE_
. O

However O
, O
addition O
of O
core I-GENE
DNA I-GENE
polymerase I-GENE
III I-GENE
to O
preinitiation _RARE_
complex O
, O
fully O
reconstituting _RARE_
holoenzyme _RARE_
resulted O
in O
replacement _RARE_
of O
gamma O
by O
alpha O
at _RARE_
the O
primer O
terminus O
. O

The O
PSD2 _RARE_
gene I-GENE
was O
heterologously _RARE_
expressed _RARE_
by O
infection O
of O
Sf _RARE_
- O
9 O
insect O
cells O
with O
recombinant O
baculovirus _RARE_
, O
resulting O
in O
a O
10 O
- O
fold _RARE_
increase O
in O
PSD _RARE_
activity O
. O

Computerized _RARE_
detection O
of O
abnormal O
asymmetry O
in O
digital O
chest O
radiographs O
. O

These O
results O
suggest O
that O
gluconeogenic _RARE_
genes O
are O
derepressed _RARE_
upon O
binding O
of O
Cat8p _RARE_
, O
whose O
synthesis _RARE_
depends O
on O
the O
release O
of O
Cat4p _RARE_
( O
Mig1p _RARE_
) O
from O
the O
CAT8 _RARE_
promoter I-GENE
. O

Like O
Epo I-GENE
, O
HNF I-GENE
- I-GENE
4 I-GENE
is O
expressed _RARE_
in O
kidney _RARE_
, O
liver O
, O
and O
Hep3B _RARE_
cells O
but O
not O
in O
HeLa O
cells O
. O

Moreover O
, O
the O
hypoxia _RARE_
- O
induced _RARE_
expression _RARE_
of O
the O
endogenous O
Epo I-GENE
gene I-GENE
was O
significantly O
inhibited O
in O
Hep3B _RARE_
cells O
stably O
transfected O
with O
HNF I-GENE
- I-GENE
4 I-GENE
delta I-GENE
C I-GENE
. O

These O
observations O
indicate O
that O
there O
are O
multiple O
mechanisms O
by O
which O
an O
individual O
transcript O
can O
be O
degraded O
following O
deadenylation _RARE_
. O

Small _RARE_
Maf I-GENE
proteins I-GENE
heterodimerize _RARE_
with O
Fos I-GENE
and O
may O
act O
as _RARE_
competitive O
repressors _RARE_
of O
the O
NF _RARE_
- I-GENE
E2 I-GENE
transcription I-GENE
factor I-GENE
. O

We O
show O
here O
that O
the O
binding O
of O
C1F _RARE_
in O
vitro O
is O
sensitive _RARE_
to O
the O
concentration O
of O
calcium _RARE_
ions O
. O

Survival _RARE_
after O
development O
of O
symptomatic O
infection O
( O
P O
- O
2 O
) O
did O
not O
differ O
by O
transmission _RARE_
mode O
. O

Both O
factors O
demonstrated O
significant O
correlations O
with O
rCBF O
in O
the O
medial O
prefrontal _RARE_
cortex O
and O
frontal O
polar _RARE_
cortex O
while O
for _RARE_
each O
factor O
there O
were O
also O
unique O
patterns O
of O
correlations O
with O
posterior O
brain O
regions O
. O

These O
data O
suggest O
that O
the O
function O
of O
the O
DS2 _RARE_
may O
be O
the O
protection O
of O
the O
nuclear O
DNA O
from O
desiccation _RARE_
. O

Glomerular _RARE_
hemodynamics O
during _RARE_
abortion O
induced _RARE_
by O
RU _RARE_
486 _RARE_
and O
sepsis O
in O
rats O
. O

The O
aim O
of O
this O
retrospective O
study O
was O
to O
demonstrate O
that O
in O
certain O
cases O
of O
expulsive _RARE_
choroidal _RARE_
hemorrhage O
( O
ECH _RARE_
) O
anatomical O
success O
and O
useful O
vision O
can O
be O
obtained O
with O
repeated _RARE_
vitreoretinal _RARE_
surgery O
. O

The O
function O
of O
the O
C O
- O
terminal O
tail _RARE_
in O
telomere _RARE_
maintenance _RARE_
is O
not O
mediated _RARE_
through O
the O
RAP1 _RARE_
interacting _RARE_
factor I-GENE
RIF1 _RARE_
: O
rap1 _RARE_
alleles I-GENE
defective _RARE_
in O
both O
the O
C O
- O
terminal O
tail _RARE_
and O
RIF1 _RARE_
interaction I-GENE
domains I-GENE
have O
additive O
effects O
on O
telomere _RARE_
length O
. O

The O
resulting O
integrated O
physical O
, O
genetic O
, O
and O
cytogenetic O
map O
constitutes O
a O
resource O
for _RARE_
the O
characterization O
of O
genes O
that O
may O
be O
involved O
in O
the O
WAGR _RARE_
syndrome _RARE_
. O

The O
contribution O
of O
skin _RARE_
flow O
to O
the O
changes O
in O
760 _RARE_
- O
800 O
nm O
absorption O
was O
investigated O
by O
simultaneous O
measurement O
of O
skin _RARE_
flow O
by O
laser O
flow O
Doppler O
and O
NIR _RARE_
recordings O
during _RARE_
hot O
water O
immersion O
. O

Proteins _RARE_
immunoprecipitated O
from O
lysates O
of O
control O
- O
and O
VEGF I-GENE
- O
stimulated _RARE_
BAEC _RARE_
with O
antisera O
to O
phospholipase I-GENE
C I-GENE
- I-GENE
gamma I-GENE
( O
PLC I-GENE
- I-GENE
gamma I-GENE
) O
were O
fractionated _RARE_
by O
SDS O
- O
polyacrylamide O
gel O
electrophoresis O
and O
transferred O
to O
Immobilon _RARE_
- O
P O
. O

Alternatively _RARE_
processed O
isoforms O
of O
cellular I-GENE
nucleic _RARE_
acid I-GENE
- I-GENE
binding I-GENE
protein I-GENE
interact O
with O
a O
suppressor O
region O
of O
the O
human I-GENE
beta I-GENE
- I-GENE
myosin I-GENE
heavy I-GENE
chain I-GENE
gene I-GENE
. O

Involvement _RARE_
of O
early I-GENE
growth I-GENE
response I-GENE
factor I-GENE
Egr _RARE_
- I-GENE
1 I-GENE
in O
apolipoprotein I-GENE
AI _RARE_
gene I-GENE
transcription O
. O

The O
wild O
- O
type O
and O
altered O
forms O
of O
the O
F I-GENE
protein I-GENE
were O
expressed _RARE_
in O
BHK _RARE_
- O
21 O
and O
HeLa O
T4 O
cells O
by O
use O
of O
the O
recombinant I-GENE
vaccinia _RARE_
virus I-GENE
- I-GENE
encoding I-GENE
T7 _RARE_
polymerase I-GENE
system _RARE_
. O

Erythrocyte _RARE_
delta I-GENE
- I-GENE
aminolevulinic _RARE_
acid I-GENE
dehydratase _RARE_
( O
ALAD _RARE_
) O
activity O
, O
erythrocyte _RARE_
zinc O
protoporphyrin _RARE_
( O
ZPP _RARE_
)/ _RARE_
heme O
ratio O
, O
and O
urinary _RARE_
coproporphyrin _RARE_
( O
UC _RARE_
) O
concentration O
have O
been O
employed O
as _RARE_
biological O
indicators O
of O
moderate O
- O
to O
high O
- O
level O
lead O
exposure O
, O
corresponding O
to O
blood _RARE_
levels O
in O
excess O
of O
50 O
micrograms O
/ O
dl O
, O
in O
human O
subjects O
. O

The O
relative O
risk O
of O
graft O
loss _RARE_
after O
conversion O
to O
azathioprine _RARE_
compared O
with O
graft O
loss _RARE_
after O
conversion O
to O
azathioprine _RARE_
compared O
with O
cyclosporin O
maintenance _RARE_
was O
0 _RARE_
. O
71 _RARE_
( O
0 _RARE_
. O
37 O
- O
1 O
. O
38 O
) O
and O
the O
relative O
risk O
of O
patient O
death _RARE_
was O
0 _RARE_
. O
57 O
( O
0 _RARE_
. O
23 _RARE_
- O
1 O
. O
41 _RARE_
). O

Three O
classes O
of O
test O
objects O
were O
considered O
: O
( O
1 O
) O
a O
multicompartment _RARE_
test O
object _RARE_
for _RARE_
31P _RARE_
MRS O
measurements O
performed O
with O
slice _RARE_
- O
selective O
sequences O
; O
( O
2 O
) O
a O
two O
- O
compartment O
test O
object _RARE_
for _RARE_
volume O
- O
selection O
1H _RARE_
MRS O
; O
and O
( O
3 O
) O
two O
- O
compartment O
test O
objects O
for _RARE_
assessing O
the O
performance O
of O
experimental O
systems _RARE_
using O
ISIS _RARE_
as _RARE_
volume O
localization _RARE_
sequence O
in O
31P _RARE_
MRS O
. O

The O
" O
tobacco O
issue _RARE_
". O

Pregnancy _RARE_
screening O
by O
uterine _RARE_
artery O
Doppler O
velocimetry _RARE_
-- _RARE_
which O
criterion O
performs _RARE_
best O
? O
OBJECTIVE O
: O
To O
test O
whether O
repeating O
Doppler O
studies O
of O
the O
uteroplacental _RARE_
circulation O
late _RARE_
in O
gestation O
will O
improve O
the O
test O
' O
s O
power O
for _RARE_
predicting O
pregnancy _RARE_
- O
induced _RARE_
hypertension O
and O
fetal _RARE_
growth O
restriction _RARE_
( O
FGR _RARE_
), _RARE_
and O
whether O
analysis O
based O
on O
a O
combination O
of O
quantitative O
and O
qualitative O
assessments _RARE_
of O
the O
uterine _RARE_
arterial O
waveforms _RARE_
will O
yield O
better O
results O
than O
analysis O
based O
on O
either O
alone O
. O

The O
effect O
of O
the O
Ca O
entry O
blocker O
nitrendipine _RARE_
, O
the O
antioxidant O
superoxide _RARE_
dismutase I-GENE
( O
SOD I-GENE
), _RARE_
and O
a O
combination O
of O
nitrendipine _RARE_
and O
superoxide _RARE_
dismutase I-GENE
on O
postischemic _RARE_
renal _RARE_
function O
was O
studied O
in O
four O
groups O
( O
n _RARE_
= O
24 _RARE_
) O
of O
rats O
. O

PURPOSE O
: O
The O
aim O
of O
this O
study O
was O
to O
evaluate O
the O
bony _RARE_
anchorage O
of O
a O
new O
implant O
( O
orderly _RARE_
wired _RARE_
surface O
effect O
with O
alloy _RARE_
Ti _RARE_
Al O
Va _RARE_
and O
ordered _RARE_
pores _RARE_
of O
488 _RARE_
mu O
). O

To O
determine O
whether O
food O
and O
/ O
or O
water O
in O
the O
gastrointestinal _RARE_
tract _RARE_
affects O
restitution _RARE_
of O
blood _RARE_
volume O
and O
plasma O
protein O
after O
hemorrhage O
, O
fed O
and O
24 _RARE_
- O
h O
- O
fasted O
awake _RARE_
rats O
received O
a O
20 O
ml O
. O
kg O
- O
1 O
x _RARE_
3 O
min O
- O
1 O
hemorrhage O
, O
and O
restitution _RARE_
of O
blood _RARE_
volume O
was O
measured O
by O
Evans _RARE_
blue O
dye _RARE_
and O
dilution O
of O
hematocrit O
. O

Cooperative _RARE_
dimerization _RARE_
of O
paired I-GENE
class O
homeo _RARE_
domains O
on O
DNA O
. O

We O
took _RARE_
advantage O
of O
the O
high O
degree O
of O
aa _RARE_
sequence O
homology O
between O
DAHPSs _RARE_
from O
several O
species O
to O
isolate O
ARO3 _RARE_
homologues _RARE_
from O
the O
pathogenic O
yeast O
Candida _RARE_
albicans _RARE_
. O

In O
this O
study O
, O
we O
demonstrate O
that O
BOX _RARE_
DNA O
enhances O
transcription O
from O
the O
thymidine _RARE_
kinase I-GENE
( O
TK I-GENE
) O
promoter O
in O
various O
EC O
cells O
. O

Deletion O
analyses O
of O
the O
construct O
revealed O
that O
the O
transcription O
of O
BOXF1 _RARE_
gene I-GENE
is O
regulated O
by O
BOX _RARE_
DNA O
, O
preferentially O
in O
undifferentiated O
EC O
cells O
versus O
differentiated O
cells O
. O

Analysis O
of O
disassociation _RARE_
rates O
indicates O
that O
the O
Grf10 _RARE_
- O
Swi5 _RARE_
- O
DNA O
complex O
has O
a O
longer O
half _RARE_
- O
life O
than O
protein O
- O
DNA O
complexes O
that O
contain O
only O
Swi5 _RARE_
or O
Grf10 _RARE_
. O

The O
presence O
of O
an O
unusual O
transcript O
possessing _RARE_
IVS2C _RARE_
beta I-GENE
1 I-GENE
at _RARE_
the O
5 O
' O
terminus O
suggests O
that O
cleavage _RARE_
of O
its O
splice _RARE_
acceptor _RARE_
is O
inefficient O
or O
negatively O
regulated O
. O

The O
mutant O
allele O
of O
the O
alpha I-GENE
1 I-GENE
- I-GENE
tubulin _RARE_
gene I-GENE
was O
designated O
tua1 _RARE_
- I-GENE
1 I-GENE
. O

During O
chronic O
treatment O
, O
when O
plasma O
concentrations O
fluctuated _RARE_
between O
23 _RARE_
. O
5 O
ng _RARE_
. O
ml O
- O
1 O
at _RARE_
8 O
h O
and O
14 O
ng _RARE_
. O
ml O
- O
1 O
at _RARE_
24 _RARE_
h O
post O
- O
dosing _RARE_
, O
ST O
segment O
depression O
at _RARE_
an O
individually O
comparable O
workload _RARE_
was O
significantly O
decreased O
by O
28 _RARE_
% O
compared O
with O
placebo O
( O
P O
< O
0 _RARE_
. O
005 O
) O
at _RARE_
both O
points O
in O
time O
. O

Results O
from O
in O
vitro O
transcription O
- O
translation O
analysis O
and O
maxicell _RARE_
experiments O
suggested O
that O
the O
447 _RARE_
- O
bp O
ORF O
was O
the O
one O
being O
actively O
expressed _RARE_
. O

Preliminary _RARE_
experiments O
demonstrated O
that O
it O
was O
possible O
to O
produce O
fasD _RARE_
mutants I-GENE
, O
whose O
products O
remain _RARE_
functional _RARE_
for _RARE_
fimbrial _RARE_
export O
and O
assembly O
. O

Evoked _RARE_
electromyographic _RARE_
response O
to O
indirect O
supramaximal _RARE_
stimulation _RARE_
at _RARE_
1 O
Hz O
was O
monitored O
in O
ten O
adult O
goats O
under O
thiopentone _RARE_
- O
halothane O
anaesthesia O
. O

313 _RARE_
, O
98 O
- O
102 _RARE_
). O

Group O
6 O
was O
given O
physostigmine _RARE_
, O
0 _RARE_
. O
1 O
mg O
/ O
kg O
i O
. O
v O
., O
known O
to O
inhibit O
cholinesterase I-GENE
degradation _RARE_
, O
5 O
min O
before O
bupivacaine _RARE_
administration O
, O
and O
Group O
7 O
received O
a O
combination O
of O
physostigmine _RARE_
pretreatment O
and O
electrical O
vagal _RARE_
stimulation _RARE_
. O

To O
examine O
the O
possibility O
that O
LNNB _RARE_
performance O
of O
the O
schizophrenic O
groups O
may O
have O
been O
related O
to O
neuroleptic O
medication O
, O
analyses O
were O
completed O
on O
the O
relationship O
between O
medication O
levels O
and O
LNNB _RARE_
scores O
. O

ISIS _RARE_
5 O
possibilities O
. O

The O
use O
of O
specific O
antibodies O
allowed O
the O
identification O
of O
at _RARE_
least O
RAR I-GENE
beta I-GENE
in O
some O
of O
the O
DNA O
- O
protein O
complexes O
, O
although O
the O
four O
sequences O
bind O
single O
RARs _RARE_
transfected O
in O
COS O
cells O
much O
less O
efficiently O
, O
or O
not O
at _RARE_
all O
, O
when O
compared O
to O
a O
canonical O
RAR I-GENE
responsive I-GENE
element I-GENE
. O

The O
present O
treatment O
strategy O
in O
progressive O
disorders O
is O
mainly O
based O
on O
the O
complementary _RARE_
effect O
of O
intensive O
radiochemotherapy _RARE_
, O
autologous O
stem _RARE_
- O
cell O
transplantation O
and O
the O
rational _RARE_
use O
of O
cytokines _RARE_
, O
mostly O
colony I-GENE
- I-GENE
stimulating I-GENE
factors I-GENE
. O

Our O
study O
cohorts _RARE_
consisted O
of O
15 _RARE_
patients O
who O
received O
SC O
rIL _RARE_
- I-GENE
2 I-GENE
at _RARE_
doses O
of O
4 O
. O
8 O
- O
14 O
. O
4 O
million O
IU O
/ O
m2 O
/ O
day O
on O
5 O
days O
per O
week O
for _RARE_
a O
total _RARE_
of O
8 O
weeks O
, O
20 O
patients O
who O
received O
rIFN _RARE_
- I-GENE
alpha I-GENE
2b _RARE_
at _RARE_
3 O
. O
0 _RARE_
- O
6 O
. O
0 _RARE_
million O
U _RARE_
/ O
m2 O
/ O
day O
thrice _RARE_
weekly O
for _RARE_
a O
total _RARE_
of O
6 O
weeks O
, O
and O
72 O
patients O
who O
were O
given O
SC O
rIFN _RARE_
- I-GENE
alpha I-GENE
2b _RARE_
at _RARE_
6 O
. O
0 _RARE_
million O
U _RARE_
/ O
m2 O
/ O
day O
thrice _RARE_
weekly O
plus _RARE_
SC O
rIL _RARE_
- I-GENE
2 I-GENE
at _RARE_
14 O
. O
4 O
- O
18 O
. O
0 _RARE_
million O
IU O
/ O
m2 O
/ O
day O
on O
days O
1 O
and O
2 O
, O
followed O
by O
4 O
. O
8 O
million O
IU O
/ O
m2 O
/ O
day O
, O
5 O
days O
per O
week O
for _RARE_
6 O
consecutive O
weeks O
. O

Analysis O
of O
a O
set O
of O
deletion O
constructs O
in O
transient O
transfection O
assays O
measuring O
heterologous O
reporter O
gene O
( O
luciferase I-GENE
) O
activity O
demonstrated O
that O
the O
182 O
- O
bp O
5 O
'- O
flanking O
region O
provides O
full O
promoter O
activity O
in O
IL _RARE_
- I-GENE
2 I-GENE
- O
stimulated _RARE_
L2 O
cells O
. O

At O
the O
MTD _RARE_
( O
8 O
mg O
/ O
m2 O
/ O
day O
), _RARE_
the O
dose O
- O
limiting O
toxicity O
of O
this O
agent O
is O
myelosuppression _RARE_
. O

Mitogen _RARE_
- O
induced _RARE_
lymphocyte O
proliferation _RARE_
was O
diminished O
. O

A O
decanucleotide _RARE_
promoter O
sequence O
homologous O
to O
those O
found O
in O
humans O
and O
mice O
was O
located _RARE_
in O
the O
5 O
' O
untranslated _RARE_
region O
of O
one O
horse _RARE_
gene O
. O

Some O
of O
these O
targets _RARE_
were O
reported O
to O
code O
for _RARE_
molecules O
involved O
in O
cell O
- O
cell O
interactions O
, O
whereas O
no _RARE_
relationship O
has O
yet O
been O
demonstrated O
between O
Hox I-GENE
genes I-GENE
and O
other O
transcription O
factors O
involved O
in O
determining _RARE_
and O
/ O
or O
maintaining O
tissue O
specificity _RARE_
. O

Northern O
analysis O
of O
RNA O
samples O
isolated O
from O
ammonium _RARE_
- O
grown O
cultures O
of O
the O
ntcA _RARE_
mutant I-GENE
showed O
reduced _RARE_
amounts O
of O
glnA _RARE_
message _RARE_
and O
the O
absence O
of O
a O
1 O
. O
7 O
- O
kb O
transcript O
. O

HER2 _RARE_
overexpressing O
cells O
showed O
a O
single O
prominent O
DNase I-GENE
I I-GENE
hypersensitive _RARE_
site O
near O
a O
conserved _RARE_
and O
hitherto O
unrecognized _RARE_
ets I-GENE
response O
element O
( O
GAGGAA _RARE_
), _RARE_
located _RARE_
38 O
bases O
down O
- O
stream _RARE_
from O
the O
CAAT O
box O
and O
directly O
5 O
' O
of O
the O
TATA O
box O
in O
the O
human I-GENE
HER2 _RARE_
promoter I-GENE
. O

Gel O
- O
shift O
assays O
with O
nuclear O
extracts O
and O
oligonucleotide _RARE_
sequences O
spanning O
the O
0 _RARE_
. O
125 _RARE_
- O
kb O
promoter O
region O
detected O
an O
ETS _RARE_
- O
immunoreactive _RARE_
complex O
, O
present O
most O
abundantly O
in O
cells O
overexpressing O
HER2 _RARE_
, O
whose O
high O
- O
affinity O
binding O
depended _RARE_
on O
the O
GAGGAA _RARE_
response O
element O
. O

Comparison O
of O
cDNA O
sequences O
revealed O
that O
the O
two O
mRNA O
species O
arise O
as _RARE_
a O
result O
of O
alternate O
use O
of O
poly _RARE_
( O
A O
)- O
addition O
sites O
. O

The O
gene O
for _RARE_
the O
RNA I-GENE
- I-GENE
dependent I-GENE
eIF I-GENE
- I-GENE
2 I-GENE
alpha I-GENE
protein I-GENE
kinase I-GENE
( O
PKR I-GENE
) O
was O
isolated O
from O
mouse O
genomic O
DNA O
and O
characterized O
. O

High _RARE_
- O
frequency O
electrical O
stimulation _RARE_
in O
the O
hippocampus O
leads O
to O
an O
increase O
in O
synaptic O
efficacy O
that O
lasts _RARE_
for _RARE_
many O
hours O
. O

Similar O
to O
the O
mouse O
gene O
, O
the O
5 O
' O
flanking O
region O
of O
human I-GENE
CD79 _RARE_
alpha I-GENE
lacks O
a O
TATA O
box O
; O
however O
, O
unlike O
mouse I-GENE
CD79 _RARE_
alpha I-GENE
, O
a O
classical O
octamer O
motif O
could O
not O
be O
identified O
in O
the O
human O
gene O
. O

Detailed _RARE_
molecular _RARE_
organization O
of O
the O
coding O
and O
upstream O
regulatory O
regions O
of O
the O
murine O
homeodomain _RARE_
- I-GENE
containing I-GENE
gene I-GENE
, O
Msx _RARE_
- I-GENE
1 I-GENE
, O
is O
reported O
. O

We O
report O
here O
the O
cloning O
of O
the O
human I-GENE
goosecoid _RARE_
gene I-GENE
( O
GSC _RARE_
) O
from O
a O
genomic O
library O
and O
the O
sequence O
of O
its O
encoded O
protein O
. O

In O
order O
to O
define O
potential _RARE_
candidate O
genes O
for _RARE_
inherited O
disorders O
characterized O
by O
aberrant O
gene O
expression _RARE_
, O
we O
utilized O
Kruppel _RARE_
- I-GENE
related I-GENE
sequences I-GENE
to O
isolate O
zinc O
finger O
- O
containing O
cDNAs O
. O

This O
virus O
is O
not O
merely _RARE_
a O
South _RARE_
African O
strain _RARE_
of O
passion _RARE_
fruit _RARE_
woodiness _RARE_
virus O
( O
PWV _RARE_
): O
the O
deduced O
CP I-GENE
sequence I-GENE
is O
only O
distantly O
related O
to O
CPs _RARE_
of O
other O
sequenced O
strains O
of O
PWV _RARE_
, O
although O
it O
is O
part O
of O
a O
distinct O
subgroup O
of O
potyviruses _RARE_
related O
to O
PWV _RARE_
. O

The O
ratio O
of O
the O
activity O
of O
arogenate _RARE_
dehydrogenase I-GENE
to O
that O
of O
prephenate _RARE_
dehydrogenase I-GENE
( O
approximately _RARE_
3 O
: O
1 O
) O
remained O
constant O
throughout O
purification O
, O
and O
the O
two O
activities O
were O
therefore O
inseparable _RARE_
. O

The O
isolated O
POT1 _RARE_
clones _RARE_
hybridized O
to O
a O
1 O
. O
4 O
kb O
RNA O
species O
, O
which O
was O
induced _RARE_
approximately _RARE_
30 _RARE_
- O
fold _RARE_
when O
oleate _RARE_
was O
the O
carbon O
source O
. O

The O
Y O
. O
lipolytica _RARE_
genomic O
POT1 _RARE_
gene O
was O
disrupted O
by O
replacing O
120 O
bp O
of O
its O
coding O
sequence O
with O
2 O
. O
7 O
kbp _RARE_
of O
DNA O
including O
the O
Y O
. O
lipolytica _RARE_
LEU2 I-GENE
gene I-GENE
. O

A O
leucine O
zipper O
domain O
of O
the O
suppressor I-GENE
of I-GENE
Hairy _RARE_
- I-GENE
wing _RARE_
protein I-GENE
mediates O
its O
repressive O
effect O
on O
enhancer O
function O
. O

It O
is O
concluded O
that O
CT _RARE_
should O
be O
routinely _RARE_
employed O
in O
patients O
with O
N1 _RARE_
- O
N3 _RARE_
neck O
disease _RARE_
to O
determine O
the O
proper O
electron O
- O
energy O
prescription _RARE_
. O

The O
predicted O
DNA O
- O
binding O
, O
zinc I-GENE
finger I-GENE
domain I-GENE
protein I-GENE
sequence O
was O
strictly O
conserved _RARE_
. O

60 _RARE_
patients O
were O
entered _RARE_
into O
a O
randomised O
study O
comparing O
vindesine _RARE_
( O
3 O
mg O
/ O
m2 O
/ O
week O
) O
plus _RARE_
interferon _RARE_
- I-GENE
alpha I-GENE
2b _RARE_
( O
6 O
U _RARE_
/ O
m2 O
3 O
times O
per O
week O
) O
to O
vindesine _RARE_
alone O
or O
to O
interferon _RARE_
alone O
for _RARE_
the O
treatment O
of O
metastatic O
malignant O
melanoma _RARE_
. O

The O
novel O
Notch I-GENE
homologue I-GENE
mouse I-GENE
Notch I-GENE
3 I-GENE
lacks O
specific O
epidermal _RARE_
growth I-GENE
factor I-GENE
- I-GENE
repeats I-GENE
and O
is O
expressed _RARE_
in O
proliferating _RARE_
neuroepithelium _RARE_
. O

BACKGROUND O
: O
We O
conducted O
a O
phase _RARE_
I O
study O
with O
MDL _RARE_
73 _RARE_
, O
147EF _RARE_
, O
a O
new O
5 I-GENE
hydroxytryptamine _RARE_
3 I-GENE
( I-GENE
5 I-GENE
- I-GENE
HT3 I-GENE
) I-GENE
receptor I-GENE
antagonist O
, O
in O
25 _RARE_
patients O
requiring O
emetogenic _RARE_
chemotherapy O
. O

In O
the O
presence O
of O
the O
in O
vivo O
reducing _RARE_
system _RARE_
( O
thioredoxin _RARE_
, O
thioredoxin _RARE_
reductase I-GENE
, O
and O
NADPH _RARE_
), _RARE_
however O
, O
each O
of O
these O
mutants O
catalyzed O
the O
formation O
of O
only O
0 _RARE_
. O
6 O
- O
0 _RARE_
. O
8 O
dCTPs _RARE_
per O
mole _RARE_
of O
enzyme O
. O

These O
genetic O
alterations O
do O
not O
affect O
synthesis _RARE_
of O
the O
major O
c I-GENE
- I-GENE
myc I-GENE
protein I-GENE
, O
p64 _RARE_
, O
which O
is O
initiated _RARE_
from O
the O
first _RARE_
AUG O
codon _RARE_
in O
exon _RARE_
2 O
. O

In O
addition O
, O
both O
the O
exon _RARE_
1 O
- O
and O
exon _RARE_
2 O
- O
initiated _RARE_
forms O
of O
the O
c I-GENE
- I-GENE
Myc _RARE_
protein I-GENE
stimulated _RARE_
transcription O
of O
a O
Myc _RARE_
/ O
Max I-GENE
- O
responsive O
reporter O
construct O
to O
a O
similar O
level O
. O

Biological O
activities O
of O
hematopoietic I-GENE
growth I-GENE
factors I-GENE
that O
lead O
to O
future O
clinical O
application O
. O

Expression O
is O
exclusively O
limited O
to O
the O
CNS O
at _RARE_
this O
and O
later O
stages O
. O

Immunoreactive _RARE_
AR _RARE_
content O
in O
transfected O
COS O
- O
1 O
cells O
was O
not O
influenced O
by O
exposure O
to O
8 O
- O
Br O
- O
cAMP O
. O

Disruption O
of O
any O
one O
of O
the O
four O
genes O
encoding O
the O
newly O
identified O
SRP I-GENE
proteins I-GENE
results O
in O
slow O
cell O
growth O
and O
inefficient O
protein O
translocation O
across O
the O
ER O
membrane O
. O

Genetic O
alterations O
in O
elements O
of O
normal O
signal O
transduction _RARE_
mechanisms O
are O
known O
to O
be O
oncogenic _RARE_
events O
often O
resulting O
in O
aberrant O
activation O
of O
programs O
of O
gene O
transcription O
. O

The O
expression _RARE_
pattern O
of O
GL2 _RARE_
, O
as _RARE_
demonstrated O
by O
in O
situ O
hybridization O
, O
indicated O
that O
the O
gene O
is O
expressed _RARE_
in O
trichome _RARE_
progenitor _RARE_
cells O
and O
at _RARE_
stages O
associated O
with O
trichome _RARE_
development O
. O

NOT4 _RARE_
interacts O
with O
NOT1 _RARE_
and O
NOT3 _RARE_
in O
the O
two O
- O
hybrid _RARE_
assay O
, O
and O
overexpression O
of O
NOT3 _RARE_
or O
NOT4 _RARE_
suppresses O
not1 _RARE_
and O
not2 _RARE_
mutations O
. O

Binding O
site O
selection O
using O
in O
vitro O
- O
synthesized O
proteins O
reveals O
that O
the O
ROR _RARE_
alpha I-GENE
1 I-GENE
and O
ROR _RARE_
alpha I-GENE
2 I-GENE
isoforms I-GENE
bind O
DNA O
as _RARE_
monomers _RARE_
to O
hormone O
response O
elements O
composed O
of O
a O
6 O
- O
bp O
AT O
- O
rich O
sequence O
preceding O
a O
half _RARE_
- O
site O
core O
motif O
PuGGTCA _RARE_
( O
RORE _RARE_
). O

The O
p73pct1 _RARE_
/ O
p85cdc10 _RARE_
complex O
binds O
both O
in O
vitro O
and O
in O
vivo O
to O
MCB _RARE_
but O
not O
SCB _RARE_
or O
E2F I-GENE
sites I-GENE
. O

We O
show O
that O
the O
en _RARE_
stripes _RARE_
expand _RARE_
anteriorly _RARE_
in O
slp _RARE_
mutant O
embryos _RARE_
and O
that O
slp _RARE_
activity O
is O
an O
absolute O
requirement O
for _RARE_
maintenance _RARE_
of O
wg _RARE_
expression _RARE_
at _RARE_
the O
same O
time O
that O
wg _RARE_
transcription O
is O
dependent O
on O
hh _RARE_
. O

The O
DNA O
sequence O
adjacent O
to O
the O
lacZ I-GENE
gene I-GENE
has O
been O
determined O
for _RARE_
91 O
vegetative _RARE_
fusion O
genes O
whose O
products O
have O
been O
localized O
and O
for _RARE_
43 _RARE_
meiotically _RARE_
induced _RARE_
fusions O
. O

CMV _RARE_
hyperimmunoglobulin _RARE_
treatment O
( O
Cytotect _RARE_
, O
Biotest _RARE_
) O
was O
started O
( O
2 O
ml O
/ O
kg O
bw _RARE_
on O
day O
1 O
and O
3 O
, O
and O
1 O
ml O
/ O
kg O
on O
days O
5 O
, O
7 O
and O
9 O
), _RARE_
which O
led O
to O
the O
eradication O
of O
the O
residual O
infiltrate _RARE_
and O
CMV _RARE_
- O
DNA O
in O
the O
myocardium O
. O

Internal _RARE_
biliary O
drainage O
, O
unlike O
external O
drainage O
, O
does O
not O
suppress O
the O
regeneration O
of O
cholestatic _RARE_
rat O
liver O
after O
partial O
hepatectomy _RARE_
. O

ORF O
2 O
potentially O
encoded O
a O
hydrophobic O
protein O
of O
29 O
, O
705 _RARE_
Da _RARE_
with O
six _RARE_
potential _RARE_
membrane O
- O
spanning O
regions O
. O

In O
eight O
groups O
of O
subjects O
operating O
various O
hand _RARE_
- O
held O
vibrating _RARE_
tools O
and O
aged O
from O
30 _RARE_
to O
59 _RARE_
years O
, O
the O
prevalence O
rates O
of O
vibration O
- O
induced _RARE_
white _RARE_
finger O
( O
VWF _RARE_
) O
and O
numbness _RARE_
, O
pain O
, O
or O
stiffness O
in O
the O
upper O
and O
lower O
extremities _RARE_
were O
investigated O
. O

DNA O
sequence O
analysis O
showed O
that O
the O
gene O
was O
525 _RARE_
bp O
long O
and O
encoded O
a O
175 O
- O
amino O
- O
acid O
protein O
with O
a O
molecular _RARE_
weight _RARE_
of O
19 O
, O
094 _RARE_
containing O
a O
21 O
- O
residue _RARE_
typical O
lipoprotein O
signal O
peptide O
and O
consensus O
prolipoprotein _RARE_
processing _RARE_
site O
. O

DNA O
sequence O
and O
functions O
of O
the O
actVI _RARE_
region I-GENE
of O
the O
actinorhodin _RARE_
biosynthetic O
gene O
cluster O
of O
Streptomyces _RARE_
coelicolor _RARE_
A3 _RARE_
( O
2 O
). O

( O
1992 O
) O
Genomics _RARE_
12 O
, O
58 O
- O
62 _RARE_
). O

A O
comparison O
of O
the O
predicted O
polypeptide O
sequence O
of O
the O
Drosophila O
protein O
with O
the O
equivalent O
subunits O
from O
mouse O
and O
yeast O
suggests O
that O
they O
are O
closely O
related O
and O
defines O
three O
conserved _RARE_
regions O
which O
are O
likely O
to O
be O
important O
for _RARE_
enzyme O
activity O
. O

Plasmids _RARE_
were O
constructed O
with O
the O
mouse O
promoter O
region O
linked _RARE_
to O
the O
reporter I-GENE
gene I-GENE
chloramphenicol I-GENE
acetyltransferase _RARE_
( O
CAT I-GENE
), _RARE_
and O
transiently O
and O
stably O
transfected O
in O
the O
INS _RARE_
- O
1 O
cells O
. O

Cytoplasmic _RARE_
dynein I-GENE
is O
a O
multisubunit _RARE_
, O
microtubule O
- O
dependent O
mechanochemical _RARE_
enzyme O
that O
has O
been O
proposed O
to O
function O
in O
a O
variety O
of O
intracellular _RARE_
movements O
, O
including O
minus O
- O
end O
- O
directed O
transport _RARE_
of O
organelles _RARE_
. O

Identification O
of O
the O
plakoglobin I-GENE
- O
binding O
domain O
in O
desmoglein _RARE_
and O
its O
role O
in O
plaque O
assembly O
and O
intermediate _RARE_
filament _RARE_
anchorage O
. O

PATIENTS O
AND _RARE_
METHODS O
: O
One O
hundred O
eighty _RARE_
- O
four O
chemotherapy O
- O
naive _RARE_
patients O
receiving O
high O
- O
dose O
cisplatin O
( O
81 _RARE_
to O
120 O
mg O
/ O
m2 O
) O
were O
randomized O
to O
receive O
one O
of O
four O
granisetron _RARE_
doses O
( O
5 O
, O
10 O
, O
20 O
, O
or O
40 O
micrograms O
/ O
kg O
) O
administered O
before O
chemotherapy O
. O

Nine _RARE_
new O
naphthalene _RARE_
related O
compounds O
( O
I O
, O
IV O
, O
V O
, O
VII O
- O
XII _RARE_
) O
together O
with O
four O
known O
compounds O
( O
II O
, O
III O
, O
VI _RARE_
, O
XIII _RARE_
) O
were O
isolated O
from O
the O
root O
bark _RARE_
of O
Oroxylum _RARE_
indicum _RARE_
Vent _RARE_
. O

Specifically O
, O
this O
study O
determined O
the O
influence O
of O
: O
( O
1 O
) O
an O
awareness _RARE_
strategy O
, O
( O
2 O
) O
a O
non O
- O
awareness _RARE_
strategy O
, O
( O
3 O
) O
a O
Five O
- O
Step _RARE_
Approach _RARE_
strategy O
and O
( O
4 O
) O
a O
control O
condition O
. O

Mutually _RARE_
exclusive _RARE_
interaction O
of O
the O
adenovirus I-GENE
E4 _RARE_
- I-GENE
6 I-GENE
/ I-GENE
7 I-GENE
protein I-GENE
and O
the O
retinoblastoma _RARE_
gene I-GENE
product I-GENE
with O
internal O
domains O
of O
E2F I-GENE
- I-GENE
1 I-GENE
and O
DP _RARE_
- I-GENE
1 I-GENE
. O

As O
shown O
previously O
, O
EBNA2 I-GENE
transactivates O
the O
promoters O
of O
the O
viral I-GENE
latent I-GENE
membrane I-GENE
proteins I-GENE
. O

We O
previously O
showed O
that O
v I-GENE
- I-GENE
Rel I-GENE
, O
the O
oncoprotein _RARE_
of O
the O
avian O
retrovirus _RARE_
Rev _RARE_
- O
T O
, O
can O
increase O
expression _RARE_
from O
promoters O
containing O
binding O
sites O
for _RARE_
the O
cellular O
transcription O
factor O
Sp1 _RARE_
in O
chicken O
embryo _RARE_
fibroblasts _RARE_
( O
S O
. O

Previous O
studies O
have O
demonstrated O
that O
the O
TATA O
element O
is O
critical O
for _RARE_
basal O
and O
Tat I-GENE
- O
induced _RARE_
HIV O
- O
1 O
gene O
expression _RARE_
. O

A O
comparison O
of O
the O
nucleotide O
sequence O
of O
the O
p54 I-GENE
gene I-GENE
carried O
by O
two O
virulent O
ASFV _RARE_
strains O
( O
E70 _RARE_
and O
E75 _RARE_
) O
with O
that O
obtained O
from O
virus O
Ba71V _RARE_
showed O
100 _RARE_
% O
similarity _RARE_
. O

The O
p55 I-GENE
mRNA I-GENE
is O
undetectable O
in O
non O
- O
EBV _RARE_
- O
infected _RARE_
B O
- O
and O
T O
- O
cell O
lines O
or O
in O
a O
myelomonocytic _RARE_
cell O
line O
( O
U937 O
). O

A O
simple O
registration _RARE_
as _RARE_
an O
incentive _RARE_
for _RARE_
improvement O

The O
transverse O
magnetization _RARE_
decays _RARE_
mentioned O
above O
exhibited O
two O
components _RARE_
, O
a O
T2 _RARE_
fast O
( O
T2f _RARE_
) O
and O
a O
T2 _RARE_
slow O
( O
T2s _RARE_
) O
component _RARE_
. O

RESULTS O
: O
The O
diagnostic O
quality O
of O
FDG O
images O
was O
at _RARE_
least O
as _RARE_
good O
as _RARE_
that O
of O
their O
Tl O
- O
201 _RARE_
counterparts O
, O
with O
less O
liver O
background O
in O
all O
but O
one O
FDG O
study O
. O

The O
coordinated _RARE_
expression _RARE_
of O
CD4 _RARE_
and O
CD8 _RARE_
during _RARE_
T O
- O
cell O
development O
is O
tightly O
coupled O
with O
the O
maturation _RARE_
state O
of O
the O
T O
cell O
. O

Expression O
of O
a O
dominant I-GENE
- I-GENE
negative I-GENE
ras I-GENE
gene I-GENE
also O
blocks O
TIS10 _RARE_
/ O
PGS2 _RARE_
induction O
by O
v I-GENE
- I-GENE
src I-GENE
. O

The O
dying _RARE_
tTG _RARE_
- O
transfected O
cells O
exhibit O
both O
cytoplasmic O
and O
nuclear O
changes O
characteristic O
of O
cells O
undergoing O
apoptosis O
. O

Using O
an O
RNase I-GENE
H I-GENE
- O
mediated _RARE_
mapping O
technique O
, O
we O
show O
that O
the O
64 _RARE_
- O
kDa O
subunit O
of O
CstF _RARE_
can O
be O
photo _RARE_
cross O
- O
linked _RARE_
to O
pre O
- O
mRNAs O
at _RARE_
U _RARE_
- O
rich O
regions O
located _RARE_
downstream _RARE_
of O
the O
cleavage _RARE_
site O
of O
the O
simian O
virus O
40 O
late _RARE_
and O
adenovirus I-GENE
L3 _RARE_
pre I-GENE
- I-GENE
mRNAs I-GENE
. O

The O
protein O
encoded O
is O
114 _RARE_
kDa O
and O
contains O
eight O
zinc O
finger O
motifs O
, O
seven _RARE_
of O
which O
are O
present O
in O
two O
clusters O
at _RARE_
opposite O
ends O
of O
the O
molecule O
. O

Tissue _RARE_
- O
specific O
expression _RARE_
of O
the O
diazepam _RARE_
- I-GENE
binding I-GENE
inhibitor I-GENE
in O
Drosophila O
melanogaster O
: O
cloning O
, O
structure _RARE_
, O
and O
localization _RARE_
of O
the O
gene O
. O

Using O
a O
v I-GENE
- I-GENE
erbA I-GENE
probe O
, O
we O
obtained O
a O
cDNA O
which O
encodes O
a O
novel O
445 _RARE_
- O
amino O
- O
acid O
protein O
, O
RLD _RARE_
- I-GENE
1 I-GENE
, O
that O
contains O
the O
characteristic O
domains O
of O
nuclear O
receptors O
. O

Only O
two O
of O
the O
isoforms O
possess O
the O
N O
- O
terminal O
zinc O
finger O
domain O
that O
is O
necessary O
and O
sufficient O
for _RARE_
TdT _RARE_
promoter I-GENE
binding O
. O

This O
study O
provides O
direct O
evidence O
that O
USF I-GENE
, O
a O
member _RARE_
of O
the O
basic I-GENE
helix I-GENE
- I-GENE
loop I-GENE
- I-GENE
helix I-GENE
leucine I-GENE
zipper I-GENE
family I-GENE
, O
binds O
to O
MLE1 _RARE_
, O
HF _RARE_
- I-GENE
1a _RARE_
, O
and O
PRE _RARE_
B I-GENE
sites I-GENE
and O
suggests O
that O
it O
is O
a O
component _RARE_
of O
protein O
complexes O
that O
may O
coordinately _RARE_
control O
the O
expression _RARE_
of O
MLC _RARE_
- I-GENE
2v _RARE_
and O
alpha I-GENE
- I-GENE
myosin I-GENE
heavy I-GENE
- I-GENE
chain I-GENE
genes I-GENE
. O

Human O
T O
- O
cell O
leukemia O
virus O
type O
I O
Tax _RARE_
activation O
of O
NF _RARE_
- I-GENE
kappa _RARE_
B I-GENE
/ O
Rel I-GENE
involves O
phosphorylation _RARE_
and O
degradation _RARE_
of O
I I-GENE
kappa _RARE_
B I-GENE
alpha I-GENE
and O
RelA _RARE_
( O
p65 _RARE_
)- O
mediated _RARE_
induction O
of O
the O
c I-GENE
- I-GENE
rel _RARE_
gene I-GENE
. O

Activation O
of O
c I-GENE
- I-GENE
fos I-GENE
gene I-GENE
expression _RARE_
by O
a O
kinase O
- O
deficient _RARE_
epidermal _RARE_
growth I-GENE
factor I-GENE
receptor I-GENE
. O

Because O
endogenous O
HSF I-GENE
DNA O
- O
binding O
activity O
is O
low O
and O
anti I-GENE
- I-GENE
hHSF1 _RARE_
antibody I-GENE
does O
not O
recognize O
Xenopus I-GENE
HSF I-GENE
, O
we O
employed O
this O
system _RARE_
for _RARE_
mapping O
regions O
in O
hHSF1 _RARE_
that O
are O
required O
for _RARE_
the O
maintenance _RARE_
of O
the O
monomeric _RARE_
state O
. O

Enhancers _RARE_
containing O
disrupted O
Ets I-GENE
- I-GENE
1 I-GENE
binding I-GENE
sites I-GENE
were O
tested O
in O
transient O
expression _RARE_
assays O
in O
the O
murine O
T O
- O
cell O
line O
EL4 _RARE_
. O
E1 O
; O
alterations O
in O
the O
LVb _RARE_
element O
affected O
constitutive _RARE_
enhancer O
activity O
, O
while O
mutation O
of O
either O
the O
LVb _RARE_
or O
LVc _RARE_
element O
disrupted O
phorbol O
ester O
- O
induced _RARE_
enhancer O
activity O
. O

The O
predominant O
binding O
activity O
was O
not O
Ets I-GENE
- I-GENE
1 I-GENE
but O
rather O
two O
independent O
DNA O
- O
protein O
complexes O
that O
comigrated _RARE_
in O
mobility O
shift O
assays O
. O

These O
RZR _RARE_
subtypes O
represent O
members O
of O
a O
new O
family O
of O
orphan I-GENE
nuclear I-GENE
receptors I-GENE
that O
most O
likely O
regulate O
specific O
gene O
expression _RARE_
. O

Interestingly O
, O
these O
response O
elements O
display O
dramatically O
reduced _RARE_
affinity O
for _RARE_
retinoic I-GENE
acid I-GENE
receptor I-GENE
- O
retinoid I-GENE
- I-GENE
X I-GENE
receptor I-GENE
heterodimers _RARE_
. O

Treatment O
with O
amphotericin O
B O
and O
flucytosine _RARE_
led O
to O
improvement O
of O
the O
symptoms O
but O
did O
not O
eradicate _RARE_
the O
micro O
- O
organisms O
from O
the O
cerebrospinal _RARE_
fluid _RARE_
( O
CSF O
). O

The O
unexpected _RARE_
presence O
of O
the O
tRNA I-GENE
( I-GENE
trp _RARE_
)( I-GENE
CCA _RARE_
)- I-GENE
gene I-GENE
transcript I-GENE
in I-GENE
mitochondria _RARE_
is O
also O
reported O
. O

The O
parameters O
of O
nonspecific O
humoral _RARE_
immunity _RARE_
-- _RARE_
serum I-GENE
immunoglobulins I-GENE
and O
immune O
complexes O
-- _RARE_
were O
evaluated O
in O
irradiated O
group O
of O
patients O
with O
uterine _RARE_
cervix O
carcinoma O
( O
Stages _RARE_
IIB _RARE_
and O
IIIB _RARE_
), _RARE_
during _RARE_
one O
year O
follow O
up _RARE_
. O

Mutation O
of O
KRKR _RARE_
to O
NGER _RARE_
retains O
MO15 _RARE_
in O
the O
cytoplasmic O
compartment O
, O
whilst _RARE_
the O
wild O
- O
type O
protein O
is O
detected O
exclusively O
in O
the O
nucleus O
. O

To O
confirm O
the O
binding O
of O
protein O
to O
these O
sites O
in O
cells O
, O
we O
carried O
out O
an O
in O
vivo O
genomic O
footprinting O
analysis O
of O
this O
portion O
of O
the O
TGF I-GENE
alpha I-GENE
promoter I-GENE
in O
normal O
and O
transformed O
rat O
liver O
epithelial _RARE_
cell O
lines O
that O
express O
the O
endogenous O
gene O
at _RARE_
varying O
levels O
. O

Strikingly _RARE_
, O
this O
subdomain _RARE_
is O
also O
present O
in O
the O
otherwise O
unrelated O
N O
- O
terminal O
activating O
region O
of O
p58c _RARE_
- I-GENE
ets I-GENE
- I-GENE
2 I-GENE
and O
was O
thus O
named O
BEC _RARE_
for _RARE_
Ets I-GENE
- I-GENE
1 I-GENE
- I-GENE
beta I-GENE
/ O
Ets I-GENE
- I-GENE
2 I-GENE
- I-GENE
Conserved _RARE_
sequence I-GENE
. O

This O
work O
unravels _RARE_
a O
new O
model O
for _RARE_
the O
ets I-GENE
- I-GENE
1 I-GENE
/ O
ets I-GENE
- I-GENE
2 I-GENE
gene I-GENE
' O
s O
evolution O
, O
based O
for _RARE_
the O
first _RARE_
time O
on O
both O
structural O
and O
functional _RARE_
evidences _RARE_
. O

The O
v I-GENE
- I-GENE
ets I-GENE
oncogene I-GENE
of O
the O
avian O
retrovirus _RARE_
E26 _RARE_
differs O
from O
its O
cellular O
progenitor _RARE_
p68c _RARE_
- I-GENE
ets I-GENE
- I-GENE
1 I-GENE
by O
two O
amino O
acid O
substitutions O
( O
alanine O
285 O
and O
isoleucine _RARE_
445 _RARE_
in O
c I-GENE
- I-GENE
ets I-GENE
- I-GENE
1 I-GENE
both O
substituted O
by O
valine _RARE_
in O
v I-GENE
- I-GENE
ets I-GENE
, O
mutations O
A O
and O
B O
respectively O
) O
and O
its O
carboxy _RARE_
- O
terminal O
end O
( O
mutation O
C O
). O

Consequently _RARE_
functional _RARE_
mRNAs O
can O
be O
produced O
by O
endogenous I-GENE
RNA I-GENE
polymerase I-GENE
I O
. O

The O
individual O
subunits O
of O
Ku _RARE_
have O
been O
difficult O
to O
isolate O
from O
human O
cells O
without O
denaturation _RARE_
and O
attempts O
to O
produce O
functional _RARE_
recombinant I-GENE
Ku _RARE_
have O
been O
largely O
unsuccessful _RARE_
. O

Using O
this O
method O
, O
we O
were O
able O
to O
select O
strong O
enhancer O
- O
type O
activation O
domains O
from O
the O
immediate I-GENE
early I-GENE
regions I-GENE
of O
two O
herpesviruses _RARE_
, O
namely O
pseudorabies O
virus O
and O
bovine O
herpesvirus _RARE_
1 O
. O

Remarkably _RARE_
, O
U21 _RARE_
contains O
a O
long O
stretch O
( O
13 _RARE_
nt O
.) O
of O
complementarity _RARE_
to O
a O
highly O
conserved _RARE_
sequence O
in O
28S I-GENE
rRNA I-GENE
. O

A O
genetic O
system _RARE_
was O
devised _RARE_
to O
select O
for _RARE_
pi _RARE_
protein I-GENE
mutants I-GENE
which O
discriminate _RARE_
between O
IR O
and O
DR _RARE_
( O
York O
et O
al O
., O
Gene _RARE_
( O
Amst _RARE_
.) O
116 _RARE_
, O
7 O
- O
12 O
, O
1992 O
; O
York O
and O
Filutowicz _RARE_
, O
J _RARE_
. O

Univariate _RARE_
statistical O
analysis O
based O
on O
Kaplan _RARE_
- O
Meier _RARE_
- O
estimates O
and O
Log _RARE_
- O
Rank _RARE_
- O
Test O
showed O
the O
following O
prognostically _RARE_
beneficial O
factors O
: O
Limited _RARE_
disease _RARE_
stage _RARE_
( O
p O
= O
0 _RARE_
. O
009 _RARE_
), _RARE_
NSE _RARE_
serum O
level O
less O
than O
25 _RARE_
micrograms O
/ O
l _RARE_
( O
p O
= O
0 _RARE_
. O
016 _RARE_
), _RARE_
serum O
alkaline _RARE_
phosphatase I-GENE
less O
than O
200 _RARE_
U _RARE_
/ O
l _RARE_
( O
p O
= O
0 _RARE_
. O
035 _RARE_
), _RARE_
normal O
serum O
albumin I-GENE
( O
p O
= O
0 _RARE_
. O
003 _RARE_
) O
and O
activity O
index O
of O
minimum O
of O
70 O
( O
p O
< O
0 _RARE_
. O
001 O
). O

These O
results O
provide O
evidence O
of O
a O
bypass O
of O
p53 I-GENE
- O
induced _RARE_
Waf1 _RARE_
/ O
Cip1 I-GENE
- O
mediated _RARE_
cell O
cycle _RARE_
regulatory O
pathways O
by O
a O
member _RARE_
of O
the O
myb I-GENE
oncogene I-GENE
family I-GENE
. O

HBx _RARE_
strongly O
elevates _RARE_
levels O
of O
GTP O
- O
bound _RARE_
Ras I-GENE
, O
activated O
and O
phosphorylated _RARE_
Raf I-GENE
, O
and O
tyrosine O
- O
phosphorylated _RARE_
and O
activated O
MAP I-GENE
kinase I-GENE
. O

Role O
of O
c I-GENE
- I-GENE
myc I-GENE
in O
simian I-GENE
virus I-GENE
40 I-GENE
large I-GENE
tumor I-GENE
antigen I-GENE
- O
induced _RARE_
DNA O
synthesis _RARE_
in O
quiescent _RARE_
3T3 O
- O
L1 O
mouse O
fibroblasts _RARE_
. O

All O
groups O
were O
challenged _RARE_
subsequently O
with O
naloxone O
( O
0 _RARE_
. O
4 O
mg O
/ O
kg O
) O
in O
the O
distinctive O
environment O
and O
then O
observed O
for _RARE_
signs O
of O
opiate _RARE_
withdrawal O
. O

Laser _RARE_
therapy O
of O
penile _RARE_
carcinoma O

A O
15 _RARE_
. O
1 O
kb O
fragment O
of O
the O
yeast O
genome O
was O
allocated O
to O
the O
centromeric _RARE_
region O
of O
chromosome _RARE_
XIV _RARE_
by O
genetic O
mapping O
. O

A O
third O
one O
is O
homologous O
in O
half _RARE_
of O
its O
length O
to O
the O
prokaryotic _RARE_
hydantoinase _RARE_
HyuA _RARE_
and O
in O
the O
other O
half _RARE_
to O
hydatoinase _RARE_
HyuB _RARE_
. O

It O
was O
shown O
that O
estradiol O
concentrations O
obtained O
after O
estradiol O
valerate _RARE_
and O
micronized _RARE_
estradiol O
ingestion O
were O
dependent O
on O
the O
patient O
' O
s O
age O
as _RARE_
well _RARE_
as _RARE_
on O
the O
constitutional _RARE_
type O
. O

There O
were O
9 O
patients O
in O
NYHA _RARE_
class O
III O
and O
8 O
in O
class O
IV O
.( O
ABSTRACT O
TRUNCATED O
AT O
250 _RARE_
WORDS O
) O

Constipation _RARE_
is O
not O
a O
risk O
factor O
for _RARE_
hemorrhoids _RARE_
: O
a O
case O
- O
control O
study O
of O
potential _RARE_
etiological _RARE_
agents O
. O

Of O
419 _RARE_
persons O
surveyed _RARE_
, O
207 _RARE_
( O
49 _RARE_
. O
4 O
%) O
were O
antigen O
- O
positive O
with O
the O
Og4C3 _RARE_
assay O
. O

TG O
- O
day O
and O
TG O
- O
night O
were O
19 O
. O
4 O
+/- O
6 O
. O
1 O
%, O
26 _RARE_
. O
6 O
+/- O
5 O
. O
3 O
%, O
( O
750 O
mm3 _RARE_
< O
T O
. O

Vibrio _RARE_
cholerae _RARE_
O139 _RARE_
in O
Calcutta _RARE_
. O

Ten O
volunteers O
were O
tested O
at _RARE_
18 O
, O
000 _RARE_
ft _RARE_
( O
5 O
, O
486 _RARE_
m O
), _RARE_
and O
through O
12 O
, O
000 _RARE_
, O
8 O
, O
000 _RARE_
, O
and O
5 O
, O
000 _RARE_
ft _RARE_
( O
3 O
, O
657 _RARE_
, O
2 O
, O
438 _RARE_
, O
and O
1 O
, O
524 _RARE_
m O
) O
with O
directional _RARE_
sounds _RARE_
recorded O
via O
a O
dummy _RARE_
head O
microphone _RARE_
and O
presented O
binaurally _RARE_
. O

Upon O
differentiation O
with O
retinoic O
acid O
( O
RA _RARE_
), _RARE_
transcription O
of O
the O
Rex _RARE_
- I-GENE
1 I-GENE
gene I-GENE
decreases O
rapidly O
. O

Sequence O
analysis O
of O
the O
zebrafish _RARE_
egr1 _RARE_
coding I-GENE
region I-GENE
revealed O
a O
high O
level O
of O
homology O
to O
the O
mouse O
, O
rat O
, O
and O
human I-GENE
Egr1 _RARE_
genes I-GENE
with O
the O
notable _RARE_
exception O
of O
a O
polymorphic O
, O
triplet O
nucleotide O
repeat O
sequence O
in O
the O
region O
coding O
for _RARE_
the O
amino O
terminus O
of O
the O
Egr1 _RARE_
protein I-GENE
. O

The O
fibrinogen I-GENE
, O
serum O
proteins O
, O
sodium _RARE_
heparin _RARE_
and O
membrane O
contributed O
to O
Cm _RARE_
by O
20 O
%, O
14 O
%, O
2 O
% O
and O
64 _RARE_
%, O
respectively O
. O

In O
these O
vectors O
the O
chimeric I-GENE
long I-GENE
terminal I-GENE
repeat I-GENE
( O
chLTR _RARE_
) O
drives _RARE_
the O
expression _RARE_
of O
the O
chloramphenicol I-GENE
acetyl I-GENE
transferase I-GENE
( O
CAT I-GENE
) O
reporter O
gene O
that O
is O
followed O
by O
an O
internal O
SV40 I-GENE
virus I-GENE
early I-GENE
region I-GENE
promoter I-GENE
linked _RARE_
to O
the O
neomycin _RARE_
phosphotransferase _RARE_
II I-GENE
( O
NEO _RARE_
) O
gene O
. O

Optima _RARE_
) O
genomic O
library O
by O
hybridizing _RARE_
with O
elicitor _RARE_
- O
induced _RARE_
stilbene _RARE_
synthase I-GENE
cDNA I-GENE
as _RARE_
a O
probe O
. O

A O
total _RARE_
of O
125 _RARE_
acute O
leukemia O
adult O
patients O
were O
autografted _RARE_
with O
bone O
marrow O
( O
BM _RARE_
) O
purged _RARE_
by O
mafosfamide _RARE_
( O
ASTA _RARE_
Z O
) O
during _RARE_
the O
period O
of O
January O
1983 O
to O
January O
1993 O
. O

The O
pretransplant _RARE_
regimen O
consisted O
of O
cyclophosphamide O
( O
120 O
mg O
/ O
kg O
) O
and O
total _RARE_
body O
irradiation O
. O

The O
site O
- O
directed O
mutation O
of O
the O
kappa _RARE_
B I-GENE
motif I-GENE
in O
IL _RARE_
- I-GENE
6 I-GENE
/ O
CAT I-GENE
plasmid _RARE_
resulted O
in O
the O
complete _RARE_
abrogation _RARE_
of O
IL _RARE_
- I-GENE
6 I-GENE
promoter I-GENE
activity O
in O
these O
cells O
. O

Curiously _RARE_
, O
testololactone _RARE_
was O
earlier O
and O
more O
widely O
used O
than O
aminoglutethimide _RARE_
in O
treating _RARE_
advanced O
breast O
carcinoma O
. O

Use O
of O
the O
vena _RARE_
cava _RARE_
to O
extend O
the O
right O
renal _RARE_
vein _RARE_
for _RARE_
cadaver _RARE_
transplantation O
is O
controversial _RARE_
. O

Enhanced _RARE_
hepatic _RARE_
portal _RARE_
blood _RARE_
flow O
induced _RARE_
by O
prostaglandin _RARE_
E1 O
following O
liver O
transplantation O
in O
pigs O
. O

One O
gene O
appears O
ubiquitously O
expressed _RARE_
while O
the O
other O
is O
prominently _RARE_
expressed _RARE_
in O
muscle O
. O

For O
HeLa O
, O
293 O
, O
U937 O
, O
and O
A549 _RARE_
cells O
, O
participation O
of O
E2F I-GENE
- I-GENE
1 I-GENE
, O
DP _RARE_
- I-GENE
1 I-GENE
, O
cyclin _RARE_
A I-GENE
, O
and O
RB _RARE_
was O
involved O
in O
formation O
of O
some O
complexes O
only O
, O
assuming _RARE_
participation O
of O
factors O
different O
from O
E2F I-GENE
- I-GENE
1 I-GENE
or O
DP _RARE_
- I-GENE
1 I-GENE
in O
others O
. O

E1A I-GENE
autoactivation _RARE_
mediated _RARE_
by O
these O
sites O
was O
about O
twofold O
compared O
with O
a O
ninefold _RARE_
activation O
described O
for _RARE_
the O
complete _RARE_
E1A I-GENE
promoter I-GENE
. O

Cestode _RARE_
invasion O
in O
irradiated O
host _RARE_
organism O
increases O
the O
negative O
effect O
of O
ionizing _RARE_
radiation O
on O
the O
hamster O
immune O
system _RARE_
. O

During O
heat O
exposure O
, O
chicks O
that O
had O
been O
subjected O
to O
early O
60 _RARE_
% O
restriction _RARE_
with O
non O
- O
metyrapone _RARE_
- O
treated O
food O
had O
lower O
H O
/ O
L O
ratios O
and O
improved O
resistance O
to O
marble _RARE_
spleen _RARE_
disease _RARE_
infection O
. O

Analyses _RARE_
of O
additional O
tumors O
induced _RARE_
in O
mice O
from O
two O
reciprocal O
crosses _RARE_
, O
A O
/ O
J _RARE_
x _RARE_
C3H O
/ O
HeJ _RARE_
F1 _RARE_
( O
hereafter _RARE_
called O
AC3F1 _RARE_
) O
and O
C3H O
/ O
HeJ _RARE_
x _RARE_
A O
/ O
J _RARE_
F1 _RARE_
( O
hereafter _RARE_
called O
C3AF1 _RARE_
), _RARE_
provided O
evidence O
for _RARE_
the O
inactivation O
of O
one O
allele O
of O
the O
putative O
chromosome _RARE_
4 O
tumor O
suppressor O
gene O
by O
parental O
imprinting O
. O

ERV1 _RARE_
is O
involved O
in O
the O
cell O
- O
division O
cycle _RARE_
and O
the O
maintenance _RARE_
of O
mitochondrial O
genomes O
in O
Saccharomyces O
cerevisiae O
. O

Lesion _RARE_
diameters O
of O
greater O
than O
20 O
mm O
and O
the O
large O
sessile _RARE_
- O
type O
configurations _RARE_
were O
factors O
that O
were O
associated O
with O
incomplete O
removal O
. O

Routinely _RARE_
collected O
, O
processed O
and O
stored O
breast O
cancer _RARE_
tissue O
blocks O
recovered O
from O
the O
archives _RARE_
of O
the O
Pathology _RARE_
laboratory O
in O
Dar _RARE_
es _RARE_
Salaam _RARE_
after O
storage _RARE_
of O
up _RARE_
to O
3 O
years O
were O
analysed O
by O
a O
flow O
cytometry _RARE_
for _RARE_
DNA O
ploidy _RARE_
and O
S O
- O
phase _RARE_
fraction O
. O

Cbf3 _RARE_
contains O
three O
proteins O
, O
Cbf3a _RARE_
, O
Cbf3b _RARE_
and O
Cbf3c _RARE_
. O

Such O
an O
interaction O
could O
be O
detected O
using O
a O
GST I-GENE
- O
POU I-GENE
fusion O
protein O
bound _RARE_
to O
glutathione _RARE_
- O
agarose O
beads _RARE_
. O

These O
mutations O
are O
localized O
in O
the O
same O
region O
where O
the O
HSV I-GENE
transactivator _RARE_
VP16 I-GENE
binds O
, O
but O
did O
not O
coincide _RARE_
with O
the O
VP16 I-GENE
contacts O
. O

In O
general _RARE_
, O
the O
filtration O
rate O
in O
relevant O
areas O
appears O
to O
be O
an O
integrative _RARE_
and O
easily O
determined O
parameter O
, O
reflecting O
hormonal O
and O
neurogenic _RARE_
vascular O
as _RARE_
well _RARE_
as _RARE_
local O
interstitial O
control O
of O
the O
Starling _RARE_
forces _RARE_
. O

Notably _RARE_
, O
these O
residues O
are O
located _RARE_
in O
different O
domains O
. O

However O
, O
rapamycin _RARE_
inhibited O
proliferation _RARE_
of O
Ba _RARE_
/ O
F3 _RARE_
- O
EpoRgp55 _RARE_
but O
not O
of O
MEL _RARE_
cells O
despite O
inhibition O
of O
p70 I-GENE
S6 I-GENE
kinase I-GENE
activity O
in O
both O
cells O
. O

Intraventricular _RARE_
injection O
of O
( O
2S _RARE_
, O
1 O
' O
R O
, O
2 O
' O
R O
, O
3 O
' O
R O
)- O
2 O
-( _RARE_
2 O
, O
3 O
- O
dicarboxycyclopropyl _RARE_
) O
glycine O
( O
DCG _RARE_
- O
IV O
), _RARE_
a O
potent O
agonist O
for _RARE_
metabotropic _RARE_
glutamate _RARE_
receptors I-GENE
, O
to O
rats O
retarded O
dose O
- O
dependently O
the O
recovery O
from O
halothane O
anesthesia O
at _RARE_
a O
dose O
range O
from O
30 _RARE_
to O
300 _RARE_
pmol _RARE_
/ O
rat O
. O

The O
hepatocyte _RARE_
nuclear I-GENE
factor I-GENE
- I-GENE
3 I-GENE
( O
HNF I-GENE
- I-GENE
3 I-GENE
)/ _RARE_
forkhead _RARE_
( O
fkh _RARE_
) O
proteins O
consist O
of O
an O
extensive O
family O
of O
tissue O
- O
specific O
and O
developmental O
gene O
regulators _RARE_
which O
share O
homology O
within O
the O
winged _RARE_
helix O
DNA O
binding O
motif O
. O

Homozygous O
null _RARE_
embryos _RARE_
also O
displayed O
abnormalities O
in O
heart _RARE_
development O
, O
consistent O
with O
the O
conclusion O
that O
Tek _RARE_
is O
necessary O
for _RARE_
endocardial _RARE_
/ O
myocardial _RARE_
interactions O
during _RARE_
development O
. O

Interestingly O
, O
dTFIIA _RARE_
- I-GENE
L I-GENE
/ I-GENE
S I-GENE
is O
also O
able O
to O
significantly O
enhance O
transcriptional O
activation O
by O
upstream O
transcription O
factors O
including O
Sp1 _RARE_
, O
VP16 I-GENE
, O
and O
NTF _RARE_
- I-GENE
1 I-GENE
. O

A O
strong O
trithorax _RARE_
binding I-GENE
site I-GENE
was O
found O
at _RARE_
the O
cytological _RARE_
location O
of O
the O
fork I-GENE
head I-GENE
gene I-GENE
, O
a O
region O
- O
specific O
homeotic I-GENE
gene I-GENE
not O
located _RARE_
within O
a O
homeotic I-GENE
complex I-GENE
. O

In O
particular O
, O
changes O
in O
intracellular _RARE_
Ca2 _RARE_
+ O
have O
the O
potential _RARE_
to O
either O
inhibit O
or O
augment _RARE_
the O
ability O
of O
cAMP O
to O
stimulate O
transcription O
, O
depending O
on O
the O
presence O
of O
specific O
forms O
of O
Ca2 _RARE_
+/ _RARE_
calmodulin I-GENE
- I-GENE
dependent I-GENE
protein I-GENE
kinases I-GENE
. O

Antibodies O
directed O
against O
the O
SNM1 _RARE_
protein I-GENE
immunoprecipitated O
RNase I-GENE
MRP I-GENE
RNA I-GENE
from O
whole O
- O
cell O
extracts O
without O
precipitating O
the O
structurally O
and O
functionally O
related O
RNase I-GENE
P I-GENE
RNA I-GENE
. O

C I-GENE
/ I-GENE
EBP I-GENE
alpha I-GENE
also O
activates O
the O
promoter O
of O
the O
rat I-GENE
class I-GENE
- I-GENE
I I-GENE
ADH I-GENE
gene I-GENE
in O
a O
sequence O
- O
specific O
manner O
[ _RARE_
Potter _RARE_
et O
al O
., O
Arch _RARE_
. O

C I-GENE
/ I-GENE
EBP I-GENE
alpha I-GENE
also O
activates O
the O
promoter O
of O
the O
rat I-GENE
class I-GENE
- I-GENE
I I-GENE
ADH I-GENE
gene I-GENE
in O
a O
sequence O
- O
specific O
manner O
[ _RARE_
Potter _RARE_
et O
al O
., O
Arch _RARE_
. O

Our O
results O
show O
that O
the O
ORF O
of O
hAMPK _RARE_
encodes O
552 _RARE_
amino O
acids _RARE_
( O
aa _RARE_
) O
( O
62 _RARE_
. O
250 _RARE_
kDa O
) O
and O
is O
highly O
conserved _RARE_
with O
rAMPK _RARE_
with O
identities O
of O
97 O
. O
3 O
and O
90 _RARE_
% O
at _RARE_
the O
aa _RARE_
and O
nt O
levels O
, O
respectively O
. O

In O
human O
brain O
, O
contactin _RARE_
was O
first _RARE_
identified O
by O
amino O
terminal O
and O
peptide O
sequencing O
of O
the O
lentil _RARE_
- I-GENE
lectin _RARE_
- I-GENE
binding I-GENE
glycoprotein I-GENE
Gp135 _RARE_
. O

The O
centromeric _RARE_
YAC O
contig O
, O
which O
consists O
of O
23 _RARE_
overlapping O
YACs O
and O
orders _RARE_
19 O
sequence O
- O
tagged _RARE_
sites O
( O
STSs _RARE_
), _RARE_
covers _RARE_
a O
minimum O
of O
2 O
. O
2 O
Mb O
and O
spans O
the O
Ewing _RARE_
sarcoma O
breakpoint _RARE_
. O
c I-GENE
- I-GENE
ets I-GENE
1 I-GENE
and O
Fli _RARE_
- I-GENE
1 I-GENE
, O
two O
members O
of O
the O
ets I-GENE
family I-GENE
, O
have O
been O
linked _RARE_
within O
400 _RARE_
kb O
of O
intervening O
DNA O
within O
this O
contig O
, O
which O
also O
comprises O
a O
polymorphic O
microsatellite _RARE_
, O
D11S912 _RARE_
( O
CA O
) O
n _RARE_
, O
which O
we O
have O
localized O
within O
the O
Fli _RARE_
- I-GENE
1 I-GENE
gene I-GENE
. O

A O
cDNA O
for _RARE_
a O
newly O
discovered O
pseudogene _RARE_
, O
closely O
related O
to O
the O
mouse I-GENE
mast _RARE_
cell I-GENE
chymases _RARE_
was O
isolated O
by O
polymerase O
chain O
reaction O
amplification O
from O
a O
mouse O
connective _RARE_
tissue O
- O
like O
mast _RARE_
cell O
line O
. O

IFI16 _RARE_
consists O
of O
ten O
exons O
and O
nine O
intervening O
introns _RARE_
spanning O
at _RARE_
least O
28 _RARE_
kilobases O
( O
kb O
) O
of O
DNA O
. O

Courses _RARE_
were O
repeated _RARE_
every O
four O
weeks O
. O

Peter _RARE_
Elfer _RARE_
explores _RARE_
the O
implications O
of O
the O
ruling _RARE_
. O

Other O
adverse O
events O
with O
incidences _RARE_
significantly O
higher _RARE_
than O
with O
placebo O
were O
dizziness _RARE_
, O
constipation _RARE_
, O
sweating _RARE_
, O
nervousness _RARE_
, O
and O
abnormal O
ejaculation _RARE_
. O

Homology _RARE_
was O
also O
detected O
between O
the O
putative O
transit O
peptide O
sequence O
of O
cysteine I-GENE
synthase I-GENE
C I-GENE
and O
other O
mitochondrion _RARE_
- O
targeting O
leader _RARE_
sequences O
. O

Furthermore O
, O
our O
data O
also O
show O
that O
, O
in O
addition O
to O
TEF I-GENE
- I-GENE
1 I-GENE
, O
another O
HF _RARE_
- I-GENE
1a _RARE_
- I-GENE
related I-GENE
factor I-GENE
may O
be O
recognized _RARE_
by O
the O
alpha I-GENE
- I-GENE
MHC I-GENE
gene I-GENE
EM O
element O
. O

Rat _RARE_
kidney _RARE_
carboxylesterase _RARE_
. O

Recombinant I-GENE
I I-GENE
- I-GENE
kappa _RARE_
B I-GENE
alpha I-GENE
inhibited O
kappa _RARE_
B I-GENE
motif I-GENE
binding O
by O
nuclear I-GENE
factor I-GENE
- I-GENE
kappa _RARE_
B1 _RARE_
, O
RelA _RARE_
, O
and O
c I-GENE
- I-GENE
Rel I-GENE
as _RARE_
indicated O
by O
studies O
using O
UV _RARE_
radiation O
- O
induced _RARE_
covalent _RARE_
cross O
- O
linking O
to O
a O
bromodeoxyuridine _RARE_
- O
substituted O
kappa _RARE_
B I-GENE
oligonucleotide _RARE_
. O

The O
physical O
and O
chemical O
stability O
of O
a O
combination O
of O
drugs O
commonly O
administered O
into O
the O
epidural _RARE_
or O
intrathecal _RARE_
space O
for _RARE_
the O
treatment O
of O
chronic O
pain O
was O
investigated O
. O

Therefore O
, O
mechanisms O
that O
control O
activation O
of O
the O
MAP I-GENE
kinase I-GENE
cascade O
temporally O
and O
spatially O
may O
be O
important O
for _RARE_
specification _RARE_
of O
cellular O
responses O
. O

A O
candidate O
gene O
for _RARE_
Bcg _RARE_
, O
designated O
natural _RARE_
resistance I-GENE
- I-GENE
associated I-GENE
macrophage I-GENE
protein I-GENE
( O
Nramp _RARE_
), _RARE_
has O
been O
isolated O
and O
shown O
to O
encode O
a O
novel O
macrophage O
- O
specific O
membrane O
protein O
, O
which O
is O
altered O
in O
susceptible O
animals O
. O

This O
motif O
is O
similar O
to O
but O
distinct O
from O
the O
LIM I-GENE
domain I-GENE
and O
the O
RING _RARE_
finger I-GENE
family I-GENE
, O
and O
is O
reminiscent _RARE_
of O
known O
metal O
- O
binding O
regions O
. O

The O
P131 _RARE_
ORF O
is O
followed O
in O
- O
frame O
by O
a O
second O
ORF O
which O
is O
probably O
expressed _RARE_
by O
partial O
readthrough O
of O
the O
UGA O
termination _RARE_
codon _RARE_
of O
the O
P131 _RARE_
ORF O
to O
produce O
a O
polypeptide O
of O
M O
( O
r _RARE_
) O
191044 _RARE_
( O
P191 _RARE_
). O

One O
hundred O
fifty _RARE_
patients O
were O
reviewed O
at _RARE_
1 O
year O
after O
arthroplasty _RARE_
. O

Elementary _RARE_
visual O
hallucinations _RARE_
in O
migraine _RARE_
and O
epilepsy O
. O

The O
influence O
of O
patient O
- O
related O
factors O
on O
inter _RARE_
- O
observer _RARE_
variability O
in O
the O
evaluation O
of O
neurological O
signs O
was O
investigated O
. O

Segments _RARE_
with O
more O
reduced _RARE_
BMIPP _RARE_
uptake O
than O
MIBI _RARE_
uptake O
( O
mismatching _RARE_
) O
showed O
either O
normal O
wall _RARE_
motion O
or O
demonstrated O
inotropic O
reserve O
during _RARE_
dobutamine _RARE_
stimulation _RARE_
. O

The O
defined O
length O
of O
the O
mRNA O
, O
1 O
, O
838 _RARE_
nucleotides O
, O
was O
in O
agreement O
with O
that O
of O
a O
1 O
. O
9 O
- O
kb O
RNA O
expressed _RARE_
throughout O
the O
replication O
cycle _RARE_
, O
starting O
at _RARE_
the O
early O
stages O
of O
infection O
. O

Infect _RARE_
. O

Transient O
transfections O
of O
a O
construct O
expressing O
the O
RNA O
transcript O
defined O
by O
clone O
B1 _RARE_
. O
1 O
into O
D17 _RARE_
cells O
led O
to O
the O
expression _RARE_
of O
an O
Env I-GENE
/ O
Mlvi _RARE_
- I-GENE
4 I-GENE
fusion O
protein O
with O
an O
apparent O
molecular _RARE_
mass O
of O
33 _RARE_
kDa O
. O

Roizman _RARE_
, O
J _RARE_
. O

Articles _RARE_
addressing _RARE_
valvular _RARE_
heart _RARE_
disease _RARE_
or O
heart _RARE_
failure O
secondary O
to O
acute O
myocardial _RARE_
infarction O
or O
Chagas _RARE_
' O
disease _RARE_
were O
excluded O
. O

The O
present O
data O
also O
indicate O
that O
patients O
with O
TGBM _RARE_
nephropathy O
often O
have O
concomitant O
IgA I-GENE
nephropathy O
and O
mesangial _RARE_
proliferative O
glomerulonephritis O
. O

All O
nuclear O
receptors O
have O
several O
well _RARE_
- O
characterized O
structural O
domains O
, O
including O
a O
conserved _RARE_
DNA O
- O
binding O
domain O
, O
and O
a O
ligand _RARE_
binding O
domain O
at _RARE_
the O
carboxyl _RARE_
terminus O
of O
the O
receptor O
. O

The O
sample O
includes O
all O
the O
HIV O
- O
infected _RARE_
- O
patients O
continuously O
referred O
to O
the O
Outpatient _RARE_
Service _RARE_
of O
the O
Infectious _RARE_
Diseases _RARE_
dept _RARE_
. O
of O
Bologna _RARE_
' O
s O
" O
Ospedale _RARE_
Maggiore _RARE_
" O
General _RARE_
Hospital _RARE_
during _RARE_
some O
five O
days O
( O
19 O
- O
23rd _RARE_
, O
July _RARE_
1993 O
). O

Using O
in O
organello _RARE_
footprint O
analysis O
, O
we O
demonstrate O
that O
within O
human O
placental _RARE_
mitochondria _RARE_
there O
is O
a O
high O
level O
of O
protein O
- O
DNA O
binding O
at _RARE_
regularly _RARE_
phased _RARE_
intervals O
throughout O
a O
500 O
- O
bp O
region O
encompassing _RARE_
the O
D O
- O
loop O
DNA O
origins O
and O
two O
promoter O
regions O
. O

The O
Nur77 _RARE_
protein I-GENE
can O
act O
as _RARE_
a O
potent O
transcription O
activator O
and O
may O
function O
to O
regulate O
the O
expression _RARE_
of O
downstream _RARE_
genes O
in O
response O
to O
extracellular O
stimuli O
. O

One O
class O
of O
plasmids O
contained O
tRNA I-GENE
( I-GENE
His _RARE_
) I-GENE
genes I-GENE
and O
conferred O
efficient O
suppression O
only O
when O
cells O
were O
starved _RARE_
for _RARE_
histidine _RARE_
; O
these O
plasmids O
suppressed O
a O
gcn2 _RARE_
deletion O
much O
less O
efficiently O
than O
they O
suppressed O
gcn2 _RARE_
- I-GENE
507 _RARE_
. O

Thus O
, O
the O
presence O
of O
the O
Cln2 _RARE_
PEST _RARE_
domain I-GENE
was O
sufficient O
to O
destabilize _RARE_
a O
heterologous O
protein O
. O

Electrophoretic O
mobility O
shift O
assays O
with O
each O
of O
these O
sequences O
demonstrated O
complexes O
with O
mobilities _RARE_
identical O
to O
those O
of O
the O
NF _RARE_
- I-GENE
kappa _RARE_
B I-GENE
site I-GENE
from O
the O
kappa _RARE_
light I-GENE
- I-GENE
chain I-GENE
gene I-GENE
. O

Although O
a O
carboxyl _RARE_
- O
terminal O
HSF I-GENE
transcriptional O
activation O
domain O
is O
critical O
for _RARE_
the O
activation O
of O
CUP1 _RARE_
transcription O
in O
response O
to O
both O
heat O
shock O
stress O
and O
glucose O
starvation O
, O
this O
region O
is O
dispensable O
for _RARE_
transient O
heat O
shock O
activation O
of O
at _RARE_
least O
two O
genes O
encoding O
members O
of O
the O
S O
. O
cerevisiae O
hsp70 I-GENE
family I-GENE
. O

We O
have O
recently O
detected O
high O
levels O
of O
CKB _RARE_
mRNA I-GENE
in O
HeLa O
cells O
and O
, O
in O
this O
study O
, O
have O
tested O
whether O
this O
may O
be O
due O
to O
the O
extremely O
low O
amounts O
of O
p53 I-GENE
protein I-GENE
present O
in O
HeLa O
cells O
. O

Distal _RARE_
lower O
motor O
neuron _RARE_
syndrome _RARE_
with O
high O
- O
titer O
serum I-GENE
IgM I-GENE
anti I-GENE
- I-GENE
GM1 _RARE_
antibodies I-GENE
: O
improvement O
following O
immunotherapy O
with O
monthly O
plasma O
exchange O
and O
intravenous O
cyclophosphamide O
. O

Regulators _RARE_
responsible O
for _RARE_
the O
pervasive _RARE_
, O
nonsex _RARE_
- O
specific O
alternative _RARE_
pre O
- O
mRNA O
splicing _RARE_
characteristic O
of O
metazoans _RARE_
are O
almost O
entirely O
unknown O
or O
uncertain _RARE_
. O

A O
normal O
systemic O
response O
was O
obtained O
after O
IF O
, O
indicating O
that O
rhG _RARE_
- I-GENE
CSF I-GENE
retains O
activity O
in O
the O
solid O
state O
. O

A O
full O
- O
length O
cDNA O
clone O
isolated O
from O
a O
rat O
lung _RARE_
library O
was O
predicted O
to O
encode O
a O
55 _RARE_
- O
kDa O
protein O
containing O
at _RARE_
its O
amino O
terminus O
a O
targeting O
domain O
that O
binds O
to O
the O
ANP I-GENE
- I-GENE
receptor I-GENE
kinase I-GENE
- I-GENE
like I-GENE
domain I-GENE
and O
containing O
at _RARE_
its O
carboxyl _RARE_
terminus O
a O
putative O
protein I-GENE
- I-GENE
serine I-GENE
phosphatase I-GENE
domain O
. O

A O
high O
- O
resolution O
restriction _RARE_
map O
of O
over O
200 _RARE_
kb O
of O
contiguous O
DNA O
containing O
N I-GENE
- I-GENE
myc I-GENE
has O
been O
generated O
by O
subcloning _RARE_
YACs O
into O
cosmids _RARE_
. O

PAI I-GENE
- I-GENE
1 I-GENE
levels O
increased O
significantly O
in O
patients O
who O
received O
iohexol _RARE_
but O
not O
in O
those O
who O
received O
ioxaglate _RARE_
. O

In O
the O
present O
article O
, O
the O
causes O
of O
death _RARE_
or O
ill _RARE_
- O
being O
as _RARE_
found O
in O
10 O
consecutive O
carcinogenicity _RARE_
studies O
-- _RARE_
5 O
studies O
with O
2400 _RARE_
OFA _RARE_
( O
Sprague O
- O
Dawley O
- O
derived O
) O
and O
Wistar _RARE_
rats O
and O
5 O
studies O
with O
2400 _RARE_
OF1 _RARE_
and O
NMRI _RARE_
mice O
-- _RARE_
were O
re O
- O
examined O
. O

Determination O
of O
potassium _RARE_
iodide _RARE_
in O
Polish _RARE_
edible _RARE_
salt O

The O
recovery O
value O
of O
systolic O
pressure O
was O
higher _RARE_
than O
diastolic O
pressure O
and O
pulse O
pressure O
increased O
. O

The O
importance O
of O
hepatitis O
C O
virus O
( O
HCV O
) O
infection O
as _RARE_
a O
cause O
of O
chronic O
liver O
disease _RARE_
has O
become O
clear O
with O
the O
introduction O
of O
serologic O
detection O
methods O
. O

Human O
adenovirus O
type O
41 _RARE_
contains O
two O
fibers O
. O

Outflow _RARE_
obstruction O
of O
pancreatic O
juice O
, O
i O
. O
e _RARE_
., O
" O
relative O
stenosis O
of O
the O
minor O
papilla _RARE_
," O
was O
considered O
to O
be O
present O
in O
the O
patients O
with O
type O
II O
papilla _RARE_
, O
and O
, O
therefore O
, O
the O
patients O
with O
type O
II O
papilla _RARE_
might O
suffer _RARE_
from O
acute O
pancreatitis O
resulting O
from O
poor O
drainage O
of O
pancreatic O
juice O
and O
excessive O
pressure O
in O
the O
dorsal O
duct O
. O

Sequencing O
of O
the O
TP53 _RARE_
transcripts I-GENE
from O
exons O
2 O
to O
10 O
, O
however O
, O
did O
not O
reveal O
mutations O
of O
the O
remaining O
allele O
in O
any O
of O
these O
tumors O
. O

An O
unusual O
complication O
in O
an O
unsuitable _RARE_
patient O
. O

In O
the O
ISO _RARE_
group O
, O
at _RARE_
pre O
- O
DEX _RARE_
, O
CBF O
increased O
from O
86 _RARE_
+/- O
8 O
to O
166 _RARE_
+/- O
19 O
mL O
. O
min O
- O
1 O
. O
100 _RARE_
g O
- O
1 O
in O
response O
to O
hypercapnia O
( O
PCO2 O
approximately _RARE_
90 _RARE_
mmHg O
).( _RARE_
ABSTRACT O
TRUNCATED O
AT O
250 _RARE_
WORDS O
) O

All O
other O
ejaculate _RARE_
parameters O
( O
density O
, O
motility _RARE_
, O
swelling O
test O
, O
penetration O
test O
) O
remained O
unchanged O
, O
and O
there O
was O
only O
one O
post O
- O
therapeutic O
pregnancy _RARE_
. O

KRN2391 _RARE_
and O
cromakalim _RARE_
produced O
a O
dose O
- O
dependent O
increase O
in O
aortic O
and O
coronary O
blood _RARE_
flow O
. O

In O
H4IIE _RARE_
rat O
hepatoma O
cells O
, O
glucocorticoids O
, O
retinoic O
acid O
and O
cyclic O
AMP O
( O
cAMP O
) O
increase O
PEPCK I-GENE
gene I-GENE
transcription O
whereas O
insulin I-GENE
and O
phorbol O
esters O
have O
the O
opposite O
effect O
. O

Acta _RARE_
572 _RARE_
, O
113 _RARE_
- O
120 O
]. O

Basal O
plasma O
AVP I-GENE
levels O
and O
AVP I-GENE
release O
after O
postural _RARE_
change O
were O
assessed O
, O
and O
plasma O
NPY _RARE_
levels O
were O
measured O
in O
the O
same O
samples O
. O

A O
stretch O
of O
16 O
nucleotides O
just O
upstream O
of O
the O
IL _RARE_
- I-GENE
4RE _RARE_
contributed O
to O
IL _RARE_
- I-GENE
4 I-GENE
inducibility O
and O
formed O
nucleoprotein _RARE_
complexes O
with O
constitutive _RARE_
factors O
. O

Our O
previous O
study O
suggested O
that O
pertussis _RARE_
toxin _RARE_
( O
IAP _RARE_
)- O
sensitive _RARE_
GTP I-GENE
- I-GENE
binding I-GENE
protein I-GENE
( I-GENE
s I-GENE
) I-GENE
( O
G I-GENE
- I-GENE
protein I-GENE
) O
is O
involved O
in O
the O
process O
of O
differentiation O
by O
hormones _RARE_
/ O
IBMX _RARE_
, O
accompanied O
by O
c I-GENE
- I-GENE
fos I-GENE
induction O
. O

ATX _RARE_
, O
like O
PC I-GENE
- I-GENE
1 I-GENE
, O
was O
found O
to O
hydrolyze _RARE_
the O
type I-GENE
I I-GENE
phosphodiesterase _RARE_
substrate O
p O
- O
nitrophenyl _RARE_
thymidine _RARE_
- O
5 O
'- O
monophosphate O
. O

The O
effect O
of O
site O
- O
specific O
mutations O
in O
the O
mouse I-GENE
platelet I-GENE
- I-GENE
derived I-GENE
growth I-GENE
factor I-GENE
( I-GENE
PDGF _RARE_
) I-GENE
beta I-GENE
- I-GENE
receptor I-GENE
on O
activation O
of O
the O
Na _RARE_
+/ _RARE_
H I-GENE
+ I-GENE
exchanger _RARE_
was O
examined O
in O
normal O
murine O
mammary O
gland _RARE_
epithelial _RARE_
( O
NMuMG _RARE_
) O
and O
Chinese _RARE_
hamster O
ovary O
( O
CHO O
) O
cells O
. O

Sequence O
analysis O
revealed O
: O
1 O
) O
a O
kinase O
catalytic O
domain O
most O
characteristic O
of O
serine I-GENE
/ I-GENE
threonine I-GENE
kinases I-GENE
but O
hybrid _RARE_
between O
members O
of O
the O
family O
of O
microtubule I-GENE
- I-GENE
associated I-GENE
protein I-GENE
kinase I-GENE
kinase I-GENE
kinases I-GENE
and O
the O
fibroblast I-GENE
growth I-GENE
factor I-GENE
receptor I-GENE
family I-GENE
; O
2 O
) O
two O
putative O
alpha O
- O
helical O
leucine O
zipper O
motifs O
separated O
by O
a O
25 _RARE_
- O
amino O
acid O
charged O
intermediate _RARE_
segment O
but O
lacking _RARE_
an O
NH2 O
- O
terminal O
basic O
domain O
; O
and O
3 O
) O
COOH _RARE_
- O
terminal O
and O
NH2 O
- O
terminal O
proline O
- O
rich O
domains O
suggestive O
of O
src I-GENE
homology I-GENE
3 I-GENE
( O
SH3 I-GENE
) O
domain O
binding O
regions O
. O

Type _RARE_
2 O
genomes O
containing O
this O
sequence O
presumably O
more O
closely O
reflect O
the O
structure _RARE_
of O
the O
infectious O
, O
replication O
- O
competent O
retrovirus _RARE_
ancestors _RARE_
of O
the O
HERV _RARE_
- O
K O
family O
than O
do O
type O
1 O
genomes O
that O
lack O
the O
sequence O
. O

However O
, O
when O
domain O
I O
and O
domain O
II O
were O
linked _RARE_
on O
the O
same O
plasmid _RARE_
, O
high O
levels O
of O
replication O
were O
observed O
. O

Point _RARE_
mutations O
that O
suppressed O
the O
in O
vitro O
binding O
of O
NF _RARE_
- I-GENE
Y I-GENE
to O
the O
internal O
palindromic O
arm _RARE_
reduced _RARE_
the O
activity O
of O
the O
resident _RARE_
P4 _RARE_
promoter O
, O
while O
those O
preventing O
complex O
formation O
with O
USF I-GENE
did O
not O
, O
as _RARE_
determined O
by O
transient O
expression _RARE_
assays O
using O
the O
luciferase I-GENE
reporter O
gene O
. O

Surprisingly O
, O
Northern O
( O
RNA O
) O
blot O
analysis O
and O
reverse I-GENE
transcriptase I-GENE
- O
PCRs _RARE_
performed O
after O
transfection O
of O
COS O
- O
7 O
or O
HeLa O
cells O
with O
these O
viral O
RNAs O
revealed O
that O
Y88S _RARE_
and O
Y88L _RARE_
RNAs I-GENE
replicated _RARE_
at _RARE_
only O
very O
low O
levels O
. O

Surprisingly O
, O
nuclear O
forms O
of O
IE110 _RARE_
were O
found O
to O
move _RARE_
a O
cytoplasmic O
form O
of O
IE175 _RARE_
into O
nuclear O
punctate _RARE_
structures _RARE_
, O
and O
a O
cytoplasmic O
form O
of O
IE110 _RARE_
was O
able O
to O
retain _RARE_
nuclear O
forms O
of O
IE175 _RARE_
in O
cytoplasmic O
punctate _RARE_
structures _RARE_
. O

Transcription O
of O
the O
gene O
for _RARE_
ivanolysin _RARE_
O I-GENE
and O
expression _RARE_
of O
other O
genes O
of O
the O
virulence _RARE_
gene I-GENE
cluster I-GENE
in I-GENE
L I-GENE
. I-GENE
ivanovii _RARE_
were O
dependent O
on O
PrfA _RARE_
. O

Moreover O
, O
by O
complementation _RARE_
of O
the O
WA _RARE_
fyuA _RARE_
mutant I-GENE
by O
the O
cloned _RARE_
fyuA _RARE_
gene I-GENE
, O
yersiniabactin _RARE_
uptake O
and O
mouse O
virulence _RARE_
were O
restored O
. O

The O
ICBF _RARE_
in O
the O
ischaemic O
cortex O
revealed O
a O
graded _RARE_
reduction O
from O
the O
ischaemic O
centre _RARE_
to O
the O
surrounding O
tissues O
. O

The O
treatment O
of O
hydronephrosis _RARE_
in O
children O

The O
inflation _RARE_
hub _RARE_
of O
the O
probe O
is O
recreated _RARE_
by O
modifying _RARE_
a O
standard O
USCI _RARE_
Tuohy _RARE_
- O
Borst _RARE_
Y O
adaptor _RARE_
and O
attaching _RARE_
this O
to O
the O
transected _RARE_
probe O
hypotube _RARE_
. O

The O
other O
element O
bound _RARE_
RBP _RARE_
- I-GENE
J _RARE_
kappa _RARE_
with O
low O
affinity O
. O

The O
basal O
promoter O
strength O
of O
constructs O
that O
contained O
deletions O
in O
the O
U5 _RARE_
region I-GENE
of O
the O
LTR O
was O
analyzed O
by O
chloramphenicol I-GENE
acetyltransferase _RARE_
( O
CAT I-GENE
) O
assays O
following O
transfection O
of O
HeLa O
cells O
or O
Jurkat O
T O
- O
cells O
in O
the O
presence O
or O
absence O
of O
viral O
transactivator _RARE_
tax _RARE_
protein O
. O

In O
reviewing _RARE_
a O
number O
of O
the O
most O
intensely _RARE_
studied O
environmentally _RARE_
inducible O
promoters O
it O
becomes O
clear O
that O
the O
presence O
of O
two O
cis O
- O
acting O
elements O
are O
critical O
for _RARE_
promoter O
activity O
, O
one O
of O
which O
is O
the O
G O
- O
box O
( O
CCACGTGG _RARE_
). O

Recently O
, O
a O
protein O
designated O
GF14 _RARE_
has O
been O
isolated O
that O
is O
associated O
with O
the O
GBF _RARE_
protein I-GENE
complex I-GENE
. O

New O
diagnostic O
strategies O
for _RARE_
lupus O
anticoagulants _RARE_
and O
antiphospholipid _RARE_
antibodies O
. O

Moreover O
, O
the O
ability O
to O
selectivity O
arrest O
elongation _RARE_
by O
polIII _RARE_
at _RARE_
defined O
positions O
within O
the O
tRNA O
gene O
transcription O
unit O
has O
permitted O
the O
identification O
of O
discrete O
functional _RARE_
properties O
of O
paused _RARE_
mammalian I-GENE
polIII _RARE_
ternary _RARE_
complexes I-GENE
. O

Propafenone _RARE_
is O
well _RARE_
tolerated O
in O
the O
majority O
of O
young O
patients O
. O

Mutational O
analysis O
of O
yeast I-GENE
CEG1 _RARE_
demonstrated O
that O
four O
of O
the O
five O
conserved _RARE_
motifs O
are O
essential O
for _RARE_
capping _RARE_
enzyme I-GENE
function O
in O
vivo O
. O

2 O
patients O
( O
11 O
%) O
had O
significant O
morbidity O
502 _RARE_
and O
529 _RARE_
days O
respectively O
after O
transplantation O
. O

A O
recent O
index O
( O
Fluorosis _RARE_
Risk O
Index _RARE_
) O
developed O
by O
Pendrys _RARE_
( O
1990 O
) O
is O
also O
included O
in O
this O
review O
. O

Alternative O
splicing _RARE_
of O
the O
cytoplasmic O
tail _RARE_
appears O
to O
generate O
multiple O
PECAM _RARE_
- I-GENE
1 I-GENE
isoforms I-GENE
that O
may O
regulate O
phosphorylation _RARE_
, O
cytoskeletal O
association O
, O
and O
affinity O
modulation O
of O
the O
mature _RARE_
protein O
. O

Transfer _RARE_
also O
correlated O
inversely O
with O
gastric _RARE_
juice O
pH O
( O
r _RARE_
= O
- O
0 _RARE_
. O
619 _RARE_
, O
P O
< O
0 _RARE_
. O
02 O
). O

This O
technique O
has O
a O
sensitivity O
and O
a O
specificity _RARE_
of O
almost O
100 _RARE_
%, O
and O
is O
currently O
the O
best O
way O
to O
diagnose _RARE_
nodal O
involvement O
, O
apart O
from O
laparotomy _RARE_
. O

The O
data O
show O
conclusively _RARE_
that O
phosphorylation _RARE_
of O
His _RARE_
- O
304 _RARE_
is O
not O
essential O
for _RARE_
any O
of O
the O
known O
functions O
of O
A I-GENE
. I-GENE
vinelandii _RARE_
NifL _RARE_
. O

The O
role O
of O
HIV I-GENE
tat I-GENE
, O
which O
is O
the O
main O
enhancing O
factor O
for _RARE_
viral I-GENE
LTR I-GENE
, O
in O
the O
regulation _RARE_
of O
IL _RARE_
- I-GENE
2 I-GENE
gene I-GENE
transcription O
has O
been O
studied O
following O
transient O
expression _RARE_
of O
the O
tat I-GENE
gene I-GENE
in O
phorbol O
ester O
and O
calcium _RARE_
ionophore _RARE_
- O
activated O
Jurkat O
cells O
transfected O
with O
IL _RARE_
- I-GENE
2 I-GENE
promoter O
- O
chloramphenicol I-GENE
acetyltransferase _RARE_
reporter O
constructs O
. O

Splice _RARE_
variations O
in O
genes O
coding O
for _RARE_
the O
transmembrane I-GENE
FGF I-GENE
receptor I-GENE
( O
FGFR I-GENE
) O
result O
in O
isoforms O
that O
vary O
in O
the O
ectodomain _RARE_
, O
intracellular _RARE_
juxtamembrane _RARE_
domain O
, O
and O
the O
intracellular _RARE_
kinase O
domain O
. O

If O
this O
is O
present O
, O
such O
patients O
should O
be O
closely O
monitored O
, O
and O
any O
atypical O
lesions O
biopsied _RARE_
. O

Cumulated _RARE_
maximum O
lod _RARE_
scores O
between O
FRDA _RARE_
and O
D9S5 _RARE_
and O
between O
FRDA _RARE_
and O
D9S15 _RARE_
are O
above O
36 _RARE_
and O
61 _RARE_
, O
respectively O
, O
at _RARE_
a O
recombination _RARE_
fraction O
of O
0 _RARE_
, O
indicating O
that O
recombination _RARE_
events O
needed O
to O
orient _RARE_
the O
search O
of O
the O
gene O
are O
very O
difficult O
to O
identify O
and O
ascertain _RARE_
. O

A O
receptor I-GENE
- I-GENE
like I-GENE
protein I-GENE
kinase I-GENE
, O
OsPK10 _RARE_
, O
has O
been O
cloned _RARE_
from O
rice _RARE_
( O
Oryza _RARE_
sativa _RARE_
). O

A O
sequence O
representing O
about O
50 O
% O
of O
the O
expected O
complete _RARE_
sequence O
was O
obtained O
by O
translation O
of O
the O
two O
open _RARE_
reading O
frames O
present O
on O
a O
1 O
. O
6 O
kb O
DNA O
genomic O
fragment O
. O

Goodpasture _RARE_
' O
s O
- O
like O
syndrome _RARE_
and O
effect O
of O
extracorporeal _RARE_
membrane O
oxygenator _RARE_
support O
. O

A O
cDNA O
clone O
pCZ1 _RARE_
, O
with O
a O
1 O
. O
1 O
kb O
insert O
, O
was O
isolated O
from O
a O
NaCl O
- O
adapted O
tobacco O
cell O
cDNA O
library O
that O
encodes O
an O
apparently O
full O
- O
length O
29 O
kDa O
protein O
( O
251 _RARE_
amino O
acids _RARE_
) O
with O
a O
calculated O
pI _RARE_
of O
5 O
. O
7 O
. O

METHODS O
-- _RARE_
16 O
volunteered _RARE_
for _RARE_
spirometry _RARE_
with O
methacholine _RARE_
provocation _RARE_
test O
including O
a O
test O
for _RARE_
small O
airways _RARE_
function O
by O
volume O
of O
trapped _RARE_
gas O
( O
VTG _RARE_
). O

Relationship _RARE_
of O
CDK I-GENE
- I-GENE
activating I-GENE
kinase I-GENE
and O
RNA I-GENE
polymerase I-GENE
II I-GENE
CTD _RARE_
kinase O
TFIIH _RARE_
/ O
TFIIK _RARE_
. O

The O
git1 _RARE_
, O
git3 _RARE_
, O
git5 _RARE_
, O
git7 _RARE_
, O
git8 _RARE_
and O
git10 _RARE_
genes I-GENE
act O
upstream O
of O
adenylate I-GENE
cyclase I-GENE
, O
presumably O
encoding O
an O
adenylate I-GENE
cyclase I-GENE
activation O
pathway _RARE_
. O

These O
same O
regions O
showed O
remarkable O
homology O
to O
two O
invertebrate _RARE_
proteins O
, O
CNC _RARE_
and O
skin _RARE_
- I-GENE
1 I-GENE
, O
postulated O
to O
regulate O
embryonic _RARE_
development O
in O
Drosophila O
melanogaster O
and O
Caenorhabditis O
elegans O
, O
respectively O
. O

DNA O
sequence O
analysis O
has O
confirmed O
that O
this O
mutation O
affects O
the O
C O
- O
terminal O
region O
of O
the O
alpha O
subunit O
, O
changing O
a O
leucine O
residue _RARE_
at _RARE_
position O
290 _RARE_
to O
a O
histidine _RARE_
( O
rpoAL290H _RARE_
). O

CONCLUSIONS O
: O
These O
findings O
indicate O
a O
physical O
barrier O
of O
oesophageal _RARE_
surfactant _RARE_
which O
could O
offer O
some O
degree O
of O
protection O
against O
gastro _RARE_
- O
oesophageal _RARE_
reflux O
but O
one O
which O
is O
particularly O
prone O
to O
attack _RARE_
by O
bile O
. O

Differential O
screening O
of O
mitochondrial O
cDNA O
libraries O
from O
male O
- O
fertile _RARE_
and O
cytoplasmic O
male O
- O
sterile _RARE_
sugar _RARE_
- O
beet _RARE_
reveals O
genome O
rearrangements _RARE_
at _RARE_
atp6 _RARE_
and O
atpA _RARE_
loci I-GENE
. O

The O
effects O
of O
social O
isolation O
on O
morphine _RARE_
- O
induced _RARE_
locomotor O
activity O
were O
compared O
in O
: O
( O
i O
) O
animals O
with O
an O
intact _RARE_
hypothalamo _RARE_
- O
pituitary O
- O
adrenal O
( O
HPA _RARE_
) O
axis O
; O
( O
ii O
) O
animals O
in O
which O
stress O
- O
induced _RARE_
corticosterone O
secretion _RARE_
was O
blocked O
by O
adrenalectomy _RARE_
. O

Using O
this O
reporter O
gene O
system _RARE_
, O
we O
previously O
showed O
that O
EPO I-GENE
- O
induced _RARE_
activation O
of O
the O
c I-GENE
- I-GENE
fos I-GENE
promoter I-GENE
can O
be O
detected O
rapidly O
and O
sensitively _RARE_
as _RARE_
an O
elevation O
of O
cellular I-GENE
luciferase I-GENE
activity O
. O

I O
hypothesize _RARE_
that O
white _RARE_
gene I-GENE
expression _RARE_
from O
P I-GENE
[ _RARE_
en _RARE_
] I-GENE
is O
repressed O
by O
the O
formation O
of O
a O
protein O
complex O
which O
is O
initiated _RARE_
at _RARE_
the O
engrailed _RARE_
PS _RARE_
sites I-GENE
and O
also O
requires O
interactions O
with O
flanking O
genomic O
DNA O
. O

SPP41 _RARE_
was O
cloned _RARE_
and O
sequenced O
and O
found O
to O
be O
essential O
. O
spp43 _RARE_
is O
allelic O
to O
the O
previously O
identified O
suppressor I-GENE
srn1 _RARE_
, O
which O
encodes O
a O
negative O
regulator O
of O
gene O
expression _RARE_
. O

Standard _RARE_
curve O
correlation O
coefficients O
of O
0 _RARE_
. O
995 _RARE_
or O
greater O
were O
obtained O
during _RARE_
validation _RARE_
experiments O
and O
analysis O
of O
study O
samples O
. O

To O
see _RARE_
if O
a O
pulse O
oximeter _RARE_
can O
monitor O
the O
fetus O
during _RARE_
labour O
we O
recruited O
100 _RARE_
Caucasian _RARE_
women O
in O
normal O
uncomplicated _RARE_
labour O
. O

There O
was O
no _RARE_
difference O
in O
plasma O
concentrations O
of O
PGI2 _RARE_
( O
figure _RARE_
4 O
) O
and O
TxA2 _RARE_
in O
patients O
with O
normal O
blood _RARE_
pressure O
, O
mild O
preeclampsia _RARE_
and O
hypotension O
, O
whereas O
in O
severe O
preeclampsia _RARE_
, O
the O
plasma O
concentration O
of O
PGI2 _RARE_
was O
significantly O
lower O
( O
p O
< O
0 _RARE_
. O
001 O
) O
and O
of O
TxA2 _RARE_
significantly O
higher _RARE_
( O
p O
< O
0 _RARE_
. O
001 O
). O

A O
causal _RARE_
analysis O
of O
secondary O
variables O
showed O
that O
the O
formation O
of O
FB O
memories _RARE_
was O
primarily O
associated O
with O
the O
level O
of O
importance O
attached O
to O
the O
event O
and O
level O
of O
affective O
response O
to O
the O
news _RARE_
. O

Deletion O
studies O
identified O
a O
distal O
response O
element O
that O
is O
responsible O
for _RARE_
the O
cytokine _RARE_
response O
and O
has O
properties O
of O
an O
inducible O
transcriptional O
enhancer O
. O

The O
IPL1 _RARE_
gene I-GENE
is O
required O
for _RARE_
high O
- O
fidelity _RARE_
chromosome _RARE_
segregation O
in O
the O
budding _RARE_
yeast O
Saccharomyces O
cerevisiae O
. O

2 O
. O

No O
drop O
in O
oxygen O
saturation O
( O
SaO2 O
) O
or O
visual O
evidence O
of O
transient O
electroencephalographic _RARE_
( O
EEG O
) O
arousals _RARE_
can O
be O
found O
at _RARE_
repeat O
polysomnography _RARE_
. O

The O
complete _RARE_
gene O
organization O
was O
obtained O
by O
combining _RARE_
the O
results O
of O
the O
sequence O
of O
these O
clones _RARE_
and O
those O
of O
the O
characterization O
of O
polymerase O
chain O
reaction O
- O
amplified O
genomic O
segments _RARE_
. O

INO2 _RARE_
, O
a O
regulatory O
gene O
in O
yeast O
phospholipid _RARE_
biosynthesis O
, O
affects O
nuclear O
segregation O
and O
bud _RARE_
pattern O
formation O
. O

The O
pentafluorobenzyl _RARE_
derivative _RARE_
of O
clonidine _RARE_
yields O
an O
intense O
ion O
fragment O
at _RARE_
m O
/ O
z O
354 _RARE_
, O
and O
the O
lower O
limit O
of O
detection O
is O
0 _RARE_
. O
025 _RARE_
ng _RARE_
/ O
ml O
for _RARE_
a O
1 O
- O
ml O
plasma O
sample O
. O

Mammalian _RARE_
ABPs _RARE_
and O
SHBGs _RARE_
bind O
sex _RARE_
steroids O
with O
high O
affinity O
, O
but O
some O
binding O
properties O
differ O
among O
species O
. O

Src I-GENE
homology I-GENE
( O
SH _RARE_
) O
domain O
dependent O
protein O
- O
protein O
interactions O
are O
important O
to O
tyrosine I-GENE
kinase I-GENE
receptor I-GENE
signal O
transduction _RARE_
. O

Sample _RARE_
treatment O
was O
optimized _RARE_
in O
order O
to O
achieve O
a O
complete _RARE_
extraction O
of O
labetalol _RARE_
diastereoisomers _RARE_
and O
to O
avoid O
racemization _RARE_
during _RARE_
extraction O
. O

Under O
resting O
conditions O
, O
activity O
levels O
of O
cardiac O
vagal _RARE_
and O
sympathetic O
outflows _RARE_
are O
not O
related O
across O
young O
, O
healthy O
human O
subjects O
and O
peripheral O
interaction O
is O
not O
manifest O
between O
the O
autonomic _RARE_
divisions _RARE_
. O

Both O
proprioceptive _RARE_
and O
electroreceptive _RARE_
units _RARE_
showed O
a O
progression O
of O
receptive _RARE_
fields O
from O
anterior O
to O
posterior O
body O
in O
the O
rostral _RARE_
to O
caudal _RARE_
direction O
along O
the O
length O
of O
DGR _RARE_
. O

In O
control O
patients O
, O
baseline O
images O
presented O
Type _RARE_
I O
in O
25 _RARE_
, O
Type _RARE_
II O
in O
7 O
, O
and O
the O
Type _RARE_
III O
& O
IV O
in O
0 _RARE_
, O
and O
the O
Type _RARE_
after O
loading O
was O
the O
same O
as _RARE_
the O
Type _RARE_
at _RARE_
baseline O
. O

A O
more O
complete _RARE_
analysis O
of O
dose O
response O
, O
time O
and O
mode O
of O
Ga O
administration O
( O
preinjury _RARE_
or O
postinjury _RARE_
), _RARE_
and O
availability O
of O
Ga O
across O
the O
blood _RARE_
- O
brain O
barrier O
is O
needed O
to O
further O
evaluate O
the O
efficacy O
of O
this O
compound O
. O

The O
presence O
of O
regulatory O
sequences O
for _RARE_
the O
binding O
of O
transcription O
factors O
such O
as _RARE_
NF _RARE_
- I-GENE
kappa _RARE_
B I-GENE
and O
AP I-GENE
- I-GENE
2 I-GENE
, O
whose O
activation O
is O
associated O
with O
the O
immediate O
response O
of O
the O
cell O
to O
an O
injury O
, O
may O
be O
an O
indication O
of O
the O
important O
role O
which O
HO _RARE_
- I-GENE
1 I-GENE
may O
play O
in O
defense O
mechanisms O
against O
tissue O
injury O
. O

Granisetron _RARE_
, O
but O
not O
saline O
, O
abolished O
vomiting _RARE_
and O
nausea _RARE_
when O
given O
as _RARE_
intervention O
after O
this O
combined O
emetic _RARE_
regimen O
. O

The O
femoroarterial _RARE_
coronary O
sinus O
difference O
in O
lactate _RARE_
turned O
negative O
, O
and O
pH O
, O
PCO2 O
and O
potassium _RARE_
differences O
increased O
in O
group O
2 O
during _RARE_
pacing O
. O

This O
was O
obtained O
with O
the O
thermal O
neutron _RARE_
fluency _RARE_
2 O
. O
0 _RARE_
x _RARE_
10 O
( O
10 O
) O
n _RARE_
/ O
cm2 O
. O

Endotoxemia _RARE_
induced _RARE_
by O
gram O
- O
negative O
bacteria O
leads O
to O
endotoxic _RARE_
shock O
pathogenetically _RARE_
stemming _RARE_
from O
the O
integral _RARE_
component _RARE_
of O
the O
bacterial O
wall _RARE_
-- _RARE_
lipid _RARE_
A O
. O

The O
study O
made O
to O
define O
the O
ability O
of O
lipid _RARE_
A I-GENE
monoclonal I-GENE
antibodies I-GENE
to O
correct O
hemodynamic O
disturbances O
due O
to O
endotoxemia _RARE_
in O
dog O
experiments O
showed O
the O
efficacy O
of O
the O
antibodies O
administration O
. O

A O
randomised O
, O
controlled _RARE_
trial O
was O
undertaken O
in O
40 O
patients O
with O
active _RARE_
Crohn O
' O
s O
disease _RARE_
to O
evaluate O
clinical O
and O
nutritional O
outcomes O
after O
an O
amino O
acid O
based O
diet O
containing O
3 O
% O
fat O
was O
given O
by O
a O
feeding O
tube O
compared O
with O
a O
peptide O
based O
diet O
containing O
33 _RARE_
% O
fat O
. O

This O
sequenced O
region O
of O
the O
V O
beta O
locus O
contains O
an O
average O
number O
of O
repetitive _RARE_
DNA O
elements O
( O
21 O
Alu I-GENE
, O
three O
L1 I-GENE
, O
three O
MER _RARE_
, O
and O
three O
retrovirus _RARE_
- O
related O
elements O
. O

The O
sequenced O
genomic O
region O
thus O
accounts _RARE_
for _RARE_
essentially O
all O
of O
the O
longest _RARE_
known O
transcript O
( O
4 O
. O
5 O
kb O
), _RARE_
although O
the O
precise O
ends O
of O
this O
transcript O
have O
not O
been O
defined O
. O

The O
pexB _RARE_
upstream I-GENE
region I-GENE
contained O
245 _RARE_
nucleotides O
within O
which O
sequences O
approximating _RARE_
the O
consensus O
for _RARE_
cyclic I-GENE
AMP I-GENE
receptor I-GENE
protein I-GENE
and O
integration _RARE_
host _RARE_
factor I-GENE
binding O
sites O
were O
discernible _RARE_
. O

The O
fepA _RARE_
- O
entD _RARE_
and O
fes _RARE_
- O
entF _RARE_
operons _RARE_
in O
the O
enterobactin _RARE_
synthesis _RARE_
and O
transport _RARE_
system _RARE_
are O
divergently O
transcribed _RARE_
from O
overlapping O
promoters O
, O
and O
both O
are O
inhibited O
by O
the O
Fur I-GENE
repressor I-GENE
protein I-GENE
under O
iron O
- O
replete _RARE_
conditions O
. O

Sequence O
analysis O
of O
a O
6 O
. O
3 O
- O
kbp _RARE_
genomic O
EcoRI I-GENE
- O
fragment O
of O
Alcaligenes _RARE_
eutrophus _RARE_
, O
which O
was O
recently O
identified O
by O
using O
a O
dihydrolipoamide _RARE_
dehydrogenase I-GENE
- O
specific O
DNA O
probe O
( O
A O
. O

Using O
a O
previously O
published O
two O
- O
frequency O
( O
AC _RARE_
excitation _RARE_
) O
three O
- O
electrode O
method O
, O
the O
admittance _RARE_
locus O
plot _RARE_
( O
ALP _RARE_
) O
in O
the O
low O
- O
frequency O
region O
(< O
1000 O
Hz O
) O
has O
been O
shown O
to O
be O
very O
well _RARE_
approximated _RARE_
by O
a O
straight _RARE_
line O
and O
can O
be O
described O
with O
frequency O
- O
independent O
parameters O
; O
phase _RARE_
angle O
alpha O
pi _RARE_
/ O
2 O
, O
conductance _RARE_
at _RARE_
extrapolated _RARE_
zero O
frequency O
G0 _RARE_
= O
1 O
/ O
R0 _RARE_
, O
and O
ion O
relaxation O
time O
tau _RARE_
. O

Intraoperative _RARE_
measurement O
of O
activated O
partial O
thromboplastin I-GENE
time O
and O
prothrombin I-GENE
time O
with O
a O
new O
compact _RARE_
monitor O
. O

In O
addition O
, O
we O
sought O
to O
test O
the O
hypothesis O
that O
, O
when O
equal O
volumes O
are O
administered O
intrathecally _RARE_
, O
significant O
differences O
exist O
in O
the O
potential _RARE_
to O
three O
commonly O
used O
anesthetic _RARE_
solutions O
to O
induce O
sensory O
impairment O
. O

In O
an O
in O
vitro O
study O
, O
10 O
/ O
0 _RARE_
nylon _RARE_
was O
found O
to O
require O
a O
significantly O
lower O
laser O
energy O
density O
to O
produce O
suture _RARE_
lysis O
following O
a O
single O
shot _RARE_
than O
either O
10 O
/ O
0 _RARE_
Dacron _RARE_
or O
10 O
/ O
0 _RARE_
prolene _RARE_
. O

The O
proteins O
encoded O
downstream _RARE_
of O
rpoN _RARE_
are O
known O
to O
negatively O
regulate O
sigma _RARE_
54 I-GENE
activity O
. O

We O
report O
here O
that O
microinjection O
of O
an O
anti I-GENE
- I-GENE
CBP I-GENE
antiserum _RARE_
into O
fibroblasts _RARE_
can O
inhibit O
transcription O
from O
a O
cAMP O
responsive O
promoter O
. O

These O
results O
demonstrate O
that O
a O
class O
of O
proline O
- O
rich O
activator O
proteins O
and O
RNA I-GENE
polymerase I-GENE
II I-GENE
possess O
a O
common O
structural O
and O
functional _RARE_
component _RARE_
which O
can O
interact O
with O
the O
same O
target O
in O
the O
general _RARE_
transcription O
machinery O
. O

Cloning O
of O
higher _RARE_
plant _RARE_
omega _RARE_
- I-GENE
3 I-GENE
fatty I-GENE
acid I-GENE
desaturases _RARE_
. O

65 O
, O
3829 _RARE_
- O
3838 _RARE_
, O
1991 O
), _RARE_
a O
truncated O
form O
of O
the O
IE I-GENE
polypeptide I-GENE
lacking _RARE_
IE I-GENE
amino I-GENE
acid I-GENE
residues I-GENE
1 I-GENE
- I-GENE
322 _RARE_
( O
and O
, O
therefore O
lacks O
the O
deduced O
transcriptional O
activation O
domain O
), _RARE_
fails O
to O
transactivate O
the O
EHV _RARE_
- I-GENE
1 I-GENE
tk I-GENE
promoter I-GENE
, O
but O
retains O
the O
ability O
to O
down O
- O
regulate O
the O
EHV _RARE_
- I-GENE
1 I-GENE
IE I-GENE
promoter I-GENE
. O

However O
, O
by O
an O
NS35 _RARE_
- I-GENE
specific I-GENE
RNA I-GENE
capture _RARE_
assay O
, O
the O
multimers _RARE_
were O
shown O
to O
possess O
the O
RNA O
- O
binding O
activity O
previously O
demonstrated O
for _RARE_
NS35 _RARE_
. O

CONCLUSION O
: O
Human O
preterm O
birth O
is O
associated O
with O
significantly O
lower O
progesterone O
/ O
17 _RARE_
beta O
- O
estradiol O
ratios O
than O
those O
of O
women O
with O
preterm O
labor _RARE_
delivered O
at _RARE_
term O
. O

Ketamine _RARE_
in O
the O
treatment O
of O
bronchospasm _RARE_
during _RARE_
mechanical O
ventilation O
. O

In O
conclusion O
, O
the O
disposition _RARE_
of O
venlafaxine _RARE_
and O
O O
- O
desmethylvenlafaxine _RARE_
is O
markedly O
altered O
in O
renal _RARE_
disease _RARE_
; O
therefore O
dosage O
adjustment O
is O
warranted O
for _RARE_
patients O
with O
creatinine _RARE_
clearance O
values O
below O
30 _RARE_
ml O
/ O
min O
. O

The O
availability O
of O
sequence O
from O
multiple O
species O
has O
permitted O
us O
to O
determine O
that O
the O
UBE _RARE_
site O
has O
close O
similarity _RARE_
to O
motifs O
that O
bind O
members O
of O
the O
NF _RARE_
- I-GENE
1 I-GENE
family I-GENE
of I-GENE
transcription I-GENE
factors I-GENE
. O

The O
incidence O
of O
HSV O
- O
2 O
positive O
subjects O
( O
HSV I-GENE
- I-GENE
2 I-GENE
/ I-GENE
HSV I-GENE
- I-GENE
1 I-GENE
antibody I-GENE
ratio O
> O
or O
= O
1 O
) O
was O
low O
in O
the O
Jewish _RARE_
Israeli _RARE_
population O
, O
compared O
to O
other O
demographic _RARE_
areas O
. O

The O
mechanism O
whereby _RARE_
zeta _RARE_
PKC I-GENE
regulates O
NF _RARE_
- I-GENE
kappa _RARE_
B I-GENE
most O
probably O
involves O
the O
activation O
of O
a O
putative O
I I-GENE
kappa _RARE_
B I-GENE
kinase I-GENE
of O
molecular _RARE_
mass O
approximately _RARE_
50 O
kDa O
, O
which O
phosphorylates O
and O
inactivates _RARE_
I I-GENE
kappa _RARE_
B I-GENE
. O

Stable O
expression _RARE_
of O
truncated I-GENE
inositol _RARE_
1 I-GENE
, I-GENE
4 I-GENE
, I-GENE
5 I-GENE
- I-GENE
trisphosphate _RARE_
receptor I-GENE
subunits I-GENE
in O
3T3 O
fibroblasts _RARE_
. O

The O
molecular _RARE_
basis O
for _RARE_
commitment _RARE_
of O
progenitors _RARE_
to O
the O
eosinophil O
lineage O
and O
mechanisms O
by O
which O
eosinophil O
- O
specific O
genes O
are O
expressed _RARE_
and O
regulated O
during _RARE_
differentiation O
is O
unknown O
. O

We O
report O
the O
identification O
and O
characterization O
of O
myr _RARE_
4 I-GENE
( O
myosin I-GENE
from I-GENE
rat I-GENE
), _RARE_
the O
first _RARE_
mammalian I-GENE
myosin I-GENE
I I-GENE
that O
is O
not O
closely O
related O
to O
brush _RARE_
border _RARE_
myosin I-GENE
I I-GENE
. O

M O
., O
and O
D O
. O

In O
addition O
, O
computer O
analysis O
suggests O
that O
sequences O
similar O
to O
the O
A O
stem _RARE_
element O
are O
present O
within O
the O
three O
AAV _RARE_
promoter I-GENE
regions O
. O

At O
least O
some O
of O
the O
difference O
in O
stability O
of O
the O
two O
kinds _RARE_
of O
complexes O
was O
due O
to O
the O
fact O
that O
the O
dissociation O
rate O
of O
the O
A O
stem _RARE_
substrate O
from O
the O
protein O
- O
DNA O
complexes O
was O
approximately _RARE_
fourfold O
faster O
than O
that O
of O
the O
complete _RARE_
TR I-GENE
. O

Processing _RARE_
of O
the O
NS3 _RARE_
'- O
5B _RARE_
polyprotein _RARE_
was O
complex O
and O
occurred O
rapidly O
. O

However O
, O
each O
promoter O
activated O
by O
IEP86 _RARE_
was O
synergistically O
affected O
by O
the O
addition O
of O
IEP72 _RARE_
. O

32Pi _RARE_
labeling O
or O
isoelectric _RARE_
focusing O
analysis O
of O
eIF I-GENE
- I-GENE
2 I-GENE
alpha I-GENE
from O
conditional O
casein I-GENE
kinase I-GENE
II I-GENE
mutants I-GENE
indicated O
that O
phosphorylation _RARE_
of O
eIF I-GENE
- I-GENE
2 I-GENE
alpha I-GENE
is O
abolished O
or O
dephosphorylated _RARE_
forms O
of O
eIF I-GENE
- I-GENE
2 I-GENE
alpha I-GENE
are O
detected O
when O
these O
strains O
are O
grown O
at _RARE_
the O
restrictive O
growth O
conditions O
. O

Thus O
, O
YMIP _RARE_
is O
a O
functional _RARE_
homolog O
of O
RMIP _RARE_
and O
represents O
a O
new O
component _RARE_
of O
the O
yeast O
mitochondrial O
import O
machinery O
. O

The O
R2 _RARE_
region O
within O
the O
class O
I O
enhancer O
acts O
as _RARE_
a O
negative O
element O
in O
Ad12 _RARE_
- O
transformed O
cells O
and O
exhibits O
a O
stronger O
binding O
activity O
than O
is O
observed O
in O
nontumorigenic _RARE_
Ad5 _RARE_
- O
transformed O
cells O
, O
which O
are O
not O
reduced _RARE_
in O
class O
I O
expression _RARE_
. O

PURPOSE O
: O
To O
evaluate O
the O
kinetics O
of O
erythropoietin I-GENE
( O
EPO I-GENE
) O
production O
and O
address O
the O
pathogenesis O
of O
anemia _RARE_
of O
prematurity _RARE_
, O
we O
measured O
EPO I-GENE
levels O
in O
infants O
during _RARE_
the O
first _RARE_
year O
of O
life O
. O

The O
nerve I-GENE
growth I-GENE
factor I-GENE
beta I-GENE
gene I-GENE
( O
NGFB _RARE_
) O
belongs O
to O
a O
conserved _RARE_
syntenic _RARE_
group O
on O
human O
chromosome _RARE_
1 O
and O
mouse O
Chromosome _RARE_
3 O
. O

Furthermore O
, O
an O
upstream O
element O
, O
collagen _RARE_
element O
I O
(- _RARE_
370 _RARE_
/- O
344 _RARE_
), _RARE_
which O
shares O
homology O
with O
the O
LAP _RARE_
binding O
cis O
- O
element O
of O
the O
albumin I-GENE
promoter I-GENE
( O
9 O
of O
13 _RARE_
bp O
) O
is O
described O
. O

Number _RARE_
and O
size O
of O
silver O
- O
stained O
nucleoli _RARE_
( O
Ag _RARE_
- O
NOR _RARE_
clusters O
) O
in O
canine O
seminomas _RARE_
: O
correlation O
with O
histological O
features O
and O
tumour _RARE_
behaviour O
. O

We O
speculate _RARE_
that O
mast _RARE_
cell O
degranulation _RARE_
may O
be O
involved O
in O
the O
pathogenesis O
of O
necrobiosis _RARE_
by O
altering O
fibroblast O
enzyme O
activity O
and O
/ O
or O
producing O
prolonged O
inflammatory O
reactions O
. O

Molecular O
cloning O
of O
a O
cysteine I-GENE
synthase I-GENE
cDNA I-GENE
from O
Citrullus _RARE_
vulgaris _RARE_
( O
watermelon _RARE_
) O
by O
genetic O
complementation _RARE_
in O
an O
Escherichia O
coli O
Cys _RARE_
- O
auxotroph _RARE_
. O

In O
earlier O
studies O
we O
identified O
several O
regulatory O
elements O
that O
control O
transcriptional O
activation O
and O
aerobic O
repression O
of O
one O
of O
these O
genes O
, O
COX5b _RARE_
. O

Although O
elevated O
serum O
levels O
of O
antibodies O
to O
the O
nicotinic _RARE_
acetylcholine _RARE_
receptor I-GENE
( O
nAChR _RARE_
) O
have O
been O
reported O
in O
neuroleptic O
treated O
patients O
with O
tardive _RARE_
dyskinesia _RARE_
, O
such O
antibodies O
have O
not O
been O
determined O
in O
comparable O
nondyskinetic _RARE_
patients O
. O

The O
tumor O
suppressor O
and O
transcriptional O
factor O
p53 I-GENE
is O
a O
phosphorylated _RARE_
protein O
. O

This O
DNA O
containing O
promoter O
activity O
has O
been O
sequenced O
in O
its O
entirety _RARE_
and O
found O
to O
contain O
multiple O
putative O
regulatory O
sites O
. O

However O
, O
Southern O
blot O
and O
karyotype _RARE_
analyses O
did O
not O
reveal O
any O
significant O
changes O
in O
copy O
number O
or O
gross O
rearrangements _RARE_
of O
the O
p53 I-GENE
gene I-GENE
in O
any O
of O
the O
p53 I-GENE
- I-GENE
cell O
lines O
. O

HupI _RARE_
showed O
strong O
identity O
to O
rubredoxin _RARE_
and O
rubredoxin _RARE_
- I-GENE
like I-GENE
proteins I-GENE
from O
many O
other O
bacteria O
. O

The O
PCr _RARE_
resynthesis _RARE_
rate O
( O
P O
< O
0 _RARE_
. O
01 O
) O
and O
the O
effective O
maximal O
rate O
of O
mitochondrial O
ATP O
synthesis _RARE_
( O
P O
< O
0 _RARE_
. O
05 O
) O
also O
improved O
. O

An O
examination O
was O
performed O
in O
15 _RARE_
patients O
who O
had O
developed O
pronounced O
osteomalacia _RARE_
following O
gastric _RARE_
resection O
. O

However O
, O
regional O
MVO2 _RARE_
increased O
to O
about O
the O
same O
extent O
in O
the O
CFX _RARE_
( O
from O
6 O
. O
0 _RARE_
+/- O
0 _RARE_
. O
7 O
to O
12 O
. O
4 O
+/- O
0 _RARE_
. O
9 O
ml O
O2 _RARE_
. O
min O
- O
1 O
times O
100 _RARE_
g O
- O
1 O
) O
and O
the O
LAD O
region O
( O
from O
7 O
. O
0 _RARE_
+/- O
0 _RARE_
. O
6 O
to O
14 O
. O
5 O
+/- O
1 O
. O
3 O
ml O
O2 _RARE_
. O
min O
- O
1 O
times O
100 _RARE_
g O
- O
1 O
). O

IGF I-GENE
I I-GENE
and O
insulin I-GENE
receptors I-GENE
are O
homologous O
proteins O
that O
function O
in O
distinct O
physiological O
pathways O
. O

Immunodepression _RARE_
was O
combined O
with O
the O
increase O
of O
glucocorticoid O
activity O
of O
adrenal O
cortex O
, O
while O
no _RARE_
significant O
changes O
in O
thyroid O
hormones _RARE_
were O
registered _RARE_
. O

Tryptic _RARE_
cleavage _RARE_
and O
peptide O
sequence O
analysis O
demonstrated O
that O
the O
98 O
- O
kD _RARE_
protein O
is O
identical O
to O
a O
recently O
cloned _RARE_
protein O
, O
special _RARE_
A I-GENE
- I-GENE
T I-GENE
- I-GENE
rich I-GENE
binding I-GENE
protein I-GENE
1 I-GENE
( O
SATB1 _RARE_
), _RARE_
that O
binds O
selectively O
to O
nuclear O
matrix _RARE_
/ O
scaffold _RARE_
- O
associated O
regions O
of O
DNA O
( O
MARs _RARE_
/ O
SARs _RARE_
). O

Aberrant _RARE_
protein O
phosphorylation _RARE_
at _RARE_
tyrosine O
is O
responsible O
for _RARE_
the O
growth O
- O
inhibitory _RARE_
action O
of O
pp60v _RARE_
- I-GENE
src I-GENE
expressed _RARE_
in O
the O
yeast O
Saccharomyces O
cerevisiae O
. O

Acute O
pancreatitis O
: O
a O
multisystem _RARE_
disease _RARE_
. O

Alginate _RARE_
biosynthesis O
is O
controlled _RARE_
by O
a O
complex O
regulatory O
mechanism O
. O

The O
sequence O
upstream O
of O
the O
rhlA _RARE_
promoter I-GENE
contains O
two O
inverted O
repeats O
which O
define O
putative O
binding O
sites O
for _RARE_
the O
RhlR _RARE_
regulator I-GENE
. O

We O
have O
examined O
by O
in O
vitro O
footprinting O
a O
region O
located _RARE_
downstream _RARE_
of O
the O
human O
immunodeficiency O
virus O
, O
type O
1 O
( O
HIV O
- O
1 O
) O
promoter O
found O
to O
be O
hypersensitive _RARE_
to O
DNase I-GENE
I I-GENE
digestion O
in O
vivo O
. O

Heparin O
had O
no _RARE_
effect O
on O
rAC _RARE_
- I-GENE
st _RARE_
myosin I-GENE
light I-GENE
chain I-GENE
phosphatase I-GENE
activity O
, O
while O
the O
B O
subunit O
- O
containing O
forms O
were O
stimulated _RARE_
2 O
- O
3 O
- O
fold _RARE_
. O

The O
relative O
abundance O
of O
each O
alternatively _RARE_
spliced _RARE_
mRNA O
was O
determined O
by O
reverse O
transcription O
- O
polymerase O
chain O
reaction O
in O
various O
human O
tissues O
and O
cell O
lines O
. O

BACKGROUND O
AND _RARE_
DESIGN O
: O
Fifty O
- O
nine O
melanocytic _RARE_
nevi _RARE_
with O
eccentric _RARE_
foci _RARE_
of O
hyperpigmentation _RARE_
(" O
small O
dark O
dots _RARE_
") _RARE_
that O
measured O
primarily O
1 O
to O
2 O
mm O
in O
diameter O
were O
prospectively _RARE_
examined O
to O
determine O
the O
histologic O
correlates O
of O
the O
dark O
dots _RARE_
. O

The O
retention O
index O
of O
201Tl _RARE_
SPECT O
is O
a O
useful O
indicator O
of O
metastatic O
potential _RARE_
, O
thereby O
facilitating O
the O
prediction O
of O
prognosis O
, O
and O
provides O
insight O
into O
the O
relationship O
between O
201Tl _RARE_
uptake O
and O
malignancy O
. O

The O
central O
globular O
domain O
is O
highly O
similar O
to O
those O
regions O
from O
other O
H1 _RARE_
molecules I-GENE
, O
and O
the O
carboxyl _RARE_
- O
terminal O
domain O
contains O
a O
repeating O
hexapeptide _RARE_
motif O
, O
variants O
of O
which O
are O
conserved _RARE_
among O
H1 _RARE_
molecules I-GENE
. O

The O
location O
and O
approximate _RARE_
length O
of O
the O
intron O
are O
conserved _RARE_
in O
both O
the O
tomato _RARE_
and O
Arabidopsis O
genes O
, O
with O
the O
intron O
separating _RARE_
the O
' O
nose _RARE_
' O
region O
( O
encoded O
by O
exon _RARE_
1 O
) O
from O
the O
central O
globular O
domain O
( O
exon _RARE_
2 O
). O

The O
topology O
and O
chain O
folding O
of O
the O
beta O
subunits O
in O
the O
artifactual _RARE_
beta O
60 _RARE_
capsid _RARE_
are O
similar O
to O
the O
native _RARE_
alpha I-GENE
3 I-GENE
beta I-GENE
60 _RARE_
enzyme I-GENE
. O

A O
single O
NMSC _RARE_
was O
present O
in O
69 _RARE_
. O
4 O
%, O
two O
in O
16 O
%, O
three O
in O
6 O
. O
4 O
%, O
four O
in O
3 O
. O
5 O
%, O
five O
to O
nine O
in O
4 O
. O
2 O
%, O
and O
0 _RARE_
. O
5 O
% O
had O
ten O
or O
more O
. O

A O
constitutive _RARE_
mutant O
form O
with O
a O
single O
substitution O
( O
V88A _RARE_
) O
in O
the O
amino O
- O
terminal O
( O
response O
regulator O
) O
region O
was O
used O
. O

Comparisons _RARE_
of O
the O
four O
operon O
control O
regions O
studied O
indicate O
that O
the O
NarL _RARE_
heptamers _RARE_
are O
arranged O
with O
diverse O
orientations _RARE_
and O
spacing _RARE_
. O

Direct _RARE_
binding O
and O
competition O
assays O
using O
30 _RARE_
- O
mer _RARE_
oligonucleotide _RARE_
probes _RARE_
representing O
the O
individual O
CBF1 I-GENE
binding I-GENE
sites I-GENE
indicated O
that O
CBF1 I-GENE
bound _RARE_
less O
efficiently O
to O
the O
CD23 I-GENE
promoter I-GENE
and O
the O
EBV _RARE_
LMP I-GENE
- I-GENE
1 I-GENE
promoter I-GENE
sites I-GENE
than O
to O
the O
Cp I-GENE
site I-GENE
. O

We O
have O
found O
a O
satisfactory O
reproducibility O
in O
vitro O
( O
T1 _RARE_
: O
1 O
. O
9 O
%; O
T2 _RARE_
: O
6 O
. O
2 O
%), O
while O
the O
reproducibility O
was O
less O
satisfactory O
in O
vivo O
( O
T1 _RARE_
: O
16 O
. O
4 O
%; O
T2 _RARE_
: O
13 _RARE_
. O
4 O
%). O

The O
two O
ParA _RARE_
proteins I-GENE
that O
are O
produced O
as _RARE_
a O
result O
of O
independent O
translation O
initiation O
at _RARE_
two O
different O
start _RARE_
codons O
within O
the O
same O
open _RARE_
reading O
frame O
were O
overexpressed O
in O
Escherichia O
coli O
and O
partially O
purified _RARE_
. O

To O
get _RARE_
further O
insights _RARE_
into O
the O
molecular _RARE_
mechanisms O
that O
control O
tal I-GENE
- I-GENE
1 I-GENE
expression _RARE_
, O
we O
have O
isolated O
5 O
' O
sequences O
of O
the O
murine O
gene O
and O
compared O
them O
to O
their O
human O
counterparts O
. O

CONCLUSION O
: O
Sonographic _RARE_
angiography O
has O
a O
possible O
role O
in O
the O
detection O
of O
small O
nodules O
in O
patients O
with O
CRF _RARE_
. O

Each O
expressed _RARE_
domain O
, O
as _RARE_
well _RARE_
as _RARE_
FKBP _RARE_
- I-GENE
33 _RARE_
itself O
, O
possesses O
peptidyl _RARE_
- I-GENE
prolyl _RARE_
cis I-GENE
- I-GENE
trans _RARE_
isomerase I-GENE
activity O
, O
though O
with O
much O
lower O
specific O
activities O
than O
FKBP _RARE_
- I-GENE
12 I-GENE
. O

The O
first _RARE_
85 _RARE_
nt O
upstream O
of O
the O
transcription O
initiation O
site O
of O
the O
mouse I-GENE
desmin _RARE_
gene I-GENE
, O
which O
contain O
an O
E O
box O
( O
E1 O
), _RARE_
the O
binding O
site O
of O
the O
helix I-GENE
- I-GENE
loop I-GENE
- I-GENE
helix I-GENE
myogenic _RARE_
regulators _RARE_
, O
are O
sufficient O
to O
confer O
low O
level O
muscle O
- O
specific O
expression _RARE_
. O

The O
acfD _RARE_
gene I-GENE
encompasses _RARE_
254 _RARE_
nt O
that O
are O
predicted O
to O
encode O
an O
88 O
- O
amino O
- O
acid O
( O
aa _RARE_
) O
protein O
. O

We O
find O
that O
beta I-GENE
II I-GENE
PKC I-GENE
phosphorylates O
nuclear I-GENE
envelope I-GENE
lamin _RARE_
B I-GENE
at _RARE_
10 O
- O
20 O
times O
the O
rate O
of O
alpha I-GENE
PKC I-GENE
, O
whereas O
both O
kinases O
phosphorylate O
soluble _RARE_
lamin _RARE_
B I-GENE
at _RARE_
similar O
rates O
. O

Regulation O
of O
parathyroid _RARE_
hormone I-GENE
- I-GENE
related I-GENE
protein I-GENE
( O
PTHrP _RARE_
) O
gene O
expression _RARE_
. O

These O
results O
demonstrate O
that O
a O
diverse O
set O
of O
carboxyl _RARE_
- O
terminal O
sequence O
motifs O
and O
posttranslational O
modifications O
lead O
to O
functional _RARE_
Ras I-GENE
proteins I-GENE
in O
yeast O
. O

We O
conclude O
that O
c I-GENE
- I-GENE
Abl I-GENE
activates O
c I-GENE
- I-GENE
myc I-GENE
transcription O
indirectly O
with O
no _RARE_
requirement O
for _RARE_
DNA O
binding O
by O
c I-GENE
- I-GENE
Abl I-GENE
. O

Long _RARE_
- O
latency _RARE_
: O
locked _RARE_
units _RARE_
responded O
to O
shocks _RARE_
with O
little O
jitter _RARE_
and O
long O
latency _RARE_
( O
4 O
- O
11 O
ms O
). O

The O
highly O
conserved _RARE_
ninth _RARE_
heptad _RARE_
, O
which O
is O
involved O
in O
heterodimerization O
, O
appears O
to O
participate O
in O
the O
receptor O
- O
inhibitor O
interaction O
, O
suggesting O
that O
the O
inhibitor O
is O
a O
related O
member _RARE_
of O
the O
receptor O
gene O
family O
. O

Here O
we O
show O
that O
for _RARE_
expression _RARE_
of O
snRNA _RARE_
genes O
in O
maize _RARE_
, O
a O
monocotyledonous _RARE_
plant _RARE_
, O
the O
USE _RARE_
and O
TATA O
elements O
are O
essential O
, O
but O
not O
sufficient O
, O
for _RARE_
transcription O
. O

Extensive _RARE_
DNA O
rearrangement O
occurs O
during _RARE_
the O
development O
of O
the O
somatic O
macronucleus _RARE_
from O
the O
germ _RARE_
line O
micronucleus _RARE_
in O
ciliated _RARE_
protozoans _RARE_
. O

An O
in O
vitro O
binding O
site O
selection O
procedure O
was O
used O
to O
determine O
DNA O
sequences O
preferentially O
bound _RARE_
by O
wild I-GENE
- I-GENE
type I-GENE
HLF _RARE_
and O
chimeric O
E2A _RARE_
- O
HLF _RARE_
proteins O
isolated O
from O
various O
t O
( O
17 _RARE_
; O
19 O
)- O
bearing _RARE_
leukemias O
. O

The O
Oct I-GENE
- I-GENE
2 I-GENE
glutamine _RARE_
- O
rich O
and O
proline O
- O
rich O
activation O
domains O
can O
synergize _RARE_
with O
each O
other O
or O
duplicates _RARE_
of O
themselves O
to O
activate O
transcription O
. O

Binding O
of O
U2 _RARE_
small I-GENE
nuclear I-GENE
ribonucleoprotein I-GENE
( O
snRNP O
) O
to O
the O
pre O
- O
mRNA O
is O
an O
early O
and O
important O
step O
in O
spliceosome O
assembly O
. O

Taken O
together O
, O
our O
data O
suggest O
that O
Dbf8p _RARE_
plays O
an O
essential O
role O
in O
chromosome _RARE_
segregation O
. O

Ariga _RARE_
, O
Biochem _RARE_
. O

Our O
results O
indicate O
that O
the O
KRAB I-GENE
domain I-GENE
present O
in O
the O
non O
- O
finger O
region O
of O
many O
ZFP _RARE_
genes I-GENE
quenches _RARE_
transcription O
possibly O
due O
to O
specific O
protein O
- O
protein O
interactions O
between O
the O
KRAB I-GENE
- I-GENE
A I-GENE
domain I-GENE
and O
components _RARE_
of O
the O
proximal O
transcriptional O
apparatus O
. O

Marine _RARE_
oils _RARE_
and O
cardiovascular O
reactivity O
. O

The O
diagnostic O
significance O
of O
creatine _RARE_
phosphokinase _RARE_
antibodies O
in O
the O
cardiac O
muscle O
in O
non O
- O
coronarogenic _RARE_
myocardial _RARE_
diseases O

According O
to O
the O
results O
of O
assays O
obtained O
with O
the O
use O
of O
assay O
systems _RARE_
ORTHO _RARE_
ELISA O
and O
ABBOTT _RARE_
HCV O
EIA _RARE_
( O
USA _RARE_
), _RARE_
the O
detection O
rate O
of O
anti I-GENE
- I-GENE
HCV I-GENE
- I-GENE
C100 _RARE_
- I-GENE
3 I-GENE
among O
primary _RARE_
blood _RARE_
donors O
in O
Moscow _RARE_
was O
1 O
. O
37 O
% O
and O
was O
not O
different O
from O
that O
among O
HBsAg I-GENE
carriers O
( O
1 O
. O
8 O
%) O
and O
among O
donors O
with O
anti I-GENE
- I-GENE
HCV I-GENE
- I-GENE
C100 _RARE_
- I-GENE
3 I-GENE
in O
the O
blood _RARE_
( O
1 O
. O
6 O
%) O
( O
p O
< O
0 _RARE_
. O
01 O
). O

We O
examined O
the O
hypothesis O
that O
the O
coronary O
vasomotor _RARE_
responses O
to O
etomidate _RARE_
( O
ETO _RARE_
), _RARE_
propofol _RARE_
( O
PRO _RARE_
), _RARE_
and O
sodium _RARE_
thiopental _RARE_
( O
STP _RARE_
) O
are O
mediated _RARE_
through O
contrasting _RARE_
effects O
on O
the O
resting O
nitric _RARE_
oxide O
( O
NO _RARE_
)- O
dependent O
vasodilator O
tone O
that O
opposes _RARE_
adrenergic O
vasoconstrictor _RARE_
activity O
in O
the O
intact _RARE_
dog O
. O

Significant O
alterations O
in O
CBC _RARE_
results O
and O
serum I-GENE
CRP I-GENE
concentration O
, O
compared O
with O
baseline O
values O
, O
were O
lacking _RARE_
in O
dogs O
of O
the O
control O
group O
. O

These O
alternative _RARE_
splice _RARE_
variants O
were O
detected O
in O
RNA O
isolated O
from O
several O
sources O
, O
including O
primary _RARE_
leptomeningeal _RARE_
tissue O
and O
an O
established O
line O
of O
leptomeningeal _RARE_
cells O
( O
LMC _RARE_
). O

Roux _RARE_
- O
en _RARE_
- O
Y O
gastroenterostomy _RARE_
severely O
disturbs _RARE_
emptying O
of O
the O
gallbladder O
. O

Surface _RARE_
- O
coil _RARE_
experiments O
on O
phantoms _RARE_
and O
on O
human O
calf _RARE_
muscles O
in O
vivo O
are O
presented O
. O

Large _RARE_
interpatient _RARE_
variation O
in O
peak O
PCZ _RARE_
plasma O
levels O
( O
91 O
- O
3215 _RARE_
ng _RARE_
/ O
ml O
) O
was O
seen O
, O
with O
the O
plasma O
half _RARE_
- O
life O
( O
t1 O
/ O
2 O
alpha O
) O
being O
approximately _RARE_
57 O
min O
in O
patients O
given O
135 O
- O
180 O
mg O
/ O
m2 O
PCZ _RARE_
. O

The O
maximal O
effect O
was O
seen O
at _RARE_
100 _RARE_
ng _RARE_
/ O
ml O
EGF _RARE_
, O
with O
a O
time O
lag _RARE_
of O
about O
5 O
h O
. O

KAR1 _RARE_
encodes O
an O
essential O
component _RARE_
of O
the O
yeast O
spindle _RARE_
pole O
body O
( O
SPB O
) O
that O
is O
required O
for _RARE_
karyogamy _RARE_
and O
SPB O
duplication O
. O

CDC31 _RARE_
is O
required O
for _RARE_
SPB O
duplication O
and O
encodes O
a O
calmodulin I-GENE
- I-GENE
like I-GENE
protein I-GENE
that O
is O
most O
closely O
related O
to O
caltractin _RARE_
/ O
centrin _RARE_
, O
a O
protein O
associated O
with O
the O
Chlamydomonas _RARE_
basal O
body O
. O

During O
transcript O
elongation _RARE_
, O
the O
sizes O
of O
the O
DNA O
footprint O
and O
the O
single O
- O
stranded _RARE_
transcription O
bubble _RARE_
vary O
markedly O
among O
transcription O
complexes O
halted _RARE_
at _RARE_
different O
template O
positions O
. O

The O
newly O
recognised _RARE_
skeletogenital _RARE_
syndrome _RARE_
. O

All O
our O
patients O
had O
polyps O
, O
23 _RARE_
( O
54 O
%) O
had O
asthma O
, O
12 O
( O
27 _RARE_
%) O
had O
aspirin _RARE_
sensitivity O
, O
20 O
( O
65 O
%) O
had O
eosinophilia _RARE_
, O
and O
9 O
( O
69 _RARE_
%) O
had O
increased O
total _RARE_
IgE I-GENE
levels O
. O

Ras I-GENE
- I-GENE
and I-GENE
ultra _RARE_
- I-GENE
violet _RARE_
- I-GENE
responsive I-GENE
protein I-GENE
kinases I-GENE
that O
phosphorylate O
c I-GENE
- I-GENE
Jun I-GENE
on O
serine O
residues O
at _RARE_
positions O
63 _RARE_
and O
73 _RARE_
and O
stimulate O
its O
transcriptional O
activity O
have O
been O
identified O
. O

A O
short O
sequence O
surrounding O
the O
major O
JNK I-GENE
phosphorylation _RARE_
site O
of O
c I-GENE
- I-GENE
Jun I-GENE
is O
conserved _RARE_
in O
c I-GENE
- I-GENE
Fos I-GENE
and O
is O
part O
of O
its O
activation O
domain O
, O
suggesting O
that O
c I-GENE
- I-GENE
Fos I-GENE
may O
be O
similarly O
regulated O
. O

c I-GENE
- I-GENE
Fos I-GENE
transcriptional O
activity O
stimulated _RARE_
by O
H I-GENE
- I-GENE
Ras I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
distinct O
from O
JNK I-GENE
and O
ERK I-GENE
. O

A O
new O
generation O
of O
information _RARE_
retrieval _RARE_
tools O
for _RARE_
biologists _RARE_
: O
the O
example O
of O
the O
ExPASy _RARE_
WWW _RARE_
server _RARE_
. O

Essential _RARE_
features O
of O
this O
model O
are O
bending _RARE_
of O
the O
DNA O
double O
helix O
and O
contact _RARE_
of O
operator O
sites O
with O
repressor O
domains O
bearing _RARE_
sequence O
homologies O
with O
the O
helix O
- O
turn _RARE_
- O
helix O
( O
HTH _RARE_
) O
motifs O
of O
other O
DNA O
- O
binding O
proteins O
. O

The O
partial O
ORF O
was O
found O
to O
be O
identical O
to O
the O
C O
terminus O
of O
HrpJ2 _RARE_
. O

The O
partial O
ORF O
was O
found O
to O
be O
identical O
to O
the O
C O
terminus O
of O
HrpJ2 _RARE_
. O

The O
binding O
of O
transcription O
factor O
AP I-GENE
- I-GENE
1 I-GENE
and O
vitamin I-GENE
D I-GENE
receptor I-GENE
( O
VDR I-GENE
) O
to O
the O
composite O
AP I-GENE
- I-GENE
1 I-GENE
plus _RARE_
vitamin I-GENE
- I-GENE
D I-GENE
- I-GENE
responsive I-GENE
promoter I-GENE
region O
( O
AP I-GENE
- I-GENE
1 I-GENE
+ I-GENE
VDRE _RARE_
) O
of O
the O
human I-GENE
osteocalcin _RARE_
gene I-GENE
was O
characterized O
in O
osteocalcin _RARE_
- O
producing O
( O
MG _RARE_
- O
63 _RARE_
) O
and O
non O
- O
producing O
( O
U2 _RARE_
- O
Os _RARE_
, O
SaOs _RARE_
- O
2 O
) O
human O
osteosarcoma O
cell O
lines O
. O

Rapid _RARE_
detection O
of O
this O
mutation O
is O
achieved O
by O
restriction _RARE_
digestion O
of O
PCR O
- O
amplified O
genomic O
DNA O
; O
a O
mismatch _RARE_
primer O
combined O
with O
the O
point O
mutation O
creates _RARE_
a O
Tru9I _RARE_
restriction _RARE_
site I-GENE
. O

Wild _RARE_
type I-GENE
and I-GENE
mutant I-GENE
Epo I-GENE
cDNAs I-GENE
were O
transiently O
expressed _RARE_
at _RARE_
high O
levels O
in O
COS1 _RARE_
and O
COS7 _RARE_
cells O
. O

OBJECTIVE O
-- _RARE_
To O
assess O
the O
risk O
of O
hepatitis O
A O
in O
international _RARE_
travelers _RARE_
and O
to O
recommend _RARE_
preventive _RARE_
measures O
. O

The O
bactericidal O
effect O
of O
disinfectants _RARE_
against O
biofilm _RARE_
cells O
was O
found O
to O
be O
considerably O
enhanced _RARE_
by O
increasing O
the O
concentrations O
of O
the O
disinfectants _RARE_
. O

Expression O
of O
ME31B _RARE_
cDNA I-GENE
in O
S O
. O
pombe O
suppresses O
the O
ste13 _RARE_
mutation O
. O

Use O
of O
Medi _RARE_
- O
Jector _RARE_
EZ _RARE_
dermojet _RARE_
for _RARE_
anesthesia O
in O
minor O
surgery O

2 O
. O

The O
immune O
response O
of O
past O
- O
infection O
of O
cytomegalovirus _RARE_
in O
the O
patients O
of O
RTID _RARE_
is O
rather O
remarkable O
. O

Acupuncture _RARE_
effect O
on O
deep O
receptors O
was O
not O
limited O
to O
one O
point O
but O
within O
a O
certain O
area O
, O
namely O
distant O
effect O
existed O
. O

Reduced _RARE_
NK _RARE_
activity O
correlates O
with O
active _RARE_
disease _RARE_
in O
HIV O
- O
patients O
with O
multidrug _RARE_
- O
resistant O
pulmonary O
tuberculosis O
. O

Smoking _RARE_
history O
and O
awake _RARE_
oxygen O
saturation O
( O
SaO2 O
) O
was O
recorded O
in O
all O
of O
them O
. O

( O
LH _RARE_
P O
< O
0 _RARE_
. O
05 O
, O
LH _RARE_
/ O
FSH I-GENE
P O
< O
0 _RARE_
. O
01 O
). O

The O
relative O
R O
- O
and O
L O
- O
brain O
weights O
were O
found O
to O
be O
inversely O
related O
to O
the O
relative O
R O
- O
L O
brain O
weight _RARE_
only O
in O
the O
RH _RARE_
female O
cats O
with O
R O
- O
L O
brain O
weight _RARE_
smaller O
than O
zero O
( O
testosterone O
in O
males O
, O
estrogen O
in O
females O
). O

This O
mode O
of O
ternary _RARE_
complex O
formation O
is O
in O
contrast O
to O
the O
one O
seen O
in O
the O
promoter O
of O
the O
c I-GENE
- I-GENE
fos I-GENE
protooncogene _RARE_
, O
where O
formation O
of O
the O
ternary _RARE_
complex O
is O
dependent O
on O
the O
prior O
assembly O
of O
the O
serum I-GENE
response I-GENE
factor I-GENE
- I-GENE
DNA I-GENE
binary _RARE_
complex I-GENE
. O

The O
LTR O
- O
binding O
activities O
of O
VBP _RARE_
, O
a1 _RARE_
/ I-GENE
EBP I-GENE
, O
and O
B I-GENE
- I-GENE
cell I-GENE
nuclear I-GENE
extract _RARE_
protein I-GENE
were O
compared O
and O
mapped O
by O
gel O
shift O
, O
DNase I-GENE
I I-GENE
footprinting O
, O
and O
methylation O
interference O
assays O
. O

These O
results O
suggest O
that O
leader _RARE_
- O
mRNA O
fusion O
in O
coronavirus O
transcription O
does O
not O
require O
direct O
RNA O
- O
RNA O
interaction O
between O
complementary _RARE_
sequences O
. O

These O
results O
suggest O
that O
leader _RARE_
- O
mRNA O
fusion O
in O
coronavirus O
transcription O
does O
not O
require O
direct O
RNA O
- O
RNA O
interaction O
between O
complementary _RARE_
sequences O
. O

Vaccinia _RARE_
virus O
- O
expressed _RARE_
, O
purified _RARE_
full I-GENE
- I-GENE
length I-GENE
HPV I-GENE
- I-GENE
16 I-GENE
and I-GENE
BPV _RARE_
- I-GENE
1 I-GENE
E2 I-GENE
proteins I-GENE
bound _RARE_
a O
consensus O
E2 I-GENE
site I-GENE
with O
high O
specific O
affinities O
( O
Kd _RARE_
= O
approximately _RARE_
10 O
(- _RARE_
9 O
) O
M O
) O
and O
stimulated _RARE_
in O
vitro O
transcription O
up _RARE_
to O
six _RARE_
- O
to O
eightfold _RARE_
. O

This O
alternatively _RARE_
spliced _RARE_
transcript O
contained O
an O
open _RARE_
reading O
frame O
extending O
from O
the O
upstream O
J _RARE_
alpha O
11 O
- O
2 O
region O
to O
82 O
nucleotides O
downstream _RARE_
of O
the O
beginning O
of O
the O
TCR I-GENE
C I-GENE
alpha I-GENE
region I-GENE
, O
and O
potentially O
encoded O
a O
36 _RARE_
amino O
acid O
polypeptide O
. O

In O
HeLa O
x _RARE_
fibroblast O
cell O
hybrids O
its O
expression _RARE_
correlates O
with O
tumorigenicity _RARE_
. O

Demographic _RARE_
characteristics O
and O
risk O
factor O
data O
for _RARE_
76 _RARE_
, O
672 _RARE_
clients _RARE_
were O
studied O
to O
characterize O
the O
distribution O
of O
infection O
with O
human O
immunodeficiency O
virus O
( O
HIV O
) O
and O
the O
use O
of O
counseling _RARE_
and O
testing O
facilities _RARE_
in O
Houston _RARE_
, O
Tex _RARE_
. O

Results O
indicate O
that O
KNM _RARE_
- O
LU _RARE_
335 _RARE_
differs O
from O
both O
human O
and O
chimpanzee _RARE_
M1s _RARE_
in O
relative O
distances O
( O
measured O
in O
three O
dimensions O
) O
between O
crown _RARE_
fissure _RARE_
termini O
. O

We O
describe O
49 _RARE_
cases O
with O
papillary _RARE_
tumor O
< O
1 O
cm O
. O

Comparison O
with O
the O
bovine O
gene O
showed O
that O
the O
5 O
'- O
flanking O
region O
of O
the O
hATP1 _RARE_
gene I-GENE
has O
an O
unconserved _RARE_
guanine O
- O
cytosine O
( O
GC _RARE_
) O
rich O
region O
, O
including O
several O
binding O
motifs O
of O
transcriptional O
factors O
, O
such O
as _RARE_
Sp1 _RARE_
, O
AP I-GENE
- I-GENE
2 I-GENE
, O
and O
GCF _RARE_
. O

Structure O
, O
promoter O
analysis O
and O
chromosomal O
assignment O
of O
the O
human I-GENE
APEX _RARE_
gene I-GENE
. O

The O
polyubiquitin _RARE_
gene I-GENE
was O
transcribed _RARE_
throughout O
the O
Volvox _RARE_
life O
cycle _RARE_
with O
peaks O
in O
the O
1 O
. O
6 O
- O
kb O
mRNA O
levels O
during _RARE_
pre O
- O
cleavage _RARE_
, O
cleavage _RARE_
, O
and O
post O
- O
inversion O
. O

Thus O
, O
in O
stress O
- O
induced _RARE_
arrhythmic _RARE_
disease _RARE_
as _RARE_
well _RARE_
as _RARE_
in O
ischemic O
heart _RARE_
disease _RARE_
, O
the O
main O
pathogenetic _RARE_
links O
are O
outside O
the O
heart _RARE_
, O
but O
they O
differ O
from O
those O
observed O
in O
ischemia O
. O

Here O
, O
we O
present O
genetic O
evidence O
in O
Saccharomyces O
cerevisiae O
for _RARE_
a O
functional _RARE_
interaction O
between O
the O
DEAH _RARE_
protein I-GENE
Prp16 _RARE_
, O
and O
the O
U6 I-GENE
and O
U2 _RARE_
spliceosomal _RARE_
snRNAs _RARE_
. O

The O
consensus O
gene O
order O
deduced O
by O
combining _RARE_
data O
from O
both O
crosses _RARE_
is O
D2Mit1 _RARE_
-( _RARE_
Dbh _RARE_
, O
Notch1 _RARE_
)-( _RARE_
Col5a1 _RARE_
, O
Rxra _RARE_
)- O
Spna2 _RARE_
- O
Ab _RARE_
l _RARE_
-( _RARE_
Ak1 _RARE_
, O
Fpgs _RARE_
)- O
( O
Grp78 _RARE_
, O
Pbx3 _RARE_
)-( _RARE_
Epb7 _RARE_
. I-GENE
2 I-GENE
, I-GENE
Hc _RARE_
, I-GENE
Gsn _RARE_
)- O
Acra _RARE_
. O

The O
high O
level O
of O
transformation O
- O
associated O
deletions O
in O
the O
human O
YACs O
was O
reduced _RARE_
over O
10 O
- O
fold _RARE_
when O
the O
host _RARE_
was O
a O
recombination _RARE_
- O
deficient _RARE_
strain _RARE_
deleted _RARE_
for _RARE_
the O
RAD52 _RARE_
gene I-GENE
. O

In O
addition O
, O
the O
megabase _RARE_
region O
surrounding O
the O
dagA _RARE_
locus I-GENE
was O
mapped O
. O

These O
mutants O
had O
deletions O
of O
the O
extreme O
amino O
- O
terminal O
residues O
as _RARE_
far O
as _RARE_
amino O
acid O
residue _RARE_
30 _RARE_
. O

SECONDARY _RARE_
OUTCOME O
MEASURE _RARE_
-- _RARE_
Double O
- O
blind O
caffeine O
- O
withdrawal O
evaluation O
. O

Elimination O
of O
natural _RARE_
antibodies O
in O
discordant _RARE_
xenografts _RARE_

An O
8 O
- O
bp O
sequence O
( O
ATTTCAAA _RARE_
) O
within O
the O
protected O
region O
shares O
significant O
homology O
with O
promoter O
sequences O
required O
for _RARE_
ethylene O
responsiveness O
from O
the O
tomato _RARE_
fruit _RARE_
- O
ripening _RARE_
E4 _RARE_
gene I-GENE
. O

We O
present O
evidence O
that O
DNA I-GENE
polymerase I-GENE
delta I-GENE
of I-GENE
Saccharomyces I-GENE
cerevisiae I-GENE
, O
an O
enzyme O
that O
is O
essential O
for _RARE_
viability O
and O
chromosomal O
replication O
, O
is O
also O
required O
for _RARE_
base _RARE_
excision _RARE_
repair O
of O
exogenous _RARE_
DNA O
methylation O
damage O
. O

We O
have O
identified O
two O
Marek _RARE_
' O
s O
Disease _RARE_
Virus _RARE_
( O
MDV _RARE_
) O
genes O
within O
the O
EcoRI I-GENE
- I-GENE
B I-GENE
fragment I-GENE
of O
MDV _RARE_
- O
GA _RARE_
genomic O
DNA O
. O

Cowpox _RARE_
virus O
contains O
two O
copies O
of O
an O
early I-GENE
gene I-GENE
encoding O
a O
soluble _RARE_
secreted _RARE_
form O
of O
the O
type I-GENE
II I-GENE
TNF I-GENE
receptor I-GENE
. O

To O
determine O
whether O
P35 _RARE_
could O
activate O
the O
39k _RARE_
promoter O
in O
the O
absence O
of O
IE1 I-GENE
, O
the O
p35 _RARE_
open _RARE_
reading O
frame O
was O
cloned _RARE_
under O
the O
control O
of O
the O
ie1 _RARE_
promoter I-GENE
. O

Mutagenesis _RARE_
of O
each O
NRF _RARE_
- I-GENE
1 I-GENE
motif I-GENE
in O
the O
ALAS _RARE_
promoter I-GENE
gave O
substantially O
lowered O
levels O
of O
chloramphenicol I-GENE
acetyltransferase _RARE_
expression _RARE_
, O
whereas O
mutagenesis O
of O
both O
NRF _RARE_
- I-GENE
1 I-GENE
motifs I-GENE
resulted O
in O
the O
almost O
complete _RARE_
loss _RARE_
of O
expression _RARE_
. O

DNase I-GENE
I I-GENE
footprinting O
analysis O
indicated O
that O
DREF _RARE_
binds O
to O
the O
24 _RARE_
- O
bp O
DRE _RARE_
region O
of O
the O
DNA I-GENE
polymerase I-GENE
alpha I-GENE
gene I-GENE
in O
which O
8 O
- O
bp O
palindromic O
sequences O
are O
centered O
. O

Novel _RARE_
8 O
- O
base _RARE_
pair _RARE_
sequence O
( O
Drosophila O
DNA O
replication O
- O
related O
element O
) O
and O
specific O
binding O
factor O
involved O
in O
the O
expression _RARE_
of O
Drosophila O
genes O
for _RARE_
DNA I-GENE
polymerase I-GENE
alpha I-GENE
and O
proliferating _RARE_
cell I-GENE
nuclear I-GENE
antigen I-GENE
. O

In O
addition O
, O
a O
microsatellite _RARE_
repeat O
polymorphism O
with O
a O
heterozygosity O
of O
71 _RARE_
% O
at _RARE_
the O
RET I-GENE
locus I-GENE
and O
a O
restriction _RARE_
fragment O
length O
polymorphism O
with O
a O
heterozygosity O
of O
42 _RARE_
% O
detected O
by O
a O
lambda O
clone O
from O
the O
D10S94 _RARE_
locus I-GENE
have O
been O
developed O
for _RARE_
high O
- O
resolution O
genetic O
linkage O
mapping O
and O
predictive O
diagnostic O
testing O
. O

However O
, O
tyrA _RARE_
can O
be O
expressed _RARE_
efficiently O
from O
an O
internal O
promoter O
which O
appears O
to O
lie _RARE_
within O
the O
3 O
' O
portion O
of O
aroF _RARE_
. O

Within O
the O
span O
of O
attenuator _RARE_
region O
encoding O
the O
three O
stem _RARE_
- O
loop O
structures _RARE_
of O
mRNA O
secondary O
configuration O
, O
hot O
spots O
of O
base _RARE_
- O
residue _RARE_
divergence O
were O
localized O
to O
looped _RARE_
- O
out O
regions O
. O

Most O
, O
however O
, O
would O
tell _RARE_
the O
spouse _RARE_
the O
full O
truth _RARE_
about O
both O
diagnosis O
and O
prognosis O
. O

Previous O
studies O
showed O
that O
mutations O
in O
the O
6K _RARE_
protein O
led O
to O
the O
slow O
release O
of O
aberrant O
, O
multi _RARE_
- O
cored _RARE_
infectious O
virions O
. O

Metabolism _RARE_
of O
calcium _RARE_
and O
vitamin O
D3 _RARE_
in O
patients O
with O
acute O
tubulointerstitial _RARE_
nephritis _RARE_
: O
a O
study O
of O
41 _RARE_
patients O
with O
nephropathia _RARE_
epidemica _RARE_
. O

Furthermore O
, O
this O
study O
demonstrates O
that O
reduced _RARE_
inotropy _RARE_
with O
timolol _RARE_
helped _RARE_
uniform O
local O
contraction O
as _RARE_
estimated O
by O
the O
increased O
LONG _RARE_
/ O
CIRC _RARE_
ratio O
, O
a O
transition O
that O
could O
improve O
contraction O
efficacy O
. O

Effects O
of O
moderate O
hypercapnia O
on O
hypothermia O
induced _RARE_
by O
cold O
He O
- O
O2 _RARE_
in O
rats O
. O

The O
RFLP _RARE_
patterns O
of O
the O
isolates O
from O
six _RARE_
of O
these O
patients O
remained O
essentially O
unchanged O
( O
two O
strains O
showed O
one O
additional O
band O
) O
despite O
the O
development O
of O
drug O
resistance O
. O

We O
recommend _RARE_
that O
ovarian O
stimulation _RARE_
is O
done O
only O
if O
there O
is O
a O
valid _RARE_
indication O
after O
proper O
assessment O
of O
the O
ovaries _RARE_
, O
and O
that O
women O
who O
have O
had O
ovarian O
stimulation _RARE_
are O
followed O
for _RARE_
longer O
than O
at _RARE_
present O
. O

A23187 _RARE_
did O
not O
induce O
any O
modifications O
of O
the O
endolymphatic _RARE_
potential _RARE_
, O
the O
ampullar _RARE_
direct O
current O
or O
the O
frequency O
of O
the O
evoked O
afferent _RARE_
spikes O
. O

Activation O
of O
the O
aboral _RARE_
ectoderm _RARE_
- I-GENE
specific I-GENE
Spec2a _RARE_
gene I-GENE
in O
blastula _RARE_
- O
stage _RARE_
sea _RARE_
urchin _RARE_
embryos _RARE_
requires O
an O
upstream O
regulatory O
region O
that O
is O
part O
of O
a O
repetitive _RARE_
sequence O
element O
( O
RSR _RARE_
) O
associated O
with O
all O
Spec1 _RARE_
/ O
Spec2 _RARE_
genes O
. O

A O
transcript O
of O
about O
2 O
kb O
is O
expected O
for _RARE_
each O
PPO _RARE_
. O

Mutations O
in O
a O
region O
located _RARE_
15 _RARE_
to O
30 _RARE_
bp O
downstream _RARE_
from O
the O
major O
transcription O
start _RARE_
site O
that O
shows O
good O
homology O
to O
a O
sequence O
in O
the O
first _RARE_
exon _RARE_
of O
c I-GENE
- I-GENE
fos I-GENE
implicated O
as _RARE_
a O
negative O
regulatory O
element O
resulted O
in O
a O
significant O
increase O
in O
basal O
gene O
expression _RARE_
but O
did O
not O
affect O
regulation _RARE_
. O

Salazopyrine _RARE_
desensitization _RARE_

During O
exercise O
, O
the O
Pes _RARE_
- O
Ves _RARE_
relation O
was O
shifted O
toward O
the O
left _RARE_
and O
the O
slope O
[ _RARE_
end O
- O
systolic O
elastance _RARE_
( O
Ees _RARE_
)] O
increased O
from O
7 O
. O
7 O
+/- O
2 O
. O
8 O
to O
12 O
. O
7 O
+/- O
4 O
. O
2 O
( O
SD O
) O
mmHg O
/ O
ml O
( O
P O
< O
0 _RARE_
. O
05 O
). O

We O
show O
that O
HRI _RARE_
and O
dsRNA _RARE_
- I-GENE
PK _RARE_
phosphorylate O
yeast I-GENE
eIF I-GENE
- I-GENE
2 I-GENE
alpha I-GENE
in O
vitro O
and O
in O
vivo O
and O
functionally O
substitute O
for _RARE_
GCN2 I-GENE
protein I-GENE
to O
stimulate O
GCN4 I-GENE
translation O
in O
yeast O
. O

Double O
- O
staining O
confirmed O
that O
there O
were O
separate O
populations O
of O
CD68 _RARE_
- O
positive O
macrophages O
and O
XIIIa _RARE_
- O
positive O
dendrocytes _RARE_
. O

Interestingly O
, O
in O
the O
adult O
, O
transgene _RARE_
expression _RARE_
patterns O
within O
the O
cerebellum _RARE_
in O
two O
lines O
appeared O
to O
mark _RARE_
distinct O
anterior O
- O
posterior O
compartments _RARE_
. O

Southern O
analysis O
on O
genomic O
DNA O
isolated O
from O
tissues O
and O
cell O
lines O
from O
several O
mouse O
strains O
using O
mCD22 _RARE_
cDNA I-GENE
demonstrated O
that O
the O
Cd22 _RARE_
locus I-GENE
encoding O
mCD22 _RARE_
is O
a O
single O
copy O
gene O
of O
< O
or O
= O
30 _RARE_
kb O
. O

The O
concentrations O
of O
plasma O
ACTH I-GENE
and O
cortisol O
increased O
by O
40 O
% O
and O
60 _RARE_
% O
after O
MPTP _RARE_
treatment O
, O
respectively O
. O

Instead O
, O
the O
results O
support O
the O
idea O
that O
Pc _RARE_
group I-GENE
products I-GENE
provide O
stable O
memory O
or O
imprinting O
of O
boundaries O
which O
are O
initially O
specified O
by O
gap _RARE_
and O
pair _RARE_
- O
rule _RARE_
regulators _RARE_
. O

To O
investigate O
the O
regulation _RARE_
of O
expression _RARE_
of O
the O
human I-GENE
mdr1 _RARE_
gene I-GENE
, O
the O
response O
of O
the O
mdr1 _RARE_
promoter I-GENE
to O
signals O
involved O
in O
cell O
proliferation _RARE_
was O
examined O
. O

The O
tyrosine I-GENE
hydroxylase I-GENE
gene I-GENE
( O
TH _RARE_
) O
contains O
a O
single O
copy O
of O
a O
consensus O
CRE _RARE_
at _RARE_
- O
45 _RARE_
to O
- O
38 O
base _RARE_
pair _RARE_
( O
bp O
) O
upstream O
of O
the O
transcription O
initiation O
site O
. O

Tobacco _RARE_
mosaic O
virus O
- O
infected _RARE_
tobacco O
( O
Nicotiana _RARE_
tabacum _RARE_
var _RARE_
. O

Through _RARE_
a O
stretch O
of O
56 _RARE_
amino O
acids _RARE_
, O
constituting _RARE_
the O
MADS I-GENE
domain I-GENE
, O
the O
two O
proteins O
are O
identical O
except O
for _RARE_
two O
conservative O
amino O
acid O
substitutions O
. O

Isolation O
and O
characterization O
of O
SRF I-GENE
accessory _RARE_
proteins I-GENE
. O

These O
data O
suggest O
that O
: O
( O
a O
) O
proSRIF _RARE_
cleavage _RARE_
is O
initiated _RARE_
in O
the O
TGN _RARE_
, O
and O
( O
b O
) O
this O
reaction O
requires O
an O
acidic _RARE_
pH O
which O
is O
facilitated O
by O
a O
Golgi _RARE_
- I-GENE
associated I-GENE
vacuolar I-GENE
- I-GENE
type I-GENE
ATPase I-GENE
. O

Fenoldopam _RARE_
, O
a O
dopamine I-GENE
receptor I-GENE
agonist O
, O
has O
been O
shown O
, O
in O
animal _RARE_
experiments O
, O
to O
improve O
renal _RARE_
perfusion O
. O

Clinical O
aspects O
of O
early O
increase O
in O
serum O
gamma I-GENE
- I-GENE
glutamyl I-GENE
transferase I-GENE
in O
cerebral O
infarction O
. O

In O
the O
3 O
' O
flanking O
region O
of O
the O
27 _RARE_
kDa I-GENE
zein _RARE_
gene I-GENE
, O
several O
AATAAA _RARE_
- O
like O
sequences O
and O
a O
sequence O
resembling O
the O
mammalian O
GT _RARE_
- O
rich O
sequence O
are O
present O
around O
the O
polyadenylation O
sites O
. O

The O
indoor _RARE_
radon _RARE_
concentration O
in O
the O
summer O
( O
1990 O
) O
period O
ranged O
between O
8 O
and O
81 _RARE_
Bq _RARE_
m O
- O
3 O
, O
while O
in O
the O
winter _RARE_
( O
1989 O
- O
1990 O
) O
it O
ranged O
between O
20 O
and O
143 _RARE_
Bq _RARE_
m O
- O
3 O
for _RARE_
the O
first _RARE_
year O
of O
measurements O
or O
between O
8 O
and O
92 O
Bq _RARE_
m O
- O
3 O
in O
the O
summer O
( O
1991 O
) O
period O
and O
between O
12 O
and O
119 O
Bq _RARE_
m O
- O
3 O
in O
the O
winter _RARE_
( O
1990 O
- O
1991 O
) O
for _RARE_
the O
second O
year O
of O
measurements O
. O

The O
results O
indicate O
that O
hrpRS _RARE_
and O
hrpL _RARE_
are O
part O
of O
a O
regulatory O
cascade O
in O
which O
HrpR _RARE_
and O
HrpS _RARE_
activate O
expression _RARE_
of O
hrpL _RARE_
and O
HrpL _RARE_
, O
a O
putative O
sigma _RARE_
factor I-GENE
, O
induces O
expression _RARE_
of O
HrpL _RARE_
- I-GENE
responsive I-GENE
genes I-GENE
. O

DtxR _RARE_
is O
an O
iron O
- O
dependent O
sequence O
- O
specific O
DNA O
- O
binding O
protein O
that O
binds O
to O
the O
tox _RARE_
operator I-GENE
, O
an O
inverted O
- O
repeat O
nucleotide O
sequence O
located _RARE_
upstream O
from O
the O
diphtheria _RARE_
toxin _RARE_
gene I-GENE
. O

Vasopressin _RARE_
( O
AVP I-GENE
), _RARE_
the O
antidiuretic _RARE_
hormone O
, O
is O
a O
cyclic O
nonapeptide _RARE_
that O
acts O
through O
binding O
to O
G I-GENE
protein I-GENE
- I-GENE
coupled I-GENE
specific I-GENE
membrane I-GENE
receptors I-GENE
pharmacologically _RARE_
divided O
into O
three O
subtypes O
( O
V1a _RARE_
, O
V1b _RARE_
, O
and O
V2 _RARE_
) O
linked _RARE_
to O
distinct O
second O
messengers _RARE_
. O

These O
results O
confirmed O
that O
cleavage _RARE_
of O
the O
leader _RARE_
peptide O
is O
the O
last O
step O
in O
nisin _RARE_
maturation _RARE_
and O
is O
necessary O
to O
generate O
a O
biologically O
active _RARE_
peptide O
. O

When O
the O
promoter O
region O
was O
linked _RARE_
with O
a O
heterologous O
reporter O
gene O
, O
we O
found O
that O
the O
promoter O
region O
is O
inducible O
by O
both O
interferons _RARE_
( O
interferon _RARE_
- I-GENE
alpha I-GENE
and I-GENE
- I-GENE
gamma I-GENE
) O
and O
interferon _RARE_
regulatory I-GENE
factor I-GENE
1 I-GENE
. O

Anti _RARE_
- I-GENE
B I-GENE
. I-GENE
burgdorferi _RARE_
, O
anti I-GENE
- I-GENE
B I-GENE
. I-GENE
turicatae _RARE_
and O
anti I-GENE
- I-GENE
B I-GENE
. I-GENE
parkeri _RARE_
antibodies I-GENE
, O
tested O
by O
the O
indirect O
immunofluorescent _RARE_
assay O
( O
IFA _RARE_
), _RARE_
were O
detected O
in O
10 O
. O
8 O
, O
16 O
. O
1 O
and O
8 O
. O
2 O
% O
of O
the O
serum O
samples O
tested O
, O
and O
confirmed O
by O
IFA _RARE_
- O
ABS _RARE_
in O
1 O
. O
3 O
, O
1 O
. O
3 O
and O
1 O
. O
0 _RARE_
%, O
respectively O
. O

The O
approach O
derives _RARE_
from O
a O
recently O
described O
strategy O
for _RARE_
making O
recombinants _RARE_
from O
five O
overlapping O
EBV _RARE_
cosmid O
- O
cloned _RARE_
DNAs _RARE_
( O
B O
. O

Evaluation O
of O
desmopressin _RARE_
for _RARE_
dental O
extractions _RARE_
in O
patients O
with O
hemostatic _RARE_
disorders O
. O

Comparative O
analysis O
with O
an O
antiandrogen _RARE_
niftolid _RARE_
and O
synthetic _RARE_
GnRH I-GENE
was O
carried O
out O
in O
22 _RARE_
normal O
subjects O
, O
14 O
patients O
with O
primary _RARE_
and O
20 O
ones O
with O
secondary O
hypogonadism _RARE_
, O
and O
in O
5 O
patients O
with O
clinical O
signs O
of O
gonadal _RARE_
insufficiency O
and O
obscure _RARE_
diagnosis O
in O
order O
to O
elucidate O
the O
pituitary I-GENE
gonadotropin I-GENE
reserves _RARE_
. O

All O
other O
normal O
and O
transformed O
lymphoid _RARE_
and O
nonlymphoid _RARE_
cell O
lines O
and O
normal O
tissues O
were O
negative O
for _RARE_
PANG _RARE_
expression _RARE_
except O
for _RARE_
the O
brain O
, O
wherein _RARE_
unique O
4 O
. O
0 _RARE_
- O
and O
6 O
. O
1 O
- O
kb O
transcripts O
were O
detected O
. O

The O
cis O
- O
acting O
regulatory O
properties O
of O
an O
872 _RARE_
bp O
promoter O
fragment O
of O
a O
B O
. O
napus _RARE_
oleosin _RARE_
gene I-GENE
were O
examined O
by O
analysis O
of O
beta I-GENE
- I-GENE
glucuronidase I-GENE
( O
GUS I-GENE
) O
expression _RARE_
in O
transgenic O
tobacco O
plants _RARE_
containing O
an O
oleosin _RARE_
promoter I-GENE
- O
GUS I-GENE
transcriptional O
fusion O
. O

This O
indicates O
that O
the O
mechanism O
by O
which O
CX _RARE_
blocks O
rapid O
degradation _RARE_
of O
tubulin _RARE_
mRNA I-GENE
in O
vivo O
is O
not O
simply _RARE_
by O
preventing O
its O
translation O
and O
suggests O
the O
involvement O
of O
an O
altered O
trans _RARE_
- O
factor O
. O

L O
., O
Greer _RARE_
, O
J _RARE_
. O
& O
Carter _RARE_
, O
G O
. O

Increasing O
the O
extracellular O
calcium _RARE_
concentration O
enhanced _RARE_
detrusor _RARE_
contractility O
in O
a O
dose O
- O
dependent O
manner O
in O
both O
control O
and O
obstructed _RARE_
bladders _RARE_
. O

Structural O
organization O
of O
the O
gene O
encoding O
the O
human I-GENE
lipocalin _RARE_
tear _RARE_
prealbumin _RARE_
and O
synthesis _RARE_
of O
the O
recombinant O
protein O
in O
Escherichia O
coli O
. O

The O
sequence O
has O
a O
1092 _RARE_
- O
bp O
open _RARE_
reading O
frame O
encoding O
a O
protein O
of O
364 _RARE_
amino O
acids _RARE_
. O

Western O
blotting O
( O
immunoblotting _RARE_
) O
with O
an O
antiserum _RARE_
to O
a O
partial O
SOD I-GENE
expressed _RARE_
in O
Escherichia O
coli O
revealed O
two O
proteins O
with O
estimated O
molecular _RARE_
masses O
of O
19 O
and O
29 O
kDa O
. O

The O
gene O
organization O
of O
CRSV _RARE_
RNA I-GENE
- I-GENE
1 I-GENE
is O
similar O
to O
those O
of O
red _RARE_
clover _RARE_
necrotic _RARE_
mosaic O
( O
RCNMV _RARE_
) O
and O
sweet _RARE_
clover _RARE_
necrotic _RARE_
mosaic O
( O
SCNMV _RARE_
) O
dianthoviruses _RARE_
with O
the O
exception O
that O
CRSV _RARE_
RNA I-GENE
- I-GENE
1 I-GENE
contains O
the O
additional O
3 O
'- O
terminal O
ORF O
. O

Members O
of O
the O
myocyte _RARE_
- I-GENE
specific I-GENE
enhancer I-GENE
- I-GENE
binding I-GENE
factor I-GENE
2 I-GENE
( O
MEF2 I-GENE
) O
family O
of O
transcription O
factors O
bind O
a O
conserved _RARE_
A O
/ O
T O
- O
rich O
sequence O
in O
the O
control O
regions O
of O
numerous O
muscle O
- O
specific O
genes O
. O

We O
have O
previously O
shown O
that O
LBP _RARE_
- I-GENE
1 I-GENE
represses O
HIV O
- O
1 O
transcription O
by O
inhibiting O
the O
binding O
of O
TFIID I-GENE
to O
the O
TATA O
box O
. O

These O
results O
illustrate _RARE_
an O
important O
role O
for _RARE_
La _RARE_
in O
RNA O
production O
by O
demonstrating O
its O
ability O
to O
clear O
the O
termination _RARE_
sites O
of O
class O
III O
templates O
, O
thereby O
promoting _RARE_
efficient O
use O
of O
transcription O
complexes O
by O
pol I-GENE
III I-GENE
. O

The O
films O
were O
analyzed O
using O
a O
scanning O
helium _RARE_
- O
neon _RARE_
laser O
densitometer _RARE_
with O
a O
small O
aperture _RARE_
of O
5 O
- O
10 O
microns O
. O

The O
GafChromic _RARE_
method O
has O
proven O
to O
be O
an O
accurate O
and O
rapid O
method O
of O
analysis O
and O
could O
be O
easily O
incorporated O
into O
a O
quality O
assurance _RARE_
program O
. O

Viral _RARE_
genomic O
RNA O
for _RARE_
these O
reactions O
was O
obtained O
directly O
from O
fecal O
specimens O
of O
infected _RARE_
infant O
rats O
. O

GATA _RARE_
- I-GENE
1 I-GENE
mRNA I-GENE
was O
present O
in O
equivalent O
levels O
in O
both O
erythroid _RARE_
cell O
lines O
, O
but O
at _RARE_
a O
low O
level O
in O
FDC _RARE_
- O
P1 O
cells O
. O

Tumor _RARE_
necrosis I-GENE
factor I-GENE
- I-GENE
alpha I-GENE
( O
TNF I-GENE
alpha I-GENE
) O
is O
one O
of O
several O
autocrine O
/ O
paracrine _RARE_
factors O
known O
to O
exert O
potent O
inhibitory _RARE_
effects O
on O
bone O
. O

We O
have O
investigated O
the O
role O
of O
cellular I-GENE
p21ras I-GENE
protein I-GENE
in O
insulin I-GENE
and O
insulin I-GENE
- I-GENE
like I-GENE
growth I-GENE
factor I-GENE
- I-GENE
I I-GENE
( O
IGF I-GENE
- I-GENE
I I-GENE
) O
signaling _RARE_
pathways O
. O

The O
lack O
of O
the O
C2 I-GENE
domain O
of O
the O
Ca I-GENE
( I-GENE
2 I-GENE
+)- _RARE_
dependent I-GENE
PKCs _RARE_
and O
the O
presence O
of O
a O
unique O
NH2 O
- O
terminal O
sequence O
with O
a O
potential _RARE_
signal O
peptide O
and O
a O
transmembrane O
domain O
suggest O
that O
PKC I-GENE
mu I-GENE
is O
a O
novel O
member _RARE_
of O
the O
subgroup O
of O
atypical O
PKCs _RARE_
. O

Moreover O
, O
we O
observed O
that O
the O
function O
of O
T3R I-GENE
- O
RXR I-GENE
heterodimers _RARE_
on O
response O
elements O
composed O
of O
two O
half _RARE_
- O
sites O
in O
a O
directly O
repeated _RARE_
orientation O
spaced _RARE_
by O
4 O
nucleotides O
is O
determined O
in O
major O
parts O
by O
the O
5 O
'- O
flanking O
sequence O
of O
the O
upstream O
half _RARE_
- O
site O
. O

However O
, O
three O
Hm1 _RARE_
mutants I-GENE
that O
were O
moderately O
deficient _RARE_
in O
stimulating O
PI O
turnover O
displayed O
normal O
sequestration _RARE_
, O
suggesting O
distinct O
mechanisms O
. O

Furthermore O
, O
in O
vitro O
decay _RARE_
reaction O
mixtures _RARE_
supplemented O
with O
the O
20 O
- O
nt O
sense O
RNA O
transcript O
resulted O
in O
stabilization O
of O
R2 _RARE_
message _RARE_
. O

Deletion O
analyses O
of O
the O
pCD41 _RARE_
ORF I-GENE
- I-GENE
A I-GENE
and O
the O
use O
of O
promoter O
constructs O
further O
mapped O
an O
internal O
functional _RARE_
promoter O
within O
the O
pCD41 _RARE_
sequence I-GENE
that O
can O
direct O
the O
synthesis _RARE_
of O
the O
trans _RARE_
- O
activating O
protein O
. O

Seven _RARE_
of O
these O
had O
counterparts O
in O
the O
US O
of O
herpes O
simplex O
type O
1 O
( O
HSV O
- O
1 O
), _RARE_
pseudorabies O
virus O
( O
PRV _RARE_
), _RARE_
and O
equine _RARE_
herpesvirus _RARE_
type O
1 O
( O
EHV _RARE_
- O
1 O
). O

The O
inferred _RARE_
amino O
acid O
sequence O
of O
the O
cyanobacterial _RARE_
HemB _RARE_
protein I-GENE
indicates O
a O
significant O
difference O
in O
the O
metal O
cofactor O
requirement O
from O
the O
higher _RARE_
- O
plant _RARE_
enzymes _RARE_
, O
which O
was O
confirmed O
by O
overexpression O
and O
biochemical O
analysis O
. O

METHODS O
AND _RARE_
RESULTS O
: O
In O
25 _RARE_
open _RARE_
- O
chest O
, O
anesthetized O
dogs O
, O
progressive O
circumflex _RARE_
artery O
stenosis O
led O
to O
a O
concordant _RARE_
decrease O
of O
circumflex _RARE_
artery O
resting O
and O
hyperemic _RARE_
flow O
, O
coronary O
flow O
reserve O
, O
and O
inverse _RARE_
angiographic O
mean O
transit O
time O
Tmicro _RARE_
- O
1 O
( O
P O
< O
. O
01 O
). O

However O
, O
a O
correlation O
was O
observed O
between O
SF _RARE_
levels O
of O
IL _RARE_
- I-GENE
8 I-GENE
with O
those O
of O
lactate _RARE_
, O
LDH _RARE_
, O
beta I-GENE
2 I-GENE
- I-GENE
microglobulin I-GENE
and O
glucose O
. O

Sodium O
- O
taurocholate _RARE_
- O
induced _RARE_
acute O
necrotizing _RARE_
pancreatitis O
does O
not O
affect O
jejunal _RARE_
oxygenation O
in O
pigs O
. O

Although O
inactive O
in O
cells O
under O
normal O
conditions O
, O
the O
CHOP _RARE_
gene I-GENE
is O
markedly O
induced _RARE_
by O
a O
variety O
of O
cellular O
stresses O
, O
including O
nutrient O
deprivation O
and O
metabolic O
perturbations _RARE_
. O

The O
ipiO _RARE_
genes I-GENE
code O
for _RARE_
two O
almost O
identical O
152 _RARE_
- O
aa _RARE_
proteins O
which O
do O
not O
have O
any O
homology O
with O
sequences O
present O
in O
data O
libraries O
. O

Sterol _RARE_
analysis O
of O
the O
disrupted O
mutant O
demonstrated O
the O
accumulation O
of O
ignosterol _RARE_
, O
indicating O
a O
loss _RARE_
of O
Erg24p _RARE_
activity O
. O

The O
previously O
described O
enhanced _RARE_
translation O
of O
spinach _RARE_
L12 _RARE_
mRNA I-GENE
from O
its O
two O
tandem _RARE_
AUG O
codons O
and O
the O
two O
functional _RARE_
rpl12 _RARE_
genes I-GENE
in O
Arabidopsis O
probably O
provide O
two O
mechanisms O
for _RARE_
generating O
the O
four O
copies O
of O
L12 _RARE_
/ I-GENE
chloroplast I-GENE
ribosome _RARE_
, O
qualitatively _RARE_
different O
from O
those O
attempted _RARE_
in O
eubacteria _RARE_
. O

In O
these O
experiments O
we O
begin O
to O
study O
the O
potential _RARE_
functions O
of O
the O
alpha I-GENE
7 I-GENE
cytoplasmic I-GENE
domain I-GENE
by O
analyzing O
homologies O
between O
the O
rat O
and O
human O
sequences O
, O
by O
immunologic O
studies O
using O
an O
anti O
- O
cytoplasmic O
domain O
antiserum _RARE_
, O
and O
by O
identifying O
two O
alternate O
forms O
. O

The O
alpha O
7A _RARE_
form O
RNA O
contains O
an O
additional O
113 _RARE_
nucleotides O
compared O
to O
the O
B O
form O
, O
and O
a O
common O
coding O
region O
in O
the O
A O
and O
B O
form O
RNAs O
is O
used O
in O
alternate O
reading O
frames O
. O

In O
order O
to O
evaluate O
the O
function O
of O
the O
hypothalamic _RARE_
- O
pituitary O
- O
thyroid O
( O
HPT _RARE_
)- O
axis O
in O
unipolar _RARE_
depression O
, O
the O
authors O
measured O
basal O
0800h _RARE_
plasma O
levels O
of O
free O
thyroxine O
( O
FT4 _RARE_
), _RARE_
free O
triiodothyronine _RARE_
( O
FT3 _RARE_
), _RARE_
and O
thyroid I-GENE
stimulating I-GENE
hormone I-GENE
( O
TSH _RARE_
) O
by O
means O
of O
the O
new O
, O
ultrasensitive _RARE_
assays O
( O
TSH _RARE_
- O
IRMA _RARE_
) O
in O
69 _RARE_
healthy O
controls O
, O
62 _RARE_
minor O
, O
101 _RARE_
simple O
major O
, O
and O
57 O
melancholic _RARE_
depressed O
subjects O
. O

CRS _RARE_
function O
in O
a O
5 O
' O
LTR O
- O
linked _RARE_
gene O
expression _RARE_
assay O
correlates O
with O
the O
ability O
of O
both O
p60CRS _RARE_
and O
p40CRS _RARE_
to O
interact O
with O
5 O
' O
LTR O
RNA O
in O
vitro O
. O

Serial _RARE_
levels O
of O
troponin _RARE_
T I-GENE
and O
the O
activity O
of O
CK _RARE_
- I-GENE
MB I-GENE
were O
measured O
6 O
, O
12 O
, O
24 _RARE_
and O
48 _RARE_
h O
after O
aortic O
unclamping _RARE_
. O

Regionalization _RARE_
of O
drug O
delivery O
is O
a O
potential _RARE_
method O
to O
avoid O
this O
problem O
. O

The O
epidemic O
occurred O
in O
a O
group O
of O
26 _RARE_
community O
members O
( O
23 _RARE_
men O
and O
3 O
women O
, O
mean O
age O
, O
28 _RARE_
. O
9 O
-- _RARE_
3 O
years O
) O
living O
and O
working O
together O
, O
who O
underwent O
acute O
and O
convalescent _RARE_
serologic O
tests O
for _RARE_
Mycoplasma _RARE_
pneumoniae _RARE_
, O
Legionella _RARE_
pneumophila _RARE_
, O
cytomegalovirus _RARE_
, O
adenovirus O
, O
Coxiella _RARE_
burnetii _RARE_
, O
and O
Chlamydia O
pneumoniae _RARE_
. O

MEK I-GENE
itself O
is O
activated O
via O
serine O
phosphorylation _RARE_
by O
upstream I-GENE
activator I-GENE
kinases I-GENE
, O
including O
c I-GENE
- I-GENE
raf _RARE_
, O
mos I-GENE
and O
MEK I-GENE
kinase I-GENE
. O

Genomic O
DNA O
clones _RARE_
containing O
the O
T I-GENE
- I-GENE
cell I-GENE
- I-GENE
specific I-GENE
human I-GENE
MAL _RARE_
gene I-GENE
were O
isolated O
. O

Members O
of O
SVA _RARE_
are O
also O
present O
in O
the O
complement I-GENE
C2 I-GENE
gene I-GENE
located _RARE_
about O
20 O
kilobases O
upstream O
of O
RP1 _RARE_
in O
the O
HLA I-GENE
and O
in O
the O
cytochrome I-GENE
CYP1A1 _RARE_
gene I-GENE
. O

Expression O
of O
the O
dibasic _RARE_
proprotein _RARE_
processing _RARE_
enzyme O
furin _RARE_
is O
directed O
by O
multiple O
promoters O
. O

European O
Community _RARE_
Huntington _RARE_
' O
s O
Disease _RARE_
Collaborative _RARE_
Study O
Group O
. O

The O
c I-GENE
- I-GENE
myc I-GENE
and O
skeletal I-GENE
alpha I-GENE
- I-GENE
actin I-GENE
gene I-GENE
promoters I-GENE
contain O
YY1 I-GENE
binding I-GENE
sites I-GENE
thought O
to O
act O
either O
as _RARE_
positive O
or O
negative O
cis O
- O
acting O
elements O
. O

MSSP _RARE_
- I-GENE
1 I-GENE
produced O
in O
E O
. O
coli O
as _RARE_
a O
fusion O
protein O
with O
GST I-GENE
specifically O
interacted O
with O
single O
- O
stranded _RARE_
TCTTAT _RARE_
( O
plus _RARE_
myc I-GENE
( O
H O
- O
P O
) O
21 O
) O
and O
ACT _RARE_
- O
ATT _RARE_
( O
in O
minus O
myc I-GENE
( O
H O
- O
P O
) O
21 O
), _RARE_
the O
consensus O
of O
which O
can O
be O
referred O
to O
as _RARE_
A O
/ O
TCTA _RARE_
/ O
TA O
/ O
TT _RARE_
. O

Within O
12 O
hours O
after O
MR O
tomography O
the O
patients O
were O
surgically O
explored O
, O
biopsied _RARE_
and O
if O
necessary O
orchiectomised _RARE_
. O

Certain _RARE_
spt10 _RARE_
spontaneous O
alleles O
are O
good O
suppressors O
but O
have O
a O
normal O
growth O
rate O
, O
suggesting O
that O
the O
SPT10 _RARE_
protein I-GENE
may O
have O
two O
distinct O
functions O
. O

Varieties _RARE_
of O
envious _RARE_
experience O
. O

The O
results O
show O
that O
both O
the O
amino O
and O
carboxy _RARE_
termini O
of O
the O
NS1 I-GENE
protein I-GENE
molecule I-GENE
and O
the O
cysteines _RARE_
at _RARE_
residues O
337 _RARE_
and O
340 _RARE_
are O
essential O
for _RARE_
tubule _RARE_
formation O
. O

The O
3 O
' O
UTR O
has O
several O
stable O
hairpins _RARE_
that O
are O
flanked O
by O
single O
- O
stranded _RARE_
( O
A O
/ O
U _RARE_
) O
UGC _RARE_
sequences O
. O

Moreover O
, O
the O
major O
site O
of O
transcriptional O
initiation O
, O
which O
was O
localized O
by O
primer O
extension O
250 _RARE_
bp O
upstream O
of O
the O
5 O
' O
end O
of O
the O
Ets I-GENE
- I-GENE
1 I-GENE
cDNA I-GENE
clone I-GENE
, O
was O
shown O
to O
be O
identical O
in O
normal O
cells O
and O
tumors O
carrying O
a O
provirus O
in O
the O
Tpl _RARE_
- I-GENE
1 I-GENE
locus I-GENE
. O

Specifically O
, O
by O
oligonucleotide _RARE_
- O
directed O
site O
- O
specific O
mutagenesis O
, O
we O
demonstrate O
that O
of O
10 O
cysteine O
residues O
in O
the O
ORF4 _RARE_
polypeptide O
, O
only O
C O
- O
421 _RARE_
and O
C O
- O
426 _RARE_
are O
essential O
for _RARE_
transactivator _RARE_
function O
and O
suggest O
that O
these O
cysteine O
residues O
may O
participate O
in O
critical O
protein O
- O
protein O
interactions O
rather O
than O
protein O
- O
nucleic _RARE_
acid O
interactions O
to O
mediate O
ORF4 _RARE_
inducibility O
. O

In O
Rat _RARE_
1a _RARE_
cells O
, O
m1R _RARE_
stimulation _RARE_
of O
phospholipase I-GENE
C I-GENE
beta I-GENE
and O
the O
marked O
rise O
in O
intracellular _RARE_
calcium _RARE_
stimulated _RARE_
cyclic O
AMP O
( O
cAMP O
) O
synthesis _RARE_
, O
resulting O
in O
the O
activation O
of O
protein I-GENE
kinase I-GENE
A I-GENE
. O

The O
mutations O
did O
not O
affect O
the O
repression O
of O
CPA1 _RARE_
by O
arginine _RARE_
. O

A O
segment O
of O
mRNA O
encoding O
the O
leader _RARE_
peptide O
of O
the O
CPA1 _RARE_
gene I-GENE
confers O
repression O
by O
arginine _RARE_
on O
a O
heterologous O
yeast O
gene O
transcript O
. O

To O
search O
for _RARE_
genes O
that O
interact O
with O
the O
SLK1 _RARE_
- O
SLT2 _RARE_
pathway _RARE_
, O
a O
synthetic _RARE_
lethal O
suppression O
screen O
was O
carried O
out O
. O

Genetic O
and O
phenotypic _RARE_
analysis O
indicates O
that O
NHP6A _RARE_
and O
NHP6B _RARE_
function O
downstream _RARE_
of O
SLT2 _RARE_
. O

In O
this O
report O
, O
we O
present O
two O
lines O
of O
evidence O
that O
all O
ribosomes _RARE_
which O
synthesize _RARE_
GCN4 I-GENE
have O
previously O
translated O
uORF1 _RARE_
, O
resumed _RARE_
scanning O
, O
and O
reinitiated _RARE_
at _RARE_
the O
GCN4 I-GENE
start _RARE_
site O
. O

Identical _RARE_
components _RARE_
of O
yeast O
transcription I-GENE
factor I-GENE
IIIB _RARE_
are O
required O
and O
sufficient O
for _RARE_
transcription O
of O
TATA O
box O
- O
containing O
and O
TATA O
- O
less O
genes O
. O

Concordantly _RARE_
, O
it O
was O
shown O
that O
the O
dnHLH _RARE_
protein I-GENE
Id1 _RARE_
inhibits O
differentiation O
of O
muscle O
and O
myeloid _RARE_
cells O
in O
vitro O
. O

RNP1 _RARE_
, O
a O
new O
ribonucleoprotein O
gene O
of O
the O
yeast O
Saccharomyces O
cerevisiae O
. O

Crohn O
' O
s O
disease _RARE_
in O
prolonged O
remission O
: O
should O
one O
augment _RARE_
protein O
- O
calorie _RARE_
intake O
as _RARE_
compared O
to O
healthy O
subjects O
?] _RARE_
The O
aim O
of O
our O
two O
year O
prospective O
study O
was O
to O
evaluate O
whether O
adult O
Crohn O
' O
s O
disease _RARE_
patients O
in O
prolonged O
remission O
( O
CDAI _RARE_
< O
150 _RARE_
), _RARE_
in O
order O
to O
maintain O
their O
body O
weight _RARE_
as _RARE_
close O
as _RARE_
possible O
to O
the O
ideal _RARE_
one O
, O
need O
a O
protein O
- O
calorie _RARE_
intake O
higher _RARE_
than O
the O
predicted O
one O
and O
that O
of O
healthy O
controls O
. O

To O
achieve O
complete _RARE_
dissection O
of O
the O
anterior O
vitreous O
, O
we O
remove _RARE_
even O
a O
clear O
lens O
during _RARE_
the O
first _RARE_
surgical O
intervention O
in O
selected _RARE_
cases O
. O

Restoration _RARE_
of O
opponens _RARE_
function O
with O
transplantation O
of O
free O
composites _RARE_
dorsal O
pedal _RARE_
skin _RARE_
flap O
containing O
m O
. O
extensor _RARE_
hallucis _RARE_
brevis _RARE_

Neither O
ethanol O
regimen O
impaired O
spontaneous O
alternation _RARE_
, O
but O
the O
4 O
g O
ethanol O
. O
kg O
- O
1 O
x _RARE_
day O
- O
1 O
regimen O
increased O
the O
percent O
completed O
trials O
. O

The O
mean O
(+/- O
sd _RARE_
) O
intra _RARE_
- O
vesicular O
pressure O
( O
IVP _RARE_
) O
and O
maximal O
urethral _RARE_
closure O
pressures O
( O
MUCP _RARE_
) O
were O
10 O
. O
3 O
(+/- O
1 O
. O
7 O
) O
and O
129 _RARE_
. O
8 O
(+/- O
19 O
. O
6 O
) O
cmH2O O
, O
respectively O
, O
and O
the O
ratio O
between O
MUCP _RARE_
and O
IVP _RARE_
was O
13 _RARE_
. O
2 O
(+/- O
2 O
. O
5 O
). O

Several O
highly O
conserved _RARE_
regions O
were O
identified O
at _RARE_
the O
near O
N O
terminus O
, O
middle _RARE_
and O
C O
terminus O
. O

Thioredoxin _RARE_
( O
TR I-GENE
) O
is O
a O
small O
ubiquitous O
dithiol _RARE_
- I-GENE
reductase I-GENE
enzyme I-GENE
first _RARE_
identified O
in O
bacteria O
and O
plants _RARE_
. O

The O
mutation O
within O
the O
asgB480 _RARE_
allele I-GENE
was O
identified O
as _RARE_
an O
A O
- O
to O
- O
G O
transition O
that O
results O
in O
a O
threonine O
- O
to O
- O
alanine O
substitution O
in O
the O
predicted O
protein O
product O
. O

The O
cysteine O
- O
rich O
region O
of O
raf _RARE_
- I-GENE
1 I-GENE
kinase I-GENE
contains O
zinc O
, O
translocates _RARE_
to O
liposomes O
, O
and O
is O
adjacent O
to O
a O
segment O
that O
binds O
GTP I-GENE
- I-GENE
ras I-GENE
. O

Kinetic _RARE_
coupling O
and O
requirement O
for _RARE_
ATP O
hydrolysis O
. O

ATP O
by O
itself O
also O
reduced _RARE_
polypeptide O
binding O
to O
Ssb1 _RARE_
/ I-GENE
2p _RARE_
to O
a O
level O
that O
was O
intermediate _RARE_
between O
that O
observed O
for _RARE_
the O
Ssa _RARE_
Hsp70 _RARE_
proteins I-GENE
tested O
and O
BiP _RARE_
and O
DnaK _RARE_
. O

Digestion _RARE_
of O
NF _RARE_
- I-GENE
IL6 I-GENE
with O
endoprotease _RARE_
Asp _RARE_
- I-GENE
N I-GENE
produced O
a O
domain O
smaller O
than O
the O
TCD _RARE_
( O
NF _RARE_
- I-GENE
IL6 I-GENE
bZIP _RARE_
domains I-GENE
( O
NFBD _RARE_
) O
( O
272 O
- O
345 _RARE_
)), _RARE_
a O
domain O
identified O
either O
in O
the O
absence O
or O
the O
presence O
of O
DNA O
. O

Signaling _RARE_
by O
tyrosine I-GENE
kinases I-GENE
involves O
direct O
associations O
between O
proteins O
with O
Src I-GENE
homology I-GENE
2 I-GENE
( O
SH2 _RARE_
) O
domains O
and O
sites O
of O
tyrosine O
phosphorylation _RARE_
. O

Rather _RARE_
, O
complete _RARE_
skipping _RARE_
of O
exon _RARE_
V O
and O
subsequent O
joining _RARE_
of O
exon _RARE_
IV O
to O
exon _RARE_
VI _RARE_
caused O
a O
shift O
in O
the O
open _RARE_
reading O
frame O
, O
which O
remodeled _RARE_
GPHe _RARE_
( I-GENE
P2 I-GENE
) I-GENE
with O
an O
elongated _RARE_
new O
hydrophobic O
sequence O
for _RARE_
membrane O
anchoring _RARE_
. O

The O
responses O
of O
the O
" O
stress O
hormones _RARE_
" O
cortisol O
, O
11 O
- O
deoxycortisol _RARE_
, O
ACTH I-GENE
, O
vasopressin I-GENE
( O
AVP I-GENE
), _RARE_
and O
corticotropin _RARE_
releasing I-GENE
factor I-GENE
( O
CRF _RARE_
) O
were O
studied O
in O
6 O
normal O
males O
in O
response O
to O
acute O
cortisol O
deficiency O
induced _RARE_
by O
the O
11 I-GENE
- I-GENE
beta I-GENE
- I-GENE
hydroxylase I-GENE
inhibitor O
, O
metyrapone _RARE_
. O

Structure O
and O
expression _RARE_
of O
the O
alternative _RARE_
sigma _RARE_
factor I-GENE
, O
RpoN _RARE_
, O
in O
Rhodobacter _RARE_
capsulatus _RARE_
; O
physiological O
relevance O
of O
an O
autoactivated _RARE_
nifU2 _RARE_
- O
rpoN _RARE_
superoperon _RARE_
. O

Thus O
our O
observations O
establish O
a O
functional _RARE_
link _RARE_
between O
the O
PKC I-GENE
and O
retinoid O
pathways O
, O
which O
are O
generally O
considered O
to O
have O
antagonistic O
activities O
on O
differentiation O
processes O
. O

The O
colony I-GENE
- I-GENE
stimulating I-GENE
factors I-GENE
( O
CSFs _RARE_
) O
principally _RARE_
involved O
in O
the O
production O
of O
neutrophils O
and O
monocytes O
are O
granulocyte _RARE_
CSF I-GENE
, O
granulocyte _RARE_
- I-GENE
macrophage I-GENE
CSF I-GENE
, O
macrophage I-GENE
CSF I-GENE
, O
and O
interleukin I-GENE
3 I-GENE
( O
sometimes _RARE_
called O
multi _RARE_
- I-GENE
CSF I-GENE
). O

The O
degree O
of O
lung _RARE_
destruction _RARE_
, O
reflected O
by O
interstitial O
hemorrhage O
was O
assessed O
by O
measuring O
hemoglobin I-GENE
content O
in O
the O
fluid _RARE_
of O
the O
lavaged _RARE_
lungs O
. O

Expression O
plasmids O
harboring O
full O
- O
length O
or O
kinase O
domain O
of O
PKC I-GENE
alpha I-GENE
and O
PKC I-GENE
delta I-GENE
( O
PKC I-GENE
alpha I-GENE
K I-GENE
and O
PKC I-GENE
delta I-GENE
K I-GENE
) O
were O
constructed O
. O

These O
results O
indicate O
that O
both O
PKC I-GENE
alpha I-GENE
( O
calcium _RARE_
dependent O
) O
and O
PKC I-GENE
delta I-GENE
( O
calcium _RARE_
independent O
) O
may O
mediate O
the O
transcription O
of O
TPA _RARE_
- O
inducible O
genes O
through O
both O
AP I-GENE
- I-GENE
1 I-GENE
and O
non O
- O
AP I-GENE
- I-GENE
1 I-GENE
sequences O
. O

With O
a O
cutoff O
level O
for _RARE_
TSST _RARE_
- I-GENE
1 I-GENE
of O
less O
than O
100 _RARE_
pg O
/ O
ml O
, O
28 _RARE_
samples O
obtained O
from O
12 O
patients O
were O
positive O
for _RARE_
TSST _RARE_
- I-GENE
1 I-GENE
. O

Insertion _RARE_
of O
short O
oligonucleotides O
encoding O
the O
basic O
amino O
acid O
motifs O
726 _RARE_
- O
GRKRKSP _RARE_
- O
732 _RARE_
from O
IE175 _RARE_
and O
500 O
- O
VRPRKRR _RARE_
- O
506 _RARE_
from O
IE110 _RARE_
into O
deleted _RARE_
cytoplasmic O
forms O
of O
the O
two O
proteins O
restored O
the O
karyophilic _RARE_
phenotype _RARE_
and O
confirmed O
that O
these O
motifs O
are O
both O
necessary O
and O
sufficient O
for _RARE_
proper O
nuclear O
localization _RARE_
. O

Mapping O
of O
intracellular _RARE_
localization _RARE_
domains O
and O
evidence O
for _RARE_
colocalization _RARE_
interactions O
between O
the O
IE110 _RARE_
and O
IE175 _RARE_
nuclear O
transactivator _RARE_
proteins O
of O
herpes O
simplex O
virus O
. O

The O
revertant _RARE_
TATA O
boxes _RARE_
accelerated O
the O
kinetics O
of O
HIV O
replication O
when O
present O
in O
the O
context O
of O
an O
LTR O
containing O
a O
Sp1 _RARE_
mutation O
( O
deletion O
or O
site O
specific O
); O
no _RARE_
effect O
was O
observed O
on O
the O
infectivity _RARE_
of O
wild O
- O
type O
HIV O
. O

Panlobular _RARE_
emphysema O

Since O
the O
ETS _RARE_
domain I-GENE
, O
which O
is O
localized O
in O
the O
carboxy _RARE_
terminal O
region O
of O
the O
encoded O
protein O
, O
is O
95 _RARE_
% O
and O
96 O
% O
identical O
to O
that O
of O
PEA3 I-GENE
and O
ER81 _RARE_
, O
respectively O
, O
we O
named O
this O
new O
member _RARE_
' I-GENE
Ets I-GENE
Related _RARE_
Molecule _RARE_
PEA3 I-GENE
- I-GENE
like I-GENE
' I-GENE
( O
ERM _RARE_
). O

Gel O
shift O
analysis O
indicates O
that O
the O
full I-GENE
- I-GENE
length I-GENE
ERM _RARE_
protein I-GENE
is O
able O
to O
bind O
specifically O
to O
an O
oligonucleotide _RARE_
containing O
the O
consensus O
nucleotide O
core O
sequence O
GGAA _RARE_
recognized _RARE_
by O
the O
Ets I-GENE
proteins O
. O

Effects O
of O
estradiol O
on O
worm _RARE_
burden O
and O
peripheral O
leukocytes _RARE_
in O
Parastrongylus _RARE_
malaysiensis _RARE_
- O
infected _RARE_
rats O
. O

Dotarizine _RARE_
produced O
arterial O
dilation _RARE_
in O
both O
systemic O
and O
pulmonary O
circulation O
: O
the O
total _RARE_
peripheral O
resistance O
dropped _RARE_
, O
and O
femoral O
artery O
flow O
rose O
; O
aortic O
and O
pulmonary O
artery O
mean O
and O
diastolic O
pressures O
declined O
, O
and O
systolic O
pressures O
remained O
almost O
stable O
. O

These O
issues O
include O
the O
use O
of O
LMWHs _RARE_
in O
patients O
with O
arterial O
thrombosis O
or O
myocardial _RARE_
infarction O
( O
e _RARE_
. O
g O
. O
in O
conjunction O
with O
thrombolytic _RARE_
treatment O
), _RARE_
and O
in O
patients O
with O
pulmonary O
embolism _RARE_
. O

The O
usefulness _RARE_
of O
the O
lambda O
PG15 _RARE_
and O
the O
lambda O
AD5 _RARE_
cloning O
vectors O
was O
demonstrated O
by O
constructing _RARE_
large O
Neurospora O
crassa O
cDNA O
libraries O
. O

Endoscopic _RARE_
transthoracic _RARE_
sympathectomy _RARE_
as _RARE_
adjuvant O
treatment O
for _RARE_
critical O
upper O
- O
limb O
ischaemia O
. O

Sequence O
comparisons O
have O
shown O
that O
Aps1p _RARE_
is O
more O
similar O
to O
the O
sigma _RARE_
subunit O
of O
the O
Golgi _RARE_
- O
localized O
mammalian O
AP I-GENE
- I-GENE
1 I-GENE
complex I-GENE
than O
Aps2p _RARE_
, O
which O
is O
more O
related O
to O
the O
plasma O
membrane O
AP I-GENE
- I-GENE
2 I-GENE
sigma _RARE_
subunit O
. O

The O
Saccharomyces I-GENE
cerevisiae I-GENE
APS1 _RARE_
gene I-GENE
encodes O
a O
homolog O
of O
the O
small O
subunit O
of O
the O
mammalian I-GENE
clathrin I-GENE
AP I-GENE
- I-GENE
1 I-GENE
complex I-GENE
: O
evidence O
for _RARE_
functional _RARE_
interaction O
with O
clathrin I-GENE
at _RARE_
the O
Golgi _RARE_
complex O
. O

These O
results O
are O
the O
first _RARE_
to O
demonstrate O
the O
structural O
organization O
of O
a O
vertebrate _RARE_
gene O
encoding O
an O
integral _RARE_
membrane O
protein O
of O
the O
nuclear O
envelope O
that O
may O
be O
a O
member _RARE_
of O
a O
family O
of O
polypeptides O
conserved _RARE_
in O
evolution O
. O

Biochemical O
characterization O
of O
valosin _RARE_
- I-GENE
containing I-GENE
protein I-GENE
, O
a O
protein I-GENE
tyrosine I-GENE
kinase I-GENE
substrate O
in O
hematopoietic O
cells O
. O

The O
presence O
of O
the O
foreign O
gene O
was O
confirmed O
by O
Southern O
analysis O
. O

All O
patients O
with O
deterioriation _RARE_
in O
mental O
status O
showed O
a O
marked O
increase O
in O
liver O
enzymes _RARE_
( O
aspartate _RARE_
and I-GENE
alanine I-GENE
aminotransaminases _RARE_
) O
and O
severe O
coagulopathy _RARE_
. O

Functional O
postnatal O
development O
of O
the O
rat O
primary _RARE_
visual O
cortex O
and O
the O
role O
of O
visual O
experience O
: O
dark O
rearing _RARE_
and O
monocular _RARE_
deprivation O
. O

Eleven _RARE_
patients O
tested O
positive O
for _RARE_
the O
hepatitis I-GENE
B I-GENE
surface I-GENE
antigen I-GENE
( O
HBsAg I-GENE
). O

The O
xylose _RARE_
isomerase I-GENE
- I-GENE
encoding I-GENE
gene I-GENE
( O
xylA _RARE_
) O
of O
Clostridium _RARE_
thermosaccharolyticum _RARE_
: O
cloning O
, O
sequencing O
and O
phylogeny _RARE_
of O
XylA _RARE_
enzymes _RARE_
. O

Two O
phosphopeptides O
, O
identified O
as _RARE_
RS _RARE_
-[ _RARE_
32P O
] O
SGASGLLTSEHHSR _RARE_
and O
S O
-[ _RARE_
32P O
] O
SGASGLLTSEHHSR _RARE_
, O
were O
obtained O
after O
stoichiometric _RARE_
phosphorylation _RARE_
and O
trypsinization _RARE_
of O
the O
peptide O
. O

Mitochondrial _RARE_
Mas70p _RARE_
signal I-GENE
anchor _RARE_
sequence I-GENE
. O

Altogether O
, O
these O
data O
suggest O
that O
Ypt51p _RARE_
, O
Ypt52p _RARE_
, O
and O
Ypt53p _RARE_
are O
required O
for _RARE_
transport _RARE_
in O
the O
endocytic O
pathway _RARE_
and O
for _RARE_
correct O
sorting _RARE_
of O
vacuolar I-GENE
hydrolases _RARE_
suggesting O
a O
possible O
intersection _RARE_
of O
the O
endocytic O
with O
the O
vacuolar O
sorting _RARE_
pathway _RARE_
. O

All O
of O
the O
basal O
TPN O
solutions O
were O
isonitrogenous _RARE_
and O
identical O
in O
nutrient O
composition O
, O
except O
for _RARE_
the O
difference O
in O
energy O
level O
, O
which O
was O
adjusted O
with O
glucose O
. O

Surprisingly O
, O
TFIIIC _RARE_
alpha I-GENE
has O
no _RARE_
homology O
to O
any O
of O
the O
yeast I-GENE
TFIIIC _RARE_
subunits I-GENE
already O
cloned _RARE_
, O
suggesting O
a O
significant O
degree O
of O
evolutionary O
divergence O
for _RARE_
RNA I-GENE
polymerase I-GENE
III I-GENE
factors I-GENE
. O

Transactivation _RARE_
domain O
is O
located _RARE_
downstream _RARE_
of O
the O
128 _RARE_
- I-GENE
amino I-GENE
- I-GENE
acid I-GENE
runt _RARE_
homology I-GENE
region I-GENE
, O
referred O
to O
as _RARE_
the O
Runt _RARE_
domain I-GENE
. O

We O
estimate O
that O
the O
protease O
activity O
is O
at _RARE_
least O
35 _RARE_
- O
fold _RARE_
greater O
in O
mature _RARE_
B O
cells O
than O
in O
pre O
- O
B O
cells O
. O

The O
ligand _RARE_
for _RARE_
RXR I-GENE
, O
9 O
- O
cis O
retinoic O
acid O
, O
has O
the O
opposite O
effect O
of O
destabilizing _RARE_
the O
heterodimeric _RARE_
- O
DNA O
complex O
. O

Cerebral125 _RARE_
albumin I-GENE
was O
increased O
to O
similar O
proportions _RARE_
in O
those O
groups O
submitted O
to O
hyperosmolality _RARE_
. O

Retrogradely _RARE_
labelled O
neurons O
significantly O
prevailed _RARE_
in O
the O
ipsilateral O
substantia _RARE_
nigra _RARE_
pars _RARE_
compacta _RARE_
. O

Response O
to O
treatment O
was O
better O
in O
patients O
with O
less O
pretreatment O
( O
one O
- O
two O
prior O
treatments O
) O
than O
in O
heavily _RARE_
pretreated O
ones O
( O
more O
than O
three O
) O
and O
this O
relation O
was O
found O
to O
be O
statistically O
significant O
( O
p O
< O
0 _RARE_
. O
05 O
). O

Therefore O
, O
the O
amino O
- O
terminal O
sequence O
of O
the O
purified _RARE_
carA _RARE_
product I-GENE
is O
identical O
to O
that O
derived O
from O
the O
nucleotide O
sequence O
in O
both O
organisms O
, O
P O
. O
stutzeri _RARE_
having O
four O
additional O
amino O
acids _RARE_
. O

Aneurysmal _RARE_
bone O
cyst O
of O
the O
jaws _RARE_
: O
analysis O
of O
11 O
cases O
. O

Location _RARE_
and O
orientation O
of O
an O
activating O
region O
in O
the O
Escherichia O
coli O
transcription O
factor O
, O
FNR _RARE_
. O

Moxidectin _RARE_
( O
at _RARE_
3 O
times O
the O
therapeutic O
dose O
) O
did O
not O
have O
deleterious _RARE_
effects O
on O
cow _RARE_
reproductive O
performance O
as _RARE_
examined O
( O
eg _RARE_
, O
at _RARE_
folliculogenesis _RARE_
, O
ovulation O
, O
and O
the O
early O
embryonic _RARE_
phase _RARE_
of O
development O
). O

Northern O
- O
blot O
analysis O
of O
mRNA O
from O
Avicel _RARE_
- O
grown O
N O
. O
patriciarum _RARE_
showed O
that O
xynB _RARE_
hybridized O
to O
a O
3 O
. O
4 O
kb O
mRNA O
species O
. O

The O
variable _RARE_
regions O
of O
vertebrate _RARE_
striated _RARE_
TnT _RARE_
isoforms I-GENE
reflect O
the O
subsequent O
addition O
and O
modification O
of O
genomic O
sequences O
to O
give O
rise O
to O
members O
of O
the O
TnT _RARE_
multigene _RARE_
family I-GENE
. O

The O
class I-GENE
II I-GENE
Escherichia I-GENE
coli I-GENE
alanine I-GENE
tRNA I-GENE
synthetase _RARE_
aminoacylates _RARE_
RNA I-GENE
miniduplexes _RARE_
, O
which O
reconstruct _RARE_
the O
acceptor _RARE_
end O
of O
alanine I-GENE
tRNA I-GENE
with O
the O
critical O
G3 _RARE_
: O
U70 _RARE_
base _RARE_
pair _RARE_
. O

Simple _RARE_
reaction O
time O
( O
RT O
) O
to O
a O
peripheral O
visual O
target O
( O
S2 _RARE_
) O
is O
shortened O
when O
a O
non O
- O
informative _RARE_
cue _RARE_
( O
S1 O
) O
is O
flashed _RARE_
at _RARE_
the O
S2 _RARE_
location O
100 _RARE_
- O
150 _RARE_
ms O
before O
target O
onset O
( O
early O
facilitation _RARE_
). O

A O
second O
study O
group O
, O
with O
intact _RARE_
cardiac O
innervation _RARE_
, O
consisted O
of O
19 O
patients O
with O
stable O
angina O
pectoris O
class O
I O
to O
III O
. O

These O
viruses O
depend O
on O
the O
host _RARE_
cell O
machinery O
for _RARE_
their O
existence O
, O
and O
interference O
with O
these O
processes O
typically O
interferes _RARE_
with O
other O
important O
host _RARE_
physiology O
. O

Treatment O
was O
well _RARE_
- O
tolerated O
. O

A O
concentration O
of O
12 O
. O
5 O
ppm O
SO2 _RARE_
induced _RARE_
a O
decrease O
from O
baseline O
values O
of O
approximately _RARE_
80 _RARE_
% O
in O
mean O
MCA _RARE_
and O
of O
roughly _RARE_
70 O
% O
in O
mean O
CBF O
. O

We O
have O
used O
these O
modified O
assay O
conditions O
to O
extend O
studies O
on O
the O
transposition _RARE_
pathway _RARE_
. O

Renal O
cell O
carcinoma O
in O
children O
: O
a O
single O
institution _RARE_
' O
s O
experience O
. O

The O
data O
suggest O
that O
ICP10 _RARE_
constitutively O
increases O
ras I-GENE
activity O
, O
and O
its O
TM _RARE_
segment O
plays O
a O
critical O
role O
in O
transformation O
- O
related O
signaling _RARE_
pathways O
. O

Thus O
, O
we O
have O
separated O
the O
signal O
function O
from O
the O
anchor _RARE_
function O
of O
the O
6 O
. O
7K _RARE_
SA O
domain O
. O

Five O
concensus _RARE_
poly _RARE_
A O
addition O
sites O
are O
located _RARE_
in O
the O
350 O
base _RARE_
pairs _RARE_
immediately O
following O
the O
protein I-GENE
IX _RARE_
coding O
region O
. O

Factors O
associated O
with O
intrafamilial _RARE_
transmission _RARE_
of O
hepatitis O
B O
virus O
infection O
in O
Korea _RARE_
. O

Exposure _RARE_
to O
higher _RARE_
TPA _RARE_
concentrations O
decreased O
the O
content O
of O
these O
transcripts O
. O

Northern O
analysis O
, O
to O
search O
for _RARE_
a O
pcbAB _RARE_
transcript I-GENE
, O
showed O
no _RARE_
distinct O
transcript O
and O
indicated O
severely O
degraded O
mRNA O
. O

Our O
results O
indicate O
that O
the O
minimal O
requirements O
for _RARE_
induction O
of O
PEPCK I-GENE
by O
PKA I-GENE
and O
inhibition O
by O
insulin I-GENE
include O
: O
1 O
) O
the O
CREB I-GENE
activation I-GENE
domain I-GENE
, O
2 O
) O
the O
PEPCK I-GENE
TATA I-GENE
sequence I-GENE
, O
and O
3 O
) O
insulin I-GENE
- O
responsive O
hepatoma O
cells O
. O

The O
high O
degree O
of O
conservation O
between O
NQO2 _RARE_
and O
NQO1 _RARE_
gene I-GENE
organization O
and O
sequence O
confirmed O
that O
NQO2 _RARE_
gene I-GENE
encodes O
for _RARE_
a O
second O
member _RARE_
of O
the O
NQO _RARE_
gene I-GENE
family I-GENE
in O
human O
. O

The O
efficacy O
of O
a O
Propionibacterium _RARE_
acnes _RARE_
product O
for _RARE_
treatment O
of O
coliform _RARE_
mastitis _RARE_
was O
evaluated O
following O
intramammary _RARE_
infusion O
of O
Escherichia O
coli O
. O

The O
human I-GENE
eps15 _RARE_
gene I-GENE
, O
encoding O
a O
tyrosine I-GENE
kinase I-GENE
substrate O
, O
is O
conserved _RARE_
in O
evolution O
and O
maps O
to O
1p31 _RARE_
- O
p32 _RARE_
. O

The O
gene O
encoding O
the O
105 _RARE_
- I-GENE
kDa I-GENE
protein I-GENE
( I-GENE
p105 _RARE_
) I-GENE
precursor I-GENE
of O
the O
p50 _RARE_
subunit I-GENE
of O
transcription O
factor O
NF _RARE_
- I-GENE
kappa _RARE_
B I-GENE
also O
encodes O
a O
p70 I-GENE
I I-GENE
kappa _RARE_
B I-GENE
protein I-GENE
, O
I I-GENE
kappa _RARE_
B I-GENE
gamma I-GENE
, O
which O
is O
identical O
to O
the O
C O
- O
terminal O
607 _RARE_
amino O
acids _RARE_
of O
p105 _RARE_
. O

Alternative O
splicing _RARE_
of O
RNA O
transcripts O
encoded O
by O
the O
murine O
p105 _RARE_
NF _RARE_
- I-GENE
kappa _RARE_
B I-GENE
gene O
generates O
I I-GENE
kappa _RARE_
B I-GENE
gamma I-GENE
isoforms I-GENE
with O
different O
inhibitory _RARE_
activities O
. O

Topical _RARE_
L O
- O
NNA _RARE_
attenuated O
the O
hypercapnic _RARE_
increase O
of O
CoBF _RARE_
by O
52 O
+/- O
6 O
% O
and O
CeBF _RARE_
by O
29 O
+/- O
5 O
% O
after O
45 _RARE_
- O
min O
exposure O
. O

The O
experiment O
included O
6 O
male O
and O
4 O
female O
healthy O
subjects O
who O
, O
during _RARE_
a O
24 _RARE_
- O
hour O
stay _RARE_
in O
the O
respiration O
chambers _RARE_
, O
performed O
, O
in O
the O
morning _RARE_
and O
afternoon _RARE_
, O
15 _RARE_
min O
cycling _RARE_
with O
the O
total _RARE_
work O
of O
6 O
, O
750 O
kg O
m O
. O

These O
rearrangements _RARE_
result O
in O
the O
formation O
of O
chimeric O
genes O
showing O
the O
tyrosine I-GENE
kinase I-GENE
domain I-GENE
of O
ret _RARE_
fused O
with O
the O
5 O
' O
end O
sequences O
of O
different O
genes O
. O

Frequent _RARE_
loss _RARE_
of O
heterozygosity O
( O
LOH _RARE_
) O
of O
> O
30 _RARE_
% O
of O
the O
informative _RARE_
cases O
was O
observed O
on O
chromosomes O
3p _RARE_
( O
41 _RARE_
. O
1 O
%), O
5q _RARE_
( O
52 O
. O
6 O
%), O
6p _RARE_
( O
30 _RARE_
. O
4 O
%), O
8p _RARE_
( O
33 _RARE_
. O
3 O
%), O
9p _RARE_
( O
35 _RARE_
. O
7 O
%), O
9q _RARE_
( O
30 _RARE_
. O
8 O
%), O
11p _RARE_
( O
32 _RARE_
. O
4 O
%), O
13q _RARE_
( O
52 O
. O
7 O
%), O
17p _RARE_
( O
55 _RARE_
. O
2 O
%), O
17q _RARE_
( O
33 _RARE_
. O
3 O
%), O
18q _RARE_
( O
45 _RARE_
. O
7 O
%), O
and O
19q _RARE_
( O
30 _RARE_
. O
4 O
%). O

A O
single O
amino O
acid O
change O
in O
the O
CPY _RARE_
vacuolar I-GENE
sorting _RARE_
signal I-GENE
prevents O
this O
interaction O
. O

Glutamyl _RARE_
- I-GENE
tRNA I-GENE
synthetase _RARE_
and O
prolyl _RARE_
- I-GENE
tRNA I-GENE
synthetase _RARE_
belong O
to O
different O
classes O
of O
aminoacyl _RARE_
- I-GENE
tRNA I-GENE
synthetases I-GENE
that O
are O
thought O
to O
have O
evolved O
along O
independent O
evolutionary O
pathways O
. O

Using O
the O
sequence O
data O
obtained O
from O
the O
human O
TCRAC _RARE_
/ O
TCRDC _RARE_
region O
, O
we O
have O
extended O
a O
polymerase O
chain O
reaction O
- O
based O
assay O
to O
test O
for _RARE_
the O
expression _RARE_
of O
the O
individual O
TCRAJ _RARE_
gene I-GENE
segments _RARE_
. O

This O
analysis O
revealed O
an O
intact _RARE_
gene O
( O
arg4 _RARE_
) O
showing O
a O
high O
degree O
of O
homology O
with O
the O
Saccharomyces I-GENE
cerevisiae I-GENE
CPA2 _RARE_
gene I-GENE
encoding O
the O
large O
subunit O
of O
carbamoyl _RARE_
- I-GENE
phosphate I-GENE
synthetase _RARE_
( O
CPS _RARE_
- I-GENE
A I-GENE
). O

Restriction O
analysis O
and O
Southern O
hybridization O
revealed O
the O
presence O
of O
Tn5422 _RARE_
in O
all O
the O
plasmid _RARE_
- O
mediated _RARE_
cadmium O
- O
resistant O
L O
. O
monocytogenes O
strains O
tested O
but O
not O
in O
strains O
encoding O
cadmium O
resistance O
on O
the O
chromosome _RARE_
. O

The O
baroreflex _RARE_
latency _RARE_
( O
from O
the O
ECG O
R O
- O
wave O
to O
the O
integrated O
MSNA _RARE_
burst O
peak O
) O
was O
constant O
at _RARE_
approximately _RARE_
1 O
. O
20 O
s O
during _RARE_
sleep O
, O
suggesting O
that O
pulse O
- O
synchronicity _RARE_
was O
maintained O
. O

DESIGN O
-- _RARE_
A O
randomised O
study O
was O
conducted O
in O
all O
women O
aged O
50 O
- O
70 O
years O
who O
were O
eligible _RARE_
for _RARE_
breast O
cancer _RARE_
screening O
and O
living O
in O
the O
city _RARE_
of O
Utrecht _RARE_
. O

Identification O
of O
an O
immediate I-GENE
- I-GENE
early I-GENE
gene I-GENE
in O
the O
Marek _RARE_
' O
s O
disease _RARE_
virus O
long O
internal O
repeat O
region O
which O
encodes O
a O
unique O
14 O
- O
kilodalton _RARE_
polypeptide O
. O

We O
have O
used O
a O
full O
- O
length O
cDNA O
clone O
of O
a O
mouse O
hepatitis O
virus O
strain _RARE_
A59 _RARE_
defective _RARE_
interfering O
( O
DI _RARE_
) O
RNA O
, O
pMIDI _RARE_
- I-GENE
C I-GENE
, O
and O
cassette _RARE_
mutagenesis O
to O
study O
the O
mechanism O
of O
coronavirus O
subgenomic _RARE_
mRNA O
synthesis _RARE_
. O

To O
study O
the O
structure _RARE_
- O
function O
of O
the O
gene I-GENE
5 I-GENE
product I-GENE
, O
wild O
- O
type O
and O
mutant O
forms O
of O
NS53 _RARE_
were O
produced O
by O
using O
a O
recombinant O
baculovirus _RARE_
expression _RARE_
system _RARE_
and O
a O
recombinant O
vaccinia _RARE_
virus O
/ O
T7 _RARE_
( O
vTF7 _RARE_
- O
3 O
) O
expression _RARE_
system _RARE_
. O

Gel O
electrophoresis O
and O
Western O
immunoblot _RARE_
analyses O
of O
intracellular _RARE_
fractions O
derived O
from O
infected _RARE_
cells O
revealed O
that O
large O
amounts O
of O
NS53 _RARE_
were O
present O
in O
the O
cytosol O
and O
in O
association O
with O
the O
cytoskeletal O
matrix _RARE_
. O

The O
transcription I-GENE
factor I-GENE
AP I-GENE
- I-GENE
2 I-GENE
is O
encoded O
by O
a O
gene O
located _RARE_
on O
chromosome _RARE_
6 O
near O
the O
HLA I-GENE
locus I-GENE
. O

The O
mature _RARE_
AP I-GENE
- I-GENE
2 I-GENE
mRNA I-GENE
is O
spliced _RARE_
from O
7 O
exons O
distributed O
over O
a O
region O
of O
18 O
kb O
genomic O
DNA O
. O

San _RARE_
Martin _RARE_
' O
s O
psychological O
traits _RARE_
coupled O
to O
his _RARE_
work O
with O
masonic _RARE_
lodges _RARE_
that O
allowed O
him _RARE_
to O
display O
his _RARE_
abilities O
as _RARE_
strategist _RARE_
and O
political _RARE_
ruler _RARE_
. O

The O
participants _RARE_
were O
homosexual _RARE_
men O
in O
hepatitis O
B O
vaccine O
trials O
in O
Amsterdam _RARE_
( O
n _RARE_
= O
74 _RARE_
), _RARE_
New O
York O
City O
( O
n _RARE_
= O
120 O
), _RARE_
and O
San _RARE_
Francisco _RARE_
( O
n _RARE_
= O
168 _RARE_
). O

The O
7 O
- O
day O
treatment O
resulted O
in O
a O
decrease O
in O
mitochondrial O
uptake O
of O
Rh123 _RARE_
and O
an O
increase O
in O
NAO _RARE_
uptake O
. O

Thrombotic _RARE_
thrombocytopenic _RARE_
purpura O
in O
systemic O
lupus O
erythematosus O
. O

Comparison O
with O
the O
crystal _RARE_
structure _RARE_
of O
Desulfovibrio _RARE_
gigas _RARE_
, O
Dg _RARE_
, O
Fd _RARE_
( O
Kissinger _RARE_
et O
al O
., O
1991 O
) O
reveals O
a O
very O
similar O
folding O
topology O
, O
although O
several O
secondary O
structural O
elements O
are O
extended O
in O
Pf _RARE_
relative O
to O
Dg _RARE_
Fd _RARE_
. O

CONCLUSIONS O
: O
Serum I-GENE
prolactin I-GENE
concentrations O
show O
age O
related O
variations O
in O
presumably O
fertile _RARE_
men O
. O

Eight O
highly O
trained _RARE_
male O
kayakers _RARE_
were O
studied O
to O
determine O
the O
relationship O
between O
critical O
power O
( O
CP O
) O
and O
the O
onset O
of O
blood _RARE_
lactate _RARE_
accumulation O
( O
OBLA _RARE_
). O

As O
in O
S O
. O
cerevisiae O
, O
the O
sequence O
of O
rhp51 _RARE_
+ I-GENE
showed O
two O
MluI _RARE_
cell I-GENE
- I-GENE
cycle _RARE_
boxes _RARE_
and O
a O
putative O
DNA O
damage O
- O
responsive O
element O
in O
its O
upstream O
region O
. O

Women _RARE_
' O
s O
opportunities _RARE_
for _RARE_
paid _RARE_
work O
outside O
the O
home O
are O
constrained _RARE_
by O
their O
role O
as _RARE_
primary _RARE_
carer _RARE_
within O
the O
family O
, O
writes _RARE_
Trudy _RARE_
Wynne _RARE_
. O

A O
partial O
cDNA O
sequence O
indicated O
that O
the O
T I-GENE
lymphocyte I-GENE
early I-GENE
- I-GENE
activation I-GENE
gene I-GENE
( O
Tea _RARE_
) O
encodes O
a O
protein O
related O
to O
the O
dual O
- O
function O
ecotropic _RARE_
retrovirus _RARE_
receptor I-GENE
/ O
cationic _RARE_
amino I-GENE
acid I-GENE
transporter _RARE_
( O
ecoR _RARE_
/ O
CAT1 _RARE_
), _RARE_
and O
RNA O
blots O
suggested O
highest O
Tea _RARE_
expression _RARE_
in O
T O
lymphocytes O
and O
liver O
( O
MacLeod _RARE_
, O
C O
. O
L O
., O
Finley _RARE_
, O
K O
., O
Kakuda _RARE_
, O
D O
. O

Furthermore O
, O
unlike O
the O
case O
for _RARE_
HIS3 I-GENE
where O
only O
a O
limited O
subset O
of O
TATA O
- O
like O
sequences O
can O
activate O
transcription O
in O
conjunction O
with O
GCN4p _RARE_
, O
many O
divergent O
TATA O
- O
like O
sequences O
allowed O
GCN4p _RARE_
activation O
of O
TRP3 _RARE_
. O

Bacterially _RARE_
expressed _RARE_
protein O
, O
as _RARE_
well _RARE_
as _RARE_
the O
in O
vitro O
reticulocyte _RARE_
lysate _RARE_
translation O
product O
, O
comigrated _RARE_
with O
the O
purified _RARE_
37 O
- O
kDa O
protein O
on O
sodium _RARE_
dodecyl O
sulfate _RARE_
- O
polyacrylamide O
gels O
. O

In O
addition O
, O
this O
kinase O
is O
well _RARE_
conserved _RARE_
evolutionarily O
, O
ubiquitously O
expressed _RARE_
, O
and O
its O
genes O
map O
to O
a O
position O
on O
human O
chromosome _RARE_
1 O
frequently O
deleted _RARE_
in O
the O
late _RARE_
stages O
of O
tumorigenesis O
. O

Deletion O
analysis O
of O
the O
ICL1 _RARE_
promoter I-GENE
led O
to O
the O
identification O
of O
an O
upstream O
activating O
sequence O
element O
, O
UASICL1 _RARE_
( O
5 O
' O
CATTCATCCG _RARE_
3 O
'), _RARE_
necessary O
and O
sufficient O
for _RARE_
conferring O
carbon O
source O
- O
dependent O
regulation _RARE_
on O
a O
heterologous O
reporter O
gene O
. O

Interestingly O
, O
the O
interaction O
of O
ZAP _RARE_
- I-GENE
70 I-GENE
with O
the O
motif O
was O
dependent O
on O
the O
presence O
of O
both O
ZAP _RARE_
- I-GENE
70 I-GENE
SH2 _RARE_
domains I-GENE
and O
both O
of O
the O
tyrosine O
residues O
in O
the O
motif O
, O
suggesting O
that O
ZAP _RARE_
- I-GENE
70 I-GENE
interacts O
with O
two O
phosphotyrosine _RARE_
residues O
and O
that O
the O
binding O
of O
the O
two O
SH2 _RARE_
domains I-GENE
is O
cooperative O
. O

PRL I-GENE
- I-GENE
1 I-GENE
is O
able O
to O
dephosphorylate _RARE_
phosphotyrosine _RARE_
substrates _RARE_
, O
and O
mutation O
of O
the O
active _RARE_
- O
site O
cysteine O
residue _RARE_
abolishes O
this O
activity O
. O

In O
Mv1Lu _RARE_
lung _RARE_
epithelial _RARE_
cells O
, O
ActR _RARE_
- I-GENE
IB _RARE_
and O
T I-GENE
beta I-GENE
R I-GENE
- I-GENE
I I-GENE
signal O
a O
common O
set O
of O
growth O
- O
inhibitory _RARE_
and O
transcriptional O
responses O
in O
association O
with O
their O
corresponding O
ligands O
and O
type I-GENE
II I-GENE
receptors I-GENE
. O

50 O
kDa O
and O
130 _RARE_
- O
170 _RARE_
kDa O
were O
detected O
. O

H O
- O
7 O
, O
which O
specifically O
, O
although O
weakly O
, O
inhibited O
PKC I-GENE
activation O
, O
had O
no _RARE_
effect O
on O
tyrosine O
phosphorylation _RARE_
and O
PtdIns _RARE_
( O
3 O
, O
4 O
) O
P2 O
production O
. O

The O
effects O
of O
systemic O
glucose O
concentration O
on O
brain O
metabolism O
following O
repeated _RARE_
brain O
ischemia O
. O

This O
strategy O
was O
used O
to O
place O
both O
the O
Tn903 _RARE_
neo _RARE_
gene I-GENE
and O
the O
Rhodosporidium _RARE_
toruloides _RARE_
phenylalanine _RARE_
ammonia _RARE_
lyase I-GENE
( O
PAL _RARE_
)- O
encoding O
gene O
under O
the O
transcriptional O
control O
of O
pPGK _RARE_
:: O
REP2 _RARE_
. O

In O
the O
case O
of O
congenital O
protein I-GENE
C I-GENE
deficiency O
, O
vitamin O
K O
antagonists O
must O
be O
started O
cautiously _RARE_
due O
to O
the O
risk O
of O
skin _RARE_
necrosis O
. O

A O
- O
69 _RARE_
- O
year O
- O
old O
patient O
with O
postoperative O
small O
- O
bowel O
obstruction O
underwent O
laparotomy _RARE_
three O
times O
. O

On O
physical O
examination O
a O
mild O
symmetrical _RARE_
polyarthritis _RARE_
of O
small O
and O
large O
joints _RARE_
was O
seen O
. O

In O
addition O
, O
we O
observe O
that O
the O
hUBF _RARE_
- I-GENE
promoter I-GENE
interaction O
is O
highly O
sensitive _RARE_
to O
the O
antagonistic O
effects O
of O
cisplatin O
- O
DNA O
adducts _RARE_
. O

We O
conclude O
that O
the O
SIMV _RARE_
is O
useful O
in O
weaning _RARE_
neonates O
from O
the O
ventilator _RARE_
. O

VP _RARE_
- O
16 O
, O
ifosfamide _RARE_
and O
cisplatin O
( O
VIP _RARE_
) O
for _RARE_
extensive O
small O
cell O
lung _RARE_
cancer _RARE_
. O

A O
total _RARE_
of O
7 O
( O
4 O
males O
and O
3 O
females O
) O
patients O
were O
included O
in O
this O
retrospective O
study O
to O
determine O
the O
sensitivity O
of O
radioimmunoscintigraphy _RARE_
with O
I O
- O
131 _RARE_
labeled O
anti I-GENE
CEA _RARE_
/ O
CA I-GENE
19 I-GENE
- I-GENE
9 I-GENE
monoclonal O
antibodies O
. O

Simultaneous _RARE_
, O
bilateral O
and O
permanent O
ventilation O
with O
a O
diaphragm O
pacing O
in O
childhood O
: O
the O
implantation O
technique O
and O
indications _RARE_

A O
genomic O
clone O
for _RARE_
the O
cyc07 _RARE_
gene I-GENE
, O
which O
is O
expressed _RARE_
specifically O
at _RARE_
the O
S O
phase _RARE_
during _RARE_
the O
cell O
cycle _RARE_
in O
synchronous _RARE_
cultures O
of O
periwinkle _RARE_
( O
Catharanthus _RARE_
roseus _RARE_
) O
cells O
, O
was O
isolated O
. O

CONCLUSIONS O
: O
Translocation _RARE_
of O
bacteria O
or O
endotoxin _RARE_
from O
the O
gastrointestinal _RARE_
tract _RARE_
into O
the O
bloodstream _RARE_
has O
been O
noted O
in O
animal _RARE_
experiments O
; O
however O
, O
translocation O
was O
not O
detected O
in O
our O
patients O
with O
hemorrhagic O
shock O
. O

The O
pyrR _RARE_
and O
pyrP _RARE_
genes I-GENE
encoded O
polypeptides O
with O
calculated O
molecular _RARE_
masses O
of O
19 O
. O
9 O
and O
45 _RARE_
. O
2 O
kDa O
, O
respectively O
. O

Southern O
blotting O
analysis O
implied _RARE_
the O
occurrence O
of O
multiple O
COXVb _RARE_
genes I-GENE
in O
the O
rat O
genome O
. O

Acylation _RARE_
with O
the O
palmitate _RARE_
analog O
was O
prevented O
when O
Gly _RARE_
- O
2 O
was O
mutated _RARE_
to O
alanine O
, O
implying O
that O
N O
- O
myristylation _RARE_
is O
required O
for _RARE_
palmitylation _RARE_
, O
and O
when O
either O
Cys _RARE_
- O
3 O
or O
Cys _RARE_
- O
6 O
was O
mutated _RARE_
to O
serine O
. O

Subunit _RARE_
composition O
and O
domain O
structure _RARE_
of O
the O
Spo0A _RARE_
sporulation _RARE_
transcription I-GENE
factor I-GENE
of I-GENE
Bacillus I-GENE
subtilis I-GENE
. O

Electrophoretic O
mobility O
shift O
analysis O
indicates O
that O
NF _RARE_
- I-GENE
IL _RARE_
- I-GENE
6 I-GENE
, O
as _RARE_
well _RARE_
as _RARE_
other O
related O
members O
of O
this O
family O
, O
bind O
specifically O
to O
the O
NF _RARE_
- I-GENE
IL _RARE_
- I-GENE
6 I-GENE
site O
in O
the O
IL _RARE_
- I-GENE
8 I-GENE
promoter I-GENE
. O

BYV _RARE_
, O
citrus _RARE_
tristeza _RARE_
virus O
( O
CTV _RARE_
), _RARE_
beet _RARE_
yellow O
stunt _RARE_
virus O
( O
BYSV _RARE_
) O
and O
carnation _RARE_
necrotic _RARE_
fleck _RARE_
virus O
templates O
produced O
1 O
kb O
amplification O
products O
, O
which O
were O
shown O
by O
sequencing O
to O
represent O
fragments O
of O
the O
respective O
HSP70 I-GENE
genes I-GENE
. O

To O
identify O
the O
precise O
location O
of O
the O
phosphorylation _RARE_
site O
on O
the O
64 _RARE_
- O
kDa O
protein O
, O
a O
step O
- O
by O
- O
step O
mutagenesis O
procedures O
was O
followed O
. O

The O
p53 I-GENE
tumor I-GENE
suppressor I-GENE
gene I-GENE
product I-GENE
, O
a O
sequence O
- O
specific O
DNA O
- O
binding O
protein O
, O
has O
been O
shown O
to O
act O
as _RARE_
a O
transcriptional O
activator O
and O
repressor O
both O
in O
vitro O
and O
in O
vivo O
. O

Mutational O
analysis O
of O
chromosomal O
segment O
64AB _RARE_
, O
a O
region O
containing O
the O
glutamic _RARE_
acid I-GENE
decarboxylase I-GENE
gene I-GENE
. O

Rearrangements _RARE_
of O
the O
NFKB2 _RARE_
gene I-GENE
are O
associated O
with O
lymphoid _RARE_
malignancies _RARE_
, O
but O
the O
functional _RARE_
significance O
of O
these O
alterations O
is O
not O
known O
. O

Cloning O
and O
sequencing O
of O
the O
corresponding O
cDNAs O
indicates O
that O
, O
via O
alternative _RARE_
splicing _RARE_
, O
the O
rearranged _RARE_
gene O
codes O
for _RARE_
two O
proteins O
of O
84 _RARE_
and O
85 _RARE_
kD _RARE_
( O
p84 _RARE_
/ I-GENE
85 _RARE_
) O
which O
retain _RARE_
the O
DNA O
- O
binding O
rel _RARE_
domain I-GENE
and O
the O
first _RARE_
five O
ankyrin _RARE_
repeats O
, O
but O
have O
lost O
their O
carboxy _RARE_
- O
terminus O
including O
the O
seventh _RARE_
ankyrin _RARE_
repeat O
. O

Transient O
co _RARE_
- O
transfection O
assays O
involving O
NFKB2 _RARE_
expression _RARE_
vectors O
and O
kappa _RARE_
B I-GENE
- O
driven _RARE_
reporter O
plasmids O
indicate O
that O
NFKB2 _RARE_
p85 I-GENE
has O
lost O
the O
transcriptional O
repressor O
functions O
typical O
of O
normal O
NFKB2 _RARE_
p52 _RARE_
. O

Also O
, O
HR21ap _RARE_
as _RARE_
well _RARE_
as _RARE_
HR21Xap _RARE_
are O
specific O
in O
their O
inhibition O
of O
Sp1 _RARE_
binding O
. O

Intravenous O
antibiotic O
therapy O
in O
cystic _RARE_
fibrosis _RARE_
: O
in O
hospital O
or O
at _RARE_
home O
? O

Open _RARE_
reading O
frames O
in O
a O
4556 _RARE_
nucleotide O
sequence O
within O
MDV _RARE_
- I-GENE
1 I-GENE
BamHI I-GENE
- I-GENE
D I-GENE
DNA I-GENE
fragment I-GENE
: O
evidence O
for _RARE_
splicing _RARE_
of O
mRNA O
from O
a O
new O
viral O
glycoprotein O
gene O
. O

The O
ns2 _RARE_
gene I-GENE
comprises O
an O
open _RARE_
reading O
frame O
( O
ORF O
) O
encoding O
a O
putative O
nonstructural _RARE_
( O
ns _RARE_
) O
protein O
of O
279 _RARE_
amino O
acids _RARE_
with O
a O
predicted O
molecular _RARE_
mass O
of O
32 _RARE_
- O
kDa O
. O

Co O
- O
transfection O
of O
a O
tat I-GENE
expressing O
plasmid _RARE_
with O
these O
viruses O
containing O
the O
tat I-GENE
ORF I-GENE
mutations O
resulted O
in O
higher _RARE_
levels O
of O
virus O
production O
demonstrating O
that O
the O
effects O
of O
both O
mutants O
are O
tat I-GENE
specific O
. O

Analysis O
of O
the O
gag I-GENE
and O
rev _RARE_
proteins I-GENE
in O
the O
transfected O
cells O
demonstrated O
that O
these O
proteins O
were O
not O
detectable O
in O
cells O
transfected O
with O
the O
tat I-GENE
mutants I-GENE
but O
could O
be O
readily O
detected O
when O
the O
mutations O
were O
complemented O
in O
trans _RARE_
with O
a O
tat I-GENE
expression _RARE_
vector O
. O

The O
hydrophobicity _RARE_
profile O
of O
the O
methyltransferase _RARE_
reveals O
the O
presence O
of O
at _RARE_
least O
five O
potential _RARE_
transmembrane O
domains O
. O

Measurement O
of O
SaO2 O
at _RARE_
moderate O
altitude O
can O
be O
helpful O
in O
the O
care O
of O
both O
healthy O
and O
ill _RARE_
newborns O
or O
infants O
. O

To O
determine O
whether O
the O
excess O
prevalence O
of O
human O
immunodeficiency O
virus O
type O
1 O
( O
HIV O
- O
1 O
) O
infection O
in O
US O
black O
and O
Hispanic _RARE_
homosexual _RARE_
men O
relative O
to O
white _RARE_
men O
can O
be O
explained O
by O
differences O
in O
sociodemographic _RARE_
factors O
, O
history O
of O
sexually _RARE_
transmitted O
diseases O
, O
or O
sexual O
and O
drug O
- O
use O
behaviors _RARE_
, O
the O
authors O
conducted O
a O
cross O
- O
sectional O
analysis O
of O
baseline O
HIV O
- O
1 O
seroprevalence _RARE_
and O
HIV O
- O
1 O
risk O
factors O
among O
4 O
, O
475 _RARE_
non O
- O
Hispanic _RARE_
white _RARE_
, O
234 _RARE_
Hispanic _RARE_
white _RARE_
, O
and O
194 _RARE_
black O
homosexual _RARE_
men O
from O
four O
centers O
in O
the O
United O
States _RARE_
( O
Baltimore _RARE_
/ O
Washington _RARE_
, O
DC O
, O
Pittsburgh _RARE_
, O
Chicago _RARE_
, O
and O
Los _RARE_
Angeles _RARE_
). O

The O
patients O
in O
one O
group O
had O
intrauterine O
catheters _RARE_
inserted O
and O
oxytocin _RARE_
was O
titrated _RARE_
to O
achieve O
the O
75th _RARE_
percentile _RARE_
of O
uterine _RARE_
activity O
observed O
in O
spontaneous O
normal O
labour O
according O
to O
parity _RARE_
. O

Continued _RARE_
development O
of O
the O
rat O
conditioning O
paradigm _RARE_
is O
especially O
warranted O
because O
of O
the O
ability O
to O
record O
sympathetic O
nerve O
activity O
in O
intact _RARE_
, O
awake _RARE_
subjects O
and O
the O
large O
number O
of O
readily O
available O
genetic O
strains O
, O
which O
model O
human O
pathological O
states O
. O

The O
ultrastructure _RARE_
of O
retinal _RARE_
vessels O
was O
examined O
in O
three O
eyes O
from O
diabetic O
patients O
and O
two O
eyes O
from O
control O
subjects O
. O

The O
regulatory O
region O
also O
has O
a O
sequence O
similar O
to O
the O
binding O
site O
for _RARE_
a O
liver O
- O
specific O
transcription O
factor O
, O
hepatocyte _RARE_
nuclear I-GENE
factor I-GENE
1 I-GENE
( O
HNF I-GENE
- I-GENE
1 I-GENE
), _RARE_
at _RARE_
positions O
- O
120 O
to O
- O
132 O
. O

Thus O
, O
we O
have O
identified O
a O
GRE _RARE_
sufficient O
to O
account O
for _RARE_
full O
glucocorticoid O
inducibility O
and O
an O
HNF I-GENE
- I-GENE
1 I-GENE
site I-GENE
close O
to O
the O
promoter O
that O
are O
major O
determinants _RARE_
of O
transcriptional O
control O
of O
the O
Xenopus I-GENE
fibrinogen I-GENE
B I-GENE
beta I-GENE
subunit I-GENE
gene I-GENE
in O
cells O
from O
normal O
liver O
tissue O
. O

Acad _RARE_
. O

The O
PRB _RARE_
- I-GENE
1b _RARE_
gene I-GENE
encodes O
for _RARE_
a O
basic O
- O
type O
component _RARE_
of O
the O
pathogenesis O
- O
related O
PR I-GENE
- I-GENE
1 I-GENE
protein I-GENE
family I-GENE
. O

Replacement _RARE_
of O
the O
CRE _RARE_
with O
a O
second O
copy O
of O
the O
AP I-GENE
- I-GENE
1 I-GENE
site I-GENE
results O
in O
a O
level O
of O
transcriptional O
activity O
comparable O
with O
that O
of O
the O
wild O
- O
type O
sequence O
, O
but O
replacement _RARE_
of O
the O
AP I-GENE
- I-GENE
1 I-GENE
site I-GENE
with O
a O
CRE _RARE_
abolishes O
activity O
. O

The O
T I-GENE
- I-GENE
cyt _RARE_
promoter I-GENE
, O
although O
of O
bacterial O
origin O
is O
active _RARE_
in O
planta _RARE_
and O
the O
30 _RARE_
bp I-GENE
cyt _RARE_
- I-GENE
1 I-GENE
element I-GENE
is O
located _RARE_
within O
a O
region O
that O
is O
essential O
for _RARE_
T I-GENE
- I-GENE
cyt _RARE_
promotor _RARE_
activity O
in O
leaf O
, O
stem _RARE_
and O
root O
cells O
of O
tobacco O
plants _RARE_
. O

Reviewing _RARE_
manuscripts _RARE_
: O
developing O
an O
efficient O
system _RARE_
. O

We O
suggest O
that O
CT _RARE_
scan O
be O
preferable _RARE_
in O
diagnosis O
of O
tumors O
in O
that O
area O
. O

SIN _RARE_
- O
1 O
had O
no _RARE_
influence O
on O
either O
the O
ischemic O
parameters O
in O
the O
surface O
electrocardiogram O
( O
ECG O
) O
or O
the O
intracoronary _RARE_
ECG O
. O

Effect O
of O
aging O
on O
respiratory O
skeletal O
muscles O
. O

Two O
BASIC _RARE_
computer O
programs O
using O
logit _RARE_
transformation O
for _RARE_
the O
analysis O
of O
S O
- O
shaped O
curves O
are O
presented O
. O

The O
yeast I-GENE
SSS1 _RARE_
gene I-GENE
is O
essential O
for _RARE_
secretory _RARE_
protein O
translocation O
and O
encodes O
a O
conserved _RARE_
protein O
of O
the O
endoplasmic O
reticulum O
. O

The O
lengths O
of O
the O
complete _RARE_
polypeptide O
chain O
of O
the O
recombinant O
enzyme O
and O
its O
transit O
peptide O
are O
388 _RARE_
and O
53 O
residues O
, O
respectively O
. O

The O
absence O
of O
H4PteGlun _RARE_
bound _RARE_
to O
the O
T I-GENE
protein I-GENE
in O
our O
experimental O
conditions O
demonstrates O
that O
H4PteGlun _RARE_
is O
not O
covalently O
linked _RARE_
to O
the O
T I-GENE
protein I-GENE
. O

TATA O
and O
CCAAT O
boxes _RARE_
are O
located _RARE_
34 _RARE_
- O
bp O
and O
68 _RARE_
- O
bp O
, O
respectively O
, O
upstream O
of O
the O
transcription O
start _RARE_
site O
, O
the O
5 O
'- O
untranslated _RARE_
leader _RARE_
is O
78 _RARE_
nucleotides O
long O
, O
and O
the O
intronless O
gene O
has O
at _RARE_
least O
two O
different O
polyadenylation O
sites O
. O

GGS1 _RARE_
is O
the O
same O
gene O
as _RARE_
TPS1 _RARE_
which O
was O
identified O
as _RARE_
encoding O
a O
subunit O
of O
the O
trehalose _RARE_
- I-GENE
6 I-GENE
- I-GENE
phosphate I-GENE
synthase I-GENE
/ I-GENE
phosphatase I-GENE
complex I-GENE
and O
it O
is O
allelic O
to O
the O
fdp1 _RARE_
, O
byp1 _RARE_
, O
glc6 _RARE_
and O
cif1 _RARE_
mutations O
. O

We O
also O
compared O
the O
sequence O
with O
the O
partly O
homologous O
products O
of O
the O
S O
. O
cerevisiae O
genes O
TPS2 _RARE_
and O
TSL1 _RARE_
which O
code O
for _RARE_
the O
larger O
subunits O
of O
the O
trehalose _RARE_
synthase I-GENE
complex I-GENE
and O
with O
a O
TSL1 _RARE_
homologue I-GENE
, O
TPS3 _RARE_
, O
of O
unknown O
function O
. O

Stroop O
interference O
: O
aging O
effects O
assessed O
with O
the O
Stroop O
Color _RARE_
- O
Word _RARE_
Test O
. O

Stimulation _RARE_
of O
[ _RARE_
3H O
] O
PA O
production O
upon O
CD3 I-GENE
cross O
- O
linking O
was O
77 O
% O
lower O
in O
permeabilized _RARE_
CD45 _RARE_
- I-GENE
cells O
than O
in O
CD45 _RARE_
+ I-GENE
cells O
, O
consistent O
with O
the O
reduced _RARE_
activity O
of O
p59fyn _RARE_
in O
CD45 _RARE_
- I-GENE
cells O
. O

CONCLUSION O
: O
The O
study O
demonstrates O
that O
transvaginal _RARE_
ultrasonography O
has O
an O
efficiency O
of O
88 O
% O
in O
differentiating O
endometriomas _RARE_
from O
other O
ovarian O
masses O
with O
a O
specificity _RARE_
of O
90 _RARE_
%. O

Genomic O
Southern O
blot O
analysis O
of O
rat I-GENE
EFIA I-GENE
( O
gene O
encoding O
enhancer I-GENE
factor I-GENE
I I-GENE
subunit I-GENE
A I-GENE
) O
reveals O
a O
complex O
band O
pattern O
when O
cDNA O
subfragment _RARE_
probes _RARE_
are O
used O
. O

The O
effect O
of O
ibopamine _RARE_
and O
furosemide O
in O
130 _RARE_
patients O
with O
NYHA _RARE_
Class _RARE_
I O
and O
II O
heart _RARE_
failure O
were O
studied O
in O
a O
parallel O
, O
double O
- O
blind O
, O
randomized O
placebo O
- O
controlled _RARE_
multi _RARE_
- O
centre _RARE_
trial O
. O

The O
nit _RARE_
- I-GENE
3 I-GENE
gene I-GENE
of I-GENE
the I-GENE
filamentous _RARE_
fungus _RARE_
Neurospora I-GENE
crassa I-GENE
encodes O
nitrate _RARE_
reductase I-GENE
, O
the O
enzyme O
which O
catalyzes O
the O
first _RARE_
step O
in O
nitrate _RARE_
assimilation _RARE_
. O

Unfolding _RARE_
can O
be O
described O
by O
a O
two O
- O
state O
process O
since O
a O
ratio O
of O
delta O
Hcalorimetric _RARE_
to O
delta O
Hvan _RARE_
' O
t O
Hoff _RARE_
equals _RARE_
0 _RARE_
. O
96 O
. O

A O
Dictyostelium O
transformant _RARE_
overexpressing O
DdPTPa _RARE_
does O
not O
develop O
normally O
. O

This O
motif O
has O
been O
shown O
to O
mediate O
protein O
interactions O
in O
the O
case O
of O
ankyrin _RARE_
as _RARE_
well _RARE_
as _RARE_
several O
other O
repeat O
- O
bearing _RARE_
proteins O
. O

[ _RARE_
Ala85 _RARE_
] I-GENE
Dk _RARE_
( I-GENE
69 _RARE_
- I-GENE
85 _RARE_
) I-GENE
retains O
full O
biological O
activity O
. O

We O
postulate _RARE_
that O
CaM I-GENE
binding O
by O
HIV I-GENE
envelope I-GENE
proteins I-GENE
is O
likely O
to O
exert O
diverse O
modulatory _RARE_
effects O
, O
and O
the O
mechanism O
for _RARE_
HIV O
- O
induced _RARE_
cytotoxicity O
may O
involve O
, O
in O
part O
, O
inhibition O
of O
CaM I-GENE
- O
regulated O
cellular O
functions O
. O

There O
was O
no _RARE_
apparent O
effect O
of O
growth O
temperature _RARE_
on O
the O
steady O
- O
state O
levels O
of O
fad7 _RARE_
mRNA I-GENE
in O
wild O
type O
plants _RARE_
. O

The O
major O
myosin I-GENE
- I-GENE
binding I-GENE
domain I-GENE
of O
skeletal I-GENE
muscle I-GENE
MyBP _RARE_
- I-GENE
C I-GENE
( O
C I-GENE
protein I-GENE
) O
resides O
in O
the O
COOH _RARE_
- O
terminal O
, O
immunoglobulin I-GENE
C2 I-GENE
motif I-GENE
. O

A O
second O
important O
molecule O
in O
TCR I-GENE
signal O
transduction _RARE_
is O
the O
guanine I-GENE
nucleotide I-GENE
binding I-GENE
protein I-GENE
, O
p21ras I-GENE
, O
which O
is O
coupled O
to O
the O
TCR I-GENE
by O
a O
protein I-GENE
tyrosine I-GENE
kinase I-GENE
dependent O
mechanism O
. O

Our O
results O
indicate O
that O
periseizure _RARE_
lipid _RARE_
accumulation O
is O
related O
to O
cortical O
oxygenation O
. O

We O
conclude O
that O
the O
QLMI _RARE_
questionnaire O
has O
good O
potential _RARE_
as _RARE_
an O
instrument O
for _RARE_
assessing O
QL _RARE_
in O
post O
- O
AMI O
patients O
and O
that O
it O
can O
be O
successfully O
self O
- O
administered O
. O

Most O
smokers O
would O
prefer _RARE_
to O
quit _RARE_
smoking O
on O
their O
own O
. O

The O
inhibitory _RARE_
response O
to O
taps _RARE_
is O
essentially O
a O
protective O
reflex O
which O
probably O
serves O
to O
reduce O
the O
activity O
of O
the O
jaw O
- O
closing _RARE_
muscles O
when O
one O
bites _RARE_
unexpectedly _RARE_
on O
hard _RARE_
objects O
. O

The O
action O
of O
nef I-GENE
was O
specific O
to O
the O
LTR O
, O
as _RARE_
expression _RARE_
of O
nef I-GENE
had O
no _RARE_
effect O
on O
the O
activity O
of O
the O
simian O
virus O
40 O
, O
c I-GENE
- I-GENE
fms I-GENE
, O
urokinase I-GENE
plasminogen I-GENE
activator I-GENE
, O
or O
type I-GENE
5 I-GENE
acid I-GENE
phosphatase I-GENE
promoter I-GENE
. O
trans _RARE_
- O
activating O
activity O
was O
also O
manifested O
by O
a O
frameshift O
mutant O
expressing O
only O
the O
first _RARE_
35 _RARE_
amino O
acids _RARE_
of O
the O
protein O
. O

The O
product O
of O
the O
vpr _RARE_
open _RARE_
reading I-GENE
frame I-GENE
of I-GENE
human I-GENE
immunodeficiency I-GENE
virus I-GENE
type I-GENE
1 I-GENE
( I-GENE
HIV I-GENE
- I-GENE
1 I-GENE
) I-GENE
is O
a O
15 _RARE_
- O
kDa O
, O
arginine _RARE_
- O
rich O
protein O
that O
is O
present O
in O
virions O
in O
molar _RARE_
quantities _RARE_
equivalent O
to O
that O
of O
Gag I-GENE
. O

The O
recombinant I-GENE
vaccinia _RARE_
virus I-GENE
- I-GENE
expressed _RARE_
mutant I-GENE
P1 I-GENE
polyproteins _RARE_
were O
analyzed O
for _RARE_
proteolytic _RARE_
processing _RARE_
defects O
in O
cells O
coinfected _RARE_
with O
a O
recombinant O
vaccinia _RARE_
virus O
( O
VVP3 _RARE_
) O
that O
expresses _RARE_
the O
poliovirus _RARE_
3CD _RARE_
protease I-GENE
and O
for _RARE_
processing _RARE_
and O
assembly O
defects O
by O
using O
a O
trans _RARE_
complementation _RARE_
system _RARE_
in O
which O
P1 I-GENE
- O
expressing O
recombinant O
vaccinia _RARE_
viruses O
provide O
capsid _RARE_
precursor I-GENE
to O
a O
defective _RARE_
poliovirus _RARE_
genome O
that O
does O
not O
express O
functional _RARE_
capsid _RARE_
proteins I-GENE
( O
D O
. O

In O
contrast O
, O
capsid _RARE_
proteins I-GENE
derived O
from O
the O
P1 I-GENE
precursor I-GENE
with O
a O
valine _RARE_
substitution O
at _RARE_
the O
amino O
terminus O
of O
VP1 _RARE_
( O
VP1 _RARE_
- I-GENE
G001V _RARE_
) O
assembled O
empty _RARE_
capsid _RARE_
particles _RARE_
but O
were O
deficient _RARE_
in O
assembling _RARE_
RNA O
- O
containing O
virions O
. O

RESULTS O
: O
In O
an O
18 O
moth _RARE_
period O
and O
out O
of O
a O
total _RARE_
of O
284 _RARE_
positive O
blood _RARE_
cultures O
( O
154 O
significant O
isolations _RARE_
) O
14 O
episodes O
of O
bacteremia _RARE_
by O
M O
. O
tuberculosis O
were O
studied O
in O
12 O
prison _RARE_
patients O
coinfected _RARE_
by O
the O
human O
immunodeficiency O
virus O
with O
associated O
severe O
immunosuppression _RARE_
( O
mean O
of O
CD4 _RARE_
= O
0 _RARE_
. O
068 _RARE_
x _RARE_
10 O
( O
9 O
)/ _RARE_
l _RARE_
). O

Acid _RARE_
instilled _RARE_
on O
the O
larynx O
of O
maturing _RARE_
rabbits O
resulted O
in O
significant O
obstructive _RARE_
, O
central O
, O
and O
mixed O
apnea O
. O

By O
using O
total _RARE_
- O
protein O
extracts O
from O
mycelia _RARE_
grown O
under O
penicillin _RARE_
producing O
conditions O
we O
have O
detected O
a O
DNA O
- O
binding O
activity O
that O
specifically O
shifts O
a O
promoter O
fragment O
located _RARE_
between O
- O
654 _RARE_
and O
- O
455 _RARE_
( O
relative O
to O
IPNS _RARE_
tsp _RARE_
). O

A O
series O
of O
5 O
'- O
deletions O
revealed O
that O
the O
fragment O
- O
218 _RARE_
to O
+ O
4 O
from O
the O
TSS _RARE_
had O
the O
highest O
promoter O
activity O
, O
nearly O
1000 O
- O
fold _RARE_
greater O
than O
the O
promoterless O
chloramphenicol I-GENE
acetyltransferase _RARE_
construct I-GENE
. O

The O
lemdr1 _RARE_
gene I-GENE
was O
cloned _RARE_
in O
the O
expression _RARE_
vector O
pALTNEO _RARE_
and O
transfected O
into O
wild O
- O
type O
L O
. O
enriettii _RARE_
and O
the O
resulting O
transfected O
cells O
were O
resistant O
to O
vinblastine _RARE_
but O
at _RARE_
lower O
levels O
than O
in O
the O
selected _RARE_
mutant O
cells O
. O

The O
bioavailability _RARE_
of O
etodolac _RARE_
from O
capsules O
exposed O
to O
stressed O
conditions O
was O
compared O
in O
both O
dogs O
and O
humans O
to O
capsules O
stored O
at _RARE_
RT O
conditions O
. O

Similar O
synergistic O
activation O
was O
observed O
in O
the O
IL _RARE_
- I-GENE
8 I-GENE
promoter I-GENE
, O
which O
also O
contains O
both O
NF _RARE_
- I-GENE
IL6 I-GENE
and O
NF _RARE_
- I-GENE
kappa _RARE_
B I-GENE
binding I-GENE
sites I-GENE
. O

Notice _RARE_
of O
retraction _RARE_
. O

No O
homology O
was O
found O
between O
the O
36K _RARE_
protein O
and O
known O
structures _RARE_
of O
proteins O
. O

We O
report O
an O
odd _RARE_
case O
of O
marked O
enlargement O
of O
suprapineal _RARE_
recess _RARE_
in O
a O
patient O
with O
triventricular _RARE_
hydrocephalus _RARE_
. O

As O
regards _RARE_
lipid _RARE_
metabolism O
, O
the O
mean O
values O
for _RARE_
total _RARE_
triglycerides _RARE_
, O
cholesterol O
, O
LDL I-GENE
- I-GENE
cholesterol I-GENE
and O
HDL _RARE_
- I-GENE
cholesterol I-GENE
seen O
at _RARE_
the O
end O
of O
five O
years O
of O
Norplant _RARE_
- O
2 O
rod _RARE_
use O
and O
six _RARE_
months O
postremoval _RARE_
were O
similar O
to O
the O
preinsertion _RARE_
mean O
. O

At O
a O
PaCO2 O
of O
40 O
mmHg O
, O
baseline O
brain O
pHi _RARE_
measured O
7 O
. O
03 O
+/- O
0 _RARE_
. O
04 O
, O
while O
regional O
cortical O
blood _RARE_
flow O
was O
47 _RARE_
. O
0 _RARE_
+/- O
4 O
. O
3 O
ml O
. O
100 _RARE_
g O
- O
1 O
. O
min O
- O
1 O
. O

CPAP _RARE_
reduced _RARE_
isotime _RARE_
( O
defined O
as _RARE_
the O
last O
common O
minute O
of O
exercise O
) O
VO2 O
and O
dyspnea _RARE_
in O
those O
patients O
with O
more O
severe O
lung _RARE_
disease _RARE_
, O
but O
these O
values O
tended O
to O
increase O
slightly O
in O
the O
patients O
with O
only O
mild O
lung _RARE_
disease _RARE_
. O

Effects O
of O
diltiazem O
on O
netilmicin _RARE_
- O
induced _RARE_
nephrotoxicity _RARE_
in O
rabbits O
. O

Four O
forms O
of O
salmonellosis _RARE_
were O
recognised _RARE_
in O
feedlots _RARE_
and O
during _RARE_
transport _RARE_
by O
sea _RARE_
: O
septicaemic _RARE_
, O
and O
acute O
, O
subacute O
and O
chronic O
enteric O
. O

About _RARE_
20 O
% O
of O
single O
- O
stranded _RARE_
DNA O
binding O
was O
observed O
in O
the O
presence O
of O
MgdTDP _RARE_
, O
but O
none O
was O
detectable O
in O
the O
absence O
of O
nucleotides O
. O

To O
our O
knowledge O
this O
is O
the O
first _RARE_
case O
in O
which O
a O
probable O
association O
between O
cholelithiasis _RARE_
and O
Wildervanck _RARE_
' O
s O
syndrome _RARE_
has O
been O
recorded O
. O

Both O
4 O
, O
8 O
- O
DiMeIQx _RARE_
and O
A O
alpha O
C O
were O
found O
at _RARE_
< O
1 O
p O
. O
p O
. O
b O
. O

Three O
cysteine O
and O
four O
tryptophan _RARE_
residues O
, O
previously O
identified O
as _RARE_
conserved _RARE_
amongst _RARE_
nitrous _RARE_
- I-GENE
oxide I-GENE
reductases _RARE_
, O
are O
found O
in O
the O
Paracoccus _RARE_
enzyme O
. O

Recombinant I-GENE
Leishmania _RARE_
surface I-GENE
glycoprotein I-GENE
GP63 _RARE_
is O
secreted _RARE_
in O
the O
baculovirus _RARE_
expression _RARE_
system _RARE_
as _RARE_
a O
latent O
metalloproteinase _RARE_
. O

Delineating _RARE_
the O
molecular _RARE_
basis O
for _RARE_
agonist O
- O
induced _RARE_
destabilization _RARE_
of O
mRNA O
of O
G I-GENE
- I-GENE
protein I-GENE
- I-GENE
linked _RARE_
receptors I-GENE
that O
contributes O
to O
receptor O
down O
- O
regulation _RARE_
is O
fundamental _RARE_
to O
our O
understanding O
of O
long O
- O
term O
regulation _RARE_
of O
receptors O
by O
agonist O
. O

Addition O
of O
phalloidin _RARE_
- O
stabilized O
F I-GENE
- I-GENE
actin I-GENE
nuclei O
and O
phalloidin _RARE_
restored O
L266D _RARE_
actin I-GENE
' O
s O
ability O
to O
polymerize _RARE_
at _RARE_
4 O
degrees O
C O
. O

These O
cells O
produce O
a O
low O
level O
of O
IL _RARE_
- I-GENE
5 I-GENE
when O
stimulated _RARE_
with O
PMA O
alone O
; O
however O
, O
N6 _RARE_
, O
O2 _RARE_
- O
dibutyryl _RARE_
cAMP O
( O
Bt2cAMP _RARE_
), _RARE_
in O
combination O
with O
PMA O
, O
augmented O
by O
more O
than O
tenfold _RARE_
the O
IL _RARE_
- I-GENE
5 I-GENE
production O
at _RARE_
the O
mRNA O
and O
the O
protein O
levels O
. O

Hu _RARE_
- I-GENE
Met _RARE_
- I-GENE
1 I-GENE
mRNA I-GENE
expression _RARE_
in O
a O
small O
number O
of O
human O
T O
cell O
tumor O
lines O
did O
not O
correlate O
with O
any O
particular O
phenotype _RARE_
or O
stage _RARE_
of O
development O
. O

Partial O
engorgement _RARE_
was O
higher _RARE_
in O
the O
treatments O
. O

Northern O
( O
RNA O
) O
analysis O
demonstrated O
expression _RARE_
of O
human O
PI I-GENE
3 I-GENE
- I-GENE
kinase I-GENE
in O
all O
tissues O
and O
cell O
lines O
tested O
. O

These O
results O
demonstrate O
the O
existence O
of O
different O
PI I-GENE
3 I-GENE
- I-GENE
kinase I-GENE
isoforms I-GENE
and O
define O
a O
family O
of O
genes O
encoding O
distinct O
PI I-GENE
3 I-GENE
- I-GENE
kinase I-GENE
catalytic I-GENE
subunits I-GENE
that O
can O
associate O
with O
p85 I-GENE
. O

In O
addition O
to O
the O
protein I-GENE
- I-GENE
tyrosine I-GENE
kinase I-GENE
domain I-GENE
, O
p56lck _RARE_
possesses O
Src I-GENE
homology I-GENE
2 I-GENE
and I-GENE
3 I-GENE
( O
SH2 _RARE_
and O
SH3 I-GENE
) O
domains O
as _RARE_
well _RARE_
as _RARE_
a O
unique O
N O
- O
terminal O
region O
. O

Strains _RARE_
bearing _RARE_
the O
drs2 _RARE_
mutation I-GENE
process O
the O
20S I-GENE
precursor I-GENE
of O
the O
mature _RARE_
18S _RARE_
rRNA I-GENE
slowly O
and O
are O
deficient _RARE_
in O
40S _RARE_
ribosomal I-GENE
subunits I-GENE
. O

Hepatitis _RARE_
B O
and O
liver O
transplantation O
. O

One O
complex O
most O
likely O
contained O
Sp1 _RARE_
, O
and O
another O
complex O
showed O
S O
- O
phase _RARE_
- O
specific O
binding O
, O
suggesting O
a O
direct O
role O
in O
the O
cell O
- O
cycle _RARE_
- O
dependent O
R1 _RARE_
gene I-GENE
expression _RARE_
. O

These O
combined O
observations O
define O
a O
promoter O
and O
an O
enhancer O
for _RARE_
the O
chicken I-GENE
L I-GENE
- I-GENE
CAM _RARE_
gene I-GENE
. O

The O
rate O
of O
enzymic _RARE_
stimulation _RARE_
induced _RARE_
by O
a O
given O
nitrate _RARE_
correlates O
closely O
with O
the O
rate O
of O
measured O
NO _RARE_
production O
from O
the O
nitrate _RARE_
molecule O
. O

Clipping _RARE_
resulted O
in O
a O
serious O
mislocalization _RARE_
of O
the O
position O
of O
the O
peak O
of O
the O
epicortical _RARE_
potential _RARE_
field O
. O

The O
duration O
of O
diabetes O
mellitus O
in O
these O
patients O
was O
from O
5 O
months O
to O
6 O
years O
, O
and O
in O
all O
patients O
this O
was O
the O
first _RARE_
myocardial _RARE_
infarction O
. O

The O
247 _RARE_
- O
kDa O
complex O
appears O
to O
contain O
two O
distinct O
protein O
- O
DNA O
complexes O
of O
approximately _RARE_
232 _RARE_
and O
256 O
kDa O
and O
represents O
two O
proteins O
covalently O
cross O
- O
linked _RARE_
to O
a O
single O
DRE _RARE_
oligonucleotide _RARE_
, O
while O
the O
97 O
, O
105 _RARE_
, O
and O
115 _RARE_
- O
kDa O
complexes O
represent O
single O
protein O
- O
DRE _RARE_
cross O
- O
links O
. O

The O
promoter O
and O
upstream O
region O
of O
the O
Brassica _RARE_
napus _RARE_
2S _RARE_
storage _RARE_
protein I-GENE
napA _RARE_
gene I-GENE
were O
studied O
to O
identify O
cis O
- O
acting O
sequences O
involved O
in O
developmental O
seed _RARE_
- O
specific O
expression _RARE_
. O

However O
, O
limited O
comparisons O
reveal O
domains O
in O
the O
NH2 O
and O
COOH _RARE_
termini O
that O
have O
a O
high O
degree O
of O
similarity _RARE_
suggesting O
functional _RARE_
conservation O
. O

Rinit _RARE_
reflects _RARE_
the O
Newtonian _RARE_
resistances _RARE_
and O
Rdiff _RARE_
represents O
the O
viscoelastic _RARE_
/ O
inhomogeneous _RARE_
pressure O
dissipations _RARE_
in O
the O
system _RARE_
. O

We O
have O
explored O
the O
mechanism O
of O
action O
of O
the O
fibronectin I-GENE
splicing _RARE_
enhancer I-GENE
and O
found O
that O
the O
SE O
element O
is O
required O
for _RARE_
efficient O
assembly O
of O
early O
splicing _RARE_
complexes O
, O
allowing O
a O
more O
efficient O
interaction O
of O
the O
U2 _RARE_
snRNP I-GENE
with O
branch O
site O
sequences O
. O

Inspection _RARE_
of O
enhancer O
mutants O
suggests O
that O
trans _RARE_
- O
activation O
by O
hLEF _RARE_
/ O
GAL4 I-GENE
is O
especially O
dependent O
on O
TCF I-GENE
- I-GENE
2 I-GENE
, O
a O
distinct O
T O
- O
cell O
- O
enriched _RARE_
protein O
that O
binds O
to O
sequences O
flanking O
the O
hLEF _RARE_
- I-GENE
binding I-GENE
site I-GENE
in O
the O
enhancer O
. O

We O
conclude O
that O
sequences O
outside O
of O
the O
hLEF _RARE_
HMG I-GENE
box I-GENE
mediate O
cell O
- O
and O
context O
- O
specific O
activation O
of O
the O
TCR I-GENE
alpha I-GENE
enhancer I-GENE
and O
may O
facilitate O
interactions O
between O
hLEF _RARE_
and O
other O
T O
- O
cell O
- O
specific O
factors O
recruited O
to O
the O
enhancer O
. O

A O
cAMP O
response O
element O
( O
CRE _RARE_
) O
consensus O
signal O
was O
identified O
in O
the O
5 O
'- O
noncoding O
region O
. O
cAMP O
regulates O
the O
expression _RARE_
of O
Kv1 _RARE_
. I-GENE
5 I-GENE
gene I-GENE
in O
a O
cell O
- O
specific O
manner O
. O

A O
number O
of O
serological O
tests O
measuring O
the O
presence O
of O
Helicobacter _RARE_
pylori _RARE_
- O
specific O
serum O
immunoglobulin I-GENE
G I-GENE
( O
IgG I-GENE
) O
are O
now O
commercially _RARE_
available O
. O

Using O
a O
series O
of O
mutant I-GENE
T I-GENE
antigens I-GENE
expressed _RARE_
by O
recombinant O
baculoviruses _RARE_
in O
Sf9 O
cells O
, O
we O
find O
that O
the O
origin O
unwinding _RARE_
activities O
of O
both O
TS677 _RARE_
--> _RARE_
A O
and O
TS677 _RARE_
, O
679 _RARE_
--> _RARE_
A O
are O
inhibited O
by O
the O
T I-GENE
- I-GENE
antigen I-GENE
kinase I-GENE
, O
as _RARE_
is O
wild I-GENE
- I-GENE
type I-GENE
T I-GENE
antigen I-GENE
. O

The O
degree O
of O
hypoperfusion _RARE_
was O
slightly O
related O
to O
decrease O
in O
FEV1 O
. O
0 _RARE_
%, O
V25 _RARE_
and O
PaO2 O
and O
increase O
in O
circulating O
blood _RARE_
volume O
and O
peripheral O
red _RARE_
blood _RARE_
cell O
counts O
. O

Two O
patients O
were O
treated O
successfully O
with O
a O
combination O
of O
metronidazole _RARE_
( O
a O
tissue O
amoebicide _RARE_
) O
and O
diloxanide _RARE_
( O
a O
lumenal _RARE_
amoebicide _RARE_
). O

We O
have O
identified O
in O
the O
5 O
' O
untranslated _RARE_
region O
of O
the O
Drosophila I-GENE
copia _RARE_
retrotransposon _RARE_
, O
3 O
' O
to O
the O
left _RARE_
LTR O
, O
a O
sequence O
for _RARE_
transcriptional O
regulation _RARE_
by O
homeoproteins _RARE_
. O

In O
the O
present O
study O
, O
lesions O
of O
the O
OPT _RARE_
complex O
( O
the O
thalamic _RARE_
source O
of O
afferents O
to O
IHA _RARE_
and O
HD O
) O
were O
found O
to O
have O
no _RARE_
effect O
on O
color O
- O
reversal O
learning O
performance O
. O

The O
fourth O
dose O
produced O
favorable _RARE_
results O
( O
66 _RARE_
. O
7 O
%) O
in O
individuals O
with O
HB _RARE_
antibodies I-GENE
between O
10 O
and O
100 _RARE_
IU O
/ O
ml O
and O
unfavorable _RARE_
ones O
( O
3 O
. O
8 O
%) O
where O
the O
HB _RARE_
antibodies I-GENE
were O
below O
10 O
IU O
/ O
ml O
. O

CONCLUSIONS O
: O
In O
our O
patients O
and O
within O
the O
range O
of O
treatment O
variables O
studied O
, O
age O
, O
Karnofsky _RARE_
index O
, O
and O
graft O
- O
versus O
- O
host _RARE_
disease _RARE_
are O
the O
most O
important O
factors O
related O
with O
early O
mortality O
. O

Nucleotide O
sequence O
analysis O
of O
the O
HA _RARE_
gene I-GENE
in O
these O
two O
mutants O
confirmed O
the O
HA _RARE_
- I-GENE
phenotype _RARE_
. O

This O
intron O
occupies _RARE_
a O
conserved _RARE_
position O
corresponding O
to O
that O
of O
intron O
1 O
in O
the O
transit O
peptide O
region O
of O
chloroplast I-GENE
GAPDH _RARE_
genes I-GENE
( O
GapA _RARE_
and O
GapB _RARE_
) O
of O
higher _RARE_
plants _RARE_
. O

The O
drug O
- O
resistant O
cell O
lines O
P388 O
/ O
ADR O
/ O
3 O
and O
P388 O
/ O
ADR O
/ O
7 O
express O
a O
shortened O
topo _RARE_
II I-GENE
alpha I-GENE
mRNA I-GENE
transcript I-GENE
in O
addition O
to O
the O
native _RARE_
transcript O
present O
in O
the O
drug O
- O
sensitive _RARE_
P388 O
/ O
4 O
cell O
line O
. O

Using O
a O
3 O
'- O
rapid O
amplification O
of O
cDNA O
ends O
strategy O
, O
we O
have O
cloned _RARE_
cDNAs O
representing O
the O
3 O
'- O
termini O
of O
both O
the O
native _RARE_
and O
mutant O
transcripts O
from O
both O
P388 O
/ O
ADR O
/ O
3 O
and O
P388 O
/ O
ADR O
/ O
7 O
cells O
. O

The O
phi _RARE_
AP3 _RARE_
factor I-GENE
is O
a O
nuclear O
phosphoprotein _RARE_
; O
the O
extent O
of O
its O
phosphorylation _RARE_
is O
regulated O
during _RARE_
the O
cell O
cycle _RARE_
. O

Similarly O
, O
the O
N O
- O
terminal O
cytoplasmic O
domain O
of O
the O
latent I-GENE
membrane I-GENE
protein I-GENE
2A _RARE_
( O
LMP2A _RARE_
) O
of O
the O
Epstein O
- O
Barr O
virus O
( O
EBV _RARE_
) O
contains O
a O
single O
copy O
of O
the O
Tyr _RARE_
- O
X O
- O
X O
- O
Leu _RARE_
/ O
Ile O
- O
containing O
motif O
which O
could O
play O
a O
critical O
role O
in O
B O
cell O
transformation O
. O

The O
functional _RARE_
homology O
of O
Cwg2 _RARE_
with O
Cdc43 _RARE_
, O
which O
has O
been O
implicated O
in O
the O
control O
of O
cell O
polarity O
, O
suggests O
a O
link _RARE_
between O
two O
morphogenetic _RARE_
events O
such O
as _RARE_
establishment O
of O
cell O
polarity O
and O
cell O
wall _RARE_
biosynthesis O
. O

Molecular O
cloning O
of O
a O
P I-GENE
- I-GENE
type I-GENE
ATPase I-GENE
gene I-GENE
from O
the O
cyanobacterium _RARE_
Synechocystis _RARE_
sp _RARE_
. O

The O
cloning O
of O
PTR2 _RARE_
represents O
the O
first _RARE_
example O
of O
the O
molecular _RARE_
genetic O
characterization O
of O
a O
eucaryotic _RARE_
peptide O
transport _RARE_
gene O
. O

By O
using O
the O
full O
- O
length O
cytoplasmic O
domain O
and O
mutants O
with O
progressive O
carboxy _RARE_
- O
terminal O
deletions O
, O
internal O
deletions O
, O
or O
point O
mutations O
, O
we O
identified O
the O
first _RARE_
150 _RARE_
amino O
acid O
residues O
of O
LIFR _RARE_
as _RARE_
the O
minimal O
region O
necessary O
for _RARE_
signaling _RARE_
. O

To O
examine O
the O
biochemical O
basis O
of O
the O
end O
joining _RARE_
, O
nuclear O
extracts O
were O
prepared O
from O
a O
wide O
variety O
of O
mammalian O
cell O
lines O
and O
tested O
for _RARE_
their O
ability O
to O
join _RARE_
test O
plasmid _RARE_
substrates _RARE_
. O

These O
data O
indicate O
that O
the O
largest O
subunit O
of O
RNA I-GENE
polymerase I-GENE
II I-GENE
and O
TFIIB _RARE_
are O
important O
determinants _RARE_
of O
transcription O
start _RARE_
site O
selection O
in O
S O
. O
cerevisiae O
and O
suggest O
that O
this O
function O
might O
be O
conferred O
by O
interaction O
between O
these O
two O
proteins O
. O

Recombinant O
expression _RARE_
of O
a O
chimeric O
EGFR I-GENE
/ O
ErbB I-GENE
- I-GENE
3 I-GENE
receptor I-GENE
in O
NIH _RARE_
3T3 O
fibroblasts _RARE_
allowed O
us O
to O
investigate O
cytoplasmic O
events O
associated O
with O
ErbB I-GENE
- I-GENE
3 I-GENE
signal O
transduction _RARE_
upon O
ligand _RARE_
activation O
. O

Oligonucleotide _RARE_
competitors _RARE_
were O
used O
to O
evaluate O
the O
accessibility _RARE_
of O
the O
TATA O
- O
binding O
site O
in O
TIF I-GENE
- I-GENE
IB _RARE_
, O
TFIID I-GENE
, O
and O
TFIIIB _RARE_
. O

The O
227 _RARE_
- O
to O
- O
239 O
region O
blocked O
ADR1 I-GENE
activity O
independently O
of O
the O
TAD _RARE_
present O
on O
ADR1 I-GENE
, O
ADR1 I-GENE
DNA O
binding O
, O
and O
specific O
ADH2 _RARE_
promoter I-GENE
sequences I-GENE
. O

Analysis O
of O
strains O
harboring O
an O
mds1 _RARE_
null _RARE_
mutation I-GENE
demonstrates O
that O
MDS1 _RARE_
is O
not O
essential O
during _RARE_
normal O
vegetative _RARE_
growth O
but O
appears O
to O
be O
required O
for _RARE_
meiosis O
. O

TGF I-GENE
beta I-GENE
1 I-GENE
expression _RARE_
is O
largely O
governed _RARE_
by O
three O
AP I-GENE
- I-GENE
1 I-GENE
binding I-GENE
sites I-GENE
located _RARE_
in O
two O
different O
promoters O
of O
this O
gene O
. O

Val _RARE_
--> _RARE_
Ala _RARE_
mutations O
selectively O
alter O
helix O
- O
helix O
packing _RARE_
in O
the O
transmembrane O
segment O
of O
phage _RARE_
M13 _RARE_
coat I-GENE
protein I-GENE
. O

Strategic _RARE_
change O
in O
the O
NHS _RARE_
. O

A O
much O
less O
expensive _RARE_
solution O
than O
UW _RARE_
, O
containing O
only O
K O
(+)- _RARE_
lactobionate _RARE_
, O
KH2PO4 _RARE_
, O
MgSO4 _RARE_
and O
raffinose _RARE_
, O
can O
be O
used O
successfully O
for _RARE_
preservation O
of O
rat O
hepatocytes O
for _RARE_
24 _RARE_
hr O
for _RARE_
drug O
transport _RARE_
studies O
. O

Repeated _RARE_
administration O
of O
GRg2 _RARE_
20 O
mg O
/ O
kg O
i O
. O
p O
. O
significantly O
improved O
the O
CYP _RARE_
- O
induced _RARE_
recognitional _RARE_
deficits O
by O
increasing O
the O
CYP _RARE_
- O
decreased O
rate O
from O
55 _RARE_
. O
8 O
+/- O
9 O
. O
6 O
to O
80 _RARE_
. O
8 O
+/- O
4 O
. O
2 O
in O
d O
3 O
learning O
acquisition O
( O
F O
( O
1 O
, O
14 O
) O
= O
5 O
. O
6 O
, O
p O
< O
0 _RARE_
. O
05 O
), _RARE_
from O
53 O
. O
4 O
+/- O
8 O
. O
4 O
to O
60 _RARE_
. O
0 _RARE_
+/- O
8 O
. O
2 O
in O
48 _RARE_
h O
memory O
acquisition O
( O
F O
( O
1 O
, O
14 O
) O
= O
7 O
. O
5 O
, O
p O
< O
0 _RARE_
. O
05 O
) O
and O
from O
55 _RARE_
. O
0 _RARE_
+/- O
5 O
. O
5 O
to O
88 O
. O
3 O
+/- O
2 O
. O
5 O
in O
24 _RARE_
h O
memory O
retention O
( O
F O
( O
1 O
, O
12 O
) O
27 _RARE_
. O
5 O
, O
p O
< O
0 _RARE_
. O
01 O
) O
as _RARE_
well _RARE_
as _RARE_
from O
60 _RARE_
. O
0 _RARE_
+/- O
6 O
. O
8 O
to O
85 _RARE_
. O
6 O
+/- O
6 O
. O
9 O
in O
48 _RARE_
h O
memory O
retrieval _RARE_
( O
F O
( O
1 O
, O
12 O
) O
= O
5 O
. O
2 O
, O
p O
< O
0 _RARE_
. O
05 O
), _RARE_
respectively O
. O

Human I-GENE
bcl3 _RARE_
protein I-GENE
specifically O
displaces _RARE_
( I-GENE
p50 _RARE_
) I-GENE
2 I-GENE
- I-GENE
DNA I-GENE
complexes I-GENE
. O

The O
therapeutic O
action O
of O
cyclosporin O
A O
( O
Sandimmun _RARE_
): O
its O
application O
in O
rheumatoid O
arthritis O
. O

In O
vitro O
translation O
experiments O
show O
that O
human O
cDNA O
derived O
RNA O
translates _RARE_
into O
a O
protein O
with O
a O
mobility O
of O
44 _RARE_
- O
46 _RARE_
kD _RARE_
on O
SDS O
polyacrylamide O
gels O
. O

After O
peripheral O
administration O
of O
both O
CRF _RARE_
and O
TRH I-GENE
, O
ACTH I-GENE
levels O
were O
significantly O
higher _RARE_
on O
the O
tumor O
side _RARE_
in O
all O
patients O
. O

Pentazocine _RARE_
analgesia O
: O
is O
there O
a O
niche _RARE_
for _RARE_
Talwin _RARE_
Nx _RARE_
? O
Pentazocine _RARE_
can O
be O
a O
useful O
analgesic O
agent O
for _RARE_
the O
management O
of O
acute O
dental O
pain O
. O

A O
sequence O
homology O
analysis O
between O
human I-GENE
nm23 _RARE_
- I-GENE
H1 _RARE_
and O
the O
homolog O
gene O
of O
the O
rat O
( O
NDP _RARE_
- I-GENE
K I-GENE
beta I-GENE
) O
shows O
that O
exon _RARE_
- O
intron O
boundaries O
are O
well _RARE_
conserved _RARE_
between O
these O
two O
species O
. O

A O
favourable O
response O
was O
achieved O
with O
a O
combination O
of O
amphotericin O
B O
and O
cotrimoxazole _RARE_
. O

Response O
durations O
were O
short O
. O

RESULTS O
: O
At O
the O
beginning O
of O
the O
QA _RARE_
/ O
QI _RARE_
process O
, O
monitoring O
of O
blood _RARE_
administration O
practices _RARE_
revealed O
that O
a O
variance _RARE_
from O
institutional _RARE_
blood _RARE_
administration O
policy _RARE_
occurred O
during _RARE_
50 O
percent O
of O
blood _RARE_
and O
component _RARE_
transfusions _RARE_
. O

In O
addition O
, O
REP21 _RARE_
plants _RARE_
were O
resistant O
to O
an O
unusually O
broad O
range O
of O
tobamoviruses _RARE_
including O
tomato _RARE_
mosaic O
virus O
, O
tobacco O
mild O
green _RARE_
mosaic O
virus O
, O
TMV _RARE_
- O
U5 _RARE_
, O
green _RARE_
tomato _RARE_
atypical O
mosaic O
virus O
, O
and O
ribgrass _RARE_
mosaic O
virus O
. O

Drug O
effect O
, O
measured O
as _RARE_
postural _RARE_
sway _RARE_
, O
was O
also O
similar O
in O
the O
patients O
with O
cirrhosis O
and O
control O
subjects O
; O
therefore O
the O
ratio O
of O
effect O
area O
under O
the O
curve O
to O
concentration O
area O
under O
the O
curve O
, O
a O
measure O
of O
sensitivity O
, O
did O
not O
differ O
significantly O
between O
the O
patients O
with O
cirrhosis O
and O
the O
control O
subjects O
. O

We O
present O
evidence O
that O
YY1 I-GENE
, O
a O
ubiquitously O
expressed _RARE_
DNA O
- O
binding O
protein O
, O
regulates O
the O
activity O
of O
the O
c I-GENE
- I-GENE
fos I-GENE
promoter I-GENE
primarily O
through O
an O
effect O
on O
DNA O
structure _RARE_
. O

In O
a O
retrospective O
analysis O
of O
first _RARE_
- O
time O
total _RARE_
colonoscopies _RARE_
in O
685 _RARE_
patients O
, O
we O
investigated O
the O
relationship O
between O
hyperplastic _RARE_
and O
adenomatous _RARE_
polyps O
. O

The O
rate O
of O
decrement _RARE_
in O
DPOAE _RARE_
amplitude O
over O
a O
prescribed _RARE_
time O
period O
was O
utilized O
as _RARE_
a O
measure O
of O
susceptibility _RARE_
to O
the O
acoustic O
trauma O
. O

Effect O
of O
single O
base _RARE_
substitutions O
at _RARE_
glycine O
- O
870 _RARE_
codon _RARE_
of O
gramicidin _RARE_
S I-GENE
synthetase _RARE_
2 I-GENE
gene I-GENE
on O
proline O
activation O
. O

The O
predicted O
Pay4p _RARE_
sequence I-GENE
contains O
two O
putative O
ATP O
- O
binding O
domains O
and O
shows O
structural O
relationships O
to O
other O
potential _RARE_
ATP I-GENE
- I-GENE
binding I-GENE
proteins I-GENE
involved O
in O
biological O
processes O
as _RARE_
diverse O
as _RARE_
peroxisome _RARE_
biogenesis O
, O
vesicle O
- O
mediated _RARE_
protein O
transport _RARE_
, O
cell O
cycle _RARE_
control O
, O
and O
transcriptional O
regulation _RARE_
. O

The O
results O
show O
that O
the O
structure _RARE_
of O
the O
decorin _RARE_
gene I-GENE
promoter I-GENE
is O
different O
from O
that O
of O
any O
other O
proteoglycan _RARE_
promoter O
characterized O
so O
far O
and O
indicate O
that O
the O
pur _RARE_
/ O
pyr _RARE_
segment O
plays O
a O
role O
in O
the O
regulation _RARE_
of O
gene O
transcription O
. O

The O
kinase O
inhibitor O
staurosporine _RARE_
( O
1 O
microM O
) O
blocks O
LPA _RARE_
- O
induced _RARE_
, O
but O
not O
epidermal _RARE_
growth O
factor O
- O
induced _RARE_
, O
activation O
of O
p21ras I-GENE
and O
MAP I-GENE
kinase I-GENE
, O
consistent O
with O
an O
intermediate _RARE_
protein O
kinase O
linking O
the O
LPA _RARE_
receptor I-GENE
to O
p21ras I-GENE
activation O
. O

267 _RARE_
, O
4870 _RARE_
- O
4877 _RARE_
)) O
indicates O
an O
overall O
identity O
of O
58 O
and O
56 _RARE_
%, O
respectively O
, O
with O
a O
91 O
and O
92 O
% O
identity O
in O
the O
highly O
conserved _RARE_
transmembrane O
and O
cytoplasmic O
domains O
. O

S O
., O
K O
. O

The O
survival O
rate O
at _RARE_
forty _RARE_
months O
in O
15 _RARE_
patients O
with O
N2 O
disease _RARE_
who O
underwent O
R2b _RARE_
operation O
was O
51 _RARE_
%. O

Mothers _RARE_
with O
severe O
anatomical O
abnormalities O
, O
who O
are O
HIV O
positive O
, O
have O
active _RARE_
TB _RARE_
or O
whose O
children O
have O
inherited O
mono O
- O
or O
disaccharide _RARE_
intolerances _RARE_
should O
not O
breastfeed _RARE_
. O

G O
. O

The O
psaD _RARE_
, O
psaF _RARE_
, O
psaH _RARE_
, O
and O
psaL _RARE_
products I-GENE
have O
two O
isoforms O
each O
that O
are O
distinguished O
by O
different O
mobilities _RARE_
in O
polyacrylamide O
gel O
electrophoresis O
, O
and O
the O
psaE _RARE_
product I-GENE
has O
four O
isoforms O
. O

When O
Hy _RARE_
- O
Vac _RARE_
SPF _RARE_
type O
V O
embryos _RARE_
were O
exposed O
to O
either O
0 _RARE_
. O
20 O
ml O
50 O
% O
ethanol O
in O
CRS _RARE_
or O
to O
0 _RARE_
. O
20 O
ml O
CRS _RARE_
( O
controls O
), _RARE_
ethanol O
- O
treated O
embryos _RARE_
showed O
a O
VSD _RARE_
incidence O
of O
34 _RARE_
. O
1 O
% O
compared O
with O
a O
3 O
. O
6 O
% O
incidence O
in O
the O
controls O
( O
P O
= O
0 _RARE_
. O
0017 _RARE_
). O

Peripheral _RARE_
vitreochorioretinal _RARE_
dystrophies _RARE_
in O
myopia _RARE_
patients O

In O
our O
studies O
, O
we O
utilized O
HIV O
- O
1 O
HXB2 _RARE_
and O
HIV O
- O
1 O
Z2Z6 _RARE_
core I-GENE
enhancers _RARE_
because O
the O
Z2Z6 _RARE_
strain _RARE_
has O
a O
single O
point O
mutation O
flanking O
the O
right O
ETS _RARE_
- I-GENE
binding I-GENE
site I-GENE
. O

The O
secondary O
, O
but O
not O
the O
primary _RARE_
, O
antibody O
responses O
of O
male O
C57Bl _RARE_
/ O
6 O
mice O
were O
higher _RARE_
among O
mice O
housed _RARE_
alone O
compared O
to O
mice O
housed _RARE_
in O
groups O
; O
differences O
were O
observed O
for _RARE_
both O
IgM I-GENE
and O
IgG I-GENE
anti I-GENE
- I-GENE
KLH _RARE_
antibodies I-GENE
. O

However O
, O
a O
surprisingly _RARE_
high O
degree O
of O
conservation O
of O
intron O
sequences O
was O
observed O
between O
both O
species O
. O

Interleukin I-GENE
- I-GENE
6 I-GENE
may O
possibly O
potentiate _RARE_
metastasis O
of O
cardiac O
myxoma _RARE_
. O

Other O
parameters O
of O
iron O
metabolism O
, O
including O
ferritin I-GENE
, O
were O
not O
found O
to O
contribute O
to O
the O
risk O
. O

Responses _RARE_
to O
the O
Plowright _RARE_
Rinderpest _RARE_
vaccine O
by O
43 _RARE_
calves O
and O
70 O
adult O
cattle O
in O
Uganda _RARE_
in O
1990 O
, O
through O
the O
production O
of O
IgG I-GENE
antibodies I-GENE
, O
were O
monitored O
for _RARE_
4 O
weeks O
using O
the O
ELISA O
assay O
. O

Because O
of O
the O
small O
number O
of O
visceral O
angiography O
procedures O
performed O
( O
38 O
), _RARE_
no _RARE_
definitive O
conclusions O
could O
be O
drawn _RARE_
as _RARE_
to O
the O
differences O
between O
ionic O
and O
nonionic _RARE_
agents O
regarding O
grade O
- O
2 O
and O
grade O
- O
3 O
adverse O
events O
. O

Tumours _RARE_
of O
the O
cavum _RARE_
oris _RARE_
and O
oropharynx _RARE_
of O
T1 _RARE_
- O
stage _RARE_
are O
possible O
only O
in O
1 O
of O
3 O
cases O
. O

Thomas _RARE_
' O
Hospital _RARE_
solution O
( O
with O
95 _RARE_
% O
O2 _RARE_
: O
5 O
% O
CO2 O
) O
can O
meet _RARE_
the O
metabolic O
demand O
of O
the O
ischaemic O
myocardium O
and O
thus O
increase O
the O
safe O
duration O
of O
cardiac O
arrest O
. O

Plasma O
, O
LDL I-GENE
and O
liver O
cholesterol O
concentrations O
were O
higher _RARE_
in O
the O
hyperlipidemic _RARE_
control O
than O
the O
nonhyperlipidemic _RARE_
control O
and O
lower O
in O
the O
groups O
fed O
diets O
containing O
pectin _RARE_
or O
prune _RARE_
fiber O
than O
in O
the O
hyperlipidemic _RARE_
control O
group O
. O

The O
Stryker _RARE_
frame O
modification O
to O
the O
standard O
Dornier _RARE_
HM3 _RARE_
lithotriptor _RARE_
allows O
for _RARE_
improved O
visualization O
and O
easier _RARE_
localization _RARE_
of O
distal O
ureteral _RARE_
calculi _RARE_
compared O
to O
the O
standard O
gantry _RARE_
. O

Glomerular _RARE_
mesangial _RARE_
cells O
expressed _RARE_
an O
abundant O
1 O
. O
1 O
kb O
mRNA O
transcript O
for _RARE_
Id1 _RARE_
, O
but O
in O
contrast O
to O
other O
cell O
types _RARE_
Id1 _RARE_
mRNA I-GENE
was O
expressed _RARE_
in O
both O
randomly O
cycling _RARE_
cells O
and O
in O
serum O
- O
deprived O
, O
quiescent _RARE_
cultures O
. O

Routine _RARE_
psychometric _RARE_
screening O
of O
IHD _RARE_
patients O
may O
provide O
a O
cost O
- O
effective O
means O
of O
alerting _RARE_
cardiologists _RARE_
and O
internists _RARE_
to O
the O
relatively O
high O
levels O
of O
distress O
among O
their O
patients O
. O

A O
single O
1 O
. O
8 O
- O
kb O
transcript O
mRNA O
was O
detected O
by O
Northern O
( O
RNA O
) O
blot O
analysis O
, O
and O
its O
5 O
' O
end O
maps O
to O
a O
position O
51 _RARE_
bp O
upstream O
from O
the O
site O
of O
initiation O
of O
protein O
synthesis _RARE_
. O

Employing _RARE_
this O
sequence O
information _RARE_
from O
c11 _RARE_
/ O
1 O
, O
the O
c11 _RARE_
/ O
1 O
- O
specific O
cDNA O
was O
generated O
from O
poly _RARE_
( O
A O
)+ O
RNA O
of O
bovine O
PMNLs _RARE_
by O
reverse O
transcription O
and O
a O
combination O
of O
polymerase O
chain O
reaction O
( O
PCR O
) O
methods O
. O

The O
sequence O
similarity _RARE_
has O
suggested O
that O
SCG10 _RARE_
and O
stathmin _RARE_
have O
been O
derived O
from O
structurally O
and O
evolutionarily O
related O
genes O
. O

These O
data O
are O
consistent O
with O
the O
idea O
that O
the O
neuron _RARE_
- I-GENE
specific I-GENE
SCG10 _RARE_
gene I-GENE
evolved O
by O
duplication O
and O
modification O
of O
the O
more O
broadly O
expressed _RARE_
stathmin _RARE_
/ O
Lap18 _RARE_
gene O
. O

The O
deduced O
amino O
acid O
sequence O
of O
the O
mouse I-GENE
HO _RARE_
- I-GENE
1 I-GENE
gene I-GENE
is O
identical O
to O
that O
of O
p32 _RARE_
, O
initially O
identified O
as _RARE_
a O
stress O
- O
induced _RARE_
protein O
in O
mouse O
BALBc _RARE_
/ O
3T3 O
cells O
. O

We O
found O
that O
T3 _RARE_
( O
10 O
(- _RARE_
8 O
) O
M O
) O
selectively O
stimulates O
transcription O
from O
rGH _RARE_
- O
TRE _RARE_
- O
and O
TREpal _RARE_
-, _RARE_
but O
not O
ME _RARE_
- O
TRE _RARE_
- O
and O
F2 O
- O
TRE _RARE_
-, _RARE_
containing O
templates O
in O
which O
these O
TREs _RARE_
are O
linked _RARE_
in O
front O
of O
the O
rGH _RARE_
minimal I-GENE
promoter I-GENE
containing O
only O
the O
TATA I-GENE
box I-GENE
binding I-GENE
protein I-GENE
, O
but O
not O
any O
other O
proximal O
binding O
protein O
, O
sequence O
. O

Using O
a O
polymerase O
chain O
reaction O
- O
based O
approach O
, O
we O
cloned _RARE_
a O
150 _RARE_
- O
base _RARE_
pair _RARE_
fragment O
of O
a O
new O
sialymotif _RARE_
from O
human O
placenta O
mRNA O
, O
which O
was O
then O
used O
as _RARE_
a O
probe O
to O
clone O
the O
complete _RARE_
coding O
sequence O
of O
the O
corresponding O
gene O
from O
a O
cDNA O
library O
. O

The O
structural O
analysis O
also O
demonstrated O
that O
the O
heterogeneity O
of O
the O
HDC _RARE_
mRNA I-GENE
is O
caused O
by O
an O
insertion _RARE_
of O
the O
seventh _RARE_
intron O
sequence O
and O
alternative _RARE_
use O
of O
the O
splicing _RARE_
acceptor _RARE_
site O
at _RARE_
the O
12th _RARE_
exon _RARE_
. O

A O
complementary _RARE_
DNA O
was O
isolated O
from O
Caenorhabditis O
elegans O
that O
encoded O
a O
polypeptide O
of O
1438 _RARE_
amino O
acid O
residues O
, O
CeGAP _RARE_
, O
which O
contains O
a O
domain O
with O
sequence O
similarity _RARE_
to O
the O
COOH _RARE_
- I-GENE
terminal I-GENE
segment I-GENE
( I-GENE
GTPase I-GENE
- I-GENE
activating I-GENE
protein I-GENE
region I-GENE
) I-GENE
of O
Bcr _RARE_
and O
other O
known O
GTPase I-GENE
- I-GENE
activating I-GENE
proteins I-GENE
of O
the O
Rho I-GENE
subfamily I-GENE
. O

Additional _RARE_
exonuclease _RARE_
III I-GENE
protection O
was O
observed O
beyond O
the O
core O
region O
on O
both O
the O
5 O
' O
and O
3 O
' O
sides O
, O
suggesting O
that O
E1 I-GENE
interacted O
with O
more O
distal O
sequences O
as _RARE_
well _RARE_
. O

Repression _RARE_
is O
alleviated _RARE_
when O
the O
two O
( O
for _RARE_
E2 I-GENE
) O
or O
three O
( O
for _RARE_
E2 I-GENE
- I-GENE
C I-GENE
) O
promoter O
- O
proximal O
copies O
of O
E2 I-GENE
- O
RS _RARE_
are O
mutated _RARE_
. O

A O
mutant O
in O
the O
AAV _RARE_
terminal O
resolution O
site O
( O
trs _RARE_
) O
was O
defective _RARE_
for _RARE_
DNA O
replication O
in O
the O
in O
vitro O
assay O
. O

The O
results O
indicate O
that O
rep _RARE_
strongly O
enhances O
the O
function O
of O
negative O
regulatory O
elements O
of O
the O
LTR O
. O

However O
, O
artificially O
ventilated O
rats O
, O
pretreated O
with O
MK O
- O
801 O
, O
were O
more O
sensitive _RARE_
( O
lethal O
cocaine O
dose O
, O
76 _RARE_
. O
6 O
+/- O
8 O
. O
0 _RARE_
mg O
/ O
kg O
, O
n _RARE_
= O
5 O
) O
than O
vehicle O
pretreated O
rats O
( O
129 _RARE_
. O
4 O
+/- O
15 _RARE_
. O
8 O
mg O
/ O
kg O
, O
n _RARE_
= O
6 O
), _RARE_
indicating O
that O
MK O
- O
801 O
may O
increase O
both O
the O
respiratory O
and O
the O
cardiac O
toxicity O
of O
cocaine O
in O
urethane _RARE_
anesthetized O
rats O
. O

The O
Oct I-GENE
- I-GENE
3 I-GENE
/ I-GENE
4 I-GENE
gene I-GENE
product I-GENE
, O
which O
belongs O
to O
the O
POU I-GENE
family I-GENE
of I-GENE
transcription I-GENE
factors I-GENE
, O
is O
a O
good O
candidate O
for _RARE_
regulating _RARE_
initial O
differentiation O
decisions _RARE_
. O

Using O
site O
- O
directed O
mutagenesis O
, O
we O
show O
that O
the O
RAREoct _RARE_
contributes O
to O
the O
transcriptional O
activation O
of O
Oct I-GENE
- I-GENE
3 I-GENE
/ I-GENE
4 I-GENE
promoter I-GENE
in O
P19 O
cells O
and O
, O
most O
interestingly _RARE_
, O
mediates O
the O
RA _RARE_
- O
induced _RARE_
repression O
in O
RA _RARE_
- O
differentiated O
EC O
cells O
. O

176 _RARE_
: O
787 _RARE_
- O
792 _RARE_
, O
1992 O
; O
M O
. O

Furthermore O
, O
the O
negative O
transcriptional O
effect O
of O
COUP I-GENE
- I-GENE
TFs _RARE_
is O
dominant O
over O
the O
activating O
effect O
of O
the O
Oct4 _RARE_
embryonic _RARE_
stem _RARE_
cell I-GENE
- I-GENE
specific I-GENE
enhancer I-GENE
. O

Analysis O
of O
mig _RARE_
/ O
CAT I-GENE
chimeric O
constructs O
transiently O
transfected O
into O
the O
RAW _RARE_
264 O
. O
7 O
mouse O
monocytic O
cell O
line O
revealed O
a O
unique O
IFN I-GENE
- I-GENE
gamma I-GENE
- I-GENE
responsive I-GENE
element I-GENE
( O
gamma I-GENE
RE _RARE_
- I-GENE
1 I-GENE
). O

When O
expressed _RARE_
alone O
in O
test O
cells O
, O
Atr _RARE_
- I-GENE
I I-GENE
is O
unable O
to O
bind O
TGF I-GENE
- I-GENE
beta I-GENE
, O
activin I-GENE
, O
or O
bone I-GENE
morphogenetic _RARE_
protein I-GENE
2 I-GENE
. O

Therefore O
, O
Mxi1 _RARE_
and O
Mad _RARE_
might O
antagonize _RARE_
Myc _RARE_
function O
and O
are O
candidate O
tumor O
suppressor O
genes O
. O

To O
our O
knowledge O
, O
type O
IV O
renal _RARE_
tubular O
acidosis O
has O
not O
been O
reported O
previously O
in O
association O
with O
Alport _RARE_
' O
s O
syndrome _RARE_
in O
an O
adult O
patient O
. O

A O
cDNA O
clone O
was O
isolated O
from O
a O
chicken O
embryo _RARE_
cDNA O
library O
employing O
a O
PCR O
- O
generated O
radiolabeled O
probe O
specific O
for _RARE_
the O
U3 _RARE_
region I-GENE
of O
the O
Rous _RARE_
sarcoma I-GENE
virus I-GENE
LTR I-GENE
. O

Two O
basic O
patterns O
of O
locomotor O
behavior O
and O
corresponding O
torso _RARE_
morphology O
exist O
among O
extant _RARE_
anthropoids _RARE_
. O

Animal _RARE_
age O
and O
sex _RARE_
had O
no _RARE_
significant O
effects O
on O
CSF O
composition O
, O
but O
serum O
IgG I-GENE
concentration O
increased O
with O
age O
. O

Fast _RARE_
continuous O
expansion O
. O

A O
randomized O
, O
multicenter _RARE_
study O
comparing O
the O
efficacy O
and O
tolerability _RARE_
of O
tropisetron _RARE_
, O
a O
new O
5 I-GENE
- I-GENE
HT3 I-GENE
receptor I-GENE
antagonist O
, O
with O
a O
metoclopramide _RARE_
- O
containing O
antiemetic _RARE_
cocktail _RARE_
in O
the O
prevention O
of O
cisplatin O
- O
induced _RARE_
emesis _RARE_
. O

Each O
repeat O
consists O
of O
12 O
nt O
, O
coding O
for _RARE_
the O
reiterated _RARE_
sequence O
, O
K O
/ O
NPAG _RARE_
. O

ENV _RARE_
also O
was O
secreted _RARE_
from O
P O
. O
pastoris _RARE_
using O
the O
S I-GENE
. I-GENE
cerevisiae I-GENE
alpha I-GENE
- I-GENE
factor I-GENE
prepro _RARE_
secretion _RARE_
leader _RARE_
and O
the O
S I-GENE
. I-GENE
cerevisiae I-GENE
invertase _RARE_
signal I-GENE
sequence I-GENE
. O

BACKGROUND O
: O
To O
determine O
the O
predictors O
of O
desipramine O
- O
refractory O
depression O
, O
the O
authors O
examined O
the O
outcome O
in O
patients O
with O
major O
depression O
who O
were O
admitted _RARE_
to O
a O
general _RARE_
hospital O
and O
treated O
with O
desipramine O
adjusted O
to O
an O
adequate O
blood _RARE_
level O
. O

Analysis O
of O
the O
intact _RARE_
hGH I-GENE
gene I-GENE
or O
hGH I-GENE
5 I-GENE
'- I-GENE
flanking I-GENE
DNA I-GENE
( I-GENE
5 I-GENE
'- I-GENE
FR _RARE_
) I-GENE
coupled O
to O
the O
hGh _RARE_
cDNA I-GENE
or O
chloramphenicol I-GENE
acetyltransferase _RARE_
or O
luciferase I-GENE
genes I-GENE
, O
indicated O
that O
cAMP O
primarily O
stimulated _RARE_
hGH I-GENE
promoter I-GENE
activity O
. O

The O
predicted O
amino O
acid O
sequence O
of O
the O
SAP _RARE_
- I-GENE
1 I-GENE
cDNA I-GENE
showed O
that O
mature _RARE_
SAP _RARE_
- I-GENE
1 I-GENE
consisted O
of O
1093 _RARE_
amino O
acids _RARE_
and O
a O
transmembrane I-GENE
- I-GENE
type I-GENE
PTP I-GENE
, O
which O
possessed O
a O
single O
PTP I-GENE
- I-GENE
conserved _RARE_
domain I-GENE
in O
the O
cytoplasmic O
region O
. O

The O
following O
evidence O
indicates O
that O
the O
69 _RARE_
- O
kD _RARE_
protein O
is O
a O
common O
, O
rather O
than O
a O
U1 _RARE_
- O
specific O
, O
protein O
, O
possibly O
associating _RARE_
with O
the O
snRNP O
core O
particles _RARE_
by O
protein O
- O
protein O
interaction O
. O

Several O
features O
of O
10 O
. O
24 _RARE_
. O
6 O
cells O
suggest O
that O
the O
mutation O
disrupts _RARE_
normal O
intracellular _RARE_
formation O
of O
peptide I-GENE
/ I-GENE
DR _RARE_
complexes I-GENE
. O

This O
distribution O
parallels _RARE_
that O
of O
the O
neurotransmitters _RARE_
glutamate _RARE_
and O
aspartate _RARE_
; O
however O
, O
neither O
of O
these O
excitatory _RARE_
amino O
acids _RARE_
is O
a O
substrate O
for _RARE_
transport _RARE_
. O

The O
Harleco _RARE_
apparatus O
is O
a O
simple O
, O
useful O
, O
cost O
- O
effective O
adjunct _RARE_
to O
the O
diagnosis O
and O
treatment O
of O
this O
life O
- O
threatening _RARE_
condition O
. O

Co O
- O
transfection O
of O
expression _RARE_
vectors O
for _RARE_
CCAAT I-GENE
/ I-GENE
enhancer I-GENE
binding I-GENE
protein I-GENE
( I-GENE
C I-GENE
/ I-GENE
EBP I-GENE
) I-GENE
alpha I-GENE
and O
C I-GENE
/ I-GENE
EBP I-GENE
beta I-GENE
trans _RARE_
- O
activated O
the O
rat I-GENE
uncoupling _RARE_
protein I-GENE
gene I-GENE
promoter I-GENE
due O
to O
sequences O
in O
the O
5 O
' O
proximal O
region O
. O

It O
was O
not O
possible O
to O
study O
the O
basis O
for _RARE_
tissue O
- O
specific O
expression _RARE_
of O
this O
gene O
, O
because O
the O
beta I-GENE
3 I-GENE
gene I-GENE
promoter I-GENE
had O
not O
been O
isolated O
previously O
. O

Isolation O
and O
characterization O
of O
a O
TATA O
- O
less O
promoter O
for _RARE_
the O
human I-GENE
beta I-GENE
3 I-GENE
integrin I-GENE
gene I-GENE
. O

Subretinal _RARE_
fluid _RARE_
was O
punctured _RARE_
on O
the O
poorer _RARE_
eye O
in O
19 O
eyes O
( O
52 O
. O
7 O
%) O
and O
on O
the O
better O
eye O
in O
7 O
eyes O
( O
19 O
. O
4 O
%). O

These O
data O
indicate O
that O
activation O
of O
these O
enzymes _RARE_
is O
not O
sufficient O
for _RARE_
the O
acute O
stimulation _RARE_
of O
glucose O
transport _RARE_
. O

The O
inserted O
region O
, O
which O
represents O
an O
intron O
in O
brain O
and O
muscle O
, O
is O
expressed _RARE_
in O
the O
tumor O
cell O
lines O
either O
as _RARE_
a O
" O
readthrough O
" O
form O
or O
with O
78 _RARE_
residues O
deleted _RARE_
from O
its O
5 O
' O
end O
. O

Concordance _RARE_
of O
IBDQ _RARE_
scores O
was O
tested O
in O
280 _RARE_
stable O
subjects O
. O

Regression _RARE_
line O
slopes _RARE_
of O
IBDQ _RARE_
scores O
were O
significantly O
different O
in O
patients O
who O
deteriorated _RARE_
from O
those O
who O
remained O
stable O
([ _RARE_
b O
] O
< O
0 _RARE_
. O
15 _RARE_
; O
P O
< O
0 _RARE_
. O
0001 O
). O

Praziquantel _RARE_
and O
Albendazole _RARE_
were O
found O
effective O
in O
the O
treatment O
of O
neurocysticercosis _RARE_
, O
but O
because O
of O
serious O
side _RARE_
effects O
encountered _RARE_
in O
some O
cases O
, O
the O
drugs O
should O
be O
used O
cautiously _RARE_
in O
selected _RARE_
cases O
only O
. O

Inhibition O
of O
erythromycin _RARE_
synthesis _RARE_
by O
disruption O
of O
malonyl _RARE_
- I-GENE
coenzyme _RARE_
A I-GENE
decarboxylase I-GENE
gene I-GENE
eryM _RARE_
in O
Saccharopolyspora _RARE_
erythraea _RARE_
. O

This O
region O
is O
required O
for _RARE_
activation O
of O
DNA O
binding O
of O
MyoD I-GENE
and O
E12 I-GENE
homodimers I-GENE
and O
E12 I-GENE
/ O
MyoD I-GENE
heterodimers _RARE_
. O

Transcriptional O
analysis O
of O
a O
series O
of O
deletion O
mutants O
of O
the O
gene O
in O
the O
nuclear O
extracts O
prepared O
from O
the O
middle _RARE_
silk _RARE_
gland _RARE_
of O
2 O
- O
day O
- O
old O
fifth _RARE_
instar _RARE_
larvae O
revealed O
the O
presence O
of O
multiple O
cis O
- O
regulatory O
elements O
located _RARE_
both O
upstream O
and O
downstream _RARE_
of O
the O
initiation O
site O
. O

One O
of O
these O
elements O
, O
the O
homeodomain _RARE_
- I-GENE
binding I-GENE
element I-GENE
, O
was O
identified O
to O
mediate O
negative O
regulation _RARE_
. O

Site _RARE_
- O
directed O
mutagenesis O
of O
the O
traI _RARE_
structural I-GENE
gene I-GENE
and O
application O
of O
purified _RARE_
mutant O
TraI _RARE_
proteins I-GENE
for _RARE_
in O
vitro O
assays O
served _RARE_
to O
evaluate O
the O
functional _RARE_
importance O
of O
conserved _RARE_
amino O
acid O
residues O
. O

Concerted _RARE_
action O
of O
three O
distinct O
domains O
in O
the O
DNA O
cleaving _RARE_
- O
joining _RARE_
reaction O
catalyzed O
by O
relaxase _RARE_
( O
TraI _RARE_
) O
of O
conjugative _RARE_
plasmid _RARE_
RP4 _RARE_
. O

The O
COOH _RARE_
- O
terminal O
46 _RARE_
codons O
of O
slyD _RARE_
encode O
a O
remarkable O
histidine _RARE_
- O
rich O
peptide O
sequence O
which O
is O
at _RARE_
least O
partly O
dispensable O
for _RARE_
slyD _RARE_
function O
in O
E I-GENE
- O
mediated _RARE_
lysis O
. O

Monospecific _RARE_
antibodies O
raised O
against O
rat I-GENE
cytochrome I-GENE
P I-GENE
- I-GENE
450 _RARE_
1A1 _RARE_
recognized _RARE_
a O
protein O
in O
the O
hepatic _RARE_
microsomes _RARE_
of O
the O
double O
- O
crested _RARE_
cormorant _RARE_
, O
and O
also O
in O
those O
of O
the O
great O
blue O
heron _RARE_
( O
Ardea _RARE_
herodias _RARE_
), _RARE_
using O
immunoblotting _RARE_
. O

We O
studied O
GSH _RARE_
- O
Px _RARE_
enzyme O
activity O
in O
serum O
after O
acute O
myocardial _RARE_
infarction O
( O
AMI O
) O
and O
unstable O
angina O
pectoris O
( O
UAP _RARE_
). O

The O
HGF I-GENE
- O
induced _RARE_
cell O
motility _RARE_
was O
mimicked O
by O
12 O
- O
0 _RARE_
- O
tetradecanoyl _RARE_
- O
phorbol O
- O
13 _RARE_
- O
acetate _RARE_
, O
a O
protein I-GENE
kinase I-GENE
C I-GENE
- O
activating O
phorbol O
ester O
, O
but O
not O
by O
Ca2 _RARE_
+ O
ionophore _RARE_
. O

In O
addition O
, O
lexical _RARE_
priming _RARE_
was O
examined O
by O
presenting _RARE_
an O
identity O
prime _RARE_
earlier O
in O
the O
text _RARE_
. O

METHODS O
: O
Forty O
- O
nine O
cases O
with O
intrahepatic O
multiple O
nodules O
of O
HCC _RARE_
, O
by O
gross O
examination O
, O
among O
184 _RARE_
consecutive O
resected _RARE_
HCCs _RARE_
were O
examined O
clinicopathologically _RARE_
. O

In O
the O
present O
report O
, O
66 _RARE_
hemochromatosis _RARE_
families _RARE_
yielding _RARE_
151 O
hemochromatosis _RARE_
chromosomes O
and O
182 O
normal O
chromosomes O
were O
RFLP _RARE_
- O
typed _RARE_
with O
a O
battery O
of O
probes _RARE_
, O
including O
two O
newly O
derived O
polymorphic O
markers O
from O
the O
6 O
. O
7 O
and O
HLA I-GENE
- I-GENE
F I-GENE
loci I-GENE
located _RARE_
150 _RARE_
and O
250 _RARE_
kb O
telomeric O
to O
HLA I-GENE
- I-GENE
A I-GENE
, O
respectively O
. O

Pneumothorax _RARE_
during _RARE_
laparoscopic O
dissection O
of O
the O
diaphragmatic _RARE_
hiatus _RARE_
. O

Different _RARE_
cortical O
malformations O
were O
produced O
in O
rats O
by O
a O
single O
dose O
of O
X O
- O
rays O
( O
200 _RARE_
cGy _RARE_
) O
given O
on O
different O
days O
during _RARE_
gestation O
. O

T2 _RARE_
cancers O
should O
not O
be O
excluded O
from O
the O
benefit O
of O
preoperative O
irradiation O
. O

IFN I-GENE
alpha I-GENE
and O
IFN I-GENE
gamma I-GENE
inducibility O
is O
mediated _RARE_
by O
a O
single O
element O
: O
a O
high O
affinity O
, O
nearly O
palindromic O
version O
of O
the O
IFN I-GENE
gamma I-GENE
activation I-GENE
site I-GENE
( O
GAS _RARE_
). O

Mutations O
in O
the O
nuclear I-GENE
gene I-GENE
CBP1 _RARE_
of I-GENE
Saccharomyces I-GENE
cerevisiae I-GENE
result O
in O
degradation _RARE_
of O
mitochondrially _RARE_
encoded I-GENE
cytochrome I-GENE
b I-GENE
( O
cob _RARE_
) O
RNA O
; O
thus O
, O
the O
cells O
are O
unable O
to O
respire _RARE_
. O

Twenty O
- O
three O
sequence O
- O
tagged _RARE_
sites O
( O
STSs _RARE_
) O
were O
mapped O
within O
the O
contig O
, O
a O
density O
of O
approximately _RARE_
1 O
per O
200 _RARE_
kb O
. O

In O
this O
paper O
, O
we O
demonstrate O
that O
binding O
of O
the O
GA _RARE_
- I-GENE
binding I-GENE
protein I-GENE
( O
GABP I-GENE
) O
to O
ets I-GENE
sequence I-GENE
motifs I-GENE
within O
each O
repeated _RARE_
unit O
is O
required O
for _RARE_
transcriptional O
activation O
of O
the O
COXIV _RARE_
promoter I-GENE
. O

To O
gain O
further O
insight O
into O
the O
pathogenesis O
of O
the O
adult O
respiratory O
distress O
syndrome _RARE_
( O
ARDS O
), _RARE_
the O
authors O
studied O
possible O
relationships O
among O
the O
activation O
status O
of O
circulating O
polymorphonuclear _RARE_
neutrophils O
( O
PMN _RARE_
), _RARE_
cytokine _RARE_
levels O
, O
and O
the O
severity O
of O
lung _RARE_
injury O
in O
31 _RARE_
patients O
: O
15 _RARE_
with O
ARDS O
, O
9 O
with O
severe O
pneumonia O
uncomplicated _RARE_
by O
ARDS O
, O
and O
7 O
mechanically _RARE_
ventilated O
patients O
with O
neither O
ARDS O
nor O
pneumonia O
. O

Amiodarone _RARE_
, O
seldom _RARE_
used O
as _RARE_
first _RARE_
- O
line O
treatment O
, O
appears O
to O
be O
the O
most O
effective O
drug O
. O

These O
results O
demonstrate O
that O
dopamine I-GENE
receptor I-GENE
stimulation _RARE_
by O
different O
dopamine O
agonists O
produces O
a O
different O
pattern O
of O
effects O
on O
the O
characteristics O
of O
the O
reaction O
time O
response O
. O

Two O
experiments O
were O
conducted O
to O
study O
the O
vacuous _RARE_
jaw O
movements O
induced _RARE_
in O
rats O
by O
acute O
administration O
of O
the O
monoamine _RARE_
- O
depleting _RARE_
agent O
reserpine _RARE_
. O

Depletion _RARE_
of O
dopamine O
in O
the O
nucleus O
accumbens _RARE_
led O
to O
a O
dramatic O
shift O
in O
behavior O
in O
which O
there O
was O
a O
significant O
decrease O
in O
lever _RARE_
pressing _RARE_
but O
a O
significant O
increase O
in O
consumption O
of O
lab _RARE_
chow _RARE_
. O

We O
have O
investigated O
the O
influence O
of O
NaFe3 _RARE_
+ O
EDTA O
, O
and O
of O
increasing O
dietary O
levels O
of O
Na2EDTA _RARE_
, O
on O
Zn _RARE_
, O
Cu _RARE_
and O
Ca O
metabolism O
in O
rats O
fed O
on O
Zn _RARE_
- O
sufficient O
and O
Zn _RARE_
- O
deficient _RARE_
soya _RARE_
- O
bean _RARE_
- O
isolate O
- O
based O
diets O
. O

Recovery _RARE_
of O
carbimazole _RARE_
- O
induced _RARE_
agranulocytosis _RARE_
following O
recombinant I-GENE
granulocyte _RARE_
- I-GENE
macrophage I-GENE
colony I-GENE
stimulating I-GENE
factor I-GENE
( O
rhGM _RARE_
- I-GENE
CSF I-GENE
) O
administration O
. O

Thus O
, O
the O
system _RARE_
can O
be O
used O
to O
detect O
and O
study O
dynamic O
perfusion O
changes O
from O
the O
brain O
surface O
with O
minimal O
tissue O
damage O
. O

The O
neglect _RARE_
of O
Richards _RARE_
' O
s O
theory O
demonstrates O
the O
range O
of O
factors O
, O
other O
than O
the O
strictly O
scientific _RARE_
, O
which O
can O
be O
important O
in O
determining _RARE_
the O
influence O
or O
otherwise O
of O
a O
psychological O
theory O
. O

The O
positive O
- O
acting O
global O
sulfur O
regulatory O
protein O
, O
CYS3 _RARE_
, O
of O
Neurospora O
crassa O
turns _RARE_
on O
the O
expression _RARE_
of O
a O
family O
of O
unlinked _RARE_
structural O
genes O
that O
encode O
enzymes _RARE_
of O
sulfur O
catabolism O
. O

Analysis O
of O
the O
upstream O
untranslated _RARE_
region O
of O
CHL15 _RARE_
revealed O
the O
presence O
of O
the O
hexamer O
element O
, O
ACGCGT _RARE_
( O
an O
MluI _RARE_
restriction _RARE_
site I-GENE
) O
controlling O
both O
the O
periodic _RARE_
expression _RARE_
and O
coordinate O
regulation _RARE_
of O
the O
DNA O
synthesis _RARE_
genes O
in O
budding _RARE_
yeast O
. O

The O
C O
- O
terminal O
region O
of O
the O
150 _RARE_
- O
kDa O
protein O
contains O
an O
NTP _RARE_
- O
binding O
helicase _RARE_
motif I-GENE
and O
the O
readthrough O
region O
, O
an O
RNA I-GENE
polymerase I-GENE
motif I-GENE
, O
indicating O
that O
these O
two O
overlapping O
proteins O
may O
form O
an O
RNA O
replication O
complex O
similar O
to O
those O
of O
tobamo _RARE_
- O
and O
tobraviruses _RARE_
. O

The O
5 O
' O
ends O
of O
F3R _RARE_
late _RARE_
transcripts O
were O
located _RARE_
to O
an O
A O
within O
the O
sequence O
5 O
'- O
TAAAG _RARE_
, O
41 _RARE_
nt O
downstream _RARE_
from O
the O
early O
promoter O
and O
17 _RARE_
nt O
upstream O
from O
the O
initiation O
codon _RARE_
. O

On O
T2 _RARE_
weighted O
images O
, O
low O
intensity O
areas O
in O
the O
thalamus _RARE_
, O
the O
striatum _RARE_
, O
the O
anterior O
limb O
of O
the O
internal O
capsule _RARE_
, O
the O
tegmentum _RARE_
of O
midbrain _RARE_
, O
high O
intensity O
areas O
in O
middle _RARE_
cerebellar _RARE_
peduncle _RARE_
, O
the O
posterior O
limb O
of O
the O
internal O
capsule _RARE_
, O
the O
lateral O
part O
of O
the O
cerebral O
peduncle _RARE_
, O
and O
the O
cerebral O
white _RARE_
matter O
were O
noted O
. O

Using O
the O
rap1t _RARE_
alleles I-GENE
to O
generate O
wild O
- O
type O
cells O
differing _RARE_
only O
in O
telomere _RARE_
tract _RARE_
lengths O
, O
we O
also O
show O
that O
telomere _RARE_
position O
effects O
are O
highly O
sensitive _RARE_
to O
changes O
in O
the O
size O
( O
or O
structure _RARE_
) O
of O
the O
telomeric O
tract _RARE_
. O

Pronounced _RARE_
microangiopathy _RARE_
characterized O
by O
avascular _RARE_
fields O
, O
enlarged _RARE_
and O
tortuous _RARE_
capillaries O
and O
increased O
transcapillary _RARE_
diffusion O
of O
sodium _RARE_
fluorescein _RARE_
, O
was O
clearly O
demonstrable _RARE_
in O
the O
area O
of O
the O
nodules O
. O

Epigenetic _RARE_
switching O
of O
transcriptional O
states O
: O
cis O
- O
and O
trans _RARE_
- O
acting O
factors O
affecting O
establishment O
of O
silencing O
at _RARE_
the O
HMR I-GENE
locus I-GENE
in O
Saccharomyces O
cerevisiae O
. O

NF _RARE_
- I-GENE
kappa _RARE_
B I-GENE
p65 _RARE_
, O
p50 _RARE_
, O
and O
Rel I-GENE
functionally O
synergize _RARE_
with O
C I-GENE
/ I-GENE
EBP I-GENE
alpha I-GENE
, O
C I-GENE
/ I-GENE
EBP I-GENE
beta I-GENE
, O
and O
C I-GENE
/ I-GENE
EBP I-GENE
delta I-GENE
. O

It O
could O
be O
detected O
exclusively O
in O
the O
culture O
medium O
of O
cDNA O
- O
transfected O
COS O
cells O
. O

The O
first _RARE_
group O
of O
sequential O
BMB _RARE_
showed O
a O
significant O
progress O
to O
myelofibrosis _RARE_
in O
so O
- O
called O
" O
Chronic O
Megakaryocytic _RARE_
- O
Granulocytic _RARE_
Myelosis _RARE_
"-- _RARE_
CMGM _RARE_
-, _RARE_
which O
corresponds O
to O
Agnogenic _RARE_
Myeloid _RARE_
Metaplasia _RARE_
- O
AMM _RARE_
- O
in O
72 O
. O
4 O
% O
( O
21 O
/ O
29 O
patients O
), _RARE_
as _RARE_
well _RARE_
as _RARE_
in O
CML O
with O
megakaryocytic _RARE_
increase O
- O
CML O
. O
MI O
- O
in O
39 _RARE_
. O
2 O
% O
( O
20 O
/ O
51 _RARE_
). O

The O
two O
methods O
identify O
the O
same O
patients O
only O
if O
micturitional _RARE_
pressures O
are O
normal O
( O
40 O
to O
60 _RARE_
cmH2O O
) O
to O
high O
( O
over O
60 _RARE_
cmH2O O
) O
and O
the O
Sussett _RARE_
formula O
is O
used O
with O
a O
higher _RARE_
( O
95th _RARE_
centile _RARE_
) O
cutoff O
. O

There O
was O
no _RARE_
clear O
correlation O
between O
the O
MFA _RARE_
and O
the O
severity O
of O
the O
UTS _RARE_
phenotype _RARE_
. O

Chicken _RARE_
sterol I-GENE
carrier I-GENE
protein I-GENE
2 I-GENE
/ O
sterol I-GENE
carrier I-GENE
protein I-GENE
x _RARE_
: O
cDNA O
cloning O
reveals O
evolutionary O
conservation O
of O
structure _RARE_
and O
regulated O
expression _RARE_
. O

The O
plasmatic _RARE_
albumin I-GENE
concentration O
( O
3 O
. O
5 O
- O
4 O
. O
5 O
g O
/ O
dl O
) O
represents O
about O
60 _RARE_
% O
of O
the O
total _RARE_
plasma O
protein O
. O

These O
lesions O
were O
asymptomatic O
, O
but O
both O
were O
characterized O
clinically O
by O
central O
ulceration O
. O

A O
single O
five O
minute O
period O
of O
rapid O
atrial _RARE_
pacing O
fails O
to O
limit O
infarct O
size O
in O
the O
in O
situ O
rabbit _RARE_
heart _RARE_
. O

Neither O
RD19 _RARE_
nor O
RD21 _RARE_
mRNA I-GENE
synthesis _RARE_
was O
responsive O
to O
cold O
or O
to O
heat O
stress O
. O

Previous O
studies O
indicated O
that O
the O
20S I-GENE
proteasome I-GENE
is O
a O
catalytic O
core O
of O
the O
26S _RARE_
proteolytic _RARE_
complex I-GENE
that O
possesses O
a O
latent O
multicatalytic _RARE_
proteinase _RARE_
activity O
and O
catalyzes O
an O
ATP O
- O
dependent O
, O
selective O
breakdown _RARE_
of O
proteins O
ligated O
to O
ubiquitin I-GENE
. O

The O
O2 _RARE_
deficit O
was O
not O
related O
to O
blood _RARE_
lactate _RARE_
during _RARE_
submaximal _RARE_
exercise O
, O
muscle O
enzyme O
activity O
( O
citrate _RARE_
synthase I-GENE
, O
3 I-GENE
- I-GENE
hydroxyacyl _RARE_
- I-GENE
CoA I-GENE
- I-GENE
dehydrogenase I-GENE
, O
lactate _RARE_
dehydrogenase I-GENE
), _RARE_
number O
of O
muscle O
capillaries O
, O
% O
ST O
fibres O
or O
muscle O
buffer _RARE_
capacity O
. O

The O
sequence O
of O
the O
putative O
RBP1 _RARE_
protein I-GENE
contains O
two O
copies O
of O
an O
RNA O
recognition O
motif O
, O
two O
glutamine _RARE_
stretches O
, O
an O
asparagine _RARE_
- O
rich O
region O
, O
a O
methionine O
- O
rich O
region O
, O
and O
two O
long O
potential _RARE_
alpha O
- O
helixes _RARE_
. O

One O
defective _RARE_
RNA O
with O
a O
large O
deletion O
in O
the O
p70 I-GENE
coding I-GENE
region I-GENE
was O
able O
to O
replicate _RARE_
efficiently O
, O
both O
when O
inoculated O
with O
the O
helper _RARE_
genome O
and O
when O
inoculated O
with O
a O
second O
complementing _RARE_
defective _RARE_
RNA O
that O
supplied O
a O
wild I-GENE
- I-GENE
type I-GENE
p70 I-GENE
. O

Release _RARE_
of O
this O
selective O
pressure O
, O
however O
, O
gave O
way O
to O
homologous O
resolution O
of O
the O
cointegrate _RARE_
structures _RARE_
. O

Complete _RARE_
nucleotide O
sequence O
of O
the O
bacteriophage _RARE_
K1F _RARE_
tail _RARE_
gene I-GENE
encoding O
endo _RARE_
- I-GENE
N I-GENE
- I-GENE
acylneuraminidase _RARE_
( O
endo _RARE_
- I-GENE
N I-GENE
) O
and O
comparison O
to O
an O
endo _RARE_
- I-GENE
N I-GENE
homolog I-GENE
in O
bacteriophage _RARE_
PK1E _RARE_
. O

Binding O
of O
U2 _RARE_
small I-GENE
nuclear I-GENE
ribonucleoprotein I-GENE
was O
partially O
inhibited O
. O

Morphometrical _RARE_
quantification _RARE_
of O
brain O
edema O
related O
to O
experimental O
multiple O
micro O
- O
infarcts _RARE_
in O
mice O
: O
assessment O
of O
neurotropin _RARE_
effect O
. O

One O
member _RARE_
of O
this O
multigene _RARE_
family O
, O
GATA _RARE_
- I-GENE
3 I-GENE
, O
is O
most O
abundantly O
expressed _RARE_
in O
T O
lymphocytes O
, O
a O
cellular O
target O
for _RARE_
human O
immunodeficiency O
virus O
type O
1 O
( O
HIV O
- O
1 O
) O
infection O
and O
replication O
. O

Indeed O
, O
significant O
level O
of O
CAT I-GENE
activity O
was O
observed O
in O
human O
lung _RARE_
adenocarcinoma O
( O
A549 _RARE_
- O
1 O
) O
cells O
which O
had O
been O
incubated O
with O
a O
complex O
of O
T7 _RARE_
RNA I-GENE
polymerase I-GENE
, O
pT7 _RARE_
- I-GENE
EMC _RARE_
- I-GENE
CAT I-GENE
DNA I-GENE
and O
DC O
- O
chol _RARE_
cationic _RARE_
liposomes O
. O

Pneumoscrotum _RARE_
is O
a O
rare O
condition O
that O
receives _RARE_
little O
discussion O
in O
standard O
texts _RARE_
of O
urology _RARE_
. O

The O
first _RARE_
gene O
codes O
for _RARE_
a O
protein O
containing O
11 O
cystein _RARE_
residues O
in O
an O
arrangement O
typical O
for _RARE_
Fe _RARE_
/ I-GENE
S I-GENE
proteins I-GENE
. O

Triton _RARE_
- O
disrupted O
cells O
retained O
capacity O
for _RARE_
activation O
of O
the O
pathway _RARE_
by O
both O
peptide O
growth O
factors O
and O
by O
addition O
of O
GTP O
- O
loaded _RARE_
p21 I-GENE
rasVal12 _RARE_
. O

To O
begin O
to O
examine O
the O
mechanism O
controlling O
expression _RARE_
of O
this O
gene O
during _RARE_
the O
cell O
- O
cycle _RARE_
, O
a O
mouse I-GENE
B I-GENE
- I-GENE
myb I-GENE
5 I-GENE
' I-GENE
flanking I-GENE
sequence I-GENE
was O
isolated O
from O
a O
cosmid O
library O
and O
shown O
to O
promote O
efficiently O
the O
transcription O
of O
a O
luciferase I-GENE
reporter I-GENE
gene I-GENE
when O
transfected O
into O
NIH3T3 O
fibroblasts _RARE_
. O

The O
influence O
of O
a O
high O
ionic O
strength O
on O
the O
resolution O
was O
clearly O
shown O
. O

The O
number O
of O
bacteria O
in O
the O
lung _RARE_
, O
peripheral O
white _RARE_
blood _RARE_
cell O
and O
BAL _RARE_
fluid _RARE_
cell O
also O
decreased O
by O
the O
administration O
of O
FN I-GENE
. O

In O
mice O
, O
three O
major O
families _RARE_
of O
L1 O
elements O
, O
termed O
" O
A O
," O
" O
F O
," O
and O
" O
V O
," O
have O
been O
defined O
on O
the O
basis O
of O
the O
sequence O
found O
at _RARE_
the O
5 O
' O
terminus O
. O

TFEC _RARE_
, O
a O
basic I-GENE
helix I-GENE
- I-GENE
loop I-GENE
- I-GENE
helix I-GENE
protein I-GENE
, O
forms O
heterodimers _RARE_
with O
TFE3 _RARE_
and O
inhibits O
TFE3 _RARE_
- O
dependent O
transcription O
activation O
. O

The O
equivalent O
of O
the O
third O
ligand _RARE_
, O
H O
- O
87 O
, O
is O
T O
- O
47 _RARE_
in O
the O
PSTAIRE _RARE_
sequence O
motif O
. O

Similar O
results O
were O
seen O
on O
Western O
blots O
of O
Autographa _RARE_
californica _RARE_
MNPV _RARE_
( O
AcMNPV _RARE_
)- O
infected _RARE_
Spodoptera _RARE_
frugiperda _RARE_
cells O
. O

In O
infected _RARE_
mammalian O
cells O
, O
the O
ARV _RARE_
G I-GENE
and O
GNS _RARE_
genes I-GENE
are O
transcribed _RARE_
primarily O
as _RARE_
a O
polycistronic _RARE_
mRNA O
which O
appears O
to O
extend O
from O
the O
consensus O
sequence O
( O
AACAG _RARE_
) O
at _RARE_
the O
start _RARE_
of O
the O
G I-GENE
gene I-GENE
to O
the O
next O
recognized _RARE_
polyadenylation O
signal O
( O
CATG _RARE_
[ _RARE_
A O
] O
7 O
) O
located _RARE_
697 _RARE_
nucleotides O
downstream _RARE_
of O
the O
GNS _RARE_
protein I-GENE
termination _RARE_
codon _RARE_
. O

Molecular O
cloning O
and O
expression _RARE_
of O
RPE65 _RARE_
, O
a O
novel O
retinal _RARE_
pigment _RARE_
epithelium O
- O
specific O
microsomal _RARE_
protein O
that O
is O
post O
- O
transcriptionally O
regulated O
in O
vitro O
. O

The O
mean O
power O
( O
in O
mu O
W _RARE_
) O
required O
to O
produce O
the O
observed O
flow O
rate O
was O
estimated O
at _RARE_
each O
outflow O
pressure O
as _RARE_
the O
product O
of O
the O
flow O
rate O
and O
the O
pressure O
across O
the O
lymphatic _RARE_
vessel O
. O

Although O
antisperm _RARE_
antibodies O
are O
associated O
with O
infertility O
, O
many O
hospital O
laboratories O
do O
not O
test O
for _RARE_
these O
antibodies O
. O

PPD _RARE_
- O
specific O
IgG I-GENE
subclass _RARE_
responses O
were O
evident O
to O
all O
four O
IgG I-GENE
subclasses _RARE_
. O

Anterior _RARE_
body O
pattern O
in O
Drosophila O
is O
specified O
by O
the O
graded _RARE_
distribution O
of O
the O
bicoid _RARE_
protein I-GENE
( O
bcd _RARE_
), _RARE_
which O
activates O
subordinate _RARE_
genes O
in O
distinct O
anterior O
domains O
. O

GAP _RARE_
- I-GENE
N I-GENE
bound _RARE_
constitutively O
to O
p190 I-GENE
in O
both O
serum O
- O
deprived O
and O
growth O
factor O
- O
stimulated _RARE_
cells O
. O

The O
peptide O
sequence O
contains O
a O
region O
of O
80 _RARE_
amino O
acids _RARE_
that O
shows O
similarity _RARE_
to O
bcl I-GENE
- I-GENE
2 I-GENE
and O
to O
the O
recently O
described O
bcl I-GENE
- I-GENE
2 I-GENE
- I-GENE
related I-GENE
gene I-GENE
, O
MCL1 _RARE_
. O

The O
phosphorylation _RARE_
efficiency O
is O
improved O
by O
increasing O
the O
number O
of O
N O
- O
terminal O
arginine _RARE_
residues O
and O
by O
moving _RARE_
the O
arginyl _RARE_
cluster O
one O
residue _RARE_
further O
away _RARE_
from O
the O
serine O
, O
the O
nonapeptide _RARE_
( O
Arg O
) O
4 O
- O
Ala _RARE_
- O
Ala _RARE_
- O
Ser _RARE_
- O
Val _RARE_
- O
Ala _RARE_
being O
the O
best O
substrate O
among O
all O
the O
short O
peptides O
tested O
( O
Km _RARE_
= O
15 _RARE_
microM O
). O

Botulinum _RARE_
toxin _RARE_
: O
preferred O
treatment O
for _RARE_
hemifacial _RARE_
spasm _RARE_
. O

The O
Saccharomyces I-GENE
cerevisiae I-GENE
GAL1 _RARE_
and O
GAL10 _RARE_
genes I-GENE
are O
controlled _RARE_
in O
response O
to O
the O
availability O
of O
galactose _RARE_
and O
glucose O
by O
multiple O
activating O
and O
repressing O
proteins O
bound _RARE_
at _RARE_
adjacent O
or O
overlapping O
sites O
in O
UASG _RARE_
. O

Surprisingly O
, O
the O
results O
of O
several O
experiments O
suggest O
that O
the O
TSF _RARE_
genes I-GENE
encode O
global O
regulatory O
factors O
. O
tsf1 _RARE_
to O
tsf6 _RARE_
mutations O
derepressed _RARE_
expression _RARE_
from O
yeast O
CYC _RARE_
- O
GAL _RARE_
hybrid _RARE_
promoters O
( O
fused O
to O
lacZ I-GENE
) O
that O
harbor O
a O
variety O
of O
operator O
sequences O
, O
and O
caused O
pleiotropic O
defects O
in O
cell O
growth O
, O
mating _RARE_
, O
and O
sporulation _RARE_
. O

Sex _RARE_
of O
calf _RARE_
( O
variate _RARE_
2 O
) O
was O
associated O
most O
closely O
with O
width _RARE_
of O
muzzle _RARE_
and O
head O
. O

Sequence O
comparison O
indicates O
that O
exons O
5 O
'/ _RARE_
L O
and O
L O
/ O
N O
in O
PSG12 _RARE_
and O
PSG12 _RARE_
psi I-GENE
are O
99 _RARE_
% O
identical O
, O
except O
that O
the O
L O
/ O
N O
exon _RARE_
in O
the O
PSG12 _RARE_
psi I-GENE
gene I-GENE
contains O
a O
stop O
codon _RARE_
. O

The O
mechanisms O
that O
govern O
the O
activation O
or O
suppression O
of O
the O
CD8 _RARE_
gene I-GENE
are O
likely O
to O
be O
central O
to O
the O
T O
cell O
development O
program O
. O

We O
suggest O
that O
the O
ER O
lumenal _RARE_
variable _RARE_
domain O
of O
gp19K _RARE_
has O
a O
specific O
tertiary O
structure _RARE_
that O
is O
important O
for _RARE_
binding O
to O
the O
polymorphic O
alpha O
1 O
and O
alpha O
2 O
domains O
of O
class I-GENE
I I-GENE
heavy I-GENE
( I-GENE
alpha I-GENE
) I-GENE
chains I-GENE
. O

We O
recently O
found O
that O
17 _RARE_
beta O
- O
estradiol O
( O
E2 O
) O
not O
only O
suppresses O
bone O
resorption O
but O
also O
stimulates O
bone O
formation O
in O
the O
cancellous _RARE_
bone O
of O
female O
rats O
. O

Recombinant I-GENE
human I-GENE
erythropoietin I-GENE
( O
epoetin _RARE_
) O
is O
approved _RARE_
to O
be O
administered O
by O
the O
intravenous O
( O
i O
. O
v O
.) O
or O
subcutaneous O
( O
SC O
) O
route O
. O

Single _RARE_
- O
photon O
emission O
computed O
tomography O
( O
SPECT O
) O
with O
99mTc O
- O
hexamethylpropyleneamine _RARE_
oxime _RARE_
( O
HMPAO O
) O
was O
used O
to O
investigate O
changes O
in O
cerebral O
blood _RARE_
flow O
in O
seven _RARE_
patients O
with O
cortical O
visual O
impairment O
. O

The O
rCBF O
ratio O
was O
mainly O
reduced _RARE_
in O
frontal O
lobes _RARE_
( O
65 O
%). O

METHODS O
: O
Twenty O
- O
two O
patients O
were O
grouped _RARE_
according O
to O
their O
etiology O
based O
on O
the O
study O
of O
antiadrenal _RARE_
antibodies O
at _RARE_
diagnosis O
of O
the O
disease _RARE_
: O
7 O
were O
positive O
( O
autoimmune _RARE_
etiology O
or O
EAA _RARE_
), _RARE_
11 O
were O
negative O
( O
tuberculous O
etiology O
or O
EAT _RARE_
) O
and O
in O
four O
serologic O
study O
was O
not O
available O
( O
undetermined _RARE_
etiology O
or O
EAI _RARE_
). O

2 O
- O
AP O
induced _RARE_
marked O
, O
steady O
rises _RARE_
in O
mRNA O
accumulation O
from O
both O
transfected O
and O
chromosomally _RARE_
integrated O
HIV O
- O
1 O
constructs O
but O
no _RARE_
increases O
from O
an O
endogenous O
gene O
encoding O
gamma I-GENE
- I-GENE
actin I-GENE
or O
glucose I-GENE
6 I-GENE
- I-GENE
phosphate I-GENE
dehydrogenase I-GENE
. O

The O
UV _RARE_
induction O
of O
c I-GENE
- I-GENE
jun I-GENE
is O
mediated _RARE_
by O
two O
UV _RARE_
response O
elements O
consisting O
of O
AP I-GENE
- I-GENE
1 I-GENE
- I-GENE
like I-GENE
sequences I-GENE
within O
its O
5 O
' O
control O
region O
. O

Protein I-GENE
tyrosine I-GENE
phosphatases _RARE_
( O
PTPs _RARE_
), _RARE_
together O
with O
protein I-GENE
tyrosine I-GENE
kinases I-GENE
( O
PTKs _RARE_
), _RARE_
are O
involved O
in O
the O
regulation _RARE_
of O
cell O
activation O
, O
growth O
, O
and O
differentiation O
. O

ST O
elevation O
occurs O
in O
5 O
patients O
( O
55 _RARE_
. O
5 O
%) O
of O
subgroup O
A O
and O
in O
no _RARE_
patient O
of O
the O
subgroup O
B O
. O

Furthermore O
, O
a O
p21X _RARE_
protein I-GENE
lacking _RARE_
the O
N O
- O
terminus O
of O
Rex1 _RARE_
was O
expressed _RARE_
at _RARE_
high O
levels O
; O
our O
data O
indicate O
that O
p21X _RARE_
is O
translated O
from O
the O
1 O
. O
6 O
- O
kb O
mRNA O
which O
is O
derived O
primarily O
from O
deleted _RARE_
proviruses _RARE_
. O

HTLV _RARE_
- O
1 O
gene O
expression _RARE_
by O
defective _RARE_
proviruses _RARE_
in O
an O
infected _RARE_
T O
- O
cell O
line O
. O

Thus O
, O
it O
was O
confirmed O
that O
the O
sodium _RARE_
lauryl _RARE_
sulfate _RARE_
method O
of O
estimating O
hemoglobin I-GENE
concentration O
is O
an O
appropriate O
alternative _RARE_
to O
the O
cyanmethemoglobin _RARE_
method O
and O
avoids _RARE_
the O
generation O
of O
toxic O
wastes _RARE_
. O

A O
comparison O
of O
the O
predicted O
amino O
acid O
sequences O
of O
the O
two O
human I-GENE
PKC I-GENE
- I-GENE
delta I-GENE
clones _RARE_
with O
the O
rat O
and O
mouse O
homologues _RARE_
indicated O
a O
greater O
degree O
of O
sequence O
divergence O
( O
89 _RARE_
- O
90 _RARE_
% O
homology O
) O
compared O
to O
the O
high O
degree O
of O
sequence O
conservation O
observed O
with O
other O
human I-GENE
PKC I-GENE
family I-GENE
members I-GENE
and O
their O
mammalian O
counterparts O
. O

XII _RARE_
. O

When O
comparing O
the O
barley _RARE_
PSI I-GENE
- I-GENE
K I-GENE
and O
PSI I-GENE
- I-GENE
G I-GENE
with O
the O
reported O
PSI I-GENE
- I-GENE
K I-GENE
sequence I-GENE
from I-GENE
Synechococcus _RARE_
vulcanus _RARE_
, O
the O
degree O
of O
similarity _RARE_
is O
equal O
, O
suggesting O
that O
an O
ancestral O
gene O
has O
been O
duplicated O
in O
a O
chloroplast O
progenitor _RARE_
but O
not O
in O
a O
cyanobacterial _RARE_
. O

On O
the O
other O
hand _RARE_
, O
the O
structures _RARE_
of O
the O
b O
- O
Zip _RARE_
domain O
are O
well _RARE_
conserved _RARE_
among O
these O
Maf I-GENE
- I-GENE
related I-GENE
proteins I-GENE
. O

Under O
these O
conditions O
, O
transfections O
with O
cDNAs O
of O
the O
NF _RARE_
- I-GENE
kappa _RARE_
B I-GENE
p50 _RARE_
and O
serum I-GENE
response I-GENE
factor I-GENE
( O
SRF I-GENE
) O
produced O
a O
factor O
( O
s O
) O
that O
mediated _RARE_
Tax _RARE_
binding O
to O
the O
NF _RARE_
- I-GENE
kappa _RARE_
B I-GENE
site I-GENE
and O
the O
CArG _RARE_
box O
respectively O
. O

We O
show O
here O
that O
v I-GENE
- I-GENE
Rel I-GENE
specifically O
increased O
expression _RARE_
from O
a O
reporter O
plasmid _RARE_
containing O
multiple O
Sp1 _RARE_
binding I-GENE
sites I-GENE
approximately _RARE_
sixfold _RARE_
in O
chicken O
embryo _RARE_
fibroblasts _RARE_
( O
CEFs _RARE_
), _RARE_
even O
though O
v I-GENE
- I-GENE
Rel I-GENE
did O
not O
bind O
directly O
to O
these O
sites O
. O
v I-GENE
- I-GENE
Rel I-GENE
also O
increased O
expression _RARE_
from O
a O
reporter O
plasmid _RARE_
containing O
a O
human I-GENE
immunodeficiency I-GENE
virus I-GENE
type I-GENE
1 I-GENE
( I-GENE
HIV I-GENE
- I-GENE
1 I-GENE
) I-GENE
long I-GENE
terminal I-GENE
repeat I-GENE
( O
LTR O
) O
in O
which O
the O
kappa _RARE_
B I-GENE
binding I-GENE
sites I-GENE
were O
mutated _RARE_
but O
which O
still O
contained O
intact _RARE_
Sp1 _RARE_
binding I-GENE
sites I-GENE
. O

The O
simultaneous O
recording O
of O
electrical O
activity O
from O
the O
surface O
electrocardiogram O
, O
right O
ventricular O
apex O
, O
His _RARE_
bundle O
, O
high O
right O
atrium O
, O
coronary O
sinus O
, O
with O
or O
without O
a O
roving _RARE_
mapping O
catheter O
, O
enables O
us O
to O
precisely O
map O
the O
electrical O
activation O
sequence O
in O
the O
heart _RARE_
. O

CONCLUSION O
: O
This O
retrospective O
analysis O
does O
not O
confirm O
the O
efficacy O
of O
one O
course O
of O
simultaneous O
Mitomycin _RARE_
- O
C O
and O
5 O
- O
fluorouracil O
, O
at _RARE_
least O
in O
association O
with O
full O
- O
dose O
radiotherapy O
incorporating _RARE_
Iridium _RARE_
- O
192 _RARE_
boost _RARE_
. O

Despite O
the O
existence O
of O
30 _RARE_
cysteine O
residues O
, O
carboxymethylation _RARE_
prevented O
the O
formation O
of O
most O
if O
not O
all O
disulfide O
bonds O
that O
otherwise O
occurred O
when O
the O
cells O
were O
sonicated _RARE_
. O

Cerebro _RARE_
- O
oculo _RARE_
- O
facioskeletal _RARE_
syndrome _RARE_
( O
Pena _RARE_
- O
Shokeir _RARE_
syndrome _RARE_
II O
) O

Most O
importantly _RARE_
, O
the O
addition O
of O
purified _RARE_
17S _RARE_
U2 _RARE_
snRNPs _RARE_
, O
but O
not O
of O
12S _RARE_
U2 _RARE_
snRNPs _RARE_
, O
to O
HeLa O
splicing _RARE_
extracts O
in O
which O
the O
endogeneous _RARE_
U2 _RARE_
snRNPs _RARE_
have O
been O
functionally O
neutralized _RARE_
with O
anti I-GENE
- I-GENE
PRP9 _RARE_
antibodies I-GENE
fully O
restores O
the O
mRNA O
- O
splicing _RARE_
activity O
of O
the O
extracts O
. O

Differences _RARE_
in O
profiles O
of O
viscosity O
variables O
between O
subgroups O
of O
EAD _RARE_
in O
RA _RARE_
patients O
were O
observed O
. O

These O
contain O
a O
single O
1977 _RARE_
- O
bp O
exon _RARE_
that O
encodes O
900 _RARE_
bp O
of O
the O
5 O
' O
and O
3 O
' O
untranslated _RARE_
sequences O
in O
addition O
to O
a O
1077 _RARE_
- O
bp O
open _RARE_
reading O
frame O
identical O
to O
that O
found O
in O
vascular I-GENE
smooth _RARE_
muscle I-GENE
cell I-GENE
AT1a _RARE_
receptor I-GENE
cDNAs I-GENE
. O

Deletion O
of O
a O
53 O
- O
bp O
early O
promoter O
region O
containing O
the O
transcription O
start _RARE_
site O
and O
a O
putative O
TATA O
box O
completely O
abolishes O
the O
ability O
of O
upstream O
elements O
to O
drive O
transcription O
of O
the O
luciferase I-GENE
cDNA I-GENE
. O

One O
chimpanzee _RARE_
reliably _RARE_
selected _RARE_
the O
larger O
numeral _RARE_
4 O
during _RARE_
testing O
with O
a O
nonadjacent _RARE_
pair _RARE_
( O
2 O
- O
4 O
), _RARE_
and O
2 O
chimps _RARE_
showed O
no _RARE_
preference O
. O

Dissipation _RARE_
of O
claudication _RARE_
pain O
after O
walking _RARE_
: O
implications O
for _RARE_
endurance _RARE_
training O
. O

Alternative O
transcript O
of O
the O
nonselective _RARE_
- O
type O
endothelin I-GENE
receptor I-GENE
from O
rat O
brain O
. O

The O
Functional O
Independence _RARE_
Measure _RARE_
: O
a O
comparative O
study O
of O
clinician _RARE_
and O
self O
ratings _RARE_
. O

Polymyxin _RARE_
B O
was O
given O
intravenously O
for _RARE_
1 O
week O
postburn _RARE_
in O
doses O
designed O
to O
neutralize _RARE_
circulating O
endotoxemia _RARE_
. O

SvO2 _RARE_
can O
be O
determined O
in O
vitro O
and O
in O
vivo O
. O

The O
transverse O
relaxation O
time O
( O
T2 _RARE_
) O
and O
apparent O
diffusion O
coefficient O
of O
water O
were O
determined O
. O

The O
Drosophila O
clathrin I-GENE
heavy I-GENE
chain I-GENE
gene O
: O
clathrin I-GENE
function O
is O
essential O
in O
a O
multicellular _RARE_
organism O
. O

The O
binding O
specificity _RARE_
of O
this O
protein O
was O
compared O
to O
that O
of O
human I-GENE
E2F I-GENE
using O
a O
number O
of O
mutant I-GENE
E2F I-GENE
sites I-GENE
as _RARE_
competitors _RARE_
. O

To O
analyze O
the O
VH _RARE_
regions O
of O
polyreactive _RARE_
antibodies O
, O
with O
particular O
attention O
at _RARE_
their O
somatically _RARE_
mutated _RARE_
status O
, O
we O
generated O
five O
IgG I-GENE
( O
three O
IgG1 _RARE_
and O
two O
IgG3 _RARE_
) O
mAb _RARE_
( O
using O
B O
cells O
from O
a O
healthy O
subject O
, O
a O
patient O
with O
insulin I-GENE
- O
dependent O
diabetes O
mellitus O
and O
a O
patient O
with O
SLE O
), _RARE_
which O
bound _RARE_
with O
various O
efficiencies _RARE_
a O
number O
of O
different O
self O
and O
foreign O
Ag _RARE_
. O

It O
is O
possible O
that O
the O
patch O
determines _RARE_
the O
proper O
conformation O
of O
the O
site O
and O
thereby O
contributes O
to O
recognition O
indirectly O
. O

These O
findings O
suggest O
a O
functional _RARE_
cross O
- O
talk _RARE_
between O
RB _RARE_
protein I-GENE
and O
p21ras I-GENE
, O
which O
balances _RARE_
the O
cell O
phenotype _RARE_
between O
normal O
and O
transformed O
states O
. O

The O
7 O
- O
kb O
mRNA O
differs O
by O
alternative _RARE_
splicing _RARE_
such O
that O
it O
encodes O
a O
protein O
with O
a O
distinct O
amino O
terminus O
. O

Kinetics _RARE_
of O
the O
inhibition O
indicated O
that O
this O
polymerase O
domain O
can O
inhibit O
viral O
replication O
only O
during _RARE_
the O
preinitiation _RARE_
stage _RARE_
. O

The O
other O
transmembrane O
regions O
as _RARE_
well _RARE_
as _RARE_
the O
nucleoplasmic _RARE_
domain O
are O
not O
required O
for _RARE_
sorting _RARE_
. O

3 O
. O

McCann _RARE_
III O
, O
F O
. O

These O
cell O
lines O
, O
selected _RARE_
for _RARE_
the O
ability O
to O
support O
the O
replication O
of O
a O
temperature _RARE_
- O
sensitive _RARE_
VP5 _RARE_
mutant I-GENE
, O
were O
used O
to O
isolate O
VP5 _RARE_
and O
VP23 _RARE_
null _RARE_
mutants O
. O

The O
E1 I-GENE
nuclear I-GENE
transport _RARE_
motif I-GENE
is O
highly O
conserved _RARE_
in O
the O
animal _RARE_
and O
human O
papillomaviruses _RARE_
and O
is O
encoded O
in O
a O
similar O
region O
in O
the O
related O
E1 I-GENE
genes I-GENE
. O

The O
E1 I-GENE
replication I-GENE
protein I-GENE
of O
bovine O
papillomavirus _RARE_
type O
1 O
contains O
an O
extended O
nuclear O
localization _RARE_
signal O
that O
includes O
a O
p34cdc2 I-GENE
phosphorylation _RARE_
site O
. O

In O
order O
to O
investigate O
to O
what O
extent O
this O
interaction O
might O
contribute O
to O
tumor O
induction O
by O
the O
virus O
, O
we O
have O
introduced O
two O
different O
point O
mutations O
within O
the O
putative O
pRb I-GENE
- I-GENE
binding I-GENE
sequence I-GENE
of O
large I-GENE
T I-GENE
antigen I-GENE
, O
and O
as _RARE_
a O
preliminary O
to O
in O
vivo O
experiments O
we O
have O
studied O
their O
effects O
in O
vitro O
on O
some O
biological O
activities O
relevant O
to O
tumor O
induction O
. O

We O
conclude O
that O
the O
conservation O
of O
nucleotides O
154 O
to O
156 _RARE_
is O
likely O
to O
be O
a O
consequence O
of O
their O
role O
as _RARE_
a O
sequence O
- O
specific O
recognition O
element O
for _RARE_
the O
SRP54 _RARE_
protein I-GENE
. O

A O
region O
of O
the O
deduced O
protein O
shares O
extensive O
homology O
with O
a O
catalytic O
region O
of O
Raf I-GENE
kinases I-GENE
, O
a O
feature O
shared O
only O
with O
TFIIE _RARE_
among O
transcription O
factors O
. O

The O
low O
molecular _RARE_
mass O
polypeptide O
complex O
is O
assumed O
to O
be O
involved O
in O
antigen O
presentation O
, O
generating O
peptides O
from O
cytosolic O
protein O
antigens O
, O
which O
are O
subsequently O
presented O
to O
cytotoxic O
T O
- O
lymphocytes O
on O
the O
cell O
surface O
. O

Secondary _RARE_
cleavage _RARE_
of O
RT I-GENE
at _RARE_
Trp _RARE_
- O
595 _RARE_
- O
Tyr _RARE_
- O
596 _RARE_
of O
Pol I-GENE
yields O
a O
truncated O
form O
lacking _RARE_
the O
C I-GENE
- I-GENE
terminal I-GENE
RNase I-GENE
H I-GENE
domain I-GENE
. O

The O
C O
- O
terminal O
approximately _RARE_
50 O
amino O
acids _RARE_
of O
Bel _RARE_
- I-GENE
1 I-GENE
are O
shown O
to O
be O
essential O
for _RARE_
Bel _RARE_
- I-GENE
1 I-GENE
activity O
but O
can O
be O
effectively O
substituted O
by O
the O
C O
- O
terminal O
activation O
domain O
of O
VP16 I-GENE
. O

Since O
the O
- O
172 _RARE_
/- O
148 _RARE_
element O
also O
conferred O
estrogen O
and O
thyroid O
hormone O
responsiveness O
, O
it O
can O
be O
considered O
a O
composite O
hormone O
response O
element O
. O

Optimal _RARE_
activation O
of O
T O
cells O
requires O
at _RARE_
least O
two O
signals O
. O

Together O
with O
a O
considerably O
shortened O
and O
interrupted O
aromatic O
aa _RARE_
stretch O
in O
this O
region O
, O
these O
differences O
are O
discussed O
in O
terms O
of O
the O
peculiar _RARE_
affinity O
of O
cyanobacterial _RARE_
cytochrome I-GENE
oxidases _RARE_
for _RARE_
acidic _RARE_
c I-GENE
- I-GENE
type I-GENE
cytochromes _RARE_
. O

All O
four O
of O
the O
genes O
have O
a O
similar O
structure _RARE_
, O
with O
the O
receptor O
protein O
encoded O
in O
a O
single O
exon _RARE_
. O

Identity _RARE_
of O
GABP I-GENE
with O
NRF _RARE_
- I-GENE
2 I-GENE
, O
a O
multisubunit _RARE_
activator O
of O
cytochrome I-GENE
oxidase I-GENE
expression _RARE_
, O
reveals O
a O
cellular O
role O
for _RARE_
an O
ETS _RARE_
domain I-GENE
activator O
of O
viral O
promoters O
. O

In O
the O
present O
study O
, O
beta O
- O
funaltrexamine _RARE_
( O
beta O
- O
FNA _RARE_
) O
and O
naltrindole _RARE_
( O
NTI _RARE_
) O
( O
nonequilibrium _RARE_
mu O
- O
and O
delta O
- O
antagonist O
, O
respectively O
) O
were O
used O
to O
precipitate _RARE_
withdrawal O
in O
butorphanol _RARE_
- O
dependent O
rats O
. O

The O
intracellular _RARE_
basic I-GENE
region I-GENE
/ I-GENE
helix I-GENE
- I-GENE
loop I-GENE
- I-GENE
helix I-GENE
( I-GENE
bHLH I-GENE
) I-GENE
dioxin _RARE_
receptor I-GENE
mediates O
signal O
transduction _RARE_
by O
dioxin _RARE_
( O
2 O
, O
3 O
, O
7 O
, O
8 O
- O
tetrachlorodibenzo _RARE_
- O
p O
- O
dioxin _RARE_
) O
and O
functions O
as _RARE_
a O
ligand _RARE_
- O
activated O
DNA O
binding O
protein O
directly O
interacting _RARE_
with O
target O
genes O
by O
binding O
to O
dioxin _RARE_
response O
elements O
. O

The O
alpha I-GENE
2A _RARE_
- I-GENE
adrenergic I-GENE
receptor I-GENE
( O
alpha I-GENE
2AAR _RARE_
) O
is O
coupled O
to O
a O
variety O
of O
effectors _RARE_
via O
pertussis _RARE_
toxin _RARE_
- O
sensitive _RARE_
GTP I-GENE
- I-GENE
binding I-GENE
proteins I-GENE
. O

A O
sequence O
comparison O
reveals O
two O
CCAAT I-GENE
/ I-GENE
enhancer I-GENE
binding I-GENE
protein I-GENE
( O
C I-GENE
/ I-GENE
EBP I-GENE
) O
consensus O
sequences O
, O
basic O
DNA O
binding O
region O
and O
leucine O
zippers _RARE_
1 O
and O
2 O
( O
bZIP1 _RARE_
and O
bZIP2 _RARE_
), _RARE_
within O
this O
region O
. O

One O
of O
these O
genes O
, O
REC114 _RARE_
, O
is O
described O
here O
, O
and O
the O
data O
confirm O
that O
REC114 _RARE_
is O
a O
meiosis O
- O
specific O
recombination _RARE_
gene O
with O
no _RARE_
detectable O
function O
in O
mitosis O
. O

The O
transactivation _RARE_
function O
of O
EBNA2 I-GENE
was O
also O
observed O
in O
the O
HeLa O
epithelial _RARE_
cell O
line O
, O
which O
suggests O
that O
EBV _RARE_
and O
HIV O
- O
1 O
infection O
of O
non O
- O
B O
cells O
may O
result O
in O
HIV I-GENE
- I-GENE
1 I-GENE
promoter I-GENE
activation O
. O

Mutation O
of O
the O
C I-GENE
/ I-GENE
EBP I-GENE
binding I-GENE
sites I-GENE
in O
the O
Rous _RARE_
sarcoma I-GENE
virus I-GENE
long I-GENE
terminal I-GENE
repeat I-GENE
and O
gag I-GENE
enhancers _RARE_
. O

Nuclear I-GENE
protein I-GENE
phosphatase I-GENE
2A _RARE_
dephosphorylates _RARE_
protein I-GENE
kinase I-GENE
A I-GENE
- O
phosphorylated _RARE_
CREB I-GENE
and O
regulates O
CREB I-GENE
transcriptional O
stimulation _RARE_
. O

We O
show O
that O
IL _RARE_
- I-GENE
6 I-GENE
activates O
JRE _RARE_
- I-GENE
IL6 I-GENE
through O
an O
H7 _RARE_
- O
sensitive _RARE_
pathway _RARE_
that O
does O
not O
involve O
protein I-GENE
kinase I-GENE
C I-GENE
, O
cyclic I-GENE
AMP I-GENE
- I-GENE
dependent I-GENE
kinase I-GENE
, O
Ca I-GENE
( I-GENE
2 I-GENE
+)- _RARE_
or I-GENE
calmodulin I-GENE
- I-GENE
dependent I-GENE
kinases I-GENE
, O
Ras I-GENE
, O
Raf I-GENE
- I-GENE
1 I-GENE
, O
or O
NF _RARE_
- I-GENE
IL6 I-GENE
( O
C I-GENE
/ I-GENE
EBP I-GENE
beta I-GENE
). O

Mutation O
of O
the O
presumptive _RARE_
phosphorylated _RARE_
tyrosine O
and O
threonine O
residues O
of O
Mpk1p _RARE_
individually O
to O
phenylalanine _RARE_
and O
alanine O
, O
respectively O
, O
severely O
impaired O
Mpk1p _RARE_
function O
. O

Growth _RARE_
factor O
stimulation _RARE_
rapidly O
induces O
a O
reversible O
change O
in O
the O
electrophoretic O
mobility O
of O
the O
ternary _RARE_
complex O
, O
accompanied O
by O
increased O
phosphorylation _RARE_
of O
the O
Elk I-GENE
- I-GENE
1 I-GENE
C I-GENE
- I-GENE
terminal I-GENE
region I-GENE
and O
by O
the O
activation O
of O
a O
42 _RARE_
kd _RARE_
cellular I-GENE
Elk I-GENE
- I-GENE
1 I-GENE
kinase I-GENE
. O

In O
contrast O
to O
the O
situation _RARE_
in O
mammalian O
cells O
, O
prolonged O
exposure O
of O
the O
agonist O
( O
24 _RARE_
h O
) O
does O
not O
result O
in O
down O
regulation _RARE_
of O
the O
remaining O
70 O
% O
of O
the O
receptors O
. O

This O
stimulatory _RARE_
effect O
could O
also O
be O
elicited O
by O
c I-GENE
- I-GENE
Jun I-GENE
, O
which O
interacts O
with O
topo _RARE_
II I-GENE
, O
but O
not O
by O
c I-GENE
- I-GENE
Fos I-GENE
, O
which O
does O
not O
bind O
topo _RARE_
II I-GENE
in O
our O
in O
vitro O
assay O
. O

The O
regulation _RARE_
of O
Myf _RARE_
- I-GENE
5 I-GENE
and O
MyoD I-GENE
function O
by O
a O
cAMP O
- O
dependent O
pathway _RARE_
may O
partly O
explain O
how O
external O
signals O
generated O
by O
serum O
and O
certain O
peptide O
growth O
factors O
can O
be O
transduced _RARE_
to O
the O
nucleus O
and O
inhibit O
dominant O
- O
acting O
factors O
that O
are O
responsible O
for _RARE_
myoblast _RARE_
differentiation O
. O

16 O
, O
99 _RARE_
- O
104 O
). O

We O
have O
previously O
reported O
that O
high O
level O
human I-GENE
desmin _RARE_
expression _RARE_
depends O
on O
a O
280 _RARE_
- O
base _RARE_
pair _RARE_
muscle O
- O
specific O
enhancer O
which O
can O
function O
not O
only O
in O
myotubes O
, O
but O
can O
also O
activate O
gene O
expression _RARE_
in O
myoblasts O
. O

After O
surgery O
, O
patients O
self O
administered O
one O
of O
three O
possible O
postsurgical _RARE_
medications _RARE_
, O
which O
included O
placebo O
, O
codeine _RARE_
60 _RARE_
mg O
, O
and O
ibuprofen _RARE_
400 _RARE_
mg O
, O
when O
their O
pain O
reached O
a O
moderate O
or O
severe O
intensity O
. O

Replacement _RARE_
of O
the O
wild O
- O
type O
5 O
'- O
regulatory O
region O
with O
either O
of O
the O
mutants O
' O
cis O
- O
acting O
regulatory O
element O
resulted O
in O
the O
anaerobic O
expression _RARE_
of O
active _RARE_
Mn _RARE_
- I-GENE
superoxide _RARE_
dismutase I-GENE
. O

The O
orf61 _RARE_
gene I-GENE
product I-GENE
, O
when O
expressed _RARE_
from O
an O
exogenous _RARE_
promoter O
, O
inhibited O
int I-GENE
- O
mediated _RARE_
integration _RARE_
at _RARE_
the O
chromosomal I-GENE
attB _RARE_
site I-GENE
. O

Expression O
in O
established O
LCLs _RARE_
, O
occurring O
irrespective O
of O
virus O
producer _RARE_
status O
, O
was O
not O
a O
consequence O
of O
continued O
in O
vitro O
passage O
; O
thus O
, O
appropriately _RARE_
spliced _RARE_
BamHI I-GENE
- I-GENE
A I-GENE
transcripts I-GENE
could O
be O
amplified O
from O
normal O
B O
cells O
within O
1 O
day O
of O
their O
experimental O
infection O
in O
vitro O
, O
along O
with O
BamHI I-GENE
- I-GENE
C I-GENE
/ I-GENE
W _RARE_
promoter O
- O
initiated _RARE_
but O
not O
BamHI I-GENE
- I-GENE
F I-GENE
promoter I-GENE
- I-GENE
initiated _RARE_
mRNAs I-GENE
. O

Analysis O
by O
cell O
surface O
immunofluorescence O
showed O
that O
the O
UL28 _RARE_
gene I-GENE
is O
not O
required O
for _RARE_
expression _RARE_
of O
viral O
glycoproteins _RARE_
on O
the O
surface O
of O
infected _RARE_
cells O
. O

Furthermore O
, O
a O
mutant O
receptor O
( O
Y977F _RARE_
/ O
Y989F _RARE_
[ _RARE_
PLC I-GENE
gamma I-GENE
- O
binding O
sites O
]) _RARE_
could O
fully O
activate O
Ras I-GENE
, O
and O
the O
direct O
activation O
of O
protein I-GENE
kinase I-GENE
C I-GENE
and O
calcium _RARE_
mobilization _RARE_
had O
almost O
no _RARE_
effect O
on O
the O
GDP O
/ O
GTP O
state O
of O
Ras I-GENE
in O
this O
cell O
line O
. O

Estrogen _RARE_
treatment O
in O
high O
doses O
is O
effective O
in O
reducing _RARE_
adult O
stature _RARE_
in O
constitutionally _RARE_
tall _RARE_
girls O
. O

Mutations O
at _RARE_
the O
extreme O
C O
- O
terminus O
of O
EIAV _RARE_
Tat I-GENE
impaired O
both O
RNA O
binding O
and O
activation O
domain O
functions O
, O
suggesting O
effects O
on O
secondary O
or O
tertiary O
structure _RARE_
. O

This O
observation O
suggests O
that O
the O
methyl _RARE_
- O
directed O
repair O
system _RARE_
utilizes _RARE_
the O
proximal O
d O
( O
GATC _RARE_
) O
sequence O
to O
direct O
correction O
. O

Uracil _RARE_
DNA I-GENE
glycosylase I-GENE
catalyzes O
the O
initial O
step O
in O
the O
repair O
pathway _RARE_
that O
removes _RARE_
potentially O
mutagenic _RARE_
uracil _RARE_
from O
duplex O
DNA O
. O

Current O
clinical O
trials O
should O
answer _RARE_
the O
question O
of O
which O
of O
the O
therapeutic O
options _RARE_
impairs _RARE_
quality O
of O
life O
less O
. O

Lithium _RARE_
phthalocyanine _RARE_
( O
LiPc _RARE_
) O
is O
a O
prototype O
of O
another O
generation O
of O
synthetic _RARE_
, O
metallic _RARE_
- O
organic O
, O
paramagnetic _RARE_
crystallites _RARE_
that O
appear O
very O
useful O
for _RARE_
in O
vitro O
and O
in O
vivo O
electron O
paramagnetic _RARE_
resonance O
oximetry _RARE_
. O

In O
this O
report O
, O
we O
focus O
on O
the O
genetics _RARE_
of O
the O
region O
of O
the O
17 _RARE_
hep _RARE_
syn _RARE_
gB _RARE_
gene I-GENE
that O
conferred O
both O
the O
syncytial _RARE_
and O
pathogenic O
phenotypes _RARE_
to O
17 _RARE_
syn _RARE_
+. _RARE_

Recipients _RARE_
with O
acute O
leukaemia _RARE_
in O
first _RARE_
remission O
or O
chronic O
myeloid _RARE_
leukaemia _RARE_
in O
first _RARE_
chronic O
phase _RARE_
were O
analysed O
as _RARE_
good O
risk O
, O
and O
those O
beyond O
these O
stages O
, O
as _RARE_
poor O
risk O
patients O
. O

Elledge _RARE_
, O
P O
. O

Drugs _RARE_
suppressed O
> O
or O
= O
75 _RARE_
% O
of O
the O
total _RARE_
premature O
ventricular O
contractions O
in O
all O
patients O
who O
had O
both O
use O
- O
dependent O
QRS O
prolongation O
and O
reverse O
use O
- O
dependent O
QT O
prolongation O
, O
in O
79 _RARE_
% O
of O
patients O
with O
use O
- O
dependent O
QRS O
prolongation O
alone O
, O
in O
70 O
% O
with O
reverse O
use O
- O
dependent O
QT O
prolongation O
alone O
, O
and O
in O
11 O
% O
with O
neither O
use O
- O
dependent O
QRS O
prolongation O
nor O
reverse O
use O
- O
dependent O
QT O
prolongation O
. O

Losses _RARE_
during _RARE_
the O
complete _RARE_
procedure O
are O
corrected O
for _RARE_
using O
radioactive _RARE_
estrogen O
conjugates _RARE_
during _RARE_
the O
first _RARE_
steps O
and O
later O
by O
adding O
deuterated _RARE_
internal O
standards _RARE_
of O
all O
compounds O
measured O
( O
matairesinol _RARE_
, O
enterodiol _RARE_
, O
enterolactone _RARE_
, O
daidzein _RARE_
, O
O O
- O
desmethylangolensin _RARE_
, O
equol _RARE_
, O
and O
genistein _RARE_
). O

IE2 I-GENE
- O
IE2 I-GENE
interactions O
were O
mapped O
to O
a O
domain O
containing O
a O
putative O
helix O
- O
turn _RARE_
- O
helix O
motif O
located _RARE_
near O
the O
C O
terminus O
of O
IE2 I-GENE
, O
between O
amino O
acids _RARE_
456 _RARE_
and O
539 _RARE_
. O

The O
Sp1 _RARE_
region I-GENE
, O
however O
, O
is O
converted O
to O
a O
functionally O
strong O
TRE _RARE_
by O
the O
viral I-GENE
tat I-GENE
factor I-GENE
. O

Precipitation _RARE_
using O
GST I-GENE
fusion I-GENE
proteins I-GENE
containing O
Fyn I-GENE
SH2 _RARE_
, O
SH3 I-GENE
, O
and O
SH2 _RARE_
/ O
SH3 I-GENE
domains O
revealed O
that O
PI I-GENE
3 I-GENE
- I-GENE
kinase I-GENE
bound _RARE_
principally _RARE_
to O
the O
SH3 I-GENE
domain I-GENE
of O
Fyn I-GENE
. O

A O
sheep O
testicular _RARE_
cDNA O
library O
constructed O
in O
pcDNA1 _RARE_
vector O
was O
screened O
with O
a O
probe O
generated O
by O
polymerase O
chain O
reaction O
( O
PCR O
) O
and O
corresponding O
to O
a O
1 O
. O
6 O
kb O
fragment O
of O
the O
rat I-GENE
luteinizing _RARE_
hormone I-GENE
receptor I-GENE
cDNA I-GENE
. O

Two O
putative O
Rev _RARE_
proteins I-GENE
with O
apparent O
molecular _RARE_
masses O
of O
18 O
and O
16 O
kDa O
were O
expressed _RARE_
by O
p2 _RARE_
/ I-GENE
2 I-GENE
and O
p176 _RARE_
, O
while O
p20 _RARE_
expressed _RARE_
only O
a O
16 O
- O
kDa O
species O
. O

Three O
group O
1 O
patients O
developed O
CMV _RARE_
disease _RARE_
; O
1 O
group O
2 O
patient O
developed O
CMV _RARE_
hepatitis O
. O

The O
ability O
of O
spt2 _RARE_
mutations I-GENE
to O
suppress O
the O
transcriptional O
interference O
caused O
by O
the O
delta I-GENE
promoter I-GENE
insertion _RARE_
his _RARE_
- I-GENE
4 I-GENE
- I-GENE
912 _RARE_
delta I-GENE
correlates O
with O
an O
increase O
in O
wild I-GENE
- I-GENE
type I-GENE
HIS4 _RARE_
mRNA I-GENE
levels O
. O

Nuclear O
localization _RARE_
and O
protein O
sequence O
similarities O
suggested O
that O
the O
SPT2 _RARE_
/ O
SIN1 _RARE_
protein O
may O
be O
related O
to O
the O
nonhistone _RARE_
chromosomal I-GENE
protein I-GENE
HMG1 _RARE_
. O

The O
conserved _RARE_
ninth _RARE_
C O
- O
terminal O
heptad _RARE_
in O
thyroid O
hormone O
and O
retinoic I-GENE
acid I-GENE
receptors I-GENE
mediates O
diverse O
responses O
by O
affecting O
heterodimer _RARE_
but O
not O
homodimer _RARE_
formation O
. O

Genetic O
interactions O
between O
BCK2 _RARE_
and O
other O
pathway _RARE_
components _RARE_
suggested O
that O
BCK2 _RARE_
functions O
on O
a O
common O
pathway _RARE_
branch O
with O
PPZ1 _RARE_
and O
PPZ2 _RARE_
. O

Steroidogenic _RARE_
factor I-GENE
1 I-GENE
, O
an O
orphan I-GENE
nuclear I-GENE
receptor I-GENE
, O
regulates O
the O
expression _RARE_
of O
the O
rat I-GENE
aromatase I-GENE
gene I-GENE
in O
gonadal _RARE_
tissues O
. O

To O
study O
the O
functional _RARE_
differences O
between O
cutaneous O
HPV5 _RARE_
and O
HPV8 _RARE_
E7s _RARE_
and O
genital _RARE_
HPV16 _RARE_
E7 I-GENE
, O
we O
cloned _RARE_
each O
of O
the O
E7 I-GENE
open _RARE_
reading O
frames O
and O
tested O
their O
immortalizing _RARE_
and O
transforming O
activities O
, O
the O
binding O
ability O
of O
their O
products O
with O
retinoblastoma _RARE_
protein I-GENE
( O
RB _RARE_
) O
and O
their O
complementation _RARE_
activity O
of O
a O
RB _RARE_
- I-GENE
nonbinding _RARE_
adenovirus I-GENE
E1A I-GENE
mutant I-GENE
. O

The O
rhaB _RARE_
transcription I-GENE
start _RARE_
site I-GENE
was O
mapped O
to O
- O
24 _RARE_
relative O
to O
the O
start _RARE_
of O
translation O
. O

Several O
lines O
of O
evidence O
demonstrate O
that O
this O
growth O
inhibition O
requires O
active _RARE_
PKA I-GENE
subunits I-GENE
and O
cAMP O
: O
( O
i O
) O
this O
phenotype _RARE_
is O
dependent O
on O
cAMP O
since O
it O
is O
not O
seen O
in O
a O
strain _RARE_
lacking _RARE_
adenylyl _RARE_
cyclase I-GENE
activity O
, O
but O
the O
growth O
rate O
of O
these O
transformants O
is O
slower O
when O
exogenous _RARE_
cAMP O
is O
added O
; O
( O
ii O
) O
normal O
growth O
occurs O
when O
wild O
- O
type O
RI _RARE_
cDNA O
is O
replaced O
by O
a O
mutant I-GENE
RI _RARE_
cDNA I-GENE
encoding O
a O
RI _RARE_
protein I-GENE
with O
reduced _RARE_
cAMP O
binding O
; O
and O
( O
iii O
) O
the O
growth O
- O
inhibited O
phenotype _RARE_
of O
the O
transformed O
BL21 _RARE_
( O
DE3 _RARE_
) O
cells O
requires O
soluble _RARE_
, O
active _RARE_
C I-GENE
alpha I-GENE
protein I-GENE
. O

Liu _RARE_
, O
B O
. O

BCR _RARE_
- O
ABL I-GENE
and O
v I-GENE
- I-GENE
abl I-GENE
oncogenes _RARE_
induce O
distinct O
patterns O
of O
thymic _RARE_
lymphoma O
involving O
different O
lymphocyte O
subsets _RARE_
. O

These O
experiments O
confirm O
that O
the O
6 O
- O
S O
liganded _RARE_
form O
of O
the O
receptor O
identified O
in O
nuclear O
extracts O
of O
cells O
treated O
with O
2 O
, O
3 O
, O
7 O
, O
8 O
- O
tetrachlorodibenzo _RARE_
- O
p O
- O
dioxin _RARE_
( O
TCDD _RARE_
) O
contains O
the O
Ah _RARE_
receptor I-GENE
protein I-GENE
and O
ARNT _RARE_
but O
not O
the O
90 _RARE_
- I-GENE
kDa I-GENE
heat I-GENE
shock I-GENE
protein I-GENE
. O

LDL I-GENE
cholesterol I-GENE
decreased O
from O
4 O
. O
74 _RARE_
+/- O
0 _RARE_
. O
87 O
to O
3 O
. O
78 _RARE_
+/- O
0 _RARE_
. O
78 _RARE_
mmol O
/ O
l _RARE_
after O
8 O
weeks O
on O
simvastatin _RARE_
( O
P O
< O
0 _RARE_
. O
001 O
), _RARE_
and O
apo _RARE_
B I-GENE
fell O
from O
142 O
+/- O
31 _RARE_
to O
112 O
+/- O
22 _RARE_
mg O
/ O
dl O
( O
P O
< O
0 _RARE_
. O
001 O
). O

LDL I-GENE
cholesterol I-GENE
decreased O
from O
4 O
. O
74 _RARE_
+/- O
0 _RARE_
. O
87 O
to O
3 O
. O
78 _RARE_
+/- O
0 _RARE_
. O
78 _RARE_
mmol O
/ O
l _RARE_
after O
8 O
weeks O
on O
simvastatin _RARE_
( O
P O
< O
0 _RARE_
. O
001 O
), _RARE_
and O
apo _RARE_
B I-GENE
fell O
from O
142 O
+/- O
31 _RARE_
to O
112 O
+/- O
22 _RARE_
mg O
/ O
dl O
( O
P O
< O
0 _RARE_
. O
001 O
). O

This O
negative O
element O
may O
, O
at _RARE_
least O
in O
part O
, O
be O
responsible O
for _RARE_
the O
cell O
type O
- O
specific O
expression _RARE_
of O
the O
DGK _RARE_
gene I-GENE
. O

Regulated _RARE_
activity O
of O
the O
distal O
promoter O
- O
like O
element O
of O
the O
human I-GENE
corticotropin _RARE_
- I-GENE
releasing I-GENE
hormone I-GENE
gene I-GENE
and O
secondary O
structural O
features O
of O
its O
corresponding O
transcripts O
. O

A O
new O
bioencapsulation _RARE_
technology O
for _RARE_
microbial _RARE_
inoculants _RARE_
. O

We O
linked _RARE_
hypersensitivity O
site O
2 O
( O
HS2 _RARE_
) O
from O
the O
locus O
control O
region O
( O
LCR _RARE_
) O
to O
a O
A I-GENE
gamma I-GENE
- I-GENE
globin I-GENE
gene O
( O
A O
gamma O
*) _RARE_
mutationally _RARE_
marked O
to O
allow O
its O
transcript O
to O
be O
distinguished O
from O
endogenous O
gamma I-GENE
- I-GENE
globin I-GENE
mRNA O
. O

INTERVENTIONS _RARE_
-- _RARE_
Patients O
allocated O
to O
treatment O
with O
levodopa _RARE_
/ I-GENE
dopa _RARE_
decarboxylase I-GENE
inhibitor O
alone O
( O
arm _RARE_
1 O
), _RARE_
levodopa _RARE_
/ I-GENE
decarboxylase I-GENE
inhibitor O
/ O
selegiline _RARE_
in O
combination O
( O
arm _RARE_
2 O
), _RARE_
or O
bromocriptine _RARE_
( O
arm _RARE_
3 O
). O

It O
contains O
three O
putative O
binding O
sites O
for _RARE_
transcription I-GENE
factor I-GENE
Sp1 _RARE_
as _RARE_
well _RARE_
as _RARE_
several O
short O
sequences O
that O
are O
similar O
to O
known O
cis O
- O
acting O
enhancers _RARE_
or O
binding O
sites O
for _RARE_
transcription O
factors O
. O

French _RARE_
bean _RARE_
contains O
a O
small O
family O
of O
genes I-GENE
encoding I-GENE
PAL _RARE_
and O
two O
of O
these O
genes O
, O
PAL2 _RARE_
and O
PAL3 _RARE_
, O
have O
been O
shown O
to O
be O
differentially O
expressed _RARE_
at _RARE_
the O
mRNA O
level O
in O
bean _RARE_
tissues O
. O

Plasma O
thromboxane _RARE_
B2 _RARE_
levels O
in O
the O
older O
group O
were O
about O
double O
those O
in O
younger _RARE_
piglets _RARE_
. O

By O
stepwise _RARE_
linear _RARE_
multiple O
regression O
analysis O
, O
ionized _RARE_
magnesium O
was O
significantly O
related O
to O
cyclosporin O
trough O
level O
and O
total _RARE_
cholesterol O
but O
not O
to O
serum O
creatinine _RARE_
, O
time O
after O
transplant O
or O
the O
dose O
of O
cyclosporin O
. O

The O
human I-GENE
insulin I-GENE
- I-GENE
like I-GENE
growth I-GENE
factor I-GENE
II I-GENE
( O
IGF I-GENE
- I-GENE
II I-GENE
) O
gene O
contains O
four O
promoters O
( O
P1 O
, O
P2 O
, O
P3 _RARE_
and O
P4 _RARE_
). O

Moreover O
, O
in O
transient O
transfection O
assays O
, O
PU _RARE_
. I-GENE
1 I-GENE
alone O
activated O
reporter O
constructs O
containing O
the O
JB _RARE_
cis O
- O
element O
, O
and O
the O
activation O
was O
shown O
to O
be O
dependent O
on O
a O
glutamine _RARE_
- O
rich O
sequence O
in O
the O
amino O
- O
terminal O
portion O
of O
PU _RARE_
. I-GENE
1 I-GENE
. O

Army _RARE_
veterans _RARE_
given O
yellow O
fever O
vaccine O
contaminated O
with O
hepatitis O
B O
virus O
in O
1942 _RARE_
and O
controls O
and O
( O
b O
) O
a O
case O
- O
control O
study O
comparing O
veterans _RARE_
with O
hepatocellular _RARE_
carcinoma O
in O
Veterans _RARE_
Affairs _RARE_
hospitals O
with O
matched O
controls O
with O
respect O
to O
receipt _RARE_
of O
contaminated O
vaccine O
in O
1942 _RARE_
. O

They O
were O
found O
to O
be O
seropositive O
for _RARE_
antibodies O
to O
hepatitis O
C O
virus O
by O
second O
- O
generation O
testing O
( O
RIBA _RARE_
2 O
, O
Ortho _RARE_
Diagnostic O
Systems _RARE_
Inc _RARE_
, O
Westwood _RARE_
, O
MA _RARE_
). O

Defects _RARE_
of O
fibrillin _RARE_
( O
FBN1 _RARE_
), _RARE_
a O
glycoprotein O
component _RARE_
of O
the O
extracellular O
microfibril _RARE_
, O
cause O
Marfan _RARE_
syndrome _RARE_
. O

When O
introduced O
into O
recJ _RARE_
+ I-GENE
strains O
, O
srjA _RARE_
mutations O
conferred O
hyperrecombinational _RARE_
and O
hyper _RARE_
- I-GENE
UVr _RARE_
phenotypes _RARE_
. O

Distinguishing _RARE_
roles O
of O
the O
membrane O
- O
cytoskeleton _RARE_
and O
cadherin _RARE_
mediated _RARE_
cell O
- O
cell O
adhesion O
in O
generating O
different O
Na _RARE_
+, _RARE_
K I-GENE
(+)- _RARE_
ATPase I-GENE
distributions _RARE_
in O
polarized _RARE_
epithelia _RARE_
. O

Neonatal _RARE_
lupus O
erythematosus O
is O
most O
often O
associated O
with O
autoantibodies O
against O
Ro _RARE_
and O
La _RARE_
antigens O
. O

Genetic O
abnormalities O
that O
could O
lead O
to O
mutagenesis O
include O
chromosomal O
abnormalities O
and O
single O
- O
gene O
mutations O
. O

Hops _RARE_
, O
and O
L O
. O

Continued _RARE_
absorption O
of O
amino O
acids _RARE_
by O
the O
NBB _RARE_
carrier O
( O
for _RARE_
neutral O
amino O
acids _RARE_
), _RARE_
the O
Y O
+ O
system _RARE_
( O
for _RARE_
dibasic _RARE_
amino O
acids _RARE_
), _RARE_
and O
the O
PHE _RARE_
carrier O
were O
operative O
even O
during _RARE_
the O
actively O
purging _RARE_
stage _RARE_
of O
watery _RARE_
diarrhoea _RARE_
due O
to O
cholera _RARE_
. O

1 O
) O
CFDN _RARE_
, O
AMPC _RARE_
and O
MNZ _RARE_
showed O
a O
potent O
antimicrobial O
activity O
against O
H O
. O
pylori _RARE_
, O
and O
especially O
, O
AMPC _RARE_
showed O
a O
marked O
bactericidal O
activity O
in O
a O
short O
time O
. O

Creutzfeldt _RARE_
- O
Jakob _RARE_
disease _RARE_
and O
lyophilised _RARE_
dura _RARE_
mater _RARE_
grafts O
: O
report O
of O
two O
cases O
. O

A O
high O
mean O
intensity O
of O
CLTPA _RARE_
( O
standardized O
multivariate O
regression O
coefficient O
beta O
- O
0 _RARE_
. O
059 _RARE_
, O
p O
= O
0 _RARE_
. O
020 _RARE_
) O
and O
a O
high O
maximal O
oxygen O
uptake O
( O
beta O
- O
0 _RARE_
. O
163 _RARE_
, O
p O
< O
0 _RARE_
. O
001 O
) O
were O
associated O
with O
reduced _RARE_
plasma I-GENE
fibrinogen I-GENE
when O
adjusting _RARE_
for _RARE_
the O
strongest O
covariates _RARE_
. O

What _RARE_
young O
people O
think _RARE_
and O
do O
when O
the O
option _RARE_
for _RARE_
cystic _RARE_
fibrosis _RARE_
carrier O
testing O
is O
available O
. O

A O
patient O
matches O
a O
PIC _RARE_
patient O
if O
both O
have O
the O
same O
mechanism O
of O
injury O
, O
the O
same O
coding O
of O
Revised _RARE_
Trauma _RARE_
Score _RARE_
variables O
( O
Glascow _RARE_
Coma _RARE_
Scale O
score O
, O
systolic O
blood _RARE_
pressure O
, O
respiratory O
rate O
), _RARE_
the O
same O
coded O
age O
per O
A O
Severity _RARE_
Characterization O
of O
Trauma _RARE_
) O
( O
ASCOT _RARE_
), _RARE_
and O
if O
they O
differ O
by O
no _RARE_
more O
than O
0 _RARE_
. O
5 O
for _RARE_
A O
, O
B O
, O
and O
C O
( O
the O
ASCOT _RARE_
components _RARE_
for _RARE_
serious O
injuries O
). O

Skin _RARE_
and O
bowel O
TPO2 _RARE_
varied O
with O
DO2 _RARE_
and O
each O
other O
( O
P O
< O
0 _RARE_
. O
05 O
). O

A O
region O
approximately _RARE_
100 _RARE_
bp O
upstream O
from O
the O
transcription O
start _RARE_
point O
of O
virB _RARE_
was O
identified O
as _RARE_
being O
necessary O
for _RARE_
full O
activation O
of O
this O
promoter O
by O
VirF _RARE_
. O

We O
have O
isolated O
a O
cosmid O
containing O
DNA O
that O
corresponds O
to O
the O
site O
of O
transposon _RARE_
insertion _RARE_
in O
257DH4 _RARE_
and O
have O
localized O
Tn5 _RARE_
on O
an O
8 I-GENE
. I-GENE
0 _RARE_
kb I-GENE
EcoRI I-GENE
fragment I-GENE
. O

The O
scr _RARE_
regulon _RARE_
of O
pUR400 _RARE_
and O
the O
chromosomally _RARE_
encoded I-GENE
scr _RARE_
regulon _RARE_
of I-GENE
Klebsiella _RARE_
pneumoniae _RARE_
KAY2026 _RARE_
are O
both O
negatively O
controlled _RARE_
by O
a O
specific O
repressor O
( O
ScrR _RARE_
). O

Although O
the O
molecular _RARE_
mechanisms O
involved O
in O
this O
regulation _RARE_
are O
currently O
being O
elucidated _RARE_
, O
very O
little O
is O
known O
about O
the O
trans _RARE_
- O
acting O
factors O
that O
allow O
expression _RARE_
of O
the O
nitrate _RARE_
and I-GENE
nitrite _RARE_
reductase I-GENE
genes I-GENE
which O
code O
for _RARE_
the O
first _RARE_
enzymes _RARE_
in O
the O
pathway _RARE_
. O

The O
Ntl1 _RARE_
gene I-GENE
is O
present O
as _RARE_
a O
unique O
copy O
in O
the O
diploid O
N O
. O
plumbaginifolia _RARE_
species O
. O

Transient O
transfection O
experiments O
revealed O
that O
Pax I-GENE
- I-GENE
8 I-GENE
isoforms I-GENE
a I-GENE
and I-GENE
b I-GENE
, O
but O
not O
c O
and O
d O
, O
strongly O
stimulate O
transcription O
from O
a O
promoter O
containing O
six _RARE_
copies O
of O
a O
paired I-GENE
- I-GENE
domain I-GENE
recognition I-GENE
sequence I-GENE
. O

The O
amino O
- O
terminal O
third O
of O
the O
protein O
contains O
a O
high I-GENE
- I-GENE
mobility I-GENE
- I-GENE
group I-GENE
motif I-GENE
characteristic O
of O
DNA O
- O
binding O
proteins O
. O

We O
have O
examined O
the O
ability O
of O
various O
NF _RARE_
- I-GENE
kappa _RARE_
B I-GENE
subunits I-GENE
to O
bind O
to O
, O
and O
activate O
transcription O
from O
, O
the O
IL _RARE_
- I-GENE
8 I-GENE
promoter I-GENE
. O

When O
multiple O
copies O
of O
the O
IL _RARE_
- I-GENE
1 I-GENE
beta I-GENE
NF _RARE_
- I-GENE
kappa _RARE_
B I-GENE
site I-GENE
were O
linked _RARE_
to O
an O
enhancerless _RARE_
simian I-GENE
virus I-GENE
40 I-GENE
promoter I-GENE
, O
this O
element O
was O
able O
to O
mediate O
phorbol O
ester O
- O
or O
lipopolysaccharide O
- O
inducible O
gene O
expression _RARE_
. O

We O
found O
that O
the O
3 O
'- O
end O
- O
adjacent O
sequence O
CA O
( O
N O
) O
3 O
- O
10AGTNNAA _RARE_
, O
conserved _RARE_
in O
plant _RARE_
Pol I-GENE
II I-GENE
- O
specific O
U _RARE_
snRNA _RARE_
genes I-GENE
, O
is O
essential O
for _RARE_
the O
3 O
'- O
end O
formation O
of O
U2 _RARE_
transcripts I-GENE
and O
, O
similar O
to O
the O
vertebrate _RARE_
3 O
' O
box O
, O
is O
highly O
tolerant _RARE_
to O
mutation O
. O

These O
results O
indicate O
that O
Rb _RARE_
protein I-GENE
is O
interacting _RARE_
with O
some O
component _RARE_
( O
s O
) O
of O
the O
cell O
cycle _RARE_
- O
regulatory O
machinery O
during _RARE_
G2 _RARE_
phase _RARE_
. O

MDBP _RARE_
from O
HeLa O
and O
Raji _RARE_
cells O
formed O
DNA O
- O
protein O
complexes O
with O
X O
- O
box O
oligonucleotides O
that O
coelectrophoresed _RARE_
with O
those O
containing O
standard O
MDBP _RARE_
sites I-GENE
. O

Transgenic _RARE_
mice O
harboring O
the O
rat O
TnI I-GENE
- O
CAT I-GENE
fusion O
gene O
expressed _RARE_
the O
reporter O
specifically O
in O
the O
skeletal O
muscle O
. O

METHODS O
: O
Fifty O
- O
one O
healthy O
eyes O
, O
169 _RARE_
ocular O
hypertensive O
eyes O
with O
normal O
visual O
fields O
, O
and O
132 O
glaucomatous _RARE_
eyes O
with O
early O
visual O
field O
defects O
were O
evaluated O
with O
qualitative O
and O
quantitative O
measures O
of O
structural O
damage O
to O
the O
optic O
nerve O
and O
nerve O
fiber O
layer O
. O

Consistent O
with O
the O
hypothesis O
that O
it O
acts O
as _RARE_
transcriptional O
regulator O
, O
wild I-GENE
- I-GENE
type I-GENE
p53 I-GENE
protein I-GENE
binds O
DNA O
and O
activates O
transcription O
of O
several O
promoters O
. O

The O
ADP _RARE_
- I-GENE
ribosylation _RARE_
factor I-GENE
( O
ARF I-GENE
) O
family O
is O
one O
of O
four O
subfamilies _RARE_
of O
the O
RAS _RARE_
superfamily I-GENE
of O
low I-GENE
molecular _RARE_
weight _RARE_
GTP I-GENE
- I-GENE
binding I-GENE
proteins I-GENE
( O
G I-GENE
proteins I-GENE
). O

The O
E1 I-GENE
gene I-GENE
is O
located _RARE_
within O
the O
first _RARE_
intron O
of O
the O
gene O
for _RARE_
RCC1 _RARE_
, O
a O
protein O
that O
regulates O
onset O
of O
mitosis O
. O

Genomic O
Southern O
blot O
analysis O
and O
chromosome _RARE_
mapping O
showed O
that O
GPRK6 _RARE_
hybridizes _RARE_
to O
two O
closely O
related O
genes O
located _RARE_
on O
chromosomes O
5 O
and O
13 _RARE_
and O
are O
, O
therefore O
, O
distinct O
from O
the O
GPRK _RARE_
located _RARE_
near O
the O
Huntington _RARE_
disease _RARE_
locus I-GENE
on O
chromosome _RARE_
4 O
. O

Metabolic _RARE_
labeling O
studies O
in O
S O
. O
cerevisiae O
and O
co _RARE_
- O
expression _RARE_
of O
nmt72p _RARE_
with O
several O
protein O
substrates _RARE_
of O
Nmt1p _RARE_
in O
Escherichia O
coli O
indicate O
that O
the O
Leu99 _RARE_
--> _RARE_
Pro _RARE_
substitution O
causes O
a O
reduction O
in O
the O
acylation _RARE_
of O
some O
but O
not O
all O
protein O
substrates _RARE_
. O

These O
CTD _RARE_
kinases I-GENE
, O
designated O
CTDK1 _RARE_
and O
CTDK2 _RARE_
, O
are O
fractionated _RARE_
by O
chromatography O
on O
Mono _RARE_
Q _RARE_
. O

Instead O
, O
mRNA O
of O
2 O
. O
0 _RARE_
and O
2 O
. O
8 O
kb O
are O
detected O
in O
varying O
abundance O
. O

Previously O
, O
we O
identified O
a O
51 _RARE_
- O
bp O
promoter O
fragment O
, O
oligo31 _RARE_
/ O
32 _RARE_
, O
which O
conferred O
heat O
shock O
inducibility O
on O
the O
heterologous O
CYC1 I-GENE
- O
lacZ I-GENE
reporter O
gene O
in O
S O
. O
cerevisiae O
( O
N O
. O

The O
sequence O
of O
the O
HIR1 _RARE_
gene I-GENE
predicts O
an O
88 O
- O
kDa O
protein O
with O
three O
repeats O
of O
a O
motif O
found O
in O
the O
G I-GENE
beta I-GENE
subunit I-GENE
of O
retinal _RARE_
transducin _RARE_
and O
in O
a O
yeast O
transcriptional O
repressor O
, O
Tup1 _RARE_
. O

All O
of O
these O
data O
suggest O
that O
replication O
of O
UV _RARE_
- O
damaged O
templates O
occurs O
in O
vitro O
as _RARE_
it O
does O
in O
vivo O
and O
that O
this O
replication O
results O
in O
mutation O
fixation O
. O

To O
identify O
factors O
that O
may O
modify O
the O
heterosexual _RARE_
transmission _RARE_
of O
human O
T O
cell O
leukemia O
/ O
lymphoma O
virus O
type O
I O
( O
HTLV _RARE_
- O
I O
), _RARE_
534 _RARE_
married _RARE_
couples _RARE_
enrolled O
in O
the O
Miyazaki _RARE_
Cohort _RARE_
Study O
between O
November _RARE_
1984 _RARE_
and O
April _RARE_
1989 O
were O
studied O
: O
95 _RARE_
husband _RARE_
HTLV _RARE_
- O
I O
- O
seropositive O
( O
H O
+)/ _RARE_
wife _RARE_
seropositive O
( O
W _RARE_
+), O
33 _RARE_
H O
+/ _RARE_
W _RARE_
-, _RARE_
64 _RARE_
H O
-/ _RARE_
W _RARE_
+, _RARE_
and O
342 _RARE_
H O
-/ _RARE_
W _RARE_
-. O

Biol O
. O

To O
characterize O
the O
expression _RARE_
of O
this O
DNA I-GENE
repair I-GENE
enzyme I-GENE
, O
we O
have O
isolated O
the O
corresponding O
genomic O
clone O
. O

L O
., O
Stange _RARE_
, O
G O
., O
Markovich _RARE_
, O
D O
., O
Biber _RARE_
, O
J _RARE_
., O
Testar _RARE_
, O
X O
., O
Zorzano _RARE_
, O
A O
., O
Palacin _RARE_
, O
M O
., O
and O
Murer _RARE_
, O
H O
. O

The O
nucleotide O
sequence O
of O
the O
gene O
predicts O
a O
polypeptide O
of O
215 O
amino O
acids _RARE_
( O
25 _RARE_
. O
2 O
kDa O
) O
with O
two O
putative O
membrane O
- O
spanning O
domains O
. O

SAECG _RARE_
, O
echocardiography O
and O
thallium O
- O
201 _RARE_
imaging O
were O
performed O
before O
and O
1 O
month O
after O
attempted _RARE_
angioplasty _RARE_
. O

They O
were O
called O
PACE4 _RARE_
and O
PC4 _RARE_
. O

265 _RARE_
, O
1102 _RARE_
- O
1110 _RARE_
). O

Both O
fusion O
proteins O
form O
stable O
specific O
complexes O
with O
a O
short O
DNA O
duplex O
harboring O
the O
CTGT _RARE_
( O
at _RARE_
) O
4ACAG _RARE_
consensus O
sequence O
of O
the O
LexA I-GENE
repressor I-GENE
. O

Ten O
selenocysteine _RARE_
residues O
( O
deduced O
) O
are O
present O
. O

CONCLUSIONS O
: O
Free _RARE_
protein I-GENE
S I-GENE
deficiency O
is O
common O
among O
hospitalized O
patients O
, O
even O
in O
the O
absence O
of O
a O
recognized _RARE_
predisposing _RARE_
condition O
. O

During O
the O
past O
decade _RARE_
, O
different O
types _RARE_
of O
endogenous O
retroviral _RARE_
sequences O
have O
been O
defined O
in O
the O
human O
genome O
usually O
by O
low O
stringency _RARE_
hybridization O
employing O
DNA O
probes _RARE_
of O
evolutionary O
conserved _RARE_
animal _RARE_
retrovirus _RARE_
genes O
. O

As O
the O
components _RARE_
of O
these O
complexes O
, O
at _RARE_
least O
five O
TRBPs _RARE_
( O
p30 _RARE_
, O
p37 _RARE_
, O
p46 _RARE_
, O
p50 _RARE_
, O
and O
p56 _RARE_
) O
showing O
specific O
binding O
to O
the O
TAR _RARE_
RNA O
were O
detected O
in O
the O
uv _RARE_
cross O
- O
linking O
assay O
. O

The O
obvious _RARE_
functional _RARE_
necessity _RARE_
for _RARE_
editing _RARE_
in O
kinetoplastid _RARE_
mitochondria _RARE_
is O
the O
formation O
of O
translatable _RARE_
mRNAs O
. O

The O
use O
of O
this O
model O
for _RARE_
investigating _RARE_
pathophysiologically _RARE_
significant O
issues O
in O
denervating _RARE_
diseases O
is O
illustrated _RARE_
with O
five O
different O
sets O
of O
parameters O
. O

An O
extensive O
inverted O
repeat O
is O
present O
3 O
' O
of O
rpeA _RARE_
; O
inverted O
repeats O
are O
found O
downstream _RARE_
of O
all O
PE _RARE_
operons _RARE_
sequenced O
to O
date O
, O
although O
the O
sequence O
is O
not O
conserved _RARE_
. O

We O
describe O
a O
novel O
cytoplasmic I-GENE
tyrosine I-GENE
kinase I-GENE
, O
termed O
BPK _RARE_
( O
B I-GENE
cell I-GENE
progenitor _RARE_
kinase I-GENE
), _RARE_
which O
is O
expressed _RARE_
in O
all O
stages O
of O
the O
B O
lineage O
and O
in O
myeloid _RARE_
cells O
. O

Large _RARE_
differences O
between O
the O
groups O
were O
not O
observed O
in O
HA _RARE_
- I-GENE
synthesizing _RARE_
enzyme I-GENE
activity O
, O
but O
degradative _RARE_
enzyme O
activity O
was O
much O
higher _RARE_
in O
aspirin _RARE_
- O
induced _RARE_
asthma O
- O
related O
polyps O
than O
in O
other O
types _RARE_
of O
nasal O
polyps O
tested O
. O

In O
the O
multivariate O
analysis O
, O
six _RARE_
variables O
were O
independently O
correlated O
with O
survival O
: O
blood _RARE_
urea O
nitrogen O
level O
, O
serum I-GENE
aspartate _RARE_
aminotransferase I-GENE
level O
, O
community O
- O
acquired O
vs _RARE_
. O
hospital O
- O
acquired O
peritonitis _RARE_
, O
age O
, O
Child _RARE_
- O
Pugh _RARE_
score O
and O
ileus _RARE_
. O

Localization O
of O
the O
intronless O
gene O
coding O
for _RARE_
calmodulin I-GENE
- I-GENE
like I-GENE
protein I-GENE
CLP _RARE_
to O
human O
chromosome _RARE_
10p13 _RARE_
- O
ter _RARE_
. O

In O
wandering _RARE_
stage _RARE_
larvae O
, O
the O
OBP _RARE_
transcript I-GENE
appeared O
to O
be O
at _RARE_
least O
250 _RARE_
- O
fold _RARE_
less O
abundant O
than O
ribosomal O
RNA O
. O

One O
such O
mutant O
also O
affects O
the O
overlapping O
- O
10 O
hexamer O
of O
PR O
and O
results O
in O
reduced _RARE_
occupancy _RARE_
by O
both O
MerR _RARE_
and O
RNA I-GENE
polymerase I-GENE
, O
likely O
as _RARE_
a O
result O
of O
inefficient O
transcriptional O
initiation O
of O
merR _RARE_
mRNA I-GENE
. O

However O
, O
L I-GENE
- I-GENE
plastin I-GENE
has O
been O
found O
in O
many O
types _RARE_
of O
malignant O
human O
cells O
of O
non O
- O
hemopoietic _RARE_
origin O
suggesting O
that O
its O
expression _RARE_
is O
induced _RARE_
accompanying O
tumorigenesis O
in O
solid O
tissues O
. O

Finally O
, O
we O
present O
evidence O
that O
fimbrin _RARE_
is O
a O
third O
distinct O
plastin I-GENE
isoform I-GENE
which O
is O
specifically O
expressed _RARE_
at _RARE_
high O
levels O
in O
the O
small O
intestine O
. O

This O
promoter O
could O
direct O
the O
constitutive _RARE_
expression _RARE_
of O
the O
reporter O
beta I-GENE
- I-GENE
galactosidase I-GENE
at _RARE_
high O
frequency O
in O
transfected O
colonies O
of O
transformed O
cells O
that O
express O
L I-GENE
- I-GENE
plastin I-GENE
constitutively O
; O
by O
contrast O
, O
this O
promoter O
was O
virtually O
inactive O
in O
transfected O
colonies O
of O
normal O
fibroblasts _RARE_
and O
it O
exhibited O
a O
low O
frequency O
of O
constitutive _RARE_
activation O
in O
transfected O
colonies O
of O
in O
vitro O
SV40 O
- O
transformed O
fibroblasts _RARE_
which O
did O
not O
exhibit O
L I-GENE
- I-GENE
plastin I-GENE
expression _RARE_
. O

The O
half _RARE_
- O
life O
of O
the O
serum O
- O
induced _RARE_
CBP I-GENE
/ O
tk I-GENE
binding O
activity O
was O
estimated O
to O
be O
less O
than O
1 O
h O
.( O
ABSTRACT O
TRUNCATED O
AT O
400 _RARE_
WORDS O
) O

The O
DNase I-GENE
I I-GENE
footprint O
extended O
5 O
' O
in O
the O
silencer _RARE_
region O
to O
include O
an O
inverted O
repeat O
of O
a O
six _RARE_
- O
nucleotide O
motif O
( O
epsilon O
- O
267 _RARE_
to O
- O
278 _RARE_
bp O
) O
which O
shares O
5 O
of O
6 O
bases O
with O
the O
GATA _RARE_
- I-GENE
1 I-GENE
consensus I-GENE
sequence I-GENE
. O

Furthermore O
, O
competitor O
containing O
the O
YY1 I-GENE
consensus I-GENE
sequence I-GENE
competed _RARE_
for _RARE_
protein I-GENE
B I-GENE
binding O
, O
whereas O
competitor O
containing O
a O
perfect O
yeast I-GENE
ABF _RARE_
- I-GENE
1 I-GENE
consensus I-GENE
sequence I-GENE
did O
not O
.( O
ABSTRACT O
TRUNCATED O
AT O
400 _RARE_
WORDS O
) O

The O
gene O
includes O
three O
exons O
and O
two O
introns _RARE_
within O
1 O
. O
6 O
kilobases O
of O
DNA O
, O
and O
the O
entire _RARE_
open _RARE_
reading O
frame O
for _RARE_
glycoprotein I-GENE
IX _RARE_
is O
included O
within O
the O
third O
exon _RARE_
. O

Rhizobium _RARE_
meliloti _RARE_
large O
plasmid _RARE_
pRmeGR4b _RARE_
carries O
the O
nodulation _RARE_
competitiveness _RARE_
locus O
nfe _RARE_
responsible O
for _RARE_
the O
nodulation _RARE_
efficiency O
and O
competitive O
ability O
of O
strain _RARE_
GR4 _RARE_
on O
alfalfa _RARE_
roots O
. O

Further O
, O
the O
ability O
of O
recombinant O
beta O
and O
/ O
or O
gamma O
chains O
to O
function O
in O
defined O
biochemical O
assays O
of O
beta O
gamma O
activity O
was O
assessed O
for _RARE_
membrane O
extracts O
and O
supernatant O
fractions O
from O
infected _RARE_
Sf9 O
cells O
. O

This O
report O
describes O
the O
identification O
of O
a O
gene O
of O
related O
function O
, O
SMD1 _RARE_
, O
located _RARE_
immediately O
3 O
' O
to O
PRP38 _RARE_
. O

These O
data O
establish O
Smd1p _RARE_
as _RARE_
a O
required O
component _RARE_
of O
the O
cellular O
splicing _RARE_
apparatus O
and O
a O
factor O
in O
snRNA _RARE_
maturation _RARE_
and O
stability O
. O

This O
study O
compared O
the O
gross O
and O
fine O
motor O
performance O
of O
14 O
traumatically _RARE_
brain O
- O
injured _RARE_
children O
( O
five O
to O
15 _RARE_
years O
old O
, O
with O
loss _RARE_
of O
consciousness _RARE_
for _RARE_
at _RARE_
least O
24 _RARE_
hours O
) O
to O
14 O
normal O
children O
group O
matched O
for _RARE_
age O
and O
sex _RARE_
. O

We O
compared O
the O
parameters O
pleural _RARE_
adenosine I-GENE
deaminase _RARE_
( O
PADA _RARE_
, O
determined O
in O
405 _RARE_
patients O
), _RARE_
the O
PADA _RARE_
/ O
serum I-GENE
ADA _RARE_
ratio O
( O
P I-GENE
/ O
SADA _RARE_
; O
276 _RARE_
cases O
), _RARE_
pleural _RARE_
lysozyme I-GENE
( O
PLYS _RARE_
, O
276 _RARE_
cases O
), _RARE_
the O
PLYS _RARE_
/ O
serum I-GENE
LYS _RARE_
ratio O
( O
P I-GENE
/ O
SLYS _RARE_
; O
276 _RARE_
cases O
), _RARE_
and O
pleural _RARE_
interferon _RARE_
gamma I-GENE
( O
IFN I-GENE
, O
145 _RARE_
cases O
) O
regarding O
their O
ability O
to O
differentiate O
tuberculous O
pleural _RARE_
effusions _RARE_
from O
others O
. O

These O
exons O
were O
identified O
by O
cloning O
and O
sequencing O
cDNAs O
obtained O
by O
polymerase O
chain O
reaction O
amplification O
of O
a O
fibroblast O
cDNA O
library O
. O

Deletion O
of O
the O
apeA _RARE_
gene I-GENE
, O
either O
with O
or O
without O
deletion O
of O
other O
proteinases _RARE_
( O
protease I-GENE
IV I-GENE
and O
aminopeptidase _RARE_
N I-GENE
), _RARE_
did O
not O
have O
any O
effect O
on O
cell O
growth O
in O
the O
various O
media O
tested O
. O

In O
Experiment O
2 O
scopolamine _RARE_
hydrobromide _RARE_
, O
0 _RARE_
. O
5 O
and O
1 O
. O
0 _RARE_
mg O
/ O
kg O
i O
. O
p O
., O
was O
administered O
1 O
h O
before O
each O
electrical O
stimulation _RARE_
until O
each O
rat O
showed O
the O
stage _RARE_
- O
3 O
seizure O
. O

PNT _RARE_
, O
ADD _RARE_
and O
BSS _RARE_
in O
the O
initial O
stage _RARE_
of O
kindling O
, O
kindling O
rate O
for _RARE_
the O
stage _RARE_
- O
3 O
and O
- O
5 O
seizures O
, O
seizure O
parameters O
at _RARE_
the O
first _RARE_
stage _RARE_
- O
3 O
and O
- O
5 O
were O
recorded O
and O
compared O
to O
the O
values O
of O
saline O
- O
treated O
, O
control O
group O
. O

CONCLUSIONS O
. O

There O
was O
a O
positive O
correlation O
between O
pyridinium _RARE_
cross O
- O
link _RARE_
excretion O
and O
thyroid O
hormone O
concentrations O
. O

Mutations O
truncating _RARE_
as _RARE_
many O
as _RARE_
143 _RARE_
C O
- O
terminal O
residues O
from O
the O
transcriptional O
activator O
encoded O
by O
the O
areA _RARE_
gene I-GENE
, O
mediating O
nitrogen O
metabolite O
repression O
in O
Aspergillus _RARE_
nidulans _RARE_
, O
do O
not O
significantly O
reduce O
the O
ability O
of O
the O
areA _RARE_
product I-GENE
to O
activate O
expression _RARE_
of O
most O
genes O
under O
areA _RARE_
control O
. O

Naval _RARE_
personnel _RARE_
who O
exceed _RARE_
standards _RARE_
for _RARE_
% O
BF _RARE_
can O
be O
separated O
from O
active _RARE_
duty _RARE_
. O

Weak _RARE_
promoter O
activity O
was O
observed O
for _RARE_
the O
promoter O
of O
the O
C1 I-GENE
and O
C2 I-GENE
ORFs _RARE_
( O
C1 I-GENE
- O
C2 I-GENE
gene O
) O
and O
for _RARE_
the O
promoter O
of O
the O
V1 _RARE_
ORF I-GENE
. O

The O
activity O
of O
the O
coat I-GENE
protein I-GENE
promoter I-GENE
of O
chloris _RARE_
striate _RARE_
mosaic O
virus O
is O
enhanced _RARE_
by O
its O
own O
and O
C1 I-GENE
- O
C2 I-GENE
gene O
products O
. O

The O
amino O
acid O
sequence O
alignment O
of O
TC _RARE_
II I-GENE
with O
that O
of O
other O
Cbl I-GENE
binding I-GENE
proteins I-GENE
( O
rat I-GENE
intrinsic _RARE_
factor I-GENE
, O
human I-GENE
transcobalamin _RARE_
I I-GENE
and O
porcine _RARE_
haptocorrin _RARE_
) O
revealed O
only O
33 _RARE_
% O
overall O
homology O
. O

This O
short O
communication _RARE_
compares _RARE_
a O
novel O
fluorimetric _RARE_
microplate _RARE_
enzyme O
immunoassay O
( O
FEIA _RARE_
) O
with O
a O
commercial O
time O
- O
resolved O
fluoroimmunoassay _RARE_
for _RARE_
the O
determination O
of O
thyrotropin I-GENE
in O
dried _RARE_
blood _RARE_
spots O
. O

The O
evaluation O
was O
performed O
using O
a O
retrospective O
study O
design O
with O
newborn O
blood _RARE_
samples O
from O
three O
screening O
centres _RARE_
. O

A O
region O
in O
the O
C O
- O
terminus O
of O
adenovirus I-GENE
2 I-GENE
/ I-GENE
5 I-GENE
E1a I-GENE
protein I-GENE
is O
required O
for _RARE_
association O
with O
a O
cellular O
phosphoprotein _RARE_
and O
important O
for _RARE_
the O
negative O
modulation O
of O
T24 _RARE_
- O
ras I-GENE
mediated _RARE_
transformation O
, O
tumorigenesis O
and O
metastasis O
. O

These O
studies O
demonstrate O
that O
both O
G I-GENE
alpha I-GENE
i I-GENE
genes I-GENE
are O
dynamically _RARE_
regulated O
in O
LLC _RARE_
- O
PK1 _RARE_
cells O
by O
both O
growth O
, O
differentiation O
, O
and O
hormone O
signals O
. O

Constructs _RARE_
containing O
the O
full I-GENE
- I-GENE
length I-GENE
PfCPK _RARE_
cDNA I-GENE
have O
been O
expressed _RARE_
in O
Escherichia O
coli O
at _RARE_
a O
high O
level O
to O
generate O
a O
60 _RARE_
- O
kDa O
recombinant O
protein O
. O

When O
ligated O
to O
the O
proIL _RARE_
- I-GENE
1 I-GENE
beta I-GENE
cap _RARE_
site I-GENE
- I-GENE
proximal I-GENE
region I-GENE
( O
located _RARE_
between O
- O
131 _RARE_
to O
+ O
12 O
), _RARE_
both O
the O
proIL _RARE_
- I-GENE
1 I-GENE
beta I-GENE
and O
the O
simian I-GENE
virus I-GENE
40 I-GENE
enhancer I-GENE
elements I-GENE
functioned O
more O
efficiently O
in O
monocytes O
than O
in O
HeLa O
cells O
, O
which O
are O
not O
normally O
competent O
for _RARE_
IL _RARE_
- I-GENE
1 I-GENE
beta I-GENE
expression _RARE_
. O

Therefore O
, O
PC I-GENE
- I-GENE
PLC I-GENE
is O
a O
component _RARE_
of O
a O
signal O
transduction _RARE_
pathway _RARE_
leading O
to O
transcription O
of O
c I-GENE
- I-GENE
fos I-GENE
and O
junB I-GENE
that O
collaborates _RARE_
with O
c I-GENE
- I-GENE
myc I-GENE
and O
is O
independent O
of O
PKC I-GENE
- I-GENE
delta I-GENE
and O
Ras I-GENE
activation O
. O

In O
mitogen O
- O
stimulated _RARE_
splenocytes _RARE_
, O
Gfi _RARE_
- I-GENE
1 I-GENE
expression _RARE_
begins O
to O
rise O
at _RARE_
12 O
h O
after O
stimulation _RARE_
and O
reaches _RARE_
very O
high O
levels O
after O
50 O
h O
, O
suggesting O
that O
it O
may O
be O
functionally O
involved O
in O
events O
occurring O
after O
the O
interaction O
of O
IL _RARE_
- I-GENE
2 I-GENE
with O
its O
receptor O
, O
perhaps O
during _RARE_
the O
transition O
from O
the O
G1 O
to O
the O
S O
phase _RARE_
of O
the O
cell O
cycle _RARE_
. O

We O
have O
isolated O
and O
characterized O
the O
GCD6 _RARE_
and O
GCD7 _RARE_
genes I-GENE
and O
shown O
that O
their O
products O
are O
required O
to O
repress O
GCN4 I-GENE
translation O
under O
nonstarvation _RARE_
conditions O
. O

The O
plateau _RARE_
MO2 _RARE_
value O
was O
that O
predicted O
by O
allometric _RARE_
relation O
. O

While O
the O
latter O
corresponded O
to O
a O
protein O
of O
824 _RARE_
amino O
acids _RARE_
, O
an O
upstream O
open _RARE_
reading O
frame O
( O
uORF _RARE_
) O
within O
the O
5 O
' O
leader _RARE_
could O
potentially O
encode O
a O
54 O
amino O
acid O
peptide O
. O

The O
SCH9 _RARE_
protein I-GENE
kinase I-GENE
mRNA I-GENE
contains O
a O
long O
5 O
' O
leader _RARE_
with O
a O
small O
open _RARE_
reading O
frame O
. O

In O
contrast O
to O
T O
cells O
, O
in O
fibroblasts _RARE_
PILOT _RARE_
gene I-GENE
expression _RARE_
requires O
only O
one O
signal O
( O
PMA O
) O
and O
is O
not O
affected O
by O
CyA _RARE_
. O

Histochemical _RARE_
localization _RARE_
of O
GUS I-GENE
revealed O
promoter O
function O
in O
leaf O
epidermis _RARE_
, O
mesophyll _RARE_
and O
vascular O
bundles _RARE_
, O
in O
the O
cortex O
and O
vascular O
cylinder _RARE_
of O
the O
root O
. O

In O
order O
to O
investigate O
how O
these O
expression _RARE_
patterns O
are O
established O
, O
we O
fused O
promoter O
regions O
of O
an O
acidic _RARE_
and O
a O
basic O
glucanase _RARE_
gene I-GENE
to O
the O
beta I-GENE
- I-GENE
glucuronidase I-GENE
( O
GUS I-GENE
) O
reporter O
gene O
and O
examined O
expression _RARE_
of O
these O
constructs O
in O
transgenic O
tobacco O
plants _RARE_
. O

Southern O
blot O
analysis O
using O
probes _RARE_
from O
the O
3 O
' O
portions O
of O
the O
genomic O
and O
B I-GENE
. I-GENE
napus _RARE_
MA _RARE_
and O
MB I-GENE
cDNA I-GENE
clones _RARE_
showed O
that O
MA _RARE_
type I-GENE
myrosinases _RARE_
are O
encoded O
by O
approximately _RARE_
4 O
genes O
, O
while O
MB I-GENE
type I-GENE
myrosinases _RARE_
are O
encoded O
by O
more O
than O
10 O
genes O
in O
B O
. O
napus _RARE_
. O

Sudomoina _RARE_
, O
A O
. O

Zinc _RARE_
fingers _RARE_
( O
Zf _RARE_
) O
are O
a O
common O
structural O
motif O
found O
in O
many O
nucleic _RARE_
acid O
- O
binding O
proteins O
. O

The O
deduced O
bovine O
EFIA I-GENE
# _RARE_
1 I-GENE
amino O
acid O
( O
aa _RARE_
) O
sequence O
is O
98 O
% O
identical O
to O
rat O
EFIA I-GENE
and O
100 _RARE_
% O
identical O
to O
human O
EFIA I-GENE
/ O
DbpB _RARE_
/ O
YB _RARE_
- I-GENE
1 I-GENE
family O
member _RARE_
DNA I-GENE
- I-GENE
binding I-GENE
protein I-GENE
B I-GENE
( O
DbpB _RARE_
). O

Effect O
of O
tracheal O
insufflation _RARE_
of O
deferoxamine _RARE_
on O
acute O
ozone _RARE_
toxicity O
in O
rats O
. O

Localization O
of O
the O
insertion _RARE_
locus O
in O
the O
yeast O
genome O
and O
complementation _RARE_
studies O
with O
the O
temperature _RARE_
- O
sensitive _RARE_
mutant O
indicate O
that O
the O
two O
mutations O
are O
allelic O
. O

Replacement _RARE_
of O
the O
spacer O
sequence O
between O
the O
two O
ARMs _RARE_
with O
a O
shorter O
stretch O
of O
sequence O
also O
reduced _RARE_
RNA O
binding O
in O
vitro O
. O

Type _RARE_
II O
could O
be O
divided O
further O
into O
two O
forms O
( O
IIA _RARE_
and O
IIB _RARE_
) O
that O
may O
represent O
two O
underscribed _RARE_
species O
or O
developmental O
stages O
of O
the O
same O
species O
. O

Second O
, O
the O
transcription I-GENE
factor I-GENE
Gal _RARE_
- I-GENE
ER I-GENE
was O
rendered _RARE_
more O
potent O
and O
less O
susceptible O
to O
cell O
type O
- O
specific O
variation O
by O
fusing _RARE_
the O
strong O
activating O
domain O
of O
the O
herpesvirus _RARE_
protein I-GENE
VP16 I-GENE
onto O
its O
C O
terminus O
. O

The O
exogenous _RARE_
fos I-GENE
gene I-GENE
was O
rapidly O
induced _RARE_
to O
maximal O
levels O
within O
1 O
- O
2 O
hr O
of O
estrogen O
addition O
. O

Elimination O
of O
Haemophilus O
influenzae O
type O
b O
meningitis O
after O
introduction O
of O
vaccination O

Endosonography _RARE_
accurately O
assessed O
tumor O
extension O
in O
two O
T2 _RARE_
tumors O
, O
14 O
T3 _RARE_
tumors O
, O
and O
seven _RARE_
T4 O
tumors O
. O

In O
the O
present O
study O
we O
demonstrated O
a O
unique O
mechanism O
of O
action O
of O
8 O
- O
Cl O
- O
cAMP O
in O
the O
regulation _RARE_
of O
these O
kinase O
isozymes _RARE_
in O
HL _RARE_
- O
60 _RARE_
human O
promyelocytic _RARE_
leukemia O
cells O
. O

Analysis O
of O
cell O
cycle _RARE_
regulation _RARE_
in O
the O
budding _RARE_
yeast O
Saccharomyces O
cerevisiae O
has O
shown O
that O
a O
central O
regulatory O
protein O
kinase O
, O
Cdc28 I-GENE
, O
undergoes O
changes O
in O
activity O
through O
the O
cell O
cycle _RARE_
by O
associating _RARE_
with O
distinct O
groups O
of O
cyclins _RARE_
that O
accumulate O
at _RARE_
different O
times O
. O

Overlapping _RARE_
clones _RARE_
representing O
full O
- O
length O
cDNAs O
for _RARE_
MMI _RARE_
alpha I-GENE
were O
obtained O
from O
mouse O
brain O
. O

The O
method O
involves O
preliminary O
isolation O
of O
oxiracetam _RARE_
and O
internal O
standard O
from O
plasma O
by O
solid O
- O
phase _RARE_
extraction O
prior O
to O
the O
formation O
of O
their O
n _RARE_
- O
propyl _RARE_
carbamate _RARE_
derivatives _RARE_
. O

There O
are O
, O
however O
, O
several O
differences O
between O
the O
two O
new O
ars _RARE_
sequences O
. O

Pathways _RARE_
linking O
the O
olfactory O
bulbs _RARE_
with O
the O
medial O
preoptic _RARE_
anterior O
hypothalamus O
are O
important O
for _RARE_
intermale _RARE_
aggression O
in O
mice O
. O

Pokeweed _RARE_
mitogen I-GENE
( O
PWM _RARE_
) O
or O
anti I-GENE
- I-GENE
CD3 I-GENE
significantly O
increases O
c I-GENE
- I-GENE
jun I-GENE
messenger _RARE_
RNA I-GENE
( I-GENE
mRNA I-GENE
) I-GENE
levels O
in O
T O
cells O
. O

Following O
seizure O
induction O
, O
MABP _RARE_
increased O
to O
105 _RARE_
mm O
Hg O
and O
brain O
pHi _RARE_
fell O
to O
6 O
. O
79 _RARE_
+/- O
0 _RARE_
. O
03 O
within O
15 _RARE_
min O
and O
remained O
at _RARE_
this O
level O
for _RARE_
1 O
h O
( O
P O
< O
0 _RARE_
. O
001 O
). O

In O
contrast O
, O
rats O
receiving O
U74500A _RARE_
( O
2 O
mg O
/ O
kg O
i O
. O
v O
. O
infusion O
commencing _RARE_
30 _RARE_
min O
prior O
to O
revascularisation _RARE_
) O
exhibited O
enhanced _RARE_
GMBF _RARE_
throughout O
reperfusion O
[ _RARE_
PI O
10 O
min O
: O
3 O
. O
26 _RARE_
( O
2 O
. O
56 _RARE_
- O
3 O
. O
63 _RARE_
); O
120 O
min O
: O
2 O
. O
03 O
( O
1 O
. O
73 _RARE_
- O
2 O
. O
25 _RARE_
); O
240 O
min O
: O
2 O
. O
13 _RARE_
( O
1 O
. O
75 _RARE_
- O
2 O
. O
44 _RARE_
), _RARE_
p O
< O
0 _RARE_
. O
01 O
vs _RARE_
. O
controls O
and O
normals O
] O
with O
complete _RARE_
muscle O
salvage _RARE_
[ _RARE_
GMV _RARE_
100 _RARE_
% O
in O
all O
reperfused _RARE_
muscles O
, O
p O
< O
0 _RARE_
. O
01 O
vs _RARE_
. O
controls O
, O
not O
significant O
( O
NS _RARE_
) O
vs _RARE_
. O
normals O
and O
6 O
h O
ischaemia O
].( _RARE_
ABSTRACT O
TRUNCATED O
AT O
250 _RARE_
WORDS O
) O

Sequencing O
of O
a O
1 O
. O
3 O
- O
kilobase _RARE_
fragment O
of O
the O
5 O
'- O
flanking O
region O
of O
the O
TSG6 _RARE_
gene I-GENE
identified O
TATA O
- O
like O
and O
CAAT O
sequences O
near O
the O
transcription O
start _RARE_
site O
. O

The O
region O
that O
imparts _RARE_
inducibility O
by O
IL _RARE_
- I-GENE
1 I-GENE
or O
TNF I-GENE
( O
positions O
- O
165 O
to O
- O
58 O
) O
contains O
potential _RARE_
binding O
sites O
for _RARE_
IRF I-GENE
- I-GENE
1 I-GENE
and I-GENE
- I-GENE
2 I-GENE
, O
AP I-GENE
- I-GENE
1 I-GENE
, O
and O
NF _RARE_
- I-GENE
IL _RARE_
- I-GENE
6 I-GENE
. O

Ig I-GENE
- I-GENE
alpha I-GENE
and O
Ig I-GENE
- I-GENE
beta I-GENE
contain O
extended O
cytoplasmic O
structure _RARE_
( O
61 _RARE_
and O
48 _RARE_
amino O
acids _RARE_
, O
respectively O
) O
and O
associate O
with O
cytoplasmic O
effectors _RARE_
indicating O
that O
they O
are O
directly O
involved O
in O
signal O
transduction _RARE_
. O

Sterile _RARE_
mutants O
of O
Saccharomyces O
cerevisiae O
were O
isolated O
from O
alpha O
* _RARE_
cells O
having O
the O
a I-GENE
/ I-GENE
alpha I-GENE
aar1 _RARE_
- I-GENE
6 I-GENE
genotype _RARE_
( O
exhibiting O
alpha O
mating _RARE_
ability O
and O
weak O
a O
mating _RARE_
ability O
as _RARE_
a O
result O
of O
a O
defect O
in O
a1 _RARE_
- I-GENE
alpha I-GENE
2 I-GENE
repression O
). O

We O
studied O
the O
functional _RARE_
interaction O
between O
human O
embryonic _RARE_
zeta _RARE_
2 I-GENE
globin I-GENE
promoter O
and O
the O
alpha I-GENE
globin I-GENE
regulatory I-GENE
element I-GENE
( O
HS _RARE_
- I-GENE
40 I-GENE
) O
located _RARE_
40 O
kb O
upstream O
of O
the O
zeta _RARE_
2 I-GENE
globin I-GENE
gene I-GENE
. O

It O
was O
shown O
by O
transient O
expression _RARE_
assay O
that O
HS _RARE_
- I-GENE
40 I-GENE
behaved _RARE_
as _RARE_
an O
authentic _RARE_
enhancer O
for _RARE_
high O
- O
level O
zeta _RARE_
2 I-GENE
globin I-GENE
promoter I-GENE
activity O
in O
K562 O
cells O
, O
an O
erythroid _RARE_
cell O
line O
of O
embryonic _RARE_
and O
/ O
or O
fetal _RARE_
origin O
. O

Initial O
results O
indicate O
that O
this O
23S _RARE_
pre I-GENE
- I-GENE
rRNA I-GENE
is O
the O
same O
as _RARE_
the O
species O
detected O
on O
depletion O
of O
the O
small I-GENE
nucleolar _RARE_
RNA I-GENE
- I-GENE
associated I-GENE
proteins I-GENE
NOP1 _RARE_
and O
GAR1 _RARE_
and O
in O
an O
snr10 _RARE_
mutant I-GENE
strain _RARE_
. O

Breitbart _RARE_
, O
L O
. O

This O
study O
evaluates _RARE_
the O
feasibility O
of O
indirect O
mesenteric _RARE_
lymphangiography _RARE_
as _RARE_
a O
colonoscopic _RARE_
technique O
in O
a O
canine O
model O
. O

OBJECTIVE O
: O
Our O
purpose O
was O
to O
determine O
the O
simultaneous O
concentrations O
of O
serum O
cotinine _RARE_
in O
both O
fetal _RARE_
and O
maternal _RARE_
blood _RARE_
. O

Internal _RARE_
amino O
acid O
sequence O
has O
now O
been O
obtained O
from O
this O
protein O
which O
shares O
50 O
- O
100 _RARE_
% O
sequence O
identity O
with O
sequences O
encoded O
by O
mammalian I-GENE
G I-GENE
alpha I-GENE
11 I-GENE
and O
G I-GENE
alpha I-GENE
q _RARE_
cDNAs I-GENE
. O

Estradiol _RARE_
is O
known O
to O
induce O
expression _RARE_
of O
certain O
proto _RARE_
- O
oncogenes _RARE_
, O
and O
this O
led O
us O
to O
examine O
potential _RARE_
regulatory O
regions O
of O
the O
cellular I-GENE
c I-GENE
- I-GENE
fos I-GENE
oncogene I-GENE
. O

Air _RARE_
lead O
was O
not O
a O
significant O
explanatory _RARE_
variable _RARE_
. O

We O
now O
show O
that O
regulation _RARE_
of O
flaN _RARE_
transcription O
in O
vivo O
depends O
on O
a O
sigma _RARE_
54 I-GENE
promoter I-GENE
and O
two O
ftr _RARE_
elements O
located _RARE_
downstream _RARE_
of O
the O
transcription O
start _RARE_
site O
at _RARE_
+ O
86 _RARE_
( O
ftr2 _RARE_
) O
and O
+ O
120 O
( O
ftr3 _RARE_
). O

5 O
micrograms O
/ O
l _RARE_
was O
detected O
in O
urine O
from O
some O
non O
- O
occupationally _RARE_
exposed O
persons O
. O

Fibular _RARE_
dimelia _RARE_
with O
deficiency O
of O
the O
tibia _RARE_
. O

This O
prospective O
study O
compared O
the O
measured O
energy O
expenditures _RARE_
of O
30 _RARE_
patients O
using O
indirect O
calorimetry _RARE_
with O
their O
predicted O
basal O
energy O
expenditure O
according O
to O
the O
Harris _RARE_
- O
Benedict _RARE_
equation O
, O
or O
their O
calculated O
energy O
expenditure O
derived O
from O
basal O
energy O
expenditure O
times O
, O
an O
activity O
factor O
, O
and O
a O
stress O
factor O
. O

However O
, O
after O
repeated _RARE_
infections O
, O
hypobiotic _RARE_
larvae O
were O
numerous O
. O

This O
was O
performed O
in O
a O
double O
blinded _RARE_
, O
randomized O
, O
placebo O
- O
controlled _RARE_
study O
. O

Group O
I O
consisted O
of O
six _RARE_
noncholestatic _RARE_
patients O
; O
group O
II O
consisted O
of O
nine O
mildly _RARE_
cholestatic _RARE_
patients O
with O
mild O
hepatic _RARE_
impairment O
( O
conjugated O
bilirubin O
, O
47 _RARE_
mumol O
liter O
- O
1 O
; O
alkaline _RARE_
phosphatase I-GENE
, O
280 _RARE_
IU O
liter O
- O
1 O
; O
gamma I-GENE
- I-GENE
glutamyltranspeptidase _RARE_
, O
190 O
IU O
liter O
- O
1 O
); O
group O
III O
consisted O
of O
six _RARE_
benign O
intrahepatic O
cholestatic _RARE_
patients O
with O
high O
isolated O
conjugated O
hyperbilirubinemia O
( O
98 O
. O
1 O
mumol O
liter O
- O
1 O
). O

There O
was O
either O
no _RARE_
change O
or O
an O
improvement O
in O
renographic _RARE_
findings O
( O
t1 O
/ O
2 O
time O
and O
/ O
or O
split _RARE_
function O
) O
in O
40 O
patients O
( O
93 O
%). O

We O
discuss O
the O
need O
to O
use O
animals O
older O
than O
3 O
months O
for _RARE_
the O
study O
of O
' O
adult O
' O
regeneration O
phenomena O
since O
3 O
- O
month O
- O
old O
rats O
may O
be O
somewhat _RARE_
immature O
. O

Nuclear I-GENE
beta I-GENE
II I-GENE
PKC I-GENE
, O
like O
p34cdc2 I-GENE
kinase I-GENE
, O
may O
function O
to O
regulate O
nuclear O
lamina _RARE_
structural O
stability O
during _RARE_
cell O
cycle _RARE_
. O

In O
situ O
copper _RARE_
- O
phenanthroline _RARE_
footprinting O
of O
individual O
gel O
shift O
assembly O
intermediates _RARE_
shows O
that O
on O
the O
302 _RARE_
- O
nucleotide O
G4oric _RARE_
, O
the O
first _RARE_
two O
SSB I-GENE
tetramers _RARE_
assemble _RARE_
at _RARE_
random O
, O
but O
the O
addition O
of O
more O
SSB I-GENE
tetramers _RARE_
results O
in O
formation O
of O
a O
unique O
structure _RARE_
. O

Effects O
of O
intramammary _RARE_
endotoxin _RARE_
infusion O
on O
milking _RARE_
- O
induced _RARE_
oxytocin _RARE_
release O
. O

Finger _RARE_
associated I-GENE
box I-GENE
- I-GENE
zinc I-GENE
finger I-GENE
proteins I-GENE
( O
FAX _RARE_
- I-GENE
ZFPs _RARE_
) O
constitute O
a O
subfamily O
of O
the O
many O
C2H2 _RARE_
type I-GENE
ZFPs _RARE_
in O
Xenopus O
laevis _RARE_
. O

Further O
evidence O
for _RARE_
a O
clustered O
organization O
of O
FAX _RARE_
- O
ZFP _RARE_
transcription O
units _RARE_
is O
provided O
by O
Southern O
blot O
analysis O
of O
large O
genomic O
restriction _RARE_
fragments O
separated O
by O
transverse O
field O
gel O
electrophoresis O
, O
and O
by O
in O
situ O
hybridization O
on O
intact _RARE_
chromosomes O
. O

A O
rat O
cDNA O
that O
encodes O
eIF I-GENE
- I-GENE
5 I-GENE
has O
been O
isolated O
and O
expressed _RARE_
in O
Escherichia O
coli O
to O
yield O
a O
catalytically O
active _RARE_
eIF I-GENE
- I-GENE
5 I-GENE
protein I-GENE
. O

Mutational O
analyses O
have O
demonstrated O
the O
importance O
of O
sequences O
within O
the O
327 _RARE_
bp O
segment O
that O
contain O
a O
putative O
cyclic I-GENE
AMP I-GENE
responsive I-GENE
element I-GENE
binding I-GENE
protein I-GENE
( O
CREB I-GENE
) O
binding O
site O
for _RARE_
TGF I-GENE
- I-GENE
beta I-GENE
1 I-GENE
and O
PMA O
responsiveness O
and O
putative O
PU _RARE_
- I-GENE
1 I-GENE
and O
Sp1 _RARE_
binding I-GENE
sites I-GENE
for _RARE_
basal O
promoter O
activity O
. O

( O
1992 O
) O
J _RARE_
. O

In O
F42A _RARE_
- O
stimulated _RARE_
internalization O
assays O
on O
forskolin O
- O
induced _RARE_
YT _RARE_
- O
1 O
cells O
, O
the O
IL _RARE_
- I-GENE
2R I-GENE
alpha I-GENE
chain I-GENE
is O
consistently O
endocytosed _RARE_
together O
with O
the O
IL _RARE_
- I-GENE
2R I-GENE
beta I-GENE
subunit I-GENE
indicating O
that O
IL _RARE_
- I-GENE
2R I-GENE
alpha I-GENE
is O
stably O
associated O
with O
the O
F42A _RARE_
- I-GENE
IL _RARE_
- I-GENE
2R I-GENE
beta I-GENE
complex I-GENE
even O
though O
the O
alpha O
- O
subunit O
contributes O
little O
if O
any O
affinity O
to O
the O
F42A _RARE_
binding O
reaction O
. O

The O
microcirculatory _RARE_
dynamics O
of O
prostaglandin _RARE_
E1 O
and O
/ O
or O
nicardipine _RARE_
and O
their O
different O
reactions O
in O
the O
hyper _RARE_
- O
and O
hypodynamic _RARE_
state O
of O
septic _RARE_
shock O
in O
a O
rat O
model O

We O
obtained O
the O
prevalence O
of O
IgG I-GENE
antibodies I-GENE
against O
Trypanosoma O
cruzi _RARE_
among O
1076 _RARE_
blood _RARE_
donors O
at _RARE_
the O
Instituto _RARE_
Nacional _RARE_
de O
Cardiologia _RARE_
" O
Ignacio _RARE_
Chavez _RARE_
" O
in O
Mexico _RARE_
City O
. O

Examination O
of O
the O
immediate O
sequence O
5 O
' O
to O
the O
mRNA O
start _RARE_
site O
reveals O
no _RARE_
TATA O
box O
and O
multiple O
known O
enhancer O
sequences O
. O

The O
short O
- O
term O
synthesis _RARE_
and O
infant O
- O
regulated O
removal O
of O
milk O
in O
lactating _RARE_
women O
. O

Pseudosubstrate _RARE_
( O
19 O
- O
36 _RARE_
), _RARE_
derived O
from O
the O
C O
- O
terminus O
of O
Ca I-GENE
- I-GENE
dependent I-GENE
PKC I-GENE
isotypes _RARE_
, O
inhibited O
beta I-GENE
- I-GENE
PKC I-GENE
but O
not O
nPKC _RARE_
activity O
using O
either O
Histone _RARE_
IIIS _RARE_
or O
peptide O
( O
19 O
- O
31 _RARE_
) O
as _RARE_
substrate O
. O

Based O
on O
these O
results O
, O
a O
new O
model O
for _RARE_
the O
regulation _RARE_
of O
nif _RARE_
/ O
fix _RARE_
gene O
expression _RARE_
in O
A O
. O
caulinodans _RARE_
is O
proposed O
. O

Nitric _RARE_
oxide O
inhalation O
selectively O
reduces O
pulmonary O
hypertension O
in O
porcine _RARE_
endotoxin _RARE_
shock O
and O
improves _RARE_
arterial O
oxygenation O
and O
pH O
with O
a O
marked O
attenuation _RARE_
of O
sympathetic O
activation O
. O

B O
cell O
- O
specific O
mb _RARE_
- I-GENE
1 I-GENE
and O
B29 _RARE_
genes I-GENE
encode O
the O
alpha O
/ O
beta O
components _RARE_
of O
the O
BCR _RARE_
- I-GENE
associated I-GENE
complex I-GENE
in O
mature _RARE_
sIgM _RARE_
+ I-GENE
B O
cells O
. O

Bipolarity _RARE_
in O
Jungian _RARE_
type O
theory O
and O
the O
Myers _RARE_
- O
Briggs _RARE_
Type _RARE_
Indicator _RARE_
. O

A O
variety O
of O
nuclear O
ribonucleoproteins _RARE_
are O
believed O
to O
associate O
directly O
with O
nascent _RARE_
RNA I-GENE
polymerase I-GENE
II I-GENE
transcripts I-GENE
and O
remain _RARE_
associated O
during _RARE_
subsequent O
nuclear O
RNA O
processing _RARE_
reactions O
, O
including O
pre O
- O
mRNA O
polyadenylation O
and O
splicing _RARE_
as _RARE_
well _RARE_
as _RARE_
nucleocytoplasmic _RARE_
mRNA O
transport _RARE_
. O

Mutations O
at _RARE_
three O
sites O
have O
larger O
effects O
in O
muscle O
than O
nonmuscle _RARE_
cells O
; O
an O
A O
/ O
T O
- O
rich O
site O
mutation O
has O
a O
pronounced O
effect O
in O
both O
striated _RARE_
muscle O
types _RARE_
, O
mutations O
at _RARE_
the O
MEF1 _RARE_
( I-GENE
Right _RARE_
E I-GENE
- I-GENE
box I-GENE
) I-GENE
site I-GENE
are O
relatively O
specific O
to O
expression _RARE_
in O
skeletal O
muscle O
, O
and O
mutations O
at _RARE_
the O
CArG _RARE_
site O
are O
relatively O
specific O
to O
expression _RARE_
in O
cardiac O
muscle O
. O

Transient O
transfection O
analysis O
with O
these O
mutations O
revealed O
that O
only O
a O
10 O
- O
bp O
region O
, O
containing O
precisely O
the O
Ets I-GENE
and O
proximal O
LyF _RARE_
- I-GENE
1 I-GENE
binding I-GENE
sites I-GENE
, O
was O
needed O
for _RARE_
D O
' O
activity O
. O

However O
, O
despite O
its O
relationship O
to O
the O
TR I-GENE
, O
Rev _RARE_
- O
Erb _RARE_
bound _RARE_
poorly O
to O
TR I-GENE
binding I-GENE
sites I-GENE
. O

We O
report O
here O
that O
a O
25 _RARE_
- O
bp O
promoter O
element O
previously O
shown O
to O
be O
important O
for _RARE_
the O
G1 O
- O
S O
activation O
of O
the O
human I-GENE
thymidine _RARE_
kinase I-GENE
( O
htk _RARE_
) O
promoter O
in O
growth O
- O
stimulated _RARE_
cells O
is O
a O
cellular O
target O
of O
cyclin _RARE_
A I-GENE
and O
the O
p33cdk2 _RARE_
complexes I-GENE
. O

These O
protective O
influences O
were O
observed O
throughout O
the O
range O
of O
filling O
pressures O
measured O
, O
from O
0 _RARE_
to O
30 _RARE_
mmHg O
. O

DNase I-GENE
I I-GENE
footprinting O
with O
rat O
liver O
nuclear O
extracts O
identified O
7 O
major O
protein O
- O
binding O
domains O
termed O
P1 O
through O
P7 _RARE_
in O
a O
796 _RARE_
base _RARE_
pair _RARE_
DNA O
fragment O
( O
base _RARE_
pairs _RARE_
- O
763 _RARE_
to O
+ O
33 _RARE_
). O

This O
may O
account O
, O
at _RARE_
least O
in O
part O
, O
for _RARE_
the O
ability O
of O
excess O
wt I-GENE
p53 I-GENE
to O
inhibit O
cell O
proliferation _RARE_
and O
to O
interfere _RARE_
with O
neoplastic O
processes O
. O

Neither O
clone O
encoded O
the O
cognate _RARE_
endonuclease O
. O

Northern O
blot O
analysis O
of O
total _RARE_
cellular O
RNA O
indicated O
that O
xylP _RARE_
encodes O
a O
1 O
. O
3 O
- O
kb O
transcript O
which O
is O
induced _RARE_
by O
xylan _RARE_
. O

The O
nifJ _RARE_
and O
nifH _RARE_
promoters I-GENE
of I-GENE
Klebsiella _RARE_
pneumoniae _RARE_
are O
divergently O
transcribed _RARE_
sigma _RARE_
54 I-GENE
- I-GENE
dependent I-GENE
promoters I-GENE
that O
are O
positively O
activated O
by O
the O
NifA _RARE_
protein I-GENE
. O

These O
data O
show O
that O
PTH _RARE_
and O
cAMP O
can O
repress O
collagen _RARE_
promoter I-GENE
activity O
in O
calvariae _RARE_
from O
transgenic O
mice O
, O
suggesting O
that O
the O
alpha I-GENE
1 I-GENE
( I-GENE
I I-GENE
) I-GENE
collagen _RARE_
promoter I-GENE
may O
contain O
cis O
elements O
down O
- O
stream _RARE_
of O
- O
2 O
. O
3 O
kilobases O
that O
mediate O
PTH _RARE_
and O
cAMP O
repression O
of O
collagen _RARE_
gene I-GENE
expression _RARE_
in O
bone O
. O

Both O
inhaled O
and O
superfused _RARE_
isoflurane O
dilated _RARE_
the O
baseline O
vein _RARE_
diameter O
before O
stimulation _RARE_
. O

Prevalence _RARE_
of O
rheumatoid O
arthritis O
and O
rheumatoid I-GENE
factor I-GENE
in O
women O
: O
evidence O
for _RARE_
a O
secular _RARE_
decline O
. O

Although O
olfactory O
associative _RARE_
conditioning O
in O
newborn O
rats O
produces O
marked O
structural O
and O
functional _RARE_
changes O
in O
the O
olfactory O
bulb O
, O
recent O
evidence O
suggests O
that O
extrabulbar _RARE_
circuits _RARE_
must O
be O
involved O
in O
storing _RARE_
these O
early O
memories _RARE_
. O

The O
fission _RARE_
yeast I-GENE
dsk1 _RARE_
+ I-GENE
gene I-GENE
, O
a O
multicopy O
suppressor O
for _RARE_
cold O
- O
sensitive _RARE_
dis1 _RARE_
mutants I-GENE
, O
encodes O
a O
novel O
61 _RARE_
- O
kd _RARE_
protein O
kinase O
. O

Closure _RARE_
of O
the O
patent _RARE_
ductus _RARE_
arteriosus _RARE_
with O
a O
Ligaclip _RARE_
through O
a O
minithoracotomy _RARE_
. O

Sequence O
comparison O
between O
the O
translated O
ORF O
and O
a O
protein O
database O
reveal O
between O
26 _RARE_
. O
5 O
and O
23 _RARE_
. O
4 O
% O
aa _RARE_
sequence O
homology O
to O
bacterial I-GENE
transmembrane I-GENE
( I-GENE
TM _RARE_
) I-GENE
proteins I-GENE
including O
those O
mediating O
chloramphenicol O
( O
Cm _RARE_
) O
and O
tetracycline _RARE_
( O
Tc O
) O
resistance O
and O
an O
arabinose _RARE_
- O
proton _RARE_
symport _RARE_
protein O
. O

The O
yeast O
gene O
that O
encodes O
eIF I-GENE
- I-GENE
5 I-GENE
, O
designated O
TIF5 _RARE_
, O
has O
been O
isolated O
and O
expressed _RARE_
in O
Escherichia O
coli O
to O
yield O
a O
catalytically O
active _RARE_
eIF I-GENE
- I-GENE
5 I-GENE
protein I-GENE
. O

The O
strategies O
by O
which O
hepatitis O
B O
and O
hepatitis O
D O
can O
be O
diminished O
and O
eventually _RARE_
eliminated _RARE_
are O
: O
immunization O
, O
measures O
to O
prevent O
exposure O
to O
infective _RARE_
blood _RARE_
or O
blood _RARE_
derivatives _RARE_
and O
education O
( O
in O
particular O
awareness _RARE_
that O
hepatitis O
B O
is O
a O
sexually _RARE_
transmitted O
disease _RARE_
). O

Xylose _RARE_
- O
and O
arabinose _RARE_
- O
containing O
polymers O
were O
better O
digested _RARE_
than O
was O
cellulose _RARE_
for _RARE_
both O
breads _RARE_
. O

The O
technical _RARE_
construction _RARE_
of O
the O
mouth O
protectors _RARE_
is O
illustrated _RARE_
, O
as _RARE_
is O
the O
need O
for _RARE_
instrumentation _RARE_
and O
its O
costs O
and O
the O
materials O
required O
to O
manufacture _RARE_
these O
mouth O
protectors _RARE_
. O

The O
alpha O
- O
subunit O
by O
itself O
binds O
to O
telomeric O
DNA O
. O

We O
conclude O
that O
the O
alpha O
- O
subunit O
of O
the O
telomere _RARE_
- I-GENE
binding I-GENE
protein I-GENE
, O
like O
many O
transcription O
factors O
, O
has O
separable _RARE_
DNA O
- O
binding O
and O
protein O
- O
protein O
interaction O
domains O
. O

Three O
patients O
had O
well _RARE_
-, _RARE_
6 O
patients O
had O
moderately O
-, _RARE_
and O
5 O
patients O
had O
poorly O
- O
differentiated O
adenocarcinoma O
of O
the O
prostate _RARE_
. O

Spontaneous _RARE_
burst O
firing _RARE_
in O
cat _RARE_
primary _RARE_
auditory O
cortex O
: O
age O
and O
depth O
dependence O
and O
its O
effect O
on O
neural _RARE_
interaction O
measures O
. O

By O
applying O
the O
potentiometric _RARE_
method O
, O
in O
aqueous O
medium O
of O
ionic O
strength O
mu O
= O
0 _RARE_
. O
2 O
, O
the O
stability O
constants O
, O
log O
beta O
1 O
= O
4 O
. O
42 _RARE_
and O
log O
beta O
2 O
= O
8 O
. O
57 O
were O
obtained O
. O

Cryopreservation _RARE_
straws _RARE_
filled O
with O
media O
plus _RARE_
additive O
are O
emersed _RARE_
below O
the O
surface O
of O
an O
unprocessed _RARE_
donor O
ejaculate _RARE_
. O

The O
bcl I-GENE
- I-GENE
2 I-GENE
gene I-GENE
can O
potentially O
encode O
26 _RARE_
- O
and O
22 _RARE_
- O
kDa O
proteins O
that O
differ O
only O
in O
their O
carboxyl _RARE_
tails O
because O
of O
an O
alternative _RARE_
splicing _RARE_
mechanism O
. O

The O
active _RARE_
open _RARE_
reading O
frame O
in O
the O
clone O
maps O
at _RARE_
27 _RARE_
min O
on O
the O
E O
. O
coli O
chromosome _RARE_
and O
is O
identical O
in O
sequence O
to O
a O
wild O
type O
counterpart _RARE_
. O

Subsequent _RARE_
cloning O
and O
nucleotide O
sequence O
analysis O
of O
the O
S I-GENE
. I-GENE
pombe I-GENE
adenylate I-GENE
kinase I-GENE
gene I-GENE
, O
adk1 _RARE_
, O
revealed O
a O
coding O
region O
of O
660 _RARE_
nucleotides O
. O

Calcification _RARE_
of O
a O
cariogenic _RARE_
Streptococcus _RARE_
and O
of O
Corynebacterium _RARE_
( O
Bacterionema _RARE_
) O
matruchotii _RARE_
. O

As O
a O
result O
of O
alternative _RARE_
splicing _RARE_
, O
the O
BGP _RARE_
gene I-GENE
is O
transcribed _RARE_
into O
at _RARE_
least O
seven _RARE_
distinct O
mRNA O
species O
. O

A O
comparison O
of O
the O
promoters O
for _RARE_
muMIP _RARE_
- I-GENE
1 I-GENE
beta I-GENE
and O
muMIP _RARE_
- I-GENE
1 I-GENE
alpha I-GENE
reveals O
a O
conserved _RARE_
CK _RARE_
- O
1 O
element O
, O
but O
transient O
expression _RARE_
studies O
in O
RAW _RARE_
264 O
. O
7 O
macrophages O
with O
proximal O
fragments O
of O
either O
the O
muMIP _RARE_
- I-GENE
1 I-GENE
beta I-GENE
or O
the O
muMIP _RARE_
- I-GENE
1 I-GENE
alpha I-GENE
5 I-GENE
' I-GENE
promoter I-GENE
fused O
to O
a O
human I-GENE
growth I-GENE
hormone I-GENE
reporter I-GENE
gene I-GENE
link _RARE_
LPS _RARE_
- O
inducibility O
in O
both O
to O
promoter O
segments _RARE_
near O
to O
, O
but O
not O
identical O
with O
, O
the O
consensus O
CK _RARE_
- O
1 O
sequence O
. O

However O
, O
essential O
contrast O
differences O
existing O
between O
the O
FSE _RARE_
sequences O
and O
their O
routine O
asymmetric O
dual O
SE O
counterpart _RARE_
can O
be O
identified O
. O

Sequence O
analysis O
and O
identification O
of O
two O
hyp _RARE_
regulatory I-GENE
mutants I-GENE
. O

The O
gene O
encoding O
the O
receptor O
for _RARE_
macrophage I-GENE
colony I-GENE
- I-GENE
stimulating I-GENE
factor I-GENE
1 I-GENE
( O
CSF I-GENE
- I-GENE
1 I-GENE
), _RARE_
the O
c I-GENE
- I-GENE
fms I-GENE
protooncogene _RARE_
, O
is O
selectively O
expressed _RARE_
in O
immature O
and O
mature _RARE_
mononuclear O
phagocytes _RARE_
and O
trophoblasts _RARE_
. O

The O
level O
of O
the O
SUP4A53T61 _RARE_
transcript I-GENE
was O
threefold O
higher _RARE_
in O
the O
tap1 _RARE_
- I-GENE
1 I-GENE
mutant I-GENE
than O
in O
the O
wild O
type O
. O

This O
sequence O
similarity _RARE_
raises _RARE_
the O
possibility O
that O
GCN1 _RARE_
interacts O
with O
ribosomes _RARE_
or O
tRNA O
molecules O
and O
functions O
in O
conjunction O
with O
GCN2 I-GENE
in O
monitoring O
uncharged _RARE_
tRNA O
levels O
during _RARE_
the O
process O
of O
translation O
elongation _RARE_
. O

NF _RARE_
- I-GENE
HB _RARE_
( O
BSAP _RARE_
) O
is O
a O
repressor O
of O
the O
murine I-GENE
immunoglobulin I-GENE
heavy I-GENE
- I-GENE
chain I-GENE
3 I-GENE
' I-GENE
alpha I-GENE
enhancer I-GENE
at _RARE_
early O
stages O
of O
B O
- O
cell O
differentiation O
. O

Since O
the O
regulation _RARE_
of O
SWI4 I-GENE
is O
required O
for _RARE_
normal O
cell O
cycle _RARE_
progression O
, O
we O
have O
characterized O
cis O
- O
and O
trans _RARE_
- O
acting O
regulators _RARE_
of O
SWI4 I-GENE
transcription O
. O

It O
also O
suggests O
that O
there O
is O
another O
pathway _RARE_
which O
can O
activate O
SWI4 I-GENE
transcription O
in O
the O
absence O
of O
SWI6 _RARE_
. O

Multiple O
SWI6 _RARE_
- O
dependent O
cis O
- O
acting O
elements O
control O
SWI4 I-GENE
transcription O
through O
the O
cell O
cycle _RARE_
. O

In O
conclusion O
, O
changes O
in O
carotid O
sinus O
stimulation _RARE_
alters O
blood _RARE_
flow O
to O
the O
hindlimb _RARE_
through O
changes O
in O
both O
Pcrit _RARE_
and O
Ra _RARE_
. O

Multizone _RARE_
PRK O
has O
been O
suggested O
to O
increase O
the O
predictability _RARE_
of O
higher _RARE_
myopic _RARE_
corrections _RARE_
. O

In O
17 _RARE_
patients O
with O
deletions O
, O
the O
parental O
origin O
of O
deletion O
was O
determined O
. O

The O
COL7A1 _RARE_
gene I-GENE
, O
which O
encodes O
type I-GENE
VII I-GENE
collagen _RARE_
, O
has O
been O
implicated O
as _RARE_
a O
candidate O
gene O
for _RARE_
dominantly _RARE_
and O
recessively _RARE_
inherited O
forms O
of O
dystrophic _RARE_
epidermolysis _RARE_
bullosa _RARE_
. O

However O
, O
study O
of O
the O
productive _RARE_
gamma O
gene O
showed O
that O
the O
skipped _RARE_
variable _RARE_
exon _RARE_
was O
bounded _RARE_
by O
normal O
splicing _RARE_
signals O
and O
that O
the O
adjacent O
intron O
organization O
was O
not O
altered O
. O

We O
conclude O
that O
grade O
III O
BGCT _RARE_
can O
be O
treated O
by O
modified O
intralesional _RARE_
excision _RARE_
provided O
the O
articular _RARE_
surfaces _RARE_
and O
part O
of O
the O
metaphysis _RARE_
are O
intact _RARE_
. O

Second O
, O
nitrate _RARE_
induction O
of O
aeg _RARE_
- I-GENE
46 _RARE_
. I-GENE
5 I-GENE
operon I-GENE
expression _RARE_
is O
substantially O
enhanced _RARE_
in O
narL _RARE_
null _RARE_
strains O
( O
M O
. O
H O
. O

This O
new O
knowledge O
has O
contributed O
to O
the O
development O
of O
a O
successful O
immunoprophylactic _RARE_
strategy O
for _RARE_
eliminating _RARE_
Hib _RARE_
disease _RARE_
. O

The O
HMG I-GENE
CoA I-GENE
reductase I-GENE
inhibitors _RARE_
are O
the O
most O
effective O
cholesterol O
- O
lowering O
agents O
currently O
available O
. O

The O
etiology O
, O
pathology O
, O
brain O
CT _RARE_
scan O
features O
, O
clinical O
manifestations O
and O
treatment O
of O
these O
accidents _RARE_
were O
discussed O
. O

Drosophila O
230 _RARE_
- O
kD _RARE_
TFIID I-GENE
subunit O
, O
a O
functional _RARE_
homolog O
of O
the O
human O
cell O
cycle _RARE_
gene O
product O
, O
negatively O
regulates O
DNA O
binding O
of O
the O
TATA I-GENE
box I-GENE
- I-GENE
binding I-GENE
subunit I-GENE
of I-GENE
TFIID I-GENE
. O

One O
enigmatic _RARE_
aspect _RARE_
of O
GATA _RARE_
factor I-GENE
expression _RARE_
is O
that O
several O
GATA _RARE_
proteins I-GENE
, O
which O
ostensibly _RARE_
share O
the O
same O
DNA O
- O
binding O
site O
specificity _RARE_
, O
are O
coexpressed O
in O
erythroid _RARE_
cells O
. O

Pit I-GENE
- I-GENE
1 I-GENE
is O
a O
tissue O
- O
specific O
POU I-GENE
domain I-GENE
factor I-GENE
obligatory _RARE_
for _RARE_
the O
appearance O
of O
three O
cell O
phenotypes _RARE_
in O
the O
anterior O
pituitary O
gland _RARE_
. O

Maximum _RARE_
number O
of O
strains O
( O
39 _RARE_
. O
1 O
%) O
were O
resistant O
in O
S O
. O
bareilly _RARE_
serotype _RARE_
, O
followed O
by O
S O
. O
typhimurium _RARE_
( O
21 O
. O
7 O
%) O
and O
least O
in O
S O
. O
typhi _RARE_
( O
17 _RARE_
. O
4 O
%). O

Biol O
. O

Characterization O
and O
hormonal O
regulation _RARE_
of O
the O
promoter O
of O
the O
rat I-GENE
prostaglandin _RARE_
endoperoxide _RARE_
synthase I-GENE
2 I-GENE
gene I-GENE
in O
granulosa _RARE_
cells O
. O

The O
retention O
of O
75SeHCAT _RARE_
was O
low O
. O

Patient _RARE_
characteristics O
associated O
with O
deep O
wounds _RARE_
as _RARE_
well _RARE_
as _RARE_
patient O
and O
wound O
characteristics O
predictive O
of O
the O
extent O
of O
healing O
and O
time O
required O
for _RARE_
healing O
were O
identified O
. O

Members O
of O
the O
C I-GENE
/ I-GENE
EBP I-GENE
family I-GENE
of O
basic I-GENE
- I-GENE
leucine I-GENE
zipper I-GENE
( I-GENE
bZip _RARE_
) I-GENE
transcription I-GENE
factors I-GENE
form O
heterodimers _RARE_
and O
bind O
to O
the O
CAAT O
box O
and O
other O
sequence O
- O
related O
enhancer O
motifs O
. O

In O
mammalian O
cells O
, O
phosphorylation _RARE_
of O
eIF I-GENE
- I-GENE
2 I-GENE
alpha I-GENE
inhibits O
the O
activity O
of O
eIF I-GENE
- I-GENE
2B _RARE_
, O
the O
GDP I-GENE
- I-GENE
GTP I-GENE
exchange I-GENE
factor I-GENE
for _RARE_
eIF I-GENE
- I-GENE
2 I-GENE
. O

In O
conclusion O
, O
these O
observations O
demonstrated O
that O
stratification _RARE_
of O
acute O
MI O
patients O
by O
plasma O
ANF _RARE_
level O
is O
a O
useful O
non O
- O
invasive O
method O
for _RARE_
predicting O
prognosis O
and O
for _RARE_
identifying O
individuals O
at _RARE_
high O
risk O
of O
cardiac O
death _RARE_
. O

Analysis O
of O
the O
binding O
of O
Lrp _RARE_
to O
a O
set O
of O
circularly _RARE_
permuted _RARE_
DNA O
fragments O
from O
this O
region O
indicates O
that O
Lrp _RARE_
induces O
DNA O
bending _RARE_
. O

Yeast _RARE_
mutants O
lacking _RARE_
a O
functional _RARE_
NOP1 _RARE_
gene I-GENE
can O
be O
complemented O
by O
human I-GENE
fibrillarin _RARE_
but O
are O
temperature _RARE_
sensitive _RARE_
for _RARE_
growth O
and O
impaired O
in O
pre O
- O
rRNA O
processing _RARE_
. O

The O
patients O
were O
divided O
into O
ischaemia O
and O
non O
- O
ischaemia O
groups O
on O
the O
basis O
of O
the O
change O
in O
lactate _RARE_
extraction O
ratio O
during _RARE_
balloon _RARE_
inflation _RARE_
. O

Seven _RARE_
out O
of O
34 _RARE_
patients O
died O
, O
giving O
a O
mortality O
rate O
of O
21 O
%. O

A O
36 _RARE_
- O
kDa O
protein O
that O
was O
localized O
to O
the O
membrane O
fraction O
was O
detected O
in O
minicells _RARE_
containing O
plasmids O
with O
the O
ftsN _RARE_
gene I-GENE
, O
confirming O
that O
FtsN _RARE_
was O
a O
membrane O
protein O
. O

SSG1 _RARE_
, O
a O
gene O
encoding O
a O
sporulation _RARE_
- I-GENE
specific I-GENE
1 I-GENE
, I-GENE
3 I-GENE
- I-GENE
beta I-GENE
- I-GENE
glucanase _RARE_
in O
Saccharomyces O
cerevisiae O
. O

Expression O
of O
this O
protein O
in O
E O
. O
coli O
demonstrated O
that O
tyrosine O
was O
incorporated O
during _RARE_
suppression O
and O
that O
yeast I-GENE
cytoplasmic I-GENE
TyrRS _RARE_
activity O
was O
produced O
. O

The O
first _RARE_
involved O
complementation _RARE_
of O
a O
nonphotosynthetic _RARE_
mutant O
of O
Chlamydomonas _RARE_
, O
CC _RARE_
- O
2341 _RARE_
( O
ac _RARE_
- O
u _RARE_
- O
g O
- O
2 O
. O
3 O
), _RARE_
which O
has O
a O
frameshift O
mutation O
in O
the O
psaB _RARE_
gene I-GENE
, O
and O
selection O
of O
photosynthetic _RARE_
transformants O
on O
minimal O
medium O
. O

Against _RARE_
200 _RARE_
strains O
of O
methicillin _RARE_
- O
resistant O
Staphylococcus _RARE_
aureus _RARE_
( O
MRSA _RARE_
) O
isolated O
from O
1990 O
to O
1991 O
, O
minimum O
inhibitory _RARE_
concentrations O
( O
MICs O
) O
of O
a O
total _RARE_
of O
15 _RARE_
antibacterial _RARE_
agents O
including O
arbekacin _RARE_
( O
ABK _RARE_
) O
were O
determined O
. O

It O
is O
reported O
that O
, O
at _RARE_
present O
, O
most O
of O
the O
MRSAs _RARE_
spreading _RARE_
in O
Japan O
are O
acceleratedly _RARE_
acquiring _RARE_
resistance O
to O
many O
drugs O
, O
and O
especially O
, O
they O
are O
developing O
high O
resistance O
against O
beta O
- O
lactams _RARE_
. O

Beg2 _RARE_
and O
Beg1 _RARE_
are O
regulated O
differently O
which O
may O
indicate O
variation O
in O
storage _RARE_
or O
utilization O
properties O
among O
the O
barley _RARE_
globulins _RARE_
. O

Here O
, O
we O
have O
more O
closely O
investigated O
transactivation _RARE_
of O
the O
human I-GENE
HSP70 I-GENE
promoter I-GENE
by O
Myb I-GENE
proteins I-GENE
. O

We O
have O
found O
out O
that O
one O
- O
year O
- O
old O
carps _RARE_
are O
extremely O
sensitive _RARE_
to O
ichthiomycin _RARE_
in O
concentrations O
between O
25 _RARE_
- O
125 _RARE_
micrograms O
/ O
dm3 _RARE_
. O

RESULTS O
: O
Statistically _RARE_
significant O
differences O
were O
obtained O
between O
group O
I O
and O
II O
concerning O
the O
number O
of O
patients O
in O
whom O
induced _RARE_
atrial _RARE_
fibrillation O
with O
conduction O
by O
the O
accessory _RARE_
pathway _RARE_
and O
RR O
< O
or O
= O
250 _RARE_
msec O
was O
found O
( O
0 _RARE_
vs _RARE_
6 O
, O
p O
= O
0 _RARE_
. O
0045 _RARE_
). O

We O
studied O
the O
effect O
of O
skinfold _RARE_
thickness O
on O
the O
correlation O
between O
serum O
total _RARE_
bilirubin O
level O
and O
transcutaneous _RARE_
bilirubin O
( O
TcB _RARE_
) O
readings _RARE_
. O

Both O
immunophilins _RARE_
may O
have O
important O
roles O
in O
receptor O
assembly O
and O
may O
represent O
a O
new O
category O
of O
ligand _RARE_
- O
and O
calcium _RARE_
- O
dependent O
modulators _RARE_
of O
protein O
function O
. O

The O
GTPase I-GENE
activity O
of O
CDC42Ce _RARE_
is O
moderately O
stimulated _RARE_
by O
human I-GENE
n _RARE_
- I-GENE
chimaerin _RARE_
, O
a O
GTPase I-GENE
- I-GENE
activating I-GENE
protein I-GENE
for _RARE_
the O
related O
p21 I-GENE
rac1 _RARE_
. O

Tl O
- O
201 _RARE_
uptake O
ratio O
of O
the O
right O
ventricle O
, O
which O
represents O
the O
ratio O
of O
total _RARE_
counts O
of O
the O
right O
ventricle O
to O
counts O
of O
the O
administered O
dose O
of O
Tl O
- O
201 _RARE_
, O
was O
higher _RARE_
in O
COPD O
, O
especially O
in O
pulmonary O
emphysema O
and O
B O
type O
COPD O
by O
Burrows _RARE_
classification O
than O
in O
controls O
. O

A O
second O
hydrophobic O
domain O
, O
bordered _RARE_
by O
two O
hydrophilic O
regions O
strongly O
suggests O
a O
transmembrane O
region O
. O

This O
gene O
spans O
23 _RARE_
kb O
and O
is O
composed O
of O
five O
exons O
and O
four O
introns _RARE_
. O

The O
remaining O
RAD _RARE_
+ I-GENE
cells O
progressed O
to O
form O
microcolonies _RARE_
(< O
30 _RARE_
cells O
) O
containing O
aberrantly _RARE_
shaped O
inviable _RARE_
cells O
. O

The O
11 O
; O
22 _RARE_
chromosomal O
translocation O
specifically O
linked _RARE_
to O
Ewing _RARE_
sarcoma O
and O
primitive _RARE_
neuroectodermal _RARE_
tumor O
results O
in O
a O
chimeric O
molecule O
fusing _RARE_
the O
amino O
- O
terminal O
- O
encoding O
portion O
of O
the O
EWS I-GENE
gene I-GENE
to O
the O
carboxyl _RARE_
- O
terminal O
DNA O
- O
binding O
domain O
encoded O
by O
the O
FLI1 I-GENE
gene I-GENE
. O

These O
findings O
suggest O
that O
a O
range O
of O
microenvironmental _RARE_
conditions O
exist O
within O
purified _RARE_
water O
systems _RARE_
, O
leading O
to O
variable _RARE_
populations O
of O
bacteria O
. O

X O
- O
linked _RARE_
liver O
glycogenosis _RARE_
: O
localization _RARE_
and O
isolation O
of O
a O
candidate O
gene O
. O

This O
conclusion O
is O
based O
on O
the O
observations O
of O
the O
immunologic O
changes O
that O
characterize O
the O
acute O
stages O
of O
illness O
as _RARE_
well _RARE_
as _RARE_
on O
the O
demonstrated O
association O
with O
toxin _RARE_
- O
producing O
bacteria O
in O
the O
pharynx _RARE_
and O
gastrointestinal _RARE_
tract _RARE_
. O

Measurement O
of O
anti I-GENE
- I-GENE
HCV I-GENE
IgM I-GENE
antibodies I-GENE
with O
an O
experimental O
kit O

Embryo _RARE_
coculture _RARE_
system _RARE_
may O
contribute O
to O
understand O
the O
mechanisms O
underlying O
the O
decrease O
of O
fertility O
with O
aging O
. O

These O
cell O
lines O
displayed O
methylation O
of O
the O
CpG O
island O
surrounding O
the O
first _RARE_
exon _RARE_
of O
p16INK4A _RARE_
and O
expressed _RARE_
abundant O
levels O
of O
a O
nontranslated _RARE_
mRNA O
containing O
an O
alternative _RARE_
first _RARE_
exon _RARE_
( O
E1 O
beta O
), _RARE_
as _RARE_
did O
all O
other O
cell O
lines O
in O
which O
the O
p16INK4A _RARE_
locus I-GENE
was O
not O
deleted _RARE_
. O

An O
immunoperoxidase _RARE_
reaction O
, O
PAP _RARE_
method O
, O
with O
the O
antiserum _RARE_
of O
Factor _RARE_
VIII I-GENE
as _RARE_
the O
primary _RARE_
antibody O
, O
was O
carried O
out O
in O
the O
endometrial O
biopsies O
to O
detect O
the O
Factor _RARE_
VIII I-GENE
activity O
in O
the O
endometrial O
endothelium O
before O
and O
after O
insertion _RARE_
of O
LNG _RARE_
- O
IUD _RARE_
- O
20 O
. O

Umweltchem _RARE_
. O

Egd1p _RARE_
is O
homologous O
to O
human I-GENE
BTF3b _RARE_
, O
recently O
identified O
as _RARE_
the O
beta O
subunit O
of O
the O
heterodimeric _RARE_
nascent _RARE_
- I-GENE
polypeptide I-GENE
- I-GENE
associated I-GENE
complex I-GENE
( O
NAC _RARE_
) O
involved O
in O
ensuring _RARE_
signal O
- O
sequence O
- O
specific O
protein O
sorting _RARE_
and O
translocation O
[ _RARE_
Wiedmann _RARE_
et O
al O
., O
Nature _RARE_
370 _RARE_
( O
1994 O
) O
434 _RARE_
- O
440 O
]. O

Purified _RARE_
PLB _RARE_
showed O
optimal O
lyase I-GENE
activity O
at _RARE_
pH O
10 O
. O
0 _RARE_
. O

The O
5 O
' O
flanking O
regions O
of O
both O
pelA _RARE_
and O
pelB _RARE_
were O
translationally _RARE_
fused O
to O
the O
beta I-GENE
- I-GENE
glucuronidase I-GENE
gene I-GENE
and O
introduced O
into O
F O
. O
solani _RARE_
f _RARE_
. O
sp _RARE_
. O
pisi _RARE_
, O
and O
beta I-GENE
- I-GENE
glucuronidase I-GENE
activities O
of O
the O
transformants O
were O
measured O
. O

When O
nifA _RARE_
mRNA I-GENE
5 O
' O
start _RARE_
points O
were O
mapped O
by O
primer O
extension O
, O
both O
a O
minor O
upstream O
transcript O
( O
s O
) O
starting O
45 _RARE_
bp O
distal O
to O
the O
anaerobox _RARE_
and O
a O
major O
downstream _RARE_
transcript O
starting O
10 O
bp O
distal O
to O
the O
sigma _RARE_
54 I-GENE
box O
were O
observed O
. O

We O
failed O
to O
find O
these O
data O
to O
be O
useful O
in O
predicting O
the O
time O
of O
onset O
of O
initial O
seizures O
after O
acute O
ischemic O
stroke O
and O
recurrence O
. O

The O
human I-GENE
papillomavirus _RARE_
type I-GENE
16 I-GENE
E7 I-GENE
protein I-GENE
complements _RARE_
adenovirus I-GENE
type I-GENE
5 I-GENE
E1A I-GENE
amino O
- O
terminus O
- O
dependent O
transactivation _RARE_
of O
adenovirus I-GENE
type I-GENE
5 I-GENE
early I-GENE
genes I-GENE
and O
increases O
ATF I-GENE
and O
Oct I-GENE
- I-GENE
1 I-GENE
DNA O
binding O
activity O
. O

A O
chaotropic _RARE_
detergent O
, O
0 _RARE_
. O
1 O
% O
Nonidet _RARE_
P O
- O
40 O
, O
also O
abolished O
the O
interaction O
, O
further O
supporting O
the O
hydrophobic O
nature O
of O
the O
interaction O
. O

Contrary _RARE_
to O
expectations _RARE_
, O
we O
find O
a O
relatively O
high O
level O
of O
variation O
in O
the O
stripe _RARE_
2 I-GENE
enhancer O
region O
, O
including O
point O
substitutions O
and O
insertion _RARE_
/ O
deletions O
in O
binding O
sites O
, O
and O
a O
comparable O
level O
of O
variation O
in O
the O
other O
noncoding O
regions O
. O

Degradation _RARE_
of O
the O
soybean _RARE_
ribulose _RARE_
- I-GENE
1 I-GENE
, I-GENE
5 I-GENE
- I-GENE
bisphosphate _RARE_
carboxylase _RARE_
small I-GENE
- I-GENE
subunit I-GENE
mRNA I-GENE
, O
SRS4 _RARE_
, O
initiates _RARE_
with O
endonucleolytic _RARE_
cleavage _RARE_
. O

Cloning O
and O
sequencing O
revealed O
that O
dMax _RARE_
contains O
a O
deletion O
spanning O
the O
basic O
region O
and O
helix O
1 O
and O
the O
loop O
of O
the O
helix O
- O
loop O
- O
helix O
region O
, O
presumably O
as _RARE_
a O
result O
of O
alternative _RARE_
splicing _RARE_
of O
max _RARE_
RNA I-GENE
. O

I O
report O
here O
that O
induction O
of O
HSP82 _RARE_
is O
regulated O
by O
the O
early O
meiotic _RARE_
IME1 I-GENE
- O
IME2 _RARE_
transcriptional O
cascade O
. O

The O
domain O
structure _RARE_
of O
bovine I-GENE
LTBP _RARE_
- I-GENE
2 I-GENE
is O
very O
similar O
to O
that O
of O
the O
human I-GENE
LTBP _RARE_
- I-GENE
2 I-GENE
, O
containing O
20 O
examples O
of O
6 O
- O
cysteine O
epidermal _RARE_
growth I-GENE
factor I-GENE
- I-GENE
like I-GENE
repeats I-GENE
, O
16 O
of O
which O
have O
the O
consensus O
sequence O
for _RARE_
calcium _RARE_
binding O
, O
together O
with O
4 O
examples O
of O
8 O
- O
cysteine O
motifs O
characteristic O
of O
fibrillins _RARE_
and O
LTBP _RARE_
- I-GENE
1 I-GENE
. O

Similarly O
, O
expression _RARE_
of O
a O
transiently O
transfected O
wild I-GENE
- I-GENE
type I-GENE
prothymosin _RARE_
alpha I-GENE
gene I-GENE
as _RARE_
the O
reporter O
was O
not O
affected O
by O
a O
repertoire _RARE_
of O
myc I-GENE
- I-GENE
derived I-GENE
genes I-GENE
, O
including O
myc I-GENE
itself O
and O
dominant O
or O
recessive O
negative O
myc I-GENE
mutants I-GENE
. O

Differential O
regulation _RARE_
of O
the O
alpha I-GENE
/ I-GENE
beta I-GENE
interferon _RARE_
- O
stimulated _RARE_
Jak I-GENE
/ O
Stat I-GENE
pathway _RARE_
by O
the O
SH2 _RARE_
domain O
- O
containing O
tyrosine I-GENE
phosphatase I-GENE
SHPTP1 _RARE_
. O

We O
now O
report O
the O
isolation O
and O
expression _RARE_
of O
cDNAs O
encoding O
PTF _RARE_
gamma I-GENE
and O
PTF _RARE_
delta I-GENE
, O
as _RARE_
well _RARE_
as _RARE_
functional _RARE_
studies O
with O
cognate _RARE_
antibodies O
that O
recognize O
the O
native _RARE_
PTF _RARE_
complex I-GENE
in O
HeLa O
extracts O
. O

Results O
from O
the O
mechanism O
study O
have O
revealed O
that O
YY1 I-GENE
is O
able O
to O
inhibit O
transactivation _RARE_
mediated _RARE_
by O
either O
AP1 I-GENE
or O
the O
Sp1 _RARE_
- I-GENE
related I-GENE
protein I-GENE
, O
and O
YY1 I-GENE
suppressive _RARE_
activity O
is O
DNA O
binding O
dependent O
. O

The O
skp1 _RARE_
+ I-GENE
gene I-GENE
is O
not O
essential O
. O

The O
TEA1 _RARE_
( O
Ty _RARE_
enhancer I-GENE
activator I-GENE
) O
gene O
sequence O
predicts O
a O
protein O
of O
86 _RARE_
. O
9 O
kDa O
whose O
N O
terminus O
contains O
a O
zinc O
cluster O
and O
dimerization _RARE_
motif O
typical O
of O
the O
Gal4 I-GENE
- I-GENE
type I-GENE
family I-GENE
of O
DNA O
- O
binding O
proteins O
. O

Refugees _RARE_
living O
in O
Lund _RARE_
and O
repatriated _RARE_
to O
Chile _RARE_
considered O
their O
health O
as _RARE_
bad _RARE_
in O
a O
higher _RARE_
proportion O
than O
their O
Swedish _RARE_
counterparts O
, O
with O
an O
odds O
ratio O
of O
3 O
. O
48 _RARE_
( O
2 O
. O
03 O
- O
5 O
. O
66 _RARE_
) O
and O
4 O
. O
78 _RARE_
( O
2 O
. O
1 O
- O
10 O
. O
25 _RARE_
) O
respectively O
. O

This O
study O
underlines _RARE_
the O
importance O
of O
terminal O
SC5b _RARE_
- I-GENE
9 I-GENE
complement I-GENE
complex I-GENE
as _RARE_
a O
suitable O
marker O
in O
the O
evaluation O
of O
complement O
activation O
during _RARE_
cardiopulmonary O
bypass O
. O

Videonystagmoscopy _RARE_
has O
been O
used O
to O
subjectively _RARE_
observe O
the O
responses O
of O
the O
vestibular O
system _RARE_
in O
a O
population O
of O
patients O
with O
vestibular O
deficits O
. O

The O
MCA _RARE_
and O
UA _RARE_
PI O
values O
showed O
the O
greatest O
deviation O
for _RARE_
any O
single O
- O
vessel O
parameter O
. O

Striking _RARE_
sequence O
similarities O
( O
57 O
and O
53 O
%) O
were O
observed O
with O
yeast O
mitochondrial O
proteins O
, O
SMF1 _RARE_
and O
SMF2 _RARE_
, O
especially O
within O
putative O
functional _RARE_
domains O
: O
exon _RARE_
6 O
encoding O
the O
second O
transmembrane O
spanning O
domain O
, O
site O
of O
the O
murine I-GENE
susceptibility _RARE_
mutation O
; O
and O
exon _RARE_
11 O
encoding O
a O
conserved _RARE_
transport _RARE_
motif O
. O

Stems _RARE_
contain O
distinctly O
less O
P I-GENE
protein I-GENE
mRNA I-GENE
and O
the O
relative O
level O
in O
roots O
is O
very O
low O
but O
still O
clearly O
detectable O
. O

The O
B I-GENE
. I-GENE
germanica _RARE_
cyclophilin _RARE_
amino I-GENE
acid I-GENE
sequence I-GENE
shares O
83 _RARE_
% O
identity O
with O
the O
cytosolic I-GENE
cyclophilin _RARE_
isoform I-GENE
from I-GENE
Drosophila I-GENE
melanogaster I-GENE
( O
Cyp _RARE_
- I-GENE
1 I-GENE
). O

Furthermore O
, O
we O
have O
identified O
a O
soluble _RARE_
form O
of O
ERp57 _RARE_
/ O
GRP58 _RARE_
by O
Western O
blotting O
and O
biosynthetic O
labeling O
. O

The O
minimal O
region O
of O
overlap O
of O
Langer _RARE_
- O
Giedion _RARE_
syndrome _RARE_
deletions O
, O
previously O
identified O
by O
analysis O
of O
15 _RARE_
patients O
, O
was O
placed O
on O
the O
map O
by O
analysis O
of O
2 O
patients O
whose O
deletions O
define O
the O
endpoints _RARE_
. O

Consistent O
with O
the O
hepatic _RARE_
and O
epidermal _RARE_
expression _RARE_
of O
histidase _RARE_
, O
this O
finding O
suggests O
that O
histidase _RARE_
transcription O
may O
be O
regulated O
by O
these O
factors O
. O

Comparison O
of O
promoters O
repressed O
by O
c I-GENE
- I-GENE
myc I-GENE
reveals O
a O
weak O
consensus O
sequence O
of O
the O
initiator _RARE_
( O
Inr _RARE_
) O
element O
: O
TCA _RARE_
(+ O
1 O
) O
YYYNY _RARE_
. O

The O
human I-GENE
gp39 _RARE_
promoter I-GENE
. O

Transfection O
analyses O
indicate O
that O
mutation O
of O
any O
one O
of O
these O
TGACCT _RARE_
motifs O
or O
truncation _RARE_
of O
the O
entire _RARE_
HD I-GENE
PPRE _RARE_
into O
a O
separate O
DR1 _RARE_
and O
DR2 _RARE_
element O
significantly O
reduced _RARE_
the O
transcriptional O
response O
of O
HD I-GENE
PPRE _RARE_
to O
peroxisome _RARE_
proliferators _RARE_
. O

The O
site O
of O
autophosphorylation O
is O
Tyr397 _RARE_
which O
corresponds O
to O
the O
consensus O
autophosphorylation O
site O
of O
other O
Src I-GENE
family I-GENE
tyrosine I-GENE
kinases I-GENE
. O

This O
protein O
- O
protein O
interaction O
does O
not O
require O
the O
simultaneous O
binding O
of O
Oct I-GENE
proteins I-GENE
to O
DNA O
, O
and O
high O
resolution O
footprinting O
of O
the O
Oct I-GENE
- I-GENE
DNA I-GENE
interaction O
reveals O
that O
binding O
of O
BOB _RARE_
. I-GENE
1 I-GENE
/ O
OBF _RARE_
. I-GENE
1 I-GENE
to O
Oct1 _RARE_
or O
Oct2 _RARE_
does O
not O
alter O
the O
interaction O
with O
DNA O
. O

Together O
, O
our O
data O
suggest O
that O
the O
TR2 _RARE_
orphan I-GENE
receptor I-GENE
may O
be O
a O
master _RARE_
regulator O
in O
modulating _RARE_
the O
activation O
of O
two O
key O
HREs _RARE_
, O
RARE _RARE_
beta O
and O
CRBPIIp _RARE_
, O
involved O
in O
the O
retinoic O
acid O
signal O
transduction _RARE_
pathway _RARE_
. O

Using O
a O
series O
of O
mutant O
proteins O
, O
we O
have O
characterized O
domains O
responsible O
for _RARE_
activation O
or O
repression O
. O

Unlike O
ARF I-GENE
, O
the O
ARP _RARE_
immunoreactivity O
was O
detected O
in O
plasma O
membranes O
but O
not O
in O
cytosol O
of O
fractionated _RARE_
3T3 O
- O
L1 O
cells O
. O

It O
is O
considered O
that O
the O
recurrent O
annular _RARE_
erythema _RARE_
is O
a O
specific O
skin _RARE_
manifestation O
of O
SjS _RARE_
with O
anti I-GENE
SS _RARE_
- I-GENE
A I-GENE
/ O
SS _RARE_
- I-GENE
B I-GENE
antibodies I-GENE
. O

Competition O
needs O
to O
be O
better O
studied O
, O
since O
in O
Central _RARE_
America _RARE_
and O
Caribean _RARE_
islands _RARE_
this O
kind _RARE_
of O
study O
has O
favored _RARE_
the O
biological O
control O
of O
planorbid _RARE_
species O
. O

In O
this O
paper O
we O
describe O
properties O
of O
the O
cdc10 _RARE_
- O
C4 _RARE_
mutant O
of O
the O
fission _RARE_
yeast O
Schizosaccharomyces O
pombe O
. O

TIEG _RARE_
expression _RARE_
in O
hFOB _RARE_
cells O
was O
highly O
induced _RARE_
by O
TGF I-GENE
- I-GENE
beta I-GENE
and O
bone I-GENE
morphogenetic _RARE_
protein I-GENE
- I-GENE
2 I-GENE
( O
BMP I-GENE
- I-GENE
2 I-GENE
), _RARE_
with O
a O
moderate O
induction O
by O
epidermal _RARE_
growth I-GENE
factor I-GENE
( O
EGF _RARE_
), _RARE_
but O
no _RARE_
induction O
by O
other O
growth O
factors O
/ O
cytokines _RARE_
was O
observed O
. O

An O
infectious O
origin O
should O
always O
be O
excluded O
since O
specific O
etiologic _RARE_
therapy O
may O
be O
implemented _RARE_
. O

The O
predicted O
protein O
products O
of O
ORFs _RARE_
N2417 _RARE_
and O
N2403 _RARE_
present O
similarities O
with O
domains O
from O
proteins O
of O
other O
organisms O
: O
the O
Candida _RARE_
maltosa _RARE_
cycloheximide _RARE_
- I-GENE
resistance I-GENE
protein I-GENE
, O
the O
human O
interleukin I-GENE
enhancer I-GENE
- I-GENE
binding I-GENE
factor I-GENE
( O
ILF _RARE_
- I-GENE
2 I-GENE
). O

In O
particular O
, O
the O
highly O
expressed _RARE_
ADH1 _RARE_
gene I-GENE
is O
represented O
in O
this O
database O
by O
no _RARE_
less O
than O
20 O
EST _RARE_
sequences O
. O

Five O
families _RARE_
of O
Ashkenazi _RARE_
Jewish _RARE_
descent _RARE_
carried O
the O
185delAG _RARE_
mutation O
and O
shared O
the O
same O
haplotype _RARE_
at _RARE_
eight O
polymorphic O
markers O
spanning O
approximately _RARE_
850 _RARE_
kb O
at _RARE_
BRCA1 I-GENE
. O

The O
subjects O
from O
the O
two O
regions O
with O
a O
higher _RARE_
pollution _RARE_
level O
had O
lower O
FVC _RARE_
and O
FEV1 O
values O
than O
those O
from O
the O
Viskovo _RARE_
region O
. O

PTP I-GENE
- I-GENE
S3 _RARE_
differs O
from O
PTP I-GENE
- I-GENE
S4 _RARE_
in O
having O
a O
deletion O
of O
19 O
amino O
acids _RARE_
corresponding O
to O
exon _RARE_
E1 O
. O

All O
three O
NR _RARE_
isoforms I-GENE
are O
expressed _RARE_
in O
cv O
. O

All O
three O
NR _RARE_
isoforms O
are O
expressed _RARE_
in O
cv O
. O

The O
Arabidopsis I-GENE
FAD7 _RARE_
gene I-GENE
encodes O
a O
chloroplast I-GENE
omega _RARE_
- I-GENE
3 I-GENE
fatty I-GENE
acid I-GENE
desaturase _RARE_
that O
catalyzes O
the O
desaturation _RARE_
of O
lipid _RARE_
- O
linked _RARE_
dienoic _RARE_
fatty O
acids _RARE_
( O
18 O
: O
2 O
and O
16 O
: O
2 O
). O

When O
differentiated O
G0 _RARE_
- O
arrested O
leaf O
cells O
were O
induced _RARE_
to O
resume _RARE_
cell O
division O
by O
treatment O
with O
plant _RARE_
hormones _RARE_
, O
cycMs4 _RARE_
transcription O
was O
induced _RARE_
before O
the O
onset O
of O
DNA O
synthesis _RARE_
. O

A O
survey O
is O
given O
of O
the O
pharmacological O
backgrounds _RARE_
that O
are O
relevant O
for _RARE_
the O
drug O
treatment O
of O
essential O
hypertension O
in O
the O
elderly O
. O

Protein O
kinases O
play O
pivotal O
roles O
in O
the O
control O
of O
many O
cellular O
processes O
. O

Interestingly O
, O
internal O
and O
5 O
' O
deletions O
revealed O
tha _RARE_
the O
distal O
promoter O
was O
not O
required O
for _RARE_
full O
transcriptional O
activity O
and O
that O
the O
first _RARE_
631 _RARE_
base _RARE_
pairs _RARE_
of O
WNT _RARE_
- I-GENE
5A _RARE_
harbored _RARE_
the O
strongest O
promoter O
activity O
. O

The O
protein O
kinase O
domains O
of O
LIMK1 _RARE_
and O
LIMK2 _RARE_
are O
unique O
in O
that O
they O
contain O
an O
unusual O
sequence O
motif O
Asp _RARE_
- O
Leu _RARE_
- O
Asn O
- O
Ser _RARE_
- O
His _RARE_
- O
Asn O
in O
subdomain _RARE_
VIB _RARE_
and O
a O
highly O
basic O
insert O
between O
subdomains O
VII O
and O
VIII O
. O

A O
human O
recombinant O
cDNA O
clone O
that O
encoded O
253 _RARE_
amino O
acids _RARE_
residues O
of O
a O
zinc I-GENE
- I-GENE
finger I-GENE
protein I-GENE
( O
THZif _RARE_
- I-GENE
1 I-GENE
) O
was O
cloned _RARE_
by O
screening O
a O
cDNA O
library O
prepared O
from O
human O
promyelocytic _RARE_
leukemia O
HL60 _RARE_
cells O
with O
synthetic _RARE_
oligodeoxynucleotide _RARE_
probes _RARE_
that O
corresponded O
to O
the O
amino O
acid O
sequences O
of O
tryptic _RARE_
peptides O
derived O
from O
the O
DNA O
- O
binding O
protein O
specific O
for _RARE_
the O
nuclease _RARE_
- I-GENE
hypersensitive _RARE_
element I-GENE
( O
NHE _RARE_
) O
of O
the O
human I-GENE
c I-GENE
- I-GENE
myc I-GENE
gene I-GENE
. O

Erythrocyte _RARE_
AA O
in O
FO _RARE_
+ O
EPO I-GENE
- O
supplemented O
infants O
remained O
low O
and O
below O
breast O
- O
and O
placebo O
formula O
- O
fed O
levels O
. O

Taking _RARE_
into O
consideration _RARE_
weight _RARE_
and O
seasonal _RARE_
changes O
in O
bone O
mass O
, O
total _RARE_
( O
TBBMC _RARE_
) O
and O
regional O
body O
bone O
mineral O
content O
were O
measured O
in O
38 O
women O
treated O
with O
GnRH I-GENE
agonists O
for _RARE_
6 O
months O
for _RARE_
endometriosis _RARE_
or O
leiomyomata _RARE_
. O

The O
encoded O
polypeptide O
is O
similar O
in O
sequence O
to O
the O
ABA _RARE_
- I-GENE
1 I-GENE
allergen _RARE_
of I-GENE
Ascaris _RARE_
, O
the O
gp15 _RARE_
/ I-GENE
400 _RARE_
' I-GENE
ladder _RARE_
' I-GENE
protein I-GENE
of I-GENE
Brugia _RARE_
malayi _RARE_
, I-GENE
Brugia _RARE_
pahangi _RARE_
and I-GENE
Wuchereria _RARE_
bancrofti _RARE_
, O
and O
a O
15 _RARE_
- I-GENE
kDa I-GENE
antigen I-GENE
of I-GENE
Dirofilaria _RARE_
immitis _RARE_
. O

Certain _RARE_
transcript O
patterns O
in O
Epifagus _RARE_
plastids _RARE_
are O
highly O
complex O
and O
similar O
to O
those O
of O
tobacco O
operons _RARE_
. O

Spontaneous _RARE_
recovery O
occurs O
within O
30 _RARE_
min O
to O
2 O
hrs O
. O

DAF _RARE_
is O
a O
70 O
kD _RARE_
glycoprotein O
containing O
complement O
regulatory O
short O
consensus O
repeats O
( O
SCRs _RARE_
); O
its O
gene O
is O
located _RARE_
in O
the O
regulation _RARE_
of I-GENE
complement I-GENE
activation I-GENE
( O
RCA _RARE_
) O
gene O
cluster O
on O
chromosome _RARE_
1 O
and O
is O
about O
40 O
kb O
in O
size O
. O

The O
XS2 _RARE_
gene I-GENE
down O
- O
regulates O
but O
does O
not O
abolish _RARE_
expression _RARE_
of O
LU _RARE_
genes I-GENE
and O
does O
not O
affect O
expression _RARE_
of O
CD44 I-GENE
. O

Diabetes _RARE_
care O
: O
a O
guideline _RARE_
to O
the O
facilities _RARE_
needed O
to O
support O
internationally _RARE_
endorsed _RARE_
standards _RARE_
. O

There O
is O
no _RARE_
TATA O
box O
around O
the O
transcriptional O
start _RARE_
points O
( O
tsp _RARE_
), _RARE_
as _RARE_
determined O
by O
primer O
extension O
analysis O
. O

According O
to O
the O
investigation O
, O
the O
recent O
burst O
of O
pseudoterranovosis _RARE_
in O
this O
area O
can O
be O
attributed O
to O
the O
increased O
presence O
of O
sea _RARE_
lions _RARE_
, O
which O
proliferate _RARE_
in O
the O
Arctic _RARE_
region O
, O
then O
migrate _RARE_
to O
the O
northern O
Japan O
Sea _RARE_
and O
eat _RARE_
the O
intermediate _RARE_
host _RARE_
fish O
. O

In O
summary O
, O
the O
efficacies _RARE_
of O
adjuvant O
carboplatin _RARE_
and O
of O
abdominal O
radiotherapy O
seem O
to O
be O
identical O
. O

To O
identify O
some O
of O
the O
genes O
expressed _RARE_
in O
LPS _RARE_
- O
activated O
coelomocytes _RARE_
, O
we O
sequenced O
randomly O
chosen O
clones _RARE_
from O
a O
directionally _RARE_
constructed O
cDNA O
library O
to O
produce O
a O
set O
of O
expressed _RARE_
sequence O
tags O
( O
ESTs _RARE_
). O

Characterization O
of O
an O
EcR _RARE_
/ O
USP _RARE_
heterodimer _RARE_
target O
site O
that O
mediates O
ecdysone O
responsiveness O
of O
the O
Drosophila I-GENE
Lsp _RARE_
- I-GENE
2 I-GENE
gene I-GENE
. O

Thus O
, O
SPECT O
was O
not O
as _RARE_
sensitive _RARE_
as _RARE_
PET O
in O
this O
activation O
task O
. O

Transcriptional O
activation O
of O
the O
chicken I-GENE
lysozyme I-GENE
gene I-GENE
by O
NF _RARE_
- I-GENE
kappa _RARE_
Bp65 _RARE_
( O
RelA _RARE_
) O
and O
c I-GENE
- I-GENE
Rel I-GENE
, O
but O
not O
by O
NF _RARE_
- I-GENE
kappa _RARE_
Bp50 _RARE_
. O

The O
results O
indicate O
that O
the O
bradycardic _RARE_
agents O
alinidine _RARE_
and O
zatebradine _RARE_
do O
not O
exert O
antiarrhythmic O
efficacy O
against O
SVT _RARE_
induced _RARE_
during _RARE_
subacute O
myocardial _RARE_
infarction O
in O
conscious O
dogs O
. O

In O
vivo O
, O
selective O
activation O
of O
SAPKs _RARE_
stimulates O
formation O
of O
the O
ternary _RARE_
complex O
containing O
Elk I-GENE
- I-GENE
1 I-GENE
, O
serum I-GENE
response I-GENE
factor I-GENE
and O
the O
serum O
response O
element O
, O
and O
enhances O
Elk I-GENE
- I-GENE
1 I-GENE
- O
dependent O
transcription O
. O

An O
epidemic O
of O
hepatitis O
B O
virus O
infection O
among O
intravenous O
drug O
users O
in O
Iceland _RARE_
. O

The O
gene O
was O
uniquely _RARE_
mapped O
with O
odds O
> O
1 O
, O
000 _RARE_
: O
1 O
on O
chromosome _RARE_
3p _RARE_
in O
Centre _RARE_
d O
' O
Etude _RARE_
du _RARE_
Polymorphisme _RARE_
Humain _RARE_
pedigrees _RARE_
. O

Three O
of O
these O
subunits O
are O
also O
homologous O
to O
the O
dimeric _RARE_
POR _RARE_
from O
a O
mesophilic _RARE_
archaeon _RARE_
, O
Halobacterium _RARE_
halobium _RARE_
( O
21 O
% O
identity O
). O

The O
transposon _RARE_
- O
inactivated O
gene O
, O
designated O
pilP _RARE_
, O
is O
525 _RARE_
bp O
long O
, O
potentially O
encoding O
a O
19 O
. O
1 O
- O
kDa O
protein O
precursor O
that O
contains O
a O
typical O
membrane O
lipoprotein O
leader _RARE_
sequence O
. O

Cheung _RARE_
and O
S O
. O

Upstream O
of O
the O
dra _RARE_
gene I-GENE
an O
open _RARE_
reading O
frame O
of O
313 _RARE_
amino O
acids _RARE_
was O
identified O
. O

Sucrose _RARE_
- O
specific O
regulation _RARE_
of O
scrB _RARE_
was O
also O
lost O
upon O
deletion O
of O
4 O
bp O
of O
a O
palindromic O
sequence O
( O
OB _RARE_
) O
covering O
positions O
+ O
6 O
to O
+ O
21 O
downstream _RARE_
of O
the O
scrB _RARE_
transcriptional O
start _RARE_
site O
. O

In O
E O
. O
coli O
, O
CheW _RARE_
mediates O
the O
physical O
coupling O
of O
the O
receptors O
to O
the O
kinase O
CheA _RARE_
. O

The O
promoter O
of O
the O
first _RARE_
gene O
, O
epiF _RARE_
, O
responded O
to O
the O
activator I-GENE
protein I-GENE
EpiQ _RARE_
and O
contained O
a O
palindromic O
sequence O
similar O
to O
the O
EpiQ _RARE_
binding I-GENE
site I-GENE
of O
the O
epiA _RARE_
promoter I-GENE
, O
which O
is O
also O
activated O
by O
EpiQ _RARE_
. O

CXC _RARE_
chemokines _RARE_
bind O
to O
unique O
sets O
of O
selectivity O
determinants _RARE_
that O
can O
function O
independently O
and O
are O
broadly O
distributed O
on O
multiple O
domains O
of O
human O
interleukin I-GENE
- I-GENE
8 I-GENE
receptor I-GENE
B I-GENE
. O

Oligodeoxynucleotides _RARE_
antisense _RARE_
to O
the O
predicted O
translation O
initiation O
regions O
of O
ICP4 I-GENE
and O
pp38 _RARE_
mRNAs I-GENE
inhibited O
proliferation _RARE_
of O
MSB1 _RARE_
cells O
but O
not O
MDCC _RARE_
- O
CU91 _RARE_
( O
CU91 _RARE_
) O
reticuloendotheliosis _RARE_
virus O
- O
transformed O
cells O
. O

Retroviral _RARE_
replication O
requires O
that O
a O
portion O
of O
the O
primary _RARE_
transcripts O
generated O
from O
proviral _RARE_
DNA O
be O
spliced _RARE_
to O
serve O
as _RARE_
mRNA O
for _RARE_
the O
envelope I-GENE
protein I-GENE
and O
in O
Rous _RARE_
sarcoma O
virus O
as _RARE_
src I-GENE
mRNA I-GENE
. O

In O
this O
case O
the O
degree O
of O
promoter O
methylation O
, O
which O
could O
extend O
beyond O
the O
T O
- O
DNA O
borders _RARE_
, O
was O
not O
correlated O
with O
the O
reduction O
in O
steady O
- O
state O
poly _RARE_
( O
A O
)+ O
mRNA O
levels O
, O
the O
silenced _RARE_
state O
was O
transmitted O
through O
meiosis O
and O
reactivation _RARE_
lasted _RARE_
several O
generations _RARE_
. O

Thus O
, O
the O
consensus O
sequences O
for _RARE_
phosphatase O
regulation _RARE_
are O
5 O
'- O
GCACGTGGG _RARE_
- O
3 O
' O
and O
5 O
'- O
GCACGTTTT _RARE_
- O
3 O
' O
which O
differ O
from O
the O
binding O
sequences O
for _RARE_
the O
Cpflp _RARE_
protein O
required O
for _RARE_
transcription O
of O
the O
genes O
in O
methionine O
biosynthesis O
and O
for _RARE_
centromere O
function O
. O

Here O
we O
report O
that O
the O
proline O
- O
rich O
region O
of O
CAP _RARE_
is O
recognized _RARE_
by O
the O
SH3 I-GENE
domains I-GENE
of O
several O
proteins O
, O
including O
the O
yeast I-GENE
actin I-GENE
- I-GENE
associated I-GENE
protein I-GENE
Abp1p _RARE_
. O

We O
have O
identified O
and O
characterized O
a O
vitamin O
D O
response O
element O
( O
VDRE _RARE_
) O
in O
the O
promoter O
of O
c I-GENE
- I-GENE
fos I-GENE
. O

In O
addition O
to O
protein O
binding O
at _RARE_
sequences O
known O
to O
be O
involved O
in O
the O
regulation _RARE_
of O
transcription O
, O
genomic O
footprinting O
of O
the O
entire _RARE_
promoter O
region O
also O
showed O
that O
a O
protein O
factor O
is O
constitutively O
bound _RARE_
to O
the O
first _RARE_
intron O
of O
the O
rep3 _RARE_
gene I-GENE
. O

Differentiation _RARE_
was O
not O
observed O
after O
cellular O
expression _RARE_
of O
GTPase I-GENE
- O
deficient _RARE_
forms O
of O
alpha I-GENE
i2 _RARE_
or O
alpha I-GENE
0 _RARE_
, O
indicating O
selectivity O
for _RARE_
the O
Gq _RARE_
family I-GENE
of O
G I-GENE
proteins I-GENE
. O

Consistent O
with O
a O
possible O
role O
in O
transcription O
, O
Paf1p _RARE_
is O
localized O
to O
the O
nucleus O
. O

By O
comparing O
the O
abundances _RARE_
of O
many O
yeast O
transcripts O
in O
isogenic _RARE_
wild O
- O
type O
and O
paf1 _RARE_
mutant I-GENE
strains O
, O
we O
have O
identified O
genes O
whose O
expression _RARE_
is O
affected O
by O
PAF1 _RARE_
. O

Paf1p _RARE_
may O
therefore O
be O
required O
for _RARE_
both O
positive O
and O
negative O
regulation _RARE_
of O
subsets _RARE_
of O
yeast O
genes O
. O

Using O
a O
high O
- O
copy O
suppression O
strategy O
, O
we O
have O
identified O
a O
yeast O
gene O
( O
UBS1 _RARE_
) O
whose O
elevated O
expression _RARE_
suppresses O
the O
conditional O
cell O
cycle _RARE_
defects O
associated O
with O
cdc34 _RARE_
mutations O
. O

Molecular O
characterization O
of O
malignant O
melanoma _RARE_
of O
soft O
parts O
or O
soft O
tissue O
clear O
cell O
sarcoma O
which O
shares O
t O
( O
12 O
; O
22 _RARE_
) O
chromosome _RARE_
translocation O
revealed O
fusion O
of O
EWS I-GENE
with O
a O
transcriptional O
factor O
gene I-GENE
ATF I-GENE
- I-GENE
1 I-GENE
. O

Clones _RARE_
that O
expressed _RARE_
DBD _RARE_
exhibited O
a O
dominant O
negative O
phenotype _RARE_
and O
did O
not O
elicit O
antiviral _RARE_
activity O
against O
vesicular O
stomatitis _RARE_
virus O
( O
VSV _RARE_
) O
infection O
upon O
IFN I-GENE
treatment O
. O

Abp1 _RARE_
preferentially O
binds O
to O
multiple O
sites O
in O
ARS _RARE_
3002 _RARE_
and O
to O
the O
DNA O
polymer _RARE_
poly _RARE_
[ _RARE_
d O
( O
A O
. O
T O
)]. O

Identification O
, O
purification O
, O
and O
molecular _RARE_
cloning O
of O
autonomously _RARE_
replicating _RARE_
sequence I-GENE
- I-GENE
binding I-GENE
protein I-GENE
1 I-GENE
from I-GENE
fission _RARE_
yeast I-GENE
Schizosaccharomyces I-GENE
pombe I-GENE
. O

A O
short O
open _RARE_
reading O
frame O
( O
ORF2 O
), _RARE_
of O
unknown O
function O
, O
is O
present O
in O
all O
FIV _RARE_
isolates O
. O

The O
patient O
was O
homozygous O
for _RARE_
the O
underlying O
mutation O
, O
which O
was O
found O
to O
be O
a O
G O
--> _RARE_
T O
transversion O
within O
the O
acceptor _RARE_
splice _RARE_
site O
between O
intron O
e _RARE_
and O
exon _RARE_
6 O
, O
abolishing _RARE_
normal O
RNA O
splicing _RARE_
. O

These O
regions O
overlap O
with O
the O
HIT _RARE_
protein I-GENE
similarity _RARE_
regions I-GENE
. O

We O
tested O
10 O
rats O
with O
electrophysiologically _RARE_
guided _RARE_
, O
ibotenic _RARE_
acid O
lesions O
of O
the O
PBN _RARE_
( O
PBNx _RARE_
) O
to O
determine O
whether O
they O
could O
acquire _RARE_
a O
LiCl _RARE_
- O
induced _RARE_
CTA _RARE_
to O
l _RARE_
- O
alanine O
( O
0 _RARE_
. O
3 O
M O
) O
or O
demonstrate O
a O
sodium _RARE_
appetite _RARE_
following O
furosemide O
treatment O
and O
overnight _RARE_
access O
to O
sodium _RARE_
deficient _RARE_
chow _RARE_
. O

Liposomal _RARE_
Amphotericin _RARE_
- O
B O
failed O
in O
6 O
/ O
7 O
patients O
with O
culture O
- O
proven O
mycosis _RARE_
who O
died O
from O
infection O
with O
Aspergillus _RARE_
( O
n _RARE_
= O
2 O
) O
and O
Candida _RARE_
( O
n _RARE_
= O
4 O
), _RARE_
respectively O
. O

Mg2 _RARE_
+ O
and O
Mn2 _RARE_
+ O
compete O
for _RARE_
binding O
sites O
, O
with O
the O
former O
having O
lower O
affinity O
. O

Magnetic O
storm _RARE_
indicators O
could O
be O
used O
in O
medicine O
, O
in O
geophysics _RARE_
and O
for _RARE_
special _RARE_
purposes _RARE_
. O

Transgenic _RARE_
tobacco O
plants _RARE_
( O
ppa _RARE_
- I-GENE
1 I-GENE
) O
constitutively O
expressing O
Escherichia I-GENE
coli I-GENE
pyrophosphatase _RARE_
behind O
the O
35S _RARE_
CaMV _RARE_
promoter I-GENE
accumulate O
high O
levels O
of O
soluble _RARE_
sugars O
in O
their O
leaves O
[ _RARE_
27 _RARE_
]. O

Human I-GENE
LAF _RARE_
- I-GENE
4 I-GENE
readily O
hybridized O
with O
genes O
in O
mouse O
and O
chicken O
, O
thus O
showing O
that O
this O
gene O
family O
has O
been O
highly O
conserved _RARE_
during _RARE_
vertebrate _RARE_
evolution O
. O

Hb _RARE_
levels O
remained O
adequate O
( O
Hb _RARE_
= O
10 O
. O
68 _RARE_
+/- O
0 _RARE_
. O
77 O
g O
/ O
dl O
) O
after O
14 O
. O
6 O
+/- O
7 O
. O
64 _RARE_
months O
. O

CBT _RARE_
is O
discussed O
in O
comparison O
with O
the O
Wisconsin _RARE_
Card _RARE_
Sorting _RARE_
Test O
as _RARE_
a O
potential _RARE_
cognitive O
activation O
task O
for _RARE_
functional _RARE_
neuroimaging _RARE_
of O
the O
frontal O
lobes _RARE_
. O

These O
data O
indicate O
that O
although O
218leu _RARE_
retains O
normal O
transactivation _RARE_
activity O
on O
a O
p53 I-GENE
promoter I-GENE
in O
yeast O
at _RARE_
physiological O
temperatures O
, O
it O
is O
not O
capable O
of O
normal O
p53 I-GENE
function O
in O
the O
presence O
of O
a O
248trp _RARE_
allele I-GENE
in O
SNU _RARE_
- O
C5 _RARE_
cells O
. O

Cycles _RARE_
were O
repeated _RARE_
every O
3 O
weeks O
. O

Neither O
class O
II O
nor O
IV O
infections O
precluded _RARE_
transplantation O
. O

Although O
a O
great O
deal _RARE_
is O
understood O
about O
how O
bHLH I-GENE
factors I-GENE
activate O
gene O
transcription O
via O
E O
- O
box O
DNA O
consensus O
sequences O
, O
studies O
of O
bHLH I-GENE
factor I-GENE
function O
in O
higher _RARE_
eukaryotes O
often O
have O
been O
hindered _RARE_
by O
the O
presence O
of O
multiple O
family O
members O
. O

Mobility _RARE_
and O
supershift O
assays O
demonstrated O
that O
upstream I-GENE
stimulatory _RARE_
factor I-GENE
( O
USF I-GENE
) O
and O
Sp1 _RARE_
bind O
to O
the O
former O
elements O
and O
competition O
experiments O
confirmed O
that O
CREB I-GENE
/ O
ATF I-GENE
and O
AP I-GENE
- I-GENE
1 I-GENE
bind O
to O
the O
CRE _RARE_
/ O
TRE _RARE_
element O
. O

Upstream O
of O
- O
37 O
, O
the O
5 O
' O
untranslated _RARE_
sequences O
of O
the O
isolates O
differ O
in O
both O
length O
and O
sequence O
. O

In O
these O
cases O
, O
greatly O
increased O
human I-GENE
chorionic _RARE_
gonadotropin I-GENE
( O
hCG I-GENE
) O
levels O
and O
suppressed O
TSH _RARE_
levels O
suggest O
that O
hCG I-GENE
has O
thyrotropic _RARE_
activity O
. O

High _RARE_
fibrinogen I-GENE
levels O
could O
thus O
be O
a O
risk O
for _RARE_
perioperative _RARE_
thrombosis O
. O

Strontium _RARE_
chloride _RARE_
Sr _RARE_
89 _RARE_
is O
costly _RARE_
, O
but O
preliminary O
analysis O
indicates O
that O
it O
may O
reduce O
management O
expenditures _RARE_
overall O
.( O
ABSTRACT O
TRUNCATED O
AT O
250 _RARE_
WORDS O
) O

We O
propose O
that O
epigenetic _RARE_
features O
of O
tissue O
- O
specific O
control O
and O
of O
the O
control O
of O
allelic O
expression _RARE_
are O
intricately _RARE_
linked _RARE_
. O

This O
study O
determined O
the O
arthritogenic _RARE_
potential _RARE_
of O
silicone _RARE_
gel O
by O
either O
mixing _RARE_
it O
with O
bovine I-GENE
collagen _RARE_
II I-GENE
( O
BII _RARE_
) O
or O
by O
injecting O
silicone _RARE_
gel O
alone O
in O
DA _RARE_
rats O
. O

SBF _RARE_
binds O
to O
the O
promoter O
prior O
to O
the O
activation O
of O
transcription O
in O
late _RARE_
G1 O
, O
suggesting O
that O
Cln _RARE_
/ O
Cdc28 I-GENE
kinase O
regulates O
the O
ability O
of O
previously O
bound _RARE_
SBF _RARE_
to O
activate O
transcription O
. O

However O
, O
it O
remains O
an O
open _RARE_
question O
whether O
vertebrate _RARE_
Hox I-GENE
genes I-GENE
expressed _RARE_
under O
the O
control O
of O
Drosophila O
regulatory O
sequences O
can O
substitute O
the O
function O
of O
Drosophila I-GENE
Hox I-GENE
genes I-GENE
. O

This O
approach O
places _RARE_
gHoxb _RARE_
- I-GENE
1 I-GENE
into O
the O
normal O
embryonic _RARE_
spatiotemporal _RARE_
context O
in O
which O
lab _RARE_
acts O
. O

This O
5 O
' O
splice _RARE_
site O
sequence O
was O
required O
for _RARE_
enhanced _RARE_
polyadenylation O
and O
was O
recognized _RARE_
by O
both O
U1 _RARE_
small I-GENE
nuclear I-GENE
ribonucleoproteins _RARE_
( O
snRNPs _RARE_
) O
and O
alternative _RARE_
splicing _RARE_
factor I-GENE
/ O
splicing _RARE_
factor I-GENE
2 I-GENE
( O
ASF _RARE_
/ O
SF2 _RARE_
). O

This O
analysis O
revealed O
that O
SAP _RARE_
145 _RARE_
, O
together O
with O
four O
other O
SF3a _RARE_
/ O
SF3b _RARE_
subunits O
, O
UV _RARE_
cross O
- O
links O
to O
pre O
- O
mRNA O
in O
a O
20 O
- O
nucleotide O
region O
upstream O
of O
the O
BPS _RARE_
. O

We O
propose O
that O
CTS1 _RARE_
and I-GENE
CTS2 _RARE_
of I-GENE
Ci _RARE_
are O
members O
of O
two O
distinct O
classes O
of O
fungal _RARE_
chitinases _RARE_
, O
an O
observation O
not O
previously O
reported O
for _RARE_
a O
single O
fungus _RARE_
. O

Although O
the O
consumption O
of O
myoglobin I-GENE
- O
bound _RARE_
O2 _RARE_
( O
MbO2 _RARE_
) O
stores _RARE_
in O
seal _RARE_
muscles O
has O
been O
demonstrated O
in O
seal _RARE_
muscles O
during _RARE_
laboratory O
simulations _RARE_
of O
diving _RARE_
, O
this O
may O
not O
be O
a O
feature O
of O
normal O
field O
diving _RARE_
in O
which O
measurements O
of O
heart _RARE_
rate O
and O
lactate _RARE_
production O
show O
marked O
differences O
from O
the O
profound O
diving _RARE_
response O
induced _RARE_
by O
forced _RARE_
immersion O
. O

The O
human I-GENE
purH _RARE_
cDNA I-GENE
is O
1776 _RARE_
base _RARE_
pairs _RARE_
in O
length O
encoding O
for _RARE_
a O
591 _RARE_
- O
amino O
acid O
polypeptic _RARE_
( O
Mr O
= O
64 _RARE_
, O
425 _RARE_
). O

The O
Saccharomyces O
cerevisiae O
spindle _RARE_
pole O
body O
duplication O
gene I-GENE
MPS1 _RARE_
is O
part O
of O
a O
mitotic _RARE_
checkpoint _RARE_
. O

In O
our O
opinion _RARE_
, O
the O
SM _RARE_
- O
CMA _RARE_
system _RARE_
is O
, O
despite O
some O
shortcomings _RARE_
in O
its O
user _RARE_
- O
interface O
, O
a O
useful O
and O
versatile _RARE_
instrument O
for _RARE_
examination O
of O
human O
semen O
samples O
, O
with O
desirable _RARE_
features O
. O

The O
purpose O
of O
the O
study O
reported O
here O
was O
to O
investigate O
whether O
differences O
in O
T1 _RARE_
and O
T2 _RARE_
between O
tumors O
are O
mainly O
a O
consequence O
of O
differences O
in O
the O
fractional O
volume O
of O
the O
extracellular O
compartment O
. O

A O
mutant I-GENE
areA _RARE_
product I-GENE
truncated O
immediately O
after O
the O
last O
residue _RARE_
of O
the O
highly O
conserved _RARE_
GATA _RARE_
( I-GENE
DNA I-GENE
- I-GENE
binding I-GENE
) I-GENE
domain I-GENE
retains O
partial O
function O
. O

Oligonucleotides _RARE_
, O
designed O
on O
the O
basis O
of O
conserved _RARE_
flanking O
amino O
acid O
sequence O
segments _RARE_
within O
the O
catalytic O
domain O
of O
eukaryotic I-GENE
protein I-GENE
kinase I-GENE
C I-GENE
( O
PKC I-GENE
) O
proteins O
, O
were O
used O
as _RARE_
primers O
for _RARE_
polymerase O
chain O
reactions O
to O
amplify _RARE_
a O
427 _RARE_
- O
bp O
chromosomal O
DNA O
fragment O
from O
the O
filamentous _RARE_
fungus _RARE_
Trichoderma _RARE_
reesei _RARE_
. O

Disruption O
of O
RB _RARE_
/ O
E2F I-GENE
- I-GENE
1 I-GENE
interaction O
by O
single O
point O
mutations O
in O
E2F I-GENE
- I-GENE
1 I-GENE
enhances O
S O
- O
phase _RARE_
entry O
and O
apoptosis O
. O

Apparent _RARE_
loss _RARE_
of O
differentiation O
markers O
characterizes _RARE_
advanced O
malignant O
neoplasms O
. O

This O
region O
contains O
a O
motif O
with O
partial O
identity O
with O
the O
binding O
site O
for _RARE_
the O
ubiquitous O
transcription O
factor O
upstream I-GENE
stimulatory _RARE_
factor I-GENE
( O
USF I-GENE
), _RARE_
which O
binds O
to O
the O
human I-GENE
insulin I-GENE
promoter I-GENE
. O

The O
method O
has O
been O
satisfactorily _RARE_
applied O
to O
the O
determination O
of O
paracetamol _RARE_
in O
pharmaceutical _RARE_
formulations _RARE_
and O
biological O
fluids O
. O

These O
primers O
yielded O
a O
PCR O
product O
of O
a O
characteristic O
length O
within O
most O
Xanthomonas _RARE_
species O
and O
pathovars _RARE_
tested O
. O

The O
Clb5 _RARE_
kinase I-GENE
, O
which O
promotes O
S O
phase _RARE_
, O
remains O
active _RARE_
during _RARE_
the O
G2 _RARE_
- O
phase _RARE_
arrest O
of O
cells O
of O
the O
parental O
strain _RARE_
, O
but O
its O
activity O
declines _RARE_
rapidly O
in O
sim _RARE_
mutants I-GENE
. O

The O
C O
/ O
D O
ratio O
was O
equal O
to O
or O
over O
0 _RARE_
. O
6 O
in O
9 O
cases O
( O
16 O
eyes O
), _RARE_
and O
the O
values O
were O
inconsistent _RARE_
between O
both O
eyes O
in O
55 _RARE_
% O
of O
the O
patients O
. O

Rad6 _RARE_
mutants I-GENE
display O
a O
remarkably O
pleiotropic O
phenotype _RARE_
, O
implicating _RARE_
the O
protein O
in O
DNA O
damage O
- O
induced _RARE_
mutagenesis O
, O
postreplication _RARE_
repair O
, O
repression O
of O
retrotransposition _RARE_
, O
and O
sporulation _RARE_
. O

RNase I-GENE
protection O
assays O
revealed O
a O
correlation O
between O
the O
levels O
of O
dorsal O
and O
ventral O
skin _RARE_
expression _RARE_
with O
pigmentation _RARE_
/ O
phaeomelanin _RARE_
phenotypes _RARE_
. O

Molecular O
cloning O
, O
expression _RARE_
pattern O
, O
and O
chromosomal O
localization _RARE_
of O
human O
CDKN2D _RARE_
/ O
INK4d _RARE_
, O
an O
inhibitor O
of O
cyclin _RARE_
D I-GENE
- I-GENE
dependent I-GENE
kinases I-GENE
. O

Overproduction _RARE_
of O
HrcA _RARE_
protein I-GENE
from O
a O
second O
copy O
of O
hrcA _RARE_
derived O
from O
a O
plasmid _RARE_
( O
phrcA _RARE_
+) O
in O
B O
. O
subtilis O
wild O
- O
type O
and O
delta O
hrcA _RARE_
strains O
prevented O
heat O
shock O
induction O
of O
the O
dnaK _RARE_
and O
groE _RARE_
operons _RARE_
at _RARE_
the O
level O
of O
transcription O
almost O
completely O
and O
strongly O
reduced _RARE_
the O
amounts O
of O
mRNA O
at _RARE_
a O
low O
temperature _RARE_
as _RARE_
well _RARE_
. O

We O
report O
the O
molecular _RARE_
cloning O
and O
functional _RARE_
characterization O
of O
USF2 _RARE_
isoforms I-GENE
, O
corresponding O
to O
a O
44 _RARE_
- O
kDa O
subunit O
, O
USF2a _RARE_
, O
and O
a O
new O
38 O
- O
kDa O
subunit O
, O
USF2b _RARE_
, O
generated O
by O
differential O
splicing _RARE_
. O

The O
preferential O
heterodimerization O
of O
USF I-GENE
subunits I-GENE
was O
reproduced _RARE_
ex _RARE_
vivo O
, O
while O
the O
in O
vitro O
association O
of O
cotranslated _RARE_
subunits O
, O
or O
recombinant I-GENE
USF I-GENE
proteins I-GENE
, O
appeared O
to O
be O
random O
. O

Activated _RARE_
PKR I-GENE
may O
exist O
as _RARE_
a O
dimer _RARE_
and O
phosphorylates O
the O
eukaryotic I-GENE
translation I-GENE
initiation I-GENE
factor I-GENE
2 I-GENE
alpha I-GENE
subunit I-GENE
( O
cIF _RARE_
- I-GENE
2 I-GENE
alpha I-GENE
) O
to O
inhibit O
polypeptide O
chain O
initiation O
. O

GRP78 _RARE_
, O
a O
molecular _RARE_
chaperone _RARE_
expressed _RARE_
in O
the O
endoplasmic O
reticulum O
, O
is O
a O
" O
glucose O
- O
regulated O
protein O
" O
induced _RARE_
by O
stress O
responses O
that O
deplete _RARE_
glucose O
or O
intracisternal _RARE_
calcium _RARE_
or O
otherwise O
disrupt O
glycoprotein O
trafficking O
. O

The O
IL _RARE_
- I-GENE
8 I-GENE
receptor I-GENE
is O
a O
seven _RARE_
- O
transmembrane O
spanning O
receptor O
coupled O
to O
specific O
heterotrimeric I-GENE
G I-GENE
proteins I-GENE
including O
Gi _RARE_
and O
G16 _RARE_
. O

In O
a O
second O
series O
of O
experiments O
, O
the O
efficacy O
of O
PDC _RARE_
/ O
HDC _RARE_
Ac _RARE_
was O
evaluated O
in O
both O
single O
and O
multiple O
dose O
regiments _RARE_
. O

To O
elucidate O
the O
functional _RARE_
significance O
of O
Fyn I-GENE
in O
the O
expression _RARE_
of O
viral O
promoters O
, O
we O
transfected O
a O
Fyn I-GENE
- O
expression _RARE_
vector O
together O
with O
a O
reporter O
plasmid _RARE_
containing O
the O
chloramphenicol I-GENE
acetyltransferase _RARE_
gene I-GENE
driven _RARE_
by O
HIV I-GENE
LTR I-GENE
into O
a O
human O
T O
cell O
line O
, O
Jurkat O
. O

We O
conducted O
a O
prospective O
, O
randomized O
controlled _RARE_
trial O
of O
metoprolol _RARE_
, O
a O
selective O
beta O
- O
blocker O
for _RARE_
prevention O
of O
gastrointestinal _RARE_
bleeding O
from O
portal _RARE_
hypertension O
in O
29 O
non O
- O
selected _RARE_
patients O
with O
liver O
disease _RARE_
and O
previous O
gastrointestinal _RARE_
bleeding O
. O

A O
genetic O
and O
molecular _RARE_
analysis O
of O
non O
- O
inducible O
qutA _RARE_
mutants I-GENE
showed O
that O
all O
23 _RARE_
mutations O
analysed O
map O
within O
the O
N O
- O
terminal O
half _RARE_
of O
the O
encoded O
QUTA _RARE_
protein I-GENE
. O

These O
studies O
indicate O
that O
the O
acidimetric _RARE_
test O
was O
less O
sensitive _RARE_
than O
the O
chromogenic _RARE_
cephalosporin _RARE_
substrates _RARE_
and O
that O
nitrocefin _RARE_
and O
S1 O
could O
be O
used O
to O
screen O
for _RARE_
beta I-GENE
- I-GENE
lactamase I-GENE
production O
in O
these O
tested O
species O
. O

Suppressors _RARE_
of O
defective _RARE_
silencing O
in O
yeast O
: O
effects O
on O
transcriptional O
repression O
at _RARE_
the O
HMR I-GENE
locus I-GENE
, O
cell O
growth O
and O
telomere _RARE_
structure _RARE_
. O

Although O
ANP I-GENE
induced _RARE_
systemic O
capillary O
filtration O
, O
in O
the O
calf _RARE_
, O
filtration O
was O
reduced _RARE_
with O
ANP I-GENE
. O

Recent O
literature O
has O
suggested O
that O
beta I-GENE
- I-GENE
2 I-GENE
transferrin I-GENE
can O
also O
be O
used O
as _RARE_
a O
clinical O
marker O
for _RARE_
perilymph _RARE_
. O

With O
current O
methodology _RARE_
beta I-GENE
- I-GENE
2 I-GENE
transferrin I-GENE
does O
not O
appear O
to O
be O
a O
reliable O
clinical O
marker O
for _RARE_
perilymph _RARE_
in O
the O
operative O
setting O
. O

The O
hIGF _RARE_
- I-GENE
I I-GENE
gene I-GENE
has O
two O
promoters O
, O
P1 O
and O
P2 O
. O

Gel O
mobility O
shift O
assays O
indicated O
that O
at _RARE_
least O
four O
nuclear O
proteins O
with O
distinct O
biochemical O
and O
binding O
properties O
possess O
the O
ability O
to O
bind O
the O
3 O
beta O
I O
- O
A O
element O
to O
produce O
four O
DNA O
- O
protein O
complexes O
( O
R1 _RARE_
to O
R4 _RARE_
). O

Sixty _RARE_
- O
five O
patients O
( O
aged O
between O
3 O
years O
5 O
months O
and O
60 _RARE_
years O
) O
suffering O
from O
medically _RARE_
resistant O
temporal O
lobe O
epilepsy O
( O
TLE _RARE_
) O
were O
operated O
on O
over O
a O
period O
of O
33 _RARE_
months O
in O
Bethel _RARE_
Epilepsy _RARE_
Center _RARE_
. O

Significant O
correlations O
existed O
between O
FEV1 O
and O
the O
corresponding O
values O
of O
Raw _RARE_
, O
MEF50 _RARE_
and O
MEF25 _RARE_
, O
although O
there O
were O
considerable O
individual O
differences O
between O
test O
results O
. O

( O
1989 O
), _RARE_
which O
is O
identical O
to O
the O
SSC1 _RARE_
gene I-GENE
( O
Smith _RARE_
et O
al O
., O
1988 O
). O

This O
region O
also O
contains O
a O
gene O
specifying _RARE_
a O
Leu _RARE_
- I-GENE
tRNA I-GENE
precursor I-GENE
and O
a O
remnant _RARE_
of O
a O
tau _RARE_
element O
. O

Occupational _RARE_
exposure O
to O
hepatitis O
B O
virus O
and O
human O
immunodeficiency O
virus O
: O
a O
comparative O
risk O
analysis O
. O

Hybrid _RARE_
female O
mice O
( O
C57BL O
x _RARE_
CBA _RARE_
) O
were O
paired O
with O
breeder _RARE_
males O
( O
CD O
- O
1 O
) O
and O
LNG _RARE_
pellets O
were O
implanted O
on O
day O
0 _RARE_
, O
the O
day O
on O
which O
copulation _RARE_
plugs _RARE_
were O
found O
, O
or O
on O
day O
2 O
or O
day O
3 O
in O
the O
postcoital _RARE_
period O
. O

This O
gene O
encodes O
a O
putative O
transcription O
factor O
with O
regions O
of O
homology O
to O
several O
other O
proteins O
including O
the O
zinc O
fingers _RARE_
and O
other O
domains O
of O
the O
Drosophila I-GENE
trithorax _RARE_
gene I-GENE
product I-GENE
, O
and O
the O
" O
AT O
- O
hook _RARE_
" O
DNA O
- O
binding O
motif O
of O
high I-GENE
mobility I-GENE
group I-GENE
proteins I-GENE
. O

Using O
reference O
probes _RARE_
as _RARE_
internal O
standards _RARE_
, O
we O
show O
that O
the O
ost _RARE_
transcription I-GENE
unit I-GENE
is O
located _RARE_
within O
the O
cytogenetic O
band O
interval O
89A1 _RARE_
, O
2 O
on O
the O
right O
arm _RARE_
of O
the O
third O
chromosome _RARE_
, O
and O
that O
it O
exerts O
diagnostic O
segmentation _RARE_
gene O
expression _RARE_
patterns O
in O
the O
embryo _RARE_
. O

The O
purified _RARE_
recombinant O
enzyme O
catalyzed O
specific O
phosphoryl _RARE_
transfer O
from O
ATP O
to O
UMP _RARE_
and O
CMP _RARE_
. O

Studies O
on O
the O
life O
cycle _RARE_
of O
Haplorchis _RARE_
pumilio _RARE_
( O
Looss _RARE_
, O
1896 _RARE_
) O
Looss _RARE_
, O
1899 _RARE_
with O
morphological O
redescription _RARE_
of O
larval _RARE_
and O
adult O
stages O
. O

Regressing _RARE_
microaneurysms _RARE_
in O
5 O
cases O
of O
hepatitis O
B O
virus O
related O
polyarteritis _RARE_
nodosa _RARE_
. O

During O
the O
following O
pregnancy _RARE_
ultrasonographic _RARE_
studies O
of O
the O
male O
fetus O
in O
the O
16th _RARE_
week O
of O
gestation O
revealed O
severe O
micrognathia _RARE_
, O
short O
and O
wide O
thumbs _RARE_
, O
and O
big _RARE_
toes _RARE_
, O
and O
bowed _RARE_
tibiae _RARE_
. O

Despite O
an O
overall O
survival O
rate O
of O
43 _RARE_
%, O
survival O
to O
discharge O
varied O
greatly O
( O
0 _RARE_
to O
100 _RARE_
%) O
among O
the O
24 _RARE_
diagnostic O
groups O
: O
tumor O
lysis O
syndrome _RARE_
and O
systemic O
lupus O
erythematosus O
( O
3 O
/ O
3 O
patients O
each O
, O
100 _RARE_
%), O
hemolytic _RARE_
uremic _RARE_
syndrome _RARE_
( O
8 O
/ O
9 O
patients O
, O
89 _RARE_
%). O

One O
hundred O
units _RARE_
/ O
kg O
of O
recombinant I-GENE
human I-GENE
erythropoietin I-GENE
( O
rhEPO _RARE_
) O
was O
given O
subcutaneously O
3 O
times O
a O
week O
for _RARE_
3 O
weeks O
. O

A O
3 O
- O
week O
regimen O
of O
erythropoietin I-GENE
may O
help O
prevent O
the O
donor O
' O
s O
need O
to O
receive O
allogeneic _RARE_
blood _RARE_
transfusion O
, O
when O
the O
initial O
Hb _RARE_
levels O
were O
below O
130 _RARE_
milligrams _RARE_
. O

In O
these O
constructs O
, O
GUS I-GENE
expression _RARE_
was O
driven _RARE_
by O
promoter O
regions O
derived O
from O
the O
Arabidopsis I-GENE
alcohol _RARE_
dehydrogenase I-GENE
( O
Adh1 _RARE_
), _RARE_
maize _RARE_
ubiquitin I-GENE
( O
Ubi1 _RARE_
), _RARE_
rice _RARE_
actin I-GENE
( O
Act1 _RARE_
) O
and O
CaMV _RARE_
35S _RARE_
genes I-GENE
. O

Its O
organization O
and O
regulation _RARE_
indicate O
that O
the O
S I-GENE
. I-GENE
pombe I-GENE
URA1 _RARE_
gene I-GENE
product I-GENE
appears O
very O
similar O
to O
the O
S I-GENE
. I-GENE
cerevisiae I-GENE
URA2 _RARE_
gene I-GENE
product I-GENE
. O

The O
mean O
body O
mass O
index O
( O
BMI O
) O
was O
31 _RARE_
. O
8 O
+/- O
6 O
. O
3 O
kg O
/ O
m2 O
and O
28 _RARE_
. O
5 O
+/- O
6 O
. O
3 O
kg O
/ O
m2 O
in O
women O
and O
men O
, O
respectively O
. O

These O
findings O
demonstrate O
that O
haemodialysis O
patients O
with O
chronic O
hepatitis O
C O
respond O
well _RARE_
to O
interferon _RARE_
treatment O
and O
that O
a O
long O
- O
term O
response O
is O
achieved O
in O
a O
high O
proportion O
of O
patients O
. O

Synthetic _RARE_
enantiomers _RARE_
of O
drugs O

Polysome _RARE_
analysis O
further O
indicated O
that O
these O
germ _RARE_
cell I-GENE
- I-GENE
specific I-GENE
Sp1 _RARE_
mRNAs I-GENE
are O
translated O
, O
albeit _RARE_
with O
a O
lower O
efficiency O
than O
the O
somatic O
transcript O
. O

In O
nondiabetics _RARE_
the O
response O
of O
tcPO2 _RARE_
but O
not O
of O
LDF _RARE_
was O
influenced O
by O
the O
values O
at _RARE_
rest O
. O

This O
study O
proposes _RARE_
an O
estimator _RARE_
for _RARE_
such O
global O
synchronizing _RARE_
effects O
upon O
unit O
- O
pair _RARE_
correlations O
based O
on O
local O
field O
potentials O
( O
LFPs _RARE_
). O

The O
assembly O
of O
sequence O
ready _RARE_
, O
high O
- O
resolution O
physical O
maps O
and O
construction _RARE_
of O
minimally _RARE_
overlapping O
contigs _RARE_
for _RARE_
the O
human O
as _RARE_
well _RARE_
as _RARE_
model O
genomes O
requires O
accurate O
determination O
of O
the O
extent O
of O
overlap O
between O
adjacent O
clones _RARE_
as _RARE_
well _RARE_
as _RARE_
their O
relative O
orientation O
. O

( O
ii O
) O
opening _RARE_
of O
KATP _RARE_
attenuates O
, O
inhibition O
of O
the O
channel _RARE_
exacerbates _RARE_
functional _RARE_
consequences O
of O
coronary O
occlusion O
, O
and O
( O
iii O
) O
KATP _RARE_
opening _RARE_
attenuates O
reperfusion O
- O
induced _RARE_
VF O
, O
but O
it O
triggers O
ischemia O
- O
induced _RARE_
VF O
. O

The O
DNA O
sequences O
upstream O
of O
these O
termini O
exhibit O
homology O
to O
plant _RARE_
mitochondrial O
- O
processing _RARE_
sites O
, O
therefore O
the O
proximal O
5 O
' O
ends O
are O
most O
probably O
generated O
by O
RNA O
processing _RARE_
. O

Curing _RARE_
shrinkage _RARE_
and O
volumetric _RARE_
changes O
of O
resin O
- O
modified O
glass O
ionomer _RARE_
restorative _RARE_
materials O
. O

Here O
we O
present O
genetic O
evidence O
suggesting O
that O
PP2A I-GENE
functions O
downstream _RARE_
of O
Ras1 _RARE_
in O
the O
Sevenless _RARE_
receptor I-GENE
tyrosine I-GENE
kinase I-GENE
( O
RTK _RARE_
) O
signal O
transduction _RARE_
pathway _RARE_
that O
specifies O
R7 _RARE_
photoreceptor _RARE_
cell O
fate O
in O
the O
developing O
Drosophila O
eye O
. O

QBMDs _RARE_
for _RARE_
a O
5 O
% O
change O
in O
response O
( O
QBMD05 _RARE_
) O
were O
6 O
- O
fold _RARE_
lower O
, O
on O
average O
, O
than O
the O
corresponding O
NOAEL _RARE_
. O

Effects O
of O
repeated _RARE_
exposures O
of O
hydrogen O
sulphide _RARE_
on O
rat O
hippocampal O
EEG O
. O

The O
gene O
encodes O
an O
ATP I-GENE
- I-GENE
binding I-GENE
cassette _RARE_
, O
ABC _RARE_
transporter _RARE_
. O

The O
T O
- O
box O
motif O
is O
present O
in O
a O
family O
of O
genes O
whose O
structural O
features O
and O
expression _RARE_
patterns O
support O
their O
involvement O
in O
developmental O
gene O
regulation _RARE_
. O

Molecular O
analysis O
of O
a O
novel O
schizosaccharomyces _RARE_
pombe O
gene O
containing O
two O
RNP _RARE_
consensus O
- O
sequence O
RNA O
- O
binding O
domains O
. O

Do _RARE_
overall O
treatment O
time O
, O
field O
size O
, O
and O
treatment O
energy O
influence O
local O
control O
of O
T1 _RARE_
- O
T2 _RARE_
squamous O
cell O
carcinomas O
of O
the O
glottic _RARE_
larynx O
? O
PURPOSE O
: O
To O
evaluate O
treatment O
and O
patient O
related O
prognostic O
factors O
that O
may O
influence O
local O
control O
in O
the O
treatment O
of O
T1 _RARE_
- O
T2 _RARE_
squamous O
cell O
carcinoma O
of O
the O
glottic _RARE_
larynx O
. O

In O
contrast O
to O
the O
signaling _RARE_
triggered O
by O
surface O
Ig I-GENE
engagement _RARE_
in O
B O
lymphocytes O
, O
CD38 _RARE_
ligation O
did O
not O
appear O
to O
induce O
tyrosine O
phosphorylation _RARE_
of O
the O
src I-GENE
- I-GENE
like I-GENE
protein I-GENE
tyrosine I-GENE
kinases I-GENE
lyn _RARE_
, O
fyn _RARE_
, O
and O
btk _RARE_
, O
or O
of O
vav _RARE_
- I-GENE
and I-GENE
ras I-GENE
- I-GENE
GTPase I-GENE
- I-GENE
activating I-GENE
protein I-GENE
, O
nor O
did O
it O
induce O
detectable O
changes O
in O
cytosolic O
CA2 _RARE_
+ O
concentrations O
. O

Mutations O
in O
the O
alpha I-GENE
- I-GENE
amanitin _RARE_
conserved _RARE_
domain O
of O
the O
largest O
subunit O
of O
yeast I-GENE
RNA I-GENE
polymerase I-GENE
III I-GENE
affect O
pausing _RARE_
, O
RNA O
cleavage _RARE_
and O
transcriptional O
transitions _RARE_
. O

The O
evidence O
presented O
here O
suggests O
that O
the O
p40 I-GENE
complex I-GENE
is O
a O
ribonucleoprotein O
complex O
containing O
L1Hs _RARE_
RNA I-GENE
( I-GENE
s I-GENE
) I-GENE
and O
that O
protein O
- O
protein O
interactions O
in O
which O
alpha O
- O
helix O
structures _RARE_
participate O
, O
for _RARE_
example O
coiled _RARE_
- O
coils _RARE_
, O
may O
occur O
in O
the O
complex O
. O

Our O
data O
suggest O
that O
trans _RARE_
- O
activation O
from O
the O
prothymosin _RARE_
intron I-GENE
enhancer I-GENE
is O
a O
faithful _RARE_
reflection _RARE_
of O
the O
transforming O
properties O
of O
the O
Myc _RARE_
protein I-GENE
. O

Pseudomembranous _RARE_
conjunctivitis _RARE_
following O
bone O
marrow O
transplantation O
: O
immunopathological _RARE_
and O
ultrastructural _RARE_
study O
of O
one O
case O
. O

In O
view O
of O
the O
presence O
of O
SECIS O
elements O
in O
the O
open _RARE_
reading O
frames O
( O
ORFs _RARE_
) O
of O
bacterial I-GENE
selenoproteins _RARE_
, O
we O
examine O
the O
effects O
in O
the O
type I-GENE
1 I-GENE
deiodinase I-GENE
of O
extending O
the O
ORF O
into O
the O
SECIS O
element O
, O
and O
find O
that O
this O
dramatically O
inhibits O
SECIS O
function O
. O

The O
5 O
' O
external O
transcribed _RARE_
spacer O
( O
ETS _RARE_
) O
region O
of O
the O
pre O
- O
rRNA O
in O
Saccharomyces O
cerevisiae O
contains O
a O
sequence O
with O
10 O
bp O
of O
perfect O
complementarity _RARE_
to O
the O
U3 _RARE_
snoRNA _RARE_
. O

These O
animals O
were O
viable O
and O
fertile _RARE_
. O

This O
spindle _RARE_
defect O
of O
pds1 _RARE_
mutants I-GENE
results O
from O
a O
temperature _RARE_
- O
sensitive _RARE_
step O
that O
occurs O
around O
the O
G1 O
/ O
S O
boundary O
about O
the O
time O
of O
spindle _RARE_
assembly O
. O

These O
data O
suggest O
that O
RPF _RARE_
- I-GENE
1 I-GENE
is O
likely O
to O
be O
involved O
in O
early O
steps O
in O
the O
differentiation O
of O
amacrine _RARE_
and O
ganglion _RARE_
cells O
. O

In O
the O
point O
mutant O
we O
observed O
normal O
repair O
of O
endonuclease I-GENE
III I-GENE
site I-GENE
( O
i O
. O
e _RARE_
. O
as _RARE_
wild O
type O
), _RARE_
but O
no _RARE_
removal O
of O
CPDs _RARE_
at _RARE_
the O
MAT _RARE_
alpha I-GENE
and O
HML _RARE_
alpha I-GENE
loci I-GENE
. O

However O
, O
for _RARE_
the O
evaluable O
cases O
, O
the O
performances _RARE_
of O
the O
CD3500 _RARE_
and O
the O
STKS _RARE_
were O
broadly O
similar O
and O
generally O
correlated O
well _RARE_
with O
the O
manual _RARE_
reference O
procedure O
. O

Carboxy _RARE_
- O
terminal O
Spc110p _RARE_
truncations _RARE_
lacking _RARE_
the O
calmodulin I-GENE
binding O
site O
can O
support O
growth O
and O
are O
also O
phosphorylated _RARE_
in O
a O
cell O
cycle _RARE_
- O
specific O
manner O
. O

Both O
EWS I-GENE
- O
FLI I-GENE
- I-GENE
1 I-GENE
and O
FLI I-GENE
- I-GENE
1 I-GENE
proteins I-GENE
function O
as _RARE_
transcription O
factors O
that O
bind O
specifically O
to O
ets I-GENE
sequences O
( O
the O
ets I-GENE
boxes _RARE_
) O
present O
in O
promoter O
elements O
. O

In O
electromobility _RARE_
shift O
assays O
, O
EWS I-GENE
- O
FLI I-GENE
- I-GENE
1 I-GENE
binding O
to O
the O
SRE O
is O
detectable O
in O
the O
absence O
of O
SRF I-GENE
whereas O
the O
binding O
of O
FLI I-GENE
- I-GENE
1 I-GENE
is O
not O
, O
suggesting O
that O
the O
interaction O
with O
DNA O
is O
the O
step O
which O
limits O
ternary _RARE_
complex O
formation O
by O
FLI I-GENE
- I-GENE
1 I-GENE
. O

Additional _RARE_
studies O
with O
new O
and O
reprocessed _RARE_
regenerated _RARE_
cellulose _RARE_
dialyzers _RARE_
comparing O
450 _RARE_
and O
220 O
mL O
/ O
min O
blood _RARE_
flow O
rates O
at _RARE_
10 O
minutes O
showed O
no _RARE_
change O
in O
BTG _RARE_
. O

DNA O
methylation O
, O
especially O
of O
either O
one O
or O
both O
of O
the O
deoxyadenosines _RARE_
at _RARE_
the O
two O
GATC _RARE_
motifs O
( O
one O
in O
the O
first _RARE_
exon _RARE_
and O
the O
other O
in O
the O
first _RARE_
intron O
of O
the O
rice _RARE_
CatA _RARE_
gene I-GENE
), _RARE_
appeared O
to O
be O
responsible O
for _RARE_
the O
CatA _RARE_
promoter I-GENE
activity O
identified O
in O
the O
transient O
assay O
. O

The O
viral I-GENE
LTR I-GENE
was O
used O
as _RARE_
the O
promoter O
. O

Overlapping _RARE_
cDNA O
clones _RARE_
were O
isolated O
and O
sequenced O
. O

In O
conclusion O
, O
IgM I-GENE
class O
CIC _RARE_
is O
the O
predominant O
CIC _RARE_
in O
acute O
hepatitis O
A O
and O
correlated O
with O
disease _RARE_
activity O
. O

Epitope _RARE_
mapping O
revealed O
that O
these O
three O
clones _RARE_
appear O
to O
recognize O
an O
identical O
epitope _RARE_
domain O
present O
on O
the O
C O
- O
terminal O
RNP _RARE_
motif O
of O
the O
U1A _RARE_
protein I-GENE
. O

Variables _RARE_
evaluated O
were O
number O
of O
weekly O
anginal _RARE_
events O
, O
data O
from O
ergometric _RARE_
exercise O
testing O
with O
simultaneous O
electrocardiographic _RARE_
registration _RARE_
, O
semiquantitative _RARE_
evaluation O
of O
Tc O
- O
99m O
2 O
- O
methoxy _RARE_
isobutyl _RARE_
isonitrile _RARE_
( O
MIBI _RARE_
) O
scans O
and O
rheologic _RARE_
variables O
. O

As O
the O
length O
of O
the O
fatty O
acid O
decreased O
, O
the O
binding O
affinity O
was O
reduced _RARE_
; O
myristic _RARE_
acid O
( O
14 O
: O
0 _RARE_
) O
bound _RARE_
with O
a O
K O
( O
d O
) O
of O
1409 _RARE_
+/- O
423 _RARE_
nM O
, O
but O
medium O
- O
chain O
( O
decanoic _RARE_
acid O
, O
10 O
: O
0 _RARE_
) O
and O
short O
- O
chain O
( O
octanoic _RARE_
acid O
, O
8 O
: O
0 _RARE_
) O
lipids O
were O
not O
bound _RARE_
at _RARE_
all O
. O

The O
membrane O
- O
distal O
cytoplasmic O
region O
of O
human I-GENE
granulocyte _RARE_
colony I-GENE
- I-GENE
stimulating I-GENE
factor I-GENE
receptor I-GENE
is O
required O
for _RARE_
STAT3 I-GENE
but O
not O
STAT1 I-GENE
homodimer _RARE_
formation O
. O

However O
, O
whether O
or O
not O
nonsense O
codon _RARE_
recognition O
within O
TPI _RARE_
transcripts I-GENE
takes _RARE_
place O
prior O
to O
or O
after O
splicing _RARE_
remained O
unresolved _RARE_
. O

Although O
some O
residues O
are O
found O
reactive O
toward O
dimethylsulphate _RARE_
and O
kethoxal _RARE_
in O
regions O
predicted O
to O
be O
unpaired _RARE_
by O
the O
phylogenetic O
secondary O
structure _RARE_
model O
of O
4 I-GENE
. I-GENE
5S I-GENE
RNA I-GENE
, O
generally O
the O
reactivity O
is O
low O
, O
and O
some O
residues O
in O
internal O
loops O
are O
not O
reactive O
at _RARE_
all O
. O

Ongoing _RARE_
and O
future O
investigations O
may O
better O
define O
the O
optimal O
approach O
for _RARE_
local O
control O
, O
the O
optimal O
duration O
of O
maintenance _RARE_
chemotherapy O
, O
and O
the O
possible O
role O
of O
biologic _RARE_
response O
modifiers _RARE_
and O
growth O
factors O
in O
further O
improving _RARE_
the O
outcome O
for _RARE_
patients O
with O
this O
disease _RARE_
. O

SUMMARY _RARE_
OF _RARE_
REVIEW _RARE_
: O
We O
discuss O
the O
criteria O
that O
make O
such O
studies O
comparable O
, O
drawing _RARE_
on O
the O
experiences _RARE_
of O
recent O
studies O
performed O
around O
the O
world O
. O

Forty O
- O
five O
patients O
with O
pleural _RARE_
lesions O
identified O
on O
CT _RARE_
scans O
were O
subsequently O
examined O
by O
MR O
imaging O
at _RARE_
0 _RARE_
. O
5 O
T O
. O

Left _RARE_
atrial _RARE_
volumes O
were O
greater O
in O
old O
compared O
with O
young O
subjects O
( O
maximal O
: O
31 _RARE_
+/- O
10 O
cm3 O
/ O
m2 O
vs _RARE_
24 _RARE_
+/- O
8 O
cm3 O
/ O
m2 O
, O
p O
= O
0 _RARE_
. O
02 O
; O
at _RARE_
onset O
of O
atrial _RARE_
systole _RARE_
: O
23 _RARE_
+/- O
8 O
cm3 O
/ O
m2 O
vs _RARE_
15 _RARE_
+/- O
5 O
cm3 O
/ O
m2 O
, O
p O
= O
0 _RARE_
. O
0002 _RARE_
; O
minimal O
: O
13 _RARE_
+/- O
5 O
cm3 O
/ O
m2 O
vs _RARE_
9 O
+/- O
4 O
cm3 O
/ O
m2 O
, O
p O
= O
0 _RARE_
. O
001 O
). O

RESULTS O
: O
Basal O
plasma I-GENE
IGF I-GENE
- I-GENE
I I-GENE
levels O
as _RARE_
well _RARE_
as _RARE_
body O
mass O
index O
( O
BMI O
) O
were O
lower O
in O
amenorrheic _RARE_
patients O
than O
in O
healthy O
controls O
. O

We O
observed O
abundant O
levels O
of O
Rev _RARE_
- O
erbA I-GENE
alpha I-GENE
mRNA O
in O
dividing _RARE_
C2C12 O
myoblasts O
, O
which O
were O
suppressed O
when O
the O
cells O
differentiated O
into O
postmitotic _RARE_
multinucleated _RARE_
myotubes O
. O

We O
then O
demonstrated O
that O
1 O
) O
GAL4 I-GENE
- O
REV _RARE_
- O
erbA I-GENE
alpha I-GENE
chimeras _RARE_
that O
contain O
the O
' O
AB _RARE_
' O
region O
and O
lack O
the O
' O
E O
' O
region O
activated O
transcription O
of O
GAL4 I-GENE
response I-GENE
elements I-GENE
in O
the O
presence O
of O
8 O
- O
Br O
- O
cAMP O
and O
2 O
) O
the O
ligand _RARE_
- O
binding O
domain O
( O
LBD _RARE_
) O
contains O
an O
active _RARE_
transcriptional O
silencer _RARE_
. O

The O
alpha O
T3 _RARE_
- O
1 O
cell O
line O
, O
a O
GnRH I-GENE
- O
responsive O
gonadotroph _RARE_
cell O
line O
developed O
by O
targeted O
oncogenesis _RARE_
in O
transgenic O
mice O
, O
was O
used O
to O
study O
regulation _RARE_
of O
the O
glycoprotein I-GENE
hormone I-GENE
alpha I-GENE
- I-GENE
subunit I-GENE
by O
activin I-GENE
. O

Cotransfection O
with O
the O
ie1 _RARE_
gene I-GENE
resulted O
in O
a O
dramatic O
increase O
in O
the O
amount O
of O
the O
two O
enzymes _RARE_
expressed _RARE_
in O
the O
transfected O
cells O
. O

As O
expected O
, O
glycosylation O
of O
Env I-GENE
produced O
from O
mutants O
was O
affected O
but O
, O
irrespective O
of O
the O
glycosylation O
phenotype _RARE_
, O
( O
i O
) O
similar O
quantities _RARE_
of O
Env I-GENE
were O
synthesized O
, O
( O
ii O
) O
the O
immunoreactivity O
of O
V3 _RARE_
was O
similar O
, O
( O
iii O
) O
gp160 _RARE_
was O
efficiently O
cleaved O
into O
gp120 I-GENE
and O
gp41 _RARE_
, O
( O
vi _RARE_
) O
Env I-GENE
was O
exposed O
at _RARE_
the O
cell O
membrane O
, O
( O
v O
) O
secreted _RARE_
gp120 I-GENE
bound _RARE_
CD4 _RARE_
, O
and O
( O
vi _RARE_
) O
membrane O
gp41 _RARE_
was O
able O
to O
induce O
membrane O
fusion O
with O
CD4 _RARE_
+ I-GENE
cells O
. O

Effects O
of O
posteroventral _RARE_
pallidotomy _RARE_
on O
Parkinson O
' O
s O
disease _RARE_
. O

On O
the O
trail _RARE_
of O
Dr _RARE_
. O

However O
, O
only O
complete _RARE_
DnaJ _RARE_
can O
cooperate O
with O
DnaK _RARE_
and O
a O
third O
protein O
, O
GrpE _RARE_
, O
in O
refolding _RARE_
denatured _RARE_
firefly _RARE_
luciferase I-GENE
. O

The O
two O
different O
phosphoforms _RARE_
of O
STAT5 I-GENE
have O
identical O
in O
vitro O
DNA O
binding O
specificity _RARE_
and O
reactivity O
with O
tyrosine O
phosphopeptides O
, O
but O
differ O
in O
their O
cellular O
localization _RARE_
. O

TNF I-GENE
Treatment O
of O
cell O
activated O
the O
p38 I-GENE
MAP I-GENE
kinase I-GENE
pathway _RARE_
, O
as _RARE_
revealed O
by O
increased O
phosphorylation _RARE_
of O
p38 I-GENE
MAP I-GENE
kinase I-GENE
itself O
, O
activation O
of O
the O
substrate O
protein O
MAPKAP _RARE_
kinase I-GENE
- I-GENE
2 I-GENE
, O
and O
culminating _RARE_
in O
the O
phosphorylation _RARE_
of O
the O
heat I-GENE
shock I-GENE
protein I-GENE
27 _RARE_
( O
hsp27 _RARE_
). O

We O
have O
isolated O
a O
novel O
protein O
from O
Drosophila O
nuclear O
extracts O
which O
binds O
specifically O
to O
a O
site O
in O
this O
second O
region O
. O

However O
, O
while O
the O
sequence O
similarity _RARE_
between O
the O
membrane O
exons O
of O
avian I-GENE
mIgY _RARE_
and O
mammalian I-GENE
mIgG _RARE_
and I-GENE
IgE I-GENE
is O
striking O
, O
the O
overall O
similarity _RARE_
with O
Xenopus I-GENE
mIgY _RARE_
is O
very O
low O
. O

Control O
of O
transcription O
of O
the O
erbB I-GENE
- I-GENE
2 I-GENE
gene I-GENE
is O
an O
important O
determinant O
of O
receptor O
expression _RARE_
. O

DNase I-GENE
I I-GENE
footprinting O
and O
electrophoretic O
mobility O
shift O
assays O
indicate O
that O
PBP _RARE_
binds O
to O
the O
half _RARE_
- O
site O
of O
each O
palindrome O
with O
the O
core O
recognition O
sequence O
TGGGAG _RARE_
. O

These O
results O
demonstrate O
that O
sequences O
in O
the O
SH2 _RARE_
/ O
SH3 I-GENE
/ O
SH2 _RARE_
region O
of O
p120 _RARE_
GAP _RARE_
are O
required O
for _RARE_
full O
catalytic O
activity O
toward O
Ras I-GENE
. O

The O
novel O
hematopoietic I-GENE
growth I-GENE
factor I-GENE
FLT3 _RARE_
ligand _RARE_
( O
FL _RARE_
) O
is O
the O
cognate _RARE_
ligand _RARE_
for _RARE_
the O
FLT3 _RARE_
, O
tyrosine I-GENE
kinase I-GENE
receptor I-GENE
( O
R I-GENE
), _RARE_
also O
referred O
to O
as _RARE_
FLK _RARE_
- I-GENE
2 I-GENE
and O
STK I-GENE
- I-GENE
1 I-GENE
. O

In O
contrast O
to O
the O
selective O
expression _RARE_
of O
the O
receptor O
, O
FL _RARE_
expression _RARE_
was O
detected O
in O
90 _RARE_
- O
100 _RARE_
% O
of O
the O
various O
cell O
types _RARE_
of O
leukemia O
cell O
lines O
from O
all O
hematopoietic O
cell O
lineages O
. O

Further O
analysis O
of O
this O
domain O
by O
in O
vitro O
mutagenesis O
pointed _RARE_
to O
a O
core O
of O
hydrophobic O
and O
acidic _RARE_
residues O
as _RARE_
critical O
for _RARE_
the O
activity O
. O

Analysis O
of O
RAR I-GENE
alpha I-GENE
mutants I-GENE
in O
transfection O
studies O
reveals O
that O
the O
DNA O
binding O
domain O
is O
sufficient O
for _RARE_
inhibition O
of O
BZLF1 _RARE_
activity O
. O

We O
measured O
serum I-GENE
hepatocyte _RARE_
growth I-GENE
factor I-GENE
( O
HGF I-GENE
) O
in O
patients O
with O
acute O
myocardial _RARE_
infarction O
, O
angina O
pectoris O
, O
and O
other O
heart _RARE_
diseases O
. O

The O
neural _RARE_
mechanism O
of O
parkinsonian _RARE_
motor O
symptoms O
, O
i O
. O
e _RARE_
., O
rigidity _RARE_
, O
tremor O
and O
akinesia _RARE_
, O
which O
are O
the O
result O
of O
nigrostriatal _RARE_
dopamine O
deficiency O
, O
is O
interpreted O
from O
long O
- O
term O
observations O
on O
the O
effect O
of O
surgical O
and O
pharmacological O
treatment O
of O
the O
disease _RARE_
in O
relation O
to O
the O
neuropathological _RARE_
findings O
within O
the O
substantia _RARE_
nigra _RARE_
zona _RARE_
compacta _RARE_
( O
SNc _RARE_
). O

Protein O
splicing _RARE_
: O
evidence O
for _RARE_
an O
N O
- O
O O
acyl _RARE_
rearrangement O
as _RARE_
the O
initial O
step O
in O
the O
splicing _RARE_
process O
. O

In O
agreement O
with O
these O
data O
, O
western _RARE_
blot O
experiments O
using O
an O
antibody O
directed O
against O
the O
carboxy _RARE_
- O
terminal O
portion O
of O
the O
mouse O
c I-GENE
- I-GENE
kit I-GENE
protein I-GENE
showed O
that O
a O
polypeptide O
, O
of O
the O
size O
predicted O
by O
the O
open _RARE_
reading O
frame O
of O
the O
spermatid _RARE_
- I-GENE
specific I-GENE
c I-GENE
- I-GENE
kit I-GENE
cDNA I-GENE
, O
accumulates O
in O
the O
latest _RARE_
stages O
of O
spermatogenesis _RARE_
and O
in O
epididymal _RARE_
spermatozoa O
. O

It O
is O
shown O
that O
the O
( O
G O
+ O
C O
)- O
rich O
element O
of O
the O
aldolase _RARE_
C I-GENE
promoter I-GENE
directs O
transcription O
in O
neuronal _RARE_
as _RARE_
well _RARE_
as _RARE_
in O
nonneuronal _RARE_
cells O
. O

LY290181 _RARE_
appears O
to O
inhibit O
uPA I-GENE
promoter I-GENE
activation O
by O
blocking O
phorbol O
ester O
- O
stimulated _RARE_
binding O
of O
nuclear O
proteins O
to O
the O
uPA I-GENE
PEA3 I-GENE
/ O
12 O
- O
0 _RARE_
- O
tetradecanoylphorbol _RARE_
13 _RARE_
- O
acetate _RARE_
responsive O
element O
( O
TRE _RARE_
). O

Treatment O
of O
keratinocytes _RARE_
expressing O
a O
normal O
epidermal _RARE_
growth I-GENE
factor I-GENE
receptor I-GENE
( O
EGFR I-GENE
) O
with O
TGFalpha _RARE_
or O
epidermal _RARE_
growth I-GENE
factor I-GENE
for _RARE_
5 O
min O
induced _RARE_
PKCdelta _RARE_
tyrosine O
phosphorylation _RARE_
. O

Only O
one O
of O
these O
bands O
was O
supershifted _RARE_
by O
antibody O
to O
p50 _RARE_
, O
whereas O
antibodies O
to O
p65 _RARE_
or O
other O
NF _RARE_
- I-GENE
kappaB I-GENE
proteins I-GENE
had O
no _RARE_
effect O
. O

We O
isolated O
a O
complementary _RARE_
DNA O
( O
cDNA O
) O
clone O
from O
an O
RL95 _RARE_
- O
2 O
expression _RARE_
library O
that O
encodes O
the O
C1 I-GENE
site I-GENE
- I-GENE
binding I-GENE
protein I-GENE
. O

Biol O
. O

In O
addition O
, O
anti I-GENE
- I-GENE
phosphotyrosine _RARE_
antibodies I-GENE
immunoprecipitated O
80K _RARE_
- I-GENE
H I-GENE
from O
cell O
lysates O
of O
FGF I-GENE
- O
stimulated _RARE_
but O
not O
from O
control O
fibroblasts _RARE_
. O

The O
novel O
protein O
kinases O
, O
c I-GENE
- I-GENE
Jun I-GENE
NH2 I-GENE
- I-GENE
terminal I-GENE
kinases I-GENE
( O
JNKs _RARE_
)/ _RARE_
stress I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinases I-GENE
, O
are O
also O
activated O
by O
TNF I-GENE
- I-GENE
alpha I-GENE
, O
IL _RARE_
- I-GENE
1 I-GENE
, O
and O
CD28 _RARE_
costimulation _RARE_
. O

Thus O
, O
hGRbeta _RARE_
potentially O
functions O
as _RARE_
a O
dominant O
negative O
inhibitor O
of O
hGRalpha _RARE_
activity O
. O

Gas6 _RARE_
contains O
an O
NH2 O
- O
terminal O
Gla _RARE_
domain O
followed O
by O
four O
epidermal _RARE_
growth I-GENE
factor I-GENE
- I-GENE
like I-GENE
repeats I-GENE
and O
tandem _RARE_
globular O
( O
G O
) O
domains O
. O

Both O
P5CDh _RARE_
cDNA I-GENE
clones _RARE_
detect O
a O
single O
3 O
. O
2 O
- O
kb O
transcript O
on O
Northern O
blots O
of O
multiple O
human O
tissues O
, O
indicating O
the O
long O
cDNA O
containing O
the O
3 O
'- O
untranslated _RARE_
intron O
represents O
the O
predominant O
transcript O
. O

Polymerization _RARE_
of O
neurofilament _RARE_
L I-GENE
protein I-GENE
in O
vitro O
was O
inhibited O
by O
phosphorylation _RARE_
of O
neurofilament _RARE_
L I-GENE
protein I-GENE
by O
PKN I-GENE
. O

The O
protein O
folds _RARE_
correctly O
with O
two O
disulfide O
bonds O
and O
a O
free O
thiol _RARE_
group O
at _RARE_
Cys25 _RARE_
. O

We O
and O
others O
have O
demonstrated O
that O
the O
c I-GENE
- I-GENE
cbl I-GENE
proto _RARE_
- I-GENE
oncogene I-GENE
product I-GENE
is O
one O
of O
the O
earliest _RARE_
targets _RARE_
of O
tyrosine O
phosphorylation _RARE_
upon O
T I-GENE
cell I-GENE
receptor I-GENE
stimulation _RARE_
. O

A O
substantial O
fraction O
of O
Cbl I-GENE
was O
constitutively O
associated O
with O
Grb2 I-GENE
and O
this O
interaction O
was O
mediated _RARE_
by O
Grb2 I-GENE
SH3 I-GENE
domains O
. O

An O
AP I-GENE
- I-GENE
1 I-GENE
binding I-GENE
sequence I-GENE
is O
essential O
for _RARE_
regulation _RARE_
of O
the O
human I-GENE
alpha2 _RARE_
( I-GENE
I I-GENE
) I-GENE
collagen _RARE_
( O
COL1A2 _RARE_
) O
promoter O
activity O
by O
transforming I-GENE
growth I-GENE
factor I-GENE
- I-GENE
beta I-GENE
. O

No O
significant O
differences O
existed O
between O
the O
two O
age O
groups O
in O
baseline O
characteristics O
, O
including O
treatment O
protocol O
, O
performance O
status O
, O
and O
serum I-GENE
lactate _RARE_
dehydrogenase I-GENE
( O
LDH _RARE_
) O
level O
. O

Only O
two O
patients O
( O
0 _RARE_
. O
3 O
%) O
had O
a O
CA I-GENE
125 _RARE_
response O
at _RARE_
the O
time O
of O
clinical O
progression O
. O

The O
men O
self O
- O
selected _RARE_
a O
prescribed _RARE_
diet O
at _RARE_
home O
emphasizing _RARE_
saturated _RARE_
fat O
as _RARE_
the O
visible _RARE_
fat O
for _RARE_
1 O
week O
. O

Conversely O
, O
when O
VDR I-GENE
is O
overexpressed O
, O
vitamin O
D3 _RARE_
attenuates O
9 O
- O
cis O
RA _RARE_
induction O
from O
an O
RXR I-GENE
- O
responsive O
element O
. O

These O
results O
illuminate _RARE_
a O
hitherto O
unanticipated _RARE_
function O
of O
U6 I-GENE
RNA I-GENE
: O
the O
modulation O
of O
a O
phosphorylation _RARE_
- O
dephosphorylation _RARE_
cycle _RARE_
of O
C1 I-GENE
hnRNP _RARE_
protein I-GENE
that O
influences O
the O
binding O
affinity O
of O
this O
protein O
for _RARE_
pre O
- O
mRNA O
. O

Inclusion _RARE_
of O
the O
extended O
N O
terminus O
into O
the O
originally _RARE_
reported O
protein O
resulted O
in O
a O
striking O
similarity _RARE_
to O
the O
lymphoid _RARE_
factor I-GENE
Lef _RARE_
- I-GENE
1 I-GENE
. O

Truncated _RARE_
mammalian I-GENE
Notch1 _RARE_
activates O
CBF1 I-GENE
/ O
RBPJk _RARE_
- O
repressed O
genes O
by O
a O
mechanism O
resembling O
that O
of O
Epstein I-GENE
- I-GENE
Barr I-GENE
virus I-GENE
EBNA2 I-GENE
. O

Electrophoretic O
mobility O
shift O
assays O
( O
EMSAs _RARE_
) O
using O
purified _RARE_
glucocorticoid I-GENE
receptor I-GENE
DNA I-GENE
binding I-GENE
domain I-GENE
( O
DBD _RARE_
) O
demonstrated O
that O
both O
GRE _RARE_
- I-GENE
2 I-GENE
and I-GENE
- I-GENE
3 I-GENE
motifs I-GENE
interact O
with O
DBD _RARE_
and O
oligonucleotide _RARE_
competition O
experiments O
established O
that O
these O
have O
different O
affinities O
for _RARE_
DBD _RARE_
. O

The O
large O
subfamily O
of O
receptor I-GENE
tyrosine I-GENE
kinases I-GENE
( O
RTKs _RARE_
) O
for _RARE_
which O
EPH _RARE_
is O
the O
prototype O
have O
likely O
roles O
in O
intercellular _RARE_
communication _RARE_
during _RARE_
normal O
mammalian O
development O
, O
but O
the O
biochemical O
signalling O
pathways O
utilised _RARE_
by O
this O
family O
are O
poorly O
characterised _RARE_
. O

The O
17 _RARE_
- O
kDa O
protein O
is O
required O
for _RARE_
the O
systemic O
infection O
of O
plants _RARE_
. O

We O
present O
here O
a O
detailed O
genomic O
sequencing O
analysis O
of O
the O
cytosine O
methylation O
patterns O
of O
the O
transposase _RARE_
binding O
sites O
within O
both O
Ac _RARE_
ends O
in O
the O
wx _RARE_
- I-GENE
m9 _RARE_
:: O
Ac _RARE_
allele I-GENE
, O
where O
Ac _RARE_
is O
inserted O
into O
the O
tenth _RARE_
exon _RARE_
of O
the O
Waxy _RARE_
gene I-GENE
. O

Krox I-GENE
- I-GENE
20 I-GENE
, O
a O
zinc I-GENE
finger I-GENE
gene I-GENE
, O
has O
a O
highly O
conserved _RARE_
pattern O
of O
expression _RARE_
in O
r3 _RARE_
and O
r5 _RARE_
and O
is O
functionally O
required O
for _RARE_
their O
maintenance _RARE_
in O
mouse O
embryos _RARE_
. O

Pituitary _RARE_
adenylate I-GENE
cyclase I-GENE
- I-GENE
activating I-GENE
polypeptide I-GENE
regulates O
prolactin I-GENE
promoter I-GENE
activity O
via O
a O
protein I-GENE
kinase I-GENE
A I-GENE
- O
mediated _RARE_
pathway _RARE_
that O
is O
independent O
of O
the O
transcriptional O
pathway _RARE_
employed O
by O
thyrotropin I-GENE
- I-GENE
releasing I-GENE
hormone I-GENE
. O

Clones _RARE_
33F _RARE_
and O
34B _RARE_
encoded O
identical O
aromatase I-GENE
proteins I-GENE
of O
503 _RARE_
amino O
acids _RARE_
, O
but O
differed O
in O
size O
due O
to O
alternative _RARE_
polyadenylation O
signal O
usage O
for _RARE_
the O
corresponding O
mRNAs O
. O

In O
sorted _RARE_
bone O
marrow O
cells O
expression _RARE_
of O
both O
VpreB _RARE_
genes I-GENE
was O
detected O
in O
pro O
- O
B O
/ O
pre O
- O
BI _RARE_
and O
large O
pre O
- O
BII _RARE_
cells O
, O
while O
the O
RNA O
steady O
state O
levels O
were O
at _RARE_
least O
100 _RARE_
- O
fold _RARE_
lower O
in O
small O
pre O
- O
BII _RARE_
and O
immature O
/ O
mature _RARE_
B O
cells O
. O

We O
have O
cloned _RARE_
and O
sequenced O
a O
3574 _RARE_
- O
bp O
Bacillus O
subtilis O
( O
Bs _RARE_
) O
DNA O
fragment O
located _RARE_
between O
the O
nrdA _RARE_
and O
citB _RARE_
genes I-GENE
at _RARE_
about O
169 _RARE_
degrees O
on O
the O
chromosome _RARE_
. O

Aeromonas _RARE_
salmonicida _RARE_
possesses O
two O
genes O
encoding O
homologs O
of O
the O
major I-GENE
outer _RARE_
membrane I-GENE
protein I-GENE
, O
OmpA _RARE_
. O

Expression O
of O
Msp _RARE_
was O
toxic O
to O
E O
. O
coli O
when O
the O
entire _RARE_
msp _RARE_
gene I-GENE
was O
present O
. O

In O
agreement O
with O
previous O
in O
vitro O
data O
, O
we O
have O
shown O
that O
UmuD _RARE_
and O
UmuD _RARE_
' I-GENE
are O
able O
to O
form O
both O
homodimers O
( O
UmuD _RARE_
- O
UmuD _RARE_
and O
UmuD _RARE_
'- O
UmuD _RARE_
') _RARE_
and O
a O
heterodimer _RARE_
( O
UmuD _RARE_
- O
UmuD _RARE_
'). _RARE_

Lyn I-GENE
kinase I-GENE
immunoprecipitated O
from O
lysates O
of O
irradiated O
BCP _RARE_
as _RARE_
well _RARE_
as _RARE_
a O
full O
- O
length O
glutathione _RARE_
S I-GENE
- I-GENE
transferase I-GENE
( O
GST I-GENE
)- O
Lyn I-GENE
fusion O
protein O
- O
phosphorylated _RARE_
recombinant I-GENE
human I-GENE
p34cdc2 I-GENE
on O
tyrosine O
15 _RARE_
. O

Mutations O
within O
conserved _RARE_
region O
2 O
( O
CR2 _RARE_
) O
of O
E1A I-GENE
that O
inhibit O
the O
binding O
of O
E1A I-GENE
to O
the O
retinoblastoma _RARE_
gene I-GENE
product I-GENE
( O
pRb I-GENE
) O
further O
enhanced _RARE_
the O
stimulation _RARE_
of O
transcription O
from O
the O
PEPCK I-GENE
promoter I-GENE
by O
2 O
3 O
- O
fold _RARE_
compared O
with O
wild I-GENE
type I-GENE
E1A I-GENE
. O

Using O
autoantibodies O
from O
a O
Sjogren _RARE_
' O
s O
syndrome _RARE_
patient O
, O
we O
have O
previously O
identified O
a O
230 _RARE_
- O
kDa O
peripheral O
membrane O
protein O
associated O
with O
the O
cytosolic O
face O
of O
the O
trans _RARE_
- O
Golgi _RARE_
( O
Kooy _RARE_
, O
J _RARE_
., O
Toh _RARE_
, O
B O
. O

Apart _RARE_
from O
two O
proline O
- O
rich O
regions O
( O
amino O
acids _RARE_
1 O
- O
117 O
and O
239 O
- O
270 O
), _RARE_
p230 _RARE_
contains O
a O
very O
high O
frequency O
of O
heptad _RARE_
repeats O
, O
characteristic O
of O
alpha O
- O
helices O
that O
form O
dimeric _RARE_
coiled _RARE_
- O
coil _RARE_
structures _RARE_
. O
p230 _RARE_
also O
includes O
the O
sequence O
ESLALEELEL _RARE_
( O
amino O
acids _RARE_
538 _RARE_
- O
546 _RARE_
), _RARE_
a O
motif O
found O
in O
the O
granin _RARE_
family I-GENE
of O
acidic _RARE_
proteins O
present O
in O
secretory _RARE_
granules O
of O
neuroendocrine _RARE_
cells O
. O

Binding O
specificity _RARE_
and O
modulation O
of O
the O
ApoA _RARE_
- I-GENE
I I-GENE
promoter I-GENE
activity O
by O
homo _RARE_
- O
and O
heterodimers _RARE_
of O
nuclear O
receptors O
. O

They O
were O
found O
to O
stimulate O
at _RARE_
nanomolar _RARE_
concentrations O
the O
turnover O
of O
biosynthetically _RARE_
labeled O
ceramide _RARE_
, O
glucosylceramide _RARE_
, O
and O
lactosylceramide _RARE_
. O

There O
is O
growing O
evidence O
that O
mammalian I-GENE
AMP I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
( O
AMPK _RARE_
) O
plays O
a O
role O
in O
protecting _RARE_
cells O
from O
stresses O
that O
cause O
ATP O
depletion O
by O
switching O
off O
ATP O
- O
consuming _RARE_
biosynthetic O
pathways O
. O

Sterol _RARE_
- O
mediated _RARE_
suppression O
of O
cleavage _RARE_
of O
SREBP I-GENE
- I-GENE
1 I-GENE
was O
found O
to O
be O
dependent O
on O
the O
extreme O
COOH _RARE_
- O
terminal O
region O
( O
residue _RARE_
1034 _RARE_
to O
the O
COOH _RARE_
terminus O
), _RARE_
which O
exists O
in O
two O
forms O
as _RARE_
a O
result O
of O
alternative _RARE_
splicing _RARE_
. O

Am _RARE_
. O

EMSA O
competition O
experiments O
showed O
that O
mutations O
within O
the O
direct O
repeats O
failed O
to O
compete O
for _RARE_
binding O
of O
the O
nuclear O
proteins O
to O
labeled O
wild O
type O
oligonucleotide _RARE_
. O

Transcription O
from O
the O
promoter O
containing O
the O
mutated _RARE_
direct O
repeats O
was O
increased O
greatly O
, O
consistent O
with O
the O
conclusion O
that O
these O
motifs O
functions O
in O
vivo O
to O
repress O
GPT _RARE_
gene I-GENE
expression _RARE_
. O

However O
, O
a O
> O
10 O
- O
fold _RARE_
increase O
in O
ERK3 _RARE_
activity O
in O
each O
PKC I-GENE
beta I-GENE
transfectant _RARE_
was O
shown O
by O
immunoprecipitation O
with O
anti I-GENE
- I-GENE
ERK3 _RARE_
monoclonal I-GENE
antibody I-GENE
followed O
by O
either O
immune O
complex O
kinase O
assay O
or O
by O
in O
gel O
kinase O
assay O
. O

Sequence O
analysis O
of O
this O
100 _RARE_
- O
bp O
Col2a1 _RARE_
enhancer I-GENE
revealed O
several O
sequence O
motifs O
similar O
to O
motifs O
present O
within O
the O
regulatory O
region O
of O
the O
link _RARE_
protein I-GENE
gene I-GENE
, O
another O
cartilage O
gene O
. O

Retinoid _RARE_
- O
dependent O
activation O
of O
the O
tissue I-GENE
transglutaminase _RARE_
promoter I-GENE
depends O
on O
both O
a O
proximal O
regulatory O
region O
containing O
sequences O
highly O
conserved _RARE_
between O
the O
human O
and O
the O
mouse I-GENE
tissue I-GENE
transglutaminase _RARE_
promoters I-GENE
and O
a O
distal O
region O
that O
includes O
a O
30 _RARE_
- O
base _RARE_
pair _RARE_
retinoid O
response O
element O
( O
mTGRRE1 _RARE_
). O
mTGRRE1 _RARE_
contains O
three O
hexanucleotide _RARE_
half _RARE_
- O
sites O
( O
two O
canonical O
and O
one O
non O
- O
canonical O
) O
in O
a O
DR7 _RARE_
/ O
DR5 _RARE_
motif O
that O
bind O
both O
RAR I-GENE
* _RARE_
RXR I-GENE
heterodimers _RARE_
and O
RXR I-GENE
homodimers I-GENE
. O

Significantly O
, O
pPKR _RARE_
is O
capable O
of O
specifically O
phosphorylating _RARE_
Ser51 _RARE_
in O
a O
synthetic _RARE_
eIF I-GENE
- I-GENE
2alpha I-GENE
peptide I-GENE
, O
a O
key O
characteristic O
of O
the O
eIF I-GENE
- I-GENE
2alpha I-GENE
kinase I-GENE
family I-GENE
. O

Vertebrate _RARE_
synapsins _RARE_
constitute O
a O
family O
of O
synaptic O
proteins O
that O
participate O
in O
the O
regulation _RARE_
of O
neurotransmitter _RARE_
release O
. O

Electrophoretic O
mobility O
shift O
assays O
using O
crude O
extracts O
from O
FREJ4 _RARE_
cells O
revealed O
the O
binding O
of O
a O
member _RARE_
( O
s O
) O
of O
the O
Ets I-GENE
family I-GENE
of I-GENE
transcription I-GENE
factors I-GENE
to O
the O
P4 _RARE_
EBS _RARE_
, O
as _RARE_
well _RARE_
as _RARE_
the O
interaction O
of O
two O
members O
of O
the O
Sp1 _RARE_
family I-GENE
, O
Sp1 _RARE_
and O
Sp3 I-GENE
, O
with O
the O
adjacent O
GC _RARE_
box O
. O

ZEBRA _RARE_
and O
cellular O
AP I-GENE
- I-GENE
1 I-GENE
bZip _RARE_
activators _RARE_
, O
such O
as _RARE_
c I-GENE
- I-GENE
Fos I-GENE
, O
have O
homologous O
DNA O
- O
binding O
domains O
, O
and O
their O
DNA O
- O
binding O
specificities _RARE_
overlap O
. O

This O
result O
suggested O
that O
mutant O
I299 _RARE_
has O
diminished O
cap _RARE_
- O
binding O
activity O
. O

UV _RARE_
cross O
- O
linking O
experiments O
demonstrated O
that O
HSV O
infection O
caused O
enhanced _RARE_
binding O
of O
protein O
factors O
, O
including O
the O
64 _RARE_
- I-GENE
kDa I-GENE
component _RARE_
of I-GENE
cleavage _RARE_
stimulation _RARE_
factor I-GENE
( O
CstF _RARE_
), _RARE_
to O
poly _RARE_
( O
A O
) O
site O
RNAs O
from O
virus O
genes O
of O
all O
temporal O
classes O
and O
that O
this O
enhanced _RARE_
binding O
required O
expression _RARE_
of O
IE63 _RARE_
. O

CM _RARE_
- I-GENE
ACO3 _RARE_
is O
expressed _RARE_
in O
flowers _RARE_
and O
is O
not O
induced _RARE_
by O
any O
of O
the O
stimuli O
tested O
. O

We O
show O
here O
that O
these O
Jun I-GENE
/ O
eb1 _RARE_
chimeras _RARE_
are O
potent O
transactivators _RARE_
of O
AP1 I-GENE
sites I-GENE
and O
that O
they O
can O
cooperate O
with O
c I-GENE
- I-GENE
Ha I-GENE
- I-GENE
Ras I-GENE
to O
induce O
foci _RARE_
. O

In O
synchronized _RARE_
HeLa O
cells O
, O
expression _RARE_
of O
luciferase I-GENE
activity O
was O
induced _RARE_
at _RARE_
the O
beginning O
of O
DNA O
synthesis _RARE_
and O
was O
dependent O
on O
the O
presence O
of O
an O
E2F I-GENE
- I-GENE
binding I-GENE
site I-GENE
in O
the O
H2A _RARE_
. I-GENE
1 I-GENE
promoter I-GENE
. O

Utilizing _RARE_
transient O
transfection O
studies O
in O
HepG2 _RARE_
cells O
, O
we O
have O
shown O
that O
deletion O
of O
the O
factor I-GENE
VIII I-GENE
promoter I-GENE
sequences I-GENE
distal O
to O
nucleotide O
- O
44 _RARE_
results O
in O
a O
significant O
but O
small O
increase O
in O
promoter O
activity O
. O

We O
constructed O
a O
yeast O
reporter O
strain _RARE_
containing O
the O
lacZ I-GENE
gene I-GENE
under O
the O
control O
of O
the O
CYC1 I-GENE
promoter I-GENE
associated O
with O
three O
copies O
of O
TRE _RARE_
- I-GENE
1 I-GENE
. O

If O
hnRNP _RARE_
K I-GENE
is O
a O
transcription O
factor O
, O
then O
interactions O
with O
the O
RNA I-GENE
polymerase I-GENE
II I-GENE
transcription O
apparatus O
are O
predicted O
. O

A O
developmentally O
regulated O
4 O
. O
6 O
kb O
mRNA O
is O
recognized _RARE_
on O
Northern O
blots O
of O
oocyte _RARE_
RNA O
using O
the O
X O
. O
laevis _RARE_
cDNA O
. O

Sequence O
conservation O
is O
greatest O
for _RARE_
residues O
located _RARE_
near O
the O
active _RARE_
centers O
of O
the O
exo _RARE_
and O
pol I-GENE
domains I-GENE
of O
the O
E I-GENE
. I-GENE
coli I-GENE
DNA I-GENE
polymerase I-GENE
I I-GENE
structure _RARE_
. O

Despite O
the O
favourable O
natural _RARE_
history O
of O
acute O
BI _RARE_
, O
mild O
, O
moderate O
, O
and O
severe O
posttraumatic _RARE_
changes O
were O
shown O
to O
appear O
as _RARE_
cicatricial _RARE_
- O
adhesive O
and O
atrophic _RARE_
processes O
, O
intracerebral _RARE_
cysts O
, O
porencephaly _RARE_
, O
which O
result O
in O
posttraumatic _RARE_
epilepsy O
, O
hydrocephalus _RARE_
, O
etc O
. O

These O
findings O
suggest O
that O
the O
increase O
in O
V O
O2 _RARE_
may O
have O
been O
a O
consequence O
of O
the O
increase O
in O
Q _RARE_
O2 _RARE_
rather O
than O
a O
response O
to O
the O
procedure O
itself O
. O

Several O
cytokines _RARE_
exhibit O
a O
high O
degree O
of O
temporal O
regulation _RARE_
as _RARE_
well _RARE_
as _RARE_
somnogenic _RARE_
potency O
( O
e _RARE_
. O
g O
., O
interleukin I-GENE
- I-GENE
1 I-GENE
[ _RARE_
IL _RARE_
- I-GENE
1 I-GENE
], O
tumor I-GENE
necrosis I-GENE
factor I-GENE
- I-GENE
alpha I-GENE
[ _RARE_
TNF I-GENE
- I-GENE
alpha I-GENE
]). _RARE_

As O
pH O
and O
Hb _RARE_
can O
also O
affect O
mixed O
venous O
CO2 O
content O
, O
the O
effect O
on O
Q _RARE_
was O
also O
assessed O
. O

No O
difference O
in O
elastin I-GENE
peptide I-GENE
concentration O
was O
observed O
between O
emphysematous _RARE_
patients O
and O
control O
subjects O
( O
mean O
+/- O
SD O
= O
2 O
. O
39 _RARE_
+/- O
1 O
. O
18 O
micrograms O
/ O
ml O
in O
patients O
versus O
2 O
. O
55 _RARE_
+/- O
1 O
. O
34 _RARE_
micrograms O
/ O
ml O
in O
policemen _RARE_
and O
2 O
. O
59 _RARE_
+/- O
1 O
. O
20 O
micrograms O
/ O
ml O
in O
coal _RARE_
miners _RARE_
). O

Identification O
of O
this O
region O
as _RARE_
the O
E I-GENE
. I-GENE
coli I-GENE
tmk _RARE_
gene I-GENE
was O
confirmed O
by O
functional _RARE_
complementation _RARE_
of O
a O
yeast I-GENE
dTMP _RARE_
kinase I-GENE
temperature _RARE_
- O
sensitive _RARE_
mutant O
and O
by O
in O
vitro O
enzyme O
assay O
of O
the O
thymidylate _RARE_
kinase I-GENE
activity O
in O
cell O
extracts O
of O
E O
. O
coli O
by O
use O
of O
tmk _RARE_
- O
overproducing _RARE_
plasmids O
. O

The O
structural O
gene O
for _RARE_
copper _RARE_
- I-GENE
and I-GENE
topa _RARE_
quinone _RARE_
- I-GENE
containing I-GENE
monoamine _RARE_
oxidase I-GENE
( O
maoA _RARE_
) O
and O
an O
unknown O
amine _RARE_
oxidase I-GENE
gene I-GENE
have O
been O
located _RARE_
at _RARE_
30 _RARE_
. O
9 O
min O
on O
the O
Escherichia O
coli O
chromosome _RARE_
. O

This O
interaction O
is O
mediated _RARE_
by O
the O
SH2 _RARE_
domain I-GENE
of O
Crk I-GENE
and O
can O
be O
inhibited O
with O
a O
phosphopeptide _RARE_
containing O
the O
Crk I-GENE
- O
SH2 _RARE_
binding O
motif O
. O

Consistent O
with O
ErbB I-GENE
- I-GENE
2 I-GENE
being O
a O
shared O
receptor O
subunit O
, O
its O
tyrosine O
phosphorylation _RARE_
was O
increased O
by O
both O
heterologous O
ligands O
and O
it O
mediated _RARE_
a O
trans _RARE_
- O
inhibitory _RARE_
effect O
of O
NDF _RARE_
on O
EGF _RARE_
binding O
. O

Identification O
of O
a O
consensus O
cyclin _RARE_
- I-GENE
dependent I-GENE
kinase I-GENE
phosphorylation _RARE_
site I-GENE
unique O
to O
the O
nuclear O
form O
of O
human I-GENE
deoxyuridine _RARE_
triphosphate _RARE_
nucleotidohydrolase _RARE_
. O

The O
cDNA O
corresponding O
to O
the O
FPS1 _RARE_
gene I-GENE
was O
isolated O
by O
functional _RARE_
complementation _RARE_
of O
a O
mutant O
yeast O
strain _RARE_
defective _RARE_
in O
FPS _RARE_
activity O
( O
Delourme _RARE_
, O
D O
., O
Lacroute _RARE_
, O
F O
., O
and O
Karst _RARE_
, O
F O
. O

The O
isolated O
plasmin _RARE_
fragments O
of O
VEGF I-GENE
were O
compared O
with O
respect O
to O
heparin _RARE_
binding O
, O
interaction O
with O
soluble _RARE_
VEGF I-GENE
receptors I-GENE
, O
and O
ability O
to O
promote O
endothelial O
cell O
mitogenesis _RARE_
. O

VDR I-GENE
/ O
RXR I-GENE
bound _RARE_
well _RARE_
to O
the O
VDREs _RARE_
and O
to O
DR4 _RARE_
and O
DR5 _RARE_
using O
the O
electrophoretic O
mobility O
shift O
assay O
. O

The O
members O
of O
the O
Myb I-GENE
family I-GENE
of I-GENE
transcription I-GENE
factors I-GENE
are O
defined O
by O
homology O
in O
the O
DNA O
- O
binding O
domain O
; O
all O
bind O
the O
Myb I-GENE
- I-GENE
binding I-GENE
site I-GENE
( O
MBS _RARE_
) O
sequence O
( O
YG _RARE_
( O
A O
/ O
G O
) O
C O
( O
A O
/ O
C O
/ O
G O
) O
GTT _RARE_
( O
G O
/ O
A O
)). _RARE_

In O
contrast O
, O
when O
the O
isoform O
containing O
the O
C O
epsilon4 _RARE_
domain O
joined _RARE_
directly O
to O
the O
M2 _RARE_
exon _RARE_
( O
IgE I-GENE
grande _RARE_
) O
is O
expressed _RARE_
in O
the O
J558L _RARE_
cell O
line O
, O
it O
is O
degraded O
intracellularly _RARE_
, O
suggesting O
a O
cell O
line O
- O
dependent O
regulation _RARE_
of O
secretion _RARE_
. O

Human I-GENE
cytomegalovirus _RARE_
immediate I-GENE
- I-GENE
early I-GENE
protein I-GENE
IE2 I-GENE
tethers _RARE_
a O
transcriptional O
repression O
domain O
to O
p53 I-GENE
. O

The O
specificity _RARE_
of O
action O
of O
C I-GENE
/ I-GENE
EBP I-GENE
family I-GENE
members I-GENE
may O
be O
derived O
from O
the O
characteristics O
of O
each O
factor O
, O
including O
the O
expression _RARE_
profiles O
, O
the O
DNA O
binding O
affinities O
, O
the O
cofactors _RARE_
, O
and O
so O
on O
, O
in O
addition O
to O
the O
DNA O
binding O
specificities _RARE_
. O

The O
antibodies O
inhibited O
specifically O
the O
transcription O
of O
DNA I-GENE
polymerase I-GENE
alpha I-GENE
promoter O
in O
vitro O
. O

Immunocytochemical _RARE_
analysis O
demonstrated O
the O
presence O
of O
DREF _RARE_
polypeptide I-GENE
in O
nuclei O
after O
the O
eighth _RARE_
nuclear O
division O
cycle _RARE_
, O
suggesting O
that O
nuclear O
accumulation O
of O
DREF _RARE_
is O
important O
for _RARE_
the O
coordinate O
zygotic _RARE_
expression _RARE_
of O
DNA O
replication O
- O
related O
genes O
carrying O
DRE _RARE_
sequences O
. O

A O
DNA O
fragment O
carrying O
1 O
, O
100 _RARE_
nucleotides O
derived O
from O
the O
5 O
'- O
flanking O
region O
of O
the O
UGT1A1 _RARE_
gene I-GENE
was O
enough O
for _RARE_
MC O
induction O
. O

This O
result O
supports O
the O
argument _RARE_
that O
the O
beta O
' O
subunit O
plays O
an O
essential O
role O
in O
determining _RARE_
the O
progress O
of O
transcription O
elongation _RARE_
. O

Two O
XPG _RARE_
regions I-GENE
with O
putative O
NLS O
[ _RARE_
amino O
acid O
( O
AA O
) O
coordinates _RARE_
: O
NLS O
- O
B O
( O
AA O
1057 _RARE_
- O
1074 _RARE_
) O
and O
NLS O
- O
C O
( O
AA O
1171 _RARE_
- O
1185 _RARE_
)] O
were O
each O
shown O
to O
independently O
localize O
the O
beta I-GENE
- I-GENE
gal _RARE_
extensively O
(> O
80 _RARE_
%) O
to O
the O
nucleus O
of O
HeLa O
cells O
. O

The O
lacS _RARE_
gene I-GENE
was O
cloned _RARE_
in O
an O
E O
. O
coli O
- O
Streptococcus _RARE_
shuttle _RARE_
vector O
and O
was O
expressed _RARE_
both O
in O
a O
lacS _RARE_
deletion O
derivative _RARE_
of O
S O
. O
thermophilus _RARE_
and O
in O
a O
pNZ63 _RARE_
- O
cured _RARE_
strain _RARE_
, O
L O
. O
lactis O
NZ6091 _RARE_
. O

The O
genome O
of O
all O
retroviruses _RARE_
consists O
of O
two O
identical O
RNAs O
noncovalently _RARE_
linked _RARE_
near O
their O
5 O
' O
end O
. O

The O
extraction O
recovery O
of O
Amphotericin _RARE_
B O
from O
the O
cerebrospinal _RARE_
fluid _RARE_
is O
higher _RARE_
than O
90 _RARE_
% O
over O
the O
entire _RARE_
linear _RARE_
range O
. O

HuEpo _RARE_
- I-GENE
R I-GENE
Ab _RARE_
inhibited O
Epo I-GENE
- O
induced _RARE_
parental O
UT O
- O
7 O
cell O
growth O
, O
but O
not O
that O
of O
cells O
of O
clone O
12 O
, O
suggesting O
that O
the O
muEpo _RARE_
- I-GENE
R I-GENE
is O
able O
to O
induce O
human O
UT O
- O
7 O
cell O
proliferation _RARE_
. O

The O
frequency O
of O
integrations _RARE_
that O
led O
to O
transcription O
of O
the O
lacZ I-GENE
gene I-GENE
was O
estimated O
to O
be O
0 _RARE_
. O
5 O
% O
of O
all O
integrations _RARE_
, O
of O
which O
14 O
% O
were O
downregulated _RARE_
on O
differentiation O
of O
32D _RARE_
cells O
towards O
neutrophils O
. O

The O
sequence O
and O
isolated O
cDNAs O
will O
provide O
useful O
reagents _RARE_
for _RARE_
studying O
the O
expression _RARE_
of O
Brca1 _RARE_
in O
the O
mouse O
, O
and O
for _RARE_
testing O
the O
importance O
of O
the O
evolutionarily O
conserved _RARE_
domains O
. O

A O
study O
was O
performed O
to O
compare O
the O
ONLINE _RARE_
and O
EMIT _RARE_
II O
immunoassays _RARE_
with O
gas O
chromatographic O
/ O
mass O
spectrometric _RARE_
( O
GC _RARE_
/ O
MS O
) O
analysis O
of O
methaqualone _RARE_
metabolites O
on O
urine O
using O
samples O
obtained O
from O
a O
clinical O
study O
. O

Interaction O
of O
the O
Fur I-GENE
repressor I-GENE
with O
a O
150 _RARE_
- O
bp O
fragment O
encompassing _RARE_
the O
pvdS _RARE_
promoter I-GENE
was O
demonstrated O
in O
vivo O
by O
the O
Fur I-GENE
titration O
assay O
and O
confirmed O
in O
vitro O
by O
gel O
retardation O
experiments O
with O
a O
partially O
purified _RARE_
Fur I-GENE
preparation O
. O

This O
protein O
encoded O
by O
this O
cDNA O
, O
which O
we O
have O
termed O
p150TSP _RARE_
( O
for _RARE_
TPR O
- O
containing O
, O
SH2 _RARE_
- I-GENE
binding I-GENE
phosphoprotein _RARE_
), _RARE_
is O
located _RARE_
predominantly O
in O
the O
nucleus O
and O
is O
highly O
conserved _RARE_
in O
evolution O
. O

Both O
mutant O
receptors O
were O
expressed _RARE_
on O
the O
cell O
surface O
and O
bound _RARE_
insulin I-GENE
normally O
, O
but O
showed O
markedly O
impaired O
autophosphorylation O
in O
response O
to O
insulin I-GENE
. O

EMBO _RARE_
J _RARE_
. O

Taken O
together O
, O
our O
results O
indicate O
that O
thrombin I-GENE
- O
stimulated _RARE_
vascular O
smooth _RARE_
muscle O
proliferation _RARE_
is O
delayed O
and O
requires O
the O
de O
novo _RARE_
expression _RARE_
of O
one O
or O
more O
autocrine O
mitogens _RARE_
. O

Transcription O
from O
adenovirus I-GENE
E2 I-GENE
- I-GENE
early I-GENE
promoter I-GENE
is O
controlled _RARE_
by O
a O
unique O
array _RARE_
of O
four O
cis O
- O
acting O
elements O
which O
include O
an O
atypical O
TBP I-GENE
site I-GENE
, O
two O
E2F I-GENE
sites I-GENE
present O
in O
an O
inverted O
orientation O
relative O
to O
each O
other O
, O
and O
an O
ATF I-GENE
site I-GENE
. O

Furthermore O
, O
we O
showed O
that O
the O
IL _RARE_
- I-GENE
6 I-GENE
/ O
interferon _RARE_
gamma I-GENE
( O
IFN I-GENE
gamma I-GENE
) O
response O
element O
in O
the O
IRF I-GENE
- I-GENE
1 I-GENE
promoter I-GENE
( O
IR I-GENE
/ O
IRF I-GENE
- I-GENE
1 I-GENE
), _RARE_
which O
contains O
a O
Stat I-GENE
- I-GENE
binding I-GENE
site I-GENE
and O
an O
adjacent O
CRE _RARE_
- O
like O
site O
, O
also O
makes O
IL _RARE_
- I-GENE
6 I-GENE
- O
induced _RARE_
binding O
complexes O
similar O
to O
JRE _RARE_
- O
IL6 I-GENE
- O
BCs _RARE_
. O

A O
second O
peptide O
( O
amino O
acids _RARE_
58 O
- O
77 O
) O
also O
antagonized _RARE_
p21 I-GENE
- O
activity O
, O
but O
this O
peptide O
did O
not O
affect O
the O
ability O
of O
p21 I-GENE
to O
interact O
with O
cyclin _RARE_
E I-GENE
/ O
Cdk2 I-GENE
. O

A O
p21 I-GENE
peptide I-GENE
spanning O
amino O
acids _RARE_
139 O
- O
164 _RARE_
was O
found O
to O
bind O
PCNA I-GENE
in O
a O
filter O
binding O
assay O
and O
this O
peptide O
suppressed O
recombinant O
p21 I-GENE
- O
PCNA I-GENE
interaction O
. O

Results O
were O
supported O
by O
the O
agar O
diffusion O
method O
for _RARE_
Y O
. O
enterocolitica _RARE_
, O
whereas O
inhibition O
activity O
was O
not O
found O
for _RARE_
A O
. O
hydrophila _RARE_
. O

OND _RARE_
8 O
mg O
tid _RARE_
days O
2 O
- O
3 O
, O
and O
8 O
mg O
tid _RARE_
prn _RARE_
days O
4 O
- O
5 O
and O
prednisolone _RARE_
75 _RARE_
- O
100 _RARE_
mg O
qds _RARE_
days O
2 O
- O
5 O
and O
2 O
) O
MCP _RARE_
30 _RARE_
mg O
/ O
metylprednisolone _RARE_
80 _RARE_
mg O
i O
. O
v O
. O
before O
CT _RARE_
and O
MCP _RARE_
20 O
mg O
p O
. O
r _RARE_
. O
after O
4 O
and O
8 O
h O
respectively O
. O

The O
dynamic O
properties O
of O
this O
protein O
fragment O
were O
measured O
and O
analyzed O
using O
both O
isotropic _RARE_
and O
anisotropic _RARE_
models O
of O
molecular _RARE_
motion O
. O

Adduction _RARE_
of O
the O
human I-GENE
N I-GENE
- I-GENE
ras I-GENE
codon _RARE_
61 _RARE_
sequence I-GENE
with O
(-)-( _RARE_
7S _RARE_
, O
8R _RARE_
, O
9R _RARE_
, O
10S _RARE_
)- O
7 O
, O
8 O
- O
dihydroxy _RARE_
- O
9 O
, O
10 O
- O
epoxy _RARE_
- O
7 O
, O
8 O
, O
9 O
, O
10 O
- O
tetrahydrobenzo _RARE_
[ _RARE_
a O
] O
pyrene _RARE_
: O
structural O
refinement _RARE_
of O
the O
intercalated _RARE_
SRSR _RARE_
( O
61 _RARE_
, O
2 O
) O
(-)-( _RARE_
7S _RARE_
, O
8R _RARE_
, O
9S _RARE_
, O
10R _RARE_
)- O
N6 _RARE_
-[ _RARE_
10 O
-( _RARE_
7 O
, O
8 O
, O
9 O
, O
10 O
- O
tetrahydrobenzo _RARE_
[ _RARE_
a O
] O
pyrenyl _RARE_
)]- _RARE_
2 O
'- O
deoxyadenosyl _RARE_
adduct _RARE_
from O
1H _RARE_
NMR O
. O

Isolation O
by O
PCR O
of O
a O
cDNA O
clone O
from O
pea _RARE_
petals _RARE_
with O
similarity _RARE_
to O
petunia _RARE_
and O
wheat _RARE_
zinc I-GENE
finger I-GENE
proteins I-GENE
. O

This O
fragment O
can O
bind O
several O
trans _RARE_
- O
acting O
factors O
in O
vitro O
, O
including O
GATA _RARE_
- I-GENE
1 I-GENE
and O
members O
of O
the O
Ets I-GENE
family I-GENE
. O

Exposure _RARE_
of O
peripheral O
blood _RARE_
T O
cells O
from O
young O
subjects O
to O
PHA _RARE_
or O
cross O
- O
linked _RARE_
anti I-GENE
- I-GENE
CD3 I-GENE
monoclonal I-GENE
antibodies I-GENE
stimulated _RARE_
rapid O
increases O
in O
MAPK _RARE_
and O
MEK I-GENE
enzymatic O
activity O
. O

These O
different O
observations O
exclude _RARE_
a O
heterozygosity O
of O
the O
A O
--> _RARE_
G O
mutation O
at _RARE_
codon _RARE_
beta O
77 O
, O
as _RARE_
well _RARE_
as _RARE_
a O
deletion O
comparable O
to O
that O
of O
Hbs _RARE_
Lepore _RARE_
or I-GENE
Kenya _RARE_
, O
or O
a O
beta I-GENE
- I-GENE
globin I-GENE
gene I-GENE
duplication O
, O
and O
point O
to O
a O
nontraditional _RARE_
inheritance _RARE_
of O
Hb _RARE_
Costa _RARE_
Rica _RARE_
. O

This O
is O
the O
first _RARE_
description O
, O
to O
our O
knowledge O
, O
of O
regulatory O
elements O
that O
control O
expression _RARE_
of O
a O
gene O
encoding O
a O
B7 I-GENE
costimulatory _RARE_
molecule I-GENE
. O

DNA I-GENE
- I-GENE
STAT I-GENE
complexes I-GENE
were O
detected O
in O
all O
Bcr _RARE_
/ O
Abl I-GENE
- O
transformed O
cell O
lines O
and O
they O
were O
supershifted _RARE_
by O
antibodies O
against O
STAT1 I-GENE
and O
STAT5 I-GENE
. O

When O
overexpressed O
in O
an O
appropriate O
cell O
line O
, O
TAN _RARE_
- I-GENE
1C _RARE_
prevented O
kappa _RARE_
B I-GENE
- O
dependent O
transactivation _RARE_
in O
transient O
reporter O
gene O
assays O
in O
a O
fashion O
similar O
to O
the O
structurally O
related O
protein O
, O
Bcl I-GENE
- I-GENE
3 I-GENE
. O

T O
cell O
leukemia O
- O
associated O
human O
Notch I-GENE
/ O
translocation O
- O
associated O
Notch I-GENE
homologue O
has O
I I-GENE
kappa _RARE_
B I-GENE
- O
like O
activity O
and O
physically O
interacts O
with O
nuclear I-GENE
factor I-GENE
- I-GENE
kappa _RARE_
B I-GENE
proteins O
in O
T O
cells O
. O

Polyprotein _RARE_
processing _RARE_
in O
Southampton _RARE_
virus O
: O
identification O
of O
3C I-GENE
- I-GENE
like I-GENE
protease I-GENE
cleavage _RARE_
sites O
by O
in O
vitro O
mutagenesis O
. O

The O
humanized _RARE_
LL2 _RARE_
( O
hLL2 _RARE_
), _RARE_
lacking _RARE_
light I-GENE
chain I-GENE
variable _RARE_
region I-GENE
glycosylation O
, O
exhibited O
immunoreactivities _RARE_
that O
were O
comparable O
to O
that O
of O
chimeric I-GENE
LL2 _RARE_
( O
cLL2 _RARE_
), _RARE_
which O
was O
shown O
previously O
to O
have O
antigen O
- O
binding O
properties O
similar O
to O
its O
murine O
counterpart _RARE_
, O
suggesting O
that O
the O
VK _RARE_
- O
appended _RARE_
oligosaccharides _RARE_
found O
in O
mLL2 _RARE_
are O
not O
necessary O
for _RARE_
antigen O
binding O
. O

An O
apparent O
N O
- O
terminal O
transit O
peptide O
in O
the O
coding O
region O
and O
a O
3 O
' O
poly _RARE_
( O
A O
) O
tail _RARE_
exist O
in O
the O
cDNA O
clone O
indicated O
that O
this O
chloroplast O
protein O
as _RARE_
nuclear O
encoded O
. O

Deletion O
analysis O
of O
rOC _RARE_
promoter I-GENE
- O
chloramphenicol I-GENE
acetyltransferase _RARE_
constructs O
demonstrates O
that O
an O
AML _RARE_
- I-GENE
1 I-GENE
- I-GENE
binding I-GENE
sequence I-GENE
within O
the O
proximal O
promoter O
(- _RARE_
138 _RARE_
to O
- O
130 _RARE_
nt O
) O
contributes O
to O
75 _RARE_
% O
of O
the O
level O
of O
osteocalcin _RARE_
gene I-GENE
expression _RARE_
. O

Thus O
, O
a O
critical O
question O
is O
how O
HOX _RARE_
proteins I-GENE
select O
the O
correct O
sets O
of O
target O
genes O
in O
vivo O
. O

RAS2val19 _RARE_
, O
a O
dominant O
activated O
form O
of O
Saccharomyces I-GENE
cerevisiae I-GENE
Ras2 _RARE_
, O
stimulates O
both O
filamentous _RARE_
growth O
and O
expression _RARE_
of O
a O
transcriptional O
reporter O
FG _RARE_
( O
TyA _RARE_
):: _RARE_
lacZ I-GENE
but O
does O
not O
induce O
the O
mating _RARE_
pathway _RARE_
reporter I-GENE
FUS1 _RARE_
:: O
lacZ I-GENE
. O

Moreover O
, O
the O
Rho I-GENE
family I-GENE
protein I-GENE
Cdc42 I-GENE
, O
a O
conserved _RARE_
morphogenetic _RARE_
G I-GENE
protein I-GENE
, O
is O
also O
a O
potent O
regulator O
of O
filamentous _RARE_
growth O
and O
FG _RARE_
( O
TyA _RARE_
):: _RARE_
lacZ I-GENE
expression _RARE_
in O
S O
. O
cerevisiae O
. O

Each O
immunoprecipitate _RARE_
contained O
a O
complex O
of O
N1 _RARE_
( I-GENE
deltaEC _RARE_
) I-GENE
and O
CBF1 I-GENE
. O

This O
region O
includes O
verA _RARE_
, O
a O
structural O
gene O
previously O
shown O
to O
be O
required O
for _RARE_
ST O
biosynthesis O
, O
and O
24 _RARE_
additional O
closely O
spaced _RARE_
transcripts O
ranging O
in O
size O
from O
0 _RARE_
. O
6 O
to O
7 O
. O
2 O
kb O
that O
are O
coordinately _RARE_
induced _RARE_
only O
under O
ST O
- O
producing O
conditions O
. O

Subcellular _RARE_
localizations _RARE_
of O
the O
wild I-GENE
- I-GENE
type I-GENE
CBFbeta _RARE_
and O
the O
CBFbeta _RARE_
- O
SMMHC _RARE_
fusion O
protein O
were O
determined O
by O
immunofluorescence O
of O
NIH _RARE_
3T3 O
cells O
that O
overexpress _RARE_
wild O
- O
type O
or O
fusion O
protein O
. O

Menstrual _RARE_
- O
cycle _RARE_
phase _RARE_
did O
not O
significantly O
affect O
personality _RARE_
variables O
in O
either O
group O
. O

We O
report O
the O
isolation O
of O
human O
cDNAs O
homologous O
to O
the O
Drosophila I-GENE
dishevelled _RARE_
( O
dsh _RARE_
) O
segment O
- O
polarity O
gene O
. O

Escherichia O
coli O
BL21 _RARE_
( O
DE3 _RARE_
) O
plysS _RARE_
, O
harbouring _RARE_
a O
recombinant O
plasmid _RARE_
containing O
the O
catalase I-GENE
- O
peroxidase I-GENE
gene O
, O
produced O
a O
large O
amount O
of O
proteins O
that O
co _RARE_
- O
migrated _RARE_
on O
SDS O
/ O
PAGE O
with O
the O
native _RARE_
enzyme O
. O

Ca2 _RARE_
+ O
decreased O
Zn2 _RARE_
+ O
binding O
in O
S100 _RARE_
beta I-GENE
but O
it O
did O
not O
influence O
binding O
to O
MRP14 _RARE_
, O
suggesting O
that O
the O
Zn2 _RARE_
+ O
binding O
site O
was O
distinct O
from O
and O
independent O
of O
the O
two O
Ca2 _RARE_
+ O
binding O
domains O
. O

Cdk2 I-GENE
formed O
a O
complex O
with O
cyclin _RARE_
D1 _RARE_
in O
this O
system _RARE_
. O

The O
Cdk2 I-GENE
- O
cyclin _RARE_
- I-GENE
D1 _RARE_
complex O
did O
not O
phosphorylate O
any O
tested O
substrates _RARE_
, O
such O
as _RARE_
H1 _RARE_
histone I-GENE
, O
pRB _RARE_
, O
SV40 I-GENE
large I-GENE
T I-GENE
antigen I-GENE
, O
p53 I-GENE
, O
E2F I-GENE
- I-GENE
1 I-GENE
or O
a O
preparation O
of O
nuclear O
proteins O
from O
HeLa O
cells O
; O
in O
contrast O
, O
Cdk2 I-GENE
- O
cyclin _RARE_
- I-GENE
E I-GENE
and O
Cdk2 I-GENE
- O
cyclin _RARE_
- I-GENE
A I-GENE
phosphorylated _RARE_
these O
proteins O
. O

Cyclin I-GENE
- I-GENE
dependent I-GENE
kinase I-GENE
- I-GENE
2 I-GENE
( O
Cdk2 I-GENE
) O
forms O
an O
inactive O
complex O
with O
cyclin _RARE_
D1 _RARE_
since O
Cdk2 I-GENE
associated O
with O
cyclin _RARE_
D1 _RARE_
is O
not O
phosphorylated _RARE_
by O
Cdk7 _RARE_
- O
cyclin _RARE_
- I-GENE
H I-GENE
. O

Two O
overlapping O
clones _RARE_
contained O
the O
complete _RARE_
Adh _RARE_
- I-GENE
2 I-GENE
gene I-GENE
composed O
of O
nine O
exons O
in O
a O
12 O
- O
kb O
region O
, O
with O
the O
placement O
of O
introns _RARE_
matching _RARE_
that O
observed O
in O
other O
mammalian I-GENE
ADH I-GENE
genes I-GENE
. O

Ligation _RARE_
of O
CD40 I-GENE
rescues _RARE_
Ramos _RARE_
- O
Burkitt _RARE_
lymphoma O
B O
cells O
from O
calcium _RARE_
ionophore _RARE_
- O
and O
antigen O
receptor O
- O
triggered O
apoptosis O
by O
inhibiting O
activation O
of O
the O
cysteine I-GENE
protease I-GENE
CPP32 _RARE_
/ O
Yama _RARE_
and O
cleavage _RARE_
of O
its O
substrate O
PARP _RARE_
. O

Large _RARE_
T I-GENE
antigen I-GENE
was O
coimmunoprecipitated _RARE_
by O
antibodies O
to O
epitope _RARE_
- O
tagged _RARE_
TBP I-GENE
, O
endogenous O
TBP I-GENE
, O
hTAF _RARE_
( I-GENE
II I-GENE
) I-GENE
100 _RARE_
, O
hTAF _RARE_
( I-GENE
II I-GENE
) I-GENE
130 _RARE_
, O
and O
hTAF _RARE_
( I-GENE
II I-GENE
) I-GENE
250 _RARE_
, O
under O
conditions O
where O
holo _RARE_
- I-GENE
TFIID I-GENE
would O
be O
precipitated O
. O

Northern O
blot O
hybridization O
demonstrated O
that O
HEP _RARE_
- O
COP _RARE_
was O
expressed _RARE_
in O
a O
wide O
range O
of O
human O
adult O
and O
fetal _RARE_
tissues O
. O

A O
human O
cytoplasmic O
signaling _RARE_
protein O
has O
been O
cloned _RARE_
that O
possesses O
the O
same O
structural O
arrangement O
of O
SH3 I-GENE
- O
SH2 _RARE_
- O
SH3 I-GENE
domains O
as _RARE_
Grb2 I-GENE
. O

A O
direct O
role O
for _RARE_
sterol I-GENE
regulatory I-GENE
element I-GENE
binding I-GENE
protein I-GENE
in O
activation O
of O
3 I-GENE
- I-GENE
hydroxy I-GENE
- I-GENE
3 I-GENE
- I-GENE
methylglutaryl _RARE_
coenzyme _RARE_
A I-GENE
reductase I-GENE
gene I-GENE
. O

E3 _RARE_
/ I-GENE
19K _RARE_
resides O
in O
the O
endoplasmic O
reticulum O
where O
it O
binds O
to O
MHC I-GENE
class I-GENE
I I-GENE
molecules I-GENE
, O
thereby O
preventing O
their O
transport _RARE_
to O
the O
cell O
surface O
. O

When O
the O
PHT _RARE_
and O
CSA _RARE_
groups O
were O
compared O
, O
Hyp _RARE_
levels O
were O
significantly O
higher _RARE_
in O
the O
PHT _RARE_
- O
GO _RARE_
+ O
group O
than O
in O
the O
CSA _RARE_
- O
GO _RARE_
+ O
group O
. O

Among O
the O
LE6 _RARE_
deletions O
, O
only O
one O
had O
a O
reduced _RARE_
transformation O
efficiency O
, O
while O
seven _RARE_
transformed O
cells O
at _RARE_
least O
as _RARE_
efficiently O
as _RARE_
wild I-GENE
- I-GENE
type I-GENE
LE6 _RARE_
. O

ORF I-GENE
E8 _RARE_
colinear _RARE_
with O
ORF I-GENE
E6 _RARE_
, O
which O
could O
generate O
a O
50 O
- O
amino O
- O
acid O
protein O
with O
a O
hydrophobic O
segment O
, O
did O
not O
transform O
cells O
when O
cloned _RARE_
into O
the O
pZipNeo _RARE_
vector O
. O

Cloning O
of O
individual O
ZI _RARE_
domains O
upstream O
of O
a O
minimal O
promoter O
demonstrated O
that O
the O
ZIA _RARE_
, O
ZIC _RARE_
, O
and O
ZID _RARE_
domains O
, O
but O
not O
the O
ZIB _RARE_
domain O
, O
are O
TPA _RARE_
responsive O
. O

Clb2 _RARE_
/ O
Cdc28 I-GENE
kinase O
is O
not O
required O
for _RARE_
the O
repression O
of O
MCB _RARE_
- I-GENE
binding I-GENE
factor I-GENE
transcriptional O
activity O
in O
G2 _RARE_
and O
M O
phase _RARE_
. O

The O
carboxy _RARE_
terminus O
of O
Mbp1 _RARE_
is O
sufficient O
for _RARE_
interaction O
with O
Swi6 _RARE_
, O
and O
the O
carboxy _RARE_
terminus O
of O
Swi6 _RARE_
is O
required O
for _RARE_
interaction O
with O
Mbp1 _RARE_
. O

Multiple O
single O
- O
stranded _RARE_
cis O
elements O
are O
associated O
with O
activated O
chromatin O
of O
the O
human I-GENE
c I-GENE
- I-GENE
myc I-GENE
gene I-GENE
in O
vivo O
. O

A O
new O
UASH _RARE_
consensus O
sequence O
derived O
from O
this O
mutational O
analysis O
closely O
matches O
a O
consensus O
Abf1 _RARE_
binding I-GENE
site I-GENE
. O

We O
have O
isolated O
and O
analyzed O
human I-GENE
CTCF I-GENE
cDNA I-GENE
clones _RARE_
and O
show O
here O
that O
the O
ubiquitously O
expressed _RARE_
11 I-GENE
- I-GENE
zinc I-GENE
- I-GENE
finger I-GENE
factor I-GENE
CTCF I-GENE
is O
an O
exceptionally _RARE_
highly O
conserved _RARE_
protein O
displaying _RARE_
93 O
% O
identity O
between O
avian O
and O
human O
amino O
acid O
sequences O
. O

Mutational O
analysis O
of O
the O
P2 I-GENE
- I-GENE
proximal I-GENE
CTCF I-GENE
binding I-GENE
site I-GENE
and O
transient O
- O
cotransfection O
experiments O
demonstrate O
that O
CTCF I-GENE
is O
a O
transcriptional O
repressor O
of O
the O
human I-GENE
c I-GENE
- I-GENE
myc I-GENE
gene I-GENE
. O

A O
chromosome _RARE_
transmission _RARE_
fidelity _RARE_
( O
ctf _RARE_
) O
mutant O
, O
s138 _RARE_
, O
of O
Saccharomyces O
cerevisiae O
was O
identified O
by O
its O
centromere O
( O
CEN _RARE_
) O
transcriptional O
readthrough O
phenotype _RARE_
, O
suggesting O
perturbed _RARE_
kinetochore _RARE_
integrity O
in O
vivo O
. O

The O
growth O
defect O
of O
a O
reg1 _RARE_
reg2 _RARE_
double I-GENE
mutant I-GENE
is O
alleviated _RARE_
by O
a O
loss _RARE_
- O
of O
- O
function O
mutation O
in O
the O
SNF1 _RARE_
- I-GENE
encoded I-GENE
protein I-GENE
kinase I-GENE
. O

Sp1 _RARE_
binds O
two O
sites O
in O
the O
CD11c _RARE_
promoter I-GENE
in O
vivo O
specifically O
in O
myeloid _RARE_
cells O
and O
cooperates _RARE_
with O
AP1 I-GENE
to O
activate O
transcription O
. O

Expression O
of O
the O
phenylalanine _RARE_
hydroxylase I-GENE
gene I-GENE
in O
livers _RARE_
and O
kidneys O
of O
rodents _RARE_
is O
activated O
at _RARE_
birth O
and O
is O
induced _RARE_
by O
glucocorticoids O
and O
cyclic O
AMP O
in O
the O
liver O
. O

We O
found O
that O
120 O
bp O
of O
the O
enhancer O
' O
s O
transcriptional O
core O
becomes O
DNase I-GENE
I I-GENE
hypersensitive _RARE_
early O
in O
B O
- O
cell O
development O
. O

A O
developmentally O
modulated O
chromatin O
structure _RARE_
at _RARE_
the O
mouse I-GENE
immunoglobulin I-GENE
kappa _RARE_
3 I-GENE
' I-GENE
enhancer I-GENE
. O

We O
report O
here O
the O
identification O
of O
a O
cDNA O
that O
encodes O
a O
new O
member _RARE_
of O
the O
GTPase I-GENE
- I-GENE
activating I-GENE
protein I-GENE
( O
GAP _RARE_
) O
family O
of O
GTPase I-GENE
regulators _RARE_
. O

In O
this O
study O
, O
we O
further O
investigated O
the O
regulation _RARE_
of O
the O
synthesis _RARE_
of O
the O
c I-GENE
- I-GENE
mos I-GENE
oncogene I-GENE
product I-GENE
, O
which O
is O
necessary O
for _RARE_
the O
activation O
of O
Cdc2 I-GENE
. O

The O
heterogeneity O
of O
bovine I-GENE
IgG2 _RARE_
-- _RARE_
VIII I-GENE
. O

The O
ability O
of O
BCL _RARE_
- I-GENE
6 I-GENE
to O
function O
as _RARE_
a O
transcriptional O
repressor O
may O
contribute O
to O
its O
ability O
to O
transform O
B O
lymphocytes O
in O
diffuse O
large O
cell O
lymphoma O
. O

Positioning _RARE_
this O
uORF _RARE_
, O
together O
with O
its O
accompanying O
Kozak _RARE_
sequences O
, O
between O
a O
heterologous O
promoter O
from O
SV40 O
and O
a O
CAT I-GENE
reporter I-GENE
gene I-GENE
resulted O
in O
marked O
inhibition O
of O
CAT I-GENE
protein I-GENE
production O
without O
a O
decrease O
in O
CAT I-GENE
mRNA I-GENE
. O

A O
secondary O
spread O
of O
an O
imported _RARE_
methicillin _RARE_
- O
resistant O
Staphylococcus _RARE_
aureus _RARE_
strain _RARE_
( O
MRSA _RARE_
) O
to O
two O
other O
patients O
occurred O
within O
a O
Danish _RARE_
surgical O
ward _RARE_
in O
spite _RARE_
of O
isolation O
of O
a O
multitraumatized _RARE_
index O
- O
patient O
immediately O
after O
arrival _RARE_
from O
a O
hospital O
in O
the O
Mediterranean _RARE_
area O
. O

Mesial _RARE_
temporal O
sclerosis O
was O
characterized O
by O
severe O
neuronal _RARE_
loss _RARE_
accompanied O
by O
gliosis _RARE_
occurring O
in O
the O
CA1 _RARE_
/ O
prosubiculum _RARE_
( O
27 _RARE_
patients O
, O
100 _RARE_
%), O
focally _RARE_
in O
the O
dentate _RARE_
gyrus O
( O
12 O
patients O
, O
44 _RARE_
%), O
and O
in O
the O
CA4 _RARE_
region O
( O
11 O
patients O
, O
41 _RARE_
%). O

Mesial _RARE_
temporal O
sclerosis O
. O

More O
specific O
adverse O
events O
, O
also O
frequently O
considered O
as _RARE_
dose O
- O
limiting O
toxicities _RARE_
, O
include O
hypotension O
with O
IL _RARE_
- I-GENE
1 I-GENE
, O
severe O
headache O
or O
skin _RARE_
rash O
with O
IL _RARE_
- I-GENE
3 I-GENE
, O
and O
nasal O
congestion _RARE_
and O
gastroduodenal _RARE_
lesions O
with O
IL _RARE_
- I-GENE
4 I-GENE
. O

Therefore O
, O
magnetic O
resonance O
imaging O
was O
used O
to O
determine O
liver O
volume O
in O
pediatric O
and O
adolescent O
patients O
, O
in O
whom O
systemic O
clearance O
of O
three O
model O
substrates _RARE_
[ _RARE_
lorazepam _RARE_
( O
0 _RARE_
. O
03 O
mg O
/ O
kg O
), _RARE_
antipyrine _RARE_
( O
10 O
mg O
/ O
kg O
), _RARE_
and O
indocyanine _RARE_
green _RARE_
( O
ICG _RARE_
; O
0 _RARE_
. O
5 O
mg O
/ O
kg O
)] O
was O
also O
determined O
. O

A O
mutational O
analysis O
has O
resolved O
a O
region O
of O
seven _RARE_
amino O
acids _RARE_
( O
amino O
acids _RARE_
26 _RARE_
- O
32 _RARE_
) O
in O
the O
N O
- O
terminus O
of O
Bob1 _RARE_
that O
are O
important O
for _RARE_
contacting _RARE_
the O
DNA I-GENE
binding I-GENE
POU I-GENE
domain I-GENE
of O
Oct I-GENE
- I-GENE
1 I-GENE
or O
Oct I-GENE
- I-GENE
2 I-GENE
. O

Heme _RARE_
oxygenase I-GENE
1 I-GENE
is O
an O
essential O
enzyme O
in O
heme O
catabolism O
that O
cleaves _RARE_
heme O
to O
form O
biliverdin _RARE_
, O
iron O
, O
and O
carbon O
monoxide _RARE_
. O

An O
inactive O
analog O
of O
wortmannin O
, O
WM12 _RARE_
, O
did O
not O
affect O
TCR I-GENE
/ O
CD3 I-GENE
- O
induced _RARE_
Erk2 _RARE_
activation O
, O
and O
wortmannin O
had O
no _RARE_
effect O
on O
the O
activity O
of O
Erk2 _RARE_
when O
added O
directly O
to O
the O
in O
vitro O
assays O
. O

155 _RARE_
aa _RARE_
, O
shares O
78 _RARE_
% O
identity O
with O
the O
analogous O
region O
of O
Xenopus O
laevis _RARE_
FGF3 _RARE_
and O
72 O
% O
identity O
with O
the O
product O
of O
the O
more O
distantly O
related O
human O
gene O
. O

The O
transcription O
start _RARE_
point O
of O
the O
proximal O
promoter O
aligns _RARE_
to O
that O
of O
mouse O
promoter O
P3 _RARE_
and O
lies O
within O
a O
conserved _RARE_
region O
of O
sequence O
. O

Defects _RARE_
in O
the O
Schizosaccharomyces O
pombe O
( O
Sp _RARE_
) O
cell O
cycle _RARE_
- O
controlling O
genes O
prevent O
the O
cell O
cycle _RARE_
progression O
. O

To O
determine O
the O
signal I-GENE
recognition I-GENE
particle _RARE_
( O
SRP I-GENE
)- O
SRP I-GENE
receptor I-GENE
( O
Srb _RARE_
) O
system _RARE_
in O
Bacillus O
subtilis O
( O
Bs _RARE_
), _RARE_
we O
cloned _RARE_
the O
Bs _RARE_
srb _RARE_
gene I-GENE
, O
which O
encodes O
a O
homologue O
of O
the O
mammalian I-GENE
SRP I-GENE
receptor I-GENE
alpha I-GENE
- I-GENE
subunit I-GENE
[ _RARE_
Oguro _RARE_
et O
al O
., O
DNA O
Res _RARE_
. O

A O
novel O
gene O
designated O
cmr _RARE_
, O
which O
mapped O
to O
18 O
. O
8 O
min O
of O
the O
Escherichia O
coli O
K O
- O
12 O
genome O
, O
was O
shown O
to O
mediate O
resistance O
to O
chloramphenicol O
when O
it O
was O
expressed _RARE_
from O
a O
multicopy O
vector O
. O

In O
addition O
, O
5 O
' O
deletions O
removing O
all O
but O
34 _RARE_
bp O
upstream O
of O
the O
transcription O
start _RARE_
point O
retained O
greater O
than O
90 _RARE_
% O
promoter O
activity O
, O
suggesting O
that O
the O
- O
35 _RARE_
hexamer O
was O
not O
essential O
for _RARE_
promoter O
activity O
. O

The O
DNA O
sequence O
immediately O
upstream O
from O
the O
- O
10 O
hexamer O
contained O
the O
TGn _RARE_
motif O
described O
as _RARE_
an O
extended O
- O
10 O
region O
in O
prokaryotic _RARE_
promoters O
. O

An O
apparent O
ufo _RARE_
mRNA I-GENE
overexpression O
was O
not O
found O
in O
any O
of O
the O
positive O
leukemia O
cell O
lines O
, O
but O
was O
identified O
in O
the O
drug O
- O
resistant O
subclones _RARE_
of O
the O
cervix O
carcinoma O
cell O
line O
HeLa O
. O

We O
conclude O
from O
these O
studies O
that O
CKII _RARE_
may O
act O
as _RARE_
a O
positive O
regulator O
of O
myogenesis _RARE_
by O
preventing O
E I-GENE
protein I-GENE
homodimers I-GENE
from O
binding O
to O
muscle O
gene O
regulatory O
elements O
. O

The O
role O
of O
negative O
regulators _RARE_
such O
as _RARE_
NCE3 _RARE_
, O
as _RARE_
well _RARE_
as _RARE_
the O
previously O
described O
SIN5 _RARE_
gene I-GENE
, O
in O
determining _RARE_
the O
promoter O
specificity _RARE_
of O
homologous O
activators _RARE_
is O
discussed O
. O

Transcriptional O
regulators _RARE_
utilizing O
the O
POU I-GENE
domain I-GENE
DNA I-GENE
- I-GENE
binding I-GENE
motif I-GENE
have O
been O
shown O
to O
form O
multi _RARE_
- O
protein O
complexes O
dependent O
on O
the O
POU I-GENE
domain I-GENE
itself O
and O
its O
flexible _RARE_
recognition O
of O
various O
octamer O
sequence O
elements O
. O

We O
found O
strand _RARE_
selective O
repair O
in O
DNA O
fragments O
within O
two O
active _RARE_
genes O
, O
DHFR I-GENE
and O
an O
unknown O
gene O
adjacent O
to O
DHFR I-GENE
. O

MATERIALS _RARE_
AND _RARE_
METHODS O
: O
Coronal _RARE_
3D _RARE_
GRE _RARE_
imaging O
was O
used O
to O
study O
the O
volar _RARE_
, O
middle _RARE_
, O
and O
dorsal O
portions O
of O
the O
SLL _RARE_
in O
14 O
patients O
with O
an O
arthroscopically _RARE_
normal O
SLL _RARE_
and O
in O
five O
cadaveric _RARE_
wrists _RARE_
that O
had O
a O
normal O
SLL _RARE_
proved O
with O
dissection O
. O

In O
an O
effort O
to O
contribute O
to O
the O
transcript O
map O
of O
human O
chromosome _RARE_
21 O
and O
the O
understanding O
of O
the O
pathophysiology O
of O
trisomy _RARE_
21 O
, O
we O
have O
used O
exon _RARE_
trapping _RARE_
to O
identify O
fragments O
of O
chromosome _RARE_
21 O
genes O
. O

Reproducing _RARE_
populations O
of O
this O
aphid _RARE_
were O
first _RARE_
detected O
in O
Puerto _RARE_
Rico _RARE_
in O
April _RARE_
1992 O
. O

The O
model O
captures _RARE_
the O
essence _RARE_
of O
predator _RARE_
- O
prey _RARE_
dynamics O
to O
provide O
reasonable O
predictions O
of O
population O
patterns O
. O

At O
cuticular _RARE_
positions O
exhibiting O
the O
Brd _RARE_
bristle _RARE_
loss _RARE_
phenotype _RARE_
, O
we O
have O
found O
that O
the O
progeny _RARE_
of O
the O
multiplied _RARE_
SOPs _RARE_
develop O
aberrantly _RARE_
, O
in O
that O
neurons O
and O
thecogen _RARE_
( O
sheath _RARE_
) O
cells O
appear O
but O
not O
trichogen _RARE_
( O
shaft _RARE_
) O
and O
tormogen _RARE_
( O
socket _RARE_
) O
cells O
. O

Transcriptional O
blockade O
was O
reversed O
by O
co _RARE_
- O
transfections O
of O
a O
wild I-GENE
- I-GENE
type I-GENE
SRF I-GENE
expression _RARE_
vector O
, O
but O
was O
not O
rescued _RARE_
by O
the O
expression _RARE_
of O
other O
myogenic _RARE_
factors O
, O
such O
as _RARE_
MyoD I-GENE
and O
Mef _RARE_
- I-GENE
2C _RARE_
. O

The O
mMIWC1 _RARE_
promoter I-GENE
was O
identified O
and O
contained O
TATA O
, O
CAAT O
, O
GATA _RARE_
, O
and O
AP I-GENE
- I-GENE
2 I-GENE
elements I-GENE
; O
primer O
extension O
revealed O
mMIWC _RARE_
transcription O
initiation O
at _RARE_
621 _RARE_
bp O
upstream O
from O
the O
mMIWC1 _RARE_
translational O
initiation O
site O
. O

Human I-GENE
MN _RARE_
/ I-GENE
CA9 _RARE_
gene I-GENE
, O
a O
novel O
member _RARE_
of O
the O
carbonic _RARE_
anhydrase I-GENE
family I-GENE
: O
structure _RARE_
and O
exon _RARE_
to O
protein O
domain O
relationships O
. O

The O
exon _RARE_
- O
intron O
distribution O
of O
Cdebp _RARE_
appears O
strikingly O
similar O
to O
that O
of O
the O
App _RARE_
gene I-GENE
in O
the O
regions O
encoding O
the O
conserved _RARE_
domains O
, O
with O
a O
divergent O
structure _RARE_
in O
the O
other O
parts O
. O

DNA O
sequence O
analysis O
reveals O
that O
the O
gene O
encodes O
a O
protein O
highly O
homologous O
to O
rat I-GENE
CRP1 _RARE_
. O

The O
gene O
was O
expressed _RARE_
as _RARE_
an O
approximately _RARE_
1 O
. O
5 O
- O
kb O
mRNA O
in O
most O
nonlymphoid _RARE_
human O
cells O
/ O
tissues O
including O
prostate _RARE_
, O
lung _RARE_
, O
liver O
, O
and O
colon O
. O

Both O
of O
these O
domains O
have O
striking O
sequence O
homology O
with O
human O
SIM _RARE_
and O
Drosophila O
SIM _RARE_
proteins O
. O

Promoter O
activity O
was O
high O
in O
cell O
lines O
that O
expressed _RARE_
high O
levels O
of O
endogenous O
D3 _RARE_
mRNA I-GENE
, O
as _RARE_
indicated O
by O
Northern O
blot O
analyses O
, O
and O
was O
significantly O
reduced _RARE_
when O
the O
promoter O
was O
truncated O
to O
- O
122 O
bp O
. O

We O
have O
obtained O
the O
human I-GENE
EP4 _RARE_
receptor I-GENE
gene I-GENE
sequence I-GENE
and O
determined O
its O
structure _RARE_
relative O
to O
EP4R _RARE_
cDNA I-GENE
synthesized O
from O
peripheral O
blood _RARE_
lymphocytes O
. O

Some O
users O
will O
willingly _RARE_
comply _RARE_
with O
management O
measures O
, O
other O
users O
will O
comply _RARE_
in O
response O
to O
education O
, O
but O
there O
will O
be O
another O
group O
who O
will O
only O
respond O
to O
enforcement _RARE_
activities O
. O

Three O
separate O
activation O
subdomains O
, O
and O
one O
negative O
- O
acting O
region O
, O
which O
function O
in O
yeast O
were O
located _RARE_
in O
the O
carboxyl _RARE_
- O
terminal O
region O
of O
NIT4 _RARE_
. O

The O
front O
( O
F O
) O
interaction O
occurs O
ahead _RARE_
of O
the O
growing O
end O
of O
RNA O
. O

Collectively O
, O
these O
data O
indicate O
that O
HIP _RARE_
is O
a O
membrane O
- O
associated O
HP _RARE_
- I-GENE
binding I-GENE
protein I-GENE
expressed _RARE_
on O
the O
surface O
of O
normal O
human O
uterine _RARE_
epithelia _RARE_
and O
uterine _RARE_
epithelial _RARE_
cell O
lines O
. O

The O
corresponding O
gene O
was O
identified O
in O
the O
GenBankTM _RARE_
data O
base _RARE_
by O
sequence O
alignment O
and O
termed O
RPS30A _RARE_
. O

The O
location O
of O
multiple O
GRK2 _RARE_
and O
GRK5 _RARE_
phosphoacceptor _RARE_
sites I-GENE
at _RARE_
the O
extreme O
carboxyl _RARE_
terminus O
of O
the O
beta2AR _RARE_
is O
highly O
reminiscent _RARE_
of O
GRK1 _RARE_
- O
mediated _RARE_
phosphorylation _RARE_
of O
rhodopsin _RARE_
. O

This O
regulation _RARE_
could O
not O
be O
appreciably _RARE_
modified O
by O
enhanced _RARE_
expression _RARE_
of O
STAT I-GENE
proteins I-GENE
. O

Receptors _RARE_
for _RARE_
interleukin I-GENE
( I-GENE
IL _RARE_
)- I-GENE
10 I-GENE
and O
IL _RARE_
- I-GENE
6 I-GENE
- I-GENE
type I-GENE
cytokines _RARE_
use O
similar O
signaling _RARE_
mechanisms O
for _RARE_
inducing O
transcription O
through O
IL _RARE_
- I-GENE
6 I-GENE
response O
elements O
. O

Specifically O
, O
the O
deduced O
FR _RARE_
- I-GENE
19 I-GENE
amino I-GENE
acid I-GENE
sequence I-GENE
has O
approximately89 _RARE_
, O
77 O
, O
and O
68 _RARE_
% O
overall O
identity O
to O
chicken I-GENE
TEF I-GENE
- I-GENE
1A _RARE_
, O
mouse I-GENE
TEF I-GENE
- I-GENE
1 I-GENE
, O
and O
mouse I-GENE
embryonic _RARE_
TEA _RARE_
domain I-GENE
- I-GENE
containing I-GENE
factor I-GENE
, O
respectively O
. O

This O
phenomenon O
did O
not O
require O
DNA O
binding O
by O
the O
" O
interfering O
" O
receptor O
but O
required O
it O
to O
be O
hormone O
- O
bound _RARE_
, O
indicating O
that O
a O
transcriptionally O
active _RARE_
form O
of O
the O
interfering O
receptor O
is O
essential O
for _RARE_
the O
interfering O
effect O
. O

The O
receptor I-GENE
for _RARE_
hyaluronan _RARE_
mediated _RARE_
motility _RARE_
( I-GENE
RHAMM _RARE_
) I-GENE
gene I-GENE
expression _RARE_
is O
markedly O
elevated O
in O
fibrosarcomas _RARE_
exposed O
to O
transforming I-GENE
growth I-GENE
factor I-GENE
- I-GENE
beta1 I-GENE
( O
TGF I-GENE
- I-GENE
beta1 I-GENE
). O

Oncogenic _RARE_
Raf I-GENE
- I-GENE
1 I-GENE
activates O
p70 I-GENE
S6 I-GENE
kinase I-GENE
via O
a O
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
- O
independent O
pathway _RARE_
. O

Hydropathy _RARE_
analysis O
of O
KCC1 _RARE_
indicates O
structural O
homology O
to O
NKCC _RARE_
, O
including O
12 O
transmembrane O
domains O
, O
a O
large O
extracellular O
loop O
with O
potential _RARE_
N O
- O
linked _RARE_
glycosylation O
sites O
, O
and O
cytoplasmic O
N O
- O
and O
C O
- O
terminal O
regions O
. O

A O
cis O
- O
acting O
DNA O
element O
located _RARE_
between O
TATA O
box O
and O
transcription O
initiation O
site O
is O
critical O
in O
response O
to O
regulatory O
sequences O
in O
human O
angiotensinogen _RARE_
gene I-GENE
. O

This O
protein O
with O
a O
hydrophobic O
amino O
terminus O
appears O
to O
be O
a O
secreted _RARE_
protein O
. O

The O
promoter O
of O
the O
rat I-GENE
PGS _RARE_
- I-GENE
2 I-GENE
gene I-GENE
contains O
a O
CAAT I-GENE
enhancer I-GENE
- I-GENE
binding I-GENE
protein I-GENE
consensus I-GENE
site I-GENE
( I-GENE
CAAT I-GENE
box I-GENE
) I-GENE
which O
can O
confer O
hormone O
inducibility O
to O
a O
PGS _RARE_
- I-GENE
2 I-GENE
. O
CAT I-GENE
reporter O
gene O
, O
as _RARE_
well _RARE_
as _RARE_
a O
putative O
E O
- O
box O
region O
. O

Notably _RARE_
, O
SRF I-GENE
has O
been O
found O
to O
be O
a O
key O
regulator O
of O
members O
of O
a O
class O
of O
cellular O
response O
genes O
termed O
immediate I-GENE
- I-GENE
early I-GENE
genes I-GENE
( O
IEGs _RARE_
), _RARE_
many O
of O
which O
are O
believed O
to O
be O
involved O
in O
regulating _RARE_
cell O
growth O
and O
differentiation O
. O

The O
final O
sigma54 _RARE_
- I-GENE
dependent I-GENE
DmpR _RARE_
activator I-GENE
regulates O
transcription O
of O
the O
dmp _RARE_
operon I-GENE
that O
encodes O
the O
enzymes _RARE_
for _RARE_
catabolism O
of O
( O
methyl _RARE_
) O
phenols _RARE_
. O

In O
this O
study O
, O
we O
have O
cloned _RARE_
the O
human I-GENE
DSG3 _RARE_
gene I-GENE
and O
examined O
the O
transcriptional O
regulation _RARE_
of O
its O
expression _RARE_
. O

Clinical O
evaluation O
of O
the O
Allergan _RARE_
Humphrey _RARE_
500 O
autorefractor _RARE_
and O
the O
Nidek _RARE_
AR _RARE_
- O
1000 O
autorefractor _RARE_
. O

None O
of O
the O
five O
proprotein _RARE_
processing _RARE_
proteases _RARE_
tested O
were O
capable O
of O
cleaving _RARE_
human I-GENE
pro I-GENE
- I-GENE
LPH _RARE_
, O
strongly O
suggesting O
that O
they O
are O
not O
involved O
in O
the O
maturation _RARE_
of O
this O
enzyme O
. O

These O
changes O
may O
be O
the O
result O
of O
, O
on O
the O
one O
hand _RARE_
, O
an O
increased O
sensitivity O
of O
the O
neuromuscular O
transmission _RARE_
and O
/ O
or O
decreased O
muscle O
contractility O
and O
, O
on O
the O
other O
hand _RARE_
, O
the O
result O
of O
a O
reduced _RARE_
plasma O
clearance O
during _RARE_
hypothermia O
. O

SETTING O
-- _RARE_
Delhi _RARE_
, O
urban _RARE_
India _RARE_
, O
1985 O
- O
6 O
. O

By O
using O
interleukin I-GENE
- I-GENE
3 I-GENE
- O
dependent O
cells O
that O
ectopically _RARE_
express O
the O
three O
ErbB I-GENE
proteins I-GENE
or O
their O
combinations O
, O
we O
found O
that O
ErbB I-GENE
- I-GENE
3 I-GENE
is O
devoid _RARE_
of O
any O
biological O
activity O
but O
both O
ErbB I-GENE
- I-GENE
1 I-GENE
and O
ErbB I-GENE
- I-GENE
2 I-GENE
can O
reconstitute _RARE_
its O
extremely O
potent O
mitogenic O
activity O
. O

ZIOS _RARE_
was O
significantly O
more O
sensitive _RARE_
than O
all O
subsequent O
methods O
, O
and O
Ptc _RARE_
, O
O2 _RARE_
was O
significantly O
more O
sensitive _RARE_
than O
FEV1 O
. O

Selective O
translation O
initiation O
by O
ribosome _RARE_
jumping _RARE_
in O
adenovirus O
- O
infected _RARE_
and O
heat O
- O
shocked _RARE_
cells O
. O

Furthermore O
, O
we O
have O
identified O
a O
43 _RARE_
- O
bp O
region O
of O
the O
24p3 _RARE_
promoter I-GENE
required O
for _RARE_
the O
Dex _RARE_
responsiveness O
. O

These O
findings O
suggest O
that O
direct O
cDNA O
mapping O
using O
fluorescence O
in O
situ O
hybridization O
provides O
an O
accurate O
and O
rapid O
approach O
to O
the O
definition O
of O
a O
transcribed _RARE_
map O
of O
the O
human O
genome O
. O

YAC O
and O
cosmid O
contigs _RARE_
spanning O
the O
Batten _RARE_
disease _RARE_
( O
CLN3 _RARE_
) O
region O
at _RARE_
16p12 _RARE_
. O
1 O
- O
p11 _RARE_
. O
2 O
. O

Isolation O
of O
a O
near O
full O
- O
length O
cDNA O
from O
a O
human O
fetal _RARE_
brain O
cDNA O
library O
revealed O
a O
protein I-GENE
serine I-GENE
- I-GENE
threonine I-GENE
phosphatase I-GENE
with O
a O
tetratricopeptide _RARE_
motif O
, O
almost O
identical O
to O
human I-GENE
PPP5C _RARE_
( O
PP5 _RARE_
) O
and O
highly O
homologous O
to O
rat I-GENE
PPT _RARE_
. O

Ly _RARE_
- I-GENE
49 _RARE_
is O
a O
family I-GENE
type I-GENE
II I-GENE
transmembrane I-GENE
proteins I-GENE
encoded O
by O
a O
gene O
cluster O
on O
murine O
chromosome _RARE_
6 O
. O

The O
Dox _RARE_
- I-GENE
A2 _RARE_
ORF I-GENE
driven _RARE_
by O
the O
TDH3 _RARE_
promoter I-GENE
complemented O
the O
phenotype _RARE_
of O
a O
strain _RARE_
deleted _RARE_
for _RARE_
sun2 _RARE_
. O

The O
introduction O
of O
hARF4 _RARE_
to O
the O
cells O
maintained O
the O
balance O
between O
cytosolic O
and O
membrane O
- O
associated O
Sec7p _RARE_
pools _RARE_
. O

Our O
data O
demonstrate O
directly O
that O
Rpm1r _RARE_
is O
transcribed _RARE_
with O
its O
substrates _RARE_
, O
tRNA I-GENE
met I-GENE
f _RARE_
and O
tRNAPro _RARE_
, O
from O
a O
promoter O
located _RARE_
upstream O
of O
the O
tRNA I-GENE
met I-GENE
f _RARE_
gene I-GENE
and O
suggest O
that O
a O
portion O
also O
originates _RARE_
from O
a O
second O
promoter O
, O
located _RARE_
between O
the O
tRNA I-GENE
met I-GENE
f _RARE_
gene I-GENE
and O
RPM1 _RARE_
. O

Furthermore O
, O
strains O
with O
mutant I-GENE
RPM1 _RARE_
genes I-GENE
also O
accumulate O
precursor I-GENE
Rpm1r _RARE_
, O
suggesting O
that O
mutations O
in O
either O
gene O
can O
lead O
to O
similar O
biogenesis O
defects O
. O

Vacuolar _RARE_
membrane O
vesicles O
from O
hum1 _RARE_
mutants I-GENE
lack O
all O
Ca2 _RARE_
+/ _RARE_
H O
+ O
antiport _RARE_
activity O
, O
demonstrating O
that O
Hum1p _RARE_
catalyzes O
the O
exchange O
of O
Ca2 _RARE_
+ O
for _RARE_
H O
+ O
across O
the O
yeast O
vacuolar O
membrane O
. O

Detailed _RARE_
mutagenesis O
of O
the O
element O
' O
s O
rare O
- O
codon _RARE_
/ O
AU _RARE_
- O
rich O
sequence O
boundary O
revealed O
that O
the O
destabilizing _RARE_
activity O
of O
the O
MATalpha1 _RARE_
IE I-GENE
is O
observed O
when O
the O
terminal O
codon _RARE_
of O
the O
element O
' O
s O
rare O
- O
codon _RARE_
interval O
is O
translated O
. O

FTF _RARE_
is O
also O
abundantly O
expressed _RARE_
in O
the O
pancreas O
and O
may O
exert O
differentiation O
functions O
in O
endodermal _RARE_
sublineages _RARE_
, O
similar O
to O
SF _RARE_
- I-GENE
1 I-GENE
in O
steroidogenic _RARE_
tissues O
. O

Merlie _RARE_
, O
Cold _RARE_
Spring _RARE_
Harbor _RARE_
Symp _RARE_
. O

Substantial _RARE_
evidence O
supports O
a O
critical O
role O
for _RARE_
the O
activation O
of O
the O
Raf I-GENE
- I-GENE
1 I-GENE
/ O
MEK I-GENE
/ O
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
pathway _RARE_
in O
oncogenic _RARE_
Ras I-GENE
- O
mediated _RARE_
transformation O
. O

Stylohyoid _RARE_
chain O
ossification _RARE_
: O
choice O
of O
the O
surgical O
approach O
. O

The O
incidence O
of O
cardiac O
death _RARE_
( O
one O
per O
group O
), _RARE_
Q _RARE_
wave O
MI O
( O
propofol _RARE_
, O
n _RARE_
= O
7 O
; O
midazolam O
, O
n _RARE_
= O
3 O
; O
P O
= O
0 _RARE_
. O
27 _RARE_
), _RARE_
or O
non O
Q _RARE_
wave O
MI O
( O
propofol _RARE_
, O
n _RARE_
= O
16 O
; O
midazolam O
, O
n _RARE_
= O
18 O
; O
P O
= O
0 _RARE_
. O
81 _RARE_
) O
did O
not O
differ O
between O
treatment O
groups O
. O

63 _RARE_
. O
3 O
micromol _RARE_
/ O
1 O
, O
p O
< O
0 _RARE_
. O
01 O
) O
and O
area O
under O
the O
plasma O
concentration O
- O
time O
curve O
extrapolated _RARE_
to O
infinity _RARE_
AUC O
9 O
( O
0 _RARE_
- O
infinity _RARE_
)( O
518 _RARE_
. O
7 O
vs _RARE_
. O

Cluster _RARE_
formation O
of O
E I-GENE
- I-GENE
cadherin _RARE_
on O
the O
cell O
surface O
is O
believed O
to O
be O
of O
major O
importance O
for _RARE_
cell O
- O
cell O
adhesion O
. O

DNA I-GENE
polymerase I-GENE
E I-GENE
, O
DNA I-GENE
ligase I-GENE
III I-GENE
and O
a O
DNA O
structure _RARE_
- O
specific O
endonuclease O
co _RARE_
- O
purify _RARE_
with O
the O
five O
polypeptide O
complex O
. O

By O
using O
reporter O
gene O
constructs O
, O
it O
is O
shown O
that O
upstream O
sequences O
of O
the O
P1 O
promoter O
contain O
several O
regions O
that O
modulate O
the O
expression _RARE_
either O
positively O
or O
negatively O
. O

The O
factor O
structure _RARE_
of O
" O
schizotypal _RARE_
' O
traits _RARE_
: O
a O
large O
replication O
study O
. O

Interestingly O
, O
however O
, O
it O
is O
homologous O
to O
several O
expressed _RARE_
sequence O
tags O
( O
EST _RARE_
) O
of O
unknown O
function O
from O
Caenorhabditis O
elegans O
, O
Oryza _RARE_
sativa _RARE_
and O
Homo _RARE_
sapiens _RARE_
. O

RESULTS O
: O
The O
bilinear _RARE_
model O
provided O
a O
significantly O
better O
fit O
to O
the O
acuity _RARE_
outcome O
data O
. O

Outcome _RARE_
of O
severe O
congenital O
hypothyroidism O
. O

Mean O
increase O
of O
milk O
protein O
yield O
was O
46 _RARE_
g O
/ O
d O
with O
Met _RARE_
plus _RARE_
Lys _RARE_
, O
and O
mean O
increase O
of O
true O
protein O
content O
was O
1 O
. O
1 O
g O
/ O
kg O
of O
milk O
. O

Nonreturn _RARE_
rates O
can O
be O
used O
to O
derive _RARE_
more O
elementary _RARE_
biological O
measures O
for _RARE_
reproductive O
efficiency O
, O
such O
as _RARE_
conception _RARE_
rate O
and O
calving _RARE_
rate O
, O
which O
separately O
might O
be O
more O
reliable O
than O
nonreturn _RARE_
rate O
itself O
to O
evaluate O
the O
fertility O
of O
a O
bull _RARE_
or O
the O
performance O
of O
an O
AI _RARE_
technician _RARE_
. O

However O
, O
if O
EMPD _RARE_
involves O
the O
glans _RARE_
penis _RARE_
or O
perianal _RARE_
area O
, O
a O
search O
for _RARE_
internal O
malignancy O
is O
still O
warranted O
. O

The O
mean O
values O
of O
protease O
activity O
were O
significantly O
higher _RARE_
in O
the O
test O
groups O
than O
in O
the O
control O
group O
at _RARE_
baseline O
. O

Each O
half _RARE_
molecule O
contains O
four O
disulfide O
linkages _RARE_
and O
four O
cis O
peptides O
. O

Only O
fully O
processed O
Pra I-GENE
( O
N0 _RARE_
and O
Nb _RARE_
) O
and O
ICP35 _RARE_
( O
ICP35 _RARE_
e _RARE_
, I-GENE
f _RARE_
) O
are O
present O
in O
B O
capsids _RARE_
, O
which O
are O
believed O
to O
be O
precursors _RARE_
of O
mature _RARE_
virions O
. O

A O
chimeric O
VP16 I-GENE
- O
Tat I-GENE
construct O
containing O
the O
leucine O
mutations O
showed O
no _RARE_
increased O
AP I-GENE
- I-GENE
1 I-GENE
responsiveness O
in O
comparison O
with O
that O
of O
the O
VP16 I-GENE
activation I-GENE
domain I-GENE
alone O
. O

However O
, O
one O
3 O
' O
splice _RARE_
site O
, O
located _RARE_
at _RARE_
nucleotide O
( O
nt O
) O
3225 _RARE_
, O
is O
used O
for _RARE_
the O
processing _RARE_
of O
most O
BPV _RARE_
- O
1 O
pre O
- O
mRNAs O
in O
BPV _RARE_
- O
1 O
- O
transformed O
C127 _RARE_
cells O
and O
at _RARE_
early O
to O
intermediate _RARE_
times O
in O
productively _RARE_
infected _RARE_
warts _RARE_
. O

Here O
, O
the O
cloning O
and O
characterization O
of O
S I-GENE
- I-GENE
RNase I-GENE
genes I-GENE
from O
two O
species O
of O
Rosaceae _RARE_
, O
apple _RARE_
( O
Malus _RARE_
x _RARE_
domestica _RARE_
) O
and O
Japanese O
pear _RARE_
( O
Pyrus _RARE_
serotina _RARE_
) O
is O
described O
and O
these O
sequences O
are O
compared O
with O
those O
of O
other O
T2 _RARE_
- I-GENE
type I-GENE
RNases _RARE_
. O

A O
phylogenetic O
tree _RARE_
of O
members O
of O
the O
T2 _RARE_
/ I-GENE
S I-GENE
- I-GENE
RNase I-GENE
superfamily I-GENE
in O
plants _RARE_
was O
obtained O
. O

In O
a O
Hoosier _RARE_
Oncology _RARE_
Group O
randomized O
study O
involving O
extensive O
- O
disease _RARE_
SCLC _RARE_
patients O
, O
VIP _RARE_
was O
superior O
to O
etoposide _RARE_
/ O
cisplatin O
with O
regard O
to O
median O
time O
to O
progression O
( O
6 O
. O
6 O
v O
5 O
. O
8 O
months O
), _RARE_
median O
survival O
times O
( O
9 O
. O
1 O
v O
7 O
. O
3 O
months O
), _RARE_
and O
2 O
- O
and O
3 O
- O
year O
survival O
rates O
( O
13 _RARE_
% O
v O
5 O
% O
and O
5 O
% O
v O
0 _RARE_
%, O
respectively O
). O

It O
was O
shown O
that O
administration O
of O
immunomodulator _RARE_
neurotropin _RARE_
( O
NSP _RARE_
) O
results O
in O
more O
steady O
consolidation _RARE_
and O
retention O
of O
feeding O
and O
avoidance _RARE_
behavior O
, O
and O
some O
neurophysiological _RARE_
mechanisms O
of O
that O
phenomena O
were O
revealed O
. O

Sestamibi _RARE_
scintigraphy O
, O
performed O
in O
70 O
patients O
, O
was O
less O
sensitive _RARE_
than O
ultrasonography O
( O
80 _RARE_
%). O

Atopic _RARE_
allergy O
and O
other O
hypersensitivities _RARE_
. O

Despite O
significant O
lethality O
and O
cardiovascular O
dysfunction O
, O
in O
the O
septic _RARE_
group O
on O
Days _RARE_
1 O
and O
2 O
, O
septic _RARE_
versus O
control O
animals O
had O
no _RARE_
significant O
differences O
in O
mean O
metabolic O
cart _RARE_
measured O
( O
Vo2DIR _RARE_
, O
ml O
/ O
kg O
/ O
min O
; O
Day O
1 O
: O
11 O
. O
9 O
versus O
12 O
. O
4 O
, O
p O
= O
0 _RARE_
. O
81 _RARE_
; O
Day O
2 O
: O
14 O
. O
2 O
versus O
13 _RARE_
. O
5 O
, O
p O
= O
0 _RARE_
. O
72 O
, O
respectively O
) O
and O
intravascular O
catheter O
calculated O
( O
Vo2INDIR _RARE_
, O
ml O
/ O
kg O
/ O
min O
; O
Day O
1 O
: O
11 O
. O
2 O
versus O
11 O
. O
2 O
, O
p O
= O
0 _RARE_
. O
99 _RARE_
; O
Day O
2 O
: O
12 O
. O
8 O
versus O
15 _RARE_
. O
4 O
, O
p O
= O
0 _RARE_
. O
49 _RARE_
, O
respectively O
). O

After O
6 O
h O
of O
reperfusion O
, O
PO2 O
/ O
FlO2 _RARE_
ratio O
was O
significantly O
better O
after O
Combined O
Therapy _RARE_
( O
372 _RARE_
+/- O
52 O
mm O
Hg O
) O
than O
in O
the O
Recipient _RARE_
Instilled _RARE_
( O
117 O
+/- O
47 _RARE_
mm O
Hg O
) O
and O
Control O
groups O
( O
87 O
+/- O
26 _RARE_
mm O
Hg O
), _RARE_
with O
intermediate _RARE_
values O
in O
Donor _RARE_
Aerosol _RARE_
dogs O
( O
232 _RARE_
+/- O
64 _RARE_
mm O
Hg O
). O

The O
euglobulin _RARE_
clot _RARE_
lysis O
time O
was O
slightly O
longer O
in O
the O
smokers O
than O
in O
the O
non O
- O
smokers O
in O
all O
three O
experimental O
situations O
, O
but O
the O
differences O
were O
not O
significant O
. O

HS _RARE_
inducibility O
required O
the O
HSE O
which O
was O
bound _RARE_
by O
HS _RARE_
transcription I-GENE
factor I-GENE
- I-GENE
1 I-GENE
( O
HSF I-GENE
- I-GENE
1 I-GENE
) O
present O
in O
extracts O
prepared O
from O
cells O
exposed O
to O
HS _RARE_
. O

Although O
the O
DSK2 _RARE_
- I-GENE
1 I-GENE
mutation I-GENE
alters O
a O
conserved _RARE_
residue _RARE_
in O
the O
Dsk2p _RARE_
ubiquitin I-GENE
- I-GENE
like I-GENE
domain I-GENE
, O
we O
detect O
no _RARE_
differences O
in O
Dsk2p _RARE_
or O
Cdc31p _RARE_
stability O
. O

Although O
IL _RARE_
- I-GENE
2 I-GENE
and O
IFN I-GENE
- I-GENE
alpha I-GENE
activated O
STAT1 I-GENE
alpha I-GENE
and O
STAT5 I-GENE
, O
IL _RARE_
- I-GENE
2 I-GENE
predominantly O
activated O
STAT5 I-GENE
, O
while O
IFN I-GENE
- I-GENE
alpha I-GENE
predominantly O
activated O
STAT1 I-GENE
alpha I-GENE
. O

Consistent O
with O
this O
interpretation O
, O
recombinant I-GENE
CREB I-GENE
and O
activating I-GENE
transcription I-GENE
factor I-GENE
proteins I-GENE
bound _RARE_
the O
junB I-GENE
CRE _RARE_
- O
like O
site O
, O
but O
did O
not O
interact O
with O
a O
mutant O
CRE _RARE_
- O
like O
site O
. O

Collectively O
, O
these O
results O
suggest O
that O
components _RARE_
of O
the O
protein I-GENE
kinase I-GENE
A I-GENE
signaling _RARE_
pathway _RARE_
are O
recruited O
by O
mIg _RARE_
to O
induce O
junB I-GENE
transcription O
. O

One O
complex O
containing O
a O
70 O
D O
protein O
was O
found O
to O
be O
associated O
specifically O
with O
transcriptionally O
active _RARE_
leukemia O
cells O
. O

Our O
results O
confirm O
the O
participation O
of O
intron O
1 O
in O
transcriptional O
regulation _RARE_
of O
the O
c I-GENE
- I-GENE
myb I-GENE
gene I-GENE
( O
in O
mouse O
and O
human O
) O
and O
implicate _RARE_
multiple O
and O
complex O
regulatory O
mechanisms O
of O
activation O
during _RARE_
myelomonocytic _RARE_
differentiation O
and O
leukemic _RARE_
cell O
growth O
control O
. O

Immunofluorescence _RARE_
microscopy O
revealed O
extensive O
deposition O
of O
such O
extracellular O
matrices _RARE_
as _RARE_
type I-GENE
IV I-GENE
collagen _RARE_
and O
laminin _RARE_
in O
the O
vascular O
wall _RARE_
. O

OBJECTIVE O
: O
To O
compare O
pregnancy _RARE_
complications O
in O
women O
having O
genetic O
amniocentesis _RARE_
at _RARE_
11 O
- O
14 O
weeks O
versus O
those O
undergoing O
amniocentesis _RARE_
at _RARE_
16 O
- O
19 O
weeks O
' O
gestation O
. O

Three O
ORFs _RARE_
( O
9765orfR002 _RARE_
, O
9765orfR011 _RARE_
and O
9765orfR013 _RARE_
) O
were O
found O
to O
be O
homologous O
with O
Schizosaccharomyces O
pombe O
polyadenylate _RARE_
binding I-GENE
protein I-GENE
, O
Escherichia O
coli O
hypothetical _RARE_
38 O
. O
1 O
- O
kDa O
protein O
in O
the O
BCR _RARE_
5 O
' O
region O
, O
and O
transcription O
regulatory O
protein O
Swi3 _RARE_
, O
respectively O
. O

Two O
new O
flavone _RARE_
glucosides _RARE_
, O
nevadensin _RARE_
5 O
- O
O O
- O
beta O
- O
D O
- O
glucoside _RARE_
and O
nevadensin _RARE_
5 O
- O
O O
- O
beta O
- O
D O
- O
glucosyl _RARE_
( O
1 O
--> _RARE_
6 O
) O
beta O
- O
D O
- O
glucoside _RARE_
, O
have O
been O
isolated O
from O
the O
aerial _RARE_
parts O
of O
Lysionotus _RARE_
pauciflorus _RARE_
. O

Recently O
, O
our O
laboratory O
developed O
a O
screen O
that O
identified O
five O
multicopy O
suppressors O
that O
can O
rescue O
lethal O
strains O
of O
clathrin I-GENE
heavy O
chain O
- O
deficient _RARE_
yeast O
( O
Chc _RARE_
- O
scd1 _RARE_
- I-GENE
i I-GENE
) O
to O
viability O
. O

Reproductive _RARE_
period O
affects O
water O
intake O
in O
heat O
- O
stressed O
dehydrated _RARE_
goats O
. O

The O
logistic _RARE_
regression O
analysis O
of O
the O
manual _RARE_
method O
( O
percentage O
normal O
morphology O
) O
and O
IVOS _RARE_
indicated O
that O
both O
were O
predictors O
of O
fertilization O
. O

METHODS O
: O
Rats _RARE_
received O
continuous O
intragastric _RARE_
infusion O
of O
elemental _RARE_
diet O
or O
with O
supplementation O
of O
oatbase _RARE_
, O
Lactobacillus _RARE_
reuteri _RARE_
R2LC _RARE_
, O
and O
Lactobacillus _RARE_
plantarum _RARE_
DSM _RARE_
9843 _RARE_
, O
with O
and O
without O
fermentation _RARE_
, O
from O
the O
beginning O
of O
the O
study O
. O

However O
, O
D8 _RARE_
binding O
was O
observed O
by O
nuclease _RARE_
protection O
with O
lactotroph _RARE_
- I-GENE
as _RARE_
well _RARE_
as _RARE_
somatotroph _RARE_
- I-GENE
like I-GENE
cell I-GENE
nuclear I-GENE
protein I-GENE
. O

Limited _RARE_
role O
for _RARE_
PCR O
- O
based O
diagnosis O
of O
Whipple _RARE_
' O
s O
disease _RARE_
from O
peripheral O
blood _RARE_
mononuclear O
cells O
. O

The O
ability O
of O
A20 _RARE_
to O
block _RARE_
NF _RARE_
- I-GENE
kappaB I-GENE
activation O
was O
mapped O
to O
its O
C O
- O
terminal O
zinc O
finger O
domain O
. O

The O
Pro _RARE_
- O
258 O
--> _RARE_
Leu _RARE_
( O
P258L _RARE_
) O
mutation O
caused O
constitutive _RARE_
receptor O
signaling _RARE_
that O
was O
equivalent O
to O
about O
45 _RARE_
% O
of O
the O
maximum O
level O
observed O
in O
wild O
- O
type O
cells O
stimulated _RARE_
with O
alpha I-GENE
- I-GENE
factor I-GENE
. O

By O
using O
a O
DNA O
sequence O
selected _RARE_
for _RARE_
its O
ability O
to O
bind O
recombinant I-GENE
BCL _RARE_
- I-GENE
6 I-GENE
in O
vitro O
, O
we O
show O
here O
that O
BCL _RARE_
- I-GENE
6 I-GENE
is O
present O
in O
DNA O
- O
binding O
complexes O
in O
nuclear O
extracts O
from O
various O
B O
- O
cell O
lines O
. O

The O
predictive O
value O
of O
a O
positive O
flag _RARE_
was O
77 O
. O
7 O
%. O

CONCLUSIONS O
: O
Our O
findings O
suggest O
that O
pre O
- O
treatment O
with O
coenzyme _RARE_
Q10 _RARE_
may O
play O
a O
protective O
role O
during _RARE_
routine O
vascular O
procedures O
requiring O
abdominal O
aortic O
cross O
clamping _RARE_
by O
attenuating _RARE_
the O
degree O
of O
peroxidative _RARE_
damage O
. O

Because O
chromosome _RARE_
X O
is O
frequently O
involved O
in O
structural O
alterations O
in O
neoplastic O
Syrian _RARE_
hamster O
cells O
transformed O
by O
chemical O
carcinogens _RARE_
and O
oncogenic _RARE_
viruses O
, O
the O
localization _RARE_
of O
the O
cph _RARE_
locus I-GENE
on O
this O
chromosome _RARE_
supports O
the O
notion O
that O
the O
cph _RARE_
oncogene I-GENE
plays O
a O
role O
in O
the O
malignant O
conversion O
of O
chemically _RARE_
transformed O
hamster O
fibroblasts _RARE_
. O

In O
a O
screen O
for _RARE_
genes O
with O
oncogenic _RARE_
potential _RARE_
expressed _RARE_
by O
the O
murine O
B6SUtA1 _RARE_
myeloid _RARE_
progenitor _RARE_
cell O
line O
, O
we O
isolated O
a O
2 O
. O

Gap1 _RARE_
( O
IP4BP _RARE_
), _RARE_
one O
of O
a O
member _RARE_
of O
Ras I-GENE
GTPase I-GENE
- I-GENE
activating I-GENE
proteins I-GENE
, O
has O
been O
identified O
as _RARE_
a O
specific O
inositol _RARE_
1 I-GENE
, I-GENE
3 I-GENE
, I-GENE
4 I-GENE
, I-GENE
5 I-GENE
- I-GENE
tetrakisphosphate _RARE_
( I-GENE
IP4 _RARE_
)- I-GENE
binding I-GENE
protein I-GENE
( O
Cullen _RARE_
, O
P O
. O

We O
previously O
described O
the O
purification O
of O
an O
83 _RARE_
- I-GENE
kDa I-GENE
phosphatidic _RARE_
acid I-GENE
phosphatase I-GENE
( O
PAP _RARE_
) O
from O
the O
porcine _RARE_
thymus _RARE_
membranes O
( O
Kanoh _RARE_
, O
H O
., O
Imai _RARE_
, O
S O
.- _RARE_
i O
., O
Yamada _RARE_
, O
K O
. O
and O
Sakane _RARE_
, O
F O
.( O
1992 O
) O
J _RARE_
. O

The O
mechanism O
involves O
Gbetagamma I-GENE
subunit O
- O
mediated _RARE_
increases O
in O
tyrosine O
phosphorylation _RARE_
of O
the O
Shc I-GENE
adapter _RARE_
protein I-GENE
, O
Shc I-GENE
* _RARE_
Grb2 I-GENE
complex O
formation O
, O
and O
recruitment O
of O
Ras I-GENE
guanine I-GENE
nucleotide I-GENE
exchange I-GENE
factor I-GENE
activity O
. O

A O
cDNA O
encoding O
the O
amino O
- O
terminal O
17 _RARE_
% O
of O
apoB _RARE_
( O
apoB17 _RARE_
) O
was O
fused O
to O
a O
cDNA O
coding O
for _RARE_
the O
last O
37 O
amino O
acids _RARE_
of O
decay _RARE_
- I-GENE
accelerating _RARE_
factor I-GENE
( O
DAF _RARE_
), _RARE_
which O
contains O
the O
signal O
for _RARE_
glycosylphosphatidylinositol _RARE_
anchor _RARE_
attachment _RARE_
. O

Next _RARE_
, O
we O
stably O
overexpressed O
wild I-GENE
- I-GENE
type I-GENE
Shc I-GENE
or O
Y317F _RARE_
mutant I-GENE
Shc I-GENE
into O
HIRc _RARE_
cells O
. O

The O
small I-GENE
GTPase I-GENE
Rho I-GENE
is O
implicated O
in O
physiological O
functions O
associated O
with O
actin I-GENE
- O
myosin I-GENE
filaments _RARE_
such O
as _RARE_
cytokinesis _RARE_
, O
cell O
motility _RARE_
, O
and O
smooth _RARE_
muscle O
contraction O
. O

Conversely O
, O
activation O
of O
this O
signaling _RARE_
pathway _RARE_
by O
expression _RARE_
of O
a O
constitutively O
active _RARE_
MKK1 _RARE_
mutant I-GENE
dramatically O
increased O
cyclin _RARE_
D1 _RARE_
promoter O
activity O
and O
cyclin _RARE_
D1 _RARE_
protein I-GENE
expression _RARE_
, O
in O
a O
growth O
factor O
- O
independent O
manner O
. O

Furthermore O
, O
upstream O
insertion _RARE_
of O
the O
GSTP1 _RARE_
silencer _RARE_
element I-GENE
failed O
to O
inhibit O
activity O
of O
a O
heterologous O
promoter O
in O
MCF7 _RARE_
cells O
. O

In O
order O
to O
delineate _RARE_
structural O
motifs O
regulating _RARE_
substrate O
affinity O
and O
recognition O
for _RARE_
the O
human I-GENE
dopamine I-GENE
transporter _RARE_
( O
DAT _RARE_
), _RARE_
we O
assessed O
[ _RARE_
3H O
] O
dopamine O
uptake O
kinetics O
and O
[ _RARE_
3H O
] O
CFT _RARE_
binding O
characteristics O
of O
COS O
- O
7 O
cells O
transiently O
expressing O
mutant I-GENE
DATs _RARE_
in O
which O
the O
COOH _RARE_
terminus O
was O
truncated O
or O
substituted O
. O

An O
expression _RARE_
library O
was O
constructed O
by O
inserting O
5 O
' O
portion O
- O
enriched _RARE_
cDNAs O
from O
phytohemagglutinin I-GENE
- O
stimulated _RARE_
peripheral O
blood _RARE_
mononuclear O
cells O
into O
upstream O
of O
signal I-GENE
sequence I-GENE
- I-GENE
deleted _RARE_
CD4 _RARE_
cDNA I-GENE
in O
an O
Epstein O
- O
Barr O
virus O
shuttle _RARE_
vector O
. O

Radiolabeled _RARE_
recombinant I-GENE
TARC _RARE_
specifically O
bound _RARE_
to O
T O
cell O
lines O
and O
peripheral O
T O
cells O
but O
not O
to O
monocytes O
or O
granulocytes _RARE_
. O

The O
cis O
- O
acting O
elements O
that O
control O
promoter O
activity O
include O
binding O
sites O
for _RARE_
transcription O
factors O
Sp1 _RARE_
and O
alphaCbf _RARE_
, O
a O
60 _RARE_
- I-GENE
kDa I-GENE
CCAAT I-GENE
box I-GENE
- I-GENE
binding I-GENE
protein I-GENE
. O

Therefore O
, O
we O
have O
identified O
a O
cis O
- O
acting O
element O
, O
the O
E1 O
E O
- O
box O
, O
located _RARE_
in O
the O
GAP _RARE_
- I-GENE
43 _RARE_
promoter O
region O
that O
modulates _RARE_
either O
positively O
or O
negatively O
the O
expression _RARE_
of O
the O
GAP _RARE_
- I-GENE
43 _RARE_
gene I-GENE
depending O
on O
which O
E I-GENE
- I-GENE
box I-GENE
- I-GENE
binding I-GENE
proteins I-GENE
occupy _RARE_
this O
site O
. O

Collectively O
, O
our O
findings O
demonstrate O
that O
SF _RARE_
- I-GENE
1 I-GENE
plays O
a O
key O
role O
in O
controlling O
the O
basal O
and O
cAMP O
- O
stimulated _RARE_
expression _RARE_
of O
the O
StAR _RARE_
gene I-GENE
. O

There O
was O
a O
general _RARE_
broadening _RARE_
of O
proton _RARE_
resonances _RARE_
for _RARE_
a O
three O
- O
nucleotide O
segment O
centered O
about O
the O
lesion O
site O
which O
resulted O
in O
a O
tentative _RARE_
assignment O
for _RARE_
the O
sugar _RARE_
protons _RARE_
of O
the O
C7 _RARE_
residue _RARE_
in O
the O
spectrum O
of O
the O
adduct _RARE_
duplex O
. O

Using O
one O
of O
the O
six _RARE_
fragments O
( O
CPK3 _RARE_
- I-GENE
8 I-GENE
), _RARE_
we O
isolated O
a O
2022 _RARE_
bp I-GENE
cDNA I-GENE
( I-GENE
VrCDPK _RARE_
- I-GENE
1 I-GENE
) I-GENE
from O
a O
Vigna _RARE_
radiata _RARE_
lambda O
gt11 O
library O
. O

However O
, O
in O
TF _RARE_
- O
1 O
cells O
grown O
on O
GM _RARE_
- I-GENE
CSF I-GENE
before O
starvation O
, O
CREB I-GENE
phosphorylation _RARE_
was O
observed O
10 O
minutes O
after O
PIXY321 _RARE_
stimulation _RARE_
. O

Workplace _RARE_
violence _RARE_
-- _RARE_
nurses _RARE_
at _RARE_
risk O
. O

RESULTS O
: O
The O
LV O
maximum O
brightness _RARE_
and O
area O
under O
the O
curve O
showed O
significant O
negative O
correlations O
( O
p O
= O
< O
0 _RARE_
. O
004 _RARE_
) O
with O
the O
FIO2 _RARE_
, O
while O
the O
minimum O
brightness _RARE_
showed O
a O
significant O
positive O
correlation O
( O
p O
= O
< O
0 _RARE_
. O
002 _RARE_
). O

The O
results O
also O
imply O
that O
the O
absence O
of O
perforin _RARE_
expression _RARE_
in O
non O
- O
cytotoxic O
cells O
may O
be O
due O
to O
the O
suppression O
of O
the O
induction O
of O
the O
killer O
- O
cell O
- O
specific O
trans _RARE_
- O
acting O
factor O
NF _RARE_
- I-GENE
P2 I-GENE
. O

We O
identify O
considerable O
spatio _RARE_
- O
temporal O
similarities O
between O
reported O
expression _RARE_
patterns O
of O
Ypr10 _RARE_
genes I-GENE
and O
ribonuclease _RARE_
genes O
, O
which O
, O
together O
with O
the O
significant O
sequence O
similarity _RARE_
to O
the O
ginseng _RARE_
ribonuclease _RARE_
, O
support O
the O
hypothesis O
of O
a O
ribonuclease _RARE_
function O
for _RARE_
PR I-GENE
- I-GENE
10 I-GENE
proteins I-GENE
and O
allow O
the O
prediction O
of O
possible O
biological O
roles O
. O

The O
expression _RARE_
of O
ERV3 _RARE_
env I-GENE
mRNA I-GENE
was O
found O
to O
be O
differentiation O
- O
associated O
, O
with O
high O
expression _RARE_
detected O
in O
the O
late _RARE_
stages O
of O
monocytic O
development O
. O

Initial O
estimates O
indicate O
that O
27 _RARE_
, O
193 O
people O
are O
either O
in O
receipt _RARE_
of O
or O
in O
need O
of O
mental O
handicap _RARE_
services _RARE_
. O

It O
is O
exclusively O
observed O
in O
smooth _RARE_
muscle O
cells O
by O
Northern O
blotting O
and O
immunohistochemical O
analysis O
and O
therefore O
designated O
" I-GENE
smoothelin _RARE_
." _RARE_
A O
human O
smooth _RARE_
muscle O
cDNA O
library O
was O
screened O
with O
the O
monoclonal I-GENE
antibody I-GENE
R4A _RARE_
, O
and O
a O
full O
- O
size O
cDNA O
of O
the O
protein O
was O
selected _RARE_
. O

Using O
immunogold _RARE_
electron O
microscopy O
, O
we O
found O
that O
p58 _RARE_
/ O
p45 _RARE_
and O
p54 I-GENE
are O
localized O
on O
both O
sides O
of O
the O
nuclear O
pore _RARE_
complex O
, O
like O
p62 I-GENE
. O

Concurrent _RARE_
with O
ligand _RARE_
- O
dependent O
uptake O
, O
we O
now O
show O
that O
the O
receptor O
undergoes O
ligand _RARE_
- O
induced _RARE_
ubiquitination O
, O
suggesting O
that O
receptor O
ubiquitination O
may O
function O
in O
the O
ligand _RARE_
- O
dependent O
endocytosis _RARE_
of O
the O
a I-GENE
- I-GENE
factor I-GENE
receptor I-GENE
as _RARE_
well _RARE_
as _RARE_
in O
its O
constitutive _RARE_
endocytosis _RARE_
. O

Transcription O
initiation O
sites O
of O
the O
rat O
II I-GENE
beta I-GENE
-, _RARE_
III I-GENE
beta I-GENE
, I-GENE
and I-GENE
O I-GENE
beta I-GENE
- I-GENE
globin I-GENE
genes O
were O
determined O
to O
be O
52 O
base _RARE_
pairs _RARE_
( O
bp O
) O
5 O
'- O
upstream O
of O
the O
translation O
initiation O
codon _RARE_
( O
ATG O
), _RARE_
in O
each O
gene O
by O
primer O
extension O
analysis O
. O

Aggravating _RARE_
process O
induced _RARE_
by O
indomethacin O
on O
chronic O
gastric _RARE_
lesion O
in O
rat O
. O

Epstein I-GENE
- I-GENE
Barr I-GENE
virus I-GENE
nuclear I-GENE
protein I-GENE
2 I-GENE
( O
EBNA2 I-GENE
) O
binds O
to O
a O
component _RARE_
of O
the O
human O
SNF _RARE_
- O
SWI _RARE_
complex O
, O
hSNF5 _RARE_
/ O
Ini1 _RARE_
. O

Our O
studies O
also O
excluded O
the O
possibility O
that O
the O
phosphorylation _RARE_
of O
Ser _RARE_
- O
2 O
, O
Ser _RARE_
- O
123 O
, O
or O
Ser _RARE_
- O
210 O
, O
had O
roles O
in O
the O
trans _RARE_
- O
suppression O
activity O
of O
the O
large I-GENE
HDAg _RARE_
, O
in O
the O
assembly O
of O
empty _RARE_
virus I-GENE
- I-GENE
like I-GENE
HDAg _RARE_
particle _RARE_
, O
and O
in O
the O
nuclear O
transport _RARE_
of O
HDAgs _RARE_
. O

Homologous _RARE_
recombination _RARE_
between O
the O
Autographa _RARE_
californica _RARE_
nuclear O
polyhedrosis _RARE_
virus O
( O
AcNPV _RARE_
) O
genome O
and O
a O
0 _RARE_
. O
6 O
- O
kbp _RARE_
- O
long O
DNA O
fragment O
derived O
from O
the O
putative O
DNA I-GENE
helicase _RARE_
gene I-GENE
of I-GENE
Bombyx _RARE_
mori _RARE_
nuclear I-GENE
polyhedrosis _RARE_
virus I-GENE
generates O
eh2 _RARE_
- O
AcNPV _RARE_
, O
an O
expanded _RARE_
- O
host _RARE_
- O
range O
AcNPV _RARE_
mutant O
( O
S O
. O

The O
data O
further O
indicate O
that O
the O
IL _RARE_
- I-GENE
7R _RARE_
alpha I-GENE
chains I-GENE
are O
directly O
involved O
in O
the O
activation O
of O
JAKs _RARE_
and O
STATs _RARE_
and O
have O
a O
major O
role O
in O
proliferative O
signaling _RARE_
in O
precursor O
B O
cells O
. O

Furthermore O
, O
the O
potency O
of O
Dacarbacine _RARE_
in O
the O
treatment O
of O
carcinoid _RARE_
tumors O
seems O
to O
be O
underestimated _RARE_
up _RARE_
to O
now O
. O

5 O
) O
We O
' O
ve _RARE_
noticed _RARE_
that O
the O
mean O
value O
of O
the O
cost O
for _RARE_
episode _RARE_
of O
pnx _RARE_
s O
. O
in O
class O
A O
was O
more O
than O
15 _RARE_
% O
compared O
to O
class O
B O
and O
the O
cost O
for _RARE_
patient O
in O
class O
A O
was O
nearly O
double O
than O
in O
class O
B O
. O

We O
have O
been O
studying O
the O
interaction O
of O
the O
oncogenic _RARE_
human O
polyomavirus _RARE_
BK _RARE_
( O
BKV _RARE_
) O
with O
the O
tumor I-GENE
- I-GENE
suppressor I-GENE
protein I-GENE
p53 I-GENE
to O
understand O
the O
biology _RARE_
of O
this O
virus O
as _RARE_
well _RARE_
as _RARE_
to O
understand O
the O
basic O
mechanisms O
of O
p53 I-GENE
transactivation _RARE_
. O

Site _RARE_
S O
- O
II O
also O
spans O
a O
23 _RARE_
bp O
sequence O
containing O
two O
tandem _RARE_
consensus O
binding O
sites O
with O
three O
base _RARE_
pair _RARE_
mismatches _RARE_
in O
each O
and O
a O
one O
base _RARE_
pair _RARE_
deletion O
. O

Cbl I-GENE
constitutively O
interacts O
with O
the O
SH3 I-GENE
domains I-GENE
of O
Grb2 I-GENE
, O
with O
a O
preference O
for _RARE_
the O
amino O
- O
terminal O
domain O
, O
and O
is O
in O
this O
way O
recruited O
to O
Shc I-GENE
upon O
BCR _RARE_
stimulation _RARE_
. O

Activation O
mediated _RARE_
by O
Cat8p _RARE_
was O
no _RARE_
longer O
detectable O
in O
a O
cat1 _RARE_
mutant I-GENE
. O

Treatment O
is O
instituted _RARE_
with O
prednisone O
and O
cyclophosphamide O
. O

Unaided _RARE_
attempts O
to O
quit _RARE_
smoking O
are O
generally O
unsuccessful _RARE_
. O

Laboratory O
evaluation O
was O
normal O
, O
and O
neuroimaging _RARE_
failed O
to O
confirm O
obstruction O
of O
venous O
or O
lymphatic _RARE_
drainage O
. O

Microcomputer _RARE_
management O
of O
chronic O
hepatitis O
B O
virus O
asymptomatic O
patients O

While O
fusion O
to O
the O
N O
- O
terminus O
required O
a O
linker _RARE_
to O
become O
surface O
accessible _RARE_
, O
both O
fusion O
to O
the O
N O
- O
terminus O
and O
to O
the O
C O
- O
terminus O
was O
compatible O
with O
particle _RARE_
assembly O
and O
preserved _RARE_
the O
native _RARE_
antigenicity _RARE_
and O
immunogenicity _RARE_
of O
HBcAg _RARE_
. O

The O
standard O
dosage O
of O
anti I-GENE
- I-GENE
D I-GENE
currently O
given O
at _RARE_
all O
gestational O
ages O
is O
1 O
ampoule _RARE_
containing O
125 _RARE_
micrograms O
of O
anti I-GENE
- I-GENE
D I-GENE
. O

We O
report O
here O
the O
molecular _RARE_
cloning O
of O
a O
putative O
adhesive O
molecule O
from O
P O
. O
falciparum O
that O
shares O
both O
sequence O
and O
structural O
similarities O
with O
a O
sporozoite _RARE_
surface O
molecule O
from O
Plasmodium _RARE_
termed O
the O
thrombospondin _RARE_
- I-GENE
related I-GENE
anonymous _RARE_
protein I-GENE
( O
TRAP _RARE_
) O
and O
, O
to O
a O
lesser O
extent O
, O
with O
the O
circumsporozoite _RARE_
( I-GENE
CS _RARE_
) I-GENE
protein I-GENE
. O

There O
are O
no _RARE_
introns _RARE_
within O
the O
gene O
, O
which O
contains O
a O
9360 _RARE_
- O
bp O
open _RARE_
reading O
frame O
and O
encodes O
a O
377 _RARE_
- O
kDa O
protein O
. O

METHODS O
: O
DSF _RARE_
was O
instilled _RARE_
in O
one O
eye O
chosen O
at _RARE_
random O
and O
CF _RARE_
in O
the O
fellow _RARE_
eye O
of O
13 _RARE_
normal O
subjects O
and O
in O
13 _RARE_
patients O
with O
KCS _RARE_
. O

The O
experience O
of O
the O
lateral O
rhinotomy _RARE_
approach O
in O
transsphenoidal _RARE_
surgery O
of O
acromegaly _RARE_
has O
been O
favourable O
. O

CONCLUSION O
: O
The O
results O
demonstrate O
that O
at _RARE_
the O
site O
of O
lumbar O
disc O
herniation _RARE_
, O
inflammatory O
cytokines _RARE_
such O
as _RARE_
interleukin I-GENE
- I-GENE
1 I-GENE
alpha I-GENE
are O
produced O
, O
which O
increases O
prostaglandin _RARE_
E2 O
production O
. O

The O
predominant O
sensitizing _RARE_
allergens O
in O
Swedish _RARE_
asthmatic O
children O
are O
furred _RARE_
pet _RARE_
animals O
. O

Our O
results O
demonstrate O
that O
distinct O
cytoplasmic O
domains O
of O
these O
cytokine _RARE_
receptors O
elicit O
convergent _RARE_
signaling _RARE_
pathways O
and O
provide O
evidence O
that O
beta I-GENE
c I-GENE
and O
IL _RARE_
- I-GENE
2R I-GENE
beta I-GENE
function O
as _RARE_
a O
complete _RARE_
signal O
transducer _RARE_
. O

In O
addition O
, O
they O
display O
common O
features O
that O
make O
them O
strikingly O
related O
to O
snoRNA _RARE_
U14 I-GENE
. O

U24 _RARE_
has O
two O
separate O
12 O
nt O
long O
complementarities _RARE_
to O
a O
highly O
conserved _RARE_
tract _RARE_
of O
28S I-GENE
rRNA I-GENE
. O

This O
complex O
interacts O
at _RARE_
the O
GTPase I-GENE
domain I-GENE
in O
the O
large O
subunit O
rRNA O
, O
overlapping O
the O
binding O
site O
of O
the O
protein I-GENE
L11 _RARE_
- I-GENE
like I-GENE
eukaryotic I-GENE
counterpart _RARE_
( O
Saccharomyces I-GENE
cerevisiae I-GENE
protein I-GENE
L15 _RARE_
and O
mammalian I-GENE
protein I-GENE
L12 _RARE_
). O

Chromatin _RARE_
repression O
of O
these O
replacement _RARE_
genes O
would O
be O
avoided _RARE_
, O
consistent O
with O
the O
high O
, O
constitutive _RARE_
expression _RARE_
of O
replacement _RARE_
H3 _RARE_
histone I-GENE
genes I-GENE
in O
plants _RARE_
. O

This O
transition O
is O
regulated O
positively O
by O
G1 I-GENE
- I-GENE
specific I-GENE
cyclin _RARE_
- I-GENE
dependent I-GENE
kinases I-GENE
( O
cdks _RARE_
) O
and O
negatively O
by O
the O
product O
of O
the O
retinoblastoma _RARE_
tumour _RARE_
suppressor I-GENE
gene I-GENE
, O
pRb I-GENE
. O

Possible _RARE_
relationship O
between O
hyperinsulinemia _RARE_
and O
glomerular O
hypertrophy O
in O
nephrosclerosis _RARE_
. O

Blood _RARE_
GSH _RARE_
- I-GENE
Px _RARE_
activity O
was O
measured O
with O
a O
spectrophotometer _RARE_
, O
using O
a O
modification O
of O
a O
previously O
described O
assay O
. O

The O
concentrations O
of O
vitamin O
A O
precursors _RARE_
and O
vitamin O
E O
in O
the O
hay _RARE_
were O
below O
currently O
recommended O
dietary O
levels O
for _RARE_
llamas _RARE_
, O
and O
alfalfa _RARE_
hay _RARE_
appears O
to O
provide O
an O
unreliable _RARE_
source O
of O
vitamins _RARE_
A O
and O
E O
in O
this O
species O
. O

Eight O
cats O
infected _RARE_
with O
H O
. O
pylori _RARE_
were O
used O
in O
the O
study O
. O

However O
, O
as _RARE_
determined O
by O
PCR O
with O
primers O
specific O
for _RARE_
the O
26 _RARE_
- O
kDa O
product O
, O
the O
majority O
of O
cats O
at _RARE_
2 O
and O
4 O
weeks O
p O
. O
t O
. O
had O
gastric _RARE_
fluid _RARE_
samples O
which O
were O
positive O
for _RARE_
H O
. O
pylori _RARE_
and O
three O
of O
three O
cats O
at _RARE_
2 O
weeks O
p O
. O
t O
. O
had O
dental O
plaque O
which O
was O
positive O
for _RARE_
H O
. O
pylori _RARE_
. O

To O
derive _RARE_
quantitative O
concentration O
changes O
from O
measurements O
of O
light O
attenuation _RARE_
, O
the O
optical O
path _RARE_
length O
must O
be O
known O
. O

STUDY _RARE_
DESIGN O
. O

Following O
the O
injection O
of O
PGF2 O
alpha O
, O
heifers O
were O
observed O
visually _RARE_
for _RARE_
signs O
of O
estrus _RARE_
at _RARE_
0730 _RARE_
and O
1630 _RARE_
( O
45 _RARE_
min O
each O
). O

Differential O
activation O
of O
the O
extracellular I-GENE
signal I-GENE
- I-GENE
regulated I-GENE
kinase I-GENE
, O
Jun I-GENE
kinase I-GENE
and O
Janus I-GENE
kinase I-GENE
- O
Stat I-GENE
pathways O
by O
oncostatin _RARE_
M I-GENE
and O
basic I-GENE
fibroblast I-GENE
growth I-GENE
factor I-GENE
in O
AIDS O
- O
derived O
Kaposi O
' O
s O
sarcoma O
cells O
. O

There O
is O
general _RARE_
agreement O
that O
the O
hepatitis O
C O
virus O
is O
efficiently O
transmitted O
parenterally _RARE_
, O
while O
data O
on O
viral O
transmission _RARE_
from O
mothers O
to O
babies O
or O
by O
sexual O
or O
non O
- O
sexual O
household _RARE_
contact _RARE_
are O
conflicting _RARE_
. O

Ten O
weeks O
after O
reconstruction O
, O
the O
regenerating _RARE_
nerves O
already O
resembled _RARE_
normal O
nerves O
. O

The O
distribution O
and O
organization O
of O
projections O
from O
the O
spinal _RARE_
cervical O
enlargement O
to O
subnucleus _RARE_
reticularis _RARE_
dorsalis _RARE_
( O
SRD _RARE_
) O
and O
the O
neighbouring _RARE_
Cuneate _RARE_
nucleus O
( O
Cu _RARE_
) O
area O
was O
studied O
in O
the O
rat O
by O
using O
microinjections _RARE_
of O
Phaseolus _RARE_
vulgaris _RARE_
leucoagglutinin _RARE_
( O
PHA _RARE_
- I-GENE
L I-GENE
) O
into O
different O
laminae _RARE_
around O
the O
C7 _RARE_
level O
. O

The O
levels O
of O
fibrinogen I-GENE
as _RARE_
well _RARE_
as _RARE_
antithrombin I-GENE
III I-GENE
( O
ATIII _RARE_
) O
and O
heparin _RARE_
cofactor I-GENE
II I-GENE
( O
HCII _RARE_
) O
activities O
were O
steadily _RARE_
increased O
in O
loop O
- O
bearing _RARE_
animals O
. O

Amplification _RARE_
and O
overexpression O
of O
the O
c I-GENE
- I-GENE
erbB I-GENE
- I-GENE
2 I-GENE
gene I-GENE
in O
21MT _RARE_
- O
2 O
and O
21MT _RARE_
- O
1 O
human O
breast O
carcinoma O
cells O
results O
in O
progressively _RARE_
elevated O
levels O
of O
constitutively O
tyrosine I-GENE
- I-GENE
phosphorylated _RARE_
p185erbB _RARE_
- I-GENE
2 I-GENE
and O
is O
associated O
with O
progressive O
insulin I-GENE
- I-GENE
like I-GENE
growth I-GENE
factor I-GENE
( O
IGF I-GENE
) O
and O
combined O
IGF I-GENE
/ O
epidermal _RARE_
growth I-GENE
factor I-GENE
( O
EGF _RARE_
) O
independence _RARE_
in O
culture O
. O

Facioscapulohumeral _RARE_
muscular O
dystrophy _RARE_
( O
FSHD _RARE_
) O
is O
an O
autosomal _RARE_
dominant O
, O
neuromuscular O
disorder O
characterized O
by O
progressive O
weakness _RARE_
of O
muscles O
in O
the O
face O
, O
shoulder _RARE_
and O
upper O
arm _RARE_
. O

The O
mature _RARE_
chromosome _RARE_
4 O
FRG1 _RARE_
transcript I-GENE
is O
1042 _RARE_
bp O
in O
length O
and O
contains O
nine O
exons O
which O
encode O
a O
putative O
protein O
of O
258 O
amino O
acid O
residues O
. O

Patients O
who O
have O
undergone O
thyroidectomy _RARE_
for _RARE_
thyroid O
carcinoma O
are O
frequently O
subjected O
to O
periods O
of O
induced _RARE_
severe O
hypothyroidism O
in O
preparation O
for _RARE_
131I O
whole O
body O
scanning O
and O
measurement O
of O
serum O
TG I-GENE
. O

Full _RARE_
thyroid O
function O
testing O
was O
performed O
on O
600 O
randomly O
selected _RARE_
samples O
with O
normal O
TSH _RARE_
values O
and O
also O
on O
subjects O
with O
abnormal O
TSH _RARE_
levels O
. O

In O
a O
third O
experiment O
, O
crossover _RARE_
AM _RARE_
between O
dissimilar _RARE_
textures _RARE_
was O
investigated O
, O
and O
it O
was O
found O
that O
the O
more O
salient _RARE_
textures _RARE_
carried O
the O
AM _RARE_
. O

The O
relative O
tumor O
FDG O
- O
uptake O
( O
Q _RARE_
- O
MRGlu _RARE_
) O
( O
tumor O
/ O
contralateral O
cortex O
) O
of O
all O
meningiomas _RARE_
was O
calculated O
with O
0 _RARE_
. O
73 _RARE_
+/- O
0 _RARE_
. O
37 O
( O
0 _RARE_
. O
24 _RARE_
- O
1 O
. O
79 _RARE_
). O

Zatebradine _RARE_
weakly O
depressed O
the O
ectopic O
ventricular O
rate O
but O
not O
the O
arrhythmic _RARE_
ratio O
of O
the O
ventricular O
arrhythmias O
induced _RARE_
by O
two O
- O
stage _RARE_
coronary O
ligation O
24 _RARE_
h O
after O
the O
ligation O
in O
conscious O
dogs O
. O

Catha _RARE_
edulis _RARE_
, O
a O
plant _RARE_
that O
has O
amphetamine O
effects O
. O

The O
predicted O
protein O
, O
Seb1p _RARE_
, O
consists O
of O
82 O
amino O
acids _RARE_
and O
contains O
one O
potential _RARE_
membrane O
- O
spanning O
region O
at _RARE_
the O
C O
- O
terminus O
but O
no _RARE_
N O
- O
terminal O
signal O
sequence O
. O

The O
SEB1 _RARE_
homologue O
thus O
isolated O
, O
SEB2 _RARE_
, O
encodes O
a O
protein O
53 O
% O
identical O
to O
Seb1p _RARE_
. O

Nonetheless _RARE_
, O
that O
ventricular O
afferents O
, O
in O
certain O
special _RARE_
settings _RARE_
, O
are O
able O
to O
induce O
e _RARE_
. O
g O
. O
generalised _RARE_
vasodilation O
and O
hypotension O
cannot O
be O
excluded O
. O

Large _RARE_
ones O
were O
similar O
in O
size O
to O
the O
main O
lobe O
and O
small O
ones O
were O
approximately _RARE_
1 O
/ O
4 O
of O
the O
length O
of O
the O
main O
lobe O
. O

Fragments _RARE_
and O
analogs _RARE_
of O
the O
hormone O
ACTH I-GENE
were O
previously O
shown O
to O
have O
beneficial O
effect O
on O
the O
outcome O
of O
head O
injury O
, O
while O
elevated O
levels O
of O
corticosterone O
( O
CS _RARE_
) O
exacerbate _RARE_
it O
. O

The O
most O
frequent O
causes O
of O
the O
meningitis O
was O
the O
external O
ventricular O
drainage O
( O
14 O
. O
8 O
%), O
post O
- O
neurosurgical _RARE_
( O
0 _RARE_
. O
8 O
%) O
and O
head O
injury O
( O
0 _RARE_
. O
0007 _RARE_
%). O

Fifty O
- O
one O
patients O
with O
primary _RARE_
refractory O
or O
relapsed _RARE_
malignant O
lymphoma O
( O
47 _RARE_
non O
- O
Hodgkin O
' O
s O
lymphoma O
and O
four O
Hodgkin O
' O
s O
disease _RARE_
) O
were O
treated O
with O
a O
new O
chemotherapeutic O
regimen O
( O
cisplatinum _RARE_
, O
methyl _RARE_
GAG _RARE_
, O
bleomocyin _RARE_
, O
methyl _RARE_
prednisolon _RARE_
). O

With O
the O
increasing O
use O
of O
ACE I-GENE
inhibitors _RARE_
, O
the O
incidence O
of O
rare O
adverse O
effects O
such O
as _RARE_
potentially O
lethal O
pancreatitis O
is O
likely O
to O
increase O
. O

In O
3 O
treatments O
the O
diet O
was O
supplemented O
with O
0 _RARE_
, O
100 _RARE_
and O
150 _RARE_
mg O
probiotic _RARE_
/ O
kg O
food O
. O

Low O
- O
dose O
aspirin _RARE_
and O
recurrent O
miscarriage _RARE_
. O

Protein O
films O
are O
distinctly O
different O
in O
mechanical O
profiles O
from O
those O
films O
made O
of O
other O
materials O
. O

Furthermore O
, O
cpxA _RARE_
* _RARE_
mutations O
suppress O
the O
toxicity O
conferred O
by O
the O
LamB _RARE_
- O
LacZ _RARE_
hybrid _RARE_
protein O
, O
which O
exerts O
its O
effects O
in O
the O
cytoplasm O
, O
sequestered _RARE_
from O
DegP _RARE_
. O

The O
PI3K_68D _RARE_
cDNA I-GENE
encodes O
a O
protein O
of O
210 O
kDa O
, O
which O
lacks O
sequences O
implicated O
in O
linking O
p110 _RARE_
PI I-GENE
3 I-GENE
- I-GENE
kinases I-GENE
to O
p85 I-GENE
adaptor _RARE_
proteins I-GENE
, O
but O
contains O
an O
amino O
- O
terminal O
proline O
- O
rich O
sequence O
, O
which O
could O
bind O
to O
SH3 I-GENE
domains I-GENE
, O
and O
a O
carboxy _RARE_
- O
terminal O
C2 I-GENE
domain O
. O

In O
vitro O
interaction O
studies O
, O
using O
proteins O
fused O
to O
glutathione _RARE_
- I-GENE
S I-GENE
- I-GENE
transferase I-GENE
, O
showed O
that O
RBP _RARE_
- I-GENE
J _RARE_
kappa _RARE_
and O
Su _RARE_
( I-GENE
H I-GENE
) I-GENE
bind O
directly O
to O
the O
RAM23 _RARE_
regions I-GENE
of O
mouse I-GENE
Notch1 _RARE_
and O
Drosophila I-GENE
Notch I-GENE
, O
respectively O
. O

AIMS _RARE_
/ O
METHODS O
: O
Reticuloendothelial _RARE_
system _RARE_
function O
, O
as _RARE_
assessed O
by O
clearance O
of O
radiolabelled _RARE_
bacteria O
, O
was O
evaluated O
in O
acute O
liver O
injury O
induced _RARE_
by O
D O
- O
galactosamine _RARE_
in O
rats O
, O
and O
compared O
with O
that O
after O
70 O
% O
liver O
resection O
model O
. O

Our O
laboratory O
and O
others O
have O
shown O
alternative _RARE_
splicing _RARE_
of O
up _RARE_
to O
ten O
exons O
at _RARE_
a O
discrete O
extracellular O
site O
to O
be O
primarily O
responsible O
for _RARE_
the O
generation O
of O
CD44 I-GENE
variant I-GENE
( O
CD44v _RARE_
) O
isoforms O
. O

Study O
groups O
were O
control O
, O
and O
those O
treated O
with O
the O
alpha1 _RARE_
- I-GENE
adrenoceptor I-GENE
- I-GENE
subtype _RARE_
blockers O
WB4101 _RARE_
( O
0 _RARE_
. O
5 O
mg O
/ O
kg O
i O
. O
v O
.) O
or O
chloroethylclonidine _RARE_
( O
1 O
. O
9 O
mg O
/ O
kg O
i O
. O
v O
.). O

This O
caused O
severe O
cortical O
damage O
and O
neuronal _RARE_
loss _RARE_
in O
hippocampus O
subfields _RARE_
CA1 _RARE_
, O
CA3 O
, O
and O
hilus _RARE_
. O

The O
occurrence O
of O
multiple O
malignancy O
was O
studied O
in O
674 _RARE_
patients O
with O
hematologic _RARE_
malignancies _RARE_
who O
were O
admitted _RARE_
to O
this O
department _RARE_
during _RARE_
the O
past O
10 O
years O
. O

The O
upTRE _RARE_
binds O
more O
T3R I-GENE
homodimers I-GENE
and O
less O
T3R I-GENE
- O
RXR I-GENE
heterodimers _RARE_
than O
the O
dnTRE _RARE_
, O
and O
T3 _RARE_
more O
readily O
facilitates _RARE_
heterodimer _RARE_
binding O
to O
the O
dn _RARE_
- O
than O
to O
the O
upTRE _RARE_
. O

Transcriptional O
control O
of O
a O
nuclear O
gene O
encoding O
a O
mitochondrial O
fatty O
acid O
oxidation O
enzyme O
in O
transgenic O
mice O
: O
role O
for _RARE_
nuclear O
receptors O
in O
cardiac O
and O
brown O
adipose _RARE_
expression _RARE_
. O

Hoeben _RARE_
, O
F O
. O
J _RARE_
. O

Twelve _RARE_
genomic O
fragments O
containing O
novel O
response O
elements O
are O
described O
, O
and O
the O
transcription O
unit O
associated O
with O
one O
of O
them O
, O
NN _RARE_
- I-GENE
84AG _RARE_
, O
was O
characterized O
in O
detail O
. O

Moreover O
, O
glucan _RARE_
synthase I-GENE
activity O
, O
which O
is O
activated O
by O
Rho1p _RARE_
, O
was O
significantly O
reduced _RARE_
in O
the O
deltabem4 _RARE_
mutant I-GENE
. O

In O
gel O
retardation O
assays O
, O
an O
RCS _RARE_
cell O
- O
specific O
protein O
and O
another O
closely O
related O
protein O
expressed _RARE_
only O
in O
RCS _RARE_
cells O
and O
primary _RARE_
chondrocytes _RARE_
bound _RARE_
to O
a O
10 O
- O
bp O
sequence O
within O
the O
18 O
- O
mer _RARE_
. O

Two O
classes O
of O
Xanthomonas _RARE_
pathogens O
evading _RARE_
Bs2 _RARE_
host _RARE_
resistance O
and O
displaying _RARE_
reduced _RARE_
fitness O
were O
found O
to O
be O
specifically O
mutated _RARE_
in O
avrBs2 _RARE_
. O

Members O
of O
the O
Ras I-GENE
subfamily I-GENE
of O
small I-GENE
GTP I-GENE
- I-GENE
binding I-GENE
proteins I-GENE
have O
been O
shown O
to O
be O
promiscuous _RARE_
towards O
a O
variety O
of O
putative O
effector O
molecules O
such O
as _RARE_
the O
protein I-GENE
kinase I-GENE
c I-GENE
- I-GENE
Raf I-GENE
and O
the O
Ral _RARE_
- I-GENE
specific I-GENE
guanine I-GENE
nucleotide I-GENE
exchange I-GENE
factor I-GENE
( O
Ral _RARE_
- I-GENE
GEF _RARE_
). O

Thus O
, O
the O
characterization O
of O
the O
promoter O
region O
should O
help O
to O
define O
regulatory O
elements O
that O
control O
neuron _RARE_
- O
specific O
and O
developmental O
expression _RARE_
of O
the O
MAP1B _RARE_
gene I-GENE
. O

The O
cDNA O
encoded O
a O
mature _RARE_
protein O
of O
240 O
amino O
acids _RARE_
, O
including O
a O
29 O
- O
amino O
acid O
signal O
sequence O
. O

Mutants _RARE_
lacking _RARE_
the O
3 O
' O
stem _RARE_
- O
loop O
exhibited O
a O
75 _RARE_
% O
reduction O
in O
the O
level O
of O
psaB _RARE_
mRNA O
. O

The O
deduced O
amino O
acid O
sequence O
was O
highly O
conserved _RARE_
across O
the O
wide O
range O
of O
eukaryotes O
( O
vertebrates _RARE_
, O
invertebrates _RARE_
, O
fungi _RARE_
, O
plants _RARE_
and O
protozoa _RARE_
) O
in O
which O
this O
gene O
has O
now O
been O
identified O
. O

Biol O
. O

Semidominant _RARE_
mutations O
in O
the O
yeast I-GENE
Rad51 _RARE_
protein I-GENE
and O
their O
relationships O
with O
the O
Srs2 _RARE_
helicase _RARE_
. O

Alterations _RARE_
of O
the O
5q23 _RARE_
- O
q31 _RARE_
interval O
are O
frequently O
observed O
in O
myelodysplasia _RARE_
and O
myeloid _RARE_
leukemia O
. O

Previous O
studies O
have O
suggested O
that O
the O
616 _RARE_
amino O
acid O
, O
70 I-GENE
- I-GENE
kDa I-GENE
subunit I-GENE
of I-GENE
RPA I-GENE
( O
RPA I-GENE
70 I-GENE
) O
is O
composed O
of O
multiple O
structural O
/ O
functional _RARE_
domains O
. O

Neurons _RARE_
were O
held O
at _RARE_
- O
67 O
mV _RARE_
to O
equate _RARE_
voltage O
- O
dependent O
effects O
. O

This O
site O
acts O
as _RARE_
a O
negative O
element O
when O
transferred O
to O
the O
thymidine _RARE_
kinase I-GENE
promoter I-GENE
, O
but O
does O
not O
confer O
inducibility O
. O

The O
extent O
of O
the O
fbpA _RARE_
operator O
sequence O
( O
42 _RARE_
bp O
), _RARE_
as _RARE_
defined O
by O
our O
footprinting O
analysis O
, O
would O
suggest O
the O
binding O
of O
two O
Fur I-GENE
repressor I-GENE
dimers _RARE_
. O

The O
structural O
similarity _RARE_
between O
Vav _RARE_
and O
other O
guanine I-GENE
nucleotide I-GENE
exchange I-GENE
factors I-GENE
for _RARE_
small I-GENE
GTP I-GENE
- I-GENE
binding I-GENE
proteins I-GENE
, O
together O
with O
the O
recent O
identification O
of O
biochemical O
routes O
specific O
for _RARE_
members O
of O
the O
Ras I-GENE
and O
Rho I-GENE
family I-GENE
of O
GTPases I-GENE
, O
prompted _RARE_
us O
to O
explore O
whether O
MAPK _RARE_
or O
JNK I-GENE
are O
downstream _RARE_
components _RARE_
of O
the O
Vav _RARE_
signaling _RARE_
pathways O
. O

CONCLUSION O
: O
Twice _RARE_
daily O
treatment O
with O
inhaled O
fluticasone _RARE_
propionate _RARE_
50 O
micrograms O
or O
100 _RARE_
micrograms O
was O
significantly O
more O
effective O
than O
theophylline O
in O
the O
treatment O
of O
mild O
- O
to O
- O
moderate O
asthma O
. O

Our O
results O
support O
a O
model O
where O
both O
E2F I-GENE
- O
and O
CDE _RARE_
- O
mediated _RARE_
repression O
, O
acting O
at _RARE_
different O
stages O
in O
the O
cell O
cycle _RARE_
, O
are O
dependent O
on O
promoter O
- O
specific O
CHR _RARE_
elements O
. O

The O
cDNA O
clone O
was O
used O
as _RARE_
a O
homologous O
probe O
to O
isolate O
a O
truncated O
genomic O
clone O
encoding O
H2A1 _RARE_
. O

Comparison O
of O
the O
deduced O
amino O
acid O
sequences O
with O
protein O
sequences O
of O
T O
. O
pyriformis _RARE_
H2As _RARE_
showed O
only O
two O
and O
three O
differences O
respectively O
, O
in O
a O
total _RARE_
of O
137 _RARE_
amino O
acids _RARE_
for _RARE_
H2A1 _RARE_
, O
and O
132 O
amino O
acids _RARE_
for _RARE_
H2A2 _RARE_
, O
indicating O
the O
two O
genes O
arose _RARE_
before O
the O
divergence O
of O
these O
two O
species O
. O

Cognitive _RARE_
visual O
dysfunction O
in O
a O
child O
with O
cerebral O
damage O
. O

Interaction O
was O
apparently O
determined O
by O
the O
N O
- O
terminal O
splice _RARE_
region O
of O
RPDE _RARE_
- I-GENE
6 I-GENE
, O
as _RARE_
the O
PDE4A _RARE_
splice _RARE_
variant O
RPDE _RARE_
- I-GENE
39 _RARE_
, O
which O
differs O
from O
RPDE _RARE_
- I-GENE
6 I-GENE
at _RARE_
the O
extreme O
N O
- O
terminus O
, O
failed O
to O
associate O
with O
v I-GENE
- I-GENE
Src I-GENE
- O
SH3 I-GENE
; O
met26RD1 _RARE_
( O
where O
RD1 _RARE_
is O
rat I-GENE
' I-GENE
dunc _RARE_
- I-GENE
like I-GENE
' I-GENE
PDE _RARE_
), _RARE_
which O
has O
the O
N O
- O
terminal O
splice _RARE_
region O
deleted _RARE_
, O
failed O
to O
associate O
with O
v I-GENE
- I-GENE
Src I-GENE
- O
SH3 I-GENE
, O
and O
the O
association O
of O
RPDE _RARE_
- I-GENE
6 I-GENE
and O
v I-GENE
- I-GENE
Src I-GENE
- O
SH3 I-GENE
was O
blocked O
by O
a O
fusion O
protein O
formed O
from O
the O
N O
- O
terminal O
splice _RARE_
region O
. O

Potentially _RARE_
load O
- O
insensitive _RARE_
measures O
of O
ventricular O
performance O
were O
therefore O
evaluated O
in O
10 O
open _RARE_
- O
and O
closed O
- O
chested _RARE_
, O
anesthetized O
rabbits O
. O

Large _RARE_
strain _RARE_
differences O
were O
found O
for _RARE_
all O
variables O
recorded O
, O
i O
. O
e _RARE_
., O
the O
proportion O
of O
attacking _RARE_
males O
, O
the O
time O
spent _RARE_
in O
the O
brightly _RARE_
lit _RARE_
box O
, O
and O
the O
number O
of O
transitions _RARE_
between O
the O
lit _RARE_
and O
the O
dark O
boxes _RARE_
. O

The O
effect O
of O
ligustrazine _RARE_
hydrochloride _RARE_
( O
LTH _RARE_
) O
on O
depressing _RARE_
pulmonary O
artery O
hypertension O
has O
been O
proved O
in O
recent O
studies O
. O

It O
is O
the O
oxidation O
peak O
of O
this O
product O
, O
arising O
in O
acidic _RARE_
media O
at _RARE_
0 _RARE_
. O
42 _RARE_
V O
, O
which O
was O
analysed O
using O
DPV _RARE_
, O
again O
following O
the O
accumulation O
of O
clenbuterol _RARE_
at _RARE_
the O
Nafion _RARE_
- O
modified O
CPE _RARE_
. O

Phenylephrine _RARE_
is O
a O
pure O
alpha I-GENE
- I-GENE
1 I-GENE
adrenoreceptor _RARE_
agonist O
known O
to O
produce O
marked O
systemic O
vasoconstriction _RARE_
and O
associated O
hypertension O
with O
occasional _RARE_
profound O
reflex O
bradycardia _RARE_
. O

The O
expression _RARE_
of O
the O
first _RARE_
two O
genes O
located _RARE_
in O
this O
unit O
( O
c I-GENE
- I-GENE
gvpD _RARE_
and O
c I-GENE
- I-GENE
gvpE _RARE_
) O
was O
also O
monitored O
by O
Western O
blot O
( O
immunoblot _RARE_
) O
analyses O
using O
antisera O
raised O
against O
these O
proteins O
synthesized O
in O
Escherichia O
coli O
. O

One O
unit O
encodes O
traA _RARE_
, O
traF _RARE_
, O
and O
traB _RARE_
, O
while O
the O
second O
encodes O
traC _RARE_
, O
traD _RARE_
, O
and O
traG _RARE_
. O

A O
. O

In O
an O
effort O
to O
isolate O
genes O
with O
down O
- O
regulated O
expression _RARE_
at _RARE_
the O
mRNA O
level O
during _RARE_
oncogenic _RARE_
transformation O
of O
human O
mammary O
epithelial _RARE_
cells O
( O
MECs _RARE_
), _RARE_
we O
performed O
subtractive _RARE_
hybridization O
between O
normal O
MEC _RARE_
strain _RARE_
76N _RARE_
and O
its O
radiation O
- O
transformed O
tumorigenic O
derivative _RARE_
76R _RARE_
- O
30 _RARE_
. O

CASE _RARE_
REPORT _RARE_
: O
Referred _RARE_
because O
of O
a O
right O
corneal O
perforation _RARE_
with O
cellular O
reaction O
in O
anterior O
chamber O
, O
a O
patient O
was O
sutured _RARE_
and O
treated O
with O
a O
single O
intravitreal _RARE_
injection O
of O
0 _RARE_
. O
2 O
ml O
( O
1 O
mg O
) O
Amikacin _RARE_
and O
0 _RARE_
. O
2 O
ml O
( O
1 O
mg O
) O
Vancomycin _RARE_
. O

In O
the O
same O
period O
we O
pointed _RARE_
out O
an O
increase O
of O
hematocrit O
( O
from O
29 O
% O
to O
35 _RARE_
%) O
and O
of O
the O
Hb _RARE_
( O
from O
9 O
. O
3 O
to O
11 O
. O
2 O
g O
/ O
dl O
). O

The O
P I-GENE
- I-GENE
wr _RARE_
and O
P I-GENE
- I-GENE
rr _RARE_
cDNA I-GENE
sequences I-GENE
are O
very O
similar O
in O
their O
5 O
' O
regions O
. O

Because O
the O
hcf109 _RARE_
locus I-GENE
was O
mapped O
at _RARE_
a O
distance O
< O
0 _RARE_
. O
1 O
centimorgans _RARE_
from O
the O
phytochrome _RARE_
C I-GENE
gene I-GENE
, O
its O
molecular _RARE_
characterization O
by O
positional _RARE_
cloning O
is O
possible O
. O

The O
human I-GENE
MSH I-GENE
- I-GENE
2 I-GENE
gene I-GENE
product I-GENE
is O
a O
member _RARE_
of O
a O
highly O
conserved _RARE_
family O
of O
proteins O
which O
are O
involved O
in O
post O
- O
replication O
mismatch _RARE_
repair O
. O
hMSH _RARE_
- I-GENE
2 I-GENE
is O
homologous O
to O
Escherichia O
coli O
( O
E O
. O
coli O
) O
MutS _RARE_
and O
Sacchromyces _RARE_
cerevisiae I-GENE
MSH I-GENE
- I-GENE
1 I-GENE
and O
MSH I-GENE
- I-GENE
2 I-GENE
proteins I-GENE
, O
which O
recognise _RARE_
heteroduplex _RARE_
DNA O
at _RARE_
the O
sites O
of O
all O
single O
base _RARE_
mismatches _RARE_
and O
deletions O
or O
insertions O
up _RARE_
to O
4 O
base _RARE_
pairs _RARE_
. O
hMSH _RARE_
- I-GENE
2 I-GENE
is O
one O
of O
the O
hereditary _RARE_
non I-GENE
- I-GENE
polyposis _RARE_
colorectal _RARE_
cancer _RARE_
( I-GENE
HNPCC _RARE_
) I-GENE
tumor I-GENE
suppressor I-GENE
genes I-GENE
, O
and O
maps O
to O
human O
chromosome _RARE_
2p16 _RARE_
. O

We O
have O
recently O
shown O
that O
the O
tissue O
- O
specific O
expression _RARE_
of O
the O
RAR I-GENE
beta I-GENE
2 I-GENE
gene I-GENE
in I-GENE
mouse I-GENE
embryos _RARE_
is O
regulated O
at _RARE_
the O
translational O
level O
by O
short O
upstream O
open _RARE_
reading O
frames O
( O
uORFs _RARE_
) O
In O
the O
5 O
'- O
untranslated _RARE_
region O
( O
Zimmer _RARE_
, O
A O
., O
A O
. O
M O
. O

We O
have O
previously O
isolated O
a O
cDNA O
for _RARE_
a O
transcription O
factor O
referred O
to O
as _RARE_
Zfhep _RARE_
( O
zinc I-GENE
finger I-GENE
homeodomain _RARE_
enhancer I-GENE
- I-GENE
binding I-GENE
protein I-GENE
) O
containing O
two O
separate O
zinc O
finger O
domains O
, O
ZD1 _RARE_
and O
ZD2 _RARE_
, O
each O
of O
which O
binds O
DNA O
, O
and O
a O
homeodomain _RARE_
. O

The O
structure _RARE_
of O
these O
genes O
suggests O
a O
common O
ancestor O
for _RARE_
all O
viperid _RARE_
PLA2 _RARE_
genes I-GENE
. O

Increased O
PTHRP _RARE_
production O
by O
a O
tyrosine I-GENE
kinase I-GENE
oncogene I-GENE
, O
Tpr _RARE_
- I-GENE
Met _RARE_
: O
role O
of O
the O
Ras I-GENE
signaling _RARE_
pathway _RARE_
. O

Subsequent _RARE_
to O
their O
secretion _RARE_
, O
the O
IGF I-GENE
- I-GENE
II I-GENE
in O
xz97 _RARE_
and O
G11 _RARE_
cells O
accumulated O
in O
the O
conditioned O
medium O
mostly O
as _RARE_
two O
partially O
processed O
species O
with O
appMr _RARE_
, O
of O
17K _RARE_
and O
14K _RARE_
, O
respectively O
. O

Paradoxically _RARE_
, O
coexpression O
of O
the O
transcriptionally O
inactive O
, O
amino O
- O
terminally _RARE_
deleted _RARE_
IDX _RARE_
- I-GENE
1 I-GENE
mutant I-GENE
proteins I-GENE
, O
either O
with O
the O
wild I-GENE
- I-GENE
type I-GENE
IDX _RARE_
- I-GENE
1 I-GENE
or O
with O
themselves O
, O
results O
in O
a O
marked O
enhancement O
of O
transactivation _RARE_
of O
the O
transcriptional O
TAAT _RARE_
- I-GENE
1 I-GENE
element I-GENE
reporter I-GENE
. O

All O
patients O
had O
abnormal O
von _RARE_
Willebrand I-GENE
factor I-GENE
( O
vWF I-GENE
) O
fragmentation _RARE_
as _RARE_
reflected O
by O
decreased O
high O
molecular _RARE_
weight _RARE_
and O
increased O
low O
molecular _RARE_
weight _RARE_
vWF I-GENE
multimers _RARE_
in O
the O
circulation O
. O

In O
an O
attempt O
to O
investigate O
whether O
the O
intergenic O
region O
between O
the O
oleosin _RARE_
and O
a O
second O
open _RARE_
reading O
frame O
( O
ORFII _RARE_
) O
in O
Brassica _RARE_
napus _RARE_
( O
L O
.) O
is O
a O
divergent O
promoter O
, O
and O
also O
to O
characterize O
the O
ORFII _RARE_
, O
cDNA I-GENE
clones _RARE_
homologous I-GENE
to I-GENE
ORFII _RARE_
were O
isolated O
from O
a O
leaf O
cDNA O
library O
. O

The O
ORFII _RARE_
gene I-GENE
product I-GENE
is O
targeted O
to O
the O
chloroplast O
, O
which O
is O
consistent O
with O
previous O
data O
indicating O
the O
presence O
of O
PMSR _RARE_
activity O
in O
the O
chloroplast O
. O

Characterization O
of O
LRP _RARE_
, O
a O
leucine I-GENE
- I-GENE
rich I-GENE
repeat I-GENE
( I-GENE
LRR _RARE_
) I-GENE
protein I-GENE
from I-GENE
tomato _RARE_
plants _RARE_
that O
is O
processed O
during _RARE_
pathogenesis O
. O

To O
test O
whether O
Sp1 _RARE_
and O
zif268 _RARE_
/ O
egr _RARE_
- I-GENE
1 I-GENE
interact O
with O
this O
motif O
, O
gel O
retardation O
assays O
were O
performed O
. O

OBJECTIVES O
: O
The O
aim O
of O
the O
study O
was O
to O
analyze O
the O
clinical O
characteristics O
, O
treatment O
and O
outcome O
of O
310 _RARE_
patients O
with O
hydatidiform _RARE_
mole _RARE_
. O

Stably _RARE_
transfected O
human O
kidney _RARE_
293 O
cells O
expressing O
the O
wild I-GENE
type I-GENE
rat I-GENE
LH _RARE_
/ I-GENE
CG _RARE_
receptor I-GENE
( O
rLHR _RARE_
) O
or O
receptors O
with O
C O
- O
terminal O
tails O
truncated O
at _RARE_
residues O
653 _RARE_
, O
631 _RARE_
, O
or O
628 _RARE_
( O
designated O
rLHR _RARE_
- I-GENE
t653 _RARE_
, O
rLHR _RARE_
- I-GENE
t631 _RARE_
, O
and O
rLHR _RARE_
- I-GENE
t628 _RARE_
) O
were O
used O
to O
probe O
the O
importance O
of O
this O
region O
on O
the O
regulation _RARE_
of O
hormonal O
responsiveness O
. O

Are _RARE_
low O
P300 _RARE_
amplitudes O
a O
marker O
for _RARE_
schizophrenia O
. O

Sleep _RARE_
was O
determined O
again O
for _RARE_
an O
additional O
3 O
days O
and O
6 O
hours O
. O

The O
patients O
are O
two O
healthy O
adult O
males O
. O

Chloroplast _RARE_
mutator _RARE_
( O
chm _RARE_
) O
of O
Arabidopsis O
is O
a O
recessive O
nuclear O
mutation O
that O
causes O
green _RARE_
and O
white _RARE_
variegation _RARE_
in O
leaves O
and O
is O
inherited O
in O
a O
non O
- O
Mendelian _RARE_
fashion O
. O

Indoor _RARE_
concentrations O
were O
only O
weakly O
correlated O
with O
outdoor _RARE_
concentrations O
, O
however O
, O
and O
personal O
exposures O
were O
even O
more O
poorly O
correlated O
with O
outdoor _RARE_
concentrations O
. O

A O
neuropsychological _RARE_
test O
battery O
was O
used O
that O
contained O
the O
Wisconsin _RARE_
card _RARE_
sorting _RARE_
test O
, O
Street _RARE_
completion _RARE_
test O
, O
Stroop O
test O
, O
a O
dichotic _RARE_
memory O
listening _RARE_
test O
, O
and O
a O
facial O
recognition O
test O
. O

We O
present O
this O
case O
because O
of O
the O
rarity _RARE_
of O
left _RARE_
ventricular O
involvement O
associated O
with O
ARVD _RARE_
. O

In O
a O
randomized O
single O
- O
blind O
3 O
x _RARE_
3 O
Latin _RARE_
- O
square O
study O
with O
corrections _RARE_
for _RARE_
any O
carryover _RARE_
effects O
, O
27 _RARE_
males O
and O
30 _RARE_
females O
consumed _RARE_
supplements _RARE_
containing O
glucose O
or O
resistant O
starch _RARE_
( O
RS _RARE_
) O
from O
raw _RARE_
high O
- O
amylose _RARE_
cornstarch _RARE_
( O
RS2 _RARE_
) O
or O
from O
retrograded _RARE_
high O
- O
amylose _RARE_
cornstarch _RARE_
( O
RS3 _RARE_
). O

The O
5 O
' O
flanking O
region O
of O
the O
mouse I-GENE
Met _RARE_
- I-GENE
ase _RARE_
- I-GENE
1 I-GENE
gene I-GENE
also O
shares O
considerable O
regions O
of O
identity O
with O
the O
5 O
' O
flanking O
region O
of O
the O
rat I-GENE
Met _RARE_
- I-GENE
ase _RARE_
- I-GENE
1 I-GENE
gene I-GENE
. O

The O
[ _RARE_
18F O
] O
FMISO _RARE_
TMRR _RARE_
is O
a O
simple O
and O
clinically O
useful O
index O
for _RARE_
detecting O
tumour _RARE_
hypoxia _RARE_
in O
NPC _RARE_
. O

Improved _RARE_
methods O
have O
been O
developed O
for _RARE_
maintaining O
and O
breeding _RARE_
the O
neotropical _RARE_
short O
- O
tailed _RARE_
fruit _RARE_
bat _RARE_
, O
Carollia _RARE_
perspicillata _RARE_
, O
in O
an O
easily O
- O
reproduced _RARE_
, O
laboratory O
setting O
. O

In O
addition O
, O
the O
time O
to O
engraftment _RARE_
was O
significantly O
shorter O
in O
the O
amifostine _RARE_
arm _RARE_
in O
both O
cohorts _RARE_
. O

Also O
like O
the O
thrombin I-GENE
receptor I-GENE
, O
PAR2 _RARE_
can O
be O
activated O
by O
the O
hexapeptide _RARE_
corresponding O
to O
its O
tethered _RARE_
ligand _RARE_
sequence O
independent O
of O
receptor O
cleavage _RARE_
. O

We O
conclude O
that O
CPET _RARE_
is O
a O
useful O
investigation O
in O
the O
management O
of O
patients O
with O
cardiopulmonary O
disease _RARE_
and O
complements _RARE_
the O
various O
other O
investigations O
offered O
by O
a O
pulmonary O
function O
laboratory O
. O

Using O
fluorescence O
in O
situ O
hybridization O
, O
we O
mapped O
the O
chromosome _RARE_
- O
17 _RARE_
breakpoint _RARE_
in O
a O
patient O
with O
acampomelic _RARE_
CMPD _RARE_
and O
sex _RARE_
reversal O
, O
who O
carries O
a O
de O
novo _RARE_
constitutional _RARE_
t O
( O
12 O
; O
17 _RARE_
) O
translocation O
, O
between O
two O
known O
cosmid O
markers O
in O
the O
17q24 _RARE_
- O
q25 _RARE_
region O
. O

This O
is O
concluded O
from O
the O
isolation O
of O
cDNAs O
from O
spinach _RARE_
( O
Spinacia _RARE_
oleracea _RARE_
) O
and O
barley _RARE_
( O
Hordeum _RARE_
vulgare _RARE_
cv O
. O

The O
data O
presented O
in O
this O
work O
indicate O
that O
thi1 _RARE_
may O
also O
be O
involved O
in O
DNA O
damage O
tolerance O
in O
plant _RARE_
cells O
. O

In O
the O
rat I-GENE
rnu _RARE_
allele I-GENE
described O
here O
, O
a O
nonsense O
mutation O
in O
exon _RARE_
8 O
of O
the O
whn _RARE_
gene I-GENE
was O
identified O
. O

Such O
an O
increase O
in O
the O
steady O
- O
state O
testicular _RARE_
TIMP I-GENE
- I-GENE
2 I-GENE
mRNA I-GENE
level O
apparently O
is O
not O
the O
result O
of O
an O
up _RARE_
- O
regulation _RARE_
by O
germ _RARE_
cells O
because O
germ _RARE_
cells O
cocultured _RARE_
with O
Sertoli _RARE_
cells O
failed O
to O
elicit O
an O
increase O
in O
the O
Sertoli _RARE_
cell O
steady O
- O
state O
TIMP I-GENE
- I-GENE
2 I-GENE
mRNA I-GENE
level O
. O

Control O
intact _RARE_
rats O
were O
age O
- O
matched O
to O
the O
different O
treated O
groups O
. O

DESIGN O
: O
A O
cross O
- O
sectional O
study O
. O

In O
the O
SPK _RARE_
and O
PTA _RARE_
category O
, O
anti O
- O
T O
- O
cell O
therapy O
significantly O
lowered O
the O
risk O
of O
graft O
loss _RARE_
. O

We O
have O
identified O
a O
strong O
Tas _RARE_
- I-GENE
responsive I-GENE
element I-GENE
, O
designated O
TRE _RARE_
( O
GP _RARE_
), _RARE_
near O
the O
3 O
' O
end O
of O
the O
gag I-GENE
gene I-GENE
and O
preceding O
the O
pol I-GENE
gene I-GENE
of O
SFV _RARE_
- O
1 O
. O

Although O
the O
binding O
of O
IE2 I-GENE
86 _RARE_
to O
nonphosphorylated _RARE_
full I-GENE
- I-GENE
length I-GENE
CREB I-GENE
or O
deltaCREB _RARE_
is O
minimal O
, O
IE2 I-GENE
86 _RARE_
does O
form O
complexes O
with O
p300 I-GENE
and O
the O
CREB I-GENE
- I-GENE
binding I-GENE
protein I-GENE
( O
CBP I-GENE
), _RARE_
which O
in O
turn _RARE_
bind O
to O
CREB I-GENE
and O
can O
serve O
as _RARE_
adaptor _RARE_
proteins O
for _RARE_
CREB I-GENE
function O
. O

A O
transgenic O
complementation _RARE_
assay O
was O
used O
to O
test O
whether O
NIa _RARE_
supplied O
in O
trans _RARE_
could O
rescue O
amplification O
- O
defective _RARE_
viral O
genomes O
encoding O
altered O
NIa _RARE_
proteins I-GENE
. O

On O
the O
basis O
of O
its O
bZIP _RARE_
structural O
homology O
, O
meq _RARE_
is O
perhaps O
the O
only O
member _RARE_
of O
the O
jun I-GENE
- O
fos I-GENE
gene O
family O
completely O
viral O
in O
origin O
. O

The O
rCBF O
and O
vasomotion _RARE_
were O
recorded O
by O
laser O
- O
doppler _RARE_
fluxmetry _RARE_
. O

Although O
basal O
vessels O
may O
constrict _RARE_
distal O
parenchymal _RARE_
vessels O
tend _RARE_
to O
dilate _RARE_
after O
SAH _RARE_
. O

The O
triple _RARE_
combination O
of O
nizatidine _RARE_
, O
clarithromycin _RARE_
, O
and O
bismuth _RARE_
subcitrate _RARE_
resulted O
in O
an O
ulcer O
healing O
rate O
of O
98 O
% O
and O
an O
H O
. O
pylori _RARE_
eradication O
rate O
of O
90 _RARE_
%. O

Several O
lines O
of O
evidence O
presented O
here O
suggest O
that O
PKC I-GENE
- I-GENE
zeta _RARE_
plays O
a O
role O
in O
alpha I-GENE
2 I-GENE
integrin I-GENE
gene I-GENE
expression _RARE_
. O

Plasma O
thrombomodulin _RARE_
: O
a O
marker O
for _RARE_
microvascular O
complications O
in O
diabetes O
mellitus O
. O

Update _RARE_
: O
diphtheria _RARE_
epidemic O
in O
the O
newly O
independent O
states O
of O
the O
former O
USSR _RARE_
, O
January O
1995 O
- O
March _RARE_
1996 O
. O

The O
characterization O
of O
the O
promoter O
region O
indicated O
that O
three O
distinct O
regulatory O
elements O
corresponding O
to O
an O
AP I-GENE
- I-GENE
1 I-GENE
binding I-GENE
site I-GENE
( O
or O
TRE _RARE_
), _RARE_
a O
PRDII _RARE_
/ O
kappaB I-GENE
domain O
, O
and O
a O
CAAT O
box O
are O
involved O
in O
the O
activation O
by O
pp60 _RARE_
( I-GENE
v I-GENE
-) _RARE_
src I-GENE
. O

Serine _RARE_
528 _RARE_
is O
phosphorylated _RARE_
in O
vivo O
in O
several O
cell O
lines O
, O
and O
substitution O
of O
serine O
528 _RARE_
to O
alanine O
( O
S528A _RARE_
) O
resulted O
in O
an O
increased O
ability O
of O
Myb I-GENE
to O
transactivate O
a O
synthetic _RARE_
promoter O
containing O
five O
copies O
of O
the O
mim _RARE_
- I-GENE
1A _RARE_
Myb I-GENE
- O
responsive O
element O
and O
a O
minimal O
herpes I-GENE
tk I-GENE
promoter I-GENE
. O

The O
DNA O
binding O
and O
multimerization _RARE_
activities O
of O
c I-GENE
- I-GENE
Myb I-GENE
appear O
to O
be O
unaffected O
by O
the O
S528A _RARE_
substitution O
, O
suggesting O
that O
phosphorylation _RARE_
of O
serine O
528 _RARE_
may O
mediate O
its O
effect O
on O
the O
transcription O
transactivating O
activity O
of O
c I-GENE
- I-GENE
Myb I-GENE
by O
regulating _RARE_
interactions O
with O
other O
proteins O
. O

The O
amount O
of O
these O
factors O
was O
reduced _RARE_
in O
GEO _RARE_
cells O
in O
which O
the O
u _RARE_
- I-GENE
PAR _RARE_
gene I-GENE
is O
only O
weakly O
transcriptionally O
activated O
. O

PIP2 O
, O
when O
incorporated O
into O
phosphatidylcholine _RARE_
carrier O
vesicles O
, O
binds O
tightly O
to O
the O
guanine O
nucleotide O
- O
depleted O
form O
of O
Cdc42Hs _RARE_
and O
weakly O
to O
the O
GDP O
- O
bound _RARE_
form O
of O
the O
GTP I-GENE
- I-GENE
binding I-GENE
protein I-GENE
but O
does O
not O
bind O
to O
GTP O
- O
bound _RARE_
Cdc42Hs _RARE_
, O
similar O
to O
what O
was O
observed O
for _RARE_
the O
Dbl _RARE_
oncoprotein _RARE_
. O

Purified _RARE_
spleen _RARE_
GAP _RARE_
accelerated O
hydrolysis O
of O
GTP O
bound _RARE_
to O
recombinant I-GENE
ARF1 _RARE_
, O
ARF3 _RARE_
, O
ARF5 _RARE_
, O
and O
ARF6 _RARE_
; O
no _RARE_
effect O
of O
NH2 O
- O
terminal O
myristoylation _RARE_
was O
observed O
. O

Biol O
. O

A O
novel O
phosphotyrosine _RARE_
- O
binding O
domain O
in O
the O
N O
- O
terminal O
transforming O
region O
of O
Cbl I-GENE
interacts O
directly O
and O
selectively O
with O
ZAP _RARE_
- I-GENE
70 I-GENE
in O
T O
cells O
. O

Cys _RARE_
- O
757 _RARE_
within O
the O
( O
Fe4S4 _RARE_
)- O
siroheme _RARE_
- O
binding O
domain O
was O
essential O
for _RARE_
native _RARE_
enzyme O
activity O
. O

Its O
transcription O
has O
been O
shown O
to O
be O
induced _RARE_
40 O
- O
50 O
- O
fold _RARE_
in O
response O
to O
oxygen O
or O
heme O
deficiency O
, O
in O
part O
through O
relief _RARE_
of O
repression O
exerted _RARE_
by O
Rox1p _RARE_
and O
in O
part O
by O
activation O
mediated _RARE_
by O
an O
upstream O
activation O
sequence O
( O
UAS O
). O

Altogether O
, O
our O
results O
indicate O
that O
the O
transcriptional O
activity O
of O
Cut _RARE_
proteins I-GENE
is O
modulated O
by O
PKC I-GENE
. O

Lck _RARE_
has O
been O
postulated O
to O
dimerize _RARE_
through O
the O
SH2 _RARE_
and O
SH3 I-GENE
domains I-GENE
. O

Furthermore O
, O
freezing _RARE_
in O
the O
presence O
of O
bovine I-GENE
lactalbumin _RARE_
resulted O
in O
a O
good O
maintenance _RARE_
of O
the O
cellular O
viability O
and O
of O
the O
CCCD _RARE_
heterogeneity O
in O
respect O
to O
fresh O
cells O
. O

Myelomatous _RARE_
pleural _RARE_
effusion _RARE_
as _RARE_
presentation O
form O
of O
multiple O
myeloma O

Five O
- O
year O
survivals _RARE_
amounted _RARE_
to O
100 _RARE_
%, O
86 _RARE_
. O
2 O
%, O
59 _RARE_
. O
4 O
%, O
29 O
. O
8 O
%, O
and O
20 O
% O
for _RARE_
stages O
I O
, O
II O
, O
III O
, O
IVA _RARE_
and O
IVB _RARE_
respectively O
. O

The O
presence O
of O
unidentified O
macroscopic _RARE_
or O
microscopic O
clusters O
of O
neoplastic O
cells O
, O
lying _RARE_
around O
, O
more O
or O
less O
close O
to O
, O
the O
line O
of O
insertion _RARE_
of O
lesion O
, O
could O
render _RARE_
any O
attempt O
to O
gain O
a O
" O
radical O
" O
excision _RARE_
useless _RARE_
. O

The O
partial O
categories O
of O
the O
SIP _RARE_
that O
were O
more O
affected O
were O
work O
, O
recreation _RARE_
and O
pastimes _RARE_
, O
home O
management O
, O
and O
sleep O
and O
rest O
. O

Northern O
blot O
analysis O
, O
using O
the O
Ltp4 _RARE_
- O
specific O
probe O
, O
indicated O
that O
Xanthomonas _RARE_
campestris _RARE_
pv _RARE_
. O
translucens _RARE_
induced _RARE_
an O
increase O
over O
basal O
levels O
of O
Ltp4 _RARE_
mRNA I-GENE
, O
while O
Pseudomonas _RARE_
syringae _RARE_
pv _RARE_
. O
japonica _RARE_
caused O
a O
decrease O
. O

Targeted _RARE_
disruption O
of O
the O
OGG1 _RARE_
gene I-GENE
in O
yeast O
revealed O
a O
second O
OG _RARE_
glycosylase I-GENE
/ I-GENE
lyase I-GENE
protein I-GENE
, O
tentatively O
named O
Ogg2 _RARE_
, O
which O
differs O
from O
Ogg1 _RARE_
in O
that O
it O
preferentially O
acts O
on O
OG _RARE_
: O
G O
. O

Furthermore O
, O
the O
use O
of O
zero O
- O
loss _RARE_
filtering _RARE_
in O
combination O
with O
exit _RARE_
wavefront _RARE_
reconstruction O
is O
considerably O
more O
effective O
at _RARE_
removing O
the O
effects O
of O
multiple O
elastic O
and O
inelastic _RARE_
scattering _RARE_
and O
microscope _RARE_
objective O
lens O
aberrations _RARE_
than O
either O
technique O
by O
itself O
. O

Transcripts _RARE_
for _RARE_
both O
ODV _RARE_
- I-GENE
E18 _RARE_
and O
ODV _RARE_
- I-GENE
EC27 _RARE_
initiate O
from O
conserved _RARE_
TAAG _RARE_
motifs O
, O
and O
transcripts O
are O
detected O
from O
16 O
through O
72 O
hr O
p O
. O
i O
. O

In O
order O
to O
determine O
which O
sequences O
in O
the O
GATA _RARE_
- I-GENE
1 I-GENE
promoter I-GENE
are O
crucial O
for _RARE_
activation O
by O
the O
ME26 _RARE_
viral I-GENE
protein I-GENE
, O
we O
made O
deletions O
of O
the O
promoter O
, O
cloned _RARE_
them O
into O
a O
luciferase I-GENE
expression _RARE_
vector O
and O
tested O
their O
activity O
in O
mouse O
fibroblasts _RARE_
, O
which O
do O
not O
express O
GATA _RARE_
- I-GENE
1 I-GENE
. O

Sequence O
analysis O
of O
the O
isolated O
genomic O
clone O
revealed O
that O
the O
DNA O
binding O
domain O
of O
this O
orphan O
receptor O
is O
most O
homologous O
to O
the O
human I-GENE
TR2 _RARE_
receptor I-GENE
. O

Genomic O
DNA O
hybridization O
suggests O
that O
SpSHR2 _RARE_
is O
a O
single O
- O
copy O
gene O
in O
the O
S O
. O
purpuratus _RARE_
genome O
. O

A O
3 O
- O
yr O
retrospective O
review O
is O
effective O
and O
detects _RARE_
94 O
% O
of O
the O
undercalls _RARE_
. O

Isolation O
and O
identification O
of O
genes O
activating O
UAS2 _RARE_
- I-GENE
dependent I-GENE
ADH2 _RARE_
expression _RARE_
in O
Saccharomyces O
cerevisiae O
. O

METHODS O
AND _RARE_
RESULTS O
: O
A O
64 _RARE_
- O
year O
- O
old O
woman O
with O
confirmed O
AV O
nodal O
reentrant _RARE_
tachycardia O
underwent O
a O
successful O
" O
slow O
pathway _RARE_
" O
AV O
modification O
with O
a O
single O
radiofrequency _RARE_
application O
. O

Patients O
with O
low O
probability _RARE_
of O
having O
aluminum O
overload O
( O
serum O
iron O
levels O
< O
40 O
micrograms O
/ O
L O
and O
DAI _RARE_
< O
150 _RARE_
micrograms O
/ O
L O
) O
had O
significantly O
higher _RARE_
values O
of O
serum O
iron O
, O
iron O
transferrin I-GENE
saturation O
, O
and O
serum I-GENE
ferritin I-GENE
levels O
compared O
with O
those O
patients O
with O
a O
high O
probability _RARE_
of O
having O
aluminum O
overload O
( O
serum O
aluminum O
levels O
> O
40 O
micrograms O
/ O
L O
and O
DAI _RARE_
> O
150 _RARE_
micrograms O
/ O
L O
). O

Although O
the O
RAD23 _RARE_
equivalents _RARE_
are O
well _RARE_
conserved _RARE_
during _RARE_
evolution O
, O
the O
mammalian O
genes O
did O
not O
express O
the O
UV _RARE_
- O
inducible O
phenotype _RARE_
of O
their O
yeast O
counterpart _RARE_
. O

Ha I-GENE
- I-GENE
RasV12 _RARE_
and O
activated O
proteins O
in O
both O
the O
extra _RARE_
- I-GENE
cellular I-GENE
regulated I-GENE
kinase I-GENE
( O
ERK I-GENE
) O
and O
the O
stress I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
( O
SAPK I-GENE
) O
or O
Jun I-GENE
N I-GENE
- I-GENE
terminal I-GENE
kinase I-GENE
( O
JNK I-GENE
) O
cascades _RARE_
independently O
stimulated _RARE_
PEA3 I-GENE
- O
mediated _RARE_
gene O
expression _RARE_
. O

Sequence O
analysis O
of O
reverse O
transcribed _RARE_
, O
amplified O
cDNA O
generated O
from O
total _RARE_
RNA O
isolated O
from O
transfected O
cells O
demonstrated O
the O
presence O
of O
abnormally _RARE_
spliced _RARE_
products O
containing O
13 _RARE_
and O
78 _RARE_
additional O
bases O
as _RARE_
well _RARE_
as _RARE_
the O
accumulation O
of O
unspliced O
mRNA O
. O

Its O
hydropathy _RARE_
profile O
predicts O
seven _RARE_
transmembrane O
spans O
and O
a O
hydrophilic O
amino O
terminus O
of O
approximately _RARE_
100 _RARE_
residues O
, O
and O
it O
suggests O
the O
presence O
of O
an O
amphiphilic _RARE_
alpha O
- O
helix O
( O
L O
- O
61 _RARE_
to O
F O
- O
97 O
) O
in O
close O
proximity _RARE_
to O
the O
first _RARE_
strongly O
hydrophobic O
segment O
of O
ProW _RARE_
. O

A O
1 O
. O
5 O
- O
kb O
HindIII I-GENE
genomic O
fragment O
carrying O
the O
vspA _RARE_
gene O
from O
M O
. O
bovis _RARE_
PG45 _RARE_
was O
cloned _RARE_
and O
sequenced O
. O

Carbon _RARE_
catabolite _RARE_
repression O
of O
the O
gnt _RARE_
operon I-GENE
of I-GENE
Bacillus I-GENE
subtilis I-GENE
is O
mediated _RARE_
by O
the O
catabolite _RARE_
control O
protein O
CcpA _RARE_
and O
by O
HPr _RARE_
, O
a O
phosphocarrier _RARE_
protein O
of O
the O
phosphotransferase _RARE_
system _RARE_
. O

Melatonin _RARE_
and O
seasonality _RARE_
: O
filling O
the O
gap _RARE_
. O

A O
subsequent O
screen O
for _RARE_
the O
loss _RARE_
of O
the O
positively O
selectable O
target O
locus O
marker O
detects _RARE_
the O
desired _RARE_
replacement _RARE_
at _RARE_
modest _RARE_
frequency O
(> O
2 O
%). O

Here O
we O
demonstrate O
that O
another O
cellular O
protein O
linked _RARE_
to O
BCR _RARE_
/ O
ABL I-GENE
through O
the O
CRKL _RARE_
- O
SH2 _RARE_
domain O
is O
p130 I-GENE
( O
CAS _RARE_
). O
p130 I-GENE
( O
CAS _RARE_
) O
was O
found O
to O
be O
tyrosine O
phosphorylated _RARE_
and O
associated O
with O
CRKL _RARE_
in O
BCR _RARE_
/ O
ABL I-GENE
expressing O
cell O
lines O
and O
in O
samples O
obtained O
from O
CML O
and O
ALL O
patients O
, O
but O
not O
in O
samples O
from O
controls O
. O

There O
are O
four O
polyglutamine _RARE_
motifs O
interspersed O
with O
histidine _RARE_
- O
rich O
regions O
. O

The O
effects O
of O
procedural _RARE_
variations O
on O
lateralized _RARE_
Stroop O
effects O
. O

In O
a O
third O
experiment O
, O
a O
Chessmaster _RARE_
gradually O
increases O
the O
number O
of O
boards _RARE_
he _RARE_
can O
reproduce _RARE_
with O
higher _RARE_
than O
70 O
% O
average O
accuracy O
to O
nine O
, O
replacing O
as _RARE_
many O
as _RARE_
160 _RARE_
pieces _RARE_
correctly O
. O

PCNA I-GENE
mRNA I-GENE
has O
a O
3 O
' O
UTR O
antisense _RARE_
to O
yellow O
crescent _RARE_
RNA O
and O
is O
localized O
in O
ascidian _RARE_
eggs O
and O
embryos _RARE_
. O

A O
1 O
. O
8 O
- O
kb O
cDNA O
clone O
( O
designed O
hKID _RARE_
, O
gene I-GENE
symbol _RARE_
AQP2L _RARE_
) O
with O
homology O
to O
the O
aquaporins _RARE_
was O
isolated O
from O
a O
human O
kidney _RARE_
cDNA O
library O
. O

PCR O
/ O
Southern O
blot O
analysis O
of O
human O
kidney _RARE_
cDNA O
using O
primers O
flanking O
the O
hKID _RARE_
coding I-GENE
sequence I-GENE
revealed O
expression _RARE_
of O
a O
full O
- O
length O
mRNA O
and O
short O
transcripts O
with O
partial O
exon _RARE_
1 O
and O
partial O
exon _RARE_
4 O
deletions O
. O

The O
high O
sequence O
homology O
, O
similar O
genomic O
structure _RARE_
, O
and O
identical O
chromosomal O
loci O
of O
hKID _RARE_
, O
MIP _RARE_
, O
and O
AQP _RARE_
- I-GENE
2 I-GENE
suggest O
a O
MIP _RARE_
family I-GENE
gene I-GENE
cluster I-GENE
at _RARE_
chromosome _RARE_
locus O
12q13 _RARE_
. O

The O
third O
ORF O
generates O
a O
transcript O
of O
1 O
. O
6 O
kb O
and O
encodes O
a O
protein O
of O
382 _RARE_
residues O
including O
a O
perfect O
match O
to O
the O
consensus O
sequence O
of O
a O
C2H2 _RARE_
zinc O
finger O
domain O
; O
it O
shares O
a O
strong O
homology O
with O
yeast I-GENE
Mig1p _RARE_
and O
Cre _RARE_
- I-GENE
A I-GENE
from I-GENE
Aspergillus _RARE_
, I-GENE
Emericella _RARE_
and I-GENE
E I-GENE
. I-GENE
coli I-GENE
. O

Adding _RARE_
phytase _RARE_
and O
nP _RARE_
improved O
the O
orderliness _RARE_
of O
development O
, O
mineralization _RARE_
and O
arrangement O
of O
cartilage O
and O
bone O
cells O
, O
and O
alleviated _RARE_
the O
effects O
of O
P O
deficiency O
on O
the O
histological O
and O
gross O
structure _RARE_
of O
the O
tibias _RARE_
. O

The O
importance O
of O
temporal O
factors O
on O
the O
presence O
and O
severity O
of O
ethanol O
withdrawal O
signs O
in O
the O
rat O
was O
quantified _RARE_
using O
rating O
scale O
, O
tremor O
, O
and O
acoustic O
startle _RARE_
paradigms _RARE_
. O

Data O
supported O
the O
brevity _RARE_
of O
the O
WISC _RARE_
- O
III O
short O
form O
and O
the O
criterion O
- O
related O
validity O
of O
both O
the O
K O
- O
FAST _RARE_
and O
and O
Kaufman _RARE_
Short O
Neuropsychological _RARE_
Assessment O
Procedure _RARE_
( O
K O
- O
SNAP _RARE_
). O

Quantitative O
analysis O
of O
plasmid _RARE_
loss _RARE_
rates O
in O
cdc28 _RARE_
- I-GENE
1N _RARE_
strains O
carrying O
plasmids O
with O
multiple O
replication O
origins O
suggests O
that O
a O
defect O
in O
initiating O
DNA O
replication O
probably O
causes O
this O
plasmid _RARE_
loss _RARE_
phenotype _RARE_
. O

Thus O
, O
the O
multidomained _RARE_
ROK _RARE_
alpha I-GENE
appears O
to O
be O
involved O
in O
reorganization _RARE_
of O
the O
cytoskeleton _RARE_
, O
with O
the O
N O
and O
C O
termini O
acting O
as _RARE_
positive O
and O
negative O
regulators _RARE_
, O
respectively O
, O
of O
the O
kinase O
domain O
whose O
activity O
is O
crucial O
for _RARE_
formation O
of O
stress O
fibers O
and O
focal _RARE_
adhesion O
complexes O
. O

These O
findings O
and O
the O
differential O
tissue O
distribution O
of O
p54 I-GENE
suggest O
that O
this O
novel O
SR I-GENE
protein I-GENE
may O
participate O
in O
regulation _RARE_
of O
alternative _RARE_
splicing _RARE_
in O
a O
tissue O
- O
and O
substrate O
- O
dependent O
manner O
. O

The O
elevation O
of O
cyclic O
AMP O
( O
cAMP O
) O
levels O
in O
the O
cell O
downregulates _RARE_
the O
activity O
of O
the O
Raf I-GENE
- I-GENE
1 I-GENE
kinase I-GENE
. O

An O
interaction O
screen O
with O
the O
repression O
domain O
of O
the O
orphan I-GENE
receptor I-GENE
RevErb _RARE_
identified O
N I-GENE
- I-GENE
CoR _RARE_
, O
the O
corepressor _RARE_
for _RARE_
thyroid I-GENE
hormone I-GENE
receptor I-GENE
( O
TR I-GENE
) O
and O
retinoic I-GENE
acid I-GENE
receptor I-GENE
( O
RAR I-GENE
). O

These O
results O
indicate O
that O
inhibition O
of O
Jun I-GENE
kinase I-GENE
activation O
was O
sufficient O
to O
inhibit O
Ras I-GENE
transformation O
even O
in O
the O
presence O
of O
activated O
Erk _RARE_
- I-GENE
2 I-GENE
. O

Our O
analysis O
suggests O
that O
Upf1p _RARE_
is O
a O
multifunctional _RARE_
protein O
with O
separable _RARE_
activities O
that O
can O
affect O
mRNA O
turnover O
and O
nonsense O
suppression O
. O

Identification O
of O
Ste4 _RARE_
as _RARE_
a O
potential _RARE_
regulator O
of O
Byr2 _RARE_
in O
the O
sexual O
response O
pathway _RARE_
of O
Schizosaccharomyces O
pombe O
. O

Two O
closely O
related O
variants O
of O
Stat5 I-GENE
, O
Stat5a I-GENE
and O
Stat5b _RARE_
, O
are O
encoded O
by O
distinct O
genes O
. O

Mutations O
in O
three O
loci O
( O
SIC1 _RARE_
, O
SWI5 _RARE_
, O
and O
RIC3 _RARE_
) O
were O
identified O
. O

The O
serine I-GENE
/ I-GENE
threonine I-GENE
kinase I-GENE
Raf I-GENE
- I-GENE
1 I-GENE
functions O
downstream _RARE_
of O
Rats _RARE_
in O
a O
signal O
transduction _RARE_
cascade O
which O
transmits _RARE_
mitogenic O
stimuli O
from O
the O
plasma O
membrane O
to O
the O
nucleus O
. O

Platelet _RARE_
- I-GENE
derived I-GENE
growth I-GENE
factor I-GENE
- O
dependent O
activation O
of O
phosphatidylinositol _RARE_
3 I-GENE
- I-GENE
kinase I-GENE
is O
regulated O
by O
receptor O
binding O
of O
SH2 _RARE_
- I-GENE
domain I-GENE
- I-GENE
containing I-GENE
proteins I-GENE
which O
influence O
Ras I-GENE
activity O
. O

In O
transient O
cotransfections _RARE_
E1A I-GENE
could O
induce O
the O
activity O
of O
the O
p53 I-GENE
promoter I-GENE
to O
a O
high O
level O
; O
12S _RARE_
E1A I-GENE
was O
threefold O
as _RARE_
efficient O
as _RARE_
13S _RARE_
E1A I-GENE
in O
this O
activity O
, O
and O
YY1 I-GENE
bound _RARE_
to O
the O
composite O
element O
was O
shown O
to O
mediate O
55 _RARE_
% O
of O
this O
induction O
. O

The O
retinoid I-GENE
Z I-GENE
receptor I-GENE
beta I-GENE
( O
RZR _RARE_
beta I-GENE
), _RARE_
an O
orphan O
receptor O
, O
is O
a O
member _RARE_
of O
the O
retinoic I-GENE
acid I-GENE
receptor I-GENE
( O
RAR I-GENE
)/ _RARE_
thyroid I-GENE
hormone I-GENE
receptor I-GENE
( O
TR I-GENE
) O
subfamily O
of O
nuclear O
receptors O
. O

DNA I-GENE
- I-GENE
dependent I-GENE
protein I-GENE
kinase I-GENE
( O
DNA I-GENE
- I-GENE
PK _RARE_
) O
consists O
of O
a O
heterodimeric _RARE_
protein O
( O
Ku _RARE_
) O
and O
a O
large O
catalytic O
subunit O
( O
DNA I-GENE
- I-GENE
PKcs _RARE_
). O

Almost _RARE_
complete _RARE_
sequence O
identity O
was O
found O
between O
the O
3 O
' O
end O
of O
the O
DXS6673E _RARE_
gene I-GENE
and O
two O
expressed _RARE_
sequence O
tags O
( O
ESTs _RARE_
) O
and O
between O
the O
5 O
' O
end O
of O
the O
DXS6673E _RARE_
gene I-GENE
and O
a O
third O
EST _RARE_
. O

Sequencing O
of O
the O
16p _RARE_
11 O
. O
1 O
/ O
Xq28 _RARE_
duplication O
breakpoints O
has O
revealed O
the O
presence O
of O
repetitive _RARE_
immunoglobulin I-GENE
- I-GENE
like I-GENE
CAGGG _RARE_
pentamer _RARE_
sequences I-GENE
at _RARE_
or O
near O
the O
paralogy _RARE_
boundaries O
. O

However O
, O
in O
a O
multivariate O
analysis O
considering _RARE_
age O
, O
gender O
, O
and O
a O
previous O
history O
of O
cardiovascular O
diseases O
, O
female O
gender O
was O
not O
independently O
associated O
with O
death _RARE_
. O

Moreover O
, O
following O
a O
single O
intravenous O
injection O
of O
the O
bicistronic _RARE_
vector O
complexed O
to O
cationic _RARE_
liposomes O
into O
recipient O
mice O
, O
delivery O
of O
MDR1 _RARE_
and O
GC _RARE_
cDNAs I-GENE
was O
achieved O
in O
all O
the O
organs O
we O
tested O
. O

The O
limits O
of O
agreement O
between O
DBS _RARE_
and O
TOF O
responses O
were O
so O
wide O
that O
they O
cannot O
be O
used O
interchangeably _RARE_
. O

The O
harpin _RARE_
- O
encoding O
hrpZ _RARE_
gene I-GENE
is O
located _RARE_
in O
an O
operon O
that O
also O
encodes O
Hrp _RARE_
secretion _RARE_
pathway _RARE_
components _RARE_
and O
is O
part O
of O
the O
functional _RARE_
cluster O
of O
hrp _RARE_
genes I-GENE
carried O
on O
cosmid O
pHIR11 _RARE_
that O
enables O
saprophytic _RARE_
bacteria O
like O
Escherichia O
coli O
and O
Pseudomonas _RARE_
fluorescens _RARE_
to O
elicit O
the O
HR O
in O
tobacco O
leaves O
. O

Despite O
the O
presence O
of O
one O
additional O
ribonucleotide _RARE_
reductase I-GENE
, O
the O
nrdAB _RARE_
- I-GENE
encoded I-GENE
enzyme I-GENE
is O
essential O
to O
the O
aerobic O
growth O
of O
the O
cell O
because O
nrdAB _RARE_
- I-GENE
defective _RARE_
mutants I-GENE
of O
both O
species O
are O
not O
viable O
in O
the O
presence O
of O
oxygen O
. O

Altogether O
, O
the O
results O
demonstrate O
that O
the O
two O
isoforms O
elicit O
similar O
responses O
in O
vivo O
despite O
differences O
in O
their O
regulation _RARE_
. O

Motivational _RARE_
factors O
focusing O
on O
attitudes _RARE_
, O
perceived O
susceptibility _RARE_
to O
pregnancy _RARE_
, O
and O
normative _RARE_
factors O
were O
also O
relevant O
. O

High _RARE_
- O
resolution O
structure _RARE_
of O
the O
diphtheria _RARE_
toxin _RARE_
repressor I-GENE
complexed O
with O
cobalt _RARE_
and O
manganese _RARE_
reveals O
an O
SH3 I-GENE
- I-GENE
like I-GENE
third O
domain O
and O
suggests O
a O
possible O
role O
of O
phosphate O
as _RARE_
co _RARE_
- O
corepressor _RARE_
. O

Titration _RARE_
of O
the O
human O
and O
porcine _RARE_
proteins O
with O
2 O
- O
nitro _RARE_
- O
5 O
- O
thiosulfabenzoate _RARE_
indicates O
that O
membrane I-GENE
dipeptidase _RARE_
additionally O
possesses O
two O
intrachain _RARE_
disulfide O
bonds O
. O

FEV1 O
did O
not O
fall O
significantly O
in O
patients O
without O
acute O
or O
chronic O
GVHD _RARE_
and O
recovered O
earlier O
than O
in O
patients O
without O
posttransplant _RARE_
pulmonary O
infection O
. O

Administration O
of O
adrenaline O
resulted O
in O
a O
large O
overestimation _RARE_
of O
the O
SaO2 O
in O
6 O
of O
the O
7 O
measurements O
. O

Therapy _RARE_
with O
dietary O
modification O
and O
triglyceride _RARE_
lowering O
drugs O
resulted O
in O
resolution O
of O
symptoms O
and O
parotid _RARE_
swelling O
in O
one O
patient O
. O

Chernoff _RARE_
, O
submitted O
for _RARE_
publication _RARE_
). O

We O
have O
cloned _RARE_
a O
novel O
protein O
kinase O
, O
termed O
hematopoietic I-GENE
progenitor _RARE_
kinase I-GENE
1 I-GENE
( O
HPK1 _RARE_
), _RARE_
that O
is O
expressed _RARE_
predominantly O
in O
hematopoietic O
cells O
, O
including O
early O
progenitor _RARE_
cells O
. O

Human O
ESP1 _RARE_
/ O
CRP2 _RARE_
protein O
has O
two O
LIM I-GENE
domains O
, O
and O
each O
shares O
35 _RARE_
. O
1 O
% O
and O
77 O
or O
79 _RARE_
% O
identical O
residues O
with O
human I-GENE
cysteine I-GENE
- I-GENE
rich I-GENE
protein I-GENE
( O
CRP I-GENE
) O
and O
rat I-GENE
CRIP _RARE_
, O
respectively O
. O

The O
fragments O
are O
separated O
and O
directly O
sized O
by O
agarose O
gel O
electrophoresis O
. O

Several O
of O
the O
exon _RARE_
boundaries O
correspond O
to O
the O
boundaries O
of O
functional _RARE_
domains O
in O
the O
p55 I-GENE
protein I-GENE
. O

Linkage _RARE_
studies O
have O
shown O
locus O
heterogeneity O
with O
one O
TSC _RARE_
gene I-GENE
mapped O
to O
chromosome _RARE_
9q34 _RARE_
and O
a O
second O
to O
16p13 _RARE_
. O
3 O
. O

The O
cytogenetic O
expression _RARE_
of O
the O
folate _RARE_
sensitive _RARE_
fragile _RARE_
site O
, O
FRAXE _RARE_
, O
is O
due O
to O
the O
expansion O
of O
a O
GCC _RARE_
repeat O
in O
proximal O
Xq28 _RARE_
of O
the O
human O
X O
chromosome _RARE_
and O
is O
associated O
with O
a O
mild O
form O
of O
mental O
handicap _RARE_
. O

DNA O
sequence O
analysis O
of O
a O
3213 _RARE_
bp O
BamHI I-GENE
- O
ClaI _RARE_
fragment O
revealed O
that O
three O
open _RARE_
reading O
frames O
( O
ORFs _RARE_
) O
were O
encoded O
in O
the O
same O
orientation O
. O

The O
initial O
inpatient _RARE_
experience O
for _RARE_
individuals O
with O
HIV O
- O
related O
TB _RARE_
may O
be O
pivotal O
to O
the O
acceptance _RARE_
of O
and O
participation O
in O
ongoing _RARE_
TB _RARE_
care O
. O

Tristetraprolin _RARE_
( O
TTP _RARE_
) O
is O
the O
prototype O
of O
a O
group O
of O
potential _RARE_
transcription O
factors O
that O
contain O
two O
or O
more O
unusual O
CCCH _RARE_
zinc O
fingers _RARE_
. O

This O
element O
, O
termed O
CREsp _RARE_
- O
a O
( O
TGACCTCA _RARE_
), _RARE_
differs O
by O
one O
nucleotide O
from O
a O
palindromic O
CRE _RARE_
( O
CREpal _RARE_
, O
TGACGTCA _RARE_
), _RARE_
which O
is O
known O
to O
bind O
CREB I-GENE
as _RARE_
a O
homodimer _RARE_
. O

Analysis O
of O
human O
genomic O
DNA O
reveals O
an O
intronless O
sequence O
with O
strong O
homology O
to O
human I-GENE
G I-GENE
alpha I-GENE
q _RARE_
cDNA I-GENE
. O

The O
complete _RARE_
exon _RARE_
- O
intron O
structure _RARE_
of O
the O
156 _RARE_
- I-GENE
kb I-GENE
human I-GENE
gene I-GENE
NFKB1 _RARE_
, O
which O
encodes O
the O
p105 _RARE_
and O
p50 _RARE_
proteins I-GENE
of O
transcription O
factors O
NF _RARE_
- I-GENE
kappa _RARE_
B I-GENE
and O
I I-GENE
kappa _RARE_
B I-GENE
- I-GENE
gamma I-GENE
: O
implications O
for _RARE_
NF _RARE_
- I-GENE
kappa _RARE_
B I-GENE
- O
mediated _RARE_
signal O
transduction _RARE_
. O

An O
inverted O
Alu I-GENE
repeat O
element O
, O
flanked O
by O
nonamer _RARE_
direct O
repeats O
, O
was O
identified O
within O
the O
region O
- O
913 _RARE_
/- O
620 _RARE_
, O
relative O
to O
the O
cap _RARE_
site O
. O

The O
ewes _RARE_
were O
returned O
to O
normoxia _RARE_
, O
and O
monitoring O
was O
continued O
for _RARE_
1 O
h O
. O

Feline _RARE_
leukemia O
viruses O
( O
FeLVs _RARE_
), _RARE_
which O
are O
replication O
- O
competent O
oncoretroviruses _RARE_
of O
the O
domestic _RARE_
cat _RARE_
species O
, O
are O
contagiously _RARE_
transmitted O
in O
natural _RARE_
environments _RARE_
. O

Comparison O
of O
the O
amino O
acid O
sequences O
of O
the O
RPO1 _RARE_
polypeptides I-GENE
of I-GENE
IIV6 _RARE_
, I-GENE
LCDV _RARE_
, I-GENE
and I-GENE
MCV _RARE_
- I-GENE
1 I-GENE
with O
the O
corresponding O
prokaryotic _RARE_
, O
eukaryotic O
, O
and O
viral O
proteins O
revealed O
differences O
in O
amino O
acid O
similarity _RARE_
and O
phylogenetic O
relationships O
. O

The O
RPO1 _RARE_
of O
LCDV _RARE_
shows O
the O
highest O
similarity _RARE_
to O
the O
RPO1 _RARE_
of O
IIV6 _RARE_
and O
significant O
lower O
similarity _RARE_
to O
the O
eukaryotic I-GENE
polymerases _RARE_
II I-GENE
and I-GENE
III I-GENE
as _RARE_
well _RARE_
as _RARE_
to O
the O
archaebacteral _RARE_
subunit O
. O

The O
use O
of O
primary _RARE_
GE _RARE_
cells O
thus O
provides O
a O
convenient _RARE_
in O
vitro O
system _RARE_
for _RARE_
further O
study O
of O
the O
endocrine O
, O
paracrine _RARE_
, O
and O
autocrine O
factors O
regulating _RARE_
endometrial O
gene O
expression _RARE_
during _RARE_
pregnancy _RARE_
. O

We O
performed O
dipole _RARE_
estimation O
of O
spikes O
and O
SEP _RARE_
components _RARE_
in O
identical O
patients O
. O

Both O
verapamil O
and O
propranolol O
can O
exhibit O
additive O
effects O
with O
adenosine O
in O
prolonging _RARE_
AV O
nodal O
conduction O
time O
; O
however O
, O
only O
verapamil O
can O
reduce O
the O
dose O
of O
adenosine O
required O
to O
produce O
AV O
nodal O
block _RARE_
. O

Proximal _RARE_
CBD _RARE_
was O
inversely O
correlated O
with O
bone I-GENE
alkaline _RARE_
phosphatase I-GENE
( O
r _RARE_
= O
- O
0 _RARE_
. O
71 _RARE_
, O
p O
< O
0 _RARE_
. O
01 O
) O
and O
intact _RARE_
PTH _RARE_
( O
r _RARE_
= O
- O
0 _RARE_
. O
59 _RARE_
, O
p O
< O
0 _RARE_
. O
05 O
). O

In O
addition O
, O
a O
comparison O
of O
the O
hCHLR _RARE_
gene I-GENE
sequences I-GENE
with O
available O
databases _RARE_
indicates O
that O
a O
large O
portion O
of O
these O
genes O
, O
including O
exons O
encoding O
two O
functional _RARE_
domains O
of O
the O
carboxyl _RARE_
- O
terminal O
region O
of O
these O
proteins O
, O
has O
been O
duplicated O
as _RARE_
part O
of O
a O
larger O
human O
telomeric O
repeat O
sequence O
found O
on O
many O
human O
chromosomes O
. O

We O
show O
here O
that O
the O
LIM I-GENE
domain I-GENE
homeobox _RARE_
protein I-GENE
isl _RARE_
- I-GENE
1 I-GENE
activates O
the O
rat I-GENE
amylin _RARE_
promoter I-GENE
in O
both O
fibroblast O
and O
islet O
cell O
lines O
. O

Although O
isl _RARE_
- I-GENE
1 I-GENE
binds O
to O
both O
the O
insulin I-GENE
and O
amylin _RARE_
gene I-GENE
promoter I-GENE
elements I-GENE
in O
vitro O
, O
these O
sequences O
display O
marked O
differences O
in O
their O
relative O
transcriptional O
properties O
when O
ligated O
adjacent O
to O
a O
heterologous O
promoter O
and O
transfected O
into O
InR1 _RARE_
- O
G9 _RARE_
islet O
cells O
. O

It O
is O
likely O
that O
other O
pathways O
involve O
alternate O
signal O
transduction _RARE_
events O
( O
e _RARE_
. O
g O
., O
calcium _RARE_
mobilization _RARE_
) O
and O
promoter O
response O
elements O
( O
e _RARE_
. O
g O
., O
SRE O
). O

The O
CD4 _RARE_
count O
at _RARE_
which O
remission O
occurs O
may O
reflect O
severe O
immunodeficiency O
such O
that O
risk O
for _RARE_
AIDS O
- O
related O
infection O
is O
high O
. O

Although O
diagnostic O
laparoscopy _RARE_
is O
still O
considered O
the O
standard O
reference O
in O
the O
diagnosis O
of O
ectopic O
pregnancy _RARE_
( O
EP _RARE_
), _RARE_
use O
of O
high O
- O
resolution O
endovaginal _RARE_
sonography _RARE_
, O
in O
conjunction O
with O
qualitative O
serum O
assays O
of O
the O
beta O
subunit O
of O
human I-GENE
chorionic _RARE_
gonadotropin I-GENE
( O
beta I-GENE
- I-GENE
hCG I-GENE
), _RARE_
allows O
detection O
of O
earlier O
and O
smaller O
EPs _RARE_
. O

Bifunctionality _RARE_
of O
the O
AcMNPV _RARE_
homologous I-GENE
region I-GENE
sequence I-GENE
( O
hr1 _RARE_
): O
enhancer O
and O
ori _RARE_
functions O
have O
different O
sequence O
requirements O
. O

RVR _RARE_
' O
loss _RARE_
of O
function O
' O
studies O
by O
constitutive _RARE_
over O
- O
expression _RARE_
of O
a O
dominant O
negative O
RVR _RARE_
delta I-GENE
E I-GENE
resulted O
in O
increased O
levels O
of O
p21Cip1 _RARE_
/ O
Waf1 _RARE_
and O
myogenin I-GENE
mRNAs I-GENE
after O
serum O
withdrawal O
. O

Neither O
CES1 _RARE_
nor O
CES4 _RARE_
is O
essential O
for _RARE_
cell O
growth O
, O
and O
a O
double O
deletion O
mutant O
is O
viable O
. O

These O
two O
repeat O
motifs O
are O
organized O
in O
an O
extremely O
well _RARE_
- O
ordered _RARE_
pattern O
in O
each O
domain O
, O
which O
suggests O
that O
SbHRGP3 _RARE_
belongs O
to O
a O
new O
group O
of O
proteins O
having O
the O
repeat O
motifs O
of O
two O
distinct O
groups O
of O
dicot _RARE_
extensins _RARE_
. O

Their O
use O
established O
that O
the O
BrAAP _RARE_
activity O
catalyzed O
both O
a O
postproline _RARE_
and O
a O
postglutamate _RARE_
cleavage _RARE_
and O
therefore O
has O
a O
broader _RARE_
specificity _RARE_
than O
previously O
recognized _RARE_
. O

To O
explore O
the O
functional _RARE_
significance O
of O
these O
subdomains O
in O
PRL I-GENE
binding O
and O
signal O
transduction _RARE_
, O
deletion O
mutants O
of O
S1 O
or O
/ O
and O
S2 _RARE_
subdomains O
were O
constructed O
. O

A O
stable O
heterologous O
cell O
line O
containing O
the O
mouse I-GENE
TRH I-GENE
receptor I-GENE
was O
constructed O
by O
transfection O
of O
nonexcitable _RARE_
293 O
cells O
, O
which O
lack O
L O
channel _RARE_
activity O
. O

To O
understand O
further O
the O
expression _RARE_
and O
regulation _RARE_
of O
the O
V1aR _RARE_
, O
we O
now O
describe O
the O
genomic O
characteristics O
, O
tissue O
expression _RARE_
, O
chromosomal O
localization _RARE_
, O
and O
regional O
mapping O
of O
the O
human I-GENE
V1aR _RARE_
gene I-GENE
, O
AVPR1A _RARE_
. O

The O
final O
predicted O
structure _RARE_
has O
an O
overall O
backbone _RARE_
deviation O
of O
0 _RARE_
. O
7 O
A O
from O
that O
of O
ras I-GENE
- O
p21 I-GENE
. O

Genomic O
organization O
of O
the O
human I-GENE
beta I-GENE
- I-GENE
catenin I-GENE
gene I-GENE
( O
CTNNB1 _RARE_
). O

Furthermore O
, O
although O
the O
regional O
distribution O
of O
lean O
tissue O
mass O
in O
the O
trunk O
and O
legs _RARE_
remained O
fairly _RARE_
constant O
at _RARE_
different O
pubertal _RARE_
stages O
, O
the O
regional O
distribution O
of O
fat O
was O
altered O
significantly O
, O
becoming _RARE_
more O
central O
and O
less O
peripheral O
. O

Thus O
, O
the O
predicted O
CD30v _RARE_
protein I-GENE
retains O
most O
of O
the O
cytoplasmic O
region O
, O
but O
lacks O
the O
extracellular O
and O
transmembrane O
domains O
. O

Constitutive _RARE_
phosphorylation _RARE_
of O
the O
CD30v _RARE_
protein I-GENE
was O
demonstrated O
by O
in O
vitro O
labeling O
with O
[ _RARE_
32P O
]. O

17 _RARE_
. O
5 O
% O
of O
cycles O
). O

We O
report O
here O
the O
discovery O
of O
a O
new O
actin I-GENE
- I-GENE
related I-GENE
gene I-GENE
in O
this O
organism O
, O
which O
we O
have O
named O
ACT4 _RARE_
. O

Two O
of O
the O
ORFs _RARE_
are O
completely O
internal O
to O
longer O
ones O
and O
a O
third O
is O
partially O
embedded O
in O
G2850 _RARE_
. O

MVR _RARE_
typing _RARE_
of O
rare O
- O
length O
alleles O
indicates O
that O
they O
are O
comprised O
of O
disorganized _RARE_
sequences O
, O
although O
they O
usually O
bear _RARE_
a O
resemblance _RARE_
to O
one O
of O
the O
common O
alleles O
at _RARE_
the O
5 O
'- O
most O
end O
. O

Plasmid _RARE_
pAL618 _RARE_
contains O
the O
genetic O
determinants _RARE_
for _RARE_
H2 O
uptake O
( O
hup _RARE_
) O
from O
Rhizobium _RARE_
leguminosarum _RARE_
bv _RARE_
. O
viciae _RARE_
, O
including O
a O
cluster O
of O
17 _RARE_
genes O
named O
hupSLCDEFGHIJK _RARE_
- I-GENE
hypABFCDE _RARE_
. O

Two O
classes O
of O
inactive O
receptors O
were O
identified O
: O
one O
in O
which O
both O
transcriptional O
activation O
and O
dimerization _RARE_
were O
compromised _RARE_
and O
a O
second O
in O
which O
only O
transcriptional O
activation O
was O
abolished O
. O

Here O
we O
localize O
a O
transferable _RARE_
40 O
- O
amino O
acid O
region O
within O
the O
LBDs _RARE_
of O
RXR I-GENE
, O
RAR I-GENE
, O
TR I-GENE
, O
and O
chicken I-GENE
ovalbumin _RARE_
upstream I-GENE
promoter I-GENE
transcription I-GENE
factor I-GENE
that O
is O
critical O
for _RARE_
determining _RARE_
identity O
in O
the O
heterodimeric _RARE_
interaction O
and O
for _RARE_
high O
- O
affinity O
DNA O
binding O
. O

OKA _RARE_
and O
calyculin _RARE_
A O
do O
not O
decrease O
OCFRE _RARE_
DNA O
- O
protein O
interactions O
, O
suggesting O
that O
important O
protein O
- O
protein O
interactions O
are O
phosphatase O
regulated O
. O

An O
open _RARE_
- O
label _RARE_
, O
placebo O
- O
controlled _RARE_
, O
randomized O
, O
two O
- O
way O
crossover _RARE_
study O
was O
performed O
in O
12 O
healthy O
volunteers O
( O
between O
20 O
and O
44 _RARE_
years O
of O
age O
) O
to O
assess O
the O
effect O
of O
orlistat _RARE_
, O
a O
gastrointestinal _RARE_
lipase I-GENE
inhibitor O
that O
reduces O
dietary O
fat O
absorption O
and O
is O
being O
developed O
for _RARE_
weight _RARE_
control O
in O
obesity O
, O
on O
the O
absorption O
of O
vitamins _RARE_
A O
and O
E O
. O

Tilmicosin _RARE_
is O
a O
novel O
macrolide _RARE_
antibiotic O
developed O
for _RARE_
exclusive _RARE_
use O
in O
veterinary _RARE_
medicine O
. O

Effect O
of O
nitrous _RARE_
oxide O
( O
N2O O
) O
on O
the O
somatosympathetic _RARE_
A O
- O
and O
C O
- O
reflexes _RARE_
was O
investigated O
using O
artificially O
ventilated O
rats O
anesthetized O
with O
alpha O
- O
chloralose _RARE_
and O
urethane _RARE_
. O

Restriction O
enzyme O
mapping O
and O
Southern O
analysis O
indicated O
further O
that O
the O
human I-GENE
MZF _RARE_
- I-GENE
1 I-GENE
gene I-GENE
is O
a O
single O
- O
copy O
gene O
. O

In O
the O
absence O
of O
Swi4 _RARE_
and O
Swi6 _RARE_
cell O
viability O
is O
lost O
, O
but O
can O
be O
regained _RARE_
by O
ectopic O
expression _RARE_
of O
the O
G1 I-GENE
cyclin _RARE_
encoding I-GENE
genes I-GENE
, O
CLN1 _RARE_
or O
CLN2 _RARE_
. O

The O
detection O
ratio O
peaked _RARE_
at _RARE_
ages O
30 _RARE_
to O
34 _RARE_
and O
decreased O
heavily _RARE_
during _RARE_
the O
next O
15 _RARE_
years O
of O
age O
. O

How _RARE_
many O
embryos _RARE_
to O
transfer O
in O
patients O
undergoing O
IVF _RARE_
? O

IMPLICATIONS _RARE_
: O
Given _RARE_
the O
small O
size O
of O
this O
study O
and O
the O
inconsistency _RARE_
of O
results O
among O
the O
few O
prospective O
studies O
of O
ovarian O
cancer _RARE_
conducted O
to O
test O
these O
associations O
, O
replications _RARE_
of O
these O
findings O
are O
highly O
desirable _RARE_
. O

The O
nonconsensus _RARE_
TATA O
box O
in O
promoter O
B O
plays O
a O
more O
important O
role O
in O
promoter O
activity O
than O
the O
TATA O
box O
in O
promoter O
A O
. O

These O
properties O
indicate O
that O
Gle1 _RARE_
is O
an O
RNA O
- O
export O
factor O
and O
that O
Rev _RARE_
may O
mediate O
viral O
RNA O
export O
by O
mimicking _RARE_
the O
function O
of O
Gle1 _RARE_
. O

Demispan _RARE_
is O
a O
reliable O
and O
reproducible _RARE_
measure O
of O
stature _RARE_
in O
the O
elderly O
. O

Two O
techniques O
based O
on O
assay O
coefficients O
of O
variation O
were O
employed O
to O
characterize O
a O
normal O
circadian O
pattern O
of O
cortisol O
. O

We O
have O
performed O
toeprinting _RARE_
analyses O
on O
repA _RARE_
mRNA I-GENE
of O
plasmid _RARE_
R1 _RARE_
, O
both O
free O
and O
in O
duplex O
with O
the O
antisense _RARE_
RNA O
, O
CopA _RARE_
. O

Previous O
work O
showed O
that O
repA _RARE_
( O
initiator _RARE_
protein O
) O
expression _RARE_
requires O
tap _RARE_
( O
leader _RARE_
peptide O
) O
translation O
. O

A O
system _RARE_
is O
described O
in O
which O
the O
volume O
flow O
rate O
of O
blood _RARE_
in O
a O
vessel O
is O
determined O
using O
transverse O
colour _RARE_
Doppler O
ultrasound O
imaging O
. O

The O
enzyme O
activities O
studied O
are O
important O
elements O
in O
the O
pathophysiology O
of O
dental O
caries _RARE_
and O
may O
even O
be O
addressed O
as _RARE_
virulence _RARE_
factors O
. O

Tonsillectomy _RARE_
is O
an O
effective O
means O
of O
prophylaxis O
for _RARE_
upper O
respiratory O
infection O
in O
habitual _RARE_
angina O
patients O
. O

In O
lean O
mice O
, O
the O
fat O
/ O
water O
intensity O
ratio O
was O
about O
1 O
: O
4 O
, O
about O
half _RARE_
that O
in O
normal O
mice O
. O

Pharmacokinetic _RARE_
parameters O
were O
similar O
to O
values O
given O
in O
the O
literature O
for _RARE_
intravenous O
( O
IV O
) O
or O
intraarterial _RARE_
( O
IA O
) O
bolus O
MMC O
injections O
( O
Tmax _RARE_
= O
7 O
. O
0 _RARE_
min O
following O
the O
beginning O
of O
MMC O
infusion O
, O
Vss _RARE_
= O
0 _RARE_
. O
57 O
1 O
/ O
kg O
, O
C1 O
= O
8 O
. O
9 O
ml O
/ O
min O
. O
kg O
, O
T1 _RARE_
/ O
2 O
alpha O
= O
8 O
. O
3 O
min O
, O
T1 _RARE_
/ O
2 O
beta O
= O
58 O
. O
6 O
min O
). O

In O
this O
study O
, O
we O
identified O
four O
distinct O
E2F I-GENE
complexes I-GENE
present O
in O
aged O
and O
senescent _RARE_
normal O
, O
human O
diploid O
fibroblasts _RARE_
. O

This O
paper O
gives O
an O
overview _RARE_
of O
the O
global O
pattern O
of O
casualties _RARE_
in O
earthquakes _RARE_
which O
occurred O
during _RARE_
the O
30 _RARE_
- O
month O
period O
from O
1 O
September _RARE_
1993 O
to O
29 O
February _RARE_
1996 O
. O

If O
we O
apply _RARE_
the O
finding O
of O
non O
- O
visualization O
of O
the O
GB _RARE_
at _RARE_
4 O
h O
post O
injection O
as _RARE_
the O
criterion O
for _RARE_
the O
diagnosis O
of O
AC _RARE_
, O
the O
diagnostic O
accuracy O
was O
only O
40 O
. O
7 O
% O
( O
11 O
/ O
27 _RARE_
). O

These O
results O
were O
corroborated _RARE_
in O
a O
subsequent O
study O
in O
which O
30 _RARE_
hypogonadal _RARE_
men O
were O
supplemented O
with O
SLT _RARE_
5 O
mg O
three O
times O
daily O
for _RARE_
6 O
months O
. O

Alternative O
processing _RARE_
of O
the O
tryptophanyl _RARE_
- I-GENE
tRNA I-GENE
synthetase _RARE_
mRNA I-GENE
from O
interferon _RARE_
- O
treated O
human O
cells O
. O

Evidence O
for _RARE_
the O
promoting _RARE_
role O
of O
the O
intra _RARE_
- I-GENE
uterine _RARE_
kinin _RARE_
release O
in O
the O
development O
of O
late _RARE_
hypertonic _RARE_
saline O
- O
induced _RARE_
abortion O
. O

This O
GAP _RARE_
activity O
was O
observed O
in O
3T3 O
- O
L1 O
adipocyte _RARE_
lysates O
, O
and O
was O
able O
to O
accelerate _RARE_
the O
hydrolysis O
of O
the O
[ _RARE_
alpha O
- O
32P O
] O
GTP O
bound _RARE_
to O
GST I-GENE
- O
Rab4 _RARE_
into O
[ _RARE_
alpha O
- O
32P O
] O
GDP O
. O

CONCLUSION O
: O
During O
chronic O
treatment O
, O
the O
haemodynamic _RARE_
response O
to O
oral O
cilazapril _RARE_
was O
attenuated O
, O
indicating O
that O
continued O
clinical O
improvement O
in O
patients O
with O
CHF _RARE_
on O
CLZ _RARE_
is O
independent O
of O
to O
its O
acute O
haemodynamic _RARE_
effects O
. O

We O
conclude O
that O
, O
in O
AIDS O
patients O
with O
cryptococcosis _RARE_
, O
tolerance O
to O
ILd _RARE_
- O
AmB _RARE_
was O
acceptable O
when O
the O
daily O
dosage O
did O
not O
exceed _RARE_
1 O
mg O
/ O
kg O
, O
but O
the O
higher _RARE_
1 O
. O
5 O
mg O
/ O
kg O
daily O
dosage O
was O
associated O
with O
an O
unacceptable _RARE_
rate O
of O
nephrotoxicity _RARE_
. O

Moreover O
, O
the O
second O
RCC1 _RARE_
- I-GENE
like I-GENE
motif I-GENE
located _RARE_
at _RARE_
the O
amino O
- O
terminus O
of O
p619 _RARE_
stimulates O
guanine O
nucleotide O
exchange O
on O
ARF1 _RARE_
and O
on O
members O
of O
the O
related O
Rab _RARE_
proteins I-GENE
, O
but O
not O
on O
other O
small I-GENE
GTP I-GENE
binding I-GENE
proteins I-GENE
such O
as _RARE_
Ran I-GENE
or O
R I-GENE
- I-GENE
Ras2 _RARE_
/ O
TC21 _RARE_
. O

The O
reconstituted O
RNA I-GENE
polymerases _RARE_
containing O
the O
mutant O
alpha O
subunits O
were O
examined O
for _RARE_
their O
response O
to O
transcription O
activation O
by O
cAMP I-GENE
- I-GENE
CRP I-GENE
and O
the O
rrnBP1 _RARE_
UP _RARE_
element I-GENE
. O

Transcription O
factor O
recognition O
surface O
on O
the O
RNA I-GENE
polymerase I-GENE
alpha I-GENE
subunit I-GENE
is O
involved O
in O
contact _RARE_
with O
the O
DNA O
enhancer O
element O
. O

Consistent O
with O
this O
similarity _RARE_
, O
the O
cdc28 _RARE_
- O
P8 _RARE_
mutant O
accumulates O
unspliced O
precursors _RARE_
at _RARE_
the O
restrictive O
temperature _RARE_
. O

A O
decrease O
of O
erythrocyte _RARE_
Mn _RARE_
with O
age O
, O
expressed _RARE_
in O
nmol O
/ O
L O
, O
was O
noted O
( O
p O
< O
0 _RARE_
. O
02 O
). O

Cloning O
and O
sequence O
analyses O
revealed O
a O
second O
cDNA O
with O
a O
95 _RARE_
- O
nt O
deletion O
in O
the O
region O
coding O
for _RARE_
the O
putative O
second O
intracellular _RARE_
loop O
and O
the O
fourth O
transmembrane O
domain O
of O
the O
5 I-GENE
- I-GENE
HT2C _RARE_
- I-GENE
R I-GENE
. O

Expression O
of O
thymidine _RARE_
kinase I-GENE
gene I-GENE
in O
normal O
human O
diploid O
cells O
is O
both O
cell O
cycle _RARE_
- O
and O
age O
- O
dependent O
and O
appears O
to O
be O
transcriptionally O
regulated O
. O

The O
minimum O
inhibitory _RARE_
concentrations O
( O
MICs O
) O
of O
ketoconazole _RARE_
, O
miconazole _RARE_
, O
itraconazole _RARE_
, O
fluconazole _RARE_
, O
and O
amphotericin O
B O
were O
significantly O
influenced O
by O
the O
inoculum _RARE_
size O
, O
regardless O
of O
the O
techniques O
used O
. O

These O
bacteria O
produce O
and O
export O
proteins O
capable O
of O
specific O
interactions O
with O
key O
mammalian O
cell O
regulatory O
molecules O
in O
order O
to O
derail _RARE_
the O
normal O
functions O
of O
the O
cells O
. O

The O
elevations O
achieved O
by O
LDEE _RARE_
given O
s O
. O
c O
. O
were O
higher _RARE_
than O
those O
achieved O
after O
i O
. O
p O
. O
administration O
and O
lasted _RARE_
for _RARE_
longer O
periods O
. O

Thus O
, O
although O
p28 _RARE_
may O
play O
only O
a O
limited O
role O
during _RARE_
the O
early O
embryonic _RARE_
cleavages _RARE_
, O
it O
may O
function O
later O
in O
development O
to O
establish O
a O
somatic O
type O
of O
cell O
cycle _RARE_
. O

The O
main O
aim O
of O
the O
contribution O
, O
which O
opens _RARE_
an O
arena _RARE_
for _RARE_
discussion O
on O
the O
Rivista _RARE_
dell _RARE_
' O
Infermiere _RARE_
is O
to O
critically _RARE_
appraise _RARE_
published O
research O
works _RARE_
focusing O
both O
on O
strengths O
and O
novelty _RARE_
and O
weaknesses _RARE_
in O
the O
hypothesis O
formulation O
, O
methods O
and O
instruments O
used O
, O
discussion O
of O
results O
. O

Moreover O
, O
it O
also O
discusses _RARE_
the O
effects O
of O
antihypertensive O
drugs O
currently O
regarded O
as _RARE_
first _RARE_
- O
choice O
agents O
, O
i O
. O
e _RARE_
. O
calcium _RARE_
antagonists O
and O
the O
angiotensin I-GENE
converting _RARE_
enzyme I-GENE
inhibitors _RARE_
, O
on O
intrarenal _RARE_
hemodynamics O
. O

Many O
human O
viruses O
are O
able O
to O
develop O
suitable O
strategies O
for _RARE_
modifying _RARE_
apoptosis O
in O
virus O
- O
infected _RARE_
cells O
and O
in O
virus O
- O
primed O
T O
cells O
. O

It O
is O
suggested O
that O
the O
observed O
clinical O
phenomena O
in O
response O
to O
morphine _RARE_
can O
be O
explained O
by O
differences O
in O
expression _RARE_
and O
sensitivity O
of O
some O
opioid _RARE_
receptor I-GENE
subtypes O
in O
migraine _RARE_
. O

Previous O
studies O
demonstrated O
that O
the O
flavin _RARE_
- I-GENE
containing I-GENE
monooxygenases _RARE_
( O
FMO _RARE_
) O
are O
expressed _RARE_
in O
a O
tissue O
- O
specific O
manner O
. O

Taken O
together O
, O
these O
observations O
indicate O
that O
the O
C O
- O
terminal O
24 _RARE_
amino O
acids _RARE_
are O
sufficient O
for _RARE_
NodO _RARE_
secretion _RARE_
although O
the O
region O
adjacent O
to O
this O
domain O
appears O
to O
affect O
secretion _RARE_
efficiency O
. O

Thus O
, O
despite O
the O
potential _RARE_
for _RARE_
common O
regulatory O
mechanisms O
, O
the O
available O
evidence O
indicates O
that O
the O
Mtx _RARE_
minimal I-GENE
promoter I-GENE
does O
not O
significantly O
affect O
Thbs3 _RARE_
gene I-GENE
expression _RARE_
. O

MSSP _RARE_
proteins I-GENE
have O
been O
identified O
by O
their O
binding O
to O
an O
upstream O
element O
of O
c I-GENE
- I-GENE
myc I-GENE
. O

Gene _RARE_
1 I-GENE
has O
been O
completely O
sequenced O
. O

B I-GENE
cell I-GENE
antigen I-GENE
receptor I-GENE
( O
BCR _RARE_
)- O
induced _RARE_
apoptosis O
in O
the O
WEHI _RARE_
- O
231 O
B O
lymphoma O
cell O
line O
can O
be O
prevented O
by O
engaging _RARE_
CD40 I-GENE
. O

Both O
alleles O
are O
functionally O
expressed _RARE_
and O
are O
distributed O
within O
CD4 _RARE_
+/ _RARE_
CD8 _RARE_
+ O
T O
cell O
subsets _RARE_
. O

The O
model O
also O
predicts O
that O
blood _RARE_
flow O
shunt O
fraction O
( O
Qs _RARE_
/ O
QT O
) O
is O
directly O
related O
to O
the O
oxygen O
sine _RARE_
- O
wave O
amplitude O
perturbations _RARE_
transmitted O
to O
end O
- O
expired _RARE_
air O
and O
arterial O
and O
mixed O
- O
venous O
blood _RARE_
through O
two O
simple O
equations _RARE_
. O

The O
deduced O
amino O
acid O
sequence O
of O
LvUSF2 _RARE_
is O
nearly O
identical O
to O
LvUSF1 _RARE_
except O
at _RARE_
the O
amino O
end O
, O
where O
they O
are O
sharply O
divergent O
. O

ECM _RARE_
disruption O
in O
Lytechinus _RARE_
embryos _RARE_
caused O
a O
relative O
drop O
in O
USF I-GENE
RNA I-GENE
accumulation O
levels O
to O
approximately _RARE_
60 _RARE_
% O
of O
control O
embryos _RARE_
, O
while O
LpS1 _RARE_
RNA I-GENE
accumulation O
levels O
dropped _RARE_
to O
less O
than O
5 O
%. O

Five O
of O
these O
eight O
patients O
in O
group O
II O
also O
received O
8 O
- O
in O
- O
1 O
chemotherapy O
. O

Sixty _RARE_
days O
after O
the O
intervention O
, O
twitch _RARE_
and O
tetanic _RARE_
tensions _RARE_
remained O
dependent O
upon O
the O
extracellular O
Ca2 _RARE_
+ O
concentration O
([ _RARE_
Ca O
] O
o _RARE_
) O
both O
in O
groups O
A O
and O
B O
. O

Discrimination _RARE_
between O
HIV O
- O
1 O
and O
HIV O
- O
2 O
showed O
evidence O
for _RARE_
the O
presence O
of O
HIV O
- O
1 O
only O
. O

However O
, O
an O
intrinsic _RARE_
DNA O
- O
binding O
subunit O
for _RARE_
HiNF _RARE_
- I-GENE
D I-GENE
was O
not O
identified O
. O

The O
HiNF _RARE_
- I-GENE
D I-GENE
( O
CDP I-GENE
/ O
cut I-GENE
) O
complex O
with O
the O
H4 _RARE_
promoter I-GENE
is O
immunoreactive _RARE_
with O
antibodies O
against O
CDP I-GENE
/ O
cut I-GENE
and O
pRB _RARE_
but O
not O
p107 I-GENE
, O
whereas O
the O
CDP I-GENE
/ O
cut I-GENE
complex O
with O
a O
nonhistone _RARE_
promoter O
( O
gp91 _RARE_
- O
phox _RARE_
) O
reacts _RARE_
only O
with O
CDP I-GENE
and O
p107 I-GENE
antibodies O
. O

Recently O
, O
a O
distantly O
related O
UmuC _RARE_
- I-GENE
homolog I-GENE
, O
DinB _RARE_
, O
has O
also O
been O
identified O
in O
E O
. O
coli O
. O

To O
study O
the O
regulation _RARE_
of O
mdr2 _RARE_
expression _RARE_
, O
the O
promoter O
of O
the O
mdr2 _RARE_
gene I-GENE
has O
been O
isolated O
from O
a O
murine O
vinblastine _RARE_
- O
resistant O
cell O
line O
, O
J7 _RARE_
. O
V2 _RARE_
- O
1 O
, O
and O
characterized O
. O

The O
amplification O
was O
achieved O
using O
two O
primers O
which O
correspond O
to O
TRH I-GENE
progenitor _RARE_
sequence I-GENE
( O
Lys _RARE_
/ O
Arg O
- O
Arg O
- O
Gln O
- O
His _RARE_
- O
Pro _RARE_
- O
Gly _RARE_
- O
Lys _RARE_
/ O
Arg O
- O
Arg O
). O

The O
intranodal _RARE_
mesothelial _RARE_
cells O
occupied O
the O
sinusoids _RARE_
of O
the O
lymph O
nodes O
and O
were O
initially O
suspected O
of O
being O
metastatic O
from O
the O
ovarian O
tumor O
in O
each O
case O
. O

The O
gene I-GENE
ccpA _RARE_
encoding O
the O
catabolite _RARE_
control I-GENE
protein I-GENE
CcpA _RARE_
of O
Staphylococcus _RARE_
xylosus _RARE_
has O
been O
cloned _RARE_
and O
characterized O
. O

An O
InlC _RARE_
deletion I-GENE
mutant I-GENE
shows O
reduced _RARE_
virulence _RARE_
when O
tested O
in O
an O
intravenous O
mouse O
model O
, O
but O
intracellular _RARE_
replication O
of O
the O
mutant O
in O
Caco _RARE_
- O
2 O
and O
J774 _RARE_
cells O
appears O
to O
be O
comparable O
with O
that O
of O
the O
wild O
- O
type O
strain _RARE_
. O

Thus O
, O
the O
N I-GENE
- O
Nus _RARE_
complex O
may O
be O
affected O
through O
contacts O
with O
the O
CTD _RARE_
of O
the O
alpha O
subunit O
of O
RNA I-GENE
polymerase I-GENE
, O
as _RARE_
is O
a O
group O
of O
regulatory O
proteins O
that O
influences O
initiation O
of O
transcription O
. O

Administration O
of O
RIFA _RARE_
at _RARE_
200 _RARE_
mg O
/ O
kg O
/ O
day O
in O
combination O
with O
ATO _RARE_
at _RARE_
100 _RARE_
mg O
/ O
kg O
/ O
day O
resulted O
in O
a O
marked O
prolongation O
of O
survival O
compared O
with O
that O
for _RARE_
mice O
that O
received O
ATO _RARE_
or O
RIFA _RARE_
alone O
. O

Eight O
- O
four O
ACOAs _RARE_
were O
tested O
in O
order O
to O
examine O
the O
fit O
of O
the O
model O
to O
the O
data O
by O
path _RARE_
analysis O
with O
LISREL _RARE_
VII O
. O

Two O
of O
seven _RARE_
initiation O
sites O
were O
flanked O
by O
a O
sequence O
homologous O
to O
the O
consensus O
promoter O
motif O
that O
includes O
the O
CRTA _RARE_
motif O
( O
where O
R O
is O
A O
or O
G O
) O
of O
the O
rice _RARE_
mitochondrion _RARE_
. O

Selection _RARE_
using O
SC O
EPD _RARE_
was O
more O
effective O
than O
phenotypic _RARE_
selection O
in O
reducing _RARE_
age O
at _RARE_
puberty _RARE_
in O
daughters _RARE_
. O

Using O
anchored _RARE_
PCR O
, O
a O
VL _RARE_
element I-GENE
rearranged _RARE_
to O
CL2 _RARE_
was O
isolated O
. O

Sodium O
polystyrene _RARE_
sulfonate _RARE_
treatment O
for _RARE_
lithium O
toxicity O
: O
effects O
on O
serum O
potassium _RARE_
concentrations O
. O

The O
mammalian I-GENE
homeodomain _RARE_
proteins I-GENE
encoded O
by O
Hox I-GENE
genes I-GENE
play O
an O
important O
role O
in O
embryonic _RARE_
development O
by O
providing O
positional _RARE_
queues _RARE_
which O
define O
developmental O
identities O
along O
the O
anteroposterior O
axis O
of O
developing O
organisms O
. O

Interferon I-GENE
stimulated _RARE_
gene I-GENE
factor I-GENE
3 I-GENE
( O
ISGF3 _RARE_
) O
is O
a O
trimeric _RARE_
transcription O
factor O
activated O
on O
treatment O
of O
cells O
with O
interferon _RARE_
- I-GENE
alpha I-GENE
and I-GENE
beta I-GENE
( O
type I-GENE
I I-GENE
IFNs _RARE_
). O

The O
TYAC _RARE_
/ O
P1 O
resource O
, O
derivative _RARE_
STSs _RARE_
, O
and O
polymorphisms _RARE_
constitute O
an O
enabling _RARE_
resource O
to O
further O
studies O
of O
telomere _RARE_
structure _RARE_
and O
function O
and O
a O
means O
for _RARE_
physical O
and O
genetic O
map O
integration _RARE_
and O
closure O
. O

Confirmatory _RARE_
statistics _RARE_
included O
item _RARE_
2 O
of O
the O
Clinical O
Global _RARE_
Impression _RARE_
( O
CGI _RARE_
), _RARE_
the O
total _RARE_
score O
of O
the O
Sandoz _RARE_
Clinical O
Assessment O
Geriatric _RARE_
( O
SCAG _RARE_
) O
scale O
, O
the O
subscale _RARE_
' O
need O
for _RARE_
help O
' O
of O
the O
nurse O
' O
s O
rating O
of O
geriatric _RARE_
patients O
( O
Beurteilungsskala _RARE_
fur _RARE_
geriatrische _RARE_
Patienten _RARE_
; O
BGP _RARE_
) O
and O
the O
total _RARE_
score O
of O
the O
Short O
Cognitive _RARE_
Performance _RARE_
Test O
( O
Syndrom _RARE_
- O
Kurztest _RARE_
; O
SKT _RARE_
). O

Three O
mutants O
were O
isolated O
from O
the O
widely O
used O
strain _RARE_
, O
PAO1 _RARE_
. O

As O
extensively O
examined O
with O
the O
myogenin I-GENE
promoter I-GENE
, O
presence O
of O
one O
or O
multiple O
copies O
of O
Me _RARE_
in O
the O
vectors O
elevated O
the O
expression _RARE_
activity O
in O
myotubes O
by O
4 O
. O
5 O
- O
to O
19 O
- O
fold _RARE_
over O
those O
without O
Me _RARE_
, O
but O
not O
significantly O
in O
myoblasts O
. O

We O
conclude O
that O
common O
upstream O
signals O
cause O
activation O
of O
Ras I-GENE
and O
TC21 _RARE_
, O
but O
activated O
TC21 _RARE_
controls O
cell O
growth O
via O
distinct O
Raf I-GENE
- O
independent O
downstream _RARE_
signaling _RARE_
pathways O
. O

Fission _RARE_
yeast I-GENE
mal2 _RARE_
+ I-GENE
is O
required O
for _RARE_
chromosome _RARE_
segregation O
. O

Selection _RARE_
was O
based O
on O
expression _RARE_
of O
an O
integrated O
DNA O
fragment O
containing O
the O
con _RARE_
- I-GENE
10 I-GENE
promoter I-GENE
- I-GENE
regulatory I-GENE
region I-GENE
followed O
by O
the O
initial O
segment O
of O
the O
con _RARE_
- I-GENE
10 I-GENE
open _RARE_
reading I-GENE
frame I-GENE
fused O
in O
frame O
with O
the O
bacterial I-GENE
hygromycin _RARE_
B I-GENE
phosphotransferase _RARE_
structural I-GENE
gene I-GENE
( O
con10 _RARE_
'-' _RARE_
hph _RARE_
). O

Mutations O
at _RARE_
two O
neighboring _RARE_
sites O
, O
serine O
242 _RARE_
and O
threonine O
255 _RARE_
, O
exacerbated _RARE_
the O
effect O
. O

IRF I-GENE
- I-GENE
1 I-GENE
acts O
as _RARE_
a O
transcriptional O
activator O
, O
while O
IRF I-GENE
- I-GENE
2 I-GENE
acts O
as _RARE_
a O
repressor O
. O

In O
contrast O
, O
cotransfection O
of O
TFIIB _RARE_
and O
IRF I-GENE
- I-GENE
1 I-GENE
into O
NIH _RARE_
3T3 O
cells O
resulted O
in O
a O
dose O
- O
dependent O
repression O
of O
promoter O
activation O
which O
occurred O
in O
a O
TATA O
- O
dependent O
manner O
. O

The O
requirement O
of O
Tyr _RARE_
- O
19 O
dephosphorylation _RARE_
for _RARE_
spindle _RARE_
assembly O
is O
also O
observed O
under O
conditions O
in O
which O
spindle _RARE_
formation O
is O
independent O
of O
mitosis O
, O
suggesting O
that O
the O
involvement O
of O
Cdc28 I-GENE
/ O
Clb _RARE_
kinase O
in O
SPB O
separation O
is O
direct O
. O

A O
subset O
of O
these O
DMP1 _RARE_
recognition I-GENE
sequences I-GENE
containing O
a O
GGA _RARE_
trinucleotide _RARE_
core O
can O
also O
function O
as _RARE_
Ets I-GENE
- I-GENE
responsive I-GENE
elements I-GENE
. O

In O
both O
settings _RARE_
, O
it O
can O
be O
phosphorylated _RARE_
by O
cyclin _RARE_
D I-GENE
- I-GENE
dependent I-GENE
kinases I-GENE
, O
suggesting O
that O
its O
transcriptional O
activity O
may O
normally O
be O
regulated O
through O
such O
mechanisms O
. O

Expression O
of O
the O
proapoptotic _RARE_
protein I-GENE
Bax _RARE_
under O
the O
control O
of O
a O
GAL10 _RARE_
promoter I-GENE
in O
Saccharomyces O
cerevisiae O
resulted O
in O
galactose _RARE_
- O
inducible O
cell O
death _RARE_
. O

This O
technique O
was O
employed O
in O
12 O
patients O
with O
a O
unicameral _RARE_
bone O
cyst O
. O

Enterococcus _RARE_
faecium _RARE_
strains O
with O
vanA _RARE_
- O
mediated _RARE_
glycopeptide _RARE_
resistance O
were O
isolated O
by O
enrichment _RARE_
culture O
from O
the O
intestines _RARE_
and O
feces _RARE_
of O
several O
animal _RARE_
species O
, O
mainly O
horses O
and O
dogs O
( O
8 O
% O
positive O
), _RARE_
chickens _RARE_
( O
7 O
% O
positive O
), _RARE_
and O
pigs O
( O
6 O
% O
positive O
). O

The O
amino O
- O
terminal O
region O
of O
E1A I-GENE
binds O
several O
high O
molecular _RARE_
weight _RARE_
proteins O
and O
inhibits O
the O
transcriptional O
coactivator _RARE_
function O
of O
p300 I-GENE
and O
the O
homologous O
cAMP I-GENE
response I-GENE
element I-GENE
( I-GENE
CRE _RARE_
)- I-GENE
binding I-GENE
protein I-GENE
. O

Transient O
transfection O
assays O
using O
reporter O
gene O
constructs O
containing O
various O
lengths O
of O
the O
5 I-GENE
' I-GENE
mdr1b _RARE_
sequences I-GENE
revealed O
that O
the O
sequence O
located _RARE_
between O
- O
247 _RARE_
to O
- O
126 O
bp O
was O
important O
for _RARE_
the O
expression _RARE_
of O
the O
reporter O
gene O
in O
many O
different O
cell O
lines O
. O

We O
show O
that O
the O
5 O
' O
UTR O
characteristic O
of O
testis _RARE_
- I-GENE
specific I-GENE
c I-GENE
- I-GENE
mos I-GENE
mRNA I-GENE
strongly O
represses O
translation O
relative O
to O
the O
translation O
of O
transcripts O
that O
contain O
a O
5 O
' O
UTR O
derived O
from O
beta I-GENE
- I-GENE
globin I-GENE
mRNA I-GENE
, O
and O
this O
is O
mainly O
due O
to O
the O
four O
uORFs _RARE_
. O

To O
address O
the O
biological O
effect O
of O
specific O
isoform O
expression _RARE_
, O
NIH3T3 O
cells O
were O
transfected O
with O
a O
eukaryotic O
expression _RARE_
vector O
containing O
cDNA O
for _RARE_
FGF8a _RARE_
, O
FGF8b _RARE_
, O
or O
FGF8e _RARE_
. O

These O
findings O
suggest O
that O
the O
F O
- O
wave O
may O
be O
elicited O
in O
motoneuron _RARE_
of O
different O
depolarization _RARE_
threshold O
but O
primarily O
in O
larger O
and O
faster O
nerve O
fibers O
, O
with O
a O
lower O
threshold O
of O
depolarization _RARE_
. O

In O
addition O
, O
carp _RARE_
JAK1 _RARE_
shows O
higher _RARE_
sequence O
homology O
to O
mammalian I-GENE
JAK1 _RARE_
in O
both O
the O
kinase O
- O
like O
( O
JH2 _RARE_
) O
and O
kinase O
( O
JH1 _RARE_
) O
domains O
( O
approximately _RARE_
70 O
% O
identity O
). O

When O
this O
DNA O
fragment O
was O
placed O
upstream O
of O
the O
chloramphenicol I-GENE
acetyltransferase _RARE_
( O
CAT I-GENE
) O
reporter O
gene O
and O
transfected O
into O
a O
carp _RARE_
CF _RARE_
cell O
line O
, O
it O
could O
drive O
the O
synthesis _RARE_
of O
CAT I-GENE
enzyme I-GENE
16 O
times O
more O
efficiently O
than O
the O
promoterless O
pCAT _RARE_
- I-GENE
Basic _RARE_
. O

Molecular O
cloning O
of O
Elk I-GENE
- I-GENE
3 I-GENE
, O
a O
new O
member _RARE_
of O
the O
Ets I-GENE
family I-GENE
expressed _RARE_
during _RARE_
mouse O
embryogenesis O
and O
analysis O
of O
its O
transcriptional O
repression O
activity O
. O

We O
report O
an O
example O
of O
an O
MDV _RARE_
- O
transformed O
T O
- O
lymphoblastoid _RARE_
cell O
line O
( O
T9 _RARE_
) O
expressing O
high O
levels O
of O
a O
truncated I-GENE
C I-GENE
- I-GENE
MYB _RARE_
protein I-GENE
as _RARE_
a O
result O
of O
RAV _RARE_
integration _RARE_
within O
one O
c I-GENE
- I-GENE
myb I-GENE
allele I-GENE
. O

Frozen _RARE_
/ O
thawed _RARE_
extensor _RARE_
digitorum _RARE_
longus _RARE_
muscle O
tendon O
units _RARE_
had O
significantly O
lower O
values O
for _RARE_
load O
to O
failure O
( O
p O
< O
0 _RARE_
. O
01 O
), _RARE_
energy O
absorbed O
to O
failure O
( O
p O
< O
0 _RARE_
. O
01 O
), _RARE_
and O
strain _RARE_
at _RARE_
failure O
( O
p O
< O
0 _RARE_
. O
01 O
), _RARE_
and O
they O
tended O
to O
fail O
at _RARE_
a O
different O
anatomic O
location O
( O
p O
< O
0 _RARE_
. O
01 O
) O
( O
broadly O
at _RARE_
the O
fascia _RARE_
- O
muscle O
interface O
as _RARE_
compared O
with O
horizontally _RARE_
at _RARE_
the O
musculotendinous _RARE_
junction _RARE_
) O
than O
fresh O
units _RARE_
. O

Northern O
analysis O
of O
the O
3 I-GENE
. I-GENE
1 I-GENE
- I-GENE
kb I-GENE
PWP2H _RARE_
cDNA I-GENE
revealed O
that O
a O
3 O
. O
3 O
- O
kb O
major O
transcript O
is O
ubiquitously O
expressed _RARE_
in O
human O
adult O
tissues O
. O

Forty O
- O
eight O
10 O
- O
12 O
- O
week O
- O
old O
male O
Sprague O
- O
Dawley O
rats O
were O
randomized O
to O
receive O
, O
daily O
for _RARE_
28 _RARE_
days O
: O
( O
1 O
) O
CsA O
vehicle O
p O
. O
o _RARE_
. O
plus _RARE_
FB O
vehicle O
sc O
; O
( O
2 O
) O
CsA O
( O
15 _RARE_
mg O
/ O
kg O
) O
p O
. O
o _RARE_
. O
plus _RARE_
FB O
vehicle O
sc O
, O
( O
3 O
) O
CsA O
vehicle O
p O
. O
o _RARE_
. O
plus _RARE_
FB O
( O
1 O
. O
5 O
mg O
/ O
kg O
) O
sc O
; O
and O
( O
4 O
) O
CsA O
( O
15 _RARE_
mg O
/ O
kg O
) O
p O
. O
o _RARE_
. O
plus _RARE_
FB O
( O
1 O
. O
5 O
mg O
/ O
kg O
) O
sc O
. O

CsA O
alone O
resulted O
in O
elevated O
bone O
turnover O
. O

Individuals _RARE_
attending _RARE_
the O
GUM _RARE_
Department _RARE_
in O
the O
Royal _RARE_
Infirmary _RARE_
of O
Edinburgh _RARE_
between O
1990 O
and O
1994 O
with O
the O
diagnosis O
of O
HIV O
infection O
, O
genital _RARE_
warts _RARE_
, O
genital _RARE_
herpes O
, O
non O
- O
specific O
genital _RARE_
infection O
( O
NSGI _RARE_
), _RARE_
gonorrhoea _RARE_
and O
syphilis _RARE_
were O
included O
in O
the O
study O
. O

Oncogenic _RARE_
activation O
of O
the O
tyrosine I-GENE
kinase I-GENE
domain I-GENE
of O
the O
human I-GENE
trk I-GENE
proto _RARE_
- I-GENE
oncogene I-GENE
by O
fusion O
to O
a O
cell O
adhesion O
molecule O
. O

Northern O
blotting O
showed O
that O
MDMX _RARE_
, O
like O
MDM2 _RARE_
, O
is O
expressed _RARE_
in O
all O
tissues O
tested O
, O
and O
that O
several O
mRNAs O
for _RARE_
MDMX _RARE_
can O
be O
detected O
. O

Physiol _RARE_
. O

The O
nucleotide O
sequence O
of O
22 _RARE_
, O
846 _RARE_
bp O
of O
the O
left _RARE_
arm _RARE_
of O
chromosome _RARE_
IV O
is O
described O
. O

They O
suggest O
that O
decreased O
steady O
- O
state O
levels O
of O
IME1 I-GENE
and O
IME2 _RARE_
mRNA I-GENE
were O
not O
merely _RARE_
the O
result O
of O
non O
- O
specific O
adverse O
affects O
on O
nucleic _RARE_
acid O
metabolism O
caused O
by O
the O
yvh1 _RARE_
disruption O
. O

Natural _RARE_
FL _RARE_
protein I-GENE
has O
been O
purified _RARE_
from O
a O
stromal _RARE_
cell O
line O
and O
shown O
to O
be O
a O
65 O
kD _RARE_
nondisulfide _RARE_
- O
linked _RARE_
homodimeric _RARE_
glycoprotein O
comprised O
of O
30 _RARE_
kD _RARE_
subunits O
, O
each O
containing O
12 O
kD _RARE_
of O
N O
- O
and O
O O
- O
linked _RARE_
sugars O
. O

The O
objective O
of O
this O
study O
was O
to O
examine O
the O
influence O
of O
HHCA _RARE_
and O
other O
serological O
factors O
upon O
the O
development O
of O
VGS _RARE_
. O

Spliced _RARE_
exons O
of O
adenovirus O
late _RARE_
RNAs O
colocalize _RARE_
with O
snRNP O
in O
a O
specific O
nuclear O
domain O
. O

Using O
Spurr _RARE_
' O
s O
resin O
as _RARE_
a O
mounting _RARE_
medium O
, O
we O
could O
observe O
thick O
specimens O
with O
oil O
immersion O
objective O
lens O
without O
the O
use O
of O
coverslips _RARE_
, O
then O
avoid O
air O
bubbles _RARE_
near O
the O
specimen _RARE_
. O

The O
present O
study O
investigated O
dose O
dependence O
and O
time O
course O
effects O
of O
the O
benzodiazepine _RARE_
( O
BDZ _RARE_
) O
partial O
inverse _RARE_
agonist O
, O
RO19 _RARE_
- O
4603 _RARE_
( O
0 _RARE_
. O
005 O
- O
0 _RARE_
. O
30 _RARE_
mg O
/ O
kg O
) O
alone O
, O
and O
in O
combination O
with O
the O
BDZ _RARE_
receptor I-GENE
antagonists O
flumazenil _RARE_
, O
ZK _RARE_
93426 _RARE_
, O
and O
CGS _RARE_
8216 _RARE_
( O
20 O
mg O
/ O
kg O
) O
in O
selectively O
bred _RARE_
alcohol _RARE_
- O
preferring _RARE_
( O
P O
) O
rats O
provided O
a O
two O
- O
bottle _RARE_
choice O
test O
between O
ethanol O
( O
EtOH _RARE_
) O
( O
10 O
% O
v O
/ O
v O
), _RARE_
and O
a O
palatable _RARE_
saccharin O
( O
0 _RARE_
. O
0125 _RARE_
% O
g O
/ O
v O
) O
solution O
. O

Beyond _RARE_
the O
Tower _RARE_
of O
Babel _RARE_
: O
a O
nomenclature _RARE_
for _RARE_
suicidology _RARE_
. O

Infection _RARE_
with O
Neisseria _RARE_
meningitidis _RARE_
group O
B O
has O
been O
difficult O
to O
detect O
, O
partly O
because O
this O
bacterial O
group O
' O
s O
polysaccharide _RARE_
is O
a O
weak O
immunogen _RARE_
. O

RNase I-GENE
protection O
analysis O
of O
two O
rRNA O
fragments O
whose O
genes O
are O
adjacent O
provided O
evidence O
for _RARE_
a O
polycistronic _RARE_
transcript O
containing O
sequences O
from O
both O
, O
as _RARE_
well _RARE_
as _RARE_
separate O
small O
RNAs O
. O

Rss1p _RARE_
encodes O
a O
novel O
essential O
protein O
of O
538 _RARE_
amino O
acids _RARE_
, O
which O
contains O
an O
extended O
predicted O
coiled _RARE_
- O
coil _RARE_
domain O
and O
is O
located _RARE_
both O
at _RARE_
nuclear O
pore _RARE_
complexes O
( O
NPCs _RARE_
) O
and O
in O
the O
cytoplasm O
. O

To O
map O
this O
regulatory O
serine O
phosphorylation _RARE_
site O
we O
developed O
a O
baculovirus _RARE_
- O
mediated _RARE_
expression _RARE_
system _RARE_
for _RARE_
wild I-GENE
- I-GENE
type I-GENE
annexin _RARE_
II I-GENE
and O
for _RARE_
a O
series O
of O
annexin _RARE_
II I-GENE
mutants I-GENE
which O
contained O
substitutions O
in O
one O
or O
more O
serine O
residues O
present O
in O
the O
N O
- O
terminal O
domain O
. O

The O
PAI I-GENE
- I-GENE
2 I-GENE
gene I-GENE
is O
one O
of O
the O
most O
TNF I-GENE
- I-GENE
responsive I-GENE
genes I-GENE
known O
and O
is O
also O
highly O
induced _RARE_
by O
the O
phorbol O
ester O
phorbol O
12 O
- O
myristate O
13 _RARE_
- O
acetate _RARE_
( O
PMA O
) O
and O
the O
phosphatase O
inhibitor O
, O
okadaic _RARE_
acid O
, O
in O
both O
HT _RARE_
- O
1080 _RARE_
fibrosarcoma _RARE_
and O
U _RARE_
- O
937 _RARE_
histiocytic _RARE_
cells O
. O

220 O
, O
263 _RARE_
- O
273 _RARE_
). O

These O
two O
contigs _RARE_
contain O
a O
total _RARE_
of O
163 _RARE_
open _RARE_
reading O
frames O
( O
ORFs _RARE_
) O
in O
26 _RARE_
- O
29 O
putative O
operons _RARE_
; O
56 _RARE_
ORFs _RARE_
could O
be O
identified O
with O
reasonable O
certainty _RARE_
. O

T O
., O
Patel _RARE_
, O
S O
. O

Growth _RARE_
factors O
induce O
the O
expression _RARE_
of O
the O
immediate I-GENE
early I-GENE
gene I-GENE
products I-GENE
MAP I-GENE
kinase I-GENE
phosphatase I-GENE
- I-GENE
1 I-GENE
( O
MKP I-GENE
- I-GENE
1 I-GENE
), _RARE_
c I-GENE
- I-GENE
Fos I-GENE
and O
c I-GENE
- I-GENE
Jun I-GENE
. O

The O
up _RARE_
- O
regulation _RARE_
of O
E I-GENE
- I-GENE
selectin I-GENE
, O
one O
of O
the O
adhesion O
molecules O
on O
the O
endothelium O
, O
is O
an O
important O
event O
in O
the O
mediation _RARE_
of O
the O
inflammatory O
response O
. O

The O
NIT2 _RARE_
protein I-GENE
is O
localised _RARE_
in O
nuclei O
and O
could O
not O
be O
detected O
in O
the O
cytoplasmic O
fraction O
of O
cells O
subjected O
to O
nitrogen O
derepression O
or O
nitrogen O
repression O
, O
indicating O
that O
the O
nuclear O
import O
of O
NIT2 _RARE_
is O
not O
regulated O
. O

In O
spite _RARE_
of O
much O
effort O
, O
no _RARE_
one O
has O
succeeded _RARE_
in O
isolating _RARE_
and O
characterizing O
the O
enzyme O
( O
s O
) O
responsible O
for _RARE_
synthesis _RARE_
of O
cellulose _RARE_
, O
the O
major O
cell O
wall _RARE_
polymer _RARE_
of O
plants _RARE_
. O

Vascular _RARE_
responses O
to O
reactive O
hyperemia _RARE_
( O
with O
flow O
increase O
leading O
to O
endothelium O
- O
dependent O
dilation _RARE_
) O
and O
to O
sublingual _RARE_
glyceryl _RARE_
trinitrate _RARE_
( O
GTN _RARE_
; O
endothelium O
- O
independent O
dilation _RARE_
) O
were O
recorded O
. O

During O
this O
period O
, O
administration O
of O
additional O
exogenous _RARE_
PRL I-GENE
did O
not O
stimulate O
further O
activation O
( O
binding O
) O
of O
the O
Stat I-GENE
factors I-GENE
. O

Intraperitoneal _RARE_
administration O
of O
L O
- O
5 O
- O
hydroxytryptophan _RARE_
( O
L O
- O
5 O
- O
HTP _RARE_
) O
at _RARE_
doses O
of O
25 _RARE_
to O
100 _RARE_
mg O
/ O
kg O
dramatically O
increase O
defecation _RARE_
in O
mice O
. O

In O
the O
VA O
- O
SMV _RARE_
mode O
, O
the O
connection _RARE_
was O
made O
with O
valved _RARE_
conduits _RARE_
from O
the O
LV O
apex O
( O
inflow _RARE_
) O
to O
the O
ascending O
aorta O
( O
outflow O
) O
( O
n _RARE_
= O
11 O
) O
or O
to O
the O
DAo _RARE_
( O
n _RARE_
= O
12 O
). O

The O
evidence O
in O
support O
of O
this O
was O
derived O
from O
the O
fact O
that O
the O
affinity O
or O
interaction O
between O
the O
two O
subunits O
was O
impaired O
as _RARE_
indicated O
by O
the O
first _RARE_
order O
rate O
constant O
of O
hCG I-GENE
alpha I-GENE
1 I-GENE
beta I-GENE
( O
km _RARE_
= O
4 O
. O
1 O
x _RARE_
10 O
(- _RARE_
2 O
) O
min O
- O
1 O
) O
at _RARE_
pH O
3 O
. O
0 _RARE_
at _RARE_
23 _RARE_
degrees O
C O
which O
is O
one O
order O
of O
magnitude O
greater O
relative O
to O
rehCG _RARE_
( O
kw _RARE_
= O
4 O
. O
6 O
x _RARE_
10 O
(- _RARE_
3 O
) O
min O
- O
1 O
). O

Factor _RARE_
V O
Leiden _RARE_
is O
a O
genetic O
disorder O
associated O
with O
an O
increased O
risk O
of O
venous O
thrombosis O
. O

This O
is O
the O
first _RARE_
determination O
of O
the O
complete _RARE_
secondary O
structure _RARE_
of O
an O
RNA O
spliced _RARE_
in O
a O
spliceosome O
. O

The O
majority O
of O
the O
cases O
with O
0 _RARE_
- O
I O
or O
0 _RARE_
- O
III O
components _RARE_
were O
sm _RARE_
. O
cancer _RARE_
. O

These O
patients O
appear O
to O
have O
slightly O
better O
pulmonary O
function O
and O
nutritional O
status O
; O
yet O
, O
they O
seem O
to O
have O
a O
higher _RARE_
degree O
of O
health O
care O
utilization O
. O

This O
observation O
calls _RARE_
for _RARE_
careful _RARE_
monitoring O
of O
calcium _RARE_
and O
alkaline _RARE_
phosphatase I-GENE
values O
and O
possible O
adjustments _RARE_
of O
vitamin O
D O
intake O
when O
fortifiers _RARE_
are O
used O
for _RARE_
extended O
periods O
. O

We O
have O
found O
that O
PEA2 _RARE_
is O
also O
required O
for _RARE_
the O
bipolar O
budding _RARE_
pattern O
and O
that O
it O
encodes O
a O
novel O
protein O
with O
a O
predicted O
coiled _RARE_
- O
coil _RARE_
domain O
. O

Signaling _RARE_
from O
the O
small I-GENE
GTP I-GENE
- I-GENE
binding I-GENE
proteins I-GENE
Rac1 I-GENE
and O
Cdc42 I-GENE
to O
the O
c I-GENE
- I-GENE
Jun I-GENE
N I-GENE
- I-GENE
terminal I-GENE
kinase I-GENE
/ O
stress I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
pathway _RARE_
. O

Percent _RARE_
identities O
of O
the O
mouse I-GENE
PP2 _RARE_
to O
mouse I-GENE
Y1 _RARE_
, O
mouse O
Y4 _RARE_
/ O
PP1 _RARE_
and O
human I-GENE
Y2 _RARE_
receptors I-GENE
are O
53 O
, O
42 _RARE_
, O
and O
31 _RARE_
, O
respectively O
. O

Correlating _RARE_
with O
the O
previous O
observation O
that O
CBF I-GENE
binding O
to O
the O
78C1 _RARE_
site O
is O
enhanced _RARE_
by O
EGTA _RARE_
and O
EDTA O
, O
these O
divalent _RARE_
cation _RARE_
chelators _RARE_
specifically O
stimulate O
78C1 _RARE_
- O
directed O
transcription O
. O

The O
human O
gene O
fragment O
ligated O
to O
the O
minimal O
rat O
liver O
glucokinase _RARE_
promoter O
was O
shown O
to O
work O
as _RARE_
an O
enhancer O
in O
the O
hepatocyte _RARE_
transfection O
system _RARE_
. O

To O
test O
the O
role O
of O
ML _RARE_
in O
human O
reproductive O
axis O
, O
128 _RARE_
healthy O
children O
, O
68 _RARE_
boys O
and O
60 _RARE_
girls O
, O
were O
studied O
. O

However O
, O
the O
truncated O
deer _RARE_
receptor I-GENE
lacks O
the O
most O
C O
- O
terminal O
tyrosine O
residue _RARE_
in O
the O
intracellular _RARE_
domain O
which O
is O
believed O
to O
be O
essential O
for _RARE_
activation O
of O
the O
beta I-GENE
- I-GENE
casein I-GENE
promoter I-GENE
. O

This O
report O
provides O
further O
evidence O
for _RARE_
the O
riMLF _RARE_
in O
the O
control O
of O
downgaze _RARE_
, O
and O
a O
synkinesis _RARE_
is O
postulated O
for _RARE_
the O
development O
of O
the O
convergence _RARE_
retraction _RARE_
nystagmus O
. O

Rifabutin _RARE_
has O
substantial O
efficacy O
when O
combined O
with O
other O
agents O
. O

Ninety _RARE_
- O
four O
percent O
of O
the O
EPs _RARE_
were O
tubal _RARE_
, O
and O
90 _RARE_
% O
of O
the O
tubes _RARE_
exhibited O
some O
pathologic O
changes O
, O
including O
chronic O
salpingitis _RARE_
( O
49 _RARE_
. O
5 O
%) O
and O
follicular O
salpingitis _RARE_
( O
10 O
%), O
among O
others O
. O

The O
assessment O
using O
7 O
H O
9 O
liquid O
medium O
by O
the O
former O
author O
demonstrated O
the O
potent O
activities O
of O
both O
CS _RARE_
- O
940 _RARE_
* _RARE_
and O
sparfloxacin _RARE_
( O
SPFX _RARE_
), _RARE_
followed O
by O
AM _RARE_
- O
1155 _RARE_
*, _RARE_
ciprofloxacin _RARE_
( O
CPFX _RARE_
), _RARE_
levofloxacin _RARE_
( O
LVFX _RARE_
), _RARE_
OPC _RARE_
- O
17116 _RARE_
*, _RARE_
NM _RARE_
- O
394 _RARE_
* _RARE_
in O
sequence O
. O

The O
STE20 _RARE_
gene I-GENE
, O
encoding O
a O
protein O
kinase O
required O
for _RARE_
pheromone O
signal O
transduction _RARE_
, O
has O
recently O
been O
identified O
in O
a O
genetic O
screen O
for _RARE_
high O
- O
gene O
- O
dosage O
suppressors O
of O
a O
partly O
defective _RARE_
G I-GENE
beta I-GENE
mutation O
. O

This O
enzyme O
is O
designated O
( I-GENE
1 I-GENE
--> _RARE_
4 I-GENE
)- I-GENE
beta I-GENE
- I-GENE
xylan _RARE_
endohydrolase _RARE_
isoenzyme _RARE_
X I-GENE
- I-GENE
I I-GENE
. O

Magnetic O
resonance O
imaging O
in O
coccidioidal _RARE_
arthritis O
. O

Moloney O
murine O
leukemia O
virus O
( O
MMLV _RARE_
)- O
derived O
pUCMoTiN _RARE_
- O
based O
retroviral _RARE_
vectors O
were O
engineered _RARE_
to O
allow O
constitutive _RARE_
and O
Tat I-GENE
( O
trans _RARE_
- I-GENE
activator I-GENE
of I-GENE
transcription I-GENE
)- O
inducible O
expression _RARE_
of O
five O
hammerhead _RARE_
ribozymes _RARE_
targeted O
against O
highly O
conserved _RARE_
sequences O
within O
the O
group I-GENE
antigen I-GENE
( O
Gag I-GENE
), _RARE_
protease I-GENE
( O
Pro _RARE_
), _RARE_
reverse I-GENE
transcriptase I-GENE
( O
RT I-GENE
), _RARE_
tat I-GENE
, O
and O
envelope I-GENE
( O
Env I-GENE
) O
coding O
regions O
of O
human O
immunodeficiency O
virus O
type O
- O
1 O
( O
HIV O
- O
1 O
) O
RNA O
. O

REM O
sleep O
deprivation O
was O
performed O
using O
the O
platform _RARE_
technique O
. O

The O
same O
ligands O
also O
exhibit O
a O
similar O
inhibitory _RARE_
effect O
on O
PDGF _RARE_
- I-GENE
BB _RARE_
- O
dependent O
[ _RARE_
3H O
] O
thymidine _RARE_
incorporation O
in O
PAE _RARE_
cells O
expressing O
the O
PDGF _RARE_
beta I-GENE
- I-GENE
receptors I-GENE
. O

We O
analyzed O
serial O
biopsy O
specimens O
from O
eight O
patients O
with O
FL _RARE_
for _RARE_
secondary O
alterations O
of O
the O
rearranged _RARE_
bcl I-GENE
- I-GENE
2 I-GENE
gene I-GENE
in O
the O
breakpoint _RARE_
and O
open _RARE_
reading O
frame O
( O
ORF O
) O
regions O
. O

In O
all O
eight O
cases O
, O
neither O
FL _RARE_
nor O
DLL _RARE_
cells O
showed O
alterations O
of O
bcl I-GENE
- I-GENE
2 I-GENE
gene I-GENE
sequences I-GENE
in O
the O
breakpoint _RARE_
region O
, O
suggesting O
high O
conservation O
of O
the O
bcl I-GENE
- I-GENE
2 I-GENE
gene I-GENE
during _RARE_
both O
t O
( O
14 O
; O
18 O
) O
translocation O
and O
morphologic O
transformation O
of O
the O
FL _RARE_
cells O
. O

BACKGROUND O
: O
The O
Bazett _RARE_
- O
corrected O
QT O
( O
QTc _RARE_
) O
interval O
during _RARE_
exercise O
has O
been O
used O
as _RARE_
a O
marker O
for _RARE_
ischemic O
disease _RARE_
, O
arrhythmogenic _RARE_
substrate O
and O
the O
long O
QT O
syndrome _RARE_
. O

An O
essential O
role O
of O
c I-GENE
- I-GENE
Jun I-GENE
and O
c I-GENE
- I-GENE
Fos I-GENE
in O
basal O
and O
PMA O
- O
stimulated _RARE_
transcription O
of O
the O
PAI I-GENE
- I-GENE
1 I-GENE
gene I-GENE
is O
demonstrated O
by O
our O
finding O
that O
antisense _RARE_
c I-GENE
- I-GENE
jun I-GENE
and O
c I-GENE
- I-GENE
fos I-GENE
oligodeoxynucleotides _RARE_
both O
strongly O
reduced _RARE_
basal O
and O
PMA O
- O
stimulated _RARE_
PAI I-GENE
- I-GENE
1 I-GENE
synthesis _RARE_
. O

Leukemia _RARE_
- I-GENE
inhibitory _RARE_
factor I-GENE
( O
LIF _RARE_
) O
is O
a O
neuropoietin _RARE_
able O
to O
regulate O
the O
differentiation O
and O
the O
survival O
of O
many O
cell O
types _RARE_
, O
which O
include O
some O
neuronal _RARE_
populations O
. O

To O
analyze O
the O
mechanism O
of O
fos I-GENE
/ O
jun I-GENE
activation O
by O
TCDD _RARE_
we O
have O
used O
electrophoretic O
mobility O
shift O
and O
transient O
expression _RARE_
assays O
of O
reporter O
gene O
constructs O
containing O
response O
elements O
for _RARE_
12 O
- O
O O
- O
tetradecanoyl _RARE_
- O
phorbol O
- O
13 _RARE_
- O
acetate _RARE_
( O
TRE _RARE_
), _RARE_
serum O
( O
SRE O
), _RARE_
cAMP O
( O
CRE _RARE_
), _RARE_
and O
aromatic O
hydrocarbons _RARE_
( O
AhRE _RARE_
) O
from O
the O
fos I-GENE
and O
jun I-GENE
genes I-GENE
fused O
to O
the O
firefly _RARE_
luciferase I-GENE
gene I-GENE
under O
the O
control O
of O
the O
SV40 I-GENE
minimal I-GENE
promoter I-GENE
. O

The O
optimal O
sequence O
for _RARE_
interaction O
with O
mu I-GENE
2 I-GENE
and O
with O
AP I-GENE
- I-GENE
2 I-GENE
has O
tyrosine O
as _RARE_
an O
anchor _RARE_
and O
prefers _RARE_
arginine _RARE_
at _RARE_
position O
Y O
+ O
2 O
and O
leucine O
at _RARE_
position O
Y O
+ O
3 O
. O

STK I-GENE
/ O
RON _RARE_
- O
expressing O
Ba _RARE_
/ O
F3 _RARE_
pro O
- O
B O
cells O
( O
BaF _RARE_
/ O
STK I-GENE
) O
exhibited O
MSP _RARE_
- O
dependent O
growth O
, O
whereas O
STK I-GENE
/ O
RON _RARE_
- O
expressing O
mouse O
erythroleukaemia _RARE_
cells O
( O
MEL _RARE_
/ O
STK I-GENE
) O
displayed O
MSP _RARE_
- O
induced _RARE_
apoptosis O
. O

In O
vitro O
DNase I-GENE
I I-GENE
footprinting O
showed O
that O
OxyR I-GENE
- I-GENE
C199S _RARE_
protected O
Pmom _RARE_
from O
- O
104 O
to O
- O
46 _RARE_
on O
the O
top O
strand _RARE_
and O
produced O
a O
protection O
pattern O
characteristic O
of O
reduced _RARE_
wild I-GENE
- I-GENE
type I-GENE
OxyR I-GENE
. O

Kss1 _RARE_
binds O
specifically O
to O
a O
GST I-GENE
- O
Dig1 _RARE_
fusion O
in O
the O
absence O
of O
any O
other O
yeast O
protein O
. O

In O
contrast O
, O
dig1 _RARE_
dig2 _RARE_
cells O
constitutively O
invade _RARE_
agar O
medium O
, O
whereas O
a O
dig1 _RARE_
dig2 _RARE_
ste12 _RARE_
triple _RARE_
mutant O
does O
not O
, O
indicating O
that O
Dig1 _RARE_
and O
Dig2 _RARE_
share O
a O
role O
in O
negatively O
regulating _RARE_
the O
invasive O
growth O
pathway _RARE_
. O

Paracrine _RARE_
activation O
of O
the O
HIV I-GENE
- I-GENE
1 I-GENE
LTR I-GENE
promoter I-GENE
by O
the O
viral I-GENE
Tat I-GENE
protein I-GENE
is O
mechanistically _RARE_
similar O
to O
trans _RARE_
- O
activation O
within O
a O
cell O
. O

Comparison O
of O
the O
sequences O
of O
the O
xFxFG _RARE_
repeat O
regions O
of O
p62 I-GENE
and O
Nsplp _RARE_
indicated O
that O
NTF2 _RARE_
was O
probably O
interacting _RARE_
with O
the O
phenylalanine _RARE_
- O
containing O
core O
of O
these O
repeats O
and O
not O
the O
intervening O
hydrophilic O
linkers _RARE_
. O

This O
is O
the O
first _RARE_
report O
of O
the O
successful O
resection O
of O
a O
MFH _RARE_
originating _RARE_
in O
the O
renal _RARE_
capsular _RARE_
tissue O
and O
extending O
into O
the O
inferior O
vena _RARE_
cava _RARE_
. O

Transient O
expression _RARE_
of O
VSF _RARE_
- I-GENE
1 I-GENE
in O
protoplasts _RARE_
stimulated _RARE_
vs _RARE_
- I-GENE
1 I-GENE
dependent O
activation O
of O
the O
- I-GENE
76 _RARE_
/ I-GENE
grp1 _RARE_
. I-GENE
8 I-GENE
minimal I-GENE
promoter I-GENE
. O

Keeping _RARE_
in O
mind _RARE_
the O
limited O
range O
of O
age O
and O
dosages _RARE_
, O
advantages O
and O
disadvantages _RARE_
of O
the O
drug O
are O
discussed O
, O
comparing O
the O
experimental O
results O
with O
those O
derived O
from O
the O
literature O
. O

Blood _RARE_
sampling O
procedures O
were O
videotaped _RARE_
. O

Analysis O
of O
one O
cDNA O
revealed O
an O
unusual O
splicing _RARE_
event O
involving O
EZH1 _RARE_
and O
a O
tandemly O
linked _RARE_
gene O
GPR2 _RARE_
and O
suggests O
a O
potential _RARE_
mechanism O
for _RARE_
modifying _RARE_
the O
EZH1 _RARE_
protein I-GENE
in O
the O
conserved _RARE_
C O
- O
terminal O
domain O
. O

A O
given O
standard O
input O
function O
and O
a O
given O
value O
of O
distribution O
volume O
( O
Vd _RARE_
) O
used O
for _RARE_
the O
rCBF O
measurement O
of O
this O
method O
were O
calculated O
from O
the O
dynamic O
study O
by O
six _RARE_
normal O
volunteers O
. O

They O
lack O
a O
predicted O
single O
stranded _RARE_
( O
ss _RARE_
) O
DNA O
binding O
motif O
that O
is O
unique O
the O
large O
terminase I-GENE
proteins I-GENE
in O
T4 I-GENE
gp17 _RARE_
, O
and O
that O
has O
been O
implicated O
in O
recognizing _RARE_
ssDNA _RARE_
regions O
in O
replicating _RARE_
and O
recombining _RARE_
T4DNA _RARE_
destined _RARE_
to O
be O
packaged _RARE_
. O

It O
can O
be O
concluded O
that O
in O
normotensive _RARE_
subjects O
, O
uric O
acid O
and O
xanthine _RARE_
oxidase I-GENE
have O
significant O
association O
with O
blood _RARE_
pressure O
and O
thus O
are O
one O
of O
the O
many O
factors O
which O
are O
involved O
in O
the O
cause O
or O
effect O
of O
hypertension O
. O

Immunoblotting _RARE_
of O
expressed _RARE_
recombinant O
proteins O
with O
the O
monoclonal I-GENE
08L _RARE_
antibody I-GENE
localized O
the O
08L _RARE_
epitope _RARE_
to O
the O
carboxyl _RARE_
end O
of O
the O
protein O
. O

We O
infer _RARE_
that O
the O
dominant O
negative O
inhibition O
results O
from O
both O
direct O
proteolysis O
of O
the O
beta I-GENE
- I-GENE
galactosidase I-GENE
tetramer _RARE_
by O
the O
fusion O
subunit O
and O
detour _RARE_
of O
the O
tetramer _RARE_
to O
the O
lysosome _RARE_
. O

The O
current O
study O
defines O
the O
vinculin _RARE_
- O
and O
FAK I-GENE
- I-GENE
interaction I-GENE
domains I-GENE
on O
paxillin I-GENE
and O
identifies O
the O
principal O
paxillin I-GENE
focal _RARE_
adhesion O
targeting O
motif O
. O

These O
data O
demonstrate O
the O
presence O
of O
a O
single O
binding O
site O
for _RARE_
vinculin _RARE_
, O
and O
at _RARE_
least O
two O
binding O
sites O
for _RARE_
FAK I-GENE
that O
are O
separated O
by O
an O
intervening O
stretch O
of O
100 _RARE_
amino O
acids _RARE_
. O

These O
data O
demonstrate O
that O
paxillin I-GENE
localizes O
to O
focal _RARE_
adhesions O
independent O
of O
interactions O
with O
vinculin _RARE_
and O
/ O
or O
FAK I-GENE
, O
and O
represents O
the O
first _RARE_
definitive O
demonstration _RARE_
of O
LIM I-GENE
domains I-GENE
functioning O
as _RARE_
a O
primary _RARE_
determinant O
of O
protein O
subcellular O
localization _RARE_
to O
focal _RARE_
adhesions O
. O

A O
single O
protease O
- O
resistant O
structure _RARE_
formed O
by O
the O
entirety _RARE_
of O
both O
PDZ I-GENE
repeats I-GENE
1 I-GENE
and I-GENE
2 I-GENE
( O
PDZ1 _RARE_
- I-GENE
2 I-GENE
) O
contains O
the O
protein I-GENE
4 I-GENE
. I-GENE
1 I-GENE
- I-GENE
binding I-GENE
site I-GENE
. O

Several O
agents O
have O
been O
tried _RARE_
for _RARE_
treatment O
, O
often O
limited O
by O
toxic O
side _RARE_
effects O
. O

Jerseys _RARE_
had O
higher _RARE_
hepatic _RARE_
Cu _RARE_
concentrations O
than O
did O
Holsteins _RARE_
on O
d O
60 _RARE_
( O
346 _RARE_
vs _RARE_
. O

RUSH _RARE_
- I-GENE
1 I-GENE
beta I-GENE
is O
a O
95 _RARE_
- O
kDa O
truncated O
version O
of O
RUSH _RARE_
- I-GENE
1 I-GENE
alpha I-GENE
that O
results O
from O
alternative _RARE_
splicing _RARE_
of O
a O
57 O
- O
bp O
exon _RARE_
as _RARE_
confirmed O
by O
genomic O
cloning O
. O

These O
results O
are O
consistent O
with O
the O
well _RARE_
established O
polarity O
of O
RXR I-GENE
heterodimer _RARE_
binding O
to O
bipartite O
hormone O
response O
elements O
, O
with O
the O
VDR I-GENE
recognizing _RARE_
the O
3 O
'- O
half _RARE_
- O
element O
. O

PPAR _RARE_
gamma I-GENE
mRNA I-GENE
levels O
were O
reduced _RARE_
by O
95 _RARE_
% O
with O
3 O
nM O
TNF I-GENE
alpha I-GENE
treatment O
for _RARE_
24 _RARE_
h O
. O

Exons _RARE_
III O
to O
VIII O
, O
which O
cover _RARE_
the O
coding O
region O
and O
the O
3 O
' O
untranslated _RARE_
region O
, O
are O
almost O
identical O
in O
all O
types _RARE_
of O
PST _RARE_
or O
AST _RARE_
cDNAs I-GENE
. O

Growth _RARE_
factor O
allows O
effective O
dose O
- O
intensive O
regimen O
in O
advanced O
breast O
cancer _RARE_
patients O
. O

Recombinant I-GENE
erythropoietin I-GENE
( O
r _RARE_
- I-GENE
HuEPO _RARE_
) O
in O
the O
treatment O
of O
anemia _RARE_
in O
multiple O
myeloma O

In O
1993 O
and O
1994 O
and O
infection O
with O
body O
lice _RARE_
was O
registered _RARE_
41 _RARE_
times O
in O
31 _RARE_
patients O
at _RARE_
the O
clinic _RARE_
for _RARE_
homeless _RARE_
of O
the O
Community _RARE_
Health O
Service _RARE_
of O
Utrecht _RARE_
. O

Ki _RARE_
- I-GENE
ras I-GENE
and O
p53 I-GENE
mutations I-GENE
in O
pancreatic O
ductal _RARE_
adenocarcinoma O
. O

Epidemiological _RARE_
data O
are O
quite O
controversial _RARE_
but O
sudden _RARE_
death _RARE_
occurring O
during _RARE_
sporting _RARE_
activity O
is O
probably O
not O
a O
rare O
occurrence O
. O

However O
, O
the O
ratio O
M O
/ O
Pc _RARE_
provides O
a O
useful O
index O
that O
seems O
to O
be O
independent O
of O
the O
metabolic O
demand O
. O

Rat _RARE_
liver I-GENE
catalase I-GENE
is O
sorted _RARE_
to O
peroxisomes _RARE_
by O
its O
C O
- O
terminal O
tripeptide _RARE_
Ala _RARE_
- O
Asn O
- O
Leu _RARE_
, O
not O
by O
the O
internal O
Ser _RARE_
- O
Lys _RARE_
- O
Leu _RARE_
motif O
. O

The O
mobility O
shift O
assay O
of O
the O
65 O
bp O
(- _RARE_
318 _RARE_
/ O
- O
254 _RARE_
) O
fragment O
with O
nuclear O
extract _RARE_
from O
the O
dark O
- O
adapted O
sample O
showed O
an O
additional O
band O
, O
not O
seen O
with O
the O
light O
- O
grown O
sample O
. O

These O
data O
provide O
strong O
evidence O
that O
E2F I-GENE
or O
an O
E2F I-GENE
- I-GENE
related I-GENE
transcription I-GENE
factor I-GENE
is O
involved O
in O
the O
regulation _RARE_
of O
nonmuscle _RARE_
myosin I-GENE
expression _RARE_
. O

When O
the O
E1A I-GENE
N I-GENE
- I-GENE
terminus I-GENE
is O
used O
as _RARE_
a O
competitor O
in O
squelshing _RARE_
experiments O
it O
abolishes O
CBP I-GENE
- O
induced _RARE_
activation O
of O
E2F1 I-GENE
/ O
DP1 _RARE_
, O
whereas O
an O
E1A I-GENE
mutant I-GENE
lacking _RARE_
CBP I-GENE
binding O
ability O
fails O
to O
do O
so O
. O

Small _RARE_
Maf I-GENE
proteins I-GENE
interact O
with O
the O
human O
transcription O
factor O
TCF11 _RARE_
/ O
Nrf1 _RARE_
/ O
LCR _RARE_
- I-GENE
F1 _RARE_
. O

On O
the O
third O
occasion _RARE_
water O
( O
W _RARE_
) O
was O
ingested _RARE_
throughout O
the O
run O
. O

The O
effect O
of O
maternal _RARE_
ingestion O
of O
the O
reduced _RARE_
energy O
sweetener _RARE_
erythritol _RARE_
was O
investigated O
in O
KBL _RARE_
: O
JW _RARE_
strain _RARE_
pregnant _RARE_
rabbits O
. O

Moreover O
, O
the O
same O
mutations O
alter O
the O
structure _RARE_
of O
junB I-GENE
5 O
' O
flanking O
DNA O
within O
chromatin O
. O

The O
nm23 _RARE_
- I-GENE
H1 _RARE_
/ O
nm23 _RARE_
- I-GENE
H2 I-GENE
gene O
transcriptional O
activity O
ratio O
varied O
depending O
on O
the O
cell O
line O
. O

CONCLUSION O
: O
Intravenous O
diazepam _RARE_
administration O
before O
EGD _RARE_
produces O
a O
significant O
fall O
in O
SpO2 _RARE_
during _RARE_
the O
procedure O
, O
and O
so O
should O
be O
avoided _RARE_
; O
continuous O
monitoring O
of O
SpO2 _RARE_
should O
be O
done O
during _RARE_
EGD _RARE_
. O

The O
nucleotide O
sequence O
alignment O
between O
mouse O
and O
human I-GENE
CA I-GENE
IV I-GENE
shows O
69 _RARE_
% O
identity O
in O
the O
coding O
region O
and O
all O
of O
the O
exon _RARE_
- O
intron O
boundaries O
are O
conserved _RARE_
, O
as _RARE_
are O
the O
sizes O
of O
the O
introns _RARE_
. O

Discordance _RARE_
on O
the O
cost O
dimension _RARE_
correlated O
negatively O
with O
G I-GENE
Hb _RARE_
, O
suggesting O
better O
glycemic _RARE_
control O
with O
greater O
disagreement _RARE_
. O

DATA _RARE_
SOURCES _RARE_
: O
Epidemiologic _RARE_
studies O
, O
research O
studies O
, O
review O
articles _RARE_
, O
and O
government _RARE_
reports O
pertaining _RARE_
to O
epidemiology _RARE_
of O
lung _RARE_
cancer _RARE_
. O

RESULTS O
: O
The O
age O
distribution O
was O
28 _RARE_
to O
83 _RARE_
years O
old O
( O
mean O
was O
54 O
. O
1 O
years O
). O

Histological O
changes O
, O
including O
cortical O
cell O
involution _RARE_
and O
hemorrhage O
occurring O
during _RARE_
the O
neonatal O
period O
, O
would O
seem O
to O
have O
crucial O
relevance O
to O
the O
remodeling O
of O
the O
adrenal O
vasculature _RARE_
. O

Furthermore O
, O
co _RARE_
- O
expression _RARE_
of O
both O
p46 _RARE_
and O
p54 I-GENE
subunits I-GENE
markedly O
altered O
the O
subcellular O
distribution O
of O
p46 _RARE_
; O
co _RARE_
- O
expressed _RARE_
p46 _RARE_
was O
transported O
into O
the O
nucleus O
as _RARE_
efficiently O
as _RARE_
p54 I-GENE
. O

The O
results O
suggest O
that O
, O
although O
both O
the O
N O
- O
and O
C O
- O
terminal O
regions O
of O
talin _RARE_
bind O
actin I-GENE
, O
the O
properties O
of O
these O
two O
regions O
of O
the O
protein O
are O
distinct O
. O

Merr _RARE_
.) O
embryo _RARE_
library O
. O

The O
accumulation O
of O
both O
LHA4 _RARE_
and O
LHA2 _RARE_
mRNAs I-GENE
is O
induced _RARE_
by O
the O
addition O
of O
exogenous _RARE_
sugars O
and O
this O
induction O
appears O
to O
be O
dependent O
on O
sugar _RARE_
uptake O
and O
metabolism O
, O
because O
mannitol _RARE_
and O
3 O
- O
O O
- O
methylglucose _RARE_
do O
not O
stimulate O
mRNA O
accumulation O
. O

Using O
the O
yeast O
one O
- O
hybrid _RARE_
screen O
with O
integrated O
NRE _RARE_
and O
flanking O
DNA O
as _RARE_
bait _RARE_
, O
the O
predominant O
clone O
obtained O
was O
bovine I-GENE
Nrl _RARE_
. O

As O
the O
rate O
of O
protein O
synthesis _RARE_
decreases O
during _RARE_
late _RARE_
embryogenesis O
, O
levels O
of O
SEC _RARE_
- I-GENE
1 I-GENE
and O
its O
cognate _RARE_
mRNA O
decline O
precipitously _RARE_
. O

These O
findings O
suggest O
that O
fodrin _RARE_
proteolysis O
in O
vivo O
may O
reflect O
the O
activity O
of O
multiple O
ICE I-GENE
/ O
Ced _RARE_
- I-GENE
3 I-GENE
proteases _RARE_
whose O
partial O
sensitivity O
to O
DEVD _RARE_
- O
CHO O
reflects _RARE_
a O
limited O
contribution O
from O
CPP32 _RARE_
, O
or O
an O
ICE I-GENE
/ O
Ced _RARE_
- I-GENE
3 I-GENE
protease O
less O
sensitive _RARE_
than O
CPP32 _RARE_
to O
DEVD _RARE_
- O
CHO O
inhibition O
. O

In O
3Y1 _RARE_
and O
3Y1 _RARE_
v I-GENE
- I-GENE
crk _RARE_
- O
transformed O
fibroblasts _RARE_
, O
almost O
all O
of O
the O
total _RARE_
PTP1B _RARE_
and O
about O
40 O
% O
of O
total _RARE_
p130 I-GENE
( O
Cas _RARE_
) O
co _RARE_
- O
sediment _RARE_
with O
membranes O
composed O
primarily O
of O
endoplasmic O
reticulum O
. O

Replacing _RARE_
residues O
405 _RARE_
- O
419 _RARE_
on O
delta419 _RARE_
with O
the O
conserved _RARE_
AF _RARE_
- O
2 O
domain O
from O
the O
vitamin I-GENE
D3 _RARE_
receptor I-GENE
or O
the O
estrogen I-GENE
receptor I-GENE
results O
in O
a O
receptor O
with O
wild O
- O
type O
or O
low O
transcriptional O
activity O
, O
respectively O
. O

Recurrent _RARE_
G O
- O
to O
- O
A O
substitution O
in O
a O
single O
codon _RARE_
of O
SREBP I-GENE
cleavage _RARE_
- I-GENE
activating I-GENE
protein I-GENE
causes O
sterol O
resistance O
in O
three O
mutant O
Chinese _RARE_
hamster O
ovary O
cell O
lines O
. O

The O
Escherichia I-GENE
coli I-GENE
tet _RARE_
- I-GENE
repressor I-GENE
( O
TetR _RARE_
) O
operator O
system _RARE_
was O
used O
to O
develop O
a O
variation O
of O
the O
yeast O
two O
- O
hybrid _RARE_
assay O
in O
which O
disruptions _RARE_
of O
protein O
- O
protein O
interactions O
can O
be O
identified O
by O
a O
positive O
selection O
. O

Recent O
studies O
have O
suggested O
that O
SHP I-GENE
- I-GENE
1 I-GENE
regulates O
the O
function O
of O
Jak I-GENE
family O
tyrosine I-GENE
kinases I-GENE
, O
as _RARE_
shown O
by O
its O
constitutive _RARE_
association O
with O
the O
Tyk2 _RARE_
kinase I-GENE
and O
the O
hyperphosphorylation _RARE_
of O
Jak I-GENE
kinases I-GENE
in O
the O
motheaten _RARE_
cells O
that O
lack O
functional _RARE_
SHP I-GENE
- I-GENE
1 I-GENE
. O

Administration O
of O
a O
second O
dose O
of O
vaccine O
during _RARE_
the O
outbreak O
was O
not O
protective O
. O

But _RARE_
, O
as _RARE_
Theriault _RARE_
explains _RARE_
, O
improvements _RARE_
in O
assessing O
exposure O
have O
not O
yet O
translated O
into O
clear O
and O
consistent O
findings O
. O

Biol O
. O

Structural O
basis O
for _RARE_
activation O
of O
human I-GENE
lymphocyte I-GENE
kinase I-GENE
Lck _RARE_
upon O
tyrosine O
phosphorylation _RARE_
. O

Evolutive _RARE_
morphology O
of O
the O
olfactory O
bulb O
in O
man O
and O
certain O
non O
- O
human O
mammals O

From O
these O
results O
, O
we O
concluded O
that O
this O
ORF O
is O
the O
FRDS _RARE_
gene I-GENE
. O

FK506 O
is O
10 O
- O
to O
100 _RARE_
- O
fold _RARE_
more O
potent O
than O
cyclosporin O
A O
in O
preventing O
organ O
rejection O
and O
in O
toxicity O
. O

These O
results O
suggest O
that O
Rho1p _RARE_
regulates O
cytoskeletal O
reorganization _RARE_
at _RARE_
least O
through O
Bni1p _RARE_
and O
Pkc1p _RARE_
. O

The O
ERH _RARE_
expression _RARE_
profile O
is O
similar O
, O
to O
that O
of O
An3 _RARE_
, O
which O
localizes O
to O
the O
animal _RARE_
hemisphere O
of O
oocytes O
and O
is O
abundantly O
expressed _RARE_
in O
the O
embryo _RARE_
. O

Waves _RARE_
N1 _RARE_
, O
P3 _RARE_
and O
CNV O
were O
recorded O
during _RARE_
a O
CNV O
paradigm _RARE_
in O
a O
simple O
reaction O
time O
task O
with O
a O
constant O
interstimulus _RARE_
interval O
( O
ISI _RARE_
) O
of O
1 O
sec O
. O

Therefore O
, O
both O
the O
Chilean _RARE_
and O
the O
Japanese O
samples O
collected O
in O
high O
- O
risk O
areas O
showed O
higher _RARE_
mutagenic _RARE_
rates O
than O
the O
Japanese O
ones O
in O
a O
low O
- O
risk O
area O
, O
with O
a O
statistical O
significance O
( O
p O
< O
0 _RARE_
. O
001 O
), _RARE_
chi _RARE_
- O
square O
test O
). O

Regulation O
of O
ASN1 _RARE_
and O
ASN2 _RARE_
expression _RARE_
was O
studied O
using O
lacZ I-GENE
fusions I-GENE
and O
both O
genes O
were O
found O
to O
be O
several O
times O
less O
expressed _RARE_
in O
the O
absence O
of O
the O
transcription O
activator O
Gcn4p _RARE_
. O

Several O
particular O
features O
of O
this O
polypeptide O
fragment O
from O
the O
hamster I-GENE
lysyl _RARE_
- I-GENE
tRNA I-GENE
synthetase _RARE_
suggest O
that O
it O
is O
implicated O
in O
the O
assembly O
of O
that O
enzyme O
within O
the O
multisynthetase _RARE_
complex O
. O

He O
is O
well _RARE_
, O
five O
years O
after O
relapse O
. O

Comparison O
of O
the O
proportion O
of O
nonsynonymous _RARE_
( O
pN _RARE_
) O
and O
synonymous _RARE_
( O
pS _RARE_
) O
substitutions O
occurring O
per O
site O
within O
tamarin _RARE_
variable _RARE_
region I-GENE
genes I-GENE
demonstrated O
a O
reduction O
in O
pN _RARE_
in O
the O
framework _RARE_
regions O
compared O
with O
pN _RARE_
in O
the O
presumed _RARE_
MHC I-GENE
contact _RARE_
regions I-GENE
( O
CDR1 _RARE_
and O
CDR2 _RARE_
). O

The O
effects O
of O
oral O
vanadyl _RARE_
sulfate _RARE_
( O
VOSO4 _RARE_
) O
( O
0 _RARE_
. O
5 O
mg O
/ O
kg O
/ O
day O
) O
on O
anthropometry _RARE_
, O
body O
composition O
, O
and O
performance O
were O
investigated O
in O
a O
12 O
- O
week O
, O
double O
- O
blind O
, O
placebo O
- O
controlled _RARE_
trial O
involving O
weight _RARE_
- O
training O
volunteers O
. O

Later _RARE_
in O
development O
, O
Tbx6 _RARE_
expression _RARE_
is O
restricted O
to O
presomitic _RARE_
, O
paraxial _RARE_
mesoderm O
and O
to O
the O
tail _RARE_
bud _RARE_
, O
which O
replaces _RARE_
the O
streak _RARE_
as _RARE_
the O
source O
of O
mesoderm O
. O

Disruption O
of O
re O
- O
replication O
control O
by O
overexpression O
of O
human I-GENE
ORC1 _RARE_
in O
fission _RARE_
yeast O
. O

Our O
results O
demonstrate O
that O
the O
promoter O
and O
enhancer O
regions O
identified O
here O
are O
essential O
for _RARE_
maintaining O
the O
efficient O
promoter O
activity O
of O
the O
human I-GENE
activin I-GENE
betaA _RARE_
subunit I-GENE
gene I-GENE
. O

Recombinant O
, O
bacterially O
expressed _RARE_
PIP5KIalpha _RARE_
possessed O
PIP5K _RARE_
activity O
and O
was O
immunoreactive _RARE_
with O
erythroid _RARE_
PIP5KI _RARE_
antibodies I-GENE
. O

Human I-GENE
acid I-GENE
ceramidase _RARE_
(( _RARE_
AC _RARE_
) O
N O
- O
acylsphingosine _RARE_
amidohydrolase _RARE_
, O
EC I-GENE
3 I-GENE
. I-GENE
5 I-GENE
. O

The O
0 _RARE_
. O
22 _RARE_
- O
kb O
NheI _RARE_
/ O
BglII _RARE_
promoter O
exhibited O
PMA O
inducibility O
in O
myeloid _RARE_
cells O
and O
contained O
a O
PMA O
- O
responsive O
element O
recognized _RARE_
by O
Sp1 _RARE_
and O
EGR _RARE_
- I-GENE
1 I-GENE
transcription I-GENE
factors I-GENE
. O

Northern O
( O
RNA O
) O
blot O
analyses O
indicated O
that O
the O
cdh _RARE_
genes I-GENE
encoding O
the O
five O
subunits O
and O
an O
open _RARE_
reading O
frame O
( O
ORF1 O
) O
with O
unknown O
function O
are O
cotranscribed O
during _RARE_
growth O
on O
acetate _RARE_
. O

Two O
classes O
of O
mutations O
were O
obtained O
: O
( O
i O
) O
those O
that O
altered O
the O
coding O
region O
of O
HOL1 _RARE_
, O
conferring O
the O
ability O
to O
take O
up _RARE_
histidinol _RARE_
; O
and O
( O
ii O
) O
cis O
- O
acting O
mutations O
( O
selected _RARE_
in O
a O
mutant O
HOL1 _RARE_
- I-GENE
1 I-GENE
background O
) O
that O
increased O
expression _RARE_
of O
the O
Hol1 _RARE_
protein I-GENE
. O

Damage _RARE_
to O
the O
BBB _RARE_
was O
judged O
by O
extravasation _RARE_
of O
Evans _RARE_
Blue _RARE_
( O
EB _RARE_
) O
dye _RARE_
, O
which O
was O
administered O
either O
2 O
, O
3 O
, O
24 _RARE_
or O
48 _RARE_
h O
after O
onset O
of O
MCAo _RARE_
. O

Lipid _RARE_
hydroperoxide _RARE_
levels O
in O
plasma O
and O
LDL I-GENE
remained O
unchanged O
throughout O
the O
study O
. O

When O
the O
degree O
of O
exercise O
was O
maximal O
, O
mPAP _RARE_
was O
maintained O
, O
SVI _RARE_
decreased O
, O
HR O
was O
unchanged O
, O
and O
CO _RARE_
and O
VO2 O
decreased O
. O

We O
report O
a O
case O
of O
vasculitis O
( O
cutaneous O
and O
neurologic O
) O
which O
led O
to O
the O
discovery O
of O
a O
selective O
immunodeficit _RARE_
towards O
EBV _RARE_
, O
similar O
to O
Purtilo _RARE_
' O
s O
syndrome _RARE_
. O

To O
elucidate O
whether O
potential _RARE_
endocrine O
changes O
resulted O
from O
acute O
hypoxaemia _RARE_
alone O
, O
the O
underlying O
disease _RARE_
, O
or O
unspecific _RARE_
influences O
connected O
with O
the O
ICU _RARE_
setting O
, O
all O
measurements O
were O
compared O
to O
those O
of O
a O
completely O
healthy O
reference O
group O
( O
REF _RARE_
) O
with O
comparable O
acute O
experimental O
hypoxaemia _RARE_
. O

There O
were O
no _RARE_
significant O
differences O
in O
graft O
survival O
between O
groups O
with O
early O
graft O
function O
( O
EGF _RARE_
) O
and O
DGF _RARE_
, O
either O
in O
first _RARE_
transplantations _RARE_
or O
retransplantations _RARE_
. O

These O
results O
suggested O
that O
the O
GG _RARE_
motifs O
contributed O
to O
the O
cell O
- O
specific O
transcription O
of O
the O
human I-GENE
insulin I-GENE
gene I-GENE
in O
association O
with O
the O
binding O
of O
the O
sequence O
- O
specific O
nuclear O
factor O
. O

Abnormal O
urinary _RARE_
coproporphyrin _RARE_
levels O
in O
patients O
infected _RARE_
by O
hepatitis O
C O
virus O
with O
or O
without O
human O
immunodeficiency O
virus O
. O

The O
determination O
of O
immunoglobulin I-GENE
E I-GENE
( O
IgE I-GENE
) O
antibodies O
by O
one O
of O
several O
laboratory O
tests O
, O
by O
skin _RARE_
- O
prick _RARE_
tests O
or O
by O
appropriate O
challenge O
procedures O
is O
useful O
either O
to O
identify O
atopic O
individuals O
or O
as _RARE_
outcome O
predictors O
in O
wheezy _RARE_
children O
. O

Thrombosis _RARE_
of O
the O
renal _RARE_
vein _RARE_
may O
be O
dramatic O
and O
include O
renal _RARE_
failure O
. O

Filter _RARE_
and O
cytocentrifuge _RARE_
preparations O
of O
the O
urine O
were O
studied O
and O
all O
cases O
displayed O
numerous O
scattered _RARE_
aggregates O
or O
single O
tumor O
cells O
in O
an O
inflammatory O
background O
. O

327 _RARE_
and O
736 _RARE_
protocols _RARE_
of O
postmortem _RARE_
examinations O
from O
Moscow _RARE_
hospitals O
N O
31 _RARE_
and O
57 O
, O
respectively O
, O
were O
evaluated O
statistically O
. O

The O
promoter O
segment O
was O
inactive O
when O
introduced O
into O
the O
rat O
glioma O
cell O
line O
C6B4 _RARE_
, O
the O
rat O
submandibular _RARE_
cell O
line O
RSMT _RARE_
- O
A5 _RARE_
, O
and O
the O
rat O
pancreatic O
beta O
cell O
line O
RIN _RARE_
- O
5AH _RARE_
, O
all O
of O
which O
do O
not O
express O
the O
endogenous O
alpha2c _RARE_
- I-GENE
AR _RARE_
gene I-GENE
. O

The O
sequencing O
of O
the O
conditional O
lethal O
mutation O
ts _RARE_
- O
A13 _RARE_
, O
localized O
in O
the O
nrdE _RARE_
cistron _RARE_
, O
and O
the O
lethality O
of O
insertional _RARE_
mutations O
targeted O
in O
the O
internal O
region O
of O
nrdE _RARE_
and O
nrdF _RARE_
, O
demonstrated O
the O
essential O
role O
of O
this O
locus O
. O

The O
microdensitometric _RARE_
scores O
and O
their O
side _RARE_
- O
to O
- O
side _RARE_
differences O
in O
patients O
correlated O
negatively O
with O
the O
serum O
25 _RARE_
- O
OHD _RARE_
concentration O
and O
positively O
with O
the O
degree O
of O
paralysis _RARE_
. O

These O
data O
do O
not O
support O
the O
use O
of O
LDD _RARE_
to O
reduce O
risk O
of O
progression O
to O
MSOF _RARE_
in O
sepsis O
. O

This O
correlated O
with O
reduced _RARE_
levels O
of O
secreted _RARE_
hepatitis I-GENE
B I-GENE
e _RARE_
antigen I-GENE
and O
increased O
intracellular _RARE_
levels O
of O
core I-GENE
and O
Pol I-GENE
proteins I-GENE
and O
replicative O
HBV _RARE_
DNA O
intermediates _RARE_
. O

In O
contrast O
, O
extracts O
of O
the O
mutant O
virions O
catalyze _RARE_
the O
wild O
- O
type O
level O
of O
transcription O
from O
an O
exogenous _RARE_
template O
containing O
an O
early O
promoter O
. O

The O
SCMV _RARE_
SNE _RARE_
sites I-GENE
contain O
potential _RARE_
overlapping O
core O
recognition O
binding O
motifs O
for _RARE_
SRF I-GENE
, O
Rel I-GENE
/ O
NFkappaB _RARE_
, O
ETS _RARE_
, O
and O
YY1 I-GENE
class I-GENE
transcription I-GENE
factors I-GENE
but O
fail O
to O
respond O
to O
either O
serum O
or O
tumor I-GENE
necrosis I-GENE
factor I-GENE
alpha I-GENE
. O

Upon O
serum O
withdrawal O
at _RARE_
the O
permissive O
temperature _RARE_
, O
p53 I-GENE
- O
mediated _RARE_
apoptosis O
was O
induced _RARE_
in O
50 O
to O
60 _RARE_
% O
of O
the O
cells O
. O

To O
circumvent _RARE_
this O
problem O
, O
a O
simple O
two O
- O
step O
strategy O
was O
devised _RARE_
by O
which O
essential O
cis O
- O
acting O
sites O
like O
the O
a O
sequence O
can O
be O
readily O
deleted _RARE_
from O
their O
natural _RARE_
loci O
in O
large O
viral O
DNA O
genomes O
. O

On O
the O
basis O
of O
serological O
studies O
, O
the O
highly O
conserved _RARE_
A O
domain O
of O
HspA _RARE_
was O
found O
to O
be O
the O
immunodominant _RARE_
domain O
. O

In O
Group O
IV O
dogs O
that O
received O
alpha I-GENE
- I-GENE
MSH I-GENE
only O
during _RARE_
reperfusion O
, O
BAEPs _RARE_
were O
increased O
approximately _RARE_
10 O
to O
14 O
% O
more O
than O
in O
Group O
II O
during _RARE_
the O
late _RARE_
reperfusion O
period O
. O

The O
Fas I-GENE
receptor I-GENE
mediates O
a O
signalling O
cascade O
resulting O
in O
programmed O
cell O
death _RARE_
( O
apoptosis O
) O
within O
hours O
of O
receptor O
cross O
- O
linking O
. O

Fas I-GENE
has O
been O
shown O
to O
require O
ICE I-GENE
( O
interleukin I-GENE
- I-GENE
1 I-GENE
beta I-GENE
- I-GENE
converting _RARE_
enzyme I-GENE
) O
family O
proteases _RARE_
to O
induce O
apoptosis O
from O
studies O
utilizing O
the O
cowpox _RARE_
ICE I-GENE
inhibitor I-GENE
protein I-GENE
CrmA _RARE_
, O
the O
synthetic _RARE_
tetrapeptide _RARE_
ICE I-GENE
inhibitor O
YVAD _RARE_
- I-GENE
CMK _RARE_
, O
and O
the O
tripeptide _RARE_
pan _RARE_
- O
ICE I-GENE
inhibitor O
Z I-GENE
- I-GENE
VAD _RARE_
- I-GENE
FMK _RARE_
. O

The O
imprinted O
expression _RARE_
of O
the O
endogenous O
gene O
can O
be O
recapitulated _RARE_
in O
mice O
by O
using O
a O
14 O
- O
kb O
transgene _RARE_
encompassing _RARE_
4 O
kb O
of O
5 O
'- O
flanking O
sequence O
, O
8 O
kb O
of O
3 O
'- O
flanking O
sequence O
, O
which O
includes O
the O
two O
endoderm O
- O
specific O
enhancers _RARE_
, O
and O
an O
internally _RARE_
deleted _RARE_
structural O
gene O
. O

In O
this O
report O
, O
we O
demonstrate O
that O
hGCN5 _RARE_
is O
also O
an O
HAT _RARE_
and O
has O
the O
same O
substrate O
specificity _RARE_
as _RARE_
yGCN5 _RARE_
. O

The O
effect O
of O
six _RARE_
arginine _RARE_
mutations O
of O
oxidative O
phosphorylation _RARE_
and O
AAC _RARE_
expression _RARE_
. O

Complementary _RARE_
DNAs _RARE_
encompassing _RARE_
the O
coat I-GENE
protein I-GENE
coding O
and O
adjacent O
regions O
of O
Agropyron _RARE_
mosaic O
virus O
( O
AgMV _RARE_
) O
and O
Hordeum _RARE_
mosaic O
virus O
( O
HoMV _RARE_
) O
were O
cloned _RARE_
and O
sequenced O
. O

In O
some O
cases O
, O
factor O
- O
induced _RARE_
Rac I-GENE
activation O
results O
in O
Rho I-GENE
activation O
, O
and O
factor O
- O
induced _RARE_
Cdc42 I-GENE
activation O
leads O
to O
Rac I-GENE
activation O
, O
as _RARE_
determined O
by O
specific O
morphological O
changes O
. O

Several O
cDNAs O
corresponding O
to O
the O
human I-GENE
PWP2 _RARE_
gene I-GENE
were O
identified O
and O
partially O
sequenced O
. O

Isolation O
and O
genomic O
structure _RARE_
of O
a O
human O
homolog O
of O
the O
yeast I-GENE
periodic _RARE_
tryptophan _RARE_
protein I-GENE
2 I-GENE
( O
PWP2 _RARE_
) O
gene O
mapping O
to O
21q22 _RARE_
. O
3 O
. O

Patterns _RARE_
defined O
by O
combinations O
of O
normal O
and O
abnormal O
laboratory O
results O
had O
decreased O
the O
likelihood O
of O
PEM _RARE_
from O
an O
all O
- O
2 O
to O
all O
- O
0 _RARE_
pattern O
. O

To O
examine O
whether O
thiamine _RARE_
( O
vitamin O
B1 _RARE_
) O
deficiency O
is O
associated O
with O
recurrent O
aphthous _RARE_
stomatitis _RARE_
, O
we O
studied O
vitamin O
B1 _RARE_
levels O
in O
70 O
patients O
with O
recurrent O
aphthous _RARE_
stomatitis _RARE_
and O
in O
50 O
members O
of O
a O
control O
group O
. O

Liver O
injuries O

By O
screening O
a O
cDNA O
library O
with O
a O
probe O
derived O
from O
sequences O
downstream _RARE_
of O
the O
p53p2 _RARE_
start _RARE_
site O
, O
we O
have O
cloned _RARE_
and O
characterized O
a O
cDNA O
that O
represents O
a O
mRNA O
that O
appears O
to O
have O
been O
initiated _RARE_
from O
the O
p53p2 _RARE_
promoter I-GENE
. O

However O
, O
we O
did O
not O
observe O
a O
correlation O
between O
serum O
and O
seminal _RARE_
plasma I-GENE
PSA I-GENE
levels O
. O

The O
implications O
for _RARE_
estimates O
of O
cortical O
magnification O
and O
possible O
differences O
in O
the O
specializations _RARE_
of O
foveal _RARE_
and O
peripheral O
vision O
are O
discussed O
. O

G I-GENE
- I-GENE
CSF I-GENE
activates O
multiple O
signaling _RARE_
molecules O
, O
including O
the O
JAK1 _RARE_
and O
JAK2 _RARE_
kinases I-GENE
and O
the O
STAT I-GENE
transcription O
factors O
. O

Mutants _RARE_
lacking _RARE_
any O
tyrosine O
residues O
in O
the O
cytoplasmic O
domain O
maintain O
their O
ability O
to O
activate O
STAT5 I-GENE
and O
STAT1 I-GENE
but O
cannot O
activate O
STAT3 I-GENE
, O
implying O
that O
STAT5 I-GENE
and O
STAT1 I-GENE
activation O
does O
not O
require O
receptor O
tyrosine O
phosphorylation _RARE_
. O

The O
RI _RARE_
alpha I-GENE
gene I-GENE
is O
composed O
of O
nine O
coding O
exons O
of O
varying O
lengths O
, O
separated O
by O
introns _RARE_
, O
giving O
the O
gene O
a O
total _RARE_
length O
of O
at _RARE_
least O
21 O
kb O
. O
our O
recent O
cloning O
of O
a O
processed O
RI _RARE_
alpha I-GENE
pseudogene _RARE_
with O
a O
5 O
'- O
noncoding O
region O
different O
from O
the O
previously O
reported O
RI _RARE_
alpha I-GENE
complementary _RARE_
RNA I-GENE
indicated O
that O
the O
RI _RARE_
alpha I-GENE
gene I-GENE
may O
have O
multiple O
leader _RARE_
exons O
giving O
rise O
to O
alternately _RARE_
spliced _RARE_
messenger _RARE_
RNAs O
( O
mRNAs O
). O

This O
establishes _RARE_
Rad3 _RARE_
/ O
Mec1 _RARE_
as _RARE_
the O
only O
conserved _RARE_
protein O
which O
is O
required O
for _RARE_
all O
the O
DNA O
structure _RARE_
checkpoints _RARE_
in O
both O
yeast O
model O
systems _RARE_
. O

In O
addition O
, O
double O
mutants O
with O
either O
dim1 _RARE_
- I-GENE
delta I-GENE
or O
dim2 _RARE_
- I-GENE
1 I-GENE
and O
the O
endocytosis _RARE_
mutants I-GENE
end4 _RARE_
- I-GENE
1 I-GENE
or O
act1 _RARE_
- I-GENE
1 I-GENE
displayed O
synthetic _RARE_
growth O
defects O
, O
indicating O
that O
the O
DIM _RARE_
gene I-GENE
products I-GENE
function O
in O
a O
common O
or O
parallel O
endocytic O
pathway _RARE_
. O

The O
identification O
of O
the O
hepatitis O
C O
virus O
as _RARE_
the O
major O
cause O
of O
liver O
disease _RARE_
both O
in O
dialysis O
patients O
and O
in O
transplant O
patients O
has O
focused O
attention O
on O
the O
epidemiology _RARE_
and O
the O
impact O
of O
continuing _RARE_
infection O
in O
these O
patient O
groups O
. O

Stable O
transfection O
of O
the O
BL _RARE_
cell O
line O
Raji _RARE_
with O
constructs O
containing O
core O
promoter O
mutations O
confirmed O
that O
the O
proximal O
Sp1 _RARE_
site I-GENE
and O
the O
TATA O
box O
are O
essential O
for _RARE_
the O
activation O
of O
promoter O
P1 O
by O
the O
Ig I-GENE
kappa _RARE_
enhancers _RARE_
. O

Such O
multisensory _RARE_
interactions O
can O
be O
significant O
for _RARE_
behavior O
. O

The O
P13 _RARE_
and O
N22 _RARE_
of O
ppSEPs _RARE_
had O
phase _RARE_
reversal O
relationship O
with O
the O
P2 O
and O
N2 O
recorded O
from O
the O
PES _RARE_
, O
respectively O
. O

The O
cDNA O
of O
cpm7 _RARE_
encodes O
a O
closely O
related O
protein O
of O
36 _RARE_
. O
8 O
kDa O
. O

Finally O
, O
the O
C O
- O
terminal O
region O
of O
ENBP1 _RARE_
shows O
strong O
homology O
to O
a O
protein O
from O
rat O
that O
is O
specifically O
expressed _RARE_
in O
testis _RARE_
tissue O
. O

The O
conservation O
of O
both O
the O
G O
- O
box O
and O
H O
- O
box O
in O
different O
CHS _RARE_
promoters I-GENE
emphasizes O
their O
importance O
as _RARE_
regulatory O
motifs O
. O

Mortality _RARE_
on O
the O
last O
ranch _RARE_
was O
particularly O
severe O
among O
certain O
segregated _RARE_
groups O
of O
turkeys _RARE_
that O
included O
toms _RARE_
, O
heavier _RARE_
birds O
, O
and O
birds O
undergoing O
a O
stressful _RARE_
event O
such O
as _RARE_
artificial O
insemination _RARE_
. O

Further O
, O
the O
PIP2 O
content O
of O
the O
85 _RARE_
- O
90 _RARE_
kDa O
protein O
appeared O
to O
decrease O
with O
CSF I-GENE
- I-GENE
1 I-GENE
treatment O
. O

Further O
, O
the O
PIP2 O
content O
of O
the O
85 _RARE_
- O
90 _RARE_
kDa O
protein O
appeared O
to O
decrease O
with O
CSF I-GENE
- I-GENE
1 I-GENE
treatment O
. O

Just _RARE_
before O
inserting O
on O
the O
anterior O
margin O
and O
apex O
of O
the O
iliac O
crest _RARE_
it O
widens _RARE_
, O
assuming _RARE_
the O
aspect _RARE_
of O
a O
small O
cone _RARE_
. O

The O
first _RARE_
identification O
of O
the O
active _RARE_
37LRP _RARE_
/ O
p40 I-GENE
gene O
presented O
in O
this O
study O
is O
a O
critical O
step O
toward O
the O
isolation O
of O
the O
corresponding O
human O
gene O
and O
the O
understanding O
of O
the O
molecular _RARE_
mechanisms O
involved O
in O
the O
up _RARE_
- O
regulation _RARE_
of O
its O
expression _RARE_
during _RARE_
tumor O
invasion O
and O
metastasis O
. O

The O
promoter O
region O
( O
P1 O
) O
corresponding O
to O
the O
main O
group O
of O
transcription O
initiation O
sites O
is O
devoid _RARE_
of O
TATA O
and O
CAAT O
boxes _RARE_
but O
has O
putative O
binding O
sites O
for _RARE_
the O
transcription I-GENE
factor I-GENE
SP1 I-GENE
and O
is O
embedded O
in O
a O
large O
G O
+ O
C O
- O
rich O
domain O
of O
a O
CpG O
island O
, O
features O
shared O
by O
the O
promoters O
of O
constitutively O
expressed _RARE_
housekeeping O
genes O
. O

The O
STAT I-GENE
- I-GENE
1 I-GENE
signaling _RARE_
pathway _RARE_
provides O
at _RARE_
least O
one O
mechanism O
for _RARE_
activation O
of O
the O
CAEV _RARE_
LTR I-GENE
by O
IFN I-GENE
- I-GENE
gamma I-GENE
in O
monocytes O
. O

Reperfusion _RARE_
caused O
a O
transient O
reduction O
in O
lactate _RARE_
production O
and O
a O
significant O
increase O
in O
LDH _RARE_
release O
. O

To O
evaluate O
the O
hepatic _RARE_
regenerative _RARE_
response O
in O
patients O
with O
alcoholic O
liver O
disease _RARE_
, O
sera _RARE_
from O
263 _RARE_
patients O
with O
severe O
alcoholic O
hepatitis O
and O
/ O
or O
cirrhosis O
were O
analyzed O
for _RARE_
hepatocyte _RARE_
growth I-GENE
factor I-GENE
( O
HGF I-GENE
) O
and O
alpha I-GENE
- I-GENE
fetoprotein I-GENE
( O
AFP _RARE_
). O

Children O
born O
from O
chronic O
alcoholic O
mothers O
have O
shown O
behavioral O
teratogenic _RARE_
effects O
more O
frequently O
than O
morphological O
malformations O
. O

INTERVENTION _RARE_
( O
S O
): O
Twenty O
- O
six _RARE_
hemostasis O
parameters O
evaluated O
repeatedly _RARE_
in O
patients O
undergoing O
IVF _RARE_
- O
ET _RARE_
. O

Here O
we O
report O
that O
expression _RARE_
of O
the O
I I-GENE
- I-GENE
POU I-GENE
/ O
tI _RARE_
- I-GENE
POU I-GENE
message _RARE_
is O
maximal O
late _RARE_
in O
the O
embryonic _RARE_
phase _RARE_
of O
Drosophila O
development O
, O
and O
I I-GENE
- I-GENE
POU I-GENE
is O
the O
preferred O
splice _RARE_
variant O
. O

Unlike O
wild I-GENE
- I-GENE
type I-GENE
p53 I-GENE
, O
the O
delta I-GENE
proAE _RARE_
mutant I-GENE
cDNA I-GENE
can O
be O
stably O
expressed _RARE_
in O
tumor O
derived O
cell O
lines O
with O
few O
immediate O
detrimental _RARE_
effects O
. O

The O
patient O
' O
s O
role O
, O
organized O
by O
the O
prerequisites _RARE_
of O
expressive _RARE_
freedom _RARE_
, O
is O
counter _RARE_
posed _RARE_
with O
the O
psychoanalyst _RARE_
' O
s O
, O
which O
is O
structured O
to O
empower _RARE_
listening _RARE_
and O
understanding O
. O

The O
most O
common O
risk O
factor O
reported O
for _RARE_
both O
recent O
and O
all O
other O
hepatitis O
C O
cases O
was O
a O
history O
of O
injecting O
drug O
use O
, O
although O
the O
proportion O
of O
cases O
with O
that O
history O
was O
different O
in O
NT _RARE_
from O
ACT _RARE_
and O
Queensland _RARE_
. O

Silencing _RARE_
can O
be O
restored O
by O
creation _RARE_
of O
a O
telomere _RARE_
at _RARE_
13 _RARE_
kb O
from O
the O
reporter O
construct O
, O
or O
by O
insertion _RARE_
of O
340 _RARE_
bp O
of O
yeast O
telomeric O
repeat O
sequence O
at _RARE_
this O
site O
without O
chromosomal O
truncation _RARE_
. O

In O
contrast O
with O
previous O
two O
- O
pool O
models O
, O
provisions _RARE_
were O
made O
for _RARE_
folate _RARE_
turnover O
by O
urinary _RARE_
folate _RARE_
excretion O
( O
as _RARE_
measured O
here O
) O
and O
by O
fecal O
excretion O
and O
catabolic _RARE_
processes O
. O

When O
voltage O
- O
operated O
Ca2 _RARE_
+ O
channels _RARE_
( O
VOC _RARE_
) O
were O
blocked O
by O
nifedipine O
, O
midazolam O
, O
in O
concentrations O
more O
than O
1 O
microM O
, O
attenuated O
both O
phasic _RARE_
and O
tonic _RARE_
responses O
. O

Several O
artifacts _RARE_
occurred O
that O
interfered _RARE_
with O
visualization O
of O
the O
diaphragm O
. O

Although O
p48 _RARE_
gene I-GENE
induction O
is O
dependent O
on O
STAT1 I-GENE
and O
JAK1 _RARE_
, O
activated O
STAT1 I-GENE
does O
not O
bind O
to O
GATE _RARE_
. O

The O
syndrome _RARE_
of O
resistance O
to O
thyroid O
hormone O
is O
characterized O
by O
elevated O
serum O
free O
thyroid O
hormones _RARE_
, O
failure O
to O
suppress O
pituitary I-GENE
thyrotropin I-GENE
secretion _RARE_
, O
and O
variable _RARE_
peripheral O
refractoriness _RARE_
to O
hormone O
action O
. O

Finally O
, O
nonphotosynthetic _RARE_
mutants O
, O
including O
the O
tscA _RARE_
- I-GENE
lacking _RARE_
photosystem _RARE_
I I-GENE
mutant I-GENE
, O
H13 _RARE_
, O
did O
not O
show O
evidence O
of O
light O
- O
stimulated _RARE_
RNA O
processing _RARE_
. O

The O
progression O
of O
acute O
bronchitis _RARE_
is O
associated O
with O
elevated O
blood _RARE_
concentrations O
of O
acute O
- O
phase _RARE_
proteins O
, O
KKS _RARE_
activation O
in O
the O
blood _RARE_
and O
high O
serotonin _RARE_
and O
lactic _RARE_
acid O
content O
in O
the O
humor _RARE_
condensated _RARE_
from O
the O
exhaled _RARE_
air O
. O

Because O
of O
the O
potential _RARE_
implications O
of O
these O
findings O
in O
human O
physiology O
, O
we O
cloned _RARE_
the O
hPACAP _RARE_
- I-GENE
R I-GENE
gene I-GENE
. O

Differential O
signaling _RARE_
and O
immediate I-GENE
- I-GENE
early I-GENE
gene I-GENE
activation O
by O
four O
splice _RARE_
variants O
of O
the O
human I-GENE
pituitary I-GENE
adenylate I-GENE
cyclase I-GENE
- I-GENE
activating I-GENE
polypeptide I-GENE
receptor I-GENE
( O
hPACAP _RARE_
- I-GENE
R I-GENE
). O

During O
skeletal O
muscle O
development O
, O
different O
types _RARE_
of O
muscle O
fibers O
are O
generated O
, O
which O
express O
different O
combinations O
of O
muscle O
- O
specific O
gene O
products O
. O

We O
discuss O
these O
results O
with O
respect O
to O
the O
transcriptional O
induction O
of O
the O
HNF I-GENE
- I-GENE
3 I-GENE
alpha I-GENE
gene I-GENE
in O
respiratory O
epithelium O
during _RARE_
embryogenesis O
. O

BACKGROUND O
: O
Mitosis _RARE_
is O
regulated O
by O
MPF _RARE_
( O
maturation _RARE_
promoting _RARE_
factor I-GENE
), _RARE_
the O
active _RARE_
form O
of O
Cdc2 I-GENE
/ I-GENE
28 _RARE_
- O
cyclin _RARE_
B I-GENE
complexes O
. O

Ectopic _RARE_
expression _RARE_
of O
Apo _RARE_
- I-GENE
3 I-GENE
in O
HEK293 _RARE_
or O
HeLa O
cells O
induced _RARE_
marked O
apoptosis O
. O

An O
N O
- O
terminal O
arm _RARE_
from O
each O
subunit O
wraps _RARE_
around O
the O
dinucleotide O
- O
binding O
domain O
of O
an O
adjacent O
subunit O
, O
covering O
the O
adenine _RARE_
ring _RARE_
of O
NADP _RARE_
. O

Similarity _RARE_
is O
most O
striking O
in O
the O
zinc O
knuckle _RARE_
region O
, O
a O
region O
characteristic O
of O
gag I-GENE
genes I-GENE
of O
most O
replication O
- O
competent O
retroelements _RARE_
. O

D O
. O
melanogaster O
HeT _RARE_
- I-GENE
A I-GENE
coding O
sequences O
have O
a O
polymorphic O
region O
with O
insertions O
/ O
deletions O
of O
1 O
- O
31 _RARE_
codons O
and O
many O
nucleotide O
changes O
. O

Eukaryotic _RARE_
initiation I-GENE
factor I-GENE
3 I-GENE
( O
eIF3 I-GENE
) O
is O
a O
large O
multisubunit _RARE_
complex O
that O
stabilizes O
the O
ternary _RARE_
complex O
, O
eIF2 _RARE_
x _RARE_
GTP O
x _RARE_
tRNA I-GENE
( I-GENE
Met _RARE_
) I-GENE
i I-GENE
and O
promotes O
mRNA O
binding O
to O
the O
40 I-GENE
S I-GENE
ribosomal I-GENE
subunit I-GENE
. O
eIF3 I-GENE
also O
functions O
as _RARE_
a O
ribosome _RARE_
subunit O
anti O
- O
association O
factor O
. O

Our O
data O
, O
combined O
with O
those O
of O
Hershey _RARE_
and O
co _RARE_
- O
workers O
, O
suggest O
that O
mammalian I-GENE
eIF3 I-GENE
is O
composed O
of O
at _RARE_
least O
10 O
subunits O
: O
p170 _RARE_
, O
p116 _RARE_
( O
hPrt1 _RARE_
), _RARE_
p110 _RARE_
, O
p66 _RARE_
, O
p48 _RARE_
, O
p47 _RARE_
, O
p44 I-GENE
, O
p40 I-GENE
, O
p36 _RARE_
, O
and O
p35 _RARE_
. O

Identification O
of O
a O
cis O
- O
acting O
element O
in O
the O
class I-GENE
I I-GENE
major I-GENE
histocompatibility I-GENE
complex I-GENE
gene I-GENE
promoter I-GENE
responsive O
to O
activation O
by O
retroviral _RARE_
sequences O
. O

The O
results O
demonstrate O
that O
( O
i O
) O
no _RARE_
intact _RARE_
capsids _RARE_
were O
assembled O
when O
the O
full O
- O
length O
or O
a O
truncated O
( O
missing O
the O
C O
- O
terminal O
65 O
amino O
acids _RARE_
) O
UL80 I-GENE
. I-GENE
5 I-GENE
protein I-GENE
was O
tested O
; O
( O
ii O
) O
when O
the O
C O
- O
terminal O
65 O
amino O
acids _RARE_
of O
the O
UL80 I-GENE
. I-GENE
5 I-GENE
protein I-GENE
were O
replaced O
with O
the O
C O
- O
terminal O
25 _RARE_
amino O
acids _RARE_
of O
the O
UL26 I-GENE
. I-GENE
5 I-GENE
protein I-GENE
, O
intact _RARE_
capsids _RARE_
were O
made O
and O
direct O
interaction O
of O
the O
UL80 I-GENE
. I-GENE
5 I-GENE
protein I-GENE
with O
VP5 _RARE_
was O
detected O
; O
( O
iii O
) O
assembly O
of O
intact _RARE_
capsids _RARE_
was O
demonstrated O
when O
the O
sequence O
of O
the O
last O
12 O
amino O
acids _RARE_
of O
the O
UL80 I-GENE
. I-GENE
5 I-GENE
protein I-GENE
was O
changed O
from O
RRIFVA _RARE_
ALNKLE _RARE_
to O
RRIFVAAMMKLE _RARE_
; O
( O
iv O
) O
self O
- O
interaction O
of O
the O
scaffold _RARE_
proteins O
is O
mediated _RARE_
by O
sequences O
N O
terminal O
to O
the O
maturation _RARE_
cleavage _RARE_
site O
; O
and O
( O
v O
) O
the O
UL26 I-GENE
. I-GENE
5 I-GENE
and O
UL80 I-GENE
. I-GENE
5 I-GENE
proteins I-GENE
will O
not O
coassemble _RARE_
into O
scaffold _RARE_
structures _RARE_
. O

Fourth _RARE_
, O
the O
3 O
'- O
region O
splice _RARE_
junctions O
of O
the O
MSRs _RARE_
during _RARE_
latent O
and O
productive _RARE_
infection O
were O
determined O
by O
sequencing O
RNA O
- O
PCR O
products O
generated O
with O
primers O
that O
flank O
the O
3 O
' O
splice _RARE_
region O
. O

( O
ii O
) O
ICP27 _RARE_
binds O
preferentially O
to O
less O
modified O
forms O
of O
ICP4 I-GENE
, O
a O
protein O
that O
is O
extensively O
modified O
posttranslationally _RARE_
. O

Lack _RARE_
of O
sufficient O
data O
on O
vibration O
measurements O
and O
employment _RARE_
durations O
add _RARE_
to O
the O
uncertainty _RARE_
, O
as _RARE_
do O
variations O
in O
tool O
conditions O
( O
grinder _RARE_
wheels _RARE_
, O
etc O
) O
and O
inherent _RARE_
difficulties _RARE_
in O
measurement O
. O

C I-GENE
/ I-GENE
EBP I-GENE
beta I-GENE
V I-GENE
> O
A O
selectively O
binds O
only O
the O
subset O
of O
C I-GENE
/ I-GENE
EBP I-GENE
sites I-GENE
that O
are O
also O
DBP _RARE_
sites I-GENE
, O
both O
as _RARE_
oligonucleotides O
and O
within O
the O
natural _RARE_
contexts _RARE_
of O
the O
albumin I-GENE
and O
cholesterol I-GENE
hydroxylase I-GENE
promoters I-GENE
. O

Specific O
IgG I-GENE
, O
specific O
IgE I-GENE
and O
total _RARE_
IgE I-GENE
immunoglobulins I-GENE
against O
Toxocara _RARE_
canis _RARE_
excretory _RARE_
/ I-GENE
secretory _RARE_
antigens I-GENE
( O
TES _RARE_
) O
were O
detected O
by O
using O
ELISA O
technique O
. O

SUMMARY _RARE_
BACKGROUND O
DATA _RARE_
: O
Melanoma _RARE_
care O
has O
not O
changed O
significantly O
in O
the O
last O
20 O
years O
, O
and O
the O
controversy _RARE_
of O
elective _RARE_
lymph O
node O
dissections _RARE_
in O
this O
disease _RARE_
continues _RARE_
to O
be O
discussed O
. O

The O
differences O
among O
subgenera _RARE_
of O
the O
genus O
Dermacentor _RARE_
are O
more O
significant O
. O

Mutating _RARE_
the O
E O
- O
box O
in O
the O
context O
of O
the O
3 O
'- O
flanking O
region O
confirmed O
that O
it O
contributes O
to O
the O
enhancement O
of O
transcriptional O
activity O
of O
the O
alpha1 _RARE_
( I-GENE
I I-GENE
) I-GENE
collagen _RARE_
gene I-GENE
promoter I-GENE
. O

Expression O
of O
neuronal _RARE_
traits _RARE_
in O
pancreatic O
beta O
cells O
. O

We O
propose O
that O
Mnt _RARE_
: O
Max I-GENE
: O
Sin3 _RARE_
complexes O
normally O
function O
to O
restrict _RARE_
Myc _RARE_
: O
Max I-GENE
activities O
associated O
with O
cell O
proliferation _RARE_
. O

Its O
transcription O
product O
, O
a O
1 O
. O
3 O
kb O
mRNA O
, O
is O
polyadenylated O
at _RARE_
a O
site O
containing O
consensus O
eukaryotic O
polyadenylation O
signals O
and O
mapping O
87 O
bp O
downstream _RARE_
of O
the O
translation O
termination _RARE_
codon _RARE_
for _RARE_
CG30 _RARE_
. O

Phenotypic _RARE_
changes O
induced _RARE_
by O
wild I-GENE
type I-GENE
and I-GENE
variant I-GENE
c I-GENE
- I-GENE
src I-GENE
genes I-GENE
carrying O
C O
- O
terminal O
sequence O
alterations O
. O

The O
resurgence _RARE_
of O
drug O
- O
resistant O
malaria O
makes O
urgent _RARE_
the O
evaluation O
of O
new O
antimalarial _RARE_
agents O
. O

In O
the O
p51 _RARE_
subunit I-GENE
, O
the O
Cys181 _RARE_
side _RARE_
- O
chain O
is O
oriented _RARE_
in O
a O
similar O
direction O
to O
the O
Tyr181 _RARE_
side _RARE_
- O
chain O
in O
the O
wild O
- O
type O
complex O
. O

The O
relatively O
high O
level O
transcription O
from O
this O
gene O
shows O
that O
the O
polymorphic O
chromosome _RARE_
ends O
of O
P O
. O
falciparum O
, O
which O
have O
been O
proposed O
to O
be O
transcriptionally O
silent _RARE_
, O
can O
be O
active _RARE_
expression _RARE_
sites O
for _RARE_
var _RARE_
genes I-GENE
. O

NUP145 _RARE_
was O
previously O
identified O
by O
using O
a O
genetic O
synthetic _RARE_
lethal O
screen O
( O
E O
. O

Prevalence _RARE_
of O
sleep O
- O
disordered _RARE_
breathing O
( O
SDB _RARE_
) O
is O
reported O
to O
increase O
in O
menopausal _RARE_
women O
. O

In O
all O
cases O
the O
antigenemia _RARE_
was O
transient O
and O
cleared _RARE_
by O
28th _RARE_
day O
post O
- O
vaccination O
. O

A O
total _RARE_
of O
1459 _RARE_
men O
aged O
48 _RARE_
to O
84 _RARE_
years O
, O
who O
were O
diagnosed O
for _RARE_
the O
first _RARE_
time O
by O
physicians O
as _RARE_
having O
BPH _RARE_
in O
1994 O
and O
who O
had O
not O
received O
treatment O
, O
participated _RARE_
in O
the O
study O
. O

BCL _RARE_
- I-GENE
2 I-GENE
, O
an O
inhibitor O
of O
apoptosis O
in O
a O
wide O
variety O
of O
cell O
types _RARE_
, O
has O
been O
reported O
to O
prevent O
oxidative O
stress O
- O
induced _RARE_
cell O
death _RARE_
. O

In O
vitro O
translation O
of O
the O
mTRF1 _RARE_
cDNA I-GENE
resulted O
in O
a O
56 _RARE_
kDa O
protein O
that O
binds O
to O
TTAGGG _RARE_
repeat O
arrays O
. O
mTRF1 _RARE_
displayed O
the O
same O
sequence O
specificity _RARE_
as _RARE_
hTRF1 _RARE_
, O
preferring _RARE_
arrays O
of O
TTAGGG _RARE_
repeats O
as _RARE_
a O
binding O
substrate O
over O
TTAGGC _RARE_
and O
TTGGGG _RARE_
repeats O
. O

The O
ubiquitously O
expressed _RARE_
E12 I-GENE
bHLH I-GENE
protein I-GENE
dimerizes _RARE_
with O
numerous O
cell O
- O
specific O
bHLH I-GENE
factors I-GENE
. O

The O
E O
- O
box O
sequence O
in O
the O
SE2 _RARE_
fragment I-GENE
of O
the O
transferrin I-GENE
promoter I-GENE
was O
CATCTG _RARE_
and O
was O
similar O
in O
gel O
shifts O
to O
the O
consensus O
E O
- O
box O
elements O
( O
CANNTG _RARE_
) O
previously O
characterized O
. O

A O
5 O
. O
3 O
- O
kb O
DNA O
fragment O
, O
which O
included O
the O
entire _RARE_
structural O
porin _RARE_
gene I-GENE
( O
named O
porCa _RARE_
) O
and O
its O
flanking O
regions O
, O
was O
identified O
. O

Full _RARE_
- I-GENE
length I-GENE
AT I-GENE
- I-GENE
PHH1 _RARE_
, O
and O
both O
AT I-GENE
- I-GENE
PHH1 _RARE_
and O
AT I-GENE
- I-GENE
PHH1 _RARE_
delta I-GENE
C I-GENE
- I-GENE
513 _RARE_
( O
truncated O
to O
be O
approximately _RARE_
the O
size O
of O
microbial _RARE_
photolyase _RARE_
genes I-GENE
) O
cDNAs O
, O
were O
overexpressed O
, O
respectively O
, O
in O
yeast O
and O
Escherichia O
coli O
mutants O
hypersensitive _RARE_
to O
ultraviolet _RARE_
light O
. O

The O
human I-GENE
p100 _RARE_
protein I-GENE
was O
recently O
identified O
as _RARE_
a O
coactivator _RARE_
of O
the O
Epstein I-GENE
- I-GENE
Barr I-GENE
virus I-GENE
nuclear I-GENE
antigen I-GENE
2 I-GENE
. O

However O
, O
five O
new O
mutation O
sites O
( O
S61 _RARE_
, O
SL1 _RARE_
, O
S29 _RARE_
, O
SL11 _RARE_
, O
SL196 _RARE_
and O
SL126 _RARE_
) O
are O
unique O
to O
the O
nrdB _RARE_
intron O
and O
disrupt O
self O
- O
splicing _RARE_
. O

This O
report O
presents O
the O
isolation O
and O
characterization O
of O
the O
5 O
'- O
flanking O
region O
( O
1 O
. O
2 O
kb O
) O
and O
exon _RARE_
1 O
of O
the O
human I-GENE
RII I-GENE
alpha I-GENE
gene I-GENE
. O

A O
cohort O
of O
Swedish _RARE_
children O
was O
monitored O
from O
6 O
months O
to O
11 O
years O
of O
age O
. O

The O
aim O
of O
this O
study O
was O
to O
assess O
the O
reproducibility O
of O
a O
number O
of O
simplified _RARE_
clearance O
methods O
using O
chromium _RARE_
- O
51 _RARE_
ethylenediamine _RARE_
tetraacetic _RARE_
acid O
( O
51Cr _RARE_
- O
EDTA O
) O
and O
to O
compare O
these O
with O
the O
multiple O
blood _RARE_
sample O
technique O
. O

The O
primary _RARE_
structure _RARE_
of O
a O
2671 _RARE_
bp O
DNA O
fragment O
between O
the O
pla _RARE_
gene I-GENE
( O
encoding O
plasminogen I-GENE
activator I-GENE
) O
and O
the O
origin O
of O
replication O
of O
the O
wild O
- O
type O
Yersinia _RARE_
pestis _RARE_
plasmid _RARE_
pYP358 _RARE_
was O
determined O
. O

Serotonin _RARE_
concentration O
in O
the O
blood _RARE_
of O
patients O
with O
hemorrhagic O
fever O
with O
renal _RARE_
syndrome _RARE_

MAIN O
OUTCOME O
MEASURES _RARE_
: O
Associations _RARE_
of O
factor O
analysis O
- O
derived O
syndromes O
with O
risk O
factors O
for _RARE_
chemical O
interactions O
that O
inhibit O
butyrylcholinesterase _RARE_
and O
neuropathy _RARE_
target O
esterase I-GENE
. O

CONCLUSION O
: O
Some O
Gulf _RARE_
War _RARE_
veterans _RARE_
may O
have O
delayed O
, O
chronic O
neurotoxic _RARE_
syndromes O
from O
wartime _RARE_
exposure O
to O
combinations O
of O
chemicals _RARE_
that O
inhibit O
butyrylcholinesterase _RARE_
and O
neuropathy _RARE_
target I-GENE
esterase I-GENE
. O

Control O
examination O
was O
performed O
at _RARE_
the O
end O
of O
each O
period O
. O

No O
correlation O
between O
the O
age O
of O
the O
horses O
and O
the O
antibody O
level O
could O
be O
found O
. O

The O
GHR _RARE_
mRNA I-GENE
: O
GHBP _RARE_
mRNA I-GENE
ratio O
was O
1 O
. O
1 O
+/- O
0 _RARE_
. O
12 O
and O
remained O
unchanged O
during _RARE_
differentiation O
. O

The O
results O
demonstrate O
( O
i O
) O
that O
the O
selenocysteine _RARE_
- O
specific O
UGA O
codon _RARE_
is O
readily O
suppressed O
under O
conditions O
where O
the O
homologous I-GENE
SelB _RARE_
protein I-GENE
is O
absent O
and O
( O
ii O
) O
that O
apart O
from O
the O
specificity _RARE_
of O
the O
SelB _RARE_
- I-GENE
mRNA I-GENE
interaction O
, O
a O
structural O
compatibility O
of O
the O
quaternary _RARE_
complex O
with O
the O
ribosome _RARE_
is O
required O
. O

One O
linker _RARE_
- O
peptide O
insertion _RARE_
in O
the O
RsaA _RARE_
C I-GENE
terminus I-GENE
( I-GENE
amino I-GENE
acid I-GENE
784 _RARE_
) I-GENE
had O
no _RARE_
effect O
on O
S O
- O
layer O
biogenesis O
, O
while O
another O
( O
amino O
acid O
907 _RARE_
) O
disrupted O
secretion _RARE_
of O
the O
protein O
, O
suggesting O
that O
RsaA _RARE_
possesses O
a O
secretion _RARE_
signal O
lying _RARE_
C O
terminal O
to O
amino O
acid O
784 _RARE_
, O
near O
or O
including O
amino O
acid O
907 _RARE_
. O

To O
characterize O
the O
gene O
products O
, O
the O
cvaA _RARE_
gene I-GENE
was O
subcloned O
and O
expressed _RARE_
under O
the O
control O
of O
T7 _RARE_
RNA I-GENE
polymerase I-GENE
promoter I-GENE
. O

PrpB _RARE_
showed O
homology O
to O
carboxyphosphonoenolpyruvate _RARE_
phosphonomutase _RARE_
of I-GENE
Streptomyces _RARE_
hygroscopicus _RARE_
and O
to O
its O
homolog O
in O
the O
carnation _RARE_
Dianthus _RARE_
caryophyllus _RARE_
; O
PrpC _RARE_
was O
homologous O
to O
both O
archaeal _RARE_
and I-GENE
bacterial I-GENE
citrate _RARE_
synthases _RARE_
; O
PrpD _RARE_
showed O
homology O
to O
yeast O
and O
Bacillus O
subtilis O
proteins O
of O
unknown O
function O
; O
PrpE _RARE_
showed O
homology O
to O
acetyl I-GENE
coenzyme _RARE_
A I-GENE
synthetases I-GENE
. O

MAIN O
OUTCOME O
MEASURES _RARE_
: O
Systemic _RARE_
and O
pulmonary O
hemodynamics O
, O
arterial O
blood _RARE_
gas O
determination O
, O
bronchoalveolar _RARE_
lavage _RARE_
protein O
and O
neutrophil _RARE_
content O
, O
neutrophil _RARE_
oxidant _RARE_
burst O
, O
lung _RARE_
myeloperoxidase _RARE_
content O
, O
and O
scanning O
electron O
micrographic _RARE_
studies O
. O

We O
have O
isolated O
a O
cDNA O
encoding O
human I-GENE
MEKK3 _RARE_
. O

To O
investigate O
the O
mechanisms O
involved O
in O
the O
transcriptional O
control O
of O
retinoid I-GENE
X I-GENE
receptor I-GENE
( O
RXR I-GENE
) O
gene O
expression _RARE_
, O
the O
5 O
'- O
flanking O
region O
of O
the O
human I-GENE
RXRgamma2 _RARE_
isoform I-GENE
was O
characterized O
. O

JNK I-GENE
and O
p38 I-GENE
are O
constitutively O
present O
in O
the O
nucleus O
, O
and O
DNA O
- O
bound _RARE_
c I-GENE
- I-GENE
JUN _RARE_
and O
ATF I-GENE
- I-GENE
2 I-GENE
are O
stably O
contacted _RARE_
by O
JNK I-GENE
and O
p38 I-GENE
, O
respectively O
. O

The O
effects O
of O
dominant O
interfering O
forms O
of O
the O
JNK I-GENE
/ O
p38 I-GENE
signaling _RARE_
pathway _RARE_
demonstrate O
that O
activation O
of O
these O
kinases O
is O
critical O
for _RARE_
cytokine _RARE_
- O
induced _RARE_
E I-GENE
- I-GENE
selectin I-GENE
gene I-GENE
expression _RARE_
. O

Sp1 _RARE_
binds O
the O
CTC _RARE_
repeat O
with O
an O
affinity O
, O
KD _RARE_
= O
0 _RARE_
. O
37 O
nM O
, O
at _RARE_
least O
as _RARE_
high O
as _RARE_
the O
consensus O
GC _RARE_
box O
. O

Identification O
of O
the O
region O
in O
actin I-GENE
- I-GENE
binding I-GENE
protein I-GENE
that O
binds O
to O
the O
cytoplasmic O
domain O
of O
glycoprotein I-GENE
IBalpha _RARE_
. O

Mutant _RARE_
enzyme O
forms O
were O
prepared O
to O
eliminate _RARE_
the O
initial O
autoprocessing _RARE_
site O
and O
thus O
form O
an O
active _RARE_
single O
- O
chain O
protein O
for _RARE_
structure _RARE_
- O
function O
studies O
. O

The O
primer O
is O
generated O
by O
a O
cleavage _RARE_
that O
occurs O
between O
bases O
11 O
and O
12 O
of O
the O
Tf1 _RARE_
mRNA I-GENE
. O

Similarly O
, O
we O
examined O
whether O
the O
ELK1 _RARE_
, O
SAP1a _RARE_
, O
FLI1 I-GENE
, O
EWS I-GENE
- O
FLI1 I-GENE
, O
ETS1 _RARE_
, O
ETS2 _RARE_
, O
PEA3 I-GENE
and O
PU _RARE_
. I-GENE
1 I-GENE
proteins I-GENE
can O
form O
ternary _RARE_
complexes O
with O
SRF I-GENE
on O
the O
Egr1 _RARE_
SREI _RARE_
and I-GENE
II I-GENE
. O

This O
R O
- O
domain O
may O
modulate O
the O
interaction O
with O
SRF I-GENE
, O
providing O
a O
mechanism O
that O
would O
be O
unique O
to O
FLI1 I-GENE
and O
EWS I-GENE
- O
FLI1 I-GENE
, O
thus O
implicating _RARE_
a O
novel O
function O
for _RARE_
these O
ETS _RARE_
transcription I-GENE
factors I-GENE
in O
the O
regulation _RARE_
of O
the O
Egr1 _RARE_
gene I-GENE
. O

The O
total _RARE_
number O
of O
specimens O
was O
131 _RARE_
with O
78 _RARE_
nonsmokers _RARE_
and O
53 O
smokers O
. O

The O
murine O
chromosomal O
locations O
of O
the O
five O
NMDA _RARE_
receptor I-GENE
channel _RARE_
subunits I-GENE
, O
the O
epsilon I-GENE
1 I-GENE
( O
Grin2a _RARE_
), _RARE_
epsilon I-GENE
2 I-GENE
( O
Grin2b _RARE_
), _RARE_
epsilon I-GENE
3 I-GENE
( O
Grin2c _RARE_
), _RARE_
epsilon I-GENE
4 I-GENE
( O
Grin2d _RARE_
) O
and O
zeta _RARE_
1 I-GENE
( O
Grinl _RARE_
) O
subunits O
, O
were O
determined O
using O
an O
interspecific _RARE_
backcross O
mapping O
panel O
derived O
from O
crosses _RARE_
of O
[( _RARE_
C57BL O
/ O
6JxM _RARE_
. O
spretus _RARE_
) O
F1xC57BL _RARE_
/ O
6J _RARE_
] O
mice O
. O

CDNA _RARE_
cloning O
of O
chick _RARE_
brain I-GENE
alpha I-GENE
- I-GENE
amino I-GENE
- I-GENE
3 I-GENE
- I-GENE
hydroxy I-GENE
- I-GENE
5 I-GENE
- I-GENE
methyl _RARE_
- I-GENE
4 I-GENE
- I-GENE
isoxazolepropionic _RARE_
acid I-GENE
receptors I-GENE
reveals O
conservation O
of O
structure _RARE_
, O
function O
and O
post O
- O
transcriptional O
processes O
with O
mammalian O
receptors O
. O

Remarkably _RARE_
, O
both O
TTD _RARE_
- O
A O
and O
XP _RARE_
- O
D O
defects O
are O
associated O
with O
subunits O
of O
TFIIH _RARE_
, O
a O
basal O
transcription O
factor O
with O
a O
second O
function O
in O
DNA O
repair O
. O

Adjustment _RARE_
for _RARE_
age O
, O
total _RARE_
cholesterol O
, O
HDL _RARE_
cholesterol I-GENE
, O
triglycerides _RARE_
, O
current O
smoking O
, O
and O
systolic O
pressure O
slightly O
reduced _RARE_
the O
association O
between O
fibrinogen I-GENE
and O
atherosclerosis O
. O

In O
Experiment O
1 O
, O
pups _RARE_
that O
had O
received O
an O
injection O
of O
the O
noncompetitive _RARE_
N I-GENE
- I-GENE
methyl _RARE_
- I-GENE
D I-GENE
- I-GENE
aspartate _RARE_
receptor I-GENE
antagonist O
MK O
- O
801 O
( O
0 _RARE_
. O
1 O
mg O
/ O
kg O
, O
i O
. O
p O
.) O
either O
30 _RARE_
min O
before O
or O
immediately O
after O
conditioning O
spent _RARE_
less O
time O
over O
the O
conditioned O
odor _RARE_
than O
saline O
- O
treated O
controls O
. O

Cholesterol _RARE_
side _RARE_
- I-GENE
chain I-GENE
cleavage _RARE_
cytochrome I-GENE
P450 I-GENE
( O
CYP11A _RARE_
; O
P450scc _RARE_
) O
gene O
expression _RARE_
is O
regulated O
by O
gonadotropins _RARE_
via O
cAMP O
in O
the O
ovary O
and O
by O
ACTH I-GENE
via O
cAMP O
in O
adrenal O
cortical O
cells O
. O

One O
possible O
solution O
is O
a O
thin O
radial _RARE_
forearm _RARE_
free O
flap O
. O

Structural O
analysis O
and O
characterization O
of O
tissue O
and O
hormonal O
responsive O
expression _RARE_
of O
the O
avian I-GENE
bone I-GENE
sialoprotein _RARE_
( O
BSP _RARE_
) O
gene O
. O

Serotonin _RARE_
receptors I-GENE
in O
suicide O
victims O
with O
major O
depression O
. O

The O
Y O
- O
type O
structural O
motif O
is O
also O
conserved _RARE_
among O
a O
number O
of O
divergent O
BiP _RARE_
mRNAs I-GENE
. O

A O
false O
positive O
marker O
screen O
was O
associated O
with O
the O
occurrence O
of O
hand _RARE_
- O
foot O
syndrome _RARE_
even O
when O
the O
effect O
of O
regimen O
was O
accounted _RARE_
for _RARE_
by O
stratification _RARE_
( O
p O
= O
. O
01 O
). O

The O
detection O
of O
ORF I-GENE
- I-GENE
1 I-GENE
sequences O
in O
human O
tumors O
, O
while O
not O
proof _RARE_
per O
se _RARE_
, O
is O
a O
prerequisite O
for _RARE_
establishing _RARE_
its O
role O
in O
tumor O
development O
. O

Phylogenetic _RARE_
analysis O
gave O
evidence O
for _RARE_
a O
close O
evolutionary O
relationship O
between O
PhHV _RARE_
- O
1 O
and O
members O
of O
the O
Varicellovirus _RARE_
genus O
of O
the O
alpha O
- O
Herpesvirinae _RARE_
and O
canid _RARE_
herpesvirus _RARE_
in O
particular O
. O

In O
this O
method O
, O
PLP _RARE_
in O
plasma O
can O
be O
determined O
with O
high O
sensitivity O
using O
derivatization _RARE_
with O
sodium _RARE_
bisulfite _RARE_
in O
the O
mobile O
phase _RARE_
. O

Both O
HEF1 I-GENE
and O
Cas _RARE_
were O
found O
to O
complex O
with O
the O
related I-GENE
adhesion I-GENE
focal _RARE_
tyrosine I-GENE
kinase I-GENE
( O
RAFTK _RARE_
), _RARE_
and O
when O
tyrosine O
phosphorylated _RARE_
, O
with O
the O
adapter _RARE_
molecule O
CrkL _RARE_
. O

SIM1 _RARE_
and O
SIM2 _RARE_
do O
not O
form O
homodimers O
, O
and O
they O
do O
not O
interact O
with O
AHR _RARE_
. O

Complexes _RARE_
of O
qTBP42 _RARE_
with O
each O
complementary _RARE_
strand _RARE_
of O
telomeric O
DNA O
and O
with O
quadruplex _RARE_
forms O
of O
the O
guanine O
- O
rich O
strand _RARE_
had O
3 O
. O
7 O
- O
14 O
. O
6 O
nM O
dissociation O
constants O
, O
Kd _RARE_
, O
whereas O
complexes O
with O
double O
- O
stranded _RARE_
telomeric O
DNA O
had O
up _RARE_
to O
100 _RARE_
- O
fold _RARE_
higher _RARE_
Kd _RARE_
values O
. O

Moreover O
, O
the O
effect O
exerted _RARE_
by O
TIS1 _RARE_
appeared O
to O
be O
selective O
for _RARE_
the O
MCK _RARE_
promoter I-GENE
. O

Experimental O
data O
showed O
that O
these O
abnormal O
proteins O
are O
constitutively O
localized O
in O
the O
nucleus O
, O
have O
lost O
the O
transcriptional O
repressor O
functions O
typical O
of O
normal O
NF _RARE_
- I-GENE
kappa _RARE_
B2p52 _RARE_
and O
may O
be O
capable O
of O
transactivation _RARE_
activity O
. O

Because O
L I-GENE
- I-GENE
plastin I-GENE
expression _RARE_
in O
tissue O
- O
specifically O
regulated O
in O
both O
humans O
and O
rodents _RARE_
, O
it O
is O
likely O
that O
similar O
mechanisms O
regulate O
L I-GENE
- I-GENE
plastin I-GENE
gene I-GENE
expression _RARE_
in O
human O
and O
rodent O
cells O
and O
that O
they O
could O
be O
identified O
by O
comparing O
the O
function O
and O
nucleotide O
sequences O
of O
the O
human O
and O
murine O
L I-GENE
- I-GENE
plastin I-GENE
gene O
promoters O
. O

What _RARE_
' O
s O
new O
in O
gynecologic O
and O
obstetrical _RARE_
surgery O
. O

The O
dnaK _RARE_
operon I-GENE
of I-GENE
Bacillus I-GENE
subtilis I-GENE
is O
heptacistronic _RARE_
. O

Moreover O
, O
expression _RARE_
of O
CBF1 I-GENE
in O
yeast O
was O
found O
to O
activate O
transcription O
of O
reporter O
genes O
containing O
the O
C O
- O
repeat O
/ O
DRE _RARE_
as _RARE_
an O
upstream O
activator O
sequence O
but O
not O
mutant O
versions _RARE_
of O
the O
DNA O
element O
. O

Forty O
- O
one O
ASA _RARE_
physical O
status O
I O
or O
II O
adult O
patients O
undergoing O
a O
variety O
of O
1 O
- O
1 O
. O
5 O
h O
surgical O
procedures O
were O
randomly O
allocated O
to O
receive O
CCA _RARE_
with O
desflurane _RARE_
or O
isoflurane O
with O
ventilation O
being O
either O
spontaneous O
or O
controlled _RARE_
. O

OBJECTIVE O
: O
Our O
goal O
was O
to O
determine O
whether O
chlamydia _RARE_
- O
infected _RARE_
women O
have O
a O
higher _RARE_
rate O
of O
febrile _RARE_
complications O
after O
postpartum _RARE_
tubal _RARE_
ligation O
. O

In O
the O
electrophoresis O
mobility O
shift O
assay O
using O
nuclear O
extracts O
of O
the O
myogenic _RARE_
cells O
, O
MyoD I-GENE
and O
myogenin I-GENE
bound _RARE_
to O
the O
right O
E O
- O
box O
in O
the O
enhancer O
region O
of O
the O
MCK _RARE_
gene I-GENE
even O
in O
the O
presence O
of O
BMP I-GENE
- I-GENE
2 I-GENE
. O

A O
heterologous O
promoter O
construct O
containing O
three O
repeats O
of O
a O
consensus O
Sp1 _RARE_
site I-GENE
, O
cloned _RARE_
upstream O
of O
a O
single O
copy O
of O
the O
ZII _RARE_
( O
CREB I-GENE
/ I-GENE
AP1 I-GENE
) O
element O
from O
the O
BZLF1 _RARE_
promoter I-GENE
linked _RARE_
to O
the O
beta I-GENE
- I-GENE
globin I-GENE
TATA O
box O
, O
exhibited O
phorbol O
ester O
inducibility O
. O

Subsequent _RARE_
experiments O
showed O
that O
motoric _RARE_
tasks O
rather O
than O
cognitive O
aspects O
of O
the O
COWA _RARE_
task O
were O
critical O
in O
potentiating _RARE_
finger O
- O
tapping _RARE_
performance O
. O

How _RARE_
does O
a O
nurse O
go _RARE_
about O
maintaining O
her _RARE_
level O
of O
competence _RARE_
when O
she _RARE_
is O
one O
of O
the O
few O
local O
practitioners _RARE_
in O
her _RARE_
field O
? O
Vancouver _RARE_
sex _RARE_
therapist _RARE_
Bianca _RARE_
Rucker _RARE_
is O
doing _RARE_
it O
by O
cultivating _RARE_
a O
network O
of O
colleagues _RARE_
and O
mentors _RARE_
in O
related O
fields O
both O
at _RARE_
home O
and O
across O
the O
continent _RARE_
. O

Finally O
, O
antibody O
binding O
to O
site O
IIIa _RARE_
on O
the O
hCG I-GENE
- I-GENE
ectodomain _RARE_
complex I-GENE
was O
also O
hindered _RARE_
by O
an O
anti O
- O
peptide O
mAb _RARE_
directed O
against O
a O
peptide O
encoded O
by O
the O
eighth _RARE_
exon _RARE_
( O
pE _RARE_
x _RARE_
8 O
) O
of O
the O
LHR I-GENE
. O

cDNA O
cloning O
, O
expression _RARE_
analysis O
, O
and O
chromosomal O
localization _RARE_
of O
a O
gene O
with O
high O
homology O
to O
wheat _RARE_
eIF I-GENE
-( _RARE_
iso _RARE_
) I-GENE
4F _RARE_
and O
mammalian I-GENE
eIF I-GENE
- I-GENE
4G _RARE_
. O

Therefore O
, O
it O
is O
important O
to O
control O
hypertension O
and O
keep _RARE_
appropriate O
renal _RARE_
blood _RARE_
flow O
during _RARE_
living O
renal _RARE_
transplantation O
surgery O
. O

The O
initial O
patients O
treated O
with O
AZQ _RARE_
and O
mitroxantrone _RARE_
experienced O
prolonged O
bone O
marrow O
suppression O
and O
, O
therefore O
, O
subsequent O
cohorts _RARE_
were O
treated O
with O
G I-GENE
- I-GENE
CSF I-GENE
, O
5 O
micrograms O
/ O
kg O
, O
beginning O
the O
day O
after O
completion _RARE_
of O
the O
third O
cycle _RARE_
of O
chemotherapy O
. O

Human I-GENE
granulocyte _RARE_
- I-GENE
macrophage I-GENE
colony I-GENE
- I-GENE
stimulating I-GENE
factor I-GENE
( O
hGM _RARE_
- I-GENE
CSF I-GENE
) O
activates O
a O
set O
of O
genes O
such O
as _RARE_
c I-GENE
- I-GENE
fos I-GENE
, O
jun I-GENE
, O
myc I-GENE
, O
and O
early I-GENE
growth I-GENE
response I-GENE
gene I-GENE
1 I-GENE
( O
egr _RARE_
- I-GENE
1 I-GENE
). O

In O
order O
to O
provide O
adequate O
local O
control O
without O
compromising _RARE_
cosmetic _RARE_
outcome O
, O
the O
amount O
of O
breast O
tissue O
that O
must O
be O
excised _RARE_
in O
BCT _RARE_
needs O
to O
be O
individualized _RARE_
. O

Surprisingly O
, O
however O
, O
TCR I-GENE
- O
mediated _RARE_
tyrosine O
phosphorylation _RARE_
of O
phospholipase I-GENE
C I-GENE
gamma I-GENE
1 I-GENE
remains O
intact _RARE_
in O
the O
Jurkat O
cells O
expressing O
the O
A2 _RARE_
/ O
HCP _RARE_
chimera _RARE_
. O

The O
14 I-GENE
. I-GENE
1 I-GENE
( I-GENE
IGLL1 _RARE_
) I-GENE
gene I-GENE
is O
expressed _RARE_
in O
a O
lineage O
- O
and O
stage _RARE_
- O
restricted O
manner O
. O

The O
interferon _RARE_
( O
IFN I-GENE
)- O
induced _RARE_
double I-GENE
- I-GENE
stranded _RARE_
RNA I-GENE
( I-GENE
dsRNA _RARE_
)- I-GENE
activated I-GENE
Ser _RARE_
/ I-GENE
Thr _RARE_
protein I-GENE
kinase I-GENE
( O
PKR I-GENE
) O
plays O
a O
role O
in O
the O
antiviral _RARE_
and O
antiproliferative _RARE_
effects O
of O
IFN I-GENE
. O

Together O
, O
the O
data O
suggest O
that O
cAMP O
- O
dependent O
control O
of O
the O
amounts O
of O
the O
activator O
SF _RARE_
- I-GENE
1 I-GENE
vs _RARE_
. O
the O
repressor O
COUP I-GENE
- I-GENE
TF _RARE_
could O
influence O
CRS2 _RARE_
- O
dependent O
transcription O
. O

Object _RARE_
relations O
, O
affect O
management O
, O
and O
psychic _RARE_
structure _RARE_
formation O
. O

When O
expressed _RARE_
in O
COS O
- O
7 O
cells O
, O
MKP I-GENE
- I-GENE
4 I-GENE
blocks O
activation O
of O
MAP I-GENE
kinases I-GENE
with O
the O
selectivity O
ERK I-GENE
> O
p38 I-GENE
= O
JNK I-GENE
/ O
SAPK I-GENE
. O

In O
rlf2 _RARE_
mutants I-GENE
, O
telomeric O
chromatin O
is O
perturbed _RARE_
: O
Telomeric _RARE_
silencing O
is O
reduced _RARE_
and O
Rap1p _RARE_
localization _RARE_
is O
altered O
. O

Most O
kinases O
are O
not O
significantly O
inhibited O
by O
roscovitine _RARE_
. O
cdc2 I-GENE
/ O
cyclin _RARE_
B I-GENE
, O
cdk2 I-GENE
/ O
cyclin _RARE_
A I-GENE
, O
cdk2 I-GENE
/ O
cyclin _RARE_
E I-GENE
and O
cdk5 _RARE_
/ O
p35 _RARE_
only O
are O
substantially O
inhibited O
( O
IC50 _RARE_
values O
of O
0 _RARE_
. O
65 O
, O
0 _RARE_
. O
7 O
, O
0 _RARE_
. O
7 O
and O
0 _RARE_
. O
2 O
microM O
, O
respectively O
). O
cdk4 _RARE_
/ O
cyclin _RARE_
D1 _RARE_
and O
cdk6 _RARE_
/ O
cyclin _RARE_
D2 _RARE_
are O
very O
poorly O
inhibited O
by O
roscovitine _RARE_
( O
IC50 _RARE_
> O
100 _RARE_
microM O
). O

This O
0 _RARE_
. O
74 _RARE_
kb O
cDNA O
contains O
an O
open _RARE_
reading O
frame O
( O
ORF O
) O
of O
477 _RARE_
bp O
encoding O
a O
polypeptide O
of O
159 _RARE_
amino O
acids _RARE_
( O
aa _RARE_
) O
which O
differs O
at _RARE_
only O
one O
position O
( O
position O
65 O
) O
from O
the O
human I-GENE
U1 _RARE_
- I-GENE
C I-GENE
protein I-GENE
. O

Interaction O
of O
Ets I-GENE
- I-GENE
1 I-GENE
and O
the O
POU I-GENE
- I-GENE
homeodomain _RARE_
protein I-GENE
GHF _RARE_
- I-GENE
1 I-GENE
/ O
Pit I-GENE
- I-GENE
1 I-GENE
reconstitutes _RARE_
pituitary O
- O
specific O
gene O
expression _RARE_
. O

Although O
Pho85 _RARE_
is O
not O
essential O
for _RARE_
viability O
, O
Pcl1 _RARE_
, I-GENE
2 I-GENE
- O
Pho85 _RARE_
kinase O
complexes O
become O
essential O
for _RARE_
Start _RARE_
in O
the O
absence O
of O
Cln1 _RARE_
, I-GENE
2 I-GENE
- O
Cdc28 I-GENE
kinases O
. O

Using O
the O
yeast O
two O
- O
hybrid _RARE_
system _RARE_
to O
screen O
for _RARE_
proteins O
which O
interact O
with O
Tax1 _RARE_
, O
we O
isolated O
the O
B O
subunit O
of O
the O
CCAAT O
binding O
protein O
NF _RARE_
- I-GENE
Y I-GENE
from O
a O
HeLa O
cDNA O
library O
. O

Enhancer _RARE_
activity O
requires O
both O
the O
AP I-GENE
- I-GENE
1 I-GENE
site I-GENE
and O
these O
adjacent O
sequences O
. O

Studies O
using O
HLA I-GENE
- I-GENE
DR _RARE_
- O
B7 I-GENE
- I-GENE
1 I-GENE
- O
LFA _RARE_
- I-GENE
3 I-GENE
triple _RARE_
transfectants O
showed O
that O
the O
LFA _RARE_
- I-GENE
3 I-GENE
- O
induced _RARE_
NF _RARE_
- I-GENE
AT I-GENE
DNA O
binding O
activity O
was O
negatively O
regulated O
by O
B7 I-GENE
- I-GENE
1 I-GENE
costimulation _RARE_
. O

Constitutive _RARE_
activation O
of O
Rac1 I-GENE
and O
RhoA I-GENE
causes O
tumorigenic O
transformation O
of O
NIH _RARE_
3T3 O
cells O
, O
and O
their O
functions O
may O
be O
required O
for _RARE_
full O
Ras I-GENE
transformation O
. O

Furthermore O
, O
Rac1 I-GENE
activation O
of O
JNK I-GENE
or O
SRF I-GENE
, O
or O
induction O
of O
lamellipodia _RARE_
, O
was O
neither O
necessary O
nor O
sufficient O
for _RARE_
Rac1 I-GENE
transforming O
activity O
. O

Overexpression O
of O
the O
bZip _RARE_
interaction O
domain O
of O
CBP I-GENE
specifically O
abolishes O
the O
positive O
cross O
talk _RARE_
between O
TR I-GENE
and O
p45 _RARE_
/ O
NF _RARE_
- I-GENE
E2 I-GENE
. O

This O
inhibitory _RARE_
domain O
has O
been O
deleted _RARE_
in O
all O
naturally O
occurring O
AHC _RARE_
deletion I-GENE
mutants I-GENE
described O
to O
date O
. O

Identification O
of O
a O
promoter O
- O
specific O
transactivation _RARE_
domain O
in O
the O
herpes I-GENE
simplex I-GENE
virus I-GENE
regulatory I-GENE
protein I-GENE
ICP4 I-GENE
. O

DNA O
sequencing O
of O
a O
17 _RARE_
- O
kb O
segment O
encompassing _RARE_
a O
gammaherpesvirus _RARE_
divergent O
locus O
( O
DL _RARE_
- O
B O
) O
between O
ORF11 _RARE_
and O
ORF17 _RARE_
revealed O
the O
presence O
of O
nine O
viral O
ORFs _RARE_
with O
predicted O
gene O
products O
related O
to O
cellular O
proteins O
. O

Studies O
in O
mammalian O
cells O
have O
correlated O
induction O
of O
inhibitory _RARE_
tyrosine O
15 _RARE_
( O
Y15 _RARE_
) O
phosphorylation _RARE_
on O
p34cdc2 I-GENE
with O
the O
response O
to O
DNA O
damage O
. O

We O
report O
herein _RARE_
the O
case O
of O
a O
30 _RARE_
- O
year O
- O
old O
man O
in O
whom O
ectopic O
mediastinal _RARE_
parathyroid _RARE_
adenoma _RARE_
was O
detected O
by O
99mTc O
- O
methoxyisobutylisonitrile _RARE_
scintigraphy O
( O
99mTc O
- O
MIBI _RARE_
). O

Cardiac _RARE_
endothelin I-GENE
release O
and O
infarct O
size O
, O
myocardial _RARE_
blood _RARE_
flow O
, O
and O
ventricular O
function O
in O
canine O
infarction O
and O
reperfusion O
. O

The O
workup _RARE_
included O
skin _RARE_
tests O
( O
up _RARE_
to O
1 O
microgram O
/ O
ml O
, O
Pharmacia O
), _RARE_
measurement O
of O
specific O
serum O
IgE I-GENE
with O
RAST O
- O
CAP _RARE_
( O
Pharmacia O
), _RARE_
and O
CAST _RARE_
with O
three O
concentrations O
of O
bee _RARE_
( O
Apis _RARE_
mellifera _RARE_
) O
and O
wasp _RARE_
( O
Vespula _RARE_
spec _RARE_
.) O
venom _RARE_
( O
Aquagen _RARE_
ALK _RARE_
). O

The O
proliferation _RARE_
potential _RARE_
protein I-GENE
- I-GENE
related I-GENE
( O
P2P _RARE_
- I-GENE
R I-GENE
) O
gene O
with O
domains O
encoding O
heterogeneous _RARE_
nuclear O
ribonucleoprotein O
association O
and O
Rb1 _RARE_
binding O
shows O
repressed O
expression _RARE_
during _RARE_
terminal O
differentiation O
. O

Recent O
application O
of O
recombinant O
canarypox _RARE_
ALVAC _RARE_
/ O
HIV O
- O
1 O
vectors O
as _RARE_
vaccine O
immunogens _RARE_
in O
HIV O
- O
1 O
,- _RARE_
noninfected _RARE_
volunteers O
has O
produced O
CTL O
responses O
in O
a O
significant O
number O
of O
vaccinees _RARE_
. O

The O
relevance O
of O
these O
elements O
in O
conferring O
anaerobic O
induction O
of O
gpc4 _RARE_
gene I-GENE
expression _RARE_
is O
discussed O
. O

Exons _RARE_
A1a _RARE_
and O
A1b _RARE_
are O
separated O
from O
each O
other O
by O
a O
124 _RARE_
- O
nucleotide O
intron O
. O

A O
MEK I-GENE
- O
specific O
inhibitor O
( O
PD098059 _RARE_
) O
( O
Dudley _RARE_
, O
D O
. O

These O
data O
support O
the O
idea O
that O
the O
repression O
activity O
of O
NRSF _RARE_
/ O
REST _RARE_
depends O
upon O
the O
species O
of O
promoter O
to O
which O
it O
is O
linked _RARE_
and O
upon O
the O
proteins O
that O
bind O
to O
those O
promoters O
. O

Enhanced _RARE_
period O
- O
peak O
analysis O
of O
electro _RARE_
- O
encephalograms _RARE_
using O
a O
fast O
sinc _RARE_
function O
. O

In O
summary O
, O
p56 _RARE_
( O
lck _RARE_
) O
activity O
stimulates O
G1 O
/ O
S O
transition O
in O
immature O
thymoblasts _RARE_
and O
maintains O
cell O
viability O
via O
transduction _RARE_
of O
constitutive _RARE_
activation O
signals O
downstream _RARE_
to O
components _RARE_
of O
the O
Ras I-GENE
/ O
Raf I-GENE
/ O
MAPK _RARE_
pathway _RARE_
. O

However O
, O
the O
action O
of O
each O
cognate _RARE_
ligand _RARE_
and O
the O
accessory _RARE_
cellular O
factors O
that O
can O
differentially O
regulate O
the O
transcriptional O
responses O
of O
a O
heterodimer _RARE_
- O
DNA O
complex O
are O
not O
well _RARE_
understood O
. O

We O
have O
measured O
the O
MBF _RARE_
on O
incisors _RARE_
and O
its O
direction O
in O
three O
dimensions O
for _RARE_
different O
jaw O
openings _RARE_
in O
ten O
subjects O
. O

These O
findings O
suggest O
that O
intraarterial _RARE_
neoadjuvant _RARE_
chemotherapy O
should O
be O
effective O
on O
advanced O
cervical O
cancer _RARE_
. O

The O
FBF _RARE_
questionnaire O
did O
not O
highlight _RARE_
a O
characteristic O
basic O
symptoms O
profile O
of O
schizoaffective _RARE_
disorder O
, O
when O
compared O
with O
bipolar O
affective O
disorder O
and O
schizophrenia O
. O

The O
alternative _RARE_
sigma _RARE_
factor I-GENE
sigmaB _RARE_
in I-GENE
Staphylococcus _RARE_
aureus _RARE_
: O
regulation _RARE_
of O
the O
sigB _RARE_
operon I-GENE
in O
response O
to O
growth O
phase _RARE_
and O
heat O
shock O

Cognate _RARE_
promoter O
elements O
implicated O
in O
glucocorticoid O
- O
and O
cAMP O
- O
mediated _RARE_
regulation _RARE_
as _RARE_
well _RARE_
as _RARE_
in O
liver O
-, _RARE_
myeloid _RARE_
-, _RARE_
and O
lymphocyte O
- O
specific O
expression _RARE_
are O
located _RARE_
within O
the O
5 O
' O
flanking O
sequence O
. O

Clinically _RARE_
meaningful _RARE_
decreases O
due O
to O
alkalinization _RARE_
alone O
within O
30 _RARE_
minutes O
are O
unlikely O
. O

We O
have O
studied O
the O
biokinetics _RARE_
of O
BLM _RARE_
labeled O
with O
indium _RARE_
- O
111 O
( O
In O
- O
111 O
). O

CD3 I-GENE
cross O
- O
linking O
induced _RARE_
tyrosine O
phosphorylation _RARE_
of O
Sam68 _RARE_
in O
uninfected _RARE_
T O
cells O
. O

Acetoin _RARE_
- O
dependent O
expression _RARE_
of O
the O
acoABCD _RARE_
operon I-GENE
could O
be O
restored O
in O
the O
E I-GENE
. I-GENE
coli I-GENE
acoK _RARE_
mutants I-GENE
by O
supplying _RARE_
a O
plasmid _RARE_
carrying O
an O
intact _RARE_
acoK _RARE_
, O
suggesting O
a O
transactivating O
function O
of O
the O
gene O
product O
. O

Mutations O
in O
the O
alpha I-GENE
and I-GENE
sigma _RARE_
- I-GENE
70 I-GENE
subunits I-GENE
of I-GENE
RNA I-GENE
polymerase I-GENE
affect O
expression _RARE_
of O
the O
mer _RARE_
operon I-GENE
. O

Taken O
together O
, O
we O
provide O
evidence O
for _RARE_
the O
existence O
of O
an O
activator O
, O
NFE _RARE_
, O
which O
in O
combination O
with O
the O
p50 _RARE_
and O
c I-GENE
- I-GENE
Rel I-GENE
proteins I-GENE
, O
are O
part O
of O
the O
transcription O
factor O
machinery O
that O
regulates O
3 O
' O
enhancer O
activity O
, O
and O
thus O
the O
control O
of O
the O
IgH _RARE_
locus I-GENE
in O
late _RARE_
B O
lymphocyte O
development O
. O

The O
neuroprotective _RARE_
efficacy O
of O
the O
selective O
N O
- O
type O
voltage O
- O
sensitive _RARE_
calcium _RARE_
channel _RARE_
blocker O
, O
SNX _RARE_
- O
111 O
, O
was O
evaluated O
in O
spontaneously O
hypertensive O
rats O
subjected O
to O
60 _RARE_
min O
of O
focal _RARE_
cerebral O
ischemia O
by O
permanent O
ligation O
of O
the O
right O
common O
carotid O
artery O
and O
temporary O
occlusion O
of O
the O
right O
middle _RARE_
cerebral O
artery O
. O

The O
genes O
encoding O
the O
transcription I-GENE
factor I-GENE
yTAFII60 _RARE_
, O
the O
G4p1 _RARE_
protein I-GENE
and O
a O
putative O
glucose O
transporter _RARE_
are O
contained O
in O
a O
12 O
. O
3 O
kb O
DNA O
fragment O
on O
the O
left _RARE_
arm _RARE_
of O
Saccharomyces O
cerevisiae O
chromosome _RARE_
VII O
. O

The O
protector _RARE_
doubled _RARE_
the O
estimated O
fall O
distance O
for _RARE_
fracture O
of O
the O
trochanter _RARE_
. O

Marinol _RARE_
/ O
marijuana _RARE_
usage O
was O
associated O
with O
depressed O
CD4 _RARE_
+ I-GENE
counts O
and O
elevated O
amylase I-GENE
levels O
within O
the O
DDI _RARE_
subgroup O
. O

METHODS O
: O
Fifty O
- O
eight O
patients O
who O
underwent O
a O
curative _RARE_
hepatic _RARE_
resection O
for _RARE_
HCC _RARE_
and O
whose O
preoperative O
AFP _RARE_
levels O
were O
> O
100 _RARE_
ng _RARE_
/ O
ml O
, O
were O
selected _RARE_
for _RARE_
this O
study O
. O

Calmodulin _RARE_
- I-GENE
binding I-GENE
peptide I-GENE
( O
CBP I-GENE
), _RARE_
a O
peptide O
of O
26 _RARE_
amino O
acids _RARE_
derived O
from O
muscle I-GENE
myosin I-GENE
light I-GENE
chain I-GENE
kinase I-GENE
( O
MLCK _RARE_
), _RARE_
binds O
to O
calmodulin I-GENE
with O
nanomolar _RARE_
affinity O
. O

Here O
we O
show O
that O
the O
type O
of O
tyrosine I-GENE
kinase I-GENE
receptor I-GENE
stimulated _RARE_
also O
participates O
in O
the O
nature O
of O
the O
cAMP O
effect O
. O

To O
gain O
insight O
into O
the O
possible O
involvement O
of O
p21 I-GENE
in O
liver O
cell O
growth O
, O
the O
expression _RARE_
and O
regulation _RARE_
of O
the O
p21 I-GENE
gene I-GENE
was O
evaluated O
in O
rodent O
models O
of O
liver O
regeneration O
and O
specimens O
of O
human O
liver O
diseases O
. O

Northern O
blot O
analysis O
of O
LeMT _RARE_
( I-GENE
A I-GENE
) I-GENE
and O
LeMT _RARE_
( I-GENE
B I-GENE
) I-GENE
showed O
that O
transcripts O
of O
both O
MT _RARE_
- I-GENE
like I-GENE
genes I-GENE
were O
more O
abundant O
in O
leaves O
than O
roots O
in O
tomato _RARE_
plants _RARE_
grown O
without O
addition O
of O
extra _RARE_
metal O
ions O
, O
a O
characteristic O
of O
type I-GENE
II I-GENE
MTs _RARE_
. O

In O
co _RARE_
- O
transfection O
studies O
, O
an O
AP I-GENE
- I-GENE
2 I-GENE
but O
not O
an O
Egr _RARE_
- I-GENE
1 I-GENE
expression _RARE_
vector O
activated O
VPF _RARE_
/ O
VEGF I-GENE
transcription O
, O
thus O
indicating O
that O
AP I-GENE
- I-GENE
2 I-GENE
protein I-GENE
is O
functionally O
important O
in O
TGF I-GENE
alpha I-GENE
- O
induced _RARE_
VPF _RARE_
/ O
VEGF I-GENE
gene O
expression _RARE_
. O

The O
HBP _RARE_
gene I-GENE
is O
composed O
of O
eight O
exons O
covering O
19 O
. O
5 O
kb O
on O
the O
short O
arm _RARE_
of O
chromosome _RARE_
4 O
. O

In O
some O
instances O
, O
this O
is O
partly O
mediated _RARE_
by O
the O
expression _RARE_
of O
virally _RARE_
encoded O
proteases _RARE_
which O
lead O
to O
the O
cleavage _RARE_
of O
initiation I-GENE
factor I-GENE
eIF4G _RARE_
. O

The O
best O
endometrial O
ablation O
was O
seen O
when O
SnET2 _RARE_
was O
given O
by O
intrauterine O
administration O
with O
light O
treatment O
at _RARE_
150 _RARE_
J _RARE_
/ O
cm O
24 _RARE_
hours O
later O
. O

Unlike O
class O
II O
- O
and O
III O
- O
specific O
TBP I-GENE
- O
TAF _RARE_
complexes O
, O
the O
corresponding O
murine O
and O
human O
class O
I O
- O
specific O
transcription O
initiation O
factor O
TIF I-GENE
- I-GENE
IB _RARE_
/ O
SL1 _RARE_
exhibits O
a O
pronounced O
selectivity O
for _RARE_
its O
homologous O
promoter O
. O

Cytohesin _RARE_
- I-GENE
1 I-GENE
, O
a O
protein O
abundant O
in O
cells O
of O
the O
immune O
system _RARE_
, O
has O
been O
proposed O
to O
be O
a O
human O
homolog O
of O
the O
Saccharomyces I-GENE
cerevisiae I-GENE
Sec7 _RARE_
gene I-GENE
product I-GENE
, O
which O
is O
crucial O
in O
protein O
transport _RARE_
. O

In O
this O
regard O
, O
it O
differs O
from O
a O
recently O
reported O
BFA _RARE_
- O
sensitive _RARE_
ARF I-GENE
- O
GEP _RARE_
that O
contains O
a O
Sec7 _RARE_
domain I-GENE
. O

We O
now O
describe O
the O
identification O
of O
DEK _RARE_
as _RARE_
this O
43 _RARE_
- I-GENE
kDa I-GENE
pets _RARE_
factor I-GENE
. O

These O
elements O
comprise O
a O
binding O
site O
for _RARE_
Krox I-GENE
proteins I-GENE
, O
one O
for _RARE_
nuclear I-GENE
factor I-GENE
1 I-GENE
, O
an O
octamer O
motif O
that O
binds O
POU I-GENE
- I-GENE
homeodomain _RARE_
proteins I-GENE
, O
and O
a O
novel O
TN _RARE_
control I-GENE
element I-GENE
. O

Tissue _RARE_
samples O
were O
obtained O
either O
from O
rats O
that O
had O
been O
exposed O
to O
opiate _RARE_
withdrawal O
following O
a O
seven _RARE_
day O
morphine _RARE_
infusion O
or O
sham O
treated O
control O
subjects O
. O

Therefore O
, O
the O
impaired O
floor _RARE_
plate _RARE_
development O
in O
oep _RARE_
mutants I-GENE
is O
not O
caused O
by O
the O
absence O
of O
the O
floor _RARE_
plate _RARE_
inducer _RARE_
shh _RARE_
. O

RESULTS O
: O
The O
medians _RARE_
of O
average O
daily O
CD34 I-GENE
+ I-GENE
cell O
yields O
for _RARE_
patients O
who O
received O
paclitaxel _RARE_
plus _RARE_
CY _RARE_
, O
CE _RARE_
, O
and O
CEP _RARE_
with O
G I-GENE
- I-GENE
CSF I-GENE
were O
12 O
. O
9 O
, O
11 O
. O
03 O
, O
and O
5 O
. O
37 O
x _RARE_
10 O
( O
6 O
)/ _RARE_
kg O
, O
respectively O
, O
compared O
with O
2 O
. O
02 O
x _RARE_
10 O
( O
6 O
)/ _RARE_
kg O
in O
the O
reference O
group O
that O
received O
CY _RARE_
with O
G I-GENE
- I-GENE
CSF I-GENE
( O
P O
= O
< O
. O
0001 O
, O
. O
002 _RARE_
, O
and O
. O
09 O
, O
respectively O
). O

Increased O
p53 I-GENE
activity O
induced _RARE_
by O
OP _RARE_
is O
not O
due O
to O
elevated O
p53 I-GENE
mRNA I-GENE
nor O
to O
protein O
levels O
. O

CONCLUSION O
: O
Chronic O
administration O
of O
misoprostol _RARE_
may O
have O
caused O
a O
negative O
natriuretic _RARE_
effect O
in O
cirrhotic _RARE_
patients O
with O
ascites _RARE_
. O

The O
intensity O
of O
the O
SSTEs _RARE_
is O
an O
order O
of O
magnitude O
larger O
than O
that O
of O
the O
MSEs _RARE_
and O
determines _RARE_
the O
signal O
contrast O
if O
both O
effects O
are O
selected _RARE_
simultaneously O
. O

In O
eukaryotic O
cells O
, O
premature O
termination _RARE_
of O
translation O
at _RARE_
nonsense O
codons O
has O
been O
implicated O
as _RARE_
the O
cause O
of O
a O
variety O
of O
posttranscriptional O
events O
, O
including O
rapid O
mRNA O
decay _RARE_
in O
the O
cytoplasm O
or O
the O
nucleus O
, O
altered O
splice _RARE_
site O
selection O
, O
and O
exon _RARE_
skipping _RARE_
. O

The O
region O
of O
plasmid _RARE_
pCM2 _RARE_
encoding O
the O
pathogenicity _RARE_
locus I-GENE
pat _RARE_
- I-GENE
1 I-GENE
was O
mapped O
by O
deletion O
analysis O
and O
complementation _RARE_
studies O
to O
a O
1 O
. O
5 O
- O
kb O
Bg _RARE_
/ I-GENE
II I-GENE
/ O
SmaI _RARE_
DNA O
fragment O
. O

Transient O
cotransfection O
of O
tat I-GENE
cDNA I-GENE
in O
sense O
orientation O
( O
tat I-GENE
/ I-GENE
S I-GENE
), _RARE_
together O
with O
a O
plasmid _RARE_
containing O
the O
c I-GENE
- I-GENE
fos I-GENE
promoter I-GENE
( O
FC3 _RARE_
, O
from O
- O
711 _RARE_
to O
+ O
42 _RARE_
) O
in O
front O
of O
the O
bacterial I-GENE
chloramphenicol I-GENE
acetyltransferase _RARE_
( O
CAT I-GENE
) O
gene O
significantly O
enhanced _RARE_
CAT I-GENE
activity O
in O
Jurkat O
cells O
activated O
by O
the O
addition O
of O
15 _RARE_
% O
fetal _RARE_
calf _RARE_
serum O
( O
FCS _RARE_
) O
or O
5 O
micrograms O
/ O
mL O
phytohemagglutinin I-GENE
plus _RARE_
10 O
(- _RARE_
7 O
) O
mol O
/ O
L O
phorbol O
myristate O
acetate _RARE_
( O
PMA O
) O
and O
U937 O
cells O
activated O
by O
15 _RARE_
% O
FCS _RARE_
or O
10 O
(- _RARE_
7 O
) O
mol O
/ O
L O
PMA O
. O

Snail _RARE_
mortality O
did O
not O
differ O
among O
the O
various O
treatment O
conditions O
. O

The O
recombinant O
protein O
was O
purified _RARE_
to O
homogeneity _RARE_
by O
( O
NH4 _RARE_
) O
2SO4 _RARE_
- O
precipitation O
and O
affinity O
chromatography O
on O
5 O
' O
AMP O
- O
Sepharose _RARE_
. O

Derepression _RARE_
of O
gene O
expression _RARE_
mediated _RARE_
by O
the O
5 O
' O
upstream O
region O
of O
the O
isocitrate _RARE_
lyase I-GENE
gene I-GENE
of I-GENE
Candida _RARE_
tropicalis _RARE_
is O
controlled _RARE_
by O
two O
distinct O
regulatory O
pathways O
in O
Saccharomyces O
cerevisiae O
. O

Exploratory _RARE_
- O
motor O
task O
to O
evaluate O
right O
frontal O
lobe O
damage O
. O

To O
avoid O
complications O
, O
accurate O
quantitative O
analysis O
of O
NO _RARE_
and O
NO2 O
is O
necessary O
during _RARE_
this O
therapy O
. O

Our O
results O
demonstrate O
that O
cis O
elements O
positioned O
between O
the O
alpha I-GENE
3 I-GENE
and O
beta I-GENE
4 I-GENE
coding O
regions O
are O
important O
for _RARE_
establishing _RARE_
part O
of O
the O
restricted O
CNS O
patterns O
of O
beta I-GENE
4 I-GENE
, O
alpha I-GENE
3 I-GENE
, O
and O
alpha I-GENE
5 I-GENE
gene I-GENE
transcription O
. O

RNase I-GENE
protection O
experiments O
confirmed O
the O
presence O
of O
the O
GHR1 _RARE_
- I-GENE
279 _RARE_
variant I-GENE
in O
IM O
- O
9 O
cells O
and O
human O
liver O
. O

Functional O
tests O
using O
a O
reporter O
gene O
, O
containing O
Stat5 I-GENE
- I-GENE
binding I-GENE
elements I-GENE
, O
confirmed O
that O
while O
the O
variant O
form O
was O
inactive O
by O
itself O
, O
it O
could O
inhibit O
the O
function O
of O
the O
full O
- O
length O
receptor O
. O

Conversely O
, O
activated O
glucocorticoid I-GENE
receptors I-GENE
suppressed O
the O
transactivation _RARE_
function O
of O
p53 I-GENE
, O
while O
transrepression _RARE_
by O
p53 I-GENE
was O
largely O
unaffected O
. O

99mTc O
- O
HMPAO O
was O
distributed O
in O
the O
territories _RARE_
of O
the O
ACA _RARE_
and O
MCA _RARE_
in O
the O
two O
patients O
who O
were O
treated O
with O
intraarterial _RARE_
infusion O
of O
papaverine _RARE_
from O
the O
C4 _RARE_
segment O
, O
but O
was O
distributed O
only O
to O
the O
territory _RARE_
of O
the O
ACA _RARE_
in O
four O
patients O
who O
were O
treated O
with O
intraarterial _RARE_
infusion O
of O
papaverine _RARE_
from O
the O
C1 O
segment O
at _RARE_
1 O
ml O
/ O
min O
. O

This O
brief O
review O
analyses O
these O
interactions O
and O
defines O
clinical O
settings _RARE_
where O
antibiotic O
- O
induced _RARE_
endotoxin _RARE_
release O
may O
prove O
to O
be O
clinically O
relevant O
. O

This O
promoter O
segment O
could O
drive O
expression _RARE_
of O
a O
luciferase I-GENE
reporter I-GENE
gene I-GENE
, O
could O
confer O
correct O
transcriptional O
initiation O
to O
the O
reporter O
and O
could O
confer O
the O
EGF _RARE_
- O
responsiveness O
previously O
observed O
in O
the O
native _RARE_
gene O
. O

This O
is O
the O
first _RARE_
report O
that O
an O
in O
vitro O
- O
synthesized O
alphavirus _RARE_
RNA O
lacking _RARE_
a O
poly _RARE_
( O
A O
) O
tail _RARE_
can O
initiate O
infection O
and O
produce O
3 O
' O
polyadenylated O
viral O
genome O
in O
vivo O
. O

The O
human O
coreceptor _RARE_
was O
as _RARE_
active _RARE_
as _RARE_
the O
simian O
for _RARE_
SIV O
entry O
. O

These O
changes O
in O
virus O
entry O
features O
may O
result O
in O
coronaviruses _RARE_
with O
novel O
pathogenic O
properties O
. O

RESULTS O
: O
Among O
women O
, O
the O
age O
- O
related O
decline O
in O
BMD O
at _RARE_
all O
non O
- O
spine O
skeletal O
sites O
was O
significantly O
different O
from O
zero O
, O
with O
the O
largest O
decline O
seen O
at _RARE_
the O
femoral O
neck O
(-. _RARE_
0038 _RARE_
g O
/ O
cm2 O
/ O
y _RARE_
, O
p O
< O
. O
001 O
) O
and O
the O
smallest O
at _RARE_
the O
trochanter _RARE_
of O
the O
hip O
(-. _RARE_
0023 _RARE_
g O
/ O
cm2 O
/ O
y _RARE_
, O
p O
= O
. O
03 O
). O

Sixty _RARE_
- O
nine O
( O
44 _RARE_
%) O
patients O
were O
administered O
250 _RARE_
MBq O
( O
7 O
mCi O
) O
99Tcm _RARE_
- O
tetrofosmin O
at _RARE_
rest O
followed O
4 O
h O
later O
by O
750 O
MBq O
( O
21 O
mCi O
) O
during _RARE_
stress O
( O
the O
1 O
day O
protocol O
), _RARE_
whereas O
88 O
( O
56 _RARE_
%) O
patients O
had O
rest O
and O
stress O
imaging O
studies O
on O
two O
separate O
days O
, O
receiving O
a O
500 O
MBq O
( O
14 O
mCi O
) O
dose O
of O
99Tcm _RARE_
- O
tetrofosmin O
on O
each O
occasion _RARE_
( O
the O
2 O
day O
protocol O
). O

Myocardial O
SPET _RARE_
imaging O
with O
99Tcm _RARE_
- O
tetrofosmin O
in O
clinical O
practice O
: O
comparison O
of O
a O
1 O
day O
and O
a O
2 O
day O
imaging O
protocol O
. O

99Tcm _RARE_
- O
DMP _RARE_
- O
HSA _RARE_
showed O
an O
almost O
identical O
behaviour O
to O
in O
vitro O
labelled O
red _RARE_
blood _RARE_
cells O
( O
RBCs _RARE_
), _RARE_
which O
are O
generally O
considered O
the O
reference O
standard O
for _RARE_
blood _RARE_
pool O
agents O
. O

Relief _RARE_
from O
autoinhibition _RARE_
and O
a O
subsequent O
10 O
- O
60 _RARE_
- O
fold _RARE_
increase O
in O
V O
( O
max _RARE_
) O
have O
been O
observed O
upon O
N I-GENE
- I-GENE
SH2 _RARE_
domain I-GENE
engagement _RARE_
by O
a O
specific O
phosphotyrosyl _RARE_
ligand _RARE_
or O
upon O
deletion O
of O
the O
SH2 _RARE_
domains I-GENE
to O
yield O
the O
catalytic O
PTPase _RARE_
domain I-GENE
. O

We O
have O
thus O
identified O
the O
first _RARE_
mammalian I-GENE
homolog I-GENE
of I-GENE
yeast I-GENE
UPF1 _RARE_
, O
a O
protein O
that O
regulates O
levels O
of O
nonsense O
mRNA O
, O
and O
we O
tentatively O
name _RARE_
this O
protein O
human I-GENE
HUPF1 _RARE_
( O
for _RARE_
human I-GENE
homolog I-GENE
of I-GENE
UPF1 _RARE_
). O

A O
miracle _RARE_
cure O
and O
its O
solution O

The O
addition O
of O
zidovudine _RARE_
did O
not O
influence O
this O
transfer O
. O

DNA O
strand _RARE_
exchange O
catalyzed O
by O
Rad51 _RARE_
protein I-GENE
is O
also O
greatly O
stimulated _RARE_
by O
RPA I-GENE
. O

Ume6p _RARE_
, O
which O
also O
controls O
the O
expression _RARE_
of O
early O
meiotic _RARE_
genes O
, O
represses O
CAR1 _RARE_
expression _RARE_
through O
a O
sequence O
called O
URS _RARE_
, O
as _RARE_
a O
function O
of O
nitrogen O
availability O
. O

The O
second O
class O
of O
cDNA O
hybridized O
to O
a O
13 _RARE_
kb O
transcript O
, O
which O
was O
approximately _RARE_
twice O
as _RARE_
large O
as _RARE_
the O
mammalian I-GENE
lactase _RARE_
mRNA I-GENE
. O

In O
cell O
lines O
transformed O
by O
BCR _RARE_
/ O
ABL I-GENE
, O
CRKL _RARE_
was O
tyrosine O
phosphorylated _RARE_
, O
while O
CRK _RARE_
was O
not O
. O

In O
untransformed _RARE_
cells O
, O
three O
major O
proteins O
coprecipitated _RARE_
with O
CRKL _RARE_
, O
identified O
as _RARE_
C3G _RARE_
, O
SOS _RARE_
and O
c I-GENE
- I-GENE
ABL I-GENE
. O

Effect O
of O
Azadirachta _RARE_
indica _RARE_
hydroalcoholic _RARE_
leaf O
extract _RARE_
on O
the O
cardiovascular O
system _RARE_
. O

RESULTS O
: O
Nodular _RARE_
opacities _RARE_
, O
mainly O
centrilobular _RARE_
in O
distribution O
, O
were O
the O
most O
common O
finding O
, O
seen O
in O
21 O
( O
72 O
%) O
and O
15 _RARE_
( O
65 O
%) O
of O
patients O
with O
MTB _RARE_
and O
NTMB _RARE_
, O
respectively O
. O

Circulating _RARE_
oxytocin _RARE_
in O
male O
guinea _RARE_
pigs O
affected O
by O
the O
female O
cohabitation _RARE_
and O
reproductive O
condition O
. O

In O
cellular O
supernatant O
fraction O
, O
SHRSP _RARE_
showed O
a O
decrease O
of O
magnesium O
in O
many O
tissues O
and O
an O
elevation O
of O
the O
calcium _RARE_
to O
magnesium O
ratio O
when O
compared O
to O
age O
- O
matched O
WKY _RARE_
and O
SHRSR _RARE_
. O

Antisense _RARE_
transcription O
of O
a O
murine I-GENE
FGFR I-GENE
- I-GENE
3 I-GENE
psuedogene _RARE_
during _RARE_
fetal _RARE_
developement _RARE_
. O

A O
previous O
report O
described O
that O
a O
548 _RARE_
- O
bp O
BglII _RARE_
- O
SmaI _RARE_
fragment O
has O
an O
SSO _RARE_
activity O
( O
ori2 _RARE_
; O
Kataoka _RARE_
et O
al O
., O
Mol _RARE_
. O

The O
human I-GENE
CD38 _RARE_
gene I-GENE
consists O
of O
8 O
exons O
that O
extend O
more O
than O
77 O
kb O
on O
the O
human O
genome O
. O

Type _RARE_
IV O
splice _RARE_
pattern O
, O
containing O
exon _RARE_
U3 _RARE_
and O
S O
was O
found O
both O
in O
kidney _RARE_
and O
ovary O
. O

GH _RARE_
deficiency O
may O
be O
absolute O
, O
but O
often O
is O
not O
and O
the O
diagnosis O
may O
be O
complicated O
by O
a O
constellation _RARE_
of O
physical O
and O
hormonal O
findings O
that O
are O
along O
a O
spectrum O
from O
low O
normal O
GH _RARE_
sufficiency _RARE_
to O
absent O
GH _RARE_
secretion _RARE_
. O

Positive _RARE_
CRP I-GENE
test O
were O
seen O
. O

During O
the O
febrile _RARE_
period O
, O
pleocytosis _RARE_
was O
associated O
with O
high O
levels O
of O
IgG I-GENE
, O
IL _RARE_
- I-GENE
6 I-GENE
, O
TNF I-GENE
- I-GENE
alpha I-GENE
, O
and O
PGE2 O
in O
the O
cerebrospinal _RARE_
fluid _RARE_
. O

Recognition _RARE_
mechanisms O
of O
the O
minus O
- O
strand _RARE_
origin O
of O
phage _RARE_
f1 _RARE_
by O
Escherichia I-GENE
coli I-GENE
RNA I-GENE
polymerase I-GENE
. O

The O
minimum O
and O
essential O
subunits O
for _RARE_
RNA O
synthesis _RARE_
have O
not O
yet O
been O
identified O
. O

Syndecan _RARE_
- I-GENE
4 I-GENE
is O
a O
focal _RARE_
adhesion O
component _RARE_
, O
and O
this O
interaction O
may O
both O
localize O
PKC I-GENE
and O
amplify _RARE_
its O
activity O
at _RARE_
sites O
of O
forming O
adhesions O
. O

The O
3ASubE _RARE_
cells O
expressing O
CXCR2 _RARE_
with O
mutation O
of O
Ser _RARE_
- O
346 _RARE_
, O
- O
347 _RARE_
, O
and O
- O
348 _RARE_
to O
alanine O
, O
or O
with O
mutation O
of O
only O
one O
serine O
in O
this O
domain O
, O
continue _RARE_
to O
be O
phosphorylated _RARE_
in O
response O
to O
ligand _RARE_
and O
are O
60 _RARE_
- O
70 O
% O
desensitized _RARE_
following O
the O
initial O
ligand _RARE_
challenge O
. O

Members O
of O
the O
MAPK _RARE_
family I-GENE
include O
the O
extracellular I-GENE
response I-GENE
kinases I-GENE
( O
ERKs I-GENE
or O
p42 _RARE_
/ I-GENE
44 _RARE_
( O
MAPK _RARE_
)), _RARE_
the O
c I-GENE
- I-GENE
Jun I-GENE
amino I-GENE
- I-GENE
terminal I-GENE
kinases I-GENE
( O
JNKs _RARE_
), _RARE_
and O
the O
p38 I-GENE
/ O
Hog _RARE_
1 I-GENE
protein O
kinases O
. O

MOP5 _RARE_
contained O
the O
characteristic O
PAS _RARE_
domain O
and O
a O
variable _RARE_
C O
terminus O
; O
it O
is O
possible O
that O
the O
cDNA O
contains O
a O
bHLH O
domain O
, O
but O
the O
entire _RARE_
open _RARE_
reading O
frame O
has O
yet O
to O
be O
completed O
. O

The O
reduced _RARE_
NO _RARE_
production O
in O
these O
cells O
was O
associated O
with O
low O
levels O
of O
mRNA O
of O
inducible I-GENE
NO _RARE_
synthetase _RARE_
. O

Some O
8 O
. O
8 O
kb O
of O
the O
Lactobacillus _RARE_
sake _RARE_
plasmid _RARE_
pCIM1 _RARE_
was O
sequenced O
, O
revealing _RARE_
eight O
tightly O
clustered O
open _RARE_
reading O
frames O
( O
ORFs _RARE_
) O
downstream _RARE_
from O
lasA _RARE_
, O
which O
encodes O
pre I-GENE
- I-GENE
lactocin _RARE_
S I-GENE
. O

Purified _RARE_
Pra I-GENE
was O
also O
shown O
to O
physically O
interact O
with O
pyruvate _RARE_
kinase I-GENE
( O
Pk _RARE_
); O
Pk _RARE_
and O
Pra I-GENE
can O
form O
a O
complex O
, O
but O
when O
the O
12 I-GENE
- I-GENE
kDa I-GENE
Ndk _RARE_
, O
Pk _RARE_
, O
and O
Pra I-GENE
are O
all O
present O
, O
Pk _RARE_
has O
a O
higher _RARE_
affinity O
than O
Pra I-GENE
for _RARE_
forming O
a O
complex O
with O
the O
12 I-GENE
- I-GENE
kDa I-GENE
Ndk _RARE_
. O

Apart _RARE_
from O
iron O
regulation _RARE_
, O
sodA _RARE_
expression _RARE_
was O
affected O
by O
changes O
in O
DNA O
topology O
induced _RARE_
by O
coumermycin _RARE_
A O
but O
not O
by O
the O
global O
virulence _RARE_
regulatory O
Bvg _RARE_
system _RARE_
. O

Molecular O
characterization O
of O
a O
large O
Borrelia _RARE_
burgdorferi _RARE_
motility _RARE_
operon O
which O
is O
initiated _RARE_
by O
a O
consensus O
sigma70 _RARE_
promoter I-GENE
. O

M I-GENE
. I-GENE
leprae _RARE_
OxyR I-GENE
was O
overproduced _RARE_
and O
purified _RARE_
, O
and O
its O
binding O
to O
the O
oxyR _RARE_
- O
ahpC _RARE_
intergenic O
region O
of O
M O
. O
leprae _RARE_
was O
demonstrated O
. O

The O
binding O
site O
for _RARE_
OxyR I-GENE
overlapped _RARE_
P1oxyR _RARE_
, O
reminiscent _RARE_
of O
the O
autoregulatory _RARE_
loops O
controlling O
expression _RARE_
of O
oxyR _RARE_
in O
enteric O
bacteria O
and O
characteristic O
of O
the O
LysR _RARE_
superfamily I-GENE
in O
general _RARE_
. O

In O
the O
present O
study O
, O
we O
have O
isolated O
and O
sequenced O
several O
p15E _RARE_
cDNA I-GENE
gene I-GENE
fragments I-GENE
amplified O
by O
means O
of O
polymerase O
chain O
reaction O
( O
PCR O
) O
from O
parental O
( O
P815 _RARE_
) O
and O
xenogenized _RARE_
( O
P815 _RARE_
/ O
DTIC _RARE_
) O
tumour _RARE_
cells O
. O

Thirty O
- O
five O
patients O
were O
included O
. O

Grade _RARE_
3 O
- O
4 O
mucositis _RARE_
was O
present O
in O
13 _RARE_
% O
of O
the O
cycles O
. O

Therefore O
more O
active _RARE_
and O
tolerable _RARE_
salvage _RARE_
regimens O
are O
needed O
. O

None O
of O
these O
organic O
manifestations O
was O
discovered O
by O
scintigraphic _RARE_
means O
. O

While O
TGF I-GENE
- I-GENE
beta1 I-GENE
does O
not O
alter O
the O
mitogen O
- O
induced _RARE_
expression _RARE_
and O
abundance O
of O
G1 O
phase _RARE_
cyclin _RARE_
D1 _RARE_
and O
cdks _RARE_
4 I-GENE
and I-GENE
2 I-GENE
in O
MCs _RARE_
, O
it O
inhibits O
cyclin _RARE_
E I-GENE
- O
cdk _RARE_
2 I-GENE
activity O
, O
thus O
preventing O
mitogen O
- O
elicited O
phosphorylation _RARE_
and O
inactivation O
of O
pRb I-GENE
in O
G1 O
phase _RARE_
and O
transition O
to O
S O
phase _RARE_
. O

However O
, O
the O
range O
of O
values O
observed O
is O
suggestive O
of O
the O
need O
to O
investigate O
districts _RARE_
with O
contrasting _RARE_
values O
of O
SYPLR _RARE_
with O
respect O
to O
the O
inter _RARE_
- O
relationships O
between O
sociodemographic _RARE_
characteristics O
, O
duration O
of O
symptoms O
, O
clinical O
presentation O
and O
treatment O
efficacy O
. O

The O
prominent O
lesions O
were O
confined O
to O
the O
cerebral O
surface O
layer O
and O
leptomeningeal _RARE_
tissue O
including O
the O
arachnoid _RARE_
vessels O
, O
which O
were O
all O
bathed _RARE_
in O
the O
cerebrospinal _RARE_
fluid _RARE_
, O
suggesting O
that O
some O
necrotizing _RARE_
toxins _RARE_
had O
been O
secreted _RARE_
into O
the O
fluid _RARE_
by O
the O
B O
. O
cereus _RARE_
. O

This O
fragment O
contained O
the O
C O
- O
terminal O
47 _RARE_
nucleotides O
of O
leuB _RARE_
, O
encoding O
3 I-GENE
- I-GENE
isopropylmalate _RARE_
dehydrogenase I-GENE
; O
asd _RARE_
, O
encoding O
aspartate _RARE_
- I-GENE
beta I-GENE
- I-GENE
semialdehyde _RARE_
dehydrogenase I-GENE
( O
Asd _RARE_
); O
and O
orfA _RARE_
, O
whose O
product O
showed O
similarity _RARE_
to O
the O
Asd _RARE_
proteins I-GENE
from I-GENE
Vibrio _RARE_
spp _RARE_
. O

Transcriptional O
activity O
was O
measured O
by O
slot _RARE_
- O
blot O
hybridization O
with O
steady O
- O
state O
RNA O
isolated O
from O
lacZ I-GENE
+ I-GENE
M I-GENE
. I-GENE
smegmatis _RARE_
clones _RARE_
. O

Hovenitin _RARE_
I O
and O
(+)- _RARE_
ampelopsin _RARE_
, O
both O
of O
which O
were O
principal O
ingredients _RARE_
of O
the O
active _RARE_
fractions O
from O
this O
natural _RARE_
medicine O
, O
were O
found O
to O
show O
an O
inhibitory _RARE_
activity O
on O
the O
ethanol O
- O
induced _RARE_
muscle O
relaxation O
in O
rats O
. O

Movement _RARE_
time O
and O
kinematic _RARE_
characteristics O
were O
analyzed O
together O
with O
the O
magnitude O
of O
cerebral O
blood _RARE_
flow O
to O
identify O
areas O
of O
brain O
activity O
proportionate _RARE_
to O
task O
and O
movement O
variables O
. O

Areas _RARE_
with O
significantly O
greater O
rCBF O
for _RARE_
targeting O
were O
the O
left _RARE_
motor O
cortex O
, O
left _RARE_
intraparietal _RARE_
sulcus _RARE_
, O
and O
left _RARE_
caudate _RARE_
. O

Recent O
studies O
have O
demonstrated O
that O
the O
U1 _RARE_
snRNP I-GENE
is O
recruited O
to O
the O
5 O
' O
splice _RARE_
site O
by O
protein O
/ O
protein O
interactions O
involving O
the O
SR I-GENE
domains O
of O
the O
U1 _RARE_
- I-GENE
70K _RARE_
protein I-GENE
and O
SF2 _RARE_
/ O
ASF _RARE_
. O

Thus O
, O
the O
tri _RARE_
- O
snRNP O
- O
specific O
27K _RARE_
protein O
could O
potentially O
be O
involved O
in O
SR I-GENE
protein O
- O
mediated _RARE_
protein O
/ O
protein O
interactions O
and O
, O
additionally O
, O
its O
phosphorylation _RARE_
state O
could O
modulate O
pre O
- O
mRNA O
splicing _RARE_
. O

Purified _RARE_
P7 _RARE_
could O
be O
assembled O
onto O
particles _RARE_
lacking _RARE_
P7 _RARE_
and O
particles _RARE_
lacking _RARE_
both O
P2 I-GENE
( O
RNA I-GENE
polymerase I-GENE
) O
and O
P7 _RARE_
. O

However O
, O
the O
same O
U1A _RARE_
peptide I-GENE
, O
when O
conjugated O
to O
BSA _RARE_
, O
inhibits O
vertebrate _RARE_
PAP _RARE_
. O

Plasma O
levels O
of O
protein I-GENE
C I-GENE
, O
protein I-GENE
S I-GENE
, O
and O
antithrombin I-GENE
III I-GENE
in O
patients O
with O
subarachnoid _RARE_
haemorrhage _RARE_
. O

Idiopathic _RARE_
bilateral O
recurrent O
branch O
retinal _RARE_
arterial O
occlusion O
( O
IBRBRAO _RARE_
) O
is O
a O
rare O
syndrome _RARE_
characterized O
by O
migraine _RARE_
headaches _RARE_
, O
tinnitus _RARE_
, O
vertigo _RARE_
, O
hearing O
loss _RARE_
, O
and O
recurrent O
branch O
retinal _RARE_
artery O
occlusion O
of O
unknown O
etiology O
. O

Epithelial _RARE_
and O
corneal O
thickness O
measurements O
by O
in O
vivo O
confocal _RARE_
microscopy O
through O
focusing O
( O
CMTF _RARE_
). O

Sequences _RARE_
downstream _RARE_
of O
the O
two O
human I-GENE
CA I-GENE
genes I-GENE
, O
possibly O
containing O
homologous O
enhancer O
elements O
, O
have O
not O
yet O
been O
reported O
. O

Recombinant O
plasmids O
containing O
the O
entire _RARE_
322 _RARE_
nt O
5 O
' O
UTR O
of O
exon _RARE_
1 O
and O
a O
1630 _RARE_
nt O
segment O
of O
5 O
' O
flanking O
sequence O
stimulated _RARE_
luciferase I-GENE
activity O
nearly O
70 O
times O
higher _RARE_
than O
a O
promoterless O
control O
plasmid _RARE_
. O

Analysis O
for _RARE_
DNA O
- O
protein O
interactions O
by O
in O
vitro O
DNase I-GENE
- I-GENE
I I-GENE
footprinting O
identified O
a O
broad O
region O
of O
protection O
extending O
from O
nt O
- O
12 O
to O
+ O
38 O
. O

It O
is O
also O
homologous O
to O
other O
sugar _RARE_
carriers O
from O
human O
, O
mouse O
and O
Escherichia O
coli O
. O

Until _RARE_
now O
, O
each O
of O
these O
loci O
was O
considered O
to O
contain O
three O
genes O
( O
for _RARE_
regulator I-GENE
, O
permease _RARE_
and O
alpha I-GENE
- I-GENE
glucosidase _RARE_
), _RARE_
but O
a O
fourth O
gene O
, O
presumably O
an O
extra _RARE_
alpha I-GENE
- I-GENE
glucosidase _RARE_
gene I-GENE
, O
was O
found O
at _RARE_
MAL1 _RARE_
adjacent O
to O
the O
usual _RARE_
cluster O
of O
three O
genes O
. O

Although O
methods O
to O
align _RARE_
the O
control O
and O
activation O
fMR _RARE_
images O
may O
correct O
for _RARE_
some O
of O
this O
motional _RARE_
error O
, O
they O
will O
be O
incomplete O
in O
correcting _RARE_
for _RARE_
those O
that O
depend O
on O
spatial O
orientation O
. O

Three O
women O
have O
had O
abnormal O
endocervical _RARE_
follow O
up _RARE_
cytology _RARE_
suggestive O
of O
residual O
disease _RARE_
. O

Autorosette _RARE_
- O
forming O
cells O
are O
characterized O
by O
a O
high O
activity O
of O
alkaline _RARE_
and I-GENE
acid I-GENE
phosphatases _RARE_
and O
low O
NBT _RARE_
- O
test O
values O
. O

Analysis O
of O
homologous O
DNA O
sequences O
within O
the O
first _RARE_
intron O
of O
the O
mouse I-GENE
and I-GENE
human I-GENE
mts1 _RARE_
genes I-GENE
: O
kB _RARE_
- I-GENE
like I-GENE
site I-GENE
and O
microsatellite _RARE_
DNA O

The O
integration _RARE_
at _RARE_
the O
VIP _RARE_
CyRE _RARE_
of O
the O
Jak I-GENE
- O
Stat I-GENE
and O
AP I-GENE
- I-GENE
1 I-GENE
signaling _RARE_
pathways O
with O
other O
pre O
- O
existing O
proteins O
provides O
a O
cellular O
mechanism O
for _RARE_
cell O
- O
and O
cytokine _RARE_
- O
specific O
signaling _RARE_
. O

These O
studies O
point O
to O
the O
involvement O
of O
the O
MAP I-GENE
kinase I-GENE
pathway _RARE_
in O
the O
activation O
of O
monocytic O
cells O
during _RARE_
transmigration _RARE_
to O
inflammatory O
sites O
. O

Our O
results O
show O
that O
the O
temperature _RARE_
- I-GENE
sensitive _RARE_
rad54 _RARE_
- I-GENE
3 I-GENE
allele I-GENE
blocks O
mitotic _RARE_
recombination _RARE_
between O
tandemly O
repeated _RARE_
DYZ3 _RARE_
satellite _RARE_
sequences I-GENE
and O
significantly O
stabilizes O
a O
human I-GENE
DYZ5 _RARE_
satellite _RARE_
- O
containing O
YAC O
clone O
. O

A O
P22 _RARE_
R17 _RARE_
derivative _RARE_
with O
an O
OcRNA _RARE_
site O
( O
P22 _RARE_
R17 _RARE_
[ _RARE_
A O
(- _RARE_
10 O
) O
U _RARE_
]) _RARE_
develops _RARE_
lytically _RARE_
following O
infection O
of O
these O
strains O
. O

Circularized _RARE_
Ac _RARE_
/ O
Ds _RARE_
transposons _RARE_
: O
formation O
, O
structure _RARE_
and O
fate O
. O

This O
site O
is O
upstream O
from O
the O
TATA O
box O
used O
in O
somatic O
cells O
. O

In O
this O
study O
, O
we O
have O
examined O
the O
regulation _RARE_
of O
B I-GENE
- I-GENE
Myb I-GENE
activity O
by O
cyclin _RARE_
- O
Cdks _RARE_
. O

Candidate _RARE_
tumor O
suppressor O
genes O
, O
Mts1 _RARE_
( O
p16INK4a _RARE_
) O
and O
Mts2 _RARE_
( O
p15INK4b _RARE_
), _RARE_
have O
been O
mapped O
to O
this O
region O
, O
but O
by O
Southern O
blot O
analysis O
, O
no _RARE_
homozygous O
deletions O
were O
detected O
in O
either O
gene O
. O

Excision _RARE_
repair O
at _RARE_
the O
level O
of O
the O
nucleotide O
in O
the O
Saccharomyces I-GENE
cerevisiae I-GENE
MFA2 _RARE_
gene I-GENE
: O
mapping O
of O
where O
enhanced _RARE_
repair O
in O
the O
transcribed _RARE_
strand _RARE_
begins O
or O
ends O
and O
identification O
of O
only O
a O
partial O
rad16 _RARE_
requisite _RARE_
for _RARE_
repairing _RARE_
upstream O
control O
sequences O
. O

An O
aromatic O
stacking _RARE_
interaction O
between O
subunits O
helps _RARE_
mediate O
DNA O
sequence O
specificity _RARE_
: O
operator O
site O
discrimination O
by O
phage _RARE_
lambda I-GENE
cI _RARE_
repressor I-GENE
. O

We O
have O
characterized O
a O
panel O
of O
6 O
monoclonal O
antibodies O
raised O
against O
human I-GENE
platelet I-GENE
talin _RARE_
by O
Western O
blotting O
, O
immune O
precipitation O
, O
and O
immunofluorescence O
, O
and O
shown O
that O
antibodies I-GENE
TA205 _RARE_
and O
TD77 _RARE_
disrupt O
actin I-GENE
stress O
fibers O
and O
focal _RARE_
adhesions O
, O
and O
inhibit O
cell O
motility _RARE_
when O
microinjected _RARE_
into O
human O
fibroblasts _RARE_
. O

This O
locus O
maps O
approximately _RARE_
160 _RARE_
kbp _RARE_
from O
the O
genes O
encoding O
cytadherence _RARE_
- O
associated O
proteins O
HMW1 _RARE_
and O
HMW3 _RARE_
, O
and O
yet O
insertions O
therein _RARE_
result O
in O
loss _RARE_
of O
these O
proteins O
and O
a O
hemadsorption _RARE_
- O
negative O
( O
HA _RARE_
-) _RARE_
phenotype _RARE_
, O
prompting _RARE_
the O
designation _RARE_
cytadherence _RARE_
- I-GENE
regulatory I-GENE
locus I-GENE
( O
crl _RARE_
). O

Coliphage _RARE_
186 _RARE_
B I-GENE
is O
a O
72 O
- O
amino O
acid O
protein O
belonging O
to O
the O
Ogr _RARE_
family O
of O
analogous O
transcription O
factors O
present O
in O
P2 O
- O
like O
phage _RARE_
, O
which O
contain O
a O
Cys _RARE_
- O
X2 O
- O
Cys _RARE_
- O
X22 _RARE_
- O
Cys _RARE_
- O
X4 _RARE_
- O
Cys _RARE_
presumptive _RARE_
zinc O
- O
finger O
motif O
. O

The O
UV _RARE_
absorption O
spectrum O
revealed O
a O
shoulder _RARE_
at _RARE_
250 _RARE_
nm O
, O
characteristic O
of O
CysS _RARE_
- O
Cd O
( O
II O
) O
ligand _RARE_
- O
to O
- O
metal O
charge _RARE_
- O
transfer O
transitions _RARE_
, O
and O
the O
difference O
absorption O
coefficient O
after O
acidification O
( O
delta O
epsilon O
248 _RARE_
, O
24 _RARE_
mM O
- O
1 O
cm O
- O
1 O
) O
indicated O
the O
presence O
of O
a O
Cd O
( O
Cys _RARE_
- O
S O
) O
4 O
center _RARE_
. O

Diacylglycerol _RARE_
kinase I-GENE
( O
DGK _RARE_
) O
attenuates O
levels O
of O
second O
messenger _RARE_
diacylglycerol _RARE_
in O
cells O
and O
produces O
another O
( O
putative O
) O
messenger _RARE_
, O
phosphatidic _RARE_
acid O
. O

Recently O
, O
we O
have O
reported O
the O
cloning O
of O
the O
germ _RARE_
cell O
- O
specific O
, O
nuclear O
orphan O
receptor O
germ _RARE_
cell I-GENE
nuclear I-GENE
factor I-GENE
( O
GCNF _RARE_
)/ _RARE_
RTR _RARE_
. O

Based O
on O
the O
sequence O
of O
the O
conRTRE _RARE_
, O
we O
located _RARE_
a O
putative O
RTRE _RARE_
, O
referred O
to O
as _RARE_
P2 I-GENE
- I-GENE
RE _RARE_
, O
in O
the O
5 O
' O
promoter O
- O
flanking O
region O
of O
the O
mouse I-GENE
protamine _RARE_
2 I-GENE
gene I-GENE
, O
which O
is O
induced _RARE_
during _RARE_
the O
same O
stage _RARE_
of O
spermatogenesis _RARE_
as _RARE_
RTR _RARE_
. O

Here O
we O
report O
the O
purification O
of O
this O
larger O
form O
as _RARE_
an O
approximately _RARE_
320 _RARE_
- O
kDa O
particle _RARE_
that O
contains O
mRNP3 _RARE_
+ I-GENE
4 I-GENE
and O
nine O
additional O
polypeptides O
, O
including O
mRNA O
- O
binding O
polypeptides O
of O
34 _RARE_
and O
36 _RARE_
kDa O
and O
a O
doublet _RARE_
of O
110 _RARE_
/ O
105 _RARE_
kDa O
that O
proved O
to O
be O
nucleolin _RARE_
. O

Active _RARE_
complexes O
eluted _RARE_
at _RARE_
a O
higher _RARE_
molecular _RARE_
weight _RARE_
than O
inactive O
complexes O
, O
were O
relatively O
deficient _RARE_
in O
both O
p21 I-GENE
and O
p27 I-GENE
, O
and O
contained O
Cdk2 I-GENE
with O
increased O
threonine O
160 _RARE_
phosphorylation _RARE_
, O
consistent O
with O
a O
mechanism O
of O
activation O
of O
cyclin _RARE_
E I-GENE
- O
Cdk2 I-GENE
involving O
both O
reduced _RARE_
CDK I-GENE
inhibitor O
association O
and O
CDK I-GENE
- I-GENE
activating I-GENE
kinase I-GENE
- O
mediated _RARE_
phosphorylation _RARE_
of O
Cdk2 I-GENE
. O

Thirty O
Class _RARE_
I O
and O
Class _RARE_
II O
recessions _RARE_
in O
30 _RARE_
patients O
were O
treated O
with O
a O
modified O
subepithelial _RARE_
connective _RARE_
tissue O
graft O
procedure O
. O

The O
derivatives _RARE_
of O
the O
latter O
two O
cell O
lines O
showed O
increased O
expression _RARE_
of O
the O
p27Kip1 _RARE_
protein I-GENE
and O
inhibition O
of O
cell O
growth O
. O

The O
perioperative _RARE_
mortality O
of O
all O
patients O
was O
1 O
. O
9 O
%, O
the O
mortality O
of O
patients O
older O
than O
70 O
years O
was O
4 O
. O
3 O
%. O

Chronic O
renal _RARE_
failure O
patients O
essentially O
die _RARE_
from O
cardiovascular O
causes O
, O
and O
the O
frequency O
of O
malignant O
disease _RARE_
responsible O
for _RARE_
death _RARE_
is O
estimated O
to O
be O
10 O
%. O

The O
new O
FIGO _RARE_
definition O
of O
cervical O
cancer _RARE_
stage _RARE_
IA O
: O
a O
critique _RARE_
. O

The O
effect O
of O
Vpu _RARE_
on O
class O
I O
biogenesis O
was O
analyzed O
in O
more O
detail O
using O
a O
Vpu _RARE_
- O
expressing O
recombinant O
vaccinia _RARE_
virus O
( O
VV _RARE_
). O

This O
study O
indicates O
that O
the O
phenotype _RARE_
of O
myofibrillar _RARE_
disarray _RARE_
seen O
in O
HCM _RARE_
patients O
which O
harbor O
either O
of O
these O
two O
mutations O
may O
not O
be O
directly O
due O
to O
the O
failure O
of O
the O
mutant I-GENE
myosin I-GENE
heavy I-GENE
chain I-GENE
protein I-GENE
to O
assemble _RARE_
and O
form O
normal O
sarcomeres _RARE_
, O
but O
may O
rather O
be O
a O
secondary O
effect O
possibly O
resulting O
from O
the O
chronic O
stress O
of O
decreased O
beta I-GENE
MHC I-GENE
function O
. O

Inductively _RARE_
coupled O
plasma O
atomic _RARE_
emission O
spectroscopy O
was O
employed O
to O
obtain O
the O
tissue O
silicon _RARE_
measurements O
. O

An O
egg _RARE_
protein O
, O
lysozyme I-GENE
, O
is O
a O
still O
unlabeled _RARE_
additive O
currently O
used O
in O
cheese _RARE_
preparation O
. O

A O
method O
for _RARE_
the O
simultaneous O
determination O
of O
de O
( O
N O
- O
methyl _RARE_
)- O
N O
- O
ethyl O
- O
8 O
, O
9 O
- O
anhydroerythromycin _RARE_
A O
6 O
, O
9 O
- O
hemiacetal _RARE_
( O
EM523 _RARE_
, O
I O
) O
and O
its O
three O
metabolites O
in O
human O
plasma O
and O
urine O
has O
been O
developed O
using O
high O
- O
performance O
liquid O
chromatography O
( O
HPLC O
) O
with O
chemiluminescence _RARE_
( O
CL O
) O
detection O
. O

Similarly O
, O
the O
DNA O
- O
binding O
activity O
of O
activator I-GENE
protein I-GENE
1 I-GENE
( O
AP I-GENE
- I-GENE
1 I-GENE
) O
is O
modified O
by O
a O
DNA I-GENE
repair I-GENE
enzyme I-GENE
, O
redox _RARE_
factor I-GENE
1 I-GENE
( O
Ref _RARE_
- I-GENE
1 I-GENE
), _RARE_
which O
is O
identical O
to O
a O
DNA I-GENE
repair I-GENE
enzyme I-GENE
, O
AP I-GENE
endonuclease I-GENE
. O

Having _RARE_
an O
LRR _RARE_
domain I-GENE
and O
an O
SH3 I-GENE
- I-GENE
binding I-GENE
domain I-GENE
, O
Acan125 _RARE_
and O
the O
C O
. O
elegans O
homologue O
define O
a O
novel O
family O
of O
bifunctional _RARE_
binding O
proteins O
. O

However O
, O
its O
participation O
in O
gagging _RARE_
induced _RARE_
by O
oropharyngeal _RARE_
irritation _RARE_
is O
unclear O
. O

The O
capacity O
to O
repair O
8 O
- O
OxoG _RARE_
has O
been O
measured O
in O
cell O
- O
free O
extracts O
of O
wild O
- O
type O
and O
ogg1 _RARE_
strains O
using O
a O
34mer _RARE_
DNA O
fragment O
containing O
a O
single O
8 O
- O
OxoG _RARE_
residue _RARE_
paired O
with O
a O
cytosine O
( O
8 O
- O
OxoG _RARE_
/ O
C O
) O
as _RARE_
a O
substrate O
. O

Results O
from O
our O
and O
other O
laboratories O
have O
suggested O
that O
UCN _RARE_
- O
01 O
induces O
preferential O
G1 O
- O
phase _RARE_
accumulation O
in O
several O
human O
tumor O
cell O
lines O
tested O
. O

Northern O
and O
RT O
- O
PCR O
analysis O
of O
Ube3a _RARE_
expression _RARE_
in O
mouse O
tissues O
from O
animals O
with O
segmental O
, O
paternal _RARE_
uniparental _RARE_
disomy _RARE_
failed O
to O
detect O
substantially O
reduced _RARE_
or O
absent O
expression _RARE_
compared O
to O
control O
animals O
, O
failing _RARE_
to O
provide O
any O
evidence O
for _RARE_
maternal _RARE_
- O
specific O
expression _RARE_
from O
this O
locus O
. O

Two O
predominant O
effects O
were O
noted O
: O
( O
i O
) O
the O
Xaa _RARE_
residue _RARE_
in O
the O
dual O
phosphorylation _RARE_
motif O
Thr _RARE_
- O
Xaa _RARE_
- O
Tyr _RARE_
as _RARE_
well _RARE_
as _RARE_
the O
length O
of O
L12 _RARE_
influence O
p38 I-GENE
substrate O
specificity _RARE_
, O
and O
( O
ii O
) O
the O
length O
of O
L12 _RARE_
plays O
a O
major O
role O
in O
controlling O
autophosphorylation O
. O

A O
novel O
, O
testis _RARE_
- I-GENE
specific I-GENE
mRNA I-GENE
transcript I-GENE
encoding O
an O
NH2 I-GENE
- I-GENE
terminal I-GENE
truncated I-GENE
nitric _RARE_
- I-GENE
oxide I-GENE
synthase I-GENE
. O
mRNA O
diversity O
represents O
a O
major O
theme _RARE_
of O
neuronal _RARE_
nitric _RARE_
- I-GENE
oxide I-GENE
synthase I-GENE
( O
nNOS _RARE_
) O
gene O
expression _RARE_
in O
somatic O
cells O
/ O
tissues O
. O

Unlike O
the O
MAR _RARE_
- O
binding O
domain O
, O
the O
homeodomain _RARE_
when O
isolated O
binds O
poorly O
and O
with O
low O
specificity _RARE_
to O
DNA O
. O

Cotransfection O
of O
Ets I-GENE
- I-GENE
2 I-GENE
and O
p44 I-GENE
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
( I-GENE
MAP I-GENE
) I-GENE
kinase I-GENE
expression _RARE_
vectors O
strongly O
potentiated _RARE_
HB _RARE_
- O
EGF _RARE_
promoter O
activation O
in O
response O
to O
deltaRaf _RARE_
- I-GENE
1 I-GENE
: O
ER I-GENE
. O

Cyclin I-GENE
D1 _RARE_
could O
not O
be O
displaced _RARE_
from O
cdk4 _RARE_
in O
the O
resistant O
184A1L5R _RARE_
cell O
lysates O
. O

The O
importance O
of O
posttranslational O
regulation _RARE_
of O
p15INK4B _RARE_
by O
TGF I-GENE
- I-GENE
beta I-GENE
is O
underlined _RARE_
by O
the O
observation O
that O
in O
TGF I-GENE
- I-GENE
beta I-GENE
- O
resistant O
184A1L5R _RARE_
, O
although O
the O
p15 _RARE_
transcript I-GENE
increased O
, O
p15INK4B _RARE_
protein I-GENE
was O
not O
stabilized O
and O
did O
not O
accumulate O
, O
and O
cyclin _RARE_
D1 _RARE_
- O
cdk _RARE_
association O
and O
kinase O
activation O
were O
not O
inhibited O
. O

The O
Rlm1 _RARE_
protein I-GENE
, O
a O
member _RARE_
of O
the O
MADS I-GENE
box I-GENE
family I-GENE
of O
transcription O
factors O
, O
functions O
downstream _RARE_
of O
Mpk1 _RARE_
in O
the O
pathway _RARE_
. O

To O
identify O
cis O
- O
acting O
elements O
that O
target O
c I-GENE
- I-GENE
myc I-GENE
mRNA I-GENE
for _RARE_
downregulation _RARE_
during _RARE_
myogenesis _RARE_
, O
we O
stably O
transfected O
C2C12 O
cells O
with O
mutant I-GENE
myc I-GENE
genes I-GENE
or O
chimeric O
genes O
in O
which O
various O
myc I-GENE
sequences I-GENE
were O
fused O
to O
the O
human I-GENE
beta I-GENE
- I-GENE
globin I-GENE
gene I-GENE
or O
to O
the O
bacterial I-GENE
chloramphenicol I-GENE
acetyltransferase _RARE_
( O
CAT I-GENE
) O
gene O
. O

Furthermore O
, O
experiments O
with O
32D _RARE_
temperature _RARE_
- O
sensitive _RARE_
p53 I-GENE
cells O
indicate O
that O
aberrant O
tal I-GENE
- I-GENE
1 I-GENE
expression _RARE_
at _RARE_
the O
permissive O
temperature _RARE_
does O
not O
exert O
a O
proliferative O
effect O
but O
causes O
p53 I-GENE
- O
mediated _RARE_
apoptosis O
, O
i O
. O
e _RARE_
., O
the O
tal I-GENE
- I-GENE
1 I-GENE
proliferative O
effect O
depends O
on O
the O
integrity O
of O
the O
cell O
cycle _RARE_
checkpoints _RARE_
of O
the O
host _RARE_
cell O
, O
as _RARE_
observed O
for _RARE_
c I-GENE
- I-GENE
myc I-GENE
and O
other O
oncogenes _RARE_
. O
tal I-GENE
- I-GENE
1 I-GENE
mutant I-GENE
experiments O
indicate O
that O
ectopic O
tal I-GENE
- I-GENE
1 I-GENE
effects O
are O
mediated _RARE_
by O
both O
the O
DNA O
- O
binding O
and O
the O
heterodimerization O
domains O
, O
while O
the O
N I-GENE
- I-GENE
terminally _RARE_
truncated I-GENE
tal I-GENE
- I-GENE
1 I-GENE
variant I-GENE
( O
M3 _RARE_
) O
expressed _RARE_
in O
T O
- O
ALL O
malignant O
cells O
mimics _RARE_
the O
effects O
of O
the O
wild O
- O
type O
protein O
. O

The O
likelihood O
that O
a O
common O
region O
of O
deletions O
would O
contain O
a O
tumor O
suppressor O
is O
strongly O
enhanced _RARE_
by O
coincidence _RARE_
of O
that O
region O
with O
a O
chromosome _RARE_
fragment O
suppressing _RARE_
tumorigenicity _RARE_
upon O
introduction O
in O
tumor O
cells O
. O

DNA O
- O
binding O
activity O
was O
not O
increased O
by O
the O
addition O
of O
forskolin O
to O
thecal _RARE_
or O
luteal _RARE_
cells O
. O

However O
, O
in O
some O
of O
them O
either O
pattern O
may O
predominate _RARE_
or O
be O
exclusively O
present O
. O

Upon O
induction O
of O
SOS _RARE_
, O
viability O
increased O
2 O
- O
6 O
- O
fold _RARE_
. O

In O
particular O
, O
Western O
, O
supershift O
, O
and O
promoter O
deletion O
analyses O
suggested O
a O
role O
for _RARE_
CCAAT I-GENE
/ I-GENE
enhancer I-GENE
- I-GENE
binding I-GENE
protein I-GENE
- I-GENE
beta I-GENE
( O
C I-GENE
/ I-GENE
EBP I-GENE
- I-GENE
beta I-GENE
) O
binding O
site O
between O
- O
2010 _RARE_
and O
- O
1954 _RARE_
in O
regulating _RARE_
transcription O
of O
collagenase _RARE_
- I-GENE
1 I-GENE
in O
monocytic O
cells O
. O

11 O
- O
Aminoundecanoyl _RARE_
- O
SK _RARE_
- O
NH2 O
and O
11 O
- O
aminoundecanoyl _RARE_
- O
SH _RARE_
- O
NH2 O
establish O
that O
a O
simple O
alkyl _RARE_
backbone _RARE_
can O
maintain O
an O
appropriate O
distance O
between O
three O
elements O
critical O
for _RARE_
recognition O
by O
the O
fungal _RARE_
enzyme O
' O
s O
peptide O
- O
binding O
site O
: O
a O
simple O
omega _RARE_
- O
terminal O
amino O
group O
, O
a O
beta O
- O
hydroxyl _RARE_
, O
and O
an O
epsilon O
- O
amino O
group O
or O
an O
imidazole _RARE_
. O

The O
carboxyl _RARE_
- O
terminal O
CCCC _RARE_
module _RARE_
is O
structurally O
related O
to O
the O
DNA O
- O
binding O
domain O
of O
the O
erythroid _RARE_
transcription I-GENE
factor I-GENE
GATA _RARE_
- I-GENE
1 I-GENE
. O

Cdc2 I-GENE
co _RARE_
- O
precipitates _RARE_
with O
Pch1 _RARE_
in O
S O
. O
pombe O
cell O
lysates O
, O
although O
Cdc2 I-GENE
may O
not O
be O
the O
major O
catalytic O
partner _RARE_
of O
a O
Pch1 _RARE_
kinase I-GENE
in O
vivo O
. O

Little _RARE_
is O
known O
about O
the O
mechanism O
, O
but O
the O
availability O
of O
rapid O
facile _RARE_
assays O
for _RARE_
monitoring O
immunoglobulin I-GENE
hypermutation _RARE_
would O
greatly O
aid O
the O
development O
of O
culture O
systems _RARE_
for _RARE_
hypermutating _RARE_
B O
cells O
as _RARE_
well _RARE_
as _RARE_
the O
screening O
for _RARE_
individuals O
deficient _RARE_
in O
the O
process O
. O

Expression O
of O
the O
human I-GENE
heat I-GENE
shock I-GENE
protein I-GENE
70 I-GENE
gene I-GENE
( O
hsp70 I-GENE
) O
is O
induced _RARE_
by O
various O
kinds _RARE_
of O
stress O
and O
by O
oncogenes _RARE_
. O

Of O
these O
proteins O
, O
five O
have O
previously O
been O
shown O
to O
be O
phosphorylated _RARE_
during _RARE_
mitosis O
( O
epithelial _RARE_
- I-GENE
microtubule I-GENE
associated I-GENE
protein I-GENE
- I-GENE
115 _RARE_
, O
Oct91 _RARE_
, O
Elongation _RARE_
factor I-GENE
1gamma _RARE_
, O
BRG1 _RARE_
and O
Ribosomal _RARE_
protein I-GENE
L18A _RARE_
), _RARE_
five O
are O
related O
to O
proteins O
postulated O
to O
have O
roles O
in O
mitosis O
( O
epithelial _RARE_
- I-GENE
microtubule I-GENE
associated I-GENE
protein I-GENE
- I-GENE
115 _RARE_
, O
Schizosaccharomyces I-GENE
pombe I-GENE
Cdc5 _RARE_
, O
innercentrosome _RARE_
protein I-GENE
, O
BRG1 _RARE_
and O
the O
RNA I-GENE
helicase _RARE_
WM6 _RARE_
), _RARE_
and O
nine O
are O
related O
to O
transcription O
factors O
( O
BRG1 _RARE_
, O
negative I-GENE
co _RARE_
- I-GENE
factor I-GENE
2alpha I-GENE
, O
Oct91 _RARE_
, O
S O
. O
pombe O
Cdc5 _RARE_
, O
HoxD1 _RARE_
, O
Sox3 _RARE_
, O
Vent2 _RARE_
, O
and O
two O
isoforms O
of O
Xbr1b _RARE_
). O

Thus O
, O
depending O
on O
their O
location O
, O
psoralen _RARE_
cross O
- O
links O
affected O
different O
steps O
in O
the O
initiation O
process O
. O

Activation O
of O
alpha I-GENE
4 I-GENE
beta I-GENE
1 I-GENE
with O
TS2 _RARE_
/ I-GENE
16 I-GENE
inhibited O
the O
cytoplasmic O
protrusions _RARE_
and O
cell O
migration O
but O
did O
not O
affect O
the O
pattern O
of O
phosphorylation _RARE_
. O

Performance _RARE_
on O
two O
verbal _RARE_
measures O
- O
the O
National O
Adult O
Reading _RARE_
Test O
- O
Revised _RARE_
( O
NART _RARE_
- O
R O
) O
and O
the O
Vocabulary _RARE_
subtest _RARE_
from O
the O
Wechsler _RARE_
Adult O
Intelligence _RARE_
Scale O
- O
Revised _RARE_
( O
WAIS _RARE_
- O
R O
)- O
showed O
strong O
correlations O
with O
level O
of O
education O
. O

L O
- O
canavanine _RARE_
, O
a O
selective O
inhibitor O
of O
the O
inducible O
nitric _RARE_
oxide I-GENE
synthase I-GENE
, O
increases O
the O
mean O
systemic O
filling O
pressure O
, O
thereby O
improving _RARE_
venous O
return O
, O
under O
these O
conditions O
. O

RESULTS O
: O
Of O
the O
29 O
patients O
who O
received O
concurrent O
chemotherapy O
and O
G I-GENE
- I-GENE
CSF I-GENE
, O
ten O
( O
34 _RARE_
%; O
95 _RARE_
% O
confidence O
interval O
[ _RARE_
CI _RARE_
], O
17 _RARE_
. O
9 O
to O
54 O
. O
3 O
%) O
were O
believed O
to O
have O
clinically O
significant O
bleomycin _RARE_
toxicity O
. O

The O
different O
holoenzyme _RARE_
RNA I-GENE
polymerases _RARE_
generated O
upon O
reconstituting _RARE_
these O
mutants O
independently O
with O
core I-GENE
RNA I-GENE
polymerase I-GENE
( O
alpha2beta _RARE_
beta O
') _RARE_
have O
shown O
reduced _RARE_
transcriptional O
activity O
in O
comparison O
to O
the O
enzyme O
containing O
wild I-GENE
- I-GENE
type I-GENE
sigma _RARE_
factor I-GENE
. O

These O
data O
are O
consistent O
with O
a O
model O
in O
which O
GATA _RARE_
- I-GENE
5 I-GENE
performs _RARE_
a O
unique O
temporally O
and O
spatially O
restricted O
function O
in O
the O
embryonic _RARE_
heart _RARE_
and O
lung _RARE_
. O

The O
exonic _RARE_
sequence O
encodes O
a O
protein O
of O
495 _RARE_
amino O
acids _RARE_
that O
is O
nearly O
identical O
to O
the O
previously O
reported O
protein O
sequence O
of O
human I-GENE
GPT _RARE_
- I-GENE
1 I-GENE
. O

Here O
we O
characterize O
an O
S I-GENE
. I-GENE
cerevisiae I-GENE
Swi3 _RARE_
homolog I-GENE
( O
Swh3 _RARE_
) O
and O
present O
evidence O
that O
it O
associates O
in O
a O
complex O
with O
a O
Snf2 _RARE_
homolog I-GENE
, O
Sthl _RARE_
. O

Shc I-GENE
stimulates O
Ras I-GENE
/ O
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
( O
MAPK _RARE_
) O
through O
forming O
a O
complex O
with O
Grb2 I-GENE
at _RARE_
the O
phosphorylated _RARE_
tyrosine O
( O
Y O
) O
residue _RARE_
317 _RARE_
. O

In O
contrast O
, O
Y239 _RARE_
/ I-GENE
240F _RARE_
Shc I-GENE
, O
but O
not O
Y317F _RARE_
Shc I-GENE
, O
reduced _RARE_
the O
EGF _RARE_
- O
induced _RARE_
c I-GENE
- I-GENE
myc I-GENE
message _RARE_
. O

The O
Ras I-GENE
guanine I-GENE
nucleotide I-GENE
- I-GENE
binding I-GENE
protein I-GENE
functions O
as _RARE_
a O
molecular _RARE_
switch O
in O
signalling O
downstream _RARE_
of O
protein I-GENE
- I-GENE
tyrosine I-GENE
kinases I-GENE
. O

We O
show O
that O
Rlm1 _RARE_
and O
Smp1 _RARE_
have O
MEF2 I-GENE
- O
related O
DNA O
- O
binding O
specificities _RARE_
: O
Rlm1 _RARE_
binds O
with O
the O
same O
specificity _RARE_
as _RARE_
MEF2 I-GENE
, O
CTA _RARE_
( I-GENE
T I-GENE
/ I-GENE
A I-GENE
) I-GENE
4TAG _RARE_
, O
while O
SMP1 _RARE_
binds O
a O
more O
extended O
consensus O
sequence O
, O
ACTACTA _RARE_
( O
T O
/ O
A O
) O
4TAG _RARE_
. O

Domains _RARE_
I O
and O
II O
of O
B I-GENE
" I-GENE
are O
buried _RARE_
upon O
assembly O
of O
the O
TFIIIB _RARE_
- I-GENE
DNA I-GENE
complex I-GENE
, O
as _RARE_
determined O
by O
protein O
footprinting O
. O

Domain _RARE_
switch O
experiments O
reveal O
that O
C I-GENE
/ I-GENE
EBP I-GENE
beta I-GENE
proteins I-GENE
containing O
either O
the O
leucine O
zipper O
or O
the O
activation O
domain O
of O
C I-GENE
/ I-GENE
EBP I-GENE
alpha I-GENE
are O
unable O
to O
stimulate O
the O
2D5 _RARE_
promoter I-GENE
yet O
are O
fully O
capable O
of O
transactivating O
an O
artificial O
promoter O
bearing _RARE_
a O
high O
- O
affinity O
C I-GENE
/ I-GENE
EBP I-GENE
site I-GENE
. O

The O
similar O
phenotypes _RARE_
of O
bur6 _RARE_
and O
bur3 _RARE_
( O
mot1 _RARE_
) O
mutations O
suggest O
that O
Bur6p _RARE_
and O
Mot1p _RARE_
have O
related O
, O
but O
not O
identical O
, O
functions O
in O
modulating _RARE_
the O
activity O
of O
the O
general _RARE_
transcription O
machinery O
in O
vivo O
. O

PRH75 _RARE_
, O
a O
new O
nucleus O
- O
localized O
member _RARE_
of O
the O
DEAD _RARE_
- I-GENE
box I-GENE
protein I-GENE
family I-GENE
from O
higher _RARE_
plants _RARE_
. O

These O
activities O
are O
all O
required O
for _RARE_
stimulation _RARE_
of O
cell O
growth O
by O
middle _RARE_
- I-GENE
T I-GENE
and O
activate O
members O
of O
the O
MAP I-GENE
kinase I-GENE
family I-GENE
. O

A O
role O
for _RARE_
the O
small I-GENE
GTPase I-GENE
Rac I-GENE
in O
polyomavirus _RARE_
middle _RARE_
- I-GENE
T I-GENE
antigen I-GENE
- O
mediated _RARE_
activation O
of O
the O
serum O
response O
element O
and O
in O
cell O
transformation O
. O

Time _RARE_
- O
activity O
curves O
from O
the O
gastric _RARE_
region O
of O
interest O
were O
used O
, O
after O
subjection _RARE_
to O
appropriate O
corrective _RARE_
procedures O
, O
to O
calculate _RARE_
the O
mean O
gastric _RARE_
transit O
time O
( O
MTT _RARE_
90 _RARE_
) O
and O
the O
fraction O
of O
the O
test O
meal _RARE_
retained O
in O
the O
stomach O
after O
90 _RARE_
min O
( O
F90 _RARE_
). O

This O
study O
provides O
a O
direct O
demonstration _RARE_
of O
a O
role O
for _RARE_
G I-GENE
betagamma _RARE_
in O
mediating O
the O
agonist O
- O
stimulated _RARE_
translocation O
of O
GRK2 _RARE_
and O
GRK3 _RARE_
in O
an O
intact _RARE_
cellular O
system _RARE_
and O
demonstrates O
isoform O
specificity _RARE_
in O
the O
interaction O
of O
these O
components _RARE_
. O

Our O
results O
indicate O
that O
RA _RARE_
- O
mediated _RARE_
repression O
of O
the O
hMGP _RARE_
gene I-GENE
is O
due O
to O
binding O
of O
liganded _RARE_
RAR I-GENE
/ O
RXR I-GENE
to O
a O
novel O
negative O
RA _RARE_
response O
element O
. O

Point _RARE_
mutations O
of O
the O
five O
tyrosine O
residues O
in O
the O
cytoplasmic O
domain O
of O
the O
receptor O
were O
subsequently O
used O
to O
confirm O
our O
conclusions O
. O

We O
describe O
a O
novel O
method O
using O
Saccharomyces O
cerevisiae O
for _RARE_
detecting O
protein O
- O
truncating _RARE_
mutations O
in O
any O
gene O
of O
interest O
. O

Hepatocellular _RARE_
injury O
during _RARE_
preservation O
of O
human O
livers _RARE_
with O
UW _RARE_
and O
HTK _RARE_
solution O
. O

The O
electromyographically _RARE_
recorded O
responses O
consisted O
of O
an O
early O
R1 _RARE_
response O
in O
the O
orbicularis _RARE_
oculi _RARE_
muscle O
ipsilateral O
to O
the O
side _RARE_
of O
stimulation _RARE_
, O
a O
bilateral O
late _RARE_
response O
( O
ipsilateral O
R2 _RARE_
and O
contralateral O
Rc _RARE_
) O
and O
a O
third O
, O
R3 _RARE_
response O
, O
in O
the O
ipsilateral O
orbicularis _RARE_
oculi _RARE_
muscle O
. O

The O
prognosis O
of O
seven _RARE_
patients O
who O
received O
ABSCT _RARE_
was O
significantly O
better O
than O
that O
of O
13 _RARE_
patients O
who O
received O
conventional O
therapy O
alone O
. O

( O
1994 O
, O
Hum _RARE_
. O

The O
pigment _RARE_
intensity O
of O
both O
melanized _RARE_
colonies O
and O
appressoria _RARE_
of O
CAL _RARE_
transformants O
was O
weaker _RARE_
than O
that O
of O
the O
wild O
type O
. O

Malonate _RARE_
decarboxylation _RARE_
in O
Malonomonas _RARE_
rubra _RARE_
involves O
the O
formation O
of O
malonyl _RARE_
- I-GENE
S I-GENE
-[ _RARE_
acyl _RARE_
- I-GENE
carrier I-GENE
protein I-GENE
] I-GENE
from O
acetyl I-GENE
- I-GENE
S I-GENE
-[ _RARE_
acyl _RARE_
- I-GENE
carrier I-GENE
protein I-GENE
] I-GENE
and O
malonate _RARE_
, O
carboxyltransfer _RARE_
to O
a O
biotin _RARE_
protein I-GENE
and O
its O
decarboxylation _RARE_
that O
is O
coupled O
to O
delta O
mu O
Na _RARE_
+ O
generation O
. O

The O
Jem _RARE_
peptide O
sequence O
shows O
a O
' O
leucine O
- O
zipper O
' O
dimerisation _RARE_
motif O
with O
limited O
homology O
to O
Fos I-GENE
/ O
Jun I-GENE
and O
ATF I-GENE
/ O
CREB I-GENE
proteins O
and O
several O
putative O
phosphorylation _RARE_
sites O
. O

Here O
we O
report O
the O
cloning O
of O
the O
protein O
that O
binds O
to O
enhancer O
site O
III O
. O

Further O
support O
for _RARE_
a O
direct O
interaction O
of O
Tub4p _RARE_
, O
Spc98p _RARE_
and O
Spc97p _RARE_
comes _RARE_
from O
the O
toxicity O
of O
strong O
SPC97 _RARE_
overexpression O
which O
is O
suppressed O
by O
co _RARE_
- O
overexpression O
of O
TUB4 _RARE_
or O
SPC98 _RARE_
. O

Sequences _RARE_
needed O
for _RARE_
iron O
- O
regulated O
expression _RARE_
of O
sid1 _RARE_
were O
localized O
to O
a O
306 _RARE_
bp O
region O
mapping O
2 O
. O
3 O
and O
2 O
. O
6 O
kb O
upstream O
of O
the O
ATG O
. O

A O
genetic O
screen O
applied O
to O
mutants O
in O
the O
branch O
site O
region O
shows O
that O
all O
positions O
in O
the O
conserved _RARE_
TACTAAC _RARE_
sequence O
are O
important O
for _RARE_
intron O
recognition O
. O

Implication _RARE_
of O
PAF _RARE_
and O
acetylhydrolase _RARE_
( O
PAF _RARE_
- I-GENE
AH _RARE_
) O
activity O
in O
periodontal O
disease _RARE_
. O

Comparison O
of O
the O
p50 _RARE_
sequence I-GENE
to O
other O
cloned _RARE_
proteins O
revealed O
89 _RARE_
% O
homology O
with O
a O
glycosaminoglycan _RARE_
- O
binding O
protein O
and O
54 O
% O
homology O
with O
Drosophila I-GENE
cell I-GENE
cycle _RARE_
control I-GENE
protein I-GENE
( I-GENE
cdc _RARE_
) I-GENE
37 O
. O

A O
polypeptide O
encoded O
by O
the O
NTS _RARE_
16 O
open _RARE_
reading O
frame O
has O
sequence O
similarity _RARE_
to O
the O
catalytic O
domain O
of O
several O
receptor I-GENE
protein I-GENE
kinases I-GENE
from I-GENE
plants _RARE_
including O
the O
S I-GENE
- I-GENE
receptor I-GENE
kinases I-GENE
implicated O
in O
the O
rejection O
of O
self O
- O
pollen O
in O
Brassica _RARE_
species O
and O
the O
Pto _RARE_
gene I-GENE
product I-GENE
of I-GENE
tomato _RARE_
which O
confers O
resistance O
to O
a O
bacterial O
pathogen _RARE_
. O

The O
atp _RARE_
1 I-GENE
and O
atp _RARE_
2 I-GENE
types _RARE_
of O
cDNA O
sequences O
were O
the O
most O
redundant _RARE_
among O
the O
28 _RARE_
different O
isoperoxidases _RARE_
identified O
among O
about O
200 _RARE_
peroxidase I-GENE
encoding I-GENE
ESTs _RARE_
. O

Additional _RARE_
information _RARE_
including O
echocardiographic O
sequences O
, O
perioperative _RARE_
video _RARE_
sequences O
, O
x _RARE_
- O
ray O
analysis O
, O
angiograms _RARE_
, O
etc O
. O
is O
represented O
in O
the O
program O
. O

We O
report O
here O
that O
constitutively O
active _RARE_
Mek1 _RARE_
could O
activate O
p96h2bk _RARE_
in O
the O
absence O
of O
oncogenic _RARE_
Ras I-GENE
. O

In O
Schizosaccharomyces O
pombe O
, O
the O
activity O
of O
the O
M O
- O
phase _RARE_
- O
inducing O
Cdc2 I-GENE
/ O
Cdc13 _RARE_
cyclin _RARE_
- O
dependent O
kinase O
is O
inhibited O
by O
Wee1 _RARE_
and O
Mik1 _RARE_
tyrosine I-GENE
kinases I-GENE
, O
and O
activated O
by O
Cdc25 _RARE_
and O
Pyp3 _RARE_
tyrosine I-GENE
phosphatases _RARE_
. O

Glycemic _RARE_
response O
to O
malted _RARE_
, O
popped _RARE_
and O
roller _RARE_
dried _RARE_
wheat _RARE_
- O
legume _RARE_
based O
foods _RARE_
in O
normal O
subjects O
. O

4 O
. O
26 _RARE_
+/- O
1 O
. O
54 O
mmol O
/ O
l _RARE_
, O
P O
< O
0 _RARE_
. O
01 O
), _RARE_
and O
systolic O
BP _RARE_
responses O
to O
intravenous O
norepinephrine O
and O
angiotensin I-GENE
II I-GENE
were O
significantly O
higher _RARE_
on O
glibenclamide _RARE_
than O
on O
metformin _RARE_
( O
P O
< O
0 _RARE_
. O
02 O
and O
P O
< O
0 _RARE_
. O
05 O
, O
respectively O
). O

The O
sequencing O
of O
Stellate _RARE_
copies O
located _RARE_
along O
the O
discontinuous _RARE_
cluster O
revealed O
a O
complex O
pattern O
of O
diversification _RARE_
. O

The O
results O
indicate O
that O
DNA O
methylation O
, O
chromatin O
structure _RARE_
, O
and O
transactivation _RARE_
at _RARE_
an O
Sp1 _RARE_
site I-GENE
contribute O
to O
the O
highly O
restricted O
expression _RARE_
of O
this O
myelomonocytic _RARE_
lineage O
specific O
gene O
. O

In O
gel O
mobility O
shift O
assays O
, O
factors O
present O
in O
nuclear O
extracts O
derived O
from O
differentiated O
osteoblast _RARE_
bound _RARE_
to O
oligonucleotide _RARE_
probes _RARE_
containing O
the O
E O
- O
box O
1 O
and O
E O
- O
box O
2 O
elements O
. O

Laboratory O
exam _RARE_
: O
IDR _RARE_
of O
the O
tuberculin _RARE_
was O
high O
positive O
, O
chest O
radiography _RARE_
shows O
hilar _RARE_
bilateral O
calcifications _RARE_
, O
ORL _RARE_
exam _RARE_
shows O
a O
tumor O
at _RARE_
the O
foot O
of O
the O
epiglottis _RARE_
and O
anatomopathological _RARE_
exam _RARE_
shows O
low O
differentiated O
epidermoid _RARE_
carcinoma O
. O

Finally O
, O
we O
show O
that O
PhLP _RARE_
complexes O
, O
at _RARE_
least O
partially O
, O
with O
Gbetagamma I-GENE
in O
vivo O
. O

CTF1alpha _RARE_
, O
expressed _RARE_
in O
Escherichia O
coli O
, O
showed O
specific O
binding O
to O
the O
palindrome O
2 O
DNA O
fragment O
but O
not O
to O
palindrome O
1 O
or O
mutant O
palindrome O
2 O
DNA O
fragments O
, O
suggesting O
specific O
binding O
of O
CTF1alpha _RARE_
to O
palindrome O
2 O
. O

Cyclin I-GENE
G2 _RARE_
is O
highly O
expressed _RARE_
in O
the O
immune O
system _RARE_
where O
immunologic O
tolerance O
subjects O
self O
- O
reactive O
lymphocytes O
to O
negative O
selection O
and O
clonal _RARE_
deletion O
via O
apoptosis O
. O

A O
sterol O
- O
regulated O
protease O
initiates _RARE_
release O
of O
the O
NH2 O
- O
terminal O
segments _RARE_
of O
sterol I-GENE
regulatory I-GENE
element I-GENE
- I-GENE
binding I-GENE
proteins I-GENE
( O
SREBPs _RARE_
) O
from O
cell O
membranes O
, O
thereby O
allowing O
them O
to O
enter _RARE_
the O
nucleus O
and O
to O
stimulate O
transcription O
of O
genes O
involved O
in O
the O
uptake O
and O
synthesis _RARE_
of O
cholesterol O
and O
fatty O
acids _RARE_
. O

Thus O
, O
the O
P O
. O
aeruginosa _RARE_
orfX _RARE_
and O
vfr _RARE_
promoters I-GENE
are O
arranged O
in O
a O
back O
- O
to O
- O
back O
orientation O
rather O
than O
the O
face O
- O
to O
- O
face O
orientation O
of O
the O
dorf _RARE_
and O
crp _RARE_
promoters I-GENE
. O

Sequence O
analysis O
of O
cloned _RARE_
PCR O
products O
confirmed O
the O
presence O
of O
two O
different O
nifV _RARE_
- I-GENE
like I-GENE
DNA I-GENE
fragments I-GENE
, O
which O
were O
subsequently O
used O
as _RARE_
nifV _RARE_
- O
and O
leuA _RARE_
- I-GENE
specific I-GENE
probes _RARE_
, O
respectively O
, O
to O
clone O
XbaI _RARE_
fragments I-GENE
of O
2 O
. O
1 O
kbp _RARE_
( O
pOST4 _RARE_
) O
and O
2 O
. O
6 O
kbp _RARE_
( O
pOST2 _RARE_
). O

In O
contrast O
, O
the O
Anabaena _RARE_
strain _RARE_
7120 _RARE_
leuA _RARE_
gene O
did O
not O
complement O
the O
nifV _RARE_
mutation I-GENE
of O
R229I _RARE_
efficiently O
. O

( O
3 O
) O
This O
effect O
occurs O
without O
removing O
TRs _RARE_
from O
the O
TRE _RARE_
. O

Is O
leishmaniasis _RARE_
endemic _RARE_
on O
the O
island O
of O
Minorca _RARE_
( O
Spain _RARE_
)? _RARE_
A O
human O
visceral O
case O
after O
living O
13 _RARE_
years O
in O
Minorca _RARE_
. O

RESULTS O
: O
Surprisingly O
, O
PAF _RARE_
blockade O
increased O
mortality O
after O
trauma O
( O
5 O
of O
11 O
WEB _RARE_
- O
2086 _RARE_
animals O
versus O
1 O
of O
9 O
vehicle O
animals O
; O
p O
= O
0 _RARE_
. O
15 _RARE_
) O
and O
depressed O
cardiac O
index O
and O
O2 _RARE_
delivery O
at _RARE_
72 O
hours O
( O
p O
< O
0 _RARE_
. O
05 O
). O

This O
finding O
is O
the O
first _RARE_
example O
of O
utilization O
of O
noncomplementary _RARE_
dinucleotide O
primer O
by O
an O
RNA I-GENE
polymerase I-GENE
. O

Pure _RARE_
T1 _RARE_
and O
dual O
- O
T1 _RARE_
images O
were O
visually _RARE_
evaluated O
for _RARE_
image O
quality O
( O
IQ _RARE_
) O
on O
a O
five O
- O
point O
scale O
( O
0 _RARE_
= O
unacceptable _RARE_
to O
4 O
= O
excellent O
). O

In O
a O
model O
of O
the O
ternary _RARE_
complex O
, O
the O
segment O
of O
NFAT I-GENE
nearest _RARE_
AP I-GENE
- I-GENE
1 I-GENE
is O
the O
Rel I-GENE
insert O
region O
( O
RIR _RARE_
), _RARE_
a O
feature O
that O
is O
notable _RARE_
for _RARE_
its O
hypervariability _RARE_
in O
size O
and O
in O
sequence O
amongst _RARE_
members O
of O
the O
Rel I-GENE
transcription I-GENE
factor I-GENE
family I-GENE
. O

We O
thus O
conclude O
that O
the O
NFAT I-GENE
RIR _RARE_
plays O
an O
essential O
dual O
role O
in O
DNA O
recognition O
and O
cooperative O
binding O
to O
AP I-GENE
- I-GENE
1 I-GENE
family I-GENE
transcription I-GENE
factors I-GENE
. O

Thus O
, O
the O
association O
of O
PS1 _RARE_
fragments I-GENE
may O
be O
maintained O
during _RARE_
cycles O
of O
phosphorylation _RARE_
/ O
dephosphorylation _RARE_
of O
the O
PS1 _RARE_
CTF _RARE_
. O

This O
conformer _RARE_
features O
a O
Type _RARE_
I O
beta O
- O
turn _RARE_
and O
has O
extensive O
hydrophobic O
contacts O
with O
the O
FKBP12 _RARE_
binding O
surface O
. O

This O
protein O
can O
bind O
to O
a O
region O
of O
the O
promoter O
of O
an O
Arabidopsis I-GENE
light I-GENE
- I-GENE
harvesting _RARE_
chlorophyll _RARE_
a I-GENE
/ I-GENE
b I-GENE
protein I-GENE
gene I-GENE
, O
Lhcb1 _RARE_
* _RARE_
3 I-GENE
, O
which O
is O
necessary O
for _RARE_
its O
regulation _RARE_
by O
phytochrome _RARE_
. O

A O
patient O
of O
Group O
B O
had O
severe O
athetoid _RARE_
CP O
with O
spasticity _RARE_
, O
being O
unable O
to O
right O
his _RARE_
trunk O
and O
neck O
. O

Dystonic _RARE_
movement O
of O
the O
left _RARE_
upper O
limb O
in O
a O
case O
of O
the O
right O
pontine _RARE_
hemorrhage O

It O
has O
repeatedly _RARE_
been O
shown O
that O
HCMV _RARE_
IE1 I-GENE
/ O
IE2 I-GENE
can O
independently O
transactivate O
HIV I-GENE
- I-GENE
1 I-GENE
LTR I-GENE
. O

TAR _RARE_
and O
Sp1 _RARE_
- O
independent O
transactivation _RARE_
of O
HIV I-GENE
long I-GENE
terminal I-GENE
repeat I-GENE
by O
the O
Tat I-GENE
protein I-GENE
in O
the O
presence O
of O
human O
cytomegalovirus _RARE_
IE1 I-GENE
/ O
IE2 I-GENE
. O

Respiratory _RARE_
chain O
enzyme O
activity O
was O
normal O
. O

Children O
' O
s O
temperament _RARE_
and O
maternal _RARE_
socialization _RARE_
at _RARE_
Time _RARE_
1 O
( O
n _RARE_
= O
103 _RARE_
, O
aged O
2 O
- O
3 O
years O
) O
were O
considered O
predictors O
of O
future O
conscience _RARE_
, O
assessed O
using O
new O
observational _RARE_
and O
narrative _RARE_
measures O
. O

Cellular _RARE_
Csk I-GENE
was O
associated O
with O
several O
phosphoproteins _RARE_
, O
some O
of O
which O
were O
interacting _RARE_
with O
the O
Csk I-GENE
SH2 _RARE_
domain I-GENE
. O

Thus O
, O
our O
studies O
suggest O
that O
pV _RARE_
- O
mediated _RARE_
activation O
of O
HIV I-GENE
- I-GENE
1 I-GENE
LTR I-GENE
activity O
is O
controlled _RARE_
by O
the O
nuclear O
translocation O
of O
the O
NF _RARE_
- I-GENE
kappaB I-GENE
transcription I-GENE
factor I-GENE
, O
which O
is O
mediated _RARE_
by O
IkappaBalpha I-GENE
serine O
phosphorylation _RARE_
and O
degradation _RARE_
, O
but O
also O
by O
a O
still O
undefined _RARE_
NF _RARE_
- I-GENE
kappaB I-GENE
- O
independent O
pathway _RARE_
. O

One O
P1 O
genomic O
clone O
and O
six _RARE_
subsequent O
plasmid _RARE_
subclones _RARE_
were O
isolated O
and O
analyzed O
for _RARE_
the O
exon _RARE_
- O
intron O
organization O
of O
the O
Ctpct _RARE_
gene I-GENE
. O

FN I-GENE
- O
stimulated _RARE_
c I-GENE
- I-GENE
Src I-GENE
PTK _RARE_
activity O
was O
enhanced _RARE_
by O
wild O
type O
FAK I-GENE
expression _RARE_
, O
whereas O
FN I-GENE
- O
stimulated _RARE_
activation O
of O
ERK2 I-GENE
was O
blocked O
by O
expression _RARE_
of O
the O
c I-GENE
- I-GENE
Src I-GENE
binding I-GENE
site I-GENE
Phe _RARE_
- I-GENE
397 _RARE_
mutant I-GENE
of O
FAK I-GENE
. O

A O
promising _RARE_
new O
cement _RARE_
, O
4 O
- O
META _RARE_
/ O
MMA _RARE_
- O
TBB _RARE_
opaque _RARE_
resin O
, O
has O
shown O
remarkable O
adhesive O
properties O
as _RARE_
a O
bone O
cement _RARE_
in O
vivo O
. O

Congruent _RARE_
with O
empirical _RARE_
predictions O
, O
the O
most O
homesick _RARE_
children O
perceived O
low O
control O
over O
homesickness _RARE_
and O
separation O
, O
and O
coped _RARE_
by O
relinquishing _RARE_
control O
. O

Each O
sample O
was O
analysed O
as _RARE_
soon _RARE_
as _RARE_
possible O
, O
and O
repeated _RARE_
15 _RARE_
, O
30 _RARE_
, O
60 _RARE_
and O
120 O
min O
after O
sampling O
. O

We O
also O
review O
the O
role O
of O
grains _RARE_
in O
the O
formation O
of O
complex O
molecules O
in O
interstellar _RARE_
molecular _RARE_
clouds _RARE_
. O

Like O
the O
elicitors _RARE_
of O
the O
hypersensitive _RARE_
reaction O
( O
HR O
) O
produced O
by O
E O
. O
chrysanthemi _RARE_
( O
HarpinEch _RARE_
) O
and O
E O
. O
amylovora _RARE_
( O
HarpinEa _RARE_
), _RARE_
the O
deduced O
36 _RARE_
- O
kDa O
protein O
does O
not O
possess O
a O
typical O
signal O
sequence O
, O
but O
it O
contains O
a O
putative O
membrane O
- O
spanning O
domain O
. O

Molecular O
characterization O
and O
expression _RARE_
of O
the O
Erwinia _RARE_
carotovora _RARE_
hrpNEcc _RARE_
gene I-GENE
, O
which O
encodes O
an O
elicitor _RARE_
of O
the O
hypersensitive _RARE_
reaction O
. O

The O
mRNA O
from O
this O
gene O
, O
termed O
HES1 _RARE_
, O
is O
ubiquitously O
expressed _RARE_
, O
but O
strongly O
so O
in O
heart _RARE_
and O
skeletal O
muscle O
. O

Anesthesia _RARE_
was O
maintained O
with O
isoflurane O
( O
ISO _RARE_
)/ _RARE_
N2O O
/ O
O2 _RARE_
inhalation O
. O

They O
observed O
depressed O
protein I-GENE
C I-GENE
activity O
that O
significantly O
( O
p O
< O
0 _RARE_
. O
005 O
) O
increased O
and O
became O
normal O
immediately O
after O
hemodialysis O
while O
factor I-GENE
X I-GENE
and O
factor I-GENE
VII I-GENE
increased O
( O
p O
< O
0 _RARE_
. O
01 O
; O
p O
< O
0 _RARE_
. O
05 O
) O
despite O
heparinization _RARE_
together O
with O
amount O
of O
serum O
lipoprotein O
( O
a O
). O

We O
present O
a O
case O
of O
type O
II O
hyperbetalipoproteinemia _RARE_
in O
a O
patient O
whose O
diagnosis O
had O
been O
previously O
unrecognized _RARE_
, O
and O
who O
had O
previously O
been O
misdiagnosed _RARE_
with O
rheumatoid O
arthritis O
and O
later O
gout _RARE_
. O

These O
data O
provide O
evidence O
that O
the O
2 I-GENE
. I-GENE
0 _RARE_
- I-GENE
kb I-GENE
LAT _RARE_
is O
an O
intron O
of O
the O
mLAT _RARE_
pre I-GENE
- I-GENE
mRNA I-GENE
with O
a O
unique O
branch O
point O
. O

The O
altered O
amino O
acid O
residues O
of O
the O
seven _RARE_
mutant I-GENE
9ORF1 _RARE_
polypeptides I-GENE
clustered O
within O
three O
separate O
regions O
referred O
to O
as _RARE_
region O
I O
( O
residues O
34 _RARE_
to O
41 _RARE_
), _RARE_
region O
II O
( O
residues O
89 _RARE_
to O
91 O
), _RARE_
and O
C O
- O
terminal O
region O
III O
( O
residues O
122 O
to O
125 _RARE_
). O

Rep I-GENE
- O
Rep I-GENE
protein O
interaction O
was O
confirmed O
in O
vitro O
through O
coimmunoprecipitation _RARE_
experiments O
with O
a O
bacterially O
expressed _RARE_
maltose _RARE_
- I-GENE
binding I-GENE
protein I-GENE
- O
Rep78 _RARE_
fusion O
protein O
in O
combination O
with O
[ _RARE_
35S _RARE_
] O
methionine O
- O
labeled O
Rep78 _RARE_
synthesized O
in O
a O
coupled O
in O
vitro O
transcription O
- O
translation O
system _RARE_
. O

The O
C O
- O
LIP _RARE_
also O
was O
compared O
with O
transcather _RARE_
arterial O
embolization _RARE_
( O
TAE _RARE_
; O
C O
- O
LIP _RARE_
followed O
by O
gelatin _RARE_
sponge _RARE_
) O
and O
percutaneous _RARE_
ethanol O
injection O
therapy O
( O
PEIT _RARE_
). O

Fourteen _RARE_
patients O
with O
New O
York O
Heart _RARE_
Association O
class O
II O
congestive _RARE_
heart _RARE_
failure O
were O
enrolled O
in O
a O
double O
- O
blind O
, O
cross O
- O
over O
study O
. O

The O
main O
advantages O
of O
Multi _RARE_
- O
MUP _RARE_
analysis O
are O
: O
( O
1 O
) O
quick _RARE_
acquisition O
of O
many O
MUPs _RARE_
; O
( O
2 O
) O
simultaneous O
collection O
of O
several O
MUPs _RARE_
at _RARE_
one O
recording O
site O
; O
( O
3 O
) O
possibility O
to O
analyze O
not O
only O
low O
threshold O
MUPs _RARE_
; O
( O
4 O
) O
less O
bias _RARE_
in O
the O
selection O
of O
MUPs _RARE_
and O
( O
5 O
) O
the O
reproducibility O
of O
the O
results O
that O
allow O
the O
same O
reference O
values O
to O
be O
used O
in O
different O
laboratories O
. O

We O
also O
demonstrate O
that O
preformed _RARE_
triplexes _RARE_
are O
quite O
stable O
when O
precipitated O
with O
ethanol O
and O
resuspended _RARE_
in O
water O
. O

Transfection O
experiments O
using O
preformed _RARE_
triplexes _RARE_
with O
a O
reporter O
plasmid _RARE_
containing O
the O
collagen _RARE_
promoter I-GENE
sequence I-GENE
showed O
significant O
inhibition O
of O
transcription O
when O
compared O
with O
a O
control O
phosphorothioate _RARE_
ODN _RARE_
. O

Thus O
, O
an O
increase O
in O
plasma I-GENE
TBG _RARE_
and O
a O
shift O
from O
adrenal O
androgen _RARE_
and O
mineralocorticoid _RARE_
steroid O
secretion _RARE_
towards O
cortisol O
secretion _RARE_
may O
be O
endocrine O
markers O
for _RARE_
progression O
of O
the O
disease _RARE_
in O
patients O
with O
HIV O
- O
infection O
. O

In O
several O
studies O
the O
RDFS _RARE_
has O
shown O
evidence O
of O
reliability O
and O
validity O
. O

Latanoprost _RARE_
produces O
an O
additional O
reduction O
of O
intraocular _RARE_
pressure O
( O
IOP O
) O
when O
used O
in O
combination O
with O
timolol _RARE_
, O
pilocarpine _RARE_
, O
acetazolamide _RARE_
and O
dipivefrin _RARE_
. O

These O
results O
suggest O
that O
dietary O
safflower _RARE_
phospholipids O
may O
be O
a O
valuable O
ingredient _RARE_
to O
layers _RARE_
for _RARE_
reducing _RARE_
liver O
triglycerides _RARE_
and O
serum O
cholesterol O
without O
any O
adverse O
effects O
. O

Using O
various O
techniques O
, O
we O
have O
undertaken O
a O
systematic O
analysis O
of O
the O
natural _RARE_
TATA O
- O
less O
human I-GENE
DNA I-GENE
polymerase I-GENE
beta I-GENE
( O
beta I-GENE
- I-GENE
pol I-GENE
) O
gene O
promoter O
. O

Saturable _RARE_
spermidine _RARE_
transport _RARE_
in O
stk2 _RARE_
:: O
lacZ I-GENE
mutants I-GENE
had O
an O
approximately _RARE_
fivefold _RARE_
- O
lower O
affinity O
and O
twofold O
- O
lower O
Vmax O
than O
in O
the O
parental O
strain _RARE_
. O

Transient O
overexpression O
of O
c I-GENE
- I-GENE
Jun I-GENE
induced _RARE_
tenascin _RARE_
- I-GENE
C I-GENE
expression _RARE_
in O
primary _RARE_
REF _RARE_
and O
in O
FR3T3 _RARE_
, O
an O
established O
fibroblast O
cell O
line O
. O

Inhibition O
of O
the O
Raf I-GENE
- I-GENE
1 I-GENE
kinase I-GENE
by O
cyclic O
AMP O
agonists O
causes O
apoptosis O
of O
v I-GENE
- I-GENE
abl I-GENE
- O
transformed O
cells O
. O

Previous O
studies O
have O
indicated O
that O
a O
hamster O
cell O
line O
( O
ts13 _RARE_
) O
with O
a O
point O
mutation O
in O
the O
TAF _RARE_
( I-GENE
II I-GENE
) I-GENE
250 _RARE_
/ O
CCG1 _RARE_
( O
TAF _RARE_
( I-GENE
II I-GENE
) I-GENE
250 _RARE_
) O
gene O
shows O
temperature _RARE_
- O
sensitive _RARE_
expression _RARE_
of O
a O
subset O
of O
genes O
and O
arrests _RARE_
in O
late _RARE_
G1 O
at _RARE_
39 _RARE_
. O
5 O
degrees O
C O
. O

We O
show O
here O
that O
the O
protein O
kinase O
MEKK1 _RARE_
can O
induce O
reporter O
gene O
expression _RARE_
from O
the O
atrial _RARE_
natriuretic _RARE_
factor I-GENE
( O
ANF _RARE_
) O
promoter O
, O
a O
genetic O
marker O
that O
is O
activated O
during _RARE_
in O
vivo O
hypertrophy O
. O

Overexpression O
of O
EFG1 _RARE_
in O
C O
. O
albicans _RARE_
leads O
to O
enhanced _RARE_
filamentous _RARE_
growth O
in O
the O
form O
of O
extended O
pseudohyphae _RARE_
in O
liquid O
and O
on O
solid O
media O
. O

Selected _RARE_
parameters O
: O
heart _RARE_
rate O
( O
HR O
), _RARE_
arterial O
blood _RARE_
pressure O
( O
ABP _RARE_
) O
and O
arterial O
O2 _RARE_
saturation O
( O
SaO2 O
) O
monitored O
by O
pulsoximetry _RARE_
were O
measured O
during _RARE_
the O
procedure O
. O

To O
determine O
if O
signing _RARE_
, O
when O
established O
, O
would O
compete O
with O
SIB _RARE_
when O
both O
were O
reinforced O
, O
extinction _RARE_
was O
then O
withdrawn _RARE_
. O

The O
husband _RARE_
in O
one O
of O
the O
married _RARE_
couples _RARE_
was O
treated O
for _RARE_
hepatitis O
of O
unidentified O
etiology O
in O
an O
Infectology _RARE_
Department _RARE_
four O
years O
ago _RARE_
. O

Both O
quantitative O
and O
qualitative O
analysis O
of O
individual O
cytoarchitectonic _RARE_
peculiarities _RARE_
of O
Meynart _RARE_
' O
s O
nucleus O
as _RARE_
well _RARE_
as _RARE_
of O
external O
part O
of O
dorsomedial _RARE_
nucleus O
of O
thalamus _RARE_
was O
performed O
in O
mentally _RARE_
normal O
individuals O
. O

We O
have O
tested O
this O
proposal _RARE_
by O
carrying O
out O
circular O
dichroism _RARE_
( O
CD O
) O
and O
NMR O
experiments O
on O
the O
Skn _RARE_
domain I-GENE
and O
five O
truncated O
proteins O
. O

Positional _RARE_
cloning O
has O
already O
produced O
the O
sequences O
of O
more O
than O
70 O
human O
genes O
associated O
with O
specific O
diseases O
. O

Genes _RARE_
for _RARE_
ocs _RARE_
element I-GENE
binding I-GENE
factors I-GENE
( O
OBFs _RARE_
), _RARE_
belonging O
to O
a O
specific O
class O
of O
basic I-GENE
- I-GENE
region I-GENE
leucine I-GENE
zipper I-GENE
( I-GENE
bZIP _RARE_
) I-GENE
transcription I-GENE
factors I-GENE
, O
have O
been O
isolated O
in O
a O
number O
of O
plants _RARE_
. O

The O
30 _RARE_
- O
day O
mortality O
in O
the O
CPB O
group O
and O
the O
non O
- O
CPB O
group O
were O
20 O
% O
and O
4 O
. O
6 O
%, O
respectively O
which O
was O
not O
statistically O
significant O
( O
p O
= O
0 _RARE_
. O
06 O
). O

As O
opposed O
to O
in O
vitro O
co _RARE_
- O
precipitation O
studies O
, O
the O
yeast O
two O
- O
hybrid _RARE_
screen O
reveals O
in O
vivo O
protein O
- O
protein O
interactions O
. O

This O
association O
appears O
to O
be O
mediated _RARE_
by O
Src I-GENE
- O
SH2 _RARE_
domain O
, O
because O
PECAM _RARE_
- I-GENE
1 I-GENE
can O
be O
precipitated O
by O
a O
GST I-GENE
- O
Src I-GENE
- O
SH2 _RARE_
affinity O
matrix _RARE_
. O

MKK3 _RARE_
autophosphorylation O
and O
activation O
of O
p38 I-GENE
was O
also O
observed O
following O
coexpression O
of O
MKK3 _RARE_
with O
MEKK3 _RARE_
, O
but O
not O
with O
MEKK2 _RARE_
. O

An O
alternatively _RARE_
spliced _RARE_
MAdCAM _RARE_
- I-GENE
1 I-GENE
variant O
was O
identified O
that O
lacks O
exon _RARE_
4 O
encoding O
the O
mucin _RARE_
domain O
, O
and O
may O
mediate O
leukocyte _RARE_
adhesion O
to O
LPAM _RARE_
- I-GENE
1 I-GENE
without O
adhesion O
to O
the O
alternate O
receptor O
, O
L I-GENE
- I-GENE
selectin I-GENE
. O

In O
summary O
, O
the O
data O
establish O
that O
the O
previously O
reported O
human I-GENE
MAdCAM _RARE_
- I-GENE
1 I-GENE
cDNA I-GENE
does O
indeed O
encode O
the O
human O
homologue O
of O
mouse I-GENE
MAdCAM _RARE_
- I-GENE
1 I-GENE
, O
despite O
gross O
dissimilarities _RARE_
in O
the O
MAdCAM _RARE_
- I-GENE
1 I-GENE
C O
- O
terminal O
structures _RARE_
. O

We O
have O
used O
a O
site O
- O
directed O
mutagenesis O
approach O
to O
examine O
how O
the O
Xaa _RARE_
and O
hydroxy O
( O
Ser _RARE_
/ O
Thr _RARE_
) O
amino O
acid O
residues O
in O
sequons _RARE_
influence O
core O
- O
glycosylation O
efficiency O
. O

MATERIAL _RARE_
AND _RARE_
METHODS O
: O
The O
authors O
analyzed O
41 _RARE_
persons O
formerly _RARE_
submitted O
to O
surgery O
( O
after O
8 O
years O
and O
4 O
months O
, O
as _RARE_
a O
mean O
), _RARE_
31 _RARE_
to O
highly O
selective O
vagotomy O
, O
and O
10 O
to O
truncal _RARE_
or O
selective O
vagotomy O
plus _RARE_
gastroduodenal _RARE_
drainage O
. O

This O
region O
does O
not O
contain O
an O
identifiable _RARE_
TATA O
element O
, O
indicating O
that O
transcription O
of O
the O
glutaminase _RARE_
gene I-GENE
is O
driven _RARE_
by O
a O
TATA O
- O
less O
promoter O
. O

SRE O
activity O
is O
dependent O
upon O
the O
activation O
by O
phosphorylation _RARE_
of O
a O
ternary _RARE_
complex O
factor O
; O
included O
among O
the O
ternary _RARE_
complex O
factors O
is O
Elk I-GENE
- I-GENE
1 I-GENE
. O

Serum I-GENE
alkaline _RARE_
phosphatase I-GENE
activity O
, O
bone O
mass O
measurements O
, O
dual O
energy O
x _RARE_
- O
ray O
absortiometric _RARE_
analysis O
of O
mineral O
density O
, O
and O
mechanical O
testing O
values O
in O
vertebrae _RARE_
and O
femora _RARE_
of O
the O
- O
D O
Sal _RARE_
animals O
did O
not O
significantly O
differ O
from O
those O
in O
+ O
D O
Sal _RARE_
animals O
. O

The O
monkey _RARE_
LHR I-GENE
cDNA I-GENE
displayed O
83 _RARE_
- O
94 O
% O
overall O
sequence O
homology O
with O
the O
other O
mammalian I-GENE
LHR I-GENE
cDNAs I-GENE
. O

In O
conclusion O
, O
marmoset _RARE_
monkey _RARE_
LHR I-GENE
seems O
to O
lack O
the O
sequence O
corresponding O
to O
exon _RARE_
10 O
of O
the O
LHR I-GENE
gene I-GENE
in O
other O
mammalian O
species O
. O

In O
unc _RARE_
- I-GENE
4 I-GENE
mutants I-GENE
, O
VA O
motor O
neurons O
assume _RARE_
the O
pattern O
of O
synaptic O
input O
normally O
reserved _RARE_
for _RARE_
their O
lineal _RARE_
sister _RARE_
cells O
, O
the O
VB _RARE_
motor O
neurons O
; O
the O
loss _RARE_
of O
normal O
input O
to O
the O
VAs _RARE_
produces O
a O
distinctive O
backward _RARE_
movement O
defect O
. O

Intracavitary _RARE_
irradiation O
was O
carried O
out O
with O
a O
microSelectron _RARE_
HDR _RARE_
afterloading _RARE_
device O
and O
usually O
22 _RARE_
. O
5 O
Gy O
was O
given O
in O
three O
fractions O
repeated _RARE_
weekly O
. O

No O
patient O
in O
group O
2 O
developed O
HAT _RARE_
( O
P O
= O
0 _RARE_
. O
006 _RARE_
versus O
group O
1 O
). O

Sequence O
comparison O
of O
the O
0 _RARE_
. O
38 O
kb O
promoter O
sequence O
with O
the O
promoters O
of O
the O
Sm _RARE_
- I-GENE
E I-GENE
gene O
and O
U1 _RARE_
snRNA _RARE_
genes I-GENE
revealed O
several O
homologous O
motifs O
, O
suggesting O
that O
genes O
encoding O
the O
snRNP O
components _RARE_
may O
be O
coordinately _RARE_
regulated O
. O

METHODS O
: O
The O
responses O
of O
a O
31 _RARE_
- O
year O
- O
old O
woman O
with O
complex O
regional O
pain O
syndrome _RARE_
type O
I O
( O
reflex O
sympathetic O
dystrophy _RARE_
) O
to O
a O
thermal O
grill _RARE_
were O
evaluated O
before O
and O
after O
stellate _RARE_
ganglion _RARE_
block _RARE_
. O

More O
recently O
, O
however O
, O
a O
number O
of O
developments _RARE_
such O
as _RARE_
the O
successful O
use O
of O
the O
inhaled O
steroid O
budesonide _RARE_
and O
oral O
dexamethasone O
have O
reinforced O
the O
argument _RARE_
for _RARE_
using O
steroids O
. O

A O
xylE _RARE_
transcriptional I-GENE
fusion I-GENE
to O
the O
putative O
mxbD _RARE_
promoter I-GENE
showed O
low O
- O
level O
expression _RARE_
in O
wild O
- O
type O
cells O
grown O
on O
one O
- O
carbon O
( O
C1 O
) O
compounds O
and O
no _RARE_
detectable O
expression _RARE_
in O
cells O
grown O
on O
succinate _RARE_
. O

In O
AcMNPV _RARE_
- O
infected _RARE_
Sf9 O
cells O
, O
late _RARE_
transcription O
initiation O
is O
detected O
from O
only O
two O
upstream O
TAAG _RARE_
sites O
and O
not O
from O
three O
downstream _RARE_
TAAG _RARE_
sites O
. O

Mutation O
of O
nucleotides O
adjacent O
to O
the O
AP I-GENE
- I-GENE
1 I-GENE
cis I-GENE
- I-GENE
response I-GENE
elements I-GENE
had O
no _RARE_
effect O
on O
trans _RARE_
- O
activation O
. O

The O
close O
proximity _RARE_
of O
the O
two O
neuropeptide _RARE_
Y I-GENE
receptor I-GENE
genes I-GENE
suggests O
that O
they O
have O
evolved O
from O
a O
gene O
duplication O
event O
with O
the O
small O
intron O
interrupting _RARE_
the O
coding O
sequence O
of O
the O
y1 _RARE_
gene I-GENE
being O
converted O
into O
a O
functional _RARE_
sequence O
within O
the O
y5 _RARE_
gene I-GENE
, O
while O
the O
reverse O
complementary _RARE_
sequence O
was O
utilized O
as _RARE_
an O
alternatively _RARE_
spliced _RARE_
5 O
' O
exon _RARE_
for _RARE_
the O
y1 _RARE_
gene I-GENE
. O

The O
mammalian I-GENE
phosphoinositide _RARE_
3 I-GENE
- I-GENE
kinases I-GENE
( O
PI3Ks _RARE_
) O
p110alpha _RARE_
, I-GENE
beta I-GENE
, I-GENE
and I-GENE
delta I-GENE
form O
heterodimers _RARE_
with O
Src I-GENE
homology I-GENE
2 I-GENE
( O
SH2 _RARE_
) O
domain O
- O
containing O
adaptors _RARE_
such O
as _RARE_
p85alpha _RARE_
or O
p55 I-GENE
( O
PIK _RARE_
). O

In O
the O
studies O
reported O
here O
, O
the O
5 O
'- O
flanking O
region O
of O
the O
human I-GENE
gp130 _RARE_
gene I-GENE
was O
isolated O
and O
the O
transcription O
initiation O
sites O
were O
mapped O
. O

Localization O
of O
the O
cytokine _RARE_
response O
element O
by O
5 O
'- O
deletion O
analysis O
and O
site O
- O
directed O
mutagenesis O
revealed O
a O
cis O
- O
acting O
binding O
site O
for _RARE_
activated O
STAT I-GENE
complexes O
. O

Insulin I-GENE
regulation _RARE_
of O
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
kinase I-GENE
( O
MEK I-GENE
), _RARE_
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
and O
casein I-GENE
kinase I-GENE
in O
the O
cell O
nucleus O
: O
a O
possible O
role O
in O
the O
regulation _RARE_
of O
gene O
expression _RARE_
. O

Sequencing O
of O
the O
three O
pag _RARE_
- I-GENE
3 I-GENE
alleles I-GENE
showed O
that O
two O
apparent O
null _RARE_
alleles O
encode O
a O
nonsense O
mutation O
before O
the O
zinc O
fingers _RARE_
and O
a O
missense O
mutation O
in O
the O
fourth O
zinc O
finger O
that O
changes O
a O
coordinating _RARE_
histidine _RARE_
to O
a O
tyrosine O
. O

Pax I-GENE
- I-GENE
3 I-GENE
is O
a O
paired I-GENE
- I-GENE
type I-GENE
homeobox _RARE_
gene I-GENE
that O
is O
specifically O
expressed _RARE_
in O
the O
dorsal O
and O
posterior O
neural _RARE_
tube O
. O

Instead O
, O
they O
contained O
dendritic _RARE_
cells O
that O
express O
melanogenic _RARE_
marker O
proteins O
such O
as _RARE_
tyrosinase _RARE_
and O
tyrosinase _RARE_
- I-GENE
related I-GENE
protein I-GENE
1 I-GENE
. O

These O
mutations O
create O
stop O
codons O
in O
exon _RARE_
7 O
and O
8 O
, O
respectively O
, O
and O
probably O
result O
in O
truncated O
proteins O
lacking _RARE_
HLH _RARE_
- O
Zip _RARE_
or O
Zip _RARE_
structure _RARE_
. O

Here O
, O
a O
case O
of O
Sjogren _RARE_
' O
s O
syndrome _RARE_
is O
presented O
that O
was O
initially O
diagnosed O
because O
of O
dental O
complaints _RARE_
, O
and O
long O
- O
term O
treatment O
of O
Sjogren _RARE_
' O
s O
patients O
is O
discussed O
. O

Cloning O
and O
characterization O
of O
a O
cDNA O
encoding O
a O
bacteriophage _RARE_
- I-GENE
type I-GENE
RNA I-GENE
polymerase I-GENE
from O
the O
higher _RARE_
plant _RARE_
Chenopodium _RARE_
album _RARE_
. O

Similarly O
, O
overexpression O
of O
increasing O
concentration O
of O
COUP I-GENE
- I-GENE
TFI I-GENE
, O
but O
not O
COUP I-GENE
- I-GENE
TFI I-GENE
delta35 _RARE_
, O
can O
squelch _RARE_
the O
silencing O
activity O
of O
the O
unliganded _RARE_
TRbeta _RARE_
. O

These O
six _RARE_
amino O
acids _RARE_
are O
part O
of O
an O
amphipathic _RARE_
helix O
that O
is O
highly O
conserved _RARE_
among O
nuclear I-GENE
hormone I-GENE
receptors I-GENE
and O
contains O
the O
core O
domain O
of O
the O
ligand _RARE_
- O
dependent O
transactivation _RARE_
function O
, O
AF _RARE_
- O
2 O
. O

Surprisingly O
, O
the O
RXR I-GENE
- O
specific O
ligand _RARE_
9 O
- O
cis O
- O
retinoic O
acid O
induced _RARE_
binding O
of O
SRC I-GENE
- I-GENE
1 I-GENE
to O
the O
RXR I-GENE
component _RARE_
of O
the O
TRE _RARE_
- O
bound _RARE_
heterodimer _RARE_
. O

In O
ciliates _RARE_
, O
both O
mechanisms O
are O
readily O
observed O
. O

Based O
on O
the O
occurrence O
of O
several O
transcription O
signals O
in O
the O
Thermus _RARE_
pyr _RARE_
promoter I-GENE
region I-GENE
and O
strong O
amino O
acid O
sequence O
identities O
( O
about O
60 _RARE_
%) O
between O
Thermus _RARE_
PyrR _RARE_
and O
the O
PyrR _RARE_
attenuation _RARE_
proteins I-GENE
of O
two O
Bacillus O
sp _RARE_
., O
we O
propose O
a O
regulatory O
mechanism O
involving O
transcriptional O
attenuation _RARE_
to O
control O
pyr _RARE_
gene I-GENE
expression _RARE_
in O
Thermus _RARE_
. O

Diver _RARE_
respiratory O
responses O
to O
a O
tunable _RARE_
closed O
- O
circuit O
breathing O
apparatus O
. O

Measurement O
of O
the O
time O
constant O
of O
VO2 O
and O
oxygen O
pulse O
during _RARE_
constant O
work O
rate O
exercise O
are O
useful O
for _RARE_
the O
objective O
evaluation O
of O
the O
training O
effect O
of O
patients O
with O
COPD O
. O

Characterization O
of O
CR1 _RARE_
repeat O
random O
PCR O
markers O
for _RARE_
mapping O
the O
chicken O
genome O
. O

A O
reversed O
- O
phase _RARE_
high O
- O
performance O
liquid O
chromatographic O
( O
HPLC O
) O
method O
for _RARE_
the O
determination O
of O
cocaine O
metabolites O
produced O
in O
vitro O
by O
serum I-GENE
and I-GENE
liver I-GENE
esterases _RARE_
is O
described O
. O

Mutational O
studies O
provide O
evidence O
to O
this O
end O
and O
indicate O
that O
the O
side _RARE_
chains O
of O
subdomain _RARE_
4 O
. O
2 O
make O
specific O
contacts O
with O
the O
nucleotides O
at _RARE_
- O
35 _RARE_
. O

It O
is O
concluded O
that O
fludarabine _RARE_
is O
a O
highly O
useful O
agent O
in O
CLL _RARE_
. O

Three O
different O
techniques O
of O
EA _RARE_
analysis O
were O
used O
in O
the O
study O
: O
1 O
) O
fast O
Fourier _RARE_
transformation O
( O
FFT _RARE_
) O
of O
EA _RARE_
in O
a O
broad O
band O
, O
2 O
) O
developed O
by O
us O
alternative _RARE_
method O
of O
non O
- O
harmonic _RARE_
expansion O
of O
the O
EEG O
curves O
taking O
into O
account O
their O
shape O
, O
3 O
) O
factor O
analysis O
of O
the O
EA _RARE_
spectral O
densities _RARE_
. O

Concomitantly _RARE_
, O
p34CDC2 _RARE_
histone I-GENE
H1 _RARE_
kinase O
activity O
increases O
in O
the O
former O
, O
but O
not O
in O
the O
latter O
cell O
lines O
, O
hence O
suggesting O
a O
role O
for _RARE_
this O
protein O
in O
radiation O
- O
induced _RARE_
cell O
death _RARE_
. O

Using O
PRL I-GENE
- I-GENE
R I-GENE
tagged _RARE_
both O
in O
the O
N O
- O
terminal O
or O
C O
- O
terminal O
regions O
of O
the O
mature _RARE_
receptor O
excludes _RARE_
the O
possibility O
of O
a O
cleaved O
fragment O
which O
could O
have O
been O
subsequently O
imported _RARE_
into O
the O
nucleus O
. O

Thus O
, O
the O
B O
- O
S O
mutant O
does O
not O
mimic O
efficiently O
the O
chloroplastic _RARE_
GAPDHs _RARE_
, O
and O
long O
- O
range O
and O
/ O
or O
second O
- O
layer O
effects O
, O
not O
easily O
predictable _RARE_
from O
visual O
inspection _RARE_
of O
three O
- O
dimensional O
structures _RARE_
, O
need O
to O
be O
taken O
into O
account O
for _RARE_
designing _RARE_
a O
true O
" O
chloroplastic _RARE_
- O
like O
" O
mutant O
of O
cytosolic I-GENE
GAPDH _RARE_
. O

Transcription O
of O
these O
genes O
was O
also O
elevated O
in O
gut O
and O
lung _RARE_
during _RARE_
freezing _RARE_
, O
but O
mRNA O
levels O
in O
these O
tissues O
were O
lower O
than O
in O
liver O
. O

Computer _RARE_
software _RARE_
assisted _RARE_
ordering _RARE_
( O
CSAO _RARE_
) O
was O
developed O
to O
integrate _RARE_
PN _RARE_
Ca O
: O
P O
solubility _RARE_
with O
clinical O
data O
to O
improve O
parenteral _RARE_
Ca O
and O
P O
administration O
. O

A O
similar O
chimera _RARE_
was O
assembled O
from O
the O
two O
halves _RARE_
of O
the O
molecule O
expressed _RARE_
separately O
in O
different O
bacteria O
and O
refolded _RARE_
together O
. O

The O
conditions O
for _RARE_
obtaining O
titanium _RARE_
dioxide O
from O
the O
substrates _RARE_
titanium _RARE_
tetrachloride _RARE_
and O
oxygen O
and O
applying O
this O
to O
a O
surgical O
stainless _RARE_
steel _RARE_
of O
the O
type O
316L _RARE_
by O
the O
plasma O
assisted _RARE_
chemical O
vapour _RARE_
deposition O
method O
have O
been O
determined O
. O

All O
six _RARE_
genes O
were O
cloned _RARE_
and O
characterised _RARE_
. O

We O
analysed O
two O
regions O
involved O
in O
preS2 _RARE_
/ O
S I-GENE
gene I-GENE
transcription O
of O
the O
HBV _RARE_
adw _RARE_
subtype _RARE_
: O
the O
diverged O
TATA O
box O
and O
a O
putative O
initiator _RARE_
element O
. O

Indeed O
the O
predicted O
folding O
of O
the O
5 O
' O
and O
3 O
'- O
untranslated _RARE_
regions O
revealed O
patterns O
of O
stem _RARE_
and O
loop O
structures _RARE_
conserved _RARE_
for _RARE_
all O
tick _RARE_
- O
borne _RARE_
flaviviruses _RARE_
suggesting O
a O
purifying _RARE_
selection O
for _RARE_
preservation O
of O
essential O
RNA O
secondary O
structures _RARE_
which O
could O
be O
involved O
in O
translational O
control O
and O
replication O
. O

EGF _RARE_
acts O
primarily O
by O
means O
of O
transactivation _RARE_
domain O
AF _RARE_
- O
1 O
, O
whereas O
cAMP O
acts O
via O
transactivation _RARE_
domain O
AF _RARE_
- O
2 O
of O
the O
ER I-GENE
. O

To O
determine O
which O
region O
of O
SulA _RARE_
is O
essential O
for _RARE_
the O
inhibition O
of O
cell O
division O
, O
we O
constructed O
a O
series O
of O
N O
- O
terminal O
and O
C O
- O
terminal O
deletions O
of O
SulA _RARE_
and O
a O
series O
of O
alanine O
substitution O
mutants O
. O

We O
have O
inactivated O
Krox I-GENE
- I-GENE
20 I-GENE
by O
homologous O
recombination _RARE_
in O
ES O
cells O
and O
demonstrated O
that O
the O
mutation O
leads O
to O
the O
deletion O
of O
r3 _RARE_
and O
r5 _RARE_
. O

Recently O
we O
have O
performed O
a O
detailed O
analysis O
of O
specific O
neuronal _RARE_
populations O
affected O
by O
the O
mutation O
which O
shed _RARE_
new O
light O
on O
the O
role O
of O
Krox I-GENE
- I-GENE
20 I-GENE
in O
the O
segmentation _RARE_
and O
on O
the O
physiological O
consequences O
of O
its O
inactivation O
. O

The O
most O
important O
one O
among O
them O
is O
Cyclosporin _RARE_
A O
, O
which O
is O
a O
selective O
immunosuppressive O
drug O
. O

Consistent O
with O
its O
role O
in O
p53 I-GENE
ubiquitination O
, O
mE6 _RARE_
- I-GENE
AP I-GENE
was O
found O
both O
in O
the O
nucleus O
and O
cytosol O
, O
while O
Nedd _RARE_
- I-GENE
4 I-GENE
was O
found O
only O
in O
the O
cytosol O
. O

SPP _RARE_
also O
induced _RARE_
transient O
tyrosine O
phosphorylation _RARE_
of O
focal _RARE_
adhesion I-GENE
kinase I-GENE
( O
p125 _RARE_
( O
FAK I-GENE
)), _RARE_
a O
cytosolic I-GENE
tyrosine I-GENE
kinase I-GENE
that O
localizes O
in O
focal _RARE_
adhesions O
, O
and O
of O
the O
cytoskeleton _RARE_
- I-GENE
associated I-GENE
protein I-GENE
paxillin I-GENE
. O

Using O
a O
conditional O
- O
lethal O
mutant O
allele O
of O
SUP45 _RARE_
( O
sup45 _RARE_
- I-GENE
2 I-GENE
) O
and O
a O
combination O
of O
in O
vivo O
and O
in O
vitro O
approaches O
, O
we O
demonstrate O
that O
the O
product O
of O
the O
SUP45 _RARE_
gene I-GENE
( O
Sup45p _RARE_
or O
eRF1 _RARE_
) O
is O
a O
factor O
required O
for _RARE_
translation O
termination _RARE_
in O
yeast O
. O

Evaluation O
of O
myocardial _RARE_
perfusion O
by O
99mTc O
- O
tetrofosmin O
SPECT O
before O
and O
after O
emergent _RARE_
percutaneous _RARE_
transluminal _RARE_
coronary O
angioplasty _RARE_
for _RARE_
acute O
myocardial _RARE_
infarction O

A O
neonatal O
alloimmune _RARE_
thrombocytopenia O
with O
an O
HPA _RARE_
- I-GENE
3a _RARE_
( O
Baka _RARE_
) O
incompatibility _RARE_
was O
confirmed O
. O

She _RARE_
was O
able O
to O
stand _RARE_
unaided _RARE_
by O
3 O
years O
of O
age O
with O
then O
progressive O
worsening _RARE_
of O
motor O
abilities O
. O

Merosin _RARE_
positive O
congenital O
muscular O
dystrophy _RARE_
with O
mental O
deficiency O
, O
epilepsy O
and O
MRI O
changes O
in O
the O
cerebral O
white _RARE_
matter O
. O

Most O
eukaryotic O
mRNAs O
are O
translated O
by O
a O
" O
scanning O
ribosome _RARE_
" O
mechanism O
. O

Comparison O
of O
Tc O
- O
99m O
sestamibi _RARE_
perfusion O
imaging O
and O
echocardiography O
using O
an O
arbutamine _RARE_
infusion O
for _RARE_
the O
detection O
of O
coronary O
artery O
disease _RARE_
. O

Also O
, O
transient O
overexpression O
of O
this O
protein O
in O
C2C12 O
cells O
reduced _RARE_
the O
transcription O
of O
a O
CAT I-GENE
- O
reporter O
regulated O
by O
an O
E12 I-GENE
/ O
MyoD I-GENE
driven _RARE_
enhancer O
. O

Five O
of O
these O
have O
ocular O
or O
oculocutaneous _RARE_
albinism _RARE_
. O

Comprising _RARE_
a O
126 O
- O
nucleotide O
5 O
' O
untranscribed _RARE_
genomic O
sequence O
and O
a O
466 _RARE_
- O
nucleotide O
5 O
' O
noncoding O
cDNA O
sequence O
, O
the O
592 _RARE_
- O
nucleotide O
5 O
' O
CpG O
island O
lacked O
TATA O
and O
CAAT O
boxes _RARE_
but O
displayed O
a O
high O
G O
+ O
C O
content O
, O
was O
enriched _RARE_
for _RARE_
CpG O
dinucleotides _RARE_
, O
and O
contained O
a O
potential _RARE_
Sp1 _RARE_
- I-GENE
binding I-GENE
site I-GENE
, O
i O
. O
e _RARE_
., O
features O
compatible O
with O
a O
housekeeping O
gene O
. O

SSeCKS _RARE_
( O
pronounced O
essex _RARE_
) O
encodes O
a O
major O
protein I-GENE
kinase I-GENE
C I-GENE
substrate O
, O
the O
expression _RARE_
of O
which O
is O
down O
- O
regulated O
in O
src I-GENE
- O
and O
ras I-GENE
- O
transformed O
rodent O
fibroblasts _RARE_
but O
not O
in O
raf _RARE_
- O
transformed O
rodent O
fibroblasts _RARE_
( O
X O
. O

Type _RARE_
I O
position O
- O
vestibular O
- O
pause _RARE_
( O
PVP _RARE_
I O
) O
and O
vestibular O
- O
only O
( O
V O
I O
) O
neurons O
, O
as _RARE_
well _RARE_
as _RARE_
a O
smaller O
number O
of O
other O
type O
I O
and O
type O
II O
eye O
- O
plus _RARE_
- O
vestibular O
neurons O
were O
studied O
. O

The O
1 O
. O
1 O
- O
and O
1 O
. O
3 O
- O
kb O
mRNA O
species O
were O
found O
only O
in O
the O
heart _RARE_
, O
and O
the O
2 O
. O
6 O
- O
kb O
species O
was O
found O
in O
the O
heart _RARE_
, O
kidney _RARE_
and O
brain O
, O
but O
not O
in O
skeletal O
muscle O
or O
liver O
. O

Taurine _RARE_
deficiency O
significantly O
depressed O
the O
amplitude O
of O
OP1 _RARE_
and O
OP4 _RARE_
. O

We O
have O
found O
that O
mcs4 _RARE_
- O
cells O
are O
defective _RARE_
at _RARE_
activation O
of O
Spc1 _RARE_
in O
response O
to O
various O
forms O
of O
stress O
. O

The O
extended O
rat I-GENE
SP I-GENE
- I-GENE
A I-GENE
isoforms I-GENE
were O
enriched _RARE_
in O
the O
more O
fully O
glycosylated O
and O
multimeric _RARE_
SP I-GENE
- I-GENE
A I-GENE
species O
separated O
on O
SDS O
- O
PAGE O
gels O
. O

Alternative O
splicing _RARE_
of O
CDC25B _RARE_
may O
therefore O
contribute O
to O
the O
control O
of O
cell O
proliferation _RARE_
. O

This O
investigation O
was O
undertaken O
to O
determine O
whether O
consuming _RARE_
several O
small O
feedings _RARE_
of O
preexercise _RARE_
carbohydrate O
( O
CHO O
), _RARE_
rather O
than O
a O
single O
bolus O
, O
would O
affect O
blood _RARE_
glucose O
and O
insulin I-GENE
responses O
during _RARE_
rest O
and O
exercise O
. O

The O
findings O
suggest O
that O
ERP _RARE_
effects O
of O
distinct O
memory O
processes O
are O
differentially O
influenced O
by O
the O
encoding O
instructions _RARE_
. O

This O
coat I-GENE
protein I-GENE
consists O
of O
Sar1p _RARE_
, O
the O
Sec23p _RARE_
protein I-GENE
complex I-GENE
containing O
Sec23p _RARE_
and O
Sec24p _RARE_
, O
and O
the O
Sec13p _RARE_
protein I-GENE
complex I-GENE
containing O
Sec13p _RARE_
and O
a O
novel O
150 _RARE_
- I-GENE
kDa I-GENE
protein I-GENE
, I-GENE
p150 _RARE_
. O

The O
second O
primary _RARE_
mutant O
contained O
a O
proline O
- O
to O
- O
leucine O
change O
at _RARE_
position O
243 _RARE_
( O
P243L _RARE_
). O

Induction O
of O
correctly O
spliced _RARE_
germline _RARE_
transcripts O
is O
necessary O
to O
target O
a O
switch O
region O
for _RARE_
recombination _RARE_
and O
switching O
. O

Thus O
, O
the O
PCE _RARE_
binds O
a O
Pbx _RARE_
dimer _RARE_
partner _RARE_
that O
behaves _RARE_
unlike O
Class _RARE_
I I-GENE
Hox I-GENE
proteins I-GENE
. O

Furthermore O
, O
the O
NH2 O
- O
terminal O
portion O
of O
the O
homologue O
was O
not O
translocated _RARE_
into O
the O
outer _RARE_
membrane O
without O
its O
COOH _RARE_
- O
terminal O
part O
. O

Molecular O
cloning O
and O
characterization O
of O
a O
cDNA O
, O
CHEMR1 _RARE_
, O
encoding O
a O
chemokine _RARE_
receptor O
with O
a O
homology O
to O
the O
human I-GENE
C I-GENE
- I-GENE
C I-GENE
chemokine _RARE_
receptor I-GENE
, O
CCR _RARE_
- I-GENE
4 I-GENE
. O

Organization O
of O
the O
human I-GENE
LU _RARE_
gene I-GENE
and O
molecular _RARE_
basis O
of O
the O
Lu _RARE_
( O
a O
)/ _RARE_
Lu _RARE_
( I-GENE
b I-GENE
) I-GENE
blood _RARE_
group O
polymorphism O
. O

Using O
mouse O
- O
human O
somatic O
hybrids O
and O
FISH _RARE_
analysis O
, O
the O
PE _RARE_
- I-GENE
2 I-GENE
gene I-GENE
is O
localized O
to O
human O
chromosome _RARE_
19q13 _RARE_
. O
2 O
, O
a O
region O
involved O
in O
translocations _RARE_
and O
deletions O
in O
leukemias O
and O
several O
solid O
tumors O
, O
suggesting O
that O
this O
novel O
ETS _RARE_
factor I-GENE
may O
play O
a O
role O
in O
carcinogenesis _RARE_
. O

Whereas O
the O
mutant O
enzymes _RARE_
terminate O
normally O
at _RARE_
the O
late _RARE_
terminator O
in O
T7 _RARE_
DNA O
( O
T O
( O
phi _RARE_
)) O
and O
rrnB _RARE_
T2 _RARE_
, O
they O
fail O
to O
terminate O
at _RARE_
one O
of O
the O
termination _RARE_
sites O
of O
rrnB _RARE_
T1 _RARE_
, O
and O
also O
fail O
to O
recognize O
the O
PTH _RARE_
and O
CJ _RARE_
signals O
. O

Cytological _RARE_
data O
suggest O
that O
the O
transgenes _RARE_
associate O
with O
a O
nucleolus _RARE_
. O

Light _RARE_
regulatory I-GENE
unit I-GENE
1 I-GENE
( O
LRU1 _RARE_
) O
is O
necessary O
for _RARE_
and O
sufficient O
to O
mediate O
light O
- O
dependent O
activation O
of O
the O
chalcone _RARE_
synthase I-GENE
( I-GENE
CHS _RARE_
) I-GENE
minimal I-GENE
promoter I-GENE
in O
Petroselinum _RARE_
crispum _RARE_
. O

Sequence O
divergence O
is O
observed O
in O
untranslated _RARE_
regions O
which O
allows O
the O
definition O
of O
gene O
- O
specific O
probes _RARE_
. O

The O
active _RARE_
state O
is O
terminated _RARE_
by O
hydrolysis O
of O
bound _RARE_
GTP O
, O
producing O
inactive O
ARF I-GENE
- I-GENE
GDP I-GENE
. O

We O
suggest O
that O
apart O
from O
the O
World _RARE_
Summit _RARE_
for _RARE_
Children O
' O
s O
under O
- O
five O
mortality O
target O
for _RARE_
the O
year O
2000 O
, O
intraregional _RARE_
targets _RARE_
to O
reduce O
geographical _RARE_
inequalities _RARE_
in O
under O
- O
five O
mortality O
should O
be O
specified O
. O

The O
immunophilin _RARE_
, O
which O
can O
be O
of O
the O
FK506 O
- O
or O
cyclosporin O
A O
- O
binding O
class O
, O
binds O
to O
hsp90 I-GENE
via O
its O
tetratricopeptide _RARE_
repeat O
( O
TPR O
) O
domain O
, O
and O
different O
receptor O
heterocomplexes _RARE_
exist O
depending O
upon O
which O
immunophilin _RARE_
occupies _RARE_
the O
TPR O
- O
binding O
region O
of O
hsp90 I-GENE
. O

In O
adherent _RARE_
macrophages O
, O
absence O
of O
CD45 _RARE_
led O
to O
the O
hyperphosphorylation _RARE_
and O
hyperactivation _RARE_
of O
p56 _RARE_
/ I-GENE
59 _RARE_
( O
hck _RARE_
) O
and O
p53 I-GENE
/ I-GENE
56 _RARE_
( O
lyn _RARE_
), _RARE_
but O
not O
of O
p58 _RARE_
( O
c I-GENE
- I-GENE
fgr _RARE_
). O

Secretion _RARE_
in O
milk O
and O
transplacental _RARE_
transfer O
of O
two O
iodized _RARE_
oils _RARE_
, O
Lipiodol _RARE_
UF _RARE_
and O
Oriodol _RARE_
, O
in O
rabbits O
. O

Sequencing O
of O
the O
facB _RARE_
gene I-GENE
revealed O
that O
it O
encodes O
a O
protein O
that O
contains O
an O
N O
- O
terminal O
GAL4 I-GENE
- O
like O
Zn _RARE_
( O
II O
) O
2Cys6 _RARE_
( O
or O
C6 _RARE_
zinc O
) O
binuclear _RARE_
cluster O
for _RARE_
DNA O
binding O
, O
leucine O
zipper O
- O
like O
heptad _RARE_
repeat O
motifs O
and O
central O
and O
C O
- O
terminal O
acidic _RARE_
alpha O
- O
helical O
regions O
, O
consistent O
with O
a O
function O
as _RARE_
a O
DNA O
- O
binding O
transcriptional O
activator O
. O

Overexpression O
of O
Sed5p _RARE_
allowed O
growth O
in O
the O
absence O
of O
Vti1p _RARE_
. O

The O
coding O
region O
of O
mkh1 _RARE_
is O
contained O
within O
a O
single O
exon _RARE_
encoding O
a O
1 O
, O
116 _RARE_
- O
amino O
- O
acid O
protein O
. O

Strikingly _RARE_
, O
stoichiometric _RARE_
association O
of O
p107 I-GENE
or O
p130 I-GENE
with O
either O
cyclin _RARE_
E I-GENE
- O
cdk2 I-GENE
or O
cyclin _RARE_
A I-GENE
- O
cdk2 I-GENE
negated _RARE_
the O
activities O
of O
these O
kinases O
. O

Furthermore O
, O
p150 _RARE_
suppresses O
actin I-GENE
gelation _RARE_
, O
which O
is O
induced _RARE_
by O
smooth _RARE_
muscle I-GENE
alpha I-GENE
- I-GENE
actinin _RARE_
. O

Denaturation _RARE_
of O
the O
simian O
virus O
40 O
origin O
of O
replication O
mediated _RARE_
by O
human I-GENE
replication I-GENE
protein I-GENE
A I-GENE
. O

This O
effect O
was O
abolished O
once O
the O
EM O
motif O
in O
the O
promoter O
- O
reporter O
construct O
was O
mutated _RARE_
, O
thus O
suggesting O
that O
the O
synergistic O
transactivation _RARE_
function O
of O
the O
TEF I-GENE
- I-GENE
1 I-GENE
- O
Max I-GENE
heterotypic _RARE_
complex O
is O
mediated _RARE_
through O
binding O
of O
the O
complex O
to O
the O
EM O
motif O
. O

Interdigitated _RARE_
residues O
within O
a O
small O
region O
of O
VP16 I-GENE
interact O
with O
Oct I-GENE
- I-GENE
1 I-GENE
, O
HCF _RARE_
, O
and O
DNA O
. O

With O
a O
view O
to O
identifying O
other O
important O
U14 I-GENE
interactions O
, O
a O
stem _RARE_
- O
loop O
domain O
required O
for _RARE_
activity O
of O
Saccharomyces I-GENE
cerevisiae I-GENE
U14 I-GENE
RNAs I-GENE
( O
the O
Y O
domain O
) O
was O
first _RARE_
subjected O
to O
detailed O
mutational O
analysis O
. O

Based O
on O
these O
results O
and O
because O
Cdc68 _RARE_
has O
been O
implicated O
as _RARE_
a O
regulator O
of O
chromatin O
structure _RARE_
, O
we O
postulate _RARE_
that O
polymerase I-GENE
alpha I-GENE
may O
interact O
with O
these O
proteins O
to O
gain O
access O
to O
its O
template O
or O
to O
origins O
of O
replication O
in O
vivo O
. O

Even _RARE_
when O
the O
inoculum _RARE_
size O
was O
reduced _RARE_
sixfold _RARE_
( O
i O
. O
e _RARE_
., O
6 O
x _RARE_
10 O
( O
6 O
) O
CFU _RARE_
/ O
mouse O
), _RARE_
50 O
% O
of O
the O
RB6 _RARE_
- I-GENE
8C5 _RARE_
- O
treated O
animals O
died O
within O
6 O
days O
. O

In O
12 O
cases O
( O
3 O
. O
1 O
%), O
a O
change O
in O
stage _RARE_
resulted O
. O

Promoter O
recognition O
algorithms _RARE_
identified O
divergent O
promoter O
elements O
within O
the O
CpG O
island O
, O
which O
lies O
between O
the O
ATM _RARE_
and O
E14 _RARE_
/ O
NPAT _RARE_
genes O
, O
and O
provide O
evidence O
for _RARE_
a O
putative O
second O
ATM _RARE_
promoter I-GENE
located _RARE_
within O
intron O
3 O
, O
immediately O
upstream O
of O
the O
first _RARE_
coding O
exon _RARE_
. O

Recombinant I-GENE
soluble _RARE_
pMCP _RARE_
that O
lacked O
transmembrane O
and O
cytoplasmic O
domains O
had O
factor I-GENE
I I-GENE
cofactor I-GENE
activity O
in O
C3b _RARE_
cleavage _RARE_
, O
indicating O
that O
it O
is O
functionally O
, O
as _RARE_
well _RARE_
as _RARE_
structurally O
homologous O
to O
MCP _RARE_
. O

Clinical O
and O
haematological _RARE_
signs O
are O
not O
specific O
in O
this O
setting O
, O
and O
the O
diagnosis O
relies _RARE_
on O
histological O
features O
, O
mainly O
bone O
marrow O
examination O
. O

Spatial _RARE_
zones _RARE_
for _RARE_
muscle O
coactivation _RARE_
and O
the O
control O
of O
postural _RARE_
stability O
. O

Liquid _RARE_
chromatographic O
separation O
was O
achieved O
on O
a O
Zorbax _RARE_
RX _RARE_
C8 _RARE_
analytical _RARE_
column O
using O
gradient O
elution _RARE_
. O

The O
linear _RARE_
plasmid _RARE_
pDHL1 _RARE_
from O
Debaryomyces _RARE_
hansenii _RARE_
encodes O
a O
protein O
highly O
homologous O
to O
the O
pGKL1 _RARE_
- I-GENE
plasmid _RARE_
DNA I-GENE
polymerase I-GENE
. O

The O
RNA O
- O
binding O
and O
RNA I-GENE
- I-GENE
DNA I-GENE
helicase _RARE_
activities O
of O
the O
Escherichia I-GENE
coli I-GENE
transcription I-GENE
termination _RARE_
factor I-GENE
rho _RARE_
have O
been O
investigated O
using O
natural _RARE_
RNA O
molecules O
that O
are O
255 _RARE_
and O
391 _RARE_
nucleotide O
residues O
in O
length O
and O
that O
contain O
the O
trp _RARE_
t I-GENE
' I-GENE
rho _RARE_
- I-GENE
dependent I-GENE
termination _RARE_
sequence I-GENE
of O
E O
. O
coli O
. O

The O
p20 _RARE_
- I-GENE
CGGBP _RARE_
gene I-GENE
is O
conserved _RARE_
among O
mammals O
but O
shows O
no _RARE_
homology O
to O
non O
- O
vertebrate _RARE_
species O
. O

The O
data O
suggest O
that O
like O
in O
yeast O
, O
in O
plants _RARE_
a O
certain O
subfamily O
of O
UBC _RARE_
is O
specifically O
involved O
in O
the O
proteolytic _RARE_
degradation _RARE_
of O
abnormal O
proteins O
as _RARE_
result O
of O
stress O
. O

The O
pWP _RARE_
- I-GENE
19 I-GENE
also O
encodes O
the O
AAV _RARE_
inverted O
terminal O
repeats O
for _RARE_
integration _RARE_
and O
replication O
and O
the O
herpes O
virus O
thymidine _RARE_
kinase I-GENE
promoter O
- O
driven _RARE_
gene O
for _RARE_
neomycin _RARE_
resistance O
( O
neoR _RARE_
). O

We O
have O
developed O
a O
rAAV _RARE_
- O
mediated _RARE_
gene O
transfer O
system _RARE_
for _RARE_
the O
rat I-GENE
preproinsulin _RARE_
II I-GENE
gene I-GENE
. O

The O
serum O
levels O
of O
beta I-GENE
- I-GENE
human I-GENE
chorionic _RARE_
gonadotropin I-GENE
( O
HCG _RARE_
) O
and O
placental _RARE_
alkaline _RARE_
phosphatase I-GENE
( O
PLAP _RARE_
) O
were O
not O
elevated O
. O

A O
striking O
feature O
of O
the O
recombinant I-GENE
H19 _RARE_
allele I-GENE
is O
the O
occurrence O
of O
a O
parental O
imprint _RARE_
set O
on O
the O
neo _RARE_
replacement _RARE_
cassette _RARE_
. O

This O
indicates O
that O
recruitment O
of O
large I-GENE
T I-GENE
antigen I-GENE
to O
the O
rRNA O
promoter O
by O
SL1 _RARE_
constitutes O
a O
crucial O
step O
in O
the O
activation O
process O
. O

In O
1990 O
, O
an O
International O
Commission _RARE_
for _RARE_
the O
Certification _RARE_
of O
Eradication _RARE_
of O
Poliomyelitis _RARE_
Eradication _RARE_
( O
ICCPE _RARE_
) O
was O
established O
by O
the O
Pan _RARE_
American O
Health O
Organization O
to O
eventually _RARE_
determine O
if O
transmission _RARE_
was O
interrupted O
. O

Functional O
and O
regulatory O
analysis O
of O
the O
two O
copies O
of O
the O
fixNOQP _RARE_
operon I-GENE
of O
Rhizobium _RARE_
leguminosarum _RARE_
strain _RARE_
VF39 _RARE_
. O

This O
study O
describes O
a O
new O
MADS I-GENE
box I-GENE
gene I-GENE
, O
nmhC5 _RARE_
, O
which O
along O
with O
nmh7 _RARE_
( O
J _RARE_
. O

Thus O
E14 _RARE_
. O
1TG3B1 _RARE_
is O
a O
useful O
ES O
cell O
line O
for _RARE_
modifying _RARE_
the O
mouse O
genome O
using O
the O
HPRT _RARE_
gene I-GENE
as _RARE_
a O
selection O
marker O
and O
for _RARE_
transmission _RARE_
at _RARE_
a O
high O
frequency O
into O
the O
mouse O
germ _RARE_
line O
. O

Lung O
and O
multi _RARE_
- O
system _RARE_
damage O
were O
early O
indicators O
of O
poor O
outcome O
in O
severe O
non O
- O
fatal O
disease _RARE_
. O

The O
results O
suggest O
that O
the O
bulbospinal _RARE_
micturition _RARE_
reflex O
evoked O
by O
bladder O
filling O
and O
L O
- O
dopa _RARE_
involves O
a O
descending _RARE_
pathway _RARE_
where O
transmission _RARE_
is O
partly O
mediated _RARE_
by O
spinal _RARE_
alpha I-GENE
1 I-GENE
- I-GENE
adrenoceptors I-GENE
. O

OBJECTIVE O
: O
This O
study O
was O
designed O
to O
analyze O
the O
common O
cause O
of O
asthenopia _RARE_
, O
mixed O
astigmatism _RARE_
. O

Disturbance _RARE_
of O
regeneration O
in O
the O
above O
pathological O
condition O
results O
from O
the O
damage O
to O
tunica _RARE_
propria _RARE_
and O
loss _RARE_
of O
its O
function O
for _RARE_
the O
support O
of O
structural O
homeostasis _RARE_
. O

Sternocleidomastoid _RARE_
, O
neck O
or O
facial O
muscles O
wasting _RARE_
were O
also O
found O
in O
three O
cases O
. O

Identification O
of O
five O
new O
genes O
, O
closely O
related O
to O
the O
interleukin I-GENE
- I-GENE
1beta I-GENE
converting _RARE_
enzyme I-GENE
gene I-GENE
, O
that O
do O
not O
encode O
functional _RARE_
proteases _RARE_
. O

The O
C O
- O
terminal O
mature _RARE_
region O
is O
highly O
conserved _RARE_
in O
other O
serine I-GENE
carboxypeptidases _RARE_
. O

One O
RNA O
construct O
which O
consisted O
of O
112 O
nucleotides O
( O
nt O
) O
from O
nt O
639 _RARE_
to O
nt O
750 O
formed O
a O
heterodimeric _RARE_
complex O
with O
the O
RNA O
which O
consisted O
of O
200 _RARE_
nucleotides O
from O
nt O
551 _RARE_
to O
nt O
750 O
. O

Here O
we O
demonstrate O
that O
AML1a _RARE_
, O
which O
solely O
has O
no _RARE_
effects O
as _RARE_
a O
transcriptional O
regulator O
, O
dominantly _RARE_
suppresses O
transcriptional O
activation O
by O
AML1b _RARE_
, O
and O
that O
AML1a _RARE_
exhibits O
the O
higher _RARE_
affinity O
for _RARE_
DNA O
- O
binding O
than O
AML1b _RARE_
. O

However O
, O
we O
could O
not O
find O
the O
homologous O
regions O
with O
guanine I-GENE
nucleotide I-GENE
exchange I-GENE
factors I-GENE
or O
GTPase I-GENE
- I-GENE
activating I-GENE
proteins I-GENE
in O
the O
c I-GENE
- I-GENE
cbl I-GENE
gene I-GENE
. O

However O
, O
using O
ATL _RARE_
- O
16T _RARE_
nuclear O
extract _RARE_
, O
we O
demonstrated O
that O
GATA _RARE_
- I-GENE
4 I-GENE
is O
the O
only O
GATA _RARE_
- I-GENE
binding I-GENE
protein I-GENE
that O
forms O
specific O
DNA O
- O
protein O
complex O
with O
the O
- O
70 O
GATA _RARE_
site O
. O

The O
impact O
of O
social O
support O
on O
the O
relationships O
of O
gay _RARE_
male O
couples _RARE_
is O
examined O
. O

The O
ubiquitously O
expressed _RARE_
hypoxia _RARE_
- I-GENE
inducible I-GENE
factor I-GENE
- I-GENE
1 I-GENE
( O
HIF I-GENE
- I-GENE
1 I-GENE
) O
is O
involved O
in O
expression _RARE_
of O
a O
large O
number O
of O
oxygen O
- O
regulated O
genes O
. O

Stromelysin _RARE_
- I-GENE
1 I-GENE
, O
matrix _RARE_
metalloproteinase _RARE_
- I-GENE
3 I-GENE
( O
MMP _RARE_
- I-GENE
3 I-GENE
), _RARE_
is O
an O
important O
endopeptidase _RARE_
selectively O
expressed _RARE_
by O
somatic O
cells O
in O
organ O
tissues O
. O

Tendon _RARE_
also O
shows O
a O
degree O
of O
extensibility _RARE_
. O

Surveillance _RARE_
for _RARE_
preeclampsia _RARE_
was O
conducted O
by O
personnel _RARE_
unaware _RARE_
of O
treatment O
- O
group O
assignments _RARE_
, O
using O
standardized O
measurements O
of O
blood _RARE_
pressure O
and O
urinary _RARE_
protein O
excretion O
at _RARE_
uniformly _RARE_
scheduled _RARE_
prenatal _RARE_
visits _RARE_
, O
protocols _RARE_
for _RARE_
monitoring O
these O
measurements O
during _RARE_
the O
hospitalization _RARE_
for _RARE_
delivery O
, O
and O
reviews _RARE_
of O
medical O
records O
of O
unscheduled _RARE_
outpatient _RARE_
visits _RARE_
and O
all O
hospitalizations _RARE_
. O

Aryl _RARE_
hydrocarbon I-GENE
receptor I-GENE
nuclear I-GENE
translocator _RARE_
( O
ARNT _RARE_
) O
is O
a O
component _RARE_
of O
the O
transcription O
factors O
, O
aryl _RARE_
hydrocarbon I-GENE
receptor I-GENE
( O
AhR _RARE_
) O
and O
hypoxia _RARE_
- I-GENE
inducible I-GENE
factor I-GENE
1 I-GENE
, O
which O
transactivate O
their O
target O
genes O
, O
such O
as _RARE_
CYP1A1 _RARE_
and O
erythropoietin I-GENE
, O
in O
response O
to O
xenobiotic _RARE_
aromatic O
hydrocarbons _RARE_
and O
to O
low O
O2 _RARE_
concentration O
, O
respectively O
. O

DNase I-GENE
I I-GENE
footprint O
analysis O
identified O
a O
protected O
region O
from O
- O
37 O
to O
- O
53 O
. O

We O
also O
provide O
evidence O
that O
gar2 _RARE_
is O
phosphorylated _RARE_
in O
vitro O
by O
a O
p13 _RARE_
( O
suc1 _RARE_
)- O
Sepharose _RARE_
- O
bound _RARE_
kinase O
from O
Schizosaccharomyces O
pombe O
extracts O
that O
displays O
cell O
cycle _RARE_
- O
regulated O
activity O
similar O
to O
that O
of O
the O
p34 _RARE_
( O
cdc2 I-GENE
( O
kinase O
. O

However O
, O
by O
immobilized _RARE_
metal O
affinity O
chromatography O
assay O
, O
self O
- O
association O
of O
PR I-GENE
- I-GENE
A I-GENE
was O
3 O
. O
5 O
- O
fold _RARE_
more O
efficient O
than O
that O
of O
either O
the O
DhLBD _RARE_
or O
hLBD _RARE_
constructs O
. O

The O
overall O
results O
of O
this O
paper O
are O
consistent O
with O
the O
conclusion O
that O
the O
carboxyl _RARE_
- O
terminal O
LBD _RARE_
is O
not O
sufficient O
for _RARE_
mediating O
PR I-GENE
dimerization _RARE_
and O
that O
multiple O
regions O
, O
including O
the O
hinge _RARE_
and O
amino O
- O
terminal O
sequences O
, O
contribute O
either O
directly O
or O
indirectly O
to O
homodimerization _RARE_
of O
PR I-GENE
. O

We O
isolated O
several O
overlapping O
A O
- O
phage _RARE_
and O
cosmid O
clones _RARE_
that O
cover _RARE_
more O
than O
100 _RARE_
kb O
of O
human O
DNA O
and O
contained O
the O
entire _RARE_
VDR I-GENE
gene I-GENE
. O

Colorectal _RARE_
carcinoma O
: O
therapeutic O
approach O
in O
patients O
already O
treated O
with O
metastasis O
resection O

Here O
, O
we O
correlate O
Dox _RARE_
effects O
on O
cell O
cycle _RARE_
with O
changes O
of O
E2F I-GENE
/ O
DP _RARE_
complexes O
and O
activity O
in O
differentiating O
C2C12 O
myocytes _RARE_
. O

The O
products O
of O
the O
Saccharomyces I-GENE
cerevisiae I-GENE
CIN1 _RARE_
, O
CIN2 _RARE_
and O
CIN4 _RARE_
genes I-GENE
participate O
in O
a O
nonessential _RARE_
pathway _RARE_
required O
for _RARE_
normal O
microtubule O
function O
. O

Vitrectomy _RARE_
was O
still O
a O
significant O
risk O
factor O
when O
macular _RARE_
holes _RARE_
were O
excluded O
. O

Invited _RARE_
editorial _RARE_
on O
" O
Acute O
and O
chronic O
effects O
of O
exercise O
on O
leptin I-GENE
levels O
in O
humans O
". O

Both O
promoters O
lack O
a O
TATA O
box O
, O
and O
Pint _RARE_
belongs O
to O
the O
MED _RARE_
- I-GENE
1 I-GENE
class O
of O
promoters O
, O
which O
initiate O
transcription O
at _RARE_
multiple O
sites O
. O

Serum I-GENE
response I-GENE
factor I-GENE
( O
SRF I-GENE
), _RARE_
a O
member _RARE_
of O
an O
ancient _RARE_
family O
of O
DNA O
- O
binding O
proteins O
, O
is O
generally O
assumed O
to O
be O
a O
ubiquitous O
transcription O
factor O
involved O
in O
regulating _RARE_
growth O
factor O
- O
responsive O
genes O
. O

We O
have O
initiated _RARE_
studies O
to O
identify O
candidate O
signal O
transducers _RARE_
that O
associate O
with O
the O
cytosolic O
domain O
( O
cd _RARE_
) O
of O
the O
IL _RARE_
- I-GENE
1R _RARE_
. O

In O
this O
study O
, O
we O
sought O
to O
identify O
mechanisms O
that O
could O
account O
for _RARE_
the O
antimitogenic _RARE_
effects O
of O
IL _RARE_
- I-GENE
4 I-GENE
. O

Pseudomonas _RARE_
aeruginosa _RARE_
strains O
infecting _RARE_
patients O
with O
cystic _RARE_
fibrosis _RARE_
( O
CF _RARE_
) O
acquire _RARE_
a O
mucoid _RARE_
phenotype _RARE_
due O
to O
overproduction _RARE_
of O
alginate _RARE_
. O

Activity _RARE_
of O
palgD _RARE_
in O
the O
cysB _RARE_
mutant I-GENE
, O
in O
CHA _RARE_
and O
in O
the O
non O
- O
mucoid _RARE_
strain _RARE_
PAO _RARE_
was O
assessed O
by O
the O
use O
of O
a O
transcriptional O
algD _RARE_
- O
xylE _RARE_
fusion O
. O

The O
Man9 _RARE_
- I-GENE
mannosidase _RARE_
specificity _RARE_
of O
the O
cDNA O
construct O
was O
verified _RARE_
by O
the O
observation O
that O
all O
peptide O
sequences O
derived O
from O
a O
previously O
purified _RARE_
, O
catalytically O
active _RARE_
49 _RARE_
- O
kDa O
fragment O
were O
found O
within O
the O
coding O
region O
. O

A O
soluble _RARE_
62 _RARE_
- O
kDa O
protein O
was O
produced O
without O
the O
proteolytic _RARE_
processing _RARE_
by O
inserting O
the O
coding O
sequence O
of O
amino O
acids _RARE_
112 O
to O
660 _RARE_
of O
ORF O
- O
2 O
in O
a O
baculovirus _RARE_
expression _RARE_
vector O
and O
using O
the O
corresponding O
virus O
to O
infect _RARE_
Sf9 O
cells O
. O

The O
CPK I-GENE
- I-GENE
MB I-GENE
isoenzyme _RARE_
showed O
no _RARE_
percentage O
increase O
of O
total _RARE_
CPK I-GENE
higher _RARE_
than O
5 O
%, O
measured O
at _RARE_
6 O
, O
12 O
, O
and O
24 _RARE_
h O
after O
the O
shock O
, O
independent O
of O
the O
number O
of O
attempts O
of O
cardioversion _RARE_
. O

Serum O
and O
peritoneal O
dialysis O
fluid _RARE_
( O
PDF _RARE_
) O
were O
collected O
for _RARE_
assay O
throughout O
the O
course O
of O
the O
study O
and O
for _RARE_
5 O
days O
thereafter O
. O

Results O
support O
the O
hypothesis O
that O
endogenous I-GENE
corticotropin _RARE_
- I-GENE
releasing I-GENE
factor I-GENE
, O
perhaps O
acting O
at _RARE_
a O
peripheral O
binding O
site O
, O
suppresses O
the O
active _RARE_
behavioral O
response O
characteristic O
of O
pups _RARE_
during _RARE_
the O
early O
phase _RARE_
of O
isolation O
in O
novel O
surroundings _RARE_
. O

Liver O
regional O
blood _RARE_
volume O
( O
LRBV _RARE_
) O
is O
altered O
by O
several O
disease _RARE_
states O
and O
various O
drugs O
. O

The O
gray O
matter O
NAA _RARE_
/ O
mI _RARE_
ratio O
clearly O
separated O
the O
two O
groups O
. O

As O
with O
the O
murine I-GENE
and I-GENE
human I-GENE
mb _RARE_
- I-GENE
1 I-GENE
genes I-GENE
, O
the O
5 O
' O
region O
of O
the O
bovine I-GENE
mb _RARE_
- I-GENE
1 I-GENE
gene I-GENE
lacked O
a O
TATA O
box O
. O

Chloramphenicol _RARE_
acetyltransferase _RARE_
assays O
examining O
the O
ability O
of O
IE86 _RARE_
to O
repress O
activity O
from O
the O
HCMV _RARE_
major O
IE I-GENE
promoter I-GENE
or O
activate O
the O
HCMV _RARE_
early I-GENE
promoter I-GENE
for _RARE_
the O
2 O
. O
2 O
- O
kb O
class O
of O
RNAs O
demonstrated O
the O
functional _RARE_
integrity O
of O
the O
IE86 _RARE_
protein I-GENE
. O

ORF O
M1 _RARE_
has O
striking O
homology O
to O
poxvirus _RARE_
serpins _RARE_
, O
while O
ORF O
M11 _RARE_
encodes O
a O
potential _RARE_
homolog O
of O
Bcl I-GENE
- I-GENE
2 I-GENE
- I-GENE
like I-GENE
molecules I-GENE
encoded O
by O
other O
gammaherpesviruses _RARE_
( O
gene I-GENE
16 I-GENE
of O
HVS O
and O
KSHV _RARE_
and O
the O
BHRF1 _RARE_
gene I-GENE
of O
EBV _RARE_
). O

Transcription O
factor O
binding O
sites O
downstream _RARE_
of O
the O
human O
immunodeficiency O
virus O
type O
1 O
transcription O
start _RARE_
site O
are O
important O
for _RARE_
virus O
infectivity _RARE_
. O

Crystal _RARE_
structure _RARE_
of O
an O
oligomer _RARE_
of O
proteolytic _RARE_
zymogens _RARE_
: O
detailed O
conformational O
analysis O
of O
the O
bovine O
ternary _RARE_
complex O
and O
implications O
for _RARE_
their O
activation O
. O

Through _RARE_
transient O
transfection O
of O
NIH3T3 O
fibroblast O
cells O
and O
gel O
mobility O
shift O
assays O
, O
the O
functional _RARE_
binding O
site O
was O
localized O
to O
a O
short O
region O
(- _RARE_
318 _RARE_
to O
- O
303 _RARE_
bp O
from O
the O
transcription O
start _RARE_
site O
) O
which O
has O
a O
CTCCC _RARE_
sequence O
. O

We O
suppose _RARE_
that O
this O
injection O
speed _RARE_
( O
0 _RARE_
. O
1 O
- O
0 _RARE_
. O
2 O
ml O
. O
s O
- O
1 O
) O
is O
suitable O
for _RARE_
spinal _RARE_
anesthesia O
. O

Alternative O
splicing _RARE_
of O
ClC _RARE_
- I-GENE
6 I-GENE
( O
a O
member _RARE_
of O
the O
CIC _RARE_
chloride _RARE_
- I-GENE
channel _RARE_
family I-GENE
) O
transcripts O
generates O
three O
truncated O
isoforms O
one O
of O
which O
, O
ClC _RARE_
- I-GENE
6c _RARE_
, O
is O
kidney _RARE_
- O
specific O
. O

The O
current O
study O
demonstrates O
that O
T3 _RARE_
- O
activated O
transcription O
of O
the O
NADPH _RARE_
: I-GENE
cytochrome I-GENE
P450 I-GENE
oxidoreductase I-GENE
( O
P450R _RARE_
) O
gene O
is O
dependent O
on O
the O
thyroid O
hormonal O
status O
of O
the O
animal _RARE_
, O
with O
both O
transcriptional O
and O
post O
- O
transcriptional O
pathways O
being O
important O
in O
regulating _RARE_
the O
cellular O
P450R _RARE_
mRNA O
level O
. O

The O
behavior O
of O
different O
types _RARE_
of O
polytetrafluoroethylene _RARE_
( O
PTFE _RARE_
) O
prostheses _RARE_
in O
the O
reparative _RARE_
scarring _RARE_
process O
of O
abdominal O
wall _RARE_
defects O
. O

The O
control O
group O
revealed O
significantly O
higher _RARE_
levels O
of O
coagulation I-GENE
factors I-GENE
II I-GENE
, I-GENE
V I-GENE
and I-GENE
VIII I-GENE
, O
compared O
to O
the O
index O
group O
. O

The O
frequency O
of O
positive O
anti I-GENE
- I-GENE
GM1 _RARE_
antibody I-GENE
titers _RARE_
in O
the O
Guillain _RARE_
- O
Barre _RARE_
syndrome _RARE_
patients O
with O
PEN _RARE_
19 O
isolates O
was O
higher _RARE_
than O
that O
in O
the O
Guillain _RARE_
- O
Barre _RARE_
syndrome _RARE_
and O
Fisher _RARE_
' O
s O
syndrome _RARE_
patients O
without O
PEN _RARE_
19 O
isolates O
. O

Stereotactic _RARE_
radiofrequency _RARE_
lesioning _RARE_
of O
the O
hamartoma _RARE_
resulted O
in O
seizure O
remission O
without O
complications O
20 O
months O
after O
surgery O
. O

NF _RARE_
- I-GENE
kappa _RARE_
B I-GENE
/ O
Rel I-GENE
transcription O
factors O
participate O
in O
the O
activation O
of O
numerous O
genes O
involved O
in O
immune O
regulation _RARE_
/ O
inflammation O
including O
cytokines _RARE_
, O
cell O
surface O
receptors O
, O
adhesion O
molecules O
, O
and O
acute O
phase _RARE_
proteins O
. O

If O
E O
. O
coli O
is O
present O
in O
any O
source O
water O
sample O
, O
the O
borehole _RARE_
and O
any O
directly O
connected O
borehole _RARE_
should O
be O
embargoed _RARE_
. O

However O
, O
mean O
food O
intake O
in O
the O
40 O
% O
group O
was O
half _RARE_
that O
of O
the O
ACT _RARE_
group O
( O
p O
< O
0 _RARE_
. O
001 O
) O
and O
significantly O
less O
( O
p O
< O
0 _RARE_
. O
01 O
) O
than O
the O
SEP _RARE_
group O
, O
which O
consumed _RARE_
amounts O
equivalent O
to O
65 O
% O
of O
daily O
requirement O
. O

The O
following O
technique O
describes O
a O
modification O
to O
a O
bar _RARE_
superstructure _RARE_
that O
provided O
the O
advantages O
of O
convenience _RARE_
, O
security _RARE_
, O
and O
consistent O
positioning O
even O
though O
one O
implant O
was O
lost O
and O
the O
angulation _RARE_
of O
implants O
limited O
accuracy O
. O

In O
summary O
, O
DDC _RARE_
express O
receptors O
for _RARE_
a O
broad O
panel O
of O
cytokines _RARE_
, O
even O
receptors O
for _RARE_
cytokines _RARE_
whose O
effects O
on O
DC O
are O
still O
unknown O
( O
i O
. O
e _RARE_
. O

Its O
potential _RARE_
as _RARE_
a O
diagnostic O
tool O
for _RARE_
epidemiological O
surveillance _RARE_
was O
assessed O
in O
comparison O
with O
three O
other O
diagnostic O
tests O
: O
stool _RARE_
examination O
, O
ELISA O
with O
soluble _RARE_
egg _RARE_
antigen I-GENE
( O
SEA _RARE_
) O
and O
the O
circumoval _RARE_
precipitin _RARE_
test O
( O
COPT _RARE_
). O

We O
have O
separated O
a O
dermatan _RARE_
sulfate _RARE_
proteoglycan _RARE_
, O
epiphycan _RARE_
, O
from O
decorin _RARE_
and O
biglycan _RARE_
by O
using O
dissociative _RARE_
extraction O
of O
bovine O
fetal _RARE_
epiphyseal _RARE_
cartilage O
, O
followed O
by O
sequential O
ion O
- O
exchange O
, O
gel O
permeation _RARE_
, O
hydrophobic O
, O
and O
Zn2 _RARE_
+ O
chelate _RARE_
chromatographic O
steps O
. O

These O
analyses O
demonstrate O
that O
the O
dUTPase _RARE_
isoforms O
are O
encoded O
by O
the O
same O
gene O
with O
isoform O
- O
specific O
transcripts O
arising O
through O
the O
use O
of O
alternative _RARE_
5 O
' O
exons O
. O

The O
selective O
5 I-GENE
- I-GENE
HT3 I-GENE
receptor I-GENE
antagonists O
ramosetron _RARE_
( O
YM060 _RARE_
), _RARE_
YM114 _RARE_
( O
KAE _RARE_
- O
393 _RARE_
), _RARE_
granisetron _RARE_
and O
ondansetron _RARE_
, O
and O
the O
substituted O
benzamides _RARE_
( O
5 I-GENE
- I-GENE
HT4 _RARE_
receptor I-GENE
agonist O
/ O
5 I-GENE
- I-GENE
HT3 I-GENE
receptor I-GENE
antagonists O
) O
cisapride _RARE_
mosapride _RARE_
and O
SC O
- O
53116 _RARE_
dose O
- O
dependently O
enhanced _RARE_
gastric _RARE_
emptying O
in O
normal O
rats O
. O

Re O
- O
evaluation O
of O
the O
biopsy O
specimen _RARE_
from O
the O
right O
hip O
taken O
at _RARE_
the O
time O
of O
the O
initial O
operation O
showed O
areas O
of O
chondrosarcoma _RARE_
arising O
in O
the O
background O
of O
synovial O
chondromatosis _RARE_
. O

All O
corneal O
buttons _RARE_
were O
processed O
for _RARE_
histopathologic _RARE_
and O
electron O
microscopic O
studies O
. O

3600 _RARE_
- O
fold _RARE_
to O
apparent O
homogeneity _RARE_
with O
a O
41 _RARE_
% O
yield O
by O
affinity O
chromatography O
utilizing O
DNA O
- O
cellulose _RARE_
; O
the O
purity _RARE_
of O
the O
final O
preparation O
was O
assessed O
by O
SDS O
/ O
PAGE O
, O
lack O
of O
contamination O
by O
other O
nucleases _RARE_
and O
production O
of O
a O
monospecific _RARE_
antibody O
against O
the O
enzyme O
. O

Human I-GENE
thymine _RARE_
- I-GENE
DNA I-GENE
glycosylase I-GENE
maps O
at _RARE_
chromosome _RARE_
12q22 _RARE_
- O
q24 _RARE_
. O
1 O
: O
a O
region O
of O
high O
loss _RARE_
of O
heterozygosity O
in O
gastric _RARE_
cancer _RARE_
. O

FOG _RARE_
is O
coexpressed O
with O
GATA _RARE_
- I-GENE
1 I-GENE
during _RARE_
embryonic _RARE_
development O
and O
in O
erythroid _RARE_
and O
megakaryocytic _RARE_
cells O
. O

The O
mean O
times O
to O
detection O
of O
all O
mycobacteria O
with O
BACTEC _RARE_
9000 _RARE_
MB O
and O
BACTEC _RARE_
460 _RARE_
TB _RARE_
were O
similar O
( O
10 O
. O
3 O
and O
10 O
. O
0 _RARE_
days O
, O
respectively O
). O

Though _RARE_
the O
BACTEC _RARE_
9000 _RARE_
MB O
system _RARE_
is O
recommended O
for _RARE_
respiratory O
specimens O
, O
we O
demonstrated O
that O
it O
can O
be O
successfully O
used O
also O
for _RARE_
recovery O
of O
mycobacteria O
from O
clinical O
specimens O
from O
various O
extrapulmonary _RARE_
sites O
. O

We O
further O
found O
that O
KmMig1p _RARE_
is O
fully O
functional _RARE_
when O
expressed _RARE_
in O
S O
. O
cerevisiae O
. O

A O
pre O
- O
boutonniere _RARE_
deformity _RARE_
was O
simulated O
by O
dividing _RARE_
the O
central O
slip _RARE_
. O

Autoimmune _RARE_
neutropenia O
( O
AIN _RARE_
) O
is O
a O
frequent O
cause O
of O
chronic O
neutropenia O
especially O
in O
youngest _RARE_
children O
. O

With O
regard O
to O
the O
characteristic O
expression _RARE_
pattern O
of O
DJ _RARE_
protein I-GENE
and O
its O
conspicuous _RARE_
repeat O
units _RARE_
possible O
functional _RARE_
roles O
are O
discussed O
. O

Future _RARE_
analysis O
of O
long O
- O
term O
outcome O
measures O
of O
performance O
with O
the O
implant O
will O
confirm O
or O
dispute _RARE_
the O
benefit O
of O
ear O
selection O
using O
the O
Prom _RARE_
- O
EABR _RARE_
. O

This O
protein O
, O
designated O
p532 _RARE_
based O
on O
its O
predicted O
molecular _RARE_
weight _RARE_
( O
EMBO _RARE_
J _RARE_
15 _RARE_
: O
5738 _RARE_
, O
1996 O
), _RARE_
contains O
multiple O
structural O
domains O
including O
two O
regions O
of O
seven _RARE_
internal O
repeats O
highly O
related O
to O
the O
cell O
cycle _RARE_
regulator O
RCC1 _RARE_
, O
a O
guanine I-GENE
nucleotide I-GENE
exchange I-GENE
factor I-GENE
for _RARE_
the O
small I-GENE
GTP I-GENE
- I-GENE
binding I-GENE
protein I-GENE
Ran I-GENE
, O
seven _RARE_
beta O
- O
repeat O
domains O
characteristic O
of O
the O
beta O
subunit O
of O
heterotrimeric I-GENE
G I-GENE
proteins I-GENE
, O
three O
putative O
SH3 I-GENE
binding I-GENE
sites I-GENE
, O
a O
putative O
leucine O
- O
zipper O
and O
a O
carboxy _RARE_
- I-GENE
terminal I-GENE
HECT _RARE_
domain I-GENE
characteristic O
of O
E3 _RARE_
ubiquitin I-GENE
- I-GENE
protein I-GENE
ligases _RARE_
. O

Thus O
, O
the O
L45 _RARE_
sequence O
between O
kinase O
subdomains O
IV O
and O
V O
specifies O
TGF I-GENE
- I-GENE
beta I-GENE
responsiveness O
of O
the O
type I-GENE
I I-GENE
receptor I-GENE
. O

The O
two O
mouse O
lines O
carrying O
the O
unfragmented _RARE_
Hnf3g _RARE_
- O
lacZ I-GENE
YAC O
showed O
tissue O
- O
specific O
, O
copy O
number O
- O
dependent O
and O
position O
- O
independent O
expression _RARE_
, O
proving _RARE_
that O
170 _RARE_
kb O
of O
the O
Hnf3g _RARE_
locus O
contain O
all O
elements O
important O
in O
the O
regulation _RARE_
of O
Hnf3g _RARE_
. O

Second O
, O
plasmid _RARE_
- O
derived O
transgenes _RARE_
and O
gene O
targeting O
of O
the O
endogenous I-GENE
Hnf3g _RARE_
gene I-GENE
locus I-GENE
were O
used O
to O
demonstrate O
that O
the O
3 O
'- O
flanking O
region O
of O
the O
gene O
is O
necessary O
and O
sufficient O
to O
direct O
reporter O
gene O
expression _RARE_
in O
liver O
, O
pancreas O
, O
stomach O
and O
small O
intestine O
. O

This O
regulation _RARE_
requires O
two O
HMG I-GENE
- I-GENE
box I-GENE
proteins I-GENE
: O
the O
ubiquitous O
Ste11 _RARE_
transcription I-GENE
factor I-GENE
and O
the O
M O
cell O
- O
controlling O
protein O
Mat1 _RARE_
- I-GENE
Mc _RARE_
. O

Here O
we O
have O
tested O
the O
hypothesis O
that O
the O
short O
transcripts O
, O
or O
proteins O
translated O
from O
the O
short O
transcripts O
, O
are O
also O
required O
for _RARE_
respiration O
. O

Upstream O
activating O
sequences O
( O
UASs _RARE_
) O
derived O
from O
known O
Ste12p _RARE_
- O
dependent O
genes O
have O
previously O
been O
characterized O
to O
require O
either O
multiple O
PREs _RARE_
or O
a O
single O
PRE _RARE_
coupled O
to O
a O
binding O
site O
for _RARE_
a O
second O
protein O
. O

Prominent _RARE_
protein O
kinase O
cascades _RARE_
are O
those O
that O
activate O
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
( I-GENE
MAP I-GENE
) I-GENE
kinases I-GENE
. O

JNK I-GENE
is O
additionally O
regulated O
by O
the O
Ras I-GENE
- O
related O
G I-GENE
proteins I-GENE
Rac I-GENE
and O
Cdc42 I-GENE
. O

In O
this O
study O
, O
we O
tested O
this O
notion O
by O
using O
ligation O
- O
mediated _RARE_
PCR O
to O
assess O
the O
formation O
of O
recombination _RARE_
- I-GENE
activating I-GENE
gene I-GENE
( O
RAG _RARE_
)- O
dependent O
double O
- O
strand _RARE_
breaks _RARE_
( O
DSBs _RARE_
) O
at _RARE_
RSSs _RARE_
3 O
' O
of O
Ddelta3 _RARE_
and O
5 O
' O
of O
Jdelta1 _RARE_
. O

Recent O
studies O
have O
demonstrated O
that O
Cbl I-GENE
, O
the O
120 O
- O
kDa O
protein O
product O
of O
the O
c I-GENE
- I-GENE
cbl I-GENE
proto _RARE_
- I-GENE
oncogene I-GENE
, O
serves O
as _RARE_
a O
substrate O
of O
a O
number O
of O
receptor I-GENE
- I-GENE
coupled I-GENE
tyrosine I-GENE
kinases I-GENE
and O
forms O
complexes O
with O
SH3 I-GENE
and O
SH2 _RARE_
domain O
- O
containing O
proteins O
, O
pointing _RARE_
to O
its O
role O
in O
signal O
transduction _RARE_
. O

Although O
neither O
constitutively O
activated O
MEK I-GENE
( O
MEK I-GENE
- I-GENE
2E _RARE_
) O
nor O
v I-GENE
- I-GENE
Src I-GENE
was O
sufficient O
individually O
to O
differentiate O
the O
H19 _RARE_
- O
7 O
cells O
, O
coexpression O
of O
constitutively O
activated O
MEK I-GENE
and O
v I-GENE
- I-GENE
Src I-GENE
induced _RARE_
neurite _RARE_
outgrowth _RARE_
. O

This O
mechanism O
is O
in O
contrast O
to O
other O
cases O
of O
splicing _RARE_
regulation _RARE_
by O
PTB _RARE_
, O
in O
which O
the O
protein O
represses O
the O
splice _RARE_
site O
to O
which O
it O
binds O
. O

While O
important O
for _RARE_
ligand _RARE_
- O
dependent O
transactivation _RARE_
, O
this O
interaction O
surface O
is O
not O
directly O
involved O
in O
transrepression _RARE_
of O
AP I-GENE
- I-GENE
1 I-GENE
activity O
. O

Gal4 I-GENE
- O
Eed _RARE_
fusion O
protein O
represses O
transcription O
of O
a O
reporter O
gene O
driven _RARE_
by O
a O
promoter O
that O
contains O
Gal4 I-GENE
- I-GENE
binding I-GENE
DNA I-GENE
elements I-GENE
. O

In O
situ O
hybridization O
analysis O
in O
adult O
rat O
tissue O
reveals O
good O
correlation O
with O
this O
pattern O
and O
indicates O
that O
drm _RARE_
mRNA I-GENE
is O
most O
highly O
expressed _RARE_
in O
nondividing _RARE_
and O
terminally _RARE_
differentiated O
cells O
, O
such O
as _RARE_
neurons O
, O
type O
1 O
lung _RARE_
cells O
, O
and O
goblet _RARE_
cells O
. O

Neither O
of O
these O
proteins O
, O
individually O
or O
as _RARE_
a O
pair _RARE_
, O
can O
bind O
the O
alpha I-GENE
- I-GENE
globin I-GENE
3 I-GENE
' I-GENE
UTR I-GENE
unless O
they O
are O
complexed O
with O
the O
remaining O
non O
- O
poly _RARE_
( O
C O
) O
binding O
proteins O
of O
the O
alpha I-GENE
- I-GENE
complex I-GENE
. O

A O
2 O
years O
and O
9 O
months O
old O
female O
patient O
, O
with O
the O
diagnosis O
of O
Weaver _RARE_
syndrome _RARE_
is O
reported O
. O

Confirming _RARE_
measures O
made O
by O
nurses _RARE_
and O
additionally O
, O
ABPM _RARE_
for _RARE_
women O
, O
seem O
to O
lessen _RARE_
this O
effect O
. O

In O
a O
series O
of O
patients O
with O
neuroinfection _RARE_
, O
Lyme _RARE_
disease _RARE_
, O
Guillain _RARE_
Barre _RARE_
syndrome _RARE_
, O
demyelinization _RARE_
, O
partial O
or O
generalized O
, O
epilepsy O
, O
we O
have O
investigated O
antiphospholipid _RARE_
antibodies O
of O
IgG I-GENE
and O
IgM I-GENE
subtypes O
, O
together O
with O
anticoagulant _RARE_
factors O
, O
member _RARE_
of O
thrombocytes _RARE_
, O
sedimentation O
rate O
of O
erythrocytes _RARE_
. O

( O
1996a _RARE_
) O
Biochemistry _RARE_
35 _RARE_
, O
1589 _RARE_
- O
1598 _RARE_
]. O

Second O
, O
the O
membrane O
expression _RARE_
of O
alpha O
and O
beta O
subunits O
was O
mimicked O
by O
cholesterol O
and O
17 _RARE_
- O
ketocholesterol _RARE_
, O
both O
of O
which O
inhibit O
HMG I-GENE
- I-GENE
CoA I-GENE
reductase I-GENE
. O

Our O
results O
suggest O
that O
Lrp _RARE_
binds O
a O
central O
palindromic O
site O
, O
interacting _RARE_
predominantly O
with O
the O
major O
groove _RARE_
of O
its O
DNA O
target O
, O
and O
that O
additional O
dimers _RARE_
bind O
to O
flanking O
sites O
to O
form O
a O
nucleoprotein _RARE_
activation O
complex O
. O

Sustained _RARE_
activation O
of O
p21 I-GENE
expression _RARE_
is O
proposed O
to O
be O
a O
distinguishing _RARE_
feature O
of O
the O
activity O
of O
NGF _RARE_
that O
contributes O
to O
PC12 O
growth O
arrest O
during _RARE_
differentiation O

The O
remaining O
80 _RARE_
patients O
underwent O
recordings O
of O
ECG O
, O
beat _RARE_
- O
to O
- O
beat _RARE_
arterial O
oxygen O
saturation O
( O
SaO2 O
), _RARE_
and O
respiration O
during _RARE_
both O
spontaneous O
and O
controlled _RARE_
breathing O
. O

The O
mean O
total _RARE_
white _RARE_
cell O
count O
increased O
from O
a O
baseline O
of O
11 O
. O
3 O
x _RARE_
10 O
( O
9 O
)/ _RARE_
L O
( O
SD O
2 O
. O
3 O
) O
to O
16 O
. O
2 O
x _RARE_
10 O
( O
9 O
)/ _RARE_
L O
( O
SD O
4 O
. O
6 O
) O
on O
day O
1 O
, O
normalising _RARE_
thereafter O
. O

A O
prospective O
observational _RARE_
study O
was O
conducted O
to O
identify O
early O
indicators O
of O
acute O
dengue _RARE_
virus O
infection O
. O

In O
all O
experimental O
eyes O
, O
there O
was O
a O
marked O
reduction O
, O
but O
never O
a O
complete _RARE_
absence O
of O
adrenergic O
nerves O
in O
the O
iris _RARE_
. O

These O
lesions O
may O
be O
treated O
by O
propranolol O
or O
phentolamine _RARE_
. O

Furthermore O
, O
ICER _RARE_
negatively O
autoregulates _RARE_
the O
alternative _RARE_
promoter O
, O
thus O
generating O
a O
feedback _RARE_
loop O
. O

This O
night O
- O
day O
oscillation _RARE_
is O
driven _RARE_
by O
the O
endogenous O
clock _RARE_
( O
located _RARE_
in O
the O
suprachiasmatic _RARE_
nucleus O
, O
SCN _RARE_
). O

It O
is O
present O
in O
the O
nucleus O
of O
the O
cells O
in O
which O
it O
is O
expressed _RARE_
and O
can O
phosphorylate O
and O
activate O
the O
cyclic I-GENE
AMP I-GENE
response I-GENE
element I-GENE
binding I-GENE
proteins I-GENE
CREB I-GENE
and O
CREM _RARE_
tau _RARE_
in O
a O
manner O
analogous O
to O
protein I-GENE
kinase I-GENE
A I-GENE
. O

These O
cells O
fail O
to O
generate O
the O
signals O
to O
phosphorylate O
CREB I-GENE
and O
produce O
significantly O
less O
of O
the O
cytokine _RARE_
Interleukin I-GENE
- I-GENE
2 I-GENE
( O
IL _RARE_
- I-GENE
2 I-GENE
) O
in O
response O
to O
agents O
that O
either O
increase O
intracellular _RARE_
Ca2 _RARE_
+ O
and O
/ O
or O
activate O
protein I-GENE
kinase I-GENE
C I-GENE
. O

Both O
of O
these O
dogs O
had O
low O
serum O
IgG I-GENE
( O
3 O
. O
5 O
to O
7 O
. O
2 O
mg O
/ O
ml O
) O
and O
the O
second O
littermate _RARE_
also O
had O
reduced _RARE_
serum O
IgA I-GENE
(< O
0 _RARE_
. O
1 O
to O
0 _RARE_
. O
15 _RARE_
mg O
/ O
ml O
). O

CONCLUSIONS O
: O
Valproate _RARE_
appears O
to O
inhibit O
the O
glucuronidation _RARE_
of O
carbamazepine _RARE_
- O
10 O
, O
11 O
- O
trans _RARE_
- O
diol _RARE_
, O
and O
probably O
also O
inhibits O
the O
conversion O
of O
carbamazepine _RARE_
- O
10 O
, O
11 O
- O
epoxide _RARE_
to O
this O
trans _RARE_
- O
diol _RARE_
derivative _RARE_
, O
rather O
than O
simply _RARE_
inhibiting O
the O
latter O
reaction O
only O
. O

The O
Ogg1 _RARE_
protein I-GENE
efficiently O
cleaves _RARE_
a O
DNA O
duplex O
where O
a O
preformed _RARE_
AP I-GENE
site I-GENE
is O
placed O
opposite O
a O
cytosine O
( O
AP O
/ O
C O
). O

A O
consensus O
sequence O
indicates O
a O
highly O
conserved _RARE_
lysine _RARE_
residue _RARE_
, O
K120 _RARE_
of O
endonuclease I-GENE
III I-GENE
or O
K241 _RARE_
of O
Ogg1 _RARE_
, O
respectively O
. O

Overall O
, O
these O
findings O
demonstrate O
that O
mutations O
E768D _RARE_
and O
V804L _RARE_
are O
gain O
- O
of O
- O
function O
mutations O
that O
confer O
to O
the O
long I-GENE
RET I-GENE
isoform I-GENE
the O
capacity O
to O
exert O
a O
biological O
effect O
, O
although O
these O
mutations O
are O
more O
weakly O
activating O
than O
the O
MEN2A _RARE_
and O
MEN2B _RARE_
mutations O
. O

Volunteers _RARE_
were O
irradiated O
on O
their O
backs _RARE_
with O
suberythemal _RARE_
UV _RARE_
daily O
for _RARE_
5 O
d O
after O
application O
of O
the O
sunscreens _RARE_
and O
their O
base _RARE_
lotion _RARE_
to O
different O
sites O
. O

E2F I-GENE
is O
a O
heterodimeric _RARE_
complex O
consisting O
of O
E2F I-GENE
family I-GENE
members I-GENE
( I-GENE
1 I-GENE
- I-GENE
5 I-GENE
) I-GENE
and O
DP _RARE_
proteins O
( O
1 O
- O
3 O
). O

EBER1 _RARE_
mRNA I-GENE
, O
a O
consistent O
marker O
of O
viral O
latency _RARE_
, O
was O
positive O
in O
all O
PEL _RARE_
cases O
, O
although O
at _RARE_
lower O
levels O
than O
in O
the O
non O
- O
PEL _RARE_
controls O
due O
to O
EBER1 _RARE_
expression _RARE_
by O
only O
a O
variable _RARE_
subset O
of O
lymphoma O
cells O
. O

METHODS O
: O
Four O
hundred O
fifty _RARE_
patients O
with O
the O
diagnosis O
of O
squamous O
cell O
carcinoma O
of O
the O
oral O
cavity O
received O
their O
primary _RARE_
treatment O
at _RARE_
Roswell _RARE_
Park _RARE_
Cancer O
Center _RARE_
( O
RPCI _RARE_
) O
from O
1971 _RARE_
to O
1991 O
. O

Therefore O
, O
use O
of O
presaturation _RARE_
is O
recommended O
for _RARE_
myocardial _RARE_
motion O
studies O
using O
cine _RARE_
PC O
velocity O
data O
. O

In O
addition O
, O
the O
DNA O
- O
binding O
experiments O
show O
that O
either O
one O
of O
the O
two O
MADS I-GENE
domains I-GENE
of O
a O
dimer _RARE_
can O
be O
sufficient O
to O
confer O
a O
particular O
DNA O
- O
binding O
specificity _RARE_
to O
the O
complex O
and O
that O
sequences O
outside O
the O
amino O
- O
terminal O
basic O
region O
of O
the O
MADS I-GENE
domain O
can O
, O
in O
some O
cases O
, O
contribute O
to O
the O
DNA O
- O
binding O
specificity _RARE_
of O
the O
proteins O
. O

PURPOSE O
/ O
OBJECTIVES O
: O
To O
examine O
the O
question O
of O
whether O
an O
early O
first _RARE_
full O
- O
term O
pregnancy _RARE_
( O
FFTP _RARE_
) O
protects _RARE_
against O
breast O
cancer _RARE_
and O
whether O
interruption _RARE_
of O
the O
pregnancy _RARE_
with O
an O
induced _RARE_
abortion O
increases O
breast O
cancer _RARE_
risk O
. O

Two O
related O
studies O
conducted O
over O
a O
five O
week O
period O
measured O
and O
typed _RARE_
HLA I-GENE
- I-GENE
DQA1 _RARE_
from O
accumulated O
DNA O
on O
autopsy O
room O
and O
Forensic _RARE_
DNA O
Laboratory O
structures _RARE_
. O

Thirty O
- O
two O
rats O
were O
divided O
into O
four O
groups O
. O

Mutagenesis _RARE_
of O
the O
pecT _RARE_
regulatory O
region O
revealed O
the O
presence O
of O
two O
sites O
in O
which O
insertions O
reproduced _RARE_
the O
pec _RARE_
- I-GENE
1 I-GENE
phenotype _RARE_
. O

BRCA1 I-GENE
, O
a O
familial O
breast O
and O
ovarian O
cancer _RARE_
susceptibility _RARE_
gene O
encodes O
nuclear O
phosphoproteins _RARE_
that O
function O
as _RARE_
tumor O
suppressors O
in O
human O
breast O
cancer _RARE_
cells O
. O

The O
alternative _RARE_
splice _RARE_
sites O
for _RARE_
the O
smallest O
adducin _RARE_
isoform O
, O
beta I-GENE
- I-GENE
3 I-GENE
, O
are O
alternative _RARE_
donor O
and O
acceptor _RARE_
sites O
within O
exons O
7 O
and O
12 O
. O

Proteinuria _RARE_
in O
a O
young O
man O
. O

Neural _RARE_
blockade O
in O
chronic O
and O
cancer _RARE_
pain O
. O

Two O
new O
temperature _RARE_
- O
sensitive _RARE_
alleles O
of O
SEC3 _RARE_
, O
1 O
of O
10 O
late _RARE_
- O
acting O
SEC _RARE_
genes I-GENE
required O
for _RARE_
targeting O
or O
fusion O
of O
post O
- O
Golgi _RARE_
secretory _RARE_
vesicles O
to O
the O
plasma O
membrane O
in O
Saccharomyces O
cerevisiae O
, O
were O
isolated O
in O
a O
screen O
for _RARE_
temperature _RARE_
- O
sensitive _RARE_
secretory _RARE_
mutants O
that O
are O
synthetically _RARE_
lethal O
with O
sec4 _RARE_
- I-GENE
8 I-GENE
. O

Five O
cell O
strains O
of O
human O
dermal O
fibroblasts _RARE_
were O
each O
treated O
with O
three O
samples O
of O
burn O
blister _RARE_
fluid _RARE_
and O
the O
effect O
compared O
with O
the O
rate O
of O
contraction O
of O
free O
floating _RARE_
fibroblast O
populated _RARE_
collagen _RARE_
lattices _RARE_
( O
FPCL _RARE_
). O

It O
is O
thus O
one O
of O
the O
key O
enzymes _RARE_
involved O
in O
the O
triiodothyronine _RARE_
- O
mediated _RARE_
control O
of O
growth O
, O
differentiation O
and O
basal O
metabolism O
in O
vertebrates _RARE_
. O

Cell O
49 _RARE_
, O
753 _RARE_
- O
761 _RARE_
]. O

Twenty O
- O
one O
ELISA O
- O
positive O
sera _RARE_
were O
tested O
and O
confirmed O
positive O
by O
plaque O
reduction O
neutralization _RARE_
testing O
. O

Patients O
received O
either O
diltiazem O
CD O
180 O
mg O
or O
placebo O
once O
/ O
day O
in O
combination O
with O
existing O
antianginal _RARE_
therapy O
. O

Reactive _RARE_
lymphoid _RARE_
hyperplasia O
was O
found O
in O
15 _RARE_
cases O
, O
2 O
cases O
had O
angiofollicular _RARE_
lymphoid _RARE_
hyperplasia O
or O
Castleman _RARE_
' O
s O
disease _RARE_
, O
atypical O
lymphoid _RARE_
hyperplasia O
suggestive O
of O
malignant O
lymphoma O
was O
observed O
in O
3 O
cases O
, O
and O
malignant O
lymphoma O
was O
diagnosed O
in O
the O
remaining O
4 O
cases O
. O

We O
had O
previously O
analyzed O
repair O
rates O
of O
cyclobutane _RARE_
pyrimidine O
dimers _RARE_
at _RARE_
nucleotide O
resolution O
along O
the O
human I-GENE
JUN _RARE_
gene I-GENE
in O
normal O
fibroblasts _RARE_
and O
found O
very O
efficient O
repair O
of O
sequences O
near O
the O
transcription O
initiation O
site O
but O
slow O
repair O
along O
the O
promoter O
. O

Tyrosine _RARE_
1356 _RARE_
forms O
a O
multisubstrate _RARE_
binding O
site O
for _RARE_
the O
Grb2 I-GENE
and O
Shc I-GENE
adaptor _RARE_
proteins I-GENE
, O
the O
p85 I-GENE
subunit I-GENE
of O
phosphatidylinositol _RARE_
3 I-GENE
'- I-GENE
kinase I-GENE
, O
phospholipase I-GENE
Cgamma _RARE_
, O
and O
a O
phosphatase O
, O
SHP2 _RARE_
. O

Then _RARE_
we O
correlated O
HRCT _RARE_
findings O
with O
the O
clinical O
features O
, O
pulmonary O
functions O
and O
methacholine _RARE_
PC20 _RARE_
( O
PC20M _RARE_
) O
and O
studied O
their O
clinical O
significance O
. O

Gtx _RARE_
mRNA I-GENE
accumulates O
in O
parallel O
with O
the O
RNAs O
encoding O
the O
major O
structural O
proteins O
of O
myelin _RARE_
, O
myelin _RARE_
basic I-GENE
protein I-GENE
( O
MBP I-GENE
), _RARE_
and O
proteolipid _RARE_
protein I-GENE
( O
PLP _RARE_
) O
during _RARE_
postnatal O
brain O
development O
; O
Gtx _RARE_
mRNA I-GENE
decreases O
in O
parallel O
with O
MBP I-GENE
and O
PLP _RARE_
mRNAs I-GENE
in O
the O
brains _RARE_
of O
myelin _RARE_
- O
deficient _RARE_
rats O
, O
which O
have O
a O
point O
mutation O
in O
the O
PLP _RARE_
gene I-GENE
. O

Contacts _RARE_
between O
Bacillus O
subtilis O
catabolite _RARE_
regulatory O
protein O
CcpA _RARE_
and O
amyO _RARE_
target O
site O
. O

They O
also O
interact O
with O
GTPase I-GENE
activating I-GENE
proteins I-GENE
encoded O
by O
IRA1 _RARE_
and O
IRA2 _RARE_
. O

For O
E2 O
, O
each O
cat _RARE_
was O
given O
either O
5 O
( O
group O
[ _RARE_
G O
] O
1 O
) O
or O
10 O
( O
G2 _RARE_
) O
mg O
of O
itraconazole _RARE_
/ O
kg O
( O
capsules O
) O
twice O
daily O
for _RARE_
6 O
weeks O
. O

RESULTS O
: O
For O
E1 O
, O
itraconazole _RARE_
plasma O
drug O
concentration O
extrapolated _RARE_
to O
time O
zero O
( O
IV O
dose O
) O
was O
5 O
. O
2 O
+/- O
1 O
. O
4 O
micrograms O
/ O
ml O
, O
and O
mean O
residence _RARE_
time O
( O
MRT _RARE_
) O
was O
37 O
+/- O
16 O
hours O
. O

The O
human O
U4 I-GENE
/ O
U6 I-GENE
snRNP O
contains O
60 _RARE_
and O
90kD _RARE_
proteins O
that O
are O
structurally O
homologous O
to O
the O
yeast O
splicing _RARE_
factors O
Prp4p _RARE_
and O
Prp3p _RARE_
. O

G I-GENE
- I-GENE
CSF I-GENE
was O
started O
on O
day O
3 O
of O
each O
cycle _RARE_
( O
5 O
microg O
/ O
kg O
/ O
day O
) O
and O
was O
stopped O
the O
day O
before O
the O
last O
apheresis _RARE_
or O
when O
absolute O
neutrophil _RARE_
count O
was O
above O
0 _RARE_
. O
5 O
x _RARE_
10 O
( O
9 O
)/ _RARE_
l _RARE_
. O

The O
used O
expression _RARE_
system _RARE_
could O
allow O
to O
produce O
mutated _RARE_
forms O
of O
SsEF _RARE_
- I-GENE
2 I-GENE
obtained O
by O
mutagenesis O
of O
the O
corresponding O
gene O
. O

Crosstalk _RARE_
among O
the O
pathways O
may O
explain O
how O
some O
forms O
of O
stress O
can O
contribute O
to O
the O
development O
of O
a O
malignancy O
. O

Supershift _RARE_
assays O
, O
using O
Jun I-GENE
and I-GENE
Fos I-GENE
family I-GENE
member _RARE_
- I-GENE
specific I-GENE
antibodies I-GENE
, O
showed O
that O
protein O
complexes O
formed O
by O
AtT _RARE_
- O
20 O
cell O
nuclear O
extracts O
bound _RARE_
to O
the O
c I-GENE
- I-GENE
jun I-GENE
AP I-GENE
- I-GENE
1 I-GENE
site I-GENE
were O
comprised O
of O
Jun I-GENE
family O
members O
, O
JunD _RARE_
, O
JunB _RARE_
, O
and O
cJun _RARE_
. O

The O
majority O
of O
PI I-GENE
kinase I-GENE
activity O
appeared O
to O
be O
cbl I-GENE
- O
associated O
after O
PRL I-GENE
stimulation _RARE_
. O

Mutation O
of O
Enh4 _RARE_
, O
an O
essential O
GT _RARE_
- I-GENE
IIC _RARE_
- I-GENE
like I-GENE
enhanson _RARE_
in O
the O
context O
of O
the O
intact _RARE_
enhancer O
, O
abolishes O
silencer _RARE_
activity O
, O
and O
multimerized _RARE_
GT _RARE_
- I-GENE
IIC _RARE_
enhansons _RARE_
mimic O
the O
intact _RARE_
CSEn _RARE_
enhancer I-GENE
/ I-GENE
silencer _RARE_
activities O
in O
BeWo _RARE_
and O
GC _RARE_
cells O
, O
respectively O
. O

Using O
lectin _RARE_
- O
affinity O
chromatography O
, O
discordance _RARE_
between O
the O
pattern O
of O
O O
- O
glycosylation O
of O
SSBP _RARE_
and O
DSBP _RARE_
was O
demonstrated O
. O

Deletion O
mapping O
experiments O
determined O
that O
the O
sequences O
required O
for _RARE_
full O
activity O
in O
MSC _RARE_
- O
1 O
cells O
were O
included O
within O
619 _RARE_
bp O
of O
the O
start _RARE_
site O
and O
identified O
several O
regions O
that O
demonstrated O
increased O
luciferase I-GENE
activity O
: O
the O
- O
583 _RARE_
bp O
to O
- O
564 _RARE_
bp O
, O
- O
503 _RARE_
bp O
to O
- O
484 _RARE_
bp O
, O
and O
- O
114 _RARE_
bp O
to O
- O
65 O
regions O
. O

Furthermore O
, O
the O
PH _RARE_
and O
PTB _RARE_
domains O
are O
highly O
homologous O
( O
at _RARE_
least O
40 O
% O
identical O
) O
to O
those O
found O
in O
insulin I-GENE
receptor I-GENE
substrates _RARE_
1 I-GENE
, I-GENE
2 I-GENE
, I-GENE
and I-GENE
3 I-GENE
( O
IRS I-GENE
- I-GENE
1 I-GENE
, O
IRS I-GENE
- I-GENE
2 I-GENE
, O
and O
IRS I-GENE
- I-GENE
3 I-GENE
). O

The O
mouse O
extracellular I-GENE
signal I-GENE
- I-GENE
regulated I-GENE
kinase I-GENE
2 I-GENE
gene I-GENE
. O

As O
demonstrated O
by O
gel O
mobility O
shift O
analysis O
and O
supershift O
experiments O
, O
FIRE1 _RARE_
, O
located _RARE_
between O
- O
516 _RARE_
and O
- O
498 _RARE_
, O
is O
responsible O
for _RARE_
binding O
NF _RARE_
- I-GENE
Y I-GENE
. O

MR O
imaging O
of O
traumatic _RARE_
head O
injuries O
using O
FLAIR _RARE_
technique O

Gag I-GENE
protein O
sequence O
motifs O
of O
the O
NC _RARE_
domain I-GENE
of O
primate O
foamy _RARE_
viruses O
assumed O
to O
be O
involved O
in O
genome O
encapsidation _RARE_
are O
not O
conserved _RARE_
in O
FeFV _RARE_
. O

Induction O
of O
B O
cell O
apoptosis O
by O
co _RARE_
- O
cross O
- O
linking O
CD23 I-GENE
and O
sIg _RARE_
involves O
aberrant O
regulation _RARE_
of O
c I-GENE
- I-GENE
myc I-GENE
and O
is O
inhibited O
by O
bcl I-GENE
- I-GENE
2 I-GENE
. O

MEASUREMENTS _RARE_
AND _RARE_
MAIN O
RESULTS O
: O
Lung O
elastance _RARE_
( O
EL _RARE_
) O
and O
resistance O
( O
RL _RARE_
) O
were O
calculated O
from O
measurements O
of O
airway O
pressure O
, O
esophageal O
pressure O
, O
and O
airway O
flow O
in O
five O
anesthetized O
, O
paralyzed _RARE_
dogs O
during _RARE_
sinusoidal _RARE_
forcing _RARE_
at _RARE_
a O
constant O
mean O
airway O
pressure O
of O
10 O
cmH2O O
in O
a O
wide O
range O
of O
breathing O
frequencies O
( O
0 _RARE_
. O
2 O
to O
1 O
. O
0 _RARE_
Hz O
in O
intervals O
of O
0 _RARE_
. O
2 O
) O
and O
tidal O
volumes O
( O
50 O
, O
100 _RARE_
, O
200 _RARE_
, O
and O
to O
300 _RARE_
mL O
). O

Here O
, O
we O
report O
theoretical _RARE_
models O
for _RARE_
the O
Gla _RARE_
and O
EGF _RARE_
- I-GENE
1 I-GENE
modules _RARE_
of O
human I-GENE
PS _RARE_
constructed O
using O
prothrombin I-GENE
and O
factor I-GENE
X I-GENE
experimental O
structures _RARE_
. O

The O
Cut9 _RARE_
subunit I-GENE
is O
likely O
to O
be O
a O
target O
for _RARE_
regulating _RARE_
APC _RARE_
/ I-GENE
cyclosome _RARE_
function O
through O
protein O
- O
protein O
interactions O
and O
phosphorylation _RARE_
. O

The O
dose O
was O
50 O
Gy O
/ O
20 O
fractions O
/ O
5 O
weeks O
. O

Because O
the O
biosynthetic O
pathway _RARE_
to O
the O
vacuole _RARE_
intersects _RARE_
with O
the O
endocytic O
pathway _RARE_
, O
internalization O
of O
a O
bulk O
membrane O
endocytic O
marker O
FM _RARE_
4 O
- O
64 _RARE_
was O
assayed O
in O
the O
sop _RARE_
mutants I-GENE
. O

All O
the O
women O
received O
13 _RARE_
. O
5 O
mg O
plain _RARE_
bupivacaine _RARE_
via O
subarachnoid _RARE_
injection O
at _RARE_
the O
L2 O
- O
3 O
interspace _RARE_
. O

Far _RARE_
from O
this O
being O
the O
case O
, O
however O
, O
the O
measurement O
of O
apo _RARE_
B I-GENE
has O
met O
every O
reasonable O
standard O
of O
laboratory O
precision _RARE_
and O
reliability O
to O
allow O
its O
widespread _RARE_
introduction O
in O
clinical O
laboratories O
. O

Two O
soybean _RARE_
cDNA O
clones _RARE_
, O
SPK _RARE_
- I-GENE
3 I-GENE
and O
SPK _RARE_
- I-GENE
4 I-GENE
, O
encoding O
putative O
protein O
kinases O
were O
isolated O
and O
characterized O
. O

Genes _RARE_
belonging O
to O
the O
ras I-GENE
superfamily I-GENE
encode O
low I-GENE
- I-GENE
molecular _RARE_
- I-GENE
weight _RARE_
GTP I-GENE
/ I-GENE
GDP I-GENE
- I-GENE
binding I-GENE
proteins I-GENE
that O
are O
highly O
conserved _RARE_
in O
wide O
variety O
of O
organisms O
. O

Naltrexone _RARE_
has O
been O
recently O
approved _RARE_
by O
the O
Food _RARE_
and O
Drug O
Administration O
for _RARE_
the O
treatment O
of O
alcohol _RARE_
dependence O
. O

Ent _RARE_
- I-GENE
kaurene _RARE_
synthase I-GENE
from I-GENE
the I-GENE
fungus _RARE_
Phaeosphaeria _RARE_
sp _RARE_
. O

In O
this O
report O
, O
we O
identify O
and O
characterize O
two O
overlapping O
ELL _RARE_
functional _RARE_
domains I-GENE
that O
govern O
its O
interaction O
with O
RNA I-GENE
polymerase I-GENE
II I-GENE
and O
the O
ternary _RARE_
elongation _RARE_
complex O
. O

Eight O
induced _RARE_
cDNA O
sequences O
were O
identified O
and O
designated O
message _RARE_
up _RARE_
- I-GENE
regulated I-GENE
during _RARE_
death _RARE_
( I-GENE
mud _RARE_
)- I-GENE
1 I-GENE
- I-GENE
8 I-GENE
. O

The O
position O
, O
transcription O
orientation O
, O
and O
imprinted O
status O
of O
the O
genes O
immediately O
flanking O
Igf2r _RARE_
have O
been O
assessed O
. O

Here O
, O
we O
describe O
directional _RARE_
chromosome _RARE_
walking _RARE_
studies O
starting O
from O
D8S260 _RARE_
as _RARE_
well _RARE_
as _RARE_
D8S285 _RARE_
. O

We O
describe O
a O
novel O
zinc I-GENE
finger I-GENE
protein I-GENE
, O
dsRBP _RARE_
- I-GENE
ZFa _RARE_
, O
isolated O
by O
screening O
an O
expression _RARE_
library O
with O
dsRNA _RARE_
. O

Our O
results O
indicate O
that O
the O
retroplasmid _RARE_
reverse I-GENE
transcriptase I-GENE
is O
uniquely _RARE_
adapted O
to O
initiate O
cDNA O
synthesis _RARE_
by O
recognizing _RARE_
a O
3 O
' O
CCA _RARE_
sequence O
. O

Nasal _RARE_
absorption O
was O
rapid O
, O
nasal O
bioavailability _RARE_
was O
43 _RARE_
%, O
and O
the O
iv O
and O
nasal O
elimination O
profiles O
were O
similar O
. O

Together O
, O
these O
results O
suggest O
that O
EGF _RARE_
/ O
Ras I-GENE
/ O
Raf I-GENE
induces O
transcription O
via O
combined O
activation O
of O
ATF3 _RARE_
/ O
c I-GENE
- I-GENE
Jun I-GENE
and O
a O
52 O
- O
kDa O
nuclear O
factor O
, O
whereas O
JunD _RARE_
acts O
as _RARE_
a O
repressor O
of O
this O
response O
. O

Together O
, O
these O
data O
support O
a O
model O
in O
which O
Tax _RARE_
anchors _RARE_
CBP I-GENE
to O
the O
HTLV _RARE_
- I-GENE
1 I-GENE
promoter I-GENE
, O
with O
strong O
transcriptional O
activation O
resulting O
from O
the O
CBP I-GENE
- O
associated O
activities O
of O
nucleosome _RARE_
remodeling O
and O
recruitment O
of O
the O
general _RARE_
transcription O
machinery O
. O

DNase I-GENE
I I-GENE
and O
1 O
, O
10 O
- O
phenanthroline _RARE_
- O
copper _RARE_
footprinting O
of O
MURA _RARE_
- O
Mu1 _RARE_
TIR _RARE_
complexes O
indicate O
that O
MURA _RARE_
binds O
to O
a O
conserved _RARE_
approximately _RARE_
32 _RARE_
- O
bp O
region O
in O
the O
TIR _RARE_
of O
Mu1 _RARE_
. O

Consistent O
with O
this O
model O
, O
a O
synthetic _RARE_
construct O
containing O
three O
tandem _RARE_
copies O
of O
the O
native _RARE_
LDL I-GENE
receptor I-GENE
SREBP I-GENE
site O
linked _RARE_
to O
a O
single O
Sp1 _RARE_
site I-GENE
was O
also O
significantly O
activated O
in O
a O
buttonhead _RARE_
- O
independent O
fashion O
. O

Various O
assays O
demonstrate O
promoter O
activity O
in O
this O
sequence O
that O
reproduces _RARE_
the O
normal O
control O
of O
E2F2 _RARE_
expression _RARE_
during _RARE_
a O
growth O
stimulation _RARE_
. O

In O
the O
adult O
mouse O
, O
ERR _RARE_
alpha I-GENE
is O
most O
highly O
expressed _RARE_
in O
kidney _RARE_
, O
heart _RARE_
, O
and O
brown O
adipocytes O
, O
tissues O
which O
preferentially O
metabolize _RARE_
fatty O
acids _RARE_
. O

The O
MCAD _RARE_
nuclear I-GENE
receptor I-GENE
response I-GENE
element I-GENE
1 I-GENE
( O
NRRE _RARE_
- I-GENE
1 I-GENE
) O
interacts O
in O
vitro O
with O
ERR _RARE_
alpha I-GENE
expressed _RARE_
in O
COS O
- O
7 O
cells O
. O

Mapping O
features O
of O
HIV I-GENE
- I-GENE
1 I-GENE
integrase I-GENE
near O
selected _RARE_
sites O
on O
viral O
and O
target O
DNA O
molecules O
in O
an O
active _RARE_
enzyme O
- O
DNA O
complex O
by O
photo _RARE_
- O
cross O
- O
linking O
. O

Analysis O
of O
the O
5 O
' O
flanking O
region O
of O
the O
gene O
also O
revealed O
the O
presence O
of O
multiple O
TATA O
and O
CAAT O
sequences O
. O

Analysis O
of O
the O
5 O
' O
flanking O
region O
of O
the O
gene O
also O
revealed O
the O
presence O
of O
multiple O
TATA O
and O
CAAT O
sequences O
. O

The O
complete _RARE_
response O
( O
CR _RARE_
) O
rate O
was O
34 _RARE_
% O
in O
the O
CODE _RARE_
with O
rhG _RARE_
- I-GENE
CSF I-GENE
group O
and O
23 _RARE_
% O
in O
the O
CODE _RARE_
alone O
group O
; O
the O
median O
survival O
was O
59 _RARE_
and O
32 _RARE_
weeks O
, O
respectively O
, O
in O
these O
groups O
( O
P O
= O
0 _RARE_
. O
004 _RARE_
). O

Heterogeneous _RARE_
nuclear I-GENE
ribonucleoprotein I-GENE
A1 _RARE_
binds O
to O
the O
transcription O
- O
regulatory O
region O
of O
mouse O
hepatitis O
virus O
RNA O
. O

The O
m7GpppN _RARE_
cap _RARE_
structure _RARE_
of O
eukaryotic O
mRNA O
is O
formed O
cotranscriptionally _RARE_
by O
the O
sequential O
action O
of O
three O
enzymes _RARE_
: O
RNA I-GENE
triphosphatase _RARE_
, O
RNA I-GENE
guanylyltransferase _RARE_
, O
and O
RNA I-GENE
( I-GENE
guanine I-GENE
- I-GENE
7 I-GENE
)- I-GENE
methyltransferase _RARE_
. O

In O
the O
first _RARE_
part O
of O
our O
study O
, O
the O
highest O
mutagenicity _RARE_
was O
revealed O
by O
TA98 _RARE_
strain _RARE_
without O
enzymatic O
activation O
, O
suggesting O
a O
direct O
- O
acting O
mutagenicity _RARE_
prevalence O
in O
diesel _RARE_
particulate O
. O

The O
addition O
of O
culture O
to O
the O
CC _RARE_
and O
CC _RARE_
: O
SW _RARE_
by O
- O
products O
resulted O
in O
pH O
values O
lower O
( O
P O
< O
0 _RARE_
. O
05 O
) O
than O
those O
without O
culture O
on O
Day O
21 O
, O
and O
the O
15 _RARE_
% O
carbohydrate O
treatment O
significantly O
reduced _RARE_
pH O
beyond O
the O
5 O
% O
carbohydrate O
. O

Myocardial O
interstitial O
edema O
is O
more O
likely O
a O
potential _RARE_
mechanism O
of O
diastolic O
dysfunction O
after O
DC O
shocks _RARE_
. O

Two O
experiments O
( O
N O
= O
20 O
each O
) O
were O
carried O
out O
to O
explore O
the O
nature O
of O
ERP _RARE_
negativities _RARE_
in O
a O
visuospatial _RARE_
memory O
task O
and O
in O
an O
auditory O
spatial O
memory O
task O
, O
respectively O
. O

Biol O
. O

The O
pattern O
and O
timing O
of O
CARP _RARE_
mRNA I-GENE
expression _RARE_
, O
including O
transient O
expression _RARE_
in O
the O
tongue _RARE_
at _RARE_
14 O
. O
5 O
days O
p O
. O
c O
., O
coincides _RARE_
with O
that O
of O
Nkx2 _RARE_
. I-GENE
5 I-GENE
/ O
Csx _RARE_
( O
a O
putative O
homolog O
of O
tinman _RARE_
, O
the O
Drosophila O
melanogaster O
gene O
responsible O
for _RARE_
cardiac O
development O
). O

Overexpression O
of O
CARP _RARE_
in O
cardiomyocytes _RARE_
suppresses O
cardiac I-GENE
troponin _RARE_
C I-GENE
and O
atrial _RARE_
natriuretic _RARE_
factor I-GENE
transcription O
. O

Substrate _RARE_
specificity _RARE_
of O
the O
RNase I-GENE
activity O
of O
yeast I-GENE
RNA I-GENE
polymerase I-GENE
III I-GENE
. O

Electrophoretic O
mobility O
shift O
assays O
and O
competition O
experiments O
showed O
that O
site O
A O
is O
recognized _RARE_
by O
an O
NF1 I-GENE
protein I-GENE
. O

Examination O
of O
the O
MMP _RARE_
- I-GENE
2 I-GENE
RE1 _RARE_
sequence I-GENE
revealed O
an O
incomplete O
Y O
- O
box O
sequence O
( O
CTGCTGGGCAAG _RARE_
), _RARE_
which O
specifically O
interacted O
with O
recombinant I-GENE
YB _RARE_
- I-GENE
1 I-GENE
on O
DMS _RARE_
protection O
footprinting O
analysis O
. O

Hence O
, O
scs32 _RARE_
only O
partially O
suppressed O
the O
ts _RARE_
phenotype _RARE_
and O
was O
unable O
to O
suppress O
the O
Ino _RARE_
- O
phenotype _RARE_
of O
rpo26 _RARE_
- I-GENE
31 _RARE_
. O

In O
contrast O
, O
both O
Sp1 _RARE_
and O
ETS _RARE_
proteins I-GENE
are O
required O
to O
bring _RARE_
about O
full O
promoter O
activity O
in O
the O
Surf I-GENE
- I-GENE
1 I-GENE
direction O
. O

CONCLUSION O
: O
Patients O
wit _RARE_
clinically O
palpable _RARE_
neck O
disease _RARE_
( O
N1 _RARE_
- O
3 O
), _RARE_
histological O
evidence O
of O
metastatic O
nodal O
disease _RARE_
, O
extracapsular _RARE_
spread O
, O
and O
three O
or O
more O
positive O
lymph O
nodes O
are O
at _RARE_
greater O
risk O
of O
developing O
failure O
at _RARE_
distant O
sites O
. O

We O
have O
subcloned O
into O
pBR322 _RARE_
deoxyribonucleic _RARE_
acid O
( O
DNA O
) O
sequences O
mapping O
either O
in O
the O
coding O
region O
, O
the O
5 O
' O
spacer O
, O
or O
the O
3 O
' O
spacer O
of O
the O
H2B _RARE_
histone I-GENE
gene I-GENE
. O

4 O
. O

Area _RARE_
under O
the O
drug O
concentration O
- O
time O
curves O
( O
AUC0 _RARE_
- O
24 _RARE_
hr O
) O
for _RARE_
MTX _RARE_
were O
2379 _RARE_
and O
3534 _RARE_
ng _RARE_
* _RARE_
hr O
/ O
ml O
from O
PG _RARE_
- O
2 O
. O
5 O
% O
Azone _RARE_
and O
PG _RARE_
- O
7 O
. O
5 O
% O
Azone _RARE_
systems _RARE_
respectively O
. O

The O
combination O
of O
hydralazine _RARE_
hydrochloride _RARE_
and O
isosorbide _RARE_
dinitrate _RARE_
also O
improves _RARE_
survival O
, O
but O
direct O
comparison O
of O
both O
regimens O
provided O
evidence O
for _RARE_
a O
less O
favourable O
effect O
than O
that O
of O
the O
ACE I-GENE
inhibitors _RARE_
. O

To O
address O
mechanisms O
that O
define O
interactions O
of O
Site _RARE_
II I-GENE
regulatory I-GENE
factors I-GENE
with O
this O
cell O
cycle _RARE_
control O
element O
, O
we O
have O
investigated O
these O
determinants _RARE_
of O
transcriptional O
regulation _RARE_
at _RARE_
the O
G1 O
/ O
S O
phase _RARE_
transition O
in O
FDC _RARE_
- O
P1 O
hematopoietic O
progenitor _RARE_
cells O
. O

The O
goal O
of O
this O
study O
was O
to O
identify O
neuronal _RARE_
cell O
cultures O
that O
express O
RC3 _RARE_
/ O
neurogranin _RARE_
, O
to O
check _RARE_
whether O
they O
are O
sensitive _RARE_
to O
T3 _RARE_
, O
and O
to O
examine O
the O
mechanism O
of O
regulation _RARE_
. O

There O
were O
differences O
between O
males O
( O
p O
< O
0 _RARE_
. O
05 O
) O
for _RARE_
most O
of O
the O
characteristics O
studied O
. O

Their O
circadian O
responses O
to O
both O
photic _RARE_
and O
non O
- O
photic _RARE_
cues _RARE_
were O
then O
tested O
. O

Although O
previous O
data O
have O
suggested O
that O
Rev _RARE_
uses O
the O
same O
export O
pathway _RARE_
as _RARE_
uracil _RARE_
- O
rich O
small O
nuclear O
RNAs O
and O
5S I-GENE
ribosomal I-GENE
RNA I-GENE
, O
the O
CTE _RARE_
seems O
to O
interact O
with O
evolutionarily O
conserved _RARE_
factors O
that O
are O
essential O
for _RARE_
cellular O
mRNA O
export O
. O

Human I-GENE
Duo _RARE_
contains O
a O
guanine I-GENE
nucleotide I-GENE
exchange I-GENE
factor I-GENE
( O
GEF _RARE_
) O
domain O
that O
is O
likely O
to O
be O
rac1 _RARE_
- O
specific O
, O
a O
pleckstrin I-GENE
homology I-GENE
( O
PH _RARE_
) O
domain O
and O
spectrin I-GENE
- I-GENE
like I-GENE
repeat I-GENE
units _RARE_
. O

S2F _RARE_
, O
a O
leaf O
- O
specific O
trans _RARE_
- O
acting O
factor O
, O
binds O
to O
a O
novel O
cis O
- O
acting O
element O
and O
differentially O
activates O
the O
RPL21 _RARE_
gene I-GENE
. O

ArgR _RARE_
was O
shown O
to O
be O
a O
dimer _RARE_
of O
two O
equal O
subunits O
, O
each O
with O
a O
molecular _RARE_
mass O
of O
37 O
, O
000 _RARE_
Da _RARE_
. O

Plasma I-GENE
leptin I-GENE
concentrations O
were O
higher _RARE_
in O
women O
than O
men O
, O
even O
after O
the O
adjustment O
for _RARE_
differences O
in O
fat O
mass O
( O
28 _RARE_
+/- O
3 O
ng _RARE_
/ O
ml O
for _RARE_
women O
vs _RARE_
. O

Consistent O
with O
effects O
on O
STAT I-GENE
activation O
, O
altered O
SHP I-GENE
- I-GENE
1 I-GENE
expression _RARE_
also O
affected O
EGF _RARE_
- O
induced _RARE_
activation O
of O
the O
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
pathway _RARE_
; O
expression _RARE_
of O
SHP I-GENE
- I-GENE
1 I-GENE
-( _RARE_
Cys _RARE_
--> _RARE_
Ser _RARE_
) I-GENE
inhibited O
activity O
of O
MEK I-GENE
by O
approximately _RARE_
25 _RARE_
%, O
whereas O
expression _RARE_
of O
SHP I-GENE
- I-GENE
1 I-GENE
resulted O
in O
a O
approximately _RARE_
25 _RARE_
% O
increase O
. O

This O
interaction O
involved O
the O
SH3 I-GENE
region I-GENE
of O
p50 _RARE_
( O
csk _RARE_
) O
and O
a O
proline O
- O
rich O
region O
( O
PPPLPERTPESFVLADM _RARE_
) O
outside O
the O
catalytic O
region O
of O
PTP I-GENE
- O
PEST _RARE_
. O

Following O
2 O
. O
5 O
Gy O
, O
HbO2 _RARE_
changes O
were O
minimal O
. O

Polarised _RARE_
expression _RARE_
of O
human O
intestinal _RARE_
N I-GENE
- I-GENE
benzoyl _RARE_
- I-GENE
L I-GENE
- I-GENE
tyrosyl _RARE_
- I-GENE
p I-GENE
- I-GENE
aminobenzoic _RARE_
acid I-GENE
hydrolase _RARE_
( O
human I-GENE
meprin _RARE_
) O
alpha O
and O
beta O
subunits O
in O
Madin _RARE_
- O
Darby _RARE_
canine O
kidney _RARE_
cells O
. O

Neither O
mutant O
exhibited O
derepression O
of O
the O
silent _RARE_
mating _RARE_
type I-GENE
loci I-GENE
. O

Among O
38 O
patients O
with O
inducible O
reentrant _RARE_
VTs _RARE_
who O
underwent O
electrophysiologic _RARE_
study O
( O
EPS _RARE_
), _RARE_
10 O
VTs _RARE_
of O
six _RARE_
patients O
were O
selected _RARE_
. O

The O
cycle _RARE_
length O
of O
induced _RARE_
VT O
( O
n _RARE_
= O
10 O
VTs _RARE_
) O
was O
380 _RARE_
+/- O
41 _RARE_
msec O
. O

Transient O
hyperammonaemia _RARE_
in O
an O
adult O
German _RARE_
shepherd _RARE_
dog O
. O

We O
established O
that O
the O
2 O
. O
6 O
kb O
mRNA O
V O
- O
1 O
and O
the O
2 O
. O
3 O
kb O
GGT _RARE_
mRNA O
V O
- O
2 O
derive _RARE_
, O
by O
alternate O
splicing _RARE_
, O
from O
a O
primary _RARE_
transcript O
initiated _RARE_
on O
a O
distal O
promoter O
on O
the O
rat I-GENE
GGT _RARE_
gene I-GENE
. O

A O
specific O
distal O
promoter O
controls O
gamma I-GENE
- I-GENE
glutamyl I-GENE
transpeptidase _RARE_
gene I-GENE
expression _RARE_
in O
undifferentiated O
rat O
transformed O
liver O
cells O
. O

These O
repressor O
sites O
are O
pyrimidine O
rich O
and O
bind O
avidly _RARE_
to O
the O
polypyrimidine _RARE_
tract _RARE_
binding I-GENE
protein I-GENE
( O
PTB _RARE_
) O
in O
HeLa O
nuclear O
extracts O
as _RARE_
determined O
by O
UV _RARE_
crosslinking _RARE_
/ O
competition O
assays O
. O

For O
higher _RARE_
expression _RARE_
of O
lipA _RARE_
in O
S O
. O
lividans _RARE_
, O
the O
gene O
was O
cloned _RARE_
next O
to O
the O
strong O
aphII _RARE_
promoter I-GENE
. O

Within O
a O
135 O
- O
bp O
core O
homology O
region O
, O
the O
human I-GENE
HS12 _RARE_
enhancers _RARE_
are O
approximately _RARE_
90 _RARE_
% O
identical O
to O
the O
murine O
homolog O
and O
include O
several O
motifs O
previously O
demonstrated O
to O
be O
important O
for _RARE_
function O
of O
the O
murine O
enhancer O
; O
additional O
segments _RARE_
of O
high O
sequence O
conservation O
suggest O
the O
possibility O
of O
previously O
unrecognized _RARE_
functional _RARE_
motifs O
. O

In O
contrast O
to O
the O
wild O
- O
type O
protein O
, O
expression _RARE_
of O
p45 _RARE_
NF _RARE_
- I-GENE
E2 I-GENE
lacking _RARE_
this O
activation O
domain O
in O
an O
NF _RARE_
- I-GENE
E2 I-GENE
null _RARE_
cell O
line O
fails O
to O
support O
enhancer O
- O
dependent O
transcription O
in O
transient O
assays O
. O

These O
findings O
suggest O
one O
potential _RARE_
mechanism O
for _RARE_
direct O
recruitment O
of O
distal O
regulatory O
regions O
of O
the O
globin I-GENE
loci I-GENE
to O
the O
individual O
promoters O
. O

The O
promoter O
region O
showed O
no _RARE_
consensus O
TATA O
box O
but O
it O
contains O
CCAAT O
and O
CreA _RARE_
boxes _RARE_
known O
to O
be O
involved O
in O
both O
stress O
and O
carbon O
- O
catabolite _RARE_
regulation _RARE_
of O
fungal _RARE_
promoters O
. O

The O
two O
cysteine O
residues O
located _RARE_
in O
this O
additional O
region O
may O
be O
involved O
in O
the O
formation O
of O
a O
disulfide O
bridge _RARE_
associated O
with O
the O
activation O
process O
of O
the O
catalytic O
activity O
. O

The O
por _RARE_
gene I-GENE
has O
been O
expressed _RARE_
, O
for _RARE_
the O
first _RARE_
time O
, O
in O
anaerobically _RARE_
grown O
Escherichia O
coli O
behind O
the O
isopropyl _RARE_
- O
beta O
- O
D O
- O
thiogalactopyranoside _RARE_
- O
inducible O
tac _RARE_
promoter I-GENE
, O
resulting O
in O
the O
production O
of O
POR _RARE_
in O
its O
active _RARE_
form O
. O

When O
the O
downstream _RARE_
operator O
was O
altered O
, O
there O
was O
a O
fourfold O
reduction O
in O
reporter O
enzyme O
levels O
. O

The O
ORF3 O
mutant O
produced O
reduced _RARE_
levels O
of O
tabtoxin _RARE_
, O
indicating O
that O
ORF3 O
may O
have O
a O
role O
in O
T I-GENE
beta I-GENE
L I-GENE
biosynthesis O
. O

Refined _RARE_
Cox O
models O
using O
a O
CD4 _RARE_
count O
of O
150 _RARE_
/ O
microL _RARE_
rather O
than O
200 _RARE_
/ O
microL _RARE_
to O
distinguish _RARE_
I0 _RARE_
and O
I1 _RARE_
yielded O
a O
simplified _RARE_
model O
with O
better O
fit O
to O
the O
observed O
data O
. O

However O
, O
the O
published O
reports O
consist O
of O
a O
small O
number O
of O
patients O
and O
limited O
data O
. O

These O
transcripts O
contain O
the O
5 O
' O
ends O
of O
mature _RARE_
UbCRBP _RARE_
mRNAs I-GENE
; O
extend O
through O
UbCRBP _RARE_
, O
across O
the O
intergenic O
region O
, O
and O
a O
significant O
distance O
3 O
' O
into O
the O
enolase _RARE_
gene I-GENE
. O

The O
distribution O
of O
cryptosporidia _RARE_
in O
the O
intestine O
and O
number O
of O
cryptosporidia _RARE_
per O
ileal _RARE_
villus _RARE_
on O
different O
DPI _RARE_
were O
also O
estimated O
for _RARE_
detailed O
characterization O
of O
the O
infection O
in O
kids _RARE_
as _RARE_
a O
model O
for _RARE_
experimental O
cryptosporidiosis _RARE_
. O

As O
a O
result O
, O
the O
subendocardial _RARE_
/ O
subepicardial _RARE_
blood _RARE_
flow O
ratio O
( O
ENDO _RARE_
/ O
EPI _RARE_
) O
increased O
from O
0 _RARE_
. O
44 _RARE_
+/- O
0 _RARE_
. O
09 O
during _RARE_
control O
stenosis O
to O
0 _RARE_
. O
85 _RARE_
+/- O
0 _RARE_
. O
13 _RARE_
after O
ITF _RARE_
1129 _RARE_
( O
10 O
micrograms O
/ O
kg O
/ O
min O
i O
. O
v O
.) O
and O
to O
0 _RARE_
. O
81 _RARE_
+/- O
0 _RARE_
. O
12 O
after O
NTG _RARE_
. O

Proteasomes _RARE_
are O
the O
multisubunit _RARE_
protease O
involved O
in O
the O
generation O
of O
peptides O
presented O
by O
MHC I-GENE
class I-GENE
I I-GENE
molecules I-GENE
. O

In O
support O
of O
this O
interpretation O
we O
demonstrate O
that O
MQ9b _RARE_
binds O
strongly O
5 O
of O
17 _RARE_
motif O
- O
positive O
, O
pathogen _RARE_
- O
derived O
synthetic _RARE_
peptides O
. O

Takahashi _RARE_
, O
H O
. O

For O
sputum _RARE_
interleukin I-GENE
- I-GENE
8 I-GENE
there O
was O
an O
estimated O
true O
treatment O
median O
difference O
of O
142 O
pg O
/ O
ml O
( O
95 _RARE_
% O
confidence O
interval O
( O
CI _RARE_
) O
8 O
to O
2866 _RARE_
pg O
/ O
ml O
) O
in O
favour _RARE_
of O
placebo O
; O
while O
for _RARE_
maximal O
expiratory O
flow O
at _RARE_
25 _RARE_
% O
( O
MEF25 _RARE_
%) O
remaining O
forced _RARE_
vital O
capacity O
predicted O
for _RARE_
sex _RARE_
and O
height O
there O
was O
a O
15 _RARE_
percentage O
points O
( O
pp _RARE_
) O
( O
95 _RARE_
% O
CI _RARE_
4 O
to O
26 _RARE_
pp _RARE_
) O
mean O
treatment O
difference O
in O
favour _RARE_
of O
placebo O
. O

However O
, O
although O
deletion O
of O
Fp1 _RARE_
in O
the O
hCRBP1 _RARE_
gene I-GENE
yielded O
increased O
CAT I-GENE
activity O
, O
pointing _RARE_
toward O
a O
negative O
regulatory O
function O
exerted _RARE_
by O
this O
element O
, O
its O
insertion _RARE_
upstream O
of O
the O
p12 _RARE_
basal I-GENE
promoter I-GENE
results O
in O
an O
impressive _RARE_
positive O
stimulation _RARE_
of O
CAT I-GENE
gene I-GENE
expression _RARE_
. O

Gaucher _RARE_
' O
s O
disease _RARE_
is O
a O
rare O
metabolic O
disorder O
characterized O
by O
the O
lack O
of O
beta I-GENE
- I-GENE
glucocerebrosidase _RARE_
enzyme I-GENE
. O

These O
discoloration _RARE_
' O
s O
can O
be O
treated O
in O
several O
ways O
but O
up _RARE_
to O
lately _RARE_
tooth O
structure _RARE_
had O
to O
be O
removed O
in O
an O
irreversible O
manner O
in O
order O
to O
provide O
sufficient O
bulk O
for _RARE_
the O
new O
restorative _RARE_
material O
. O

The O
9 O
; O
22 _RARE_
chromosomal O
translocation O
characteristic O
of O
CML O
results O
in O
a O
fused O
bcr _RARE_
/ O
abl I-GENE
gene O
and O
an O
abnormal O
fusion O
protein O
, O
p210bcr _RARE_
/ O
abl I-GENE
. O

Overexpression O
of O
BAG _RARE_
- I-GENE
1 I-GENE
also O
protected O
certain O
cell O
lines O
from O
heat O
shock O
- O
induced _RARE_
cell O
death _RARE_
. O

The O
5 O
' O
flanking O
region O
contains O
potential _RARE_
binding O
sites O
for _RARE_
TATA I-GENE
- I-GENE
binding I-GENE
protein I-GENE
, O
Sp1 _RARE_
, O
nuclear I-GENE
factor I-GENE
1 I-GENE
( O
NF1 I-GENE
), _RARE_
CAAT I-GENE
- I-GENE
box I-GENE
binding I-GENE
protein I-GENE
( O
C I-GENE
/ I-GENE
EBP I-GENE
), _RARE_
hepatocyte _RARE_
nuclear I-GENE
factors I-GENE
1 I-GENE
and I-GENE
5 I-GENE
( O
HNF1 _RARE_
, O
HNF5 _RARE_
) O
and O
activator I-GENE
proteins I-GENE
1 I-GENE
and I-GENE
2 I-GENE
( O
AP1 I-GENE
, O
AP2 I-GENE
). O

The O
recognition O
specificity _RARE_
of O
the O
p55 I-GENE
PDZ I-GENE
domain I-GENE
appears O
to O
be O
unique O
, O
since O
the O
three O
PDZ I-GENE
domains I-GENE
of O
hDlg _RARE_
( O
human O
lymphocyte O
homologue O
of O
the O
Drosophila I-GENE
discs _RARE_
large I-GENE
tumor I-GENE
suppressor I-GENE
) O
do O
not O
bind O
the O
cytoplasmic O
domain O
of O
glycophorin _RARE_
C I-GENE
. O

By O
analyzing O
the O
RanGAP _RARE_
activity O
of O
a O
series O
of O
recombinantly _RARE_
expressed _RARE_
rna1p _RARE_
mutant I-GENE
derivatives _RARE_
, O
we O
show O
that O
the O
highly O
acidic _RARE_
sequence O
in O
the O
C O
- O
terminal O
domain O
of O
both O
yeast O
proteins O
is O
indispensable _RARE_
for _RARE_
activating O
Ran I-GENE
- O
mediated _RARE_
GTP O
hydrolysis O
. O

In O
the O
absence O
of O
MHC I-GENE
class I-GENE
II I-GENE
, O
purified _RARE_
soluble _RARE_
D10 _RARE_
TCR I-GENE
bound _RARE_
to O
Staphylococcus _RARE_
aureus _RARE_
enterotoxin _RARE_
C2 I-GENE
with O
an O
association O
rate O
of O
1 O
. O
69 _RARE_
+/- O
0 _RARE_
. O
12 O
x _RARE_
10 O
( O
4 O
) O
M O
(- _RARE_
1 O
) O
sec O
(- _RARE_
1 O
) O
and O
a O
dissociation O
rate O
of O
1 O
. O
9 O
+/- O
0 _RARE_
. O
47 _RARE_
x _RARE_
10 O
(- _RARE_
2 O
) O
sec O
(- _RARE_
1 O
), _RARE_
giving O
a O
dissociation O
constant O
of O
1 O
. O
1 O
microM O
. O

Evidence O
for _RARE_
such O
peak O
shifts O
has O
been O
found O
in O
the O
responses O
of O
auditory O
nerve O
fibers O
, O
cochlear O
microphonics _RARE_
, O
and O
the O
responses O
of O
outer _RARE_
hair _RARE_
cells O
and O
supporting O
cells O
in O
the O
cochlea _RARE_
, O
as _RARE_
well _RARE_
as _RARE_
in O
basilar _RARE_
membrane O
vibration O
measurements O
, O
and O
indirectly O
, O
in O
psychophysical _RARE_
data O
. O

Mnt _RARE_
: O
Max I-GENE
complexes O
also O
efficiently O
suppress O
Myc _RARE_
- O
dependent O
activation O
from O
the O
same O
promoter O
. O

In O
the O
United O
States _RARE_
high O
- O
MW _RARE_
HES _RARE_
480 _RARE_
which O
is O
difficult O
to O
degrade _RARE_
is O
most O
frequently O
used O
and O
results O
in O
a O
larger O
in O
vivo O
MW _RARE_
and O
subsequent O
decrease O
in O
factor I-GENE
VIII I-GENE
/ O
von _RARE_
Willebrand I-GENE
factor I-GENE
levels O
. O

Assays _RARE_
of O
total _RARE_
cholesterol O
as _RARE_
well _RARE_
as _RARE_
the O
HDL _RARE_
, O
HDL2 I-GENE
, O
LDL I-GENE
, O
triglycerides _RARE_
, O
endothelin I-GENE
- I-GENE
1 I-GENE
, O
lipoprotein O
( O
a O
), _RARE_
estradiol O
and O
FSH I-GENE
were O
also O
obtained O
at _RARE_
baseline O
before O
receiving O
ERT _RARE_
and O
after O
3 O
months O
of O
ERT _RARE_
. O

Six O
tandem _RARE_
repeats O
of O
the O
P I-GENE
element I-GENE
linked _RARE_
to O
the O
SV40 I-GENE
promoter I-GENE
responded O
to O
phorbol O
12 O
- O
myristate O
13 _RARE_
- O
acetate _RARE_
, O
while O
that O
of O
other O
elements O
did O
not O
. O

The O
distributed O
current O
density O
J _RARE_
is O
calculated O
within O
the O
volume O
defined O
by O
the O
motor O
unit O
. O

The O
cleavage _RARE_
dipeptides _RARE_
of O
C1YVV _RARE_
NIa _RARE_
protease I-GENE
are O
Q _RARE_
( O
E O
)/ _RARE_
S O
( O
A O
, O
G O
). O

In O
our O
previous O
studies O
, O
transcriptional O
activation O
was O
shown O
to O
correlate O
with O
IEP86 _RARE_
binding O
to O
both O
the O
TATA I-GENE
- I-GENE
box I-GENE
binding I-GENE
protein I-GENE
( O
TBP I-GENE
) O
and O
the O
transcription O
factor O
bound _RARE_
upstream O
. O

However O
, O
we O
were O
unable O
to O
identify O
a O
p4 _RARE_
molecule O
. O

( O
iv O
) O
The O
accumulation O
of O
cyclin _RARE_
D3 _RARE_
protein I-GENE
in O
Vero _RARE_
cells O
infected _RARE_
with O
an O
alpha0 _RARE_
deletion I-GENE
mutant I-GENE
was O
reduced _RARE_
relative O
to O
that O
of O
cells O
infected _RARE_
with O
wild O
- O
type O
virus O
or O
a O
recombinant O
virus O
in O
which O
the O
deleted _RARE_
alpha0 _RARE_
sequences I-GENE
were O
restored O
. O

We O
report O
the O
preliminary O
biochemical O
characterization O
of O
the O
T I-GENE
antigens I-GENE
encoded O
by O
three O
SV40 O
mutants O
, O
5030 _RARE_
, O
5031 _RARE_
, O
and O
5061 _RARE_
, O
each O
of O
which O
have O
altered O
residues O
within O
or O
near O
the O
ATP O
binding O
pocket O
. O

These O
effects O
were O
abrogated O
by O
co _RARE_
- O
expression _RARE_
of O
kinase I-GENE
- I-GENE
deficient _RARE_
PKC I-GENE
zeta _RARE_
and O
inhibition O
of O
phosphatidylinositol _RARE_
3 I-GENE
- I-GENE
kinase I-GENE
p85alpha _RARE_
- O
p110 _RARE_
by O
wortmannin O
, O
LY294002 _RARE_
and O
a O
dominant O
- O
negative O
mutant O
of O
p85alpha _RARE_
. O

Protein I-GENE
phosphatase I-GENE
2A _RARE_
is O
a O
critical O
regulator O
of O
protein I-GENE
kinase I-GENE
C I-GENE
zeta _RARE_
signaling _RARE_
targeted O
by O
SV40 I-GENE
small I-GENE
t I-GENE
to O
promote O
cell O
growth O
and O
NF _RARE_
- I-GENE
kappaB I-GENE
activation O
. O

Interestingly O
, O
the O
RXRalphaF318A _RARE_
constitutive _RARE_
activity O
generated O
within O
heterodimers _RARE_
in O
the O
presence O
of O
BMS614 _RARE_
requires O
the O
integrity O
of O
both O
RXR I-GENE
and O
RAR I-GENE
AF _RARE_
- O
2 O
domains O
. O

These O
introns _RARE_
contain O
only O
single O
snoRNA _RARE_
genes I-GENE
and O
their O
processing _RARE_
involves O
exonucleolytic _RARE_
release O
of O
the O
snoRNA _RARE_
from O
debranched _RARE_
intron O
lariats _RARE_
. O

Recent O
studies O
have O
shown O
that O
the O
Src I-GENE
homology I-GENE
- I-GENE
2 I-GENE
( O
SH2 _RARE_
) O
domain O
- O
containing O
protein I-GENE
- I-GENE
tyrosine I-GENE
phosphatase I-GENE
, O
SHP I-GENE
- I-GENE
2 I-GENE
, O
associates O
with O
the O
cytoplasmic O
domain O
of O
PECAM _RARE_
- I-GENE
1 I-GENE
as _RARE_
it O
becomes O
tyrosine O
- O
phosphorylated _RARE_
during _RARE_
platelet O
aggregation _RARE_
: O
a O
process O
that O
can O
be O
mimicked O
in O
part O
by O
small O
synthetic _RARE_
phosphopeptides O
corresponding O
to O
the O
cytoplasmic O
domain O
of O
PECAM _RARE_
- I-GENE
1 I-GENE
encompassing _RARE_
tyrosine O
residues O
Tyr _RARE_
- O
663 _RARE_
or O
Tyr _RARE_
- O
686 _RARE_
. O

Underlying _RARE_
the O
clustering _RARE_
of O
these O
risk O
variables O
were O
three O
factors O
. O

Supplementation _RARE_
was O
stopped O
when O
pl _RARE_
- I-GENE
ALB _RARE_
reached O
2 O
. O
0 _RARE_
g O
/ O
dL O
. O

Detection O
of O
airborne _RARE_
Mycobacterium O
tuberculosis O
by O
air O
filtration O
and O
polymerase O
chain O
reaction O
. O

These O
findings O
show O
that O
EBP50 _RARE_
is O
a O
physiologically _RARE_
relevant O
ezrin _RARE_
binding I-GENE
protein I-GENE
. O

Previously O
, O
we O
reported O
that O
scanthrough _RARE_
translation O
, O
where O
the O
initiating O
AUG O
of O
a O
primary _RARE_
open _RARE_
reading O
frame O
is O
bypassed _RARE_
, O
is O
most O
likely O
to O
account O
for _RARE_
the O
presentation O
of O
cryptic _RARE_
epitopes _RARE_
from O
alternative _RARE_
reading O
frames O
within O
the O
influenza _RARE_
A I-GENE
PR I-GENE
/ I-GENE
8 I-GENE
/ I-GENE
34 _RARE_
nucleoprotein _RARE_
gene I-GENE
. O

This O
family O
of O
proteins O
binds O
GC _RARE_
- O
rich O
motifs O
widely O
distributed O
in O
gene O
promoters O
, O
resulting O
in O
distinct O
activation O
or O
repression O
of O
transcriptional O
activities O
. O

Deletion O
of O
the O
POR2 _RARE_
gene I-GENE
alone O
had O
no _RARE_
detectable O
phenotype _RARE_
, O
while O
yeasts _RARE_
with O
deletions O
of O
both O
the O
POR1 _RARE_
and O
POR2 _RARE_
genes I-GENE
were O
viable O
and O
able O
to O
grow O
on O
glycerol _RARE_
at _RARE_
30 _RARE_
degrees O
C O
, O
albeit _RARE_
more O
slowly O
than O
delta I-GENE
por1 _RARE_
single I-GENE
mutants I-GENE
. O

Furthermore O
, O
our O
novel O
observation O
that O
expression _RARE_
of O
a O
highly O
activated O
FGFR3 _RARE_
kinase I-GENE
domain I-GENE
is O
able O
to O
morphologically _RARE_
transform O
fibroblasts _RARE_
suggests O
that O
dysregulation _RARE_
of O
FGFR3 _RARE_
has O
the O
potential _RARE_
to O
play O
a O
role O
in O
human O
neoplasia _RARE_
. O

The O
deduced O
amino O
acid O
sequence O
of O
the O
gene O
has O
significant O
homology O
to O
the O
interferon _RARE_
regulatory I-GENE
factors I-GENE
( O
IRFs _RARE_
). O

Involvement _RARE_
of O
AP I-GENE
- I-GENE
2 I-GENE
in O
regulation _RARE_
of O
the O
R I-GENE
- I-GENE
FABP _RARE_
gene I-GENE
in O
the O
developing O
chick _RARE_
retina O
. O

However O
, O
Cbf5p _RARE_
was O
found O
to O
be O
nucleolar _RARE_
and O
is O
highly O
homologous O
to O
the O
rat I-GENE
nucleolar _RARE_
protein I-GENE
NAP57 _RARE_
, O
which O
coimmunoprecipitates _RARE_
with O
Nopp140 _RARE_
and O
which O
is O
postulated O
to O
be O
involved O
in O
nucleolar _RARE_
- O
cytoplasmic O
shuttling _RARE_
( O
U _RARE_
. O

This O
newly O
described O
organism O
was O
difficult O
to O
identify O
due O
to O
discrepancies _RARE_
between O
the O
Vitek _RARE_
and O
API _RARE_
20E _RARE_
identification O
systems _RARE_
. O

Ig I-GENE
heavy I-GENE
chain I-GENE
class O
switching O
is O
directed O
by O
cytokines _RARE_
inducing O
transcription O
from O
unrearranged _RARE_
CH _RARE_
genes I-GENE
. O

The O
available O
data O
suggest O
that O
the O
NF _RARE_
kappa _RARE_
B2 _RARE_
nucleoprotein _RARE_
complex I-GENE
may O
cooperate O
with O
DNA O
- O
bound _RARE_
STAT6 _RARE_
to O
achieve O
IL _RARE_
- I-GENE
4 I-GENE
- O
dependent O
activation O
of O
the O
human I-GENE
IgE I-GENE
germline _RARE_
gene I-GENE
. O

EXERCISE _RARE_
IN _RARE_
THE _RARE_
TERRESTRIAL _RARE_
CHRISTMAS _RARE_
ISLAND _RARE_
RED _RARE_
CRAB _RARE_
GECARCOIDEA _RARE_
NATALIS _RARE_
- O
ENERGETICS _RARE_
OF _RARE_
LOCOMOTION _RARE_

THE _RARE_
SCALING _RARE_
OF _RARE_
SONG _RARE_
FREQUENCY _RARE_
IN _RARE_
CICADAS _RARE_

The O
pheromone O
response O
pathway _RARE_
activates O
transcription O
of O
Ty5 _RARE_
retrotransposons _RARE_
located _RARE_
within O
silent _RARE_
chromatin O
of O
Saccharomyces O
cerevisiae O
. O

In O
this O
study O
we O
have O
introduced O
mutations O
into O
the O
corresponding O
elements O
of O
two O
cox3 _RARE_
promoters I-GENE
and O
show O
that O
while O
the O
core O
element O
is O
essential O
for _RARE_
cox3 _RARE_
promoter I-GENE
activity O
, O
upstream O
element O
mutations O
have O
little O
or O
no _RARE_
effect O
. O

We O
found O
that O
multiple O
tumor O
suppressor O
genes O
( O
e _RARE_
. O
g O
., O
p53 I-GENE
, O
DCC _RARE_
, O
APC _RARE_
, O
MCC _RARE_
, O
BRCA1 I-GENE
, O
and O
WAF1 I-GENE
/ O
CIP1 _RARE_
) O
were O
inactivated O
at _RARE_
different O
frequencies O
via O
various O
mechanisms O
[ _RARE_
e _RARE_
. O
g O
., O
loss _RARE_
of O
heterozygosity O
( O
LOH _RARE_
), _RARE_
loss _RARE_
of O
expression _RARE_
( O
LOE _RARE_
), _RARE_
mutation O
, O
and O
inactivation O
by O
cellular O
binding O
protein O
]. O

The O
histidine _RARE_
- O
tagged _RARE_
gene O
, O
rpoCHIS _RARE_
, O
was O
used O
to O
replace O
the O
wild O
- O
type O
allele O
in O
the O
chromosome _RARE_
of O
S O
. O
coelicolor _RARE_
and O
S O
. O
lividans _RARE_
. O

Because O
the O
deletion O
included O
the O
TK I-GENE
gene I-GENE
, O
selection O
with O
gancyclovir _RARE_
against O
cells O
not O
having O
undergone O
recombination _RARE_
was O
possible O
. O

The O
malate _RARE_
synthase I-GENE
gene I-GENE
, O
MLS1 _RARE_
, O
of O
the O
yeast O
Saccharomyces O
cerevisiae O
is O
transcriptionally O
regulated O
by O
the O
carbon O
source O
in O
the O
growth O
medium O
. O

By O
deletion O
analysis O
of O
the O
MLS1 _RARE_
control O
region O
, O
we O
identified O
two O
sites O
, O
UAS1 O
and O
UAS2 _RARE_
, O
as _RARE_
important O
for _RARE_
efficient O
derepression O
of O
the O
gene O
. O

Lack _RARE_
of O
controlled _RARE_
prospective O
studies O
of O
sleep O
electroencephalograms _RARE_
( O
EEG O
), _RARE_
and O
the O
use O
of O
medication O
, O
in O
children O
with O
developmental O
dysphasia _RARE_
, O
may O
deny _RARE_
appropriate O
treatment O
strategies O
to O
children O
with O
severe O
developmental O
speech O
and O
language O
disorders O
. O

Prior _RARE_
to O
meals _RARE_
2 O
to O
3 O
times O
daily O
, O
1 O
- O
2 O
tablespoons _RARE_
of O
Alzoon _RARE_
are O
recommended O
. O

Widening _RARE_
of O
the O
abdominal O
aortic O
wall _RARE_
on O
an O
ultrasound O
examination O
was O
the O
key O
to O
the O
incidental _RARE_
diagnosis O
of O
a O
clinically O
unsuspected _RARE_
type O
B O
dissection O
. O

Fermentation _RARE_
process O
after O
supplementation O
of O
nitrate _RARE_
, O
nitrite _RARE_
, O
lactic _RARE_
acid O
bacteria O
and O
formic _RARE_
acid O

Substrates _RARE_
include O
the O
p21 I-GENE
( O
ras I-GENE
) O
proteins O
, O
nuclear I-GENE
lamins _RARE_
, O
and O
a O
series O
of O
retinal _RARE_
proteins O
. O

Ovaries _RARE_
of O
10 O
animals O
per O
group O
from O
16 O
studies O
in O
CD O
- O
1 O
mice O
and O
1 O
study O
each O
in O
C3H O
and O
C57BL O
/ O
6 O
mice O
were O
sectioned _RARE_
serially _RARE_
at _RARE_
6 O
microm O
. O

The O
Trx _RARE_
- O
CT _RARE_
fusion O
protein O
was O
produced O
less O
efficiently O
( O
20 O
% O
of O
total _RARE_
soluble _RARE_
cellular O
protein O
). O

These O
results O
suggest O
that O
UBP41 _RARE_
may O
play O
an O
important O
role O
in O
the O
recycling _RARE_
of O
ubiquitin I-GENE
by O
hydrolysis O
of O
branched _RARE_
poly _RARE_
- I-GENE
ubiquitin I-GENE
chains I-GENE
generated O
by O
the O
action O
of O
26 _RARE_
S I-GENE
proteasome I-GENE
on O
poly _RARE_
- O
ubiquitinated _RARE_
protein O
substrates _RARE_
, O
as _RARE_
well _RARE_
as _RARE_
in O
the O
production O
of O
free O
ubiquitin I-GENE
from O
linear _RARE_
poly _RARE_
- I-GENE
ubiquitin I-GENE
chains I-GENE
and O
of O
certain O
ribosomal O
proteins O
from O
ubiquitin I-GENE
fusion I-GENE
proteins I-GENE
. O

A O
data O
base _RARE_
homology O
search O
revealed O
that O
the O
predicted O
ER1 _RARE_
amino O
acid O
sequence O
contains O
three O
regions O
of O
similarity _RARE_
to O
the O
rat O
and O
human O
proteins O
encoded O
by O
the O
metastasis O
- O
associated O
gene O
, O
mta1 _RARE_
, O
and O
two O
regions O
of O
similarity _RARE_
to O
the O
Caenorhabditis O
elegans O
sequence O
that O
is O
similar O
to O
mta1 _RARE_
. O

The O
sequenced O
cDNA O
predicts O
a O
704 _RARE_
- O
amino O
acid O
protein O
80 _RARE_
% O
identical O
to O
human I-GENE
progelatinase _RARE_
B I-GENE
. O

The O
inhibition O
by O
cytosolic O
Ca2 _RARE_
+ O
was O
caused O
by O
a O
decrease O
in O
cooperativity O
and O
by O
a O
shift O
in O
EC50 _RARE_
toward O
higher _RARE_
InsP3 _RARE_
concentrations O
. O

RESULTS O
: O
The O
standardised _RARE_
mortality O
ratio O
( O
SMR _RARE_
) O
for _RARE_
all O
malignant O
neoplasms O
was O
94 O
( O
95 _RARE_
% O
CI _RARE_
74 _RARE_
to O
118 O
). O

Sequence O
analysis O
of O
this O
region O
revealed O
three O
eight O
- O
bp O
repetitive _RARE_
elements O
, O
the O
deletion O
of O
which O
restored O
wild O
- O
type O
levels O
of O
luciferase I-GENE
activity O
to O
the O
- O
916 _RARE_
- O
bp O
reporter O
plasmid _RARE_
. O

Using O
5 O
' O
RACE O
and O
reverse O
transcription O
- O
PCR O
( O
RT O
- O
PCR O
) O
methodologies _RARE_
, O
we O
cloned _RARE_
these O
sequences O
from O
brain O
and O
placenta O
and O
found O
this O
material O
to O
be O
composed O
of O
alternatively _RARE_
spliced _RARE_
exons O
using O
a O
previously O
reported O
noncoding O
exon _RARE_
( O
1A _RARE_
) O
and O
a O
novel O
97 O
- O
bp O
noncoding O
exon _RARE_
( O
1B _RARE_
). O

This O
is O
the O
first _RARE_
study O
in O
which O
mutation O
screening O
has O
been O
performed O
for _RARE_
both O
the O
EXT1 _RARE_
and O
EXT2 _RARE_
genes I-GENE
prior O
to O
any O
linkage O
analysis O
. O

The O
regurgitation _RARE_
of O
large O
vitreous O
injections O
. O

Positron _RARE_
emission O
tomography O
radioligands _RARE_
for _RARE_
dopamine I-GENE
transporters _RARE_
and O
studies O
in O
human O
and O
nonhuman _RARE_
primates O
. O

Attenuation _RARE_
from O
the O
vit _RARE_
A2 _RARE_
consensus O
ERE _RARE_
is O
not O
necessarily O
dependent O
on O
DNA O
binding O
as _RARE_
the O
TR I-GENE
alpha I-GENE
DNA O
binding O
mutant O
was O
still O
able O
to O
inhibit O
E O
- O
dependent O
transactivation _RARE_
. O

Expression O
from O
this O
element O
is O
regulated O
by O
a O
heteromeric _RARE_
protein O
complex O
containing O
ubiquitous O
( O
i O
. O
e _RARE_
. O
the O
E2A _RARE_
- O
and O
HEB _RARE_
- I-GENE
encoded I-GENE
proteins I-GENE
) O
and O
islet O
- O
enriched _RARE_
members O
of O
the O
bHLH I-GENE
family I-GENE
. O

Thus O
, O
the O
CCAAT O
box O
also O
has O
tissue O
- O
specific O
characteristics O
that O
assist _RARE_
in O
targeting O
expression _RARE_
of O
the O
alpha I-GENE
- I-GENE
subunit I-GENE
gene I-GENE
to O
trophoblasts _RARE_
. O

U4 I-GENE
/ O
U6 I-GENE
snRNP O
is O
one O
of O
four O
essential O
small O
nuclear O
ribonucleoprotein O
( O
snRNP O
) O
particles _RARE_
( O
U1 _RARE_
, O
U2 _RARE_
, O
U5 _RARE_
and O
U4 I-GENE
/ O
U6 I-GENE
) O
present O
in O
the O
spliceosome O
. O

Hprp3p _RARE_
is O
a O
77 O
kDa O
protein O
, O
which O
is O
homologous O
to O
the O
Saccharomyces I-GENE
cerevisiae I-GENE
splicing _RARE_
factor I-GENE
Prp3p _RARE_
. O

The O
growth O
- O
promoting _RARE_
properties O
of O
the O
retroviral _RARE_
v I-GENE
- I-GENE
erbA I-GENE
oncogene I-GENE
, O
a O
highly O
mutated _RARE_
version O
of O
the O
chicken I-GENE
thyroid I-GENE
hormone I-GENE
receptor I-GENE
( I-GENE
TR I-GENE
) I-GENE
alpha I-GENE
, O
have O
so O
far O
exclusively O
been O
linked _RARE_
to O
dominant O
repression O
of O
the O
antimitogenic _RARE_
roles O
of O
TR I-GENE
and O
retinoic I-GENE
acid I-GENE
receptors I-GENE
. O

We O
cloned _RARE_
a O
complete _RARE_
cDNA O
( O
2 O
. O
9 O
kb O
) O
for _RARE_
HET _RARE_
from O
an O
MCF _RARE_
- O
7 O
cDNA O
library O
. O

The O
most O
common O
grade O
3 O
toxicity O
was O
neutropenia O
, O
thrombocytopenia O
, O
and O
parasthesias _RARE_
( O
observed O
in O
< O
10 O
% O
of O
cycles O
). O

Serum O
concentrations O
of O
E2 O
and O
TBOH _RARE_
were O
measured O
on O
d O
0 _RARE_
, O
1 O
, O
3 O
, O
5 O
, O
7 O
, O
13 _RARE_
, O
21 O
, O
28 _RARE_
, O
42 _RARE_
, O
56 _RARE_
, O
84 _RARE_
, O
112 O
, O
and O
140 _RARE_
in O
finishing _RARE_
heifers O
administered O
the O
following O
treatments O
: O
1 O
) O
control O
; O
2 O
) O
MGA O
, O
. O
5 O
mg O
per O
heifer _RARE_
daily O
; O
3 O
) O
Revalor _RARE_
- O
H O
( O
140 _RARE_
mg O
TBA _RARE_
+ O
14 O
mg O
E2 O
); O
4 O
) O
Revalor _RARE_
- O
H O
+ O
MGA O
; O
5 O
) O
Finaplix _RARE_
- O
H O
( O
200 _RARE_
mg O
TBA _RARE_
); O
and O
6 O
) O
Finaplix _RARE_
- O
H O
+ O
MGA O
. O

Serum O
E2 O
concentrations O
increased O
numerically _RARE_
two O
- O
to O
threefold O
from O
d O
56 _RARE_
to O
140 _RARE_
in O
controls O
fed O
MGA O
, O
compared O
with O
controls O
not O
fed O
MGA O
. O

Interferon I-GENE
Regulatory _RARE_
Factor _RARE_
( I-GENE
IRF I-GENE
)- I-GENE
1 I-GENE
has O
been O
characterized O
as _RARE_
an O
important O
growth O
regulatory O
and O
immunomodulatory _RARE_
transcription O
factor O
. O

The O
genomic O
structure _RARE_
of O
brk _RARE_
consists O
of O
8 O
exons O
, O
whose O
boundaries O
are O
distinct O
from O
other O
non O
- O
receptor O
PTK _RARE_
family I-GENE
members O
, O
again O
indicating O
a O
structural O
and O
functional _RARE_
divergence O
. O

We O
have O
previously O
reported O
that O
expression _RARE_
of O
a O
tumour _RARE_
derived O
brk _RARE_
cDNA I-GENE
in O
mouse O
embryonic _RARE_
fibroblasts _RARE_
and O
human O
mammary O
epithelial _RARE_
cells O
supports O
anchorage O
independent O
growth O
, O
and O
in O
the O
latter O
potentiates O
the O
mitogenic O
response O
to O
epidermal _RARE_
growth I-GENE
factor I-GENE
. O

Anti _RARE_
- I-GENE
hepatitis I-GENE
A I-GENE
virus O
( O
HAV _RARE_
) O
titer O
after O
vaccination O
was O
measured O
in O
83 _RARE_
HIV O
- O
positive O
and O
39 _RARE_
HIV O
- O
negative O
men O
. O

One O
skull _RARE_
does O
not O
a O
species O
make O
. O

Surprisingly O
, O
calf _RARE_
thymus _RARE_
CstF _RARE_
contained O
an O
additional O
, O
novel O
form O
of O
the O
64 _RARE_
- O
kDa O
subunit O
with O
a O
molecular _RARE_
mass O
of O
70 O
kDa O
. O

Null _RARE_
mutations O
in O
daf _RARE_
- I-GENE
3 I-GENE
suppress O
mutations O
in O
genes O
encoding O
this O
TGF I-GENE
- I-GENE
beta I-GENE
signal O
, O
its O
receptors O
, O
and O
associated O
Smad I-GENE
signal I-GENE
transduction _RARE_
proteins I-GENE
. O
daf _RARE_
- I-GENE
3 I-GENE
encodes O
a O
Smad I-GENE
protein I-GENE
that O
is O
most O
closely O
related O
to O
mammalian I-GENE
DPC4 _RARE_
, O
and O
is O
expressed _RARE_
throughout O
development O
in O
many O
of O
the O
tissues O
that O
are O
remodeled _RARE_
during _RARE_
dauer _RARE_
development O
. O

Our O
results O
favor _RARE_
the O
possibility O
that O
the O
Drosophila I-GENE
EGF _RARE_
receptor I-GENE
DER I-GENE
/ O
Egfr _RARE_
expressed _RARE_
by O
the O
EMA _RARE_
cells O
functions O
as _RARE_
a O
receptor O
for _RARE_
Vein _RARE_
. O

PATIENTS O
AND _RARE_
METHODS O
: O
In O
807 _RARE_
consecutive O
patients O
from O
the O
Chilean _RARE_
National O
Registry _RARE_
of O
Acute O
Myocardial O
Infarction _RARE_
we O
analyzed O
the O
resolution O
of O
chest O
pain O
and O
ST O
segment O
elevation O
over O
50 O
% O
within O
the O
first _RARE_
90 _RARE_
min O
, O
abrupt _RARE_
CK _RARE_
rise O
within O
8 O
h O
and O
T O
wave O
inversion O
in O
infarct O
related O
EKG _RARE_
leads O
within O
the O
first _RARE_
24 _RARE_
h O
after O
thrombolysis _RARE_
. O

Because O
of O
the O
operon O
structure _RARE_
of O
this O
organism O
, O
traditional _RARE_
methods O
such O
as _RARE_
insertional _RARE_
mutagenesis O
run O
the O
risk O
of O
introducing _RARE_
polar _RARE_
effects O
on O
downstream _RARE_
genes O
or O
creating _RARE_
secondary O
mutations O
elsewhere _RARE_
in O
the O
genome O
. O

It O
has O
been O
proposed O
that O
the O
parCBA _RARE_
operon I-GENE
encodes O
a O
plasmid _RARE_
partitioning _RARE_
system _RARE_
( O
M O
. O

Furthermore O
, O
the O
insertion _RARE_
of O
the O
ColE1 _RARE_
cer _RARE_
site I-GENE
into O
the O
RK2 _RARE_
plasmid _RARE_
deleted _RARE_
for _RARE_
the O
par _RARE_
region O
failed O
to O
stabilize _RARE_
the O
plasmid _RARE_
in O
the O
MC1061K _RARE_
strain _RARE_
, O
indicating O
that O
the O
multimer _RARE_
resolution O
activity O
encoded O
by O
parCBA _RARE_
is O
not O
by O
itself O
responsible O
for _RARE_
the O
stabilization O
activity O
observed O
for _RARE_
this O
operon O
. O

To O
examine O
the O
basis O
for _RARE_
the O
apparent O
differences O
in O
postsegregational _RARE_
killing _RARE_
between O
the O
two O
E O
. O
coli O
strains O
, O
transformation O
assays O
were O
carried O
out O
to O
determine O
the O
relative O
sensitivities _RARE_
of O
the O
strains O
to O
the O
ParE _RARE_
toxin _RARE_
protein I-GENE
. O

Splice _RARE_
- O
junction _RARE_
elements O
and O
intronic _RARE_
sequences O
regulate O
alternative _RARE_
splicing _RARE_
of O
the O
Drosophila O
myosin I-GENE
heavy I-GENE
chain I-GENE
gene I-GENE
transcript O
. O

Nucleotide O
sequence O
analysis O
of O
R O
has O
revealed O
similarities O
to O
the O
R1 _RARE_
plasmid _RARE_
found O
in O
some O
South _RARE_
American O
maize _RARE_
races _RARE_
with O
RU _RARE_
cytoplasm O
, O
to O
the O
M1 _RARE_
plasmid _RARE_
found O
in O
one O
source O
of O
Zea _RARE_
luxurians _RARE_
teosinte _RARE_
, O
to O
the O
atp9 _RARE_
mitochondrial I-GENE
gene I-GENE
and O
its O
3 O
' O
flanking O
sequence O
, O
and O
also O
to O
a O
region O
3 O
' O
to O
the O
orf221 _RARE_
gene I-GENE
. O

We O
have O
measured O
the O
kinetics O
of O
the O
recovery O
of O
mRNA O
synthesis _RARE_
in O
the O
inducible O
GAL10 _RARE_
and O
RNR3 _RARE_
genes I-GENE
after O
exposure O
of O
yeast O
cells O
to O
ultraviolet _RARE_
( O
UV _RARE_
) O
radiation O
. O

Cloning O
of O
a O
human I-GENE
phosphoinositide _RARE_
3 I-GENE
- I-GENE
kinase I-GENE
with O
a O
C2 I-GENE
domain O
that O
displays O
reduced _RARE_
sensitivity O
to O
the O
inhibitor O
wortmannin O
. O

Ea _RARE_
value O
was O
calculated O
as _RARE_
the O
ratio O
of O
the O
steady O
- O
state O
end O
- O
systolic O
aortic O
pressure O
( O
ESAP _RARE_
) O
to O
stroke O
volume O
( O
thermodilution _RARE_
). O

Functional O
analysis O
of O
promoter O
activity O
of O
the O
5 O
'- O
flanking O
region O
of O
cyclin _RARE_
D2 _RARE_
suggested O
that O
the O
region O
- O
1 O
, O
100 _RARE_
to O
- O
805 _RARE_
including O
C I-GENE
/ I-GENE
EBP I-GENE
, O
PEA3 I-GENE
, O
AP2 I-GENE
, O
NF _RARE_
- I-GENE
Y I-GENE
, O
c I-GENE
- I-GENE
Myc _RARE_
, O
and O
Sp1 _RARE_
may O
have O
a O
major O
positive O
regulatory O
activity O
for _RARE_
expression _RARE_
of O
cyclin _RARE_
D2 _RARE_
. O

Effect O
of O
alcohol _RARE_
on O
minimal O
effective O
nCPAP _RARE_
pressure O

In O
contrast O
, O
resensitization _RARE_
of O
a O
sequestration _RARE_
- O
impaired O
beta2AR _RARE_
mutant O
( O
Y326A _RARE_
) O
was O
reestablished _RARE_
following O
the O
overexpression O
of O
either O
GRK2 _RARE_
or O
beta I-GENE
- I-GENE
arrestin _RARE_
1 I-GENE
. O

The O
medium O
chains O
of O
these O
complexes O
, O
mu1 _RARE_
and O
mu2 _RARE_
, O
have O
been O
implicated O
in O
two O
types _RARE_
of O
interaction O
: O
assembly O
with O
the O
beta1 I-GENE
and I-GENE
beta2 _RARE_
chains I-GENE
of O
the O
corresponding O
complexes O
and O
recognition O
of O
tyrosine O
- O
based O
sorting _RARE_
signals O
. O

We O
have O
overexpressed O
, O
purified _RARE_
, O
characterized O
, O
and O
crystallized _RARE_
the O
BTB I-GENE
/ O
POZ _RARE_
domain O
from O
PLZF I-GENE
( O
PLZF I-GENE
- O
BTB I-GENE
/ O
POZ _RARE_
). O

Osmotic _RARE_
shock O
stimulates O
GLUT4 _RARE_
translocation O
in O
3T3L1 _RARE_
adipocytes O
by O
a O
novel O
tyrosine I-GENE
kinase I-GENE
pathway _RARE_
. O

We O
also O
identified O
Sp1 _RARE_
, O
Sp3 I-GENE
, O
and O
NGFI _RARE_
- I-GENE
A I-GENE
/ O
Egr _RARE_
- I-GENE
1 I-GENE
as _RARE_
the O
primary _RARE_
nuclear O
transcription O
factors O
binding O
to O
TRE1 _RARE_
which O
mediate O
Tax _RARE_
responsiveness O
. O

Interestingly O
, O
segment O
nesting _RARE_
differentially O
increases O
the O
copy O
number O
of O
genes O
encoded O
by O
segment O
W _RARE_
, O
suggesting O
that O
the O
unusual O
genomic O
organization O
of O
PDVs _RARE_
may O
be O
directly O
linked _RARE_
to O
the O
unique O
functions O
of O
this O
virus O
in O
its O
obligate _RARE_
mutualistic _RARE_
association O
with O
parasitic _RARE_
wasps _RARE_
. O

Furthermore O
, O
deletion O
and O
mutation O
analyses O
of O
the O
VCAM _RARE_
- I-GENE
1 I-GENE
promoter I-GENE
performed O
with O
chloramphenicol I-GENE
acetyltransferase _RARE_
constructs I-GENE
revealed O
that O
Tax _RARE_
was O
trans _RARE_
activating O
the O
VCAM _RARE_
- I-GENE
1 I-GENE
promoter I-GENE
via O
two O
NF _RARE_
- I-GENE
kappaB I-GENE
sites I-GENE
present O
at _RARE_
bp O
- O
72 O
and O
- O
57 O
in O
the O
VCAM _RARE_
- I-GENE
1 I-GENE
gene I-GENE
promoter I-GENE
, O
with O
both O
of O
them O
being O
required O
for _RARE_
the O
Tax _RARE_
- O
induced _RARE_
expression _RARE_
of O
this O
adhesion O
molecule O
. O

The O
AGM _RARE_
and I-GENE
NIH _RARE_
/ I-GENE
Swiss _RARE_
mouse I-GENE
CCR5 _RARE_
proteins I-GENE
are O
97 O
. O
7 O
to O
98 O
. O
3 O
% O
and O
79 _RARE_
. O
8 O
% O
identical O
to O
the O
human O
protein O
, O
respectively O
. O

Processivity _RARE_
of O
DNA O
synthesis _RARE_
by O
the O
mutant O
holoenzyme _RARE_
containing O
pcna _RARE_
- I-GENE
79 _RARE_
was O
unaffected O
on O
poly _RARE_
( O
dA _RARE_
) O
x _RARE_
oligo _RARE_
( O
dT O
) O
but O
was O
dramatically O
reduced _RARE_
on O
a O
natural _RARE_
template O
with O
secondary O
structure _RARE_
. O

Alanine _RARE_
substitution O
mutations O
in O
the O
Zta I-GENE
activation I-GENE
domain I-GENE
which O
eliminate _RARE_
the O
ability O
of O
Zta I-GENE
to O
stimulate O
the O
D I-GENE
- I-GENE
A I-GENE
complex I-GENE
were O
examined O
. O

The O
Scm _RARE_
and O
ph _RARE_
proteins O
share O
a O
homology O
domain O
with O
38 O
% O
identity O
over O
a O
length O
of O
65 O
amino O
acids _RARE_
, O
termed O
the O
SPM _RARE_
domain O
, O
that O
is O
located _RARE_
at _RARE_
their O
respective O
C O
termini O
. O

It O
has O
been O
previously O
shown O
that O
genes O
transcribed _RARE_
by O
RNA I-GENE
polymerase I-GENE
II I-GENE
( O
RNAP I-GENE
II I-GENE
) O
are O
subject O
to O
position O
effect O
variegation _RARE_
when O
located _RARE_
near O
yeast O
telomeres _RARE_
. O

Likewise _RARE_
, O
rad6 _RARE_
- I-GENE
delta I-GENE
reduces O
silencing O
of O
the O
telomere _RARE_
- I-GENE
located _RARE_
RNAP I-GENE
II I-GENE
- I-GENE
transcribed _RARE_
genes I-GENE
URA3 _RARE_
and O
ADE2 _RARE_
. O

The O
amplitude O
of O
detrusor _RARE_
contractions O
at _RARE_
6 O
, O
12 O
, O
and O
24 _RARE_
hours O
showed O
no _RARE_
significant O
difference O
from O
that O
in O
the O
controls O
. O

In O
the O
predicted O
transmembrane O
domain O
, O
Casr _RARE_
- I-GENE
rs2 _RARE_
and O
Casr _RARE_
- I-GENE
rs3 _RARE_
are O
95 _RARE_
% O
identical O
to O
Casr _RARE_
- I-GENE
rs1 _RARE_
. O

Recently O
, O
roles O
also O
have O
been O
suggested O
for _RARE_
the O
nuclear O
trans _RARE_
- O
factor O
GATA _RARE_
- I-GENE
1 I-GENE
in O
regulating _RARE_
progenitor _RARE_
cell O
proliferation _RARE_
. O

PET O
activation O
studies O
are O
performed O
widely O
to O
study O
human O
brain O
function O
. O

F I-GENE
- I-GENE
box I-GENE
proteins I-GENE
are O
receptors O
that O
recruit O
phosphorylated _RARE_
substrates _RARE_
to O
the O
SCF _RARE_
ubiquitin I-GENE
- O
ligase I-GENE
complex O
. O

In O
the O
context O
of O
liver O
allograft _RARE_
shortage _RARE_
, O
our O
results O
suggest O
that O
an O
ELT _RARE_
should O
not O
be O
performed O
in O
patients O
with O
cardiac O
failure O
, O
more O
than O
two O
OSF _RARE_
, O
or O
an O
APACHE _RARE_
II O
score O
higher _RARE_
than O
30 _RARE_
. O

The O
SH3 I-GENE
domains I-GENE
of O
Grb2 I-GENE
bound _RARE_
in O
vitro O
to O
specific O
proline O
- O
rich O
motifs O
in O
the O
HPK1 _RARE_
tail _RARE_
and O
functioned O
synergistically O
to O
direct O
the O
stable O
binding O
of O
Grb2 I-GENE
to O
HPK1 _RARE_
in O
transfected O
Cos1 _RARE_
cells O
. O

By O
far O
- O
Western O
analysis O
and O
coimmunoprecipitation _RARE_
studies O
, O
we O
demonstrate O
that O
ZNF74 _RARE_
interacts O
, O
via O
its O
zinc O
finger O
domain O
, O
with O
the O
hyperphosphorylated _RARE_
largest O
subunit O
of O
RNA I-GENE
polymerase I-GENE
II I-GENE
( O
pol I-GENE
IIo _RARE_
) O
but O
not O
with O
the O
hypophosphorylated _RARE_
form O
. O

Thus O
, O
ZNF74 _RARE_
sublocalization _RARE_
in O
nuclear O
domains O
enriched _RARE_
in O
pre O
- O
mRNA O
maturating _RARE_
factors O
, O
its O
RNA O
binding O
activity O
, O
and O
its O
direct O
phosphodependent _RARE_
interaction O
with O
the O
pol I-GENE
IIo _RARE_
, O
a O
form O
of O
the O
RNA I-GENE
polymerase I-GENE
functionally O
associated O
with O
pre O
- O
mRNA O
processing _RARE_
, O
suggest O
a O
role O
for _RARE_
this O
member _RARE_
of O
the O
KRAB I-GENE
multifinger _RARE_
protein I-GENE
family I-GENE
in O
RNA O
processing _RARE_
. O

Ki _RARE_
- I-GENE
ras4BVal _RARE_
- I-GENE
12 I-GENE
transfectant _RARE_
cells O
expressed _RARE_
2 O
- O
fold _RARE_
elevated O
protein O
levels O
of O
the O
lysosomal _RARE_
cysteine I-GENE
protease I-GENE
cathepsin _RARE_
B I-GENE
but O
did O
not O
up _RARE_
- O
regulate O
cathepsin _RARE_
B I-GENE
mRNA I-GENE
expression _RARE_
. O

The O
cellular O
rate O
of O
anticoagulant _RARE_
heparan _RARE_
sulfate _RARE_
proteoglycan _RARE_
( O
HSPGact _RARE_
) O
generation O
is O
determined O
by O
the O
level O
of O
a O
kinetically _RARE_
limiting O
microsomal _RARE_
activity O
, O
HSact _RARE_
conversion O
activity O
, O
which O
is O
predominantly O
composed O
of O
the O
long O
sought O
heparan _RARE_
sulfate _RARE_
D I-GENE
- I-GENE
glucosaminyl _RARE_
3 I-GENE
- I-GENE
O I-GENE
- I-GENE
sulfotransferase _RARE_
( O
3 I-GENE
- I-GENE
OST _RARE_
) O
( O
Shworak _RARE_
, O
N O
. O

Interestingly O
, O
EGF _RARE_
, O
but O
not O
insulin I-GENE
, O
stimulated _RARE_
tyrosine O
phosphorylation _RARE_
of O
c I-GENE
- I-GENE
cbl I-GENE
and O
its O
association O
with O
Crk I-GENE
- I-GENE
II I-GENE
. O

An O
end O
to O
the O
lottery _RARE_
. O

We O
previously O
showed O
that O
the O
N O
- O
terminal O
portion O
common O
to O
various O
chimeric I-GENE
MLL _RARE_
products I-GENE
, O
as _RARE_
well _RARE_
as _RARE_
to O
MLL _RARE_
- I-GENE
LTG9 _RARE_
and O
MLL _RARE_
- I-GENE
LTG19 _RARE_
, O
localizes O
in O
the O
nuclei O
, O
and O
therefore O
suggested O
that O
it O
might O
play O
an O
important O
role O
in O
leukemogenesis _RARE_
. O

Our O
results O
suggest O
that O
the O
pattern O
of O
blood _RARE_
supply O
is O
relevant O
to O
the O
structural O
organisation _RARE_
of O
mature _RARE_
lamellar _RARE_
bone O
around O
the O
implant O
. O

Induction O
of O
AtP5CS1 _RARE_
mRNA I-GENE
accumulation O
in O
salt O
- O
treated O
seedlings O
involves O
an O
immediate O
early O
transcriptional O
response O
regulated O
by O
ABA _RARE_
signalling O
that O
is O
not O
inhibited O
by O
cycloheximide _RARE_
, O
but O
abolished O
by O
the O
deficiency O
of O
ABA _RARE_
biosynthesis O
in O
the O
aba1 _RARE_
Arabidopsis I-GENE
mutant I-GENE
. O

It O
thus O
appears O
that O
MAPK _RARE_
functions O
in O
meiotic _RARE_
maturation _RARE_
by O
preventing O
unfertilized _RARE_
eggs O
from O
proceeding _RARE_
into O
parthenogenetic _RARE_
development O
. O

( O
ii O
) O
An O
AF _RARE_
G I-GENE
- I-GENE
CSF I-GENE
level O
> O
2000 O
pg O
/ O
ml O
is O
a O
strong O
positive O
predictor O
of O
CAM _RARE_
. O

A O
positive O
correlation O
between O
serum I-GENE
myoglobin I-GENE
and O
CA I-GENE
III I-GENE
concentrations O
( O
rs O
= O
0 _RARE_
. O
933 _RARE_
, O
P O
< O
0 _RARE_
. O
001 O
) O
was O
observed O
in O
hemodialyzed _RARE_
patients O
with O
chronic O
renal _RARE_
failure O
. O

Furthermore O
, O
the O
over O
- O
replication O
phenotype _RARE_
produced O
by O
this O
mutant I-GENE
p65cdc18 _RARE_
is O
resistant O
to O
increased O
mitotic _RARE_
cyclin _RARE_
/ O
CDK I-GENE
activity O
, O
a O
known O
inhibitor O
of O
over O
- O
replication O
. O

Rip1p _RARE_
is O
inessential _RARE_
, O
associated O
with O
nuclear O
pore _RARE_
complexes O
, O
and O
structurally O
related O
to O
the O
FG _RARE_
- I-GENE
nucleoporin _RARE_
family I-GENE
of O
pore _RARE_
proteins O
. O

The O
CNXA _RARE_
domain O
is O
similar O
at _RARE_
the O
amino O
acid O
level O
to O
the O
Escherichia I-GENE
coli I-GENE
moaA _RARE_
gene I-GENE
product I-GENE
, O
while O
CNXC _RARE_
is O
similar O
to O
the O
E I-GENE
. I-GENE
coli I-GENE
moaC _RARE_
product I-GENE
, O
with O
both O
E O
. O
coli O
products O
encoded O
by O
different O
cistrons _RARE_
. O

Deletions _RARE_
in O
each O
of O
these O
regions O
abolish _RARE_
membrane O
localization _RARE_
of O
Tiam1 _RARE_
and O
membrane O
ruffling _RARE_
, O
suggesting O
that O
they O
function O
cooperatively _RARE_
. O

However O
, O
besides _RARE_
the O
kinase O
catalytic O
domain O
and O
double O
leucine O
/ O
isoleucine _RARE_
zippers _RARE_
, O
there O
was O
no _RARE_
significant O
homology O
with O
known O
proteins O
. O

RNA I-GENE
polymerase I-GENE
II I-GENE
inhibition O
increased O
the O
binding O
of O
ARE _RARE_
( O
AUBP _RARE_
activity O
) O
and O
poly _RARE_
( O
U _RARE_
)- O
Sepharose _RARE_
by O
cytoplasmic I-GENE
hnRNP _RARE_
A1 _RARE_
, O
while O
nuclear I-GENE
hnRNP _RARE_
A1 _RARE_
binding O
was O
unaffected O
. O

Modulation _RARE_
of O
AUUUA _RARE_
response O
element O
binding O
by O
heterogeneous _RARE_
nuclear I-GENE
ribonucleoprotein I-GENE
A1 _RARE_
in O
human O
T O
lymphocytes O
. O

Histological O
slides _RARE_
of O
one O
biopsy O
of O
each O
patient O
( O
formalin O
- O
fixed O
and O
paraffin _RARE_
- O
embedded O
) O
were O
stained O
with O
a O
Modified _RARE_
Giemsa _RARE_
( O
MG _RARE_
), _RARE_
the O
Warthin _RARE_
- O
Starry _RARE_
( O
WS _RARE_
), _RARE_
and O
an O
immunohistochemical O
method O
( O
IMM _RARE_
) O
using O
purified _RARE_
polyclonal _RARE_
H O
. O
pylori _RARE_
antiserum _RARE_
( O
DAKO _RARE_
B471 _RARE_
). O

Their O
biosynthesis O
proceeds _RARE_
via O
linear _RARE_
precursors _RARE_
that O
become O
branched _RARE_
by O
beta1 I-GENE
, I-GENE
6 I-GENE
- I-GENE
GlcNAc _RARE_
transferases _RARE_
( O
IGnT6 _RARE_
, O
GlcNAc _RARE_
to O
Gal _RARE_
). O

These O
findings O
indicate O
that O
the O
t O
( O
4 O
; O
14 O
)( O
p16 _RARE_
. O
3 O
; O
q32 _RARE_
) O
represents O
a O
novel O
, O
recurrent O
chromosomal O
translocation O
in O
MM _RARE_
, O
and O
suggest O
that O
the O
FGFR3 _RARE_
gene I-GENE
may O
be O
the O
target O
of O
this O
abnormality O
and O
thus O
contribute O
to O
tumorigenesis O
in O
MM _RARE_
. O

In O
addition O
, O
mutation O
of O
the O
Sp1 _RARE_
site I-GENE
also O
significantly O
reduced _RARE_
promoter O
activity O
. O

Amino O
acid O
residues O
of O
beta O
1 O
', _RARE_
alpha O
A O
', _RARE_
alpha O
B O
', _RARE_
and O
the O
loop O
containing O
His539 _RARE_
of O
the O
RNase I-GENE
H I-GENE
domain I-GENE
interact O
with O
the O
primer O
strand _RARE_
of O
the O
dsDNA _RARE_
. O

Moreover O
, O
in O
one O
patient O
with O
a O
sarcoma O
who O
underwent O
a O
leg O
- O
sparing _RARE_
procedure O
, O
no _RARE_
sciatic _RARE_
nerve O
enlargement O
was O
seen O
postoperatively O
. O

The O
full O
length O
cDNA O
sequence O
of O
a O
Type _RARE_
I I-GENE
transforming I-GENE
growth I-GENE
factor I-GENE
- I-GENE
beta I-GENE
( I-GENE
TGF I-GENE
- I-GENE
beta I-GENE
) I-GENE
receptor I-GENE
has O
been O
isolated O
from O
the O
filarial _RARE_
parasitic _RARE_
nematode O
Brugia _RARE_
pahangi _RARE_
. O

This O
sequence O
possessed O
homology O
with O
a O
methylation O
- O
sensitive _RARE_
promoter O
element O
, O
Enh2 _RARE_
, O
present O
in O
the O
LTR O
of O
mouse O
intractisternal _RARE_
A O
- O
particles _RARE_
. O

Codon _RARE_
optimization _RARE_
for _RARE_
high O
- O
level O
expression _RARE_
of O
human I-GENE
erythropoietin I-GENE
( O
EPO I-GENE
) O
in O
mammalian O
cells O
. O

Parodoxical _RARE_
rise O
in O
urinary _RARE_
albumin I-GENE
levels O
after O
treatment O
of O
essential O
hypertension O
. O

20 O
% O
of O
total _RARE_
HSL _RARE_
transcripts I-GENE
in O
human O
subcutaneous O
adipocytes O
. O

Taken O
together O
, O
our O
data O
suggest O
that O
Rat7p _RARE_
/ O
Nup159p _RARE_
is O
anchored _RARE_
within O
the O
NPC _RARE_
through O
its O
coiled _RARE_
- O
coil _RARE_
region O
and O
adjacent O
sequences O
. O

In O
a O
group O
of O
13 _RARE_
patients O
with O
obliterative _RARE_
arteriopathies _RARE_
of O
the O
lower O
limbs _RARE_
the O
plasma O
levels O
of O
thrombomodulin _RARE_
( O
TM _RARE_
), _RARE_
betathromboglobulin _RARE_
( O
beta I-GENE
- I-GENE
TG I-GENE
), _RARE_
D O
- O
dimer _RARE_
( O
DD _RARE_
) O
and O
plasminogen I-GENE
activator I-GENE
- I-GENE
inhibitor I-GENE
( O
pAI _RARE_
- I-GENE
1 I-GENE
) O
were O
measured O
, O
and O
compared O
to O
the O
values O
obtained O
from O
10 O
healthy O
volunteers O
. O

These O
residues O
, O
Ile244 _RARE_
at _RARE_
the O
extracellular O
end O
of O
transmembrane O
helix O
3 O
, O
and O
Tyr318 _RARE_
at _RARE_
the O
COOH _RARE_
- O
terminal O
portion O
of O
extracellular O
loop O
2 O
, O
are O
replaced O
by O
Leu _RARE_
and O
Ile O
in O
the O
PTH _RARE_
- I-GENE
1 I-GENE
receptor I-GENE
, O
respectively O
. O

We O
have O
now O
shown O
that O
in O
vivo O
phosphorylation _RARE_
of O
14 I-GENE
- I-GENE
3 I-GENE
- I-GENE
3 I-GENE
zeta _RARE_
at _RARE_
the O
CKIalpha _RARE_
site I-GENE
( I-GENE
Thr _RARE_
- I-GENE
233 _RARE_
) I-GENE
negatively O
regulates O
its O
binding O
to O
c I-GENE
- I-GENE
Raf I-GENE
, O
and O
may O
be O
important O
in O
Raf I-GENE
- O
mediated _RARE_
signal O
transduction _RARE_
. O

Mouse _RARE_
mast _RARE_
cell I-GENE
protease I-GENE
9 I-GENE
, O
a O
novel O
member _RARE_
of O
the O
chromosome _RARE_
14 O
family O
of O
serine I-GENE
proteases _RARE_
that O
is O
selectively O
expressed _RARE_
in O
uterine _RARE_
mast _RARE_
cells O
. O

A O
DNase I-GENE
I I-GENE
- I-GENE
hypersensitive _RARE_
site I-GENE
has O
also O
been O
mapped O
in O
the O
258 O
- O
base _RARE_
pair _RARE_
enhancer O
region O
. O

[ _RARE_
Pulmonary _RARE_
vascular O
resistance O
( O
PVR _RARE_
) O
during _RARE_
10 O
% O
O2 _RARE_
- O
PVR _RARE_
during _RARE_
21 O
% O
O2 _RARE_
/ O
PVR _RARE_
during _RARE_
21 O
% O
O2 _RARE_
] O
x _RARE_
100 _RARE_
was O
termed O
as _RARE_
hypoxic O
pulmonary O
vasoconstriction _RARE_
( O
HPV O
). O

Together O
, O
our O
results O
show O
that O
tinman _RARE_
is O
controlled _RARE_
by O
an O
array _RARE_
of O
discrete O
enhancer O
elements O
that O
are O
activated O
successively _RARE_
by O
differential O
genetic O
inputs O
, O
as _RARE_
well _RARE_
as _RARE_
by O
closely O
linked _RARE_
activator O
and O
repressor O
binding O
sites O
within O
an O
early O
- O
acting O
enhancer O
, O
which O
restrict _RARE_
twist _RARE_
activity O
to O
specific O
areas O
within O
the O
twist _RARE_
expression _RARE_
domain I-GENE
. O

An O
unusual O
cysteine O
triplet O
conserved _RARE_
in O
the O
sequences O
of O
TB _RARE_
domains I-GENE
is O
localized O
to O
the O
hydrophobic O
core O
, O
at _RARE_
the O
C O
- O
terminus O
of O
an O
alpha O
- O
helix O
. O

The O
Fis _RARE_
protein I-GENE
regulates O
site O
- O
specific O
DNA O
inversion O
catalyzed O
by O
a O
family O
of O
DNA I-GENE
invertases _RARE_
when O
bound _RARE_
to O
a O
cis O
- O
acting O
recombinational _RARE_
enhancer O
. O

Protein O
phosphatases _RARE_
play O
a O
critical O
role O
in O
the O
regulation _RARE_
of O
the O
eukaryotic O
cell O
cycle _RARE_
and O
signal O
transduction _RARE_
. O

The O
cell O
cycle _RARE_
- O
regulated O
transcription O
factor O
E2F I-GENE
is O
also O
known O
to O
bend _RARE_
DNA O
upon O
binding O
. O

Our O
study O
reveals O
that O
the O
modular _RARE_
structure _RARE_
of O
the O
FSH I-GENE
receptor I-GENE
gene O
generates O
motifs O
that O
allows O
coupling O
to O
different O
effectors _RARE_
. O

Transcriptional O
regulation _RARE_
of O
SUP35 _RARE_
and O
SUP45 _RARE_
in I-GENE
Saccharomyces I-GENE
cerevisiae I-GENE
. O

These O
studies O
serve O
as _RARE_
the O
basis O
for _RARE_
the O
further O
characterization O
of O
the O
regulatory O
mechanism O
of O
aromatase I-GENE
expression _RARE_
in O
human O
breast O
cancer _RARE_
and O
ASCs _RARE_
. O

Xenopus I-GENE
Ran I-GENE
- I-GENE
binding I-GENE
protein I-GENE
1 I-GENE
: O
molecular _RARE_
interactions O
and O
effects O
on O
nuclear O
assembly O
in O
Xenopus O
egg _RARE_
extracts O
. O

She _RARE_
improved O
with O
a O
combination O
of O
benzodiazepines _RARE_
and O
the O
acetylcholinesterase _RARE_
inhibitor O
physostigmine _RARE_
. O

METHODS O
: O
Total O
muscle O
paralysis _RARE_
was O
induced _RARE_
under O
general _RARE_
anesthesia O
in O
a O
group O
of O
obese O
persons O
( O
n _RARE_
= O
9 O
; O
body O
mass O
index O
, O
32 _RARE_
+/- O
3 O
kg O
[- _RARE_
2 O
]) _RARE_
and O
in O
a O
group O
of O
nonobese _RARE_
persons O
( O
n _RARE_
= O
9 O
; O
body O
mas _RARE_
index O
, O
21 O
+/- O
2 O
kg O
[- _RARE_
2 O
]). _RARE_

PKA I-GENE
phosphorylated _RARE_
WT1 I-GENE
at _RARE_
Ser _RARE_
- O
365 _RARE_
and O
Ser _RARE_
- O
393 _RARE_
in O
vitro O
, O
as _RARE_
well _RARE_
as _RARE_
at _RARE_
additional O
sites O
, O
and O
this O
phosphorylation _RARE_
abolished O
the O
DNA O
- O
binding O
activity O
of O
WT1 I-GENE
in O
vitro O
. O

Our O
findings O
provide O
the O
first _RARE_
evidence O
that O
the O
function O
of O
WT1 I-GENE
can O
be O
modulated O
by O
its O
phosphorylation _RARE_
in O
vivo O
. O

Re O
: O
" O
Assessing _RARE_
the O
direction O
of O
causality _RARE_
in O
cross O
- O
sectional O
studies O
". O

A O
second O
aim O
was O
to O
determine O
whether O
the O
decrease O
in O
muscle O
- O
tendon O
unit O
rest O
length O
produced O
by O
prolonged O
immobilisation _RARE_
in O
a O
shortened O
position O
is O
mediated _RARE_
primarily O
by O
adaptations _RARE_
of O
the O
muscle O
or O
tendon O
. O

The O
presence O
of O
an O
additional O
sequence O
of O
nucleotides O
145 _RARE_
- O
165 O
from O
the O
3 O
' O
end O
of O
RNA3 _RARE_
enhanced _RARE_
template O
recognition O
by O
RdRp _RARE_
in O
vitro O
and O
accumulation O
of O
RNA3 _RARE_
in O
vivo O
to O
wild O
- O
type O
levels O
. O

We O
argue _RARE_
that O
the O
primary _RARE_
role O
of O
hh _RARE_
in O
controlling O
polarity O
is O
to O
cause O
anterior O
compartment O
cells O
to O
reverse O
their O
interpretation O
of O
an O
underlying O
symmetric _RARE_
polarization _RARE_
. O

Restriction O
enzyme O
mapping O
, O
subcloning _RARE_
, O
and O
DNA O
sequencing O
analysis O
of O
recombinant O
phage _RARE_
lambda O
and O
P1 O
clones _RARE_
revealed O
that O
exons O
encoding O
the O
1 O
. O
9 O
- O
kb O
mouse I-GENE
TS _RARE_
mRNA I-GENE
are O
dispersed _RARE_
over O
> O
150 _RARE_
kb O
genomic O
DNA O
. O

Transfection O
analyses O
indicated O
that O
the O
expression _RARE_
of O
Tbxas1 _RARE_
is O
controlled _RARE_
by O
a O
short O
( O
70 O
- O
bp O
) O
positive O
regulatory O
sequence O
and O
several O
upstream O
repressive O
elements O
. O

The O
results O
of O
this O
study O
suggest O
that O
NF _RARE_
- I-GENE
kappaB I-GENE
activity O
may O
be O
regulated O
by O
its O
interaction O
with O
the O
cell O
cycle _RARE_
regulatory O
protein O
, O
E2F I-GENE
- I-GENE
1 I-GENE
. O

The O
lysozyme I-GENE
FEF _RARE_
site O
is O
immediately O
5 O
' O
to O
a O
PU _RARE_
. O

Osteocalcin _RARE_
( O
OC _RARE_
) O
is O
a O
matrix _RARE_
calcium _RARE_
- I-GENE
binding I-GENE
protein I-GENE
expressed _RARE_
in O
osteoblasts _RARE_
and O
odontoblasts _RARE_
undergoing O
mineralization _RARE_
. O

In O
this O
study O
, O
we O
examine O
the O
effects O
of O
Msx2 _RARE_
expression _RARE_
on O
OC _RARE_
promoter I-GENE
activation O
( O
luciferase I-GENE
reporter I-GENE
) O
by O
FGF2 _RARE_
/ O
FSK _RARE_
and O
calcitriol _RARE_
in O
MC3T3 _RARE_
- O
E1 O
osteoblasts _RARE_
. O

Thus O
, O
unlike O
other O
proteins O
reported O
to O
inhibit O
SRF I-GENE
activity O
, O
the O
repressor O
activity O
associated O
with O
the O
GC _RARE_
- O
rich O
element O
does O
not O
appear O
to O
function O
through O
direct O
inhibition O
of O
SRF I-GENE
binding O
. O

However O
, O
one O
CAK I-GENE
- O
phosphorylated _RARE_
phosphopeptide _RARE_
comigrates _RARE_
with O
a O
Cdc2 I-GENE
- O
phosphorylated _RARE_
phosphopeptide _RARE_
previously O
shown O
to O
be O
mitosis O
- O
specific O
, O
suggesting O
that O
, O
in O
vitro O
, O
CAK I-GENE
is O
able O
to O
phosphorylate O
at _RARE_
least O
one O
site O
that O
is O
also O
phosphorylated _RARE_
in O
vivo O
. O

The O
pen _RARE_
can O
heal _RARE_
. O

The O
mHIF _RARE_
- I-GENE
1 I-GENE
alpha I-GENE
structural I-GENE
gene I-GENE
is O
composed O
of O
15 _RARE_
exons O
. O

However O
, O
when O
a O
second O
, O
upstream I-GENE
IRE _RARE_
- I-GENE
like I-GENE
sequence I-GENE
was O
evaluated O
by O
EMSA O
, O
a O
DNA O
binding O
pattern O
distinct O
from O
that O
seen O
following O
exposure O
to O
IFN I-GENE
- I-GENE
gamma I-GENE
alone O
was O
observed O
after O
prolonged O
stimulation _RARE_
with O
both O
IFN I-GENE
- I-GENE
alpha I-GENE
and O
IFN I-GENE
- I-GENE
gamma I-GENE
. O

In O
Arabidopsis O
, O
the O
induction O
of O
a O
dehydration _RARE_
- O
responsive O
gene O
, O
rd22 _RARE_
, O
is O
mediated _RARE_
by O
abscisic _RARE_
acid O
( O
ABA _RARE_
) O
and O
requires O
protein O
biosynthesis O
for _RARE_
ABA _RARE_
- O
dependent O
gene O
expression _RARE_
. O

A O
cDNA O
encoding O
a O
MYC _RARE_
- I-GENE
related I-GENE
DNA I-GENE
binding I-GENE
protein I-GENE
was O
isolated O
by O
DNA O
- O
ligand _RARE_
binding O
screening O
, O
using O
the O
67 O
- O
bp O
region O
as _RARE_
a O
probe O
, O
and O
designated O
rd22BP1 _RARE_
. O

Human I-GENE
PDK1 _RARE_
is O
homologous O
to O
the O
Drosophila I-GENE
protein I-GENE
kinase I-GENE
DSTPK61 _RARE_
, O
which O
has O
been O
implicated O
in O
the O
regulation _RARE_
of O
sex _RARE_
differentiation O
, O
oogenesis _RARE_
and O
spermatogenesis _RARE_
. O

Thus O
, O
the O
synergistic O
effects O
of O
HNF I-GENE
- I-GENE
1beta I-GENE
and O
the O
GR I-GENE
on O
dexamethasone O
- O
stimulated _RARE_
promoter O
activity O
require O
that O
they O
are O
bound _RARE_
to O
the O
HNF I-GENE
- I-GENE
1 I-GENE
site I-GENE
and O
the O
GRE _RARE_
, O
respectively O
, O
and O
may O
involve O
protein O
- O
protein O
interactions O
between O
the O
transcription O
factors O
, O
or O
between O
them O
and O
the O
basal O
transcription O
machinery O
or O
a O
steroid I-GENE
receptor I-GENE
coactivator _RARE_
. O

Mutational O
analysis O
shows O
that O
both O
an O
AP I-GENE
- I-GENE
1 I-GENE
like I-GENE
sequence I-GENE
(- _RARE_
294 _RARE_
/- O
285 O
, O
TGAATCATCA _RARE_
) O
and O
an O
A O
/ O
T O
- O
rich O
myocyte _RARE_
enhancer I-GENE
factor I-GENE
( I-GENE
MEF I-GENE
)- I-GENE
2 I-GENE
like I-GENE
sequence I-GENE
(- _RARE_
310 _RARE_
/- O
298 _RARE_
, O
TTAAAAATAAAAA _RARE_
) O
in O
the O
33 _RARE_
- O
bp O
region O
are O
necessary O
for _RARE_
the O
OP _RARE_
- I-GENE
1 I-GENE
effect O
. O

Unlike O
most O
other O
members O
of O
the O
Bcl I-GENE
- I-GENE
2 I-GENE
family I-GENE
, O
BAD _RARE_
( O
Bcl I-GENE
- I-GENE
xL _RARE_
/ I-GENE
Bcl I-GENE
- I-GENE
2 I-GENE
associated I-GENE
death _RARE_
promoter I-GENE
), _RARE_
a O
death _RARE_
enhancer I-GENE
, O
has O
no _RARE_
C O
- O
terminal O
transmembrane O
domain O
for _RARE_
targeting O
to O
the O
outer _RARE_
mitochondrial O
membrane O
and O
nuclear O
envelope O
. O

Electromobility _RARE_
shift O
and O
cotransfection O
assays O
demonstrated O
that O
HNF1alpha _RARE_
, O
but O
not O
HNF4 _RARE_
, O
bound _RARE_
to O
its O
cognate _RARE_
site O
and O
transactivated O
G6Pase _RARE_
gene I-GENE
expression _RARE_
. O

An O
open _RARE_
reading O
frame O
of O
2862 _RARE_
bp O
encoding O
a O
954 _RARE_
amino O
acid O
protein O
was O
identified O
. O

One O
of O
these O
, O
an O
AACA _RARE_
motif O
, O
has O
been O
shown O
to O
be O
a O
negative O
regulator O
in O
non O
- O
seed _RARE_
tissues O
and O
has O
a O
similarity _RARE_
to O
the O
barley _RARE_
gibberellin _RARE_
responsive O
element O
recognized _RARE_
by O
MYB _RARE_
- I-GENE
like I-GENE
DNA I-GENE
binding I-GENE
proteins I-GENE
. O

Strain _RARE_
CFN037 _RARE_
is O
an O
R O
. O
etli _RARE_
mutant O
induced _RARE_
by O
a O
single O
Tn5mob _RARE_
insertion _RARE_
in O
the O
promoter O
region O
of O
the O
thiCOGE _RARE_
gene I-GENE
cluster I-GENE
. O

Expression O
of O
thiamin _RARE_
biosynthetic O
genes O
( O
thiCOGE _RARE_
) O
and O
production O
of O
symbiotic _RARE_
terminal I-GENE
oxidase I-GENE
cbb3 _RARE_
in O
Rhizobium _RARE_
etli _RARE_
. O

We O
have O
cloned _RARE_
and O
sequenced O
a O
region O
encoding O
a O
lipase I-GENE
operon I-GENE
and O
a O
putative O
, O
previously O
uncharacterized O
metalloprotease _RARE_
of I-GENE
Vibrio _RARE_
cholerae _RARE_
O1 _RARE_
. O

Furthermore O
, O
the O
amount O
of O
tRNA I-GENE
( I-GENE
3Lys _RARE_
) I-GENE
that O
was O
placed O
onto O
viral O
RNA O
in O
mutated _RARE_
viruses O
was O
significantly O
less O
than O
that O
placed O
in O
the O
wild O
- O
type O
virus O
. O

This O
protein O
is O
present O
in O
both O
HeLa O
nuclear O
extracts O
and O
S100 _RARE_
extracts O
but O
absent O
from O
SR I-GENE
protein I-GENE
preparations O
, O
suggesting O
that O
it O
is O
not O
a O
classical O
SR I-GENE
protein I-GENE
. O

Differential O
regulation _RARE_
of O
the O
pre I-GENE
- I-GENE
C I-GENE
and O
pregenomic _RARE_
promoters O
of O
human O
hepatitis O
B O
virus O
by O
members O
of O
the O
nuclear I-GENE
receptor I-GENE
superfamily I-GENE
. O

Acad _RARE_
. O

Chimeras _RARE_
containing O
IE1 I-GENE
peptides I-GENE
dramatically O
activated O
transcription O
of O
the O
basal O
promoter O
only O
when O
lac I-GENE
operator I-GENE
sequences I-GENE
were O
present O
. O

The O
results O
of O
replicase _RARE_
assays O
performed O
with O
mutant I-GENE
VP2 _RARE_
containing O
a O
deletion O
in O
its O
RNA O
- O
binding O
domain O
suggests O
that O
the O
essential O
role O
for _RARE_
VP2 _RARE_
in O
replication O
is O
linked _RARE_
to O
the O
protein O
' O
s O
ability O
to O
bind O
the O
mRNA O
template O
for _RARE_
minus O
- O
strand _RARE_
synthesis _RARE_
. O

We O
previously O
described O
two O
alanine O
cluster O
mutations O
, O
R77 _RARE_
to O
A O
( O
R77A _RARE_
)- O
K79A _RARE_
and O
E192A _RARE_
- O
E194A _RARE_
, O
which O
selectively O
inactivated O
the O
triphosphatase _RARE_
component _RARE_
. O

Transfection O
of O
HepG2 _RARE_
and O
SK _RARE_
- O
N O
- O
MC O
cells O
with O
constructs O
deleted _RARE_
of O
additional O
5 O
'- O
flanking O
fragments O
permitted O
the O
definition O
of O
a O
minimal O
200 _RARE_
bp O
promoter O
fragment O
containing O
the O
pseudo _RARE_
- O
TATA O
box O
and O
two O
putative O
SP1 I-GENE
- I-GENE
binding I-GENE
sites I-GENE
. O

Both O
inserts O
are O
larger O
than O
their O
homologues _RARE_
in O
eIF I-GENE
- I-GENE
2alpha I-GENE
kinases I-GENE
. O

Three O
monopolar _RARE_
electrodes O
were O
inserted O
into O
the O
left _RARE_
and O
right O
lateral O
vestibulospinal _RARE_
tract _RARE_
( O
LVST _RARE_
) O
and O
medial O
vestibulospinal _RARE_
tract _RARE_
( O
MVST _RARE_
) O
of O
the O
C1 O
segment O
, O
to O
determine O
the O
pathway _RARE_
of O
axons _RARE_
. O

Epitopes _RARE_
of O
adhesion O
- O
perturbing _RARE_
monoclonal O
antibodies O
map O
within O
a O
predicted O
alpha O
- O
helical O
domain O
of O
the O
integrin I-GENE
beta I-GENE
1 I-GENE
subunit I-GENE
. O

Polyhomeotic _RARE_
and I-GENE
Posterior _RARE_
Sex _RARE_
Combs _RARE_
may O
participate O
in O
a O
more O
general _RARE_
transcriptional O
mechanism O
that O
causes O
modulated O
gene O
repression O
, O
whereas O
the O
inclusion O
of O
Polycomb _RARE_
protein I-GENE
in O
the O
complex O
at _RARE_
PREs _RARE_
leads O
to O
stable O
silencing O
. O

Furthermore O
, O
both O
rhHR23 _RARE_
proteins I-GENE
function O
in O
a O
defined O
NER _RARE_
system _RARE_
reconstituted O
with O
purified _RARE_
proteins O
, O
indicating O
direct O
involvement O
of O
hHR23 _RARE_
proteins I-GENE
in O
the O
DNA O
repair O
reaction O
via O
interaction O
with O
XPC _RARE_
. O

The O
yeast O
silent _RARE_
information _RARE_
regulator I-GENE
Sir4p _RARE_
anchors _RARE_
and O
partitions _RARE_
plasmids O
. O

These O
results O
implicate _RARE_
a O
precursor O
- O
specific O
base _RARE_
- O
paired O
structure _RARE_
involving O
sequences O
on O
both O
sides O
of O
the O
mature _RARE_
cleavage _RARE_
site O
in O
the O
3 O
' O
processing _RARE_
of O
human I-GENE
U2 _RARE_
RNA I-GENE
. O

Polysome _RARE_
analyses O
in O
a O
temperature _RARE_
- O
sensitive _RARE_
fal1 _RARE_
- I-GENE
1 I-GENE
mutant I-GENE
and O
a O
Fal1p _RARE_
- O
depleted O
strain _RARE_
reveal O
a O
decrease O
in O
the O
number O
of O
40S _RARE_
ribosomal I-GENE
subunits I-GENE
. O

Sequence O
analysis O
identified O
some O
of O
these O
cDNA O
clones _RARE_
as _RARE_
Dlc _RARE_
- I-GENE
1 I-GENE
, O
a O
sequence O
encoding O
a O
small O
, O
9 I-GENE
- I-GENE
kDa I-GENE
human I-GENE
homolog I-GENE
of I-GENE
the I-GENE
outer _RARE_
- I-GENE
arm _RARE_
dynein I-GENE
light I-GENE
- I-GENE
chain I-GENE
protein O
. O

Importantly _RARE_
, O
in O
HeLa O
and O
293 O
cells O
, O
endogenous O
and O
transfected O
I I-GENE
kappaB I-GENE
alpha I-GENE
coimmunoprecipitated _RARE_
with O
Myc _RARE_
- O
tagged _RARE_
or O
endogenous O
Dlc _RARE_
- I-GENE
1 I-GENE
. O

The O
mouse I-GENE
M I-GENE
- I-GENE
lysozyme I-GENE
downstream _RARE_
enhancer I-GENE
has O
been O
previously O
characterized O
on O
several O
levels O
of O
gene O
regulation _RARE_
. O

Identification O
of O
dynein I-GENE
heavy I-GENE
chain I-GENE
genes I-GENE
expressed _RARE_
in O
human O
and O
mouse O
testis _RARE_
: O
chromosomal O
localization _RARE_
of O
an O
axonemal _RARE_
dynein I-GENE
gene I-GENE
. O

Bitter _RARE_
cassava _RARE_
contains O
cyanogenic _RARE_
glycosides _RARE_
; O
processing _RARE_
breaks _RARE_
them O
down O
to O
acetone _RARE_
cyanohydrin _RARE_
and O
hydrogen O
cyanide _RARE_
. O

The O
proposed O
mechanism O
of O
effect O
states O
that O
mono O
( O
2 O
- O
ethylhexyl _RARE_
) O
phthalate _RARE_
( O
MEHP _RARE_
), _RARE_
the O
primary _RARE_
hydrolysis O
product O
of O
DEHP _RARE_
, O
mimics _RARE_
the O
inducing O
prostaglandins O
( O
PG _RARE_
) O
PGD _RARE_
( O
2 O
), _RARE_
9alpha _RARE_
, O
11betaPGF2 _RARE_
, O
and O
PGF2alpha _RARE_
, O
and O
thromboxanes _RARE_
in O
the O
lungs O
, O
thereby O
increasing O
the O
risk O
of O
inducing O
inflammation O
in O
the O
airways _RARE_
, O
which O
is O
a O
characteristic O
of O
asthma O
. O

We O
found O
14 O
protein O
binding O
sites O
that O
were O
occupied O
in O
vivo O
. O

Constitutive _RARE_
protection O
of O
E2F I-GENE
recognition I-GENE
sequences I-GENE
in O
the O
human I-GENE
thymidine _RARE_
kinase I-GENE
promoter I-GENE
during _RARE_
cell O
cycle _RARE_
progression O
. O

Comparison O
of O
genomic O
sequence O
shows O
that O
the O
ph _RARE_
locus I-GENE
has O
been O
duplicated O
, O
and O
that O
it O
contains O
proximal O
and O
distal O
transcription O
units _RARE_
. O

Radiation _RARE_
decreased O
the O
levels O
of O
T4 O
and O
T3 _RARE_
6 O
h O
and O
72 O
h O
in O
group O
C O
, O
in O
group O
A O
at _RARE_
72 O
h O
, O
in O
group O
B O
at _RARE_
24 _RARE_
h O
postexposure O
. O

We O
have O
reviewed O
the O
experience O
of O
a O
major O
MMT _RARE_
general _RARE_
practice O
with O
hepatitis O
C O
virus O
( O
HCV O
) O
infection O
from O
1991 O
to O
1995 O
. O

The O
author O
analyzes _RARE_
extensive O
own O
data O
based O
on O
study O
into O
particular O
features O
of O
cardiovascular O
disorders O
in O
chronic O
renal _RARE_
impairement _RARE_
with O
making O
use O
of O
modern O
diagnostic O
tools O
. O

In O
this O
paper O
, O
characterization O
is O
given O
of O
clinical O
and O
biochemical O
features O
of O
VH _RARE_
B O
course O
against O
the O
background O
of O
narcomania _RARE_
. O

447 _RARE_
microns O
for _RARE_
A O
. O
microcephalum _RARE_
and O
350 O
microns O
for _RARE_
A O
. O
wedli _RARE_
), _RARE_
and O
fewer O
testes O
per O
proglottis _RARE_
( O
44 _RARE_
- O
73 _RARE_
vs _RARE_
. O

The O
ZnF20 _RARE_
cDNA I-GENE
hybridized O
to O
multiple O
transcripts O
in O
a O
thyroid O
cancer _RARE_
cell O
line O
( O
8 O
. O
0 _RARE_
, O
4 O
. O
5 O
and O
2 O
kb O
) O
that O
increased O
after O
cycloheximide _RARE_
treatment O
and O
decayed _RARE_
< O
2 O
h O
after O
addition O
of O
actinomycin _RARE_
D O
. O

Glutathione _RARE_
S I-GENE
- I-GENE
transferase I-GENE
( O
GST I-GENE
)- O
E2F I-GENE
and O
GST I-GENE
- O
DP _RARE_
fusion O
proteins O
were O
found O
to O
cooperate O
in O
binding O
to O
the O
three O
E2F I-GENE
sites I-GENE
in O
the O
DNA I-GENE
polymerase I-GENE
alpha I-GENE
gene I-GENE
promoter I-GENE
in O
vitro O
. O

Two O
sterol O
regulatory O
element O
- O
like O
sequences O
mediate O
up _RARE_
- O
regulation _RARE_
of O
caveolin _RARE_
gene I-GENE
transcription O
in O
response O
to O
low I-GENE
density I-GENE
lipoprotein I-GENE
free O
cholesterol O
. O

Furthermore O
, O
DNA O
- O
bound _RARE_
LAZ3 _RARE_
/ O
BCL6 _RARE_
recruits _RARE_
SMRT I-GENE
in O
vivo O
, O
and O
both O
overexpressed O
proteins O
completely O
colocalize _RARE_
in O
nuclear O
dots _RARE_
. O

CONCLUSIONS O
: O
We O
obtained O
normal O
EPO I-GENE
levels O
for _RARE_
mothers O
and O
newborns O
for _RARE_
our O
area O
, O
similarly O
to O
the O
previously O
described O
ones O
. O

Ischaemia _RARE_
was O
induced _RARE_
by O
a O
low O
flow O
rate O
of O
0 _RARE_
. O
8 O
mL O
min O
- O
1 O
for _RARE_
30 _RARE_
min O
, O
and O
was O
followed O
by O
a O
40 O
- O
minute O
reperfusion O
. O

First O
, O
two O
MCTs _RARE_
using O
a O
long O
electrode O
, O
3 O
cm O
in O
size O
, O
were O
performed O
in O
the O
central O
area O
of O
the O
tumor O
, O
and O
eight O
MCTs _RARE_
by O
a O
short O
electrode O
, O
2 O
cm O
in O
size O
, O
were O
done O
in O
the O
peripheral O
and O
surrounding O
area O
of O
the O
tumor O
. O

BACKGROUND O
: O
Checkpoint _RARE_
pathways O
prevent O
cell O
- O
cycle _RARE_
progression O
in O
the O
event O
of O
DNA O
lesions O
. O

Direct _RARE_
proof _RARE_
that O
the O
heightened _RARE_
renal _RARE_
cellular O
apoptosis O
in O
PKD _RARE_
is O
not O
occurring O
through O
p53 I-GENE
was O
obtained O
by O
successive O
matings _RARE_
between O
SBM _RARE_
and O
p53 I-GENE
(-/-) _RARE_
mice O
. O

Accumulated _RARE_
evidence O
indicates O
that O
, O
upon O
stimulation _RARE_
with O
interferon _RARE_
- I-GENE
gamma I-GENE
( O
IFN I-GENE
- I-GENE
gamma I-GENE
), _RARE_
three O
beta O
- O
type O
subunits O
, O
designated O
LMP2 _RARE_
, O
LMP7 _RARE_
, O
and O
PSMB10 _RARE_
, O
are O
incorporated O
into O
the O
20S I-GENE
proteasome I-GENE
by O
displacing _RARE_
the O
housekeeping O
beta O
- O
type O
subunits O
designated O
PSMB6 _RARE_
, O
PSMB5 _RARE_
, O
and O
PSMB7 _RARE_
, O
respectively O
. O

The O
major O
RNase I-GENE
E I-GENE
cleavage _RARE_
product O
( O
denoted _RARE_
pSok _RARE_
- I-GENE
6 I-GENE
) O
is O
rapidly O
degraded O
by O
polynucleotide _RARE_
phosphorylase _RARE_
( O
PNPase _RARE_
). O

This O
difference O
may O
result O
from O
the O
lower O
match O
to O
the O
ARG _RARE_
box O
consensus O
of O
the O
O I-GENE
( I-GENE
rocD _RARE_
) I-GENE
site I-GENE
. O

Ask _RARE_
AONE _RARE_
' O
s O
experts _RARE_
... _RARE_
about O
productivity _RARE_
indicators O
. O

All O
pigs O
had O
significant O
regional O
LV O
dysfunction O
and O
reduced _RARE_
LV O
ejection O
fraction O
( O
41 _RARE_
+/- O
11 O
%). O

The O
progress O
of O
morphological O
research O
on O
the O
parabrachial _RARE_
nucleus O

The O
amplitudes O
of O
DPOAE _RARE_
also O
recovered O
to O
a O
greater O
extent O
and O
outer _RARE_
hair _RARE_
cell O
losses _RARE_
were O
less O
severe O
in O
the O
R O
- O
PIA _RARE_
- O
treated O
ears O
. O

The O
data O
provide O
evidence O
both O
for _RARE_
a O
signal O
transduction _RARE_
pathway _RARE_
independent O
of O
JNK I-GENE
, O
ERK I-GENE
, O
and O
p38 I-GENE
MAP I-GENE
kinase I-GENE
to O
be O
involved O
in O
the O
induction O
of O
rhoB _RARE_
by O
genotoxic _RARE_
stress O
, O
and O
furthermore _RARE_
, O
indicate O
autoregulation O
of O
rhoB _RARE_
. O

In O
an O
effort O
to O
separate O
domains O
of O
FadR _RARE_
required O
for _RARE_
DNA O
binding O
, O
dimerization _RARE_
, O
and O
ligand _RARE_
binding O
, O
chimeric O
protein O
fusions O
between O
the O
DNA O
binding O
domain O
of O
LexA I-GENE
and O
different O
regions O
of O
FadR _RARE_
were O
constructed O
. O

Inhibition O
appears O
to O
result O
from O
titration O
of O
general _RARE_
transcription O
factors O
because O
MDM2 _RARE_
overexpression O
inhibits O
c I-GENE
- I-GENE
fos I-GENE
as _RARE_
well _RARE_
as _RARE_
other O
promoters O
in O
vivo O
and O
basal O
transcription O
in O
vitro O
. O

4 O
) O
PU _RARE_
and O
PD _RARE_
lacked O
the O
canonical O
TATA O
or O
CAAT O
motifs O
, O
and O
are O
AT O
- O
rich O
. O

We O
also O
show O
by O
immunogold _RARE_
electron O
microscopy O
immunocytochemistry _RARE_
that O
amphiphysin _RARE_
I I-GENE
is O
localized O
in O
the O
nerve O
terminal O
cytomatrix _RARE_
and O
is O
partially O
associated O
with O
endocytic O
intermediates _RARE_
. O

The O
mobility O
shift O
of O
both O
of O
these O
proteins O
is O
abolished O
by O
treatment O
with O
inhibitors _RARE_
of O
PKC I-GENE
or O
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
/ O
extracellular I-GENE
signal I-GENE
- I-GENE
related I-GENE
kinase I-GENE
kinase I-GENE
. O

The O
prescription _RARE_
for _RARE_
apoplexy _RARE_
includes O
C1 O
- O
7 O
, O
T1 _RARE_
- O
9 O
and O
L2 O
- O
4 O
. O

During O
the O
aftermath _RARE_
of O
excitation _RARE_
of O
the O
skin _RARE_
sympathetic O
nerve O
by O
mental O
arithmetics _RARE_
, O
3 O
/ O
12 O
A O
delta O
units _RARE_
were O
turned O
to O
the O
active _RARE_
state O
with O
decreased O
mechanical O
threshold O
. O

In O
a O
similar O
fashion O
to O
adipose _RARE_
stromal _RARE_
cells O
, O
serum O
potentiated _RARE_
the O
response O
to O
dexamethasone O
but O
had O
no _RARE_
effect O
on O
phorbol O
ester O
- O
stimulated _RARE_
activity O
. O

Thus O
, O
Hex _RARE_
expression _RARE_
marks _RARE_
the O
earliest _RARE_
unequivocal _RARE_
molecular _RARE_
anteroposterior O
asymmetry O
in O
the O
mouse O
embryo _RARE_
and O
indicates O
that O
the O
anteroposterior O
axis O
of O
the O
embryo _RARE_
develops _RARE_
from O
conversion O
of O
a O
proximodistal _RARE_
asymmetry O
established O
in O
the O
primitive _RARE_
endoderm O
lineage O
. O

Thus O
, O
dpp _RARE_
and O
omb _RARE_
promote O
both O
dorsal O
leg O
cell O
fate O
as _RARE_
well _RARE_
as _RARE_
transdetermination _RARE_
- O
competent O
leg O
disc O
cells O
. O

CONCLUSIONS O
: O
While O
INR _RARE_
correction O
may O
be O
achieved O
by O
all O
the O
above O
methods O
, O
that O
relating _RARE_
log O
reference O
INR _RARE_
to O
log O
local O
prothrombin I-GENE
time O
by O
linear _RARE_
regression O
analysis O
is O
the O
simplest _RARE_
to O
perform O
. O

RESULTS O
: O
The O
overall O
FNF _RARE_
for _RARE_
1992 O
was O
12 O
. O
3 O
% O
and O
was O
19 O
. O
1 O
%, O
22 _RARE_
. O
2 O
%, O
3 O
. O
8 O
% O
and O
6 O
. O
1 O
% O
per O
successive O
quarters _RARE_
in O
1992 O
. O

Western O
blot O
analysis O
of O
various O
bovine O
tissues O
with O
human O
NMT _RARE_
peptide I-GENE
antibody I-GENE
indicated O
a O
common O
prominent O
immunoreactive _RARE_
band O
with O
an O
apparent O
molecular _RARE_
mass O
of O
48 _RARE_
. O
5 O
- O
50 O
kDa O
in O
all O
tissues O
. O

Transcription O
start _RARE_
sites O
of O
the O
plastid _RARE_
ACCase _RARE_
genes I-GENE
were O
estimated O
from O
the O
longest _RARE_
cDNA O
clones _RARE_
obtained O
by O
5 O
'- O
RACE O
( O
rapid O
amplification O
of O
cDNA O
ends O
). O

AIDS O
- O
related O
disseminated _RARE_
histoplasmosis _RARE_
in O
San _RARE_
Francisco _RARE_
, O
California _RARE_
. O

Thus O
, O
Fis _RARE_
acts O
as _RARE_
an O
accessory _RARE_
transcriptional O
activator O
at _RARE_
the O
mar _RARE_
promoter I-GENE
. O

These O
observations O
provide O
strong O
support O
for _RARE_
the O
idea O
that O
expression _RARE_
of O
mutant O
tRNA O
can O
confer O
a O
mutator _RARE_
phenotype _RARE_
, O
including O
the O
UVM _RARE_
- O
constitutive _RARE_
phenotype _RARE_
observed O
in O
mutA _RARE_
and O
mutC _RARE_
cells O
. O

TNF I-GENE
- I-GENE
alpha I-GENE
exposure O
markedly O
increased O
activity O
of O
several O
RNA O
- O
binding O
proteins O
, O
especially O
a O
novel O
Mr O
50 O
, O
000 _RARE_
- O
55 _RARE_
, O
000 _RARE_
RNA O
- O
binding O
protein O
. O

We O
speculate _RARE_
that O
the O
human O
papillomavirus _RARE_
late _RARE_
mRNAs O
, O
produced O
from O
several O
hundred O
copies O
of O
the O
virus O
genome O
present O
in O
infected _RARE_
cells O
, O
compete O
with O
the O
c I-GENE
- I-GENE
fos I-GENE
mRNAs I-GENE
for _RARE_
destabilizing _RARE_
cellular O
factors O
and O
that O
this O
may O
lead O
to O
elevated O
Fos I-GENE
protein I-GENE
levels O
in O
human O
papillomavirus _RARE_
infected _RARE_
cells O
. O

Two O
closely O
related O
IgH _RARE_
constant O
region O
genes O
, O
CHA _RARE_
and O
CHB _RARE_
, O
have O
been O
sequenced O
completely O
. O

The O
aim O
of O
this O
study O
was O
to O
find O
out O
whether O
it O
was O
possible O
to O
detect O
normal O
lymph O
nodes O
by O
high O
- O
resolution O
mediastinal _RARE_
US O
. O

To O
study O
the O
role O
of O
heavy O
chain O
motifs O
in O
substrate O
recognition O
, O
secreted _RARE_
variants O
of O
recombinant I-GENE
bovine I-GENE
proenteropeptidase _RARE_
were O
constructed O
by O
replacing O
the O
transmembrane O
domain O
with O
a O
signal O
peptide O
. O

CKbeta4GT _RARE_
- I-GENE
II I-GENE
is O
predicted O
to O
encode O
a O
type I-GENE
II I-GENE
transmembrane I-GENE
glycoprotein I-GENE
of O
43 _RARE_
kDa O
with O
five O
potential _RARE_
N O
- O
linked _RARE_
glycosylation O
sites O
. O

We O
now O
demonstrate O
that O
CCAAT I-GENE
/ I-GENE
enhancer I-GENE
- I-GENE
binding I-GENE
protein I-GENE
( I-GENE
C I-GENE
/ I-GENE
EBP I-GENE
) I-GENE
delta I-GENE
is O
a O
major O
component _RARE_
of O
a O
PGE2 O
- O
stimulated _RARE_
DNA O
- O
protein O
complex O
involving O
HS3D _RARE_
and O
find O
that O
C I-GENE
/ I-GENE
EBPdelta _RARE_
transactivates O
IGF I-GENE
- I-GENE
I I-GENE
promoter I-GENE
1 I-GENE
through O
this O
site O
. O

PATIENTS O
AND _RARE_
METHODS O
: O
Semen _RARE_
analyses O
were O
performed O
on O
58 O
patients O
with O
stages O
I O
- O
III O
HD O
before O
, O
during _RARE_
, O
and O
after O
chemotherapy O
and O
after O
the O
sperm O
count O
recovered O
from O
the O
effects O
of O
abdominal O
radiotherapy O
that O
was O
given O
after O
chemotherapy O
. O

Thus O
, O
the O
absence O
of O
residual O
infarct O
- O
zone O
viability O
discriminates _RARE_
patients O
who O
develop O
progressive O
left _RARE_
ventricular O
dilation _RARE_
after O
reperfused _RARE_
AMI O
from O
those O
who O
maintain O
normal O
left _RARE_
ventricular O
geometry _RARE_
. O

With O
a O
BMI O
cutoff O
of O
27 _RARE_
, O
mean O
cardiac O
NE _RARE_
spillover _RARE_
was O
46 _RARE_
% O
lower O
in O
the O
obese O
subjects O
when O
compared O
with O
the O
lean O
subjects O
( O
P O
=. O
017 _RARE_
). O

The O
gene O
( O
ApxII _RARE_
) O
encoding O
both O
chloroplastic _RARE_
ascorbate _RARE_
peroxidase I-GENE
isoenzymes _RARE_
was O
isolated O
and O
the O
organization O
of O
the O
gene O
was O
determined O
. O

This O
emphasizes O
the O
conclusion O
that O
CDF _RARE_
- I-GENE
1 I-GENE
is O
not O
an O
E2F I-GENE
family I-GENE
member _RARE_
and O
points O
to O
profound O
differences O
in O
the O
cell O
cycle _RARE_
regulation _RARE_
of O
CDF _RARE_
- I-GENE
1 I-GENE
and O
E2F I-GENE
. O

The O
proofreading _RARE_
domain O
of O
Escherichia I-GENE
coli I-GENE
DNA I-GENE
polymerase I-GENE
I I-GENE
and O
other O
DNA I-GENE
and I-GENE
/ I-GENE
or I-GENE
RNA I-GENE
exonuclease _RARE_
domains I-GENE
. O

Interleukin I-GENE
- I-GENE
1 I-GENE
levels O
remained O
low O
throughout O
the O
course O
. O

Responsibility _RARE_
matters _RARE_
-- _RARE_
this O
is O
a O
scientific _RARE_
council _RARE_

Southern O
blot O
analysis O
of O
endonuclease O
- O
digested _RARE_
genomic O
DNA O
from O
primary _RARE_
chick _RARE_
embryo _RARE_
fibroblasts _RARE_
( O
CEF _RARE_
) O
suggested O
that O
MEK2 _RARE_
is O
a O
single O
- O
copy O
gene O
in O
this O
vertebrate _RARE_
species O
. O

Sequences _RARE_
required O
for _RARE_
interaction O
of O
mu2 _RARE_
and O
CTLA _RARE_
- I-GENE
4 I-GENE
were O
localized O
to O
residues O
, O
161TTGVY _RARE_
in O
CTLA _RARE_
- I-GENE
4 I-GENE
; O
this O
sequence O
is O
N O
- O
terminal O
to O
, O
but O
overlaps _RARE_
with O
, O
a O
previously O
identified O
SH2 _RARE_
binding I-GENE
motif I-GENE
, O
165YVKM _RARE_
, O
involved O
in O
CTLA _RARE_
- I-GENE
4 I-GENE
signaling _RARE_
. O

Here O
, O
we O
report O
that O
a O
transfected O
Chinese _RARE_
hamster O
ovary O
( O
CHO O
) O
cell O
line O
expressing O
a O
murine I-GENE
CD4 _RARE_
fragment I-GENE
containing O
the O
first _RARE_
two O
N O
- O
terminal O
domains O
secretes _RARE_
both O
monomeric _RARE_
molecules O
and O
disulfide O
- O
linked _RARE_
multimers _RARE_
. O

SCID _RARE_
V I-GENE
( O
D I-GENE
) O
J _RARE_
recombination _RARE_
can O
be O
partly O
rescued _RARE_
in O
T O
- O
lymphocytes O
by O
either O
DNA O
- O
damaging _RARE_
agents O
( O
gamma O
- O
irradiation O
and O
bieomycin _RARE_
) O
or O
a O
null _RARE_
mutation O
of O
the O
p53 I-GENE
gene I-GENE
, O
possibly O
because O
of O
transiently O
elevated O
DNA O
repair O
activity O
in O
response O
to O
DNA O
damage O
or O
to O
delayed O
apoptosis O
in O
the O
absence O
of O
p53 I-GENE
. O

Coexpression _RARE_
of O
mouse O
PKR I-GENE
( I-GENE
1 I-GENE
- I-GENE
515 _RARE_
) I-GENE
WT _RARE_
as _RARE_
a O
Gal4 I-GENE
DNA O
- O
binding O
domain O
fusion O
with O
either O
the O
catalytic O
- O
deficient _RARE_
human O
PKR I-GENE
( I-GENE
1 I-GENE
- I-GENE
551 _RARE_
) I-GENE
K296R _RARE_
mutant O
, O
the O
RNA O
- O
binding O
- O
deficient _RARE_
human O
PKR I-GENE
( I-GENE
1 I-GENE
- I-GENE
551 _RARE_
) I-GENE
K64E _RARE_
/ I-GENE
K296R _RARE_
double O
mutant O
, O
or O
wild O
- O
type O
mouse O
PKR I-GENE
( I-GENE
1 I-GENE
- I-GENE
515 _RARE_
) I-GENE
WT _RARE_
as _RARE_
full O
- O
length O
PKR I-GENE
- O
Gal4 I-GENE
activation O
domain O
fusions O
resulted O
in O
activation O
of O
the O
HIS3 I-GENE
and O
lacZ I-GENE
reporters _RARE_
. O

Using O
GST I-GENE
- O
PKR I-GENE
fusion O
chromatography O
, O
direct O
physical O
interaction O
between O
the O
mouse O
and O
human I-GENE
PKR I-GENE
homologs I-GENE
was O
established O
. O

An O
even O
greater O
inflammatory O
response O
was O
observed O
after O
intratracheal _RARE_
instillation _RARE_
of O
ufCB _RARE_
, O
but O
not O
after O
CB _RARE_
instillation _RARE_
. O

Interestingly O
, O
the O
avirulent _RARE_
strain _RARE_
H37Ra _RARE_
showed O
weak O
hybridization O
with O
these O
two O
probes _RARE_
, O
suggesting O
that O
these O
genes O
might O
have O
been O
deleted _RARE_
in O
the O
avirulent _RARE_
strain _RARE_
or O
are O
present O
in O
limited O
copy O
numbers O
as _RARE_
opposed O
to O
those O
in O
the O
virulent O
strain _RARE_
H37Rv _RARE_
. O

These O
defects O
no _RARE_
doubt _RARE_
impair _RARE_
the O
folding O
and O
configuration O
necessary O
for _RARE_
normal O
processing _RARE_
of O
the O
AVP I-GENE
gene I-GENE
precursor I-GENE
. O

Similarities _RARE_
between O
the O
hIGFBP _RARE_
- I-GENE
1 I-GENE
and O
phosphoenolpyruvate I-GENE
kinase I-GENE
( O
PEPCK I-GENE
) O
promoters O
, O
including O
regions O
conferring O
insulin I-GENE
, O
glucocorticoid O
, O
and O
cyclic O
adenosine O
- O
monophosphate O
responses O
, O
are O
consistent O
with O
our O
previous O
hypothesis O
that O
IGFBP _RARE_
- I-GENE
1 I-GENE
is O
involved O
in O
regulation _RARE_
of O
glucose O
metabolism O
. O

This O
binary _RARE_
repeat O
contains O
repetitive _RARE_
DNA O
elements O
that O
include O
LINES _RARE_
, O
SINES _RARE_
, O
medium O
reiteration _RARE_
frequency O
repeats O
, O
and O
a O
transposon _RARE_
- O
like O
element O
. O

At O
60 _RARE_
days O
the O
amount O
of O
gangliosides _RARE_
was O
on O
average O
lower O
in O
females O
than O
in O
males O
, O
even O
if O
with O
some O
exception O
. O

Large _RARE_
genomic O
constructs O
integrate _RARE_
at _RARE_
the O
endogenous O
locus O
by O
homologous O
recombination _RARE_
, O
but O
cDNA O
- O
derived O
sequences O
lacking _RARE_
long O
stretches O
of O
contiguous O
genomic O
DNA O
( O
due O
to O
intron O
excision _RARE_
) O
typically O
integrate _RARE_
into O
chromosomal O
DNA O
by O
nonhomologous _RARE_
recombination _RARE_
. O

The O
existence O
of O
these O
two O
categories O
of O
strains O
offers O
a O
new O
genetic O
system _RARE_
in O
which O
the O
properties O
of O
a O
potential _RARE_
invertebrate _RARE_
retrovirus _RARE_
can O
be O
tested O
. O

During O
the O
conditioning O
procedure O
, O
the O
C O
- O
fiber O
reflex O
was O
facilitated O
( O
wind _RARE_
- O
up _RARE_
) O
in O
a O
stimulus O
- O
dependent O
fashion O
in O
intact _RARE_
, O
anesthetized O
animals O
during _RARE_
the O
application O
of O
the O
first _RARE_
seven _RARE_
conditioning O
stimuli O
; O
thereafter O
, O
the O
magnitude O
of O
the O
responses O
reached O
a O
plateau _RARE_
and O
then O
decreased O
. O

As O
a O
sequence O
- O
specific O
DNA O
binding O
transcription O
factor O
, O
p53 I-GENE
specifically O
binds O
to O
a O
20 O
- O
bp O
consensus O
motif O
5 O
'- O
PuPuPuC _RARE_
( O
A O
/ O
T O
) O
( O
T O
/ O
A O
) O
GPyPyPyPuPuPuC _RARE_
( O
A O
/ O
T O
)( O
T O
/ O
A O
) O
GPyPyPy _RARE_
- O
3 O
'. O

TSA _RARE_
treatment O
, O
however O
, O
did O
not O
detectably _RARE_
alter O
enhancer O
factor O
binding O
or O
the O
positioning O
of O
nuc _RARE_
- I-GENE
1 I-GENE
on O
the O
majority O
of O
the O
chromatin O
templates O
indicating O
that O
protein O
acetylation O
and O
chromatin O
remodeling O
may O
be O
limiting O
steps O
that O
occur O
only O
on O
transcriptionally O
competent O
templates O
, O
or O
that O
remodeling O
of O
nuc _RARE_
- I-GENE
1 I-GENE
requires O
additional O
factors O
. O

Upon O
UV _RARE_
damage O
, O
Crb2 _RARE_
is O
transiently O
modified O
, O
probably O
phosphorylated _RARE_
, O
with O
a O
similar O
timing O
of O
phosphorylation _RARE_
in O
Chk1 _RARE_
kinase I-GENE
, O
which O
is O
reported O
to O
restrain _RARE_
Cdc2 I-GENE
activation O
. O

Moreover O
, O
moderate O
overexpression O
of O
Chk1 _RARE_
suppresses O
the O
phenotypes _RARE_
of O
cut5 _RARE_
and O
crb2 _RARE_
mutants I-GENE
. O

Tcn1p _RARE_
/ O
Crz1p _RARE_
, O
a O
calcineurin _RARE_
- O
dependent O
transcription O
factor O
that O
differentially O
regulates O
gene O
expression _RARE_
in O
Saccharomyces O
cerevisiae O
. O

Structure O
and O
localization _RARE_
of O
the O
human O
gene O
encoding O
SR I-GENE
- I-GENE
BI _RARE_
/ O
CLA _RARE_
- I-GENE
1 I-GENE
. O

We O
introduced O
the O
gel O
technique O
as _RARE_
a O
routine O
assay O
for _RARE_
antibody O
detection O
and O
identification O
in O
1993 O
. O

Stability _RARE_
of O
pyrimethamine _RARE_
in O
a O
liquid O
dosage O
formulation O
stored O
for _RARE_
three O
months O
. O

Multiple O
regression O
analyses O
revealed O
that O
WAIS _RARE_
- O
R O
factor O
scores O
Verbal _RARE_
Comprehension _RARE_
and O
Freedom _RARE_
from O
Distractibility _RARE_
accounted _RARE_
for _RARE_
up _RARE_
to O
42 _RARE_
% O
of O
the O
variance _RARE_
in O
WMS _RARE_
- O
R O
and O
CVLT _RARE_
indices O
. O

Bilateral _RARE_
basal O
arteries O
were O
measured O
by O
the O
transtemporal _RARE_
approach O
with O
a O
2 O
MHz _RARE_
pulsed O
Doppler O
instrument O
( O
TC _RARE_
- O
2 O
64B _RARE_
EME _RARE_
). O

At O
the O
genomic O
level O
, O
the O
sequences O
of O
two O
members O
of O
this O
family O
are O
known O
in O
the O
rat O
Rattus _RARE_
norvegicus _RARE_
: O
the O
VCSA1 _RARE_
gene I-GENE
, O
encoding O
the O
prohormone _RARE_
- I-GENE
like I-GENE
polypeptide I-GENE
SMR1 _RARE_
, O
and O
the O
VCSB1 _RARE_
gene I-GENE
, O
encoding O
a O
salivary _RARE_
Pro _RARE_
- O
rich O
polypeptide O
. O

The O
Saccharomyces I-GENE
cerevisiae I-GENE
RAD30 _RARE_
gene I-GENE
, O
a O
homologue I-GENE
of I-GENE
Escherichia I-GENE
coli I-GENE
dinB _RARE_
and O
umuC _RARE_
, O
is O
DNA O
damage O
inducible O
and O
functions O
in O
a O
novel O
error O
- O
free O
postreplication _RARE_
repair O
mechanism O
. O

However O
, O
in O
a O
new O
experiment O
in O
which O
the O
deletion O
task O
was O
presented O
as _RARE_
a O
puppet _RARE_
game _RARE_
, O
and O
with O
pretraining _RARE_
and O
selection O
on O
vowel _RARE_
deletion O
, O
a O
significantly O
higher _RARE_
level O
of O
success O
was O
achieved O
by O
the O
children O
working O
with O
the O
CVCC _RARE_
material O
. O

Diet _RARE_
therapy O
with O
soy _RARE_
proteins O
for _RARE_
chronic O
stomach O
ulcers O

In O
ICU _RARE_
patients O
, O
the O
LIS _RARE_
related O
to O
the O
postoperative O
rise O
in O
IL _RARE_
- I-GENE
6 I-GENE
level O
only O
, O
even O
though O
the O
rise O
in O
plasma O
concentrations O
of O
cytokines _RARE_
interrelated _RARE_
. O

Resistance O
training O
shifts O
the O
power O
curve O
in O
a O
positive O
direction O
when O
the O
measurements O
are O
determined O
with O
absolute O
loads _RARE_
, O
but O
the O
increased O
power O
may O
not O
be O
transferred O
to O
an O
absolute O
performance O
task O
like O
the O
SSP _RARE_
. O

Gel O
- O
shift O
assays O
identified O
two O
Sp1 _RARE_
binding I-GENE
sites I-GENE
within O
this O
element O
. O

Y15170 _RARE_
( O
Surf I-GENE
- I-GENE
2 I-GENE
, O
Surf I-GENE
- I-GENE
4 I-GENE
), _RARE_
Y15171 _RARE_
( O
Surf I-GENE
- I-GENE
3 I-GENE
, O
Surf I-GENE
- I-GENE
1 I-GENE
, O
Surf I-GENE
- I-GENE
6 I-GENE
), _RARE_
and O
Y15172 _RARE_
( O
Surf I-GENE
- I-GENE
5 I-GENE
.)] _RARE_

Gel O
mobility O
shift O
and O
super _RARE_
- O
shift O
assays O
using O
liver O
nuclear O
extracts O
from O
either O
rat O
liver O
or O
DDT1MF _RARE_
- O
2 O
cells O
demonstrated O
that O
the O
CRE _RARE_
in O
the O
alpha I-GENE
1B _RARE_
- I-GENE
AR _RARE_
gene I-GENE
bound _RARE_
CRE _RARE_
binding I-GENE
protein I-GENE
. O

These O
results O
suggest O
that O
, O
in O
this O
experimental O
model O
, O
ACE I-GENE
inhibitors _RARE_
limit O
the O
arrhythmias O
following O
ischemia O
- O
reperfusion O
and O
free O
radical O
scavenging _RARE_
action O
of O
these O
drugs O
does O
not O
have O
a O
major O
contributory _RARE_
role O
in O
their O
protective O
effect O
. O

The O
mean O
values O
of O
the O
first _RARE_
three O
components _RARE_
were O
not O
significantly O
different O
in O
ARVD _RARE_
patients O
and O
control O
subjects O
. O

However O
, O
the O
signaling _RARE_
cascade O
utilized O
by O
the O
urokinase I-GENE
receptor I-GENE
is O
only O
incompletely _RARE_
understood O
. O

The O
murine O
Htf9 _RARE_
- I-GENE
a I-GENE
/ O
RanBP1 _RARE_
and O
Htf9 _RARE_
- I-GENE
c I-GENE
genes I-GENE
are O
divergently O
transcribed _RARE_
from O
a O
shared O
TATA O
- O
less O
promoter O
. O

In O
accordance _RARE_
with O
clinical O
improvement O
we O
found O
a O
decrease O
of O
laboratory O
indicators O
of O
inflammation O
( O
C I-GENE
- I-GENE
reactive I-GENE
protein I-GENE
, O
alpha I-GENE
2 I-GENE
- I-GENE
globuline _RARE_
, O
prostaglandin _RARE_
E2 O
). O

We O
have O
previously O
reported O
that O
depletion O
of O
protein I-GENE
kinase I-GENE
C I-GENE
by O
long O
- O
term O
treatment O
of O
B16 _RARE_
mouse O
melanoma _RARE_
cells O
with O
phorbol O
dibutyrate _RARE_
( O
PDBu _RARE_
) O
prevented O
cell O
density O
- O
dependent O
melanogenesis _RARE_
. O

Replacement _RARE_
of O
residues O
in O
positions O
+ O
3 O
( O
His128Asn _RARE_
) O
and O
+ O
2 O
( O
Gln155Lys _RARE_
) O
of O
the O
reading O
helices O
of O
fingers _RARE_
2 O
and O
3 O
, O
respectively O
, O
prevented O
binding O
. O

Two O
disulphide _RARE_
bridges _RARE_
, O
which O
are O
conserved _RARE_
in O
all O
spermadhesin _RARE_
molecules O
and O
many O
CUB _RARE_
domains O
, O
crosslink _RARE_
loop O
LA O
and O
strand _RARE_
beta O
4 O
and O
loops O
LE _RARE_
and O
LG _RARE_
, O
respectively O
, O
at _RARE_
opposite O
edges _RARE_
of O
the O
same O
face O
of O
the O
domain O
. O

Mg _RARE_
- I-GENE
chelatase _RARE_
of O
tobacco O
: O
identification O
of O
a O
Chl _RARE_
D I-GENE
cDNA I-GENE
sequence I-GENE
encoding O
a O
third O
subunit O
, O
analysis O
of O
the O
interaction O
of O
the O
three O
subunits O
with O
the O
yeast O
two O
- O
hybrid _RARE_
system _RARE_
, O
and O
reconstitution _RARE_
of O
the O
enzyme O
activity O
by O
co _RARE_
- O
expression _RARE_
of O
recombinant I-GENE
CHL _RARE_
D I-GENE
, O
CHL _RARE_
H I-GENE
and O
CHL _RARE_
I I-GENE
. O

One O
R O
- O
EST _RARE_
and O
one O
Pto _RARE_
- I-GENE
like I-GENE
sequence I-GENE
each O
mapped O
to O
two O
locations O
. O

The O
multidomain _RARE_
structure _RARE_
includes O
a O
cysteine O
- O
rich O
motif O
resembling O
those O
of O
protein I-GENE
kinase I-GENE
C I-GENE
and O
n _RARE_
- I-GENE
chimaerin _RARE_
and O
a O
putative O
pleckstrin I-GENE
homology I-GENE
domain I-GENE
. O

The O
interaction O
between O
DDB _RARE_
and O
E2F1 I-GENE
can O
also O
be O
detected O
by O
coimmunoprecipitation _RARE_
experiments O
. O

271 _RARE_
: O
31290 _RARE_
- O
31295 _RARE_
, O
1996 O
). O

Nevertheless O
, O
antibodies O
directed O
against O
an O
epitope _RARE_
- O
tagged _RARE_
version O
of O
Prp42p _RARE_
specifically O
precipitate _RARE_
U1 _RARE_
snRNA _RARE_
from O
yeast O
extracts O
. O

These O
results O
indicate O
that O
in O
addition O
to O
Grb2 I-GENE
- O
mediated _RARE_
activation O
of O
Ras I-GENE
, O
PLC I-GENE
- I-GENE
gamma1 _RARE_
- O
mediated _RARE_
DAG _RARE_
production O
is O
required O
for _RARE_
EGF _RARE_
- O
and O
PDGF _RARE_
- O
induced _RARE_
S O
- O
phase _RARE_
entry O
and O
gene O
expression _RARE_
, O
possibly O
through O
activation O
of O
PKC I-GENE
. O

In O
this O
study O
, O
we O
investigated O
STAT I-GENE
activation O
in O
a O
panel O
of O
rodent O
fibroblast O
cell O
lines O
stably O
transformed O
by O
diverse O
viral O
oncoproteins _RARE_
. O

In O
serum O
- O
stimulated _RARE_
cells O
, O
the O
binding O
of O
NF _RARE_
- I-GENE
Y I-GENE
/ O
CBF I-GENE
to O
TKC1 _RARE_
increased O
gradually O
, O
reaching _RARE_
a O
plateau _RARE_
at _RARE_
the O
S O
phase _RARE_
. O

CONCLUSION O
: O
In O
our O
animal _RARE_
model O
, O
blood _RARE_
- O
brain O
barrier O
disruption O
was O
a O
reproducible _RARE_
, O
integral _RARE_
finding O
of O
single O
- O
fraction O
, O
high O
- O
dose O
irradiation O
injury O
. O

To O
facilitate O
the O
investigation O
of O
parameters O
that O
govern O
selective O
export O
in O
adenovirus O
- O
infected _RARE_
cells O
, O
we O
constructed O
a O
marked O
human O
beta I-GENE
- I-GENE
actin I-GENE
minigene _RARE_
under O
the O
control O
of O
the O
glucocorticoid I-GENE
- I-GENE
inducible I-GENE
enhancer I-GENE
- I-GENE
promoter I-GENE
of O
mouse O
mammary O
tumor O
virus O
and O
introduced O
it O
into O
the O
left _RARE_
end O
of O
the O
adenovirus O
type O
5 O
( O
Ad5 _RARE_
) O
genome O
. O

Cell O
factor O
- O
mediated _RARE_
regulatory O
interactions O
are O
involved O
in O
regulating _RARE_
the O
restricted O
expression _RARE_
of O
the O
HCMV _RARE_
major I-GENE
immediate I-GENE
- I-GENE
early I-GENE
( I-GENE
IE I-GENE
) I-GENE
gene I-GENE
( O
J _RARE_
. O

MpB _RARE_
GroEL _RARE_
has O
extensive O
sequence O
similarity _RARE_
( O
92 O
%) O
with O
Escherichia I-GENE
coli I-GENE
GroEL _RARE_
and O
other O
members O
of O
the O
chaperonin _RARE_
- I-GENE
60 _RARE_
family I-GENE
. O

The O
critical O
mutations O
were O
likely O
to O
have O
been O
multiple O
and O
dispersed _RARE_
, O
including O
elongation _RARE_
of O
the O
TM _RARE_
and O
Nef I-GENE
coding I-GENE
sequences I-GENE
; O
changes O
in O
RNA O
splice _RARE_
donor O
and O
acceptor _RARE_
sites O
, O
TATA O
box O
sites O
, O
and O
Sp1 _RARE_
sites I-GENE
; O
multiple O
changes O
in O
the O
V2 _RARE_
region O
of O
SU _RARE_
, O
including O
a O
consensus O
neutralization _RARE_
epitope _RARE_
; O
and O
five O
new O
N O
- O
linked _RARE_
glycosylation O
sites O
in O
SU _RARE_
. O

C O
. O

These O
are O
the O
long O
terminal O
repeat O
( O
LTR O
) O
promoter O
, O
which O
regulates O
expression _RARE_
of O
the O
viral O
structural O
proteins O
, O
and O
a O
second O
internal O
promoter O
, O
located _RARE_
towards O
the O
3 O
' O
end O
of O
the O
env I-GENE
gene I-GENE
, O
that O
directs O
expression _RARE_
of O
the O
viral O
auxiliary _RARE_
proteins O
. O

The O
5 O
' O
end O
of O
the O
genomic O
RNA O
of O
rubella _RARE_
virus O
( O
RUB _RARE_
) O
contains O
a O
14 O
- O
nucleotide O
( O
nt O
) O
single O
- O
stranded _RARE_
leader _RARE_
( O
ss _RARE_
- O
leader _RARE_
) O
followed O
by O
a O
stem _RARE_
- O
and O
- O
loop O
structure _RARE_
[ _RARE_
5 O
'(+) _RARE_
SL _RARE_
] O
( O
nt O
15 _RARE_
to O
65 O
), _RARE_
the O
complement O
of O
which O
at _RARE_
the O
3 O
' O
end O
of O
the O
minus O
- O
strand _RARE_
RNA O
[ _RARE_
3 O
'(-) _RARE_
SL _RARE_
] O
has O
been O
proposed O
to O
function O
as _RARE_
a O
promoter O
for _RARE_
synthesis _RARE_
of O
genomic O
plus _RARE_
strands _RARE_
. O

To O
investigate O
the O
requirements O
for _RARE_
CBF2 I-GENE
binding O
, O
we O
synthesized O
a O
series O
of O
oligonucleotides O
carrying O
double O
transversion O
mutations O
spanning O
both O
the O
conserved _RARE_
core O
sequence O
and O
outside O
flanking O
sequences O
. O

In O
addition O
, O
the O
affinities O
of O
CBF2 I-GENE
for _RARE_
binding O
to O
the O
LMP I-GENE
- I-GENE
1 I-GENE
, O
LMP I-GENE
- I-GENE
2 I-GENE
, O
and O
CD23 I-GENE
promoters I-GENE
were O
also O
measured O
. O

CONCLUSIONS O
: O
The O
myocardial _RARE_
uptake O
of O
99mTc O
sestamibi _RARE_
in O
normal O
subjects O
and O
patients O
with O
coronary O
artery O
disease _RARE_
is O
comparable O
after O
exercise O
, O
dipyridamole _RARE_
, O
and O
adenosine O
stress O
. O

The O
SR I-GENE
protein I-GENE
family I-GENE
is O
involved O
in O
constitutive _RARE_
and O
regulated O
pre O
- O
mRNA O
splicing _RARE_
and O
has O
been O
found O
to O
be O
evolutionarily O
conserved _RARE_
in O
metazoan _RARE_
organisms O
. O

To O
investigate O
the O
activity O
of O
TCF11 _RARE_
through O
this O
selected _RARE_
site O
, O
both O
alone O
and O
in O
the O
presence O
of O
MafG _RARE_
, O
we O
have O
used O
a O
transient O
transfection O
assay O
. O

These O
and O
other O
comparisons O
suggest O
that O
, O
during _RARE_
evolution O
, O
both O
the O
RNA I-GENE
- I-GENE
polymerase I-GENE
specificity _RARE_
of O
telomerase I-GENE
RNA I-GENE
- I-GENE
gene I-GENE
promoters I-GENE
and O
, O
more O
recently O
, O
the O
position O
of O
the O
template O
sequence O
in O
the O
telomerase I-GENE
RNA I-GENE
changed O
. O

Deadenylation _RARE_
and O
decay _RARE_
of O
beta I-GENE
- I-GENE
globin I-GENE
mRNA I-GENE
in O
K562 O
cells O
is O
extraordinarily _RARE_
slow O
compared O
with O
NIH _RARE_
3T3 O
cells O
, O
suggesting O
that O
the O
increased O
stability O
gained _RARE_
by O
beta I-GENE
- I-GENE
globin I-GENE
mRNA I-GENE
in O
K562 O
cells O
is O
mainly O
controlled _RARE_
at _RARE_
the O
deadenylation _RARE_
step O
. O

Holliday _RARE_
junction _RARE_
resolvase _RARE_
in O
Schizosaccharomyces O
pombe O
has O
identical O
endonuclease O
activity O
to O
the O
CCE1 _RARE_
homologue O
YDC2 _RARE_
. O

Ca2 _RARE_
+/ _RARE_
calmodulin I-GENE
- I-GENE
dependent I-GENE
protein I-GENE
kinase I-GENE
II I-GENE
( O
CaMK _RARE_
II I-GENE
) O
is O
a O
multifunctional _RARE_
serine I-GENE
/ I-GENE
threonine I-GENE
protein I-GENE
kinase I-GENE
that O
regulates O
ion O
channels _RARE_
, O
metabolic O
enzymes _RARE_
, O
cytoskeletal O
proteins O
, O
and O
possibly O
transcription O
factors O
. O

A O
cAMP O
- O
responsive O
element O
- O
like O
( O
CRE _RARE_
- O
like O
, O
TGACGTGA _RARE_
) O
promoter O
sequence O
and O
a O
protein I-GENE
kinase I-GENE
A I-GENE
signaling _RARE_
pathway _RARE_
are O
involved O
in O
this O
induction O
, O
and O
activation O
of O
both O
CRE _RARE_
binding I-GENE
protein I-GENE
( O
CREB I-GENE
) O
and O
activating I-GENE
transcription I-GENE
factor I-GENE
- I-GENE
2 I-GENE
( O
ATF I-GENE
- I-GENE
2 I-GENE
) O
is O
required O
in O
the O
above O
process O
. O

IVOX _RARE_
was O
named O
as _RARE_
an O
acronym _RARE_
for _RARE_
intravascular O
oxygenator _RARE_
. O

Histopathologically _RARE_
, O
a O
cystic _RARE_
lymphangioma _RARE_
was O
diagnosed O
because O
of O
the O
morphological O
features O
and O
the O
immunohistochemical O
stainings _RARE_
of O
CD34 I-GENE
and O
Factor _RARE_
VIII I-GENE
related I-GENE
antigen I-GENE
which O
were O
observed O
positive O
reactions O
in O
endothelial O
cells O
of O
the O
cysts O
. O

Protease _RARE_
activities O
in O
cultures O
of O
the O
streptococcal _RARE_
strains O
were O
associated O
with O
species O
of O
different O
molecular _RARE_
masses O
ranging O
from O
130 _RARE_
to O
200 _RARE_
kDa O
, O
suggesting O
posttranslational O
processing _RARE_
possibly O
as _RARE_
a O
result O
of O
autoproteolysis _RARE_
at _RARE_
post O
- O
proline O
peptide O
bonds O
in O
the O
N O
- O
terminal O
parts O
of O
the O
molecules O
. O

The O
mechanism O
underlying O
such O
analgesia O
has O
been O
suggested O
to O
involve O
the O
interaction O
between O
the O
two O
separate O
but O
interconnected _RARE_
motivational _RARE_
systems _RARE_
" O
defense O
" O
and O
" O
pain O
." _RARE_
To O
determine O
the O
developmental O
course O
of O
defense O
and O
nociception _RARE_
, O
these O
processes O
were O
analyzed O
during _RARE_
early O
ontogeny _RARE_
in O
rats O
. O

Three O
large O
field O
placement O
errors _RARE_
( O
two O
patients O
with O
11 O
. O
5 O
and O
16 O
. O
0 _RARE_
mm O
distances O
of O
the O
planned _RARE_
versus O
simulated O
isocenter _RARE_
, O
respectively O
and O
one O
patient O
with O
a O
7 O
degree O
rotational _RARE_
error O
) O
were O
detected O
and O
, O
as _RARE_
with O
the O
smaller O
errors _RARE_
, O
were O
immediately O
corrected O
. O

In O
addition O
, O
a O
catalytically O
inactive O
version O
of O
the O
Src I-GENE
family I-GENE
member _RARE_
, O
Lck _RARE_
( O
lymphoid _RARE_
cell I-GENE
kinase I-GENE
), _RARE_
was O
expressed _RARE_
, O
purified _RARE_
, O
and O
evaluated O
as _RARE_
a O
Csk I-GENE
substrate O
. O

A O
., O
Swift _RARE_
, O
A O
. O

Neuronal _RARE_
mechanisms O
underlying O
stimulus O
- O
response O
( O
S O
- O
R O
) O
associations O
in O
S O
- O
R O
compatibility O
tasks O
were O
identified O
in O
2 O
experiments O
with O
monkeys O
. O

The O
c I-GENE
- I-GENE
myc I-GENE
/ O
TGF I-GENE
- I-GENE
alpha I-GENE
HCCs _RARE_
were O
also O
characterized O
by O
a O
particularly O
strong O
expression _RARE_
of O
TGF I-GENE
- I-GENE
alpha I-GENE
and O
very O
low O
apoptotic O
index O
in O
contrast O
to O
high O
levels O
of O
apoptosis O
in O
peritumorous _RARE_
tissues O
and O
c I-GENE
- I-GENE
myc I-GENE
HCCs _RARE_
. O

Taken O
together O
, O
our O
data O
suggest O
that O
the O
antagonistic O
effects O
of O
CRP I-GENE
and O
KdgR _RARE_
on O
the O
expression _RARE_
of O
the O
pectinolysis _RARE_
genes I-GENE
occur O
by O
different O
mechanisms O
, O
including O
direct O
competition O
between O
the O
two O
regulators _RARE_
or O
between O
the O
repressor O
and O
RNA I-GENE
polymerase I-GENE
for _RARE_
the O
occupation _RARE_
of O
a O
common O
DNA O
region O
on O
the O
target O
genes O
. O

The O
well _RARE_
- O
known O
Rel I-GENE
/ O
NF _RARE_
- I-GENE
kappaB I-GENE
family O
of O
vertebrate _RARE_
transcription O
factors O
comprises O
a O
number O
of O
structurally O
related O
, O
interacting _RARE_
proteins O
that O
bind O
DNA O
as _RARE_
dimers _RARE_
and O
whose O
activity O
is O
regulated O
by O
subcellular O
location O
. O

The O
cglIM _RARE_
gene I-GENE
is O
organized O
in O
an O
unusual O
operon O
which O
contains O
, O
in O
addition O
, O
two O
genes O
encoding O
stress O
- O
sensitive _RARE_
restriction _RARE_
enzymes _RARE_
. O

Lysine _RARE_
- I-GENE
ketoglutarate _RARE_
reductase I-GENE
and O
saccharopine _RARE_
dehydrogenase I-GENE
from O
Arabidopsis O
thaliana O
: O
nucleotide O
sequence O
and O
characterization O
. O

The O
purpose O
of O
this O
investigation O
was O
to O
describe O
a O
new O
formulation O
of O
silver O
sulfadiazine _RARE_
in O
a O
water O
soluble _RARE_
gel O
, O
poloxamer _RARE_
188 _RARE_
. O

The O
study O
goals _RARE_
were O
to O
isolate O
a O
full O
- O
length O
clone O
encoding O
CO _RARE_
- I-GENE
Ag _RARE_
from O
a O
bovine O
corneal O
cDNA O
library O
and O
to O
express O
this O
clone O
in O
Escherichia O
coli O
( O
E O
. O
coli O
). O

The O
pel _RARE_
gene I-GENE
from O
an O
Amycolata _RARE_
sp _RARE_
. O
encoding O
a O
pectate _RARE_
lyase I-GENE
( O
EC I-GENE
4 I-GENE
. I-GENE
2 I-GENE
. I-GENE
2 I-GENE
. I-GENE
2 I-GENE
) O
was O
isolated O
by O
activity O
screening O
a O
genomic O
DNA O
library O
in O
Streptomyces _RARE_
lividans _RARE_
TK24 _RARE_
. O

The O
gene O
contains O
six _RARE_
exons O
separated O
by O
1 O
. O
1 O
- O
5 O
. O
8 O
kb O
introns _RARE_
and O
has O
been O
localized O
to O
the O
murine O
chromosome _RARE_
2 O
by O
linkage O
analysis O
. O

In O
Xenopus O
embryos _RARE_
, O
the O
engineered _RARE_
PDGF _RARE_
receptor I-GENE
protein I-GENE
induced _RARE_
the O
formation O
of O
mesoderm O
from O
animal _RARE_
- O
pole O
explants _RARE_
in O
an O
FK1012 _RARE_
- O
dependent O
manner O
. O

A O
cytosolic O
variant O
of O
the O
protein O
underwent O
efficient O
transphosphorylation _RARE_
, O
yet O
failed O
to O
activate O
appreciably _RARE_
either O
p70 I-GENE
( O
S6k _RARE_
) O
or O
MAP I-GENE
kinase I-GENE
following O
treatment O
with O
FK1012 _RARE_
. O

Small _RARE_
- O
molecule O
control O
of O
insulin I-GENE
and O
PDGF _RARE_
receptor I-GENE
signaling _RARE_
and O
the O
role O
of O
membrane O
attachment _RARE_
. O

Conversely O
, O
the O
inactive O
dAK _RARE_
subunit I-GENE
is O
progressively _RARE_
activated O
by O
1 O
) O
association O
with O
a O
dGK _RARE_
or O
dCK _RARE_
subunit I-GENE
and O
2 O
) O
the O
conformationally _RARE_
driven _RARE_
heterotropic _RARE_
affect O
of O
dGuo _RARE_
or O
dCyd _RARE_
bound _RARE_
to O
the O
opposing _RARE_
subunit O
. O

CONCLUSIONS O
: O
A O
50 O
- O
mg O
daily O
dose O
of O
bicalutamide _RARE_
is O
sufficient O
when O
given O
in O
combination O
with O
an O
agent O
, O
such O
as _RARE_
a O
LHRH _RARE_
- O
A O
, O
that O
lowers _RARE_
serum O
testosterone O
, O
but O
higher _RARE_
doses O
of O
bicalutamide _RARE_
may O
be O
needed O
when O
the O
drug O
is O
given O
as _RARE_
monotherapy _RARE_
. O

A O
genomic O
clone O
was O
isolated O
that O
contained O
12 O
. O
5 O
kb O
of O
the O
5 O
'- O
flanking O
region O
and O
the O
first _RARE_
exon _RARE_
of O
the O
p69 _RARE_
/ I-GENE
71 _RARE_
2 I-GENE
- I-GENE
5A _RARE_
synthetase _RARE_
gene I-GENE
. O

Although O
the O
gene O
is O
substantially O
smaller O
than O
the O
human O
genes O
for _RARE_
other O
mitochondrial O
enzymes _RARE_
, O
its O
intron O
/ O
exon _RARE_
organization O
is O
very O
similar O
, O
especially O
to O
that O
of O
P450scc _RARE_
. O

RESULTS O
: O
Looking _RARE_
at _RARE_
the O
question O
of O
its O
benefits O
, O
we O
were O
unable O
to O
find O
any O
methodologically _RARE_
sound O
studies O
that O
have O
shown O
efficacy O
for _RARE_
EMDR _RARE_
in O
eating _RARE_
disorders O
, O
or O
, O
indeed O
, O
any O
psychiatric O
disorder O
. O

In O
the O
clinical O
study O
, O
the O
defect O
size O
shown O
by O
BMIPP _RARE_
imaging O
was O
greater O
in O
anterior O
than O
in O
inferior O
infarcts _RARE_
( O
p O
< O
0 _RARE_
. O
001 O
) O
and O
correlated O
well _RARE_
with O
the O
risk O
area O
revealed O
by O
contrast O
ventriculography _RARE_
( O
r _RARE_
= O
0 _RARE_
. O
80 _RARE_
, O
p O
< O
0 _RARE_
. O
0001 O
) O
CONCLUSION O
: O
The O
above O
preliminary O
data O
, O
admittedly _RARE_
from O
a O
small O
group O
of O
patients O
, O
suggest O
that O
tomographic _RARE_
BMIPP _RARE_
imaging O
provides O
an O
accurate O
quantification _RARE_
of O
defect O
size O
by O
means O
of O
a O
simple O
threshold O
technique O
and O
, O
in O
the O
subacute O
phase _RARE_
, O
permits O
determination O
of O
the O
amount O
of O
myocardium O
at _RARE_
risk O
after O
acute O
myocardial _RARE_
infarction O
. O

Transient O
overexpression O
of O
mutant I-GENE
EphB1 _RARE_
receptors I-GENE
( O
Y594F _RARE_
) O
blocked O
Nck _RARE_
recruitment O
to O
EphB1 _RARE_
, O
attenuated O
downstream _RARE_
JNK I-GENE
activation O
, O
and O
blocked O
cell O
attachment _RARE_
responses O
. O

The O
promoter O
for _RARE_
HMG I-GENE
- I-GENE
CoA I-GENE
synthase I-GENE
contains O
two O
binding O
sites O
for _RARE_
the O
sterol I-GENE
regulatory I-GENE
element I-GENE
- I-GENE
binding I-GENE
proteins I-GENE
( O
SREBPs _RARE_
). O

S O
., O
and O
Walter _RARE_
, O
P O
. O

Here O
we O
demonstrate O
that O
Hh _RARE_
and O
Patched _RARE_
( O
Ptc _RARE_
) O
act O
through O
those O
Ci _RARE_
binding O
sites O
to O
modulate O
the O
level O
of O
Ci _RARE_
- O
dependent O
transcriptional O
activation O
in O
S2 _RARE_
cells O
. O

Furthermore O
the O
median O
increase O
in O
cyclosporine O
DR _RARE_
/ O
C O
( O
SS _RARE_
trough O
) O
was O
18 O
l _RARE_
h O
- O
1 O
(- _RARE_
3 O
. O
1 O
to O
42 _RARE_
. O
1 O
l _RARE_
h O
- O
1 O
, O
interquartile _RARE_
range O
). O

Patients O
and O
their O
relatives _RARE_
must O
be O
informed _RARE_
about O
the O
available O
effective O
treatment O
possibilities O
and O
about O
the O
right O
moment _RARE_
for _RARE_
their O
application O
in O
an O
individual O
patient O
. O

Several O
PTPases _RARE_
were O
expressed _RARE_
abundantly O
in O
the O
5 O
- O
FU O
- O
treated O
bone O
marrow O
stem _RARE_
cells O
. O

Expression O
of O
PTPRO _RARE_
was O
also O
observed O
in O
human I-GENE
CD34 I-GENE
+ I-GENE
bone O
marrow O
cells O
and O
5 O
- O
FU O
- O
treated O
murine O
primitive _RARE_
stem _RARE_
cells O
. O

The O
organization O
of O
SPP1 _RARE_
genes I-GENE
involved O
in O
the O
replication O
, O
DNA O
packaging _RARE_
and O
phage _RARE_
assembly O
proteins O
resembles O
the O
organization O
of O
genes O
of O
equivalent O
regions O
of O
different O
E O
. O
coli O
double O
- O
stranded _RARE_
DNA O
phages _RARE_
. O

Our O
results O
showed O
that O
compared O
to O
the O
primary _RARE_
photon O
fluence _RARE_
, O
the O
extra _RARE_
- O
focal _RARE_
photon O
fluence _RARE_
from O
the O
primary _RARE_
collimator _RARE_
and O
the O
flattening _RARE_
filter O
was O
11 O
%- _RARE_
16 O
% O
at _RARE_
the O
isocenter _RARE_
, O
among O
which O
70 O
% O
was O
contributed O
by O
the O
flattening _RARE_
filter O
. O

The O
functional _RARE_
mature _RARE_
domain O
of O
pediocin _RARE_
AcH _RARE_
( I-GENE
Lys _RARE_
+ I-GENE
1 I-GENE
to I-GENE
Cys _RARE_
+ I-GENE
44 _RARE_
) I-GENE
is O
targeted O
into O
the O
E O
. O
coli O
sec O
machinery O
and O
secreted _RARE_
to O
the O
periplasm _RARE_
in O
active _RARE_
form O
when O
fused O
in O
frame O
to O
the O
COOH _RARE_
terminus O
of O
the O
secretory _RARE_
protein I-GENE
maltose _RARE_
- I-GENE
binding I-GENE
protein I-GENE
( O
MBP I-GENE
). O

Isomers _RARE_
were O
differentiated O
based O
on O
the O
MS O
- O
MS O
data O
of O
the O
trofluoroacetyl _RARE_
- O
biphenylol _RARE_
derivatives _RARE_
. O

Although O
RAD17 _RARE_
, O
RAD24 _RARE_
and O
MEC3 _RARE_
are O
not O
required O
for _RARE_
cell O
cycle _RARE_
arrest O
when O
S O
phase _RARE_
is O
inhibited O
by O
hydroxyurea _RARE_
( O
HU _RARE_
), _RARE_
they O
do O
contribute O
to O
the O
viability O
of O
yeast O
cells O
grown O
in O
the O
presence O
of O
HU _RARE_
, O
possibly O
because O
they O
are O
required O
for _RARE_
the O
repair O
of O
HU _RARE_
- O
induced _RARE_
DNA O
damage O
. O

Clinical O
value O
of O
the O
estimation O
of O
growth O
kinetics O
of O
primary _RARE_
ovarian O
cancer _RARE_
recurrences _RARE_
by O
CA125 _RARE_
doubling _RARE_
time O

This O
review O
seeks _RARE_
to O
summarize _RARE_
the O
disease _RARE_
, O
to O
propose O
pathways O
of O
carcinogenesis _RARE_
and O
to O
suggest O
ways O
in O
which O
the O
" O
traditional _RARE_
" O
risk O
factors O
may O
be O
interpreted O
on O
the O
basis O
of O
evolving _RARE_
knowledge O
. O

The O
patient O
underwent O
two O
intracytoplasmic _RARE_
sperm O
injection O
cycles O
with O
thawed _RARE_
epididymal _RARE_
spermatozoa O
, O
in O
which O
, O
due O
to O
a O
pharmacist _RARE_
' O
s O
mistake _RARE_
, O
ovarian O
stimulation _RARE_
was O
carried O
out O
by O
a O
combination O
of O
long O
- O
acting O
gonadotrophin _RARE_
- I-GENE
releasing I-GENE
hormone I-GENE
agonist O
( O
leuprolide _RARE_
depot _RARE_
) O
and O
gonadotrophins _RARE_
. O

Protein I-GENE
C I-GENE
deficiency O
or O
protein I-GENE
S I-GENE
deficiency O
was O
the O
only O
identified O
risk O
factor O
for _RARE_
5 O
. O
4 O
% O
( O
2 O
patients O
) O
and O
13 _RARE_
. O
5 O
% O
( O
5 O
patients O
), _RARE_
respectively O
, O
of O
these O
37 O
children O
. O

Perhaps _RARE_
in O
addition O
to O
, O
or O
as _RARE_
part O
of O
, O
its O
essential O
function O
in O
late _RARE_
mitosis O
, O
MOB1 _RARE_
is O
required O
for _RARE_
a O
cell O
cycle _RARE_
reset _RARE_
function O
necessary O
for _RARE_
the O
initiation O
of O
the O
spindle _RARE_
pole O
body O
duplication O
. O

In O
contrast O
, O
overproduction _RARE_
of O
Der3p _RARE_
is O
lethal O
in O
a O
sec61 _RARE_
- I-GENE
2 I-GENE
strain _RARE_
at _RARE_
the O
permissive O
temperature _RARE_
of O
25 _RARE_
degrees O
C O
. O

Normal _RARE_
baseline O
( O
day O
- O
8 O
) O
PC O
levels O
( O
86 _RARE_
and O
89 _RARE_
%) O
were O
markedly O
reduced _RARE_
in O
both O
patients O
at _RARE_
the O
time O
of O
VOD _RARE_
manifestation O
on O
day O
20 O
and O
40 O
, O
respectively O
( O
26 _RARE_
and O
31 _RARE_
%). O

To O
examine O
the O
role O
of O
this O
CE2 _RARE_
element O
in O
regulating _RARE_
Hoxa1 _RARE_
expression _RARE_
in O
vivo O
, O
transgenic O
mice O
were O
generated O
which O
express O
a O
Hoxa1 _RARE_
beta I-GENE
- I-GENE
galactosidase I-GENE
reporter O
gene O
that O
contains O
a O
mutation O
in O
the O
CE2 _RARE_
element O
. O

An O
evolutionary O
conserved _RARE_
element O
is O
essential O
for _RARE_
somite _RARE_
and O
adjacent O
mesenchymal O
expression _RARE_
of O
the O
Hoxa1 _RARE_
gene I-GENE
. O

RESULTS O
: O
The O
bovine O
cDNA O
insert O
sequence O
was O
273 _RARE_
nucleotides O
in O
length O
for _RARE_
the O
entire _RARE_
mRNA O
coding O
region O
, O
212 _RARE_
nucleotides O
in O
the O
5 O
' O
untranslated _RARE_
region O
, O
83 _RARE_
nucleotides O
in O
the O
3 O
' O
untranslated _RARE_
region O
and O
a O
poly _RARE_
( O
A O
) O
tail _RARE_
. O

Altogether O
46 _RARE_
phase _RARE_
III O
activities O
were O
recorded O
. O

We O
have O
previously O
identified O
a O
liver O
- O
enriched _RARE_
transcription O
factor O
, O
HNF I-GENE
- I-GENE
6 I-GENE
, O
which O
is O
required O
for _RARE_
HNF I-GENE
- I-GENE
3 I-GENE
beta I-GENE
promoter I-GENE
activity O
and O
also O
recognizes O
the O
regulatory O
region O
of O
numerous O
hepatocyte _RARE_
- O
specific O
genes O
. O

A O
cDNA O
clone O
was O
identified O
encoding O
a O
second O
GHS _RARE_
- I-GENE
R I-GENE
- I-GENE
related I-GENE
gene I-GENE
( O
GPR39 _RARE_
). O

( O
1997 O
) O
Science _RARE_
275 _RARE_
, O
1927 _RARE_
- O
1930 _RARE_
). O

P O
., O
Peyron _RARE_
, O
J _RARE_
. O

A O
hybridoma _RARE_
clone O
( O
7H1 _RARE_
) O
resulting O
from O
the O
fusion O
between O
CEMLAI _RARE_
/ O
NP _RARE_
and O
human O
embryonic _RARE_
fibroblasts _RARE_
MRC5 _RARE_
cells O
produced O
very O
large O
amounts O
of O
P47 _RARE_
that O
was O
purified _RARE_
using O
Jacalin _RARE_
lectin _RARE_
( O
specific O
for _RARE_
O O
- O
glycans _RARE_
) O
and O
microsequenced _RARE_
. O

This O
information _RARE_
, O
together O
with O
estimation O
of O
the O
size O
of O
the O
deglycosylated _RARE_
A O
subunit O
relative O
to O
a O
series O
of O
C I-GENE
- I-GENE
terminal I-GENE
truncated I-GENE
TSHR _RARE_
ectodomain _RARE_
variants I-GENE
, O
places _RARE_
cleavage _RARE_
Site _RARE_
1 O
in O
the O
vicinity O
of O
, O
or O
closely O
upstream O
to O
, O
residue _RARE_
317 _RARE_
. O

In O
vitro O
DNase I-GENE
I I-GENE
footprinting O
of O
the O
200 _RARE_
- O
bp O
proximal O
region O
of O
the O
promoter O
with O
a O
murine O
Hepa _RARE_
1 O
- O
6 O
cell O
nuclear O
extract _RARE_
revealed O
a O
clear O
footprint O
of O
a O
region O
corresponding O
to O
- O
80 _RARE_
to O
- O
28 _RARE_
bp O
of O
the O
murine I-GENE
fVII _RARE_
gene I-GENE
, O
suggesting O
that O
liver O
factors O
interact O
with O
this O
region O
of O
the O
DNA O
. O

A O
reciprocal O
binding O
assay O
using O
IM O
- O
9 O
cells O
as _RARE_
a O
source O
of O
SHP I-GENE
- I-GENE
1 I-GENE
and O
SHP I-GENE
- I-GENE
2 I-GENE
revealed O
specific O
association O
of O
SHP I-GENE
- I-GENE
2 I-GENE
( O
but O
not O
SHP I-GENE
- I-GENE
1 I-GENE
) O
with O
a O
glutathione _RARE_
S I-GENE
- I-GENE
transferase I-GENE
fusion I-GENE
incorporating _RARE_
GHR _RARE_
cytoplasmic I-GENE
domain I-GENE
residues I-GENE
485 _RARE_
- I-GENE
620 _RARE_
, O
but O
only O
if O
the O
fusion O
was O
first _RARE_
rendered _RARE_
tyrosine O
- O
phosphorylated _RARE_
. O

Both O
increasing O
basal O
FSH I-GENE
and O
age O
were O
associated O
significantly O
with O
increased O
total _RARE_
gonadotrophin _RARE_
dose O
, O
and O
reduced _RARE_
number O
of O
oocytes O
collected O
and O
pregnancy _RARE_
rate O
. O

A O
comparative O
study O
was O
undertaken O
between O
an O
enzymatic O
immunohistochemical O
technique O
( O
EIT _RARE_
) O
developed O
for _RARE_
the O
diagnosis O
of O
human O
trichinellosis _RARE_
and O
the O
indirect O
immunofluorescence O
test O
( O
IIF _RARE_
), _RARE_
analysing _RARE_
sera _RARE_
from O
outbreaks _RARE_
of O
human O
trichinellosis _RARE_
in O
Argentina _RARE_
. O

Our O
results O
establish O
GKLF _RARE_
as _RARE_
a O
sequence O
- O
specific O
transcription O
factor O
likely O
involved O
in O
regulation _RARE_
of O
expression _RARE_
of O
endogenous O
genes O
. O

CES4 _RARE_
on O
a O
multicopy O
plasmid _RARE_
was O
unable O
to O
suppress O
tif1 _RARE_
- I-GENE
A79V _RARE_
. O

Here O
we O
report O
that O
in O
cultured O
cells O
from O
Drosophila O
melanogaster O
human I-GENE
Sp1 _RARE_
efficiently O
activates O
transcription O
from O
synthetic _RARE_
promoters O
containing O
TATA O
boxes _RARE_
, O
but O
not O
from O
promoters O
that O
contain O
an O
initiator _RARE_
instead O
of O
a O
TATA O
box O
. O

No O
apparent O
clinical O
signs O
indicative O
of O
systemic O
toxicity O
were O
observed O
in O
the O
F0 _RARE_
and O
F1 _RARE_
animals O
of O
either O
sex _RARE_
. O

We O
have O
used O
mutation O
- O
directed O
chemical O
cross O
- O
linking O
with O
bis _RARE_
( O
sulfosuccinimidyl _RARE_
) O
suberate _RARE_
( O
BS3 _RARE_
) O
to O
investigate O
the O
architecture O
of O
the O
gp41 _RARE_
oligomer _RARE_
. O

In O
an O
effort O
to O
identify O
the O
USH1C _RARE_
disease _RARE_
gene I-GENE
we O
have O
isolated O
the O
region O
between O
these O
markers O
in O
yeast O
artificial O
chromosomes O
( O
YACs O
) O
using O
a O
combination O
of O
STS _RARE_
content O
mapping O
and O
Alu I-GENE
- O
PCR O
hybridization O
. O

PowerBLAST _RARE_
analysis O
identified O
six _RARE_
clusters O
of O
expressed _RARE_
sequence O
tags O
( O
ESTs _RARE_
), _RARE_
two O
known O
genes O
( O
BIR _RARE_
, O
SUR1 _RARE_
) O
mapped O
previously O
to O
this O
region O
, O
and O
a O
previously O
characterized O
but O
unmapped _RARE_
gene I-GENE
NEFA _RARE_
( O
DNA I-GENE
binding I-GENE
/ I-GENE
EF _RARE_
hand _RARE_
/ I-GENE
acidic _RARE_
amino I-GENE
- I-GENE
acid I-GENE
- I-GENE
rich I-GENE
). O

A O
fusion O
protein O
composed O
of O
beta I-GENE
- I-GENE
galactosidase I-GENE
and O
full I-GENE
- I-GENE
length I-GENE
Ahr _RARE_
translocates _RARE_
from O
the O
cytoplasm O
to O
the O
nucleus O
in O
a O
ligand _RARE_
- O
dependent O
manner O
. O

Reconstitution _RARE_
of O
Raf I-GENE
- I-GENE
1 I-GENE
activity O
was O
observed O
only O
with O
kinase O
active _RARE_
Jak1 _RARE_
in O
both O
cell O
lines O
. O

In O
addition O
, O
negatively O
regulatory O
region O
may O
exist O
from O
- O
1782 _RARE_
to O
- O
1295 _RARE_
bp O
. O

The O
hypothesis O
of O
Geisler _RARE_
( O
Brain _RARE_
Res _RARE_
. O

The O
second O
transcript O
, O
rhis4l _RARE_
, O
is O
bicistronic _RARE_
. O

Consistent O
with O
this O
interpretation O
, O
a O
mutant O
form O
of O
XRN1 _RARE_
, O
which O
encodes O
a O
5 O
'- O
3 O
' O
exonuclease _RARE_
, O
was O
identified O
as _RARE_
an O
extragenic _RARE_
suppressor O
that O
increases O
the O
half _RARE_
- O
life O
of O
rhis4 _RARE_
mRNA I-GENE
, O
leading O
to O
a O
10 O
- O
fold _RARE_
increase O
in O
steady O
- O
state O
mRNA O
levels O
compared O
to O
the O
wild I-GENE
- I-GENE
type I-GENE
HIS4 _RARE_
mRNA I-GENE
level O
. O

Sip1 _RARE_
was O
initially O
identified O
by O
virtue _RARE_
of O
its O
interaction O
with O
SC35 _RARE_
, O
a O
splicing _RARE_
factor O
of O
the O
SR I-GENE
family I-GENE
. O

Consistent O
with O
previous O
reports O
, O
addition O
of O
a O
myristoylation _RARE_
signal O
to O
mSos1 _RARE_
( O
MyrSos1 _RARE_
) O
rendered _RARE_
it O
transforming O
for _RARE_
NIH _RARE_
3T3 O
cells O
and O
deletion O
of O
the O
mSos _RARE_
C I-GENE
terminus I-GENE
( O
MyrSos1 _RARE_
- I-GENE
deltaC _RARE_
) O
did O
not O
interfere _RARE_
with O
this O
activity O
. O

Such O
mutations O
are O
thought O
to O
exert O
their O
dominant O
phenotype _RARE_
by O
sequestration _RARE_
of O
the O
guanine I-GENE
nucleotide I-GENE
exchange I-GENE
factor I-GENE
( O
GNEF _RARE_
). O

Several O
studies O
have O
characterized O
the O
upstream O
regulatory O
region O
of O
c I-GENE
- I-GENE
fos I-GENE
, O
and O
identified O
cis O
- O
acting O
elements O
termed O
the O
cyclic O
AMP O
( O
cAMP O
) O
response O
elements O
( O
CREs _RARE_
) O
that O
are O
critical O
for _RARE_
c I-GENE
- I-GENE
fos I-GENE
transcription O
in O
response O
to O
a O
variety O
of O
extracellular O
stimuli O
. O

We O
have O
cloned _RARE_
a O
kinase O
, O
Nlk _RARE_
, O
that O
is O
a O
murine I-GENE
homolog I-GENE
of I-GENE
the I-GENE
Drosophila I-GENE
nemo _RARE_
( O
nmo _RARE_
) O
gene O
. O

Our O
findings O
suggest O
that O
striatal _RARE_
FDG O
and O
particularly O
RACLO _RARE_
are O
sensitive _RARE_
and O
effective O
measures O
of O
striatal _RARE_
function O
and O
may O
help O
characterizing O
patients O
with O
multiple O
system _RARE_
atrophy O
. O

Childhood _RARE_
misbehavior _RARE_
and O
the O
risk O
of O
injecting O
drug O
use O
. O

Genetic O
analysis O
has O
subsequently O
identified O
subpathways _RARE_
of O
the O
DNA O
structure _RARE_
checkpoints _RARE_
, O
including O
the O
reversible O
arrest O
of O
DNA O
synthesis _RARE_
. O

Thus O
, O
Esigma54 _RARE_
promoters I-GENE
are O
responsive O
to O
CRP I-GENE
, O
a O
protein O
unrelated O
to O
sigma54 _RARE_
activators _RARE_
, O
and O
the O
repression O
exerted _RARE_
is O
the O
direct O
result O
of O
an O
interaction O
between O
Esigma54 _RARE_
and O
the O
CRP I-GENE
- I-GENE
cAMP I-GENE
complex I-GENE
. O

GlcNAc _RARE_
- O
and O
GlcNAc2 _RARE_
- O
PP _RARE_
- O
Dolichol _RARE_
biosynthesis O
could O
be O
shown O
with O
isolated O
S O
. O
cerevisiae O
membranes O
from O
cells O
harboring O
the O
recombinant O
plasmid _RARE_
and O
grown O
on O
glucose O
thus O
suppressing _RARE_
transcription O
of O
the O
endogenous O
gene O
. O

Demonstration _RARE_
of O
tissue O
lesions O
after O
intramuscular _RARE_
injection O
by O
determination O
of O
creatine _RARE_
kinase I-GENE
in O
blood _RARE_

Antibodies O
raised O
against O
GST I-GENE
mSH2 _RARE_
- I-GENE
B I-GENE
identified O
a O
cellular O
protein O
of O
92 O
kDa O
that O
was O
not O
found O
to O
be O
phosphorylated _RARE_
on O
Tyr _RARE_
. O

Interleukin I-GENE
- I-GENE
6 I-GENE
( O
IL _RARE_
- I-GENE
6 I-GENE
) O
is O
a O
pleiotropic O
cytokine _RARE_
, O
which O
is O
involved O
in O
inflammatory O
and O
immune O
responses O
, O
acute O
phase _RARE_
reactions O
, O
and O
hematopoiesis _RARE_
. O

Upon O
analysis O
of O
various O
deletion O
and O
point O
- O
mutated _RARE_
variants O
of O
the O
human I-GENE
IL _RARE_
- I-GENE
6 I-GENE
gene I-GENE
promoter I-GENE
coupled O
to O
a O
reporter O
gene O
, O
we O
screened O
for _RARE_
possible O
cooperating _RARE_
transcription O
factors O
. O

This O
region O
, O
however O
, O
contains O
a O
CCAATC _RARE_
box O
in O
the O
reverse O
complement O
and O
several O
GC _RARE_
boxes _RARE_
that O
are O
recognition O
sites O
for _RARE_
SP1 I-GENE
. O

Our O
purpose O
was O
to O
determine O
if O
intact _RARE_
perianal _RARE_
( O
S4 _RARE_
- O
5 O
) O
pin _RARE_
sensation _RARE_
( O
PPS _RARE_
) O
and O
bulbocavernosus _RARE_
( O
S2 _RARE_
- O
4 O
) O
reflex O
( O
BCR _RARE_
) O
shortly _RARE_
after O
spinal _RARE_
cord O
injury O
( O
SCI _RARE_
) O
are O
predictive O
of O
bladder O
function O
recovery O
. O

The O
correct O
termination _RARE_
of O
retroviral _RARE_
transcripts O
at _RARE_
the O
3 O
' O
LTR O
R O
/ O
U5 _RARE_
junction _RARE_
is O
primarily O
dependent O
on O
the O
canonical O
AAUAAA _RARE_
polyadenylation O
signal O
, O
so O
we O
have O
analyzed O
the O
effect O
of O
mutating _RARE_
the O
polyadenylation O
signal O
sequences O
on O
the O
properties O
of O
a O
selectable O
murine O
retroviral _RARE_
vector O
. O

Levels _RARE_
of O
the O
MEK I-GENE
inhibitor O
PD98059 O
that O
block _RARE_
EGF _RARE_
- O
induced _RARE_
mitogenesis _RARE_
and O
MAP I-GENE
kinase I-GENE
phosphorylation _RARE_
also O
abrogate O
EGF _RARE_
- O
induced _RARE_
focal _RARE_
adhesion O
disassembly _RARE_
and O
cell O
motility _RARE_
. O

ALT _RARE_
levels O
in O
responders O
were O
lowered O
by O
46 _RARE_
% O
and O
AST _RARE_
levels O
were O
lowered O
by O
35 _RARE_
% O
after O
12 O
weeks O
of O
vitamin O
E O
treatment O
. O

Surprisingly O
, O
the O
COOH _RARE_
- O
terminal O
domain O
of O
RanGAP1 _RARE_
was O
also O
found O
to O
harbor O
a O
nuclear O
localization _RARE_
signal O
. O

51 _RARE_
. O
9 O
% O
( O
P O
= O
0 _RARE_
. O
0006 _RARE_
) O
in O
the O
MMF _RARE_
versus O
the O
AZA _RARE_
groups O
, O
respectively O
. O

Our O
study O
was O
designed O
to O
investigate O
the O
effect O
of O
MMF _RARE_
on O
in O
vivo O
bone O
mineral O
metabolism O
. O

Pao2 _RARE_
increased O
from O
15 _RARE_
. O
5 O
+/- O
5 O
. O
6 O
kPa _RARE_
( O
116 _RARE_
+/- O
42 _RARE_
mm O
Hg O
) O
to O
17 _RARE_
. O
3 O
+/- O
6 O
. O
3 O
kPa _RARE_
( O
130 _RARE_
+/- O
47 _RARE_
mm O
Hg O
) O
( O
P O
< O
0 _RARE_
. O
05 O
). O

Typical _RARE_
configurations _RARE_
of O
psychosocial _RARE_
stress O
factors O
of O
psychiatrically _RARE_
conspicuous _RARE_
children O
and O
adolescents _RARE_

Nine _RARE_
cats O
received O
PMEA _RARE_
at _RARE_
a O
dosage O
of O
10 O
mg O
/ O
kg O
body O
weight _RARE_
, O
nine O
cats O
received O
FPMPA _RARE_
at _RARE_
a O
dosage O
of O
25 _RARE_
mg O
/ O
kg O
body O
weight _RARE_
. O

Resistance O
to O
thyroid O
hormone O
: O
implications O
for _RARE_
neurodevelopmental _RARE_
research O
on O
the O
effects O
of O
thyroid O
hormone O
disruptors _RARE_
. O

Here O
, O
we O
present O
evidence O
that O
exposure O
of O
DT40 _RARE_
lymphoma O
B O
cells O
to O
low O
energy O
electromagnetic _RARE_
field O
( O
EMF _RARE_
) O
results O
in O
a O
tyrosine I-GENE
kinase I-GENE
- O
dependent O
activation O
of O
phospholipase I-GENE
Cgamma2 _RARE_
( O
PLC I-GENE
- I-GENE
gamma2 _RARE_
) O
leading O
to O
increased O
inositol _RARE_
phospholipid _RARE_
turnover O
. O

We O
present O
the O
preliminary O
results O
obtained O
on O
36 _RARE_
patients O
which O
were O
followed O
for _RARE_
a O
mean O
period O
of O
12 O
months O
. O

Moreover O
, O
xTAK1KN _RARE_
could O
block _RARE_
the O
expression _RARE_
of O
ventral O
mesoderm O
marker O
genes O
induced _RARE_
by O
Smad1 _RARE_
or I-GENE
5 I-GENE
. O

PATIENTS O
AND _RARE_
METHOD _RARE_
: O
Since O
1986 O
, O
62 _RARE_
patients O
were O
irradiated O
stereotactically _RARE_
. O

The O
assay O
exhibits O
a O
dynamic O
range O
of O
0 _RARE_
. O
1 O
- O
100 _RARE_
micrograms O
l _RARE_
- O
1 O
using O
a O
monoclonal O
antibody O
or O
alternatively _RARE_
10 O
micrograms O
l _RARE_
- O
1 O
to O
10 O
mg O
l _RARE_
- O
1 O
using O
commercially _RARE_
available O
antiserum _RARE_
. O

Training _RARE_
for _RARE_
audit _RARE_
. O

A O
canonical O
TATA O
box O
was O
not O
detected O
. O

Expression O
and O
characterization O
of O
recombinant I-GENE
single I-GENE
- I-GENE
chain I-GENE
Fv _RARE_
and O
Fv _RARE_
fragments I-GENE
derived O
from O
a O
set O
of O
catalytic O
antibodies O
. O

A O
putative O
inhibitor O
( O
s O
) O
appears O
to O
co _RARE_
- O
elute _RARE_
in O
the O
inactive O
fraction O
that O
blocked O
the O
L I-GENE
( I-GENE
alpha I-GENE
) I-GENE
activity O
. O

Platelet _RARE_
aggregation _RARE_
in O
response O
to O
10 O
micrograms O
collagen _RARE_
/ O
ml O
was O
decreased O
in O
parallel O
after O
treatment O
with O
ASA _RARE_
. O

Using O
himA _RARE_
mutants I-GENE
, O
we O
confirmed O
that O
IHF _RARE_
plays O
a O
role O
in O
the O
molybdate _RARE_
- O
dependent O
regulation _RARE_
of O
dmsA _RARE_
- O
lacZ I-GENE
expression _RARE_
in O
vivo O
. O

Cross O
- O
talking _RARE_
among O
Drosophila O
nuclear O
receptors O
at _RARE_
the O
promiscuous _RARE_
response O
element O
of O
the O
ng _RARE_
- I-GENE
1 I-GENE
and O
ng _RARE_
- I-GENE
2 I-GENE
intermolt _RARE_
genes I-GENE
. O

The O
ipsilateral O
breast O
tumor O
relapse O
rate O
was O
similar O
between O
the O
PALP _RARE_
and O
MGDET _RARE_
groups O
. O

Sibling _RARE_
aggregation _RARE_
of O
low I-GENE
- I-GENE
and I-GENE
high I-GENE
- I-GENE
density I-GENE
lipoprotein I-GENE
cholesterol I-GENE
and O
apolipoproteins _RARE_
B I-GENE
and I-GENE
A I-GENE
- I-GENE
I I-GENE
levels O
in O
black O
and O
white _RARE_
children O
: O
the O
Bogalusa _RARE_
Heart _RARE_
Study O
. O

The O
CAPLC1 _RARE_
protein I-GENE
also O
exhibited O
several O
unique O
features O
, O
including O
a O
novel O
stretch O
of O
18 O
- O
19 O
amino O
acid O
residues O
within O
the O
X O
domain O
and O
an O
unusually O
long O
N O
- O
terminus O
which O
did O
not O
contain O
a O
recognizable _RARE_
EF _RARE_
- O
hand _RARE_
Ca O
( O
2 O
+)- _RARE_
binding O
domain O
. O

This O
hypothesis O
is O
consistent O
with O
the O
occurrence O
of O
PEA3 I-GENE
binding I-GENE
sites I-GENE
in O
the O
PEA3 I-GENE
promoter I-GENE
and O
with O
the O
ability O
of O
PEA3 I-GENE
to O
transactivate O
this O
promoter O
. O

Pet _RARE_
- I-GENE
1 I-GENE
can O
bind O
specifically O
to O
a O
PEA3 I-GENE
ETS _RARE_
DNA O
- O
binding O
motif O
and O
can O
modulate O
transcription O
of O
synthetic _RARE_
promoter O
constructs O
in O
a O
sequence O
- O
specific O
manner O
. O

The O
protein O
expressed _RARE_
by O
F2771 _RARE_
cDNA I-GENE
in O
transfected O
COS O
cells O
is O
localized O
in O
the O
cytoplasm O
. O

Northern O
analysis O
indicated O
differential O
expression _RARE_
by O
tissue O
with O
highest O
expression _RARE_
in O
the O
heart _RARE_
. O

As O
well _RARE_
, O
further O
deletion O
of O
the O
promoter O
region O
to O
nucleotide O
- O
110 _RARE_
, O
which O
contains O
only O
one O
SF _RARE_
- I-GENE
1 I-GENE
binding I-GENE
site I-GENE
, O
still O
retained O
the O
ability O
to O
respond O
to O
exogenous _RARE_
SF _RARE_
- I-GENE
1 I-GENE
. O

The O
observation O
that O
beta I-GENE
2m _RARE_
with O
covalently O
attached O
peptide O
can O
effectively O
create O
CTL O
target O
structures _RARE_
in O
vitro O
offers O
new O
possibilities O
for _RARE_
the O
in O
vivo O
induction O
of O
epitope _RARE_
- O
specific O
CTL O
responses O
by O
either O
DNA O
immunization O
or O
injection O
of O
the O
purified _RARE_
epitope _RARE_
- O
linked _RARE_
beta I-GENE
2m _RARE_
. O

The O
mRNAs O
of O
these O
genes O
contain O
respectively O
one O
( O
YAP1 _RARE_
uORF _RARE_
) O
and O
two O
( O
YAP2 _RARE_
uORF1 _RARE_
and O
uORF2 _RARE_
) O
upstream O
open _RARE_
reading O
frames O
. O
uORF _RARE_
- O
mediated _RARE_
modulation O
of O
post O
- O
termination _RARE_
events O
on O
the O
5 O
'- O
untranslated _RARE_
region O
( O
5 O
'- O
UTR O
) O
directs O
differential O
control O
not O
only O
of O
translation O
but O
also O
of O
mRNA O
decay _RARE_
. O

To O
further O
investigate O
the O
nature O
of O
the O
site O
specificity _RARE_
a O
set O
of O
deletion O
mutants O
of O
the O
160 _RARE_
bp O
sequence O
were O
analysed O
. O

In O
the O
tissues O
tested O
, O
except O
brain O
, O
the O
message _RARE_
for _RARE_
CLIP _RARE_
- I-GENE
170 _RARE_
was O
more O
abundant O
than O
that O
for _RARE_
Restin _RARE_
. O

BACKGROUND O
: O
Chemicals _RARE_
vary O
considerably O
in O
their O
intrinsic _RARE_
ability O
to O
cause O
allergic O
contact _RARE_
dermatitis O
. O

Cytoskeletal _RARE_
polarization _RARE_
of O
T O
cells O
is O
regulated O
by O
an O
immunoreceptor _RARE_
tyrosine O
- O
based O
activation O
motif O
- O
dependent O
mechanism O
. O

Here O
we O
have O
examined O
the O
ability O
of O
the O
cellular O
protein O
YB _RARE_
- I-GENE
1 I-GENE
to O
modulate O
transcription O
of O
the O
HIV I-GENE
- I-GENE
1 I-GENE
promoter I-GENE
in O
a O
human O
astrocytic _RARE_
cell O
line O
( O
U _RARE_
- O
87MG _RARE_
), _RARE_
a O
neuronal _RARE_
cell O
line O
( O
SK _RARE_
- O
N O
- O
MC O
) O
and O
lymphoid _RARE_
cells O
( O
Jurkat O
) O
by O
transfection O
assay O
. O

Also O
, O
the O
deduced O
amino O
acids _RARE_
of O
the O
antigenic _RARE_
regions I-GENE
A I-GENE
, I-GENE
B I-GENE
and I-GENE
C I-GENE
of I-GENE
VP7 _RARE_
were O
nearly O
conserved _RARE_
within O
the O
phylogenetic O
lineages O
. O

The O
cloned _RARE_
alcR _RARE_
gene I-GENE
provided O
in O
trans _RARE_
restored O
these O
siderophore _RARE_
system _RARE_
activities O
to O
the O
mutants O
. O

The O
cloned _RARE_
alcR _RARE_
gene I-GENE
provided O
in O
trans _RARE_
restored O
these O
siderophore _RARE_
system _RARE_
activities O
to O
the O
mutants O
. O

Copyright O
1998 O
Academic O
Press O
. O

It O
may O
also O
be O
suggested O
that O
particular O
care O
should O
be O
taken O
when O
such O
a O
trans _RARE_
- O
dominant O
Rev _RARE_
mutant I-GENE
is O
considered O
to O
be O
used O
as _RARE_
a O
genetic O
therapy O
against O
HIV O
- O
I O
infection O
, O
in O
individuals O
infected _RARE_
with O
both O
HIV O
- O
I O
and O
HTLV _RARE_
- O
1 O
. O

PATIENTS O
AND _RARE_
METHODS O
: O
Between _RARE_
January O
1992 O
and O
June _RARE_
1994 O
at _RARE_
St _RARE_
. O

The O
frequency O
of O
SPs _RARE_
for _RARE_
both O
the O
moderate O
and O
severe O
groups O
was O
significantly O
higher _RARE_
than O
that O
in O
patients O
with O
a O
normal O
MMFCV _RARE_
( O
p O
< O
. O
01 O
); O
of O
154 O
arms _RARE_
with O
a O
normal O
MMFCV _RARE_
, O
only O
9 O
( O
6 O
%) O
had O
an O
SP O
. O

We O
analyzed O
the O
P O
- O
SAECG _RARE_
in O
the O
time O
and O
frequency O
domain O
in O
23 _RARE_
patients O
with O
Paf _RARE_
and O
19 O
controls O
. O

Competitive _RARE_
reverse O
transcription O
- O
polymerase O
chain O
reaction O
and O
HPLC O
analysis O
showed O
that O
RUSH _RARE_
- I-GENE
1alpha I-GENE
is O
the O
progesterone O
- O
dependent O
splice _RARE_
variant O
. O

TOR2 _RARE_
is O
part O
of O
two O
related O
signaling _RARE_
pathways O
coordinating _RARE_
cell O
growth O
in O
Saccharomyces O
cerevisiae O
. O

Transcervical _RARE_
amnioinfusion _RARE_
. O

SETTING O
: O
A O
division O
of O
a O
large O
tea _RARE_
plantation _RARE_
in O
Kandy _RARE_
. O

Simple _RARE_
models O
of O
bimolecular _RARE_
interaction O
did O
not O
fully O
account O
for _RARE_
the O
kinetic O
profiles O
obtained O
with O
the O
parental O
antibodies O
and O
the O
hybrids O
, O
and O
this O
complexity O
suggested O
the O
existence O
of O
a O
conformational O
heterogeneity O
in O
these O
molecules O
. O

In O
order O
to O
decipher _RARE_
the O
pathway _RARE_
that O
leads O
to O
Hox I-GENE
gene I-GENE
induction O
, O
we O
have O
investigated O
whether O
a O
Hox I-GENE
gene I-GENE
regulator O
, O
the O
leucine O
zipper O
transcription O
factor O
MafB _RARE_
/ O
Kr _RARE_
, O
is O
itself O
transcriptionally O
regulated O
by O
the O
environmental O
signals O
. O

Substrates _RARE_
for _RARE_
p210 _RARE_
( O
bcr _RARE_
- O
abl I-GENE
) O
are O
likely O
to O
be O
involved O
in O
the O
pathogenesis O
of O
CML O
. O

Reporter _RARE_
constructs O
function O
in O
a O
parallel O
manner O
, O
demonstrating O
the O
key O
role O
of O
the O
AhR _RARE_
in O
constitutive _RARE_
as _RARE_
well _RARE_
as _RARE_
TCDD _RARE_
- O
induced _RARE_
expression _RARE_
of O
Cyp1B1 _RARE_
in O
mouse O
embryo _RARE_
fibroblasts _RARE_
. O

Transfection O
studies O
also O
showed O
that O
3 O
'- O
deletion O
of O
sequences O
downstream _RARE_
of O
the O
transcriptional O
start _RARE_
site O
(+ O
1 O
/+ _RARE_
47 _RARE_
) O
markedly O
reduced _RARE_
OSM _RARE_
- O
fold _RARE_
induction O
. O

Oncostatin _RARE_
M I-GENE
stimulates O
c I-GENE
- I-GENE
Fos I-GENE
to O
bind O
a O
transcriptionally O
responsive O
AP I-GENE
- I-GENE
1 I-GENE
element I-GENE
within O
the O
tissue I-GENE
inhibitor I-GENE
of I-GENE
metalloproteinase _RARE_
- I-GENE
1 I-GENE
promoter I-GENE
. O

We O
have O
isolated O
a O
new O
human I-GENE
RING _RARE_
- I-GENE
finger I-GENE
gene I-GENE
( O
RNF4 _RARE_
) O
that O
encodes O
a O
190 O
- O
amino O
- O
acid O
protein O
. O

To O
elucidate O
the O
regulatory O
mechanism O
of O
human I-GENE
AM _RARE_
gene I-GENE
expression _RARE_
, O
functional _RARE_
elements O
of O
5 O
'- O
flanking O
region O
of O
AM _RARE_
gene I-GENE
were O
studied O
in O
human O
aortic O
endothelial O
cells O
( O
HAEC _RARE_
). O

The O
COOH _RARE_
- O
terminal O
region O
of O
the O
transcripts O
contained O
fifteen _RARE_
triplet O
repeats O
( O
GCT _RARE_
; O
alanine O
) O
at _RARE_
nucleotide O
465 _RARE_
to O
509 _RARE_
, O
which O
is O
significantly O
expanded _RARE_
compared O
to O
the O
rat I-GENE
RL14 _RARE_
. O

Soluble _RARE_
FasR _RARE_
ligand _RARE_
- O
binding O
domain O
: O
high O
- O
yield O
production O
of O
active _RARE_
fusion O
and O
non O
- O
fusion O
recombinant O
proteins O
using O
the O
baculovirus _RARE_
/ O
insect O
cell O
system _RARE_
. O

Control O
of O
fatty O
liver O
syndrome _RARE_
in O
a O
Jersey _RARE_
herd O
by O
a O
change O
of O
diet O
and O
the O
use O
of O
recombinant O
bovine O
somatotrophin _RARE_
. O

The O
inhibition O
of O
focus O
formation O
observed O
in O
the O
presence O
of O
C3G _RARE_
was O
not O
due O
to O
toxic O
effects O
on O
cell O
viability O
, O
since O
transfected O
C3G _RARE_
cells O
exhibited O
the O
same O
survival O
and O
growth O
rates O
as _RARE_
untransfected _RARE_
NIH3T3 O
cells O
or O
cells O
transfected O
with O
plasmid _RARE_
vector O
alone O
. O

C O
. O
D2 _RARE_
- O
Chr O
4 O
congenic _RARE_
strains O
harboring O
DBA _RARE_
/ O
2 O
alleles O
associated O
with O
the O
Pctr1 _RARE_
locus I-GENE
contained O
DBA _RARE_
/ O
2 O
" O
resistant O
" O
alleles O
of O
the O
CDK4 _RARE_
/ O
CDK6 _RARE_
inhibitors _RARE_
p16 _RARE_
and O
p15 _RARE_
. O

When O
tested O
with O
wild O
- O
type O
( O
DBA _RARE_
/ O
2 O
) O
p16 _RARE_
, O
both O
A134C _RARE_
and O
G232A _RARE_
BALB _RARE_
/ O
c O
- O
specific O
variants O
of O
p16 _RARE_
were O
inefficient O
in O
their O
ability O
to O
inhibit O
the O
activity O
of O
cyclin _RARE_
D2 _RARE_
/ O
CDK4 _RARE_
in O
kinase O
assays O
with O
retinoblastoma _RARE_
protein I-GENE
, O
suggesting O
this O
defective _RARE_
, O
inherited O
allele O
plays O
an O
important O
role O
in O
the O
genetic O
susceptibility _RARE_
of O
BALB _RARE_
/ O
c O
mice O
for _RARE_
plasmacytoma _RARE_
induction O
and O
that O
p16 _RARE_
( O
INK4a _RARE_
) O
is O
a O
strong O
candidate O
for _RARE_
the O
Pctr1 _RARE_
locus I-GENE
. O

Despite O
this O
there O
was O
no _RARE_
difference O
in O
the O
intubating _RARE_
conditions O
at _RARE_
one O
minute O
with O
25 _RARE_
excellent O
/ O
5 O
good O
in O
the O
suxamethonium _RARE_
group O
and O
27 _RARE_
excellent O
/ O
3 O
good O
in O
the O
rocuronium _RARE_
group O
. O

Cloning O
and O
expression _RARE_
of O
two O
genes O
encoding O
auxin _RARE_
- I-GENE
binding I-GENE
proteins I-GENE
from O
tobacco O
. O

Furthermore O
, O
direct O
association O
with O
D3 _RARE_
phosphatidylinositides _RARE_
seems O
to O
be O
essential O
for _RARE_
activation O
of O
PKB I-GENE
/ O
Akt I-GENE
. O

The O
FMN _RARE_
moiety _RARE_
but O
not O
the O
[ _RARE_
3Fe _RARE_
- O
4S _RARE_
] O
cluster O
of O
the O
subunit O
appears O
to O
participate O
in O
this O
reaction O
. O

Alison _RARE_
Bell _RARE_
Memorial _RARE_
Award _RARE_
. O

METHODS O
: O
A O
population O
survey O
was O
undertaken O
in O
10 O
, O
148 _RARE_
individuals O
to O
measure O
the O
prevalence O
and O
identify O
the O
causes O
of O
blindness _RARE_
in O
Lebanon _RARE_
. O

During O
organogenesis _RARE_
, O
HFH _RARE_
- I-GENE
8 I-GENE
expression _RARE_
is O
found O
in O
the O
splanchnic _RARE_
mesoderm O
in O
close O
apposition _RARE_
of O
the O
gut O
endoderm O
, O
suggesting O
a O
role O
in O
mesenchymal O
- O
epithelial _RARE_
induction O
of O
lung _RARE_
and O
gut O
morphogenesis _RARE_
. O

However O
, O
laparoscopy _RARE_
failed O
to O
establish O
inoperability _RARE_
in O
any O
cases O
of O
carcinoma O
spread O
to O
areas O
not O
accessible _RARE_
to O
laparoscopic O
visualization O
. O

No O
difference O
in O
telomere _RARE_
length O
was O
seen O
in O
mutants O
affected O
in O
the O
regulation _RARE_
of O
Cdc2 I-GENE
, O
whereas O
some O
of O
the O
DNA O
repair O
mutants O
examined O
had O
slightly O
longer O
telomeres _RARE_
than O
did O
the O
wild O
type O
. O

The O
mean O
duration O
of O
pain O
relief _RARE_
was O
4 O
- O
6 O
weeks O
. O

The O
ESEM _RARE_
differs O
from O
conventional O
SEM _RARE_
in O
that O
no _RARE_
sample O
preparation O
is O
needed O
, O
eliminating _RARE_
artifactual _RARE_
changes O
. O

Sp1 _RARE_
can O
activate O
transcription O
through O
immunoglobulin I-GENE
kappa _RARE_
- I-GENE
chain I-GENE
enhancer I-GENE
or O
P I-GENE
- I-GENE
selectin I-GENE
promoter I-GENE
NF _RARE_
- I-GENE
kappaB I-GENE
sites I-GENE
. O
p50 _RARE_
homodimers I-GENE
replace O
Sp1 _RARE_
from O
the O
P I-GENE
- I-GENE
selectin I-GENE
promoter I-GENE
by O
binding O
site O
competition O
and O
thereby O
either O
inhibit O
basal O
Sp1 _RARE_
- O
driven _RARE_
expression _RARE_
or O
, O
in O
concert _RARE_
with O
Bcl I-GENE
- I-GENE
3 I-GENE
, O
stimulate O
expression _RARE_
. O

The O
3 O
' O
fragment O
was O
shown O
to O
accumulate O
as _RARE_
full O
- O
length O
mRNA O
disappeared O
in O
actinomycin _RARE_
D O
- O
treated O
cells O
, O
indicating O
a O
precursor O
- O
product O
relationship O
. O

The O
TATA I-GENE
box I-GENE
- I-GENE
binding I-GENE
protein I-GENE
( O
TBP I-GENE
) O
plays O
an O
essential O
role O
in O
transcription O
by O
all O
three O
eukaryotic O
nuclear I-GENE
RNA I-GENE
polymerases _RARE_
, O
polymerases _RARE_
( I-GENE
Pol I-GENE
) I-GENE
I I-GENE
, I-GENE
II I-GENE
, I-GENE
and I-GENE
III I-GENE
. O

A O
triple _RARE_
- I-GENE
mutant I-GENE
TBP I-GENE
( O
R231E _RARE_
+ O
R235E _RARE_
+ O
R239S _RARE_
) O
had O
greatly O
reduced _RARE_
activity O
for _RARE_
yeast I-GENE
U6 I-GENE
snRNA _RARE_
gene I-GENE
transcription O
while O
remaining O
active _RARE_
for _RARE_
Pol I-GENE
II I-GENE
basal O
transcription O
. O

E2F I-GENE
activity O
is O
regulated O
in O
part O
by O
the O
retinoblastoma _RARE_
family I-GENE
of I-GENE
tumor I-GENE
suppressor I-GENE
proteins I-GENE
. O

This O
resulted O
in O
a O
complete _RARE_
inhibition O
of O
Site _RARE_
- O
1 O
cleavage _RARE_
that O
was O
restored O
by O
concomitant O
overexpression O
of O
full O
- O
length O
SCAP _RARE_
. O

To O
determine O
the O
true O
molecular _RARE_
identity O
of O
SFD _RARE_
, O
both O
the O
50 O
- O
and O
57 O
- O
kDa O
polypeptides O
were O
directly O
sequenced O
. O

Molecular O
characterization O
of O
the O
50 O
- O
and O
57 O
- O
kDa O
subunits O
of O
the O
bovine I-GENE
vacuolar I-GENE
proton _RARE_
pump _RARE_
. O

In O
C O
. O
albicans _RARE_
, O
HST6 _RARE_
is O
expressed _RARE_
constitutively O
at _RARE_
high O
levels O
in O
the O
different O
cell O
types _RARE_
analysed O
( O
yeast O
, O
hyphae _RARE_
, O
white _RARE_
and O
opaque _RARE_
), _RARE_
demonstrating O
that O
HST6 _RARE_
transcription O
is O
not O
repressed O
in O
this O
diploid O
yeast O
, O
unlike O
in O
diploid O
S O
. O
cerevisiae O
, O
and O
suggesting O
a O
basic O
biological O
function O
for _RARE_
the O
Hst6p _RARE_
transporter _RARE_
in O
C O
. O
albicans _RARE_
. O

Furthermore O
, O
binding O
of O
recombinant I-GENE
Myb I-GENE
and O
Ets I-GENE
- I-GENE
2 I-GENE
protein I-GENE
to O
these O
fragments O
could O
be O
competed _RARE_
with O
an O
excess O
of O
double O
stranded _RARE_
oligodeoxynucleotides _RARE_
containing O
canonical O
, O
but O
not O
mutated _RARE_
, O
Myb I-GENE
- O
or O
Ets I-GENE
- I-GENE
binding I-GENE
sites I-GENE
. O

This O
structure _RARE_
interconnects _RARE_
specific O
triplets _RARE_
of O
the O
basal O
bodies _RARE_
with O
the O
microtubular _RARE_
bundles _RARE_
that O
emerge _RARE_
from O
the O
basal O
apparatus O
. O

To O
understand O
the O
regulatory O
mechanism O
controlling O
its O
expression _RARE_
at _RARE_
low O
temperature _RARE_
, O
the O
promoter O
region O
has O
been O
characterized O
. O

In O
the O
current O
study O
, O
the O
roles O
of O
two O
putative O
cis O
- O
acting O
elements O
within O
the O
- O
73 _RARE_
to O
+ O
44 _RARE_
region O
in O
basal O
exon _RARE_
2 O
promoter O
activity O
were O
evaluated O
using O
mutagenesis O
and O
nuclear O
protein O
- O
DNA O
binding O
assays O
. O

For O
the O
5HT5A _RARE_
receptor I-GENE
the O
addition O
of O
yohimbine _RARE_
resulted O
in O
a O
similar O
but O
smaller O
effect O
. O

We O
have O
examined O
reporter O
gene O
( O
beta I-GENE
- I-GENE
gal _RARE_
) O
expression _RARE_
directed O
by O
human I-GENE
heat I-GENE
shock I-GENE
transcription I-GENE
factors I-GENE
1 I-GENE
and I-GENE
2 I-GENE
( O
HSF1 I-GENE
and O
HSF2 _RARE_
) O
in O
HeLa O
cells O
and O
in O
yeast O
( O
Saccharomyces O
cerevisiae O
). O

Localized _RARE_
fluorescence O
was O
detectable O
only O
in O
cells O
containing O
a O
visible _RARE_
midcell _RARE_
constriction _RARE_
, O
suggesting O
that O
FtsK _RARE_
targeting O
normally O
occurs O
only O
at _RARE_
a O
late _RARE_
stage _RARE_
of O
septation _RARE_
. O

No O
TATA O
box O
was O
found O
in O
the O
putative O
promoter O
region O
, O
but O
multiple O
GC _RARE_
boxes _RARE_
were O
found O
around O
the O
cap _RARE_
sites O
, O
supporting O
the O
previously O
inferred _RARE_
housekeeping O
nature O
of O
CYP51 _RARE_
gene I-GENE
and O
the O
existence O
of O
the O
multiple O
transcription O
initiation O
sites O
. O

Structural O
and O
evolutionary O
studies O
on O
sterol I-GENE
14 I-GENE
- I-GENE
demethylase _RARE_
P450 I-GENE
( O
CYP51 _RARE_
), _RARE_
the O
most O
conserved _RARE_
P450 I-GENE
monooxygenase _RARE_
: O
I O
. O

Its O
expression _RARE_
pattern O
is O
representative O
of O
many O
B O
cell O
- O
specific O
proteins O
, O
which O
are O
essential O
for _RARE_
B O
cell O
development O
and O
activation O
but O
are O
down O
- O
regulated O
after O
B O
cells O
become O
terminally _RARE_
differentiated O
plasma O
cells O
. O

The O
intercistronic _RARE_
gene O
junctions O
of O
vesicular O
stomatitis _RARE_
virus O
( O
VSV _RARE_
) O
contain O
conserved _RARE_
sequence O
elements O
that O
are O
important O
for _RARE_
polyadenylation O
and O
transcription O
termination _RARE_
of O
upstream O
transcript O
as _RARE_
well _RARE_
as _RARE_
reinitiation _RARE_
of O
transcription O
of O
downstream _RARE_
transcript O
. O

Infectious _RARE_
mutant O
virus O
progeny _RARE_
was O
obtained O
only O
on O
complementing _RARE_
gK _RARE_
- O
expressing O
cells O
, O
suggesting O
that O
gK _RARE_
has O
an O
important O
function O
in O
the O
replication O
cycle _RARE_
. O

Cleavage _RARE_
and O
DNA O
joining _RARE_
reactions O
, O
carried O
out O
by O
human I-GENE
immunodeficiency I-GENE
virus I-GENE
type I-GENE
1 I-GENE
( I-GENE
HIV I-GENE
- I-GENE
1 I-GENE
) I-GENE
integrase I-GENE
, O
are O
necessary O
to O
effect O
the O
covalent _RARE_
insertion _RARE_
of O
HIV O
- O
1 O
DNA O
into O
the O
host _RARE_
genome O
. O

The O
DSF _RARE_
regimen O
appears O
to O
have O
significant O
activity O
in O
patients O
who O
have O
metastatic O
pancreatic O
islet O
- O
cell O
carcinoma O
, O
and O
patient O
tolerance O
of O
the O
regimen O
is O
excellent O
, O
thus O
warranting _RARE_
further O
investigation O
. O

Activation O
of O
the O
mitogen I-GENE
activated I-GENE
protein I-GENE
( I-GENE
MAP I-GENE
) I-GENE
kinase I-GENE
is O
a O
primary _RARE_
consequence O
of O
Ras I-GENE
activation O
and O
plays O
a O
key O
role O
in O
mediating O
Ras I-GENE
signal O
transduction _RARE_
. O

Histone _RARE_
acetylation O
levels O
in O
cells O
result O
from O
a O
dynamic O
equilibrium O
between O
competing _RARE_
histone I-GENE
acetylases _RARE_
and I-GENE
deacetylases _RARE_
. O

CONCLUSIONS O
: O
XCoe2 _RARE_
may O
play O
a O
pivotal O
role O
in O
the O
transcriptional O
cascade O
that O
specifies O
primary _RARE_
neurons O
in O
Xenopus O
embryos _RARE_
: O
by O
maintaining O
Delta _RARE_
- O
Notch I-GENE
signalling O
, O
XCoe2 _RARE_
stabilises _RARE_
the O
higher _RARE_
neural _RARE_
potential _RARE_
of O
selected _RARE_
progenitor _RARE_
cells O
that O
express O
X I-GENE
- I-GENE
ngnr _RARE_
- I-GENE
1 I-GENE
, O
ensuring _RARE_
the O
transition O
between O
neural _RARE_
competence _RARE_
and O
irreversible O
commitment _RARE_
to O
a O
neural _RARE_
fate O
; O
and O
it O
promotes O
neuronal _RARE_
differentiation O
by O
activating O
XNeuroD _RARE_
expression _RARE_
, O
directly O
or O
indirectly O
. O

RESULTS O
: O
Patients O
in O
Group O
A O
had O
a O
higher _RARE_
incidence O
of O
posterolateral _RARE_
wall _RARE_
motion O
abnormalities O
( O
p O
< O
0 _RARE_
. O
001 O
) O
on O
radionuclide _RARE_
ventriculography _RARE_
, O
a O
larger O
infarct O
area O
( O
as _RARE_
evidenced _RARE_
by O
higher _RARE_
peak O
creatine _RARE_
kinase I-GENE
levels O
) O
( O
p O
< O
0 _RARE_
. O
02 O
) O
and O
a O
lower O
left _RARE_
ventricular O
ejection O
fraction O
( O
LVEF O
) O
at _RARE_
hospital O
discharge O
( O
p O
< O
0 _RARE_
. O
008 _RARE_
) O
than O
those O
in O
Group O
B O
. O

CyIIa _RARE_
transcription O
follows O
, O
and O
is O
therefore O
downstream _RARE_
of O
, O
the O
initial O
specification _RARE_
of O
these O
embryonic _RARE_
domains O
. O

Cis _RARE_
- O
regulation _RARE_
downstream _RARE_
of O
cell O
type O
specification _RARE_
: O
a O
single O
compact _RARE_
element O
controls O
the O
complex O
expression _RARE_
of O
the O
CyIIa _RARE_
gene I-GENE
in O
sea _RARE_
urchin _RARE_
embryos _RARE_
. O

We O
also O
present O
evidence O
that O
human I-GENE
HYAL1 _RARE_
is O
identical O
to O
an O
uncharacterized O
gene O
positionally _RARE_
cloned _RARE_
by O
others O
from O
chromosome _RARE_
3p21 _RARE_
. O
3 O
that O
is O
homozygously _RARE_
deleted _RARE_
in O
several O
small O
- O
cell O
lung _RARE_
carcinoma O
cell O
lines O
. O

In O
patients O
with O
myalgia _RARE_
, O
Raynaud _RARE_
' O
s O
syndrome _RARE_
, O
skin _RARE_
vasculitis O
and O
vascular O
diseases O
WFAg _RARE_
concentrations O
were O
higher _RARE_
than O
in O
patients O
without O
them O
. O

Although O
the O
expression _RARE_
of O
the O
4E _RARE_
- I-GENE
BP1 _RARE_
gene I-GENE
alone O
has O
not O
yet O
been O
accomplished _RARE_
, O
the O
gene O
was O
expressed _RARE_
in O
Escherichia O
coli O
[ _RARE_
BL21 _RARE_
( O
DE3 _RARE_
)] O
as _RARE_
a O
fusion O
gene O
with O
the O
glutathione _RARE_
- I-GENE
S I-GENE
- I-GENE
transferase I-GENE
( O
GST I-GENE
) O
gene O
using O
a O
prokaryotic _RARE_
gene O
fusion O
vector O
( O
pGEX _RARE_
- O
4T _RARE_
- O
2 O
), _RARE_
which O
contains O
a O
gene O
sequence O
coding O
the O
cleavage _RARE_
site O
for _RARE_
a O
specific O
protease O
, O
alpha I-GENE
- I-GENE
thrombin I-GENE
. O

Randomised _RARE_
comparison O
of O
addition O
of O
autologous O
bone O
- O
marrow O
transplantation O
to O
intensive O
chemotherapy O
for _RARE_
acute O
myeloid _RARE_
leukaemia _RARE_
in O
first _RARE_
remission O
: O
results O
of O
MRC _RARE_
AML _RARE_
10 O
trial O
. O

Therapeutic _RARE_
use O
of O
cannabis _RARE_
. O

Analysis O
of O
intragenic _RARE_
revertants _RARE_
shows O
that O
this O
function O
depends O
on O
the O
amino O
acid O
preceding O
the O
first _RARE_
cysteine O
residue _RARE_
of O
the O
DNA O
- O
binding O
domain O
of O
Hap1p _RARE_
. O

Peripheral _RARE_
visual O
stimuli O
and O
monoaural _RARE_
auditory O
stimuli O
were O
used O
as _RARE_
targets _RARE_
. O

A O
review O
of O
studies O
published O
between O
1983 O
and O
1995 O
shows O
that O
there O
are O
some O
common O
factors O
as _RARE_
regards _RARE_
the O
psychological O
distress O
and O
social O
and O
functional _RARE_
limitations O
this O
group O
of O
patients O
has O
to O
deal _RARE_
with O
. O

PKC I-GENE
- I-GENE
gamma I-GENE
, O
which O
is O
not O
present O
in O
keratinocytes _RARE_
, O
also O
induces O
involucrin _RARE_
gene I-GENE
expression _RARE_
in O
a O
TPA _RARE_
- O
independent O
manner O
, O
when O
introduced O
into O
SVHK _RARE_
cells O
. O

Identification O
and O
characterization O
of O
specific O
DNA O
- O
binding O
complexes O
containing O
members O
of O
the O
Myc _RARE_
/ O
Max I-GENE
/ O
Mad _RARE_
network O
of O
transcriptional O
regulators _RARE_
. O

We O
further O
show O
that O
proteolytic _RARE_
targeting O
by O
calpain _RARE_
II I-GENE
and O
the O
proteasome O
involves O
different O
structural O
elements O
of O
YY1 I-GENE
. O

Primers _RARE_
for _RARE_
subsequent O
rounds _RARE_
of O
RACE O
were O
designed O
from O
the O
5 O
'- O
ends O
of O
amplified O
RACE O
products O
. O

Human O
ZFM1 _RARE_
protein I-GENE
is O
a O
transcriptional O
repressor O
that O
interacts O
with O
the O
transcription I-GENE
activation I-GENE
domain I-GENE
of I-GENE
stage _RARE_
- I-GENE
specific I-GENE
activator I-GENE
protein I-GENE
. O

Surprisingly O
, O
the O
CSF1R _RARE_
/ O
IRDelta960 _RARE_
was O
as _RARE_
effective O
as _RARE_
the O
CSF1R _RARE_
/ O
IR I-GENE
in O
mediating O
CSF I-GENE
- I-GENE
1 I-GENE
protection O
of O
cells O
from O
staurosporine _RARE_
- O
induced _RARE_
apoptosis O
. O

CONCLUSIONS O
: O
The O
special _RARE_
clinical O
presentation O
of O
our O
case O
of O
possible O
Gardner _RARE_
' O
s O
syndrome _RARE_
is O
discussed O
. O

These O
results O
would O
suggest O
that O
a O
high O
UV _RARE_
sensitivity O
is O
associated O
with O
high O
phaeomelanin _RARE_
and O
low O
eumelanin _RARE_
levels O
, O
and O
point O
to O
the O
eumelanin _RARE_
/ O
phaeomelanin _RARE_
ratio O
as _RARE_
a O
novel O
chemical O
parameter O
that O
could O
be O
used O
for _RARE_
predicting O
individuals O
at _RARE_
high O
risk O
for _RARE_
skin _RARE_
cancer _RARE_
and O
melanoma _RARE_
. O

In O
ferrets _RARE_
naturally O
infected _RARE_
with O
H O
. O
mustelae _RARE_
, O
a O
single O
dose O
( O
50 O
mg O
/ O
kg O
, O
per O
os _RARE_
) O
of O
fluorofamide _RARE_
completely O
inhibited O
bacterial I-GENE
urease I-GENE
. O

The O
cAMP O
- O
dependent O
mitogenic O
pathway _RARE_
is O
unique O
as _RARE_
it O
is O
independent O
of O
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
activation O
and O
differs O
from O
growth O
factor O
- O
dependent O
pathways O
at _RARE_
the O
level O
of O
the O
expression _RARE_
of O
several O
protooncogenes _RARE_
/ O
transcription O
factors O
. O

CONCLUSIONS O
: O
Use O
of O
the O
first _RARE_
method O
was O
associated O
with O
a O
reduction O
in O
the O
time O
patients O
remained O
in O
the O
ICU _RARE_
before O
transfer O
to O
another O
unit O
and O
savings _RARE_
in O
nursing O
time O
, O
but O
the O
two O
methods O
did O
not O
differ O
according O
to O
clinical O
outcomes O
. O

We O
have O
elucidated _RARE_
the O
exon _RARE_
- O
intron O
organization O
of O
the O
entire _RARE_
human O
CD58 _RARE_
gene I-GENE
, O
including O
approximately _RARE_
2 O
. O
5 O
kilobases O
( O
kb O
) O
of O
5 O
'- O
flanking O
DNA O
. O

The O
risk O
factors O
for _RARE_
hematuria _RARE_
in O
patients O
with O
renal _RARE_
hypouricemia _RARE_
are O
the O
elevation O
of O
urinary _RARE_
urate _RARE_
concentration O
and O
the O
subtypes O
of O
Post O
and O
Secretion _RARE_
. O

Two O
hundred O
sixty _RARE_
- O
four O
patients O
scheduled _RARE_
for _RARE_
DCBM _RARE_
were O
randomized O
to O
receive O
intravenously O
geG _RARE_
0 _RARE_
. O
25 _RARE_
mg O
( O
geG _RARE_
- O
25 _RARE_
), _RARE_
or O
geG _RARE_
0 _RARE_
. O
5 O
mg O
( O
geG _RARE_
- O
50 O
), _RARE_
or O
HBB _RARE_
20 O
mg O
as _RARE_
hypotonic _RARE_
agent O
. O

If O
the O
haemoglobin _RARE_
concentration O
( O
Hb _RARE_
) O
was O
less O
than O
12 O
g O
dL O
- O
1 O
they O
were O
given O
a O
four O
week O
course O
of O
ferrous _RARE_
sulphate _RARE_
. O

In O
all O
cells O
, O
the O
accumulation O
of O
high O
Dsg _RARE_
protein I-GENE
levels O
required O
calcium _RARE_
and O
was O
not O
observed O
in O
low O
calcium _RARE_
( O
0 _RARE_
. O
05 O
- O
0 _RARE_
. O
07 O
mM O
) O
media O
. O

Based O
on O
restriction _RARE_
enzyme O
analysis O
, O
Southern O
blots O
, O
polymerase O
chain O
reaction O
analysis O
and O
DNA O
sequencing O
, O
it O
was O
confirmed O
that O
the O
three O
overlapping O
clones _RARE_
isolated O
cover _RARE_
the O
entire _RARE_
cHO _RARE_
- I-GENE
1 I-GENE
gene I-GENE
, O
as _RARE_
well _RARE_
as _RARE_
approximately _RARE_
10 O
kb O
of O
the O
flanking O
regions O
on O
both O
ends O
. O

RESULTS O
: O
Using O
information _RARE_
in O
the O
dbEST _RARE_
database O
of O
expressed _RARE_
sequence O
tags O
, O
we O
isolated O
an O
Arabidopsis O
thaliana O
gene O
( O
GCR1 _RARE_
) O
that O
encodes O
a O
protein O
with O
seven _RARE_
predicted O
membrane O
- O
spanning O
domains O
and O
other O
features O
characteristic O
of O
7TM _RARE_
receptors I-GENE
. O

E1A I-GENE
represses O
apolipoprotein I-GENE
AI _RARE_
enhancer I-GENE
activity O
in O
liver O
cells O
through O
a O
pRb I-GENE
- O
and O
CBP I-GENE
- O
independent O
pathway _RARE_
. O

Position _RARE_
- O
independent O
expression _RARE_
of O
a O
human O
nerve I-GENE
growth I-GENE
factor I-GENE
- O
luciferase I-GENE
reporter O
gene O
cloned _RARE_
on O
a O
yeast O
artificial O
chromosome _RARE_
vector O
. O

Calcitriol _RARE_
therapy O
was O
associated O
with O
a O
decrease O
in O
serum O
iPTH _RARE_
levels O
( O
701 _RARE_
+/- O
103 _RARE_
. O
9 O
vs _RARE_
. O

Alterations _RARE_
in O
DNase I-GENE
I I-GENE
reactivity O
of O
the O
GC _RARE_
- O
response O
element O
region O
suggest O
that O
GC _RARE_
receptor I-GENE
- I-GENE
GC _RARE_
complexes I-GENE
may O
associate O
, O
in O
a O
transient O
manner O
, O
with O
the O
promoter O
in O
the O
actively O
transcribing _RARE_
control O
state O
. O

Most O
pituitary O
hormone O
- O
coding O
gene O
promoters O
are O
activated O
by O
Ptx1 _RARE_
. O

One O
of O
these O
small I-GENE
inteins _RARE_
might O
be O
inactive O
or O
a O
" I-GENE
pseudo _RARE_
intein _RARE_
." _RARE_
The O
results O
suggest O
a O
modular _RARE_
architecture O
for _RARE_
inteins _RARE_
, O
clarify O
their O
origin O
and O
relationship O
to O
other O
protein O
families _RARE_
, O
and O
extend O
recent O
experimental O
findings O
on O
the O
functional _RARE_
roles O
of O
intein _RARE_
N I-GENE
, I-GENE
C I-GENE
, I-GENE
and I-GENE
EN _RARE_
motifs I-GENE
. O

Purification _RARE_
of O
MvaT _RARE_
enriched _RARE_
for _RARE_
two O
polypeptides O
of O
approximate _RARE_
molecular _RARE_
mass O
15 _RARE_
kDa O
and O
16 O
kDa O
, O
designated O
P15 _RARE_
and O
P16 _RARE_
. O

M I-GENE
- I-GENE
66 _RARE_
identified O
the O
14 O
- O
kDa O
protein O
in O
another O
MMTV _RARE_
bearing _RARE_
T O
- O
cell O
lymphoma O
, O
EL _RARE_
- O
4 O
. O

These O
results O
indicate O
that O
TGF I-GENE
- I-GENE
betaf _RARE_
potentiates O
the O
c I-GENE
- I-GENE
fos I-GENE
SRE O
activated O
by O
PKC I-GENE
through O
the O
SRF I-GENE
binding I-GENE
site I-GENE
. O

RT O
- O
PCR O
indicated O
that O
p21 I-GENE
mRNA I-GENE
was O
induced _RARE_
1 O
. O
4 O
-, _RARE_
2 O
. O
0 _RARE_
-, _RARE_
and O
3 O
. O
1 O
- O
fold _RARE_
in O
the O
2 O
- O
day O
neonatal O
, O
7 O
- O
day O
neonatal O
, O
and O
adult O
stages O
, O
respectively O
, O
compared O
to O
the O
17 _RARE_
- O
day O
fetal _RARE_
stage _RARE_
. O

Ganciclovir _RARE_
and O
foscarnet _RARE_
efficacy O
in O
AIDS O
- O
related O
CMV _RARE_
polyradiculopathy _RARE_
. O

BACKGROUND O
: O
Defensins _RARE_
, O
also O
known O
as _RARE_
human I-GENE
neutrophil _RARE_
peptides I-GENE
, O
are O
antimicrobial O
peptides O
present O
in O
the O
azurophil _RARE_
granules O
of O
neutrophils O
. O

The O
spontaneous O
mutation O
blocking O
pca _RARE_
gene I-GENE
expression _RARE_
was O
located _RARE_
in O
the O
promoter O
for _RARE_
the O
pca _RARE_
operon I-GENE
. O

From O
250 _RARE_
g O
of O
cells O
, O
we O
isolated O
1 O
mg O
of O
PDH _RARE_
complex I-GENE
with O
a O
specific O
activity O
of O
12 O
. O
6 O
U _RARE_
/ O
mg O
of O
protein O
. O

The O
PDH _RARE_
complex I-GENE
- I-GENE
encoding I-GENE
genes I-GENE
were O
identified O
by O
hybridization O
experiments O
and O
sequence O
analysis O
in O
two O
separate O
gene O
regions O
in O
the O
genome O
of O
Z O
. O
mobilis _RARE_
. O

We O
have O
identified O
two O
functional _RARE_
elements O
, O
both O
located _RARE_
downstream _RARE_
from O
the O
TATA O
motif O
, O
that O
control O
Id4 _RARE_
promoter I-GENE
activity O
. O

Azithromycin _RARE_
is O
a O
new O
generation O
macrolide _RARE_
antibiotic O
with O
unusual O
and O
favorable _RARE_
pharmacokinetics O
, O
and O
seems O
to O
be O
a O
very O
promising _RARE_
agent O
for _RARE_
innovative _RARE_
anti O
- O
H O
. O
pylori _RARE_
regimens O
. O

The O
study O
enrolled O
994 _RARE_
people O
co _RARE_
- O
infected _RARE_
with O
CMV _RARE_
and O
HIV O
, O
with O
at _RARE_
least O
one O
CD4 _RARE_
count O
recorded O
< O
100 _RARE_
x _RARE_
10 O
( O
6 O
) O
cells O
/ O
l _RARE_
. O

BACKGROUND O
AND _RARE_
OBJECTIVES O
: O
The O
sexually _RARE_
transmitted O
diseases O
( O
STD _RARE_
) O
control O
program O
for _RARE_
female O
sex _RARE_
workers O
( O
FSW _RARE_
) O
in O
Lima _RARE_
, O
Peru _RARE_
, O
provided O
periodic _RARE_
serological O
tests O
for _RARE_
syphilis _RARE_
and O
cervical O
smears O
for _RARE_
gonococci _RARE_
, O
but O
not O
medication O
for _RARE_
STD _RARE_
or O
condoms _RARE_
. O

National O
certification _RARE_
: O
a O
vital O
component _RARE_
of O
quality O
assurance _RARE_
. O

Two O
rare O
novel O
mutations O
, O
D811N _RARE_
in O
exon _RARE_
20 O
and O
R835C _RARE_
in O
exon _RARE_
21 O
, O
were O
identified O
in O
the O
first _RARE_
nucleotide O
- O
binding O
fold _RARE_
( O
NBF _RARE_
), _RARE_
a O
functionally O
important O
region O
of O
SUR1 _RARE_
, O
in O
one O
patient O
each O
, O
both O
heterozygotes _RARE_
. O

Chimaeric _RARE_
VP16 I-GENE
- O
E2 I-GENE
molecules O
suggest O
that O
the O
epithelial _RARE_
specific O
transcriptional O
activation O
of O
the O
BPV _RARE_
- I-GENE
4 I-GENE
LCR _RARE_
promoter I-GENE
is O
mediated _RARE_
by O
the O
E2 I-GENE
transactivation _RARE_
domain I-GENE
. O

In O
order O
to O
examine O
the O
potential _RARE_
role O
of O
transcriptional O
silencing O
during _RARE_
productive _RARE_
HSV O
- O
1 O
infection O
, O
recombinant O
viruses O
were O
generated O
in O
which O
wild I-GENE
- I-GENE
type I-GENE
or I-GENE
mutant I-GENE
ICP34 _RARE_
. I-GENE
5 I-GENE
promoters I-GENE
controlling O
the O
expression _RARE_
of O
a O
chloramphenicol I-GENE
acetyltransferase _RARE_
reporter I-GENE
gene I-GENE
were O
inserted O
into O
the O
thymidine _RARE_
kinase I-GENE
gene I-GENE
of O
the O
viral O
genome O
. O

These O
changes O
correlate O
directly O
with O
an O
increase O
in O
the O
acetylation O
levels O
of O
all O
four O
core I-GENE
histones _RARE_
in O
vivo O
. O

Drosophila I-GENE
orthodenticle _RARE_
( O
otd _RARE_
) O
and O
murine I-GENE
Otx _RARE_
genes I-GENE
exemplify _RARE_
this O
, O
both O
in O
terms O
of O
expression _RARE_
patterns O
and O
mutant O
phenotypes _RARE_
. O

APETALA3 _RARE_
transcripts I-GENE
are O
first _RARE_
detected O
in O
a O
meristematic _RARE_
region O
that O
will O
give O
rise O
to O
the O
petal _RARE_
and O
stamen _RARE_
primordia _RARE_
, O
and O
expression _RARE_
is O
maintained O
in O
this O
region O
during _RARE_
subsequent O
development O
of O
these O
organs O
. O

We O
also O
recovered O
mutations O
in O
the O
60A _RARE_
gene I-GENE
which O
encodes O
another O
TGF I-GENE
- I-GENE
beta I-GENE
- I-GENE
related I-GENE
factor I-GENE
in O
Drosophila O
. O

Cell O
lines O
are O
checked _RARE_
to O
find O
out O
whether O
they O
develop O
tumors O
in O
nude O
mice O
followed O
by O
an O
analysis O
of O
the O
karyotype _RARE_
. O

Cervicovaginal _RARE_
foetal _RARE_
fibronectin I-GENE
in O
the O
prediction O
of O
preterm O
labour O
in O
a O
low O
- O
risk O
population O
. O

In O
addition O
, O
IgM I-GENE
can O
be O
absent O
in O
children O
with O
congenital O
toxoplasmosis _RARE_
or O
subjects O
with O
secondary O
reactivation _RARE_
. O

Both O
variants O
display O
the O
seven _RARE_
- O
transmembrane O
topology O
that O
is O
typical O
for _RARE_
G I-GENE
protein I-GENE
- I-GENE
coupled I-GENE
receptors I-GENE
. O

A O
constitutive _RARE_
allele O
of O
GPA2 _RARE_
could O
stimulate O
growth O
of O
a O
strain _RARE_
lacking _RARE_
both O
RAS _RARE_
genes I-GENE
. O

The O
COOH _RARE_
- O
terminus O
of O
this O
new O
isoform O
, O
which O
we O
designate _RARE_
beta I-GENE
4 I-GENE
, O
lacks O
a O
22 _RARE_
amino O
acid O
lysine _RARE_
- O
rich O
sequence O
common O
to O
both O
the O
human I-GENE
red _RARE_
cell I-GENE
alpha I-GENE
- I-GENE
and I-GENE
beta I-GENE
- I-GENE
adducin _RARE_
subunits I-GENE
and O
homologous O
to O
a O
highly O
conserved _RARE_
region O
in O
MARCKS _RARE_
, O
a O
filamentous _RARE_
actin I-GENE
- O
cross O
linking O
protein O
regulated O
by O
protein I-GENE
kinase I-GENE
C I-GENE
and O
calcium _RARE_
/ O
calmodulin I-GENE
. O
beta I-GENE
4 I-GENE
- I-GENE
adducin _RARE_
preserves _RARE_
a O
previously O
identified O
calmodulin I-GENE
binding I-GENE
domain I-GENE
. O

PCR O
analysis O
indicates O
that O
this O
new O
beta I-GENE
- I-GENE
adducin _RARE_
isoform I-GENE
is O
expressed _RARE_
in O
fetal _RARE_
brain O
and O
liver O
, O
bone O
marrow O
, O
and O
NT _RARE_
- O
2 O
( O
neuroepithelial _RARE_
) O
cells O
, O
but O
is O
not O
detected O
in O
several O
other O
tissues O
. O

The O
gene I-GENE
lac I-GENE
- I-GENE
1 I-GENE
, O
encoding O
the O
enzyme O
laccase _RARE_
, O
is O
the O
best O
characterized O
of O
a O
number O
of O
genes O
in O
the O
chestnut _RARE_
blight _RARE_
fungus _RARE_
, O
Cryphonectria _RARE_
parasitica _RARE_
, O
that O
are O
repressed O
by O
hypoviruses _RARE_
, O
a O
group O
of O
virulence _RARE_
- O
attenuating _RARE_
mycoviruses _RARE_
. O
lac I-GENE
- I-GENE
1 I-GENE
has O
also O
been O
shown O
to O
be O
transcriptionally O
activated O
by O
low O
concentrations O
of O
the O
translational O
inhibitor O
cycloheximide _RARE_
( O
CHX _RARE_
) O
and O
by O
the O
immunosuppressant _RARE_
cyclosporin O
A O
. O

Both O
TRE _RARE_
- O
like O
elements O
were O
capable O
of O
binding O
AP1 I-GENE
. O

The O
hp55 _RARE_
gamma I-GENE
protein I-GENE
interacts O
strongly O
with O
the O
activated O
IGFIR _RARE_
but O
not O
with O
the O
kinase O
- O
negative O
mutant O
receptor O
. O
hp55 _RARE_
gamma I-GENE
also O
interacts O
with O
the O
insulin I-GENE
receptor I-GENE
( O
IR I-GENE
) O
in O
the O
yeast O
two O
- O
hybrid _RARE_
system _RARE_
. O

The O
plant _RARE_
protein O
maintains O
all O
the O
functional _RARE_
domains O
found O
in O
the O
other O
proteins O
, O
including O
nuclear O
localization _RARE_
signal O
, O
DNA O
- O
binding O
domain O
and O
helicase _RARE_
motifs I-GENE
, O
suggesting O
that O
it O
might O
also O
act O
as _RARE_
part O
of O
the O
RNA O
transcription O
apparatus O
, O
as _RARE_
well _RARE_
as _RARE_
nucleotide O
excision _RARE_
repair O
in O
plant _RARE_
cells O
. O

This O
paper O
describes O
the O
genomic O
organization O
of O
mouse O
gC1qBP _RARE_
and O
the O
characterization O
of O
its O
5 O
' O
flanking O
region O
. O

LysR _RARE_
proteins I-GENE
have O
been O
shown O
to O
regulate O
urease I-GENE
in I-GENE
Klebsiella _RARE_
aerogenes _RARE_
( O
NAC _RARE_
), _RARE_
and O
catalase I-GENE
in I-GENE
Escherichia I-GENE
coli I-GENE
( O
OxyR I-GENE
), _RARE_
which O
offers O
the O
intracellular _RARE_
bacterium O
protection O
from O
phagolysosome _RARE_
damage O
. O

Also O
, O
the O
anti O
- O
inflammatory O
activities O
of O
an O
aqueous O
extract _RARE_
of O
Buddleia _RARE_
cordata _RARE_
and O
its O
principal O
glycoside _RARE_
linarin _RARE_
were O
evaluated O
. O

Regulation O
of O
the O
Raf I-GENE
kinase I-GENE
in O
T O
cells O
differs O
from O
findings O
with O
a O
variety O
of O
cell O
lines O
that O
the O
catalytic I-GENE
domain I-GENE
of I-GENE
Raf I-GENE
( O
Raf I-GENE
( O
delta26 _RARE_
- O
303 _RARE_
)) O
shows O
no _RARE_
activity O
. O

Full _RARE_
- I-GENE
length I-GENE
FLAP _RARE_
clones _RARE_
were O
isolated O
from O
a O
mouse O
skeletal O
muscle O
cDNA O
library O
. O

Members O
of O
the O
meis1 _RARE_
and O
pbx _RARE_
homeodomain _RARE_
protein I-GENE
families _RARE_
cooperatively _RARE_
bind O
a O
cAMP O
- O
responsive O
sequence O
( O
CRS1 _RARE_
) O
from O
bovine I-GENE
CYP17 _RARE_
. O

We O
have O
visualized _RARE_
DNA O
- O
protein O
complexes O
by O
electron O
microscopy O
and O
a O
high O
- O
affinity O
binding O
site O
of O
WDV _RARE_
Rep I-GENE
protein I-GENE
within O
the O
core O
element O
has O
been O
mapped O
to O
approximately _RARE_
144 _RARE_
+/- O
18 O
bp O
upstream O
from O
the O
initiation O
site O
, O
between O
the O
start _RARE_
site O
for _RARE_
complementary _RARE_
- O
sense O
transcription O
and O
the O
TATA O
box O
. O

Rex _RARE_
- I-GENE
1 I-GENE
, O
a O
gene O
encoding O
a O
transcription O
factor O
expressed _RARE_
in O
the O
early O
embryo _RARE_
, O
is O
regulated O
via O
Oct I-GENE
- I-GENE
3 I-GENE
/ I-GENE
4 I-GENE
and O
Oct I-GENE
- I-GENE
6 I-GENE
binding O
to O
an O
octamer O
site O
and O
a O
novel O
protein O
, O
Rox _RARE_
- I-GENE
1 I-GENE
, O
binding O
to O
an O
adjacent O
site O
. O

However O
, O
inhibition O
of O
both O
the O
ERK I-GENE
/ O
RSK _RARE_
and O
the O
p38 I-GENE
/ O
MAPKAP _RARE_
kinase I-GENE
2 I-GENE
pathways O
completely O
abolished O
NGF _RARE_
- O
induced _RARE_
CREB I-GENE
Ser _RARE_
- O
133 _RARE_
phosphorylation _RARE_
. O

Cells _RARE_
respond O
to O
the O
accumulation O
of O
unfolded _RARE_
proteins O
in O
the O
endoplasmic O
reticulum O
( O
ER O
) O
by O
increasing O
the O
transcription O
of O
the O
genes O
encoding O
ER I-GENE
- I-GENE
resident _RARE_
chaperone _RARE_
proteins I-GENE
. O

The O
RAS _RARE_
- O
cyclic I-GENE
AMP I-GENE
- I-GENE
dependent I-GENE
protein I-GENE
kinase I-GENE
cAPK _RARE_
pathway _RARE_
prevents O
the O
UAS O
activity O
of O
IREu _RARE_
in O
the O
presence O
of O
glucose O
as _RARE_
the O
sole _RARE_
carbon O
source O
, O
while O
the O
transcriptional O
activators _RARE_
Msn2p _RARE_
and O
Msn4p _RARE_
promote O
the O
UAS O
activity O
of O
this O
repeat O
in O
the O
presence O
of O
acetate _RARE_
. O

The O
mei4 _RARE_
+ I-GENE
gene I-GENE
of O
the O
fission _RARE_
yeast O
Schizosaccharomyces O
pombe O
was O
cloned _RARE_
by O
functional _RARE_
complementation _RARE_
. O

Alternative O
splicing _RARE_
of O
fibroblast I-GENE
growth I-GENE
factor I-GENE
receptor I-GENE
2 I-GENE
( O
FGF I-GENE
- I-GENE
R2 _RARE_
) O
is O
an O
example O
of O
highly O
regulated O
alternative _RARE_
splicing _RARE_
in O
which O
exons O
IIIb _RARE_
and O
IIIc _RARE_
are O
utilized O
in O
a O
mutually _RARE_
exclusive _RARE_
manner O
in O
different O
cell O
types _RARE_
. O

In O
some O
cases O
, O
the O
aberrant O
methylation O
of O
CpGs _RARE_
within O
5 O
' O
regulatory O
regions O
has O
led O
to O
suppression O
of O
gene O
activity O
. O

The O
genomic O
fragments O
were O
fused O
upstream O
of O
the O
luciferase I-GENE
reporter I-GENE
gene I-GENE
. O

Cotransfection O
analyses O
of O
the O
T I-GENE
/ I-GENE
EBP I-GENE
promoter I-GENE
- I-GENE
reporter I-GENE
constructs I-GENE
with O
a O
T I-GENE
/ I-GENE
EBP I-GENE
expression _RARE_
vector O
into O
human O
HepG2 _RARE_
cells O
, O
which O
do O
not O
express O
T I-GENE
/ I-GENE
EBP I-GENE
, O
suggested O
that O
autoregulation O
may O
be O
involved O
in O
controlling O
both O
rat O
and O
human I-GENE
T I-GENE
/ I-GENE
EBP I-GENE
gene I-GENE
expression _RARE_
. O

Deletion O
of O
the O
last O
two O
Ser _RARE_
residues O
, O
including O
one O
PKC I-GENE
consensus O
site O
in O
the O
receptor O
tail _RARE_
, O
prevented O
only O
phorbol O
12 O
- O
myristate O
13 _RARE_
- O
acetate _RARE_
- O
induced _RARE_
desensitization _RARE_
by O
30 _RARE_
%. O

Flap _RARE_
survival O
depends O
on O
the O
development O
of O
a O
small O
number O
of O
vascular O
connections _RARE_
between O
vessels O
arising O
from O
the O
pedicle _RARE_
and O
preexisting _RARE_
dermal O
vessels O
. O

Jean _RARE_
Klig _RARE_
reviews _RARE_
recent O
literature O
about O
lower O
respiratory O
tract _RARE_
infection O
in O
children O
. O

Potential _RARE_
indicators O
were O
assessed O
for _RARE_
the O
two O
classifications _RARE_
of O
protein O
- O
energy O
malnutrition _RARE_
in O
the O
guidelines O
for _RARE_
integrated O
management O
of O
childhood O
illness O
: O
severe O
malnutrition _RARE_
, O
which O
requires O
immediate O
referral _RARE_
to O
hospital O
, O
and O
very O
low O
weight _RARE_
, O
which O
calls _RARE_
for _RARE_
feeding O
assessment O
, O
nutritional O
counselling _RARE_
and O
follow O
- O
up _RARE_
. O

SNAC _RARE_
or O
PBS _RARE_
was O
infused O
for _RARE_
6 O
. O
5 O
h O
, O
beginning O
30 _RARE_
min O
before O
ischemia O
and O
continuing _RARE_
throughout O
the O
duration O
of O
reperfusion O
. O

Despite O
its O
requirement O
for _RARE_
enhancer O
- O
dependent O
splicing _RARE_
activity O
in O
vitro O
, O
the O
dU2AF38 _RARE_
RS _RARE_
domain I-GENE
was O
also O
inessential _RARE_
in O
vivo O
. O

In O
vitro O
binding O
studies O
using O
GST I-GENE
fusion O
proteins O
and O
yeast O
extracts O
defined O
distinct O
binding O
sites O
on O
yAP180A _RARE_
for _RARE_
Pan1p _RARE_
and O
clathrin I-GENE
. O
yAP180 _RARE_
proteins I-GENE
and O
Pan1p _RARE_
, O
like O
actin I-GENE
, O
localize O
to O
peripheral O
patches _RARE_
along O
the O
plasma O
membrane O
. O

In O
vitro O
affinity O
analyses O
demonstrated O
that O
recombinant O
130 _RARE_
- O
kD _RARE_
protein O
directly O
interacts O
with O
ZO _RARE_
- I-GENE
1 I-GENE
and O
the O
cytoplasmic O
domain O
of O
occludin _RARE_
, O
but O
not O
with O
ZO _RARE_
- I-GENE
2 I-GENE
. O

Cytochrome _RARE_
b I-GENE
in O
human I-GENE
complex I-GENE
II I-GENE
( O
succinate _RARE_
- I-GENE
ubiquinone _RARE_
oxidoreductase I-GENE
): O
cDNA O
cloning O
of O
the O
components _RARE_
in O
liver O
mitochondria _RARE_
and O
chromosome _RARE_
assignment O
of O
the O
genes O
for _RARE_
the O
large O
( O
SDHC _RARE_
) O
and O
small O
( O
SDHD _RARE_
) O
subunits O
to O
1q21 _RARE_
and O
11q23 _RARE_
. O

A O
possible O
decrease O
in O
theophylline O
' O
s O
volume O
of O
distribution O
at _RARE_
4 O
days O
, O
but O
not O
immediately O
, O
after O
administration O
of O
chloroquine _RARE_
was O
suggested O
, O
although O
this O
just O
failed O
to O
achieve O
statistical O
significance O
( O
p O
= O
0 _RARE_
. O
055 _RARE_
). O

The O
addition O
of O
a O
Paf _RARE_
- O
containing O
extract _RARE_
does O
not O
lead O
to O
significant O
protein O
binding O
to O
these O
two O
hly _RARE_
target I-GENE
sequences I-GENE
in O
the O
absence O
of O
PrfA _RARE_
but O
converts _RARE_
the O
complex O
( O
CIII _RARE_
) O
consisting O
of O
PrfA _RARE_
and O
the O
109 _RARE_
bp I-GENE
hly _RARE_
DNA I-GENE
fragment I-GENE
to O
a O
slower O
migrating _RARE_
PrfA _RARE_
- O
Paf _RARE_
- O
DNA O
complex O
( O
CI _RARE_
). O

Moreover O
, O
it O
is O
the O
assumptions _RARE_
behind O
steady O
- O
state O
O2 _RARE_
uptake O
that O
do O
not O
permit O
proper O
interpretation O
of O
energy O
expenditure O
during _RARE_
EPOC _RARE_
; O
1 O
l _RARE_
O2 _RARE_
not O
= O
20 O
. O
9 O
kJ _RARE_
. O

The O
predicted O
amino O
acid O
sequence O
of O
m I-GENE
- I-GENE
Staf _RARE_
is O
highly O
homologous O
to O
that O
of O
Staf _RARE_
, O
another O
selenocysteine _RARE_
tRNA I-GENE
gene I-GENE
transcription I-GENE
activating I-GENE
factor I-GENE
of O
Xenopus O
laevis _RARE_
. O

ROCK _RARE_
- I-GENE
I I-GENE
, O
Kinectin _RARE_
, O
and O
mDia2 _RARE_
can O
bind O
the O
wild O
type O
forms O
of O
both O
RhoA I-GENE
and O
Cdc42 I-GENE
in O
a O
GTP O
- O
dependent O
manner O
in O
vitro O
. O

Among O
three O
isoforms O
, O
the O
beta O
isoform O
has O
the O
greatest O
Vmax O
value O
for _RARE_
the O
PtdIns _RARE_
( I-GENE
4 I-GENE
) I-GENE
P I-GENE
kinase I-GENE
activity O
and O
the O
gamma O
isoform O
is O
most O
markedly O
stimulated _RARE_
by O
phosphatidic _RARE_
acid O
. O

The O
beta O
subunit O
of O
the O
heterotrimeric I-GENE
G I-GENE
proteins I-GENE
that O
transduce _RARE_
signals O
across O
the O
plasma O
membrane O
is O
made O
up _RARE_
of O
an O
amino O
- O
terminal O
alpha O
- O
helical O
segment O
followed O
by O
seven _RARE_
repeating O
units _RARE_
called O
WD _RARE_
( O
Trp _RARE_
- O
Asp _RARE_
) O
repeats O
that O
occur O
in O
about O
140 _RARE_
different O
proteins O
. O

Two O
differentially O
expressed _RARE_
LNX _RARE_
messages _RARE_
encode O
overlapping O
proteins O
with O
predicted O
molecular _RARE_
masses O
of O
80 _RARE_
kDa I-GENE
( I-GENE
LNX _RARE_
) I-GENE
and O
70 O
kDa O
( O
LNX _RARE_
- O
b O
). O

In O
contrast O
, O
the O
contractile O
action O
of O
arachidonic _RARE_
acid O
, O
via O
a O
presumed _RARE_
cyclooxygenase _RARE_
product O
that O
mediated _RARE_
the O
contractions O
caused O
by O
both O
TF _RARE_
and O
EGF _RARE_
, O
was O
not O
blocked O
by O
any O
of O
the O
signal O
pathway _RARE_
probe O
inhibitors _RARE_
. O

Recent O
studies O
have O
revealed O
unconventional _RARE_
myosin I-GENE
V I-GENE
to O
be O
an O
important O
actin I-GENE
- O
based O
molecular _RARE_
motor O
involved O
in O
vesicular O
movement O
. O

On O
a O
separate O
occasion _RARE_
the O
T1 _RARE_
weighted O
and O
T2 _RARE_
weighted O
sagittal _RARE_
and O
T2 _RARE_
weighted O
axial O
sequences O
were O
reported O
blind O
in O
relation O
to O
the O
initial O
assessment O
. O

Furthermore O
, O
a O
minor O
start _RARE_
site O
was O
localized O
179 _RARE_
bp O
upstream O
of O
the O
major O
site O
using O
reverse I-GENE
transcriptase I-GENE
- O
polymerase O
chain O
reaction O
with O
various O
P1 O
primers O
( O
primer O
walking _RARE_
), _RARE_
primer O
extension O
, O
and O
cDNA O
cloning O
. O

Analysis O
of O
promoter O
and O
androgen _RARE_
regulatory O
sequences O
required O
for _RARE_
optimal O
transcription O
of O
the O
rat O
androgen _RARE_
- I-GENE
binding I-GENE
protein I-GENE
gene O
. O

The O
iron O
dependence O
of O
transcription O
and O
expression _RARE_
of O
cvaA _RARE_
, O
which O
encodes O
a O
transporter _RARE_
accessory _RARE_
protein O
, O
and O
cvi _RARE_
, O
encoding O
the O
colicin _RARE_
V I-GENE
immunity _RARE_
protein I-GENE
, O
was O
assessed O
under O
conditions O
of O
iron O
excess O
or O
depletion O
. O

In O
a O
gntR _RARE_
deletion I-GENE
mutant I-GENE
, O
the O
expression _RARE_
of O
a O
chromosomal O
gntT _RARE_
:: O
lacZ I-GENE
fusion O
is O
both O
high O
and O
constitutive _RARE_
, O
confirming O
that O
GntR _RARE_
is O
the O
negative O
regulator O
of O
gntT _RARE_
. O

Furthermore O
, O
the O
deletion O
of O
bcp _RARE_
from O
the O
chromosome _RARE_
had O
no _RARE_
effect O
on O
gcv _RARE_
- O
lacZ I-GENE
expression _RARE_
. O

Of O
these O
sites O
, O
PEA3 I-GENE
and O
STAT I-GENE
contributed O
specifically O
to O
induction O
by O
v I-GENE
- I-GENE
src I-GENE
, O
whereas O
the O
remaining O
elements O
were O
also O
involved O
in O
induction O
by O
the O
phorbol O
ester O
phorbol O
myristate O
acetate _RARE_
( O
PMA O
). O

BRCA1 I-GENE
protein I-GENE
contains O
an O
amino O
- O
terminal O
zinc O
finger O
motif O
and O
a O
carboxy _RARE_
- O
terminal O
acidic _RARE_
region O
. O

The O
mitochondrial I-GENE
regulatory I-GENE
region I-GENE
( O
mrr _RARE_
) O
located _RARE_
between O
the O
tRNAPhe _RARE_
and O
tRNAPro _RARE_
genes I-GENE
of O
mitochondrial O
DNA O
( O
mtDNA _RARE_
) O
is O
essential O
for _RARE_
regulation _RARE_
of O
replication O
and O
transcription O
of O
the O
mitochondrial O
genome O
. O

In O
this O
report O
, O
we O
investigate O
the O
mechanism O
underlying O
Ras I-GENE
activation O
upon O
stimulation _RARE_
of O
these O
two O
types _RARE_
of O
receptors O
in O
hematopoietic O
cells O
. O

Thus O
, O
Sir _RARE_
proteins I-GENE
from O
K O
. O
lactis O
have O
roles O
in O
both O
silencing O
and O
telomere _RARE_
length O
maintenance _RARE_
, O
reflecting O
conserved _RARE_
functional _RARE_
themes _RARE_
. O

Therefore O
, O
we O
conclude O
that O
DnaA _RARE_
may O
contact _RARE_
the O
beta O
subunit O
of O
RNA I-GENE
polymerase I-GENE
during _RARE_
activation O
of O
the O
pR _RARE_
promoter I-GENE
. O

Expression O
of O
Bcl I-GENE
- I-GENE
XL _RARE_
inhibited O
the O
association O
of O
Apaf _RARE_
- I-GENE
1 I-GENE
with O
caspase _RARE_
- I-GENE
9 I-GENE
in O
mammalian O
cells O
. O

Whole _RARE_
- O
mount _RARE_
in O
situ O
hybridization O
to O
early O
mouse O
embryos _RARE_
of O
9 O
. O
5 O
- O
10 O
. O
5 O
days O
indicated O
a O
complex O
pattern O
of O
Arp1 _RARE_
expression _RARE_
spatially O
overlapping O
with O
the O
expression _RARE_
of O
All1 _RARE_
. O

These O
mutants O
were O
tested O
for _RARE_
ability O
to O
bind O
each O
of O
the O
Site _RARE_
II I-GENE
cognate _RARE_
proteins I-GENE
, O
and O
subsequently O
evaluated O
for _RARE_
ability O
to O
confer O
H4 _RARE_
transcriptional O
activity O
using O
chimeric O
H4 _RARE_
promoter O
/ O
CAT I-GENE
fusion O
constructs O
in O
different O
cell O
types _RARE_
. O

Increased O
plasma O
IgE I-GENE
was O
also O
confirmed O
in O
the O
NC _RARE_
mice O
, O
and O
treatment O
with O
FK506 O
ointment _RARE_
reduced _RARE_
the O
plasma O
IgE I-GENE
level O
. O

Creatine _RARE_
kinase I-GENE
release O
after O
hepatic _RARE_
artery O
embolization _RARE_
in O
patients O
with O
carcinoid _RARE_
tumors O
. O

Furthermore O
, O
in O
the O
ischemia O
/ O
angiotension _RARE_
II I-GENE
- O
induced _RARE_
AHF _RARE_
model O
, O
NIC _RARE_
decreased O
left _RARE_
ventricular O
end O
- O
diastolic O
pressure O
( O
LVEDP _RARE_
). O

Group O
A O
( O
68 _RARE_
. O
7 O
+/- O
2 O
. O
7 O
years O
) O
consisted O
of O
patients O
with O
0 _RARE_
or O
1 O
risk O
factors O
; O
B O
( O
68 _RARE_
. O
3 O
+/- O
4 O
. O
2 O
years O
) O
those O
with O
2 O
risk O
factors O
; O
and O
C O
( O
69 _RARE_
. O
2 O
+/- O
3 O
. O
6 O
years O
) O
those O
with O
3 O
or O
more O
risk O
factors O
. O

We O
further O
demonstrate O
that O
RU486 _RARE_
- O
PR I-GENE
- I-GENE
B I-GENE
interacts O
physically O
with O
NCoR _RARE_
in O
vitro O
. O

PRL I-GENE
receptor I-GENE
also O
activates O
SHP I-GENE
- I-GENE
2 I-GENE
, O
a O
cytosolic I-GENE
tyrosine I-GENE
phosphatase I-GENE
. O

The O
dominant O
negative O
mutant O
of O
SHP I-GENE
- I-GENE
2 I-GENE
was O
found O
to O
inhibit O
the O
induction O
of O
tyrosine O
phosphorylation _RARE_
and O
DNA O
- O
binding O
activity O
of O
m I-GENE
- I-GENE
Stat5a I-GENE
, O
m I-GENE
- I-GENE
Stat5b _RARE_
, O
and O
the O
carboxyl _RARE_
- O
terminal O
deletion O
variant O
m I-GENE
- I-GENE
Stat5adelta749 _RARE_
, O
as _RARE_
well _RARE_
as _RARE_
the O
transactivation _RARE_
potential _RARE_
of O
m I-GENE
- I-GENE
Stat5a I-GENE
and O
m I-GENE
- I-GENE
Stat5b _RARE_
. O

CONCLUSIONS O
: O
These O
routinely _RARE_
collected O
data O
provided O
quantitative O
estimates O
of O
changes O
in O
CBZ _RARE_
Cl O
/ O
F O
due O
to O
comedication _RARE_
and O
an O
age O
- O
related O
decrease O
in O
Cl O
/ O
F O
The O
derived O
regression O
equations _RARE_
reasonably _RARE_
predicted O
concentrations O
in O
a O
separate O
validation _RARE_
set O
. O

Sites _RARE_
1 O
and O
4 O
in O
lumican _RARE_
and O
keratocan _RARE_
are O
in O
a O
homologous O
location O
. O

Our O
observations O
suggest O
that O
members O
of O
the O
HMG I-GENE
- I-GENE
I I-GENE
family I-GENE
play O
an O
important O
role O
in O
SRF I-GENE
- O
dependent O
transcription O
and O
that O
their O
effect O
is O
mediated _RARE_
primarily O
by O
a O
protein O
- O
protein O
interaction O
. O

ATP O
- O
dependent O
assembly O
of O
a O
ternary _RARE_
complex O
consisting O
of O
a O
DNA O
mismatch _RARE_
and O
the O
yeast O
MSH2 _RARE_
- O
MSH6 _RARE_
and O
MLH1 _RARE_
- O
PMS1 _RARE_
protein O
complexes O
. O

Mutation O
of O
the O
central O
Tyr497 _RARE_
to O
Phe _RARE_
blocks O
the O
tyrosine O
phosphorylation _RARE_
of O
the O
insulin I-GENE
receptor I-GENE
substrate I-GENE
1 I-GENE
( O
IRS1 _RARE_
) O
and O
diminishes _RARE_
proliferation _RARE_
in O
response O
to O
IL _RARE_
- I-GENE
4 I-GENE
. O

Instead O
, O
it O
contained O
two O
tandem _RARE_
kappaB I-GENE
elements I-GENE
and O
a O
variant O
activating I-GENE
transcription I-GENE
factor I-GENE
/ I-GENE
cAMP I-GENE
response I-GENE
element I-GENE
site O
, O
which O
closely O
resembled _RARE_
sites O
in O
the O
E I-GENE
- I-GENE
selectin I-GENE
gene I-GENE
that O
are O
required O
for _RARE_
TNF I-GENE
- I-GENE
alpha I-GENE
- O
or O
LPS _RARE_
- O
inducible O
expression _RARE_
. O

We O
recently O
characterized O
a O
single O
yeast I-GENE
hnRNP _RARE_
methyltransferase _RARE_
( O
HMT1 _RARE_
). O

We O
recently O
characterized O
a O
single O
yeast I-GENE
hnRNP _RARE_
methyltransferase _RARE_
( O
HMT1 _RARE_
). O

Recombinant I-GENE
HRMT1L2 _RARE_
protein I-GENE
encoded O
by O
the O
most O
common O
5 O
'- O
variant O
exhibited O
methyltransferase _RARE_
activity O
in O
vitro O
. O

The O
possible O
roles O
of O
HRMT1L1 _RARE_
and O
HRMT1L2 _RARE_
in O
human O
disease _RARE_
are O
currently O
unknown O
. O

Identification O
and O
characterization O
of O
two O
putative O
human I-GENE
arginine _RARE_
methyltransferases _RARE_
( O
HRMT1L1 _RARE_
and O
HRMT1L2 _RARE_
). O

Interestingly O
, O
the O
activated O
PDGF _RARE_
beta I-GENE
- I-GENE
receptor I-GENE
was O
found O
not O
to O
bind O
Crk I-GENE
proteins I-GENE
. O

Furthermore O
, O
interactions O
were O
identified O
between O
endogenous I-GENE
E I-GENE
- I-GENE
cadherin _RARE_
and O
the O
chimera _RARE_
containing O
the O
E I-GENE
- I-GENE
cadherin _RARE_
extracellular I-GENE
domain I-GENE
and O
the O
desmoglein _RARE_
1 I-GENE
intracellular _RARE_
domain I-GENE
providing O
in O
vivo O
evidence O
for _RARE_
previously O
predicted O
lateral O
interactions O
of O
E I-GENE
- I-GENE
cadherin _RARE_
extracellular I-GENE
domains I-GENE
. O

The O
ether O
phospholipid _RARE_
1 O
- O
O O
- O
octadecyl _RARE_
- O
2 O
- O
O O
- O
methyl _RARE_
- O
rac _RARE_
- O
glycero _RARE_
- O
3 O
- O
phosphocholine _RARE_
( O
ET _RARE_
- O
18 O
- O
OCH3 _RARE_
; O
edelfosine _RARE_
) O
is O
a O
potent O
inducer _RARE_
of O
apoptosis O
in O
human O
tumor O
cells O
. O

In O
addition O
to O
a O
previously O
characterized O
promoter O
( O
P1 O
), _RARE_
we O
now O
show O
the O
existence O
of O
a O
second O
promoter O
for _RARE_
the O
human I-GENE
IL _RARE_
- I-GENE
5Ralpha _RARE_
gene I-GENE
. O

Serum O
levels O
of O
testosterone O
also O
showed O
no _RARE_
significant O
changes O
by O
exposure O
to O
p O
, O
p O
'- O
DDE _RARE_
under O
the O
conditions O
of O
this O
study O
. O

Overall O
agreement O
between O
rest O
/ O
postnitroglycerin _RARE_
technetium O
- O
99m O
tetrofosmin O
SPET _RARE_
studies O
and O
rest O
/ O
redistribution _RARE_
or O
rest O
/ O
reinjection _RARE_
thallium O
- O
201 _RARE_
SPET _RARE_
studies O
, O
regarding O
the O
presence O
of O
myocardial _RARE_
viability O
, O
was O
87 O
% O
and O
90 _RARE_
%, O
respectively O
. O

Their O
use O
resulted O
in O
a O
sensitivity O
of O
73 _RARE_
% O
and O
a O
specificity _RARE_
of O
74 _RARE_
% O
with O
regard O
to O
predictability _RARE_
of O
ALT _RARE_
levels O
increasing O
during _RARE_
the O
trial O
. O

One O
hundred O
replicate _RARE_
data O
sets O
of O
100 _RARE_
subjects O
each O
were O
simulated O
for _RARE_
each O
missing O
data O
scenario _RARE_
. O

Spatial _RARE_
accuracy O
of O
primary _RARE_
and O
secondary O
memory O
- O
guided _RARE_
saccades _RARE_
in O
schizophrenic O
patients O
. O

Successful _RARE_
treatment O
with O
nasal O
continuous O
positive O
airway O
pressure O
( O
8 O
. O
3 O
+/- O
1 O
. O
5 O
cmH2O O
) O
for _RARE_
3 O
days O
caused O
a O
significant O
decrease O
in O
mean O
blood _RARE_
pressure O
in O
OSAS _RARE_
. O

When O
data O
were O
expressed _RARE_
in O
a O
cumulative O
manner O
, O
the O
response O
to O
intravenous O
adenosine O
3 O
mg O
, O
6 O
mg O
, O
9 O
mg O
and O
12 O
mg O
in O
the O
24 _RARE_
episodes O
of O
PSVT _RARE_
were O
5 O
episodes O
( O
21 O
%), O
16 O
episodes O
( O
67 O
%), O
20 O
episodes O
( O
83 _RARE_
%) O
and O
20 O
episodes O
( O
83 _RARE_
%) O
respectively O
. O

RNAs O
are O
not O
only O
essential O
components _RARE_
of O
both O
ribosomal O
subunits O
but O
also O
transiently O
interacting _RARE_
factors O
during _RARE_
particle _RARE_
formation O
. O

To O
study O
retinoid O
signalling O
in O
zebrafish _RARE_
embryos _RARE_
, O
we O
developed O
a O
novel O
method O
to O
detect O
endogenous O
retinoids _RARE_
in O
situ O
in O
embryos _RARE_
, O
using O
a O
fusion O
protein O
of O
the O
ligand _RARE_
inducible O
transactivation _RARE_
domain O
of O
a O
retinoic I-GENE
acid I-GENE
receptor I-GENE
and O
a O
heterologous O
DNA O
binding O
domain O
. O

To O
identify O
nuclear O
regulatory O
factors O
, O
we O
have O
located _RARE_
and O
functionally O
characterized O
the O
CCR5 _RARE_
gene I-GENE
promoter I-GENE
. O

Fluorescence _RARE_
in O
situ O
hybridization O
of O
metaphase _RARE_
spreads _RARE_
of O
chromosome _RARE_
8 O
, O
containing O
hybrid _RARE_
cell O
line O
706 _RARE_
- O
B6 _RARE_
clone O
17 _RARE_
( O
CL O
- O
17 _RARE_
) O
with O
cosmid O
c101F1 _RARE_
, O
placed O
the O
9804 _RARE_
gene I-GENE
close O
to O
the O
telomere _RARE_
at _RARE_
8q24 _RARE_
. O
3 O
. O

The O
interaction O
between O
piroxicam _RARE_
and O
poloxamer _RARE_
was O
studied O
by O
x _RARE_
- O
ray O
diffractometry _RARE_
( O
XRD _RARE_
), _RARE_
infrared _RARE_
( O
IR O
) O
spectroscopy O
and O
differential O
thermal O
analysis O
( O
DTA _RARE_
) O
with O
a O
solid O
dispersion O
, O
coprecipitate _RARE_
, O
or O
physical O
mixture O
. O

Cell O
survival O
by O
Epo I-GENE
did O
not O
require O
activation O
of O
other O
known O
signaling _RARE_
pathways O
including O
PI I-GENE
- I-GENE
3 I-GENE
kinase I-GENE
, O
PLC I-GENE
- I-GENE
gamma I-GENE
, O
Ras I-GENE
or O
Stats _RARE_
. O

The O
N O
- O
syndecan _RARE_
- O
dependent O
neurite _RARE_
outgrowth _RARE_
is O
inhibited O
by O
the O
tyrosine I-GENE
kinase I-GENE
inhibitors _RARE_
herbimycin _RARE_
A O
and O
PP1 _RARE_
. O

An O
in O
vivo O
ZAP _RARE_
- I-GENE
70 I-GENE
substrate O
, O
SLP _RARE_
- I-GENE
76 _RARE_
, O
implicated O
in O
Erk _RARE_
activation O
, O
also O
became O
rapidly O
tyrosine O
- O
phosphorylated _RARE_
in O
Jurkat O
cells O
, O
but O
not O
in O
P116 _RARE_
cells O
, O
upon O
treatment O
with O
H2O2 _RARE_
. O

The O
pharmacokinetic O
patterns O
of O
estradiol O
( O
CAS _RARE_
50 O
- O
28 _RARE_
- O
2 O
) O
and O
of O
estrone _RARE_
( O
CAS _RARE_
53 O
- O
16 O
- O
7 O
) O
were O
investigated O
in O
18 O
women O
in O
natural _RARE_
or O
surgical O
menopause _RARE_
during _RARE_
the O
application O
of O
a O
new O
estradiol O
transdermal _RARE_
patch O
with O
active _RARE_
matrix _RARE_
and O
without O
absorption O
enhancers _RARE_
designed O
for _RARE_
epicutaneous _RARE_
applications O
of O
7 O
days O
( O
hereinafter _RARE_
called O
" O
patch O
7D _RARE_
"). _RARE_

The O
results O
confirm O
that O
a O
single O
base _RARE_
change O
in O
the O
branchpoint O
consensus O
sequence O
of O
an O
intron O
can O
cause O
human O
disease _RARE_
although O
this O
sequence O
is O
poorly O
conserved _RARE_
in O
mammals O
. O

Conversely O
, O
the O
central O
regions O
are O
highly O
variable _RARE_
. O

Among O
the O
H I-GENE
/ I-GENE
ACA _RARE_
snoRNAs _RARE_
associated O
with O
Gar1p _RARE_
, O
one O
can O
distinguish _RARE_
a O
large O
group O
of O
snoRNAs _RARE_
that O
are O
not O
essential O
in O
yeast O
and O
serve O
as _RARE_
guides _RARE_
for _RARE_
pseudouridine _RARE_
synthesis _RARE_
onto O
the O
pre O
- O
rRNA O
molecule O
. O

It O
bound _RARE_
to O
vitamin I-GENE
D I-GENE
receptor I-GENE
( O
VDR I-GENE
) O
but O
not O
retinoic I-GENE
acid I-GENE
Xalpha _RARE_
receptor I-GENE
( O
RXRalpha _RARE_
) O
in O
the O
human O
T O
cell O
line O
MT2 _RARE_
cells O
. O

Further O
studies O
demonstrated O
that O
the O
PPARalpha I-GENE
ligand _RARE_
8 O
( O
S O
)- O
hydroxyeicosatetraenoic _RARE_
acid O
strongly O
promotes O
the O
interaction O
of O
PPARalpha I-GENE
with O
the O
co _RARE_
- O
activator O
RIP _RARE_
- I-GENE
140 _RARE_
but O
decreases O
the O
interaction O
of O
PPARalpha I-GENE
with O
the O
co _RARE_
- O
repressor O
SMRT I-GENE
. O

Based O
on O
the O
current O
literature O
, O
the O
mechanisms O
involved O
in O
the O
toxicity O
of O
OA _RARE_
indicate O
three O
major O
effects O
: O
( O
1 O
) O
inhibition O
of O
mitochondrial O
respiration O
correlated O
with O
a O
depletion O
of O
ATP O
; O
( O
2 O
) O
inhibition O
of O
tRNA I-GENE
- I-GENE
synthetase _RARE_
accompanied O
by O
a O
reduced _RARE_
protein O
synthesis _RARE_
; O
and O
( O
3 O
) O
enhanced _RARE_
lipid _RARE_
peroxidation O
. O

We O
previously O
demonstrated O
that O
acute O
expression _RARE_
of O
the O
bovine O
papillomavirus _RARE_
type O
1 O
( O
BPV1 _RARE_
) O
E2 I-GENE
protein I-GENE
in O
HeLa O
and O
HT _RARE_
- O
3 O
cervical O
carcinoma O
cell O
lines O
greatly O
reduced _RARE_
cellular O
proliferation _RARE_
by O
imposing _RARE_
a O
specific O
G1 O
/ O
S O
phase _RARE_
growth O
arrest O
. O

Four O
possible O
isoforms O
( O
hGli2 _RARE_
alpha I-GENE
, I-GENE
beta I-GENE
, I-GENE
gamma I-GENE
, I-GENE
and I-GENE
delta I-GENE
) O
are O
formed O
by O
combinations O
of O
two O
independent O
alternative _RARE_
splicings _RARE_
, O
and O
all O
the O
isoforms O
could O
bind O
to O
a O
DNA O
motif O
, O
TRE2S _RARE_
, O
in O
the O
LTR O
. O

Specialized _RARE_
actin I-GENE
tails O
that O
propel _RARE_
IEV _RARE_
particles _RARE_
to O
the O
periphery _RARE_
and O
virus O
- O
tipped _RARE_
microvilli _RARE_
( O
both O
common O
in O
wild O
- O
type O
- O
infected _RARE_
cells O
) O
were O
absent O
in O
cells O
infected _RARE_
with O
vA33delta _RARE_
. O

Their O
mean O
IOP O
was O
15 _RARE_
. O
3 O
( O
SD O
3 O
. O
7 O
) O
mmHg O
prior O
to O
induction O
of O
anesthesia O
, O
13 _RARE_
. O
5 O
( O
SD O
3 O
. O
5 O
) O
mmHg O
after O
loss _RARE_
of O
eyelash _RARE_
reflex O
following O
injection O
of O
methohexitone _RARE_
, O
16 O
. O
1 O
( O
SD O
2 O
. O
4 O
) O
mmHg O
after O
cessation O
of O
muscle O
fasciculations _RARE_
induced _RARE_
by O
suxamethonium _RARE_
, O
19 O
. O
2 O
( O
SD O
5 O
. O
6 O
) O
mmHg O
after O
cessation O
of O
convulsion _RARE_
and O
15 _RARE_
. O
5 O
( O
SD O
4 O
. O
4 O
) O
mmHg O
following O
resumption _RARE_
of O
regular O
spontaneous O
respiration O
. O

A O
cDNA O
, O
cak1At _RARE_
, O
was O
isolated O
that O
suppressed O
the O
CAK I-GENE
mutation I-GENE
in O
budding _RARE_
yeast O
, O
and O
it O
also O
complemented O
a O
fission _RARE_
yeast I-GENE
CAK I-GENE
mutant I-GENE
. O
cak1At _RARE_
encodes O
a O
protein O
related O
to O
animal _RARE_
CAKs _RARE_
. O

Post O
- O
translational O
modifications O
such O
as _RARE_
glycosylation O
and O
phosphorylation _RARE_
could O
be O
excluded O
as _RARE_
potential _RARE_
explanations _RARE_
for _RARE_
the O
protein O
heterogeneity O
. O

In O
addition O
to O
restoring _RARE_
checkpoint _RARE_
control O
, O
overexpression O
of O
sum1 _RARE_
+ I-GENE
inhibits O
the O
normal O
cell O
cycle _RARE_
response O
to O
osmotic O
stress O
. O

Ime1 _RARE_
plays O
a O
pivotal O
role O
in O
the O
initiation O
of O
meiosis O
in O
a O
/ O
alpha O
diploid O
cells O
of O
Saccharomyces O
cerevisiae O
. O

Rhesus _RARE_
macaques _RARE_
and O
BALB _RARE_
/ O
c O
mice O
inoculated O
with O
the O
Mengo _RARE_
virus O
SIV O
recombinants _RARE_
failed O
to O
develop O
CTL O
responses O
against O
the O
SIV O
gene O
products O
, O
while O
one O
of O
the O
HIV I-GENE
- I-GENE
Nef I-GENE
recombinants _RARE_
induced _RARE_
a O
weak O
CTL O
response O
in O
mice O
directed O
to O
an O
HIV1 _RARE_
Nef I-GENE
peptide I-GENE
spanning O
positions O
182 O
- O
198 O
. O

Deltamethrin _RARE_
was O
most O
effective O
on O
the O
thatched _RARE_
surface O
and O
produced O
100 _RARE_
% O
mortality O
of O
An O
. O
culicifacies _RARE_
adults O
up _RARE_
to O
12 O
weeks O
, O
even O
when O
exposed O
at _RARE_
the O
lowest O
dose O
/ O
12 O
. O
5 O
mg O
/ O
m2 O
. O

Trichloroethylene _RARE_
, O
in O
turn _RARE_
, O
increased O
the O
AUC O
5 O
. O
0 _RARE_
( O
1 O
. O
9 O
- O
13 _RARE_
. O
4 O
), _RARE_
25 _RARE_
. O
8 O
( O
8 O
. O
2 O
- O
80 _RARE_
. O
8 O
) O
and O
2 O
. O
9 O
( O
1 O
. O
6 O
- O
5 O
. O
4 O
), _RARE_
respectively O
, O
whereas O
the O
corresponding O
values O
for _RARE_
n _RARE_
- O
hexane _RARE_
were O
1 O
. O
9 O
( O
0 _RARE_
. O
7 O
- O
5 O
. O
1 O
), _RARE_
1 O
. O
5 O
( O
0 _RARE_
. O
5 O
- O
4 O
. O
6 O
), _RARE_
and O
3 O
. O
2 O
( O
1 O
. O
8 O
- O
5 O
. O
9 O
). O

Solution _RARE_
structure _RARE_
of O
the O
IRF I-GENE
- I-GENE
2 I-GENE
DNA I-GENE
- I-GENE
binding I-GENE
domain I-GENE
: O
a O
novel O
subgroup O
of O
the O
winged _RARE_
helix I-GENE
- I-GENE
turn _RARE_
- I-GENE
helix I-GENE
family I-GENE
. O

In O
contrast O
, O
receptor I-GENE
/ I-GENE
G I-GENE
protein I-GENE
coupling O
appeared O
unaffected O
by O
expression _RARE_
of O
loop O
3i _RARE_
domains O
derived O
from O
two O
receptors O
coupled O
to O
G I-GENE
( I-GENE
i I-GENE
/ I-GENE
o _RARE_
) I-GENE
proteins I-GENE
( O
M2Ach _RARE_
- I-GENE
muscarinic _RARE_
and I-GENE
alpha2A _RARE_
- I-GENE
adrenergic I-GENE
receptors I-GENE
). O

These O
data O
indicate O
that O
the O
third O
intracellular _RARE_
loop O
of O
the O
rat I-GENE
GnRH I-GENE
- I-GENE
R I-GENE
is O
involved O
in O
receptor I-GENE
G I-GENE
( I-GENE
q _RARE_
/ I-GENE
11 I-GENE
) I-GENE
protein I-GENE
coupling O
and O
/ O
or O
selectivity O
, O
and O
in O
the O
GGH _RARE_
( O
3 O
) O
1 O
' O
cell O
line O
, O
this O
loop O
is O
also O
involved O
in O
signal O
transduction _RARE_
mediated _RARE_
through O
the O
Gs _RARE_
protein O
pathway _RARE_
. O

Decreased _RARE_
levels O
of O
alpha2 _RARE_
- I-GENE
antiplasmin _RARE_
were O
also O
observed O
in O
the O
mediastinum _RARE_
( O
0 _RARE_
. O
50 O
versus O
0 _RARE_
. O
61 _RARE_
U _RARE_
/ O
mL O
; O
p O
< O
0 _RARE_
. O
05 O
). O

A O
catalytic O
domain O
of O
eukaryotic I-GENE
DNA I-GENE
topoisomerase I-GENE
I I-GENE
. O

A O
cluster O
of O
basic O
amino O
acids _RARE_
, O
KKKR _RARE_
, O
generated O
by O
joining _RARE_
of O
the O
sequences O
encoded O
by O
the O
constitutive _RARE_
exon _RARE_
13 _RARE_
and O
the O
alternative _RARE_
exon _RARE_
16 O
, O
is O
necessary O
for _RARE_
the O
nuclear O
targeting O
of O
4 I-GENE
. I-GENE
1H _RARE_
, O
as _RARE_
demonstrated O
by O
site O
- O
directed O
mutagenesis O
analysis O
. O

Another O
stem _RARE_
- O
loop O
called O
structure _RARE_
III O
near O
the O
3 O
'- O
end O
of O
repY _RARE_
sequesters _RARE_
both O
the O
5 O
'- O
rCGCC _RARE_
- O
3 O
' O
sequence O
and O
the O
repZ _RARE_
ribosome _RARE_
- I-GENE
binding I-GENE
site I-GENE
. O

All O
three O
genes O
have O
been O
mapped O
precisely O
to O
a O
small O
region O
on O
human O
chromosome _RARE_
16p12 _RARE_
. O
1 O
- O
p11 _RARE_
. O
2 O
( O
homologous O
to O
mouse O
chromosome _RARE_
7 O
), _RARE_
using O
somatic O
cell O
hybrids O
and O
cosmid O
clones _RARE_
. O

In O
fus3 _RARE_
mutants I-GENE
, O
the O
levels O
of O
Ty1 I-GENE
RNA I-GENE
, O
protein O
synthesis _RARE_
, O
and O
proteolytic _RARE_
processing _RARE_
were O
not O
altered O
relative O
to O
those O
in O
FUS3 _RARE_
strains O
but O
steady O
- O
state O
levels O
of O
TyA _RARE_
, O
integrase I-GENE
, O
and O
reverse I-GENE
transcriptase I-GENE
proteins O
and O
Ty1 I-GENE
cDNA I-GENE
were O
all O
increased O
. O

Posttranslational _RARE_
regulation _RARE_
of O
Ty1 I-GENE
retrotransposition _RARE_
by O
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
Fus3 _RARE_
. O

The O
general _RARE_
transcription I-GENE
factor I-GENE
IIA _RARE_
( O
TFIIA _RARE_
) O
interacts O
with O
the O
TATA I-GENE
binding I-GENE
protein I-GENE
( O
TBP I-GENE
) O
and O
promoter O
DNA O
to O
mediate O
transcription O
activation O
in O
vitro O
. O

Their O
function O
is O
not O
only O
to O
recruit O
Pho2 _RARE_
to O
the O
promoter O
but O
to O
allow O
cooperative O
binding O
of O
Pho4 _RARE_
together O
with O
Pho2 _RARE_
. O

Substitution O
of O
the O
Ser _RARE_
- O
Thr _RARE_
sites O
with O
the O
phosphomimetic _RARE_
Asp _RARE_
generated O
a O
constitutively O
active _RARE_
form O
of O
IRF I-GENE
- I-GENE
3 I-GENE
that O
functioned O
as _RARE_
a O
very O
strong O
activator O
of O
promoters O
containing O
PRDI _RARE_
- O
PRDIII _RARE_
or O
ISRE _RARE_
regulatory I-GENE
elements I-GENE
. O

New O
- O
onset O
angina O
preceding O
acute O
myocardial _RARE_
infarction O
is O
associated O
with O
improved O
contractile O
recovery O
after O
thrombolysis _RARE_
. O

In O
this O
study O
, O
the O
effect O
of O
acute O
administration O
of O
various O
doses O
of O
malathion _RARE_
via O
oral O
and O
dermal O
routes O
to O
mice O
and O
rats O
on O
serum O
levels O
of O
histamine _RARE_
was O
evaluated O
. O

Fetal _RARE_
growth O
retardation O
as _RARE_
a O
cause O
of O
impaired O
ovarian O
development O
. O

Similarly O
, O
PCDFs _RARE_
/ O
PCDDs _RARE_
ratio O
in O
ESP _RARE_
ash _RARE_
was O
lower O
than O
that O
in O
boiler _RARE_
ash _RARE_
. O

In O
addition O
to O
DNA O
- O
protein O
interactions O
, O
protein O
- O
protein O
interactions O
with O
partner _RARE_
proteins O
often O
play O
major O
roles O
in O
targeting O
ETS _RARE_
- I-GENE
domain I-GENE
proteins I-GENE
to O
specific O
promoters O
. O

Localization O
of O
67 O
exons O
on O
a O
YAC O
contig O
spanning O
1 O
. O
5 O
Mb O
around O
the O
multidrug _RARE_
resistance I-GENE
gene I-GENE
region I-GENE
of O
human O
chromosome _RARE_
7q21 _RARE_
. O
1 O
. O

The O
complete _RARE_
exon _RARE_
- O
intron O
organization O
of O
the O
murine O
gene O
encoding O
M I-GENE
- I-GENE
protein I-GENE
, O
a O
structural O
protein O
of O
sarcomeric _RARE_
myofibrils _RARE_
, O
was O
determined O
. O

PURPOSE O
: O
To O
introduce _RARE_
an O
image O
analysis O
of O
the O
cornea _RARE_
in O
photorefractive _RARE_
keratectomy _RARE_
( O
PRK O
) O
for _RARE_
preoperative O
and O
early O
postoperative O
determination O
of O
changes O
in O
the O
condition O
of O
the O
cornea _RARE_
. O

Mean O
+/- O
SD O
serum I-GENE
VEGF I-GENE
concentrations O
were O
significantly O
higher _RARE_
( O
P O
< O
0 _RARE_
. O
001 O
) O
in O
women O
with O
PCO _RARE_
and O
PCOS _RARE_
( O
3 O
. O
4 O
+/- O
0 _RARE_
. O
7 O
and O
3 O
. O
2 O
+/- O
0 _RARE_
. O
66 _RARE_
ng _RARE_
/ O
ml O
respectively O
) O
compared O
with O
women O
with O
normal O
ovaries _RARE_
( O
2 O
. O
3 O
+/- O
0 _RARE_
. O
5 O
ng _RARE_
/ O
ml O
). O

Strikingly _RARE_
, O
these O
cells O
contain O
a O
missense O
mutation O
of O
the O
p53 I-GENE
gene I-GENE
at _RARE_
codon _RARE_
242 _RARE_
( O
p53 I-GENE
( O
242 _RARE_
)), _RARE_
which O
substitutes _RARE_
alanine O
for _RARE_
glycine O
. O

The O
new O
algorithm O
, O
called O
RBI _RARE_
- O
MAP O
, O
is O
based O
on O
the O
rescaled _RARE_
block _RARE_
iterative _RARE_
EM O
( O
RBI _RARE_
- O
EM O
) O
algorithm O
. O

A O
third O
ORF O
, O
ORF5 _RARE_
, O
shows O
homology O
with O
gene I-GENE
agrB _RARE_
from O
Staphylococcus _RARE_
aureus _RARE_
, O
which O
is O
involved O
in O
the O
mechanism O
of O
regulation _RARE_
of O
the O
virulence _RARE_
phenotype _RARE_
in O
this O
species O
. O

An O
association O
between O
hSIE _RARE_
and O
Stat I-GENE
- I-GENE
3 I-GENE
after O
MHC I-GENE
- I-GENE
I I-GENE
ligation O
was O
directly O
demonstrated O
by O
precipitating O
Stat I-GENE
- I-GENE
3 I-GENE
from O
nuclear O
extracts O
with O
biotinylated _RARE_
hSIE _RARE_
probe O
and O
avidin _RARE_
- O
coupled O
agarose O
. O

Transcriptional O
repression O
mediated _RARE_
by O
LysR _RARE_
- I-GENE
type I-GENE
regulator I-GENE
CatR _RARE_
bound _RARE_
at _RARE_
multiple O
binding O
sites O
. O

Two O
of O
these O
resulted O
in O
increased O
levels O
of O
the O
alpha O
subunit O
, O
and O
one O
caused O
a O
substitution O
of O
glycine O
for _RARE_
the O
aspartic _RARE_
acid O
residue _RARE_
at _RARE_
position O
171 _RARE_
, O
in O
the O
N O
- O
terminal O
domain O
. O

These O
two O
mRNA O
species O
are O
produced O
by O
differential O
polyadenylation O
site O
usage O
. O

Using O
Southern O
blot O
analysis O
and O
restriction _RARE_
mapping O
of O
genomic O
YAC O
( O
yeast O
artificial O
chromosome _RARE_
) O
and O
cosmid O
clones _RARE_
, O
we O
located _RARE_
the O
human I-GENE
RIL _RARE_
gene I-GENE
240 O
- O
260 O
kb O
telomeric O
to O
the O
IRF1 _RARE_
gene I-GENE
and O
characterized O
its O
genomic O
structure _RARE_
. O

U73 _RARE_
contains O
C O
, O
D O
and O
D O
' O
boxes _RARE_
and O
a O
12 O
- O
nucleotide O
antisense _RARE_
complementarity _RARE_
to O
the O
28S I-GENE
ribosomal I-GENE
RNA I-GENE
. O

However O
, O
mandibular O
position O
( O
S O
- O
N O
- O
B O
and O
S O
- O
N O
- O
Pog _RARE_
) O
was O
found O
to O
be O
significantly O
more O
retrusive _RARE_
in O
Class _RARE_
II O
when O
compared O
with O
Class _RARE_
I O
subjects O
. O

Echinostomiasis _RARE_
is O
aggravated _RARE_
by O
socioeconomic _RARE_
factors O
such O
as _RARE_
poverty _RARE_
, O
malnutrition _RARE_
, O
an O
explosively _RARE_
growing O
free O
- O
food O
market _RARE_
, O
a O
lack O
of O
supervised _RARE_
food O
inspection _RARE_
, O
poor O
or O
insufficient O
sanitation _RARE_
, O
other O
helminthiases _RARE_
, O
and O
declining _RARE_
economic _RARE_
conditions O
. O

The O
localization _RARE_
of O
ZAP _RARE_
- I-GENE
70 I-GENE
to O
the O
cell O
cortex O
is O
, O
therefore O
, O
regulated O
by O
the O
activity O
of O
SRC I-GENE
- I-GENE
family I-GENE
kinases I-GENE
, O
independently O
of O
their O
ability O
to O
phosphorylate O
immunoreceptor _RARE_
tyrosine O
- O
based O
activation O
motifs O
of O
the O
TCR I-GENE
. O

Finally O
, O
a O
role O
for _RARE_
NF _RARE_
- I-GENE
kappaB I-GENE
in O
preventing O
apoptosis O
induced _RARE_
by O
ER O
calcium _RARE_
release O
was O
demonstrated O
by O
data O
showing O
that O
sAPPalpha _RARE_
prevents O
thapsigargin _RARE_
- O
induced _RARE_
apoptosis O
, O
an O
effect O
blocked O
by O
kappaB I-GENE
decoy _RARE_
DNA O
. O

Many O
cytokine _RARE_
receptors O
employ _RARE_
Janus I-GENE
protein I-GENE
tyrosine I-GENE
kinases I-GENE
( O
Jaks _RARE_
) O
and O
signal I-GENE
transducers _RARE_
and I-GENE
activators _RARE_
of I-GENE
transcription I-GENE
( O
Stats _RARE_
) O
for _RARE_
nuclear O
signaling _RARE_
. O

A O
site O
- O
directed O
R618K _RARE_
mutation O
in O
the O
Stat5 I-GENE
SH2 _RARE_
domain I-GENE
abolished O
the O
phosphorylation _RARE_
by O
Jak2 _RARE_
, O
while O
deletion O
of O
the O
C O
terminus O
led O
to O
Stat5 I-GENE
hyperphosphorylation _RARE_
. O

The O
effect O
of O
nitric _RARE_
oxide I-GENE
synthase I-GENE
inhibitor O
on O
reperfusion O
injury O
of O
the O
brain O
under O
hypothermic _RARE_
circulatory O
arrest O
. O

Specifically O
, O
recombination _RARE_
at _RARE_
HMR I-GENE
was O
used O
to O
produce O
rings _RARE_
that O
lacked O
the O
E O
and O
I O
silencers _RARE_
. O

In O
angiodysplasia _RARE_
, O
ectatic _RARE_
vessels O
in O
the O
mucosa O
appeared O
to O
contain O
less O
collagen _RARE_
type I-GENE
IV I-GENE
than O
similarly O
sized O
vessels O
in O
the O
submucosa _RARE_
, O
and O
perforating _RARE_
vessels O
appeared O
in O
many O
cases O
to O
lose _RARE_
staining O
at _RARE_
the O
level O
of O
the O
muscularis _RARE_
mucosae _RARE_
. O

We O
studied O
the O
human O
vestibulo _RARE_
- O
ocular O
reflex O
( O
VOR _RARE_
) O
in O
response O
to O
head O
' O
impulses _RARE_
': _RARE_
brief O
, O
unpredictable _RARE_
, O
passive O
, O
high O
- O
acceleration _RARE_
( O
up _RARE_
to O
4000 _RARE_
degrees O
/ O
s2 _RARE_
), _RARE_
low O
- O
amplitude O
( O
20 O
- O
30 _RARE_
degrees O
) O
head O
rotations _RARE_
. O

To O
clarify O
whether O
seizure O
- O
offset _RARE_
patterns O
are O
reliable O
in O
predicting O
seizure O
outcome O
, O
we O
studied O
SEEG _RARE_
/ O
ECoG _RARE_
in O
a O
similar O
group O
of O
patients O
with O
temporal O
lobe O
epilepsy O
( O
TLE _RARE_
). O

In O
this O
study O
, O
to O
characterize O
the O
gene O
for _RARE_
protein I-GENE
Z I-GENE
, O
its O
organization O
and O
structure _RARE_
were O
determined O
by O
a O
combination O
of O
PCR O
amplification O
of O
leukocyte _RARE_
DNA O
and O
isolation O
of O
phage _RARE_
clones _RARE_
from O
a O
human O
genomic O
library O
. O

These O
modifications O
may O
improve O
the O
interlaboratory _RARE_
reproducibility O
of O
CD34 I-GENE
determinations O
due O
to O
the O
reduction O
in O
sample O
handling _RARE_
and O
calculation _RARE_
of O
results O
. O

The O
present O
results O
demonstrate O
that O
rats O
with O
relatively O
small O
remnants _RARE_
of O
one O
olfactory O
bulb O
can O
perform O
a O
variety O
of O
odor _RARE_
detection O
and O
discrimination O
tasks O
as _RARE_
well _RARE_
or O
nearly O
as _RARE_
well _RARE_
as _RARE_
controls O
. O

UDP _RARE_
- I-GENE
GlcNAc _RARE_
: O
alpha I-GENE
- I-GENE
6 I-GENE
- I-GENE
D I-GENE
- I-GENE
mannoside _RARE_
beta I-GENE
- I-GENE
1 I-GENE
, I-GENE
2 I-GENE
- I-GENE
N I-GENE
- I-GENE
acetylglucosaminyltransferase _RARE_
II I-GENE
( O
GnT _RARE_
II I-GENE
; O
EC I-GENE
2 I-GENE
. I-GENE
4 I-GENE
. I-GENE
1 I-GENE
. I-GENE
143 _RARE_
) O
is O
essential O
for _RARE_
the O
normal O
assembly O
of O
complex O
Asn O
- O
linked _RARE_
glycans _RARE_
. O

These O
patients O
failed O
to O
respond O
to O
intravenous O
cyclophosphamide O
and O
steroids O
and O
were O
then O
changed O
to O
receive O
oral O
cyclosporine O
A O
, O
at _RARE_
a O
dose O
of O
5 O
mg O
/ O
kg O
/ O
day O
. O

The O
predicted O
amino O
acid O
sequence O
is O
78 _RARE_
. O
0 _RARE_
% O
identical O
to O
the O
cytoplasmic I-GENE
dynein I-GENE
heavy I-GENE
chain I-GENE
of I-GENE
Neurospora I-GENE
crassa I-GENE
, O
70 O
. O
2 O
% O
identical O
to O
that O
of O
Aspergillus _RARE_
nidulans _RARE_
and O
24 _RARE_
. O
8 O
% O
identical O
to O
that O
of O
Saccharomyces O
cerevisiae O
. O

The O
DNA O
binding O
activities O
of O
the O
three O
repressor O
preparations O
were O
studied O
using O
fragments O
containing O
CIRs _RARE_
( O
CIR3 _RARE_
- O
CIR6 _RARE_
) O
from O
the O
essential O
early O
region O
as _RARE_
templates O
for _RARE_
DNase I-GENE
I I-GENE
footprinting O
. O

Molecular O
modelling _RARE_
suggested O
that O
the O
tetramerization _RARE_
domain O
was O
a O
four O
- O
helix O
bundle O
, O
stabilized O
by O
interactions O
of O
seven _RARE_
conserved _RARE_
aromatic O
amino O
acids _RARE_
. O

In O
the O
present O
study O
, O
we O
sought O
to O
investigate O
whether O
constitutive _RARE_
NF _RARE_
- I-GENE
kappaB I-GENE
activity O
in O
chronically _RARE_
HIV O
- O
1 O
- O
infected _RARE_
promonocytic _RARE_
U937 O
( O
U9 _RARE_
- O
IIIB _RARE_
) O
and O
myeloblastic _RARE_
PLB _RARE_
- O
985 _RARE_
( O
PLB _RARE_
- O
IIIB _RARE_
) O
cells O
affects O
apoptotic O
signaling _RARE_
. O

Taken O
together O
, O
these O
results O
suggest O
that O
silymarin _RARE_
may O
exert O
a O
strong O
anticarcinogenic _RARE_
effect O
against O
PCA _RARE_
and O
that O
this O
effect O
is O
likely O
to O
involve O
impairment O
of O
erbB1 _RARE_
- O
SHC _RARE_
- O
mediated _RARE_
signaling _RARE_
pathway _RARE_
, O
induction O
of O
CDKIs _RARE_
, O
and O
a O
resultant _RARE_
G1 O
arrest O
. O

In O
connective _RARE_
tissue O
, O
cell O
structure _RARE_
contributes O
to O
type I-GENE
I I-GENE
collagen _RARE_
expression _RARE_
. O

To O
explore O
the O
function O
of O
human O
SINA _RARE_
- I-GENE
homologous I-GENE
( I-GENE
Siah _RARE_
) I-GENE
proteins I-GENE
, O
expression _RARE_
plasmids O
encoding O
Siah _RARE_
- I-GENE
1A _RARE_
were O
transiently O
transfected O
into O
293 O
epithelial _RARE_
cells O
and O
GM701 _RARE_
fibroblast O
cells O
, O
resulting O
in O
growth O
arrest O
without O
induction O
of O
apoptosis O
. O

A O
point O
mutation O
in O
Galphao _RARE_
and O
Galphai1 _RARE_
blocks O
interaction O
with O
regulator O
of O
G I-GENE
protein I-GENE
signaling _RARE_
proteins O
. O

Indeed O
, O
it O
is O
shown O
that O
it O
mediates O
the O
formation O
of O
disulfide O
- O
linked _RARE_
homodimers O
and O
that O
the O
formation O
of O
homo _RARE_
- O
and O
heterodimers _RARE_
are O
mutually _RARE_
excluded O
. O

N O
., O
and O
Fanning _RARE_
, O
E O
. O

We O
have O
shown O
previously O
that O
GH3 _RARE_
cells O
transfected O
with O
the O
rat I-GENE
GnRH I-GENE
receptor I-GENE
cDNA I-GENE
( O
GGH3 _RARE_
- O
1 O
' O
cells O
) O
support O
the O
expression _RARE_
of O
a O
cotransfected O
fusion O
gene O
composed O
of O
797 _RARE_
base _RARE_
pairs _RARE_
of O
rat I-GENE
LHbeta _RARE_
gene I-GENE
5 I-GENE
'- I-GENE
flanking I-GENE
sequence I-GENE
and O
the O
first _RARE_
5 O
base _RARE_
pairs _RARE_
of O
the O
5 O
'- O
untranslated _RARE_
region O
fused O
to O
a O
luciferase I-GENE
reporter I-GENE
(- _RARE_
797 _RARE_
/+ _RARE_
5LHbetaLUC _RARE_
) I-GENE
and O
respond O
to O
a O
GnRH I-GENE
agonist O
with O
a O
10 O
- O
fold _RARE_
stimulation _RARE_
of O
activity O
. O

The O
5 O
'- O
flanking O
region O
, O
from O
nucleotide O
- O
837 _RARE_
to O
- O
336 _RARE_
, O
contains O
TATA O
and O
inverted O
CAAT O
boxes _RARE_
as _RARE_
well _RARE_
as _RARE_
GATA _RARE_
- I-GENE
1 I-GENE
/ O
SP1 I-GENE
erythroid _RARE_
- O
specific O
cis O
- O
acting O
regulatory O
elements O
. O

We O
established O
the O
radiosensitive _RARE_
cell O
line O
SX9 _RARE_
from O
mammary O
carcinoma O
cell O
line O
FM3A _RARE_
. O

In O
patients O
with O
type O
IA O
maple _RARE_
syrup _RARE_
urine O
disease _RARE_
, O
the O
E1alpha _RARE_
subunit I-GENE
is O
affected O
, O
resulting O
in O
the O
loss _RARE_
of O
E1 I-GENE
and O
branched _RARE_
- I-GENE
chain I-GENE
ketoacid _RARE_
dehydrogenase I-GENE
catalytic O
activities O
. O

Results O
showed O
that O
the O
mean O
bond O
strength O
of O
H O
. O
T O
. O
V O
. O
specimens O
ranged O
from O
9 O
. O
6 O
to O
13 _RARE_
. O
12 O
kg O
/ O
cm2 O
, O
while O
the O
mean O
bond O
strength O
of O
R O
. O
T O
. O
V O
. O
specimens O
ranged O
from O
0 _RARE_
. O
36 _RARE_
to O
1 O
. O
75 _RARE_
kg O
/ O
cm2 O
. O

OBJECTIVES O
: O
To O
measure O
coagulation I-GENE
factor I-GENE
VIII I-GENE
: I-GENE
coagulant _RARE_
( O
F I-GENE
. I-GENE
VIII I-GENE
: I-GENE
C I-GENE
) O
and O
C1 I-GENE
- I-GENE
esterase I-GENE
inhibitor I-GENE
( O
C1 I-GENE
- I-GENE
INH _RARE_
), _RARE_
hemostasis O
- O
associated O
acute O
- O
phase _RARE_
reactant _RARE_
proteins O
and O
coagulation I-GENE
factors I-GENE
VII I-GENE
( O
F I-GENE
. I-GENE
VII I-GENE
), _RARE_
IX _RARE_
( O
F I-GENE
. I-GENE
IX _RARE_
), _RARE_
and O
X O
( O
F I-GENE
. I-GENE
X I-GENE
), _RARE_
hemostasis O
proteins O
not O
associated O
with O
an O
acute O
- O
phase _RARE_
response O
, O
in O
a O
select O
population O
of O
horses O
with O
colic _RARE_
and O
hemostasis O
abnormalities O
, O
and O
presumed _RARE_
to O
have O
acute O
- O
phase _RARE_
changes O
. O

RESULTS O
: O
Horses _RARE_
with O
colic _RARE_
had O
significantly O
higher _RARE_
fibrinogen I-GENE
concentration O
, O
greater O
alpha I-GENE
2AP _RARE_
and O
protein I-GENE
C I-GENE
activities O
, O
and O
longer O
PT O
and O
APTT _RARE_
than O
did O
healthy O
horses O
. O

The O
data O
suggest O
that O
plasminogen I-GENE
, O
alpha I-GENE
2AP _RARE_
, O
and O
C1 I-GENE
- I-GENE
INH _RARE_
, O
should O
be O
considered O
equine _RARE_
acute O
- O
phase _RARE_
proteins O
. O

None O
of O
the O
patients O
was O
obese O
. O

Marked O
elevation O
of O
creatine _RARE_
kinase I-GENE
was O
observed O
while O
serum O
albumin I-GENE
, O
immunoglobulin I-GENE
, O
and O
complement O
were O
decreased O
. O

DESIGN O
AND _RARE_
METHODS O
: O
Case _RARE_
study O
. O

METHODS O
: O
A O
total _RARE_
of O
15 _RARE_
pigs O
were O
randomised O
to O
ligation O
of O
left _RARE_
marginal _RARE_
arteries O
( O
infarction O
group O
, O
n _RARE_
= O
5 O
), _RARE_
to O
TMLR _RARE_
of O
the O
left _RARE_
lateral O
wall _RARE_
using O
a O
holmium _RARE_
: O
yttrium _RARE_
- O
aluminium _RARE_
garnet _RARE_
( O
Ho _RARE_
: O
YAG _RARE_
) O
laser O
( O
laser O
group O
, O
n _RARE_
= O
5 O
), _RARE_
and O
to O
both O
( O
laser O
- O
infarction O
group O
, O
n _RARE_
= O
5 O
). O

RACK1 _RARE_
, O
a O
receptor O
for _RARE_
activated I-GENE
C I-GENE
kinase I-GENE
and O
a O
homolog O
of O
the O
beta O
subunit O
of O
G I-GENE
proteins I-GENE
, O
inhibits O
activity O
of O
src I-GENE
tyrosine I-GENE
kinases I-GENE
and O
growth O
of O
NIH _RARE_
3T3 O
cells O
. O

Peptide _RARE_
sequences O
of O
the O
zinc I-GENE
finger I-GENE
protein I-GENE
Ttk _RARE_
and O
the O
transcription I-GENE
factor I-GENE
Adf _RARE_
- I-GENE
1 I-GENE
were O
obtained O
. O

The O
same O
IL _RARE_
- I-GENE
4 I-GENE
- O
inducible O
reporter O
gene O
is O
also O
synergistically O
activated O
by O
the O
endogenous I-GENE
Stat6 _RARE_
and O
NF _RARE_
- I-GENE
kappaB I-GENE
proteins I-GENE
in O
IL _RARE_
- I-GENE
4 I-GENE
- O
stimulated _RARE_
I O
. O
29mu _RARE_
B O
lymphoma O
cells O
. O

HEF1 I-GENE
, O
p130 I-GENE
( O
Cas _RARE_
), _RARE_
and O
Efs _RARE_
/ O
Sin _RARE_
constitute O
a O
family O
of O
multidomain _RARE_
docking _RARE_
proteins O
that O
have O
been O
implicated O
in O
coordinating _RARE_
the O
regulation _RARE_
of O
cell O
adhesion O
. O

In O
support O
of O
a O
role O
at _RARE_
the O
spindle _RARE_
, O
two O
- O
hybrid _RARE_
library O
screening O
with O
HEF1 I-GENE
identifies O
the O
human O
homolog O
of O
the O
G2 _RARE_
/ I-GENE
M I-GENE
spindle _RARE_
- I-GENE
regulatory I-GENE
protein I-GENE
Dim1p _RARE_
as _RARE_
a O
specific O
interactor _RARE_
with O
a O
region O
of O
HEF1 I-GENE
encompassed _RARE_
in O
p55 I-GENE
( O
HEF1 I-GENE
). O

Our O
data O
showed O
that O
activation O
of O
the O
raf _RARE_
- O
ERK I-GENE
pathway _RARE_
led O
to O
activation O
of O
TF _RARE_
expression _RARE_
in O
breast O
carcinoma O
cells O
and O
suggested O
that O
constitutive _RARE_
activation O
of O
this O
pathway _RARE_
leads O
to O
high O
TF _RARE_
expression _RARE_
in O
MDA _RARE_
- O
MB O
- O
231 O
cells O
. O

However O
, O
a O
zinc O
- O
depleted O
enzyme O
was O
obtained O
after O
prolonged O
dialysis O
against O
the O
specific O
chelating _RARE_
agent O
1 O
, O
10 O
- O
phenanthroline _RARE_
. O

All O
patients O
diagnosed O
of O
H O
. O
influenza _RARE_
type O
b O
meningitis O
were O
less O
than O
3 O
years O
old O
. O

The O
lines O
also O
differed O
in O
postsynaptic _RARE_
, O
but O
not O
presynaptic _RARE_
, O
5 I-GENE
- I-GENE
HT1A _RARE_
receptors I-GENE
. O

Convulsive _RARE_
seizure O
during _RARE_
a O
treatment O
with O
interferon _RARE_
alpha I-GENE
for _RARE_
chronic O
viral O
hepatitis O
C O

Immunohistochemically _RARE_
, O
anticytokeratin _RARE_
19 I-GENE
antibody I-GENE
revealed O
strong O
staining O
in O
both O
epithelial _RARE_
and O
sarcomatous _RARE_
MPM _RARE_
tissues O
. O

Genetic O
studies O
in O
Drosophila O
have O
led O
to O
the O
identification O
of O
several O
components _RARE_
of O
the O
Notch I-GENE
pathway _RARE_
. O

The O
bZP2 _RARE_
cDNA O
( O
115 _RARE_
- O
1914 _RARE_
nt O
, O
1 O
. O
8 O
kb O
), _RARE_
excluding O
sequences O
coding O
for _RARE_
N O
- O
terminal O
signal O
sequence O
and O
C O
- O
terminal O
transmembranelike _RARE_
domain O
, O
was O
PCR O
amplified O
and O
Sac1 _RARE_
- O
Sal1 _RARE_
restricted O
fragment O
cloned _RARE_
in O
frame O
downstream _RARE_
of O
the O
T5 _RARE_
promoter O
under O
the O
lac I-GENE
operator I-GENE
control O
in O
a O
pQE _RARE_
- O
30 _RARE_
vector O
. O

Control O
subjects O
' O
evoked O
potentials O
( O
EPs _RARE_
) O
were O
characterized O
by O
an O
initial O
positivity _RARE_
in O
the O
90 _RARE_
- O
140 _RARE_
ms O
range O
( O
P1 O
) O
at _RARE_
the O
temporo _RARE_
- O
occipital _RARE_
site O
. O

Class _RARE_
I I-GENE
alpha1 _RARE_
, I-GENE
2 I-GENE
- I-GENE
mannosidases _RARE_
play O
an O
essential O
role O
in O
the O
elaboration _RARE_
of O
complex O
and O
hybrid _RARE_
N O
- O
glycans _RARE_
in O
mammalian O
cells O
. O

Structural O
features O
of O
the O
minimal O
DNA O
binding O
domain O
( O
M98 _RARE_
- O
F219 _RARE_
) O
of O
human I-GENE
nucleotide I-GENE
excision _RARE_
repair I-GENE
protein I-GENE
XPA _RARE_
. O

Amongst _RARE_
other O
qualities _RARE_
, O
the O
book _RARE_
' O
s O
importance O
lies O
in O
the O
fact O
that O
it O
associates O
an O
elaborate _RARE_
theoretical _RARE_
construction _RARE_
with O
the O
empirical _RARE_
data O
, O
working O
within O
the O
possibilities O
provided O
by O
late _RARE_
19th _RARE_
- O
century _RARE_
moral _RARE_
statistics _RARE_
. O

The O
results O
point O
to O
the O
effectiveness O
of O
the O
educational _RARE_
intervention O
. O

The O
mechanistic _RARE_
implications O
of O
aromatic O
non O
- O
responsiveness O
of O
autonomously _RARE_
expressed _RARE_
A O
- O
domain O
, O
despite O
its O
demonstrated O
ability O
to O
bind O
phenol _RARE_
, O
are O
discussed O
. O

RESULTS O
: O
Acetabular _RARE_
index O
returned O
to O
normal O
gradually O
as _RARE_
the O
time O
went _RARE_
by O
and O
significantly O
within O
one O
year O
after O
the O
reduction O
of O
developmental O
dislocation O
of O
the O
hip O
. O

Recently O
, O
extremely O
high O
levels O
of O
endothelin I-GENE
- I-GENE
1 I-GENE
( O
ET _RARE_
- I-GENE
1 I-GENE
) O
were O
detected O
in O
the O
pericardial _RARE_
fluid _RARE_
of O
patients O
undergoing O
cardiac O
surgery O
. O

Consequently _RARE_
, O
it O
is O
not O
known O
how O
knee _RARE_
loading O
changes O
following O
ACL _RARE_
transection _RARE_
, O
and O
how O
it O
contributes O
to O
cartilage O
degeneration O
. O

We O
show O
that O
the O
surfaces _RARE_
of O
tracheal O
cartilage O
matrix _RARE_
are O
collagen _RARE_
- O
rich O
and O
surround _RARE_
a O
proteoglycan _RARE_
- O
rich O
core O
. O

Comparative O
mapping O
of O
the O
Brassica _RARE_
S I-GENE
locus I-GENE
region I-GENE
and O
its O
homeolog _RARE_
in O
Arabidopsis O
. O

Roles _RARE_
of O
the O
Candida _RARE_
albicans _RARE_
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
homolog I-GENE
, O
Cek1p _RARE_
, O
in O
hyphal _RARE_
development O
and O
systemic O
candidiasis O
. O

Neither O
the O
reaction O
of O
monosaccharides _RARE_
nor O
the O
disaccharides _RARE_
with O
beta O
- O
alanine O
resulted O
in O
the O
formation O
of O
maltol _RARE_
. O

In O
most O
subjects O
, O
markers O
of O
bone O
formation O
and O
resorption O
were O
normal O
. O

Analysis O
of O
a O
Mac1p _RARE_
mutant I-GENE
, O
refractile _RARE_
for _RARE_
copper _RARE_
- O
dependent O
repression O
of O
the O
Cu _RARE_
( I-GENE
I I-GENE
) I-GENE
transport _RARE_
genes I-GENE
, O
showed O
an O
aberrant O
pattern O
of O
CUP1 _RARE_
expression _RARE_
and O
copper _RARE_
sensitivity O
. O

The O
DNA O
sequencing O
of O
the O
recombinant O
clones _RARE_
revealed O
the O
expression _RARE_
of O
RXR I-GENE
alpha I-GENE
and O
RXR I-GENE
beta I-GENE
. O

A O
stratified _RARE_
random O
sample O
of O
20 O
active _RARE_
employees _RARE_
from O
a O
cohort O
of O
phenoxy _RARE_
herbicide _RARE_
workers O
was O
selected _RARE_
in O
1995 O
for _RARE_
determining _RARE_
PCDD _RARE_
and O
PCDF _RARE_
congeners _RARE_
in O
blood _RARE_
lipids O
to O
assess O
the O
extent O
of O
past O
PCDD _RARE_
and O
PCDF _RARE_
exposure O
in O
this O
cohort O
and O
whether O
that O
exposure O
might O
explain O
site O
- O
specific O
cancer _RARE_
findings O
in O
the O
total _RARE_
cohort O
. O

The O
clinical O
and O
laboratory O
features O
of O
72 O
children O
with O
Henoch _RARE_
- O
Schonlein _RARE_
purpura O
( O
HSP _RARE_
) O
were O
examined O
to O
determine O
if O
there O
were O
associations O
between O
the O
laboratory O
indices O
-- _RARE_
including O
white _RARE_
blood _RARE_
cell O
( O
WBC O
) O
counts O
, O
serum I-GENE
C I-GENE
- I-GENE
reactive I-GENE
protein I-GENE
( O
CRP I-GENE
) O
levels O
, O
platelet O
( O
PLT _RARE_
) O
counts O
-- _RARE_
and O
the O
clinical O
manifestations O
of O
acute O
HSP _RARE_
. O

We O
provide O
community O
metabolic O
data O
that O
indicate O
that O
large O
changes O
in O
CO2 O
concentration O
can O
occur O
in O
coral _RARE_
reef _RARE_
waters _RARE_
via O
biogeochemical _RARE_
processes O
not O
directly O
associated O
with O
photosynthesis _RARE_
, O
respiration O
, O
calcification _RARE_
, O
and O
CaCO3 _RARE_
dissolution O
. O

In O
contrast O
to O
other O
known O
retroviruses _RARE_
, O
the O
FV _RARE_
pol I-GENE
genes I-GENE
are O
expressed _RARE_
via O
spliced _RARE_
transcripts O
. O

Substitution O
of O
bulky _RARE_
hydrophobic O
residues O
with O
charged O
residues O
within O
PEP1 _RARE_
affects O
the O
fusion O
activity O
of O
the O
S I-GENE
protein I-GENE
without O
affecting O
processing _RARE_
and O
surface O
expression _RARE_
. O

Tributyltin _RARE_
and O
its O
breakdown _RARE_
products O
, O
mono O
- O
and O
di _RARE_
- O
butyltin _RARE_
, O
were O
determined O
in O
water O
birds O
collected O
from O
Lake _RARE_
Huron _RARE_
( O
the O
Great _RARE_
Lakes _RARE_
), _RARE_
marine _RARE_
coastal _RARE_
United O
States _RARE_
, O
and O
the O
west _RARE_
coast _RARE_
of O
British _RARE_
Columbia _RARE_
, O
Canada _RARE_
. O

The O
5 O
' O
flanking O
region O
of O
the O
CD1 _RARE_
gene I-GENE
contained O
the O
binding O
motifs O
for _RARE_
two O
cytokine _RARE_
- O
inducible O
transcription O
factors O
, O
NF _RARE_
- I-GENE
IL2 _RARE_
- I-GENE
A I-GENE
and O
NF _RARE_
- I-GENE
IL6 I-GENE
. O

Fregnac _RARE_
, O
M O
. O

GLRaV _RARE_
- O
2 O
is O
the O
only O
closterovirus _RARE_
, O
so O
far O
, O
that O
matches O
the O
genome O
organization O
of O
the O
type O
member _RARE_
of O
the O
group O
, O
BYV _RARE_
, O
and O
thus O
can O
be O
unambiguously _RARE_
classified O
as _RARE_
a O
definitive O
member _RARE_
of O
the O
genus O
Closterovirus _RARE_
. O

Demographic _RARE_
and O
clinical O
data O
were O
compared O
with O
a O
control O
group O
of O
339 _RARE_
healthy O
age O
- O
matched O
women O
and O
with O
a O
sample O
of O
224 _RARE_
women O
with O
wrist O
fracture O
. O

Combined O
expression _RARE_
of O
c I-GENE
- I-GENE
Jun I-GENE
and O
p65 _RARE_
induced _RARE_
vigorous _RARE_
transcription O
of O
IL _RARE_
- I-GENE
2 I-GENE
promoter O
- O
and O
CD28RE _RARE_
- I-GENE
driven _RARE_
reporter I-GENE
constructs I-GENE
in O
both O
LFA _RARE_
- I-GENE
3 I-GENE
- O
and O
B7 I-GENE
- I-GENE
1 I-GENE
- O
costimulated _RARE_
Jurkat O
cells O
. O

Identical _RARE_
results O
were O
obtained O
when O
transfections O
and O
mobility O
shift O
assays O
were O
performed O
in O
primary _RARE_
rat O
hepatocytes O
in O
which O
the O
endogenous O
ALS _RARE_
gene I-GENE
is O
expressed _RARE_
. O

This O
E O
box O
sequence O
( O
CACGTG _RARE_
) O
is O
identical O
to O
the O
binding O
element O
for _RARE_
USF I-GENE
( O
upstream I-GENE
stimulatory _RARE_
factor I-GENE
), _RARE_
a O
member _RARE_
of O
the O
helix I-GENE
- I-GENE
loop I-GENE
- I-GENE
helix I-GENE
family I-GENE
of I-GENE
transcription I-GENE
factors I-GENE
. O

Interferon I-GENE
beta I-GENE
therapy O
was O
discontinued _RARE_
for _RARE_
4 O
weeks O
. O

Liquid _RARE_
chromatographic O
method O
for _RARE_
analysis O
of O
all O
- O
rac _RARE_
- O
alpha O
- O
tocopheryl _RARE_
acetate _RARE_
and O
retinyl _RARE_
palmitate _RARE_
in O
milk O
- O
based O
infant O
formula O
using O
matrix _RARE_
solid O
- O
phase _RARE_
dispersion O
. O

We O
specially _RARE_
devised _RARE_
3 O
types _RARE_
of O
turbo _RARE_
pumps _RARE_
, O
a O
centrifugal _RARE_
pump _RARE_
( O
CFP _RARE_
), _RARE_
a O
mixed O
flow O
pump _RARE_
( O
MFP _RARE_
), _RARE_
and O
an O
axial O
flow O
pump _RARE_
( O
AFP _RARE_
), _RARE_
and O
analyzed O
their O
in O
vitro O
performance O
. O

Examination O
of O
the O
mitochondrial I-GENE
bc1 _RARE_
complex I-GENE
crystal _RARE_
structure _RARE_
[ _RARE_
Zhang _RARE_
, O
Z O
., O
Huang _RARE_
, O
L O
., O
Shulmeister _RARE_
, O
V O
. O

Two O
protease O
- O
resistant O
fragments O
spanning O
the O
N O
- O
and O
C O
- O
terminal O
halves _RARE_
of O
the O
nuclease _RARE_
were O
identified O
using O
different O
proteases _RARE_
which O
cleave _RARE_
the O
protein O
in O
the O
same O
region O
. O

The O
side _RARE_
- O
to O
- O
side _RARE_
difference O
was O
statistically O
significant O
at _RARE_
EXT _RARE_
30 _RARE_
degrees O
/ O
s O
and O
60 _RARE_
degrees O
/ O
s O
( O
p O
< O
0 _RARE_
. O
05 O
). O

CONCLUSION O
: O
In O
women O
who O
want _RARE_
or O
require O
conservative O
management O
of O
grade O
4 O
prolapse _RARE_
and O
are O
unable O
to O
retain _RARE_
a O
single O
pessary _RARE_
, O
the O
placement O
of O
two O
pessaries _RARE_
often O
will O
be O
successful O
. O

The O
ability O
to O
maintain O
expression _RARE_
of O
FAS1 _RARE_
in O
nmt1 _RARE_
- O
451Dino2 _RARE_
Delta _RARE_
cells O
suggests O
the O
existence O
of O
another O
transcription O
factor O
, O
or O
factors O
, O
whose O
expression _RARE_
/ O
activity O
is O
inversely O
related O
to O
overall O
levels O
of O
cellular O
protein O
N O
- O
myristoy _RARE_
- O
lation _RARE_
. O

Rev _RARE_
- O
erbAalpha _RARE_
/ I-GENE
beta I-GENE
), _RARE_
Mxi _RARE_
- I-GENE
1 I-GENE
and O
Mad _RARE_
bHLH O
- O
zip _RARE_
proteins O
and O
the O
oncoproteins _RARE_
PLZF I-GENE
and O
LAZ3 _RARE_
/ O
BCL6 _RARE_
is O
mediated _RARE_
by O
the O
corepressors _RARE_
N I-GENE
- I-GENE
CoR _RARE_
and O
SMRT I-GENE
. O

The O
identified O
isolates O
of O
CSF O
( O
20 O
of O
29 O
) O
were O
: O
ECHO O
30 _RARE_
( O
9 O
), _RARE_
ECHO O
11 O
( O
7 O
), _RARE_
ECHO O
9 O
( O
3 O
) O
and O
ECHO O
7 O
( O
1 O
). O

There O
was O
no _RARE_
evidence O
of O
any O
persistent O
oscillation _RARE_
within O
the O
ULF _RARE_
band O
. O

The O
ParaSight _RARE_
- O
F O
test O
alone O
was O
used O
to O
monitor O
serum O
antigen O
levels O
after O
treatment O
in O
24 _RARE_
patients O
. O

The O
purified _RARE_
recombinant O
protein O
was O
assayed O
for _RARE_
its O
enzyme O
activity O
by O
monitoring O
transfer O
of O
[ _RARE_
3H O
] O
methyl _RARE_
groups O
from O
the O
substrate O
DNA O
to O
the O
MGMT _RARE_
protein I-GENE
; O
the O
activity O
was O
found O
to O
be O
stable O
at _RARE_
90 _RARE_
degrees O
C O
for _RARE_
at _RARE_
least O
30 _RARE_
min O
. O

A O
deproteinization _RARE_
procedure O
was O
coupled O
with O
a O
reversed O
- O
phase _RARE_
HPLC O
separation O
using O
a O
250x4 _RARE_
. O
6 O
mm O
I O
. O
D O
. O

Elimination O
of O
the O
inducible O
response O
requires O
simultaneous O
mutation O
of O
both O
sequences O
, O
however O
, O
in O
the O
presence O
of O
an O
intact _RARE_
EpRE _RARE_
the O
upstream O
AP I-GENE
- I-GENE
1 I-GENE
site I-GENE
is O
irrelevant _RARE_
to O
induction O
. O

Three O
high I-GENE
mobility I-GENE
group I-GENE
- I-GENE
like I-GENE
sequences I-GENE
within O
a O
48 _RARE_
- O
base _RARE_
pair _RARE_
enhancer O
of O
the O
Col2a1 _RARE_
gene I-GENE
are O
required O
for _RARE_
cartilage O
- O
specific O
expression _RARE_
in O
vivo O
. O

The O
sequence O
contains O
an O
open _RARE_
reading O
frame O
of O
1744 _RARE_
nt O
in O
the O
virus O
- O
sense O
strand _RARE_
, O
a O
3 O
' O
untranslated _RARE_
region O
of O
1360 _RARE_
nt O
and O
a O
3 O
' O
poly _RARE_
( O
A O
) O
tail _RARE_
. O

A O
phylogenetic O
analysis O
of O
the O
reverse I-GENE
transcriptase I-GENE
domain I-GENE
confirms _RARE_
our O
differential O
genetic O
assessment O
that O
Cyclops _RARE_
from O
pea _RARE_
is O
a O
novel O
element O
with O
no _RARE_
specific O
relationship O
to O
the O
previously O
described O
Gypsy _RARE_
- I-GENE
like I-GENE
elements I-GENE
from O
plants _RARE_
. O

At O
physiological O
doses O
, O
either O
insulin I-GENE
- I-GENE
like I-GENE
growth I-GENE
factor I-GENE
I I-GENE
( O
IGF I-GENE
- I-GENE
I I-GENE
) O
or O
insulin I-GENE
turned O
out O
to O
be O
as _RARE_
potent O
as _RARE_
dibutyryl _RARE_
cAMP O
( O
dbcAMP _RARE_
) O
in O
increasing O
UCP1 _RARE_
gene I-GENE
transcription O
rate O
( O
1 O
h O
) O
and O
also O
UCP1 _RARE_
mRNA I-GENE
accumulation O
( O
3 O
h O
), _RARE_
their O
maximal O
effect O
( O
15 _RARE_
- O
fold _RARE_
increase O
) O
reached O
upon O
treatment O
for _RARE_
24 _RARE_
h O
. O

In O
addition O
, O
insulin I-GENE
induced _RARE_
AP I-GENE
- I-GENE
1 I-GENE
DNA O
binding O
activity O
, O
this O
effect O
being O
totally _RARE_
prevented O
in O
the O
presence O
of O
MEK I-GENE
- I-GENE
1 I-GENE
inhibitor O
. O

Essentially _RARE_
, O
2 O
'- O
O O
- O
methyl _RARE_
oligoribonucleotides _RARE_
( O
2 O
' O
OMeRNA _RARE_
) O
were O
delivered O
to O
the O
nuclei O
of O
primary _RARE_
mdx _RARE_
myoblasts O
in O
culture O
. O

A O
large O
deletion O
in O
the O
CTD _RARE_
- I-GENE
binding I-GENE
motif I-GENE
blocks O
down O
- O
regulation _RARE_
but O
does O
not O
affect O
the O
essential O
function O
of O
Nrd1 _RARE_
. O

Regulation O
of O
the O
human O
p21 I-GENE
/ O
WAF1 I-GENE
/ O
Cip1 I-GENE
promoter O
in O
hepatic _RARE_
cells O
by O
functional _RARE_
interactions O
between O
Sp1 _RARE_
and O
Smad I-GENE
family I-GENE
members I-GENE
. O

RESULTS O
: O
We O
isolated O
a O
C O
. O
elegans O
cDNA O
that O
encoded O
a O
protein O
which O
was O
similar O
to O
, O
but O
not O
exactly _RARE_
homologous O
with O
mammalian O
p120 _RARE_
Ras I-GENE
- O
GAP _RARE_
. O

The O
weak O
base _RARE_
ketoconazole _RARE_
showed O
complete _RARE_
dissolution O
from O
a O
tablet O
formulation O
in O
Simulated _RARE_
Gastric _RARE_
Fluid _RARE_
without O
pepsin _RARE_
( O
SGFsp _RARE_
) O
within O
30 _RARE_
minutes O
, O
70 O
% O
dissolution O
in O
2 O
hours O
under O
fed O
state O
simulated O
upper O
jejunal _RARE_
conditions O
but O
only O
6 O
% O
dissolution O
in O
2 O
hours O
under O
fasted O
state O
conditions O
. O

In O
mammals O
, O
the O
Rb _RARE_
protein I-GENE
interacts O
specifically O
with O
D I-GENE
- I-GENE
type I-GENE
cyclins _RARE_
and O
regulates O
cell O
proliferation _RARE_
by O
binding O
and O
inhibiting O
E2F I-GENE
transcription I-GENE
factors I-GENE
. O

In O
addition O
to O
the O
signals O
obtained O
by O
ligation O
of O
the O
TCR I-GENE
, O
T O
cells O
need O
additional O
, O
co _RARE_
- O
stimulatory _RARE_
signals O
to O
be O
activated O
. O

Moreover O
, O
the O
observation O
of O
enhanced _RARE_
luteal _RARE_
HSP _RARE_
- I-GENE
27 _RARE_
phosphorylation _RARE_
in O
vivo O
, O
in O
late _RARE_
pregnancy _RARE_
, O
when O
PKC I-GENE
- I-GENE
delta I-GENE
is O
abundant O
and O
active _RARE_
, O
suggests O
that O
select O
PKC I-GENE
family I-GENE
members I-GENE
contribute O
to O
sHSP _RARE_
phosphorylation _RARE_
events O
in O
vivo O
. O

We O
characterized O
the O
structure _RARE_
of O
this O
leader _RARE_
mRNA O
by O
using O
the O
program O
Mfold _RARE_
and O
a O
combination O
of O
nested _RARE_
and O
internal O
deletions O
transcriptionally O
fused O
to O
a O
promoterless O
lac I-GENE
operon I-GENE
. O

The O
importance O
of O
these O
sites O
for _RARE_
transcriptional O
activation O
was O
studied O
by O
site O
- O
directed O
mutagenesis O
followed O
by O
promoter O
function O
analysis O
of O
the O
mutants O
with O
a O
chloramphenicol I-GENE
acetyltransferase _RARE_
reporter I-GENE
system _RARE_
. O

Routine _RARE_
blood _RARE_
examination O
showed O
leukocytosis _RARE_
, O
thrombocytopenia O
, O
positive O
CRP I-GENE
, O
and O
elevated O
myocardial _RARE_
enzymes _RARE_
. O

Previous O
studies O
have O
suggested O
that O
moderate O
cooling _RARE_
increases O
the O
responsiveness O
of O
vascular I-GENE
alpha2 _RARE_
- I-GENE
adrenoceptors I-GENE
. O

Two O
members O
of O
the O
Cbl I-GENE
family I-GENE
have O
since O
been O
defined O
in O
mammals O
( O
c I-GENE
- I-GENE
Cbl I-GENE
and O
Cbl I-GENE
- I-GENE
b I-GENE
), _RARE_
one O
in O
C O
. O
elegans O
( O
Sli _RARE_
- I-GENE
1 I-GENE
) O
and O
one O
in O
Drosophila O
( O
D I-GENE
- I-GENE
Cbl I-GENE
). O

Anti _RARE_
- I-GENE
PTB _RARE_
antibodies I-GENE
did O
not O
inhibit O
the O
binding O
of O
PTB _RARE_
to O
RNA O
because O
they O
were O
able O
to O
supershift O
RNA I-GENE
- I-GENE
PTB _RARE_
complexes I-GENE
. O

The O
use O
of O
antibodies O
to O
the O
polypyrimidine _RARE_
tract _RARE_
binding I-GENE
protein I-GENE
( O
PTB _RARE_
) O
to O
analyze O
the O
protein O
components _RARE_
that O
assemble _RARE_
on O
alternatively _RARE_
spliced _RARE_
pre O
- O
mRNAs O
that O
use O
distant O
branch O
points O
. O

The O
therapeutic O
use O
of O
botulinum I-GENE
toxin _RARE_
( O
Botox _RARE_
) O
is O
increasing O
in O
popularity _RARE_
. O

The O
viral I-GENE
oncoprotein _RARE_
E1A I-GENE
inhibits O
NFAT I-GENE
- O
dependent O
transactivation _RARE_
in O
a O
p300 I-GENE
- O
dependent O
manner O
. O

We O
have O
applied O
the O
mRNA O
differential O
display O
method O
to O
compare O
and O
analyze O
mRNAs O
prepared O
from O
five O
normal O
nasopharyngeal _RARE_
epithelial _RARE_
cell O
cultures O
and O
five O
nasopharyngeal _RARE_
carcinoma O
cell O
lines O
. O

Similar O
experiments O
with O
TR I-GENE
support O
the O
high O
affinity O
of O
RIP140 _RARE_
to O
the O
RXR I-GENE
subunit I-GENE
and O
also O
suggest O
that O
either O
partner _RARE_
in O
the O
TR I-GENE
/ O
RXR I-GENE
heterodimer _RARE_
can O
independently O
respond O
to O
ligand _RARE_
. O

SETTING O
: O
University O
hospital O
- O
based O
, O
tertiary O
care O
infertility O
center _RARE_
. O

RESULT _RARE_
( O
S O
): O
In O
patients O
with O
elevated O
FSH I-GENE
levels O
on O
cycle _RARE_
day O
3 O
, O
a O
low O
oocyte _RARE_
yield O
was O
achieved O
( O
7 O
versus O
11 O
) O
and O
a O
high O
number O
of O
ampules _RARE_
of O
hMG _RARE_
was O
necessary O
( O
56 _RARE_
versus O
33 _RARE_
). O

RESULTS O
: O
Of O
the O
patients O
with O
IS _RARE_
, O
67 O
% O
had O
significantly O
greater O
values O
of O
directional _RARE_
preponderance _RARE_
on O
the O
OVAR _RARE_
test O
( O
a O
measure O
of O
otolith _RARE_
system _RARE_
imbalance _RARE_
) O
compared O
with O
control O
subjects O
. O

In O
the O
ePTFE _RARE_
specimens O
, O
tissue O
coverage _RARE_
had O
increased O
. O

As O
predicted O
by O
the O
Wing _RARE_
and O
Kristofferson _RARE_
model O
, O
the O
durations O
of O
successive O
ISIs _RARE_
tended O
to O
be O
negatively O
correlated O
. O

Thus O
, O
included O
in O
the O
KG1a _RARE_
EST _RARE_
dataset _RARE_
are O
candidates _RARE_
for _RARE_
new O
human O
genes O
that O
may O
play O
roles O
in O
hematopoietic O
differentiative _RARE_
progression O
and O
lineage O
commitment _RARE_
. O

We O
found O
the O
following O
: O
Specific O
mutations O
affected O
the O
precise O
carbohydrate O
structure _RARE_
and O
folding O
of O
the O
HA _RARE_
trimer _RARE_
. O

The O
results O
show O
that O
ROS _RARE_
production O
by O
viable O
spermatozoa O
is O
highly O
correlated O
with O
the O
concentration O
of O
PMN _RARE_
elastase I-GENE
and O
the O
number O
of O
both O
peroxidase I-GENE
- O
positive O
and O
round O
cells O
. O

Yeast _RARE_
U1 _RARE_
snRNP I-GENE
is O
considerably O
more O
complex O
than O
its O
metazoan _RARE_
counterpart _RARE_
, O
which O
suggests O
possible O
differences O
between O
yeast O
and O
metazoa _RARE_
in O
early O
splicing _RARE_
events O
. O

Yeast _RARE_
U1 _RARE_
snRNP I-GENE
therefore O
contains O
16 O
different O
proteins O
, O
including O
seven _RARE_
snRNP I-GENE
core I-GENE
proteins I-GENE
, O
three O
homologues _RARE_
of O
the O
metazoan _RARE_
U1 _RARE_
snRNP I-GENE
- I-GENE
specific I-GENE
proteins I-GENE
, O
and O
six _RARE_
yeast I-GENE
- I-GENE
specific I-GENE
U1 _RARE_
snRNP I-GENE
proteins I-GENE
. O

After O
the O
first _RARE_
cycle _RARE_
, O
18 O
cases O
were O
treated O
at _RARE_
dose O
level O
1 O
, O
after O
a O
second O
cycle _RARE_
, O
13 _RARE_
cases O
were O
treated O
at _RARE_
dose O
level O
2 O
. O

The O
opioid _RARE_
antagonist O
naltrexone O
( O
0 _RARE_
. O
01 O
- O
1 O
. O
0 _RARE_
mg O
/ O
kg O
) O
antagonized _RARE_
the O
discriminative _RARE_
stimulus O
effects O
of O
heroin _RARE_
, O
but O
naltrexone O
at _RARE_
doses O
up _RARE_
to O
10 O
mg O
/ O
kg O
had O
no _RARE_
effect O
on O
the O
discriminative _RARE_
stimulus O
effects O
of O
cocaine O
. O

In O
this O
study O
we O
examined O
hepatic _RARE_
stellate _RARE_
cell O
regulation _RARE_
of O
M6P _RARE_
/ O
IGFIIR _RARE_
expression _RARE_
and O
found O
that O
M6P _RARE_
/ O
IGFIIR _RARE_
mRNA O
transcript O
levels O
increased O
in O
stellate _RARE_
cells O
from O
rats O
exposed O
to O
carbon O
tetrachloride _RARE_
( O
CCl4 _RARE_
), _RARE_
a O
potent O
fibrogenic _RARE_
stimulant _RARE_
. O

One O
cDNA O
clone O
designated O
NCoA _RARE_
- O
62 _RARE_
, O
encoded O
a O
62 _RARE_
, O
000 _RARE_
- O
Da _RARE_
protein O
that O
is O
highly O
related O
to O
BX42 _RARE_
, O
a O
Drosophila O
melanogaster O
nuclear O
protein O
involved O
in O
ecdysone O
- O
stimulated _RARE_
gene O
expression _RARE_
. O

These O
widely O
expressed _RARE_
proteins O
share O
a O
C O
- O
terminal O
region O
that O
bears _RARE_
significant O
sequence O
homology O
to O
a O
group O
of O
GDP I-GENE
/ I-GENE
GTP I-GENE
exchange I-GENE
proteins I-GENE
for _RARE_
the O
Rab3 _RARE_
family I-GENE
of O
small I-GENE
GTP I-GENE
binding I-GENE
proteins I-GENE
. O

Whereas O
p82 _RARE_
expression _RARE_
had O
no _RARE_
effect O
on O
ERK2 I-GENE
activation O
by O
p126 _RARE_
, O
p70 I-GENE
completely O
abrogated O
this O
activity O
. O

The O
pre O
- O
mRNA O
splicing _RARE_
factor O
U2AF _RARE_
( O
U2 _RARE_
small I-GENE
nuclear I-GENE
ribonucleoprotein I-GENE
particle _RARE_
[ _RARE_
snRNP I-GENE
] I-GENE
auxiliary _RARE_
factor I-GENE
) O
plays O
a O
critical O
role O
in O
3 O
' O
splice _RARE_
site O
selection O
. O

The O
brackets _RARE_
were O
bonded _RARE_
to O
100 _RARE_
freshly _RARE_
extracted O
bovine O
incisors _RARE_
, O
and O
, O
after O
storage _RARE_
in O
tap _RARE_
water O
at _RARE_
room O
temperature _RARE_
for _RARE_
24 _RARE_
hours O
, O
they O
were O
subsequently O
tested O
in O
a O
shear O
mode O
using O
a O
universal _RARE_
testing O
machine O
. O

Exercise _RARE_
training O
has O
become O
increasingly _RARE_
important O
in O
the O
treatment O
of O
heart _RARE_
failure O
patients O
. O

The O
growth O
of O
Aer _RARE_
. O
hydrophila _RARE_
in O
filter O
- O
sterilized _RARE_
lettuce _RARE_
extract _RARE_
was O
completely O
inhibited O
by O
0 _RARE_
. O
1 O
% O
( O
v O
/ O
v O
) O
BMC _RARE_
whereas O
that O
of O
Ps _RARE_
. O
fluorescens _RARE_
was O
not O
significantly O
affected O
by O
1 O
% O
( O
v O
/ O
v O
) O
BMC _RARE_
. O

Despite O
continuous O
compliance O
, O
unexplained _RARE_
resurgence _RARE_
of O
serum O
ferritin I-GENE
levels O
occurred O
in O
4 O
/ O
7 O
patients O
of O
the O
' O
veteran _RARE_
' O
group O
after O
4 O
- O
5 O
years O
on O
L1 O
. O

Hematocrit _RARE_
and O
PaO2 O
did O
not O
change O
. O

Regulation O
of O
myosin I-GENE
phosphatase I-GENE
activity O
involves O
changes O
in O
subunit O
interactions O
, O
although O
molecular _RARE_
mechanisms O
are O
not O
defined O
. O

Commutative _RARE_
saccadic _RARE_
generator _RARE_
is O
sufficient O
to O
control O
a O
3 O
- O
D O
ocular O
plant _RARE_
with O
pulleys _RARE_
. O

The O
virus O
- O
associated O
VAI _RARE_
RNA O
of O
adenovirus O
is O
a O
small O
highly O
structured O
RNA O
that O
is O
required O
for _RARE_
the O
efficient O
translation O
of O
cellular O
and O
viral O
mRNAs O
at _RARE_
late _RARE_
times O
after O
infection O
. O

Structure O
of O
the O
gene O
encoding O
the O
human O
cyclin _RARE_
- I-GENE
dependent I-GENE
kinase I-GENE
inhibitor O
p18 _RARE_
and O
mutational O
analysis O
in O
breast O
cancer _RARE_
. O

The O
YccA _RARE_
protein I-GENE
was O
found O
to O
be O
degraded O
in O
an O
FtsH _RARE_
- O
dependent O
manner O
in O
vivo O
and O
in O
vitro O
, O
whereas O
the O
YccA11 _RARE_
mutant I-GENE
protein I-GENE
, O
lacking _RARE_
eight O
amino O
acid O
residues O
within O
the O
amino O
- O
terminal O
cytoplasmic O
domain O
, O
was O
refractory O
to O
the O
degradation _RARE_
. O

The O
major O
type O
involves O
activator O
proteins O
that O
bind O
to O
DNA O
adjacent O
to O
where O
the O
RNA I-GENE
polymerase I-GENE
( O
RNAP I-GENE
) O
holoenzyme _RARE_
binds O
, O
usually O
assisting _RARE_
in O
recruitment O
of O
the O
RNAP I-GENE
to O
the O
promoter O
. O

A O
conserved _RARE_
role O
for _RARE_
L1 I-GENE
as _RARE_
a O
transmembrane O
link _RARE_
between O
neuronal _RARE_
adhesion O
and O
membrane O
cytoskeleton _RARE_
assembly O
. O

Atmospheric _RARE_
benzene _RARE_
, O
urinary _RARE_
muconic _RARE_
acid O
( O
tt _RARE_
- O
MA _RARE_
) O
and O
leukocyte _RARE_
alkaline _RARE_
phosphatase I-GENE
activity O
( O
LAPA _RARE_
) O
were O
evaluated O
among O
66 _RARE_
car _RARE_
mechanics _RARE_
, O
34 _RARE_
road _RARE_
tanker _RARE_
drivers _RARE_
, O
and O
28 _RARE_
nonexposed _RARE_
workers O
. O

It O
contains O
a O
5 O
'- O
noncoding O
region O
( O
NCR O
) O
of O
73 _RARE_
nucleotides O
, O
five O
open _RARE_
reading O
frames O
( O
ORFs _RARE_
1 O
to O
5 O
) O
which O
encode O
proteins O
with O
M O
( O
r _RARE_
) O
160 _RARE_
kDa O
RNA O
- O
dependent O
RNA O
polymerase O
( O
ORF1 O
), _RARE_
26 _RARE_
kDa O
movement O
protein O
1 O
( O
ORF2 O
), _RARE_
13 _RARE_
kDa O
movement O
protein O
2 O
( O
ORF3 O
), _RARE_
10 O
kDa O
movement O
protein O
3 O
( O
ORF4 _RARE_
), _RARE_
24 _RARE_
kDa O
coat O
protein O
( O
OFR5 _RARE_
), _RARE_
and O
a O
3 O
' O
NCR O
of O
76 _RARE_
nucleotides O
. O

After O
profound O
normovolemic _RARE_
hemodilution _RARE_
( O
Hct _RARE_
9 O
%) O
superiority _RARE_
of O
LV O
MC O
and O
LV O
diastolic O
properties O
was O
found O
, O
when O
myocardial _RARE_
oxygenation O
was O
supported O
by O
i O
. O
v O
. O
perflubron _RARE_
emulsion _RARE_
, O
a O
temporary O
O2 _RARE_
carrier O
. O

Sp1 _RARE_
and O
two O
Sp3 I-GENE
isoforms I-GENE
were O
detected O
as _RARE_
the O
primary _RARE_
cellular O
constituents _RARE_
of O
DNA O
- O
protein O
complexes O
formed O
with O
the O
NF _RARE_
- I-GENE
kappaB I-GENE
- I-GENE
proximal I-GENE
site I-GENE
. O

These O
genes O
may O
represent O
interesting _RARE_
targets _RARE_
for _RARE_
new O
therapeutic O
strategies O
. O

It O
could O
also O
inhibit O
C1q _RARE_
- O
dependent O
haemolysis _RARE_
of O
both O
IgG I-GENE
- O
and O
IgM I-GENE
- O
sensitized _RARE_
erythrocytes _RARE_
. O

3 O
) O
and O
one O
distal O
(- _RARE_
11 O
. O
8 O
/- O
10 O
. O
9 O
), _RARE_
presented O
an O
enhancer O
activity O
in O
pituitary O
cells O
when O
placed O
upstream O
of O
the O
SV40 I-GENE
promoter I-GENE
. O

The O
second O
patient O
had O
received O
pituitary I-GENE
- I-GENE
derived I-GENE
growth I-GENE
hormone I-GENE
for _RARE_
treatment O
of O
growth I-GENE
hormone I-GENE
deficiency O
, O
secondary O
to O
a O
third O
ventricle O
teratoma _RARE_
, O
exised _RARE_
13 _RARE_
yr O
earlier O
. O

3 O
-- _RARE_
It O
is O
necessary O
to O
think _RARE_
about O
cosmetic _RARE_
consequences O
of O
the O
chinese _RARE_
flap O
and O
consider O
other O
possibilities O
of O
the O
flap O
choice O
. O

CONCLUSION O
: O
TNF I-GENE
alpha I-GENE
, O
TGF I-GENE
beta I-GENE
, O
PDGF _RARE_
and O
IL _RARE_
- I-GENE
1beta I-GENE
increased O
LDLr _RARE_
gene I-GENE
expression _RARE_
by O
increasing O
sterol O
- O
independent O
and O
mitogenesis _RARE_
- O
independent O
gene O
transcription O
. O

Binding O
affinities O
of O
different O
nucleotide O
mono O
-, _RARE_
di _RARE_
- O
and O
triphosphates _RARE_
and O
non O
- O
hydrolyzable _RARE_
analogs _RARE_
indicate O
that O
the O
beta O
- O
phosphate O
moiety _RARE_
is O
required O
for _RARE_
substrate O
binding O
. O

However O
, O
it O
is O
only O
one O
- O
half _RARE_
and O
one O
- O
third O
the O
size O
of O
the O
proteolipids _RARE_
from O
M O
. O
thermoautotrophicum _RARE_
and O
M O
. O
jannaschii _RARE_
, O
respectively O
. O
ahaK _RARE_
is O
expressed _RARE_
in O
Escherichia O
coli O
, O
and O
it O
is O
incorporated O
into O
the O
cytoplasmic O
membrane O
despite O
the O
different O
chemical O
natures _RARE_
of O
lipids O
from O
archaea _RARE_
and O
bacteria O
. O

In O
this O
report O
we O
studied O
the O
role O
of O
protein I-GENE
- I-GENE
tyrosine I-GENE
phosphatase I-GENE
SHP I-GENE
- I-GENE
2 I-GENE
in O
ErbB I-GENE
- O
mediated _RARE_
activation O
of O
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
( O
MAPK _RARE_
) O
by O
overexpressing O
SHP I-GENE
- I-GENE
2 I-GENE
mutants I-GENE
in O
COS O
- O
7 O
cells O
. O

Osteoadherin _RARE_
is O
a O
recently O
described O
bone O
proteoglycan _RARE_
containing O
keratan _RARE_
sulfate _RARE_
. O

Intron _RARE_
8 O
harbored _RARE_
a O
strong O
erythroid _RARE_
- O
specific O
enhancer O
activity O
which O
was O
orientation O
- O
dependent O
. O

The O
intron O
8 O
enhancer O
region O
was O
not O
activated O
by O
GATA _RARE_
- I-GENE
1 I-GENE
together O
with O
Sp1 _RARE_
in O
transactivation _RARE_
experiments O
in O
COS O
- O
1 O
cells O
indicating O
the O
involvement O
of O
a O
related O
Sp1 _RARE_
protein I-GENE
or O
of O
another O
unidentified O
erythroid _RARE_
factor O
. O

The O
cleavage _RARE_
of O
Fak _RARE_
by O
caspases _RARE_
may O
thus O
play O
an O
important O
role O
in O
the O
execution _RARE_
of O
the O
suicide O
program O
by O
disabling _RARE_
the O
anti O
- O
apoptotic O
function O
of O
Fak _RARE_
. O

Moreover O
, O
the O
mass O
estimated O
with O
the O
QCM _RARE_
response O
through O
the O
Sauerbrey _RARE_
equation O
and O
the O
mass O
which O
can O
be O
measured O
thanks _RARE_
to O
other O
analytical _RARE_
techniques O
, O
in O
our O
case O
an O
enzymatic O
assay O
, O
are O
different O
: O
the O
deposited _RARE_
mass O
is O
generally O
overestimated _RARE_
by O
the O
QCM _RARE_
. O

[ _RARE_
Treatment O
of O
early O
T1 _RARE_
small O
T2N _RARE_
breast O
cancers O
. O

Transcription O
initiation O
occurred O
predominantly O
at _RARE_
the O
putative O
sigmaA _RARE_
- I-GENE
dependent I-GENE
promoter I-GENE
in O
exponentially _RARE_
growing O
cells O
and O
was O
induced _RARE_
under O
stress O
conditions O
. O

The O
genes O
encoding O
( I-GENE
2Fe _RARE_
- I-GENE
2S _RARE_
) I-GENE
plant _RARE_
- I-GENE
like I-GENE
ferredoxins _RARE_
were O
studied O
in O
the O
widely O
used O
cyanobacterium _RARE_
Synechocystis _RARE_
PCC6803 _RARE_
. O

RNA O
of O
GBV _RARE_
- O
C O
was O
detected O
in O
14 O
( O
18 O
%) O
patients O
before O
BMT _RARE_
. O

A O
major O
pool O
of O
Dsg _RARE_
- O
plakoglobin I-GENE
complexes O
sedimented _RARE_
at _RARE_
8S _RARE_
and O
exhibited O
a O
1 O
: O
1 O
stoichiometry _RARE_
. O

Our O
results O
indicate O
that O
the O
binding O
of O
CBF I-GENE
/ O
NF _RARE_
- I-GENE
Y I-GENE
to O
the O
inverted O
CCAAT O
box O
is O
responsible O
for _RARE_
transcriptional O
activation O
of O
the O
nTPH _RARE_
gene I-GENE
. O

In O
macrophages O
, O
LPS _RARE_
- O
inducible O
HIV O
- O
1 O
gene O
expression _RARE_
is O
mediated _RARE_
in O
part O
by O
binding O
of O
NF _RARE_
- I-GENE
kappa _RARE_
B I-GENE
to O
identical O
tandem _RARE_
binding O
sites O
located _RARE_
within O
the O
long O
terminal O
repeat O
( O
LTR O
). O

The O
influence O
of O
p53 I-GENE
on O
cytokine _RARE_
- O
triggered O
Janus I-GENE
kinase I-GENE
- O
STAT I-GENE
signaling _RARE_
was O
investigated O
in O
human O
hepatoma O
Hep3B _RARE_
cell O
lines O
engineered _RARE_
to O
constitutively O
express O
the O
temperature _RARE_
- O
sensitive _RARE_
Val135 _RARE_
mutant I-GENE
of I-GENE
p53 I-GENE
. O

It O
can O
also O
be O
used O
to O
examine O
various O
laryngeal _RARE_
parameters O
obtained O
from O
videotaped _RARE_
endoscopic _RARE_
and O
stroboscopic _RARE_
examinations O
. O

CONCLUSIONS O
: O
Two O
consecutive O
sets O
of O
transrectal _RARE_
ultrasound O
guided _RARE_
sextant _RARE_
biopsies O
of O
the O
prostate _RARE_
performed O
in O
a O
single O
office _RARE_
visit _RARE_
represent O
a O
cost O
- O
effective O
biopsy O
strategy O
for _RARE_
men O
presenting _RARE_
with O
an O
abnormal O
digital O
rectal O
examination O
and O
/ O
or O
elevated O
serum I-GENE
PSA I-GENE
. O

Examination O
of O
nuclear O
magnetic O
resonance O
( O
NMR O
) O
spectra O
of O
a O
series O
of O
N I-GENE
- I-GENE
terminally _RARE_
truncated I-GENE
MIP _RARE_
- I-GENE
1 I-GENE
beta I-GENE
variants I-GENE
reveals O
that O
these O
proteins O
possess O
a O
range O
of O
ability O
to O
dimerize _RARE_
. O

Interestingly O
, O
PKA I-GENE
activity O
is O
dispensable O
in O
a O
strain _RARE_
lacking _RARE_
Msn2p _RARE_
and O
Msn4p _RARE_
activity O
. O

They O
also O
indicate O
that O
direct O
interactions O
between O
C I-GENE
/ I-GENE
EBPs _RARE_
and O
specific O
Ets I-GENE
family O
members O
, O
together O
with O
GATA _RARE_
- I-GENE
1 I-GENE
, O
are O
important O
for _RARE_
eosinophil O
lineage O
determination O
. O

Recently O
, O
a O
human I-GENE
transcription I-GENE
elongation _RARE_
factor I-GENE
P I-GENE
- I-GENE
TEFb _RARE_
, O
consisting O
of O
CDK9 _RARE_
kinase I-GENE
, O
cyclin _RARE_
T I-GENE
and O
other O
associated O
factors O
, O
has O
been O
shown O
to O
interact O
with O
Tat I-GENE
to O
restore _RARE_
Tat I-GENE
activation O
in O
HeLa O
nuclear O
extract _RARE_
depleted O
of O
P I-GENE
- I-GENE
TEFb _RARE_
. O

We O
have O
used O
the O
hydrophobic O
repeats O
of O
the O
HSF1 I-GENE
trimerization _RARE_
domain I-GENE
in O
the O
yeast O
two O
- O
hybrid _RARE_
protein O
interaction O
assay O
to O
identify O
heat I-GENE
shock I-GENE
factor I-GENE
binding I-GENE
protein I-GENE
1 I-GENE
( O
HSBP1 _RARE_
), _RARE_
a O
novel O
, O
conserved _RARE_
, O
76 _RARE_
- O
amino O
- O
acid O
protein O
that O
contains O
two O
extended O
arrays O
of O
hydrophobic O
repeats O
that O
interact O
with O
the O
HSF1 I-GENE
heptad _RARE_
repeats I-GENE
. O

Genomic O
and O
cDNA O
clones _RARE_
homologous O
to O
the O
yeast O
GCN2 I-GENE
eIF I-GENE
- I-GENE
2alpha I-GENE
kinase O
( O
yGCN2 _RARE_
) O
were O
isolated O
from O
Drosophila O
melanogaster O
. O

The O
general _RARE_
recombination _RARE_
at _RARE_
a O
polarizing _RARE_
voltage O
of O
300 _RARE_
V O
is O
less O
than O
2 O
% O
for _RARE_
dose O
- O
rates O
up _RARE_
to O
about O
100 _RARE_
mGy _RARE_
min O
- O
1 O
. O

The O
low O
number O
of O
false O
positives _RARE_
indicates O
that O
our O
scheme _RARE_
would O
not O
confuse _RARE_
the O
radiologist _RARE_
by O
suggesting O
normal O
regions O
as _RARE_
suspicious _RARE_
. O

Strengthening _RARE_
the O
biological O
weapons _RARE_
convention _RARE_
and O
implications O
on O
the O
pharmaceutical _RARE_
and O
biotechnology _RARE_
industry _RARE_
. O

VirD2 _RARE_
is O
one O
of O
the O
key O
Agrobacterium _RARE_
tumefaciens _RARE_
proteins O
involved O
in O
T O
- O
DNA O
processing _RARE_
and O
transfer O
. O

Taken O
together O
, O
these O
data O
indicate O
that O
the O
VirD2 _RARE_
omega _RARE_
domain I-GENE
is O
important O
for _RARE_
efficient O
T O
- O
DNA O
integration _RARE_
. O

The O
DHEAS _RARE_
levels O
in O
all O
stages O
of O
decreased O
BMD O
were O
significantly O
lower O
than O
those O
in O
the O
group O
with O
normal O
BMD O
. O

Orientation _RARE_
of O
the O
nuclear O
spin O
system _RARE_
by O
optical O
pumping _RARE_
causes O
an O
Overhauser _RARE_
shift O
of O
the O
excitonic _RARE_
energy O
levels O
proportional _RARE_
to O
the O
degree O
of O
nuclear O
orientation O
. O

Cystatin _RARE_
A I-GENE
, O
a O
cysteine I-GENE
proteinase _RARE_
inhibitor O
, O
is O
one O
of O
the O
precursor O
proteins O
of O
cornified _RARE_
cell I-GENE
envelope I-GENE
of O
keratinocytes _RARE_
and O
is O
expressed _RARE_
during _RARE_
the O
late _RARE_
stage _RARE_
of O
keratinocyte _RARE_
differentiation O
. O

A O
role O
for _RARE_
RalGDS _RARE_
and O
a O
novel O
Ras I-GENE
effector O
in O
the O
Ras I-GENE
- O
mediated _RARE_
inhibition O
of O
skeletal O
myogenesis _RARE_
. O

GTPase I-GENE
activating O
specificity _RARE_
of O
RGS12 _RARE_
and O
binding O
specificity _RARE_
of O
an O
alternatively _RARE_
spliced _RARE_
PDZ I-GENE
( O
PSD _RARE_
- I-GENE
95 _RARE_
/ O
Dlg _RARE_
/ O
ZO _RARE_
- I-GENE
1 I-GENE
) O
domain O
. O

However O
, O
mutations O
in O
the O
HNF I-GENE
- I-GENE
4 I-GENE
binding I-GENE
site I-GENE
on O
element I-GENE
CIIB _RARE_
and O
inhibition O
of O
HNF I-GENE
- I-GENE
4 I-GENE
synthesis _RARE_
in O
HepG2 _RARE_
cells O
by O
antisense _RARE_
HNF I-GENE
- I-GENE
4 I-GENE
constructs I-GENE
decreased O
the O
apoCII _RARE_
promoter I-GENE
activity O
to O
25 _RARE_
- O
40 O
% O
of O
the O
control O
, O
indicating O
that O
HNF I-GENE
- I-GENE
4 I-GENE
is O
a O
positive O
regulator O
of O
the O
apoCII _RARE_
gene I-GENE
. O

272 O
, O
19107 _RARE_
- O
19110 _RARE_
). O

In O
addition O
, O
we O
find O
that O
E2F I-GENE
- I-GENE
1 I-GENE
can O
cause O
apoptosis O
in O
p53 I-GENE
-/- _RARE_
tumour _RARE_
cells O
and O
further O
p300 I-GENE
, O
which O
also O
functions O
as _RARE_
a O
co _RARE_
- O
activator O
for _RARE_
the O
E2F I-GENE
/ O
DP _RARE_
heterodimer _RARE_
, O
enhances O
the O
apoptotic O
activity O
of O
E2F I-GENE
- I-GENE
1 I-GENE
. O

Blocked _RARE_
shift O
/ O
supershift O
analysis O
indicates O
that O
Fos I-GENE
family I-GENE
member _RARE_
proteins O
especially O
Fra _RARE_
- I-GENE
1 I-GENE
and O
Fra _RARE_
- I-GENE
2 I-GENE
are O
related O
to O
progression O
and O
no _RARE_
changes O
found O
in O
the O
Jun I-GENE
family I-GENE
member _RARE_
proteins O
although O
they O
are O
present O
in O
the O
AP I-GENE
- I-GENE
1 I-GENE
/ I-GENE
DNA I-GENE
binding I-GENE
complex I-GENE
. O

Initially _RARE_
, O
we O
observed O
that O
unmutated _RARE_
p53 I-GENE
is O
strongly O
expressed _RARE_
in O
premalignant _RARE_
mammary O
glands O
and O
in O
mammary O
tumors O
derived O
from O
the O
MMTV _RARE_
- O
c I-GENE
- I-GENE
myc I-GENE
strain _RARE_
. O

These O
data O
show O
that O
heterologous O
virus O
RNAs O
( O
BSMV _RARE_
) O
can O
serve O
as _RARE_
primer O
donors O
for _RARE_
MStV _RARE_
mRNA O
capped _RARE_
RNA O
- O
primed O
transcription O
in O
doubly _RARE_
infected _RARE_
plants _RARE_
. O

Human O
isoforms O
, O
designated O
1 O
to O
4 O
, O
differ O
from O
each O
other O
by O
the O
start _RARE_
codon _RARE_
used O
. O

Comparison O
of O
cDNA O
and O
genomic O
sequences O
shows O
that O
the O
ZNF189 _RARE_
gene I-GENE
spans O
approximately _RARE_
11 O
kb O
and O
is O
organized O
into O
at _RARE_
least O
four O
exons O
, O
the O
large O
3 O
'- O
end O
exon _RARE_
coding O
for _RARE_
the O
complete _RARE_
zinc O
finger O
domain O
and O
the O
3 O
' O
untranslated _RARE_
region O
. O

Malaria _RARE_
had O
diminished O
significantly O
by O
the O
early O
1940s _RARE_
, O
and O
this O
paper O
queries _RARE_
whether O
that O
reduction O
was O
due O
to O
the O
control O
projects _RARE_
of O
the O
thirties _RARE_
, O
and O
, O
if O
so O
, O
whether O
such O
projects _RARE_
should O
be O
a O
model O
for _RARE_
the O
current O
developing O
world O
, O
where O
malaria O
is O
a O
growing O
problem O
today _RARE_
. O

The O
gp330 _RARE_
/ O
Megalin _RARE_
/ O
LRP _RARE_
- I-GENE
2 I-GENE
protein O
belongs O
to O
the O
low I-GENE
- I-GENE
density I-GENE
lipoprotein I-GENE
receptor I-GENE
gene I-GENE
family I-GENE
and O
is O
believed O
to O
function O
as _RARE_
an O
endocytic O
receptor O
for _RARE_
the O
uptake O
of O
lipoproteins _RARE_
and O
many O
other O
ligands O
. O

In O
the O
DNA O
recognition O
helix O
of O
finger O
II O
, O
the O
conserved _RARE_
Arg O
at _RARE_
position O
62 _RARE_
( O
N O
- O
terminal O
side _RARE_
of O
the O
first _RARE_
zinc O
- O
coordinating _RARE_
histidine _RARE_
) O
was O
changed O
to O
a O
Leu _RARE_
or O
Gln O
. O

Dosage _RARE_
in O
both O
cases O
was O
0 _RARE_
. O
2 O
g O
/ O
m2 O
. O

Five O
additional O
copies O
of O
Lian _RARE_
elements I-GENE
were O
isolated O
, O
mapped O
by O
restriction _RARE_
digestion O
, O
and O
partially O
sequenced O
. O

Evolutionary _RARE_
relationships O
among O
putative O
RNA I-GENE
- I-GENE
dependent I-GENE
RNA I-GENE
polymerases _RARE_
encoded O
by O
a O
mitochondrial O
virus O
- O
like O
RNA O
in O
the O
Dutch _RARE_
elm _RARE_
disease _RARE_
fungus _RARE_
, O
Ophiostoma _RARE_
novo _RARE_
- O
ulmi _RARE_
, O
by O
other O
viruses O
and O
virus O
- O
like O
RNAs O
and O
by O
the O
Arabidopsis O
mitochondrial O
genome O
. O

Role O
of O
the O
transcription O
start _RARE_
site O
core O
region O
and O
transcription I-GENE
factor I-GENE
YY1 I-GENE
in O
Rous _RARE_
sarcoma I-GENE
virus I-GENE
long I-GENE
terminal I-GENE
repeat I-GENE
promoter I-GENE
activity O
. O

Fowlpox _RARE_
virus O
encodes O
nonessential _RARE_
homologs O
of O
cellular I-GENE
alpha I-GENE
- I-GENE
SNAP _RARE_
, O
PC I-GENE
- I-GENE
1 I-GENE
, O
and O
an O
orphan O
human O
homolog O
of O
a O
secreted _RARE_
nematode O
protein O
. O

Addition O
of O
Rap _RARE_
or O
KN62 _RARE_
after O
exposure O
of O
cells O
to O
progesterone O
agonist O
Org _RARE_
2058 _RARE_
had O
no _RARE_
effect O
on O
induction O
of O
CAT I-GENE
activity O
. O

The O
Dax _RARE_
- I-GENE
1 I-GENE
gene I-GENE
encodes O
a O
protein O
that O
is O
structurally O
related O
to O
members O
of O
the O
orphan I-GENE
nuclear I-GENE
receptor I-GENE
superfamily I-GENE
. O

He O
was O
administered O
recombinant I-GENE
IFN I-GENE
alpha I-GENE
- I-GENE
2b _RARE_
under O
the O
diagnosis O
of O
chronic O
hepatitis O
C O
. O

Further O
, O
Ser _RARE_
/ O
Thr _RARE_
phosphorylation _RARE_
of O
downstream _RARE_
molecules O
Akt I-GENE
and O
p70 I-GENE
S6 I-GENE
kinase I-GENE
was O
inhibited O
. O

Quantitative O
evaluation O
of O
the O
steady O
state O
kinetics O
of O
MEK I-GENE
inhibition O
by O
these O
compounds O
reveals O
that O
U0126 _RARE_
has O
approximately _RARE_
100 _RARE_
- O
fold _RARE_
higher _RARE_
affinity O
for _RARE_
deltaN3 _RARE_
- I-GENE
S218E _RARE_
/ I-GENE
S222D _RARE_
MEK I-GENE
than O
does O
PD098059 _RARE_
. O

Regulation O
at _RARE_
37 O
degrees O
C O
, O
therefore O
, O
involves O
the O
action O
of O
three O
protein O
kinase O
cascades _RARE_
that O
repress O
HSF1 I-GENE
through O
phosphorylation _RARE_
of O
serine O
residues O
303 _RARE_
, O
307 _RARE_
, O
and O
363 _RARE_
and O
may O
promote O
growth O
by O
suppressing _RARE_
the O
heat O
shock O
response O
. O

Clinical O
implication _RARE_
of O
protein O
levels O
of O
IL _RARE_
- I-GENE
5 I-GENE
in O
induced _RARE_
sputum _RARE_
in O
asthmatic O
patients O
. O

In O
these O
cells O
, O
ras I-GENE
- O
induced _RARE_
transition O
is O
accompanied O
by O
a O
strong O
induction O
of O
AP I-GENE
- I-GENE
1 I-GENE
- O
binding O
activity O
along O
with O
increased O
expression _RARE_
of O
CD44 I-GENE
mRNA I-GENE
and O
protein O
. O

However O
, O
little O
is O
known O
regarding O
the O
genomic O
organization O
and O
developmental O
expression _RARE_
of O
the O
caveolin _RARE_
gene I-GENE
family I-GENE
. O

Tensile _RARE_
bond O
strengths O
between O
resin O
composite O
and O
bovine O
dentin O
using O
dentin O
adhesive O
systems _RARE_
( O
Clearfil _RARE_
Liner _RARE_
Bond _RARE_
II O
: O
LB _RARE_
II O
; O
Scotchbond _RARE_
Multi _RARE_
- O
Purpose _RARE_
: O
MP O
) O
bonding _RARE_
systems _RARE_
showed O
a O
large O
scatter _RARE_
among O
students O
and O
dentists _RARE_
. O

This O
distribution O
implies _RARE_
that O
the O
polycistronic _RARE_
precursor O
is O
imported _RARE_
into O
the O
nucleolus _RARE_
for _RARE_
processing _RARE_
to O
the O
mature _RARE_
snoRNAs _RARE_
, O
and O
that O
the O
import O
or O
processing _RARE_
pathway _RARE_
involves O
coiled _RARE_
bodies _RARE_
. O

Suppressive _RARE_
therapy O
for _RARE_
thyroid O
nodules O
. O

Fourteen _RARE_
healthy O
male O
volunteers O
completed O
the O
study O
. O

In O
the O
absence O
of O
Mg2 _RARE_
+, _RARE_
a O
hydrophobic O
exonuclease _RARE_
site O
dominates _RARE_
over O
the O
polymerase O
site O
for _RARE_
possession _RARE_
of O
the O
primer O
terminus O
. O

As O
the O
high O
- O
affinity O
Mg2 _RARE_
+ O
binding O
sites O
are O
filled O
, O
the O
primer O
terminus O
migrates _RARE_
from O
the O
exonuclease _RARE_
site O
to O
a O
highly O
based O
stacked _RARE_
polymerase O
active _RARE_
site O
. O

One O
missense O
allele O
( O
P236S _RARE_
) O
with O
complete _RARE_
loss _RARE_
of O
function O
at _RARE_
30 _RARE_
degreesC _RARE_
and O
four O
missense O
alleles O
( O
L173F _RARE_
, O
E225K _RARE_
, O
S269L _RARE_
and O
E274K _RARE_
) O
that O
conferred O
a O
temperature _RARE_
sensitive _RARE_
phenotype _RARE_
were O
identified O
. O

Structural O
analysis O
of O
the O
5 O
'- O
regulatory O
region O
reveals O
that O
the O
c I-GENE
- I-GENE
met I-GENE
promoter I-GENE
lacks O
TATA O
or O
CAAT O
elements O
but O
has O
an O
extremely O
high O
G O
- O
C O
content O
and O
multiple O
Sp1 _RARE_
binding I-GENE
sites I-GENE
. O

The O
report O
highlights _RARE_
the O
possible O
contribution O
of O
stress O
factors O
in O
the O
context O
of O
therapy O
resistant O
periodontal O
disease _RARE_
, O
and O
the O
results O
seem O
to O
be O
understandable _RARE_
within O
the O
context O
of O
a O
stress O
system _RARE_
disorder O
perspective _RARE_
. O

Acute O
pancreatitis O
is O
a O
rather O
common O
abdominal O
disorder O
. O

To O
better O
understand O
the O
role O
of O
Ets I-GENE
proteins I-GENE
in O
Ras I-GENE
transformation O
, O
we O
have O
now O
analyzed O
the O
effects O
of O
stably O
expressing O
a O
variety O
of O
Ets2 _RARE_
constructs I-GENE
in O
Ras I-GENE
- O
transformed O
NIH3T3 O
( O
DT _RARE_
) O
cells O
. O

Each O
binding O
site O
, O
however O
, O
was O
different O
in O
its O
preference O
for _RARE_
binding O
partners O
. O

We O
isolated O
the O
human I-GENE
FGF I-GENE
- I-GENE
BP _RARE_
promoter I-GENE
and O
determined O
by O
deletion O
analysis O
that O
TPA _RARE_
regulatory O
elements O
were O
all O
contained O
in O
the O
first _RARE_
118 O
base _RARE_
pairs _RARE_
upstream O
of O
the O
transcription O
start _RARE_
site O
. O

Manipulation _RARE_
of O
the O
checkpoint _RARE_
regulators _RARE_
involved O
in O
cell O
cycle _RARE_
arrest O
and O
apoptosis O
may O
thus O
provide O
a O
novel O
strategy O
to O
cancer _RARE_
therapy O
. O

Electrophoretic O
mobility O
shift O
assays O
demonstrated O
specific O
nuclear O
protein O
binding O
to O
- O
85 _RARE_
/- O
64 _RARE_
, O
and O
single O
point O
mutations O
suggested O
important O
binding O
nucleotides O
between O
- O
79 _RARE_
/- O
68 _RARE_
with O
five O
critical O
bases O
between O
- O
74 _RARE_
/- O
70 O
( O
5 O
'- O
CTCCT _RARE_
- O
3 O
'). _RARE_

The O
diagnostic O
accuracy O
of O
serum O
PE _RARE_
- I-GENE
1 I-GENE
was O
0 _RARE_
. O
80 _RARE_
, O
and O
that O
of O
amylase I-GENE
0 _RARE_
. O
97 O
. O

We O
demonstrate O
that O
Ddc1p _RARE_
interacts O
physically O
in O
vivo O
with O
Mec3p _RARE_
, O
and O
this O
interaction O
requires O
Rad17p _RARE_
. O

" O
Complex _RARE_
partial O
" O
seizures O
. O

B I-GENE
cell I-GENE
antigen I-GENE
receptor I-GENE
( O
BCR _RARE_
)- O
mediated _RARE_
formation O
of O
a O
SHP I-GENE
- I-GENE
2 I-GENE
- O
pp120 _RARE_
complex O
and O
its O
inhibition O
by O
Fc I-GENE
gamma I-GENE
RIIB1 _RARE_
- O
BCR _RARE_
coligation _RARE_
. O

Chem O
., O
270 O
: O
7117 _RARE_
- O
7124 _RARE_
, O
1995 O
; O
and O
MT _RARE_
Hartsough _RARE_
et O
al O
., O
J _RARE_
. O

Deleting _RARE_
SNF1 _RARE_
repressed O
meiosis O
at _RARE_
the O
same O
three O
steps O
that O
were O
inhibited O
by O
glucose O
, O
suggesting O
that O
glucose O
blocks O
meiosis O
by O
inhibiting O
Snf1 _RARE_
. O

Here O
we O
investigate O
the O
role O
of O
c I-GENE
- I-GENE
Cbl I-GENE
in O
development O
and O
homeostasis _RARE_
in O
mice O
by O
targeted O
disruption O
of O
the O
c I-GENE
- I-GENE
Cbl I-GENE
locus I-GENE
. O
c I-GENE
- I-GENE
Cbl I-GENE
- O
deficient _RARE_
mice O
were O
viable O
, O
fertile _RARE_
, O
and O
outwardly _RARE_
normal O
in O
appearance O
. O

One O
is O
to O
act O
within O
the O
visceral O
endoderm O
to O
promote O
proper O
streak _RARE_
morphogenesis _RARE_
. O

We O
propose O
that O
noi _RARE_
/ O
pax2 _RARE_
. I-GENE
1 I-GENE
participates O
in O
sequential O
signaling _RARE_
processes O
as _RARE_
a O
key O
integrator _RARE_
of O
midbrain _RARE_
- O
hindbrain _RARE_
boundary O
development O
. O

Ligand _RARE_
- O
independent O
activation O
of O
platelet I-GENE
- I-GENE
derived I-GENE
growth I-GENE
factor I-GENE
receptor I-GENE
is O
a O
necessary O
intermediate _RARE_
in O
lysophosphatidic _RARE_
, O
acid O
- O
stimulated _RARE_
mitogenic O
activity O
in O
L O
cells O
. O

METHODS O
: O
Fibrotic _RARE_
changes O
involving O
bone O
marrow O
were O
evaluated O
histologically O
semiquantitatively _RARE_
using O
reticulin _RARE_
fiber O
impregnation _RARE_
( O
method O
of O
Gomori _RARE_
). O

In O
canrenoate _RARE_
- O
treated O
rats O
, O
ANP I-GENE
infusion O
caused O
greater O
increases O
in O
sodium _RARE_
excretion O
( O
FENA _RARE_
from O
3 O
. O
05 O
+/- O
0 _RARE_
. O
71 _RARE_
to O
7 O
. O
21 O
+/- O
0 _RARE_
. O
45 _RARE_
%; O
P O
< O
0 _RARE_
. O
05 O
; O
n _RARE_
= O
8 O
) O
than O
saline O
infusion O
( O
FENA _RARE_
from O
4 O
. O
16 O
+/- O
1 O
. O
11 O
to O
5 O
. O
47 _RARE_
+/- O
0 _RARE_
. O
66 _RARE_
%; O
n _RARE_
= O
6 O
), _RARE_
despite O
the O
hypocapnia _RARE_
. O

We O
then O
studied O
four O
unrelated O
Japanese O
families _RARE_
with O
GSD _RARE_
- O
Ib _RARE_
, O
and O
found O
three O
novel O
mutations O
: O
a O
four O
- O
base _RARE_
deletion O
/ O
two O
- O
base _RARE_
insertion _RARE_
, O
a O
point O
mutation O
within O
a O
consensus O
splicing _RARE_
donor O
site O
, O
and O
a O
missense O
mutation O
( O
W118R _RARE_
). O

Removal O
of O
the O
carboxyl _RARE_
region O
severely O
reduced _RARE_
transcriptional O
activation O
. O

A O
" O
Level _RARE_
A O
" O
in O
vitro O
/ O
in O
vivo O
correlation O
was O
established O
for _RARE_
a O
sustained O
release O
theophylline O
( O
CAS _RARE_
58 O
- O
55 _RARE_
- O
9 O
) O
preparation O
( O
Bronchoretard _RARE_
) O
under O
investigation O
. O

METHOD _RARE_
: O
50 O
consecutive O
children O
aged O
from O
6 O
months O
to O
17 _RARE_
years O
were O
included O
into O
the O
study O
which O
comprised O
questionnaires _RARE_
of O
patient O
and O
family O
histories _RARE_
, O
serological O
screening O
tests O
for _RARE_
common O
inhalational _RARE_
allergens O
( O
CAP _RARE_
SX1 _RARE_
), _RARE_
and O
determination O
of O
total _RARE_
serum I-GENE
immunoglobulin I-GENE
E I-GENE
( O
IgE I-GENE
) O
and O
of O
latex O
- O
specific O
serum I-GENE
IgE I-GENE
by O
solid O
- O
phase _RARE_
immunoassays _RARE_
. O

The O
PDE4A _RARE_
- I-GENE
subfamily I-GENE
- I-GENE
specific I-GENE
linker _RARE_
region I-GENE
LR1 _RARE_
, O
which O
joins O
UCR1 _RARE_
and O
UCR2 _RARE_
, O
is O
encoded O
by O
two O
exons O
, O
whereas O
LR2 _RARE_
, O
which O
joins O
UCR2 _RARE_
to O
the O
catalytic O
unit O
, O
is O
encoded O
by O
a O
single O
exon _RARE_
. O

Pol32Delta _RARE_
strains O
are O
weak O
antimutators _RARE_
and O
are O
defective _RARE_
for _RARE_
damage O
- O
induced _RARE_
mutagenesis O
. O

At O
the O
same O
time O
, O
the O
results O
indicate O
that O
p53 I-GENE
plays O
a O
defensive _RARE_
role O
against O
HBV _RARE_
by O
transcriptionally O
repressing O
the O
HBV _RARE_
core I-GENE
promoter I-GENE
through O
liver I-GENE
- I-GENE
specific I-GENE
enhancer I-GENE
II I-GENE
and O
HBx _RARE_
is O
required O
to O
counteract _RARE_
this O
inhibitory _RARE_
function O
of O
p53 I-GENE
. O

To O
gain O
insight O
into O
the O
expression _RARE_
of O
the O
AtCP1 _RARE_
gene I-GENE
, O
northern O
blot O
analysis O
was O
carried O
out O
. O

The O
aim O
of O
the O
study O
was O
to O
correlate O
the O
responsiveness O
to O
bronchoprovocation _RARE_
with O
methacholine _RARE_
in O
subjects O
a O
with O
allergic O
rhinitis _RARE_
during _RARE_
and O
out O
of O
the O
pollen O
season O
with O
total _RARE_
serum O
IgE I-GENE
and O
blood _RARE_
eosinophils O
. O

These O
results O
provide O
the O
first _RARE_
demonstration _RARE_
that O
an O
SR I-GENE
protein I-GENE
can O
influence O
splicing _RARE_
of O
specific O
pre O
- O
mRNAs O
in O
vivo O
. O

In O
particular O
, O
the O
potential _RARE_
for _RARE_
prostate _RARE_
cancer _RARE_
chemoprevention _RARE_
using O
nonsteroidal _RARE_
anti O
- O
inflammatory O
drugs O
( O
cyclo _RARE_
- I-GENE
oxygenase I-GENE
inhibitors _RARE_
; O
NSAIDs _RARE_
) O
has O
received O
little O
attention O
. O

This O
study O
reports O
the O
isolation O
of O
a O
P O
. O
hybrida _RARE_
gene O
, O
jaf13 _RARE_
, O
encoding O
a O
basic I-GENE
helix I-GENE
- I-GENE
loop I-GENE
- I-GENE
helix I-GENE
protein I-GENE
that O
, O
on O
the O
basis O
of O
sequence O
homology O
and O
intron O
/ O
exon _RARE_
structure _RARE_
, O
represents O
the O
P O
. O
hybrida _RARE_
orthologue _RARE_
of O
the O
Z I-GENE
. I-GENE
mays _RARE_
r _RARE_
genes I-GENE
. O

Identical _RARE_
c I-GENE
- I-GENE
erbB3 _RARE_
transcripts I-GENE
are O
expressed _RARE_
in O
normal O
human O
placental _RARE_
tissues O
. O

During O
the O
past O
4 O
years O
, O
a O
purposeful _RARE_
search O
was O
made O
for _RARE_
electrocardiograms _RARE_
with O
documented _RARE_
reversible O
QRS O
changes O
associated O
with O
all O
acute O
injury O
pattern O
. O

Mutating _RARE_
a O
potential _RARE_
cleavage _RARE_
site O
located _RARE_
N O
- O
terminal O
to O
the O
protease O
domain O
, O
Gln2526 _RARE_
- O
Asp2527 _RARE_
, O
diminished O
processing _RARE_
. O

METHODS O
: O
Millipore _RARE_
ultrafiltration _RARE_
membranes O
of O
three O
different O
pore _RARE_
sizes O
were O
used O
as _RARE_
model O
lenticule _RARE_
materials O
. O
The O
nominal _RARE_
membrane O
pore _RARE_
sizes O
were O
0 _RARE_
. O
1 O
microm O
, O
0 _RARE_
. O
45 _RARE_
microm O
, O
and O
3 O
microm O
; O
the O
surface O
roughness _RARE_
increased O
in O
the O
same O
order O
The O
membranes O
were O
coated _RARE_
with O
a O
thin O
layer O
of O
collagen _RARE_
I I-GENE
and O
implanted O
in O
a O
circular O
pocket O
of O
the O
anterior O
cornea _RARE_
of O
adult O
cats O
, O
and O
were O
clinically O
evaluated O
for _RARE_
the O
extent O
of O
epithelialization _RARE_
and O
the O
persistence _RARE_
of O
epithelial _RARE_
attachment _RARE_
. O

The O
role O
of O
calcitonin I-GENE
, O
and O
other O
agonists O
which O
activate O
the O
cAMP O
pathway _RARE_
, O
in O
regulating _RARE_
transcription O
of O
the O
human I-GENE
parathyroid _RARE_
hormone I-GENE
- I-GENE
related I-GENE
protein I-GENE
( O
PTHrP _RARE_
) O
gene O
was O
investigated O
in O
a O
human O
lung _RARE_
cancer _RARE_
cell O
line O
( O
BEN _RARE_
). O

The O
combination O
of O
Pitx2 _RARE_
and O
another O
homeodomain _RARE_
protein I-GENE
, O
Pit I-GENE
- I-GENE
1 I-GENE
, O
yielded O
a O
synergistic O
55 _RARE_
- O
fold _RARE_
activation O
of O
the O
prolactin I-GENE
promoter I-GENE
in O
transfection O
assays O
. O

The O
biochemical O
and O
molecular _RARE_
spectrum O
of O
ornithine _RARE_
transcarbamylase _RARE_
deficiency O
. O

To O
further O
understand O
the O
role O
of O
cis O
- O
acting O
elements O
in O
these O
regulatory O
mechanisms O
, O
we O
have O
characterized O
a O
transcriptional O
promoter O
that O
drives _RARE_
germline _RARE_
expression _RARE_
of O
TCR I-GENE
beta I-GENE
gene I-GENE
segments _RARE_
in O
vivo O
. O

Our O
results O
suggest O
that O
the O
crucial O
role O
of O
the O
mutations O
activating O
v I-GENE
- I-GENE
erbA I-GENE
as _RARE_
an O
oncogene O
is O
to O
' O
freeze _RARE_
' O
c I-GENE
- I-GENE
ErbA _RARE_
/ O
TRalpha _RARE_
in O
its O
non O
- O
liganded _RARE_
, O
repressive O
conformation O
and O
to O
facilitate O
its O
overexpression O
. O

Downregulation _RARE_
of O
FUS _RARE_
expression _RARE_
in O
BCR _RARE_
/ O
ABL I-GENE
- O
expressing O
32Dcl3 _RARE_
cells O
was O
associated O
with O
suppression O
of O
growth O
factor O
- O
independent O
colony O
formation O
, O
restoration _RARE_
of O
G I-GENE
- I-GENE
CSF I-GENE
- O
induced _RARE_
granulocytic _RARE_
differentiation O
and O
reduced _RARE_
tumorigenic O
potential _RARE_
in O
vivo O
. O

In O
this O
study O
, O
we O
describe O
a O
mammalian O
cell O
- O
free O
transcription O
system _RARE_
reconstituted O
with O
only O
recombinant O
proteins O
and O
epitope _RARE_
- O
tagged _RARE_
multiprotein _RARE_
complexes O
. O

This O
repressor O
is O
however O
unlikely O
to O
mediate O
spi _RARE_
2 I-GENE
. I-GENE
3 I-GENE
3 I-GENE
' I-GENE
UTR I-GENE
silencer _RARE_
action O
since O
it O
was O
not O
detected O
in O
rat O
hepatocytes O
. O

A O
prerequisite O
for _RARE_
the O
synthesis _RARE_
of O
sialylated _RARE_
glycoconjugates _RARE_
is O
the O
activated O
sugar _RARE_
- O
nucleotide O
cytidine _RARE_
5 O
'- O
monophosphate O
N O
- O
acetylneuraminic _RARE_
acid O
( O
CMP _RARE_
- O
Neu5Ac _RARE_
), _RARE_
which O
provides O
a O
substrate O
for _RARE_
Golgi _RARE_
sialyltransferases _RARE_
. O

Thus O
, O
the O
bovine I-GENE
PEDF _RARE_
cDNA I-GENE
isolated O
here O
codes O
for _RARE_
a O
functional _RARE_
soluble _RARE_
secreted _RARE_
PEDF _RARE_
glycoprotein I-GENE
. O

We O
propose O
a O
model O
in O
which O
Sro7 _RARE_
function O
is O
involved O
in O
the O
targeting O
of O
the O
myosin I-GENE
proteins I-GENE
to O
their O
intrinsic _RARE_
pathways O
. O

We O
found O
sequences O
related O
to O
this O
insertion _RARE_
in O
wild O
- O
type O
strains O
of O
N O
. O
crassa O
and O
other O
Neurospora O
species O
. O

When O
cysteine O
is O
scanned _RARE_
through O
the O
helices O
, O
characteristic O
repeating O
patterns O
of O
solvent O
exposure O
and O
burial _RARE_
are O
observed O
. O

Human I-GENE
ULK1 _RARE_
, O
a O
novel O
serine I-GENE
/ I-GENE
threonine I-GENE
kinase I-GENE
related O
to O
UNC I-GENE
- I-GENE
51 _RARE_
kinase I-GENE
of O
Caenorhabditis O
elegans O
: O
cDNA O
cloning O
, O
expression _RARE_
, O
and O
chromosomal O
assignment O
. O

Specifically O
, O
I O
use O
molecular _RARE_
markers O
that O
identify O
particular O
neuroectodermal _RARE_
domains O
, O
all O
neuroblasts O
or O
individual O
neuroblasts O
, O
to O
show O
that O
in O
DER I-GENE
mutant I-GENE
embryos _RARE_
( O
1 O
) O
intermediate _RARE_
column O
neuroblasts O
do O
not O
form O
, O
( O
2 O
) O
medial O
column O
neuroblasts O
often O
acquire _RARE_
identities O
inappropriate _RARE_
for _RARE_
their O
position O
, O
while O
( O
3 O
) O
lateral O
neuroblasts O
develop O
normally O
. O

Cochlear _RARE_
microphonic _RARE_
potentials O
in O
patients O
with O
vestibular O
schwannomas _RARE_
. O

These O
results O
with O
clozapine _RARE_
illustrate _RARE_
that O
LI _RARE_
is O
sensitive _RARE_
to O
antipsychotics _RARE_
which O
differ O
in O
their O
mode O
of O
action O
and O
furthermore _RARE_
emphasize _RARE_
the O
value O
of O
LI _RARE_
as _RARE_
a O
test O
model O
for _RARE_
detecting O
the O
antipsychotic _RARE_
potential _RARE_
of O
novel O
drugs O
. O

The O
complement I-GENE
C3a _RARE_
anaphylatoxin _RARE_
receptor I-GENE
( O
C3aR _RARE_
) O
is O
a O
seven _RARE_
- I-GENE
transmembrane I-GENE
G I-GENE
- I-GENE
protein I-GENE
coupled I-GENE
chemoattractant _RARE_
receptor I-GENE
that O
on O
binding O
the O
C3a _RARE_
peptide I-GENE
ligand _RARE_
mediates O
numerous O
cellular O
responses O
, O
including O
histamine _RARE_
release O
from O
mast _RARE_
cells O
. O
smooth _RARE_
muscle O
contraction O
, O
and O
the O
directed O
migration O
of O
eosinophils O
. O

CONCLUSIONS O
: O
Significant O
elevations O
of O
IL _RARE_
- I-GENE
1alpha I-GENE
and O
IL _RARE_
- I-GENE
1beta I-GENE
occur O
in O
patients O
with O
bacterial O
cystitis _RARE_
and O
microscopic O
hematuria _RARE_
. O

Band _RARE_
- O
shift O
assays O
were O
performed O
using O
the O
LPS _RARE_
- I-GENE
and I-GENE
IL _RARE_
- I-GENE
1 I-GENE
- I-GENE
responsive I-GENE
element I-GENE
( O
LILRE _RARE_
) O
oligonucleotide _RARE_
, O
a O
gamma I-GENE
interferon _RARE_
activation I-GENE
site I-GENE
- I-GENE
like I-GENE
site I-GENE
that O
is O
present O
in O
the O
human I-GENE
IL _RARE_
- I-GENE
1beta I-GENE
promoter I-GENE
. O

The O
C O
- O
terminal O
region O
contains O
the O
PTP I-GENE
- I-GENE
like I-GENE
domain I-GENE
, O
whereas O
the O
N O
- O
terminal O
region O
shows O
no _RARE_
homology O
to O
any O
known O
mammalian O
protein O
. O

In O
addition O
, O
and O
in O
support O
of O
a O
mediating O
role O
of O
STATs _RARE_
in O
the O
activation O
of O
the O
p21 I-GENE
promoter I-GENE
, O
overexpression O
of O
Stat3 I-GENE
potentiated _RARE_
the O
cytokine _RARE_
effect O
on O
the O
p21 I-GENE
promoter I-GENE
; O
whereas O
a O
dominant I-GENE
negative I-GENE
Stat3 I-GENE
, O
or O
a O
mutation O
of O
the O
STAT I-GENE
response I-GENE
element I-GENE
on O
the O
promoter O
, O
significantly O
reduced _RARE_
the O
cytokine _RARE_
effect O
. O

The O
heterogeneous _RARE_
nuclear I-GENE
ribonucleoprotein I-GENE
C I-GENE
protein I-GENE
tetramer _RARE_
binds O
U1 _RARE_
, O
U2 _RARE_
, O
and O
U6 I-GENE
snRNAs _RARE_
through O
its O
high O
affinity O
RNA O
binding O
domain O
( O
the O
bZIP _RARE_
- O
like O
motif O
). O

On O
the O
comparison O
of O
correlated O
proportions _RARE_
for _RARE_
clustered O
data O
. O

A O
safe O
and O
simple O
system _RARE_
for _RARE_
the O
detection O
of O
sudden _RARE_
infant O
death _RARE_
syndrome _RARE_
( O
SIDS _RARE_
) O
is O
proposed O
. O

The O
resulting O
mutants O
were O
coexpressed O
with O
gE _RARE_
in O
the O
vaccinia _RARE_
virus O
- O
based O
vTF7 _RARE_
- O
3 O
system _RARE_
, O
and O
the O
formation O
and O
endoplasmic O
reticulum O
( O
ER O
)- O
to O
- O
Golgi _RARE_
transport _RARE_
of O
the O
hetero _RARE_
- O
oligomeric _RARE_
complex O
were O
monitored O
. O

Homozygous O
mutant O
mice O
, O
designated O
Cux _RARE_
/ O
CDPDeltaCR1 _RARE_
, O
display O
a O
phenotype _RARE_
characterized O
by O
curly _RARE_
vibrissae _RARE_
and O
wavy _RARE_
hair _RARE_
. O

The O
mutant O
protein O
is O
present O
at _RARE_
levels O
slightly O
greater O
than O
wild O
- O
type O
, O
but O
exhibits O
the O
same O
tissue O
distribution O
as _RARE_
wild O
- O
type O
protein O
, O
and O
has O
approximately _RARE_
normal O
affinity O
for _RARE_
known O
target O
sequences O
( O
though O
no _RARE_
DNA O
targets _RARE_
identified O
to O
date O
require O
the O
first _RARE_
cut O
repeat O
for _RARE_
binding O
). O

METHODS O
: O
We O
retrospectively _RARE_
reviewed O
242 _RARE_
adult O
cadaveric _RARE_
renal _RARE_
transplant O
recipients O
treated O
between O
11 O
/ O
91 O
and O
5 O
/ O
97 O
. O

The O
spectrum O
of O
age O
- O
associated O
brain O
abnormalities O
: O
their O
measurement O
and O
histopathological O
correlates O
. O

Our O
laboratory O
has O
recently O
identified O
two O
phosducin _RARE_
- I-GENE
like I-GENE
orphan I-GENE
proteins I-GENE
( O
PhLOP1 _RARE_
and O
PhLOP2 _RARE_
) O
that O
lack O
the O
ability O
to O
interact O
with O
Gbetagamma I-GENE
. O

Reverse _RARE_
transcriptase I-GENE
- O
polymerase O
chain O
reaction O
( O
RT I-GENE
- O
PCR O
) O
was O
performed O
using O
eyestalk _RARE_
complementary _RARE_
DNA O
of O
the O
sand _RARE_
shrimp _RARE_
Metapenaeus _RARE_
ensis _RARE_
. O

In O
contrast O
, O
transcription O
initiating O
from O
opuE _RARE_
P I-GENE
- I-GENE
1 I-GENE
( O
sigma _RARE_
A I-GENE
) O
rose O
in O
proportion O
to O
the O
external O
osmolarity _RARE_
and O
was O
maintained O
at _RARE_
high O
levels O
. O

Randomly _RARE_
selected _RARE_
300 _RARE_
children O
aged O
3 O
months O
- O
3 O
yr O
were O
analysed O
over O
a O
period O
of O
one O
year O
for _RARE_
estimating O
prevalence O
of O
nutritional O
anaemia _RARE_
. O

In O
insects _RARE_
, O
arylalkylamine _RARE_
N I-GENE
- I-GENE
acetyltransferases _RARE_
( O
AANATs _RARE_
) O
have O
been O
implicated O
in O
several O
physiological O
processes O
, O
including O
sclerotization _RARE_
, O
inactivation O
of O
certain O
neurotransmitters _RARE_
, O
and O
, O
similar O
to O
the O
function O
in O
vertebrates _RARE_
, O
catalysis _RARE_
of O
the O
rate O
- O
limiting O
step O
in O
melatonin O
biosynthesis O
. O

In O
experiments O
with O
the O
D1 _RARE_
antagonist O
SCH _RARE_
23390 _RARE_
, O
buprenorphine _RARE_
- O
induced _RARE_
depression O
was O
consistently O
blocked O
, O
but O
facilitation _RARE_
was O
unaffected O
. O

These O
results O
establish O
that O
hydroquinones _RARE_
lead O
to O
mutagenicity _RARE_
and O
carcinogenicity _RARE_
. O

IA O
- O
CT _RARE_
with O
cisplatin O
50 O
mg O
and O
doxorubicin _RARE_
30 _RARE_
mg O
was O
administered O
by O
one O
shot _RARE_
method O
in O
bilateral O
internal O
iliac O
arteries O
. O

Arnt3 _RARE_
mRNA I-GENE
was O
expressed _RARE_
in O
brain O
, O
skeletal O
muscle O
, O
13 _RARE_
. O
5 O
- O
day O
embryos _RARE_
, O
and O
P19 O
cells O
treated O
with O
retinoic O
acid O
. O

Acute O
idiopathic O
thrombocytopenic _RARE_
purpura O
presenting _RARE_
a O
high O
serum O
level O
of O
immunoglobulin I-GENE
E I-GENE
and O
eosinophilia _RARE_
in O
an O
elderly O
patient O
. O

The O
genomic O
structure _RARE_
and O
chromosomal O
location O
of O
the O
human I-GENE
TR2 _RARE_
orphan I-GENE
receptor I-GENE
, O
a O
member _RARE_
of O
the O
steroid I-GENE
receptor I-GENE
superfamily I-GENE
. O

Correlation _RARE_
of O
skin _RARE_
disorders O
with O
CD4 _RARE_
lymphocyte O
counts O
in O
patients O
with O
HIV O
/ O
AIDS O
. O

E2F I-GENE
- I-GENE
6 I-GENE
shares O
significant O
homology O
with O
E2Fs _RARE_
1 I-GENE
- I-GENE
5 I-GENE
, O
especially O
within O
the O
DNA O
binding O
, O
heterodimerization O
and O
marked O
box O
domains O
. O

The O
IE13 _RARE_
. O
1 O
cell O
line O
was O
able O
to O
complement O
a O
recombinant O
virus O
in O
which O
both O
copies O
of O
the O
IE I-GENE
gene I-GENE
were O
replaced O
by O
insertion _RARE_
of O
the O
Escherichia I-GENE
coli I-GENE
lacZ I-GENE
gene I-GENE
. O

DNase I-GENE
I I-GENE
footprinting O
and O
electrophoretic O
mobility O
shift O
analyses O
revealed O
two O
hepatocyte _RARE_
nuclear I-GENE
factor I-GENE
- I-GENE
1 I-GENE
( O
HNF1 _RARE_
), _RARE_
three O
CCAAT I-GENE
/ I-GENE
enhancer I-GENE
- I-GENE
binding I-GENE
protein I-GENE
( O
C I-GENE
/ I-GENE
EBP I-GENE
), _RARE_
and O
one O
consensus O
palindromic O
thyroid O
hormone O
response O
elements O
within O
the O
first _RARE_
215 O
base _RARE_
pairs _RARE_
( O
bp O
) O
of O
the O
promoter O
sequence O
of O
rat I-GENE
Std _RARE_
. O

Thus O
, O
these O
studies O
on O
rat I-GENE
Std _RARE_
promoter I-GENE
function O
indicate O
that O
( O
i O
) O
HNF1 _RARE_
and O
C I-GENE
/ I-GENE
EBP I-GENE
are O
responsible O
for _RARE_
liver O
specificity _RARE_
of O
the O
rat I-GENE
Std _RARE_
gene I-GENE
; O
( O
ii O
) O
androgenic _RARE_
repression O
of O
the O
gene O
requires O
the O
presence O
of O
all O
of O
the O
OCT _RARE_
- I-GENE
1 I-GENE
and O
C I-GENE
/ I-GENE
EBP I-GENE
elements I-GENE
between O
positions O
- O
231 O
and O
- O
292 _RARE_
; O
and O
( O
iii O
) O
AR _RARE_
may O
exert O
its O
negative O
regulatory O
effect O
indirectly O
through O
transcriptional O
interference O
of O
OCT _RARE_
- I-GENE
1 I-GENE
and O
C I-GENE
/ I-GENE
EBP I-GENE
rather O
than O
through O
a O
direct O
DNA I-GENE
- I-GENE
AR _RARE_
interaction O
. O

Purified _RARE_
Hsk1 _RARE_
phosphorylates O
the O
Cdc19 _RARE_
( O
Mcm2 _RARE_
) O
subunit O
of O
the O
six _RARE_
- I-GENE
member _RARE_
minichromosome _RARE_
maintenance _RARE_
protein I-GENE
complex I-GENE
purified _RARE_
from O
fission _RARE_
yeast O
. O

The O
yeast I-GENE
MMS2 _RARE_
gene I-GENE
was O
cloned _RARE_
by O
its O
ability O
to O
complement O
the O
methyl _RARE_
methanesulfonate _RARE_
sensitivity O
of O
the O
mms2 _RARE_
- I-GENE
1 I-GENE
mutant I-GENE
and O
was O
later O
shown O
to O
be O
involved O
in O
DNA O
post O
- O
replication O
repair O
. O

Expression O
of O
the O
human I-GENE
papillomavirus _RARE_
type I-GENE
11 I-GENE
E5A _RARE_
protein I-GENE
from O
the O
E1E4 _RARE_
, I-GENE
E5 _RARE_
transcript I-GENE
. O

Anesthesia _RARE_
with O
M O
/ O
K O
was O
reversed O
after O
41 _RARE_
. O
6 O
min O
of O
immobilization _RARE_
with O
atipamezole _RARE_
. O

There O
was O
no _RARE_
evident O
inciting _RARE_
agent O
of O
the O
disease _RARE_
. O

MK O
- O
801 O
administration O
resulted O
in O
a O
biphasic O
response O
in O
seizure O
latency _RARE_
. O

In O
contrast O
, O
the O
distribution O
of O
endocytic O
markers O
is O
not O
affected O
. O

Toxicity _RARE_
during _RARE_
the O
therapeutic O
period O
was O
not O
significant O
in O
the O
study O
group O
compared O
with O
the O
historical _RARE_
control O
, O
treated O
with O
the O
same O
regimen O
without O
G I-GENE
- I-GENE
CSF I-GENE
. O

The O
purpose O
of O
this O
article O
is O
to O
discuss O
the O
factors O
involved O
in O
the O
selection O
of O
antibodies O
, O
radionuclides _RARE_
and O
labeling O
methods O
in O
the O
development O
of O
radioimmunotherapy _RARE_
( O
RIT _RARE_
) O
for _RARE_
non O
- O
Hodgkin O
' O
s O
lymphoma O
( O
NHL _RARE_
) O
from O
a O
single O
clinical O
study O
site O
through O
multicenter _RARE_
trials O
and O
commercialization _RARE_
. O

Both O
methods O
were O
employed O
for _RARE_
various O
focal _RARE_
- O
film _RARE_
distances O
, O
image O
intensifier _RARE_
tube O
modes O
and O
laser O
printer _RARE_
formats _RARE_
. O

The O
effect O
of O
Rho I-GENE
on O
AP I-GENE
- I-GENE
1 I-GENE
is O
independent O
of O
the O
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
pathway _RARE_
, O
as _RARE_
a O
dominant I-GENE
- I-GENE
negative I-GENE
MEK I-GENE
and O
a O
MEK I-GENE
inhibitor O
( O
PD98059 O
) O
did O
not O
affect O
Rho I-GENE
- O
induced _RARE_
AP I-GENE
- I-GENE
1 I-GENE
activity O
. O

Site _RARE_
- O
directed O
mutagenesis O
of O
residues O
in O
this O
domain O
( O
R82A _RARE_
, O
K85A _RARE_
, O
K88A _RARE_
, O
and O
V89A _RARE_
) O
resulted O
in O
proteins O
which O
failed O
to O
transactivate O
from O
the O
HTLV _RARE_
- I-GENE
1 I-GENE
LTR I-GENE
in O
vivo O
. O

Mutations O
within O
the O
C O
terminus O
of O
c I-GENE
- I-GENE
fos I-GENE
at _RARE_
serine O
residues O
that O
are O
phosphorylation _RARE_
targets _RARE_
for _RARE_
growth O
factors O
and O
MAP I-GENE
kinase I-GENE
completely O
abrogate O
transactivation _RARE_
and O
block _RARE_
potentiation O
by O
MAP I-GENE
kinase I-GENE
. O

In O
the O
former O
cells O
, O
ets I-GENE
- I-GENE
2 I-GENE
was O
a O
CSF I-GENE
- I-GENE
1 I-GENE
immediate O
- O
early O
response O
gene O
, O
and O
phosphorylated _RARE_
ets I-GENE
- I-GENE
2 I-GENE
was O
detected O
after O
2 O
to O
4 O
h O
, O
coincident _RARE_
with O
expression _RARE_
of O
ets I-GENE
- I-GENE
2 I-GENE
protein I-GENE
. O

Persistent _RARE_
activation O
of O
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinases I-GENE
p42 _RARE_
and O
p44 I-GENE
and O
ets I-GENE
- I-GENE
2 I-GENE
phosphorylation _RARE_
in O
response O
to O
colony I-GENE
- I-GENE
stimulating I-GENE
factor I-GENE
1 I-GENE
/ O
c I-GENE
- I-GENE
fms I-GENE
signaling _RARE_
. O

Identification O
of O
a O
proline O
- O
rich O
sequence O
in O
the O
CD2 _RARE_
cytoplasmic I-GENE
domain I-GENE
critical O
for _RARE_
regulation _RARE_
of O
integrin I-GENE
- O
mediated _RARE_
adhesion O
and O
activation O
of O
phosphoinositide _RARE_
3 I-GENE
- I-GENE
kinase I-GENE
. O

Vam7p _RARE_
, O
a O
SNAP _RARE_
- I-GENE
25 _RARE_
- I-GENE
like I-GENE
molecule I-GENE
, O
and O
Vam3p _RARE_
, O
a O
syntaxin _RARE_
homolog I-GENE
, O
function O
together O
in O
yeast O
vacuolar O
protein O
trafficking O
. O

We O
have O
tested O
this O
possibility O
by O
constructing _RARE_
a O
consecutive O
series O
of O
cysteine O
substitutions O
in O
the O
Neu _RARE_
juxtamembrane _RARE_
domain I-GENE
in O
order O
to O
force O
dimerization _RARE_
along O
a O
series O
of O
interreceptor _RARE_
faces _RARE_
. O

It O
has O
been O
demonstrated O
previously O
that O
Pax I-GENE
- I-GENE
6 I-GENE
, O
a O
paired I-GENE
domain I-GENE
( O
PD _RARE_
)/ _RARE_
homeodomain _RARE_
( O
HD I-GENE
) O
transcription O
factor O
critical O
for _RARE_
eye O
development O
, O
contributes O
to O
the O
activation O
of O
the O
alphaB _RARE_
-, _RARE_
alphaA _RARE_
-, _RARE_
delta1 _RARE_
-, _RARE_
and I-GENE
zeta _RARE_
- I-GENE
crystallin _RARE_
genes O
in O
the O
lens O
. O

Tctex _RARE_
- I-GENE
1 I-GENE
binding O
required O
the O
first _RARE_
19 O
amino O
acids _RARE_
of O
Fyn I-GENE
and O
integrity O
of O
two O
lysine _RARE_
residues O
within O
this O
sequence O
that O
were O
previously O
shown O
to O
be O
important O
for _RARE_
Fyn I-GENE
interactions O
with O
the O
immunoreceptor _RARE_
tyrosine O
- O
based O
activation O
motifs O
( O
ITAMs _RARE_
) O
of O
lymphocyte I-GENE
Ag _RARE_
receptors I-GENE
. O

The O
prothrombin I-GENE
gene I-GENE
G20210A _RARE_
mutation I-GENE
is O
not O
found O
among O
Japanese O
patients O
with O
deep O
vein _RARE_
thrombosis O
and O
healthy O
individuals O
. O

Transcriptional O
regulation _RARE_
of O
the O
GluR2 _RARE_
gene I-GENE
: O
neural _RARE_
- O
specific O
expression _RARE_
, O
multiple O
promoters O
, O
and O
regulatory O
elements O
. O

The O
binding O
of O
NF _RARE_
- I-GENE
ATp _RARE_
, O
although O
not O
NF _RARE_
- I-GENE
AT4 _RARE_
, O
to O
this O
enhancer O
also O
occurs O
along O
with O
HTLV _RARE_
- O
I O
- O
mediated _RARE_
infection O
of O
human O
peripheral O
blood _RARE_
T O
- O
cells O
. O

Thus O
, O
TRAF2 I-GENE
initiates _RARE_
SAPK I-GENE
and O
p38 I-GENE
activation O
by O
binding O
two O
proximal O
protein O
kinases O
: O
GCK _RARE_
and O
RIP _RARE_
. O

Tumor _RARE_
necrosis I-GENE
factor I-GENE
signaling _RARE_
to O
stress I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
( O
SAPK I-GENE
)/ _RARE_
Jun I-GENE
NH2 I-GENE
- I-GENE
terminal I-GENE
kinase I-GENE
( O
JNK I-GENE
) O
and O
p38 I-GENE
. O

The O
activity O
of O
the O
minimal O
promoter O
was O
found O
to O
be O
controlled _RARE_
by O
a O
combination O
of O
the O
activities O
of O
the O
transcription O
factors O
Sp1 _RARE_
, O
Sp3 I-GENE
, O
and O
NF _RARE_
- I-GENE
Y I-GENE
. O

In O
the O
studies O
described O
in O
this O
report O
, O
we O
have O
investigated O
the O
signaling _RARE_
pathway _RARE_
( O
s O
) O
that O
are O
responsible O
for _RARE_
CREB I-GENE
activation O
in O
normal O
T O
cells O
. O

Respondents _RARE_
who O
lived _RARE_
with O
a O
spouse _RARE_
/ O
partner _RARE_
only O
were O
less O
likely O
to O
have O
an O
unfavorable _RARE_
BMI O
status O
than O
people O
in O
the O
other O
two O
groups O
. O

Isolation O
of O
a O
novel O
TP53 _RARE_
target I-GENE
gene I-GENE
from O
a O
colon O
cancer _RARE_
cell O
line O
carrying O
a O
highly O
regulated O
wild I-GENE
- I-GENE
type I-GENE
TP53 _RARE_
expression _RARE_
system _RARE_
. O

Overexpression O
of O
MDR1 _RARE_
has O
been O
demonstrated O
in O
many O
cancers O
, O
both O
in O
patient O
tumors O
and O
in O
cell O
lines O
selected _RARE_
with O
a O
variety O
of O
chemotherapeutic O
agents O
. O

Cytogenetic _RARE_
and O
molecular _RARE_
characterization O
of O
random O
chromosomal O
rearrangements _RARE_
activating O
the O
drug O
resistance O
gene O
, O
MDR1 _RARE_
/ O
P I-GENE
- I-GENE
glycoprotein I-GENE
, O
in O
drug O
- O
selected _RARE_
cell O
lines O
and O
patients O
with O
drug O
refractory O
ALL O
. O

BACKGROUND O
: O
It O
is O
generally O
accepted O
that O
smoking O
increases O
blood _RARE_
pressure O
and O
inhibits O
muscle O
sympathetic O
nerve O
activity O
( O
SNA _RARE_
). O

When O
the O
blood _RARE_
pressure O
increase O
in O
response O
to O
smoking O
was O
blunted _RARE_
by O
nitroprusside _RARE_
infusion O
, O
there O
was O
a O
striking O
increase O
in O
muscle O
SNA _RARE_
. O

After O
that O
report O
, O
carboxypeptidase _RARE_
D I-GENE
( O
CPD _RARE_
) O
was O
subsequently O
purified _RARE_
from O
bovine O
pituitary O
and O
characterized O
as _RARE_
a O
novel O
carboxypeptidase _RARE_
E I-GENE
( O
CPE _RARE_
)- O
like O
enzyme O
, O
with O
many O
characteristics O
in O
common O
with O
duck _RARE_
gp180 _RARE_
( O
Song _RARE_
, O
L O
., O
Fricker _RARE_
, O
L O
. O
D O
., O
1995 O
. O

RA _RARE_
- O
treatment O
of O
these O
transfectants O
induced _RARE_
morphologic O
and O
immunophenotypic _RARE_
maturation _RARE_
, O
changes O
in O
RA _RARE_
- O
regulated O
genes O
, O
and O
a O
G1 O
cell O
cycle _RARE_
arrest O
in O
a O
manner O
similar O
to O
parental O
NT2 _RARE_
/ O
D1 _RARE_
cells O
. O

The O
histopathology _RARE_
and O
neovascularization _RARE_
did O
not O
appreciably _RARE_
differ O
between O
xenograft _RARE_
tumors O
derived O
from O
FGF4 _RARE_
over O
- O
expressing O
versus O
control O
transfectants O
. O

For O
smaller O
vessels O
up _RARE_
to O
a O
diameter O
of O
0 _RARE_
. O
5 O
mm O
, O
treatments O
at _RARE_
16 O
and O
18 O
J _RARE_
/ O
cm2 O
showed O
good O
results O
in O
60 _RARE_
and O
82 O
% O
respectively O
; O
for _RARE_
vessels O
up _RARE_
to O
1 O
mm O
in O
27 _RARE_
and O
33 _RARE_
%. O

Pressure _RARE_
ulcers O
. O

RXR I-GENE
- I-GENE
gamma I-GENE
expression _RARE_
produced O
significant O
reduction O
in O
levels O
of O
RA _RARE_
- O
responsive O
genes O
including O
the O
cyclin _RARE_
- I-GENE
dependent I-GENE
kinase I-GENE
inhibitors _RARE_
p21Cip1 _RARE_
/ O
WAF1 I-GENE
and O
p27Kip1 _RARE_
, O
resulting O
in O
increased O
cdc2 I-GENE
and O
cdk2 I-GENE
kinase I-GENE
activity O
and O
RB _RARE_
phosphorylation _RARE_
. O

TBP I-GENE
can O
be O
phosphorylated _RARE_
in O
vitro O
by O
extracts O
of O
U937 O
cells O
or O
by O
bacterially O
expressed _RARE_
activated O
ERK2 I-GENE
; O
the O
phosphorylation _RARE_
sites O
were O
mapped O
to O
ERK I-GENE
kinase I-GENE
consensus I-GENE
sites I-GENE
in O
the O
TBP I-GENE
amino I-GENE
- I-GENE
terminal I-GENE
domain I-GENE
. O

During O
the O
CR _RARE_
/ O
PP _RARE_
diet O
only O
the O
HS _RARE_
subjects O
did O
not O
show O
the O
stress O
- O
induced _RARE_
rise O
in O
depression O
, O
decline O
in O
vigour _RARE_
and O
cortisol O
elevation O
that O
they O
showed O
after O
the O
PR O
/ O
CP O
diet O
. O

Generally _RARE_
ILC _RARE_
and O
ILVF _RARE_
values O
decreased O
with O
increasing O
exposure O
time O
with O
rate O
constants O
ranging O
from O
0 _RARE_
. O
03 O
to O
0 _RARE_
. O
33 _RARE_
day O
- O
1 O
( O
wet _RARE_
and O
lipid _RARE_
weight _RARE_
) O
for _RARE_
ILC _RARE_
and O
0 _RARE_
. O
03 O
to O
0 _RARE_
. O
31 _RARE_
day O
- O
1 O
for _RARE_
ILVF _RARE_
. O

These O
sequence O
analyses O
suggest O
that O
xIRS _RARE_
- I-GENE
u _RARE_
is O
a O
novel O
member _RARE_
of O
the O
IRS I-GENE
family I-GENE
rather O
than O
a O
Xenopus O
homolog O
of O
an O
existing O
member _RARE_
. O

The O
present O
study O
sought O
to O
develop O
an O
equation O
to O
estimate O
VO2peak _RARE_
in O
peripheral O
arterial O
occlusive _RARE_
disease _RARE_
( O
PAOD _RARE_
) O
patients O
with O
intermittent O
claudication _RARE_
and O
to O
determine O
independent O
predictors O
of O
VO2peak _RARE_
in O
this O
population O
. O

Evidence O
for _RARE_
a O
novel O
MAPKKK _RARE_
- O
independent O
pathway _RARE_
controlling O
the O
stress O
activated O
Sty1 _RARE_
/ O
Spc1 _RARE_
MAP O
kinase O
in O
fission _RARE_
yeast O
. O

The O
Abbreviated _RARE_
Injury _RARE_
Scale O
( O
AIS _RARE_
), _RARE_
Injury _RARE_
Severity _RARE_
Scale O
and O
TRISS _RARE_
methodology _RARE_
comprise O
a O
mathematically _RARE_
sound O
system _RARE_
for _RARE_
the O
analysis O
of O
injuries O
and O
injured _RARE_
patients O
. O

This O
hypothesis O
was O
tested O
by O
introducing _RARE_
mutations O
at _RARE_
each O
of O
the O
three O
histidine _RARE_
pairs _RARE_
, O
the O
H382 _RARE_
- O
X2 O
- O
H385 _RARE_
pair _RARE_
, O
the O
H411 _RARE_
- O
X2 O
- O
H414 _RARE_
pair _RARE_
and O
the O
H430 _RARE_
- O
X5 _RARE_
- O
H436 _RARE_
pair _RARE_
, O
which O
constitute O
the O
histidine _RARE_
- O
rich O
region O
near O
the O
C O
terminus O
of O
gp17 _RARE_
. O

Using O
backcross O
analysis O
, O
both O
exons O
1 O
and O
4 O
mapped O
to O
a O
proximal O
region O
of O
murine O
Chromosome _RARE_
4 O
indistinguishable O
from O
the O
vacillans _RARE_
gene I-GENE
. O

Seventy O
- O
five O
percent O
of O
children O
who O
received O
a O
second O
transplant O
for _RARE_
HCV O
hepatitis O
had O
early O
histologic O
recurrence O
that O
led O
to O
liver O
failure O
and O
death _RARE_
. O

However O
, O
both O
TPN O
groups O
showed O
a O
marked O
increase O
in O
activities O
of O
liver O
lysosomal _RARE_
enzymes _RARE_
. O

Regulation O
of O
embryonic _RARE_
growth O
and O
lysosomal _RARE_
targeting O
by O
the O
imprinted O
Igf2 _RARE_
/ O
Mpr _RARE_
gene O
. O

Furthermore O
, O
we O
demonstrated O
that O
Galpha11 _RARE_
Q209L _RARE_
stimulated _RARE_
Src I-GENE
family I-GENE
kinase O
activity O
and O
induced _RARE_
tyrosine O
phosphorylation _RARE_
of O
several O
proteins O
in O
HEK _RARE_
- O
293 O
cells O
. O

The O
micturition _RARE_
pressure O
was O
significantly O
decreased O
only O
after O
injection O
with O
BUP _RARE_
- O
4 O
in O
both O
normal O
and O
obstructed _RARE_
rats O
. O

Peroxisome _RARE_
proliferator _RARE_
- I-GENE
activated I-GENE
receptors I-GENE
( O
PPAR _RARE_
) O
modulate O
transcription O
by O
binding O
to O
specific O
peroxisome _RARE_
proliferator _RARE_
- O
response O
elements O
( O
PPRE _RARE_
) O
through O
heterodimerization O
with O
the O
9 I-GENE
- I-GENE
cis I-GENE
retinoic I-GENE
acid I-GENE
receptor I-GENE
( O
RXR I-GENE
). O

Furthermore O
, O
early O
- O
and O
late _RARE_
- O
firing _RARE_
origins O
differ O
not O
in O
the O
timing O
of O
their O
recruitment O
of O
an O
Mcm _RARE_
protein I-GENE
, O
but O
in O
the O
timing O
of O
RPA I-GENE
' I-GENE
s I-GENE
recruitment O
. O

Thus O
, O
in O
the O
presence O
of O
active _RARE_
S I-GENE
- I-GENE
CDKs _RARE_
and O
Dbf4 _RARE_
/ O
Cdc7 _RARE_
, O
Mcms _RARE_
may O
open _RARE_
origins O
and O
thereby O
facilitate O
the O
loading O
of O
RPA I-GENE
. O

Tyrosine _RARE_
phosphorylated _RARE_
STATs _RARE_
dimerize _RARE_
and O
translocate _RARE_
into O
the O
nucleus O
to O
activate O
specific O
genes O
. O

Nonsynonymous _RARE_
substitution O
in O
abalone _RARE_
sperm O
fertilization O
genes O
exceeds _RARE_
substitution O
in O
introns _RARE_
and O
mitochondrial O
DNA O
. O

Gel O
retardation O
assays O
detected O
ZiaR _RARE_
- O
dependent O
complexes O
forming O
with O
the O
zia _RARE_
operator I-GENE
- I-GENE
promoter I-GENE
and O
ZiaR _RARE_
- O
DNA O
binding O
was O
enhanced _RARE_
by O
treatment O
with O
a O
metal O
- O
chelator _RARE_
in O
vitro O
. O

CONCLUSION O
: O
Although O
quantitative O
and O
qualitative O
criteria O
for _RARE_
diagnosing _RARE_
fatty O
liver O
on O
helical O
CT _RARE_
can O
be O
determined O
, O
they O
are O
protocol O
- O
specific O
. O

The O
PC O
- O
based O
RTPS _RARE_
is O
designed O
to O
run O
in O
the O
Microsoft _RARE_
Windows _RARE_
3 O
. O
11 O
environment O
( O
and O
later O
versions _RARE_
), _RARE_
for _RARE_
computers _RARE_
equipped _RARE_
with O
486 _RARE_
or O
Pentium _RARE_
processors _RARE_
. O

Alternatively _RARE_
, O
the O
similarity _RARE_
in O
apparent O
regulatory O
action O
of O
the O
genes O
may O
indicate O
allelic O
differences O
wherein _RARE_
the O
IS1112C _RARE_
Rf3 _RARE_
allele I-GENE
may O
differ O
from O
alleles O
of O
maintainer _RARE_
lines O
by O
the O
capability _RARE_
to O
regulate O
both O
orf107 _RARE_
and O
urf209 _RARE_
processing _RARE_
activities O
. O

JCAHO _RARE_
revised O
interpretation O

Molecular O
cloning O
and O
functional _RARE_
characterization O
of O
murine I-GENE
sphingosine _RARE_
kinase I-GENE
. O

A O
human O
SPT3 _RARE_
- O
TAFII31 _RARE_
- O
GCN5 _RARE_
- O
L I-GENE
acetylase _RARE_
complex O
distinct O
from O
transcription I-GENE
factor I-GENE
IID _RARE_
. O

Oleate _RARE_
induced _RARE_
steady O
- O
state O
levels O
of O
M I-GENE
- I-GENE
CPT _RARE_
I I-GENE
mRNA I-GENE
4 O
. O
5 O
- O
fold _RARE_
. O

Mapping O
of O
the O
DNA O
binding O
domain O
of O
the O
copper _RARE_
- O
responsive O
transcription O
factor O
Mac1 _RARE_
from I-GENE
Saccharomyces I-GENE
cerevisiae I-GENE
. O

A O
further O
mechanism O
increasing O
specific O
activation O
was O
cooperation O
of O
receptors O
at _RARE_
multiple O
and O
weak O
HREs _RARE_
, O
which O
was O
accentuated _RARE_
in O
the O
presence O
of O
both O
the O
AR _RARE_
N O
terminus O
and O
ligand _RARE_
binding O
domain O
. O

Previously O
, O
we O
characterized O
a O
DNA O
- O
binding O
protein O
, O
HS2NF5 _RARE_
, O
that O
bound _RARE_
tightly O
to O
a O
conserved _RARE_
region O
within O
hypersensitive _RARE_
site O
2 O
( O
HS2 _RARE_
) O
of O
the O
human I-GENE
beta I-GENE
- I-GENE
globin I-GENE
locus I-GENE
control I-GENE
region I-GENE
( O
LCR _RARE_
) O
( O
Lam _RARE_
, O
L O
. O

The O
CBF1 I-GENE
site I-GENE
within O
HS2 _RARE_
resides O
near O
sites O
for _RARE_
hematopoietic O
regulators _RARE_
such O
as _RARE_
GATA _RARE_
- I-GENE
1 I-GENE
, O
NF _RARE_
- I-GENE
E2 I-GENE
, O
and O
TAL1 _RARE_
. O

The O
rat I-GENE
branched _RARE_
- I-GENE
chain I-GENE
- I-GENE
2 I-GENE
- I-GENE
oxo _RARE_
- I-GENE
acid I-GENE
dehydrogenase I-GENE
( I-GENE
BCOD _RARE_
) I-GENE
kinase I-GENE
mRNA I-GENE
is O
transcribed _RARE_
from O
a O
TATA O
- O
less O
promoter O
that O
has O
GC _RARE_
- O
rich O
sequences O
and O
two O
putative O
Sp1 _RARE_
binding I-GENE
sites I-GENE
near O
the O
transcription O
start _RARE_
site O
. O

Co O
- O
transfection O
of O
the O
Sp1 _RARE_
expression _RARE_
plasmid _RARE_
and O
the O
- O
58 O
promoter O
construct O
into O
Drosophila O
Schneider _RARE_
cells O
revealed O
that O
Sp1 _RARE_
contributed O
to O
the O
kinase O
basal O
promoter O
activity O
by O
binding O
to O
the O
non O
- O
consensus O
site O
in O
the O
- O
58 O
region O
. O

Until _RARE_
such O
investigations O
are O
performed O
, O
we O
conclude O
that O
the O
role O
for _RARE_
adjuvant O
treatment O
is O
questionable _RARE_
and O
that O
TME _RARE_
surgery O
is O
preferred O
as _RARE_
the O
treatment O
option _RARE_
for _RARE_
Stage O
T1 _RARE_
- O
T3 _RARE_
rectal O
cancers O
. O

Likewise _RARE_
, O
at _RARE_
150 _RARE_
degrees O
C O
with O
2 O
% O
APS _RARE_
the O
surface O
density O
of O
NH2 O
groups O
reached O
a O
maximum O
at _RARE_
24 _RARE_
hr O
and O
remained O
relatively O
constant O
up _RARE_
to O
96 O
hr O
. O

Taken O
together O
, O
these O
results O
suggest O
that O
the O
cooperation O
of O
transcription I-GENE
factors I-GENE
NF _RARE_
- I-GENE
kappaB I-GENE
and O
AP I-GENE
- I-GENE
1 I-GENE
is O
essential O
for _RARE_
transactivation _RARE_
of O
IL _RARE_
- I-GENE
8 I-GENE
gene I-GENE
by O
HTLV _RARE_
- I-GENE
I I-GENE
Tax _RARE_
. O

This O
study O
examines _RARE_
the O
cooperative O
effects O
of O
a O
human O
estrogen I-GENE
receptor I-GENE
- I-GENE
alpha I-GENE
( O
ERalpha _RARE_
) O
isoform O
on O
estrogen O
( O
E2 O
)- O
mediated _RARE_
gene O
activation O
in O
U2 _RARE_
- O
OS _RARE_
osteosarcoma O
cells O
. O

Transfection O
of O
increasing O
amounts O
of O
delta5ERalpha _RARE_
expression _RARE_
vector O
into O
[ _RARE_
ERalpha _RARE_
+] _RARE_
OS _RARE_
cells O
resulted O
in O
potentiation O
of O
E2 O
- O
stimulated _RARE_
ERELuc _RARE_
activity O
in O
a O
synergistic O
, O
dose O
- O
dependent O
manner O
. O

Studies O
using O
the O
yeast O
two O
- O
hybrid _RARE_
system _RARE_
also O
did O
not O
provide O
evidence O
for _RARE_
the O
formation O
of O
a O
VDR I-GENE
- O
TR I-GENE
protein O
- O
protein O
interaction O
. O

Our O
results O
show O
that O
, O
from O
a O
thermodynamical _RARE_
standpoint _RARE_
, O
melatonin O
may O
directly O
scavenge _RARE_
hydroxyl _RARE_
radicals O
both O
in O
vacuum _RARE_
and O
in O
aqueous O
solution O
. O

This O
sequence O
, O
Thr _RARE_
- O
Gly _RARE_
- O
X O
- O
X O
- O
Gly _RARE_
- O
Asp _RARE_
- O
Gly _RARE_
- O
Lys _RARE_
- O
Ile O
- O
Phe _RARE_
, O
forms O
part O
of O
the O
B O
- O
loop O
and O
is O
conserved _RARE_
in O
a O
wide O
variety O
of O
organisms O
that O
include O
bacteria O
, O
algae _RARE_
and O
archeabacteria _RARE_
. O

We O
did O
not O
observe O
any O
changes O
in O
Bcl I-GENE
- I-GENE
2 I-GENE
or O
Bcl I-GENE
- I-GENE
2 I-GENE
- I-GENE
related I-GENE
proteins I-GENE
( O
Bcl I-GENE
- I-GENE
x _RARE_
, O
Bax _RARE_
, O
and O
Bad _RARE_
) O
in O
control O
or O
KCREB _RARE_
- O
transfected O
cells O
before O
or O
after O
treatment O
with O
Tg _RARE_
. O

Tyrosine _RARE_
112 O
of O
latent I-GENE
membrane I-GENE
protein I-GENE
2A _RARE_
is O
essential O
for _RARE_
protein I-GENE
tyrosine I-GENE
kinase I-GENE
loading O
and O
regulation _RARE_
of O
Epstein O
- O
Barr O
virus O
latency _RARE_
. O

The O
only O
abundant O
viral O
transcript O
expressed _RARE_
during _RARE_
latency _RARE_
is O
the O
latency _RARE_
- I-GENE
related I-GENE
( O
LR _RARE_
) O
RNA O
. O

To O
improve O
test O
efficiency O
, O
we O
modified O
our O
previously O
introduced O
contrast O
/ O
color O
card _RARE_
test O
by O
including O
a O
patterned _RARE_
test O
stimulus O
and O
reducing _RARE_
the O
number O
of O
stimuli O
in O
both O
experimental O
phases O
. O

The O
defect O
in O
these O
proteins O
was O
also O
uniformly _RARE_
suppressed O
by O
either O
Mn2 _RARE_
+, _RARE_
or O
the O
Mu _RARE_
B I-GENE
protein I-GENE
in O
the O
presence O
of O
ATP O
and O
target O
DNA O
. O

Using O
homology O
cloning O
techniques O
, O
we O
identified O
a O
mouse O
homologue O
of O
E O
( O
Pc _RARE_
), _RARE_
termed O
Epc1 _RARE_
, O
a O
yeast O
protein O
that O
we O
name _RARE_
EPL1 _RARE_
, O
and O
as _RARE_
well _RARE_
as _RARE_
additional O
ESTs _RARE_
from O
Caenorhabditis O
elegans O
, O
mice O
and O
humans O
. O

Second O
, O
the O
wild I-GENE
- I-GENE
type I-GENE
m8 _RARE_
3 I-GENE
' I-GENE
UTR I-GENE
strongly O
reduces O
accumulation O
of O
heterologous O
transcripts O
in O
vivo O
, O
an O
activity O
that O
requires O
its O
K O
box O
sequences O
. O

In O
particular O
, O
unc _RARE_
- I-GENE
86 _RARE_
encodes O
a O
POU I-GENE
- I-GENE
type I-GENE
homeodomain _RARE_
protein I-GENE
needed O
for _RARE_
the O
production O
of O
the O
touch _RARE_
cells O
, O
while O
mec _RARE_
- I-GENE
3 I-GENE
encodes O
a O
LIM I-GENE
- I-GENE
type I-GENE
homeodomain _RARE_
protein I-GENE
needed O
for _RARE_
the O
differentiation O
of O
the O
touch _RARE_
cells O
. O

During O
the O
2h _RARE_
resuscitation O
period O
, O
extracellular O
aspartate _RARE_
and O
glutamate _RARE_
concentrations O
in O
the O
cerebral O
striatum _RARE_
were O
higher _RARE_
during _RARE_
hypoxaemic _RARE_
resuscitation O
( O
p O
= O
0 _RARE_
. O
044 _RARE_
and O
p O
= O
0 _RARE_
. O
055 _RARE_
, O
respectively O
) O
than O
during _RARE_
resuscitation O
with O
21 O
% O
O2 _RARE_
or O
100 _RARE_
% O
O2 _RARE_
, O
suggesting O
an O
unfavourable _RARE_
accumulation O
of O
potent O
excitotoxins _RARE_
during _RARE_
hypoxaemic _RARE_
resuscitation O
. O

Expression O
of O
constitutively O
active _RARE_
MEK1 _RARE_
, O
the O
kinase O
that O
activates O
ERKs I-GENE
, O
or O
overexpression O
of O
ERK2 I-GENE
, O
but O
not O
JNK1 I-GENE
, O
inhibited O
Stat3 I-GENE
activation O
. O

MEKs _RARE_
and O
ERKs I-GENE
inhibited O
IL _RARE_
- I-GENE
6 I-GENE
activation O
of O
Stat3 I-GENE
harboring O
a O
mutation O
at _RARE_
serine O
- O
727 _RARE_
, O
the O
major O
site O
for _RARE_
serine O
phosphorylation _RARE_
, O
similar O
to O
inhibition O
of O
wild I-GENE
- I-GENE
type I-GENE
Stat3 I-GENE
, O
and O
inhibited O
Janus I-GENE
kinases I-GENE
Jak1 _RARE_
and O
Jak2 _RARE_
upstream O
of O
Stat3 I-GENE
in O
the O
Jak I-GENE
- O
STAT I-GENE
- O
signaling _RARE_
pathway _RARE_
. O

Furthermore O
, O
phosphatidylinositol _RARE_
( O
3 O
, O
4 O
, O
5 O
) O
trisphosphate _RARE_
specifically O
stimulates O
the O
activity O
of O
ILK I-GENE
in O
vitro O
, O
and O
in O
addition O
, O
membrane O
targetted _RARE_
constitutively O
active _RARE_
Pi _RARE_
( I-GENE
3 I-GENE
) I-GENE
K I-GENE
activates O
ILK I-GENE
in O
vivo O
. O

Transfection O
and O
in O
vitro O
binding O
studies O
identified O
within O
HEFT1 _RARE_
a I-GENE
promoter I-GENE
whose O
basal O
activity O
required O
a O
GC _RARE_
box O
activated O
by O
Sp1 _RARE_
or O
Sp3 I-GENE
. O

Plasma O
was O
tested O
before O
and O
after O
( O
14 O
+/- O
7 O
. O
5 O
[ _RARE_
SD O
] O
days O
) O
surgery O
for _RARE_
IgG I-GENE
antibodies I-GENE
to O
the O
complex O
of O
heparin _RARE_
/ I-GENE
platelet I-GENE
factor I-GENE
4 I-GENE
, O
using O
a O
standardized O
, O
validated _RARE_
enzyme O
- O
linked _RARE_
immunosorbent O
assay O
( O
ELISA O
). O

Genome _RARE_
plasticity _RARE_
in O
the O
distal O
tail _RARE_
fiber O
locus O
of O
the O
T O
- O
even O
bacteriophage _RARE_
: O
recombination _RARE_
between O
conserved _RARE_
motifs O
swaps _RARE_
adhesin _RARE_
specificity _RARE_
. O

The O
FAS _RARE_
promoter I-GENE
was O
up _RARE_
- O
regulated O
by O
insulin I-GENE
through O
the O
proximal O
insulin I-GENE
response I-GENE
sequence I-GENE
containing O
an O
E O
- O
box O
motif O
at _RARE_
the O
- O
65 O
- O
base _RARE_
pair _RARE_
position O
. O

The O
effect O
of O
independent O
predictors O
on O
survival O
was O
examined O
in O
a O
Cox O
regression O
model O
with O
adjustment O
for _RARE_
existing O
illnesses _RARE_
. O

Effects O
of O
rhG _RARE_
- I-GENE
CSF I-GENE
on O
neutrophil _RARE_
functions O
and O
survival O
in O
sepsis O
induced _RARE_
diabetic O
rats O
. O

OBJECTIVE O
: O
The O
purpose O
of O
this O
article O
is O
to O
review O
balance O
instruments O
developed O
within O
the O
past O
10 O
years O
that O
can O
be O
used O
in O
the O
clinic _RARE_
or O
home O
environment O
. O

CASE _RARE_
REPORT _RARE_
: O
We O
observed O
a O
congenital O
skin _RARE_
defect O
located _RARE_
exclusively O
on O
the O
trunk O
. O

Whereas O
, O
in O
the O
single O
- O
chambered _RARE_
body O
box O
, O
PenH _RARE_
units _RARE_
( O
Enhanced _RARE_
Pause _RARE_
) O
reflect O
" O
effort O
of O
breathing O
." _RARE_
This O
is O
measured O
as _RARE_
the O
pause _RARE_
between O
inspiration _RARE_
and O
expiration _RARE_
. O

Anastrozole _RARE_
is O
the O
first _RARE_
aromatase I-GENE
inhibitor O
to O
show O
a O
significant O
survival O
advantage O
over O
megestrol _RARE_
acetate _RARE_
in O
post O
- O
menopausal _RARE_
women O
with O
advanced O
breast O
cancer _RARE_
. O

W _RARE_
. O

Moritta _RARE_
) O
and O
contains O
Bis _RARE_
- O
GMA _RARE_
. O

Mutation O
of O
either O
the O
AP I-GENE
- I-GENE
1 I-GENE
or O
the O
ets I-GENE
component _RARE_
of O
this O
site O
also O
prevented O
promoter O
activity O
in O
SMCs _RARE_
. O

ANIMALS _RARE_
: O
Fifty O
dogs O
with O
naturally O
developing O
DM O
. O

Surprisingly O
, O
double O
mutants O
of O
the O
shy2 _RARE_
- I-GENE
1D _RARE_
mutant I-GENE
with O
the O
phytochrome _RARE_
- O
deficient _RARE_
mutants O
hy2 _RARE_
, O
hy3 _RARE_
( O
phyB _RARE_
- I-GENE
1 I-GENE
) O
and O
fre1 _RARE_
- I-GENE
1 I-GENE
( O
phyA _RARE_
- I-GENE
201 _RARE_
) O
showed O
reduced _RARE_
photomorphogenic _RARE_
response O
in O
darkness _RARE_
with O
a O
longer O
hypocotyl _RARE_
, O
a O
longer O
inflorescence _RARE_
stem _RARE_
, O
and O
a O
lower O
level O
expression _RARE_
of O
the O
CAB _RARE_
gene I-GENE
than O
the O
shy2 _RARE_
- I-GENE
1D _RARE_
single I-GENE
mutant I-GENE
. O

This O
suggests O
that O
while O
underpredictions _RARE_
of O
pain O
do O
not O
hurt _RARE_
more O
, O
disruption O
on O
primary _RARE_
tasks O
and O
physiological O
impact O
are O
higher _RARE_
. O

Laser _RARE_
ablation O
has O
been O
employed O
as _RARE_
a O
therapeutic O
measure O
for _RARE_
chronic O
pulmonary O
emphysema O
. O

The O
SH2 _RARE_
- O
containing O
adapter _RARE_
protein O
GRB10 _RARE_
interacts O
with O
BCR _RARE_
- O
ABL I-GENE
. O

Saccharomyces O
cerevisiae O
contains O
four O
known O
acyl _RARE_
- I-GENE
CoA I-GENE
synthetases I-GENE
( O
fatty I-GENE
acid I-GENE
activation I-GENE
proteins I-GENE
, O
Faaps _RARE_
). O

We O
recently O
reported O
a O
placenta O
- O
specific O
enhancer O
in O
the O
human I-GENE
leukemia I-GENE
inhibitory _RARE_
factor I-GENE
receptor I-GENE
( O
LIFR _RARE_
) O
gene O
and O
now O
show O
detailed O
characterization O
of O
the O
226 _RARE_
- O
base _RARE_
pair _RARE_
enhancer O
(- _RARE_
4625 _RARE_
/- O
4400 _RARE_
nucleotides O
). O

Copyright O
1998 O
Elsevier _RARE_
Science _RARE_
B O
. O
V O
. O

It O
may O
be O
time O
to O
reevaluate _RARE_
the O
dichotomy _RARE_
between O
AD O
and O
VaD _RARE_
. O

Clone _RARE_
39 _RARE_
was O
a O
homolog O
of O
CONSTANS _RARE_
, O
which O
is O
a O
gene O
involved O
in O
controlling O
the O
flowering _RARE_
time O
in O
Arabidopsis O
. O

Badcock _RARE_
and O
Westheimer _RARE_
( O
Spatial _RARE_
Vision _RARE_
1 O
( O
1 O
), _RARE_
3 O
- O
11 O
, O
1985 O
) O
showed O
that O
a O
thin O
vertical O
line O
induces O
nearby _RARE_
zones _RARE_
of O
attraction _RARE_
and O
repulsion _RARE_
; O
this O
study O
extends _RARE_
those O
results O
by O
more O
closely O
examining O
the O
horizontal O
and O
vertical O
extents _RARE_
of O
the O
repulsion _RARE_
zone O
and O
by O
using O
an O
illusory _RARE_
contour _RARE_
to O
induce O
repulsion _RARE_
. O

The O
effects O
of O
high O
intensity O
light O
emissions _RARE_
, O
produced O
by O
a O
novel O
pulsed O
power O
energization _RARE_
technique O
( O
PPET _RARE_
), _RARE_
on O
the O
survival O
of O
bacterial O
populations O
of O
verocytotoxigenic _RARE_
Escherichia O
coli O
( O
serotype _RARE_
0157 _RARE_
: O
H7 _RARE_
) O
and O
Listeria _RARE_
monocytogenes O
( O
serotype _RARE_
4b _RARE_
) O
were O
investigated O
. O

Multiple O
chemical O
sensitivity O
( O
MCS _RARE_
) O
is O
a O
syndrome _RARE_
in O
which O
multiple O
symptoms O
reportedly _RARE_
occur O
with O
low O
- O
level O
chemical O
exposure O
. O

POU I-GENE
- I-GENE
domain I-GENE
proteins I-GENE
, O
such O
as _RARE_
the O
pituitary I-GENE
- I-GENE
specific I-GENE
factor I-GENE
Pit I-GENE
- I-GENE
1 I-GENE
, O
are O
members O
of O
the O
homeodomain _RARE_
family I-GENE
of O
proteins O
which O
are O
important O
in O
development O
and O
homeostasis _RARE_
, O
acting O
constitutively O
or O
in O
response O
to O
signal O
- O
transduction _RARE_
pathways O
to O
either O
repress O
or O
activate O
the O
expression _RARE_
of O
specific O
genes O
. O

Wild _RARE_
- O
type O
and O
mutant O
MyoD I-GENE
were O
introduced O
into O
cells O
using O
an O
E1 I-GENE
, O
E3 _RARE_
- O
deleted _RARE_
adenoviral _RARE_
vector O
. O

These O
results O
suggest O
that O
Thr115 _RARE_
may O
play O
an O
important O
role O
in O
the O
regulation _RARE_
of O
MyoD I-GENE
function O
under O
conditions O
of O
high O
mitogenesis _RARE_
. O

This O
and O
previous O
results O
suggest O
that O
the O
CRE _RARE_
and O
Sp1 _RARE_
site I-GENE
may O
synergistically O
activate O
TH _RARE_
transcription O
in O
a O
promoter O
context O
- O
dependent O
manner O
. O

desmethyltrimebutine _RARE_
was O
inactive O
. O

Endoscopic _RARE_
examinations O
, O
peripheral O
white _RARE_
blood _RARE_
cell O
( O
WBC O
) O
counts O
, O
and O
assays O
of O
myeloperoxidase _RARE_
activity O
( O
MPO _RARE_
) O
in O
homogenates _RARE_
of O
colon O
mucosa O
were O
performed O
after O
one O
week O
( O
4 O
% O
DSS _RARE_
model O
) O
and O
eight O
weeks O
( O
1 O
% O
DSS _RARE_
model O
). O

T7 _RARE_
transcription O
could O
be O
manipulated _RARE_
to O
achieve O
different O
levels O
of O
constitutive _RARE_
expression _RARE_
, O
through O
the O
use O
of O
promoter O
mutations O
. O

The O
primers O
were O
degenerate O
sets O
of O
oligonucleotides O
derived O
from O
known O
amino O
acid O
sequences O
of O
the O
PBAN _RARE_
precursor I-GENE
. O

Plants _RARE_
transformed O
with O
the O
35S _RARE_
- O
1 I-GENE
- I-GENE
sst _RARE_
construct O
accumulated O
the O
oligofructans _RARE_
1 O
- O
kestose _RARE_
( O
GF2 _RARE_
), _RARE_
1 O
, O
1 O
- O
nystose _RARE_
( O
GF3 _RARE_
) O
and O
1 O
, O
1 O
, O
1 O
- O
fructosylnystose _RARE_
( O
GF4 _RARE_
). O

Based O
on O
the O
comparison O
of O
the O
predicted O
amino O
acid O
sequences O
of O
1 I-GENE
- I-GENE
sst _RARE_
and O
1 I-GENE
- I-GENE
fft _RARE_
with O
those O
of O
other O
plant _RARE_
fructosyl _RARE_
transferase I-GENE
genes I-GENE
, O
we O
postulate _RARE_
that O
both O
plant _RARE_
fructan _RARE_
genes I-GENE
have O
evolved O
from O
plant _RARE_
invertase _RARE_
genes O
. O

However O
, O
ICK1 _RARE_
was O
induced _RARE_
by O
ABA _RARE_
, O
and O
along O
with O
ICK1 _RARE_
induction O
there O
was O
a O
decrease O
in O
Cdc2 I-GENE
- I-GENE
like I-GENE
histone I-GENE
H1 _RARE_
kinase I-GENE
activity O
. O

A O
5 O
. O
0 _RARE_
- O
kb O
transcript O
detected O
by O
the O
differential O
display O
amplicon _RARE_
3G1 _RARE_
was O
found O
to O
correlate O
strongly O
with O
RAG1 _RARE_
mRNA I-GENE
expression _RARE_
in O
various O
human O
cell O
lines O
. O

The O
hBRAG _RARE_
gene I-GENE
was O
localized O
to O
the O
long O
arm _RARE_
of O
chromosome _RARE_
10 O
( O
10q26 _RARE_
). O

Here O
, O
we O
report O
that O
swa5 _RARE_
- I-GENE
1 I-GENE
is O
a O
new O
temperature _RARE_
- O
sensitive _RARE_
allele O
of O
the O
clathrin I-GENE
heavy I-GENE
chain I-GENE
gene I-GENE
( O
chc1 _RARE_
- I-GENE
5 I-GENE
), _RARE_
which O
carries O
a O
frameshift O
mutation O
near O
the O
3 O
' O
end O
of O
the O
CHC1 _RARE_
open _RARE_
reading O
frame O
. O

We O
have O
determined O
the O
molecular _RARE_
lesions O
of O
nine O
Scm _RARE_
mutant I-GENE
alleles I-GENE
, O
which O
identify O
functional _RARE_
requirements O
for _RARE_
specific O
domains O
. O

Intriguingly _RARE_
, O
three O
hypomorphic _RARE_
Scm _RARE_
mutations O
, O
which O
map O
within O
an O
mbt _RARE_
repeat I-GENE
, O
interact O
with O
PcG _RARE_
mutations I-GENE
more O
strongly O
than O
do O
Scm _RARE_
null _RARE_
alleles O
. O

Northern O
analysis O
revealed O
no _RARE_
detectable O
expression _RARE_
of O
the O
transcript O
in O
diapause _RARE_
- O
or O
nondiapause _RARE_
- O
programmed O
wandering _RARE_
larvae O
, O
and O
only O
trace _RARE_
expression _RARE_
in O
nondiapausing _RARE_
pupae _RARE_
. O

Besides _RARE_
the O
characterization O
and O
discussion O
of O
the O
experimental O
setup _RARE_
used O
, O
the O
rate O
constants O
obtained O
are O
discussed O
and O
compared O
with O
estimated O
values O
. O

Genomic O
locus O
of O
chCTCF _RARE_
contains O
a O
GC _RARE_
- O
rich O
untranslated _RARE_
exon _RARE_
separated O
from O
seven _RARE_
coding O
exons O
by O
a O
long O
intron O
. O

The O
presence O
of O
PDZ I-GENE
and O
SAM _RARE_
domains O
in O
the O
KS5 _RARE_
protein I-GENE
suggests O
that O
it O
may O
act O
as _RARE_
a O
molecular _RARE_
adaptor _RARE_
, O
promoting _RARE_
and O
relaying _RARE_
information _RARE_
in O
a O
signal O
transduction _RARE_
pathway _RARE_
. O

BACKGROUND O
: O
Fluoroquinolones _RARE_
( O
FQ _RARE_
) O
are O
contraindicated _RARE_
in O
children O
because O
of O
the O
risk O
of O
cartilage O
damage O
. O

In O
analyses O
with O
control O
for _RARE_
multiple O
variables O
, O
relative O
risk O
for _RARE_
microalbuminuria _RARE_
( O
urinary _RARE_
albumin I-GENE
excretion O
, O
20 O
- O
199 _RARE_
microg O
/ O
min O
) O
in O
men O
and O
women O
was O
2 O
. O
51 _RARE_
and O
1 O
. O
62 _RARE_
, O
respectively O
, O
with O
18 O
mm O
Hg O
higher _RARE_
( O
1 O
SD O
) O
systolic O
blood _RARE_
pressure O
; O
2 O
. O
25 _RARE_
and O
2 O
. O
10 O
, O
respectively O
, O
with O
1 O
. O
0 _RARE_
- O
mmol O
/ O
L O
( O
40 O
mg O
/ O
dL O
) O
higher _RARE_
plasma O
cholesterol O
level O
; O
1 O
. O
99 _RARE_
and O
1 O
. O
91 O
, O
respectively O
, O
for _RARE_
smokers O
vs _RARE_
nonsmokers _RARE_
; O
and O
1 O
. O
83 _RARE_
and O
1 O
. O
33 _RARE_
, O
respectively O
, O
with O
4 O
kg O
/ O
m2 O
higher _RARE_
body O
mass O
index O
. O

However O
, O
while O
IL _RARE_
- I-GENE
1beta I-GENE
and O
TNF I-GENE
- I-GENE
alpha I-GENE
both O
induced _RARE_
nuclear O
binding O
of O
the O
Rel I-GENE
proteins I-GENE
p50 _RARE_
and O
p65 _RARE_
to O
an O
NF _RARE_
- I-GENE
kappaB I-GENE
consensus I-GENE
oligonucleotide _RARE_
in O
gel O
shift O
assays O
and O
caused O
transient O
degradation _RARE_
of O
inhibitor I-GENE
of I-GENE
NF _RARE_
- I-GENE
kappaB I-GENE
- I-GENE
alpha I-GENE
( O
IkappaB _RARE_
- I-GENE
alpha I-GENE
) O
in O
the O
cytoplasm O
of O
myofibroblasts _RARE_
, O
only O
IL _RARE_
- I-GENE
1beta I-GENE
upregulated _RARE_
PDGF _RARE_
- I-GENE
Ralpha _RARE_
. O

Cotransfections _RARE_
with O
ATF I-GENE
- I-GENE
2 I-GENE
and O
HNF I-GENE
- I-GENE
4 I-GENE
expression _RARE_
plasmids O
resulted O
in O
additive O
transactivation _RARE_
of O
the O
apoCIII _RARE_
promoter I-GENE
. O

Phosphocreatine _RARE_
hydrolysis O
during _RARE_
submaximal _RARE_
exercise O
: O
the O
effect O
of O
FIO2 _RARE_
. O

Pseudocontact _RARE_
shifts O
arise O
from O
the O
isotropic _RARE_
reorientational _RARE_
average O
of O
the O
dipolar _RARE_
coupling O
between O
unpaired _RARE_
electron O
and O
nuclei O
, O
in O
the O
presence O
of O
magnetic O
susceptibility _RARE_
anisotropy _RARE_
. O

GETS _RARE_
- I-GENE
1 I-GENE
is O
expressed _RARE_
in O
many O
tissues O
, O
but O
is O
enriched _RARE_
in O
retina O
and O
brain O
. O

The O
interaction O
of O
U1 _RARE_
- I-GENE
70K _RARE_
with O
the O
SRZ _RARE_
proteins I-GENE
is O
confirmed O
further O
in O
vitro O
using O
a O
blot O
overlay _RARE_
assay O
. O

The O
major O
phenotypes _RARE_
resulting O
from O
Fab1p _RARE_
kinase I-GENE
inactivation O
include O
temperature _RARE_
- O
sensitive _RARE_
growth O
, O
vacuolar O
acidification O
defects O
, O
and O
dramatic O
increases O
in O
vacuolar O
size O
. O

Small _RARE_
GTPases I-GENE
of O
the O
Ypt _RARE_
/ O
Rab _RARE_
family O
are O
involved O
in O
the O
regulation _RARE_
of O
vesicular O
transport _RARE_
. O

The O
GEF _RARE_
and O
GAP _RARE_
activities O
for _RARE_
Ypt1p _RARE_
localize O
to O
particulate O
cellular O
fractions O
. O

Dopamine _RARE_
beta I-GENE
- I-GENE
hydroxylase I-GENE
( O
DBH _RARE_
) O
catalyzes O
the O
conversion O
of O
dopamine O
to O
noradrenaline O
and O
is O
selectively O
expressed _RARE_
in O
noradrenergic O
and O
adrenergic O
neurons O
and O
neuroendocrine _RARE_
cells O
. O

Collectively O
, O
this O
study O
emphasizes O
a O
critical O
role O
of O
Phox2a _RARE_
as _RARE_
well _RARE_
as _RARE_
its O
functional _RARE_
synergism _RARE_
with O
other O
transcription O
factors O
( O
e _RARE_
. O
g O
., O
CREB I-GENE
, O
AP2 I-GENE
, O
and O
Sp1 _RARE_
) O
in O
transcriptional O
activation O
of O
the O
DBH _RARE_
gene I-GENE
. O

Interestingly O
, O
an O
antibody O
against O
N I-GENE
- I-GENE
SMase _RARE_
can O
abrogate O
Ox _RARE_
- I-GENE
LDL I-GENE
- O
and O
TNF I-GENE
- I-GENE
alpha I-GENE
- O
induced _RARE_
apoptosis O
and O
therefore O
may O
be O
useful O
for _RARE_
in O
vivo O
studies O
of O
apoptosis O
in O
experimental O
animals O
. O

We O
found O
that O
virulent O
Ngo _RARE_
strains O
induce O
phosphorylation _RARE_
and O
activation O
of O
JNK I-GENE
but O
not O
of O
p38 I-GENE
kinase O
. O

Focused _RARE_
beams _RARE_
of O
classical O
light O
ablate _RARE_
elements O
of O
the O
cell O
division O
machinery O
and O
switch O
the O
beating _RARE_
of O
hearts O
on O
a O
cellular O
basis O
. O

The O
human O
T O
cell O
lymphotropic _RARE_
retrovirus _RARE_
type O
I O
( O
HTLV _RARE_
- O
I O
) O
trans _RARE_
- O
activator O
, O
Tax _RARE_
, O
interacts O
specifically O
with O
the O
basic I-GENE
- I-GENE
domain I-GENE
/ I-GENE
leucine I-GENE
- I-GENE
zipper I-GENE
( I-GENE
bZip _RARE_
) I-GENE
protein I-GENE
, O
cAMP I-GENE
response I-GENE
element I-GENE
binding I-GENE
protein I-GENE
( O
CREB I-GENE
), _RARE_
bound _RARE_
to O
the O
viral I-GENE
Tax _RARE_
- I-GENE
responsive I-GENE
element I-GENE
consisting O
of O
three O
imperfect _RARE_
21 O
- O
base _RARE_
pair _RARE_
repeats O
, O
each O
with O
a O
cAMP O
response O
element O
core O
flanked O
by O
G O
/ O
C O
- O
rich O
sequences O
. O

This O
sequence O
is O
very O
similar O
to O
the O
insulin I-GENE
response I-GENE
sequence I-GENE
found O
in O
the O
regulatory O
region O
of O
other O
genes O
negatively O
regulated O
by O
insulin I-GENE
such O
as _RARE_
those O
encoding O
phosphoenolpyruvate I-GENE
carboxykinase _RARE_
, O
tyrosine I-GENE
aminotransferase I-GENE
, O
and O
insulin I-GENE
- I-GENE
like I-GENE
growth I-GENE
factor I-GENE
- I-GENE
binding I-GENE
protein I-GENE
1 I-GENE
. O

The O
murine I-GENE
facilitative _RARE_
glucose I-GENE
transporter _RARE_
isoform I-GENE
3 I-GENE
( O
Glut _RARE_
3 I-GENE
) O
is O
developmentally O
regulated O
and O
is O
predominantly O
expressed _RARE_
in O
neurons O
and O
trophoblasts _RARE_
. O

However O
, O
changing O
the O
half _RARE_
- O
site O
to O
the O
consensus O
sequence O
AGGTCA _RARE_
( O
IRper _RARE_
- O
1 O
) O
increased O
binding O
of O
AaEcR _RARE_
. I-GENE
AaUSP _RARE_
10 O
- O
fold _RARE_
over O
IRhsp _RARE_
- O
1 O
and O
, O
at _RARE_
the O
same O
time O
, O
reduced _RARE_
the O
stringency _RARE_
of O
the O
spacer O
length O
requirement O
, O
with O
IRper _RARE_
- O
0 _RARE_
to O
IRper _RARE_
- O
5 O
showing O
detectable O
binding O
. O

The O
levels O
of O
transactivation _RARE_
are O
correlated O
with O
the O
respective O
binding O
affinities O
of O
the O
response O
elements O
( O
IRper _RARE_
- O
1 O
> O
DR _RARE_
- O
4 O
> O
IRhsp _RARE_
- O
1 O
). O

The O
high O
density O
of O
tegumental _RARE_
spines _RARE_
on O
posterior O
half _RARE_
of O
the O
body O
and O
the O
distribution O
of O
type O
II O
papillae _RARE_
on O
dorsal O
surface O
are O
considered O
to O
be O
characteristic O
of O
C O
. O
armatus _RARE_
. O

Inactivation _RARE_
of O
p53 I-GENE
but O
not O
p73 _RARE_
by O
adenovirus I-GENE
type I-GENE
5 I-GENE
E1B I-GENE
55 _RARE_
- I-GENE
kilodalton _RARE_
and I-GENE
E4 _RARE_
34 _RARE_
- I-GENE
kilodalton _RARE_
oncoproteins _RARE_
. O

The O
Epstein I-GENE
- I-GENE
Barr I-GENE
virus I-GENE
transactivator _RARE_
Zta I-GENE
triggers O
lytic O
gene O
expression _RARE_
and O
is O
essential O
for _RARE_
replication O
of O
the O
lytic O
origin O
, O
oriLyt _RARE_
. O

Cotransfection O
of O
the O
helicase _RARE_
- O
primase I-GENE
proteins O
, O
one O
of O
which O
was O
fused O
to O
a O
heterologous O
activation O
domain O
, O
led O
to O
Zta I-GENE
- O
dependent O
superactivation _RARE_
of O
CAT I-GENE
expression _RARE_
. O

Sequence O
comparisons O
strongly O
suggest O
that O
the O
S27a _RARE_
and O
the O
ubiquitin I-GENE
coding O
sequences O
found O
in O
the O
genome O
of O
CP O
Rit _RARE_
were O
both O
derived O
from O
a O
bovine O
mRNA O
encoding O
a O
hybrid _RARE_
protein O
with O
the O
structure _RARE_
NH2 O
- O
ubiquitin I-GENE
- O
S27a _RARE_
- O
COOH _RARE_
. O

J _RARE_
. O

There O
was O
a O
trend O
in O
all O
studies O
favouring _RARE_
PVI _RARE_
. O

A O
single O
rectal O
dose O
of O
25 _RARE_
mg O
/ O
kg O
will O
obtain O
this O
lower O
concentration O
within O
1 O
h O
of O
administration O
and O
maintain O
it O
for _RARE_
up _RARE_
to O
6 O
h O
. O

This O
domain O
, O
although O
adjacent O
to O
the O
5 O
' O
edge _RARE_
of O
the O
SD O
sequence O
, O
does O
not O
inhibit O
ribosome _RARE_
binding O
as _RARE_
long O
as _RARE_
the O
single O
- O
stranded _RARE_
region O
of O
domain O
3 O
is O
present O
. O

Although O
YopH _RARE_
is O
a O
highly O
active _RARE_
PTP I-GENE
, O
it O
preferentially O
targets _RARE_
a O
subset O
of O
tyrosine O
- O
phosphorylated _RARE_
proteins O
in O
host _RARE_
cells O
, O
including O
p130Cas _RARE_
. O

Phylogenetic _RARE_
position O
of O
the O
Phacotaceae _RARE_
within O
the O
Chlamydophyceaeas _RARE_
revealed O
by O
analysis O
of O
18S _RARE_
rDNA _RARE_
and O
rbcL _RARE_
sequences I-GENE
. O

Previous O
genetic O
studies O
led O
to O
the O
conclusion O
that O
nitrate _RARE_
and O
nitrite _RARE_
induction O
of O
nasF _RARE_
operon I-GENE
expression _RARE_
is O
determined O
by O
a O
transcriptional O
antitermination _RARE_
mechanism O
. O

The O
activation O
and O
injury O
of O
endothelial O
cells O
induced _RARE_
by O
TNF I-GENE
and O
other O
proinflammatory _RARE_
cytokines _RARE_
may O
underlie _RARE_
the O
local O
effects O
of O
these O
mediators _RARE_
in O
vivo O
. O

A O
technique O
for _RARE_
thermal O
imaging O
of O
the O
animal _RARE_
and O
human O
brain O
cortex O
using O
an O
infrared _RARE_
optical O
system _RARE_
is O
described O
. O

EGFR I-GENE
levels O
were O
found O
to O
be O
elevated O
5 O
-, _RARE_
3 O
. O

Here O
we O
demonstrate O
that O
THOV _RARE_
NP _RARE_
contains O
a O
motif O
( O
KRxxxxxxxxxKTKK _RARE_
) O
at _RARE_
amino O
acid O
positions O
179 _RARE_
- O
193 O
that O
represents O
a O
classical O
bipartite O
nuclear O
localization _RARE_
signal O
( O
NLS O
). O

As O
PP2A I-GENE
exerts O
a O
range O
of O
cellular O
functions O
including O
cell O
cycle _RARE_
regulation _RARE_
and O
cell O
fate O
determination O
, O
we O
were O
surprised _RARE_
to O
find O
that O
these O
embryos _RARE_
develop O
normally O
until O
postimplantation _RARE_
, O
around O
embryonic _RARE_
day O
5 O
. O
5 O
/ O
6 O
. O
0 _RARE_
. O

The O
most O
frequent O
risk O
factor O
for _RARE_
ischaemic O
was O
hypertension O
. O

The O
results O
indicate O
that O
anthraquinone _RARE_
sennoside _RARE_
B O
and O
rhein _RARE_
are O
weakly O
genotoxic _RARE_
. O

Furthermore O
, O
LB1 _RARE_
gene I-GENE
mapped O
to O
chromosome _RARE_
13q14 _RARE_
, O
a O
region O
that O
has O
been O
involved O
as _RARE_
a O
chromosomal O
breakpoint _RARE_
in O
DLBL _RARE_
. O

16 O
subjects O
were O
repatch _RARE_
tested O
to O
ethylmercury _RARE_
chloride _RARE_
( O
EtHgCl _RARE_
) O
and O
to O
solutions O
containing O
EtHgCl _RARE_
mixed O
with O
L O
- O
cysteine O
and O
glutathione _RARE_
, O
respectively O
. O

Wild _RARE_
- I-GENE
type I-GENE
AT1A _RARE_
receptors I-GENE
, O
expressed _RARE_
in O
Chinese _RARE_
hamster O
ovary O
cells O
, O
rapidly O
internalized _RARE_
after O
Ang _RARE_
II I-GENE
stimulation _RARE_
[ _RARE_
t1 O
/ O
2 O
2 O
. O
3 O
min O
; O
maximal O
level O
of O
internalization O
( O
Ymax O
) O
78 _RARE_
. O
2 O
%], _RARE_
as _RARE_
did O
mutant O
receptors O
carrying O
single O
acidic _RARE_
substitutions O
( O
T332E _RARE_
, O
t1 O
/ O
2 O
2 O
. O
7 O
min O
, O
Ymax O
76 _RARE_
. O
3 O
%; O
S335D _RARE_
, O
t1 O
/ O
2 O
2 O
. O
4 O
min O
, O
Ymax O
76 _RARE_
. O
7 O
%; O
T336E _RARE_
, O
t1 O
/ O
2 O
2 O
. O
5 O
min O
, O
Ymax O
78 _RARE_
. O
2 O
%; O
S338D _RARE_
, O
t1 O
/ O
2 O
2 O
. O
6 O
min O
, O
Ymax O
78 _RARE_
. O
4 O
%). O

The O
activated O
glucocorticoid I-GENE
receptor I-GENE
forms O
a O
complex O
with O
Stat5 I-GENE
and O
enhances O
Stat5 I-GENE
- O
mediated _RARE_
transcriptional O
induction O
. O

T O
., O
Mahasneh _RARE_
, O
A O
., O
and O
Cote _RARE_
, O
G O
. O

The O
carboxyl _RARE_
- O
terminal O
portion O
of O
UKLF _RARE_
contains O
three O
zinc O
fingers _RARE_
of O
the O
Cys2 _RARE_
- O
His2 _RARE_
type O
and O
binds O
in O
vitro O
to O
the O
CACCC _RARE_
motif O
of O
the O
beta I-GENE
- I-GENE
globin I-GENE
promoter I-GENE
and O
to O
the O
Sp1 _RARE_
recognition I-GENE
sequence I-GENE
. O

We O
have O
recently O
identified O
a O
mouse O
enzyme O
termed O
gamma I-GENE
- I-GENE
glutamyl I-GENE
leukotrienase _RARE_
( O
GGL _RARE_
) O
that O
converts _RARE_
leukotriene _RARE_
C4 _RARE_
( O
LTC4 _RARE_
) O
to O
leukotriene _RARE_
D4 _RARE_
( O
LTD4 _RARE_
). O

UGA O
codon _RARE_
position O
affects O
the O
efficiency O
of O
selenocysteine _RARE_
incorporation O
into O
glutathione _RARE_
peroxidase I-GENE
- I-GENE
1 I-GENE
. O

Forskolin _RARE_
significantly O
enhanced _RARE_
heregulin _RARE_
- O
stimulated _RARE_
expression _RARE_
of O
cyclin _RARE_
D I-GENE
and O
phosphorylation _RARE_
of O
the O
retinoblastoma _RARE_
gene I-GENE
product I-GENE
. O

The O
ARF I-GENE
promoter I-GENE
was O
also O
found O
to O
be O
highly O
responsive O
to O
E2F1 I-GENE
expression _RARE_
, O
in O
keeping _RARE_
with O
previous O
results O
at _RARE_
the O
RNA O
level O
. O

RESULTS O
: O
The O
binding O
of O
99mTc O
d O
, O
1 O
- O
HMPAO O
to O
human O
placenta O
ranged O
from O
2 O
. O
95 _RARE_
% O
+/- O
1 O
. O
5 O
% O
to O
5 O
. O
82 O
% O
+/- O
0 _RARE_
. O
3 O
% O
per O
1 O
ml O
standard O
solution O
. O

CM _RARE_
reduced _RARE_
the O
nuclear O
binding O
activity O
of O
transcription I-GENE
factor I-GENE
AP I-GENE
- I-GENE
1 I-GENE
. O

NF _RARE_
- I-GENE
kappaB I-GENE
, O
which O
is O
probably O
important O
for _RARE_
basal O
activity O
of O
the O
human I-GENE
NOS _RARE_
II I-GENE
promoter I-GENE
, O
is O
unlikely O
to O
function O
as _RARE_
a O
major O
effector O
of O
CM _RARE_
in O
DLD _RARE_
- O
1 O
cells O
. O

Observers _RARE_
with O
brain O
injury O
and O
control O
participants _RARE_
performed O
a O
vigilance _RARE_
task O
during _RARE_
which O
they O
received O
periodic _RARE_
whiffs _RARE_
of O
unscented _RARE_
air O
or O
air O
scented _RARE_
with O
peppermint _RARE_
. O

A O
simple O
analytical _RARE_
method O
for _RARE_
l _RARE_
- O
menthol _RARE_
by O
high O
- O
performance O
liquid O
chromatography O
with O
a O
polarized _RARE_
photometric _RARE_
detector O
was O
established O
. O

RESULTS O
: O
The O
cardiac O
index O
significantly O
changed O
with O
varying O
PaCO2 O
levels O
( O
hypocapnia _RARE_
, O
- O
9 O
%; O
hypercapnia O
, O
13 _RARE_
%). O

After O
measuring O
baseline O
Vmca _RARE_
at _RARE_
a O
partial O
pressure O
of O
carbon O
dioxide O
in O
arterial O
blood _RARE_
( O
PaCO2 O
) O
of O
37 O
. O
7 O
+/- O
4 O
. O
5 O
mmHg O
( O
mean O
+/- O
SD O
), _RARE_
measurements O
were O
repeated _RARE_
at _RARE_
a O
PaCO _RARE_
of O
44 _RARE_
. O
2 O
+/- O
3 O
. O
8 O
mmHg O
, O
and O
the O
carbon O
dioxide O
reactivity O
( O
absolute O
value O
: O
cm O
x _RARE_
s O
(- _RARE_
1 O
) O
x _RARE_
mmHg O
(- _RARE_
1 O
); O
relative O
value O
: O
percentage O
of O
baseline O
Vmca _RARE_
/ O
mmHg O
) O
was O
calculated O
. O

Multivariate _RARE_
Cox O
survival O
analysis O
identified O
baseline O
EF _RARE_
< O
or O
= O
30 _RARE_
%, O
presence O
of O
significant O
mitral O
regurgitation _RARE_
(> O
2 O
+) O
before O
ablation O
, O
and O
failure O
to O
exhibit O
improved O
cardiac O
performance O
by O
1 O
month O
after O
ablation O
as _RARE_
the O
only O
independent O
predictors O
of O
death _RARE_
. O

We O
have O
developed O
a O
new O
method O
for _RARE_
estimation O
of O
regional O
CBF O
( O
rCBF O
) O
and O
cerebrovascular _RARE_
reserve O
capacity O
on O
a O
pixel _RARE_
- O
by O
- O
pixel _RARE_
basis O
by O
means O
of O
dynamic O
magnetic O
resonance O
imaging O
( O
MRI O
). O

Cost _RARE_
- O
effectiveness O
analysis O
provides O
a O
rational _RARE_
means O
of O
allocating _RARE_
limited O
health O
care O
resources _RARE_
by O
allowing O
the O
comparison O
of O
the O
costs O
of O
lipid _RARE_
- O
lowering O
therapy O
, O
in O
particular O
, O
therapy O
with O
beta I-GENE
- I-GENE
hydroxy I-GENE
- I-GENE
beta I-GENE
- I-GENE
methylglutaryl _RARE_
- I-GENE
CoA I-GENE
( I-GENE
coenzyme _RARE_
A I-GENE
) I-GENE
reductase I-GENE
inhibitors _RARE_
( O
statins _RARE_
), _RARE_
with O
the O
costs O
of O
atherosclerosis O
that O
could O
be O
prevented O
by O
lowering O
cholesterol O
. O

Although O
E2FBP1 _RARE_
lacks O
the O
transactivation _RARE_
domain O
, O
it O
stimulates O
E2F I-GENE
site O
- O
dependent O
transcription O
in O
cooperation O
with O
E2F I-GENE
- I-GENE
1 I-GENE
. O

Sequencing O
of O
a O
40 O
- O
kb O
DNA O
segment O
of O
the O
FK506 O
gene O
cluster O
from O
Streptomyces _RARE_
sp _RARE_
. O

The O
predicted O
domain O
structures _RARE_
of O
FkbB _RARE_
and O
FkbC _RARE_
are O
analogous O
to O
that O
of O
FkbA _RARE_
and O
comprise O
30 _RARE_
fatty I-GENE
- I-GENE
acid I-GENE
- I-GENE
synthase I-GENE
( O
FAS _RARE_
)- O
like O
domains O
arranged O
in O
6 O
modules _RARE_
. O

Analysis O
of O
Msy2 _RARE_
mRNA I-GENE
expression _RARE_
in O
prepubertal _RARE_
and O
adult O
mouse O
testes O
, O
and O
in O
isolated O
populations O
of O
germ _RARE_
cells O
, O
reveals O
maximal O
expression _RARE_
in O
postmeiotic _RARE_
round O
spermatids _RARE_
, O
a O
cell O
type O
with O
abundant O
amounts O
of O
stored O
messenger _RARE_
ribonucleoproteins _RARE_
. O

1 O
in O
Ho _RARE_
Chi O
Minh _RARE_
City O
was O
studied O
by O
culture O
and O
latex O
agglutination _RARE_
of O
blood _RARE_
, O
cerebrospinal _RARE_
fluid _RARE_
, O
urine O
and O
pleural _RARE_
fluid _RARE_
. O

Glycogen _RARE_
synthesis _RARE_
and O
catabolism O
, O
gluconeogenesis _RARE_
, O
glycolysis _RARE_
, O
motility _RARE_
, O
cell O
surface O
properties O
and O
adherence _RARE_
are O
modulated O
by O
csrA _RARE_
in I-GENE
Escherichia I-GENE
coli I-GENE
, O
while O
the O
production O
of O
several O
secreted _RARE_
virulence _RARE_
factors O
, O
the O
plant _RARE_
hypersensitive _RARE_
response O
elicitor _RARE_
HrpN _RARE_
( O
Ecc _RARE_
) O
and O
, O
potentially O
, O
other O
secondary O
metabolites O
are O
regulated O
by O
rsmA _RARE_
in I-GENE
Erwinia _RARE_
carotovora _RARE_
. O

The O
cwg2 _RARE_
- I-GENE
1 I-GENE
mutation I-GENE
was O
identified O
as _RARE_
a O
guanine O
to O
adenine _RARE_
substitution O
at _RARE_
nucleotide O
604 _RARE_
of O
the O
coding O
region O
, O
originating _RARE_
the O
change O
A202T _RARE_
in O
the O
cwg2p _RARE_
. O

Deletion O
analysis O
revealed O
that O
the O
essential O
domain O
of O
this O
promoter O
, O
termed O
the O
ORF5 _RARE_
/ I-GENE
deltaX _RARE_
transcript I-GENE
promoter I-GENE
, O
mapped O
to O
nucleotides O
1525 _RARE_
- O
1625 _RARE_
. O

Some O
of O
the O
peptide I-GENE
: I-GENE
MBP I-GENE
fusions I-GENE
were O
also O
analyzed O
using O
surface O
plasmon _RARE_
resonance O
. O

Cardiac _RARE_
myosin I-GENE
- I-GENE
binding I-GENE
protein I-GENE
C I-GENE
( O
MyBP _RARE_
- I-GENE
C I-GENE
): O
identification O
of O
protein I-GENE
kinase I-GENE
A I-GENE
and O
protein I-GENE
kinase I-GENE
C I-GENE
phosphorylation _RARE_
sites O
. O

Handling _RARE_
on O
PND _RARE_
9 O
did O
not O
result O
in O
elevated O
CORT _RARE_
levels O
in O
any O
of O
the O
groups O
. O

Analysis O
of O
chromosomal O
DNA O
sequence O
immediately O
downstream _RARE_
of O
the O
transposon _RARE_
insertion _RARE_
identified O
two O
open _RARE_
reading O
frames O
, O
designated O
csrR _RARE_
and O
csrS _RARE_
, O
which O
exhibited O
sequence O
similarity _RARE_
to O
bacterial O
two O
- O
component _RARE_
regulatory O
systems _RARE_
. O

633 _RARE_
+/- O
258 O
aggregates O
/ O
ml O
at _RARE_
0 _RARE_
rpm _RARE_
; O
P O
< O
0 _RARE_
. O
001 O
). O

We O
previously O
delineated _RARE_
a O
region O
in O
the O
fatty I-GENE
- I-GENE
acid I-GENE
synthase I-GENE
promoter I-GENE
, O
which O
was O
responsible O
for _RARE_
obesity O
- O
related O
overexpression O
of O
the O
fatty I-GENE
- I-GENE
acid I-GENE
synthase I-GENE
( O
FAS _RARE_
) O
gene O
, O
by O
negatively O
regulating _RARE_
the O
activity O
of O
the O
downstream _RARE_
promoter O
in O
lean O
but O
not O
obese O
rat O
fat O
cells O
. O

Finally O
, O
using O
in O
vitro O
binding O
studies O
, O
we O
showed O
that O
SREBP2 _RARE_
was O
able O
to O
displace _RARE_
ADD1 _RARE_
/ O
SREBP1 _RARE_
binding O
from O
the O
sterol O
regulatory O
element O
( O
SRE O
) O
site O
. O

Thus O
, O
IRF I-GENE
- I-GENE
7 I-GENE
exhibits O
functional _RARE_
similarity _RARE_
to O
IRF I-GENE
- I-GENE
3 I-GENE
; O
however O
, O
the O
preferential O
expression _RARE_
of O
IRF I-GENE
- I-GENE
7 I-GENE
in O
lymphoid _RARE_
cells O
( O
the O
cell O
type O
that O
expresses _RARE_
IFNA _RARE_
) O
suggests O
that O
IRF I-GENE
- I-GENE
7 I-GENE
may O
play O
a O
critical O
role O
in O
regulating _RARE_
the O
IFNA _RARE_
gene I-GENE
expression _RARE_
. O

J _RARE_
. O

PURPOSE O
: O
The O
role O
interleukin I-GENE
- I-GENE
6 I-GENE
( O
IL _RARE_
- I-GENE
6 I-GENE
) O
in O
the O
treatment O
of O
congenital O
thrombocytopenias _RARE_
is O
unknown O
. O

CKII _RARE_
as _RARE_
a O
CD44 I-GENE
- I-GENE
associated I-GENE
serine I-GENE
kinase I-GENE
therefore O
may O
serve O
as _RARE_
an O
important O
molecule O
in O
a O
signaling _RARE_
cascade O
that O
produces O
a O
variety O
of O
cellular O
responses O
in O
MDA231 _RARE_
breast O
cancer _RARE_
cells O
. O

Galphaq _RARE_
, O
Galpha12 _RARE_
, O
and O
Galpha13 _RARE_
, O
but O
not O
Galphai _RARE_
, O
activate O
SRF I-GENE
through O
RhoA I-GENE
. O

Additionally O
in O
seven _RARE_
subjects O
adrenaline O
( O
A O
) O
and O
noradrenaline O
( O
NA O
) O
concentrations O
were O
determined O
. O

Northern O
blot O
analyses O
show O
that O
the O
hBub1 _RARE_
mRNA I-GENE
level O
is O
abundantly O
expressed _RARE_
in O
tissues O
or O
cells O
with O
a O
high O
mitotic _RARE_
index O
. O

We O
mapped O
two O
overlapping O
expressed _RARE_
sequence O
tag O
clones _RARE_
within O
a O
genomic O
contig O
on O
human O
chromosome _RARE_
5 O
, O
band O
q31 _RARE_
. O

Htra2 _RARE_
- I-GENE
beta3 _RARE_
is O
developmentally O
regulated O
and O
expressed _RARE_
predominantly O
in O
brain O
, O
liver O
testis _RARE_
, O
and O
weakly O
in O
kidney _RARE_
. O

Gng3lg _RARE_
transcripts I-GENE
are O
expressed _RARE_
in O
a O
variety O
of O
tissues O
including O
both O
brain O
and O
testes O
. O

Using O
an O
interspecific _RARE_
backcross O
panel O
, O
we O
localized O
both O
Gng3 _RARE_
and O
Gng3lg _RARE_
to O
the O
same O
locus O
on O
chromosome _RARE_
19 O
. O

We O
also O
raised O
a O
polyclonal _RARE_
antibody O
against O
the O
glutathione _RARE_
S I-GENE
- I-GENE
transferase I-GENE
fusion I-GENE
protein I-GENE
containing O
the O
NH2 O
- O
terminal O
86 _RARE_
amino O
acids _RARE_
of O
human I-GENE
NRAMP2 _RARE_
. O

Inhibition O
of O
the O
apolipoprotein I-GENE
B I-GENE
mRNA I-GENE
editing _RARE_
enzyme O
- O
complex O
by O
hnRNP _RARE_
C1 I-GENE
protein I-GENE
and O
40S _RARE_
hnRNP _RARE_
complexes I-GENE
. O

SRC I-GENE
- I-GENE
1 I-GENE
can O
relieve _RARE_
the O
NF _RARE_
- I-GENE
kappaB I-GENE
- O
mediated _RARE_
repression O
of O
GR I-GENE
activity O
. O

However O
the O
sequence O
surrounding O
the O
transcription O
start _RARE_
site O
CTCA _RARE_
(+ O
1 O
) O
TTCC _RARE_
was O
similar O
to O
the O
consensus O
CTCA _RARE_
(+ O
1 O
) O
NTCT _RARE_
( O
N O
is O
any O
nucleoside _RARE_
) O
for _RARE_
an O
initiator _RARE_
element O
found O
in O
terminal I-GENE
deoxynucleotidyltransferase _RARE_
and O
a O
number O
of O
other O
highly O
regulated O
genes O
. O

These O
results O
indicate O
that O
the O
total _RARE_
number O
of O
subunit O
c O
in O
F0 _RARE_
should O
be O
a O
multiple O
of O
2 O
and O
3 O
. O

Expression O
of O
a O
dominant O
- O
negative O
mutant O
of O
JNK1 I-GENE
also O
suppressed O
glucose O
deprivation O
- O
induced _RARE_
JNK1 I-GENE
activation O
as _RARE_
well _RARE_
as _RARE_
HSP70 I-GENE
gene I-GENE
expression _RARE_
. O

The O
interaction O
of O
AF _RARE_
- O
1 O
with O
proteins O
that O
regulate O
distinct O
steps O
of O
transcription O
may O
provide O
a O
mechanism O
for _RARE_
synergistic O
activation O
of O
gene O
expression _RARE_
by O
AF _RARE_
- O
1 O
. O

The O
role O
of O
protein I-GENE
kinase I-GENE
C I-GENE
signaling _RARE_
in O
activated O
DRA _RARE_
transcription O
. O

Ligand _RARE_
binding O
to O
the O
receptor O
complex O
leads O
to O
tyrosine O
phosphorylation _RARE_
and O
activation O
of O
Janus I-GENE
kinases I-GENE
( O
Jak I-GENE
), _RARE_
phosphorylation _RARE_
of O
the O
signal I-GENE
transducing _RARE_
subunit I-GENE
gp130 _RARE_
, O
followed O
by O
recruitment O
and O
phosphorylation _RARE_
of O
the O
signal I-GENE
transducer _RARE_
and I-GENE
activator I-GENE
of I-GENE
transcription I-GENE
factors I-GENE
STAT3 I-GENE
and O
STAT1 I-GENE
and O
the O
src I-GENE
homology I-GENE
domain I-GENE
( O
SH2 _RARE_
)- O
containing O
protein I-GENE
tyrosine I-GENE
phosphatase I-GENE
( O
SHP2 _RARE_
). O

Interestingly O
, O
an O
increase O
of O
distance O
per O
se _RARE_
did O
not O
have O
a O
deleterious _RARE_
effect O
on O
translation O
efficiency O
. O

We O
also O
mapped O
a O
3 O
'- O
polyadenylation O
site O
504bp _RARE_
downstream _RARE_
of O
the O
TGA _RARE_
stop O
codon _RARE_
, O
consistent O
with O
the O
2 O
. O
5kb _RARE_
transcript O
size O
. O

RBP56 _RARE_
protein I-GENE
turned O
out O
to O
be O
hTAFII68 _RARE_
which O
was O
isolated O
as _RARE_
a O
TATA I-GENE
- I-GENE
binding I-GENE
protein I-GENE
associated I-GENE
factor I-GENE
( O
TAF _RARE_
) O
from O
a O
sub O
- O
population O
of O
TFIID I-GENE
complexes I-GENE
( O
Bertolotti _RARE_
A O
., O
Lutz _RARE_
, O
Y O
., O
Heard _RARE_
, O
D O
. O
J _RARE_
., O
Chambon _RARE_
, O
P O
., O
Tora _RARE_
, O
L O
., O
1996 O
. O
hTAFII68 _RARE_
, O
a O
novel O
RNA O
/ O
ssDNA _RARE_
- O
binding O
protein O
with O
homology O
to O
the O
proto _RARE_
- O
oncoproteins _RARE_
TLS _RARE_
/ O
FUS _RARE_
and O
EWS I-GENE
is O
associated O
with O
both O
TFIID I-GENE
and O
RNA I-GENE
polymerase I-GENE
II I-GENE
. O

An O
electrophoretic O
mobility O
shift O
assay O
was O
performed O
to O
characterize O
the O
binding O
property _RARE_
of O
TR2 _RARE_
and O
its O
truncated O
isoform O
. O

Gel O
- O
mobility O
shift O
analysis O
was O
also O
performed O
for _RARE_
the O
CCAAT O
motif O
at _RARE_
- O
67 O
. O

BACKGROUND O
: O
The O
c I-GENE
- I-GENE
myc I-GENE
proto _RARE_
- I-GENE
oncogene I-GENE
has O
been O
suggested O
to O
play O
key O
roles O
in O
cell O
proliferation _RARE_
, O
differentiation O
, O
transformation O
and O
apoptosis O
. O

AMY _RARE_
- I-GENE
1 I-GENE
was O
localized O
in O
the O
cytoplasm O
in O
cells O
expressing O
c I-GENE
- I-GENE
myc I-GENE
at _RARE_
low O
levels O
, O
but O
in O
the O
nucleus O
in O
the O
cells O
of O
a O
high O
c I-GENE
- I-GENE
myc I-GENE
expression _RARE_
in O
transiently O
transfected O
cells O
. O

RESULTS O
: O
We O
identified O
a O
full O
- O
length O
cDNA O
with O
an O
open _RARE_
reading O
frame O
of O
2883 _RARE_
bp O
corresponding O
to O
a O
predicted O
protein O
of O
961 _RARE_
amino O
acids _RARE_
that O
shares O
greater O
than O
95 _RARE_
% O
homology O
with O
the O
rat I-GENE
gamma I-GENE
- I-GENE
aminobutyric _RARE_
acid I-GENE
B I-GENE
( I-GENE
GABAB _RARE_
) I-GENE
receptor I-GENE
. O

On O
Day O
8 O
, O
the O
CIDR _RARE_
- O
B O
was O
removed O
and O
500 O
micrograms O
cloprostenol _RARE_
injected O
, O
IM O
. O

Antidepressant _RARE_
- O
like O
properties O
of O
some O
serotonin _RARE_
receptor I-GENE
ligands O
and O
calcium _RARE_
channel _RARE_
antagonists O
measured O
with O
the O
forced _RARE_
swimming O
test O
in O
mice O
. O

Another O
tentative _RARE_
hotspot _RARE_
mutation O
in O
the O
third O
patient O
, O
a O
frame O
shift O
caused O
by O
a O
G O
nucleotide O
insertion _RARE_
in O
a O
monotonous _RARE_
repeat O
of O
six _RARE_
Gs _RARE_
in O
HPRT _RARE_
exon _RARE_
3 I-GENE
, O
has O
been O
reported O
previously O
in O
three O
other O
LN _RARE_
patients O
. O

SRF I-GENE
- O
deficient _RARE_
embryos _RARE_
( O
Srf _RARE_
-/-) _RARE_
have O
a O
severe O
gastrulation _RARE_
defect O
and O
do O
not O
develop O
to O
term O
. O

These O
characteristic O
structural O
features O
were O
used O
to O
create O
the O
abbreviation _RARE_
AZF1 _RARE_
( O
Asparagine _RARE_
- I-GENE
rich I-GENE
Zinc _RARE_
Finger _RARE_
protein I-GENE
). O

Over _RARE_
- O
expression _RARE_
of O
Azf1p _RARE_
in O
the O
yeast O
cell O
does O
not O
influence O
the O
expression _RARE_
level O
of O
the O
mitochondrial I-GENE
transcription I-GENE
factor I-GENE
Mtf1p _RARE_
, O
indicating O
that O
the O
influence O
of O
Azf1p _RARE_
on O
the O
suppression O
of O
the O
special _RARE_
mitochondrial I-GENE
RNA I-GENE
polymerase I-GENE
mutant I-GENE
is O
an O
indirect O
one O
. O

We O
have O
generated O
a O
computer O
model O
of O
the O
C O
- O
terminal O
domain O
of O
the O
434 _RARE_
repressor O
based O
on O
the O
crystal _RARE_
structure _RARE_
of O
the O
homologous I-GENE
UmuD _RARE_
' I-GENE
protein I-GENE
. O

Large _RARE_
- O
scale O
sequencing O
of O
two O
regions O
in O
human O
chromosome _RARE_
7q22 _RARE_
: O
analysis O
of O
650 _RARE_
kb O
of O
genomic O
sequence O
around O
the O
EPO I-GENE
and O
CUTL1 _RARE_
loci I-GENE
reveals O
17 _RARE_
genes O
. O

Because O
Trp53 _RARE_
( O
the O
mouse I-GENE
homolog I-GENE
of I-GENE
human I-GENE
TP53 _RARE_
) O
is O
located _RARE_
with O
Tk1 _RARE_
on O
chromosome _RARE_
11 O
and O
is O
critical O
in O
regulating _RARE_
cellular O
responses O
following O
exposure O
to O
DNA O
damaging _RARE_
agents O
, O
we O
wanted _RARE_
to O
determine O
if O
these O
mouse O
lymphoma O
cells O
harbor O
mutations O
in O
Trp53 _RARE_
. O

One O
of O
these O
fragments O
shows O
the O
highest O
amino O
acid O
sequence O
homology O
to O
the O
insect O
ecdysone O
inducible O
gene I-GENE
E75 _RARE_
. O

The O
full O
- O
length O
N I-GENE
gene I-GENE
, O
encoded O
by O
open _RARE_
reading O
frame O
7 O
, O
was O
cloned _RARE_
from O
the O
Canadian _RARE_
PRRS _RARE_
virus O
, O
PA O
- O
8 O
. O

Based O
on O
sequence O
homology O
, O
the O
genes O
were O
identified O
as _RARE_
TEF I-GENE
, O
encoding O
translation I-GENE
elongation _RARE_
factor I-GENE
- I-GENE
1 I-GENE
alpha I-GENE
and O
RPS7 _RARE_
, O
encoding O
ribosomal O
protein O
S7 _RARE_
. O

We O
have O
previously O
shown O
that O
ARNO _RARE_
localizes O
to O
the O
plasma O
membrane O
in O
vivo O
and O
efficiently O
catalyzes O
ARF6 _RARE_
nucleotide O
exchange O
in O
vitro O
. O

Renal O
pathology O
and O
long O
- O
term O
outcome O
in O
childhood O
SLE O
. O

Transcription O
factors O
of O
the O
Stat I-GENE
family I-GENE
are O
controlled _RARE_
by O
protein O
kinases O
. O

We O
propose O
that O
two O
pathways O
regulate O
Stat5 I-GENE
serine O
phosphorylation _RARE_
, O
one O
that O
is O
prolactin I-GENE
- O
activated O
and O
PD98059 O
- O
resistant O
and O
one O
that O
is O
constitutively O
active _RARE_
and O
PD98059 O
- O
sensitive _RARE_
and O
preferentially O
targets _RARE_
Stat5a I-GENE
. O

An O
approximately _RARE_
37 O
- O
kDa O
cytoplasmic O
protein O
is O
rapidly O
tyrosine O
- O
phosphorylated _RARE_
in O
the O
response O
of O
mouse O
BAC1 _RARE_
. O
2F5 _RARE_
macrophages O
to O
colony I-GENE
stimulating I-GENE
factor I-GENE
- I-GENE
1 I-GENE
( O
CSF I-GENE
- I-GENE
1 I-GENE
). O
pp37 _RARE_
was O
purified _RARE_
from O
the O
cytosolic O
fraction O
by O
anti I-GENE
- I-GENE
Tyr _RARE_
( I-GENE
P I-GENE
) I-GENE
affinity O
chromatography O
, O
size O
exclusion O
chromatography O
, O
and O
C4 _RARE_
reverse O
phase _RARE_
high O
pressure O
liquid O
chromatography O
. O

Dose _RARE_
of O
20 O
ig _RARE_
were O
administered O
within O
a O
scheme _RARE_
from O
0 _RARE_
. O
1 O
to O
6 O
months O
in O
order O
to O
study O
its O
immunogenicity _RARE_
, O
which O
was O
evaluated O
at _RARE_
2 O
, O
7 O
, O
and O
12 O
months O
after O
the O
first _RARE_
dose O
. O

The O
various O
available O
data O
strongly O
suggesting O
an O
environmental O
toxic O
origin O
for _RARE_
the O
" O
sperm O
fall O
" O
will O
be O
presented O
as _RARE_
well _RARE_
as _RARE_
the O
most O
frequently O
suspected O
class O
of O
substances O
, O
the O
xenoestrogens _RARE_
. O

This O
association O
was O
independently O
significant O
for _RARE_
patients O
treated O
primarily O
( O
not O
for _RARE_
recurrence O
). O

CONCLUSION O
: O
Local _RARE_
control O
was O
highest O
with O
Preop _RARE_
in O
patients O
presenting _RARE_
primarily O
with O
gross O
disease _RARE_
, O
and O
with O
Postop _RARE_
in O
patients O
presenting _RARE_
primarily O
following O
gross O
total _RARE_
excision _RARE_
. O

Its O
interaction O
with O
RFX5 _RARE_
and O
RFXAP _RARE_
is O
essential O
for _RARE_
binding O
of O
the O
RFX _RARE_
complex I-GENE
to O
MHC I-GENE
- I-GENE
II I-GENE
promoters I-GENE
. O

We O
have O
previously O
mapped O
the O
defect O
in O
RIIIS _RARE_
/ O
J _RARE_
to O
distal O
mouse O
Chr O
11 O
, O
distinct O
from O
the O
Vwf _RARE_
locus I-GENE
on O
Chr O
6 O
. O

These O
data O
may O
also O
aid O
in O
the O
localization _RARE_
of O
other O
disease _RARE_
loci O
mapped O
to O
this O
region O
, O
including O
the O
gene O
for _RARE_
tricho _RARE_
- O
dento _RARE_
- O
osseous _RARE_
syndrome _RARE_
and O
a O
murine O
locus O
for _RARE_
susceptibility _RARE_
to O
ozone _RARE_
- O
induced _RARE_
acute O
lung _RARE_
injury O
. O

Copyright O
1998 O
Academic O
Press O
. O

An O
open _RARE_
reading O
frame O
encoding O
a O
protein O
which O
shows O
significant O
similarity _RARE_
to O
invertases _RARE_
and O
resolvases _RARE_
was O
located _RARE_
immediately O
upstream O
of O
the O
Pac25I _RARE_
R I-GENE
- I-GENE
M I-GENE
operon I-GENE
. O

Identification O
of O
a O
new O
gene O
in O
the O
streptococcal _RARE_
plasmid _RARE_
pLS1 _RARE_
: O
the O
rnaI _RARE_
gene I-GENE
. O

Rather _RARE_
, O
usp _RARE_
is O
required O
in O
late _RARE_
third O
instar _RARE_
larvae O
for _RARE_
appropriate O
developmental O
and O
transcriptional O
responses O
to O
the O
ecdysone O
pulse O
that O
triggers O
puparium _RARE_
formation O
. O

An O
intact _RARE_
neurovascular _RARE_
supply O
is O
essential O
for _RARE_
the O
viability O
of O
a O
muscle O
flap O
. O

Examination O
of O
DNA O
: O
protein O
binding O
complexes O
by O
gel O
- O
shift O
analysis O
indicated O
that O
nuclear O
factors O
from O
both O
proliferative O
and O
growth O
- O
arrested O
cells O
bound _RARE_
to O
the O
DNA O
fragment O
spanning O
- O
949 _RARE_
- O
- O
722 _RARE_
bp O
. O

BACKGROUND O
: O
Studies O
in O
lean O
men O
show O
poor O
regulation _RARE_
of O
energy O
( O
EB _RARE_
) O
and O
fat O
balance O
( O
FB O
) O
during _RARE_
manipulation _RARE_
of O
dietary O
ratios O
of O
fat O
to O
carbohydrate O
. O

Fatal _RARE_
apneusis _RARE_
was O
observed O
under O
following O
conditions O
: O
( O
1 O
) O
Persistent _RARE_
apnea O
was O
produced O
after O
a O
single O
KA _RARE_
microinjection O
in O
one O
side _RARE_
of O
the O
VRG _RARE_
- O
Apa _RARE_
( O
5 O
animals O
). O

A O
comparative O
analysis O
of O
the O
reported O
MOCT _RARE_
- O
associated O
malignant O
melanomas O
emphasizes O
the O
singularity _RARE_
of O
our O
case O
in O
the O
amelanotic _RARE_
character O
of O
the O
melanoma _RARE_
, O
its O
lymphotropism _RARE_
and O
the O
coexistence _RARE_
of O
invasive O
squamous O
cell O
carcinoma O
. O

RESULTS O
: O
An O
herpetic _RARE_
seroconversion _RARE_
is O
observed O
with O
presence O
of O
type O
I O
herpes O
simplex O
virus O
( O
HSV O
I O
) O
nucleic _RARE_
acids _RARE_
in O
the O
recipient O
' O
s O
aqueous O
humor _RARE_
. O

These O
results O
indicate O
that O
HIV O
- O
1 O
Gag I-GENE
sequences I-GENE
can O
influence O
the O
viral I-GENE
PR I-GENE
- O
mediated _RARE_
processing _RARE_
of O
the O
MuLV O
TM _RARE_
Env I-GENE
protein I-GENE
p15 _RARE_
( O
E O
). O

These O
results O
demonstrate O
a O
specific O
association O
of O
SIV O
and O
HIV I-GENE
- I-GENE
2 I-GENE
nef I-GENE
, O
but O
not O
HIV I-GENE
- I-GENE
1 I-GENE
nef I-GENE
, O
with O
TCRzeta _RARE_
. O

Competition O
EMSA O
established O
that O
constitutively O
expressed _RARE_
nuclear O
proteins O
bound _RARE_
the O
KCS _RARE_
element I-GENE
selectively O
; O
KCS _RARE_
protein I-GENE
binding O
activity O
correlated O
with O
promoter O
activity O
in O
the O
transient O
transfection O
reporter O
assay O
. O

Mechanism O
of O
interferon _RARE_
action O
: O
identification O
of O
essential O
positions O
within O
the O
novel O
15 _RARE_
- I-GENE
base _RARE_
- I-GENE
pair _RARE_
KCS _RARE_
element I-GENE
required O
for _RARE_
transcriptional O
activation O
of O
the O
RNA I-GENE
- I-GENE
dependent I-GENE
protein I-GENE
kinase I-GENE
pkr _RARE_
gene I-GENE
. O

GH _RARE_
failed O
to O
stimulate O
phosphorylation _RARE_
or O
activation O
of O
Jun I-GENE
N I-GENE
- I-GENE
terminal I-GENE
kinase I-GENE
under O
the O
conditions O
used O
. O

Expression O
of O
a O
novel O
murine I-GENE
phospholipase I-GENE
D I-GENE
homolog I-GENE
coincides _RARE_
with O
late _RARE_
neuronal _RARE_
development O
in O
the O
forebrain _RARE_
. O

We O
detected O
no _RARE_
effect O
of O
deleting _RARE_
YCL024W _RARE_
, O
either O
alone O
or O
in O
combination O
with O
deletion O
of O
GIN4 _RARE_
. O

Paralemmin _RARE_
is O
also O
phosphorylated _RARE_
, O
and O
its O
mRNA O
is O
differentially O
spliced _RARE_
in O
a O
tissue O
- O
specific O
and O
developmentally O
regulated O
manner O
. O

The O
deduced O
amino O
acid O
sequence O
of O
CBP90 _RARE_
had O
no _RARE_
significant O
similarity _RARE_
to O
any O
other O
protein O
, O
but O
it O
had O
a O
proline O
- O
rich O
domain O
at _RARE_
the O
C O
- O
terminal O
region O
. O

The O
effect O
of O
low O
- O
profile O
serine O
substitutions O
in O
the O
V3 _RARE_
loop O
of O
HIV O
- O
1 O
gp120 I-GENE
IIIB _RARE_
/ O
LAI _RARE_
on O
the O
immunogenicity _RARE_
of O
the O
envelope I-GENE
protein O
. O

Transcription O
start _RARE_
site O
mapping O
identified O
the O
presence O
of O
an O
aphidicolin _RARE_
- O
sensitive _RARE_
late _RARE_
transcript O
arising O
from O
a O
TAAG _RARE_
motif O
located _RARE_
at _RARE_
- O
352 _RARE_
nucleotides O
and O
an O
aphidicolin _RARE_
- O
insensitive _RARE_
early O
transcript O
originating _RARE_
from O
a O
TTGT _RARE_
motif O
located _RARE_
35 _RARE_
nucleotides O
downstream _RARE_
to O
a O
TATA O
box O
at _RARE_
- O
312 _RARE_
nucleotides O
, O
with O
respect O
to O
the O
+ O
1 O
ATG O
of O
lef2 _RARE_
. O

The O
human I-GENE
2 I-GENE
', _RARE_
5 I-GENE
'- I-GENE
oligoadenylate _RARE_
( I-GENE
2 I-GENE
- I-GENE
5A _RARE_
) I-GENE
synthetases I-GENE
are O
members O
of O
a O
family O
interferon _RARE_
( O
IFN I-GENE
)- O
inducible O
anti I-GENE
- I-GENE
viral I-GENE
proteins I-GENE
. O

Our O
findings O
demonstrate O
a O
dose O
- O
dependent O
blockade O
of O
the O
mechanical O
sensitivity O
caused O
by O
a O
mild O
thermal O
injury O
by O
both O
GBP _RARE_
and O
IBG _RARE_
. O

These O
striations _RARE_
were O
caused O
by O
contact _RARE_
between O
the O
sharp _RARE_
edge _RARE_
of O
the O
upper O
canine O
and O
the O
P3 _RARE_
during _RARE_
honing _RARE_
( O
canine O
/ O
premolar _RARE_
complex O
). O

Low O
PbrO2 _RARE_
readings _RARE_
, O
however O
, O
could O
be O
caused O
by O
local O
microhemorrhages _RARE_
, O
undetectable O
on O
CT _RARE_
or O
MRI O
. O

The O
consequences O
of O
intensive O
swine O
production O
on O
the O
environment O
and O
possible O
solutions O
by O
means O
of O
nutrition O
are O
outlined _RARE_
. O

This O
study O
demonstrates O
that O
alteration O
of O
CDKN2 _RARE_
is O
one O
of O
the O
most O
frequent O
genetic O
abnormalities O
in O
prostate _RARE_
cancer _RARE_
and O
may O
contribute O
to O
prostate _RARE_
carcinogenesis _RARE_
. O

The O
pharmacokinetic O
parameters O
which O
helped _RARE_
predict O
these O
toxicities _RARE_
included O
area O
under O
the O
curve O
and O
peak O
plasma O
level O
. O

A O
Chinese _RARE_
( O
HK _RARE_
) O
SF _RARE_
- O
36 _RARE_
survey O
form O
was O
developed O
by O
an O
iterative _RARE_
translation O
process O
. O

However O
, O
the O
use O
of O
cyclosporin O
A O
is O
associated O
with O
an O
increased O
prevalence O
of O
hypertension O
in O
kidney _RARE_
transplant O
recipients O
. O

PURPOSE O
: O
To O
determine O
the O
effects O
of O
hypercholesterolemia _RARE_
and O
atherosclerosis O
- O
induced _RARE_
chronic O
cavernosal _RARE_
arterial O
insufficiency O
on O
cavernosal _RARE_
smooth _RARE_
muscle O
tone O
, O
nitric _RARE_
oxide I-GENE
synthase I-GENE
( O
NOS _RARE_
) O
activity O
and O
cavernosal _RARE_
tissue O
synthesis _RARE_
of O
constrictor _RARE_
eicosanoids _RARE_
. O

Characterization O
of O
the O
regulatory O
regions O
of O
the O
human I-GENE
aromatase I-GENE
( O
P450arom _RARE_
) O
gene O
involved O
in O
placenta O
- O
specific O
expression _RARE_
. O

Recombinant I-GENE
FVIIa _RARE_
was O
stable O
in O
the O
infusion O
pump _RARE_
for _RARE_
several O
days O
at _RARE_
room O
temperature _RARE_
and O
for _RARE_
24 _RARE_
h O
at _RARE_
body O
temperature _RARE_
. O

CD4 _RARE_
lymphocyte O
and O
viral O
load O
levels O
suggested O
an O
optimal O
response O
to O
ARV _RARE_
therapy O
at _RARE_
the O
time O
LD _RARE_
developed O
. O

( O
1992 O
) O
Biochemistry _RARE_
31 _RARE_
, O
3351 _RARE_
- O
3358 _RARE_
]. O

Levels _RARE_
of O
serum O
IgE I-GENE
were O
measured O
monthly O
, O
and O
nasal O
IgE I-GENE
was O
measured O
at _RARE_
the O
height O
and O
end O
of O
the O
season O
. O

A O
mutation O
in O
the O
5 O
' O
C2U4 _RARE_
repeat O
causes O
underaccumulation _RARE_
of O
snR13F _RARE_
, O
whereas O
mutations O
in O
the O
3 O
' O
C2U4 _RARE_
repeat O
cause O
the O
accumulation O
of O
two O
novel O
RNAs O
that O
migrate _RARE_
in O
the O
500 O
- O
nt O
range O
. O

By O
directly O
interacting _RARE_
with O
both O
Arfs _RARE_
and O
tyrosine I-GENE
kinases I-GENE
involved O
in O
regulating _RARE_
cell O
growth O
and O
cytoskeletal O
organization O
, O
ASAP1 _RARE_
could O
coordinate O
membrane O
remodeling O
events O
with O
these O
processes O
. O

By O
DNase I-GENE
I I-GENE
footprint O
analysis O
of O
the O
PNR _RARE_
element O
, O
a O
palindrome O
of O
two O
high O
- O
affinity O
Ets I-GENE
- I-GENE
binding I-GENE
sites I-GENE
( O
CTTCCCTGGAAG _RARE_
) O
was O
identified O
. O

These O
sorting _RARE_
nexins _RARE_
also O
associated O
with O
the O
long O
isoform O
of O
the O
leptin I-GENE
receptor I-GENE
but O
not O
with O
the O
short O
and O
medium O
isoforms O
. O

Cyclophilins _RARE_
are O
cis I-GENE
- I-GENE
trans _RARE_
- I-GENE
peptidyl _RARE_
- I-GENE
prolyl _RARE_
isomerases _RARE_
that O
bind O
to O
and O
are O
inhibited O
by O
the O
immunosuppressant _RARE_
cyclosporin O
A O
( O
CsA O
). O

In O
vitro O
protein O
retention O
experiments O
in O
which O
Hsp90 _RARE_
heterocomplexes _RARE_
were O
precipitated O
resulted O
in O
coprecipitation _RARE_
of O
Cns1 _RARE_
. O

The O
Ras I-GENE
- I-GENE
related I-GENE
GTPases I-GENE
are O
small O
, O
20 O
- O
to O
25 _RARE_
- O
kDa O
proteins O
which O
cycle _RARE_
between O
an O
inactive O
GDP O
- O
bound _RARE_
form O
and O
an O
active _RARE_
GTP O
- O
bound _RARE_
state O
. O

To O
modulate O
transcription O
, O
regulatory O
factors O
communicate _RARE_
with O
basal O
transcription O
factors O
and O
/ O
or O
RNA I-GENE
polymerases _RARE_
in O
a O
variety O
of O
ways O
. O

Endogenous _RARE_
RMP _RARE_
was O
immunologically _RARE_
detected O
interacting _RARE_
with O
assembled O
RPB5 _RARE_
in O
RNA I-GENE
polymerase I-GENE
in O
mammalian O
cells O
. O

In O
this O
study O
, O
rabbits O
were O
used O
to O
evaluate O
the O
sutured _RARE_
wound O
reaction O
with O
Dexon _RARE_
or O
nylon _RARE_
in O
the O
conjunctival _RARE_
flap O
1 O
, O
4 O
, O
7 O
, O
14 O
and O
28 _RARE_
days O
after O
trabeculectomy _RARE_
surgery O
with O
or O
without O
the O
use O
of O
mitomycin _RARE_
- O
C O
. O

The O
mapping O
was O
completed O
with O
Southern O
blotting O
and O
restriction _RARE_
analysis O
. O

The O
zona _RARE_
pellucida _RARE_
( O
ZP _RARE_
), _RARE_
the O
extracellular O
glycocalyx _RARE_
that O
surrounds _RARE_
the O
oocyte _RARE_
, O
is O
well _RARE_
known O
to O
mediate O
homologous O
gamete _RARE_
interaction O
. O

Therapeutic _RARE_
use O
of O
continuous O
subcutaneous O
infusion O
of O
recombinant I-GENE
human I-GENE
erythropoietin I-GENE
in O
malnourished _RARE_
predialysis _RARE_
anemic _RARE_
patients O
with O
diabetic O
nephropathy O
. O

Although O
pathological O
thyroid O
function O
is O
related O
to O
changes O
in O
energy O
expenditure O
and O
body O
composition O
, O
its O
possible O
influence O
on O
leptin I-GENE
levels O
remains O
to O
be O
determined O
. O

These O
cognitive O
deficits O
were O
prevented O
in O
animals O
treated O
with O
MK O
- O
801 O
during _RARE_
SE O
. O

Here O
we O
demonstrate O
that O
the O
mechanism O
of O
activation O
of O
HIF I-GENE
- I-GENE
1alpha I-GENE
is O
a O
multi _RARE_
- O
step O
process O
which O
includes O
hypoxia _RARE_
- O
dependent O
nuclear O
import O
and O
activation O
( O
derepression O
) O
of O
the O
transactivation _RARE_
domain O
, O
resulting O
in O
recruitment O
of O
the O
CREB I-GENE
- I-GENE
binding I-GENE
protein I-GENE
( O
CBP I-GENE
)/ _RARE_
p300 I-GENE
coactivator _RARE_
. O

Thus O
, O
hypoxia _RARE_
- O
inducible O
nuclear O
import O
and O
transactivation _RARE_
by O
recruitment O
of O
CBP I-GENE
can O
be O
functionally O
separated O
from O
one O
another O
and O
play O
critical O
roles O
in O
signal O
transduction _RARE_
by O
HIF I-GENE
- I-GENE
1alpha I-GENE
. O

The O
rat I-GENE
aldolase _RARE_
C I-GENE
gene I-GENE
encodes O
a O
glycolytic _RARE_
enzyme O
strongly O
expressed _RARE_
in O
adult O
brain O
. O

A O
synergistic O
effect O
on O
HCK _RARE_
promoter I-GENE
activity O
was O
observed O
at _RARE_
high O
concentrations O
of O
Sp1 _RARE_
. O

Quinone _RARE_
- O
binding O
domain O
and O
amino O
acid O
residues O
involved O
in O
quinone _RARE_
binding O
. O

Western O
analyses O
with O
antisera O
raised O
against O
Lu _RARE_
- I-GENE
ECAM _RARE_
- I-GENE
1 I-GENE
peptides I-GENE
show O
that O
the O
N O
- O
terminal O
region O
of O
the O
predicted O
open _RARE_
reading O
frame O
is O
present O
only O
in O
the O
larger O
size O
proteins O
( O
i O
. O
e _RARE_
. O

Mammalian _RARE_
sperm O
motility _RARE_
is O
regulated O
by O
a O
cascade O
of O
cAMP O
- O
dependent O
protein O
phosphorylation _RARE_
events O
mediated _RARE_
by O
protein I-GENE
kinase I-GENE
A I-GENE
. O

In O
this O
paper O
, O
we O
show O
that O
, O
like O
BAP2 _RARE_
, O
the O
expression _RARE_
of O
the O
BAP3 _RARE_
gene I-GENE
in O
S O
. O
cerevisiae O
is O
induced _RARE_
by O
the O
addition O
of O
branched _RARE_
- O
chain O
amino O
acids _RARE_
to O
the O
medium O
. O

Effect O
of O
enteral _RARE_
nutritional O
products O
differing _RARE_
in O
carbohydrate O
and O
fat O
on O
indices O
of O
carbohydrate O
and O
lipid _RARE_
metabolism O
in O
patients O
with O
NIDDM _RARE_
. O

Low O
- O
grade O
gastric _RARE_
MALT _RARE_
lymphoma O
and O
helicobacter _RARE_
heilmannii _RARE_
( O
Gastrospirillum _RARE_
hominis _RARE_

These O
studies O
support O
the O
view O
that O
HMG I-GENE
I I-GENE
( I-GENE
Y I-GENE
) I-GENE
is O
an O
important O
cofactor O
for _RARE_
HLA I-GENE
- I-GENE
DRA _RARE_
gene I-GENE
activation O
by O
Oct I-GENE
- I-GENE
2A _RARE_
and O
provide O
insights _RARE_
into O
its O
mechanism O
of O
action O
. O

In O
contrast O
to O
hemodynamic O
and O
histopathological O
predictors O
of O
survival O
, O
vWF I-GENE
: O
Ag _RARE_
does O
not O
require O
invasive O
techniques O
to O
be O
determined O
. O

CONCLUSION O
: O
We O
were O
unable O
to O
identify O
features O
of O
disease _RARE_
likely O
to O
be O
associated O
with O
a O
clinically O
useful O
response O
to O
inhaled O
NO _RARE_
therapy O
using O
the O
parameters O
studied O
. O

We O
find O
that O
BCL _RARE_
- I-GENE
6 I-GENE
POZ _RARE_
domain O
mutations O
that O
disrupt O
the O
interaction O
with O
N I-GENE
- I-GENE
CoR _RARE_
and O
SMRT I-GENE
no _RARE_
longer O
repress O
transcription O
. O

Partial O
characterization O
of O
the O
active _RARE_
site O
human I-GENE
platelet I-GENE
cAMP I-GENE
phosphodiesterase _RARE_
, O
PDE3A _RARE_
, O
by O
site O
- O
directed O
mutagenesis O
. O

This O
core O
sequence O
, O
along O
with O
additional O
nonspecific O
downstream _RARE_
nucleotides O
, O
is O
sufficient O
for _RARE_
partial O
suppression O
of O
spliceosome O
assembly O
and O
splicing _RARE_
of O
BPV _RARE_
- O
1 O
pre O
- O
mRNAs O
. O

Over _RARE_
- O
expression _RARE_
of O
the O
cofactor O
p300 I-GENE
, O
which O
functions O
as _RARE_
a O
coactivator _RARE_
of O
myoD I-GENE
- O
mediated _RARE_
transcription O
, O
alleviated _RARE_
repression O
by O
COUP I-GENE
- I-GENE
TF _RARE_
II I-GENE
. O

Familial _RARE_
autoimmune _RARE_
hepatitis O
and O
C4 _RARE_
deficiency O

No O
mutations O
were O
found O
in O
follicular O
adenomas _RARE_
. O

Since O
glutathione _RARE_
peroxidase I-GENE
( O
GPX _RARE_
) O
and O
superoxide _RARE_
dismutase I-GENE
( O
SOD I-GENE
) O
play O
a O
significant O
role O
in O
erythrocyte _RARE_
antioxidative _RARE_
defence _RARE_
, O
it O
is O
very O
important O
to O
determine O
their O
activity O
in O
occupationally _RARE_
exposed O
workers O
. O

Retroviral _RARE_
nucleocapsid _RARE_
proteins I-GENE
( O
NCPs _RARE_
) O
are O
CCHC _RARE_
- I-GENE
type I-GENE
zinc I-GENE
finger I-GENE
proteins I-GENE
that O
mediate O
virion O
RNA O
binding O
activities O
associated O
with O
retrovirus _RARE_
assembly O
and O
genomic O
RNA O
encapsidation _RARE_
. O

The O
Schizosaccharomyces I-GENE
pombe I-GENE
rad1 _RARE_
+ I-GENE
cell I-GENE
cycle _RARE_
checkpoint _RARE_
control I-GENE
gene I-GENE
is O
required O
for _RARE_
S O
- O
phase _RARE_
and O
G2 _RARE_
/ O
M O
arrest O
in O
response O
to O
both O
DNA O
damage O
and O
incomplete O
DNA O
replication O
. O

It O
is O
now O
well _RARE_
established O
that O
progression O
through O
the O
eukaryotic O
cell O
cycle _RARE_
is O
controlled _RARE_
by O
oscillations _RARE_
in O
the O
activity O
of O
cyclin _RARE_
- I-GENE
dependent I-GENE
kinases I-GENE
( O
CDKs _RARE_
). O

Positive _RARE_
genetic O
selections _RARE_
for _RARE_
inhibition O
of O
cyclin _RARE_
/ O
CDK I-GENE
function O
were O
characterized O
using O
the O
E I-GENE
. I-GENE
coli I-GENE
neo _RARE_
and O
yeast I-GENE
LEU2 I-GENE
genes I-GENE
. O

The O
hematopoietic I-GENE
colony I-GENE
- I-GENE
stimulating I-GENE
factors I-GENE
( O
CSF I-GENE
) O
have O
been O
introduced O
into O
clinical O
practice O
as _RARE_
additional O
supportive _RARE_
measures O
that O
can O
reduce O
the O
incidence O
of O
infectious O
complications O
in O
patients O
with O
cancer _RARE_
and O
neutropenia O
. O

All O
injections O
of O
CSF I-GENE
were O
given O
after O
the O
initiation O
of O
neutropenia O
and O
continued O
until O
the O
occurrence O
of O
an O
absolute O
neutrophil _RARE_
recovery O
. O
rHu _RARE_
GM _RARE_
- I-GENE
CSF I-GENE
and O
rHu _RARE_
G I-GENE
- I-GENE
CSF I-GENE
, O
administered O
once O
daily O
at _RARE_
the O
250 _RARE_
microg O
m O
(- _RARE_
2 O
) O
day O
(- _RARE_
1 O
) O
and O
5 O
microg O
kg O
(- _RARE_
1 O
) O
day O
(- _RARE_
1 O
) O
level O
, O
were O
effective O
in O
increasing O
the O
absolute O
neutrophil _RARE_
count O
and O
neutrophil _RARE_
function O
, O
as _RARE_
measured O
by O
an O
automated O
chemiluminescence _RARE_
system _RARE_
. O

Expression O
of O
lacZ I-GENE
from O
the O
promoter O
of O
the O
Escherichia I-GENE
coli I-GENE
spc _RARE_
operon I-GENE
cloned _RARE_
into O
vectors O
carrying O
the O
W205 _RARE_
trp _RARE_
- O
lac I-GENE
fusion O
. O

We O
evaluated O
regional O
right O
ventricular O
wall _RARE_
motion O
during _RARE_
systole _RARE_
in O
patients O
with O
surgically O
repaired _RARE_
tetralogy _RARE_
of O
Fallot _RARE_
( O
TOF O
) O
using O
color O
kinesis _RARE_
imaging O
. O

RT O
- O
PCR O
analysis O
showed O
that O
PLP _RARE_
- I-GENE
H I-GENE
as _RARE_
well _RARE_
as _RARE_
PLP _RARE_
- I-GENE
C I-GENE
and O
PLP _RARE_
- I-GENE
D I-GENE
are O
expressed _RARE_
in O
all O
rat O
strains O
examined O
, O
confirming O
that O
PLP _RARE_
diversity O
is O
not O
due O
to O
strain _RARE_
differences O
. O

Molecular O
cloning O
and O
characterization O
of O
a O
new O
member _RARE_
of O
the O
rat I-GENE
placental _RARE_
prolactin I-GENE
( O
PRL I-GENE
) O
family O
, O
PRL I-GENE
- O
like O
protein I-GENE
H I-GENE
. O

Interestingly O
, O
we O
find O
that O
the O
interaction O
between O
Tat I-GENE
and O
hCycT1 _RARE_
requires O
zinc O
as _RARE_
well _RARE_
as _RARE_
essential O
cysteine O
residues O
in O
both O
proteins O
. O

Thus O
, O
we O
have O
identified O
an O
activation O
target O
of O
a O
human O
activator O
, O
Oct I-GENE
- I-GENE
1 I-GENE
, O
within O
its O
cognate _RARE_
basal O
transcription O
complex O
. O

During O
early O
neurogenesis _RARE_
, O
Vnd _RARE_
protein I-GENE
is O
restricted O
to O
ventral O
column O
neuroectoderm _RARE_
and O
neuroblasts O
; O
later O
it O
is O
detected O
in O
a O
complex O
pattern O
of O
neurons O
. O

The O
repression O
domain O
, O
and O
indeed O
the O
entire _RARE_
Cdc68 _RARE_
protein I-GENE
, O
is O
highly O
conserved _RARE_
, O
as _RARE_
shown O
by O
the O
sequence O
of O
the O
Cdc68 _RARE_
functional _RARE_
homolog I-GENE
from O
the O
yeast O
Kluyveromyces _RARE_
lactis O
and O
by O
database O
searches _RARE_
. O

The O
exodomain _RARE_
alone O
has O
the O
high O
affinity O
hormone O
binding O
site O
but O
is O
not O
capable O
of O
generating O
hormonal O
signal O
. O

Pyrrolidine _RARE_
dithiocarbamate _RARE_
, O
a O
potent O
transcriptional O
inhibitor O
of O
the O
viral I-GENE
LTR I-GENE
, O
abrogated O
the O
cytokine _RARE_
responses O
in O
both O
U1 _RARE_
and O
ACH _RARE_
- O
2 O
cells O
, O
suggesting O
a O
common O
TNF I-GENE
- I-GENE
alpha I-GENE
- O
mediated _RARE_
transcriptional O
mechanism O
in O
these O
cell O
types _RARE_
despite O
their O
different O
modes O
of O
provirus O
latency _RARE_
. O

Furthermore O
, O
synergistic O
activation O
of O
ERK2 I-GENE
occurred O
in O
the O
absence O
of O
changes O
in O
intracellular _RARE_
Ca2 _RARE_
+, _RARE_
and O
was O
not O
blocked O
by O
inhibition O
of O
protein I-GENE
kinase I-GENE
C I-GENE
activity O
and O
represents O
a O
separate O
pathway _RARE_
by O
which O
CD19 _RARE_
regulates O
B O
cell O
function O
. O

The O
retrovesical _RARE_
hydatid _RARE_
cyst O
is O
a O
very O
rare O
site O
. O

Biochemical O
analysis O
reveals O
that O
KS1 _RARE_
is O
a O
nuclear O
protein O
containing O
two O
transcriptional O
repressor O
domains O
, O
R1 _RARE_
and O
R2 _RARE_
. O

However O
, O
the O
BCH _RARE_
group O
showed O
inferior O
gross O
motor O
performance O
on O
the O
Bruininks _RARE_
- O
Oseretsky _RARE_
Test O
of O
Motor _RARE_
Proficiency _RARE_
( O
Bruininks _RARE_
1978 _RARE_
). O

The O
results O
raise _RARE_
the O
possibility O
that O
pH O
induced _RARE_
post O
- O
translational O
modifications O
of O
DdRPA _RARE_
are O
involved O
in O
events O
that O
halt _RARE_
cell O
proliferation _RARE_
and O
induce O
differentiation O
in O
Dictyostelium O
. O

We O
report O
here O
that O
, O
for _RARE_
a O
constant O
amount O
of O
transfected O
DNA O
, O
the O
level O
of O
chloramphenicol I-GENE
acetyltransferase _RARE_
( O
CAT I-GENE
) O
mRNA O
is O
increased O
in O
Vpr _RARE_
- O
expressing O
cells O
using O
either O
HIV O
- O
1 O
or O
a O
murine O
leukemia I-GENE
virus I-GENE
( I-GENE
MLV _RARE_
) I-GENE
SL3 _RARE_
- I-GENE
3 I-GENE
LTR I-GENE
- O
CAT I-GENE
reporter O
construct O
. O

We O
identified O
telSMN _RARE_
mutations O
in O
11 O
of O
these O
unrelated O
SMA _RARE_
- O
like O
individuals O
who O
carry O
a O
single O
copy O
of O
telSMN _RARE_
: O
these O
include O
two O
frameshift O
mutations O
( O
800ins11 _RARE_
and O
542delGT _RARE_
) O
and O
three O
missense O
mutations O
( O
A2G _RARE_
, O
S262I _RARE_
, O
and O
T274I _RARE_
). O

The O
decrease O
of O
TNF I-GENE
receptors I-GENE
by O
IL _RARE_
- I-GENE
4 I-GENE
was O
accompanied O
by O
down O
- O
regulation _RARE_
of O
TNF I-GENE
- O
induced _RARE_
activities O
, O
including O
cytotoxicity O
, O
caspase _RARE_
- I-GENE
3 I-GENE
activation O
, O
NF _RARE_
- I-GENE
kappaB I-GENE
and O
AP I-GENE
- I-GENE
1 I-GENE
activation O
, O
and O
c I-GENE
- I-GENE
Jun I-GENE
N I-GENE
- I-GENE
terminal I-GENE
kinase I-GENE
induction O
. O

Type _RARE_
2 I-GENE
deiodinase I-GENE
( O
D2 _RARE_
) O
catalyzes O
the O
5 O
'- O
deiodination _RARE_
of O
thyroxine O
to O
form O
3 O
, O
5 O
, O
3 O
'- O
triiodothyronine _RARE_
. O

We O
have O
identified O
two O
overlapping O
expressed _RARE_
sequence O
tag O
clones _RARE_
, O
which O
contain O
the O
missing O
4 O
. O
4 O
- O
kb O
3 O
'- O
UTR O
of O
the O
human I-GENE
D2 _RARE_
( O
hD2 _RARE_
) O
cDNA O
. O

Biol O
. O

Here O
we O
have O
investigated O
the O
structural O
requirements O
and O
consequences O
of O
regulatory O
phosphorylation _RARE_
for _RARE_
the O
interaction O
between O
c I-GENE
- I-GENE
Jun I-GENE
and O
JNK I-GENE
in O
vivo O
. O

P I-GENE
- I-GENE
CIP1 _RARE_
, O
a O
novel O
protein O
that O
interacts O
with O
the O
cytosolic O
domain O
of O
peptidylglycine _RARE_
alpha I-GENE
- I-GENE
amidating _RARE_
monooxygenase _RARE_
, O
is O
associated O
with O
endosomes _RARE_
. O

Immunolocalization _RARE_
of O
Sop1p _RARE_
revealed O
a O
cytoplasmic O
distribution O
and O
cell O
fractionation O
studies O
showed O
that O
a O
significant O
fraction O
of O
Sop1p _RARE_
was O
recovered O
in O
a O
sedimentable _RARE_
fraction O
of O
the O
cytosolic O
material O
. O

Resultant _RARE_
activation O
of O
c I-GENE
- I-GENE
Jun I-GENE
N I-GENE
- I-GENE
terminal I-GENE
kinase I-GENE
/ O
stress I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
( O
JNK I-GENE
/ O
SAPK I-GENE
). O

Here O
we O
report O
the O
full O
- O
length O
coding O
cDNA O
sequence O
of O
the O
mouse I-GENE
homologue I-GENE
of I-GENE
MPP3 _RARE_
. O

The O
method O
also O
eliminates _RARE_
tagging _RARE_
of O
venous O
spins _RARE_
and O
concern _RARE_
about O
asymmetric O
magnetization _RARE_
transfer O
effects O
. O

Consistent O
with O
this O
, O
purified _RARE_
Dlk _RARE_
phosphorylated _RARE_
core O
histones _RARE_
H3 _RARE_
, O
H2A _RARE_
and O
H4 _RARE_
as _RARE_
exogenous _RARE_
substrates _RARE_
and O
endogenous O
histone I-GENE
H3 _RARE_
in O
kinase O
assays O
with O
nuclear O
extracts O
. O

In O
this O
study O
we O
provide O
evidence O
that O
B I-GENE
- I-GENE
Myb I-GENE
is O
a O
direct O
physiological O
target O
for _RARE_
cyclin _RARE_
A I-GENE
/ O
Cdk2 I-GENE
. O

Neither O
Ha I-GENE
- I-GENE
Ras I-GENE
( O
G12V _RARE_
, O
T35S _RARE_
) O
( O
Ha I-GENE
- I-GENE
RasV12S35 _RARE_
), _RARE_
which O
activates O
the O
Rafl _RARE_
signaling _RARE_
pathway _RARE_
, O
nor O
Ha I-GENE
- I-GENE
Ras I-GENE
( I-GENE
G12V _RARE_
, I-GENE
E37G _RARE_
) I-GENE
( O
Ha I-GENE
- I-GENE
RasV12G37 _RARE_
), _RARE_
which O
stimulates O
the O
RalGDS _RARE_
pathway _RARE_
, O
did O
not O
have O
significant O
effects O
on O
factor O
- O
withdrawal O
apoptosis O
of O
myeloid _RARE_
cells O
. O

We O
have O
isolated O
a O
novel O
human I-GENE
cyclin _RARE_
, O
cyclin _RARE_
E2 I-GENE
, O
that O
contains O
significant O
homology O
to O
cyclin _RARE_
E I-GENE
. O

Initial O
experience O
with O
the O
new O
technology O
indicates O
that O
SieScape _RARE_
is O
an O
alternative _RARE_
to O
other O
methods O
such O
as _RARE_
CT _RARE_
and O
MRI O
. O

The O
dopamine I-GENE
D4 _RARE_
receptor I-GENE
as _RARE_
well _RARE_
as _RARE_
many O
other O
catecholaminergic _RARE_
receptors I-GENE
contain O
several O
putative O
SH3 I-GENE
binding I-GENE
domains I-GENE
. O

The O
highly O
amyloidogenic _RARE_
42 _RARE_
- O
residue _RARE_
form O
of O
Abeta _RARE_
( O
Abeta42 _RARE_
) O
is O
the O
first _RARE_
species O
to O
be O
deposited _RARE_
in O
both O
sporadic _RARE_
and O
familial O
AD O
. O

This O
model O
is O
supported O
by O
experiments O
showing O
that O
Cdr2 _RARE_
associates O
with O
the O
N I-GENE
- I-GENE
terminal I-GENE
regulatory I-GENE
domain I-GENE
of I-GENE
Wee1 _RARE_
in O
cell O
lysates O
and O
phosphorylates O
Wee1 _RARE_
in O
vitro O
. O

Schizosaccharomyces O
pombe O
cells O
respond O
to O
nutrient O
deprivation O
by O
altering O
G2 _RARE_
/ O
M O
cell O
size O
control O
. O

A O
- O
tracts _RARE_
functioned O
best O
when O
positioned O
close O
to O
the O
- O
35 _RARE_
hexamer O
rather O
than O
one O
helical O
turn _RARE_
farther _RARE_
upstream O
, O
similar O
to O
the O
positioning O
optimal O
for _RARE_
UP _RARE_
element O
function O
. O

Pyk2 _RARE_
phosphorylation _RARE_
increased O
upon O
adherence _RARE_
of O
FLG _RARE_
29 O
. O
1 O
cells O
to O
fibronectin I-GENE
and O
to O
ST2 _RARE_
stromal _RARE_
cells O
. O

Raf I-GENE
is O
a O
key O
serine I-GENE
- I-GENE
threonine I-GENE
protein I-GENE
kinase I-GENE
which O
participates O
in O
the O
transmission _RARE_
of O
growth O
, O
anti O
- O
apoptotic O
and O
differentiation O
messages _RARE_
. O

The O
US O
National O
Institute O
on O
Alcohol _RARE_
Abuse _RARE_
and O
Alcoholism _RARE_
( O
NIAAA _RARE_
) O
recognizes O
two O
forms O
of O
problematic _RARE_
drinking O
: O
' O
willful _RARE_
alcohol _RARE_
abuse _RARE_
', _RARE_
a O
behavioural _RARE_
problem O
, O
and O
' O
alcohol _RARE_
dependence O
', _RARE_
a O
true O
medical O
disorder O
, O
which O
includes O
a O
genetic O
component _RARE_
, O
that O
can O
be O
scientifically _RARE_
understood O
and O
medically _RARE_
treated O
. O

Collagen _RARE_
was O
extracted O
from O
the O
skin _RARE_
, O
and O
the O
lack O
of O
type I-GENE
III I-GENE
collagen _RARE_
was O
determined O
by O
means O
of O
sodium _RARE_
dodecyl O
sulfate _RARE_
- O
polyacrylamide O
gel O
electrophoresis O
( O
SDS O
- O
PAGE O
). O

RESULTS O
: O
During O
the O
7 O
- O
year O
period O
, O
10 O
, O
331 _RARE_
symptomatic O
duodenal O
ulcer O
diseases O
were O
diagnosed O
. O

RESULTS O
: O
Significant O
changes O
from O
pretreatment O
to O
posttreatment _RARE_
were O
observed O
( O
p O
< O
0 _RARE_
. O
001 O
). O

In O
turn _RARE_
, O
assembly O
of O
this O
complex O
mediates O
the O
enzymatic O
activation O
of O
the O
p21 I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
1 I-GENE
and O
facilitates _RARE_
actin I-GENE
polymerization _RARE_
. O

The O
tip _RARE_
of O
the O
button _RARE_
caused O
a O
perforation _RARE_
of O
the O
posterior O
stomach O
wall _RARE_
, O
leading O
to O
death _RARE_
. O

Jembrana _RARE_
disease _RARE_
virus O
( O
JDV _RARE_
) O
is O
a O
newly O
identified O
bovine O
lentivirus _RARE_
that O
is O
closely O
related O
to O
the O
bovine O
immunodeficiency O
virus O
( O
BIV _RARE_
). O

Approximately O
50 O
% O
of O
the O
residues O
are O
conserved _RARE_
among O
all O
three O
sequences O
, O
yet O
all O
three O
viruses O
have O
retained O
response O
elements O
for _RARE_
glucocorticoids O
, O
two O
positionally _RARE_
conserved _RARE_
CCAAT O
boxes _RARE_
, O
and O
positionally _RARE_
conserved _RARE_
TATA O
boxes _RARE_
. O

Nhp2p _RARE_
is O
a O
highly O
basic O
protein O
that O
belongs O
to O
a O
family O
of O
putative O
RNA O
- O
binding O
proteins O
. O

This O
survey O
included O
3000 _RARE_
randomly O
selected _RARE_
Norwegians _RARE_
above O
18 O
years O
of O
age O
who O
received O
the O
European O
Organization O
for _RARE_
Research O
and O
Treatment O
of O
Cancer O
Core _RARE_
Quality _RARE_
of O
Life _RARE_
Questionnaire _RARE_
( O
EORTC _RARE_
QLQ _RARE_
- O
C30 _RARE_
(+ O
3 O
) O
by O
mail _RARE_
. O

During O
presentation O
of O
happy _RARE_
facial O
expressions _RARE_
, O
we O
detected O
a O
signal O
increase O
predominantly O
in O
the O
left _RARE_
anterior O
cingulate _RARE_
gyrus O
, O
bilateral O
posterior O
cingulate _RARE_
gyri _RARE_
, O
medial O
frontal O
cortex O
and O
right O
supramarginal _RARE_
gyrus O
, O
brain O
regions O
previously O
implicated O
in O
visuospatial _RARE_
and O
emotion _RARE_
processing _RARE_
tasks O
. O

Down _RARE_
- O
regulation _RARE_
of O
IRS I-GENE
- I-GENE
1 I-GENE
is O
linked _RARE_
to O
its O
serine O
phosphorylation _RARE_
dependent O
on O
PI I-GENE
3 I-GENE
- I-GENE
kinase I-GENE
activity O
and O
appears O
required O
for _RARE_
differentiation O
to O
occur O
, O
as _RARE_
IRS I-GENE
- I-GENE
1 I-GENE
is O
not O
modified O
and O
continues _RARE_
to O
accumulate O
in O
a O
nondifferentiating _RARE_
myoblast _RARE_
cell O
line O
. O

This O
study O
utilizes _RARE_
the O
mammalian O
two O
- O
hybrid _RARE_
system _RARE_
to O
examine O
the O
role O
of O
ligand _RARE_
in O
the O
dimerization _RARE_
of O
human I-GENE
progesterone I-GENE
receptor I-GENE
( O
hPR _RARE_
). O

One O
of O
its O
unique O
features O
appears O
to O
be O
the O
unusually O
short O
5 O
'- O
untranslated _RARE_
regions O
( O
UTR O
) O
( O
1 O
- O
6 O
nucleotides O
( O
nts _RARE_
)) O
and O
the O
apparent O
absence O
of O
5 O
'- O
cap _RARE_
structures _RARE_
from O
its O
mRNAs O
. O

The O
gene I-GENE
encoding I-GENE
human I-GENE
tissue I-GENE
- I-GENE
type I-GENE
plasminogen I-GENE
activator I-GENE
( O
t I-GENE
- I-GENE
PA I-GENE
) O
is O
regulated O
in O
a O
cell O
- O
type O
- O
specific O
manner O
. O

Both O
the O
presence O
of O
arginine _RARE_
and O
anaerobiosis _RARE_
are O
needed O
to O
trigger _RARE_
induction O
of O
the O
pathway _RARE_
. O

Competition O
with O
a O
putative O
MADS I-GENE
box I-GENE
consensus O
binding O
site O
from O
the O
promoter O
of O
the O
coordinately _RARE_
regulated O
opaque _RARE_
- I-GENE
phase _RARE_
- I-GENE
specific I-GENE
gene I-GENE
PEP1 _RARE_
( O
SAP1 _RARE_
) O
and O
the O
human I-GENE
MADS I-GENE
box I-GENE
consensus I-GENE
binding I-GENE
site I-GENE
for _RARE_
serum I-GENE
response I-GENE
factor I-GENE
demonstrated O
that O
one O
of O
the O
three O
complexes O
formed O
was O
specific O
to O
the O
OP4 _RARE_
sequence I-GENE
. O

The O
human I-GENE
SHBG I-GENE
proximal I-GENE
promoter I-GENE
was O
analyzed O
by O
DNase I-GENE
I I-GENE
footprinting O
, O
and O
the O
functional _RARE_
significance O
of O
6 O
footprinted _RARE_
regions O
( O
FP1 _RARE_
- O
FP6 _RARE_
) O
within O
the O
proximal O
promoter O
was O
studied O
in O
human O
HepG2 _RARE_
hepatoblastoma _RARE_
cells O
. O

In O
vitro O
translation O
and O
in O
vivo O
polysome _RARE_
profile O
analysis O
indicated O
that O
transcripts I-GENE
C I-GENE
and I-GENE
E I-GENE
were O
translated O
with O
similar O
translational O
efficiencies _RARE_
that O
are O
substantially O
greater O
than O
that O
of O
transcript I-GENE
D I-GENE
, O
suggesting O
that O
5 O
'- O
untranslated _RARE_
regions O
play O
a O
role O
in O
translational O
control O
. O

We O
have O
introduced O
a O
mutation O
( O
Ser36 _RARE_
--> _RARE_
Asn O
) O
into O
this O
domain O
of O
p190 I-GENE
that O
decreased O
its O
ability O
to O
bind O
guanine O
nucleotide O
when O
expressed _RARE_
as _RARE_
a O
hemagglutinin I-GENE
( O
HA _RARE_
)- O
tagged _RARE_
protein O
in O
COS O
cells O
. O

Wild _RARE_
type O
HA _RARE_
- O
p190 I-GENE
induced _RARE_
a O
phenotype _RARE_
of O
rounded _RARE_
cells O
with O
long O
, O
beaded _RARE_
extensions _RARE_
similar O
to O
that O
seen O
when O
Rho I-GENE
function O
is O
disrupted O
by O
ADP _RARE_
- O
ribosylation _RARE_
. O

We O
emphasize _RARE_
that O
ANCA _RARE_
- O
associated O
vasculitis O
is O
another O
important O
complication O
of O
RA _RARE_
. O

The O
downstream _RARE_
, O
TATA O
- O
less O
promoter O
has O
high O
G O
+ O
C O
content O
, O
and O
exon _RARE_
1b _RARE_
predominates _RARE_
among O
abundantly O
expressed _RARE_
mRNA O
species O
. O

Although O
we O
predicted O
that O
overexpression O
of O
the O
COOH _RARE_
- O
terminal O
domains O
, O
which O
were O
thought O
to O
be O
involved O
in O
the O
regulation _RARE_
of O
SREBP I-GENE
processing _RARE_
, O
would O
result O
in O
disruption O
of O
the O
SREBP I-GENE
- O
dependent O
transcriptional O
regulation _RARE_
of O
several O
genes O
, O
the O
mRNA O
levels O
for _RARE_
3 I-GENE
- I-GENE
hydroxy I-GENE
- I-GENE
3 I-GENE
- I-GENE
methylglutaryl _RARE_
coenzyme _RARE_
A I-GENE
( I-GENE
HMG I-GENE
CoA I-GENE
) I-GENE
synthase I-GENE
in O
these O
two O
cell O
lines O
were O
regulated O
in O
a O
sterol O
- O
dependent O
manner O
. O

Dry _RARE_
matter O
intake O
, O
apparent O
nutrient O
digestibilities _RARE_
, O
serum O
chemistry O
profiles O
, O
sphingolipid _RARE_
concentrations O
, O
and O
persistency _RARE_
of O
FB1 _RARE_
in O
tissues O
were O
evaluated O
. O

However O
, O
no _RARE_
studies O
have O
been O
conducted O
to O
further O
investigate O
this O
potentially O
hazardous O
effect O
of O
lidocaine O
. O

E O
., O
Scott _RARE_
, O
J _RARE_
. O

Yap1p _RARE_
is O
constitutively O
nuclear O
in O
a O
crm1 _RARE_
mutant I-GENE
, O
and O
Crm1p _RARE_
binds O
to O
a O
nuclear O
export O
sequence O
( O
NES _RARE_
)- O
like O
sequence O
in O
Yap1p _RARE_
in O
the O
presence O
of O
RanGTP _RARE_
. O

Mean O
intake O
of O
vitamin O
A O
amounted _RARE_
to O
1 O
. O
1 O
and O
0 _RARE_
. O
9 O
mg O
RE _RARE_
/ O
day O
for _RARE_
men O
and O
women O
, O
respectively O
; O
the O
contributions _RARE_
of O
meat O
, O
fats _RARE_
and O
oils _RARE_
, O
vegetables _RARE_
and O
dairy _RARE_
products O
to O
total _RARE_
intake O
were O
35 _RARE_
%, O
24 _RARE_
%, O
16 O
%, O
and O
16 O
%, O
respectively O
. O

Also O
, O
the O
amplitude O
of O
the O
oscillatory _RARE_
potentials O
( O
O1 _RARE_
+ O
O2 _RARE_
+ O
O3 _RARE_
+ O
O4 _RARE_
) O
was O
significantly O
reduced _RARE_
in O
the O
early O
postoperative O
period O
. O

Furthermore O
, O
RING1 _RARE_
overexpression O
results O
in O
enhanced _RARE_
expression _RARE_
of O
the O
proto _RARE_
- O
oncogenes _RARE_
c I-GENE
- I-GENE
jun I-GENE
and O
c I-GENE
- I-GENE
fos I-GENE
. O

The O
yeast I-GENE
RER2 _RARE_
gene I-GENE
, O
identified O
by O
endoplasmic O
reticulum O
protein O
localization _RARE_
mutations O
, O
encodes O
cis I-GENE
- I-GENE
prenyltransferase _RARE_
, O
a O
key O
enzyme O
in O
dolichol _RARE_
synthesis _RARE_
. O

The O
yeast O
retrotransposon _RARE_
Ty5 _RARE_
preferentially O
integrates _RARE_
into O
regions O
of O
silent _RARE_
chromatin O
. O

The O
loss _RARE_
of O
SKO1 _RARE_
completely O
restored O
ENA1 _RARE_
expression _RARE_
in O
a O
hog1 _RARE_
mutant I-GENE
and O
partially O
suppressed O
the O
osmotic O
stress O
sensitivity O
, O
qualifying _RARE_
Sko1p _RARE_
as _RARE_
a O
downstream _RARE_
effector O
of O
the O
HOG _RARE_
pathway _RARE_
. O

Elevated _RARE_
expression _RARE_
of O
a O
previously O
uncharacterized O
gene O
, O
SPP381 _RARE_
, O
efficiently O
suppresses O
the O
growth O
and O
splicing _RARE_
defects O
of O
a O
temperature _RARE_
- O
sensitive _RARE_
( O
Ts _RARE_
) O
mutant I-GENE
prp38 _RARE_
- I-GENE
1 I-GENE
. O

The O
slower O
- O
electrophoretic O
- O
mobility O
form O
of O
p68 _RARE_
was O
absent O
in O
human O
cells O
in O
G1 O
/ O
S O
and O
appeared O
as _RARE_
the O
cells O
entered _RARE_
G2 _RARE_
/ O
M O
. O

We O
have O
identified O
amino O
acid O
sequences O
in O
mammalian O
and O
Xenopus O
NeuroD1 _RARE_
/ O
BETA2 _RARE_
that O
are O
necessary O
for _RARE_
insulin I-GENE
gene I-GENE
expression _RARE_
and O
ectopic O
neurogenesis _RARE_
. O

Both O
NUP98 _RARE_
- O
HOXA9 _RARE_
chimeras _RARE_
transformed O
NIH _RARE_
3T3 O
fibroblasts _RARE_
, O
and O
this O
transformation O
required O
the O
HOXA9 _RARE_
domains I-GENE
for _RARE_
DNA O
binding O
and O
PBX _RARE_
interaction O
. O

Recent O
studies O
have O
suggested O
that O
Y319 _RARE_
also O
positively O
regulate O
ZAP _RARE_
- I-GENE
70 I-GENE
function O
. O

Genetic O
and O
molecular _RARE_
data O
indicate O
that O
wild I-GENE
- I-GENE
type I-GENE
Pan _RARE_
and O
CiD _RARE_
compete O
for _RARE_
binding O
to O
Arm _RARE_
, O
leading O
to O
a O
compromised _RARE_
transduction _RARE_
of O
the O
Wg _RARE_
signal O
in O
heterozygous _RARE_
ciD _RARE_
/+ _RARE_
animals O
and O
to O
a O
dramatic O
enhancement O
of O
the O
gain O
- O
of O
- O
function O
activity O
of O
CiD _RARE_
in O
homozygous O
mutants O
. O

Another O
ORF O
, O
dda _RARE_
. I-GENE
2 I-GENE
located _RARE_
between O
modA _RARE_
and O
dda _RARE_
, O
shares O
sequence O
similarity _RARE_
with O
sigma70 _RARE_
, O
and O
we O
call _RARE_
it O
srd _RARE_
. O

The O
location O
of O
the O
IBS _RARE_
within O
the O
catB _RARE_
structural I-GENE
gene I-GENE
, O
the O
cooperativity O
observed O
in O
footprinting O
studies O
and O
phasing _RARE_
studies O
suggest O
that O
the O
IBS _RARE_
participates O
in O
the O
interaction O
of O
CatR _RARE_
with O
the O
upstream O
binding O
sites O
by O
looping _RARE_
out O
the O
intervening O
DNA O
. O

In O
vitro O
transcription O
assays O
demonstrate O
that O
the O
TCA _RARE_
- O
cycle _RARE_
intermediate _RARE_
, O
fumarate _RARE_
, O
directly O
and O
specifically O
inhibits O
the O
formation O
of O
the O
clcA _RARE_
transcript I-GENE
. O

BIAcore _RARE_
analysis O
gave O
a O
Kaff _RARE_
of O
4 O
. O
4 O
x _RARE_
10 O
( O
10 O
) O
M O
- O
1 O
for _RARE_
the O
binding O
of O
N I-GENE
- I-GENE
A3 _RARE_
to O
T84 _RARE_
. I-GENE
1 I-GENE
and O
2 O
. O
2 O
x _RARE_
10 O
( O
10 O
) O
M O
- O
1 O
for _RARE_
the O
binding O
of O
N I-GENE
- I-GENE
A3 _RARE_
to O
T84 _RARE_
. I-GENE
66 _RARE_
. O

Expression O
of O
p130 I-GENE
( O
Cas _RARE_
) O
( O
Cas _RARE_
), _RARE_
a O
major O
binding O
protein O
for _RARE_
the O
Crk I-GENE
SH2 _RARE_
- I-GENE
domain I-GENE
, O
also O
induced _RARE_
JNK I-GENE
activation O
, O
which O
was O
blocked O
by O
the O
SH2 _RARE_
- I-GENE
mutant I-GENE
of O
Crk I-GENE
. O

Positive _RARE_
correlations O
were O
seen O
between O
the O
measurements O
for _RARE_
protein O
intake O
( O
r _RARE_
=. O
58 O
, O
P O
=. O
0026 _RARE_
) O
energy O
intake O
( O
r _RARE_
=. O
78 _RARE_
, O
P O
<. _RARE_
00001 _RARE_
), _RARE_
with O
mean O
differences O
of O
. O
066 _RARE_
g O
/ O
kg O
/ O
d O
( O
SD O
. O
38 O
) O
2 O
. O
04 O
kcal _RARE_
/ O
kg O
/ O
day O
( O
SD O
6 O
. O
67 O
), _RARE_
respectively O
. O

The O
Og4C3 _RARE_
enzyme O
- O
linked _RARE_
immunosorbent O
assay O
( O
ELISA O
) O
to O
detect O
circulating O
Wuchereria _RARE_
bancrofti _RARE_
antigen I-GENE
uses O
50 O
microL _RARE_
of O
serum O
. O

We O
now O
show O
that O
gp200 _RARE_
- O
MR6 _RARE_
ligation O
can O
also O
mimic O
IL _RARE_
- I-GENE
4 I-GENE
and O
have O
an O
anti O
- O
proliferative O
pro O
- O
maturational _RARE_
influence O
within O
the O
immune O
system _RARE_
, O
causing O
up _RARE_
- O
regulation _RARE_
of O
co _RARE_
- O
stimulatory _RARE_
molecules O
on O
B O
lymphocytes O
. O

The O
Mig1 _RARE_
repressor I-GENE
is O
a O
zinc I-GENE
finger I-GENE
protein I-GENE
that O
mediates O
glucose O
repression O
in O
yeast O
. O

Ethylene _RARE_
is O
involved O
in O
endosperm _RARE_
rupture _RARE_
and O
high O
- O
level O
betaGLU _RARE_
I I-GENE
expression _RARE_
; O
but O
, O
it O
does O
not O
affect O
the O
spatial O
and O
temporal O
pattern O
of O
betaGLU _RARE_
I I-GENE
expression _RARE_
. O

The O
divergence O
in O
primary _RARE_
structure _RARE_
between O
the O
sheep O
CRF1 _RARE_
and O
the O
other O
mammalian I-GENE
CRF1s _RARE_
is O
primarily O
localized O
to O
the O
extracellular O
amino O
terminal O
domain O
of O
the O
receptor O
( O
18 O
of O
22 _RARE_
divergent O
residues O
, O
ovine _RARE_
vs _RARE_
human I-GENE
CRF1 _RARE_
). O

Agonist _RARE_
- O
induced _RARE_
receptor O
internalization O
, O
determined O
as _RARE_
the O
percent O
of O
total _RARE_
[ _RARE_
125I _RARE_
] O
Tyr0 _RARE_
- I-GENE
oCRF _RARE_
bound _RARE_
located _RARE_
in O
the O
acid O
- O
resistant O
fraction O
of O
transfected O
Cos _RARE_
7 O
cells O
, O
increased O
with O
time O
( O
0 _RARE_
- O
60 _RARE_
min O
at _RARE_
37 O
degrees O
C O
) O
for _RARE_
both O
wild O
- O
type O
and O
variant O
oCRF1 _RARE_
. O

Recurrent _RARE_
arterial O
thrombotic O
disease _RARE_
on O
young O
onset O
and O
protein I-GENE
S I-GENE
deficiency O
. O

We O
showed O
that O
Stat3 I-GENE
and O
Stat3beta _RARE_
were O
affinity O
purified _RARE_
using O
phosphopeptides O
containing O
Y704 _RARE_
and O
Y744 _RARE_
but O
not O
by O
nonphosphorylated _RARE_
peptide O
analogues O
or O
by O
phosphopeptides O
containing O
Y729 _RARE_
and O
Y764 _RARE_
. O

Taken O
together O
, O
our O
results O
indicate O
that O
the O
FCR1 _RARE_
gene I-GENE
behaves _RARE_
as _RARE_
a O
negative O
regulator O
of O
drug O
resistance O
in O
C O
. O
albicans _RARE_
and O
constitute O
the O
first _RARE_
evidence O
that O
FCZ _RARE_
resistance O
can O
result O
from O
the O
inactivation O
of O
a O
regulatory O
factor O
such O
as _RARE_
Fcr1p _RARE_
. O

These O
findings O
suggest O
that O
late _RARE_
MYO _RARE_
/ O
M O
is O
more O
useful O
than O
washout O
rate O
to O
assess O
the O
effect O
of O
treatment O
on O
heart _RARE_
failure O
due O
to O
DCM _RARE_
. O

This O
study O
was O
undertaken O
to O
evaluate O
how O
couplers _RARE_
and O
their O
placement O
affect O
the O
ALGO2 _RARE_
click _RARE_
spectral O
properties O
. O

CONCLUSIONS O
: O
Pretreatment _RARE_
with O
OCs _RARE_
prior O
to O
pituitary O
suppression O
in O
the O
early O
follicular O
phase _RARE_
decreases O
ovarian O
cyst O
formation O
, O
without O
an O
apparent O
effect O
on O
subsequent O
follicular O
recruitment O
or O
pregnancy _RARE_
rates O
. O

With O
regard O
to O
the O
optimal O
threshold O
values O
, O
sensitivity O
and O
specificity _RARE_
were O
100 _RARE_
%/ _RARE_
97 O
% O
and O
95 _RARE_
%/ _RARE_
95 _RARE_
% O
with O
FDG O
PET O
, O
compared O
to O
86 _RARE_
%/ _RARE_
92 O
% O
and O
77 O
%/ _RARE_
82 O
% O
with O
IS _RARE_
, O
respectively O
. O

This O
c I-GENE
- I-GENE
Jun I-GENE
activity O
is O
inhibited O
by O
c I-GENE
- I-GENE
Fos I-GENE
, O
another O
protooncoprotein _RARE_
that O
can O
dimerize _RARE_
with O
c I-GENE
- I-GENE
Jun I-GENE
to O
form O
the O
transcription O
factor O
AP I-GENE
- I-GENE
1 I-GENE
. O

Dorsal _RARE_
root O
ganglia _RARE_
neuron _RARE_
- O
specific O
promoter O
activity O
of O
the O
rabbit _RARE_
beta I-GENE
- I-GENE
galactoside _RARE_
alpha1 _RARE_
, I-GENE
2 I-GENE
- I-GENE
fucosyltransferase _RARE_
gene I-GENE
. O

CONCLUSION O
: O
Our O
study O
shows O
that O
( O
1 O
) O
total _RARE_
body O
BMD O
and O
femoral O
neck O
BMD O
were O
significantly O
higher _RARE_
in O
the O
study O
group O
that O
performed O
weight _RARE_
- O
bearing _RARE_
exercises _RARE_
than O
in O
control O
subjects O
, O
( O
2 O
) O
swimming O
exercise O
had O
no _RARE_
effect O
on O
BMD O
, O
and O
( O
3 O
) O
although O
swimming O
is O
not O
a O
bone O
- O
building _RARE_
exercise O
, O
it O
can O
significantly O
improve O
shoulder _RARE_
, O
back O
, O
and O
grip _RARE_
muscle O
strength O
. O

This O
suggests O
roles O
for _RARE_
both O
the O
CE1 _RARE_
and O
CE2 _RARE_
elements O
in O
regulating _RARE_
Hoxb1 _RARE_
gene I-GENE
expression _RARE_
during _RARE_
development O
. O

CAL _RARE_
gain O
amounted _RARE_
to O
4 O
. O
2 O
+/- O
1 O
. O
3 O
mm O
, O
60 _RARE_
% O
of O
the O
defects O
showing O
CAL _RARE_
gain O
> O
or O
= O
4 O
mm O
. O

Comparisons _RARE_
with O
other O
known O
germins _RARE_
and O
germin _RARE_
- I-GENE
like I-GENE
proteins I-GENE
indicate O
that O
these O
Arabidopsis O
GLP _RARE_
subfamilies _RARE_
are O
unique O
from O
wheat _RARE_
germin _RARE_
. O

Lead _RARE_
fixation O
in O
dogs O
achieved O
with O
RF _RARE_
energy O
. O

However O
, O
there O
has O
not O
been O
any O
evidence O
of O
A O
. O
salmonicida _RARE_
infections O
, O
specifically O
furunculosis _RARE_
, O
associated O
with O
the O
fish O
in O
this O
loch _RARE_
. O

Further O
, O
we O
show O
that O
this O
EIA _RARE_
- O
inducible O
CBF O
/ O
cdc2 I-GENE
is O
related O
to O
the O
CBF I-GENE
which O
was O
shown O
to O
activate O
the O
heat I-GENE
shock I-GENE
protein I-GENE
70 I-GENE
promoter I-GENE
. O

The O
percutaneous _RARE_
absorption O
of O
clindamycin O
was O
studied O
in O
healthy O
male O
volunteers O
, O
comparing O
two O
investigative _RARE_
clindamycin O
(% _RARE_
w O
/ O
v O
)/ _RARE_
tretinoin _RARE_
( O
0 _RARE_
. O
025 _RARE_
% O
w O
/ O
v O
) O
gels O
, O
containing O
clindamycin O
phosphate O
ester O
and O
clindamycin O
HCl _RARE_
, O
respectively O
, O
relative O
to O
a O
clindamycin O
phosphate O
lotion _RARE_
( O
1 O
% O
clindamycin O
; O
Dalacin _RARE_
T O
). O

The O
BAL _RARE_
concentrations O
of O
the O
nine O
cytokines _RARE_
evaluated O
for _RARE_
the O
more O
and O
less O
affected O
lungs O
were O
compared O
: O
interleukin I-GENE
- I-GENE
6 I-GENE
( O
IL _RARE_
- I-GENE
6 I-GENE
), _RARE_
IL _RARE_
- I-GENE
8 I-GENE
, O
IL _RARE_
- I-GENE
12 I-GENE
, O
tumor I-GENE
necrosis I-GENE
factor I-GENE
- I-GENE
alpha I-GENE
( O
TNF I-GENE
- I-GENE
alpha I-GENE
), _RARE_
and O
interferon _RARE_
gamma I-GENE
( O
IFN I-GENE
- I-GENE
gamma I-GENE
) O
showed O
significant O
differences O
( O
p O
ranged O
between O
0 _RARE_
. O

Phosphorylation _RARE_
analyses O
indicated O
that O
inhibition O
of O
ERK I-GENE
- I-GENE
1 I-GENE
/ I-GENE
2 I-GENE
decreased O
okadaic _RARE_
acid O
- O
elevated O
phosphorylation _RARE_
of O
JunD _RARE_
and O
FosB _RARE_
. O

Two O
- O
way O
analysis O
of O
variance _RARE_
was O
used O
to O
determine O
whether O
composite O
knowledge O
score O
differed O
among O
patient O
groups O
. O

The O
human O
pathogenic O
bacterium O
group O
A O
Streptococcus _RARE_
produces O
an O
extracellular O
cysteine I-GENE
protease I-GENE
[ _RARE_
streptococcal _RARE_
pyrogenic _RARE_
exotoxin _RARE_
B I-GENE
( O
SpeB _RARE_
)] O
that O
is O
a O
critical O
virulence _RARE_
factor O
for _RARE_
invasive O
disease _RARE_
episodes O
. O

The O
orbitofrontal _RARE_
, O
cingulate _RARE_
, O
and O
anteromedial _RARE_
part O
of O
the O
dorsal O
premotor _RARE_
areas O
were O
preferentially O
activated O
by O
the O
self O
- O
initiated _RARE_
hand _RARE_
movement O
task O
( O
SELF _RARE_
). O

Improving _RARE_
the O
evidence O
base _RARE_
for _RARE_
anaesthesia O
. O

Plasma O
CCK _RARE_
levels O
were O
determined O
at _RARE_
regular O
intervals O
. O

The O
peroxisome _RARE_
biogenesis O
disorders O
( O
PBDs _RARE_
) O
are O
a O
set O
of O
lethal O
genetic O
diseases O
characterized O
by O
peroxisomal _RARE_
metabolic O
deficiencies O
, O
multisystem _RARE_
abnormalities O
, O
mental O
retardation O
, O
and O
premature O
death _RARE_
. O

The O
active _RARE_
site O
includes O
the O
acidic _RARE_
triad _RARE_
Asp53 _RARE_
( O
the O
site O
of O
phosphorylation _RARE_
), _RARE_
Asp10 _RARE_
and O
Glu9 _RARE_
. O

Consistent O
with O
these O
findings O
, O
relatively O
weak O
transcriptional O
silencing O
by O
the O
native _RARE_
VDR I-GENE
was O
observed O
using O
the O
osteopontin _RARE_
VDRE _RARE_
. O

In O
PAV _RARE_
- O
3 O
, O
the O
E1A I-GENE
region I-GENE
is O
located _RARE_
between O
1 O
. O
5 O
and O
3 O
. O
8 O
map O
units _RARE_
. O

Six O
putative O
MDV _RARE_
genome O
products O
, O
including O
one O
Rep I-GENE
and O
five O
non O
- O
Rep I-GENE
proteins O
, O
show O
high O
( O
70 O
. O
4 O
- O
90 _RARE_
. O
9 O
%) O
amino O
acid O
identity O
to O
the O
corresponding O
six _RARE_
FBNYV _RARE_
proteins I-GENE
, O
whereas O
two O
other O
Rep I-GENE
proteins I-GENE
encoded O
by O
MDV _RARE_
- I-GENE
C2 I-GENE
and O
C3 _RARE_
are O
82 O
. O
3 O
% O
and O
73 _RARE_
. O
0 _RARE_
% O
identical O
to O
those O
encoded O
by O
SCSV _RARE_
- I-GENE
C2 I-GENE
and O
C6 _RARE_
, O
respectively O
. O

MPO _RARE_
was O
labeled O
with O
1 O
mCi O
125I _RARE_
by O
a O
technique O
of O
self O
- O
labeling O
in O
the O
presence O
of O
10 O
(- _RARE_
4 O
) O
M O
hydrogen O
peroxide _RARE_
. O

It O
is O
related O
to O
a O
variety O
of O
mammalian O
Golgi _RARE_
- O
associated O
proteins O
and O
to O
the O
yeast O
Uso1p _RARE_
, O
an O
essential O
protein O
involved O
in O
docking _RARE_
of O
endoplasmic O
reticulum O
- O
derived O
vesicles O
to O
the O
cis O
- O
Golgi _RARE_
. O

The O
data O
indicate O
that O
Bmp2 _RARE_
is O
directly O
regulated O
by O
retinoic O
acid O
- O
bound _RARE_
receptors O
and O
Sp1 _RARE_
. O

Both O
proteins O
were O
shown O
to O
be O
constitutively O
associated O
with O
tubulin _RARE_
. O

HEED _RARE_
was O
found O
to O
bind O
to O
MA _RARE_
protein I-GENE
in O
vitro O
, O
as _RARE_
efficiently O
as _RARE_
in O
vivo O
in O
yeast O
cells O
. O

Fas I-GENE
- O
resistant O
DT _RARE_
- O
40 O
lymphoma O
B O
- O
cells O
rendered _RARE_
BTK _RARE_
- O
deficient _RARE_
through O
targeted O
disruption O
of O
the O
btk _RARE_
gene I-GENE
by O
homologous O
recombination _RARE_
knockout _RARE_
underwent O
apoptosis O
after O
Fas I-GENE
ligation O
, O
but O
wild O
- O
type O
DT _RARE_
- O
40 O
cells O
or O
BTK _RARE_
- O
deficient _RARE_
DT _RARE_
- O
40 O
cells O
reconstituted O
with O
wild I-GENE
- I-GENE
type I-GENE
human I-GENE
btk _RARE_
gene I-GENE
did O
not O
. O

A O
motif O
( O
TGATGTCA _RARE_
) O
which O
matches O
a O
CREB I-GENE
site I-GENE
and O
is O
similar O
to O
an O
AP I-GENE
- I-GENE
1 I-GENE
site I-GENE
is O
embedded O
within O
ER2 _RARE_
. O

Conventionally _RARE_
, O
four O
nominal _RARE_
allotypic _RARE_
variants O
, O
b4 _RARE_
, O
b5 _RARE_
, O
b6 _RARE_
and O
b9 _RARE_
have O
been O
shown O
to O
be O
co _RARE_
- O
dominantly _RARE_
expressed _RARE_
at _RARE_
the O
Ckappa1 _RARE_
gene I-GENE
locus I-GENE
. O

Therefore O
, O
in O
order O
to O
search O
for _RARE_
the O
latent O
genes O
, O
we O
used O
allotype _RARE_
- O
specific O
oligonucleotides O
for _RARE_
b5 _RARE_
, O
b6 _RARE_
and O
b9 _RARE_
to O
probe O
DNAs _RARE_
from O
both O
normal O
and O
T O
. O
brucei _RARE_
- O
infected _RARE_
rabbits O
by O
Southern O
blotting O
. O

TRAF2 I-GENE
is O
known O
to O
associate O
with O
TRADD _RARE_
, O
and O
expression _RARE_
of O
a O
dominant O
- O
negative O
N O
- O
terminal O
deletion O
TRAF2 I-GENE
mutant I-GENE
was O
found O
to O
partially O
inhibit O
LMP1 I-GENE
- O
induced _RARE_
JNK I-GENE
activation O
in O
293 O
cells O
. O

These O
data O
further O
define O
a O
role O
for _RARE_
TRADD _RARE_
and O
TRAF2 I-GENE
in O
JNK I-GENE
activation O
and O
confirm O
that O
LMP1 I-GENE
utilizes _RARE_
signalling O
mechanisms O
used O
by O
the O
TNF I-GENE
receptor I-GENE
/ O
CD40 I-GENE
family O
to O
elicit O
its O
pleiotropic O
activities O
. O

Epstein I-GENE
- I-GENE
Barr I-GENE
virus I-GENE
- I-GENE
encoded I-GENE
latent I-GENE
membrane I-GENE
protein I-GENE
1 I-GENE
activates O
the O
JNK I-GENE
pathway _RARE_
through O
its O
extreme O
C O
terminus O
via O
a O
mechanism O
involving O
TRADD _RARE_
and O
TRAF2 I-GENE
. O

In O
contrast O
, O
transiently O
transfected O
cells O
expressing O
EBNA I-GENE
- I-GENE
3 I-GENE
revealed O
a O
sixfold _RARE_
increase O
in O
EBNA I-GENE
- I-GENE
3 I-GENE
protein I-GENE
expression _RARE_
from O
the O
genomic O
EBNA I-GENE
- I-GENE
3 I-GENE
gene I-GENE
compared O
to O
EBNA I-GENE
- I-GENE
3 I-GENE
cDNA I-GENE
. O

However O
, O
serial O
passages _RARE_
of O
fetal _RARE_
lamb _RARE_
kidney _RARE_
( O
FLK _RARE_
) O
cells O
, O
which O
are O
sensitive _RARE_
to O
infection O
with O
BLV _RARE_
, O
after O
transient O
transfection O
revealed O
that O
mutation O
of O
a O
second O
tyrosine O
residue _RARE_
in O
the O
N O
- O
terminal O
motif O
completely O
prevented O
the O
propagation _RARE_
of O
the O
virus O
. O

Varicella _RARE_
- I-GENE
zoster _RARE_
virus I-GENE
( I-GENE
VZV _RARE_
) I-GENE
glycoprotein I-GENE
gI _RARE_
is O
a O
type I-GENE
1 I-GENE
transmembrane I-GENE
glycoprotein I-GENE
which O
is O
one O
component _RARE_
of O
the O
heterodimeric _RARE_
gE _RARE_
: O
gI _RARE_
Fc I-GENE
receptor I-GENE
complex O
. O

To O
this O
end O
, O
we O
analyzed O
the O
phosphorylation _RARE_
status O
of O
a O
universal _RARE_
tyrosine I-GENE
kinase I-GENE
substrate O
, O
the O
transforming O
Shc I-GENE
adapter _RARE_
protein I-GENE
, O
in O
fibroblasts _RARE_
expressing O
the O
viral O
oncogene O
. O

These O
genes O
were O
expressed _RARE_
in O
a O
Saccharomyces O
cerevisiae O
mutant O
in O
which O
the O
endogenous I-GENE
ferrochelatase _RARE_
gene I-GENE
( O
HEM15 _RARE_
) O
had O
been O
deleted _RARE_
, O
and O
the O
phenotypes _RARE_
of O
the O
transformants O
were O
characterized O
. O

In O
this O
study O
, O
evidence O
is O
presented O
that O
temporally O
and O
spatially O
specific O
mef2 _RARE_
expression _RARE_
is O
controlled _RARE_
by O
a O
complex O
array _RARE_
of O
cis O
- O
acting O
regulatory O
modules _RARE_
that O
are O
responsive O
to O
different O
genetic O
signals O
. O

Furthermore O
, O
using O
transgenic O
mouse O
technology O
we O
localized O
independent O
cis O
- O
regulatory O
elements O
controlling O
the O
tissue O
- O
specific O
expression _RARE_
of O
Pax6 _RARE_
. O

In O
the O
second O
experiment O
, O
a O
stable O
nickel O
isotope _RARE_
, O
61Ni _RARE_
, O
was O
given O
in O
drinking O
water O
to O
20 O
nickel O
- O
sensitized _RARE_
women O
and O
20 O
age O
- O
matched O
controls O
, O
both O
groups O
having O
vesicular O
hand _RARE_
eczema _RARE_
of O
the O
pompholyx _RARE_
type O
. O

Folded _RARE_
tissue O
and O
crimped _RARE_
collagen _RARE_
fibers O
in O
the O
tunica _RARE_
albuginea _RARE_
permit O
its O
expansion O
during _RARE_
erection _RARE_
. O

Number _RARE_
of O
patients O
infected _RARE_
with O
nontuberculous _RARE_
mycobacteria O
( O
NTM _RARE_
) O
is O
increasing O
world O
- O
wide O
in O
recent O
years O
. O

Comparison O
of O
the O
sequences O
of O
attP _RARE_
, O
attB _RARE_
and O
bacteria O
- O
prophage _RARE_
junctions O
attL _RARE_
and O
attR _RARE_
showed O
a O
26 _RARE_
bp O
common O
core O
sequence O
, O
where O
recombination _RARE_
takes _RARE_
place O
, O
near O
the O
5 O
' O
end O
of O
the O
integrase I-GENE
gene I-GENE
. O

Interferon I-GENE
- I-GENE
alpha I-GENE
treatment O
of O
posttransplant _RARE_
lymphoproliferative _RARE_
disorder O
in O
recipients O
of O
solid O
organ O
transplants _RARE_
. O

Immunological _RARE_
testing O
was O
performed O
on O
all O
brewery _RARE_
workers O
and O
some O
control O
volunteers O
using O
skin _RARE_
prick _RARE_
testing O
with O
hops _RARE_
, O
barley _RARE_
, O
and O
yeast O
antigens O
as _RARE_
well _RARE_
as _RARE_
other O
nonoccupational _RARE_
allergens O
, O
and O
by O
determining _RARE_
total _RARE_
serum I-GENE
IgE I-GENE
levels O
. O

OBJECTIVE O
: O
To O
evaluate O
the O
accuracy O
of O
working O
casts _RARE_
for _RARE_
crown _RARE_
and O
bridge _RARE_
restorations O
made O
from O
twin _RARE_
mix _RARE_
putty _RARE_
/ O
wash _RARE_
silicone _RARE_
elastomeric _RARE_
impression _RARE_
materials O
using O
different O
types _RARE_
of O
stock _RARE_
tray _RARE_
. O

OBJECTIVES O
: O
To O
assess O
the O
ability O
of O
pretreatment O
and O
post O
- O
treatment O
prostate _RARE_
- I-GENE
specific I-GENE
antigen I-GENE
( O
PSA I-GENE
) O
measurements O
, O
clinical O
tumor O
stage _RARE_
, O
tumor O
grade O
, O
Gleason _RARE_
sum O
, O
race _RARE_
, O
age O
, O
and O
radiation O
dose O
to O
predict O
the O
recurrence O
of O
prostate _RARE_
cancer _RARE_
following O
external O
beam O
radiation O
therapy O
( O
XRT _RARE_
) O
since O
the O
introduction O
of O
PSA I-GENE
as _RARE_
a O
tumor O
marker O
at _RARE_
one O
tertiary O
care O
center _RARE_
. O

To O
evaluate O
whether O
the O
human O
gene O
is O
also O
a O
target O
of O
thyroid O
hormone O
we O
have O
searched _RARE_
for _RARE_
T3 _RARE_
- O
responsive O
elements O
in O
NRGN _RARE_
cloned _RARE_
genomic O
fragments O
spanning O
the O
whole O
gene O
. O

The O
transcriptional O
activity O
of O
PPARgamma I-GENE
is O
positively O
modulated O
by O
ligand _RARE_
binding O
and O
negatively O
regulated O
by O
phosphorylation _RARE_
mediated _RARE_
by O
the O
MEK I-GENE
/ O
ERK I-GENE
signaling _RARE_
pathway _RARE_
. O

BACKGROUND O
: O
Diazepam _RARE_
, O
one O
of O
the O
benzodiazepine _RARE_
group O
of O
tranquilizers _RARE_
, O
is O
used O
as _RARE_
an O
adjunctive _RARE_
drug O
for _RARE_
sedation O
and O
for _RARE_
relief _RARE_
of O
anxiety O
in O
the O
treatment O
of O
epilepsy O
. O

Bioplastique _RARE_
granuloma O
presents O
with O
irregularly _RARE_
shaped O
cystic _RARE_
spaces _RARE_
of O
varying O
size O
containing O
jagged _RARE_
, O
translucent _RARE_
, O
nonbirefringent _RARE_
foreign O
bodies _RARE_
whereas O
Artecoll _RARE_
granuloma O
shows O
numerous O
round O
vacuoles _RARE_
nearly O
identical O
in O
size O
and O
shape O
enclosing _RARE_
round O
and O
sharply O
circumscribed _RARE_
, O
translucent _RARE_
, O
nonbirefringent _RARE_
foreign O
bodies _RARE_
. O

This O
Tbx6 _RARE_
- I-GENE
subfamily I-GENE
gene I-GENE
is O
likely O
to O
participate O
in O
paraxial _RARE_
mesoderm O
formation O
and O
somitogenesis _RARE_
in O
human O
embryo _RARE_
. O

Structure O
- O
function O
analysis O
of O
the O
Z O
- O
DNA O
- O
binding O
domain O
Zalpha _RARE_
of O
dsRNA _RARE_
adenosine I-GENE
deaminase _RARE_
type I-GENE
I I-GENE
reveals O
similarity _RARE_
to O
the O
( I-GENE
alpha I-GENE
+ I-GENE
beta I-GENE
) I-GENE
family I-GENE
of O
helix I-GENE
- I-GENE
turn _RARE_
- I-GENE
helix I-GENE
proteins I-GENE
. O

In O
addition O
, O
the O
regulation _RARE_
of O
Glvr _RARE_
- I-GENE
1 I-GENE
gene I-GENE
expression _RARE_
also O
has O
potential _RARE_
applications O
to O
gene O
therapy O
, O
since O
retroviral _RARE_
vectors O
carrying O
gibbon _RARE_
ape _RARE_
leukemia I-GENE
virus I-GENE
envelope I-GENE
proteins I-GENE
are O
used O
for _RARE_
gene O
delivery O
into O
different O
cell O
types _RARE_
. O

Carbohydrates _RARE_
and O
glycoconjugates _RARE_
biophysical _RARE_
methods O
. O

Molecular O
cloning O
of O
mouse I-GENE
glycolate _RARE_
oxidase I-GENE
. O

In O
such O
a O
manner O
, O
activated O
PKR I-GENE
inhibits O
cell O
growth O
and O
induces O
apoptosis O
, O
whereas O
disruption O
of O
normal O
PKR I-GENE
signaling _RARE_
results O
in O
unregulated _RARE_
cell O
growth O
. O

We O
isolated O
a O
ribosomal I-GENE
protein I-GENE
L18 _RARE_
by O
interaction O
with O
PKR I-GENE
. O

Processing _RARE_
of O
the O
polycistronic _RARE_
precursor O
requires O
nucleases _RARE_
also O
involved O
in O
rRNA O
processing _RARE_
, O
i O
. O
e _RARE_
., O
Rnt1p _RARE_
and O
Rat1p _RARE_
. O

To O
search O
for _RARE_
transcriptional O
regulators _RARE_
, O
we O
used O
a O
fragment O
of O
the O
SpHE _RARE_
promoter I-GENE
containing O
several O
individual O
elements O
instead O
of O
the O
conventional O
bait _RARE_
that O
contains O
a O
multimerized _RARE_
cis O
element O
. O

As O
expected O
for _RARE_
a O
positive O
SpHE _RARE_
transcriptional I-GENE
regulator I-GENE
, O
the O
timing O
of O
SpEts4 _RARE_
gene I-GENE
expression _RARE_
precedes _RARE_
the O
transient O
expression _RARE_
of O
SpHE _RARE_
in O
the O
very O
early O
sea _RARE_
urchin _RARE_
blastula _RARE_
. O

Furthermore O
, O
rhoA _RARE_
- O
mediated _RARE_
SRE O
activation O
was O
blocked O
by O
dominant O
negative O
mutants O
of O
PKC I-GENE
- I-GENE
alpha I-GENE
or O
PKC I-GENE
- I-GENE
epsilon I-GENE
. O

Nip7p _RARE_
- O
depleted O
cells O
exhibited O
the O
same O
defects O
as _RARE_
Nop8p _RARE_
- O
depleted O
cells O
, O
except O
that O
they O
accumulated O
27S _RARE_
precursors _RARE_
. O

We O
show O
that O
the O
Sm _RARE_
- I-GENE
binding I-GENE
site I-GENE
and O
stem _RARE_
- O
loop O
III O
structures _RARE_
are O
necessary O
for _RARE_
correct O
3 O
'- O
end O
formation O
. O

Five O
different O
subtypes O
of O
spondyloarthropathy _RARE_
( O
SpA _RARE_
) O
are O
now O
recognized _RARE_
. O

Further O
experiments O
will O
be O
required O
to O
highlight _RARE_
the O
in O
vivo O
role O
of O
ELE1 _RARE_
in O
nuclear O
receptor O
functioning O
. O

Overexpression O
of O
PTTG _RARE_
in O
transfected O
NIH _RARE_
3T3 O
cells O
also O
stimulated _RARE_
expression _RARE_
and O
secretion _RARE_
of O
basic I-GENE
fibroblast I-GENE
growth I-GENE
factor I-GENE
, O
a O
human I-GENE
pituitary I-GENE
tumor I-GENE
growth I-GENE
- I-GENE
regulating _RARE_
factor I-GENE
. O

The O
perifascicular _RARE_
connective _RARE_
tissue O
sheath _RARE_
is O
important O
in O
organising _RARE_
the O
contraction O
of O
the O
myocardium O
by O
preventing O
lateral O
spread O
of O
conduction O
and O
by O
permitting _RARE_
transmission _RARE_
of O
the O
impulse _RARE_
only O
at _RARE_
the O
termination _RARE_
of O
the O
purkinje _RARE_
fibre O
. O

E1 I-GENE
, O
a O
DNA I-GENE
helicase _RARE_
, O
collaborates _RARE_
with O
the O
HPV I-GENE
E2 I-GENE
protein I-GENE
in O
ori _RARE_
- O
dependent O
replication O
. O

Here O
we O
describe O
a O
mutant O
alpha O
subunit O
designed O
to O
inhibit O
receptor O
- O
mediated _RARE_
hormonal O
activation O
of O
Gs _RARE_
, O
the O
stimulatory _RARE_
regulator O
of O
adenylyl _RARE_
cyclase I-GENE
. O

A O
gapped _RARE_
search O
with O
the O
C O
- O
terminal O
region O
of O
CDED _RARE_
/ O
LIOR _RARE_
revealed O
a O
36 _RARE_
- O
41 _RARE_
% O
similarity _RARE_
to O
several O
proteins O
related O
to O
signal O
transduction _RARE_
and O
cell O
replication O
, O
such O
as _RARE_
ORC1 _RARE_
and O
KSR _RARE_
. O

Northern O
blot O
analysis O
demonstrated O
the O
ubiquitous O
expression _RARE_
of O
2 O
. O
9 O
kb O
and O
3 O
. O

Additionally O
, O
a O
variety O
of O
regulatory O
schemes _RARE_
contribute O
temporal O
and O
/ O
or O
spatial O
restriction _RARE_
to O
TGF I-GENE
- I-GENE
beta I-GENE
responses O
. O

Induction O
of O
anaesthesia O
was O
standardised _RARE_
: O
fentanyl O
( O
3 O
micrograms O
/ O
kg O
), _RARE_
thiopentone _RARE_
( O
5 O
mg O
/ O
kg O
), _RARE_
atracurium _RARE_
( O
0 _RARE_
. O
4 O
mg O
/ O
kg O
). O

A O
comparison O
of O
the O
clinical O
profile O
of O
cavernous _RARE_
malformations O
with O
and O
without O
associated O
venous O
malformations O
. O

Conserved _RARE_
and O
distinct O
roles O
of O
kreisler _RARE_
in O
regulation _RARE_
of O
the O
paralogous _RARE_
Hoxa3 _RARE_
and O
Hoxb3 _RARE_
genes I-GENE
. O

Magnetically _RARE_
induced _RARE_
optical O
self O
- O
pulsing _RARE_
in O
a O
nonlinear _RARE_
resonator _RARE_
. O

Wave _RARE_
cybernetics _RARE_
: O
A O
simple O
model O
of O
wave O
- O
controlled _RARE_
nonlinear _RARE_
and O
nonlocal _RARE_
cooperative O
phenomena O
. O

Autoionization _RARE_
rates O
and O
energy O
levels O
of O
triplet O
nf _RARE_
, O
v O
= O
1 O
Rydberg _RARE_
states O
of O
H2 O
. O

Unitary _RARE_
- O
group O
approach O
to O
spin O
- O
dependent O
operators _RARE_
. O

Nonlocal _RARE_
approach O
to O
scattering _RARE_
in O
a O
one O
- O
dimensional O
problem O
. O

Soft _RARE_
- O
x _RARE_
- O
ray O
lasing _RARE_
at _RARE_
32 _RARE_
. O
6 O
nm O
in O
Ne _RARE_
- O
like O
Ti _RARE_
ions O
driven _RARE_
by O
40 O
J _RARE_
of O
energy O
from O
two O
650 _RARE_
- O
ps _RARE_
laser O
pulses _RARE_
. O

Next _RARE_
, O
to O
identify O
regions O
of O
the O
promoter O
involved O
, O
we O
examined O
a O
series O
of O
tenascin _RARE_
- I-GENE
C I-GENE
promoter I-GENE
constructs I-GENE
with O
5 O
' O
deletions O
and O
showed O
that O
denatured _RARE_
collagen _RARE_
- I-GENE
dependent I-GENE
promoter I-GENE
activity O
was O
retained O
by O
a O
122 O
- O
base _RARE_
pair _RARE_
element O
, O
located _RARE_
- O
43 _RARE_
to O
- O
165 O
bp O
upstream O
of O
the O
RNA O
start _RARE_
site O
. O

Nuclear I-GENE
factor I-GENE
kappa _RARE_
B I-GENE
( O
NF _RARE_
- I-GENE
kappaB I-GENE
) O
is O
an O
important O
transcription O
factor O
for _RARE_
the O
genes O
of O
many O
pro O
- O
inflammatory O
proteins O
and O
is O
strongly O
activated O
by O
the O
cytokines _RARE_
interleukin I-GENE
- I-GENE
1 I-GENE
and O
tumor I-GENE
necrosis I-GENE
factor I-GENE
( I-GENE
TNF I-GENE
) I-GENE
alpha I-GENE
under O
various O
pathological O
conditions O
. O

Moreover O
, O
this O
enhancement O
of O
transcriptional O
activation O
by O
COUP I-GENE
- I-GENE
TFI I-GENE
requires O
specifically O
the O
AF _RARE_
- O
1 O
transactivation _RARE_
function O
of O
ER I-GENE
and O
can O
be O
observed O
in O
the O
presence O
of O
E2 O
or O
4 O
- O
hydroxytamoxifen _RARE_
but O
not O
ICI _RARE_
164384 _RARE_
. O

Recombinant I-GENE
Ffh _RARE_
has O
a O
melting _RARE_
point O
of O
tm _RARE_
= O
89 _RARE_
degreesC _RARE_
. O

Unilateral _RARE_
naris _RARE_
occlusion O
and O
the O
rat O
accessory _RARE_
olfactory O
bulb O
. O

This O
region O
of O
hsp90 I-GENE
mediates O
ATP O
- O
independent O
chaperone _RARE_
activity O
, O
overlaps _RARE_
the O
hsp90 I-GENE
dimerization _RARE_
domain I-GENE
, O
and O
includes O
structural O
elements O
important O
for _RARE_
steroid I-GENE
receptor I-GENE
interaction O
. O

The O
promoter O
of O
the O
rat O
pgp2 _RARE_
/ O
mdr1b _RARE_
gene O
has O
a O
GC _RARE_
- O
rich O
region O
( O
pgp2GC _RARE_
) O
that O
is O
highly O
conserved _RARE_
in O
mdr _RARE_
genes I-GENE
and O
contains O
an O
consensus O
Sp1 _RARE_
site I-GENE
. O

Sp1 _RARE_
' O
s O
role O
in O
transactivation _RARE_
of O
the O
pgp2 _RARE_
/ O
mdr1b _RARE_
promoter O
was O
tested O
in O
Drosophila O
Schneider _RARE_
cells O
. O

Measurements O
included O
bone O
mineral O
density O
of O
the O
lumbar O
spine O
and O
proximal O
femur O
( O
by O
dual O
- O
energy O
X O
- O
ray O
absorptiometry _RARE_
) O
and O
biochemical O
markers O
of O
bone O
remodeling O
( O
serum O
bone O
- O
specific O
alkaline _RARE_
phosphatase I-GENE
by O
immunoassay O
and O
urine O
deoxypyridinoline _RARE_
by O
high O
- O
pressure O
liquid O
chromatography O
). O

Human I-GENE
MGP _RARE_
is O
a O
10 I-GENE
- I-GENE
kD _RARE_
skeletal I-GENE
extracellular I-GENE
matrix _RARE_
( I-GENE
ECM _RARE_
) I-GENE
protein I-GENE
that O
consists O
of O
an O
84 _RARE_
- O
aa _RARE_
mature _RARE_
protein O
and O
a O
19 O
- O
aa _RARE_
transmembrane O
signal O
peptide O
. O

Dual _RARE_
roles O
of O
p82 _RARE_
, O
the O
clam _RARE_
CPEB _RARE_
homolog I-GENE
, O
in O
cytoplasmic O
polyadenylation O
and O
translational O
masking _RARE_
. O

The O
RNA I-GENE
polymerase I-GENE
III I-GENE
- I-GENE
recruiting _RARE_
factor I-GENE
TFIIIB _RARE_
induces O
a O
DNA O
bend _RARE_
between O
the O
TATA O
box O
and O
the O
transcriptional O
start _RARE_
site O
. O

The O
pattern O
of O
RNase I-GENE
E I-GENE
digestion O
of O
finP305 _RARE_
RNA I-GENE
differed O
from O
FinP _RARE_
, O
and O
GST I-GENE
- O
FinO _RARE_
did O
not O
protect O
finP305 _RARE_
RNA I-GENE
from O
cleavage _RARE_
in O
vitro O
. O

Transcription O
readthrough O
into O
the O
inverted O
repeats O
has O
little O
effect O
on O
this O
event O
. O

Analysis O
of O
hematopoietic I-GENE
growth I-GENE
factor I-GENE
prescriptions _RARE_
in O
19 O
french _RARE_
cancer _RARE_
centers O

In O
the O
second O
case O
, O
an O
epidermal _RARE_
cyst O
was O
diagnosed O
. O

MotA _RARE_
also O
binds O
a O
DNA O
sequence O
( O
a O
MotA _RARE_
box I-GENE
), _RARE_
centered O
at _RARE_
position O
- O
30 _RARE_
. O

We O
suggest O
that O
MotA _RARE_
and O
AsiA _RARE_
may O
function O
like O
certain O
eukaryotic I-GENE
TAFs _RARE_
( O
TATA I-GENE
binding I-GENE
protein I-GENE
( I-GENE
TBP I-GENE
) I-GENE
associated I-GENE
factors I-GENE
) O
whose O
binding O
to O
TBP I-GENE
results O
in O
transcription O
from O
new O
core O
promoter O
sequences O
. O

The O
S229A _RARE_
variant O
can O
better O
flip _RARE_
modified O
bases O
but O
does O
not O
tightly O
lock _RARE_
the O
flipped _RARE_
base _RARE_
into O
the O
adenine _RARE_
- O
binding O
pocket O
, O
suggesting O
that O
Ser229 _RARE_
could O
form O
a O
contact _RARE_
to O
the O
flipped _RARE_
adenine _RARE_
. O

The O
high O
conservation O
of O
the O
3 O
' O
terminus O
suggests O
that O
this O
region O
directs O
the O
assembly O
of O
proteins O
required O
for _RARE_
the O
initiation O
of O
RNA O
replication O
. O

All O
stimulations _RARE_
were O
down O
- O
regulated O
with O
GnRH I-GENE
- I-GENE
a I-GENE
commenced _RARE_
on O
day O
21 O
in O
a O
long O
protocol O
before O
gonadotropin I-GENE
stimulation _RARE_
. O

The O
sequence O
up _RARE_
to O
- O
267 _RARE_
bp O
relative O
to O
the O
transcription O
start _RARE_
site O
was O
sufficient O
to O
enhance O
reporter O
gene O
expression _RARE_
depending O
on O
the O
mesodermal _RARE_
differentiation O
of O
P19 O
cells O
. O

Chem O
. O

No O
significant O
differences O
between O
the O
substituted O
and O
wild O
type O
peptides O
were O
observed O
, O
suggesting O
that O
this O
substitution O
in O
the O
intact _RARE_
protein O
may O
cause O
disruption O
of O
global O
rather O
than O
local O
structures _RARE_
. O

These O
results O
suggest O
that O
the O
c I-GENE
- I-GENE
met I-GENE
gene I-GENE
is O
also O
a O
target O
of O
p53 I-GENE
gene I-GENE
regulation _RARE_
. O

C3 _RARE_
toxin _RARE_
completely O
inhibited O
RhoA I-GENE
function O
, O
partially O
inhibited O
SRE O
: O
Luc _RARE_
activity O
, O
but O
had O
no _RARE_
effect O
on O
LPA _RARE_
- O
stimulated _RARE_
c I-GENE
- I-GENE
Fos I-GENE
expression _RARE_
. O

However O
, O
C3 _RARE_
toxin _RARE_
alone O
or O
in O
combination O
with O
growth O
factors O
did O
not O
stimulate O
AP I-GENE
- I-GENE
1 I-GENE
: O
Luc _RARE_
activity O
and O
actually _RARE_
antagonized _RARE_
the O
synergistic O
activation O
of O
AP I-GENE
- I-GENE
1 I-GENE
: O
Luc _RARE_
observed O
in O
response O
to O
co _RARE_
- O
stimulation _RARE_
with O
growth O
factors O
and O
Ro _RARE_
- O
31 _RARE_
- O
8220 _RARE_
. O

The O
aim O
of O
the O
present O
study O
was O
to O
examine O
the O
antimicrobial O
susceptibility _RARE_
to O
10 O
currently O
used O
antimicrobial O
agents O
of O
50 O
strains O
of O
P O
. O
acnes _RARE_
isolated O
from O
acne _RARE_
lesions O
and O
identified O
using O
a O
Rap _RARE_
ID _RARE_
ANA _RARE_
II O
panel O
. O

The O
role O
of O
intraoperative _RARE_
echocardiography O
in O
surgery O
of O
the O
heart _RARE_
and O
large O
vessels O

Taken O
together O
, O
our O
results O
demonstrate O
that O
CAP1 _RARE_
is O
involved O
in O
multidrug _RARE_
resistance O
and O
oxidative O
stress O
response O
in O
C O
. O
albicans _RARE_
. O

Trinipatch _RARE_
is O
a O
small O
, O
transparent _RARE_
, O
matricial _RARE_
, O
monolayer _RARE_
patch O
with O
an O
absorption O
promoter O
, O
marketed _RARE_
in O
two O
dose O
- O
strengths O
( O
5 O
mg O
/ O
24 _RARE_
h O
and O
10 O
mg O
/ O
24 _RARE_
h O
) O
by O
Laboratoires _RARE_
Synthelabo _RARE_
. O

The O
RMRI _RARE_
was O
tested O
for _RARE_
interrater _RARE_
reliability O
using O
three O
simulated O
and O
10 O
actual O
patients O
. O

The O
starting O
point O
is O
the O
consideration _RARE_
that O
the O
conceptions _RARE_
underlying O
the O
ICIDH _RARE_
are O
not O
suitable O
to O
serve O
as _RARE_
a O
mainstay _RARE_
of O
a O
model O
for _RARE_
diagnostics _RARE_
in O
rehabilitation _RARE_
because O
they O
do O
not O
reflect O
essential O
characteristics O
of O
the O
diagnostic O
process O
which O
is O
the O
basis O
for _RARE_
intervention O
. O

Pokeweed _RARE_
antiviral _RARE_
protein I-GENE
( O
PAP _RARE_
) O
from O
Phytolacca _RARE_
americana _RARE_
is O
a O
highly O
specific O
N I-GENE
- I-GENE
glycosidase _RARE_
removing O
adenine _RARE_
residues O
( O
A4324 _RARE_
in O
28S I-GENE
rRNA I-GENE
and O
A2660 _RARE_
in O
23S _RARE_
rRNA I-GENE
) O
from O
intact _RARE_
ribosomes _RARE_
of O
both O
eukaryotes O
and O
prokaryotes _RARE_
. O

OBJECTIVE O
: O
This O
meta _RARE_
- O
analysis O
of O
67 O
controlled _RARE_
trials O
was O
performed O
to O
quantify _RARE_
the O
cholesterol O
- O
lowering O
effect O
of O
major O
dietary O
fibers O
. O

Among O
these O
360 _RARE_
ZFPs _RARE_
, O
a O
novel O
ZFP _RARE_
cDNA I-GENE
named O
HFHZ _RARE_
( O
human I-GENE
fetal _RARE_
heart _RARE_
ZFP _RARE_
) O
with O
sequence O
homology O
to O
a O
Kruppel _RARE_
- I-GENE
associated I-GENE
box I-GENE
( O
KRAB I-GENE
) O
was O
identified O
. O

The O
3 O
. O
3 O
- O
fold _RARE_
higher _RARE_
expression _RARE_
in O
the O
fetal _RARE_
heart _RARE_
than O
in O
the O
adult O
heart _RARE_
suggests O
that O
HFHZ _RARE_
mRNA I-GENE
is O
downregulated _RARE_
in O
the O
process O
of O
development O
. O

When O
the O
high O
affinity O
hnRNP _RARE_
A1 _RARE_
binding I-GENE
site I-GENE
was O
inserted O
into O
the O
beta I-GENE
- I-GENE
globin I-GENE
reporter I-GENE
, O
Rev _RARE_
was O
able O
to O
increase O
the O
cytoplasmic O
levels O
of O
unspliced O
mRNAs O
to O
14 O
%. O

To O
date O
, O
two O
such O
proteins O
, O
PLZF I-GENE
and O
LAZ _RARE_
- I-GENE
3 I-GENE
/ O
BCL _RARE_
- I-GENE
6 I-GENE
, O
have O
been O
implicated O
in O
oncogenesis _RARE_
. O

Overexpression O
of O
POG1 _RARE_
inhibits O
alpha I-GENE
- I-GENE
factor I-GENE
- O
induced _RARE_
G1 O
arrest O
and O
transcriptional O
repression O
of O
the O
CLN1 _RARE_
and O
CLN2 _RARE_
genes I-GENE
. O

We O
now O
show O
that O
RNU2 _RARE_
fragility _RARE_
can O
be O
induced _RARE_
by O
transfection O
with O
an O
expression _RARE_
vector O
encoding O
Ad12 _RARE_
E1B I-GENE
55 _RARE_
kDa O
alone O
but O
not O
by O
an O
E1 I-GENE
vector O
encoding O
all O
E1 I-GENE
products I-GENE
( O
3 O
E1A I-GENE
proteins I-GENE
, O
as _RARE_
well _RARE_
as _RARE_
the O
E1B I-GENE
19 O
kDa O
and O
55 _RARE_
kDa O
proteins O
). O

Competitionsupershift _RARE_
EMSA O
assays O
revealed O
that O
multiple O
proteins O
were O
involved O
in O
bandshift _RARE_
complex O
formation O
with O
KCS _RARE_
, O
one O
of O
which O
was O
identified O
as _RARE_
factor O
Sp1 _RARE_
. O

Similarity _RARE_
of O
DNA O
binding O
and O
transcriptional O
regulation _RARE_
by O
Caenorhabditis I-GENE
elegans I-GENE
MAB _RARE_
- I-GENE
3 I-GENE
and O
Drosophila I-GENE
melanogaster I-GENE
DSX _RARE_
suggests O
conservation O
of O
sex _RARE_
determining _RARE_
mechanisms O
. O

CONTEXT _RARE_
: O
ThinPrep _RARE_
, O
AutoPap _RARE_
, O
and O
Papnet _RARE_
are O
3 O
new O
technologies _RARE_
that O
increase O
the O
sensitivity O
and O
cost O
of O
cervical O
cancer _RARE_
screening O
. O

Experiments O
on O
narcotized _RARE_
cats O
demonstrated O
that O
the O
derivatives _RARE_
of O
2 O
- O
mercaptobenzimidazole _RARE_
possessing _RARE_
the O
properties O
of O
specific O
bradycardic _RARE_
agents O
and O
coded O
as _RARE_
CM _RARE_
- O
251 _RARE_
, O
CM _RARE_
- O
266 _RARE_
, O
and O
CM _RARE_
- O
345 _RARE_
, O
reduce O
the O
mean O
rise O
of O
segment O
ST O
on O
numerous O
leads O
of O
the O
epicardial _RARE_
electrogram _RARE_
during _RARE_
5 O
- O
min O
occlusion O
of O
the O
anterior O
descending _RARE_
branch O
of O
the O
left _RARE_
coronary O
artery O
. O

Neither O
the O
p42 _RARE_
/ I-GENE
44 _RARE_
nor O
the O
JNK I-GENE
pathway _RARE_
was O
involved O
in O
the O
action O
of O
IL _RARE_
- I-GENE
1beta I-GENE
. O

In O
protocol O
2 O
, O
eight O
different O
subjects O
performed O
Con _RARE_
and O
Ecc _RARE_
arm _RARE_
curls _RARE_
to O
fatigue _RARE_
, O
followed O
by O
postexercise _RARE_
muscle O
ischemia O
, O
by O
using O
the O
same O
resistance O
as _RARE_
in O
protocol O
1 O
. O

Airflow _RARE_
was O
measured O
with O
a O
custom _RARE_
- O
designed O
turbine _RARE_
and O
a O
45 _RARE_
- O
ft _RARE_
.- _RARE_
long O
cable _RARE_
to O
reach O
the O
volume O
- O
measuring O
module _RARE_
. O

Both O
mutations O
confer O
amino O
acid O
substitutions O
in O
the O
viral I-GENE
coat I-GENE
protein I-GENE
but O
differ O
in O
their O
relative O
abilities O
to O
utilize _RARE_
the O
foreign O
scaffolding _RARE_
protein I-GENE
. O

Complete _RARE_
recovery O
of O
liver O
function O
after O
this O
surgery O
tended O
to O
be O
slow O
. O

Although O
both O
transcripts O
share O
the O
first _RARE_
nine O
exons O
, O
exon _RARE_
10 O
of O
ZIS _RARE_
- I-GENE
2 I-GENE
is O
lacking _RARE_
in O
ZIS _RARE_
- I-GENE
1 I-GENE
, O
and O
instead O
, O
exon _RARE_
11 O
( O
10th _RARE_
exon _RARE_
) O
of O
ZIS _RARE_
- I-GENE
1 I-GENE
is O
larger O
in O
size O
, O
leading O
to O
the O
longer O
3 O
'- O
UTR O
. O

Expression O
of O
the O
second O
gene O
( O
XT3 _RARE_
) O
was O
found O
to O
be O
conserved _RARE_
in O
human O
kidney _RARE_
, O
and O
partial O
sequence O
was O
obtained O
from O
a O
human O
cDNA O
library O
. O

IFN I-GENE
- I-GENE
gamma I-GENE
was O
elevated O
during _RARE_
active _RARE_
TB _RARE_
when O
compared O
with O
healthy O
controls O
, O
declining _RARE_
during _RARE_
and O
after O
treatment O
. O

The O
missing O
5 O
' O
sequences O
were O
obtained O
by O
5 O
'- O
rapid O
amplification O
of O
cDNA O
ends O
and O
by O
analysis O
of O
an O
NHE5 _RARE_
genomic I-GENE
clone I-GENE
, O
and O
the O
missing O
3 O
' O
sequences O
were O
obtained O
by O
3 O
'- O
rapid O
amplification O
of O
cDNA O
ends O
. O

If O
no _RARE_
alloantibodies _RARE_
are O
detected O
, O
further O
analysis O
to O
define O
a O
role O
of O
drug O
- O
related O
or O
autoantibodies O
is O
required O
. O

This O
dependence O
, O
however O
, O
can O
be O
overcome O
to O
a O
large O
extent O
by O
dividing _RARE_
min O
LVdP _RARE_
/ O
dt O
by O
mean O
aortic O
pressure O
. O

Genoa _RARE_
, O
Italy _RARE_
, O
24 _RARE_
- O
28 _RARE_
August O
1997 O
. O

Electronic _RARE_
structure _RARE_
of O
delta O
- O
plutonium O
and O
of O
single O
Al O
, O
Ga O
, O
and O
Sc _RARE_
impurities _RARE_
in O
delta O
- O
plutonium O
. O

Bound _RARE_
- O
exciton _RARE_
transfer O
and O
photoluminescence _RARE_
undulation _RARE_
spectra O
for _RARE_
acceptors _RARE_
in O
ZnTe _RARE_
. O

Unified _RARE_
theory O
of O
segregated _RARE_
- O
stack _RARE_
organic O
charge _RARE_
- O
transfer O
solids _RARE_
: O
Magnetic O
properties O
. O

Internal _RARE_
modes O
of O
a O
soliton _RARE_
. O

II O
. O

Envelope _RARE_
- O
function O
matching _RARE_
conditions O
for _RARE_
GaAs _RARE_
/( _RARE_
Al O
, O
Ga O
) O
As O
heterojunctions _RARE_
. O

Neutron _RARE_
scattering _RARE_
measurements O
of O
critical O
exponents _RARE_
in O
CsMnBr3 _RARE_
: O
A O
Z2 _RARE_
& O
gt _RARE_
;= _RARE_
1 O
antiferromagnet _RARE_
. O

( O
2 O
) O
Erythroid _RARE_
32D _RARE_
Epo1 _RARE_
cells O
showed O
a O
lower O
level O
of O
bulk O
PKC I-GENE
catalytic O
activity O
, O
lacked O
the O
expression _RARE_
of O
epsilon I-GENE
and I-GENE
eta _RARE_
PKC I-GENE
isoforms I-GENE
, O
and O
showed O
a O
weak O
or O
absent O
upregulation _RARE_
of O
the O
remaining O
isoforms O
, O
except O
betaI _RARE_
, O
upon O
readdition _RARE_
of O
Epo I-GENE
to O
growth O
factor O
- O
starved _RARE_
cells O
. O

We O
used O
expression _RARE_
cloning O
to O
identify O
interleukin I-GENE
- I-GENE
6 I-GENE
( O
IL _RARE_
- I-GENE
6 I-GENE
) O
as _RARE_
one O
factor O
that O
suppressed O
growth O
of O
a O
pre O
- O
B O
- O
cell O
variant O
line O
, O
1A9 _RARE_
- O
M O
. O

Airflow _RARE_
through O
the O
dust O
trap _RARE_
was O
controlled _RARE_
with O
a O
vacuum _RARE_
pump _RARE_
. O

Thus O
, O
in O
normal O
intestinal _RARE_
epithelial _RARE_
goblet _RARE_
cells O
, O
TbetaRI _RARE_
and O
TbetaRII _RARE_
can O
respond O
to O
autocrine O
but O
not O
exogenous _RARE_
TGF I-GENE
- I-GENE
beta I-GENE
without O
the O
participation O
of O
TbetaRIII _RARE_
. O

The O
history O
of O
exposure O
and O
carboxyhemoglobin _RARE_
levels O
should O
alert _RARE_
the O
physician _RARE_
to O
this O
diagnosis O
. O

The O
odds O
ratio O
for _RARE_
CHD _RARE_
was O
1 O
. O
21 O
( O
95 _RARE_
% O
confidence O
interval O
, O
0 _RARE_
. O
84 _RARE_
- O
1 O
. O
75 _RARE_
) O
given O
a O
positive O
serostatus _RARE_
of O
specific O
IgG I-GENE
antibodies O
after O
adjustment O
for _RARE_
covariates _RARE_
. O

Another O
group O
of O
HIPP _RARE_
- O
and O
HCX _RARE_
- O
lesioned O
animals O
trained _RARE_
on O
the O
tasks O
after O
the O
lesion O
showed O
reduced _RARE_
impairments _RARE_
of O
the O
type O
described O
above O
, O
suggesting O
that O
extrahippocampal _RARE_
structures _RARE_
trained _RARE_
after O
the O
lesion O
can O
assume _RARE_
the O
role O
of O
the O
hippocampus O
to O
some O
degree O
. O

The O
case O
for _RARE_
neutrinos _RARE_
from O
SN _RARE_
1987A _RARE_
. O

Scaling _RARE_
of O
fluctuations O
in O
one O
- O
dimensional O
interface O
and O
hopping _RARE_
models O
. O

Model _RARE_
of O
spatiotemporal _RARE_
dynamics O
of O
stick _RARE_
- O
slip _RARE_
motion O
. O

NMR O
of O
diffusing _RARE_
atoms _RARE_
in O
a O
periodic _RARE_
porous _RARE_
medium O
in O
the O
presence O
of O
a O
nonuniform _RARE_
magnetic O
field O
. O

Microstructure _RARE_
and O
conductivity _RARE_
of O
hierarchical _RARE_
laminate _RARE_
composites _RARE_
. O

Anisotropic _RARE_
heat O
transport _RARE_
in O
the O
octylcyanobiphenyl _RARE_
( O
8CB _RARE_
) O
liquid O
crystal _RARE_
. O

Direct _RARE_
approach O
to O
the O
study O
of O
soliton _RARE_
perturbations _RARE_
. O

Mutations O
affecting O
only O
CD4 _RARE_
regulation _RARE_
mapped O
to O
residues O
previously O
shown O
to O
mediate O
the O
binding O
of O
Nef I-GENE
to O
this O
receptor O
, O
such O
as _RARE_
W57 _RARE_
and O
L58 _RARE_
, O
as _RARE_
well _RARE_
as _RARE_
to O
an O
AP I-GENE
- I-GENE
recruiting _RARE_
dileucine _RARE_
motif I-GENE
and O
to O
an O
acidic _RARE_
dipeptide _RARE_
in O
the O
C O
- O
terminal O
region O
of O
the O
protein O
. O

Several O
mutations O
disrupted O
the O
endonuclease O
and O
helicase _RARE_
activities O
; O
however O
, O
only O
one O
amino I-GENE
- I-GENE
terminal I-GENE
- I-GENE
charge _RARE_
cluster I-GENE
mutant I-GENE
protein I-GENE
( O
D40A _RARE_
- O
D42A _RARE_
- O
D44A _RARE_
) O
completely O
lost O
AAV _RARE_
hairpin O
DNA O
binding O
activity O
. O

The O
lytic O
cycle _RARE_
of O
KSHV _RARE_
, O
probably O
under O
the O
initial O
control O
of O
the O
KSHV _RARE_
/ I-GENE
Rta _RARE_
gene I-GENE
, O
may O
directly O
contribute O
to O
tumor O
pathogenesis O
. O

We O
conclude O
that O
( O
i O
) O
we O
have O
identified O
several O
candidate O
latency _RARE_
genes O
of O
murine O
gammaHV68 _RARE_
, O
( O
ii O
) O
expression _RARE_
of O
genes O
during _RARE_
latency _RARE_
may O
be O
different O
in O
different O
organs O
, O
consistent O
with O
multiple O
latency _RARE_
programs O
and O
/ O
or O
multiple O
cellular O
sites O
of O
latency _RARE_
, O
and O
( O
iii O
) O
regions O
of O
the O
viral O
genome O
( O
v I-GENE
- I-GENE
bcl I-GENE
- I-GENE
2 I-GENE
gene I-GENE
, O
v I-GENE
- I-GENE
GCR _RARE_
gene I-GENE
, O
and O
gene I-GENE
73 _RARE_
) O
are O
transcribed _RARE_
during _RARE_
latency _RARE_
with O
both O
gammaHV68 _RARE_
and O
primate O
gammaherpesviruses _RARE_
. O

These O
data O
indicate O
a O
functional _RARE_
role O
for _RARE_
U1 _RARE_
in O
NRS _RARE_
- O
mediated _RARE_
splicing _RARE_
inhibition O
. O

This O
suggests O
that O
the O
DcuS _RARE_
- O
DcuR _RARE_
system _RARE_
responds _RARE_
to O
external O
substrates _RARE_
. O

Here O
we O
describe O
the O
identification O
and O
characterization O
of O
several O
Sp100 _RARE_
splice _RARE_
variant I-GENE
proteins I-GENE
and O
support O
their O
existence O
by O
elucidation _RARE_
of O
the O
3 O
'- O
end O
of O
the O
Sp100 _RARE_
gene I-GENE
. O

Crossover _RARE_
in O
the O
specific O
heat O
of O
dilute _RARE_
magnets _RARE_
induced _RARE_
by O
critical O
spin O
- O
wave O
dynamics O
. O

Erratum _RARE_
: O
Absence _RARE_
of O
precursor O
effects O
above O
the O
martensitic _RARE_
transformation O
in O
a O
virgin _RARE_
crystal _RARE_
of O
Li O
metal O

Interplane _RARE_
coupling O
in O
the O
superconductor _RARE_
Y2Ba4Cu7O15 _RARE_
as _RARE_
revealed O
by O
NQR _RARE_
spin O
- O
echo O
double O
resonance O
. O

Electronic _RARE_
structure _RARE_
of O
a O
buried _RARE_
NiSi2 _RARE_
or O
CoSi2 _RARE_
layer O
in O
bulk O
Si _RARE_
. O

Raman _RARE_
investigation O
of O
YBa2 _RARE_
- O
xLaxCu3O7 _RARE_
ceramics _RARE_
. O

Effects O
of O
point O
defects O
on O
lattice _RARE_
parameters O
of O
semiconductors _RARE_
. O

Chaotic _RARE_
electron O
dynamics O
around O
a O
single O
elliptically _RARE_
shaped O
antidot _RARE_
. O

However O
, O
deletions O
of O
the O
C O
terminal O
11 O
or O
14 O
amino O
acids _RARE_
had O
more O
substantial O
effects O
. O

Sixty _RARE_
months O
after O
the O
initial O
vaccination O
, O
all O
vaccinees _RARE_
who O
received O
annual O
follow O
- O
up _RARE_
still O
had O
protective O
levels O
of O
anti I-GENE
- I-GENE
HAV _RARE_
. O

However O
, O
after O
PRK O
at _RARE_
5 O
weeks O
of O
age O
, O
partial O
retreatment _RARE_
may O
be O
necessary O
due O
to O
regression O
of O
the O
PRK O
effect O
. O

Its O
early O
lesions O
were O
characterized O
by O
angiomatosis _RARE_
, O
vasculopathy _RARE_
, O
and O
proliferation _RARE_
of O
synoviocytes _RARE_
and O
fibroblasts _RARE_
. O

Molecular O
cloning O
of O
human O
cDNA O
encoding O
a O
novel O
beta1 I-GENE
, I-GENE
6 I-GENE
- I-GENE
N I-GENE
- I-GENE
acetylglucosaminyltransferase _RARE_
forming O
core O
2 O
and O
core O
4 O
. O

Interspecific _RARE_
mouse O
back O
- O
cross O
analysis O
identified O
the O
loci O
for _RARE_
mouse I-GENE
3Ost _RARE_
genes I-GENE
and O
syntenic _RARE_
assignments _RARE_
of O
corresponding O
human O
isologs _RARE_
were O
confirmed O
by O
the O
identification O
of O
mapped O
sequence O
- O
tagged _RARE_
site O
markers O
. O

The O
Scales _RARE_
of O
Cognitive _RARE_
Impairment _RARE_
Rated _RARE_
From O
Institutional _RARE_
Records _RARE_
( O
SCIRFIR _RARE_
), _RARE_
a O
battery O
based O
on O
commonly O
used O
dementia O
rating O
instruments O
, O
was O
tested O
on O
the O
records O
of O
26 _RARE_
chronically _RARE_
institutionalized _RARE_
, O
elderly O
schizophrenia O
patients O
, O
for _RARE_
the O
purpose O
of O
retrospectively _RARE_
evaluating O
the O
long O
- O
term O
course O
of O
cognitive O
change O
in O
schizophrenia O
and O
relating _RARE_
it O
to O
available O
autopsy O
materials O
. O

It O
was O
demonstrated O
that O
the O
processing _RARE_
signals O
in O
the O
transcript O
, O
i O
. O
e _RARE_
. O
both O
donor O
splice _RARE_
sites O
and O
the O
polyadenylation O
site O
located _RARE_
in O
the O
muscle O
- O
specific O
intron O
, O
have O
to O
be O
weak O
. O

Most O
recently O
, O
the O
use O
of O
the O
product O
of O
brain O
weight _RARE_
and O
clearance O
has O
been O
proposed O
. O

Recombination _RARE_
and O
transcription O
of O
the O
endogenous I-GENE
Ig I-GENE
heavy I-GENE
chain I-GENE
locus I-GENE
is O
effected _RARE_
by O
the O
Ig I-GENE
heavy I-GENE
chain I-GENE
intronic _RARE_
enhancer I-GENE
core I-GENE
region I-GENE
in O
the O
absence O
of O
the O
matrix _RARE_
attachment _RARE_
regions O
. O

Two O
of O
these O
motifs O
are O
part O
of O
a O
highly O
conserved _RARE_
and O
inducible O
dyad _RARE_
symmetry _RARE_
element O
shown O
previously O
to O
control O
a O
remote _RARE_
IL _RARE_
- I-GENE
2 I-GENE
enhancer I-GENE
and O
the O
CD18 _RARE_
promoter I-GENE
. O

In O
concert _RARE_
with O
the O
coactivator _RARE_
CREB I-GENE
binding I-GENE
protein I-GENE
/ O
p300 I-GENE
, O
which O
interacts O
with O
GABPalpha _RARE_
, O
the O
binding O
of O
GABPalpha _RARE_
and I-GENE
- I-GENE
beta I-GENE
to O
the O
dyad _RARE_
symmetry _RARE_
element O
controls O
the O
induction O
of O
IL _RARE_
- I-GENE
16 I-GENE
promoter I-GENE
in O
T O
cells O
. O

TPO _RARE_
by O
itself O
did O
not O
activate O
ERK1 I-GENE
, O
ERK2 I-GENE
and O
protein I-GENE
kinase I-GENE
C I-GENE
( O
PKC I-GENE
), _RARE_
whereas O
TPO _RARE_
directly O
enhanced _RARE_
the O
PKC I-GENE
- O
dependent O
activation O
of O
ERKs I-GENE
induced _RARE_
by O
other O
agonists O
including O
thrombin I-GENE
and O
phorbol O
esters O
, O
without O
affecting O
the O
PKC I-GENE
activation O
by O
those O
agonists O
. O

BACKGROUND O
: O
In O
the O
ubiquitin I-GENE
- O
dependent O
proteolysis O
pathway _RARE_
, O
a O
ubiquitin I-GENE
ligase I-GENE
( O
E3 _RARE_
) O
is O
responsible O
for _RARE_
substrate O
selectivity O
and O
timing O
of O
degradation _RARE_
. O

CONCLUSIONS O
: O
Fission _RARE_
yeast I-GENE
SCF _RARE_
is O
composed O
of O
Pop1 _RARE_
and O
Pop2 _RARE_
, O
two O
structurally O
related O
but O
functionally O
independent O
F I-GENE
- I-GENE
box I-GENE
/ I-GENE
WD _RARE_
- I-GENE
repeat I-GENE
proteins I-GENE
. O

19F _RARE_
NMR O
studies O
in O
ABF4 _RARE_
- O
type O
layered _RARE_
antiferromagnets _RARE_
. O

Optical _RARE_
- O
absorption O
spectra O
, O
crystal _RARE_
- O
field O
energy O
levels O
, O
and O
transition O
line O
strengths O
of O
holmium _RARE_
in O
trigonal _RARE_
Na3 _RARE_

Observation _RARE_
of O
dipolar _RARE_
interactions O
between O
Pb0 _RARE_
defects O
at _RARE_
the O
( O
111 O
) O
Si _RARE_
/ O
SiO2 _RARE_
interface O
. O

Quantum _RARE_
- O
statistical O
theory O
of O
high O
- O
field O
transport _RARE_
phenomena O
. O

NH3 _RARE_
and O
NO _RARE_
interaction O
with O
Si _RARE_
( O
100 _RARE_
)-( _RARE_
2 O
x _RARE_
1 O
) O
surfaces _RARE_
. O

Chirality _RARE_
- O
glass O
and O
spin O
- O
glass O
correlations O
in O
the O
two O
- O
dimensional O
random O
- O
bond O
XY _RARE_
model O
. O

Echo _RARE_
modulation O
in O
Pr3 _RARE_
+: _RARE_
YAlO3 _RARE_
. O

Mechanisms _RARE_
of O
visible _RARE_
- O
light O
emission O
from O
electro _RARE_
- O
oxidized _RARE_
porous _RARE_
silicon _RARE_
. O

Far _RARE_
- O
infrared _RARE_
hopping _RARE_
conductivity _RARE_
in O
the O
CuO _RARE_
chains O
of O
a O
single O
- O
domain O
YBa2Cu3O7 _RARE_
- O
delta O
crystal _RARE_
. O

Surface _RARE_
spin O
waves O
in O
a O
Heisenberg _RARE_
ferrimagnet _RARE_
with O
a O
single O
- O
ion O
anisotropy _RARE_
( O
uniaxial _RARE_
and O
nonuniaxial _RARE_
). O

Optically _RARE_
detected O
librons _RARE_
and O
phonons _RARE_
in O
crystalline O
C60 _RARE_
. O

Multilayer _RARE_
- O
relaxation O
geometry _RARE_
and O
electronic _RARE_
structure _RARE_
of O
a O
W _RARE_
( O
111 O
) O
surface O
. O

Temperature _RARE_
dependence O
of O
the O
sublattice _RARE_
spontaneous O
magnetization _RARE_
of O
YBa2Cu3O6 _RARE_
. O

GW _RARE_
Gamma _RARE_
approximation _RARE_
for _RARE_
electron O
self O
- O
energies _RARE_
in O
semiconductors _RARE_
and O
insulators _RARE_
. O

Precision _RARE_
measurement O
of O
the O
pion _RARE_
mass O
difference O
m O
pi _RARE_
-- _RARE_
m O
pi _RARE_
0 _RARE_
. O

Testing _RARE_
gravity _RARE_
to O
second O
post O
- O
Newtonian _RARE_
order O
: O
A O
field O
- O
theory O
approach O
. O

Genetic O
experiments O
using O
mutants O
defective _RARE_
in O
apontic _RARE_
and O
bruno _RARE_
reveal O
a O
functional _RARE_
interaction O
between O
these O
genes O
. O

In O
the O
current O
model O
, O
Wingless _RARE_
/ O
Wnt I-GENE
signal O
stabilizes O
Armadillo _RARE_
/ O
beta I-GENE
- I-GENE
catenin I-GENE
, O
which O
then O
accumulates O
in O
nuclei O
and O
binds O
TCF I-GENE
/ O
LEF _RARE_
family O
proteins O
, O
forming O
bipartite O
transcription O
factors O
which O
activate O
transcription O
of O
Wingless _RARE_
/ O
Wnt I-GENE
responsive O
genes O
. O

In O
support O
of O
clinical O
antianginal _RARE_
studies O
, O
the O
vasodilator O
nicorandil _RARE_
( O
NIC _RARE_
) O
was O
combined O
with O
the O
beta I-GENE
- I-GENE
adrenergic I-GENE
receptor I-GENE
antagonists O
propranolol O
( O
PRO _RARE_
) O
and O
atenolol _RARE_
( O
ATN _RARE_
) O
and O
with O
the O
calcium _RARE_
channel _RARE_
blocker O
diltiazem O
( O
DTZ _RARE_
) O
to O
determine O
their O
cardiovascular O
and O
pharmacokinetic O
interactions O
. O

Factors O
influencing O
direct O
- O
immersion O
( O
DI _RARE_
)- O
SPME _RARE_
process O
were O
also O
checked _RARE_
and O
chosen O
experimentally O
. O

In O
contrast O
, O
an O
amino O
- O
terminal O
fragment O
containing O
the O
C O
/ O
H1 _RARE_
domain O
was O
sufficient O
for _RARE_
coactivation _RARE_
of O
Zta I-GENE
transcription O
and O
viral O
reactivation _RARE_
function O
. O

In O
addition O
, O
a O
potent O
splicing _RARE_
enhancer O
sequence O
isolated O
in O
the O
selection O
specifically O
binds O
a O
20 I-GENE
- I-GENE
kDa I-GENE
SR I-GENE
protein I-GENE
. O

Elimination O
of O
ETH1 _RARE_
in O
apn1 _RARE_
strains O
also O
increased O
spontaneous O
mutation O
rates O
9 O
- O
or O
31 _RARE_
- O
fold _RARE_
compared O
to O
the O
wild O
type O
as _RARE_
determined O
by O
reversion _RARE_
to O
adenine _RARE_
or O
lysine _RARE_
prototrophy _RARE_
, O
respectively O
. O

Elimination O
of O
ETH1 _RARE_
in O
apn1 _RARE_
strains O
also O
increased O
spontaneous O
mutation O
rates O
9 O
- O
or O
31 _RARE_
- O
fold _RARE_
compared O
to O
the O
wild O
type O
as _RARE_
determined O
by O
reversion _RARE_
to O
adenine _RARE_
or O
lysine _RARE_
prototrophy _RARE_
, O
respectively O
. O

These O
data O
suggest O
that O
other O
Ras I-GENE
effectors _RARE_
can O
collaborate _RARE_
with O
PI I-GENE
3 I-GENE
- I-GENE
kinase I-GENE
and O
with O
each O
other O
to O
activate O
Pak _RARE_
. O

Mammalian _RARE_
Ras I-GENE
GTPase I-GENE
- I-GENE
activating I-GENE
protein I-GENE
( O
GAP _RARE_
), _RARE_
p120 _RARE_
Ras I-GENE
- O
GAP _RARE_
, O
has O
been O
implicated O
as _RARE_
both O
a O
downregulator _RARE_
and O
effector O
of O
Ras I-GENE
proteins I-GENE
, O
but O
its O
precise O
role O
in O
Ras I-GENE
- O
mediated _RARE_
signal O
transduction _RARE_
pathways O
is O
unclear O
. O

Three O
mog _RARE_
- I-GENE
1 I-GENE
alleles I-GENE
possess O
premature O
stop O
codons O
and O
are O
likely O
to O
be O
null _RARE_
alleles O
, O
and O
one O
is O
a O
missense O
mutation O
and O
is O
likely O
to O
retain _RARE_
residual O
activity O
. O
mog _RARE_
- I-GENE
1 I-GENE
mRNA I-GENE
is O
expressed _RARE_
in O
both O
germ _RARE_
line O
and O
somatic O
tissues O
and O
appears O
to O
be O
ubiquitous O
. O

However O
, O
unlike O
the O
SIN3 _RARE_
gene I-GENE
of O
Saccharomyces O
cerevisiae O
, O
pst1 _RARE_
(+) _RARE_
is O
essential O
for _RARE_
cell O
viability O
. O

The O
Nmd3 _RARE_
protein I-GENE
sequence I-GENE
does O
not O
contain O
readily O
recognizable _RARE_
motifs O
of O
known O
function O
. O

The O
distribution O
of O
the O
various O
repeats O
suggests O
its O
organization O
is O
similar O
to O
the O
beta O
- O
heterochromatic _RARE_
regions O
near O
the O
base _RARE_
of O
the O
major O
chromosome _RARE_
arms _RARE_
. O

Calcitonin _RARE_
simultaneously O
regulates O
both O
periosteal _RARE_
hyperostosis _RARE_
and O
trabecular _RARE_
osteopenia _RARE_
in O
the O
spinal _RARE_
hyperostotic _RARE_
mouse O
( O
twy _RARE_
/ O
twy _RARE_
) O
in O
vivo O
. O

Electrophoretic O
mobility O
- O
shift O
assays O
performed O
with O
the O
HNF I-GENE
- I-GENE
3 I-GENE
X O
and O
Y O
sites O
demonstrated O
that O
both O
sites O
are O
capable O
of O
binding O
HNF I-GENE
- I-GENE
3alpha _RARE_
and O
HNF I-GENE
- I-GENE
3beta _RARE_
. O

In O
addition O
, O
we O
also O
show O
that O
cdk7 _RARE_
may O
phosphorylate O
the O
carboxy _RARE_
- O
terminal O
domain O
( O
CTD _RARE_
) O
of O
RNA I-GENE
pol I-GENE
II I-GENE
in O
the O
absence O
of O
promoter O
opening _RARE_
. O

The O
therapy O
with O
a O
H2 I-GENE
- I-GENE
receptor I-GENE
antagonist O
is O
less O
effective O
than O
the O
triple _RARE_
therapies _RARE_
with O
omeprazole O
or O
lansoprazole _RARE_
. O

In O
humans O
, O
three O
tissue I-GENE
- I-GENE
specific I-GENE
plastin I-GENE
isoforms I-GENE
have O
been O
identified O
. O

No O
TATA O
or O
Inr _RARE_
sequence O
was O
found O
. O

The O
inhibition O
by O
the O
RIalpha _RARE_
subunit I-GENE
is O
reversed O
by O
addition O
of O
nanomolar _RARE_
concentrations O
of O
cAMP O
( O
Ka _RARE_
= O
40 O
nM O
), _RARE_
thus O
demonstrating O
that O
PrKX _RARE_
is O
a O
novel O
, O
type I-GENE
I I-GENE
cAMP I-GENE
- I-GENE
dependent I-GENE
protein I-GENE
kinase I-GENE
that O
is O
activated O
at _RARE_
lower O
cAMP O
concentrations O
than O
the O
holoenzyme _RARE_
with O
the O
Calpha _RARE_
subunit I-GENE
of O
cAMP I-GENE
- I-GENE
dependent I-GENE
protein I-GENE
kinase I-GENE
. O

Proteins _RARE_
known O
to O
bind O
the O
PEPCK I-GENE
CRE _RARE_
include O
the O
CRE _RARE_
- I-GENE
binding I-GENE
protein I-GENE
( O
CREB I-GENE
) O
and O
members O
of O
the O
CCAAT I-GENE
/ I-GENE
enhancer I-GENE
- I-GENE
binding I-GENE
protein I-GENE
( O
C I-GENE
/ I-GENE
EBP I-GENE
) O
family O
. O

This O
construct O
, O
termed O
pDeltaCREC _RARE_
/ O
EBP I-GENE
, O
binds O
C I-GENE
/ I-GENE
EBPalpha _RARE_
and I-GENE
beta I-GENE
but O
not O
CREB I-GENE
, O
yet O
it O
confers O
a O
nearly O
complete _RARE_
glucocorticoid O
response O
when O
transiently O
transfected O
into O
H4IIE _RARE_
rat O
hepatoma O
cells O
. O

In O
addition O
, O
in O
vitro O
mutagenesis O
of O
both O
Engrailed _RARE_
and O
Pbx1 _RARE_
sites I-GENE
indicated O
that O
other O
unidentified O
sites O
are O
responsible O
for _RARE_
the O
transcriptional O
enhancement O
observed O
with O
the O
intronic _RARE_
fragment O
. O

Several O
secondary O
structure _RARE_
elements O
were O
identified O
. O

Here O
, O
we O
evidence O
that O
the O
developmental O
functions O
of O
the O
family O
of O
transcription O
factors O
characterized O
by O
the O
POU I-GENE
DNA I-GENE
binding I-GENE
motif I-GENE
exerts O
roles O
in O
mammalian O
development O
. O

High _RARE_
- O
affinity O
site O
- O
specific O
DNA O
binding O
by O
POU I-GENE
domain I-GENE
transcription I-GENE
factors I-GENE
requires O
both O
the O
POU I-GENE
- I-GENE
specific I-GENE
and O
the O
POU I-GENE
- I-GENE
homeodomain _RARE_
. O

In O
the O
Oct I-GENE
- I-GENE
1 I-GENE
crystal _RARE_
, O
the O
POU I-GENE
- I-GENE
specific I-GENE
domain I-GENE
recognizes O
a O
GCAT _RARE_
half _RARE_
- O
site O
, O
while O
the O
corresponding O
sequence O
recognized _RARE_
by O
the O
Pit I-GENE
- I-GENE
1 I-GENE
POU I-GENE
- O
specific O
domain O
, O
GTAT _RARE_
, O
is O
on O
the O
opposing _RARE_
strand _RARE_
. O

Systematic _RARE_
functional _RARE_
analysis O
of O
V1a _RARE_
/ I-GENE
V2 _RARE_
hybrid _RARE_
receptors I-GENE
showed O
that O
the O
second O
intracellular _RARE_
loop O
of O
the O
V1a _RARE_
receptor I-GENE
is O
required O
and O
sufficient O
for _RARE_
efficient O
coupling O
to O
Gq _RARE_
/ I-GENE
11 I-GENE
, O
whereas O
the O
third O
intracellular _RARE_
loop O
of O
the O
V2 _RARE_
receptor I-GENE
is O
required O
and O
sufficient O
for _RARE_
coupling O
to O
Gs _RARE_
. O

Most O
other O
end O
points O
were O
highly O
significant O
, O
and O
death _RARE_
, O
which O
was O
monitored O
across O
the O
U _RARE_
. O
S O
. O
program O
, O
was O
different O
with O
p O
< O
0 _RARE_
. O
0001 O
. O

The O
other O
is O
located _RARE_
at _RARE_
- O
1335 _RARE_
, O
outside O
this O
highly O
conserved _RARE_
region O
. O

The O
fatigue _RARE_
exercise O
showed O
relatively O
high O
blood _RARE_
lactate _RARE_
concentration O
[ _RARE_
12 O
. O
5 O
( O
SD O
2 O
. O
6 O
) O
mmol O
x _RARE_
l _RARE_
(- _RARE_
1 O
)] O
and O
an O
increase O
of O
serum I-GENE
creatine _RARE_
kinase I-GENE
( O
CK _RARE_
) O
activity O
delayed O
by O
2 O
days O
[ _RARE_
540 _RARE_
( O
SD O
407 _RARE_
) O
U _RARE_
x _RARE_
l _RARE_
(- _RARE_
1 O
)]. O

Those _RARE_
radiological _RARE_
aspects O
were O
distributed O
in O
two O
categories O
: O
1 O
) O
type O
I O
- O
presenting _RARE_
variable _RARE_
sinusoidal _RARE_
filling O
. O

Results O
demonstrated O
that O
the O
presence O
of O
myofibroblasts _RARE_
varied O
considerably O
from O
case O
to O
case O
and O
was O
always O
related O
to O
smooth _RARE_
muscle O
cell O
dispersion O
, O
which O
occurred O
around O
medium O
- O
sized O
damaged O
portal _RARE_
vein _RARE_
branches _RARE_
. O

New O
Langevin _RARE_
equations _RARE_
for _RARE_
a O
translating _RARE_
and O
simultaneously O
rotating _RARE_
asymmetric O
top O
. O

Radiative _RARE_
corrections _RARE_
to O
beta O
decay _RARE_
and O
the O
possibility O
of O
a O
fourth O
generation O
. O

Depth _RARE_
- O
controlled _RARE_
grazing _RARE_
- O
incidence O
diffraction _RARE_
of O
synchrotron _RARE_
x _RARE_
radiation O
. O

Oscillatory _RARE_
exchange O
of O
atoms _RARE_
between O
traps _RARE_
containing O
Bose _RARE_
condensates _RARE_
. O

Structure O
determination O
of O
an O
adsorbate _RARE_
- O
induced _RARE_
multilayer _RARE_
reconstruction O
: O
( O
1 O
x _RARE_
2 O
)- O
H O
/ O
Ni _RARE_
( O
110 _RARE_
). O

Magnetic O
trapping _RARE_
of O
spin O
- O
polarized _RARE_
atomic _RARE_
hydrogen O
. O

Northern O
blot O
and O
in O
situ O
hybridization O
analyses O
revealed O
GPR34 _RARE_
mRNA I-GENE
transcripts I-GENE
in O
several O
human O
and O
rat O
brain O
regions O
. O

The O
microphthalmia _RARE_
- I-GENE
TFE _RARE_
( O
MiT _RARE_
) O
subfamily O
of O
basic I-GENE
helix I-GENE
- I-GENE
loop I-GENE
- I-GENE
helix I-GENE
leucine I-GENE
zipper I-GENE
( I-GENE
bHLH I-GENE
- I-GENE
ZIP _RARE_
) I-GENE
transcription I-GENE
factors I-GENE
, O
including O
TFE3 _RARE_
, O
TFEB _RARE_
, O
TFEC _RARE_
, O
and O
Mitf _RARE_
, O
has O
been O
implicated O
in O
the O
regulation _RARE_
of O
tissue O
- O
specific O
gene O
expression _RARE_
in O
several O
cell O
lineages O
. O

Fifty O
- O
seven _RARE_
patients O
aged O
< O
55 _RARE_
years O
with O
acute O
lymphoblastic _RARE_
leukemia O
( O
ALL O
) O
in O
second O
or O
third O
bone O
marrow O
( O
BM _RARE_
) O
relapse O
or O
refractory O
to O
first _RARE_
- O
line O
therapy O
were O
enrolled O
in O
an O
Italian O
cooperative O
study O
. O

The O
dorsal O
nerves O
of O
the O
penis _RARE_
were O
anesthetized O
bilaterally _RARE_
with O
lidocaine O
. O

In O
the O
brain O
, O
muscarinic _RARE_
receptors I-GENE
mediate O
motor O
and O
memory O
function O
by O
interaction O
with O
their O
ligand _RARE_
acetylcholine _RARE_
. O

Early O
- O
onset O
scleral _RARE_
necrosis O
after O
iodine O
I O
125 _RARE_
plaque O
radiotherapy O
for _RARE_
ciliochoroidal _RARE_
melanoma _RARE_
. O

Successful _RARE_
interaction O
of O
ARF I-GENE
and O
PKC I-GENE
- I-GENE
alpha I-GENE
with O
PLD1 _RARE_
was O
not O
achieved O
, O
but O
a O
C O
- O
terminal O
fragment O
of O
human I-GENE
PLD1 _RARE_
( O
denoted _RARE_
" O
D4 _RARE_
") _RARE_
interacted O
with O
the O
active _RARE_
mutant O
of O
RhoA I-GENE
, O
RhoAVal _RARE_
- I-GENE
14 I-GENE
. O

In O
this O
study O
, O
we O
investigated O
the O
signal O
transduction _RARE_
pathways O
that O
are O
involved O
in O
OM _RARE_
- O
induced _RARE_
LDLR _RARE_
transcription O
. O

Vacuum _RARE_
Rabi _RARE_
splitting _RARE_
as _RARE_
a O
feature O
of O
linear _RARE_
- O
dispersion O
theory O
: O
Analysis O
and O
experimental O
observations O
. O

High _RARE_
- O
pressure O
effects O
on O
ultrafast _RARE_
- O
relaxation O
kinetics O
of O
excitons _RARE_
in O
polydiacetylene _RARE_
4BCMU _RARE_
. O

Drag _RARE_
reduction O
in O
turbulent _RARE_
flows _RARE_
by O
polymers O
. O

Large _RARE_
scale O
electronic _RARE_
structure _RARE_
calculations _RARE_
. O

Current O
world O
literature O
. O

These O
results O
show O
that O
Ski _RARE_
is O
a O
component _RARE_
of O
the O
HDAC _RARE_
complex I-GENE
and O
that O
Ski _RARE_
is O
required O
for _RARE_
the O
transcriptional O
repression O
mediated _RARE_
by O
this O
complex O
. O

Recombinant O
unr _RARE_
acts O
synergistically O
with O
recombinant O
PTB _RARE_
to O
stimulate O
translation O
dependent O
on O
the O
rhinovirus _RARE_
IRES _RARE_
. O

Analysis O
of O
the O
consensus O
binding O
sequence O
and O
the O
DNA O
- O
binding O
domain O
of O
ZF5 _RARE_
. O

Mapping O
of O
the O
human I-GENE
Voltage _RARE_
- I-GENE
Dependent _RARE_
Anion _RARE_
Channel _RARE_
isoforms I-GENE
1 I-GENE
and I-GENE
2 I-GENE
reconsidered _RARE_
. O

Identification O
of O
RNase I-GENE
T I-GENE
as _RARE_
a O
high O
- O
copy O
suppressor O
of O
the O
UV _RARE_
sensitivity O
associated O
with O
single I-GENE
- I-GENE
strand _RARE_
DNA I-GENE
exonuclease _RARE_
deficiency O
in O
Escherichia O
coli O
. O

Inhibition O
of O
phosphatidylinositol _RARE_
- I-GENE
3 I-GENE
kinase I-GENE
did O
not O
have O
a O
significant O
effect O
on O
p53 I-GENE
conformation O
but O
did O
have O
a O
weak O
but O
significant O
effect O
on O
Tpo _RARE_
- O
enhanced _RARE_
viability O
. O

No O
difference O
in O
percentage O
of O
males O
in O
semen O
production O
was O
noted O
between O
strains O
, O
CP O
levels O
, O
or O
feeding O
regimens O
. O

The O
Lp _RARE_
mouse I-GENE
mutant I-GENE
provides O
a O
model O
for _RARE_
the O
severe O
human O
neural _RARE_
tube O
defect O
( O
NTD _RARE_
), _RARE_
cranio _RARE_
- O
rachischisis _RARE_
. O

Further O
analysis O
of O
AP I-GENE
- I-GENE
1 I-GENE
DNA O
binding O
activities O
in O
7 O
- O
to O
14 O
- O
day O
culture O
activated O
HSCs _RARE_
led O
to O
the O
discovery O
of O
high I-GENE
mobility I-GENE
AP I-GENE
- I-GENE
1 I-GENE
complexes I-GENE
( O
HMAP _RARE_
- I-GENE
1 I-GENE
). O

Mutations O
of O
the O
AP I-GENE
- I-GENE
1 I-GENE
site I-GENE
of O
the O
TIMP I-GENE
- I-GENE
1 I-GENE
promoter I-GENE
that O
prevented O
formation O
of O
HMAP _RARE_
- I-GENE
1 I-GENE
caused O
a O
70 O
% O
loss _RARE_
of O
activity O
in O
transfected O
activated O
HSCs _RARE_
. O

STUDY _RARE_
DESIGN O
: O
Salivary _RARE_
immunoglobulin I-GENE
A I-GENE
levels O
of O
each O
of O
20 O
subjects O
were O
determined O
on O
3 O
occasions _RARE_
: O
first _RARE_
, O
while O
the O
subject O
was O
still O
smoking O
; O
second O
, O
7 O
days O
after O
cessation O
of O
smoking O
; O
third O
, O
on O
the O
14th _RARE_
day O
after O
cessation O
. O

Therefore O
, O
high O
set O
- O
up _RARE_
accuracy O
and O
reproducibility O
are O
mandatory _RARE_
. O

Role O
of O
g2 _RARE_
in O
relating _RARE_
the O
Schwinger _RARE_
and O
Gerasimov _RARE_
- O
Drell _RARE_
- O
Hearn _RARE_
sum O
rules _RARE_
. O

Spectroscopy _RARE_
of O
negative O
ions O
utilizing O
multiphoton _RARE_
detachment _RARE_
in O
a O
Raman _RARE_
coupling O
regime _RARE_
. O

Band _RARE_
structure _RARE_
effects O
of O
transport _RARE_
properties O
in O
icosahedral _RARE_
quasicrystals _RARE_
. O

Acoustic _RARE_
transmission _RARE_
spectra O
in O
the O
Penrose _RARE_
lattice _RARE_
. O

Two O
- O
Channel _RARE_
Kondo _RARE_
Lattice _RARE_
: O
An O
Incoherent _RARE_
Metal _RARE_
. O

Basal O
midexpiratory _RARE_
lower O
esophageal O
sphincter _RARE_
pressure O
was O
similar O
in O
the O
study O
group O
( O
mean O
[ _RARE_
SD O
] O
20 O
. O
1 O
[ _RARE_
9 O
. O
1 O
] O
mmHg O
) O
and O
controls O
( O
17 _RARE_
. O
6 O
[ _RARE_
6 O
. O
0 _RARE_
] O
mmHg O
); O
the O
pressure O
did O
not O
change O
following O
EVS _RARE_
or O
EVL _RARE_
. O

CPDs _RARE_
at _RARE_
these O
three O
sites O
may O
partially O
displace _RARE_
TFIIIA _RARE_
, O
thereby O
enabling _RARE_
rapid O
repair O
. O

There O
was O
no _RARE_
difference O
in O
the O
hormone O
receptor O
status O
between O
the O
cases O
without O
lymph O
node O
metastases O
and O
with O
lymph O
node O
metastases O
, O
' O
clandestine _RARE_
' O
or O
macrometastases _RARE_
. O

On O
the O
other O
hand _RARE_
, O
subjects O
with O
air O
trapping _RARE_
( O
residual O
volume O
( O
RV O
)/ _RARE_
total _RARE_
lung _RARE_
capacity O
( O
TLC _RARE_
) O
> O
37 O
%) O
disclosed _RARE_
not O
only O
a O
higher _RARE_
n _RARE_
( O
mit _RARE_
) O
( O
0 _RARE_
. O
63 _RARE_
+/- O
0 _RARE_
. O
17 _RARE_
versus O
0 _RARE_
. O
43 _RARE_
+/- O
0 _RARE_
. O
07 O
mt _RARE_
x _RARE_
microm O
(- _RARE_
2 O
), _RARE_
p O
< O
0 _RARE_
. O
05 O
) O
but O
shorter O
sarcomeres _RARE_
( O
L O
( O
sar _RARE_
)) O
than O
subjects O
without O
this O
functional _RARE_
abnormality O
( O
2 O
. O
08 _RARE_
+/- O
0 _RARE_
. O
16 O
to O
2 O
. O
27 _RARE_
+/- O
0 _RARE_
. O
15 _RARE_
microm O
, O
p O
< O
0 _RARE_
. O
05 O
). O

Gel O
filtration O
, O
sedimentation O
velocity O
, O
and O
immunoprecipitation O
experiments O
revealed O
that O
beta4 _RARE_
is O
a O
component _RARE_
of O
a O
multisubunit _RARE_
complex O
( O
AP I-GENE
- I-GENE
4 I-GENE
) O
that O
also O
contains O
the O
sigma4 _RARE_
polypeptide O
and O
two O
additional O
adaptor _RARE_
subunit O
homologs O
named O
mu4 _RARE_
( O
mu O
- O
ARP2 _RARE_
) O
and O
epsilon O
. O

Cyclin I-GENE
D1 _RARE_
- I-GENE
associated I-GENE
kinase I-GENE
activity O
and O
protein O
levels O
were O
increased O
in O
mammary O
tumors O
from O
murine O
mammary O
tumor O
virus O
- O
pp60 _RARE_
( O
c I-GENE
- I-GENE
src527F _RARE_
) O
transgenic O
mice O
. O

The O
SH2 _RARE_
domain I-GENE
- I-GENE
containing I-GENE
inositol _RARE_
5 I-GENE
'- I-GENE
phosphatase I-GENE
( O
SHIP _RARE_
) O
recruits _RARE_
the O
p85 I-GENE
subunit I-GENE
of O
phosphoinositide _RARE_
3 I-GENE
- I-GENE
kinase I-GENE
during _RARE_
FcgammaRIIb1 _RARE_
- O
mediated _RARE_
inhibition O
of O
B I-GENE
cell I-GENE
receptor I-GENE
signaling _RARE_
. O

We O
show O
that O
the O
mouse O
genome O
contains O
four O
copies O
of O
the O
ubc _RARE_
- I-GENE
9 I-GENE
gene I-GENE
. O

An O
increase O
in O
bone O
mineral O
density O
at _RARE_
the O
spine O
, O
total _RARE_
hip O
, O
and O
total _RARE_
body O
has O
been O
reported O
with O
raloxifene _RARE_
but O
seems O
to O
be O
less O
than O
that O
seen O
with O
estrogen O
or O
alendronate _RARE_
therapy O
. O

However O
, O
in O
those O
studies O
due O
to O
the O
presence O
of O
thiol _RARE_
agents O
in O
the O
PKC I-GENE
preparations O
, O
the O
sensitive _RARE_
reaction O
of O
BPO _RARE_
with O
redox _RARE_
- O
active _RARE_
cysteine O
residues O
in O
PKC I-GENE
was O
not O
observed O
. O

Interestingly O
, O
Csx _RARE_
/ O
Nkx2 _RARE_
. O

We O
also O
identified O
an O
alternative _RARE_
spliced _RARE_
form O
of O
Lyp _RARE_
RNA I-GENE
, O
Lyp2 _RARE_
. O

The O
costs O
were O
DM O
11 O
, O
562 _RARE_
for _RARE_
a O
PE _RARE_
, O
DM O
12 O
, O
477 _RARE_
for _RARE_
a O
VR _RARE_
and O
DM O
7 O
, O
532 _RARE_
for _RARE_
a O
MR O
. O

We O
now O
provide O
evidence O
for _RARE_
physical O
and O
functional _RARE_
interaction O
between O
Doa4 _RARE_
and O
the O
proteasome O
. O

Independent _RARE_
splicing _RARE_
events O
involve O
three O
previously O
described O
cassette _RARE_
exons O
, O
which O
are O
predicted O
to O
encode O
most O
of O
the O
second O
transmembrane O
domain O
. O

Each O
of O
these O
genes O
contains O
a O
putative O
upstream O
ORF O
, O
while O
STA2 _RARE_
has O
two O
additional O
in O
- O
frame O
AUG O
codons O
5 O
' O
to O
the O
major O
cistron _RARE_
. O

Nipponbare _RARE_
as _RARE_
well _RARE_
as _RARE_
O O
. O
australiensis _RARE_
. O

In O
addition O
, O
mapping O
of O
the O
promoter O
region O
and O
the O
identification O
of O
putative O
promoter O
regulatory O
sequences O
should O
give O
insight O
into O
the O
transcriptional O
regulation _RARE_
of O
UCP2 _RARE_
expression _RARE_
-- _RARE_
in O
particular O
by O
anyone _RARE_
of O
the O
above O
mentioned O
factors O
-- _RARE_
in O
vitro O
and O
in O
vivo O
. O

The O
rate O
of O
resectability _RARE_
is O
low O
and O
5 O
- O
year O
survival O
is O
very O
poor O
. O

In O
order O
to O
better O
characterize O
the O
distribution O
of O
ML _RARE_
and O
MAP O
estimates O
under O
these O
conditions O
, O
we O
derive _RARE_
a O
point O
approximation _RARE_
to O
density O
values O
of O
the O
conditional O
distribution O
of O
such O
estimates O
. O

RT O
- O
PCR O
was O
performed O
using O
previously O
reported O
degenerate O
oligonucleotide _RARE_
primers O
to O
the O
ligand _RARE_
binding O
domain O
( O
LBD _RARE_
) O
of O
known O
beta I-GENE
integrin I-GENE
subunits I-GENE
and O
Bge _RARE_
cDNA I-GENE
. O

The O
lowest O
culture O
failure O
rate O
of O
0 _RARE_
. O
2 O
per O
cent O
was O
found O
after O
EAF _RARE_
compared O
with O
0 _RARE_
. O
9 O
per O
cent O
among O
CVS _RARE_
. O

Ectopic _RARE_
expression _RARE_
of O
d I-GENE
- I-GENE
axin _RARE_
inhibited O
Wingless _RARE_
signaling _RARE_
. O

The O
corresponding O
differences O
in O
FVIIa _RARE_
and O
PAI I-GENE
- I-GENE
1 I-GENE
were O
not O
statistically O
significant O
. O

Primary O
and O
secondary O
structural O
elements O
required O
for _RARE_
synthesis _RARE_
of O
barley _RARE_
yellow O
dwarf _RARE_
virus O
subgenomic _RARE_
RNA1 _RARE_
. O

On O
the O
other O
side _RARE_
, O
when O
the O
aortic O
ring _RARE_
was O
perfused O
with O
L O
- O
NNA _RARE_
( O
NO _RARE_
- O
synthesis _RARE_
inhibitor O
) O
or O
methylene O
blue O
( O
soluble _RARE_
cGMPase _RARE_
inhibitor O
), _RARE_
the O
changes O
could O
be O
attenuated O
. O

Nevertheless O
, O
inactivation O
of O
the O
cyclin _RARE_
E I-GENE
- O
Cdk2 I-GENE
complex O
in O
response O
to O
mitogen O
starvation O
occurs O
normally O
in O
MEFs _RARE_
that O
have O
a O
homozygous O
deletion O
of O
the O
p27 I-GENE
gene I-GENE
. O

Identification O
and O
characterization O
of O
IS2404 _RARE_
and O
IS2606 _RARE_
: O
two O
distinct O
repeated _RARE_
sequences O
for _RARE_
detection O
of O
Mycobacterium O
ulcerans _RARE_
by O
PCR O
. O

Taken O
together O
, O
these O
results O
are O
consistent O
with O
the O
possibility O
that O
p202 _RARE_
protein I-GENE
contributes O
to O
the O
cell O
growth O
retardation O
activity O
of O
the O
IFNs _RARE_
, O
at _RARE_
least O
in O
part O
, O
by O
modulating _RARE_
p21 I-GENE
protein I-GENE
levels O
. O

Similar O
results O
were O
also O
obtained O
with O
a O
HepG2 _RARE_
hepatoblastoma _RARE_
cell O
line O
carrying O
wt I-GENE
p53 I-GENE
. O

Partial O
sequencing O
of O
the O
region O
downstream _RARE_
of O
ORF I-GENE
- I-GENE
Pto _RARE_
revealed O
homology O
to O
the O
ru _RARE_
/ I-GENE
AB _RARE_
genes I-GENE
, O
involved O
in O
UV _RARE_
resistance O
, O
from O
plasmid _RARE_
pPSR1 _RARE_
. O

The O
MSY2 _RARE_
associated O
kinase O
is O
not O
casein I-GENE
kinase I-GENE
2 I-GENE
, O
the O
kinase O
believed O
to O
phosphorylate O
mRNP3 _RARE_
+ I-GENE
4 I-GENE
in O
oocytes O
, O
but O
a O
yet O
unidentified O
kinase O
. O

This O
suggests O
that O
helicase _RARE_
- I-GENE
like I-GENE
genes I-GENE
may O
be O
involved O
in O
the O
biosynthesis O
of O
nucleic _RARE_
acids _RARE_
and O
proteins O
, O
and O
that O
the O
genes O
can O
be O
transcriptionally O
activated O
by O
heat O
shock O
to O
compensate _RARE_
for _RARE_
the O
repressed O
synthesis _RARE_
of O
mRNA O
and O
protein O
. O

These O
data O
provide O
the O
molecular _RARE_
tools O
for _RARE_
the O
final O
identification O
of O
the O
MKS _RARE_
and O
the O
MUL _RARE_
genes I-GENE
. O

The O
H O
- O
reflex O
recovery O
curve O
was O
obtained O
after O
stimulation _RARE_
of O
the O
median O
nerve O
at _RARE_
the O
elbow _RARE_
and O
recording O
from O
the O
flexor _RARE_
carpi _RARE_
radialis _RARE_
. O

The O
origins O
of O
reflected O
light O
changes O
associated O
with O
neuronal _RARE_
activity O
( O
optical O
signals O
) O
were O
investigated O
in O
rat O
somatosensory _RARE_
cortex O
with O
optical O
imaging O
, O
microspectrophotometry _RARE_
, O
and O
laser O
- O
Doppler O
flowmetry _RARE_
, O
and O
dynamic O
changes O
in O
local O
hemoglobin I-GENE
concentration O
and O
oxygenation O
were O
focused O
on O
. O

Human I-GENE
neuronal _RARE_
Elav _RARE_
- I-GENE
like I-GENE
proteins I-GENE
contain O
three O
RNP _RARE_
- O
type O
RNA O
recognition O
motifs O
( O
RRMs _RARE_
). O

Comparison O
of O
frequencies O
of O
atrial _RARE_
fibrillation O
after O
coronary O
artery O
bypass O
grafting _RARE_
with O
and O
without O
the O
use O
of O
cardiopulmonary O
bypass O
. O

The O
results O
of O
supershift O
analysis O
using O
specific O
antibodies O
against O
transcription O
factors O
suggested O
that O
both O
binding O
complexes O
contained O
the O
NF _RARE_
- I-GENE
kappaB I-GENE
components _RARE_
p50 _RARE_
and O
p65 _RARE_
, O
and O
did O
not O
contain O
other O
NF _RARE_
- I-GENE
kappaB I-GENE
proteins I-GENE
( O
p52 _RARE_
, O
c I-GENE
- I-GENE
Rel I-GENE
, O
Rel I-GENE
B I-GENE
), _RARE_
AP I-GENE
- I-GENE
1 I-GENE
proteins I-GENE
( O
c I-GENE
- I-GENE
Fos I-GENE
, O
C I-GENE
- I-GENE
Jun I-GENE
), _RARE_
CREB I-GENE
or O
C I-GENE
/ I-GENE
EBPbeta I-GENE
( O
NF _RARE_
- I-GENE
IL6 I-GENE
). O

A O
set O
of O
peptides O
corresponding O
to O
the O
individual O
elements O
of O
secondary O
structure _RARE_
derived O
from O
the O
N O
- O
terminal O
domain O
of O
the O
ribosomal I-GENE
protein I-GENE
L9 _RARE_
have O
been O
synthesized O
. O

The O
results O
showed O
that O
IFN I-GENE
- I-GENE
gamma I-GENE
stimulated _RARE_
the O
rapid O
accumulation O
of O
interferon _RARE_
regulated I-GENE
factor I-GENE
( I-GENE
IRF I-GENE
)- I-GENE
1 I-GENE
mRNA I-GENE
, O
followed O
by O
a O
delayed O
and O
dose O
- O
dependent O
inhibition O
of O
alpha1 _RARE_
( I-GENE
I I-GENE
) I-GENE
procollagen _RARE_
mRNA I-GENE
expression _RARE_
in O
skin _RARE_
fibroblasts _RARE_
from O
several O
different O
donors O
. O

Functional O
domains O
of O
c I-GENE
- I-GENE
myc I-GENE
promoter I-GENE
binding I-GENE
protein I-GENE
1 I-GENE
involved O
in O
transcriptional O
repression O
and O
cell O
growth O
regulation _RARE_
. O

Therefore O
, O
we O
have O
named O
this O
gene O
UBP43 _RARE_
. O

These O
results O
continue _RARE_
to O
support O
the O
hypothesis O
that O
HS2 _RARE_
, O
HS3 _RARE_
, O
and O
HS4 _RARE_
act O
as _RARE_
a O
single O
, O
integral _RARE_
unit O
to O
regulate O
human I-GENE
globin I-GENE
gene I-GENE
transcription O
as _RARE_
a O
holocomplex _RARE_
, O
but O
they O
can O
also O
be O
interpreted O
to O
say _RARE_
that O
formation O
of O
a O
DNase I-GENE
I I-GENE
hypersensitive _RARE_
holocomplex _RARE_
alone O
is O
not O
sufficient O
for _RARE_
mediating O
high O
- O
level O
globin I-GENE
gene I-GENE
transcription O
. O

To O
identify O
additional O
non O
- O
Sir _RARE_
factors I-GENE
that O
affect O
rDNA _RARE_
silencing O
, O
we O
performed O
a O
genetic O
screen O
designed O
to O
isolate O
mutations O
which O
alter O
the O
expression _RARE_
of O
reporter O
genes O
integrated O
within O
the O
rDNA _RARE_
. O

Because O
there O
is O
great O
need O
for _RARE_
iron O
in O
the O
EPO I-GENE
- O
stimulated _RARE_
erythroid _RARE_
progenitors _RARE_
, O
it O
is O
essential O
that O
serum I-GENE
ferritin I-GENE
and O
transferrin I-GENE
saturation O
levels O
should O
be O
maintained O
over O
300 _RARE_
microg O
/ O
liter O
and O
30 _RARE_
%, O
respectively O
. O

These O
results O
indicate O
that O
the O
p33 _RARE_
subunit I-GENE
of O
eIF3 I-GENE
plays O
an O
important O
role O
in O
the O
initiation O
phase _RARE_
of O
protein O
synthesis _RARE_
and O
that O
its O
RNA O
- O
binding O
domain O
is O
required O
for _RARE_
optimal O
activity O
. O

In O
this O
study O
, O
we O
elucidate O
signaling _RARE_
pathways O
induced _RARE_
by O
photodynamic _RARE_
therapy O
( O
PDT _RARE_
) O
with O
hypericin _RARE_
. O

These O
results O
indicate O
that O
ATF I-GENE
- I-GENE
2 I-GENE
plays O
a O
central O
role O
in O
TGF I-GENE
- I-GENE
beta I-GENE
signaling _RARE_
by O
acting O
as _RARE_
a O
common O
nuclear O
target O
of O
both O
Smad I-GENE
and O
TAK1 _RARE_
pathways O
. O

KEY _RARE_
WORDS O
: O
Melaleuca _RARE_
; O
Lake _RARE_
Okeechobee _RARE_
; O
Littoral _RARE_
zone O
; O
Water _RARE_
level O
; O
Regulation O
schedule O

The O
systolic O
peak O
of O
pulmonary O
vein _RARE_
was O
higher _RARE_
than O
the O
diastolic O
peak O
in O
45 _RARE_
out O
of O
56 _RARE_
cases O
. O

Specimens _RARE_
were O
assayed O
for _RARE_
alpha I-GENE
- I-GENE
fetoprotein I-GENE
, O
unconjugated _RARE_
estriol _RARE_
, O
free O
alpha I-GENE
hCG I-GENE
, O
and O
total _RARE_
hCG I-GENE
. O

FASEB _RARE_
Federal _RARE_
Funding _RARE_
Consensus _RARE_
Conference _RARE_
FY _RARE_
2000 O
. O

The O
following O
data O
were O
recorded O
at _RARE_
arrival _RARE_
in O
the O
intensive O
care O
unit O
6 O
, O
12 O
, O
24 _RARE_
, O
and O
48 _RARE_
hours O
after O
termination _RARE_
of O
CPB O
: O
heart _RARE_
rate O
, O
blood _RARE_
pressure O
, O
left _RARE_
atrial _RARE_
pressure O
, O
central O
- O
peripheral O
temperature _RARE_
difference O
, O
arterial O
- O
central O
venous O
oxygen O
saturation O
difference O
, O
urine O
output O
, O
serum O
creatinine _RARE_
, O
lactate _RARE_
and O
neutrophil _RARE_
elastase I-GENE
levels O
, O
the O
Doppler O
echocardiographic O
factors O
shortening O
fraction O
and O
preejection _RARE_
period O
/ O
left _RARE_
- O
ventricular O
ejection O
time O
, O
and O
cumulative O
doses O
of O
catecholamines O
( O
epinephrine O
), _RARE_
enoximone _RARE_
, O
and O
furosemide O
. O

MDS1 _RARE_
/ O
EVI1 _RARE_
, O
located _RARE_
on O
chromosome _RARE_
3 O
band O
q26 _RARE_
, O
encodes O
a O
zinc I-GENE
- I-GENE
finger I-GENE
DNA I-GENE
- I-GENE
binding I-GENE
transcription I-GENE
activator I-GENE
not O
detected O
in O
normal O
hematopoietic O
cells O
but O
expressed _RARE_
in O
several O
normal O
tissues O
. O

Analysis O
of O
the O
protein O
sequences O
of O
these O
two O
replicases _RARE_
, O
together O
with O
previously O
characterized O
H I-GENE
. I-GENE
pylori _RARE_
plasmid _RARE_
replication I-GENE
proteins I-GENE
, O
supports O
the O
formation O
of O
a O
distinct O
class O
of O
H I-GENE
. I-GENE
pylori _RARE_
plasmid _RARE_
proteins I-GENE
. O

The O
JTc _RARE_
delta O
among O
the O
three O
groups O
did O
not O
differ O
as _RARE_
well _RARE_
: O
JTc _RARE_
delta O
of O
the O
VT O
group O
was O
70 O
ms O
+/- O
30 _RARE_
ms O
, O
the O
JTc _RARE_
delta O
of O
the O
PVC _RARE_
group O
was O
60 _RARE_
msec O
+/- O
25 _RARE_
msec O
, O
and O
the O
JTc _RARE_
delta O
of O
the O
control O
group O
was O
70 O
ms O
+/- O
30 _RARE_
ms O
. O

In O
contrast O
, O
deletion O
of O
the O
upstream O
portion O
of O
the O
delta O
promoter O
led O
to O
a O
10 O
fold _RARE_
decrease O
in O
expression _RARE_
. O

Site _RARE_
- O
directed O
mutagenesis O
of O
binding O
sites O
for _RARE_
the O
repressor I-GENE
proteins I-GENE
BP1 _RARE_
and O
BP2 _RARE_
in O
the O
upstream O
portion O
of O
the O
beta I-GENE
globin I-GENE
gene I-GENE
flanking I-GENE
region I-GENE
led O
to O
a O
4 O
- O
6 O
fold _RARE_
increase O
in O
promoter O
activity O
. O

However O
, O
with O
the O
alpha1 _RARE_
antagonist O
prazosin _RARE_
( O
5 O
x _RARE_
10 O
(- _RARE_
8 O
)- O
5 O
x _RARE_
10 O
(- _RARE_
7 O
) O
M O
), _RARE_
no _RARE_
relaxation O
occurred O
. O

Differential O
expression _RARE_
of O
AP I-GENE
- I-GENE
2alpha I-GENE
and O
AP I-GENE
- I-GENE
2beta _RARE_
in O
the O
developing O
chick _RARE_
retina O
: O
repression O
of O
R I-GENE
- I-GENE
FABP _RARE_
promoter I-GENE
activity O
by O
AP I-GENE
- I-GENE
2 I-GENE
. O

The O
algorithm O
also O
limited O
TG O
to O
20 O
and O
64 _RARE_
%, O
apoB _RARE_
to O
6 O
and O
20 O
%, O
and O
Lp _RARE_
( I-GENE
a I-GENE
) I-GENE
to O
15 _RARE_
and O
56 _RARE_
%, O
of O
low O
- O
and O
high O
- O
risk O
groups O
, O
respectively O
. O

The O
mean O
value O
of O
the O
CD79b _RARE_
to O
the O
CD79b _RARE_
internally _RARE_
deleted _RARE_
ratio O
was O
0 _RARE_
. O
64 _RARE_
+/- O
0 _RARE_
. O
20 O
SD O
in O
normal O
donors O
and O
0 _RARE_
. O
44 _RARE_
+/- O
0 _RARE_
. O
27 _RARE_
SD O
in O
B O
- O
CLL _RARE_
( O
P O
=. O
01 O
). O

As O
normal O
B O
cells O
also O
present O
this O
variant O
, O
the O
mechanism O
of O
CD79b _RARE_
posttranscriptional O
regulation _RARE_
might O
reflect O
the O
activation O
stage _RARE_
of O
the O
normal O
B O
cell O
from O
which O
B O
- O
CLL _RARE_
derives _RARE_
. O

Conformational _RARE_
studies O
combining _RARE_
secondary O
structure _RARE_
predictions O
, O
CD O
and O
NMR O
spectroscopy O
together O
with O
ELISA O
assays O
, O
showed O
that O
the O
greater O
is O
the O
propensity O
of O
the O
epitope _RARE_
for _RARE_
helix O
formation O
the O
higher _RARE_
is O
the O
recognition O
by O
anti I-GENE
- I-GENE
K159 _RARE_
. O

Schwab _RARE_
and O
England _RARE_
ADL _RARE_
scores O
in O
the O
" O
off O
" O
state O
were O
improved O
by O
18 O
% O
and O
in O
the O
" O
on O
" O
state O
the O
scores O
declined O
by O
2 O
%. O

High _RARE_
- O
level O
gains _RARE_
( O
HLGs _RARE_
) O
indicative O
of O
gene O
amplifications _RARE_
were O
identified O
at _RARE_
11q13 _RARE_
in O
two O
cases O
, O
and O
in O
one O
case O
each O
at _RARE_
2q33 _RARE_
- O
34 _RARE_
, O
3q25 _RARE_
- O
29 O
, O
5p15 _RARE_
. O
1 O
- O
15 _RARE_
. O
2 O
, O
7q21 _RARE_
- O
22 _RARE_
, O
11p11 _RARE_
. O
2 O
, O
12p11 _RARE_
. O
2 O
- O
12 O
, O
and O
13q34 _RARE_
. O

With O
respect O
to O
the O
distribution O
of O
active _RARE_
MREs _RARE_
over O
the O
promoter O
region O
, O
the O
hMT _RARE_
- I-GENE
IIA _RARE_
gene I-GENE
is O
largely O
different O
from O
the O
mouse O
metallothionein _RARE_
- I-GENE
I I-GENE
gene I-GENE
, O
suggesting O
that O
MRE _RARE_
arrangement O
is O
not O
an O
important O
factor O
for _RARE_
metal O
regulation _RARE_
. O

The O
cDNA O
was O
expressed _RARE_
in O
Saccharomyces O
cerevisiae O
under O
the O
control O
of O
the O
yeast I-GENE
triose _RARE_
phosphate I-GENE
isomerase I-GENE
promoter I-GENE
. O

Interestingly O
, O
the O
RNA O
sequences O
selected _RARE_
by O
the O
mutated _RARE_
zinc I-GENE
knuckle _RARE_
9G8 _RARE_
variant I-GENE
are O
efficiently O
recognized _RARE_
by O
SRp20 _RARE_
, O
in O
agreement O
with O
the O
fact O
that O
the O
RBD _RARE_
of O
9G8 _RARE_
and O
SRp20 _RARE_
are O
similar O
. O

Topoisomerase _RARE_
II I-GENE
is O
a O
major O
target O
of O
the O
protein I-GENE
kinase I-GENE
casein I-GENE
kinase I-GENE
2 I-GENE
( O
PK _RARE_
CK2 _RARE_
) O
in O
vivo O
. O

Recent O
work O
in O
this O
laboratory O
has O
shown O
that O
the O
gene O
coding O
for _RARE_
acetate _RARE_
kinase I-GENE
( O
ackA _RARE_
) O
in O
Sinorhizobium _RARE_
meliloti _RARE_
is O
up _RARE_
- O
regulated O
in O
response O
to O
phosphate O
limitation O
. O

All O
numbers O
refer _RARE_
to O
nucleotide O
positions O
on O
the O
wild O
- O
type O
HIV O
- O
1 O
transcript O
. O

Sequence O
analysis O
revealed O
that O
the O
MEMA _RARE_
protein I-GENE
is O
identical O
with O
a O
160 _RARE_
kDa I-GENE
nuclear I-GENE
' I-GENE
domain I-GENE
rich I-GENE
in I-GENE
serines _RARE_
' I-GENE
( I-GENE
DRS _RARE_
) I-GENE
protein I-GENE
occurring O
free O
in O
the O
nucleoplasm _RARE_
and O
in O
U2 _RARE_
- I-GENE
ribonucleoprotein I-GENE
structures _RARE_
. O

Here O
, O
we O
report O
the O
complete _RARE_
structure _RARE_
of O
the O
human I-GENE
topoisomerase I-GENE
IIalpha _RARE_
gene I-GENE
, O
which O
consists O
of O
35 _RARE_
exons O
spanning O
27 _RARE_
. O
5 O
kb O
. O

Dopaminergic _RARE_
modulation O
of O
transcallosal _RARE_
activity O
of O
cat _RARE_
motor O
cortical O
neurons O
. O

Previous O
studies O
characterized O
a O
cytokine _RARE_
- O
inducible O
, O
functional _RARE_
nuclear I-GENE
factor I-GENE
( I-GENE
NF _RARE_
)- I-GENE
kappaB I-GENE
consensus I-GENE
element I-GENE
in O
the O
immediate O
5 O
' O
regulatory O
region O
of O
the O
MGSA _RARE_
/ O
GRO _RARE_
- I-GENE
alpha I-GENE
gene O
at _RARE_
- O
78 _RARE_
bp O
. O

An O
exon _RARE_
that O
prevents O
transport _RARE_
of O
a O
mature _RARE_
mRNA O
. O

Four O
CsA O
- O
treated O
patients O
developed O
persistently _RARE_
elevated O
UAER _RARE_
> O
30 _RARE_
mg O
/ O
24 _RARE_
h O
( O
n _RARE_
= O
3 O
with O
microalbuminuria _RARE_
), _RARE_
whereas O
all O
the O
17 _RARE_
placebo O
- O
treated O
patients O
had O
normal O
UAER _RARE_
(< O
30 _RARE_
mg O
/ O
24 _RARE_
h O
) O
after O
7 O
years O
of O
follow O
- O
up _RARE_
. O

Mutational O
analysis O
of O
the O
- O
84 _RARE_
/- O
55 _RARE_
DNA O
showed O
that O
JEG _RARE_
- O
3 O
nuclear O
proteins O
bound _RARE_
to O
a O
site O
containing O
, O
but O
not O
identical O
to O
, O
the O
SF _RARE_
- I-GENE
1 I-GENE
sequence I-GENE
. O

In O
contrast O
, O
no _RARE_
change O
was O
detected O
in O
the O
phenotype _RARE_
of O
' O
unstressed _RARE_
' O
clones _RARE_
, O
with O
respect O
to O
any O
of O
the O
following O
parameters O
: O
proliferation _RARE_
rate O
in O
monolayer _RARE_
, O
serum O
- O
dependence O
for _RARE_
proliferation _RARE_
or O
survival O
, O
tumorigenicity _RARE_
, O
cellular O
morphology O
, O
or O
tissue O
- O
specific O
differentiation O
markers O
. O

A O
high O
reactor _RARE_
pH O
(+/- O
8 O
), _RARE_
a O
short O
solid O
retention O
time O
(< O
150 _RARE_
days O
), _RARE_
and O
the O
presence O
of O
a O
substantial O
SRB _RARE_
population O
in O
the O
inoculum _RARE_
may O
considerably O
reduce O
the O
time O
required O
for _RARE_
acetate _RARE_
- O
utilising _RARE_
SRB _RARE_
to O
outcompete _RARE_
MB O
. O

In O
throttling _RARE_
valves _RARE_
, O
the O
aim O
is O
to O
correlate O
the O
effect O
of O
shear O
to O
a O
parameter O
related O
to O
the O
inner O
geometry _RARE_
of O
the O
valve O
and O
to O
operating O
conditions O
. O

The O
induced _RARE_
respiratory O
burst O
was O
investigated O
by O
the O
intracellular _RARE_
oxidative O
transformation O
of O
dihydrorhodamine _RARE_
123 O
to O
the O
fluorescent _RARE_
dye _RARE_
rhodamine _RARE_
123 O
via O
flow O
cytometry _RARE_
. O

A O
mutation O
linked _RARE_
to O
the O
SOC1 _RARE_
gene I-GENE
, O
previously O
defined O
by O
recessive O
mutations O
that O
suppress O
cbp1 _RARE_
ts _RARE_
alleles I-GENE
and O
stabilize _RARE_
many O
mitochondrial O
mRNAs O
, O
was O
also O
isolated O
. O

A O
deletion O
mutation O
analysis O
of O
the O
recombinant O
protein O
has O
shown O
that O
the O
N O
- O
terminal O
region O
and O
the O
two O
leucine O
zippers _RARE_
are O
necessary O
for _RARE_
the O
binding O
. O

A O
database O
search O
has O
revealed O
as _RARE_
the O
most O
significative _RARE_
homology O
a O
match O
with O
the O
human I-GENE
mitochondrial I-GENE
transcription I-GENE
termination _RARE_
factor I-GENE
( O
mTERF _RARE_
), _RARE_
a O
protein O
that O
also O
binds O
DNA O
as _RARE_
a O
monomer _RARE_
and O
contains O
three O
leucine O
zippers _RARE_
forming O
intramolecular _RARE_
interactions O
. O

In O
all O
trials O
, O
antigen O
challenge O
followed O
1 O
h O
after O
the O
last O
treatment O
. O

31 _RARE_
, O
1997 O
, O
40 O
patients O
had O
died O
( O
35 _RARE_
in O
the O
ERA _RARE_
- O
II O
group O
and O
5 O
in O
the O
ERA _RARE_
- O
III O
group O
), _RARE_
for _RARE_
a O
crude O
mortality O
rate O
of O
8 O
. O
0 _RARE_
%. O

We O
found O
that O
total _RARE_
PSA I-GENE
can O
be O
detected O
in O
all O
cyst O
fluids O
and O
in O
about O
75 _RARE_
% O
of O
female O
sera _RARE_
. O

Type _RARE_
I O
cysts O
( O
with O
a O
high O
K O
+/ _RARE_
Na _RARE_
+ O
ratio O
) O
tend _RARE_
to O
have O
higher _RARE_
total _RARE_
PSA I-GENE
than O
Type _RARE_
II O
cysts O
. O

Despite O
this O
DNA O
binding O
activity O
, O
AP I-GENE
- I-GENE
1 I-GENE
reporter I-GENE
activity O
was O
suppressed O
in O
these O
cells O
. O

A O
single O
N O
- O
glycosylation O
site O
present O
in O
chicken I-GENE
gp42 _RARE_
is O
conserved _RARE_
among O
all O
five O
of O
these O
proteins O
: O
carbohydrate O
analysis O
of O
gp42 _RARE_
revealed O
the O
presence O
of O
a O
complex O
type O
glycan _RARE_
chain O
at _RARE_
this O
site O
. O

Here O
we O
describe O
the O
optimization _RARE_
and O
characterization O
of O
a O
140 _RARE_
- O
residue _RARE_
fragment O
, O
containing O
the O
Runt _RARE_
domain I-GENE
of O
AML1 _RARE_
, O
which O
is O
suitable O
for _RARE_
structural O
studies O
. O

Judge _RARE_
OKs _RARE_
docs _RARE_
' O
bid _RARE_
for _RARE_
Chicago _RARE_
hospital O
. O

HANYS _RARE_
criticizes _RARE_
laparoscopic O
gall _RARE_
bladder O
guidelines O
. O

Groups _RARE_
dicker _RARE_
for _RARE_
price _RARE_
breaks _RARE_
as _RARE_
anesthetic _RARE_
gas O
goes _RARE_
multi _RARE_
- O
source O
. O

Troubled _RARE_
CareNetwork _RARE_
gets _RARE_
pact _RARE_
from O
largest O
teacher _RARE_
union _RARE_
in O
Wis _RARE_
. O

JCAHO _RARE_
asks _RARE_
for _RARE_
hospitals O
' O
patience _RARE_
. O

Ultrasonography _RARE_
provides O
excellent O
intraoperative _RARE_
evaluation O
of O
spinal _RARE_
cord O
injury O
. O

UPMC _RARE_
is O
not O
the O
only O
organization O
pursuing _RARE_
controlled _RARE_
NHBC _RARE_
organ O
procurement _RARE_
, O
however O
. O

Because O
of O
concerns _RARE_
regarding O
blood _RARE_
transfusion O
- O
related O
communicable _RARE_
disease _RARE_
( O
eg _RARE_
, O
acquired O
immune O
deficiency O
syndrome _RARE_
and O
non O
- O
A O
, O
non O
- O
B O
hepatitis O
), _RARE_
there O
has O
been O
increasing O
research O
effort O
into O
postoperative O
hemorrhage O
related O
to O
cardiopulmonary O
bypass O
with O
extracorporeal _RARE_
circulation O
. O

They O
contrast O
trends _RARE_
in O
fertility O
, O
life O
expectancy _RARE_
ratios O
, O
and O
gender O
differences O
in O
these O
countries _RARE_
with O
the O
Hispanic _RARE_
population O
of O
the O
United O
States _RARE_
. O

Holger _RARE_
v O
. O

Hospital _RARE_
hit _RARE_
for _RARE_
hiring _RARE_
AHERF _RARE_
physicians O
. O

Overexpression O
of O
either O
DAP _RARE_
- I-GENE
1 I-GENE
or O
sentrin _RARE_
causes O
apoptosis O
of O
TNF I-GENE
- O
sensitive _RARE_
L929 _RARE_
fibroblast O
cell O
line O
, O
as _RARE_
well _RARE_
as _RARE_
TNF I-GENE
- O
resistant O
osteosarcoma O
cell O
line O
, O
U2OS _RARE_
. O

This O
is O
in O
contrast O
to O
PPARgamma2 _RARE_
, O
which O
was O
previously O
shown O
to O
be O
phosphorylated _RARE_
at _RARE_
a O
single O
site O
in O
a O
motif O
that O
is O
not O
homologous O
to O
the O
sites O
now O
described O
in O
PPARalpha I-GENE
. O

These O
results O
suggest O
KCC3 _RARE_
is O
a O
new O
member _RARE_
of O
the O
KCC _RARE_
family I-GENE
that O
is O
under O
distinct O
regulation _RARE_
from O
KCC1 _RARE_
. O

We O
have O
screened O
the O
elastin I-GENE
gene I-GENE
for _RARE_
mutations O
responsible O
for _RARE_
supravalvular _RARE_
aortic O
stenosis O
( O
SVAS _RARE_
) O
in O
two O
large O
, O
independently O
collected O
families _RARE_
with O
isolated O
( O
nonsyndromic _RARE_
) O
SVAS _RARE_
. O

Spatiotemporal _RARE_
expression _RARE_
of O
the O
PAX3 _RARE_
gene I-GENE
is O
tightly O
regulated O
during _RARE_
development O
. O

25 _RARE_
- O
OH O
- O
D3 _RARE_
did O
not O
adversely _RARE_
affect O
animal _RARE_
health O
at _RARE_
the O
proposed O
use O
level O
of O
99 _RARE_
micrograms O
/ O
kg O
feed O
when O
replacing O
vitamin O
D3 _RARE_
in O
turkey _RARE_
rations _RARE_
. O

A O
list _RARE_
of O
12 O
names _RARE_
for _RARE_
the O
disease _RARE_
and O
37 O
diagnostic O
criteria O
were O
proposed O
to O
a O
Consensus _RARE_
Panel _RARE_
of O
12 O
Italian O
experts _RARE_
who O
ranked _RARE_
them O
in O
order O
so O
as _RARE_
to O
identify O
a O
core O
set O
of O
criteria O
. O

Methanesulfonyl _RARE_
fluoride O
( O
MSF _RARE_
): O
a O
double O
- O
blind O
, O
placebo O
- O
controlled _RARE_
study O
of O
safety O
and O
efficacy O
in O
the O
treatment O
of O
senile O
dementia O
of O
the O
Alzheimer _RARE_
type O
. O

METHODS O
: O
Between _RARE_
August O
1991 O
and O
June _RARE_
1994 O
, O
198 O
men O
with O
clinical O
T2 _RARE_
or O
T3 _RARE_
classified O
( O
TNM _RARE_
) O
prostate _RARE_
carcinoma O
( O
bone O
scan O
negative O
) O
who O
were O
at _RARE_
high O
risk O
of O
lymph O
node O
involvement O
underwent O
a O
111In _RARE_
- O
capromab _RARE_
pendetide _RARE_
scan O
prior O
to O
staging _RARE_
lymphadenectomy _RARE_
. O

Voluntary _RARE_
wheel _RARE_
running _RARE_
did O
not O
significantly O
increase O
estimated O
alanine O
or O
pyruvate _RARE_
Gneo _RARE_
or O
absolute O
glycerol _RARE_
Ra _RARE_
. O

Immediately _RARE_
after O
surgery O
, O
dialysate _RARE_
PGE2 O
and O
adenosine O
concentrations O
were O
3 O
. O
7 O
+/- O
0 _RARE_
. O
7 O
and O
296 O
+/- O
127 _RARE_
nM O
, O
respectively O
. O

Because O
of O
the O
probable O
causal _RARE_
relationship O
between O
constitutive _RARE_
p210 _RARE_
( O
bcr _RARE_
/ O
abl I-GENE
) O
protein I-GENE
tyrosine I-GENE
kinase I-GENE
activity O
and O
manifestations O
of O
chronic O
- O
phase _RARE_
chronic O
myelogenous _RARE_
leukemia O
( O
CML O
; O
myeloid _RARE_
expansion O
), _RARE_
a O
key O
goal O
is O
to O
identify O
relevant O
p210 _RARE_
substrates _RARE_
in O
primary _RARE_
chronic O
- O
phase _RARE_
CML O
hematopoietic O
progenitor _RARE_
cells O
. O

In O
vitro O
precipitation O
with O
a O
glutathione _RARE_
- I-GENE
S I-GENE
- I-GENE
transferase I-GENE
- I-GENE
fusion I-GENE
protein I-GENE
containing O
the O
C O
- O
terminal O
transactivation _RARE_
domain O
of O
STAT5a _RARE_
showed O
GH _RARE_
- O
regulated O
association O
of O
ERK1 I-GENE
/ I-GENE
2 I-GENE
with O
the O
fusion O
protein O
, O
while O
this O
was O
not O
seen O
when O
serine O
780 _RARE_
in O
STAT5a _RARE_
was O
changed O
to O
alanine O
. O

One O
such O
element O
, O
1P _RARE_
, O
was O
employed O
to O
clone O
from O
a O
rat O
pituitary O
cDNA O
expression _RARE_
library O
a O
novel O
417 _RARE_
- I-GENE
amino I-GENE
acid I-GENE
WD _RARE_
protein I-GENE
, O
designated O
PREB _RARE_
( I-GENE
PRL I-GENE
regulatory I-GENE
element I-GENE
binding I-GENE
) I-GENE
protein I-GENE
. O

Characterization O
of O
the O
transcription I-GENE
factor I-GENE
MTF _RARE_
- I-GENE
1 I-GENE
from O
the O
Japanese O
pufferfish _RARE_
( O
Fugu _RARE_
rubripes _RARE_
) O
reveals O
evolutionary O
conservation O
of O
heavy O
metal O
stress O
response O
. O

The O
peroxisome _RARE_
proliferator _RARE_
- I-GENE
activated I-GENE
receptors I-GENE
( O
PPARs _RARE_
) O
are O
members O
of O
the O
nuclear I-GENE
hormone I-GENE
receptor I-GENE
superfamily I-GENE
. O

However O
, O
F I-GENE
- I-GENE
SRC I-GENE
- I-GENE
1 I-GENE
mutant I-GENE
lacking _RARE_
CBP I-GENE
- I-GENE
interacting _RARE_
domain I-GENE
still O
preserved _RARE_
enhancing O
activity O
. O

The O
catalytic O
site O
has O
an O
S1 O
pocket O
lined _RARE_
with O
conserved _RARE_
hydrophobic O
residues O
to O
accommodate _RARE_
the O
pyroglutamyl _RARE_
residue _RARE_
. O

The O
complete _RARE_
circular O
TTV _RARE_
genome O
contained O
a O
novel O
sequence O
of O
113 _RARE_
nt O
( O
nt O
3740 _RARE_
to O
3852 _RARE_
[= _RARE_
0 _RARE_
]) _RARE_
in O
between O
the O
known O
3 O
'- O
and O
5 O
'- O
end O
arms _RARE_
, O
forming O
a O
117 O
- O
nt O
GC _RARE_
- O
rich O
stretch O
( O
GC _RARE_
content O
, O
90 _RARE_
. O
6 O
% O
at _RARE_
nt O
3736 _RARE_
to O
3852 _RARE_
). O

The O
Asian _RARE_
mouse O
Mus _RARE_
castaneus _RARE_
is O
resistant O
to O
infection O
by O
the O
polytropic _RARE_
mink _RARE_
cell O
focus O
- O
inducing O
( O
MCF _RARE_
) O
subgroup O
of O
murine O
leukemia O
viruses O
( O
MuLVs _RARE_
). O

To O
determine O
the O
function O
of O
VZV _RARE_
gK _RARE_
in O
virus O
growth O
, O
a O
series O
of O
gK _RARE_
deletion I-GENE
mutants I-GENE
were O
constructed O
with O
VZV _RARE_
cosmid O
DNA O
derived O
from O
the O
Oka _RARE_
strain _RARE_
. O

CCAAT I-GENE
displacement _RARE_
protein I-GENE
binds O
to O
and O
negatively O
regulates O
human O
papillomavirus _RARE_
type O
6 O
E6 _RARE_
, O
E7 I-GENE
, O
and O
E1 I-GENE
promoters O
. O

As O
such O
the O
findings O
support O
existing O
studies O
that O
have O
identified O
given O
social O
characteristics O
of O
drink _RARE_
drivers _RARE_
. O

Three O
different O
site O
- O
directed O
mutations O
of O
the O
cyclic O
AMP O
response O
element O
each O
reduced _RARE_
the O
nerve I-GENE
growth I-GENE
factor I-GENE
effect O
by O
> O
90 _RARE_
%. O

Using O
an O
RNase I-GENE
H I-GENE
protection O
assay O
and O
specific O
blocking O
oligonucleotides O
, O
we O
find O
that O
recognition O
of O
the O
5 O
' O
splice _RARE_
- O
site O
( O
5 O
' O
ss _RARE_
) O
and O
branchpoint O
sequence O
( O
BPS _RARE_
) O
elements O
by O
U11 _RARE_
and O
U12 _RARE_
snRNPs _RARE_
, O
respectively O
, O
displays O
strong O
cooperativity O
, O
requiring O
both O
sites O
in O
the O
pre O
- O
mRNA O
substrate O
for _RARE_
efficient O
complex O
formation O
. O

Analysis O
of O
lacZ I-GENE
transcriptional I-GENE
fusions I-GENE
shows O
that O
the O
KdgR _RARE_
- I-GENE
binding I-GENE
sites I-GENE
negatively O
affect O
the O
expression _RARE_
of O
rsmB _RARE_
. O

Many O
eukaryotic O
cell O
surface O
proteins O
are O
anchored _RARE_
in O
the O
lipid _RARE_
bilayer _RARE_
through O
glycosylphosphatidylinositol _RARE_
( O
GPI _RARE_
). O

In O
the O
cell O
- O
free O
import O
assay O
, O
beta I-GENE
- I-GENE
catenin I-GENE
rapidly O
migrates _RARE_
into O
the O
nucleus O
without O
the O
exogenous _RARE_
addition O
of O
cytosol O
, O
Ran I-GENE
, O
or O
ATP O
/ O
GTP O
. O

In O
ischemic O
and O
hypoxic O
hypoxia _RARE_
, O
a O
strong O
correlation O
was O
found O
between O
cyt _RARE_
a O
, O
a3 _RARE_
oxidation O
level O
and O
VO2 O
in O
both O
ischemic O
and O
hypoxic O
hypoxia _RARE_
( O
r2 _RARE_
=. O
90 _RARE_
and O
. O
87 O
, O
respectively O
). O

An O
endogenous O
mammalian O
regulator O
of O
this O
process O
, O
named O
Usurpin _RARE_
, O
has O
been O
identified O
( O
aliases _RARE_
for _RARE_
Usurpin _RARE_
include O
CASH _RARE_
, O
Casper _RARE_
, O
CLARP _RARE_
, O
FLAME _RARE_
- I-GENE
1 I-GENE
, O
FLIP _RARE_
, O
I I-GENE
- I-GENE
FLICE _RARE_
and O
MRIT _RARE_
). O

Plasma O
glucose O
, O
immunoreactive _RARE_
insulin I-GENE
( O
IRI _RARE_
), _RARE_
C I-GENE
- I-GENE
peptide I-GENE
, O
glucagon I-GENE
, O
and O
GLP _RARE_
- I-GENE
1 I-GENE
levels O
at _RARE_
each O
time O
point O
during _RARE_
OGTT _RARE_
were O
measured O
. O

Each O
recombinant O
product O
was O
a O
fusion O
protein O
with O
a O
B O
domain O
of O
Staphylococcal _RARE_
protein I-GENE
A I-GENE
( O
SPA _RARE_
). O

Polypyrimidine _RARE_
and O
ssDNA _RARE_
binding O
by O
the O
isolated O
VH _RARE_
domain I-GENE
of O
immunization O
- O
induced _RARE_
anti O
- O
Z O
- O
DNA O
Ab _RARE_
resembles O
the O
activity O
of O
natural _RARE_
autoantibodies O
and O
suggests O
that O
VH _RARE_
- O
dependent O
binding O
to O
a O
ligand _RARE_
mimicked O
by O
polypyrimidines _RARE_
may O
play O
a O
role O
in O
B O
cell O
selection O
before O
immunization O
with O
Z O
- O
DNA O
. O

Technetium _RARE_
- O
99m O
methylene O
diphosphonate _RARE_
scintimammography _RARE_
for _RARE_
evaluation O
of O
palpable _RARE_
breast O
masses O
. O

INTERVENTIONS _RARE_
: O
Study O
patients O
were O
randomly O
divided O
into O
four O
parallel O
groups O
to O
receive O
either O
terbinafine _RARE_
250 _RARE_
mg O
a O
day O
for _RARE_
12 O
or O
16 O
weeks O
( O
groups O
T12 _RARE_
and O
T16 _RARE_
) O
or O
itraconazole _RARE_
400 _RARE_
mg O
a O
day O
for _RARE_
1 O
week O
in O
every O
4 O
weeks O
for _RARE_
12 O
or O
16 O
weeks O
( O
groups O
I3 _RARE_
and O
I4 _RARE_
). O

Nuclear O
receptors O
( O
NRs _RARE_
) O
can O
function O
as _RARE_
ligandinducible _RARE_
transregulators _RARE_
in O
both O
mammalian O
and O
yeast O
cells O
, O
indicating O
that O
important O
features O
of O
transcriptional O
control O
have O
been O
conserved _RARE_
throughout O
evolution O
. O

When O
tethered _RARE_
to O
a O
heterologous O
DNA O
- O
binding O
domain O
, O
PSU1 _RARE_
can O
activate O
transcription O
on O
its O
own O
. O

OBJECTIVE O
: O
To O
follow O
- O
up _RARE_
prospectively _RARE_
patients O
with O
arthritis O
after O
infection O
with O
beta O
- O
haemolytic _RARE_
streptococci _RARE_
of O
Lancefield _RARE_
group O
A O
( O
beta O
HSA _RARE_
), _RARE_
with O
emphasis _RARE_
on O
clinical O
characteristics O
and O
serological O
features O
. O

Bacteria _RARE_
can O
also O
cause O
a O
labyrinthitis _RARE_
acting O
directly O
on O
the O
inner O
ear O
: O
among O
these O
, O
Treponemas _RARE_
Pallidum _RARE_
, O
a O
spirochaete _RARE_
which O
causes O
syphilis _RARE_
and O
Borrelia _RARE_
Burgdorferi _RARE_
, O
a O
spirochaete _RARE_
that O
causes O
Lyme _RARE_
Disease _RARE_
, O
must O
be O
mentioned O
. O

We O
found O
that O
the O
expression _RARE_
of O
the O
protein O
was O
maximum O
in O
mitosis O
and O
minimum O
in O
G1 O
, O
which O
correlated O
with O
the O
expression _RARE_
of O
its O
messenger _RARE_
RNA O
. O

These O
findings O
demonstrate O
that O
signature _RARE_
- O
tagged _RARE_
mutagenesis O
is O
a O
viable O
approach O
to O
identify O
bacterial O
genes O
associated O
with O
the O
ability O
to O
infect _RARE_
the O
urinary _RARE_
tract _RARE_
. O

Pathol _RARE_
. O

The O
eukaryotic O
cell O
cycle _RARE_
is O
governed _RARE_
in O
part O
by O
the O
periodic _RARE_
transcription O
of O
cyclin _RARE_
genes I-GENE
, O
whose O
protein O
products O
associate O
with O
and O
positively O
regulate O
the O
cyclin _RARE_
- I-GENE
dependent I-GENE
kinases I-GENE
. O

The O
GAC1 _RARE_
gene I-GENE
encodes O
the O
regulatory O
subunit O
for _RARE_
a O
type I-GENE
1 I-GENE
serine I-GENE
/ I-GENE
threonine I-GENE
phosphoprotein _RARE_
phosphatase I-GENE
, O
Glc7 _RARE_
. O

The O
results O
demonstrate O
that O
the O
Glc7 _RARE_
phosphatase I-GENE
and O
its O
Gac1 _RARE_
regulatory O
subunit O
play O
positive O
roles O
in O
HSF I-GENE
activation O
of O
CUP1 _RARE_
transcription O
. O

MEF I-GENE
and O
AML1B _RARE_
synergistically O
transactivated O
an O
interleukin I-GENE
3 I-GENE
promoter I-GENE
reporter I-GENE
gene I-GENE
construct I-GENE
, O
yet O
the O
activating O
activity O
of O
MEF I-GENE
was O
abolished O
when O
MEF I-GENE
was O
coexpressed O
with O
AML1 _RARE_
/ O
ETO _RARE_
. O

Mechanistically _RARE_
, O
the O
presence O
of O
the O
GRR _RARE_
appears O
to O
stop O
further O
degradation _RARE_
of O
p50 _RARE_
and O
to O
stabilize _RARE_
the O
molecule O
. O

This O
phosphorylation _RARE_
can O
be O
catalyzed O
by O
a O
break _RARE_
- O
ended _RARE_
double O
- O
stranded _RARE_
DNA O
- O
activated O
protein O
kinase O
activity O
from O
the O
sea _RARE_
urchin _RARE_
nucleus O
in O
vitro O
. O

Concomitantly _RARE_
, O
the O
total _RARE_
cellular O
level O
of O
p21 I-GENE
increased O
severalfold _RARE_
via O
a O
posttranscriptional O
mechanism O
. O

Moreover O
, O
when O
added O
to O
the O
osteoclast _RARE_
cultures O
, O
mrIhh _RARE_
- I-GENE
N I-GENE
markedly O
stimulated _RARE_
the O
formation O
of O
resorption O
pits _RARE_
on O
dentine _RARE_
slices _RARE_
. O

Overall O
, O
our O
results O
suggest O
that O
resistant O
genotypes _RARE_
exist O
among O
the O
WAD _RARE_
goat _RARE_
population O
. O

The O
molecular _RARE_
mechanism O
by O
which O
Gle2p _RARE_
and O
the O
Gle2p _RARE_
- O
Nup116p _RARE_
interaction O
function O
in O
mRNA O
export O
is O
unknown O
. O

The O
Fyn I-GENE
NH2 I-GENE
terminus I-GENE
was O
necessary O
but O
not O
sufficient O
for _RARE_
interaction O
with O
zeta _RARE_
and O
both O
Fyn I-GENE
kinase I-GENE
and O
SH2 _RARE_
domains I-GENE
were O
required O
, O
directing _RARE_
phosphorylation _RARE_
of O
zeta _RARE_
ITAM _RARE_
tyrosines _RARE_
and O
binding O
to O
zeta _RARE_
ITAM _RARE_
phosphotyrosines _RARE_
. O

In O
budding _RARE_
yeast O
, O
the O
protein O
Skp1p _RARE_
, O
the O
cullin _RARE_
- I-GENE
family I-GENE
member _RARE_
Cdc53p _RARE_
, O
and O
the O
F O
- O
box O
/ O
WD _RARE_
- O
repeat O
protein O
Cdc4p _RARE_
form O
the O
SCFCdc4p _RARE_
ubiquitin I-GENE
ligase I-GENE
complex O
, O
which O
targets _RARE_
the O
cyclin _RARE_
- I-GENE
dependent I-GENE
kinase I-GENE
( O
Cdk I-GENE
) O
inhibitor O
Sic1p _RARE_
for _RARE_
proteolysis O
[ _RARE_
3 O
] O
[ _RARE_
4 O
] O
[ _RARE_
5 O
] O
[ _RARE_
6 O
] O
[ _RARE_
7 O
] O
[ _RARE_
8 O
]. O

We O
show O
here O
that O
, O
despite O
their O
structural O
and O
functional _RARE_
similarities O
, O
the O
pop1 _RARE_
and O
pop2 _RARE_
genes I-GENE
fail O
to O
complement O
each O
other O
' O
s O
deletion O
phenotypes _RARE_
, O
indicating O
that O
they O
perform O
non O
- O
redundant _RARE_
, O
but O
potentially O
interdependent _RARE_
, O
functions O
in O
proteolysis O
. O

Antithrombin _RARE_
III I-GENE
prevents O
60 _RARE_
min O
warm _RARE_
intestinal _RARE_
ischemia O
reperfusion O
injury O
in O
rats O
. O

In O
retrospect _RARE_
, O
the O
diagnoses _RARE_
were O
reconsidered _RARE_
applying O
strict _RARE_
criteria O
. O

These O
observations O
of O
elevated O
serum I-GENE
lipase I-GENE
and O
serum O
CA I-GENE
19 I-GENE
- I-GENE
9 I-GENE
in O
Sjogren _RARE_
' O
s O
syndrome _RARE_
without O
evidence O
of O
malignancy O
may O
reflect O
pancreatic O
involvement O
in O
this O
disorder O
. O

Acute O
pancreatitis O
as _RARE_
a O
complication O
of O
polyarteritis _RARE_
nodosa _RARE_
. O

Significantly O
greater O
improvement O
( O
p O
< O
0 _RARE_
. O
05 O
) O
in O
the O
sertraline _RARE_
group O
first _RARE_
became O
apparent O
by O
the O
end O
of O
week O
3 O
on O
the O
Y O
- O
BOCS _RARE_
and O
the O
CGI _RARE_
Improvement _RARE_
scale O
, O
and O
by O
the O
end O
of O
weeks O
6 O
and O
8 O
, O
respectively O
, O
on O
the O
NIMH _RARE_
and O
CGI _RARE_
Severity _RARE_
scale O
. O

Stress _RARE_
- I-GENE
inducible I-GENE
protein I-GENE
kinases I-GENE
capable O
of O
activating O
c I-GENE
- I-GENE
jun I-GENE
expression _RARE_
include O
stress I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
/ O
c I-GENE
- I-GENE
Jun I-GENE
N I-GENE
- I-GENE
terminal I-GENE
protein I-GENE
kinase I-GENE
( O
SAPK I-GENE
/ O
JNK I-GENE
) O
and O
p38 I-GENE
members O
of O
the O
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
( O
MAPK _RARE_
) O
superfamily O
of O
signaling _RARE_
molecules O
. O

Transforming _RARE_
growth I-GENE
factor I-GENE
( I-GENE
TGF I-GENE
)- I-GENE
beta1 I-GENE
induces O
extracellular O
matrix _RARE_
deposition O
and O
proliferation _RARE_
of O
mesenchymal O
cells O
. O

Chronotherapeutics _RARE_
in O
cardiovascular O
disease _RARE_
. O

Group O
psychometric _RARE_
functions O
for _RARE_
listeners _RARE_
with O
hearing O
loss _RARE_
do O
not O
show O
a O
decrease O
in O
performance O
at _RARE_
the O
largest O
values O
of O
delta O
f _RARE_
included O
in O
this O
study O
. O

Uroflowmetry _RARE_
can O
detect O
dysuria _RARE_
, O
which O
may O
be O
poorly O
perceived O
or O
even O
unknown O
to O
the O
subjects O
themselves O
. O

Marked O
racial _RARE_
variation O
in O
birthweight _RARE_
percentiles _RARE_
by O
gestational O
age O
was O
evident O
. O

Significant O
correlations O
between O
mental O
status O
as _RARE_
measured O
by O
the O
Mini _RARE_
- O
Mental _RARE_
State O
Examination O
and O
NA O
/ O
mI _RARE_
, O
mI _RARE_
/ O
Cr _RARE_
and O
NA O
were O
found O
. O

Glucagon _RARE_
also O
induced _RARE_
LUC _RARE_
activity O
very O
strongly O
when O
the O
CRE1 _RARE_
and O
CRE2 _RARE_
sites O
were O
combined O
; O
induction O
of O
the O
( O
CRE1 _RARE_
) O
3 O
( O
CRE2 _RARE_
) O
2SV40 _RARE_
- O
LUC _RARE_
constructs O
was O
positively O
modulated O
by O
the O
pO2 _RARE_
. O

In O
this O
study O
, O
we O
report O
the O
isolation O
and O
characterization O
of O
the O
entire _RARE_
rat I-GENE
GSTA3 _RARE_
( O
rGST _RARE_
Yc1 _RARE_
) O
subunit O
gene O
. O

Calcinosis _RARE_
cutis _RARE_
following O
intravenous O
infusion O
of O
calcium _RARE_
gluconate _RARE_
. O

Initial O
control O
of O
bleeding O
is O
similar O
, O
but O
eradication O
is O
achieved O
in O
fewer O
sessions _RARE_
with O
EVL _RARE_
. O

Finally O
, O
we O
determined O
the O
genomic O
organization O
of O
the O
human I-GENE
TrxR2 _RARE_
gene I-GENE
, O
which O
consists O
of O
18 O
exons O
spanning O
about O
67 O
kb O
, O
and O
its O
chromosomal O
localization _RARE_
at _RARE_
position O
22q11 _RARE_
. O
2 O
. O

The O
aims _RARE_
of O
this O
study O
were O
to O
determine O
and O
rank _RARE_
the O
frequency O
of O
self O
reported O
visual O
disability _RARE_
in O
daily O
tasks O
performed O
by O
glaucoma O
patients O
; O
to O
examine O
the O
interrelation _RARE_
between O
disabilities _RARE_
using O
factor O
analysis O
; O
to O
study O
the O
relation O
between O
perceived O
visual O
difficulty _RARE_
and O
a O
measure O
of O
the O
severity O
of O
visual O
field O
loss _RARE_
; O
to O
develop O
a O
glaucoma O
specific O
subgroup O
of O
questions O
; O
and O
examine O
the O
validity O
and O
reliability O
of O
this O
subgroup O
of O
questions O
. O

Furthermore O
, O
the O
validity O
of O
this O
new O
subset O
of O
questions O
was O
shown O
to O
be O
significant O
( O
r _RARE_
= O
0 _RARE_
. O
037 _RARE_
, O
p O
< O
0 _RARE_
. O
05 O
) O
for _RARE_
the O
correlation O
between O
a O
measure O
of O
the O
severity O
of O
binocular _RARE_
visual O
field O
loss _RARE_
and O
the O
mean O
score O
of O
the O
variables O
used O
in O
the O
glaucoma O
specific O
subgroup O
of O
questions O
. O

Sequence O
comparison O
of O
cytochromes _RARE_
bd _RARE_
and O
their O
homologs O
from O
various O
organisms O
demonstrates O
that O
the O
proteins O
can O
be O
classified O
into O
two O
subfamilies _RARE_
, O
a O
proteobacterial _RARE_
type O
including O
E I-GENE
. I-GENE
coli I-GENE
bd _RARE_
and O
a O
more O
widely O
distributed O
type O
including O
the O
B O
. O
stearothermophilus _RARE_
enzyme O
, O
suggesting O
that O
the O
latter O
type O
is O
evolutionarily O
older O
. O

Canalith _RARE_
repositioning _RARE_
is O
the O
mainstay _RARE_
of O
treatment O
. O

Solution _RARE_
structure _RARE_
and O
mechanism O
of O
the O
MutT _RARE_
pyrophosphohydrolase _RARE_
. O

In O
11 O
eyes O
that O
had O
been O
selected _RARE_
at _RARE_
random O
10 O
micrograms O
of O
recombinant I-GENE
tissue I-GENE
plasminogen I-GENE
activator I-GENE
were O
injected O
midvitreally _RARE_
24 _RARE_
hrs O
later O
. O

RESULTS O
AND _RARE_
CONCLUSIONS O
: O
Brandt _RARE_
' O
s O
double O
cuff _RARE_
- O
tubes _RARE_
( O
G2 _RARE_
) O
succeed _RARE_
in O
avoiding _RARE_
uncontrolled _RARE_
increase O
of O
cuff _RARE_
- O
pressure O
during _RARE_
anaesthesia O
with O
N2O O
. O

Accordingly _RARE_
, O
we O
designated O
this O
gene I-GENE
CTL1 _RARE_
( O
capping _RARE_
enzyme I-GENE
RNAtriphosphatase _RARE_
- I-GENE
like I-GENE
1 I-GENE
). O

The O
binding O
of O
PH _RARE_
domains I-GENE
to O
Gbetagamma I-GENE
was O
inhibited O
by O
preincubation _RARE_
of O
Gbetagamma I-GENE
with O
the O
GDP O
- O
bound _RARE_
but O
not O
the O
GTP O
- O
bound _RARE_
form O
of O
Gialpha _RARE_
. O

Their O
afterglows _RARE_
are O
brighter _RARE_
than O
supernovae _RARE_
and O
therefore O
are O
called O
hypernovae _RARE_
. O

Constrictive _RARE_
pericarditis _RARE_
and O
pleuropulmonary _RARE_
disease _RARE_
linked _RARE_
to O
ergot _RARE_
dopamine O
agonist O
therapy O
( O
cabergoline _RARE_
) O
for _RARE_
Parkinson O
' O
s O
disease _RARE_
. O

An O
undilated _RARE_
type O
of O
APBD _RARE_
is O
frequently O
associated O
with O
AMT _RARE_
and O
we O
believe _RARE_
, O
therefore O
, O
that O
clinicians _RARE_
should O
be O
aware _RARE_
of O
a O
possible O
coexistence _RARE_
of O
APBD _RARE_
and O
AMT _RARE_
. O

In O
addition O
, O
we O
also O
constructed O
and O
expressed _RARE_
chimeric O
fusion O
protein O
that O
contains O
HIV I-GENE
- I-GENE
2 I-GENE
gag I-GENE
with O
V3 _RARE_
domains O
of O
HIV O
- O
1IIIB _RARE_
, O
HIV O
- O
1MN _RARE_
, O
HIV O
- O
1SF2 _RARE_
and O
HIV O
- O
1RF _RARE_
. O

Our O
results O
indicate O
that O
V3 _RARE_
peptides O
from O
all O
major O
clades _RARE_
of O
HIV O
- O
1 O
carried O
by O
HIV I-GENE
- I-GENE
2 I-GENE
gag I-GENE
can O
be O
used O
as _RARE_
a O
potential _RARE_
HIV O
/ O
AIDS O
vaccine O
. O

Efficacy _RARE_
was O
determined O
by O
responses O
to O
question O
3 O
( O
ability O
to O
achieve O
an O
erection _RARE_
) O
and O
question O
4 O
( O
ability O
to O
maintain O
an O
erection _RARE_
) O
of O
the O
15 _RARE_
- O
item _RARE_
International O
Index _RARE_
of O
Erectile _RARE_
Function _RARE_
( O
IIEF _RARE_
). O

Evidence O
for _RARE_
the O
involvement O
of O
the O
Glc7 _RARE_
- O
Reg1 _RARE_
phosphatase O
and O
the O
Snf1 _RARE_
- O
Snf4 _RARE_
kinase O
in O
the O
regulation _RARE_
of O
INO1 _RARE_
transcription O
in O
Saccharomyces O
cerevisiae O
. O

In O
XO _RARE_
males O
, O
two O
her _RARE_
- I-GENE
1 I-GENE
mRNAs I-GENE
, O
her _RARE_
- I-GENE
1a _RARE_
and O
her _RARE_
- I-GENE
1b _RARE_
, O
are O
transcribed _RARE_
from O
two O
separate O
promoters O
: O
P1 O
, O
located _RARE_
in O
the O
5 O
'- O
flanking O
region O
, O
and O
P2 O
, O
located _RARE_
in O
the O
large O
second O
intron O
. O

Induction O
of O
Fas I-GENE
ligand _RARE_
expression _RARE_
by O
HIV O
involves O
the O
interaction O
of O
Nef I-GENE
with O
the O
T I-GENE
cell I-GENE
receptor I-GENE
zeta _RARE_
chain I-GENE
. O

Receptor _RARE_
protein I-GENE
tyrosine I-GENE
phosphatases _RARE_
( O
RPTPs _RARE_
) O
comprise O
a O
family O
of O
proteins O
that O
feature O
intracellular _RARE_
phosphatase O
domains O
and O
an O
ectodomain _RARE_
with O
putative O
ligand _RARE_
- O
binding O
motifs O
. O

These O
well _RARE_
- O
characterized O
brain O
regions O
may O
provide O
a O
basis O
for _RARE_
future O
studies O
of O
RPTP _RARE_
- I-GENE
kappa _RARE_
function O
. O

Commonly _RARE_
used O
stressors _RARE_
are O
mental O
arithmetics _RARE_
, O
speech O
tasks O
, O
the O
Stroop O
test O
, O
videogame _RARE_
playing _RARE_
, O
films O
or O
videotapes _RARE_
and O
interviews _RARE_
. O

The O
control O
group O
included O
8 O
afterbirth _RARE_
samples O
from O
physiological O
full O
- O
term O
pregnancies _RARE_
. O

However O
, O
we O
identified O
a O
gene O
between O
the O
MDV2 _RARE_
UL54 _RARE_
and O
UL55 _RARE_
genes I-GENE
with O
homology O
to O
the O
first _RARE_
ORF I-GENE
( I-GENE
ORF I-GENE
- I-GENE
1 I-GENE
) I-GENE
of I-GENE
equine _RARE_
herpesvirus _RARE_
type I-GENE
1 I-GENE
and O
corresponding O
gene O
identified O
in O
pseudorabies O
virus O
. O

In O
contrast O
, O
the O
loss _RARE_
of O
MAD2 _RARE_
staining O
in O
meiosis O
was O
not O
correlated O
with O
initial O
microtubule O
attachment _RARE_
but O
was O
correlated O
with O
a O
measure O
of O
tension O
: O
the O
distance O
between O
homologous O
or O
sister _RARE_
kinetochores _RARE_
( O
in O
meiosis O
I O
and O
II O
, O
respectively O
). O

In O
epithelial _RARE_
cells O
, O
the O
PH _RARE_
domain I-GENE
of O
Akt I-GENE
/ O
PKB I-GENE
localised _RARE_
to O
sites O
of O
cell O
- O
cell O
and O
cell O
- O
matrix _RARE_
contact _RARE_
, O
distinct O
from O
focal _RARE_
contacts O
, O
even O
in O
the O
absence O
of O
serum O
. O

The O
5 O
' O
untranslated _RARE_
and O
coding O
regions O
are O
contained O
within O
12 O
exons O
, O
with O
the O
translation O
start _RARE_
site O
located _RARE_
within O
the O
first _RARE_
exon _RARE_
. O

The O
motility _RARE_
of O
sperm O
, O
except O
for _RARE_
those O
adjacent O
to O
both O
electrodes O
, O
did O
not O
change O
after O
stimulation _RARE_
for _RARE_
60s _RARE_
, O
despite O
a O
high O
electrical O
energy O
. O

Induction O
of O
the O
CINC _RARE_
promoter I-GENE
by O
IL _RARE_
- I-GENE
17 _RARE_
in O
IEC _RARE_
- O
6 O
cells O
was O
TNF I-GENE
receptor I-GENE
- I-GENE
associated I-GENE
factor I-GENE
- I-GENE
6 I-GENE
( O
TRAF6 _RARE_
), _RARE_
but O
not O
TRAF2 I-GENE
, O
dependent O
. O

SCFFWD1 _RARE_
may O
be O
critical O
for _RARE_
tumor O
development O
and O
suppression O
through O
regulation _RARE_
of O
beta I-GENE
- I-GENE
catenin I-GENE
protein I-GENE
stability O
. O

A O
Bub2p _RARE_
- O
dependent O
spindle _RARE_
checkpoint _RARE_
pathway _RARE_
regulates O
the O
Dbf2p _RARE_
kinase I-GENE
in I-GENE
budding _RARE_
yeast I-GENE
. O

We O
analyzed O
the O
modular _RARE_
organization O
of O
DNA I-GENE
polymerase I-GENE
beta I-GENE
and O
found O
that O
residues O
making O
contact _RARE_
with O
DNA O
phosphates _RARE_
were O
localized O
to O
five O
modules _RARE_
. O

RESULTS O
: O
Cholinergic _RARE_
nerves O
are O
mainly O
involved O
in O
the O
regulation _RARE_
of O
enteric O
nerve O
responses O
to O
EFS _RARE_
in O
the O
normal O
IAS _RARE_
. O

Two O
- O
dimensional O
gel O
electrophoresis O
of O
anti I-GENE
- I-GENE
p59fyn _RARE_
immunoprecipitates _RARE_
obtained O
from O
non O
- O
transformed O
resting O
human O
T O
lymphocytes O
resulted O
in O
the O
identification O
of O
an O
oligomeric _RARE_
protein O
complex O
which O
is O
constitutively O
formed O
between O
Fyn I-GENE
and O
several O
additional O
phosphoproteins _RARE_
( O
pp43 _RARE_
, O
pp72 _RARE_
, O
pp85 _RARE_
, O
the O
protein I-GENE
tyrosine I-GENE
kinase I-GENE
Pyk2 _RARE_
, O
as _RARE_
well _RARE_
as _RARE_
the O
two O
recently O
cloned _RARE_
adaptor _RARE_
proteins O
, O
SKAP55 _RARE_
and O
SLAP _RARE_
- I-GENE
130 _RARE_
). O

We O
show O
that O
other O
cdc33 _RARE_
mutants I-GENE
also O
arrest O
in O
G1 O
. O

A O
cdc33 _RARE_
- I-GENE
1 I-GENE
strain _RARE_
expressing O
either O
stable O
Cln3p _RARE_
( O
Cln3 _RARE_
- I-GENE
1p _RARE_
) O
or O
a O
hybrid _RARE_
UBI4 _RARE_
5 I-GENE
'- I-GENE
CLN3 _RARE_
mRNA O
, O
whose O
translation O
displays O
decreased O
dependence O
on O
eIF4E _RARE_
, O
arrested O
randomly O
in O
the O
cell O
cycle _RARE_
. O

Regulatory _RARE_
motifs O
for _RARE_
gene O
expression _RARE_
such O
as _RARE_
nuclear I-GENE
- I-GENE
factor I-GENE
- I-GENE
kappaB I-GENE
- I-GENE
binding I-GENE
- I-GENE
site I-GENE
- I-GENE
like I-GENE
sequence I-GENE
( O
kappaB I-GENE
site I-GENE
) O
and O
nuclear I-GENE
- I-GENE
factor I-GENE
- I-GENE
interleukin I-GENE
- I-GENE
6 I-GENE
- I-GENE
binding I-GENE
- I-GENE
site I-GENE
- I-GENE
like I-GENE
sequence I-GENE
( O
NF _RARE_
- I-GENE
IL _RARE_
- I-GENE
6 I-GENE
site I-GENE
) O
were O
found O
in O
the O
5 O
'- O
upstream O
regulatory O
region O
. O

The O
gene O
structure _RARE_
of O
Elk1 _RARE_
spans O
15 _RARE_
. O
2 O
kb O
and O
consists O
of O
seven _RARE_
exons O
and O
six _RARE_
introns _RARE_
. O

Total O
serum O
calcium _RARE_
was O
7 O
. O
8 O
+/- O
0 _RARE_
. O
8 O
mg O
/ O
dl O
, O
whereas O
ionized _RARE_
calcium _RARE_
was O
5 O
. O
7 O
+/- O
0 _RARE_
. O
7 O
mg O
/ O
dl O
, O
phosphorus O
3 O
. O
2 O
+/- O
1 O
. O
2 O
mg O
/ O
dl O
, O
and O
alkaline _RARE_
phosphatase I-GENE
149 _RARE_
+/- O
48 _RARE_
. O
6 O
U _RARE_
/ O
liter O
. O

Sequence O
analysis O
suggests O
that O
TtrA _RARE_
contains O
a O
molybdopterin _RARE_
guanine O
dinucleotide O
cofactor O
and O
a O
[ _RARE_
4Fe _RARE_
- O
4S _RARE_
] O
cluster O
, O
that O
TtrB _RARE_
binds O
four O
[ _RARE_
4Fe _RARE_
- O
4S _RARE_
] O
clusters O
, O
and O
that O
TtrC _RARE_
is O
an O
integral _RARE_
membrane O
protein O
containing O
a O
quinol _RARE_
oxidation O
site O
. O

Cranio _RARE_
- O
caudal _RARE_
differences O
in O
granulation _RARE_
tissue O
formation O
: O
an O
experimental O
study O
in O
the O
rat O
. O

Site _RARE_
- O
directed O
mutagenesis O
showed O
that O
two O
adjacent O
SP1 I-GENE
sites I-GENE
proximal O
to O
exon _RARE_
1 O
were O
equally O
important O
in O
sustaining _RARE_
basal O
promoter O
activity O
. O

Breast _RARE_
- O
fed O
newborn O
infants O
synthesize _RARE_
n _RARE_
- O
6 O
long O
- O
chain O
polyunsaturated _RARE_
fatty O
acids _RARE_
already O
during _RARE_
the O
first _RARE_
week O
of O
life O
, O
but O
the O
contribution O
of O
endogenous O
synthesis _RARE_
to O
the O
total _RARE_
plasma O
long O
- O
chain O
polyunsaturated _RARE_
pool O
is O
small O
. O

Ischemia _RARE_
and O
reperfusion O
markedly O
increased O
the O
release O
of O
6 O
- O
keto _RARE_
- O
PGF1 _RARE_
alpha O
and O
TXB2 _RARE_
. O

Prostate _RARE_
- I-GENE
specific I-GENE
antigen I-GENE
( O
PSA I-GENE
) O
promoter O
- O
driven _RARE_
androgen _RARE_
- O
inducible O
expression _RARE_
of O
sodium _RARE_
iodide _RARE_
symporter _RARE_
in O
prostate _RARE_
cancer _RARE_
cell O
lines O
. O

It O
is O
clear O
that O
subclinical O
and O
silent _RARE_
CD O
exist O
in O
a O
large O
subgroup O
of O
the O
celiac _RARE_
population O
. O

Ras2p _RARE_
activates O
invasive O
growth O
using O
either O
of O
two O
downstream _RARE_
signaling _RARE_
pathways O
, O
the O
filamentation _RARE_
MAPK _RARE_
( O
Cdc42p _RARE_
/ O
Ste20p _RARE_
/ O
MAPK _RARE_
) O
cascade O
or O
the O
cAMP I-GENE
- I-GENE
dependent I-GENE
protein I-GENE
kinase I-GENE
( O
Cyr1p _RARE_
/ O
cAMP O
/ O
PKA I-GENE
) O
pathway _RARE_
. O

Consistent O
with O
this O
prediction O
, O
transfections O
into O
the O
hematopoietic O
cell O
line O
Jurkat O
showed O
a O
9 O
. O
0 _RARE_
- O
and O
2 O
. O
5 O
- O
fold _RARE_
activation O
of O
the O
mim _RARE_
- I-GENE
1 I-GENE
promoter I-GENE
by O
the O
p32 _RARE_
and O
p30 _RARE_
isoforms I-GENE
, O
respectively O
. O

Previous O
work O
has O
shown O
that O
spleen _RARE_
necrosis I-GENE
virus I-GENE
( I-GENE
SNV _RARE_
) I-GENE
long I-GENE
terminal I-GENE
repeats I-GENE
( O
LTRs _RARE_
) O
are O
associated O
with O
Rex _RARE_
/ O
Rex _RARE_
- O
responsive O
element O
- O
independent O
expression _RARE_
of O
bovine O
leukemia O
virus O
RNA O
and O
supports O
the O
hypothesis O
that O
SNV _RARE_
RNA O
contains O
a O
cis O
- O
acting O
element O
that O
interacts O
with O
cellular I-GENE
Rex _RARE_
- I-GENE
like I-GENE
proteins I-GENE
. O

Despite O
the O
reported O
detrimental _RARE_
effects O
on O
CNS O
development O
, O
a O
number O
of O
animal _RARE_
studies O
have O
shown O
that O
pretreatment O
with O
corticosteroids O
nevertheless _RARE_
protect O
the O
brain O
from O
hypoxia _RARE_
- O
ischemic O
injury O
; O
however O
, O
clinically O
such O
treatment O
is O
no _RARE_
longer O
favored _RARE_
. O

In O
one O
mechanism O
, O
a O
specialized O
ubiquitin I-GENE
- O
dependent O
proteolytic _RARE_
system _RARE_
( O
called O
the O
APC _RARE_
- O
dependent O
proteolysis O
machinery O
) O
degrades _RARE_
the O
mitotic _RARE_
( O
Clb _RARE_
) O
cyclin _RARE_
subunit I-GENE
. O

Predictors _RARE_
of O
success O
in O
pharmacy _RARE_
school _RARE_
: O
PCAT _RARE_
vs _RARE_
. O
other O
admission O
criteria O
. O

Canadian _RARE_
survey O
reveals O
widespread _RARE_
dissatisfaction _RARE_
among O
physicians O
. O

In O
a O
series O
of O
16 O
full O
- O
scale O
fire _RARE_
tests O
, O
investigators _RARE_
at _RARE_
the O
IIT _RARE_
Research O
Institute O
have O
concluded O
that O
automatic O
door _RARE_
control O
in O
the O
room O
of O
fire _RARE_
origin O
can O
significantly O
reduce O
the O
spread O
of O
toxic O
smoke O
and O
gases O
. O

Online _RARE_
LATCH _RARE_
demonstrates O
a O
shift O
in O
identification O
of O
the O
library O
as _RARE_
an O
isolated O
unit O
to O
an O
interactive _RARE_
resource O
center _RARE_
. O

Reporting _RARE_
of O
adverse O
events O
occurring O
during _RARE_
clinical O
trials O
of O
investigational _RARE_
drugs O
is O
a O
complex O
and O
controversial _RARE_
issue _RARE_
. O

Medicare _RARE_
SNF _RARE_
benefits O
revised O
-- _RARE_
again O
. O

In O
this O
paper O
, O
the O
current O
status O
of O
the O
understanding O
of O
the O
interaction O
mechanisms O
of O
ultrasound O
with O
biological O
media O
and O
the O
factors O
that O
govern O
different O
biological O
effects O
are O
surveyed _RARE_
. O

Members O
of O
the O
mitogen I-GENE
activated I-GENE
protein I-GENE
( I-GENE
MAP I-GENE
) I-GENE
kinase I-GENE
family I-GENE
, O
extracellular I-GENE
signal I-GENE
- I-GENE
regulated I-GENE
kinase I-GENE
, O
stress I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
- I-GENE
1 I-GENE
/ O
c I-GENE
- I-GENE
Jun I-GENE
NH2 I-GENE
- I-GENE
terminal I-GENE
kinase I-GENE
, O
and O
p38 I-GENE
, O
are O
central O
elements O
that O
transduce _RARE_
the O
signal O
generated O
by O
growth O
factors O
, O
cytokines _RARE_
, O
and O
stressing _RARE_
agents O
. O

In O
the O
present O
study O
, O
we O
have O
investigated O
the O
functional _RARE_
role O
of O
the O
other O
MAP I-GENE
kinases I-GENE
in O
PDGF _RARE_
- O
mediated _RARE_
cellular O
responses O
. O

Analyses _RARE_
of O
tyrosine O
residue _RARE_
- O
mutated _RARE_
PDGF _RARE_
receptors I-GENE
show O
that O
Src I-GENE
homology I-GENE
2 I-GENE
domain I-GENE
- I-GENE
containing I-GENE
proteins I-GENE
including O
Src I-GENE
family I-GENE
kinases I-GENE
, O
phosphatidylinositol _RARE_
3 I-GENE
- I-GENE
kinase I-GENE
, O
the O
GTPase I-GENE
- I-GENE
activating I-GENE
protein I-GENE
of O
Ras I-GENE
, O
the O
Src I-GENE
homology I-GENE
2 I-GENE
domain I-GENE
- I-GENE
containing I-GENE
phosphatase I-GENE
SHP I-GENE
- I-GENE
2 I-GENE
, O
phospholipase I-GENE
C I-GENE
- I-GENE
gamma I-GENE
, O
and O
Crk I-GENE
do O
not O
play O
a O
major O
role O
in O
mediating O
the O
PDGF _RARE_
- O
induced _RARE_
activation O
of O
p38 I-GENE
. O

Here O
we O
show O
that O
calpeptin _RARE_
inhibits O
tyrosine I-GENE
phosphatases _RARE_
, O
enhancing O
tyrosine O
phosphorylation _RARE_
particularly O
of O
paxillin I-GENE
. O

Three O
- O
dimensional O
structural O
studies O
using O
electron O
cryomicroscopy _RARE_
showed O
that O
the O
binding O
of O
one O
Fab _RARE_
( O
8H2 _RARE_
/ O
G5 _RARE_
) O
does O
not O
affect O
the O
conformation O
of O
the O
capsid _RARE_
, O
and O
the O
efficiency O
of O
mRNA O
production O
is O
similar O
to O
that O
of O
the O
native _RARE_
subviral _RARE_
particle _RARE_
. O

Further O
, O
mutational O
analysis O
of O
NS5A _RARE_
assigned O
the O
SH3 I-GENE
- I-GENE
binding I-GENE
region I-GENE
to O
a O
proline O
- O
rich O
motif O
that O
is O
highly O
conserved _RARE_
among O
HCV O
genotypes _RARE_
. O

Taken O
together O
, O
these O
findings O
show O
that O
16K _RARE_
hPRL _RARE_
inhibits O
the O
VEGF I-GENE
- O
induced _RARE_
Ras I-GENE
activation O
; O
this O
antagonism _RARE_
represents O
a O
novel O
and O
potentially O
important O
mechanism O
for _RARE_
the O
control O
of O
angiogenesis O
. O

Analysis O
of O
SRE O
oligonucleotide _RARE_
gel O
mobility O
shift O
assays O
with O
nuclear O
extracts O
from O
Sertoli _RARE_
cells O
demonstrated O
the O
presence O
of O
both O
the O
SRF I-GENE
and O
the O
ubiquitously O
expressed _RARE_
bHLH O
protein O
E12 I-GENE
/ O
E47 _RARE_
. O

We O
calculated O
differences O
in O
late _RARE_
occlusion O
rates O
by O
the O
chi2 _RARE_
( O
chi _RARE_
- O
square O
) O
test O
, O
and O
found O
these O
differences O
were O
significant O
( O
P O
=. O
04 O
). O

Baseline _RARE_
electrocorticography _RARE_
over O
the O
surface O
of O
the O
temporal O
lobe O
and O
depth O
electrode O
recordings O
in O
the O
amygdala O
and O
hippocampus O
were O
obtained O
, O
followed O
by O
10 O
min O
of O
recording O
before O
and O
after O
the O
i O
. O
v O
. O
administration O
of O
both O
alfentanil _RARE_
50 O
microg O
/ O
kg O
and O
fentanyl O
10 O
microg O
/ O
kg O
. O

We O
describe O
a O
genetic O
system _RARE_
for _RARE_
further O
characterizing O
the O
role O
of O
the O
extreme O
C O
- O
terminus O
of O
the O
beta O
subunit O
of O
E I-GENE
. I-GENE
coli I-GENE
RNA I-GENE
polymerase I-GENE
. O

We O
suggest O
that O
FlgN _RARE_
and O
FliT _RARE_
are O
substrate O
- O
specific O
flagellar _RARE_
chaperones _RARE_
that O
prevent O
oligomerization O
of O
the O
HAPs _RARE_
by O
binding O
to O
their O
helical O
domains O
before O
export O
. O

Post O
and O
core O
fabrication _RARE_
for _RARE_
divergent O
canals _RARE_
with O
a O
cast _RARE_
post O
and O
core O
and O
a O
prefabricated _RARE_
dowel _RARE_
. O

Rep63A _RARE_
( O
513 _RARE_
amino O
acids _RARE_
[ _RARE_
aa _RARE_
]), _RARE_
encoded O
by O
the O
largest O
ORF O
, O
displayed O
strong O
similarity _RARE_
( O
40 O
% O
identity O
) O
to O
the O
replication O
proteins O
from O
plasmids O
pAMbeta1 _RARE_
, O
pIP501 _RARE_
, O
and O
pSM19035 _RARE_
, O
indicating O
that O
the O
pAW63 _RARE_
replicon _RARE_
belongs O
to O
the O
pAMbeta1 _RARE_
family O
of O
gram O
- O
positive O
theta _RARE_
- O
replicating _RARE_
plasmids O
. O

Here O
we O
report O
the O
cloning O
and O
characterization O
of O
Xenopus I-GENE
Pax I-GENE
- I-GENE
5 I-GENE
and O
Pax I-GENE
- I-GENE
8 I-GENE
, O
two O
orthologues _RARE_
of O
the O
Pax I-GENE
- I-GENE
2 I-GENE
/ I-GENE
5 I-GENE
/ I-GENE
8 I-GENE
gene I-GENE
family I-GENE
. O

Km _RARE_
values O
for _RARE_
ammonium _RARE_
, O
2 O
- O
oxoglutarate _RARE_
, O
NADH _RARE_
, O
glutamate _RARE_
and O
NAD _RARE_
+ O
were O
6 O
. O
5 O
, O
3 O
. O
5 O
, O
0 _RARE_
. O
06 O
, O
37 O
. O
1 O
and O
0 _RARE_
. O
046 _RARE_
mM O
, O
respectively O
. O

Interferon I-GENE
- I-GENE
alpha I-GENE
may O
exacerbate _RARE_
cryoblobulinemia _RARE_
- O
related O
ischemic O
manifestations O
: O
an O
adverse O
effect O
potentially O
related O
to O
its O
anti O
- O
angiogenic _RARE_
activity O
. O

Interferon I-GENE
- I-GENE
alpha I-GENE
may O
exacerbate _RARE_
cryoblobulinemia _RARE_
- O
related O
ischemic O
manifestations O
: O
an O
adverse O
effect O
potentially O
related O
to O
its O
anti O
- O
angiogenic _RARE_
activity O
. O

In O
addition O
, O
we O
demonstrate O
that O
the O
production O
of O
active _RARE_
recombinant I-GENE
telomerase I-GENE
requires O
a O
factor O
in O
rabbit _RARE_
reticulocyte _RARE_
lysate _RARE_
that O
promotes O
ribonucleoprotein O
assembly O
. O

The O
enhanced _RARE_
binding O
of O
c I-GENE
- I-GENE
Abl I-GENE
to O
DNA O
containing O
5 O
- O
methylcytosine _RARE_
residues O
may O
result O
from O
an O
increased O
propensity O
of O
the O
double O
helix O
to O
denature _RARE_
locally O
coupled O
with O
a O
protein O
- O
induced _RARE_
reduction O
in O
the O
base _RARE_
stacking _RARE_
interaction O
. O

Homozygous O
mutation O
in O
two O
children O
led O
to O
amputation _RARE_
of O
legs _RARE_
due O
to O
purpura O
fulminans _RARE_
. O

According O
to O
pilot _RARE_
experiments O
which O
considered O
various O
durations O
of O
global O
no _RARE_
- O
flow O
ischemia O
ranging O
from O
10 O
to O
20 O
minutes O
, O
two O
durations O
were O
chosen O
for _RARE_
the O
present O
study O
: O
20 O
minutes O
( O
group O
20 O
) O
in O
which O
ventricular O
fibrillation O
( O
VF O
) O
was O
the O
predominant O
form O
of O
arrhythmias O
, O
and O
18 O
minutes O
( O
group O
18 O
) O
in O
which O
the O
prevalence O
of O
VF O
was O
markedly O
lower O
despite O
the O
small O
difference O
in O
the O
duration O
of O
ischemia O
. O

An O
end O
- O
to O
- O
end O
pancreaticojejunostomy _RARE_
using O
a O
mechanical O
purse _RARE_
- O
string _RARE_
device O
. O

We O
further O
demonstrate O
that O
the O
Stress _RARE_
- I-GENE
Activated _RARE_
- I-GENE
Protein I-GENE
- I-GENE
Kinase _RARE_
( O
SAPK I-GENE
) O
target O
sites O
of O
ATF2 _RARE_
, O
Thr69 _RARE_
and O
Thr71 _RARE_
are O
not O
required O
for _RARE_
the O
formation O
of O
the O
p300 I-GENE
/ O
CBP I-GENE
- O
ATF2 _RARE_
multiprotein _RARE_
complex O
. O

Blood _RARE_
samples O
were O
obtained O
daily O
during _RARE_
this O
supplementation O
period O
and O
5 O
d O
thereafter O
( O
d O
11 O
to O
15 _RARE_
). O

These O
results O
suggest O
that O
mitochondrial O
presequences _RARE_
interact O
with O
the O
mt _RARE_
- I-GENE
hsp70 I-GENE
during _RARE_
or O
after O
mitochondrial O
protein O
import O
. O

The O
3 O
' O
terminus O
of O
the O
genome O
can O
be O
folded O
into O
a O
tRNA O
- O
like O
secondary O
structure _RARE_
that O
has O
a O
valine _RARE_
anticodon _RARE_
; O
the O
tRNA O
- O
like O
structure _RARE_
lacks O
a O
pseudoknot _RARE_
in O
the O
aminoacyl _RARE_
stem _RARE_
, O
a O
feature O
common O
to O
both O
genera _RARE_
of O
tetraviruses _RARE_
. O

O I-GENE
. I-GENE
novo _RARE_
- I-GENE
ulmi _RARE_
RNA I-GENE
- I-GENE
7 I-GENE
, O
previously O
believed O
to O
be O
a O
satellite _RARE_
- O
like O
RNA O
, O
is O
shown O
to O
be O
a O
defective _RARE_
RNA O
, O
derived O
from O
OnuMV4 _RARE_
- I-GENE
Ld _RARE_
RNA I-GENE
by O
multiple O
internal O
deletions O
. O

Only O
one O
gene O
, O
fibronectin I-GENE
( O
FN I-GENE
), _RARE_
was O
highly O
overexpressed O
(> O
60 _RARE_
- O
fold _RARE_
) O
in O
LNCaP _RARE_
- O
r _RARE_
cells O
, O
consistent O
with O
previously O
reported O
overexpression O
of O
FN I-GENE
in O
prostate _RARE_
cancer _RARE_
. O

We O
also O
observed O
that O
cell O
surface O
CD4 _RARE_
(-) _RARE_
CD8 _RARE_
(-) _RARE_
CD3 I-GENE
(-) _RARE_
cells O
with O
rearranged _RARE_
TCR I-GENE
genes I-GENE
developed O
from O
Id3 _RARE_
- O
transduced _RARE_
but O
not O
from O
control O
- O
transduced _RARE_
pre O
- O
T O
cells O
in O
an O
FTOC _RARE_
. O

As O
determined O
in O
a O
modified O
yeast O
two O
- O
hybrid _RARE_
system _RARE_
, O
mIRS3 _RARE_
bound _RARE_
strongly O
to O
the O
p85 I-GENE
subunit I-GENE
of O
phosphatidylinositol _RARE_
3 I-GENE
- I-GENE
kinase I-GENE
. O

Insulin I-GENE
stimulation _RARE_
promoted O
the O
association O
of O
mIRS3 _RARE_
with O
p85 I-GENE
, O
SHP2 _RARE_
, O
Nck _RARE_
, O
and O
Shc I-GENE
. O

The O
mRNA O
expression _RARE_
of O
RFX1 _RARE_
, O
RFX2 _RARE_
, O
and O
RFX3 _RARE_
was O
detected O
ubiquitously O
, O
but O
in O
transient O
- O
transfection O
assays O
, O
multimerized _RARE_
RFX _RARE_
binding I-GENE
sites I-GENE
in O
front O
of O
a O
basal O
promoter O
efficiently O
functioned O
in O
a O
tissue O
- O
and O
lineage O
- O
specific O
manner O
. O

In O
the O
case O
of O
the O
unspliceable _RARE_
intron O
, O
repression O
of O
luciferase I-GENE
expression _RARE_
likely O
involved O
two O
AUF1 _RARE_
- I-GENE
binding I-GENE
sequences I-GENE
, O
since O
luciferase I-GENE
expression _RARE_
was O
increased O
by O
deletion O
of O
these O
sites O
. O

Thus O
, O
VDR I-GENE
acts O
selectively O
on O
the O
two O
components _RARE_
required O
for _RARE_
activation O
of O
this O
promoter O
/ O
enhancer O
: O
it O
competes _RARE_
with O
NFAT1 _RARE_
for _RARE_
binding O
to O
the O
composite O
site O
, O
positioning O
itself O
adjacent O
to O
Jun I-GENE
- O
Fos I-GENE
on O
the O
DNA O
. O

Two O
evolutionarily O
conserved _RARE_
kinases O
, O
the O
cyclin _RARE_
B I-GENE
( O
Clb _RARE_
)/ _RARE_
cyclin _RARE_
- I-GENE
dependent I-GENE
kinase I-GENE
( O
Cdk I-GENE
/ O
Cdc28p _RARE_
) O
and O
Cdc7p _RARE_
along O
with O
its O
interacting _RARE_
factor O
Dbf4p _RARE_
, O
are O
required O
late _RARE_
in O
G1 O
to O
initiate O
DNA O
replication O
. O

The O
RanQ69L _RARE_
preincubation _RARE_
leads O
to O
accumulation O
of O
CRM1 _RARE_
at _RARE_
the O
cytoplasmic O
periphery _RARE_
of O
the O
nuclear O
pore _RARE_
complex O
( O
NPC _RARE_
) O
in O
association O
with O
the O
p62 I-GENE
complex I-GENE
and O
Can _RARE_
/ O
Nup214 _RARE_
. O

All O
of O
the O
elements O
exhibited O
a O
uniform O
structure _RARE_
. O

In O
contrast O
, O
the O
deduced O
amino O
acid O
sequence O
of O
a O
second O
family O
( O
ART5 _RARE_
) O
of O
transferases _RARE_
, O
cloned _RARE_
from O
murine O
lymphoma O
cells O
and O
expressed _RARE_
in O
high O
abundance O
in O
testis _RARE_
, O
displays O
a O
hydrophobic O
amino O
terminus O
, O
consistent O
with O
a O
signal O
sequence O
, O
but O
lacks O
a O
hydrophobic O
signal O
sequence O
at _RARE_
its O
carboxyl _RARE_
terminus O
, O
suggesting O
that O
the O
protein O
is O
destined _RARE_
for _RARE_
export O
. O

RESULTS O
: O
Each O
year O
, O
on O
average O
39 _RARE_
% O
of O
cases O
seen O
in O
Sardinia _RARE_
are O
notified _RARE_
; O
646 _RARE_
( O
40 O
%) O
of O
the O
1591 _RARE_
patients O
notified _RARE_
during _RARE_
the O
study O
period O
were O
never O
seen O
by O
regional O
medical O
centres _RARE_
. O

This O
dimer _RARE_
interface O
is O
likely O
important O
for _RARE_
increasing O
the O
DNA O
- O
binding O
specificity _RARE_
and O
affinity O
of O
the O
trimeric _RARE_
form O
of O
HSF I-GENE
, O
as _RARE_
well _RARE_
as _RARE_
for _RARE_
increasing O
cooperativity O
between O
adjacent O
trimers _RARE_
. O

The O
paramyxovirus _RARE_
fusion I-GENE
( I-GENE
F I-GENE
) I-GENE
protein I-GENE
mediates O
membrane O
fusion O
. O

Additionally O
, O
deletion O
analysis O
of O
the O
UCP2 _RARE_
promoter O
- O
PLAP _RARE_
constructs O
indicated O
that O
the O
minimal O
region O
exhibiting O
the O
promoter O
activity O
was O
located _RARE_
between O
nt O
- O
33 _RARE_
and O
+ O
100 _RARE_
, O
and O
that O
a O
strong O
enhancer O
was O
present O
within O
601 _RARE_
bp O
of O
the O
5 O
'- O
promoter O
region O
. O

The O
hTERT _RARE_
gene I-GENE
encompasses _RARE_
more O
than O
37kb _RARE_
and O
consists O
of O
16 O
exons O
. O

Both O
betaAPP _RARE_
mRNA I-GENE
and O
Abeta _RARE_
levels O
are O
increased O
in O
trisomy _RARE_
21 O
. O

In O
reperfusion O
B O
, O
only O
the O
diabetic O
group O
demonstrated O
a O
significant O
increase O
in O
IL _RARE_
- I-GENE
8 I-GENE
concentrations O
at _RARE_
1 O
and O
15 _RARE_
min O
compared O
to O
nondiabetics _RARE_
. O

This O
repression O
was O
reversed O
agonists O
of O
either O
receptor O
demonstrating O
a O
functional _RARE_
interaction O
between O
NCoR _RARE_
and O
PPARalpha I-GENE
. O
RXRalpha _RARE_
heterodimeric _RARE_
complexes O
in O
mammalian O
cells O
. O

In O
the O
present O
study O
, O
we O
show O
that O
SRm160 _RARE_
/ I-GENE
300 _RARE_
is O
required O
for _RARE_
a O
purine _RARE_
- O
rich O
ESE _RARE_
to O
promote O
the O
splicing _RARE_
of O
a O
pre O
- O
mRNA O
derived O
from O
the O
Drosophila I-GENE
doublesex _RARE_
gene I-GENE
. O

Spc42p _RARE_
also O
was O
identified O
as _RARE_
a O
component _RARE_
of O
a O
cytoplasmic O
SPB O
subcomplex _RARE_
containing O
Spc94p _RARE_
/ O
Nud1p _RARE_
, O
Cnm67p _RARE_
, O
and O
Spc42p _RARE_
. O

The O
average O
coefficients O
of O
correlation O
were O
0 _RARE_
. O
9998 _RARE_
and O
0 _RARE_
. O
9993 _RARE_
for _RARE_
the O
QMF _RARE_
and O
the O
QIT _RARE_
system _RARE_
, O
respectively O
. O

The O
5 O
- O
year O
OS _RARE_
for _RARE_
stage _RARE_
IIIB _RARE_
was O
30 _RARE_
. O
9 O
%, O
compared O
to O
7 O
. O
8 O
% O
for _RARE_
stage _RARE_
IV O
. O

Furthermore O
, O
heparin _RARE_
lyase I-GENE
treatment O
of O
extracts O
of O
cells O
expressing O
recombinant I-GENE
YD _RARE_
- I-GENE
repeat I-GENE
protein I-GENE
releases _RARE_
this O
protein O
from O
high O
molecular _RARE_
mass O
aggregates O
. O

The O
coefficient O
of O
determination O
, O
r2 _RARE_
, O
of O
the O
other O
scores O
ranged O
from O
0 _RARE_
. O
56 _RARE_
to O
0 _RARE_
. O
61 _RARE_
. O

While O
determination O
of O
the O
protein O
content O
of O
the O
formulae _RARE_
gave O
no _RARE_
valid _RARE_
information _RARE_
, O
RAST O
/ O
EAST _RARE_
inhibition O
was O
highest O
for _RARE_
cow _RARE_
' O
s O
milk O
, O
followed O
by O
the O
partially O
hydrolysed _RARE_
whey _RARE_
formula O
, O
partially O
hydrolysed _RARE_
whey _RARE_
/ O
casein I-GENE
formula O
, O
soy _RARE_
/ I-GENE
pork _RARE_
collagen _RARE_
formula O
, O
and O
the O
amino O
acid O
formula O
. O

In O
light O
of O
the O
importance O
of O
GnRHR _RARE_
, O
the O
molecular _RARE_
mechanisms O
underlying O
the O
transcriptional O
regulation _RARE_
of O
the O
human I-GENE
GnRHR _RARE_
( O
hGnRHR _RARE_
) O
gene O
become O
a O
key O
issue _RARE_
in O
understanding O
human O
reproduction _RARE_
. O

Competitive _RARE_
mobility O
shift O
assays O
using O
either O
alphaT3 _RARE_
- O
1 O
nuclear O
extract _RARE_
or O
recombinant I-GENE
SF _RARE_
- I-GENE
1 I-GENE
protein I-GENE
clearly O
indicated O
that O
SF _RARE_
- I-GENE
1 I-GENE
is O
able O
to O
interact O
specifically O
with O
this O
GSE _RARE_
element I-GENE
positioned O
at _RARE_
- O
134 _RARE_
. O

Grade _RARE_
3 O
mucositis _RARE_
was O
reported O
in O
1 O
patient O
. O

CDK4 _RARE_
kinase I-GENE
activities O
were O
unaffected O
, O
as _RARE_
were O
the O
levels O
of O
the O
CDK I-GENE
inhibitor O
p21Cip1 _RARE_
present O
in O
cyclin _RARE_
E I-GENE
immunocomplexes _RARE_
. O

The O
recombinant O
purified _RARE_
protein O
expressed _RARE_
in O
the O
baculovirus _RARE_
system _RARE_
had O
an O
approximate _RARE_
molecular _RARE_
size O
20 O
kDa O
with O
amino O
- O
terminal O
sequence O
of O
AVQGP _RARE_
. O

Induction O
of O
the O
urokinase I-GENE
promoter I-GENE
by O
HGF I-GENE
/ O
SF _RARE_
via O
the O
Met _RARE_
receptor I-GENE
was O
blocked O
by O
co _RARE_
- O
expression _RARE_
of O
a O
dominant O
- O
negative O
Grb2 I-GENE
and O
Sos1 _RARE_
expression _RARE_
construct O
. O

Serine _RARE_
phosphorylation _RARE_
of O
STAT3 I-GENE
was O
only O
apparent O
after O
somatostatin I-GENE
treatment O
and O
was O
abolished O
by O
pertussis _RARE_
toxin _RARE_
or O
PD _RARE_
98059 _RARE_
, O
together O
with O
the O
associated O
increases O
in O
proliferation _RARE_
. O

Nevertheless O
, O
we O
demonstrate O
that O
the O
entire _RARE_
three O
- O
component _RARE_
yeast O
capping _RARE_
apparatus O
, O
consisting O
of O
RNA I-GENE
5 I-GENE
'- I-GENE
triphosphatase _RARE_
( O
Cet1p _RARE_
), _RARE_
RNA I-GENE
guanylyltransferase _RARE_
( O
Ceg1p _RARE_
), _RARE_
and O
Abd1p _RARE_
could O
be O
replaced O
in O
vivo O
by O
the O
two O
- O
component _RARE_
mammalian O
apparatus O
consisting O
of O
a O
bifunctional _RARE_
triphosphatase _RARE_
- I-GENE
guanylyltransferase _RARE_
Mce1p _RARE_
and O
the O
methyltransferase _RARE_
Hcm1 _RARE_
( I-GENE
121 _RARE_
- I-GENE
476 _RARE_
) I-GENE
p I-GENE
. O

The O
IC50 _RARE_
values O
for _RARE_
rat O
and O
dog O
urinary _RARE_
bladder O
were O
3 O
. O
9 O
x _RARE_
10 O
(- _RARE_
6 O
) O
M O
and O
3 O
. O
8 O
x _RARE_
10 O
(- _RARE_
6 O
) O
M O
, O
respectively O
. O

Although O
it O
has O
two O
potential _RARE_
binding O
sites O
, O
the O
purified _RARE_
MerR _RARE_
homodimer _RARE_
binds O
only O
one O
Hg O
( O
II O
) O
ion O
, O
employing O
Cys82 _RARE_
from O
one O
monomer _RARE_
and O
Cys117 _RARE_
and O
Cys126 _RARE_
from O
the O
other O
. O

The O
influence O
of O
Epstein O
- O
Barr O
virus O
seropositivity _RARE_
on O
the O
efficacy O
of O
intravenous O
immune I-GENE
globulin I-GENE
in O
children O
with O
immune O
thrombocytopenic _RARE_
purpura O
. O

The O
results O
of O
the O
lab _RARE_
and O
field O
tests O
yielded O
high O
levels O
of O
infestation _RARE_
in O
larvae O
with O
values O
ranging O
from O
90 _RARE_
to O
100 _RARE_
% O
and O
from O
85 _RARE_
to O
95 _RARE_
%, O
respectively O
. O

Amisulpride _RARE_
400 _RARE_
mg O
had O
several O
adverse O
effects O
on O
psychomotor _RARE_
and O
, O
although O
less O
severe O
, O
on O
cognitive O
performance O
on O
the O
fifth _RARE_
day O
only O
. O

MutY _RARE_
is O
an O
adenine _RARE_
- I-GENE
DNA I-GENE
glycosylase I-GENE
with O
specificity _RARE_
for _RARE_
mismatches _RARE_
involving O
8 O
- O
oxoguanine _RARE_
( O
oG _RARE_
. O
A O
) O
or O
guanine O
( O
G O
. O
A O
). O

The O
kinetics O
of O
kinase O
activity O
within O
these O
complexes O
compared O
to O
CheA _RARE_
alone O
indicate O
approximately _RARE_
a O
50 O
% O
decrease O
in O
the O
KM _RARE_
for _RARE_
ATP O
and O
a O
100 _RARE_
- O
fold _RARE_
increase O
in O
the O
Vmax O
. O

Latexin _RARE_
, O
a O
carboxypeptidase _RARE_
A I-GENE
inhibitor O
, O
is O
expressed _RARE_
in O
a O
cell O
type O
- O
specific O
manner O
in O
both O
central O
and O
peripheral O
nervous O
systems _RARE_
in O
the O
rat O
. O

Regression _RARE_
analyses O
identified O
7 O
risk O
and O
7 O
protective O
factors O
with O
minimal O
overlap O
. O

During O
1985 O
, O
1990 O
, O
and O
1995 O
, O
respectively O
, O
11 O
. O
7 O
, O
11 O
. O
3 O
, O
and O
11 O
. O
4 O
infants O
per O
100 _RARE_
, O
000 _RARE_
live O
births O
had O
a O
diagnosis O
of O
HSV O
( O
P O
=. O
98 O
). O

Subsets _RARE_
of O
patients O
were O
performed O
according O
to O
the O
severity O
of O
trauma O
( O
ISS _RARE_
< O
9 O
; O
9 O
- O
17 _RARE_
; O
18 O
- O
31 _RARE_
; O
> O
32 _RARE_
), _RARE_
based O
on O
the O
different O
injury O
pattern O
, O
and O
survivors _RARE_
versus O
nonsurvivors _RARE_
as _RARE_
well _RARE_
. O

The O
median O
age O
was O
33 _RARE_
years O
( O
range O
17 _RARE_
- O
56 _RARE_
years O
). O

Developmental _RARE_
follow O
- O
up _RARE_
at _RARE_
age O
2 O
years O
was O
performed O
. O

In O
the O
whole O
group O
of O
infected _RARE_
children O
, O
an O
age O
- O
specific O
z O
score O
< O
- O
2 O
for _RARE_
weight _RARE_
and O
for _RARE_
FFM _RARE_
was O
significantly O
associated O
with O
an O
increased O
risk O
of O
death _RARE_
[ _RARE_
relative O
risk O
( O
95 _RARE_
% O
CI _RARE_
) O
= O
11 O
. O
4 O
( O
3 O
. O
1 O
, O
41 _RARE_
. O
0 _RARE_
) O
and O
5 O
. O
1 O
( O
1 O
. O
5 O
, O
18 O
. O
2 O
), _RARE_
respectively O
]; _RARE_
when O
only O
children O
with O
more O
severe O
disease _RARE_
were O
considered O
, O
only O
z O
score O
for _RARE_
weight _RARE_
was O
significantly O
associated O
with O
an O
increased O
risk O
[ _RARE_
4 O
. O
6 O
( O
1 O
. O
4 O
, O
14 O
. O
9 O
)]. O

In O
addition O
, O
these O
cells O
contained O
one O
, O
two O
, O
or O
multiple O
nuclei O
indicative O
of O
a O
G2 _RARE_
/ O
M O
delay O
in O
nuclear O
division O
and O
also O
a O
defect O
in O
cytokinesis _RARE_
and O
/ O
or O
cell O
separation O
. O

DAF16 _RARE_
is O
known O
to O
be O
a O
component _RARE_
of O
a O
signaling _RARE_
pathway _RARE_
that O
has O
been O
partially O
dissected _RARE_
genetically O
and O
includes O
homologues _RARE_
of O
the O
insulin I-GENE
/ O
IGF I-GENE
- I-GENE
1 I-GENE
receptor I-GENE
, O
PtdIns _RARE_
3 I-GENE
- I-GENE
kinase I-GENE
and O
PKB I-GENE
. O

However O
, O
neu I-GENE
differentiation O
factor O
- O
induced _RARE_
heterodimers _RARE_
of O
ErbB2 _RARE_
and O
ErbB4 _RARE_
activated O
Stat5 I-GENE
. O

Although O
linker _RARE_
regions O
in O
transcription O
factors O
are O
known O
to O
modulate O
DNA O
binding O
specificity _RARE_
, O
our O
studies O
suggest O
that O
the O
human I-GENE
HSF1 I-GENE
linker _RARE_
plays O
no _RARE_
role O
in O
determining _RARE_
HSF1 I-GENE
binding O
preferences _RARE_
in O
vivo O
but O
is O
a O
critical O
determinant O
in O
regulating _RARE_
the O
HSF1 I-GENE
monomer _RARE_
- I-GENE
trimer _RARE_
equilibrium O
. O

Modulation _RARE_
of O
human I-GENE
heat I-GENE
shock I-GENE
factor I-GENE
trimerization _RARE_
by O
the O
linker _RARE_
domain O
. O

Both O
functional _RARE_
analyses O
in O
undifferentiated O
and O
differentiated O
F9 O
cells O
and O
characterization O
of O
DNA O
- O
protein O
complexes O
in O
vitro O
have O
identified O
the O
sequence O
motifs O
GTGACT _RARE_
( O
C O
), _RARE_
ATTGT _RARE_
, O
and O
GATA _RARE_
as _RARE_
the O
key O
transcription O
factor O
binding O
sites O
. O

These O
results O
suggest O
that O
the O
phenotype _RARE_
of O
XLP _RARE_
may O
result O
from O
perturbed _RARE_
signaling _RARE_
not O
only O
through O
SLAM _RARE_
, O
but O
also O
other O
cell O
surface O
molecules O
that O
utilize _RARE_
SAP _RARE_
as _RARE_
a O
signaling _RARE_
adaptor _RARE_
protein O
. O

We O
also O
localized O
the O
Fra _RARE_
- I-GENE
2 I-GENE
phosphorylation _RARE_
sites I-GENE
by O
MAPK _RARE_
to O
three O
threonine O
and O
three O
serine O
residues O
in O
the O
COOH _RARE_
- O
terminal O
region O
by O
means O
of O
site O
- O
directed O
mutagenesis O
and O
showed O
that O
the O
threonine O
residues O
were O
more O
susceptible O
to O
MAPK _RARE_
. O

Nevertheless O
, O
they O
are O
functionally O
distinct O
in O
that O
FcalphaRI _RARE_
binds O
human I-GENE
IgA I-GENE
( O
hIgA _RARE_
) O
but O
not O
bovine I-GENE
IgG2 _RARE_
( O
bIgG2 _RARE_
), _RARE_
whereas O
bFcgamma2R _RARE_
binds O
bIgG2 _RARE_
but O
not O
hIgA _RARE_
. O

Vac1p _RARE_
was O
found O
to O
bind O
the O
Sec1p _RARE_
homologue I-GENE
Vps45p _RARE_
. O

In O
a O
heterologous O
transcriptional O
system _RARE_
in O
which O
the O
upstream O
regions O
of O
oIFNtau _RARE_
were O
inserted O
in O
front O
of O
simian I-GENE
virus I-GENE
40 I-GENE
( I-GENE
SV40 I-GENE
) I-GENE
promoter I-GENE
, O
the O
regions O
between O
bases O
- O
654 _RARE_
and O
- O
555 _RARE_
were O
determined O
as _RARE_
being O
the O
enhancer O
region O
required O
for _RARE_
oIFNtau _RARE_
- O
SV40 O
- O
CAT I-GENE
transactivation _RARE_
. O

In O
co _RARE_
- O
transfection O
studies O
, O
the O
expression _RARE_
of O
c I-GENE
- I-GENE
Jun I-GENE
plus _RARE_
c I-GENE
- I-GENE
Fos I-GENE
enhanced _RARE_
the O
transactivation _RARE_
of O
oIFNtau _RARE_
- O
CAT I-GENE
but O
the O
expression _RARE_
of O
GATA _RARE_
- I-GENE
1 I-GENE
, O
GATA _RARE_
- I-GENE
2 I-GENE
or O
GATA _RARE_
- I-GENE
3 I-GENE
did O
not O
. O

To O
identify O
these O
sites O
, O
Cdk2 I-GENE
- O
phosphorylated _RARE_
MARCKS _RARE_
was O
digested _RARE_
with O
lysyl _RARE_
endoprotease _RARE_
and O
analysed O
by O
electrospray _RARE_
MS O
. O

The O
yeast I-GENE
LPD1 _RARE_
gene I-GENE
encoding O
lipoamide _RARE_
dehydrogenase I-GENE
is O
subject O
to O
the O
general _RARE_
control O
of O
amino O
acid O
biosynthesis O
mediated _RARE_
by O
the O
GCN4 I-GENE
transcription I-GENE
factor I-GENE
. O

The O
relatively O
mild O
defects O
observed O
in O
Rpd3 _RARE_
mutants I-GENE
suggest O
that O
the O
recently O
identified O
Groucho _RARE_
and O
dCtBP _RARE_
corepressor _RARE_
proteins I-GENE
do O
not O
function O
solely O
through O
the O
recruitment O
of O
histone I-GENE
deacetylases _RARE_
. O

However O
, O
the O
serum I-GENE
TNF I-GENE
- I-GENE
a I-GENE
concentration O
decreased O
significantly O
in O
patients O
receiving O
pentoxifylline _RARE_
( O
basal O
623 _RARE_
+/- O
366 _RARE_
pg O
/ O
ml O
; O
6th _RARE_
month O
562 _RARE_
+/- O
358 _RARE_
pg O
/ O
ml O
, O
p O
< O
0 _RARE_
. O
01 O
), _RARE_
but O
not O
in O
the O
control O
group O
. O

In O
addition O
, O
we O
show O
that O
the O
expression _RARE_
of O
individual O
members O
of O
one O
subfamily O
of O
KRAB I-GENE
zinc I-GENE
finger I-GENE
genes I-GENE
is O
restricted O
to O
specific O
hematopoietic O
cell O
lineages O
. O

Employing _RARE_
fluorescence O
spectroscopy O
and O
circular O
dichroism _RARE_
, O
we O
showed O
that O
the O
binding O
of O
Ca2 _RARE_
+ O
to O
ALG _RARE_
- I-GENE
2 I-GENE
induced _RARE_
significant O
conformational O
changes O
in O
both O
the O
N O
- O
terminal O
and O
C O
- O
terminal O
domains O
of O
the O
protein O
. O

They O
also O
occur O
in O
similar O
locations O
in O
the O
promoters O
of O
several O
other O
ribosomal I-GENE
protein I-GENE
genes I-GENE
. O

Both O
carbachol O
( O
100 _RARE_
microM O
) O
and O
EGF _RARE_
( O
10 O
nM O
) O
induced _RARE_
Ras I-GENE
activation O
. O

Dominant _RARE_
negative O
Sos I-GENE
did O
not O
affect O
carbachol O
stimulation _RARE_
of O
HA _RARE_
- O
ERK2 I-GENE
but O
inhibited O
the O
stimulatory _RARE_
effect O
of O
EGF _RARE_
by O
60 _RARE_
%. O

RESULTS O
: O
Transpulmonary _RARE_
passage O
of O
contrast O
occurred O
in O
sufficient O
amounts O
to O
enhance O
the O
intensity O
of O
the O
Doppler O
signal O
significantly O
, O
but O
the O
duration O
of O
this O
effect O
was O
short O
. O

In O
this O
paper O
, O
such O
lesions O
in O
two O
cases O
were O
evaluated O
by O
ultrasonography O
. O

These O
regions O
contain O
inverted O
E O
- O
box O
palindromic O
or O
direct O
repeat O
motifs O
and O
bind O
SREBP I-GENE
- I-GENE
1 I-GENE
with O
different O
affinities O
. O

To O
address O
these O
questions O
, O
a O
recombinant O
FRAP _RARE_
/ O
mTOR _RARE_
protein O
and O
a O
FRAP _RARE_
/ O
mTOR _RARE_
immunoprecipitate _RARE_
were O
utilized O
in O
in O
vitro O
kinase O
assays O
to O
phosphorylate O
4E _RARE_
- I-GENE
BP1 _RARE_
. O

Hrs _RARE_
has O
a O
FYVE _RARE_
double O
zinc O
finger O
domain O
, O
which O
specifically O
binds O
phosphatidylinositol _RARE_
( O
3 O
)- O
phosphate O
and O
is O
conserved _RARE_
in O
several O
proteins O
involved O
in O
vesicular O
traffic _RARE_
. O

The O
coexpression O
of O
full O
- O
length O
expression _RARE_
constructs O
for _RARE_
both O
DBP _RARE_
and O
hepatic _RARE_
leukemia I-GENE
factor I-GENE
resulted O
in O
a O
dramatic O
increase O
in O
activation O
mediated _RARE_
by O
the O
GAL4 I-GENE
- O
DBP _RARE_
fusion O
proteins O
, O
suggesting O
the O
involvement O
of O
a O
regulated O
coactivator _RARE_
in O
this O
process O
. O

Three O
subgenomes _RARE_
also O
comprised O
15 _RARE_
to O
75 _RARE_
nucleotides O
derived O
from O
the O
5 O
' O
part O
of O
the O
NS2 _RARE_
gene I-GENE
. O

Cp I-GENE
is O
normally O
the O
main O
promoter O
for _RARE_
EBNA I-GENE
mRNA I-GENE
initiation O
, O
so O
it O
appears O
that O
EBNA3C _RARE_
contributes O
to O
a O
negative O
autoregulatory _RARE_
control O
loop O
. O

These O
indications _RARE_
of O
deregulated _RARE_
signalling O
in O
the O
absence O
of O
tyrosine O
118 O
were O
substantiated _RARE_
by O
sustained O
activation O
of O
STAT3 I-GENE
. O

With O
exon _RARE_
trapping _RARE_
, O
we O
could O
isolate O
five O
potential _RARE_
exons O
from O
the O
YAC O
946E12 _RARE_
that O
spans O
the O
region O
, O
four O
of O
which O
could O
be O
placed O
in O
the O
contig O
in O
the O
vicinity O
of O
the O
breakpoints O
. O

Campomelic _RARE_
dysplasia O
translocation O
breakpoints O
are O
scattered _RARE_
over O
1 O
Mb O
proximal O
to O
SOX9 _RARE_
: O
evidence O
for _RARE_
an O
extended O
control O
region O
. O

The O
most O
common O
characteristics O
of O
VRE _RARE_
patients O
were O
recent O
prior O
vancomycin O
use O
, O
recent O
prior O
susceptible O
enterococcal _RARE_
infection O
, O
coinfection _RARE_
with O
other O
microbial _RARE_
pathogens O
, O
and O
concurrent O
fungal _RARE_
infection O
. O

A O
coiled _RARE_
- O
coil _RARE_
domain O
, O
conserved _RARE_
within O
each O
encoded O
protein O
, O
serves O
as _RARE_
a O
potential _RARE_
interaction O
motif O
for _RARE_
FLI I-GENE
LRR _RARE_
. O

Binding O
affinities O
of O
these O
recombinant O
phages _RARE_
as _RARE_
determined O
by O
the O
retention O
of O
these O
phages _RARE_
by O
a O
His _RARE_
- O
tag O
immobilized _RARE_
gp17 _RARE_
column O
, O
and O
by O
co _RARE_
- O
immunoprecipitation O
with O
purified _RARE_
terminase I-GENE
supported O
the O
specific O
nature O
of O
the O
portal _RARE_
protein I-GENE
and O
terminase I-GENE
interaction I-GENE
sites I-GENE
. O

Although O
the O
terminase I-GENE
apparently O
interacts O
with O
this O
gp20 _RARE_
portal _RARE_
peptide I-GENE
, O
polyclonal _RARE_
antibody O
against O
the O
portal _RARE_
peptide O
appears O
unable O
to O
access O
it O
in O
the O
native _RARE_
structure _RARE_
, O
suggesting O
intimate _RARE_
association O
of O
gp20 _RARE_
and O
gp17 _RARE_
possibly O
internalizes _RARE_
terminase I-GENE
regions I-GENE
within O
the O
portal _RARE_
in O
the O
packasome _RARE_
complex O
. O

The O
hybrid _RARE_
viruses O
were O
found O
to O
accumulate O
to O
high O
levels O
in O
infected _RARE_
plants _RARE_
, O
to O
form O
stable O
virions O
, O
and O
to O
be O
mechanically _RARE_
transmissible _RARE_
. O

cDNA O
and O
structural O
organization O
of O
the O
gene I-GENE
Pole1 _RARE_
for _RARE_
the O
mouse I-GENE
DNA I-GENE
polymerase I-GENE
epsilon I-GENE
catalytic I-GENE
subunit I-GENE
. O

Nevertheless O
cryopreservation _RARE_
of O
spermatozoa O
in O
a O
medium O
containing O
neither O
SP O
nor O
biological O
substances O
could O
offer O
an O
acceptable O
cryoprotection _RARE_
of O
spermatozoa O
to O
be O
used O
in O
assisted _RARE_
fertilization O
procedures O
, O
especially O
for _RARE_
intracytoplasmic _RARE_
sperm O
injection O
. O

A O
liquid O
chromatographic O
method O
is O
described O
for _RARE_
analysis O
of O
beta O
- O
carotene _RARE_
in O
medical O
food O
. O

The O
FCMS _RARE_
conditions O
were O
as _RARE_
follows O
: O
2 O
kW _RARE_
maximum O
electrical O
power O
consumption O
, O
800 O
V O
maximum O
capacitor _RARE_
voltage O
, O
720 _RARE_
microseconds _RARE_
pulsewidth _RARE_
( O
180 O
microseconds _RARE_
rise O
time O
), _RARE_
and O
5 O
- O
30 _RARE_
Hz O
frequency O
. O

Severe _RARE_
hemolysis _RARE_
resulted O
in O
statistically O
significant O
changes O
in O
the O
mean O
values O
of O
the O
above O
analytes _RARE_
in O
addition O
to O
the O
following O
increases O
: O
alanine I-GENE
aminotransferase I-GENE
, O
calcium _RARE_
, O
and O
serum I-GENE
globulins _RARE_
( O
P O
< O
0 _RARE_
. O
001 O
) O
and O
albumin I-GENE
and O
total _RARE_
protein O
( O
P O
< O
0 _RARE_
. O
01 O
). O

EMSA O
with O
crude O
nuclear O
extracts O
demonstrated O
that O
stimulation _RARE_
with O
CD40L _RARE_
results O
in O
the O
induction O
of O
NF _RARE_
- I-GENE
kappaB I-GENE
complexes I-GENE
that O
bind O
to O
each O
of O
the O
three O
NF _RARE_
- I-GENE
kappaB I-GENE
sites I-GENE
and O
are O
composed O
mainly O
of O
p50 _RARE_
and O
RelB _RARE_
, O
but O
also O
include O
c I-GENE
- I-GENE
Rel I-GENE
and O
p65 _RARE_
. O

Optimal _RARE_
monitoring O
of O
ODA _RARE_
remains O
undefined _RARE_
. O

The O
major O
transcription O
factors O
controlling O
arginine _RARE_
metabolism O
in O
Escherichia O
coli O
and O
Bacillus O
subtilis O
, O
ArgR _RARE_
and O
AhrC _RARE_
, O
respectively O
, O
are O
homologous O
multimeric _RARE_
proteins O
that O
form O
l _RARE_
- O
arginine _RARE_
- O
dependent O
DNA O
- O
binding O
complexes O
capable O
of O
repressing O
transcription O
of O
the O
biosynthetic O
genes O
( O
both O
), _RARE_
activating O
transcription O
of O
catabolic _RARE_
genes O
( O
AhrC _RARE_
only O
) O
or O
facilitating O
plasmid _RARE_
dimer _RARE_
resolution O
( O
both O
). O

The O
studied O
protein O
fragments O
consist O
of O
residues O
Arg183 _RARE_
- O
His267 _RARE_
of O
the O
human I-GENE
ER I-GENE
and O
residues O
Lys438 _RARE_
- O
Gln520 _RARE_
of O
the O
rat O
GR I-GENE
. O

The O
exon _RARE_
: O
intron O
structure _RARE_
of O
chicken I-GENE
IL8 _RARE_
corresponds O
almost O
exactly _RARE_
to O
that O
of O
human I-GENE
IL8 _RARE_
and O
differs O
from O
those O
of O
other O
known O
mammalian I-GENE
CXC _RARE_
chemokine _RARE_
genes I-GENE
. O

The O
Aa _RARE_
- I-GENE
Pri2 _RARE_
gene I-GENE
, O
specifically O
expressed _RARE_
during _RARE_
basidiocarp _RARE_
differentiation O
of O
the O
mushroom _RARE_
Agrocybe _RARE_
aegerita _RARE_
, O
was O
cloned _RARE_
. O

The O
main O
causes O
of O
liver O
disease _RARE_
in O
the O
patients O
with O
HCC _RARE_
were O
hepatitis O
C O
virus O
( O
HCV O
) O
( O
77 O
%), O
alcohol _RARE_
abuse _RARE_
( O
73 _RARE_
%), O
and O
the O
combination O
of O
HCV O
and O
alcohol _RARE_
abuse _RARE_
( O
50 O
%). O

Three O
new O
aromatase I-GENE
inhibitors _RARE_
have O
recently O
completed O
phase _RARE_
III O
evaluation O
as _RARE_
treatment O
of O
metastatic O
breast O
cancer _RARE_
in O
post O
- O
menopausal _RARE_
women O
whose O
disease _RARE_
has O
progressed O
despite O
tamoxifen _RARE_
therapy O
: O
anastrozole _RARE_
( O
ARIMIDEX _RARE_
, O
Zeneca _RARE_
), _RARE_
letrozole _RARE_
( O
FEMARA _RARE_
, O
Novartis _RARE_
) O
and O
vorozole _RARE_
( O
RIVIZOR _RARE_
, O
Janssen _RARE_
). O

CONCLUSIONS O
: O
Turbutest _RARE_
is O
a O
valuable O
tool O
in O
asthmatic O
patients O
' O
training O
, O
allowing O
identification O
and O
improvement O
of O
an O
inadequate _RARE_
inhalation O
technique O
with O
Turbuhaler _RARE_
. O

Of O
those O
injuries O
, O
143 _RARE_
cases O
were O
snowboard _RARE_
related O
and O
158 _RARE_
cases O
were O
ski _RARE_
related O
. O

The O
femoral O
artery O
/ O
vein _RARE_
and O
the O
soleus _RARE_
and O
gastrocnemius _RARE_
muscles O
were O
examined O
in O
healthy O
human O
male O
volunteers O
. O

SRFDelta5 _RARE_
acts O
as _RARE_
a O
naturally O
occurring O
dominant O
negative O
regulatory O
mutant O
that O
blocks O
SRF I-GENE
- O
dependent O
skeletal I-GENE
alpha I-GENE
- I-GENE
actin I-GENE
, O
cardiac I-GENE
alpha I-GENE
- I-GENE
actin I-GENE
, O
smooth _RARE_
alpha I-GENE
- I-GENE
actin I-GENE
, O
SM22alpha _RARE_
, O
and O
SRF I-GENE
promoter O
- O
luciferase I-GENE
reporter O
activities O
. O

In O
serum O
- O
free O
media O
, O
p50E4F _RARE_
accelerated O
E1A I-GENE
- O
induced _RARE_
apoptosis O
. O

The O
potency O
of O
the O
effect O
of O
Nim _RARE_
( O
0 _RARE_
. O
5 O
mg O
. O
kg O
- O
1 O
i O
. O
p O
.) O
was O
similar O
to O
that O
of O
NBP _RARE_
( O
10 O
mg O
. O
kg O
- O
1 O
i O
. O
p O
.). O

CONCLUSION O
: O
NBP _RARE_
pre O
- O
treatment O
or O
post O
- O
treatment O
markedly O
enhanced _RARE_
the O
rCBF O
to O
striatum _RARE_
in O
RMCAO _RARE_
rats O
. O

Progression _RARE_
after O
first _RARE_
- O
line O
chemotherapy O
was O
associated O
with O
significantly O
worse _RARE_
survival O
for _RARE_
patients O
with O
metastasis O
. O

Mutations O
within O
human O
UTR1 _RARE_
modulate O
NRF _RARE_
- I-GENE
1 I-GENE
expression _RARE_
by O
interfering O
with O
mRNA O
translational O
efficiency O
in O
transfected O
cells O
and O
in O
an O
in O
vitro O
translation O
system _RARE_
. O

As O
is O
deduced O
from O
the O
nucleotide O
sequence O
of O
the O
cDNA O
, O
CBS _RARE_
- I-GENE
1 I-GENE
contains O
an O
open _RARE_
reading O
frame O
consisting O
of O
182 O
amino O
acids _RARE_
, O
with O
a O
molecular _RARE_
weight _RARE_
of O
19 O
. O
5kDa _RARE_
. O

Corticostriatal _RARE_
and O
corticosubthalamic _RARE_
input O
zones _RARE_
from O
the O
presupplementary _RARE_
motor O
area O
in O
the O
macaque _RARE_
monkey _RARE_
: O
comparison O
with O
the O
input O
zones _RARE_
from O
the O
supplementary O
motor O
area O
. O

Basic _RARE_
fibroblast I-GENE
growth I-GENE
factor I-GENE
( O
bFGF _RARE_
) O
has O
been O
shown O
to O
induce O
angiogenesis O
in O
various O
animal _RARE_
models O
, O
but O
the O
methods O
of O
administration O
used O
experimentally O
are O
not O
clinically O
feasible _RARE_
. O

Both O
filters _RARE_
equally O
contributed O
to O
elevation O
of O
iliac O
venous O
pressure O
( O
median O
, O
9 O
. O
3 O
and O
7 O
. O
2 O
mm O
Hg O
[ _RARE_
n _RARE_
= O
9 O
] O
with O
the O
spring _RARE_
filter O
and O
RF02 _RARE_
filter O
, O
respectively O
). O

12 O
healthy O
women O
( O
age O
18 O
- O
38 O
years O
) O
were O
examined O
using O
the O
2 O
- O
hour O
' O
s O
method O
of O
passive O
leg O
rising _RARE_
( O
PLR _RARE_
) O
in O
follicular O
( O
FP _RARE_
) O
and O
luteal _RARE_
( O
LP _RARE_
) O
phases O
of O
normal O
ovulatory _RARE_
cycle _RARE_
. O

Thus O
, O
sgRNA2 _RARE_
has O
the O
3 O
' O
TE _RARE_
in O
its O
5 O
' O
UTR O
. O

These O
single O
mutational O
defects O
in O
the O
eRF1 _RARE_
- O
eRF3 _RARE_
interaction O
became O
evident O
when O
either O
truncated O
protein O
eRF3C _RARE_
or O
C O
- O
terminally _RARE_
altered O
eRF1 _RARE_
proteins O
were O
used O
for _RARE_
the O
authentic _RARE_
protein O
, O
providing O
further O
support O
for _RARE_
the O
presence O
of O
a O
C O
- O
terminal O
interaction O
. O

Removal O
of O
each O
of O
three O
contiguous O
segments _RARE_
from O
the O
N O
- O
terminal O
half _RARE_
specifically O
inhibits O
the O
formation O
of O
5 I-GENE
. I-GENE
8Ss _RARE_
rRNA I-GENE
, O
whereas O
deleting _RARE_
part O
of O
the O
C O
- O
terminal O
region O
of O
the O
protein O
only O
blocks O
the O
production O
of O
18S _RARE_
rRNA I-GENE
. O

Ras I-GENE
is O
not O
associated O
with O
the O
tegument _RARE_
. O

Green _RARE_
fluorescent _RARE_
protein O
- O
tagged _RARE_
UNC I-GENE
- I-GENE
49B _RARE_
and O
UNC I-GENE
- I-GENE
49C _RARE_
subunits I-GENE
are O
coexpressed O
in O
muscle O
cells O
and O
are O
colocalized _RARE_
to O
synaptic O
regions O
. O

We O
show O
that O
a O
protein O
, O
UBC9 _RARE_
, O
interacts O
specifically O
with O
TEL _RARE_
in O
vitro O
and O
in O
vivo O
. O

The O
aim O
of O
this O
study O
was O
to O
investigate O
the O
spontaneous O
reports O
of O
suspected O
adverse O
drug O
reactions O
, O
observed O
in O
elderly O
patients O
( O
over O
65 O
years O
of O
age O
) O
in O
Sicily _RARE_
( O
Italy _RARE_
) O
during _RARE_
the O
period O
from O
1 O
January O
1995 O
to O
31 _RARE_
December _RARE_
1997 O
. O

Molecules _RARE_
of O
NH3 _RARE_
are O
capable O
of O
emitting _RARE_
stimulated _RARE_
radiation O
( O
MASER _RARE_
). O

The O
major O
findings O
of O
our O
studies O
are O
as _RARE_
follows O
: O
1 O
) O
There O
are O
no _RARE_
detectable O
signals O
around O
GDF _RARE_
- I-GENE
9 I-GENE
- O
deficient _RARE_
follicles _RARE_
for _RARE_
several O
theca _RARE_
cell O
layer O
markers O
[ _RARE_
i O
. O
e _RARE_
. O

Interestingly O
, O
highly O
charged O
residues O
were O
abundantly O
possessed O
in O
the O
carboxy _RARE_
- O
terminal O
part O
of O
the O
MDV2 _RARE_
UL10 _RARE_
protein I-GENE
. O

Identification O
and O
structure _RARE_
of O
the O
Marek _RARE_
' I-GENE
s I-GENE
disease _RARE_
virus I-GENE
serotype _RARE_
2 I-GENE
glycoprotein I-GENE
M I-GENE
gene I-GENE
: O
comparison O
with O
glycoprotein I-GENE
M I-GENE
genes I-GENE
of O
Herpesviridae _RARE_
family O
. O

OBJECTIVE O
: O
To O
perform O
a O
cost O
- O
effectiveness O
analysis O
( O
CEA _RARE_
) O
between O
a O
standard O
antiemetic _RARE_
regimen O
- O
chlorpromazine _RARE_
+ O
dexamethasone O
( O
CPM _RARE_
- O
DEX _RARE_
)- O
and O
a O
5 I-GENE
- I-GENE
HT3 I-GENE
receptor I-GENE
antagonist O
- O
tropisetron _RARE_
( O
TROP _RARE_
)-- _RARE_
in O
the O
control O
of O
acute O
emesis _RARE_
induced _RARE_
by O
highly O
emetogenic _RARE_
chemotherapy O
in O
children O
, O
considering _RARE_
two O
analytic _RARE_
perspectives _RARE_
: O
hospital O
and O
patients O
. O

Baseline _RARE_
data O
were O
obtained O
from O
10 O
adults O
. O

A O
comparison O
of O
the O
nucleotide O
and O
deduced O
amino O
acid O
sequences O
of O
the O
core O
regions O
of O
the O
RNA I-GENE
- I-GENE
dependent I-GENE
RNA I-GENE
polymerase I-GENE
domains I-GENE
found O
in O
these O
three O
dsRNAs _RARE_
suggested O
that O
these O
dsRNAs _RARE_
probably O
evolved O
independently O
within O
each O
host _RARE_
plant _RARE_
from O
a O
common O
ancestor O
. O

Consistent O
with O
this O
possibility O
, O
a O
non O
- O
MBD _RARE_
region O
of O
Bin1 _RARE_
was O
sufficient O
to O
recruit O
a O
repression O
function O
to O
DNA O
that O
was O
unrelated O
to O
histone I-GENE
deacetylase _RARE_
. O

Forty O
- O
eight O
sequences O
, O
30 _RARE_
not O
previously O
identified O
as _RARE_
IR O
- O
responsive O
, O
were O
significantly O
regulated O
by O
IR O
. O

A O
recently O
described O
protein O
, O
metaxin _RARE_
1 I-GENE
, O
serves O
as _RARE_
a O
component _RARE_
of O
a O
preprotein _RARE_
import O
complex O
in O
the O
outer _RARE_
membrane O
of O
the O
mammalian O
mitochondrion _RARE_
. O

Molecular O
cloning O
of O
rat I-GENE
SH2 _RARE_
- I-GENE
containing I-GENE
inositol _RARE_
phosphatase I-GENE
2 I-GENE
( O
SHIP2 _RARE_
) O
and O
its O
role O
in O
the O
regulation _RARE_
of O
insulin I-GENE
signaling _RARE_
. O

Slp1 _RARE_
represses O
transcription O
via O
this O
binding O
site O
in O
yeast O
cells O
, O
consistent O
with O
its O
role O
as _RARE_
a O
direct O
repressor O
of O
ftz _RARE_
stripes _RARE_
in O
interstripe _RARE_
regions O
during _RARE_
late _RARE_
stages O
of O
embryogenesis O
. O

The O
results O
of O
these O
studies O
support O
a O
model O
in O
which O
VirB4 _RARE_
dimers _RARE_
or O
homomultimers _RARE_
contribute O
structural O
information _RARE_
for _RARE_
the O
assembly O
of O
a O
transenvelope _RARE_
channel _RARE_
competent O
for _RARE_
bidirectional _RARE_
DNA O
transfer O
, O
whereas O
an O
ATP O
- O
dependent O
activity O
is O
required O
for _RARE_
configuring _RARE_
this O
channel _RARE_
as _RARE_
a O
dedicated _RARE_
export O
machine O
. O

The O
penicillin _RARE_
binding I-GENE
proteins I-GENE
( O
PBPs _RARE_
) O
synthesize _RARE_
and O
remodel _RARE_
peptidoglycan _RARE_
, O
the O
structural O
component _RARE_
of O
the O
bacterial O
cell O
wall _RARE_
. O

TCR I-GENE
alpha I-GENE
( O
TCRA _RARE_
) O
expression _RARE_
was O
examined O
in O
RNA O
samples O
from O
PBMC _RARE_
and O
isolated O
populations O
of O
CD4 _RARE_
+, _RARE_
CD8 _RARE_
+, _RARE_
and O
DN _RARE_
T O
cells O
from O
15 _RARE_
healthy O
individuals O
. O

Similar O
results O
were O
obtained O
with O
xylitol _RARE_
, O
an O
activator O
of O
the O
pentose _RARE_
phosphate O
pathway _RARE_
. O

The O
high I-GENE
density I-GENE
lipoprotein I-GENE
( I-GENE
HDL _RARE_
) I-GENE
receptor I-GENE
mediates O
the O
uptake O
of O
cholesterol O
and O
cholesteryl _RARE_
esters O
, O
substrates _RARE_
for _RARE_
steroidogenesis _RARE_
, O
from O
an O
HDL _RARE_
particle _RARE_
in O
the O
adrenal O
gland _RARE_
and O
gonads _RARE_
. O

D3S1261 _RARE_
is O
physically O
located _RARE_
at _RARE_
or O
near O
the O
MITF _RARE_
locus I-GENE
, O
while O
D3S2465 _RARE_
and O
D3S1766 _RARE_
are O
flanking O
the O
locus O
at _RARE_
about O
17 _RARE_
. O
5 O
cM _RARE_
genetic O
distance O
each O
side _RARE_
. O

The O
percentages _RARE_
of O
recovery O
decreased O
with O
storage _RARE_
time O
, O
although O
the O
addition O
of O
dispersant _RARE_
( O
Tris _RARE_
- O
Tween _RARE_
80 _RARE_
) O
before O
storage _RARE_
appeared O
to O
partially O
prevent O
adhesion O
. O

Point _RARE_
mutations O
of O
the O
site O
that O
suppressed O
Pit I-GENE
- I-GENE
1 I-GENE
binding O
in O
vitro O
restored O
full O
tiGH _RARE_
promoter I-GENE
activity O
. O

A O
human I-GENE
Raf I-GENE
- I-GENE
responsive I-GENE
zinc I-GENE
- I-GENE
finger I-GENE
protein I-GENE
that O
binds O
to O
divergent O
sequences O
. O

We O
are O
reporting _RARE_
an O
autopsy O
case O
of O
so O
- O
called O
" O
acute O
multiple O
sclerosis O
" O
that O
was O
difficult O
to O
differentiate O
from O
a O
brain O
tumor O
on O
MRI O
findings O
. O

Furthermore O
, O
MOM _RARE_
- I-GENE
4 I-GENE
and O
TAK1 _RARE_
bind O
related O
proteins O
that O
promote O
their O
kinase O
activities O
. O

BACKGROUND O
: O
The O
MAZE _RARE_
- O
III O
is O
the O
surgical O
treatment O
of O
choice O
for _RARE_
medically _RARE_
refractory O
atrial _RARE_
fibrillation O
. O

Gab2 _RARE_
, O
a O
new O
pleckstrin I-GENE
homology O
domain O
- O
containing O
adapter _RARE_
protein O
, O
acts O
to O
uncouple _RARE_
signaling _RARE_
from O
ERK I-GENE
kinase I-GENE
to O
Elk I-GENE
- I-GENE
1 I-GENE
. O

The O
presence O
of O
cutaneous O
xanthomas _RARE_
with O
normal O
serum O
lipid _RARE_
levels O
is O
due O
to O
the O
antibetalipoproteic _RARE_
activity O
of O
the O
monoclonal I-GENE
immunoglobulin I-GENE
. O

In O
an O
attempt O
to O
reduce O
the O
incidence O
of O
NSAID O
- O
induced _RARE_
gastrointestinal _RARE_
lesions O
, O
the O
following O
approaches O
have O
been O
proposed O
: O
( O
i O
) O
use O
of O
the O
prostaglandin _RARE_
analogue O
misoprostol _RARE_
, O
which O
is O
an O
antiulcer _RARE_
drug O
which O
has O
been O
proven O
to O
be O
as _RARE_
effective O
in O
the O
prevention O
of O
NSAID O
- O
induced _RARE_
gastric _RARE_
and O
duodenal O
ulcers O
as _RARE_
in O
the O
reduction O
of O
serious O
upper O
gastrointestinal _RARE_
complications O
; O
( O
ii O
) O
histamine _RARE_
H2 I-GENE
receptor I-GENE
antagonists O
( O
H2 O
antagonists O
), _RARE_
e _RARE_
. O
g O
. O
ranitidine O
, O
cimetidine O
and O
famotidine _RARE_
, O
which O
are O
useful O
in O
the O
prevention O
of O
NSAID O
- O
induced _RARE_
duodenal O
ulcers O
during _RARE_
long O
term O
treatment O
, O
but O
not O
in O
the O
prevention O
of O
NSAID O
- O
induced _RARE_
gastric _RARE_
ulcers O
; O
( O
iii O
) O
proton _RARE_
pump _RARE_
inhibitors _RARE_
, O
e _RARE_
. O
g O
omeprazole O
, O
and O
pantoprazole _RARE_
, O
whose O
efficacy O
in O
preventing O
NSAID O
- O
associated O
ulcers O
has O
been O
recently O
demonstrated O
; O
and O
( O
iv O
) O
barrier O
agents O
, O
e _RARE_
. O
g O
. O
sucralfate _RARE_
, O
which O
cannot O
be O
recommended O
as _RARE_
prophylactic O
agents O
to O
prevent O
NSAID O
- O
induced _RARE_
gastropathy _RARE_
. O

Lung O
mesenchyme _RARE_
serves O
as _RARE_
a O
' O
compleat _RARE_
' O
inducer _RARE_
of O
lung _RARE_
morphogenesis _RARE_
by O
secreting O
soluble _RARE_
peptide O
growth O
factors O
. O

The O
activation O
of O
the O
HIV O
promoter O
required O
the O
nuclear O
localization _RARE_
of O
c I-GENE
- I-GENE
Abl I-GENE
and O
could O
be O
correlated O
with O
increased O
tyrosine O
phosphorylation _RARE_
of O
RNA I-GENE
polymerase I-GENE
II I-GENE
. O

The O
bovine I-GENE
papillomavirus _RARE_
E2 I-GENE
protein I-GENE
can O
inhibit O
the O
proliferation _RARE_
of O
HT _RARE_
- O
3 O
cells O
, O
a O
p53 I-GENE
- O
negative O
cervical O
carcinoma O
cell O
line O
containing O
integrated O
human O
papillomavirus _RARE_
type O
30 _RARE_
DNA O
. O

E2 I-GENE
point O
mutants O
unable O
to O
inhibit O
cell O
growth O
did O
not O
repress O
cdc25A _RARE_
and O
cdc25B _RARE_
expression _RARE_
, O
nor O
did O
the O
cell O
cycle _RARE_
inhibitors _RARE_
hydroxyurea _RARE_
and O
mimosine _RARE_
. O

BACKGROUND O
/ O
PURPOSE O
: O
Anomalous _RARE_
arrangement O
of O
the O
pancreaticobiliary _RARE_
duct O
( O
AAPBD _RARE_
) O
is O
closely O
related O
to O
congenital O
biliary O
dilatation O
and O
frequently O
associated O
with O
biliary O
tract _RARE_
malignancy O
. O

Neurospora O
crassa O
CYT _RARE_
- I-GENE
18 I-GENE
, O
can O
rescue O
the O
exonic _RARE_
trap _RARE_
and O
intron O
mutants O
which O
cause O
a O
structural O
defect O
. O

DDP1 _RARE_
also O
localizes O
to O
heterochromatin _RARE_
in O
interphase _RARE_
nuclei O
of O
larval _RARE_
neuroblasts O
. O

In O
a O
reconstituted O
human O
DNA O
repair O
system _RARE_
containing O
DNA I-GENE
polymerase I-GENE
beta I-GENE
and O
DNA I-GENE
ligase I-GENE
III I-GENE
- O
XRCC1 _RARE_
, O
accurate O
rejoining _RARE_
of O
a O
3 O
' O
mismatched _RARE_
base _RARE_
residue _RARE_
at _RARE_
a O
single O
- O
strand _RARE_
break _RARE_
is O
dependent O
on O
addition O
of O
the O
exonuclease _RARE_
. O

The O
PAC _RARE_
clone O
with O
an O
insert O
size O
of O
120kb _RARE_
was O
isolated O
and O
mapped O
by O
restriction _RARE_
analysis O
. O

Sequence O
of O
10q24 _RARE_
locus I-GENE
surrounding O
the O
HOX11 _RARE_
oncogene I-GENE
reveals O
a O
new O
gene O
HUG1 _RARE_
expressed _RARE_
in O
a O
T O
- O
ALL O
cell O
line O
. O

About _RARE_
20 O
kb O
upstream O
of O
LAMB2 _RARE_
we O
found O
a O
gene O
encoding O
a O
transcribed _RARE_
, O
non O
- O
processed O
LAMB2 _RARE_
- I-GENE
like I-GENE
pseudogene _RARE_
( O
LAMB2L _RARE_
). O

Site _RARE_
- O
directed O
mutagenesis O
of O
the O
R2 _RARE_
protein I-GENE
was O
used O
to O
provide O
evidence O
that O
this O
motif O
is O
also O
part O
of O
the O
active _RARE_
site O
of O
the O
endonuclease O
encoded O
by O
this O
element O
. O

The O
infected _RARE_
cell I-GENE
protein I-GENE
no _RARE_
. I-GENE
0 _RARE_
( O
ICP0 _RARE_
) O
of O
herpes O
simplex O
virus O
1 O
is O
a O
promiscuous _RARE_
transactivator _RARE_
shown O
to O
enhance O
the O
expression _RARE_
of O
genes O
introducted _RARE_
into O
cells O
by O
infection O
or O
transfection O
. O

Wrist _RARE_
measurement O
of O
blood _RARE_
pressure O
: O
some O
critical O
remarks _RARE_
to O
oscillometry _RARE_
. O

G O
- O
box O
- O
directed O
expression _RARE_
in O
leaves O
required O
the O
presence O
of O
an O
enhancer O
region O
from O
the O
cauliflower _RARE_
mosaic O
virus O
( O
CaMV _RARE_
) O
35S _RARE_
promoter I-GENE
. O

Another O
element O
necessary O
for _RARE_
augmenting _RARE_
the O
amplitude O
of O
the O
oscillation _RARE_
lies O
between O
- O
178 _RARE_
and O
- O
264 O
. O

This O
scFv _RARE_
was O
therefore O
used O
as _RARE_
control O
in O
experiments O
where O
another O
anti I-GENE
- I-GENE
Ras I-GENE
scFv _RARE_
( O
Y259 _RARE_
scFv _RARE_
, O
derived O
from O
the O
neutralizing _RARE_
anti I-GENE
- I-GENE
Ras I-GENE
mAb _RARE_
Y13 _RARE_
- I-GENE
259 _RARE_
) O
blocked O
the O
Ras I-GENE
pathway _RARE_
in O
vitro O
and O
led O
to O
tumor O
regression O
in O
a O
nude O
mouse O
model O
[ _RARE_
Cochet _RARE_
, O
O O
., O
Kenigsberg _RARE_
, O
M O
., O
Delumeau _RARE_
, O
I O
., O
Virone _RARE_
- O
Oddos _RARE_
, O
A O
., O
Multon _RARE_
, O
M O
. O
C O
., O
Fridman _RARE_
, O
W _RARE_
. O
H O
., O
Schweighoffer _RARE_
, O
F O
., O
Teillaud _RARE_
, O
J _RARE_
. O
L O
., O
Tocque _RARE_
, O
B O
., O
1998 O
. O

There O
was O
no _RARE_
competition O
between O
activin I-GENE
A I-GENE
and O
OP _RARE_
- I-GENE
1 I-GENE
for _RARE_
availability O
of O
Smad4 _RARE_
, O
indicating O
that O
the O
concentration O
of O
this O
common O
signal O
transducer _RARE_
is O
not O
limiting O
for _RARE_
generating O
the O
observed O
biological O
responses O
. O

Our O
data O
therefore O
indicate O
that O
it O
is O
possible O
to O
engineer _RARE_
the O
HA _RARE_
envelope I-GENE
glycoprotein I-GENE
by O
fusing _RARE_
ligands O
to O
its O
amino O
- O
terminal O
end O
without O
affecting O
its O
fusion O
activity O
. O

However O
, O
the O
favored _RARE_
, O
parallel O
beta O
helix O
model O
is O
a O
compact _RARE_
coil _RARE_
of O
ten O
helically _RARE_
arranged O
beta O
strands _RARE_
forming O
two O
parallel O
beta O
sheet _RARE_
faces _RARE_
. O

This O
is O
predicted O
to O
encode O
a O
315 _RARE_
- O
residue _RARE_
protein O
containing O
seven _RARE_
hydrophobic O
helical O
regions O
and O
a O
17 _RARE_
amino O
acid O
motif O
characteristic O
of O
the O
R7G _RARE_
family I-GENE
of O
G I-GENE
- I-GENE
protein I-GENE
coupled I-GENE
membrane I-GENE
- I-GENE
bound _RARE_
receptors I-GENE
. O

Characterisation _RARE_
of O
the O
chicken I-GENE
apolipoprotein I-GENE
A I-GENE
- I-GENE
I I-GENE
gene I-GENE
5 O
'- O
flanking O
region O
. O

These O
results O
suggest O
that O
members O
of O
the O
ATF I-GENE
family I-GENE
are O
involved O
in O
mediating O
the O
transcriptional O
regulation _RARE_
of O
the O
KGF _RARE_
gene I-GENE
in O
response O
to O
extracellular O
stimuli O
via O
a O
novel O
CRE _RARE_
regulatory O
element O
. O

Moreover O
, O
a O
high O
proportion O
of O
blood _RARE_
samples O
from O
a O
random O
sample O
of O
the O
rest O
of O
the O
suspects _RARE_
tested O
positive O
for _RARE_
trypanosome _RARE_
- O
specific O
DNA O
by O
PCR O
( O
79 _RARE_
. O
9 O
% O
for _RARE_
T O
. O
b O
. O
gambiense _RARE_
and O
13 _RARE_
. O
9 O
% O
for _RARE_
T O
. O
b O
. O
rhodesiense _RARE_
). O

A O
multi _RARE_
- O
centre _RARE_
evaluation O
of O
the O
card _RARE_
indirect O
agglutination _RARE_
test O
for _RARE_
trypanosomiasis _RARE_
( O
TrypTect _RARE_
CIATT _RARE_
). O

Results O
for _RARE_
men O
who O
drank _RARE_
up _RARE_
to O
two O
drinks _RARE_
per O
day O
suggest O
that O
if O
the O
dependence O
criteria O
were O
invalid _RARE_
, O
reductions O
in O
the O
prevalence O
of O
specific O
indicators O
of O
alcohol _RARE_
dependence O
would O
range O
from O
0 _RARE_
. O
3 O
% O
to O
5 O
. O
2 O
%. O

Mutagenesis _RARE_
of O
the O
CDE _RARE_
/ O
CHR _RARE_
elements O
and O
Sp1 _RARE_
sites I-GENE
in O
this O
region O
, O
alone O
or O
in O
combination O
, O
reduced _RARE_
transcriptional O
activity O
by O
40 O
- O
60 _RARE_
% O
in O
asynchronously _RARE_
growing O
cells O
and O
abolished O
cell O
cycle _RARE_
periodicity _RARE_
in O
G2 _RARE_
- O
M O
- O
synchronized _RARE_
cells O
. O

Using O
Scheffe _RARE_
' O
s O
procedure O
as _RARE_
an O
illustration _RARE_
, O
comparisons O
are O
made O
to O
usual _RARE_
sample O
size O
methods O
that O
incorrectly _RARE_
ignore _RARE_
the O
stochastic _RARE_
nature O
of O
S2p _RARE_
. O

The O
crystal _RARE_
structure _RARE_
of O
the O
VP16 I-GENE
core I-GENE
has O
been O
determined O
at _RARE_
2 O
. O
1 O
A O
resolution O
. O

Ozagrel _RARE_
, O
ifenprodil _RARE_
, O
cinnarizine _RARE_
and O
dilazep _RARE_
were O
more O
effective O
than O
pentoxifylline _RARE_
in O
increasing O
rCBF O
at _RARE_
the O
HPC _RARE_
. O

The O
latter O
method O
adds _RARE_
clamping _RARE_
of O
the O
inferior O
vena _RARE_
cava _RARE_
, O
which O
results O
in O
hypotension O
, O
requiring O
invasive O
anesthetic _RARE_
management O
. O

By O
contrast O
, O
PvirE _RARE_
or O
Plac _RARE_
promoter I-GENE
constructs I-GENE
yielded O
functional _RARE_
VirE2 _RARE_
only O
if O
virE1 _RARE_
was O
coexpressed O
with O
virE2 _RARE_
. O

Simian _RARE_
parainfluenza _RARE_
virus O
5 O
( O
SV5 _RARE_
) O
is O
a O
prototype O
of O
the O
Paramyxoviridae _RARE_
family O
of O
nonsegmented _RARE_
negative O
- O
sense O
RNA O
viruses O
. O

To O
investigate O
the O
functions O
of O
GE _RARE_
, O
IG _RARE_
, O
and O
GS _RARE_
sequences O
in O
transcription O
, O
we O
constructed O
plasmids O
containing O
cDNAs O
of O
the O
full O
- O
length O
SV5 _RARE_
genome O
in O
which O
the O
gene O
junction _RARE_
sequences O
( O
GE _RARE_
, O
IG _RARE_
, O
and O
GS _RARE_
sequences O
) O
located _RARE_
between O
the O
hemagglutinin I-GENE
- I-GENE
neuraminidase _RARE_
( O
HN _RARE_
) O
and O
the O
polymerase I-GENE
( I-GENE
L I-GENE
) I-GENE
genes I-GENE
were O
replaced O
with O
the O
counterpart _RARE_
sequences O
from O
other O
gene O
junctions O
. O

CXCR4 _RARE_
is O
a O
chemokine _RARE_
receptor O
and O
a O
coreceptor _RARE_
for _RARE_
T O
- O
cell O
- O
line O
- O
tropic _RARE_
( O
X4 _RARE_
) O
and O
dual O
- O
tropic _RARE_
( O
R5X4 _RARE_
) O
human O
immunodeficiency O
virus O
type O
1 O
( O
HIV O
- O
1 O
) O
isolates O
. O

These O
data O
will O
help O
us O
to O
better O
detail O
the O
CXCR4 _RARE_
structural O
requirements O
exhibited O
by O
different O
HIV O
- O
1 O
strains O
and O
will O
direct O
further O
mutagenesis O
efforts _RARE_
aimed O
at _RARE_
better O
defining _RARE_
the O
domains O
in O
CXCR4 _RARE_
involved O
in O
the O
HIV O
- O
1 O
Env I-GENE
- O
mediated _RARE_
fusion O
process O
. O

The O
results O
of O
these O
analyses O
indicate O
that O
the O
proteinase _RARE_
cleaves _RARE_
at _RARE_
amino O
acid O
residues O
E960 _RARE_
- O
A961 _RARE_
, O
E1071 _RARE_
- O
S1072 _RARE_
, O
E1345 _RARE_
- O
T1346 _RARE_
, O
and O
E1419 _RARE_
- O
G1420 _RARE_
; O
however O
, O
the O
cleavage _RARE_
efficiency O
is O
varied O
. O

y _RARE_
. O

SM _RARE_
is O
also O
shown O
to O
be O
associated O
in O
vivo O
with O
other O
components _RARE_
of O
the O
CRM _RARE_
1 I-GENE
export O
pathway _RARE_
, O
including O
the O
small I-GENE
GTPase I-GENE
Ran I-GENE
and O
the O
nucleoporin _RARE_
CAN _RARE_
/ O
Nup214 _RARE_
. O

Identification O
of O
a O
spliced _RARE_
gene O
from O
Kaposi O
' O
s O
sarcoma O
- O
associated O
herpesvirus _RARE_
encoding O
a O
protein O
with O
similarities O
to O
latent I-GENE
membrane I-GENE
proteins I-GENE
1 I-GENE
and I-GENE
2A _RARE_
of I-GENE
Epstein I-GENE
- I-GENE
Barr I-GENE
virus I-GENE
. O

Auditory _RARE_
clicks _RARE_
were O
given O
at _RARE_
a O
rate O
of O
20 O
s O
(- _RARE_
1 O
). O

Myosin _RARE_
light I-GENE
chain I-GENE
kinase I-GENE
functions O
downstream _RARE_
of O
Ras I-GENE
/ O
ERK I-GENE
to O
promote O
migration O
of O
urokinase I-GENE
- I-GENE
type I-GENE
plasminogen I-GENE
activator I-GENE
- O
stimulated _RARE_
cells O
in O
an O
integrin I-GENE
- O
selective O
manner O
. O

The O
inhibition O
of O
StAR _RARE_
gene I-GENE
transcription O
by O
DAX _RARE_
- I-GENE
1 I-GENE
was O
dose O
- O
dependent O
reducing _RARE_
transcription O
to O
6 O
% O
of O
control O
levels O
. O

In O
a O
prospective O
randomized O
study O
, O
287 _RARE_
patients O
with O
advanced O
non O
- O
small O
cell O
lung _RARE_
cancer _RARE_
( O
NSCLC _RARE_
) O
stage _RARE_
IIIb _RARE_
or O
IV O
with O
ECOG _RARE_
performance O
status O
( O
PS _RARE_
) O
0 _RARE_
- O
1 O
or O
2 O
were O
randomly O
assigned O
to O
receive O
either O
best O
supportive _RARE_
care O
( O
BSC _RARE_
) O
or O
supportive _RARE_
care O
plus _RARE_
combination O
chemotherapy O
( O
IEP _RARE_
regimen O
: O
ifosfamide _RARE_
3 O
gm _RARE_
/ O
m2 O
IV O
with O
mesna _RARE_
uroprotection _RARE_
, O
epirubicin _RARE_
60 _RARE_
mg O
/ O
m2 O
IV O
on O
day O
1 O
and O
cisplatin O
60 _RARE_
mg O
/ O
m2 O
IV O
on O
day O
2 O
; O
or O
MVP _RARE_
regimen O
: O
mitomycin _RARE_
- O
C O
8 O
mg O
/ O
m2 O
, O
cisplatin O
100 _RARE_
mg O
/ O
m2 O
IV O
on O
day O
1 O
, O
vinblastine _RARE_
4 O
mg O
/ O
m2 O
IV O
on O
days O
1 O
and O
15 _RARE_
). O

Using O
sequence O
information _RARE_
from O
human I-GENE
BMAL1 _RARE_
( O
hBMAL1 _RARE_
) O
cDNAs O
previously O
reported O
by O
our O
laboratory O
, O
we O
have O
isolated O
and O
characterized O
cDNAs O
encoding O
three O
splice _RARE_
variants O
of O
the O
mouse I-GENE
BMAL1 _RARE_
( O
mBMAL1 _RARE_
) O
gene O
. O

Comparison O
with O
the O
bHLH I-GENE
/ O
PAS _RARE_
family O
genes O
revealed O
that O
the O
intron O
/ O
exon _RARE_
splice _RARE_
pattern O
of O
mBMAL1 _RARE_
most O
closely O
matches O
that O
of O
the O
mAhr _RARE_
, O
which O
suggests O
that O
BMAL1 _RARE_
and O
Ahr _RARE_
belong O
to O
the O
same O
subclass _RARE_
and O
may O
be O
derived O
from O
a O
common O
primordial _RARE_
gene O
. O

The O
transcriptional O
activities O
of O
the O
full O
- O
length O
promoter O
(- _RARE_
295 _RARE_
to O
+ O
85 _RARE_
) O
and O
of O
three O
deletion O
constructs O
(- _RARE_
197 _RARE_
, O
- O
154 O
and O
- O
74 _RARE_
to O
+ O
85 _RARE_
) O
were O
significantly O
down O
- O
regulated O
in O
resistant O
cells O
. O

We O
were O
able O
to O
detect O
significant O
differences O
in O
functional _RARE_
residual O
capacity O
adjusted O
for _RARE_
weight _RARE_
or O
height O
, O
and O
compliance O
of O
the O
respiratory O
system _RARE_
adjusted O
for _RARE_
weight _RARE_
or O
lung _RARE_
volume O
in O
the O
ILD _RARE_
infants O
compared O
to O
the O
healthy O
controls O
or O
infants O
who O
had O
PPHN _RARE_
, O
indicating O
that O
these O
PFTs _RARE_
were O
sensitive _RARE_
enough O
to O
determine O
abnormal O
lung _RARE_
function O
in O
this O
age O
group O
. O

A O
13 _RARE_
- O
bp O
cis O
- O
regulatory O
element O
in O
the O
LTR O
promoter O
of O
the O
tobacco I-GENE
retrotransposon _RARE_
Tto1 _RARE_
is O
involved O
in O
responsiveness O
to O
tissue O
culture O
, O
wounding _RARE_
, O
methyl _RARE_
jasmonate _RARE_
and O
fungal _RARE_
elicitors _RARE_
. O

In O
this O
study O
we O
describe O
that O
platelet I-GENE
- I-GENE
derived I-GENE
growth I-GENE
factor I-GENE
( O
PDGF _RARE_
), _RARE_
12 O
- O
O O
- O
tetradecanoyl _RARE_
- O
phorbol O
- O
acetate _RARE_
( O
TPA _RARE_
), _RARE_
and O
forskolin O
induced _RARE_
CREB I-GENE
( O
cAMP I-GENE
- I-GENE
responsive I-GENE
element I-GENE
- I-GENE
binding I-GENE
protein I-GENE
) O
Ser _RARE_
- O
133 _RARE_
phosphorylation _RARE_
with O
comparable O
magnitude O
and O
kinetics O
in O
NIH _RARE_
3T3 O
cells O
. O

This O
constitutes O
evidence O
for _RARE_
an O
in O
vivo O
role O
of O
SRC I-GENE
- I-GENE
1 I-GENE
in O
dimerization _RARE_
- O
induced _RARE_
activation O
by O
OR1 _RARE_
/ O
RXRalpha _RARE_
. O

By O
contrast O
, O
mTRAP100 _RARE_
coprecipitates _RARE_
in O
vivo O
with O
another O
component _RARE_
of O
the O
TRAP _RARE_
complex I-GENE
( O
TRAP220 _RARE_
), _RARE_
which O
directly O
contacts O
TR I-GENE
and O
the O
vitamin I-GENE
D I-GENE
receptor I-GENE
in O
a O
ligand _RARE_
- O
dependent O
manner O
. O

This O
sequence O
also O
confers O
VDR I-GENE
and O
vitamin O
D O
responsiveness O
to O
a O
heterologous O
promoter O
. O

Classical _RARE_
ligand _RARE_
- O
activated O
nuclear O
receptors O
( O
e _RARE_
. O
g O
. O
thyroid I-GENE
hormone I-GENE
receptor I-GENE
, O
retinoic I-GENE
acid I-GENE
receptor I-GENE
), _RARE_
orphan I-GENE
nuclear I-GENE
receptors I-GENE
( O
e _RARE_
. O
g O
. O

Expression O
of O
GlcNAc _RARE_
- I-GENE
TI _RARE_
mRNA I-GENE
in O
tobacco O
leaves O
was O
detected O
using O
RT O
- O
PCR O
. O

Chemical O
stability O
tests O
and O
site O
- O
specific O
mutagenesis O
identified O
amino O
acids _RARE_
H219 _RARE_
and O
D63 _RARE_
of O
RegS _RARE_
and O
RegR _RARE_
, O
respectively O
, O
as _RARE_
the O
phosphorylated _RARE_
residues O
. O

An O
overexpression O
of O
the O
betaAPP _RARE_
gene I-GENE
in O
certain O
areas O
of O
the O
AD O
brain O
has O
been O
suggested O
to O
be O
an O
important O
factor O
in O
the O
neuropathology _RARE_
of O
AD O
. O

For O
functional _RARE_
studies O
, O
two O
promoter O
regions O
were O
cloned _RARE_
upstream O
of O
the O
reporter O
gene O
, O
chloramphenicol I-GENE
acetyl I-GENE
transferase I-GENE
( O
CAT I-GENE
): O
( O
i O
) O
phbetaE _RARE_
- O
B O
- O
the O
plasmid _RARE_
that O
contains O
the O
human O
( O
h O
) O
promoter O
region O
(- _RARE_
2832 _RARE_
to O
+ O
101 _RARE_
) O
including O
URE _RARE_
, O
and O
( O
ii O
) O
prhbetaE _RARE_
- O
B O
- O
the O
plasmid _RARE_
that O
contains O
the O
rhesus _RARE_
( O
rh _RARE_
) O
promoter O
region O
excluding O
URE _RARE_
as _RARE_
it O
lacks O
a O
270 O
bp O
region O
of O
the O
hbetaAPP _RARE_
promoter I-GENE
(- _RARE_
2435 _RARE_
to O
- O
2165 _RARE_
). O

67 O
393 _RARE_
bp O
of O
contiguous O
DNA O
located _RARE_
between O
markers O
cdc18 _RARE_
and O
cdc14 _RARE_
on O
the O
right O
arm _RARE_
of O
fission _RARE_
yeast O
chromosome _RARE_
II O
has O
been O
sequenced O
as _RARE_
part O
of O
the O
European O
Union _RARE_
Schizosaccharomyces O
pombe O
genome O
sequencing O
project _RARE_
. O

67 O
393 _RARE_
bp O
of O
contiguous O
DNA O
located _RARE_
between O
markers O
cdc18 _RARE_
and O
cdc14 _RARE_
on O
the O
right O
arm _RARE_
of O
fission _RARE_
yeast O
chromosome _RARE_
II O
has O
been O
sequenced O
as _RARE_
part O
of O
the O
European O
Union _RARE_
Schizosaccharomyces O
pombe O
genome O
sequencing O
project _RARE_
. O

G I-GENE
- I-GENE
CSF I-GENE
( O
480 _RARE_
micrograms O
subcutaneously O
( O
s O
. O
c O
.)) _RARE_
were O
used O
in O
55 _RARE_
and O
GM _RARE_
- I-GENE
CSF I-GENE
( O
400 _RARE_
micrograms O
s O
. O
c O
.) O
in O
28 _RARE_
chemotherapeutic O
cycles O
. O

Overexpression O
of O
H411 _RARE_
cDNA I-GENE
in O
the O
RAW _RARE_
264 O
. O
7 O
macrophage O
cell O
line O
promoted O
an O
increased O
growth O
rate O
, O
suggesting O
that O
expression _RARE_
of O
H411 _RARE_
is O
part O
of O
the O
proliferative O
cell O
response O
to O
LPS _RARE_
. O

Human O
expressed _RARE_
sequence O
tag O
clones _RARE_
were O
identified O
by O
sequence O
similarity _RARE_
to O
mammalian I-GENE
and I-GENE
yeast I-GENE
oligosaccharide _RARE_
- I-GENE
processing _RARE_
mannosidases _RARE_
, O
and O
the O
full O
- O
length O
coding O
region O
of O
the O
putative O
mannosidase _RARE_
homolog I-GENE
was O
isolated O
by O
a O
combination O
of O
5 O
'- O
rapid O
amplification O
of O
cDNA O
ends O
and O
direct O
polymerase O
chain O
reaction O
from O
human O
placental _RARE_
cDNA O
. O

Activation O
of O
ERK1 I-GENE
/ I-GENE
2 I-GENE
is O
correlated O
with O
induction O
of O
the O
immediate I-GENE
- I-GENE
early I-GENE
response I-GENE
genes I-GENE
. O

The O
transcription O
of O
most O
RP _RARE_
genes I-GENE
is O
activated O
by O
two O
Rap1p _RARE_
binding I-GENE
sites I-GENE
, O
250 _RARE_
to O
400 _RARE_
bp O
upstream O
from O
the O
initiation O
of O
transcription O
. O

We O
have O
isolated O
three O
mutant O
alleles O
of O
CDC4 _RARE_
( O
cdc4 _RARE_
- I-GENE
10 I-GENE
, O
cdc4 _RARE_
- I-GENE
11 I-GENE
, O
and O
cdc4 _RARE_
- I-GENE
16 I-GENE
) O
which O
suppress O
the O
nuclear O
division O
defect O
of O
cdc20 _RARE_
- I-GENE
1 I-GENE
cells O
. O

Role O
of O
secondary O
structure _RARE_
in O
discrimination O
between O
constitutive _RARE_
and O
inducible O
activators _RARE_
. O

In O
summary O
, O
Ca O
( O
2 O
+)- _RARE_
dependent O
activation O
of O
NO _RARE_
production O
mediates O
apoptosis O
after O
TG I-GENE
exposure O
in O
JT _RARE_
/ O
Neo _RARE_
cells O
. O

Accumulation _RARE_
of O
the O
U4 I-GENE
/ O
U6 I-GENE
duplex O
was O
relieved _RARE_
by O
overexpression O
of O
wild I-GENE
- I-GENE
type I-GENE
Prp44p _RARE_
. O

Our O
results O
, O
when O
combined O
with O
previously O
published O
in O
vitro O
results O
, O
support O
a O
direct O
role O
for _RARE_
Prp44p _RARE_
in O
unwinding _RARE_
of O
the O
U4 I-GENE
/ O
U6 I-GENE
helix O
. O

This O
approximately _RARE_
125 _RARE_
- O
nt O
RNA O
proved O
to O
arise O
via O
RNase I-GENE
E I-GENE
cleavage _RARE_
from O
the O
3 O
'- O
terminal O
region O
of O
the O
mRNAs O
bearing _RARE_
the O
terminator O
. O

The O
mysteries _RARE_
of O
geographic _RARE_
variability O
in O
nonmelanoma _RARE_
skin _RARE_
cancer _RARE_
incidence O
. O

In O
Saccharomyces O
cerevisiae O
the O
cAMP I-GENE
- I-GENE
dependent I-GENE
kinases I-GENE
( O
PKAs _RARE_
) O
promote O
cytoplasmic O
growth O
and O
modulate O
the O
growth O
- O
regulated O
mechanism O
triggering _RARE_
the O
begin O
of O
DNA O
synthesis _RARE_
. O

We O
have O
shown O
previously O
that O
in O
contrast O
to O
other O
extracellular O
matrix _RARE_
molecules O
pepsin _RARE_
- O
solubilized _RARE_
collagen _RARE_
VI _RARE_
( O
CVI _RARE_
) O
can O
stimulate O
DNA O
synthesis _RARE_
of O
various O
mesenchymal O
cell O
types _RARE_
, O
apparently O
independent O
of O
integrin I-GENE
- O
mediated _RARE_
signal O
transduction _RARE_
. O

A O
recombinant O
derivative _RARE_
harboring O
the O
pMJ101 _RARE_
replication O
region O
proved O
to O
be O
compatible O
with O
pJM1 _RARE_
, O
a O
plasmid _RARE_
containing O
the O
iron O
acquisition O
system _RARE_
required O
for _RARE_
the O
virulence _RARE_
of O
V O
. O
anguillarum _RARE_
775 _RARE_
, O
another O
important O
pathogen _RARE_
that O
causes O
vibriosis _RARE_
. O

FAK I-GENE
localizes O
to O
sites O
of O
transmembrane I-GENE
integrin I-GENE
receptor I-GENE
clustering _RARE_
and O
facilitates _RARE_
intracellular _RARE_
signaling _RARE_
events O
. O

Expression O
of O
various O
FAK I-GENE
mutants I-GENE
in O
the O
FAK I-GENE
- O
cells O
showed O
that O
FAK I-GENE
kinase I-GENE
activity O
, O
the O
Tyr _RARE_
- I-GENE
397 _RARE_
/ I-GENE
SH2 _RARE_
domain I-GENE
binding I-GENE
site I-GENE
, O
and O
the O
first _RARE_
proline O
- O
rich O
SH3 I-GENE
binding I-GENE
region I-GENE
in O
the O
FAK I-GENE
C I-GENE
- I-GENE
terminal I-GENE
domain I-GENE
were O
individually O
needed O
to O
promote O
full O
FAK I-GENE
- O
mediated _RARE_
FAK I-GENE
- O
cell O
migration O
to O
FN I-GENE
whereas O
direct O
paxillin I-GENE
binding O
to O
FAK I-GENE
was O
not O
required O
. O

This O
dominant O
- O
negative O
effect O
of O
FRNK _RARE_
was O
reversed O
by O
a O
point O
mutation O
( O
Leu _RARE_
- O
1034 _RARE_
to O
Ser _RARE_
) O
which O
prevented O
FRNK _RARE_
localization _RARE_
to O
focal _RARE_
contact _RARE_
sites O
. O

Fifty O
six _RARE_
young O
patients O
( O
age O
< O
45 _RARE_
yr O
) O
with O
doppler _RARE_
- O
proven O
DVT _RARE_
were O
investigated O
for _RARE_
the O
presence O
of O
resistance O
to O
activated I-GENE
protein I-GENE
C I-GENE
( O
APC _RARE_
- I-GENE
R I-GENE
), _RARE_
lupus O
anticoagulant _RARE_
( O
LA O
), _RARE_
anticardiolipin _RARE_
antibodies I-GENE
and O
deficiencies O
of O
protein I-GENE
C I-GENE
, O
protein I-GENE
S I-GENE
, O
ATIII _RARE_
activities O
. O

DESIGN O
: O
Comparison O
of O
number O
of O
women O
with O
PKU _RARE_
aged O
15 _RARE_
- O
44 _RARE_
years O
on O
the O
NSW _RARE_
PKU _RARE_
database O
( O
observed O
number O
) O
with O
expected O
number O
derived O
from O
population O
data O
. O

PURPOSE O
: O
The O
purposes _RARE_
of O
the O
present O
study O
were O
to O
assess O
the O
effects O
of O
a O
12 O
- O
wk O
laboratory O
based O
aerobic O
exercise O
program O
on O
cardiopulmonary O
function O
, O
CD4 _RARE_
cell O
count O
, O
and O
physician _RARE_
- O
assessed O
health O
status O
among O
symptomatic O
pre O
- O
AIDS O
HIV O
- O
infected _RARE_
individuals O
( O
N O
= O
28 _RARE_
) O
and O
to O
assess O
the O
degree O
to O
which O
ill _RARE_
health O
was O
associated O
with O
exercise O
relapse O
. O

The O
enzyme O
displays O
optimal O
activity O
at _RARE_
about O
0 _RARE_
. O
5 O
mM O
pantoate _RARE_
( O
k _RARE_
( O
cat _RARE_
) O
0 _RARE_
. O
63 _RARE_
s O
(- _RARE_
1 O
)) O
and O
at _RARE_
pH O
7 O
. O
8 O
. O

Taken O
together O
, O
these O
results O
demonstrate O
that O
the O
RP _RARE_
, O
like O
the O
20S I-GENE
proteasome I-GENE
, O
is O
functionally O
and O
structurally O
conserved _RARE_
among O
eukaryotes O
and O
indicate O
that O
the O
plant _RARE_
RPT _RARE_
subunits I-GENE
, O
like O
their O
yeast O
counterparts O
, O
have O
non O
- O
redundant _RARE_
functions O
. O

Epidemiologic _RARE_
evidence O
indicates O
that O
estrogen O
replacement _RARE_
therapy O
after O
menopause _RARE_
increases O
breast O
cancer _RARE_
risk O
. O

In O
addition O
to O
its O
elongation _RARE_
activity O
, O
ELL _RARE_
contains O
a O
novel O
type O
of O
RNA I-GENE
polymerase I-GENE
II I-GENE
interaction I-GENE
domain I-GENE
that O
is O
capable O
of O
repressing O
polymerase O
activity O
in O
promoter O
- O
specific O
transcription O
. O

A O
diagnosis O
of O
IgA I-GENE
lambda I-GENE
multiple O
myeloma O
with O
peritoneal O
involvement O
was O
made O
. O

The O
radiation O
burden O
associated O
with O
the O
majority O
of O
examinations O
in O
nuclear O
medicine O
expressed _RARE_
as _RARE_
the O
effective O
dose O
is O
comparable O
with O
the O
radiation O
burden O
of O
radiodiagnostic _RARE_
examinations O
, O
only O
after O
administration O
of O
preparations O
with O
131I O
, O
201Tl _RARE_
, O
67Ga _RARE_
and O
111In _RARE_
it O
is O
markedly O
higher _RARE_
. O

Although O
the O
risk O
of O
malformation _RARE_
in O
children O
born O
after O
ICSI _RARE_
is O
not O
increased O
there O
is O
an O
increased O
risk O
to O
transmit _RARE_
genetic O
abnormalities O
in O
case O
of O
NOA _RARE_
( O
such O
as _RARE_
the O
rate O
of O
sex _RARE_
chromosome _RARE_
, O
or O
microdeletions _RARE_
of O
the O
Y O
chromosome _RARE_
) O
and O
in O
case O
of O
congenital O
OA _RARE_
( O
mutations O
of O
the O
cystic _RARE_
fibrosis _RARE_
gene I-GENE
). O

TaV _RARE_
particles _RARE_
have O
a O
buoyant _RARE_
density O
of O
1 O
. O
296 O
g O
/ O
cm3 O
in O
CsCl _RARE_
and O
consist O
of O
two O
capsid _RARE_
proteins I-GENE
of O
56 _RARE_
and O
6 O
kDa O
. O

CONCLUSION O
: O
These O
results O
suggest O
that O
vibration O
- O
induced _RARE_
neural _RARE_
involvement O
can O
be O
considered O
neither O
pure O
digital O
neuropathy _RARE_
, O
nor O
definite O
CTS _RARE_
, O
as _RARE_
previously O
described O
. O

In O
about O
770 _RARE_
bp O
upstream O
region O
of O
Spam1 _RARE_
that O
has O
been O
cloned _RARE_
and O
sequenced O
, O
multiple O
transcription O
factor O
binding O
sites O
including O
a O
CRE _RARE_
( O
cAMP O
- O
responsive O
element O
) O
were O
found O
. O

The O
in O
vitro O
relaxivity _RARE_
of O
the O
complex O
is O
16 O
. O
24 _RARE_
s O
(- _RARE_
1 O
) O
mM O
(- _RARE_
1 O
). O

Structure O
and O
expression _RARE_
of O
the O
mouse I-GENE
growth I-GENE
hormone I-GENE
receptor I-GENE
/ O
growth I-GENE
hormone I-GENE
binding I-GENE
protein I-GENE
gene I-GENE
. O

Bacterial _RARE_
recovery O
of O
SA O
from O
the O
liver O
/ O
spleen _RARE_
and O
the O
cecal _RARE_
tonsil _RARE_
in O
contact _RARE_
poults _RARE_
and O
SG _RARE_
from O
contact _RARE_
chicks O
treated O
with O
ILK I-GENE
was O
dramatically O
reduced _RARE_
when O
compared O
to O
non O
- O
treated O
contact _RARE_
poults _RARE_
and O
chicks O
. O

The O
results O
of O
the O
ISIS _RARE_
- O
2 O
trial O
and O
the O
data O
from O
the O
Antiplatelet _RARE_
Trialists _RARE_
' O
Collaboration _RARE_
indicated O
that O
aspirin _RARE_
is O
mandatory _RARE_
in O
patients O
with O
acute O
myocardial _RARE_
infarction O
and O
for _RARE_
secondary O
prevention O
. O

This O
study O
was O
performed O
to O
assess O
the O
role O
of O
additional O
diagnostic O
laparoscopy _RARE_
in O
the O
preoperative O
staging _RARE_
of O
patients O
with O
adenocarcinoma O
of O
the O
esophagus _RARE_
, O
gastric _RARE_
cancer _RARE_
and O
pancreatic O
cancer _RARE_
prior O
to O
intended _RARE_
curative _RARE_
surgery O
. O

This O
report O
presents O
state O
- O
specific O
MMRs _RARE_
for _RARE_
1987 O
- O
1996 O
, O
focusing O
on O
persistent O
disparities _RARE_
in O
maternal _RARE_
mortality O
between O
black O
and O
white _RARE_
women O
. O

Preheparin _RARE_
LPL _RARE_
mass O
level O
did O
not O
significantly O
differ O
in O
individuals O
from O
19 O
to O
70 O
years O
old O
, O
for _RARE_
both O
men O
and O
women O
. O

A O
decrease O
in O
insulin I-GENE
- O
induced _RARE_
receptor O
kinase O
activity O
was O
observed O
for _RARE_
solubilized _RARE_
chimeric O
receptors O
. O

Cat _RARE_
- I-GENE
1 I-GENE
is O
identical O
to O
the O
recently O
identified O
binding O
partner _RARE_
for _RARE_
the O
beta I-GENE
- I-GENE
adrenergic I-GENE
receptor I-GENE
kinase I-GENE
( O
betaARK _RARE_
or O
GRK _RARE_
- I-GENE
2 I-GENE
), _RARE_
which O
was O
shown O
to O
have O
Arf _RARE_
- O
GAP _RARE_
activity O
. O

Cat _RARE_
proteins I-GENE
are O
tyrosine O
- O
phosphorylated _RARE_
when O
co _RARE_
- O
expressed _RARE_
in O
cells O
with O
the O
focal _RARE_
adhesion I-GENE
kinase I-GENE
Fak _RARE_
and O
Src I-GENE
. O

Immunoprecipitation _RARE_
experiments O
using O
DokR _RARE_
- I-GENE
specific I-GENE
antibodies I-GENE
revealed O
an O
interaction O
between O
endogenous I-GENE
DokR _RARE_
and O
a O
150 _RARE_
- O
kDa O
protein O
that O
is O
tyrosine O
- O
phosphorylated _RARE_
in O
EGF _RARE_
- O
stimulated _RARE_
BaF _RARE_
/ O
3 O
cells O
. O

Expansins _RARE_
are O
a O
family O
of O
proteins O
that O
catalyse _RARE_
long O
- O
term O
extension O
of O
isolated O
plant _RARE_
cell O
walls _RARE_
due O
to O
an O
as _RARE_
yet O
unknown O
biochemical O
mechanism O
. O

This O
review O
summarizes _RARE_
the O
clinical O
evidence O
to O
support O
current O
therapies _RARE_
in O
irritable _RARE_
bowel O
syndrome _RARE_
( O
IBS _RARE_
). O

The O
responsive O
region O
of O
the O
alpha I-GENE
2 I-GENE
( I-GENE
V I-GENE
) I-GENE
collagen _RARE_
gene I-GENE
was O
localized O
to O
a O
fragment O
including O
100 _RARE_
bp O
of O
basal O
promoter O
and O
150 _RARE_
bp O
of O
exon _RARE_
1 O
sequences O
, O
which O
contained O
two O
CRE _RARE_
- O
like O
elements O
. O

Furthermore O
, O
addition O
of O
B I-GENE
- I-GENE
Myb I-GENE
- O
glutathionine _RARE_
S I-GENE
- I-GENE
transferase I-GENE
fusion O
protein O
inhibited O
complex O
formation O
. O

APOE _RARE_
- O
epsilon4 _RARE_
count O
predicts O
age O
when O
prevalence O
of O
AD O
increases O
, O
then O
declines _RARE_
: O
the O
Cache _RARE_
County _RARE_
Study O
. O

Repair _RARE_
of O
double O
- O
strand _RARE_
breaks _RARE_
( O
DSBs _RARE_
) O
in O
chromosomal O
DNA O
by O
nonhomologous _RARE_
end O
- O
joining _RARE_
( O
NHEJ _RARE_
) O
is O
not O
well _RARE_
characterized O
in O
the O
yeast O
Saccharomyces O
cerevisiae O
. O

A O
new O
DNA I-GENE
repair I-GENE
gene I-GENE
from O
Schizosaccharomyces O
pombe O
with O
homology O
to O
RecA _RARE_
was O
identified O
and O
characterized O
. O

Among O
mucus O
- O
secreting O
cells O
, O
the O
gastric _RARE_
gland _RARE_
mucous _RARE_
cells O
, O
Brunner _RARE_
' O
s O
glands O
, O
accessory _RARE_
glands O
of O
pancreaticobiliary _RARE_
tract _RARE_
, O
and O
pancreatic O
ducts _RARE_
exhibiting O
gastric _RARE_
metaplasia _RARE_
are O
unique O
in O
that O
they O
express O
class I-GENE
III I-GENE
mucin _RARE_
identified O
by O
paradoxical _RARE_
Con _RARE_
A I-GENE
staining O
composed O
of O
periodate _RARE_
oxidation O
, O
sodium _RARE_
borohydride _RARE_
reduction O
, O
Con _RARE_
A I-GENE
, O
and O
horseradish _RARE_
peroxidase I-GENE
reaction O
. O

The O
C O
- O
terminal O
mutants O
were O
strongly O
dominant O
over O
TraR _RARE_
, O
suggesting O
that O
they O
can O
form O
heteromultimers _RARE_
with O
the O
wild O
- O
type O
activator O
. O

Thus O
, O
elongin _RARE_
C I-GENE
is O
found O
to O
oligomerize _RARE_
in O
solution O
and O
to O
undergo O
significant O
structural O
rearrangements _RARE_
upon O
binding O
of O
two O
different O
partner _RARE_
proteins O
. O

The O
data O
imply O
that O
JAK _RARE_
/ O
STAT I-GENE
signaling _RARE_
has O
a O
role O
in O
EBV _RARE_
- O
associated O
malignancies _RARE_
. O

There O
were O
27 _RARE_
men O
and O
156 _RARE_
women O
. O

A O
., O
Bowers _RARE_
, O
K O
. O
E O
, O
and O
Matthews _RARE_
, O
C O
. O

Spfkh1 _RARE_
is O
transcribed _RARE_
in O
one O
open _RARE_
reading O
frame O
that O
contains O
the O
DNA O
binding O
domain O
, O
nuclear O
localization _RARE_
signal O
and O
transactivation _RARE_
domain O
. O

The O
molecular _RARE_
mechanism O
of O
Tax _RARE_
- O
mediated _RARE_
trans _RARE_
- O
activation O
has O
been O
well _RARE_
investigated O
. O

Gel O
filtration O
and O
co _RARE_
- O
immunoprecipitation O
analyses O
reveal O
that O
Mad2p _RARE_
tightly O
associates O
with O
another O
spindle _RARE_
checkpoint _RARE_
component _RARE_
, O
Mad1p _RARE_
. O

METHODS O
: O
109 _RARE_
suspected O
cases O
with O
SS _RARE_
underwent O
the O
biopsies O
. O

We O
also O
identify O
several O
regulatory O
domain O
mutants O
in O
which O
Cd O
( O
2 O
+) O
tolerance O
of O
the O
mutant O
strain _RARE_
and O
transport _RARE_
activity O
of O
the O
protein O
are O
dissociated _RARE_
. O

The O
human I-GENE
immunodeficiency I-GENE
virus I-GENE
type I-GENE
- I-GENE
1 I-GENE
( I-GENE
HIV I-GENE
- I-GENE
1 I-GENE
) I-GENE
Tat I-GENE
protein I-GENE
regulates O
transcription O
by O
stimulating O
RNA I-GENE
polymerase I-GENE
processivity _RARE_
. O

One O
of O
these O
SEBPs _RARE_
, O
SEBP2 _RARE_
, O
was O
shown O
to O
be O
the O
product O
of O
the O
homeotic I-GENE
gene I-GENE
fork I-GENE
head I-GENE
. O

Identity _RARE_
elements O
in O
tRNA O
for _RARE_
mono O
- O
and O
dimethylation _RARE_
reactions O
by O
the O
recombinant I-GENE
pfTrm1p _RARE_
were O
identified O
using O
in O
vitro O
T7 _RARE_
transcripts O
of O
33 _RARE_
variants O
of O
tRNA I-GENE
( I-GENE
Asp _RARE_
) I-GENE
and O
tRNA I-GENE
( I-GENE
Phe _RARE_
) I-GENE
from O
yeast O
. O

In O
insulin I-GENE
- O
responsive O
cells O
, O
Akt I-GENE
phosphorylates O
and O
inactivates _RARE_
the O
serine I-GENE
/ I-GENE
threonine I-GENE
kinase I-GENE
glycogen _RARE_
synthase I-GENE
kinase I-GENE
- I-GENE
3 I-GENE
( O
GSK _RARE_
- I-GENE
3 I-GENE
). O

The O
B I-GENE
cell I-GENE
antigen I-GENE
receptor I-GENE
activates O
the O
Akt I-GENE
( O
protein I-GENE
kinase I-GENE
B I-GENE
)/ _RARE_
glycogen _RARE_
synthase I-GENE
kinase I-GENE
- I-GENE
3 I-GENE
signaling _RARE_
pathway _RARE_
via O
phosphatidylinositol _RARE_
3 I-GENE
- I-GENE
kinase I-GENE
. O

Fewer _RARE_
recombination _RARE_
events O
are O
detected O
in O
four O
different O
B O
and O
T O
cell O
lines O
that O
do O
not O
undergo O
switch O
recombination _RARE_
of O
their O
endogenous O
genes O
. O

IL _RARE_
- I-GENE
1 I-GENE
and O
TNF I-GENE
increase O
AND _RARE_
- I-GENE
34 _RARE_
transcript I-GENE
levels O
in O
thymic _RARE_
cortical O
reticular _RARE_
, O
thymic _RARE_
nurse O
, O
and O
fibroblast O
cell O
lines O
. O

To O
determine O
what O
role O
eIF4E _RARE_
might O
play O
in O
c I-GENE
- I-GENE
myc I-GENE
expression _RARE_
, O
the O
c I-GENE
- I-GENE
myc I-GENE
5 I-GENE
' I-GENE
untranslated _RARE_
region I-GENE
( I-GENE
UTR I-GENE
) I-GENE
was O
fused O
in O
- O
frame O
to O
CAT I-GENE
reporters _RARE_
, O
and O
several O
more O
derivative _RARE_
constructs O
were O
made O
. O

Analysis O
of O
cell O
cycle _RARE_
proteins O
showed O
that O
24 _RARE_
h O
of O
lovastatin _RARE_
treatment O
in O
the O
control O
cells O
caused O
an O
elevation O
in O
the O
levels O
of O
the O
cyclin _RARE_
- I-GENE
dependent I-GENE
kinase I-GENE
inhibitor O
p27 I-GENE
( O
kip1 _RARE_
), _RARE_
inhibition O
of O
both O
cyclin _RARE_
E I-GENE
- I-GENE
and I-GENE
cyclin _RARE_
A I-GENE
- I-GENE
dependent I-GENE
kinase I-GENE
activity O
, O
and O
decreased O
levels O
of O
hyperphosphorylated _RARE_
retinoblastoma _RARE_
protein I-GENE
( O
pRb I-GENE
). O

RESULTS O
: O
Circulating _RARE_
leptin I-GENE
concentrations O
in O
AN _RARE_
were O
3 O
. O
5 O
+/- O
0 _RARE_
. O
5 O
versus O
7 O
. O
6 O
+/- O
1 O
. O
2 O
ng _RARE_
/ O
ml O
in O
control O
subjects O
. O

Copyright O
1999 _RARE_
Academic O
Press O
. O

Oligonucleotide _RARE_
probes _RARE_
corresponding O
to O
wild O
- O
type O
and O
mutant O
EpRE _RARE_
sequences O
were O
used O
in O
gel O
- O
shift O
and O
super _RARE_
- O
shift O
analyses O
to O
identify O
proteins O
binding O
. O

PKNbeta _RARE_
had O
high O
sequence O
homology O
with O
PKNalpha _RARE_
, O
originally _RARE_
isolated O
PKN I-GENE
, O
especially O
in O
the O
repeats O
of O
charged O
amino O
acid O
- O
rich O
region O
with O
leucine O
- O
zipper O
like O
sequences O
( O
CZ _RARE_
region O
/ O
HR1 _RARE_
), _RARE_
in O
the O
carboxyl _RARE_
- O
terminal O
catalytic O
domain O
, O
and O
in O
approximately _RARE_
130 _RARE_
amino O
acid O
stretch O
( O
D O
region O
/ O
HR2 _RARE_
), _RARE_
located _RARE_
between O
CZ _RARE_
region O
/ O
HR1 _RARE_
and O
the O
catalytic O
domain O
. O

At O
baseline O
, O
serum O
levels O
of O
lycopene _RARE_
and O
FLOP _RARE_
were O
abnormally _RARE_
high O
and O
serum O
FLOP _RARE_
was O
correlated O
significantly O
with O
plasma O
cyclosporine O
levels O
( O
r _RARE_
= O
0 _RARE_
. O
646 _RARE_
, O
p O
= O
0 _RARE_
. O
016 _RARE_
). O

BACKGROUND O
: O
Chronic O
alcohol _RARE_
consumption O
has O
been O
demonstrated O
to O
be O
deleterious _RARE_
to O
bone O
health O
. O

Interestingly O
, O
following O
induction O
of O
stress O
by O
heat O
shock O
, O
high O
salt O
, O
or O
ethanol O
, O
conditions O
under O
which O
most O
mRNA O
export O
is O
blocked O
, O
Npl3p _RARE_
is O
still O
exported _RARE_
from O
the O
nucleus O
. O

For O
symptomatic O
relief _RARE_
and O
inhibition O
of O
the O
growth O
of O
the O
metastases O
interferon _RARE_
- I-GENE
a I-GENE
and O
somatostatin I-GENE
analogues O
can O
be O
employed O
. O

In O
summary O
, O
the O
no _RARE_
- O
adverse O
- O
effect O
- O
level O
for _RARE_
this O
study O
was O
determined O
to O
be O
1000 O
ppm O
, O
based O
on O
decreased O
weight _RARE_
gain O
in O
female O
rats O
, O
and O
on O
slight O
organ O
weight _RARE_
changes O
in O
both O
sexes _RARE_
at _RARE_
3000 _RARE_
ppm O
. O

Some O
of O
them O
produce O
gigantic _RARE_
sperm O
several O
times O
the O
total _RARE_
male O
body O
length O
. O

John _RARE_
leonard _RARE_
dawson _RARE_

PDGF _RARE_
A I-GENE
- I-GENE
chain I-GENE
levels O
increase O
in O
cultured O
vascular O
smooth _RARE_
muscle O
cells O
( O
SMCs _RARE_
) O
exposed O
to O
ATII _RARE_
. O

M I-GENE
- I-GENE
Ras I-GENE
interacted O
poorly O
in O
a O
yeast O
two O
- O
hybrid _RARE_
assay O
with O
multiple O
Ras I-GENE
effectors _RARE_
, O
including O
c I-GENE
- I-GENE
Raf I-GENE
- I-GENE
1 I-GENE
, O
A I-GENE
- I-GENE
Raf I-GENE
, O
B I-GENE
- I-GENE
Raf I-GENE
, O
phosphoinositol _RARE_
- I-GENE
3 I-GENE
kinase I-GENE
delta I-GENE
, O
RalGDS _RARE_
, O
and O
Rin1 _RARE_
. O

Deletion O
mapping O
of O
the O
human I-GENE
presenilin _RARE_
- I-GENE
1 I-GENE
( O
PS1 _RARE_
) O
promoter O
delineated _RARE_
the O
most O
active _RARE_
fragment O
from O
- O
118 O
to O
+ O
178 _RARE_
in O
relation O
to O
the O
transcription O
start _RARE_
site O
mapped O
in O
this O
study O
, O
in O
both O
human O
neuroblastoma O
SK _RARE_
- O
N O
- O
SH _RARE_
and O
hepatoma O
HepG2 _RARE_
cells O
. O

Microcirculatory _RARE_
oxygenation O
and O
shunting _RARE_
in O
sepsis O
and O
shock O
. O

Analysis O
of O
the O
E2F1 I-GENE
gene I-GENE
promoter I-GENE
showed O
that O
the O
- O
146 _RARE_
to O
- O
54 O
region O
was O
required O
for _RARE_
E2 I-GENE
- O
responsiveness O
in O
transient O
transfection O
assays O
, O
and O
subsequent O
deletion O
/ O
mutation O
analysis O
showed O
that O
a O
single O
upstream O
GC _RARE_
- O
rich O
and O
two O
downstream _RARE_
CCAAT O
- O
binding O
sites O
were O
required O
for _RARE_
transactivation _RARE_
by O
E2 I-GENE
. O

In O
the O
course O
of O
investigating _RARE_
the O
mechanisms O
by O
which O
OF5 _RARE_
and O
OF3 _RARE_
regulated O
CYP11A1 _RARE_
transcription O
, O
we O
found O
that O
OF5 _RARE_
and O
OF3 _RARE_
bound _RARE_
Sp1 _RARE_
and O
Sp3 I-GENE
in O
JEG _RARE_
- O
3 O
cells O
. O

In O
contrast O
, O
the O
differentiation O
of O
neoplastically _RARE_
transformed O
cells O
does O
not O
repress O
mitogenic O
responsiveness O
or O
junB I-GENE
or O
c I-GENE
- I-GENE
fos I-GENE
inducibility O
. O

Adipocyte _RARE_
differentiation O
of O
nontransformed _RARE_
cells O
also O
markedly O
represses O
the O
ability O
of O
SRF I-GENE
to O
bind O
to O
the O
junB I-GENE
SRE O
, O
the O
c I-GENE
- I-GENE
fos I-GENE
SRE O
, O
and O
other O
SREs _RARE_
, O
as _RARE_
determined O
by O
mobility O
shift O
and O
gel O
supershift O
assays O
, O
without O
affecting O
the O
DNA O
binding O
characteristics O
of O
the O
nuclear O
protein O
SP O
- O
1 O
. O

Transformation _RARE_
blocks O
differentiation O
- O
induced _RARE_
inhibition O
of O
serum I-GENE
response I-GENE
factor I-GENE
interactions O
with O
serum O
response O
elements O
. O

The O
core I-GENE
enzyme I-GENE
is O
homologous O
to O
those O
of O
bacteriophages _RARE_
T3 _RARE_
, O
T7 _RARE_
and O
SP6 _RARE_
whereas O
the O
specificity _RARE_
factor O
shows O
similarities O
with O
bacterial I-GENE
sigma _RARE_
factors I-GENE
. O

The O
Cr _RARE_
. I-GENE
psbA _RARE_
- I-GENE
4 I-GENE
ORF I-GENE
contains O
an O
H O
- O
N O
- O
H O
motif O
, O
and O
possibly O
a O
GIY _RARE_
- O
YIG _RARE_
motif O
. O

The O
interaction O
of O
zf4 _RARE_
- I-GENE
6 I-GENE
with O
full I-GENE
- I-GENE
length I-GENE
5 I-GENE
S I-GENE
RNA I-GENE
was O
far O
more O
sensitive _RARE_
to O
non O
- O
specific O
competitor O
concentration O
than O
was O
the O
zf4 _RARE_
- I-GENE
7 I-GENE
: O
5 I-GENE
S I-GENE
RNA I-GENE
interaction O
, O
suggesting O
that O
finger O
seven _RARE_
contributes O
to O
both O
affinity O
and O
specificity _RARE_
in O
this O
protein O
: O
RNA O
interaction O
. O

The O
STAT I-GENE
protein I-GENE
accumulation O
resulting O
from O
C I-GENE
/ I-GENE
EBP I-GENE
expression _RARE_
was O
tightly O
coupled O
to O
the O
morphological O
conversion O
of O
fibroblasts _RARE_
to O
adipocytes O
and O
represents O
an O
expression _RARE_
profile O
identical O
to O
that O
reported O
for _RARE_
mature _RARE_
adipocytes O
in O
vivo O
. O

The O
median O
durations O
for _RARE_
response O
and O
survival O
time O
in O
the O
late _RARE_
phase _RARE_
II O
trial O
were O
2 O
. O
3 O
months O
and O
5 O
. O
8 O
months O
, O
respectively O
. O

The O
role O
of O
' O
scientific _RARE_
psychiatry _RARE_
' O
in O
understanding O
patients O
with O
chronic O
schizophrenia O
or O
severe O
personality _RARE_
disorder O
. O

Myocardial O
antioxidant O
enzymes _RARE_
, O
catalase I-GENE
, O
glutathione _RARE_
peroxidase I-GENE
and O
superoxide _RARE_
dismutase I-GENE
, O
in O
the O
MCT _RARE_
- O
treated O
rats O
were O
not O
different O
compared O
to O
control O
rats O
. O

The O
second O
goal O
was O
to O
ascertain _RARE_
the O
somatotopic _RARE_
arrangement O
of O
the O
GPi _RARE_
in O
PD _RARE_
. O

These O
overall O
results O
indicate O
that O
there O
is O
generally O
one O
PERV _RARE_
copy O
per O
integration _RARE_
site O
. O

The O
present O
investigation O
conducted O
in O
a O
population O
of O
258 O
dentally _RARE_
aware _RARE_
individuals O
in O
the O
age O
range O
20 O
- O
69 _RARE_
years O
, O
was O
initiated _RARE_
to O
elucidate O
the O
relationship O
between O
tobacco O
smoking O
and O
supragingival _RARE_
calculus _RARE_
, O
taking O
into O
account O
possible O
confounding _RARE_
factors O
such O
as _RARE_
age O
, O
gender O
, O
oral O
hygiene _RARE_
and O
gingival _RARE_
inflammation O
. O

OBJECTIVE O
: O
To O
determine O
whether O
administration O
of O
misoprostol _RARE_
prevents O
gastric _RARE_
hemorrhage O
in O
healthy O
dogs O
treated O
with O
high O
doses O
of O
methylprednisolone _RARE_
sodium _RARE_
succinate _RARE_
( O
MPSS _RARE_
). O

Patients O
were O
assessed O
for _RARE_
cardiac O
MIBG _RARE_
uptake O
, O
circulating O
norepinephrine O
concentration O
, O
LVEF O
, O
peak O
Vo2 _RARE_
, O
x _RARE_
- O
ray O
cardiothoracic _RARE_
ratio O
, O
M O
- O
mode O
echographic _RARE_
end O
- O
diastolic O
diameter O
and O
right O
- O
sided _RARE_
heart _RARE_
catheterization _RARE_
parameters O
. O

Nuclear O
hormone O
receptors O
( O
NRs _RARE_
) O
are O
ligand _RARE_
- O
inducible O
transcription O
factors O
that O
mediate O
critical O
functions O
in O
many O
species O
. O

These O
cells O
were O
able O
to O
present O
influenza _RARE_
virus O
particles _RARE_
to O
HLA I-GENE
- I-GENE
DR1 _RARE_
- O
restricted O
T O
cell O
clones _RARE_
. O

Sequencing O
of O
zebrafish _RARE_
( O
Danio _RARE_
rerio _RARE_
) O
bacterial O
artificial O
chromosome _RARE_
and O
P1 O
artificial O
chromosome _RARE_
genomic O
clone O
fragments O
and O
of O
cDNA O
clones _RARE_
has O
led O
to O
the O
identification O
of O
five O
new O
loci O
coding O
for _RARE_
beta O
subunits O
of O
proteasomes _RARE_
( O
PSMB _RARE_
). O

In O
addition O
to O
homologues _RARE_
of O
the O
human I-GENE
genes I-GENE
PSMB5 _RARE_
through O
PSMB9 _RARE_
, O
two O
new O
genes O
, O
PSMB11 _RARE_
and O
PSMB12 _RARE_
, O
have O
been O
found O
for _RARE_
which O
there O
are O
no _RARE_
known O
corresponding O
genes O
in O
humans O
. O

It O
applies _RARE_
Udry _RARE_
' O
s O
biosocial _RARE_
perspective _RARE_
, O
which O
attempts O
to O
reconcile _RARE_
the O
biological O
and O
sociological _RARE_
models O
of O
premarital _RARE_
sexual O
and O
reproductive O
behaviour O
. O

Weight _RARE_
and O
height O
z O
- O
scores O
were O
significantly O
associated O
with O
BMD O
z O
- O
scores O
. O

A O
limited O
sampling O
strategy O
was O
used O
based O
on O
a O
bayesian _RARE_
parameter O
estimation O
algorithm O
that O
is O
part O
of O
the O
ADAPT _RARE_
II O
software _RARE_
package _RARE_
. O

Interaction O
of O
HRI _RARE_
with O
Hsc70 _RARE_
was O
required O
for _RARE_
the O
transformation O
of O
HRI _RARE_
, O
as _RARE_
the O
Hsc70 _RARE_
antagonist O
clofibric _RARE_
acid O
inhibited O
the O
folding O
of O
HRI _RARE_
into O
a O
mature _RARE_
- O
competent O
conformation O
. O

The O
amino O
acid O
changes O
D206A _RARE_
and O
D208A _RARE_
abolish _RARE_
singly _RARE_
or O
in O
combination O
the O
exonuclease _RARE_
activity O
in O
vivo O
. O

Previous O
experimental O
evidence O
had O
indicated O
that O
Reg1 _RARE_
might O
target O
Glc7 _RARE_
to O
nuclear O
substrates _RARE_
such O
as _RARE_
the O
Snf1 _RARE_
kinase I-GENE
complex I-GENE
. O

In O
the O
budding _RARE_
yeast O
, O
Saccharomyces O
cerevisiae O
, O
replicators _RARE_
can O
function O
outside O
the O
chromosome _RARE_
as _RARE_
autonomously _RARE_
replicating _RARE_
sequence O
( O
ARS _RARE_
) O
elements O
; O
however O
, O
within O
chromosome _RARE_
III O
, O
certain O
ARSs _RARE_
near O
the O
transcriptionally O
silent _RARE_
HML _RARE_
locus I-GENE
show O
no _RARE_
replication O
origin O
activity O
. O

These O
results O
suggest O
that O
, O
for _RARE_
the O
HML _RARE_
ARS _RARE_
cluster O
( O
ARS303 _RARE_
, O
ARS320 _RARE_
, O
and O
ARS302 _RARE_
), _RARE_
inactivity _RARE_
of O
origins O
is O
independent O
of O
local O
transcriptional O
silencing O
, O
even O
though O
origins O
and O
silencers _RARE_
share O
key O
cis O
- O
and O
trans _RARE_
- O
acting O
components _RARE_
. O

In O
the O
present O
study O
, O
we O
demonstrate O
that O
expression _RARE_
of O
TD _RARE_
- I-GENE
IkappaBalpha I-GENE
blocked O
phorbol O
myristate O
acetate _RARE_
- I-GENE
phytohemagglutinin I-GENE
or O
tumor I-GENE
necrosis I-GENE
factor I-GENE
alpha I-GENE
- O
induced _RARE_
IkappaBalpha I-GENE
gene I-GENE
transcription O
and O
abolished O
NF _RARE_
- I-GENE
kappaB I-GENE
DNA O
binding O
activity O
, O
due O
to O
the O
continued O
cytoplasmic O
sequestration _RARE_
of O
RelA _RARE_
( O
p65 _RARE_
) O
by O
TD _RARE_
- I-GENE
IkappaBalpha I-GENE
. O

( O
i O
) O
Complete _RARE_
Grb10 _RARE_
expression _RARE_
from O
cDNA O
with O
an O
ecdysone O
- O
regulated O
transient O
expression _RARE_
system _RARE_
stimulated _RARE_
PDGF _RARE_
- I-GENE
BB _RARE_
-, _RARE_
IGF I-GENE
- I-GENE
I I-GENE
, O
and O
insulin I-GENE
- O
but O
not O
epidermal _RARE_
growth I-GENE
factor I-GENE
( O
EGF _RARE_
)- O
induced _RARE_
DNA O
synthesis _RARE_
in O
an O
ecdysone O
dose O
- O
responsive O
fashion O
. O

The O
analysis O
of O
two O
distinct O
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
pathways O
shows O
that O
stress I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
- O
Jun I-GENE
N I-GENE
- I-GENE
terminal I-GENE
kinase I-GENE
activation O
, O
resulting O
in O
the O
phosphorylation _RARE_
of O
ATF I-GENE
- I-GENE
2 I-GENE
, O
c I-GENE
- I-GENE
Jun I-GENE
, O
and O
JunD _RARE_
, O
is O
required O
not O
only O
for _RARE_
the O
IL _RARE_
- I-GENE
1 I-GENE
- O
but O
also O
for _RARE_
the O
TPA _RARE_
- O
dependent O
induction O
, O
while O
the O
extracellular I-GENE
signal I-GENE
- I-GENE
related I-GENE
kinase I-GENE
1 I-GENE
( O
ERK I-GENE
- I-GENE
1 I-GENE
) O
and O
ERK I-GENE
- I-GENE
2 I-GENE
activation O
is O
involved O
in O
the O
TPA _RARE_
- O
but O
not O
in O
the O
IL _RARE_
- I-GENE
1 I-GENE
- O
dependent O
stimulation _RARE_
of O
the O
uPA I-GENE
enhancer I-GENE
. O

CONCLUSIONS O
: O
In O
healthy O
individuals O
, O
whole O
body O
insulin I-GENE
sensitivity O
is O
related O
, O
or O
" O
coupled O
, O
" O
to O
the O
anaerobic O
threshold O
. O

Interdomain _RARE_
signaling _RARE_
in O
a O
two O
- O
domain O
fragment O
of O
the O
human I-GENE
glucocorticoid I-GENE
receptor I-GENE
. O

In O
contrast O
, O
the O
xtRNA _RARE_
( O
Sec _RARE_
) O
gene O
needs O
the O
binding O
of O
the O
seven _RARE_
Staf _RARE_
zinc I-GENE
fingers _RARE_
, O
but O
not O
Oct I-GENE
- I-GENE
1 I-GENE
, O
for _RARE_
optimal O
transcriptional O
capacity O
. O

Collectively O
, O
these O
results O
show O
that O
the O
differential O
utilization O
of O
Staf _RARE_
zinc I-GENE
finger I-GENE
1 I-GENE
represents O
a O
new O
, O
critical O
determinant O
of O
the O
transcriptional O
activation O
mechanism O
for _RARE_
the O
Xenopus I-GENE
tRNA I-GENE
( O
Sec _RARE_
) O
and O
human I-GENE
U6 I-GENE
snRNA _RARE_
genes I-GENE
. O

In O
B O
cells O
, O
HEF1 I-GENE
is O
phosphorylated _RARE_
by O
a O
cytoskeleton _RARE_
- O
dependent O
mechanism O
that O
is O
triggered O
by O
integrin I-GENE
ligation O
. O

The O
calcitonin I-GENE
- O
induced _RARE_
tyrosine O
phosphorylation _RARE_
of O
HEF1 I-GENE
increased O
in O
a O
time O
- O
and O
dose O
- O
dependent O
manner O
. O

Independent _RARE_
protrudor _RARE_
muscle O
stimulation _RARE_
increased O
VI _RARE_
, O
max _RARE_
( O
peak O
increase O
61 _RARE_
%, O
P O
< O
0 _RARE_
. O
05 O
), _RARE_
did O
not O
change O
Pcrit _RARE_
, O
and O
decreased O
Rn _RARE_
( O
peak O
decrease O
of O
41 _RARE_
%, O
P O
< O
0 _RARE_
. O
05 O
). O

We O
report O
the O
construction _RARE_
of O
an O
approximately _RARE_
1 O
. O
7 O
- O
Mb O
sequence O
- O
ready _RARE_
YAC O
/ O
BAC _RARE_
clone O
contig O
of O
8p22 _RARE_
- O
p23 _RARE_
. O

The O
human I-GENE
RAD30B _RARE_
and O
mouse I-GENE
Rad30b _RARE_
mRNA I-GENE
transcripts I-GENE
, O
like O
many O
repair O
proteins O
, O
are O
highly O
expressed _RARE_
in O
the O
testis _RARE_
. O

Analysis O
of O
the O
mouse I-GENE
STAP _RARE_
gene I-GENE
isolated O
from O
the O
genomic O
library O
revealed O
that O
the O
STAP _RARE_
gene I-GENE
spans O
a O
region O
of O
over O
11 O
kb O
and O
comprises O
eight O
exons O
. O

A O
reduced _RARE_
matrix _RARE_
distribution O
and O
enhanced _RARE_
cell O
density O
were O
observed O
as _RARE_
the O
biofilm _RARE_
aged O
. O

After O
10 O
months O
of O
treatment O
with O
the O
conjugated O
estrogen O
, O
both O
his _RARE_
height O
and O
weight _RARE_
showed O
improvement O
, O
while O
his _RARE_
bone O
mineral O
density O
and O
bone O
age O
were O
increased O
. O

Viscosity _RARE_
experiments O
on O
the O
catalytic O
fragment O
kinase O
reaction O
demonstrated O
that O
the O
chemical O
( O
phosphoryl _RARE_
transfer O
) O
step O
had O
a O
reduced _RARE_
rate O
. O

Velocity _RARE_
sedimentation O
, O
cross O
- O
linking O
, O
and O
immunoprecipitation O
analyses O
of O
detergent O
- O
solubilized _RARE_
rat O
brain O
revealed O
that O
the O
32 _RARE_
and O
34 _RARE_
kDa O
polypeptides O
reside O
within O
heterotetramers _RARE_
. O

In O
vitro O
expression _RARE_
levels O
of O
the O
different O
plasmids O
differed O
by O
as _RARE_
much O
as _RARE_
tenfold _RARE_
. O

In O
EEG O
only O
single O
slow O
waves O
above O
left _RARE_
temporal O
region O
were O
revealed O
. O

Molecular O
characterization O
of O
type O
- O
specific O
capsular _RARE_
polysaccharide _RARE_
biosynthesis O
genes O
of O
Streptococcus _RARE_
agalactiae _RARE_
type O
Ia _RARE_
. O

( O
1998 O
) O
FASEB _RARE_
J _RARE_
. O

IL _RARE_
- I-GENE
1beta I-GENE
( O
10 O
ng _RARE_
/ O
ml O
) O
drastically _RARE_
increased O
both O
PDGFalphaR _RARE_
and O
CCAAT I-GENE
/ I-GENE
enhancer I-GENE
- I-GENE
binding I-GENE
protein I-GENE
delta I-GENE
( O
C I-GENE
/ I-GENE
EBPdelta _RARE_
) O
mRNA O
levels O
in O
a O
time O
dependent O
manner O
. O

The O
recruitment O
of O
constitutively O
phosphorylated _RARE_
p185 _RARE_
( O
neu I-GENE
) O
and O
the O
activated O
mitogenic O
pathway _RARE_
proteins O
to O
this O
membrane O
- O
microfilament _RARE_
interaction O
site O
provides O
a O
physical O
model O
for _RARE_
integrating _RARE_
the O
assembly O
of O
the O
mitogenic O
pathway _RARE_
with O
the O
transmission _RARE_
of O
growth O
factor O
signal O
to O
the O
cytoskeleton _RARE_
. O

Transient O
tyrosine O
phosphorylation _RARE_
of O
Crk I-GENE
in O
fibroblast I-GENE
growth I-GENE
factor I-GENE
- I-GENE
2 I-GENE
- O
stimulated _RARE_
endothelial O
cells O
was O
dependent O
on O
the O
juxtamembrane _RARE_
tyrosine O
residue _RARE_
463 _RARE_
in O
FGFR I-GENE
- I-GENE
1 I-GENE
, O
and O
a O
Crk I-GENE
SH2 _RARE_
domain I-GENE
precipitated O
FGFR I-GENE
- I-GENE
1 I-GENE
via O
phosphorylated _RARE_
Tyr _RARE_
- O
463 _RARE_
, O
indicating O
direct O
complex O
formation O
between O
Crk I-GENE
and O
FGFR I-GENE
- I-GENE
1 I-GENE
. O

ECG O
- O
gated O
myocardial _RARE_
Technetium _RARE_
- O
99m O
sestamibi _RARE_
SPECT O
is O
a O
useful O
technique O
to O
measure O
myocardial _RARE_
perfusion O
and O
function O
simultaneously O
. O

Role O
of O
the O
3 O
' O
untranslated _RARE_
region O
of O
baculovirus _RARE_
p10 _RARE_
mRNA I-GENE
in O
high O
- O
level O
expression _RARE_
of O
foreign O
genes O
. O

The O
intron O
RNA O
consists O
of O
2492 _RARE_
nucleotides O
which O
can O
be O
folded O
into O
a O
secondary O
structure _RARE_
with O
all O
the O
expected O
sequence O
motifs O
of O
subgroup O
- O
IIA1 _RARE_
introns _RARE_
( O
Michel _RARE_
et O
al O
. O

The O
intron O
is O
capable O
of O
splicing _RARE_
despite O
the O
fact O
that O
both O
the O
EBS1 _RARE_
/ O
IBS1 _RARE_
and O
the O
EBS2 _RARE_
/ O
IBS2 _RARE_
sequence O
motifs O
, O
thought O
to O
be O
necessary O
for _RARE_
correct O
splicing _RARE_
, O
extend O
over O
5 O
instead O
of O
6 O
bp O
. O

The O
Trk _RARE_
/ I-GENE
Nerve _RARE_
Growth _RARE_
Factor _RARE_
receptor I-GENE
mediates O
the O
rapid O
activation O
of O
a O
number O
of O
intracellular _RARE_
signaling _RARE_
proteins O
, O
including O
phosphatidylinositol _RARE_
3 I-GENE
- I-GENE
kinase I-GENE
( O
PI I-GENE
3 I-GENE
- I-GENE
kinase I-GENE
). O

The O
controversy _RARE_
of O
significance O
testing O
: O
misconceptions _RARE_
and O
alternatives _RARE_
. O

Chemical O
uptake O
into O
human O
stratum _RARE_
corneum _RARE_
in O
vivo O
from O
volatile O
and O
non O
- O
volatile O
solvents _RARE_
. O

Like O
DNA O
binding O
, O
transcriptional O
enhancement O
required O
amino O
- O
terminally _RARE_
located _RARE_
basic O
amino O
acid O
residues O
but O
not O
the O
carboxyl _RARE_
- O
terminal O
portion O
of O
Hap46 _RARE_
known O
to O
participate O
in O
hsp70 I-GENE
interaction O
. O

We O
have O
tested O
the O
function O
of O
two O
potential _RARE_
NF _RARE_
- I-GENE
kappaB I-GENE
- I-GENE
like I-GENE
sites I-GENE
present O
in O
the O
PAI I-GENE
- I-GENE
2 I-GENE
proximal I-GENE
promoter I-GENE
for _RARE_
responsiveness O
to O
TNFalpha _RARE_
using O
chloramphenicol I-GENE
acetyl I-GENE
transferase I-GENE
reporter I-GENE
gene I-GENE
deletion O
and O
mutation O
analyses O
. O

N O
- O
terminal O
sequence O
analysis O
and O
NMR O
measurements O
revealed O
that O
this O
fragment O
originates _RARE_
from O
the O
C O
- O
terminal O
80 _RARE_
residues O
of O
MBF1 _RARE_
and O
form O
a O
well _RARE_
structured O
C O
- O
terminal O
domain O
of O
MBF1 _RARE_
, O
MBF1CTD _RARE_
. O

The O
nucleosomal _RARE_
response O
associated O
with O
immediate I-GENE
- I-GENE
early I-GENE
gene I-GENE
induction O
is O
mediated _RARE_
via O
alternative _RARE_
MAP I-GENE
kinase I-GENE
cascades _RARE_
: O
MSK1 _RARE_
as _RARE_
a O
potential _RARE_
histone I-GENE
H3 _RARE_
/ O
HMG I-GENE
- I-GENE
14 I-GENE
kinase O
. O

The O
arrangement O
of O
these O
cutoff O
- O
levels O
leads O
to O
a O
sensitivity O
of O
85 _RARE_
% O
at _RARE_
a O
specificity _RARE_
of O
55 _RARE_
% O
for _RARE_
Protein I-GENE
S100 _RARE_
when O
measured O
by O
RIA _RARE_
, O
and O
to O
a O
sensitivity O
of O
77 O
% O
at _RARE_
a O
specificity _RARE_
of O
61 _RARE_
% O
when O
measured O
by O
LIA _RARE_
. O

272 O
, O
1904 _RARE_
]. O

Using O
16 O
strains O
of O
C O
. O
trachomatis _RARE_
in O
triplicate _RARE_
assays O
, O
we O
found O
the O
RT O
- O
PCR O
method O
consistently O
more O
sensitive _RARE_
than O
the O
conventional O
technique O
for _RARE_
all O
eight O
antimicrobials _RARE_
tested O
, O
with O
resultant _RARE_
MICs O
determined O
by O
RT O
- O
PCR O
ranging O
from O
1 O
. O
6 O
- O
fold _RARE_
higher _RARE_
( O
erythromycin _RARE_
) O
to O
>/= O
195 _RARE_
- O
fold _RARE_
higher _RARE_
( O
amoxicillin O
). O

Null _RARE_
alleles O
of O
SAS4 _RARE_
and O
SAS5 _RARE_
bypassed _RARE_
the O
role O
of O
the O
Abf1p _RARE_
binding I-GENE
site I-GENE
of O
the O
HMR I-GENE
- I-GENE
E I-GENE
silencer _RARE_
but O
not O
the O
role O
of O
the O
ACS _RARE_
or O
Rap1p _RARE_
binding I-GENE
site I-GENE
. O

Recent O
molecular _RARE_
analysis O
has O
revealed O
that O
the O
S I-GENE
locus I-GENE
is O
highly O
polymorphic O
and O
contains O
several O
genes O
, O
i O
. O
e _RARE_
., O
SLG _RARE_
, O
SRK _RARE_
, O
the O
as _RARE_
- O
yet O
- O
unidentified O
pollen O
S O
gene O
( O
s O
), _RARE_
and O
other O
linked _RARE_
genes O
. O

A O
cDNA O
encoding O
a O
putative O
RNA I-GENE
and I-GENE
/ I-GENE
or I-GENE
DNA I-GENE
helicase _RARE_
has O
been O
isolated O
from O
Arabidopsis O
thaliana O
cDNA O
libraries O
. O

In O
vivo O
, O
MyoD I-GENE
requires O
this O
tryptophan _RARE_
motif O
to O
evoke _RARE_
chromatin O
remodeling O
in O
the O
Myogenin _RARE_
promoter I-GENE
and O
to O
activate O
Myogenin _RARE_
transcription O
. O

RESULTS O
: O
256 O
Periods _RARE_
of O
TTP _RARE_
or O
PUNP _RARE_
were O
reported O
by O
men O
and O
174 _RARE_
by O
women O
. O

Feed _RARE_
intake O
and O
BW _RARE_
gains _RARE_
were O
decreased O
( O
P O
< O
0 _RARE_
. O
05 O
) O
by O
dietary O
treatments O
containing O
M O
. O

The O
N O
terminus O
of O
beta O
( O
95 _RARE_
kDa O
) O
corresponds O
to O
alpha O
with O
the O
integrase I-GENE
domain I-GENE
attached O
to O
the O
C O
terminus O
( O
32 _RARE_
kDa O
). O

Skn _RARE_
- I-GENE
1a _RARE_
lacking _RARE_
the O
C O
- O
terminal O
region O
completely O
lost O
transactivation _RARE_
ability O
, O
irrespective O
of O
the O
promoter O
tested O
, O
and O
was O
able O
to O
block _RARE_
transactivation _RARE_
by O
normal O
Skn _RARE_
- I-GENE
1a _RARE_
in O
competition O
assays O
. O

In O
early O
Xenopus O
embryos _RARE_
, O
the O
transforming I-GENE
growth I-GENE
factor I-GENE
- I-GENE
beta I-GENE
member _RARE_
activin I-GENE
induces O
the O
gene I-GENE
Mix _RARE_
. I-GENE
2 I-GENE
by O
stimulating O
the O
formation O
of O
a O
multiprotein _RARE_
complex O
, O
activin I-GENE
- I-GENE
responsive I-GENE
factor I-GENE
( O
ARF I-GENE
). O

To O
further O
characterize O
the O
structure _RARE_
and O
evolutionary O
synthesis _RARE_
of O
the O
CMT1A _RARE_
- O
REP _RARE_
repeat O
, O
fluorescent _RARE_
in O
situ O
hybridization O
( O
FISH _RARE_
) O
analysis O
and O
heterologous O
PCR O
- O
based O
assays O
were O
carried O
out O
for _RARE_
a O
series O
of O
primates O
. O

Natl _RARE_
. O

In O
the O
face O
of O
the O
outbreak O
, O
there O
was O
a O
delay O
before O
vaccination O
was O
able O
to O
stop O
deaths O
. O

Here O
we O
show O
that O
a O
novel O
isoform O
of O
Rapl _RARE_
GTPase I-GENE
- I-GENE
activating I-GENE
protein I-GENE
, O
called O
rap1GAPII _RARE_
, O
binds O
specifically O
to O
the O
alpha O
- O
subunits O
of O
the O
G I-GENE
( I-GENE
i I-GENE
) I-GENE
family I-GENE
of O
heterotrimeric I-GENE
G I-GENE
- I-GENE
proteins I-GENE
. O

The O
B O
- O
oligomer _RARE_
of O
pertussis _RARE_
toxin _RARE_
deactivates _RARE_
CC _RARE_
chemokine _RARE_
receptor I-GENE
5 I-GENE
and O
blocks O
entry O
of O
M O
- O
tropic _RARE_
HIV O
- O
1 O
strains O
. O

Cross O
- O
linking O
the O
B I-GENE
cell I-GENE
Ag _RARE_
receptor I-GENE
( O
BCR _RARE_
) O
to O
surface I-GENE
Fc I-GENE
receptors I-GENE
for _RARE_
IgG I-GENE
( O
Fc I-GENE
gamma I-GENE
R I-GENE
) O
inhibits O
G1 O
- O
to O
- O
S O
progression O
; O
the O
mechanism O
by O
which O
this O
occurs O
is O
not O
completely O
known O
. O

Cross O
- O
linking O
the O
B I-GENE
cell I-GENE
Ag _RARE_
receptor I-GENE
( O
BCR _RARE_
) O
to O
surface I-GENE
Fc I-GENE
receptors I-GENE
for _RARE_
IgG I-GENE
( O
Fc I-GENE
gamma I-GENE
R I-GENE
) O
inhibits O
G1 O
- O
to O
- O
S O
progression O
; O
the O
mechanism O
by O
which O
this O
occurs O
is O
not O
completely O
known O
. O

TRAF2 I-GENE
is O
a O
potent O
activator O
of O
a O
95 _RARE_
- I-GENE
kDa I-GENE
serine I-GENE
/ I-GENE
threonine I-GENE
kinase I-GENE
termed O
germinal _RARE_
center _RARE_
kinase I-GENE
related I-GENE
( O
GCKR _RARE_
, O
also O
referred O
to O
as _RARE_
KHS1 _RARE_
), _RARE_
which O
signals O
activation O
of O
the O
SAPK I-GENE
pathway _RARE_
. O

An O
activation O
- O
responsive O
element O
in O
single I-GENE
C I-GENE
motif I-GENE
- I-GENE
1 I-GENE
/ O
lymphotactin _RARE_
promoter O
is O
a O
site O
of O
constitutive _RARE_
and O
inducible O
DNA O
- O
protein O
interactions O
involving O
nuclear O
factor O
of O
activated O
T O
cell O
. O

Cytokine _RARE_
- O
induced _RARE_
NF _RARE_
- I-GENE
kappa _RARE_
B I-GENE
DNA O
binding O
activity O
, O
RelA _RARE_
nuclear O
translocation O
, O
I I-GENE
kappa _RARE_
B I-GENE
alpha I-GENE
degradation _RARE_
, O
I I-GENE
kappa _RARE_
B I-GENE
serine O
32 _RARE_
phosphorylation _RARE_
, O
and O
I I-GENE
kappa _RARE_
B I-GENE
kinase I-GENE
( O
IKK _RARE_
) O
activity O
were O
blocked O
by O
curcumin _RARE_
treatment O
. O

A O
portion O
of O
p193 _RARE_
is O
nuclear O
and O
localizes O
to O
the O
mitotic _RARE_
spindle _RARE_
. O

The O
main O
issues O
are O
the O
need O
to O
explain O
a O
number O
of O
still O
unknown O
mechanisms O
, O
to O
determine O
which O
" O
natural _RARE_
diet O
" O
carries O
the O
minimum O
coronary O
risk O
and O
whether O
" O
new O
" O
foods _RARE_
produced O
by O
modern O
technology O
are O
really _RARE_
needed O
to O
contrast O
this O
epidemic O
. O

Cotransfection O
of O
the O
coactivator _RARE_
CREB I-GENE
- I-GENE
binding I-GENE
protein I-GENE
relieved _RARE_
the O
transcriptional O
repression O
of O
PPARalphawt _RARE_
by O
PPARalphatr _RARE_
, O
suggesting O
that O
the O
dominant O
negative O
effect O
of O
PPARalphatr _RARE_
might O
occur O
through O
competition O
for _RARE_
essential O
coactivators _RARE_
. O

SF _RARE_
- I-GENE
1 I-GENE
does O
not O
have O
an O
N O
- O
terminal O
AF1 _RARE_
domain O
. O

To O
estimate O
the O
locations O
of O
sources O
with O
the O
TF _RARE_
- O
MUSIC _RARE_
algorithm O
, O
we O
first _RARE_
set O
the O
target O
region O
on O
the O
spectrogram _RARE_
of O
the O
somatosensory _RARE_
responses O
. O

We O
discuss O
these O
results O
in O
terms O
of O
the O
influence O
that O
time O
and O
nutritional O
constraints _RARE_
have O
on O
odonate _RARE_
development O
patterns O
and O
fitness O
. O

OBJECTIVE O
: O
1998 O
Surveillance _RARE_
, O
Epidemiology _RARE_
, O
and O
End _RARE_
Results O
( O
SEER _RARE_
) O
data O
estimate O
an O
83 _RARE_
. O
1 O
% O
5 O
- O
year O
survival O
rate O
for _RARE_
corpus _RARE_
uteri _RARE_
adenocarcinoma O
FIGO _RARE_
stage _RARE_
II O
. O

A O
novel O
Drosophila I-GENE
A I-GENE
kinase I-GENE
anchor _RARE_
protein I-GENE
, O
Drosophila I-GENE
A I-GENE
kinase I-GENE
anchor _RARE_
protein I-GENE
200 _RARE_
( O
DAKAP200 _RARE_
), _RARE_
is O
predicted O
to O
be O
involved O
in O
routing _RARE_
, O
mediating O
, O
and O
integrating _RARE_
signals O
carried O
by O
cAMP O
, O
Ca O
( O
2 O
+), O
and O
diacylglycerol _RARE_
( O
Li O
, O
Z O
., O
Rossi _RARE_
, O
E O
. O

In O
vitro O
transcription O
results O
indicate O
that O
this O
5 O
' O
structure _RARE_
functions O
in O
the O
attenuation _RARE_
mechanism O
, O
since O
deletion O
of O
the O
stem _RARE_
- O
loop O
caused O
an O
increase O
in O
transcription O
readthrough O
. O

A O
5 O
' O
RNA O
stem _RARE_
- O
loop O
participates O
in O
the O
transcription O
attenuation _RARE_
mechanism O
that O
controls O
expression _RARE_
of O
the O
Bacillus I-GENE
subtilis I-GENE
trpEDCFBA _RARE_
operon I-GENE
. O

Single _RARE_
- O
alanine O
- O
substitution O
mutations O
had O
minimal O
, O
if O
any O
, O
effects O
on O
S O
- O
induced _RARE_
cell O
- O
to O
- O
cell O
fusion O
. O

Furthermore O
, O
we O
demonstrate O
that O
transcription O
from O
the O
MMTV _RARE_
5 I-GENE
' I-GENE
LTR I-GENE
is O
highly O
active _RARE_
in O
the O
absence O
of O
Stat5a I-GENE
, O
a O
transcription O
factor O
that O
had O
been O
shown O
previously O
to O
be O
required O
for _RARE_
transcription O
from O
the O
MMTV _RARE_
LTR I-GENE
. O

Regional _RARE_
insertional _RARE_
mutagenesis O
of O
specific O
genes O
on O
the O
CIC5F11 _RARE_
/ O
CIC2B9 _RARE_
locus O
of O
Arabidopsis O
thaliana O
chromosome _RARE_
5 O
using O
the O
Ac _RARE_
/ O
Ds _RARE_
transposon _RARE_
in O
combination O
with O
the O
cDNA O
scanning O
method O
. O

RESULTS O
: O
CK _RARE_
- O
MB I-GENE
elevation O
was O
detected O
in O
313 _RARE_
patients O
( O
18 O
. O
7 O
%), O
with O
1 O
- O
3x _RARE_
in O
12 O
. O
8 O
%, O
3 O
- O
5x _RARE_
in O
3 O
. O
5 O
% O
and O
> O
5x _RARE_
normal O
in O
2 O
. O
4 O
% O
of O
patients O
. O

Thus O
, O
NART _RARE_
- O
R O
performance O
may O
not O
be O
a O
valid _RARE_
estimate O
of O
baseline O
IQ _RARE_
for _RARE_
patients O
with O
neurologic O
disorders O
with O
suspected O
language O
impairment O
. O

Activated _RARE_
areas O
have O
been O
identified O
by O
means O
of O
cross O
- O
correlation O
analysis O
. O

Natural _RARE_
Haemophilus O
influenzae O
type O
b O
capsular _RARE_
polysaccharide _RARE_
antibodies O
in O
412 _RARE_
infants O
and O
children O
from O
West _RARE_
Africa _RARE_
( O
Burkina _RARE_
- O
Faso _RARE_
) O
and O
France _RARE_
: O
a O
cross O
- O
sectional O
serosurvey _RARE_
. O

In O
this O
study O
, O
we O
identified O
Sp1 _RARE_
and O
Sp3 I-GENE
as _RARE_
major O
factors O
binding O
to O
the O
Sp1 _RARE_
sites I-GENE
of O
the O
p21 I-GENE
/ O
WAF1 I-GENE
/ O
Cip1 I-GENE
promoter O
in O
MG63 _RARE_
cells O
through O
electrophoretic O
mobility O
shift O
assays O
and O
showed O
that O
TSA _RARE_
treatment O
did O
not O
change O
their O
binding O
activities O
. O

Galoyan _RARE_
has O
summarized _RARE_
the O
results O
of O
his _RARE_
discovery O
of O
cardioactive _RARE_
neurohormones _RARE_
. O

To O
study O
the O
regulation _RARE_
of O
its O
expression _RARE_
, O
the O
human I-GENE
aldehyde _RARE_
reductase I-GENE
gene I-GENE
and O
promoter O
were O
cloned _RARE_
and O
characterized O
. O

Immunohistochemical _RARE_
staining O
with O
MIB _RARE_
- I-GENE
1 I-GENE
and O
p53 I-GENE
antibodies I-GENE
showed O
low O
(< O
1 O
%) O
and O
negative O
reaction O
. O

The O
C2C _RARE_
- O
Prx _RARE_
is O
encoded O
as _RARE_
a O
preprotein _RARE_
of O
273 _RARE_
amino O
acids _RARE_
containing O
a O
putative O
chloroplast O
- O
targeting O
signal O
of O
65 O
amino O
acids _RARE_
at _RARE_
its O
N O
- O
terminus O
. O

Immediately _RARE_
before O
surgery O
patients O
received O
either O
intravenous O
hydrocortisone _RARE_
100 _RARE_
mg O
or O
placebo O
in O
random O
, O
double O
- O
blind O
order O
. O

A O
tyrosine O
- O
based O
sorting _RARE_
signal O
in O
the O
beta2 _RARE_
integrin I-GENE
cytoplasmic I-GENE
domain I-GENE
mediates O
its O
recycling _RARE_
to O
the O
plasma O
membrane O
and O
is O
required O
for _RARE_
ligand _RARE_
- O
supported O
migration O
. O

The O
injection O
of O
XDRP1 _RARE_
protein I-GENE
into O
fertilized _RARE_
Xenopus O
eggs O
blocked O
embryonic _RARE_
cell O
division O
. O

Using O
transgenic O
Xenopus O
embryos _RARE_
, O
we O
demonstrate O
that O
the O
integrity O
of O
these O
two O
sequences O
is O
necessary O
for _RARE_
correct O
spatial O
expression _RARE_
of O
a O
Xbra2 _RARE_
promoter I-GENE
- I-GENE
driven _RARE_
reporter I-GENE
gene I-GENE
. O

In O
order O
to O
screen O
for _RARE_
such O
cofactors _RARE_
, O
we O
have O
used O
a O
transcriptionally O
inactive O
mutant O
of O
Xenopus I-GENE
MEF2D _RARE_
in O
a O
yeast O
two O
- O
hybrid _RARE_
screen O
. O

NuA4 _RARE_
has O
an O
apparent O
molecular _RARE_
mass O
of O
1 O
. O
3 O
MDa _RARE_
. O

ATF1 _RARE_
transcription O
is O
negatively O
regulated O
by O
unsaturated _RARE_
fatty O
acids _RARE_
and O
oxygen O
. O

Two O
patients O
with O
recurrent O
tumors O
had O
high O
S O
- O
phase _RARE_
fractions O
both O
on O
the O
first _RARE_
resected _RARE_
specimens O
and O
at _RARE_
the O
time O
of O
the O
second O
operation O
. O

Mutation O
of O
TTF I-GENE
- I-GENE
1 I-GENE
- I-GENE
binding I-GENE
sites I-GENE
( I-GENE
TBE _RARE_
) I-GENE
1 I-GENE
, I-GENE
3 I-GENE
, I-GENE
and I-GENE
4 I-GENE
in O
combination O
markedly O
decreased O
transcriptional O
activity O
of O
SP I-GENE
- I-GENE
A I-GENE
promoter O
- O
chloramphenicol I-GENE
acetyltransferase _RARE_
constructs O
containing O
SP I-GENE
- I-GENE
A I-GENE
gene I-GENE
sequences O
from O
- O
256 O
to O
+ O
45 _RARE_
. O

Insulin I-GENE
- I-GENE
like I-GENE
growth I-GENE
factor I-GENE
- I-GENE
I I-GENE
induces O
bcl I-GENE
- I-GENE
2 I-GENE
promoter I-GENE
through O
the O
transcription O
factor O
cAMP I-GENE
- I-GENE
response I-GENE
element I-GENE
- I-GENE
binding I-GENE
protein I-GENE
. O

Synthesis _RARE_
of O
antisense _RARE_
RNA O
and O
S O
phase _RARE_
- O
dependent O
binding O
of O
E2F I-GENE
complexes I-GENE
in O
intron O
1 O
. O

Identification O
of O
eotaxin _RARE_
- I-GENE
3 I-GENE
will O
further O
promote O
our O
understanding O
of O
the O
control O
of O
eosinophil O
trafficking O
and O
other O
CCR3 _RARE_
- O
mediated _RARE_
biological O
phenomena O
. O

NF _RARE_
- I-GENE
kappaB I-GENE
plays O
a O
critical O
role O
in O
activation O
of O
HIV O
- O
1 O
gene O
expression _RARE_
by O
cytokines _RARE_
and O
other O
stimuli O
, O
but O
the O
signal O
transduction _RARE_
pathways O
that O
regulate O
the O
switch O
from O
latent O
to O
productive _RARE_
infection O
have O
not O
been O
defined O
. O

These O
studies O
suggest O
that O
MAPK _RARE_
acts O
by O
stimulating O
AP I-GENE
- I-GENE
1 I-GENE
and O
a O
subsequent O
physical O
and O
functional _RARE_
interaction O
of O
AP I-GENE
- I-GENE
1 I-GENE
with O
NF _RARE_
- I-GENE
kappaB I-GENE
, O
resulting O
in O
a O
complex O
that O
synergistically O
transactivates O
the O
HIV I-GENE
- I-GENE
1 I-GENE
LTR I-GENE
. O

ERK I-GENE
MAP I-GENE
kinase I-GENE
links O
cytokine _RARE_
signals O
to O
activation O
of O
latent O
HIV O
- O
1 O
infection O
by O
stimulating O
a O
cooperative O
interaction O
of O
AP I-GENE
- I-GENE
1 I-GENE
and O
NF _RARE_
- I-GENE
kappaB I-GENE
. O

A O
human O
nuclear O
- O
localized O
chaperone _RARE_
that O
regulates O
dimerization _RARE_
, O
DNA O
binding O
, O
and O
transcriptional O
activity O
of O
bZIP _RARE_
proteins I-GENE
. O

Clinical O
differentiation O
of O
patients O
with O
mild O
diplegic _RARE_
cerebral O
palsy _RARE_
( O
CP O
) O
and O
idiopathic O
toe O
walking _RARE_
( O
ITW _RARE_
) O
can O
be O
difficult O
. O

Sputum _RARE_
IL _RARE_
- I-GENE
8 I-GENE
and O
MPO _RARE_
were O
significantly O
increased O
after O
BPT _RARE_
in O
both O
TDI _RARE_
- O
and O
grain _RARE_
dust O
- O
asthma O
( O
P O
< O
0 _RARE_
. O
05 O
). O

Montelukast _RARE_
reduces O
airway O
eosinophilic _RARE_
inflammation O
in O
asthma O
: O
a O
randomized O
, O
controlled _RARE_
trial O
. O

Treatment O
of O
unstable O
angina O
: O
role O
of O
antithrombotic _RARE_
therapy O
. O

Here O
, O
we O
demonstrate O
that O
kinase O
- O
dead _RARE_
but O
not O
wild O
- O
type O
forms O
of O
Fyn I-GENE
, O
Lck _RARE_
, O
and O
ZAP _RARE_
- I-GENE
70 I-GENE
block _RARE_
70Z _RARE_
Cbl I-GENE
- O
mediated _RARE_
NFAT I-GENE
activation O
. O

Substitutions _RARE_
of O
region O
I O
with O
synthetic _RARE_
sequences O
showed O
that O
no _RARE_
specific O
sequence O
but O
rather O
repeats O
of O
three O
or O
more O
consecutive O
adenines _RARE_
or O
thymines _RARE_
, O
without O
interruption _RARE_
by O
guanine O
or O
cytosine O
, O
are O
required O
for _RARE_
the O
ARS _RARE_
activity O
. O

In O
Saccharomyces O
cerevisiae O
, O
PHO85 _RARE_
encodes O
a O
cyclin _RARE_
- I-GENE
dependent I-GENE
protein I-GENE
kinase I-GENE
( O
Cdk I-GENE
) O
catalytic O
subunit O
with O
multiple O
regulatory O
roles O
thought O
to O
be O
specified O
by O
association O
with O
different O
cyclin _RARE_
partners O
( O
Pcls _RARE_
). O

Mutants _RARE_
with O
mild O
lace _RARE_
alleles I-GENE
grow O
to O
become O
adults O
with O
multiple O
aberrant O
morphologies _RARE_
in O
the O
appendages _RARE_
, O
compound O
eye O
, O
and O
bristles _RARE_
. O

In O
fact O
, O
SPT _RARE_
activity O
in O
the O
fly _RARE_
expressing O
epitope _RARE_
- O
tagged _RARE_
Lace _RARE_
was O
absorbed O
by O
epitope _RARE_
- O
specific O
antibody O
. O

Mutations O
of O
the O
RET I-GENE
gene I-GENE
, O
encoding O
a O
receptor I-GENE
tyrosine I-GENE
kinase I-GENE
, O
have O
been O
associated O
with O
the O
inherited O
cancer _RARE_
syndromes O
MEN _RARE_
2A _RARE_
and O
MEN _RARE_
2B _RARE_
. O

These O
results O
show O
that O
targeting O
of O
Ras I-GENE
- O
GAP _RARE_
could O
represent O
a O
novel O
anticancer _RARE_
approach O
. O

EB _RARE_
- I-GENE
1 I-GENE
, O
a O
tyrosine I-GENE
kinase I-GENE
signal I-GENE
transduction _RARE_
gene I-GENE
, O
is O
transcriptionally O
activated O
in O
the O
t O
( O
1 O
; O
19 O
) O
subset O
of O
pre O
- O
B O
ALL O
, O
which O
express O
oncoprotein _RARE_
E2a _RARE_
- O
Pbx1 _RARE_
. O

Protein I-GENE
kinase I-GENE
A I-GENE
- I-GENE
Ialpha _RARE_
subunit O
- O
directed O
antisense _RARE_
inhibition O
of O
ovarian O
cancer _RARE_
cell O
growth O
: O
crosstalk _RARE_
with O
tyrosine I-GENE
kinase I-GENE
signaling _RARE_
pathway _RARE_
. O

BCL6 _RARE_
encodes O
a O
POZ _RARE_
/ I-GENE
Zn _RARE_
finger I-GENE
protein I-GENE
, O
a O
structure _RARE_
similar O
to O
that O
of O
many O
Drosophila O
developmental O
regulators _RARE_
and O
to O
another O
protein O
involved O
in O
a O
human O
hematopoietic O
malignancy O
, O
PLZF I-GENE
. O

Beta _RARE_
1 I-GENE
integrin I-GENE
- O
and O
proteoglycan _RARE_
- O
mediated _RARE_
stimulation _RARE_
of O
T O
lymphoma O
cell O
adhesion O
and O
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
signaling _RARE_
by O
thrombospondin _RARE_
- I-GENE
1 I-GENE
and O
thrombospondin _RARE_
- I-GENE
1 I-GENE
peptides I-GENE
. O

Optical _RARE_
CD O
, O
and O
spectral O
and O
activity O
analyses O
were O
used O
to O
examine O
reactivity O
of O
HO _RARE_
isozymes _RARE_
with O
NO _RARE_
species O
produced O
by O
NO _RARE_
donors O
. O

The O
phosphotransferase _RARE_
system _RARE_
( O
PTS _RARE_
) O
of O
Streptomyces _RARE_
coelicolor _RARE_
identification O
and O
biochemical O
analysis O
of O
a O
histidine _RARE_
phosphocarrier _RARE_
protein I-GENE
HPr _RARE_
encoded O
by O
the O
gene O
ptsH _RARE_
. O

Serum O
concentrations O
of O
bone I-GENE
specific I-GENE
alkaline _RARE_
phosphatase I-GENE
( O
BALP _RARE_
) O
and O
osteocalcin _RARE_
( O
bone I-GENE
Gla _RARE_
protein I-GENE
, O
BGP _RARE_
), _RARE_
urinary _RARE_
levels O
of O
pyridinoline _RARE_
( O
Pyr _RARE_
) O
and O
deoxypyridinoline _RARE_
( O
Dpyr _RARE_
) O
and O
computed O
tomography O
( O
CT _RARE_
) O
measurements O
of O
the O
cross O
- O
sectional O
areas O
of O
the O
vertebrae _RARE_
and O
the O
femurs _RARE_
, O
the O
apparent O
density O
of O
cancellous _RARE_
bone O
in O
the O
vertebrae _RARE_
, O
and O
the O
volume O
and O
the O
material O
density O
of O
cortical O
bone O
in O
the O
femurs _RARE_
were O
determined O
in O
126 O
boys O
and O
143 _RARE_
girls O
, O
ages O
7 O
- O
18 O
years O
. O

In O
another O
study O
, O
intravenous O
administration O
of O
devazepide _RARE_
, O
a O
specific O
cholecystokinin _RARE_
- I-GENE
A I-GENE
receptor I-GENE
antagonist O
, O
at _RARE_
a O
dose O
of O
0 _RARE_
. O
1 O
mg O
/ O
kg O
/ O
hr O
was O
begun _RARE_
15 _RARE_
min O
before O
postprandial _RARE_
saline O
intake O
and O
continued O
for _RARE_
1 O
hr O
. O

This O
cluster O
consisted O
of O
four O
apparently O
unrelated O
ESTs _RARE_
and O
two O
genes O
, O
pregnancy _RARE_
- I-GENE
associated I-GENE
plasma I-GENE
protein I-GENE
- I-GENE
A I-GENE
( O
PAPP _RARE_
- I-GENE
A I-GENE
) O
and O
a O
novel O
gene O
( O
tentatively O
named O
EST _RARE_
- I-GENE
YD1 _RARE_
). O

Prognostic _RARE_
value O
of O
a O
treadmill _RARE_
exercise O
score O
in O
symptomatic O
patients O
with O
nonspecific O
ST O
- O
T O
abnormalities O
on O
resting O
ECG O
. O

Structural O
changes O
in O
the O
C O
- O
terminus O
of O
Ca2 _RARE_
+- _RARE_
bound _RARE_
rat I-GENE
S100B _RARE_
( O
beta I-GENE
beta I-GENE
) O
upon O
binding O
to O
a O
peptide O
derived O
from O
the O
C O
- O
terminal O
regulatory O
domain O
of O
p53 I-GENE
. O

We O
propose O
that O
Gly84 _RARE_
is O
part O
of O
a O
putative O
" O
oxyanion _RARE_
hole _RARE_
" O
involved O
in O
the O
stabilization O
of O
the O
transition O
state O
similar O
to O
the O
C I-GENE
group I-GENE
of O
the O
esterase I-GENE
/ O
lipase I-GENE
family O
. O

The O
solution O
structure _RARE_
of O
the O
adduct _RARE_
derived O
from O
the O
covalent _RARE_
bonding _RARE_
of O
the O
fjord _RARE_
region O
(+)-( _RARE_
11S _RARE_
, O
12R _RARE_
, O
13R _RARE_
, O
14S _RARE_
) O
stereoisomer _RARE_
of O
anti O
- O
11 O
, O
12 O
- O
dihydroxy _RARE_
- O
13 _RARE_
, O
14 O
- O
epoxy _RARE_
- O
11 O
, O
12 O
, O
13 _RARE_
, O
14 O
- O
tetrahydrobenzo _RARE_
[ _RARE_
g O
] O
chrysene _RARE_
, O
(+)- _RARE_
anti O
- O
B O
[ _RARE_
g O
] O
CDE _RARE_
, O
to O
the O
exocyclic _RARE_
N O
( O
6 O
) O
amino O
group O
of O
the O
adenine _RARE_
residue _RARE_
dA6 _RARE_
, O
( O
designated O
(+)- _RARE_
trans _RARE_
- O
anti O
-( _RARE_
B O
[ _RARE_
g O
] O
C O
) O
dA6 _RARE_
), _RARE_
positioned O
opposite O
a O
thymine _RARE_
residue _RARE_
dT17 _RARE_
in O
the O
DNA O
sequence O
context O
d O
( O
C1 O
- O
T2 _RARE_
- O
C3 _RARE_
- O
T4 O
- O
C5 _RARE_
-( _RARE_
B O
[ _RARE_
g O
] O
C O
) O
A6 _RARE_
- O
C7 _RARE_
- O
T8 _RARE_
- O
T9 _RARE_
- O
C10 _RARE_
- O
C11 _RARE_
). O
d O
( O
G12 _RARE_
- O
G13 _RARE_
- O
A14 _RARE_
- O
A15 _RARE_
- O
G16 _RARE_
- O
T17 _RARE_
- O
G18 _RARE_
- O
A19 _RARE_
- O
G20 _RARE_
++ _RARE_
+- _RARE_
A21 _RARE_
- O
G22 _RARE_
) O
( O
designated O
( O
B O
[ _RARE_
g O
] O
C O
) O
dA _RARE_
. O
dT O
11 O
- O
mer _RARE_
duplex O
), _RARE_
has O
been O
studied O
using O
structural O
information _RARE_
derived O
from O
NMR O
data O
in O
combination O
with O
molecular _RARE_
dynamics O
( O
MD _RARE_
) O
calculations _RARE_
. O

Since O
sildenafil _RARE_
came _RARE_
on O
the O
market _RARE_
, O
it O
seems O
that O
the O
place O
of O
MUSE _RARE_
is O
reduced _RARE_
because O
comparative O
studies O
give O
better O
results O
for _RARE_
sildenafil _RARE_
than O
MUSE _RARE_
( O
70 O
% O
vs _RARE_
40 O
%) O
and O
of O
course O
with O
a O
better O
acceptance _RARE_
. O

Serum O
antibodies O
were O
detected O
in O
at _RARE_
least O
95 _RARE_
% O
of O
the O
infected _RARE_
guinea _RARE_
pigs O
between O
4 O
- O
30 _RARE_
WPI _RARE_
and O
rats O
between O
3 O
- O
16 O
WPI _RARE_
. O

During O
both O
encephalopathy _RARE_
episodes O
, O
CSF O
protein O
and O
immunoglobulin I-GENE
G I-GENE
( O
IgG I-GENE
) O
levels O
were O
elevated O
without O
an O
increased O
IgG I-GENE
index O
or O
IgG I-GENE
synthesis _RARE_
rate O
. O

CONCLUSIONS O
: O
These O
results O
show O
that O
once O
daily O
oral O
valganciclovir _RARE_
can O
produce O
exposures O
of O
ganciclovir _RARE_
( O
AUC24 _RARE_
) O
exceeding _RARE_
those O
attained _RARE_
using O
intravenous O
ganciclovir _RARE_
10 O
mg O
/ O
kg O
. O

Except _RARE_
for _RARE_
nonperfusion _RARE_
of O
neurosensory _RARE_
retinal _RARE_
vessels O
at _RARE_
a O
light O
dose O
of O
150 _RARE_
J _RARE_
/ O
cm2 O
, O
no _RARE_
other O
adverse O
events O
were O
of O
concern _RARE_
. O

Except _RARE_
for _RARE_
nonperfusion _RARE_
of O
neurosensory _RARE_
retinal _RARE_
vessels O
at _RARE_
a O
light O
dose O
of O
150 _RARE_
J _RARE_
/ O
cm2 O
, O
no _RARE_
other O
adverse O
events O
were O
of O
concern _RARE_
. O

The O
healing O
rate O
in O
HIV O
- O
positive O
patients O
was O
66 _RARE_
percent O
after O
14 O
weeks O
and O
100 _RARE_
percent O
after O
32 _RARE_
weeks O
; O
the O
corresponding O
figures _RARE_
for _RARE_
patients O
with O
acquired O
immunodeficiency O
syndrome _RARE_
were O
0 _RARE_
and O
50 O
percent O
. O

The O
P I-GENE
mRNA I-GENE
also O
contains O
a O
third O
ORF O
for _RARE_
the O
V I-GENE
protein I-GENE
, O
although O
it O
is O
unclear O
how O
or O
whether O
this O
ORF O
is O
accessed _RARE_
. O

A O
genetic O
screen O
in O
yeast O
has O
allowed O
us O
to O
identify O
a O
novel O
transcriptional O
factor O
binding O
to O
the O
GlRE _RARE_
, O
i O
. O
e _RARE_
. O
the O
chicken I-GENE
ovalbumin _RARE_
upstream I-GENE
promoter I-GENE
- I-GENE
transcription I-GENE
factor I-GENE
II I-GENE
( O
COUP I-GENE
- I-GENE
TFII _RARE_
). O

We O
have O
cloned _RARE_
the O
single O
- O
copy O
gene O
for _RARE_
the O
trans _RARE_
- I-GENE
spliceosomal _RARE_
U5 _RARE_
snRNA _RARE_
from O
the O
trypanosomatid _RARE_
species O
Leptomonas _RARE_
seymouri _RARE_
, O
using O
U5 _RARE_
RNA I-GENE
affinity O
selection O
and O
cDNA O
cloning O
. O

The O
MMPI O
- O
A O
( O
Butcher _RARE_
et O
al O
., O
1992 O
), _RARE_
like O
the O
older O
MMPI O
( O
Hathaway _RARE_
& O
McKinley _RARE_
, O
1983 O
), _RARE_
distinguishes _RARE_
between O
anorexia _RARE_
and O
bulimia _RARE_
. O

On O
the O
other O
hand _RARE_
, O
phosphatidyl _RARE_
inositol _RARE_
4 O
, O
5 O
bisphosphate _RARE_
( O
PIP2 O
) O
hydrolysis O
requires O
direct O
phosphorylation _RARE_
at _RARE_
tyrosine O
residue _RARE_
of O
the O
PLC I-GENE
- I-GENE
gamma1 _RARE_
isozyme _RARE_
. O

A O
G22V _RARE_
mutant I-GENE
of O
M I-GENE
- I-GENE
Ras I-GENE
was O
constitutively O
active _RARE_
and O
its O
expression _RARE_
in O
an O
interleukin I-GENE
- I-GENE
3 I-GENE
( O
IL _RARE_
- I-GENE
3 I-GENE
)- O
dependent O
mast _RARE_
cell O
/ O
megakaryocyte _RARE_
cell O
line O
resulted O
in O
increased O
survival O
in O
the O
absence O
of O
IL _RARE_
- I-GENE
3 I-GENE
, O
increased O
growth O
in O
IL _RARE_
- I-GENE
4 I-GENE
, O
and O
, O
at _RARE_
high O
expression _RARE_
levels O
, O
in O
factor O
- O
independent O
growth O
. O

Mammalian _RARE_
M I-GENE
- I-GENE
Ras I-GENE
and O
a O
Caenorhabditis O
elegans O
orthologue _RARE_
exhibit O
conserved _RARE_
structural O
features O
, O
and O
these O
are O
likely O
to O
mediate O
activation O
of O
distinctive O
signaling _RARE_
paths _RARE_
that O
function O
in O
parallel O
to O
those O
downstream _RARE_
of O
p21 I-GENE
Ras I-GENE
. O

Taken O
together O
, O
our O
data O
suggest O
that O
PecS _RARE_
attenuates O
pelD _RARE_
and O
pelE _RARE_
expression _RARE_
rather O
than O
acting O
as _RARE_
a O
true O
repressor O
like O
KdgR _RARE_
. O

These O
observations O
establish O
that O
RsmC _RARE_
negatively O
regulates O
rsmB _RARE_
transcription O
but O
positively O
affects O
RsmA _RARE_
production O
. O

All O
were O
experienced O
hearing O
aid O
users O
who O
wore _RARE_
linear _RARE_
Class _RARE_
D O
instruments O
with O
input O
compression O
limiting O
at _RARE_
the O
time O
of O
their O
enrollment _RARE_
in O
this O
study O
. O

SCOB _RARE_
testing O
of O
food O
- O
restricted O
animals O
, O
using O
a O
multiple O
fixed O
ratio O
( O
FR _RARE_
)/ _RARE_
fixed O
interval O
( O
FI _RARE_
) O
schedule O
( O
FR20 _RARE_
: O
FI120 _RARE_
), _RARE_
was O
conducted O
prior O
to O
each O
exposure O
to O
maintain O
the O
operant _RARE_
behavior O
; O
the O
data O
from O
Weeks _RARE_
- O
1 O
, O
4 O
, O
8 O
, O
and O
13 _RARE_
were O
evaluated O
for _RARE_
evidence O
of O
neurotoxicity O
. O

Ribonuclease _RARE_
protection O
assays O
revealed O
that O
hmg1 _RARE_
and O
hmg2 _RARE_
are O
differentially O
expressed _RARE_
in O
a O
developmentally O
- O
and O
spatially O
- O
modulated O
manner O
during _RARE_
morphogenesis _RARE_
of O
specialized O
terpenoid _RARE_
- O
containing O
pigment _RARE_
glands O
in O
embryos _RARE_
. O

Differential O
expression _RARE_
was O
confirmed O
by O
Northern O
blot O
analysis O
employing O
multiple O
normal O
and O
tumor O
cell O
lines O
. O

Inactivation _RARE_
of O
the O
Neurospora I-GENE
crassa I-GENE
mitochondrial I-GENE
outer _RARE_
membrane I-GENE
protein I-GENE
TOM70 _RARE_
by O
repeat O
- O
induced _RARE_
point O
mutation O
( O
RIP _RARE_
) O
causes O
defects O
in O
mitochondrial O
protein O
import O
and O
morphology O
. O

Several O
genes O
or O
transcriptional O
units _RARE_
were O
identified O
, O
including O
the O
3 O
' O
end O
of O
ribosomal I-GENE
s6 _RARE_
kinase I-GENE
( O
Rsk3 _RARE_
); O
two O
apparently O
intronless O
and O
ORF O
- O
less O
genes O
; O
and O
Gpr31 _RARE_
, O
an O
intronless O
, O
putative O
G I-GENE
- I-GENE
protein I-GENE
coupled I-GENE
receptor I-GENE
. O

The O
results O
suggest O
that O
GATA _RARE_
- I-GENE
5 I-GENE
may O
have O
specific O
downstream _RARE_
targets _RARE_
and O
that O
GATA _RARE_
- I-GENE
4 I-GENE
, I-GENE
- I-GENE
5 I-GENE
, I-GENE
and I-GENE
- I-GENE
6 I-GENE
can O
only O
partially O
substitute O
for _RARE_
each O
other O
in O
cardiogenesis _RARE_
. O

This O
study O
was O
designed O
to O
compare O
the O
efficacy O
of O
efegatran _RARE_
plus _RARE_
streptokinase _RARE_
versus O
heparin _RARE_
plus _RARE_
accelerated O
tissue I-GENE
plasminogen I-GENE
activator I-GENE
( O
TPA _RARE_
) O
in O
coronary O
reperfusion O
in O
acute O
MI O
. O

Recently O
, O
cell O
- O
surface O
TRAIL _RARE_
has O
been O
shown O
to O
be O
expressed _RARE_
by O
activated O
human O
and O
mouse O
T O
lymphocytes O
, O
raising _RARE_
the O
possibility O
that O
TRAIL _RARE_
might O
be O
involved O
in O
T O
cell O
- O
mediated _RARE_
cytotoxicity O
and O
/ O
or O
immune O
regulation _RARE_
. O

A O
panel O
of O
pharmacologic _RARE_
inhibitors _RARE_
was O
used O
to O
investigate O
the O
signal O
transduction _RARE_
pathways O
involved O
in O
TRAIL _RARE_
gene I-GENE
induction O
following O
T O
lymphocyte O
activation O
. O

From O
February _RARE_
1991 O
to O
August O
1997 O
, O
124 _RARE_
patients O
with O
endometrial O
carcinoma O
were O
treated O
postoperatively O
with O
high O
- O
dose O
- O
rate O
vaginal O
vault _RARE_
brachytherapy _RARE_
as _RARE_
the O
only O
adjuvant O
treatment O
. O

Twelve _RARE_
patients O
had O
stage _RARE_
IBG3 _RARE_
, O
14 O
had O
ICG1 _RARE_
, O
9 O
had O
ICG2 _RARE_
, O
and O
3 O
had O
ICG3 _RARE_
disease _RARE_
. O

Defective _RARE_
provirus O
genomes O
of O
human O
T O
- O
cell O
leukemia O
virus O
type O
I O
are O
frequently O
detected O
in O
lymphocytes O
from O
infected _RARE_
individuals O
and O
in O
infected _RARE_
cell O
lines O
. O

A O
total _RARE_
of O
174 _RARE_
primer O
pairs _RARE_
gave O
interpretable _RARE_
banding _RARE_
patterns O
, O
137 _RARE_
( O
79 _RARE_
%) O
of O
which O
revealed O
at _RARE_
least O
two O
alleles O
on O
native _RARE_
polyacrylamide O
gels O
. O

A O
population O
pharmacokinetic O
study O
of O
cyclosporin O
in O
organ O
transplant O
patients O
, O
including O
elderly O
allograft _RARE_
recipients O
up _RARE_
to O
75 _RARE_
years O
of O
age O
, O
did O
not O
identify O
age O
as _RARE_
a O
covariable _RARE_
influencing O
cyclosporin O
pharmacokinetics O
. O

Immunofluoresence _RARE_
data O
indicated O
that O
once O
bound _RARE_
to O
the O
mutant O
receptor O
, O
fluorescent _RARE_
- O
labeled O
RAP _RARE_
co _RARE_
- O
localized O
with O
markers O
of O
the O
endosomal _RARE_
pathway _RARE_
, O
whereas O
, O
in O
cells O
expressing O
the O
wild O
- O
type O
receptor O
, O
RAP _RARE_
fluorescence O
co _RARE_
- O
localized O
with O
lysosomal _RARE_
markers O
. O

Interleukin I-GENE
- I-GENE
12 I-GENE
( O
IL _RARE_
- I-GENE
12 I-GENE
) O
is O
a O
cytokine _RARE_
produced O
by O
peripheral O
blood _RARE_
mononuclear O
cells O
( O
PBMC _RARE_
) O
that O
causes O
interferon _RARE_
- I-GENE
gamma I-GENE
( O
IFN I-GENE
- I-GENE
gamma I-GENE
) O
production O
and O
enhancement O
of O
cell O
- O
mediated _RARE_
cytotoxicity O
. O

IL _RARE_
- I-GENE
12 I-GENE
production O
was O
correlated O
with O
C3a _RARE_
concentration O
measured O
at _RARE_
the O
outlet _RARE_
of O
hemodialyzer _RARE_
after O
15 _RARE_
min O
of O
dialysis O
( O
r _RARE_
= O
0 _RARE_
. O
69 _RARE_
, O
P O
< O
0 _RARE_
. O
01 O
). O

In O
HeLa O
cells O
, O
the O
JNKK2 _RARE_
- O
JNK1 I-GENE
fusion O
protein O
showed O
significant O
JNK I-GENE
activity O
, O
which O
was O
comparable O
with O
that O
of O
JNK1 I-GENE
activated O
by O
many O
stimuli O
and O
activators _RARE_
, O
including O
EGF _RARE_
, O
TNF I-GENE
- I-GENE
alpha I-GENE
, O
anisomycin _RARE_
, O
UV _RARE_
irradiation O
, O
MEKK1 _RARE_
, O
and O
small I-GENE
GTP I-GENE
binding I-GENE
proteins I-GENE
Rac1 I-GENE
and O
Cdc42Hs _RARE_
. O

J _RARE_
. O

Our O
results O
implicate _RARE_
TGF I-GENE
- I-GENE
beta I-GENE
RII I-GENE
as _RARE_
a O
direct O
target O
of O
EWS I-GENE
- O
FLI1 I-GENE
. O

The O
reduction O
in O
saturated _RARE_
fatty O
acids _RARE_
intake O
led O
to O
modest _RARE_
( O
but O
in O
group O
1 O
significant O
) O
0 _RARE_
. O
15 _RARE_
mmol O
/ O
l _RARE_
( O
2 O
. O
5 O
%) O
reduction O
in O
total _RARE_
serum O
cholesterol O
level O
. O

Secondly _RARE_
, O
an O
ethanol O
repression O
autoregulation O
( O
ERA _RARE_
)/ _RARE_
twelve _RARE_
- O
fold _RARE_
TA O
repeat O
( O
TAB _RARE_
) O
repressor O
element O
was O
identified O
within O
the O
promoter O
region O
of O
the O
GLK1 _RARE_
gene I-GENE
. O

A O
crucial O
transcription O
factor O
in O
this O
process O
is O
STAT6 _RARE_
, O
which O
binds O
to O
a O
specific O
DNA O
element O
upon O
cytokine _RARE_
activation O
. O

CONCLUSIONS O
: O
Congenital _RARE_
horizontal O
tarsal _RARE_
kink _RARE_
is O
rare O
and O
its O
cause O
is O
unknown O
. O

A O
local O
, O
high O
- O
density O
, O
single O
- O
nucleotide O
polymorphism O
map O
used O
to O
clone O
Caenorhabditis I-GENE
elegans I-GENE
cdf _RARE_
- I-GENE
1 I-GENE
. O

This O
machinery O
involves O
a O
secondary O
structure _RARE_
, O
SECIS O
element O
, O
in O
the O
selenoprotein _RARE_
- O
encoding O
mRNA O
, O
directing _RARE_
selenocysteine _RARE_
insertion _RARE_
at _RARE_
the O
position O
of O
an O
opal _RARE_
( O
UGA O
) O
codon _RARE_
, O
normally O
conferring O
termination _RARE_
of O
translation O
. O

High _RARE_
- O
level O
expression _RARE_
in O
Escherichia O
coli O
of O
selenocysteine _RARE_
- O
containing O
rat I-GENE
thioredoxin _RARE_
reductase I-GENE
utilizing O
gene O
fusions O
with O
engineered _RARE_
bacterial O
- O
type O
SECIS O
elements O
and O
co _RARE_
- O
expression _RARE_
with O
the O
selA _RARE_
, O
selB _RARE_
and O
selC _RARE_
genes I-GENE
. O

In O
Wnt I-GENE
signaling _RARE_
, O
beta I-GENE
- I-GENE
catenin I-GENE
and O
plakoglobin I-GENE
transduce _RARE_
signals O
to O
the O
nucleus O
through O
interactions O
with O
TCF I-GENE
- I-GENE
type I-GENE
transcription I-GENE
factors I-GENE
. O

Assembly _RARE_
of O
a O
complex O
between O
FAK I-GENE
and O
Src I-GENE
kinases I-GENE
may O
serve O
to O
regulate O
the O
subcellular O
localization _RARE_
and O
the O
enzymatic O
activity O
of O
members O
of O
the O
Src I-GENE
family I-GENE
of O
kinases O
. O

For O
EPV _RARE_
3 O
, O
10 O
, O
or O
40 O
, O
the O
bias _RARE_
exceeded _RARE_
25 _RARE_
% O
for _RARE_
7 O
, O
3 O
, O
and O
1 O
in O
the O
8 O
- O
predictor O
model O
respectively O
, O
when O
a O
conventional O
selection O
criterion O
was O
used O
( O
alpha O
= O
0 _RARE_
. O
05 O
). O

Our O
study O
also O
demonstrated O
significant O
increases O
in O
the O
number O
of O
larger O
myelinated _RARE_
fibers O
crossing _RARE_
the O
repair O
site O
in O
comparison O
with O
the O
neonatal O
and O
adult O
groups O
( O
p O
< O
0 _RARE_
. O
04 O
). O

Me _RARE_
( O
2 O
) O
SO _RARE_
- O
induced _RARE_
neuronal _RARE_
differentiation O
of O
N1E _RARE_
- O
115 _RARE_
neuroblastoma O
cells O
increased O
both O
the O
expression _RARE_
of O
the O
endogenous I-GENE
Ntr _RARE_
- I-GENE
1 I-GENE
gene I-GENE
and O
reporter O
genes O
driven _RARE_
by O
NTR _RARE_
- I-GENE
1 I-GENE
promoter I-GENE
sequences I-GENE
by O
3 O
- O
4 O
- O
fold _RARE_
. O

Cortical _RARE_
dysplasias _RARE_
, O
genetics _RARE_
, O
and O
epileptogenesis _RARE_
. O

In O
the O
work O
reported O
here O
, O
we O
used O
peptide O
mapping O
, O
mass O
spectrometry O
, O
and O
site O
- O
directed O
mutagenesis O
to O
identify O
two O
sets O
of O
pAP _RARE_
phosphorylation _RARE_
sites O
. O

Both O
HERV _RARE_
- O
K O
type O
1 O
and O
2 O
clones _RARE_
were O
isolated O
. O

Duch _RARE_
, O
and O
F O
. O

At O
all O
time O
- O
points O
, O
most O
patients O
(>/= _RARE_
87 O
%) O
were O
receiving O
irbesartan _RARE_
/ O
HCTZ _RARE_
alone O
. O

Modification _RARE_
of O
dopamine I-GENE
D2 _RARE_
receptor I-GENE
activity O
by O
pergolide _RARE_
in O
Parkinson O
' O
s O
disease _RARE_
: O
an O
in O
vivo O
study O
by O
PET O
. O

High _RARE_
- O
affinity O
binding O
sites O
for _RARE_
both O
GR I-GENE
and O
AP I-GENE
- I-GENE
1 I-GENE
nucleoproteins _RARE_
were O
identified O
at _RARE_
adjacent O
elements O
within O
the O
nGRE _RARE_
. O

When O
the O
73 _RARE_
- O
bp O
fragment O
was O
fused O
to O
an O
alpha1 _RARE_
- I-GENE
globin I-GENE
promoter O
- O
CAT I-GENE
construct O
and O
cotransfected O
with O
CCAAT I-GENE
transcription I-GENE
factor I-GENE
1 I-GENE
( O
CTF1 _RARE_
)/ _RARE_
NF1 I-GENE
into O
Drosophila O
Schneider _RARE_
SL2 _RARE_
insect O
cells O
( O
which O
lack O
NF1 I-GENE
- I-GENE
like I-GENE
proteins I-GENE
) O
trans _RARE_
- O
activation O
of O
CAT I-GENE
activity O
was O
observed O
. O

Western O
blot O
analysis O
showed O
a O
rapid O
corresponding O
increase O
in O
p21WAF1 _RARE_
/ O
CIP1 _RARE_
protein O
, O
whereas O
protein O
levels O
of O
another O
member _RARE_
of O
the O
cyclin _RARE_
- I-GENE
dependent I-GENE
kinase I-GENE
inhibitor I-GENE
family I-GENE
, O
p27kip1 _RARE_
, O
were O
unchanged O
. O

Aggregation _RARE_
of O
vHnf1 _RARE_
- O
deficient _RARE_
embryonic _RARE_
stem _RARE_
cells O
with O
wild O
- O
type O
tetraploid _RARE_
embryos _RARE_
, O
which O
contribute O
exclusively O
to O
extraembryonic _RARE_
tissues O
, O
rescues _RARE_
periimplantation _RARE_
lethality O
and O
allows O
development O
to O
progress O
to O
early O
organogenesis _RARE_
. O

nos _RARE_
- I-GENE
1 I-GENE
and O
nos _RARE_
- I-GENE
2 I-GENE
, O
two O
genes O
related O
to O
Drosophila I-GENE
nanos _RARE_
, O
regulate O
primordial _RARE_
germ _RARE_
cell O
development O
and O
survival O
in O
Caenorhabditis O
elegans O
. O

Although O
upstream O
regulators _RARE_
of O
Tec _RARE_
family I-GENE
kinases I-GENE
are O
relatively O
well _RARE_
characterized O
, O
little O
is O
known O
of O
the O
downstream _RARE_
effectors _RARE_
of O
these O
enzymes _RARE_
. O

Efficient _RARE_
phosphorylation _RARE_
of O
BRDG1 _RARE_
by O
Tec _RARE_
required O
the O
PH _RARE_
and O
SH2 _RARE_
domains I-GENE
as _RARE_
well _RARE_
as _RARE_
the O
kinase O
domain O
of O
the O
latter O
. O

CONCLUSION O
: O
These O
findings O
imply O
that O
eotaxin _RARE_
either O
is O
mechanistically _RARE_
involved O
in O
acute O
asthma O
or O
serves O
as _RARE_
a O
biomarker _RARE_
for _RARE_
activity O
of O
the O
CCR3 _RARE_
receptor I-GENE
ligand _RARE_
system _RARE_
, O
which O
is O
functionally O
linked _RARE_
to O
asthma O
. O

The O
expression _RARE_
analysis O
of O
the O
KlHIS4 _RARE_
gene I-GENE
under O
phosphate O
starvation O
or O
high O
adenine _RARE_
supply O
shows O
that O
factors O
, O
such O
as _RARE_
Bas1 _RARE_
or O
Bas2 _RARE_
, O
involved O
in O
the O
basal O
control O
may O
also O
operate _RARE_
in O
a O
different O
way O
in O
K O
. O
lactis O
. O

These O
thyroid O
hormone O
changes O
may O
be O
mediated _RARE_
in O
part O
by O
cytokines _RARE_
or O
other O
inflammatory O
mediators _RARE_
, O
acting O
at _RARE_
the O
level O
of O
the O
hypothalamus O
and O
pituitary O
gland _RARE_
, O
the O
thyroid O
gland _RARE_
, O
and O
the O
hepatic _RARE_
deiodinase I-GENE
system _RARE_
. O

ESS _RARE_
type O
1 O
, O
with O
FT3 _RARE_
low O
and O
FT4 _RARE_
and O
TSH _RARE_
normal O
, O
is O
the O
most O
frequent O
form O
. O

METHODS O
: O
We O
studied O
20 O
symptomatic O
patients O
with O
HOCM _RARE_
( O
12 O
men O
), _RARE_
mean O
age O
52 O
+/- O
17 _RARE_
years O
, O
before O
and O
after O
septal O
reduction O
using O
echocardiography O
and O
electrocardiogram O
( O
ECG O
). O

Paleoceanographic _RARE_
data O
from O
the O
Laurentian _RARE_
Fan _RARE_
, O
used O
as _RARE_
a O
proxy _RARE_
for _RARE_
sea _RARE_
surface O
temperature _RARE_
, O
reveal O
that O
surface O
slope O
waters _RARE_
north _RARE_
of O
the O
Gulf _RARE_
Stream _RARE_
experienced O
warming _RARE_
during _RARE_
the O
Little _RARE_
Ice _RARE_
Age _RARE_
of O
the O
16th _RARE_
to O
19th _RARE_
centuries _RARE_
and O
support O
the O
notion O
of O
an O
NAO _RARE_
- O
driven _RARE_
coupled O
system _RARE_
. O

This O
effect O
required O
( O
i O
) O
IR I-GENE
activation O
since O
it O
was O
abrogated O
by O
IR I-GENE
mutation O
at _RARE_
tyrosines _RARE_
1162 _RARE_
and O
1163 _RARE_
and O
( O
ii O
) O
NF _RARE_
- I-GENE
kappaB I-GENE
activation O
since O
it O
was O
abolished O
by O
overexpression O
of O
dominant I-GENE
- I-GENE
negative I-GENE
IkappaB _RARE_
- I-GENE
alpha I-GENE
( I-GENE
A32 _RARE_
/ I-GENE
36 _RARE_
) I-GENE
and O
mimicked O
by O
overexpression O
of O
the O
NF _RARE_
- I-GENE
kappaB I-GENE
c I-GENE
- I-GENE
Rel I-GENE
subunit I-GENE
. O

The O
factor O
designated O
B O
formed O
a O
complex O
centered O
on O
the O
sequence O
TGTGGT _RARE_
, O
a O
core O
motif O
recognized _RARE_
by O
members O
of O
the O
AML _RARE_
/ I-GENE
CBFalpha _RARE_
transcription I-GENE
factor I-GENE
family I-GENE
. O

Furthermore O
, O
overexpression O
of O
AML3 _RARE_
/ O
CBFalpha1 _RARE_
could O
rescue O
the O
AML1 _RARE_
- O
ETO _RARE_
repression O
. O

We O
examined O
Akt I-GENE
activation O
in O
Lyn I-GENE
-, _RARE_
Syk _RARE_
- O
and O
Btk _RARE_
- O
deficient _RARE_
DT40 _RARE_
cells O
and O
B O
cells O
from O
Lyn I-GENE
(-/-) _RARE_
mice O
. O

Regulators _RARE_
of O
G I-GENE
protein I-GENE
signaling _RARE_
( I-GENE
RGS _RARE_
) I-GENE
proteins I-GENE
that O
contain O
DEP _RARE_
( O
disheveled _RARE_
, O
EGL _RARE_
- I-GENE
10 I-GENE
, O
pleckstrin I-GENE
) O
and O
GGL _RARE_
( O
G I-GENE
protein I-GENE
gamma I-GENE
subunit I-GENE
- I-GENE
like I-GENE
) O
domains O
form O
a O
subfamily O
that O
includes O
the O
mammalian I-GENE
RGS _RARE_
proteins I-GENE
RGS6 _RARE_
, O
RGS7 _RARE_
, O
RGS9 _RARE_
, O
and O
RGS11 _RARE_
. O

Cloning O
and O
expression _RARE_
of O
a O
specific O
human I-GENE
alpha I-GENE
1 I-GENE
, I-GENE
2 I-GENE
- I-GENE
mannosidase _RARE_
that O
trims _RARE_
Man9GlcNAc2 _RARE_
to O
Man8GlcNAc2 _RARE_
isomer _RARE_
B O
during _RARE_
N O
- O
glycan _RARE_
biosynthesis O
. O

The O
ORs _RARE_
of O
GC _RARE_
, O
adjusted O
for _RARE_
age O
and O
sex _RARE_
, O
varied O
from O
17 _RARE_
. O
1 O
, O
for _RARE_
those O
with O
baseline O
diagnoses _RARE_
of O
superficial O
intestinal _RARE_
metaplasia _RARE_
( O
IM O
), _RARE_
to O
29 O
. O
3 O
, O
for _RARE_
those O
with O
deep O
IM O
or O
mild O
dysplasia O
( O
DYS _RARE_
) O
or O
IM O
with O
glandular _RARE_
atrophy O
and O
neck O
hyperplasia O
, O
to O
104 O
. O
2 O
, O
for _RARE_
those O
with O
moderate O
or O
severe O
DYS _RARE_
, O
as _RARE_
compared O
with O
subjects O
with O
superficial O
gastritis _RARE_
( O
SG _RARE_
) O
or O
chronic O
atrophic _RARE_
gastritis _RARE_
( O
CAG _RARE_
) O
at _RARE_
baseline O
. O

Here O
we O
report O
that O
Dbp5p _RARE_
and O
Rat7p _RARE_
interact O
through O
their O
Nterminal _RARE_
domains O
. O

Thus O
, O
the O
nematode O
genes O
could O
be O
the O
homologs I-GENE
of I-GENE
Hh _RARE_
molecules I-GENE
in O
other O
phyla _RARE_
. O

A O
subset O
of O
mutations O
in O
the O
Psi _RARE_
synthase I-GENE
domain I-GENE
impairs _RARE_
association O
of O
the O
altered O
Cbf5p _RARE_
proteins I-GENE
with O
selected _RARE_
box O
H I-GENE
/ I-GENE
ACA _RARE_
snoRNAs _RARE_
, O
suggesting O
that O
the O
functional _RARE_
catalytic O
domain O
is O
essential O
for _RARE_
that O
interaction O
. O

Although O
the O
Src I-GENE
tyrosine I-GENE
kinase I-GENE
induces O
constitutive _RARE_
Stat3 I-GENE
phosphorylation _RARE_
on O
tyrosine O
, O
activation O
of O
Stat3 I-GENE
- O
mediated _RARE_
gene O
regulation _RARE_
requires O
both O
tyrosine O
and O
serine O
phosphorylation _RARE_
of O
Stat3 I-GENE
. O

The O
transcription I-GENE
factor I-GENE
CHOP _RARE_
( O
C I-GENE
/ I-GENE
EBP I-GENE
homologous I-GENE
protein I-GENE
10 I-GENE
) O
is O
a O
bZIP _RARE_
protein I-GENE
induced _RARE_
by O
a O
variety O
of O
stimuli O
that O
evoke _RARE_
cellular O
stress O
responses O
and O
has O
been O
shown O
to O
arrest O
cell O
growth O
and O
to O
promote O
programmed O
cell O
death _RARE_
. O

Thus O
, O
CHOP _RARE_
not O
only O
is O
a O
negative O
or O
a O
positive O
regulator O
of O
C I-GENE
/ I-GENE
EBP I-GENE
target O
genes O
but O
also O
, O
when O
tethered _RARE_
to O
AP I-GENE
- I-GENE
1 I-GENE
factors I-GENE
, O
can O
activate O
AP I-GENE
- I-GENE
1 I-GENE
target O
genes O
. O

This O
motif O
, O
first _RARE_
described O
for _RARE_
the O
Drosophila I-GENE
homeobox _RARE_
activator I-GENE
DEAF _RARE_
- I-GENE
1 I-GENE
, O
identifies O
an O
emerging _RARE_
group O
of O
metazoan _RARE_
transcriptional O
modulators _RARE_
. O

RNase I-GENE
MRP I-GENE
is O
a O
ribonucleoprotein O
endoribonuclease _RARE_
that O
has O
been O
shown O
to O
have O
roles O
in O
both O
mitochondrial O
DNA O
replication O
and O
nuclear I-GENE
5 I-GENE
. I-GENE
8S _RARE_
rRNA I-GENE
processing _RARE_
. O

We O
have O
examined O
the O
regulation _RARE_
of O
the O
FGFR I-GENE
- I-GENE
1 I-GENE
gene I-GENE
( O
cek _RARE_
- I-GENE
1 I-GENE
) O
in O
avian O
myogenic _RARE_
cultures O
by O
immunocytochemistry _RARE_
and O
Northern O
blot O
analysis O
. O

Regulation O
of O
avian I-GENE
fibroblast I-GENE
growth I-GENE
factor I-GENE
receptor I-GENE
1 I-GENE
( O
FGFR I-GENE
- I-GENE
1 I-GENE
) O
gene O
expression _RARE_
during _RARE_
skeletal O
muscle O
differentiation O
. O

The O
backbone _RARE_
dynamics O
of O
residues O
located _RARE_
in O
the O
folded O
part O
of O
CRP2 _RARE_
( O
LIM2 _RARE_
) O
R122A _RARE_
have O
been O
characterized O
by O
proton _RARE_
- O
detected O
( O
15 _RARE_
) O
N O
NMR O
spectroscopy O
. O

Rac I-GENE
causes O
uncapping _RARE_
of O
actin I-GENE
filaments _RARE_
( O
F I-GENE
- I-GENE
actin I-GENE
) O
at _RARE_
the O
plus _RARE_
- O
ends O
, O
through O
phosphatidylinositol _RARE_
4 O
, O
5 O
bisphosphate _RARE_
( O
PIP2 O
), _RARE_
and O
eventually _RARE_
induces O
membrane O
ruffling _RARE_
. O

However O
, O
a O
specific O
ICE I-GENE
/ O
caspase _RARE_
- I-GENE
1 I-GENE
inhibitor O
called O
N1445 _RARE_
completely O
abolished O
the O
CK _RARE_
- O
induced _RARE_
apoptosis O
by O
reactivating _RARE_
PKB I-GENE
, O
but O
without O
affecting O
the O
CK _RARE_
- O
induced _RARE_
suppression O
of O
Ras I-GENE
transformation O
. O

OBJECTIVE O
: O
Although O
the O
preponderance _RARE_
of O
findings O
offer O
support O
for _RARE_
transient O
( O
where O
is O
it O
?) _RARE_
as _RARE_
opposed O
to O
sustained O
( O
what O
is O
it O
?) _RARE_
deficit O
, O
a O
need O
remains O
for _RARE_
specific O
depiction _RARE_
of O
the O
deficit O
. O

The O
AL _RARE_
- O
R8 _RARE_
SI _RARE_
: O
the O
next O
generation O
staging _RARE_
container _RARE_
for _RARE_
plutonium O
pits _RARE_
at _RARE_
the O
USDOE _RARE_
Pantex _RARE_
Plant _RARE_
. O

RESULTS O
: O
Factors O
associated O
with O
significantly O
( O
P O
<. _RARE_
05 O
) O
increased O
risk O
of O
treatment O
failure O
in O
a O
Cox O
multivariate O
analysis O
included O
age O
older O
than O
45 _RARE_
years O
( O
relative O
hazard _RARE_
, O
1 O
. O
17 _RARE_
; O
95 _RARE_
% O
confidence O
interval O
[ _RARE_
CI _RARE_
], O
1 O
. O
02 O
- O
1 O
. O
33 _RARE_
), _RARE_
Karnofsky _RARE_
performance O
score O
less O
than O
90 _RARE_
% O
( O
1 O
. O
27 _RARE_
; O
95 _RARE_
% O
CI _RARE_
, O
1 O
. O
07 O
- O
1 O
. O
51 _RARE_
), _RARE_
absence O
of O
hormone O
receptors O
( O
1 O
. O
31 _RARE_
; O
95 _RARE_
% O
CI _RARE_
, O
1 O
. O
15 _RARE_
- O
1 O
. O
51 _RARE_
), _RARE_
prior O
use O
of O
adjuvant O
chemotherapy O
( O
1 O
. O
31 _RARE_
; O
95 _RARE_
% O
CI _RARE_
, O
1 O
. O
10 O
- O
1 O
. O
56 _RARE_
), _RARE_
initial O
disease _RARE_
- O
free O
survival O
interval O
after O
adjuvant O
treatment O
of O
no _RARE_
more O
than O
18 O
months O
( O
1 O
. O
99 _RARE_
; O
95 _RARE_
% O
CI _RARE_
, O
1 O
. O
62 _RARE_
- O
2 O
. O
43 _RARE_
), _RARE_
metastases O
in O
the O
liver O
( O
1 O
. O
47 _RARE_
; O
95 _RARE_
% O
CI _RARE_
, O
1 O
. O
20 O
- O
1 O
. O
80 _RARE_
) O
or O
central O
nervous O
system _RARE_
( O
1 O
. O
56 _RARE_
; O
95 _RARE_
% O
CI _RARE_
, O
0 _RARE_
. O
99 _RARE_
- O
2 O
. O
46 _RARE_
[ _RARE_
approaches O
significance O
]) _RARE_
vs _RARE_
soft O
tissue O
, O
bone O
, O
or O
lung _RARE_
, O
3 O
or O
more O
sites O
of O
metastatic O
disease _RARE_
( O
1 O
. O
32 _RARE_
; O
95 _RARE_
% O
CI _RARE_
, O
1 O
. O
13 _RARE_
- O
1 O
. O
54 O
), _RARE_
and O
incomplete O
response O
vs _RARE_
complete _RARE_
response O
to O
standard O
- O
dose O
chemotherapy O
( O
1 O
. O
65 O
; O
95 _RARE_
% O
CI _RARE_
, O
1 O
. O
36 _RARE_
- O
1 O
. O
99 _RARE_
). O

One O
form O
of O
the O
SBEI _RARE_
gene I-GENE
transcript I-GENE
in O
12 O
- O
day O
old O
kernels _RARE_
contained O
the O
exon _RARE_
I O
+ O
II O
+ O
III O
combination O
at _RARE_
the O
5 O
' O
end O
, O
whereas O
other O
forms O
differed O
by O
inclusion O
of O
intron O
1 O
or O
exclusion O
of O
exon _RARE_
II O
sequences O
. O

In O
PC O
, O
rare O
MNGCs _RARE_
had O
intranuclear _RARE_
inclusions _RARE_
and O
grooves _RARE_
. O

16 O
percent O
, O
P O
< O
0 _RARE_
. O
001 O
), _RARE_
and O
sustained O
normalization _RARE_
of O
serum I-GENE
alanine I-GENE
aminotransferase I-GENE
levels O
( O
41 _RARE_
percent O
vs _RARE_
. O

Its O
C O
- O
terminal O
catalytic O
domain O
was O
found O
to O
be O
highly O
conserved _RARE_
in O
the O
homologues _RARE_
p140 _RARE_
( O
ras I-GENE
- O
GRF _RARE_
) O
and O
Sos I-GENE
. O

356 _RARE_
, O
93 O
- O
98 O
]. O

The O
proteasome O
is O
a O
large O
complex O
consisting O
of O
two O
multisubunit _RARE_
structures _RARE_
, O
the O
20S I-GENE
and O
19S _RARE_
( O
PA700 _RARE_
) O
or O
P28 _RARE_
complexes I-GENE
, O
that O
combine _RARE_
to O
form O
the O
26S _RARE_
particles _RARE_
. O

In O
assays O
with O
purified _RARE_
enzymes _RARE_
, O
wild O
- O
type O
but O
not O
PTPS _RARE_
- O
S19A _RARE_
was O
a O
specific O
substrate O
for _RARE_
the O
cGMP _RARE_
- I-GENE
dependent I-GENE
protein I-GENE
kinase I-GENE
( I-GENE
cGK _RARE_
) I-GENE
type I-GENE
I I-GENE
and I-GENE
II I-GENE
. O

R O
., O
Fleischmann _RARE_
, O
R O
., O
Venter _RARE_
, O
J _RARE_
. O

The O
N O
- O
terminal O
domain O
of O
approximately _RARE_
70 O
kDa O
exhibits O
11 O
imperfect _RARE_
amino O
acid O
repeats O
that O
show O
some O
homology O
to O
promastigote _RARE_
surface O
glycoproteins _RARE_
of O
the O
psa2 _RARE_
/ O
gp46 _RARE_
complex O
. O

In O
contrast O
to O
previously O
characterized O
proteophosphoglycans _RARE_
, O
the O
ppg1 _RARE_
gene O
product O
is O
predominantly O
membrane O
- O
associated O
and O
it O
is O
expressed _RARE_
on O
the O
promastigote _RARE_
cell O
surface O
. O

Most O
important O
, O
infection O
of O
the O
cells O
with O
an O
adenoviral _RARE_
construct O
expressing O
this O
mutant O
inhibited O
the O
induction O
of O
VEGF I-GENE
mRNA I-GENE
under O
conditions O
that O
mimic O
hypoxia _RARE_
. O

Neuregulin _RARE_
stimulates O
ErbB2 _RARE_
, O
ErbB3 _RARE_
, O
and O
ErbB4 _RARE_
, O
members O
of O
the O
ErbB I-GENE
family I-GENE
of O
receptor I-GENE
tyrosine I-GENE
kinases I-GENE
. O

Our O
results O
suggest O
that O
Anu2p _RARE_
is O
the O
yeast I-GENE
homologue I-GENE
of I-GENE
mammalian I-GENE
epsilon I-GENE
- I-GENE
COP _RARE_
and O
the O
abrupt _RARE_
accumulation O
of O
the O
ER O
membrane O
caused O
by O
a O
blockage _RARE_
of O
the O
early O
protein O
transport _RARE_
pathway _RARE_
leads O
to O
alteration O
of O
nuclear O
morphology O
of O
the O
budding _RARE_
yeast O
cells O
. O

In O
PC12 O
cells O
, O
nerve I-GENE
growth I-GENE
factor I-GENE
induces O
neuronal _RARE_
differentiation O
and O
repressed O
expression _RARE_
of O
nrg _RARE_
- I-GENE
1 I-GENE
. O

In O
a O
PC12 O
cell O
mutant O
that O
is O
deficient _RARE_
in O
protein I-GENE
kinase I-GENE
A I-GENE
activity O
( O
AB _RARE_
. O
11 O
), _RARE_
all O
three O
differentiating O
agents O
were O
unable O
to O
down O
- O
regulate O
nrg _RARE_
- I-GENE
1 I-GENE
mRNA I-GENE
. O

TSC1 _RARE_
mutations I-GENE
include O
two O
nonsense O
mutations O
, O
four O
insertions O
, O
and O
three O
splice _RARE_
mutations O
. O

Twelve _RARE_
patients O
without O
abnormalities O
in O
the O
PTT _RARE_
are O
assumed O
to O
harbor O
missense O
mutations O
, O
probably O
in O
TSC2 _RARE_
. O

The O
first _RARE_
algorithm O
, O
FOREPROJ _RARE_
, O
is O
a O
fast O
- O
forward _RARE_
projection _RARE_
algorithm O
that O
allows O
calculation _RARE_
of O
the O
3 O
- O
D O
attenuation _RARE_
correction O
factors O
( O
ACF _RARE_
' O
s O
) O
directly O
from O
a O
two O
- O
dimensional O
( O
2 O
- O
D O
) O
transmission _RARE_
scan O
, O
without O
first _RARE_
reconstructing _RARE_
the O
attenuation _RARE_
map O
and O
then O
performing _RARE_
a O
3 O
- O
D O
forward _RARE_
projection _RARE_
. O

We O
have O
cloned _RARE_
cDNA O
and O
genomic O
DNA O
for _RARE_
a O
mouse O
gene O
encoding O
a O
protein O
with O
significant O
sequence O
similarity _RARE_
to O
conserved _RARE_
domains O
found O
in O
proteins O
of O
the O
Spo11p _RARE_
family I-GENE
. O

RT O
- O
PCR O
and O
in O
situ O
hybridization O
analyses O
of O
a O
time O
course O
of O
juvenile O
testis _RARE_
development O
indicate O
that O
Spo11 _RARE_
expression _RARE_
begins O
in O
early O
meiotic _RARE_
Prophase _RARE_
I O
, O
prior O
to O
the O
pachytene _RARE_
stage _RARE_
, O
with O
increasing O
accumulation O
of O
mRNA O
through O
the O
pachytene _RARE_
stage _RARE_
. O

Animals O
were O
put _RARE_
to O
death _RARE_
8 O
weeks O
later O
and O
the O
grafts O
were O
sterilely _RARE_
explanted _RARE_
and O
analyzed O
via O
microbiologic _RARE_
culture O
and O
standard O
histologic O
procedures O
for _RARE_
evidence O
of O
infection O
. O

The O
RMR _RARE_
was O
measured O
twice O
in O
each O
phase _RARE_
and O
found O
to O
be O
similar O
( O
F O
( O
1 O
, O
18 O
) O
= O
0 _RARE_
. O
863 _RARE_
) O
across O
the O
follicular O
( O
5018 _RARE_
kJ _RARE_
/ O
24 _RARE_
h O
) O
and O
the O
luteal _RARE_
( O
5098 _RARE_
kJ _RARE_
/ O
24 _RARE_
h O
) O
phases O
. O

Oseltamivir _RARE_
( O
GS4104 _RARE_
), _RARE_
which O
can O
be O
administered O
orally O
, O
is O
the O
prodrug _RARE_
of O
GS4071 _RARE_
, O
a O
potent O
and O
selective O
inhibitor O
of O
influenzavirus _RARE_
neuraminidases _RARE_
. O

In O
gel O
mobility O
shift O
assays O
, O
we O
found O
no _RARE_
evidence O
for _RARE_
VDR I-GENE
- O
TR I-GENE
heterodimer _RARE_
interaction O
with O
any O
tested O
element O
. O

The O
relative O
importance O
of O
these O
two O
mechanisms O
differed O
in O
a O
response O
element O
- O
specific O
manner O
. O

After O
14 O
d O
of O
overfeeding _RARE_
, O
hepatic _RARE_
PL _RARE_
profiles O
were O
identical O
in O
the O
two O
breeds _RARE_
and O
similar O
to O
that O
in O
control O
livers _RARE_
; O
choline _RARE_
- O
containing O
PL _RARE_
accounted _RARE_
for _RARE_
95 _RARE_
% O
of O
total _RARE_
PL _RARE_
. O

C O
- O
SP O
duration O
was O
significantly O
reduced _RARE_
in O
ALS _RARE_
patients O
compared O
to O
controls O
at _RARE_
low O
stimulation _RARE_
intensity O
corresponding O
to O
an O
MEP _RARE_
threshold O
increased O
by O
15 _RARE_
%. O

These O
data O
show O
that O
the O
spv _RARE_
virulence _RARE_
genes I-GENE
belong O
simultaneously O
to O
several O
regulons _RARE_
in O
the O
cell O
, O
raising _RARE_
the O
possibility O
that O
spv _RARE_
expression _RARE_
can O
be O
fine O
- O
tuned _RARE_
in O
response O
to O
multiple O
environmental O
inputs O
. O

Intensive _RARE_
synthesis _RARE_
of O
PNA _RARE_
in O
the O
cells O
of O
microvascular O
wall _RARE_
evidenced _RARE_
of O
their O
high O
functional _RARE_
activity O
, O
and O
the O
synthesis _RARE_
of O
DNA O
in O
them O
showed O
their O
ability O
for _RARE_
proliferation _RARE_
, O
i O
. O
g O
.-- _RARE_
for _RARE_
growth O
. O

Tracheal _RARE_
transsection _RARE_
combined O
with O
hilar _RARE_
ligation O
( O
TL _RARE_
& O
PL _RARE_
) O
effected _RARE_
a O
reduction O
of O
19 O
. O
9 O
% O
( O
n _RARE_
. O
s O
.). O

Kinase _RARE_
- O
deficient _RARE_
erbB I-GENE
proteins I-GENE
reduced _RARE_
epidermal _RARE_
growth I-GENE
factor I-GENE
( O
EGF _RARE_
)- O
induced _RARE_
tyrosine O
phosphorylation _RARE_
of O
endogenous O
Shc I-GENE
proteins I-GENE
and O
also O
reduced _RARE_
immediate O
and O
sustained O
EGF _RARE_
- I-GENE
induced _RARE_
ERK I-GENE
MAPK _RARE_
activities O
in O
human O
glioblastoma _RARE_
cells O
, O
although O
basal O
ERK I-GENE
MAPK _RARE_
activities O
were O
unaffected O
. O

Using O
immunolocalization _RARE_
, O
we O
observe O
that O
ACE3 _RARE_
, O
a O
440 O
- O
bp O
chorion _RARE_
element O
that O
contains O
information _RARE_
sufficient O
to O
drive O
amplification O
, O
directs O
DmORC _RARE_
localization _RARE_
in O
follicle _RARE_
cells O
. O

Therefore O
, O
homozygous O
co _RARE_
- O
deletions O
of O
CDKN2A _RARE_
and O
CDKN2B _RARE_
rather O
than O
mutations O
targeting O
individual O
transcripts O
are O
frequently O
selected _RARE_
for _RARE_
in O
these O
tumors O
. O

Here O
, O
we O
show O
that O
aortic O
explants _RARE_
isolated O
from O
PPARalpha I-GENE
- O
null _RARE_
mice O
display O
an O
exacerbated _RARE_
response O
to O
inflammatory O
stimuli O
, O
such O
as _RARE_
lipopolysaccharide O
( O
LPS _RARE_
), _RARE_
as _RARE_
demonstrated O
by O
increased O
IL _RARE_
- I-GENE
6 I-GENE
secretion _RARE_
. O

Albumin _RARE_
expression _RARE_
is O
maintained O
in O
the O
liver O
by O
a O
combination O
of O
liver O
- O
enriched _RARE_
transcription O
factors O
such O
as _RARE_
CAAT I-GENE
enhancer I-GENE
- I-GENE
binding I-GENE
protein I-GENE
( I-GENE
C I-GENE
/ I-GENE
EBP I-GENE
) I-GENE
alpha I-GENE
and O
C I-GENE
/ I-GENE
EBPbeta I-GENE
. O

The O
requirement O
for _RARE_
proteolytic _RARE_
activity O
of O
both O
FVIIa _RARE_
and O
FXa _RARE_
suggests O
that O
protease O
- O
activated O
receptors O
may O
be O
involved O
. O

Amyloid _RARE_
beta I-GENE
- I-GENE
protein I-GENE
( O
Abeta _RARE_
) O
is O
the O
main O
constituent _RARE_
of O
amyloid _RARE_
fibrils _RARE_
found O
in O
senile O
plaques _RARE_
and O
cerebral O
vessels O
in O
Alzheimer _RARE_
' O
s O
disease _RARE_
( O
AD O
) O
and O
is O
derived O
by O
proteolysis O
from O
the O
beta I-GENE
- I-GENE
amyloid _RARE_
precursor I-GENE
protein I-GENE
( O
APP _RARE_
). O

We O
also O
show O
that O
activation O
of O
protein I-GENE
kinase I-GENE
A I-GENE
( O
PKA I-GENE
) O
signaling _RARE_
is O
sufficient O
to O
down O
- O
regulate O
caveolin _RARE_
- I-GENE
1 I-GENE
protein I-GENE
expression _RARE_
and O
promoter O
activity O
. O

The O
importin _RARE_
alpha I-GENE
. I-GENE
beta I-GENE
heterodimer _RARE_
mediates O
nuclear O
import O
of O
proteins O
containing O
classical O
nuclear O
localization _RARE_
signals O
. O

The O
expressed _RARE_
G1 I-GENE
- O
G2 _RARE_
bound _RARE_
to O
both O
hyaluronan _RARE_
and O
link _RARE_
protein I-GENE
indicating O
that O
the O
immunoglobulin I-GENE
- I-GENE
fold _RARE_
motif I-GENE
and O
proteoglycan _RARE_
tandem _RARE_
repeat O
loops O
of O
the O
G1 I-GENE
domain I-GENE
were O
correctly O
folded O
. O

The O
results O
suggest O
that O
the O
presence O
or O
absence O
per O
se _RARE_
of O
keratan _RARE_
sulfate _RARE_
on O
native _RARE_
G1 O
- O
G2 _RARE_
does O
not O
affect O
the O
activity O
of O
atrolysin _RARE_
C O
toward O
the O
two O
sites O
. O

Despite O
i O
. O
v O
. O
steroid O
therapy O
, O
[ _RARE_
NOexh _RARE_
] O
remained O
elevated O
throughout O
recovery O
( O
37 O
. O
9 O
+/- O
4 O
. O
8 O
ppb O
, O
p O
< O
0 _RARE_
. O
001 O
) O
until O
discharge O
( O
40 O
. O
9 O
+/- O
4 O
. O
3 O
ppb O
, O
p O
< O
0 _RARE_
. O
001 O
). O

It O
contains O
binding O
sites O
for _RARE_
several O
transcription O
factors O
, O
for _RARE_
example O
: O
( O
i O
) O
a O
well _RARE_
- O
characterized O
binding O
site O
for _RARE_
rel _RARE_
/ O
NF _RARE_
- I-GENE
kappaB I-GENE
transcription O
factors O
in O
its O
3 O
'- O
end O
( O
the O
H2TF1 _RARE_
or O
kappaB1 _RARE_
element I-GENE
), _RARE_
( O
ii O
) O
a O
second O
kappaB I-GENE
site I-GENE
( O
the O
kappaB2 _RARE_
element I-GENE
), _RARE_
which O
is O
located _RARE_
immediately O
adjacent O
5 O
' O
to O
the O
H2TF1 _RARE_
element I-GENE
and O
which O
is O
recognized _RARE_
by O
p65 _RARE_
/ O
relA _RARE_
in O
the O
human I-GENE
HLA I-GENE
system _RARE_
, O
and O
( O
iii O
) O
an O
AP I-GENE
- I-GENE
1 I-GENE
/ O
ATF I-GENE
recognition O
sequence O
in O
the O
5 O
' O
end O
( O
EnA _RARE_
- I-GENE
TRE _RARE_
). O

The O
tumorigenic O
E1A I-GENE
+ O
cHa _RARE_
- I-GENE
ras I-GENE
cells O
are O
characterized O
by O
high O
and O
constitutive _RARE_
DNA O
binding O
activities O
of O
AP I-GENE
- I-GENE
1 I-GENE
, O
in O
contrast O
to O
nontransformed _RARE_
cells O
and O
the O
E1A I-GENE
cells O
. O

The O
yeast O
C I-GENE
- I-GENE
type I-GENE
cyclin _RARE_
Ume3p _RARE_
/ O
Srb11p _RARE_
and O
its O
cyclin _RARE_
- I-GENE
dependent I-GENE
kinase I-GENE
( O
Cdk I-GENE
) O
Ume5p _RARE_
are O
required O
for _RARE_
the O
full O
repression O
of O
genes O
involved O
in O
the O
stress O
response O
or O
meiosis O
. O

In O
particular O
, O
the O
S1 I-GENE
' I-GENE
specificity _RARE_
site I-GENE
is O
a O
deep O
and O
highly O
hydrophobic O
cavity O
. O

FZD4 _RARE_
is O
homologous O
to O
FZD9 _RARE_
and O
FZD10 _RARE_
, O
and O
overall O
amino O
acid O
identity O
is O
as _RARE_
follows O
: O
FZD4 _RARE_
vs _RARE_
FZD9 _RARE_
, O
51 _RARE_
. O
6 O
%; O
FZD4 _RARE_
vs _RARE_
FZD10 _RARE_
, O
51 _RARE_
. O
2 O
%; O
FZD9 _RARE_
vs _RARE_
FZD10 _RARE_
, O
65 O
. O
7 O
%. O

The O
NF _RARE_
- I-GENE
kappaB I-GENE
responsive O
reporter O
construct O
, O
( O
PRDII _RARE_
)( O
4 O
)- O
CAT I-GENE
, O
was O
used O
to O
explore O
transcription O
resulting O
from O
NF _RARE_
- I-GENE
kappaB I-GENE
activated O
by O
Tat I-GENE
. O

The O
RNA O
transcripts O
structurally O
equivalent O
to O
I I-GENE
( I-GENE
2 I-GENE
) I-GENE
sgRNAs _RARE_
of O
TMV _RARE_
U1 _RARE_
and O
crTMV _RARE_
, O
but O
containing O
a O
hairpin O
structure _RARE_
( O
H O
) O
immediately O
upstream O
of O
IRES _RARE_
( I-GENE
MP I-GENE
, I-GENE
75 _RARE_
) I-GENE
( I-GENE
HIRES _RARE_
( I-GENE
MP I-GENE
), _RARE_
( I-GENE
75 _RARE_
)( I-GENE
CR _RARE_
)- I-GENE
MP I-GENE
- I-GENE
CP I-GENE
- I-GENE
3 I-GENE
' I-GENE
UTR I-GENE
; O
HIRES _RARE_
( I-GENE
MP I-GENE
, I-GENE
75 _RARE_
)( I-GENE
U1 _RARE_
)- I-GENE
MP I-GENE
- I-GENE
CP I-GENE
- I-GENE
3 I-GENE
' I-GENE
UTR I-GENE
), _RARE_
were O
able O
to O
express O
the O
MP I-GENE
gene I-GENE
in O
vitro O
. O

EIAV _RARE_
LTR I-GENE
sequence I-GENE
variability O
is O
confined O
mostly O
to O
a O
small O
portion O
of O
the O
enhancer O
within O
the O
U3 _RARE_
segment O
of O
the O
LTR O
. O

Phosphatidylinositol _RARE_
3 I-GENE
- I-GENE
kinase I-GENE
requirement O
in O
activation O
of O
the O
ras I-GENE
/ O
C I-GENE
- I-GENE
raf _RARE_
- I-GENE
1 I-GENE
/ O
MEK I-GENE
/ O
ERK I-GENE
and O
p70 I-GENE
( O
s6k _RARE_
) O
signaling _RARE_
cascade O
by O
the O
insulinomimetic _RARE_
agent O
vanadyl _RARE_
sulfate _RARE_
. O

The O
core O
of O
this O
enhancer O
contains O
two O
evolutionarily O
conserved _RARE_
binding O
sites O
for _RARE_
the O
homeodomain _RARE_
protein I-GENE
Tinman _RARE_
( O
Tin _RARE_
), _RARE_
expressed _RARE_
in O
developing O
cardiac O
, O
somatic O
, O
and O
visceral O
muscle O
lineages O
. O

For O
example O
, O
introduction O
of O
immunogenic _RARE_
and O
purification O
tag O
sequences O
into O
the O
C O
- O
terminal O
coding O
region O
significantly O
decreased O
bop _RARE_
gene I-GENE
mRNA I-GENE
and O
protein O
accumulation O
. O

Furthermore O
, O
the O
striking O
ability O
of O
polyoma _RARE_
middle _RARE_
T I-GENE
antigens I-GENE
to O
promote O
retinoic O
acid O
- O
induced _RARE_
differentiation O
appears O
to O
utilize _RARE_
ERK I-GENE
, O
but O
not O
JNK I-GENE
/ O
SPK _RARE_
or O
p38 I-GENE
signaling _RARE_
. O

We O
recommend _RARE_
that O
paracervical _RARE_
block _RARE_
with O
lignocaine _RARE_
should O
be O
used O
in O
conjunction O
with O
i O
. O
v O
. O
sedation O
/ O
analgesia O
during _RARE_
egg _RARE_
collection O
performed O
through O
the O
transvaginal _RARE_
route O
under O
ultrasound O
guidance _RARE_
( O
TUGOR _RARE_
) O
to O
reduce O
the O
pain O
of O
the O
procedure O
. O

All O
loci O
have O
a O
similar O
organization O
, O
except O
for _RARE_
H1 _RARE_
. I-GENE
8 I-GENE
that O
harbors _RARE_
two O
TcP2beta _RARE_
genes I-GENE
arranged O
in O
tandem _RARE_
and O
separated O
by O
a O
short O
repetitive _RARE_
sequence O
, O
named O
SIRE _RARE_
( O
short O
interspersed O
repetitive _RARE_
element O
), _RARE_
which O
is O
also O
found O
upstream O
of O
the O
first _RARE_
gene O
of O
the O
tandem _RARE_
and O
downstream _RARE_
of O
the O
second O
. O

A O
proportion O
of O
APC _RARE_
wild O
- O
type O
colon O
carcinomas O
and O
melanomas O
also O
contains O
constitutive _RARE_
nuclear O
Tcf _RARE_
- I-GENE
4 I-GENE
/ O
beta I-GENE
- I-GENE
catenin I-GENE
complexes O
as _RARE_
a O
result O
of O
dominant O
mutations O
in O
the O
N O
terminus O
of O
beta I-GENE
- I-GENE
catenin I-GENE
that O
render _RARE_
it O
insensitive _RARE_
to O
downregulation _RARE_
by O
APC _RARE_
, O
GSK3 _RARE_
beta I-GENE
, O
and O
Axin _RARE_
/ O
Conductin _RARE_
. O

Similar O
mechanisms O
leading O
to O
deregulation _RARE_
of O
Tcf _RARE_
target I-GENE
gene I-GENE
activity O
are O
likely O
to O
be O
involved O
in O
melanoma _RARE_
and O
other O
forms O
of O
cancer _RARE_
. O

This O
report O
describes O
a O
patient O
with O
a O
previous O
inferior O
acute O
myocardial _RARE_
infarction O
who O
developed O
right O
ventricular O
infarction O
with O
significant O
anterior O
lead O
ST O
segment O
elevation O
( O
V1 _RARE_
- O
V4 _RARE_
) O
caused O
by O
the O
loss _RARE_
of O
two O
large O
right O
ventricular O
branches _RARE_
during _RARE_
a O
coronary O
angioplasty _RARE_
of O
the O
right O
coronary O
artery O
. O

PATIENTS O
AND _RARE_
METHODS O
: O
Immediately _RARE_
before O
radical O
prostatectomy _RARE_
, O
bone O
marrow O
aspirates _RARE_
from O
both O
sides O
of O
the O
iliac O
crest _RARE_
were O
taken O
from O
287 _RARE_
patients O
. O

PURPOSE O
: O
Previous O
WR O
- O
2721 O
human O
pharmacokinetic O
studies O
were O
limited O
to O
plasma O
levels O
in O
patients O
receiving O
platinum _RARE_
- O
based O
compounds O
, O
and O
none O
includes O
the O
effects O
of O
WR O
- O
2721 O
on O
endogenous O
thiols _RARE_
. O

With O
regard O
to O
nonhematologic _RARE_
toxicities _RARE_
, O
diarrhea _RARE_
, O
infection O
and O
elevated O
serum I-GENE
alkaline _RARE_
phosphatase I-GENE
of O
grade O
3 O
or O
over O
were O
observed O
in O
2 O
% O
of O
cycles O
, O
but O
were O
tolerable _RARE_
and O
reversible O
. O

LHbeta _RARE_
is O
expressed _RARE_
in O
pituitary O
gonadotrope _RARE_
cells O
and O
CGbeta _RARE_
is O
expressed _RARE_
in O
placental _RARE_
trophoblast _RARE_
cells O
. O

Regulation O
of O
HIV O
- O
1 O
transcription O
. O

Human I-GENE
LTBP _RARE_
- I-GENE
1 I-GENE
is O
known O
to O
exist O
in O
different O
forms O
. O

In O
an O
earlier O
study O
( O
Kimura _RARE_
, O
Y O
., O
Kurzydlowski _RARE_
, O
K O
., O
Tada _RARE_
, O
M O
., O
and O
MacLennan _RARE_
, O
D O
. O

It O
consists O
of O
2185 _RARE_
amino O
acid O
residues O
encoded O
by O
a O
9 O
- O
kilobase _RARE_
pair _RARE_
mRNA O
; O
several O
splice _RARE_
variants O
have O
been O
detected O
in O
human O
and O
rat O
cDNA O
libraries O
. O

Cyclic _RARE_
AMP I-GENE
- I-GENE
dependent I-GENE
protein I-GENE
kinase I-GENE
binding O
to O
A I-GENE
- I-GENE
kinase I-GENE
anchoring _RARE_
proteins O
in O
living O
cells O
by O
fluorescence O
resonance O
energy O
transfer O
of O
green _RARE_
fluorescent _RARE_
protein I-GENE
fusion O
proteins O
. O

CONCLUSIONS O
: O
In O
addition O
to O
the O
superiority _RARE_
of O
octafluoropropane _RARE_
- O
filled O
microspheres O
to O
air O
- O
filled O
microspheres O
for _RARE_
LV O
opacification _RARE_
, O
the O
efficacy O
of O
OCTA _RARE_
is O
relatively O
unaffected O
by O
impaired O
LV O
function O
and O
is O
less O
susceptible O
to O
the O
effects O
of O
poor O
echogenicity _RARE_
than O
AIR _RARE_
. O

Factor _RARE_
XI _RARE_
deficiency O
is O
a O
rare O
hereditary _RARE_
bleeding O
disorder O
affecting O
the O
intrinsic _RARE_
pathway _RARE_
. O

The O
Ishasha _RARE_
samples O
show O
a O
range O
encompassing _RARE_
three O
trophic _RARE_
levels O
. O

The O
more O
traditional _RARE_
SERMS _RARE_
, O
clomiphene _RARE_
citrate _RARE_
and O
tamoxifen _RARE_
, O
will O
be O
reviewed O
along O
with O
such O
modern O
drugs O
as _RARE_
raloxifene _RARE_
and O
faslodex _RARE_
, O
with O
emphasis _RARE_
upon O
their O
actions O
on O
breast O
, O
uterus _RARE_
, O
bone O
and O
lipids O
. O

Ti _RARE_
exhibited O
a O
feather _RARE_
- O
like O
morphology O
. O

This O
organization O
suggests O
that O
duplication O
events O
that O
have O
generated O
the O
primate O
FUT3 _RARE_
- O
FUT5 _RARE_
- O
FUT6 _RARE_
cluster O
might O
have O
occurred O
through O
a O
long O
- O
interspersed O
- O
nuclear O
- O
element O
- O
based O
mechanism O
of O
unequal _RARE_
crossing _RARE_
over O
, O
as _RARE_
described O
for _RARE_
the O
globin I-GENE
cluster I-GENE
. O

S O
., O
Kim _RARE_
, O
S O
. O

The O
cop _RARE_
region I-GENE
also O
harbors _RARE_
a O
region O
of O
plasmid _RARE_
incompatibility _RARE_
, O
inc _RARE_
, O
encompassing _RARE_
a O
stem _RARE_
- O
loop O
structure _RARE_
, O
the O
repA _RARE_
promoter I-GENE
, O
Prep _RARE_
, O
as _RARE_
well _RARE_
as _RARE_
two O
distinct O
RepA _RARE_
binding I-GENE
sites I-GENE
, O
BD _RARE_
- O
1 O
and O
BD _RARE_
- O
2 O
. O

WA _RARE_
constructs O
afforded _RARE_
relaxed _RARE_
and O
positive O
topoisomers _RARE_
, O
and O
cyclization _RARE_
kinetics O
indicated O
slow O
interconversion _RARE_
of O
precursors _RARE_
to O
the O
two O
topoisomers _RARE_
. O

The O
RFX _RARE_
protein I-GENE
family I-GENE
includes O
members O
from O
yeast O
to O
humans O
, O
which O
function O
in O
various O
biological O
systems _RARE_
, O
and O
share O
a O
DNA O
- O
binding O
domain O
and O
a O
conserved _RARE_
C O
- O
terminal O
region O
. O

Binding O
to O
sulphatides _RARE_
and O
the O
alpha I-GENE
- I-GENE
dystroglycan _RARE_
receptor I-GENE
was O
much O
stronger O
and O
required O
at _RARE_
least O
two O
LG _RARE_
modules _RARE_
. O

Here O
, O
we O
propose O
that O
an O
antagonistic O
, O
BMP I-GENE
/ O
ALK2 _RARE_
/ O
Smad I-GENE
- O
mediated _RARE_
signaling _RARE_
pathway _RARE_
is O
active _RARE_
on O
the O
right O
side _RARE_
of O
the O
Xenopus O
embryo _RARE_
. O

These O
kinases O
belong O
to O
a O
new O
subfamily O
related O
to O
the O
Trk _RARE_
subfamily I-GENE
. O

The O
data O
indicate O
that O
etr _RARE_
- I-GENE
1 I-GENE
is O
essential O
for _RARE_
muscle O
development O
in O
C O
. O
elegans O
, O
perhaps O
by O
playing _RARE_
a O
role O
in O
post O
- O
transcriptional O
processing _RARE_
of O
some O
muscle O
component _RARE_
, O
and O
thus O
suggesting O
a O
possible O
conservation O
of O
gene O
function O
with O
human I-GENE
CUG _RARE_
- I-GENE
bp I-GENE
. O

Gentamicin _RARE_
given O
by O
DPI _RARE_
and O
SVN _RARE_
significantly O
decreased O
the O
sputum _RARE_
Psa _RARE_
density O
( O
p O
< O
0 _RARE_
. O
05 O
), _RARE_
by O
almost O
one O
order O
of O
magnitude O
. O

CONCLUSIONS O
: O
The O
largest O
value O
of O
the O
joint O
space O
may O
be O
used O
when O
evaluating O
rheumatoid O
AC _RARE_
joint O
space O
. O

An O
analysis O
of O
sequence O
of O
the O
mutant I-GENE
recN _RARE_
gene I-GENE
revealed O
a O
G O
: O
C O
to O
T O
: O
A O
transversion O
near O
the O
3 O
' O
end O
of O
the O
coding O
region O
. O

Nevertheless O
, O
in O
view O
of O
the O
potential _RARE_
transmission _RARE_
rates O
of O
HGV _RARE_
and O
the O
lack O
of O
effective O
immunization O
, O
HGV _RARE_
should O
be O
regarded O
as _RARE_
a O
potential _RARE_
occupational _RARE_
hazard _RARE_
for _RARE_
medical O
and O
dental O
staff _RARE_
. O

Detection O
of O
poisoning O
by O
Impila _RARE_
( O
Callilepis _RARE_
laureola _RARE_
) O
in O
a O
mother _RARE_
and O
child O
. O

We O
have O
previously O
identified O
mouse I-GENE
and I-GENE
human I-GENE
cDNAs I-GENE
encoding I-GENE
UNC I-GENE
- I-GENE
51 _RARE_
- I-GENE
like I-GENE
kinase I-GENE
( O
ULK1 _RARE_
). O

ULKs _RARE_
and O
UNC I-GENE
- I-GENE
51 _RARE_
share O
a O
typical O
domain O
structure _RARE_
of O
an O
amino O
- O
terminal O
kinase O
domain O
, O
a O
central O
proline O
/ O
serine O
rich O
( O
PS _RARE_
) O
domain O
, O
and O
a O
carboxy _RARE_
- O
terminal O
( O
C O
) O
domain O
. O

These O
results O
suggest O
that O
ULK2 _RARE_
is O
involved O
in O
a O
previously O
uncharacterized O
signaling _RARE_
pathway _RARE_
in O
mammalian O
cells O
. O

Connector _RARE_
enhancer I-GENE
of I-GENE
KSR _RARE_
( O
CNK _RARE_
) O
is O
a O
multidomain _RARE_
protein O
required O
for _RARE_
RAS _RARE_
signaling _RARE_
. O

In O
simpler _RARE_
organisms O
, O
the O
ATP I-GENE
sulfurylase _RARE_
and O
APS _RARE_
kinase I-GENE
reactions O
are O
catalyzed O
by O
separate O
enzymes _RARE_
encoded O
by O
two O
or O
three O
genes O
, O
suggesting O
that O
a O
fusion O
of O
separate O
genes O
during _RARE_
the O
course O
of O
evolution O
generated O
the O
bifunctional _RARE_
enzyme O
. O

Epstein I-GENE
- I-GENE
Barr I-GENE
virus I-GENE
( I-GENE
EBV _RARE_
) I-GENE
latent I-GENE
membrane I-GENE
protein I-GENE
1 I-GENE
( O
LMP1 I-GENE
) O
is O
essential O
for _RARE_
EBV _RARE_
- O
mediated _RARE_
transformation O
of O
primary _RARE_
B O
lymphocytes O
. O

The O
amino O
- O
terminal O
half _RARE_
of O
1a _RARE_
is O
a O
distant O
homolog I-GENE
of I-GENE
alphavirus _RARE_
nonstructural _RARE_
protein I-GENE
nsP1 _RARE_
, O
which O
has O
been O
implicated O
in O
capping _RARE_
viral O
RNAs O
. O

Moreover O
, O
a O
recombinant O
Ad _RARE_
expressing O
Ad5 _RARE_
E4orf6 _RARE_
/ I-GENE
7 I-GENE
induced _RARE_
apoptosis O
in O
rat O
cells O
when O
coinfected _RARE_
with O
wild O
- O
type O
p53 I-GENE
- O
expressing O
Ad _RARE_
. O

In O
HCMV _RARE_
( O
Towne _RARE_
)- O
infected _RARE_
HF _RARE_
cells O
at _RARE_
24 _RARE_
to O
48 _RARE_
h O
, O
IE2 I-GENE
also O
accumulated O
in O
newly O
formed O
viral O
DNA O
replication O
compartments _RARE_
containing O
the O
polymerase I-GENE
processivity _RARE_
factor I-GENE
( O
UL44 _RARE_
), _RARE_
the O
single I-GENE
- I-GENE
stranded _RARE_
DNA I-GENE
binding I-GENE
protein I-GENE
( O
SSB I-GENE
; O
UL57 _RARE_
), _RARE_
the O
UL112 _RARE_
- I-GENE
113 _RARE_
accessory _RARE_
protein I-GENE
, O
and O
newly O
incorporated O
bromodeoxyuridine _RARE_
( O
BrdU _RARE_
). O

Macroscopic _RARE_
researches _RARE_
on O
heart _RARE_
vascularization _RARE_
have O
indicated O
that O
the O
angioarchitecture _RARE_
of O
the O
conducting _RARE_
system _RARE_
differs O
from O
that O
of O
the O
normal O
myocardium O
. O

CONCLUSION O
( O
S O
): O
Measuring _RARE_
urinary _RARE_
LH _RARE_
levels O
is O
an O
excellent O
method O
for _RARE_
determining _RARE_
ovulation O
. O

However O
, O
reoperation _RARE_
for _RARE_
bulky _RARE_
cervical O
disease _RARE_
( O
group O
3 O
) O
rarely O
results O
in O
normal O
calcitonin I-GENE
levels O
and O
is O
associated O
with O
a O
high O
incidence O
of O
permanent O
hypoparathyroidism _RARE_
. O

We O
present O
a O
case O
of O
carcinoma O
of O
the O
breast O
presenting _RARE_
concurrently _RARE_
with O
SSc _RARE_
that O
subsequently O
progressed O
to O
dialysis O
- O
dependent O
renal _RARE_
failure O
in O
just O
1 O
month O
. O

PURPOSE O
: O
To O
evaluate O
the O
disease _RARE_
- O
free O
survival O
( O
DFS _RARE_
) O
and O
overall O
survival O
( O
OS _RARE_
), _RARE_
prognostic O
factors O
, O
and O
treatment O
- O
related O
mortality O
of O
women O
with O
stage _RARE_
IIIB _RARE_
inflammatory O
breast O
cancer _RARE_
( O
IBC _RARE_
) O
treated O
with O
combined O
modality O
therapy O
( O
CMT _RARE_
) O
and O
high O
- O
dose O
chemotherapy O
( O
HDCT _RARE_
) O
with O
autologous O
stem _RARE_
- O
cell O
transplantation O
. O

The O
GPI _RARE_
anchor _RARE_
moiety _RARE_
is O
either O
absent O
or O
present O
at _RARE_
a O
very O
low O
level O
in O
the O
polypeptide O
expressed _RARE_
from O
the O
cDNA O
that O
contained O
both O
the O
signal O
peptide O
and O
GPI _RARE_
signal O
sequences O
. O

We O
have O
cloned _RARE_
a O
novel O
100 _RARE_
- O
kDa O
mammalian O
protein O
, O
which O
was O
recognized _RARE_
by O
an O
anti O
- O
peptide O
antibody O
against O
an O
epitope _RARE_
- O
containing O
nuclear O
localization _RARE_
signal O
of O
NF _RARE_
- I-GENE
kappaB I-GENE
p65 _RARE_
subunit I-GENE
. O

Insulin I-GENE
- O
regulated O
events O
, O
however O
, O
occur O
in O
all O
cells O
. O

Regulatory _RARE_
regions O
in O
the O
promoter O
and O
third O
intron O
of O
the O
growth I-GENE
hormone I-GENE
gene I-GENE
in I-GENE
rainbow _RARE_
trout _RARE_
, O
Oncorhynchus _RARE_
mykiss _RARE_
walbaum _RARE_
. O

Although O
most O
SFV _RARE_
genes O
have O
homologs O
encoded O
by O
other O
Chordopoxvirinae _RARE_
, O
the O
SFV _RARE_
genome O
lacks O
a O
key O
gene O
required O
for _RARE_
the O
production O
of O
extracellular O
enveloped _RARE_
virus O
. O

They O
self O
- O
completed O
the O
SF _RARE_
- O
36 _RARE_
questionnaire O
and O
their O
QoL _RARE_
was O
described O
and O
retrospectively _RARE_
compared O
to O
that O
of O
historical _RARE_
controls O
. O

There O
was O
a O
trend O
toward O
an O
association O
between O
IENF _RARE_
and O
sural _RARE_
nerve O
unmyelinated _RARE_
fiber O
densities _RARE_
( O
r _RARE_
= O
0 _RARE_
. O
32 _RARE_
, O
p O
= O
0 _RARE_
. O
054 _RARE_
). O

In O
addition O
, O
media O
containing O
F I-GENE
beta I-GENE
alpha I-GENE
/ O
CG _RARE_
beta I-GENE
displayed O
high O
- O
affinity O
binding O
to O
both O
CG _RARE_
and I-GENE
FSH I-GENE
receptors I-GENE
. O

In O
contrast O
, O
AP I-GENE
- I-GENE
2 I-GENE
binding O
activity O
was O
significantly O
greater O
in O
T47D _RARE_
cells O
, O
and O
Western O
blots O
confirmed O
increased O
AP I-GENE
- I-GENE
2 I-GENE
protein I-GENE
levels O
in O
these O
cells O
. O

N O
. O
van _RARE_
Hoek _RARE_
, O
and O
M O
. O

Here O
, O
we O
describe O
a O
tyrosine O
- O
phosphorylated _RARE_
nuclear O
protein O
, O
YT521 _RARE_
- I-GENE
B I-GENE
, O
and O
show O
that O
it O
interacts O
with O
the O
nuclear I-GENE
transcriptosomal _RARE_
component _RARE_
scaffold _RARE_
attachment _RARE_
factor I-GENE
B I-GENE
, O
and O
the O
68 _RARE_
- I-GENE
kDa I-GENE
Src I-GENE
substrate O
associated O
during _RARE_
mitosis O
, O
Sam68 _RARE_
. O

These O
mutants O
all O
failed O
to O
interact O
with O
the O
TraR _RARE_
fusion I-GENE
in O
the O
two O
- O
hybrid _RARE_
system _RARE_
. O

PhoP _RARE_
- O
PhoQ _RARE_
homologues _RARE_
in O
Pseudomonas _RARE_
aeruginosa _RARE_
regulate O
expression _RARE_
of O
the O
outer _RARE_
- I-GENE
membrane I-GENE
protein I-GENE
OprH _RARE_
and O
polymyxin _RARE_
B O
resistance O
. O

Deletion O
of O
fdsR _RARE_
revealed O
a O
dual O
regulatory O
effect O
of O
FdsR _RARE_
on O
the O
fds _RARE_
operon I-GENE
by O
acting O
as _RARE_
transcriptional O
activator O
in O
the O
presence O
of O
formate O
or O
as _RARE_
repressor O
in O
the O
absence O
of O
formate O
. O

With O
constructs O
containing O
the O
binding O
site O
of O
one O
gene O
fused O
to O
the O
promoter O
of O
the O
other O
, O
we O
demonstrated O
that O
the O
positional _RARE_
requirements O
are O
a O
function O
of O
the O
specific O
binding O
site O
, O
not O
the O
promoter O
. O

In O
addition O
, O
all O
three O
Opa _RARE_
proteins I-GENE
of O
C751 _RARE_
bind O
equally O
well _RARE_
to O
HeLa O
cells O
transfected O
with O
cDNA O
encoding O
the O
carcinoembryonic _RARE_
antigen I-GENE
[ _RARE_
CEA _RARE_
( O
CD66e _RARE_
)] O
subgroup O
of O
the O
CD66 _RARE_
family I-GENE
, O
but O
show O
distinct O
tropism _RARE_
for _RARE_
CGM1 _RARE_
- O
( O
CD66d _RARE_
) O
and O
NCA _RARE_
( O
CD66c _RARE_
)- O
expressing O
cells O
. O

FISH _RARE_
using O
a O
whole O
chromosome _RARE_
4 O
paint _RARE_
demonstrated O
multiple O
rearrangements _RARE_
involving O
chromosome _RARE_
4 O
in O
MCF _RARE_
- O
7 O
AdVp3000 _RARE_
and O
MCF _RARE_
- O
7 O
MX _RARE_
, O
while O
S1 O
- O
M1 _RARE_
- O
80 _RARE_
contained O
only O
a O
simple O
reciprocal O
translocation O
. O

The O
MXR _RARE_
gene I-GENE
encodes O
a O
half _RARE_
- O
transporter _RARE_
and O
the O
absence O
of O
cytogenetic O
evidence O
of O
coamplification _RARE_
of O
other O
regions O
suggests O
that O
a O
partner _RARE_
may O
not O
be O
overexpressed O
, O
and O
instead O
the O
MXR _RARE_
half _RARE_
- I-GENE
transporter _RARE_
homodimerizes _RARE_
to O
mediate O
drug O
transport _RARE_
. O

The O
effect O
of O
smoking O
was O
not O
examined O
in O
this O
study O
, O
as _RARE_
such O
data O
were O
not O
available O
. O

Serum I-GENE
insulin I-GENE
- I-GENE
like I-GENE
growth I-GENE
factor I-GENE
I I-GENE
( O
IGF I-GENE
- I-GENE
I I-GENE
) O
SD O
score O
increased O
from O
- O
2 O
. O
2 O
and O
- O
4 O
. O
2 O
in O
men O
and O
women O
, O
respectively O
, O
to O
1 O
. O
8 O
and O
- O
0 _RARE_
. O
9 O
at _RARE_
6 O
months O
and O
0 _RARE_
. O
8 O
and O
- O
0 _RARE_
. O
7 O
at _RARE_
12 O
months O
. O

BACKGROUND O
: O
Measurement O
of O
stereoacuity _RARE_
at _RARE_
varying O
distances O
, O
by O
real O
or O
simulated O
depth O
stereoacuity _RARE_
tests O
, O
is O
helpful O
in O
the O
evaluation O
of O
patients O
with O
binocular _RARE_
imbalance _RARE_
or O
strabismus _RARE_
. O

Additional _RARE_
studies O
revealed O
that O
bovine I-GENE
brain I-GENE
Galpha _RARE_
( I-GENE
q _RARE_
/ I-GENE
11 I-GENE
) I-GENE
could O
also O
bind O
to O
an O
N O
- O
terminal O
construct O
of O
GRK2 _RARE_
, O
while O
no _RARE_
binding O
of O
Galpha _RARE_
( O
q _RARE_
/ O
11 O
), _RARE_
Galpha _RARE_
( O
s O
), _RARE_
Galpha _RARE_
( O
i O
), _RARE_
or O
Galpha _RARE_
( I-GENE
12 I-GENE
/ I-GENE
13 _RARE_
) I-GENE
to O
comparable O
constructs O
of O
GRK5 _RARE_
or O
GRK6 _RARE_
was O
observed O
. O

The O
elm1 _RARE_
kinase I-GENE
functions O
in O
a O
mitotic _RARE_
signaling _RARE_
network O
in O
budding _RARE_
yeast O
. O

Reverse _RARE_
transcription O
( O
RT O
)- O
PCR O
products O
were O
synthesized O
with O
two O
degenerate O
primers O
derived O
from O
the O
conserved _RARE_
motifs O
of O
various O
tyrosine I-GENE
kinases I-GENE
. O

In O
addition O
, O
the O
acetyltransferase _RARE_
activity O
of O
p300 I-GENE
was O
observed O
to O
be O
distinct O
from O
the O
broadly O
essential O
activation O
function O
of O
the O
CH3 _RARE_
domain I-GENE
/ O
E1A I-GENE
- O
binding O
region O
. O

The O
proliferation _RARE_
- O
specific O
HNF I-GENE
- I-GENE
3 I-GENE
/ O
fork I-GENE
head I-GENE
homolog I-GENE
- I-GENE
11B _RARE_
protein O
( O
HFH _RARE_
- I-GENE
11B _RARE_
; O
also O
known O
as _RARE_
Trident _RARE_
and O
Win _RARE_
) O
is O
a O
family O
member _RARE_
of O
the O
winged _RARE_
helix I-GENE
/ O
fork I-GENE
head I-GENE
transcription O
factors O
and O
in O
regenerating _RARE_
liver O
its O
expression _RARE_
is O
reactivated _RARE_
prior O
to O
hepatocyte _RARE_
entry O
into O
DNA O
replication O
( O
S O
phase _RARE_
). O

In O
the O
mouse O
, O
CtBP1 _RARE_
is O
expressed _RARE_
from O
embryo _RARE_
to O
adult O
, O
but O
CtBP2 _RARE_
is O
mainly O
expressed _RARE_
during _RARE_
embryogenesis O
. O

The O
multiple O
functions O
of O
Pmt3p _RARE_
described O
here O
suggest O
that O
several O
nuclear O
proteins O
are O
regulated O
by O
Pmt3p _RARE_
conjugation O
. O

The O
role O
of O
transport _RARE_
by O
sea _RARE_
ice _RARE_
from O
the O
Kara _RARE_
Sea _RARE_
into O
the O
Arctic _RARE_
Ocean _RARE_
was O
assessed O
by O
a O
small O
subgroup O
at _RARE_
GEOMAR _RARE_
. O

We O
determined O
whether O
a O
single O
injection O
of O
slow O
- O
release O
estradiol O
- O
17beta _RARE_
( O
SRE2 _RARE_
) O
would O
induce O
pseudopregnancy _RARE_
in O
gilts _RARE_
and O
whether O
PGF2alpha _RARE_
would O
regress _RARE_
the O
corpora _RARE_
lutea _RARE_
( O
CL O
) O
of O
pseudopregnancy _RARE_
. O

The O
level O
of O
serum I-GENE
creatine _RARE_
kinase I-GENE
was O
significantly O
high O
2 O
days O
after O
ESWIB _RARE_
, O
but O
it O
recovered O
in O
a O
week O
. O

Among O
the O
remaining O
22 _RARE_
sites O
, O
six _RARE_
are O
in O
the O
promoters O
of O
known O
alpha O
- O
specific O
genes O
and O
two O
other O
sites O
have O
an O
alpha2 _RARE_
- O
Mcm1 _RARE_
- O
dependent O
role O
in O
determining _RARE_
the O
direction O
of O
mating _RARE_
type O
switching O
. O

Activation O
of O
T O
cells O
via O
the O
TCR I-GENE
and O
other O
costimulatory _RARE_
receptors O
triggers O
a O
number O
of O
signaling _RARE_
cascades _RARE_
. O

A O
phylogenetic O
analysis O
with O
the O
TK I-GENE
domains I-GENE
from O
these O
sequences O
and O
a O
fourth O
, O
from O
a O
novel O
scavenger _RARE_
RTK _RARE_
( O
all O
domains O
comprise O
the O
signature _RARE_
for _RARE_
the O
TK I-GENE
class I-GENE
II I-GENE
receptors I-GENE
), _RARE_
showed O
that O
they O
are O
distantly O
related O
to O
the O
insulin I-GENE
and O
insulin I-GENE
- I-GENE
like I-GENE
receptors I-GENE
. O

Several O
7SL _RARE_
RNA I-GENE
- I-GENE
encoding I-GENE
sequences I-GENE
and O
various O
intergenic O
spacers _RARE_
were O
amplified O
from O
the O
individual O
HindIII I-GENE
fragments I-GENE
of O
about O
1 O
. O
3 O
and O
2 O
. O
8 O
kb O
. O

Results O
confirmed O
that O
stress O
produced O
CA3 O
dendritic _RARE_
atrophy O
and O
tianeptine _RARE_
prevented O
it O
. O

We O
have O
isolated O
a O
binding O
partner _RARE_
for _RARE_
the O
Fanconi _RARE_
anemia _RARE_
group I-GENE
C I-GENE
protein I-GENE
( O
FANCC _RARE_
) O
by O
yeast O
two O
- O
hybrid _RARE_
screening O
. O

These O
results O
suggest O
that O
both O
transcription O
activators _RARE_
depend O
on O
or O
interact O
with O
different O
subunits O
of O
RNA I-GENE
polymerase I-GENE
, O
although O
their O
role O
in O
formation O
of O
proper O
DNA O
geometry _RARE_
may O
also O
be O
crucial O
. O

Klebsiella _RARE_
oxytoca _RARE_
can O
assimilate _RARE_
nitrate _RARE_
and O
nitrite _RARE_
by O
using O
enzymes _RARE_
encoded O
by O
the O
nasFEDCBA _RARE_
operon I-GENE
. O

Marked O
hemolysis _RARE_
significantly O
increased O
plasma O
values O
of O
potassium _RARE_
, O
phosphorus O
, O
total _RARE_
protein O
, O
and O
aspartate _RARE_
aminotransferase I-GENE
. O

Studies O
have O
substantiated _RARE_
the O
involvement O
of O
numerous O
loci O
on O
certain O
chromosomes O
; O
in O
excess O
of O
10 O
chromosomes O
are O
thought O
to O
be O
involved O
. O

By O
negatively O
regulating _RARE_
GRK _RARE_
- O
mediated _RARE_
receptor O
phosphorylation _RARE_
, O
beta I-GENE
- I-GENE
arrestin _RARE_
- O
mediated _RARE_
processes O
such O
as _RARE_
Src I-GENE
recruitment O
and O
clathrin I-GENE
- O
mediated _RARE_
internalization O
, O
which O
are O
required O
for _RARE_
GPCR _RARE_
- O
mediated _RARE_
ERK I-GENE
activation O
, O
are O
inhibited O
, O
thus O
dampening _RARE_
further O
ERK I-GENE
activation O
. O

Based O
on O
subcellular O
fractionation O
, O
the O
47 _RARE_
- I-GENE
kDa I-GENE
P I-GENE
- I-GENE
CIP2 _RARE_
protein I-GENE
is O
mostly O
cytosolic O
. O

Supershift _RARE_
EMSAs _RARE_
identified O
that O
upstream I-GENE
stimulatory _RARE_
factor I-GENE
- I-GENE
1 I-GENE
and I-GENE
- I-GENE
2 I-GENE
( O
USF I-GENE
- I-GENE
1 I-GENE
and I-GENE
- I-GENE
2 I-GENE
) O
were O
part O
of O
these O
complexes O
. O

Conversely O
, O
E1A I-GENE
binding O
to O
only O
p300 I-GENE
/ O
CBP I-GENE
results O
in O
an O
increase O
in O
PARP _RARE_
enzyme I-GENE
activity O
and O
consequently _RARE_
in O
cell O
death _RARE_
susceptibility _RARE_
to O
irradiation O
, O
which O
is O
effectively O
counteracted _RARE_
by O
the O
PARP _RARE_
chemical O
inhibitor O
3 O
- O
aminobenzamide _RARE_
. O

Analysis O
of O
its O
genomic O
region O
revealed O
that O
the O
13 _RARE_
- O
kb O
Cdc6 _RARE_
gene I-GENE
is O
divided O
into O
12 O
exons O
by O
11 O
introns _RARE_
. O

These O
include O
the O
CACCC _RARE_
and O
CAAT O
motifs O
. O

Skin _RARE_
pH O
changes O
associated O
with O
iontophoresis _RARE_
. O

This O
distinction _RARE_
was O
based O
upon O
whether O
the O
diagnosis O
provided O
a O
straightforward _RARE_
range O
of O
prognoses _RARE_
or O
an O
ambiguous _RARE_
clinical O
implication _RARE_
. O

The O
availability O
of O
potent O
regulatory O
DNA O
cassettes _RARE_
harboring O
the O
murine I-GENE
D1A _RARE_
gene I-GENE
promoter I-GENE
could O
aid O
testing O
the O
neuronal _RARE_
- O
specific O
expression _RARE_
of O
transgenes _RARE_
in O
vivo O
. O

It O
may O
be O
dependent O
on O
location O
of O
a O
focus O
( O
according O
to O
EEG O
) O
as _RARE_
well _RARE_
as _RARE_
on O
the O
character O
and O
manifestation O
of O
the O
accompanying O
neuropsychologic _RARE_
symptomatology _RARE_
. O

The O
results O
of O
these O
studies O
demonstrate O
that O
the O
rat O
HDL _RARE_
receptor O
SR I-GENE
- I-GENE
BI _RARE_
promoter O
contains O
two O
sterol O
response O
elements O
( O
pSRE _RARE_
and O
dSRE _RARE_
) O
through O
which O
SREBP I-GENE
- I-GENE
1a _RARE_
can O
bind O
and O
activate O
transcription O
of O
this O
gene O
. O

Phosphorylation _RARE_
of O
myosin I-GENE
- I-GENE
binding I-GENE
subunit I-GENE
( O
MBS _RARE_
) O
of O
myosin I-GENE
phosphatase I-GENE
by O
Rho I-GENE
- I-GENE
kinase I-GENE
in O
vivo O
. O

Of O
these O
patients O
, O
46 _RARE_
, O
164 _RARE_
were O
placed O
on O
a O
waiting _RARE_
list _RARE_
for _RARE_
transplantation O
, O
23 _RARE_
, O
275 _RARE_
of O
whom O
received O
a O
first _RARE_
cadaveric _RARE_
transplant O
between O
1991 O
and O
1997 O
. O

In O
electrophoretic O
mobility O
shift O
assay O
( O
EMSA O
), _RARE_
this O
GLUT4 _RARE_
repressor I-GENE
element I-GENE
( O
G4RE _RARE_
) O
generated O
specific O
bands O
with O
nuclear O
extracts O
from O
preadipocytes _RARE_
, O
but O
not O
from O
adipocytes O
. O

Syndromes _RARE_
of O
abnormal O
fat O
redistribution _RARE_
and O
metabolic O
complications O
in O
HIV O
- O
infected _RARE_
patients O
. O

Cytoprotection _RARE_
with O
amifostine _RARE_
in O
radiotherapy O
or O
radio _RARE_
- O
chemotherapy O
of O
head O
and O
neck O
tumors O

Immunohistochemical _RARE_
staining O
was O
positive O
for _RARE_
S I-GENE
- I-GENE
100 _RARE_
in O
all O
9 O
cases O
stained O
, O
positive O
for _RARE_
HMB _RARE_
- I-GENE
45 _RARE_
in O
9 O
( O
90 _RARE_
%) O
of O
10 O
, O
and O
negative O
for _RARE_
cytokeratin _RARE_
in O
all O
9 O
cases O
in O
which O
myxoid _RARE_
melanoma _RARE_
remained O
in O
the O
block _RARE_
after O
previous O
sections O
. O

Patients O
with O
types _RARE_
I O
and O
III O
MPGN _RARE_
did O
not O
differ O
in O
age O
at _RARE_
apparent O
onset O
, O
age O
at _RARE_
diagnosis O
, O
or O
interval O
from O
apparent O
onset O
of O
symptoms O
to O
diagnosis O
( O
biopsy O
). O

Residual _RARE_
urinary _RARE_
abnormalities O
were O
significantly O
more O
frequent O
in O
patients O
with O
type O
III O
than O
type O
I O
MPGN _RARE_
. O

Taken O
together O
, O
differences O
in O
signaling _RARE_
and O
tissue O
expression _RARE_
suggest O
that O
the O
human I-GENE
intermediate _RARE_
PRLr _RARE_
differs O
from O
the O
long I-GENE
PRLr _RARE_
in O
physiological O
function O
. O

We O
describe O
here O
a O
Drosophila I-GENE
melanogaster I-GENE
FAK I-GENE
homologue I-GENE
, O
DFak56 _RARE_
, O
which O
maps O
to O
band O
56D _RARE_
on O
the O
right O
arm _RARE_
of O
the O
second O
chromosome _RARE_
. O

Because O
the O
Pit I-GENE
- I-GENE
1 I-GENE
sites I-GENE
in O
the O
hGH I-GENE
- I-GENE
N I-GENE
gene I-GENE
promoter I-GENE
are O
insufficient O
for _RARE_
such O
gene O
activation O
in O
vivo O
, O
these O
data O
suggested O
a O
unique O
chromatin O
- O
mediated _RARE_
developmental O
role O
for _RARE_
Pit I-GENE
- I-GENE
1 I-GENE
in O
the O
hGH I-GENE
LCR _RARE_
. O

Recombinant I-GENE
prenylcysteine _RARE_
lyase I-GENE
was O
produced O
in O
a O
baculovirus _RARE_
- O
Sf9 O
expression _RARE_
system _RARE_
. O

We O
show O
here O
that O
the O
third O
SH3 I-GENE
domain I-GENE
binds O
to O
Sos I-GENE
, O
a O
guanine I-GENE
nucleotide I-GENE
exchange I-GENE
factor I-GENE
for _RARE_
Ras I-GENE
and O
Rac I-GENE
, O
both O
in O
vitro O
and O
in O
vivo O
. O

Point _RARE_
mutations O
in O
the O
third O
SH3 I-GENE
domain I-GENE
abolished O
the O
vinexin _RARE_
- O
Sos I-GENE
interaction O
. O

In O
gel O
mobility O
shift O
assays O
, O
low O
binding O
activity O
of O
CBF I-GENE
to O
the O
wild I-GENE
- I-GENE
type I-GENE
AtpC _RARE_
promoter I-GENE
sequence I-GENE
was O
observed O
with O
nuclear O
extracts O
from O
tissue O
with O
low O
AtpC _RARE_
expression _RARE_
levels O
, O
i O
. O
e _RARE_
. O
extracts O
from O
etiolated _RARE_
and O
photobleached _RARE_
seedlings O
, O
whereas O
high O
binding O
activity O
was O
detectable O
with O
extracts O
from O
tissues O
with O
high O
AtpC _RARE_
expression _RARE_
levels O
, O
i O
. O
e _RARE_
. O
extracts O
from O
light O
- O
grown O
seedlings O
and O
etiolated _RARE_
seedlings O
treated O
with O
cytokinin _RARE_
. O

Mycoplasma _RARE_
hominis _RARE_
infections O
are O
easily O
missed _RARE_
because O
conventional O
methods O
for _RARE_
bacterial O
detection O
may O
fail O
. O

For O
this O
purpose O
, O
we O
used O
a O
series O
of O
plasmid _RARE_
constructs O
encoding O
different O
forms O
of O
the O
envelope I-GENE
glycoprotein I-GENE
E I-GENE
of I-GENE
the I-GENE
flavivirus _RARE_
tick _RARE_
- I-GENE
borne _RARE_
encephalitis _RARE_
virus I-GENE
. O

They O
are O
subdivided _RARE_
into O
two O
types _RARE_
that O
activate O
transduction _RARE_
pathways O
via O
different O
cell O
surface O
receptors O
. O

We O
report O
here O
that O
out O
of O
the O
major O
pro O
- O
inflammatory O
cytokines _RARE_
examined O
, O
IL _RARE_
- I-GENE
1alpha I-GENE
, O
IL _RARE_
- I-GENE
1beta I-GENE
, O
TNF I-GENE
- I-GENE
alpha I-GENE
and O
IL _RARE_
- I-GENE
6 I-GENE
, O
only O
IL _RARE_
- I-GENE
6 I-GENE
was O
generated O
and O
secreted _RARE_
in O
PKCeta _RARE_
- O
expressing O
cells O
without O
any O
additional O
inducer _RARE_
in O
serum O
- O
supplemented O
cultures O
( O
10 O
% O
FCS _RARE_
). O

Demyelinating _RARE_
diseases O
involving O
the O
grey _RARE_
matter O
were O
very O
rare O
, O
but O
we O
must O
consider O
the O
presence O
of O
symmetrical _RARE_
thalamic _RARE_
involvement O
in O
patients O
with O
ADEM _RARE_
. O

To O
define O
the O
minimal O
VDRE _RARE_
binding O
domain O
for _RARE_
human I-GENE
VDR I-GENE
( O
hVDR _RARE_
), _RARE_
a O
series O
of O
C O
- O
terminally _RARE_
truncated O
hVDR _RARE_
mutants I-GENE
( O
Delta134 _RARE_
, O
Delta113 _RARE_
, O
Delta102 _RARE_
, O
Delta90 _RARE_
, O
Delta84 _RARE_
, O
Delta80 _RARE_
, O
and O
Delta60 _RARE_
) O
was O
generated O
and O
expressed _RARE_
in O
bacteria O
. O

By O
an O
induced _RARE_
- O
fit O
mechanism O
, O
contacts O
with O
the O
anticodon _RARE_
can O
activate O
formation O
of O
a O
robust _RARE_
transition O
state O
at _RARE_
a O
site O
over O
70 O
A O
away _RARE_
. O

These O
REPs _RARE_
, O
or O
clusters O
of O
paralogous _RARE_
loci O
, O
are O
15 _RARE_
- O
100 _RARE_
kb O
and O
harbor O
at _RARE_
least O
four O
ESTs _RARE_
and O
an O
expressed _RARE_
SH3GL _RARE_
pseudogene _RARE_
. O

This O
revealed O
a O
minimum O
of O
six _RARE_
novel O
OSBP _RARE_
- I-GENE
related I-GENE
proteins I-GENE
, O
designated O
ORP _RARE_
- I-GENE
1 I-GENE
to O
ORP _RARE_
- I-GENE
6 I-GENE
. O

In O
part O
as _RARE_
a O
result O
of O
its O
inability _RARE_
to O
sustain _RARE_
radiative _RARE_
loses _RARE_
, O
the O
BB _RARE_
resonator _RARE_
has O
extremely O
low O
RF _RARE_
power O
requirements O
. O

In O
addition O
, O
narZ _RARE_
expression _RARE_
was O
induced _RARE_
approximately _RARE_
20 O
- O
fold _RARE_
intracellularly _RARE_
in O
Madin _RARE_
- O
Darby _RARE_
canine O
kidney _RARE_
epithelial _RARE_
cells O
and O
16 O
- O
fold _RARE_
in O
intracellular _RARE_
salts _RARE_
medium O
, O
which O
is O
believed O
to O
mimic O
the O
intracellular _RARE_
milieu _RARE_
. O

However O
, O
mechanisms O
underlying O
HIV O
- O
1 O
gene O
expression _RARE_
in O
the O
CNS O
are O
poorly O
understood O
. O

Is O
radical O
trachelectomy _RARE_
a O
safe O
alternative _RARE_
to O
radical O
hysterectomy O
for _RARE_
patients O
with O
stage _RARE_
IA O
- O
B O
carcinoma O
of O
the O
cervix O
? O
BACKGROUND O
: O
The O
prognosis O
associated O
with O
lymph O
node O
negative O
, O
early O
stage _RARE_
carcinoma O
of O
the O
cervix O
is O
excellent O
, O
with O
5 O
- O
year O
survival O
rates O
greater O
than O
90 _RARE_
%. O

A O
key O
event O
in O
this O
process O
is O
the O
selective O
recognition O
of O
the O
target O
membrane O
by O
the O
vesicle O
and O
the O
current O
view O
is O
that O
SNARE _RARE_
protein I-GENE
interactions O
likely O
play O
a O
central O
role O
in O
vesicle O
- O
target O
recognition O
and O
or O
membrane O
fusion O
. O

Scapulae _RARE_
with O
a O
Type _RARE_
I O
configuration O
were O
found O
to O
have O
low O
values O
for _RARE_
the O
coraco _RARE_
- O
glenoid _RARE_
angle O
and O
coracoid _RARE_
overlap O
, O
which O
are O
known O
to O
be O
associated O
with O
a O
short O
coraco _RARE_
- O
humeral _RARE_
distance O
. O

Measurements O
in O
the O
LWS _RARE_
p O
. O
a O
. O
, O
LWS _RARE_
lat _RARE_
. O
and O
at _RARE_
Ward _RARE_
' O
s O
triangle _RARE_
were O
made O
in O
a O
total _RARE_
of O
100 _RARE_
patients O
. O

A O
group O
of O
66 _RARE_
DSM _RARE_
- O
IV O
paranoid _RARE_
schizophrenic O
in O
- O
patients O
were O
assessed O
three O
times O
using O
the O
SAPS _RARE_
, O
SANS _RARE_
, O
BPRS _RARE_
and O
PAS _RARE_
. O

In O
conclusion O
: O
( O
i O
) O
TECRA _RARE_
kit O
is O
suggested O
to O
be O
used O
for _RARE_
screening O
SE O
producing O
strains O
; O
( O
ii O
) O
SET _RARE_
- O
RPLA _RARE_
and O
RIDASCREEN _RARE_
kits _RARE_
are O
suitable O
for _RARE_
epidemiological O
investigation O
of O
SE O
types _RARE_
, O
but O
the O
lack O
of O
ability O
for _RARE_
detecting O
SEE _RARE_
, O
long O
time O
required O
for _RARE_
testing O
with O
SET _RARE_
- O
RPLA _RARE_
kit O
and O
high O
background O
when O
using O
RIDASCREEN _RARE_
kit O
must O
be O
overcome O
; O
and O
( O
iii O
) O
because O
of O
the O
complicated O
test O
procedures O
and O
the O
lack O
of O
ability O
for _RARE_
detecting O
SEE _RARE_
, O
the O
practicality _RARE_
of O
SET _RARE_
- O
EIA _RARE_
kit O
in O
screening O
and O
epidemiological O
research O
purposes _RARE_
is O
low O
. O

Comparison O
of O
immunoassay O
kits _RARE_
for _RARE_
detection O
of O
staphylococcal _RARE_
enterotoxins _RARE_
produced O
by O
Staphylococcus _RARE_
aureus _RARE_

Despite O
the O
high O
frequency O
of O
natural _RARE_
infection O
, O
the O
seropositive O
rates O
of O
JEV _RARE_
antibody O
still O
correlated O
well _RARE_
with O
the O
dose O
of O
vaccine O
received O
, O
i O
. O
e _RARE_
., O
67 O
% O
( O
1122 _RARE_
/ O
1664 _RARE_
), _RARE_
66 _RARE_
% O
( O
65 O
/ O
97 O
), _RARE_
33 _RARE_
% O
( O
4 O
/ O
12 O
) O
and O
40 O
% O
( O
19 O
/ O
47 _RARE_
) O
for _RARE_
children O
receiving O
3 O
, O
2 O
, O
1 O
, O
and O
0 _RARE_
dose O
of O
JE _RARE_
vaccines O
, O
respectively O
( O
P O
< O
0 _RARE_
. O
0001 O
Chi O
- O
square O
for _RARE_
trend O
test O
). O

Furthermore O
, O
in O
vivo O
and O
in O
vitro O
protein O
- O
protein O
interaction O
experiments O
have O
shown O
that O
SR33 _RARE_
protein I-GENE
interacts O
with O
itself O
and O
with O
SR45 _RARE_
protein I-GENE
but O
not O
with O
two O
other O
members O
( O
SRZ21 _RARE_
and O
SRZ22 _RARE_
) O
of O
the O
SR I-GENE
family I-GENE
that O
are O
known O
to O
interact O
with O
the O
Arabidopsis O
full O
- O
length O
U _RARE_
- I-GENE
70K _RARE_
only O
. O

In O
summary O
, O
WT1 I-GENE
is O
enriched _RARE_
by O
oligo _RARE_
( O
dT O
) O
chromatography O
, O
as _RARE_
are O
U2AF65 _RARE_
, O
the O
U5 _RARE_
small I-GENE
nuclear I-GENE
RNP _RARE_
- I-GENE
associated I-GENE
protein I-GENE
p116 _RARE_
and O
hnRNP _RARE_
A1 _RARE_
. O

Six O
out O
of O
ten O
hearts O
from O
macerated _RARE_
stillborn _RARE_
infants O
showed O
varying O
degrees O
of O
positive O
staining O
. O

Tih1 _RARE_
maps O
to O
distal O
mouse O
Chr O
1 O
and O
human O
Chr O
1q31 _RARE_
, O
chromosomal O
regions O
that O
have O
not O
shown O
evidence O
for _RARE_
imprinting O
and O
, O
in O
contrast O
to O
Ipl _RARE_
, O
Tih1 _RARE_
is O
expressed _RARE_
equally O
from O
both O
parental O
alleles O
. O

A O
novel O
pleckstrin I-GENE
homology I-GENE
- I-GENE
related I-GENE
gene I-GENE
family I-GENE
defined O
by O
Ipl _RARE_
/ O
Tssc3 _RARE_
, O
TDAG51 _RARE_
, O
and O
Tih1 _RARE_
: O
tissue O
- O
specific O
expression _RARE_
, O
chromosomal O
location O
, O
and O
parental O
imprinting O
. O

The O
potential _RARE_
for _RARE_
highly O
reactive O
nanoparticles _RARE_
( O
RNP _RARE_
) O
to O
absorb _RARE_
destructively _RARE_
, O
i O
. O
e _RARE_
. O
to O
neutralize _RARE_
highly O
toxic O
substances O
such O
as _RARE_
the O
warfare _RARE_
agents O
GA _RARE_
, O
GB _RARE_
, O
HD O
and O
VX _RARE_
, O
has O
been O
demonstrated O
in O
the O
laboratory O
. O

There O
were O
minimal O
negative O
effects O
on O
hematological _RARE_
parameters O
, O
acid O
- O
base _RARE_
status O
, O
and O
blood _RARE_
gases O
. O

Twelve _RARE_
out O
of O
43 _RARE_
renal _RARE_
failure O
patients O
had O
troponin _RARE_
I I-GENE
0 _RARE_
. O
13 _RARE_
- O
0 _RARE_
. O
9 O
microg O
/ O
l _RARE_
using O
Axsym _RARE_
method O
and O
4 O
had O
levels O
of O
0 _RARE_
. O
07 O
- O
0 _RARE_
. O
13 _RARE_
microg O
/ O
l _RARE_
using O
Immuno _RARE_
1 O
. O

Therefore O
, O
we O
propose O
that O
p27 I-GENE
represents O
a O
crucial O
molecule O
in O
HMBA _RARE_
signaling _RARE_
that O
cannot O
be O
replaced O
by O
p21 I-GENE
. O

Transient O
, O
high O
- O
level O
Ras I-GENE
- O
expression _RARE_
induces O
transcriptional O
activation O
of O
p21 I-GENE
mediated _RARE_
by O
a O
GC _RARE_
- O
rich O
region O
in O
p21 I-GENE
promoter I-GENE
- O
83 _RARE_
- O
54 O
bp O
relative O
to O
the O
transcription O
initiation O
site O
containing O
binding O
sites O
for _RARE_
Sp1 _RARE_
- I-GENE
family I-GENE
transcription I-GENE
factors I-GENE
. O

The O
RET I-GENE
/ O
PTC3 _RARE_
rearrangement O
is O
formed O
by O
fusion O
of O
the O
ELE1 _RARE_
and O
RET I-GENE
genes I-GENE
, O
and O
is O
highly O
prevalent _RARE_
in O
radiation O
- O
induced _RARE_
post O
- O
Chernobyl _RARE_
papillary _RARE_
thyroid O
carcinomas O
. O

Apoptosis _RARE_
of O
small O
cells O
is O
still O
observed O
after O
co _RARE_
- O
transfection O
of O
JBD _RARE_
and O
LMP1 I-GENE
but O
in O
addition O
a O
few O
apoptotic O
HD O
- O
MyZ _RARE_
cells O
with O
large O
fused O
nuclear O
masses O
are O
identified O
suggesting O
that O
specific O
inhibition O
of O
JNK I-GENE
leads O
also O
to O
apoptosis O
of O
LMP1 I-GENE
induced _RARE_
RS _RARE_
cells O
. O

In O
addition O
to O
the O
bZIP _RARE_
protein I-GENE
Opaque2 _RARE_
( O
O2 _RARE_
), _RARE_
there O
are O
other O
maize _RARE_
endosperm _RARE_
nuclear O
proteins O
that O
recognize O
the O
O2 _RARE_
box I-GENE
in O
22 _RARE_
kDa O
zein _RARE_
gene O
promoters O
. O

The O
mEmBP _RARE_
- I-GENE
1 I-GENE
protein I-GENE
can O
activate O
transcription O
from O
a O
truncated O
promoter O
containing O
a O
pentamer _RARE_
of O
the O
O2 _RARE_
site I-GENE
in O
yeast O
cells O
; O
however O
, O
it O
inhibited O
regulated O
transcription O
of O
a O
22 _RARE_
kDa I-GENE
zein _RARE_
promoter I-GENE
in O
a O
transient O
expression _RARE_
assay O
using O
cultured O
maize _RARE_
endosperm _RARE_
cells O
. O

GHB _RARE_
, O
2 O
CB _RARE_
, O
HMB _RARE_
, O
are O
some O
of O
these O
recent O
substances O
. O

There O
were O
15 _RARE_
deaths O
, O
seven _RARE_
of O
which O
were O
felt _RARE_
to O
be O
avoidable _RARE_
. O

With O
this O
GH _RARE_
and O
estrogen O
treatment O
regimen O
, O
most O
girls O
with O
TS _RARE_
can O
grow O
and O
develop O
much O
more O
in O
conformity _RARE_
with O
their O
healthy O
peers _RARE_
. O

We O
propose O
that O
the O
reduced _RARE_
responsiveness O
of O
CYP3A2 _RARE_
is O
the O
result O
of O
preferential O
binding O
of O
COUP I-GENE
- I-GENE
TF _RARE_
at _RARE_
the O
CYP3A2 _RARE_
DexRE _RARE_
- I-GENE
1 I-GENE
site I-GENE
. O

Higher _RARE_
CYP3A23 _RARE_
basal O
activity O
appears O
to O
be O
due O
to O
an O
E O
- O
box O
in O
3A23SiteA _RARE_
that O
interacts O
with O
USF1 _RARE_
, O
a O
ubiquitous O
bHLH I-GENE
/ I-GENE
leucine I-GENE
zipper I-GENE
transcription I-GENE
factor I-GENE
. O

The O
first _RARE_
one O
is O
a O
TPA _RARE_
- O
responsive O
element O
that O
controls O
the O
base _RARE_
- O
line O
ST3 _RARE_
promoter I-GENE
activity O
but O
is O
not O
required O
for _RARE_
its O
activation O
. O

To O
understand O
the O
basis O
for _RARE_
the O
increased O
cell O
surface O
stability O
compared O
with O
wild O
- O
type O
peptide O
and O
to O
understand O
the O
differences O
in O
T O
cell O
recognition O
between O
I1Y _RARE_
and O
I1F _RARE_
, O
we O
determined O
the O
x _RARE_
- O
ray O
crystal _RARE_
structures _RARE_
of O
the O
two O
class I-GENE
I I-GENE
MHC I-GENE
- I-GENE
peptide I-GENE
complexes I-GENE
. O

Redistribution _RARE_
of O
mannosidase _RARE_
I I-GENE
was O
also O
observed O
in O
cells O
incubated O
at _RARE_
15 _RARE_
degrees O
C O
. O

In O
addition O
, O
using O
biochemical O
activity O
assays O
for _RARE_
Rho I-GENE
- O
like O
GTPases I-GENE
, O
we O
show O
that O
the O
expression _RARE_
of O
beta1A _RARE_
, O
beta1D _RARE_
, O
or O
IL2R _RARE_
- O
beta1A _RARE_
in O
GE11 _RARE_
or O
GD25 _RARE_
cells O
triggers O
activation O
of O
both O
RhoA I-GENE
and O
Rac1 I-GENE
, O
but O
not O
of O
Cdc42 I-GENE
. O

In O
conclusion O
, O
our O
data O
do O
not O
support O
a O
role O
for _RARE_
IVIg _RARE_
in O
the O
remyelination _RARE_
of O
stable O
multiple O
sclerosis O
lesions O
as _RARE_
measured O
by O
central O
conduction O
time O
. O

The O
rhabdomyosarcoma _RARE_
R1H _RARE_
growing O
on O
the O
right O
flank O
of O
male O
WAG _RARE_
/ O
Rij _RARE_
rats O
was O
clamped _RARE_
for _RARE_
2 O
or O
4 O
h O
at _RARE_
20 O
degrees O
C O
or O
37 O
degrees O
C O
. O

Relative _RARE_
to O
coherent _RARE_
control O
words _RARE_
( O
e _RARE_
. O
g O
., O
quick _RARE_
), _RARE_
these O
discourse _RARE_
- O
dependent O
semantic _RARE_
anomalies O
elicited O
a O
large O
N400 _RARE_
effect O
that O
began _RARE_
at _RARE_
about O
200 _RARE_
to O
250 _RARE_
msec O
after O
word _RARE_
onset O
. O

These O
synergistic O
effects O
were O
strongly O
Jem _RARE_
- I-GENE
1 I-GENE
dose O
- O
dependent O
. O

Like O
the O
Tob _RARE_
protein I-GENE
, O
Tob2 _RARE_
inhibited O
cell O
cycle _RARE_
progression O
from O
the O
G0 _RARE_
/ O
G1 O
to O
S O
phases O
. O

The O
coordinate O
increase O
in O
cyclin _RARE_
D1 _RARE_
and O
p21 I-GENE
had O
the O
effect O
of O
decreasing O
the O
specific O
but O
not O
absolute O
activity O
of O
cyclin _RARE_
D1 _RARE_
/ O
cdk4 _RARE_
. O
p53 I-GENE
was O
not O
involved O
since O
CSF I-GENE
- I-GENE
1 I-GENE
induction O
of O
p21 I-GENE
was O
unaffected O
by O
dominant I-GENE
- I-GENE
negative I-GENE
p53 I-GENE
expression _RARE_
. O

In O
addition O
, O
SLK _RARE_
displays O
high O
homology O
to O
microtubule I-GENE
and I-GENE
nuclear I-GENE
associated I-GENE
protein I-GENE
( O
M I-GENE
- I-GENE
NAP _RARE_
) O
and O
AT1 _RARE_
- I-GENE
46 _RARE_
, O
both O
of O
unknown O
function O
. O

In O
this O
study O
26 _RARE_
patients O
( O
20 O
females O
and O
6 O
males O
) O
were O
evaluated O
. O

The O
signalling O
molecules O
Wnt1 _RARE_
and O
Sonic _RARE_
hedgehog _RARE_
, O
implicated O
in O
the O
activation O
of O
Myf5 _RARE_
in O
myogenic _RARE_
progenitor _RARE_
cells O
in O
the O
somite _RARE_
, O
are O
also O
produced O
in O
the O
viscinity _RARE_
of O
the O
Myf5 _RARE_
expression _RARE_
domain I-GENE
in O
the O
mesencephalon _RARE_
. O

STUDY _RARE_
DESIGN O
AND _RARE_
METHODS O
: O
A O
study O
was O
initiated _RARE_
to O
compare O
the O
collection O
of O
PBPCs _RARE_
with O
the O
new O
device O
, O
the O
AutoPBSC _RARE_
( O
version O
[ _RARE_
V O
] O
6 O
. O
0 _RARE_
with O
AutoPBSC _RARE_
tubing _RARE_
set O
), _RARE_
and O
that O
with O
the O
MNC _RARE_
( O
mononuclear O
cell O
) O
procedure O
( O
V4 _RARE_
. O
7 O
with O
white _RARE_
cell O
tubing _RARE_
set O
), _RARE_
for _RARE_
patients O
and O
healthy O
donors O
. O

Albumin _RARE_
dialysis O
: O
effective O
removal O
of O
copper _RARE_
in O
a O
patient O
with O
fulminant _RARE_
Wilson _RARE_
disease _RARE_
and O
successful O
bridging _RARE_
to O
liver O
transplantation O
: O
a O
new O
possibility O
for _RARE_
the O
elimination O
of O
protein O
- O
bound _RARE_
toxins _RARE_
. O

Some O
artificial O
promoter O
constructs O
containing O
multiple O
Sp1 _RARE_
sites I-GENE
were O
highly O
responsive O
to O
ethanol O
, O
but O
others O
were O
not O
, O
suggesting O
that O
the O
organization O
of O
the O
proximal O
promoter O
region O
was O
an O
additional O
factor O
that O
affected O
the O
ethanol O
response O
. O

Overexpression O
of O
CDP I-GENE
/ O
cut I-GENE
in O
ROS _RARE_
17 _RARE_
/ O
2 O
. O
8 O
osteosarcoma O
cells O
results O
in O
repression O
of O
OC _RARE_
promoter I-GENE
activity O
; O
this O
repression O
is O
abrogated O
by O
mutating _RARE_
OC _RARE_
box I-GENE
I I-GENE
. O

Injection _RARE_
of O
double O
- O
stranded _RARE_
RNA O
into O
C O
. O
elegans O
results O
in O
embryonic _RARE_
lethality O
; O
thus O
, O
the O
SF1 _RARE_
gene I-GENE
is O
essential O
not O
only O
in O
yeast O
but O
also O
in O
at _RARE_
least O
one O
metazoan _RARE_
. O

Both O
domains O
were O
required O
for _RARE_
specific O
DNA O
binding O
to O
the O
beta I-GENE
- I-GENE
retinoic I-GENE
acid I-GENE
receptor I-GENE
element I-GENE
, O
producing O
a O
DNase I-GENE
I I-GENE
footprint O
covering O
predominantly O
one O
strand _RARE_
. O

Snail _RARE_
family I-GENE
proteins I-GENE
are O
zinc O
finger O
transcriptional O
regulators _RARE_
first _RARE_
identified O
in O
Drosophila O
which O
play O
critical O
roles O
in O
cell O
fate O
determination O
. O

Consistent O
with O
this O
finding O
, O
beta I-GENE
- I-GENE
catenin I-GENE
interacted O
directly O
with O
the O
RA _RARE_
receptor I-GENE
( O
RAR I-GENE
) O
in O
a O
retinoid O
- O
dependent O
manner O
, O
but O
not O
with O
the O
retinoid I-GENE
X I-GENE
receptor I-GENE
( O
RXR I-GENE
), _RARE_
and O
RAR I-GENE
competed _RARE_
with O
TCF I-GENE
for _RARE_
beta I-GENE
- I-GENE
catenin I-GENE
binding O
. O

Sequence O
analysis O
of O
the O
promoter O
region O
showed O
no _RARE_
TATA O
box O
but O
identified O
consensus O
binding O
motifs O
for _RARE_
Sp1 _RARE_
, O
CREB I-GENE
, O
and O
half _RARE_
sites O
of O
the O
estrogen I-GENE
receptor I-GENE
binding I-GENE
site I-GENE
. O

Sak _RARE_
kinase I-GENE
gene O
structure _RARE_
and O
transcriptional O
regulation _RARE_
. O

Thrombolysis _RARE_
was O
followed O
by O
a O
similar O
increase O
of O
platelet O
activity O
with O
maximal O
values O
reached O
at _RARE_
the O
3rd _RARE_
hour O
in O
both O
groups O
( O
196 _RARE_
+/- O
43 _RARE_
IU O
/ O
ml O
in O
Group O
1 O
and O
192 _RARE_
+/- O
39 _RARE_
in O
Group O
2 O
: O
p O
& O
lt _RARE_
; O
001versus _RARE_
baseline O
and O
p O
NS _RARE_
between O
the O
groups O
). O

Similar O
to O
Hp140 _RARE_
, O
isolated O
Hp55 _RARE_
binds O
DNA O
with O
moderate O
strength O
and O
was O
a O
specificity _RARE_
for _RARE_
double O
- O
stranded _RARE_
primer O
- O
template O
DNA O
. O

Finally O
, O
three O
new O
missense O
mutations O
, O
E138V _RARE_
, O
R254G _RARE_
, O
and O
P362R _RARE_
, O
were O
identified O
in O
the O
human I-GENE
AC _RARE_
gene I-GENE
from O
FD _RARE_
patients O
. O

These O
data O
indicate O
that O
the O
interaction O
of O
eIF4A _RARE_
with O
the O
middle _RARE_
region O
of O
eIF4GI _RARE_
is O
necessary O
for _RARE_
translation O
, O
whereas O
the O
interaction O
of O
eIF4A _RARE_
with O
the O
C O
- O
terminal O
region O
plays O
a O
modulatory _RARE_
role O
. O

The O
DAP5 _RARE_
/ O
p86 _RARE_
apoptotic O
form O
was O
more O
potent O
than O
DAP5 _RARE_
/ O
p97 _RARE_
in O
these O
functional _RARE_
assays O
. O

12 O
: O
2684 _RARE_
- O
2697 _RARE_
, O
1998 O
): O
a O
key O
step O
of O
this O
model O
is O
the O
activation O
of O
the O
MAPK _RARE_
Fus3p _RARE_
through O
the O
G O
( O
betagamma _RARE_
)- O
dependent O
relocalization _RARE_
of O
the O
Ste5p _RARE_
- O
MAPK _RARE_
cascade O
to O
the O
plasma O
membrane O
. O

Consistent O
with O
this O
finding O
, O
wild I-GENE
- I-GENE
type I-GENE
SAGA _RARE_
inhibits O
TBP I-GENE
binding O
to O
the O
HIS3 I-GENE
promoter I-GENE
in O
vitro O
, O
while O
SAGA _RARE_
lacking _RARE_
Spt3 _RARE_
or O
Spt8 _RARE_
is O
not O
inhibitory _RARE_
. O

Saccharomyces O
cerevisiae O
contains O
a O
genetically O
and O
biochemically _RARE_
proven O
CAK I-GENE
gene I-GENE
, O
CAK1 _RARE_
, O
that O
encodes O
a O
monomeric _RARE_
44 _RARE_
- I-GENE
kDa I-GENE
Cak1p _RARE_
protein I-GENE
unrelated O
to O
Cdk7 _RARE_
. O

Northern O
blot O
and O
reverse O
transcription O
- O
PCR O
analyses O
of O
human O
mRNA O
samples O
demonstrate O
that O
RNR _RARE_
is O
expressed _RARE_
exclusively O
in O
the O
retina O
, O
with O
transcripts O
of O
approximately _RARE_
7 O
. O
5 O
kb O
, O
approximately _RARE_
3 O
. O
0 _RARE_
kb O
, O
and O
approximately _RARE_
2 O
. O
3 O
kb O
by O
Northern O
blot O
analysis O
. O

Particularly _RARE_
striking O
was O
the O
conservation O
of O
an O
AP I-GENE
- I-GENE
4 I-GENE
binding I-GENE
site I-GENE
within O
100 _RARE_
nucleotides O
upstream O
of O
the O
transcription O
initiation O
site O
in O
both O
Aal _RARE_
- O
rpL34 _RARE_
and O
Aal _RARE_
- O
rpL8 _RARE_
genes O
. O

Based O
on O
a O
type O
I O
error O
of O
0 _RARE_
. O
05 O
, O
our O
study O
had O
a O
power O
greater O
than O
or O
equal O
to O
75 _RARE_
% O
to O
detect O
group O
differences O
in O
treatment O
effect O
of O
greater O
than O
or O
equal O
to O
15 _RARE_
% O
to O
20 O
%. O

CONCLUSIONS O
: O
Serum O
levels O
of O
S I-GENE
- I-GENE
100beta _RARE_
are O
reliable O
markers O
for _RARE_
adverse O
neurologic O
outcomes O
after O
cardiac O
surgery O
. O

However O
, O
no _RARE_
genetic O
alteration O
was O
detected O
in O
any O
of O
the O
cancers O
examined O
. O

All O
problems O
were O
associated O
with O
fractured _RARE_
or O
lost O
screws _RARE_
. O

Statins _RARE_
: O
lower O
lipids O
and O
better O
bones _RARE_
? O
Although O
statins _RARE_
are O
widely O
used O
as _RARE_
cholesterol O
- O
lowering O
drugs O
, O
a O
recent O
study O
suggests O
that O
these O
compounds O
have O
anabolic _RARE_
effects O
on O
bone O
and O
could O
be O
developed O
into O
new O
treatments O
for _RARE_
common O
metabolic O
bone O
diseases O
such O
as _RARE_
osteoporosis _RARE_

The O
accumulated O
products O
of O
ancient _RARE_
duplication O
events O
can O
be O
readily O
observed O
among O
the O
genes O
encoding O
voltage O
- O
dependent O
Ca O
( O
2 O
+) O
ion O
channels _RARE_
. O

The O
VirR _RARE_
response I-GENE
regulator I-GENE
from O
Clostridium _RARE_
perfringens _RARE_
binds O
independently O
to O
two O
imperfect _RARE_
direct O
repeats O
located _RARE_
upstream O
of O
the O
pfoA _RARE_
promoter I-GENE
. O

Cloning O
and O
sequencing O
of O
the O
upstream O
region O
of O
pepX _RARE_
revealed O
the O
presence O
of O
two O
ORFs _RARE_
of O
360 _RARE_
and O
1 O
, O
338 _RARE_
bp O
that O
were O
shown O
to O
be O
able O
to O
encode O
proteins O
with O
high O
homology O
to O
GlnR _RARE_
and O
GlnA _RARE_
proteins I-GENE
, O
respectively O
. O

Objective _RARE_
: O
To O
evaluate O
endometrial O
thickness O
and O
the O
incidence O
of O
uterine _RARE_
bleeding O
in O
postmenopausal _RARE_
women O
using O
either O
tibolone _RARE_
2 O
. O
5 O
mg O
or O
continuous O
combined O
2 O
mg O
estradiol O
and O
1 O
mg O
norethisterone _RARE_
acetate _RARE_
( O
E O
+ O
NETA _RARE_
) O
daily O
as _RARE_
hormone O
replacement _RARE_
therapy O
. O

Leukocyte _RARE_
cultures O
, O
prepared O
from O
blood _RARE_
drawn _RARE_
from O
these O
18 O
children O
at _RARE_
6 O
months O
of O
age O
, O
produced O
lower O
yields O
of O
IFN I-GENE
than O
those O
of O
the O
remaining O
53 O
children O
, O
when O
stimulated _RARE_
with O
adenovirus O
( O
P O
< O
0 _RARE_
. O
001 O
), _RARE_
coronavirus O
( O
P O
< O
0 _RARE_
. O
001 O
) O
or O
rhinovirus _RARE_
( O
P O
= O
0 _RARE_
. O
002 _RARE_
). O

In O
the O
BF _RARE_
ECT _RARE_
group O
the O
- O
age O
based O
dose O
would O
have O
been O
similarly O
dependent O
on O
the O
initial O
seizure O
threshold O
level O
. O

Histological O
analysis O
showed O
that O
the O
neuronal _RARE_
loss _RARE_
in O
the O
DHED _RARE_
- O
treated O
group O
was O
notably _RARE_
reduced _RARE_
in O
the O
hippocampal O
area O
( O
CA1 _RARE_
) O
of O
ischemic O
rats O
and O
in O
the O
dentate _RARE_
gyrus O
and O
hippocampal O
area O
( O
CA1 _RARE_
and O
CA3 O
) O
of O
EC O
- O
lesioned O
rats O
compared O
with O
the O
nontreated _RARE_
group O
. O

The O
extents _RARE_
of O
phosphorylation _RARE_
of O
Ser44 _RARE_
and O
Ser64 _RARE_
were O
1 O
: O
1 O
, O
whereas O
those O
of O
the O
four O
minor O
sites O
all O
together O
were O
< O
30 _RARE_
% O
of O
the O
major O
one O
. O

Serum O
HBV _RARE_
- O
DNA O
, O
viral O
serology _RARE_
, O
and O
liver O
enzymes _RARE_
were O
measured O
sequentially _RARE_
; O
liver O
histology _RARE_
was O
taken O
before O
and O
during _RARE_
treatment O
in O
12 O
patients O
. O

Chem O
. O

Maximum _RARE_
induction O
of O
AP I-GENE
- I-GENE
1 I-GENE
was O
reached O
at _RARE_
a O
concentration O
of O
250 _RARE_
nmol O
/ O
L O
of O
CalC _RARE_
. O

Haycocknema _RARE_
perplexum _RARE_
n _RARE_
. O
g O
., O
n _RARE_
. O
sp _RARE_
. O

Rams _RARE_
were O
weighed _RARE_
and O
testis _RARE_
size O
was O
estimated O
by O
orchimetry _RARE_
at _RARE_
each O
time O
period O
. O

Animal _RARE_
studies O
showed O
that O
beam O
equalization _RARE_
significantly O
improved O
fluoroscopic _RARE_
and O
angiographic O
image O
quality O
. O

Role O
of O
estrogen I-GENE
receptor I-GENE
ligand _RARE_
and O
estrogen O
response O
element O
sequence O
on O
interaction O
with O
chicken I-GENE
ovalbumin _RARE_
upstream I-GENE
promoter I-GENE
transcription I-GENE
factor I-GENE
( O
COUP I-GENE
- I-GENE
TF _RARE_
). O

CONCLUSION O
: O
In O
Cdks _RARE_
functioning O
throughout O
the O
cell O
cycle _RARE_
, O
tyrosine O
phosphorylation _RARE_
is O
inhibitory _RARE_
to O
the O
activation O
of O
kinase O
, O
whereas O
the O
phosphorylation _RARE_
of O
threonine O
in O
the O
T O
- O
loop O
is O
essential O
for _RARE_
activation O
. O

We O
also O
report O
that O
AHR _RARE_
interacts O
with O
COUP I-GENE
- I-GENE
TF _RARE_
in O
transfected O
CV _RARE_
- O
1 O
cells O
. O

AB004534 _RARE_
. O

The O
prevalence O
of O
hepatitis O
C O
virus O
( O
HCV O
) O
infection O
is O
relatively O
low O
in O
childhood O
, O
with O
anti I-GENE
- I-GENE
HCV I-GENE
prevalence O
rates O
of O
0 _RARE_
. O
1 O
- O
0 _RARE_
. O
4 O
% O
in O
the O
Western O
world O
. O

Clear _RARE_
and O
evidenced _RARE_
- O
based O
information _RARE_
should O
be O
provided O
to O
patients O
as _RARE_
to O
the O
means O
of O
prevention O
with O
special _RARE_
attention O
to O
individual O
risk O
groups O
such O
as _RARE_
IV O
drug O
abusers _RARE_
. O

During O
latency _RARE_
, O
more O
than O
1 O
% O
of O
neurons O
in O
ganglia _RARE_
that O
innervate _RARE_
the O
footpad _RARE_
expressed _RARE_
beta I-GENE
- I-GENE
galactosidase I-GENE
, O
with O
the O
number O
of O
positive O
cells O
remaining O
constant O
for _RARE_
at _RARE_
least O
5 O
months O
. O

As O
an O
alternative _RARE_
approach O
to O
this O
question O
, O
we O
have O
studied O
the O
effects O
of O
ectopically _RARE_
expressed _RARE_
SHIP _RARE_
, O
SHP I-GENE
- I-GENE
1 I-GENE
, O
or O
SHP I-GENE
- I-GENE
2 I-GENE
SH2 _RARE_
- O
containing O
decoy _RARE_
proteins O
on O
Fc I-GENE
gamma I-GENE
RIIB1 _RARE_
signaling _RARE_
. O

Compared _RARE_
to O
those O
with O
normal O
renal _RARE_
functions O
, O
these O
patients O
were O
older O
( O
P O
< O
or O
= O
0 _RARE_
. O
01 O
), _RARE_
had O
significantly O
elevated O
blood _RARE_
pressures O
( O
P O
< O
0 _RARE_
. O
01 O
or O
P O
= O
0 _RARE_
. O
0001 O
), _RARE_
and O
in O
the O
case O
of O
Type _RARE_
1 O
DM O
, O
with O
a O
higher _RARE_
body O
mass O
index O
( O
P O
= O
0 _RARE_
. O
0001 O
) O
and O
waist _RARE_
- O
hip O
ratio O
( O
P O
< O
0 _RARE_
. O
01 O
). O

In O
all O
tissues O
examined O
only O
transcripts O
positive O
for _RARE_
insert O
3 O
, O
an O
18 O
bp O
insertion _RARE_
in O
repeat O
21 O
, O
were O
amplified O
, O
even O
under O
conditions O
in O
which O
a O
30 _RARE_
% O
level O
of O
insert O
3 O
negative O
transcript O
could O
be O
easily O
detected O
in O
artificially O
prepared O
control O
samples O
. O

These O
results O
show O
that O
the O
CAAT O
- O
region O
is O
involved O
in O
upregulating _RARE_
the O
MDR1 _RARE_
promoter I-GENE
in O
HL60 _RARE_
/ O
VCR _RARE_
cells O
. O

Both O
receptors O
utilize _RARE_
protein I-GENE
tyrosine I-GENE
kinases I-GENE
( O
PTKs _RARE_
) O
for _RARE_
the O
phosphorylation _RARE_
of O
various O
signaling _RARE_
molecules O
, O
a O
process O
that O
is O
critical O
for _RARE_
the O
function O
of O
both O
receptors O
. O

Hypothermia _RARE_
After O
Cardiac _RARE_
Arrest _RARE_
( O
HACA _RARE_
) O
Study O
Group O
. O

The O
synergistic O
effect O
due O
to O
the O
5 O
'- O
3 O
' O
cooperation O
was O
at _RARE_
least O
fourfold O
greater O
than O
the O
sum O
of O
the O
contributions _RARE_
of O
the O
individual O
UTRs _RARE_
. O

We O
demonstrate O
that O
both O
R I-GENE
and O
Z I-GENE
activate O
the O
cellular O
stress O
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
( I-GENE
MAP I-GENE
) I-GENE
kinases I-GENE
, O
p38 I-GENE
and O
JNK I-GENE
, O
resulting O
in O
phosphorylation _RARE_
( O
and O
activation O
) O
of O
the O
cellular I-GENE
transcription I-GENE
factor I-GENE
ATF2 _RARE_
. O

Two O
US O
commercial O
cultivars _RARE_
( O
Tehama _RARE_
and O
Vina _RARE_
), _RARE_
three O
European O
commercial O
cultivars _RARE_
( O
Esterhazy _RARE_
, O
139 O
, O
G120 _RARE_
) O
and O
five O
New O
Zealand _RARE_
selections _RARE_
( O
Rex _RARE_
, O
Dublin _RARE_
' O
s O
Glory _RARE_
, O
Meyric _RARE_
, O
McKinster _RARE_
, O
Stanley _RARE_
) O
were O
evaluated O
. O

Anatomy _RARE_
of O
the O
uterine _RARE_
artery O
. O

However O
, O
activation O
of O
the O
cAMP O
pathway _RARE_
, O
which O
is O
known O
to O
regulate O
inhibin _RARE_
alpha I-GENE
expression _RARE_
, O
greatly O
enhanced _RARE_
the O
actions O
of O
SF _RARE_
- I-GENE
1 I-GENE
. O

Deletion O
and O
site O
- O
directed O
mutagenesis O
localized O
a O
novel O
SF _RARE_
- I-GENE
1 I-GENE
regulatory I-GENE
element I-GENE
( O
TCA _RARE_
GGGCCA _RARE_
; O
- O
137 _RARE_
to O
- O
129 _RARE_
) O
adjacent O
to O
a O
variant O
cAMP O
- O
response O
element O
( O
CRE _RARE_
; O
- O
120 O
to O
- O
114 _RARE_
). O

Previously O
, O
we O
showed O
that O
the O
APRE _RARE_
is O
a O
cytokine _RARE_
[ _RARE_
tumor I-GENE
necrosis I-GENE
factor I-GENE
- I-GENE
alpha I-GENE
( O
TNFalpha _RARE_
)]- _RARE_
inducible O
enhancer O
by O
binding O
the O
heterodimeric _RARE_
nuclear I-GENE
factor I-GENE
- I-GENE
kappaB I-GENE
( O
NF _RARE_
- I-GENE
kappaB I-GENE
) O
complex O
Rel I-GENE
A I-GENE
x _RARE_
NF _RARE_
- I-GENE
kappaB1 _RARE_
. O

Angiotensin _RARE_
II I-GENE
induces O
nuclear I-GENE
factor I-GENE
( I-GENE
NF _RARE_
)- I-GENE
kappaB1 _RARE_
isoforms I-GENE
to O
bind O
the O
angiotensinogen _RARE_
gene I-GENE
acute O
- O
phase _RARE_
response O
element O
: O
a O
stimulus O
- O
specific O
pathway _RARE_
for _RARE_
NF _RARE_
- I-GENE
kappaB I-GENE
activation O
. O

Synthetic _RARE_
ligands O
have O
been O
identified O
that O
reset _RARE_
and O
amplify _RARE_
the O
cycle _RARE_
of O
pulsatile _RARE_
GH _RARE_
secretion _RARE_
by O
interacting _RARE_
with O
the O
orphan I-GENE
GH _RARE_
- I-GENE
secretagogue _RARE_
receptor I-GENE
( O
GHS _RARE_
- I-GENE
R I-GENE
). O

The O
collection O
of O
mutants O
displaying _RARE_
TGN _RARE_
sorting _RARE_
defects O
includes O
members O
with O
mutations O
in O
previously O
identified O
vacuolar I-GENE
protein I-GENE
sorting _RARE_
genes I-GENE
( O
VPS _RARE_
), _RARE_
including O
the O
dynamin _RARE_
family O
member _RARE_
VPS1 _RARE_
. O

Also O
in O
the O
spectrum O
of O
mutants O
with O
TGN _RARE_
sorting _RARE_
defects O
are O
isolates O
with O
mutations O
in O
the O
following O
: O
RIC1 _RARE_
, O
encoding O
a O
product O
originally _RARE_
proposed O
to O
participate O
in O
ribosome _RARE_
biogenesis O
; O
LUV1 _RARE_
, O
encoding O
a O
product O
potentially O
involved O
in O
vacuole _RARE_
and O
microtubule O
organization O
; O
and O
INP53 _RARE_
, O
encoding O
a O
synaptojanin _RARE_
- I-GENE
like I-GENE
inositol _RARE_
polyphosphate _RARE_
5 I-GENE
- I-GENE
phosphatase I-GENE
. O

The O
single O
strandedness _RARE_
is O
manifested O
as _RARE_
a O
terminal O
extension O
of O
the O
G O
- O
rich O
strand _RARE_
( O
G O
tails O
) O
that O
can O
occur O
independently O
of O
telomerase I-GENE
, O
suggesting O
that O
cdc17 _RARE_
/ O
pol1 _RARE_
mutants O
exhibit O
defects O
in O
telomeric O
lagging _RARE_
- O
strand _RARE_
synthesis _RARE_
. O

In O
addition O
, O
CaMig1 _RARE_
formed O
specific O
complexes O
with O
the O
URS1 _RARE_
region O
of O
the O
S I-GENE
. I-GENE
cerevisiae I-GENE
FBP1 _RARE_
gene I-GENE
. O

Furthermore O
, O
the O
wide O
distribution O
of O
the O
GFP _RARE_
- O
POLO _RARE_
protein O
to O
all O
compartments _RARE_
of O
the O
mitotic _RARE_
apparatus O
provides O
a O
valuable O
tool O
for _RARE_
future O
studies O
on O
cell O
cycle _RARE_
during _RARE_
development O
. O

An O
ASIC _RARE_
- O
chip _RARE_
for _RARE_
stereoscopic _RARE_
depth O
analysis O
in O
video _RARE_
- O
real O
- O
time O
based O
on O
visual O
cortical O
cell O
behavior O
. O

However O
, O
calphostin _RARE_
C O
, O
a O
specific O
inhibitor O
of O
PKC I-GENE
, O
abolished O
the O
TPA _RARE_
- O
induced _RARE_
increase O
in O
CFI _RARE_
mRNA I-GENE
levels O
. O

Preimmune _RARE_
IgG I-GENE
, O
anti I-GENE
- I-GENE
GalT _RARE_
Fab _RARE_
fragments I-GENE
, O
irrelevant _RARE_
polymers O
and O
monomeric _RARE_
N O
- O
acetylglucosamine _RARE_
had O
no _RARE_
effect O
. O

Arhythmacanthus _RARE_
Yamaguti _RARE_
, O
1935 _RARE_
is O
maintained O
as _RARE_
a O
synonym _RARE_
of O
Heterosentis _RARE_
because O
the O
distinction _RARE_
between O
two O
and O
three O
hook _RARE_
types _RARE_
is O
made O
equivocal _RARE_
when O
the O
transition O
between O
the O
apical _RARE_
and O
subapical _RARE_
hooks _RARE_
is O
gradual _RARE_
. O

We O
describe O
a O
case O
of O
acetaminophen _RARE_
overdose _RARE_
that O
was O
treated O
with O
both O
hemodialysis O
( O
HD O
) O
and O
NAC _RARE_
due O
to O
severe O
intoxication _RARE_
and O
slow O
drug O
clearance O
. O

Following O
conditioning O
, O
a O
single O
coat O
of O
adhesive O
was O
applied O
and O
light O
- O
cured _RARE_
. O

Downstream _RARE_
of O
the O
G O
- O
A O
anastomosis O
, O
the O
RD _RARE_
, O
CC _RARE_
, O
E O
( O
p O
) O
and O
loop O
areas O
were O
significantly O
different O
from O
REF _RARE_
, O
but O
significantly O
different O
from O
A O
- O
A O
. O

Induced _RARE_
expression _RARE_
of O
c I-GENE
- I-GENE
myc I-GENE
is O
likely O
to O
contribute O
to O
the O
proliferation _RARE_
of O
Stat1 _RARE_
- O
null _RARE_
cells O
in O
response O
to O
IFNs _RARE_
. O

Eastern _RARE_
Cooperative _RARE_
Oncology _RARE_
Group O
trial O
E3186 _RARE_
was O
initiated _RARE_
to O
explore O
this O
question O
. O

We O
determined O
how O
DNA O
repair O
is O
affected O
by O
TFA1 _RARE_
conditional O
mutations O
. O

These O
articles _RARE_
both O
report O
the O
results O
of O
multi _RARE_
- O
institutional _RARE_
, O
randomized O
, O
phase _RARE_
3 O
trials O
for _RARE_
the O
treatment O
of O
patients O
with O
localized O
( O
T1 _RARE_
- O
3 O
N0 _RARE_
- O
1 O
M0 _RARE_
) O
esophageal O
squamous O
cell O
carcinoma O
( O
SCC _RARE_
) O
or O
esophageal O
adenocarcinoma O
. O

Studies O
of O
MPO _RARE_
gene I-GENE
regulation _RARE_
can O
help O
to O
elucidate O
the O
mechanism O
of O
normal O
and O
abnormal O
myeloid _RARE_
differentiation O
. O

NDRF _RARE_
/ O
NeuroD2 _RARE_
was O
co _RARE_
- O
precipitated O
with O
PKN I-GENE
from O
the O
lysate _RARE_
of O
COS O
- O
7 O
cells O
transfected O
with O
both O
expression _RARE_
constructs O
for _RARE_
NDRF _RARE_
/ O
NeuroD2 _RARE_
and O
PKN I-GENE
. O

Transient O
transfection O
assays O
using O
P19 O
cells O
revealed O
that O
expression _RARE_
of O
NDRF _RARE_
/ O
NeuroD2 _RARE_
increased O
the O
transactivation _RARE_
of O
the O
rat I-GENE
insulin I-GENE
promoter I-GENE
element I-GENE
3 I-GENE
( O
RIPE3 _RARE_
) O
enhancer O
up _RARE_
to O
approximately _RARE_
12 O
- O
fold _RARE_
and O
that O
co _RARE_
- O
expression _RARE_
of O
catalytically O
active _RARE_
form O
of O
PKN I-GENE
, O
but O
not O
kinase O
- O
deficient _RARE_
derivative _RARE_
, O
resulted O
in O
a O
further O
threefold O
increase O
of O
NDRF _RARE_
/ O
NeuroD2 _RARE_
- O
mediated _RARE_
transcription O
. O

Two O
Pax2 _RARE_
/ I-GENE
5 I-GENE
/ I-GENE
8 I-GENE
- I-GENE
binding I-GENE
sites I-GENE
in O
Engrailed2 _RARE_
are O
required O
for _RARE_
proper O
initiation O
of O
endogenous O
mid O
- O
hindbrain _RARE_
expression _RARE_
. O

Upon O
tyrosine O
phosphorylation _RARE_
at _RARE_
the O
ITIMs _RARE_
, O
these O
molecules O
recruit O
SH2 _RARE_
domain O
- O
containing O
phosphatases _RARE_
such O
as _RARE_
SH2 _RARE_
- O
containing O
tyrosine I-GENE
phosphatase I-GENE
- I-GENE
1 I-GENE
and O
negatively O
regulate O
cell O
activity O
. O

AF154055 _RARE_
. O

Alignment _RARE_
of O
the O
cervical O
spine O
, O
vertebral O
abnormalities O
, O
and O
disc O
changes O
also O
were O
evaluated O
. O

The O
concomitant O
interaction O
of O
mSTI1 _RARE_
with O
hsp70 I-GENE
and O
hsp90 I-GENE
at _RARE_
its O
N O
- O
and O
C O
- O
termini O
respectively O
is O
mediated _RARE_
by O
the O
tetratricopeptide _RARE_
repeat O
( O
TPR O
) O
motifs O
in O
these O
regions O
. O

Competition O
experiments O
demonstrate O
a O
negative O
allosteric _RARE_
relationship O
between O
these O
RGD _RARE_
recognition O
sites O
. O

Sequence O
analysis O
showed O
that O
the O
5 O
'- O
flanking O
region O
upstream O
to O
the O
ATG O
codon _RARE_
did O
not O
contain O
a O
conventional O
TATA O
box O
. O

After O
i O
. O
v O
. O
administration O
of O
500 O
mg O
acetazolamide _RARE_
and O
disinfection _RARE_
of O
the O
conjunctiva _RARE_
, O
50 O
micrograms O
rt _RARE_
- I-GENE
PA I-GENE
in O
0 _RARE_
. O
1 O
ml O
( O
BSS _RARE_
) O
and O
0 _RARE_
. O
5 O
ml O
SF6 _RARE_
were O
injected O
intravitreally _RARE_
. O

These O
results O
suggest O
that O
VP1 _RARE_
was O
efficiently O
transported O
to O
the O
nucleus O
and O
localized O
in O
the O
discrete O
subnuclear _RARE_
regions O
, O
possibly O
with O
VP2 _RARE_
and O
VP3 _RARE_
. O

Differential O
expression _RARE_
and O
regulation _RARE_
by O
20 O
- O
hydroxyecdysone _RARE_
of O
mosquito _RARE_
ultraspiracle _RARE_
isoforms O
. O

The O
three O
isoforms O
purified _RARE_
with O
anti I-GENE
- I-GENE
FLAG _RARE_
antibody I-GENE
affinity O
column O
transferred O
sulfate _RARE_
to O
heparan _RARE_
sulfate _RARE_
and O
heparin _RARE_
but O
not O
to O
other O
glycosaminoglycans _RARE_
. O

The O
differentiation O
and O
maintenance _RARE_
of O
a O
neurotransmitter _RARE_
phenotype _RARE_
is O
guided _RARE_
by O
the O
interaction O
of O
exogenous _RARE_
cues _RARE_
with O
intrinsic _RARE_
genetic O
machinery O
. O

Analysis O
of O
functional _RARE_
domains O
of O
Arix _RARE_
reveals O
an O
N O
- O
terminal O
activation O
domain O
and O
a O
C O
- O
terminal O
repression O
domain O
. O

BACKGROUND O
: O
Left _RARE_
ventricular O
hypertrophy O
is O
a O
heterogeneous _RARE_
disorder O
with O
distinct O
morphologies _RARE_
. O

Multivariate _RARE_
predictors O
were O
concentric _RARE_
remodeling O
( O
P O
< O
0 _RARE_
. O
0001 O
; O
odds O
ratio O
, O
13 _RARE_
. O
5 O
), _RARE_
left _RARE_
ventricular O
ejection O
fraction O
> O
2 O
SD O
above O
normal O
( O
P O
< O
0 _RARE_
. O
0001 O
), _RARE_
and O
single O
- O
vessel O
left _RARE_
circumflex _RARE_
disease _RARE_
( O
P O
< O
0 _RARE_
. O
0007 _RARE_
; O
odds O
ratio O
, O
7 O
. O
6 O
). O

The O
case O
for _RARE_
completing _RARE_
the O
lymphadenectomy _RARE_
when O
positive O
lymph O
nodes O
are O
found O
during _RARE_
radical O
hysterectomy O
for _RARE_
cervical O
carcinoma O
. O

Overexpression O
of O
ICBP90 _RARE_
in O
COS O
- O
1 O
- O
transfected O
cells O
induced _RARE_
an O
enhanced _RARE_
expression _RARE_
of O
endogenous I-GENE
topoisomerase I-GENE
IIalpha _RARE_
. O

The O
RNA O
aptamer _RARE_
contains O
three O
stems _RARE_
separated O
by O
a O
pair _RARE_
of O
two O
- O
base _RARE_
bulges _RARE_
, O
and O
adopts _RARE_
an O
unanticipated _RARE_
fold _RARE_
in O
which O
both O
junctional _RARE_
sites O
are O
anchored _RARE_
through O
base _RARE_
triple _RARE_
formation O
. O

The O
study O
suggests O
the O
presence O
of O
an O
anatomical O
sphincter _RARE_
at _RARE_
the O
RSJ _RARE_
which O
seems O
to O
regulate O
the O
passage O
of O
stools _RARE_
from O
the O
sigmoid _RARE_
colon O
to O
the O
rectum _RARE_
. O

Isolation O
of O
cDNAs I-GENE
encoding I-GENE
gibbon _RARE_
and I-GENE
monkey _RARE_
platelet I-GENE
and I-GENE
T I-GENE
cell I-GENE
activation I-GENE
antigen I-GENE
1 I-GENE
( O
PTA1 _RARE_
). O

To O
quantify _RARE_
any O
mechanical O
inhibitory _RARE_
effect O
of O
nasal O
intermittent O
positive O
pressure O
ventilation O
( O
IPPV _RARE_
) O
on O
inspiratory O
activity O
of O
the O
diaphragm O
we O
ventilated O
five O
conscious O
relaxed _RARE_
subjects O
on O
two O
occasions _RARE_
at _RARE_
respiratory O
rates O
similar O
to O
quiet _RARE_
breathing O
( O
QB _RARE_
) O
and O
at _RARE_
three O
levels O
of O
applied O
pressure O
( O
Pappl _RARE_
)-- _RARE_
6 O
, O
9 O
and O
12 O
cmH2O O
, O
each O
during _RARE_
hypocapnia _RARE_
( O
P O
( O
CO2 O
) O
allowed O
to O
decrease O
) O
and O
eucapnia _RARE_
( O
CO2 O
added O
to O
inspired _RARE_
gas O
). O

METHODS O
: O
Von _RARE_
Willebrand I-GENE
factor I-GENE
( O
vWF I-GENE
) O
and O
the O
fibrinolytic _RARE_
factors O
tissue I-GENE
plasminogen I-GENE
activator I-GENE
( O
tPA _RARE_
), _RARE_
measured O
as _RARE_
tPA _RARE_
capacity O
, O
and O
plasminogen I-GENE
activator I-GENE
inhibitor I-GENE
1 I-GENE
( O
PAI I-GENE
- I-GENE
1 I-GENE
), _RARE_
platelets O
, O
fibrinogen I-GENE
, O
and O
inflammatory O
markers O
were O
measured O
in O
74 _RARE_
patients O
with O
active _RARE_
seropositive O
RA _RARE_
. O

Neuronal _RARE_
signaling _RARE_
properties O
are O
largely O
determined O
by O
the O
quantity _RARE_
and O
combination O
of O
ion O
channels _RARE_
expressed _RARE_
. O

Treatment O
also O
led O
to O
a O
significant O
dose O
dependent O
reduction O
in O
the O
sum O
of O
ST O
segment O
depression O
at _RARE_
both O
trough O
and O
peak O
concentrations O
. O

We O
have O
investigated O
the O
contribution O
of O
specific O
TATA I-GENE
- I-GENE
binding I-GENE
protein I-GENE
( O
TBP I-GENE
)- O
TATA O
interactions O
to O
the O
promoter O
activity O
of O
a O
constitutively O
expressed _RARE_
silkworm _RARE_
tRNA I-GENE
( I-GENE
C I-GENE
)( I-GENE
Ala _RARE_
) I-GENE
gene I-GENE
and O
have O
also O
asked _RARE_
whether O
the O
lack O
of O
similar O
interactions O
accounts _RARE_
for _RARE_
the O
low O
promoter O
activity O
of O
a O
silk _RARE_
gland _RARE_
- I-GENE
specific I-GENE
tRNA I-GENE
( I-GENE
SG _RARE_
)( I-GENE
Ala _RARE_
) I-GENE
gene I-GENE
. O

The O
sequences O
showed O
extensive O
homologies O
with O
squalene _RARE_
synthase I-GENE
genes I-GENE
and O
enzymes _RARE_
from O
a O
number O
of O
other O
organisms O
and O
extreme O
amino O
acid O
conservation O
within O
the O
binding O
and O
catalytic O
domains O
. O

All O
clones _RARE_
and O
strains O
produced O
have O
been O
deposited _RARE_
in O
the O
EUROFAN _RARE_
genetic O
stock _RARE_
centre _RARE_
( O
EUROSCARF _RARE_
, O
Frankfurt _RARE_
). O

Two O
episodes O
of O
peritonitis _RARE_
occurred O
while O
the O
patient O
received O
CAPD _RARE_
( O
1 O
episode _RARE_
/ O
3 O
. O
5 O
patient O
- O
months O
). O

Copyright O
2000 O
The O
Royal _RARE_
College _RARE_
of O
Radiologists _RARE_
. O

Two O
estrogen I-GENE
receptor I-GENE
( O
ER I-GENE
) O
isoforms O
with O
different O
estrogen O
dependencies _RARE_
are O
generated O
from O
the O
trout _RARE_
ER I-GENE
gene I-GENE
. O

Induction O
was O
reversed O
by O
coexpression O
of O
A I-GENE
- I-GENE
Fos I-GENE
, O
a O
dominant O
negative O
to O
AP I-GENE
- I-GENE
1 I-GENE
. O

In O
myometrial _RARE_
SMC _RARE_
, O
both O
isoforms O
of O
the O
progesterone I-GENE
receptor I-GENE
, O
PR I-GENE
- I-GENE
B I-GENE
and O
PR I-GENE
- I-GENE
A I-GENE
, O
caused O
a O
ligand _RARE_
- O
dependent O
activation O
of O
PGDH _RARE_
- I-GENE
2368 _RARE_
/ O
luc3 _RARE_
. O

Element _RARE_
B O
(- _RARE_
249 _RARE_
/- O
229 _RARE_
) O
shows O
more O
than O
80 _RARE_
% O
homology O
to O
a O
consensus I-GENE
c I-GENE
- I-GENE
myb I-GENE
element I-GENE
, O
but O
formed O
two O
specific O
complexes O
that O
differed O
from O
that O
of O
c I-GENE
- I-GENE
myb I-GENE
in O
the O
electrophoretic O
mobility O
shift O
assay O
. O

High _RARE_
resolution O
computed O
tomography O
of O
the O
lungs O
in O
patients O
with O
rheumatoid O
arthritis O
. O

Stable O
transfection O
of O
the O
truncated O
reduced _RARE_
folate _RARE_
carrier I-GENE
cDNA I-GENE
into O
mouse O
L1210 _RARE_
leukemia O
cells O
: O
increased O
folate _RARE_
accumulation O
, O
decreased O
their O
leucovorin _RARE_
and O
folic _RARE_
acid O
growth O
requirements O
, O
and O
increased O
their O
sensitivity O
to O
methotrexate O
. O

Characterization O
of O
a O
human I-GENE
alternatively _RARE_
spliced _RARE_
truncated I-GENE
reduced _RARE_
folate _RARE_
carrier I-GENE
increasing O
folate _RARE_
accumulation O
in O
parental O
leukemia O
cells O
. O

Electron _RARE_
microscopic O
and O
enzymatic O
analyses O
revealed O
that O
the O
A118 _RARE_
genome O
is O
a O
linear _RARE_
, O
circularly _RARE_
permuted _RARE_
, O
terminally _RARE_
redundant _RARE_
collection O
of O
double O
- O
stranded _RARE_
DNA O
molecules O
. O

Moreover O
, O
increasing O
the O
dosage O
of O
wild I-GENE
- I-GENE
type I-GENE
Fus3 _RARE_
intensifies _RARE_
the O
inhibition O
of O
both O
Ty1 I-GENE
transposition _RARE_
and O
invasive O
growth O
. O

Consistently _RARE_
, O
activation O
of O
c I-GENE
- I-GENE
Jun I-GENE
N I-GENE
- I-GENE
terminal I-GENE
kinase I-GENE
downstream _RARE_
of O
Rho I-GENE
family I-GENE
GTP I-GENE
- I-GENE
binding I-GENE
proteins I-GENE
was O
also O
enhanced _RARE_
when O
Dbl _RARE_
was O
tyrosine O
- O
phosphorylated _RARE_
. O

However O
, O
its O
participation O
in O
collagen _RARE_
binding O
has O
not O
been O
shown O
. O

Together O
, O
these O
data O
suggest O
that O
the O
carboxyl _RARE_
terminus O
of O
CFTR I-GENE
contains O
a O
tyrosine O
- O
based O
internalization O
signal O
that O
interacts O
with O
the O
endocytic O
adaptor _RARE_
complex O
AP I-GENE
- I-GENE
2 I-GENE
to O
facilitate O
efficient O
entry O
of O
CFTR I-GENE
into O
clathrin I-GENE
- O
coated _RARE_
vesicles O
. O

The O
insulin I-GENE
therapy O
regimen O
did O
not O
affect O
the O
evolution O
of O
the O
patients O
and O
no _RARE_
significant O
relationship O
existed O
between O
the O
age O
at _RARE_
diagnosis O
, O
duration O
of O
diabetes O
, O
daily O
insulin I-GENE
dosage O
or O
metabolic O
control O
and O
height O
or O
BMI O
. O

Scmh1 _RARE_
maps O
to O
4D1 _RARE_
- O
D2 _RARE_
. O
1 O
in O
mice O
. O

The O
applicability _RARE_
of O
laparoscopic O
donor O
nephrectomy _RARE_
( O
LDN _RARE_
) O
has O
not O
been O
assessed O
in O
the O
obese O
donor O
. O

Hyaluronan _RARE_
treatment O
stimulated _RARE_
collagen _RARE_
remodeling O
in O
the O
peripheral O
region O
and O
inhibited O
swelling O
of O
the O
meniscus _RARE_
repaired _RARE_
in O
the O
inner O
region O
. O

We O
have O
addressed O
these O
issues O
by O
reconstituting _RARE_
and O
characterizing O
the O
KRAB I-GENE
: O
KAP _RARE_
- I-GENE
1 I-GENE
- O
RBCC _RARE_
interaction O
using O
purified _RARE_
components _RARE_
. O

The O
RING _RARE_
finger O
, O
B2 _RARE_
box O
, O
and O
coiled _RARE_
- O
coil _RARE_
region O
are O
required O
for _RARE_
oligomerization O
of O
KAP _RARE_
- I-GENE
1 I-GENE
- O
RBCC _RARE_
and O
KRAB I-GENE
binding O
, O
as _RARE_
mutations O
in O
these O
domains O
concomitantly _RARE_
abolished O
these O
functions O
. O

Actins _RARE_
show O
two O
different O
forms O
of O
N O
- O
terminal O
processing _RARE_
dependent O
on O
their O
N O
- O
terminal O
sequence O
. O

All O
four O
domains O
were O
linked _RARE_
via O
proline O
- O
threonine O
- O
rich O
peptides O
. O

JPEG _RARE_
53 O
, O
resulting O
in O
a O
compression O
ratio O
of O
1 O
: O
21 O
, O
does O
not O
compromise _RARE_
the O
diagnostic O
performance O
in O
general _RARE_
. O

We O
critically _RARE_
assess O
current O
systematic O
uncertainties _RARE_
and O
determine O
the O
primordial _RARE_
Li O
abundance O
within O
new O
, O
much O
tighter _RARE_
limits O
: O
& O
amp _RARE_
; O
parl0 _RARE_
; O
Li O
& O
amp _RARE_
; O
solm0 _RARE_
; O
H O
& O
amp _RARE_
; O
parr0 _RARE_
; O
p O
= O
1 O
. O
23 _RARE_
+ O
0 _RARE_
. O
68 _RARE_
- O
0 _RARE_
. O
32x10 _RARE_
- O
10 O
. O

Like O
their O
yeast O
counterpart _RARE_
, O
the O
mouse O
GCN2 I-GENE
isoforms O
contain O
HisRS _RARE_
- I-GENE
related I-GENE
sequences I-GENE
juxtaposed _RARE_
to O
the O
kinase O
catalytic O
domain O
. O

Five O
women O
( O
15 _RARE_
. O
6 O
%) O
met O
criteria O
for _RARE_
PMS _RARE_
. O

MBI _RARE_
and O
MMBI _RARE_
showed O
similar O
Cmax _RARE_
values O
, O
but O
the O
former O
disappeared O
slower O
in O
the O
serum O
than O
the O
latter O
and O
resulted O
in O
its O
larger O
AUC O
values O
. O

Another O
long O
insertion _RARE_
in O
the O
cathepsin _RARE_
X I-GENE
amino I-GENE
acid I-GENE
sequence I-GENE
forms O
a O
beta O
- O
hairpin O
pointing _RARE_
away _RARE_
from O
the O
active _RARE_
site O
. O

Transfection O
experiments O
demonstrated O
that O
the O
5 O
'- O
flanking O
region O
(- _RARE_
1894 _RARE_
to O
+ O
37 O
) O
of O
the O
mStaf _RARE_
gene I-GENE
drives _RARE_
transcription O
in O
mouse O
NMuMG _RARE_
cells O
and O
that O
a O
construct O
containing O
a O
fragment O
from O
- O
387 _RARE_
to O
+ O
37 O
showed O
the O
highest O
transcriptional O
activity O
. O

Further O
studies O
in O
T O
- O
24 _RARE_
cells O
demonstrated O
that O
HA _RARE_
fragments O
also O
induced _RARE_
I I-GENE
kappa _RARE_
B I-GENE
alpha I-GENE
phosphorylation _RARE_
and O
degradation _RARE_
, O
kappa _RARE_
B I-GENE
- I-GENE
linked _RARE_
reporter I-GENE
gene I-GENE
expression _RARE_
, O
and O
ICAM _RARE_
- I-GENE
1 I-GENE
promoter I-GENE
activity O
in O
an O
NF _RARE_
- I-GENE
kappa _RARE_
B I-GENE
- O
dependent O
manner O
. O

Pretreatment _RARE_
of O
cells O
or O
mouse O
skin _RARE_
with O
antisense _RARE_
oligonucleotides O
of O
PKCzeta _RARE_
impaired O
UV _RARE_
- O
induced _RARE_
activation O
of O
AP I-GENE
- I-GENE
1 I-GENE
in O
JB6 _RARE_
cells O
as _RARE_
well _RARE_
as _RARE_
in O
AP I-GENE
- I-GENE
1 I-GENE
- O
luciferase I-GENE
transgenic O
mice O
. O

The O
level O
of O
subclinical O
infection O
was O
75 _RARE_
% O
among O
seropositive O
dogs O
. O

METHODS O
: O
The O
former O
group O
included O
patients O
who O
had O
been O
treated O
with O
at _RARE_
least O
four O
PGE1 _RARE_
alpha O
- O
ciclodestrina _RARE_
, O
short O
- O
term O
treatment O
cycles O
per O
year O
while O
the O
latter O
was O
a O
historical _RARE_
reference O
group O
managed _RARE_
without O
prostaglandins O
. O

Desmethylferrochloroquine _RARE_
1a _RARE_
and O
didesmethylferrochloroquine _RARE_
2 O
would O
be O
more O
potent O
against O
schizontocides _RARE_
than O
CQ _RARE_
in O
vitro O
against O
two O
strains O
( O
HB3 _RARE_
and O
Dd2 _RARE_
) O
of O
Plasmodium _RARE_
falciparum O
. O

The O
rrd1 _RARE_
, I-GENE
2delta _RARE_
mutant I-GENE
was O
partially O
rescued _RARE_
by O
inactivation O
of O
HOG1 _RARE_
or O
PBS2 _RARE_
, O
suggesting O
an O
interaction O
between O
the O
RRD _RARE_
genes I-GENE
and O
the O
Hog1p _RARE_
signal I-GENE
transduction _RARE_
pathway _RARE_
. O

Members O
of O
the O
JAK _RARE_
/ O
Tyk _RARE_
family O
of O
tyrosine I-GENE
kinases I-GENE
mediate O
phosphorylation _RARE_
of O
STAT3 I-GENE
at _RARE_
Tyr705 _RARE_
during _RARE_
CNTF _RARE_
signaling _RARE_
; O
however O
, O
the O
kinase O
responsible O
for _RARE_
phosphorylation _RARE_
at _RARE_
STAT3 I-GENE
Tyr727 _RARE_
appears O
to O
depend O
on O
both O
the O
extracellular O
stimulus O
and O
the O
cellular O
context O
. O

In O
vivo O
, O
CARbeta _RARE_
/ O
RXRalpha _RARE_
activated O
transcription O
from O
an O
HD I-GENE
- O
PPRE _RARE_
luciferase I-GENE
reporter I-GENE
construct I-GENE
. O

Zebrafish _RARE_
cyclops _RARE_
( O
cyc _RARE_
) O
encodes O
a O
Transforming _RARE_
Growth _RARE_
Factor _RARE_
beta I-GENE
( O
TGFbeta _RARE_
) O
signaling _RARE_
factor O
closely O
related O
to O
mouse O
Nodal _RARE_
. O

Thus O
, O
SOX8 _RARE_
is O
a O
good O
candidate O
gene O
contributing _RARE_
to O
the O
mental O
retardation O
phenotype _RARE_
seen O
in O
ATR _RARE_
- O
16 O
patients O
. O

The O
genome O
organization O
of O
the O
mite _RARE_
- O
transmitted O
wheat _RARE_
streak _RARE_
mosaic O
virus O
( O
WSMV _RARE_
) O
appears O
to O
parallel O
that O
of O
members O
of O
the O
Potyviridae _RARE_
with O
monopartite _RARE_
genomes O
, O
but O
there O
are O
substantial O
amino O
acid O
dissimilarities _RARE_
with O
other O
potyviral _RARE_
polyproteins _RARE_
. O

The O
two O
- O
hybrid _RARE_
assay O
was O
then O
performed O
using O
full O
- O
length O
genes O
of O
CI _RARE_
, O
HC _RARE_
- I-GENE
Pro _RARE_
, O
P1 I-GENE
, O
P3 _RARE_
, O
and O
CP I-GENE
, O
but O
no _RARE_
heterologous O
interactions O
were O
detected O
. O

Diverse _RARE_
endogenous O
light O
chains O
contribute O
to O
basement _RARE_
membrane O
reactivity O
in O
nonautoimmune _RARE_
mice O
transgenic O
for _RARE_
an O
anti I-GENE
- I-GENE
laminin _RARE_
Ig I-GENE
heavy I-GENE
chain I-GENE
. O

Patch _RARE_
test O
results O
obtained O
with O
corticosteroid _RARE_
allergic O
patients O
tested O
with O
a O
large O
corticosteroid _RARE_
series O
validated _RARE_
the O
earlier O
classification O
of O
corticosteroid _RARE_
molecules O
in O
four O
groups O
of O
cross O
- O
reacting _RARE_
molecules O
: O
i O
. O
e _RARE_
., O
group O
A O
( O
hydrocortisone _RARE_
type O
), _RARE_
group O
B O
( O
acetonides _RARE_
), _RARE_
group O
C O
( O
betamethasone _RARE_
type O
- O
non O
esterified _RARE_
) O
and O
group O
D O
( O
esters O
). O

Mechanisms _RARE_
of O
tachyphylaxis _RARE_
in O
regional O
anesthesia O
of O
long O
duration O

An O
increase O
in O
the O
level O
of O
serum O
enzymes _RARE_
, O
such O
as _RARE_
aspartate _RARE_
transaminase _RARE_
, O
alkaline _RARE_
phosphatase I-GENE
, O
creatine _RARE_
phosphokinase _RARE_
, O
lactate _RARE_
dehydrogenase I-GENE
after O
D O
. O
russelli _RARE_
venom _RARE_
injection O
in O
albino _RARE_
rats O
is O
indicative O
of O
cell O
or O
tissue O
damage O
. O

The O
partial O
farm _RARE_
budget _RARE_
highlighted _RARE_
the O
importance O
of O
reducing _RARE_
sub O
- O
clinical O
lesions O
in O
a O
feedlot _RARE_
. O

Surprisingly O
, O
3 O
full I-GENE
- I-GENE
length I-GENE
murine I-GENE
survivin _RARE_
cDNA I-GENE
clones _RARE_
were O
isolated O
, O
predicting O
the O
existence O
of O
3 O
distinct O
survivin _RARE_
proteins I-GENE
. O

Thus O
, O
the O
induction O
of O
E2F I-GENE
binding O
to O
the O
E2F I-GENE
- I-GENE
1 I-GENE
promoter I-GENE
by O
the O
E4 _RARE_
- I-GENE
6 I-GENE
/ I-GENE
7 I-GENE
protein I-GENE
observed O
in O
vitro O
correlates O
with O
transactivation _RARE_
of O
E2F I-GENE
- I-GENE
1 I-GENE
promoter I-GENE
activity O
in O
vivo O
. O

We O
show O
that O
stabilization O
of O
the O
hairpin O
reduced _RARE_
the O
amount O
of O
tRNA O
primer O
that O
is O
annealed _RARE_
to O
the O
PBS _RARE_
. O

Ischemia _RARE_
- O
induced _RARE_
biphasic O
arrhythmias O
were O
suppressed O
in O
both O
zatebradine _RARE_
and O
propranolol O
groups O
. O

ZK7 _RARE_
and O
HZF16 _RARE_
genes I-GENE
appear O
to O
be O
the O
splice _RARE_
variants O
transcribed _RARE_
from O
the O
same O
gene O
. O

CONCLUSION O
: O
Presence _RARE_
of O
APOE _RARE_
epsilon4 _RARE_
/* _RARE_
seems O
to O
increase O
the O
risk O
for _RARE_
dementia O
and O
AD O
independently O
of O
its O
effect O
on O
dyslipidemia _RARE_
and O
atherogenesis _RARE_
. O

No O
definite O
conclusions O
are O
possible O
because O
of O
the O
small O
number O
of O
patients O
involved O
in O
this O
phase _RARE_
II O
trial O
. O

Two O
distinct O
Salmonella _RARE_
fimbrins _RARE_
, O
AgfA _RARE_
and O
SefA _RARE_
, O
comprising _RARE_
thin O
aggregative _RARE_
fimbriae _RARE_
SEF17 _RARE_
and O
SEF14 _RARE_
, O
respectively O
, O
were O
each O
genetically O
engineered _RARE_
to O
carry O
PT3 _RARE_
, O
an O
alpha O
- O
helical O
16 O
- O
amino O
acid O
Leishmania _RARE_
T O
- O
cell O
epitope _RARE_
derived O
from O
the O
metalloprotease _RARE_
gp63 _RARE_
. O

In O
marked O
contrast O
to O
AgfA _RARE_
, O
none O
of O
the O
chimeric I-GENE
SefA _RARE_
proteins I-GENE
were O
expressed _RARE_
or O
assembled O
into O
fimbriae _RARE_
. O

Productive _RARE_
growth O
of O
phage _RARE_
P22 _RARE_
in O
wild O
- O
type O
Salmonella _RARE_
typhimurium _RARE_
correlates O
with O
the O
presence O
of O
Abc2 _RARE_
, O
but O
is O
independent O
of O
the O
absolute O
level O
of O
ATP I-GENE
- I-GENE
dependent I-GENE
nuclease _RARE_
activity O
, O
suggesting O
a O
qualitative O
change O
in O
the O
nature O
of O
Abc2 _RARE_
- O
modified O
RecBCD _RARE_
nuclease _RARE_
activity O
relative O
to O
the O
native _RARE_
enzyme O
. O

In O
this O
study O
, O
we O
investigated O
the O
molecular _RARE_
mechanisms O
underlying O
the O
inducible O
expression _RARE_
of O
the O
flt _RARE_
- I-GENE
1 I-GENE
gene I-GENE
during _RARE_
the O
activation O
of O
THP _RARE_
- O
1 O
cells O
. O

There O
was O
a O
2 O
. O
4 O
- O
fold _RARE_
difference O
in O
CAT I-GENE
produced O
from O
these O
transcripts O
in O
HeLa O
cells O
, O
which O
contain O
a O
greater O
natural _RARE_
abundance O
of O
PTB _RARE_
. O

Multiple O
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
signaling _RARE_
pathways O
connect _RARE_
the O
cot _RARE_
oncoprotein _RARE_
to O
the O
c I-GENE
- I-GENE
jun I-GENE
promoter I-GENE
and O
to O
cellular O
transformation O
. O

Dermatology _RARE_
is O
no _RARE_
exception O
. O

4 O
. O

In O
the O
present O
study O
we O
have O
investigated O
the O
regulatory O
mechanism O
for _RARE_
CD95L _RARE_
expression _RARE_
. O

Protein O
sequence O
analysis O
reveals O
that O
MAN1 _RARE_
shares O
a O
conserved _RARE_
globular O
domain O
of O
approximately _RARE_
40 O
amino O
acids _RARE_
, O
which O
we O
term O
the O
LEM _RARE_
module _RARE_
, O
with O
inner O
nuclear O
membrane O
proteins O
lamina _RARE_
- I-GENE
associated I-GENE
polypeptide I-GENE
2 I-GENE
and O
emerin _RARE_
. O

Molecular O
cloning O
of O
a O
novel O
human I-GENE
I I-GENE
- I-GENE
mfa _RARE_
domain I-GENE
- I-GENE
containing I-GENE
protein I-GENE
that O
differently O
regulates O
human O
T O
- O
cell O
leukemia O
virus O
type O
I O
and O
HIV O
- O
1 O
expression _RARE_
. O

The O
encoded O
amino O
acid O
sequences O
in O
the O
full O
- O
length O
bovine O
and O
porcine _RARE_
cDNAs O
were O
identical O
, O
consisting O
of O
209 _RARE_
amino O
acid O
residues O
, O
and O
were O
nearly O
the O
same O
as _RARE_
the O
published O
sequence O
determined O
by O
Edman _RARE_
degradation _RARE_
. O

With O
chemical O
shift O
imaging O
, O
the O
signal O
intensity O
decreased O
on O
the O
out O
- O
of O
- O
phase _RARE_
images O
in O
six _RARE_
of O
seven _RARE_
( O
86 _RARE_
%) O
patients O
with O
APA _RARE_
and O
in O
eight O
of O
nine O
( O
89 _RARE_
%) O
patients O
with O
BAH _RARE_
. O

For O
each O
night O
, O
the O
diary _RARE_
allowed O
the O
subjective _RARE_
measurement O
of O
bedtime _RARE_
, O
wake _RARE_
time O
, O
time O
in O
bed _RARE_
( O
TIB _RARE_
), _RARE_
sleep O
efficiency O
, O
number O
of O
minutes O
of O
wake _RARE_
after O
sleep O
onset O
( O
WASO _RARE_
), _RARE_
alertness _RARE_
on O
awakening _RARE_
, O
and O
percentage O
of O
morning _RARE_
needing _RARE_
an O
alarm _RARE_
( O
or O
a O
person _RARE_
functioning O
as _RARE_
one O
). O

Acad _RARE_
. O

Copyright O
2000 O
Academic O
Press O
. O

The O
central O
( O
R O
) O
domain O
is O
responsible O
for _RARE_
receptor O
- O
binding O
activity O
whereas O
the O
N O
- O
terminal O
( O
T O
) O
domain O
mediates O
translocation O
, O
the O
process O
by O
which O
the O
C O
- O
terminal O
cytotoxic O
domain O
is O
transported O
from O
the O
receptor O
to O
the O
site O
of O
its O
cytotoxicity O
. O

We O
have O
previously O
demonstrated O
that O
expression _RARE_
of O
the O
gene O
for _RARE_
the O
reproductive O
neuropeptide _RARE_
, O
GnRH I-GENE
, O
is O
repressed O
by O
the O
glutamate _RARE_
/ O
NO _RARE_
/ O
cyclic O
GMP _RARE_
( O
cGMP _RARE_
) O
signal O
transduction _RARE_
pathway _RARE_
through O
cGMP _RARE_
- I-GENE
dependent I-GENE
protein I-GENE
kinase I-GENE
in O
the O
hypothalamic _RARE_
GnRH I-GENE
- O
secreting O
neuronal _RARE_
cell O
line O
GT1 _RARE_
- O
7 O
. O

These O
data O
suggest O
that O
combined O
lesions O
of O
cholinergic O
and O
serotonergic _RARE_
neurons O
in O
the O
rat O
brain O
do O
not O
alter O
olfactory O
perception _RARE_
or O
olfactory O
short O
- O
term O
memory O
. O

Extreme _RARE_
potency O
of O
botulinum I-GENE
toxin _RARE_
. O

In O
contrast O
, O
c I-GENE
- I-GENE
Src I-GENE
activated O
by O
isoproterenol O
led O
to O
tyrosine O
phosphorylation _RARE_
of O
Shc I-GENE
and O
subsequent O
Erk _RARE_
activation O
, O
but O
not O
tyrosine O
phosphorylation _RARE_
of O
cortactin _RARE_
or O
Stat3 I-GENE
. O

MSSPs _RARE_
are O
believed O
to O
regulate O
DNA O
replication O
, O
transcription O
, O
apopotosis _RARE_
and O
cell O
cycle _RARE_
progression O
by O
interacting _RARE_
with O
the O
C I-GENE
- I-GENE
MYC _RARE_
protein I-GENE
. O

For O
wild O
type O
MutT _RARE_
and O
its O
E53D _RARE_
and O
E44D _RARE_
mutants I-GENE
, O
plots _RARE_
of O
log O
( O
k _RARE_
( O
cat _RARE_
)) O
versus O
pH O
exhibited O
a O
limiting O
slope O
of O
1 O
on O
the O
ascending O
limb O
and O
then O
a O
hump _RARE_
, O
i O
. O
e _RARE_
., O
a O
sharply O
defined O
maximum O
near O
pH O
8 O
followed O
by O
a O
plateau _RARE_
, O
yielding _RARE_
apparent O
pK _RARE_
( O
a O
) O
values O
of O
7 O
. O
6 O
+/- O
0 _RARE_
. O
3 O
and O
8 O
. O
4 O
+/- O
0 _RARE_
. O
4 O
for _RARE_
an O
essential O
base _RARE_
and O
a O
nonessential _RARE_
acid O
catalyst _RARE_
, O
respectively O
, O
in O
the O
active _RARE_
quaternary _RARE_
MutT _RARE_
- O
Mg _RARE_
( O
2 O
+)- _RARE_
dGTP _RARE_
- O
Mg _RARE_
( O
2 O
+) O
complex O
. O

Structural O
changes O
in O
the O
kinetically _RARE_
more O
damaged O
E44D _RARE_
mutant O
detected O
in O
( O
1 O
) O
H O
-( _RARE_
15 _RARE_
) O
N O
HSQC _RARE_
spectra O
were O
largely O
limited O
to O
the O
loop O
I O
- O
helix O
I O
motif O
, O
suggesting O
that O
Glu O
- O
44 _RARE_
stabilizes O
the O
active _RARE_
site O
region O
. O

In O
vitro O
expression _RARE_
of O
four O
different O
naturally O
occurring O
nonsense O
and O
missense O
mutations O
revealed O
a O
dramatically O
altered O
subcellular O
location O
of O
the O
protein O
in O
cultured O
cells O
. O

After O
i O
. O
v O
. O

Immunity _RARE_
acquired O
by O
mice O
during _RARE_
I O
. O
scapularis _RARE_
nymphal _RARE_
activity O
in O
early O
summer O
may O
exclude _RARE_
a O
large O
proportion O
of O
the O
mouse O
population O
from O
maintaining O
E O
. O
phagocytophila _RARE_
during _RARE_
the O
period O
of O
larval _RARE_
activity O
later O
in O
the O
season O
. O

The O
emerging _RARE_
view O
based O
on O
studies O
in O
yeast O
is O
that O
each O
class O
of O
snoRNPs _RARE_
is O
composed O
of O
a O
unique O
set O
of O
proteins O
. O

BCR _RARE_
cross O
- O
linking O
also O
led O
to O
increased O
MAPK _RARE_
- O
activated O
protein I-GENE
kinase I-GENE
- I-GENE
2 I-GENE
activity O
, O
an O
enzyme O
that O
lies O
immediately O
downstream _RARE_
from O
p38 I-GENE
MAPK _RARE_
; O
MAPK _RARE_
- O
activated O
protein I-GENE
kinase I-GENE
- I-GENE
2 I-GENE
immune O
complexes O
phosphorylated _RARE_
a O
peptide O
substrate O
containing O
the O
CREB I-GENE
serine I-GENE
133 _RARE_
phosphoacceptor _RARE_
motif I-GENE
. O

Activation O
of O
a O
CRE _RARE_
- O
dependent O
junB I-GENE
promoter I-GENE
/ O
chloramphenicol I-GENE
acetyltransferase _RARE_
( O
CAT I-GENE
) O
reporter O
gene O
by O
the O
BCR _RARE_
was O
also O
blocked O
by O
SB203580 _RARE_
. O

We O
present O
evidence O
that O
the O
upstream O
open _RARE_
reading O
frame O
( O
uORF _RARE_
) O
represses O
the O
translation O
of O
the O
downstream _RARE_
major O
open _RARE_
reading O
frame O
( O
mORF _RARE_
). O

METHODS O
: O
TBN _RARE_
measurements O
were O
performed O
in O
31 _RARE_
female O
outpatients _RARE_
with O
breast O
carcinoma O
who O
were O
undergoing O
standard O
cyclophosphamide O
, O
methotrexate O
, O
and O
5 O
- O
fluorouracil O
( O
CMF _RARE_
)- O
based O
chemotherapy O
( O
median O
age O
, O
48 _RARE_
years O
; O
range O
, O
26 _RARE_
- O
77 O
years O
). O

A O
385 _RARE_
bp O
Glucocorticoid _RARE_
Response O
Unit _RARE_
( O
GRU _RARE_
) O
was O
identified O
whose O
glucocorticoid O
induction O
was O
enhanced _RARE_
by O
dibutyryl _RARE_
- O
cAMP O
and O
reduced _RARE_
by O
phorbol O
esters O
. O

No O
somatic O
mutations O
were O
found O
in O
any O
of O
the O
samples O
, O
suggesting O
that O
ING1 _RARE_
is O
not O
a O
tumor O
suppressor O
gene O
target O
in O
head O
and O
neck O
cancer _RARE_
. O

Ras I-GENE
- O
GRF1 _RARE_
transiently O
expressed _RARE_
with O
v I-GENE
- I-GENE
Src I-GENE
was O
tyrosine O
- O
phosphorylated _RARE_
and O
showed O
significant O
GEF _RARE_
activity O
toward O
Rac I-GENE
, O
but O
not O
Rho I-GENE
and O
Cdc42 I-GENE
, O
which O
was O
comparable O
with O
that O
induced _RARE_
by O
Gbetagamma I-GENE
. O

As O
no _RARE_
complete _RARE_
PPARgamma I-GENE
antagonists O
have O
been O
described O
hitherto O
, O
we O
have O
constructed O
a O
dominant O
- O
negative O
mutant O
receptor O
to O
inhibit O
wild O
- O
type O
PPARgamma I-GENE
action O
. O

EMSA O
showed O
that O
nuclear O
proteins O
from O
PC12 O
but O
not O
C6 _RARE_
or O
Rat2 _RARE_
cells O
bind O
the O
CRE _RARE_
as _RARE_
a O
complex O
containing O
activating I-GENE
transcription I-GENE
factor I-GENE
( I-GENE
ATF I-GENE
)- I-GENE
4 I-GENE
and O
CCAAT I-GENE
enhancer I-GENE
- I-GENE
binding I-GENE
protein I-GENE
beta I-GENE
, O
while O
both O
PC12 O
and O
C6 _RARE_
cell O
nuclear O
extracts O
were O
recruited O
by O
the O
CCAAT O
- O
box O
as _RARE_
a O
complex O
containing O
nuclear I-GENE
factor I-GENE
Y I-GENE
. O

EMSA O
showed O
that O
nuclear O
proteins O
from O
PC12 O
but O
not O
C6 _RARE_
or O
Rat2 _RARE_
cells O
bind O
the O
CRE _RARE_
as _RARE_
a O
complex O
containing O
activating I-GENE
transcription I-GENE
factor I-GENE
( I-GENE
ATF I-GENE
)- I-GENE
4 I-GENE
and O
CCAAT I-GENE
enhancer I-GENE
- I-GENE
binding I-GENE
protein I-GENE
beta I-GENE
, O
while O
both O
PC12 O
and O
C6 _RARE_
cell O
nuclear O
extracts O
were O
recruited O
by O
the O
CCAAT O
- O
box O
as _RARE_
a O
complex O
containing O
nuclear I-GENE
factor I-GENE
Y I-GENE
. O

Despite O
resolution O
of O
the O
solid O
portion O
of O
the O
tumor O
, O
serial O
MRI O
showed O
enlargement O
of O
a O
bilobar _RARE_
tumor O
cyst O
3 O
years O
after O
the O
original O
diagnosis O
. O

LPO _RARE_
and O
SOD I-GENE
levels O
were O
measured O
at _RARE_
five O
points O
before O
and O
during _RARE_
the O
operation O
. O

Sustained _RARE_
ventricular O
tachycardia O
and O
its O
successful O
prophylaxis O
during _RARE_
high O
- O
dose O
bolus O
interleukin I-GENE
- I-GENE
2 I-GENE
therapy O
for _RARE_
metastatic O
renal _RARE_
cell O
carcinoma O
. O

Second O
, O
when O
the O
NBF1 _RARE_
+ I-GENE
R I-GENE
protein I-GENE
, O
the O
NBF2 _RARE_
protein I-GENE
, O
and O
a O
mixture O
of O
the O
two O
proteins O
were O
folded O
separately O
and O
analyzed O
by O
molecular _RARE_
sieve _RARE_
chomatography _RARE_
, O
the O
mixture O
was O
found O
to O
elute _RARE_
prior O
to O
either O
NBF1 _RARE_
+ I-GENE
R I-GENE
or O
NBF2 _RARE_
. O

Collectively O
, O
these O
experiments O
demonstrate O
that O
CFTR I-GENE
' I-GENE
s I-GENE
NBF1 _RARE_
+ I-GENE
R I-GENE
region I-GENE
and O
its O
NBF2 _RARE_
domain I-GENE
, O
after O
folding O
separately O
as _RARE_
distinct O
units _RARE_
, O
have O
a O
strong O
propensity O
to O
interact O
and O
that O
this O
interaction O
is O
stable O
in O
the O
absence O
of O
added O
nucleotides O
or O
exogenously _RARE_
induced _RARE_
phosphorylation _RARE_
. O

Copyright O
2000 O
Academic O
Press O
. O

Sulfhydryl _RARE_
titration O
with O
iodoacetamide _RARE_
, O
monitored O
by O
quantitating _RARE_
the O
residual O
thiols _RARE_
after O
reaction O
with O
a O
maleimide _RARE_
derivative _RARE_
of O
biotin _RARE_
, O
revealed O
a O
striking O
difference O
in O
the O
apparent O
pK _RARE_
( O
a O
) O
values O
of O
the O
cysteines _RARE_
at _RARE_
the O
two O
splice _RARE_
junctions O
. O

After O
nitric _RARE_
oxide O
inhalation O
, O
the O
results O
showed O
moderate O
increases O
in O
PaO2 O
and O
SaO2 O
( O
P O
> O
0 _RARE_
. O
05 O
) O
and O
a O
significant O
decrease O
in O
Qs _RARE_
/ O
Q _RARE_
tau _RARE_
ratio O
( O
P O
< O
0 _RARE_
. O
01 O
). O

The O
results O
showed O
that O
MIP _RARE_
, O
MMIF _RARE_
, O
FIC _RARE_
, O
Wimax _RARE_
, O
P0 _RARE_
. O
1 O
and O
minute O
ventilation O
( O
Vr _RARE_
) O
were O
significantly O
increased O
after O
administration O
of O
methylphenidatum _RARE_
and O
aminophylline _RARE_
. O

Forty O
4 O
- O
month O
old O
SD O
female O
rats O
were O
randomly O
divided O
into O
four O
groups O
, O
namely O
sham O
operation O
, O
bilateral O
ovariectomy _RARE_
, O
ovariectomy _RARE_
plus _RARE_
supplementary O
ethinyl _RARE_
estradiol O
( O
0 _RARE_
. O
2 O
microgram O
/ O
100 _RARE_
g O
B O
. O

It O
has O
also O
been O
shown O
that O
a O
variety O
of O
extracellular O
factors O
stimulate O
a O
pair _RARE_
of O
MAPK _RARE_
p44 I-GENE
and O
MAPK _RARE_
p42 _RARE_
of O
MAPK _RARE_
family I-GENE
members I-GENE
. O

Covalent _RARE_
modification O
of O
the O
transactivator _RARE_
protein O
IE2 I-GENE
- O
p86 _RARE_
of O
human O
cytomegalovirus _RARE_
by O
conjugation O
to O
the O
ubiquitin I-GENE
- I-GENE
homologous I-GENE
proteins I-GENE
SUMO _RARE_
- I-GENE
1 I-GENE
and O
hSMT3b _RARE_
. O

73 _RARE_
: O
658 _RARE_
- O
666 _RARE_
, O
1999 _RARE_
). O

The O
interaction O
between O
U _RARE_
( O
L O
) O
3 O
. O

Protamine _RARE_
and O
heparin _RARE_
doses O
, O
their O
sum O
( O
Sigma _RARE_
- O
dose O
) O
and O
differential O
( O
Delta _RARE_
- O
dose O
) O
doses O
, O
and O
activated O
clotting _RARE_
times O
were O
tabulated _RARE_
. O

In O
this O
study O
, O
a O
common O
mechanism O
has O
been O
identified O
to O
coordinate O
the O
growth O
- O
and O
FC _RARE_
- O
dependent O
expression _RARE_
of O
caveolin _RARE_
. O

Comparison O
of O
the O
plant _RARE_
nuclear O
tRNA O
3 O
' O
processing _RARE_
enzyme O
with O
the O
plant _RARE_
mitochondrial O
one O
suggests O
that O
both O
activities O
are O
different O
enzymes _RARE_
. O

The O
requirement O
of O
3 O
' O
complementarity _RARE_
for _RARE_
a O
ligation O
reaction O
is O
reaffirmed _RARE_
by O
results O
from O
1 O
nt O
insertions O
on O
either O
the O
3 O
'- O
or O
5 O
'- O
side _RARE_
of O
the O
nick _RARE_
. O

NKX2 _RARE_
. I-GENE
1 I-GENE
is O
a O
member _RARE_
of O
the O
NK2 _RARE_
family I-GENE
of O
homeodomain _RARE_
- I-GENE
containing I-GENE
transcription I-GENE
factors I-GENE
whose O
targeted O
disruption O
in O
mouse O
results O
in O
the O
absence O
of O
thyroid O
tissue O
and O
a O
severely O
abnormal O
lung _RARE_
phenotype _RARE_
. O

National O
abortion O
laws _RARE_
usually O
do O
not O
allow O
abortion O
when O
a O
foetus _RARE_
is O
independently O
viable O
, O
i O
. O
e _RARE_
. O
from O
a O
gestational O
age O
of O
about O
24 _RARE_
weeks O
. O

Expression O
in O
early O
postnatal O
pituitary O
and O
in O
pre O
- O
somatotrophic _RARE_
cells O
suggests O
that O
Zn _RARE_
- I-GENE
16 I-GENE
could O
play O
a O
role O
in O
pituitary O
development O
prior O
to O
somatotroph _RARE_
differentiation O
. O

Mouse _RARE_
growth I-GENE
hormone I-GENE
transcription I-GENE
factor I-GENE
Zn _RARE_
- I-GENE
16 I-GENE
: O
unique O
bipartite O
structure _RARE_
containing O
tandemly O
repeated _RARE_
zinc O
finger O
domains O
not O
reported O
in O
rat I-GENE
Zn _RARE_
- I-GENE
15 _RARE_
. O

The O
CCAAT O
core O
sequence O
mutants O
in O
which O
both O
CIII _RARE_
and O
CI _RARE_
/ O
CII _RARE_
were O
abolished O
, O
also O
increased O
the O
promoter O
activity O
. O

Deglutition _RARE_
is O
considered O
to O
be O
immature O
in O
infants O
and O
to O
mature _RARE_
postnatally _RARE_
. O

This O
repression O
does O
not O
require O
the O
PU _RARE_
. I-GENE
1 I-GENE
transactivation _RARE_
or O
PEST _RARE_
domains O
and O
cannot O
be O
reversed O
by O
p300 I-GENE
expression _RARE_
. O

First O
, O
human O
erythroid _RARE_
K562 O
cells O
stably O
integrated O
with O
various O
HS _RARE_
- I-GENE
40 I-GENE
mutants I-GENE
cis O
linked _RARE_
to O
a O
human I-GENE
alpha I-GENE
- I-GENE
globin I-GENE
promoter I-GENE
- O
growth I-GENE
hormone I-GENE
hybrid _RARE_
gene O
were O
analyzed O
by O
genomic O
footprinting O
and O
expression _RARE_
analysis O
. O

Interestingly O
, O
addition O
of O
purified _RARE_
CBP I-GENE
to O
the O
nuclear O
extracts O
of O
T47D _RARE_
cells O
markedly O
stimulated _RARE_
progesterone O
- O
and O
PR I-GENE
- O
dependent O
transcription O
from O
a O
nucleosome _RARE_
- O
free O
, O
progesterone O
response O
element O
( O
PRE _RARE_
)- O
linked _RARE_
reporter O
DNA O
template O
. O

Its O
cognate _RARE_
binding O
protein O
, O
REST _RARE_
/ O
NRSF _RARE_
, O
is O
an O
essential O
transcription O
factor O
; O
its O
null _RARE_
mutations O
result O
in O
embryonic _RARE_
lethality O
, O
and O
its O
dominant O
negative O
mutants O
produce O
aberrant O
expression _RARE_
of O
neuron _RARE_
- O
specific O
genes O
. O

Removal O
of O
all O
core I-GENE
histone I-GENE
tail _RARE_
domains O
by O
limited O
trypsin I-GENE
proteolysis O
or O
acetylation O
of O
the O
core I-GENE
histone I-GENE
tails O
significantly O
relieves _RARE_
this O
inhibition O
and O
allows O
TFIIIA _RARE_
to O
exhibit O
high O
- O
affinity O
binding O
to O
nucleosomal _RARE_
DNA O
. O

Finally O
, O
the O
mechanism O
of O
ASK1 _RARE_
activation O
involves O
, O
in O
part O
, O
homo _RARE_
- O
oligomerization O
. O

OUTCOME O
: O
Acetylcholine _RARE_
receptor I-GENE
antibodies I-GENE
and O
single O
- O
fibre O
electromyogram _RARE_
were O
useful O
in O
the O
diagnosis O
of O
myasthenia _RARE_
gravis _RARE_
. O

Two O
other O
patients O
underwent O
PRFR _RARE_
. O

The O
variations O
were O
caused O
by O
opposite O
shifts O
in O
TSH _RARE_
frequency O
distribution O
in O
mothers O
and O
neonates O
. O

Characterization O
of O
the O
5 O
'- O
flanking O
region O
of O
the O
human I-GENE
multidrug _RARE_
resistance I-GENE
protein I-GENE
2 I-GENE
( O
MRP2 _RARE_
) O
gene O
and O
its O
regulation _RARE_
in O
comparison O
withthe _RARE_
multidrug _RARE_
resistance I-GENE
protein I-GENE
3 I-GENE
( O
MRP3 _RARE_
) O
gene O
. O

However O
, O
such O
a O
mechanism O
was O
not O
detected O
in O
preliminary O
observations O
on O
M O
. O
synoviae _RARE_
. O

These O
results O
suggest O
that O
the O
M O
. O
jannaschii _RARE_
as _RARE_
well _RARE_
as _RARE_
related O
archaeal _RARE_
20S I-GENE
proteasomes _RARE_
require O
a O
nucleotidase _RARE_
complex O
such O
as _RARE_
PAN _RARE_
to O
mediate O
the O
energy O
- O
dependent O
hydrolysis O
of O
folded O
- O
substrate O
proteins O
and O
that O
the O
N O
- O
terminal O
73 _RARE_
amino O
acid O
residues O
of O
PAN _RARE_
are O
not O
absolutely _RARE_
required O
for _RARE_
this O
reaction O
. O

The O
transcription O
factor O
E2F I-GENE
plays O
an O
important O
role O
in O
G O
( O
1 O
) O
to O
S O
phase _RARE_
transition O
in O
the O
higher _RARE_
eukaryotic O
cell O
cycle _RARE_
. O

In O
two O
- O
field O
nodal O
dissection O
, O
two O
components _RARE_
are O
included O
with O
( O
modern O
two O
- O
field O
) O
or O
without O
( O
traditional _RARE_
two O
- O
field O
) O
nodal O
dissection O
around O
both O
recurrent O
laryngeal _RARE_
nerve O
chains O
in O
the O
upper O
mediastinum _RARE_
. O

Of O
the O
153 _RARE_
patients O
studied O
, O
CK _RARE_
- I-GENE
MB I-GENE
results O
were O
positive O
in O
91 O
( O
59 _RARE_
%) O
patients O
; O
ECG O
revealed O
AMI O
in O
72 O
( O
47 _RARE_
%) O
patients O
. O

The O
effect O
of O
MIB _RARE_
on O
the O
dose O
- O
response O
curve O
of O
externally _RARE_
applied O
noradrenaline O
was O
also O
studied O
. O

The O
regional O
blockade O
of O
H1R _RARE_
was O
observed O
mainly O
in O
the O
frontal O
, O
temporal O
and O
anterior O
cingulate _RARE_
cortices _RARE_
, O
and O
the O
intravenous O
administration O
of O
d O
- O
chlorpheniramine _RARE_
as _RARE_
a O
therapeutic O
dose O
( O
2 O
mg O
) O
blocked O
over O
60 _RARE_
% O
of O
H1R _RARE_
in O
the O
frontal O
cortices _RARE_
. O

The O
expression _RARE_
of O
the O
yam8 _RARE_
(+) _RARE_
cDNA I-GENE
in O
the O
mid1 _RARE_
mutant I-GENE
cells O
partially O
remediated _RARE_
the O
mid O
phenotype _RARE_
and O
resulted O
in O
a O
slight O
increase O
in O
Ca O
( O
2 O
+) O
uptake O
activity O
. O

Linearized _RARE_
overall O
infection O
rates O
( O
events O
/ O
100 _RARE_
patient O
- O
days O
) O
were O
2 O
. O
05 O
+/- O
0 _RARE_
. O
33 _RARE_
( O
heart _RARE_
- O
lung _RARE_
) O
and O
2 O
. O
34 _RARE_
+/- O
0 _RARE_
. O
34 _RARE_
( O
double O
- O
lung _RARE_
; O
P O
= O
NS _RARE_
) O
at _RARE_
3 O
months O
. O

Static _RARE_
and O
dynamic O
compliance O
was O
measured O
after O
induction O
of O
anesthesia O
, O
before O
and O
immediately O
after O
filtration O
in O
the O
operating O
theater _RARE_
, O
1 O
hour O
after O
return O
to O
the O
pediatric O
intensive O
care O
unit O
, O
and O
24 _RARE_
hours O
after O
the O
operation O
. O

Antipyretic _RARE_
therapy O
: O
physiologic _RARE_
rationale _RARE_
, O
diagnostic O
implications O
, O
and O
clinical O
consequences O
. O

There O
is O
no _RARE_
correlation O
between O
C2 O
- O
C3 _RARE_
disk _RARE_
morphology O
and O
the O
diskographically _RARE_
provoked _RARE_
response O
. O

KFC _RARE_
, O
a O
Ste20 _RARE_
- I-GENE
like I-GENE
kinase I-GENE
with O
mitogenic O
potential _RARE_
and O
capability _RARE_
to O
activate O
the O
SAPK I-GENE
/ O
JNK I-GENE
pathway _RARE_
. O

TIP30 _RARE_
has O
an O
intrinsic _RARE_
kinase O
activity O
required O
for _RARE_
up _RARE_
- O
regulation _RARE_
of O
a O
subset O
of O
apoptotic O
genes O
. O

We O
have O
mapped O
the O
human I-GENE
STAG3 _RARE_
gene I-GENE
to O
the O
7q22 _RARE_
region O
of O
chromosome _RARE_
7 O
; O
six _RARE_
human I-GENE
STAG3 _RARE_
- I-GENE
related I-GENE
genes I-GENE
have O
also O
been O
mapped O
: O
two O
at _RARE_
7q22 _RARE_
near O
the O
functional _RARE_
gene O
, O
one O
at _RARE_
7q11 _RARE_
. O
22 _RARE_
, O
and O
three O
at _RARE_
7q11 _RARE_
. O
23 _RARE_
, O
two O
of O
them O
flanking O
the O
breakpoints O
commonly O
associated O
with O
the O
Williams _RARE_
- I-GENE
Beuren _RARE_
syndrome _RARE_
( I-GENE
WBS _RARE_
) I-GENE
deletion I-GENE
. O

Reaction _RARE_
time O
( O
RT O
) O
and O
P300 _RARE_
were O
collected O
simultaneously O
. O

In O
experiment O
2 O
the O
rats O
had O
free O
access O
to O
two O
bottles _RARE_
, O
one O
of O
which O
contained O
tap _RARE_
water O
, O
and O
the O
other O
contained O
either O
an O
ethanol O
( O
6 O
%) O
or O
a O
sucrose O
( O
5 O
%) O
solution O
. O

Furthermore O
, O
Zelen _RARE_
' O
s O
method O
is O
used O
to O
balance O
the O
number O
of O
patients O
allocated O
to O
the O
two O
groups O
within O
each O
institution _RARE_
( O
M O
. O

RESULTS O
: O
In O
this O
group O
of O
patients O
, O
male O
gender O
( O
P O
= O
0 _RARE_
. O

Selective O
visual O
attention O
involves O
dynamic O
interplay _RARE_
between O
attentional _RARE_
control O
systems _RARE_
and O
sensory O
brain O
structures _RARE_
. O

The O
patient O
had O
developed O
left _RARE_
- O
sided _RARE_
low O
- O
frequency O
tremor O
and O
hemidystonia _RARE_
after O
a O
severe O
head O
trauma O
sustained O
at _RARE_
15 _RARE_
years O
of O
age O
. O

However O
, O
the O
a1 _RARE_
isoform O
is O
expressed _RARE_
most O
heavily _RARE_
in O
brain O
and O
heart _RARE_
, O
a2 _RARE_
in O
liver O
and O
kidney _RARE_
, O
and O
a3 _RARE_
in O
liver O
, O
lung _RARE_
, O
heart _RARE_
, O
brain O
, O
spleen _RARE_
, O
and O
kidney _RARE_
. O

During O
the O
cloning O
by O
reverse I-GENE
transcriptase I-GENE
- O
polymerase O
chain O
reaction O
of O
the O
human I-GENE
HIF I-GENE
- I-GENE
1alpha I-GENE
subunit I-GENE
, O
we O
isolated O
two O
cDNA O
clones _RARE_
which O
corresponded O
to O
alternative _RARE_
splicing _RARE_
of O
the O
HIF I-GENE
- I-GENE
1alpha I-GENE
gene I-GENE
. O

To O
assess O
the O
relationship O
between O
G O
( O
q _RARE_
)/ _RARE_
G I-GENE
( I-GENE
11 I-GENE
) I-GENE
function O
with O
the O
phosphatidylinositol _RARE_
3 I-GENE
- I-GENE
kinase I-GENE
dependent O
pathway _RARE_
, O
expression _RARE_
of O
a O
dominant O
- O
interfering O
p85 I-GENE
regulatory I-GENE
subunit I-GENE
, O
as _RARE_
well _RARE_
as _RARE_
wortmannin O
treatment O
inhibited O
insulin I-GENE
- O
stimulated _RARE_
but O
not O
G I-GENE
( I-GENE
q _RARE_
)/ _RARE_
Q209L _RARE_
- O
stimulated _RARE_
GLUT4 _RARE_
- O
EGFP _RARE_
translocation O
. O

In O
endemic _RARE_
BL _RARE_
, O
the O
RB2 _RARE_
/ O
p130 I-GENE
gene O
is O
mutated _RARE_
in O
most O
of O
the O
cases O
, O
and O
the O
protein O
is O
restricted O
to O
the O
cytoplasm O
. O

Together O
, O
these O
data O
identify O
ERK2 I-GENE
as _RARE_
a O
specific O
and O
direct O
target O
of O
HePTP _RARE_
and O
are O
consistent O
with O
a O
model O
in O
which O
HePTP _RARE_
negatively O
regulates O
ERK2 I-GENE
activity O
as _RARE_
part O
of O
a O
feedback _RARE_
mechanism O
. O

Cross O
- O
reaction O
between O
a O
monoclonal O
antibody O
and O
two O
alpha I-GENE
beta I-GENE
T I-GENE
cell I-GENE
receptors I-GENE
. O

Strontium _RARE_
nitrate _RARE_
mixed O
with O
glycolic _RARE_
acid O
, O
in O
comparison O
with O
glycolic _RARE_
acid O
alone O
, O
markedly O
( O
p O
< O
0 _RARE_
. O
01 O
) O
shortened O
the O
duration O
of O
the O
irritation _RARE_
sensation _RARE_
from O
24 _RARE_
. O
4 O
+/- O
4 O
. O
1 O
( O
mean O
+/- O
SEM _RARE_
) O
min O
to O
8 O
. O
9 O
+/- O
3 O
. O
7 O
( O
mean O
+/- O
SEM _RARE_
) O
min O
, O
and O
significantly O
( O
p O
< O
0 _RARE_
. O
05 O
) O
reduced _RARE_
the O
mean O
magnitude O
of O
the O
irritation _RARE_
sensation _RARE_
at _RARE_
all O
time O
points O
( O
overall O
). O

The O
pCMBS _RARE_
- O
reactive O
sulfhydryl _RARE_
groups O
were O
located _RARE_
exclusively O
in O
the O
exofacial _RARE_
half _RARE_
of O
the O
plasma O
membrane O
and O
, O
when O
presented O
in O
a O
helical O
model O
, O
lie _RARE_
along O
one O
side _RARE_
of O
the O
helices O
. O

Analysis O
of O
1 O
Mb O
of O
published O
sequence O
from O
the O
region O
of O
conserved _RARE_
synteny _RARE_
on O
human O
chromosome _RARE_
5q31 _RARE_
- O
q33 _RARE_
identified O
45 _RARE_
gene O
candidates _RARE_
, O
including O
35 _RARE_
expressed _RARE_
genes O
in O
the O
human I-GENE
IL _RARE_
- I-GENE
4 I-GENE
cytokine _RARE_
gene I-GENE
cluster I-GENE
. O

Human I-GENE
AP I-GENE
- I-GENE
2rep _RARE_
repressed O
both O
reporter O
expression _RARE_
from O
a O
transiently O
transfected O
AP I-GENE
- I-GENE
2alpha I-GENE
promoter I-GENE
and O
the O
endogenous O
AP I-GENE
- I-GENE
2alpha I-GENE
gene I-GENE
and O
inversely O
was O
negatively O
regulated O
by O
AP I-GENE
- I-GENE
2alpha I-GENE
. O

In O
order O
to O
gain O
deeper _RARE_
insight O
into O
the O
role O
of O
the O
amino O
- O
terminal O
domain O
of O
the O
p24 _RARE_
( O
CA I-GENE
) O
protein O
during _RARE_
viral O
replication O
, O
eight O
highly O
conserved _RARE_
proline O
residues O
known O
to O
promote O
turns _RARE_
and O
to O
terminate O
alpha O
- O
helices O
within O
the O
p24 _RARE_
tertiary O
structure _RARE_
were O
replaced O
by O
a O
leucine O
residue _RARE_
( O
P O
- O
position O
- O
L O
). O

Clb _RARE_
/ O
Cdc28 I-GENE
kinases O
promote O
nuclear O
export O
of O
the O
replication I-GENE
initiator _RARE_
proteins I-GENE
Mcm2 _RARE_
- I-GENE
7 I-GENE
. O

Alternatively _RARE_
, O
PC12 O
- O
E2 O
cells O
were O
submitted O
to O
treatment O
with O
antibodies O
to O
the O
fibroblast I-GENE
growth I-GENE
factor I-GENE
( I-GENE
FGF I-GENE
) I-GENE
receptor I-GENE
, O
inhibitors _RARE_
of O
the O
nonreceptor _RARE_
tyrosine I-GENE
kinase I-GENE
p59 _RARE_
( O
fyn _RARE_
), _RARE_
PLC I-GENE
, O
PKC I-GENE
and O
MEK I-GENE
and O
an O
activator O
of O
PKC I-GENE
, O
phorbol O
- O
12 O
- O
myristate O
- O
13 _RARE_
- O
acetate _RARE_
( O
PMA O
). O

Cooperative _RARE_
roles O
of O
Bozozok _RARE_
/ O
Dharma _RARE_
and O
Nodal _RARE_
- I-GENE
related I-GENE
proteins I-GENE
in O
the O
formation O
of O
the O
dorsal O
organizer _RARE_
in O
zebrafish _RARE_
. O

Thiopentone _RARE_
sodium _RARE_
administered O
at _RARE_
30 _RARE_
and O
10 O
min O
before O
or O
5 O
, O
10 O
and O
15 _RARE_
min O
after O
exposure O
to O
NOC _RARE_
- O
5 O
, O
but O
not O
thereafter O
, O
significantly O
attenuated O
NO _RARE_
- O
induced _RARE_
neurotoxicity O
compared O
with O
controls O
. O

We O
also O
show O
that O
zygotically _RARE_
activated O
Xretpos _RARE_
transcripts O
are O
restricted O
to O
ventro _RARE_
- O
posterior O
specific O
regions O
and O
induced _RARE_
by O
UV _RARE_
- O
irradiation O
and O
BMP I-GENE
- I-GENE
4 I-GENE
overexpression O
in O
cycloheximide _RARE_
- O
dependent O
way O
. O
genesis _RARE_
26 _RARE_
: O
198 O
- O
207 _RARE_
, O
2000 O
. O

In O
all O
other O
cases O
, O
vestibular O
neurectomy _RARE_
or O
chemical O
vestibular O
labyrinthectomy _RARE_
, O
by O
means O
of O
intratympanic _RARE_
low O
concentration O
gentamicin _RARE_
( O
20 O
mg O
/ O
mL O
), _RARE_
are O
indicated O
. O

However O
, O
when O
, O
where O
and O
how O
the O
DSPP _RARE_
is O
cleaved O
into O
DSP _RARE_
and O
DPP _RARE_
is O
not O
clear O
. O

It O
has O
a O
grave _RARE_
prognosis O
with O
> O
70 O
% O
mortality O
in O
3 O
months O
, O
despite O
mechanical O
ventilation O
. O

We O
found O
that O
TCR I-GENE
signaling _RARE_
induces O
AP I-GENE
- I-GENE
1 I-GENE
binding O
to O
this O
site O
and O
regulates O
the O
fasl _RARE_
promoter I-GENE
function O
in O
a O
fashion O
dependent O
on O
NF _RARE_
- I-GENE
kappaB I-GENE
binding O
. O

Thus O
, O
patients O
with O
metastatic O
melanoma _RARE_
are O
not O
tolerant _RARE_
to O
gp100 _RARE_
Ag _RARE_
based O
on O
the O
detection O
of O
CD8 _RARE_
+ I-GENE
T O
cells O
specific O
for _RARE_
multiple O
HLA I-GENE
- I-GENE
A I-GENE
* _RARE_
0201 _RARE_
- O
restricted O
, O
gp100 _RARE_
- O
derived O
epitopes _RARE_
. O

Approximately O
20 O
% O
of O
ALCLs _RARE_
that O
express O
ALK _RARE_
do O
not O
contain O
the O
t O
( O
2 O
; O
5 O
), _RARE_
suggesting O
that O
other O
genetic O
abnormalities O
can O
result O
in O
aberrant O
ALK _RARE_
expression _RARE_
. O

In O
addition O
, O
expected O
decreases O
in O
ATIC _RARE_
enzymatic O
function O
in O
ATIC _RARE_
- O
ALK _RARE_
- O
containing O
lymphomas O
may O
render _RARE_
these O
tumors O
more O
sensitive _RARE_
to O
antifolate _RARE_
drugs O
such O
as _RARE_
methotrexate O
. O

Following O
the O
observation O
that O
non O
- O
organ O
- O
specific O
antibodies O
are O
related O
with O
pregnancy _RARE_
loss _RARE_
and O
preeclampsia _RARE_
, O
the O
role O
of O
organ O
- O
specific O
antibodies O
is O
currently O
being O
extensively O
investigated O
. O

Manganese _RARE_
ions O
were O
found O
to O
be O
essential O
for _RARE_
autophosphorylation O
of O
BGLF4 _RARE_
, O
and O
magnesium O
can O
stimulate O
the O
activity O
. O

The O
Mif1 _RARE_
5 I-GENE
' I-GENE
flanking I-GENE
region I-GENE
contains O
a O
functional _RARE_
ER O
stress O
- O
responsive O
element O
which O
is O
sufficient O
for _RARE_
induction O
by O
tunicamycin _RARE_
. O

Rigid _RARE_
point O
feature O
registration _RARE_
using O
mutual _RARE_
information _RARE_
. O

Methysergide _RARE_
is O
a O
serotonin _RARE_
antagonist O
and O
has O
been O
demonstrated O
to O
reduce O
wound O
blood _RARE_
flow O
and O
edema O
formation O
. O

Serum O
leptin I-GENE
concentrations O
in O
women O
during _RARE_
gonadotropin I-GENE
stimulation _RARE_
cycles O
. O

Valuing _RARE_
families _RARE_
: O
social O
work O
practice O
with O
families _RARE_
from O
a O
strengths O
perspective _RARE_
. O

PURPOSE O
: O
A O
two O
- O
generation O
consanguineous _RARE_
Pakistani _RARE_
family O
with O
autosomal _RARE_
recessive O
Leber _RARE_
congenital O
amaurosis _RARE_
( O
LCA _RARE_
, O
MIM _RARE_
204 _RARE_
, O
000 _RARE_
) O
and O
keratoconus _RARE_
was O
identified O
. O

Ste18p _RARE_
was O
targeted O
to O
the O
plasma O
membrane O
even O
in O
the O
absence O
of O
prenylation _RARE_
or O
thioacylation _RARE_
. O

Here O
, O
we O
show O
that O
IRF I-GENE
- I-GENE
1 I-GENE
is O
degraded O
via O
the O
ubiquitin I-GENE
- O
proteasome O
pathway _RARE_
. O

An O
amino O
- O
acid O
sequence O
comparison O
revealed O
that O
Bacillus I-GENE
YM55 _RARE_
- I-GENE
1 I-GENE
aspartase _RARE_
shared O
71 _RARE_
% O
homology O
with O
Bacillus I-GENE
subtilis I-GENE
aspartase _RARE_
and O
49 _RARE_
% O
with O
Escherichia O
coli O
and O
Pseudomonas _RARE_
fluorescens _RARE_
aspartases _RARE_
. O

Unique _RARE_
to O
this O
system _RARE_
, O
the O
activity O
of O
TraR _RARE_
is O
negatively O
modulated O
by O
an O
antiactivator _RARE_
called O
TraM _RARE_
. O

As O
assessed O
by O
a O
genetic O
assay O
that O
measures O
AAI _RARE_
- O
dependent O
DNA O
binding O
, O
TraM _RARE_
inhibited O
TraR _RARE_
function O
before O
and O
after O
the O
transcription O
factor O
had O
bound _RARE_
to O
its O
DNA O
recognition O
site O
. O

Here O
we O
show O
that O
IIIa _RARE_
pre O
- O
mRNA O
splicing _RARE_
is O
activated O
more O
than O
200 _RARE_
- O
fold _RARE_
in O
nuclear O
extracts O
prepared O
from O
late _RARE_
adenovirus O
- O
infected _RARE_
cells O
( O
Ad _RARE_
- O
NE _RARE_
) O
compared O
to O
uninfected _RARE_
HeLa O
cell O
nuclear O
extracts O
( O
HeLa O
- O
NE _RARE_
). O

Inactivation _RARE_
of O
Ulp2 _RARE_
also O
suppresses O
several O
ulp1 _RARE_
( I-GENE
ts _RARE_
) I-GENE
defects O
, O
and O
the O
double O
mutant O
accumulates O
far O
fewer O
Smt3 _RARE_
- I-GENE
protein I-GENE
conjugates _RARE_
than O
either O
single O
mutant O
. O

Collectively O
, O
the O
results O
suggest O
that O
ARF I-GENE
binding O
to O
Mdm2 _RARE_
induces O
a O
conformational O
change O
that O
facilitates _RARE_
nucleolar _RARE_
import O
of O
the O
ARF I-GENE
- O
Mdm2 _RARE_
complex O
and O
p53 I-GENE
- O
dependent O
cell O
cycle _RARE_
arrest O
. O

Cyclin I-GENE
A I-GENE
expression _RARE_
is O
repressed O
in O
quiescent _RARE_
cells O
by O
E2F I-GENE
acting O
in O
conjunction O
with O
its O
pocket O
protein O
partners O
Rb _RARE_
, O
p107 I-GENE
, O
and O
p130 I-GENE
; O
however O
, O
v I-GENE
- I-GENE
Jun I-GENE
overrides _RARE_
this O
control O
, O
causing O
phosphorylated _RARE_
Rb _RARE_
and O
proliferation _RARE_
- O
specific O
E2F I-GENE
- O
p107 I-GENE
complexes O
to O
persist _RARE_
after O
mitogen O
withdrawal O
. O

D I-GENE
- I-GENE
cyclin _RARE_
- O
cdk _RARE_
activity O
is O
required O
for _RARE_
Rb _RARE_
phosphorylation _RARE_
in O
v I-GENE
- I-GENE
Jun I-GENE
- O
transformed O
cells O
, O
since O
ectopic O
expression _RARE_
of O
the O
cdk4 _RARE_
- O
and O
cdk6 _RARE_
- O
specific O
inhibitor O
p16 _RARE_
( O
INK4A _RARE_
) O
inhibits O
both O
DNA O
synthesis _RARE_
and O
cell O
proliferation _RARE_
. O

CONCLUSION O
: O
A O
valve O
- O
like O
mechanism O
formed O
by O
the O
capsulorhexis _RARE_
rim _RARE_
partially O
adhered _RARE_
to O
the O
IOL _RARE_
optic O
can O
occur O
postoperatively O
. O

The O
protein O
first _RARE_
identified O
by O
the O
monoclonal I-GENE
antibody I-GENE
Q18 _RARE_
is O
encoded O
by O
a O
gene O
located _RARE_
in O
57A _RARE_
on O
polytene _RARE_
chromosomes O
and O
has O
been O
consequently _RARE_
named O
Hrb57A _RARE_
. O

3 O
' O
RNA O
boundary O
experiments O
indicate O
that O
the O
5 O
' O
structure _RARE_
reduces O
the O
number O
of O
( O
G O
/ O
U _RARE_
) O
AG _RARE_
repeats O
required O
for _RARE_
stable O
TRAP _RARE_
- O
trp _RARE_
leader _RARE_
RNA O
association O
. O

Gene _RARE_
silencing O
associated O
with O
repeated _RARE_
DNA O
sequences O
has O
been O
reported O
for _RARE_
many O
eukaryotes O
, O
including O
plants _RARE_
. O

The O
AtERF _RARE_
genes I-GENE
were O
differentially O
regulated O
by O
ethylene O
and O
by O
abiotic _RARE_
stress O
conditions O
, O
such O
as _RARE_
wounding _RARE_
, O
cold O
, O
high O
salinity _RARE_
, O
or O
drought _RARE_
, O
via O
ETHYLENE _RARE_
- I-GENE
INSENSITIVE2 _RARE_
( O
EIN2 _RARE_
)- O
dependent O
or O
- O
independent O
pathways O
. O

Animals O
received O
a O
dose O
of O
dexamethasone O
( O
10 O
mg O
/ O
kg O
i O
. O
p O
.) O
prior O
to O
the O
protein O
- O
free O
surfactant _RARE_
preparation O
Exosurf _RARE_
( O
pure O
phospholipids O
containing O
surfactant _RARE_
, O
Wellcome _RARE_
GmbH _RARE_
, O
Burgwedel _RARE_
, O
Germany _RARE_
) O
and O
a O
rSP _RARE_
- O
C O
based O
surfactant _RARE_
, O
respectively O
. O

BACKGROUND O
: O
The O
aim O
of O
this O
study O
was O
to O
determine O
the O
response O
rates O
and O
toxicity O
of O
two O
regimens O
containing O
granulocyte _RARE_
- I-GENE
macrophage I-GENE
- I-GENE
colony I-GENE
stimulating I-GENE
factor I-GENE
( O
GM _RARE_
- I-GENE
CSF I-GENE
) O
in O
combination O
with O
interleukin I-GENE
- I-GENE
2 I-GENE
( O
IL _RARE_
- I-GENE
2 I-GENE
) O
in O
the O
treatment O
of O
patients O
with O
metastatic O
renal _RARE_
cell O
carcinoma O
. O

We O
show O
, O
by O
injection O
of O
synthetic _RARE_
mRNAs O
, O
that O
the O
cis O
- O
acting O
sequences O
responsible O
for _RARE_
repression O
of O
cyclin _RARE_
B1 _RARE_
mRNA I-GENE
reside O
within O
its O
3 O
' O
UTR O
. O

These O
data O
indicate O
that O
expansion O
of O
the O
dodecamer _RARE_
repeat O
located _RARE_
in O
the O
proximal O
promoter O
of O
CSTB _RARE_
severely O
disrupts _RARE_
the O
function O
of O
the O
promoter O
and O
thereby O
reduces O
transcription O
of O
CSTB _RARE_
. O

Thus O
, O
while O
the O
genomic O
organization O
of O
mHuA _RARE_
is O
similar O
to O
the O
neural _RARE_
- O
restricted O
members O
of O
the O
Elav _RARE_
family I-GENE
, O
the O
promoter O
element O
differs O
substantially O
both O
by O
sequence O
analysis O
and O
transcriptional O
activity O
in O
non O
- O
neural _RARE_
cell O
types _RARE_
. O

Analysis O
of O
the O
5 O
' O
end O
of O
the O
mouse I-GENE
Elavl1 _RARE_
( O
mHuA _RARE_
) O
gene O
reveals O
a O
transcriptional O
regulatory O
element O
and O
evidence O
for _RARE_
conserved _RARE_
genomic O
organization O
. O
mHuA _RARE_
( O
Elavl1 _RARE_
) O
belongs O
to O
a O
highly O
conserved _RARE_
family O
of O
genes O
encoding O
RNA O
- O
binding O
proteins O
and O
has O
been O
linked _RARE_
to O
cell O
growth O
and O
proliferation _RARE_
through O
its O
regulation _RARE_
of O
mRNA O
stability O
. O

Electrophoretic O
mobility O
shift O
assays O
revealed O
that O
Sp1 _RARE_
binds O
to O
two O
different O
regions O
in O
the O
proximal O
promoter O
, O
a O
typical O
Sp1 _RARE_
site I-GENE
located _RARE_
at _RARE_
(- _RARE_
38 O
; O
- O
33 _RARE_
) O
and O
a O
G O
/ O
C O
- O
rich O
region O
between O
(- _RARE_
67 O
; O
- O
62 _RARE_
). O

Fgd3 _RARE_
and O
FGD1 _RARE_
share O
a O
high O
degree O
of O
sequence O
identity O
that O
spans O
> O
560 _RARE_
contiguous O
amino O
acid O
residues O
. O

Molecular O
cloning O
of O
mouse I-GENE
thioredoxin _RARE_
reductases _RARE_
. O

The O
HPLC O
method O
involves O
an O
octadecylsilane _RARE_
column O
at _RARE_
55 _RARE_
degrees O
C O
, O
a O
mixture O
of O
water O
- O
acetonitrile _RARE_
- O
orthophosphoric _RARE_
acid O
( O
779 _RARE_
: O
220 O
: O
1 O
, O
v O
/ O
v O
) O
as _RARE_
mobile O
phase _RARE_
and O
detection O
at _RARE_
226 _RARE_
nm O
. O

Eight O
patients O
received O
1 O
. O
5 O
mg O
of O
adefovir _RARE_
dipivoxil _RARE_
per O
kg O
of O
body O
weight _RARE_
, O
and O
six _RARE_
patients O
received O
3 O
. O
0 _RARE_
mg O
of O
adefovir _RARE_
dipivoxil _RARE_
per O
kg O
. O

CYC2 _RARE_
encodes O
a O
24 _RARE_
- O
kDa O
protein O
that O
has O
sequence O
identity O
to O
the O
Neurospora I-GENE
crassa I-GENE
PREG1 _RARE_
and O
the O
S I-GENE
. I-GENE
cerevisiae I-GENE
PHO80 _RARE_
cyclin _RARE_
. O

To O
determine O
if O
CYC2 _RARE_
is O
found O
in O
a O
complex O
with O
previously O
identified O
trypanosome _RARE_
cdc2 I-GENE
- I-GENE
related I-GENE
kinases I-GENE
( O
CRKs _RARE_
), _RARE_
the O
CYC2 _RARE_
gene I-GENE
was O
fused O
to O
the O
TY _RARE_
epitope _RARE_
tag O
, O
integrated O
into O
the O
trypanosome _RARE_
genome O
, O
and O
expressed _RARE_
under O
inducible O
control O
. O

These O
findings O
indicate O
the O
involvement O
of O
Sp1 _RARE_
and O
an O
Inr _RARE_
in O
non O
- O
cell O
- O
specific O
regulation _RARE_
and O
a O
Kruppel _RARE_
- I-GENE
like I-GENE
transcription I-GENE
factor I-GENE
and O
Sp1 _RARE_
in O
the O
cell O
- O
specific O
regulation _RARE_
of O
the O
LTC _RARE_
( I-GENE
4 I-GENE
) I-GENE
S I-GENE
gene I-GENE
. O

Here O
we O
review O
progress O
to O
date O
in O
this O
area O
. O

Additionally O
, O
the O
mouse O
promoter O
contains O
22 _RARE_
copies O
of O
a O
CT _RARE_
dinucleotide O
repeat O
sequence O
located _RARE_
approximately _RARE_
155 _RARE_
bp O
5 O
' O
to O
exon _RARE_
1 O
. O

The O
newly O
defined O
region O
contains O
an O
intron O
that O
may O
be O
alternatively _RARE_
spliced _RARE_
and O
seven _RARE_
polyadenylation O
signal O
sequences O
. O

Depleted _RARE_
and O
enriched _RARE_
U3O8 _RARE_
standard O
reference O
materials O
were O
used O
to O
calibrate _RARE_
the O
system _RARE_
. O

Therefore O
, O
the O
positive O
cAMP O
control O
of O
the O
hypoxic O
SRP1 _RARE_
and O
HEM13 _RARE_
genes I-GENE
was O
uncoupled _RARE_
from O
the O
HOG _RARE_
pathway _RARE_
. O

Most O
likely O
they O
might O
represent O
regulatory O
RNAs O
or O
transcribed _RARE_
transposable _RARE_
elements O
. O

This O
paper O
reviews _RARE_
the O
middleware _RARE_
- O
based O
approach O
adopted O
by O
CEN _RARE_
ENV _RARE_
12967 _RARE_
- O
1 O
and O
the O
specialisation _RARE_
necessary O
for _RARE_
the O
healthcare _RARE_
record O
based O
on O
CEN _RARE_
ENV _RARE_
12265 _RARE_
' O
Electronic _RARE_
Healthcare _RARE_
Record _RARE_
Architecture _RARE_
'. O

Sequence O
analyses O
of O
sos2 _RARE_
mutant I-GENE
alleles I-GENE
reveal O
that O
both O
the O
N O
- O
terminal O
catalytic O
domain O
and O
the O
C O
- O
terminal O
regulatory O
domain O
of O
SOS2 _RARE_
are O
functionally O
essential O
. O

A O
mutation O
which O
abrogates _RARE_
the O
binding O
of O
these O
factors O
reduces O
Wp _RARE_
reporter I-GENE
activity O
specifically O
in O
B O
cell O
lines O
, O
whereas O
a O
mutation O
which O
converts _RARE_
the O
site O
to O
a O
consensus O
CREB I-GENE
- I-GENE
binding I-GENE
sequence I-GENE
maintains O
wild O
- O
type O
promoter O
function O
. O

Here O
we O
describe O
the O
cloning O
, O
tissue O
- O
specific O
expression _RARE_
pattern O
, O
and O
functional _RARE_
characterization O
of O
two O
novel O
TEF I-GENE
- I-GENE
1 I-GENE
isoforms I-GENE
, O
TEF I-GENE
- I-GENE
1beta I-GENE
and O
TEF I-GENE
- I-GENE
1gamma _RARE_
. O

Therefore O
the O
binding O
sites O
for _RARE_
liver O
- O
enriched _RARE_
factors O
, O
present O
in O
the O
hamster I-GENE
CYP7A1 _RARE_
proximal I-GENE
promoter I-GENE
in O
close O
vicinity O
and O
conserved _RARE_
between O
species O
, O
constitute O
a O
regulatory O
unit O
important O
for _RARE_
basal O
hepatic _RARE_
expression _RARE_
and O
tissue O
restriction _RARE_
of O
the O
action O
of O
hormones _RARE_
such O
as _RARE_
insulin I-GENE
. O

The O
kinase O
activity O
of O
PfPK6 _RARE_
is O
sensitive _RARE_
to O
CDK I-GENE
inhibitors _RARE_
such O
as _RARE_
olomoucine _RARE_
and O
roscovitine _RARE_
. O

Although O
MAP I-GENE
( I-GENE
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
) I-GENE
kinases I-GENE
are O
implicated O
in O
cell O
proliferation _RARE_
and O
differentiation O
in O
many O
cell O
types _RARE_
, O
the O
role O
of O
MAP I-GENE
kinases I-GENE
in O
cardiac O
hypertrophy O
remains O
unclear O
. O

Transfection O
with O
a O
CSF I-GENE
- I-GENE
1R _RARE_
expression _RARE_
plasmid _RARE_
permitted O
CSF I-GENE
- I-GENE
1 I-GENE
- O
dependent O
activation O
of O
the O
signalling O
pathway _RARE_
targeting O
an O
Ets I-GENE
/ O
AP1 I-GENE
( O
activator I-GENE
protein I-GENE
1 I-GENE
) O
element O
in O
the O
uPA I-GENE
promoter I-GENE
that O
has O
been O
shown O
previously O
to O
be O
a O
target O
of O
oncogenic _RARE_
ras I-GENE
and O
protein O
kinase O
C O
pathways O
. O

Regulation O
of O
urokinase I-GENE
plasminogen I-GENE
activator I-GENE
gene I-GENE
transcription O
in O
the O
RAW264 _RARE_
murine O
macrophage O
cell O
line O
by O
macrophage I-GENE
colony I-GENE
- I-GENE
stimulating I-GENE
factor I-GENE
( O
CSF I-GENE
- I-GENE
1 I-GENE
) O
is O
dependent O
upon O
the O
level O
of O
cell O
- O
surface O
receptor O
. O

Molecule _RARE_
( O
s O
) O
secreted _RARE_
by O
neuronal _RARE_
cultures O
contribute O
to O
this O
induction O
of O
GLT _RARE_
- I-GENE
1 I-GENE
, O
but O
little O
is O
known O
about O
the O
signaling _RARE_
pathways O
mediating O
this O
regulation _RARE_
. O

Coactivation _RARE_
of O
endogenous O
or O
exogenous _RARE_
G I-GENE
( I-GENE
q _RARE_
)- I-GENE
coupled I-GENE
receptors I-GENE
with O
the O
delta I-GENE
- I-GENE
opioid _RARE_
receptor I-GENE
produced O
strong O
stimulations _RARE_
of O
PLCbeta _RARE_
and O
such O
responses O
could O
be O
partially O
blocked O
by O
pertussis _RARE_
toxin _RARE_
. O

Patients O
enrolled O
in O
the O
Integrilin _RARE_
to O
Minimize _RARE_
Platelet _RARE_
Aggregation _RARE_
and O
Coronary O
Thrombosis _RARE_
- O
II O
( O
IMPACT _RARE_
- O
II O
) O
trial O
were O
analyzed O
. O

The O
Wnt I-GENE
signaling _RARE_
pathway _RARE_
functions O
reiteratively _RARE_
during _RARE_
animal _RARE_
development O
to O
control O
cell O
fate O
decisions _RARE_
. O

This O
mutation O
no _RARE_
longer O
repressed O
the O
HPV O
- O
11 O
upstream O
regulatory O
region O
- O
controlled _RARE_
reporter O
expression _RARE_
. O

In O
the O
icosahaedral _RARE_
MVMi _RARE_
capsid _RARE_
, O
this O
sequence O
forms O
the O
carboxy _RARE_
end O
of O
the O
amphipathic _RARE_
beta O
- O
strand _RARE_
I O
( O
betaI _RARE_
), _RARE_
and O
all O
its O
basic O
residues O
are O
contiguously _RARE_
positioned O
at _RARE_
the O
face O
that O
in O
the O
unassembled _RARE_
subunit O
would O
be O
exposed O
to O
solvent O
. O

The O
two O
contiguous O
IGF2 _RARE_
( O
human I-GENE
insulin I-GENE
- I-GENE
like I-GENE
growth I-GENE
factor I-GENE
II I-GENE
) O
and O
H19 _RARE_
genes I-GENE
are O
reciprocally _RARE_
imprinted O
in O
both O
human O
and O
mouse O
. O

The O
asymmetric O
methylation O
was O
associated O
with O
tissue O
- O
specific O
disruption O
of O
H19 _RARE_
genomic O
imprinting O
in O
fetal _RARE_
brain O
. O

The O
comparison O
of O
the O
expression _RARE_
patterns O
of O
the O
known O
Kv4 _RARE_
family I-GENE
members I-GENE
shows O
subtype _RARE_
specificity _RARE_
with O
significant O
overlaps _RARE_
. O

Early O
treatment O
mechanics _RARE_
of O
the O
Class _RARE_
II O
division O
2 O
malocclusion _RARE_
. O

Preliminary _RARE_
use O
of O
the O
Nottingham _RARE_
Eczema _RARE_
Severity _RARE_
Score _RARE_
would O
support O
further O
development O
as _RARE_
a O
research O
tool O
for _RARE_
a O
simple O
assessment O
of O
disease _RARE_
severity O
that O
could O
be O
used O
in O
epidemiological O
studies O
. O

The O
consensus O
highlights _RARE_
the O
importance O
of O
residues O
other O
than O
the O
eight O
motifs O
that O
are O
often O
associated O
with O
DEAD _RARE_
- I-GENE
box I-GENE
RNA I-GENE
helicases _RARE_
, O
as _RARE_
well _RARE_
as _RARE_
de O
- O
emphasising _RARE_
the O
importance O
of O
the O
" O
A O
" O
residue _RARE_
within O
the O
" O
DEAD _RARE_
" O
motif O
. O

Advanced _RARE_
adenoma _RARE_
was O
defined O
as _RARE_
an O
adenoma _RARE_
larger O
than O
10 O
mm O
or O
an O
adenoma _RARE_
of O
any O
size O
with O
villous _RARE_
component _RARE_
, O
high O
- O
grade O
dysplasia O
or O
invasive O
carcinoma O
. O

In O
transient O
assays O
, O
using O
rice _RARE_
suspension _RARE_
- O
cultured O
cells O
transformed O
by O
particle _RARE_
bombardment _RARE_
, O
we O
showed O
previously O
that O
Oshox1 _RARE_
can O
transcriptionally O
repress O
the O
activity O
of O
reporter O
gene O
constructs O
with O
upstream O
HD I-GENE
- I-GENE
Zip _RARE_
binding O
sites O
. O

Results O
of O
two O
- O
hybrid _RARE_
assays O
and O
electrophoretic O
mobility O
shift O
assays O
strongly O
suggest O
that O
all O
HD I-GENE
- I-GENE
Zip _RARE_
proteins I-GENE
of O
families _RARE_
I O
and O
II O
can O
form O
homodimers O
and O
also O
heterodimers _RARE_
with O
all O
HD I-GENE
- I-GENE
Zip _RARE_
proteins I-GENE
of O
the O
same O
family O
. O

Among O
mammalian I-GENE
HSFs _RARE_
, O
HSF1 I-GENE
has O
been O
shown O
to O
be O
important O
for _RARE_
regulation _RARE_
of O
the O
heat O
- O
induced _RARE_
stress O
gene O
expression _RARE_
, O
whereas O
the O
function O
of O
HSF2 _RARE_
in O
stress O
response O
is O
unclear O
. O

Importantly _RARE_
, O
concomitant O
expression _RARE_
of O
constitutive _RARE_
activated O
Raf I-GENE
and O
V12N38 _RARE_
Ras I-GENE
results O
in O
almost O
complete _RARE_
loss _RARE_
of O
TTF I-GENE
- I-GENE
1 I-GENE
activity O
. O

They O
share O
many O
downstream _RARE_
targets _RARE_
, O
including O
remodeling O
of O
the O
actin I-GENE
cytoskeleton _RARE_
, O
activation O
of O
p70 I-GENE
( I-GENE
S6 I-GENE
) I-GENE
kinase I-GENE
and O
c I-GENE
- I-GENE
jun I-GENE
N I-GENE
- I-GENE
terminal I-GENE
kinase I-GENE
( O
JNK I-GENE
), _RARE_
and O
regulation _RARE_
of O
transcription O
and O
cell O
proliferation _RARE_
. O

Expression O
of O
activated O
Cdc42 I-GENE
results O
in O
the O
translocation O
of O
PKClambda _RARE_
from O
the O
nucleus O
into O
the O
cytosol O
, O
and O
Cdc42 I-GENE
and O
PKClambda _RARE_
colocalize _RARE_
at _RARE_
the O
plasma O
membrane O
and O
in O
the O
cytoplasm O
. O

Copyright O
2000 O
Academic O
Press O
. O

To O
understand O
whether O
Shc I-GENE
localization _RARE_
in O
membrane O
rafts _RARE_
is O
sufficient O
to O
regulate O
Shc I-GENE
function O
, O
we O
constructed O
a O
Shc I-GENE
chimera _RARE_
containing O
the O
Ras I-GENE
membrane I-GENE
localization _RARE_
motif I-GENE
at _RARE_
the O
C O
- O
terminus O
. O

Southern O
blotting O
and O
single O
strand _RARE_
conformation O
polymorphism O
analyses O
did O
not O
show O
tumor O
- O
specific O
alterations O
of O
this O
gene O
in O
gliomas _RARE_
and O
RT O
- O
PCR O
studies O
showed O
expression _RARE_
in O
glioma O
cell O
lines O
, O
suggesting O
that O
ANOVA _RARE_
is O
not O
the O
chromosome _RARE_
19q _RARE_
glioma O
tumor O
suppressor O
gene O
. O

RegA _RARE_
is O
a O
positive O
yet O
nonessential _RARE_
regulator O
of O
tol _RARE_
- O
oprL _RARE_
expression _RARE_
. O

Enzyme _RARE_
I I-GENE
of O
the O
phosphoenolpyruvate I-GENE
: I-GENE
sugar _RARE_
phosphotransferase _RARE_
system _RARE_
. O

Based O
on O
these O
data O
, O
we O
conclude O
that O
transcription O
of O
prgX _RARE_
is O
initiated _RARE_
from O
the O
Qa _RARE_
promoter I-GENE
in O
prgQ _RARE_
, O
and O
PrgX _RARE_
autoregulates _RARE_
its O
transcription O
either O
by O
mediating O
transcriptional O
readthrough O
or O
increasing O
mRNA O
stability O
. O

It O
was O
established O
that O
intrathecal _RARE_
or O
intraperitoneal _RARE_
PTFL _RARE_
, O
elevated O
the O
nociceptive _RARE_
threshold O
for _RARE_
mechanical O
stimuli O
in O
the O
formalin O
test O
in O
rats O
. O

Molecular O
mimicry _RARE_
of O
human O
cytokine _RARE_
and O
cytokine _RARE_
response O
pathway _RARE_
genes O
by O
KSHV _RARE_
. O

Family _RARE_
environment O
was O
an O
important O
influence O
on O
interpersonal _RARE_
relationships O
, O
substance _RARE_
use O
, O
and O
social O
support O
. O

By O
electrophoresis O
mobility O
shift O
assays O
using O
probes _RARE_
corresponding O
to O
different O
segments _RARE_
of O
the O
putative O
human I-GENE
c I-GENE
- I-GENE
myb I-GENE
intron I-GENE
1 I-GENE
transcription I-GENE
pause _RARE_
region I-GENE
and O
nuclear O
extracts O
from O
myeloid _RARE_
leukemia O
HL _RARE_
60 _RARE_
and O
fibroblast O
WI _RARE_
38 O
cells O
, O
we O
detected O
a O
HL _RARE_
- O
60 _RARE_
- O
specific O
DNA O
- O
protein O
complex O
with O
a O
123 O
- O
bp O
fragment O
containing O
binding O
sites O
for _RARE_
the O
interferon _RARE_
regulatory I-GENE
factors I-GENE
( O
IRFs _RARE_
) O
nuclear O
proteins O
. O

STUDY _RARE_
DESIGN O
: O
Fine _RARE_
needle _RARE_
aspiration _RARE_
cytologic _RARE_
smears O
from O
21 O
cases O
of O
invasive O
lobular _RARE_
carcinoma O
( O
ILC _RARE_
) O
of O
breast O
were O
subjected O
to O
detailed O
cytomorphologic _RARE_
analysis O
. O

Electrophile _RARE_
Response O
Elements _RARE_
( O
EpREs _RARE_
), _RARE_
located _RARE_
in O
5 O
'- O
flanking O
sequences O
of O
both O
the O
GCSh _RARE_
and O
GCSl _RARE_
subunit I-GENE
genes I-GENE
, O
are O
hypothesized _RARE_
to O
at _RARE_
least O
partially O
mediate O
gene O
induction O
following O
xenobiotic _RARE_
exposure O
. O

A O
new O
technique O
to O
create O
an O
artificial O
stenosis O
in O
the O
native _RARE_
LAD O
using O
a O
hemoclip _RARE_
. O

Dll3 _RARE_
is O
mutated _RARE_
in O
the O
X O
- O
ray O
- O
induced _RARE_
mouse I-GENE
mutant I-GENE
pudgy _RARE_
( O
pu _RARE_
), _RARE_
causing O
a O
variety O
of O
vertebrocostal _RARE_
defects O
similar O
to O
SD O
phenotypes _RARE_
. O

Schlegel _RARE_
, O
J _RARE_
. O

TbRAB31 _RARE_
behaviour O
was O
also O
studied O
during _RARE_
the O
cell O
cycle _RARE_
; O
TbRAB31 _RARE_
always O
localised _RARE_
to O
a O
discrete O
structure _RARE_
that O
duplicated O
very O
early O
in O
mitosis O
and O
relocated _RARE_
to O
daughter O
cells O
in O
a O
coordinate O
manner O
with O
the O
basal O
body O
and O
kinetoplast _RARE_
, O
suggesting O
the O
involvement O
of O
microtubules _RARE_
. O

The O
early O
dg _RARE_
. O
of O
rejection O
and O
especially O
acute O
rejection O
, O
it O
' O
s O
adequate O
management O
, O
decreased O
risk O
for _RARE_
the O
future O
chronic O
rejection O
nephropathy O
. O

Invertases _RARE_
are O
responsible O
for _RARE_
the O
breakdown _RARE_
of O
sucrose O
to O
fructose _RARE_
and O
glucose O
. O

To O
investigate O
the O
molecular _RARE_
mechanisms O
of O
this O
Tax _RARE_
- O
mediated _RARE_
inhibition O
, O
we O
analyzed O
its O
effect O
on O
the O
transcriptional O
activity O
of O
the O
myogenic _RARE_
MyoD I-GENE
protein I-GENE
, O
which O
was O
used O
as _RARE_
a O
paradigm _RARE_
of O
bHLH I-GENE
factors I-GENE
. O

The O
human I-GENE
T I-GENE
cell I-GENE
leukemia I-GENE
/ I-GENE
lymphotropic _RARE_
virus I-GENE
type I-GENE
1 I-GENE
Tax _RARE_
protein I-GENE
represses O
MyoD I-GENE
- O
dependent O
transcription O
by O
inhibiting O
MyoD I-GENE
- O
binding O
to O
the O
KIX _RARE_
domain I-GENE
of O
p300 I-GENE
. O

Phosphorylation _RARE_
and O
spindle _RARE_
pole O
body O
localization _RARE_
of O
the O
Cdc15p _RARE_
mitotic _RARE_
regulatory I-GENE
protein I-GENE
kinase I-GENE
in I-GENE
budding _RARE_
yeast I-GENE
. O

Thus O
, O
both O
the O
hyperplasia O
and O
thrombotic O
complications O
which O
often O
follow O
stenting _RARE_
might O
be O
minimized _RARE_
by O
employing O
gold _RARE_
stents _RARE_
, O
which O
have O
a O
greater O
capacity O
than O
steel _RARE_
in O
supporting O
a O
functional _RARE_
neo _RARE_
- O
endothelium O
. O

The O
cell O
cycle _RARE_
and O
transcriptional O
defects O
caused O
by O
taf17 _RARE_
( O
slm7 _RARE_
- I-GENE
1 I-GENE
) O
are O
consistent O
with O
the O
role O
of O
TAF _RARE_
( I-GENE
II I-GENE
) I-GENE
s I-GENE
as _RARE_
modulators _RARE_
of O
transcriptional O
activation O
and O
may O
reflect O
a O
role O
for _RARE_
TAF17 _RARE_
in O
regulating _RARE_
activation O
by O
SBF _RARE_
and O
MBF _RARE_
. O

Extracellular _RARE_
- I-GENE
regulated I-GENE
kinase I-GENE
( O
ERK I-GENE
) O
activation O
and O
molecular _RARE_
coupling O
of O
the O
adaptor _RARE_
proteins O
p130 I-GENE
Crk I-GENE
- I-GENE
associated I-GENE
substrate I-GENE
( O
CAS _RARE_
) O
and O
c I-GENE
- I-GENE
CrkII _RARE_
( O
Crk I-GENE
) O
represent O
two O
distinct O
pathways O
that O
induce O
cell O
invasion O
and O
protect O
cells O
from O
apoptosis O
in O
a O
three O
- O
dimensional O
collagen _RARE_
matrix _RARE_
. O

Proteolysis _RARE_
of O
Mbp1 _RARE_
and O
Swi4 _RARE_
DNA I-GENE
- I-GENE
protein I-GENE
complexes I-GENE
has O
revealed O
the O
extent O
of O
these O
sequences O
, O
and O
C O
- O
terminally _RARE_
extended O
molecules O
with O
substantially O
enhanced _RARE_
DNA O
binding O
activity O
compared O
to O
the O
core O
domains O
alone O
have O
been O
produced O
. O

The O
evolution O
of O
the O
CCR5 _RARE_
cis I-GENE
- I-GENE
regulatory I-GENE
region I-GENE
versus O
the O
open _RARE_
reading O
frame O
as _RARE_
well _RARE_
as _RARE_
among O
different O
domains O
of O
the O
open _RARE_
reading O
frame O
differed O
from O
one O
another O
. O

These O
results O
indicate O
that O
residue _RARE_
266 _RARE_
serves O
as _RARE_
a O
" O
protein O
sensor _RARE_
" O
of O
altered O
minor O
groove _RARE_
interactions O
and O
identifies O
which O
base _RARE_
pair _RARE_
interactions O
are O
altered O
by O
these O
lesions O
. O

The O
recombinant O
enzymes _RARE_
exist O
as _RARE_
monomers _RARE_
. O

A O
pathway _RARE_
for _RARE_
regulation _RARE_
of O
B I-GENE
lymphocyte I-GENE
antigen I-GENE
receptor I-GENE
- O
induced _RARE_
calcium _RARE_
flux _RARE_
. O

We O
now O
describe O
a O
second O
RIM _RARE_
protein I-GENE
, O
called O
RIM2 _RARE_
, O
that O
is O
highly O
homologous O
to O
RIM1 _RARE_
and O
also O
expressed _RARE_
primarily O
in O
brain O
. O

Inhibitor _RARE_
- I-GENE
1 I-GENE
( O
I I-GENE
- I-GENE
1 I-GENE
) O
and O
inhibitor I-GENE
- I-GENE
2 I-GENE
( O
I I-GENE
- I-GENE
2 I-GENE
) O
selectively O
inhibit O
type I-GENE
1 I-GENE
protein I-GENE
serine I-GENE
/ I-GENE
threonine I-GENE
phosphatases _RARE_
( O
PP1 _RARE_
). O

Scanning _RARE_
mutations O
throughout O
the O
AC _RARE_
element O
interfered _RARE_
with O
induction O
but O
allowed O
us O
to O
define O
five O
overlapping O
sites O
for _RARE_
regulatory O
factors O
in O
AC _RARE_
and O
to O
design O
probes _RARE_
binding O
just O
one O
or O
two O
factors O
. O

The O
substrates _RARE_
for _RARE_
glycan _RARE_
synthesis _RARE_
in O
the O
lumen _RARE_
of O
the O
Golgi _RARE_
are O
nucleotide O
sugars O
that O
must O
be O
transported O
from O
the O
cytosol O
by O
specific O
membrane O
- O
bound _RARE_
transporters _RARE_
. O

Synaptic _RARE_
targeting O
of O
the O
postsynaptic _RARE_
density I-GENE
protein I-GENE
PSD _RARE_
- I-GENE
95 _RARE_
mediated _RARE_
by O
a O
tyrosine O
- O
based O
trafficking O
signal O
. O

( O
1998 O
) O
J _RARE_
. O

Bites _RARE_
by O
two O
species O
of O
adders _RARE_
( O
Vipera _RARE_
aspis _RARE_
and O
Vipera _RARE_
berus _RARE_
) O
can O
lead O
to O
extensive O
swelling O
with O
multiorgan _RARE_
failure O
. O

Both O
normal O
and O
transforming O
PCPH _RARE_
proteins I-GENE
have O
guanosine _RARE_
diphosphatase _RARE_
activity O
but O
only O
the O
oncoprotein _RARE_
cooperates _RARE_
with O
Ras I-GENE
in O
activating O
extracellular I-GENE
signal I-GENE
- I-GENE
regulated I-GENE
kinase I-GENE
ERK1 I-GENE
. O

These O
results O
indicate O
that O
virulence _RARE_
- O
associated O
genes O
and O
their O
overall O
chromosomal O
arrangement O
are O
relatively O
well _RARE_
conserved _RARE_
between O
B O
. O
henselae _RARE_
and O
other O
gram O
- O
negative O
bacteria O
such O
as _RARE_
A O
. O
tumefaciens _RARE_
. O

An O
important O
mechanism O
by O
which O
the O
tumor O
suppressor O
p53 I-GENE
maintains O
genomic O
stability O
is O
to O
induce O
cell O
cycle _RARE_
arrest O
through O
activation O
of O
the O
cyclin _RARE_
- I-GENE
dependent I-GENE
kinase I-GENE
inhibitor O
p21 I-GENE
( O
WAF1 I-GENE
/ O
Cip1 I-GENE
) O
gene O
. O

Paxillin _RARE_
acts O
as _RARE_
an O
adaptor _RARE_
molecule O
in O
integrin I-GENE
signaling _RARE_
. O

Thus O
, O
growth O
factor O
activation O
of O
ER I-GENE
can O
mediate O
transactivation _RARE_
vs _RARE_
ER I-GENE
/ O
Sp1 _RARE_
binding O
to O
GC _RARE_
- O
rich O
sites O
and O
represents O
a O
novel O
pathway _RARE_
for _RARE_
ligand _RARE_
- O
independent O
ER I-GENE
action O
. O

Furthermore O
, O
analysis O
of O
deletion O
promoter O
- O
reporter O
constructs O
found O
that O
the O
basal O
activity O
of O
P2 O
resided _RARE_
in O
the O
proximal O
region O
of O
P2 O
. O

RESULTS O
: O
Auditory _RARE_
thresholds _RARE_
collected O
during _RARE_
audiometric _RARE_
tests O
increased O
gradually O
in O
proportion O
with O
age O
, O
especially O
in O
the O
hypertensive O
group O
( O
p O
< O
0 _RARE_
. O
05 O
). O

In O
addition O
, O
the O
transcription O
of O
c I-GENE
- I-GENE
IAP2 _RARE_
promoter I-GENE
was O
strongly O
up _RARE_
- O
regulated O
when O
CD40 I-GENE
or O
Epstein I-GENE
- I-GENE
Barr I-GENE
virus I-GENE
latent I-GENE
membrane I-GENE
protein I-GENE
1 I-GENE
was O
overexpressed O
. O

A O
variety O
of O
professional _RARE_
and O
self O
- O
applied O
fluoride O
products O
are O
available O
and O
new O
fluoride O
delivery O
systems _RARE_
have O
recently O
entered _RARE_
the O
market _RARE_
. O

These O
studies O
identify O
several O
of O
the O
signal O
- O
transduction _RARE_
events O
involved O
in O
the O
apoptosis O
of O
malignant O
B O
cells O
that O
transpire _RARE_
following O
ligation O
of O
CD20 _RARE_
by O
anti I-GENE
- I-GENE
CD20 _RARE_
antibodies I-GENE
in O
the O
presence O
of O
Fc I-GENE
- I-GENE
receptor I-GENE
- O
expressing O
cells O
or O
secondary O
goat _RARE_
anti I-GENE
-( _RARE_
mouse I-GENE
Ig I-GENE
) I-GENE
antibodies I-GENE
and O
which O
may O
contribute O
to O
the O
tumor O
regressions _RARE_
observed O
in O
mouse O
models O
and O
clinical O
trials O
. O

CONCLUSION O
: O
Treatment O
of O
sepsis O
with O
the O
platelet I-GENE
- I-GENE
activating I-GENE
factor I-GENE
antagonist O
BB _RARE_
- O
882 _RARE_
offers O
no _RARE_
advantage O
over O
placebo O
on O
survival O
, O
hemodynamic O
status O
, O
respiratory O
function O
, O
or O
organ O
failure O
scores O
. O

Phenazone _RARE_
potentiates O
the O
local O
anaesthetic _RARE_
effect O
of O
lidocaine O
in O
mice O
. O

The O
solubility _RARE_
of O
all O
the O
mutated _RARE_
proteins O
was O
remarkably O
reduced _RARE_
. O

Recently O
, O
identical O
RBE _RARE_
sequences I-GENE
have O
been O
identified O
at _RARE_
other O
locations O
in O
the O
human O
genome O
. O

EM O
analysis O
demonstrated O
that O
only O
one O
Rep I-GENE
- I-GENE
DNA I-GENE
complex I-GENE
was O
formed O
on O
ch _RARE_
- O
19 O
target O
DNA O
. O

The O
protein O
was O
associated O
with O
purified _RARE_
vaccinia _RARE_
virus O
particles _RARE_
and O
with O
membranes O
of O
immature O
and O
mature _RARE_
virions O
that O
were O
visualized _RARE_
by O
electron O
microscopy O
of O
infected _RARE_
cells O
. O

In O
vivo O
dimethyl O
sulfate _RARE_
footprinting O
of O
the O
cyclin _RARE_
E I-GENE
promoter I-GENE
revealed O
several O
regions O
of O
protection O
and O
hypersensitivity O
that O
were O
unique O
to O
infected _RARE_
cells O
. O

A O
total _RARE_
of O
194 _RARE_
STSs _RARE_
map O
to O
this O
interval O
of O
3 O
Mb O
, O
giving O
an O
average O
marker O
resolution O
of O
approximately _RARE_
one O
per O
15 _RARE_
kb O
. O

Recently O
, O
a O
mutation O
in O
the O
amino O
- O
terminus O
of O
IB1 _RARE_
was O
associated O
with O
diabetes O
. O

CONCLUSION O
: O
More O
than O
50 O
% O
of O
patients O
with O
perennial _RARE_
rhinitis _RARE_
and O
CRS _RARE_
do O
not O
improve O
after O
surgery O
, O
a O
response O
that O
may O
be O
predicted O
by O
more O
cells O
expressing O
IL _RARE_
- I-GENE
5 I-GENE
mRNA I-GENE
in O
the O
ethmoid _RARE_
sinuses _RARE_
. O

Biol O
. O

On O
the O
basis O
of O
size O
, O
the O
CRS _RARE_
sequence O
to O
which O
it O
binds O
, O
and O
its O
tentative _RARE_
identification O
as _RARE_
a O
zinc I-GENE
finger I-GENE
protein I-GENE
, O
Adx _RARE_
factor I-GENE
has O
been O
identified O
as _RARE_
a O
Kruppel _RARE_
- I-GENE
like I-GENE
zinc I-GENE
finger I-GENE
protein I-GENE
( O
a O
mouse I-GENE
ZBP _RARE_
- I-GENE
89 _RARE_
homologue I-GENE
). O

METHODS O
: O
The O
most O
distal O
muscle O
fibres O
from O
the O
deep O
and O
superficial O
finger O
flexors _RARE_
were O
measured O
relative O
to O
the O
pisiform _RARE_
bone O
in O
18 O
cadaveric _RARE_
specimens O
. O

Here O
we O
report O
on O
the O
isolation O
of O
ICK2 _RARE_
, O
and O
show O
that O
it O
interacts O
with O
Cdc2aAt _RARE_
, O
but O
not O
with O
a O
second O
CDK I-GENE
from I-GENE
Arabidopsis I-GENE
, O
Cdc2bAt _RARE_
. O

Systemic _RARE_
impact O
of O
risk O
- O
sharing _RARE_
arrangements _RARE_
. O

METHODS O
: O
We O
determined O
an O
odds O
ratio O
( O
OR O
), _RARE_
as _RARE_
a O
measure O
of O
the O
relative O
risk O
of O
being O
exposed O
to O
a O
potential _RARE_
interaction O
, O
comparing O
the O
use O
of O
the O
H2 I-GENE
- I-GENE
receptor I-GENE
antagonist O
, O
cimetidine O
, O
with O
that O
of O
the O
noninteracting _RARE_
agents O
ranitidine O
, O
famotidine _RARE_
and O
nizatidine _RARE_
in O
users O
and O
nonusers _RARE_
of O
warfarin _RARE_
, O
phenytoin O
and O
theophylline O
. O

The O
prevalence O
of O
malnutrition _RARE_
was O
30 _RARE_
% O
in O
the O
47 _RARE_
patients O
without O
CVD _RARE_
and O
was O
significantly O
higher _RARE_
( O
70 O
%, O
P O
< O
0 _RARE_
. O
001 O
) O
in O
the O
70 O
patients O
with O
CVD _RARE_
, O
who O
also O
had O
lower O
tHcy _RARE_
, O
SAlb _RARE_
, O
plasma I-GENE
IGF I-GENE
- I-GENE
1 I-GENE
, O
serum O
creatinine _RARE_
( O
SCr _RARE_
), _RARE_
and O
blood _RARE_
hemoglobin I-GENE
. O

Our O
data O
suggest O
that O
, O
at _RARE_
least O
at _RARE_
high O
temperature _RARE_
, O
a O
critical O
minimal O
level O
of O
Ypt _RARE_
protein I-GENE
prenylation _RARE_
is O
required O
for _RARE_
maintaining O
vesicle O
polarization _RARE_
. O

The O
second O
functional _RARE_
pair _RARE_
of O
CreA _RARE_
sites I-GENE
is O
located _RARE_
between O
the O
two O
transcription O
initiation O
sites O
. O

A O
distinct O
staining O
pattern O
for _RARE_
the O
N I-GENE
- I-GENE
utrophin _RARE_
was O
not O
detectable O
, O
although O
it O
was O
expected O
to O
localise _RARE_
at _RARE_
the O
actin I-GENE
stress O
fibers O
. O

The O
' O
Newcastle _RARE_
' O
model O
, O
which O
is O
based O
on O
Hotelling _RARE_
' O
s O
T2 _RARE_
statistic _RARE_
, O
proved O
to O
be O
more O
sensitive _RARE_
and O
diagnosed O
a O
systematic O
displacement _RARE_
for _RARE_
three O
prostate _RARE_
patients O
. O

The O
MMA _RARE_
, I-GENE
DMA _RARE_
, I-GENE
and I-GENE
TMA _RARE_
methyltransferases _RARE_
are O
not O
homologs O
; O
however O
, O
like O
the O
MMA _RARE_
methyltransferase _RARE_
gene I-GENE
, O
the O
genes O
encoding O
the O
DMA _RARE_
and I-GENE
TMA _RARE_
methyltransferases _RARE_
each O
contain O
a O
single O
in O
- O
frame O
amber _RARE_
codon _RARE_
. O

After O
phosphorylation _RARE_
, O
STAT I-GENE
proteins I-GENE
are O
transported O
into O
the O
nucleus O
and O
exhibit O
transcriptional O
activity O
. O

Overexpression O
of O
mcl _RARE_
- I-GENE
1 I-GENE
is O
sufficient O
to O
protect O
against O
apoptosis O
, O
while O
transfection O
of O
a O
mcl _RARE_
- I-GENE
1 I-GENE
antisense _RARE_
plasmid _RARE_
causes O
cell O
death _RARE_
. O

Thus O
, O
although O
multiple O
senescence _RARE_
pathways O
are O
activated O
in O
response O
to O
a O
ras I-GENE
oncogene I-GENE
, O
inactivation O
of O
TGFbeta1 _RARE_
secretion _RARE_
or O
response O
is O
sufficient O
to O
block _RARE_
the O
senescence _RARE_
program O
. O

In O
this O
study O
, O
the O
abilities O
of O
constitutive _RARE_
and O
conditional O
forms O
of O
the O
three O
Raf I-GENE
kinases I-GENE
to O
abrogate O
the O
cytokine _RARE_
dependency _RARE_
of O
FDC _RARE_
- O
P1 O
cells O
were O
examined O
. O

Application _RARE_
of O
the O
method O
to O
a O
representative O
set O
of O
50 O
known O
genes O
from O
Arabidopsis O
thaliana O
showed O
significant O
improvement O
in O
prediction O
accuracy O
compared O
to O
previous O
spliced _RARE_
alignment O
methods O
. O

The O
complete _RARE_
cDNA O
sequence O
of O
human I-GENE
betaV _RARE_
spectrin I-GENE
is O
available O
from O
GenBank _RARE_
( O
TM _RARE_
) O
as _RARE_
accession _RARE_
number O
. O

Transactivation _RARE_
of O
naturally O
occurring O
HIV I-GENE
- I-GENE
1 I-GENE
long I-GENE
terminal I-GENE
repeats I-GENE
by O
the O
JNK I-GENE
signaling _RARE_
pathway _RARE_
. O

These O
data O
show O
that O
the O
alpha O
- O
helix O
domain O
of O
p57 _RARE_
( O
Kip2 _RARE_
), _RARE_
which O
is O
conserved _RARE_
in O
the O
Cip _RARE_
/ O
Kip _RARE_
proteins O
, O
is O
implicated O
in O
protein O
- O
protein O
interaction O
and O
confers O
a O
specific O
regulatory O
mechanism O
, O
outside O
of O
their O
Cdk I-GENE
- O
inhibitory _RARE_
activity O
, O
by O
which O
the O
p57 _RARE_
( O
Kip2 _RARE_
) O
family O
members O
positively O
act O
on O
myogenic _RARE_
differentiation O
. O

The O
mode O
of O
resistance O
to O
quinupristin _RARE_
/ O
dalfopristin _RARE_
was O
not O
evident O
( O
sat _RARE_
A O
- O
negative O
by O
PCR O
); O
and O
these O
cases O
illustrate _RARE_
the O
existence O
of O
streptogramin _RARE_
- O
resistant O
isolates O
before O
the O
introduction O
of O
this O
antimicrobial O
class O
into O
human O
clinical O
practice O
. O

This O
study O
was O
carried O
out O
to O
analyze O
PRL I-GENE
secretion _RARE_
in O
metastatic O
prostate _RARE_
cancer _RARE_
patients O
both O
at _RARE_
basal O
conditions O
and O
in O
response O
to O
L O
- O
Dopa _RARE_
and O
metoclopramide _RARE_
, O
which O
represents O
the O
most O
classical O
inhibitory _RARE_
and O
stimulatory _RARE_
tests O
for _RARE_
PRL I-GENE
secretion _RARE_
, O
respectively O
. O

Integrin _RARE_
adhesion I-GENE
receptors I-GENE
transduce _RARE_
signals O
that O
control O
complex O
cell O
functions O
which O
require O
the O
regulation _RARE_
of O
gene O
expression _RARE_
, O
such O
as _RARE_
proliferation _RARE_
, O
differentiation O
and O
survival O
. O

Recombination _RARE_
, O
replication O
, O
repair O
: O
from O
complexity O
to O
harmony _RARE_
. O

The O
somatoform _RARE_
conundrum _RARE_
: O
a O
question O
of O
nosological _RARE_
valves _RARE_
. O

Intra _RARE_
- O
operative O
ultrasound O
( O
IOUS _RARE_
) O
has O
been O
widely O
used O
in O
an O
attempt O
to O
overcome O
these O
difficulties _RARE_
, O
but O
is O
limited O
by O
its O
two O
- O
dimensional O
nature O
, O
inter _RARE_
- O
user _RARE_
variability O
, O
and O
image O
obliteration _RARE_
with O
ablative _RARE_
or O
resectional _RARE_
techniques O
. O

CONCLUSIONS O
: O
This O
randomized O
study O
shows O
that O
Vivostat _RARE_
fibrin I-GENE
sealant _RARE_
is O
effective O
in O
preventing O
air O
leakage _RARE_
after O
small O
lung _RARE_
resections _RARE_
in O
pigs O
, O
even O
at _RARE_
high O
inspiratory O
pressures O
. O

Hailey _RARE_
- O
Hailey _RARE_
disease _RARE_
is O
caused O
by O
mutations O
in O
ATP2C1 _RARE_
encoding O
a O
novel O
Ca O
( O
2 O
+) O
pump _RARE_
. O

Hex _RARE_
is O
expressed _RARE_
in O
the O
developing O
liver O
coincident _RARE_
with O
the O
forkhead _RARE_
/ O
winged _RARE_
helix I-GENE
transcription O
factor O
, O
Hepatocyte _RARE_
Nuclear I-GENE
Factor _RARE_
3beta _RARE_
( O
HNF3beta _RARE_
). O

As O
an O
extension O
of O
our O
structural O
characterization O
of O
the O
exon _RARE_
- O
intron O
organization O
of O
the O
mouse I-GENE
Pkr _RARE_
gene I-GENE
, O
we O
now O
have O
isolated O
and O
characterized O
the O
mouse I-GENE
Pkr _RARE_
promoter I-GENE
region I-GENE
required O
for _RARE_
IFN I-GENE
- O
inducible O
transcription O
. O

The O
CRE _RARE_
, O
5 O
'- O
TGACGTCA _RARE_
- O
3 O
', _RARE_
has O
been O
described O
as _RARE_
the O
consensus O
sequence O
for _RARE_
the O
cis O
- O
element O
that O
directs O
cAMP O
- O
regulated O
gene O
expression _RARE_
. O

Kidney _RARE_
length O
did O
not O
significantly O
differ O
between O
right O
and O
left _RARE_
, O
however O
, O
kidney _RARE_
width _RARE_
, O
cortical O
thickness O
and O
size O
did O
( O
p O
< O
0 _RARE_
. O
05 O
). O

The O
clinical O
stage _RARE_
was O
I O
( O
T1N0M0 _RARE_
), _RARE_
and O
S2 _RARE_
sleeve _RARE_
segmentectomy _RARE_
with O
lymph O
node O
dissection O
( O
R O
2 O
b O
) O
was O
performed O
. O

Benztropine _RARE_
for _RARE_
venlafaxine _RARE_
- O
induced _RARE_
night O
sweats _RARE_
. O

A O
cause O
of O
increase O
of O
alkaline _RARE_
phosphatase I-GENE
in O
children O

The O
physicians O
in O
charge _RARE_
of O
all O
patients O
with O
evidence O
of O
acute O
Q _RARE_
fever O
( O
seroconversion _RARE_
and O
/ O
or O
presence O
of O
IgM I-GENE
) O
or O
chronic O
Q _RARE_
fever O
( O
prolonged O
disease _RARE_
and O
/ O
or O
IgG I-GENE
antibody I-GENE
titer O
to O
phase _RARE_
I O
of O
Coxiella _RARE_
burnetii _RARE_
> O
or O
= O
800 O
) O
were O
asked _RARE_
to O
complete _RARE_
a O
questionnaire O
, O
which O
was O
computerized O
. O

Copyright O
2000 O
Academic O
Press O
. O

Viral _RARE_
cell O
- O
to O
- O
cell O
movement O
of O
PVX _RARE_
CP I-GENE
mutant I-GENE
was O
complemented O
in O
Nicotiana _RARE_
tabacum _RARE_
cv O
. O

Induction O
of O
CD86 _RARE_
expression _RARE_
by O
stimulation _RARE_
of O
U937 O
cells O
with O
IFN I-GENE
- I-GENE
gamma I-GENE
revealed O
the O
presence O
of O
two O
functional _RARE_
GAS _RARE_
( O
gamma I-GENE
- I-GENE
interferon _RARE_
activation I-GENE
site I-GENE
) O
elements O
. O

Significantly O
, O
two O
proximal O
GATA _RARE_
- I-GENE
1 I-GENE
- I-GENE
binding I-GENE
sites I-GENE
(- _RARE_
118 O
/- O
113 _RARE_
and O
- O
98 O
/- O
93 O
) O
and O
a O
region O
located _RARE_
within O
- O
518 _RARE_
to O
- O
315bp _RARE_
of O
the O
mouse I-GENE
ALAS2 _RARE_
promoter I-GENE
were O
essential O
for _RARE_
transcriptional O
activation O
during _RARE_
chemically _RARE_
induced _RARE_
differentiation O
of O
MEL _RARE_
cells O
, O
implying O
their O
importance O
in O
conferring O
erythroid _RARE_
specificity _RARE_
to O
the O
ALAS2 _RARE_
transcriptional O
activation O
. O

SNAP _RARE_
- I-GENE
23 _RARE_
plays O
an O
important O
role O
in O
the O
regulation _RARE_
of O
vesicle O
trafficking O
in O
mammalian O
cells O
. O

The O
HMG I-GENE
domain I-GENE
of O
both O
HMG20 _RARE_
proteins I-GENE
is O
most O
similar O
to O
that O
of O
yeast I-GENE
NHP6A _RARE_
( O
38 O
% O
to O
42 _RARE_
%). O

IgM I-GENE
and O
IgG I-GENE
anti I-GENE
A I-GENE
and O
anti I-GENE
B I-GENE
antibody I-GENE
status O
of O
100 _RARE_
antenatal _RARE_
O O
group O
mothers O
( O
who O
had O
non O
O O
group O
husbands _RARE_
) O
were O
studied O
. O

In O
an O
attempt O
to O
understand O
Wee1 _RARE_
regulation _RARE_
during _RARE_
cell O
cycle _RARE_
, O
yeast O
two O
- O
hybrid _RARE_
screening O
was O
used O
to O
identify O
Wee1 _RARE_
- O
binding O
protein O
( O
s O
). O

Retroviral _RARE_
transduction _RARE_
of O
T I-GENE
/ I-GENE
T I-GENE
( I-GENE
L I-GENE
) I-GENE
causes O
a O
rapidly O
fatal O
myeloproliferative _RARE_
disease _RARE_
in O
a O
murine O
bone O
marrow O
transplant O
( O
BMT _RARE_
) O
model O
, O
whereas O
T I-GENE
/ I-GENE
T I-GENE
( I-GENE
F I-GENE
) I-GENE
causes O
a O
long O
- O
latency _RARE_
, O
pre O
- O
B O
- O
cell O
lymphoblastic _RARE_
lymphoma O
. O

Ab _RARE_
- O
MLV _RARE_
strains O
expressing O
P70 _RARE_
/ O
S2 _RARE_
failed O
to O
transform O
NIH _RARE_
3T3 O
cells O
and O
demonstrated O
a O
greatly O
reduced _RARE_
capacity O
to O
mediate O
signaling _RARE_
events O
associated O
with O
the O
Ras I-GENE
- O
dependent O
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
( I-GENE
MAP I-GENE
) I-GENE
kinase I-GENE
pathway _RARE_
. O

The O
codon _RARE_
usage O
is O
particularly O
marked O
for _RARE_
the O
gag I-GENE
, O
pol I-GENE
, O
and O
env I-GENE
genes I-GENE
. O

The O
p53 I-GENE
- I-GENE
homolog I-GENE
p73beta _RARE_
also O
activated O
the O
PIG3 _RARE_
promoter I-GENE
, O
but O
in O
contrast O
to O
p53 I-GENE
, O
the O
proline O
- O
rich O
domain O
of O
p73beta _RARE_
( I-GENE
residues I-GENE
81 _RARE_
- I-GENE
113 _RARE_
) I-GENE
was O
dispensable O
to O
induce O
the O
PIG3 _RARE_
promoter I-GENE
. O

Results O
from O
transient O
assays O
using O
these O
mutants O
showed O
that O
the O
DE1 _RARE_
received O
signals O
from O
phytochromes _RARE_
A I-GENE
and I-GENE
B I-GENE
, O
demonstrating O
that O
this O
element O
is O
indeed O
a O
light O
- O
responsive O
element O
. O

Co O
- O
immunoprecipitation O
and O
DNA O
affinity O
chromatography O
prove O
that O
Sp1 _RARE_
heterodimerizes _RARE_
with O
ZBP _RARE_
- I-GENE
89 _RARE_
when O
bound _RARE_
to O
the O
silencer _RARE_
element O
to O
yield O
a O
DNA O
- O
protein O
complex O
whose O
mobility O
is O
indistinguishable O
from O
that O
displayed O
by O
HeLa O
nuclear O
extract _RARE_
in O
band O
shift O
assays O
. O

The O
ZNF274 _RARE_
gene I-GENE
is O
mapped O
distal O
to O
marker O
RP _RARE_
S28 _RARE_
1 O
in O
the O
human O
chromosome _RARE_
19qter _RARE_
region O
, O
by O
RH _RARE_
mapping O
. O

The O
C I-GENE
- I-GENE
terminal I-GENE
Cdk2 I-GENE
truncations _RARE_
, O
however O
, O
were O
non O
- O
functional _RARE_
in O
these O
strains O
and O
thus O
dependent O
for _RARE_
activity O
on O
the O
pho85 _RARE_
coding I-GENE
region I-GENE
which O
remained O
in O
the O
mutant I-GENE
pho85 _RARE_
:: O
HIS3 I-GENE
chromosomal I-GENE
locus I-GENE
. O

We O
report O
here O
on O
the O
molecular _RARE_
nature O
of O
an O
EMS _RARE_
- O
induced _RARE_
mutant O
, O
mn1 _RARE_
- I-GENE
89 _RARE_
, O
a O
leaky _RARE_
semidominant _RARE_
allele O
of O
the O
Miniature1 _RARE_
( O
Mn1 _RARE_
) O
seed _RARE_
locus O
that O
encodes O
a O
seed _RARE_
- I-GENE
specific I-GENE
cell I-GENE
wall _RARE_
invertase _RARE_
, O
INCW2 _RARE_
. O

We O
conclude O
that O
, O
both O
in O
atrial _RARE_
myocytes _RARE_
and O
in O
Xenopus O
oocytes O
, O
beta O
- O
adrenergic O
stimulation _RARE_
potentiates O
the O
ACh _RARE_
- O
evoked O
GIRK _RARE_
channels _RARE_
via O
a O
pathway _RARE_
that O
involves O
PKA I-GENE
- O
catalyzed O
phosphorylation _RARE_
downstream _RARE_
from O
beta I-GENE
( I-GENE
2 I-GENE
) I-GENE
AR _RARE_
. O

Slap _RARE_
negatively O
regulates O
Src I-GENE
mitogenic O
function O
but O
does O
not O
revert _RARE_
Src I-GENE
- O
induced _RARE_
cell O
morphology O
changes O
. O

Identification O
of O
a O
novel O
E2F3 _RARE_
product I-GENE
suggests O
a O
mechanism O
for _RARE_
determining _RARE_
specificity _RARE_
of O
repression O
by O
Rb _RARE_
proteins I-GENE
. O

In O
DNase I-GENE
I I-GENE
footprinting O
protection O
analysis O
, O
both O
SFRE _RARE_
and O
ERE _RARE_
regions O
were O
protected O
by O
glutathione _RARE_
S I-GENE
- I-GENE
transferase I-GENE
- O
ERRalpha1 _RARE_
fusion O
protein O
. O

Overexpressing _RARE_
the O
coactivator _RARE_
, O
SRC1a _RARE_
or O
GRIP1 _RARE_
, O
further O
enhances O
ERRalpha1 _RARE_
- O
induced _RARE_
transcriptional O
activity O
. O

Estrogen _RARE_
receptor I-GENE
- I-GENE
related I-GENE
receptor I-GENE
alpha I-GENE
1 I-GENE
interacts O
with O
coactivator _RARE_
and O
constitutively O
activates O
the O
estrogen O
response O
elements O
of O
the O
human I-GENE
lactoferrin _RARE_
gene I-GENE
. O

We O
examine O
current O
models O
of O
the O
effects O
of O
aging O
on O
mean O
response O
time O
and O
show O
how O
they O
might O
be O
reinterpreted _RARE_
. O

The O
effects O
of O
these O
mutations O
on O
protein O
function O
require O
further O
examination O
. O

The O
median O
levels O
of O
particles _RARE_
with O
50 O
% O
cut O
- O
off O
aerodynamic _RARE_
diameters O
of O
10 O
( O
PM10 _RARE_
) O
and O
2 O
. O
5 O
microm O
( O
PM2 _RARE_
. O
5 O
) O
were O
170 _RARE_
( O
range O
103 _RARE_
- O
613 _RARE_
) O
and O
95 _RARE_
( O
range O
61 _RARE_
- O
218 _RARE_
) O
micro O
x _RARE_
m O
- O
3 O
, O
respectively O
. O

Kaposi O
' O
s O
sarcoma O
- O
associated O
herpesvirus _RARE_
viral I-GENE
interferon _RARE_
regulatory I-GENE
factor I-GENE
confers O
resistance O
to O
the O
antiproliferative _RARE_
effect O
of O
interferon _RARE_
- I-GENE
alpha I-GENE
. O

Specific O
and O
heritable _RARE_
genetic O
interference O
by O
double O
- O
stranded _RARE_
RNA O
in O
Arabidopsis O
thaliana O
. O

Comparison O
of O
sequences O
from O
- O
215 O
to O
+ O
1 O
bp O
identified O
consensus O
binding O
sites O
for _RARE_
the O
homeodomain _RARE_
transcription I-GENE
factor I-GENE
thyroid I-GENE
transcription I-GENE
factor I-GENE
- I-GENE
1 I-GENE
( O
TTF I-GENE
- I-GENE
1 I-GENE
). O

Two O
additional O
cis O
- O
acting O
sequences O
, O
conserved _RARE_
in O
both O
the O
region O
1 O
and O
3 O
promoters O
, O
were O
identified O
, O
suggesting O
a O
role O
for _RARE_
these O
sequences O
in O
the O
coordinate O
regulation _RARE_
of O
transcription O
from O
these O
promoters O
. O

Purple _RARE_
photosynthetic _RARE_
bacteria O
are O
capable O
of O
generating O
cellular O
energy O
from O
several O
sources O
, O
including O
photosynthesis _RARE_
, O
respiration O
, O
and O
H O
( O
2 O
) O
oxidation O
. O

An O
analysis O
of O
synthetic _RARE_
peptides O
revealed O
a O
minimal O
CTD _RARE_
sequence O
that O
is O
sufficient O
to O
bind O
to O
the O
second O
Rsp5 _RARE_
WW _RARE_
domain I-GENE
( O
Rsp5 _RARE_
WW2 _RARE_
) O
in O
vitro O
and O
in O
yeast O
two O
- O
hybrid _RARE_
assays O
. O

Furthermore O
, O
bone O
marrow O
- O
derived O
macrophages O
from O
LAT _RARE_
- O
deficient _RARE_
mice O
displayed O
reduced _RARE_
phagocytic O
efficiency O
in O
comparison O
to O
the O
macrophages O
from O
wild O
- O
type O
mice O
. O

T1 _RARE_
- O
weighted O
MRI O
on O
the O
49th _RARE_
postoperative O
day O
demonstrated O
bilateral O
and O
symmetrical _RARE_
hyperintense _RARE_
lesions O
in O
the O
globus _RARE_
pallidus _RARE_
. O

The O
method O
is O
applied O
to O
determine O
aberration _RARE_
constants O
of O
a O
CM300 _RARE_
FEG _RARE_
/ O
UT O
microscope _RARE_
with O
correction O
of O
the O
three O
- O
fold _RARE_
astigmatism _RARE_
. O

The O
interaction O
does O
not O
depend O
on O
the O
presence O
of O
the O
correct O
amino O
- O
terminal O
DNA O
binding O
domain O
or O
the O
amino O
acid O
sequences O
between O
the O
DNA O
binding O
domain O
and O
the O
last O
ten O
amino O
acids _RARE_
. O

METHOD _RARE_
: O
The O
sample O
of O
subjects O
was O
drawn _RARE_
from O
the O
Suffolk _RARE_
County _RARE_
Mental _RARE_
Health O
Project _RARE_
, O
a O
longitudinal O
epidemiologic _RARE_
study O
of O
first _RARE_
- O
hospitalized O
subjects O
with O
psychotic _RARE_
disorders O
; O
the O
present O
study O
focused O
on O
patients O
with O
schizophrenic O
disorders O
. O

Marrow _RARE_
dysplasia O
is O
a O
major O
characteristic O
of O
patients O
with O
myelodysplastic _RARE_
syndrome _RARE_
( O
MDS _RARE_
), _RARE_
along O
with O
marrow O
blastosis _RARE_
, O
cytopenia _RARE_
and O
cytogenetic O
anomalies O
. O

Eight O
of O
the O
non O
- O
acceptable O
inlays _RARE_
/ O
onlays _RARE_
and O
five O
of O
the O
direct O
restorations O
were O
replaced O
, O
while O
the O
other O
ones O
were O
repaired _RARE_
with O
resin O
composite O
. O

How _RARE_
plants _RARE_
respond O
to O
attack _RARE_
by O
the O
range O
of O
herbivores _RARE_
and O
pathogens O
that O
confront _RARE_
them O
in O
the O
field O
is O
the O
subject O
of O
considerable O
research O
by O
both O
molecular _RARE_
biologists _RARE_
and O
ecologists _RARE_
. O

CONCLUSION O
: O
The O
probability _RARE_
of O
cardiopulmonary O
complications O
increases O
significantly O
when O
patients O
develop O
class O
1 O
HELLP _RARE_
syndrome _RARE_
. O

The O
rate O
- O
limiting O
step O
for _RARE_
telomerase I-GENE
activity O
seems O
to O
be O
the O
expression _RARE_
of O
the O
catalytic O
subunit O
of O
the O
enzyme O
, O
encoded O
by O
the O
human I-GENE
telomerase I-GENE
reverse I-GENE
transcriptase I-GENE
( O
hTERT _RARE_
) O
gene O
. O

In O
the O
control O
group O
, O
platelet O
markers O
increased O
1 O
h O
after O
surgery O
. O

However O
, O
the O
element O
proximal O
to O
the O
transcription O
start _RARE_
site O
is O
dependent O
on O
the O
SRE O
- O
1 O
. O

AMDA _RARE_
white _RARE_
paper O
identifies O
ways O
to O
improve O
pharmaceutical _RARE_
care O
in O
SNFs _RARE_
. O

Since O
proteins O
containing O
TPR O
elements O
are O
typically O
involved O
in O
multiple O
protein O
- O
protein O
interactions O
, O
we O
suggest O
that O
the O
102kD _RARE_
protein O
interacts O
within O
the O
tri _RARE_
- O
snRNP O
with O
both O
the O
U5 _RARE_
and O
U4 I-GENE
/ O
U6 I-GENE
snRNPs _RARE_
, O
thus O
bridging _RARE_
the O
two O
particles _RARE_
. O

Antibodies O
raised O
against O
a O
C O
- O
terminal O
portion O
of O
Sec31A _RARE_
co _RARE_
- O
precipitate _RARE_
Sec13 _RARE_
and O
inhibit O
ER O
- O
Golgi _RARE_
transport _RARE_
of O
temperature _RARE_
- O
arrested O
vesicular O
stomatitis _RARE_
G I-GENE
protein I-GENE
in O
a O
semi _RARE_
- O
intact _RARE_
cell O
assay O
. O

Regulation O
of O
mitochondrial O
single O
- O
stranded _RARE_
DNA O
- O
binding O
protein O
gene O
expression _RARE_
links O
nuclear O
and O
mitochondrial O
DNA O
replication O
in O
drosophila _RARE_
. O

Genetic O
and O
molecular _RARE_
complexity O
of O
the O
position O
effect O
variegation _RARE_
modifier _RARE_
mod _RARE_
( O
mdg4 _RARE_
) O
in O
Drosophila O
. O
mod _RARE_
( O
mdg4 _RARE_
), _RARE_
also O
known O
as _RARE_
E I-GENE
( I-GENE
var _RARE_
) I-GENE
3 I-GENE
- I-GENE
93D _RARE_
, O
is O
involved O
in O
a O
variety O
of O
processes O
, O
such O
as _RARE_
gene O
silencing O
in O
position O
effect O
variegation _RARE_
( O
PEV _RARE_
), _RARE_
the O
control O
of O
gypsy _RARE_
insulator _RARE_
sequences I-GENE
, O
regulation _RARE_
of O
homeotic I-GENE
gene I-GENE
expression _RARE_
, O
and O
programmed O
cell O
death _RARE_
. O

They O
are O
present O
in O
many O
kinds _RARE_
of O
living O
things _RARE_
, O
but O
their O
functions O
, O
especially O
those O
in O
humans O
, O
are O
unclear O
. O

This O
tendency O
is O
likely O
due O
to O
the O
biased _RARE_
nucleotide O
composition O
of O
the O
asparagus _RARE_
genome O
, O
rather O
than O
to O
the O
translational O
selection O
for _RARE_
specific O
codons O
. O

Transduction _RARE_
of O
the O
human O
leukemic _RARE_
cell O
line O
K562 O
showed O
that O
viral O
MRP1 _RARE_
- O
PG13 _RARE_
supernatants _RARE_
routinely _RARE_
transfer O
the O
MRP1 _RARE_
gene I-GENE
to O
approximately _RARE_
35 _RARE_
% O
of O
target O
K562 O
cells O
, O
of O
which O
at _RARE_
least O
one O
third O
are O
capable O
of O
proliferating _RARE_
in O
the O
presence O
of O
otherwise O
toxic O
concentrations O
of O
etoposide _RARE_
. O

Regulation O
of O
pituitary O
vasopressin I-GENE
V1b _RARE_
receptors I-GENE
plays O
a O
critical O
role O
in O
regulating _RARE_
pituitary I-GENE
adrenocorticotropic _RARE_
hormone I-GENE
( O
ACTH I-GENE
) O
secretion _RARE_
during _RARE_
adaptation O
to O
stress O
. O

Identification O
of O
an O
AfsA _RARE_
homologue I-GENE
( O
BarX _RARE_
) O
from O
Streptomyces _RARE_
virginiae _RARE_
as _RARE_
a O
pleiotropic O
regulator O
controlling O
autoregulator _RARE_
biosynthesis O
, O
virginiamycin _RARE_
biosynthesis O
and O
virginiamycin _RARE_
M1 _RARE_
resistance O
. O

Because O
the O
mutant O
defective _RARE_
in O
DNA O
binding O
also O
fails O
to O
stimulate O
Abf1 _RARE_
ARS1 _RARE_
DNA O
- O
binding O
activity O
, O
our O
results O
suggest O
that O
Cdc6 _RARE_
DNA O
- O
binding O
activity O
may O
play O
a O
pivotal O
role O
in O
the O
initiation O
of O
DNA O
replication O
. O

Given _RARE_
its O
relative O
longevity _RARE_
on O
the O
Web _RARE_
, O
TIE _RARE_
researchers _RARE_
have O
been O
in O
a O
unique O
position O
to O
observe O
trends _RARE_
in O
telemedicine _RARE_
. O

The O
structural O
study O
of O
peptides O
belonging O
to O
the O
terminal O
domains O
of O
histone I-GENE
H1 _RARE_
can O
be O
considered O
as _RARE_
a O
step O
toward O
the O
understanding O
of O
the O
function O
of O
H1 _RARE_
in O
chromatin O
. O

The O
recovery O
rates O
for _RARE_
the O
MB O
/ O
BacT _RARE_
, O
MGIT _RARE_
960 _RARE_
, O
and O
solid O
media O
were O
91 O
. O
6 O
, O
87 O
. O
4 O
, O
and O
54 O
. O
7 O
%, O
respectively O
, O
for _RARE_
all O
mycobacteria O
; O
the O
recovery O
rates O
were O
93 O
. O
6 O
, O
88 O
. O
9 O
, O
and O
63 _RARE_
. O
4 O
%, O
respectively O
, O
for _RARE_
M O
. O
tuberculosis O
complex O
alone O
, O
and O
87 O
. O
5 O
, O
84 _RARE_
. O
4 O
, O
and O
37 O
. O
5 O
%, O
respectively O
, O
for _RARE_
all O
nontuberculous _RARE_
mycobacteria O
. O

Cerebral _RARE_
vasculitis O
secondary O
to O
Crohn O
' O
s O
disease _RARE_
seems O
to O
be O
a O
very O
rare O
phenomenon O
. O

SELECTION _RARE_
CRITERIA _RARE_
: O
Randomised _RARE_
and O
possibly O
randomised O
trials O
using O
acupuncture _RARE_
to O
treat O
asthma O
and O
asthma O
- O
like O
symptoms O
. O

SELECTION _RARE_
CRITERIA _RARE_
: O
Randomised _RARE_
trials O
comparing O
children O
undergoing O
systematic O
therapy O
focusing O
on O
the O
family O
in O
conjunction O
with O
asthma O
medication O
, O
with O
children O
taking O
asthma O
medication O
only O
. O

To O
test O
the O
hypothesis O
that O
progestin _RARE_
- O
mediated _RARE_
increases O
in O
resting O
core O
temperature _RARE_
and O
the O
core O
temperature _RARE_
threshold O
for _RARE_
sweating _RARE_
onset O
are O
counteracted _RARE_
by O
estrogen O
, O
we O
studied O
eight O
women O
( O
24 _RARE_
+/- O
2 O
yr O
) O
at _RARE_
27 _RARE_
degrees O
C O
rest O
, O
during _RARE_
20 O
min O
of O
passive O
heating _RARE_
( O
35 _RARE_
degrees O
C O
), _RARE_
and O
during _RARE_
40 O
min O
of O
exercise O
at _RARE_
35 _RARE_
degrees O
C O
. O

The O
models O
were O
tested O
by O
studying O
their O
response O
to O
disturbances O
of O
the O
afferent _RARE_
signal O
from O
the O
bladder O
. O

Our O
data O
show O
also O
that O
phagocytic O
killing _RARE_
of O
meningococci _RARE_
is O
probably O
a O
more O
consistent O
assay O
than O
antibody O
titer O
levels O
for _RARE_
antimeningococcal _RARE_
immunity _RARE_
, O
especially O
in O
LCC _RARE_
- O
deficient _RARE_
patients O
. O

These O
studies O
suggest O
an O
additional O
component _RARE_
or O
cellular O
environment O
is O
required O
for _RARE_
SPRK _RARE_
activation O
by O
Cdc42 I-GENE
. O

M O
. O

Jkappa _RARE_
DNA I-GENE
- I-GENE
binding I-GENE
sites I-GENE
were O
not O
required O
for _RARE_
this O
activation O
, O
and O
a O
mutant I-GENE
EBNA I-GENE
- I-GENE
3C I-GENE
protein I-GENE
unable O
to O
bind O
Jkappa _RARE_
activated O
transcription O
as _RARE_
efficiently O
as _RARE_
wild I-GENE
- I-GENE
type I-GENE
EBNA I-GENE
- I-GENE
3C I-GENE
, O
indicating O
that O
EBNA I-GENE
- I-GENE
3C I-GENE
can O
regulate O
transcription O
through O
a O
mechanism O
that O
is O
independent O
of O
Jkappa _RARE_
. O

Thus O
, O
both O
YY1 I-GENE
and O
CDP I-GENE
appear O
to O
be O
negative O
regulators _RARE_
of O
the O
differentiation O
- O
induced _RARE_
HPV I-GENE
- I-GENE
6 I-GENE
E1 I-GENE
promoter I-GENE
and O
thereby O
the O
HPV O
life O
cycle _RARE_
. O

Sequential _RARE_
cleavage _RARE_
by O
metallopeptidases _RARE_
and O
proteasomes _RARE_
is O
involved O
in O
processing _RARE_
HIV I-GENE
- I-GENE
1 I-GENE
ENV _RARE_
epitope _RARE_
for _RARE_
endogenous O
MHC I-GENE
class I-GENE
I I-GENE
antigen I-GENE
presentation O
. O

Cloning O
and O
characterization O
of O
human I-GENE
Lnk _RARE_
, O
an O
adaptor _RARE_
protein O
with O
pleckstrin I-GENE
homology O
and O
Src I-GENE
homology I-GENE
2 I-GENE
domains I-GENE
that O
can O
inhibit O
T O
cell O
activation O
. O

Vancomycin _RARE_
data O
were O
analyzed O
according O
to O
a O
one O
- O
compartment O
open _RARE_
model O
with O
use O
of O
NONMEM _RARE_
population O
pharmacokinetic O
software _RARE_
. O

Finally O
, O
Cas _RARE_
existed O
mainly O
in O
cytosol O
and O
membrane O
cytoskeleton _RARE_
fractions O
in O
the O
resting O
state O
, O
and O
remained O
unchanged O
during _RARE_
platelet O
aggregation _RARE_
, O
when O
FAK I-GENE
translocated _RARE_
to O
the O
cytoskeletal O
fraction O
. O

We O
also O
show O
that O
p65 _RARE_
binds O
to O
these O
targets _RARE_
with O
almost O
equal O
affinity O
and O
that O
different O
residues O
have O
variable _RARE_
roles O
in O
binding O
different O
kappaB I-GENE
targets _RARE_
. O

Transcriptional O
regulation _RARE_
of O
the O
yeast I-GENE
PHO8 _RARE_
promoter I-GENE
in O
comparison O
to O
the O
coregulated _RARE_
PHO5 _RARE_
promoter I-GENE
. O

The O
Siglecs _RARE_
are O
a O
subfamily O
of O
I I-GENE
- I-GENE
type I-GENE
lectins _RARE_
( O
immunoglobulin I-GENE
superfamily I-GENE
proteins I-GENE
that O
bind O
sugars O
) O
that O
specifically O
recognize O
sialic _RARE_
acids _RARE_
. O

Our O
data O
provide O
a O
biochemical O
explanation O
for _RARE_
the O
similarity _RARE_
in O
phenotype _RARE_
between O
A O
- O
T O
and O
NBS _RARE_
. O

PATIENTS O
OR O
OTHER _RARE_
PARTICIPANTS _RARE_
: O
Twenty O
children O
met O
the O
criteria O
for _RARE_
being O
learning O
disabled _RARE_
. O

Update _RARE_
on O
maternal _RARE_
- O
fetal _RARE_
infections O
by O
hepatitis O
C O
, O
HIV O
and O
cytomegalovirus _RARE_

In O
the O
present O
study O
, O
we O
characterized O
cis O
- O
elements O
of O
the O
human I-GENE
PCI I-GENE
gene I-GENE
required O
for _RARE_
expression _RARE_
in O
the O
hepatoma O
- O
derived O
cell O
line O
, O
HepG2 _RARE_
cells O
, O
and O
also O
evaluated O
rat I-GENE
PCI I-GENE
mRNA I-GENE
expression _RARE_
, O
particularly O
on O
the O
effect O
of O
androgen _RARE_
in O
rat O
reproductive O
tissues O
. O

In O
the O
study O
on O
PCI I-GENE
mRNA I-GENE
expression _RARE_
in O
the O
reproductive O
organs O
, O
we O
first _RARE_
cloned _RARE_
rat I-GENE
PCI I-GENE
cDNA I-GENE
and O
then O
evaluated O
the O
effect O
of O
androgen _RARE_
on O
the O
PCI I-GENE
mRNA I-GENE
expression _RARE_
. O

To O
illustrate _RARE_
its O
performance O
, O
measurements O
of O
photoluminescence _RARE_
in O
GaAs _RARE_
/ O
AlGaAs _RARE_
heterostructures _RARE_
are O
presented O
. O

The O
stoichiometry _RARE_
of O
the O
complexes O
formed O
with O
the O
dodeca _RARE_
- O
satellite _RARE_
C O
strand _RARE_
suggests O
that O
, O
in O
DDP1 _RARE_
, O
the O
15 _RARE_
consecutive O
KH _RARE_
domains O
are O
organized O
such O
that O
they O
define O
two O
nucleic _RARE_
acid O
binding O
surfaces _RARE_
. O

Mutational O
analysis O
of O
mammalian I-GENE
translation I-GENE
initiation I-GENE
factor I-GENE
5 I-GENE
( O
eIF5 _RARE_
): O
role O
of O
interaction O
between O
the O
beta O
subunit O
of O
eIF2 _RARE_
and O
eIF5 _RARE_
in O
eIF5 _RARE_
function O
in O
vitro O
and O
in O
vivo O
. O

Much _RARE_
evidence O
indicates O
that O
p38 I-GENE
is O
an O
activator O
of O
MyoD I-GENE
: O
( O
i O
) O
p38 I-GENE
kinase I-GENE
activity O
is O
required O
for _RARE_
the O
expression _RARE_
of O
MyoD I-GENE
- O
responsive O
genes O
, O
( O
ii O
) O
enforced _RARE_
induction O
of O
p38 I-GENE
stimulates O
the O
transcriptional O
activity O
of O
a O
Gal4 I-GENE
- O
MyoD I-GENE
fusion O
protein O
and O
allows O
efficient O
activation O
of O
chromatin O
- O
integrated O
reporters _RARE_
by O
MyoD I-GENE
, O
and O
( O
iii O
) O
MyoD I-GENE
- O
dependent O
myogenic _RARE_
conversion O
is O
reduced _RARE_
in O
mouse O
embryonic _RARE_
fibroblasts _RARE_
derived O
from O
p38alpha _RARE_
(-/-) _RARE_
embryos _RARE_
. O

This O
activity O
is O
stimulated _RARE_
by O
complex O
formation O
with O
the O
other O
eIF2B _RARE_
subunits I-GENE
. O

Our O
analysis O
of O
nonsense O
mutations O
indicates O
that O
the O
C O
terminus O
of O
eIF2Bepsilon _RARE_
( I-GENE
residues I-GENE
518 _RARE_
to I-GENE
712 _RARE_
) I-GENE
is O
required O
for _RARE_
both O
catalytic O
activity O
and O
interaction O
with O
eIF2 _RARE_
. O

In O
contrast O
, O
mutations O
affecting O
the O
other O
two O
Nim1p _RARE_
- I-GENE
related I-GENE
kinases I-GENE
in O
S O
. O
cerevisiae O
, O
Hsl1p _RARE_
and O
Kcc4p _RARE_
, O
produce O
no _RARE_
detectable O
effect O
on O
septin _RARE_
organization O
. O

CONCLUSIONS O
: O
Physiologic _RARE_
pacing O
provides O
little O
benefit O
over O
ventricular O
pacing O
for _RARE_
the O
prevention O
of O
stroke O
or O
death _RARE_
due O
to O
cardiovascular O
causes O
. O

Among O
non O
- O
cirrhotics _RARE_
, O
lack O
of O
portal _RARE_
vein _RARE_
visualisation _RARE_
had O
a O
90 _RARE_
% O
sensitivity O
, O
88 O
% O
specificity _RARE_
, O
94 O
% O
negative O
predictive O
value O
, O
and O
83 _RARE_
% O
positive O
predictive O
value O
in O
the O
diagnosis O
of O
pre O
- O
sinusoidal _RARE_
portal _RARE_
hypertension O
. O

D5 _RARE_
/ I-GENE
D1 _RARE_
( I-GENE
CT _RARE_
) I-GENE
or O
D5 _RARE_
/ I-GENE
D1D _RARE_
( I-GENE
CT _RARE_
) I-GENE
tail _RARE_
substitution O
mutants O
displayed O
a O
rank _RARE_
order O
of O
potency O
and O
agonist O
affinities O
virtually O
mimicking _RARE_
wild I-GENE
- I-GENE
type I-GENE
( I-GENE
wt I-GENE
) I-GENE
D1 _RARE_
receptors I-GENE
, O
as _RARE_
indexed _RARE_
by O
both O
ligand _RARE_
binding O
and O
dopamine O
- O
stimulated _RARE_
cAMP O
accumulation O
assays O
, O
and O
, O
similar O
to O
wt O
D1 _RARE_
receptors I-GENE
, O
did O
not O
exhibit O
receptor O
constitutive _RARE_
activity O
or O
responsiveness O
to O
inverse _RARE_
agonists O
. O

Modeling _RARE_
also O
revealed O
a O
very O
hydrophobic O
surface O
due O
to O
the O
absence O
of O
H12 _RARE_
, O
exposing _RARE_
residues O
from O
H3 _RARE_
, O
loop O
3 O
- O
4 O
, O
H4 _RARE_
, O
and O
H11 _RARE_
. O

The O
serine I-GENE
- I-GENE
threonine I-GENE
kinase I-GENE
gene I-GENE
is O
likely O
functional _RARE_
, O
whereas O
the O
zinc O
finger O
motif O
is O
likely O
nonfunctional _RARE_
. O

Stat I-GENE
activation O
in O
response O
to O
GH _RARE_
and O
IL _RARE_
- I-GENE
6 I-GENE
was O
determined O
by O
reporter O
gene O
induction O
. O

HFA _RARE_
134a _RARE_
had O
a O
greater O
tendency O
to O
take O
up _RARE_
moisture _RARE_
from O
the O
environment O
than O
did O
HFA _RARE_
227 _RARE_
. O

RESULTS O
: O
Abnormal O
color O
perception _RARE_
was O
found O
in O
32 _RARE_
% O
of O
the O
epilepsy O
patients O
treated O
with O
vigabatrin _RARE_
monotherapy _RARE_
and O
28 _RARE_
% O
of O
the O
epilepsy O
patients O
treated O
with O
carbamazepine _RARE_
monotherapy _RARE_
. O

In O
the O
SPP2 _RARE_
screening O
test O
, O
a O
few O
plates O
were O
not O
seen O
in O
both O
groups O
. O

Mitogen _RARE_
- I-GENE
activated I-GENE
protein I-GENE
( I-GENE
MAP I-GENE
) I-GENE
kinase I-GENE
phosphatase I-GENE
- I-GENE
3 I-GENE
( O
MKP I-GENE
- I-GENE
3 I-GENE
) O
is O
a O
dual O
specificity _RARE_
phosphatase O
that O
inactivates _RARE_
extracellular I-GENE
signal I-GENE
- I-GENE
regulated I-GENE
kinase I-GENE
( O
ERK I-GENE
) O
MAP I-GENE
kinases I-GENE
. O

Consistent O
with O
this O
, O
we O
show O
that O
peptides O
representing O
docking _RARE_
sites O
within O
the O
target O
substrates _RARE_
Elk I-GENE
- I-GENE
1 I-GENE
and O
p90 _RARE_
( O
rsk _RARE_
) O
inhibit O
ERK I-GENE
- O
dependent O
activation O
of O
MKP I-GENE
- I-GENE
3 I-GENE
. O

HPLC O
phosphopeptide _RARE_
mapping O
, O
amino O
acid O
sequencing O
, O
and O
site O
- O
directed O
mutagenesis O
determined O
that O
NCLK _RARE_
phosphorylates O
Ser _RARE_
( O
67 O
) O
of O
I I-GENE
- I-GENE
1 I-GENE
. O

When O
the O
entire _RARE_
diet O
consisted O
of O
SBF _RARE_
, O
voluntary _RARE_
feed O
intake O
was O
reduced _RARE_
, O
indicating O
that O
SBF _RARE_
should O
not O
be O
fed O
to O
ponies _RARE_
as _RARE_
the O
sole _RARE_
dietary O
ingredient _RARE_
. O

Hepatitis _RARE_
C O
virus O
infection O
and O
lymphoproliferative _RARE_
diseases O
in O
France _RARE_
: O
a O
national O
study O
. O

The O
immune O
system _RARE_
is O
closely O
integrated O
with O
the O
neuroendocrine _RARE_
system _RARE_
, O
and O
infection O
- O
induced _RARE_
increases O
in O
cytokines _RARE_
such O
as _RARE_
IL _RARE_
- I-GENE
1 I-GENE
, O
IL _RARE_
- I-GENE
6 I-GENE
and O
TNF I-GENE
have O
numerous O
effects O
on O
the O
central O
nervous O
system _RARE_
. O

Interestingly O
, O
a O
decreased O
transcription O
from O
the O
endogenous O
c I-GENE
- I-GENE
Myb I-GENE
promoter I-GENE
was O
observed O
in O
several O
HTLV _RARE_
- O
I O
transformed O
T O
- O
cell O
lines O
. O

H19 _RARE_
and O
Igf2 _RARE_
monoallelic _RARE_
expression _RARE_
is O
regulated O
in O
two O
distinct O
ways O
by O
a O
shared O
cis O
acting O
regulatory O
region O
upstream O
of O
H19 _RARE_
. O

C O
. O
elegans O
KLP _RARE_
- I-GENE
11 I-GENE
/ O
OSM _RARE_
- I-GENE
3 I-GENE
/ O
KAP _RARE_
- I-GENE
1 I-GENE
: O
orthologs _RARE_
of O
the O
sea _RARE_
urchin _RARE_
kinesin _RARE_
- I-GENE
II I-GENE
, O
and O
mouse O
KIF3A _RARE_
/ O
KIFB _RARE_
/ O
KAP3 _RARE_
kinesin _RARE_
complexes O
. O

Flavonoids _RARE_
from O
Brosimum _RARE_
acutifolium _RARE_
. O

BACKGROUND O
: O
Hepatic _RARE_
encephalopathy _RARE_
is O
a O
neuropsychiatric _RARE_
syndrome _RARE_
associated O
with O
acute O
liver O
failure O
, O
chronic O
parenchymal _RARE_
liver O
disease _RARE_
or O
portal _RARE_
systemic O
anastomosis O
. O

These O
natural _RARE_
antisense _RARE_
S I-GENE
transcripts I-GENE
co _RARE_
- O
exist O
with O
several O
less O
abundant O
sense O
S I-GENE
transcripts I-GENE
. O

Nor _RARE_
is O
such O
adjustment O
possible O
unless O
one O
posits _RARE_
a O
model O
that O
relates _RARE_
the O
missing O
observations O
to O
other O
observed O
information _RARE_
for _RARE_
each O
subject O
- O
models O
that O
are O
inherently _RARE_
untestable _RARE_
. O

However O
, O
the O
presence O
of O
effacement _RARE_
seems O
to O
be O
a O
more O
reliable O
and O
practical _RARE_
parameter O
that O
will O
be O
preferred O
in O
that O
prediction O
. O

The O
data O
are O
compatible O
with O
the O
idea O
that O
YLL031c _RARE_
transfers _RARE_
the O
ethanolaminephosphate _RARE_
to O
the O
inner O
alpha1 _RARE_
- O
2 O
- O
linked _RARE_
mannose _RARE_
, O
i O
. O
e _RARE_
. O
the O
group O
that O
links O
the O
GPI _RARE_
lipid _RARE_
anchor _RARE_
to O
proteins O
, O
whereas O
Mcd4p _RARE_
and O
Gpi7p _RARE_
transfer O
ethanolaminephosphate _RARE_
onto O
the O
alpha1 _RARE_
- O
4 O
- O
and O
alpha1 _RARE_
- O
6 O
- O
linked _RARE_
mannoses _RARE_
of O
the O
GPI _RARE_
anchor _RARE_
, O
respectively O
. O

The O
C O
terminus O
of O
TRBP _RARE_
binds O
to O
CBP I-GENE
/ O
p300 I-GENE
and O
DRIP130 _RARE_
, O
a O
component _RARE_
of O
the O
DRIP _RARE_
/ O
TRAP _RARE_
/ O
ARC _RARE_
complex O
, O
which O
suggests O
that O
TRBP _RARE_
may O
activate O
transcription O
by O
means O
of O
such O
interactions O
. O

The O
patients O
who O
presented O
with O
mucocutaneous _RARE_
disease _RARE_
also O
had O
low O
CD4 _RARE_
+ I-GENE
T O
lymphocyte O
counts O
, O
and O
most O
of O
them O
had O
AIDS O
defining _RARE_
illnesses _RARE_
. O

Increased O
dietary O
energy O
decreased O
PAB _RARE_
and O
the O
use O
of O
added O
dietary O
CO _RARE_
rather O
than O
PF _RARE_
decreased O
PSHL _RARE_
in O
broiler _RARE_
breeders _RARE_
between O
26 _RARE_
and O
47 _RARE_
wk O
of O
age O
. O

The O
gene O
amplification O
model O
of O
Coquelle _RARE_
et O
al O
. O

Hierarchy _RARE_
of O
protein I-GENE
tyrosine I-GENE
kinases I-GENE
in O
interleukin I-GENE
- I-GENE
2 I-GENE
( O
IL _RARE_
- I-GENE
2 I-GENE
) O
signaling _RARE_
: O
activation O
of O
syk _RARE_
depends O
on O
Jak3 _RARE_
; O
however O
, O
neither O
Syk _RARE_
nor O
Lck _RARE_
is O
required O
for _RARE_
IL _RARE_
- I-GENE
2 I-GENE
- O
mediated _RARE_
STAT I-GENE
activation O
. O

Immobilized _RARE_
dimers _RARE_
of O
N I-GENE
- I-GENE
cadherin _RARE_
- O
Fc I-GENE
chimera _RARE_
mimic O
cadherin _RARE_
- O
mediated _RARE_
cell O
contact _RARE_
formation O
: O
contribution O
of O
both O
outside O
- O
in O
and O
inside _RARE_
- O
out O
signals O
. O

Although O
the O
OC _RARE_
promoter I-GENE
is O
activated O
in O
a O
C O
terminus O
dependent O
manner O
, O
the O
MDR _RARE_
, O
LTR O
and O
BSP _RARE_
promoters I-GENE
are O
repressed O
by O
three O
distinct O
mechanisms O
, O
either O
independent O
of O
or O
involving O
the O
AML _RARE_
C I-GENE
terminus I-GENE
, O
or O
requiring O
only O
the O
conserved _RARE_
C O
- O
terminal O
pentapeptide _RARE_
VWRPY _RARE_
. O

The O
monoclonal O
immunoglobulin I-GENE
products O
of O
plasma O
cell O
neoplasm _RARE_
can O
give O
rise O
to O
a O
variety O
of O
manifestations O
including O
hyperviscosity _RARE_
, O
amyloidosis _RARE_
, O
cryoglobulinemia _RARE_
, O
neuropathy _RARE_
, O
and O
renal _RARE_
failure O
. O

Investigation _RARE_
of O
the O
structural O
basis O
of O
the O
interaction O
between O
human I-GENE
Igs _RARE_
and O
gp120 I-GENE
shows O
that O
the O
viral I-GENE
gp120 I-GENE
SAg _RARE_
can O
interact O
only O
with O
a O
subset O
of O
human I-GENE
V I-GENE
( I-GENE
H I-GENE
) I-GENE
3 I-GENE
+ I-GENE
Igs _RARE_
. O

Double O
- O
blind O
, O
placebo O
- O
controlled _RARE_
trial O
. O

Here O
, O
it O
is O
shown O
that O
TAFII250 _RARE_
, O
the O
largest O
subunit O
of O
TFIID I-GENE
, O
contains O
two O
tandem _RARE_
bromodomain _RARE_
modules _RARE_
that O
bind O
selectively O
to O
multiply _RARE_
acetylated _RARE_
histone I-GENE
H4 _RARE_
peptides I-GENE
. O

Endostatin _RARE_
treatment O
for _RARE_
10 O
minutes O
or O
24 _RARE_
hours O
induced _RARE_
tyrosine O
phosphorylation _RARE_
of O
Shb _RARE_
and O
formation O
of O
multiprotein _RARE_
complexes O
. O

Therefore O
, O
analogs _RARE_
of O
vitamin O
D3 _RARE_
have O
been O
investigated O
in O
a O
number O
of O
trials O
showing O
improvement O
of O
psoriasis O
. O

The O
transcript O
was O
initially O
identified O
as _RARE_
a O
partial O
cDNA O
sequence O
in O
the O
course O
of O
constructing _RARE_
a O
transcript O
map O
of O
the O
region O
between O
markers O
D11S1765 _RARE_
and O
uteroglobin _RARE_
known O
to O
encompass _RARE_
the O
gene O
causing O
Best _RARE_
disease _RARE_
. O

The O
real O
challenge O
for _RARE_
the O
future O
will O
be O
the O
management O
of O
patients O
who O
do O
not O
respond O
to O
first _RARE_
- O
line O
treatment O
. O

Iodine _RARE_
deficiency O
disorders O
in O
Bangladesh _RARE_
. O

The O
network O
evolution O
was O
interpreted O
by O
an O
approach O
based O
on O
the O
Flory _RARE_
model O
. O

RESULTS O
: O
Soluble _RARE_
CD23 I-GENE
levels O
were O
significantly O
higher _RARE_
in O
women O
with O
endometriosis _RARE_
before O
treatment O
than O
in O
ten O
normal O
controls O
. O

CONCLUSION O
: O
Our O
findings O
suggest O
that O
endometriosis _RARE_
increases O
soluble _RARE_
CD23 I-GENE
levels O
, O
which O
can O
be O
suppressed O
with O
either O
danazol _RARE_
or O
leuprolide _RARE_
acetate _RARE_
injection O
. O

To O
isolate O
this O
gene O
, O
a O
P O
- O
1 O
artificial O
chromosome _RARE_
( O
PAC _RARE_
) O
library O
was O
screened O
with O
a O
full I-GENE
length I-GENE
UGT2B7 _RARE_
probe O
and O
a O
clone O
of O
approximately _RARE_
100 _RARE_
kb O
in O
length O
was O
isolated O
. O

Age _RARE_
>/= O
50 O
years O
( O
odds O
ratio O
[ _RARE_
OR O
], O
14 O
. O
1 O
), _RARE_
BMI O
>/= O
28 _RARE_
kg O
/ O
m O
( O
2 O
) O
( O
OR O
, O
5 O
. O
7 O
), _RARE_
triglycerides _RARE_
>/= O
1 O
. O
7 O
mmol O
/ O
L O
( O
OR O
, O
5 O
), _RARE_
and O
alanine I-GENE
aminotransferase I-GENE
( O
ALT _RARE_
) O
>/= O
2N _RARE_
( O
OR O
, O
4 O
. O
6 O
) O
were O
independently O
associated O
with O
septal O
fibrosis _RARE_
. O

Biologically _RARE_
significant O
amounts O
of O
platelet I-GENE
activating I-GENE
factor I-GENE
were O
eluted _RARE_
from O
the O
sorbent _RARE_
during _RARE_
the O
entire _RARE_
treatment O
time O
. O

However O
, O
the O
elderly O
group O
showed O
significantly O
longer O
mean O
residence _RARE_
times O
( O
MRTs _RARE_
) O
and O
lower O
plasma O
clearance O
of O
lidocaine O
during _RARE_
the O
period O
compared O
with O
the O
adult O
group O
( O
P O
< O
. O
05 O
). O

Here O
, O
we O
show O
that O
the O
zinc I-GENE
finger I-GENE
protein I-GENE
Gis1 _RARE_
acts O
as _RARE_
a O
dosage O
- O
dependent O
suppressor O
of O
the O
rim15Delta _RARE_
defect O
in O
nutrient O
limitation O
- O
induced _RARE_
transcriptional O
derepression O
of O
SSA3 _RARE_
. O

The O
so O
- O
called O
" I-GENE
SH3 I-GENE
" I-GENE
segment I-GENE
of O
the O
linker _RARE_
domain O
, O
in O
contrast O
, O
shows O
species O
- O
specific O
sequence O
identity O
in O
all O
but O
one O
amino O
acid O
residues O
in O
both O
factors O
, O
in O
cattle O
, O
human O
, O
and O
mouse O
. O

No O
differences O
in O
total _RARE_
cholesterol O
levels O
were O
observed O
between O
mapuches _RARE_
and O
aymaras _RARE_
. O

Up _RARE_
to O
95 _RARE_
% O
of O
the O
total _RARE_
UV _RARE_
exposure O
received O
is O
in O
the O
UV _RARE_
- O
A O
waveband _RARE_
( O
320 _RARE_
- O
400 _RARE_
nm O
). O

To O
begin O
to O
characterize O
the O
role O
of O
the O
RNA O
subunits O
in O
enzyme O
function O
and O
substrate O
specificity _RARE_
, O
we O
swapped _RARE_
two O
hairpin O
structures _RARE_
( O
MRP3 _RARE_
and O
P3 _RARE_
) O
between O
RNase I-GENE
MRP I-GENE
RNA I-GENE
and O
RNase I-GENE
P I-GENE
RNA I-GENE
of I-GENE
S I-GENE
. I-GENE
cerevisiae I-GENE
. O

Among O
genes O
induced _RARE_
by O
added O
pMesogenin1 _RARE_
is O
Xwnt _RARE_
- I-GENE
8 I-GENE
, O
a O
signaling _RARE_
factor O
that O
induces O
a O
similar O
repertoire _RARE_
of O
marker O
genes O
and O
a O
similar O
cellular O
phenotype _RARE_
. O

Accordingly _RARE_
, O
no _RARE_
Ha I-GENE
- I-GENE
ras I-GENE
codon _RARE_
12 I-GENE
mutations O
are O
found O
in O
the O
EtNU _RARE_
- O
induced _RARE_
mammary O
tumors O
. O

False _RARE_
positive O
PET O
FDG O
corresponded O
to O
lung _RARE_
infection O
, O
degenerative _RARE_
bone O
disease _RARE_
, O
and O
reconstruction O
artifact _RARE_
. O

Tumor _RARE_
stages O
were O
IIB _RARE_
( O
T3 _RARE_
N0 _RARE_
) O
in O
52 O
%, O
IIIA _RARE_
in O
15 _RARE_
%, O
and O
IIIB _RARE_
in O
27 _RARE_
% O
of O
patients O
. O

Similarly O
, O
comparison O
of O
percentage O
reductions O
of O
heart _RARE_
rate O
at _RARE_
supine O
, O
sitting _RARE_
and O
exercise O
by O
repeated _RARE_
measure O
analysis O
showed O
the O
Malays _RARE_
to O
have O
significantly O
higher _RARE_
change O
compared O
to O
the O
Chinese _RARE_
( O
p O
= O
0 _RARE_
. O
040 _RARE_
). O

Consistent O
with O
our O
model O
, O
CTCF I-GENE
binding O
is O
abolished O
by O
DNA O
methylation O
. O

OBJECTIVE O
: O
To O
determine O
the O
efficacy O
and O
safety O
of O
amphotericin O
B O
oral O
suspension _RARE_
( O
ABOS _RARE_
) O
for _RARE_
the O
treatment O
of O
fluconazole _RARE_
refractory O
oral O
candidiasis O
in O
persons O
with O
HIV O
infection O
. O

Mucin _RARE_
gene I-GENE
expression _RARE_
has O
been O
shown O
to O
be O
altered O
in O
many O
intestinal _RARE_
diseases O
and O
especially O
cancers O
of O
the O
gastrointestinal _RARE_
tract _RARE_
. O

The O
experimentally O
mapped O
regions O
of O
RPB5 _RARE_
involved O
in O
these O
interactions O
correspond O
to O
distinct O
and O
surface O
- O
exposed O
alpha O
- O
helical O
structures _RARE_
. O

The O
model O
indicates O
that O
a O
0 _RARE_
. O
076 _RARE_
% O
reduction O
in O
cigarette _RARE_
consumption O
is O
associated O
with O
the O
availability O
of O
nicotine O
patches _RARE_
after O
1992 O
. O

Paper _RARE_
alert _RARE_
. O

The O
tryptase _RARE_
locus I-GENE
also O
contains O
at _RARE_
least O
four O
tryptase _RARE_
- I-GENE
like I-GENE
pseudogenes _RARE_
, O
including O
mastin _RARE_
, O
a O
gene O
expressed _RARE_
in O
dogs O
but O
not O
in O
humans O
. O

The O
cellular O
part O
of O
the O
third O
chimeric O
clone O
shows O
significant O
homology O
to O
an O
exon _RARE_
of O
the O
human I-GENE
tyrosine I-GENE
phosphatase I-GENE
1 I-GENE
gene I-GENE
, O
although O
oriented _RARE_
in O
the O
antisense _RARE_
direction O
compared O
to O
the O
adjacent O
LTR O
. O

OBJECTIVE O
: O
This O
study O
was O
conducted O
to O
assess O
the O
relative O
roles O
of O
99mTc O
- O
sestamibi _RARE_
scintimammography _RARE_
and O
sonography _RARE_
in O
the O
evaluation O
of O
breast O
lesions O
that O
are O
indeterminate _RARE_
or O
suspicious _RARE_
on O
mammography _RARE_
or O
clinical O
examination O
. O

Mutational O
analyses O
showed O
that O
in O
- O
frame O
stop O
codons O
introduced O
into O
five O
of O
seven _RARE_
RNA I-GENE
2 I-GENE
ORFs _RARE_
did O
not O
affect O
accumulation O
of O
progeny _RARE_
LIYV _RARE_
RNA I-GENE
1 I-GENE
or O
RNA I-GENE
2 I-GENE
, O
confirming O
that O
RNA I-GENE
2 I-GENE
does O
not O
encode O
proteins O
necessary O
for _RARE_
LIYV _RARE_
RNA O
replication O
. O

Role O
of O
NH _RARE_
( O
2 O
)- O
and O
COOH _RARE_
- O
terminal O
domains O
of O
the O
P I-GENE
protein I-GENE
of O
human O
parainfluenza _RARE_
virus O
type O
3 O
in O
transcription O
and O
replication O
. O

Phosphorylation _RARE_
of O
tyrosine O
residues O
in O
the O
kinase O
domain O
and O
juxtamembrane _RARE_
region O
regulates O
the O
biological O
and O
catalytic O
activities O
of O
Eph _RARE_
receptors I-GENE
. O

RESULTS O
: O
Fournier _RARE_
' O
s O
gangrene _RARE_
occurs O
worldwide _RARE_
. O

Genomic O
DNA O
sequencing O
in O
the O
vicinity O
of O
methylmalonyl _RARE_
- I-GENE
CoA I-GENE
mutase _RARE_
gene I-GENE
( O
mutAB _RARE_
) O
from O
a O
rifamycin _RARE_
SV O
- O
producing O
Amycolatopsis _RARE_
mediterranei _RARE_
U32 _RARE_
allowed O
us O
to O
clone O
, O
sequence O
, O
and O
identify O
a O
gene O
encoding O
a O
novel O
serine I-GENE
/ I-GENE
threonine I-GENE
protein I-GENE
kinase I-GENE
( O
amk _RARE_
). O

IL _RARE_
- I-GENE
2 I-GENE
is O
accepted O
as _RARE_
a O
standard O
treatment O
used O
alone O
, O
or O
in O
combination O
with O
chemotherapy O
or O
biotherapy _RARE_
in O
the O
management O
of O
metastatic O
melanoma _RARE_
and O
metastatic O
renal _RARE_
cell O
carcinoma O
. O

Moreover O
, O
expression _RARE_
of O
antisense _RARE_
Ha I-GENE
- I-GENE
Ras I-GENE
or O
dominant I-GENE
negative I-GENE
Raf I-GENE
- I-GENE
1 I-GENE
abrogated O
the O
mitogenic O
effect O
of O
TGF I-GENE
- I-GENE
beta1 I-GENE
in O
TSU _RARE_
- O
Pr1 _RARE_
, O
and O
the O
TGF I-GENE
- I-GENE
beta1 I-GENE
inhibition O
of O
DU145 _RARE_
was O
switched _RARE_
to O
stimulation _RARE_
by O
V12Ha _RARE_
- I-GENE
Ras I-GENE
transfection O
. O

Taken O
together O
, O
our O
data O
suggest O
that O
prostate _RARE_
carcinomas O
with O
the O
Ras I-GENE
/ O
MAPK _RARE_
pathway _RARE_
activation O
might O
have O
a O
selective O
growth O
advantage O
by O
autocrine O
TGF I-GENE
- I-GENE
beta1 I-GENE
production O
. O

Vbeta _RARE_
segments _RARE_
are O
appended _RARE_
to O
DJbeta _RARE_
rearrangements _RARE_
, O
with O
little O
or O
no _RARE_
direct O
Vbeta _RARE_
to O
Jbeta _RARE_
joining _RARE_
, O
despite O
12 O
/ O
23 _RARE_
compatibility O
of O
Vbeta _RARE_
23 _RARE_
- I-GENE
RSSs _RARE_
and O
Jbeta12 _RARE_
- I-GENE
RSSs _RARE_
. O

For O
oral O
administration O
, O
AUC0 _RARE_
- O
infinity _RARE_
was O
58 O
. O
47 _RARE_
+/- O
16 O
. O
37 O
microg O
x _RARE_
h O
/ O
ml O
, O
t1 O
/ O
2beta _RARE_
was O
18 O
. O
39 _RARE_
+/- O
0 _RARE_
. O
06 O
hours O
, O
maximum O
concentration O
( O
Cmax _RARE_
) O
was O
2 O
. O
12 O
+/- O
00 O
. O
51 _RARE_
microg O
/ O
ml O
, O
time O
to O
Cmax _RARE_
was O
2 O
. O
20 O
+/- O
2 O
. O
17 _RARE_
hours O
, O
mean O
absorption O
time O
was O
2 O
. O
09 O
+/- O
0 _RARE_
. O
51 _RARE_
hours O
, O
and O
bioavailability _RARE_
was O
42 _RARE_
+/- O
0 _RARE_
. O
42 _RARE_
%. O

In O
experiment O
2 O
, O
no _RARE_
difference O
in O
gastric _RARE_
emptying O
of O
40 O
% O
peptone _RARE_
or O
25 _RARE_
% O
glucose O
was O
found O
between O
rats O
receiving O
TPN O
and O
those O
receiving O
intragastric _RARE_
nutrition O
for _RARE_
10 O
to O
12 O
days O
. O

In O
contrast O
, O
H I-GENE
- I-GENE
NS _RARE_
negative O
regulation _RARE_
operated O
only O
in O
the O
absence O
of O
Fur I-GENE
. O

Thus O
, O
SAG _RARE_
appears O
to O
control O
cell O
cycle _RARE_
progression O
in O
yeast O
by O
promoting _RARE_
ubiquitination O
and O
degradation _RARE_
of O
cell O
cycle _RARE_
regulatory O
proteins O
. O

E2F I-GENE
- I-GENE
1 I-GENE
is O
a O
transcription O
factor O
that O
regulates O
cell O
cycle _RARE_
progression O
into O
S O
- O
phase _RARE_
. O

It O
brings _RARE_
about O
fatigue _RARE_
, O
negative O
moods _RARE_
, O
and O
impaired O
health O
, O
sleep O
, O
safety O
, O
and O
working O
capacity O
. O

This O
demonstrates O
that O
treatment O
of O
the O
graft O
recipient O
for _RARE_
a O
relatively O
short O
period O
during _RARE_
and O
after O
surgery O
has O
a O
favorable _RARE_
effect O
on O
the O
survival O
of O
grafted _RARE_
dopaminergic O
neurons O
. O

The O
relationships O
among O
blood _RARE_
concentrations O
of O
thyroid O
hormones _RARE_
and O
selenium O
, O
zinc O
, O
retinol _RARE_
, O
and O
alpha O
- O
tocopherol _RARE_
were O
studied O
in O
44 _RARE_
healthy O
Northern O
Italian O
oldest _RARE_
- O
old O
subjects O
( O
age O
range O
, O
90 _RARE_
- O
107 _RARE_
yr O
), _RARE_
selected _RARE_
by O
the O
criteria O
of O
the O
SENIEUR _RARE_
protocol O
. O

Chinese _RARE_
Spring _RARE_
( O
CS _RARE_
) O
carrying O
the O
Q _RARE_
gene I-GENE
to O
those O
of O
a O
chromosome _RARE_
deletion O
line O
of O
CS _RARE_
, O
namely O
, O
q5 _RARE_
, O
which O
lacks O
15 _RARE_
% O
of O
5AL _RARE_
including O
the O
Q _RARE_
gene I-GENE
. O

Investigations _RARE_
using O
hippocampal O
slices _RARE_
maintained O
in O
vitro O
have O
demonstrated O
that O
bursts _RARE_
of O
oscillatory _RARE_
field O
potentials O
in O
the O
gamma O
frequency O
range O
( O
30 _RARE_
- O
80 _RARE_
Hz O
) O
are O
followed O
by O
a O
slower O
oscillation _RARE_
in O
the O
beta O
1 O
range O
( O
12 O
- O
20 O
Hz O
). O

Karger _RARE_
AG _RARE_
, O
Basel _RARE_

During O
surgery O
bone O
cysts O
were O
excised _RARE_
and O
filled O
by O
bone O
grafts O
. O

Urinary _RARE_
LTE4 _RARE_
increased O
after O
both O
challenges _RARE_
the O
rise O
being O
higher _RARE_
following O
oral O
as _RARE_
compared O
to O
inhalation O
provocation _RARE_
( O
p O
= O
0 _RARE_
. O
0001 O
). O

Basal O
FVR _RARE_
was O
reduced _RARE_
by O
approximately _RARE_
18 O
% O
by O
ERT _RARE_
and O
HRT _RARE_
, O
but O
FVR _RARE_
responses O
to O
noradrenaline O
, O
angiotensin I-GENE
II I-GENE
, O
acetylcholine _RARE_
and O
nitroprusside _RARE_
were O
unaffected O
. O

Three O
FGF I-GENE
- I-GENE
AS _RARE_
cDNAs I-GENE
were O
isolated O
; O
the O
full I-GENE
- I-GENE
length I-GENE
FGF I-GENE
- I-GENE
AS _RARE_
mRNA I-GENE
and O
two O
alternative _RARE_
splice _RARE_
variants O
lacking _RARE_
exon _RARE_
2 O
or O
exons O
2 O
and O
3 O
of O
the O
FGF I-GENE
- I-GENE
AS _RARE_
sequence I-GENE
. O

Taken O
together O
, O
these O
results O
indicate O
that O
MAP I-GENE
kinase I-GENE
stimulates O
the O
hPL _RARE_
- I-GENE
B I-GENE
enhancer I-GENE
by O
an O
NF _RARE_
- I-GENE
IL _RARE_
- I-GENE
6 I-GENE
- O
dependent O
pathway _RARE_
. O

Characterization O
of O
polymorphic O
TNRs _RARE_
in O
novel O
and O
even O
known O
genes O
expressed _RARE_
in O
human O
spinal _RARE_
cord O
is O
likely O
to O
help O
in O
the O
identification O
of O
new O
candidates _RARE_
for _RARE_
genes O
involved O
in O
neurodegenerative _RARE_
disorders O
. O

Finally O
, O
in O
situ O
RNA O
hybridization O
studies O
revealed O
a O
very O
specific O
pattern O
of O
EphA8 _RARE_
gene I-GENE
expression _RARE_
restricted O
to O
the O
rostral _RARE_
region O
of O
midbrain _RARE_
tectum _RARE_
during _RARE_
embryonic _RARE_
development O
. O

Transfection O
of O
cDNAs O
for _RARE_
three O
mutant O
enzymes _RARE_
into O
FPGS _RARE_
- O
null _RARE_
Chinese _RARE_
hamster O
ovary O
cells O
restored O
a O
reduced _RARE_
level O
of O
clonal _RARE_
growth O
, O
whereas O
a O
T339I _RARE_
mutant O
supported O
growth O
at _RARE_
a O
level O
comparable O
to O
that O
of O
the O
wild O
- O
type O
enzyme O
. O

SETTING O
: O
University O
of O
Paris _RARE_
VII O
hospital O
. O
Patient _RARE_
( O
s O
): O
Nine _RARE_
women O
had O
embolization _RARE_
for _RARE_
symptomatic O
myoma _RARE_
, O
with O
12 O
pregnancies _RARE_
observed O
. O

Improving _RARE_
fissure _RARE_
sealant _RARE_
quality O
: O
mechanical O
preparation O
and O
filling O
level O
. O

The O
Menopause _RARE_
- O
Rating _RARE_
- O
Scale O
( O
MRS O
I O
) O
was O
used O
in O
clinical O
practice O
since O
1992 O
. O

The O
MRS O
II O
meets _RARE_
a O
high O
methodological _RARE_
standard O
as _RARE_
an O
instrument O
standardized O
in O
the O
population O
. O

The O
protein O
encoded O
by O
the O
fruA _RARE_
transcript I-GENE
is O
well _RARE_
conserved _RARE_
with O
the O
D I-GENE
. I-GENE
melanogaster I-GENE
type I-GENE
A I-GENE
protein I-GENE
, O
particularly O
the O
BTB I-GENE
protein I-GENE
- O
protein O
- O
binding O
domain O
, O
which O
is O
encoded O
by O
exons O
I O
and O
II O
and O
is O
100 _RARE_
% O
conserved _RARE_
. O

In O
addition O
, O
the O
mouse O
ortholog _RARE_
( O
Mharp _RARE_
/ O
Smarcal1 _RARE_
) O
was O
cloned _RARE_
, O
and O
the O
Caenorhabditis O
elegans O
ortholog _RARE_
( O
CEHARP _RARE_
) O
was O
identified O
in O
the O
GenBank _RARE_
database O
. O

Sparfloxacin _RARE_
and O
clinafloxacin _RARE_
were O
evaluated O
against O
Enterococcus _RARE_
faecium _RARE_
SF2149 _RARE_
and O
Enterococcus _RARE_
faecalis _RARE_
WH245 _RARE_
, O
respectively O
. O

ECP _RARE_
and O
tryptase _RARE_
levels O
in O
serum O
were O
measured O
before O
and O
after O
the O
last O
oral O
challenge O
. O

Tolterodine _RARE_
users O
were O
7 O
. O
5 O
times O
more O
likely O
to O
have O
received O
another O
spasmolytic _RARE_
drug O
( O
RR O
7 O
. O
5 O
, O
95 _RARE_
% O
CI _RARE_
4 O
. O
8 O
to O
11 O
. O
9 O
). O

For O
an O
unsupervised _RARE_
program O
, O
the O
costs O
were O
estimated O
at _RARE_
$ _RARE_
311 _RARE_
for _RARE_
the O
first _RARE_
year O
and O
$ _RARE_
73 _RARE_
for _RARE_
all O
additional O
years O
. O

The O
presence O
of O
such O
a O
putative O
RNA O
- O
binding O
domain O
suggests O
a O
mechanism O
for _RARE_
the O
observed O
autoregulation O
of O
bacteriophage _RARE_
T4 I-GENE
DNA I-GENE
polymerase I-GENE
synthesis _RARE_
by O
binding O
to O
its O
own O
mRNA O
. O

Deletion O
and O
mutational O
analyses O
revealed O
two O
positive O
cis O
- O
regulatory O
elements O
in O
this O
region O
that O
are O
essential O
for _RARE_
CSX1 _RARE_
expression _RARE_
in O
cardiomyocytes _RARE_
. O

Functional O
studies O
which O
introduced O
a O
mutation O
in O
the O
AP2 I-GENE
core I-GENE
binding I-GENE
region I-GENE
as _RARE_
well _RARE_
as _RARE_
cotransfection O
experiments O
using O
an O
AP2 I-GENE
expression _RARE_
vector O
revealed O
that O
AP2 I-GENE
exerts O
a O
repressive O
role O
on O
the O
HGF I-GENE
gene I-GENE
promoter I-GENE
activity O
. O

Using O
adenoviral _RARE_
transfer O
of O
IkappaBalpha I-GENE
( O
IkappaBalpha I-GENE
overexpression O
), _RARE_
the O
production O
of O
TNF I-GENE
- I-GENE
alpha I-GENE
induced _RARE_
by O
whole O
GBS _RARE_
was O
inhibited O
by O
only O
20 O
%. O

In O
reconstitution _RARE_
experiments O
, O
we O
first _RARE_
showed O
that O
expression _RARE_
in O
the O
RAW _RARE_
264 O
. O
7 O
cell O
line O
of O
C I-GENE
- I-GENE
terminal I-GENE
Src I-GENE
kinase I-GENE
( O
Csk I-GENE
) O
inhibited O
and O
that O
of O
a O
membrane O
- O
anchored _RARE_
, O
gain O
- O
of O
- O
function O
Csk I-GENE
abolished O
the O
Fc I-GENE
gamma I-GENE
R I-GENE
- O
mediated _RARE_
signaling _RARE_
that O
leads O
to O
phagocytosis _RARE_
in O
a O
kinase O
- O
dependent O
manner O
. O

In O
contrast O
, O
c I-GENE
- I-GENE
Src I-GENE
- I-GENE
derived I-GENE
construct I-GENE
( O
a I-GENE
- I-GENE
Src I-GENE
), _RARE_
that O
was O
excluded O
from O
detergent O
- O
resistant O
membranes O
, O
could O
not O
restore _RARE_
the O
series O
of O
phagocytosis _RARE_
signaling _RARE_
. O

The O
delta I-GENE
srb10 _RARE_
mutation I-GENE
also O
influenced O
on O
the O
transcript O
levels O
of O
meiosis O
- O
inducing O
genes O
called O
IME1 I-GENE
and O
IME2 _RARE_
: O
the O
mutation O
elevated O
the O
transcript O
level O
of O
IME1 I-GENE
but O
reduced _RARE_
that O
of O
IME2 _RARE_
, O
resulting O
in O
partial O
defects O
in O
premeiotic _RARE_
DNA O
synthesis _RARE_
and O
meiosis O
. O

We O
also O
found O
that O
environmental O
conditions O
for _RARE_
meiosis O
finely _RARE_
regulate O
the O
transcript O
levels O
of O
KIN28 _RARE_
and O
CCL1 _RARE_
, O
such O
that O
nitrogen O
starvation O
first _RARE_
elevates _RARE_
them O
but O
subsequent O
alkalization _RARE_
of O
medium O
decreases O
them O
. O

The O
pJR _RARE_
vectors O
differ O
among O
them O
in O
: O
( O
a O
) O
the O
selectable O
marker O
( O
Saccharomyces O
cerevisiae O
LEU _RARE_
2 I-GENE
gene I-GENE
, O
which O
complements _RARE_
S I-GENE
. I-GENE
pombe I-GENE
leu1 _RARE_
- I-GENE
gene I-GENE
and O
S O
. O
pombe O
ura4 _RARE_
+ I-GENE
and O
his3 _RARE_
+ I-GENE
genes I-GENE
); O
( O
b O
) O
the O
thiamine _RARE_
- O
repressible _RARE_
nmt1 _RARE_
promoter I-GENE
( O
3X _RARE_
, O
41X _RARE_
and O
81X _RARE_
with O
extremely O
high O
, O
moderate O
or O
low O
transcription O
efficiency O
, O
respectively O
); O
and O
( O
c O
) O
the O
multiple O
cloning O
site O
( O
two O
multiple O
cloning O
sites O
, O
with O
12 O
restriction _RARE_
sites O
each O
). O

( O
GUT _RARE_
) O
Sera _RARE_
of O
30 _RARE_
montoux _RARE_
negative O
healthy O
adults O
( O
age O
/ O
sex _RARE_
matched O
) O
were O
taken O
as _RARE_
control O
by O
detecting O
IgG I-GENE
anti I-GENE
bodies _RARE_
to O
A60 _RARE_
antigen I-GENE
. O

The O
effect O
of O
acute O
, O
mid O
- O
cervical O
spinal _RARE_
cord O
lesions O
on O
neuronal _RARE_
and O
reflex O
activity O
evoked O
by O
the O
noxious _RARE_
visceral O
stimulus O
, O
colorectal _RARE_
distension _RARE_
( O
CRD _RARE_
; O
80 _RARE_
mmHg O
, O
20 O
s O
), _RARE_
was O
determined O
in O
halothane O
- O
anesthetized O
rats O
. O

Franz _RARE_
Schubert _RARE_
-- _RARE_
his _RARE_
life O
, O
music _RARE_
and O
diseases O

The O
results O
suggest O
that O
the O
role O
of O
S O
. O
argyrostoma _RARE_
in O
the O
dissemination _RARE_
of O
Trichinella _RARE_
larvae O
in O
nature O
is O
limited O
in O
comparison O
to O
the O
role O
played O
by O
mammals O
with O
scavenger _RARE_
and O
cannibalistic _RARE_
behavior O
. O

The O
equilibrium O
dissociation O
binding O
constant O
for _RARE_
the O
interaction O
of O
TnrA _RARE_
with O
the O
nrgAB _RARE_
promoter I-GENE
fragment I-GENE
was O
7 O
. O
7 O
nM O
under O
the O
conditions O
used O
here O
. O

These O
results O
demonstrate O
that O
N O
- O
glycans _RARE_
flanking O
the O
receptor O
- O
binding O
site O
of O
the O
HA _RARE_
molecule I-GENE
are O
potent O
regulators _RARE_
of O
influenza _RARE_
virus O
growth O
, O
with O
the O
glycan _RARE_
at _RARE_
Asn149 _RARE_
being O
dominant O
and O
that O
at _RARE_
Asn123 _RARE_
being O
less O
effective O
. O

RESULTS O
: O
The O
introduction O
of O
the O
PAIP _RARE_
resulted O
in O
a O
significant O
( O
p O
< O
0 _RARE_
. O
001 O
) O
reduction O
in O
contaminating _RARE_
WBCs _RARE_
( O
median O
, O
30 _RARE_
, O
000 _RARE_
) O
from O
the O
numbers O
seen O
with O
FIP _RARE_
( O
median O
, O
2 O
, O
300 _RARE_
, O
000 _RARE_
) O
while O
maintaining O
the O
separation O
efficacy O
( O
47 _RARE_
%) O
and O
separation O
time O
. O

All O
were O
tested O
for _RARE_
serum O
ferritin I-GENE
( O
SF _RARE_
), _RARE_
hemoglobin I-GENE
( O
Hb _RARE_
) O
level O
and O
asked _RARE_
for _RARE_
detailed O
histories _RARE_
of O
donations _RARE_
and O
iron O
supplementation O
. O

Vascular _RARE_
endothelial I-GENE
growth I-GENE
factor I-GENE
( O
VEGF I-GENE
), _RARE_
a O
potent O
agonist O
secreted _RARE_
by O
virtually O
all O
cells O
, O
controls O
migration O
and O
division O
of O
vascular O
endothelial O
cells O
. O

The O
antioxidant O
agent O
pyrrolidine _RARE_
dithiocarbamate _RARE_
( O
PDTC _RARE_
) O
has O
been O
shown O
to O
protect O
endothelial O
cells O
( O
EC O
) O
from O
pro O
- O
inflammatory O
- O
induced _RARE_
and O
pro O
- O
oxidant _RARE_
- O
induced _RARE_
NF _RARE_
- I-GENE
kappaB I-GENE
activation O
. O

We O
further O
studied O
the O
effects O
of O
SIE _RARE_
- I-GENE
1 I-GENE
hypermethylation _RARE_
on O
p21WAF1 _RARE_
induction O
by O
STAT I-GENE
activation O
. O

Phd _RARE_
antibody O
- O
immunoreactive _RARE_
peptides O
are O
seen O
in O
light O
- O
adapted O
mouse O
retinal _RARE_
cytosolic O
and O
nuclear O
extracts O
. O

In O
the O
pRb I-GENE
(-) _RARE_
SAOS _RARE_
- O
2 O
cell O
line O
transiently O
transfected O
with O
a O
reporter O
plasmid _RARE_
containing O
six _RARE_
tal I-GENE
- I-GENE
1 I-GENE
binding I-GENE
site I-GENE
, O
pRb I-GENE
enhances O
the O
transcriptional O
activity O
of O
tal I-GENE
- I-GENE
1 I-GENE
- O
E12 I-GENE
- O
Lmo2 _RARE_
and O
tal I-GENE
- I-GENE
1 I-GENE
- O
E12 I-GENE
- O
Lmo2 _RARE_
- O
Ldb1 _RARE_
complexes O
but O
not O
that O
of O
a O
tal I-GENE
- I-GENE
1 I-GENE
- O
E12 I-GENE
heterodimer _RARE_
. O

This O
effect O
was O
not O
seen O
in O
conjunction O
with O
oxycodone _RARE_
, O
a O
morphine _RARE_
- I-GENE
like I-GENE
mu I-GENE
- I-GENE
receptor I-GENE
agonist O
. O

In O
contrast O
to O
the O
morphological O
criteria O
, O
the O
few O
data O
available O
from O
recent O
studies O
at _RARE_
the O
genetic O
level O
have O
suggested O
that O
EPVs _RARE_
infecting _RARE_
different O
insect O
orders _RARE_
are O
phylogenetically _RARE_
distant O
. O

Neurofibromatosis _RARE_
of O
the O
breast O
in O
a O
patient O
with O
Morbus _RARE_
von _RARE_
Recklinghausen _RARE_

In O
the O
premating _RARE_
period O
male O
rate O
of O
aggression O
was O
not O
significantly O
correlated O
with O
testosterone O
level O
. O

These O
results O
support O
the O
hypothesis O
that O
in O
the O
presence O
of O
tryptophan _RARE_
the O
ribosome _RARE_
translating _RARE_
tnaC _RARE_
blocks O
Rho I-GENE
' O
s O
access O
to O
the O
boxA _RARE_
and O
rut _RARE_
sites I-GENE
, O
thereby O
preventing O
transcription O
termination _RARE_
. O

In O
situ O
hybridization O
with O
the O
antisense _RARE_
RNA O
probes _RARE_
further O
supported O
the O
expression _RARE_
changes O
of O
these O
six _RARE_
clones _RARE_
and O
localized O
the O
changes O
in O
multiple O
germ _RARE_
cell O
stages O
as _RARE_
well _RARE_
as _RARE_
other O
cell O
types _RARE_
( O
Sertoli _RARE_
, O
interstitial O
and O
peritubular _RARE_
cells O
). O

The O
administration O
of O
the O
GnRH I-GENE
agonist O
reduced _RARE_
the O
bone O
mineral O
density O
in O
the O
whole O
femur O
to O
91 O
. O
0 _RARE_
% O
of O
that O
in O
the O
control O
group O
. O

Prevention O
, O
differential O
diagnosis O
and O
therapy O
of O
travel _RARE_
diarrhea _RARE_

This O
study O
shows O
that O
C I-GENE
/ I-GENE
EBPbeta I-GENE
is O
the O
predominant O
C I-GENE
/ I-GENE
EBP I-GENE
isoform I-GENE
found O
in O
activated O
stellate _RARE_
cells O
and O
that O
increased O
C I-GENE
/ I-GENE
EBPbeta I-GENE
protein I-GENE
and O
C I-GENE
/ I-GENE
EBPbeta I-GENE
binding O
to O
a O
proximal O
C I-GENE
/ I-GENE
EBP I-GENE
binding I-GENE
site I-GENE
in O
the O
promoter O
mediates O
the O
activating O
effect O
of O
acetaldehyde _RARE_
. O

Mutation O
analysis O
demonstrates O
that O
the O
motif O
TCCCCT _RARE_
is O
critical O
for _RARE_
PyRo1 _RARE_
interaction O
. O

As O
with O
VP16 I-GENE
, O
the O
transactivation _RARE_
function O
of O
Luman _RARE_
is O
also O
regulated O
by O
HCF _RARE_
. O

After O
two O
successive O
rounds _RARE_
of O
selection O
by O
focus O
formation O
assay O
, O
a O
transforming O
ribozyme _RARE_
( O
Rz007 _RARE_
) O
was O
identified O
. O

G O
., O
and O
Hyde _RARE_
, O
C O
. O

Our O
results O
suggest O
that O
proteasome O
inhibition O
leads O
to O
upregulation _RARE_
of O
specific O
members O
of O
transcription O
factor O
families _RARE_
controlling O
cellular O
stress O
response O
and O
proliferation _RARE_
. O

The O
ATR _RARE_
- O
X O
syndrome _RARE_
results O
from O
mutations O
of O
the O
XH2 _RARE_
gene I-GENE
, O
located _RARE_
on O
the O
X O
chromosome _RARE_
( O
Xq13 _RARE_
. O
3 O
) O
and O
coding O
for _RARE_
a O
transacting _RARE_
factor O
which O
regulates O
gene O
expression _RARE_
. O

AIMS _RARE_
: O
To O
evaluate O
the O
role O
of O
environmental O
intra _RARE_
- O
uterine _RARE_
factors O
in O
determining _RARE_
the O
birthweights _RARE_
of O
twins _RARE_
with O
increased O
susceptibility _RARE_
to O
diabetes O
and O
discordant _RARE_
for _RARE_
abnormal O
responses O
to O
the O
oral O
glucose O
tolerance O
test O
( O
OGTT _RARE_
) O
and O
verify _RARE_
the O
possible O
association O
of O
within O
- O
pair _RARE_
birthweight _RARE_
differences O
and O
metabolic O
abnormalities O
in O
adult O
life O
. O

In O
NASCIS _RARE_
III O
, O
a O
randomization _RARE_
imbalance _RARE_
occurred O
that O
allocated O
a O
disproportionate _RARE_
number O
of O
patients O
with O
no _RARE_
motor O
deficit O
( O
and O
therefore O
no _RARE_
chance _RARE_
for _RARE_
recovery O
) O
to O
the O
lower O
dose O
control O
group O
. O

Penicillin _RARE_
acylase _RARE_
( O
PA I-GENE
) O
from O
Escherichia O
coli O
ATCC11105 _RARE_
is O
a O
periplasmic _RARE_
heterodimer _RARE_
consisting O
of O
a O
24 _RARE_
kDa O
small O
subunit O
and O
a O
65 O
kDa O
large O
subunit O
. O

A O
murine O
expressed _RARE_
sequence O
tag O
( O
EST _RARE_
) O
showing O
homology O
with O
erythropoietin I-GENE
receptor I-GENE
( O
EPOR _RARE_
) O
was O
identified O
in O
the O
EST _RARE_
database O
. O

When O
the O
LCx _RARE_
was O
partially O
occluded O
, O
mild O
PM _RARE_
- O
induced _RARE_
tachycardia O
resulted O
in O
decreased O
AoP _RARE_
( O
P O
= O
0 _RARE_
. O
045 _RARE_
) O
as _RARE_
well _RARE_
as _RARE_
in O
decreased O
SV O
( O
P O
= O
0 _RARE_
. O
048 _RARE_
); O
the O
LVEDP _RARE_
remained O
high O
( O
P O
= O
0 _RARE_
. O
002 _RARE_
). O

Activation O
of O
nuclear I-GENE
factor I-GENE
( I-GENE
NF _RARE_
)- I-GENE
kappaB I-GENE
and O
subsequent O
proinflammatory _RARE_
gene O
expression _RARE_
in O
human O
airway O
epithelial _RARE_
cells O
can O
be O
evoked O
by O
oxidative O
stress O
. O

GAP _RARE_
JUNCTIONS _RARE_
IN _RARE_
THE _RARE_
BRAIN _RARE_
: O
PREFACE _RARE_
. O

We O
have O
isolated O
and O
functionally O
characterized O
the O
mouse O
gene O
for _RARE_
the O
C2 O
subunit O
of O
the O
20S I-GENE
proteasome I-GENE
. O

Furthermore O
, O
as _RARE_
in O
the O
human O
gene O
, O
the O
3 O
' O
end O
of O
the O
Cacna1f _RARE_
gene I-GENE
maps O
within O
5 O
kb O
of O
the O
5 O
' O
end O
of O
the O
mouse I-GENE
synaptophysin _RARE_
gene I-GENE
in O
a O
region O
orthologous _RARE_
to O
Xp11 _RARE_
. O
23 _RARE_
. O

With O
the O
human I-GENE
Rhotekin _RARE_
cDNA I-GENE
as _RARE_
a O
probe O
, O
Northern O
hybridization O
revealed O
that O
a O
4 O
. O
0 _RARE_
- O
kb O
transcript O
was O
expressed _RARE_
at _RARE_
a O
high O
level O
in O
prostate _RARE_
and O
at _RARE_
a O
middle _RARE_
level O
in O
13 _RARE_
of O
16 O
tissues O
examined O
, O
but O
it O
cannot O
be O
detected O
in O
liver O
and O
lung _RARE_
tissues O
. O

Similarly O
, O
co _RARE_
- O
expression _RARE_
of O
a O
dominant O
- O
negative O
mutant O
of O
p38alpha _RARE_
, O
but O
not O
of O
ERK1 I-GENE
, O
ERK2 I-GENE
, O
JNK1 I-GENE
, O
or O
JNK2 _RARE_
, O
reduces O
basal O
and O
cadmium O
- O
induced _RARE_
pE1 _RARE_
- I-GENE
luc _RARE_
activity O
. O

BACKGROUND O
: O
Gamma _RARE_
knife _RARE_
radiosurgery _RARE_
( O
GKR _RARE_
) O
is O
a O
safe O
and O
effective O
alternative _RARE_
to O
surgery O
for _RARE_
intracranial _RARE_
lesions O
. O

In O
hemodialyzed _RARE_
patients O
( O
Epo I-GENE
and O
Non O
- O
Epo I-GENE
group O
) O
leptin I-GENE
levels O
were O
significantly O
higher _RARE_
when O
compared O
to O
CAPD _RARE_
patients O
( O
Epo I-GENE
and O
Non O
- O
Epo I-GENE
group O
, O
respectively O
). O

It O
is O
mainly O
transcribed _RARE_
in O
neural _RARE_
structures _RARE_
and O
in O
developing O
organs O
characterized O
by O
epithelial _RARE_
- O
mesenchymal O
interactions O
. O

CONCLUSION O
: O
The O
alpha2 _RARE_
- O
adrenergic O
antagonist O
idazoxan _RARE_
increases O
glucose O
- O
induced _RARE_
sympathetic O
activity O
but O
not O
energy O
expenditure O
in O
obese O
subjects O
. O

ID _RARE_
- O
PaGIA _RARE_
diphtheria _RARE_
toxin _RARE_
polymer _RARE_
particle _RARE_
diagnostic O
agent O
manufactured _RARE_
by O
DiaMed _RARE_
AG _RARE_
, O
Switzerland _RARE_
, O
was O
tried _RARE_
at _RARE_
bacteriological _RARE_
laboratory O
of O
Institute O
of O
Childhood _RARE_
Infections _RARE_
in O
St _RARE_
. O

Next _RARE_
, O
we O
show O
that O
two O
EMS _RARE_
- O
induced _RARE_
mutations O
, O
previously O
shown O
to O
interact O
genetically O
with O
zipper O
( O
Ebr _RARE_
), _RARE_
disrupt O
the O
RhoA I-GENE
locus I-GENE
. O

Therefore O
, O
the O
results O
indicate O
that O
repeated _RARE_
exposure O
to O
amphetamine O
or O
apomorphine _RARE_
overcomes _RARE_
the O
context O
- O
dependent O
component _RARE_
of O
sensitization O
of O
amphetamine O
- O
or O
apomorphine _RARE_
- O
induced _RARE_
stereotyped _RARE_
behavior O
. O

Testing _RARE_
for _RARE_
serum I-GENE
IgM I-GENE
binding O
to O
GM1 _RARE_
ganglioside _RARE_
in O
clinical O
practice O
. O

Objective _RARE_
responses O
also O
occurred O
in O
studies O
that O
explored O
sequential O
use O
of O
exemestane _RARE_
after O
failure O
of O
aminoglutethimide _RARE_
( O
26 _RARE_
% O
with O
exemestane _RARE_
200 _RARE_
mg O
/ O
day O
) O
or O
other O
nonsteroidal _RARE_
aromatase I-GENE
inhibitors _RARE_
( O
6 O
. O
6 O
% O
with O
exemestane _RARE_
25 _RARE_
mg O
/ O
day O
). O

Topics _RARE_
reviewed O
here O
include O
: O
data O
supporting O
the O
association O
of O
myositis O
with O
cancer _RARE_
and O
the O
appropriate O
evaluations _RARE_
for _RARE_
malignancy O
in O
a O
myositis O
patient O
; O
an O
approach O
to O
the O
assessment O
of O
patients O
with O
dermatomyositis _RARE_
sine _RARE_
myositis O
; O
the O
usefulness _RARE_
of O
the O
clinicopathological _RARE_
and O
serological O
classifications _RARE_
; O
a O
discussion O
of O
whether O
childhood O
and O
adult O
myositis O
are O
the O
same O
or O
different O
entities _RARE_
; O
a O
review O
of O
those O
prognostic O
factors O
to O
consider O
in O
the O
clinical O
management O
of O
myositis O
patients O
; O
current O
approaches O
and O
their O
limitations O
for _RARE_
assessing O
disease _RARE_
activity O
and O
damage O
. O

The O
science _RARE_
of O
tissue O
engineering _RARE_
. O

Endonuclease _RARE_
III I-GENE
( O
Nth _RARE_
) O
of O
Escherichia O
coli O
is O
a O
DNA I-GENE
glycosylase I-GENE
essential O
for _RARE_
the O
removal O
of O
oxidised _RARE_
pyrimidine O
base _RARE_
residues O
from O
DNA O
. O

The O
duration O
of O
reactive O
hyperemia _RARE_
decreased O
with O
aging O
, O
but O
the O
difference O
between O
males O
and O
females O
was O
not O
significant O
at _RARE_
any O
age O
. O

Acquired _RARE_
bile O
duct O
blockage _RARE_
: O
entry O
of O
hepatobiliary _RARE_
agent O
into O
an O
intrahepatic O
abscess O
. O

Furthermore O
, O
this O
study O
looks _RARE_
at _RARE_
the O
impact O
of O
synthesis _RARE_
conditions O
on O
block _RARE_
length O
and O
crystallinity _RARE_
, O
and O
the O
impact O
of O
the O
blocking O
on O
both O
, O
crystallinity _RARE_
and O
solubility _RARE_
of O
the O
polymers O
. O

However O
, O
little O
was O
understood O
about O
the O
normal O
function O
of O
CREB I-GENE
- I-GENE
2 I-GENE
in O
mammalian O
development O
or O
organ O
physiology O
. O

The O
outer _RARE_
diameter O
and O
the O
thickness O
of O
the O
rotor _RARE_
are O
60 _RARE_
mm O
and O
8 O
mm O
, O
respectively O
. O

Both O
the O
MVBF _RARE_
and O
the O
maximum O
EMG O
activity O
in O
the O
right O
masseter _RARE_
and O
the O
left _RARE_
anterior O
temporalis _RARE_
muscles O
were O
significantly O
decreased O
during _RARE_
muscle O
pain O
when O
the O
subjects O
bit _RARE_
on O
the O
painful _RARE_
side _RARE_
. O

CONCLUSIONS O
: O
There O
is O
a O
relation O
in O
the O
topography _RARE_
of O
some O
visual O
field O
areas O
assessed O
by O
SWAP _RARE_
and O
the O
inferotemporal _RARE_
neuroretinal _RARE_
rim _RARE_
area O
, O
which O
may O
play O
a O
role O
in O
the O
diagnosis O
and O
follow O
- O
up _RARE_
of O
suspected O
glaucoma O
. O

The O
total _RARE_
alkaloids _RARE_
contained O
in O
the O
peel _RARE_
of O
Atzimba _RARE_
, O
Lopez _RARE_
, O
Marciana _RARE_
, O
Montsama _RARE_
, O
Murca _RARE_
, O
and O
Puebla _RARE_
was O
lower O
than O
the O
limits O
recommended O
for _RARE_
food O
safety O
. O

The O
detection O
success O
rate O
was O
determined O
for _RARE_
different O
markers O
using O
this O
MEK I-GENE
. O

Herein _RARE_
, O
we O
show O
that O
Smad3 _RARE_
physically O
interacts O
with O
the O
HMG I-GENE
box O
domain O
of O
LEF1 _RARE_
and O
that O
TGFbeta _RARE_
and O
Wnt I-GENE
pathways O
synergize _RARE_
to O
activate O
transcription O
of O
the O
Xenopus O
homeobox _RARE_
gene O
twin _RARE_
( O
Xtwn _RARE_
). O

The O
transmembrane O
topology O
of O
Na _RARE_
(+)/ _RARE_
H O
(+) _RARE_
exchanger _RARE_
NHE3 _RARE_
has O
been O
studied O
using O
in O
vitro O
transcription O
/ O
translation O
of O
two O
types _RARE_
of O
fusion O
vectors O
designed O
to O
test O
membrane O
insertion _RARE_
properties O
of O
cDNA O
sequences O
encoding O
putative O
NHE3 _RARE_
membrane O
spanning O
domains O
( O
msds _RARE_
). O

ACE I-GENE
- I-GENE
2 I-GENE
has O
a O
hydrophobic O
C O
terminus O
of O
H O
type O
. O

Members O
of O
the O
titin _RARE_
/ O
myosin I-GENE
light I-GENE
chain I-GENE
kinase I-GENE
family O
play O
an O
essential O
role O
in O
the O
organization O
of O
the O
actin I-GENE
/ O
myosin I-GENE
cytoskeleton _RARE_
, O
especially O
in O
sarcomere _RARE_
assembly O
and O
function O
. O

We O
concluded O
that O
activation O
of O
c I-GENE
- I-GENE
fosER _RARE_
mediated _RARE_
transcriptional O
inhibition O
of O
p21 I-GENE
( O
Cip1 I-GENE
/ O
WAF1 I-GENE
) O
through O
a O
previously O
uncharacterized O
AP I-GENE
- I-GENE
1 I-GENE
site I-GENE
, O
revealing _RARE_
an O
important O
role O
for _RARE_
c I-GENE
- I-GENE
fos I-GENE
in O
negative O
control O
of O
cell O
cycle _RARE_
regulatory O
genes O
. O

Furthermore O
, O
a O
pTyr317 _RARE_
Shc I-GENE
phosphopeptide _RARE_
selectively O
recognized _RARE_
Grb2 I-GENE
, O
Sos1 _RARE_
, O
SHIP _RARE_
, O
and O
the O
p85 I-GENE
subunit I-GENE
of O
phosphatidylinositol _RARE_
3 I-GENE
' I-GENE
kinase I-GENE
from O
mast _RARE_
cells O
, O
as _RARE_
characterized O
by O
mass O
spectrometry O
. O

Although O
increased O
expression _RARE_
of O
the O
HMG I-GENE
- I-GENE
I I-GENE
/ I-GENE
Y I-GENE
proteins I-GENE
is O
associated O
with O
cellular O
proliferation _RARE_
, O
neoplastic O
transformation O
, O
and O
several O
human O
cancers O
, O
the O
role O
of O
these O
proteins O
in O
the O
pathogenesis O
of O
malignancy O
remains O
unclear O
. O

The O
naltrexone O
/ O
lofexidine _RARE_
combination O
was O
associated O
with O
a O
more O
rapid O
resolution O
of O
the O
opiate _RARE_
withdrawal O
syndrome _RARE_
than O
a O
7 O
- O
day O
lofexidine _RARE_
- O
only O
treatment O
schedule O
, O
without O
substantial O
increases O
in O
withdrawal O
symptoms O
or O
hypotensive O
side _RARE_
- O
effects O
. O

The O
first _RARE_
symptoms O
of O
enzootic _RARE_
calcinosis _RARE_
were O
noted O
in O
March _RARE_
1998 O
, O
when O
some O
of O
the O
cows O
developed O
locomotor O
abnormalities O
. O

Screening _RARE_
, O
counseling _RARE_
, O
and O
treatment O
for _RARE_
alcohol _RARE_
and O
illicit _RARE_
drug O
use O
should O
be O
essential O
components _RARE_
in O
comprehensive _RARE_
HBP _RARE_
care O
. O

Transcriptional O
regulation _RARE_
of O
the O
mouse I-GENE
cytosolic I-GENE
chaperonin _RARE_
subunit I-GENE
gene I-GENE
Ccta _RARE_
/ I-GENE
t I-GENE
- I-GENE
complex I-GENE
polypeptide I-GENE
1 I-GENE
by O
selenocysteine _RARE_
tRNA I-GENE
gene I-GENE
transcription I-GENE
activating I-GENE
factor I-GENE
family I-GENE
zinc I-GENE
finger I-GENE
proteins I-GENE
. O

The O
unfolded _RARE_
protein O
response O
regulates O
multiple O
aspects O
of O
secretory _RARE_
and O
membrane O
protein O
biogenesis O
and O
endoplasmic O
reticulum O
quality O
control O
. O

PNRC _RARE_
: O
a O
proline O
- O
rich O
nuclear O
receptor O
coregulatory _RARE_
protein O
that O
modulates _RARE_
transcriptional O
activation O
of O
multiple O
nuclear O
receptors O
including O
orphan O
receptors O
SF1 _RARE_
( O
steroidogenic _RARE_
factor I-GENE
1 I-GENE
) O
and O
ERRalpha1 _RARE_
( O
estrogen I-GENE
related I-GENE
receptor I-GENE
alpha I-GENE
- I-GENE
1 I-GENE
). O

Studies O
using O
a O
reporter O
plasmid _RARE_
with O
a O
functionally O
disrupted O
sterol O
- O
responsive O
element O
( O
SRE O
)- O
1 O
revealed O
a O
reduced _RARE_
stimulatory _RARE_
response O
to O
IL _RARE_
- I-GENE
6 I-GENE
. O

However O
, O
there O
is O
still O
a O
subset O
of O
tumors O
that O
displayed O
no _RARE_
changes O
in O
these O
genes O
. O

We O
have O
shown O
that O
the O
epidural _RARE_
( O
EPI _RARE_
) O
delivery O
of O
morphine _RARE_
encapsulated _RARE_
in O
multivesicular _RARE_
liposomes O
( O
DepoFoam _RARE_
drug O
delivery O
system _RARE_
) O
produces O
a O
sustained O
clearance O
of O
morphine _RARE_
and O
a O
prolonged O
analgesia O
. O

Following O
EPI _RARE_
- O
C0401 _RARE_
, O
but O
not O
saline O
or O
DepoFoam _RARE_
vehicle O
, O
there O
were O
transient O
(< O
72 O
hr O
) O
decreases O
in O
food O
consumption O
, O
arousal _RARE_
, O
hindlimb _RARE_
muscle O
tone O
, O
and O
body O
temperature _RARE_
. O

Bailey _RARE_
Instruments _RARE_
and O
Owen _RARE_
Mumford _RARE_
filaments _RARE_
were O
the O
most O
accurate O
with O
100 _RARE_
% O
buckling _RARE_
within O
+/- O
1 O
. O
0 _RARE_
g O
of O
10 O
g O
. O

PARTICIPANTS _RARE_
: O
Convenience _RARE_
sample O
of O
ambulatory O
outpatients _RARE_
with O
hereditary _RARE_
motor O
and O
sensory O
neuropathy _RARE_
, O
type O
I O
( O
n _RARE_
= O
9 O
), _RARE_
myotonic _RARE_
muscular O
dystrophy _RARE_
( O
n _RARE_
= O
10 O
), _RARE_
and O
able O
- O
bodied _RARE_
controls O
( O
n _RARE_
= O
11 O
). O

The O
effect O
of O
water O
deprivation O
for _RARE_
19 O
h O
on O
renal _RARE_
Na _RARE_
excretion O
of O
conscious O
adrenalectomized _RARE_
( O
ADX _RARE_
) O
sheep O
maintained O
on O
a O
constant O
intravenous O
infusion O
of O
aldosterone O
and O
cortisol O
( O
ADX _RARE_
- O
constant O
steroid O
sheep O
) O
was O
investigated O
. O

Neither O
is O
it O
a O
major O
cause O
of O
rehydration _RARE_
- O
induced _RARE_
renal _RARE_
Na _RARE_
retention O
. O

CONCLUSION O
: O
Rheumatic _RARE_
fever O
in O
the O
Nazareth _RARE_
area O
is O
still O
manifest O
. O

Antithrombin _RARE_
III I-GENE
deficiency O
: O
when O
substitute O
, O
when O
heparin _RARE_
? O
Thrombosis _RARE_
ABC _RARE_
, O
3 O
: O
The O
role O
of O
antithrombin I-GENE
III I-GENE

Specific O
class I-GENE
I I-GENE
and I-GENE
II I-GENE
histone I-GENE
deacetylases _RARE_
( O
HDACs _RARE_
) O
interact O
in O
vivo O
with O
BCoR _RARE_
, O
suggesting O
that O
BCoR _RARE_
may O
functionally O
link _RARE_
these O
two O
classes O
of O
HDACs _RARE_
. O

This O
is O
the O
first _RARE_
example O
of O
a O
eukaryotic O
transcription O
factor O
complex O
containing O
both O
a O
MADS I-GENE
- I-GENE
box I-GENE
and O
a O
forkhead _RARE_
protein I-GENE
, O
and O
it O
has O
important O
implications O
for _RARE_
the O
regulation _RARE_
of O
mammalian O
gene O
expression _RARE_
. O

After O
screening O
the O
Berkeley _RARE_
Drosophila O
Genome _RARE_
Project _RARE_
database O
with O
sequences O
from O
a O
recently O
characterized O
Leu _RARE_
- I-GENE
rich I-GENE
repeats I-GENE
- I-GENE
containing I-GENE
G I-GENE
protein I-GENE
- I-GENE
coupled I-GENE
receptor I-GENE
( O
LGR _RARE_
) O
from O
Drosophila O
( O
DLGR _RARE_
- I-GENE
1 I-GENE
), _RARE_
we O
identified O
a O
second O
gene O
for _RARE_
a O
different O
LGR _RARE_
( O
DLGR _RARE_
- I-GENE
2 I-GENE
) O
and O
cloned _RARE_
its O
cDNA O
. O

Degenerate _RARE_
primers O
homologous O
to O
highly O
conserved _RARE_
regions O
of O
known O
CYP3A _RARE_
sequences I-GENE
were O
used O
for _RARE_
initial O
RT O
- O
PCRs _RARE_
. O

When O
cells O
were O
microinjected _RARE_
with O
TFOs _RARE_
designed O
to O
bind O
to O
a O
30 _RARE_
- O
bp O
polypurine _RARE_
site O
situated O
between O
the O
two O
TK I-GENE
genes I-GENE
, O
recombination _RARE_
was O
observed O
at _RARE_
frequencies O
in O
the O
range O
of O
1 O
%, O
2 O
, O
500 O
- O
fold _RARE_
above O
the O
background O
. O

Methyllevamisole _RARE_
was O
used O
as _RARE_
the O
internal O
standard O
. O

Resistance O
ratios O
for _RARE_
the O
other O
field O
strains O
obtained O
by O
comparison O
with O
the O
R5 _RARE_
strain _RARE_
ranged O
from O
24 _RARE_
. O
5 O
to O
239 O
for _RARE_
topical _RARE_
application O
and O
from O
1 O
. O
2 O
to O
9 O
. O
8 O
for _RARE_
the O
glass O
jar _RARE_
method O
. O

Only O
transcripts O
specific O
for _RARE_
TSGF _RARE_
- I-GENE
2 I-GENE
are O
detected O
in O
ovary O
and O
testes O
tissues O
of O
adults O
as _RARE_
well _RARE_
as _RARE_
in O
puparia _RARE_
, O
while O
neither O
gene O
is O
expressed _RARE_
during _RARE_
the O
larval _RARE_
developmental O
stages O
. O

In O
a O
gel O
retardation O
assay O
using O
HepG2 _RARE_
nuclear O
extracts O
, O
the O
5 O
' O
flanking O
sequence O
from O
- O
74 _RARE_
to O
- O
46 _RARE_
showed O
a O
shifted O
band O
. O

Reliability _RARE_
of O
cervical O
range O
of O
motion O
using O
the O
OSI _RARE_
CA O
6000 _RARE_
spine O
motion O
analyser _RARE_
on O
asymptomatic O
and O
symptomatic O
subjects O
. O

Coimmunoprecipitation _RARE_
experiments O
performed O
in O
transfected O
cells O
showed O
that O
BCMA _RARE_
associates O
with O
TNFR _RARE_
- I-GENE
associated I-GENE
factor I-GENE
( I-GENE
TRAF _RARE_
) I-GENE
1 I-GENE
, O
TRAF2 I-GENE
, O
and O
TRAF3 _RARE_
adaptor _RARE_
proteins I-GENE
. O

Since O
the O
RINX _RARE_
gene I-GENE
is O
likely O
an O
ortholog _RARE_
of O
the O
goldfish _RARE_
Vsx1 _RARE_
gene I-GENE
, O
it O
has O
been O
named O
VSX1 _RARE_
by O
the O
Human O
Gene _RARE_
Nomenclature _RARE_
Committee O
. O

The O
chromosomal O
localization _RARE_
on O
distal O
chromosome _RARE_
7 O
places _RARE_
it O
in O
a O
cluster O
of O
imprinted O
genes O
, O
flanked O
by O
the O
previously O
described O
Tapa1 _RARE_
and O
Kcnq1 _RARE_
genes I-GENE
. O

Activation O
of O
PKA I-GENE
by O
8 O
- O
bromo _RARE_
- O
cyclic O
AMP O
or O
forskolin O
, O
and O
inhibition O
of O
PKC I-GENE
by O
calphostin _RARE_
C O
, O
resulted O
in O
a O
significant O
decrease O
in O
3TP _RARE_
activity O
as _RARE_
well _RARE_
as _RARE_
in O
vitro O
ERK I-GENE
kinase I-GENE
activity O
in O
CRAC _RARE_
. O

The O
present O
study O
was O
designed O
to O
evaluate O
the O
sensitivity O
and O
specificity _RARE_
of O
AMP O
CT _RARE_
( O
Gen _RARE_
- O
Probe _RARE_
Incorporated _RARE_
, O
San _RARE_
Diego _RARE_
, O
CA O
, O
USA _RARE_
) O
on O
urogenital _RARE_
specimens O
taken O
from O
symptomatic O
patients O
and O
on O
first _RARE_
void _RARE_
urine O
( O
FVU _RARE_
) O
specimens O
from O
asymptomatic O
patients O
. O

Mus81p _RARE_
also O
shares O
homology O
with O
motifs O
found O
in O
the O
XPF _RARE_
endonuclease I-GENE
superfamily I-GENE
. O

Double O
mutant O
analysis O
suggests O
that O
Rad54p _RARE_
and O
Mus81p _RARE_
act O
in O
one O
pathway _RARE_
for _RARE_
the O
repair O
of O
, O
or O
tolerance O
to O
, O
UV _RARE_
- O
induced _RARE_
DNA O
damage O
. O

The O
linear _RARE_
plasmid _RARE_
pCLU1 _RARE_
from O
the O
yeast O
Kluyveromyces _RARE_
lactis O
normally O
replicates _RARE_
in O
the O
cytoplasm O
, O
with O
the O
aid O
of O
the O
helper _RARE_
linear _RARE_
plasmid _RARE_
pGKL2 _RARE_
, O
using O
terminal I-GENE
protein I-GENE
( O
TP _RARE_
) O
as _RARE_
a O
primer O
. O

The O
repetitive _RARE_
ETn _RARE_
( O
early I-GENE
transposon _RARE_
) O
family O
of O
sequences O
represents O
an O
active _RARE_
" O
mobile O
mutagen _RARE_
" O
in O
the O
mouse O
genome O
. O

The O
two O
main O
experimental O
variables O
were O
the O
attended _RARE_
hemifield _RARE_
( O
left _RARE_
or O
right O
) O
and O
the O
proportion O
of O
trials O
requiring O
a O
shift O
within O
that O
hemifield _RARE_
( O
20 O
% O
or O
80 _RARE_
%). O

The O
measurement O
of O
NO _RARE_
in O
biological O
systems _RARE_
using O
chemiluminescence _RARE_
. O

Biochemical O
examinations O
of O
calcium _RARE_
- O
phosphorus O
metabolism O
included O
ions O
and O
PTH _RARE_
concentrations O
in O
blood _RARE_
serum O
, O
and O
the O
activity O
of O
bone O
isoenzyme _RARE_
of O
AP I-GENE
. O

Atorvastatin _RARE_
was O
the O
most O
cost O
- O
effective O
HMG I-GENE
- I-GENE
CoA I-GENE
reductase I-GENE
inhibitor O
. O

Pharmacoeconomic _RARE_
assessment O
of O
HMG I-GENE
- I-GENE
CoA I-GENE
reductase I-GENE
inhibitor O
therapy O
: O
an O
analysis O
based O
on O
the O
CURVES _RARE_
study O
. O

Interestingly O
, O
although O
E O
domains O
of O
these O
two O
receptors O
are O
much O
less O
conserved _RARE_
, O
replacement _RARE_
of O
this O
domain O
in O
rtER _RARE_
by O
its O
human O
counterpart _RARE_
resulted O
in O
higher _RARE_
estradiol O
sensitivity O
but O
no _RARE_
increase O
in O
the O
magnitude O
of O
transactivation _RARE_
. O

G O
- O
DNA O
is O
a O
four O
- O
stranded _RARE_
DNA O
structure _RARE_
with O
diverse O
putative O
biological O
roles O
. O

The O
effectiveness O
of O
NRT _RARE_
appears O
to O
be O
largely O
independent O
of O
the O
intensity O
of O
additional O
support O
provided O
to O
the O
smoker _RARE_
. O

SELECTION _RARE_
CRITERIA _RARE_
: O
All O
controlled _RARE_
trials O
where O
adults O
with O
schizophrenia O
or O
similar O
illnesses _RARE_
were O
randomised O
to O
quetiapine _RARE_
, O
placebo O
or O
other O
neuroleptic O
drugs O
and O
where O
clinically O
relevant O
outcomes O
were O
reported O
. O

8 O
% O
( O
95 _RARE_
% O
CI _RARE_
, O
21 O
. O
3 O
- O
44 _RARE_
. O
3 O
%). O

In O
contrast O
, O
the O
action O
of O
GLP _RARE_
- I-GENE
1 I-GENE
at _RARE_
the O
CRE _RARE_
was O
not O
blocked O
by O
cotransfection O
with O
M1 _RARE_
- I-GENE
CREB I-GENE
, O
an O
isoform O
that O
lacks O
a O
consensus O
serine O
residue _RARE_
serving _RARE_
as _RARE_
substrate O
for _RARE_
PKA I-GENE
- O
mediated _RARE_
phosphorylation _RARE_
. O

Because O
all O
PDGFbetaR _RARE_
fusions I-GENE
described O
thus O
far O
result O
in O
splicing _RARE_
to O
a O
common O
exon _RARE_
of O
this O
gene O
, O
we O
performed O
5 O
'- O
rapid O
amplification O
of O
cDNA O
ends O
PCR O
on O
patient O
RNA O
. O

CONCLUSIONS O
: O
In O
essential O
hypertension O
an O
acute O
protein O
load O
induces O
a O
decrease O
in O
GFR O
that O
may O
normalize _RARE_
under O
antihypertensive O
treatment O
. O

This O
finding O
suggested O
that O
the O
PI3K _RARE_
- O
Akt I-GENE
activation O
pathway _RARE_
plays O
some O
role O
in O
the O
antiapoptotic _RARE_
effect O
of O
EPO I-GENE
. O

Nine _RARE_
DNA O
fragments O
that O
were O
specifically O
recognized _RARE_
and O
bound _RARE_
by O
histidine _RARE_
- O
tagged _RARE_
AdpA _RARE_
were O
isolated O
by O
cycles O
of O
a O
gel O
mobility O
shift O
- O
PCR O
method O
. O

To O
determine O
whether O
the O
NTP _RARE_
- O
binding O
motif O
is O
important O
for _RARE_
Rad24 _RARE_
function O
, O
we O
mutated _RARE_
the O
conserved _RARE_
lysine _RARE_
( O
115 _RARE_
) O
residue _RARE_
in O
this O
motif O
. O

The O
carboxyl _RARE_
- O
terminal O
proline O
- O
rich O
domain O
of O
SOS1 _RARE_
is O
involved O
in O
the O
interaction O
with O
the O
PLC I-GENE
- I-GENE
gamma1 _RARE_
SH3 I-GENE
domain I-GENE
. O

From O
transient O
expression _RARE_
studies O
, O
we O
could O
demonstrate O
that O
the O
SH3 I-GENE
domain I-GENE
of O
PLC I-GENE
- I-GENE
gamma1 _RARE_
is O
necessary O
for _RARE_
the O
association O
with O
SOS1 _RARE_
in O
vivo O
. O

Six O
distinct O
Ets I-GENE
mRNAs I-GENE
were O
identified O
: O
Ets2 _RARE_
, O
Fli1 _RARE_
, O
GABPalpha _RARE_
, O
SAP1 _RARE_
, O
Elk1 _RARE_
, O
and O
PE1 _RARE_
. O

A O
2 O
kb O
transcript O
was O
isolated O
from O
brain O
that O
encodes O
a O
approximately _RARE_
57 O
kDa O
protein O
; O
the O
predicted O
protein O
contains O
the O
known O
N I-GENE
- I-GENE
terminal I-GENE
Ets I-GENE
domain I-GENE
of O
PE1 _RARE_
and O
a O
novel O
C O
- O
terminal O
domain O
with O
signficant _RARE_
homology O
to O
murine I-GENE
ERF _RARE_
. O

Twenty O
eligible _RARE_
patients O
with O
cirrhosis O
were O
randomized O
into O
two O
groups O
: O
10 O
patients O
treated O
with O
6 O
million O
units _RARE_
of O
natural _RARE_
IFN I-GENE
- I-GENE
beta I-GENE
twice O
a O
week O
for _RARE_
36 _RARE_
months O
and O
10 O
patients O
without O
IFN I-GENE
therapy O
. O

Wnt I-GENE
- I-GENE
1 I-GENE
overexpression O
in O
mammary O
epithelial _RARE_
cells O
induced _RARE_
cyclin _RARE_
D1 _RARE_
mRNA I-GENE
and O
targeted O
overexpression O
of O
Wnt I-GENE
- I-GENE
1 I-GENE
in O
the O
mammary O
gland _RARE_
of O
transgenic O
mice O
increased O
both O
ILK I-GENE
activity O
and O
cyclin _RARE_
D1 _RARE_
levels O
. O

Intravenous O
versus O
oral O
administration O
of O
amitriptyline _RARE_
in O
patients O
with O
major O
depression O
. O

Deletion O
of O
the O
RVH _RARE_
domain I-GENE
resulted O
in O
loss _RARE_
of O
Ca O
( O
2 O
+)- _RARE_
dependent O
activation O
. O

Logistic _RARE_
regression O
analysis O
revealed O
that O
physicians O
were O
3 O
. O
6 O
times O
more O
likely O
to O
detect O
thin O
lesions O
(</= _RARE_
0 _RARE_
. O
75 _RARE_
mm O
) O
compared O
with O
nonphysician _RARE_
detectors _RARE_
( O
95 _RARE_
% O
confidence O
interval O
[ _RARE_
95 _RARE_
% O
CI _RARE_
], O
2 O
. O
1 O
, O
6 O
. O
5 O
; O
P O
= O
0 _RARE_
. O
0001 O
). O

Erythema _RARE_
exsudativum _RARE_
multiforme _RARE_
induced _RARE_
by O
granulocyte _RARE_
colony I-GENE
- I-GENE
stimulating I-GENE
factor I-GENE
in O
an O
allogeneic _RARE_
peripheral O
blood _RARE_
stem _RARE_
cell O
donor O
. O

VaI _RARE_
and O
VaII _RARE_
co _RARE_
- O
immunoprecipitated O
with O
ErbB2 _RARE_
, O
but O
not O
with O
ErbB1 _RARE_
, O
ErbB3 _RARE_
, O
or O
ErbB4 _RARE_
. O

While O
interactions O
of O
WT _RARE_
and O
variant O
TGF I-GENE
- I-GENE
alpha I-GENE
with O
the O
ErbBs _RARE_
all O
result O
in O
ErbB2 _RARE_
activation O
, O
they O
produce O
different O
biological O
consequences O
, O
suggesting O
that O
the O
various O
TGF I-GENE
- I-GENE
alpha I-GENE
precursors _RARE_
differentially O
modulate O
ErbB I-GENE
signaling _RARE_
. O

It O
is O
now O
well _RARE_
accepted O
that O
the O
p53 I-GENE
C I-GENE
- I-GENE
terminus I-GENE
plays O
a O
central O
role O
in O
controlling O
the O
activity O
of O
the O
wild O
- O
type O
molecule O
. O

In O
contrast O
to O
full I-GENE
- I-GENE
length I-GENE
E2F I-GENE
- I-GENE
3 I-GENE
, O
which O
is O
expressed _RARE_
only O
at _RARE_
the O
G1 O
/ O
S O
boundary O
, O
E2F I-GENE
- I-GENE
3B _RARE_
is O
detected O
throughout O
the O
cell O
cycle _RARE_
with O
peak O
levels O
in O
GO _RARE_
where O
it O
is O
associated O
with O
Rb _RARE_
. O

The O
transcription O
factor O
Jun I-GENE
( O
c I-GENE
- I-GENE
Jun I-GENE
) O
functions O
as _RARE_
a O
recipient O
of O
extracellular O
growth O
signals O
and O
converts _RARE_
them O
into O
patterns O
of O
gene O
expression _RARE_
. O

Developmental _RARE_
toxicity O
of O
the O
class O
III O
antiarrhythmic O
agent O
almokalant _RARE_
in O
mice O
. O

This O
compound O
is O
the O
main O
bioactive _RARE_
metabolite O
of O
trimebutine _RARE_
II O
( O
Debridat _RARE_
, O
CAS _RARE_
39133 _RARE_
- O
31 _RARE_
- O
8 O
), _RARE_
an O
antispasmodic _RARE_
widely O
used O
for _RARE_
intestinal _RARE_
diseases O
since O
1969 _RARE_
. O

In O
addition O
to O
its O
effect O
in O
augmenting _RARE_
the O
neutrophil _RARE_
response O
to O
eccentric _RARE_
exercise O
, O
vitamin O
E O
causes O
a O
greater O
increase O
in O
circulating O
creatine _RARE_
kinase I-GENE
activity O
, O
perhaps O
indicating O
increased O
skeletal O
muscle O
repair O
. O

This O
enabled _RARE_
the O
formation O
of O
stem _RARE_
- O
loop O
templates O
with O
the O
fusion O
point O
of O
the O
chimeric O
transcript O
in O
the O
loop O
and O
the O
use O
of O
MLL _RARE_
primers O
in O
two O
- O
sided _RARE_
PCR O
. O

CONCLUSION O
: O
The O
authors O
emphasize _RARE_
that O
the O
initial O
management O
of O
primary _RARE_
STS _RARE_
should O
be O
adequate O
and O
suggest O
that O
safty _RARE_
margin O
of O
> O
or O
= O
2 O
cm O
should O
be O
adhered _RARE_
to O
. O

Measurements O
were O
compared O
with O
two O
computerised _RARE_
treatment O
planning O
systems _RARE_
-- _RARE_
Theraplan _RARE_
VO5B _RARE_
and O
ADAC _RARE_
Pinnacle3 _RARE_
V4 _RARE_
. O
0b _RARE_
. O

Activation O
was O
biphasic O
; O
peaking _RARE_
at _RARE_
5 O
- O
10 O
min O
and O
24 _RARE_
h O
after O
treatment O
. O

Whereas O
MARTA1 _RARE_
is O
clearly O
detectable O
in O
crude O
lysates O
, O
cytosolic O
and O
ribosomal O
salt O
- O
wash _RARE_
fractions O
, O
and O
in O
nuclear O
extracts O
, O
MARTA2 _RARE_
is O
preferentially O
found O
in O
the O
ribosomal O
salt O
- O
wash _RARE_
preparation O
. O

It O
contains O
25 _RARE_
exons O
coding O
for _RARE_
a O
4 O
. O
7kb _RARE_
transcript O
including O
large O
5 O
'- O
and O
3 O
'- O
( O
1218bp _RARE_
and O
701bp _RARE_
, O
respectively O
) O
untranslated _RARE_
regions O
( O
UTRs _RARE_
). O

Five O
of O
the O
PDP1 _RARE_
isoforms I-GENE
differ O
by O
the O
substitution O
or O
insertion _RARE_
of O
amino O
acids _RARE_
at _RARE_
or O
near O
the O
N O
- O
terminal O
of O
the O
protein O
. O

The O
optimum _RARE_
technique O
for _RARE_
the O
pathological O
examination O
of O
sentinel _RARE_
lymph O
nodes O
( O
SLNs _RARE_
) O
is O
still O
under O
debate _RARE_
. O

Partial O
correction O
of O
anemia _RARE_
with O
recombinant I-GENE
human I-GENE
erythropoietin I-GENE
likely O
reduces O
left _RARE_
ventricular O
mass O
and O
volume O
. O

This O
study O
demonstrated O
that O
the O
PFA _RARE_
- O
100 _RARE_
analyzer _RARE_
can O
accurately O
assess O
vWF I-GENE
- O
dependent O
platelet O
function O
and O
detect O
other O
platelet O
defects O
under O
high O
shear O
stress O
in O
complex O
patient O
populations O
. O

We O
recently O
reported O
the O
molecular _RARE_
cloning O
of O
a O
PL _RARE_
scramblase _RARE_
of O
human O
( O
HuPLSCR1 _RARE_
) O
and O
mouse O
origin O
, O
respectively O
. O

To O
analyze O
the O
regulatory O
activity O
of O
Gtx _RARE_
, O
we O
first _RARE_
identified O
the O
optimal O
Gtx _RARE_
- I-GENE
binding I-GENE
sequence I-GENE
using O
an O
in O
vitro O
DNA O
- O
binding O
assay O
. O

Using O
an O
oligomer _RARE_
duplex O
5 O
'- O
A O
( O
GGGTTA _RARE_
)( O
5 O
)- O
3 O
'/ _RARE_
5 O
'-( _RARE_
TAACCC _RARE_
)( O
5 O
) O
T O
- O
3 O
' O
as _RARE_
a O
template O
- O
primer O
, O
we O
show O
that O
both O
the O
Klenow _RARE_
fragment I-GENE
of I-GENE
Escherichia I-GENE
coli I-GENE
DNA I-GENE
polymerase I-GENE
I I-GENE
and O
HIV I-GENE
reverse I-GENE
transcriptase I-GENE
could O
expand _RARE_
telomere _RARE_
DNA O
sequences O
as _RARE_
well _RARE_
, O
giving O
products O
greater O
than O
the O
size O
of O
the O
template O
DNA O
. O

Cdk2 I-GENE
and O
MAPK _RARE_
precipitates _RARE_
from O
untreated O
tumor O
lysates O
phosphorylated _RARE_
recombinant I-GENE
wild I-GENE
- I-GENE
type I-GENE
p27 I-GENE
but O
not O
the O
T187A _RARE_
mutant O
in O
vitro O
. O

The O
loss _RARE_
of O
avirulence _RARE_
activity O
because O
of O
mutations O
in O
the O
acidic _RARE_
transcriptional O
activation O
domain O
was O
restored O
by O
addition O
of O
the O
activation O
domain O
from O
the O
herpes I-GENE
simplex I-GENE
viral I-GENE
protein I-GENE
VP16 I-GENE
. O

Mutations O
in O
the O
RP2 _RARE_
locus I-GENE
at _RARE_
Xp11 _RARE_
. I-GENE
3 I-GENE
were O
found O
in O
a O
further O
10 O
- O
20 O
% O
of O
XLRP _RARE_
patients O
, O
as _RARE_
predicted O
from O
linkage O
studies O
. O

The O
limit O
between O
the O
cecum _RARE_
and O
the O
ascending O
colon O
was O
externally _RARE_
marked O
by O
the O
sulcus _RARE_
cecocolicus _RARE_
dorsalis _RARE_
and O
ventralis _RARE_
. O

Subsequently _RARE_
, O
HD O
inhibited O
healing O
because O
it O
significantly O
delayed O
epithelialization _RARE_
and O
caused O
protracted _RARE_
inflammation O
. O

The O
effectiveness O
of O
the O
haemodialysate _RARE_
Solcoseryl _RARE_
for _RARE_
second O
- O
intention _RARE_
wound O
healing O
in O
horses O
and O
ponies _RARE_
. O

Although O
there O
is O
little O
evidence O
that O
diet O
composition O
plays O
a O
clinically O
important O
role O
in O
the O
absorption O
or O
expenditure O
of O
energy O
, O
it O
does O
appear O
to O
play O
a O
role O
in O
food O
intake O
. O

These O
findings O
were O
reinforced O
by O
an O
analysis O
that O
was O
restricted O
to O
living O
donor O
transplants _RARE_
without O
acute O
rejection O
. O

These O
results O
further O
support O
an O
important O
role O
for _RARE_
CBF2 I-GENE
in O
mediating O
EBNA2 I-GENE
transactivation _RARE_
; O
they O
identify O
the O
hnRNP _RARE_
protein I-GENE
AUF1 _RARE_
as _RARE_
a O
major O
component _RARE_
of O
CBF2 I-GENE
and O
are O
also O
the O
first _RARE_
evidence O
of O
a O
cis O
- O
acting O
sequence O
other O
than O
a O
CBF1 I-GENE
binding I-GENE
element I-GENE
that O
is O
able O
to O
confer O
responsiveness O
to O
EBNA2 I-GENE
. O

The O
genome O
of O
the O
human O
herpesvirus _RARE_
8 O
( O
HHV _RARE_
- O
8 O
) O
contains O
a O
cluster O
of O
open _RARE_
reading O
frames O
( O
ORFs _RARE_
) O
encoding O
proteins O
with O
homology O
to O
the O
cellular O
transcription O
factors O
of O
the O
interferon _RARE_
regulatory I-GENE
factor I-GENE
( O
IRF I-GENE
) O
family O
. O

Despite O
these O
limitations O
the O
CHIME _RARE_
monitor O
provides O
an O
opportunity _RARE_
to O
record O
physiological O
data O
previously O
unavailable _RARE_
in O
the O
home O
. O

DATA _RARE_
SYNTHESIS _RARE_
: O
Intracoronary _RARE_
ultrasound O
has O
been O
shown O
to O
improve O
upon O
demonstrated O
weaknesses _RARE_
of O
coronary O
angiography O
. O

TB _RARE_
bone O
area O
( O
p O
< O
0 _RARE_
. O
001 O
), _RARE_
height O
( O
p O
< O
0 _RARE_
. O
01 O
), _RARE_
years O
in O
present O
colony O
( O
p O
= O
0 _RARE_
. O
03 O
), _RARE_
and O
menses _RARE_
( O
p O
< O
0 _RARE_
. O
01 O
) O
predicted O
TB _RARE_
BMC _RARE_
. O

CREST _RARE_
syndrome _RARE_
; O
a O
changing O
clinical O
significance O

Troglitazone _RARE_
also O
induced _RARE_
an O
endogenous I-GENE
PPARgamma I-GENE
target I-GENE
gene I-GENE
in O
T24 _RARE_
cells O
, O
adipocyte _RARE_
- I-GENE
type I-GENE
fatty I-GENE
acid I-GENE
binding I-GENE
protein I-GENE
( O
A I-GENE
- I-GENE
FABP _RARE_
), _RARE_
the O
expression _RARE_
of O
which O
correlates O
with O
bladder O
cancer _RARE_
differentiation O
. O

Viruses _RARE_
were O
isolated O
from O
9 O
lungs O
: O
7 O
with O
PI O
- O
3V _RARE_
, O
1 O
with O
NCP _RARE_
BVDV _RARE_
type O
1 O
, O
and O
1 O
with O
both O
BVHV _RARE_
- O
1 O
and O
BVDV _RARE_
. O

The O
RS447 _RARE_
human I-GENE
megasatellite _RARE_
tandem _RARE_
repetitive _RARE_
sequence I-GENE
encodes O
a O
novel O
deubiquitinating _RARE_
enzyme O
with O
a O
functional _RARE_
promoter O
. O

Previous O
experience O
and O
contextual _RARE_
cues _RARE_
are O
essential O
elements O
in O
the O
generation O
of O
a O
subjective _RARE_
prediction O
. O

To O
characterize O
this O
effect O
, O
we O
looked _RARE_
for _RARE_
targets _RARE_
of O
NS1 I-GENE
influenza _RARE_
virus I-GENE
protein I-GENE
among O
cellular O
translation O
factors O
. O

Collectively O
, O
these O
and O
previously O
published O
data O
suggest O
a O
model O
where O
NS1 I-GENE
recruits _RARE_
eIF4GI _RARE_
specifically O
to O
the O
5 O
' O
untranslated _RARE_
region O
( O
5 O
' O
UTR O
) O
of O
the O
viral O
mRNA O
, O
allowing O
for _RARE_
the O
preferential O
translation O
of O
the O
influenza _RARE_
virus O
messengers _RARE_
. O

Eukaryotic _RARE_
translation I-GENE
initiation I-GENE
factor I-GENE
4GI _RARE_
is O
a O
cellular O
target O
for _RARE_
NS1 I-GENE
protein I-GENE
, O
a O
translational O
activator O
of O
influenza _RARE_
virus O
. O

Splicing _RARE_
of O
the O
K I-GENE
- I-GENE
SAM _RARE_
alternative _RARE_
exon _RARE_
of O
the O
fibroblast I-GENE
growth I-GENE
factor I-GENE
receptor I-GENE
2 I-GENE
gene I-GENE
is O
heavily _RARE_
dependent O
on O
the O
U _RARE_
- O
rich O
sequence O
IAS1 _RARE_
lying _RARE_
immediately O
downstream _RARE_
from O
its O
5 O
' O
splice _RARE_
site O
. O

( O
iii O
) O
In O
these O
cells O
, O
PKCbeta _RARE_
plays O
a O
unique O
Ras I-GENE
- O
independent O
role O
in O
mediating O
insulin I-GENE
but O
not O
EGF _RARE_
or O
other O
growth O
factor O
mitogenic O
signals O
. O

However O
, O
it O
is O
not O
known O
whether O
the O
recently O
identified O
isoforms O
Vav2 _RARE_
and O
Vav3 _RARE_
, O
which O
are O
broadly O
expressed _RARE_
, O
can O
couple _RARE_
with O
similar O
classes O
of O
receptors O
, O
nor O
is O
it O
known O
whether O
all O
Vav _RARE_
isoforms I-GENE
possess O
identical O
functional _RARE_
activities O
. O

Transcriptional O
regulation _RARE_
of O
fbp1 _RARE_
promoter I-GENE
constructs I-GENE
containing O
only O
UAS1 O
or O
UAS2 _RARE_
confirms _RARE_
that O
the O
PKA I-GENE
and O
MAPK _RARE_
regulation _RARE_
is O
targeted O
to O
both O
sites O
. O

X O
- O
ray O
crystallographic _RARE_
data O
show O
that O
the O
PLZF I-GENE
BTB I-GENE
/ O
POZ _RARE_
domain O
forms O
an O
obligate _RARE_
homodimer _RARE_
via O
an O
extensive O
interface O
. O

The O
ability O
of O
SMRT I-GENE
to O
associate O
with O
these O
transcription O
factors O
and O
thereby O
to O
mediate O
repression O
is O
strongly O
inhibited O
by O
activation O
of O
tyrosine I-GENE
kinase I-GENE
signaling _RARE_
pathways O
, O
such O
as _RARE_
that O
represented O
by O
the O
epidermal _RARE_
growth I-GENE
factor I-GENE
receptor I-GENE
. O

In O
addition O
, O
the O
ketamine _RARE_
- O
treated O
rats O
had O
more O
neurons O
and O
glial _RARE_
cells O
surrounding O
the O
ventricles O
. O

The O
differences O
were O
as _RARE_
follows O
: O
for _RARE_
overall O
response O
rate O
p O
= O
0 _RARE_
. O
004 _RARE_
; O
power O
( O
for _RARE_
p O
= O
0 _RARE_
. O
05 O
) O
85 _RARE_
%; O
for _RARE_
survival O
p O
= O
0 _RARE_
. O
09 O
; O
for _RARE_
grade O
IV O
granulocytopenia _RARE_
p O
= O
0 _RARE_
. O
3 O
; O
and O
for _RARE_
febrile _RARE_
neutropenia O
p O
= O
0 _RARE_
. O
61 _RARE_
. O

Patients O
were O
randomly O
assigned O
to O
treatment O
with O
the O
ACE I-GENE
inhibitor O
perindopril _RARE_
( O
and O
the O
diuretic O
indapamide _RARE_
for _RARE_
those O
with O
no _RARE_
definite O
indication O
for _RARE_
or O
contraindication _RARE_
to O
treatment O
with O
a O
diuretic O
) O
or O
matching _RARE_
placebo O
( O
s O
). O

The O
results O
indicate O
that O
the O
open _RARE_
- O
section O
effect O
decreases O
the O
torsional _RARE_
stiffness O
and O
stress O
concentration O
effects O
decrease O
the O
torsional _RARE_
strength O
of O
a O
long O
bone O
with O
a O
longitudinal O
defect O
. O

These O
regions O
may O
be O
differentially O
involved O
in O
tissue O
- O
specificity _RARE_
, O
and O
/ O
or O
circadian O
regulation _RARE_
, O
of O
the O
human I-GENE
hPer1 _RARE_
gene I-GENE
transcription O
. O

Additionally O
, O
putative O
CF1 _RARE_
/ O
USP _RARE_
and O
Broad _RARE_
Complex _RARE_
Z2 _RARE_
transcription O
factor O
elements O
were O
found O
in O
the O
upstream O
regions O
of O
MIH _RARE_
and O
MO _RARE_
- I-GENE
IH _RARE_
genes O
respectively O
. O

Sequence O
analysis O
reveals O
that O
the O
newly O
discovered O
oasA2 _RARE_
gene I-GENE
represents O
a O
pseudogene _RARE_
that O
is O
still O
transcribed _RARE_
, O
but O
is O
not O
functionally O
translated O
. O

Genomic O
and O
functional _RARE_
characterization O
of O
the O
oas _RARE_
gene I-GENE
family I-GENE
encoding O
O I-GENE
- I-GENE
acetylserine _RARE_
( I-GENE
thiol _RARE_
) I-GENE
lyases _RARE_
, O
enzymes _RARE_
catalyzing _RARE_
the O
final O
step O
in O
cysteine O
biosynthesis O
in O
Arabidopsis O
thaliana O
. O

Two O
distinct O
recessive O
susceptibility _RARE_
loci O
for _RARE_
vasculitis O
were O
mapped O
on O
chromosome _RARE_
( O
Chr O
) O
4 O
at _RARE_
D4Mit89 _RARE_
and O
D4Mit147 _RARE_
in O
both O
progenies _RARE_
. O

During O
treatment O
, O
the O
phosphorylation _RARE_
state O
of O
Rb _RARE_
shifted O
to O
a O
hypophosphorylated _RARE_
form O
. O
mRNA O
for _RARE_
the O
HPV O
E6 _RARE_
/ O
E7 I-GENE
genes O
decreased O
; O
however O
, O
significant O
changes O
in O
the O
E7 I-GENE
protein I-GENE
were O
not O
observed O
, O
while O
increased O
levels O
of O
Rb _RARE_
immunoprecipitated O
with O
anti I-GENE
- I-GENE
E7 I-GENE
antibodies I-GENE
were O
observed O
. O

Further O
characterization O
of O
these O
putative O
Hoxa _RARE_
- I-GENE
1 I-GENE
target I-GENE
genes I-GENE
will O
aid O
in O
delineating _RARE_
the O
functions O
of O
the O
Hoxa _RARE_
- I-GENE
1 I-GENE
protein I-GENE
in O
the O
differentiation O
processes O
which O
occur O
during _RARE_
embryogenesis O
. O

The O
ability O
of O
U6 I-GENE
- O
U57 _RARE_
mutants O
to O
influence O
the O
fidelity _RARE_
of O
both O
branch O
site O
and O
3 O
' O
splice _RARE_
site O
recognition O
suggests O
that O
this O
nucleotide O
may O
participate O
in O
the O
formation O
of O
the O
active _RARE_
site O
( O
s O
) O
of O
the O
spliceosome O
. O

We O
have O
determined O
the O
structure _RARE_
of O
the O
WNT _RARE_
- I-GENE
2B _RARE_
gene I-GENE
. O

The O
role O
of O
daunorubicin _RARE_
in O
induction O
therapy O
for _RARE_
adult O
acute O
myeloid _RARE_
leukemia O

Five O
of O
the O
Aeromonas _RARE_
strains O
and O
one O
of O
V O
cholerae _RARE_
non O
- O
O1 _RARE_
were O
positive O
for _RARE_
enterotoxin _RARE_
activity O
. O

TNF I-GENE
- I-GENE
alpha I-GENE
induced _RARE_
a O
dose O
- O
and O
time O
- O
dependent O
increase O
in O
cyclooxygenase _RARE_
- I-GENE
2 I-GENE
( O
COX _RARE_
- I-GENE
2 I-GENE
) O
expression _RARE_
and O
PGE2 O
formation O
in O
human O
NCI _RARE_
- O
H292 _RARE_
epithelial _RARE_
cells O
. O

The O
therapy O
time O
to O
deliver _RARE_
the O
NCS _RARE_
therapeutic O
dose O
of O
10000 _RARE_
RBE _RARE_
- O
cGy _RARE_
, O
is O
27 _RARE_
times O
longer O
when O
157Gd _RARE_
is O
used O
instead O
of O
10B _RARE_
. O

Mis3 _RARE_
is O
needed O
for _RARE_
the O
formation O
of O
18S _RARE_
ribosome _RARE_
RNA I-GENE
, O
and O
may O
hence O
direct O
the O
level O
of O
proteins O
required O
for _RARE_
the O
coupling O
. O

Losartan _RARE_
Intervention _RARE_
For O
Endpoint _RARE_
. O

CONCLUSION O
: O
Vitrectomy _RARE_
for _RARE_
vitreous O
hemorrhage O
in O
Terson _RARE_
syndrome _RARE_
is O
a O
safe O
and O
effective O
procedure O
, O
offering _RARE_
a O
rapid O
and O
prolonged O
improvement O
in O
vision O
. O

RNA O
in O
situ O
hybridization O
on O
brain O
sections O
of O
normal O
human O
embryos _RARE_
revealed O
a O
strong O
labeling O
in O
restricted O
areas O
of O
the O
cerebral O
cortex O
. O

To O
facilitate O
manipulation _RARE_
of O
large O
genomic O
sequences O
, O
we O
developed O
a O
method O
of O
converting _RARE_
Escherichia O
coli O
P1 O
artificial O
chromosomes O
( O
PACs _RARE_
) O
into O
yeast O
artificial O
chromosomes O
( O
YACs O
). O

After O
gamma O
- O
irradiation O
, O
the O
majority O
of O
F9 O
cells O
undergo O
apoptosis O
implying O
that O
wt I-GENE
- I-GENE
p53 I-GENE
likely O
triggers O
pro O
- O
apoptotic O
gene O
expression _RARE_
in O
DNA O
damaged O
cells O
. O

Mobilization _RARE_
with O
cyclophosphamide O
and O
granulocyte _RARE_
- I-GENE
colony I-GENE
stimulating I-GENE
factor I-GENE
was O
effective O
in O
terms O
of O
CD34 I-GENE
+ I-GENE
cell O
shift O
to O
peripheral O
blood _RARE_
and O
the O
good O
quality O
autograft _RARE_
reliably _RARE_
led O
to O
haematopoetic _RARE_
recovery O
after O
megachemotherapy _RARE_
. O

This O
suggests O
that O
cardiovascular O
magnetic O
resonance O
is O
the O
preferred O
technique O
for _RARE_
volume O
and O
ejection O
fraction O
estimation O
in O
heart _RARE_
failure O
patients O
, O
because O
of O
its O
3D _RARE_
approach O
for _RARE_
non O
- O
symmetric _RARE_
ventricles O
and O
superior O
image O
quality O
. O

A O
degenerate O
DNA O
transposon _RARE_
, O
Pat _RARE_
, O
was O
identified O
in O
the O
genomes O
of O
various O
wild O
- O
type O
strains O
of O
the O
filamentous _RARE_
fungus _RARE_
Podospora _RARE_
anserina _RARE_
. O

However O
, O
the O
presence O
of O
Tax _RARE_
I I-GENE
increased O
the O
extent O
and O
altered O
the O
profile O
of O
proteins O
binding O
TRE _RARE_
- I-GENE
2 I-GENE
in O
vivo O
. O

We O
have O
also O
identified O
a O
functional _RARE_
domain O
in O
the O
ORF O
50 O
protein O
, O
an O
immediate I-GENE
- I-GENE
early I-GENE
gene I-GENE
product I-GENE
that O
is O
mainly O
encoded O
by O
ORF O
50 O
. O

A O
2 O
. O
3 O
- O
kb O
full O
- O
length O
cDNA O
clone O
of O
an O
Atlantic _RARE_
halibut _RARE_
Mx _RARE_
gene I-GENE
was O
isolated O
from O
a O
liver O
cDNA O
library O
. O

PLUS _RARE_
- O
3 O
is O
a O
new O
Swedish _RARE_
protocol O
of O
natural _RARE_
speech O
in O
3 O
- O
year O
- O
old O
children O
. O

Once O
HIT _RARE_
II O
is O
suspected O
, O
heparin _RARE_
( O
and O
low O
- O
molecular _RARE_
- O
weight _RARE_
heparins _RARE_
) O
should O
be O
stopped O
immediately O
. O

The O
reduced _RARE_
efficiency O
in O
the O
glycosylase I-GENE
activity O
is O
also O
reflected O
in O
a O
reduced _RARE_
ability O
of O
S120K _RARE_
MutY _RARE_
to O
prevent O
DNA O
mutations O
in O
vivo O
. O

METHODS O
AND _RARE_
RESULTS O
: O
We O
prospectively _RARE_
compared O
the O
automated O
measurements O
of O
left _RARE_
ventricular O
ejection O
fraction O
( O
LVEF O
) O
and O
volumes O
from O
rest O
- O
injected O
gated O
Technetium _RARE_
99m O
( O
Tc99m _RARE_
) O
perfusion O
SPECT O
with O
equilibrium O
radionuclide _RARE_
angiocardiography _RARE_
( O
ERNA _RARE_
) O
in O
62 _RARE_
patients O
and O
the O
assessment O
of O
regional O
function O
with O
echocardiography O
in O
22 _RARE_
patients O
. O

The O
2 O
cDNAs O
differed O
in O
the O
length O
of O
their O
respective O
3 O
' O
untranslated _RARE_
regions O
, O
of O
577 _RARE_
bp O
in O
Cp I-GENE
. I-GENE
F6 _RARE_
and O
72 O
bp O
in O
Cp I-GENE
. I-GENE
F10 _RARE_
, O
in O
both O
of O
which O
a O
putative O
polyadenylation O
signal O
was O
identified O
. O

This O
intracellular _RARE_
signaling _RARE_
, O
known O
as _RARE_
the O
unfolded _RARE_
protein O
response O
( O
UPR _RARE_
), _RARE_
is O
mediated _RARE_
by O
the O
cis O
- O
acting O
ER O
stress O
response O
element O
( O
ERSE _RARE_
) O
in O
mammals O
. O

A O
Y I-GENE
. I-GENE
lipolytica _RARE_
Kar2p _RARE_
mutant I-GENE
was O
isolated O
that O
restored O
interaction O
with O
an O
Sls1p _RARE_
mutant I-GENE
, O
suggesting O
that O
the O
interaction O
with O
Sls1p _RARE_
could O
be O
nucleotide O
and O
/ O
or O
conformation O
dependent O
. O

We O
have O
carried O
out O
a O
comprehensive _RARE_
and O
systematic O
mutagenesis O
of O
the O
Cse4p _RARE_
N I-GENE
terminus I-GENE
to O
analyze O
its O
function O
. O

The O
spacing _RARE_
of O
the O
essential O
N O
- O
terminal O
domain O
( O
END _RARE_
) O
relative O
to O
the O
HFD _RARE_
can O
be O
changed O
significantly O
without O
an O
apparent O
effect O
on O
Cse4p _RARE_
function O
. O

The O
bases O
of O
this O
comparison O
are O
reviewed O
and O
discussed O
. O

In O
invertebrates _RARE_
, O
Fhit _RARE_
is O
encoded O
as _RARE_
a O
fusion O
protein O
with O
Nit _RARE_
, O
a O
member _RARE_
of O
the O
nitrilase _RARE_
superfamily I-GENE
. O

Platelet _RARE_
counts O
and O
function O
as _RARE_
well _RARE_
as _RARE_
fibrinogen I-GENE
and O
von _RARE_
Willebrand I-GENE
factor I-GENE
( O
vWF I-GENE
) O
levels O
were O
determined O
in O
each O
sample O
. O

The O
manifestations O
often O
include O
a O
moderate O
thrombocytopenia O
and O
, O
less O
commonly O
, O
hemolysis _RARE_
. O

A O
beta2 _RARE_
RARE _RARE_
reporter I-GENE
construct I-GENE
in O
which O
the O
methylation O
- O
susceptible O
cytosines _RARE_
in O
the O
sense O
strand _RARE_
were O
replaced O
by O
thymine _RARE_
displayed O
marked O
loss _RARE_
of O
activity O
in O
a O
replicated _RARE_
chromatin O
- O
dependent O
manner O
. O

Non O
- O
poliomyelitis _RARE_
AFP _RARE_
rate O
had O
increased O
from O
0 _RARE_
. O
9 O
in O
1997 O
to O
2 O
. O
8 O
in O
1998 O
. O

Consciousness _RARE_
is O
connected O
with O
attention O
, O
working O
memory O
and O
perception _RARE_
. O

Multiparity _RARE_
had O
a O
protective O
effect O
with O
0 _RARE_
. O
66 _RARE_
less O
risk O
( O
95 _RARE_
% O
CI _RARE_
0 _RARE_
. O
44 _RARE_
- O
0 _RARE_
. O
99 _RARE_
). O

Picture _RARE_
the O
smell _RARE_
. O

The O
aim O
of O
our O
study O
was O
to O
evaluate O
the O
level O
of O
oxidative O
stress O
in O
healthy O
controls O
( O
CTL O
) O
compared O
with O
CRF _RARE_
and O
HD O
patients O
before O
( O
pre O
- O
HD O
) O
and O
after O
( O
post O
- O
HD O
) O
the O
dialysis O
session O
, O
carried O
out O
on O
a O
high O
biocompatible _RARE_
polyacrylonitrile _RARE_
membrane O
AN69 _RARE_
. O

Indirect _RARE_
plasma O
parameters O
such O
as _RARE_
vitamin O
E O
, O
thiol _RARE_
and O
uric O
acid O
levels O
were O
also O
quantified _RARE_
. O

Only O
two O
of O
27 _RARE_
participants _RARE_
( O
7 O
. O
4 O
%) O
with O
definite O
POAG _RARE_
had O
been O
previously O
diagnosed O
and O
treated O
, O
and O
66 _RARE_
. O
7 O
% O
of O
the O
previously O
undiagnosed _RARE_
had O
IOP O
less O
than O
22 _RARE_
mmHg O
. O

Taken O
together O
, O
they O
uphold _RARE_
the O
emerging _RARE_
concern _RARE_
that O
women O
with O
ER I-GENE
(+) _RARE_
cancers O
may O
not O
benefit O
significantly O
from O
endocrine O
treatment O
if O
the O
tumors O
also O
overexpress _RARE_
HER _RARE_
- I-GENE
2 I-GENE
. O

Promoter O
activity O
was O
dose O
- O
dependently O
inhibited O
by O
cotransfection O
with O
either O
ras I-GENE
or O
mos I-GENE
oncogenes _RARE_
, O
but O
oncogene O
inhibition O
was O
reversed O
and O
the O
overall O
activity O
increased O
when O
cells O
were O
treated O
with O
the O
MAP I-GENE
kinase I-GENE
kinase I-GENE
( O
MKK _RARE_
) O
inhibitor O
PD98059 O
. O

Our O
results O
indicate O
that O
the O
expression _RARE_
of O
Cktsf1b1 _RARE_
, O
a O
gene O
associated O
with O
early O
development O
and O
cell O
transformation O
, O
is O
sensitive _RARE_
to O
MKK _RARE_
levels O
and O
may O
be O
regulated O
via O
multiple O
transcription O
factor O
complexes O
. O

INTERVENTIONS _RARE_
: O
Subcutaneous _RARE_
tissue O
PO2 O
and O
PCO2 O
tensions _RARE_
were O
measured O
directly O
in O
patients O
with O
necrotising _RARE_
fasciitis _RARE_
and O
in O
healthy O
volunteers O
during _RARE_
normobaric _RARE_
and O
hyperbaric _RARE_
conditions O
. O

Because O
GH _RARE_
- O
induced _RARE_
Akt I-GENE
activation O
was O
completely O
inhibited O
in O
both O
cells O
by O
the O
same O
concentration O
of O
LY294002 _RARE_
, O
these O
findings O
indicate O
that O
the O
wortmannin O
sensitivity O
of O
both O
the O
IRS I-GENE
- I-GENE
1 I-GENE
- O
independent O
and O
- O
dependent O
GH _RARE_
- O
induced _RARE_
MAP I-GENE
kinase I-GENE
activation O
may O
reflect O
the O
activity O
of O
another O
wortmannin O
- O
sensitive _RARE_
target O
( O
s O
) O
in O
addition O
to O
PI3K _RARE_
in O
mediation _RARE_
of O
GH _RARE_
- O
induced _RARE_
MAP I-GENE
kinase I-GENE
activation O
in O
these O
cells O
. O

Insulin I-GENE
receptor I-GENE
substrate I-GENE
- I-GENE
1 I-GENE
- O
mediated _RARE_
enhancement O
of O
growth I-GENE
hormone I-GENE
- O
induced _RARE_
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
activation O
. O

Functional O
magnetic O
resonance O
imaging O
( O
fMRI _RARE_
) O
has O
been O
increasingly _RARE_
used O
in O
studying O
human O
brain O
function O
given O
its O
non O
- O
invasive O
feature O
and O
good O
spatial O
resolution O
. O

After O
declamping _RARE_
of O
the O
aorta O
, O
there O
were O
also O
severe O
edema O
, O
local O
fibre O
necrosis O
, O
and O
adhesion O
of O
leucocytes _RARE_
, O
whereas O
muscle O
fibre O
areas O
became O
3 O
, O
935 _RARE_
. O
18 O
micro O
531 _RARE_
microm O
( O
2 O
) O
for _RARE_
type O
I O
and O
5 O
, O
804 _RARE_
+/- O
1 O
, O
075 _RARE_
microm O
( O
2 O
) O
for _RARE_
type O
II O
. O

The O
results O
indicate O
that O
the O
relationship O
between O
comprehension _RARE_
and O
production O
is O
different O
at _RARE_
different O
stages O
in O
development O
. O

It O
was O
found O
that O
increase O
in O
the O
RH _RARE_
level O
boosts _RARE_
the O
current O
values O
by O
2 O
- O
3 O
orders _RARE_
of O
magnitude O
; O
contrariwise _RARE_
, O
the O
voltage O
values O
rise O
by O
about O
three O
times O
with O
drop O
in O
the O
RH _RARE_
. O

On O
long O
- O
term O
follow O
- O
up _RARE_
, O
there O
was O
no _RARE_
significant O
difference O
in O
the O
incidence O
of O
hospitalizations _RARE_
( O
1 O
per O
2 O
. O
1 O
vs _RARE_
. O

Genomic O
libraries O
were O
stored O
as _RARE_
frozen _RARE_
cultures O
in O
a O
96 O
- O
well _RARE_
format _RARE_
, O
each O
well _RARE_
containing O
approximately _RARE_
300 _RARE_
- O
600 O
colonies O
( O
12 O
plates O
for _RARE_
small O
library O
, O
four O
for _RARE_
medium O
- O
size O
library O
and O
four O
for _RARE_
large O
library O
). O

In O
several O
cell O
lines O
, O
mTOR _RARE_
or O
its O
downstream _RARE_
targets _RARE_
can O
be O
regulated O
by O
phosphatidylinositol _RARE_
( I-GENE
PI I-GENE
) I-GENE
3 I-GENE
- I-GENE
kinase I-GENE
; O
protein I-GENE
kinases I-GENE
A I-GENE
, I-GENE
B I-GENE
, I-GENE
and I-GENE
C I-GENE
; O
heterotrimeric I-GENE
G I-GENE
- I-GENE
proteins I-GENE
; O
a O
PD98059 O
- O
sensitive _RARE_
kinase O
or O
calcium _RARE_
; O
as _RARE_
well _RARE_
as _RARE_
by O
amino O
acids _RARE_
. O

The O
tumor I-GENE
- I-GENE
suppressor I-GENE
protein I-GENE
p53 I-GENE
is O
involved O
in O
maintaining O
genomic O
stability O
. O

Abrogation _RARE_
of O
p53 I-GENE
function O
by O
E6 _RARE_
resulted O
in O
an O
increase O
in O
the O
spontaneous O
mutation O
frequencies O
at _RARE_
the O
heterozygous _RARE_
thymidine _RARE_
kinase I-GENE
( O
TK I-GENE
) O
locus O
but O
not O
at _RARE_
the O
hemizygous _RARE_
hypoxanthine _RARE_
phosphoribosyl _RARE_
transferase I-GENE
( O
HPRT _RARE_
) O
locus O
. O

Cytogenetic _RARE_
analysis O
of O
LOH _RARE_
mutants O
by O
chromosome _RARE_
painting _RARE_
indicated O
a O
mosaic O
of O
chromosomal O
aberrations _RARE_
involving O
chromosome _RARE_
17 _RARE_
, O
in O
which O
partial O
chromosome _RARE_
deletions O
, O
amplifications _RARE_
, O
and O
multiple O
translocations _RARE_
appeared O
heterogeneously _RARE_
in O
a O
single O
mutant O
. O

These O
results O
support O
a O
model O
in O
which O
p53 I-GENE
protein I-GENE
contributes O
to O
the O
maintenance _RARE_
of O
genomic O
integrity O
through O
recombinational _RARE_
repair O
. O

The O
importance O
of O
this O
new O
epidemiological O
profile O
of O
schistosomiasis _RARE_
in O
the O
State O
of O
Pernambuco _RARE_
relies _RARE_
on O
the O
fact O
that O
it O
can O
be O
related O
with O
the O
drastic _RARE_
human O
interference O
on O
the O
environment O
. O

In O
patients O
with O
type O
II O
tumors O
, O
the O
pattern O
of O
lymphatic _RARE_
spread O
was O
primarily O
directed O
toward O
the O
paracardial _RARE_
, O
lesser O
curvature _RARE_
, O
and O
left _RARE_
gastric _RARE_
artery O
nodes O
; O
esophagectomy _RARE_
offered O
no _RARE_
survival O
benefit O
over O
extended O
gastrectomy _RARE_
in O
these O
patients O
. O

RESULTS O
: O
No O
significant O
deformation _RARE_
in O
vertebral O
artery O
flow O
was O
noted O
in O
the O
flexion _RARE_
- O
distraction _RARE_
Stage O
I O
injuries O
within O
the O
physiologic _RARE_
range O
of O
cervical O
flexion _RARE_
. O

We O
screened O
a O
K562 O
cDNA O
library O
and O
identified O
novel O
transcripts O
, O
MZF1B _RARE_
and O
MZF1C _RARE_
. O

The O
human O
cDNA O
clone O
NFBD1 _RARE_
( O
previously O
designated O
KIAA0170 _RARE_
) O
encodes O
a O
novel O
protein O
( O
2089 _RARE_
amino O
acids _RARE_
in O
length O
; O
calculated O
molecular _RARE_
mass O
226 _RARE_
, O
440 O
D O
) O
with O
possible O
BRCT _RARE_
domains I-GENE
at _RARE_
its O
carboxy _RARE_
terminus O
( O
amino O
acid O
residues O
1894 _RARE_
- O
2089 _RARE_
). O

RESULTS O
: O
Neither O
basal O
FSH I-GENE
level O
nor O
stimulated _RARE_
FSH I-GENE
level O
alone O
were O
statistically O
significant O
predictors O
of O
IVF _RARE_
success O
; O
however O
, O
no _RARE_
patient O
with O
a O
day O
3 O
FSH I-GENE
level O
> O
11 O
. O
1 O
mIU _RARE_
/ O
ml O
or O
a O
stimulated _RARE_
day O
10 O
FSH I-GENE
level O
> O
13 _RARE_
. O
5 O
mIU _RARE_
/ O
ml O
conceived _RARE_
and O
carried O
a O
pregnancy _RARE_
. O

Parathyroid _RARE_
hormone I-GENE
regulation _RARE_
of O
bone I-GENE
sialoprotein _RARE_
( O
BSP _RARE_
) O
gene O
transcription O
is O
mediated _RARE_
through O
a O
pituitary I-GENE
- I-GENE
specific I-GENE
transcription I-GENE
factor I-GENE
- I-GENE
1 I-GENE
( O
Pit I-GENE
- I-GENE
1 I-GENE
) O
motif O
in O
the O
rat I-GENE
BSP _RARE_
gene I-GENE
promoter I-GENE
. O

Recent O
target O
BP _RARE_
goals _RARE_
promulgated _RARE_
by O
the O
Sixth _RARE_
Report _RARE_
from O
the O
Joint _RARE_
National O
Committee O
( O
JNC _RARE_
VI _RARE_
) O
are O
based O
on O
the O
premise _RARE_
that O
the O
intensity O
of O
treatment O
directly O
corresponds O
to O
the O
magnitude O
of O
pretreatment O
risk O
. O

Linking _RARE_
continuous O
community O
- O
based O
morbidity O
recording O
of O
influenza _RARE_
- O
like O
illness O
( O
ILI _RARE_
) O
with O
virological _RARE_
sampling O
has O
consistently O
proved O
its O
value O
as _RARE_
one O
of O
the O
earliest _RARE_
indicators O
of O
circulating O
influenza _RARE_
activity O
. O

The O
muskox _RARE_
is O
a O
new O
host _RARE_
record O
for _RARE_
T O
. O
gondii _RARE_
. O

These O
include O
NPF _RARE_
repeats O
, O
a O
leucine O
heptad _RARE_
repeat O
enriched _RARE_
in O
charged O
residues O
, O
and O
a O
proline O
- O
rich O
SH3 I-GENE
- I-GENE
like I-GENE
and O
/ O
or O
WW _RARE_
domain O
- O
binding O
site O
in O
the O
N O
- O
terminal O
domain O
, O
which O
is O
followed O
by O
a O
membrane O
core O
containing O
four O
putative O
transmembrane O
spans O
and O
three O
amphiphilic _RARE_
segments _RARE_
that O
are O
the O
most O
highly O
conserved _RARE_
structural O
elements O
. O

We O
show O
here O
that O
this O
difference O
is O
due O
to O
the O
presence O
of O
a O
Mot3 _RARE_
binding I-GENE
site I-GENE
in O
OpA _RARE_
. O

The O
article O
deals _RARE_
with O
the O
diagnosing _RARE_
and O
correction O
of O
reversible O
ischemia O
of O
the O
intestine O
. O

Mucosal _RARE_
application O
of O
NCX _RARE_
- O
4016 _RARE_
, O
however O
, O
did O
not O
cause O
PD _RARE_
reduction O
and O
luminal O
H O
+ O
loss _RARE_
, O
but O
produced O
a O
marked O
hyperemia _RARE_
, O
resulting O
in O
no _RARE_
damage O
in O
the O
stomach O
of O
both O
normal O
and O
STZ _RARE_
- O
diabetic O
rats O
. O

Functional O
recognition O
of O
5 O
' O
splice _RARE_
site O
by O
U4 I-GENE
/ O
U6 I-GENE
. O
U5 _RARE_
tri _RARE_
- O
snRNP O
defines O
a O
novel O
ATP O
- O
dependent O
step O
in O
early O
spliceosome O
assembly O
. O

As O
control O
, O
the O
cells O
were O
transfected O
with O
DNA O
mixtures _RARE_
containing O
vector O
mU6 _RARE_
- O
C1 O
or O
mU6 _RARE_
- O
C2 O
. O

The O
amino O
acid O
sequence O
of O
matrilysin _RARE_
- I-GENE
2 I-GENE
also O
contains O
a O
threonine O
residue _RARE_
adjacent O
to O
the O
Zn _RARE_
- O
binding O
site O
that O
has O
been O
defined O
as _RARE_
a O
specific O
feature O
of O
matrilysin _RARE_
. O

In O
this O
regard O
, O
we O
have O
recently O
observed O
that O
a O
constitutively O
active _RARE_
G I-GENE
protein I-GENE
- I-GENE
coupled I-GENE
receptor I-GENE
( O
GPCR _RARE_
) O
encoded O
by O
the O
Kaposi O
' O
s O
sarcoma O
- O
associated O
herpes O
virus O
( O
KSHV _RARE_
)/ _RARE_
human O
herpes O
virus O
8 O
is O
oncogenic _RARE_
and O
stimulates O
angiogenesis O
by O
increasing O
the O
secretion _RARE_
of O
vascular I-GENE
endothelial I-GENE
growth I-GENE
factor I-GENE
( O
VEGF I-GENE
), _RARE_
which O
is O
a O
key O
angiogenic _RARE_
stimulator _RARE_
and O
a O
critical O
mitogen O
for _RARE_
the O
development O
of O
Kaposi O
' O
s O
sarcoma O
. O

No O
specific O
subgroup O
of O
clients _RARE_
benefited _RARE_
more O
from O
URD _RARE_
, O
although O
a O
prospective O
study O
employing O
random O
assignment O
might O
be O
more O
successful O
in O
identifying O
such O
a O
group O
. O

In O
the O
lattice _RARE_
, O
23 _RARE_
% O
of O
the O
sites O
are O
occupied O
, O
95 _RARE_
% O
of O
the O
atoms _RARE_
are O
in O
the O
lowest O
energy O
magnetic O
sublevel _RARE_
, O
and O
37 O
% O
are O
in O
the O
lowest O
3D _RARE_
vibrational _RARE_
state O
. O

Coexisting _RARE_
vertical O
and O
horizontal O
one O
and O
a O
half _RARE_
syndromes O
. O

As O
in O
the O
other O
three O
members O
whose O
gene O
expression _RARE_
is O
altered O
during _RARE_
tumorigenesis O
, O
PI12 _RARE_
expression _RARE_
was O
found O
to O
be O
down O
- O
regulated O
in O
tumor O
brain O
tissues O
and O
in O
two O
brain O
cancer _RARE_
cell O
lines O
: O
U _RARE_
- O
87 O
MG _RARE_
and O
H4 _RARE_
. O

Regarding _RARE_
" O
the O
relation O
between O
sexual O
orientation O
and O
penile _RARE_
size O
," O
by O
A O
. O

This O
slope O
was O
further O
significantly O
decreased O
at _RARE_
5 O
min O
ischemia O
(- _RARE_
26 _RARE_
. O
5 O
+/- O
8 O
. O
8 O
microm O
/ O
mmHg O
) O
but O
returned O
toward O
control O
values O
in O
short O
- O
term O
hibernating _RARE_
myocardium O
at _RARE_
90 _RARE_
min O
ischemia O
(- _RARE_
17 _RARE_
. O
2 O
+/- O
6 O
. O
6 O
microm O
/ O
mmHg O
). O

Whereas O
both O
MAP O
and O
MSNA _RARE_
increase O
during _RARE_
SHG _RARE_
, O
the O
transition O
from O
SHG _RARE_
to O
PHI _RARE_
is O
characterized O
by O
a O
transient O
reduction O
in O
MAP O
but O
sustained O
elevation O
in O
MSNA _RARE_
, O
facilitating O
separation O
of O
these O
factors O
in O
vivo O
. O

Analysis O
of O
Standard _RARE_
Reference _RARE_
Material _RARE_
1846 _RARE_
, O
Infant _RARE_
Formula _RARE_
, O
gave O
a O
mean O
value O
of O
0 _RARE_
. O
95 _RARE_
+/- O
0 _RARE_
. O
088 _RARE_
mg O
vitamin O
K O
/ O
kg O
( O
K O
or O
K1 _RARE_
?) _RARE_
( O
n _RARE_
= O
31 _RARE_
) O
with O
a O
coefficient O
of O
variation O
of O
9 O
. O
26 _RARE_
. O

We O
have O
recently O
discovered O
that O
CCAAAT _RARE_
/ I-GENE
enhancer I-GENE
- I-GENE
binding I-GENE
protein I-GENE
- I-GENE
beta I-GENE
( O
C I-GENE
/ I-GENE
EBP I-GENE
- I-GENE
beta I-GENE
) O
induces O
gene O
transcription O
through O
a O
novel O
IFN I-GENE
response I-GENE
element I-GENE
called O
the O
gamma I-GENE
- I-GENE
IFN I-GENE
- I-GENE
activated I-GENE
transcriptional I-GENE
element I-GENE

Northern O
blot O
analysis O
demonstrated O
that O
the O
STORP _RARE_
gene I-GENE
has O
a O
ubiquitous O
pattern O
of O
expression _RARE_
similar O
to O
that O
of O
the O
PML _RARE_
gene I-GENE
. O

In O
the O
TLE _RARE_
patients O
the O
NAA _RARE_
: O
Cr _RARE_
ratios O
were O
reduced _RARE_
in O
the O
seizure O
focus O
, O
while O
in O
the O
FLE _RARE_
patients O
they O
were O
not O
always O
reduced _RARE_
in O
the O
seizure O
focus O
. O

The O
Spo0F _RARE_
residues I-GENE
making O
up _RARE_
the O
hydrophobic O
patch O
are O
very O
similar O
in O
all O
response O
regulators _RARE_
suggesting O
that O
the O
binding O
is O
initiated _RARE_
through O
the O
same O
residues O
in O
all O
interacting _RARE_
response O
regulator O
- O
kinase O
pairs _RARE_
. O

The O
psychologic _RARE_
factors O
associated O
wth _RARE_
serious O
illness O
, O
terminal O
prognoses _RARE_
, O
and O
dying _RARE_
complicate _RARE_
the O
scenario _RARE_
even O
more O
as _RARE_
compared O
with O
that O
of O
nonmalignant _RARE_
pain O
. O

However O
, O
if O
the O
spatial O
resolution O
is O
not O
critical O
and O
interest O
is O
to O
compare O
a O
pathologic O
area O
with O
a O
contralateral O
VOI _RARE_
, O
then O
the O
acquisition O
of O
two O
single O
- O
voxel _RARE_
spectra O
may O
be O
preferred O
. O

Quantitative O
evaluation O
of O
magneto _RARE_
- O
optical O
parameters O
is O
necessary O
in O
order O
to O
apply _RARE_
scanning O
near O
- O
field O
optical O
microscope _RARE_
( O
SNOM _RARE_
) O
technology O
to O
the O
study O
of O
magnetism _RARE_
on O
the O
mesoscopic _RARE_
scale O
. O

We O
found O
that O
the O
amplitude O
of O
the O
cortical O
evoked O
potentials O
( O
amplitude O
of O
the O
N2 O
/ O
P2 O
peak O
) O
increased O
from O
5 O
. O
1 O
+/- O
0 _RARE_
. O
7 O
microV _RARE_
at _RARE_
5 O
mA _RARE_
to O
16 O
. O
3 O
+/- O
1 O
. O
1 O
microV _RARE_
at _RARE_
20 O
mA _RARE_
. O

While O
mutations O
in O
K I-GENE
- I-GENE
Rev _RARE_
that O
inactivate _RARE_
any O
one O
of O
these O
properties O
also O
blocked O
K I-GENE
- I-GENE
Rev _RARE_
- O
dependent O
nuclear O
RNA O
export O
, O
several O
K I-GENE
- I-GENE
Rev _RARE_
mutants I-GENE
were O
comparable O
to O
wild O
type O
when O
assayed O
for _RARE_
any O
of O
these O
individual O
activities O
yet O
nevertheless _RARE_
defective _RARE_
for _RARE_
RNA O
export O
. O

LMP I-GENE
- I-GENE
1 I-GENE
is O
targeted O
to O
the O
plasma O
membrane O
, O
where O
it O
binds O
TRAF _RARE_
, O
TRADD _RARE_
, O
and O
JAK _RARE_
molecules I-GENE
to O
activate O
NF _RARE_
- I-GENE
kappaB I-GENE
-, _RARE_
AP I-GENE
- I-GENE
1 I-GENE
-, _RARE_
and O
STAT I-GENE
- O
dependent O
pathways O
as _RARE_
does O
CD40 I-GENE
. O

Identification O
of O
an O
enhancer O
and O
an O
alternative _RARE_
promoter O
in O
the O
first _RARE_
intron O
of O
the O
alpha I-GENE
- I-GENE
fetoprotein I-GENE
gene I-GENE
. O

Studying _RARE_
intracellular _RARE_
signaling _RARE_
pathways O
, O
which O
may O
be O
involved O
in O
malignant O
transformation O
of O
Ret _RARE_
- I-GENE
9bp _RARE_
expressing O
NIH3T3 O
cells O
, O
we O
could O
demonstrate O
Ret _RARE_
- I-GENE
9bp _RARE_
dependent O
phosphorylation _RARE_
of O
insulin I-GENE
receptor I-GENE
substrate I-GENE
- I-GENE
2 I-GENE
( O
IRS I-GENE
- I-GENE
2 I-GENE
) O
with O
consecutive O
activation O
of O
phosphatidylinositol _RARE_
3 I-GENE
- I-GENE
kinase I-GENE
( O
PI I-GENE
3 I-GENE
- I-GENE
kinase I-GENE
) O
and O
protein I-GENE
kinase I-GENE
B I-GENE
( O
PKB I-GENE
/ O
AKT _RARE_
). O

METHODS O
: O
In O
the O
current O
study O
the O
authors O
reported O
on O
PPB _RARE_
cases O
from O
a O
national O
retrospective O
search O
performed O
in O
18 O
Italian O
Associations _RARE_
for _RARE_
Pediatric _RARE_
Hematology _RARE_
and O
Oncology _RARE_
centers O
. O

Phylogenetic _RARE_
analysis O
showed O
that O
the O
ToLCV _RARE_
isolates O
from O
Bangalore _RARE_
constitute O
a O
group O
of O
viruses O
separated O
from O
those O
of O
Northern O
India _RARE_
. O

Mutating _RARE_
the O
Fcp1p _RARE_
- O
binding O
motif O
KEFGK _RARE_
in O
the O
RAP74 _RARE_
( O
Tfg1p _RARE_
) O
subunit O
of O
TFIIF _RARE_
to O
EEFGE _RARE_
led O
to O
both O
synthetic _RARE_
phenotypes _RARE_
in O
certain O
fcp1 _RARE_
tfg1 _RARE_
double O
mutants O
and O
a O
reduced _RARE_
ability O
of O
Fcp1p _RARE_
to O
activate O
transcription O
when O
it O
is O
artificially O
tethered _RARE_
to O
a O
promoter O
. O

These O
results O
suggest O
that O
Cdc42p _RARE_
is O
in O
fact O
required O
for _RARE_
pheromone O
response O
and O
that O
interaction O
with O
the O
PAK _RARE_
Ste20p _RARE_
is O
critical O
for _RARE_
that O
role O
. O

Deletion O
of O
an O
intergenic O
DNA O
- O
binding O
site O
for _RARE_
this O
complex O
from O
a O
human I-GENE
beta I-GENE
- I-GENE
globin I-GENE
locus I-GENE
construct I-GENE
results O
in O
delayed O
human I-GENE
gamma I-GENE
- I-GENE
to I-GENE
beta I-GENE
- I-GENE
globin I-GENE
switching O
in O
transgenic O
mice O
, O
suggesting O
that O
the O
PYR _RARE_
complex I-GENE
acts O
to O
facilitate O
the O
switch O
. O

The O
product O
of O
rat I-GENE
gene I-GENE
33 _RARE_
was O
identified O
as _RARE_
an O
ErbB I-GENE
- I-GENE
2 I-GENE
- I-GENE
interacting _RARE_
protein I-GENE
in O
a O
two O
- O
hybrid _RARE_
screen O
employing O
the O
ErbB I-GENE
- I-GENE
2 I-GENE
juxtamembrane _RARE_
and I-GENE
kinase I-GENE
domains I-GENE
as _RARE_
bait _RARE_
. O

Studies O
suggest O
that O
the O
DGOR _RARE_
without O
acid O
reflux O
may O
result O
in O
symptoms O
but O
unless O
acid O
reflux O
is O
present O
simultaneously O
, O
it O
does O
not O
cause O
oesophagitis _RARE_
. O

Symptoms _RARE_
, O
however O
, O
appear O
to O
correlate O
poorly O
with O
oesophagitis _RARE_
; O
hence O
, O
severe O
symptoms O
do O
not O
indicate O
there O
is O
greater O
oesophageal _RARE_
damage O
. O

OBJECTIVE O
: O
To O
evaluate O
the O
relationship O
between O
blood _RARE_
flow O
in O
the O
tumor O
assessed O
by O
color O
Doppler O
ultrasound O
, O
microvessel _RARE_
density O
, O
and O
vascular I-GENE
endothelial I-GENE
growth I-GENE
factor I-GENE
levels O
in O
endometrial O
carcinoma O
. O

These O
results O
demonstrate O
Ras I-GENE
- O
and O
Raf I-GENE
- O
independent O
ERK I-GENE
MAPK _RARE_
activation O
maintains O
cell O
viability O
following O
heat O
shock O
. O

Three O
cDNAs O
encoding O
basic I-GENE
leucine I-GENE
zipper I-GENE
( I-GENE
bZIP _RARE_
)- I-GENE
type I-GENE
ABRE _RARE_
- I-GENE
binding I-GENE
proteins I-GENE
were O
isolated O
by O
using O
the O
yeast O
one O
- O
hybrid _RARE_
system _RARE_
and O
were O
designated O
AREB1 _RARE_
, O
AREB2 _RARE_
, O
and O
AREB3 _RARE_
( O
ABA _RARE_
- I-GENE
responsive I-GENE
element I-GENE
binding I-GENE
protein I-GENE
). O

Recombinant O
AROM _RARE_
- O
p64 _RARE_
displayed O
high O
binding O
to O
single O
- O
stranded _RARE_
DNA O
and O
poly _RARE_
( O
A O
) O
homopolymers _RARE_
suggesting O
that O
this O
protein O
could O
play O
a O
role O
in O
mRNA O
maturation _RARE_
/ O
metabolism O
. O

The O
protein I-GENE
- I-GENE
tyrosine I-GENE
kinase I-GENE
fer _RARE_
associates O
with O
signaling _RARE_
complexes O
containing O
insulin I-GENE
receptor I-GENE
substrate I-GENE
- I-GENE
1 I-GENE
and O
phosphatidylinositol _RARE_
3 I-GENE
- I-GENE
kinase I-GENE
. O

The O
variable _RARE_
phenotype _RARE_
of O
the O
allotetraploids _RARE_
could O
not O
be O
explained O
by O
cytological _RARE_
abnormalities O
. O

In O
the O
PMR _RARE_
target O
area O
but O
not O
in O
the O
nontreated _RARE_
area O
an O
improvement O
in O
regional O
myocardial _RARE_
flow O
reserve O
occurs O
in O
wall _RARE_
segments _RARE_
with O
initially O
severely O
or O
moderately O
reduced _RARE_
stress O
perfusion O
. O

Analysis O
of O
intron O
/ O
exon _RARE_
boundaries O
of O
the O
genomic O
BAC _RARE_
clones _RARE_
demonstrate O
that O
junctin _RARE_
, O
junctate _RARE_
, O
and O
aspartyl _RARE_
beta I-GENE
- I-GENE
hydroxylase I-GENE
result O
from O
alternative _RARE_
splicing _RARE_
of O
the O
same O
gene O
. O

It O
is O
now O
estimated O
that O
inactivation O
mutants O
of O
PTEN _RARE_
exist O
in O
60 _RARE_
% O
of O
all O
forms O
of O
solid O
tumors O
. O

We O
have O
demonstrated O
that O
the O
activity O
of O
ILK I-GENE
is O
constitutively O
elevated O
in O
PTEN _RARE_
mutant I-GENE
cells O
. O

The O
growth I-GENE
factor I-GENE
receptor I-GENE
- I-GENE
bound _RARE_
protein I-GENE
2 I-GENE
( O
Grb2 I-GENE
) O
adaptor _RARE_
when O
complexed O
with O
Sos I-GENE
( O
Son _RARE_
of I-GENE
sevenless _RARE_
), _RARE_
the O
exchange O
factor O
of O
Ras I-GENE
, O
conveys _RARE_
the O
signal O
induced _RARE_
by O
tyrosine I-GENE
kinase I-GENE
- I-GENE
activated I-GENE
receptor I-GENE
to O
Ras I-GENE
by O
recruiting _RARE_
Sos I-GENE
to O
the O
membrane O
, O
allowing O
activation O
of O
Ras I-GENE
. O

Mutations O
in O
genes O
encoding O
PR65 _RARE_
/ I-GENE
A I-GENE
subunits I-GENE
have O
been O
identified O
in O
several O
different O
human O
cancers O
and O
the O
PP2A I-GENE
inhibitor O
, O
termed O
fostriecin _RARE_
, O
is O
being O
tested O
as _RARE_
an O
anticancer _RARE_
drug O
. O

For O
this O
purpose O
, O
a O
segment O
of O
dxr _RARE_
was O
amplified O
from O
Synechococcus _RARE_
leopoliensis _RARE_
SAUG _RARE_
1402 _RARE_
- O
1 O
DNA O
via O
PCR O
using O
oligonucleotides O
for _RARE_
conserved _RARE_
regions O
. O

Perceptual _RARE_
learning O
for _RARE_
a O
pattern O
discrimination O
task O
. O

The O
detector O
has O
the O
advantage O
of O
finding O
both O
ST O
segment O
deviations _RARE_
and O
entire _RARE_
ST O
- O
T O
complex O
changes O
thereby O
providing O
a O
wider _RARE_
characterization O
of O
the O
potential _RARE_
ischemic O
events O
. O

While O
this O
Saccharomyces O
cerevisiae O
SIN4 _RARE_
gene I-GENE
product I-GENE
is O
a O
component _RARE_
of O
a O
mediator _RARE_
complex O
associated O
with O
RNA I-GENE
polymerase I-GENE
II I-GENE
, O
various O
studies O
suggest O
the O
involvement O
of O
Sin4 _RARE_
in O
the O
alteration O
of O
higher _RARE_
- O
order O
chromatin O
structure _RARE_
. O

Primary O
adrenal O
hypersensitivity O
to O
ACTH I-GENE
drive O
in O
obesity O
has O
also O
been O
suggested O
. O

In O
addition O
, O
a O
noncanonical _RARE_
C I-GENE
/ I-GENE
EBP I-GENE
- I-GENE
binding I-GENE
site I-GENE
within O
the O
Gadd45gamma _RARE_
promoter I-GENE
where O
C I-GENE
/ I-GENE
EBPbeta I-GENE
and O
C I-GENE
/ I-GENE
EBPdelta _RARE_
could O
bind O
, O
was O
identified O
by O
electrophoretic O
mobility O
shift O
assay O
( O
EMSA O
) O
and O
reporter O
gene O
analysis O
. O

Src I-GENE
activation O
induced _RARE_
by O
FGF1 _RARE_
was O
blocked O
by O
the O
SH2 _RARE_
domain I-GENE
of O
Src I-GENE
and O
PP2 _RARE_
, O
a O
specific O
inhibitor O
of O
Src I-GENE
. O

The O
use O
of O
the O
PLCgamma _RARE_
inhibitory _RARE_
peptide I-GENE
, O
neomycin _RARE_
and O
the O
calcium _RARE_
chelator _RARE_
BAPTA _RARE_
- O
AM _RARE_
on O
oocytes O
expressing O
FGFR1 _RARE_
or O
the O
stimulation _RARE_
by O
PDGF _RARE_
- I-GENE
BB _RARE_
of O
oocytes O
expressing O
PDGFR _RARE_
- O
FGFR1 _RARE_
mutated _RARE_
on O
the O
PLCgamma _RARE_
binding I-GENE
site I-GENE
, O
prevented O
GVBD _RARE_
and O
ERK2 I-GENE
phosphorylation _RARE_
. O

Multiple O
transcription O
start _RARE_
sites O
were O
revealed O
by O
primer O
extension O
analysis O
of O
the O
mouse O
gene O
, O
and O
transfection O
constructs O
containing O
the O
prospective O
promoter O
generated O
transcriptional O
activity O
comparable O
to O
that O
of O
the O
SV40 I-GENE
promoter I-GENE
. O

From O
two O
inhibitor O
scaffolds _RARE_
, O
we O
have O
identified O
potent O
and O
selective O
inhibitors _RARE_
for _RARE_
sensitized _RARE_
kinases O
from O
five O
distinct O
subfamilies _RARE_
. O

To O
determine O
whether O
interaction O
of O
arsenite _RARE_
with O
the O
hormone O
- O
binding O
domain O
results O
in O
receptor O
activation O
, O
COS O
- O
1 O
cells O
were O
transiently O
cotransfected O
with O
the O
chimeric I-GENE
receptors I-GENE
GAL _RARE_
- I-GENE
ER I-GENE
, O
which O
contains O
the O
hormone O
- O
binding O
domain O
of O
ERalpha _RARE_
and O
the O
DNA O
- O
binding O
domain O
of O
the O
transcription O
factor O
GAL4 I-GENE
, O
and O
a O
GAL4 I-GENE
- O
responsive O
CAT I-GENE
reporter I-GENE
gene I-GENE
. O

By O
progressive O
5 O
'- O
deletion O
studies O
, O
we O
have O
identified O
a O
248 _RARE_
- O
bp O
DNA O
fragment O
(- _RARE_
1018 _RARE_
to O
- O
771 _RARE_
, O
relative O
to O
the O
translation O
start _RARE_
site O
) O
at _RARE_
the O
5 O
'- O
flanking O
region O
of O
the O
human I-GENE
GnRHR _RARE_
gene I-GENE
that O
is O
responsible O
for _RARE_
the O
GnRHa _RARE_
- O
mediated _RARE_
down O
- O
regulation _RARE_
of O
human I-GENE
GnRHR _RARE_
promoter I-GENE
activity O
. O

The O
mean O
day O
of O
diagnosis O
of O
periventricular _RARE_
echodensities _RARE_
was O
3 O
+/- O
2 O
days O
( O
range O
1 O
- O
11 O
days O
), _RARE_
and O
of O
cystic _RARE_
PVL _RARE_
21 O
+/- O
8 O
days O
( O
range O
2 O
- O
47 _RARE_
days O
). O

The O
LAMMER _RARE_
protein O
kinase O
encoded O
by O
the O
Doa _RARE_
locus I-GENE
of O
Drosophila O
is O
required O
in O
both O
somatic O
and O
germline _RARE_
cells O
and O
is O
expressed _RARE_
as _RARE_
both O
nuclear O
and O
cytoplasmic O
isoforms O
throughout O
development O
. O

We O
have O
mutated _RARE_
to O
cysteine O
, O
one O
at _RARE_
a O
time O
, O
21 O
consecutive O
residues O
in O
the O
fourth O
TMS _RARE_
( O
TM4 _RARE_
). O

( O
1995 O
) O
J _RARE_
. O

HYPOTHESIS _RARE_
: O
The O
aim O
of O
this O
study O
was O
to O
investigate O
the O
oxidative O
susceptibility _RARE_
of O
apolipoprotein I-GENE
B I-GENE
- I-GENE
containing I-GENE
lipoproteins _RARE_
and O
antioxidant O
status O
in O
patients O
with O
acute O
coronary O
syndromes O
and O
chronic O
stable O
angina O
pectoris O
. O

In O
group O
B O
37 O
MBq O
in O
150 _RARE_
microL _RARE_
of O
99mTc O
- O
HSA _RARE_
nanocolloid _RARE_
was O
additionally O
injected O
intradermally _RARE_
18 O
h O
before O
surgery O
( O
3 O
- O
6 O
aliquots _RARE_
injected O
perilesionally _RARE_
). O

Post O
- O
operative O
functional _RARE_
outcome O
is O
related O
to O
pre O
- O
operative O
functional _RARE_
status O
. O

We O
cloned _RARE_
a O
DNA O
fragment O
encoding O
the O
N O
- O
terminal O
part O
of O
a O
protein O
with O
significant O
similarity _RARE_
to O
members O
of O
the O
LysR _RARE_
family I-GENE
of I-GENE
transcriptional I-GENE
regulators _RARE_
( O
LTTRs _RARE_
). O

AGO1 _RARE_
is O
similar O
to O
QDE _RARE_
- I-GENE
2 I-GENE
required O
for _RARE_
quelling _RARE_
and O
RDE _RARE_
- I-GENE
1 I-GENE
required O
for _RARE_
RNAi _RARE_
. O

Intracellular _RARE_
localization _RARE_
studies O
using O
the O
mDAP _RARE_
- I-GENE
3 I-GENE
/ O
EGFP _RARE_
fusion O
protein O
, O
cell O
fractionation O
and O
protease O
protection O
experiments O
localized O
mDAP _RARE_
- I-GENE
3 I-GENE
to O
the O
mitochondrial O
matrix _RARE_
. O

We O
could O
demonstrate O
the O
involvement O
of O
cAMP I-GENE
- I-GENE
dependent I-GENE
protein I-GENE
kinase I-GENE
( O
PKA I-GENE
) O
in O
the O
phosphorylation _RARE_
of O
CDC25Mm _RARE_
in O
fibroblasts _RARE_
overexpressing O
this O
RasGEF _RARE_
as _RARE_
well _RARE_
as _RARE_
in O
mouse O
brain O
synaptosomal _RARE_
membranes O
. O

Reporter _RARE_
gene O
expression _RARE_
analyses O
indicate O
that O
both O
WASP _RARE_
promoters I-GENE
show O
high O
levels O
of O
expression _RARE_
in O
different O
hematopoietic O
cell O
lines O
. O

We O
find O
that O
3T1 _RARE_
- O
3T2 _RARE_
mixing _RARE_
has O
a O
pronounced O
effect O
on O
the O
line O
shape O
and O
radiative _RARE_
decay _RARE_
rate O
of O
emission O
from O
the O
3T2 _RARE_
state O
and O
that O
the O
extent O
of O
mixing _RARE_
depends O
critically _RARE_
on O
the O
magnitude O
of O
nontetrahedral _RARE_
distortions _RARE_
. O

A O
total _RARE_
of O
576 _RARE_
1 O
- O
day O
- O
old O
Ross _RARE_
broiler _RARE_
chicks O
were O
housed _RARE_
in O
six _RARE_
treatment O
groups O
[ _RARE_
six _RARE_
replicates _RARE_
of O
16 O
each O
; O
control O
, O
CLI _RARE_
( O
15 _RARE_
g O
kg O
(- _RARE_
1 O
) O
diet O
), _RARE_
50 O
parts O
per O
billion _RARE_
( O
ppb O
) O
AF _RARE_
, O
50 O
ppb O
AF _RARE_
plus _RARE_
CLI _RARE_
, O
100 _RARE_
ppb O
AF _RARE_
, O
100 _RARE_
ppb O
AF _RARE_
plus _RARE_
CLI _RARE_
] O
for _RARE_
42 _RARE_
days O
. O

The O
cost O
per O
test O
is O
less O
than O
those O
for _RARE_
CC _RARE_
, O
kEIA _RARE_
and O
PACE2 _RARE_
. O

Altogether O
these O
results O
suggest O
that O
, O
in O
KG1a _RARE_
cells O
, O
TNFalpha _RARE_
can O
stimulate O
in O
parallel O
PC I-GENE
- I-GENE
PLC I-GENE
and O
PLD _RARE_
, O
whose O
lipid _RARE_
products O
activate O
in O
turn _RARE_
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
( O
MAP I-GENE
kinase I-GENE
) O
and O
NF _RARE_
- I-GENE
kappaB I-GENE
signalling O
respectively O
. O

Concurrently _RARE_
, O
we O
monitored O
weather _RARE_
conditions O
and O
used O
time O
- O
activity O
budget _RARE_
data O
of O
free O
- O
living O
birds O
and O
laboratory O
data O
on O
resting O
metabolic O
rate O
to O
construct O
time O
- O
activity O
laboratory O
( O
TAL _RARE_
) O
estimates O
of O
daily O
energy O
expenditure O
( O
DEE _RARE_
) O
and O
to O
partition _RARE_
the O
verdins _RARE_
' O
energy O
budget _RARE_
into O
thermoregulatory _RARE_
, O
activity O
and O
basal O
components _RARE_
. O

L O
/ O
H O
> O
0 _RARE_
. O
61 _RARE_
( O
chi _RARE_
( O
2 O
)= _RARE_
10 O
. O
8 O
; O
P O
:< _RARE_
0 _RARE_
. O
001 O
) O
and O
a O
restrictive O
filling O
pattern O
( O
chi _RARE_
( O
2 O
)= _RARE_
3 O
. O
6 O
; O
P O
:< _RARE_
0 _RARE_
. O
05 O
) O
were O
independent O
predictors O
of O
events O
. O

The O
high O
selectivity O
of O
arrestins _RARE_
for _RARE_
this O
particular O
functional _RARE_
form O
of O
receptor O
ensures _RARE_
their O
timely _RARE_
binding O
and O
dissociation O
. O

When O
cotransfected O
in O
fibroblasts _RARE_
with O
a O
C I-GENE
/ I-GENE
EBP I-GENE
alpha I-GENE
expression _RARE_
vector O
, O
reporter O
gene O
expression _RARE_
increased O
3 O
- O
fold _RARE_
only O
in O
the O
wild O
- O
type O
constructs O
. O

Expression O
of O
a O
dominant I-GENE
negative I-GENE
Smad2 _RARE_
significantly O
reduces O
the O
level O
of O
luciferase I-GENE
reporter I-GENE
activity O
induced _RARE_
by O
nodal O
treatment O
. O

Normal _RARE_
alpha1 _RARE_
( I-GENE
I I-GENE
) I-GENE
collagen _RARE_
mRNA I-GENE
showed O
no _RARE_
significant O
reduction O
when O
AR _RARE_
or O
IR O
was O
expressed _RARE_
from O
the O
pHbetaAPr _RARE_
- O
1 O
- O
neo _RARE_
vector O
and O
a O
small O
( O
10 O
- O
20 O
%) O
but O
significant O
reduction O
when O
either O
ribozyme _RARE_
was O
expressed _RARE_
from O
the O
pCI _RARE_
. O
neo _RARE_
vector O
. O

Nature _RARE_
398 _RARE_
, O
828 _RARE_
- O
830 _RARE_
) O
that O
the O
amino O
acid O
sequences O
of O
peptide O
fragments O
obtained O
from O
a O
polypeptide O
found O
in O
a O
complex O
of O
proteins O
that O
alters O
chromatin O
structure _RARE_
( O
ARC _RARE_
) O
are O
identical O
to O
portions O
of O
the O
deduced O
open _RARE_
reading O
frame O
of O
TIG _RARE_
- I-GENE
1 I-GENE
mRNA I-GENE
. O

Abnormalities _RARE_
of O
plasma I-GENE
cholecystokinin _RARE_
were O
observed O
only O
in O
patients O
with O
delayed O
gastric _RARE_
emptying O
. O

5 O
( O
Sunset _RARE_
Yellow _RARE_
FCF _RARE_
) O
were O
determined O
using O
liquid O
chromatography O
/ O
mass O
spectrometry O
( O
LC _RARE_
/ O
MS O
) O
with O
electrospray _RARE_
ionization _RARE_
. O

Polysome _RARE_
and O
40S _RARE_
ribosome _RARE_
fractions O
were O
severely O
decreased O
in O
the O
krr1 _RARE_
mutant I-GENE
and O
Kri1p _RARE_
- O
depleted O
cells O
. O

They O
also O
negatively O
modulate O
the O
PI I-GENE
3 I-GENE
- I-GENE
kinase I-GENE
catalytic O
activity O
but O
to O
different O
extents _RARE_
, O
dependent O
on O
the O
unique O
N O
- O
terminal O
structure _RARE_
of O
each O
isoform O
. O

Cam _RARE_
kinase I-GENE
II I-GENE
induces O
in O
vivo O
phosphorylation _RARE_
of O
Smad2 _RARE_
and O
Smad4 _RARE_
and O
, O
to O
a O
lesser O
extent O
, O
Smad3 _RARE_
. O

The O
Drosophila I-GENE
melanogaster I-GENE
suppressor I-GENE
of I-GENE
sable _RARE_
gene I-GENE
, O
su _RARE_
( O
s O
), _RARE_
encodes O
a O
novel O
, O
150 _RARE_
- O
kDa O
nuclear O
RNA O
binding O
protein O
, O
SU _RARE_
( O
S O
), _RARE_
that O
negatively O
regulates O
RNA O
accumulation O
from O
mutant O
alleles O
of O
other O
genes O
that O
have O
transposon _RARE_
insertions O
in O
the O
5 O
' O
transcribed _RARE_
region O
. O

As O
a O
result O
, O
we O
have O
defined O
two O
arginine _RARE_
- O
rich O
motifs O
( O
ARM1 _RARE_
and O
ARM2 _RARE_
) O
that O
mediate O
the O
RNA O
binding O
activity O
of O
SU _RARE_
( O
S O
). O

This O
interaction O
inhibits O
the O
histone I-GENE
acetyltransferase _RARE_
activity O
of O
p300 I-GENE
, O
resulting O
in O
drastic _RARE_
reduction O
of O
nucleosomal _RARE_
histone I-GENE
acetylation O
and O
alteration O
of O
chromatin O
structure _RARE_
. O

Recombinant I-GENE
BRI1 _RARE_
- I-GENE
KD _RARE_
autophosphorylated _RARE_
on O
serine O
( O
Ser _RARE_
) O
and O
threonine O
( O
Thr _RARE_
) O
residues O
with O
p O
- O
Ser _RARE_
predominating _RARE_
. O

Flow _RARE_
cytomery _RARE_
was O
used O
for _RARE_
cell O
cycle _RARE_
analysis O
. O

Further O
research O
is O
required O
to O
better O
measure O
treatment O
effects O
, O
modification O
of O
MS O
natural _RARE_
history O
, O
and O
net _RARE_
societal _RARE_
costs O
of O
IFN I-GENE
beta I-GENE
- I-GENE
1b _RARE_
in O
RRMS _RARE_
. O

Cost _RARE_
- O
effectiveness O
of O
interferon _RARE_
beta I-GENE
- I-GENE
1b _RARE_
in O
slowing _RARE_
multiple O
sclerosis O
disability _RARE_
progression O
. O

Both O
the O
Cmax _RARE_
and O
AUC O
values O
were O
almost O
doubled _RARE_
with O
doubling _RARE_
the O
dose O
. O

Hyperactivation _RARE_
of O
Cdc2 I-GENE
in O
fission _RARE_
yeast O
causes O
cells O
to O
undergo O
a O
lethal O
premature O
mitosis O
called O
mitotic _RARE_
catastrophe _RARE_
. O

Diary _RARE_
. O

Cells _RARE_
differentiate O
in O
response O
to O
various O
extracellular O
stimuli O
. O

Transforming _RARE_
growth I-GENE
factor I-GENE
- I-GENE
beta1 I-GENE
( O
TGF I-GENE
- I-GENE
beta1 I-GENE
) O
can O
act O
as _RARE_
a O
tumor O
suppressor O
or O
a O
tumor O
promoter O
depending O
on O
the O
characteristics O
of O
the O
malignant O
cell O
. O

Vasoactive _RARE_
intestinal _RARE_
peptide I-GENE
and O
pituitary I-GENE
adenylate I-GENE
cyclase I-GENE
- I-GENE
activating I-GENE
polypeptide I-GENE
inhibit O
nuclear I-GENE
factor I-GENE
- I-GENE
kappa _RARE_
B I-GENE
- I-GENE
dependent I-GENE
gene I-GENE
activation O
at _RARE_
multiple O
levels O
in O
the O
human O
monocytic O
cell O
line O
THP _RARE_
- O
1 O
. O

Mn2 _RARE_
+ O
increased O
both O
the O
junction _RARE_
binding O
and O
cleaving _RARE_
activities O
of O
the O
mutant O
proteins O
. O

While O
Pt _RARE_
; I-GENE
cycH _RARE_
; I-GENE
1 I-GENE
and O
Os _RARE_
; I-GENE
cycH _RARE_
; I-GENE
1 I-GENE
were O
expressed _RARE_
in O
all O
tissues O
examined O
, O
the O
transcripts O
accumulated O
abundantly O
in O
dividing _RARE_
cells O
. O

Moreover O
, O
an O
in O
vitro O
pull _RARE_
- O
down O
assay O
showed O
that O
Os _RARE_
; I-GENE
CycH _RARE_
; I-GENE
1 I-GENE
specifically O
bound _RARE_
to O
R2 _RARE_
but O
not O
to O
other O
rice _RARE_
CDKs _RARE_
. O

In O
transient O
analysis O
using O
particle _RARE_
bombardment _RARE_
of O
tobacco O
leaf O
sections O
, O
a O
tetramer _RARE_
of O
the O
distB _RARE_
ABRE _RARE_
( O
abscisic _RARE_
acid O
- O
responsive O
element O
) O
mediated _RARE_
transactivation _RARE_
by O
ABI3 _RARE_
and O
ABI3 _RARE_
- O
dependent O
response O
to O
ABA _RARE_
, O
whereas O
a O
tetramer _RARE_
of O
the O
composite O
RY _RARE_
/ O
G O
complex O
, O
containing O
RY _RARE_
repeats O
and O
a O
G O
- O
box O
, O
mediated _RARE_
only O
ABA _RARE_
- O
independent O
transactivation _RARE_
by O
ABI3 _RARE_
. O

The O
major O
neurological O
manifestations O
of O
brain O
injury O
in O
these O
babies O
are O
spastic _RARE_
motor O
deficits O
. O

Spores _RARE_
from O
Rhizopus _RARE_
stolonifer _RARE_
were O
suspended _RARE_
in O
distilled _RARE_
water O
( O
1 O
x _RARE_
10 O
( O
6 O
) O
spores _RARE_
/ O
mL O
) O
and O
used O
as _RARE_
starter _RARE_
. O

Overexpression O
of O
Trdpm1 _RARE_
in O
a O
dpm1 _RARE_
(+):: _RARE_
his7 _RARE_
/ I-GENE
dpm1 _RARE_
(+) _RARE_
S O
. O
pombe O
diploid O
resulted O
in O
a O
4 O
- O
fold _RARE_
increase O
in O
specific O
DPM _RARE_
synthase I-GENE
activity O
. O

The O
LMW _RARE_
FGF I-GENE
- I-GENE
2 I-GENE
up _RARE_
- O
regulated O
the O
PKC I-GENE
epsilon I-GENE
levels O
by O
1 O
. O
6 O
- O
fold _RARE_
; O
by O
contrast O
the O
HMW _RARE_
isoform I-GENE
down O
- O
regulated O
the O
level O
of O
this O
PKC I-GENE
isotype _RARE_
by O
about O
3 O
- O
fold _RARE_
and O
increased O
the O
amount O
of O
PKC I-GENE
delta I-GENE
by O
1 O
. O
7 O
- O
fold _RARE_
. O

Helicobacter _RARE_
pylori _RARE_
and O
stomach O
diseases O
: O
from O
clinical O
point O
of O
view O

For O
this O
purpose O
, O
the O
writhing _RARE_
test O
, O
capsaicin _RARE_
and O
formalin O
induced _RARE_
- O
pain O
in O
mice O
were O
used O
. O

2000 O
update _RARE_
of O
recommendations _RARE_
for _RARE_
the O
use O
of O
hematopoietic I-GENE
colony I-GENE
- I-GENE
stimulating I-GENE
factors I-GENE
: O
evidence O
- O
based O
, O
clinical O
practice O
guidelines O
. O

Prominent _RARE_
findings O
were O
chronic O
pancreatitis O
with O
acinar _RARE_
and O
ductal _RARE_
plugs _RARE_
, O
granulomatous _RARE_
and O
necrotizing _RARE_
peripancreatic _RARE_
steatitis _RARE_
, O
degenerative _RARE_
myopathy _RARE_
, O
testicular _RARE_
atrophy O
, O
candidiasis O
and O
bacterial O
necrotizing _RARE_
glossitis _RARE_
. O

Taken O
together O
, O
our O
data O
indicate O
that O
multiple O
survival O
pathways O
are O
triggered O
via O
this O
receptor O
, O
whereas O
NF _RARE_
- I-GENE
kappaB I-GENE
/ O
Rel I-GENE
and O
PI I-GENE
- I-GENE
3K _RARE_
are O
crucial O
for _RARE_
CD40 I-GENE
- O
induced _RARE_
proliferation _RARE_
. O

In O
vitro O
, O
Arix _RARE_
and O
NBPhox _RARE_
form O
DNA O
- O
independent O
multimers _RARE_
and O
exhibit O
cooperative O
binding O
to O
the O
DB1 _RARE_
regulatory I-GENE
element I-GENE
, O
which O
contains O
two O
homeodomain _RARE_
recognition I-GENE
sites I-GENE
. O

We O
conclude O
from O
this O
study O
that O
Arix _RARE_
and O
NBPhox _RARE_
exhibit O
indistinguishable O
and O
independent O
transcriptional O
regulatory O
properties O
on O
the O
DBH _RARE_
promoter I-GENE
. O

METHODS O
AND _RARE_
RESULTS O
: O
Studies O
were O
undertaken O
in O
9 O
isolated O
guinea _RARE_
pig _RARE_
hearts O
, O
which O
demonstrated O
reverse O
use O
- O
dependent O
prolongation O
of O
cardiac O
repolarization _RARE_
by O
100 _RARE_
nmol O
/ O
L O
domperidone _RARE_
. O

The O
N O
- O
terminal O
small O
segment O
of O
yeast I-GENE
TAF145 _RARE_
( O
yTAF145 _RARE_
) O
binds O
to O
TBP I-GENE
and O
thereby O
inhibits O
TBP I-GENE
function O
. O

OBJECTIVE O
: O
To O
evaluate O
the O
overall O
performance O
of O
a O
new O
oscillometric _RARE_
wrist O
blood _RARE_
pressure O
monitor O
( O
Braun _RARE_
PrecisionSensor _RARE_
, O
Braun _RARE_
GmbH _RARE_
, O
Kronberg _RARE_
, O
Germany _RARE_
) O
as _RARE_
defined O
by O
the O
ANSI _RARE_
/ O
AAMI _RARE_
SP10 _RARE_
- O
1992 O
guidelines O
, O
and O
to O
analyze O
the O
data O
for _RARE_
the O
optimized _RARE_
selection O
of O
the O
algorithm O
that O
derives _RARE_
the O
blood _RARE_
pressure O
values O
from O
the O
oscillometric _RARE_
blood _RARE_
pressure O
curves O
. O

Following O
the O
results O
of O
toxicological O
experiments O
in O
the O
target O
animals O
" O
Toxicological _RARE_
Drinking _RARE_
Water _RARE_
Standards _RARE_
for _RARE_
Animals O
" O
can O
be O
established O
. O

An O
increase O
in O
hypothalamic _RARE_
expression _RARE_
of O
at _RARE_
least O
two O
of O
the O
erbB I-GENE
receptors I-GENE
is O
initiated _RARE_
before O
the O
pubertal _RARE_
augmentation _RARE_
of O
gonadal _RARE_
steroid O
secretion _RARE_
and O
is O
completed O
on O
the O
day O
of O
the O
first _RARE_
preovulatory _RARE_
surge _RARE_
of O
gonadotropins _RARE_
. O

Dsh _RARE_
is O
required O
for _RARE_
two O
different O
pathways O
, O
the O
Wnt I-GENE
pathway _RARE_
and O
planar _RARE_
polarity O
pathway _RARE_
in O
Drosophila O
. O

Catch _RARE_
- O
up _RARE_
growth O
and O
craniofacial _RARE_
dimensions O
following O
administration O
of O
the O
antineoplastic _RARE_
agent O
vincristine O
to O
young O
rats O
. O

CONCLUSIONS O
: O
LSCC _RARE_
malformation _RARE_
, O
like O
other O
inner O
ear O
malformations O
such O
as _RARE_
large O
vestibular O
aqueduct _RARE_
and O
X O
- O
linked _RARE_
mixed O
deafness _RARE_
with O
perilymph _RARE_
gusher _RARE_
, O
can O
be O
associated O
with O
CHL _RARE_
, O
SNHL _RARE_
, O
or O
normal O
hearing O
. O

Escalation _RARE_
to O
180 O
mg O
/ O
m2 O
was O
to O
be O
carried O
out O
if O
white _RARE_
blood _RARE_
cell O
nadir _RARE_
count O
was O
> O
2 O
. O
0 _RARE_
x _RARE_
10 O
( O
9 O
)/ _RARE_
l _RARE_
and O
platelet O
nadir _RARE_
count O
was O
> O
75 _RARE_
x _RARE_
10 O
( O
9 O
)/ _RARE_
l _RARE_
. O

Methyl _RARE_
formate O
was O
used O
as _RARE_
the O
solvent O
of O
biodegradable _RARE_
oligoesters _RARE_
for _RARE_
the O
fabrication _RARE_
of O
microspheres O
with O
encapsulated _RARE_
bovine I-GENE
serum I-GENE
albumin I-GENE
( O
BSA _RARE_
). O

The O
small I-GENE
monomeric _RARE_
GTP I-GENE
- I-GENE
binding I-GENE
proteins I-GENE
of O
the O
RAB _RARE_
subfamily I-GENE
are O
key O
regulatory O
elements O
of O
the O
machinery O
that O
controls O
membrane O
traffic _RARE_
in O
eukaryotic O
cells O
. O

Furthermore O
, O
loss _RARE_
of O
methylation O
also O
greatly O
reduced _RARE_
the O
association O
of O
another O
yeast O
B O
- O
type O
subunit O
, O
Rts1p _RARE_
. O

Thus O
, O
methylation O
of O
Pph21p _RARE_
is O
important O
for _RARE_
formation O
of O
PP2A I-GENE
trimeric _RARE_
and I-GENE
dimeric _RARE_
complexes I-GENE
, O
and O
consequently _RARE_
, O
for _RARE_
PP2A I-GENE
function O
. O

The O
purpose O
of O
this O
study O
was O
to O
analyze O
the O
temporal O
characteristics O
and O
the O
spatial O
mapping O
of O
the O
independent O
components _RARE_
identified O
by O
ICA _RARE_
when O
the O
subject O
performs _RARE_
a O
finger O
- O
tapping _RARE_
task O
. O

The O
authors O
present O
the O
only O
two O
studies O
that O
have O
proved O
successful O
in O
treating _RARE_
animal _RARE_
models O
of O
osteoarthritis _RARE_
using O
gene O
therapy O
, O
and O
propose O
an O
overview _RARE_
of O
several O
strategies O
for _RARE_
the O
development O
of O
gene O
therapy O
in O
osteoarthritis _RARE_
treatment O
in O
the O
future O
. O

Together O
, O
these O
results O
indicate O
that O
IL _RARE_
- I-GENE
1 I-GENE
beta I-GENE
induces O
VEGF I-GENE
gene I-GENE
expression _RARE_
at _RARE_
both O
transcriptional O
and O
post O
- O
transcriptional O
levels O
, O
and O
IL _RARE_
- I-GENE
1 I-GENE
beta I-GENE
evokes _RARE_
p38 I-GENE
MAPK _RARE_
and O
JNK I-GENE
signalings _RARE_
, O
which O
in O
turn _RARE_
stimulate O
the O
transcription O
of O
the O
VEGF I-GENE
gene I-GENE
through O
Sp1 _RARE_
- I-GENE
binding I-GENE
sites I-GENE
. O

Binding O
of O
NusA _RARE_
to O
RNA O
in O
the O
presence O
of O
alpha O
or O
N O
involves O
an O
amino I-GENE
- I-GENE
terminal I-GENE
S1 I-GENE
homology I-GENE
region I-GENE
that O
is O
otherwise O
inactive O
in O
full I-GENE
- I-GENE
length I-GENE
NusA _RARE_
. O

The O
subjects O
were O
diagnosed O
on O
the O
basis O
of O
DSM _RARE_
- O
IV O
pathological O
gambling _RARE_
criteria O
and O
completed O
the O
Turkish _RARE_
Version _RARE_
of O
South _RARE_
Oaks _RARE_
Gambling _RARE_
Screen _RARE_
( O
SOGS _RARE_
). O

Lys _RARE_
( O
193 O
) O
and O
Arg O
( O
194 _RARE_
), _RARE_
located _RARE_
at _RARE_
the O
COOH _RARE_
- O
terminal O
end O
of O
HD I-GENE
, O
are O
essential O
for _RARE_
dimerization _RARE_
. O

Elevation _RARE_
of O
intracellular _RARE_
Ca O
( O
2 O
+) O
levels O
are O
also O
involved O
because O
treatment O
with O
receptor O
- O
associated O
protein O
, O
nifedipine O
, O
MK801 _RARE_
, O
removal O
of O
Ca O
( O
2 O
+) O
from O
the O
medium O
and O
dantrolene _RARE_
all O
served _RARE_
to O
inhibit O
calcium _RARE_
elevation O
and O
attenuate _RARE_
the O
activation O
of O
CREB I-GENE
. O

The O
present O
study O
shows O
that O
phosphatidylinositol _RARE_
3 I-GENE
- I-GENE
kinase I-GENE
- O
dependent O
p38 I-GENE
kinase I-GENE
activation O
regulates O
Akt I-GENE
phosphorylation _RARE_
and O
activity O
in O
human O
neutrophils O
. O

When O
BFDS _RARE_
was O
taken O
as _RARE_
the O
reference O
, O
W _RARE_
/ O
A O
Z O
scores O
showed O
consistent O
positive O
increments _RARE_
, O
from O
birth O
in O
girls O
and O
1 O
mo O
in O
boys O
. O

These O
probable O
border _RARE_
sequences O
are O
closely O
related O
to O
those O
of O
other O
known O
T O
- O
regions O
and O
define O
a O
second O
T O
- O
region O
of O
pTiChry5 _RARE_
, O
called O
T O
- O
right O
( O
TR O
), _RARE_
that O
confers O
production O
of O
the O
Amadoriopines _RARE_
. O

Using O
purified _RARE_
recombinant I-GENE
HMG I-GENE
I I-GENE
, O
we O
have O
identified O
several O
high O
- O
affinity O
binding O
sites O
which O
overlap O
important O
transcription O
factor O
binding O
sites O
. O

High _RARE_
- I-GENE
mobility I-GENE
- I-GENE
group I-GENE
protein I-GENE
I I-GENE
can O
modulate O
binding O
of O
transcription O
factors O
to O
the O
U5 _RARE_
region I-GENE
of O
the O
human I-GENE
immunodeficiency I-GENE
virus I-GENE
type I-GENE
1 I-GENE
proviral _RARE_
promoter I-GENE
. O

Another O
cis O
- O
acting O
element O
, O
exonic _RARE_
splicing _RARE_
suppressor O
1 O
( O
ESS1 _RARE_
), _RARE_
represses O
use O
of O
the O
nt O
3225 _RARE_
3 O
' O
splice _RARE_
site O
. O

Leptinaemia _RARE_
does O
not O
correlate O
with O
the O
actual O
or O
mean O
blood _RARE_
pressure O
reading O
nor O
with O
stage _RARE_
of O
hypertension O
according O
to O
the O
WHO _RARE_
classification O
. O

5 O
'- O
RACE O
analysis O
suggested O
a O
single O
transcription O
initiation O
site O
187 _RARE_
bp O
upstream O
from O
the O
translational O
start _RARE_
site O
. O

Thus O
, O
diamide _RARE_
treatment O
of O
nuclear O
extracts O
strongly O
reduces O
the O
binding O
of O
NFI _RARE_
proteins I-GENE
, O
and O
the O
addition O
of O
higher _RARE_
concentrations O
of O
dithiothreitol _RARE_
to O
nuclear O
extracts O
from O
TG I-GENE
- O
treated O
cells O
restores O
NFI _RARE_
- I-GENE
DNA I-GENE
binding O
to O
levels O
in O
extracts O
from O
untreated O
cells O
. O

LMP2A _RARE_
enhances O
Lyn I-GENE
and O
Syk _RARE_
ubiquitination O
in O
vivo O
in O
a O
fashion O
that O
depends O
on O
the O
activity O
of O
Nedd4 _RARE_
family O
members O
and O
correlates O
with O
destabilization _RARE_
of O
the O
Lyn I-GENE
tyrosine I-GENE
kinase I-GENE
. O

Further O
, O
Tax _RARE_
- O
mediated _RARE_
apoptosis O
was O
effectively O
prevented O
by O
ectopic O
expression _RARE_
of O
the O
p300 I-GENE
coactivator _RARE_
. O

Our O
results O
, O
however O
, O
were O
obtained O
for _RARE_
Z O
itself O
and O
not O
for _RARE_
[ _RARE_
Z O
]. O

Fisher _RARE_
' O
s O
exact _RARE_
test O
or O
Pearson _RARE_
' O
s O
chi2 _RARE_
test O
were O
used O
for _RARE_
statistical O
analysis O
. O

RESULTS O
: O
In O
the O
pregnant _RARE_
group O
, O
serum O
PP14 _RARE_
concentrations O
were O
markedly O
increased O
after O
ET _RARE_
, O
and O
a O
significant O
difference O
between O
the O
pregnant _RARE_
group O
and O
the O
nonpregnant _RARE_
group O
was O
observed O
8 O
days O
following O
ET _RARE_
( O
p O
< O
0 _RARE_
. O
01 O
). O

Thromboelastography _RARE_
is O
a O
test O
that O
could O
potentially O
correlate O
with O
the O
degree O
of O
anticoagulation _RARE_
produced O
by O
low O
molecular _RARE_
weight _RARE_
heparin _RARE_
. O

High _RARE_
expression _RARE_
of O
the O
peroxisome _RARE_
proliferator _RARE_
- I-GENE
activated I-GENE
receptor I-GENE
alpha I-GENE
( O
PPARalpha I-GENE
) O
differentiates _RARE_
brown O
fat O
from O
white _RARE_
, O
and O
is O
related O
to O
its O
high O
capacity O
of O
lipid _RARE_
oxidation O
. O

This O
- O
2485 _RARE_
/- O
2458 _RARE_
element O
bound _RARE_
PPARalpha I-GENE
and O
PPARgamma I-GENE
from O
brown O
fat O
nuclei O
. O

These O
results O
provide O
direct O
evidence O
for _RARE_
differential O
susceptibility _RARE_
to O
endonuclease O
- O
mediated _RARE_
mRNA O
decay _RARE_
resulting O
from O
the O
differential O
affinity O
of O
a O
RNA O
- O
binding O
protein O
for _RARE_
cis O
- O
acting O
stability O
determinants _RARE_
. O

RESULTS O
: O
Twenty O
- O
two O
( O
26 _RARE_
%) O
patients O
had O
PHG _RARE_
before O
( O
group O
A O
) O
and O
64 _RARE_
( O
74 _RARE_
%) O
developed O
PHG _RARE_
after O
variceal _RARE_
eradication O
( O
group O
B O
). O

Response O
was O
extremely O
poor O
in O
African O
Americans _RARE_
and O
those O
with O
HCV O
genotype _RARE_
1 O
. O

Aspirin _RARE_
causes O
peptic _RARE_
ulcers O
predominately _RARE_
by O
reducing _RARE_
gastric _RARE_
mucosal _RARE_
cyclooxygenase _RARE_
( O
COX _RARE_
) O
activity O
and O
prostaglandin _RARE_
synthesis _RARE_
. O

A O
total _RARE_
of O
1060 _RARE_
clones _RARE_
were O
randomly O
selected _RARE_
for _RARE_
sequencing O
of O
one O
end O
. O

Expression O
of O
a O
hybrid _RARE_
protein O
containing O
the O
cytoplasmic O
C O
- O
terminal O
half _RARE_
of O
UhpB _RARE_
fused O
to O
glutathione _RARE_
S I-GENE
- I-GENE
transferase I-GENE
( O
GST I-GENE
) O
also O
interfered _RARE_
with O
Uhp _RARE_
signaling _RARE_
. O

CONCLUSIONS O
: O
The O
surgical O
or O
multimodality _RARE_
treatment O
of O
MSGT _RARE_
has O
provided O
a O
good O
locoregional _RARE_
control O
( O
78 _RARE_
%) O
and O
68 _RARE_
% O
10 O
- O
year O
survival O
in O
a O
series O
of O
patients O
treated O
at _RARE_
the O
oncology _RARE_
department _RARE_
of O
a O
general _RARE_
hospital O
in O
Quito _RARE_
, O
Ecuador _RARE_
. O

RESULTS O
: O
Glaucoma _RARE_
suspects _RARE_
were O
divided O
into O
two O
groups O
according O
to O
their O
SWAP _RARE_
results O
: O
high O
risk O
( O
with O
SWAP _RARE_
abnormalities O
) O
and O
low O
risk O
( O
with O
normal O
SWAP _RARE_
result O
). O

The O
gene O
is O
separated O
into O
four O
exons O
by O
three O
short O
introns _RARE_
, O
and O
the O
open _RARE_
reading O
frame O
consists O
of O
6660 _RARE_
base _RARE_
pairs _RARE_
( O
bp O
) O
capable O
of O
encoding O
a O
polypeptide O
of O
2220 _RARE_
amino O
acid O
residues O
. O

Like O
the O
p190 I-GENE
- I-GENE
B I-GENE
exon _RARE_
, O
the O
first _RARE_
exon _RARE_
of O
p190 I-GENE
- I-GENE
A I-GENE
is O
extremely O
large O
( O
3 O
. O
7 O
kb O
in O
length O
), _RARE_
encoding O
both O
the O
GTPase I-GENE
and O
middle _RARE_
domains O
( O
residues O
1 O
- O
1228 _RARE_
), _RARE_
but O
not O
the O
remaining O
GAP _RARE_
domain I-GENE
, O
suggesting O
a O
high O
conservation O
of O
genomic O
structure _RARE_
between O
two O
p190 I-GENE
genes I-GENE
. O

The O
entire _RARE_
human I-GENE
teneurin _RARE_
- I-GENE
1 I-GENE
( O
TEN1 _RARE_
) O
gene O
is O
contained O
in O
eight O
PAC _RARE_
clones _RARE_
representing O
part O
of O
the O
chromosomal O
locus O
Xq25 _RARE_
. O

The O
plexiform _RARE_
neurofibroma _RARE_
and O
multiple O
localized O
neurofibromas _RARE_
are O
characteristic O
of O
NF1 I-GENE
. O

In O
general _RARE_
lookback _RARE_
, O
all O
patients O
who O
received O
blood _RARE_
before O
being O
tested O
for _RARE_
hepatitis O
C O
are O
advised _RARE_
to O
undergo O
testing O
. O

The O
proposed O
algorithm O
consists O
of O
several O
steps O
. O

It O
contained O
seven _RARE_
extra _RARE_
amino O
acids _RARE_
of O
FVVLNLQ _RARE_
; O
this O
short O
stretch O
of O
extra _RARE_
sequence O
was O
found O
between O
Gln O
( O
421 _RARE_
) O
and O
Phe _RARE_
( O
422 _RARE_
) O
within O
the O
SET _RARE_
( O
Suvar3 _RARE_
- I-GENE
9 I-GENE
, O
Enhancer _RARE_
- I-GENE
of I-GENE
- I-GENE
zeste _RARE_
, O
Trithorax _RARE_
) O
interacting _RARE_
domain O
( O
SID _RARE_
) O
of O
rMTM _RARE_
. O

MED1 _RARE_
has O
a O
weak O
glycosylase I-GENE
activity O
on O
the O
mutagenic _RARE_
adduct _RARE_
3 O
, O
N O
( O
4 O
)- O
ethenocytosine _RARE_
, O
a O
metabolite O
of O
vinyl O
chloride _RARE_
and O
ethyl O
carbamate _RARE_
. O

There O
were O
no _RARE_
instances O
of O
major O
flap O
necrosis O
although O
two O
flaps _RARE_
showed O
tip _RARE_
ischaemia O
. O

These O
results O
suggest O
that O
XAB1 _RARE_
is O
a O
novel O
cytoplasmic I-GENE
GTPase I-GENE
involved O
in O
nuclear O
localization _RARE_
of O
XPA _RARE_
. O

One O
of O
these O
factors O
, O
IRF I-GENE
- I-GENE
2 I-GENE
, O
was O
initially O
cloned _RARE_
as _RARE_
an O
antagonistic O
counterpart _RARE_
to O
IRF I-GENE
- I-GENE
1 I-GENE
with O
oncogenic _RARE_
potential _RARE_
. O

Among O
the O
total _RARE_
CDSs _RARE_
, O
8 O
. O
8 O
% O
match O
sequences O
of O
proteins O
found O
only O
in O
Bacillus O
subtilis O
and O
66 _RARE_
. O
7 O
% O
are O
widely O
conserved _RARE_
in O
comparison O
with O
the O
proteins O
of O
various O
organisms O
, O
including O
B O
. O
subtilis O
. O

Tobramycin _RARE_
- O
loaded _RARE_
SLN _RARE_
administered O
i O
. O
v O
. O
showed O
a O
prolonged O
circulation O
time O
compared O
to O
the O
i O
. O
v O
. O
administered O
tobramycin _RARE_
solution O
. O

Bacteriol _RARE_
. O

Terminal _RARE_
deoxynucleotidyl _RARE_
transferase I-GENE
- O
mediated _RARE_
nick _RARE_
end O
labeling O
assays O
revealed O
that O
hormonal O
activation O
of O
the O
PAX3 _RARE_
repressors _RARE_
induced _RARE_
extensive O
apoptosis O
that O
correlated O
with O
down O
- O
regulation _RARE_
of O
BCL _RARE_
- I-GENE
X I-GENE
( I-GENE
L I-GENE
) I-GENE
expression _RARE_
. O

VEGF I-GENE
promoter I-GENE
activity O
in O
transient O
transfections O
was O
decreased O
by O
either O
pharmacological O
or O
genetic O
inhibition O
of O
EGFR I-GENE
, O
Ras I-GENE
, O
or O
phosphatidylinositol _RARE_
3 I-GENE
'- I-GENE
kinase I-GENE
[ _RARE_
PI O
( O
3 O
) O
kinase O
]. O

Epidermal _RARE_
growth I-GENE
factor I-GENE
receptor I-GENE
transcriptionally O
up _RARE_
- O
regulates O
vascular I-GENE
endothelial I-GENE
growth I-GENE
factor I-GENE
expression _RARE_
in O
human O
glioblastoma _RARE_
cells O
via O
a O
pathway _RARE_
involving O
phosphatidylinositol _RARE_
3 I-GENE
'- I-GENE
kinase I-GENE
and O
distinct O
from O
that O
induced _RARE_
by O
hypoxia _RARE_
. O

Thus O
, O
IHHNV _RARE_
is O
closely O
related O
to O
densoviruses _RARE_
of O
the O
genus O
Brevidensovirus _RARE_
in O
the O
family O
Parvoviridae _RARE_
, O
and O
we O
therefore O
propose O
to O
rename _RARE_
this O
virus O
Penaeus _RARE_
stylirostris _RARE_
densovirus _RARE_
( O
PstDNV _RARE_
). O

Stress _RARE_
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
1 I-GENE
( O
SAPK1 _RARE_
), _RARE_
also O
called O
c I-GENE
- I-GENE
Jun I-GENE
N I-GENE
- I-GENE
terminal I-GENE
kinase I-GENE
( O
JNK I-GENE
), _RARE_
becomes O
activated O
in O
vivo O
in O
response O
to O
pro O
- O
inflammatory O
cytokines _RARE_
or O
cellular O
stresses O
. O

Catalytic _RARE_
activation O
of O
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
( I-GENE
MAP I-GENE
) I-GENE
kinase I-GENE
phosphatase I-GENE
- I-GENE
1 I-GENE
by O
binding O
to O
p38 I-GENE
MAP I-GENE
kinase I-GENE
: O
critical O
role O
of O
the O
p38 I-GENE
C I-GENE
- I-GENE
terminal I-GENE
domain I-GENE
in O
its O
negative O
regulation _RARE_
. O

Thus O
, O
the O
class I-GENE
C I-GENE
- O
Vps _RARE_
complex O
directs O
multiple O
reactions O
during _RARE_
the O
docking _RARE_
and O
fusion O
of O
vesicles O
with O
the O
vacuole _RARE_
, O
each O
of O
which O
contributes O
to O
the O
overall O
specificity _RARE_
and O
efficiency O
of O
this O
transport _RARE_
process O
. O

Combined O
intravenous O
and O
intra _RARE_
- O
arterial O
recombinant O
tissue I-GENE
plasminogen I-GENE
activator I-GENE
in O
acute O
ischemic O
stroke O
. O

To O
begin O
to O
understand O
this O
role O
, O
we O
overexpressed O
ATF I-GENE
- I-GENE
2 I-GENE
in O
a O
human O
cancer _RARE_
cell O
line O
. O

Signal _RARE_
transduction _RARE_
via O
modulation O
of O
phosphorylation _RARE_
after O
selective O
inhibition O
of O
protein I-GENE
phosphatase I-GENE
( I-GENE
PP _RARE_
) I-GENE
1 I-GENE
and O
/ O
or O
PP2A I-GENE
appears O
to O
play O
a O
role O
in O
okadaic _RARE_
acid O
( O
OA _RARE_
)- O
mediated _RARE_
effects O
. O

Botulinum _RARE_
toxin _RARE_
A I-GENE
in O
the O
treatment O
of O
hemiplegic _RARE_
spastic _RARE_
foot O
drop O
-- _RARE_
clinical O
and O
functional _RARE_
outcomes O
. O

Exon _RARE_
A O
is O
located _RARE_
approximately _RARE_
7 O
kb O
5 O
' O
to O
the O
HSL _RARE_
translation I-GENE
start _RARE_
site I-GENE
. O

NF _RARE_
- I-GENE
kappaB I-GENE
is O
a O
redox _RARE_
- O
sensitive _RARE_
transcription O
factor O
known O
to O
be O
activated O
by O
oxidative O
stress O
as _RARE_
well _RARE_
as _RARE_
chemical O
and O
biological O
reductants _RARE_
. O

Cardiovascular _RARE_
risk O
factors O
and O
antihypertensive O
treatment O
. O

What _RARE_
to O
look _RARE_
for _RARE_
during _RARE_
a O
compliance O
review O
: O
10 O
common O
mistakes _RARE_
made O
by O
SNFs _RARE_
. O

CONCLUSIONS O
: O
EBCT _RARE_
technology O
allows O
minimally _RARE_
invasive O
evaluation O
of O
intramyocardial _RARE_
microcirculatory _RARE_
function O
and O
permits O
assessment O
of O
microvascular O
BV _RARE_
distribution O
in O
different O
functional _RARE_
components _RARE_
. O

These O
two O
mAbs _RARE_
used O
the O
same O
V O
( O
H O
) O
and O
J _RARE_
( O
H O
) O
gene O
segments _RARE_
, O
but O
different O
D O
, O
Vkappa _RARE_
, O
and O
Jkappa _RARE_
genes O
. O

SSF _RARE_
experiments O
were O
carried O
out O
in O
bench _RARE_
- O
scale O
bioreactors _RARE_
( O
equipped _RARE_
with O
CO2 O
and O
volatile O
organic O
traps _RARE_
) O
containing O
a O
mixture O
of O
lignocellulosic _RARE_
materials O
and O
a O
radiolabeled O
pesticide _RARE_
. O

Characterization O
of O
a O
Xenopus I-GENE
laevis _RARE_
CXC _RARE_
chemokine _RARE_
receptor I-GENE
4 I-GENE
: O
implications O
for _RARE_
hematopoietic O
cell O
development O
in O
the O
vertebrate _RARE_
embryo _RARE_
. O

Patients O
had O
to O
have O
adequate O
liver O
, O
renal _RARE_
, O
and O
marrow O
functions O
. O

Inhibition O
of O
RNA2 _RARE_
translation O
was O
selective O
, O
with O
no _RARE_
effect O
on O
general _RARE_
cellular O
translation O
or O
translation O
of O
BMV _RARE_
RNA1 _RARE_
- O
encoded O
replication I-GENE
factor I-GENE
1a _RARE_
, O
and O
was O
independent O
of O
p20 _RARE_
, O
a O
cellular O
antagonist O
of O
DED1 _RARE_
function O
in O
translation O
. O

Abbreviations _RARE_
: O
CAS _RARE_
, O
CRK _RARE_
- I-GENE
associated I-GENE
substrate I-GENE
; O
CH _RARE_
, O
calponin _RARE_
- I-GENE
homology I-GENE
domain I-GENE
; O
CSK _RARE_
, O
C I-GENE
- I-GENE
terminal I-GENE
SRC I-GENE
kinase I-GENE
; O
E6 _RARE_
, O
Papillomavirus _RARE_
E6 _RARE_
protein I-GENE
; O
FAK I-GENE
, O
focal _RARE_
adhesion I-GENE
kinase I-GENE
; O
GIT _RARE_
, O
GRK _RARE_
interacter _RARE_
; O
GPCR _RARE_
, O
heterotrimeric I-GENE
- I-GENE
G I-GENE
- I-GENE
protein I-GENE
- I-GENE
coupled I-GENE
receptor I-GENE
; O
GRK _RARE_
, O
G I-GENE
- I-GENE
protein I-GENE
- I-GENE
coupled I-GENE
- I-GENE
receptor I-GENE
kinase I-GENE
; O
MAPK _RARE_
, O
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinase I-GENE
( O
ERK I-GENE
, O
p38 I-GENE
, O
JNK I-GENE
); O
PAK _RARE_
, O
p21 I-GENE
- I-GENE
activated I-GENE
kinase I-GENE
; O
PBS _RARE_
, O
paxillin I-GENE
- I-GENE
binding I-GENE
subdomain _RARE_
; O
PIX _RARE_
, O
PAK _RARE_
- I-GENE
interacting _RARE_
exchange I-GENE
factor I-GENE
; O
PKL _RARE_
, O
paxillin I-GENE
kinase I-GENE
linker _RARE_
; O
POR1 _RARE_
, O
partner _RARE_
of I-GENE
Rac I-GENE
; O
PS _RARE_
, O
phosphoserine _RARE_
; O
PT O
, O
phosphothreonine _RARE_
; O
PY _RARE_
, O
phosphotyrosine _RARE_
; O
RTK _RARE_
, O
growth I-GENE
factor I-GENE
receptor I-GENE
tyrosine I-GENE
kinase I-GENE
; O
SH _RARE_
, O
SRC I-GENE
- I-GENE
homology I-GENE
domain I-GENE
. O

In O
15 _RARE_
ventilator _RARE_
- O
dependent O
, O
SB _RARE_
, O
and O
actively O
expiring _RARE_
patients O
, O
we O
found O
that O
the O
difference O
PEEP _RARE_
( O
i O
), _RARE_
dyn _RARE_
- O
Pga _RARE_
, O
total _RARE_
decay _RARE_
( O
mean O
+/- O
SD O
, O
5 O
. O
7 O
+/- O
1 O
. O
9 O
cm O
H O
( O
2 O
) O
O O
) O
was O
quite O
similar O
to O
PEEP _RARE_
( O
i O
), _RARE_
dyn _RARE_
ref _RARE_
( O
5 O
. O
3 O
+/- O
1 O
. O
9 O
cm O
H O
( O
2 O
) O
O O
). O

Of O
208 _RARE_
eligible _RARE_
subjects O
, O
82 O
received O
supervised _RARE_
IPT _RARE_
at _RARE_
a O
dose O
of O
900 _RARE_
mg O
twice O
weekly O
for _RARE_
6 O
mo O
( O
Regimen _RARE_
A O
), _RARE_
73 _RARE_
received O
unsupervised _RARE_
IPT _RARE_
900 _RARE_
mg O
twice O
weekly O
for _RARE_
6 O
mo O
( O
Regimen _RARE_
B O
), _RARE_
and O
53 O
received O
unsupervised _RARE_
IPT _RARE_
300 _RARE_
mg O
daily O
for _RARE_
6 O
mo O
( O
Regimen _RARE_
C O
). O

There O
were O
122 O
cases O
of O
tuberculosis O
over O
an O
average O
10 O
. O
3 O
yr O
of O
follow O
- O
up _RARE_
( O
crude O
annual O
incidence O
, O
76 _RARE_
. O
2 O
/ O
100 _RARE_
, O
000 _RARE_
). O

These O
results O
suggested O
that O
BACH1t _RARE_
recruits _RARE_
BACH1 _RARE_
to O
the O
nucleus O
through O
BTB I-GENE
domain O
- O
mediated _RARE_
interaction O
. O

The O
U17 _RARE_
/ O
U16 _RARE_
and O
the O
U16 _RARE_
+ I-GENE
gene I-GENE
products I-GENE
transactivated O
the O
HIV I-GENE
LTR I-GENE
. O

Transcription O
of O
the O
six _RARE_
EBNA I-GENE
genes I-GENE
, O
which O
are O
expressed _RARE_
in O
EBV _RARE_
- O
immortalized _RARE_
primary _RARE_
B O
cells O
, O
arises _RARE_
from O
one O
of O
two O
promoters O
, O
Cp I-GENE
and O
Wp _RARE_
, O
located _RARE_
near O
the O
left _RARE_
end O
of O
the O
viral O
genome O
. O

The O
Cili _RARE_
- I-GENE
2 I-GENE
sequences I-GENE
possess O
similarity _RARE_
to O
the O
RNaseH _RARE_
domain I-GENE
of O
Lian _RARE_
- O
Aa1 _RARE_
, O
a O
mosquito _RARE_
non I-GENE
- I-GENE
LTR I-GENE
retrotransposon _RARE_
. O

This O
dynamic O
response O
strongly O
suggests O
that O
the O
p53 I-GENE
and O
Rb _RARE_
tumor O
suppressor O
pathways O
are O
intact _RARE_
in O
HeLa O
cells O
and O
that O
repression O
of O
HPV I-GENE
E6 _RARE_
and O
E7 I-GENE
mobilizes _RARE_
these O
pathways O
in O
an O
orderly _RARE_
fashion O
to O
deliver _RARE_
growth O
inhibitory _RARE_
signals O
to O
the O
cells O
. O

Thus O
, O
blocks O
in O
the O
RARalpha _RARE_
- O
specific O
pathway _RARE_
of O
retinoid O
- O
induced _RARE_
differentiation O
may O
be O
bypassed _RARE_
during _RARE_
retinoid O
induction O
of O
FR _RARE_
- I-GENE
beta I-GENE
expression _RARE_
. O

Is O
more O
better O
? O
About _RARE_
dose O
levels O
of O
ACE I-GENE
inhibitors _RARE_
in O
chronic O
heart _RARE_
failure O
. O

To O
test O
whether O
or O
not O
SOCS _RARE_
- I-GENE
3 I-GENE
also O
binds O
to O
the O
IGFIR _RARE_
, O
we O
cloned _RARE_
human I-GENE
SOCS _RARE_
- I-GENE
3 I-GENE
by O
reverse O
transcription O
- O
polymerase O
chain O
reaction O
from O
human O
skeletal O
muscle O
mRNA O
. O

A O
protein O
lacking _RARE_
the O
SH2 _RARE_
and O
RING _RARE_
finger O
domains O
has O
no _RARE_
activity O
, O
but O
a O
chimeric O
protein O
with O
the O
SH2 _RARE_
and O
RING _RARE_
finger O
domains O
of O
SLI _RARE_
- I-GENE
1 I-GENE
replaced O
by O
the O
equivalent O
domains O
of O
c I-GENE
- I-GENE
Cbl I-GENE
has O
activity O
. O

To O
evaluate O
the O
effects O
of O
HRT _RARE_
on O
those O
factors O
in O
end O
- O
stage _RARE_
renal _RARE_
disease _RARE_
( O
ESRD _RARE_
) O
patients O
, O
we O
evaluated O
the O
changes O
of O
lipid _RARE_
profile O
, O
coagulation O
and O
fibrinolysis _RARE_
markers O
, O
and O
plasma O
homocysteine _RARE_
levels O
after O
treatment O
. O

There O
was O
a O
weak O
significant O
correlation O
between O
TGF I-GENE
beta I-GENE
1 I-GENE
levels O
and O
normal O
cell O
radiosensitivity _RARE_
( O
lymphocyte O
SF2 _RARE_
). O

Acute O
feasibility O
and O
safety O
of O
a O
smoking O
reduction O
strategy O
for _RARE_
smokers O
with O
schizophrenia O
. O

Tightly _RARE_
ordered _RARE_
proteasomal _RARE_
degradation _RARE_
of O
proteins O
critical O
for _RARE_
cell O
cycle _RARE_
control O
implies _RARE_
a O
role O
of O
the O
proteasome O
in O
maintaining O
cell O
proliferation _RARE_
and O
cell O
survival O
. O

The O
sixth _RARE_
nucleotide O
was O
bulged _RARE_
out O
to O
allow O
stacking _RARE_
of O
this O
U _RARE_
. O
G O
pair _RARE_
on O
the O
adjacent O
helical O
region O
. O

Functional O
analysis O
of O
the O
mutant I-GENE
desmin _RARE_
in O
SW13 _RARE_
( O
vim _RARE_
-) _RARE_
cells O
showed O
aggregation _RARE_
of O
abnormal O
coarse _RARE_
clumps _RARE_
of O
desmin _RARE_
positive O
material O
dispersed _RARE_
throughout O
the O
cytoplasm O
. O

Patients O
with O
lesions O
affecting O
the O
PRC _RARE_
but O
sparing _RARE_
the O
PHC _RARE_
, O
and O
patients O
with O
lesions O
affecting O
both O
PRC _RARE_
and O
PHC _RARE_
, O
performed O
an O
oculomotor _RARE_
delayed O
response O
task O
with O
unpredictably _RARE_
varied O
memory O
delays _RARE_
of O
up _RARE_
to O
30 _RARE_
s O
. O

In O
addition O
, O
26 _RARE_
amino O
acid O
residues O
, O
K69 _RARE_
, O
D88 _RARE_
, O
E94 _RARE_
, O
D134 _RARE_
, O
R154 _RARE_
, O
K169 _RARE_
, O
H197 _RARE_
, O
D233 _RARE_
, O
G235 _RARE_
, O
G236 _RARE_
, O
G237 _RARE_
, O
F238 _RARE_
, O
E274 _RARE_
, O
G276 _RARE_
, O
R277 _RARE_
, O
Y278 _RARE_
, O
K294 _RARE_
, O
Y323 _RARE_
, O
Y331 _RARE_
, O
D332 _RARE_
, O
C360 _RARE_
, O
D361 _RARE_
, O
D364 _RARE_
, O
G387 _RARE_
, O
Y389 _RARE_
, O
and O
F397 _RARE_
( O
mouse O
ODC _RARE_
numbering _RARE_
), _RARE_
all O
of O
which O
are O
implicated O
in O
the O
formation O
of O
the O
pyridoxal _RARE_
phosphate O
- O
binding O
domain O
and O
the O
substrate O
- O
binding O
domain O
and O
in O
dimer _RARE_
stabilization O
with O
the O
eukaryotic O
ODCs _RARE_
, O
were O
also O
conserved _RARE_
in O
S O
. O
ruminantium _RARE_
LDC _RARE_
. O

The O
Psc2 _RARE_
cDNA I-GENE
contained O
an O
open _RARE_
reading O
frame O
homologous O
to O
CP2 _RARE_
family I-GENE
proteins I-GENE
. O

Our O
results O
indicate O
that O
Shh _RARE_
can O
drive O
continued O
cycling _RARE_
in O
immature O
, O
proliferating _RARE_
CGNPs _RARE_
. O

The O
QT O
interval O
was O
related O
to O
various O
components _RARE_
of O
the O
insulin I-GENE
resistance O
syndrome _RARE_
, O
including O
BP _RARE_
and O
insulin I-GENE
sensitivity O
. O

The O
wavenumbers _RARE_
corresponding O
to O
the O
normal O
modes O
of O
vibration O
were O
calculated O
using O
the O
DFT _RARE_
( O
B3LYP _RARE_
/ O
6 O
- O
31G _RARE_
**) _RARE_
approximation _RARE_
and O
their O
agreement O
with O
the O
measured O
values O
improved O
after O
scaling _RARE_
of O
the O
associated O
force O
field O
. O

The O
data O
provide O
strong O
evidence O
that O
ThlA _RARE_
is O
involved O
in O
the O
metabolism O
of O
both O
acid O
and O
solvent O
formation O
, O
whereas O
the O
physiological O
function O
of O
ThlB _RARE_
has O
yet O
to O
be O
elucidated _RARE_
. O

In O
addition O
, O
npm3 _RARE_
, O
which O
is O
usually O
coactivated _RARE_
with O
fgf8 _RARE_
by O
MMTV _RARE_
insertion _RARE_
, O
was O
not O
up _RARE_
- O
regulated O
by O
androgens _RARE_
in O
SC O
- O
3 O
cells O
. O

Experiments O
with O
epitope _RARE_
- O
tagged _RARE_
proteins O
show O
that O
UEV1A _RARE_
is O
a O
nuclear O
protein O
, O
whereas O
both O
Kua _RARE_
and O
Kua _RARE_
- O
UEV _RARE_
localize O
to O
cytoplasmic O
structures _RARE_
, O
indicating O
that O
the O
Kua _RARE_
domain I-GENE
determines _RARE_
the O
cytoplasmic O
localization _RARE_
of O
Kua _RARE_
- O
UEV _RARE_
. O

Stoichiometric _RARE_
phosphorylation _RARE_
of O
human I-GENE
p53 I-GENE
at _RARE_
Ser315 _RARE_
stimulates O
p53 I-GENE
- O
dependent O
transcription O
. O
p53 I-GENE
protein I-GENE
activity O
as _RARE_
a O
transcription O
factor O
can O
be O
activated O
in O
vivo O
by O
antibodies O
that O
target O
its O
C O
- O
terminal O
negative O
regulatory O
domain O
suggesting O
that O
cellular O
enzymes _RARE_
that O
target O
this O
domain O
may O
play O
a O
role O
in O
stimulating O
p53 I-GENE
- O
dependent O
gene O
expression _RARE_
. O

Interestingly O
, O
this O
mutant O
cell O
line O
lacks O
expression _RARE_
of O
the O
IKK _RARE_
regulatory I-GENE
protein I-GENE
, O
IKKgamma _RARE_
. O

The O
Tax _RARE_
/ O
IKKgamma _RARE_
interaction O
serves O
to O
recruit O
Tax _RARE_
to O
the O
IKK _RARE_
catalytic I-GENE
subunits I-GENE
, O
IKKalpha _RARE_
and O
IKKbeta _RARE_
, O
and O
this O
recruitment O
appears O
to O
be O
an O
essential O
mechanism O
by O
which O
Tax _RARE_
stimulates O
the O
activity O
of O
IKK _RARE_
. O

An O
anchored _RARE_
AFLP _RARE_
- O
and O
retrotransposon _RARE_
- O
based O
map O
of O
diploid O
Avena _RARE_
. O

In O
addition O
, O
we O
identified O
a O
novel O
type O
of O
inhibitory _RARE_
domain O
in O
the O
N O
- O
terminal O
60 _RARE_
amino O
acids _RARE_
of O
IRF I-GENE
- I-GENE
1 I-GENE
which O
strongly O
inhibits O
its O
transcriptional O
activity O
. O

Effects O
of O
spatial O
and O
temporal O
smoothing _RARE_
on O
stimulated _RARE_
brillouin _RARE_
scattering _RARE_
in O
the O
independent O
- O
hot O
- O
spot _RARE_
model O
limit O
The O
influence O
of O
laser O
beam O
smoothing _RARE_
on O
stimulated _RARE_
Brillouin _RARE_
backscattering _RARE_
( O
SBBS _RARE_
) O
is O
studied O
analytically _RARE_
in O
the O
limit O
of O
the O
independent O
hot O
spot _RARE_
model O
. O

Simultaneous _RARE_
determination O
of O
theophylline O
and O
its O
metabolites O
by O
HPLC O
] O
A O
high O
performance O
liquid O
chromatography O
( O
HPLC O
) O
method O
has O
been O
developed O
for _RARE_
the O
simultaneous O
determination O
of O
theophylline O
and O
its O
metabolites O
, O
with O
caffeine O
and O
its O
metabolites O
. O

Ten O
males O
performed O
both O
test O
conditions O
and O
oxygen O
uptake O
VO2 O
, O
heart _RARE_
rate O
, O
minute O
ventilation O
VE O
, O
perceived O
exertion _RARE_
and O
spinal _RARE_
shrinkage _RARE_
were O
recorded O
. O

CONCLUSION O
: O
SPT _RARE_
is O
more O
useful O
than O
WST _RARE_
in O
differentiating O
patients O
predisposed _RARE_
to O
aspiration _RARE_
. O

Studied _RARE_
groups O
were O
( O
1 O
) O
untreated O
control O
, O
n _RARE_
= O
12 O
; O
( O
2 O
) O
FK O
- O
1 O
, O
n _RARE_
= O
8 O
; O
( O
3 O
) O
FK O
- O
3 O
, O
n _RARE_
= O
8 O
. O

DNA O
binding O
and O
glutathione _RARE_
S I-GENE
- I-GENE
transferase I-GENE
pull _RARE_
- O
down O
assays O
demonstrate O
that O
binding O
requires O
Elk I-GENE
- I-GENE
1 I-GENE
( I-GENE
1 I-GENE
- I-GENE
212 _RARE_
) I-GENE
but O
not O
the O
C O
- O
terminal O
transactivation _RARE_
domain O
. O

Unexpectedly _RARE_
, O
ALK7 _RARE_
signaling _RARE_
produced O
a O
remarkable O
change O
in O
cell O
morphology O
characterized O
by O
cell O
flattening _RARE_
and O
elaboration _RARE_
of O
blunt _RARE_
, O
short O
cell O
processes O
. O

The O
swa2 _RARE_
- I-GENE
1 I-GENE
allele I-GENE
recovered O
from O
the O
original O
screen O
carries O
a O
point O
mutation O
in O
its O
tetratricopeptide _RARE_
repeat O
( O
TPR O
) O
domain O
, O
a O
motif O
not O
found O
in O
auxilin _RARE_
but O
known O
in O
other O
proteins O
to O
mediate O
interaction O
with O
heat I-GENE
- I-GENE
shock I-GENE
proteins I-GENE
. O

Association O
of O
stress O
during _RARE_
delivery O
with O
increased O
numbers O
of O
nucleated _RARE_
cells O
and O
hematopoietic O
progenitor _RARE_
cells O
in O
umbilical _RARE_
cord O
blood _RARE_
. O

In O
slightly O
older O
embryos _RARE_
, O
the O
expression _RARE_
was O
skewed _RARE_
to O
one O
side _RARE_
of O
the O
embryo _RARE_
and O
by O
E6 _RARE_
. O
5 O
, O
at _RARE_
the O
onset O
of O
gastrulation _RARE_
, O
expression _RARE_
was O
seen O
in O
the O
epiblast _RARE_
, O
visceral O
endoderm O
, O
nascent _RARE_
mesoderm O
, O
and O
the O
primitive _RARE_
streak _RARE_
. O

Transformation _RARE_
of O
the O
sconC3 _RARE_
mutant I-GENE
with O
sconB _RARE_
+ I-GENE
restores O
the O
wild O
- O
type O
phenotype _RARE_
. O

The O
authors O
proposed O
that O
the O
highly O
convergent _RARE_
inputs O
to O
the O
entorhinal _RARE_
cortex O
indicate O
this O
region O
may O
be O
particularly O
important O
for _RARE_
selecting _RARE_
or O
compressing _RARE_
information _RARE_
. O

Influence O
of O
oil O
emulsions _RARE_
and O
diphenyl _RARE_
on O
post O
- O
harvest _RARE_
physiconutritional _RARE_
changes O
in O
Kagzi _RARE_
limes _RARE_
( O
Citrus _RARE_
aurantifolia _RARE_
) O
was O
studied O
. O

Detailed _RARE_
analysis O
of O
alpha1 _RARE_
, I-GENE
3GT _RARE_
transcripts I-GENE
revealed O
two O
major O
alternative _RARE_
splicing _RARE_
patterns O
in O
the O
5 O
'- O
untranslated _RARE_
region O
( O
5 O
'- O
UTR O
) O
and O
evidence O
for _RARE_
minor O
splicing _RARE_
activity O
that O
occurs O
in O
a O
tissue O
- O
specific O
manner O
. O

A O
thermal O
Kubo _RARE_
- O
Martin _RARE_
- O
Schwinger _RARE_
condition O
arises _RARE_
due O
to O
the O
coupling O
of O
a O
computer O
to O
a O
strong O
periodic _RARE_
source O
, O
namely O
, O
the O
daily O
and O
weekly O
usage O
patterns O
of O
the O
system _RARE_
. O

The O
non O
- O
homologous O
sequences O
in O
the O
5 O
' O
untranslated _RARE_
regions O
might O
be O
acquired O
at _RARE_
or O
after O
transcription O
during _RARE_
retrotransposition _RARE_
of O
the O
ATLN _RARE_
elements O
. O

The O
time O
course O
of O
RNA1 _RARE_
replication O
and O
RNA3 _RARE_
synthesis _RARE_
in O
induced _RARE_
yeast O
paralleled _RARE_
that O
in O
yeast O
transfected O
with O
natural _RARE_
FHV _RARE_
virion O
RNA O
. O

The O
transcription O
and O
alternative _RARE_
splicing _RARE_
of O
human I-GENE
ORL1 _RARE_
and O
GAIP _RARE_
are O
cell O
- O
type O
specific O
. O

RESULTS O
: O
The O
main O
effect O
of O
muscle O
pain O
, O
compared O
to O
non O
- O
painful _RARE_
stimulation _RARE_
, O
was O
a O
significant O
and O
long O
- O
lasting O
increase O
of O
delta O
( O
1 O
- O
3 O
Hz O
) O
power O
and O
an O
alpha O
- O
1 O
( O
9 O
- O
11 O
Hz O
) O
power O
increase O
over O
the O
contralateral O
parietal _RARE_
locus O
. O

The O
extraction O
was O
subsequently O
rated _RARE_
as _RARE_
' O
easy _RARE_
' O
or O
' O
difficult O
'. O
Taking _RARE_
Pell _RARE_
- O
Gregory _RARE_
class O
C O
as _RARE_
a O
predictor O
of O
a O
' O
difficult O
' O
extraction O
, O
specificity _RARE_
was O
88 O
% O
but O
sensitivity O
was O
low O
at _RARE_
15 _RARE_
%. O

In O
addition O
, O
our O
results O
show O
that O
ERKs I-GENE
and O
PI3Ks _RARE_
can O
synergise _RARE_
to O
convert _RARE_
ectoderm _RARE_
into O
mesoderm O
. O

Based O
on O
16S _RARE_
rRNA I-GENE
gene I-GENE
sequence I-GENE
analysis O
, O
the O
11 O
species O
having O
two O
tuf _RARE_
genes I-GENE
all O
have O
a O
common O
ancestor O
, O
while O
the O
six _RARE_
species O
having O
only O
one O
copy O
diverged O
from O
the O
enterococcal _RARE_
lineage O
before O
that O
common O
ancestor O
. O

Nevertheless O
, O
protein I-GENE
kinase I-GENE
A I-GENE
stimulation _RARE_
induces O
CREMalpha _RARE_
to O
activate O
the O
complex O
native _RARE_
promoter O
in O
the O
phosphoenolpyruvate I-GENE
carboxykinase _RARE_
( O
PEPCK I-GENE
) O
gene O
. O

Another O
putative O
HNF3 _RARE_
site I-GENE
in O
close O
apposition _RARE_
to O
a O
NF1 I-GENE
/ O
CTF _RARE_
site O
was O
localized O
upstream O
of O
the O
silencer _RARE_
- O
like O
element O
. O

This O
transcriptional O
regulation _RARE_
occurs O
through O
modulation O
of O
the O
forkhead _RARE_
transcription I-GENE
factor I-GENE
FKHR _RARE_
- I-GENE
L1 I-GENE
, O
and O
IL _RARE_
- I-GENE
3 I-GENE
inhibited O
FKHR _RARE_
- I-GENE
L1 I-GENE
activity O
in O
a O
PI3K _RARE_
- O
dependent O
manner O
. O

Taken O
together O
, O
these O
observations O
indicate O
that O
inhibition O
of O
p27 I-GENE
( O
KIP1 _RARE_
) O
transcription O
through O
PI3K _RARE_
- O
induced _RARE_
FKHR _RARE_
- I-GENE
L1 I-GENE
phosphorylation _RARE_
provides O
a O
novel O
mechanism O
of O
regulating _RARE_
cytokine _RARE_
- O
mediated _RARE_
survival O
and O
proliferation _RARE_
. O

DNase I-GENE
I I-GENE
genomic O
footprinting O
revealed O
that O
the O
c I-GENE
- I-GENE
Myb I-GENE
site I-GENE
is O
occupied O
in O
a O
tissue O
- O
specific O
fashion O
in O
vivo O
. O

We O
conclude O
that O
c I-GENE
- I-GENE
Myb I-GENE
regulates O
the O
RAG _RARE_
- I-GENE
2 I-GENE
promoter I-GENE
in O
T O
cells O
by O
binding O
to O
this O
consensus I-GENE
c I-GENE
- I-GENE
Myb I-GENE
binding I-GENE
site I-GENE
. O

A O
recently O
reported O
new O
member _RARE_
of O
the O
Vav _RARE_
family I-GENE
proteins I-GENE
, O
Vav3 _RARE_
has O
been O
identified O
as _RARE_
a O
Ros _RARE_
receptor I-GENE
protein I-GENE
tyrosine I-GENE
kinase I-GENE
( O
RPTK _RARE_
) O
interacting _RARE_
protein O
by O
yeast O
two O
- O
hybrid _RARE_
screening O
. O

Subsequently _RARE_
, O
we O
show O
that O
the O
reexpression _RARE_
of O
the O
r _RARE_
- I-GENE
PTPeta _RARE_
gene I-GENE
in O
highly O
malignant O
rat O
thyroid O
cells O
transformed O
by O
retroviruses _RARE_
carrying O
the O
v I-GENE
- I-GENE
mos I-GENE
and O
v I-GENE
- I-GENE
ras I-GENE
- I-GENE
Ki _RARE_
oncogenes _RARE_
suppresses O
their O
malignant O
phenotype _RARE_
. O

Induced _RARE_
expression _RARE_
of O
Rnd3 _RARE_
is O
associated O
with O
transformation O
of O
polarized _RARE_
epithelial _RARE_
cells O
by O
the O
Raf I-GENE
- O
MEK I-GENE
- O
extracellular O
signal O
- O
regulated O
kinase O
pathway _RARE_
. O

The O
activity O
of O
the O
transcription I-GENE
factor I-GENE
CREB I-GENE
is O
regulated O
by O
extracellular O
stimuli O
that O
result O
in O
its O
phosphorylation _RARE_
at _RARE_
a O
critical O
serine O
residue _RARE_
, O
Ser133 _RARE_
. O

RESULTS O
: O
Average _RARE_
age O
at _RARE_
symptom _RARE_
onset O
was O
41 _RARE_
. O
2 O
years O
. O

When O
10 O
fields O
were O
analysed O
, O
a O
strong O
relationship O
was O
found O
between O
the O
presence O
of O
bacteria O
on O
Gram O
staining O
and O
the O
final O
diagnosis O
of O
VAP _RARE_
( O
for _RARE_
PSB _RARE_
and O
PTC _RARE_
respectively O
: O
sensitivity O
74 _RARE_
and O
81 _RARE_
%, O
specificity _RARE_
94 O
and O
100 _RARE_
%, O
positive O
predictive O
value O
91 O
and O
100 _RARE_
%, O
negative O
predictive O
value O
82 O
and O
88 O
%). O

Unlike O
the O
mammalian O
proteins O
, O
XFGF3 _RARE_
is O
efficiently O
secreted _RARE_
as _RARE_
a O
Mr O
31 _RARE_
, O
000 _RARE_
glycoprotein O
, O
gp31 _RARE_
, O
which O
undergoes O
proteolytic _RARE_
cleavage _RARE_
to O
produce O
an O
NH2 O
- O
terminally _RARE_
truncated O
product O
, O
gp27 _RARE_
. O

NH2 O
- O
terminal O
trimming _RARE_
of O
Xenopus O
and O
mammalian I-GENE
FGF3s _RARE_
may O
therefore O
be O
a O
prerequisite O
of O
optimal O
biological O
activity O
. O

Here O
, O
we O
identified O
three O
cis O
- O
elements O
required O
for _RARE_
replication O
within O
the O
200 _RARE_
bp O
promoter O
, O
using O
autonomously _RARE_
replicating _RARE_
plasmids O
carrying O
various O
mutations O
and O
deletions O
. O

Tranilast _RARE_
in O
the O
Therapy _RARE_
of O
Coronary O
Artery _RARE_
Disease _RARE_
. O

The O
objectives _RARE_
of O
the O
present O
study O
were O
to O
evaluate O
the O
effects O
of O
adding O
Equex _RARE_
to O
a O
TRIS _RARE_
- O
extender _RARE_
, O
diluting _RARE_
the O
semen O
in O
1 O
or O
2 O
steps O
, O
freezing _RARE_
according O
to O
2 O
methods O
, O
thawing _RARE_
at _RARE_
2 O
rates O
, O
and O
the O
interactions O
between O
these O
treatments O
, O
on O
the O
post O
- O
thaw _RARE_
survival O
of O
dog O
spermatozoa O
at _RARE_
38 O
degrees O
C O
. O

This O
study O
is O
a O
further O
and O
more O
extensive O
validation _RARE_
of O
the O
clinician _RARE_
rated _RARE_
NIMH _RARE_
- O
LCM _RARE_
- O
p O
. O

The O
Aie1 _RARE_
locus I-GENE
was O
mapped O
to O
mouse O
chromosome _RARE_
7A2 _RARE_
- O
A3 _RARE_
by O
fluorescent _RARE_
in O
situ O
hybridization O
. O

Psychiatric _RARE_
disorders O
in O
children O
and O
adolescents _RARE_
carry O
considerable O
morbidity O
, O
impede _RARE_
development O
, O
and O
carry O
a O
significant O
mortality O
by O
suicide O
. O

Molecular O
cloning O
and O
expression _RARE_
of O
human I-GENE
UDP _RARE_
- I-GENE
d I-GENE
- I-GENE
Xylose _RARE_
: I-GENE
proteoglycan _RARE_
core I-GENE
protein I-GENE
beta I-GENE
- I-GENE
d I-GENE
- I-GENE
xylosyltransferase _RARE_
and O
its O
first _RARE_
isoform I-GENE
XT _RARE_
- I-GENE
II I-GENE
. O

Thyrotoxicosis _RARE_
due O
to O
amiodarone _RARE_
is O
difficult O
to O
treat O
and O
is O
further O
complicated O
by O
the O
pro O
- O
arrhythmic _RARE_
potential _RARE_
of O
thyrotoxicosis _RARE_
and O
the O
fading _RARE_
antiarrhythmic O
effect O
after O
amiodarone _RARE_
withdrawal O
. O

Chaperones _RARE_
/ O
HSPs _RARE_
thus O
play O
important O
roles O
within O
cell O
cycle _RARE_
processes O
. O

Oncogenic _RARE_
signalling O
by O
E2F1 I-GENE
has O
recently O
been O
linked _RARE_
to O
stabilization O
and O
activation O
of O
the O
tumour _RARE_
suppressor O
p53 I-GENE
( O
refs _RARE_
1 O
, O
3 O
, O
4 O
). O

This O
study O
allows O
us O
to O
draw _RARE_
conclusions O
about O
the O
identity O
of O
proteins O
required O
for _RARE_
the O
development O
of O
the O
nervous O
system _RARE_
in O
Drosophila O
and O
provides O
an O
example O
of O
a O
molecular _RARE_
approach O
to O
characterize O
en _RARE_
masse _RARE_
transposon _RARE_
- O
tagged _RARE_
mutations O
identified O
in O
genetic O
screens _RARE_
. O

We O
describe O
the O
identification O
and O
initial O
characterization O
of O
neurobeachin _RARE_
, O
a O
neuron _RARE_
- O
specific O
multidomain _RARE_
protein O
of O
327 _RARE_
kDa O
with O
a O
high O
- O
affinity O
binding O
site O
( O
K O
( O
d O
), _RARE_
10 O
nm O
) O
for _RARE_
the O
type I-GENE
II I-GENE
regulatory I-GENE
subunit I-GENE
of I-GENE
protein I-GENE
kinase I-GENE
A I-GENE
( O
PKA I-GENE
RII I-GENE
). O

Children O
with O
ADD _RARE_
showed O
an O
attenuated O
frontal O
CNV O
- O
1 O
amplitude O
and O
a O
trend O
towards O
increased O
CNV O
- O
1 O
and O
CNV O
- O
2 O
occipital _RARE_
amplitudes O
. O

Where _RARE_
UMDNJ _RARE_
is O
headed _RARE_
. O

Overexpression O
of O
c I-GENE
- I-GENE
Myc _RARE_
in O
serum O
- O
starved _RARE_
human O
or O
mouse O
embryonic _RARE_
cells O
leads O
to O
apoptosis O
which O
is O
significantly O
reduced _RARE_
in O
the O
presence O
of O
growth O
factor O
- O
containing O
serum O
. O
c I-GENE
- I-GENE
Myc _RARE_
- O
induced _RARE_
apoptosis O
appears O
to O
be O
deficient _RARE_
in O
bax _RARE_
- O
null _RARE_
as _RARE_
compared O
with O
bax _RARE_
- O
wild O
- O
type O
mouse O
embryonic _RARE_
fibroblasts _RARE_
. O

Antimicrobial _RARE_
Susceptibility _RARE_
of O
Klebsiella _RARE_
pneumoniae _RARE_
Producing _RARE_
Extended _RARE_
- I-GENE
Spectrum _RARE_
beta I-GENE
- I-GENE
lactamase I-GENE
( O
ESBL _RARE_
) O
Isolated _RARE_
in O
Hospitals _RARE_
in O
Brazil _RARE_
. O

CONCLUSION O
: O
Our O
results O
suggest O
that O
AIF _RARE_
peak O
saturation O
leads O
to O
a O
significant O
systematic O
error O
in O
the O
determination O
of O
CBV _RARE_
and O
CBF O
values O
and O
has O
necessarily O
to O
be O
taken O
into O
account O
for _RARE_
dynamic O
contrast O
- O
enhanced _RARE_
MR O
perfusion O
studies O
. O

METHODS O
: O
T2 _RARE_
*- _RARE_
weighted O
, O
three O
- O
dimensional O
gradient O
- O
echo O
images O
were O
acquired O
by O
exploiting _RARE_
the O
magnetic O
susceptibility _RARE_
difference O
between O
oxygenated _RARE_
and O
deoxygenated _RARE_
hemoglobin I-GENE
in O
the O
vasculature _RARE_
and O
microvasculature _RARE_
. O

In O
the O
COPD O
patients O
, O
the O
variability O
of O
Delta _RARE_
- O
inst _RARE_
Rrs _RARE_
( O
30 _RARE_
%) O
was O
greater O
than O
that O
of O
FOT _RARE_
Rrs _RARE_
( O
21 O
%). O

Toward _RARE_
this O
end O
, O
we O
prepared O
synthetic _RARE_
proteins O
with O
either O
the O
catalytic O
domain O
of O
FAP _RARE_
- I-GENE
1 I-GENE
( I-GENE
C I-GENE
- I-GENE
terminal I-GENE
399 _RARE_
amino I-GENE
acids _RARE_
) I-GENE
or O
its O
inactive O
form O
( O
Cys2408 _RARE_
--> _RARE_
Ser _RARE_
) O
fused O
to O
glutathione _RARE_
- I-GENE
S I-GENE
- I-GENE
transferase I-GENE
( O
GST I-GENE
). O

Thus O
, O
Pet111p _RARE_
could O
play O
dual O
roles O
in O
both O
membrane O
localization _RARE_
and O
regulation _RARE_
of O
Cox2p _RARE_
synthesis _RARE_
within O
mitochondria _RARE_
. O

Furthermore O
, O
transfection O
of O
cells O
with O
the O
spacer O
- O
RING _RARE_
domain O
alone O
suppressed O
the O
antiapoptotic _RARE_
function O
of O
the O
N O
- O
terminal O
BIR _RARE_
domain O
of O
c I-GENE
- I-GENE
IAP1 _RARE_
and O
induced _RARE_
apoptosis O
. O

The O
determination O
of O
the O
double O
bounds _RARE_
in O
blood _RARE_
serum O
lipids O
by O
titration O
with O
ozone _RARE_
: O
the O
pathophysiology O
and O
diagnostic O
significance O
] O
In O
this O
article O
the O
method O
of O
definition O
of O
double O
binders _RARE_
in O
lipids O
of O
blood _RARE_
serum O
in O
patients O
with O
different O
diseases O
basically _RARE_
atherosclerosis O
and O
ischemic O
heart _RARE_
disease _RARE_
, O
with O
use O
titration O
by O
ozone _RARE_
is O
given O
. O

Ang _RARE_
II I-GENE
- O
induced _RARE_
fibronectin I-GENE
mRNA O
was O
not O
affected O
by O
PKC I-GENE
inhibitors _RARE_
or O
PKC I-GENE
depletion O
, O
whereas O
specific O
inhibition O
of O
EGF _RARE_
- I-GENE
R I-GENE
function O
by O
a O
dominant I-GENE
negative I-GENE
EGF _RARE_
- I-GENE
R I-GENE
mutant I-GENE
and O
tyrphostin _RARE_
AG1478 _RARE_
abolished O
induction O
of O
fibronectin I-GENE
mRNA I-GENE
. O

Acoust _RARE_
. O

Video _RARE_
images O
of O
the O
nostrils _RARE_
were O
captured _RARE_
and O
then O
analyzed O
for _RARE_
area O
, O
perimeter _RARE_
, O
centroid _RARE_
, O
principal O
axis O
, O
moments _RARE_
about O
the O
major O
and O
minor O
axes _RARE_
( O
I11 _RARE_
, O
I22 _RARE_
), _RARE_
anisometry _RARE_
, O
bulkiness _RARE_
, O
lateral O
offset _RARE_
, O
internostril _RARE_
angle O
, O
and O
rotational _RARE_
angle O
. O

MS O
characteristics O
of O
coumarins _RARE_
, O
psoralens _RARE_
and O
polymethoxylated _RARE_
flavones _RARE_
with O
different O
substitution O
patterns O
were O
determined O
on O
the O
basis O
of O
the O
response O
obtained O
with O
the O
APcI _RARE_
interface O
. O

Young _RARE_
fish O
( O
Oreochromis _RARE_
mossambicus _RARE_
) O
were O
exposed O
to O
microgravity _RARE_
( O
micro O
g O
) O
for _RARE_
9 O
to O
10 O
days O
during _RARE_
space O
missions _RARE_
STS _RARE_
- O
55 _RARE_
and O
STS _RARE_
- O
84 _RARE_
, O
or O
to O
hypergravity _RARE_
( O
hg _RARE_
) O
for _RARE_
9 O
days O
. O

S6K2 _RARE_
is O
highly O
homologous O
to O
S6K1 _RARE_
in O
the O
core O
kinase O
and O
linker _RARE_
regulatory O
domains O
but O
differs O
from O
S6K1 _RARE_
in O
the O
N O
- O
and O
C O
- O
terminal O
regions O
and O
is O
differently O
localized O
primarily O
to O
the O
nucleus O
because O
of O
a O
C O
- O
terminal O
nuclear O
localization _RARE_
signal O
unique O
to O
S6K2 _RARE_
. O

Pretreatment _RARE_
of O
cells O
with O
the O
mitogen I-GENE
- I-GENE
activated I-GENE
protein I-GENE
- I-GENE
extracellular I-GENE
signal I-GENE
- I-GENE
regulated I-GENE
kinase I-GENE
kinase I-GENE
( O
MEK I-GENE
) O
inhibitor O
U0126 _RARE_
inhibited O
S6K2 _RARE_
activation O
to O
a O
greater O
extent O
than O
S6K1 _RARE_
. O

T O
cells O
express O
two O
isoforms O
of O
S6k1 _RARE_
: O
a O
70 O
kDa O
cytoplasmic O
kinase O
and O
an O
85 _RARE_
kDa O
isoform O
that O
has O
a O
classic _RARE_
nuclear O
localisation _RARE_
. O

Ketanserin _RARE_
, O
a O
hypotensive O
drug O
with O
5 I-GENE
- I-GENE
HT2 I-GENE
receptor I-GENE
antagonism _RARE_
, O
when O
administered O
by O
topical _RARE_
infusion O
of O
a O
0 _RARE_
. O
25 _RARE_
% O
w O
/ O
v O
solution O
by O
corneal O
and O
scleral _RARE_
applications O
, O
was O
found O
to O
lower O
intraocular _RARE_
pressure O
with O
four O
times O
more O
activity O
than O
its O
metabolite O
, O
ketanserinol _RARE_
. O

A O
prospectively _RARE_
gated O
2D _RARE_
axial O
sequence O
with O
velocity O
encoding O
in O
the O
craniocaudal _RARE_
direction O
in O
the O
cervical O
region O
was O
set O
at _RARE_
a O
velocity O
of O
+/- O
10 O
cm O
/ O
s O
. O

It O
was O
subsequently O
shown O
that O
Tip60 _RARE_
had O
histone I-GENE
acetyltransferase _RARE_
( O
HAT _RARE_
) O
activity O
. O

Our O
data O
show O
that O
multiple O
MLSN1 _RARE_
transcripts I-GENE
, O
both O
constitutively O
expressed _RARE_
and O
inducible O
, O
are O
present O
in O
cultured O
pigmented _RARE_
melanoma _RARE_
cells O
, O
and O
suggest O
that O
MLSN1 _RARE_
expression _RARE_
can O
be O
regulated O
at _RARE_
the O
level O
of O
both O
transcription O
and O
mRNA O
processing _RARE_
. O

Copyright O
2000 O
Academic O
Press O
. O

Plectin _RARE_
and O
desmoplakin _RARE_
have O
GSR _RARE_
- O
containing O
domains O
at _RARE_
their O
C O
- O
termini O
and O
we O
further O
demonstrate O
that O
the O
GSR _RARE_
- O
containing O
domain O
of O
plectin _RARE_
, O
but O
not O
desmoplakin _RARE_
, O
can O
bind O
to O
MTs _RARE_
in O
vivo O
. O

Characterization O
of O
the O
microtubule O
binding O
domain O
of O
microtubule I-GENE
actin I-GENE
crosslinking _RARE_
factor I-GENE
( O
MACF _RARE_
): O
identification O
of O
a O
novel O
group O
of O
microtubule I-GENE
associated I-GENE
proteins I-GENE
. O

These O
results O
also O
suggest O
the O
involvement O
of O
additional O
elements O
in O
the O
UPR _RARE_
. O

We O
show O
that O
in O
contrast O
to O
SRC1 _RARE_
, O
direct O
binding O
of O
CBP I-GENE
to O
the O
estrogen I-GENE
receptor I-GENE
is O
weak O
, O
suggesting O
that O
SRC1 _RARE_
functions O
primarily O
as _RARE_
an O
adaptor _RARE_
to O
recruit O
CBP I-GENE
and O
p300 I-GENE
. O

Remarkably _RARE_
, O
a O
construct O
corresponding O
to O
residues O
631 _RARE_
to O
970 _RARE_
, O
which O
contains O
only O
the O
LXXLL _RARE_
motifs O
and O
the O
AD1 _RARE_
region O
of O
SRC1 _RARE_
, O
retained O
strong O
coactivator _RARE_
activity O
in O
our O
assays O
. O

Since O
MEK I-GENE
acts O
as _RARE_
a O
cytoplasmic O
anchor _RARE_
for _RARE_
the O
ERKs I-GENE
, O
the O
lack O
of O
a O
MEK I-GENE
interaction O
resulted O
in O
the O
aberrant O
nuclear O
localization _RARE_
of O
ERK2 I-GENE
- O
Delta19 _RARE_
- I-GENE
25 _RARE_
mutants O
in O
serum O
- O
starved _RARE_
cells O
. O

Pmt2 _RARE_
is O
a O
member _RARE_
of O
a O
six _RARE_
- O
protein O
family O
in O
yeast O
that O
catalyzes O
the O
first _RARE_
step O
in O
O O
mannosylation _RARE_
of O
target O
proteins O
. O

Fecal _RARE_
samples O
were O
collected O
at _RARE_
the O
beginning O
and O
end O
of O
each O
trial O
period O
and O
were O
analyzed O
for _RARE_
gastrointestinal _RARE_
nematode O
eggs O
and O
Giardia _RARE_
cyst O
. O

The O
aim O
of O
this O
study O
was O
to O
determine O
the O
risk O
factors O
for _RARE_
background O
diabetic O
retinopathy _RARE_
( O
BDR _RARE_
) O
and O
PDR _RARE_
by O
following O
394 _RARE_
Japanese O
patients O
with O
early O
- O
onset O
type O
2 O
diabetes O
diagnosed O
before O
30 _RARE_
years O
of O
age O
( O
mean O
age O
27 _RARE_
, O
mean O
blood _RARE_
pressure O
at _RARE_
entry O
116 _RARE_
/ O
73 _RARE_
mm O
Hg O
). O

Of O
the O
21 O
quadrants _RARE_
positive O
in O
the O
controls O
, O
17 _RARE_
were O
correlated O
with O
previously O
detected O
jaw O
pathoses _RARE_
. O

Four O
cases O
of O
synovial O
chondromatosis _RARE_
are O
presented O
. O

Previous O
studies O
have O
shown O
that O
the O
pro O
- O
inflammatory O
cytokines _RARE_
tumor I-GENE
necrosis I-GENE
factor I-GENE
alpha I-GENE
and O
interferon _RARE_
gamma I-GENE
reduce O
the O
expression _RARE_
of O
the O
cystic _RARE_
fibrosis _RARE_
transmembrane I-GENE
conductance _RARE_
regulator I-GENE
( O
CFTR I-GENE
) O
gene O
( O
CFTR I-GENE
) O
in O
HT _RARE_
- O
29 O
and O
T84 _RARE_
cells O
by O
acting O
post O
- O
transcriptionally O
. O

Regulation O
of O
RhoA I-GENE
is O
required O
to O
maintain O
adhesion O
in O
stationary O
cells O
, O
but O
is O
also O
critical O
for _RARE_
cell O
spreading _RARE_
and O
migration O
[ _RARE_
3 O
]. O

Here O
we O
show O
in O
mouse O
fibroblasts _RARE_
stably O
transformed O
by O
v I-GENE
- I-GENE
Src I-GENE
that O
mRNA O
and O
protein O
levels O
of O
p21 I-GENE
( O
WAF1 I-GENE
/ O
CIP1 _RARE_
), _RARE_
cyclin _RARE_
D1 _RARE_
, O
and O
cyclin _RARE_
E I-GENE
are O
elevated O
. O

ORFA _RARE_
and O
ccdA _RARE_
were O
constitutively O
cotranscribed O
as _RARE_
determined O
by O
primer O
extension O
analysis O
. O

Mouse _RARE_
Impact _RARE_
is O
a O
paternally _RARE_
expressed _RARE_
gene O
encoding O
an O
evolutionarily O
conserved _RARE_
protein O
of O
unknown O
function O
. O

These O
cells O
produced O
P2Y _RARE_
( I-GENE
11 I-GENE
) I-GENE
mRNA I-GENE
during _RARE_
culture O
. O

Coexpression _RARE_
studies O
indicate O
that O
insulin I-GENE
and O
PKB I-GENE
suppress O
transactivation _RARE_
by O
C I-GENE
/ I-GENE
EBPbeta I-GENE
, O
but O
not O
C I-GENE
/ I-GENE
EBPalpha _RARE_
, O
and O
that O
N O
- O
terminal O
transactivation _RARE_
domains O
in O
C I-GENE
/ I-GENE
EBPbeta I-GENE
are O
required O
. O

Among O
eight O
graminaceous _RARE_
species O
tested O
, O
Ids3 _RARE_
expression _RARE_
was O
observed O
only O
in O
Fe _RARE_
- O
deficient _RARE_
roots O
of O
H O
. O
vulgare _RARE_
and O
Secale _RARE_
cereale _RARE_
. O
which O
not O
only O
secrete _RARE_
2 O
'- O
deoxymugineic _RARE_
acid O
( O
DMA _RARE_
), _RARE_
but O
also O
mugineic _RARE_
acid O
( O
MA _RARE_
) O
and O
3 O
- O
epihydroxymugineic _RARE_
acid O
( O
epiHMA _RARE_
, O
H O
. O
vulgare _RARE_
), _RARE_
and O
3 O
- O
hydroxymugineic _RARE_
acid O
( O
HMA _RARE_
, O
S O
. O
cereale _RARE_
). O

In O
contrast O
, O
high O
COUP I-GENE
- I-GENE
TFI I-GENE
expression _RARE_
impeded _RARE_
the O
neuronal _RARE_
differentiation O
of O
P19 O
cells O
induced _RARE_
with O
RA _RARE_
, O
resulting O
in O
cell O
cultures O
lacking _RARE_
neurons O
. O

Because O
PET O
is O
also O
useful O
for _RARE_
the O
pretreatment O
and O
follow O
- O
up _RARE_
evaluation O
, O
the O
use O
of O
stereotactic _RARE_
PET O
in O
these O
patients O
can O
enable _RARE_
an O
accurate O
comparison O
of O
PET O
- O
based O
metabolic O
data O
with O
MR O
- O
based O
anatomical O
data O
. O

Therefore O
, O
in O
our O
in O
vitro O
model O
, O
the O
localization _RARE_
of O
the O
mutation O
in O
the O
K I-GENE
- I-GENE
ras I-GENE
gene I-GENE
predisposes _RARE_
to O
a O
different O
level O
of O
aggressiveness _RARE_
in O
the O
transforming O
phenotype _RARE_
. O

Here O
, O
we O
describe O
the O
isolation O
of O
MdPin1 _RARE_
, O
a O
Pin1 _RARE_
homologue O
from O
the O
plant _RARE_
species O
apple _RARE_
( O
Malus _RARE_
domestica _RARE_
) O
and O
show O
that O
it O
has O
the O
same O
phosphorylation _RARE_
- O
specific O
substrate O
specificity _RARE_
and O
can O
be O
inhibited O
by O
juglone _RARE_
in O
vitro O
, O
as _RARE_
is O
the O
case O
for _RARE_
Pin1 _RARE_
. O

Differential O
association O
of O
products O
of O
alternative _RARE_
transcripts O
of O
the O
candidate O
tumor I-GENE
suppressor I-GENE
ING1 _RARE_
with O
the O
mSin3 _RARE_
/ O
HDAC1 _RARE_
transcriptional O
corepressor _RARE_
complex O
. O

These O
and O
other O
data O
presented O
suggest O
that O
TAg _RARE_
' O
re O
- O
models O
' O
host _RARE_
cell O
transcription O
factors O
that O
are O
used O
early O
in O
viral O
infection O
, O
and O
thereby O
mimics _RARE_
an O
event O
that O
naturally O
occurs O
during _RARE_
transformation O
. O

This O
sensitivity O
analysis O
showed O
that O
the O
practical _RARE_
limits O
of O
the O
accuracy O
of O
the O
used O
screening O
test O
jeopardize _RARE_
the O
estimation O
of O
the O
true O
herd O
prevalence O
within O
reasonable O
confidence O
limits O
, O
because O
the O
within O
- O
herd O
PTB _RARE_
true O
prevalence O
was O
low O
. O
For O
this O
reason _RARE_
we O
augmented O
the O
herd O
specificity _RARE_
for _RARE_
herds _RARE_
with O
larger O
adult O
herd O
size O
(> O
5 O
). O

ORFK10 _RARE_
. I-GENE
5 I-GENE
encodes O
a O
protein O
, O
latency _RARE_
- I-GENE
associated I-GENE
nuclear I-GENE
antigen I-GENE
2 I-GENE
( O
LANA2 _RARE_
), _RARE_
which O
is O
expressed _RARE_
in O
KSHV _RARE_
- O
infected _RARE_
hematopoietic O
tissues O
, O
including O
PEL _RARE_
and O
CD O
but O
not O
KS O
lesions O
. O

As O
hypothesized _RARE_
, O
believers _RARE_
showed O
relatively O
higher _RARE_
right O
hemispheric _RARE_
activation O
and O
reduced _RARE_
hemispheric _RARE_
asymmetry O
of O
functional _RARE_
complexity O
. O

In O
Xenopus O
, O
BMPs _RARE_
act O
as _RARE_
epidermal _RARE_
inducers _RARE_
and O
also O
as _RARE_
negative O
regulators _RARE_
of O
neurogenesis _RARE_
. O

Presently _RARE_
four O
unique O
variants O
carrying O
distinct O
GAF _RARE_
sequences I-GENE
in O
the O
N O
- O
terminal O
region O
have O
been O
identified O
. O

Genomic O
organization O
of O
the O
human O
phosphodiesterase _RARE_
PDE11A _RARE_
gene I-GENE
. O

The O
present O
findings O
revealed O
that O
the O
rib _RARE_
- I-GENE
2 I-GENE
protein I-GENE
was O
a O
unique O
alpha1 _RARE_
, I-GENE
4 I-GENE
- I-GENE
N I-GENE
- I-GENE
acetylglucosaminyltransferase _RARE_
involved O
in O
the O
biosynthetic O
initiation O
and O
elongation _RARE_
of O
heparan _RARE_
sulfate _RARE_
. O

Inhibition O
of O
the O
Mek _RARE_
/ O
Erk _RARE_
pathway _RARE_
in O
Rat1 _RARE_
/ O
ras I-GENE
cells O
, O
using O
the O
Mek _RARE_
inhibitor O
, O
PD98059 O
, O
resulted O
in O
complete _RARE_
cytoskeletal O
recovery O
, O
indistinguishable O
from O
that O
induced _RARE_
by O
HR12 _RARE_
. O

The O
transcription O
factor O
CHOP _RARE_
/ O
GADD153 _RARE_
gene O
is O
induced _RARE_
by O
cellular O
stress O
and O
is O
involved O
in O
mediating O
apoptosis O
. O

Addition O
of O
synthetic _RARE_
tyrosine O
- O
phosphorylated _RARE_
peptides O
derived O
from O
betac _RARE_
cytoplasmic O
tyrosines _RARE_
prior O
to O
GM _RARE_
- I-GENE
CSF I-GENE
stimulation _RARE_
inhibited O
the O
in O
vitro O
activation O
of O
STAT5 I-GENE
. O

MAIN O
OUTCOME O
MEASURES _RARE_
: O
Percentage _RARE_
change O
in O
the O
apnea O
- O
hypopnea _RARE_
index O
( O
AHI _RARE_
; O
apnea O
events O
+ O
hypopnea _RARE_
events O
per O
hour O
of O
sleep O
) O
and O
odds O
of O
developing O
moderate O
- O
to O
- O
severe O
SDB _RARE_
( O
defined O
by O
an O
AHI _RARE_
> O
or O
= O
15 _RARE_
events O
per O
hour O
of O
sleep O
), _RARE_
with O
respect O
to O
change O
in O
weight _RARE_
. O

Paraneoplastic _RARE_
rheumatic _RARE_
syndromes O
. O

This O
article O
reviews _RARE_
recent O
information _RARE_
on O
the O
frequency O
, O
characteristics O
, O
and O
possible O
pathogenic O
mechanisms O
of O
the O
vasculitides _RARE_
occurring O
in O
patients O
with O
the O
main O
connective _RARE_
tissue O
diseases O
. O

Tec _RARE_
kinase I-GENE
signaling _RARE_
in O
T O
cells O
is O
regulated O
by O
phosphatidylinositol _RARE_
3 I-GENE
- I-GENE
kinase I-GENE
and O
the O
Tec _RARE_
pleckstrin I-GENE
homology I-GENE
domain I-GENE
. O

Current O
evidence O
for _RARE_
this O
type O
of O
DNA O
supercoiling _RARE_
- O
dependent O
transcriptional O
coupling O
, O
based O
largely O
on O
the O
in O
vivo O
activities O
of O
promoters O
contained O
in O
engineered _RARE_
DNA O
constructs O
, O
suggests O
that O
the O
transcription O
complex O
must O
be O
physically O
hindered _RARE_
to O
generate O
DNA O
supercoils _RARE_
and O
to O
prevent O
their O
diffusion O
throughout O
the O
DNA O
duplex O
. O

The O
structure _RARE_
of O
the O
free O
SH2 _RARE_
domain I-GENE
has O
been O
compared O
to O
that O
of O
the O
SH2 _RARE_
complexed O
with O
a O
doubly _RARE_
phosphorylated _RARE_
peptide O
derived O
from O
polyomavirus _RARE_
middle _RARE_
T I-GENE
antigen I-GENE
( O
MT _RARE_
). O

We O
have O
identified O
three O
binding O
sites O
for _RARE_
protein O
complexes O
: O
a O
palindrome O
, O
a O
direct O
repeat O
, O
and O
a O
C O
+ O
T O
sequence O
that O
corresponds O
to O
seven _RARE_
GAGA _RARE_
motifs O
on O
the O
transcribed _RARE_
strand _RARE_
. O

Copyright O
2000 O
Academic O
Press O
. O

Nucleotide O
sequence O
, O
genome O
organization O
and O
phylogenetic O
analysis O
of O
pineapple _RARE_
mealybug _RARE_
wilt _RARE_
- O
associated O
virus O
- O
2 O
. O

Patients O
underwent O
pretreatment O
cystoscopy _RARE_
and O
detailed O
tumor O
mapping O
, O
and O
were O
treated O
with O
75 _RARE_
mg O
. O
/ O
m O
. O
2 O
cisplatin O
on O
day O
1 O
and O
1 O
gm _RARE_
./ _RARE_
m O
. O
2 O
daily O
, O
5 O
- O
fluorouracil O
on O
days O
1 O
to O
4 O
and O
definitive O
radiotherapy O
. O

All O
9 O
untreated O
patients O
underwent O
laparoscopy _RARE_
, O
which O
identified O
3 O
intra _RARE_
- O
abdominal O
, O
3 O
vanished _RARE_
and O
2 O
peeping _RARE_
testes O
, O
and O
1 O
atrophic _RARE_
testis _RARE_
in O
the O
inguinal _RARE_
canal _RARE_
. O

This O
philosophy _RARE_
was O
instituted _RARE_
for _RARE_
the O
compound O
RP _RARE_
73401 _RARE_
, O
a O
specific O
phosphodiesterase _RARE_
IV I-GENE
inhibitor O
, O
that O
was O
being O
developed O
simultaneously O
for _RARE_
delivery O
by O
both O
oral O
and O
pulmonary O
routes O
of O
administration O
. O

Increased O
levels O
of O
anticardiolipin _RARE_
immunoglobulin I-GENE
G I-GENE
may O
also O
cause O
bleeding O
. O

RESULTS O
: O
Prevalence _RARE_
of O
obesity O
( O
BMI O
SDS O
> O
2 O
. O
0 _RARE_
) O
was O
< O
2 O
% O
at _RARE_
diagnosis O
, O
but O
increased O
to O
16 O
% O
at _RARE_
3y _RARE_
. O

One O
of O
the O
sequelae _RARE_
of O
the O
antiphospholipid _RARE_
- O
antibodies O
is O
an O
impaired O
uteroplacental _RARE_
circulation O
. O

Bupropion _RARE_
to O
aid O
smoking O
cessation O
. O

Using O
a O
natural _RARE_
dominant O
negative O
for _RARE_
AP I-GENE
- I-GENE
1 I-GENE
transcriptional O
activity O
in O
ROS _RARE_
17 _RARE_
/ O
2 O
. O
8 O
cells O
, O
we O
then O
showed O
that O
AP I-GENE
- I-GENE
1 I-GENE
transcription I-GENE
factors I-GENE
mediated _RARE_
TGF I-GENE
- I-GENE
beta1 I-GENE
- O
and O
BMP I-GENE
- I-GENE
2 I-GENE
- O
regulated O
expression _RARE_
of O
the O
( I-GENE
alpha1 _RARE_
) I-GENE
collagen _RARE_
I I-GENE
gene I-GENE
as _RARE_
well _RARE_
as _RARE_
TGF I-GENE
- I-GENE
beta1 I-GENE
- O
regulated O
expression _RARE_
of O
the O
parathyroid _RARE_
hormone I-GENE
( O
PTH _RARE_
)/ _RARE_
PTH _RARE_
- I-GENE
related I-GENE
peptide I-GENE
( I-GENE
PTHrP _RARE_
) I-GENE
receptor I-GENE
. O

PM _RARE_
12 O
or O
18 O
mg O
/ O
kg O
daily O
plus _RARE_
a O
standard O
dose O
of O
SB _RARE_
for _RARE_
21 O
days O
was O
statistically O
more O
effective O
than O
SB _RARE_
in O
producing O
a O
final O
cure O
for _RARE_
patients O
with O
VL _RARE_
in O
Bihar _RARE_
, O
India _RARE_
. O

Adjuvant _RARE_
therapy O
for _RARE_
colon O
cancer _RARE_
] O
Surgery _RARE_
alone O
may O
fail O
to O
cure O
a O
considerable O
number O
of O
locally O
advanced O
colon O
cancers O
. O

There O
were O
significant O
differences O
( O
p O
< O
0 _RARE_
. O
05 O
) O
between O
the O
fracture O
and O
nonfracture _RARE_
groups O
in O
the O
total _RARE_
femur O
BMD O
( O
13 _RARE_
%), O
trabecular _RARE_
BMD O
in O
the O
distal O
radius _RARE_
( O
4 O
%), O
and O
the O
fractal _RARE_
dimension _RARE_
in O
the O
radiographs O
( O
FD2 _RARE_
) O
( O
3 O
%). O

BACKGROUND O
: O
The O
aim O
of O
this O
study O
was O
to O
determine O
and O
compare O
interleukin I-GENE
- I-GENE
6 I-GENE
( O
IL _RARE_
- I-GENE
6 I-GENE
) O
levels O
in O
gingival _RARE_
crevicular _RARE_
fluid _RARE_
( O
GCF _RARE_
) O
and O
clinical O
periodontal O
findings O
in O
patients O
with O
rheumatoid O
arthritis O
( O
RA _RARE_
) O
and O
adult O
periodontitis _RARE_
( O
AP O
). O

In O
a O
prospective O
, O
multicentre _RARE_
trial O
the O
efficacy O
of O
an O
Vitex _RARE_
agnus _RARE_
castus _RARE_
L O
extract _RARE_
Ze _RARE_
440 O
was O
investigated O
in O
50 O
patients O
with O
pre O
- O
menstrual O
syndrome _RARE_
( O
PMS _RARE_
). O

Studies O
are O
necessary O
to O
assess O
the O
source O
of O
contamination O
and O
potential _RARE_
role O
of O
MRSA _RARE_
- O
contaminated O
milk O
in O
the O
transmission _RARE_
of O
MRSA _RARE_
to O
neonates O
. O

Effects O
of O
Trypanosoma O
vivax _RARE_
on O
pregnancy _RARE_
of O
Yankasa _RARE_
sheep O
and O
the O
results O
of O
homidum _RARE_
chloride _RARE_
chemotherapy O
. O

NF _RARE_
kappa _RARE_
B I-GENE
was O
activated O
to O
a O
much O
greater O
extent O
by O
roscovitine _RARE_
in O
the O
WT _RARE_
cells O
than O
in O
Y8 _RARE_
cells O
. O

Depending _RARE_
on O
treatment O
exposures O
, O
this O
at _RARE_
- O
risk O
population O
may O
experience O
life O
- O
threatening _RARE_
late _RARE_
effects O
, O
such O
as _RARE_
cirrhosis O
secondary O
to O
hepatitis O
C O
or O
late _RARE_
- O
onset O
anthracycline _RARE_
- O
induced _RARE_
cardiomyopathy O
, O
or O
life O
- O
changing O
late _RARE_
effects O
, O
such O
as _RARE_
cognitive O
dysfunction O
. O

The O
presence O
of O
locus O
- O
specific O
residues O
throughout O
the O
entire _RARE_
promoter O
region O
strongly O
suggests O
that O
the O
various O
HLA I-GENE
class I-GENE
I I-GENE
loci I-GENE
are O
differentially O
regulated O
. O

Because O
the O
number O
of O
parameters O
required O
by O
a O
Volterra _RARE_
series O
grows _RARE_
rapidly O
with O
both O
the O
length O
of O
its O
memory O
and O
the O
order O
of O
its O
nonlinearity _RARE_
, O
methods O
for _RARE_
identifying O
these O
models O
from O
measurements O
of O
input O
/ O
output O
data O
are O
limited O
to O
low O
- O
order O
systems _RARE_
with O
relatively O
short O
memories _RARE_
. O

The O
standard O
method O
for _RARE_
calculating _RARE_
the O
composite O
score O
on O
the O
S O
- O
B O
IV O
excludes _RARE_
subtests _RARE_
with O
a O
raw _RARE_
score O
of O
0 _RARE_
, O
which O
overestimates _RARE_
cognitive O
functioning O
in O
young O
biologically O
high O
risk O
children O
. O

NiCl _RARE_
( O
2 O
)- O
induced _RARE_
MCP _RARE_
- I-GENE
1 I-GENE
synthesis _RARE_
required O
activation O
of O
NF _RARE_
- I-GENE
kappaB I-GENE
since O
mutation O
of O
NF _RARE_
- I-GENE
kappaB I-GENE
- I-GENE
binding I-GENE
sites I-GENE
in O
the O
promoter O
resulted O
in O
complete _RARE_
loss _RARE_
of O
inducible O
promoter O
activity O
. O

Engagement _RARE_
of O
human I-GENE
CD2 _RARE_
by O
mitogenic O
pairs _RARE_
of O
anti I-GENE
- I-GENE
CD2 _RARE_
mAb _RARE_
induces O
tyrosine O
phosphorylation _RARE_
of O
a O
number O
of O
intracellular _RARE_
proteins O
including O
a O
120 O
kDa O
phosphoprotein _RARE_
that O
we O
identify O
as _RARE_
the O
proto _RARE_
- I-GENE
oncogene I-GENE
c I-GENE
- I-GENE
Cbl I-GENE
. O

Validity _RARE_
of O
NIR _RARE_
spectroscopy O
for _RARE_
quantitatively _RARE_
measuring O
muscle O
oxidative O
metabolic O
rate O
in O
exercise O
. O

Previous O
studies O
have O
demonstrated O
that O
tissue O
- O
restricted O
transcription O
factors O
including O
PU _RARE_
. I-GENE
1 I-GENE
and O
PU _RARE_
. I-GENE
1 I-GENE
interaction I-GENE
partner _RARE_
( O
PIP _RARE_
) O
function O
synergistically O
with O
c I-GENE
- I-GENE
Fos I-GENE
plus _RARE_
c I-GENE
- I-GENE
Jun I-GENE
to O
stimulate O
the O
kappaE3 _RARE_
'- I-GENE
enhancer I-GENE
in O
3T3 O
cells O
. O

The O
murine I-GENE
int I-GENE
- I-GENE
6 I-GENE
locus I-GENE
, O
identified O
as _RARE_
a O
frequent O
integration _RARE_
site O
of O
mouse O
mammary O
tumor O
viruses O
, O
encodes O
the O
48 _RARE_
- I-GENE
kDa I-GENE
eIF3e _RARE_
subunit I-GENE
of I-GENE
translation I-GENE
initiation I-GENE
factor I-GENE
eIF3 I-GENE
. O

An O
int6 _RARE_
deletion I-GENE
( O
int6Delta _RARE_
) O
mutant O
was O
viable O
but O
grew _RARE_
slowly O
in O
minimal O
medium O
. O

Additionally O
, O
MIP _RARE_
- I-GENE
2A _RARE_
antagonizes _RARE_
cell O
growth O
regulatory O
role O
of O
MBP I-GENE
- I-GENE
1 I-GENE
. O

We O
produced O
transgenic O
plants _RARE_
expressing O
the O
antisense _RARE_
Arabidopsis I-GENE
HD I-GENE
( O
AtHD1 _RARE_
) O
gene O
. O

3 O
. O
04 O
+/- O
1 O
. O
2 O
, O
P O
< O
0 _RARE_
. O
0001 O
), _RARE_
large O
accelerations _RARE_
/ O
30 _RARE_
min O
( O
1 O
. O
46 _RARE_
+/- O
1 O
. O
96 O
vs _RARE_
. O

Four O
transcription O
initiation O
sites O
have O
been O
identified O
by O
full O
- O
length O
RNA I-GENE
ligase I-GENE
- O
mediated _RARE_
rapid O
amplification O
of O
cDNA O
ends O
( O
RLM _RARE_
- O
RACE O
) O
between O
- O
61 _RARE_
and O
- O
32 _RARE_
bp O
from O
the O
translation O
initiation O
codon _RARE_
. O
Reverse _RARE_
transcription O
- O
PCR O
analysis O
revealed O
that O
PFK I-GENE
- I-GENE
A I-GENE
, O
PFK I-GENE
- I-GENE
B I-GENE
and O
PFK I-GENE
- I-GENE
C I-GENE
genes I-GENE
were O
expressed _RARE_
, O
in O
all O
mouse O
tissues O
tested O
, O
at _RARE_
varying O
levels O
. O

PFK I-GENE
- I-GENE
A I-GENE
mRNA O
was O
more O
abundantly O
expressed _RARE_
in O
all O
tissues O
than O
were O
the O
PFK I-GENE
- I-GENE
B I-GENE
and O
PFK I-GENE
- I-GENE
C I-GENE
genes I-GENE
. O

We O
used O
the O
Toshiba _RARE_
IIDR _RARE_
system _RARE_
, O
which O
is O
composed O
of O
an O
X O
- O
ray O
TV _RARE_
system _RARE_
and O
a O
digital O
image O
managing _RARE_
circuit O
. O

In O
whole O
sardine _RARE_
, O
domoic _RARE_
acid O
was O
detected O
in O
levels O
exceeding _RARE_
sometimes _RARE_
the O
regulatory O
limit O
. O

In O
addition O
, O
we O
identified O
two O
mutations O
, O
Delta _RARE_
M1281 _RARE_
and O
IVS51 _RARE_
+ O
5G _RARE_
--> _RARE_
A O
, O
in O
a O
German _RARE_
USH1 _RARE_
patient O
. O

Closeup _RARE_
: O
a O
resource O
for _RARE_
nurses _RARE_
who O
smoke O
. O

[ _RARE_
18F O
](+)- _RARE_
4 O
- O
fluorobenzyltrozamicol _RARE_
( O
FBT _RARE_
), _RARE_
which O
selectively O
binds O
to O
the O
vesicular O
acetylcholine _RARE_
transporter _RARE_
in O
the O
presynaptic _RARE_
cholinergic O
neuron _RARE_
, O
has O
previously O
been O
shown O
to O
be O
a O
useful O
ligand _RARE_
for _RARE_
the O
study O
of O
cholinergic O
terminal O
density O
in O
the O
basal O
ganglia _RARE_
with O
PET O
. O

We O
demonstrate O
that O
the O
protein O
is O
a O
murine I-GENE
homologue I-GENE
of I-GENE
SAF _RARE_
- I-GENE
A I-GENE
which O
has O
been O
shown O
to O
bind O
selectively O
to O
MARs _RARE_
and O
is O
responsible O
for _RARE_
the O
satMa _RARE_
- O
binding O
activity O
in O
the O
chromatographic O
fractions O
. O

The O
molecular _RARE_
associations O
dictating _RARE_
INCENP _RARE_
behavior O
during _RARE_
mitosis O
are O
currently O
unknown O
. O

Ang _RARE_
II I-GENE
significantly O
induced _RARE_
Ang2 _RARE_
mRNA I-GENE
accumulations _RARE_
without O
affecting O
Ang1 _RARE_
or O
Tie2 _RARE_
expression _RARE_
, O
which O
was O
inhibited O
by O
protein I-GENE
kinase I-GENE
C I-GENE
inhibitors _RARE_
and O
by O
intracellular _RARE_
Ca O
( O
2 O
+) O
chelating _RARE_
agents O
. O

Promoter O
analysis O
demonstrated O
that O
the O
sequence O
identical O
to O
consensus O
cAMP O
- O
responsive O
element O
( O
CRE _RARE_
) O
located _RARE_
at _RARE_
- O
481 _RARE_
of O
the O
SMemb _RARE_
promoter I-GENE
was O
critical O
for _RARE_
Hex _RARE_
responsiveness O
. O

LH _RARE_
/ I-GENE
CG _RARE_
receptor I-GENE
activation O
of O
ARNO _RARE_
is O
not O
mediated _RARE_
by O
activation O
of O
phosphatidylinositol _RARE_
3 I-GENE
- I-GENE
kinase I-GENE
( O
PI I-GENE
3 I-GENE
- I-GENE
kinase I-GENE
) O
or O
by O
G I-GENE
protein I-GENE
beta I-GENE
gamma I-GENE
subunits I-GENE
. O

Deletion O
analysis O
showed O
that O
the O
- O
321 _RARE_
/+ _RARE_
41 _RARE_
sequence O
was O
sufficient O
for _RARE_
both O
the O
constitutive _RARE_
promoter O
activity O
and O
auto _RARE_
- O
activation O
and O
electrophoretic O
mobility O
shift O
assays O
identified O
the O
interaction O
of O
C I-GENE
/ I-GENE
EBPs _RARE_
and O
Sp1 _RARE_
to O
this O
region O
. O

Termination _RARE_
of O
induced _RARE_
VT O
on O
the O
first _RARE_
attempt O
was O
comparable O
with O
BV _RARE_
pacing O
( O
87 O
. O
4 O
%) O
versus O
RV O
pacing O
( O
89 _RARE_
. O
6 O
%). O

We O
compare O
the O
results O
of O
this O
algorithm O
with O
the O
results O
obtained O
with O
two O
other O
algorithms _RARE_
, O
the O
optimal O
algorithm O
for _RARE_
monochannel _RARE_
nonoverlapping _RARE_
noise O
and O
the O
optimal O
algorithm O
for _RARE_
multichannel _RARE_
additive O
noise O
, O
and O
we O
show O
that O
in O
both O
cases O
improvement O
can O
be O
obtained O
. O

Changes O
in O
stimulation _RARE_
levels O
over O
time O
in O
nucleus O
22 _RARE_
cochlear O
implant O
users O
. O

Nuclease _RARE_
probing _RARE_
and O
structure _RARE_
- O
directed O
mutagenesis O
revealed O
that O
the O
105 _RARE_
- O
nt O
TE _RARE_
( O
TE105 _RARE_
) O
forms O
a O
cruciform _RARE_
secondary O
structure _RARE_
containing O
four O
helices O
connected O
by O
single O
- O
stranded _RARE_
regions O
. O

Tele _RARE_
- O
Talk _RARE_
has O
the O
extra _RARE_
capability _RARE_
of O
operating O
in O
live O
conference _RARE_
situations O
using O
microphone _RARE_
input O
. O

A O
marked O
decrease O
in O
the O
type I-GENE
1 I-GENE
insulin I-GENE
- I-GENE
like I-GENE
growth I-GENE
factor I-GENE
( I-GENE
IGF I-GENE
) I-GENE
receptor I-GENE
( O
IGF I-GENE
- I-GENE
IR I-GENE
) O
occurs O
in O
prostate _RARE_
epithelial _RARE_
cells O
during _RARE_
transformation O
from O
the O
benign O
to O
the O
metastatic O
state O
. O

The O
P69 _RARE_
cell O
line O
was O
derived O
by O
immortalization _RARE_
of O
human O
primary _RARE_
prostate _RARE_
epithelial _RARE_
cells O
with O
simian I-GENE
virus I-GENE
- I-GENE
40 I-GENE
T I-GENE
antigen I-GENE
and O
is O
rarely O
tumorigenic O
. O

We O
determined O
whether O
the O
human I-GENE
StAR _RARE_
promoter I-GENE
is O
responsive O
to O
sterol I-GENE
regulatory I-GENE
element I-GENE
- I-GENE
binding I-GENE
proteins I-GENE
( O
SREBPs _RARE_
). O

Expression O
of O
SREBP I-GENE
- I-GENE
1a _RARE_
stimulated _RARE_
StAR _RARE_
promoter I-GENE
activity O
in O
the O
context O
of O
COS O
- O
1 O
cells O
and O
human O
granulosa _RARE_
- O
lutein _RARE_
cells O
. O

Because O
the O
high I-GENE
- I-GENE
density I-GENE
lipoprotein I-GENE
receptor I-GENE
( O
HDL _RARE_
- I-GENE
R I-GENE
) O
is O
a O
key O
element O
in O
cholesterol O
homeostasis _RARE_
and O
a O
potential _RARE_
therapeutic O
target O
for _RARE_
hypercholesterolemic _RARE_
drugs O
, O
an O
understanding O
of O
HDL _RARE_
- I-GENE
R I-GENE
regulation _RARE_
is O
essential O
. O

IFN I-GENE
- I-GENE
stimulated _RARE_
gene I-GENE
factor I-GENE
- I-GENE
3 I-GENE
and O
STAT1 I-GENE
homodimers I-GENE
formed O
and O
bound _RARE_
an O
IFN I-GENE
- I-GENE
stimulated _RARE_
response I-GENE
element I-GENE
( O
ISRE _RARE_
) O
and O
gamma I-GENE
- I-GENE
activated I-GENE
sequence I-GENE
( O
GAS _RARE_
) O
element O
, O
respectively O
. O

We O
have O
therefore O
studied O
the O
molecular _RARE_
mechanisms O
of O
TGF I-GENE
- I-GENE
beta1 I-GENE
action O
on O
thyroglobulin _RARE_
( O
TG I-GENE
) O
gene O
expression _RARE_
by O
focusing O
our O
attention O
on O
TGF I-GENE
- I-GENE
beta1 I-GENE
regulation _RARE_
of O
thyroid O
- O
specific O
transcription O
factors O
. O

The O
epitope _RARE_
- O
protected O
lysine _RARE_
( O
K O
) O
was O
present O
in O
a O
30 _RARE_
- I-GENE
aa _RARE_
TPO _RARE_
fragment I-GENE
that O
, O
by O
N O
- O
terminal O
sequencing O
, O
was O
found O
to O
be O
K713 _RARE_
. O

To O
understand O
the O
molecular _RARE_
regulation _RARE_
of O
these O
genes O
in O
thyroid O
cells O
, O
the O
effect O
of O
thyroid I-GENE
transcription I-GENE
factor I-GENE
1 I-GENE
( O
TTF I-GENE
- I-GENE
1 I-GENE
) O
and O
the O
paired I-GENE
domain I-GENE
- I-GENE
containing I-GENE
protein I-GENE
8 I-GENE
( O
Pax I-GENE
- I-GENE
8 I-GENE
) O
on O
the O
transcriptional O
activity O
of O
the O
deiodinase I-GENE
promoters I-GENE
were O
studied O
. O
